{"meta":{"query_hash":"40235122e924","filters":{"venue":"Annals of the Rheumatic Diseases"},"cohort_total":2612,"direct_labels_cover":7,"predictions_cover":2612,"exported":2612,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/40235122e924","api":"https://metacan.xera.ac/api/v1/cohort?venue=Annals+of+the+Rheumatic+Diseases"},"results":[{"id":"W1483015171","doi":"","title":"The spondyloarthritis research consortium of Canada (SPARCC) magnetic resonance imaging (MRI) index: A new scoring system for the evaluation of sacroiliac joint inflammation in spondyloarthritis","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axial spondyloarthritis; Magnetic resonance imaging; Sacroiliac joint; Ankylosing spondylitis; Index (typography); Sacroiliitis; Radiology; Internal medicine","score_opus":0.07279603073873904,"score_gpt":0.34349319511957715,"score_spread":0.27069716438083813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1483015171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87605125,0.115758136,0.00001783034,0.00506599,0.00026083118,0.0024839316,0.00017099778,0.000009589271,0.00018142923],"genre_scores_gemma":[0.9962064,0.0032686815,0.000041861982,0.000028168379,0.000045467033,0.00030742644,0.000008249979,0.00002203087,0.0000717118],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964906,0.0002997161,0.00097565464,0.00024317791,0.001526853,0.0004640295],"domain_scores_gemma":[0.9967107,0.0009785087,0.00044047672,0.0007122893,0.0010519825,0.00010605067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001960665,0.00018480112,0.00051141315,0.00012546836,0.00037689004,0.00002669306,0.0002795135,0.000034790293,0.00001924108],"category_scores_gemma":[0.0027364097,0.00011293456,0.00020034412,0.0005401715,0.00043246383,0.00010030421,0.0001264704,0.00013443934,8.534613e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002245662,0.00043812033,0.061259616,0.0022066862,0.00035103134,0.000036646146,0.0021696803,0.0036426266,0.000607754,0.00550818,0.0035819444,0.91795206],"study_design_scores_gemma":[0.01206493,0.00048922544,0.938386,0.018613374,0.00035864202,0.000052957817,0.0068868985,0.0025920542,0.01245873,0.006993381,0.0008790117,0.0002247796],"about_ca_topic_score_codex":0.07614458,"about_ca_topic_score_gemma":0.109760664,"teacher_disagreement_score":0.9177273,"about_ca_system_score_codex":0.0002239988,"about_ca_system_score_gemma":0.0020452866,"threshold_uncertainty_score":0.93000746},"labels":[],"label_agreement":null},{"id":"W1499124767","doi":"10.1136/ard.2006.061937","title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Statement (logic); MEDLINE; Intensive care medicine","score_opus":0.0748275383078571,"score_gpt":0.35219157579483085,"score_spread":0.27736403748697375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499124767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692515,0.021493804,0.000030780313,0.0051148813,0.00015391079,0.002173241,0.0015776518,0.0000386387,0.00016559345],"genre_scores_gemma":[0.9748399,0.023976294,0.00005239541,0.00018568081,0.000030049932,0.00024816013,0.00020002449,0.000022670563,0.00044480237],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99790245,0.00018897973,0.00074822136,0.00022717302,0.00052931206,0.00040383343],"domain_scores_gemma":[0.99760234,0.000986394,0.0003583348,0.00067039195,0.00021872946,0.00016381661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018440043,0.00025037228,0.0006010118,0.00008245629,0.00019413802,0.00002593166,0.00025270303,0.00004040673,0.00029015206],"category_scores_gemma":[0.0003749518,0.0001160724,0.00051403977,0.00017355433,0.0005039496,0.00002965756,0.000038338494,0.00004458331,0.000016449474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009896955,0.028997254,0.07942201,0.0015699188,0.0064565167,0.00003318854,0.00086827425,0.0018090246,0.0003093968,0.01644723,0.5337665,0.3204237],"study_design_scores_gemma":[0.017306734,0.009638251,0.85947186,0.004204436,0.00040451504,0.000022304132,0.0013410647,0.0046259575,0.0064213127,0.024472272,0.07142869,0.0006626144],"about_ca_topic_score_codex":0.00034460015,"about_ca_topic_score_gemma":0.000017350718,"teacher_disagreement_score":0.78004986,"about_ca_system_score_codex":0.000036652265,"about_ca_system_score_gemma":0.00015311313,"threshold_uncertainty_score":0.4733295},"labels":[],"label_agreement":null},{"id":"W1633990863","doi":"10.1136/annrheumdis-2015-eular.1944","title":"OP0056 Macitentan in Patients with Digital Ulcers Associated with Systemic Sclerosis: Results from the Dual-1 and Dual-2 Randomised Controlled Trials","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital","funders":"","keywords":"Medicine; Dual (grammatical number); Clinical trial; Randomized controlled trial; Internal medicine","score_opus":0.06506909773404859,"score_gpt":0.26722840372395684,"score_spread":0.20215930598990825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1633990863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985862,0.007728067,0.0000013879248,0.0010514364,0.00012480143,0.003687047,0.0013218042,0.000041797146,0.00018161736],"genre_scores_gemma":[0.99866533,0.000513099,0.000003145444,0.000283059,0.00003302692,0.00014722388,0.00022239465,0.00003404093,0.00009867987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959127,0.00094742794,0.0015130613,0.00033663155,0.0009856919,0.00030450014],"domain_scores_gemma":[0.9932399,0.0039055003,0.0014496051,0.0006142235,0.0004445868,0.00034618948],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016293197,0.00033020138,0.0019384775,0.00009009384,0.000094344934,0.00013088975,0.00017291139,0.00009690585,0.000010956439],"category_scores_gemma":[0.015682407,0.00012716214,0.00036535575,0.00033428174,0.00027729906,0.0001951118,0.00006430017,0.00012019678,0.000003798363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.315626,0.0032203277,0.64169025,0.0003065772,0.01197741,0.000022465998,0.0038796137,0.00051893067,0.00004718921,0.000031047435,0.016965382,0.0057148067],"study_design_scores_gemma":[0.30065885,0.000482447,0.6615686,0.031147178,0.0023233574,0.0000048056027,0.0032260022,0.00023646561,0.00003426357,0.000084096486,0.0000025554543,0.00023140268],"about_ca_topic_score_codex":0.00016243588,"about_ca_topic_score_gemma":0.000010149014,"teacher_disagreement_score":0.030840602,"about_ca_system_score_codex":0.000053144744,"about_ca_system_score_gemma":0.00027751274,"threshold_uncertainty_score":0.9926089},"labels":[],"label_agreement":null},{"id":"W1895520487","doi":"10.1136/annrheumdis-2015-207546","title":"Recommendations for the management of autoinflammatory diseases","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children","funders":"Executive Agency for Health and Consumers; Rosetrees Trust","keywords":"Medicine; Rheumatology; Rheumatism; Anakinra; Familial Mediterranean fever; Canakinumab; Alternative medicine; Family medicine; Intensive care medicine; Physical therapy; Internal medicine; Disease; Pathology","score_opus":0.08521083827468794,"score_gpt":0.3690985710055719,"score_spread":0.28388773273088397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895520487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047300888,0.9970067,0.00004757318,0.00033057455,0.00026164006,0.0012360753,0.0008345681,0.0000064194646,0.00022914243],"genre_scores_gemma":[0.00016547278,0.99785185,0.00005163741,0.000058029145,0.00003515981,0.00040938405,0.000529824,0.000034858116,0.00086377363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986632,0.00012436547,0.0006382347,0.0001979146,0.00018328773,0.00019303555],"domain_scores_gemma":[0.9980309,0.00009487365,0.0006835026,0.00096752803,0.00017105357,0.000052147265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023026645,0.00024925597,0.00062533875,0.000040380914,0.00010971903,0.000015293119,0.00081513607,0.00008121519,0.000023918503],"category_scores_gemma":[0.00012313432,0.00013809674,0.0010214857,0.00011785245,0.00016936901,0.000005129414,0.00030493387,0.00004715401,0.000004791715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022673503,0.00012041692,0.00000401254,0.014506497,0.0017816196,1.1497889e-7,0.000018366685,0.000011566819,3.412253e-7,0.00049011176,0.06614501,0.91689926],"study_design_scores_gemma":[0.00019658096,0.00005183751,0.00006156512,0.0057603195,0.0018432346,7.724051e-7,0.00016015142,0.000006788564,0.000023234003,0.0005418326,0.9911861,0.0001675724],"about_ca_topic_score_codex":0.0000040317577,"about_ca_topic_score_gemma":9.4343903e-7,"teacher_disagreement_score":0.9250411,"about_ca_system_score_codex":0.000006095276,"about_ca_system_score_gemma":0.0002459444,"threshold_uncertainty_score":0.5631422},"labels":[],"label_agreement":null},{"id":"W1920228500","doi":"10.1136/annrheumdis-2015-207653","title":"Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Santen; Eli Lilly and Company","keywords":"Medicine; Placebo; Double blind; Systemic reaction; Lupus erythematosus; Systemic disease; Internal medicine; Dermatology; Clinical trial; Surgery; Physical therapy; Immunology; Immunopathology; Alternative medicine; Antibody; Pathology; Allergy","score_opus":0.044644839080855134,"score_gpt":0.3185217653247155,"score_spread":0.27387692624386034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920228500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98085356,0.0021839738,0.000008130163,0.00012513141,0.00018175754,0.016110903,0.00030367746,0.000042651183,0.00019021542],"genre_scores_gemma":[0.99901545,0.00015217849,0.00003164119,0.000017373834,0.000022215901,0.00030764783,0.00008425557,0.000059339847,0.00030987512],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941149,0.00078567694,0.0022353425,0.0005922165,0.0017283766,0.00054349634],"domain_scores_gemma":[0.99348336,0.0024683543,0.0013253201,0.0013446204,0.0008647515,0.0005136046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015423879,0.00047367552,0.002451767,0.00034060955,0.00008071721,0.000039184935,0.00048707635,0.00011092992,0.000028777262],"category_scores_gemma":[0.0034075018,0.00027519814,0.00026196128,0.0005091059,0.00032346437,0.00015717518,0.00023347257,0.00021255256,0.000008364146],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88909554,0.009927722,0.08482693,0.0010699647,0.0016281985,0.000079766076,0.012085759,0.00013048161,0.000009452871,0.0000057482516,0.00034035507,0.0008000982],"study_design_scores_gemma":[0.96819496,0.0023217464,0.0027060274,0.009279278,0.0010249823,0.00040893164,0.014352163,0.0013400016,0.00006687215,0.000024755474,0.0000025618506,0.0002777116],"about_ca_topic_score_codex":0.0006817121,"about_ca_topic_score_gemma":0.00006914978,"teacher_disagreement_score":0.0821209,"about_ca_system_score_codex":0.000107140804,"about_ca_system_score_gemma":0.0004463888,"threshold_uncertainty_score":0.99997},"labels":[],"label_agreement":null},{"id":"W1930289245","doi":"10.1136/annrheumdis-2014-206504","title":"The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Mount Sinai Hospital; Western University; University of Calgary; University of Manitoba; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Prospective cohort study; Cohort; Confounding; Gastroenterology; Surgery; Toxicity","score_opus":0.1268715213645007,"score_gpt":0.3898055074003745,"score_spread":0.2629339860358738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1930289245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9339222,0.06304684,0.00006116444,0.0006072742,0.0002940975,0.0017066959,0.00020401251,0.00001528404,0.00014247751],"genre_scores_gemma":[0.9359349,0.063684255,0.00007527178,0.000007917182,0.00001078259,0.00020707032,0.000009960602,0.000018474637,0.000051346142],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978295,0.0005926646,0.00052315183,0.00016477548,0.0005716582,0.00031827533],"domain_scores_gemma":[0.99263686,0.0055297934,0.00036738437,0.0006651552,0.0006314782,0.00016932112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000749535,0.0002069233,0.00079361344,0.000051574036,0.00019643319,0.000028327791,0.00034945368,0.00003547125,0.000014062709],"category_scores_gemma":[0.0009352539,0.000092772396,0.00049981853,0.00021165072,0.00088462146,0.00007552343,0.000050798022,0.000056617053,0.0000044818753],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13311033,0.0068437723,0.017213402,0.001545009,0.016223684,0.000024699364,0.02032818,0.0007348936,0.0010527775,0.020246632,0.0067768544,0.77589977],"study_design_scores_gemma":[0.117373005,0.11191203,0.33699235,0.025109557,0.0010483352,0.00031465388,0.034341533,0.006481746,0.251575,0.07319039,0.039761674,0.0018997238],"about_ca_topic_score_codex":0.0005290258,"about_ca_topic_score_gemma":0.000081524144,"teacher_disagreement_score":0.77400005,"about_ca_system_score_codex":0.000026132524,"about_ca_system_score_gemma":0.00028943867,"threshold_uncertainty_score":0.37831485},"labels":[],"label_agreement":null},{"id":"W1963872077","doi":"10.1136/ard.2003.006163","title":"Seronegative antiphospholipid syndrome","year":2003,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Ultrasound; Radiological weapon; Ultrasonography; Radiology; Pediatrics","score_opus":0.05980015102628243,"score_gpt":0.32620535807211704,"score_spread":0.2664052070458346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963872077","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24506277,0.010535031,0.000008676561,0.7342691,0.0012166097,0.0029198616,0.00061415514,0.00011003113,0.00526379],"genre_scores_gemma":[0.19054067,0.002744819,0.00013688828,0.74797535,0.00059770996,0.00033747053,0.0003114026,0.000378515,0.056977194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959744,0.00044437256,0.00082724384,0.00044892542,0.0016460323,0.0006590235],"domain_scores_gemma":[0.99630153,0.0006173551,0.0006424785,0.0018094914,0.00043951612,0.00018962973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003417136,0.00045792482,0.0014115579,0.00021785563,0.00010060672,0.00003691161,0.0007261145,0.00040589058,0.00081415253],"category_scores_gemma":[0.0015423499,0.00028211254,0.0008267622,0.00046077196,0.0004382661,0.000079194506,0.00020424911,0.0008991895,0.00028900045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042098476,0.00014518834,0.0042394735,0.008956407,0.00095018256,0.0002413947,0.00018371815,0.0000011202081,0.0000026504638,0.000022335313,0.9847378,0.00047763487],"study_design_scores_gemma":[0.008244699,0.001659219,0.033602364,0.13353892,0.004596224,0.048487704,0.0023183778,0.00018111021,0.0035431758,0.012635335,0.74797964,0.0032132163],"about_ca_topic_score_codex":0.00008934042,"about_ca_topic_score_gemma":7.8048953e-7,"teacher_disagreement_score":0.23675814,"about_ca_system_score_codex":0.00006523463,"about_ca_system_score_gemma":0.00063779694,"threshold_uncertainty_score":0.9999631},"labels":[],"label_agreement":null},{"id":"W1965219192","doi":"10.1136/annrheumdis-2012-eular.944","title":"AB0944 Baseline serum 14-3-3 ETA levels predict ACR50 response to adalimumab therapy in psoriatic arthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Achieve Life Sciences (Canada)","funders":"","keywords":"Adalimumab; Medicine; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Receiver operating characteristic; Arthritis; Etanercept; Gastroenterology; Oncology","score_opus":0.037572651348766715,"score_gpt":0.3222120095141855,"score_spread":0.2846393581654188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965219192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897254,0.0056120604,0.00017234664,0.003726309,0.00036020408,0.0006171329,0.00045352615,0.00001652735,0.0000693463],"genre_scores_gemma":[0.9970166,0.0011071984,0.00019605587,0.00088141975,0.00013658678,0.0001503265,0.000022127593,0.00003300015,0.00045666168],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980316,0.0005682795,0.00047648908,0.00023836766,0.00028063156,0.00040459578],"domain_scores_gemma":[0.9984569,0.000193956,0.00018709342,0.00082142017,0.00013917533,0.00020146614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008164499,0.00020752614,0.00026916168,0.00009205128,0.000077724566,0.00002475996,0.00043057982,0.000086136715,0.0002115707],"category_scores_gemma":[0.0026426434,0.00016074812,0.00021563793,0.00021259881,0.000075115364,0.000023590022,0.00017992796,0.00009021318,0.000037356815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011769959,0.004948492,0.053101115,0.00053103315,0.0017218835,0.000009861092,0.0036881058,0.0019593514,0.17380539,0.00033356974,0.10309054,0.6450407],"study_design_scores_gemma":[0.0028929086,0.0010620198,0.70976055,0.0016311873,0.000063161446,0.000026945294,0.0005544081,0.00014077402,0.25218353,0.0009813173,0.029997552,0.0007056223],"about_ca_topic_score_codex":0.00005495361,"about_ca_topic_score_gemma":0.00003370383,"teacher_disagreement_score":0.6566595,"about_ca_system_score_codex":0.0000134501925,"about_ca_system_score_gemma":0.00013183696,"threshold_uncertainty_score":0.6555118},"labels":[],"label_agreement":null},{"id":"W1965584489","doi":"10.1136/ard.2006.060269","title":"Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon γ","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"Canadian Institutes of Health Research; Arthritis Society","keywords":"STAT1; Molecular biology; IRF1; Gene knockdown; STAT protein; Small interfering RNA; Transfection; Activator (genetics); Interferon; Gene expression; Receptor; Chemistry; Signal transduction; Medicine; Biology; STAT3; Cell biology; Internal medicine; Gene; Immunology; Biochemistry","score_opus":0.021037175516412866,"score_gpt":0.29554180932096674,"score_spread":0.27450463380455387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965584489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716544,0.0015838281,0.000009631285,0.00018797345,0.000052694257,0.00059151696,0.000047875707,0.000022601127,0.0003384247],"genre_scores_gemma":[0.9992271,0.000041853735,0.00006751077,0.000034529832,0.000013475657,0.000058379253,0.000089064684,0.000017644341,0.00045040782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988197,0.00008036639,0.0005039243,0.00016254545,0.0002655338,0.0001679216],"domain_scores_gemma":[0.9992558,0.00003961534,0.0002667094,0.00031608134,0.00006308589,0.000058733858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010048371,0.00015720031,0.00040985813,0.00012459533,0.00003547739,0.000009649804,0.000100075085,0.000053618238,0.0001065041],"category_scores_gemma":[0.0000721684,0.00010700652,0.00020336019,0.00013560263,0.000058569978,0.00012464942,0.00006807414,0.0000650452,0.0000046119594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038276275,0.0014727566,0.0013118349,0.00058287557,0.000038886916,0.000015256233,0.0002484778,0.000004158041,0.9869126,0.00029405454,0.0015987909,0.0071375193],"study_design_scores_gemma":[0.0021050076,0.000997389,0.0027641205,0.004538133,0.00008317305,0.0000059177837,0.00022455206,0.000013765508,0.98563325,0.0035272427,0.000013230157,0.00009420807],"about_ca_topic_score_codex":0.0002720866,"about_ca_topic_score_gemma":0.000049829996,"teacher_disagreement_score":0.0070433114,"about_ca_system_score_codex":0.00002127664,"about_ca_system_score_gemma":0.000024810666,"threshold_uncertainty_score":0.4363599},"labels":[],"label_agreement":null},{"id":"W1966477053","doi":"10.1136/annrheumdis-2015-207620","title":"Response to: ‘Does it make sense to investigate whether the offspring of people with a total knee replacement for severe primary knee osteoarthritis have a higher risk of worsening knee pain?’ by Lei et al","year":2015,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Knee pain; Offspring; Physical therapy; Knee replacement; Knee Joint; Physical medicine and rehabilitation; Orthopedic surgery; Surgery; Alternative medicine; Pregnancy; Pathology","score_opus":0.02085518362092116,"score_gpt":0.2665127339359744,"score_spread":0.24565755031505326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966477053","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7201098,0.0011635929,0.000031550775,0.27153105,0.00024990138,0.0042207837,0.0024768673,0.000042418596,0.00017404607],"genre_scores_gemma":[0.46937066,0.00017621036,0.0033385963,0.49347797,0.00026437966,0.0023555881,0.00071415014,0.00044660742,0.02985582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955295,0.0012115024,0.0009421228,0.00056373473,0.0011797572,0.00057339866],"domain_scores_gemma":[0.99476904,0.002100434,0.0009766197,0.0013667232,0.00048479263,0.00030237937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019878685,0.0005945647,0.0013524804,0.00020224023,0.00013162575,0.000042996286,0.00022882484,0.00019876704,0.00009724052],"category_scores_gemma":[0.0019801522,0.00033512566,0.0005272868,0.00024569052,0.0002074743,0.00008796441,0.00027677513,0.00042600158,0.0000057556786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018697996,0.0004219874,0.0025894267,0.001916667,0.0016253731,0.00006311854,0.006406523,0.00010106995,0.00094858126,0.000013698744,0.9438091,0.023406457],"study_design_scores_gemma":[0.045911703,0.08623183,0.018575061,0.09269675,0.009852674,0.00040970076,0.01320912,0.00014494936,0.013162457,0.0021312127,0.71368587,0.0039886986],"about_ca_topic_score_codex":0.00023156799,"about_ca_topic_score_gemma":0.00013344748,"teacher_disagreement_score":0.25073913,"about_ca_system_score_codex":0.00006469254,"about_ca_system_score_gemma":0.00052949245,"threshold_uncertainty_score":0.99991006},"labels":[],"label_agreement":null},{"id":"W1967599448","doi":"10.1136/annrheumdis-2014-206404","title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Leids Universitair Medisch Centrum; Cambridge University Hospitals; National Institute for Health and Care Research; GlaxoSmithKline; Biogen; Universiteit Leiden; University of Cambridge; NIHR Cambridge Biomedical Research Centre; Royal Adelaide Hospital; Wellcome Trust","keywords":"Rituximab; Medicine; Cyclophosphamide; Azathioprine; Internal medicine; Vasculitis; Immunosuppression; Gastroenterology; Microscopic polyangiitis; Anti-neutrophil cytoplasmic antibody; Surgery; Immunology; Chemotherapy; Lymphoma; Disease","score_opus":0.05460857334095061,"score_gpt":0.31307523583244473,"score_spread":0.25846666249149414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967599448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906725,0.0027191949,0.0000026614623,0.0018882081,0.0004206123,0.0010764531,0.0003166835,0.000031023857,0.0028726219],"genre_scores_gemma":[0.9987757,0.0007061709,0.000036907422,0.00006365216,0.000033238968,0.000050938655,0.00009717508,0.000015278185,0.00022093883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99792266,0.00025242046,0.00085302984,0.00018107593,0.00054897607,0.00024183934],"domain_scores_gemma":[0.9982429,0.0004081073,0.00041903675,0.0004786363,0.00024839034,0.00020291006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062068447,0.00014719198,0.0007291286,0.00010485454,0.000039296472,0.000009476713,0.00018418963,0.00009929797,0.000057049492],"category_scores_gemma":[0.0064737205,0.00009797271,0.0005534638,0.0004033384,0.00016591833,0.00007682387,0.00005319967,0.00013610942,0.0000129366135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8850191,0.010116808,0.0017456909,0.0005449325,0.0050588627,0.000064506115,0.0034740416,0.000704223,0.000045210043,0.0014453994,0.08076998,0.011011215],"study_design_scores_gemma":[0.956163,0.00096270203,0.03464434,0.0026159678,0.0007741495,0.000003043771,0.00054380624,0.00019812812,0.0003968117,0.0032812965,0.0002481053,0.00016864894],"about_ca_topic_score_codex":0.00032965426,"about_ca_topic_score_gemma":0.000025745032,"teacher_disagreement_score":0.080521874,"about_ca_system_score_codex":0.000035336103,"about_ca_system_score_gemma":0.00037997973,"threshold_uncertainty_score":0.77501154},"labels":[],"label_agreement":null},{"id":"W1969693005","doi":"10.1136/ard.2004.032615","title":"OMERACT 7 psoriatic arthritis workshop: synopsis","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Psoriatic arthritis; Medicine; Clinical trial; Delphi method; Delphi; Rheumatology; Arthritis; Physical therapy; Alternative medicine; Internal medicine; Family medicine; Pathology; Artificial intelligence","score_opus":0.11170052615810562,"score_gpt":0.41390707292101575,"score_spread":0.30220654676291014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969693005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009849,0.99568176,0.00000288182,0.00093034253,0.0001882184,0.0013992458,0.00010745589,0.00005227881,0.0015393354],"genre_scores_gemma":[0.0002767292,0.9959526,0.00002754278,0.00022358987,0.00011705833,0.00019937054,0.000092725546,0.000086413536,0.0030239606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964574,0.00034152146,0.0014750618,0.0003468956,0.00086993957,0.0005091935],"domain_scores_gemma":[0.99657726,0.000654483,0.0008756651,0.0014686049,0.00018415805,0.00023983023],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038297952,0.00048670548,0.003008225,0.0002740027,0.00014302002,0.00004977002,0.00069000147,0.00021761394,0.0014158809],"category_scores_gemma":[0.002136202,0.00029520475,0.0020305533,0.00064204313,0.00026010594,0.00014450653,0.00026057742,0.00045089115,0.00040663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017194903,0.00033355018,0.000006834558,0.024023965,0.00090150186,0.000008714122,0.000045785753,0.0000015790293,1.285537e-8,0.00009157555,0.030763248,0.94380605],"study_design_scores_gemma":[0.00034636832,0.000055237513,0.00021748501,0.10625316,0.0012639409,0.000034655,0.00006766591,0.000018505887,7.2682275e-7,0.00019141384,0.89128375,0.00026708253],"about_ca_topic_score_codex":0.000016029058,"about_ca_topic_score_gemma":0.0000025746738,"teacher_disagreement_score":0.94353896,"about_ca_system_score_codex":0.000039530947,"about_ca_system_score_gemma":0.0010363521,"threshold_uncertainty_score":0.99995},"labels":[],"label_agreement":null},{"id":"W1974429147","doi":"10.1136/annrheumdis-2014-eular.2210","title":"THU0416 Attrition Bias in Rheumatoid Arthritis Randomised Trials with Different Modified Intention-To-Treat Approaches: A Meta-Epidemiological Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Population; Rheumatoid arthritis; Meta-analysis; Internal medicine; Intention-to-treat analysis; Sample size determination; Physical therapy; Imputation (statistics); Study heterogeneity; Missing data; Statistics","score_opus":0.6572351615281036,"score_gpt":0.44747438123377986,"score_spread":0.2097607802943237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974429147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457786,0.0005577875,0.04773262,0.0009078414,0.000040020634,0.004547081,0.000058239202,0.0001901363,0.00018766335],"genre_scores_gemma":[0.99482375,0.000497969,0.0024047112,0.0001434373,0.0000103230095,0.0020306432,0.0000133119365,0.000037550988,0.000038294053],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99232614,0.0042371014,0.0019797503,0.00047047794,0.0005766143,0.00040990443],"domain_scores_gemma":[0.9866925,0.010833746,0.0011123366,0.000990726,0.00017682964,0.0001938524],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0050612288,0.0005110107,0.0031926022,0.00022062649,0.00010218041,0.000051840783,0.00055886805,0.000094773,0.00009092163],"category_scores_gemma":[0.033633053,0.00024221106,0.00085681217,0.00035311352,0.00018752142,0.0001815049,0.0001820125,0.0001852763,0.0000045936545],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049207836,0.066729434,0.09167966,0.006591593,0.020461792,0.00004156403,0.012112012,0.0061140787,0.0004670206,0.4710855,0.016228653,0.25928086],"study_design_scores_gemma":[0.015849346,0.0015384281,0.023208547,0.003472989,0.0012486029,0.000008746874,0.001630544,0.002030072,0.0023899353,0.94789886,0.000008056888,0.00071586703],"about_ca_topic_score_codex":0.00009714511,"about_ca_topic_score_gemma":0.00010068565,"teacher_disagreement_score":0.47681338,"about_ca_system_score_codex":0.000032299024,"about_ca_system_score_gemma":0.000031430467,"threshold_uncertainty_score":0.98770803},"labels":[{"model":"gemma","categories":["metaresearch","metaepi_broad","metaepi_narrow"],"domain":"methods","study_design":"meta_analysis","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch","metaepi_narrow","metaepi_broad"],"domain":"methods","study_design":"meta_analysis","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W1981498496","doi":"10.1136/ard.2004.034165","title":"Psoriatic arthritis assessment tools in clinical trials","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Dactylitis; Psoriatic arthritis; Enthesitis; Clinical trial; Psoriasis; Physical therapy; Ankylosing spondylitis; Rheumatology; Quality of life (healthcare); Secukinumab; Rheumatoid arthritis; Intensive care medicine; Internal medicine; Dermatology","score_opus":0.4107648613109914,"score_gpt":0.5528628719041665,"score_spread":0.14209801059317512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981498496","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035283502,0.9944602,0.0000012279506,0.00056414935,0.00062278437,0.0027172614,0.0005349348,0.00002346182,0.0007230992],"genre_scores_gemma":[0.0008969372,0.9977164,0.00011381632,0.00021183593,0.0002329032,0.000421516,0.00012361453,0.00004786872,0.00023506716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931532,0.0017066634,0.003778516,0.0004092195,0.0005739639,0.00037841292],"domain_scores_gemma":[0.99352056,0.0034722644,0.0017439065,0.00094942586,0.00010082991,0.00021302293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023867332,0.00047113805,0.006512968,0.00015969008,0.00007091762,0.00003964583,0.00031240596,0.00020344759,0.00036778965],"category_scores_gemma":[0.0073071327,0.00026606536,0.0032564558,0.00034435888,0.00016801145,0.00008126311,0.0001920401,0.0003204905,0.00006521065],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031206462,0.0012714833,0.0002875492,0.0064612376,0.0015768039,0.000030716543,0.000013855377,3.2647e-7,1.0005196e-9,0.00017174549,0.0047638575,0.9853912],"study_design_scores_gemma":[0.0044521457,0.00045246267,0.017459339,0.20774917,0.005412399,0.000045385095,0.000058194684,0.0000066439557,1.2570968e-7,0.000546721,0.76343507,0.00038232259],"about_ca_topic_score_codex":0.000030419278,"about_ca_topic_score_gemma":0.000023108796,"teacher_disagreement_score":0.9850089,"about_ca_system_score_codex":0.00006434477,"about_ca_system_score_gemma":0.0007258269,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W1984243932","doi":"10.1136/annrheumdis-2013-204448","title":"Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Waterloo; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psoriatic arthritis; Obesity; Psoriasis; Arthritis; Physical therapy; Disease; Internal medicine; Dermatology","score_opus":0.011661494380720677,"score_gpt":0.23529218826792458,"score_spread":0.2236306938872039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984243932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976876,0.00027032103,0.000013887629,0.00037270904,0.000040918636,0.0011591746,0.00035941906,0.000030013189,0.00006595591],"genre_scores_gemma":[0.99962467,0.000082153856,0.000032585136,0.00007443246,0.000006791817,0.000055843648,0.000027975848,0.000024711626,0.000070838374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815565,0.00018643303,0.0003687239,0.00029422427,0.00065802113,0.00033694998],"domain_scores_gemma":[0.99777067,0.00023270518,0.0005466839,0.0005925492,0.000609564,0.00024785756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001771761,0.00025854842,0.00071904704,0.000048582206,0.00015201213,0.000015533946,0.00013058144,0.000029997529,0.0000537378],"category_scores_gemma":[0.00151102,0.00015021344,0.00020206351,0.00030148766,0.00040645205,0.00016325555,0.000100452016,0.00007803645,0.0000012745469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029204134,0.004491087,0.9812095,0.00058410125,0.00087108894,0.0000075195726,0.0003046453,0.000014126084,7.0638737e-7,0.000018735132,0.0001682022,0.009409885],"study_design_scores_gemma":[0.004879601,0.0014672675,0.98887134,0.003393269,0.0004918461,3.7700923e-7,0.0000622166,0.00012259393,0.00005498575,0.00050056184,0.0000031014138,0.00015281508],"about_ca_topic_score_codex":0.00015459019,"about_ca_topic_score_gemma":0.000113749586,"teacher_disagreement_score":0.00925707,"about_ca_system_score_codex":0.000039382445,"about_ca_system_score_gemma":0.0001527316,"threshold_uncertainty_score":0.61255264},"labels":[],"label_agreement":null},{"id":"W1985380203","doi":"10.1136/ard.2007.080960","title":"Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Dutch Arthritis Association","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Rheumatology; Internal medicine; Autoantibody; Rheumatoid factor; Gastroenterology; Antibody; Immunology; Pathology","score_opus":0.03733941556840234,"score_gpt":0.36221755226661284,"score_spread":0.32487813669821053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985380203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954053,0.001883406,0.0005048213,0.0014899108,0.000078721925,0.00049740466,0.00010965587,0.000009547294,0.000021243784],"genre_scores_gemma":[0.998207,0.0014770789,0.00016888048,0.000027139775,0.000006021118,0.0000082531515,0.0000035860703,0.000012025785,0.00009007067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818426,0.0003252915,0.00067887123,0.0001319785,0.0005144696,0.00016512007],"domain_scores_gemma":[0.99789995,0.00080045353,0.00039618142,0.00042346853,0.00033612453,0.000143838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021889298,0.000097823075,0.00038316418,0.00031236515,0.000042746393,0.000006328306,0.00014748954,0.000041579704,0.00004390057],"category_scores_gemma":[0.0038889886,0.00007371171,0.00011580646,0.00031316676,0.0003007142,0.00009152637,0.00006444599,0.000040439787,0.000002748373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05463461,0.0008794437,0.0010965153,0.0009203686,0.00036854824,0.0000032147743,0.0012146567,0.0000031578643,0.8544767,0.0010461877,0.0006493722,0.084707245],"study_design_scores_gemma":[0.0013436053,0.00079515035,0.23181018,0.0013827777,0.000026451675,0.000010083172,0.00091549166,0.00004191633,0.7615443,0.0019446607,0.000120132514,0.0000652412],"about_ca_topic_score_codex":0.00010743838,"about_ca_topic_score_gemma":0.000008754917,"teacher_disagreement_score":0.23071368,"about_ca_system_score_codex":0.0000099902,"about_ca_system_score_gemma":0.00012926251,"threshold_uncertainty_score":0.46557635},"labels":[],"label_agreement":null},{"id":"W1986926239","doi":"10.1136/ard.2004.034447","title":"A re-examination of the whiplash associated disorders (WAD) as a systemic illness","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Whiplash; Neck pain; Population; Physical therapy; Cohort; Injury prevention; Poison control; Injury Severity Score; Psychiatry; Physical medicine and rehabilitation; Emergency medicine; Internal medicine; Pathology; Alternative medicine","score_opus":0.014530238332043973,"score_gpt":0.2912924311248666,"score_spread":0.2767621927928226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986926239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952925,0.0007100897,0.000007953356,0.006974845,0.0001284064,0.00073736487,0.000021285692,0.000023213046,0.0018676012],"genre_scores_gemma":[0.9987418,0.00016546853,0.0000090057265,0.00025109018,0.000015824691,0.000030460256,0.0000102638005,0.000013040847,0.0007630517],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984558,0.0003657766,0.00043221426,0.000120759905,0.00048895413,0.00013645367],"domain_scores_gemma":[0.99847305,0.00043467028,0.0004008264,0.00044251443,0.000190709,0.00005824552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049396633,0.00011201827,0.00028706036,0.000057224024,0.000086661246,0.000006924361,0.00019676622,0.0000549931,0.0000759308],"category_scores_gemma":[0.0038043875,0.000058901333,0.00034555496,0.0003096316,0.0001815288,0.000079283804,0.00005194997,0.00006732837,0.000010105657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073533517,0.010137978,0.2319851,0.036324427,0.002979435,5.6581973e-7,0.03421996,0.0034259537,0.0039472543,0.0084734885,0.027454717,0.6403158],"study_design_scores_gemma":[0.000769741,0.00013361797,0.98736525,0.0049883546,0.00017684599,6.115524e-7,0.0026622715,0.0016874251,0.00048655496,0.0015392508,0.000086338,0.00010373889],"about_ca_topic_score_codex":0.000070294125,"about_ca_topic_score_gemma":0.000059652695,"teacher_disagreement_score":0.75538015,"about_ca_system_score_codex":0.000029386752,"about_ca_system_score_gemma":0.000093054085,"threshold_uncertainty_score":0.4554482},"labels":[],"label_agreement":null},{"id":"W1989876988","doi":"10.1136/annrheumdis-2014-205665","title":"The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pulmonary embolism; Deep vein; Giant cell arteritis; Population; Internal medicine; Rate ratio; Cohort; Venous thrombosis; Incidence (geometry); Thrombosis; Cohort study; Surgery; Confidence interval; Vasculitis; Disease","score_opus":0.015058491819356491,"score_gpt":0.2714701716334416,"score_spread":0.25641167981408514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989876988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624056,0.0019518195,0.000023616114,0.0011016546,0.00006182773,0.0004500183,0.000048622845,0.000009542754,0.000112360714],"genre_scores_gemma":[0.99890393,0.00087085617,0.00003607975,0.0000934983,0.000014715926,0.000035004086,0.000014349209,0.000010975366,0.00002059138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892944,0.00023260768,0.00036296927,0.00011804441,0.0002182379,0.00013868981],"domain_scores_gemma":[0.99908024,0.00021896797,0.00020131428,0.00036905365,0.00006117927,0.000069220005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020618095,0.000097765354,0.0003029651,0.000053905074,0.00014279301,0.000012927319,0.00010936951,0.000032538705,0.000022128243],"category_scores_gemma":[0.00018127511,0.000054008415,0.0001498751,0.00012747012,0.00008206684,0.000033321867,0.000031858726,0.00007709657,0.0000014944125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010162518,0.005553217,0.9406448,0.0006231334,0.0006470527,0.0000072347843,0.0013797786,0.0019943279,0.000104901905,0.000681271,0.00027933443,0.047983352],"study_design_scores_gemma":[0.00072437717,0.00020508801,0.9852924,0.00038879705,0.00032012886,0.0000020790123,0.00045429246,0.009600822,0.000032142456,0.0029131738,0.000006637517,0.00006011363],"about_ca_topic_score_codex":0.00062971277,"about_ca_topic_score_gemma":0.000064418804,"teacher_disagreement_score":0.047923237,"about_ca_system_score_codex":0.000005970571,"about_ca_system_score_gemma":0.000031867676,"threshold_uncertainty_score":0.22023992},"labels":[],"label_agreement":null},{"id":"W1992611800","doi":"10.1136/annrheumdis-2013-204835","title":"Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Memorial University of Newfoundland; Toronto Western Hospital; University of Alberta","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; U.S. Public Health Service; Versus Arthritis","keywords":"Medicine; Ankylosing spondylitis; Single-nucleotide polymorphism; SNP; Genotyping; Internal medicine; Pathology; Genotype; Genetics; Gene; Biology","score_opus":0.028577915614342527,"score_gpt":0.2951251993187899,"score_spread":0.26654728370444736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992611800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969966,0.007961253,0.0000014067639,0.0013795246,0.000030386698,0.0008703731,0.00003343784,0.0000041805642,0.000019781792],"genre_scores_gemma":[0.9964627,0.0033962012,0.000010992738,0.00005382632,0.0000046141167,0.000048674134,0.0000074193395,0.00000468549,0.000010899126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990874,0.00017478876,0.00035410072,0.00008002372,0.00021849615,0.000085187356],"domain_scores_gemma":[0.9992479,0.00018569951,0.00029289737,0.00015514753,0.0000876694,0.00003070476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043269258,0.00006950216,0.0003184278,0.00011317161,0.000048750207,0.0000051510583,0.000031007847,0.000020546582,0.000004804893],"category_scores_gemma":[0.00037036688,0.00004080262,0.000058607522,0.00022532475,0.000057750392,0.00007196799,0.000043718675,0.000024542293,1.5046325e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094012957,0.00088851654,0.89879006,0.00048417848,0.00037611532,0.0000012681961,0.0108255455,0.000008964685,0.00007108512,0.0004423924,0.00007241232,0.087099314],"study_design_scores_gemma":[0.003797878,0.00046186033,0.991979,0.0009431557,0.00022127405,0.0000032829037,0.0012931335,0.00031420085,0.00009309147,0.00084507617,0.000013622162,0.000034432018],"about_ca_topic_score_codex":0.00054372125,"about_ca_topic_score_gemma":0.00011840349,"teacher_disagreement_score":0.09318891,"about_ca_system_score_codex":0.0000096364265,"about_ca_system_score_gemma":0.0000038505796,"threshold_uncertainty_score":0.16638826},"labels":[],"label_agreement":null},{"id":"W1992960024","doi":"10.1136/annrheumdis-2011-200343","title":"The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review","year":2011,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Rheumatoid arthritis; Confounding; Physical therapy; Arthritis; Correlation; Meta-analysis; Inclusion and exclusion criteria; Internal medicine; Physical medicine and rehabilitation; Pathology; Alternative medicine","score_opus":0.1646405759135482,"score_gpt":0.366965523896305,"score_spread":0.2023249479827568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992960024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008430733,0.9932044,0.0000021547564,0.0009732353,0.000098313736,0.0045864675,0.00017876204,0.000031881453,0.000081696526],"genre_scores_gemma":[0.008928454,0.989848,0.000007166663,0.00008582675,0.00002423261,0.0008984351,0.00007795874,0.000048881004,0.00008104625],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9944369,0.0017077955,0.0023130176,0.0003907041,0.000702317,0.00044927056],"domain_scores_gemma":[0.99255496,0.0044585243,0.0010534594,0.0014785908,0.00016366332,0.00029082407],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0022259096,0.00046717166,0.0035223342,0.00011863831,0.00031872894,0.00007360578,0.00041794605,0.00013310209,0.000075461925],"category_scores_gemma":[0.01081383,0.00023260918,0.0010522085,0.00050077605,0.0009929109,0.00015905444,0.00027097168,0.0005219306,0.000044472592],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001937339,0.00020302211,0.0052165785,0.8593744,0.00057644106,0.0000028143875,0.00007055794,2.844317e-8,3.6562313e-9,0.0023499387,0.0019454268,0.13024141],"study_design_scores_gemma":[0.00035980088,0.000067503264,0.047099784,0.938052,0.00027064167,0.00006454596,0.00006434137,0.0000012806635,1.0209128e-7,0.004367356,0.00943464,0.00021803354],"about_ca_topic_score_codex":0.00006205405,"about_ca_topic_score_gemma":0.000033860764,"teacher_disagreement_score":0.13002338,"about_ca_system_score_codex":0.00005426802,"about_ca_system_score_gemma":0.0004588012,"threshold_uncertainty_score":0.9975185},"labels":[],"label_agreement":null},{"id":"W1993476952","doi":"10.1136/annrheumdis-2011-200805","title":"Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Bone mineral; Cohort; Internal medicine; Confidence interval; Osteoporosis; Pediatrics; Surgery","score_opus":0.0383528098172449,"score_gpt":0.29815936335164367,"score_spread":0.25980655353439874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993476952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895878,0.008589507,0.000005837497,0.000076542216,0.00049021776,0.0009944696,0.00005177836,0.000030353993,0.00017348185],"genre_scores_gemma":[0.99936503,0.00024857125,0.00003619373,0.000022462838,0.000087132496,0.00004539086,0.000012208064,0.00003383057,0.00014920684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967014,0.00032267201,0.0011098742,0.00022200965,0.0010706958,0.0005733164],"domain_scores_gemma":[0.9974953,0.00053676387,0.00063206506,0.0007045835,0.0003508453,0.00028045065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090552715,0.00023473527,0.00092105876,0.00033254686,0.000054110256,0.000008357826,0.000256533,0.00009077423,0.000036998106],"category_scores_gemma":[0.0021904968,0.00015743867,0.0003813265,0.0005802001,0.00016946545,0.00017954744,0.00019558627,0.00016789207,0.000012884578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027123594,0.0011041363,0.98767364,0.0072973263,0.00015622655,0.0000052674245,0.0014692668,0.000018229732,0.00009425558,0.000037280104,0.0012264113,0.0006467236],"study_design_scores_gemma":[0.0024466587,0.00013801636,0.9873299,0.006175978,0.00021696849,0.0015879214,0.0010612274,0.000320262,0.00049240794,0.000069548354,0.000002502799,0.00015860499],"about_ca_topic_score_codex":0.00012151587,"about_ca_topic_score_gemma":0.000009600508,"teacher_disagreement_score":0.009777192,"about_ca_system_score_codex":0.00007588815,"about_ca_system_score_gemma":0.00017544466,"threshold_uncertainty_score":0.6420163},"labels":[],"label_agreement":null},{"id":"W1996434844","doi":"10.1136/annrheumdis-2014-eular.3426","title":"SAT0070 Levels of 14-3-3Eta Predict Good Eular Response to Anti-TNF Treatment in Patients with Rheumatoid Arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cohort; TNF inhibitor; Biomarker; Rheumatology; Adalimumab; Refractory (planetary science); Tumor necrosis factor alpha; Gastroenterology","score_opus":0.013251175294098139,"score_gpt":0.26064188012660766,"score_spread":0.24739070483250952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996434844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977853,0.0005025891,0.00010732607,0.0003882729,0.00007584173,0.00063570845,0.00041025388,0.000007991269,0.000086731285],"genre_scores_gemma":[0.9992469,0.00022941866,0.00016434587,0.00009880481,0.000009815437,0.00007895016,0.000031571955,0.00002409005,0.00011609363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985285,0.00030702792,0.0004196201,0.00025720985,0.00026355425,0.00022412793],"domain_scores_gemma":[0.9986049,0.000095649826,0.0002527659,0.00075072685,0.00018295675,0.00011301882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021784806,0.00018945249,0.00033137092,0.000085950145,0.00005029628,0.000014448774,0.00029179972,0.00005593753,0.000040962033],"category_scores_gemma":[0.00085607334,0.00013166835,0.00015583808,0.00014867223,0.00010237468,0.000011749529,0.00011623446,0.000038681017,0.0000073891506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009694702,0.0077221687,0.791466,0.00048507188,0.001902822,0.000004114601,0.0012995347,0.0039102877,0.040699966,0.00027474103,0.0059995963,0.136541],"study_design_scores_gemma":[0.0019127403,0.0018351541,0.8991759,0.0010763728,0.000025606532,0.0000019830773,0.00006514183,0.000026548141,0.09377946,0.00013511919,0.0017682206,0.00019775193],"about_ca_topic_score_codex":0.00009234968,"about_ca_topic_score_gemma":0.000045837525,"teacher_disagreement_score":0.13634324,"about_ca_system_score_codex":0.000013464434,"about_ca_system_score_gemma":0.00010799529,"threshold_uncertainty_score":0.53692794},"labels":[],"label_agreement":null},{"id":"W1999278749","doi":"10.1136/annrheumdis-2013-eular.2066","title":"SAT0341 Strontium Ranelate Improves Osteoarthritis Symptoms Compared to Placebo in Patients with Knee OA - The Sekoia Study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Strontium ranelate; Osteoarthritis; WOMAC; Placebo; Physical therapy; Population; Knee pain; Randomized controlled trial; Internal medicine; Osteoporosis","score_opus":0.014156015829547652,"score_gpt":0.2695215399140561,"score_spread":0.2553655240845084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999278749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926193,0.00034343416,0.0000012868776,0.0017073366,0.000108519744,0.0050195283,0.000050419698,0.000024017672,0.00012619034],"genre_scores_gemma":[0.998682,0.000009106668,0.00002255299,0.00059007877,0.000007660407,0.0004075781,0.000017992419,0.000022672079,0.00024031023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835736,0.00014857455,0.00044652008,0.00021574122,0.00046452586,0.0003672655],"domain_scores_gemma":[0.998615,0.00015111349,0.00018177419,0.0006363364,0.00015373965,0.00026202132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010646581,0.00020549374,0.0004685847,0.000071792994,0.000111198104,0.00003134318,0.00018863897,0.000027697646,0.00008030563],"category_scores_gemma":[0.00012792512,0.000100415586,0.00009284825,0.00022303202,0.00008552996,0.000116032905,0.000087151355,0.00009839605,0.000066688866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015425265,0.0024378991,0.9477104,0.00016916431,0.00030420738,0.0000026212488,0.0011268083,0.00003951465,0.0000013056458,0.0000073383476,0.0014551627,0.04520308],"study_design_scores_gemma":[0.008641725,0.0018473585,0.9877489,0.0006549038,0.00015314868,9.4966066e-7,0.0006709734,0.00007127424,0.000013691138,0.00007562824,0.00002138931,0.000100032],"about_ca_topic_score_codex":0.0014922224,"about_ca_topic_score_gemma":0.00019510135,"teacher_disagreement_score":0.045103047,"about_ca_system_score_codex":0.00002328268,"about_ca_system_score_gemma":0.00009233815,"threshold_uncertainty_score":0.40948287},"labels":[],"label_agreement":null},{"id":"W2000876799","doi":"10.1136/ard.2003.010819","title":"Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada","funders":"Norsk Revmatikerforbund; Norges Forskningsråd","keywords":"Medicine; Osteoporosis; Rheumatoid arthritis; Bone mineral; Lumbar; Ultrasound; Radiology; Internal medicine; Surgery; Nuclear medicine; Physical therapy","score_opus":0.02000654084042261,"score_gpt":0.2903865905160321,"score_spread":0.27038004967560947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000876799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929872,0.00526678,0.0000043798545,0.000785291,0.000011290727,0.0008465694,0.0000620426,0.000011358786,0.000025051204],"genre_scores_gemma":[0.9974788,0.0020010308,0.0001746751,0.00027013663,0.0000024182343,0.000034262535,0.000012964699,0.000015203108,0.000010503147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866575,0.00008985479,0.0003199603,0.00023435187,0.0003909859,0.000299112],"domain_scores_gemma":[0.9989835,0.0002018074,0.00013270487,0.00022857593,0.0001758206,0.00027757965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021371555,0.00017763472,0.0005558406,0.00008325827,0.00011802718,0.000032928132,0.000045247587,0.00003904593,0.0000045213374],"category_scores_gemma":[0.00051020214,0.00010016317,0.000033346427,0.000108760134,0.0009265028,0.00022434682,0.000048757473,0.00012506945,3.8709152e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026636957,0.00039068918,0.9886929,0.00079499395,0.00007319392,0.0000033484298,0.0010971286,0.000002754565,0.000017103655,0.0004941737,0.000021517506,0.005748523],"study_design_scores_gemma":[0.007453485,0.0014527618,0.9856701,0.0026286386,0.000036453173,0.00004069269,0.0011458019,0.000029803432,0.00007605575,0.0013429753,0.0000015685484,0.00012166926],"about_ca_topic_score_codex":0.0005994604,"about_ca_topic_score_gemma":0.00072656356,"teacher_disagreement_score":0.0056268536,"about_ca_system_score_codex":0.000020008172,"about_ca_system_score_gemma":0.00019130929,"threshold_uncertainty_score":0.40845355},"labels":[],"label_agreement":null},{"id":"W2001266250","doi":"10.1136/ard.61.suppl_2.ii2","title":"Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)","year":2002,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Statement (logic); Intensive care medicine; Immunology","score_opus":0.16916830151224416,"score_gpt":0.3969993968795711,"score_spread":0.22783109536732693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001266250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061544343,0.98312235,0.0000051702864,0.00081539026,0.00021429805,0.005114375,0.004427504,0.000048622158,0.000097875294],"genre_scores_gemma":[0.0060646716,0.9921348,0.00003233208,0.00015603815,0.000032809392,0.0009427735,0.00016685882,0.00008969968,0.00038002586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568975,0.0006094205,0.0017672662,0.00053674483,0.0007405664,0.0006562595],"domain_scores_gemma":[0.99437946,0.0026421072,0.0011662041,0.0011983194,0.00021731727,0.00039659507],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003230126,0.0007611251,0.0030288098,0.0002231187,0.00029984253,0.00006861421,0.00046380053,0.00015911493,0.0010122573],"category_scores_gemma":[0.0008658871,0.0003559855,0.0014935447,0.00029883685,0.0010820093,0.000041819527,0.000103053564,0.00014371233,0.000044661872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003126539,0.002387515,0.00016527461,0.0047728205,0.003477226,0.000007908536,0.00020030476,0.000005178133,1.0586855e-7,0.00053343095,0.035602305,0.9525353],"study_design_scores_gemma":[0.0030625483,0.0022408862,0.00059405185,0.057297595,0.0002759822,0.00005287292,0.00021323163,0.00014765929,0.0000092978835,0.00045053323,0.935269,0.00038635253],"about_ca_topic_score_codex":0.0000976407,"about_ca_topic_score_gemma":0.000009132545,"teacher_disagreement_score":0.9521489,"about_ca_system_score_codex":0.000059790244,"about_ca_system_score_gemma":0.00029130167,"threshold_uncertainty_score":0.99990094},"labels":[],"label_agreement":null},{"id":"W2004646141","doi":"10.1136/ard.2006.056747","title":"Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Etanercept; Medicine; Ankylosing spondylitis; Placebo; Internal medicine; Spondylitis; Gastroenterology; Rheumatoid arthritis; Pathology","score_opus":0.010023936772228908,"score_gpt":0.2703157102357979,"score_spread":0.260291773463569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004646141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893015,0.0030686916,0.000002226617,0.0017570393,0.00009999034,0.0011903158,0.00048827118,0.00003635225,0.0040556253],"genre_scores_gemma":[0.9978284,0.00019599374,0.000064506676,0.00081072364,0.000030869334,0.00008373864,0.00011626285,0.000037596277,0.0008318572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979737,0.00013128192,0.00044735536,0.00036293638,0.0006507291,0.00043404486],"domain_scores_gemma":[0.9985471,0.00031868188,0.00027063314,0.00051385077,0.00021295634,0.00013681997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010425652,0.00031407035,0.0006457977,0.00011853551,0.00017627062,0.000030915926,0.00016743274,0.000058050697,0.00039009744],"category_scores_gemma":[0.00033334602,0.00020696431,0.00023207568,0.00037204192,0.0002214106,0.00017249658,0.00010330234,0.00011548992,0.000068321766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036101486,0.0041549043,0.9446817,0.0005855489,0.0008948609,0.000107658474,0.0012017445,0.000032575274,0.000028919327,0.00053588714,0.0073593943,0.03680664],"study_design_scores_gemma":[0.0051313424,0.0014879622,0.9857178,0.004211654,0.00030841338,0.000013152637,0.00041647544,0.000013549814,0.000273422,0.0014886813,0.0007252126,0.00021237422],"about_ca_topic_score_codex":0.0029495752,"about_ca_topic_score_gemma":0.000086031854,"teacher_disagreement_score":0.04103604,"about_ca_system_score_codex":0.00006927064,"about_ca_system_score_gemma":0.00008811549,"threshold_uncertainty_score":0.84397596},"labels":[],"label_agreement":null},{"id":"W2005151938","doi":"10.1136/ard.2004.030973","title":"Psoriatic arthritis clinical registries and genomics","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Disease; Data collection; Radiological weapon; Genomics; Arthritis; Medical physics; Data science; Pathology; Internal medicine; Surgery; Genome","score_opus":0.1522424917738973,"score_gpt":0.42901370563499364,"score_spread":0.2767712138610964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005151938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00077322737,0.9968393,4.945771e-7,0.0004812464,0.0002821355,0.00090675056,0.00043382714,0.000021612,0.00026142856],"genre_scores_gemma":[0.00032811676,0.99864495,0.000078240344,0.00015760465,0.00016653346,0.00006870803,0.000054550746,0.000038896593,0.00046239872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979668,0.00014960191,0.0010969806,0.00029496735,0.00025185186,0.00023977146],"domain_scores_gemma":[0.99789196,0.0004730724,0.0006927559,0.0006794888,0.00007819571,0.00018454937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018302652,0.00033544045,0.002427913,0.00005794523,0.00011517468,0.000024454253,0.00017214214,0.00012962216,0.000060556886],"category_scores_gemma":[0.00092449866,0.00019964999,0.0010315322,0.00013280826,0.00039176896,0.000038926275,0.00019264144,0.00015317646,0.000030311001],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000203423,0.0002712288,0.00014399138,0.0067840572,0.0012000762,0.000012430566,0.000022612216,3.605718e-8,4.286262e-10,0.00012499855,0.007444693,0.9839755],"study_design_scores_gemma":[0.0009264823,0.00019574242,0.0018718649,0.05141119,0.003073904,0.00009781959,0.00003652692,0.000001298015,9.1123944e-8,0.000346061,0.9418594,0.00017956833],"about_ca_topic_score_codex":0.000018233332,"about_ca_topic_score_gemma":0.000008790487,"teacher_disagreement_score":0.98379594,"about_ca_system_score_codex":0.000020466321,"about_ca_system_score_gemma":0.00029840734,"threshold_uncertainty_score":0.814149},"labels":[],"label_agreement":null},{"id":"W2006302083","doi":"10.1136/ard.2003.011783","title":"Detecting structural changes in early experimental osteoarthritis of tibial cartilage by microscopic magnetic resonance imaging and polarised light microscopy","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"Canadian Institutes of Health Research; Canadian Arthritis Network; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Society","keywords":"Cartilage; Tibia; Osteoarthritis; Polarized light microscopy; Anatomy; Medicine; Magnetic resonance imaging; Microscopy; Meniscus; Materials science; Biomedical engineering; Pathology; Radiology; Optics","score_opus":0.00946336052817003,"score_gpt":0.26706496156313897,"score_spread":0.25760160103496893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006302083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90965563,0.089182205,6.6586756e-7,0.00044200325,0.00010487786,0.00047858464,0.00009726358,0.000014845959,0.000023907392],"genre_scores_gemma":[0.99942094,0.00015677026,0.00018403896,0.0001306864,0.000015373462,0.00002092389,0.00000768418,0.000020637191,0.00004295889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989682,0.000047124715,0.0003120332,0.0002069069,0.00020285723,0.00026290913],"domain_scores_gemma":[0.99940896,0.00003416047,0.00017848413,0.00024156577,0.000040515824,0.000096293086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005763676,0.00017451789,0.00037162553,0.00007635751,0.00007377744,0.000022544333,0.000099646764,0.000038298364,0.000029066985],"category_scores_gemma":[0.00007785627,0.0001385019,0.000087614295,0.00012630314,0.00015061148,0.00009738504,0.000072099705,0.00006693324,0.0000011709982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028610262,0.00016723636,0.035543915,0.00019626493,0.000008287709,0.000019268506,0.0020482882,3.1518402e-7,0.9174914,0.000027146349,0.000027747563,0.044184078],"study_design_scores_gemma":[0.004325693,0.0011850285,0.035729263,0.0022932724,0.000047470592,0.000026336606,0.0006111741,0.0000025300235,0.9553936,0.00025582366,0.000013147376,0.000116662995],"about_ca_topic_score_codex":0.00020921252,"about_ca_topic_score_gemma":0.00006529033,"teacher_disagreement_score":0.08976528,"about_ca_system_score_codex":0.000021197435,"about_ca_system_score_gemma":0.000047452115,"threshold_uncertainty_score":0.56479436},"labels":[],"label_agreement":null},{"id":"W2009656202","doi":"10.1136/annrheumdis-2014-eular.1696","title":"SAT0337 Clinical Response and Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Three Years of Adalimumab Therapy","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Adalimumab; Internal medicine; Contraindication; Axial spondyloarthritis; Population; BASDAI; Mallinckrodt; Placebo; Randomized controlled trial; Gastroenterology; Physical therapy; Surgery; Ankylosing spondylitis; Arthritis; Disease; Psoriatic arthritis; Pathology","score_opus":0.01832197013891887,"score_gpt":0.28727573451283045,"score_spread":0.2689537643739116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009656202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996147,0.0027841546,0.0000018141026,0.00039335058,0.00007043031,0.0005073227,0.000060198283,0.000008185023,0.000027547449],"genre_scores_gemma":[0.99790335,0.0017741653,0.00007361401,0.00016911385,0.00001447881,0.000026473099,0.0000074616496,0.000018772042,0.00001258627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985863,0.0001848478,0.00046842426,0.000212156,0.00035962416,0.0001886786],"domain_scores_gemma":[0.99877226,0.00035961965,0.00020711917,0.00043541993,0.000102004924,0.00012358613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033751977,0.00014963676,0.00054156844,0.000115569615,0.000038029124,0.000007022187,0.00009283645,0.000054872446,0.000034345067],"category_scores_gemma":[0.0004170264,0.000094121955,0.00018973819,0.00022037902,0.0003275935,0.000056868863,0.00006195572,0.000076299955,0.0000014569385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016121829,0.00082980376,0.85480416,0.00006198373,0.0001594616,0.0000073324436,0.00012877015,6.3595263e-7,0.0000029097753,0.0000067813817,0.0001276025,0.12774876],"study_design_scores_gemma":[0.010121296,0.0022229243,0.98497516,0.0020174498,0.00007223044,0.0000021922408,0.000030061048,0.00001277036,0.000025591598,0.00029984125,0.00012937967,0.00009107606],"about_ca_topic_score_codex":0.0000701689,"about_ca_topic_score_gemma":0.000036643538,"teacher_disagreement_score":0.13017106,"about_ca_system_score_codex":0.000005462208,"about_ca_system_score_gemma":0.000047224185,"threshold_uncertainty_score":0.38381818},"labels":[],"label_agreement":null},{"id":"W2009870147","doi":"10.1136/annrheumdis-2012-eular.1965","title":"LB0005 12-week results of a phase 2B dose-ranging study of LY3009104 (INCB028050), an oral JAK1/JAK2 inhibitor, in combination with traditional dmards in patients with rheumatoid arthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Placebo; Clinical endpoint; Randomized controlled trial; Gastroenterology; Dose-ranging study; Double blind","score_opus":0.04502402965561749,"score_gpt":0.30302430279740256,"score_spread":0.2580002731417851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009870147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964949,0.0013492471,0.0000043143496,0.000184899,0.0000605074,0.0014968442,0.00029997886,0.00001837623,0.00009097076],"genre_scores_gemma":[0.99837655,0.0012008653,0.00009361557,0.000026166097,0.000010126606,0.000087598266,0.00016486568,0.00003374925,0.000006465546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966024,0.0003939757,0.0010181287,0.00025349914,0.0012712023,0.00046075543],"domain_scores_gemma":[0.998157,0.00023898514,0.0005056683,0.00051019684,0.0003401856,0.0002479462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067000464,0.00025733642,0.000808596,0.00044981073,0.00007481329,0.000020331705,0.00023234736,0.00005010916,0.000049316244],"category_scores_gemma":[0.00041725804,0.00017380208,0.000109424676,0.0005542074,0.00033627273,0.0006860341,0.000055328204,0.00017100912,0.000001316715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017955167,0.07422555,0.8374483,0.00046829943,0.0004430185,0.00001129746,0.010228792,0.00012152273,0.00007160535,0.000501709,0.00041996443,0.058104772],"study_design_scores_gemma":[0.05035461,0.009438967,0.9296411,0.005879201,0.000016587706,0.0000073734723,0.0033448022,0.00019162719,0.000508777,0.00039510743,0.000016997545,0.00020484003],"about_ca_topic_score_codex":0.00074890227,"about_ca_topic_score_gemma":0.0004682009,"teacher_disagreement_score":0.09219281,"about_ca_system_score_codex":0.000035729423,"about_ca_system_score_gemma":0.00023317874,"threshold_uncertainty_score":0.7087443},"labels":[],"label_agreement":null},{"id":"W2010004624","doi":"10.1136/ard.2006.058933","title":"Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Rheumatoid arthritis; Citrulline; Autoantibody; Autoimmune hepatitis; Immunology; Citrullination; Rheumatoid factor; Arthritis; Internal medicine; Gastroenterology; Autoimmune disease; Antibody; Arginine; Hepatitis; Biology","score_opus":0.03133641968811447,"score_gpt":0.2876241488264684,"score_spread":0.25628772913835396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010004624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922352,0.0034135475,0.00004766274,0.0018445789,0.00016340458,0.0010295458,0.0009145403,0.00008614057,0.00026539245],"genre_scores_gemma":[0.9932973,0.0049907793,0.000057976835,0.00077957433,0.000053983964,0.00007162886,0.00019766256,0.000056146135,0.0004949846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687433,0.00027313348,0.0010104877,0.00044181725,0.0007932796,0.0006069436],"domain_scores_gemma":[0.99729323,0.0004110676,0.0004286095,0.0011655524,0.0002520384,0.0004494708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031070315,0.00041614924,0.0009591161,0.00022932143,0.0001965196,0.000066656874,0.0004713069,0.00008403807,0.000463584],"category_scores_gemma":[0.0008592313,0.00028685445,0.00061187753,0.0005660603,0.00032545134,0.00028977726,0.0002564034,0.00023772373,0.00004537799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006574609,0.010559458,0.94316626,0.0028550734,0.00069714035,0.00039638326,0.0003760489,0.00096184877,0.001136328,0.00068916765,0.014040694,0.01854698],"study_design_scores_gemma":[0.0028603992,0.0001398378,0.98768723,0.004246237,0.00016522565,0.000020964204,0.0001991237,0.0008151751,0.0018423352,0.0015584606,0.00012265457,0.00034234035],"about_ca_topic_score_codex":0.003139792,"about_ca_topic_score_gemma":0.0001276492,"teacher_disagreement_score":0.044520978,"about_ca_system_score_codex":0.000053306318,"about_ca_system_score_gemma":0.00042306722,"threshold_uncertainty_score":0.99995834},"labels":[],"label_agreement":null},{"id":"W2010037912","doi":"10.1136/annrheumdis-2014-eular.3299","title":"SAT0041 14-3-3Eta Predicts Radiographic Progression in Recent-Onset Polyarthritis Patients","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"","keywords":"Medicine; Internal medicine; Polyarthritis; Cohort; Univariate analysis; Serology; Mann–Whitney U test; Arthritis; Concomitant; Gastroenterology; Surgery; Multivariate analysis; Immunology; Antibody","score_opus":0.020228955241448698,"score_gpt":0.3012731430917156,"score_spread":0.2810441878502669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010037912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98043495,0.014554202,0.0000055827004,0.0031261852,0.00023127982,0.00087381765,0.00009493896,0.000052801854,0.0006262302],"genre_scores_gemma":[0.95737886,0.041960716,0.00005876743,0.0003531197,0.00002718814,0.000072642375,0.00006775897,0.00002780975,0.000053150085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746907,0.00036603172,0.00056254736,0.00026307136,0.00085694256,0.00048231013],"domain_scores_gemma":[0.99835235,0.00021794657,0.00021294251,0.0006507044,0.00024488405,0.00032117724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000402796,0.00020795754,0.0005005238,0.00027423113,0.000121815734,0.00003741808,0.0003132193,0.0000665991,0.00020477737],"category_scores_gemma":[0.001970875,0.00013795437,0.0002577813,0.0005511899,0.00035962363,0.00017506444,0.000121826684,0.00016716972,0.000020991332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038882488,0.0010992552,0.5507533,0.00027077156,0.00010766207,0.000003208701,0.00020521639,0.000002798405,0.000011530453,0.00015578972,0.011678802,0.43532282],"study_design_scores_gemma":[0.0038254815,0.0006995254,0.9797994,0.0059883655,0.000014123612,0.000010250005,0.0000619188,0.0001965364,0.00049157086,0.0033817198,0.0053614313,0.00016969487],"about_ca_topic_score_codex":0.000059924423,"about_ca_topic_score_gemma":0.00003181682,"teacher_disagreement_score":0.43515313,"about_ca_system_score_codex":0.000011585623,"about_ca_system_score_gemma":0.00011038678,"threshold_uncertainty_score":0.5625616},"labels":[],"label_agreement":null},{"id":"W2016578352","doi":"10.1136/annrheumdis-2013-eular.1568","title":"FRI0441 Infection risk in ankylosing spondylitis: results from a longitudinal observational cohort","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Ankylosing spondylitis; Internal medicine; Rheumatoid arthritis; Observational study; Spondylitis; Logistic regression; Respiratory tract infections; Retrospective cohort study; Respiratory system","score_opus":0.06475186604715247,"score_gpt":0.3125219249315228,"score_spread":0.24777005888437034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016578352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945391,0.0016698715,0.0000054572756,0.0013928617,0.00014456241,0.0006180658,0.0011245348,0.000025146,0.00048042688],"genre_scores_gemma":[0.9979489,0.0012186035,0.00013216157,0.00016841399,0.000040703184,0.00008870008,0.00027734655,0.000012029866,0.00011314016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864817,0.00008989004,0.0004891816,0.00022776726,0.00033966434,0.00020534651],"domain_scores_gemma":[0.9988062,0.00031612327,0.00025815426,0.0003606557,0.00016899865,0.000089868634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001355301,0.00014658018,0.00035434257,0.000069355854,0.00011169503,0.000024299512,0.00007285024,0.000040333693,0.00038412403],"category_scores_gemma":[0.0012477961,0.00010166159,0.0001833302,0.00023439819,0.00009627983,0.00017952535,0.00006811964,0.00008501728,0.000042626354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026525196,0.00045348247,0.9861443,0.000042489253,0.00032757147,0.00000639926,0.00014305217,0.000031400825,0.0000055285286,0.00006212762,0.0028656027,0.009652767],"study_design_scores_gemma":[0.0019813788,0.00010009173,0.9915001,0.0012069781,0.00017489916,0.0000043346163,0.000064105574,0.00028287567,0.000083285195,0.0043891836,0.00012655644,0.000086238695],"about_ca_topic_score_codex":0.016312575,"about_ca_topic_score_gemma":0.00029354988,"teacher_disagreement_score":0.016019024,"about_ca_system_score_codex":0.000031509466,"about_ca_system_score_gemma":0.00005800035,"threshold_uncertainty_score":0.9902379},"labels":[],"label_agreement":null},{"id":"W2016967911","doi":"10.1136/ard.2003.007229","title":"Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MAB-Mackay Rehabilitation Centre; Centre Hospitalier de l’Université de Montréal","funders":"Arthritis Society","keywords":"Collagenase; Cartilage; Flow cytometry; Galectin; Galectin-3; Molecular biology; Medicine; Pathology; Chemistry; Biology; Biochemistry; Immunology; Anatomy; Enzyme","score_opus":0.03889487429981877,"score_gpt":0.31003128839790833,"score_spread":0.2711364140980896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016967911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958841,0.0017397745,0.00006974617,0.0007971357,0.000530649,0.0004924891,0.00022377283,0.000041974366,0.00022031917],"genre_scores_gemma":[0.99852574,0.00015174571,0.000029464083,0.00036513255,0.000020004556,0.000051336716,0.000060351183,0.000017594488,0.0007786315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988995,0.00012400116,0.0003327183,0.00025348418,0.00005285929,0.00033744084],"domain_scores_gemma":[0.99904436,0.00010907139,0.00026388685,0.00038478296,0.00016264037,0.00003526655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096301526,0.00018503852,0.0003110713,0.00003884704,0.00036969886,0.000013754358,0.00035001602,0.00012302495,0.0001708022],"category_scores_gemma":[0.00017479832,0.00012218244,0.00028686036,0.000112246824,0.00020787957,0.000043728938,0.00005489718,0.000094276475,0.00003801184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025280418,0.0024526885,0.0014218894,0.00062920555,0.0008851539,0.0000040231153,0.0009578612,0.0057623773,0.93477607,0.0069648186,0.039722234,0.0038956574],"study_design_scores_gemma":[0.0033126615,0.0009606498,0.023872415,0.00075704296,0.00011124379,0.000015830437,0.00039247752,0.0000036276015,0.95961195,0.010165248,0.000519092,0.00027777464],"about_ca_topic_score_codex":0.00011723984,"about_ca_topic_score_gemma":0.000038223803,"teacher_disagreement_score":0.03920314,"about_ca_system_score_codex":0.000017230026,"about_ca_system_score_gemma":0.00010557619,"threshold_uncertainty_score":0.49824548},"labels":[],"label_agreement":null},{"id":"W2018123987","doi":"10.1136/annrheumdis-2014-eular.3978","title":"AB0042 Human Host Defense Peptide Cathelicidin (LL37) Serum Levels Are Increased in Anti-Cyclical Citrullinated Peptide Positive Patients with Recent Onset Inflammatory Arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Manitoba","funders":"","keywords":"Medicine; Cathelicidin; Immunology; Rheumatoid arthritis; Arthritis; Innate immune system; Inflammatory arthritis; Synovitis; Immune system; Internal medicine","score_opus":0.018916094953494365,"score_gpt":0.2715474462854676,"score_spread":0.25263135133197323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018123987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434793,0.0014325384,0.000005957656,0.0018546004,0.00005393678,0.0011549732,0.00083520426,0.00006996418,0.0002449177],"genre_scores_gemma":[0.9958234,0.0031433506,0.0000386332,0.000641727,0.000027824643,0.00007598461,0.00012417752,0.000065904336,0.000058998314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962265,0.00079842977,0.000843835,0.0004402114,0.0009838226,0.00070718833],"domain_scores_gemma":[0.9970974,0.0005028505,0.00046442874,0.0008188661,0.000614276,0.0005022353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000589919,0.0004060661,0.0009234536,0.00027978967,0.00029639943,0.00006497238,0.00037605778,0.000103826605,0.0002448673],"category_scores_gemma":[0.001989962,0.00028461977,0.00025878838,0.00042725765,0.00056408334,0.000224997,0.00015897932,0.00037360494,0.000040061914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009765,0.0019452948,0.9806327,0.00033875625,0.0004015531,0.000047854828,0.0008604585,0.000021573711,0.00023451555,0.00027359405,0.0019264641,0.01234073],"study_design_scores_gemma":[0.0052708946,0.0006039551,0.982513,0.007623192,0.000026419844,0.000018494919,0.0003524245,0.000060457558,0.0021744627,0.0007828335,0.00025089068,0.00032294766],"about_ca_topic_score_codex":0.0003988398,"about_ca_topic_score_gemma":0.00046421553,"teacher_disagreement_score":0.012017782,"about_ca_system_score_codex":0.000054068776,"about_ca_system_score_gemma":0.00021806973,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W2018583759","doi":"10.1136/ard.2005.039826","title":"Clinical and radiological damage in psoriatic arthritis","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Waterloo","funders":"University of Toronto","keywords":"Medicine; Psoriatic arthritis; Radiological weapon; Dermatology; Psoriasis; Arthritis; Internal medicine; Radiology","score_opus":0.054505955466129456,"score_gpt":0.36045134544272855,"score_spread":0.3059453899765991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018583759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793846,0.015938625,0.0000010430756,0.0038557607,0.0000727599,0.00025752754,0.000022074935,0.000012604417,0.00045502253],"genre_scores_gemma":[0.98415345,0.014855372,0.00016352572,0.00065298146,0.000045672892,0.000017406552,0.0000037784891,0.000006337374,0.00010150175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990526,0.00009025445,0.00040852404,0.00014590856,0.00014099493,0.00016174745],"domain_scores_gemma":[0.9993351,0.00021105862,0.000087441425,0.00023437223,0.000029657698,0.0001023389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016133561,0.00009760181,0.00042662295,0.000031238986,0.000044530847,0.000006605165,0.00006768783,0.00003744435,0.00010668145],"category_scores_gemma":[0.0006806161,0.000058492864,0.00014871133,0.00008791338,0.00025082694,0.00004475429,0.00007399813,0.00006842406,0.00001244747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013515467,0.0007897345,0.5594261,0.00006833918,0.00014745665,0.000022124046,0.0001391876,0.0000034261516,9.1809306e-7,0.0005005435,0.0032081932,0.43555877],"study_design_scores_gemma":[0.002522752,0.00022122602,0.99408436,0.0007489314,0.000057072146,0.000016877031,0.00011961166,0.00009630981,0.000010188741,0.0013846811,0.00068035757,0.00005761605],"about_ca_topic_score_codex":0.000022285078,"about_ca_topic_score_gemma":0.000037779748,"teacher_disagreement_score":0.43550116,"about_ca_system_score_codex":0.00000487548,"about_ca_system_score_gemma":0.000026042655,"threshold_uncertainty_score":0.23852699},"labels":[],"label_agreement":null},{"id":"W2018829324","doi":"10.1136/annrheumdis-2012-202035","title":"Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Toronto Rehabilitation Institute; University of Toronto","funders":"Janssen Biotech; Chugai Pharmaceutical; Astellas Pharma; Zalicus; Sanofi; Exelixis; Biogen; Celgene; IC Design Education Center; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Pfizer; Genentech; National Psoriasis Foundation; Amgen","keywords":"Golimumab; Medicine; Psoriatic arthritis; Internal medicine; Placebo; Rheumatology; Psoriasis Area and Severity Index; Etanercept; Psoriasis; Surgery; Physical therapy; Arthritis; Rheumatoid arthritis; Dermatology; Pathology","score_opus":0.026469012440360585,"score_gpt":0.31077722826037296,"score_spread":0.28430821582001237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018829324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908691,0.00395126,4.8100844e-7,0.000109915,0.00014005067,0.0045361742,0.00036452714,0.000006917747,0.000021585363],"genre_scores_gemma":[0.99728924,0.0024890928,0.000032694385,0.00002820997,0.000016030319,0.00008629891,0.000026923975,0.000017603461,0.000013921305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975627,0.00043774463,0.0010417419,0.0002578205,0.00045179177,0.0002482097],"domain_scores_gemma":[0.99700475,0.0015291596,0.00067463564,0.00057891646,0.0001113554,0.0001011593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032565848,0.00023119683,0.0013774897,0.00006540825,0.000075742646,0.0000056725553,0.00012147915,0.000051766656,0.000009735235],"category_scores_gemma":[0.00097102503,0.0001178576,0.00043263106,0.0002256749,0.0003056158,0.0000950183,0.00009452064,0.00008042162,8.824833e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15468398,0.0092490725,0.79236156,0.0000461215,0.0024411166,0.0000040604336,0.0030744537,0.0000046658615,7.824746e-7,0.0000030883468,0.000032650587,0.038098477],"study_design_scores_gemma":[0.25958008,0.0014615139,0.7354698,0.0019753368,0.0010213407,9.177453e-7,0.00036069346,0.0000031225654,0.000022436747,0.00003260558,8.029854e-7,0.000071340895],"about_ca_topic_score_codex":0.0003720668,"about_ca_topic_score_gemma":0.00009245513,"teacher_disagreement_score":0.104896106,"about_ca_system_score_codex":0.00002556894,"about_ca_system_score_gemma":0.00006225152,"threshold_uncertainty_score":0.48060936},"labels":[],"label_agreement":null},{"id":"W2019026866","doi":"10.1136/annrheumdis-2012-201691","title":"The association between objectively measured physical activity and knee structural change using MRI","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Cartilage; Osteoarthritis; Knee Joint; Cartilage damage; Internal medicine; Surgery; Articular cartilage; Pathology; Anatomy","score_opus":0.08037174920688728,"score_gpt":0.33575438598665,"score_spread":0.2553826367797627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019026866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971567,0.0013766886,0.000003134719,0.0007287324,0.0001390675,0.00046284255,0.000055175602,0.000017081411,0.000060579576],"genre_scores_gemma":[0.99958277,0.000060085556,0.00002280768,0.000039991315,0.00017804766,0.000019237452,0.0000039559854,0.000010727956,0.00008237017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913716,0.00011766698,0.000099896286,0.00008469414,0.00032902052,0.00023158696],"domain_scores_gemma":[0.9991864,0.0002570036,0.0001939744,0.00017546053,0.00007834133,0.00010879686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016888323,0.000110384215,0.000248151,0.000019800296,0.00020176143,0.000019658,0.000053051626,0.000033783388,0.0000032935297],"category_scores_gemma":[0.00028506664,0.000059420567,0.00013494959,0.00007906507,0.000055327157,0.00020393309,0.000051148254,0.000059220958,0.0000021283097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021476239,0.00031564737,0.59447336,0.00017917917,0.00075349567,5.329342e-7,0.0019710674,5.84065e-7,0.0012991084,0.0006675471,0.00010124242,0.4000235],"study_design_scores_gemma":[0.000657429,0.0001699458,0.9909245,0.00023405698,0.0005212169,0.0000022707893,0.00013380923,0.00010894939,0.0057050264,0.0014462242,0.000022942164,0.00007366669],"about_ca_topic_score_codex":0.000051801395,"about_ca_topic_score_gemma":0.0000046853115,"teacher_disagreement_score":0.39994982,"about_ca_system_score_codex":0.000033302174,"about_ca_system_score_gemma":0.000029785597,"threshold_uncertainty_score":0.24231005},"labels":[],"label_agreement":null},{"id":"W2019120227","doi":"10.1136/annrheumdis-2014-eular.3326","title":"SAT0037 Serum 14-3-3Eta Predicts the Risk of RA Development and Its Higher Titres Are Associated with Higher Risk","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Biomarker; Cohort; Gastroenterology; Rheumatology; Joint pain; Arthritis; Percentile; Risk factor; Immunology; Surgery","score_opus":0.018017613924470096,"score_gpt":0.24705417162149176,"score_spread":0.22903655769702166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019120227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962124,0.002134462,0.000022446999,0.0006180794,0.000116576535,0.0002718497,0.00025127173,0.0000111013505,0.00036179254],"genre_scores_gemma":[0.9977335,0.00044924914,0.000048823065,0.00014499546,0.000028345677,0.000040608174,0.000020555486,0.000019384734,0.0015145662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882954,0.00029682764,0.0002730176,0.00019029048,0.00023624547,0.0001740683],"domain_scores_gemma":[0.99854136,0.00014684419,0.00060421595,0.00042956698,0.00020898908,0.0000690236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025124894,0.0001590349,0.000212098,0.000023379953,0.00015390478,0.000019709492,0.00028596132,0.00006607772,0.000062843865],"category_scores_gemma":[0.0009008571,0.00008546871,0.000098564095,0.00008636672,0.00013315793,0.000008909241,0.00016157066,0.00008340313,0.0000042207075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000999605,0.0021247163,0.857096,0.0010558101,0.010907855,0.0000023578625,0.0011629772,0.0018752058,0.0048460388,0.0008841688,0.08653342,0.032511853],"study_design_scores_gemma":[0.0004552671,0.00012906296,0.95239395,0.00051677454,0.00022029167,8.1909957e-7,0.000053953478,0.000074808566,0.040985875,0.00040524712,0.00461912,0.00014485628],"about_ca_topic_score_codex":0.00004258371,"about_ca_topic_score_gemma":0.000064856446,"teacher_disagreement_score":0.09529793,"about_ca_system_score_codex":0.000005475691,"about_ca_system_score_gemma":0.000058051806,"threshold_uncertainty_score":0.34853128},"labels":[],"label_agreement":null},{"id":"W2019449067","doi":"10.1136/ard.2004.026906","title":"The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Kinase; p38 mitogen-activated protein kinases; Phosphorylation; Medicine; Molecular biology; Pharmacology; Biology; Protein kinase A; Biochemistry","score_opus":0.016532251562576157,"score_gpt":0.26153158470845345,"score_spread":0.2449993331458773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019449067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98788625,0.008871284,0.0000023428206,0.0015125315,0.00007080194,0.0011190712,0.0004861986,0.000016910864,0.000034606965],"genre_scores_gemma":[0.9990779,0.00042333736,0.0000105583795,0.00014180432,0.00002604081,0.00006129928,0.00015050673,0.000030364658,0.00007819727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976791,0.00025701936,0.00092477497,0.00024447733,0.00062654563,0.0002680808],"domain_scores_gemma":[0.99792427,0.0003542462,0.0007535603,0.00063825207,0.00022010885,0.00010953854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036918191,0.0002591721,0.00053638883,0.00007611092,0.00029664979,0.00002373528,0.00024750276,0.00009234314,0.000028461547],"category_scores_gemma":[0.00031436258,0.00013530294,0.00023891064,0.00030530535,0.0005895837,0.0001818124,0.000094541225,0.000118110795,9.253035e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030574822,0.0015892332,0.00277464,0.0009116437,0.00014002252,0.000002433961,0.0027340825,0.000052248637,0.9827805,0.001626491,0.0009737004,0.0061092223],"study_design_scores_gemma":[0.0035480212,0.0014309278,0.012517365,0.0047759605,0.0001876185,0.0000045916586,0.0016437263,0.000026108204,0.96592915,0.00976327,0.000020382433,0.00015289197],"about_ca_topic_score_codex":0.00033989697,"about_ca_topic_score_gemma":0.00034965735,"teacher_disagreement_score":0.016851397,"about_ca_system_score_codex":0.000024417352,"about_ca_system_score_gemma":0.00011931447,"threshold_uncertainty_score":0.5517494},"labels":[],"label_agreement":null},{"id":"W2020409699","doi":"10.1136/ard.2008.099713","title":"Dual energy computed tomography in tophaceous gout","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Arthritis Research Centre of Canada","funders":"","keywords":"Tophus; Medicine; Gout; Nuclear medicine; Uric acid; Digital Enhanced Cordless Telecommunications; Radiology; Hyperuricemia; Internal medicine","score_opus":0.035697498010720766,"score_gpt":0.27191335220904983,"score_spread":0.23621585419832908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020409699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911089,0.00499611,0.00005536783,0.0019488516,0.00016090683,0.0002251603,0.000030074654,0.00006148988,0.0014131591],"genre_scores_gemma":[0.99744403,0.0005510756,0.00018051536,0.0013339923,0.000044674754,0.000018570381,0.00001612278,0.00002174116,0.00038930264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845374,0.00010581059,0.000456461,0.00020875563,0.00047764517,0.00029757462],"domain_scores_gemma":[0.99873173,0.0001960294,0.00017821566,0.0006180288,0.00009957568,0.00017640756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098458346,0.00018275247,0.00048377382,0.00018263838,0.000071582246,0.0000068314616,0.00023200955,0.00006168391,0.0001062632],"category_scores_gemma":[0.0003093876,0.00012596551,0.00031280934,0.0005858795,0.00022523578,0.0000726765,0.00011949969,0.00009837891,0.000014049929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013667378,0.010136941,0.65070456,0.0021774962,0.002711832,0.001121319,0.005222231,0.0012984134,0.0006982827,0.0038107801,0.18138556,0.13936587],"study_design_scores_gemma":[0.0021117318,0.00029540056,0.9863756,0.0012235544,0.00023786938,0.00032920967,0.00022134795,0.001778728,0.002670059,0.0021332595,0.0023130157,0.0003102598],"about_ca_topic_score_codex":0.0003375605,"about_ca_topic_score_gemma":0.000008972804,"teacher_disagreement_score":0.33567104,"about_ca_system_score_codex":0.000014731462,"about_ca_system_score_gemma":0.00013839456,"threshold_uncertainty_score":0.5136724},"labels":[],"label_agreement":null},{"id":"W2022111076","doi":"10.1136/annrheumdis-2014-206005","title":"The offspring of people with a total knee replacement for severe primary knee osteoarthritis have a higher risk of worsening knee pain over 8 years","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Offspring; Knee pain; WOMAC; Physical therapy; Rheumatology; Internal medicine; Confounding; Body mass index; Pregnancy; Pathology","score_opus":0.010658423203818624,"score_gpt":0.23853035539609657,"score_spread":0.22787193219227794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022111076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960542,0.0015825741,0.000086403656,0.00022522264,0.00012246172,0.0013070528,0.0001248779,0.000021932536,0.00047528313],"genre_scores_gemma":[0.9978468,0.00008531549,0.00054382195,0.00009955471,0.000034049135,0.00016564023,0.000021477934,0.000035087804,0.0011682777],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983331,0.00021764816,0.0004913202,0.00020726888,0.0004677822,0.00028290888],"domain_scores_gemma":[0.9976437,0.0009093384,0.0005580815,0.00063632854,0.00014721665,0.00010530162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006992697,0.00019472421,0.00054992794,0.00005840479,0.00012316117,0.000015974401,0.00010837509,0.000047476486,0.000066810346],"category_scores_gemma":[0.00054240396,0.00011705,0.0003330153,0.00011675493,0.00012991513,0.00007639652,0.00009236647,0.00008104538,0.0000015037756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073175794,0.0010848457,0.14067522,0.0024136128,0.001588864,0.000005717963,0.0027081685,0.00019416795,0.0006535067,0.0017391451,0.0019396651,0.83967954],"study_design_scores_gemma":[0.029841885,0.029678114,0.90367407,0.014964734,0.002948223,0.000046123812,0.003786937,0.001075647,0.00643765,0.004682966,0.002067572,0.0007961049],"about_ca_topic_score_codex":0.00008670309,"about_ca_topic_score_gemma":0.0000570831,"teacher_disagreement_score":0.8388834,"about_ca_system_score_codex":0.000017627659,"about_ca_system_score_gemma":0.00010277449,"threshold_uncertainty_score":0.47731605},"labels":[],"label_agreement":null},{"id":"W2022144190","doi":"10.1136/annrheumdis-2012-201574","title":"Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Inclusion and exclusion criteria; MEDLINE; Meta-analysis; Clinical trial; Internal medicine; Intensive care medicine; Physical therapy; Alternative medicine; Pathology","score_opus":0.5904529731560979,"score_gpt":0.49718596240608554,"score_spread":0.09326701075001237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022144190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8416067,0.1551848,0.000079786216,0.0009677212,0.00008927704,0.0012885897,0.00075454306,0.00001529121,0.000013336919],"genre_scores_gemma":[0.9183256,0.08068702,0.00051909575,0.0000814718,0.000011939253,0.00023843894,0.00010216547,0.00001985091,0.000014387072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620956,0.001026653,0.0014026739,0.00028212578,0.0006214531,0.00045753113],"domain_scores_gemma":[0.99454665,0.0027172472,0.0011970467,0.0009034784,0.00038614337,0.0002494189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095350813,0.0003723323,0.0026047537,0.00016080134,0.00012025712,0.000021951228,0.0004682651,0.00008477737,0.00033599325],"category_scores_gemma":[0.0032309613,0.00015831366,0.0017810875,0.00027173694,0.0005832026,0.00023005523,0.0001329813,0.00008680262,8.438431e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034337214,0.019190911,0.82784694,0.0019482846,0.037599195,0.0000012572774,0.002723303,0.00004199806,0.0032234474,0.0023204973,0.0055252896,0.096145146],"study_design_scores_gemma":[0.0058044586,0.0052610273,0.8286307,0.003185898,0.0031432242,0.000017883169,0.0019255003,0.0005393458,0.14616318,0.0039723907,0.00097102777,0.00038539298],"about_ca_topic_score_codex":0.00045951165,"about_ca_topic_score_gemma":0.00008775882,"teacher_disagreement_score":0.14293973,"about_ca_system_score_codex":0.000023333909,"about_ca_system_score_gemma":0.000056437882,"threshold_uncertainty_score":0.64558434},"labels":[],"label_agreement":null},{"id":"W2022268100","doi":"10.1136/ard.62.suppl_2.ii43","title":"Metalloproteinases, inflammation, and rheumatoid arthritis","year":2003,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Proinflammatory cytokine; Inflammation; Matrix metalloproteinase; Rheumatoid arthritis; Medicine; Chemokine; Immunology; Proteases; Arthritis; Extracellular matrix; Cell biology; Biology; Enzyme; Internal medicine; Biochemistry","score_opus":0.03282708093950063,"score_gpt":0.2964392320444044,"score_spread":0.26361215110490377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022268100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007328109,0.99786395,0.000027777429,0.000041039788,0.00013685033,0.000857589,0.0001746665,0.000009763916,0.00015555209],"genre_scores_gemma":[0.00074575783,0.99847525,0.00007764144,0.00005582577,0.0000500625,0.00020028457,0.00013588104,0.000042780015,0.0002164962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982911,0.0002910681,0.000641337,0.0003258386,0.00022499583,0.00022569354],"domain_scores_gemma":[0.9984278,0.000030762538,0.000587663,0.00073219603,0.00009963719,0.0001219363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022652015,0.00034780343,0.00087770156,0.000057950874,0.000105339306,0.000038318114,0.0003490639,0.0001893252,0.000039233822],"category_scores_gemma":[0.00046730007,0.00023562722,0.0005754842,0.00012353808,0.00013431067,0.000008483878,0.00022068252,0.00008889548,0.000010971245],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000065980635,0.00006064193,0.0000014996269,0.006387619,0.00043948813,0.0000011811807,0.000008433827,5.198417e-7,0.000066064684,0.0010653377,0.004571102,0.98739153],"study_design_scores_gemma":[0.0001772958,0.000092453876,0.0000025331856,0.014894319,0.00018322976,0.000041839277,0.000011271665,9.674545e-7,0.0056407736,0.0021744326,0.97642744,0.00035344178],"about_ca_topic_score_codex":0.000010093178,"about_ca_topic_score_gemma":0.0000027821256,"teacher_disagreement_score":0.9870381,"about_ca_system_score_codex":0.000004116268,"about_ca_system_score_gemma":0.00025155518,"threshold_uncertainty_score":0.9608599},"labels":[],"label_agreement":null},{"id":"W2028986071","doi":"10.1136/annrheumdis-2013-204544","title":"An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Versus Arthritis; National Institute for Health and Care Research; Heart and Stroke Foundation of Canada","keywords":"Rituximab; Medicine; Rheumatoid arthritis; Rheumatism; Rheumatology; Internal medicine; Placebo; Gastroenterology; Methotrexate; Adverse effect; Immunology; Surgery; Lymphoma; Pathology","score_opus":0.02780273007957545,"score_gpt":0.3283322529149131,"score_spread":0.3005295228353376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028986071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306065,0.0020234338,0.00005535818,0.00046875887,0.0001888192,0.0039824005,0.00006953078,0.00003210291,0.00011895566],"genre_scores_gemma":[0.9948271,0.0044167344,0.00016027059,0.0001693649,0.000046011806,0.00029409584,0.00003927749,0.000037384933,0.000009747829],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941242,0.0024678619,0.0017369149,0.00034509733,0.0009022083,0.0004237496],"domain_scores_gemma":[0.99492705,0.0026462416,0.0007614071,0.0008510151,0.0004538587,0.0003604073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023549725,0.00028742306,0.0017781071,0.00022901932,0.00010815836,0.0000428107,0.00038108215,0.00009674303,0.00011863105],"category_scores_gemma":[0.0044845534,0.0001783751,0.0005642038,0.0002539801,0.00068638194,0.00024694658,0.000074483476,0.00022578984,0.000007672657],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.948963,0.0072505265,0.012408382,0.00018105471,0.00025052155,0.0000052785663,0.00026842288,0.000009023351,0.00010704328,0.000079853744,0.00018983617,0.030287055],"study_design_scores_gemma":[0.8287025,0.007657543,0.15941335,0.0022142078,0.000023726014,0.0000040148448,0.000115681156,0.00066639844,0.00027193414,0.0006407175,0.00009299414,0.00019694223],"about_ca_topic_score_codex":0.00009181261,"about_ca_topic_score_gemma":0.000028629755,"teacher_disagreement_score":0.14700496,"about_ca_system_score_codex":0.00001162836,"about_ca_system_score_gemma":0.0004163543,"threshold_uncertainty_score":0.72739255},"labels":[],"label_agreement":null},{"id":"W2029552477","doi":"10.1136/ard.2006.062554","title":"Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Osteoporosis Canada; McMaster University Medical Centre","funders":"","keywords":"Medicine; Rheumatoid arthritis; Placebo; Internal medicine; Rheumatology; Antagonist; Clinical endpoint; Arthritis; Clinical trial; Gastroenterology; Receptor; Pathology","score_opus":0.028620284800411528,"score_gpt":0.3168251182891742,"score_spread":0.2882048334887627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029552477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182683,0.0054522185,0.000007266101,0.00075624324,0.00020245575,0.0012383148,0.00018108252,0.000027908727,0.00030769015],"genre_scores_gemma":[0.9813097,0.018207364,0.00012805143,0.00007436052,0.00004458873,0.000053535452,0.00007232149,0.000032380056,0.000077657496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966691,0.00031461153,0.0013608874,0.00029231075,0.000941786,0.0004212794],"domain_scores_gemma":[0.9978231,0.00041698595,0.00052914914,0.0006837028,0.00035164127,0.00019542464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055640674,0.0002319625,0.0009773826,0.00018774663,0.0000806031,0.000026822536,0.00030554505,0.00008079916,0.00018574018],"category_scores_gemma":[0.0010568128,0.00014717747,0.00040165047,0.00044131782,0.00067509693,0.00016741875,0.00009668875,0.00018193916,0.00001553997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056059927,0.008270943,0.8132436,0.0003376927,0.00036242823,0.000005986205,0.00015980052,0.000019893207,0.000020826405,0.0009465329,0.010431334,0.110141],"study_design_scores_gemma":[0.10334606,0.004248777,0.88083,0.006119084,0.0000140058655,0.000003848133,0.00013681634,0.000038504964,0.00068234594,0.0014333153,0.0028789074,0.00026835248],"about_ca_topic_score_codex":0.00042545897,"about_ca_topic_score_gemma":0.00007340244,"teacher_disagreement_score":0.10987265,"about_ca_system_score_codex":0.000015549336,"about_ca_system_score_gemma":0.000343353,"threshold_uncertainty_score":0.60017234},"labels":[],"label_agreement":null},{"id":"W2031518856","doi":"10.1136/ard.2005.042937","title":"Rituximab in Churg-Strauss syndrome","year":2006,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuromyelitis optica; Montreal Cognitive Assessment; Internal medicine; Spectrum disorder; Rituximab; Multiple sclerosis; Pediatrics; Disease; Immunology; Cognitive impairment; Psychiatry","score_opus":0.026653980605212096,"score_gpt":0.27848729538358524,"score_spread":0.2518333147783731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031518856","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13144912,0.006764093,0.0000028674378,0.855599,0.00042295372,0.0008747783,0.0008349903,0.00006349404,0.003988722],"genre_scores_gemma":[0.70917094,0.0013904778,0.000036901678,0.27483192,0.00030765613,0.00013805622,0.0015127467,0.00011191274,0.012499364],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981384,0.00010589294,0.00061600097,0.0002530131,0.0005277784,0.0003589071],"domain_scores_gemma":[0.9986587,0.00013580383,0.00028272008,0.00076017174,0.00008904801,0.00007353002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086073946,0.0002700707,0.00085704564,0.00021500248,0.000058898073,0.000020814387,0.00030285015,0.0003780803,0.0005911687],"category_scores_gemma":[0.00011939319,0.0001726611,0.0007125351,0.00027298048,0.00019561265,0.000053554017,0.00006420604,0.00077611103,0.00011637303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000061854844,0.00054882444,0.00059200055,0.0013993429,0.00037086522,0.0005336025,0.000024785433,0.000013404355,4.0828874e-7,0.00006260286,0.99524975,0.001198256],"study_design_scores_gemma":[0.009334553,0.00042308957,0.7154914,0.044928562,0.003455277,0.0013573583,0.00011117468,0.00017562143,0.000057539553,0.033081003,0.1902662,0.0013181813],"about_ca_topic_score_codex":0.0002433975,"about_ca_topic_score_gemma":0.0000053979247,"teacher_disagreement_score":0.8049835,"about_ca_system_score_codex":0.000024515151,"about_ca_system_score_gemma":0.00018534726,"threshold_uncertainty_score":0.7040915},"labels":[],"label_agreement":null},{"id":"W2033766015","doi":"10.1136/ard.2006.056457","title":"Predictors for radiological damage in psoriatic arthritis: results from a single centre","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Radiological weapon; Erythrocyte sedimentation rate; Arthritis; Internal medicine; Cartilage damage; Surgery; Pathology; Osteoarthritis; Articular cartilage","score_opus":0.03225458259790276,"score_gpt":0.2733913053947195,"score_spread":0.24113672279681675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033766015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838955,0.006784023,0.0000062577083,0.0020693773,0.00015569426,0.00070042483,0.0013703806,0.000028784043,0.00049549766],"genre_scores_gemma":[0.99862504,0.00048514892,0.00020669133,0.00013818587,0.0000672708,0.000044678553,0.00022574078,0.00001250361,0.00019473476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987933,0.00006009728,0.0004870108,0.00021227644,0.00019838462,0.00024893106],"domain_scores_gemma":[0.9989594,0.00042175478,0.00017258486,0.0003144193,0.000062261504,0.0000695674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008295684,0.00014330789,0.00043883873,0.000041102303,0.000063305146,0.000011553606,0.00010233432,0.000044930133,0.000043418455],"category_scores_gemma":[0.00096967333,0.00009142129,0.00022665337,0.00012263817,0.00010993567,0.0000446676,0.000047360725,0.000041373132,0.00000491444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080745695,0.015453886,0.6269183,0.0007408976,0.001996377,0.00021053654,0.0021847712,0.0003433332,0.00020179721,0.0018895459,0.16811518,0.17387076],"study_design_scores_gemma":[0.009540991,0.00040352767,0.9774021,0.0024112046,0.00018517405,0.0000026864834,0.00039147175,0.00022897894,0.00036064853,0.008175899,0.00076676905,0.00013056087],"about_ca_topic_score_codex":0.00038598716,"about_ca_topic_score_gemma":0.00024672147,"teacher_disagreement_score":0.35048375,"about_ca_system_score_codex":0.000019921381,"about_ca_system_score_gemma":0.00003310792,"threshold_uncertainty_score":0.3728052},"labels":[],"label_agreement":null},{"id":"W2034204736","doi":"10.1136/annrheumdis-2014-eular.1113","title":"OP0201 Outcome of Lupus Nephritis: Results from an International, Prospective, Inception Cohort Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Capital District Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Lupus nephritis; Internal medicine; Nephrology; Rheumatology; Systemic lupus erythematosus; Kidney disease; Cohort; Prospective cohort study; Renal function; Disease","score_opus":0.0534480080040694,"score_gpt":0.37620495886358507,"score_spread":0.32275695085951567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034204736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955284,0.0001609018,0.00003240627,0.00071698125,0.0003985561,0.0016191407,0.00023232341,0.000039206458,0.0012720994],"genre_scores_gemma":[0.99894786,0.00012027649,0.00008371968,0.0000880064,0.00007668767,0.00008352171,0.000059609367,0.000023019606,0.0005172878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971469,0.00033757318,0.00090536015,0.0003144513,0.0011112139,0.00018449269],"domain_scores_gemma":[0.9973563,0.00039384695,0.00048617588,0.0011014198,0.00051114464,0.00015113503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086355035,0.0001545858,0.0005883848,0.00012583507,0.000053098054,0.000024860668,0.000531771,0.000046767833,0.000117270945],"category_scores_gemma":[0.0037296407,0.000102020604,0.00017866369,0.00018823701,0.00016264989,0.00020690844,0.00018168909,0.00009923692,0.000023906885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005997005,0.0013205996,0.99235046,0.00023062067,0.00042189297,0.0000017562112,0.0012712388,0.000015156371,0.0000490091,0.00013475149,0.001364721,0.0022400923],"study_design_scores_gemma":[0.0028147714,0.0003709031,0.9910422,0.001321172,0.0001404617,0.00003489791,0.0017683295,0.0007388778,0.00022368983,0.0014066636,0.000043785243,0.00009427684],"about_ca_topic_score_codex":0.00093208434,"about_ca_topic_score_gemma":0.000046757574,"teacher_disagreement_score":0.0034194868,"about_ca_system_score_codex":0.000038829927,"about_ca_system_score_gemma":0.00006688368,"threshold_uncertainty_score":0.44649976},"labels":[],"label_agreement":null},{"id":"W2037208330","doi":"10.1136/ard.2004.031286","title":"Autoantibodies in biological agent naive patients with psoriatic arthritis","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Institute of Musculoskeletal Health and Arthritis; Arthritis Society","keywords":"Medicine; Autoantibody; Psoriatic arthritis; Rheumatoid factor; Rheumatoid arthritis; Anti-nuclear antibody; Antibody; Internal medicine; Systemic lupus erythematosus; Immunology; Etanercept; Psoriasis; Arthritis; Rheumatology; Gastroenterology; Disease","score_opus":0.028280922396857,"score_gpt":0.29212565625787185,"score_spread":0.26384473386101487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037208330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853827,0.011210864,0.000005008397,0.0024636693,0.00005712335,0.0005368575,0.00005430581,0.000028487917,0.00026101072],"genre_scores_gemma":[0.9791853,0.020221552,0.00014160051,0.0003088023,0.000023112863,0.000038990125,0.000020159689,0.000012832283,0.000047645346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985381,0.000120225784,0.00037950958,0.00017538846,0.00045995892,0.00032684088],"domain_scores_gemma":[0.9990978,0.00014681825,0.00012947066,0.00033091617,0.00014500335,0.00014997309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013817094,0.00015338343,0.000412511,0.00010023527,0.00007370246,0.000020426309,0.00017666866,0.000034495522,0.00025963824],"category_scores_gemma":[0.0005861235,0.000082820094,0.00014430843,0.00019098948,0.00029382235,0.00012450387,0.0000737868,0.000099495366,0.000036202196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006579556,0.0019574186,0.6017313,0.00016597987,0.00029237857,0.000009840717,0.00087703357,0.00004919828,0.000009042933,0.0009918705,0.0034283102,0.38982967],"study_design_scores_gemma":[0.0026306582,0.0004772428,0.99146616,0.0024437888,0.000006836985,0.000004639579,0.00020534263,0.00009766547,0.00018989058,0.0011273107,0.0012281279,0.00012232161],"about_ca_topic_score_codex":0.00004655392,"about_ca_topic_score_gemma":0.000036149275,"teacher_disagreement_score":0.38973486,"about_ca_system_score_codex":0.000015788019,"about_ca_system_score_gemma":0.00008620405,"threshold_uncertainty_score":0.33773053},"labels":[],"label_agreement":null},{"id":"W2040026984","doi":"10.1136/annrheumdis-2015-207491","title":"Response to: ‘Concerns about report suggesting glucosamine and chondroitin protect against cartilage loss’ by Felson","year":2015,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PerkinElmer Biosignal; Université de Montréal","funders":"","keywords":"Medicine; Chondroitin sulphate; Glucosamine; Cartilage; Chondroitin; Bioinformatics; Glycosaminoglycan; Anatomy; Biochemistry; Biology","score_opus":0.03806864254343672,"score_gpt":0.3070001719046648,"score_spread":0.26893152936122805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040026984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7358922,0.0054993583,0.000004453751,0.254796,0.0002868137,0.002184096,0.00082740095,0.00009137584,0.0004183122],"genre_scores_gemma":[0.5868167,0.001052208,0.00048025738,0.3426308,0.0014174602,0.001049868,0.00276084,0.00042777183,0.06336407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701846,0.0002980941,0.0007526008,0.0005348721,0.0008863853,0.0005095656],"domain_scores_gemma":[0.99729085,0.0003895551,0.00064446713,0.0010302695,0.00030094964,0.00034390634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060353614,0.00047657065,0.0010031742,0.00014161666,0.00011327913,0.00006187808,0.00025527025,0.00027958798,0.00004205865],"category_scores_gemma":[0.0036720533,0.00033740015,0.00030670874,0.00019724572,0.00017720458,0.000097094504,0.00018674358,0.00040057677,0.000020364625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008952872,0.00014934482,0.00043900346,0.0009929516,0.0001436301,0.0019110622,0.00024474252,0.0000013746657,0.0016991156,0.00000204964,0.97429997,0.019221487],"study_design_scores_gemma":[0.009238579,0.006338411,0.0029441759,0.043619446,0.0022575867,0.0017241661,0.00031771697,0.000035733738,0.04759622,0.0012385037,0.8826938,0.0019956178],"about_ca_topic_score_codex":0.000053722582,"about_ca_topic_score_gemma":0.000004820615,"teacher_disagreement_score":0.14907548,"about_ca_system_score_codex":0.00006098366,"about_ca_system_score_gemma":0.00041050778,"threshold_uncertainty_score":0.9999078},"labels":[],"label_agreement":null},{"id":"W2040739084","doi":"10.1136/annrheumdis-2014-205267","title":"Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Inflammation; Psoriasis; Arthritis; Dermatology; Internal medicine","score_opus":0.009494289473797829,"score_gpt":0.22885745089622625,"score_spread":0.21936316142242843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040739084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825066,0.00044513005,0.0000019114962,0.00041444032,0.00001413015,0.0006859762,0.00009296257,0.00000882944,0.0000859749],"genre_scores_gemma":[0.99965394,0.00014481602,0.0000139222,0.00006901242,0.00000804577,0.0000326079,0.000028793262,0.000015748317,0.000033137647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987133,0.00012913407,0.00038265498,0.000119902776,0.000501886,0.00015307877],"domain_scores_gemma":[0.9986046,0.00025824254,0.00051389326,0.0003501651,0.00022581933,0.000047256948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015286662,0.00014498911,0.000500204,0.00005408354,0.000046849713,0.0000061218307,0.00011035486,0.000028596472,0.00008261205],"category_scores_gemma":[0.00042603462,0.000071457056,0.0001015161,0.00020331476,0.00017819893,0.00006646219,0.00004064188,0.000041753297,0.000002658259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018521595,0.0021145344,0.9533732,0.00054037885,0.0020569758,0.0000021866435,0.0033361956,0.00017293733,0.00006493026,0.00016271867,0.0008961633,0.035427634],"study_design_scores_gemma":[0.0055112345,0.0009638597,0.9870143,0.0050841044,0.0002514884,3.592344e-7,0.00011916469,0.00030553833,0.00042630872,0.00024345242,0.000005296935,0.00007492647],"about_ca_topic_score_codex":0.00040835512,"about_ca_topic_score_gemma":0.000053231455,"teacher_disagreement_score":0.035352707,"about_ca_system_score_codex":0.000016861952,"about_ca_system_score_gemma":0.000043321626,"threshold_uncertainty_score":0.29139343},"labels":[],"label_agreement":null},{"id":"W2041141449","doi":"10.1136/annrheumdis-2013-204599","title":"Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; Université de Montréal","funders":"","keywords":"Autophagy; PI3K/AKT/mTOR pathway; RPTOR; Cell biology; Chondrocyte; Mechanistic target of rapamycin; mTORC2; FOXO3; AMPK; Cartilage; Medicine; Kinase; Cancer research; Protein kinase B; Protein kinase A; Signal transduction; Biology; Apoptosis; mTORC1; Anatomy; Biochemistry","score_opus":0.018060247864816435,"score_gpt":0.2435924278040848,"score_spread":0.22553217993926836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041141449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905343,0.007948455,0.000026645934,0.00047142303,0.000111194044,0.00061175984,0.00009354164,0.000030328296,0.00017233168],"genre_scores_gemma":[0.9989545,0.00037114372,0.00030214983,0.000089241395,0.000036554207,0.00003932366,0.000028937058,0.000017251607,0.00016091889],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900836,0.00009213272,0.0003130469,0.00017877088,0.00024987987,0.0001578262],"domain_scores_gemma":[0.9990822,0.00013787646,0.00020231729,0.0003577851,0.000105501975,0.000114302326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009348417,0.0001409732,0.00038569522,0.000046461828,0.000057104844,0.000012985801,0.0000897273,0.000050980838,0.00009515063],"category_scores_gemma":[0.00017563887,0.00009961507,0.00014903024,0.0000839054,0.00013585361,0.00007821374,0.000052677482,0.0000403703,0.000008211142],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009841566,0.0008124925,0.0035466035,0.0010880135,0.00018060386,0.00000885819,0.0010735457,0.000012369129,0.14053233,0.0027610718,0.0014299591,0.84757],"study_design_scores_gemma":[0.004362391,0.0027059533,0.06532593,0.0045213937,0.00031270736,0.000016627515,0.0002447729,0.0001775637,0.90826267,0.013051857,0.0007894532,0.00022866302],"about_ca_topic_score_codex":0.00003782392,"about_ca_topic_score_gemma":0.000008285209,"teacher_disagreement_score":0.84734136,"about_ca_system_score_codex":0.0000052973064,"about_ca_system_score_gemma":0.000027702088,"threshold_uncertainty_score":0.40621847},"labels":[],"label_agreement":null},{"id":"W2042454450","doi":"10.1136/annrheumdis-2014-205227","title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institutes of Health; Versus Arthritis; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Observational study; Prospective cohort study; Arthritis; Cohort study; Cohort; Physical therapy; Internal medicine","score_opus":0.040725986430317336,"score_gpt":0.35022131291267233,"score_spread":0.309495326482355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042454450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957034,0.0009973976,0.00006119184,0.00048281276,0.00006966379,0.0023268384,0.000048584498,0.000017199103,0.00029293407],"genre_scores_gemma":[0.9981972,0.001118748,0.0002873436,0.00005837908,0.00004075086,0.00023640569,0.000023170527,0.000021626458,0.000016394864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965289,0.0004934252,0.0012047115,0.00031394578,0.0011482419,0.0003107766],"domain_scores_gemma":[0.9974125,0.0010290697,0.0005007084,0.00048697117,0.0004343004,0.00013645025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021118112,0.00020267886,0.00080902793,0.0001071403,0.00018835875,0.00003142579,0.00032441466,0.00004356982,0.000048462032],"category_scores_gemma":[0.0012016469,0.00011017463,0.00020460166,0.00038284218,0.00052002945,0.00015793095,0.00015063013,0.0002316282,0.0000053199824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022255753,0.0017546627,0.9589446,0.000090416856,0.00083010976,0.0000021776768,0.0031163855,0.000017794933,0.0000057436823,0.00028199196,0.000110100715,0.034623414],"study_design_scores_gemma":[0.002930647,0.0008628717,0.99021405,0.0030712595,0.000023981238,0.000005784374,0.0020427108,0.00014740427,0.00016115596,0.00039322767,0.000030503796,0.000116421725],"about_ca_topic_score_codex":0.000060105,"about_ca_topic_score_gemma":0.000076370736,"teacher_disagreement_score":0.03450699,"about_ca_system_score_codex":0.000016845344,"about_ca_system_score_gemma":0.00037806976,"threshold_uncertainty_score":0.4492791},"labels":[],"label_agreement":null},{"id":"W2042905056","doi":"10.1136/ard.2004.030825","title":"Introduction/overview on clinical registries","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Epidemiology; Observational study; MEDLINE; Clinical trial; Disease; Family medicine; Cohort; Health care; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.7917909597604409,"score_gpt":0.5860674629489896,"score_spread":0.2057234968114513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042905056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019954043,0.953154,0.000014412039,0.04141192,0.0016935985,0.0011267132,0.0014197397,0.000039203576,0.0011204293],"genre_scores_gemma":[0.000020542406,0.99045575,0.00009061449,0.0048400033,0.001681174,0.00015105262,0.00009700271,0.0000614019,0.0026024836],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98763,0.0014013307,0.00966555,0.0007260371,0.00019471644,0.00038235978],"domain_scores_gemma":[0.98426074,0.0033486497,0.0100064045,0.002058424,0.000094902935,0.0002308737],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.011638425,0.00043753907,0.004771417,0.00026459497,0.0001783797,0.00008149888,0.0010752275,0.00026534023,0.0011915823],"category_scores_gemma":[0.021881131,0.0003627299,0.0018405969,0.0003417824,0.00027998595,0.0002418948,0.00016156268,0.0003350732,0.0041400874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000047642916,0.00025025092,0.00005910128,0.018176256,0.00043066303,1.4407698e-7,0.00003836391,0.00001161011,2.4369028e-11,0.06339076,0.5558774,0.3617607],"study_design_scores_gemma":[0.00013422164,0.000063401305,0.0003525496,0.011889776,0.00015261151,0.000003221142,0.000032734897,0.0000171661,1.0226663e-8,0.0070872866,0.97995144,0.00031556984],"about_ca_topic_score_codex":0.00006625609,"about_ca_topic_score_gemma":0.000007590055,"teacher_disagreement_score":0.42407405,"about_ca_system_score_codex":0.0001511765,"about_ca_system_score_gemma":0.00051714765,"threshold_uncertainty_score":0.99988246},"labels":[],"label_agreement":null},{"id":"W2043344789","doi":"10.1136/ard.61.suppl_2.ii78","title":"Type II collagen degradation and its regulation in articular cartilage in osteoarthritis","year":2002,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":304,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Jewish General Hospital; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research; Canadian Arthritis Network; National Institutes of Health; Shriners Hospitals for Children; Amgen","keywords":"Medicine; Osteoarthritis; Cartilage; Rheumatoid arthritis; Population; Extracellular matrix; Chondrocyte; Arthritis; Type II collagen; Degeneration (medical); Pathology; Bioinformatics; Surgery; Internal medicine; Anatomy; Cell biology; Biology","score_opus":0.07274705240112894,"score_gpt":0.32492924456206784,"score_spread":0.2521821921609389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043344789","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044060685,0.95397335,3.141078e-7,0.00011932766,0.00009219754,0.0015256836,0.000048255046,0.000013172009,0.00016698551],"genre_scores_gemma":[0.06446906,0.93451506,0.00001467321,0.00002801995,0.000014464422,0.00008959733,0.00011285348,0.000025823103,0.00073045166],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985761,0.0001681959,0.000594908,0.00021985022,0.00024760107,0.00019333942],"domain_scores_gemma":[0.99918616,0.00008493399,0.000270336,0.0003046056,0.000066707435,0.000087250315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013650423,0.00022831047,0.0010095469,0.00020084182,0.000046953748,0.000013719086,0.00008105052,0.000121357196,0.00011374587],"category_scores_gemma":[0.00031918572,0.00016211852,0.00020198287,0.00043866877,0.000034954202,0.00009653966,0.00006807193,0.00006203601,0.000015720312],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026502112,0.00022201898,0.000050499897,0.0060483776,0.000029757444,0.000021884223,0.000123543,0.0000010634773,0.0000068494287,0.00017160989,0.00015465377,0.99314326],"study_design_scores_gemma":[0.015213352,0.0073389634,0.007516423,0.73724914,0.0080444785,0.00040660016,0.00044916698,0.0004254458,0.0026825825,0.0040155686,0.21439375,0.0022645271],"about_ca_topic_score_codex":0.000009080356,"about_ca_topic_score_gemma":0.000044342996,"teacher_disagreement_score":0.9908787,"about_ca_system_score_codex":0.00003304288,"about_ca_system_score_gemma":0.00010017684,"threshold_uncertainty_score":0.6611001},"labels":[],"label_agreement":null},{"id":"W2044691534","doi":"10.1136/annrheumdis-2015-207259.108","title":"A5.2 Kawasaki disease and exposure to fine particulate air pollution","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Air pollution; Metropolitan area; Particulates; Pollution; Environmental health; Environmental science; Meteorology; Geography; Pathology","score_opus":0.08552354551965025,"score_gpt":0.33458032862688886,"score_spread":0.2490567831072386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044691534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94420093,0.00046991647,0.00006500212,0.054670807,0.00006679783,0.0002728493,0.000057037243,0.000022306713,0.0001743301],"genre_scores_gemma":[0.99342346,0.000037082867,0.00009258794,0.006173731,0.000013978969,0.000014041786,0.0000027858625,0.0000069143475,0.0002354129],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988933,0.000125835,0.00024369158,0.00014832236,0.0003444777,0.00024433783],"domain_scores_gemma":[0.998664,0.00004797188,0.00010654703,0.00033317824,0.000015727486,0.0008325767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003077433,0.0001008692,0.00015148,0.000017055954,0.0001037007,0.000013519542,0.0001681955,0.000020300376,0.00013487619],"category_scores_gemma":[0.00086209434,0.00006743355,0.000056530884,0.00015649889,0.00015203646,0.00017255482,0.00019606204,0.00003488922,0.00011326592],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083250424,0.0011355886,0.28379348,0.00067982095,0.000101738595,0.000007823327,0.0056427587,0.06658193,0.00003859391,0.0018854045,0.552174,0.087126374],"study_design_scores_gemma":[0.00024162457,0.00012736054,0.98643136,0.00017332926,0.000035521763,8.798206e-7,0.00012301812,0.0007032667,0.00009783052,0.010219644,0.0017366821,0.000109476714],"about_ca_topic_score_codex":0.00022486987,"about_ca_topic_score_gemma":0.00004148462,"teacher_disagreement_score":0.70263785,"about_ca_system_score_codex":0.000021619786,"about_ca_system_score_gemma":0.000042786807,"threshold_uncertainty_score":0.27498603},"labels":[],"label_agreement":null},{"id":"W2046730711","doi":"10.1136/ard.59.suppl_1.i32","title":"Efficacy and toxicity of old and new disease modifying antirheumatic drugs","year":2000,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Seriousness; Disease; Intensive care medicine; Evidence-based medicine; Psychosocial; Physical therapy; Alternative medicine; Internal medicine; Psychiatry; Pathology","score_opus":0.09766010639764669,"score_gpt":0.3733425305787751,"score_spread":0.2756824241811284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046730711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043930292,0.953882,0.0000024153876,0.00035363625,0.000051736155,0.0013969677,0.00021597695,0.00002965043,0.0001373386],"genre_scores_gemma":[0.018466426,0.98094094,0.00004457997,0.000067185145,0.00002886201,0.000032998654,0.00003622734,0.000055092343,0.0003277188],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972238,0.00028896306,0.0010427714,0.0003816964,0.0006662378,0.00039653585],"domain_scores_gemma":[0.99692386,0.00077790726,0.0005678553,0.0008629853,0.00008196597,0.00078540354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002665968,0.00046087915,0.0024013878,0.00024190037,0.00012450984,0.000056619247,0.00033879062,0.000099843965,0.00017919105],"category_scores_gemma":[0.0010376875,0.000285796,0.00062903523,0.0003094972,0.0005849759,0.00013706325,0.00022036814,0.0002189294,0.000008483988],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018231547,0.0003222521,0.000102481834,0.048184436,0.00065255235,0.000004649046,0.00025608545,9.645009e-7,3.5440135e-7,0.00022898545,0.0014592183,0.9486057],"study_design_scores_gemma":[0.0070486497,0.0007390319,0.007872911,0.79264116,0.0024365687,0.00014293814,0.00019799972,0.00025918562,0.000037174468,0.007584155,0.17969956,0.0013406458],"about_ca_topic_score_codex":0.0000976089,"about_ca_topic_score_gemma":0.0000010565544,"teacher_disagreement_score":0.9472651,"about_ca_system_score_codex":0.00001091478,"about_ca_system_score_gemma":0.0005960749,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W2048405539","doi":"10.1136/ard.2005.038232","title":"Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjögren's syndrome","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Vasoactive intestinal peptide; Medicine; Sialadenitis; Immunology; Submandibular gland; Saliva; Salivary gland; Endocrinology; Internal medicine; Receptor; Neuropeptide","score_opus":0.03192300950369006,"score_gpt":0.3077012230043019,"score_spread":0.2757782135006119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048405539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781257,0.00059012696,0.00016374412,0.00036661452,0.000017412243,0.00035947494,0.0000687208,0.000011029849,0.0006103115],"genre_scores_gemma":[0.99958146,0.000087270106,0.000082243554,0.000064380896,0.000007729272,0.000024988327,0.000014384206,0.000012589097,0.00012498387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990116,0.00007660368,0.00041519973,0.00012057927,0.00023400543,0.00014203064],"domain_scores_gemma":[0.9992294,0.00021264315,0.00009961564,0.00030532776,0.000078984674,0.00007406541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017275433,0.0001312217,0.0004936682,0.0001249884,0.000027415286,0.0000021270837,0.00012122967,0.000029647657,0.000110482644],"category_scores_gemma":[0.00017286108,0.00008275378,0.0002692068,0.00018332328,0.00013318048,0.00006707527,0.000029232655,0.00007017039,0.0000018827188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010764425,0.01882297,0.8189206,0.017026525,0.0041744383,0.00004688546,0.0068288413,0.047017343,0.021893574,0.0038039787,0.003902566,0.046797864],"study_design_scores_gemma":[0.010350728,0.0062659993,0.86052555,0.0072768927,0.002146941,0.00010156419,0.0004899883,0.03568276,0.072524615,0.0041829273,0.0000074298737,0.0004445958],"about_ca_topic_score_codex":0.00017055594,"about_ca_topic_score_gemma":0.000016957714,"teacher_disagreement_score":0.05063104,"about_ca_system_score_codex":0.000008300057,"about_ca_system_score_gemma":0.000060936072,"threshold_uncertainty_score":0.33746013},"labels":[],"label_agreement":null},{"id":"W2048491272","doi":"10.1136/annrheumdis-2014-eular.2204","title":"FRI0127 Eular Recommendations for the Use of Imaging in Spondyloarthritis in Clinical Practice","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Clinical Practice; Ankylosing spondylitis; Physical therapy; Medical physics; Intensive care medicine; Dermatology; Sacroiliitis; Internal medicine","score_opus":0.14302355033731934,"score_gpt":0.41529526998884386,"score_spread":0.2722717196515245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048491272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9117635,0.011133927,0.0002336383,0.074078776,0.00047693678,0.0017359583,0.00028055435,0.000016910597,0.00027981837],"genre_scores_gemma":[0.9927661,0.0043155914,0.0011367631,0.0015921324,0.000024319743,0.00008669359,0.000017362505,0.000013013941,0.000048026537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986154,0.00021596407,0.00067850144,0.00013865811,0.000177118,0.00017434939],"domain_scores_gemma":[0.99529207,0.0037919423,0.0002973752,0.00041207758,0.00015697433,0.000049583567],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00060872035,0.00009927691,0.00036292584,0.000063392006,0.000066808214,0.000011999838,0.000119794204,0.000022501416,0.000035400313],"category_scores_gemma":[0.0086658215,0.00006054817,0.00022824989,0.00018367804,0.00014678667,0.00016015631,0.00007485936,0.00007633413,0.0000026706311],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007504922,0.0023521236,0.3246302,0.0002283419,0.0003016947,0.000008762445,0.0005361881,0.00007203327,0.0000040378695,0.0018854175,0.020664657,0.648566],"study_design_scores_gemma":[0.0055992175,0.00030526597,0.92235494,0.0029968251,0.00036390204,0.000016588669,0.0010877891,0.0022683681,0.000064833956,0.0020280064,0.062787145,0.00012714468],"about_ca_topic_score_codex":0.0003540844,"about_ca_topic_score_gemma":0.00010354961,"teacher_disagreement_score":0.6484389,"about_ca_system_score_codex":0.000009093126,"about_ca_system_score_gemma":0.00004748973,"threshold_uncertainty_score":0.99968463},"labels":[],"label_agreement":null},{"id":"W2058763135","doi":"10.1136/annrheumdis-2013-203630","title":"Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University Health Network; Toronto Western Hospital","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research; Arthritis Society; University Health Network","keywords":"Medicine; Sclerostin; Ankylosing spondylitis; Immunology; Immune system; Internal medicine; Antibody; Endocrinology; Biology; Biochemistry","score_opus":0.07496659506462795,"score_gpt":0.30295371719322556,"score_spread":0.22798712212859762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058763135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907246,0.005572988,0.000002905805,0.0017911618,0.000045913745,0.0005385317,0.0011842282,0.000014144306,0.00012548109],"genre_scores_gemma":[0.99907756,0.00046928428,0.00014358707,0.00016084341,0.0000066813927,0.000022506025,0.000014604943,0.000014819744,0.0000901308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988973,0.000041294235,0.00045439418,0.00015336463,0.00022528143,0.00022835577],"domain_scores_gemma":[0.99902785,0.00016843152,0.00026162274,0.0003035883,0.00015731089,0.0000811986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008647579,0.00015351048,0.0005466646,0.00008193636,0.000067573535,0.000013534404,0.000094942036,0.000030644995,0.00031929713],"category_scores_gemma":[0.0003803376,0.00010568635,0.000118070435,0.00021306681,0.00022271877,0.000098660705,0.00011723482,0.000051741084,0.000004037762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003877578,0.0031951186,0.9164405,0.0023914175,0.0009487484,0.00001735808,0.0012047453,0.000027764498,0.008101529,0.00083394774,0.0010747126,0.06537641],"study_design_scores_gemma":[0.00249165,0.00012468708,0.9886366,0.004486253,0.00007431166,0.000010913198,0.00058363477,0.00016532477,0.002733342,0.0005882287,0.000017116083,0.00008791508],"about_ca_topic_score_codex":0.0006449084,"about_ca_topic_score_gemma":0.000034967776,"teacher_disagreement_score":0.07219613,"about_ca_system_score_codex":0.000010272806,"about_ca_system_score_gemma":0.000030986186,"threshold_uncertainty_score":0.43097642},"labels":[],"label_agreement":null},{"id":"W2061394912","doi":"10.1136/ard.2005.035824","title":"Antiphospholipid antibody tests: spreading the net","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Thrombosis; Internal medicine; Gastroenterology; Antibody; Systemic lupus erythematosus; Immunology; Disease","score_opus":0.04670030120327219,"score_gpt":0.3697862649220894,"score_spread":0.3230859637188172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061394912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733278,0.006253722,0.000017584174,0.014417744,0.00017442748,0.0007604392,0.000034811303,0.00005663622,0.0049568205],"genre_scores_gemma":[0.99519,0.0009413032,0.000058272144,0.0009083798,0.00015325443,0.000026166144,0.0000087477365,0.000029857338,0.0026839743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980156,0.0001372363,0.0004900344,0.00019952265,0.0007652303,0.00039237473],"domain_scores_gemma":[0.9976983,0.0005976601,0.00022686184,0.0011099193,0.00019561344,0.00017165474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052769366,0.00017447675,0.00041916457,0.00007470359,0.00015517484,0.000039888593,0.0005718413,0.0000450694,0.00033114813],"category_scores_gemma":[0.0016524309,0.000084556625,0.0003041142,0.0003738531,0.00027934177,0.00011663096,0.00019473181,0.00014072201,0.00013737706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040853707,0.0014143892,0.6431338,0.0034022653,0.0010994831,0.000016684047,0.0031111843,0.00016876032,0.0029795908,0.003115091,0.28359732,0.057552878],"study_design_scores_gemma":[0.007615642,0.00073225854,0.8176783,0.035857413,0.0013646425,0.005038729,0.007557907,0.014803366,0.03964609,0.0059330827,0.06247717,0.0012954207],"about_ca_topic_score_codex":0.000084391846,"about_ca_topic_score_gemma":0.0000048100333,"teacher_disagreement_score":0.22112015,"about_ca_system_score_codex":0.000026670357,"about_ca_system_score_gemma":0.00017963162,"threshold_uncertainty_score":0.36258397},"labels":[],"label_agreement":null},{"id":"W2062295516","doi":"10.1136/ard.2004.033928","title":"Psoriatic arthritis and imaging","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Ankylosis; Osteolysis; Magnetic resonance imaging; Ankylosing spondylitis; Radiography; Radiology; Periostitis; Arthritis; Spondylitis; Sacroiliitis; Deformity; Enthesis; Surgery; Internal medicine; Tendon","score_opus":0.061757984217481444,"score_gpt":0.37040019937579405,"score_spread":0.3086422151583126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062295516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015280004,0.9978262,4.0406542e-7,0.00046100194,0.00015843932,0.0007239041,0.0001867286,0.000022953673,0.00046754256],"genre_scores_gemma":[0.0009020222,0.9984354,0.000037984923,0.00015607335,0.000076392294,0.00008502136,0.000031346037,0.000035887777,0.00023986901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99866784,0.000072393836,0.000544101,0.00022569565,0.00025824545,0.00023173666],"domain_scores_gemma":[0.99880105,0.00017931379,0.0003605784,0.00046806497,0.00005912952,0.00013185159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000730106,0.00030058992,0.0016174758,0.00007911417,0.000104026505,0.000021307475,0.00012148601,0.000044806275,0.000103437],"category_scores_gemma":[0.00029273736,0.00017548932,0.00064423523,0.00014689374,0.00015810397,0.000048217127,0.00014408649,0.00009065236,0.000028310866],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005534869,0.00015322877,0.00007641446,0.0085296165,0.00059142563,0.000013841241,0.0000282556,2.987755e-8,1.3717604e-9,0.00007769391,0.0030367794,0.9874872],"study_design_scores_gemma":[0.0009971206,0.000075851116,0.0018731531,0.17610082,0.0035410344,0.00022142756,0.000052374533,0.000004799062,2.5898163e-7,0.00043192555,0.8164575,0.00024370184],"about_ca_topic_score_codex":0.000023993865,"about_ca_topic_score_gemma":0.0000040392015,"teacher_disagreement_score":0.9872435,"about_ca_system_score_codex":0.00001545518,"about_ca_system_score_gemma":0.00011894761,"threshold_uncertainty_score":0.7156247},"labels":[],"label_agreement":null},{"id":"W2065369177","doi":"10.1136/annrheumdis-2014-eular.1131","title":"AB0741 Multidimensional Health Related Quality of Life Assessment Using PROMIS (Patient Reported Outcome Measurement Information System) Measures in Psoriatic Arthritis Flares","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Psoriatic arthritis; Quality of life (healthcare); Physical therapy; Population; Patient-Reported Outcomes Measurement Information System; Computerized adaptive testing; Internal medicine; Psychometrics; Arthritis; Clinical psychology","score_opus":0.13899909960988802,"score_gpt":0.364791027849282,"score_spread":0.225791928239394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065369177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911202,0.0054738503,0.00026305552,0.0013403537,0.00021752751,0.0013982579,0.000048578193,0.000041291933,0.000096844364],"genre_scores_gemma":[0.99823946,0.000942401,0.00055922335,0.00015617284,0.0000085646,0.000053614578,0.00002279712,0.000015549545,0.0000022079373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932775,0.0010966136,0.0029357485,0.00019295365,0.0021442962,0.000352898],"domain_scores_gemma":[0.9962219,0.00020771565,0.0017878632,0.0006302029,0.0008572553,0.00029503848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036168718,0.00021276485,0.0010729543,0.00024662042,0.00013722805,0.00002389989,0.00014826917,0.00005814869,0.00002461796],"category_scores_gemma":[0.006287728,0.00014879114,0.0002920209,0.00031082582,0.00014987498,0.00027439184,0.00008547773,0.00016027554,0.0000029695489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029183317,0.004220747,0.59701294,0.01912092,0.0032391546,0.0000102549375,0.008624606,0.0049524736,0.0013259082,0.009627223,0.0020510931,0.34689638],"study_design_scores_gemma":[0.0052740434,0.0005632075,0.96625316,0.014097908,0.000027638816,0.00002234728,0.0019372101,0.010416201,0.0005245847,0.00056231755,0.0000828013,0.00023859568],"about_ca_topic_score_codex":0.0024759993,"about_ca_topic_score_gemma":0.00008803879,"teacher_disagreement_score":0.36924022,"about_ca_system_score_codex":0.00015447462,"about_ca_system_score_gemma":0.0008862053,"threshold_uncertainty_score":0.7527452},"labels":[],"label_agreement":null},{"id":"W2065541822","doi":"10.1136/annrheumdis-2012-eular.2728","title":"FRI0271 The SPARCC/SPARTAN (SPAR) reference imaging module for calibration of readers scoring with the msasss: Preliminary validation","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Medical physics; Radiography; CLARITY; Physical therapy; Radiology","score_opus":0.07109114586113136,"score_gpt":0.3197475845505307,"score_spread":0.24865643868939935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065541822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862352,0.004491258,0.0004320014,0.0074560503,0.000092972616,0.0009821197,0.00007294813,0.000017721975,0.00021973484],"genre_scores_gemma":[0.9990529,0.00031179306,0.00014058905,0.00018816536,0.000037041445,0.00013897705,0.000029551422,0.000014548857,0.00008642351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991092,0.000067064175,0.00023062134,0.00010798452,0.00027476047,0.00021036147],"domain_scores_gemma":[0.99885464,0.0002901095,0.0002651602,0.00041150703,0.00012430717,0.00005429032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019711952,0.00011972845,0.0002164256,0.000024777657,0.0002169801,0.000014208486,0.00013675044,0.000015279167,0.000017279152],"category_scores_gemma":[0.00021252646,0.000052326104,0.00010283404,0.00011748946,0.00017672959,0.00018331526,0.000054950524,0.00004331904,0.0000012072147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039009957,0.0024834129,0.8727518,0.0024879524,0.002528357,0.0000031433326,0.01482317,0.0011765944,0.00035854647,0.0065604583,0.03226414,0.06066145],"study_design_scores_gemma":[0.0028682097,0.0008809265,0.95065486,0.0040237606,0.0017326778,0.000024395722,0.014340403,0.003634783,0.019212758,0.0018263928,0.00053024775,0.00027056749],"about_ca_topic_score_codex":0.00012876844,"about_ca_topic_score_gemma":0.000010650037,"teacher_disagreement_score":0.0779031,"about_ca_system_score_codex":0.000010525026,"about_ca_system_score_gemma":0.00004174494,"threshold_uncertainty_score":0.21337967},"labels":[],"label_agreement":null},{"id":"W2065667870","doi":"10.1136/annrheumdis-2013-eular.1595","title":"FRI0468 Socioeconomic status predicts radiographic progression in ankylosing spondylitis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ankylosing spondylitis; Radiography; Univariate analysis; Internal medicine; Cohort; Spondylitis; Socioeconomic status; Physical therapy; Prospective cohort study; Cohort study; Multivariate analysis; Surgery; Population","score_opus":0.02200832273694236,"score_gpt":0.3006333444813916,"score_spread":0.27862502174444925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065667870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831483,0.013303498,7.292151e-7,0.001810101,0.00012928786,0.00089243264,0.00017019956,0.00003090609,0.00051459554],"genre_scores_gemma":[0.9961269,0.0032245566,0.000088522596,0.00025403532,0.000021336533,0.00013898843,0.00004558092,0.000018969406,0.000081106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987358,0.00006965962,0.00039757713,0.00019675143,0.00022363832,0.00037659126],"domain_scores_gemma":[0.999111,0.00010793208,0.00018041077,0.0003579765,0.000074795484,0.00016787615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008232657,0.00016384407,0.00041192124,0.00013099522,0.00009814263,0.000023648805,0.00010644348,0.000043419714,0.0006344562],"category_scores_gemma":[0.00015048242,0.00010716697,0.00024512372,0.00017215499,0.0001946404,0.00015335728,0.00008218915,0.000073601404,0.0000401912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001446089,0.0007533484,0.89671206,0.00035061873,0.00031019733,0.000012912911,0.00047279443,0.0000057410175,0.000021180402,0.00013838481,0.00480028,0.096277855],"study_design_scores_gemma":[0.0018424804,0.00022240222,0.9922301,0.0019381257,0.00008903044,0.000008852996,0.00035153102,0.00012343681,0.00015546671,0.0026190076,0.00032187768,0.00009769348],"about_ca_topic_score_codex":0.0004406169,"about_ca_topic_score_gemma":0.000019590447,"teacher_disagreement_score":0.09618016,"about_ca_system_score_codex":0.000028540486,"about_ca_system_score_gemma":0.00007207186,"threshold_uncertainty_score":0.6946851},"labels":[],"label_agreement":null},{"id":"W2065973713","doi":"10.1136/annrheumdis-2014-eular.3767","title":"OP0260 Denosumab for Patients Receiving Long-Term Glucocorticoids Who do not Have Adequate Response to Bisphosphonate Treatment: A Randomized Controlled Trial","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Denosumab; Bisphosphonate; Prednisolone; Discontinuation; Femoral neck; Osteoporosis; Bone mineral; Bone remodeling; Randomized controlled trial; Internal medicine; Surgery; Urology","score_opus":0.031609748543810615,"score_gpt":0.3379512742439828,"score_spread":0.3063415257001722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065973713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97934717,0.00076057354,0.00009232397,0.0027399291,0.00049141195,0.016321292,0.00011099933,0.00004530145,0.00009098864],"genre_scores_gemma":[0.9918858,0.0003370494,0.0000967128,0.00091434194,0.000028984934,0.004137771,0.000038503116,0.000052283078,0.002508579],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962951,0.0008970286,0.0013214502,0.00039014476,0.0005402946,0.00055599964],"domain_scores_gemma":[0.99320203,0.004332075,0.0007622328,0.00078617845,0.00035136714,0.00056613],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010733526,0.00039335262,0.00247183,0.000171027,0.0002272909,0.00005039087,0.00020235502,0.000087812325,0.00007432741],"category_scores_gemma":[0.010851313,0.00021708722,0.0012922562,0.00015263022,0.00013680707,0.00008783877,0.00006072376,0.00005944102,0.000029174962],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9253853,0.0023097377,0.007228807,0.00022616456,0.0014019181,0.0000029758005,0.00051976903,0.000006846752,0.0000039610873,0.00005848307,0.00029197044,0.0625641],"study_design_scores_gemma":[0.8642318,0.0037480984,0.12756336,0.0013770061,0.0017898733,0.0000016535521,0.000018902496,0.00038623915,0.00029837622,0.00034977178,0.000053321684,0.00018159961],"about_ca_topic_score_codex":0.00020024853,"about_ca_topic_score_gemma":0.000021571348,"teacher_disagreement_score":0.12033455,"about_ca_system_score_codex":0.00008523142,"about_ca_system_score_gemma":0.00028814533,"threshold_uncertainty_score":0.9974807},"labels":[],"label_agreement":null},{"id":"W2066163405","doi":"10.1136/annrheumdis-2012-eular.567","title":"AB0567 Safety of SC abatacept in patients with ra: Update from pooled clinical trial data","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Abatacept; Internal medicine; Incidence (geometry); Clinical trial; Rheumatoid arthritis; Adverse effect; Gastroenterology; Surgery","score_opus":0.05353156848443266,"score_gpt":0.3216012160168523,"score_spread":0.2680696475324197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066163405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97963333,0.017413327,0.000012423703,0.0001929051,0.0010728711,0.0004699966,0.0010985148,0.000012424412,0.00009423169],"genre_scores_gemma":[0.9984002,0.00038257006,0.000010804701,0.00014431468,0.0000040863115,0.0000069976622,0.0009834314,0.000012108996,0.000055478806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978696,0.0005481529,0.00093381916,0.00021894065,0.00009883186,0.00033063127],"domain_scores_gemma":[0.99768996,0.0004162128,0.0005699063,0.001239485,0.00007008504,0.000014364196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066538446,0.00016732392,0.0005692042,0.00005315525,0.000084825726,0.000005954322,0.001020512,0.000106314474,0.00040974945],"category_scores_gemma":[0.0009023004,0.0001032411,0.00016152143,0.00016441551,0.0004727843,0.00029177382,0.00040552535,0.00016737693,0.000062626816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10396241,0.020474983,0.60192466,0.00019925692,0.0034660117,4.4629832e-7,0.0016133834,0.000060990405,0.00014545702,0.0008809782,0.008048867,0.25922254],"study_design_scores_gemma":[0.02461833,0.00020767197,0.9723765,0.00038226644,0.00020750661,1.3981351e-7,0.000220258,0.000008079833,0.00023227144,0.00020699948,0.001383255,0.00015670588],"about_ca_topic_score_codex":0.0002741852,"about_ca_topic_score_gemma":0.00000464242,"teacher_disagreement_score":0.37045184,"about_ca_system_score_codex":0.0000043858217,"about_ca_system_score_gemma":0.000094980765,"threshold_uncertainty_score":0.4486469},"labels":[],"label_agreement":null},{"id":"W2070426536","doi":"10.1136/annrheumdis-2011-200976","title":"Dual energy CT in gout: a prospective validation study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"University of British Columbia; British Heart Foundation","keywords":"Medicine; Gout; Nuclear medicine; Intraclass correlation; Reproducibility; Tophus; Prospective cohort study; Uric acid; Internal medicine; Hyperuricemia","score_opus":0.04072788859102475,"score_gpt":0.32192374124442796,"score_spread":0.2811958526534032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070426536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650764,0.0010572536,0.000015368665,0.0006651517,0.00014380833,0.00063571415,0.000016664588,0.00003195351,0.00092646753],"genre_scores_gemma":[0.9991112,0.00005427949,0.00003265969,0.00023144261,0.000060812872,0.00009687874,0.000008934919,0.000020254925,0.0003835434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851644,0.00016728125,0.0003870559,0.00016106862,0.00048299113,0.00028516416],"domain_scores_gemma":[0.9989127,0.00014930565,0.00019848149,0.00051033444,0.00008585438,0.00014335105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031804666,0.00015288641,0.00036101506,0.00010344546,0.00004721225,0.00001104667,0.00013908025,0.000022523514,0.00010729306],"category_scores_gemma":[0.0008666909,0.000100057936,0.00013678164,0.00035400328,0.00006876049,0.00019653807,0.000109244414,0.000080318525,0.000022255246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014500601,0.0048968396,0.98204917,0.00015691282,0.00036156306,0.000008879151,0.0029446397,0.00002859274,0.000045417502,0.00070368254,0.0020513195,0.0066079814],"study_design_scores_gemma":[0.0011723008,0.00021421694,0.9925505,0.00031985273,0.00030366736,0.000020917094,0.0018344289,0.00007493448,0.0022106713,0.0010924137,0.000087105494,0.0001190207],"about_ca_topic_score_codex":0.0003394062,"about_ca_topic_score_gemma":0.000008284212,"teacher_disagreement_score":0.010501305,"about_ca_system_score_codex":0.00003904788,"about_ca_system_score_gemma":0.000085860986,"threshold_uncertainty_score":0.40802443},"labels":[],"label_agreement":null},{"id":"W2072598730","doi":"10.1136/annrheumdis-2012-eular.3031","title":"SAT0084 Effects of different steroid doses on adverse events and radiographic progression of certolizumab pegol-treated rheumatoid arthritis patients","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Rheumatoid arthritis; Certolizumab pegol; Adverse effect; Internal medicine; Placebo; Methotrexate; Prednisone; Incidence (geometry); Gastroenterology; Surgery; Arthritis; Adalimumab; Pathology","score_opus":0.013326545960858914,"score_gpt":0.2797568371324685,"score_spread":0.2664302911716096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072598730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741152,0.024221797,0.0000016202067,0.00018393702,0.00016485076,0.0011433533,0.000089404726,0.000024987157,0.000054827688],"genre_scores_gemma":[0.93398,0.06583803,0.00001829725,0.000018275996,0.000010480329,0.00006172442,0.00003133162,0.000029311994,0.0000125370925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754155,0.00030743444,0.0006501446,0.00020230889,0.0008665132,0.00043202814],"domain_scores_gemma":[0.9979966,0.0004093948,0.00049328187,0.0005359568,0.00021257464,0.00035215679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000862272,0.00028236836,0.00081343553,0.0002690794,0.000097554934,0.000005735412,0.0001949282,0.0000659918,0.000045866553],"category_scores_gemma":[0.00064965896,0.00017188615,0.00035913775,0.00025901597,0.00040195129,0.00018322695,0.00013160384,0.000108250664,0.0000032834275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013269186,0.0038362523,0.8843565,0.001959761,0.00054066733,0.000003941334,0.00064104836,5.790901e-7,0.0003414897,0.00017325526,0.00038758043,0.10643199],"study_design_scores_gemma":[0.004879906,0.0015555443,0.95403284,0.016102009,0.00003206355,0.000019760348,0.00011767876,0.000017087417,0.022672335,0.00039278317,0.000026174212,0.00015183566],"about_ca_topic_score_codex":0.000051076066,"about_ca_topic_score_gemma":0.0000034735313,"teacher_disagreement_score":0.106280155,"about_ca_system_score_codex":0.000010825368,"about_ca_system_score_gemma":0.00003905387,"threshold_uncertainty_score":0.7009314},"labels":[],"label_agreement":null},{"id":"W2074332591","doi":"10.1136/annrheumdis-2013-eular.479","title":"OP0274 Recommendations for Screening and Detection of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; DLCO; CTD; Pulmonary hypertension; Mixed connective tissue disease; Internal medicine; Connective tissue disease; Scleroderma (fungus); Interstitial lung disease; Asymptomatic; Cardiology; Intensive care medicine; Disease; Pathology; Diffusing capacity; Lung; Autoimmune disease; Lung function","score_opus":0.06693960603646809,"score_gpt":0.29924559648651855,"score_spread":0.23230599045005046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074332591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149454,0.0032057497,0.00018264724,0.003459786,0.00021473775,0.0011641429,0.00021951711,0.000030332847,0.000028526763],"genre_scores_gemma":[0.9988263,0.0005837878,0.00006173456,0.00021596593,0.0000346335,0.00012377754,0.000061962906,0.000017768547,0.0000740566],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989459,0.00010777621,0.00043110986,0.00016948735,0.00019474425,0.00015098418],"domain_scores_gemma":[0.9984418,0.0004050235,0.00034281617,0.00025437522,0.00035505774,0.00020093838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012477528,0.0001264888,0.0003587449,0.000074091506,0.00013244798,0.000016548605,0.000076217366,0.000055372468,0.000070144],"category_scores_gemma":[0.0016108892,0.00008327292,0.00019879136,0.00013520922,0.000107019834,0.0001261845,0.000046426958,0.000038934537,0.0000022760241],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002940501,0.0050089527,0.04039062,0.003627441,0.0026545306,0.000004446781,0.00061421376,0.00010705098,0.10653452,0.00028787364,0.025231967,0.8125979],"study_design_scores_gemma":[0.0018307233,0.00022262779,0.9734974,0.0066625564,0.0009017905,0.000008720158,0.0008065214,0.0067491317,0.0072043682,0.0018631082,0.00008930988,0.00016374001],"about_ca_topic_score_codex":0.00012657235,"about_ca_topic_score_gemma":0.0000013109988,"teacher_disagreement_score":0.9331068,"about_ca_system_score_codex":0.000009007343,"about_ca_system_score_gemma":0.000048988837,"threshold_uncertainty_score":0.33957714},"labels":[],"label_agreement":null},{"id":"W2076213451","doi":"10.1136/ard.2005.041855","title":"PD-0200347, an α2δ ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: a PKCα dependent effect","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Pfizer","keywords":"Medicine; In vivo; p38 mitogen-activated protein kinases; Phosphorylation; Cartilage; Kinase; CREB; Protein kinase C; Internal medicine; Signal transduction; Endocrinology; Osteoarthritis; Cell biology; Protein kinase A; Anatomy; Transcription factor; Chemistry; Biology; Pathology; Biochemistry","score_opus":0.022481728173436633,"score_gpt":0.278079485809335,"score_spread":0.25559775763589837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076213451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555147,0.0017876353,0.0000027026927,0.0005947928,0.00013721922,0.0016726345,0.00011192296,0.000015539285,0.00012607985],"genre_scores_gemma":[0.99929625,0.00012272604,0.0000065929207,0.00020541529,0.000026146574,0.00007445677,0.000010918656,0.000026379563,0.00023110886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794346,0.00029102206,0.00066511333,0.00023476734,0.0005636971,0.0003019377],"domain_scores_gemma":[0.99839306,0.00026617714,0.00041963044,0.0007008461,0.00011982441,0.00010045984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033559953,0.00024851217,0.00058103877,0.00013749383,0.000067246845,0.000011778554,0.0003102009,0.00009730284,0.00004363886],"category_scores_gemma":[0.00076361257,0.00013205655,0.00026757354,0.00050059997,0.00014773283,0.00020039281,0.00011976833,0.00014865825,0.000002846613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042449133,0.0099372445,0.071764044,0.0052716555,0.0004220777,0.0000266439,0.0119827045,0.0016140594,0.6866968,0.00072999264,0.00057390356,0.20673591],"study_design_scores_gemma":[0.004304941,0.0009884026,0.017651277,0.008455179,0.00009528276,0.000009343692,0.00037134177,0.00020105406,0.9673882,0.00038558219,0.000023071303,0.00012630188],"about_ca_topic_score_codex":0.00015176102,"about_ca_topic_score_gemma":0.0005053382,"teacher_disagreement_score":0.2806914,"about_ca_system_score_codex":0.00004377262,"about_ca_system_score_gemma":0.00019941031,"threshold_uncertainty_score":0.538511},"labels":[],"label_agreement":null},{"id":"W2076575100","doi":"10.1136/ard.2008.092304","title":"Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Hospital for Sick Children; Toronto Western Hospital","funders":"","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Age of onset; Disease","score_opus":0.12467608342906154,"score_gpt":0.40847317553764423,"score_spread":0.28379709210858267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076575100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888633,0.009007325,0.0000015333646,0.0004441875,0.00019628105,0.00029757383,0.0010344401,0.000013092038,0.00014225191],"genre_scores_gemma":[0.9939856,0.0056827758,0.00016559678,0.00006585815,0.000014606588,0.000008563476,0.00004444701,0.000011814677,0.000020734367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981672,0.00015466944,0.00094500306,0.00018597413,0.0003600542,0.00018705487],"domain_scores_gemma":[0.99808204,0.00060170965,0.0005120406,0.00043505093,0.0002234912,0.0001456443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017771484,0.0001577063,0.0010871671,0.00008455387,0.00011278383,0.0000031177385,0.000115393275,0.00005667435,0.00006448453],"category_scores_gemma":[0.0011852726,0.00011214935,0.0004544704,0.00025089594,0.0010060753,0.000054382097,0.00009462915,0.00008445727,0.0000011830961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022290156,0.0012364738,0.98319715,0.0004441578,0.00072146475,0.000011427854,0.00040304856,0.0000012847922,0.0000016313118,0.00005338152,0.0032676088,0.008433368],"study_design_scores_gemma":[0.004183486,0.0008161313,0.9919629,0.001288075,0.00042770454,0.000039376104,0.00043959735,0.00008346174,0.0003457503,0.00022930675,0.00009698942,0.00008720707],"about_ca_topic_score_codex":0.00025773337,"about_ca_topic_score_gemma":0.000024135506,"teacher_disagreement_score":0.008765777,"about_ca_system_score_codex":0.000003877117,"about_ca_system_score_gemma":0.00009330819,"threshold_uncertainty_score":0.45733178},"labels":[],"label_agreement":null},{"id":"W2079467457","doi":"10.1136/annrheumdis-2013-eular.455","title":"OP0250 Denosumab Treatment of Postmenopausal Women with Osteoporosis for 7 Years: Clinical Fracture Results from the First 4 Years of the Freedom Extension","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Denosumab; Osteoporosis; Incidence (geometry); Postmenopausal women; Surgery; Internal medicine; Mathematics","score_opus":0.055797879566158684,"score_gpt":0.35274348224835655,"score_spread":0.2969456026821979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079467457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861043,0.0012273025,8.88079e-7,0.00915817,0.00009692494,0.0027838,0.00059829553,0.000009497466,0.000020794681],"genre_scores_gemma":[0.99811363,0.000565491,0.00010466384,0.0007958217,0.0000566987,0.00018522047,0.000027997172,0.000025029796,0.0001254523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976919,0.0002144576,0.00085864164,0.00025979313,0.00065223174,0.00032293453],"domain_scores_gemma":[0.9954288,0.00211036,0.00060411595,0.0012907225,0.0003654435,0.00020053133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000428625,0.00016595828,0.0006369617,0.000035735622,0.00010485221,0.00001660118,0.00039137917,0.00008324874,0.00009497211],"category_scores_gemma":[0.0014589368,0.00007054607,0.00024056135,0.00019679009,0.00040749807,0.000062238636,0.00010686895,0.00011071886,0.000008061711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039428674,0.022726964,0.43694156,0.0019377167,0.00392574,0.000013540491,0.038884755,0.00031896547,0.0003467023,0.000036859878,0.14590576,0.30953273],"study_design_scores_gemma":[0.0046088495,0.004580834,0.9857161,0.0008684054,0.00022107919,0.0000016221787,0.002485488,0.00007672794,0.0002490789,0.0002878016,0.00083206623,0.00007197262],"about_ca_topic_score_codex":0.0034667102,"about_ca_topic_score_gemma":0.00017146395,"teacher_disagreement_score":0.5487745,"about_ca_system_score_codex":0.000032516804,"about_ca_system_score_gemma":0.0003650032,"threshold_uncertainty_score":0.5240652},"labels":[],"label_agreement":null},{"id":"W2082627748","doi":"10.1136/ard.2008.091454","title":"Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Institute of Population and Public Health; University of Toronto; University of British Columbia; Institute for Work & Health","funders":"National Institutes of Health","keywords":"Medicine; Rheumatism; Clinical trial; Physical therapy; Rheumatology; Rheumatoid arthritis; MEDLINE; Disease; Systematic review; Internal medicine; Family medicine","score_opus":0.1329094048603239,"score_gpt":0.4186799448739687,"score_spread":0.28577054001364477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082627748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894313,0.0059058936,0.000030056926,0.002525112,0.00012421538,0.0013480975,0.00049691874,0.000025399235,0.00011298032],"genre_scores_gemma":[0.94746023,0.05204467,0.00017526798,0.000096402364,0.00001571239,0.00008869236,0.00006687177,0.000024093051,0.000028044553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938478,0.0015389625,0.0032159977,0.0002993025,0.00076979975,0.00032815756],"domain_scores_gemma":[0.9929754,0.0016138919,0.0035397285,0.00070606073,0.0007768005,0.00038812813],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0031400954,0.00021445102,0.0015075819,0.00017805095,0.00016639498,0.000017059838,0.0002035828,0.000053625274,0.00017212305],"category_scores_gemma":[0.032246284,0.0001364926,0.00048588956,0.00059670984,0.00063343864,0.00028771663,0.00009986997,0.00021242176,0.0000041852322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037670543,0.0034890405,0.90943044,0.00023406124,0.00049962196,0.000026139533,0.0005319496,0.000020344196,0.000010223049,0.0001703271,0.004392216,0.077428564],"study_design_scores_gemma":[0.004605638,0.00043694704,0.98824656,0.0047749877,0.000017131837,0.000005128573,0.00028251676,0.000086226304,0.00036791575,0.0006411449,0.00038754588,0.00014823177],"about_ca_topic_score_codex":0.00007921765,"about_ca_topic_score_gemma":0.0000374089,"teacher_disagreement_score":0.07881613,"about_ca_system_score_codex":0.000017320055,"about_ca_system_score_gemma":0.0009376311,"threshold_uncertainty_score":0.97590554},"labels":[],"label_agreement":null},{"id":"W2083479520","doi":"10.1136/ard.2005.038802","title":"Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.06211584255055696,"score_gpt":0.3281969231015703,"score_spread":0.2660810805510133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083479520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966089,0.00066386955,0.00000788135,0.00033693935,0.000034257697,0.0022867573,0.0000222431,0.000014737314,0.000024371699],"genre_scores_gemma":[0.99965215,0.00007761021,0.000042736483,0.000053624688,0.00000787955,0.00008446218,0.0000063579573,0.000020111409,0.000055085875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762523,0.00023711383,0.0008294606,0.00025494283,0.00084141566,0.00021184162],"domain_scores_gemma":[0.99811476,0.00019552722,0.00041241143,0.00078016386,0.00038221013,0.00011490935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169521,0.00016554953,0.00064108474,0.0001510988,0.00003723927,0.000011849825,0.00018568804,0.000041242605,0.0000061083833],"category_scores_gemma":[0.00041694182,0.000093738716,0.00007943384,0.00023609272,0.0001171592,0.0001219081,0.00011127016,0.0000845626,0.0000026600153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008099497,0.00244228,0.9832311,0.0028121017,0.00014297642,7.863924e-7,0.0016489413,0.000027804233,0.00024930644,0.000025256059,0.00007336728,0.008536098],"study_design_scores_gemma":[0.0068337074,0.0006896623,0.9819562,0.004975617,0.00012105462,0.00012202553,0.0044044196,0.00037644213,0.0003482332,0.00005695321,0.0000014727228,0.00011424418],"about_ca_topic_score_codex":0.00012643285,"about_ca_topic_score_gemma":0.000016602069,"teacher_disagreement_score":0.008421853,"about_ca_system_score_codex":0.00005021303,"about_ca_system_score_gemma":0.00009115321,"threshold_uncertainty_score":0.38225538},"labels":[],"label_agreement":null},{"id":"W2083721301","doi":"10.1136/ard.2008.100164","title":"Role of contextual factors in health-related quality of life in ankylosing spondylitis","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Quality of life (healthcare); Spondylitis; Physical therapy; Internal medicine; Nursing","score_opus":0.0617976912341012,"score_gpt":0.3456696812469696,"score_spread":0.28387199001286845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083721301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813709,0.016517848,2.554095e-7,0.0011673673,0.000027672948,0.00037064514,0.0003040207,0.000007208731,0.00023403141],"genre_scores_gemma":[0.9990238,0.0007531945,0.000012785349,0.00014957132,0.0000025298027,0.000003915153,0.00002747246,0.000006249048,0.00002047894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980895,0.00018543428,0.0011223634,0.00012544726,0.00027435215,0.00020289456],"domain_scores_gemma":[0.998792,0.00024328743,0.00052346505,0.00026802009,0.000075594035,0.000097669596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000271745,0.00012169913,0.00087393576,0.000112247835,0.00002537777,0.000002223217,0.00009099981,0.00003584243,0.000085506865],"category_scores_gemma":[0.0011279332,0.00008508047,0.00019707266,0.00028638323,0.0001192165,0.00005253657,0.000030560288,0.00006026879,6.802197e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008771328,0.0021901636,0.97030747,0.00062455394,0.00019771015,0.0000031425748,0.0028613177,0.000029231433,0.00013279483,0.0015359952,0.000114153365,0.021126365],"study_design_scores_gemma":[0.0022799207,0.0003701965,0.9894053,0.002581016,0.000019567895,8.8868194e-7,0.0021267217,0.000022028127,0.00045243537,0.002675777,0.000009213459,0.000056986293],"about_ca_topic_score_codex":0.004758522,"about_ca_topic_score_gemma":0.00024421694,"teacher_disagreement_score":0.021069378,"about_ca_system_score_codex":0.00002214484,"about_ca_system_score_gemma":0.00012085538,"threshold_uncertainty_score":0.7193493},"labels":[],"label_agreement":null},{"id":"W2084283665","doi":"10.1136/ard.61.11.1030","title":"Case Number 25: A butterfly rash","year":2002,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Butterfly; Rash; Dermatology; Ecology","score_opus":0.06951113865600476,"score_gpt":0.30786552216887414,"score_spread":0.23835438351286936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084283665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801233,0.0018844892,0.000006155312,0.0080125565,0.00010631834,0.00027383261,0.000042897806,0.00003692568,0.009513524],"genre_scores_gemma":[0.9932284,0.00043539485,0.000043083837,0.0016381233,0.000021697493,0.000015059776,0.0000032782536,0.0000180478,0.0045969468],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9989693,0.00005347744,0.00032293395,0.00014873403,0.0002880801,0.00021745794],"domain_scores_gemma":[0.99897426,0.00010794501,0.00012600668,0.0005524075,0.00008435009,0.00015505514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000850318,0.0001383444,0.00034175193,0.000036775862,0.00008598857,0.000018280145,0.00014722542,0.000036473193,0.0029645422],"category_scores_gemma":[0.0003280267,0.00008587536,0.0002920423,0.00016953709,0.00014584594,0.000074675896,0.00006528709,0.00006551907,0.00021002602],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009462204,0.004655441,0.15231818,0.0023986062,0.0012001615,0.0017275809,0.002684593,0.000016958507,0.00003613943,0.0032859955,0.6515784,0.18000329],"study_design_scores_gemma":[0.0132367,0.0012552456,0.8364777,0.010096846,0.0033814942,0.03642557,0.004824033,0.0084449425,0.0013817649,0.051493455,0.030727543,0.0022547354],"about_ca_topic_score_codex":0.00007006987,"about_ca_topic_score_gemma":0.0000033837425,"teacher_disagreement_score":0.6841595,"about_ca_system_score_codex":0.0000049479095,"about_ca_system_score_gemma":0.00002175793,"threshold_uncertainty_score":0.99794686},"labels":[],"label_agreement":null},{"id":"W2090029532","doi":"10.1136/annrheumdis-2014-eular.5739","title":"OP0042 Do We Know How and When to Stop Immunosuppressants in Lupus Patients?","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Systemic lupus erythematosus; Leukopenia; Prednisone; Azathioprine; Context (archaeology); Methotrexate; Internal medicine; Pediatrics; Surgery; Disease; Chemotherapy","score_opus":0.02789724854196859,"score_gpt":0.302110876268538,"score_spread":0.27421362772656943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090029532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982175,0.007666981,0.000011456809,0.008662049,0.00020340575,0.0009160347,0.00003826323,0.000028641734,0.00029817683],"genre_scores_gemma":[0.99673146,0.0015900469,0.00006624867,0.00020747779,0.00002198753,0.00006262801,0.0000042279885,0.000033779954,0.0012821316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981367,0.00025476838,0.00036752963,0.00025134656,0.0006439534,0.0003456783],"domain_scores_gemma":[0.9982091,0.00040929913,0.00014567492,0.00078233005,0.00020127551,0.0002523057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040314256,0.00017446143,0.0005159905,0.00018479793,0.000053834065,0.00004701789,0.0003451481,0.000052083986,0.00005977803],"category_scores_gemma":[0.002477779,0.00011024879,0.0001201522,0.00020826657,0.00012372945,0.00011023835,0.00029658605,0.000097062846,0.000029885256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037183444,0.00063190015,0.81316507,0.0032037562,0.00016486883,0.00000300982,0.0041761086,0.000009472711,0.000074937336,0.00023975193,0.052049495,0.12590979],"study_design_scores_gemma":[0.011410186,0.0013758397,0.884461,0.056138903,0.0002774387,0.00032735223,0.005123735,0.0012344181,0.0021423723,0.015092712,0.021565113,0.0008509323],"about_ca_topic_score_codex":0.000059919876,"about_ca_topic_score_gemma":0.0000071325585,"teacher_disagreement_score":0.12505886,"about_ca_system_score_codex":0.000024286854,"about_ca_system_score_gemma":0.0000668253,"threshold_uncertainty_score":0.4495815},"labels":[],"label_agreement":null},{"id":"W2091506057","doi":"10.1136/annrheumdis-2013-203433","title":"The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Framingham Risk Score; Subclinical infection; Internal medicine; Disease; Psoriatic arthritis; Psoriasis; Atherosclerotic cardiovascular disease; Cardiology; Dermatology","score_opus":0.029271372255711157,"score_gpt":0.2807024411139245,"score_spread":0.25143106885821337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091506057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244595,0.003922694,0.0000028348911,0.0022966855,0.00008683717,0.0011268619,0.00008371213,0.000010701468,0.000023753242],"genre_scores_gemma":[0.9976838,0.0019255528,0.000024809558,0.00015015677,0.000010096504,0.00014324272,0.000007715809,0.00001853662,0.00003604822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846977,0.0001400133,0.00048884284,0.00016750822,0.0004797344,0.00025413305],"domain_scores_gemma":[0.9976988,0.00089677033,0.00038801433,0.0007018013,0.00018670042,0.00012791263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015269389,0.00017333683,0.00037042372,0.000025527652,0.00022524213,0.000026320742,0.0002540996,0.000023935094,0.0000538988],"category_scores_gemma":[0.0012425898,0.000065905246,0.00021690862,0.00018200208,0.0004796407,0.00006440085,0.00012306827,0.00009188731,0.000011727949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003241152,0.001163213,0.9845631,0.00011589038,0.00032912017,4.43354e-7,0.00014606793,0.00003341407,1.8198213e-7,0.00013533855,0.0006550324,0.012534045],"study_design_scores_gemma":[0.0020066944,0.00034353987,0.992256,0.0015197765,0.00033813762,1.5189546e-7,0.00026988584,0.00020383752,0.000009022338,0.0029751502,0.000007754695,0.00007007201],"about_ca_topic_score_codex":0.00048218266,"about_ca_topic_score_gemma":0.000052399395,"teacher_disagreement_score":0.012463972,"about_ca_system_score_codex":0.000013928047,"about_ca_system_score_gemma":0.0000646822,"threshold_uncertainty_score":0.2687538},"labels":[],"label_agreement":null},{"id":"W2092145505","doi":"10.1136/ard.2008.106351","title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital; McGill University; Toronto Western Hospital; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; Versus Arthritis; National Center for Research Resources; Wellcome Trust","keywords":"Medicine; Systemic lupus erythematosus; Internal medicine; Rheumatology; Cohort; Quality of life (healthcare); Disease; Prospective cohort study; Cohort study; Pediatrics","score_opus":0.01661239084654932,"score_gpt":0.3069171220254591,"score_spread":0.2903047311789098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092145505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776036,0.00031427853,0.000022517102,0.00012461036,0.00010583783,0.0014008713,0.00017456785,0.000014321533,0.00008261588],"genre_scores_gemma":[0.999627,0.0001262082,0.000025690426,0.000027899989,0.000010770005,0.000040234478,0.00008377153,0.00001561708,0.000042804546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972173,0.00022239587,0.00084117503,0.0002826343,0.0012371772,0.0001993198],"domain_scores_gemma":[0.9974957,0.000110190595,0.0007245692,0.0007695692,0.0007253205,0.00017463768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002837694,0.00017558542,0.0007591124,0.000735852,0.0000256535,0.000005783406,0.00039850618,0.000035473233,0.000040050905],"category_scores_gemma":[0.00047889425,0.000110656794,0.00029401333,0.0014612302,0.00010804778,0.00019755446,0.00005697503,0.000078412646,0.0000014621172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018357944,0.0022678727,0.9923134,0.00092955236,0.00096487993,0.0000020542273,0.00044801083,0.0005581245,0.000014225684,0.0001528686,0.000026786189,0.00048643033],"study_design_scores_gemma":[0.0018455911,0.0003255986,0.9921735,0.0022941574,0.0010178195,0.000018129478,0.00025330397,0.0016167955,0.000023133065,0.0003422171,1.8173758e-7,0.00008955607],"about_ca_topic_score_codex":0.000037746075,"about_ca_topic_score_gemma":0.000008000369,"teacher_disagreement_score":0.0019422739,"about_ca_system_score_codex":0.000060693703,"about_ca_system_score_gemma":0.0001747288,"threshold_uncertainty_score":0.4512453},"labels":[],"label_agreement":null},{"id":"W2094039937","doi":"10.1136/annrheumdis-2011-201230.20","title":"Biologics use in sle in 23 centers – data from the international registry for biologics in SLE","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University Health Centre; McGill University; Capital District Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Belimumab; Abatacept; Adalimumab; Etanercept; Rituximab; Internal medicine; Infliximab; Hydroxychloroquine; Antirheumatic drugs; Tocilizumab; Rheumatology; Rheumatoid arthritis; Physical therapy; Disease; Antirheumatic Agents; Immunology; Antibody; Coronavirus disease 2019 (COVID-19)","score_opus":0.1382779257132014,"score_gpt":0.3255733079318835,"score_spread":0.18729538221868208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094039937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727115,0.022376163,0.000018635397,0.00180878,0.0013068069,0.00034725227,0.0013484154,0.000009853527,0.000072596304],"genre_scores_gemma":[0.9969365,0.0011142439,0.000016905986,0.00060336187,0.0000037607838,0.000026390204,0.0010615126,0.0000070559945,0.00023029573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986904,0.00025105628,0.0004611695,0.0002042054,0.000041822357,0.0003513326],"domain_scores_gemma":[0.99793917,0.001021829,0.00023346372,0.00077095313,0.00002832026,0.0000062456133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005273412,0.00014061549,0.00025553693,0.00006419286,0.000064991546,0.000017870638,0.0015601369,0.00011265125,0.00008371341],"category_scores_gemma":[0.0021701988,0.00008217158,0.00010061197,0.0001588829,0.00028672733,0.00024820108,0.00045752325,0.00016020401,0.000028623821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005600774,0.001806923,0.96714914,0.00004688356,0.0001998193,6.9313194e-7,0.0012306505,0.00020806599,0.0028442964,0.0014157397,0.015906679,0.008631063],"study_design_scores_gemma":[0.0016518376,0.000044204473,0.9711258,0.00054092344,0.00002775482,0.0000020999412,0.0033118085,0.0002945247,0.0012818414,0.0029987348,0.018488768,0.00023171068],"about_ca_topic_score_codex":0.0013779021,"about_ca_topic_score_gemma":0.00014794289,"teacher_disagreement_score":0.024224976,"about_ca_system_score_codex":0.000015938098,"about_ca_system_score_gemma":0.000046881814,"threshold_uncertainty_score":0.335086},"labels":[],"label_agreement":null},{"id":"W2094503456","doi":"10.1136/ard.2010.129742","title":"Varus and valgus alignment and incident and progressive knee osteoarthritis","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":501,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging","keywords":"Osteoarthritis; Medicine; Valgus; Risk factor; Orthodontics; Physical therapy; Internal medicine; Pathology","score_opus":0.014273643506870562,"score_gpt":0.2732301914809617,"score_spread":0.2589565479740912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094503456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852056,0.012618139,7.625472e-7,0.0010737596,0.0001273691,0.00067172793,0.000044234825,0.000020357737,0.00023807233],"genre_scores_gemma":[0.9985167,0.0007517643,0.00019543608,0.00023928232,0.000024453399,0.00006297268,0.0000072769285,0.000013614893,0.00018849998],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991879,0.000032415257,0.00020490076,0.00018211575,0.00022249021,0.0001701732],"domain_scores_gemma":[0.9992696,0.000081399216,0.00012343624,0.0002487411,0.000057596408,0.00021923047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088647204,0.00014466018,0.0002815381,0.00004258188,0.00009683312,0.000034257093,0.00004527163,0.000044647597,0.000063380205],"category_scores_gemma":[0.00016075873,0.00009530786,0.000059709706,0.000045828583,0.00023545131,0.00008167691,0.00012364644,0.00006640314,0.0000025501117],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018210571,0.00030921143,0.028658645,0.00039792666,0.00012804776,0.0000464302,0.00072312565,7.1643534e-8,0.0020146898,0.0023390676,0.00029795355,0.9649027],"study_design_scores_gemma":[0.014431065,0.0109223155,0.875399,0.0060774772,0.0017375585,0.0014557801,0.0019838416,0.0000846751,0.047505423,0.038245466,0.0013515564,0.00080584333],"about_ca_topic_score_codex":0.000019336952,"about_ca_topic_score_gemma":0.000013097744,"teacher_disagreement_score":0.9640969,"about_ca_system_score_codex":0.0000028786972,"about_ca_system_score_gemma":0.000030704276,"threshold_uncertainty_score":0.3886542},"labels":[],"label_agreement":null},{"id":"W2094597878","doi":"10.1136/annrheumdis-2014-eular.4527","title":"THU0230 Stiffness from the Perspective of People Living with Rheumatoid Arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Stiffness; Focus group; Thematic analysis; Internal medicine; Qualitative research","score_opus":0.017430939312899053,"score_gpt":0.27573878666832574,"score_spread":0.25830784735542667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094597878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97326976,0.01992469,0.000105501,0.005124336,0.00009069095,0.00048027473,0.00011712119,0.000037208345,0.00085044466],"genre_scores_gemma":[0.979062,0.02049191,0.00006360475,0.0002143656,0.000037822912,0.00004176997,0.000007884412,0.000031154803,0.00004944527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792695,0.00031372678,0.00041881297,0.00024007726,0.000773068,0.0003273539],"domain_scores_gemma":[0.9966756,0.0014728707,0.00031009232,0.00088017946,0.0004898611,0.0001713708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035531181,0.00020610716,0.0006151151,0.00005863122,0.00020231723,0.000043507607,0.0004480247,0.000037463717,0.00034291932],"category_scores_gemma":[0.0025364326,0.00010420518,0.00027663563,0.00029976625,0.00056824327,0.00014591642,0.00015240721,0.00014808844,0.000015991942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002465116,0.0038266953,0.5602525,0.0010488458,0.005511955,0.000009927341,0.04680664,0.00022131196,0.00085556036,0.06607017,0.02426538,0.28866595],"study_design_scores_gemma":[0.0016523332,0.0003572941,0.965439,0.0103181405,0.00002963843,0.000024227475,0.009655853,0.00032577326,0.0007809206,0.010896787,0.0003295256,0.00019051522],"about_ca_topic_score_codex":0.0019545972,"about_ca_topic_score_gemma":0.000298819,"teacher_disagreement_score":0.40518653,"about_ca_system_score_codex":0.000012069497,"about_ca_system_score_gemma":0.00019627175,"threshold_uncertainty_score":0.4249364},"labels":[],"label_agreement":null},{"id":"W2095725985","doi":"10.1136/annrheumdis-2012-202259","title":"Quality indicators in rheumatoid arthritis care: using measurement to promote quality improvement","year":2012,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Bombardier (Canada); University of Toronto","funders":"Canada Research Chairs","keywords":"Medicine; Rheumatology; Quality (philosophy); Health care; Quality management; Rheumatoid arthritis; Internal medicine; Family medicine; Physical therapy; Intensive care medicine; Marketing; Business","score_opus":0.18207995228000448,"score_gpt":0.42472171251196006,"score_spread":0.24264176023195558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095725985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025534356,0.96906215,0.000012705436,0.00022213244,0.00033678184,0.004244702,0.00040239727,0.00004751634,0.0001372299],"genre_scores_gemma":[0.056606274,0.9425143,0.00012450489,0.00011267324,0.000053054788,0.00043003447,0.00005384926,0.000090051966,0.000015249293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99205005,0.001153484,0.0026898936,0.0006089481,0.0024824422,0.0010151986],"domain_scores_gemma":[0.995641,0.0002126361,0.0012679668,0.0016311348,0.00043371934,0.0008135452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028005838,0.00070690096,0.003562463,0.0008183708,0.00018200607,0.00007441637,0.0007472009,0.00021111418,0.00015619003],"category_scores_gemma":[0.0019920284,0.0004789525,0.0013825704,0.0012758037,0.00026870234,0.00017706113,0.0004846635,0.00045732062,0.00004708333],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007475433,0.00074465753,0.00072158844,0.028163675,0.0006459831,0.000003469704,0.0007209406,0.00000100498,0.0000048215697,0.0002291367,0.00019669688,0.9684933],"study_design_scores_gemma":[0.0023908855,0.000494081,0.0077587464,0.2785494,0.00019401486,0.000037867525,0.00092960155,0.0000027356277,0.00018404241,0.00045742167,0.7076982,0.001302944],"about_ca_topic_score_codex":0.00081210095,"about_ca_topic_score_gemma":0.00014843642,"teacher_disagreement_score":0.9671903,"about_ca_system_score_codex":0.0003715751,"about_ca_system_score_gemma":0.0015799636,"threshold_uncertainty_score":0.99976623},"labels":[],"label_agreement":null},{"id":"W2096107056","doi":"10.1136/annrheumdis-2014-207001","title":"Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Agence Française de Sécurité Sanitaire des Produits de Santé; Sanofi; Centre hospitalier régional universitaire de Lille; GlaxoSmithKline; Pfizer","keywords":"Medicine; Sildenafil; Placebo; Internal medicine; Pathology; Alternative medicine","score_opus":0.09073152546928201,"score_gpt":0.32105876916940945,"score_spread":0.23032724370012744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096107056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236567,0.012796798,0.0000018458556,0.0010642528,0.00027791815,0.0030121023,0.000052896405,0.000037800695,0.0003907343],"genre_scores_gemma":[0.9989575,0.00039806578,0.0000016285065,0.00024376437,0.000053918593,0.00013017376,0.0000064891265,0.000032816264,0.00017561001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691254,0.00041780816,0.0011682877,0.00028590154,0.0009094261,0.0003060317],"domain_scores_gemma":[0.9969386,0.0010141178,0.00062927644,0.0009326509,0.0002361717,0.00024921907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008171834,0.0002727932,0.0010437089,0.0001583024,0.000075320604,0.00004600558,0.00045096572,0.000071109855,0.000016735798],"category_scores_gemma":[0.0029569776,0.00013123741,0.0004962115,0.00042153097,0.00016246822,0.00011662097,0.00011346951,0.00016122722,0.000023540948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15487914,0.068661585,0.5237808,0.008307738,0.016396157,0.00009361925,0.045161128,0.05036874,0.0028344616,0.0013374463,0.06598309,0.06219608],"study_design_scores_gemma":[0.13764004,0.0028851626,0.649691,0.12532122,0.0034341628,0.00009285629,0.073767245,0.003859808,0.0018985689,0.000506299,0.000023842962,0.00087977975],"about_ca_topic_score_codex":0.00017726584,"about_ca_topic_score_gemma":0.0000030490344,"teacher_disagreement_score":0.12591018,"about_ca_system_score_codex":0.00004749278,"about_ca_system_score_gemma":0.00034786222,"threshold_uncertainty_score":0.5351706},"labels":[],"label_agreement":null},{"id":"W2096308905","doi":"10.1136/ard.2011.149831","title":"Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Versus Arthritis; Research Councils UK","keywords":"Medicine; Resveratrol; Arthritis; Function (biology); Collagen-induced arthritis; Immunology; Cell biology; Pharmacology","score_opus":0.03786574352501037,"score_gpt":0.25721418217510045,"score_spread":0.21934843865009007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096308905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98609436,0.010480249,0.00002747792,0.0010214326,0.00017630379,0.00042268643,0.000030482805,0.00004088552,0.0017061083],"genre_scores_gemma":[0.9963635,0.0020847502,0.00006295575,0.0008480566,0.00006766862,0.000020228736,0.0000150571,0.000024387666,0.0005133989],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987101,0.00007668944,0.00041886687,0.00021723467,0.00033735804,0.00023973398],"domain_scores_gemma":[0.99900734,0.00009377993,0.00021734685,0.00033494225,0.00014361175,0.00020296949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021234977,0.00018107591,0.00040608156,0.00007122651,0.00014076929,0.000015812677,0.00009846664,0.00006441107,0.00022425714],"category_scores_gemma":[0.00029670072,0.00011324533,0.00014335639,0.00016475814,0.00014595638,0.00009196822,0.00007574949,0.0000872334,0.000007162231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055148345,0.007463201,0.09637602,0.006112457,0.0027251916,0.00015092026,0.0061736526,0.000032112588,0.2327231,0.0020149106,0.2527045,0.3880091],"study_design_scores_gemma":[0.01939148,0.0058967345,0.44585958,0.011878011,0.0019997112,0.00020551951,0.0051083737,0.003142842,0.49216208,0.01193732,0.0012275382,0.0011908154],"about_ca_topic_score_codex":0.0001384708,"about_ca_topic_score_gemma":0.0000036520514,"teacher_disagreement_score":0.3868183,"about_ca_system_score_codex":0.0000067171327,"about_ca_system_score_gemma":0.000054439897,"threshold_uncertainty_score":0.46180105},"labels":[],"label_agreement":null},{"id":"W2096349837","doi":"10.1136/ard.2008.101121","title":"Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Bristol-Myers Squibb Canada; Genentech; Abbott Canada; Synarc; GlaxoSmithKline; Biogen; Bristol-Myers Squibb; Amgen Canada; Servier; Amgen","keywords":"Medicine; Abatacept; Methotrexate; Rheumatoid arthritis; Internal medicine; Adverse effect; Placebo; Gastroenterology; Rheumatoid factor; Rituximab; Pathology","score_opus":0.02696491592765335,"score_gpt":0.31944673449699496,"score_spread":0.29248181856934163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096349837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874347,0.010811252,0.0000075283915,0.0005780964,0.00003327852,0.00095179555,0.000104628285,0.000017557244,0.000061158215],"genre_scores_gemma":[0.95325047,0.04648016,0.00013994212,0.000073401614,0.0000049052887,0.0000073575584,0.000018742783,0.000015743366,0.000009266373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997924,0.0002872668,0.00074325583,0.00026337308,0.0004783035,0.0003038296],"domain_scores_gemma":[0.9979954,0.0009085522,0.0002920613,0.00032729088,0.00019718752,0.00027953403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003544741,0.00020743416,0.0007716894,0.00013277774,0.000072252566,0.00002548448,0.00014280716,0.00005720472,0.00003374448],"category_scores_gemma":[0.0020519763,0.00012502256,0.000120203236,0.00022965111,0.00056104496,0.00018042828,0.000070240356,0.00016008994,0.0000013307703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011741432,0.00094705296,0.8257359,0.00010925061,0.00016215547,0.0000033114823,0.0006011652,0.0000011430666,0.0000051632305,0.00019477405,0.000112217785,0.1709537],"study_design_scores_gemma":[0.0052582463,0.0017145325,0.98639107,0.0053706723,0.000013138899,0.0000043627724,0.00019597582,0.000020012234,0.00011451305,0.00075876666,0.00003322839,0.00012549422],"about_ca_topic_score_codex":0.000091977454,"about_ca_topic_score_gemma":0.000015110487,"teacher_disagreement_score":0.17082821,"about_ca_system_score_codex":0.0000054076054,"about_ca_system_score_gemma":0.00009612237,"threshold_uncertainty_score":0.5098272},"labels":[],"label_agreement":null},{"id":"W2096516128","doi":"10.1136/annrheumdis-2013-203887","title":"Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis?","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliac joint; Ankylosing spondylitis; Confidence interval; Radiography; Radiology; Sacroiliitis; Axial spondyloarthritis; Low back pain; Magnetic resonance imaging; Back pain; Nuclear medicine; Surgery; Internal medicine; Pathology","score_opus":0.00809705298478779,"score_gpt":0.24601499361107873,"score_spread":0.23791794062629093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096516128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959294,0.0006777368,0.0000056098193,0.0013210558,0.00029900868,0.0013572256,0.00028115764,0.000012715151,0.0001160447],"genre_scores_gemma":[0.9989015,0.0003382957,0.00009840844,0.00044780303,0.000034799657,0.00009547833,0.000022507204,0.000028005681,0.00003318868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978652,0.00014722085,0.0005594845,0.00030101143,0.0007471574,0.0003799459],"domain_scores_gemma":[0.9984288,0.00023579824,0.00029321428,0.0006995996,0.00016315414,0.00017940108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018608941,0.00027620237,0.0006816252,0.00015059576,0.00014514448,0.000015144266,0.00029516828,0.000043269363,0.00007607927],"category_scores_gemma":[0.00075147976,0.00012898678,0.0003099418,0.000525078,0.00033004407,0.00008909709,0.00021866945,0.00010105305,0.000010203273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012109434,0.0016974628,0.9862164,0.00029201686,0.00034846275,0.0000059442195,0.00025294395,0.000037195146,0.000012904471,0.00007397443,0.0012873395,0.008564364],"study_design_scores_gemma":[0.005759727,0.0015822513,0.98525226,0.005717246,0.00024576377,0.000002988837,0.0001355422,0.000017588207,0.0006569876,0.0004030142,0.00006982905,0.00015677417],"about_ca_topic_score_codex":0.0005213623,"about_ca_topic_score_gemma":0.0003346208,"teacher_disagreement_score":0.00840759,"about_ca_system_score_codex":0.000025693911,"about_ca_system_score_gemma":0.00006079675,"threshold_uncertainty_score":0.5259929},"labels":[],"label_agreement":null},{"id":"W2096713466","doi":"10.1136/ard.2006.065839","title":"Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Concordance; Cohort; Rheumatoid factor; Rheumatology; Rheumatism; Physical therapy","score_opus":0.056167791747269206,"score_gpt":0.3662365373275189,"score_spread":0.31006874558024966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096713466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866748,0.011648234,0.00010007171,0.0003076061,0.00007239237,0.00080494105,0.00018071699,0.000024127554,0.00018714053],"genre_scores_gemma":[0.99105895,0.00874914,0.00007056214,0.000033634507,0.000009685474,0.000018628294,0.000019849678,0.00002640376,0.000013126802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970251,0.0003290072,0.00091823953,0.00025612762,0.0010554257,0.00041612727],"domain_scores_gemma":[0.9974702,0.0003974444,0.0005132566,0.0006883425,0.0004923898,0.00043834525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007176032,0.00022859935,0.0010372594,0.0002622142,0.0000827821,0.000018419347,0.00033452082,0.000057905825,0.00005347366],"category_scores_gemma":[0.0005017528,0.00017488239,0.00033723543,0.0004073999,0.00070444494,0.0002914064,0.00010674353,0.00017973404,0.0000032257149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039148545,0.00275307,0.9339848,0.0004026865,0.00031090478,0.000009198228,0.0010007698,0.000046342087,0.004465259,0.00040261212,0.00013153654,0.052577943],"study_design_scores_gemma":[0.001464396,0.00062344916,0.93706554,0.0041793096,0.000017268801,0.0000027590124,0.0003785917,0.00021541862,0.05523923,0.00065809063,0.00001172222,0.00014423752],"about_ca_topic_score_codex":0.00075293053,"about_ca_topic_score_gemma":0.0002129584,"teacher_disagreement_score":0.052433703,"about_ca_system_score_codex":0.000021047148,"about_ca_system_score_gemma":0.00020891929,"threshold_uncertainty_score":0.71314967},"labels":[],"label_agreement":null},{"id":"W2096805122","doi":"10.1136/ard.2010.144311","title":"Low bone mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Bone mineral; Internal medicine; Body mass index; Cohort; Osteoporosis; Logistic regression; Bone density; Gastroenterology","score_opus":0.03969654608982973,"score_gpt":0.28563289803613007,"score_spread":0.24593635194630034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096805122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306065,0.00370804,0.000007389495,0.0003530635,0.00044023318,0.0018670788,0.00007183966,0.000050803235,0.00044087617],"genre_scores_gemma":[0.99794835,0.00077536464,0.0000500169,0.00020380442,0.00005994927,0.0001387832,0.00001559463,0.00005010837,0.00075800635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963533,0.0003383642,0.0010795183,0.0004075992,0.001199341,0.0006218254],"domain_scores_gemma":[0.99702173,0.0004373947,0.00049714954,0.0012264255,0.00044853863,0.00036876916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000461214,0.00032475905,0.00095238595,0.00034076755,0.000071875584,0.000021389156,0.00050065934,0.00011711244,0.00018150863],"category_scores_gemma":[0.0015103017,0.00021335986,0.00045735913,0.0006595009,0.00018324376,0.00015043051,0.00032358587,0.00017983344,0.00009969001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045648313,0.0019039671,0.9625298,0.0052022533,0.0001871876,0.000074049385,0.0038201364,0.0000055301343,0.000023805413,0.00003901514,0.023424499,0.0023332841],"study_design_scores_gemma":[0.013449582,0.00060368417,0.95691955,0.016669668,0.00047827073,0.002888721,0.0026498204,0.0011553733,0.0026628114,0.0017746807,0.000045001558,0.0007028563],"about_ca_topic_score_codex":0.00041387914,"about_ca_topic_score_gemma":0.000018542696,"teacher_disagreement_score":0.023379497,"about_ca_system_score_codex":0.00008016824,"about_ca_system_score_gemma":0.00024873202,"threshold_uncertainty_score":0.8700563},"labels":[],"label_agreement":null},{"id":"W2097677296","doi":"10.1136/annrheumdis-2011-143578","title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":310,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Placebo; Rheumatoid arthritis; Etanercept; Internal medicine; Rheumatology; Methotrexate; Discontinuation; Gastroenterology; Placebo-controlled study; Pathology; Double blind","score_opus":0.04058819895899907,"score_gpt":0.3226859953672563,"score_spread":0.2820977964082572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097677296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958745,0.0027089368,0.00000478849,0.00031335803,0.000055878347,0.0008359645,0.00018045402,0.000001950815,0.000024117955],"genre_scores_gemma":[0.9987845,0.0010049642,0.00001796913,0.00006095287,0.000018090988,0.000046886435,0.00002405366,0.000017081029,0.000025501464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796593,0.00071808195,0.0005024114,0.00018488943,0.00045426845,0.00017442154],"domain_scores_gemma":[0.9979704,0.00035904435,0.00072091434,0.00063524937,0.00023519792,0.00007921769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050224806,0.00018915064,0.00034038065,0.000025703837,0.000077825265,0.000006841455,0.00027861478,0.00004225258,0.000028967277],"category_scores_gemma":[0.00066906394,0.00006968741,0.00018478178,0.00019111302,0.00045802008,0.0000130629405,0.00011380233,0.00005655853,2.5367123e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008503145,0.0049522812,0.92898214,0.00018652374,0.0012809022,2.840367e-7,0.0006449574,0.0018505461,0.0011005326,0.00015805663,0.0005517879,0.05178883],"study_design_scores_gemma":[0.0038425305,0.0017391116,0.95898324,0.0014135153,0.00026568378,9.0937175e-7,0.00015271925,0.00009437796,0.03322943,0.00006719326,0.00006727778,0.00014398494],"about_ca_topic_score_codex":0.0000434719,"about_ca_topic_score_gemma":0.000009935938,"teacher_disagreement_score":0.051644847,"about_ca_system_score_codex":0.000009735451,"about_ca_system_score_gemma":0.00020915564,"threshold_uncertainty_score":0.28417704},"labels":[],"label_agreement":null},{"id":"W2097785638","doi":"10.1136/ard.2010.146407","title":"Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Knee pain; Surgery; Joint replacement; Internal medicine; Arthroplasty; Pathology","score_opus":0.1350802706357679,"score_gpt":0.33776056964278617,"score_spread":0.20268029900701826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097785638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730307,0.00031116558,0.0000033044887,0.000020253743,0.00022958433,0.0013134262,0.0007631276,0.000007823964,0.00004825232],"genre_scores_gemma":[0.99911153,0.00024829665,0.00051206374,0.000013900282,0.000017764683,0.000013944511,0.00005359336,0.000013034274,0.000015884667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777097,0.0002787284,0.001230458,0.00021827132,0.00034528086,0.00015626932],"domain_scores_gemma":[0.9982131,0.00036367867,0.000828968,0.00042519995,0.00008990231,0.00007914878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040332437,0.00012653485,0.0005976178,0.000107441454,0.0000134947,0.0000028960358,0.00008507304,0.00008152625,0.00006409639],"category_scores_gemma":[0.00210419,0.000098867,0.0002647362,0.00016208667,0.00009911817,0.00008159961,0.0000665429,0.00009503415,0.000001108732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1102393,0.004423476,0.8439848,0.00015467928,0.00033001747,0.000012726192,0.008053219,0.00008516258,0.00021152134,0.000051971376,0.000069596244,0.03238357],"study_design_scores_gemma":[0.06881143,0.0041803494,0.9172475,0.0032445076,0.00027001338,2.1128886e-7,0.0016020859,0.0004848476,0.0033877655,0.000683809,0.0000023299908,0.000085183456],"about_ca_topic_score_codex":0.0022760006,"about_ca_topic_score_gemma":0.00019575303,"teacher_disagreement_score":0.0732627,"about_ca_system_score_codex":0.000024180248,"about_ca_system_score_gemma":0.00011211905,"threshold_uncertainty_score":0.40316793},"labels":[],"label_agreement":null},{"id":"W2097973532","doi":"10.1136/annrheumdis-2013-204902","title":"Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Janssen Scientific Affairs","keywords":"Medicine; Golimumab; Psoriatic arthritis; Internal medicine; Placebo; Rheumatology; Psoriasis; Randomized controlled trial; Body surface area; Psoriasis Area and Severity Index; Physical therapy; Methotrexate; Rheumatoid arthritis; Surgery; Adalimumab; Dermatology; Pathology","score_opus":0.021240103505435648,"score_gpt":0.3003750601502275,"score_spread":0.2791349566447919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097973532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907117,0.0013258178,0.0000013620881,0.00012688385,0.00013203132,0.0074508227,0.00022335346,0.0000090021285,0.000019008132],"genre_scores_gemma":[0.99755555,0.0021430843,0.000033000662,0.000026229585,0.00002248445,0.00014925291,0.000038633014,0.000019473178,0.000012294627],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99704224,0.0006110964,0.0012917245,0.0003480597,0.00048557523,0.00022132757],"domain_scores_gemma":[0.9951118,0.0032700635,0.00079197995,0.0006022897,0.00013537712,0.000088480294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040587372,0.00025444373,0.0017372868,0.00008140252,0.00008010952,0.000008829708,0.00013277873,0.000058544923,0.000008690725],"category_scores_gemma":[0.0015633304,0.00013430005,0.00047970895,0.00021178063,0.00035095224,0.000053360425,0.00006740771,0.000086623506,9.669756e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80880207,0.007819595,0.103220075,0.00004045983,0.0025623997,0.000019579928,0.0018420839,0.0000108440445,4.5157918e-7,0.0000037438178,0.000020806683,0.0756579],"study_design_scores_gemma":[0.46659735,0.0061076465,0.52496517,0.0011294108,0.0009100603,0.0000017409287,0.0001486033,0.000011910702,0.0000053465324,0.000059870927,7.251725e-7,0.00006215636],"about_ca_topic_score_codex":0.00041880834,"about_ca_topic_score_gemma":0.00015034736,"teacher_disagreement_score":0.4217451,"about_ca_system_score_codex":0.000021973272,"about_ca_system_score_gemma":0.00007345829,"threshold_uncertainty_score":0.5476597},"labels":[],"label_agreement":null},{"id":"W2098356207","doi":"10.1136/ard.2004.026443","title":"Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal Heart Institute; Institute of Population and Public Health; McMaster University","funders":"","keywords":"WOMAC; Medicine; Osteoarthritis; Physical therapy; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.03733895111248682,"score_gpt":0.3162978251776734,"score_spread":0.2789588740651866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098356207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956682,0.0010829235,0.0000048452653,0.00052272313,0.00006506323,0.0021164156,0.0004049789,0.00001758499,0.00011729666],"genre_scores_gemma":[0.9992428,0.000019274334,0.00010886196,0.00009818136,0.000009166533,0.00022630619,0.0001562455,0.000023668877,0.00011553154],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838066,0.00018185632,0.00040601476,0.00018088076,0.0006375791,0.00021298247],"domain_scores_gemma":[0.9986573,0.00012103546,0.00023110851,0.00037308474,0.0005181326,0.00009935415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048748156,0.00016642877,0.00040412153,0.00013595998,0.000044624347,0.000009804238,0.000087981236,0.000047010584,0.00006776274],"category_scores_gemma":[0.00063948164,0.00011205361,0.00015041936,0.00018591959,0.00007088226,0.00010493809,0.000023273898,0.000033415847,0.0000039981887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066101074,0.010282532,0.14246303,0.0015615285,0.0009165703,0.000020696376,0.0027520934,0.00036133608,0.0073187007,0.00032371338,0.0013944125,0.7665043],"study_design_scores_gemma":[0.096471034,0.051072698,0.7550324,0.015169621,0.0026045516,0.000014854282,0.00074290414,0.0002133323,0.068236716,0.009731374,0.00015621075,0.0005543092],"about_ca_topic_score_codex":0.000046692257,"about_ca_topic_score_gemma":0.00006913059,"teacher_disagreement_score":0.76595,"about_ca_system_score_codex":0.00004866967,"about_ca_system_score_gemma":0.00025905634,"threshold_uncertainty_score":0.45694137},"labels":[],"label_agreement":null},{"id":"W2098714783","doi":"10.1136/ard.2010.138883","title":"ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"BASDAI; Medicine; Cartilage oligomeric matrix protein; Ankylosing spondylitis; Internal medicine; N-terminal telopeptide; Osteocalcin; Endocrinology; Arthritis; Osteoarthritis; Pathology; Alkaline phosphatase","score_opus":0.016966051764177124,"score_gpt":0.22657142747970496,"score_spread":0.20960537571552784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098714783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713033,0.0015954046,8.5126004e-7,0.0001692036,0.000014728677,0.0008754089,0.00016170368,0.000009939508,0.000042422635],"genre_scores_gemma":[0.99930245,0.0005271297,0.00003605144,0.00001825551,0.0000046050286,0.000046422705,0.000022904147,0.000015204884,0.00002700034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908465,0.00007596926,0.00031346464,0.00019881388,0.00017622512,0.00015090103],"domain_scores_gemma":[0.9993005,0.00010305356,0.00017289254,0.0002050958,0.00009624285,0.0001222433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005430925,0.00020749857,0.00043241438,0.00014224488,0.00006608087,0.000009448474,0.000025418934,0.000033022767,0.000011161108],"category_scores_gemma":[0.00007739826,0.00010562547,0.000041372226,0.0001588099,0.00020608935,0.00009847792,0.00003499003,0.000025171623,2.4281985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062900474,0.0005076235,0.9700819,0.0001182741,0.0002766186,0.0000073626807,0.0032734587,5.752025e-7,0.00008905153,0.000017479199,0.000016041544,0.019321563],"study_design_scores_gemma":[0.0058976593,0.0027229076,0.98460877,0.0016067007,0.00015867215,0.0000066978323,0.00042384627,0.000005130869,0.004397728,0.000058639755,0.000010347469,0.00010292262],"about_ca_topic_score_codex":0.00026957237,"about_ca_topic_score_gemma":0.00026822873,"teacher_disagreement_score":0.01921864,"about_ca_system_score_codex":0.000019747851,"about_ca_system_score_gemma":0.000021641397,"threshold_uncertainty_score":0.43072817},"labels":[],"label_agreement":null},{"id":"W2099148197","doi":"10.1136/annrheumdis-2012-201341","title":"The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":319,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Receiver operating characteristic; Rheumatoid arthritis; Disease; Psoriasis; Internal medicine; Area under the curve; Arthritis; Physical therapy; Dermatology","score_opus":0.04427246283006806,"score_gpt":0.337840673622396,"score_spread":0.2935682107923279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099148197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97880065,0.018897645,0.000013636346,0.00095605175,0.00011429851,0.0009903377,0.00017567675,0.000009099501,0.00004261415],"genre_scores_gemma":[0.9978031,0.0015525577,0.00024220151,0.000061252766,0.000016230453,0.00017019427,0.000012361402,0.000012680898,0.00012941824],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99886334,0.00008900887,0.0003588139,0.00012353425,0.00030268892,0.00026261937],"domain_scores_gemma":[0.99865776,0.00045654434,0.00032306352,0.00031201466,0.000104866995,0.00014576378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000300474,0.00014312835,0.00035269026,0.000042079882,0.0003495475,0.000016944276,0.00009919818,0.000019319275,0.000006841948],"category_scores_gemma":[0.0004461749,0.000075755284,0.00014267986,0.00011008496,0.00018459393,0.000099300494,0.000102614584,0.00003512669,0.0000012872608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007368306,0.0026874167,0.43497148,0.0024665832,0.0027810107,0.0000032075675,0.0064744297,0.0000019958288,0.00018265168,0.00075282215,0.0033754925,0.5389346],"study_design_scores_gemma":[0.0016524992,0.00011753096,0.99358433,0.001007193,0.00025304116,0.000002275926,0.00042593744,0.000023670766,0.0015767606,0.00036540042,0.0009023402,0.000088987945],"about_ca_topic_score_codex":0.00004774737,"about_ca_topic_score_gemma":0.000049358714,"teacher_disagreement_score":0.5586129,"about_ca_system_score_codex":0.0000125421275,"about_ca_system_score_gemma":0.00016172549,"threshold_uncertainty_score":0.3089211},"labels":[],"label_agreement":null},{"id":"W2099278684","doi":"10.1136/ard.2004.035063","title":"Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Adeno-associated virus; Gene transfer; Genetic enhancement; Arthritis; Gene; Virus; Gene delivery; Virology; Bioinformatics; Immunology; Genetics; Vector (molecular biology); Recombinant DNA; Biology","score_opus":0.06506897241303711,"score_gpt":0.35827790537165227,"score_spread":0.29320893295861516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099278684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99031085,0.0040504425,0.0026308154,0.0017624943,0.000053599833,0.0008601709,0.00030583295,0.000014435564,0.000011364342],"genre_scores_gemma":[0.99624443,0.0017095605,0.00030003872,0.0013643274,0.000074975695,0.00012446515,0.000078898476,0.000041955416,0.000061355626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986236,0.00016752213,0.0003523038,0.00028525016,0.00019215432,0.00037914288],"domain_scores_gemma":[0.9987395,0.000052894204,0.000055606004,0.0006201803,0.0003651404,0.00016672701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026557167,0.00018001373,0.00024353874,0.0000542139,0.00018172617,0.000027717586,0.00038854417,0.00007717458,0.000046357727],"category_scores_gemma":[0.000371239,0.00014417552,0.000250931,0.00022847891,0.000087966444,0.000009160872,0.00004997417,0.000052660955,0.000010611525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008284413,0.00036122865,0.00005552499,0.00001858155,0.00028797347,8.1657774e-8,0.00008978073,0.0015301114,0.97580683,0.000021144877,0.00040404682,0.020596225],"study_design_scores_gemma":[0.00076439884,0.00083861133,0.003047732,0.000057572674,0.00003957214,0.000001285773,0.000016865955,0.00021550334,0.9941905,0.00035974395,0.00028908852,0.0001790949],"about_ca_topic_score_codex":0.000009688039,"about_ca_topic_score_gemma":0.00006174229,"teacher_disagreement_score":0.02041713,"about_ca_system_score_codex":0.000018138344,"about_ca_system_score_gemma":0.0001827611,"threshold_uncertainty_score":0.5879307},"labels":[],"label_agreement":null},{"id":"W2099392634","doi":"10.1136/ard.2003.006916","title":"Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Infliximab; Cytokine; Internal medicine; Gastroenterology; Interleukin 10; Immunology; Tumor necrosis factor alpha; Interleukin 6","score_opus":0.085788710593895,"score_gpt":0.39014463194266225,"score_spread":0.3043559213487672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099392634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943951,0.0030260412,0.000008408353,0.00067452603,0.00016427814,0.0005478582,0.000980792,0.00001110397,0.00019189231],"genre_scores_gemma":[0.99791586,0.0015693964,0.00014443134,0.0001078974,0.000011701502,0.000026500024,0.00001811979,0.000017224054,0.00018887052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810505,0.00027238094,0.0009116948,0.00018931742,0.00031208378,0.00020949698],"domain_scores_gemma":[0.99791706,0.0007697047,0.00039175662,0.0005606762,0.00019571863,0.00016508822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002687952,0.0001774905,0.0008851861,0.00008692289,0.000048545753,0.000004017754,0.00009260723,0.000045309844,0.00023838217],"category_scores_gemma":[0.0019448869,0.00011153257,0.00050092314,0.00020301514,0.00015552413,0.000036455902,0.000044376262,0.000032797176,0.0000061459905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006399099,0.004240282,0.9517109,0.00031071846,0.0011982336,0.00003438099,0.0008398821,0.000018458599,0.00010216334,0.00031704063,0.00042569745,0.034403156],"study_design_scores_gemma":[0.0041874074,0.0034273602,0.98148197,0.0020319244,0.0004600696,0.000019270907,0.00046614694,0.000014128073,0.0064310473,0.00029015823,0.0010914312,0.00009906218],"about_ca_topic_score_codex":0.00011995234,"about_ca_topic_score_gemma":0.000009018811,"teacher_disagreement_score":0.034304094,"about_ca_system_score_codex":0.000018736633,"about_ca_system_score_gemma":0.0001206211,"threshold_uncertainty_score":0.4548166},"labels":[],"label_agreement":null},{"id":"W2099479709","doi":"10.1136/ard.2008.105296","title":"ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Memorial University of Newfoundland","funders":"","keywords":"Ankylosing spondylitis; Medicine; Single-nucleotide polymorphism; Haplotype; Internal medicine; Spondylitis; Genotype; Gastroenterology; Genetics; Gene; Biology","score_opus":0.0316838416422434,"score_gpt":0.2826333351993675,"score_spread":0.2509494935571241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099479709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98946834,0.003644815,0.0000011701082,0.004849574,0.000040058276,0.00032743832,0.00032360377,0.000030409308,0.0013145877],"genre_scores_gemma":[0.9984605,0.0003215735,0.00001960493,0.0008593425,0.000011802436,0.000011868696,0.000055195076,0.000012477606,0.00024765273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892133,0.000054696036,0.0002765193,0.0001629055,0.00031060452,0.0002739385],"domain_scores_gemma":[0.9992056,0.00009568132,0.00020139752,0.00031211728,0.00008505442,0.000100140445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077089855,0.00015857273,0.00043879307,0.00007747993,0.00008412797,0.00001296168,0.0000909336,0.000032541848,0.00011788937],"category_scores_gemma":[0.00036420082,0.00009693425,0.000151117,0.00030849263,0.000105753694,0.00007026465,0.000024594063,0.00006047644,0.0000042129896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011661666,0.0042576906,0.9385659,0.00014276375,0.00087964523,0.00042286792,0.001003524,0.00003598093,0.000040697305,0.0008909733,0.0047010337,0.047892757],"study_design_scores_gemma":[0.0019658552,0.00039635666,0.9912116,0.004184369,0.00014954439,0.00001760855,0.00026200662,0.000022395261,0.0002484155,0.0013655582,0.000074804426,0.00010152208],"about_ca_topic_score_codex":0.00009776468,"about_ca_topic_score_gemma":0.000085411186,"teacher_disagreement_score":0.052645665,"about_ca_system_score_codex":0.000028914892,"about_ca_system_score_gemma":0.00004973867,"threshold_uncertainty_score":0.3952864},"labels":[],"label_agreement":null},{"id":"W2099673765","doi":"10.1136/annrheumdis-2012-202959","title":"Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psoriatic arthritis; Methotrexate; Internal medicine; Radiography; Cohort; Rheumatoid arthritis; Surgery; Psoriasis; Logistic regression; Gastroenterology; Dermatology","score_opus":0.014712867567921275,"score_gpt":0.26526284567516506,"score_spread":0.2505499781072438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099673765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456483,0.001717991,0.0000015216568,0.0008749747,0.00004688316,0.0026183405,0.00014166966,0.000015408377,0.000018394554],"genre_scores_gemma":[0.9988039,0.0005344886,0.000066818626,0.000072565985,0.000007830689,0.00045623857,0.00003352172,0.000019947092,0.0000046453833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835837,0.00025054606,0.00040755214,0.0002028835,0.0005370505,0.00024361018],"domain_scores_gemma":[0.9986049,0.0001863694,0.0005214299,0.00037490984,0.00022495387,0.000087418885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012017891,0.00022152108,0.0005600312,0.00014326395,0.00011208975,0.000021931693,0.00010703953,0.000038456692,0.000035973473],"category_scores_gemma":[0.00029689173,0.00010733317,0.00026091223,0.00045645723,0.00031079116,0.00015764138,0.000059492115,0.000096927506,0.0000023557288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017981605,0.0013511656,0.97691756,0.0004096239,0.00038480695,0.000008860022,0.001661489,0.000005421971,0.000036136946,0.0000076199067,0.00054334244,0.018494155],"study_design_scores_gemma":[0.003204855,0.00063781784,0.98472464,0.008063707,0.00019150606,0.0000015746058,0.0013582443,0.000035600835,0.0013126459,0.00036472105,8.395632e-7,0.00010387263],"about_ca_topic_score_codex":0.00057197124,"about_ca_topic_score_gemma":0.00006428692,"teacher_disagreement_score":0.018390281,"about_ca_system_score_codex":0.000014746965,"about_ca_system_score_gemma":0.000020428053,"threshold_uncertainty_score":0.43769196},"labels":[],"label_agreement":null},{"id":"W2099981272","doi":"10.1136/ard.2009.108472","title":"Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Internal medicine; Family medicine; Immunology","score_opus":0.020433560433554977,"score_gpt":0.3036179370637169,"score_spread":0.28318437663016194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099981272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83567333,0.15302667,0.000004236586,0.0099373795,0.00007227592,0.00065175345,0.00036502338,0.000020225907,0.00024907888],"genre_scores_gemma":[0.79612947,0.20349474,0.00001984252,0.00012179527,0.000009135998,0.000028278819,0.00001657925,0.000011010613,0.0001691369],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99784344,0.00023208848,0.0006491465,0.00022430174,0.0007219372,0.0003291074],"domain_scores_gemma":[0.9984184,0.00018227863,0.00023909679,0.00073673506,0.00024607772,0.00017744541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005265184,0.00020498368,0.0005739591,0.00010830728,0.00015772278,0.000023195747,0.00021577241,0.00004599592,0.0000587004],"category_scores_gemma":[0.0019360161,0.000112193346,0.00023887852,0.00022848498,0.00041685347,0.000114063434,0.000088297835,0.0000809247,0.0000035808505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009553137,0.0024941345,0.03578034,0.00038659188,0.00089782884,0.00007110217,0.0074434057,0.00008547017,0.0005644037,0.0018673632,0.06056601,0.8802902],"study_design_scores_gemma":[0.031334236,0.0048213494,0.88069093,0.027026271,0.000051446084,0.0002132255,0.0017619847,0.00050556305,0.017456159,0.021537712,0.014017924,0.0005832082],"about_ca_topic_score_codex":0.00040546787,"about_ca_topic_score_gemma":0.00040782997,"teacher_disagreement_score":0.879707,"about_ca_system_score_codex":0.00005172282,"about_ca_system_score_gemma":0.00027774088,"threshold_uncertainty_score":0.4575112},"labels":[],"label_agreement":null},{"id":"W2100239394","doi":"10.1136/annrheumdis-2014-205739","title":"The role of kinin B1 receptor and the effect of angiotensin I-converting enzyme inhibition on acute gout attacks in rodents","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Kinin; Gout; Medicine; Bradykinin; Internal medicine; Endocrinology; Inflammation; Agonist; Arthritis; Receptor; Pharmacology","score_opus":0.00829661146559221,"score_gpt":0.2662540304439077,"score_spread":0.25795741897831553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100239394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931501,0.0036088717,0.000004623041,0.002488904,0.00008289213,0.00048342085,0.000019701769,0.000010263364,0.00015118359],"genre_scores_gemma":[0.9993005,0.00033988696,0.0000075651046,0.00020102988,0.000029465595,0.00001467882,0.00001009372,0.000014001144,0.00008280987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984903,0.00034851092,0.0005172077,0.00013701305,0.00033692076,0.00017006438],"domain_scores_gemma":[0.9975834,0.0014423386,0.00044368175,0.0003896598,0.000084539824,0.000056413195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008300712,0.00014232141,0.0004639986,0.000057229387,0.00009099328,0.00001255478,0.00013375201,0.000043347896,0.00001376347],"category_scores_gemma":[0.0014066799,0.00006702692,0.00023539428,0.00015704942,0.00033660594,0.0000604561,0.000071055336,0.000069135036,0.0000030701244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009267643,0.0006444041,0.6435982,0.0013739615,0.001334847,0.0000017673311,0.005449797,0.00029924946,0.0057083745,0.0064215953,0.006403648,0.3194965],"study_design_scores_gemma":[0.006205411,0.00085913326,0.75648427,0.0057156975,0.0005488317,0.0000058549613,0.00034771606,0.008338949,0.21604063,0.005029194,0.00024241231,0.00018189152],"about_ca_topic_score_codex":0.00016918052,"about_ca_topic_score_gemma":0.000010516349,"teacher_disagreement_score":0.31931463,"about_ca_system_score_codex":0.000007512337,"about_ca_system_score_gemma":0.000026788472,"threshold_uncertainty_score":0.27332786},"labels":[],"label_agreement":null},{"id":"W2100422140","doi":"10.1136/annrheumdis-2013-203301","title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":825,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Actelion Pharmaceuticals; Genentech; Medac; Albert-Ludwigs-Universität Freiburg; University of Michigan; Division of Materials Research; Gilead Sciences; FibroGen; Teva Pharmaceutical Industries; United Therapeutics Corporation; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Pulmonary hypertension; Referral; Internal medicine; Cardiology; Nomogram; Medical diagnosis; Radiology","score_opus":0.12008850452698629,"score_gpt":0.30711253477808204,"score_spread":0.18702403025109576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100422140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049294,0.0061441846,0.000004927387,0.0012525263,0.00010105528,0.001966641,0.00001004962,0.000016620994,0.00001107226],"genre_scores_gemma":[0.99875396,0.0007524118,0.000005987421,0.0001861502,0.000016327827,0.00024459633,0.000002177965,0.00001388157,0.000024492449],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99805236,0.00042945993,0.00048118114,0.00019380725,0.0006149302,0.00022828976],"domain_scores_gemma":[0.9982302,0.0004906431,0.00020784719,0.0006742944,0.00028036712,0.00011661824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030709317,0.00015129827,0.0004266785,0.00013076217,0.00009008151,0.000015805024,0.00023680684,0.00003791855,0.00005715785],"category_scores_gemma":[0.0009734517,0.00007240938,0.00021069232,0.00034828854,0.00013556756,0.0001601641,0.00008219125,0.000090637724,0.000024011204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005939865,0.015376462,0.27885816,0.002675414,0.0011415388,0.00026558523,0.00030359544,0.0002858003,0.31937137,0.000004152419,0.0011806539,0.3745974],"study_design_scores_gemma":[0.0011272514,0.0006233868,0.9758268,0.006926135,0.00017976074,0.000043808544,0.0006554251,0.004493464,0.009896963,0.00015535101,7.7849194e-7,0.000070869784],"about_ca_topic_score_codex":0.0009423807,"about_ca_topic_score_gemma":0.000011429346,"teacher_disagreement_score":0.6969686,"about_ca_system_score_codex":0.000021084974,"about_ca_system_score_gemma":0.00012430364,"threshold_uncertainty_score":0.29527688},"labels":[],"label_agreement":null},{"id":"W2100586280","doi":"10.1136/ard.2009.116319","title":"Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Golimumab; Medicine; Rheumatoid arthritis; Methotrexate; Placebo; Internal medicine; Rheumatology; Adverse effect; Arthritis; Surgery; Adalimumab; Pathology","score_opus":0.02301421961244162,"score_gpt":0.29134362869254943,"score_spread":0.26832940908010783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100586280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415827,0.0018646922,0.0000021130754,0.0010063909,0.00017443694,0.002166137,0.0002985311,0.00002703302,0.00030240644],"genre_scores_gemma":[0.992232,0.007335492,0.00007322611,0.000115092305,0.000012169921,0.00010156277,0.000015340787,0.00004448726,0.00007058581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966133,0.00051980215,0.0008564393,0.0003511667,0.0011775835,0.00048166126],"domain_scores_gemma":[0.99688447,0.00049304427,0.0005989091,0.0013015677,0.0005105506,0.00021148866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006482715,0.00031376356,0.00080761773,0.00018457313,0.00016312102,0.00003842437,0.0006416949,0.00006611704,0.000092202805],"category_scores_gemma":[0.001607063,0.00016080987,0.0003183751,0.0006279768,0.000624089,0.00024442372,0.00020013578,0.000398063,0.000009304592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013091156,0.0110511985,0.6380048,0.00017055952,0.0014058265,0.000008556181,0.007109964,0.000036072226,0.00022085688,0.00024935356,0.0014774883,0.3271742],"study_design_scores_gemma":[0.013407482,0.0017009804,0.97679603,0.002105447,0.000013388332,0.00000455044,0.0010829517,0.000025210335,0.0032844832,0.0010904247,0.000301477,0.00018760347],"about_ca_topic_score_codex":0.0004950207,"about_ca_topic_score_gemma":0.00042087157,"teacher_disagreement_score":0.33879122,"about_ca_system_score_codex":0.000015815023,"about_ca_system_score_gemma":0.00029332045,"threshold_uncertainty_score":0.6557636},"labels":[],"label_agreement":null},{"id":"W2100736304","doi":"10.1136/ard.2010.146852","title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":692,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Abatacept; Tocilizumab; Statement (logic); Family medicine; Biologic Agents; Alternative medicine; Consensus conference; Credibility; Infliximab; Rheumatoid arthritis; Internal medicine; Rituximab; Pathology; Political science; Law","score_opus":0.1794371107752009,"score_gpt":0.36371480380490984,"score_spread":0.18427769302970895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100736304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98108566,0.01289675,0.000024792502,0.002454833,0.0002555494,0.0021894835,0.0008883609,0.00003602156,0.0001685311],"genre_scores_gemma":[0.9576508,0.041399274,0.00008794364,0.00019883967,0.000015264779,0.00025278298,0.00007599352,0.000021784068,0.00029732328],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998088,0.0001926407,0.0006714491,0.00022115432,0.00044647025,0.00038030744],"domain_scores_gemma":[0.99768496,0.0007415851,0.0003502181,0.0007644222,0.00022000702,0.00023879943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020329443,0.00024073698,0.0005831796,0.000079222176,0.00017018139,0.000015036595,0.00030275882,0.000042221236,0.00071992324],"category_scores_gemma":[0.0005457727,0.00010893824,0.0004939718,0.0001414667,0.0005669385,0.00003321265,0.000048454287,0.000050752224,0.000023869055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019263746,0.035676338,0.08212955,0.001782738,0.012872195,0.000041379193,0.006984178,0.00011954823,0.00023674255,0.013564385,0.24524365,0.58208555],"study_design_scores_gemma":[0.0128706135,0.013031026,0.92108333,0.0036493205,0.00039245078,0.0000201773,0.0027161944,0.0018879418,0.007922948,0.016827537,0.019048298,0.0005501511],"about_ca_topic_score_codex":0.0002043528,"about_ca_topic_score_gemma":0.000008556893,"teacher_disagreement_score":0.8389538,"about_ca_system_score_codex":0.000025195692,"about_ca_system_score_gemma":0.0001524423,"threshold_uncertainty_score":0.78826547},"labels":[],"label_agreement":null},{"id":"W2100860198","doi":"10.1136/ard.2009.115378","title":"Cytokines in Sjögren's syndrome: potential therapeutic targets","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institutes of Health","keywords":"Medicine; Etanercept; Cytokine; Infliximab; Immunology; Tumor necrosis factor alpha; Proinflammatory cytokine; Clinical trial; Pharmacology; Inflammation; Internal medicine","score_opus":0.020212752075106904,"score_gpt":0.28409535605218356,"score_spread":0.26388260397707664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100860198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922152,0.001947972,0.000033816086,0.0042042453,0.00046687011,0.00026150869,0.000031265925,0.000027770431,0.00081132865],"genre_scores_gemma":[0.9987197,0.0001880662,0.000035052217,0.00068830536,0.000025884545,0.000019120369,0.000015819889,0.000012578891,0.00029546203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921376,0.000032234057,0.00024181303,0.00012259604,0.00021287927,0.00017669407],"domain_scores_gemma":[0.9993197,0.00006524713,0.0000855472,0.00037923668,0.00006149576,0.000088778565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086984925,0.00010925262,0.0002464799,0.000085476044,0.000059966645,0.000011656639,0.00013933005,0.000044616652,0.0006122485],"category_scores_gemma":[0.00020016801,0.00006551254,0.00019213725,0.0001982479,0.00011019326,0.00006527225,0.000040620216,0.00011384769,0.000019311394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011481445,0.006170782,0.85313874,0.001324315,0.0009716864,0.00012316917,0.0009299582,0.00026896203,0.0020180766,0.0067865164,0.030427227,0.0966924],"study_design_scores_gemma":[0.00084582553,0.00009979692,0.9878412,0.00018122958,0.00012353208,0.00006428562,0.00016892389,0.00041628818,0.00014598666,0.009512918,0.0005035635,0.000096441174],"about_ca_topic_score_codex":0.00008876718,"about_ca_topic_score_gemma":0.000023514607,"teacher_disagreement_score":0.13470244,"about_ca_system_score_codex":0.0000022335157,"about_ca_system_score_gemma":0.0000745115,"threshold_uncertainty_score":0.6703692},"labels":[],"label_agreement":null},{"id":"W2101223619","doi":"10.1136/ard.62.10.976","title":"Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"School of Medicine, University of California, San Diego; University of California, San Diego; University of Toronto; Suomalais-Norjalainen Lääketieteen Säätiö","keywords":"Peptidoglycan; Medicine; Pathogenesis; Arthritis; Microbiology; Cell wall; Immunology; Genetics; Biology","score_opus":0.01304172350186809,"score_gpt":0.22101611631924956,"score_spread":0.20797439281738148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101223619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350625,0.0052980795,0.0000010329693,0.00010764891,0.00009750247,0.00016292188,0.00020325702,0.000004171696,0.00061912846],"genre_scores_gemma":[0.9988487,0.0008819582,0.000013715871,0.00006962234,0.000004231178,0.0000067599117,0.000015528287,0.00000789217,0.00015159459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895585,0.00035098032,0.00036985142,0.00010163587,0.00004752937,0.00017413961],"domain_scores_gemma":[0.9991042,0.00022025833,0.00030554843,0.00030715292,0.000053089618,0.000009735418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019749346,0.00011186692,0.00032707246,0.000045618137,0.000050814455,0.000005516946,0.00030276616,0.00005803427,0.00035964354],"category_scores_gemma":[0.00013960815,0.000067722445,0.00020864709,0.00010211066,0.00031609432,0.000056481313,0.000041982934,0.000055000983,0.0000078858375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004163424,0.0018460613,0.022236412,0.0005537089,0.00024386623,0.0000012204379,0.004913268,0.00006664124,0.94400865,0.0048175496,0.0052545583,0.0156417],"study_design_scores_gemma":[0.0011666055,0.00026110545,0.21807161,0.0007039449,0.00011099434,0.000011818533,0.0064665424,0.0000021564074,0.76668996,0.004550648,0.0017313081,0.00023331442],"about_ca_topic_score_codex":0.000317399,"about_ca_topic_score_gemma":0.000060497434,"teacher_disagreement_score":0.19583519,"about_ca_system_score_codex":0.000002321933,"about_ca_system_score_gemma":0.00006432458,"threshold_uncertainty_score":0.39378443},"labels":[],"label_agreement":null},{"id":"W2101251179","doi":"10.1136/ard.2010.147793","title":"The association between smoking and the development of psoriatic arthritis among psoriasis patients","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Waterloo; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Association (psychology); Internal medicine","score_opus":0.03295787155441493,"score_gpt":0.26210494968685155,"score_spread":0.22914707813243662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101251179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485207,0.0034840754,0.0000028277968,0.00032004088,0.00015333114,0.0005013274,0.000031924686,0.0000085901265,0.0006457942],"genre_scores_gemma":[0.9979251,0.00181461,0.000054556414,0.000040614825,0.000016748607,0.000054579294,0.000006819314,0.000009668072,0.00007732777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866927,0.000114942675,0.00049647555,0.00010425119,0.00043321625,0.00018186649],"domain_scores_gemma":[0.99844784,0.0005385739,0.00051782257,0.00025829906,0.00018319333,0.000054285978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039905225,0.000116132556,0.00035939197,0.000024415775,0.00034235136,0.000013226643,0.00012957964,0.00003132804,0.000014871894],"category_scores_gemma":[0.0010449839,0.00005347803,0.00014823242,0.000112344096,0.00020628693,0.000052704483,0.00011282037,0.000050949588,0.0000018145388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010143744,0.00014295324,0.8154735,0.000064198626,0.0012261382,1.861956e-7,0.0028199495,9.3075336e-8,7.105177e-8,0.00020246867,0.0002823957,0.17968664],"study_design_scores_gemma":[0.0028458415,0.00006628348,0.9931666,0.0007712502,0.00041284668,1.8903516e-7,0.00053530803,0.000003387667,0.00019611091,0.0018629554,0.00008669468,0.00005251924],"about_ca_topic_score_codex":0.000115451265,"about_ca_topic_score_gemma":0.00005809375,"teacher_disagreement_score":0.17963411,"about_ca_system_score_codex":0.000021647546,"about_ca_system_score_gemma":0.00004405666,"threshold_uncertainty_score":0.26331243},"labels":[],"label_agreement":null},{"id":"W2101254888","doi":"10.1136/ard.2010.131102","title":"Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Antibody; Antigen; Western blot; Epitope; Immunology; Citrullination; Medicine; Autoantibody; Molecular biology; Biology; Biochemistry; Amino acid; Citrulline; Gene","score_opus":0.01970016873011159,"score_gpt":0.28349745552641287,"score_spread":0.26379728679630127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101254888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992734,0.0045753885,0.000017041162,0.0010877133,0.000117554155,0.0010991272,0.00009154733,0.000058585043,0.00021903853],"genre_scores_gemma":[0.9854425,0.0140690105,0.00013452065,0.000058874564,0.0000226796,0.000037983278,0.000016912814,0.000035693476,0.00018183327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979035,0.00015747012,0.00064209354,0.0003468997,0.0005201257,0.00042991005],"domain_scores_gemma":[0.9979749,0.00035397452,0.0005961552,0.00044732072,0.00042995808,0.000197699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004245467,0.0003209336,0.0010578504,0.00032738372,0.00034556468,0.00008162748,0.00016922818,0.00011072187,0.000032705266],"category_scores_gemma":[0.0015583216,0.00023724654,0.00020109593,0.00035650376,0.001049871,0.00035649145,0.00017318862,0.00032267268,0.0000013546369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071787083,0.0007454658,0.52934235,0.003455497,0.0011887422,0.000022599217,0.001835421,0.0000062027934,0.45434433,0.00099286,0.00077605556,0.0065726056],"study_design_scores_gemma":[0.0018763671,0.00025673158,0.9196197,0.0065327254,0.000049741462,0.000057102534,0.0020349366,0.00084002287,0.06654249,0.001850768,0.00008393013,0.0002554779],"about_ca_topic_score_codex":0.0009945788,"about_ca_topic_score_gemma":0.00016837756,"teacher_disagreement_score":0.39027736,"about_ca_system_score_codex":0.000009955274,"about_ca_system_score_gemma":0.00016190094,"threshold_uncertainty_score":0.9674633},"labels":[],"label_agreement":null},{"id":"W2101351985","doi":"10.1136/ard.2008.100149","title":"Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Adalimumab; Magnetic resonance imaging; Joint disease; Arthritis; Psoriasis; Dermatology; Disease; Pathology; Internal medicine; Radiology; Osteoarthritis; Alternative medicine","score_opus":0.005974373180870926,"score_gpt":0.2424161308020429,"score_spread":0.23644175762117198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101351985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94024223,0.05782512,0.0000010080329,0.0004752123,0.000051148083,0.0007937516,0.00048076373,0.000018742883,0.00011204096],"genre_scores_gemma":[0.99796826,0.0017419106,0.00002127694,0.00013472427,0.000007616423,0.000029775672,0.000039330407,0.00001762908,0.00003948798],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998452,0.00012093555,0.00040532305,0.0002041501,0.00058734755,0.00023025433],"domain_scores_gemma":[0.9986913,0.00018439449,0.00031727322,0.0004996224,0.00017414997,0.00013324009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007471641,0.00022719798,0.00063251355,0.0000734638,0.000066773886,0.0000065083705,0.00011833076,0.00001995146,0.000043482556],"category_scores_gemma":[0.0005402073,0.00013194249,0.00022854144,0.0002175931,0.00016991342,0.000048888243,0.00003312129,0.000058140613,0.0000015685088],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057099517,0.002038678,0.11757229,0.00081221235,0.00019715975,0.000014731215,0.00011350843,0.0000072024077,0.000036141053,0.00005987991,0.0042368565,0.86920136],"study_design_scores_gemma":[0.006031482,0.004141785,0.9795018,0.006122489,0.0003637358,0.000001486345,0.000017953784,0.00001616433,0.0034488945,0.00020969148,0.00003338145,0.000111177535],"about_ca_topic_score_codex":0.000044605116,"about_ca_topic_score_gemma":0.0000031092236,"teacher_disagreement_score":0.8690902,"about_ca_system_score_codex":0.000013380659,"about_ca_system_score_gemma":0.000039503786,"threshold_uncertainty_score":0.5380459},"labels":[],"label_agreement":null},{"id":"W2101453675","doi":"10.1136/annrheumdis-2013-204615","title":"Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; European League Against Rheumatism","keywords":"Medicine; Rheumatism; Internal medicine; Construct validity; Physical therapy; Severity of illness; Systemic disease; Disease; Surgery; Patient satisfaction","score_opus":0.019961154208615762,"score_gpt":0.2537365668023735,"score_spread":0.23377541259375773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101453675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638397,0.0012606718,0.00012270098,0.0014580177,0.00010103548,0.00031012378,0.00008200038,0.000020727834,0.00026075676],"genre_scores_gemma":[0.9992623,0.00024599634,0.00002681024,0.00035367752,0.000008954199,0.000021687725,0.000024897754,0.000011804205,0.00004388677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990463,0.00009879248,0.00025785845,0.00015142816,0.000318199,0.00012738646],"domain_scores_gemma":[0.99892277,0.00016867103,0.00022408488,0.0004149372,0.00009673896,0.00017279135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010207625,0.00012237938,0.00032533752,0.000070805785,0.000076102326,0.000010452614,0.0000816824,0.000030975945,0.000065600776],"category_scores_gemma":[0.0004570875,0.00007989947,0.00015858083,0.00012700813,0.00014628607,0.000118960816,0.00008023727,0.000051078103,0.0000023342977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015773429,0.0033345444,0.88195395,0.0042267935,0.0005465098,0.0000062433014,0.00059974997,0.00021847928,0.00035444362,0.0012920398,0.0036903461,0.10219957],"study_design_scores_gemma":[0.000628718,0.000254284,0.9937937,0.0006373475,0.00029189745,0.000006067125,0.000063714055,0.00028986362,0.0007356357,0.0030595937,0.00014242176,0.00009675505],"about_ca_topic_score_codex":0.000057997506,"about_ca_topic_score_gemma":6.295638e-7,"teacher_disagreement_score":0.111839764,"about_ca_system_score_codex":0.000005921985,"about_ca_system_score_gemma":0.00007654289,"threshold_uncertainty_score":0.32582062},"labels":[],"label_agreement":null},{"id":"W2101733459","doi":"10.1136/ard.2007.079921","title":"Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"Actelion Pharmaceuticals; United Therapeutics Corporation; Pfizer; Bristol-Myers Squibb","keywords":"Bosentan; Medicine; Tolerability; Internal medicine; Quality of life (healthcare); Endothelin receptor antagonist; Adverse effect; Pulmonary hypertension; Population; Connective tissue disease; Connective tissue; Surgery; Endothelin receptor; Pathology; Receptor; Disease","score_opus":0.04283736752953364,"score_gpt":0.35658812509571747,"score_spread":0.3137507575661838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101733459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957797,0.0017005454,0.0000040427476,0.0008553229,0.00013320701,0.0012322867,0.00018139125,0.000013699466,0.00009979159],"genre_scores_gemma":[0.9992532,0.00045560303,0.000009425271,0.00017062979,0.000009646833,0.00001153064,0.00004048871,0.00001473131,0.000034715933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975559,0.00042136078,0.0008440155,0.00030450444,0.00059489976,0.00027928324],"domain_scores_gemma":[0.9966183,0.001850731,0.0002786324,0.0005793417,0.00023959453,0.00043345135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000471022,0.00019890556,0.0009768389,0.00015821296,0.000053022515,0.00000437619,0.00013454139,0.0000655022,0.000036629623],"category_scores_gemma":[0.0038914639,0.00012939436,0.00017908786,0.00031767553,0.00026792445,0.00007298189,0.00013123637,0.00008497294,0.0000029712612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017419156,0.007858424,0.94306815,0.0025402217,0.00040426818,0.00025495674,0.00011286678,0.0000093616945,0.005608296,0.00010465801,0.00008414683,0.02253549],"study_design_scores_gemma":[0.0021832362,0.00084830646,0.98844916,0.0020081983,0.00011274724,0.00000910458,0.000102683196,0.000033024837,0.0055960766,0.00055135577,0.0000017060407,0.00010443299],"about_ca_topic_score_codex":0.00034123167,"about_ca_topic_score_gemma":0.000025774361,"teacher_disagreement_score":0.045380972,"about_ca_system_score_codex":0.000026566533,"about_ca_system_score_gemma":0.00011129242,"threshold_uncertainty_score":0.5276549},"labels":[],"label_agreement":null},{"id":"W2101776443","doi":"10.1136/ard.2009.122002","title":"Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Osteoarthritis; Biomarker; Cartilage oligomeric matrix protein; WOMAC; Internal medicine; Univariate analysis; N-terminal telopeptide; C-reactive protein; Population; Cartilage; Gastroenterology; Urology; Surgery; Multivariate analysis; Pathology; Inflammation","score_opus":0.01814784775730921,"score_gpt":0.2882008989861237,"score_spread":0.2700530512288145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101776443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068236,0.0019800833,0.0000058172386,0.00025414702,0.00011069413,0.0029759365,0.0039146934,0.000012194785,0.000064098596],"genre_scores_gemma":[0.99932694,0.00008550542,0.00017255478,0.000041988274,0.0000052324467,0.00019699204,0.00007177603,0.000039807084,0.000059192254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719757,0.0003642983,0.0008718691,0.00033046887,0.0008995995,0.00033618804],"domain_scores_gemma":[0.9972201,0.00061176217,0.0008257618,0.00076814025,0.00035084426,0.00022339201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031024197,0.0003519906,0.001080439,0.00021173537,0.00005818662,0.000010619809,0.0003111774,0.00008987522,0.0000820549],"category_scores_gemma":[0.0011519347,0.00021320292,0.00040525617,0.0005642797,0.00049449404,0.0002558073,0.00014376345,0.00019416424,0.0000012509428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00939907,0.0038098341,0.9364089,0.0031131413,0.00045200146,0.00001335622,0.0017317232,0.000037609385,0.0038293765,0.00043090392,0.00013954162,0.040634573],"study_design_scores_gemma":[0.022368709,0.011036618,0.79951376,0.013618872,0.0008597153,0.0000024905319,0.00069077977,0.00007209658,0.15063646,0.0008844391,0.0000071105596,0.00030896833],"about_ca_topic_score_codex":0.00033356977,"about_ca_topic_score_gemma":0.00018937567,"teacher_disagreement_score":0.14680709,"about_ca_system_score_codex":0.000019277533,"about_ca_system_score_gemma":0.00030341276,"threshold_uncertainty_score":0.8694163},"labels":[],"label_agreement":null},{"id":"W2101808795","doi":"10.1136/ard.62.suppl_2.ii79","title":"Therapeutic targets in osteoarthritis: from today to tomorrow with new imaging technology","year":2003,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Acetaminophen; Celecoxib; Pathophysiology; Inflammation; Joint pain; Internal medicine; Bioinformatics; Pharmacology; Pathology","score_opus":0.031148152771983042,"score_gpt":0.3229047519527859,"score_spread":0.2917565991808029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101808795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012481326,0.9956412,0.00002747063,0.00075107755,0.00026313425,0.0018013591,0.0000712736,0.00004878672,0.0001475925],"genre_scores_gemma":[0.003940991,0.99449015,0.00011758607,0.0007956896,0.00007223293,0.00022146078,0.000042357937,0.00009116481,0.00022837623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979326,0.00018674502,0.0006935929,0.00037592268,0.00038353767,0.00042758603],"domain_scores_gemma":[0.99808365,0.0002587126,0.00039508566,0.0009163527,0.00007861453,0.00026756368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000189806,0.0004527016,0.0019908648,0.00039160013,0.000045701643,0.000019539502,0.0003880902,0.0001476475,0.00017079627],"category_scores_gemma":[0.00036676528,0.00026203194,0.0004014922,0.0007095873,0.00012072325,0.000060350445,0.000091427966,0.00028312235,0.000068913134],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046324447,0.000112191505,0.00078201847,0.0063655335,0.00020112524,0.000053361946,0.00010007794,0.0000012700555,5.8952594e-7,0.000060449758,0.002329268,0.9899478],"study_design_scores_gemma":[0.0024879787,0.00064934563,0.0020280378,0.32090124,0.0030633216,0.00015294431,0.0002292518,0.000008218328,0.00020743755,0.002876801,0.666334,0.0010614631],"about_ca_topic_score_codex":0.00007863567,"about_ca_topic_score_gemma":0.00003464933,"teacher_disagreement_score":0.9888863,"about_ca_system_score_codex":0.000041100277,"about_ca_system_score_gemma":0.00077137764,"threshold_uncertainty_score":0.9999832},"labels":[],"label_agreement":null},{"id":"W2102184797","doi":"10.1136/annrheumdis-2014-205174","title":"Response to: ‘The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis’ by González-Gay et al","year":2014,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Randomized controlled trial; Physical therapy; Surgery","score_opus":0.05084033207247974,"score_gpt":0.3388306241345647,"score_spread":0.287990292062085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102184797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6929077,0.00087207824,0.000002677205,0.3052304,0.000057999318,0.0008086814,0.000102097394,0.0000043971636,0.00001398488],"genre_scores_gemma":[0.8887508,0.0011840238,0.00007243977,0.10960321,0.000024095678,0.00024475146,0.000057400357,0.000024136114,0.000039164563],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.996271,0.00094381196,0.0014309011,0.00025084804,0.00081909343,0.00028432262],"domain_scores_gemma":[0.9961302,0.002173437,0.0007298879,0.0007654734,0.0001558062,0.00004517534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016713062,0.00026898045,0.0008727988,0.00012768572,0.00006251123,0.000014148321,0.0004880432,0.00012947962,0.000017930039],"category_scores_gemma":[0.002996259,0.00014516916,0.00024886316,0.00034881063,0.00021726797,0.00005229142,0.00014085037,0.00033971094,0.000010647937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031703338,0.0018317199,0.065996796,0.0018678602,0.0010998392,0.000026141981,0.015642943,0.00027422918,0.00022999606,0.00006940015,0.8618108,0.047979955],"study_design_scores_gemma":[0.0029263676,0.0005084249,0.94089764,0.014052175,0.00014132996,0.0000049820574,0.0003866429,0.000013636985,0.0003665952,0.00036107237,0.04011893,0.00022222016],"about_ca_topic_score_codex":0.00015479999,"about_ca_topic_score_gemma":0.00018952508,"teacher_disagreement_score":0.8749008,"about_ca_system_score_codex":0.000032322554,"about_ca_system_score_gemma":0.00023773871,"threshold_uncertainty_score":0.59198266},"labels":[],"label_agreement":null},{"id":"W2102347678","doi":"10.1136/ard.2011.154179","title":"Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Likert scale; Rheumatoid arthritis; Clinical Practice; Physical therapy; Family medicine; Rheumatology; Scale (ratio); Alternative medicine; Internal medicine; Pathology","score_opus":0.047427561103629015,"score_gpt":0.34375999560921255,"score_spread":0.29633243450558355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102347678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92941916,0.018786354,0.0042252024,0.0315563,0.0006837091,0.0025199146,0.0005254065,0.00025894737,0.01202503],"genre_scores_gemma":[0.97906435,0.011553233,0.008381306,0.0005171654,0.000025636327,0.00018685228,0.000046989542,0.000026298454,0.00019818138],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978325,0.00032894267,0.000738342,0.00022522558,0.0005566952,0.00031833132],"domain_scores_gemma":[0.99824387,0.0002697507,0.0002816809,0.0004566754,0.00041822196,0.0003297879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006824499,0.00018390086,0.0005101007,0.00017554706,0.00027805072,0.000035265537,0.0002406877,0.000037812453,0.0015335135],"category_scores_gemma":[0.002601573,0.00012890188,0.00033147325,0.0002951457,0.00015186344,0.00020360436,0.00011632863,0.00012651942,0.000053568365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022767996,0.0023614413,0.133358,0.00025922817,0.0008266829,0.000015495614,0.003411501,0.000037463484,0.00014606386,0.025115129,0.03088636,0.803355],"study_design_scores_gemma":[0.0017282296,0.00048129982,0.9618373,0.009333662,0.000016584649,0.00009363153,0.001158163,0.0010865461,0.002586688,0.016243026,0.005110986,0.0003238864],"about_ca_topic_score_codex":0.0001978293,"about_ca_topic_score_gemma":0.000027731845,"teacher_disagreement_score":0.8284793,"about_ca_system_score_codex":0.000027937931,"about_ca_system_score_gemma":0.00026358725,"threshold_uncertainty_score":0.9993792},"labels":[],"label_agreement":null},{"id":"W2103819978","doi":"10.1136/ard.59.6.455","title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis","year":2000,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":572,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Matrix metalloproteinase; Medicine; Synovial fluid; Osteoarthritis; Rheumatoid arthritis; Cartilage; Arthritis; Pathology; Immunology; Internal medicine; Anatomy","score_opus":0.012324746801491714,"score_gpt":0.26657530900728105,"score_spread":0.25425056220578934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103819978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531072,0.04413081,0.00000320623,0.00044801453,0.000054107604,0.0015530742,0.00054862775,0.000037249873,0.000117725074],"genre_scores_gemma":[0.95283955,0.046261895,0.0003953822,0.000057935362,0.00002094216,0.0001467277,0.000071085575,0.000047912745,0.00015855666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99697125,0.0002399761,0.0009509422,0.00039950665,0.00097107555,0.00046723706],"domain_scores_gemma":[0.9982276,0.00032600033,0.00027454863,0.0006393067,0.00024331846,0.00028922444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020658481,0.00036298146,0.0011192679,0.00022050973,0.00011973199,0.00005138362,0.0002761811,0.00008583826,0.0019026162],"category_scores_gemma":[0.0006646005,0.00022600351,0.00020082593,0.0004900658,0.00076567515,0.00037124282,0.00011230482,0.00016035441,0.000015214616],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006860921,0.0025193356,0.08959562,0.000735865,0.0007874283,0.00009106879,0.00081100495,0.000020866959,0.0011761726,0.00022192896,0.0007599218,0.8964199],"study_design_scores_gemma":[0.031615254,0.009933089,0.7812634,0.04246492,0.00013776755,0.0001095032,0.0012755266,0.00008204719,0.12154012,0.004606048,0.0055916393,0.0013806846],"about_ca_topic_score_codex":0.0016389431,"about_ca_topic_score_gemma":0.0003982065,"teacher_disagreement_score":0.8950392,"about_ca_system_score_codex":0.000013794163,"about_ca_system_score_gemma":0.00022180426,"threshold_uncertainty_score":0.9990098},"labels":[],"label_agreement":null},{"id":"W2104005171","doi":"10.1136/annrheumdis-2012-202231","title":"Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Medical Research Council; Merck Sharp and Dohme; Versus Arthritis; National Institute for Health and Care Research; Eli Lilly and Company; GlaxoSmithKline; Amgen","keywords":"Strontium ranelate; Medicine; Osteoarthritis; Placebo; WOMAC; Knee pain; Population; Internal medicine; Osteoporosis; Placebo-controlled study; Physical therapy; Double blind; Pathology","score_opus":0.04254470508598433,"score_gpt":0.3107065926320479,"score_spread":0.26816188754606357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104005171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98052096,0.009933087,0.0000017130614,0.00033354096,0.00015897007,0.008321825,0.00014051446,0.000007106481,0.00058228656],"genre_scores_gemma":[0.99812925,0.0012542272,0.00003214656,0.000014009224,0.000037595066,0.00032926488,0.000031510546,0.000013632744,0.00015834888],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99771774,0.00033128713,0.0011524066,0.00014427473,0.00040139098,0.0002529213],"domain_scores_gemma":[0.99747777,0.0010766737,0.00073125045,0.0005129217,0.00009704745,0.000104323175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066622,0.00021451652,0.0012766157,0.00011405328,0.00003788478,0.000005393554,0.00012320856,0.00006672052,0.000025041209],"category_scores_gemma":[0.00035879292,0.00011101424,0.00049298396,0.00015284597,0.00018530364,0.00008461827,0.000024269464,0.000046336907,9.632837e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96377784,0.004118123,0.0002788008,0.00018750843,0.0004733874,0.0000018852368,0.0025401588,0.000013054137,0.00016690184,0.0002022084,0.000028697044,0.028211406],"study_design_scores_gemma":[0.9807173,0.008689016,0.002459397,0.0012700813,0.0011941376,0.000004913204,0.0006211998,0.000011918051,0.004817949,0.00010210689,0.000029367811,0.000082622624],"about_ca_topic_score_codex":0.00005946283,"about_ca_topic_score_gemma":0.000015294994,"teacher_disagreement_score":0.028128782,"about_ca_system_score_codex":0.000010896694,"about_ca_system_score_gemma":0.000090220696,"threshold_uncertainty_score":0.45270294},"labels":[],"label_agreement":null},{"id":"W2104389209","doi":"10.1136/ard.2010.142901","title":"Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Intraclass correlation; Construct validity; Physical therapy; Internal medicine; Arthritis; Psychometrics; Surgery; Patient satisfaction; Clinical psychology","score_opus":0.056557973274402124,"score_gpt":0.30129748548619095,"score_spread":0.24473951221178883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104389209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96651906,0.03077093,0.00003348664,0.00010096958,0.000055031305,0.001193,0.0012315649,0.000016224663,0.00007974042],"genre_scores_gemma":[0.9393897,0.06039035,0.000068878806,0.000016967786,0.0000048258976,0.00004144065,0.00005195412,0.000034699977,0.0000011686808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625784,0.0006395798,0.0014344851,0.00026754223,0.001045676,0.0003548755],"domain_scores_gemma":[0.99556357,0.00033319092,0.0017689648,0.0008606356,0.0011582706,0.00031538057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044583055,0.0003473542,0.0011791493,0.00026400096,0.000115919494,0.000016307386,0.00035740455,0.0000761719,0.00021872722],"category_scores_gemma":[0.0017542555,0.00021563808,0.0010726338,0.00051602296,0.0012202681,0.000390155,0.00018928041,0.000148789,0.0000011655304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008293483,0.004121996,0.8761155,0.0020178843,0.004345372,0.0000072611756,0.016217625,0.0002854886,0.028714804,0.00093920896,0.0008802016,0.058061197],"study_design_scores_gemma":[0.0032791265,0.0017285318,0.87100965,0.018678376,0.00004110813,0.000024845274,0.00066564284,0.00020955951,0.09945549,0.0046987035,0.0000016348253,0.00020731844],"about_ca_topic_score_codex":0.0015598477,"about_ca_topic_score_gemma":0.000020327085,"teacher_disagreement_score":0.070740685,"about_ca_system_score_codex":0.000030110958,"about_ca_system_score_gemma":0.00072242646,"threshold_uncertainty_score":0.87934655},"labels":[],"label_agreement":null},{"id":"W2104470303","doi":"10.1136/annrheumdis-2014-206917","title":"Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Gout; Cohort; Disease; Alzheimer's disease; Cohort study; Population; Body mass index; Internal medicine; Gerontology; Physical therapy; Environmental health","score_opus":0.0412596181250306,"score_gpt":0.31332405675957337,"score_spread":0.27206443863454277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104470303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98744184,0.0076182606,0.00002351546,0.0025098724,0.00010214451,0.0020206391,0.0001315274,0.000035992914,0.00011622586],"genre_scores_gemma":[0.9991967,0.00015783076,0.00006837647,0.00032474523,0.00002892414,0.00010665048,0.000025143823,0.000027208229,0.000064394546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974987,0.0004856359,0.0006412186,0.00024444557,0.0009202457,0.00020976656],"domain_scores_gemma":[0.9970552,0.00058034254,0.00060830935,0.0011405923,0.000272866,0.00034268913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009995389,0.00021926535,0.0007321239,0.000073673655,0.00010051083,0.000019354373,0.00028718266,0.000037594546,0.000041834344],"category_scores_gemma":[0.0036998154,0.000112819755,0.00028994287,0.00027131976,0.00034063644,0.00008402993,0.00014464601,0.0001135376,0.000008585791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009614864,0.0008485868,0.99251926,0.0001638235,0.0013770049,0.0000028580812,0.0005788989,0.00040290368,5.46893e-7,0.000096538795,0.001855822,0.0011922956],"study_design_scores_gemma":[0.0032651324,0.00012770559,0.98435986,0.00035666328,0.00522456,0.0000025080235,0.00093510107,0.0031490813,0.000024441299,0.0024216252,0.000016352298,0.00011696305],"about_ca_topic_score_codex":0.0013447868,"about_ca_topic_score_gemma":0.000011235418,"teacher_disagreement_score":0.011754905,"about_ca_system_score_codex":0.000014462241,"about_ca_system_score_gemma":0.00025924965,"threshold_uncertainty_score":0.4600656},"labels":[],"label_agreement":null},{"id":"W2104669609","doi":"10.1136/ard.2010.138461","title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4875,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Women's College Hospital; University of Toronto; Mount Sinai Hospital","funders":"Versus Arthritis; European League Against Rheumatism; National Institute for Health and Care Research","keywords":"Medicine; Rheumatism; Rheumatology; Rheumatoid arthritis; Synovitis; Internal medicine; Disease; Physical therapy; League; Arthritis","score_opus":0.03715915128226353,"score_gpt":0.3219765123607498,"score_spread":0.28481736107848626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104669609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871323,0.0035871617,0.00005244671,0.0036744163,0.00061102037,0.0011415809,0.0019446576,0.000109303175,0.0017470956],"genre_scores_gemma":[0.9440172,0.054541606,0.0007524494,0.00028307186,0.000022534792,0.00009274336,0.00015825134,0.00008038087,0.00005180975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954446,0.0010832011,0.0014581681,0.0005189523,0.0008861525,0.0006089039],"domain_scores_gemma":[0.99485004,0.0006403671,0.0012974052,0.0014068197,0.0012702525,0.0005350921],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008925867,0.00044884352,0.0013579205,0.00035079545,0.00034148878,0.000052166917,0.00073736167,0.00010982932,0.0003177288],"category_scores_gemma":[0.002827552,0.00034412806,0.0003838504,0.0009299862,0.0026856852,0.00056799245,0.00020157071,0.0004974889,0.00005169922],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035070507,0.009039996,0.18075539,0.0018345634,0.0035998728,0.00010288874,0.014270906,0.000027195845,0.040000133,0.050886363,0.09105221,0.6049234],"study_design_scores_gemma":[0.0066203848,0.0021528378,0.93801606,0.009362985,0.000050197956,0.00032912337,0.016125176,0.0017786769,0.014397337,0.006930009,0.0031917538,0.0010454832],"about_ca_topic_score_codex":0.0002148455,"about_ca_topic_score_gemma":0.00028340612,"teacher_disagreement_score":0.7572606,"about_ca_system_score_codex":0.000018934341,"about_ca_system_score_gemma":0.0006431571,"threshold_uncertainty_score":0.99990106},"labels":[],"label_agreement":null},{"id":"W2104861305","doi":"10.1136/ard.2010.139345","title":"Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Versus Arthritis; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Internal medicine; Adverse effect; Placebo; Incidence (geometry); Methotrexate; Rheumatology; Randomized controlled trial; Surgery; Rituximab","score_opus":0.032170804378488634,"score_gpt":0.3055377467443372,"score_spread":0.2733669423658486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104861305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929536,0.0035885777,0.000007259745,0.00067612407,0.000023825158,0.002378264,0.00034088508,0.000017849872,0.000013622682],"genre_scores_gemma":[0.98238736,0.017164309,0.00021191587,0.000032137188,0.00000846354,0.00008443754,0.00008191573,0.000024766066,0.0000046720206],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976498,0.00071209273,0.00054374617,0.0003191383,0.0005108099,0.00026443924],"domain_scores_gemma":[0.99815446,0.0005731255,0.0002934005,0.0005730479,0.0001493129,0.00025667137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005531854,0.00022744463,0.0005330745,0.00018328204,0.00012385889,0.000033564414,0.00012653918,0.000044491324,0.000022390372],"category_scores_gemma":[0.0005489134,0.00010995073,0.000070133254,0.0003399403,0.0004896171,0.00020816695,0.00007320319,0.00008971965,9.028024e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52634925,0.0023659205,0.22694677,0.000058396876,0.0003369254,0.000014710132,0.0062261685,0.000002809796,0.000037712034,0.000037173704,0.00004692434,0.23757724],"study_design_scores_gemma":[0.06733717,0.009685644,0.9144173,0.006922927,0.000022797705,0.0000038301555,0.00032996014,0.0000074952313,0.0010008129,0.0001350071,0.00000948226,0.00012754183],"about_ca_topic_score_codex":0.00053908763,"about_ca_topic_score_gemma":0.00026178235,"teacher_disagreement_score":0.68747056,"about_ca_system_score_codex":0.000012907253,"about_ca_system_score_gemma":0.000114783135,"threshold_uncertainty_score":0.44836605},"labels":[],"label_agreement":null},{"id":"W2104948653","doi":"10.1136/ard.2009.122770","title":"Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Arthritis Research Centre of Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Gout; Myocardial infarction; Internal medicine; Relative risk; Population; Cohort; Incidence (geometry); Cohort study; Proportional hazards model; Confidence interval; Environmental health","score_opus":0.01575511370235375,"score_gpt":0.3030639530055985,"score_spread":0.28730883930324475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104948653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794334,0.00003548426,0.0000080015925,0.00042786833,0.00016701246,0.0011246084,0.00019594804,0.000020833184,0.00007691891],"genre_scores_gemma":[0.99969953,0.00001989358,0.000013521023,0.00009588635,0.0000345178,0.000069369,0.0000122592955,0.000022850976,0.000032178985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978141,0.0002794607,0.00061558787,0.0001856185,0.00087505765,0.00023014589],"domain_scores_gemma":[0.99721247,0.0005241126,0.0008465016,0.001050679,0.000223552,0.00014268978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006457632,0.0002061028,0.0005558605,0.00014164642,0.00009175177,0.000013339097,0.0003158654,0.0000736763,0.00021291745],"category_scores_gemma":[0.0015140693,0.00010629541,0.0005476334,0.000313166,0.0001383851,0.00008623488,0.00006638048,0.00027639937,0.000004963229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005325223,0.0014620359,0.99040407,0.000086957734,0.0027658644,0.0000011028488,0.0012724514,0.00064628833,0.0002478445,0.000022255774,0.00036985287,0.0021887317],"study_design_scores_gemma":[0.0011362577,0.001316345,0.9940789,0.00021191344,0.0010515342,0.0000015467473,0.0005974323,0.00053667725,0.00035590114,0.0006207223,0.0000012666854,0.0000915304],"about_ca_topic_score_codex":0.0019111336,"about_ca_topic_score_gemma":0.00002342501,"teacher_disagreement_score":0.0036747805,"about_ca_system_score_codex":0.000041400755,"about_ca_system_score_gemma":0.00022106252,"threshold_uncertainty_score":0.4334601},"labels":[],"label_agreement":null},{"id":"W2105000414","doi":"10.1136/annrheumdis-2014-205408","title":"Candidate lesion-based criteria for defining a positive sacroiliac joint MRI in two cohorts of patients with axial spondyloarthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliac joint; Ankylosing spondylitis; Quadrant (abdomen); Axial spondyloarthritis; Radiology; Radiography; Lesion; BASDAI; Back pain; Nuclear medicine; Magnetic resonance imaging; Physical therapy; Surgery; Internal medicine; Arthritis; Sacroiliitis; Psoriatic arthritis; Pathology","score_opus":0.020731569974750296,"score_gpt":0.305650553390098,"score_spread":0.2849189834153477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105000414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965181,0.0005682985,0.000063287036,0.00055697234,0.00009500887,0.0009282871,0.0011358642,0.000011480197,0.00012272096],"genre_scores_gemma":[0.99887633,0.000082105136,0.00045314076,0.00025911833,0.000011151771,0.00010230306,0.00017998113,0.000023294784,0.000012597333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986759,0.00008686174,0.00044678192,0.00021289555,0.00031299097,0.0002645671],"domain_scores_gemma":[0.9987527,0.00026992016,0.00028639685,0.00032669728,0.00026338108,0.000100899626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013810187,0.00018638569,0.0006467882,0.000095859315,0.00009115244,0.000010120066,0.000081698505,0.000023717115,0.00004502079],"category_scores_gemma":[0.00039486634,0.000121755256,0.00019849505,0.00014777784,0.00016772834,0.00005562028,0.00004680885,0.000042207655,0.000001795155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049878126,0.0025276886,0.9564206,0.0010115779,0.0005354323,0.000011308076,0.0006994247,0.00011687003,0.000062216604,0.00046471698,0.0014820376,0.03168034],"study_design_scores_gemma":[0.010722367,0.001267392,0.97969717,0.005177761,0.00023353142,0.0000016019719,0.00010395728,0.00037584238,0.0016334822,0.00059318927,0.00004716478,0.00014654137],"about_ca_topic_score_codex":0.0004266552,"about_ca_topic_score_gemma":0.0002746868,"teacher_disagreement_score":0.0315338,"about_ca_system_score_codex":0.000019836703,"about_ca_system_score_gemma":0.000092910195,"threshold_uncertainty_score":0.49650353},"labels":[],"label_agreement":null},{"id":"W2105037937","doi":"10.1136/ard.2008.092577","title":"Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Bristol-Myers Squibb; Genentech; Amgen","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Internal medicine; Rheumatology; Placebo; Physical therapy; Methotrexate; Alternative medicine; Pathology; Rituximab","score_opus":0.6070778469196079,"score_gpt":0.569533115370734,"score_spread":0.03754473154887383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105037937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851524,0.011439784,0.00030367085,0.0006955844,0.00023037095,0.0017220405,0.00039705005,0.000016629818,0.00004244005],"genre_scores_gemma":[0.9688719,0.030477434,0.00040253045,0.0000323519,0.00002792233,0.00009278532,0.00006351318,0.000022912809,0.0000086667005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99222726,0.0034069633,0.0014923962,0.0004351429,0.0021073185,0.00033094702],"domain_scores_gemma":[0.9943912,0.0017901572,0.0006842539,0.0019857283,0.0007013457,0.0004473135],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0047193523,0.00023931709,0.0013762786,0.0002893683,0.00007386122,0.00001468565,0.00074167224,0.00006426881,0.00020204137],"category_scores_gemma":[0.01887462,0.00016244226,0.0004948311,0.00051803276,0.0005225671,0.00029715564,0.00043879662,0.00017528312,0.0000031978939],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050744507,0.016611092,0.16641809,0.0009744669,0.0027279558,0.000016253767,0.0010063213,0.00033610724,0.0028931089,0.00019995063,0.0040542018,0.75401795],"study_design_scores_gemma":[0.032799706,0.0010679031,0.9413084,0.0046616914,0.00016431017,0.000005370992,0.00023964443,0.0076576406,0.009884995,0.0019307366,0.000044269516,0.00023533143],"about_ca_topic_score_codex":0.00024044943,"about_ca_topic_score_gemma":0.000082744235,"teacher_disagreement_score":0.7748903,"about_ca_system_score_codex":0.000023802944,"about_ca_system_score_gemma":0.0010248158,"threshold_uncertainty_score":0.98938984},"labels":[],"label_agreement":null},{"id":"W2105058874","doi":"10.1136/annrheumdis-2011-200795","title":"Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Mount Sinai Hospital","funders":"National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Giant cell arteritis; Arteritis; Aorta; Internal medicine; Cardiology; Pathology; Vasculitis; Disease; Radiology","score_opus":0.02344609041605416,"score_gpt":0.27188874518152484,"score_spread":0.24844265476547067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105058874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944474,0.0026349286,0.000048498892,0.0016677298,0.00016073747,0.00024389876,0.0005381588,0.000010056669,0.00024858725],"genre_scores_gemma":[0.9981995,0.0014770036,0.000035400353,0.00007018763,0.000030632393,0.000019000474,0.00010395742,0.00000801755,0.00005627973],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99913406,0.00006474883,0.00035158312,0.000088917644,0.0001648276,0.00019588404],"domain_scores_gemma":[0.9993854,0.000052850817,0.00013106533,0.00023614854,0.000054841996,0.00013968698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000919158,0.000093590905,0.0002859708,0.000045284603,0.000051380397,0.00000790445,0.000061527484,0.000051971536,0.00015125475],"category_scores_gemma":[0.00010954006,0.00006573501,0.00014880474,0.00012538349,0.0001623172,0.000107132306,0.000039052215,0.00006365371,0.0000053739527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011364978,0.022511601,0.19882385,0.010652143,0.0018424155,0.00012036627,0.009154821,0.00006799801,0.03577328,0.022818323,0.0983559,0.5987428],"study_design_scores_gemma":[0.0010292104,0.00009474299,0.99391997,0.0014610058,0.00014474615,0.000045937657,0.00026954158,0.0000701609,0.0016924149,0.0009724869,0.00021889868,0.000080861755],"about_ca_topic_score_codex":0.00006434651,"about_ca_topic_score_gemma":0.0000037083898,"teacher_disagreement_score":0.79509616,"about_ca_system_score_codex":0.0000076155156,"about_ca_system_score_gemma":0.00003824184,"threshold_uncertainty_score":0.26805958},"labels":[],"label_agreement":null},{"id":"W2105156544","doi":"10.1136/annrheumdis-2013-204962","title":"Protection against murine osteoarthritis by inhibition of the 26S proteasome and lysine-48 linked ubiquitination","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Medical Research Council","keywords":"Ubiquitin; Medicine; Lysine; Proteasome; Osteoarthritis; Pharmacology; Cell biology; Biochemistry; Pathology; Biology; Amino acid; Gene","score_opus":0.01659208490829181,"score_gpt":0.2464539254757601,"score_spread":0.22986184056746828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105156544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993963,0.0007737414,0.000049669954,0.00303338,0.00010289741,0.0016474664,0.000068688845,0.000030342773,0.00033080872],"genre_scores_gemma":[0.99891764,0.00016165679,0.000039909803,0.00023337308,0.000033420347,0.0001530981,0.00004188117,0.000016542805,0.00040248796],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887836,0.00014514751,0.00034190362,0.00015487087,0.00033695955,0.00014274094],"domain_scores_gemma":[0.9990562,0.000042884247,0.00033318537,0.0003233094,0.00017070361,0.00007372447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018034651,0.00013865592,0.00028220486,0.000053386633,0.0001139006,0.000015060688,0.000070588554,0.00005471943,0.000020712272],"category_scores_gemma":[0.00047806444,0.000084396765,0.00015573362,0.00016650191,0.00014325713,0.000119425255,0.00006375183,0.000068896166,0.0000037021678],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004637648,0.0012344439,0.0026292992,0.0021828364,0.00014017517,0.0000016091013,0.00053358707,0.000013056475,0.109874226,0.0018731819,0.0019676066,0.8790862],"study_design_scores_gemma":[0.010493077,0.0036993336,0.05316536,0.012666747,0.00058190955,0.000039532108,0.00036231845,0.00095091737,0.9025296,0.013996571,0.0011051988,0.0004094194],"about_ca_topic_score_codex":0.000020499725,"about_ca_topic_score_gemma":0.000009521619,"teacher_disagreement_score":0.8786768,"about_ca_system_score_codex":0.000011169722,"about_ca_system_score_gemma":0.000036864192,"threshold_uncertainty_score":0.34416002},"labels":[],"label_agreement":null},{"id":"W2105190398","doi":"10.1136/ard.2010.147421","title":"IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University Health Network; Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Krembil Foundation; University of Toronto; Arthritis Society","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Genetic marker; Immunology; Gene; Genetics","score_opus":0.03751114802023366,"score_gpt":0.2430001526999564,"score_spread":0.20548900467972273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105190398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988666,0.0076253167,0.000022970142,0.00019932562,0.0012230114,0.0007311832,0.0011154461,0.000042929227,0.00037382153],"genre_scores_gemma":[0.9967588,0.0010420433,0.00012732926,0.00031461255,0.000023994486,0.00022253665,0.0001184989,0.00003109672,0.001361074],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985335,0.00019441087,0.0005038015,0.00028320754,0.00008424463,0.0004008716],"domain_scores_gemma":[0.99860823,0.0001799369,0.0003887933,0.00059334293,0.00016018566,0.00006952977],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014758769,0.00026453743,0.00046390024,0.00009177908,0.00022070791,0.000011314442,0.00041803316,0.0001380155,0.0013647969],"category_scores_gemma":[0.0003672139,0.00018570115,0.0005297316,0.00014414261,0.00022024498,0.00013501804,0.00010032194,0.000049403363,0.000115305076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001275047,0.0027014504,0.14744651,0.0002882749,0.004212564,0.0000020605792,0.0033752797,8.2209135e-7,0.00022568501,0.0006228122,0.06353473,0.7763148],"study_design_scores_gemma":[0.003488758,0.00029742697,0.95274305,0.00040042892,0.00069822534,0.0000029341732,0.00013000383,0.000005939236,0.035908427,0.004992534,0.0010021869,0.0003300889],"about_ca_topic_score_codex":0.00020133532,"about_ca_topic_score_gemma":0.000012401717,"teacher_disagreement_score":0.80529654,"about_ca_system_score_codex":0.000011406622,"about_ca_system_score_gemma":0.0000668017,"threshold_uncertainty_score":0.9995481},"labels":[],"label_agreement":null},{"id":"W2105257662","doi":"10.1136/ard.59.9.700","title":"Physiotherapy for anterior knee pain: a randomised controlled trial","year":2000,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Knee injuries and reconstruction techniques","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Physical therapy; WOMAC; Visual analogue scale; Randomized controlled trial; Hospital Anxiety and Depression Scale; Rehabilitation; Anxiety; Osteoarthritis; Patient satisfaction; Depression (economics); Minimal clinically important difference; Physical medicine and rehabilitation; Surgery","score_opus":0.01813294009856041,"score_gpt":0.32807891938338457,"score_spread":0.30994597928482415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105257662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860694,0.001551008,0.00016702492,0.0036276826,0.00020607072,0.00739943,0.000048141523,0.00010006806,0.00083122216],"genre_scores_gemma":[0.9914428,0.0013806133,0.00040364315,0.0022099656,0.00018235293,0.0011870557,0.0000071847608,0.000029122013,0.0031572524],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99886817,0.00012605709,0.00056388765,0.00012035741,0.00016759092,0.0001539601],"domain_scores_gemma":[0.9988258,0.00042644996,0.00024484305,0.000321062,0.00010329132,0.000078541765],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003859789,0.00012921395,0.00079405215,0.00004928458,0.000084383195,0.000016005244,0.00010633151,0.000042976524,0.0013104512],"category_scores_gemma":[0.0005177369,0.00006848553,0.0009889823,0.000075229334,0.00014791903,0.000046300313,0.00000775072,0.00003609318,0.000003224016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63170844,0.00047899006,0.00007808914,0.0003393575,0.0005273626,3.03546e-7,0.0000750531,0.0000017201464,0.000107636755,0.00005998078,0.01426945,0.3523536],"study_design_scores_gemma":[0.9827033,0.0020302231,0.00094574573,0.0013084543,0.00034203805,0.000006782598,0.0001078178,0.0007895747,0.0022974736,0.0055834483,0.0037049686,0.0001801558],"about_ca_topic_score_codex":0.000010015028,"about_ca_topic_score_gemma":3.5829575e-7,"teacher_disagreement_score":0.35217345,"about_ca_system_score_codex":0.0000055615747,"about_ca_system_score_gemma":0.000077981254,"threshold_uncertainty_score":0.9996025},"labels":[],"label_agreement":null},{"id":"W2105302212","doi":"10.1136/ard.2002.001784","title":"Satisfactory cross cultural equivalence of the Dutch WOMAC in patients with hip osteoarthritis waiting for arthroplasty","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":291,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia; University of Alberta","funders":"","keywords":"Medicine; WOMAC; Osteoarthritis; Arthroplasty; Hip surgery; Equivalence (formal languages); Total hip arthroplasty; Physical therapy; Hip arthroplasty; Surgery; Alternative medicine","score_opus":0.02626462101791087,"score_gpt":0.297133640024961,"score_spread":0.2708690190070501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105302212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751085,0.00060455536,0.0000053735407,0.0003358047,0.00018994871,0.001010502,0.00017333955,0.000015263495,0.00015437405],"genre_scores_gemma":[0.9994171,0.000029775496,0.00011466618,0.00016495267,0.000007826443,0.000040194533,0.0000059206063,0.000022178248,0.00019734308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983499,0.00012044669,0.00052009645,0.00019373021,0.00049463625,0.00032121164],"domain_scores_gemma":[0.9983955,0.00036021206,0.00038543151,0.00048402336,0.00028195183,0.00009288689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015334808,0.00018931286,0.00042809715,0.00004276886,0.000113443464,0.000018689952,0.00016660617,0.000039914354,0.00007148929],"category_scores_gemma":[0.0020381438,0.00009858749,0.00024687682,0.00022261022,0.0004977342,0.00020113912,0.00007471627,0.00009200695,0.0000029029163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002368997,0.00024241465,0.989603,0.000529125,0.0000654594,5.596767e-7,0.00044040187,0.00007656073,0.000018819603,0.00036842248,0.00023042418,0.008187952],"study_design_scores_gemma":[0.00344887,0.00031733245,0.99174535,0.0020931072,0.00005682879,0.0000037325933,0.00038019705,0.000026929418,0.0014127131,0.00032371047,0.000070899325,0.0001203184],"about_ca_topic_score_codex":0.00003539911,"about_ca_topic_score_gemma":0.000041589927,"teacher_disagreement_score":0.008067634,"about_ca_system_score_codex":0.000017214901,"about_ca_system_score_gemma":0.00013332712,"threshold_uncertainty_score":0.40202808},"labels":[],"label_agreement":null},{"id":"W2105366979","doi":"10.1136/annrheumdis-2012-201497","title":"The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Psoriasis; Erythrocyte sedimentation rate; Confounding; Psoriasis Area and Severity Index; Subclinical infection; Gastroenterology; Arthritis; Multivariate analysis; Bayesian multivariate linear regression; Surgery; Dermatology; Linear regression","score_opus":0.02259623376324823,"score_gpt":0.2651471040501234,"score_spread":0.2425508702868752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105366979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916297,0.0059833117,0.0000012560757,0.0010055214,0.00009538445,0.000867454,0.00013292051,0.000015622754,0.00026882655],"genre_scores_gemma":[0.99855167,0.0009459486,0.000098588236,0.00011440131,0.000040335963,0.00010152928,0.000021145814,0.000028334156,0.00009805707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838835,0.000084281295,0.00038945608,0.00016614309,0.0006031301,0.00036861497],"domain_scores_gemma":[0.9985686,0.00019099136,0.00033364934,0.0005597081,0.00021370598,0.00013337588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009561788,0.0002383461,0.0006333617,0.0000557514,0.00012834219,0.000015292855,0.00014792531,0.000027975047,0.000058765738],"category_scores_gemma":[0.000051178387,0.00010460857,0.00010024561,0.00025288502,0.0003091483,0.00014096135,0.000053526666,0.000068724636,0.0000047260023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028082598,0.0016909861,0.97729766,0.0002644507,0.0016889463,0.000005268519,0.0028341238,0.000024451507,8.33796e-7,0.00010809141,0.002400694,0.010876259],"study_design_scores_gemma":[0.0077947457,0.001109032,0.9844726,0.00450208,0.000398811,0.0000054451198,0.0011240839,0.0000065882655,0.00018735115,0.000111729154,0.00013629252,0.00015127248],"about_ca_topic_score_codex":0.0004978099,"about_ca_topic_score_gemma":0.00008696137,"teacher_disagreement_score":0.010724986,"about_ca_system_score_codex":0.000019027857,"about_ca_system_score_gemma":0.000060133672,"threshold_uncertainty_score":0.42658135},"labels":[],"label_agreement":null},{"id":"W2105600582","doi":"10.1136/ard.2007.087593","title":"Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Etanercept; Medicine; Internal medicine; Methotrexate; Adverse effect; Arthritis; Combination therapy; Rheumatology; Juvenile rheumatoid arthritis; Rheumatoid arthritis; Surgery","score_opus":0.04526888677963128,"score_gpt":0.3134629495038443,"score_spread":0.26819406272421303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105600582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353194,0.0043184673,0.000010911832,0.00082010654,0.000008191807,0.00091271446,0.00032288829,0.000007355572,0.000067410525],"genre_scores_gemma":[0.9972099,0.0023667498,0.00008081887,0.00005331419,0.0000030557264,0.000012090172,0.00019816474,0.00001549387,0.00006039462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835736,0.00024810407,0.0005574796,0.00023314217,0.00044894707,0.000154942],"domain_scores_gemma":[0.9981899,0.0002939001,0.00036020274,0.00092541246,0.00014365668,0.00008691171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023390065,0.00016129624,0.0006715608,0.00006356483,0.00008926122,0.0000073101014,0.00025640157,0.000035419605,0.000033246415],"category_scores_gemma":[0.00023782841,0.00008579318,0.00004575654,0.000195587,0.0004331482,0.00012329294,0.00016607055,0.00008401489,9.577925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013848788,0.0039872304,0.8105265,0.00090598926,0.00072517473,0.000023282853,0.01071894,0.00009877919,0.000086967695,0.00004470602,0.0009665425,0.15806709],"study_design_scores_gemma":[0.005510146,0.0015546683,0.9887285,0.0027761194,0.00013519455,0.000008344225,0.000565578,0.0003821518,0.00013863744,0.000054152497,0.000055276505,0.000091178474],"about_ca_topic_score_codex":0.00067560724,"about_ca_topic_score_gemma":0.00008500756,"teacher_disagreement_score":0.17820205,"about_ca_system_score_codex":0.000015035838,"about_ca_system_score_gemma":0.00023417652,"threshold_uncertainty_score":0.34985444},"labels":[],"label_agreement":null},{"id":"W2106085759","doi":"10.1136/ard.2010.140848","title":"Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Université du Québec à Trois-Rivières; Université de Montréal; Université Laval; Cegep de Sainte Foy; Hôpital Notre-Dame","funders":"Université de Montréal; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Osteoarthritis; Synovitis; Cartilage; Placebo; Viscosupplementation; Surgery; Arthropathy; Knee pain; Knee Joint; Arthritis; Internal medicine; Pathology; Anatomy","score_opus":0.049304174610658426,"score_gpt":0.28934502153289554,"score_spread":0.24004084692223712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106085759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904276,0.003066411,0.0000010717187,0.00007863224,0.0001066072,0.006026139,0.00005982569,0.000024667414,0.00020904373],"genre_scores_gemma":[0.9988496,0.00023843435,0.000053281,0.000085841675,0.000016043681,0.00057064084,0.00001519147,0.000039858474,0.0001311654],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975997,0.0003188663,0.0009498858,0.00030435948,0.0004924827,0.000334655],"domain_scores_gemma":[0.99847335,0.00015724887,0.00061554904,0.00037304248,0.00020363393,0.0001771532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042723556,0.00028957767,0.0009350946,0.00023366579,0.00010841326,0.00003594055,0.0001067085,0.000050692717,0.00016011579],"category_scores_gemma":[0.000281261,0.00021273752,0.00021156955,0.00021095441,0.00013406742,0.0003385896,0.00007820967,0.00009328855,0.0000058365126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7695343,0.009142322,0.17151554,0.00027302708,0.00048429062,0.00013956871,0.014690936,0.000010532355,0.0028423453,0.00003895434,0.00001758621,0.031310614],"study_design_scores_gemma":[0.79009193,0.02886629,0.1437069,0.004500403,0.0011396153,0.000014467208,0.0038992574,0.00006805704,0.025579782,0.0016256606,0.0000016844135,0.0005059482],"about_ca_topic_score_codex":0.0006426958,"about_ca_topic_score_gemma":0.00014373333,"teacher_disagreement_score":0.030804666,"about_ca_system_score_codex":0.00002000594,"about_ca_system_score_gemma":0.00012747744,"threshold_uncertainty_score":0.8675184},"labels":[],"label_agreement":null},{"id":"W2106216235","doi":"10.1136/ard.2007.069690","title":"Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Ottawa","funders":"","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Quality of life (healthcare); Physical therapy; Confidence interval; Internal medicine; Placebo; Minimal clinically important difference; SF-36; Randomized controlled trial; Health related quality of life; Alternative medicine; Disease","score_opus":0.14029500396499836,"score_gpt":0.4057427453816186,"score_spread":0.2654477414166202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106216235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056715,0.0065333564,0.0006168645,0.0008053906,0.000060032635,0.0012271374,0.00013637217,0.00002255123,0.00003112626],"genre_scores_gemma":[0.99283165,0.0065078805,0.00046659895,0.00004934159,0.000004807848,0.000073863564,0.000024315055,0.000024324314,0.000017234988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970567,0.00033466468,0.001259985,0.00025956612,0.000777142,0.00031192633],"domain_scores_gemma":[0.9947001,0.002746625,0.0011662343,0.00058219885,0.00056243164,0.00024241334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012950762,0.000230626,0.0011482347,0.00017626272,0.00016317428,0.000017152286,0.000120498116,0.00005260138,0.000009209975],"category_scores_gemma":[0.0054361573,0.00014747531,0.00043152983,0.0002505498,0.0003315815,0.0002023109,0.00008348681,0.000057178775,2.0058482e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00659593,0.0017558903,0.8563341,0.0012508354,0.0026507403,0.000005056155,0.0039629634,0.000033208482,0.0022434837,0.0011852386,0.000058353977,0.12392421],"study_design_scores_gemma":[0.004969786,0.0014836246,0.96845895,0.002747996,0.000036151636,0.000005358498,0.0031936239,0.000031506454,0.017903425,0.0009405691,0.00004609291,0.00018291107],"about_ca_topic_score_codex":0.0006907165,"about_ca_topic_score_gemma":0.00021476406,"teacher_disagreement_score":0.1237413,"about_ca_system_score_codex":0.000026611948,"about_ca_system_score_gemma":0.00027234675,"threshold_uncertainty_score":0.6507981},"labels":[],"label_agreement":null},{"id":"W2106302854","doi":"10.1136/ard.2004.028498","title":"The utility of tumour necrosis factor blockade in orphan diseases","year":2004,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Infliximab; Etanercept; Polyarteritis nodosa; Dermatomyositis; Adalimumab; Blockade; Vasculitis; Immunology; Giant cell arteritis; Tumor necrosis factor alpha; Polymyositis; Disease; Dermatology; Internal medicine; Receptor","score_opus":0.0640354195585142,"score_gpt":0.3542086252019451,"score_spread":0.2901732056434309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106302854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002417561,0.9933747,0.0000011050037,0.00075512246,0.00017844814,0.001243176,0.0018501335,0.000024308307,0.0001554591],"genre_scores_gemma":[0.080994286,0.9184691,0.000004475969,0.00003022298,0.000024560904,0.00010760454,0.000102828,0.000035438406,0.00023148552],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973262,0.0002958396,0.001231567,0.00028001962,0.00052374543,0.00034260686],"domain_scores_gemma":[0.9971339,0.00064554357,0.00081024953,0.0010375351,0.000149335,0.00022342184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015159145,0.00037431027,0.0018247896,0.00013525077,0.00015224877,0.000025791525,0.00056651107,0.00016056072,0.00033257843],"category_scores_gemma":[0.0011714501,0.00017617152,0.0020259966,0.00052468095,0.00045770718,0.00005442082,0.00015350633,0.00029142233,0.000017616872],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053894026,0.0019424016,0.0007258337,0.07705524,0.00246349,0.0000190418,0.00018002512,0.0000059068616,5.3133516e-7,0.00045972862,0.0043219933,0.91277194],"study_design_scores_gemma":[0.0029864565,0.00037807363,0.20481847,0.60832435,0.01746992,0.00010123804,0.0003693081,0.000069517046,0.000052417694,0.016190376,0.1481099,0.0011299591],"about_ca_topic_score_codex":0.00016749965,"about_ca_topic_score_gemma":0.000012037222,"teacher_disagreement_score":0.91164196,"about_ca_system_score_codex":0.0000350887,"about_ca_system_score_gemma":0.0010057214,"threshold_uncertainty_score":0.7184066},"labels":[],"label_agreement":null},{"id":"W2106808645","doi":"10.1136/ard.2004.021477","title":"Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome","year":2004,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Rheumatoid arthritis; Rheumatoid factor; Polyarthritis; Autoantibody; Immunology; Serology; Autoimmune disease; Antibody; Arthritis; Internal medicine; Gastroenterology","score_opus":0.01236056015511619,"score_gpt":0.24098596454402957,"score_spread":0.22862540438891338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106808645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96230257,0.0027391256,0.000019103958,0.032663558,0.00022265657,0.0013609473,0.00055417826,0.00004257936,0.00009529964],"genre_scores_gemma":[0.97097576,0.0024754654,0.00008622653,0.025789449,0.000027227588,0.00007786403,0.00041851352,0.00007528452,0.00007422387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973059,0.00013019635,0.00090253854,0.0004030758,0.0007850011,0.00047327564],"domain_scores_gemma":[0.9975343,0.0006539393,0.0005310677,0.00085796986,0.00027447782,0.00014825286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010500953,0.00045499703,0.001409534,0.00046549254,0.00008372684,0.000022105272,0.0003333188,0.00021664063,0.00012455537],"category_scores_gemma":[0.001563796,0.00029920883,0.00039456747,0.000583221,0.00025121958,0.00009470734,0.000114392875,0.00043945722,0.000021334514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003711651,0.0011741107,0.8521298,0.0028953655,0.0009757548,0.0002079043,0.00023439495,0.0007444811,0.0000014070973,0.000027455339,0.13912027,0.002117859],"study_design_scores_gemma":[0.00272162,0.0008506125,0.9715564,0.022349853,0.00021696642,0.000030607247,0.000048961883,0.0000068217023,0.000031730826,0.0012458174,0.0005948593,0.00034573037],"about_ca_topic_score_codex":0.0012156784,"about_ca_topic_score_gemma":0.000053596912,"teacher_disagreement_score":0.13852541,"about_ca_system_score_codex":0.000029832525,"about_ca_system_score_gemma":0.0002975586,"threshold_uncertainty_score":0.999946},"labels":[],"label_agreement":null},{"id":"W2106864054","doi":"10.1136/ard.2006.069039","title":"The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Toronto Western Hospital; University of Toronto; Centre Hospitalier de l’Université de Montréal; McGill University; University of Calgary; McGill University Health Centre","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Medicine; Internal medicine; Cancer; Cohort; Azathioprine; Cyclophosphamide; Risk factor; Hazard ratio; Systemic lupus erythematosus; Cohort study; Oncology; Chemotherapy; Disease","score_opus":0.08131814762527642,"score_gpt":0.3911433331357405,"score_spread":0.3098251855104641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106864054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984,0.011953097,0.000017102911,0.0012074296,0.00018363587,0.0024899885,0.000020141355,0.000028038596,0.00010055606],"genre_scores_gemma":[0.998757,0.00051673787,0.0000071664494,0.000033044595,0.000054862136,0.00024315162,0.000004972128,0.000023841549,0.00035922695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971627,0.00038432484,0.00094406726,0.00025422248,0.0009039054,0.00035075194],"domain_scores_gemma":[0.9943496,0.004098553,0.00037489468,0.00079344615,0.00018848832,0.00019500103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033062182,0.00016836723,0.00050357677,0.00018504326,0.00024136207,0.000032942964,0.00026397337,0.00006890557,0.000008157764],"category_scores_gemma":[0.0035787907,0.00009108088,0.00010530752,0.00046232843,0.00024638796,0.00008860072,0.00012522614,0.00018246443,0.000005077299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090748166,0.00014580732,0.9918238,0.0013990934,0.00023448262,0.00007002824,0.0025780657,0.0000025719949,0.0000021725477,0.00018881023,0.0006434127,0.0028210129],"study_design_scores_gemma":[0.0009885825,0.00007808474,0.9777087,0.0038925738,0.00020415973,0.004865099,0.011414718,0.000040349434,0.000020913225,0.0006913033,0.000008733248,0.00008678948],"about_ca_topic_score_codex":0.0009319712,"about_ca_topic_score_gemma":0.0005803552,"teacher_disagreement_score":0.014756987,"about_ca_system_score_codex":0.00007584029,"about_ca_system_score_gemma":0.00020331271,"threshold_uncertainty_score":0.42844054},"labels":[],"label_agreement":null},{"id":"W2106914983","doi":"10.1136/annrheumdis-2013-203993","title":"Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Genentech; Swedish Orphan Biovitrum; Versus Arthritis; Chugai Pharmaceutical; Amgen; Pfizer; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Internal medicine; Erythrocyte sedimentation rate; TNF inhibitor; Observational study; Clinical endpoint; Gastroenterology; Physical therapy; Surgery; Randomized controlled trial; Adalimumab; Lymphoma","score_opus":0.05875335825035089,"score_gpt":0.3411242294116987,"score_spread":0.2823708711613478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106914983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305946,0.0010224665,0.00006684421,0.00056546315,0.00023995488,0.00462909,0.00026287316,0.000059331316,0.0000945447],"genre_scores_gemma":[0.99865186,0.00025062263,0.00016963483,0.00023251853,0.00004404286,0.00053777004,0.000054108168,0.000043999542,0.00001546343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99520177,0.0012294325,0.0008160417,0.0006638735,0.001479627,0.00060927897],"domain_scores_gemma":[0.9964397,0.0008278006,0.0003132356,0.0008907552,0.0009062275,0.00062228646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007184262,0.00045905277,0.001342549,0.00027783655,0.00021683167,0.00014719453,0.0005002009,0.00005919355,0.000052947093],"category_scores_gemma":[0.0020110626,0.00033092024,0.00017578666,0.0009809566,0.00022091746,0.0005290453,0.00026988407,0.00018029736,0.000049529717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06489527,0.029854227,0.80055606,0.0005321156,0.0016350147,0.00003329317,0.012715031,0.0010196593,0.00010694205,0.00085407397,0.0041884515,0.083609864],"study_design_scores_gemma":[0.021689719,0.013592198,0.952731,0.008174505,0.000019928335,0.0000021762803,0.0014953649,0.00015320483,0.00082207477,0.0006406405,0.0002668614,0.00041229112],"about_ca_topic_score_codex":0.00056086225,"about_ca_topic_score_gemma":0.0009953828,"teacher_disagreement_score":0.15217498,"about_ca_system_score_codex":0.00016062419,"about_ca_system_score_gemma":0.0002839301,"threshold_uncertainty_score":0.9999143},"labels":[],"label_agreement":null},{"id":"W2107216509","doi":"10.1136/annrheumdis-2012-202865","title":"Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; GlaxoSmithKline","keywords":"Belimumab; Medicine; Placebo; Internal medicine; Quality of life (healthcare); Randomized controlled trial; Systemic lupus erythematosus; Adverse effect; Physical therapy; B-cell activating factor; Immunology; Antibody; Disease; Pathology","score_opus":0.041018063930946605,"score_gpt":0.313622220978431,"score_spread":0.2726041570474844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107216509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730171,0.009433484,0.00001663674,0.0009211568,0.0001839699,0.016108973,0.00024193639,0.000032960692,0.000043793978],"genre_scores_gemma":[0.99847955,0.00037232137,0.00002940938,0.00017439143,0.000022188447,0.000713471,0.00006811036,0.00006292701,0.00007765167],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9887622,0.0038332853,0.004389289,0.0005131075,0.0018603291,0.0006418143],"domain_scores_gemma":[0.9870518,0.006927397,0.0034335935,0.0013391438,0.00089507457,0.00035302778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043907813,0.00048115486,0.0041415775,0.0002961433,0.00010749092,0.000060148148,0.00057662185,0.00013110747,0.00011424819],"category_scores_gemma":[0.0050439425,0.00021841576,0.0004947188,0.00083408493,0.0003812436,0.00023153785,0.0001524056,0.00026065187,0.000013674859],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14166352,0.0024718593,0.84227586,0.0036159738,0.0025306947,0.0000051679585,0.0044920444,0.00033800703,0.0002084707,0.00007457622,0.0009207199,0.0014030903],"study_design_scores_gemma":[0.519835,0.0010157904,0.4359058,0.03680276,0.00023656456,0.000036241665,0.0039259987,0.0012455393,0.0002679187,0.00037060058,0.000001424636,0.00035637725],"about_ca_topic_score_codex":0.006355427,"about_ca_topic_score_gemma":0.00008324418,"teacher_disagreement_score":0.40637007,"about_ca_system_score_codex":0.00023570628,"about_ca_system_score_gemma":0.0012488853,"threshold_uncertainty_score":0.9607547},"labels":[],"label_agreement":null},{"id":"W2107358534","doi":"10.1136/annrheumdis-2012-202315","title":"Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; School of Medicine, Indiana University; School of Medicine, Stanford University; Pfizer; Hospital for Sick Children; National Center for Research Resources; Georgia Clinical and Translational Science Alliance; Seattle Children's Research Institute; University of California, Los Angeles; University of South Carolina; Creighton University; Cincinnati Children's Hospital Medical Center; National Institutes of Health; Center for Advanced Holocaust Studies, United States Holocaust Memorial Museum; Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago; Nationwide Children's Hospital; Children's Hospital of Philadelphia","keywords":"Atorvastatin; Medicine; Internal medicine; C-reactive protein; Post-hoc analysis; Intima-media thickness; Placebo; Clinical endpoint; Gastroenterology; Subgroup analysis; Lipoprotein; Systemic lupus erythematosus; Lipid profile; Randomized controlled trial; Endocrinology; Cholesterol; Inflammation; Disease; Pathology; Carotid arteries","score_opus":0.030163131722845685,"score_gpt":0.32389996124119375,"score_spread":0.29373682951834806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107358534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945741,0.00018269233,9.684705e-7,0.00031708268,0.000044475204,0.004590362,0.00009955622,0.000019137915,0.0001715996],"genre_scores_gemma":[0.99848366,0.0000073839124,0.00007152008,0.000020080546,0.0000065400873,0.00079197215,0.000046944435,0.000035556033,0.0005363304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703234,0.00039779206,0.00072882575,0.00034208424,0.0011627999,0.00033614063],"domain_scores_gemma":[0.99762046,0.0002462661,0.0005882545,0.0008349173,0.0005305624,0.0001795304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034894503,0.00023218272,0.00088243163,0.00036794916,0.000050205832,0.000024703582,0.00030965128,0.000054208653,0.00041429375],"category_scores_gemma":[0.00037141176,0.00012904782,0.00022457048,0.0012975072,0.00019301505,0.00020572115,0.0001519358,0.00014641254,0.000011200275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043409178,0.0037484395,0.98608184,0.00084533566,0.0016189722,0.000001413196,0.0023682518,0.00000944436,0.00026750646,0.000009210117,0.00079785916,0.003817645],"study_design_scores_gemma":[0.0024939794,0.000594306,0.98912126,0.0031511171,0.000489858,0.0000028435365,0.0025254968,0.00009152729,0.0013478596,0.000045722,0.000004511495,0.0001315024],"about_ca_topic_score_codex":0.000933139,"about_ca_topic_score_gemma":0.000058903122,"teacher_disagreement_score":0.0039095464,"about_ca_system_score_codex":0.000053256954,"about_ca_system_score_gemma":0.0001882744,"threshold_uncertainty_score":0.5262418},"labels":[],"label_agreement":null},{"id":"W2107510226","doi":"10.1136/ard.2006.058339","title":"Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Texas Rio Grande Valley","keywords":"Medicine; Psoriatic arthritis; Infliximab; Psoriasis; Dermatology; Internal medicine; Arthritis; Clinical trial; Adalimumab; Etanercept; Physical therapy; Antirheumatic Agents; Rheumatoid arthritis; Tumor necrosis factor alpha","score_opus":0.05759758296608489,"score_gpt":0.3530800859068701,"score_spread":0.29548250294078526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107510226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938478,0.0007174825,7.41206e-7,0.00060122553,0.000089779736,0.0013051226,0.0032879845,0.00000779828,0.00014209672],"genre_scores_gemma":[0.9991132,0.00051821425,0.000084583204,0.000031881664,0.0000424158,0.000042583462,0.00012703516,0.000017789413,0.000022323044],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976658,0.00042687065,0.001067512,0.00022309953,0.00039535447,0.00022133488],"domain_scores_gemma":[0.99644935,0.0018508818,0.00080960203,0.00065455126,0.00017836102,0.000057277448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024147189,0.000212558,0.0009517444,0.000045438872,0.000053328637,0.000006454281,0.00014884023,0.000057955167,0.000039958122],"category_scores_gemma":[0.0017290986,0.000100355486,0.0004261727,0.00024626078,0.00041877342,0.000081847546,0.000058901536,0.00007143664,0.0000027692022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69909227,0.009374454,0.24383867,0.00003668753,0.0021903487,0.000014582355,0.0013197679,0.00009455157,0.0000010420465,0.00014162037,0.0009639795,0.04293206],"study_design_scores_gemma":[0.11906067,0.0073115975,0.86996466,0.0012876133,0.00028168617,4.5052616e-7,0.00040219814,0.0000065648874,0.00011749459,0.001480872,0.000011528329,0.0000746549],"about_ca_topic_score_codex":0.011918861,"about_ca_topic_score_gemma":0.00043996563,"teacher_disagreement_score":0.626126,"about_ca_system_score_codex":0.000052451942,"about_ca_system_score_gemma":0.00027689151,"threshold_uncertainty_score":0.99466085},"labels":[],"label_agreement":null},{"id":"W2107690729","doi":"10.1136/ard.2006.057018","title":"Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Bristol-Myers Squibb","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Internal medicine; Placebo; Quality of life (healthcare); Physical therapy; Rheumatology; Methotrexate; Clinical trial; Population; Rituximab; Alternative medicine","score_opus":0.015309197623842832,"score_gpt":0.2985069573704528,"score_spread":0.28319775974661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107690729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807952,0.0088112,0.000011995794,0.008493241,0.000029049155,0.0013240264,0.0004631684,0.0000178845,0.00005424125],"genre_scores_gemma":[0.9872853,0.012080614,0.000076015174,0.00021048723,0.000012703217,0.0000773656,0.000033100754,0.00002853109,0.00019587413],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99787444,0.00042715177,0.00045144034,0.00024374323,0.00061653636,0.0003866987],"domain_scores_gemma":[0.9984298,0.00037015454,0.00029194437,0.00052961713,0.00013248665,0.00024603863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003152728,0.0002415064,0.0006646841,0.00009798842,0.00022764852,0.000038496437,0.00017534287,0.000020997124,0.000019918329],"category_scores_gemma":[0.00020793114,0.0001194918,0.00018285173,0.00018054471,0.0004591624,0.00012070946,0.00009917002,0.000071306255,0.0000031963511],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021018978,0.0062412648,0.09717907,0.00061667565,0.0015816306,0.000007760817,0.012850672,0.000058520898,0.000787797,0.0012713005,0.017614355,0.840772],"study_design_scores_gemma":[0.0058101686,0.0048334585,0.97746,0.0027334844,0.000013673788,0.000010228284,0.0010946046,0.00026588462,0.0039459052,0.0009622286,0.0026529632,0.0002173894],"about_ca_topic_score_codex":0.0008730738,"about_ca_topic_score_gemma":0.00013083866,"teacher_disagreement_score":0.8802809,"about_ca_system_score_codex":0.000033029573,"about_ca_system_score_gemma":0.00020636866,"threshold_uncertainty_score":0.48727342},"labels":[],"label_agreement":null},{"id":"W2107730744","doi":"10.1136/ard.2004.033217","title":"Psoriasis: epidemiology, clinical features, and quality of life","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Epidemiology; Disease; Psychosocial; Dermatology; Quality of life (healthcare); Pathology; Psychiatry","score_opus":0.28487102146392945,"score_gpt":0.4508351941802997,"score_spread":0.16596417271637026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107730744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018061025,0.99515676,0.0000011233141,0.00025383104,0.00081400963,0.0005777137,0.0012290888,0.000024832385,0.00013653755],"genre_scores_gemma":[0.0016558192,0.997049,0.000040324285,0.0001813955,0.000075168515,0.000060710307,0.00021886149,0.000026170757,0.0006925806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99191946,0.004860323,0.002391722,0.0004226189,0.00006218786,0.0003437007],"domain_scores_gemma":[0.9897753,0.0066659786,0.002414751,0.0009646911,0.000091678696,0.00008761296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019892403,0.00044956306,0.0042226757,0.000101996025,0.00010301126,0.0000045044217,0.00064987165,0.00065933634,0.00015800064],"category_scores_gemma":[0.007028593,0.00025269564,0.0019034332,0.00015617268,0.0007917029,0.000047041278,0.0002639442,0.00027052886,0.00005312677],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009558019,0.0004041954,0.0012622422,0.0065004043,0.003429407,1.738783e-7,0.00002361642,1.9774998e-7,8.594449e-8,0.0010034023,0.013598352,0.97368234],"study_design_scores_gemma":[0.0016692642,0.0002391047,0.08376278,0.019665372,0.007886483,0.00002425476,0.000069710746,1.7243165e-7,0.0000067243814,0.0012879719,0.8847347,0.0006534734],"about_ca_topic_score_codex":0.000110166955,"about_ca_topic_score_gemma":0.000014450974,"teacher_disagreement_score":0.9730289,"about_ca_system_score_codex":0.000008310619,"about_ca_system_score_gemma":0.00032227705,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W2107834854","doi":"10.1136/ard.2009.109983","title":"Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST–RA database","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Professional Engineers Ontario","funders":"","keywords":"Medicine; Gross domestic product; Rheumatoid arthritis; Per capita; Cohort; Rheumatology; Internal medicine; Disease; Environmental health; Population; Economic growth","score_opus":0.03210420673548513,"score_gpt":0.33850045516112054,"score_spread":0.3063962484256354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107834854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94856054,0.026545452,0.000010491877,0.02291078,0.000105102685,0.0015270105,0.00020616694,0.000034927805,0.000099560646],"genre_scores_gemma":[0.9390393,0.059514802,0.000027247903,0.0011113109,0.00002765702,0.00020914972,0.000026500318,0.000021458067,0.00002260344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967062,0.00050637743,0.0007026898,0.00043588897,0.0009080108,0.0007408336],"domain_scores_gemma":[0.9976371,0.0007292159,0.00016388063,0.0010502285,0.00011436409,0.00030520838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001130897,0.00031680748,0.0007424776,0.0004140462,0.00014726233,0.00014575158,0.0006188074,0.00003772084,0.00003522711],"category_scores_gemma":[0.004533451,0.0002077646,0.00017840775,0.0009034307,0.00035180603,0.00062064163,0.00015385564,0.0003287357,0.000015496838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00393473,0.0043280893,0.8547986,0.001319035,0.000096990654,0.00046972962,0.0030818451,0.00028434407,0.00015034946,0.008104467,0.004559543,0.11887225],"study_design_scores_gemma":[0.0018874413,0.00021331749,0.9777278,0.011753569,0.0000053311364,0.000032107022,0.00074068946,0.0001990414,0.00022443813,0.0066768546,0.00028356077,0.00025586854],"about_ca_topic_score_codex":0.0014737404,"about_ca_topic_score_gemma":0.00091353117,"teacher_disagreement_score":0.122929156,"about_ca_system_score_codex":0.000058794012,"about_ca_system_score_gemma":0.00040103347,"threshold_uncertainty_score":0.8472395},"labels":[],"label_agreement":null},{"id":"W2108153267","doi":"10.1136/ard.2007.077800","title":"Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"","keywords":"MMP3; Cartilage; Inflammation; S100A9; Arthritis; Medicine; ADAMTS; S100A8; Matrix metalloproteinase; Immunology; Thrombospondin; Aggrecan; Cartilage oligomeric matrix protein; Osteoarthritis; Pathology; Metalloproteinase; Internal medicine; Biology; Anatomy; Gene expression; Articular cartilage","score_opus":0.015912651023578146,"score_gpt":0.2463949256597664,"score_spread":0.23048227463618826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108153267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975265,0.0012816133,0.00011913633,0.0003771381,0.00009414964,0.0004490482,0.000020522351,0.00002116056,0.000110726],"genre_scores_gemma":[0.99856156,0.0010636586,0.000075619304,0.000024667474,0.0000651489,0.000017512635,0.000014018411,0.000020264526,0.00015756526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988432,0.00006590424,0.0004259808,0.0002312717,0.00018193945,0.00025169997],"domain_scores_gemma":[0.999136,0.000010513184,0.0002754199,0.00036634944,0.000108127075,0.00010358968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025399364,0.00015784717,0.00018303593,0.00006032094,0.00016588159,0.000026583779,0.00012225706,0.000097261705,0.000019826914],"category_scores_gemma":[0.00023027434,0.00011552681,0.00013778213,0.00011145411,0.00011823502,0.000019760751,0.00011323121,0.000048393453,0.000003319515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007786743,0.00003549124,0.001568914,0.0001001445,0.000053905496,0.0000022056424,0.00008298224,0.000014194638,0.9501088,0.00016010656,0.000047292007,0.047748078],"study_design_scores_gemma":[0.0004226145,0.00008669093,0.16397338,0.00041864364,0.000012300416,0.00001748754,0.000073048825,0.000011058835,0.8336008,0.0011471338,0.000098821176,0.00013802877],"about_ca_topic_score_codex":0.000023088078,"about_ca_topic_score_gemma":0.000024105799,"teacher_disagreement_score":0.16240446,"about_ca_system_score_codex":0.000006515736,"about_ca_system_score_gemma":0.00004227379,"threshold_uncertainty_score":0.47110465},"labels":[],"label_agreement":null},{"id":"W2108546319","doi":"10.1136/annrheumdis-2014-205372","title":"The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Janeway Children's Health and Rehabilitation Centre; University of Toronto; Memorial University of Newfoundland; McMaster University; University of Manitoba; Children's Hospital of Eastern Ontario; University of Calgary; SickKids Foundation; London Health Sciences Centre; Dalhousie University; University of Ottawa; McGill University Health Centre; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; Western University; Université de Sherbrooke; Izaak Walton Killam Health Centre; Royal University Hospital; University of Saskatchewan; Centre hospitalier de l'Université Laval; BC Children's Hospital; Children's Hospital of Winnipeg; Alberta Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Polyarthritis; Oligoarthritis; Arthritis; Cohort; Rheumatology; Internal medicine; Macrophage activation syndrome; Disease; Pediatrics; Juvenile; Physical therapy; Surgery","score_opus":0.026816889079972584,"score_gpt":0.28655418483837497,"score_spread":0.2597372957584024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108546319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795319,0.010263118,0.0000040555005,0.007086981,0.000035291,0.0011241394,0.00015854208,0.000019456891,0.0017765384],"genre_scores_gemma":[0.99652976,0.0024244355,0.000005986168,0.0003269315,0.000012064744,0.00007521076,0.000056413206,0.000020220354,0.00054896745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764985,0.0004439315,0.000884257,0.0002018053,0.00058488664,0.00023526726],"domain_scores_gemma":[0.9973934,0.0007514911,0.00050397177,0.0011737931,0.000111181645,0.000066119894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010188959,0.00017938878,0.00071380974,0.000045835477,0.00016784939,0.000025132094,0.00047483534,0.000043096254,0.000016113967],"category_scores_gemma":[0.0018569474,0.000073981515,0.00021598673,0.00016566007,0.0004122469,0.00010171456,0.00012078699,0.00015590753,0.000011783884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088364276,0.0004101314,0.96000385,0.000054586253,0.0011555102,0.0000033780293,0.0006700041,0.000011717049,0.000009328236,0.00018774194,0.005575094,0.031035021],"study_design_scores_gemma":[0.0032801996,0.00021229549,0.99257225,0.001521496,0.00011128102,0.0000019963934,0.00054655934,0.00007442437,0.00022063829,0.001080573,0.0002946339,0.000083640996],"about_ca_topic_score_codex":0.0018741203,"about_ca_topic_score_gemma":0.00015046935,"teacher_disagreement_score":0.032568417,"about_ca_system_score_codex":0.0000129589735,"about_ca_system_score_gemma":0.0002185741,"threshold_uncertainty_score":0.30168784},"labels":[],"label_agreement":null},{"id":"W2108827080","doi":"10.1136/annrheumdis-2012-202136","title":"Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Agency for Healthcare Research and Quality","keywords":"Medicine; Rheumatoid arthritis; Vaccination; Heart failure; Tuberculosis; Antagonist; BCG vaccine; Arthritis; Internal medicine; Immunology; Pediatrics; Pathology","score_opus":0.01369503633790254,"score_gpt":0.26241225435920623,"score_spread":0.2487172180213037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108827080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98685306,0.010474324,0.000017174074,0.0013136243,0.00013003631,0.000744444,0.000217996,0.00007209491,0.00017722356],"genre_scores_gemma":[0.9921691,0.0070821997,0.0002788866,0.00024002991,0.00004136186,0.000058876667,0.000041770716,0.000048572234,0.00003923797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730957,0.00024139049,0.00055349997,0.00022560732,0.0009200907,0.00074987055],"domain_scores_gemma":[0.99785084,0.0002251713,0.00037840154,0.0006899312,0.0003079202,0.00054772024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038548952,0.00027273453,0.00059969793,0.00011096371,0.00038023206,0.00007053851,0.00023257495,0.00005432217,0.00032958263],"category_scores_gemma":[0.0009489321,0.00016788136,0.0002969637,0.0003039423,0.00054850726,0.0005058874,0.00012691965,0.00022619852,0.000050060924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027051877,0.0008498158,0.96311444,0.00014213976,0.00032316352,0.0000011433635,0.0005038495,0.0000069888733,0.000008504644,0.00014179427,0.014509579,0.020128084],"study_design_scores_gemma":[0.0023439687,0.0003258051,0.9890091,0.0032459048,0.000017735181,0.000008896148,0.0005525383,0.000037909183,0.0008937468,0.00040873614,0.002931209,0.00022445041],"about_ca_topic_score_codex":0.00029058312,"about_ca_topic_score_gemma":0.00005724567,"teacher_disagreement_score":0.025894683,"about_ca_system_score_codex":0.000016487998,"about_ca_system_score_gemma":0.00012423228,"threshold_uncertainty_score":0.6846003},"labels":[],"label_agreement":null},{"id":"W2108988182","doi":"10.1136/annrheumdis-2013-203967","title":"Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Rasch model; Medicine; International Classification of Functioning, Disability and Health; Ankylosing spondylitis; Set (abstract data type); Reliability (semiconductor); Core (optical fiber); Kappa; Index (typography); Differential item functioning; Physical therapy; Item response theory; Statistics; Psychometrics; Clinical psychology; Rehabilitation; Surgery; Computer science; Mathematics","score_opus":0.05492523300988121,"score_gpt":0.3117985629139621,"score_spread":0.25687332990408085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108988182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557513,0.00042751295,0.00003482368,0.0018200967,0.000028890121,0.0006649993,0.00085104094,0.00000687268,0.00059063785],"genre_scores_gemma":[0.9989816,0.000024092775,0.0003016167,0.00055217516,0.0000030663575,0.000034905886,0.00007995825,0.000010331705,0.000012282899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980455,0.0002364003,0.00069622375,0.00017510666,0.00061015494,0.00023663942],"domain_scores_gemma":[0.99847776,0.00026577356,0.00060039514,0.0003596028,0.00022016096,0.00007630909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034922143,0.00017751865,0.0005577601,0.00004898061,0.00010194357,0.000005523071,0.0001419831,0.000026793112,0.00004850428],"category_scores_gemma":[0.00068704895,0.000095985575,0.000103301805,0.0003158321,0.0001841557,0.000039057355,0.000058713464,0.000053407533,0.000001084042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030615542,0.0034211106,0.94470465,0.00061907724,0.00046773907,0.0000019897334,0.0013098043,0.000051341016,0.0000014488799,0.00042038146,0.005998956,0.039941955],"study_design_scores_gemma":[0.00490758,0.00085635966,0.9878365,0.0051365336,0.000048618804,5.2045004e-7,0.00034138493,0.000122715,0.00017383938,0.00029368498,0.00019817353,0.00008410743],"about_ca_topic_score_codex":0.0002728872,"about_ca_topic_score_gemma":0.00006466674,"teacher_disagreement_score":0.04313184,"about_ca_system_score_codex":0.00007141329,"about_ca_system_score_gemma":0.00034637898,"threshold_uncertainty_score":0.39141783},"labels":[],"label_agreement":null},{"id":"W2109037568","doi":"10.1136/annrheumdis-2013-204488","title":"Weight change and change in tibial cartilage volume and symptoms in obese adults","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; McMaster University","keywords":"Medicine; Weight change; WOMAC; Osteoarthritis; Weight loss; Cartilage; Body mass index; Weight gain; Knee pain; Patella; Obesity; Surgery; Internal medicine; Body weight; Anatomy; Pathology","score_opus":0.029994699812109456,"score_gpt":0.27278260679878547,"score_spread":0.24278790698667602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109037568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920598,0.0055336608,3.3803403e-7,0.001485377,0.00008625881,0.0006760221,0.00002921645,0.000013835509,0.00011545778],"genre_scores_gemma":[0.998263,0.0009587674,0.0000128862275,0.00047412736,0.000054737797,0.00010684263,0.000011335143,0.00001341535,0.00010490701],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991682,0.0000711341,0.00021665233,0.00017355029,0.00016297727,0.00020745068],"domain_scores_gemma":[0.999476,0.00005514207,0.000094591065,0.00022333176,0.000026146203,0.00012477892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012361493,0.00013174204,0.00033141844,0.00010119752,0.000026424343,0.000010473679,0.000060104823,0.00004644377,0.000038694347],"category_scores_gemma":[0.0001531188,0.00009122663,0.000054719545,0.00010508162,0.00007881592,0.00013003773,0.00007143712,0.000048671336,0.0000063842235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040939928,0.00052643474,0.44504339,0.0008943596,0.00002315829,0.000020677635,0.004759143,8.6722245e-8,0.0000868083,0.00050873274,0.00012012868,0.5476077],"study_design_scores_gemma":[0.0049137734,0.0012004303,0.9854129,0.005436116,0.00008808828,0.000012771007,0.00017794833,0.00054737495,0.00079092535,0.0010732563,0.00018699953,0.00015940651],"about_ca_topic_score_codex":0.00028866078,"about_ca_topic_score_gemma":0.00041965905,"teacher_disagreement_score":0.5474483,"about_ca_system_score_codex":0.000007515968,"about_ca_system_score_gemma":0.000012283227,"threshold_uncertainty_score":0.3720114},"labels":[],"label_agreement":null},{"id":"W2109041707","doi":"10.1136/annrheumdis-2012-201299","title":"Obesity and the risk of psoriatic arthritis: a population-based study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":306,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Psoriatic arthritis; Obesity; Psoriasis; Population; Environmental health; Internal medicine; Dermatology","score_opus":0.020786116741324932,"score_gpt":0.25965122072503694,"score_spread":0.238865103983712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109041707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97515154,0.0238055,0.00000640625,0.00013370624,0.00024606055,0.0004890157,0.00013157088,0.000011982775,0.000024242145],"genre_scores_gemma":[0.9993402,0.00048869837,0.000010226317,0.000039461254,0.0000098972605,0.000042589974,0.000015145254,0.000006222016,0.00004761135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985516,0.0008368868,0.00030390386,0.00008910665,0.000058431324,0.00016007469],"domain_scores_gemma":[0.9984469,0.0007891756,0.0003343363,0.00036421957,0.000043977583,0.000021389826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004566877,0.000115306975,0.0003361805,0.000034459652,0.00017565873,0.0000054727425,0.00016432018,0.00003880524,0.00008195678],"category_scores_gemma":[0.0005335179,0.0000583301,0.0001768983,0.00009380886,0.00014962006,0.00005979676,0.000051348234,0.00004199771,0.000012024842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027210152,0.0012000026,0.9516192,0.000053969594,0.00086648867,8.3266116e-8,0.0009288418,0.000014311365,0.000007215919,0.0005498363,0.00019012517,0.044297818],"study_design_scores_gemma":[0.0024135262,0.00006893016,0.994197,0.00012341721,0.0006619667,8.207807e-7,0.00042887207,0.00000922043,0.0004996817,0.0015218804,0.000011148224,0.00006350611],"about_ca_topic_score_codex":0.0005402893,"about_ca_topic_score_gemma":0.00003650009,"teacher_disagreement_score":0.044234313,"about_ca_system_score_codex":0.0000032593784,"about_ca_system_score_gemma":0.000022688106,"threshold_uncertainty_score":0.23786324},"labels":[],"label_agreement":null},{"id":"W2109087897","doi":"10.1136/annrheumdis-2013-203561","title":"ADAMTS-7 forms a positive feedback loop with TNF-α in the pathogenesis of osteoarthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Rheumatology Research Foundation","keywords":"ADAMTS; Cartilage; Medicine; Gene knockdown; Osteoarthritis; Chondrocyte; Matrix metalloproteinase; Pathogenesis; Endochondral ossification; Tumor necrosis factor alpha; Immunohistochemistry; Pathology; Cancer research; Metalloproteinase; Immunology; Internal medicine; Biology; Gene; Anatomy; Thrombospondin; Genetics","score_opus":0.0175428863808622,"score_gpt":0.25302793523766853,"score_spread":0.23548504885680632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109087897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930344,0.0023368716,0.0000037520886,0.0019758316,0.000032157586,0.0013183075,0.000112325746,0.000011950594,0.0011743609],"genre_scores_gemma":[0.9986999,0.00024137943,0.0001011029,0.0004973221,0.000010569774,0.00016829124,0.000025685695,0.000018238008,0.00023749207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873966,0.000097201766,0.00034802107,0.00015179673,0.00042223965,0.00024107499],"domain_scores_gemma":[0.99887425,0.00017148117,0.00021071182,0.00047968526,0.00017718427,0.00008671869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011917866,0.0001726176,0.0004086154,0.00006786495,0.000054071214,0.000017357159,0.00020247362,0.000039869698,0.00013388699],"category_scores_gemma":[0.00011280163,0.00008061654,0.00020153848,0.00026223093,0.00016191642,0.00014709927,0.000046530586,0.0000573255,0.000022076001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000962527,0.0025577322,0.036544517,0.0008556622,0.0003517777,0.000060368242,0.0032408994,0.000010410013,0.0027337275,0.0024675482,0.0015565109,0.94865835],"study_design_scores_gemma":[0.00768103,0.0069645117,0.94078267,0.008031053,0.0005941631,0.00013054098,0.0067144744,0.000043856147,0.021438846,0.007234534,0.000050091003,0.00033423438],"about_ca_topic_score_codex":0.00014864607,"about_ca_topic_score_gemma":0.00006343681,"teacher_disagreement_score":0.9483241,"about_ca_system_score_codex":0.000008382057,"about_ca_system_score_gemma":0.00008762168,"threshold_uncertainty_score":0.3287447},"labels":[],"label_agreement":null},{"id":"W2109338462","doi":"10.1136/ard.2008.103804","title":"Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Memorial University of Newfoundland; University Health Network; Toronto Western Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Ankylosing spondylitis; Medicine; Haplotype; Association (psychology); Spondylitis; Genetic association; Immunology; Genetics; Dermatology; Allele; Single-nucleotide polymorphism; Genotype; Gene; Biology","score_opus":0.02141003288340904,"score_gpt":0.2929605354870699,"score_spread":0.27155050260366087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109338462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519706,0.0016044836,0.0000032592936,0.0020178838,0.0000604797,0.00027963665,0.00023629994,0.00002361096,0.000577306],"genre_scores_gemma":[0.99863064,0.00046916405,0.00016425588,0.00039224367,0.000026194739,0.000005823863,0.000045211164,0.000010172843,0.0002562711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896735,0.000057860296,0.0002672753,0.00012925615,0.00039794584,0.00018031115],"domain_scores_gemma":[0.99909025,0.00007350078,0.00025812708,0.0002961069,0.00019825528,0.00008374078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009495885,0.000120465935,0.0003650691,0.000047648067,0.00008275127,0.000009456742,0.0000819538,0.0000318908,0.0000768489],"category_scores_gemma":[0.00020056259,0.00007496564,0.00014349837,0.00017379415,0.00005799185,0.00010407168,0.000016003021,0.000041953994,0.0000024738406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006297177,0.0076676435,0.63674384,0.0007403109,0.0036481547,0.00007221506,0.0023890862,0.000080552316,0.00062599505,0.0019602783,0.0076389476,0.3321358],"study_design_scores_gemma":[0.0020622357,0.0015378685,0.99152976,0.0009970627,0.0003752147,0.000009063422,0.0001874221,0.00005710394,0.0014984434,0.001423468,0.00023335085,0.00008903279],"about_ca_topic_score_codex":0.00010024866,"about_ca_topic_score_gemma":0.000026362964,"teacher_disagreement_score":0.3547859,"about_ca_system_score_codex":0.000017431577,"about_ca_system_score_gemma":0.00005869272,"threshold_uncertainty_score":0.30570102},"labels":[],"label_agreement":null},{"id":"W2109409650","doi":"10.1136/ard.2003.010983","title":"Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Leflunomide; Medicine; Rheumatoid arthritis; Radiography; Internal medicine; Surgery","score_opus":0.01893068399169364,"score_gpt":0.2954491988298459,"score_spread":0.27651851483815226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109409650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408926,0.013948929,0.000004544763,0.00018351813,0.000017593627,0.0015327304,0.0001753487,0.0000159729,0.00003213206],"genre_scores_gemma":[0.99035627,0.009299507,0.000059657952,0.000016777989,0.000003376279,0.00010451892,0.00012904759,0.000028385239,0.0000024901583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973106,0.00020264005,0.00058103283,0.00022852792,0.0013914171,0.00028578582],"domain_scores_gemma":[0.9981571,0.00007661561,0.00043986464,0.00053564046,0.0005653443,0.00022543331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037083204,0.00019801522,0.0005693196,0.0003436345,0.000046335572,0.0000146517295,0.00019102843,0.000036076304,0.000057541747],"category_scores_gemma":[0.00030686392,0.000121415826,0.00017445872,0.0006235734,0.00055931427,0.00021473333,0.00004187746,0.000088524546,0.0000011397651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029875173,0.0018952448,0.9319489,0.0003815631,0.00028811287,0.000009941911,0.00034054922,0.0002282284,0.000026872365,0.000071770526,0.000030143934,0.061791148],"study_design_scores_gemma":[0.010140187,0.000793055,0.9731208,0.013800239,0.00004736756,0.00000384768,0.00007548599,0.000047149202,0.0010770251,0.0007702288,0.0000017149886,0.00012286514],"about_ca_topic_score_codex":0.00014685372,"about_ca_topic_score_gemma":0.00010909484,"teacher_disagreement_score":0.061668284,"about_ca_system_score_codex":0.000025767076,"about_ca_system_score_gemma":0.0004670824,"threshold_uncertainty_score":0.49511936},"labels":[],"label_agreement":null},{"id":"W2109441608","doi":"10.1136/annrheumdis-2013-203631","title":"What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?","year":2013,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Osteoarthritis; Joint replacement; Radiography; Knee Joint; Synovitis; Knee replacement; Magnetic resonance imaging; Radiology; Cartilage; Arthropathy; Arthroplasty; Surgery; Arthritis; Pathology; Internal medicine; Anatomy","score_opus":0.06697645198047049,"score_gpt":0.34257536358632984,"score_spread":0.27559891160585936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109441608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018445435,0.98833954,0.000008530935,0.0006905971,0.00073779875,0.0069213454,0.0014033223,0.000011175364,0.000043155967],"genre_scores_gemma":[0.0036655974,0.99391496,0.000021542397,0.00014745706,0.000037859463,0.0017527518,0.00012435559,0.0000333559,0.00030211156],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969675,0.000333955,0.0014093735,0.0003266019,0.0006267506,0.00033584243],"domain_scores_gemma":[0.99311846,0.003704571,0.0014955222,0.0013048631,0.0002818652,0.00009472396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074235577,0.00041393033,0.0021295478,0.0001481151,0.00008272572,0.000031555883,0.00041707428,0.00012841931,0.000127637],"category_scores_gemma":[0.00079305505,0.00018916202,0.001583522,0.00033202636,0.00035512928,0.00018242357,0.00017716017,0.00015620708,0.000007716451],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001695117,0.00038364902,0.00008888553,0.018126974,0.0006241189,0.0000011429402,0.00038293086,0.0000023538294,2.5018136e-7,0.00024067427,0.0060486537,0.97393084],"study_design_scores_gemma":[0.005401789,0.008312751,0.00077753497,0.7632809,0.01494281,0.000064092965,0.00467479,0.00013269701,0.00055244315,0.0050768857,0.19585425,0.0009290458],"about_ca_topic_score_codex":0.000041953066,"about_ca_topic_score_gemma":0.00000630718,"teacher_disagreement_score":0.97300184,"about_ca_system_score_codex":0.000027010245,"about_ca_system_score_gemma":0.00055463566,"threshold_uncertainty_score":0.7713803},"labels":[],"label_agreement":null},{"id":"W2109675827","doi":"10.1136/ard.2008.094623","title":"Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Placebo; Viscosupplementation; Double blind; Arthropathy; Physical therapy; Internal medicine; Surgery; Intra articular; Alternative medicine; Pathology","score_opus":0.016222312525676068,"score_gpt":0.24569124034160023,"score_spread":0.22946892781592415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109675827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98402745,0.0011713055,0.0000035309731,0.00067006954,0.00010560059,0.013599058,0.00004586773,0.000027960345,0.00034917492],"genre_scores_gemma":[0.99880356,0.00006109793,0.00007600479,0.00022478336,0.000021060172,0.00054032536,0.000050917617,0.00002744157,0.00019481144],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975727,0.00025027408,0.0008045325,0.00027078934,0.0007299253,0.00037174977],"domain_scores_gemma":[0.99805933,0.00027932227,0.00061041233,0.00069699326,0.00017932708,0.00017460986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015692285,0.00036630494,0.0012624429,0.00011438396,0.000086030355,0.000027215538,0.0001764853,0.00006664991,0.000040809504],"category_scores_gemma":[0.00012825229,0.00016686333,0.00042854802,0.0002960963,0.00014317817,0.00012924078,0.000029664718,0.00007876909,0.0000032498956],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9473432,0.007374631,0.0049892752,0.00016945683,0.00056818797,0.000013073391,0.0005885512,0.00004534966,0.00009101317,0.000033187316,0.000033628447,0.038750503],"study_design_scores_gemma":[0.9651873,0.019313624,0.0065370607,0.0033254072,0.0015345047,0.000006122415,0.00015145817,0.000043178516,0.003618366,0.00008715713,0.000008293922,0.00018753996],"about_ca_topic_score_codex":0.000019652407,"about_ca_topic_score_gemma":0.000050860082,"teacher_disagreement_score":0.038562965,"about_ca_system_score_codex":0.000067134206,"about_ca_system_score_gemma":0.00022590019,"threshold_uncertainty_score":0.6804489},"labels":[],"label_agreement":null},{"id":"W2109680824","doi":"10.1136/ard.61.5.414","title":"Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome","year":2002,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Menzies Centre for Australian Studies, King's College London, University of London; King's College London; Lupus Research Alliance","keywords":"Medicine; Intensive care unit; Antiphospholipid syndrome; Proportional hazards model; Systemic lupus erythematosus; Internal medicine; Disease; Survival analysis; Severity of illness; Hazard ratio; Thrombosis; Confidence interval","score_opus":0.03614518885858817,"score_gpt":0.3089697967700415,"score_spread":0.27282460791145335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109680824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646568,0.025725925,0.000008372167,0.0072951308,0.00033971938,0.0010863754,0.000025559457,0.000034739765,0.0008273902],"genre_scores_gemma":[0.9963575,0.002412532,0.000012142124,0.00022094189,0.00002198095,0.00011765259,0.0000013073428,0.000032431046,0.00082349655],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9973471,0.00041480365,0.0007254139,0.00027603537,0.00078550633,0.0004511077],"domain_scores_gemma":[0.99677855,0.0017267513,0.00016621724,0.0009431452,0.0001824538,0.00020291358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006778923,0.00022016423,0.00085743744,0.00013734233,0.000131528,0.000049503484,0.00041932194,0.000076152646,0.00019076015],"category_scores_gemma":[0.0037985595,0.00011068566,0.00025599214,0.00044303824,0.0009800487,0.000118299824,0.0002232939,0.00019068462,0.00005677573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023402914,0.0028717043,0.82805943,0.050081946,0.0013020332,0.00082545594,0.021164948,0.00004223462,0.000111171146,0.04393894,0.033393126,0.015868733],"study_design_scores_gemma":[0.045113526,0.0008335427,0.11752183,0.12212494,0.0016192917,0.60664785,0.035703417,0.034157507,0.0011517211,0.032564677,0.0005784464,0.0019832212],"about_ca_topic_score_codex":0.00008571701,"about_ca_topic_score_gemma":0.0000032577445,"teacher_disagreement_score":0.7105376,"about_ca_system_score_codex":0.000028047709,"about_ca_system_score_gemma":0.000058792615,"threshold_uncertainty_score":0.4547505},"labels":[],"label_agreement":null},{"id":"W2109773166","doi":"10.1136/ard.2009.118307","title":"Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission","year":2010,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Rheumatoid arthritis; Infliximab; Internal medicine; Methotrexate; Combination therapy; Abatacept; Clinical trial; Surgery; Disease; Rituximab","score_opus":0.2938033011937885,"score_gpt":0.4760440886390958,"score_spread":0.1822407874453073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109773166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27628002,0.72211105,0.000005887928,0.00010202029,0.00005895679,0.0012633071,0.00014719104,0.000012805639,0.00001877661],"genre_scores_gemma":[0.13259332,0.8669815,0.00015314821,0.000019050587,0.000009156474,0.00013242167,0.0000711418,0.000035411438,0.000004862007],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99401337,0.0019278642,0.0024304,0.00049933954,0.0008057063,0.00032329568],"domain_scores_gemma":[0.9936323,0.002989094,0.0018475275,0.00095281925,0.00031208986,0.0002661723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018434612,0.00048621968,0.0069923867,0.0010060576,0.000060361595,0.000026813488,0.00043730627,0.00031589073,0.00014725358],"category_scores_gemma":[0.0014440385,0.000245443,0.0041058767,0.0016199846,0.001243134,0.00009622354,0.00009025771,0.0005138504,8.091664e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036530427,0.0019576298,0.002481509,0.0013427039,0.0927824,0.000008715369,0.00022658812,0.0000016423891,0.0000017015246,0.00029309763,0.000024559104,0.8972264],"study_design_scores_gemma":[0.1178801,0.0323342,0.42491445,0.16842158,0.14244787,0.00016687305,0.0005995686,0.00048592474,0.00043084472,0.0047297105,0.10336428,0.004224613],"about_ca_topic_score_codex":0.0001721643,"about_ca_topic_score_gemma":0.00002739085,"teacher_disagreement_score":0.8930018,"about_ca_system_score_codex":0.0000057777065,"about_ca_system_score_gemma":0.00035481187,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W2109777848","doi":"10.1136/annrheumdis-2014-205743","title":"PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McGill University; University Health Network; Université de Montréal","funders":"Canadian Arthritis Network; Medical Research Council; Canadian Institutes of Health Research; Arthritis Society","keywords":"Medicine; Osteoarthritis; Articular cartilage; PI3K/AKT/mTOR pathway; Cartilage; Signalling; Bioinformatics; Internal medicine; Pathology; Signal transduction; Anatomy; Cell biology; Alternative medicine","score_opus":0.06694450799386248,"score_gpt":0.28870476499540204,"score_spread":0.22176025700153956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109777848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419695,0.0023479974,0.0000030363622,0.0013561342,0.00006435018,0.0009265967,0.00007993542,0.000028036728,0.00099695],"genre_scores_gemma":[0.9992548,0.000076074095,0.000025700965,0.0003484268,0.0000109201565,0.00007670731,0.00006108903,0.000018528035,0.00012771234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979423,0.00029240784,0.0005395245,0.00022893833,0.0006241709,0.0003726288],"domain_scores_gemma":[0.9988184,0.00023475639,0.00022548533,0.0004034361,0.00017999986,0.00013794191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006477652,0.00019837686,0.00042841968,0.000100241436,0.00006245961,0.00003763418,0.0002175414,0.000060399325,0.00001562982],"category_scores_gemma":[0.0010803328,0.000107885986,0.000119855526,0.000616936,0.00010038779,0.00014191626,0.000039688577,0.00012660574,0.000010210812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038858093,0.05455064,0.34631434,0.0030318352,0.0016045917,0.008386409,0.14354815,0.017663699,0.022262556,0.0059231617,0.027308637,0.33054787],"study_design_scores_gemma":[0.1528331,0.030937713,0.58309925,0.055807393,0.002556445,0.00048815843,0.038286593,0.0037404124,0.11036173,0.018634297,0.00044850883,0.0028063997],"about_ca_topic_score_codex":0.00010049813,"about_ca_topic_score_gemma":0.00042260962,"teacher_disagreement_score":0.32774147,"about_ca_system_score_codex":0.000037632934,"about_ca_system_score_gemma":0.00021827278,"threshold_uncertainty_score":0.4399463},"labels":[],"label_agreement":null},{"id":"W2110217426","doi":"10.1136/annrheumdis-2014-205351","title":"Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; F. Hoffmann-La Roche","keywords":"Tocilizumab; Medicine; Placebo; Internal medicine; Adverse effect; Methotrexate; Arthritis; Clinical endpoint; Rheumatology; Rheumatoid arthritis; Gastroenterology; Randomized controlled trial; Surgery","score_opus":0.025094197368805693,"score_gpt":0.3093936000634985,"score_spread":0.2842994026946928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110217426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940629,0.0023505806,0.000016077283,0.0006892923,0.00004493071,0.0025416715,0.00013121376,0.000014399979,0.00014895096],"genre_scores_gemma":[0.9994582,0.00025050124,0.000016147702,0.00005778514,0.000020776586,0.000066960114,0.00007684666,0.000020179412,0.00003260142],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973678,0.00027750188,0.0011404116,0.0002638267,0.00067443954,0.00027602265],"domain_scores_gemma":[0.9981459,0.00032278377,0.00051630987,0.00065337983,0.00020266404,0.00015899328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071650353,0.00019586267,0.00095730316,0.00009731153,0.00007766283,0.00001973245,0.00018703962,0.00006953763,0.00004722229],"category_scores_gemma":[0.001381067,0.00012316577,0.00016824878,0.0002309473,0.0003213987,0.00014236936,0.000084080726,0.00015542672,0.0000036760123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93386674,0.0037171608,0.004154405,0.00021751525,0.00027843955,0.0000035604505,0.0006897174,0.000044073644,0.000015718102,0.000038572005,0.00021166123,0.056762464],"study_design_scores_gemma":[0.8810744,0.0022527417,0.11158879,0.003494823,0.00018988337,9.4305386e-7,0.00015977936,0.0003185778,0.00054032984,0.00018681254,0.00004831057,0.00014458182],"about_ca_topic_score_codex":0.0002480363,"about_ca_topic_score_gemma":0.000030138372,"teacher_disagreement_score":0.107434385,"about_ca_system_score_codex":0.000012059723,"about_ca_system_score_gemma":0.00032953435,"threshold_uncertainty_score":0.5022554},"labels":[],"label_agreement":null},{"id":"W2111203217","doi":"10.1136/ard.2004.034504","title":"Non-Hodgkin's lymphoma in systemic lupus erythematosus","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Calgary; University Health Network; McGill University; Montreal General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; Lupus Research Alliance; Canadian Institutes of Health Research; University of Toronto; National Cancer Institute; National Institutes of Health; Canadian Arthritis Network; Fonds de Recherche du Québec - Santé; Pennsylvania Department of Health; Arthritis Society; Cancer Care Ontario; Institute of Musculoskeletal Health and Arthritis; Lupus Canada","keywords":"Medicine; Lymphoma; Internal medicine; Cohort; Etiology; Diffuse large B-cell lymphoma; Systemic lupus erythematosus; Disease; Non-Hodgkin's lymphoma; Systemic disease; Gastroenterology","score_opus":0.03279999422169223,"score_gpt":0.319984652172181,"score_spread":0.2871846579504888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111203217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877458,0.005896934,0.000014591034,0.0024608376,0.0002619165,0.0011548871,0.000024584655,0.000055037646,0.0023853972],"genre_scores_gemma":[0.9965485,0.0006475183,0.00007674391,0.00029314772,0.000083690386,0.000118518394,0.000005906476,0.0000492653,0.002176741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711347,0.00015947262,0.00091963814,0.00031433842,0.00094694586,0.0005461522],"domain_scores_gemma":[0.99765426,0.0003502202,0.00032351544,0.0011935495,0.0002164166,0.00026206658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005851931,0.00026268058,0.00082900864,0.00028170962,0.0000670625,0.00002754973,0.000554566,0.00009624119,0.0001463804],"category_scores_gemma":[0.00076499354,0.00016856992,0.0003879181,0.00056580047,0.00018620979,0.00014567391,0.00020314772,0.000105367595,0.00020685291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084766856,0.0022070736,0.8792533,0.013331829,0.0006047598,0.00008391883,0.004129808,0.00026899696,0.00050158094,0.00094914145,0.04270858,0.05511329],"study_design_scores_gemma":[0.05136031,0.0015175992,0.5408259,0.19152036,0.0013773387,0.11311865,0.023586286,0.03623973,0.023801014,0.007871586,0.005642423,0.003138817],"about_ca_topic_score_codex":0.00009012345,"about_ca_topic_score_gemma":0.00001752509,"teacher_disagreement_score":0.33842745,"about_ca_system_score_codex":0.00011643329,"about_ca_system_score_gemma":0.00037295368,"threshold_uncertainty_score":0.6874082},"labels":[],"label_agreement":null},{"id":"W2113074108","doi":"10.1136/annrheumdis-2012-201918","title":"Healthcare service utilisation costs are reduced when rheumatoid arthritis patients achieve sustained remission","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Disease; Health care; Physical therapy","score_opus":0.036625627938654884,"score_gpt":0.31176362698644766,"score_spread":0.2751379990477928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113074108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563671,0.021179907,0.00000677213,0.020502234,0.00032355922,0.0010604487,0.00015322,0.00008355878,0.00032320814],"genre_scores_gemma":[0.97210526,0.026195876,0.00006560808,0.0012098011,0.00005721607,0.00006617529,0.00015517455,0.00004463371,0.00010024402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970145,0.0003915343,0.0006784267,0.00025123157,0.0009721898,0.0006921108],"domain_scores_gemma":[0.9969705,0.00021209216,0.00047686728,0.00076701195,0.0008853097,0.00068825425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041802952,0.00027200242,0.00057938695,0.00013950508,0.00030021425,0.00004237359,0.00030276764,0.00009609999,0.00025010708],"category_scores_gemma":[0.0017577533,0.00019257833,0.00025677867,0.00034235578,0.00014581274,0.00045543787,0.00017286434,0.000195346,0.000046536137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022788697,0.0031856229,0.51693165,0.002497369,0.0005214918,0.0000050167873,0.006221272,0.000004610003,0.0002903905,0.0019679589,0.056092255,0.4100035],"study_design_scores_gemma":[0.004681926,0.0004963554,0.9602265,0.016838487,0.000019431898,0.000030500674,0.0051011276,0.00018579676,0.0035041547,0.004182107,0.0042844526,0.00044918415],"about_ca_topic_score_codex":0.0003927919,"about_ca_topic_score_gemma":0.00003987722,"teacher_disagreement_score":0.44329482,"about_ca_system_score_codex":0.00007353817,"about_ca_system_score_gemma":0.0002341179,"threshold_uncertainty_score":0.78531164},"labels":[],"label_agreement":null},{"id":"W2113317539","doi":"10.1136/annrheumdis-2014-205198","title":"Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Placebo; Psoriatic arthritis; Bristol-Myers; Presenteeism; Work productivity; Internal medicine; Absenteeism; Arthritis; Productivity; Physical therapy; Rheumatoid arthritis; Alternative medicine; Adalimumab","score_opus":0.03226778408063328,"score_gpt":0.2913182179532685,"score_spread":0.2590504338726352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113317539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924358,0.001232487,5.3253723e-7,0.00017410622,0.00003715126,0.0059401914,0.00016491472,0.000005204929,0.000009606583],"genre_scores_gemma":[0.9986167,0.00020823654,0.000011364921,0.0000062134177,0.0000063424145,0.001104998,0.000015910444,0.000015897122,0.00001436035],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99789333,0.00038681107,0.00087405095,0.0002626129,0.00039823455,0.00018498511],"domain_scores_gemma":[0.998042,0.0005593567,0.0007958293,0.00043622468,0.00009869106,0.0000679221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028461407,0.00023486315,0.0011193468,0.00012347024,0.00005374862,0.000008786161,0.000060897943,0.000030661333,0.00000380755],"category_scores_gemma":[0.00040603313,0.00012241713,0.00010203258,0.00020484923,0.00024840358,0.000101667356,0.00005990687,0.000041404386,5.8303186e-8],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5444014,0.011459775,0.42788592,0.00025324238,0.00078634283,0.0000044421477,0.004789654,0.000016081824,0.000015529109,0.0000029446007,0.0000042973475,0.010380377],"study_design_scores_gemma":[0.4560634,0.0037818486,0.5370011,0.0009955687,0.00051895384,7.006277e-7,0.00066154485,0.00004728017,0.00080770825,0.000047856625,3.1687554e-7,0.00007374843],"about_ca_topic_score_codex":0.00062443776,"about_ca_topic_score_gemma":0.0010040576,"teacher_disagreement_score":0.109115176,"about_ca_system_score_codex":0.000029853813,"about_ca_system_score_gemma":0.00005510385,"threshold_uncertainty_score":0.49920255},"labels":[],"label_agreement":null},{"id":"W2114142124","doi":"10.1136/ard.2010.129726","title":"Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Waterloo; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"BASDAI; Medicine; Psoriatic arthritis; Ankylosing spondylitis; Physical therapy; Internal medicine; Psoriasis; Cohort; Arthritis; Dermatology","score_opus":0.02767579461300815,"score_gpt":0.30425046626784896,"score_spread":0.2765746716548408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114142124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905076,0.0020501497,0.0000013954573,0.0059573087,0.00028090525,0.0005718519,0.00022408133,0.000016609189,0.00039007096],"genre_scores_gemma":[0.9985101,0.0006750815,0.00003174865,0.00053613476,0.000049870505,0.00006131564,0.000008082953,0.000021245207,0.00010637878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846447,0.00008391859,0.00038137683,0.00023306852,0.0005584351,0.0002787316],"domain_scores_gemma":[0.9985998,0.00014762302,0.00024058172,0.000650535,0.00013803506,0.00022342372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001500481,0.00020748512,0.0005753154,0.00008959794,0.00007465018,0.00001220976,0.00017243247,0.000054052485,0.00035734463],"category_scores_gemma":[0.0008423992,0.00014291958,0.00039920706,0.0002182158,0.00022423908,0.00011301119,0.000103832404,0.00015035803,0.000024339432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034676956,0.0059099626,0.718113,0.0013895932,0.001260271,0.00008675646,0.0014910244,0.0000031004781,0.0006551381,0.00062112935,0.0053076833,0.2616946],"study_design_scores_gemma":[0.0032307198,0.0002722004,0.9869068,0.0022162972,0.00025393438,0.0000059402378,0.000100771504,0.000035640358,0.0020760032,0.0046319813,0.00012700642,0.00014269316],"about_ca_topic_score_codex":0.00042857786,"about_ca_topic_score_gemma":0.00019380155,"teacher_disagreement_score":0.2687938,"about_ca_system_score_codex":0.000009947911,"about_ca_system_score_gemma":0.0001695503,"threshold_uncertainty_score":0.58280915},"labels":[],"label_agreement":null},{"id":"W2114286851","doi":"10.1136/ard.2008.104117","title":"ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"International Classification of Functioning, Disability and Health; Ankylosing spondylitis; Medicine; Set (abstract data type); Core (optical fiber); Family medicine; Physical therapy; Gerontology; Rehabilitation; Computer science; Surgery","score_opus":0.102427402933135,"score_gpt":0.4122931193535345,"score_spread":0.3098657164203995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114286851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97043735,0.0040692077,0.000007694323,0.023529226,0.00006405714,0.00092380506,0.00042282668,0.000014827198,0.00053099176],"genre_scores_gemma":[0.9971588,0.00073491334,0.000046996505,0.0016226108,0.00002592352,0.000027256487,0.00002703246,0.000012801224,0.0003436333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903494,0.0000412547,0.00024943126,0.00016900408,0.00025073532,0.00025464068],"domain_scores_gemma":[0.998922,0.00022898032,0.00022184523,0.00033512316,0.00011931132,0.00017276178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001673482,0.00016194563,0.00045735203,0.00005898616,0.00025072976,0.000024350325,0.000072487994,0.000025882056,0.000049744856],"category_scores_gemma":[0.0005203235,0.00008511942,0.00027450218,0.00015588063,0.000084359664,0.000050343075,0.00003389113,0.000049464066,0.0000023647926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056740204,0.002148499,0.07370201,0.0010210333,0.0023121322,0.00001724886,0.0043308814,0.00016239125,0.000090195004,0.005032395,0.15104784,0.75446135],"study_design_scores_gemma":[0.0018596163,0.0065029566,0.9814993,0.003473088,0.00015266296,0.0000390049,0.0009042965,0.00010464243,0.00017294948,0.004598472,0.00058893574,0.00010404333],"about_ca_topic_score_codex":0.00032610248,"about_ca_topic_score_gemma":0.000011363043,"teacher_disagreement_score":0.90779734,"about_ca_system_score_codex":0.000035105222,"about_ca_system_score_gemma":0.00012531874,"threshold_uncertainty_score":0.34710693},"labels":[],"label_agreement":null},{"id":"W2114308202","doi":"10.1136/ard.2008.092932","title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Chugai Pharmaceutical; Versus Arthritis","keywords":"Medicine; Tocilizumab; Rheumatoid arthritis; Internal medicine; Adverse effect; Placebo; Gastroenterology; Rash; Methotrexate; Refractory (planetary science); Surgery; Pathology","score_opus":0.029773023989463108,"score_gpt":0.26963820499568697,"score_spread":0.23986518100622387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114308202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860268,0.0013689873,0.0000043508007,0.001299572,0.00015826555,0.009399455,0.0016287944,0.000076927434,0.000036846362],"genre_scores_gemma":[0.98504263,0.013182759,0.00020818594,0.00014433257,0.00002582067,0.0009904233,0.00025271918,0.000045462864,0.000107660046],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99606264,0.00055615767,0.0012554609,0.0005899978,0.0009162465,0.00061949086],"domain_scores_gemma":[0.99640656,0.0014795397,0.0006316159,0.0006817646,0.00034204347,0.00045850282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022180924,0.00052258815,0.0019508948,0.00023176966,0.00023430905,0.00005834172,0.00021807099,0.000108740445,0.00015118519],"category_scores_gemma":[0.002963453,0.0002619832,0.0004719886,0.00029559768,0.0003387628,0.00026966762,0.00007027876,0.00017189878,0.000027684435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93754894,0.0076440843,0.03460943,0.000038427035,0.001114295,0.000021897762,0.0021433188,0.000024018742,0.00036804186,0.0000028866332,0.0007100185,0.015774643],"study_design_scores_gemma":[0.73968136,0.0076142503,0.24800353,0.0023346518,0.000028222366,0.0000024286926,0.00039061796,0.00003059998,0.0014503025,0.000034639947,0.000110369874,0.00031903607],"about_ca_topic_score_codex":0.0009301649,"about_ca_topic_score_gemma":0.00020371738,"teacher_disagreement_score":0.2133941,"about_ca_system_score_codex":0.000100052865,"about_ca_system_score_gemma":0.00035346,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W2114376947","doi":"10.1136/ard.2008.088732","title":"Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Université Laval; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Osteoarthritis; Naproxen; Cartilage; Clinical trial; Surgery; Knee Joint; Internal medicine; Pathology; Anatomy","score_opus":0.06905281691397593,"score_gpt":0.34789039905914276,"score_spread":0.27883758214516685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114376947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917251,0.0031664327,0.000005978012,0.00021936958,0.00044572304,0.004304541,0.000078048804,0.000025172003,0.000029663994],"genre_scores_gemma":[0.99895877,0.00041981664,0.00025036282,0.00007066814,0.00005589292,0.00018541772,0.000009345728,0.00003168626,0.00001805895],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977209,0.00036266536,0.0007905554,0.00037344923,0.00042467448,0.00032774918],"domain_scores_gemma":[0.99755746,0.0011771924,0.00043941443,0.00044112286,0.00014932893,0.00023548688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023393685,0.0002886223,0.0008915661,0.00015473427,0.00013399319,0.000009838616,0.00010545575,0.000120677745,0.000009098965],"category_scores_gemma":[0.0025317266,0.00021255127,0.0003672633,0.00026930522,0.00039730166,0.00013513734,0.00009670472,0.00017150745,0.000005570378],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81539553,0.029640567,0.028967083,0.008539942,0.001951875,0.003587332,0.022804528,0.00020438833,0.0042635403,0.0014666026,0.00054036814,0.08263824],"study_design_scores_gemma":[0.66897494,0.1091568,0.071750075,0.036835007,0.0019336783,0.00014736877,0.0033649348,0.0011324752,0.10391277,0.0015144369,0.00004673967,0.0012308003],"about_ca_topic_score_codex":0.00012580596,"about_ca_topic_score_gemma":0.000119527234,"teacher_disagreement_score":0.14642063,"about_ca_system_score_codex":0.000033619097,"about_ca_system_score_gemma":0.00021441815,"threshold_uncertainty_score":0.8667589},"labels":[],"label_agreement":null},{"id":"W2114419814","doi":"10.1136/annrheumdis-2012-203075","title":"The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celltrion; Sanofi; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Golimumab; Medicine; Placebo; Ankylosing spondylitis; Crossover study; Spondylitis; Internal medicine; Gastroenterology; Surgery; Rheumatoid arthritis; Pathology; Etanercept","score_opus":0.024644736490706583,"score_gpt":0.3404752853790283,"score_spread":0.31583054888832174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114419814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875558,0.008206049,1.0386604e-7,0.001265551,0.00025729882,0.0021417004,0.00018605054,0.000011479455,0.0003759898],"genre_scores_gemma":[0.9979575,0.0017316723,0.0000134422435,0.000050814047,0.000028223145,0.00014238078,0.000010444898,0.000016400529,0.00004908744],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979654,0.00041187723,0.00063903164,0.00018502407,0.00053942215,0.00025927176],"domain_scores_gemma":[0.99734557,0.0012802538,0.0005036568,0.0007316292,0.000086359236,0.000052562824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035550236,0.00018008146,0.00055202586,0.00006514612,0.00013112582,0.000016541435,0.00027560673,0.00003930063,0.000020688702],"category_scores_gemma":[0.0015518708,0.000079011326,0.00047053947,0.00043485605,0.00047879133,0.000079987294,0.00012101769,0.00009711099,0.0000036924487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14985447,0.00570099,0.21566316,0.002437077,0.0031582548,0.000040392835,0.0045977025,0.00012638619,0.00027465672,0.0015217237,0.015133405,0.60149175],"study_design_scores_gemma":[0.08034797,0.005519929,0.8858318,0.016522264,0.0005577295,0.000009898172,0.0004393979,0.000055465425,0.0064172884,0.0036583045,0.0004437656,0.00019623153],"about_ca_topic_score_codex":0.0004988623,"about_ca_topic_score_gemma":0.000026678419,"teacher_disagreement_score":0.6701686,"about_ca_system_score_codex":0.000014290332,"about_ca_system_score_gemma":0.00004841663,"threshold_uncertainty_score":0.32219884},"labels":[],"label_agreement":null},{"id":"W2114638396","doi":"10.1136/ard.2010.130476","title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":727,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"European League Against Rheumatism","keywords":"Medicine; Autoimmune encephalitis; Antiphospholipid syndrome; Chorea; Peripheral neuropathy; Pediatrics; Internal medicine; Disease; Autoantibody; Immunology; Diabetes mellitus; Thrombosis","score_opus":0.06968520368388396,"score_gpt":0.3821380901989141,"score_spread":0.3124528865150301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114638396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789937,0.0022842716,0.0043335077,0.005694748,0.00088101276,0.00709854,0.0004408388,0.000022786453,0.00025055202],"genre_scores_gemma":[0.9955206,0.0010169202,0.0023328064,0.00003607082,0.00003271366,0.00042264687,0.000019754814,0.00004620293,0.0005722724],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99675596,0.00023327593,0.0017122803,0.00026087867,0.00076766603,0.0002699248],"domain_scores_gemma":[0.99329233,0.0021987483,0.0019050443,0.001713865,0.0007969128,0.000093108436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002080699,0.00019633469,0.00071836833,0.00012641339,0.0001844275,0.000013207929,0.0007287357,0.000059572212,0.000016512915],"category_scores_gemma":[0.0013659329,0.00009523103,0.0006448182,0.00048674553,0.00041284744,0.00006950154,0.00017448516,0.00015661569,5.2914834e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056673666,0.0057154032,0.6748714,0.15789288,0.015262488,0.000045001467,0.0066213165,0.0005929798,0.0013948356,0.048346728,0.07192671,0.011662907],"study_design_scores_gemma":[0.069686964,0.008626625,0.17663546,0.22757468,0.04015991,0.05583092,0.30921236,0.03438886,0.010201931,0.05957935,0.005247571,0.0028553756],"about_ca_topic_score_codex":0.0000269917,"about_ca_topic_score_gemma":0.000008575503,"teacher_disagreement_score":0.4982359,"about_ca_system_score_codex":0.000016276646,"about_ca_system_score_gemma":0.0002590612,"threshold_uncertainty_score":0.38834086},"labels":[],"label_agreement":null},{"id":"W2114741262","doi":"10.1136/annrheumdis-2011-200276","title":"A population-based assessment of live births in women with systemic lupus erythematosus","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Live birth; Population; Incidence (geometry); Demography; Epidemiology; Pediatrics; Obstetrics; Pregnancy; Internal medicine; Environmental health","score_opus":0.04482438654213269,"score_gpt":0.32015849258842827,"score_spread":0.2753341060462956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114741262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971485,0.0007298265,0.000041064985,0.00014618554,0.00007727934,0.0011852855,0.00003761881,0.000029143595,0.0006051002],"genre_scores_gemma":[0.9991855,0.000076947676,0.00026720169,0.00006679266,0.0000080561485,0.00021936539,0.000005683737,0.000034728917,0.00013572865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975096,0.00024884762,0.00078391837,0.00022919559,0.0008607386,0.0003677137],"domain_scores_gemma":[0.9977441,0.0003745768,0.00053319515,0.0008719775,0.00029142256,0.00018475682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005504872,0.0001999799,0.0008136989,0.00028216763,0.000036140133,0.000008306506,0.00032945562,0.00005558241,0.0002217308],"category_scores_gemma":[0.00040674012,0.000116503055,0.0001482244,0.0004797422,0.00014141468,0.00007755937,0.00007255432,0.000105103674,0.000007843588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007801216,0.0007730476,0.98630106,0.0077561876,0.0002479464,0.000014421743,0.0029885727,0.00009695825,0.0000336492,0.00031111873,0.00013315906,0.00056377496],"study_design_scores_gemma":[0.003954337,0.00071671477,0.95496595,0.027294932,0.00012827691,0.00095735816,0.008076074,0.0022134967,0.00037632938,0.0010914687,0.000002024867,0.00022305916],"about_ca_topic_score_codex":0.0005861723,"about_ca_topic_score_gemma":0.000023814398,"teacher_disagreement_score":0.03133511,"about_ca_system_score_codex":0.00011362708,"about_ca_system_score_gemma":0.000564776,"threshold_uncertainty_score":0.47508568},"labels":[],"label_agreement":null},{"id":"W2115248330","doi":"10.1136/ard.2009.119727","title":"Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-Sleep questionnaire Sleep Disturbance Scale","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Placebo; Internal medicine; Sleep disorder; Pittsburgh Sleep Quality Index; Physical therapy; Rheumatology; Actigraphy; Sleep quality; Insomnia; Psychiatry; Pathology; Circadian rhythm; Alternative medicine","score_opus":0.01746840321667031,"score_gpt":0.29300140669108604,"score_spread":0.2755330034744157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115248330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185646,0.0037482644,0.000009136946,0.002888604,0.00011241634,0.001221983,0.000101777536,0.000013686051,0.000047666384],"genre_scores_gemma":[0.9958693,0.0038700753,0.00002229227,0.00010832367,0.000013440436,0.000070035894,0.00001654695,0.000020292982,0.000009684913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698883,0.00084841216,0.00073223276,0.0002365817,0.0009191716,0.00027475806],"domain_scores_gemma":[0.99699646,0.00071467884,0.0006582289,0.0011034092,0.0003801692,0.00014707482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011506366,0.00024229553,0.0006095131,0.00006632249,0.00025577156,0.000038203652,0.0005033569,0.000062648156,0.000031440646],"category_scores_gemma":[0.0027061214,0.0000955125,0.00030010528,0.00038950733,0.002584465,0.0002055624,0.00015834151,0.0003445099,0.0000016557949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012107225,0.0005171212,0.95872426,0.0002156587,0.00020736842,2.0755746e-7,0.0035486433,0.00011102552,0.000065206936,0.0018668582,0.0002693457,0.033263583],"study_design_scores_gemma":[0.0034026285,0.00033074876,0.98247975,0.0029772238,0.000012615456,0.000002369088,0.00027234724,0.00054672593,0.0013185667,0.0085414415,0.000007099968,0.00010851],"about_ca_topic_score_codex":0.0027857397,"about_ca_topic_score_gemma":0.0008509935,"teacher_disagreement_score":0.033155072,"about_ca_system_score_codex":0.00002020869,"about_ca_system_score_gemma":0.00015033895,"threshold_uncertainty_score":0.952257},"labels":[],"label_agreement":null},{"id":"W2115257773","doi":"10.1136/ard.2011.153064","title":"Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Sacroiliitis; Medicine; Axial spondyloarthritis; Likelihood ratios in diagnostic testing; Gold standard (test); Cohort; Sacroiliac joint; Internal medicine; Radiology; Magnetic resonance imaging; Nuclear medicine; Receiver operating characteristic","score_opus":0.06554662392123829,"score_gpt":0.3102000576541148,"score_spread":0.2446534337328765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115257773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975157,0.00055848353,0.0000064185315,0.0001272278,0.00011990059,0.00089437905,0.0006629277,0.0000025573524,0.000112449095],"genre_scores_gemma":[0.99937344,0.00037439566,0.00014003536,0.000021720089,0.000005813655,0.000041201667,0.000024592287,0.000008896347,0.000009914881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894047,0.00013048123,0.00048020305,0.00011128624,0.00023965671,0.00009790308],"domain_scores_gemma":[0.9988871,0.00008943614,0.000477631,0.00029726315,0.00022019936,0.000028319553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018293926,0.000094818075,0.00039621055,0.000052341173,0.00003938679,0.0000025072877,0.00009311695,0.000035978745,0.000033354467],"category_scores_gemma":[0.00031011325,0.000056950495,0.00021998832,0.00014182336,0.00029879337,0.00007864221,0.00007134088,0.000029348366,1.5626696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003826413,0.0030992948,0.9423144,0.0017029144,0.00093722873,0.0000020395732,0.013001064,0.0000070327346,0.014774244,0.0027292587,0.00040972081,0.017196428],"study_design_scores_gemma":[0.0018547206,0.0005574534,0.94482255,0.0022505878,0.0002701196,0.0000027058923,0.00080087635,0.000017085564,0.044564422,0.0048142,9.3035976e-7,0.00004437916],"about_ca_topic_score_codex":0.00045783256,"about_ca_topic_score_gemma":0.000075175274,"teacher_disagreement_score":0.029790176,"about_ca_system_score_codex":0.000009611083,"about_ca_system_score_gemma":0.000050463943,"threshold_uncertainty_score":0.23223738},"labels":[],"label_agreement":null},{"id":"W2115503161","doi":"10.1136/ard.2007.075721","title":"The relationship of dyspnoea to function and quality of life in systemic sclerosis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Western University; Université de Montréal; University of Alberta; University of Saskatchewan; Moncton Hospital; Dalhousie University; University of Calgary; McGill University; University of Ottawa; Jewish General Hospital","funders":"","keywords":"Medicine; Vital capacity; Internal medicine; Pulmonary function testing; Interstitial lung disease; Quality of life (healthcare); Population; Confounding; DLCO; Cohort; Physical therapy; Cardiology; SF-36; Disease; Diffusing capacity; Lung function; Health related quality of life; Lung","score_opus":0.1411422489224595,"score_gpt":0.34040553636569254,"score_spread":0.19926328744323304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115503161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784479,0.019955294,0.00004247184,0.0006988845,0.00012005088,0.000521321,0.000029023122,0.00000982652,0.0001752341],"genre_scores_gemma":[0.9987106,0.0010563794,0.000009154497,0.00012660743,0.000013372903,0.000013676682,0.000002571345,0.000009106747,0.000058545174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980951,0.0001966589,0.0010399219,0.00012455227,0.00039343128,0.00015034394],"domain_scores_gemma":[0.99709487,0.0015987925,0.00052114995,0.00044233626,0.00018435462,0.00015847653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012992478,0.000098753684,0.00041579793,0.00010717022,0.00006794977,0.0000067021397,0.00012812129,0.000058695376,0.0000090227095],"category_scores_gemma":[0.0046945605,0.000053694388,0.00016649818,0.00039769063,0.00015475521,0.000044554312,0.00005229691,0.00006002441,0.0000021869523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081439386,0.00026690162,0.9844496,0.0015458339,0.00017083778,8.2278845e-8,0.000354458,0.00006527856,0.0017653526,0.0033203654,0.00066966773,0.006577228],"study_design_scores_gemma":[0.0006805639,0.00008207835,0.98656386,0.009531519,0.00012010613,8.891465e-7,0.0017960621,0.000022387609,0.00049308693,0.0006548923,0.000002331891,0.000052203548],"about_ca_topic_score_codex":0.00029621425,"about_ca_topic_score_gemma":0.000021996568,"teacher_disagreement_score":0.020262692,"about_ca_system_score_codex":0.000013410437,"about_ca_system_score_gemma":0.00009407765,"threshold_uncertainty_score":0.56201667},"labels":[],"label_agreement":null},{"id":"W2115654445","doi":"10.1136/annrheumdis-2011-200308","title":"Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Janssen Biotech","keywords":"Medicine; Placebo; Golimumab; Ankylosing spondylitis; Spondylitis; Magnetic resonance imaging; Internal medicine; Nuclear medicine; Surgery; Physical therapy; Radiology; Rheumatoid arthritis; Pathology; Adalimumab","score_opus":0.048288139740100475,"score_gpt":0.311301283603021,"score_spread":0.2630131438629205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115654445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110645,0.002833145,7.793347e-7,0.00075961306,0.00016739794,0.003290743,0.00015033553,0.000016155323,0.0016753689],"genre_scores_gemma":[0.99911606,0.00040192236,0.000029212928,0.000041069863,0.000024765002,0.0001908259,0.0000089370415,0.000015159074,0.00017205383],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977071,0.0003683014,0.000996206,0.00021574055,0.0004680897,0.0002445199],"domain_scores_gemma":[0.9982098,0.00028670207,0.0006610623,0.0005806951,0.00018471306,0.000077035154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000560793,0.000208664,0.0008409419,0.000103567654,0.00011851507,0.0000119814185,0.00023739424,0.00003792243,0.00006597487],"category_scores_gemma":[0.0018450945,0.00011170815,0.00039021022,0.00027398436,0.0002096469,0.000107129345,0.0001217459,0.00008269029,0.000004508439],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78188497,0.012573289,0.120149985,0.0012335329,0.0052386024,0.000114766975,0.026094584,0.00013840057,0.0003685016,0.00047280913,0.002278198,0.04945238],"study_design_scores_gemma":[0.24706374,0.0014565868,0.7335854,0.0052567823,0.0010522659,0.000014747492,0.0051398277,0.000099567835,0.0046239235,0.0014716742,0.000044241293,0.00019119699],"about_ca_topic_score_codex":0.00040185676,"about_ca_topic_score_gemma":0.00009772247,"teacher_disagreement_score":0.61343545,"about_ca_system_score_codex":0.000023943914,"about_ca_system_score_gemma":0.000113466675,"threshold_uncertainty_score":0.4555326},"labels":[],"label_agreement":null},{"id":"W2115899272","doi":"10.1136/ard.62.6.501","title":"Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs","year":2003,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":445,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Inflammation; Pharmacology; Anti-inflammatory; Immunology","score_opus":0.016438371507793197,"score_gpt":0.2953430000409077,"score_spread":0.2789046285331145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115899272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25667733,0.7411486,0.000001291123,0.000015973445,0.00015146169,0.001652962,0.00010841199,0.000011756741,0.00023222047],"genre_scores_gemma":[0.36021176,0.6395117,0.000009849058,0.000035959252,0.00004973163,0.00006830718,0.00001357309,0.000059354858,0.000039779392],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970492,0.00042112442,0.0011820375,0.00040003879,0.00057438004,0.00037323497],"domain_scores_gemma":[0.9966789,0.0007228142,0.0014697657,0.00054434023,0.00034316562,0.0002410315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005531477,0.00057905726,0.002945071,0.00030299043,0.00008829888,0.000013884083,0.00018480177,0.00026558325,0.000013358131],"category_scores_gemma":[0.00027360115,0.00037542343,0.0006583298,0.00040228988,0.00060213683,0.00010923696,0.00012987471,0.00031103255,0.0000028309441],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004123718,0.0009995183,0.010197752,0.17584695,0.005609375,0.00001651266,0.00446526,0.0000030107537,0.0002196474,0.00018889655,0.0017447995,0.8002959],"study_design_scores_gemma":[0.018106217,0.008649922,0.18361959,0.61222786,0.050122906,0.0006893825,0.005869965,0.0005567612,0.05284139,0.0048815343,0.056195326,0.006239159],"about_ca_topic_score_codex":0.000032621614,"about_ca_topic_score_gemma":0.0000019538227,"teacher_disagreement_score":0.7940568,"about_ca_system_score_codex":0.00003175221,"about_ca_system_score_gemma":0.00074248074,"threshold_uncertainty_score":0.99986976},"labels":[],"label_agreement":null},{"id":"W2116048670","doi":"10.1136/ard.2008.102103","title":"Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases","year":2009,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Regeneron Pharmaceuticals; Procter and Gamble; GlaxoSmithKline; AstraZeneca; Pfizer; Amgen; Bristol-Myers Squibb; Abbott Laboratories","keywords":"Adalimumab; Medicine; Psoriatic arthritis; Ankylosing spondylitis; Population; Internal medicine; Psoriasis; Rheumatoid arthritis; Malignancy; Clinical trial; Infliximab; Mortality rate; Arthritis; Standardized mortality ratio; Disease; Immunology","score_opus":0.17099623034899453,"score_gpt":0.473548971548869,"score_spread":0.30255274119987446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116048670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023313109,0.9605169,6.6122163e-7,0.00014715258,0.00032066,0.0018035583,0.013777331,0.00003607808,0.00008450177],"genre_scores_gemma":[0.013023795,0.9856413,0.0000137374145,0.0000905421,0.00010527711,0.00005393307,0.0010139244,0.0000307571,0.000026737369],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99265903,0.0016858771,0.0042430726,0.00047498458,0.00061310636,0.0003239501],"domain_scores_gemma":[0.9914381,0.0037655658,0.0031245432,0.0010984903,0.00021436841,0.00035895547],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011013094,0.00059965265,0.007185746,0.000064097854,0.00011140035,0.000022265265,0.0003401315,0.00023960648,0.0001492042],"category_scores_gemma":[0.00975243,0.00034223727,0.002956021,0.00027274265,0.0005841239,0.00007662773,0.00026918048,0.0001685926,0.000012415637],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006862662,0.001414119,0.033777058,0.011821104,0.008660261,0.000033055316,0.000020382424,3.2368087e-7,4.0170477e-8,0.00009144929,0.0014466468,0.94204926],"study_design_scores_gemma":[0.005921154,0.0005588637,0.80810416,0.10054818,0.028325133,0.000012471095,0.00009860851,0.000007465993,0.0000015293544,0.0017254797,0.054166444,0.0005305114],"about_ca_topic_score_codex":0.00025827464,"about_ca_topic_score_gemma":0.000020503634,"teacher_disagreement_score":0.9415188,"about_ca_system_score_codex":0.000038401755,"about_ca_system_score_gemma":0.0006426047,"threshold_uncertainty_score":0.99990296},"labels":[],"label_agreement":null},{"id":"W2116170087","doi":"10.1136/ard.2005.046300","title":"EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":843,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Kawasaki disease; Consensus conference; Henoch-Schonlein purpura; Polyarteritis nodosa; Vasculitis; Pediatrics; Systemic vasculitis; Delphi method; Disease; Dermatology; Pathology; Internal medicine; Artificial intelligence","score_opus":0.05355024938540719,"score_gpt":0.33404548783687943,"score_spread":0.28049523845147223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116170087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95279384,0.009011213,0.00014389821,0.03530457,0.00017368862,0.0012517779,0.00047040172,0.00003687519,0.0008137205],"genre_scores_gemma":[0.998187,0.00086408353,0.00020019364,0.00036068965,0.00006243289,0.000077191486,0.0000358613,0.000013402844,0.00019914428],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999034,0.00007326332,0.00040747647,0.00011632929,0.00022186858,0.00014706796],"domain_scores_gemma":[0.99844587,0.0005220722,0.00023009874,0.0005102816,0.00022337335,0.000068284746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017608817,0.00010346677,0.00026527586,0.000043227978,0.00013745167,0.000011849533,0.00017261943,0.00004234396,0.00018841443],"category_scores_gemma":[0.0008631775,0.0000539735,0.00046999252,0.00011020746,0.00024339158,0.0000378075,0.000026880018,0.000057479752,0.0000062383388],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095805986,0.008716756,0.008941219,0.0049522803,0.013976733,0.000004674,0.008193533,0.0015966701,0.011215136,0.09544187,0.34725326,0.49874982],"study_design_scores_gemma":[0.0026737833,0.00017241809,0.9677804,0.0016531132,0.0017125162,0.00003129406,0.0013578414,0.0040897583,0.0075968937,0.008670789,0.0041012,0.00015995798],"about_ca_topic_score_codex":0.000023435385,"about_ca_topic_score_gemma":0.000003063167,"teacher_disagreement_score":0.95883924,"about_ca_system_score_codex":0.000006126044,"about_ca_system_score_gemma":0.000098289114,"threshold_uncertainty_score":0.22009754},"labels":[],"label_agreement":null},{"id":"W2116618422","doi":"10.1136/ard.2008.101501","title":"New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":642,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Physical therapy; Back pain; Axial spondyloarthritis; Low back pain; Chronic pain; Spondylarthritis; Alternative medicine; Ankylosing spondylitis; Internal medicine; Sacroiliitis; Pathology","score_opus":0.014992114536067282,"score_gpt":0.28685316515569115,"score_spread":0.27186105061962385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116618422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070114,0.003419544,0.00009144008,0.0028584306,0.00014294113,0.001758839,0.0008595849,0.000012338169,0.00015573225],"genre_scores_gemma":[0.99579096,0.0019039962,0.000993397,0.0006591089,0.000042354386,0.0001116039,0.00036627104,0.000022193057,0.000110144305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829197,0.00012863496,0.0005631383,0.00025010394,0.000502908,0.000263237],"domain_scores_gemma":[0.99860793,0.0003143749,0.00034206777,0.00043212814,0.00018936665,0.00011411145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024400094,0.00023192388,0.0004888465,0.000028161165,0.0000767153,0.000022580927,0.00022512945,0.000048997146,0.00030962765],"category_scores_gemma":[0.00014055087,0.00013722201,0.0003025853,0.00011344416,0.00010587206,0.000114894916,0.00007083174,0.000056679746,0.0000019841534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011902668,0.0020988407,0.3391217,0.00029158968,0.0006460402,0.0000032654173,0.0014931515,0.000018913037,0.000034889585,0.000040438877,0.31815958,0.33690134],"study_design_scores_gemma":[0.009894533,0.0026157228,0.97519773,0.007190055,0.00013037719,5.4362664e-7,0.0007186411,0.00049143756,0.00016134065,0.0005015105,0.002872472,0.00022564786],"about_ca_topic_score_codex":0.00029825242,"about_ca_topic_score_gemma":0.000059687096,"teacher_disagreement_score":0.63607603,"about_ca_system_score_codex":0.00008495983,"about_ca_system_score_gemma":0.00020628716,"threshold_uncertainty_score":0.55957514},"labels":[],"label_agreement":null},{"id":"W2116695847","doi":"10.1136/ard.2003.014498","title":"Genetic risk of knee osteoarthritis: a sibling study","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Odds ratio; Osteoarthritis; Knee pain; Sibling; Confidence interval; Physical therapy; Population; Internal medicine; Pathology","score_opus":0.024712951313051092,"score_gpt":0.28637333799033426,"score_spread":0.2616603866772832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116695847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928234,0.0054463134,0.00001885523,0.00016346459,0.00012157508,0.0010907813,0.00007275671,0.0000306759,0.00023215059],"genre_scores_gemma":[0.9990573,0.00029843955,0.00037715802,0.00007363381,0.000022826765,0.000052717238,0.0000041545018,0.000020562054,0.0000932232],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986973,0.00007995135,0.0004564926,0.00016746644,0.00039997871,0.00019881982],"domain_scores_gemma":[0.9988285,0.00007750984,0.0002911124,0.0005455323,0.00013270744,0.00012464993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011989982,0.00015404735,0.00043290402,0.00010039161,0.00007339396,0.000009890779,0.00013468441,0.00003192753,0.000060883707],"category_scores_gemma":[0.0003459067,0.00010398711,0.00029377406,0.00023477584,0.00009304238,0.000059438633,0.00007034343,0.00006134579,0.000016024247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010167834,0.010201546,0.32986376,0.0009940452,0.0013525721,0.00009740146,0.004073305,0.000613598,0.0008322863,0.0009269436,0.00018668866,0.64984107],"study_design_scores_gemma":[0.025475595,0.023828065,0.8822085,0.0073954375,0.003347386,0.000065195105,0.006057813,0.000028591563,0.019269265,0.03184238,0.00003910139,0.0004426598],"about_ca_topic_score_codex":0.00010349286,"about_ca_topic_score_gemma":0.000033435197,"teacher_disagreement_score":0.6493984,"about_ca_system_score_codex":0.000009209125,"about_ca_system_score_gemma":0.00012087616,"threshold_uncertainty_score":0.42404714},"labels":[],"label_agreement":null},{"id":"W2116749206","doi":"10.1136/annrheumdis-2013-205139","title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","year":2014,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":727,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Rheumatology; Task force; Alternative medicine; Rheumatoid arthritis; MEDLINE; Internal medicine; Sports medicine; Evidence-based medicine; Family medicine; Intensive care medicine; Physical therapy; Pathology","score_opus":0.07357214166603984,"score_gpt":0.4045464671143542,"score_spread":0.3309743254483144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116749206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005586914,0.98553455,0.000094812596,0.0012490193,0.0010980443,0.003414793,0.0016525899,0.000079298654,0.0012900097],"genre_scores_gemma":[0.004280936,0.99065447,0.0002167937,0.00020669798,0.00020551469,0.0007158511,0.0011093797,0.00013476748,0.0024756049],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949802,0.0009178611,0.001953588,0.00065272255,0.000999495,0.00049614604],"domain_scores_gemma":[0.9949094,0.0013376096,0.000994659,0.0020006653,0.00030192186,0.00045573374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007924355,0.0005649811,0.0030439603,0.00069097476,0.00007861597,0.00007501588,0.0014830745,0.00023263515,0.00037803824],"category_scores_gemma":[0.0021792497,0.0003587564,0.000994915,0.0006291079,0.00010667897,0.0001918457,0.00036740134,0.00032261753,0.0002541442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025954412,0.0018953595,0.013671462,0.16378148,0.0029565832,0.00006293737,0.0023976597,0.000031827596,0.0000023639454,0.0010520015,0.040606506,0.7732823],"study_design_scores_gemma":[0.0021435684,0.00024840116,0.0002139757,0.608843,0.0017320048,0.005666026,0.0011730118,0.00063547766,0.0000059167605,0.0019385079,0.3765315,0.00086856395],"about_ca_topic_score_codex":0.00019438243,"about_ca_topic_score_gemma":0.000021437996,"teacher_disagreement_score":0.77241373,"about_ca_system_score_codex":0.00022152156,"about_ca_system_score_gemma":0.0006304318,"threshold_uncertainty_score":0.99988645},"labels":[],"label_agreement":null},{"id":"W2117002365","doi":"10.1136/annrheumdis-2013-203771","title":"Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Health and Medical Research Council; Versus Arthritis; Medical Research Council; State Government of Victoria; Australian Government","keywords":"Interleukin 17; Glycoprotein 130; Medicine; T cell; Arthritis; Immunology; Molecular biology; Cytokine; Internal medicine; Interleukin 6; Biology; Immune system","score_opus":0.02369706498808092,"score_gpt":0.25759801512165653,"score_spread":0.23390095013357562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117002365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436265,0.0039114603,0.0000036354913,0.0007154432,0.00017450514,0.0005151551,0.00021559448,0.000016808313,0.00008474807],"genre_scores_gemma":[0.9986977,0.00050560804,0.000018109246,0.00017510747,0.000004822889,0.00010048825,0.000014975862,0.000013472443,0.00046973064],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984684,0.00051445037,0.00049243396,0.00018956848,0.000085971806,0.00024920492],"domain_scores_gemma":[0.99863815,0.00056697516,0.00025781698,0.00034634463,0.00014737165,0.000043357548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027324216,0.00016812359,0.00039967723,0.00016236724,0.00006390226,0.000009530905,0.00028174772,0.000101674246,0.00080904097],"category_scores_gemma":[0.00044555432,0.00012364186,0.00017587112,0.00020582323,0.00010227046,0.00013192285,0.00010623501,0.00007611091,0.00024731847],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070049064,0.002512063,0.08087923,0.00032298474,0.003058883,0.00001844416,0.012260648,0.000535509,0.5385346,0.00025345877,0.012080578,0.34253874],"study_design_scores_gemma":[0.0017545954,0.00025044882,0.74212277,0.0012220249,0.00010643097,0.000006103432,0.0012083105,0.000012110955,0.25160092,0.0011222711,0.00035820567,0.00023584127],"about_ca_topic_score_codex":0.0003071504,"about_ca_topic_score_gemma":0.00002381749,"teacher_disagreement_score":0.6612435,"about_ca_system_score_codex":0.00001718576,"about_ca_system_score_gemma":0.000104177525,"threshold_uncertainty_score":0.88584316},"labels":[],"label_agreement":null},{"id":"W2117710877","doi":"10.1136/ard.61.suppl_2.ii32","title":"Role of RANKL and RANK in bone loss and arthritis","year":2002,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":223,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"University of Toronto; Pohang University of Science and Technology; Österreichischen Akademie der Wissenschaften","keywords":"RANKL; Osteoprotegerin; Medicine; Osteoclast; Osteoporosis; Bone remodeling; Arthritis; Receptor; Internal medicine; Endocrinology; Cancer research; Cell biology; Biology; Activator (genetics)","score_opus":0.02358768774184043,"score_gpt":0.2886184176514843,"score_spread":0.2650307299096439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117710877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02327211,0.97577137,4.6692986e-7,0.000028735385,0.000039493665,0.00033711223,0.00046623655,0.0000027122942,0.00008178855],"genre_scores_gemma":[0.040224835,0.95953095,0.0000099467115,0.000033266275,0.00002322815,0.00003223702,0.000046851856,0.00002029102,0.000078422316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874336,0.00017210863,0.00053186173,0.00024744254,0.00013870264,0.00016653385],"domain_scores_gemma":[0.9990248,0.00005922865,0.0003422448,0.0004317775,0.000041203246,0.00010073789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011370498,0.00023635564,0.0010405408,0.00006861198,0.000027650478,0.000013539522,0.00018753824,0.000116085896,0.00002048121],"category_scores_gemma":[0.0002984166,0.00016372878,0.0003263295,0.000106146384,0.00027558094,0.000005144021,0.0002114765,0.000052107887,0.0000011005346],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022271512,0.0001660207,0.000227507,0.0076860483,0.00012558885,0.0000014567668,0.000021861855,5.162664e-7,0.0000087017315,0.00008864946,0.0007566612,0.99089473],"study_design_scores_gemma":[0.00292126,0.00026646696,0.013535385,0.06396137,0.0022382468,0.00011285337,0.00018104167,0.00001714308,0.0004194154,0.0046575265,0.91037685,0.0013124412],"about_ca_topic_score_codex":0.000032740503,"about_ca_topic_score_gemma":0.000008427272,"teacher_disagreement_score":0.9895823,"about_ca_system_score_codex":0.0000010170324,"about_ca_system_score_gemma":0.000070200775,"threshold_uncertainty_score":0.66766655},"labels":[],"label_agreement":null},{"id":"W2117779687","doi":"10.1136/ard.2009.111179","title":"Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Merck Sharp and Dohme; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Menopause; Rheumatoid arthritis; Menarche; Cohort; Hormone replacement therapy (female-to-male); Internal medicine; Allele; Pregnancy; Immunology","score_opus":0.022794802951199684,"score_gpt":0.28467688605983676,"score_spread":0.2618820831086371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117779687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95234054,0.017645443,0.000007040172,0.025890935,0.000052053387,0.0036617096,0.00035204686,0.000022297907,0.000027946391],"genre_scores_gemma":[0.9100846,0.08880875,0.000040941588,0.0004242873,0.000060969367,0.0004332723,0.000018313647,0.000022467213,0.00010640504],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972542,0.00059464906,0.00066485326,0.00036347526,0.0007025122,0.0004203468],"domain_scores_gemma":[0.9971955,0.0011125505,0.0005330191,0.0008461649,0.0002119541,0.00010085749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020755304,0.00024208016,0.00051253225,0.00005054626,0.0005177476,0.00008078481,0.0003823842,0.000045146266,0.0000119252045],"category_scores_gemma":[0.002391852,0.00009421212,0.0001301186,0.0002749047,0.0005576344,0.0001572109,0.000056205103,0.0002761167,5.5841997e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064743474,0.0017329289,0.03923401,0.00021461549,0.0024938432,0.000006665483,0.03243753,0.00025465077,0.003705732,0.00012712581,0.03547081,0.8195786],"study_design_scores_gemma":[0.007906536,0.0035878136,0.9552411,0.006304347,0.000044889002,0.000020980055,0.01215608,0.00033476326,0.009152337,0.0019977763,0.0029420557,0.00031135353],"about_ca_topic_score_codex":0.000790038,"about_ca_topic_score_gemma":0.00007831966,"teacher_disagreement_score":0.91600704,"about_ca_system_score_codex":0.00002385589,"about_ca_system_score_gemma":0.00019962713,"threshold_uncertainty_score":0.39821482},"labels":[],"label_agreement":null},{"id":"W2117842776","doi":"10.1136/ard.2010.142455","title":"Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; Arthritis Research Centre of Canada","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Discontinuation; Statin; Rheumatoid arthritis; Myocardial infarction; Internal medicine; Population; Hazard ratio; Cohort; Proportional hazards model; Cohort study; Lower risk; Physical therapy; Confidence interval; Environmental health","score_opus":0.013507008242051689,"score_gpt":0.26002052713088486,"score_spread":0.24651351888883316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117842776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973595,0.0007369782,0.000024837145,0.000050331997,0.00003925723,0.0015853348,0.00015535948,0.000015188786,0.00003317716],"genre_scores_gemma":[0.995025,0.004661966,0.00011777211,0.000016911501,0.0000033637725,0.00009522691,0.00005938926,0.000016811913,0.0000035872501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825674,0.00027911126,0.000514589,0.00018519007,0.00058049784,0.00018384344],"domain_scores_gemma":[0.99883944,0.00011680786,0.00037443853,0.0003412963,0.00022733187,0.00010066447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003424239,0.00014476213,0.0004648852,0.00016644414,0.00007242137,0.000014791996,0.00008982376,0.000026515374,0.00004953844],"category_scores_gemma":[0.00036672826,0.000094390394,0.00010978202,0.00022323635,0.00014718581,0.000194768,0.000036336263,0.000086830434,0.000001140726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012708073,0.0015830003,0.9768471,0.00004296725,0.00089519745,8.4211575e-7,0.00096025394,0.00001460449,9.2147525e-7,0.000039620296,0.000032820008,0.018311875],"study_design_scores_gemma":[0.0043381266,0.0011015232,0.9922971,0.0011410017,0.000058195925,6.586042e-7,0.00033591132,0.00013037633,0.000044506323,0.00045882812,0.0000012253906,0.00009256036],"about_ca_topic_score_codex":0.0024884036,"about_ca_topic_score_gemma":0.00026517594,"teacher_disagreement_score":0.018219316,"about_ca_system_score_codex":0.000011087115,"about_ca_system_score_gemma":0.00008413704,"threshold_uncertainty_score":0.38491285},"labels":[],"label_agreement":null},{"id":"W2117917818","doi":"10.1136/ard.2002.001164","title":"Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Ankle; Lupus erythematosus; Systemic lupus erythematosus; Internal medicine; Immunology; Pathology; Disease; Antibody","score_opus":0.05800417771433409,"score_gpt":0.3394068084800288,"score_spread":0.2814026307656947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117917818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954213,0.0021361788,0.000008848805,0.0000707896,0.00011610837,0.0019258067,0.00007851353,0.000022792847,0.00021969742],"genre_scores_gemma":[0.99944144,0.00015414215,0.000025232657,0.000026430189,0.000013854834,0.00014282053,0.000003192274,0.000024690193,0.00016818309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968463,0.0008057897,0.000882013,0.00026597187,0.00087766,0.0003222259],"domain_scores_gemma":[0.9978267,0.00051731424,0.00047600336,0.0007471676,0.0002509766,0.00018184581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012760571,0.0001902206,0.00069491856,0.00023213307,0.00007496954,0.000021980852,0.00030024291,0.00004429842,0.00004323868],"category_scores_gemma":[0.0023998914,0.00013166927,0.00010188874,0.00043411934,0.00016808936,0.00019714248,0.000106651365,0.00014011686,0.0000033855306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022427447,0.0029869983,0.98938656,0.004124319,0.00019020602,0.0000079051,0.0022022822,0.00002785556,0.000052248655,0.0004754394,0.00012730533,0.00019461071],"study_design_scores_gemma":[0.003738645,0.0013805536,0.980569,0.004912412,0.00018589819,0.0014708583,0.0057361224,0.00045630347,0.00018088675,0.0012126731,9.776509e-7,0.00015566946],"about_ca_topic_score_codex":0.00021504305,"about_ca_topic_score_gemma":0.000060435512,"teacher_disagreement_score":0.008817555,"about_ca_system_score_codex":0.000041847437,"about_ca_system_score_gemma":0.00030652437,"threshold_uncertainty_score":0.5369317},"labels":[],"label_agreement":null},{"id":"W2118152420","doi":"10.1136/annrheumdis-2011-201208","title":"Does the change in season affect disease activity in patients with psoriatic arthritis?","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psoriatic arthritis; Ankylosing spondylitis; Demographics; Logistic regression; Multivariate analysis; Disease; Cohort; Univariate analysis; Psoriasis; Internal medicine; Demography; Physical therapy; Immunology","score_opus":0.02789906327987857,"score_gpt":0.29270295088310433,"score_spread":0.26480388760322576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118152420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909255,0.0053722584,2.8258893e-7,0.0020536308,0.00018167686,0.0013031109,0.00010235064,0.000012674396,0.000048498026],"genre_scores_gemma":[0.9983056,0.00106805,0.000004645556,0.00027131662,0.000040261966,0.00026252252,0.000011869106,0.000017096876,0.000018625406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987629,0.00015254907,0.00019268092,0.00014779222,0.00038389952,0.00036019768],"domain_scores_gemma":[0.9990426,0.00017405079,0.00013980805,0.00043276584,0.000045376808,0.00016544409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014091947,0.00017711753,0.0003670121,0.000057691926,0.00007758041,0.000010738731,0.00011187969,0.000022318478,0.000050176757],"category_scores_gemma":[0.00027546656,0.00007024822,0.00012774928,0.0002552593,0.00011917001,0.0002121831,0.000082143626,0.000079003265,0.00000751757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009172379,0.002093498,0.9343853,0.00020166204,0.00010412526,0.0000044849066,0.00047841162,0.0000012802739,1.6035767e-7,0.00005579986,0.00008305911,0.061675005],"study_design_scores_gemma":[0.0031069717,0.00020385151,0.99387383,0.00231857,0.00010868422,4.0643198e-7,0.00008279615,0.000017113269,0.000016615813,0.00014750134,0.00002970288,0.000093934534],"about_ca_topic_score_codex":0.0003432591,"about_ca_topic_score_gemma":0.00024510664,"teacher_disagreement_score":0.06158107,"about_ca_system_score_codex":0.00002924883,"about_ca_system_score_gemma":0.000035251247,"threshold_uncertainty_score":0.28646395},"labels":[],"label_agreement":null},{"id":"W2118359937","doi":"10.1136/ard.62.9.793","title":"Established criteria for disease controlling drugs in ankylosing spondylitis","year":2003,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Ankylosing spondylitis; Ankylosis; Sacroiliitis; Arthritis; Surgery; Inflammatory arthritis; Deformity; Spondylitis; Rheumatoid arthritis; Anterior longitudinal ligament; Cervical spine; Internal medicine","score_opus":0.044612366712733824,"score_gpt":0.32820627973118754,"score_spread":0.2835939130184537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118359937","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2361978,0.047142316,0.000029156634,0.6958719,0.0016039411,0.005336487,0.012988594,0.00008091858,0.00074893056],"genre_scores_gemma":[0.42225966,0.0041893646,0.00045171697,0.5634578,0.0010375249,0.0014180006,0.0034817732,0.00029454284,0.0034095978],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974761,0.0001828735,0.0007719472,0.00044794133,0.0005085277,0.0006126241],"domain_scores_gemma":[0.99775463,0.00064485095,0.00041185535,0.0007697105,0.0002455995,0.00017333557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020677231,0.00044038924,0.001248353,0.0002005274,0.00014512597,0.00006517931,0.00023588595,0.00016967002,0.000300919],"category_scores_gemma":[0.0012261801,0.00031442888,0.0008212829,0.0002297268,0.00018410952,0.00011425108,0.000074550284,0.0002775116,0.0000052522987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012718535,0.0005785622,0.0056188144,0.0044780727,0.00086482166,0.00022622794,0.00023718379,0.0000038871317,0.0000017446803,0.00006499323,0.97936946,0.0072843484],"study_design_scores_gemma":[0.035791975,0.0011494191,0.104348525,0.054765493,0.007861378,0.00006742379,0.001067373,0.00091936387,0.00017477361,0.028733585,0.76280934,0.002311329],"about_ca_topic_score_codex":0.00012393315,"about_ca_topic_score_gemma":0.000005759999,"teacher_disagreement_score":0.21656013,"about_ca_system_score_codex":0.00005542057,"about_ca_system_score_gemma":0.00023499787,"threshold_uncertainty_score":0.9999308},"labels":[],"label_agreement":null},{"id":"W2118596556","doi":"10.1136/ard.2008.104018","title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1645,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Medical physics; Axial spondyloarthritis; Spondylitis; Clinical trial; Physical therapy; Sacroiliitis; Pathology; Surgery","score_opus":0.039168006231586686,"score_gpt":0.37334192909224806,"score_spread":0.3341739228606614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118596556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93666154,0.015637068,0.00027267844,0.03154256,0.0010082452,0.0018195078,0.00084582414,0.000079005746,0.012133555],"genre_scores_gemma":[0.9876485,0.007195253,0.0016600353,0.0013634857,0.000078866775,0.00007843318,0.000034000204,0.000020856458,0.0019205562],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976766,0.00007635407,0.000736318,0.0002752575,0.00086277287,0.0003726892],"domain_scores_gemma":[0.9979951,0.00030770843,0.0003388911,0.00070408336,0.00045542343,0.00019884152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032563185,0.0002488297,0.00056305085,0.00006093524,0.00030911516,0.00005208745,0.00045365273,0.000052008843,0.00012588367],"category_scores_gemma":[0.0005009065,0.00015392494,0.0006994533,0.00028743834,0.00023984381,0.0001100579,0.00018350418,0.000108528984,0.000010252792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007656447,0.003166471,0.060376633,0.0002850622,0.0027188223,0.00007648683,0.00090983603,0.00008549185,0.001177247,0.008352142,0.3363559,0.58573025],"study_design_scores_gemma":[0.0050706677,0.0014370604,0.9198089,0.0049771513,0.00036986693,0.00008280785,0.0010411214,0.00024280866,0.003147752,0.0030012282,0.06047758,0.0003430238],"about_ca_topic_score_codex":0.000051257823,"about_ca_topic_score_gemma":0.000029715695,"teacher_disagreement_score":0.8594323,"about_ca_system_score_codex":0.00005037284,"about_ca_system_score_gemma":0.0002288238,"threshold_uncertainty_score":0.6276877},"labels":[],"label_agreement":null},{"id":"W2118619492","doi":"10.1136/ard.2008.089441","title":"Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Toronto Western Hospital","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Dermatology; Arthritis; Immunology","score_opus":0.04847509184846016,"score_gpt":0.31183437196092034,"score_spread":0.2633592801124602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118619492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95832574,0.03870944,0.00036072565,0.0010362925,0.00015988582,0.0011545725,0.00011077813,0.00002723549,0.00011530145],"genre_scores_gemma":[0.99070513,0.007159592,0.0016052503,0.0001672127,0.000064863256,0.00019994989,0.00003748191,0.000019674188,0.000040832518],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985156,0.00007699933,0.00059993035,0.00018780447,0.0003939822,0.00022570416],"domain_scores_gemma":[0.9988351,0.00019877161,0.00033232378,0.00031021587,0.00022587556,0.00009774169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020235372,0.00018484124,0.00048558056,0.00003431707,0.00038825293,0.000014135404,0.00011524385,0.000040033126,0.000030251698],"category_scores_gemma":[0.00068360276,0.00011878292,0.00018096881,0.000098283184,0.00021711958,0.00015036718,0.00007968531,0.000041364365,0.0000016842572],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005605951,0.0006985195,0.012507923,0.0006410423,0.0011653847,0.0000117223835,0.0041702706,0.00001795533,0.00001023177,0.0014831052,0.0016931389,0.9770401],"study_design_scores_gemma":[0.014987718,0.0013790078,0.9446795,0.020191263,0.0009035369,0.00022859906,0.0038259171,0.00041340556,0.007357506,0.00395381,0.0015162376,0.00056347175],"about_ca_topic_score_codex":0.00034393088,"about_ca_topic_score_gemma":0.00021816307,"teacher_disagreement_score":0.9764766,"about_ca_system_score_codex":0.000021541775,"about_ca_system_score_gemma":0.00013060952,"threshold_uncertainty_score":0.4843827},"labels":[],"label_agreement":null},{"id":"W2118771994","doi":"10.1136/ard.2008.100271","title":"Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Coping (psychology); Disease; Internal medicine; Clinical psychology","score_opus":0.0483599809063851,"score_gpt":0.3144725471675702,"score_spread":0.2661125662611851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118771994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617804,0.03528522,0.000019368592,0.0012139542,0.00008834139,0.00089170196,0.0005301123,0.00002240036,0.00016847055],"genre_scores_gemma":[0.93659055,0.063127786,0.000030832744,0.00009358198,0.00001643304,0.000049998493,0.000027906071,0.00002815424,0.000034756606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737406,0.0003640686,0.00079155783,0.00020831125,0.00094028143,0.0003216965],"domain_scores_gemma":[0.9971877,0.00032210743,0.00063760544,0.0009075522,0.00065950496,0.00028558468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024647676,0.00023664231,0.000661198,0.0001342246,0.0001935551,0.000011116662,0.0004092556,0.000048280803,0.00020595762],"category_scores_gemma":[0.002346325,0.00013398784,0.0007956059,0.00058268174,0.0011032164,0.0002726377,0.00017424235,0.00014534117,0.0000063882358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008973276,0.0056525185,0.88428783,0.0022062436,0.0031575798,0.000050057115,0.0070974864,0.00073174,0.0018188488,0.0026818397,0.031383574,0.051958993],"study_design_scores_gemma":[0.0017907373,0.0009168211,0.980656,0.006409269,0.00002671149,0.00003448315,0.0002530962,0.0003191727,0.006179029,0.0032222115,0.00004754293,0.00014490182],"about_ca_topic_score_codex":0.00018725578,"about_ca_topic_score_gemma":0.000006911014,"teacher_disagreement_score":0.09636818,"about_ca_system_score_codex":0.00002111116,"about_ca_system_score_gemma":0.0010701871,"threshold_uncertainty_score":0.54638654},"labels":[],"label_agreement":null},{"id":"W2118781965","doi":"10.1136/ard.2010.148890","title":"Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Janssen Biotech","keywords":"Medicine; Ankylosing spondylitis; Golimumab; Spondylitis; Internal medicine; Immunology; Physical therapy; Gastroenterology; Etanercept; Rheumatoid arthritis","score_opus":0.03850229408041961,"score_gpt":0.28069795293602784,"score_spread":0.24219565885560823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118781965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974259,0.00022225578,0.0000010017762,0.00014991588,0.000030631552,0.00097227696,0.00044626434,0.00003098412,0.00072076975],"genre_scores_gemma":[0.9992844,0.0001038916,0.000073676994,0.00021906901,0.0000052520886,0.00004984929,0.00009898666,0.000033880897,0.00013102846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831647,0.00010633187,0.0004729063,0.00028381086,0.00045343267,0.0003670421],"domain_scores_gemma":[0.9987045,0.000114020164,0.00035446082,0.00043110296,0.00023448128,0.00016146248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014721318,0.00025142613,0.0006143727,0.00007361464,0.00008771128,0.000011394235,0.00011519265,0.000046230165,0.0001750667],"category_scores_gemma":[0.00016164345,0.00012625642,0.00012448333,0.00032859648,0.00026885985,0.000102639366,0.00005524587,0.000094963674,0.0000027757799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071837823,0.003085117,0.97340465,0.00008160989,0.001389597,0.000042141073,0.00017990611,0.0000013013844,1.4156822e-7,0.000012997625,0.00014439716,0.014474341],"study_design_scores_gemma":[0.012359592,0.005642623,0.9773693,0.0035431867,0.00051734666,0.0000025261645,0.0002882686,0.000011490091,0.000052243395,0.000045226858,0.000011348691,0.00015681665],"about_ca_topic_score_codex":0.00035726893,"about_ca_topic_score_gemma":0.00020224205,"teacher_disagreement_score":0.014317524,"about_ca_system_score_codex":0.000046569916,"about_ca_system_score_gemma":0.00010109516,"threshold_uncertainty_score":0.5148587},"labels":[],"label_agreement":null},{"id":"W2118850273","doi":"10.1136/ard.2008.091611","title":"Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Dutch Arthritis Association; Abbott Laboratories","keywords":"Medicine; Prednisone; Adalimumab; Rheumatoid arthritis; Bone mineral; Femoral neck; Internal medicine; Femur; Surgery; Bone density; Urology; Osteoporosis","score_opus":0.02209442644738438,"score_gpt":0.26554476461116694,"score_spread":0.24345033816378256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118850273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754744,0.02289222,0.000002057812,0.0006096803,0.00012927986,0.00061050005,0.00013395683,0.00002525828,0.00012262432],"genre_scores_gemma":[0.89911944,0.10044007,0.00005552527,0.0001909344,0.00001887885,0.00005151176,0.000029775487,0.000031659707,0.000062212916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997433,0.00019137257,0.00081730296,0.0002584811,0.0008538692,0.00044598684],"domain_scores_gemma":[0.9983237,0.00014734754,0.0002894797,0.0006811804,0.0003270109,0.00023130399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002183245,0.00024507896,0.0008287076,0.00020422362,0.00008707823,0.000013268457,0.00020124228,0.000069418005,0.00033160116],"category_scores_gemma":[0.00060877594,0.00017546827,0.00038362152,0.00033656982,0.0006506817,0.00018720565,0.00012620745,0.00015880428,0.000027676913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002427207,0.0023916787,0.9698255,0.00020645179,0.0002443309,0.000087425964,0.0011060314,0.000008169157,0.0001291846,0.00010017133,0.004805799,0.018668018],"study_design_scores_gemma":[0.005514571,0.0003654884,0.9887472,0.0024272115,0.0000043182554,0.00004444851,0.00012317112,0.000026645315,0.0016000462,0.00065582443,0.00030510957,0.0001859642],"about_ca_topic_score_codex":0.0002538247,"about_ca_topic_score_gemma":0.000072607465,"teacher_disagreement_score":0.07754785,"about_ca_system_score_codex":0.000018707375,"about_ca_system_score_gemma":0.00018936262,"threshold_uncertainty_score":0.71553886},"labels":[],"label_agreement":null},{"id":"W2119067278","doi":"10.1136/ard.2007.084244","title":"Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of British Columbia; University of Saskatchewan; University of Alberta","funders":"","keywords":"BASFI; Medicine; BASDAI; Enthesitis; Ankylosing spondylitis; Physical therapy; Intraclass correlation; Cohort; Adalimumab; Quality of life (healthcare); Internal medicine; Rheumatoid arthritis; Psychometrics; Psoriatic arthritis","score_opus":0.08116285192440426,"score_gpt":0.3185016719784103,"score_spread":0.23733882005400603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119067278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942847,0.0035900883,6.852854e-7,0.0010570511,0.00006746931,0.00038884862,0.0000949628,0.0000033332542,0.00051288586],"genre_scores_gemma":[0.99843556,0.0011318966,0.000044517346,0.00006200975,0.000006542124,0.000023704253,0.000005216823,0.000008348901,0.00028222013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984507,0.00011637538,0.00039879486,0.00012082484,0.0007137487,0.0001995464],"domain_scores_gemma":[0.9988436,0.00024120789,0.00020613991,0.0003283351,0.00029827826,0.00008244782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001932651,0.00009723846,0.00032781903,0.00005104902,0.00022296284,0.000002989717,0.00012867419,0.000023355711,0.000061665785],"category_scores_gemma":[0.0005747957,0.000058583068,0.000082575505,0.00022116951,0.00044658835,0.000032509844,0.00013915541,0.00005818915,5.374039e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043997704,0.0009196222,0.9451795,0.0010435715,0.0008808296,0.000041144776,0.0029417356,0.000018428424,0.00021264589,0.000600668,0.011994183,0.035727695],"study_design_scores_gemma":[0.0009432246,0.00008001295,0.9561978,0.0013826959,0.00004625577,0.000031456406,0.00067703135,0.0000069936855,0.03967496,0.00020880639,0.00069286796,0.000057885605],"about_ca_topic_score_codex":0.01916416,"about_ca_topic_score_gemma":0.008125692,"teacher_disagreement_score":0.039462313,"about_ca_system_score_codex":0.000025522802,"about_ca_system_score_gemma":0.00076856784,"threshold_uncertainty_score":0.98736733},"labels":[],"label_agreement":null},{"id":"W2119331637","doi":"10.1136/annrheumdis-2012-202325","title":"Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Adiponectin; Psoriatic arthritis; Adipokine; Internal medicine; Psoriasis; Insulin resistance; Confounding; Metabolic syndrome; Leptin; Gastroenterology; Psoriasis Area and Severity Index; Body mass index; Endocrinology; Arthritis; Insulin; Obesity; Immunology","score_opus":0.013130340277632883,"score_gpt":0.23568101902227123,"score_spread":0.22255067874463835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119331637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973614,0.008906486,0.0000057271654,0.00055364723,0.00005661419,0.00056933286,0.00013040875,0.000012440112,0.000029189945],"genre_scores_gemma":[0.99825597,0.0015304661,0.000026340278,0.000081837716,0.000015761632,0.000042378924,0.000014303785,0.000015464277,0.000017502514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923414,0.000052974774,0.00015615164,0.00014417761,0.00019933164,0.00021324829],"domain_scores_gemma":[0.9992808,0.00010449463,0.00013006471,0.00022249846,0.00006781275,0.00019432098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059385216,0.00016894708,0.00034750506,0.00005283317,0.000089901856,0.000011471823,0.00003248934,0.000020733309,0.000015636935],"category_scores_gemma":[0.000117459385,0.00008819224,0.00004099562,0.00013814618,0.0001437397,0.0002184182,0.000046567864,0.000045134406,9.715653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011875945,0.00077394134,0.8858177,0.00016324851,0.00021253286,0.0000014749452,0.00030769742,0.0000033120946,2.2563302e-7,0.00003394247,0.000043502347,0.111454844],"study_design_scores_gemma":[0.004628223,0.00037585932,0.9925374,0.0017674168,0.00020147144,0.0000032465261,0.00013163422,0.000052972846,0.000021859714,0.0001679124,0.0000118997805,0.000100100464],"about_ca_topic_score_codex":0.000071733426,"about_ca_topic_score_gemma":0.000047673737,"teacher_disagreement_score":0.111354746,"about_ca_system_score_codex":0.000009602453,"about_ca_system_score_gemma":0.000026428339,"threshold_uncertainty_score":0.35963753},"labels":[],"label_agreement":null},{"id":"W2119421191","doi":"10.1136/annrheumdis-2012-202779","title":"EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Rheumatoid arthritis; Rheumatism; Rheumatology; Context (archaeology); Internal medicine; Cohort; Physical therapy; Arthritis; Disease","score_opus":0.04489619875765995,"score_gpt":0.29701987424854526,"score_spread":0.2521236754908853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119421191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713678,0.019854989,0.000014503246,0.0069219205,0.00018557177,0.0011406328,0.0001840368,0.000017199955,0.0003133606],"genre_scores_gemma":[0.95759284,0.041912038,0.00007316484,0.0001435605,0.000012828563,0.00015761708,0.000031940122,0.00002531979,0.000050699902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747777,0.00034493857,0.0008903131,0.00022483984,0.00074083655,0.00032130623],"domain_scores_gemma":[0.9975783,0.00021677716,0.00052276714,0.00095912203,0.0004999515,0.00022307779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002891816,0.00020348867,0.00057030265,0.00015724523,0.000097610784,0.000030567437,0.00042906599,0.00006317299,0.00053053367],"category_scores_gemma":[0.0016278074,0.00012717456,0.0004016556,0.0004290098,0.0005219885,0.00029690863,0.00014329242,0.00014500725,0.00002683626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027773737,0.010824879,0.5919811,0.00774123,0.0017682366,0.000022880824,0.008079092,0.00008693551,0.11554479,0.050395552,0.08177301,0.1290049],"study_design_scores_gemma":[0.0016710709,0.00015289924,0.94516,0.008812579,0.000019274179,0.0000065558006,0.0006453956,0.00048528888,0.014644629,0.027947165,0.00029014813,0.00016502869],"about_ca_topic_score_codex":0.0003878926,"about_ca_topic_score_gemma":0.000023370774,"teacher_disagreement_score":0.35317886,"about_ca_system_score_codex":0.000015931368,"about_ca_system_score_gemma":0.0002340266,"threshold_uncertainty_score":0.58089715},"labels":[],"label_agreement":null},{"id":"W2119601740","doi":"10.1136/annrheumdis-2011-200355","title":"Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Mount Sinai Hospital","funders":"","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Adverse effect; Internal medicine; Immunogenicity; Erythema; Surgery; Immunology; Antibody","score_opus":0.058053297493841874,"score_gpt":0.34794200671089087,"score_spread":0.289888709217049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119601740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685806,0.021561958,0.000007563862,0.006640646,0.00024402815,0.0018901055,0.0008824086,0.00004208302,0.0001506087],"genre_scores_gemma":[0.98965603,0.008745675,0.00003169934,0.0010666198,0.00015661135,0.00009490255,0.00008096714,0.000042445943,0.00012505084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968781,0.0005076721,0.00074127904,0.00033676252,0.00087837724,0.0006578119],"domain_scores_gemma":[0.9964459,0.0014689513,0.00021966365,0.0012923414,0.00014361012,0.00042953464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006300772,0.00029558834,0.0006869055,0.00010217977,0.00018004837,0.000070661394,0.0006368757,0.000053889347,0.00029467794],"category_scores_gemma":[0.0017414474,0.00016345312,0.00022159184,0.0004277977,0.00017570387,0.00018195732,0.00019146423,0.00023700649,0.00008169691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027782626,0.025784547,0.1925479,0.00008764636,0.0027191464,0.00019787335,0.10747875,0.00005132087,0.001531242,0.00016979943,0.038024027,0.6036251],"study_design_scores_gemma":[0.01907772,0.0034629025,0.95025504,0.0028744163,0.00007531186,0.00002965518,0.012366545,0.00013519415,0.0034621712,0.0025885045,0.005131991,0.0005405813],"about_ca_topic_score_codex":0.0086472295,"about_ca_topic_score_gemma":0.00083923945,"teacher_disagreement_score":0.7577071,"about_ca_system_score_codex":0.000026576383,"about_ca_system_score_gemma":0.00015091339,"threshold_uncertainty_score":0.99795425},"labels":[],"label_agreement":null},{"id":"W2120165929","doi":"10.1136/ard.61.12.1075","title":"Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis","year":2002,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Medicine; Circadian rhythm; Osteoarthritis; Rhythm; Chronobiology; Population; Physical therapy; Confidence interval; Physical medicine and rehabilitation; Internal medicine; Pathology","score_opus":0.023963926862816416,"score_gpt":0.2826815633702921,"score_spread":0.2587176365074757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120165929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249244,0.0025714883,0.000022432507,0.004252634,0.0000403602,0.0004251177,0.000017765953,0.000008065986,0.00016968002],"genre_scores_gemma":[0.9990131,0.0004467875,0.000055169752,0.0003013134,0.000010738438,0.000034914952,0.0000055613773,0.0000063942607,0.00012600118],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99908394,0.00021943067,0.00029759016,0.0001192214,0.00015449159,0.00012535058],"domain_scores_gemma":[0.99928904,0.00033001948,0.000071509705,0.00020294177,0.000044272394,0.00006222798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031574655,0.00008020481,0.00021618426,0.00009273658,0.000041707866,0.000013447052,0.000047619124,0.000034178083,0.00012544327],"category_scores_gemma":[0.0014549835,0.00005692289,0.000070903465,0.00018698786,0.00015973917,0.00008213198,0.000028992974,0.000060535353,0.000004320396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019330821,0.0017541521,0.2001482,0.0050096354,0.000063642416,0.000010612132,0.004257259,0.000056177974,0.0006719355,0.0014464953,0.0022867096,0.78410184],"study_design_scores_gemma":[0.0009180924,0.00008820296,0.9911507,0.0015697237,0.000012989314,0.0000023010248,0.00020190522,0.0024200308,0.000015236341,0.003513944,0.00004541553,0.00006150509],"about_ca_topic_score_codex":0.00010509623,"about_ca_topic_score_gemma":0.00009023221,"teacher_disagreement_score":0.79100245,"about_ca_system_score_codex":0.00000910567,"about_ca_system_score_gemma":0.000018362507,"threshold_uncertainty_score":0.2321248},"labels":[],"label_agreement":null},{"id":"W2120361989","doi":"10.1136/ard.2004.031765","title":"Association of SEEK1 and psoriatic arthritis in two distinct Canadian populations","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Arthritis Society","keywords":"Psoriatic arthritis; Linkage disequilibrium; Medicine; Odds ratio; Population; Psoriasis; SNP; Internal medicine; Allele; Genome-wide association study; Immunology; Single-nucleotide polymorphism; Genetics; Haplotype; Genotype; Biology","score_opus":0.02684029313695235,"score_gpt":0.2803873358360567,"score_spread":0.25354704269910433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120361989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911166,0.0063847336,0.0000012471944,0.0016143328,0.0001551785,0.00014766146,0.00030643496,0.00000646276,0.00026736286],"genre_scores_gemma":[0.99901915,0.00042655473,0.00002297532,0.000053346346,0.000008661508,0.000013155139,0.000052831154,0.0000049330133,0.00039836724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928063,0.00015524785,0.0002806096,0.000085343985,0.000036573827,0.00016156529],"domain_scores_gemma":[0.99943435,0.00015347442,0.00019149053,0.00015127144,0.00004132895,0.000028108228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014356717,0.00007923529,0.00021651876,0.00008593073,0.00007375071,0.0000049695286,0.00008907768,0.000041001083,0.00014578941],"category_scores_gemma":[0.00034081165,0.00006111855,0.000075105876,0.000113665235,0.00004519967,0.000063127394,0.000019719831,0.000031569987,0.000015984559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003257508,0.00023548039,0.63292867,0.000051422227,0.0003261738,5.9056356e-7,0.00059032766,0.000065201864,0.00008701428,0.0013001804,0.003092525,0.36128983],"study_design_scores_gemma":[0.0008397914,0.000019740592,0.9957303,0.00020498701,0.00010551978,0.00000174746,0.00006393616,0.000026770547,0.00067103107,0.001823912,0.0004429992,0.000069295405],"about_ca_topic_score_codex":0.01749022,"about_ca_topic_score_gemma":0.13086928,"teacher_disagreement_score":0.36280158,"about_ca_system_score_codex":0.00002812358,"about_ca_system_score_gemma":0.00007354482,"threshold_uncertainty_score":0.9890524},"labels":[],"label_agreement":null},{"id":"W2120393706","doi":"10.1136/annrheumdis-2016-210715","title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5775,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"European League Against Rheumatism; National Institute for Health and Care Research","keywords":"Medicine; Abatacept; Adalimumab; Certolizumab pegol; Tocilizumab; Infliximab; Golimumab; Etanercept; Rituximab; Rheumatoid arthritis; Antirheumatic drugs; Rheumatism; Antirheumatic Agents; Intensive care medicine; Disease; Physical therapy; Internal medicine","score_opus":0.14033822475919308,"score_gpt":0.3964591459019126,"score_spread":0.25612092114271956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120393706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005356835,0.9914894,0.00014591446,0.0028970635,0.00014741952,0.0037551974,0.0009189915,0.000034374927,0.000075921256],"genre_scores_gemma":[0.007474102,0.9908577,0.00042389234,0.00005812405,0.000017959737,0.0008623277,0.00014436983,0.000069397924,0.000092123235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694455,0.00032066746,0.0011717011,0.00047452154,0.0005763081,0.0005122687],"domain_scores_gemma":[0.9952796,0.00118968,0.0012880369,0.0016975721,0.00022940287,0.00031572027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007753757,0.00052665884,0.002180196,0.00017362957,0.0006341239,0.00012617471,0.0008718138,0.00009378064,0.0001000442],"category_scores_gemma":[0.0005071132,0.00024657723,0.00093895826,0.00018647636,0.0011818291,0.00015489839,0.00037138528,0.00020999911,0.0000117496675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017058798,0.00028657186,0.00004352677,0.025416458,0.002955147,0.000005901831,0.00008565215,9.988964e-7,3.7882355e-8,0.0018096808,0.002780659,0.9664448],"study_design_scores_gemma":[0.0017796514,0.00025505907,0.0005250302,0.38983333,0.00059984444,0.00006798986,0.00042690462,0.000117954725,0.0000021521405,0.0027669482,0.6032027,0.00042246134],"about_ca_topic_score_codex":0.000026728247,"about_ca_topic_score_gemma":0.0000017912129,"teacher_disagreement_score":0.9660223,"about_ca_system_score_codex":0.000017228389,"about_ca_system_score_gemma":0.0003365877,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W2120485875","doi":"10.1136/annrheumdis-2012-201308","title":"Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University Health Network; Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Allele; Association (psychology); Dermatology; Arthritis; Immunology; Genetics; Gene","score_opus":0.041330850515651066,"score_gpt":0.31549601681529355,"score_spread":0.2741651662996425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120485875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486864,0.0031334274,0.000008109475,0.0006626444,0.00022373458,0.0008056419,0.00013207243,0.00004052029,0.0001252271],"genre_scores_gemma":[0.99882066,0.00047662502,0.000021360991,0.00013238404,0.00016669543,0.000093001145,0.000057424084,0.000021621767,0.00021020112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807423,0.00021668381,0.0004656039,0.00017571158,0.0006915057,0.00037626072],"domain_scores_gemma":[0.9985558,0.0003127455,0.00052403065,0.0002860683,0.00015829837,0.00016305727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029906104,0.00019900737,0.00061001035,0.0000705895,0.00027274425,0.00003385027,0.000087026485,0.00007088032,0.00007032538],"category_scores_gemma":[0.00070707,0.00014661536,0.00022742305,0.00014790932,0.00003152502,0.000124939,0.000076490374,0.0000871065,0.00001240303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005576306,0.0016283878,0.9788755,0.000099953235,0.001748062,9.565388e-7,0.0005824522,7.8297904e-7,0.0000138681635,0.00002945391,0.002269785,0.014694992],"study_design_scores_gemma":[0.0046671266,0.0003820443,0.99203175,0.00035948295,0.0013145857,3.087511e-7,0.000585092,0.000011196244,0.00017385159,0.000247426,0.00010186908,0.00012529259],"about_ca_topic_score_codex":0.00019830163,"about_ca_topic_score_gemma":0.000031435793,"teacher_disagreement_score":0.0145697,"about_ca_system_score_codex":0.00012022362,"about_ca_system_score_gemma":0.000039147773,"threshold_uncertainty_score":0.59788007},"labels":[],"label_agreement":null},{"id":"W2120816859","doi":"10.1136/ard.2008.089367","title":"Familial aggregation of psoriatic arthritis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Dermatology; Arthritis; Psoriasis; Immunology","score_opus":0.04118858685083437,"score_gpt":0.2898997990920239,"score_spread":0.24871121224118953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120816859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889875,0.009328521,0.0000050651056,0.00059055444,0.00015390635,0.00028188006,0.000069283415,0.000014288989,0.0005690051],"genre_scores_gemma":[0.9906385,0.008925874,0.00006994996,0.00012103473,0.000024250323,0.000017680532,0.000010361061,0.000008906205,0.00018344005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99912184,0.000032345946,0.0003208684,0.00009581622,0.00030276095,0.00012636418],"domain_scores_gemma":[0.99925053,0.00007655786,0.0001914417,0.0002897389,0.0001297175,0.00006202386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003975091,0.00009463089,0.0003451284,0.00003913179,0.00008689679,0.0000018350185,0.00007333509,0.000022091226,0.000080078615],"category_scores_gemma":[0.00038124324,0.000062574494,0.00022880324,0.00014002922,0.00018400735,0.00004666626,0.00003954012,0.000027613312,0.000011550769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008338749,0.0035454417,0.30791405,0.0012334215,0.0019190907,0.00007560939,0.0027740113,0.00003739878,0.00012588028,0.0017152642,0.02327177,0.65655416],"study_design_scores_gemma":[0.0030171312,0.00042439264,0.9879288,0.0023418253,0.00019931345,0.000051427272,0.00027111598,0.000052518877,0.0032375848,0.0021743155,0.00020336568,0.000098172386],"about_ca_topic_score_codex":0.000117025185,"about_ca_topic_score_gemma":0.000007935013,"teacher_disagreement_score":0.6800148,"about_ca_system_score_codex":0.0000063686384,"about_ca_system_score_gemma":0.00006485674,"threshold_uncertainty_score":0.2551714},"labels":[],"label_agreement":null},{"id":"W2121025927","doi":"10.1136/ard.2002.003624","title":"Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Osteocalcin; Osteoblast; Osteoarthritis; Bone remodeling; Endocrinology; Alkaline phosphatase; Internal medicine; Placebo; Tibia; Surgery; Pathology; Biology; In vitro","score_opus":0.01884666217368308,"score_gpt":0.27248383713101443,"score_spread":0.25363717495733135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121025927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978907,0.0178667,0.0000013999876,0.00019269667,0.00014757554,0.0010412679,0.00005340687,0.000028148255,0.0017618333],"genre_scores_gemma":[0.9972235,0.00053178373,0.0002518049,0.00011656983,0.000018368886,0.00020356233,0.000030965693,0.00003316717,0.001590275],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984515,0.00013403388,0.00039843415,0.00025528664,0.00038197995,0.00037879788],"domain_scores_gemma":[0.99906254,0.00004572076,0.00017506303,0.0004605273,0.0000452553,0.00021087937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065547996,0.000283958,0.00058863504,0.000102623846,0.000076022,0.000019377085,0.000096577474,0.00005169838,0.00021002359],"category_scores_gemma":[0.000027522832,0.00017609994,0.00025463113,0.00020206728,0.00010150519,0.00016134494,0.000031320644,0.000060196515,0.000020995692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014351793,0.10151264,0.34403816,0.0028277878,0.0021203787,0.0034985,0.021869963,0.00014643338,0.116483785,0.013496154,0.003729016,0.3759254],"study_design_scores_gemma":[0.029063838,0.009994725,0.020243626,0.0016676296,0.00059310894,0.00030338494,0.0017133739,0.000008781686,0.9342616,0.0004907352,0.00116979,0.00048939517],"about_ca_topic_score_codex":0.00005274204,"about_ca_topic_score_gemma":0.000024183084,"teacher_disagreement_score":0.8177778,"about_ca_system_score_codex":0.000037093272,"about_ca_system_score_gemma":0.00014652252,"threshold_uncertainty_score":0.71811473},"labels":[],"label_agreement":null},{"id":"W2121108580","doi":"10.1136/ard.2007.080077","title":"Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ankylosing spondylitis; Medicine; Descriptive statistics; Multivariate analysis; Physical therapy; Trial registration; Internal medicine; Family medicine; Clinical trial; Statistics","score_opus":0.0794375372768542,"score_gpt":0.40293477234269703,"score_spread":0.3234972350658428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121108580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251163,0.0032469884,0.000039275026,0.0011809545,0.000097425385,0.002309213,0.00038446896,0.0000048892534,0.00022515049],"genre_scores_gemma":[0.99898016,0.00071812863,0.00010945938,0.00001031716,0.000003661699,0.00008282296,0.000030247553,0.000008041012,0.00005718271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841124,0.0001312651,0.00066532637,0.0001368884,0.0005298375,0.00012542732],"domain_scores_gemma":[0.9977012,0.00067804684,0.0006729733,0.00046869917,0.00044942598,0.000029607409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015000876,0.00010691277,0.0003107862,0.000057947123,0.00014392189,0.000005817234,0.00014195284,0.000022096454,0.000012203221],"category_scores_gemma":[0.00077803375,0.00005562234,0.00016138669,0.00024094865,0.0002381867,0.000055065942,0.00010848075,0.000030283056,9.0390486e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030330003,0.006620836,0.4818295,0.0033476562,0.006335039,0.00000283426,0.010899645,0.00013569364,0.00006796217,0.0029236665,0.003340661,0.48146352],"study_design_scores_gemma":[0.0027791883,0.00026452934,0.9804411,0.0034146872,0.0015070864,0.0000019669412,0.009081061,0.0003614739,0.0010652017,0.0009955161,0.000040335868,0.00004787615],"about_ca_topic_score_codex":0.00017058892,"about_ca_topic_score_gemma":0.000069581336,"teacher_disagreement_score":0.4986116,"about_ca_system_score_codex":0.00001672786,"about_ca_system_score_gemma":0.00002629511,"threshold_uncertainty_score":0.22682132},"labels":[],"label_agreement":null},{"id":"W2121276278","doi":"10.1136/annrheumdis-2013-203210","title":"The longitudinal relationship between changes in body weight and changes in medial tibial cartilage, and pain among community-based adults with and without meniscal tears","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Knee pain; WOMAC; Tears; Cartilage; Cohort; Medial meniscus; Surgery; Internal medicine; Anatomy; Pathology","score_opus":0.03605786682846404,"score_gpt":0.2800354870066885,"score_spread":0.24397762017822447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121276278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286836,0.0010316557,0.0000018759843,0.005141382,0.000019998099,0.0008681835,0.000026590662,0.000013150993,0.000028781711],"genre_scores_gemma":[0.9993907,0.0002280572,0.00004177413,0.00011261179,0.000023941164,0.0001226031,0.000023554147,0.00001469238,0.000042071344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987453,0.00048015328,0.00019652145,0.00014011367,0.00022131976,0.00021657946],"domain_scores_gemma":[0.99844664,0.0009929506,0.00013775355,0.00023972572,0.000043880656,0.00013902923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056738645,0.0001581338,0.00032022884,0.00009831246,0.00019364833,0.0000399712,0.000079801976,0.00005502479,0.0000066076504],"category_scores_gemma":[0.00041687296,0.00008742773,0.000024606727,0.00012014909,0.0003988407,0.000090087226,0.00006626988,0.00016283411,5.6347045e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025680623,0.00009554369,0.98737574,0.00024062466,0.000020983956,0.0000024702,0.0010866682,2.1549319e-7,0.000026810663,0.00003974855,0.00005176206,0.01080262],"study_design_scores_gemma":[0.0028977068,0.0010368231,0.99125373,0.0022675695,0.000106106716,0.0000033146034,0.0010540971,0.00010115827,0.00045930326,0.00071481796,0.0000075749444,0.00009777729],"about_ca_topic_score_codex":0.00039517615,"about_ca_topic_score_gemma":0.0083717825,"teacher_disagreement_score":0.010704842,"about_ca_system_score_codex":0.000008595668,"about_ca_system_score_gemma":0.000032780204,"threshold_uncertainty_score":0.46716508},"labels":[],"label_agreement":null},{"id":"W2121283103","doi":"10.1136/annrheumdis-2015-207714","title":"Statin use and mortality in rheumatoid arthritis: a general population-based cohort study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Internal medicine; Statin; Rheumatoid arthritis; Propensity score matching; Population; Cohort; Context (archaeology); Hazard ratio; Confounding; Incidence (geometry); Rate ratio; Cohort study; Confidence interval; Environmental health","score_opus":0.06458160514913384,"score_gpt":0.34542964787019315,"score_spread":0.2808480427210593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121283103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929579,0.005042944,0.000010181396,0.0004380591,0.00007518212,0.0013261638,0.00008289497,0.000034360506,0.000032309446],"genre_scores_gemma":[0.9954911,0.003996117,0.00011971639,0.00017279391,0.000010524899,0.00011912649,0.000040766405,0.000021264399,0.00002859426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770385,0.00037792954,0.00059274613,0.00025227157,0.00077396526,0.00029921986],"domain_scores_gemma":[0.9984929,0.00022476977,0.00017299825,0.0005462018,0.0002280301,0.00033507586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067291025,0.00017995016,0.0005610518,0.00014245491,0.000072618,0.0000759967,0.00014080915,0.00003321552,0.000045624834],"category_scores_gemma":[0.0018692147,0.00012846806,0.0001100452,0.00025329227,0.00015698613,0.00025593422,0.00007632323,0.00010829181,0.0000045075094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001973892,0.0009879835,0.9920969,0.00006556493,0.0001656732,0.000014266288,0.00039914518,0.00012914144,0.000003047428,0.00018698964,0.000727133,0.005026758],"study_design_scores_gemma":[0.002848005,0.00026510382,0.99192953,0.0009024606,0.000008733502,0.000006778606,0.00050128275,0.001517726,0.000037854497,0.0018287692,0.000029891718,0.00012387896],"about_ca_topic_score_codex":0.006034267,"about_ca_topic_score_gemma":0.0009078512,"teacher_disagreement_score":0.0051264158,"about_ca_system_score_codex":0.000022833225,"about_ca_system_score_gemma":0.0002540272,"threshold_uncertainty_score":0.9122047},"labels":[],"label_agreement":null},{"id":"W2121410450","doi":"10.1136/annrheumdis-2013-204195","title":"Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pfizer Pharmaceuticals; F. Hoffmann-La Roche; GlaxoSmithKline; Genentech; Bristol-Myers Squibb; AstraZeneca; Pfizer; Amgen; Eisai; Celltrion; Sanofi; Abbott Laboratories","keywords":"Golimumab; Medicine; Psoriatic arthritis; Placebo; Rheumatoid arthritis; Internal medicine; Ankylosing spondylitis; Methotrexate; Adverse effect; Arthritis; Surgery; Adalimumab; Pathology","score_opus":0.06501003918027788,"score_gpt":0.3286827251089564,"score_spread":0.26367268592867854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121410450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974439,0.011610959,0.000013961413,0.0005998339,0.00013501038,0.005697618,0.0074595194,0.000023951896,0.0000201003],"genre_scores_gemma":[0.97880805,0.016672567,0.00013329573,0.00012429216,0.000022151027,0.00026204134,0.003920677,0.000042155683,0.0000147562105],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9940851,0.0011502984,0.002795532,0.00056263607,0.00095775403,0.00044872196],"domain_scores_gemma":[0.9917102,0.0030546386,0.0020275337,0.002219949,0.0007550574,0.00023263783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012357061,0.00045945914,0.004444608,0.0003305286,0.00019204075,0.00006170214,0.0006542168,0.00010320146,0.002331111],"category_scores_gemma":[0.0035792913,0.00023001389,0.00076175993,0.0010379247,0.00043860934,0.00045971473,0.00027847305,0.00015010976,0.000008109492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5616274,0.0054782154,0.36234078,0.00022425798,0.03185271,0.000026915872,0.00080824713,0.000107871034,0.000023875135,0.000117278134,0.00078839523,0.03660405],"study_design_scores_gemma":[0.353778,0.0004908527,0.6345066,0.004581788,0.00519269,0.0000031747707,0.00064002076,0.00036162516,0.000089006266,0.00013885216,0.000004208121,0.00021319727],"about_ca_topic_score_codex":0.0023643903,"about_ca_topic_score_gemma":0.0015758097,"teacher_disagreement_score":0.2721658,"about_ca_system_score_codex":0.000030848878,"about_ca_system_score_gemma":0.0002779271,"threshold_uncertainty_score":0.9985809},"labels":[],"label_agreement":null},{"id":"W2121933593","doi":"10.1136/ard.2007.081364","title":"Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis","year":2007,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Alberta; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; U.S. Public Health Service; Versus Arthritis","keywords":"Ankylosing spondylitis; Medicine; Spondylitis; Meta-analysis; Interleukin; Immunology; Prospective cohort study; Interleukin 1β; Internal medicine; Bioinformatics; Cytokine","score_opus":0.2785240364225106,"score_gpt":0.4196006100809577,"score_spread":0.1410765736584471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121933593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011739852,0.98179525,0.000009234578,0.00014031888,0.000045796074,0.0018149073,0.014340544,0.000019435822,0.00066053635],"genre_scores_gemma":[0.03069561,0.96628916,0.00019357118,0.00011811298,0.000021610316,0.00025937226,0.0020691485,0.0000568093,0.00029659638],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99696326,0.00024317237,0.0011930031,0.00039020993,0.0008827454,0.000327632],"domain_scores_gemma":[0.9961204,0.00055850105,0.0017187756,0.00086572085,0.00059397944,0.00014264486],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000354937,0.00048622474,0.0061004064,0.00048229023,0.00013289748,0.000021049034,0.0002630274,0.00010132039,0.001301808],"category_scores_gemma":[0.0003255282,0.00025612352,0.004818902,0.0014841807,0.0003336784,0.000051647898,0.00012064109,0.00013234477,0.0000046425394],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010390699,0.0012345698,0.0016192524,0.0038475064,0.83844954,0.000030279032,0.0002618178,0.000004714824,1.4896965e-7,0.00042556284,0.00052065076,0.15350208],"study_design_scores_gemma":[0.0008012454,0.00029883912,0.023900261,0.0049300143,0.95181257,0.000028912531,0.00011705338,0.000009204905,0.000011921086,0.0001342649,0.017671233,0.0002844649],"about_ca_topic_score_codex":0.00044582062,"about_ca_topic_score_gemma":0.00011283391,"teacher_disagreement_score":0.15321761,"about_ca_system_score_codex":0.00010536292,"about_ca_system_score_gemma":0.00028552834,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W2123037260","doi":"10.1136/ard.2003.006031","title":"The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Arthritis Society; University Health Network","funders":"University Health Network","keywords":"Medicine; Rheumatoid arthritis; Comorbidity; Indirect costs; Internal medicine; Physical therapy; Disease burden; Disease; Demography","score_opus":0.03468777272701531,"score_gpt":0.29178263961908046,"score_spread":0.2570948668920652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123037260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532151,0.04172986,0.000002230472,0.003419798,0.00008988292,0.0012397124,0.000055755492,0.000045739896,0.00020192644],"genre_scores_gemma":[0.9529501,0.046724565,0.000015593683,0.000103876904,0.00002132557,0.00010062823,0.000011062602,0.000023909462,0.00004890109],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980941,0.00023076279,0.00049083534,0.00027335322,0.00050730526,0.00040363896],"domain_scores_gemma":[0.99822664,0.0004988246,0.00025108442,0.0005602165,0.00021503904,0.00024821234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035721625,0.00024334437,0.00065256073,0.00006125275,0.0005730647,0.00014633183,0.00025366584,0.00003760854,0.000036238198],"category_scores_gemma":[0.00042053842,0.00012943376,0.00014791719,0.00015516451,0.0008131171,0.00020681004,0.00013277768,0.00016362424,0.00002052076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009000612,0.00799181,0.09330754,0.00038876658,0.012608683,0.0003951425,0.029297926,0.0017535315,0.0002667971,0.018245412,0.018471383,0.8082724],"study_design_scores_gemma":[0.03859959,0.009731634,0.86492795,0.020303471,0.000112763475,0.000688765,0.042778213,0.00037741478,0.0014613995,0.017833808,0.0021706538,0.0010143174],"about_ca_topic_score_codex":0.000351523,"about_ca_topic_score_gemma":0.00067195116,"teacher_disagreement_score":0.80725807,"about_ca_system_score_codex":0.000036628106,"about_ca_system_score_gemma":0.0003783424,"threshold_uncertainty_score":0.5278155},"labels":[],"label_agreement":null},{"id":"W2123127083","doi":"10.1136/ard.2008.099861","title":"Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis","year":2008,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Hôpital Notre-Dame; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Hydroxychloroquine; Methotrexate; Combination therapy; Internal medicine; Leflunomide; Adverse effect; Azathioprine; Sulfasalazine; Toxicity; Etanercept; Meta-analysis; Pharmacology; Disease; Ulcerative colitis","score_opus":0.1368094940806338,"score_gpt":0.3849568027077549,"score_spread":0.2481473086271211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123127083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0197494,0.97301906,0.000016094778,0.00038640978,0.000023122515,0.006528495,0.00022485023,0.000034127443,0.000018450357],"genre_scores_gemma":[0.049373113,0.94936067,0.000093137845,0.00012797052,0.0000035318878,0.0008738217,0.00008367968,0.000066260094,0.000017790426],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99335504,0.0019657845,0.0024368432,0.00071444514,0.0010079859,0.0005198969],"domain_scores_gemma":[0.9933907,0.0025773374,0.0020105045,0.0013044769,0.00030526044,0.00041171807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011402185,0.00088248565,0.011576747,0.00066304154,0.00017204504,0.00006513175,0.0005156088,0.0001625209,0.0000961445],"category_scores_gemma":[0.0013959376,0.00045838667,0.0023482107,0.0014422958,0.00080406223,0.00020798265,0.00015056372,0.00034743376,0.000003252839],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012392395,0.0021138263,0.0001731214,0.72713965,0.18590738,0.000028383223,0.0007888474,0.0000070330716,7.069627e-7,0.00023169097,0.00011826403,0.082251884],"study_design_scores_gemma":[0.01382436,0.0020137497,0.0024738424,0.85605913,0.12226379,0.00017452484,0.00026814122,0.0002625082,0.000018059402,0.00052658585,0.00053715013,0.0015781472],"about_ca_topic_score_codex":0.00009027474,"about_ca_topic_score_gemma":0.000008859223,"teacher_disagreement_score":0.12891951,"about_ca_system_score_codex":0.000031978605,"about_ca_system_score_gemma":0.0003335564,"threshold_uncertainty_score":0.9997868},"labels":[],"label_agreement":null},{"id":"W2123235923","doi":"10.1136/annrheumdis-2011-200859","title":"Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Adalimumab; Spondylitis; Ankylosis; Placebo; BASDAI; Surgery; Internal medicine; Gastroenterology; Rheumatoid arthritis; Pathology; Psoriatic arthritis","score_opus":0.12601247228357804,"score_gpt":0.3709201600742575,"score_spread":0.24490768779067945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123235923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991713,0.006262794,0.000030967807,0.0008515743,0.000036258796,0.0010128131,0.000078287696,0.0000041552075,0.000010139398],"genre_scores_gemma":[0.9987708,0.0009950359,0.00007047313,0.000031337244,0.000013366076,0.000059061378,0.000046468987,0.0000059130452,0.000007572182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991157,0.00008161373,0.00039893066,0.00007991211,0.00019680308,0.00012704094],"domain_scores_gemma":[0.9988737,0.00043071204,0.00030360688,0.00020241496,0.000067764246,0.000121785844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020912723,0.00008748187,0.00028120697,0.00012084117,0.000026255917,0.0000033331678,0.000039693292,0.000023659972,0.0000060320067],"category_scores_gemma":[0.0019716858,0.000062729596,0.00007425528,0.0001297739,0.000042856034,0.0003238761,0.000028810375,0.000026775037,2.1468013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010534316,0.0023573013,0.5781033,0.016663678,0.00015590135,0.0000069624325,0.0061148484,0.00015381642,0.0078527825,0.0017981563,0.0004483358,0.3758106],"study_design_scores_gemma":[0.00201828,0.00020782759,0.9639428,0.013121611,0.00010969772,0.0000018381634,0.00015594522,0.0005612328,0.01821414,0.0016081941,0.000007253273,0.00005115834],"about_ca_topic_score_codex":0.00009844159,"about_ca_topic_score_gemma":0.000009039337,"teacher_disagreement_score":0.3858395,"about_ca_system_score_codex":0.000019435387,"about_ca_system_score_gemma":0.00004962855,"threshold_uncertainty_score":0.25580388},"labels":[],"label_agreement":null},{"id":"W2123414080","doi":"10.1136/annrheumdis-2014-206478","title":"Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"F. Hoffmann-La Roche; Genentech; AstraZeneca; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Sanofi; Abbott Laboratories","keywords":"Medicine; Rheumatoid arthritis; Placebo; Methotrexate; Rheumatology; Internal medicine; Adverse effect; Clinical endpoint; Arthritis; Gastroenterology; Clinical trial; Surgery; Pathology","score_opus":0.01944185259460256,"score_gpt":0.289764675680215,"score_spread":0.27032282308561245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123414080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948932,0.0020503707,0.000044099397,0.0017223117,0.000037764003,0.0008971493,0.000140119,0.000021846601,0.00019313126],"genre_scores_gemma":[0.99323934,0.006062737,0.00019679047,0.0002607032,0.0000063235793,0.00002814182,0.00002528322,0.000038264414,0.00014241421],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969381,0.0008538673,0.00072414905,0.00033422947,0.00071200234,0.0004376205],"domain_scores_gemma":[0.99730355,0.00095327786,0.00028049113,0.0007406197,0.00026887225,0.00045319684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010097777,0.00025359457,0.0008528151,0.0002662287,0.00013022042,0.000029438577,0.00026055143,0.00005504119,0.0000926867],"category_scores_gemma":[0.0028798205,0.00016948664,0.0001282061,0.00030149028,0.00038814446,0.00018513332,0.00019691614,0.0001326975,0.00000842873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06266038,0.0023360327,0.44333708,0.00050895277,0.00047827626,0.0000099872805,0.0044412613,0.00018210076,0.00020610391,0.00085332786,0.0013905249,0.48359597],"study_design_scores_gemma":[0.008442424,0.0022609443,0.98047584,0.0052978946,0.0000093340595,0.000006471733,0.00019876554,0.00032656867,0.0013553075,0.0003965332,0.0010266554,0.00020326689],"about_ca_topic_score_codex":0.00023653047,"about_ca_topic_score_gemma":0.00013747475,"teacher_disagreement_score":0.53713876,"about_ca_system_score_codex":0.000022985118,"about_ca_system_score_gemma":0.00010749308,"threshold_uncertainty_score":0.69114643},"labels":[],"label_agreement":null},{"id":"W2123436542","doi":"10.1136/ard.2006.068882","title":"Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues","year":2007,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Osteoarthritis; Medicine; Chondroitin; Articular cartilage; Inflammation; Arthritis; Cartilage; Chondroitin sulfate; Disease; Joint pain; Internal medicine; Bioinformatics; Pathology; Glycosaminoglycan; Anatomy; Alternative medicine","score_opus":0.042473168977013545,"score_gpt":0.35144462045237235,"score_spread":0.3089714514753588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123436542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07270257,0.92439306,4.688059e-7,0.00009574688,0.00022779664,0.0019114598,0.00037375177,0.000017957076,0.00027718482],"genre_scores_gemma":[0.049854316,0.94944745,0.00002039581,0.00004596171,0.00004528922,0.000097970544,0.00007944006,0.000058197464,0.00035099938],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973816,0.0003473347,0.0009894134,0.00027672504,0.0007046173,0.0003002986],"domain_scores_gemma":[0.99689645,0.0008781094,0.00088617235,0.0010869799,0.00010712955,0.00014514678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032180833,0.00043281424,0.0023336601,0.00013653631,0.000049044953,0.000008279308,0.00039250366,0.00018153901,0.0001167191],"category_scores_gemma":[0.0010759055,0.00021326977,0.0019441386,0.0003790214,0.00030923728,0.000032430453,0.00013978618,0.00015721953,0.000020595677],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014183576,0.00029484948,0.00007811504,0.029203054,0.00039650846,0.000010674509,0.000027882872,2.0794184e-7,0.000031564807,0.00012672706,0.0006590003,0.9690296],"study_design_scores_gemma":[0.0056298524,0.010623987,0.00040806853,0.60523623,0.013771364,0.00012311191,0.00005270871,0.000001685714,0.29989132,0.00044030033,0.06314796,0.0006733917],"about_ca_topic_score_codex":0.00001182486,"about_ca_topic_score_gemma":0.0000018555035,"teacher_disagreement_score":0.9683562,"about_ca_system_score_codex":0.000019247851,"about_ca_system_score_gemma":0.0001411483,"threshold_uncertainty_score":0.86968887},"labels":[],"label_agreement":null},{"id":"W2123673052","doi":"10.1136/ard.2004.029942","title":"DREAMing about arthritic pain","year":2004,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Chronic pain; Neuropathic pain; Dream; Neuroscience; Pathological; Arthritis; Anesthesia; Internal medicine; Physical therapy; Psychology","score_opus":0.0849886297883758,"score_gpt":0.38041255832544113,"score_spread":0.29542392853706534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123673052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057652232,0.9981846,0.000039287144,0.00013282441,0.00012736372,0.0010139875,0.00012486607,0.000039194405,0.00028022745],"genre_scores_gemma":[0.00090047787,0.9978976,0.0001227219,0.0002469231,0.00003498832,0.000119243094,0.00008740494,0.000053376694,0.0005372181],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99810064,0.00028678862,0.00065717916,0.00025216868,0.00040318852,0.0003000504],"domain_scores_gemma":[0.99809206,0.00037921092,0.00046931536,0.0007928486,0.000071856804,0.00019469355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004140081,0.00037098597,0.001737253,0.00010855659,0.00008799621,0.000020050315,0.0002645305,0.00011585427,0.00012618091],"category_scores_gemma":[0.0010829602,0.00020652973,0.0013110546,0.00022029737,0.00009020353,0.000038625858,0.00008044953,0.00013316135,0.00007087666],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004433523,0.00038918448,0.00001153832,0.057184327,0.00071282923,0.000021325764,0.000029205077,5.961551e-7,1.5963346e-8,0.0005304412,0.0005195628,0.9405965],"study_design_scores_gemma":[0.00089389423,0.00029042544,0.0003748256,0.7427313,0.006139526,0.00007026191,0.000059009195,0.000013822449,0.000005369157,0.009598659,0.2393795,0.00044343184],"about_ca_topic_score_codex":0.00003098713,"about_ca_topic_score_gemma":9.611018e-7,"teacher_disagreement_score":0.9401531,"about_ca_system_score_codex":0.000042412456,"about_ca_system_score_gemma":0.0005230394,"threshold_uncertainty_score":0.8422038},"labels":[],"label_agreement":null},{"id":"W2124279530","doi":"10.1136/ard.2005.045658","title":"The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Infliximab; Psoriatic arthritis; Internal medicine; Placebo; Surgery; Psoriasis; Clinical endpoint; Gastroenterology; Randomized controlled trial; Rheumatoid arthritis; Dermatology; Disease","score_opus":0.02748261614962155,"score_gpt":0.33875548893396773,"score_spread":0.3112728727843462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124279530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781651,0.0182344,0.000001903761,0.001126071,0.00018968299,0.0013626099,0.00037705185,0.00001517989,0.0005280286],"genre_scores_gemma":[0.99703765,0.0023334695,0.000037368813,0.00004841519,0.00008076515,0.00020513959,0.000035308294,0.000012806288,0.00020905944],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980954,0.00014487056,0.00081171433,0.00015268766,0.0005680088,0.00022730086],"domain_scores_gemma":[0.99793607,0.000767471,0.0005076048,0.00043835735,0.0002819876,0.00006852035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024082212,0.00017620235,0.0006785754,0.000106998035,0.0001469344,0.00002207908,0.00013701522,0.000036468067,0.00005471015],"category_scores_gemma":[0.0012727095,0.00008681018,0.0008935442,0.00031393833,0.00029245368,0.00005721071,0.000048598966,0.00005476986,0.0000048570623],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8054472,0.00978232,0.06257213,0.00040105617,0.012191047,0.000048950373,0.00059075776,0.0004060699,0.00005427072,0.0016755032,0.037237342,0.06959331],"study_design_scores_gemma":[0.3429391,0.0009998401,0.6501448,0.0009962808,0.0008573701,0.0000061935716,0.00015743622,0.00019344992,0.00020246804,0.0031340574,0.00022705489,0.00014190785],"about_ca_topic_score_codex":0.00037897815,"about_ca_topic_score_gemma":0.00007557598,"teacher_disagreement_score":0.5875727,"about_ca_system_score_codex":0.000012437009,"about_ca_system_score_gemma":0.00009564104,"threshold_uncertainty_score":0.3540016},"labels":[],"label_agreement":null},{"id":"W2124332978","doi":"10.1136/ard.61.suppl_3.iii40","title":"Conventional treatments for ankylosing spondylitis","year":2002,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Disease; Intensive care medicine; Bisphosphonate; Adverse effect; Clinical trial; Pharmacotherapy; Surgery; Osteoporosis; Internal medicine","score_opus":0.17082021996490113,"score_gpt":0.4055029622075918,"score_spread":0.23468274224269067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124332978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017869748,0.9907833,0.00000257298,0.00017292499,0.00027440404,0.002124298,0.0059406105,0.000024056399,0.0004991452],"genre_scores_gemma":[0.00015536767,0.99521965,0.00009052718,0.00007334858,0.00006656231,0.0004985975,0.0008374082,0.00005084103,0.0030077065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831724,0.00007567821,0.000682864,0.00028832554,0.00033249386,0.0003034105],"domain_scores_gemma":[0.998368,0.00032761582,0.00052703073,0.0005075855,0.0001336983,0.0001360257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006402106,0.00037709883,0.0018072794,0.00009910926,0.00016774189,0.000018409573,0.00016815256,0.0000934982,0.0006494671],"category_scores_gemma":[0.00026672607,0.00022254867,0.0021035483,0.00017830875,0.00013932654,0.00004415614,0.00007825085,0.00006258388,0.000037699363],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051964864,0.00086033635,0.00009220047,0.018305443,0.0040628384,0.000011295272,0.000018948942,6.868479e-8,6.4937775e-9,0.0003464472,0.010890469,0.96536],"study_design_scores_gemma":[0.0019004245,0.0003388522,0.0007321537,0.07437984,0.010242251,0.000060450213,0.000020562018,0.0000046992504,0.0000012841116,0.00067754666,0.9114281,0.00021382465],"about_ca_topic_score_codex":0.00001483522,"about_ca_topic_score_gemma":8.8175716e-7,"teacher_disagreement_score":0.9651462,"about_ca_system_score_codex":0.00004854044,"about_ca_system_score_gemma":0.00013263628,"threshold_uncertainty_score":0.90752715},"labels":[],"label_agreement":null},{"id":"W2124433729","doi":"10.1136/ard.2004.022905","title":"Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1096,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health","funders":"Ministerul Cercetării, Inovării şi Digitalizării; McMaster University","keywords":"Medicine; Osteoarthritis; Physical therapy; Minimal clinically important difference; Surgery; Alternative medicine; Pathology; Randomized controlled trial","score_opus":0.054787434147893846,"score_gpt":0.3456583936608216,"score_spread":0.29087095951292774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124433729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990572,0.0029541848,5.632715e-7,0.004188333,0.00014471095,0.0020178338,0.000039161314,0.000011019545,0.000072238065],"genre_scores_gemma":[0.99815315,0.0009915084,0.00013198431,0.0004619427,0.000010303295,0.00020684562,0.000012817774,0.0000152494595,0.000016185768],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99640095,0.00021425562,0.0019757447,0.00026393664,0.0009068799,0.00023824273],"domain_scores_gemma":[0.997688,0.000348359,0.0010240163,0.00055647735,0.0002831329,0.0001000064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023872633,0.00018225813,0.00062049704,0.00009771238,0.00003546823,0.000010372692,0.000111645204,0.00007145699,0.00002535614],"category_scores_gemma":[0.004049981,0.000102911836,0.00019884572,0.0001656438,0.00016954978,0.000057488454,0.00010184009,0.000109603556,9.855121e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010655365,0.002625444,0.27722785,0.00023338456,0.00023886269,0.000050454077,0.0015884857,0.000026110893,0.00088168186,0.0002050699,0.000021032756,0.7158361],"study_design_scores_gemma":[0.024838483,0.020431958,0.909881,0.007102362,0.0014051027,0.000045794604,0.003626173,0.00016493975,0.0064975414,0.02565892,0.000018180304,0.00032954008],"about_ca_topic_score_codex":0.00011019744,"about_ca_topic_score_gemma":0.00040318133,"teacher_disagreement_score":0.71550655,"about_ca_system_score_codex":0.000036344372,"about_ca_system_score_gemma":0.00035316075,"threshold_uncertainty_score":0.48484978},"labels":[],"label_agreement":null},{"id":"W2124551692","doi":"10.1136/ard.2011.151027","title":"2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis","year":2011,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":981,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Ankylosing spondylitis; Spondylitis; Physical therapy; Internal medicine","score_opus":0.1564132080490612,"score_gpt":0.3880864414854432,"score_spread":0.231673233436382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124551692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017127485,0.9912871,0.000012943963,0.0015933167,0.00047819997,0.0025397844,0.0035014555,0.00000816433,0.00040773707],"genre_scores_gemma":[0.0007891384,0.9975752,0.00022310678,0.000082402374,0.000020680569,0.00029333748,0.00014523609,0.000034421628,0.0008364682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983136,0.00013290052,0.00086215546,0.00019689073,0.00027486807,0.00021956091],"domain_scores_gemma":[0.997194,0.00036855575,0.0010604553,0.00114914,0.00017466828,0.00005321591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002573143,0.00027686352,0.0012266327,0.00006131743,0.00019603822,0.000008665034,0.00051574945,0.00005820317,0.00030467007],"category_scores_gemma":[0.00013649125,0.000121362864,0.0013929255,0.00026812355,0.00026183348,0.0000386851,0.00030869665,0.00008693229,0.000005078516],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005001508,0.00046578547,0.000058382655,0.026184533,0.0051623033,0.0000011887302,0.00009753374,3.4935948e-7,2.3562627e-8,0.0028744168,0.016860332,0.9482451],"study_design_scores_gemma":[0.00071645225,0.000114647315,0.0021790788,0.08091298,0.011012783,0.000010411072,0.00023984554,0.0000032931034,0.000009452261,0.0017249038,0.9029404,0.00013577804],"about_ca_topic_score_codex":0.00008351948,"about_ca_topic_score_gemma":0.000005919771,"teacher_disagreement_score":0.9481094,"about_ca_system_score_codex":0.000017125556,"about_ca_system_score_gemma":0.000091699,"threshold_uncertainty_score":0.4949034},"labels":[],"label_agreement":null},{"id":"W2124878922","doi":"10.1136/ard.2003.007039","title":"Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institutes of Health","keywords":"Medicine; Rheumatoid arthritis; Rheumatoid factor; Internal medicine; Granzyme B; Arthritis; Gastroenterology; Granzyme; Spondyloarthropathy; Immunology; Immune system; T cell; CD8","score_opus":0.022469462721830313,"score_gpt":0.2595792598561815,"score_spread":0.2371097971343512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124878922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930268,0.0027059335,0.00003108528,0.0014713471,0.00006849075,0.0014909917,0.0010044832,0.00008957888,0.00011127318],"genre_scores_gemma":[0.9944399,0.004975308,0.000057245215,0.00022034203,0.000006362179,0.000099821744,0.00008800271,0.00007605587,0.00003695652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964773,0.00023858028,0.0007283053,0.00043450829,0.0013511961,0.00077012775],"domain_scores_gemma":[0.997315,0.00032388078,0.0005472609,0.0006946243,0.00066964695,0.00044958293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018978602,0.00044829087,0.0010391367,0.00027542436,0.00028654718,0.00008931564,0.00037835486,0.00010437397,0.00017814856],"category_scores_gemma":[0.0010208784,0.000274833,0.00027325941,0.0007592752,0.0006176569,0.0004396143,0.00010621242,0.0003215253,0.000023994256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022564337,0.0037705293,0.984158,0.00012890283,0.0009774048,0.000043239856,0.0023596962,0.00009952449,0.00004229842,0.0005475282,0.00038644735,0.0052300077],"study_design_scores_gemma":[0.01348304,0.0011836193,0.96301466,0.01980761,0.000008486243,0.000010494355,0.00031981556,0.0000065767517,0.0008212395,0.0009926069,0.000014988208,0.00033686782],"about_ca_topic_score_codex":0.00033754756,"about_ca_topic_score_gemma":0.00030486527,"teacher_disagreement_score":0.02114333,"about_ca_system_score_codex":0.00008400232,"about_ca_system_score_gemma":0.00044277654,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W2124972291","doi":"10.1136/ard.2008.091967","title":"Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Arthritis Research Centre of Canada","funders":"Versus Arthritis","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Statin; Odds ratio; Population; Logistic regression; Hyperlipidemia; Medical prescription; Endocrinology; Diabetes mellitus; Pharmacology","score_opus":0.042535385569006906,"score_gpt":0.2831657091064279,"score_spread":0.240630323537421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124972291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622906,0.034836847,0.000074011085,0.0019969926,0.0000686518,0.0005208523,0.00009870287,0.000023451808,0.00008988358],"genre_scores_gemma":[0.6844511,0.3149604,0.00033339605,0.00015480764,0.000008863651,0.00002414089,0.000004402952,0.000014826184,0.000048060017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979802,0.0003787909,0.0006062836,0.00017137556,0.00057068595,0.00029270188],"domain_scores_gemma":[0.9973112,0.0013495485,0.00036524856,0.0005316451,0.00029453074,0.000147871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047094133,0.00017357289,0.00062064064,0.00008299075,0.00030947634,0.000029152961,0.00022391054,0.00003621448,0.000057356672],"category_scores_gemma":[0.0038382935,0.0000924946,0.00026257787,0.00022644729,0.0014533916,0.00020938148,0.00014367886,0.00014636133,0.0000059946587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002840571,0.0006822311,0.7239483,0.001005271,0.0024183888,0.000028210403,0.0104493415,0.00006137442,0.00018799285,0.018232288,0.016195558,0.22395048],"study_design_scores_gemma":[0.007506028,0.00021298025,0.97019565,0.005785773,0.000030899373,0.00027659704,0.0013897585,0.0004969416,0.0031980614,0.008910266,0.0017349838,0.0002620595],"about_ca_topic_score_codex":0.0006164448,"about_ca_topic_score_gemma":0.000029266675,"teacher_disagreement_score":0.28012353,"about_ca_system_score_codex":0.0000068218633,"about_ca_system_score_gemma":0.00024361508,"threshold_uncertainty_score":0.5355082},"labels":[],"label_agreement":null},{"id":"W2125163971","doi":"10.1136/annrheumdis-2011-200731","title":"Exploring the cost–utility of stratified primary care management for low back pain compared with current best practice within risk-defined subgroups","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Versus Arthritis; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Quality-adjusted life year; Health care; Cost effectiveness; Cost–benefit analysis; Activity-based costing; Cost–utility analysis; Physical therapy; Risk analysis (engineering)","score_opus":0.48379589130239903,"score_gpt":0.4198270077892911,"score_spread":0.06396888351310792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125163971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96015036,0.014672363,0.0064025098,0.0074935895,0.0009817542,0.005677082,0.0025421917,0.000033954893,0.002046193],"genre_scores_gemma":[0.9959504,0.00071958755,0.0017016329,0.0008301748,0.00006101981,0.00060563255,0.00007200109,0.000026612031,0.00003295939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956218,0.0009045006,0.002609623,0.00029032814,0.00020044128,0.00037330278],"domain_scores_gemma":[0.99133915,0.0033885972,0.0039724936,0.00093722966,0.000206799,0.0001557256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011644487,0.00021284855,0.0008233032,0.00009116888,0.0002363548,0.00004763196,0.0004891728,0.000029263061,0.000044201952],"category_scores_gemma":[0.0038046786,0.00015910497,0.00021739003,0.00019024126,0.00016491134,0.0007446928,0.0000937745,0.00010212439,0.000046476864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023963822,0.009393004,0.4995395,0.10748081,0.0042479383,5.044924e-7,0.058762494,0.011432456,8.402807e-7,0.18040702,0.06965905,0.056680016],"study_design_scores_gemma":[0.00418769,0.0005055581,0.8812163,0.0071060667,0.0005258594,0.0000023806178,0.06544662,0.014629347,0.00007537216,0.011574387,0.013628616,0.0011017998],"about_ca_topic_score_codex":0.0003499472,"about_ca_topic_score_gemma":0.000052734726,"teacher_disagreement_score":0.3816768,"about_ca_system_score_codex":0.00009076573,"about_ca_system_score_gemma":0.00011645838,"threshold_uncertainty_score":0.6488112},"labels":[],"label_agreement":null},{"id":"W2125497658","doi":"10.1136/annrheumdis-2013-203863","title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":612,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Autoantibody; Immunology; Antibody; Antigen; Extractable nuclear antigens; Anti-nuclear antibody","score_opus":0.08657399474717208,"score_gpt":0.4160761538357637,"score_spread":0.3295021590885916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125497658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8201058,0.00030805814,0.00018102698,0.17447066,0.00034997924,0.0015937745,0.00039195828,0.000023637951,0.0025751432],"genre_scores_gemma":[0.99196565,0.001161956,0.0021629462,0.0022794665,0.00006813228,0.00009107212,0.000051454757,0.000023821292,0.002195509],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983024,0.00007191649,0.00052787794,0.00021306454,0.0005880414,0.00029668567],"domain_scores_gemma":[0.99788946,0.00054093363,0.00019006043,0.00050846924,0.0006732135,0.00019783499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002773164,0.00017144097,0.00041612887,0.00015511217,0.0002338438,0.00005111312,0.00057651504,0.000033197663,0.001005096],"category_scores_gemma":[0.0007793753,0.00009449628,0.00035237425,0.00022933281,0.00017274402,0.000105560415,0.00034825932,0.00009005358,0.00007323104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006263942,0.0022728753,0.07406211,0.001936261,0.0038236985,0.0000043443288,0.0029456704,0.00066284393,0.028705832,0.02509145,0.7555907,0.10427784],"study_design_scores_gemma":[0.00061561645,0.0006080729,0.86546695,0.0015872979,0.00022343818,0.0000081713515,0.0017284858,0.0048259106,0.009158161,0.0022142923,0.11330241,0.00026118074],"about_ca_topic_score_codex":0.00051096117,"about_ca_topic_score_gemma":0.000005638759,"teacher_disagreement_score":0.79140484,"about_ca_system_score_codex":0.00001512763,"about_ca_system_score_gemma":0.00011911199,"threshold_uncertainty_score":0.99990815},"labels":[],"label_agreement":null},{"id":"W2125578086","doi":"10.1136/ard.2011.155416","title":"Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature","year":2011,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research","keywords":"Medicine; Thematic analysis; Psychological intervention; Qualitative research; Rheumatoid arthritis; Help-seeking; Interpretation (philosophy); Alternative medicine; Grounded theory; Public health; Family medicine; Psychiatry; Nursing; Mental health; Pathology","score_opus":0.07406417483489558,"score_gpt":0.3707470719951127,"score_spread":0.2966828971602171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125578086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022161037,0.97277653,0.0000024654962,0.00017528563,0.00013149432,0.0031466552,0.001443717,0.000012313765,0.00015049333],"genre_scores_gemma":[0.1912844,0.80810356,0.000013105243,0.000024415222,0.000007639467,0.0004167309,0.000023218607,0.0000557643,0.000071172646],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9910264,0.004037777,0.0029477954,0.00034856016,0.0011735135,0.0004659305],"domain_scores_gemma":[0.9884609,0.0055808392,0.0033102138,0.0019578063,0.000545446,0.00014481136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023221974,0.0005698626,0.004568838,0.00035847077,0.00013190348,0.000026202506,0.0013162713,0.00021225885,0.000120494406],"category_scores_gemma":[0.0073285988,0.00025463753,0.0021750517,0.0010799979,0.0011236602,0.00012360493,0.0004936706,0.00040124726,0.000008645928],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003540691,0.0012885282,0.0005016475,0.7484229,0.0055641686,0.000011190391,0.024008559,0.0000035028738,0.0000047413255,0.0030882435,0.0016335187,0.2151189],"study_design_scores_gemma":[0.00054615154,0.00020671579,0.00036108066,0.99217165,0.00029479273,0.00014844537,0.0030698518,0.000015809897,0.00016298638,0.0013626658,0.0014078032,0.00025204127],"about_ca_topic_score_codex":0.00022594584,"about_ca_topic_score_gemma":0.00007943758,"teacher_disagreement_score":0.24374872,"about_ca_system_score_codex":0.00004741526,"about_ca_system_score_gemma":0.00064370094,"threshold_uncertainty_score":0.9999906},"labels":[],"label_agreement":null},{"id":"W2125628766","doi":"10.1136/ard.62.suppl_2.ii34","title":"Advances in targeted therapy: safety of biological agents","year":2003,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Amgen","keywords":"Medicine; Etanercept; Infliximab; Adalimumab; Clinical trial; Rheumatoid arthritis; Intensive care medicine; Internal medicine; Disease","score_opus":0.12650999722349937,"score_gpt":0.40611801144893317,"score_spread":0.2796080142254338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125628766","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010682138,0.9965162,0.0000018457451,0.000084645646,0.00012607661,0.001232321,0.00022454523,0.000013846107,0.00073229236],"genre_scores_gemma":[0.0027969354,0.9968486,0.000025758582,0.000067621695,0.000012680506,0.00008430386,0.00007019515,0.000028425215,0.00006546798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719864,0.0006467755,0.0010762323,0.00025257873,0.00047823976,0.00034753425],"domain_scores_gemma":[0.998097,0.00044143578,0.0005811449,0.00060870213,0.000121170466,0.00015051891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003779621,0.00032156156,0.0022055113,0.00019748531,0.000045769026,0.00000886963,0.0004264682,0.00012845489,0.00051293336],"category_scores_gemma":[0.0009048281,0.00016440457,0.0009510905,0.0004893381,0.000394169,0.00008483932,0.000084338164,0.00019935616,0.000013623771],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013717455,0.00055640104,0.0005574299,0.008073562,0.00029877538,0.0000046986966,0.000045439236,9.5185834e-7,2.031141e-7,0.0002580053,0.00075221556,0.98931515],"study_design_scores_gemma":[0.0009939914,0.00029925402,0.0023714802,0.064590424,0.000037732298,0.00001509869,0.000056822464,0.000002936908,0.000012062352,0.0014480992,0.9299637,0.00020839507],"about_ca_topic_score_codex":0.000015794058,"about_ca_topic_score_gemma":0.0000023208715,"teacher_disagreement_score":0.9891068,"about_ca_system_score_codex":0.00001640442,"about_ca_system_score_gemma":0.00035551316,"threshold_uncertainty_score":0.6704224},"labels":[],"label_agreement":null},{"id":"W2125748229","doi":"10.1136/annrheumdis-2012-201998","title":"Consequences of inflammatory arthritis for workplace productivity loss and sick leave: a systematic review","year":2012,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Sick leave; Arthritis; Absenteeism; Inflammatory arthritis; Presenteeism; Productivity; Intensive care medicine; Immunology; Physical therapy","score_opus":0.10176081361429032,"score_gpt":0.43200884772523773,"score_spread":0.3302480341109474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125748229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101320045,0.983778,0.00000611737,0.001286673,0.0005007476,0.013847205,0.00031701493,0.000034946854,0.00012795872],"genre_scores_gemma":[0.0006426166,0.995444,0.000036010915,0.00033177642,0.00012290903,0.0028438473,0.000027787119,0.00005707929,0.00049398234],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99242836,0.0032000786,0.002884429,0.00035962774,0.00043682026,0.00069071166],"domain_scores_gemma":[0.98871464,0.0050403113,0.0044774115,0.0010997294,0.00035669256,0.00031120863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036868283,0.00048288354,0.0046748654,0.00011574229,0.00044754604,0.000009301277,0.00053397095,0.00024829558,0.00005877867],"category_scores_gemma":[0.005573138,0.0002901208,0.00073816424,0.0003414461,0.000496098,0.00016780091,0.00022743913,0.0004236858,0.000030350124],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015239233,0.00006939606,0.000116260904,0.9365147,0.00025020892,4.9912904e-7,0.00022314895,1.0956168e-7,2.3178593e-8,0.0011646013,0.003395309,0.05825051],"study_design_scores_gemma":[0.00016729531,0.000032733406,0.000030208445,0.9689647,0.002729766,0.000010823558,0.00013316878,7.359813e-7,9.1686167e-7,0.0016681778,0.026009442,0.0002520572],"about_ca_topic_score_codex":0.00003250867,"about_ca_topic_score_gemma":0.0000124036,"teacher_disagreement_score":0.057998452,"about_ca_system_score_codex":0.000040120824,"about_ca_system_score_gemma":0.0015229165,"threshold_uncertainty_score":0.9999551},"labels":[],"label_agreement":null},{"id":"W2126139459","doi":"10.1136/ard.2009.111906","title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Haplotype; Linkage disequilibrium; Immunology; Allele; HLA-DRB1; Genetics; Medicine; Genotyping; Human leukocyte antigen; Major histocompatibility complex; Allele frequency; Genotype; Biology; Antigen; Gene","score_opus":0.12085798176042865,"score_gpt":0.34164245586526226,"score_spread":0.2207844741048336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126139459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734178,0.021064749,0.000003647381,0.0030771364,0.000033728986,0.0022193321,0.00009749521,0.000046159752,0.00003994431],"genre_scores_gemma":[0.99628437,0.0032030498,0.00002365241,0.0002720922,0.000019431242,0.00012949278,0.000011515744,0.000019225312,0.00003718406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970902,0.0005802816,0.001032077,0.0005702485,0.00036695495,0.00036024046],"domain_scores_gemma":[0.9979207,0.0005118748,0.0005079613,0.00056011893,0.00021638733,0.00028298257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048338328,0.00034331816,0.0012859169,0.00023613728,0.00017305408,0.000050148592,0.00014563432,0.00009967925,0.000039698756],"category_scores_gemma":[0.0014443913,0.00021391152,0.00013285177,0.0005489656,0.0005372127,0.00015723897,0.0000945979,0.00017047032,8.219769e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009231538,0.006773006,0.8207461,0.006882809,0.0012455672,0.000053373577,0.005555404,0.00018111036,0.034733135,0.00037525076,0.0016853588,0.11253735],"study_design_scores_gemma":[0.0024062935,0.0009396903,0.98466825,0.006551849,0.00036848985,0.00008069055,0.002932052,0.0014235293,0.00020769716,0.00016930942,0.000015176622,0.0002369902],"about_ca_topic_score_codex":0.0049109734,"about_ca_topic_score_gemma":0.0023806388,"teacher_disagreement_score":0.16392213,"about_ca_system_score_codex":0.00009694036,"about_ca_system_score_gemma":0.00021806725,"threshold_uncertainty_score":0.87230587},"labels":[],"label_agreement":null},{"id":"W2126442626","doi":"10.1136/annrheumdis-2013-203989","title":"Disease-modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Servier; Fondation du CHUM","keywords":"Medicine; Osteoarthritis; Strontium ranelate; Placebo; Cartilage; Internal medicine; Surgery; Gastroenterology; Urology; Osteoporosis; Pathology","score_opus":0.03213766798577853,"score_gpt":0.31231425887622144,"score_spread":0.2801765908904429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126442626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910547,0.0023844484,0.0000072288362,0.00011466931,0.00012416144,0.0058856835,0.00040860692,0.00001281076,0.000007655856],"genre_scores_gemma":[0.9993965,0.00007744677,0.00004948152,0.000013211653,0.0000100260695,0.0003198235,0.00009616922,0.000026128464,0.000011237063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757606,0.00061176385,0.0007856574,0.0002677548,0.00048049097,0.0002782644],"domain_scores_gemma":[0.99837035,0.000294824,0.00052458636,0.0005173881,0.00016519027,0.00012764329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030501856,0.00025031884,0.00077505066,0.0001536717,0.00008304557,0.000015358633,0.00014492325,0.00004766743,0.000030500996],"category_scores_gemma":[0.00046848645,0.0001583579,0.0002440834,0.00034497716,0.0001770925,0.0002435816,0.00009006703,0.0001220839,0.0000023877885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027836908,0.0245734,0.690203,0.0034058418,0.0009439172,0.00017530276,0.02500322,0.002646548,0.05396708,0.00007290053,0.00019806945,0.17097381],"study_design_scores_gemma":[0.102720395,0.01877053,0.76555556,0.026592653,0.0016776692,0.000004782081,0.013442293,0.0035117252,0.06595544,0.0010788696,0.0000020534706,0.00068801607],"about_ca_topic_score_codex":0.0007977763,"about_ca_topic_score_gemma":0.0001129548,"teacher_disagreement_score":0.17028579,"about_ca_system_score_codex":0.00003388117,"about_ca_system_score_gemma":0.00009627621,"threshold_uncertainty_score":0.64576477},"labels":[],"label_agreement":null},{"id":"W2126583107","doi":"10.1136/annrheumdis-2011-200477","title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":429,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cyclophosphamide; Internal medicine; Regimen; Vasculitis; Gastroenterology; Systemic vasculitis; Surgery; Chemotherapy; Disease","score_opus":0.07692901268228287,"score_gpt":0.3182037674268137,"score_spread":0.24127475474453086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126583107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596685,0.0017608012,0.000015909352,0.00037011117,0.0006718563,0.0006336161,0.000113455266,0.000026469777,0.00044093112],"genre_scores_gemma":[0.99830544,0.0009968035,0.00005228052,0.00004910909,0.000014322184,0.000052589417,0.00011165261,0.000019553154,0.00039826817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871624,0.00008175906,0.0005251904,0.00017907844,0.00026878738,0.00022896472],"domain_scores_gemma":[0.99887127,0.0000904877,0.00031404055,0.00040259206,0.00019773454,0.00012385804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021787408,0.00014055397,0.00042915271,0.00010088179,0.00007015095,0.000005616611,0.00015470621,0.00011468573,0.00022046582],"category_scores_gemma":[0.0011012328,0.00009724742,0.0004535392,0.0002933542,0.000110173685,0.00012579662,0.00004254928,0.00010048803,0.0000038154294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012184951,0.010935745,0.59919095,0.0057095243,0.007300596,0.00005925901,0.008550602,0.00010360592,0.0015893499,0.0033204718,0.028875113,0.32217982],"study_design_scores_gemma":[0.007527134,0.00035846062,0.9834293,0.0029193407,0.00060201064,0.0000038224916,0.00026660317,0.0000525614,0.0023501783,0.0023517024,0.000017685328,0.00012119268],"about_ca_topic_score_codex":0.0002752005,"about_ca_topic_score_gemma":0.00004289151,"teacher_disagreement_score":0.38423833,"about_ca_system_score_codex":0.000030024532,"about_ca_system_score_gemma":0.00012813776,"threshold_uncertainty_score":0.39656347},"labels":[],"label_agreement":null},{"id":"W2126989429","doi":"10.1136/ard.2009.100354","title":"Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Infliximab; Discontinuation; Methotrexate; Rheumatoid arthritis; Juvenile rheumatoid arthritis; Internal medicine; Incidence (geometry); Surgery; Arthritis; Disease","score_opus":0.06203050255109806,"score_gpt":0.38043506840364405,"score_spread":0.318404565852546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126989429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780726,0.017865587,0.0000371962,0.001314872,0.00008210308,0.0023245958,0.0002667182,0.000014721902,0.000021625456],"genre_scores_gemma":[0.9788074,0.020472327,0.00025028514,0.0000597103,0.000011654465,0.00017365318,0.00007052473,0.000031206055,0.00012322454],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981872,0.0001282297,0.0007778802,0.00027780246,0.00034821348,0.00028066474],"domain_scores_gemma":[0.9973853,0.0007485003,0.00041476314,0.0010623183,0.00022850276,0.00016057395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003139724,0.0002483988,0.00093788194,0.00006282814,0.00020148569,0.000035687954,0.0003591253,0.00007358513,0.00013632183],"category_scores_gemma":[0.00038487124,0.0001323618,0.0002081208,0.0001317955,0.00046409134,0.00018366323,0.00012436244,0.00006833994,0.0000025643399],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010181155,0.018567363,0.03374962,0.0006003304,0.0033365788,0.000013763805,0.006394014,0.000068009496,0.023033999,0.0006106803,0.00054793444,0.9028965],"study_design_scores_gemma":[0.02693463,0.0049158596,0.9102821,0.0020465006,0.00074354326,0.000014365932,0.0007645343,0.0028756896,0.050090153,0.00062842434,0.00045767127,0.00024657365],"about_ca_topic_score_codex":0.0005832486,"about_ca_topic_score_gemma":0.00008498464,"teacher_disagreement_score":0.90265,"about_ca_system_score_codex":0.00002043522,"about_ca_system_score_gemma":0.0003339063,"threshold_uncertainty_score":0.5397558},"labels":[],"label_agreement":null},{"id":"W2127487303","doi":"10.1136/annrheumdis-2013-204485","title":"Evidence in support of the validity of the TNF brake hypothesis","year":2013,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Arterial blood; Liter; Blood volume; Nuclear medicine; Artery; Liver function; Inhalation; Blood flow; Internal medicine; Anesthesia","score_opus":0.15248549832010203,"score_gpt":0.3034823403125162,"score_spread":0.15099684199241417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127487303","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4265626,0.0021719944,0.0000060124494,0.56723666,0.0008399326,0.0018934625,0.0005333286,0.00001864247,0.0007373958],"genre_scores_gemma":[0.89244914,0.0017192212,0.000039976672,0.09934128,0.00013830779,0.00006812955,0.000013809486,0.000057611283,0.006172516],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99693316,0.0003248307,0.0009644157,0.00025922115,0.0011947035,0.0003236496],"domain_scores_gemma":[0.99606025,0.00078683515,0.0010649451,0.0017958881,0.00023215433,0.00005990633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045946316,0.00031022241,0.0009915638,0.00008607144,0.000060737806,0.000009762749,0.0013267065,0.0002336084,0.0005532328],"category_scores_gemma":[0.0011087959,0.00013313493,0.001119156,0.0003557465,0.0005292873,0.00007927808,0.00014782762,0.00046388168,0.000008916934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007931103,0.00038039862,0.023269746,0.0088312235,0.00035468492,0.000009919444,0.0003619652,0.000012775488,0.00017003017,0.00006282701,0.9637143,0.0027527988],"study_design_scores_gemma":[0.00076958176,0.00016209517,0.9004886,0.039555557,0.0019500793,0.00001188598,0.00017281002,0.000019496729,0.024378892,0.011037144,0.021015447,0.00043840214],"about_ca_topic_score_codex":0.00019884403,"about_ca_topic_score_gemma":0.00003614019,"teacher_disagreement_score":0.9426989,"about_ca_system_score_codex":0.00001850976,"about_ca_system_score_gemma":0.000449201,"threshold_uncertainty_score":0.6057511},"labels":[],"label_agreement":null},{"id":"W2127532898","doi":"10.1136/ard.2007.084459","title":"Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":892,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Bristol-Myers Squibb","keywords":"Medicine; Rheumatism; Erythrocyte sedimentation rate; Rheumatoid arthritis; Internal medicine; Abatacept; Physical therapy; Placebo; C-reactive protein; Rheumatology; Rituximab; Pathology","score_opus":0.02933482162693064,"score_gpt":0.2866136214184094,"score_spread":0.2572787997914788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127532898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914302,0.0011237938,0.00003681124,0.0038385142,0.00003583653,0.0032239815,0.00023664217,0.00003615677,0.000038023252],"genre_scores_gemma":[0.99808115,0.0011892346,0.0000364,0.00035532628,0.0000068869126,0.00015671346,0.00010936269,0.00005771424,0.0000072128732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995429,0.0021119888,0.0005415829,0.00044927595,0.001118282,0.00034988803],"domain_scores_gemma":[0.9973653,0.00047402977,0.0006983047,0.00083591195,0.00026359726,0.00036287346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000771314,0.0003905127,0.0005732653,0.00020289113,0.00050608633,0.000077747536,0.00022891803,0.0000364051,0.000014001247],"category_scores_gemma":[0.0009152547,0.00019833603,0.00013380797,0.00035031143,0.0010414176,0.00032585688,0.00010366654,0.0002649688,0.0000017010451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1981347,0.011013538,0.66129416,0.0020655752,0.00045885157,0.00008966352,0.0034283178,0.0052935435,0.0028581682,0.00008002635,0.0012254836,0.11405796],"study_design_scores_gemma":[0.007416281,0.0013420923,0.9510199,0.024945324,0.00002067168,0.0000014183531,0.00019183528,0.00804536,0.0067346725,0.00003834614,0.000011459133,0.00023266068],"about_ca_topic_score_codex":0.00003319623,"about_ca_topic_score_gemma":0.000008078596,"teacher_disagreement_score":0.2897257,"about_ca_system_score_codex":0.000048310943,"about_ca_system_score_gemma":0.00036041127,"threshold_uncertainty_score":0.80879086},"labels":[],"label_agreement":null},{"id":"W2127756765","doi":"10.1136/ard.2005.041137","title":"ASAS/EULAR recommendations for the management of ankylosing spondylitis","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":704,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Delphi method; Psychological intervention; Rheumatism; Ankylosing spondylitis; Scientific evidence; Medical prescription; Delphi; Evidence-based medicine; Physical therapy; Alternative medicine; Intensive care medicine; Surgery; Internal medicine; Nursing; Pathology","score_opus":0.0670757592052375,"score_gpt":0.35370889528635513,"score_spread":0.2866331360811176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127756765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8404952,0.0384634,0.00044396735,0.11006471,0.00047868871,0.003400598,0.0023663193,0.000054734173,0.004232331],"genre_scores_gemma":[0.99297845,0.004111683,0.0014410323,0.0004072732,0.000028885093,0.00011126538,0.00004341894,0.000012721055,0.000865246],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99925214,0.000023365481,0.00029288774,0.00010004222,0.0001830239,0.00014852516],"domain_scores_gemma":[0.9991387,0.00018826545,0.00015420224,0.0003778803,0.00009780423,0.000043159427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011309083,0.000093175884,0.0002221362,0.00002871118,0.00015985162,0.000007674637,0.00012438095,0.000013770435,0.00024542454],"category_scores_gemma":[0.00006566479,0.000051720384,0.00025378674,0.00011655898,0.00009131617,0.000047282792,0.00007005241,0.000023390681,0.0000043541822],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004527001,0.0016017379,0.0050336365,0.0013786989,0.0042160484,0.0000038905678,0.0006826967,0.000071124945,0.000010418799,0.011590082,0.059242774,0.9157162],"study_design_scores_gemma":[0.010324966,0.00095652946,0.58789736,0.012339225,0.005829256,0.00003446177,0.0063635143,0.0013685226,0.0036878244,0.012663598,0.35808182,0.00045290083],"about_ca_topic_score_codex":0.000028503415,"about_ca_topic_score_gemma":0.000005297054,"teacher_disagreement_score":0.9152633,"about_ca_system_score_codex":0.00001129931,"about_ca_system_score_gemma":0.000017115059,"threshold_uncertainty_score":0.26872268},"labels":[],"label_agreement":null},{"id":"W2128084341","doi":"10.1136/ard.2010.133488","title":"ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Piroxicam; Meloxicam; Etodolac; Etoricoxib; Ibuprofen; Diclofenac; Naproxen; Aceclofenac; Ketoprofen; Phenylbutazone; Rheumatoid arthritis; Rofecoxib; Nabumetone; Celecoxib; Ankylosing spondylitis; Clinical trial; Naproxen Sodium; Tramadol; Internal medicine; Analgesic; Pharmacology; Nonsteroidal; Cyclooxygenase; Alternative medicine","score_opus":0.5095584965069455,"score_gpt":0.5601400284085635,"score_spread":0.05058153190161796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128084341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369544,0.001188198,0.000013436673,0.0035265516,0.0006320317,0.0008625523,0.000020433097,0.00001518211,0.000046195713],"genre_scores_gemma":[0.99800336,0.0007081987,0.0006895338,0.00030136484,0.00013495947,0.000099191384,0.000011313756,0.000010838077,0.00004122349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952379,0.0010625643,0.003059611,0.00025016992,0.00014980379,0.00023997588],"domain_scores_gemma":[0.9866948,0.010605224,0.0020938062,0.0003057933,0.000161806,0.00013858546],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017100222,0.00014596159,0.0014743446,0.00016488155,0.000107813416,0.000012443525,0.000084379826,0.00010668356,0.0000335492],"category_scores_gemma":[0.25856236,0.00009062923,0.00041085487,0.0002755396,0.0002640393,0.00006954287,0.00007316205,0.00029342205,6.808981e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082813966,0.00047017305,0.84069335,0.0007539013,0.00030798189,0.000026608383,0.0008119387,0.000013223656,0.00014578167,0.00032593583,0.0070084534,0.1486145],"study_design_scores_gemma":[0.0037250607,0.00042771385,0.9791273,0.0034939966,0.00031689706,0.000029761635,0.001376999,0.0023446826,0.00042357354,0.007726583,0.0008015525,0.00020587858],"about_ca_topic_score_codex":0.00005314334,"about_ca_topic_score_gemma":0.0002891259,"teacher_disagreement_score":0.24146214,"about_ca_system_score_codex":0.000013000905,"about_ca_system_score_gemma":0.00013537104,"threshold_uncertainty_score":0.7476831},"labels":[],"label_agreement":null},{"id":"W2128125903","doi":"10.1136/ard.2004.031864","title":"Interleukin (IL) 1α, IL1β, IL receptor antagonist, and IL10 polymorphisms in psoriatic arthritis","year":2005,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of Newfoundland and Labrador; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Interleukin 1 receptor antagonist; Interleukin 10; Cytokine; Proinflammatory cytokine; Receptor antagonist; Immunology; Synovial fluid; Interleukin-21 receptor; Psoriatic arthritis; Arthritis; Interleukin; Synovial membrane; Cytokine receptor; Interleukin-6 receptor; Interleukin 20; Receptor; Internal medicine; Osteoarthritis; Antagonist; Interleukin 5; Inflammation; Pathology","score_opus":0.025340936757105,"score_gpt":0.27758549377053865,"score_spread":0.2522445570134336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128125903","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3942952,0.059194546,9.945338e-7,0.5413483,0.00096547237,0.001404623,0.0020659897,0.00006405451,0.0006608648],"genre_scores_gemma":[0.5848951,0.0859991,0.00029643098,0.31972682,0.0018690679,0.00044605433,0.00089789875,0.00024661524,0.005622911],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997254,0.00015280799,0.0009497377,0.0004869002,0.0005950144,0.0005615305],"domain_scores_gemma":[0.9981957,0.00026881645,0.0005118897,0.00076918106,0.00010537906,0.00014902276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013799162,0.00052189874,0.0013297609,0.00022401108,0.00012752072,0.000049448532,0.00028107298,0.00026789075,0.0004637836],"category_scores_gemma":[0.00040509773,0.00037434045,0.00045310915,0.00023385038,0.00039356505,0.00010204296,0.00022432666,0.0005069939,0.000061144936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021035595,0.0005366654,0.0042774323,0.0008572976,0.0008977211,0.00027628784,0.00047243244,6.184991e-7,0.000007407272,0.000038644244,0.82230973,0.17011541],"study_design_scores_gemma":[0.016232997,0.0020654127,0.11683932,0.05131126,0.0019693172,0.00059363607,0.00082325435,0.000058340782,0.00055904576,0.0035643799,0.80404305,0.0019400096],"about_ca_topic_score_codex":0.0004155008,"about_ca_topic_score_gemma":0.0000941415,"teacher_disagreement_score":0.22162142,"about_ca_system_score_codex":0.000066899585,"about_ca_system_score_gemma":0.0001440144,"threshold_uncertainty_score":0.99987084},"labels":[],"label_agreement":null},{"id":"W2128404753","doi":"10.1136/ard.2006.064030","title":"Reversal of Sjögren's-like syndrome in non-obese diabetic mice","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Health Canada; National Institutes of Health; Canada Research Chairs","keywords":"Nod; NOD mice; Medicine; Salivary gland; Autoimmunity; Immunology; Autoimmune disease; Diabetes mellitus; Tumor necrosis factor alpha; Endocrinology; Internal medicine; Splenocyte; Immune system; Antibody","score_opus":0.01543928300535272,"score_gpt":0.2601011637126214,"score_spread":0.24466188070726866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128404753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946266,0.0020405676,0.000015798068,0.0012941558,0.00013162522,0.0002628154,0.000050998657,0.000012234167,0.0015652518],"genre_scores_gemma":[0.9988446,0.00015425424,0.000040500523,0.0002508432,0.0000115465255,0.000014773963,0.000020418744,0.000011388626,0.00065166684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990687,0.000038781003,0.0003711242,0.000119412216,0.00023085011,0.00017118371],"domain_scores_gemma":[0.9992375,0.00013782374,0.00014351578,0.00035057883,0.00006738595,0.0000632147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009624542,0.00010689899,0.00034568613,0.00010527339,0.000029872492,0.0000046860687,0.00012750796,0.000035796926,0.00014068795],"category_scores_gemma":[0.00017000613,0.000071263166,0.00019860141,0.00030324658,0.00011368858,0.000058321995,0.000042623124,0.000055260287,0.00001221465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030971973,0.0033640272,0.93857753,0.0022024782,0.00024075313,0.000028602914,0.00028747902,0.0003697365,0.00022986293,0.0007400371,0.050810255,0.0028395166],"study_design_scores_gemma":[0.0010233412,0.000121957186,0.99390453,0.0011592442,0.00014358351,0.000012383483,0.00018550303,0.00024346265,0.00015447973,0.0028824676,0.000085531676,0.00008353099],"about_ca_topic_score_codex":0.0007782659,"about_ca_topic_score_gemma":0.000029023284,"teacher_disagreement_score":0.055326983,"about_ca_system_score_codex":0.000006030816,"about_ca_system_score_gemma":0.00006521,"threshold_uncertainty_score":0.29060277},"labels":[],"label_agreement":null},{"id":"W2128457788","doi":"10.1136/ard.2006.057901","title":"Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Dermatology Life Quality Index; Placebo; Quality of life (healthcare); Internal medicine; Physical therapy; Psoriasis; Psoriasis Area and Severity Index; Severity of illness; Arthritis; Disease; Dermatology; Alternative medicine; Pathology","score_opus":0.00902319086723351,"score_gpt":0.22782903285058126,"score_spread":0.21880584198334774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128457788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905699,0.0050857887,7.0103357e-7,0.00031100353,0.00050651835,0.0033430294,0.0001112796,0.000023817358,0.000047995698],"genre_scores_gemma":[0.99918896,0.00036355108,0.000012436492,0.000047184072,0.000010615866,0.00026121875,0.000057302354,0.000035169513,0.00002353835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965526,0.00035399516,0.0014839555,0.00038729492,0.0008247054,0.0003974801],"domain_scores_gemma":[0.9979169,0.0003340196,0.00089951843,0.0005430916,0.00021504726,0.000091432885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027498565,0.00037890786,0.0011616702,0.00019652057,0.00013169435,0.000019270088,0.00011528317,0.000100446145,0.000044889133],"category_scores_gemma":[0.0004937771,0.00021988113,0.00034787002,0.0005796822,0.00030185806,0.00014852206,0.00013267736,0.00016344784,0.000001710581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01519893,0.008294894,0.9024512,0.0004934676,0.001906422,0.00002728818,0.0005111373,0.00027667684,0.000008514099,0.00022600923,0.0001378391,0.0704676],"study_design_scores_gemma":[0.101541564,0.001718779,0.88947386,0.004191238,0.00030727877,0.000008922099,0.00019287053,0.000053209817,0.000124921,0.0021988484,0.000002375333,0.00018614992],"about_ca_topic_score_codex":0.0011513681,"about_ca_topic_score_gemma":0.000336262,"teacher_disagreement_score":0.08634263,"about_ca_system_score_codex":0.000082176986,"about_ca_system_score_gemma":0.00017487332,"threshold_uncertainty_score":0.89664924},"labels":[],"label_agreement":null},{"id":"W2128468094","doi":"10.1136/annrheumdis-2013-203726","title":"Value of biomarkers in osteoarthritis: current status and perspectives","year":2013,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":325,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Osteoarthritis; Medicine; Cartilage; N-terminal telopeptide; Biomarker; Disease; Bone remodeling; Aggrecan; Bioinformatics; Biomarker discovery; Cartilage oligomeric matrix protein; Internal medicine; Pathology; Proteomics; Articular cartilage; Biology; Osteocalcin","score_opus":0.07430538353076419,"score_gpt":0.3567792068096352,"score_spread":0.28247382327887105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128468094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0101827355,0.98729944,3.3071046e-7,0.00006365923,0.000151103,0.0018452645,0.00027245056,0.00001280319,0.00017218312],"genre_scores_gemma":[0.0058285985,0.9938037,0.00004936512,0.0000073950573,0.00001569302,0.00016101637,0.000048716563,0.000032210562,0.000053315387],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99825263,0.00020155364,0.00069480814,0.00026998177,0.00030368145,0.0002773183],"domain_scores_gemma":[0.9985476,0.0002109164,0.0005090478,0.00046094527,0.00009932042,0.000172142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011537993,0.00032147308,0.0016847638,0.00023524181,0.00002841209,0.000013722688,0.00013945995,0.00008696268,0.00007335566],"category_scores_gemma":[0.000329888,0.00019811907,0.0005725435,0.0002490944,0.00023852887,0.00007869748,0.0001171334,0.000115819246,0.000008359358],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023880375,0.000385733,0.0001413669,0.021809595,0.00028684444,0.0000027119593,0.0002449613,4.4743647e-8,3.86606e-7,0.0007066545,0.00015089553,0.97624695],"study_design_scores_gemma":[0.007430423,0.003924346,0.0048586675,0.81985736,0.008351012,0.00008849107,0.0036256546,0.000008829141,0.00009541293,0.005806262,0.14480989,0.001143634],"about_ca_topic_score_codex":0.000050727267,"about_ca_topic_score_gemma":0.0000051371076,"teacher_disagreement_score":0.9751033,"about_ca_system_score_codex":0.000027264854,"about_ca_system_score_gemma":0.00031118368,"threshold_uncertainty_score":0.8079061},"labels":[],"label_agreement":null},{"id":"W2128600935","doi":"10.1136/annrheumdis-2012-201956","title":"Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Biogen; Sanofi; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Adverse effect; Clinical trial; Term (time); Physical therapy; Intensive care medicine; Internal medicine; Lymphoma","score_opus":0.08179128181499007,"score_gpt":0.3540507520473209,"score_spread":0.2722594702323308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128600935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946187,0.0025409386,0.0000025473857,0.00027466533,0.00028511806,0.0019522675,0.00020840163,0.000008287245,0.00010906527],"genre_scores_gemma":[0.993575,0.006251541,0.00003096578,0.000026314752,0.000014584308,0.00005829941,0.000014933636,0.000019777603,0.000008621663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964231,0.0006064954,0.0015654854,0.00021071674,0.00071501196,0.00047918604],"domain_scores_gemma":[0.99764675,0.00036832437,0.00081493234,0.0007172011,0.00023442351,0.00021837204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008978372,0.00022590345,0.0010697944,0.00012007469,0.000033963395,0.000004268474,0.0004544137,0.00008652795,0.00006076628],"category_scores_gemma":[0.0022850377,0.00012958267,0.0005301254,0.0004572506,0.0005861708,0.00017153948,0.00020019861,0.00020166382,0.0000043696596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047039587,0.010439602,0.88325095,0.0003420092,0.0002889676,0.0000016582164,0.00037106907,0.0000021275778,0.0000014340193,0.0006127648,0.0000677292,0.05758211],"study_design_scores_gemma":[0.09244779,0.0020214801,0.8897616,0.0142714605,0.000016721573,0.0000032317143,0.0003058248,0.0000070164447,0.00024026095,0.0008072615,0.000008698737,0.00010861489],"about_ca_topic_score_codex":0.00030566906,"about_ca_topic_score_gemma":0.00060624536,"teacher_disagreement_score":0.057473496,"about_ca_system_score_codex":0.00003665746,"about_ca_system_score_gemma":0.00028026354,"threshold_uncertainty_score":0.5284228},"labels":[],"label_agreement":null},{"id":"W2128943349","doi":"10.1136/ard.2010.128652","title":"Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists","year":2010,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Expert opinion; Methotrexate; Family medicine; Alternative medicine; MEDLINE; Intensive care medicine; Internal medicine; Pathology","score_opus":0.148466630382795,"score_gpt":0.4130734557697972,"score_spread":0.2646068253870022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128943349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9351606,0.0020700346,0.000023137085,0.055878118,0.00017990309,0.005228954,0.0013962537,0.0000098491155,0.00005319062],"genre_scores_gemma":[0.99127257,0.0070831506,0.00022503929,0.00061121106,0.000011851958,0.00047181945,0.00025077464,0.000037934635,0.000035646095],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99485266,0.0016468783,0.0016734208,0.00032904005,0.0012163456,0.00028164787],"domain_scores_gemma":[0.99008816,0.0054164985,0.0022584125,0.0009717895,0.0012043089,0.000060809274],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0022943646,0.00030499185,0.0011811014,0.00041935715,0.000102819664,0.000026524385,0.00041763115,0.0002587216,0.000032041797],"category_scores_gemma":[0.01856634,0.00018859036,0.00038480407,0.0004899804,0.000888357,0.00027131065,0.00018685676,0.00057247,2.6641985e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036024426,0.009906878,0.27888566,0.024315,0.0056293975,0.0000035107603,0.04168437,0.00016237171,0.0001996443,0.00039503182,0.31710613,0.31810954],"study_design_scores_gemma":[0.0110377,0.0014572612,0.9037107,0.05486963,0.0008488915,0.000007826705,0.005473051,0.0051296563,0.0019856966,0.01409465,0.0008399828,0.00054491905],"about_ca_topic_score_codex":0.0007834726,"about_ca_topic_score_gemma":0.00073544105,"teacher_disagreement_score":0.62482506,"about_ca_system_score_codex":0.00002272943,"about_ca_system_score_gemma":0.00036193262,"threshold_uncertainty_score":0.9897007},"labels":[],"label_agreement":null},{"id":"W2129257749","doi":"10.1136/annrheumdis-2013-204741","title":"Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Janssen Biotech; Alexion Pharmaceuticals","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Placebo; Internal medicine; Psoriasis; Methotrexate; Gastroenterology; Rheumatoid arthritis; Surgery; Adalimumab; Dermatology; Pathology","score_opus":0.05476146153236468,"score_gpt":0.35887149384083383,"score_spread":0.30411003230846917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129257749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849441,0.0042545823,0.000016925584,0.00019336744,0.00009621539,0.005278141,0.00518014,0.00002373228,0.000012767351],"genre_scores_gemma":[0.9917555,0.0033606614,0.00025120267,0.00003989014,0.000029859842,0.00015687285,0.0043682335,0.000035136934,0.0000026348125],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99407315,0.0017220159,0.0020927482,0.00073293585,0.00097018946,0.00040898513],"domain_scores_gemma":[0.9928648,0.0021068158,0.0022877492,0.001992748,0.00047603628,0.0002718719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018541141,0.0005097897,0.0033102257,0.00077496073,0.00018353715,0.000052435847,0.00066163373,0.00012333176,0.000020831758],"category_scores_gemma":[0.0029125328,0.00026246524,0.0006356676,0.0017256389,0.0006060665,0.00045820742,0.00020778403,0.00018815137,4.3011042e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6621682,0.008864092,0.22924638,0.00016940881,0.016209243,0.000008373072,0.0010604068,0.00015485127,0.00003613268,0.000010923932,0.00010440961,0.08196757],"study_design_scores_gemma":[0.57114947,0.0018259523,0.40556026,0.003607069,0.009588721,0.000001040886,0.000835863,0.0067160027,0.0004084978,0.00006080072,0.0000063596544,0.00023998093],"about_ca_topic_score_codex":0.0012200772,"about_ca_topic_score_gemma":0.0013318555,"teacher_disagreement_score":0.17631388,"about_ca_system_score_codex":0.0000137536335,"about_ca_system_score_gemma":0.00011891037,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2129501695","doi":"10.1136/ard.2005.042630","title":"An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Ankylosing spondylitis; Medicine; Internal medicine; Spondylitis; Tumor necrosis factor alpha; Disease; Physical therapy; Surgery","score_opus":0.07263892903304153,"score_gpt":0.365805083909544,"score_spread":0.2931661548765025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129501695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977596,0.00026311702,0.0000012075841,0.00054700626,0.00016152734,0.00047026805,0.00025630742,0.000025609394,0.0005153838],"genre_scores_gemma":[0.9995595,0.000038785678,0.000023785244,0.0001919648,0.000039258826,0.000026627415,0.000041849376,0.000017946604,0.00006023198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985888,0.00008584454,0.00042130682,0.00021878589,0.00045021236,0.0002350709],"domain_scores_gemma":[0.9992662,0.00009019047,0.00018665037,0.00030666214,0.00008142311,0.00006887441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010535435,0.00015829138,0.00031398356,0.00011887778,0.000113877904,0.000038591494,0.0001628556,0.000020122492,0.00014813713],"category_scores_gemma":[0.00019309168,0.000113815695,0.00013973955,0.00016755893,0.000045186098,0.00013603352,0.0000678998,0.0000644312,0.000005595591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022120084,0.0032931322,0.98727703,0.000039348324,0.00016211858,0.000064780776,0.0006253033,0.00009655862,0.000064442014,0.000062714644,0.00020390416,0.00788947],"study_design_scores_gemma":[0.0018164146,0.0003866528,0.9943686,0.0010052014,0.00006037942,0.0000031827626,0.0009759205,0.00016966948,0.0005482642,0.0005432238,0.000030884814,0.00009159524],"about_ca_topic_score_codex":0.0010447504,"about_ca_topic_score_gemma":0.000099217265,"teacher_disagreement_score":0.007797875,"about_ca_system_score_codex":0.0000428449,"about_ca_system_score_gemma":0.000027246899,"threshold_uncertainty_score":0.46412694},"labels":[],"label_agreement":null},{"id":"W2129543954","doi":"10.1136/ard.2004.023028","title":"Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":630,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health","funders":"","keywords":"Medicine; Osteoarthritis; Physical therapy; Alternative medicine; Pathology","score_opus":0.03891915525899298,"score_gpt":0.3232168637813823,"score_spread":0.28429770852238934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129543954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310714,0.003798766,0.0000012697176,0.0011457157,0.000106739455,0.001685825,0.00005958577,0.000012113092,0.000082864484],"genre_scores_gemma":[0.99870116,0.00081352127,0.00007206732,0.00021301833,0.0000026383304,0.0001440058,0.000020779064,0.000014792855,0.000018041834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997283,0.00026886995,0.001195905,0.0002077246,0.0008184627,0.00022604692],"domain_scores_gemma":[0.99828255,0.00028837885,0.00058139605,0.0004679927,0.0002959792,0.00008372442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009016674,0.00016241154,0.00049191725,0.00010085717,0.00003997229,0.00001419225,0.00008534986,0.00003915925,0.00003037042],"category_scores_gemma":[0.0017274137,0.00009254621,0.00014273592,0.00019486029,0.0001285557,0.000111227964,0.000085039224,0.000085173066,0.0000017959104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059102266,0.002031069,0.18594867,0.00020814527,0.00020974505,0.000031023905,0.0049306783,0.001216497,0.000122309,0.00011505907,0.000041472813,0.8045543],"study_design_scores_gemma":[0.020302698,0.008636457,0.8802057,0.008010168,0.00093470345,0.000038492155,0.0058091213,0.00043190637,0.007413552,0.067844726,0.000027457021,0.00034503435],"about_ca_topic_score_codex":0.0002493075,"about_ca_topic_score_gemma":0.00019145588,"teacher_disagreement_score":0.8042093,"about_ca_system_score_codex":0.00004299322,"about_ca_system_score_gemma":0.00027073966,"threshold_uncertainty_score":0.37739247},"labels":[],"label_agreement":null},{"id":"W2129579697","doi":"10.1136/ard.2008.106005","title":"Rapidity of rheumatology consultation for people in an early inflammatory arthritis cohort","year":2009,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Cohort; Internal medicine; Referral; Rheumatoid factor; Physical therapy; Arthritis; Inflammatory arthritis; Family medicine","score_opus":0.02865761116993789,"score_gpt":0.3093087356490057,"score_spread":0.2806511244790678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129579697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9215829,0.009277452,0.000017560535,0.06602937,0.00020599598,0.0022411703,0.0005443148,0.000036990987,0.00006425313],"genre_scores_gemma":[0.9444979,0.038169682,0.00012971238,0.015758423,0.00009462268,0.00040300493,0.0007238815,0.000077959085,0.00014483214],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9967777,0.00042084872,0.0012008871,0.0003657575,0.00071201083,0.00052280014],"domain_scores_gemma":[0.99662167,0.0010064938,0.00075494224,0.0008254672,0.00064264814,0.00014877108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046799233,0.00033351488,0.0015518323,0.00035792144,0.000088800545,0.000030679355,0.0004283827,0.00034484902,0.00010532999],"category_scores_gemma":[0.002108189,0.00026213253,0.00047735445,0.00025624403,0.00048524566,0.0002124944,0.000056579534,0.000468873,0.000006798534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012974383,0.0010908408,0.37047118,0.006378893,0.0009759577,0.00004101869,0.0017684076,0.000018821725,0.0000710189,0.0005635977,0.5538353,0.063487574],"study_design_scores_gemma":[0.0070987144,0.001840666,0.9484523,0.016611153,0.000101478574,0.00008299703,0.00031922825,0.00027785968,0.00084826536,0.013197325,0.010522779,0.00064721465],"about_ca_topic_score_codex":0.00039550065,"about_ca_topic_score_gemma":0.00020275654,"teacher_disagreement_score":0.5779812,"about_ca_system_score_codex":0.000021375936,"about_ca_system_score_gemma":0.0005119436,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W2129597937","doi":"10.1136/ard.2011.150938","title":"Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Waterloo; University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Disease; Internal medicine; Arthritis; Severity of illness; Surgery; Dermatology","score_opus":0.03833698704004574,"score_gpt":0.2738852774635448,"score_spread":0.23554829042349906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129597937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929041,0.003796784,8.746838e-7,0.0012868311,0.000083896484,0.0011062684,0.00013154394,0.000017369353,0.00067232567],"genre_scores_gemma":[0.99874324,0.0005350353,0.000028301461,0.0003511123,0.00003333658,0.00016804504,0.00002124931,0.000025139838,0.00009456991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982864,0.00014870078,0.00036615125,0.00024305163,0.0006012415,0.0003543991],"domain_scores_gemma":[0.9987509,0.00011279421,0.0001962076,0.00068441214,0.0001258154,0.00012985163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001018061,0.00022059245,0.0003799715,0.00006174601,0.00014190738,0.000037524707,0.00026529247,0.000027119568,0.00013177368],"category_scores_gemma":[0.00015892375,0.00010652144,0.0002102493,0.00019208541,0.00015626781,0.00015263713,0.0001365825,0.00009054511,0.00001406916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033808508,0.0011848198,0.9761457,0.00017996882,0.00031546163,0.000039621584,0.003066532,0.000001296934,7.197223e-8,0.000069642,0.0012109058,0.01744792],"study_design_scores_gemma":[0.0021966733,0.0002310539,0.99255484,0.0025579797,0.00022232631,0.0000018633267,0.0003720878,0.000010776322,0.000018169007,0.0016313416,0.00008311853,0.00011978287],"about_ca_topic_score_codex":0.0002419093,"about_ca_topic_score_gemma":0.000037912007,"teacher_disagreement_score":0.017328138,"about_ca_system_score_codex":0.000008764071,"about_ca_system_score_gemma":0.000032484175,"threshold_uncertainty_score":0.4343818},"labels":[],"label_agreement":null},{"id":"W2129673229","doi":"10.1136/annrheumdis-2012-202076","title":"Identification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Locus (genetics); Single-nucleotide polymorphism; Allele; Genetics; Haplotype; Cohort; Logistic regression; Medicine; Rheumatoid arthritis; Genotype; Human leukocyte antigen; Gene; Biology; Internal medicine; Antigen","score_opus":0.024719474577349694,"score_gpt":0.3080561763426611,"score_spread":0.2833367017653114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129673229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720566,0.023265837,0.00019089135,0.0016899089,0.00027453311,0.0021355955,0.00019484202,0.00003711149,0.00015463118],"genre_scores_gemma":[0.9860751,0.013003076,0.00007562047,0.00009180317,0.00004668169,0.0003318075,0.000010184813,0.000039864175,0.00032584375],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973821,0.00028051267,0.00083300564,0.00020798802,0.00078806764,0.00050831883],"domain_scores_gemma":[0.99712,0.00042843004,0.00089012616,0.0009220215,0.00041372245,0.00022568628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083007565,0.00021755592,0.0005068628,0.000095020056,0.00029030797,0.00004362741,0.00044391077,0.000064829124,0.00009506088],"category_scores_gemma":[0.0045461897,0.00013066127,0.0005171734,0.00032715558,0.00042565388,0.000323087,0.00015473005,0.00016372457,0.000022726135],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019834577,0.0040400703,0.075117625,0.0033135742,0.0022984527,0.0000016587971,0.0070028035,0.0000739625,0.03861767,0.010744604,0.016928667,0.8398774],"study_design_scores_gemma":[0.009165955,0.001059166,0.14020438,0.025606789,0.00012523212,0.00012845511,0.0061044153,0.00086994935,0.75760615,0.046670653,0.011468025,0.0009908251],"about_ca_topic_score_codex":0.00023220418,"about_ca_topic_score_gemma":0.000012464531,"teacher_disagreement_score":0.8388866,"about_ca_system_score_codex":0.000019599262,"about_ca_system_score_gemma":0.00022213896,"threshold_uncertainty_score":0.5442542},"labels":[],"label_agreement":null},{"id":"W2130082562","doi":"10.1136/annrheumdis-2013-204963","title":"Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Adverse effect; Placebo; Internal medicine; Clinical endpoint; Ankylosing spondylitis; Neutropenia; Randomized controlled trial; Toxicity","score_opus":0.06819954645693337,"score_gpt":0.36564150645009136,"score_spread":0.297441959993158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130082562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820173,0.006634942,0.000027064922,0.0009856104,0.00018134828,0.008858321,0.00094020605,0.000016983064,0.0003382163],"genre_scores_gemma":[0.99723387,0.0011360648,0.000045506717,0.00004929785,0.000048948987,0.0010006027,0.00005422331,0.000023218823,0.000408287],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99776083,0.00018131551,0.0010842308,0.00025483436,0.00044118727,0.00027762074],"domain_scores_gemma":[0.9962,0.0017495613,0.0007999411,0.0008326026,0.0003148836,0.00010299381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005537164,0.00027656322,0.0014322465,0.00009162677,0.00026496575,0.000012742115,0.00019703162,0.00003839057,0.000042795033],"category_scores_gemma":[0.000870206,0.000134641,0.0008955579,0.00017952289,0.00021189869,0.000054157852,0.00005425057,0.000031066418,0.0000010115494],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91645956,0.0218568,0.0008038869,0.0002954403,0.0066362973,0.000003900606,0.0034053482,0.00004595512,0.000041183528,0.00020041954,0.0009342642,0.04931697],"study_design_scores_gemma":[0.9712882,0.015188689,0.0020800633,0.000987895,0.0046996735,0.0000049205983,0.0019748716,0.0005836475,0.001968669,0.00036505333,0.0007235521,0.00013477885],"about_ca_topic_score_codex":0.00035738843,"about_ca_topic_score_gemma":0.000047778136,"teacher_disagreement_score":0.05482865,"about_ca_system_score_codex":0.000023307857,"about_ca_system_score_gemma":0.000090365116,"threshold_uncertainty_score":0.5490501},"labels":[],"label_agreement":null},{"id":"W2130454548","doi":"10.1136/ard.2004.030809","title":"Psoriatic arthritis imaging: a review of scoring methods","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Arthritis; Medical physics; Dermatology; Physical therapy; Psoriasis; Internal medicine","score_opus":0.10868028735057374,"score_gpt":0.4710884927160239,"score_spread":0.36240820536545015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130454548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005632709,0.99639064,0.00003266148,0.00083165505,0.00024397926,0.0017186532,0.0001532589,0.000035446694,0.0005880646],"genre_scores_gemma":[0.00001962559,0.9979442,0.0011975201,0.00029672892,0.00009584615,0.0001911047,0.000043900964,0.00007311385,0.0001379863],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99556774,0.0009741717,0.0018346084,0.00034035684,0.0008320309,0.00045107512],"domain_scores_gemma":[0.9958603,0.0008565326,0.001271083,0.0013625718,0.00035629582,0.00029325765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001241158,0.00045856464,0.003901241,0.0002460519,0.000078725396,0.000024856563,0.00064901024,0.00007322798,0.0006090409],"category_scores_gemma":[0.0045020464,0.0002807838,0.0022077558,0.000589372,0.00036976836,0.00013077086,0.00024607734,0.00029544096,0.000035048994],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008216672,0.00018054507,0.0000055905684,0.21893309,0.0005688465,0.0000038614053,0.000023697901,5.694622e-8,8.1876e-8,0.0001892983,0.006120527,0.7739662],"study_design_scores_gemma":[0.00021982414,0.000041668176,0.000024175955,0.5046824,0.0002833094,0.00006935162,0.000010484897,0.000004731041,0.000005114994,0.00030342318,0.49422014,0.00013533291],"about_ca_topic_score_codex":0.000028110686,"about_ca_topic_score_gemma":0.0000011214719,"teacher_disagreement_score":0.77383083,"about_ca_system_score_codex":0.000026381893,"about_ca_system_score_gemma":0.00083823974,"threshold_uncertainty_score":0.9999644},"labels":[],"label_agreement":null},{"id":"W2130527001","doi":"10.1136/annrheumdis-2012-202562","title":"The genetic contribution to severe post-traumatic osteoarthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Osteoarthritis; Internal medicine; Arthroplasty; Knee replacement; Joint replacement; Surgery; Pathology","score_opus":0.015469251686735333,"score_gpt":0.265320504287554,"score_spread":0.24985125260081867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130527001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845361,0.0037796004,0.000013074337,0.009082295,0.00022327881,0.0019160014,0.00007486162,0.0000420723,0.00033271403],"genre_scores_gemma":[0.99707764,0.0002518086,0.00011314565,0.0013107676,0.000032607797,0.0002607598,0.00002198279,0.000019417106,0.00091189647],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986463,0.00009373983,0.00038838078,0.00015798587,0.00038015682,0.00033339296],"domain_scores_gemma":[0.99843585,0.00021313092,0.0001460654,0.0005825813,0.0003819733,0.00024037105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009670375,0.0001682709,0.00030654215,0.000042118667,0.00023465192,0.000061161336,0.00021282633,0.000041486954,0.00025982322],"category_scores_gemma":[0.000669518,0.00009108093,0.00025003575,0.00016352693,0.000097651806,0.00009567497,0.00008136096,0.000057527675,0.00036900866],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024585592,0.00048778232,0.004048128,0.00025506524,0.00022961671,0.000009183721,0.00058292033,0.000013855172,0.0017162735,0.0024234012,0.009750992,0.98023695],"study_design_scores_gemma":[0.008124414,0.007994285,0.9279703,0.0063755205,0.00093822216,0.00026924734,0.0028118456,0.00017107023,0.015525639,0.02532678,0.0037781766,0.00071453553],"about_ca_topic_score_codex":0.00007645888,"about_ca_topic_score_gemma":0.00003675325,"teacher_disagreement_score":0.9795224,"about_ca_system_score_codex":0.0000161327,"about_ca_system_score_gemma":0.000079726145,"threshold_uncertainty_score":0.47429827},"labels":[],"label_agreement":null},{"id":"W2130940048","doi":"10.1136/annrheumdis-2013-203325","title":"Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative","year":2013,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network; University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Innovative Research Group Project of the National Natural Science Foundation of China","keywords":"Medicine; Expert opinion; Gout; Systematic review; Multinational corporation; Alternative medicine; MEDLINE; Family medicine; Medical physics; Internal medicine; Intensive care medicine; Pathology","score_opus":0.30879320657790893,"score_gpt":0.4426046443972215,"score_spread":0.1338114378193126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130940048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008619307,0.9867699,0.000061994906,0.004847572,0.000055521075,0.007818895,0.00034119788,0.0000051524416,0.000013555399],"genre_scores_gemma":[0.0050970525,0.9899483,0.000745984,0.00038010947,0.000006688172,0.0037109302,0.00008339487,0.000019264362,0.000008312239],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99648386,0.0009131286,0.0017701908,0.00024084731,0.0004401772,0.00015179437],"domain_scores_gemma":[0.98724467,0.0090959,0.0024785134,0.00069497235,0.00044055702,0.000045363962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013530434,0.00032273703,0.002164609,0.00015927618,0.00006736946,0.000021801723,0.00048742845,0.00009405351,0.000014982034],"category_scores_gemma":[0.0060558533,0.00013913,0.00048532442,0.0005406934,0.00034618526,0.00013726339,0.00015262963,0.00016642125,3.4926043e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012651854,0.00028619956,0.00015855172,0.8677934,0.00084022275,4.5800397e-7,0.0010749281,7.8479377e-7,5.1024475e-8,0.0006594594,0.0023991463,0.12677416],"study_design_scores_gemma":[0.00035348602,0.00011302134,0.00085009955,0.99259955,0.0027817104,0.000018741744,0.001551703,0.00017321587,0.0000027434385,0.000111627116,0.0013233599,0.00012071745],"about_ca_topic_score_codex":0.0000653846,"about_ca_topic_score_gemma":0.0000019984172,"teacher_disagreement_score":0.12665343,"about_ca_system_score_codex":0.000023646833,"about_ca_system_score_gemma":0.00014036424,"threshold_uncertainty_score":0.72498596},"labels":[],"label_agreement":null},{"id":"W2131374835","doi":"10.1136/ard.2007.074765","title":"Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Gene signature; Medicine; Immunology; Gene expression profiling; Gene expression; Gene; Microarray; Disease; Biomarker; Microarray analysis techniques; Systemic lupus erythematosus; Internal medicine; Biology; Genetics","score_opus":0.025317501825112398,"score_gpt":0.2991564021696568,"score_spread":0.2738389003445444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131374835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951453,0.0023934206,0.000080366626,0.00048317088,0.000117843796,0.0013240257,0.00028279916,0.000032760257,0.00014026983],"genre_scores_gemma":[0.9988179,0.00011881875,0.00014554127,0.000026914257,0.000033670964,0.00007673775,0.000031021766,0.00003303881,0.00071636366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707973,0.00028479082,0.0006677593,0.0002896299,0.0012846482,0.00039344525],"domain_scores_gemma":[0.9970182,0.00076753856,0.0007786598,0.0008383218,0.0003221353,0.00027515081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083426957,0.0002049451,0.00072264107,0.0001910006,0.000049840466,0.000014090416,0.0002807509,0.000087361506,0.00005096549],"category_scores_gemma":[0.0013915993,0.00012591829,0.00021124688,0.00044539926,0.000093808594,0.0001440385,0.00010230447,0.00014190895,0.000010623682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021313482,0.0012582103,0.967741,0.004358907,0.0003511788,0.000046779547,0.00082677824,0.000026830876,0.021536795,0.000009161245,0.0011445624,0.0005684368],"study_design_scores_gemma":[0.0077141766,0.00034840795,0.7355713,0.04091043,0.00082817755,0.00046657003,0.0022159128,0.0005484071,0.21058442,0.00043614168,0.000012710537,0.00036330702],"about_ca_topic_score_codex":0.00024277686,"about_ca_topic_score_gemma":0.00003481077,"teacher_disagreement_score":0.23216966,"about_ca_system_score_codex":0.00009348046,"about_ca_system_score_gemma":0.00033242017,"threshold_uncertainty_score":0.5134799},"labels":[],"label_agreement":null},{"id":"W2131513122","doi":"10.1136/annrheumdis-2015-207718","title":"Assessment and determinants of aesthetic discomfort in hand osteoarthritis","year":2015,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Depression (economics); Anxiety; Quality of life (healthcare); Visual analogue scale; Physical therapy; Radiography; Hospital Anxiety and Depression Scale; Multivariate analysis; Internal medicine; Surgery; Psychiatry; Alternative medicine; Pathology","score_opus":0.05859841736439587,"score_gpt":0.3640499479467602,"score_spread":0.30545153058236435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131513122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9275064,0.008649361,8.1221947e-7,0.06245539,0.00009805632,0.00082971854,0.00020257251,0.0000071742625,0.00025055368],"genre_scores_gemma":[0.9957851,0.0011322997,0.00003934095,0.0020532608,0.000022347855,0.00005735753,0.000074339805,0.000043469336,0.00079245004],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9977395,0.00017207793,0.00061961974,0.00024238786,0.0008763367,0.00035007307],"domain_scores_gemma":[0.99864894,0.00013089136,0.00031085985,0.0006866113,0.0001025039,0.00012016893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027859758,0.00023336767,0.00092910684,0.00018220267,0.000036807236,0.00002268893,0.0002752536,0.00018534507,0.000084117164],"category_scores_gemma":[0.00012502697,0.00015201018,0.000217022,0.00016641422,0.00062923407,0.00006106816,0.00019406564,0.0004254796,0.0000025726877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017311597,0.00077710766,0.15614155,0.06346343,0.00029353568,0.0005811374,0.0005970281,0.000005540844,0.000024453891,0.000034233064,0.7034392,0.07446966],"study_design_scores_gemma":[0.009042896,0.0046038837,0.8164997,0.14937714,0.00095276703,0.0010698098,0.00055607007,0.00070946635,0.0007027302,0.007899102,0.007513507,0.0010729403],"about_ca_topic_score_codex":0.00015778556,"about_ca_topic_score_gemma":0.0000068644995,"teacher_disagreement_score":0.6959257,"about_ca_system_score_codex":0.00003843968,"about_ca_system_score_gemma":0.000840567,"threshold_uncertainty_score":0.6198795},"labels":[],"label_agreement":null},{"id":"W2131811713","doi":"10.1136/annrheumdis-2012-201710","title":"Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Strontium ranelate; Osteoarthritis; Medicine; Cartilage; Synovial fluid; Cathepsin K; Internal medicine; Pathology; Anterior cruciate ligament; Pathophysiology; Endocrinology; Surgery; Anatomy; Osteoporosis; Osteoclast","score_opus":0.021602584016656372,"score_gpt":0.30328351380748225,"score_spread":0.2816809297908259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131811713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695649,0.027867602,5.8537506e-7,0.00068236113,0.000053625565,0.001583313,0.00010980315,0.0000052319547,0.00013258397],"genre_scores_gemma":[0.99939495,0.00030503748,0.000030215975,0.000031798718,0.000016381391,0.00017283263,0.000011733988,0.000012988001,0.000024080842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826735,0.0003613106,0.00056743115,0.00012620157,0.0004419779,0.00023570635],"domain_scores_gemma":[0.99881184,0.0002725661,0.00047329883,0.0003360955,0.000052363503,0.00005381725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053245225,0.00015982508,0.00039384412,0.0000527506,0.000073954834,0.000009656608,0.00020057728,0.000044763157,0.000016880376],"category_scores_gemma":[0.00022848937,0.000068174304,0.00013966327,0.00015736281,0.0003553321,0.00016086806,0.00011998634,0.000088620865,3.0538527e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012051887,0.0033600482,0.033183206,0.0011432028,0.00005652121,0.0000054258226,0.023406567,0.0000067945452,0.8972353,0.0003208989,0.0007071121,0.039369762],"study_design_scores_gemma":[0.0017477749,0.0007824037,0.008702627,0.006488434,0.00007081157,0.000009371137,0.012376366,0.0000072163175,0.9696311,0.00010349276,0.000013191045,0.00006721632],"about_ca_topic_score_codex":0.00007627769,"about_ca_topic_score_gemma":0.0000074804557,"teacher_disagreement_score":0.072395824,"about_ca_system_score_codex":0.000005578752,"about_ca_system_score_gemma":0.00004111985,"threshold_uncertainty_score":0.27800673},"labels":[],"label_agreement":null},{"id":"W2131967871","doi":"10.1136/ard.2005.043158","title":"Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"British Society for Rheumatology; Arthritis Society; University of Manchester; Amgen; Abbott Laboratories","keywords":"Medicine; Rheumatoid arthritis; Comorbidity; Internal medicine; Baseline (sea); Register (sociolinguistics); Rheumatology; Physical therapy; Oncology","score_opus":0.03866277051704369,"score_gpt":0.2905704558140146,"score_spread":0.2519076852969709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131967871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843768,0.0074504646,0.000008681523,0.0030132807,0.000034370416,0.0006617133,0.0041438676,0.000031530366,0.00027927535],"genre_scores_gemma":[0.98510164,0.01397432,0.000226467,0.00035954447,0.00001696022,0.00003745177,0.00024217962,0.000017830793,0.0000236123],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976669,0.00026306653,0.00067519635,0.000312563,0.00077820075,0.00030405802],"domain_scores_gemma":[0.99826455,0.000443027,0.00028009096,0.00037188322,0.0004422722,0.00019819177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035231464,0.00021610559,0.00051998405,0.00013053151,0.00009586499,0.000037928396,0.00014109314,0.000053930056,0.00015046386],"category_scores_gemma":[0.0016335245,0.00012985124,0.00010461402,0.00020819063,0.00034635552,0.0001908555,0.00009125224,0.00012959758,0.00000846282],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0118979905,0.0027839309,0.42906025,0.00013567686,0.0006498853,0.00002094941,0.0013508112,0.00015903008,0.000044997043,0.0003601119,0.016991226,0.53654516],"study_design_scores_gemma":[0.01249305,0.0009786494,0.97387767,0.00549037,0.000009820446,0.000009016517,0.00019882216,0.00047562429,0.00080636475,0.0022234826,0.0031704018,0.0002667348],"about_ca_topic_score_codex":0.00023355872,"about_ca_topic_score_gemma":0.0002449091,"teacher_disagreement_score":0.54481745,"about_ca_system_score_codex":0.00003392589,"about_ca_system_score_gemma":0.00015556315,"threshold_uncertainty_score":0.529518},"labels":[],"label_agreement":null},{"id":"W2132078597","doi":"10.1136/annrheumdis-2011-200265","title":"The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre","funders":"","keywords":"Medicine; Internal medicine; Endothelin receptor antagonist; Pulmonary hypertension; Cohort; Cohort study; Cardiology; Gastroenterology; Endothelin receptor; Receptor","score_opus":0.20320475532090027,"score_gpt":0.36841455985586347,"score_spread":0.1652098045349632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132078597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636495,0.00083585916,0.0000043120617,0.00032586782,0.00008442232,0.0020066728,0.00025159778,0.000017981161,0.00010835841],"genre_scores_gemma":[0.99931353,0.00020984218,0.000020684836,0.00013172302,0.0000089918285,0.00015160737,0.00010594122,0.000028760216,0.000028932207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951595,0.0010943182,0.00078972674,0.00033660437,0.002069186,0.0005506676],"domain_scores_gemma":[0.9955986,0.00039156672,0.0005272641,0.00087526726,0.0022630421,0.00034422104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083311595,0.00025345944,0.000772983,0.00012944585,0.00041132834,0.000021521888,0.00039615444,0.00006291892,0.00003143412],"category_scores_gemma":[0.0011824064,0.000115896786,0.00013976553,0.00052922074,0.00042492952,0.00013127852,0.00023860557,0.00019655746,0.000017716508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011914322,0.01379885,0.96469855,0.000507662,0.0007746006,0.000012988127,0.0005656629,0.000002132862,0.00023016041,0.000023596145,0.00085240987,0.006619038],"study_design_scores_gemma":[0.0027148079,0.0028314614,0.98541117,0.0065756063,0.00015340543,0.0000011352612,0.0006137846,0.00004091987,0.0014099167,0.000108944434,0.0000054101783,0.00013345812],"about_ca_topic_score_codex":0.00031694063,"about_ca_topic_score_gemma":0.000023664552,"teacher_disagreement_score":0.020712571,"about_ca_system_score_codex":0.00006137585,"about_ca_system_score_gemma":0.00026334892,"threshold_uncertainty_score":0.47261336},"labels":[],"label_agreement":null},{"id":"W2132079297","doi":"10.1136/ard.2010.146043","title":"Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years","year":2011,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Methotrexate; Rheumatoid arthritis; Internal medicine; Clinical endpoint; Clinical trial; Physical therapy; Surgery","score_opus":0.15178225918148247,"score_gpt":0.4218754189955652,"score_spread":0.2700931598140827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132079297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32938236,0.66000295,5.667331e-7,0.0001971425,0.00021432084,0.0022740813,0.007915682,0.000006741335,0.0000061446904],"genre_scores_gemma":[0.25715968,0.7422389,0.0000091023485,0.00005334038,0.000033357122,0.00018550504,0.0002725614,0.000035910107,0.0000116616875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99154806,0.0030081123,0.0038823267,0.00043529575,0.0006920226,0.00043420892],"domain_scores_gemma":[0.99117273,0.0033177286,0.0035166887,0.0014550226,0.00035821568,0.00017958638],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0033509396,0.0004388184,0.0052821096,0.0005972393,0.00006424277,0.0000564179,0.000902229,0.0002655095,0.00006835041],"category_scores_gemma":[0.010553907,0.00020840333,0.0027007717,0.0013844592,0.00051611423,0.00010865308,0.00023838726,0.00043572887,0.0000010660913],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007385081,0.0014437566,0.00715108,0.0061640115,0.0027152994,0.0000047200715,0.0017066261,0.0000012886345,0.000001474338,0.0000737882,0.0008242256,0.9791752],"study_design_scores_gemma":[0.0052518584,0.0012871228,0.6651088,0.26974502,0.0014829143,0.0000143971465,0.0006640441,0.00010270805,0.000049998845,0.00052419736,0.055148967,0.0006199837],"about_ca_topic_score_codex":0.0002803225,"about_ca_topic_score_gemma":0.00047423824,"teacher_disagreement_score":0.97855526,"about_ca_system_score_codex":0.000027930208,"about_ca_system_score_gemma":0.00040296986,"threshold_uncertainty_score":0.9977806},"labels":[],"label_agreement":null},{"id":"W2132327827","doi":"10.1136/ard.2009.119529","title":"Spondyloarthritis: state of the art and future perspectives","year":2010,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Modalities; Medical physics; Pathology","score_opus":0.03211645825711246,"score_gpt":0.33079798882037387,"score_spread":0.2986815305632614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132327827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042843637,0.99194825,9.208208e-8,0.00092209235,0.00033117432,0.0010830016,0.00084537105,0.00001250643,0.00057316065],"genre_scores_gemma":[0.0014291106,0.997509,0.000018999088,0.000056450557,0.000087038316,0.00006680372,0.000018503148,0.00003463828,0.00077943713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984881,0.00013047343,0.0005375155,0.00025240696,0.0003736868,0.00021777551],"domain_scores_gemma":[0.9981675,0.00016935833,0.00060685736,0.0007915791,0.00015898378,0.000105734434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010492402,0.00033526935,0.0015841818,0.000066566885,0.00013165537,0.000014719581,0.00025142462,0.000089165966,0.000095088835],"category_scores_gemma":[0.00026242845,0.00015669072,0.0009532859,0.00023580718,0.000517886,0.00004264693,0.00022180143,0.00023408359,0.0000092323635],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028313785,0.00030496746,0.000150795,0.008578021,0.00080490106,0.0000059363388,0.0003192422,2.8550925e-8,9.412991e-8,0.00024260521,0.002368651,0.98719645],"study_design_scores_gemma":[0.000829913,0.00018426453,0.010680746,0.050541963,0.0025609634,0.00011309369,0.00054619164,3.8128366e-7,0.000005394866,0.00077172474,0.93355286,0.00021250673],"about_ca_topic_score_codex":0.0000145727945,"about_ca_topic_score_gemma":0.000017552087,"teacher_disagreement_score":0.98698395,"about_ca_system_score_codex":0.000010904318,"about_ca_system_score_gemma":0.00019963132,"threshold_uncertainty_score":0.63896614},"labels":[],"label_agreement":null},{"id":"W2132657800","doi":"10.1136/ard.2011.153718","title":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Hospital for Sick Children","funders":"","keywords":"Medicine; Juvenile dermatomyositis; Cohort; Confounding; Internal medicine; Dermatomyositis; Corticosteroid; Observational study; Disease; Cohort study","score_opus":0.04948655600851986,"score_gpt":0.28431281654573637,"score_spread":0.2348262605372165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132657800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946663,0.0022498458,0.000011190573,0.000407611,0.00009645182,0.00044892367,0.00003158512,0.000024922285,0.0020631878],"genre_scores_gemma":[0.9983779,0.00089603674,0.000099589095,0.00053037115,0.000014912924,0.00002015691,0.0000056578606,0.000019934116,0.000035421115],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986374,0.000099177654,0.00061498396,0.0001321197,0.0002833573,0.00023298676],"domain_scores_gemma":[0.9988433,0.00011360349,0.00028660786,0.0005343418,0.00011799771,0.000104147104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014346675,0.00014953746,0.00051249145,0.00011377557,0.00004142299,0.0000055358546,0.000230389,0.000053724216,0.0002867658],"category_scores_gemma":[0.000154298,0.000101154255,0.00027051652,0.00022622953,0.00018816235,0.00008120368,0.00006132736,0.00008385756,0.000013688182],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055802683,0.010475692,0.38157994,0.0054160785,0.0014543014,0.00044758385,0.039319348,0.00005614008,0.0013733016,0.010929494,0.019628022,0.5237398],"study_design_scores_gemma":[0.0020542545,0.00023961424,0.9648633,0.0015489088,0.000063918415,0.00007282736,0.0003570438,0.00007446154,0.028312212,0.002065458,0.00021234865,0.00013566033],"about_ca_topic_score_codex":0.00020361539,"about_ca_topic_score_gemma":0.0000045266324,"teacher_disagreement_score":0.58328336,"about_ca_system_score_codex":0.000008661998,"about_ca_system_score_gemma":0.00012612013,"threshold_uncertainty_score":0.41249508},"labels":[],"label_agreement":null},{"id":"W2132788916","doi":"10.1136/annrheumdis-2013-203772","title":"The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council; Versus Arthritis; National Health and Medical Research Council; Arthritis Australia; Tasmanian Community Fund; University of Tasmania; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Body mass index; Osteoarthritis; Mendelian inheritance; Index (typography); Obesity; Internal medicine; Bioinformatics; Gerontology; Demography; Physical therapy; Genetics; Alternative medicine; Pathology; Gene","score_opus":0.009678352276708175,"score_gpt":0.27064011914969627,"score_spread":0.2609617668729881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132788916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720675,0.0005269317,0.00018983129,0.0006165735,0.00009911652,0.0011338139,0.000111283945,0.0000061824785,0.000109545654],"genre_scores_gemma":[0.99887234,0.00059636636,0.00002699677,0.00016049508,0.000026751859,0.00020968674,0.000049897928,0.000012497271,0.000044974502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972196,0.0016643354,0.00050012313,0.00019370593,0.00023494603,0.00018726951],"domain_scores_gemma":[0.99765956,0.00096231035,0.0006329156,0.0005242586,0.00017010076,0.000050847993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010089765,0.00015283222,0.0003153196,0.000025604108,0.00020509059,0.000018132088,0.0002661742,0.00009261221,0.000037311405],"category_scores_gemma":[0.004489023,0.0000860737,0.0002013593,0.00011652559,0.00009381731,0.0000076211663,0.000065695844,0.000072469964,0.000010984052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016351126,0.0005964194,0.9468956,0.00010848554,0.0016192459,2.4455287e-7,0.00086973194,0.00094175397,0.00711975,0.000052502364,0.013800323,0.026360825],"study_design_scores_gemma":[0.0041012317,0.0021547112,0.9827176,0.00006807479,0.00018155416,3.5905182e-7,0.000400943,0.00091437146,0.0066203317,0.00262126,0.000087714325,0.00013186138],"about_ca_topic_score_codex":0.0009609452,"about_ca_topic_score_gemma":0.00003111442,"teacher_disagreement_score":0.03582198,"about_ca_system_score_codex":0.0000067185724,"about_ca_system_score_gemma":0.000045131677,"threshold_uncertainty_score":0.5374104},"labels":[],"label_agreement":null},{"id":"W2132843336","doi":"10.1136/ard.2009.111500","title":"Demyelinating events in rheumatoid arthritis after drug exposures","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Rheumatoid arthritis; Drug; Immunology; Arthritis; Dermatology; Pharmacology","score_opus":0.018545341733107196,"score_gpt":0.2990980914875279,"score_spread":0.28055274975442074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132843336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95418465,0.039566875,0.000006171,0.0052285832,0.00009582747,0.0004798286,0.000024634617,0.00004017623,0.00037325252],"genre_scores_gemma":[0.955954,0.043091163,0.00009624165,0.00064500765,0.00002264157,0.000054038705,0.000007258973,0.000018404278,0.00011120659],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997826,0.00019557454,0.0006484368,0.0002281735,0.0006480854,0.00045374263],"domain_scores_gemma":[0.9988006,0.00018054814,0.00017315401,0.00049577723,0.00013788293,0.00021204272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037578194,0.00020234834,0.00050868315,0.00017683396,0.00008991137,0.000021430205,0.00027077302,0.000041960644,0.00022850616],"category_scores_gemma":[0.00097234396,0.00014243418,0.00029782762,0.00030923903,0.0001341232,0.00021146232,0.0000753329,0.00016329823,0.000029719284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000842933,0.0015646867,0.46346635,0.0002752249,0.00019250702,0.00004763434,0.0020709564,0.0000359167,0.00015548457,0.0009594458,0.0060052522,0.5243836],"study_design_scores_gemma":[0.0017916486,0.0001813678,0.97438407,0.0070085004,0.0000034225118,0.000031855197,0.0003376372,0.00013147088,0.0014342549,0.01416698,0.0003581739,0.00017063512],"about_ca_topic_score_codex":0.00008783344,"about_ca_topic_score_gemma":0.00004793734,"teacher_disagreement_score":0.52421296,"about_ca_system_score_codex":0.000015033963,"about_ca_system_score_gemma":0.00012424009,"threshold_uncertainty_score":0.58082974},"labels":[],"label_agreement":null},{"id":"W2132981126","doi":"10.1136/ard.2004.029751","title":"Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":464,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Dutch Arthritis Association","keywords":"Medicine; Rheumatoid arthritis; Biomarker; Immunology; Arthritis; Synovial membrane; Inflammatory response; Pathology; Internal medicine; Inflammation","score_opus":0.02042312677950182,"score_gpt":0.3044000688635611,"score_spread":0.28397694208405927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132981126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991006,0.0017745702,0.000093495626,0.0040270193,0.000070784736,0.0025553473,0.0004141383,0.000029614705,0.000028989956],"genre_scores_gemma":[0.99646676,0.0024882543,0.00037633436,0.00023878411,0.000009469436,0.0002721607,0.000034406356,0.000037704936,0.00007613953],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99821746,0.000160154,0.0004201557,0.00028349238,0.00047248253,0.00044627168],"domain_scores_gemma":[0.99850476,0.00032781664,0.00012418226,0.0004673297,0.00028095217,0.00029493158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022894843,0.0002409787,0.0005563588,0.00021957321,0.0001154453,0.00003397543,0.00013720799,0.000041960124,0.000038360264],"category_scores_gemma":[0.0008662177,0.00014916481,0.00017503113,0.00033593102,0.00021717725,0.00011192741,0.000052131403,0.000049688086,0.000024128702],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14823803,0.012859473,0.09240604,0.000672629,0.0023683063,0.00020225171,0.010390911,0.00046312876,0.0020510138,0.00075187243,0.002707598,0.7268887],"study_design_scores_gemma":[0.021908773,0.006690646,0.9478783,0.007021707,0.000015817814,0.000024938789,0.0006302811,0.000017689166,0.012811867,0.001024169,0.0016528873,0.00032293377],"about_ca_topic_score_codex":0.0002933171,"about_ca_topic_score_gemma":0.000118373246,"teacher_disagreement_score":0.85547227,"about_ca_system_score_codex":0.00008180913,"about_ca_system_score_gemma":0.00035498315,"threshold_uncertainty_score":0.6082764},"labels":[],"label_agreement":null},{"id":"W2133147279","doi":"10.1136/ard.2010.146068","title":"Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Methotrexate; Inflammation; Internal medicine; Arthritis; Physical therapy; Etanercept","score_opus":0.025732931323547828,"score_gpt":0.292052061195083,"score_spread":0.26631912987153517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133147279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957789,0.0015633907,0.000013601826,0.00071314466,0.00006947376,0.0012761833,0.00025812007,0.0000116121955,0.00031556148],"genre_scores_gemma":[0.9876331,0.011972064,0.00023308958,0.000018399807,0.0000044235926,0.000051102335,0.000019141402,0.000022274506,0.00004640666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670374,0.001005301,0.0010169105,0.00022207157,0.0007691742,0.00028277762],"domain_scores_gemma":[0.99738204,0.00068181136,0.00082941266,0.00066886,0.00030604706,0.0001318511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014732074,0.00019692101,0.0006369284,0.00016615052,0.000082519786,0.000017755447,0.00029310465,0.000054880384,0.00004214097],"category_scores_gemma":[0.0025045655,0.00011314819,0.00015661893,0.00037243386,0.0004945388,0.0002448255,0.00016149432,0.00015694718,9.651784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3273018,0.0042910166,0.38171297,0.0016355445,0.0014502855,0.000009893205,0.0134741515,0.000071213064,0.002287416,0.0011255201,0.0040144706,0.26262572],"study_design_scores_gemma":[0.035631713,0.0014726331,0.94551516,0.0068039023,0.000017559587,0.0000023145162,0.0004677288,0.00014736541,0.008433584,0.0012497943,0.00011348227,0.00014474754],"about_ca_topic_score_codex":0.00041744605,"about_ca_topic_score_gemma":0.00010533667,"teacher_disagreement_score":0.56380224,"about_ca_system_score_codex":0.000020695696,"about_ca_system_score_gemma":0.00024413275,"threshold_uncertainty_score":0.46140492},"labels":[],"label_agreement":null},{"id":"W2133514499","doi":"10.1136/ard.61.suppl_3.iii51","title":"Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience","year":2002,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Infliximab; Etanercept; Ankylosing spondylitis; Rheumatoid arthritis; Inflammatory bowel disease; Tumor necrosis factor alpha; Internal medicine; Adalimumab; Disease; Immunology; Surgery","score_opus":0.16169810916648097,"score_gpt":0.4086994682056133,"score_spread":0.24700135903913234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133514499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062778164,0.98714375,0.0000037998882,0.00029616329,0.0005604424,0.0016102224,0.0039253603,0.000032088083,0.00015038028],"genre_scores_gemma":[0.007375972,0.9911159,0.00006653761,0.00016020446,0.000093302,0.000453136,0.00022463074,0.000052417472,0.00045788602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982481,0.000064165055,0.0006844088,0.0003380901,0.00035720377,0.00030803663],"domain_scores_gemma":[0.99834955,0.00029391525,0.0005561743,0.00049275096,0.00018243327,0.00012518319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054173215,0.0003935972,0.0016238227,0.000111754634,0.00015760255,0.000048879865,0.00037967085,0.000087278495,0.0006142293],"category_scores_gemma":[0.00039346438,0.00023306099,0.0013972563,0.00018246908,0.00015673898,0.000093925184,0.00010759892,0.0000831267,0.000013392499],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053154814,0.00059215276,0.0003119822,0.0046980525,0.0012846815,0.0000075213484,0.00026404063,1.303992e-7,3.2164476e-7,0.00005903304,0.0027397336,0.9899892],"study_design_scores_gemma":[0.0015238938,0.00026376318,0.0033568463,0.052977324,0.00088944455,0.000048673188,0.00013535917,0.000010739698,0.000023547072,0.00021035502,0.940228,0.00033205427],"about_ca_topic_score_codex":0.00002843527,"about_ca_topic_score_gemma":8.540303e-7,"teacher_disagreement_score":0.98965716,"about_ca_system_score_codex":0.00003784906,"about_ca_system_score_gemma":0.00009687606,"threshold_uncertainty_score":0.9503951},"labels":[],"label_agreement":null},{"id":"W2133526094","doi":"10.1136/ard.2010.135087","title":"Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Logistic regression; Joint pain; Arthritis; Joint (building); Psoriasis; Internal medicine; Physical therapy; Surgery; Dermatology","score_opus":0.06011252929059103,"score_gpt":0.3078118428300415,"score_spread":0.24769931353945046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133526094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551374,0.0005895848,0.0000016017327,0.0025073888,0.00023616651,0.0008686792,0.00008989569,0.000022810027,0.00017012384],"genre_scores_gemma":[0.99889123,0.00044531337,0.00014050295,0.0002738981,0.000042986187,0.000119863806,0.000039153463,0.000016867412,0.000030162555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985291,0.00007948906,0.0004883739,0.00020357607,0.00042750104,0.00027198263],"domain_scores_gemma":[0.9990518,0.000062518084,0.00016080828,0.00047579603,0.00007029084,0.00017879746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026719936,0.00016387951,0.0004460617,0.00020876792,0.000055675053,0.000027896103,0.0001373151,0.000052075156,0.00010899422],"category_scores_gemma":[0.00079844275,0.00011880408,0.00011355408,0.00026321295,0.000077360426,0.0001882119,0.00012753475,0.00013759917,0.000018006533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002806854,0.0020033678,0.5766695,0.0004840552,0.00023790062,0.00009570589,0.0071794265,0.00009625085,0.0006589543,0.0007327803,0.0012401398,0.41032124],"study_design_scores_gemma":[0.0022359092,0.00029255153,0.99117714,0.0019038166,0.000047590987,0.000006910917,0.0006210714,0.00010577304,0.0017580393,0.0016989353,0.000047254467,0.00010499892],"about_ca_topic_score_codex":0.00024154324,"about_ca_topic_score_gemma":0.0019437296,"teacher_disagreement_score":0.41450766,"about_ca_system_score_codex":0.000016100636,"about_ca_system_score_gemma":0.00007609889,"threshold_uncertainty_score":0.48446897},"labels":[],"label_agreement":null},{"id":"W2133541603","doi":"10.1136/ard.2003.013052","title":"Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":620,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"National Center for Advancing Translational Sciences; Abbott Laboratories","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Placebo; Internal medicine; Adverse effect; Clinical endpoint; Gastroenterology; Clinical trial","score_opus":0.02328535516048667,"score_gpt":0.2820597866873076,"score_spread":0.2587744315268209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133541603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96920764,0.025270721,0.00006852391,0.0017021003,0.000041647214,0.003421037,0.00023770562,0.00003472516,0.000015900448],"genre_scores_gemma":[0.9392328,0.06007588,0.00025169793,0.00007628538,0.000006583459,0.0002212077,0.000061886734,0.000052220785,0.000021426315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757195,0.00013701228,0.0008479072,0.00036486622,0.00061665435,0.0004616299],"domain_scores_gemma":[0.9979503,0.0003851857,0.0003947965,0.0006695263,0.00023244169,0.00036771534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020481698,0.00035613237,0.000996702,0.00020030014,0.00024275425,0.000073901356,0.00021666923,0.00004225122,0.000039532795],"category_scores_gemma":[0.000507662,0.00022624624,0.00027088338,0.0002559223,0.00061292056,0.00023414912,0.000056555757,0.000081642655,0.0000031092743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05389339,0.013585762,0.53698653,0.0035006397,0.0027349403,0.000021970578,0.010819199,0.0020967491,0.00004207957,0.0022871697,0.00033170675,0.37369984],"study_design_scores_gemma":[0.07225956,0.002866667,0.8914254,0.024665602,0.000058249174,0.0000065486634,0.0004800995,0.00031866657,0.00082721625,0.0064523267,0.00021155029,0.0004281587],"about_ca_topic_score_codex":0.00046711412,"about_ca_topic_score_gemma":0.00007437446,"teacher_disagreement_score":0.3732717,"about_ca_system_score_codex":0.000056620476,"about_ca_system_score_gemma":0.0005799426,"threshold_uncertainty_score":0.9226054},"labels":[],"label_agreement":null},{"id":"W2133633410","doi":"10.1136/annrheumdis-2011-201244","title":"Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease","year":2012,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":586,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Ankylosing spondylitis; Internal medicine; Psoriasis; Rheumatoid arthritis; Population; Infliximab; Adverse effect; Arthritis; Incidence (geometry); Dermatology; Disease","score_opus":0.106666833382017,"score_gpt":0.40573874476715416,"score_spread":0.29907191138513717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133633410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11240543,0.8693025,0.000008364537,0.0002997206,0.0014269542,0.004743641,0.011700337,0.00008456627,0.000028468145],"genre_scores_gemma":[0.12613781,0.8704613,0.00005302802,0.00014225594,0.00032754726,0.00048851216,0.0022113905,0.00016485366,0.000013311243],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97613966,0.009093504,0.009518882,0.0015063396,0.0019566095,0.0017850029],"domain_scores_gemma":[0.9880464,0.004145556,0.0034754039,0.002060244,0.00036964714,0.0019027236],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0073663397,0.0014977764,0.01157389,0.000632169,0.00030410313,0.00032114037,0.0010039216,0.00071885454,0.0005632831],"category_scores_gemma":[0.018410893,0.0011887419,0.002958979,0.0011454645,0.0010254745,0.00078657386,0.0007377438,0.001267961,0.00008666241],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015835625,0.0026083137,0.08603483,0.0087053,0.00082400744,0.00034540563,0.00013078071,7.9401366e-7,2.8208714e-8,0.00025692483,0.0005215013,0.89898854],"study_design_scores_gemma":[0.015756328,0.00039642147,0.5034053,0.43530053,0.00047966128,0.00011208701,0.00008591132,0.000016906595,9.296609e-7,0.0033889175,0.039673343,0.0013836777],"about_ca_topic_score_codex":0.00074762176,"about_ca_topic_score_gemma":0.0010812089,"teacher_disagreement_score":0.8976049,"about_ca_system_score_codex":0.00030489013,"about_ca_system_score_gemma":0.002152645,"threshold_uncertainty_score":0.99977714},"labels":[],"label_agreement":null},{"id":"W2134009713","doi":"10.1136/annrheumdis-2013-204231","title":"Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":468,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Genentech; Ablynx; Celgene; Biogen; National Center for Advancing Translational Sciences; Chugai Pharmaceutical; Celltrion; Synarc; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Certolizumab pegol; Ankylosing spondylitis; BASDAI; Placebo; BASFI; Axial spondyloarthritis; Internal medicine; Clinical endpoint; Adverse effect; Spondylitis; Physical therapy; Randomized controlled trial; Arthritis; Etanercept; Sacroiliitis; Rheumatoid arthritis; Psoriatic arthritis","score_opus":0.0739254593812622,"score_gpt":0.34784654864763137,"score_spread":0.27392108926636916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134009713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841244,0.003206807,0.000002400888,0.0004534592,0.00013609855,0.006574174,0.00073037966,0.000021544296,0.0004626912],"genre_scores_gemma":[0.99909645,0.00036678425,0.00003168959,0.00002040864,0.00003178844,0.00028079082,0.00005165627,0.000034784483,0.000085643056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964882,0.00031291577,0.0016860006,0.00037997545,0.00076608383,0.00036680623],"domain_scores_gemma":[0.9957245,0.0017005067,0.0012320207,0.0006929927,0.00044242627,0.0002075591],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002899562,0.0003768037,0.002043463,0.00028961684,0.00014983697,0.000021817725,0.00022202384,0.00007221532,0.0001611772],"category_scores_gemma":[0.0016980274,0.00025472124,0.00058374694,0.00033702093,0.0004217946,0.00014468827,0.0001734881,0.00010992685,0.0000028627214],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93345046,0.01775985,0.0030227392,0.0009260124,0.003887898,0.00007441687,0.004310972,0.000029563484,0.00094467314,0.00014049487,0.00029157332,0.035161335],"study_design_scores_gemma":[0.95472854,0.013265406,0.016607534,0.005777731,0.0017217061,0.000046404948,0.0022934757,0.000149954,0.004862247,0.0002776491,0.000010966741,0.00025839225],"about_ca_topic_score_codex":0.00055832777,"about_ca_topic_score_gemma":0.000015834681,"teacher_disagreement_score":0.034902945,"about_ca_system_score_codex":0.000021623293,"about_ca_system_score_gemma":0.00012786358,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W2134122064","doi":"10.1136/ard.2004.035105","title":"Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Amgen","keywords":"Etanercept; Medicine; Ankylosing spondylitis; Placebo; Tolerability; Spondylitis; Internal medicine; Clinical trial; Surgery; Adverse effect; Rheumatoid arthritis","score_opus":0.03335016904944053,"score_gpt":0.3222726216996275,"score_spread":0.28892245265018696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134122064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901101,0.003620422,0.0000058747346,0.0048000193,0.00003154574,0.0008052321,0.00040132322,0.000010360561,0.00021515261],"genre_scores_gemma":[0.9991154,0.00035453614,0.00024045941,0.000134221,0.000014380307,0.000042780463,0.000018864233,0.000009205984,0.00007014959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988786,0.00006533839,0.00048938993,0.00018523756,0.00017525034,0.00020617395],"domain_scores_gemma":[0.99891734,0.0003344104,0.0001555589,0.00035415083,0.00015781377,0.000080722224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023891419,0.00012609639,0.0005249121,0.00004824434,0.00005941362,0.0000059321806,0.000071291346,0.0000340809,0.00009674347],"category_scores_gemma":[0.0010601742,0.000085974636,0.00019310725,0.00012887554,0.00024047597,0.000073221425,0.00008346218,0.000039481336,4.4578175e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023791047,0.0029293722,0.72568095,0.0033718778,0.00037915996,0.000005618794,0.001761324,0.000032905198,0.00010561677,0.0012812004,0.00082460145,0.26124823],"study_design_scores_gemma":[0.0030129869,0.0003664676,0.9874004,0.00091928855,0.00015194621,0.00000756826,0.0010196632,0.0002591407,0.0010140507,0.00548434,0.00026832565,0.000095834956],"about_ca_topic_score_codex":0.00015151063,"about_ca_topic_score_gemma":0.000082465835,"teacher_disagreement_score":0.2617194,"about_ca_system_score_codex":0.000028671808,"about_ca_system_score_gemma":0.000064452215,"threshold_uncertainty_score":0.3505944},"labels":[],"label_agreement":null},{"id":"W2134280423","doi":"10.1136/ard.2004.020875","title":"Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Etanercept; Medicine; Ankylosing spondylitis; BASDAI; Placebo; Internal medicine; Spondylitis; Clinical endpoint; Adverse effect; Randomized controlled trial; Physical therapy; Surgery; Rheumatoid arthritis; Pathology","score_opus":0.08563958308029335,"score_gpt":0.4016217886403743,"score_spread":0.31598220556008094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134280423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436843,0.0011765524,0.0000069034163,0.0018775366,0.0002060718,0.001556565,0.00039669033,0.000013681996,0.00039758784],"genre_scores_gemma":[0.9985003,0.00074091094,0.00028034186,0.0002306441,0.00002581557,0.000032973825,0.000017448714,0.000015691674,0.00015591214],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980245,0.00012516747,0.0010416043,0.00018727039,0.0004094085,0.00021202047],"domain_scores_gemma":[0.9981214,0.00059478293,0.00041754785,0.0005142772,0.00017550946,0.00017650097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022796459,0.0001779088,0.0011880368,0.000072583585,0.000049534436,0.0000047735816,0.00014459921,0.000047984162,0.00015339589],"category_scores_gemma":[0.002513762,0.00010589008,0.0008681461,0.00017794926,0.00020394074,0.00004155524,0.000081466955,0.000048430586,0.0000063651332],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5593909,0.020704161,0.2455745,0.0020502433,0.0052389754,0.000076424934,0.0037366697,0.00016764896,0.00015921163,0.00077012094,0.0017787459,0.16035238],"study_design_scores_gemma":[0.47598672,0.0024733678,0.51328754,0.0027892422,0.0015903083,0.000006854236,0.00069936574,0.0000087679,0.0020336104,0.0008739788,0.00008763234,0.00016260637],"about_ca_topic_score_codex":0.00024324204,"about_ca_topic_score_gemma":0.000017209213,"teacher_disagreement_score":0.26771304,"about_ca_system_score_codex":0.000015325746,"about_ca_system_score_gemma":0.00011463888,"threshold_uncertainty_score":0.43180722},"labels":[],"label_agreement":null},{"id":"W2134639926","doi":"10.1136/ard.2010.148502","title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal General Hospital; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Toronto Western Hospital","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Autoantibody; Internal medicine; Lupus anticoagulant; Proportional hazards model; Systemic lupus erythematosus; Rheumatology; Cohort; Biomarker; Antiphospholipid syndrome; Connective tissue disease; Immunology; Prospective cohort study; Gastroenterology; Antibody; Disease; Thrombosis; Autoimmune disease","score_opus":0.06729429183448325,"score_gpt":0.3211611214472387,"score_spread":0.2538668296127554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134639926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798794,0.007717228,0.00006111941,0.00052738376,0.00072332163,0.0023958334,0.00010945765,0.000034299963,0.0004434151],"genre_scores_gemma":[0.9977183,0.0015577455,0.00004733784,0.000045565062,0.000024964731,0.00018393874,0.0000058865644,0.000033593333,0.0003826975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977435,0.00021776363,0.0008680427,0.00022427604,0.0006268585,0.00031957257],"domain_scores_gemma":[0.9975408,0.0007270058,0.000500447,0.0008639114,0.0002673639,0.00010049573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006551977,0.00018774343,0.00054461975,0.0002564094,0.000082083825,0.0000051593224,0.0004900236,0.000060458882,0.000041804527],"category_scores_gemma":[0.0015330636,0.00009965223,0.00040905477,0.0005208458,0.00019816568,0.0000820726,0.00011582004,0.000084315216,0.000010664064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013519418,0.0007400025,0.97529924,0.010839877,0.00088867365,0.000002649616,0.0027239518,0.000015499532,0.0001956235,0.00076814654,0.0047470527,0.0024273433],"study_design_scores_gemma":[0.008943252,0.001355502,0.9172603,0.029602056,0.0014881438,0.0058661154,0.0137280105,0.0064424616,0.003033344,0.011755654,0.000110335735,0.00041481067],"about_ca_topic_score_codex":0.00021364559,"about_ca_topic_score_gemma":0.0000057732805,"teacher_disagreement_score":0.058038924,"about_ca_system_score_codex":0.000025050887,"about_ca_system_score_gemma":0.00023236343,"threshold_uncertainty_score":0.40636998},"labels":[],"label_agreement":null},{"id":"W2134864031","doi":"10.1136/annrheumdis-2014-205800","title":"Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Arthritis Research Centre of Canada","funders":"Canadian Institutes of Health Research; Division of Electrical, Communications and Cyber Systems; University of British Columbia","keywords":"Medicine; Pulmonary embolism; Dermatomyositis; Internal medicine; Population; Venous thrombosis; Polymyositis; Cohort; Deep vein; Incidence (geometry); Thrombosis; Cohort study; Surgery","score_opus":0.011511264166865506,"score_gpt":0.2650353862379702,"score_spread":0.2535241220711047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134864031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972945,0.0012943755,0.000042963795,0.0005296886,0.000026001857,0.00066056015,0.000082177095,0.000020039746,0.00004967895],"genre_scores_gemma":[0.99909633,0.00019051135,0.0002439194,0.00036753344,0.000016368276,0.00004220758,0.00001616417,0.000023218421,0.0000037188915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839616,0.00029881884,0.0005026214,0.00020872445,0.00037876502,0.00021490183],"domain_scores_gemma":[0.99879926,0.00022858677,0.0003658958,0.00038819783,0.00008527812,0.00013280426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002498884,0.00019493824,0.0006385766,0.00016529589,0.00011668654,0.000023866407,0.000107352316,0.000050716244,0.0000134008205],"category_scores_gemma":[0.00013069583,0.00013310493,0.000083797495,0.000199216,0.00013172175,0.00011360158,0.00007354928,0.00008651704,5.2768615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006977123,0.00062600925,0.9908445,0.0005034448,0.00018510639,0.0000080063355,0.000838238,0.00010927209,0.000008434349,0.0001379004,0.00002588068,0.0066434485],"study_design_scores_gemma":[0.0013876237,0.00032987093,0.9912884,0.0008791315,0.00040025348,0.000034494424,0.0004429161,0.0042958925,0.00013876974,0.0006569322,0.0000039630945,0.00014174428],"about_ca_topic_score_codex":0.0009263196,"about_ca_topic_score_gemma":0.00005690858,"teacher_disagreement_score":0.006501704,"about_ca_system_score_codex":0.000008427591,"about_ca_system_score_gemma":0.00004841578,"threshold_uncertainty_score":0.5427861},"labels":[],"label_agreement":null},{"id":"W2135530788","doi":"10.1136/ard.2005.040196","title":"Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Infliximab; Placebo; Internal medicine; Quality of life (healthcare); Dermatology Life Quality Index; Psoriasis; Physical therapy; Rheumatology; Arthritis; Disease; Dermatology; Alternative medicine","score_opus":0.0226106188548325,"score_gpt":0.29227112464410687,"score_spread":0.26966050578927436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135530788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274236,0.0051399027,7.997916e-7,0.0015469418,0.000030718784,0.00044363423,0.00004591698,0.000010088858,0.000039661365],"genre_scores_gemma":[0.999073,0.00063779426,0.000027949915,0.0001979517,0.000009412252,0.000016850125,0.000014736385,0.000008706518,0.000013549509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989402,0.00007733095,0.00045117302,0.00012593923,0.00026258538,0.00014274522],"domain_scores_gemma":[0.99919856,0.00008781667,0.00032811574,0.00020880783,0.00008291709,0.000093812145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009545426,0.00010612213,0.00051485753,0.000041804866,0.000044706572,0.0000038639023,0.000035661786,0.000018251807,0.000010651074],"category_scores_gemma":[0.00028685888,0.0000652272,0.00007857053,0.00014072719,0.00015086128,0.00008220927,0.00003439319,0.000046198184,0.0000014901199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017904566,0.0033874393,0.70043504,0.00064716925,0.0004927677,3.8924983e-7,0.0011854584,0.000017253424,0.0000025638335,0.0004822115,0.00027471807,0.29128453],"study_design_scores_gemma":[0.0062396056,0.0009290543,0.9909156,0.0009139337,0.000043847012,3.4308295e-7,0.00026150543,0.00004934054,0.000011872074,0.0005726734,0.0000069125153,0.000055317487],"about_ca_topic_score_codex":0.0003489323,"about_ca_topic_score_gemma":0.00008825361,"teacher_disagreement_score":0.29122922,"about_ca_system_score_codex":0.000013578331,"about_ca_system_score_gemma":0.00006745327,"threshold_uncertainty_score":0.2659888},"labels":[],"label_agreement":null},{"id":"W2135590726","doi":"10.1136/ard.59.11.864","title":"Inflammatory arthritis in children with osteochondrodysplasias","year":2000,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Arthritis; Osteoarthritis; Rheumatology; Degenerative arthritis; Inflammatory arthritis; Internal medicine; Radiological weapon; Population; Pathology; Physical therapy; Surgery; Alternative medicine","score_opus":0.00990158785282912,"score_gpt":0.26092167856924825,"score_spread":0.2510200907164191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135590726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500304,0.0035119734,0.000002295544,0.00031500895,0.000008994668,0.000306795,0.0000370041,0.000005205141,0.00080967427],"genre_scores_gemma":[0.9979441,0.0014140055,0.000010657909,0.000089038724,0.000011851127,0.000035372665,0.00002432458,0.000014336299,0.0004562953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916285,0.00009906573,0.00017365208,0.00017997228,0.00018793093,0.00019653742],"domain_scores_gemma":[0.9994105,0.000017892082,0.00005179085,0.00041093607,0.00005158936,0.000057258945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008504509,0.00010448884,0.00014161004,0.000037346814,0.000039656945,0.000011898526,0.000275679,0.00003568668,0.0002731561],"category_scores_gemma":[0.00014766555,0.00007494684,0.00007600835,0.00012996308,0.00015526563,0.000005792352,0.00006215749,0.000050494888,0.000018071754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043107104,0.00042787747,0.67100674,0.000080330945,0.00030488212,0.0000034440736,0.00017629021,0.00071838853,0.0013716822,0.00010662522,0.0033731703,0.32199952],"study_design_scores_gemma":[0.00085906195,0.000184386,0.98643464,0.00023867557,0.000009525715,0.0000150636415,0.00006822016,0.000019836165,0.0109979035,0.00036721287,0.000654491,0.000150992],"about_ca_topic_score_codex":0.00006653987,"about_ca_topic_score_gemma":0.00014252527,"teacher_disagreement_score":0.32184854,"about_ca_system_score_codex":0.0000027907552,"about_ca_system_score_gemma":0.00008774498,"threshold_uncertainty_score":0.30562434},"labels":[],"label_agreement":null},{"id":"W2135611859","doi":"10.1136/annrheumdis-2014-205200","title":"Response to: ‘Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?‘ by Jan Damoiseaux","year":2014,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Toronto Western Hospital; McGill University; Jewish General Hospital; Mount Sinai Hospital; Western University","funders":"","keywords":"Medicine; Autoantibody; Immunology; Antibody","score_opus":0.03738295043415541,"score_gpt":0.3042310469666591,"score_spread":0.2668480965325037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135611859","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44773492,0.026962949,0.00017454823,0.5047622,0.0011076665,0.009271214,0.009655184,0.00031270183,0.000018665382],"genre_scores_gemma":[0.6594297,0.0010324045,0.00011916001,0.33225274,0.00037859025,0.002991507,0.0015748664,0.00037393067,0.0018470502],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99094665,0.0015774475,0.003003586,0.001347042,0.0017548078,0.0013704367],"domain_scores_gemma":[0.98775333,0.0052343807,0.0017818866,0.0027803327,0.0011137668,0.0013362927],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012746926,0.001337614,0.003521093,0.0011230669,0.00032560673,0.00018119309,0.001479977,0.0006940042,0.00012316284],"category_scores_gemma":[0.017406518,0.0009765689,0.0010325371,0.0018624226,0.0002595127,0.00016453041,0.00045919965,0.0006567658,0.00012917162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021057108,0.0008790934,0.0024514112,0.007063451,0.0011066062,0.00013919288,0.0007279062,0.0004582252,0.00053369434,0.000007398493,0.982965,0.0015623292],"study_design_scores_gemma":[0.024072606,0.0049093943,0.27404317,0.57297486,0.011612673,0.00022483399,0.0050103804,0.003864988,0.002735173,0.00040241185,0.09247712,0.007672385],"about_ca_topic_score_codex":0.0005518694,"about_ca_topic_score_gemma":0.00000865745,"teacher_disagreement_score":0.89048785,"about_ca_system_score_codex":0.00033357553,"about_ca_system_score_gemma":0.0012868996,"threshold_uncertainty_score":0.9999375},"labels":[],"label_agreement":null},{"id":"W2136160479","doi":"10.1136/ard.2009.108274","title":"Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Intraclass correlation; BASDAI; Axial spondyloarthritis; Ankylosing spondylitis; Magnetic resonance imaging; Sagittal plane; Nuclear medicine; Radiology; Internal medicine; Arthritis; Psoriatic arthritis; Sacroiliitis","score_opus":0.014339078550111814,"score_gpt":0.29199189326262076,"score_spread":0.27765281471250897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136160479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975021,0.00049758266,0.000006447475,0.00065435574,0.00006245247,0.00066887867,0.00030553463,0.000008024438,0.000294643],"genre_scores_gemma":[0.9993,0.00031590316,0.0000876066,0.00008061659,0.000014453257,0.000029124254,0.00014282503,0.00000936268,0.00002009791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861217,0.00007233576,0.00042055524,0.0001605188,0.0005618406,0.00017257176],"domain_scores_gemma":[0.99887735,0.00004376452,0.00046335324,0.0002567268,0.00029260493,0.00006621544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100397585,0.00015410194,0.00046939697,0.00012666968,0.000046536188,0.000005133422,0.00009729564,0.00003488706,0.000045648547],"category_scores_gemma":[0.00007555627,0.00010864721,0.0001416061,0.00017841955,0.00015452343,0.0001085997,0.00003961648,0.000058230748,0.0000011942253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025106284,0.0050495854,0.9515042,0.00062149536,0.0006712592,0.000012469431,0.0002813891,0.000121089884,0.00021011155,0.00073440355,0.00030649264,0.037976887],"study_design_scores_gemma":[0.0051630554,0.0018208377,0.9862501,0.003320042,0.00012285907,9.4669315e-7,0.00021469186,0.000022834534,0.002677399,0.0002944984,0.000025596297,0.00008714784],"about_ca_topic_score_codex":0.000019605715,"about_ca_topic_score_gemma":0.000014761767,"teacher_disagreement_score":0.03788974,"about_ca_system_score_codex":0.000028621535,"about_ca_system_score_gemma":0.00012178869,"threshold_uncertainty_score":0.44305044},"labels":[],"label_agreement":null},{"id":"W2136316716","doi":"10.1136/ard.61.4.370","title":"Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology","year":2002,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"University of Ottawa; Dartmouth College; Medizinischen Hochschule Hannover; McMaster University; World Health Organization","keywords":"Medicine; Rheumatology; Rheumatoid arthritis; Guideline; Alternative medicine; Osteoporosis; Internal medicine; Physical therapy; Osteoarthritis; Family medicine; Pathology","score_opus":0.43863960953990017,"score_gpt":0.5035206498921337,"score_spread":0.06488104035223358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136316716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78586376,0.017597955,0.0026700823,0.18489352,0.001340087,0.0034466586,0.0028497388,0.00008938212,0.0012487917],"genre_scores_gemma":[0.9933287,0.0006031891,0.0017389276,0.003452536,0.000050158756,0.0005222811,0.00008218646,0.000041561372,0.00018044321],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.993692,0.000411259,0.0048895106,0.00045390378,0.00010555057,0.0004477953],"domain_scores_gemma":[0.9953653,0.0008589765,0.0025902938,0.0008889353,0.000110393106,0.00018608382],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0071756295,0.0002154457,0.0011127174,0.00031897164,0.00016484162,0.000053496315,0.0006446679,0.00010282489,0.0014597024],"category_scores_gemma":[0.0039014276,0.00021761846,0.0002850131,0.0001431107,0.00020537552,0.00057946966,0.00007361042,0.000081697886,0.00047653104],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010976159,0.0026254007,0.14054033,0.0035869812,0.00065570005,7.3747395e-7,0.006693051,0.015438521,6.717188e-7,0.30621597,0.4743714,0.04976147],"study_design_scores_gemma":[0.0033488395,0.00036609947,0.13046432,0.00087184017,0.00006615359,0.000011451389,0.002265798,0.5812055,0.000028711807,0.2463174,0.03407035,0.0009835465],"about_ca_topic_score_codex":0.0007156152,"about_ca_topic_score_gemma":0.00017114935,"teacher_disagreement_score":0.565767,"about_ca_system_score_codex":0.00016297791,"about_ca_system_score_gemma":0.00017876178,"threshold_uncertainty_score":0.9994531},"labels":[],"label_agreement":null},{"id":"W2136590838","doi":"10.1136/ard.2008.093146","title":"Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Immunology; Interferon; Disease; Internal medicine; Antibody; Anti-dsDNA antibodies; Connective tissue disease; Gene expression; Systemic disease; Lupus erythematosus; Autoimmune disease; Gene; Biology; Genetics","score_opus":0.08778918884723036,"score_gpt":0.3430785911876672,"score_spread":0.25528940234043684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136590838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968816,0.005448154,0.000004227594,0.0036244772,0.0000881628,0.0010000335,0.00008448687,0.0000137739235,0.00004853631],"genre_scores_gemma":[0.9981195,0.0014680922,0.000003442479,0.000041720235,0.00003321124,0.00006526891,0.000005559852,0.000019857938,0.00024338932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774885,0.00044666958,0.0005017554,0.00023245775,0.0007524179,0.0003178534],"domain_scores_gemma":[0.99748397,0.0011907212,0.00046860546,0.00054765004,0.00016610086,0.00014297845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080395193,0.00018541468,0.0007256765,0.00020241909,0.00005866269,0.000010715273,0.0002919774,0.000090440764,0.000016123797],"category_scores_gemma":[0.0017336003,0.00010656867,0.00015135318,0.00044704037,0.00020968966,0.00009695295,0.00018384156,0.00023557973,0.0000030670483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047357523,0.00023833859,0.991984,0.0039361487,0.00017675177,0.0000151466165,0.0017351982,0.000013360724,0.00009667334,0.000026654332,0.0006829593,0.0006212044],"study_design_scores_gemma":[0.0014113457,0.00012294072,0.98716223,0.008837375,0.00012591439,0.00028594528,0.0006894664,0.00029367275,0.0005563045,0.00039758324,0.000005563403,0.000111650064],"about_ca_topic_score_codex":0.0001568391,"about_ca_topic_score_gemma":0.00007985511,"teacher_disagreement_score":0.00843131,"about_ca_system_score_codex":0.00011222985,"about_ca_system_score_gemma":0.00018899649,"threshold_uncertainty_score":0.43457443},"labels":[],"label_agreement":null},{"id":"W2136692335","doi":"10.1136/ard.2008.092676","title":"Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cohort; Internal medicine; Rheumatoid factor; Arthritis; Physical therapy","score_opus":0.026127173119503994,"score_gpt":0.26367797051167974,"score_spread":0.23755079739217574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136692335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959192,0.0025080864,0.00013983191,0.000073485055,0.000051591804,0.0010029606,0.00026406208,0.000016900918,0.000023876195],"genre_scores_gemma":[0.9898366,0.009434814,0.0004404715,0.00000956547,0.0000039382544,0.00009293517,0.0001493248,0.000020200667,0.000012189142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811393,0.000077474,0.0008023279,0.00016062013,0.000609673,0.0002360007],"domain_scores_gemma":[0.99864197,0.000113464666,0.00039307534,0.00028693175,0.00046341165,0.000101159174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001654339,0.0001452855,0.0005376237,0.00019433713,0.00009143508,0.000006834246,0.00013221007,0.000042492316,0.00005082474],"category_scores_gemma":[0.00032395488,0.00010353165,0.00014029352,0.000261731,0.00024242533,0.00016195764,0.00003930082,0.000057976722,0.0000016079935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018492911,0.002217546,0.927239,0.0005155247,0.0004434215,0.0000010780581,0.0026042117,0.00002458265,0.00022582995,0.00013619187,0.00044241792,0.064300895],"study_design_scores_gemma":[0.005863266,0.0006284609,0.96572864,0.005917356,0.000004505888,0.000003350784,0.00010332598,0.000037856815,0.021112867,0.00046754218,0.0000402394,0.00009259969],"about_ca_topic_score_codex":0.00006623454,"about_ca_topic_score_gemma":0.000016805674,"teacher_disagreement_score":0.06420829,"about_ca_system_score_codex":0.000014272078,"about_ca_system_score_gemma":0.00026459858,"threshold_uncertainty_score":0.42218983},"labels":[],"label_agreement":null},{"id":"W2136843961","doi":"10.1136/ard.2008.093161","title":"Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Polymyositis; Dermatomyositis; Population; Demography; Epidemiology; Rural area; Internal medicine; Pediatrics; Environmental health; Pathology","score_opus":0.11001533369736559,"score_gpt":0.33125362401030295,"score_spread":0.22123829031293735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136843961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882354,0.008309578,0.00004678265,0.002297258,0.000049455182,0.00029382054,0.0006458943,0.000016968674,0.000104819876],"genre_scores_gemma":[0.99629295,0.0024498396,0.00055716396,0.00052637706,0.000039006376,0.000012935257,0.000026876762,0.000010510494,0.00008433439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862957,0.00014499424,0.00044425795,0.00023250733,0.00038453544,0.0001641539],"domain_scores_gemma":[0.99818677,0.0006188153,0.0003491557,0.0006446305,0.00008335334,0.00011729123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119293465,0.00016619668,0.0004092117,0.00003198671,0.00025684282,0.000023551858,0.00031160866,0.000040773622,0.000035749694],"category_scores_gemma":[0.00028062542,0.0000953855,0.00007664705,0.00008863259,0.0009940551,0.00019270276,0.0002758232,0.00008940787,8.083952e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022640928,0.0002692828,0.96326464,0.004112516,0.0006079224,0.0001586472,0.006966934,0.000003829393,0.0001403886,0.00065898034,0.010795902,0.012794535],"study_design_scores_gemma":[0.00040363293,0.0000689961,0.99174577,0.0020162165,0.00023862386,0.00042060745,0.0004132092,0.002657733,0.00066548464,0.0012276794,0.000033181474,0.00010888049],"about_ca_topic_score_codex":0.00021519685,"about_ca_topic_score_gemma":0.0000064244073,"teacher_disagreement_score":0.028481102,"about_ca_system_score_codex":0.000003181085,"about_ca_system_score_gemma":0.000120110606,"threshold_uncertainty_score":0.3889708},"labels":[],"label_agreement":null},{"id":"W2137101132","doi":"10.1136/annrheumdis-2013-204655","title":"Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":658,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Astellas Pharma; Incyte; Eli Lilly and Company; CSL Behring; Tufts Medical Center; Celgene; Alexion Pharmaceuticals; Amgen; Pfizer; Regeneron Pharmaceuticals; Novo Nordisk; Teva Pharmaceutical Industries; GlaxoSmithKline","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Internal medicine; Placebo; Psoriasis; Psoriasis Area and Severity Index; Rheumatology; Clinical endpoint; Gastroenterology; Arthritis; Surgery; Tumor necrosis factor alpha; Randomized controlled trial; Immunology; Adalimumab; Pathology","score_opus":0.03503453515663549,"score_gpt":0.30328505710263504,"score_spread":0.2682505219459995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137101132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258894,0.0009513539,0.0000030003544,0.00038168352,0.00011821584,0.005148034,0.00077863474,0.000006222617,0.000023918175],"genre_scores_gemma":[0.99700713,0.0027509474,0.000028586923,0.000044513203,0.000022522981,0.0000745949,0.000049781775,0.0000134695465,0.000008450888],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976346,0.00045103306,0.0008603291,0.00036035213,0.00041179455,0.00028190084],"domain_scores_gemma":[0.9973615,0.0011951715,0.0008120383,0.0003402558,0.00017179443,0.00011926929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035359693,0.00031409078,0.0012547979,0.000054412863,0.0001980701,0.000022425367,0.00017540474,0.00010035114,0.000020721243],"category_scores_gemma":[0.0010232668,0.00013506303,0.0003031136,0.00016326093,0.00078218844,0.00007690393,0.00016378399,0.00013401626,3.8724585e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7413924,0.0027621512,0.24305591,0.00006508583,0.0008788579,0.0000011891956,0.00032322863,0.00000853852,0.00006616644,0.00002132685,0.000015713307,0.011409476],"study_design_scores_gemma":[0.47337267,0.0012412937,0.52393883,0.0007385466,0.000142855,0.0000011420182,0.00008553296,0.000079297104,0.0002733604,0.000040606574,0.0000046651717,0.000081211074],"about_ca_topic_score_codex":0.00007485039,"about_ca_topic_score_gemma":0.000021722091,"teacher_disagreement_score":0.2808829,"about_ca_system_score_codex":0.000011172315,"about_ca_system_score_gemma":0.00005852517,"threshold_uncertainty_score":0.55077106},"labels":[],"label_agreement":null},{"id":"W2137659055","doi":"10.1136/ard.2011.154211","title":"Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Italfarmaco; Universiteit van Amsterdam","keywords":"Medicine; Rheumatoid arthritis; Histone deacetylase; Cancer research; Messenger RNA; Fibroblast; Immunology; Histone; Gene; Cell culture; Genetics; Biology","score_opus":0.025956880234214514,"score_gpt":0.2758928229200386,"score_spread":0.24993594268582406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137659055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874851,0.010971645,0.000026709304,0.00023964401,0.00027248653,0.00048994325,0.00022291706,0.00002932883,0.00026224405],"genre_scores_gemma":[0.9946874,0.004083391,0.00018567563,0.00007993993,0.00006196894,0.00007727455,0.000074383206,0.000055804827,0.0006941926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977521,0.0002551685,0.00057972205,0.00053570705,0.00042540513,0.00045194812],"domain_scores_gemma":[0.99839115,0.000042742748,0.00032358195,0.00076528196,0.00021986806,0.00025737306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032194334,0.00030306375,0.0003438123,0.000082677136,0.00029437343,0.00004726312,0.00040335947,0.00013105765,0.000074125135],"category_scores_gemma":[0.0005838873,0.00025434617,0.00020188012,0.00018206508,0.000534317,0.000037842543,0.00038555652,0.0001539017,0.000012517203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055412337,0.0009593379,0.0009939894,0.000682402,0.00033321895,0.0000117215395,0.0010894574,0.000053255237,0.76934457,0.000059176215,0.18392467,0.041994054],"study_design_scores_gemma":[0.00049380335,0.00021891536,0.001204749,0.0006810816,0.000015871221,0.00004357626,0.00018598279,0.000048111157,0.994924,0.000056578647,0.0018300115,0.00029731423],"about_ca_topic_score_codex":0.00021741887,"about_ca_topic_score_gemma":0.00004119646,"teacher_disagreement_score":0.22557943,"about_ca_system_score_codex":0.000019881647,"about_ca_system_score_gemma":0.0001274034,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2137931573","doi":"10.1136/ard.2004.025296","title":"A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Polymyalgia rheumatica; Gold standard (test); Sensitivity (control systems); Internal medicine; Giant cell arteritis; Disease","score_opus":0.05097624853991661,"score_gpt":0.370879547409831,"score_spread":0.31990329886991437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137931573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987009,0.0023839555,0.00022305513,0.008901712,0.00012950697,0.0007215233,0.00039406185,0.000013549188,0.00022361867],"genre_scores_gemma":[0.9992669,0.000238403,0.00017709669,0.00014505144,0.000017815079,0.000025739088,0.000013392516,0.000012837089,0.00010277006],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987044,0.00015895278,0.00058544945,0.00010431201,0.00028648932,0.00016043901],"domain_scores_gemma":[0.9971245,0.0016300246,0.00040911016,0.00053820625,0.00022016942,0.000078018384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002403639,0.00011574786,0.0005222088,0.000042295487,0.00008788918,0.0000056607,0.00014981595,0.000050626837,0.00013598097],"category_scores_gemma":[0.0035457835,0.00006251492,0.0005328952,0.00015431452,0.0002778191,0.000047645026,0.00006761315,0.00006765931,0.0000033865977],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013984774,0.025212456,0.28476506,0.031906378,0.010621818,0.0000061490796,0.017259808,0.004369561,0.017060153,0.04314771,0.29918537,0.26506704],"study_design_scores_gemma":[0.0021321776,0.00033052667,0.92502207,0.010766267,0.0017584935,0.000025403911,0.0007711767,0.016248686,0.037563663,0.004875984,0.00029820477,0.00020734487],"about_ca_topic_score_codex":0.00005947505,"about_ca_topic_score_gemma":0.000008510155,"teacher_disagreement_score":0.640257,"about_ca_system_score_codex":0.000007459559,"about_ca_system_score_gemma":0.00010388579,"threshold_uncertainty_score":0.424489},"labels":[],"label_agreement":null},{"id":"W2138185297","doi":"10.1136/ard.2008.092353","title":"Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto","funders":"Versus Arthritis","keywords":"Medicine; Rheumatism; Rheumatology; Rheumatoid arthritis; MEDLINE; Cochrane Library; Clinical trial; Physical therapy; Systematic review; Disease; Evidence-based medicine; Internal medicine; Alternative medicine; Intensive care medicine; Randomized controlled trial; Pathology","score_opus":0.21404503956001358,"score_gpt":0.47660036089374636,"score_spread":0.26255532133373277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138185297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943462,0.0028586048,0.0002626577,0.0012476426,0.000113054055,0.0008981054,0.00018050348,0.00001778889,0.000075430136],"genre_scores_gemma":[0.9702313,0.028061736,0.0015167345,0.00006587783,0.000011055499,0.000046273482,0.000028939983,0.000025008698,0.000013103589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99314857,0.002382932,0.0032090892,0.00027469482,0.0006905982,0.00029409453],"domain_scores_gemma":[0.99130577,0.0035240273,0.003667954,0.00077520136,0.0004227434,0.00030428678],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005172485,0.00019894405,0.0015895087,0.00021747462,0.00012212234,0.000009027252,0.00021141977,0.000051826646,0.00014238719],"category_scores_gemma":[0.047158066,0.00012842902,0.000630937,0.00038392973,0.00050953217,0.00018454865,0.00010330915,0.00020746232,0.0000013688118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025556786,0.0032037417,0.70394605,0.00036842862,0.00040795456,0.000009990386,0.00035187122,0.00003420891,0.000059028876,0.00013876437,0.0007157257,0.28820857],"study_design_scores_gemma":[0.0031212892,0.0005427563,0.9854234,0.007586526,0.000018485815,0.000004397095,0.00013438487,0.00016084111,0.0019960436,0.00077185954,0.000115040464,0.0001249788],"about_ca_topic_score_codex":0.000102952916,"about_ca_topic_score_gemma":0.000014540668,"teacher_disagreement_score":0.28808358,"about_ca_system_score_codex":0.000013653928,"about_ca_system_score_gemma":0.00044095283,"threshold_uncertainty_score":0.9608681},"labels":[],"label_agreement":null},{"id":"W2138198084","doi":"10.1136/annrheumdis-2011-200300","title":"A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Foundation","keywords":"Medicine; Osteoarthritis; Asymptomatic; Cohort; Single-nucleotide polymorphism; Internal medicine; Chronic pain; Knee pain; Minor allele frequency; Joint pain; Allele; Gastroenterology; Pathology; Genotype; Genetics; Gene; Physical therapy; Biology","score_opus":0.033969715124418744,"score_gpt":0.29414963893207896,"score_spread":0.2601799238076602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138198084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761768,0.021916239,0.000017435757,0.0008860077,0.000081559425,0.000767063,0.00009681934,0.000016668419,0.000041392967],"genre_scores_gemma":[0.9986273,0.0005239087,0.0002747396,0.00025048724,0.000059027618,0.0001101133,0.000022968152,0.000015756867,0.000115692106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989883,0.00012600626,0.00027665042,0.00013148236,0.00022275884,0.00025483713],"domain_scores_gemma":[0.99892235,0.00047200284,0.00018732315,0.00022387042,0.00006998548,0.00012444316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032709606,0.000118621065,0.00029471717,0.00004170854,0.000066428605,0.00001624985,0.00006696494,0.000051821004,0.00005623416],"category_scores_gemma":[0.0010662028,0.00008860871,0.00011300301,0.00007616837,0.00003082846,0.00013209521,0.000037130136,0.000040000516,0.000005392442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036369872,0.00087912066,0.5710566,0.00047587443,0.00017217611,0.0000034477875,0.002898991,0.0000026892826,0.01308661,0.0002932946,0.00093812234,0.40982938],"study_design_scores_gemma":[0.0043077436,0.001913034,0.95994735,0.0062459344,0.00050909375,0.000003842323,0.0008949337,0.0001564627,0.012780793,0.012747059,0.00023672853,0.00025702582],"about_ca_topic_score_codex":0.00011980705,"about_ca_topic_score_gemma":0.00009373665,"teacher_disagreement_score":0.40957236,"about_ca_system_score_codex":0.000028059845,"about_ca_system_score_gemma":0.00003391774,"threshold_uncertainty_score":0.3613358},"labels":[],"label_agreement":null},{"id":"W2138766095","doi":"10.1136/ard.2007.078139","title":"Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Amgen","keywords":"Medicine; Etanercept; Ankylosing spondylitis; Adverse effect; Internal medicine; Placebo; Spondylitis; Randomized controlled trial; Surgery; Rheumatoid arthritis","score_opus":0.021910109807062587,"score_gpt":0.29442211409689967,"score_spread":0.2725120042898371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138766095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680305,0.0018056371,0.0000052825594,0.0002671146,0.000038457125,0.000642332,0.00022424209,0.000005068729,0.0002087983],"genre_scores_gemma":[0.9991167,0.0006035296,0.00009185178,0.000111957976,0.0000046714895,0.0000046068703,0.000019720479,0.000011603749,0.00003535046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897426,0.000033516288,0.00039605354,0.00012813631,0.0002930478,0.0001749882],"domain_scores_gemma":[0.99916184,0.00017310628,0.00017511807,0.00026654932,0.00013192637,0.000091458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013161793,0.00012102271,0.0004384552,0.00009166953,0.00003420386,0.0000026823495,0.00006998452,0.00002307407,0.00006601959],"category_scores_gemma":[0.00016113014,0.00007246666,0.00007597139,0.00022965204,0.00013961105,0.0000371828,0.000046080546,0.000033164833,5.9308434e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009535044,0.001319812,0.82704145,0.0002584032,0.00037236654,0.000005446216,0.001849677,0.000008252477,0.00003113501,0.00010219001,0.0001268879,0.1593493],"study_design_scores_gemma":[0.006425843,0.0012917996,0.9889923,0.0020743608,0.00006268522,0.0000016061914,0.00032225266,0.0000015280972,0.00061024365,0.000070638045,0.000083473846,0.00006331396],"about_ca_topic_score_codex":0.00016579063,"about_ca_topic_score_gemma":0.000028064364,"teacher_disagreement_score":0.16195078,"about_ca_system_score_codex":0.000009434837,"about_ca_system_score_gemma":0.000027883842,"threshold_uncertainty_score":0.29551047},"labels":[],"label_agreement":null},{"id":"W2138889175","doi":"10.1136/ard.2010.147744","title":"Predicting the outcome of ankylosing spondylitis therapy","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Vlaamse regering; Fonds Wetenschappelijk Onderzoek","keywords":"Medicine; BASFI; Ankylosing spondylitis; Logistic regression; Enthesitis; Golimumab; Population; Univariate; Internal medicine; Physical therapy; BASDAI; Outcome (game theory); Spondylitis; Infliximab; Disease; Multivariate statistics; Machine learning; Psoriatic arthritis","score_opus":0.1392084997305119,"score_gpt":0.3366582050186021,"score_spread":0.19744970528809022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138889175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885876,0.007754832,0.0000024882693,0.0007467985,0.00013743718,0.0003886984,0.00018202138,0.000019213414,0.0021808965],"genre_scores_gemma":[0.9980518,0.0013804508,0.000056684577,0.0003107026,0.000019016023,0.000020897498,0.0000061476176,0.000013780439,0.00014047016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998969,0.00006439277,0.00039969487,0.00011054541,0.00027702344,0.00017934044],"domain_scores_gemma":[0.998941,0.00015808964,0.0002585661,0.00047074887,0.00011337333,0.000058236234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014622213,0.0001222586,0.00034363064,0.000032323464,0.00012434754,0.0000051676498,0.00017206406,0.000022187647,0.00032084988],"category_scores_gemma":[0.00031414191,0.0000585108,0.00029565595,0.00014389698,0.00022437985,0.000050774852,0.000076344295,0.00004962698,0.0000039210377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033923573,0.0005901995,0.96161354,0.00018688134,0.0006297745,0.000006096182,0.001983809,8.0937025e-7,0.00001707374,0.0006565598,0.00045995842,0.03351606],"study_design_scores_gemma":[0.0010302453,0.00027588263,0.99318653,0.0007898061,0.00017602526,0.000013214191,0.00089332287,0.000020158412,0.0017259698,0.0016207567,0.00020874332,0.00005933197],"about_ca_topic_score_codex":0.00039650308,"about_ca_topic_score_gemma":0.000007610174,"teacher_disagreement_score":0.033456728,"about_ca_system_score_codex":0.00000549892,"about_ca_system_score_gemma":0.000029158258,"threshold_uncertainty_score":0.35130814},"labels":[],"label_agreement":null},{"id":"W2139101049","doi":"10.1136/annrheumdis-2014-eular.6038","title":"THU0105 Auto-Antibodies to A Specific 14-3-3Eta Epitope is A Marker of Ankylosing Spondylitis, is Associated with SIJ Inflammation and Predicts Radiographic Progression","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Rheumatology; Internal medicine; Inflammation; BASDAI; Receiver operating characteristic; Spondylitis; Mann–Whitney U test; Gastroenterology; Autoantibody; Antibody; Immunology; Disease; Psoriatic arthritis","score_opus":0.02081223962011384,"score_gpt":0.28835016355762494,"score_spread":0.2675379239375111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139101049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98285544,0.011397802,0.000040618157,0.004238752,0.000053571173,0.00086905,0.0002648638,0.000043147244,0.000236774],"genre_scores_gemma":[0.9856919,0.013676292,0.00021253769,0.00019786677,0.000028190752,0.000035557194,0.00004381071,0.000027613542,0.00008622422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977901,0.00026383725,0.00051210896,0.0002634656,0.00082589727,0.0003445813],"domain_scores_gemma":[0.9981436,0.00031978777,0.00034638672,0.00049958937,0.0003883413,0.00030230585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005700207,0.00021704055,0.0005965688,0.0002637608,0.00015364526,0.000061034763,0.0001853016,0.00006021481,0.0002111015],"category_scores_gemma":[0.0012289577,0.00013432518,0.00017810598,0.00046932936,0.00042749548,0.0002126128,0.00010486178,0.00010415157,0.0000032677617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003765654,0.001155102,0.4866887,0.0027601747,0.0023497501,0.0000171543,0.008366094,0.000012089156,0.003819906,0.0011929206,0.030895317,0.45897713],"study_design_scores_gemma":[0.0026161175,0.0011808933,0.9583501,0.01987251,0.00008305736,0.000026276402,0.00030235254,0.001187748,0.009299093,0.0026621073,0.004151869,0.0002678487],"about_ca_topic_score_codex":0.00003267553,"about_ca_topic_score_gemma":0.000008135907,"teacher_disagreement_score":0.47166142,"about_ca_system_score_codex":0.000010269482,"about_ca_system_score_gemma":0.00009663112,"threshold_uncertainty_score":0.54776216},"labels":[],"label_agreement":null},{"id":"W2139198208","doi":"10.1136/annrheumdis-2013-205171","title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital; University of Calgary; University of Manitoba; Centre hospitalier universitaire de Québec; Toronto Western Hospital; Dalhousie University; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre","funders":"National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute for Health and Care Research; Canadian Institutes of Health Research; Versus Arthritis; Wellcome Trust","keywords":"Medicine; Systemic lupus erythematosus; Cohort; Internal medicine; Rheumatology; Systemic lupus; Ethnic group; Proportional hazards model; Disease","score_opus":0.03961258084733179,"score_gpt":0.3045877842346829,"score_spread":0.26497520338735114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139198208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953597,0.00025380185,0.00003166492,0.00040216872,0.00060575135,0.0022598095,0.0008218631,0.00007308684,0.00019213221],"genre_scores_gemma":[0.99875,0.00006944723,0.000016497333,0.00010953365,0.00006419778,0.000100430516,0.00057931343,0.00006463411,0.00024596855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99468786,0.0009837713,0.0014139283,0.00050464994,0.0019527277,0.00045707202],"domain_scores_gemma":[0.9929186,0.0030730239,0.0015007635,0.0012000764,0.0011168716,0.00019067648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015554748,0.00039183346,0.0009848872,0.00016725298,0.00017561745,0.00010811089,0.0008253874,0.0001459572,0.000023373148],"category_scores_gemma":[0.007498571,0.00018984027,0.00017023292,0.00074549415,0.00027670807,0.0002545292,0.00021953054,0.00030742487,0.000011058706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012088412,0.0004278294,0.9921036,0.00047156718,0.0007816584,0.0000025358406,0.0029611355,0.00028902828,0.0000081482385,0.00004213702,0.0014456396,0.00025789248],"study_design_scores_gemma":[0.009532156,0.0003803923,0.9474727,0.029974308,0.00031628823,0.00010122767,0.008859167,0.0029389174,0.000032028416,0.00007902785,0.00001421531,0.00029957606],"about_ca_topic_score_codex":0.0002023408,"about_ca_topic_score_gemma":0.0001469508,"teacher_disagreement_score":0.044630893,"about_ca_system_score_codex":0.0002457274,"about_ca_system_score_gemma":0.00039365125,"threshold_uncertainty_score":0.89770323},"labels":[],"label_agreement":null},{"id":"W2139255442","doi":"10.1136/ard.2010.147025","title":"Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Allele; Enhancer; Medicine; Allele frequency; Immunology; Locus (genetics); Lupus erythematosus; Molecular biology; Antibody; Internal medicine; Genetics; Biology; Transcription factor; Gene","score_opus":0.016632791138573404,"score_gpt":0.23945818153350507,"score_spread":0.22282539039493166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139255442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91713405,0.08119818,0.000007095315,0.00016189335,0.00093354215,0.00023625024,0.00014476228,0.000012177252,0.00017203181],"genre_scores_gemma":[0.99504507,0.0036045585,0.0000056158124,0.000033250413,0.000009532385,0.000014356833,0.000004178418,0.000012595065,0.0012708657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985514,0.0004440609,0.0005166456,0.00012667962,0.000065762135,0.00029540373],"domain_scores_gemma":[0.9980914,0.00039263835,0.0007656601,0.0006425763,0.000082485305,0.00002526882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002569844,0.00016732526,0.0004907058,0.000050196115,0.00012100901,0.0000030144208,0.00045795596,0.00012072758,0.00020047433],"category_scores_gemma":[0.00026250837,0.00008718917,0.00026817797,0.00012538314,0.0008125749,0.00007071701,0.00025848963,0.00011932067,0.00002699722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002997422,0.0009329442,0.2475154,0.0008649561,0.0018634383,2.06212e-7,0.00276737,0.000009080504,0.73115987,0.0028065736,0.0054423236,0.006338121],"study_design_scores_gemma":[0.0013128411,0.00014798339,0.07764438,0.0017097675,0.00073203386,0.00022987065,0.0013735461,0.0000036648787,0.91427994,0.001954276,0.000386781,0.00022492],"about_ca_topic_score_codex":0.00028971472,"about_ca_topic_score_gemma":0.0000050092344,"teacher_disagreement_score":0.18312009,"about_ca_system_score_codex":0.000005102508,"about_ca_system_score_gemma":0.000048631362,"threshold_uncertainty_score":0.3555471},"labels":[],"label_agreement":null},{"id":"W2139317340","doi":"10.1136/annrheumdis-2012-202099","title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; Université Laval; Royal Victoria Regional Health Centre; McGill University Health Centre; University of Manitoba; Toronto Western Hospital; Royal Victoria Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Systemic lupus; Systemic lupus erythematosus; Lymphoma; Systemic disease; Disease; Dermatology; Internal medicine; Rheumatology; Immunology","score_opus":0.0329120045944078,"score_gpt":0.3166042749182942,"score_spread":0.2836922703238864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139317340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914497,0.0053582815,0.000005743547,0.00035783328,0.0003333108,0.0022535955,0.000053219985,0.000027551618,0.0001607439],"genre_scores_gemma":[0.997294,0.0018939491,0.000008133511,0.000015458418,0.0000209398,0.00035553394,0.0000043332257,0.000027305136,0.0003803626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780464,0.000465273,0.00049142446,0.00024763466,0.0006458815,0.00034514914],"domain_scores_gemma":[0.99659485,0.0014609306,0.00039469742,0.0010479409,0.000174045,0.00032751323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001947868,0.00022714633,0.0007419167,0.000172255,0.00004546119,0.000014083089,0.00027286093,0.000052345073,0.000059689235],"category_scores_gemma":[0.0020728954,0.00013346762,0.0003982978,0.0003256012,0.00017732538,0.00012480463,0.00010903209,0.000051108513,0.000058969472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044931695,0.003968345,0.88954633,0.023109956,0.0012379347,0.000028772327,0.0015096043,0.000083780054,0.00062253076,0.0000938119,0.0024765069,0.07282928],"study_design_scores_gemma":[0.019064793,0.0015559945,0.9390778,0.024774505,0.00095407537,0.0001771158,0.001224054,0.0034789485,0.008363797,0.0009587483,0.000022132435,0.00034801458],"about_ca_topic_score_codex":0.0012899376,"about_ca_topic_score_gemma":0.000012830675,"teacher_disagreement_score":0.07248126,"about_ca_system_score_codex":0.00015181716,"about_ca_system_score_gemma":0.00036228783,"threshold_uncertainty_score":0.54426515},"labels":[],"label_agreement":null},{"id":"W2139525798","doi":"10.1136/ard.2011.151563","title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":410,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sulfasalazine; Ankylosing spondylitis; Antirheumatic drugs; Axial spondyloarthritis; Spondylitis; Internal medicine; Adalimumab; Drug; Tumor necrosis factor alpha; Antirheumatic Agents; Disease; Physical therapy; Surgery; Pharmacology; Sacroiliitis","score_opus":0.12146093156715604,"score_gpt":0.30913466337871576,"score_spread":0.18767373181155972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139525798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947178,0.00028500927,0.000008007071,0.002561357,0.00039193156,0.0008528592,0.0011103,0.0000042288675,0.00006850714],"genre_scores_gemma":[0.99864703,0.00066505786,0.0002013961,0.00023920444,0.000008922807,0.0000545769,0.00004930871,0.0000121829635,0.00012232034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901927,0.000045517227,0.00038546283,0.00011336992,0.00030236773,0.00013399438],"domain_scores_gemma":[0.99877083,0.00017840895,0.00035516868,0.00040404985,0.00025670038,0.000034834586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008439277,0.00011126089,0.0002684816,0.000051250823,0.00008340924,0.000006950613,0.0002560913,0.00002207943,0.00019016604],"category_scores_gemma":[0.00035066027,0.00005289921,0.0001896633,0.00014607183,0.0002043048,0.00010487867,0.000125314,0.0000455825,0.000001680466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095689396,0.0020471818,0.9441891,0.00008852781,0.0008595793,8.6115375e-7,0.000611897,0.000015863925,0.0000027956437,0.00035696736,0.016319674,0.034550715],"study_design_scores_gemma":[0.0029034102,0.00020670363,0.9932723,0.00092546147,0.00017925909,9.617085e-7,0.0001214549,0.000041983425,0.00033369983,0.00029523697,0.0016675834,0.000051966632],"about_ca_topic_score_codex":0.00034411624,"about_ca_topic_score_gemma":0.00011261326,"teacher_disagreement_score":0.049083233,"about_ca_system_score_codex":0.000009413716,"about_ca_system_score_gemma":0.000048350306,"threshold_uncertainty_score":0.2157167},"labels":[],"label_agreement":null},{"id":"W2140224717","doi":"10.1136/ard.2007.074591","title":"Individualising the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) function subscale: incorporating patient priorities for improvement to measure functional impairment in hip or knee osteoarthritis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"WOMAC; Osteoarthritis; Medicine; Physical therapy; Physical medicine and rehabilitation; Alternative medicine","score_opus":0.031658528763064395,"score_gpt":0.2577934937758745,"score_spread":0.2261349650128101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140224717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435997,0.0012163636,0.00016223486,0.0011252611,0.00034628157,0.0025136694,0.000118796954,0.00002957023,0.00012786135],"genre_scores_gemma":[0.9976015,0.00002161837,0.000119958364,0.0010522207,0.00005857446,0.00016445182,0.000036700523,0.000026829675,0.00091812696],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806195,0.00006964388,0.000582165,0.00029330724,0.0005985384,0.00039441467],"domain_scores_gemma":[0.99877286,0.00025885148,0.00027257507,0.0002725457,0.00023728922,0.00018587448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042959212,0.00027007036,0.00040091,0.00018384443,0.00027302816,0.000071055474,0.00009849928,0.00007768165,0.00007163308],"category_scores_gemma":[0.000082009356,0.00017571883,0.00015605621,0.00022431894,0.00013517174,0.00024599922,0.00015091957,0.00012723659,0.0000019066691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005401442,0.00035091417,0.10425446,0.00032044997,0.0001656657,0.000020489471,0.0060068863,0.000024942217,0.0002505992,0.00019576328,0.00024931252,0.8827591],"study_design_scores_gemma":[0.01909745,0.031493027,0.8965902,0.0067975554,0.0006808693,0.00012239184,0.034587264,0.000020603187,0.0054748957,0.002156502,0.002284268,0.00069500157],"about_ca_topic_score_codex":0.0007398003,"about_ca_topic_score_gemma":0.016963843,"teacher_disagreement_score":0.88206404,"about_ca_system_score_codex":0.0001749164,"about_ca_system_score_gemma":0.00037294652,"threshold_uncertainty_score":0.94662225},"labels":[],"label_agreement":null},{"id":"W2141125661","doi":"10.1136/ard.2006.051904","title":"Association of polymorphisms in the peroxisome proliferator-activated receptor γ gene and osteoarthritis of the knee","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Hôpital du Sacré-Cœur de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Peroxisome proliferator-activated receptor gamma; Peroxisome proliferator-activated receptor; Peroxisome proliferator-activated receptor alpha; Gene; Receptor; Internal medicine; Peroxisome proliferator; Bioinformatics; Genetics; Pathology; Transcription factor; Alternative medicine; Nuclear receptor; Biology","score_opus":0.008463351344857546,"score_gpt":0.2267874356309709,"score_spread":0.21832408428611336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141125661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955462,0.0023940357,0.0000022223967,0.0012261342,0.000101623904,0.00044987505,0.00020364023,0.0000044532435,0.000071794784],"genre_scores_gemma":[0.9992805,0.00030169555,0.000019537627,0.00015321816,0.000039923496,0.000044243283,0.000028406017,0.000016466358,0.00011597893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984491,0.0003719207,0.00045735954,0.00017842648,0.00034310363,0.00020007759],"domain_scores_gemma":[0.99873984,0.00008359435,0.0005416292,0.00045082293,0.00015185121,0.000032293046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003007006,0.00015793438,0.0002665564,0.000043224863,0.00007375477,0.0000151858685,0.00036539405,0.00011534825,0.000018402956],"category_scores_gemma":[0.0005083514,0.00008949036,0.00016976421,0.0002681117,0.00018948237,0.00001371652,0.00012987413,0.00008629589,6.369475e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014016697,0.00035087715,0.131298,0.00009585214,0.00013428429,1.16405374e-7,0.00018226617,0.000053152606,0.8634976,0.00007920359,0.002323482,0.0018449778],"study_design_scores_gemma":[0.0005274022,0.0001442992,0.10694468,0.00016437944,0.000032678665,0.000001986993,0.00011272606,0.0000075420867,0.89148825,0.000269479,0.00020732186,0.00009923639],"about_ca_topic_score_codex":0.0001077443,"about_ca_topic_score_gemma":0.00002339862,"teacher_disagreement_score":0.027990649,"about_ca_system_score_codex":0.000012601243,"about_ca_system_score_gemma":0.000101949925,"threshold_uncertainty_score":0.36493108},"labels":[],"label_agreement":null},{"id":"W2141181988","doi":"10.1136/ard.2009.116624","title":"EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Henoch-Schonlein purpura; Polyarteritis nodosa; Takayasu arteritis; Vasculitis; Purpura (gastropod); Arteritis; Systemic vasculitis; Dermatology; Pediatrics; Pathology; Disease","score_opus":0.04787717070497026,"score_gpt":0.3429895696883762,"score_spread":0.2951123989834059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141181988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830771,0.00399306,0.00013013279,0.00923028,0.00074995967,0.0013404136,0.001348069,0.00007381968,0.000057181267],"genre_scores_gemma":[0.9897984,0.0057586227,0.0019046561,0.001538563,0.00033540936,0.0001841749,0.00035150576,0.000060597555,0.00006801931],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997207,0.00038959854,0.0010700186,0.000564983,0.00029928054,0.0004691074],"domain_scores_gemma":[0.9977685,0.00042297045,0.0004548388,0.00073567696,0.00018722643,0.0004307903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058914407,0.00037550356,0.0009880961,0.00014263479,0.00033808273,0.00011168409,0.00023731419,0.0002881262,0.00040424036],"category_scores_gemma":[0.0010944509,0.0002851201,0.000579542,0.00012431256,0.0004949206,0.00028238058,0.00014879224,0.0003565919,0.000008333467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000859017,0.0128434915,0.14380121,0.002685535,0.010046977,0.00006379588,0.009971716,0.00000449639,0.010168954,0.007486306,0.0423617,0.7597068],"study_design_scores_gemma":[0.0031599707,0.00044131087,0.9868732,0.0009726858,0.00089037325,0.00037141045,0.00013845536,0.00008219934,0.0007982109,0.0047859913,0.0011669219,0.00031924687],"about_ca_topic_score_codex":0.0000802558,"about_ca_topic_score_gemma":0.000021428594,"teacher_disagreement_score":0.843072,"about_ca_system_score_codex":0.000005665237,"about_ca_system_score_gemma":0.00011492089,"threshold_uncertainty_score":0.9999601},"labels":[],"label_agreement":null},{"id":"W2141264604","doi":"10.1136/annrheumdis-2015-207416","title":"ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients","year":2015,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Toronto Rehabilitation Institute; University Health Network; University of Toronto; Memorial University of Newfoundland; Toronto Western Hospital","funders":"National Health and Medical Research Council; National Institutes of Health; Versus Arthritis; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Royal Australasian College of Physicians; Medical Research Council; National Institute for Health and Care Research","keywords":"Allele; Haplotype; Linkage disequilibrium; Ankylosing spondylitis; Locus (genetics); Human leukocyte antigen; Genetics; Biology; Immunology; Antigen; Gene","score_opus":0.03159125954960245,"score_gpt":0.28079332802403834,"score_spread":0.24920206847443588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141264604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9009855,0.005832616,4.6763e-7,0.08011206,0.00018532143,0.0016225398,0.010105117,0.00003573551,0.0011206742],"genre_scores_gemma":[0.86521155,0.0017285453,0.00005021251,0.1285747,0.000155447,0.00016981542,0.0024831237,0.00013584159,0.0014907893],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9971062,0.00029049674,0.00059946504,0.0005017544,0.00095373834,0.0005483407],"domain_scores_gemma":[0.9974229,0.0005958672,0.00065553735,0.0004985541,0.00065772363,0.00016945822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015153724,0.00054003287,0.0013276269,0.00020601823,0.00015371814,0.00004659667,0.00018472993,0.00025465808,0.00013793551],"category_scores_gemma":[0.0009857034,0.00035120244,0.00025828037,0.00038534252,0.0004346244,0.00014774523,0.0001765241,0.00046114816,0.000007775554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012420659,0.0017225661,0.21728511,0.000978451,0.004969161,0.0007018611,0.0045353244,0.0000016006477,4.49963e-7,0.000012811118,0.75572705,0.012823523],"study_design_scores_gemma":[0.011738298,0.0020774195,0.9434254,0.02872631,0.0018810534,0.000034414985,0.0006406347,0.00002751588,0.00009950562,0.002401456,0.008180025,0.00076796423],"about_ca_topic_score_codex":0.00070650765,"about_ca_topic_score_gemma":0.000091190035,"teacher_disagreement_score":0.74754703,"about_ca_system_score_codex":0.00011483298,"about_ca_system_score_gemma":0.00020899391,"threshold_uncertainty_score":0.999894},"labels":[],"label_agreement":null},{"id":"W2141537603","doi":"10.1136/ard.2011.153742","title":"Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatism; Rheumatoid arthritis; Internal medicine; Rheumatology; Cohort; Observational study; Rheumatoid factor; Arthritis; Cohort study; Physical therapy","score_opus":0.09509774179134468,"score_gpt":0.31685218600694015,"score_spread":0.22175444421559548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141537603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896678,0.0058406885,0.0000016718814,0.0025331185,0.00005818059,0.00050591223,0.00018419523,0.000015734373,0.0011927547],"genre_scores_gemma":[0.9807748,0.018846959,0.000019820345,0.00022836067,0.0000050493973,0.00004679879,0.000013046652,0.000014380325,0.000050759496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803567,0.0003437404,0.00053819164,0.0001844898,0.00061753666,0.00028038633],"domain_scores_gemma":[0.99866027,0.00034396775,0.00023199174,0.0005244816,0.00008910971,0.00015018367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052227965,0.00016315733,0.00044611882,0.00015023479,0.000056889356,0.000016812979,0.0002854515,0.000045157678,0.00018183046],"category_scores_gemma":[0.001737926,0.00009376182,0.00016442766,0.0002672508,0.00044975986,0.00012186718,0.000054405213,0.00016851907,0.000015372858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008183476,0.008210739,0.82234776,0.0014359026,0.00039186433,0.0001492332,0.005817059,0.000008317927,0.0016201107,0.011022445,0.05241092,0.08840219],"study_design_scores_gemma":[0.0019748565,0.0005589914,0.97491205,0.006152719,0.000007850387,0.000008696753,0.00045883076,0.00004241017,0.004500109,0.010876527,0.0003351477,0.00017183305],"about_ca_topic_score_codex":0.0006157557,"about_ca_topic_score_gemma":0.000040587027,"teacher_disagreement_score":0.15256429,"about_ca_system_score_codex":0.000014627913,"about_ca_system_score_gemma":0.00016561427,"threshold_uncertainty_score":0.38234958},"labels":[],"label_agreement":null},{"id":"W2141825494","doi":"10.1136/ard.2007.085787","title":"Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"National Center for Research Resources; National Institutes of Health; Versus Arthritis; National Institute for Health and Care Research; Biogen","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Internal medicine; Placebo; Methotrexate; Gastroenterology; Clinical endpoint; TNF inhibitor; Arthritis; Surgery; Clinical trial; Pathology; Etanercept; Lymphoma","score_opus":0.026199097370654668,"score_gpt":0.26851879924680455,"score_spread":0.24231970187614987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141825494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945704,0.0017864433,0.0000071655068,0.0018476648,0.000054775915,0.001359867,0.00028221586,0.00006971369,0.000021779211],"genre_scores_gemma":[0.9965958,0.002418603,0.00038540075,0.0003321125,0.000015534617,0.000094841496,0.000036468828,0.00007155099,0.00004967917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965295,0.0004598584,0.0006941599,0.00044137804,0.0011979911,0.0006771155],"domain_scores_gemma":[0.99774456,0.00018313785,0.00027294902,0.00078545726,0.00045095003,0.00056295464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025994345,0.0004206767,0.00093295606,0.00037381516,0.00030415168,0.0000804419,0.00033257462,0.00006250503,0.00017071844],"category_scores_gemma":[0.0006305781,0.00024848734,0.00016474671,0.00062208646,0.00056908623,0.00059683924,0.00013473353,0.00024757045,0.00002054806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056039006,0.0042400626,0.86074585,0.0004226949,0.0007159812,0.00013889764,0.016144387,0.00011542337,0.0016169007,0.00015531515,0.0017661186,0.05789939],"study_design_scores_gemma":[0.009857657,0.003390069,0.975692,0.004286216,0.000004936411,0.000038126767,0.0005590618,0.000048321443,0.0054020756,0.00028782766,0.00008465938,0.00034905397],"about_ca_topic_score_codex":0.00029823644,"about_ca_topic_score_gemma":0.00019996462,"teacher_disagreement_score":0.11494617,"about_ca_system_score_codex":0.00004554217,"about_ca_system_score_gemma":0.00039381871,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W2141953337","doi":"10.1136/annrheumdis-2013-203684","title":"The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Amgen (Canada); Southlake Regional Health Center; Centre Hospitalier de l’Université de Montréal; St Joseph's Health Centre","funders":"Genentech; AstraZeneca; Amgen Canada; Pfizer; Amgen; Bristol-Myers Squibb; Pfizer Pharmaceuticals; Pfizer Canada; Abbott Laboratories","keywords":"Medicine; Etanercept; Methotrexate; Rheumatoid arthritis; Internal medicine; Combination therapy; Clinical endpoint; Gastroenterology; Surgery; Clinical trial","score_opus":0.04059478235058027,"score_gpt":0.33128450913683216,"score_spread":0.2906897267862519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141953337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96243525,0.03140797,0.000004945771,0.0016939221,0.00018382186,0.004019944,0.000063623585,0.00001647609,0.00017405915],"genre_scores_gemma":[0.924486,0.074688196,0.00019985832,0.00005305027,0.0000150844835,0.00042756813,0.0000040588475,0.000044491004,0.000081717175],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945853,0.001955079,0.001605594,0.00040048876,0.0007970314,0.0006565284],"domain_scores_gemma":[0.99430907,0.0033755626,0.0007018032,0.00079792604,0.0003781191,0.00043754067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030288412,0.0004012493,0.001642392,0.00033497636,0.00021587014,0.00013849908,0.00037698966,0.00010638213,0.00016240394],"category_scores_gemma":[0.004242417,0.00023468013,0.000409296,0.00038342157,0.00093649485,0.00029912996,0.00015742292,0.00034760885,0.0000024975088],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11016403,0.0010018173,0.091340594,0.00039703873,0.0023369088,0.00003481873,0.02619642,0.000015608168,0.0007497873,0.00023896739,0.00017453868,0.7673495],"study_design_scores_gemma":[0.32739875,0.0031385801,0.6408543,0.005169024,0.00013296067,0.000026454449,0.017851945,0.000558258,0.0014420538,0.0023764838,0.00037342636,0.0006777738],"about_ca_topic_score_codex":0.048417196,"about_ca_topic_score_gemma":0.036007687,"teacher_disagreement_score":0.7666717,"about_ca_system_score_codex":0.000024903988,"about_ca_system_score_gemma":0.00023099194,"threshold_uncertainty_score":0.98158264},"labels":[],"label_agreement":null},{"id":"W2142605757","doi":"10.1136/ard.60.12.1088","title":"Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Doxycycline; Placebo; Internal medicine; Arthritis; Reactive arthritis; Quality of life (healthcare); Clinical trial; Physical therapy; Surgery; Antibiotics; Pathology","score_opus":0.04599040717958664,"score_gpt":0.33853676869671956,"score_spread":0.2925463615171329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142605757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97424626,0.014627566,0.000048018912,0.0020681773,0.00030095654,0.007834104,0.00019029879,0.000021633623,0.0006629689],"genre_scores_gemma":[0.9890665,0.009048592,0.00006707729,0.00012904234,0.00010882825,0.0009607076,0.00002251288,0.000020534539,0.00057624653],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983585,0.00009706616,0.000756281,0.00018395756,0.00033884385,0.00026538517],"domain_scores_gemma":[0.9978257,0.0009109407,0.00050904206,0.00038701785,0.00025559202,0.00011171322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024131706,0.00019912531,0.0012233275,0.000065313056,0.000108803375,0.000007881635,0.00012618618,0.000047859194,0.00017510573],"category_scores_gemma":[0.0015473902,0.00012172413,0.0008335251,0.00014688146,0.00020678455,0.000056124198,0.000047257094,0.000048522437,0.000005273235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9481923,0.0020034062,0.00054295285,0.00027216793,0.0022386215,0.00000734539,0.00017136394,0.000030467843,0.000027593485,0.0002046763,0.0027002431,0.04360887],"study_design_scores_gemma":[0.9899217,0.0024013005,0.0021465009,0.0015592382,0.00074814743,0.000010416637,0.00021304467,0.00018635191,0.00063984253,0.0016877435,0.0003712375,0.00011450126],"about_ca_topic_score_codex":0.000050713905,"about_ca_topic_score_gemma":0.000037643167,"teacher_disagreement_score":0.04349437,"about_ca_system_score_codex":0.000020012396,"about_ca_system_score_gemma":0.00016860059,"threshold_uncertainty_score":0.49637657},"labels":[],"label_agreement":null},{"id":"W2142671052","doi":"10.1136/annrheumdis-2012-201777","title":"Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ankylosing spondylitis; Medicine; Referral; Spondylitis; Axial spondyloarthritis; Radiology; Physical therapy; Sacroiliitis; Internal medicine; Family medicine","score_opus":0.11237323116756179,"score_gpt":0.4045266847218872,"score_spread":0.2921534535543254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142671052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648637,0.03218831,0.0000129728205,0.0005462966,0.000263303,0.0014060183,0.0005832296,0.000016312544,0.0001198609],"genre_scores_gemma":[0.9979284,0.0013567832,0.00035004131,0.000067841254,0.00006937357,0.00016045447,0.000027727165,0.000027950951,0.000011470194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980051,0.00018353075,0.00080973154,0.00020525738,0.0004217792,0.0003745882],"domain_scores_gemma":[0.99745625,0.0011722225,0.00057028723,0.0004478409,0.00023534351,0.00011805835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004369183,0.00023679738,0.0008868844,0.00008335518,0.00027639052,0.000031589985,0.00015548556,0.0000397449,0.000043797638],"category_scores_gemma":[0.00076185394,0.00014814473,0.0002858204,0.0002176811,0.000394041,0.0002551815,0.00013538793,0.00008599549,5.4060325e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075248734,0.003179638,0.929848,0.0007233162,0.0007282663,0.0000026356213,0.005479849,0.000008972395,0.000038200116,0.00090202445,0.0009894046,0.05734718],"study_design_scores_gemma":[0.0059672105,0.0023219932,0.9466801,0.0055858726,0.0017215685,0.000022622295,0.029700266,0.000051208644,0.0039201668,0.003440058,0.0003332916,0.00025560684],"about_ca_topic_score_codex":0.000469724,"about_ca_topic_score_gemma":0.0000792684,"teacher_disagreement_score":0.057091575,"about_ca_system_score_codex":0.000014982082,"about_ca_system_score_gemma":0.00007623716,"threshold_uncertainty_score":0.6041166},"labels":[],"label_agreement":null},{"id":"W2142766993","doi":"10.1136/annrheumdis-2011-201038","title":"ASAS recommendations for variables to be collected in clinical trials/epidemiological studies of spondyloarthritis","year":2012,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Clinical trial; Data collection; Physical therapy; Medical physics; Epidemiology; Alternative medicine; Family medicine; Pathology; Statistics","score_opus":0.48435137084873703,"score_gpt":0.5128488217366031,"score_spread":0.028497450887866038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142766993","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046717387,0.029626636,0.000017804678,0.91225284,0.0014265671,0.0043235947,0.0053782077,0.000033510903,0.00022342954],"genre_scores_gemma":[0.116419695,0.07573631,0.0071239993,0.78358126,0.0029931208,0.0050502038,0.0030684343,0.00024588488,0.005781107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99408555,0.0017547682,0.002902987,0.0003946153,0.00035964182,0.0005024596],"domain_scores_gemma":[0.9806075,0.016724546,0.0013271705,0.00067028543,0.00051923736,0.00015126071],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0032885636,0.00038789507,0.0037511336,0.0002181518,0.00012510561,0.000008519824,0.00027241875,0.00036452946,0.00024168911],"category_scores_gemma":[0.056953486,0.00023481315,0.001340501,0.00041496218,0.00033807423,0.000048739606,0.00022386067,0.00037306474,0.000005671431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062606327,0.00085478905,0.006417055,0.000942061,0.0023652415,0.000011366617,0.00019349135,0.0000015526556,8.491816e-7,0.00012598354,0.9726599,0.015801637],"study_design_scores_gemma":[0.010900441,0.003184911,0.10900163,0.018170806,0.0043887724,0.00002549034,0.001048415,0.000018481413,0.000065254615,0.009417613,0.84309876,0.00067944144],"about_ca_topic_score_codex":0.00009241453,"about_ca_topic_score_gemma":0.000048564194,"teacher_disagreement_score":0.12956117,"about_ca_system_score_codex":0.0000416749,"about_ca_system_score_gemma":0.00019854266,"threshold_uncertainty_score":0.9575403},"labels":[],"label_agreement":null},{"id":"W2143033188","doi":"10.1136/ard.60.3.293","title":"Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Anti-neutrophil cytoplasmic antibody; Vasculitis; Malignancy; Systemic vasculitis; Lymphoma; Pathology; Immunology","score_opus":0.01802767418836101,"score_gpt":0.2736835371595603,"score_spread":0.2556558629711993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143033188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99237794,0.0027035924,0.000032604887,0.0024259884,0.00013970147,0.00047509442,0.00013083493,0.0000997716,0.0016144975],"genre_scores_gemma":[0.99493164,0.0035939345,0.000012908236,0.00034408458,0.000033617493,0.000023912204,0.00014076082,0.00003394639,0.0008851931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834955,0.0001201388,0.0004546037,0.00023263572,0.00049538806,0.00034768615],"domain_scores_gemma":[0.99849397,0.00014591186,0.00030652413,0.0005942511,0.00026213776,0.00019722684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001247533,0.00021987512,0.0005571894,0.00010549283,0.00018167171,0.000027059366,0.00021086872,0.00008987144,0.0001913803],"category_scores_gemma":[0.00032200676,0.00012833004,0.00042772287,0.0005096818,0.0001917988,0.0001086451,0.00004787497,0.00011972538,0.000044155982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006872841,0.004075213,0.9410742,0.0020908867,0.010171602,0.0006604566,0.0009469292,0.0015341406,0.0018438749,0.003572192,0.019105667,0.014237557],"study_design_scores_gemma":[0.0047641974,0.00040109555,0.97597384,0.011448881,0.0016523509,0.0026953623,0.00037401434,0.00079014315,0.00048074377,0.0007539329,0.00031806988,0.00034736018],"about_ca_topic_score_codex":0.00007166419,"about_ca_topic_score_gemma":0.000005460225,"teacher_disagreement_score":0.034899652,"about_ca_system_score_codex":0.000029260942,"about_ca_system_score_gemma":0.00022288074,"threshold_uncertainty_score":0.52331465},"labels":[],"label_agreement":null},{"id":"W2143253835","doi":"10.1136/annrheumdis-2011-201070","title":"The role of varus and valgus alignment in the initial development of knee cartilage damage by MRI: the MOST study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging","keywords":"Medicine; Valgus; Cartilage; Cartilage damage; Orthodontics; Knee cartilage; Anatomy; Osteoarthritis; Articular cartilage; Pathology","score_opus":0.026624711169909904,"score_gpt":0.30125199583117745,"score_spread":0.27462728466126757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143253835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890002,0.008782838,0.0000024504566,0.00046763622,0.00006665926,0.0011632917,0.00004139331,0.0000048315133,0.00047069334],"genre_scores_gemma":[0.99948025,0.000174502,0.000030404739,0.00011727433,0.000012782727,0.00011087151,0.0000066194975,0.000010241983,0.0000570321],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985371,0.0002411999,0.00043580247,0.00009320875,0.00047129128,0.00022139483],"domain_scores_gemma":[0.99883634,0.00036787434,0.00022206135,0.00045731658,0.000051183586,0.000065196706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065841613,0.00013633426,0.00027341783,0.000026670283,0.00014607015,0.00001330977,0.00022596012,0.000022346116,0.000020770058],"category_scores_gemma":[0.00013779692,0.000055507884,0.000079677826,0.00012580378,0.00015392427,0.000059118553,0.00012154666,0.000053887543,0.0000019585077],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016149691,0.016200416,0.1472725,0.00070165383,0.0012782713,0.000012779789,0.13546754,0.000010796238,0.0112392455,0.005969538,0.0039790957,0.6762532],"study_design_scores_gemma":[0.008606338,0.004433825,0.3932135,0.0025219137,0.0018282437,0.000024425013,0.17283955,0.00006750808,0.40633076,0.007332783,0.002298875,0.0005022612],"about_ca_topic_score_codex":0.000051262366,"about_ca_topic_score_gemma":0.000030681753,"teacher_disagreement_score":0.6757509,"about_ca_system_score_codex":0.000008943629,"about_ca_system_score_gemma":0.00006503107,"threshold_uncertainty_score":0.22635458},"labels":[],"label_agreement":null},{"id":"W2143461461","doi":"10.1136/ard.2005.037523","title":"Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cargill (Canada); Hôpital Notre-Dame","funders":"","keywords":"Chordin; Medicine; Bone morphogenetic protein; Cartilage; Osteoarthritis; Internal medicine; Endocrinology; Andrology; Pathology; Anatomy; Noggin; Chemistry; Gene","score_opus":0.012884370674355008,"score_gpt":0.24867239123889584,"score_spread":0.23578802056454085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143461461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965876,0.0016861056,0.000001825262,0.0004990096,0.000059084956,0.00088694674,0.0000546495,0.000012464429,0.0002123115],"genre_scores_gemma":[0.99917084,0.00003712964,0.000021875734,0.000025145137,0.00002769452,0.00004787508,0.00003235589,0.000014235738,0.0006228593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988882,0.00007718705,0.00041984813,0.00014400254,0.000289815,0.00018094077],"domain_scores_gemma":[0.9992975,0.00003899562,0.00022014485,0.00034096267,0.000053221986,0.000049201026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063848995,0.00014220405,0.00033505773,0.00006816957,0.00010331525,0.000014963215,0.00010069958,0.000043443186,0.000078246],"category_scores_gemma":[0.00006867894,0.000086816864,0.0001792589,0.00014446324,0.00019709363,0.00007952739,0.00007544506,0.000057266872,0.000001204479],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086404267,0.0025808297,0.11737709,0.002032503,0.00014767268,0.000013608102,0.0003808593,0.000031748663,0.8310082,0.010815542,0.00047150388,0.03427639],"study_design_scores_gemma":[0.0038577279,0.00052289217,0.58957285,0.0028704691,0.000185999,0.000020893634,0.00009654053,0.000046357243,0.39647436,0.0062087458,0.000014676645,0.00012847353],"about_ca_topic_score_codex":0.00016054635,"about_ca_topic_score_gemma":0.00014795085,"teacher_disagreement_score":0.47219577,"about_ca_system_score_codex":0.000011109298,"about_ca_system_score_gemma":0.000050829804,"threshold_uncertainty_score":0.35402888},"labels":[],"label_agreement":null},{"id":"W2143475422","doi":"10.1136/ard.2010.145268","title":"Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Abbott Canada","keywords":"Abatacept; Medicine; Methotrexate; Rheumatoid arthritis; Internal medicine; Rheumatology; Adverse effect; Surgery; Rituximab","score_opus":0.020343780201841112,"score_gpt":0.2706314235121027,"score_spread":0.25028764331026154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143475422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922262,0.0059648515,0.0000063249804,0.000205777,0.000011011706,0.0014064594,0.000114828596,0.000030318435,0.000034252684],"genre_scores_gemma":[0.98578024,0.013869981,0.00016271349,0.000017004872,0.0000016681839,0.00006105657,0.00006788624,0.000030619187,0.000008820612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981928,0.00021959419,0.00044355358,0.00028682745,0.0005495549,0.00030766227],"domain_scores_gemma":[0.9985075,0.00020691149,0.00031483814,0.00031134274,0.000284774,0.00037460626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001745609,0.00026402,0.0006055245,0.0003090455,0.00009901881,0.000021787813,0.00008518261,0.000045533736,0.000039357037],"category_scores_gemma":[0.00067982345,0.00013680164,0.00009698931,0.00040731695,0.00061407825,0.00026725375,0.00009019375,0.00010549301,3.0635633e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002561381,0.00094818516,0.9774857,0.00051241013,0.00019466926,0.000014906863,0.0008488782,4.5046767e-7,0.00002062674,0.0001239784,0.000036749745,0.017252032],"study_design_scores_gemma":[0.004720653,0.00110156,0.98050535,0.0107235415,0.000031843432,0.000002975639,0.0009473349,0.000023721244,0.0010607914,0.0007199146,0.000002407364,0.0001599041],"about_ca_topic_score_codex":0.00015228959,"about_ca_topic_score_gemma":0.000019442561,"teacher_disagreement_score":0.017092127,"about_ca_system_score_codex":0.000008756965,"about_ca_system_score_gemma":0.0001030097,"threshold_uncertainty_score":0.5578609},"labels":[],"label_agreement":null},{"id":"W2143692536","doi":"10.1136/annrheumdis-2012-202872","title":"The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Versus Arthritis; Nuffield Foundation","keywords":"Liver X receptor; Synovitis; Medicine; Cytokine; Downregulation and upregulation; Synovial fluid; Immunology; Chemokine; Macrophage; Cancer research; Arthritis; Inflammation; Biology; Nuclear receptor; Pathology; Transcription factor","score_opus":0.013026240186141423,"score_gpt":0.23482780506626866,"score_spread":0.22180156488012723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143692536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632563,0.027689286,0.0000017460825,0.00787757,0.0002417967,0.00070673693,0.00012282691,0.000040223895,0.000063540276],"genre_scores_gemma":[0.95883745,0.039739516,0.000047041573,0.0006515075,0.00005670087,0.00006221068,0.000017011997,0.00003020836,0.0005583248],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981912,0.00017461689,0.000601147,0.0002733838,0.00039339176,0.00036630983],"domain_scores_gemma":[0.998461,0.00024422575,0.00026873787,0.00060311594,0.00018825276,0.00023463057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017207951,0.00024811432,0.0005231578,0.00008449855,0.00017410266,0.00008852445,0.0002622409,0.00007705322,0.00038577963],"category_scores_gemma":[0.00047107443,0.00013936641,0.00022183367,0.00023398738,0.00035614675,0.00020404611,0.00017988971,0.00015280432,0.00007873551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005807807,0.0010937515,0.018137299,0.00076068775,0.00057531986,0.000021261149,0.001586375,0.000029188517,0.007051401,0.00056657137,0.029121127,0.94047624],"study_design_scores_gemma":[0.004081211,0.00028026054,0.96064645,0.0050201034,0.00011366325,0.00005828774,0.0004102448,0.0015914375,0.018160481,0.0020992826,0.0071340594,0.0004045335],"about_ca_topic_score_codex":0.0005122713,"about_ca_topic_score_gemma":0.000018065579,"teacher_disagreement_score":0.9425091,"about_ca_system_score_codex":0.000009898563,"about_ca_system_score_gemma":0.00007508033,"threshold_uncertainty_score":0.56831974},"labels":[],"label_agreement":null},{"id":"W2143706838","doi":"10.1136/annrheumdis-2012-202376","title":"Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto; British Columbia Children's Hospital","funders":"National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Immunology; Systemic lupus; Systemic disease; Lupus erythematosus; Blisibimod; Juvenile; Antibody; Internal medicine; Immunopathology; Disease","score_opus":0.05205124361186742,"score_gpt":0.31707252453348994,"score_spread":0.2650212809216225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143706838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987716,0.0032366011,0.00013731048,0.0009938132,0.00094221,0.0065951473,0.00022573656,0.00006447547,0.000088706736],"genre_scores_gemma":[0.9957325,0.0002354085,0.00007258953,0.00012420288,0.000045166013,0.0010208695,0.00002593524,0.000104607796,0.0026387253],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941271,0.0009013779,0.0021344903,0.00053434056,0.0015381436,0.00076458196],"domain_scores_gemma":[0.9924,0.0025030356,0.001410413,0.002388867,0.0010276219,0.0002700592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014423298,0.00047967886,0.0015179227,0.0004858575,0.00016153014,0.00009506523,0.0010889038,0.00023560025,0.00010319439],"category_scores_gemma":[0.003930156,0.00027772464,0.00084415014,0.0010088134,0.00039694796,0.0004060365,0.00037478548,0.00026514582,0.000047854403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010186087,0.0006984829,0.9500757,0.02098874,0.0005415928,0.0000064524297,0.0024650844,0.00033393747,0.0011900559,0.00045131508,0.021657865,0.0005721752],"study_design_scores_gemma":[0.052725714,0.001826025,0.24615894,0.34345776,0.0033100138,0.17205437,0.062465776,0.037322126,0.047642402,0.028804298,0.00041254872,0.0038200428],"about_ca_topic_score_codex":0.00038912258,"about_ca_topic_score_gemma":0.00002100929,"teacher_disagreement_score":0.7039167,"about_ca_system_score_codex":0.00017504221,"about_ca_system_score_gemma":0.0006704818,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W2144134939","doi":"10.1136/annrheumdis-2012-201697","title":"Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Probity Medical Research","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Internal medicine; Biomarker; C-reactive protein; Rheumatoid arthritis; Rheumatology; Gastroenterology; Psoriasis; Etanercept; Oncology; Immunology; Inflammation","score_opus":0.03125083177400596,"score_gpt":0.2901188113474112,"score_spread":0.25886797957340524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144134939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965144,0.002468488,0.0000017664612,0.00020948374,0.000023867298,0.00070944993,0.00003519688,0.000008101646,0.000029256438],"genre_scores_gemma":[0.9984112,0.001429523,0.00003815939,0.000032070675,0.0000054787656,0.0000393566,0.000017329312,0.000014368219,0.000012530172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983728,0.00024667286,0.00065898674,0.00013661283,0.00035565646,0.00022927792],"domain_scores_gemma":[0.99880236,0.0003497895,0.00039615817,0.00021124913,0.00014805846,0.0000923928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006317725,0.00014388362,0.00053128065,0.000108116416,0.000034147233,0.0000054953953,0.000041759162,0.000042404445,0.000005218218],"category_scores_gemma":[0.0010487791,0.00008721905,0.00006885946,0.00023943519,0.0001320962,0.000112366106,0.000031569736,0.00006529034,4.0504443e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009033713,0.0013396852,0.92606765,0.00011153823,0.0003406109,0.000005126019,0.00041338077,0.000028985012,0.000011187498,0.0000073857727,0.00002287463,0.06261787],"study_design_scores_gemma":[0.009152013,0.0015799558,0.98359627,0.0046986137,0.00015605793,0.0000015653148,0.0002604188,0.00019683696,0.00021722002,0.000053071046,0.0000025841641,0.00008537337],"about_ca_topic_score_codex":0.00019269662,"about_ca_topic_score_gemma":0.00020631246,"teacher_disagreement_score":0.06253249,"about_ca_system_score_codex":0.00003761932,"about_ca_system_score_gemma":0.000057973615,"threshold_uncertainty_score":0.35566896},"labels":[],"label_agreement":null},{"id":"W2144427335","doi":"10.1136/ard.2004.028217","title":"Pharmacogenetics in the rheumatic diseases","year":2004,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Center for Research Resources; National Institute of General Medical Sciences; School of Medicine, New York University; National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism; York University","keywords":"Pharmacogenetics; Medicine; Rheumatoid arthritis; Population; Drug; Pharmacogenomics; Toxicity; Pharmacology; Bioinformatics; Intensive care medicine; Internal medicine; Environmental health; Genetics; Biology; Genotype","score_opus":0.10121731320884637,"score_gpt":0.41376211776504623,"score_spread":0.3125448045561999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144427335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012882986,0.9939994,0.0000035985465,0.0010065222,0.00024997038,0.0026394748,0.0004953227,0.000043808315,0.00027355325],"genre_scores_gemma":[0.008313411,0.9904872,0.000022691213,0.0003088997,0.00006919086,0.00043941542,0.00013732832,0.00008913228,0.00013268394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951863,0.0008903688,0.0014381859,0.00041797807,0.0013547319,0.00071242184],"domain_scores_gemma":[0.99616396,0.0011430745,0.0006871945,0.0014972677,0.00016137949,0.00034711947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051113893,0.0006459723,0.0024085632,0.0003261373,0.00018859537,0.000110181856,0.0014162243,0.00013402122,0.00035435642],"category_scores_gemma":[0.0014451989,0.00032225632,0.0017230362,0.0008675921,0.00060538127,0.0001186811,0.00024932084,0.00048217364,0.00011972029],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047919988,0.0011135798,0.00014362212,0.050107967,0.0008778701,0.000039027058,0.00032297196,0.000009012364,5.2993627e-8,0.0004798532,0.005814557,0.94104356],"study_design_scores_gemma":[0.002860024,0.00041999563,0.0042950567,0.39731637,0.0015899163,0.00031006156,0.0005131147,0.000046001533,0.000005748316,0.008126008,0.58360445,0.00091324275],"about_ca_topic_score_codex":0.00008465034,"about_ca_topic_score_gemma":0.000008608374,"teacher_disagreement_score":0.9401303,"about_ca_system_score_codex":0.00005805317,"about_ca_system_score_gemma":0.0013939464,"threshold_uncertainty_score":0.99992293},"labels":[],"label_agreement":null},{"id":"W2145117068","doi":"10.1136/ard.62.suppl_2.ii2","title":"Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)","year":2003,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Heritage Medical Research Clinic; Mount Sinai Hospital","funders":"","keywords":"Medicine; Credibility; Rheumatoid arthritis; Statement (logic); Alternative medicine; Family medicine; Adverse effect; Consensus conference; Immunology; Internal medicine; Pathology; Political science; Law","score_opus":0.10920276163724159,"score_gpt":0.378271972965381,"score_spread":0.26906921132813943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145117068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009637234,0.9805507,0.000002194342,0.00038612256,0.00025258926,0.004793286,0.004294463,0.000037690963,0.00004568725],"genre_scores_gemma":[0.002966059,0.9953845,0.000017344795,0.00014081803,0.000022674678,0.0008642007,0.0003722861,0.00007553083,0.00015658721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606764,0.00070976536,0.0016366199,0.00043082124,0.0006065356,0.0005486162],"domain_scores_gemma":[0.9954831,0.0017509247,0.0010863993,0.000992112,0.00035446696,0.0003329875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038558926,0.00064022565,0.002525389,0.00018733802,0.0002355828,0.000042601438,0.00035005444,0.0001571682,0.00036957645],"category_scores_gemma":[0.0012916757,0.00030111385,0.00096734305,0.00036087513,0.0010344918,0.00003375973,0.000073147305,0.00013073428,0.000019229754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006510857,0.0022441135,0.0005254762,0.0044539706,0.004935545,0.000013751703,0.00017113685,0.0000034879426,8.373177e-7,0.00085513043,0.01880997,0.9673355],"study_design_scores_gemma":[0.00290149,0.0014152237,0.0009930407,0.027869446,0.0001799946,0.000027800434,0.00016752465,0.000026182359,0.000024144658,0.00020582571,0.965892,0.00029728975],"about_ca_topic_score_codex":0.00006123967,"about_ca_topic_score_gemma":0.000006668049,"teacher_disagreement_score":0.9670382,"about_ca_system_score_codex":0.000051358307,"about_ca_system_score_gemma":0.0006844108,"threshold_uncertainty_score":0.9999441},"labels":[],"label_agreement":null},{"id":"W2145134414","doi":"10.1136/ard.2007.077297","title":"Magnetic resonance imaging can accurately assess the long-term progression of knee structural changes in experimental dog osteoarthritis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Osteoarthritis; Magnetic resonance imaging; Term (time); Pathology; Radiology; Alternative medicine","score_opus":0.04058827835676608,"score_gpt":0.3506473682028605,"score_spread":0.3100590898460944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145134414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506719,0.04720502,7.261407e-7,0.00084032374,0.00018933274,0.00088658545,0.00004650558,0.000018910863,0.00014066456],"genre_scores_gemma":[0.9993375,0.00023160804,0.000051427232,0.000161713,0.00003217494,0.000056221972,0.000020535785,0.00002023399,0.00008861039],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859166,0.000082982915,0.00038857752,0.00018724885,0.0004235807,0.00032594838],"domain_scores_gemma":[0.9990376,0.00013405352,0.00023329735,0.00040878932,0.00008578853,0.00010044451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018987923,0.0001887064,0.000350391,0.00008622171,0.00008558795,0.00002090315,0.00020126674,0.000034905825,0.00009876088],"category_scores_gemma":[0.00010735785,0.000108417276,0.00013618072,0.00020234211,0.00022813954,0.00009269355,0.00010915822,0.00008170169,0.0000014353528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034366737,0.00025847848,0.23157756,0.00020142968,0.000014736286,0.00006420691,0.00083373056,5.011516e-7,0.0048770355,0.00015922192,0.000045687186,0.76162374],"study_design_scores_gemma":[0.002552344,0.0012558136,0.7956067,0.0039885663,0.00006968912,0.00005611359,0.0010912503,0.000016801494,0.1949481,0.00026903796,0.0000118797025,0.00013371099],"about_ca_topic_score_codex":0.000047014044,"about_ca_topic_score_gemma":0.00019626039,"teacher_disagreement_score":0.76149005,"about_ca_system_score_codex":0.000021611817,"about_ca_system_score_gemma":0.00006664168,"threshold_uncertainty_score":0.4421128},"labels":[],"label_agreement":null},{"id":"W2145539024","doi":"10.1136/annrheumdis-2011-200702","title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":334,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Université de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Prednisolone; Rheumatoid arthritis; Nested case-control study; Internal medicine; Odds ratio; Risk assessment; Arthritis; Glucocorticoid","score_opus":0.011829353906167206,"score_gpt":0.2900395497210258,"score_spread":0.2782101958148586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145539024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854859,0.013087784,0.000021240341,0.00004562454,0.000033120134,0.0010012756,0.00030462744,0.0000120864115,0.00000834009],"genre_scores_gemma":[0.95618683,0.043679196,0.000015160628,0.000026698537,0.000004238861,0.000042216656,0.00002237934,0.00002136187,0.0000019056342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980099,0.00035908987,0.0006386328,0.0001656136,0.00047047038,0.00035629663],"domain_scores_gemma":[0.99815327,0.00034881046,0.0005786945,0.0004382733,0.00027049365,0.00021045556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003548914,0.0002198142,0.0008906353,0.00039658605,0.000052430067,0.000013323761,0.00007882688,0.00005257973,0.00008426402],"category_scores_gemma":[0.0004535494,0.00012721289,0.00038718357,0.00070379203,0.0002232766,0.00022472921,0.000027436117,0.00011909453,0.0000015175209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002646974,0.0016759161,0.9272948,0.00009149607,0.00359187,0.000004974388,0.00079109037,0.00031706868,0.000020324096,0.000010497042,0.000025035546,0.06352995],"study_design_scores_gemma":[0.008103457,0.001615342,0.9880831,0.000898736,0.000116301075,0.000025482017,0.00009318791,0.00062620715,0.0002655342,0.000054543812,0.0000016807201,0.00011640358],"about_ca_topic_score_codex":0.0044585858,"about_ca_topic_score_gemma":0.00029949457,"teacher_disagreement_score":0.06341355,"about_ca_system_score_codex":0.000018064524,"about_ca_system_score_gemma":0.000103282415,"threshold_uncertainty_score":0.6740078},"labels":[],"label_agreement":null},{"id":"W2145583696","doi":"10.1136/annrheumdis-2012-202111","title":"Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; BC Children's Hospital; University of Toronto; SickKids Foundation","funders":"Grantová Agentura, Univerzita Karlova","keywords":"Medicine; Vasculitis; Erythrocyte sedimentation rate; Internal medicine; Disease; Physical therapy","score_opus":0.027873558352019098,"score_gpt":0.28730068203427744,"score_spread":0.25942712368225834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145583696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926585,0.003982795,0.000036663005,0.0019698224,0.00016681211,0.0009237249,0.000098828874,0.00001894827,0.00014390037],"genre_scores_gemma":[0.998415,0.00121002,0.00007325786,0.00007286454,0.000036339476,0.000108065855,0.000022226328,0.000017323011,0.00004492142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982153,0.00030200707,0.00039380582,0.000205975,0.00058121193,0.00030168146],"domain_scores_gemma":[0.9985469,0.00019418192,0.0003228076,0.0005802459,0.00009448145,0.00026136218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037101816,0.00019691816,0.00039935583,0.00010854911,0.00016736652,0.000014615838,0.0001779693,0.00006841757,0.000059898437],"category_scores_gemma":[0.00037992292,0.00011779271,0.00036479702,0.00037898103,0.0001603664,0.0002922344,0.00020812878,0.00020157649,0.000002478264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021637036,0.0061999555,0.8312933,0.0022840954,0.0011219818,0.0000044950657,0.0022996857,0.00020045714,0.000058190464,0.00080472865,0.00067813497,0.15483864],"study_design_scores_gemma":[0.00112983,0.00006354586,0.9942996,0.0014524538,0.0005453367,0.000009312592,0.0001387021,0.000086754495,0.0015861867,0.00052494847,0.00003277765,0.00013058298],"about_ca_topic_score_codex":0.000069787275,"about_ca_topic_score_gemma":0.0000036314893,"teacher_disagreement_score":0.1630063,"about_ca_system_score_codex":0.000046533067,"about_ca_system_score_gemma":0.00044335585,"threshold_uncertainty_score":0.48034474},"labels":[],"label_agreement":null},{"id":"W2146502982","doi":"10.1136/ard.2008.094474","title":"Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":491,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hôpital Notre-Dame; Université de Montréal; University of Toronto","funders":"","keywords":"Medicine; Rheumatism; Systematic review; Rheumatoid arthritis; Methotrexate; Evidence-based medicine; Rheumatology; MEDLINE; Alternative medicine; Family medicine; Physical therapy; Evidence-based practice; Delphi method; Internal medicine; Pathology","score_opus":0.3095871953673112,"score_gpt":0.41782717300927796,"score_spread":0.10823997764196674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146502982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90252596,0.067875974,0.0008630792,0.022986142,0.00012256794,0.005192965,0.00037726923,0.000015644106,0.000040422015],"genre_scores_gemma":[0.8673718,0.13067514,0.0011313527,0.000083556224,0.0000040290574,0.00068083155,0.000031823125,0.000017250182,0.0000042340585],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99573153,0.0013711335,0.0012664036,0.00025455919,0.0010861201,0.00029023984],"domain_scores_gemma":[0.9812347,0.01642278,0.0007924411,0.0005360536,0.0009520674,0.00006190485],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020157034,0.00022418806,0.0008020269,0.0005614492,0.00017254548,0.000044487795,0.000507169,0.00006507037,0.000014147295],"category_scores_gemma":[0.013492745,0.00011219209,0.00020084532,0.0008715734,0.0013167053,0.00038170806,0.00008945618,0.00029893103,3.215829e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025575783,0.021325124,0.29762274,0.08622153,0.005377916,0.00003817647,0.24917586,0.0044751447,0.0005242133,0.100009605,0.008767496,0.2008864],"study_design_scores_gemma":[0.01044999,0.0032459407,0.16230491,0.74389696,0.00002241897,0.00014173084,0.031528085,0.035755806,0.0020116682,0.010131188,0.000082025945,0.00042927734],"about_ca_topic_score_codex":0.0009440469,"about_ca_topic_score_gemma":0.00035417697,"teacher_disagreement_score":0.65767545,"about_ca_system_score_codex":0.000030227357,"about_ca_system_score_gemma":0.0003251498,"threshold_uncertainty_score":0.994817},"labels":[],"label_agreement":null},{"id":"W2146503911","doi":"10.1136/ard.2010.149211","title":"Measuring participation in people with spondyloarthritis using the social role participation questionnaire","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Ankylosing spondylitis; Intraclass correlation; Construct validity; Physical therapy; Social support; Clinical psychology; Psychometrics; Psychology; Internal medicine","score_opus":0.09758221565580634,"score_gpt":0.33456279676041945,"score_spread":0.23698058110461312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146503911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971402,0.0015225131,0.000024975903,0.00055325683,0.000053787782,0.00041958163,0.000014165294,0.000019190466,0.00025229834],"genre_scores_gemma":[0.9995824,0.000104826926,0.000047135625,0.000101356214,0.000023371531,0.00010462191,0.0000048937413,0.000014308341,0.000017064927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998936,0.00011497733,0.0002901848,0.00013229562,0.00029901756,0.00022752432],"domain_scores_gemma":[0.9993811,0.000038921164,0.00017487424,0.00022292697,0.0001262615,0.000055893997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013841943,0.000121820136,0.00025697766,0.00004587639,0.00024458088,0.000012118955,0.00008068362,0.000026962358,0.00004837356],"category_scores_gemma":[0.00018746855,0.000069213114,0.00010348424,0.00026592406,0.00013086112,0.000119016724,0.00004236194,0.000055548902,0.0000039788365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000553615,0.0010622429,0.9560006,0.00014513767,0.00022417906,0.000009442282,0.011957359,0.00009241777,0.00003258181,0.00065331464,0.000049960174,0.029219126],"study_design_scores_gemma":[0.001019601,0.0001420654,0.9944672,0.0010366437,0.00021057346,0.00000655133,0.0011303279,0.00044394002,0.0007222943,0.00073825684,0.000005941121,0.000076633696],"about_ca_topic_score_codex":0.0008898957,"about_ca_topic_score_gemma":0.0009712634,"teacher_disagreement_score":0.038466547,"about_ca_system_score_codex":0.000026205034,"about_ca_system_score_gemma":0.00006814069,"threshold_uncertainty_score":0.2822429},"labels":[],"label_agreement":null},{"id":"W2147350349","doi":"10.1136/ard.2010.137778","title":"Long-term patient survival in ANCA-associated vasculitis","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":930,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; ANCA-Associated Vasculitis; Term (time); Vasculitis; Intensive care medicine; Immunology; Dermatology; Internal medicine; Disease","score_opus":0.03258416309032705,"score_gpt":0.3050672619379488,"score_spread":0.2724830988476218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147350349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960904,0.0010090374,0.0000018484262,0.001131864,0.00048279803,0.00031335154,0.00010536904,0.0000179068,0.00084742944],"genre_scores_gemma":[0.99888384,0.00053284917,0.00001534209,0.00032903568,0.000022970382,0.000020034277,0.000022413571,0.000014507211,0.00015902866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988642,0.000068374626,0.00034123161,0.00014511046,0.00035654628,0.00022458613],"domain_scores_gemma":[0.99904954,0.000107732165,0.00017005084,0.00043968976,0.00009394275,0.0001390532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017623164,0.00011784487,0.0003711972,0.000058017093,0.000034952413,0.000011920853,0.00013616451,0.000040668405,0.00044170942],"category_scores_gemma":[0.0005922386,0.00007829987,0.0002851838,0.00021406397,0.00009357158,0.000050944567,0.00006695851,0.000121724,0.000009934683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002047231,0.0021921587,0.68693113,0.00071167684,0.00048177992,0.000021308577,0.00066692365,0.000012137022,0.000579432,0.00024975376,0.0049468935,0.3030021],"study_design_scores_gemma":[0.0010429369,0.00008429196,0.99545735,0.00062381546,0.00013340918,0.0000026091764,0.00006304006,0.000013656859,0.00196873,0.00027806853,0.0002404458,0.000091653805],"about_ca_topic_score_codex":0.00036603978,"about_ca_topic_score_gemma":0.0005030225,"teacher_disagreement_score":0.30852622,"about_ca_system_score_codex":0.000013040914,"about_ca_system_score_gemma":0.00011841534,"threshold_uncertainty_score":0.48364085},"labels":[],"label_agreement":null},{"id":"W2147486889","doi":"10.1136/annrheumdis-2013-203933","title":"Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Université Laval; University of Manitoba; Toronto Western Hospital; Centre hospitalier universitaire de Québec; McGill University Health Centre; Montreal General Hospital; Dalhousie University; University of Toronto","funders":"National Center for Research Resources; National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Versus Arthritis; Canadian Institutes of Health Research; Lupus Research Alliance; Sandwell and West Birmingham Hospitals NHS Trust; National Center for Advancing Translational Sciences; Wellcome Trust; University Health Network; Johns Hopkins University; Eusko Jaurlaritza; Manchester Biomedical Research Centre; Université Laval; National Institute for Health and Care Research; U.S. Department of Veterans Affairs","keywords":"Medicine; Systemic lupus erythematosus; Cohort; Internal medicine; Metabolic syndrome; Disease; Logistic regression; Cohort study; Obesity","score_opus":0.06921522016524528,"score_gpt":0.37575511071106993,"score_spread":0.30653989054582464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147486889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630886,0.00078672887,0.00002697151,0.00015512029,0.00030243577,0.0009391854,0.0013511883,0.000034844954,0.00009468768],"genre_scores_gemma":[0.99891263,0.00035261855,0.000015048992,0.000029291801,0.000040838782,0.00003796125,0.0004982992,0.000040687715,0.00007262031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966301,0.00047264007,0.0008834095,0.0004528151,0.0012525476,0.0003085261],"domain_scores_gemma":[0.9958907,0.0005615523,0.0005293566,0.002420217,0.00022311244,0.00037511063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006709829,0.00027028646,0.0009044825,0.00034242132,0.000038956692,0.00003515007,0.0012828863,0.000068646754,0.00020447541],"category_scores_gemma":[0.0022547666,0.00016492343,0.00032750855,0.00031715276,0.00017375263,0.0004377862,0.00031548546,0.0001422762,0.000032902608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006086309,0.0008328038,0.9955071,0.00058960123,0.0006741009,0.00000730285,0.00043670126,0.0001209977,0.000072575174,0.0001911502,0.00030027353,0.0006587268],"study_design_scores_gemma":[0.0012120039,0.0002261959,0.9876676,0.005483442,0.00020612772,0.00017199299,0.00022989915,0.0038160835,0.000043010823,0.00080051424,0.0000039378897,0.00013919269],"about_ca_topic_score_codex":0.0013002352,"about_ca_topic_score_gemma":0.000014378005,"teacher_disagreement_score":0.007839536,"about_ca_system_score_codex":0.00006730133,"about_ca_system_score_gemma":0.00026362302,"threshold_uncertainty_score":0.6725382},"labels":[],"label_agreement":null},{"id":"W2147791981","doi":"10.1136/annrheumdis-2012-201766","title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":532,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Cilag; Procter and Gamble; Chugai Pharmaceutical; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Sanofi; Abbott Laboratories","keywords":"Adalimumab; Medicine; BASDAI; Ankylosing spondylitis; Placebo; Internal medicine; Spondylitis; Clinical endpoint; Visual analogue scale; Physical therapy; Randomized controlled trial; Arthritis; Disease; Psoriatic arthritis; Pathology","score_opus":0.012939495338902865,"score_gpt":0.2608029505348781,"score_spread":0.24786345519597525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147791981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910232,0.0029672133,8.836899e-7,0.00014893543,0.00011980495,0.0052578957,0.00026202944,0.000007867426,0.0002121976],"genre_scores_gemma":[0.9991155,0.000587776,0.00003826925,0.000021626442,0.000021838134,0.00015595931,0.000029677209,0.000015997224,0.00001335246],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977758,0.00022519084,0.0010323694,0.00019238929,0.0004809518,0.00029328113],"domain_scores_gemma":[0.99774784,0.00087024394,0.0006040983,0.00045525085,0.00017287821,0.00014971706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050940894,0.00021946202,0.0013409194,0.00016214018,0.000057789224,0.000004365891,0.00010465899,0.000053032738,0.000022513594],"category_scores_gemma":[0.0014153037,0.00012937514,0.00034516424,0.0003083894,0.00036365047,0.00009843944,0.000060713577,0.00007008782,5.247912e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8742079,0.004274786,0.11462793,0.00026314036,0.00084543554,0.0000012498801,0.0005894645,0.000005829584,0.000004242871,0.000019678893,0.00006909137,0.005091235],"study_design_scores_gemma":[0.54520106,0.0013996441,0.4515831,0.0012310558,0.00035703875,8.0936917e-7,0.000077349214,0.000005472411,0.00004480907,0.000030102989,0.000004754109,0.00006482412],"about_ca_topic_score_codex":0.00011774271,"about_ca_topic_score_gemma":0.000017522374,"teacher_disagreement_score":0.33695516,"about_ca_system_score_codex":0.000011113835,"about_ca_system_score_gemma":0.000074750904,"threshold_uncertainty_score":0.5275765},"labels":[],"label_agreement":null},{"id":"W2148260833","doi":"10.1136/annrheumdis-2012-202021","title":"Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Health and Care Research","keywords":"Medicine; Need to know; Adverse effect; Intensive care medicine; Drug; Value (mathematics); Decision aids; Alternative medicine; Pharmacology; Pathology","score_opus":0.060349847605203004,"score_gpt":0.30049151607621455,"score_spread":0.24014166847101154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148260833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649967,0.026613196,0.00013238659,0.004371768,0.0002371423,0.00095551374,0.00000943307,0.00003594608,0.0026479238],"genre_scores_gemma":[0.9967015,0.0016922165,0.000011442838,0.0012469831,0.000039257353,0.000025133295,0.0000030358092,0.000028261464,0.0002521873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984834,0.00016369337,0.00037167495,0.00013344309,0.0005191232,0.0003286742],"domain_scores_gemma":[0.9977332,0.0011357951,0.0003418252,0.00059628894,0.000055808418,0.0001371198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002999383,0.00020043663,0.00043365112,0.0000654518,0.00012402046,0.000014406254,0.0002536028,0.00004304543,0.00002753557],"category_scores_gemma":[0.00066128606,0.00009439667,0.0003799305,0.00018011495,0.00012241963,0.00012450352,0.000083941915,0.00013448863,0.000013588685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017200947,0.02541405,0.31077272,0.020551367,0.014605396,0.000045637167,0.17718986,0.00281859,0.008799486,0.119499415,0.11140218,0.19170035],"study_design_scores_gemma":[0.007846204,0.0019286026,0.8743821,0.017370163,0.0016849121,0.00003480435,0.020307377,0.001706327,0.026321592,0.046638895,0.0008729518,0.0009061031],"about_ca_topic_score_codex":0.00006926383,"about_ca_topic_score_gemma":0.000004723664,"teacher_disagreement_score":0.56360936,"about_ca_system_score_codex":0.000021681099,"about_ca_system_score_gemma":0.00007946374,"threshold_uncertainty_score":0.38493848},"labels":[],"label_agreement":null},{"id":"W2148301853","doi":"10.1136/ard.59.suppl_1.i46","title":"Etanercept (Enbrel): update on therapeutic use","year":2000,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Etanercept; Medicine; Methotrexate; Rheumatoid arthritis; Placebo; Adverse effect; Internal medicine; Psoriatic arthritis; Arthritis; Juvenile rheumatoid arthritis; Surgery; Pathology","score_opus":0.16306380982848742,"score_gpt":0.409752862170552,"score_spread":0.2466890523420646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148301853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018025078,0.9957938,0.0000011107308,0.00055921084,0.00009325472,0.0013731609,0.00015688062,0.000052856893,0.001789455],"genre_scores_gemma":[0.000478532,0.9937458,0.0000042206248,0.0009573628,0.00003225577,0.00010419507,0.00013143371,0.00009079747,0.0044553955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692476,0.00044654222,0.0010383143,0.00034641402,0.00079803145,0.00044596344],"domain_scores_gemma":[0.997118,0.00042987504,0.00051131635,0.0016484833,0.000108001,0.00018433515],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002389629,0.0004887052,0.0022640214,0.000241635,0.00012932719,0.000057773574,0.00067623623,0.00019743435,0.0021522667],"category_scores_gemma":[0.00036872088,0.0002645612,0.0016885063,0.00042954396,0.00029883222,0.00012193599,0.00012870926,0.00043868096,0.0008109776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073933756,0.00038816247,0.000012226424,0.013702419,0.000822345,0.000009290606,0.000032538872,0.0000022293357,2.6141105e-8,0.00022151691,0.01571181,0.9690235],"study_design_scores_gemma":[0.00028292002,0.00015059092,0.00053974614,0.039987866,0.001327406,0.000018968089,0.000018868885,0.000012808086,0.0000018757934,0.00032161287,0.95708454,0.0002527818],"about_ca_topic_score_codex":0.000020704121,"about_ca_topic_score_gemma":5.4619517e-7,"teacher_disagreement_score":0.96877074,"about_ca_system_score_codex":0.000027389351,"about_ca_system_score_gemma":0.0007184253,"threshold_uncertainty_score":0.9999807},"labels":[],"label_agreement":null},{"id":"W2148501245","doi":"10.1136/ard.2011.152496","title":"MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Anakinra; Medicine; Canakinumab; Macrophage activation syndrome; Monocytosis; Immunology; Internal medicine; Gastroenterology; Erythrocyte sedimentation rate; Arthritis; Bone marrow; Disease","score_opus":0.032360766098911,"score_gpt":0.2506443220662226,"score_spread":0.2182835559673116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148501245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943454,0.004852103,0.000007906612,0.0001344051,0.00005485203,0.00025545238,0.00017948085,0.000006481075,0.00016390959],"genre_scores_gemma":[0.997504,0.002287618,0.000009205538,0.00006714604,0.0000051525194,0.000017365806,0.00003006515,0.000017565473,0.00006189171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887407,0.00020392545,0.00028843095,0.00023817971,0.00016568867,0.00022972385],"domain_scores_gemma":[0.9990352,0.000040658375,0.0003254521,0.00038974194,0.00011815817,0.000090802205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017227078,0.00018459113,0.00031033077,0.000057134548,0.00006374094,0.000010950804,0.00018543839,0.00006742681,0.000035431985],"category_scores_gemma":[0.00027832753,0.00014573097,0.00020905044,0.00014898236,0.0003649611,0.000016349457,0.00015495624,0.00005117411,0.000001720504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013203647,0.008309075,0.6166704,0.0029332286,0.005531766,0.00008092477,0.0066792984,0.00016901363,0.26268515,0.00023555005,0.011258215,0.07224368],"study_design_scores_gemma":[0.0006812442,0.00015396399,0.89082456,0.00042737668,0.00007137607,0.0000011307596,0.0008166351,0.000057516412,0.10645519,0.00022614637,0.00007015336,0.00021471523],"about_ca_topic_score_codex":0.00009314549,"about_ca_topic_score_gemma":0.000025491,"teacher_disagreement_score":0.2741541,"about_ca_system_score_codex":0.000006396913,"about_ca_system_score_gemma":0.000066616914,"threshold_uncertainty_score":0.5942736},"labels":[],"label_agreement":null},{"id":"W2148973270","doi":"10.1136/annrheumdis-2012-201937","title":"Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; University of Calgary; SickKids Foundation; Alberta Children's Hospital","funders":"European League Against Rheumatism; European Commission","keywords":"Medicine; Azathioprine; Internal medicine; Cyclophosphamide; Proteinuria; Lupus nephritis; Cohort; Gastroenterology; Prospective cohort study; Surgery; Disease; Chemotherapy; Kidney","score_opus":0.12807970248445,"score_gpt":0.3696252446984958,"score_spread":0.24154554221404578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148973270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843533,0.009833455,0.000078425976,0.0005692106,0.00033612645,0.0046763616,0.000094446164,0.000021092565,0.000037579197],"genre_scores_gemma":[0.9980288,0.0005584043,0.00003423836,0.00002447345,0.00008625116,0.00085952005,0.000018274633,0.000034810997,0.00035520218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976066,0.0003155619,0.00074650743,0.00023802141,0.0007142725,0.0003790487],"domain_scores_gemma":[0.99734133,0.00081096555,0.0003750966,0.0010492603,0.00017832856,0.00024500917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006218602,0.00022928198,0.00058494206,0.00013555173,0.00007698175,0.000021425236,0.0005102856,0.000037298112,0.000043386928],"category_scores_gemma":[0.00042475542,0.0001136181,0.00035802642,0.00019370142,0.00015344683,0.00017331129,0.00007630327,0.000055752556,0.0000049591695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015176181,0.0106458,0.95885074,0.0016776365,0.0010412084,0.0000027030317,0.015407366,0.00032635624,0.000024151217,0.00044972927,0.00008069477,0.009976023],"study_design_scores_gemma":[0.021503568,0.0023146807,0.81590044,0.008884659,0.0028225447,0.0007964535,0.09280908,0.05161578,0.0009708468,0.0012247716,0.00051355246,0.0006436186],"about_ca_topic_score_codex":0.000088199486,"about_ca_topic_score_gemma":0.00002009464,"teacher_disagreement_score":0.14295027,"about_ca_system_score_codex":0.00010110871,"about_ca_system_score_gemma":0.00018095368,"threshold_uncertainty_score":0.46332118},"labels":[],"label_agreement":null},{"id":"W2149835953","doi":"10.1136/ard.2009.110965","title":"Oral treatment with a Brachystemma calycinum D don plant extract reduces disease symptoms and the development of cartilage lesions in experimental dog osteoarthritis: inhibition of protease-activated receptor 2","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Osteoarthritis; Cartilage; Anterior cruciate ligament; Nitric oxide synthase; Chondrocyte; Receptor; Internal medicine; Arthritis; Pathology; Nitric oxide; Surgery; Anatomy","score_opus":0.02776338705284226,"score_gpt":0.2812082019096194,"score_spread":0.25344481485677717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149835953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358755,0.0035623745,0.0000018840942,0.00050546066,0.000029326964,0.0020855302,0.0001626477,0.00001758428,0.000047635527],"genre_scores_gemma":[0.9992833,0.00012180749,0.00015434626,0.000033646957,0.00000796,0.0002433181,0.00009115258,0.000014046066,0.000050385308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984528,0.00017949758,0.00059359154,0.00021161736,0.00036109437,0.00020139969],"domain_scores_gemma":[0.99900794,0.000096454554,0.00037236637,0.00029103216,0.000068372414,0.00016384234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001460188,0.00022885614,0.00058897684,0.00009443072,0.000089394634,0.000012177829,0.000070608985,0.000037847356,0.000026876176],"category_scores_gemma":[0.00006159544,0.0001171592,0.000143352,0.00016409019,0.00022389028,0.00012710482,0.000028626959,0.000046144378,7.324644e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03283911,0.014409645,0.011529936,0.0012947217,0.00058100314,0.00011294299,0.018270638,0.000027290553,0.47403285,0.00088374177,0.0001129122,0.4459052],"study_design_scores_gemma":[0.011077689,0.0040255375,0.020127092,0.0072894664,0.0002339185,0.000015634512,0.0023217178,0.000017939745,0.9545749,0.00014178731,0.0000147957835,0.00015954336],"about_ca_topic_score_codex":0.000048219234,"about_ca_topic_score_gemma":0.000029510824,"teacher_disagreement_score":0.48054203,"about_ca_system_score_codex":0.00004153457,"about_ca_system_score_gemma":0.00023691588,"threshold_uncertainty_score":0.47776136},"labels":[],"label_agreement":null},{"id":"W2150114897","doi":"10.1136/ard.2010.144741","title":"The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Medicine; Rheumatoid arthritis; Glucocorticoid; Prednisolone; Internal medicine; Incidence (geometry); Cohort; Methotrexate; Comorbidity; Relative risk; Rate ratio; Nested case-control study; Cohort study","score_opus":0.01244492199616929,"score_gpt":0.2614844470342797,"score_spread":0.24903952503811042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150114897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827587,0.013028945,0.000011340806,0.000058298647,0.000069890135,0.0039686756,0.000071843155,0.000016937494,0.00001537646],"genre_scores_gemma":[0.95156974,0.04809588,0.0000047912226,0.000029857201,0.0000044063563,0.00026184227,0.000001765347,0.000027528977,0.0000041871554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969985,0.0007519433,0.0009788821,0.00021667418,0.0007078949,0.00034611172],"domain_scores_gemma":[0.99676377,0.0006790481,0.0008997469,0.00097294006,0.00058527954,0.000099213554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078400754,0.00024279949,0.00068874174,0.0001307976,0.00019579534,0.000024936133,0.00033534088,0.00004530632,0.00002410293],"category_scores_gemma":[0.00076712086,0.00010905084,0.00022004571,0.00047510417,0.0004053621,0.00019188778,0.00006782855,0.00019202249,0.000003463757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020191935,0.0019536132,0.9494916,0.00019499908,0.00084287155,0.000014490248,0.0048703547,0.00026053115,0.00003235377,0.000028411192,0.000017460032,0.040274095],"study_design_scores_gemma":[0.007159622,0.0016772641,0.98419636,0.0041128015,0.00003276034,0.00007356734,0.0020390549,0.00018678937,0.00026103063,0.00014833595,0.0000023298376,0.00011005235],"about_ca_topic_score_codex":0.004049569,"about_ca_topic_score_gemma":0.00079833076,"teacher_disagreement_score":0.040164042,"about_ca_system_score_codex":0.000014736366,"about_ca_system_score_gemma":0.00020110728,"threshold_uncertainty_score":0.61217636},"labels":[],"label_agreement":null},{"id":"W2150301963","doi":"10.1136/ard.2003.013961","title":"Infliximab in active early rheumatoid arthritis","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Infliximab; Rheumatoid arthritis; Dermatology; Arthritis; Antirheumatic Agents; Immunology; Tumor necrosis factor alpha","score_opus":0.024974519092034502,"score_gpt":0.2999805682685394,"score_spread":0.2750060491765049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150301963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98136395,0.011043227,0.000009216495,0.0059592137,0.00010401483,0.0005675815,0.000056120774,0.000043268326,0.00085341313],"genre_scores_gemma":[0.9537013,0.04573332,0.00006869024,0.00033869513,0.000015034752,0.000062836545,0.000008176325,0.000025222364,0.000046710706],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981499,0.00009616366,0.0005039116,0.00021724105,0.00059727306,0.00043555498],"domain_scores_gemma":[0.99877596,0.00013289835,0.00016319465,0.00053853035,0.00015937779,0.00023005444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017218564,0.00019061004,0.0005159801,0.00018487855,0.00009129889,0.000034881978,0.00027971467,0.000054584845,0.00016480322],"category_scores_gemma":[0.00082706515,0.0001351818,0.00028499865,0.0004032961,0.0004995305,0.00026786333,0.00011133089,0.00018558468,0.000065279135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003964633,0.006786755,0.12396681,0.000935727,0.0014947256,0.00021849116,0.013749185,0.00050053967,0.00077211723,0.041635975,0.005920424,0.8000546],"study_design_scores_gemma":[0.011072142,0.0007402885,0.90064484,0.012837507,0.000008105688,0.00011155953,0.001862877,0.000046174486,0.013353123,0.05749899,0.0014182162,0.00040620644],"about_ca_topic_score_codex":0.000949232,"about_ca_topic_score_gemma":0.00016586622,"teacher_disagreement_score":0.7996484,"about_ca_system_score_codex":0.000032550117,"about_ca_system_score_gemma":0.00032022654,"threshold_uncertainty_score":0.5512554},"labels":[],"label_agreement":null},{"id":"W2150703501","doi":"10.1136/ard.2008.094946","title":"Treatment recommendations for psoriatic arthritis","year":2008,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":561,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dactylitis; Medicine; Enthesitis; Psoriatic arthritis; Psoriasis; Disease; Dermatology; Arthritis; Physical therapy; Intensive care medicine; Internal medicine","score_opus":0.16006060602859723,"score_gpt":0.41109519399931077,"score_spread":0.25103458797071354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150703501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003246015,0.99374765,0.0000030606527,0.0011864486,0.00038124973,0.0026456837,0.0017604404,0.00002922727,0.00021375691],"genre_scores_gemma":[0.00008085286,0.99679947,0.00018444912,0.00008115016,0.00008092603,0.0013422092,0.00048703238,0.000049539656,0.00089439866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984514,0.00008074721,0.0007387622,0.00025969668,0.00020036037,0.00026901255],"domain_scores_gemma":[0.9981202,0.00046991557,0.0005243416,0.0006366558,0.00011742547,0.00013147813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029422978,0.00037921724,0.0020413748,0.000094053925,0.0002312902,0.00001196042,0.00014429931,0.00008030011,0.00009875418],"category_scores_gemma":[0.00033075648,0.00021321475,0.0019062142,0.0001893746,0.000104823856,0.000035455178,0.00005420567,0.00005017689,0.000034549557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018084287,0.0007408535,0.000010012466,0.0049055465,0.002029241,0.0000059414924,0.000064058535,7.668358e-8,9.846266e-10,0.00013670775,0.02442279,0.9676667],"study_design_scores_gemma":[0.0015128212,0.0005338721,0.00007550204,0.037810903,0.0026073814,0.00011334496,0.00003942324,0.0000017381218,5.9110545e-7,0.0003332678,0.95680857,0.0001626056],"about_ca_topic_score_codex":0.00004217722,"about_ca_topic_score_gemma":0.000007848555,"teacher_disagreement_score":0.9675041,"about_ca_system_score_codex":0.00006443822,"about_ca_system_score_gemma":0.00033604557,"threshold_uncertainty_score":0.8694645},"labels":[],"label_agreement":null},{"id":"W2151047243","doi":"10.1136/ard.2006.058453","title":"Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?","year":2006,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Radiological weapon; Psoriasis; Inflammatory arthritis; Arthritis; Dermatology; Spondylarthropathies; Immunology; Surgery","score_opus":0.14191961756396468,"score_gpt":0.399316631629152,"score_spread":0.25739701406518734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151047243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032800246,0.96290517,0.0000030459066,0.00048742793,0.0004012232,0.0014076339,0.0018369678,0.000025169962,0.00013314122],"genre_scores_gemma":[0.008239806,0.99009585,0.000031367486,0.0005688653,0.00017738264,0.00038376302,0.0003083554,0.000046922076,0.00014768657],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99626446,0.00046435624,0.0018251935,0.00057213067,0.00052937964,0.00034445457],"domain_scores_gemma":[0.997272,0.0007660019,0.00091514306,0.0007272996,0.000074625306,0.00024489622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018086574,0.0005664454,0.0032102067,0.00012326484,0.00011573868,0.000039527335,0.00016057573,0.00019846314,0.0006238319],"category_scores_gemma":[0.0003036728,0.00031833805,0.0013683365,0.00014694224,0.00037657726,0.0000557609,0.00023712848,0.00030690455,0.000024440213],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006934724,0.0023812344,0.0325369,0.0070347134,0.0028903738,0.000049044364,0.0000386348,7.219953e-7,1.7809555e-8,0.00010546963,0.025783645,0.9291099],"study_design_scores_gemma":[0.0036854022,0.0003360144,0.75600314,0.0862068,0.0044354047,0.000016131024,0.00010335779,0.000019825671,1.4501876e-7,0.0021547396,0.14656252,0.0004765423],"about_ca_topic_score_codex":0.00011412666,"about_ca_topic_score_gemma":0.000023301804,"teacher_disagreement_score":0.92863333,"about_ca_system_score_codex":0.0000638168,"about_ca_system_score_gemma":0.0002873207,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W2151277711","doi":"10.1136/annrheumdis-2012-202106","title":"Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Université Laval; University of Manitoba; Toronto Western Hospital; Centre hospitalier universitaire de Québec; McGill University Health Centre; Montreal General Hospital; Dalhousie University; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; Versus Arthritis; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Manchester Biomedical Research Centre; Eusko Jaurlaritza; Lupus Research Alliance; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs; National Institute for Health and Care Research; Johns Hopkins University","keywords":"Medicine; Internal medicine; Cohort; Systemic lupus erythematosus; Metabolic syndrome; Lupus nephritis; Logistic regression; Disease; Obesity","score_opus":0.1439246158021298,"score_gpt":0.4279552119573109,"score_spread":0.2840305961551811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151277711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924707,0.00350144,0.00001631363,0.0007791718,0.0010893104,0.0009366384,0.00097146654,0.000021663684,0.00021333063],"genre_scores_gemma":[0.99825555,0.0010277813,0.00006195798,0.00011083955,0.000101680394,0.000045006487,0.00022099659,0.00002402747,0.00015215707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620914,0.0008296911,0.0012723248,0.00026289234,0.0011357632,0.00029019357],"domain_scores_gemma":[0.99581337,0.0008584086,0.0008066185,0.0020902974,0.0002556685,0.0001756273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002240871,0.0001564626,0.0007666079,0.00012363105,0.00005695701,0.000018780667,0.0014254885,0.0001008531,0.0001469564],"category_scores_gemma":[0.004303801,0.000090356676,0.00027520573,0.00036476366,0.00021903965,0.00047967435,0.00060505,0.00019058581,0.000031633095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048188653,0.00088508223,0.9950306,0.00025806777,0.0006047561,9.709456e-7,0.0004984306,0.000007902456,0.000028166744,0.0003866259,0.0013809571,0.00087025395],"study_design_scores_gemma":[0.00087086554,0.000023030681,0.9930552,0.0028438505,0.0002850786,0.00047345794,0.0007539107,0.0009652883,0.00004072598,0.0005513777,0.000054307962,0.00008289661],"about_ca_topic_score_codex":0.0004003848,"about_ca_topic_score_gemma":0.000037753187,"teacher_disagreement_score":0.0057848883,"about_ca_system_score_codex":0.000049223658,"about_ca_system_score_gemma":0.00024442506,"threshold_uncertainty_score":0.51523626},"labels":[],"label_agreement":null},{"id":"W2151392262","doi":"10.1136/annrheumdis-2012-201451","title":"An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"National Institute on Aging; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Osteoarthritis; Hazard ratio; Prospective cohort study; Interquartile range; Internal medicine; Osteoporosis; Proportional hazards model; Physical therapy; Cohort study; Odds ratio; Confidence interval; Pathology","score_opus":0.01135820370938245,"score_gpt":0.28537703087038946,"score_spread":0.274018827161007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151392262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956261,0.00052016316,0.000003485497,0.00007783003,0.000034685752,0.003543738,0.000100387544,0.00003520791,0.00005838057],"genre_scores_gemma":[0.9988589,0.000036620026,0.00026947906,0.00012260934,0.000019060426,0.0006225291,0.000027419104,0.000028348753,0.0000149765665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980088,0.00033116687,0.0005697652,0.00026663663,0.00044806392,0.00037559413],"domain_scores_gemma":[0.99852884,0.00015633283,0.0003775978,0.00043315746,0.00023066447,0.00027341757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007559709,0.00023191211,0.0006165236,0.00022018688,0.00005267891,0.000012793688,0.00012848666,0.00005109192,0.00004886697],"category_scores_gemma":[0.00046796165,0.00015825061,0.000056731704,0.00043525308,0.00005332719,0.00025461963,0.000042832184,0.0001303469,0.0000036128176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002303834,0.0075666956,0.9798314,0.000084370244,0.0002778141,0.000030545405,0.006092722,0.00009629933,0.0003941763,0.000018577675,0.000006949548,0.0032966358],"study_design_scores_gemma":[0.007005407,0.0059682815,0.981163,0.0009055831,0.00029720285,0.0000118583275,0.0026225396,0.000042645945,0.0016202827,0.00020506933,0.0000017028656,0.00015637219],"about_ca_topic_score_codex":0.00048908486,"about_ca_topic_score_gemma":0.00020779502,"teacher_disagreement_score":0.004701573,"about_ca_system_score_codex":0.00008027121,"about_ca_system_score_gemma":0.00017564849,"threshold_uncertainty_score":0.6453272},"labels":[],"label_agreement":null},{"id":"W2151660169","doi":"10.1136/ard.61.4.330","title":"Development of a radiographic index to assess the tarsal involvement in patients with spondyloarthropathies","year":2002,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Radiography; Concordance; Plantar fascia; Kappa; Spondyloarthropathy; Cohen's kappa; Orthodontics; Sesamoid bone; Nuclear medicine; Radiology; Surgery; Anatomy; Heel; Ankylosing spondylitis; Internal medicine","score_opus":0.04902134381737556,"score_gpt":0.2715454289685967,"score_spread":0.22252408515122113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151660169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676627,0.0014857155,0.000005910831,0.0007040206,0.000056869136,0.00082326494,0.000035100027,0.000008862444,0.00011399162],"genre_scores_gemma":[0.9991692,0.00019807625,0.00021945081,0.00028569103,0.0000051875913,0.000068810456,0.0000075923135,0.000013244769,0.000032756503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859655,0.000056247718,0.00042033786,0.00015469122,0.0005498388,0.0002223561],"domain_scores_gemma":[0.99912655,0.00007376798,0.00018283888,0.00038706514,0.00014312926,0.00008662772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012459043,0.0001615408,0.0003780245,0.00014000511,0.00010392387,0.000008688231,0.00016662444,0.000020737883,0.000078183024],"category_scores_gemma":[0.00010798145,0.000080189864,0.00011439129,0.00051572936,0.00016092982,0.000049256152,0.00010667671,0.00005466172,0.000004985779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032379504,0.0017780688,0.97144794,0.00018309399,0.00041249456,0.0000038053918,0.0024701473,0.000020666808,0.0000028378329,0.00007594205,0.0006216487,0.022659529],"study_design_scores_gemma":[0.0022366908,0.0003534691,0.99442387,0.0014725236,0.00007980472,7.7270107e-7,0.00081056036,0.000017698272,0.00019784775,0.000058982412,0.00025922793,0.0000885295],"about_ca_topic_score_codex":0.000052741903,"about_ca_topic_score_gemma":0.00012077863,"teacher_disagreement_score":0.022975922,"about_ca_system_score_codex":0.000018042263,"about_ca_system_score_gemma":0.00004477246,"threshold_uncertainty_score":0.3270048},"labels":[],"label_agreement":null},{"id":"W2152107925","doi":"10.1136/ard.2008.098202","title":"Occurrence and correlates of fatigue in psoriatic arthritis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Toronto; University of Waterloo","funders":"","keywords":"Medicine; Psoriatic arthritis; Dermatology; Arthritis; Psoriasis; Internal medicine","score_opus":0.05529392009939111,"score_gpt":0.30592833711647477,"score_spread":0.25063441701708367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152107925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748926,0.024209935,0.0000012573435,0.00032532887,0.00007147638,0.00022633662,0.00012117642,0.000006288948,0.00014556163],"genre_scores_gemma":[0.9820571,0.017819436,0.000024347397,0.000048598475,0.0000033625254,0.000014948872,0.000008173802,0.0000032302733,0.000020830123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992932,0.000028663755,0.00029076234,0.00009795854,0.00016995,0.00011944219],"domain_scores_gemma":[0.99943197,0.00013621082,0.00013086353,0.00018930798,0.000056864472,0.00005479453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041942327,0.00008805467,0.00034740957,0.000047109053,0.000046221583,0.0000018812922,0.000054800003,0.000019241725,0.00003933471],"category_scores_gemma":[0.00038308915,0.000058809008,0.00008633304,0.00014106366,0.00022449234,0.000041740488,0.00004640681,0.000035795965,0.0000027201688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104961255,0.00062330643,0.93391716,0.00033675955,0.00016580067,0.000025538196,0.0010606059,0.000009516371,0.000004017153,0.0001906364,0.0018278005,0.061733887],"study_design_scores_gemma":[0.0017016822,0.00020018948,0.99423456,0.002334472,0.000055316737,0.00003514383,0.00024413604,0.000047233818,0.00020015235,0.0008667048,0.000020740703,0.000059662274],"about_ca_topic_score_codex":0.00009847634,"about_ca_topic_score_gemma":0.000014515958,"teacher_disagreement_score":0.061674222,"about_ca_system_score_codex":0.0000036247213,"about_ca_system_score_gemma":0.000040579354,"threshold_uncertainty_score":0.23981617},"labels":[],"label_agreement":null},{"id":"W2152261275","doi":"10.1136/ard.2010.130310","title":"The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Statistical Methods in Epidemiology","field":"Mathematics","cited_by":202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Mount Sinai Hospital","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Rheumatism; Rheumatoid arthritis; Rheumatology; League; Internal medicine; Physical therapy; Alternative medicine; Family medicine; Pathology","score_opus":0.3082178203430275,"score_gpt":0.49523024309952646,"score_spread":0.18701242275649893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152261275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8395532,0.0010485991,0.14315498,0.008183631,0.0027279137,0.0022221538,0.002228142,0.00018572673,0.0006957008],"genre_scores_gemma":[0.745492,0.0030539266,0.2506918,0.00021095124,0.000030760366,0.00029471287,0.00004059964,0.00008561887,0.00009967626],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9905737,0.0046544783,0.0030309614,0.00058397884,0.00048768628,0.0006691979],"domain_scores_gemma":[0.9429044,0.05069979,0.0034302839,0.0020720358,0.0006435137,0.00024999006],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.010288005,0.0004349562,0.0017170501,0.000116218325,0.00047262496,0.000030444606,0.0014240482,0.00016042242,0.00007215384],"category_scores_gemma":[0.20275746,0.00026470606,0.00065431057,0.000369995,0.0031714032,0.00012039926,0.00031448883,0.00044271824,0.000008457666],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005420179,0.0013923477,0.0027752193,0.0007670141,0.00063205423,0.000014138548,0.00033791142,0.0000046557493,0.0027085969,0.5909923,0.09121485,0.3086189],"study_design_scores_gemma":[0.0018510394,0.00043594258,0.028082853,0.0014192881,0.00014336962,0.00032876682,0.0011750505,0.004681585,0.0020763257,0.957133,0.0021250104,0.0005477459],"about_ca_topic_score_codex":0.00004672971,"about_ca_topic_score_gemma":0.000043798213,"teacher_disagreement_score":0.36614072,"about_ca_system_score_codex":0.00001495408,"about_ca_system_score_gemma":0.00017164691,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W2152436168","doi":"10.1136/ard.61.12.1081","title":"Investigation of chromosome 2q in osteoarthritis of the hand: no significant linkage in a Tasmanian population","year":2002,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Menzies Institute for Medical Research; Australian Government; McGill University; University of Tasmania; Arthritis Foundation of Australia; Arthritis Foundation","keywords":"Medicine; Linkage (software); Population; Genetic linkage; Genetics; Heritability; Biology; Gene","score_opus":0.036958745132090784,"score_gpt":0.2528180313463262,"score_spread":0.2158592862142354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152436168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969148,0.0012897619,5.4219123e-7,0.00072202936,0.00009405808,0.00071585155,0.0000725775,0.000006593236,0.00018375613],"genre_scores_gemma":[0.99943835,0.00020684484,0.000041022387,0.00008904146,0.000012178762,0.000031642703,0.000021735375,0.000011679499,0.0001475388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987364,0.00013195034,0.00055224914,0.00012502642,0.00031102996,0.00014337957],"domain_scores_gemma":[0.99909806,0.0000715841,0.00033045764,0.00036381255,0.00007889634,0.00005720087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013446379,0.000114904644,0.0003679873,0.00011181481,0.000030473366,0.0000061509213,0.00013002187,0.000050647133,0.00010442705],"category_scores_gemma":[0.00034258878,0.00007384944,0.00015552194,0.00031496835,0.00014395255,0.0000923955,0.000041781033,0.000057292807,0.0000048644297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003875623,0.0018167432,0.7798157,0.00304656,0.00012660936,0.000023751032,0.006723086,0.00011609418,0.053352755,0.0016644697,0.0006984238,0.15222827],"study_design_scores_gemma":[0.0051706694,0.0013580535,0.8818298,0.012602377,0.00015032588,0.0000075734874,0.00034999027,0.00061448413,0.09242048,0.0053006285,0.000020335116,0.00017527008],"about_ca_topic_score_codex":0.00024492532,"about_ca_topic_score_gemma":0.00018664874,"teacher_disagreement_score":0.152053,"about_ca_system_score_codex":0.000016443983,"about_ca_system_score_gemma":0.000035046556,"threshold_uncertainty_score":0.30114928},"labels":[],"label_agreement":null},{"id":"W2152721826","doi":"10.1136/ard.2011.154500","title":"Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"Janssen Biotech; Chugai Pharmaceutical; Versus Arthritis; National Institute for Health and Care Research; GlaxoSmithKline; Genentech; Novartis Pharmaceuticals Corporation; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Amgen; Sanofi; Abbott Laboratories","keywords":"Medicine; Rheumatoid arthritis; Radiography; Internal medicine; Pathology; Radiology","score_opus":0.04232801470332707,"score_gpt":0.30586988356402095,"score_spread":0.26354186886069386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152721826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925274,0.0065647434,0.0000027038195,0.00019363049,0.00004131892,0.00050588255,0.00009929985,0.000009411127,0.000055566063],"genre_scores_gemma":[0.9687289,0.031080995,0.000071345006,0.00006419683,0.0000033634092,0.000022450195,0.0000047148296,0.000017373497,0.0000066317148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787724,0.00035610006,0.00068377587,0.00017635696,0.0006876859,0.00021885018],"domain_scores_gemma":[0.9979679,0.00028996464,0.00063586957,0.00048109936,0.00050738436,0.00011779678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005768289,0.0001528285,0.0006373944,0.00018238537,0.00006534134,0.000010045553,0.00021493879,0.000054885626,0.000034993973],"category_scores_gemma":[0.000741392,0.000079096935,0.00017094096,0.00068935874,0.0006647088,0.0001984135,0.00006904532,0.00013838633,6.614172e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006738649,0.00082505826,0.99399793,0.00018666082,0.0005522109,7.7941695e-7,0.00085803494,0.0000024072162,0.000016000864,0.000095521515,0.0005717184,0.0022198155],"study_design_scores_gemma":[0.0029933157,0.00062762346,0.9898602,0.0040027853,0.000027684768,6.670931e-7,0.00051736383,0.0000065974286,0.0015881488,0.00025983853,0.000028307099,0.0000874621],"about_ca_topic_score_codex":0.000120082594,"about_ca_topic_score_gemma":0.000087526394,"teacher_disagreement_score":0.024516251,"about_ca_system_score_codex":0.0000094503075,"about_ca_system_score_gemma":0.000210728,"threshold_uncertainty_score":0.32254794},"labels":[],"label_agreement":null},{"id":"W2152808869","doi":"10.1136/ard.2006.061002","title":"Consensus statement on the use of rituximab in patients with rheumatoid arthritis","year":2006,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Rituximab; Statement (logic); Alternative medicine; Clinical trial; Physical therapy; Antirheumatic Agents; Internal medicine; Intensive care medicine; Family medicine; Pathology; Lymphoma","score_opus":0.039899175301195064,"score_gpt":0.27146704635592733,"score_spread":0.23156787105473225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152808869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931584,0.002373028,0.000003177615,0.0031831018,0.000041354593,0.00088451133,0.00021008312,0.000014789138,0.00013153387],"genre_scores_gemma":[0.994828,0.004749043,0.00006376046,0.0002147521,0.0000048050724,0.000041985913,0.00002442223,0.000020432139,0.00005281428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997903,0.00020719126,0.0006250136,0.00016519945,0.00078963075,0.00030999098],"domain_scores_gemma":[0.9982134,0.00056703045,0.00029223078,0.0005815326,0.00026066598,0.000085116146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002113287,0.0001723997,0.00045984078,0.000112750546,0.000082446786,0.00002903252,0.00017842489,0.000025783827,0.00013041696],"category_scores_gemma":[0.0005392433,0.000087007975,0.0001458616,0.00024458254,0.0004634499,0.00007740237,0.000058137975,0.00010790866,0.000011290226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00455705,0.01198212,0.8548015,0.00045950687,0.00062457146,0.000019063711,0.00053878187,0.00052777043,0.000026381875,0.009720588,0.06466235,0.052080344],"study_design_scores_gemma":[0.008038511,0.00083152414,0.97920585,0.0064477795,0.000007105078,0.000003738925,0.00019547064,0.00012739557,0.00096061704,0.0021271992,0.0018978742,0.00015691496],"about_ca_topic_score_codex":0.00061946316,"about_ca_topic_score_gemma":0.00010841412,"teacher_disagreement_score":0.1244044,"about_ca_system_score_codex":0.000015462982,"about_ca_system_score_gemma":0.00013389236,"threshold_uncertainty_score":0.3548082},"labels":[],"label_agreement":null},{"id":"W2153090765","doi":"10.1136/annrheumdis-2013-205009","title":"Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Medicine; Rheumatoid arthritis; Serology; Family history; Phenotype; Family studies; Arthritis; Immunology; Internal medicine; Genetics; Antibody; Gene","score_opus":0.06108244773947036,"score_gpt":0.28894918119703317,"score_spread":0.2278667334575628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153090765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107133,0.08668769,0.0015414755,0.00018288089,0.00010586086,0.0006155653,0.0000627785,0.000026816288,0.00006362442],"genre_scores_gemma":[0.85092664,0.14662841,0.0021357352,0.00020514421,0.000016902064,0.00004523648,0.000005171124,0.000020671594,0.000016065404],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982217,0.00026879157,0.000653463,0.00025044306,0.0002419382,0.00036363973],"domain_scores_gemma":[0.9979474,0.00065655215,0.0005033538,0.00048049513,0.00024470824,0.00016750523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059980433,0.00020227283,0.00075147755,0.00009498206,0.00013179645,0.000008325407,0.0002168807,0.00006987102,0.000020777],"category_scores_gemma":[0.0016052538,0.00013452988,0.0002540102,0.00007829468,0.0005650582,0.0001377591,0.00009625338,0.000103668186,0.0000011194371],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034053952,0.0011945479,0.14623027,0.0045906496,0.0013599729,0.0000019718432,0.0012861995,0.008894429,0.0077194683,0.003733915,0.004652998,0.8169302],"study_design_scores_gemma":[0.0036627566,0.0022540027,0.22280522,0.0035315,0.0000616763,0.000040905892,0.00019861253,0.735928,0.0015030573,0.029037012,0.0006055904,0.00037164142],"about_ca_topic_score_codex":0.00020735558,"about_ca_topic_score_gemma":0.0000059322647,"teacher_disagreement_score":0.81655854,"about_ca_system_score_codex":0.000018784924,"about_ca_system_score_gemma":0.00013849193,"threshold_uncertainty_score":0.5485969},"labels":[],"label_agreement":null},{"id":"W2153124348","doi":"10.1136/annrheumdis-2013-203695","title":"Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"UCB Pharma","keywords":"Medicine; Certolizumab pegol; Internal medicine; Rheumatoid arthritis; Adverse effect; Population; Rheumatology; Randomized controlled trial; Erythrocyte sedimentation rate; Surgery; Adalimumab","score_opus":0.05611268790375145,"score_gpt":0.331847857232679,"score_spread":0.27573516932892755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153124348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668733,0.025240729,0.0000031587517,0.0047944635,0.000031073447,0.002865797,0.00011739831,0.0000054681523,0.00006863009],"genre_scores_gemma":[0.81642926,0.18334588,0.00005493099,0.000030091527,0.0000057549746,0.00007838094,0.00003544863,0.000011839971,0.000008422639],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976838,0.0006786324,0.0007455428,0.00023715422,0.00044323516,0.00021163325],"domain_scores_gemma":[0.99687177,0.001902664,0.00038012207,0.0006123139,0.00015084166,0.000082270264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037998144,0.00018109643,0.0006772016,0.00009049745,0.00008730892,0.00005674418,0.00029277924,0.00004092728,0.00004343635],"category_scores_gemma":[0.0008370331,0.00008200847,0.00006948943,0.00023381104,0.00046192328,0.00019748144,0.00009065738,0.00008624887,0.0000013483276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12373925,0.010247872,0.029221525,0.00020529352,0.0006290169,0.00003185587,0.011684954,0.000009752687,0.00021245716,0.00067114754,0.0006401995,0.8227067],"study_design_scores_gemma":[0.1495951,0.0036227002,0.83778995,0.005383826,0.000020582196,0.000032585747,0.001426341,0.00023662014,0.00048007956,0.0012543086,0.000040179795,0.00011775018],"about_ca_topic_score_codex":0.0024321289,"about_ca_topic_score_gemma":0.00025753802,"teacher_disagreement_score":0.8225889,"about_ca_system_score_codex":0.000012209725,"about_ca_system_score_gemma":0.000101666476,"threshold_uncertainty_score":0.36766675},"labels":[],"label_agreement":null},{"id":"W2153700383","doi":"10.1136/ard.2010.140210","title":"Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; McGill University; Arthritis Research Centre of Canada","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Rheumatoid arthritis; Proportional hazards model; Cohort; Internal medicine; Population; Cumulative dose; Hazard ratio; Confidence interval","score_opus":0.03322551881684305,"score_gpt":0.2528148342436767,"score_spread":0.21958931542683363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153700383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962877,0.0014035066,0.000021542884,0.000094604904,0.000021217182,0.001953621,0.00019407689,0.000018847291,0.000004869958],"genre_scores_gemma":[0.9986453,0.0010599456,0.000053245087,0.00004640095,0.0000021728608,0.0001112743,0.000042896165,0.00003323677,0.0000055137752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688387,0.00060053566,0.00074885436,0.0002302795,0.0012332613,0.0003032084],"domain_scores_gemma":[0.9970483,0.00043143771,0.0008113617,0.00092245935,0.0005839133,0.00020248046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039022937,0.00023231874,0.0006923906,0.0001780119,0.00010193979,0.000019140418,0.00028963303,0.000031023494,0.000081835635],"category_scores_gemma":[0.0020644441,0.00011813721,0.0002447487,0.0005243786,0.00033216295,0.0002058641,0.000075338154,0.00013807799,0.0000010895767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022512083,0.005481601,0.9866872,0.00012202664,0.00096065964,0.000004020235,0.00095580594,0.0003873838,4.883742e-7,0.00003955553,0.000058273097,0.0030518232],"study_design_scores_gemma":[0.0061279368,0.001247889,0.9874527,0.004046851,0.00008799024,3.4396035e-7,0.0004204372,0.00024338403,0.000060380247,0.00017873953,0.0000025692211,0.0001308123],"about_ca_topic_score_codex":0.002448652,"about_ca_topic_score_gemma":0.0008647803,"teacher_disagreement_score":0.004233712,"about_ca_system_score_codex":0.000022309834,"about_ca_system_score_gemma":0.00026957283,"threshold_uncertainty_score":0.48174956},"labels":[],"label_agreement":null},{"id":"W2153921781","doi":"10.1136/annrheumdis-2011-201089","title":"Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital; University of Manitoba; Centre hospitalier universitaire de Québec; Toronto Western Hospital; University of Toronto; Dalhousie University; Nova Scotia Health Authority; Université Laval; Queen Elizabeth II Health Sciences Centre; Nova Scotia Hospital","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Systemic lupus erythematosus; Cohort; Prospective cohort study; Lupus anticoagulant; Rheumatology; Antiphospholipid syndrome; Cohort study; Proportional hazards model; Autoantibody; Disease; Immunology; Antibody; Thrombosis","score_opus":0.03474770908339948,"score_gpt":0.34837859295369944,"score_spread":0.31363088387029997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153921781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934092,0.0009791285,0.000011966758,0.00055912766,0.00067083637,0.0031020571,0.00017051985,0.00006143067,0.0010356945],"genre_scores_gemma":[0.99863887,0.00042588532,0.000028107488,0.00004164494,0.00010274086,0.00028194182,0.000076464115,0.000038355385,0.00036597592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676925,0.00044438988,0.0008846182,0.00037111575,0.001138168,0.00039244513],"domain_scores_gemma":[0.9976433,0.00035752275,0.00040802805,0.0011254158,0.00023110253,0.0002346153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010440893,0.00023323609,0.0006092065,0.0002226599,0.00007154765,0.000034406923,0.0005195116,0.00007473361,0.00008114131],"category_scores_gemma":[0.0016795109,0.00015549357,0.00017326622,0.00038694174,0.0001263429,0.00046089877,0.00019308187,0.00017150126,0.00004403023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007671069,0.0027460207,0.9870986,0.00036167473,0.0004109251,0.0000029791618,0.0068217115,0.000035525136,0.000025052834,0.00008144794,0.0007276,0.0009213929],"study_design_scores_gemma":[0.0034053025,0.0001390344,0.980189,0.0027386567,0.00012291856,0.00028606484,0.0118620945,0.00044793182,0.000047733378,0.00058924186,0.000017554647,0.00015443287],"about_ca_topic_score_codex":0.00088495895,"about_ca_topic_score_gemma":0.00013050559,"teacher_disagreement_score":0.006909529,"about_ca_system_score_codex":0.00013419322,"about_ca_system_score_gemma":0.0001177298,"threshold_uncertainty_score":0.6340844},"labels":[],"label_agreement":null},{"id":"W2153939786","doi":"10.1136/ard.62.4.316","title":"Number needed to treat (NNT): implication in rheumatology clinical practice","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; Association of Universities and Colleges of Canada","funders":"McMaster University","keywords":"Medicine; Number needed to treat; Number needed to harm; Rheumatology; Rheumatoid arthritis; Placebo; Internal medicine; Confidence interval; Systematic review; Adverse effect; Psychological intervention; Physical therapy; Leflunomide; Clinical trial; Relative risk; MEDLINE; Alternative medicine; Psychiatry; Pathology","score_opus":0.05503096659544432,"score_gpt":0.4234503251261048,"score_spread":0.3684193585306605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153939786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734508,0.0025319126,0.000038370163,0.01772807,0.00014993871,0.00072281563,0.000016609909,0.000030504061,0.0053309905],"genre_scores_gemma":[0.9874633,0.010093996,0.00058875914,0.0014946818,0.000009103122,0.000086261534,0.000007249961,0.000022058102,0.00023459541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976036,0.00057836744,0.0007976014,0.00025319002,0.00039868447,0.00036857158],"domain_scores_gemma":[0.9973455,0.0011525725,0.00021798292,0.0006881384,0.0002744841,0.0003213301],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0007761069,0.00015608828,0.00054528046,0.00010090501,0.00007107049,0.00002486661,0.00022045817,0.00007087751,0.00033276834],"category_scores_gemma":[0.013181019,0.00010657633,0.00023533014,0.00041564374,0.00018444646,0.0001780435,0.00006268913,0.00015368327,0.00021357091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003309113,0.0073138187,0.5263055,0.0011546651,0.0007328543,0.000044907723,0.0023004839,0.000041121435,0.00024445867,0.06355923,0.20626445,0.18872944],"study_design_scores_gemma":[0.012667109,0.0015576256,0.8376456,0.006290985,0.00013789107,0.0011627107,0.007527403,0.00017167472,0.0075179334,0.03221964,0.09218017,0.000921264],"about_ca_topic_score_codex":0.00037325505,"about_ca_topic_score_gemma":0.000013902442,"teacher_disagreement_score":0.31134012,"about_ca_system_score_codex":0.000016954249,"about_ca_system_score_gemma":0.00025555515,"threshold_uncertainty_score":0.9951314},"labels":[],"label_agreement":null},{"id":"W2153979152","doi":"10.1136/ard.2006.066514","title":"Intracellular localisation of galectin-3 has a protective role in chondrocyte survival","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré de Santé et de Services Sociaux des Laurentides; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Chondrocyte; Intracellular; Cartilage; Medicine; Osteoarthritis; Viability assay; Internal medicine; Galectin-3; In vitro; Endocrinology; Pathology; Andrology; Cell biology; Chemistry; Biology; Anatomy; Biochemistry","score_opus":0.03119148871370775,"score_gpt":0.270810381206517,"score_spread":0.23961889249280927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153979152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923735,0.005860359,0.00031687735,0.00032168784,0.00030013724,0.00036627016,0.000026003689,0.000013398407,0.00042175854],"genre_scores_gemma":[0.99967235,0.00008392766,0.000009740352,0.000042646574,0.000008607151,0.000018585619,0.000010709425,0.000007944471,0.0001454843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988971,0.00023642828,0.00041474795,0.0001538544,0.000050819464,0.00024706192],"domain_scores_gemma":[0.999159,0.00016724088,0.00029637743,0.0002530328,0.00010679601,0.000017563576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045938586,0.00011338779,0.00030827138,0.00009711949,0.00006669531,0.000003968631,0.00022726167,0.00010534468,0.00014704079],"category_scores_gemma":[0.00037408035,0.00008064452,0.00012917312,0.0002451183,0.00034312892,0.000043616958,0.00006120565,0.00012706686,0.000011361883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049005696,0.0032468894,0.13239446,0.0009672364,0.0014521434,0.000006274092,0.008224525,0.00050335005,0.5213383,0.00606358,0.002221121,0.3186816],"study_design_scores_gemma":[0.0010561134,0.00030728735,0.34573326,0.00031463284,0.000049101745,0.000009494921,0.0013359496,0.000021533047,0.6436105,0.0063655167,0.0010356975,0.00016090316],"about_ca_topic_score_codex":0.00084772985,"about_ca_topic_score_gemma":0.00039862317,"teacher_disagreement_score":0.3185207,"about_ca_system_score_codex":0.000016817376,"about_ca_system_score_gemma":0.00009808057,"threshold_uncertainty_score":0.3288588},"labels":[],"label_agreement":null},{"id":"W2154319559","doi":"10.1136/ard.2010.130625","title":"Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Expert opinion; Multinational corporation; Alternative medicine; Systematic review; Inflammatory arthritis; Arthritis; MEDLINE; Family medicine; Internal medicine; Physical therapy; Intensive care medicine; Pathology","score_opus":0.15602807672707042,"score_gpt":0.39141344014798307,"score_spread":0.23538536342091265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154319559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737285,0.008607516,0.000018955077,0.016218496,0.00017708537,0.001108158,0.000106601365,0.0000100930365,0.000024616947],"genre_scores_gemma":[0.98821896,0.010976537,0.0002758054,0.00021967797,0.000014263323,0.00022497796,0.00004504423,0.000011919463,0.000012820726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973833,0.00079712167,0.00061080605,0.0002146976,0.00078311254,0.00021094129],"domain_scores_gemma":[0.99603176,0.0023518857,0.00032618808,0.00034447014,0.0008190138,0.00012669797],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012323096,0.00016463442,0.000465826,0.00039702427,0.0001283612,0.000104075436,0.00032574046,0.000068143425,0.000022816543],"category_scores_gemma":[0.011502832,0.00009756079,0.00009981217,0.00040831833,0.00077512226,0.00026756368,0.000116479125,0.00034459683,5.4065083e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008127,0.0067349724,0.486892,0.06756396,0.0028148137,0.000048156817,0.18420678,0.00008395622,0.023497956,0.10735691,0.013635663,0.0990378],"study_design_scores_gemma":[0.0067492,0.0018364259,0.4787179,0.4658145,0.000017940329,0.000081824255,0.02362004,0.0063999067,0.0076757954,0.008572257,0.00009758521,0.00041663778],"about_ca_topic_score_codex":0.0001114983,"about_ca_topic_score_gemma":0.00014820727,"teacher_disagreement_score":0.39825055,"about_ca_system_score_codex":0.000015254167,"about_ca_system_score_gemma":0.0001941209,"threshold_uncertainty_score":0.9968237},"labels":[],"label_agreement":null},{"id":"W2154632498","doi":"10.1136/ard.62.10.923","title":"Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Medical Research Council; Reumatikerförbundet; Lunds Universitet","keywords":"Medicine; WOMAC; Osteoarthritis; Quality of life (healthcare); Physical therapy; Prospective cohort study; SF-36; Orthopedic surgery; Surgery; Internal medicine; Health related quality of life; Disease","score_opus":0.01958614789966133,"score_gpt":0.2898597398307154,"score_spread":0.27027359193105405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154632498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411696,0.0009752188,0.000010828691,0.0003569574,0.00041235855,0.003775754,0.00018376547,0.000030682953,0.0001374618],"genre_scores_gemma":[0.9987374,0.0000130725475,0.0001412551,0.0001311289,0.000014557756,0.0005163502,0.000003713612,0.000029174667,0.00041332698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979456,0.00012494426,0.00083762483,0.00026204798,0.00056052033,0.000269259],"domain_scores_gemma":[0.9983325,0.00023940114,0.00038441937,0.0006644171,0.00023674336,0.00014250766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022282616,0.00020884455,0.0006039531,0.00007970551,0.00005688644,0.000009633896,0.00009594393,0.000032667293,0.00010660089],"category_scores_gemma":[0.0020729408,0.00013523785,0.0003921543,0.00015563022,0.00014896525,0.000087651584,0.000080836835,0.00006505512,0.0000068452873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015079161,0.00245298,0.9901554,0.00061860983,0.00048147462,0.0000046007654,0.0022877457,0.000022628597,0.000013818184,0.0001774116,0.00054949033,0.0017279343],"study_design_scores_gemma":[0.00462017,0.0057834643,0.9813035,0.00077622966,0.0004983566,0.00001598165,0.003915121,0.00001242727,0.0021237717,0.0006779465,0.00010253708,0.00017046015],"about_ca_topic_score_codex":0.000015304384,"about_ca_topic_score_gemma":0.000008103582,"teacher_disagreement_score":0.008851856,"about_ca_system_score_codex":0.000029533205,"about_ca_system_score_gemma":0.00010515972,"threshold_uncertainty_score":0.5514839},"labels":[],"label_agreement":null},{"id":"W2154662505","doi":"10.1136/annrheumdis-2013-204948","title":"Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"European League Against Rheumatism; National Institute for Health and Care Research; Parker Institute for Cancer Immunotherapy; Versus Arthritis; Oak Foundation","keywords":"Medicine; Randomized controlled trial; Rheumatism; Delphi; Delphi method; Clinical trial; Medical physics; Physical therapy; Family medicine; Internal medicine; Computer science; Artificial intelligence","score_opus":0.4372635990200015,"score_gpt":0.526955027771311,"score_spread":0.08969142875130948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154662505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773086,0.006321453,0.00020291984,0.004432682,0.00036111433,0.00090829574,0.0000094130755,0.0000074777577,0.000025805668],"genre_scores_gemma":[0.98629624,0.011447402,0.002046157,0.000061899496,0.00001371298,0.000093410716,0.000007212806,0.000010064836,0.000023876322],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99592775,0.0002871915,0.0031547525,0.00014842964,0.00029883638,0.0001830316],"domain_scores_gemma":[0.993286,0.003378714,0.002312295,0.00048439414,0.00047497777,0.00006362873],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0041978257,0.00009862413,0.0009258694,0.00008083596,0.0001031916,0.0000038117819,0.00018847048,0.000037581398,0.000021339518],"category_scores_gemma":[0.04032877,0.000051969004,0.00032128656,0.00014284579,0.0004012464,0.000044179673,0.00011258404,0.000083511935,8.27916e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018260708,0.0028870848,0.04718824,0.0038217504,0.0024350816,0.0000016691243,0.006008222,0.000053667438,0.00017976179,0.0053526023,0.01401754,0.8997937],"study_design_scores_gemma":[0.15445551,0.0058908053,0.62622255,0.06362302,0.000445733,0.00009549767,0.02969585,0.010196121,0.01895425,0.055342056,0.03410377,0.00097483484],"about_ca_topic_score_codex":0.000029447856,"about_ca_topic_score_gemma":0.000020233792,"teacher_disagreement_score":0.89881885,"about_ca_system_score_codex":0.00000514912,"about_ca_system_score_gemma":0.0002531806,"threshold_uncertainty_score":0.96775496},"labels":[],"label_agreement":null},{"id":"W2154986972","doi":"10.1136/ard.2008.091025","title":"The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events","year":2008,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Meta-analysis; Odds ratio; Adverse effect; Randomized controlled trial; Relative risk; Surgery; Gastroenterology; Confidence interval","score_opus":0.09822328117143739,"score_gpt":0.37133933279147696,"score_spread":0.2731160516200396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154986972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12722637,0.86979765,8.9899396e-7,0.00010458517,0.00007709613,0.0017313171,0.0010199833,0.000016423168,0.000025686924],"genre_scores_gemma":[0.1861645,0.8134944,0.000019900826,0.000011188037,0.0000059949757,0.000135933,0.0000647188,0.000050370138,0.000053033626],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949515,0.0009112358,0.0022498984,0.0004024489,0.0009703753,0.0005145745],"domain_scores_gemma":[0.9956884,0.001049677,0.0016473975,0.0010484547,0.000300105,0.00026600852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003233771,0.00063053187,0.0045579323,0.00036973695,0.00019054684,0.000014324011,0.0005804457,0.0001565052,0.00007743495],"category_scores_gemma":[0.0012053059,0.00032661197,0.0020249756,0.00069175457,0.0007196461,0.00016500521,0.00024226466,0.00023804276,0.000004505052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005085712,0.0015542762,0.0049491054,0.0120325405,0.023372622,0.000028901824,0.00044674153,0.000010575541,0.000021172627,0.000045225017,0.0003462186,0.95668405],"study_design_scores_gemma":[0.023665328,0.0034542964,0.41531682,0.4888108,0.009826637,0.000880472,0.002055408,0.00010098842,0.0017105849,0.0014433649,0.050180595,0.0025546853],"about_ca_topic_score_codex":0.0005904291,"about_ca_topic_score_gemma":0.00008249824,"teacher_disagreement_score":0.95412934,"about_ca_system_score_codex":0.000032650172,"about_ca_system_score_gemma":0.00060245075,"threshold_uncertainty_score":0.9999186},"labels":[],"label_agreement":null},{"id":"W2155069742","doi":"10.1136/annrheumdis-2011-200347","title":"Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Health Research Board; University Health Network","keywords":"HLA-B27; Ankylosing spondylitis; Peripheral blood mononuclear cell; Endoplasmic reticulum; Monoclonal antibody; Medicine; Epitope; Transfection; Human leukocyte antigen; Molecular biology; Antigen; Flow cytometry; Pathogenesis; Antibody; Immunology; In vitro; Biology; Cell biology; Cell culture; Genetics","score_opus":0.03379049881133114,"score_gpt":0.2824380497196861,"score_spread":0.24864755090835497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155069742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949207,0.002494879,0.0000070694414,0.0012124445,0.00015119795,0.0005277001,0.00012939936,0.000019957744,0.00053666695],"genre_scores_gemma":[0.9987148,0.00056787755,0.00013196288,0.00024084932,0.000037933092,0.00003897742,0.000034337376,0.000018493043,0.00021475536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988181,0.000074029536,0.00032373087,0.00020537153,0.0002800334,0.00029873045],"domain_scores_gemma":[0.99908626,0.0002018931,0.00014511048,0.0002565606,0.00010788716,0.00020230447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014047368,0.00018074384,0.00034776147,0.000115030765,0.00010024056,0.000021059366,0.000055054483,0.000032278353,0.00019156966],"category_scores_gemma":[0.0002787047,0.00011648549,0.00008334116,0.0002456476,0.00011212936,0.00018954683,0.000064840984,0.00009127882,0.00001818292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028435122,0.0016014092,0.9788027,0.00037939352,0.0004320938,0.00003684107,0.0015568604,0.00004325182,0.00057773007,0.0005918312,0.0014638617,0.011670538],"study_design_scores_gemma":[0.0013261035,0.0004886548,0.9888772,0.0024753585,0.00014992342,0.00007984665,0.0010638261,0.00002536883,0.004733985,0.00014881397,0.0004882371,0.00014268218],"about_ca_topic_score_codex":0.00020653068,"about_ca_topic_score_gemma":0.00006797587,"teacher_disagreement_score":0.011527856,"about_ca_system_score_codex":0.000033721448,"about_ca_system_score_gemma":0.000038129256,"threshold_uncertainty_score":0.47501406},"labels":[],"label_agreement":null},{"id":"W2155109530","doi":"10.1136/ard.2009.123919","title":"Treating rheumatoid arthritis to target: recommendations of an international task force","year":2010,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2097,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Montreal Clinical Research Institute","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Task force; Rheumatoid arthritis; Task (project management); Immunology; Physical therapy; Intensive care medicine; Management; Public administration","score_opus":0.05184403448186096,"score_gpt":0.38439224610746686,"score_spread":0.3325482116256059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155109530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012000458,0.99249536,0.000051114766,0.0013148073,0.000483936,0.0015173289,0.001718188,0.000043587617,0.0011756507],"genre_scores_gemma":[0.0012044375,0.99608946,0.0013337795,0.000102897924,0.00007346928,0.00025971507,0.0005218131,0.000071816,0.0003426407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626297,0.00049143384,0.001763737,0.00036269217,0.00074579456,0.00037335753],"domain_scores_gemma":[0.9960623,0.00082184427,0.0011445079,0.0010980389,0.0004389547,0.0004343523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008502423,0.00039831782,0.0025105155,0.0004091516,0.00014870307,0.00006556676,0.0008498778,0.00015054003,0.00053179136],"category_scores_gemma":[0.0047642468,0.0002608108,0.0012882814,0.0003938725,0.00022686206,0.0002626754,0.00023670118,0.00036425292,0.000043222124],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033670913,0.0004801437,0.000038506878,0.0026908813,0.0007037102,0.0000039915467,0.00020083973,0.000001723008,0.0000032081882,0.0007140281,0.0028383296,0.992291],"study_design_scores_gemma":[0.00053345924,0.00025439367,0.00019264981,0.09025599,0.00007091332,0.00014213243,0.00015006268,0.00005877325,0.00005234973,0.0011910197,0.906826,0.00027223918],"about_ca_topic_score_codex":0.000086392916,"about_ca_topic_score_gemma":0.00002348032,"teacher_disagreement_score":0.9920187,"about_ca_system_score_codex":0.000022924034,"about_ca_system_score_gemma":0.0005435942,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W2155178043","doi":"10.1136/annrheumdis-2012-201506","title":"Incidence and predictors of secondary fibromyalgia in an early arthritis cohort","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Western University; Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; Hôpital Notre-Dame; Université de Montréal","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Internal medicine; Incidence (geometry); Arthritis; Cohort; Fibromyalgia; Cumulative incidence; Cohort study; Psoriatic arthritis; Inflammatory arthritis; Physical therapy","score_opus":0.0258284806283143,"score_gpt":0.30786505803886716,"score_spread":0.2820365774105529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155178043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955953,0.009560887,0.0000015355191,0.0002454419,0.00005781365,0.00037751975,0.000048818296,0.000011774003,0.0001366717],"genre_scores_gemma":[0.99876714,0.0010375499,0.000046821984,0.000007772166,0.000007082652,0.000019111203,0.000010721618,0.000014009157,0.00008980424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985772,0.00012812657,0.0003959319,0.0001378151,0.00045091918,0.00031000868],"domain_scores_gemma":[0.99893034,0.00015177263,0.00013243797,0.00043440174,0.00009052603,0.00026053152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033638664,0.0001178678,0.0003896237,0.00010558192,0.00003405666,0.000009233275,0.00016961798,0.000053859658,0.000248366],"category_scores_gemma":[0.00034661224,0.000083815095,0.00009713835,0.00020897225,0.0003395955,0.0003090617,0.000110251065,0.00012621935,0.000004433515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007345666,0.00029092553,0.9900865,0.0038087573,0.00009004077,0.0000027384133,0.000588482,0.0000015524724,0.00023332528,0.00012922511,0.0005707046,0.004124281],"study_design_scores_gemma":[0.00053985254,0.00034126115,0.9922731,0.004641386,0.00003985591,0.000019696718,0.0001756659,0.000052081366,0.001511239,0.00032677304,0.0000036758147,0.00007544211],"about_ca_topic_score_codex":0.00023385987,"about_ca_topic_score_gemma":0.0000025835598,"teacher_disagreement_score":0.009207589,"about_ca_system_score_codex":0.000013407069,"about_ca_system_score_gemma":0.00020823463,"threshold_uncertainty_score":0.34178805},"labels":[],"label_agreement":null},{"id":"W2155991285","doi":"10.1136/ard.2007.079970","title":"A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Gout; Physical therapy; Tophus; Delphi method; Quality of life (healthcare); Rheumatology; Internal medicine; Hyperuricemia; Uric acid","score_opus":0.0915356319634911,"score_gpt":0.38153549463112274,"score_spread":0.28999986266763167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155991285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98865324,0.006826632,0.0001729069,0.002490862,0.000056372737,0.001589784,0.00015719623,0.000013539874,0.000039476952],"genre_scores_gemma":[0.9979907,0.0008229188,0.00064659846,0.000288342,0.000017829681,0.00006634211,0.0000034917205,0.000023850038,0.00013987225],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983212,0.00004046679,0.00073348306,0.00019216385,0.0004246464,0.00028805475],"domain_scores_gemma":[0.99723536,0.0010822166,0.0005101772,0.0006758013,0.00034744764,0.00014900381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000503756,0.00020917779,0.0008327087,0.00010135262,0.00007838546,0.000005321862,0.00022372373,0.000034529407,0.000005989688],"category_scores_gemma":[0.00084781885,0.00010082302,0.00022420124,0.0002228571,0.00045364353,0.000034187182,0.00013678633,0.00006114727,7.7152777e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05550478,0.010875699,0.2477703,0.06169642,0.05340759,0.00028570995,0.058888428,0.003764267,0.036357723,0.0034713063,0.023924088,0.44405368],"study_design_scores_gemma":[0.018459594,0.0075772586,0.8376408,0.01961669,0.023022318,0.00033780804,0.01634912,0.0032579273,0.06819504,0.0040788907,0.00029714376,0.0011673796],"about_ca_topic_score_codex":0.000046127105,"about_ca_topic_score_gemma":0.00001735938,"teacher_disagreement_score":0.5898705,"about_ca_system_score_codex":0.000026436532,"about_ca_system_score_gemma":0.000120201425,"threshold_uncertainty_score":0.41114432},"labels":[],"label_agreement":null},{"id":"W2156077420","doi":"10.1136/ard.2007.078808","title":"Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Everolimus; Placebo; Internal medicine; Rheumatoid arthritis; Discontinuation; Rheumatology; Adverse effect; Methotrexate; Clinical endpoint; Concomitant; Clinical trial; Placebo-controlled study; Gastroenterology; Surgery; Double blind; Pathology","score_opus":0.028319670044559916,"score_gpt":0.3056764417983197,"score_spread":0.2773567717537598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156077420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97481465,0.014440401,0.00020735511,0.00025099056,0.0001452137,0.009684145,0.00004426704,0.00004405351,0.00036892042],"genre_scores_gemma":[0.9961806,0.0028169022,0.00026499643,0.00007135407,0.000020053067,0.0005076048,0.000026921138,0.000062544605,0.000049012182],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948092,0.000639116,0.0018111534,0.00047497253,0.0014506093,0.0008149109],"domain_scores_gemma":[0.9957453,0.0014928298,0.00090821553,0.00092336786,0.00052931183,0.00040095398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022796171,0.00046763115,0.0020387785,0.00039924242,0.0001665382,0.000055641256,0.0005061857,0.00009753311,0.00015386348],"category_scores_gemma":[0.0014571637,0.00028989126,0.00050005893,0.00063426886,0.00048725572,0.00033023208,0.00015011837,0.00031955325,0.0000044125154],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64191836,0.0077910796,0.23823704,0.00027127593,0.0019564775,0.000044593125,0.0032851978,0.00026041036,0.000008695821,0.00016570494,0.00033860098,0.10572256],"study_design_scores_gemma":[0.77451164,0.0043641487,0.20955782,0.006576322,0.00007863738,0.000014934462,0.00272688,0.00014685451,0.0009553783,0.0005494468,0.000051679795,0.00046627494],"about_ca_topic_score_codex":0.0003716842,"about_ca_topic_score_gemma":0.0005331053,"teacher_disagreement_score":0.13259327,"about_ca_system_score_codex":0.000046109748,"about_ca_system_score_gemma":0.00026368274,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W2156140442","doi":"10.1136/ard.2005.044404","title":"Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Methotrexate; Rheumatoid arthritis; Adverse effect; Dose; Internal medicine; Placebo; Surgery","score_opus":0.01870353610485748,"score_gpt":0.297637988851635,"score_spread":0.27893445274677753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156140442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887034,0.009303433,0.000008451947,0.0003369236,0.000031829943,0.001437893,0.00006061997,0.000023361208,0.000094068375],"genre_scores_gemma":[0.9834442,0.016246583,0.00014279965,0.000049556056,0.000008824241,0.00003456399,0.0000143285515,0.000029911078,0.000029234707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976932,0.0002678414,0.0006882533,0.00026306332,0.00074019877,0.00034744217],"domain_scores_gemma":[0.9985084,0.00024618802,0.00028041087,0.0005621359,0.00019556099,0.00020729155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003581846,0.00022412626,0.00073450623,0.00017408331,0.000081338716,0.000024720252,0.00022364594,0.000034392247,0.00012029271],"category_scores_gemma":[0.00039885702,0.0001447132,0.00011199552,0.0002739653,0.00031347983,0.00020772575,0.0001334203,0.000140916,0.0000053527965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063087507,0.0045198966,0.7552986,0.00029676245,0.00065145746,0.000010412487,0.0020997988,0.000057553472,0.000011120196,0.00013463966,0.00018642916,0.23042454],"study_design_scores_gemma":[0.017106088,0.0009702337,0.97693515,0.0038529318,0.000016545215,0.0000055864807,0.00056662346,0.000042624153,0.0002311315,0.000101674894,0.000025737401,0.00014569552],"about_ca_topic_score_codex":0.00009657903,"about_ca_topic_score_gemma":0.000112769725,"teacher_disagreement_score":0.23027885,"about_ca_system_score_codex":0.000021607846,"about_ca_system_score_gemma":0.00015518945,"threshold_uncertainty_score":0.5901233},"labels":[],"label_agreement":null},{"id":"W2156166356","doi":"10.1136/annrheumdis-2013-204345","title":"Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Placebo; Endocrinology; Tocilizumab; Apolipoprotein B; Lipoprotein; Lipid profile; Fibrinogen; Gastroenterology; Cholesterol; Pathology","score_opus":0.011789684742565922,"score_gpt":0.27686943632687533,"score_spread":0.2650797515843094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156166356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97301614,0.01986514,0.0000033018748,0.0002043771,0.00011694996,0.006533636,0.000047653317,0.000028912795,0.00018385926],"genre_scores_gemma":[0.96976924,0.029273074,0.000017556848,0.000017540664,0.000011922026,0.0008384913,0.000006674217,0.000038652313,0.000026822961],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99444574,0.0022409786,0.0014259793,0.00031416165,0.0011392876,0.00043385813],"domain_scores_gemma":[0.9947347,0.0029744594,0.0007670858,0.0009031427,0.00038964118,0.00023096874],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0024765239,0.0003609386,0.0021931364,0.00036851963,0.00007410424,0.000028542307,0.00044086922,0.000072756695,0.00044619697],"category_scores_gemma":[0.008490161,0.00021456237,0.00095514813,0.00038062848,0.00037181246,0.00015157962,0.00010869432,0.00024926412,0.000036347785],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2801039,0.015028168,0.39114562,0.003226348,0.011807306,0.000015120661,0.0062443567,0.00039159865,0.0029281343,0.00016807149,0.0040742583,0.28486714],"study_design_scores_gemma":[0.6860392,0.016862536,0.16893692,0.040880654,0.0002793727,0.000016455915,0.0042905267,0.0013127405,0.07876226,0.001781046,0.00006246587,0.00077583804],"about_ca_topic_score_codex":0.0011613579,"about_ca_topic_score_gemma":0.00006975357,"teacher_disagreement_score":0.4059353,"about_ca_system_score_codex":0.000018803621,"about_ca_system_score_gemma":0.00014175262,"threshold_uncertainty_score":0.9998617},"labels":[],"label_agreement":null},{"id":"W2156291147","doi":"10.1136/ard.2008.102277","title":"From gene expression to serum proteins: biomarker discovery in ankylosing spondylitis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Ankylosing spondylitis; Erythrocyte sedimentation rate; Medicine; Fold change; Infliximab; Biomarker; Gene expression; Pathogenesis; Internal medicine; Microarray; C-reactive protein; Tumor necrosis factor alpha; Immunology; Inflammation; Gastroenterology; Gene; Biology; Biochemistry","score_opus":0.055195007619717566,"score_gpt":0.30894645648851227,"score_spread":0.2537514488687947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156291147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151176,0.004826312,0.000015309704,0.0017184837,0.00011450624,0.0007140825,0.00094442925,0.00001988334,0.00013521299],"genre_scores_gemma":[0.99803036,0.0007291313,0.0004027704,0.0003760146,0.000032025284,0.00008361051,0.000054008247,0.000018607296,0.00027347976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878556,0.000072820214,0.00033841538,0.00023038122,0.00032640868,0.00024644195],"domain_scores_gemma":[0.9991685,0.00009142082,0.00010633976,0.00045655877,0.000051764324,0.00012542444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059277056,0.00016065087,0.0003882884,0.00008385563,0.00011209033,0.000013015951,0.000120565484,0.000036133315,0.00015486997],"category_scores_gemma":[0.00033102848,0.000103078055,0.00018003168,0.00023708423,0.00009106765,0.0001520922,0.00015196382,0.000046997364,0.000015579302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039151255,0.0046517923,0.8689299,0.0006358339,0.0009824849,0.00074245036,0.005181945,0.000044268087,0.013047183,0.00005552513,0.016688537,0.08512491],"study_design_scores_gemma":[0.0015211799,0.00011873878,0.9703526,0.0034467438,0.00005196953,0.00001710938,0.00028708638,0.000014185207,0.023203308,0.0006085449,0.00026044046,0.00011813265],"about_ca_topic_score_codex":0.00063572836,"about_ca_topic_score_gemma":0.000022742686,"teacher_disagreement_score":0.101422615,"about_ca_system_score_codex":0.00002264842,"about_ca_system_score_gemma":0.000059881877,"threshold_uncertainty_score":0.4203401},"labels":[],"label_agreement":null},{"id":"W2156410123","doi":"10.1136/annrheumdis-2014-206844","title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Executive Agency for Health and Consumers; Rosetrees Trust","keywords":"Familial Mediterranean fever; Medicine; Family medicine; Intensive care medicine; Pathology; Disease","score_opus":0.20208378521585266,"score_gpt":0.39230019108459113,"score_spread":0.19021640586873848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156410123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008466026,0.9965011,0.000055202385,0.00041161024,0.00033550375,0.0010124195,0.0008123462,0.0000044903595,0.000020752843],"genre_scores_gemma":[0.00092266465,0.9974297,0.00017258518,0.00015144216,0.00007088943,0.00051382784,0.0005867373,0.000037436846,0.000114677736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836296,0.00023855688,0.0007461453,0.00024056481,0.00020955599,0.00020222507],"domain_scores_gemma":[0.9979171,0.0002379168,0.0007185157,0.0007451476,0.00031063036,0.000070656904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026162303,0.00026901424,0.0008246894,0.00007391361,0.000058702746,0.000012108455,0.0006550223,0.00015168301,0.000047118847],"category_scores_gemma":[0.001343101,0.00018394351,0.0010471543,0.00013481869,0.0001573516,0.0000070813003,0.00012751624,0.000053235737,0.000003768254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031394884,0.00015941341,0.00005219703,0.010139231,0.00038107164,8.576765e-8,0.00002502729,0.000016161206,0.0000028161264,0.0000062620124,0.07449952,0.9146868],"study_design_scores_gemma":[0.00035567675,0.00026473578,0.000112304355,0.024884108,0.0012010862,8.9517255e-7,0.0000455238,0.000020834868,0.0005030516,0.00022694077,0.97207683,0.00030801556],"about_ca_topic_score_codex":0.000019893496,"about_ca_topic_score_gemma":0.0000044535263,"teacher_disagreement_score":0.9143788,"about_ca_system_score_codex":0.0000074653735,"about_ca_system_score_gemma":0.00061054295,"threshold_uncertainty_score":0.7500999},"labels":[],"label_agreement":null},{"id":"W2156445500","doi":"10.1136/ard.2004.030429","title":"Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"Deutsche Forschungsgemeinschaft","keywords":"Serum amyloid A; Cathepsin B; Amyloidosis; Serum Amyloid A Protein; Amyloid (mycology); Proteases; AA amyloidosis; Amyloid disease; Cathepsin; Proteolysis; Biochemistry; Amyloid precursor protein; Chemistry; Biology; Medicine; Pathology; Alzheimer's disease; Immunology; Amyloid β; Inflammation; Enzyme; Amyloid fibril; Familial Mediterranean fever; Disease","score_opus":0.014867090427422375,"score_gpt":0.2592062010171348,"score_spread":0.24433911058971244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156445500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756888,0.014605848,0.00015561348,0.0036084868,0.000028169261,0.0045874077,0.0012554585,0.0000340336,0.000036165504],"genre_scores_gemma":[0.9925995,0.0035471304,0.00089028734,0.00029262278,0.000057358884,0.0018230522,0.00014736973,0.00006512869,0.00057757914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972528,0.0003654342,0.00090403506,0.0005740098,0.0004140085,0.0004896984],"domain_scores_gemma":[0.99760187,0.000067555906,0.00091828447,0.00093792967,0.0002333985,0.00024094738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036530616,0.00055379653,0.00070590177,0.00011888586,0.00022786582,0.00007399165,0.00046819384,0.00017227099,0.000033782686],"category_scores_gemma":[0.00040742895,0.0003783681,0.0003383695,0.00023139486,0.00040059263,0.00007679558,0.00036912723,0.00010609367,0.000004214834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013517425,0.010490705,0.07010631,0.007734767,0.0042979345,0.0000051667134,0.0051056705,0.00066429976,0.69683826,0.00034331204,0.011953103,0.19110876],"study_design_scores_gemma":[0.0014305218,0.00092667155,0.014793438,0.0008612474,0.0002914358,0.000020818654,0.0004393637,0.00037318602,0.97853994,0.00033361145,0.0014815653,0.00050820585],"about_ca_topic_score_codex":0.00024147774,"about_ca_topic_score_gemma":0.00010758673,"teacher_disagreement_score":0.2817017,"about_ca_system_score_codex":0.000033625376,"about_ca_system_score_gemma":0.0001559712,"threshold_uncertainty_score":0.99986684},"labels":[],"label_agreement":null},{"id":"W2156489607","doi":"10.1136/ard.2010.132068","title":"An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University; Toronto Western Hospital","funders":"Science Foundation Ireland","keywords":"Medicine; Flare; Systemic lupus erythematosus; Intraclass correlation; Internal medicine; Physical therapy; Disease","score_opus":0.01706551488797362,"score_gpt":0.33607043679564536,"score_spread":0.3190049219076717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156489607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960686,0.0016049187,0.000011842356,0.00022242057,0.000090658505,0.0017317864,0.00021008457,0.000010375554,0.000049334576],"genre_scores_gemma":[0.99969083,0.00009928357,0.000067621215,0.000013300724,0.000007652521,0.00004070777,0.000031644264,0.000024637966,0.000024332006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970333,0.00037015282,0.00094408216,0.0002307486,0.0011852516,0.0002364911],"domain_scores_gemma":[0.9966442,0.00050991937,0.0008742666,0.0011157261,0.00064501143,0.00021087959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006782719,0.00020501978,0.0010448137,0.00019226255,0.000050399805,0.000010234585,0.00043160722,0.00006186432,0.000034562894],"category_scores_gemma":[0.0006629638,0.000100751095,0.0001814044,0.0003739918,0.00061009376,0.00012226048,0.00014471183,0.00017407544,7.588598e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023683733,0.0014725118,0.98152024,0.011545651,0.00021295586,9.699335e-7,0.0015242454,0.00009120095,0.00021313709,0.00022220642,0.00036604196,0.00046244485],"study_design_scores_gemma":[0.013521001,0.00085821,0.9462014,0.024486955,0.00054101483,0.0000585744,0.0070675598,0.005511691,0.0012097362,0.00034146538,0.000003885368,0.00019851123],"about_ca_topic_score_codex":0.00012540721,"about_ca_topic_score_gemma":0.000023321229,"teacher_disagreement_score":0.035318866,"about_ca_system_score_codex":0.000021899785,"about_ca_system_score_gemma":0.00040389696,"threshold_uncertainty_score":0.41085106},"labels":[],"label_agreement":null},{"id":"W2156605473","doi":"10.1136/ard.2009.108233","title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3622,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Eisai; Chugai Pharmaceutical; Amgen; Pfizer; Allergan; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Axial spondyloarthritis; Selection (genetic algorithm); Medical physics; Ankylosing spondylitis; Artificial intelligence; Sacroiliitis; Surgery","score_opus":0.07745721264098593,"score_gpt":0.3746734031394758,"score_spread":0.29721619049848985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156605473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464273,0.0011288936,0.00024138924,0.0026331292,0.0002327263,0.00068080984,0.00019718958,0.000012147235,0.0002309742],"genre_scores_gemma":[0.99514425,0.0014313395,0.0029681195,0.0000622459,0.000046108995,0.0000777634,0.000114571136,0.000008182505,0.00014742943],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862653,0.000043586162,0.0006308018,0.00016882483,0.00037281658,0.00015742252],"domain_scores_gemma":[0.9987631,0.000155582,0.00044278422,0.00018381471,0.0004031376,0.00005160559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003225409,0.00013312532,0.00030577963,0.000043188422,0.00034664807,0.000018926232,0.00011206611,0.000041441675,0.000031304386],"category_scores_gemma":[0.00021775115,0.00009154468,0.00021835766,0.00012831176,0.00015774627,0.00010368089,0.00005033356,0.00004424375,2.732521e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001599373,0.0026518228,0.033140406,0.00062439014,0.0013349496,7.8140704e-7,0.0020788184,0.000016523598,0.0059024864,0.008166878,0.01338555,0.93109804],"study_design_scores_gemma":[0.0039666593,0.0010686656,0.9725583,0.0015824647,0.00023386713,0.00001533015,0.0006825499,0.0011204126,0.012335331,0.002501813,0.0037847888,0.00014981582],"about_ca_topic_score_codex":0.000006183293,"about_ca_topic_score_gemma":0.000010043442,"teacher_disagreement_score":0.9394179,"about_ca_system_score_codex":0.00003093857,"about_ca_system_score_gemma":0.00017417184,"threshold_uncertainty_score":0.3733084},"labels":[],"label_agreement":null},{"id":"W2156661254","doi":"10.1136/annrheumdis-2014-206792","title":"Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":280,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"Medical Research Council","keywords":"Medicine; Osteoarthritis; Celecoxib; WOMAC; Chondroitin sulfate; Internal medicine; Visual analogue scale; Rheumatology; Physical therapy; Randomized controlled trial","score_opus":0.08217558496386673,"score_gpt":0.33061496734264173,"score_spread":0.248439382378775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156661254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882032,0.0022332598,0.00002749197,0.00093954545,0.0009577815,0.007022332,0.00017015984,0.000059870392,0.00038634206],"genre_scores_gemma":[0.9977071,0.00022275359,0.00027633653,0.00014255915,0.00013347194,0.0007516805,0.00018394171,0.00004045895,0.00054168527],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99808675,0.00010283322,0.00063339336,0.00031595657,0.00043194467,0.0004291078],"domain_scores_gemma":[0.99778056,0.000548515,0.00033615498,0.00051073526,0.00033426375,0.000489762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042306623,0.00031365783,0.000850878,0.00009646989,0.00012645069,0.000056516645,0.00015388496,0.00010087059,0.000035972975],"category_scores_gemma":[0.0012130826,0.00022822757,0.00041717108,0.00016254037,0.00015207133,0.00017297,0.00009566011,0.00009054412,0.000012314919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93469995,0.0011381035,0.0003134311,0.0003593772,0.00031325372,0.000011520154,0.00032670778,0.0000021111514,0.000098547804,0.00028688513,0.0008464499,0.061603665],"study_design_scores_gemma":[0.98105806,0.009866461,0.0005621877,0.00080102484,0.0009103073,0.000007023362,0.00049221114,0.00021393292,0.004591659,0.0008816098,0.00035877345,0.00025672434],"about_ca_topic_score_codex":0.00003692521,"about_ca_topic_score_gemma":0.000037010723,"teacher_disagreement_score":0.06134694,"about_ca_system_score_codex":0.000025905867,"about_ca_system_score_gemma":0.00024294003,"threshold_uncertainty_score":0.93068504},"labels":[],"label_agreement":null},{"id":"W2157474780","doi":"10.1136/ard.2003.006775","title":"Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Infliximab; Internal medicine; Psoriatic arthritis; Gastroenterology; Psoriasis; Adalimumab; Adverse effect; Refractory (planetary science); Arthritis; Methotrexate; Rheumatoid arthritis; Surgery; Disease; Dermatology","score_opus":0.06862360540388271,"score_gpt":0.30994323016787845,"score_spread":0.24131962476399574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157474780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953178,0.002970537,0.0000016428714,0.00020991843,0.000060423383,0.0010972058,0.0001666031,0.000010297924,0.00016554462],"genre_scores_gemma":[0.9984121,0.0012584842,0.00007703404,0.00003697529,0.00001060269,0.000103556966,0.000036081816,0.00001572152,0.000049474074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858415,0.00004226767,0.0005201452,0.00015770936,0.0005410511,0.00015466941],"domain_scores_gemma":[0.9986692,0.00009688137,0.00044803123,0.00042681655,0.00027931,0.00007973976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029739105,0.0001773485,0.0006130743,0.000060562743,0.00006385065,0.000003732852,0.00008511006,0.000022661681,0.000036925896],"category_scores_gemma":[0.00014719443,0.000102322454,0.00017097313,0.00015692336,0.00012350889,0.00007793289,0.00003470549,0.000023378701,0.0000017310263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016038228,0.03579925,0.8986319,0.00030144837,0.0023023318,0.000011961471,0.0031317007,0.00014311365,0.0000049019955,0.00016074917,0.00014778305,0.057761062],"study_design_scores_gemma":[0.016879985,0.010871183,0.9684707,0.001360263,0.00043880526,0.00000229502,0.0011191869,0.000004109238,0.00024868065,0.0004821201,0.000038507227,0.00008414103],"about_ca_topic_score_codex":0.0009061663,"about_ca_topic_score_gemma":0.00022608477,"teacher_disagreement_score":0.069838844,"about_ca_system_score_codex":0.000054475466,"about_ca_system_score_gemma":0.00013245003,"threshold_uncertainty_score":0.41725886},"labels":[],"label_agreement":null},{"id":"W2157673714","doi":"10.1136/annrheumdis-2013-205007","title":"Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Reumatikerförbundet; Vetenskapsrådet; Canadian Institutes of Health Research; Stockholms Läns Landsting; French Muscular Dystrophy Association; Magnus Bergvalls Stiftelse; Åke Wiberg Stiftelse; Muscular Dystrophy Association; Karolinska Institutet; Stiftelsen för Strategisk Forskning","keywords":"Medicine; Muscle weakness; Actin; Arthritis; Weakness; Biophysics; Anatomy; Internal medicine; Cell biology; Biology","score_opus":0.05016236729253813,"score_gpt":0.2835489144951377,"score_spread":0.23338654720259955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157673714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996498,0.00018877703,0.00061160245,0.001936364,0.00012318944,0.000181771,0.000053790493,0.0000050551703,0.00040145853],"genre_scores_gemma":[0.9994519,0.000120027216,0.000022336013,0.00020230524,0.000031393356,0.00001306099,0.000023679162,0.000007597846,0.00012771269],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99933594,0.00014241126,0.00019168697,0.00011947768,0.0001252492,0.000085227126],"domain_scores_gemma":[0.99922794,0.000047367972,0.00020348841,0.00034937423,0.00012618904,0.000045645218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009676916,0.00007832527,0.00011481257,0.00001769058,0.00012266317,0.000009695923,0.00014065608,0.000038097143,0.000019950077],"category_scores_gemma":[0.0004106588,0.0000505689,0.000100235215,0.00007833404,0.00015175401,0.000005475012,0.000072751114,0.00002916973,0.0000011563835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005244364,0.0016478184,0.0070695174,0.00077607244,0.0006284378,1.9523944e-7,0.00151907,0.005175977,0.52032423,0.02361524,0.031966113,0.40675288],"study_design_scores_gemma":[0.0012537716,0.00020597357,0.7834996,0.00038052013,0.000084729,0.0000042322213,0.0010408468,0.009429078,0.19299616,0.00833847,0.002485328,0.00028130392],"about_ca_topic_score_codex":0.00003080076,"about_ca_topic_score_gemma":0.000012530075,"teacher_disagreement_score":0.7764301,"about_ca_system_score_codex":0.0000023555488,"about_ca_system_score_gemma":0.000039191906,"threshold_uncertainty_score":0.206214},"labels":[],"label_agreement":null},{"id":"W2157868553","doi":"10.1136/ard.61.suppl_2.ii43","title":"Treatments no longer in development for rheumatoid arthritis","year":2002,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Arthritis; Intensive care medicine; Physical therapy; Internal medicine","score_opus":0.16089678370566005,"score_gpt":0.40722704944816895,"score_spread":0.2463302657425089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157868553","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009814922,0.99538356,0.0000010205525,0.0002223529,0.00014607576,0.002115372,0.00032494508,0.00001544389,0.0008097579],"genre_scores_gemma":[0.00016430534,0.99167067,0.00017209342,0.00008784246,0.00003926488,0.00060067757,0.00020353224,0.000050945302,0.007010685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974104,0.00012970467,0.001085678,0.0003336987,0.0005628465,0.00047766333],"domain_scores_gemma":[0.99819225,0.00052588154,0.0003843753,0.0005052983,0.00016939922,0.00022276513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019809016,0.00042251952,0.0020758768,0.00021976263,0.000096956086,0.000021720238,0.00037495175,0.00013169093,0.00049647054],"category_scores_gemma":[0.00049196754,0.00023961341,0.0010713547,0.00027002054,0.00013865047,0.00004900978,0.00015729747,0.0001653673,0.0002554384],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006699252,0.00071740197,0.00018180342,0.029081061,0.0007969249,0.000012452631,0.000084264626,2.2205127e-7,4.1548578e-8,0.000049601855,0.009249871,0.95975935],"study_design_scores_gemma":[0.00069522456,0.00013435936,0.0010668148,0.10422358,0.00018876485,0.00003495751,0.000012224039,0.000013209148,0.000006118217,0.00011174304,0.8932631,0.00024989987],"about_ca_topic_score_codex":0.0000414065,"about_ca_topic_score_gemma":0.000008486547,"teacher_disagreement_score":0.9595095,"about_ca_system_score_codex":0.00005638439,"about_ca_system_score_gemma":0.0005031018,"threshold_uncertainty_score":0.97711515},"labels":[],"label_agreement":null},{"id":"W2158058290","doi":"10.1136/ard.2008.099010","title":"Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":541,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Methotrexate; Rheumatoid factor; Immunology; Antibody; Internal medicine; Etanercept","score_opus":0.03950382936973801,"score_gpt":0.33806141874878315,"score_spread":0.29855758937904514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158058290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97938496,0.014083114,0.000013302179,0.0028446736,0.00011250404,0.0027837963,0.0005256279,0.00008601316,0.0001660333],"genre_scores_gemma":[0.95259607,0.046312504,0.00003155034,0.00038893698,0.000022112235,0.00031564283,0.00003677689,0.00007011761,0.0002263154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959665,0.00082474283,0.0009066573,0.0005023128,0.0010501103,0.0007497018],"domain_scores_gemma":[0.9974001,0.0005498662,0.000342639,0.000984451,0.00031483322,0.00040809886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041725705,0.0004517059,0.0010134293,0.00031536978,0.0007043375,0.000095420066,0.0007057656,0.00007422688,0.00022790938],"category_scores_gemma":[0.00081087084,0.00028081966,0.00047123016,0.0008578194,0.000460408,0.000276138,0.00022297273,0.00036991658,0.00005032835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012532756,0.023648307,0.48636422,0.00043821486,0.0066553024,0.0007209741,0.09166923,0.0005916731,0.02803641,0.00027606508,0.070803456,0.2782634],"study_design_scores_gemma":[0.0077127866,0.0049846126,0.9609159,0.0029174278,0.000028726692,0.00027312525,0.008043167,0.00014201473,0.0096038245,0.0017384136,0.0028639282,0.0007760601],"about_ca_topic_score_codex":0.0030544458,"about_ca_topic_score_gemma":0.00038905692,"teacher_disagreement_score":0.4745517,"about_ca_system_score_codex":0.00006222428,"about_ca_system_score_gemma":0.00023321938,"threshold_uncertainty_score":0.9999644},"labels":[],"label_agreement":null},{"id":"W2158169120","doi":"10.1136/ard.2009.109884","title":"Menopause, postmenopausal hormone use and risk of incident gout","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Vancouver General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Erasmus+; National Institutes of Health; Vereniging Trustfonds Erasmus Universiteit Rotterdam","keywords":"Medicine; Menopause; Gout; Internal medicine; Gynecology","score_opus":0.02797058548823265,"score_gpt":0.286361441461057,"score_spread":0.25839085597282435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158169120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899243,0.007726891,0.000014288895,0.0014409871,0.00004377292,0.00045542064,0.00013010179,0.000031941974,0.00023229288],"genre_scores_gemma":[0.993727,0.0051752585,0.0002563681,0.0005855991,0.00002088864,0.000006732228,0.000010509724,0.000017518518,0.00020011915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983571,0.00012675964,0.0005353147,0.00020178697,0.00053451984,0.00024450375],"domain_scores_gemma":[0.9981061,0.00029383047,0.0004775773,0.0007184999,0.00018722255,0.00021672662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024919902,0.00019815355,0.00054448046,0.00009426944,0.00006740464,0.000019071704,0.0002037236,0.000057128163,0.00003346554],"category_scores_gemma":[0.00180166,0.00012716342,0.00012194789,0.0002195601,0.00018362289,0.00018721973,0.00011172918,0.000116651114,0.000007712586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003984098,0.008130606,0.74666584,0.0020551698,0.00612428,0.00010252401,0.005793799,0.00021628902,0.02893809,0.0024839074,0.06558656,0.12991883],"study_design_scores_gemma":[0.000990983,0.0009820196,0.99099416,0.00047767645,0.0011296131,0.000032919925,0.00014603659,0.000117803385,0.0028232785,0.0020518366,0.0001235492,0.00013009987],"about_ca_topic_score_codex":0.00032045908,"about_ca_topic_score_gemma":0.0000032113262,"teacher_disagreement_score":0.24432833,"about_ca_system_score_codex":0.000015071919,"about_ca_system_score_gemma":0.00009347493,"threshold_uncertainty_score":0.5185574},"labels":[],"label_agreement":null},{"id":"W2158174717","doi":"10.1136/ard.2011.155044","title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; Toronto Western Hospital","funders":"Canadian Institutes of Health Research","keywords":"Psoriasis; Medicine; Psoriatic arthritis; Human leukocyte antigen; Allele; Haplotype; Linkage disequilibrium; Immunology; Internal medicine; Genotype; Gastroenterology; Antigen; Genetics; Biology; Gene","score_opus":0.034678386069115635,"score_gpt":0.2698397700825236,"score_spread":0.23516138401340794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158174717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953012,0.0024857044,0.000014890826,0.00007151151,0.00012726961,0.001137818,0.00036242596,0.00003551902,0.00046370333],"genre_scores_gemma":[0.9975269,0.0016862721,0.0003235814,0.00008074441,0.000028433578,0.00015812035,0.00004499222,0.000033779725,0.00011716644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987124,0.000052321968,0.0003827765,0.00022800257,0.0003246485,0.00029983558],"domain_scores_gemma":[0.9986816,0.000073078816,0.00037550274,0.0004825719,0.0002475018,0.00013973966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084473795,0.0002153142,0.00051421975,0.00005886855,0.00029338527,0.000012837735,0.00015446002,0.00003802888,0.00013117075],"category_scores_gemma":[0.00024765648,0.00012970513,0.000299207,0.000120103185,0.00021339935,0.00010335812,0.000062265135,0.000049150527,0.0000073219644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000458594,0.0014941553,0.92664886,0.00021985506,0.0016142696,0.0000040784525,0.0007680381,0.0000018992364,5.5201457e-7,0.00022259739,0.00288325,0.065683834],"study_design_scores_gemma":[0.005070757,0.0009601429,0.98968345,0.0012232477,0.000502062,0.0000010182298,0.00023067633,0.000008611122,0.00023811363,0.0018281947,0.0001094001,0.00014434649],"about_ca_topic_score_codex":0.00046049777,"about_ca_topic_score_gemma":0.00014713829,"teacher_disagreement_score":0.06553949,"about_ca_system_score_codex":0.000011050103,"about_ca_system_score_gemma":0.000036664707,"threshold_uncertainty_score":0.5289222},"labels":[],"label_agreement":null},{"id":"W2158451924","doi":"10.1136/ard.2004.030775","title":"Genetic epidemiology of psoriasis and psoriatic arthritis","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":236,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Psoriasis; Psoriatic arthritis; Medicine; Proband; Epidemiology; Human leukocyte antigen; Population; Immunology; Dermatology; Genetics; Antigen; Pathology; Biology; Mutation; Environmental health","score_opus":0.08897557196478321,"score_gpt":0.3433414651356648,"score_spread":0.2543658931708816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158451924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026225355,0.99510187,0.0000040773884,0.000087575354,0.00068354944,0.0006498073,0.0007684965,0.00002180935,0.000060278824],"genre_scores_gemma":[0.0030812775,0.9961538,0.00010770598,0.00004950818,0.0000525568,0.000118752694,0.00009358263,0.000036625446,0.00030619706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961891,0.0015108002,0.0014654624,0.00037855137,0.00005875889,0.00039733236],"domain_scores_gemma":[0.9953452,0.0022365046,0.0014739814,0.0008134845,0.000076385484,0.000054490876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000383035,0.0004741869,0.0030879304,0.00017415339,0.00010647714,0.0000035720846,0.0005382659,0.00039442512,0.00030987224],"category_scores_gemma":[0.0011884185,0.00029528746,0.0011093477,0.00021167824,0.0004949168,0.000044030545,0.00019827326,0.0001399922,0.00008462797],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019515865,0.00019149361,0.00024016491,0.005339904,0.002026169,8.264553e-7,0.00006131543,0.000001115456,1.7170447e-7,0.00031077102,0.0017029875,0.99010557],"study_design_scores_gemma":[0.0024837472,0.0005356786,0.026702696,0.06609456,0.016523661,0.00025702646,0.00010971528,0.0000030104159,0.000045271725,0.0062150746,0.8797563,0.0012732722],"about_ca_topic_score_codex":0.000059911457,"about_ca_topic_score_gemma":0.000009416718,"teacher_disagreement_score":0.9888323,"about_ca_system_score_codex":0.000012057827,"about_ca_system_score_gemma":0.00018644975,"threshold_uncertainty_score":0.99994993},"labels":[],"label_agreement":null},{"id":"W2158855588","doi":"10.1136/ard.2008.089375","title":"Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Tolerability; Rheumatoid arthritis; Arthritis; Internal medicine; Adverse effect; Tumor necrosis factor alpha; Inflammatory arthritis; Gastroenterology; Placebo; Immunology; Pathology","score_opus":0.03758904774121259,"score_gpt":0.30625128364004567,"score_spread":0.2686622358988331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158855588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918054,0.0064563425,0.000017430364,0.00031496905,0.00006930444,0.0011394793,0.0001581317,0.000027447453,0.0000115332305],"genre_scores_gemma":[0.9917078,0.008130816,0.000018281193,0.00003701284,0.0000074683035,0.000045442062,0.000018882552,0.000019244972,0.000015022953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750906,0.00042027686,0.0009678825,0.00025719247,0.00052359956,0.00032201072],"domain_scores_gemma":[0.9984801,0.00034941456,0.00036396354,0.0003399799,0.00026228928,0.00020428479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043658348,0.00020076797,0.00082245324,0.00013249072,0.00017889707,0.00002121852,0.00014527762,0.000055487308,0.00007912703],"category_scores_gemma":[0.00078557595,0.00015264507,0.00018513898,0.00025351247,0.00047601922,0.00019213952,0.00010474521,0.00015708983,0.0000017391935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0086332485,0.008334546,0.9058644,0.0005474145,0.00066013914,0.000104004146,0.0096803,0.000021969932,0.0028854543,0.00005566773,0.0001874247,0.06302542],"study_design_scores_gemma":[0.0091393525,0.0015472152,0.9829847,0.0016803716,0.00001586409,0.00002796917,0.0016689826,0.0006557533,0.0019310848,0.00019133004,0.000013745455,0.000143613],"about_ca_topic_score_codex":0.000565141,"about_ca_topic_score_gemma":0.00021463707,"teacher_disagreement_score":0.07712031,"about_ca_system_score_codex":0.000050976938,"about_ca_system_score_gemma":0.0003259229,"threshold_uncertainty_score":0.62246853},"labels":[],"label_agreement":null},{"id":"W2159342661","doi":"10.1136/annrheumdis-2014-206593","title":"What are the effects of medication adherence interventions in rheumatic diseases: a systematic review","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Psychological intervention; MEDLINE; Intervention (counseling); Physical therapy; Alternative medicine; Systematic review; Disease management; Family medicine; Intensive care medicine; Disease; Internal medicine; Psychiatry; Pathology","score_opus":0.09954540225774572,"score_gpt":0.4171319031710691,"score_spread":0.31758650091332336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159342661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121944206,0.9897786,0.0000055237815,0.0007818339,0.0004715769,0.0086533725,0.00013802007,0.000028591217,0.000020587391],"genre_scores_gemma":[0.0017705867,0.9952858,0.0000053044505,0.00014843268,0.000017348228,0.002454923,0.00010250146,0.000053018364,0.00016207404],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9928072,0.0022796853,0.0027337035,0.00034969967,0.0014299147,0.00039976957],"domain_scores_gemma":[0.9915903,0.002567296,0.002996255,0.0020163478,0.0004888244,0.000340936],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0015108199,0.00050774374,0.00494388,0.00029176648,0.000088727225,0.00007597197,0.0012618888,0.0001131892,0.00008739756],"category_scores_gemma":[0.017043704,0.0002444117,0.002250792,0.00090239686,0.0005351439,0.0003192777,0.00029652493,0.000341601,0.000055708308],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011225709,0.0005627408,0.000020716625,0.84453106,0.0009216641,0.0000055923047,0.00017979793,1.4302395e-7,1.5235464e-8,0.00009941186,0.0042235535,0.14944406],"study_design_scores_gemma":[0.00049162976,0.00020678231,0.00021300706,0.9929207,0.0025338784,0.000035426623,0.00049902906,0.0000128636,5.397372e-7,0.00096176076,0.0019303211,0.00019406405],"about_ca_topic_score_codex":0.000046866007,"about_ca_topic_score_gemma":0.000018643772,"teacher_disagreement_score":0.14925,"about_ca_system_score_codex":0.00006837159,"about_ca_system_score_gemma":0.00085016293,"threshold_uncertainty_score":0.99668205},"labels":[],"label_agreement":null},{"id":"W2159624824","doi":"10.1136/ard.2004.023796","title":"Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":546,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Osteoarthritis; Cartilage; Magnetic resonance imaging; Medial meniscus; Anatomy; Nuclear medicine; Pathology; Radiology","score_opus":0.013554118079068015,"score_gpt":0.28377345215705746,"score_spread":0.2702193340779894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159624824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97282314,0.025221813,0.000009670681,0.00070097554,0.000035489178,0.00085503137,0.00013792235,0.00003839433,0.00017756628],"genre_scores_gemma":[0.99903584,0.0002160722,0.00042526156,0.00006138429,0.0000043216396,0.00005737888,0.00003679853,0.000027315764,0.00013564726],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985246,0.00010696124,0.00036692136,0.00022338315,0.000534047,0.00024405876],"domain_scores_gemma":[0.99883664,0.00016100823,0.0004075857,0.000277836,0.00017921807,0.00013774214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012339054,0.00020797877,0.0004915429,0.00006528592,0.000108439075,0.000022998804,0.00009334743,0.00004305216,0.000035532357],"category_scores_gemma":[0.0004166796,0.00013306364,0.00010440737,0.00018989918,0.0002638921,0.00016166571,0.00006273161,0.00007212597,0.0000028880768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032570427,0.006169214,0.18761264,0.0020459131,0.0003777214,0.0001831255,0.0028039406,0.000027185664,0.014133919,0.0035052393,0.00078102597,0.77910304],"study_design_scores_gemma":[0.03887906,0.037321664,0.73056954,0.11102056,0.0018559131,0.00016676223,0.007328079,0.00046022088,0.060705274,0.0106681865,0.000071694434,0.0009530428],"about_ca_topic_score_codex":0.000026026864,"about_ca_topic_score_gemma":0.000012884172,"teacher_disagreement_score":0.77815,"about_ca_system_score_codex":0.000021248488,"about_ca_system_score_gemma":0.00012038909,"threshold_uncertainty_score":0.5426178},"labels":[],"label_agreement":null},{"id":"W2159697181","doi":"10.1136/ard.2008.092767","title":"Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Research Manitoba","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Adept; Psoriasis; Dermatology; Antirheumatic Agents; Arthritis; Internal medicine; Rheumatoid arthritis; Pharmacology","score_opus":0.10759642714020638,"score_gpt":0.3519008615012833,"score_spread":0.2443044343610769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159697181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443493,0.048200827,0.000020661677,0.0006568439,0.00056345353,0.0037852996,0.002364134,0.000026576376,0.000032923188],"genre_scores_gemma":[0.9690971,0.029473655,0.00007628336,0.00007522454,0.00017286967,0.0005934369,0.00043507526,0.000043973218,0.000032423282],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99724853,0.0003455122,0.0009367916,0.0004820953,0.0005685756,0.0004184927],"domain_scores_gemma":[0.9957474,0.0018764279,0.00047537047,0.001621828,0.00015036852,0.00012861121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025330737,0.00036867702,0.0013208702,0.00007663234,0.00022869787,0.000019211255,0.0004855304,0.00008157372,0.00010043158],"category_scores_gemma":[0.0010388389,0.00022238187,0.0005137087,0.00027256677,0.00032731757,0.0001593623,0.00017569883,0.00007111734,0.000012162021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08897205,0.019170487,0.25800547,0.0015975129,0.00864539,0.00025326858,0.0034085906,0.0000653189,0.000022239221,0.00039314685,0.004546916,0.6149196],"study_design_scores_gemma":[0.15382124,0.0037813857,0.8308587,0.0071788314,0.0010083865,0.000031412605,0.00043216333,0.00012439293,0.0005607094,0.0017819018,0.0001271471,0.00029371056],"about_ca_topic_score_codex":0.0009511407,"about_ca_topic_score_gemma":0.00060345745,"teacher_disagreement_score":0.61462593,"about_ca_system_score_codex":0.00006571018,"about_ca_system_score_gemma":0.00027744076,"threshold_uncertainty_score":0.90684694},"labels":[],"label_agreement":null},{"id":"W2159841158","doi":"10.1136/ard.2004.030882","title":"Consensus exercise on domains in psoriatic arthritis","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Arthritis; Physical therapy; Dermatology; Psoriasis; Internal medicine","score_opus":0.07681319259220905,"score_gpt":0.3750181770309402,"score_spread":0.29820498443873117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159841158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015684392,0.9949328,4.88675e-8,0.0004093733,0.0002504808,0.0016536706,0.0003831587,0.000024922587,0.00077711913],"genre_scores_gemma":[0.0029573007,0.9961134,0.000027368264,0.00014170512,0.000057734178,0.00024613,0.00005195699,0.00004979967,0.00035456376],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978262,0.00013872006,0.00092835625,0.00031668216,0.00043317425,0.00035687033],"domain_scores_gemma":[0.99808013,0.00041810493,0.000495291,0.00078994286,0.0000621801,0.00015435483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011905135,0.00043521015,0.0025699353,0.00019317397,0.000078850826,0.000014179037,0.0002077667,0.00011712274,0.00014856289],"category_scores_gemma":[0.0004685743,0.00026327017,0.0010445812,0.0003387003,0.00016967897,0.000019528574,0.000100242585,0.00017293084,0.00013060764],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057775098,0.0008795049,0.000054822867,0.0076990235,0.00046502746,0.000077830635,0.000053098862,0.0000010073488,1.6457715e-9,0.00013795383,0.00450777,0.98606616],"study_design_scores_gemma":[0.0036674137,0.00040993645,0.0027401363,0.5070193,0.0031171595,0.00009044829,0.00011545253,0.000003417144,8.186218e-7,0.0007454941,0.4816261,0.0004643561],"about_ca_topic_score_codex":0.000052615553,"about_ca_topic_score_gemma":0.00003274864,"teacher_disagreement_score":0.98560184,"about_ca_system_score_codex":0.00005392192,"about_ca_system_score_gemma":0.00024112363,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W2160006834","doi":"10.1136/annrheumdis-2014-206824","title":"On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Body mass index; Population; Comorbidity; Risk factor; Obesity; Angina; Framingham Risk Score; Arthritis; Disease; Myocardial infarction","score_opus":0.07904074043472524,"score_gpt":0.31298998761456154,"score_spread":0.23394924717983628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160006834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839498,0.00878625,0.000017992461,0.0017629197,0.00008987129,0.002879511,0.0025001245,0.000011794947,0.0000017319117],"genre_scores_gemma":[0.99869007,0.00027906644,0.000022314021,0.00041145552,0.00001727383,0.00013659245,0.00042099433,0.000020117275,0.000002103236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822885,0.00031519588,0.00033808342,0.00029307927,0.0006219366,0.00020287538],"domain_scores_gemma":[0.997287,0.0008238931,0.00023070267,0.0013423483,0.000106537576,0.00020952034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038090165,0.00019480709,0.0004960467,0.00003055732,0.00024741451,0.00002768231,0.00024636812,0.000014565453,0.000007410886],"category_scores_gemma":[0.0022558707,0.00008043565,0.00017580016,0.00013767554,0.00007547913,0.00006799846,0.00010576354,0.00006722728,0.0000013128644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068104063,0.001359108,0.9892827,0.00004007413,0.0011643457,0.0000011458983,0.000468593,0.00044958905,4.916528e-10,0.000029393635,0.0011248424,0.005399142],"study_design_scores_gemma":[0.006179499,0.000720263,0.988226,0.00084618706,0.00066763046,4.308255e-8,0.0011837399,0.00051908946,1.3017352e-7,0.0015520967,0.000021557875,0.0000837387],"about_ca_topic_score_codex":0.006730211,"about_ca_topic_score_gemma":0.0009442762,"teacher_disagreement_score":0.014740278,"about_ca_system_score_codex":0.000028717988,"about_ca_system_score_gemma":0.00017021438,"threshold_uncertainty_score":0.99988407},"labels":[],"label_agreement":null},{"id":"W2160323500","doi":"10.1136/annrheumdis-2011-201201","title":"Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University","funders":"","keywords":"Medicine; Delphi method; Delphi; Physical therapy; Flare; Rheumatoid arthritis; Health care; Family medicine; Internal medicine","score_opus":0.08917061865135563,"score_gpt":0.3655316860651918,"score_spread":0.2763610674138362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160323500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986117,0.010152187,0.00001385453,0.002301993,0.0003166198,0.00082390866,0.00010673812,0.000034744662,0.0001329288],"genre_scores_gemma":[0.98956895,0.009448099,0.00028061497,0.0004966038,0.000025243851,0.00009373279,0.000037971397,0.000027533488,0.000021268823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790335,0.00017280344,0.00058209995,0.00022270232,0.0006639117,0.00045515195],"domain_scores_gemma":[0.9984031,0.0002640053,0.00018998451,0.00041293856,0.00023059583,0.0004993806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037133816,0.00019860701,0.00043804603,0.00021838486,0.00012330874,0.00008101281,0.00022075798,0.000045019282,0.00013847137],"category_scores_gemma":[0.0012216283,0.00014756349,0.000122049234,0.00021454641,0.00019326902,0.00034420344,0.00019382645,0.0001402392,0.000014686708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018909605,0.0034732744,0.75796664,0.0005924048,0.00071327906,0.000057118064,0.010813853,0.000040861207,0.0013427957,0.0048153475,0.00757558,0.21071787],"study_design_scores_gemma":[0.0043936735,0.0006449807,0.9708535,0.008276094,0.00001244914,0.00019707806,0.007935027,0.0004239158,0.0020199297,0.0035598911,0.001274567,0.00040891368],"about_ca_topic_score_codex":0.00015438264,"about_ca_topic_score_gemma":0.00009158849,"teacher_disagreement_score":0.21288683,"about_ca_system_score_codex":0.000026255597,"about_ca_system_score_gemma":0.00012392798,"threshold_uncertainty_score":0.60174644},"labels":[],"label_agreement":null},{"id":"W2161025469","doi":"10.1136/annrheumdis-2014-206853","title":"Response to: ‘Venous thromboembolic events in systemic vasculitis’ by Novikov et al","year":2014,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Giant cell arteritis; Systemic vasculitis; Venous thromboembolism; Vasculitis; Internal medicine; Venous thrombosis; Cardiology; Thrombosis; Disease","score_opus":0.030723431839240423,"score_gpt":0.31604959138782707,"score_spread":0.28532615954858664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161025469","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26016024,0.0024089385,0.000019551071,0.733822,0.00047857664,0.002286412,0.00030674008,0.00006430199,0.00045327152],"genre_scores_gemma":[0.3370357,0.0013507225,0.000016904854,0.66042006,0.00008967329,0.0002819538,0.00017270724,0.000096238684,0.000536032],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952227,0.0011036616,0.0010627065,0.0006282854,0.0012457971,0.0007368341],"domain_scores_gemma":[0.9967768,0.00057555566,0.00056372373,0.0016938838,0.00016290521,0.00022713127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011911629,0.00056133536,0.0021295648,0.00035633278,0.00008105753,0.000032436594,0.0008337381,0.0002616551,0.00015387502],"category_scores_gemma":[0.0011260168,0.00040924203,0.0007127867,0.00038025653,0.00010697455,0.00008136086,0.0003501047,0.00059776945,0.0001874199],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016126421,0.0011644389,0.0004697131,0.0022706375,0.00058556226,0.00004429347,0.0003550824,0.000042078056,0.00003258363,0.000043906402,0.993475,0.0013554068],"study_design_scores_gemma":[0.0023429098,0.0011019357,0.161575,0.027764382,0.0011565924,0.00007788539,0.00017651636,0.000044410204,0.00009372027,0.0008077294,0.80396503,0.00089389656],"about_ca_topic_score_codex":0.000698682,"about_ca_topic_score_gemma":0.000012584849,"teacher_disagreement_score":0.18951002,"about_ca_system_score_codex":0.00010862838,"about_ca_system_score_gemma":0.00030114266,"threshold_uncertainty_score":0.99983597},"labels":[],"label_agreement":null},{"id":"W2161369617","doi":"10.1136/ard.2006.065763","title":"Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Toronto Western Hospital","funders":"Krembil Foundation; Arthritis Society; Canadian Rheumatology Association","keywords":"Medicine; Cronbach's alpha; Intraclass correlation; Psoriatic arthritis; Physical therapy; Fibromyalgia; Internal medicine; Chronic fatigue; Arthritis; Chronic fatigue syndrome; Psychometrics; Clinical psychology","score_opus":0.03033920833226771,"score_gpt":0.3137099120923368,"score_spread":0.28337070376006906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161369617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452895,0.0038886273,0.00004851063,0.0003638805,0.00015494993,0.00063265057,0.00009865947,0.000009770645,0.0002740268],"genre_scores_gemma":[0.99822134,0.0013966042,0.0000707808,0.00015797079,0.000020769165,0.0000357502,0.000034585664,0.000016203981,0.000046013625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998532,0.00003997409,0.0004425929,0.0001693013,0.0005794676,0.0002366517],"domain_scores_gemma":[0.99901074,0.000113393406,0.00025172275,0.000340231,0.00020254657,0.000081377926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014933014,0.00015866706,0.0004427709,0.000087979446,0.000075209944,0.0000058876412,0.00008766003,0.000030877265,0.00028901236],"category_scores_gemma":[0.00004582286,0.000096899035,0.00015704989,0.00026307555,0.00014879751,0.00007126437,0.000040759907,0.00005699826,0.0000019631964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000474511,0.0028546436,0.8461993,0.00022244944,0.00047089093,0.000003484023,0.0002901126,0.000033610762,0.000003848937,0.00009268044,0.00070391403,0.14865056],"study_design_scores_gemma":[0.006702115,0.00084914104,0.98939925,0.0018899171,0.000071151844,0.000001467691,0.00020243149,0.00002487676,0.00043867988,0.000268181,0.000054096374,0.00009868162],"about_ca_topic_score_codex":0.00011647821,"about_ca_topic_score_gemma":0.000071685514,"teacher_disagreement_score":0.14855188,"about_ca_system_score_codex":0.0000451025,"about_ca_system_score_gemma":0.00013270212,"threshold_uncertainty_score":0.3951428},"labels":[],"label_agreement":null},{"id":"W2161634440","doi":"10.1136/annrheumdis-2015-207419","title":"Response to: ‘Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr Boers","year":2015,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Innovaderm (Canada); St Joseph's Health Care; Western University; University of Toronto; University of British Columbia; Hôpital Saint-Luc; Université Laval; Lynde Centre for Dermatology; Université de Montréal; University of Alberta; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Glucocorticoid; Arthritis; Inflammatory arthritis; Internal medicine; Intensive care medicine","score_opus":0.01996757251392182,"score_gpt":0.28125191995804744,"score_spread":0.2612843474441256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161634440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81081736,0.12322001,0.0000045120114,0.063482545,0.00013421585,0.0013753722,0.000855577,0.000025515163,0.00008491091],"genre_scores_gemma":[0.8703308,0.07521891,0.00006507054,0.05279986,0.00015771962,0.00027322856,0.000084429215,0.00021183993,0.0008581111],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99569577,0.0012777132,0.00090474833,0.0004441956,0.0011470728,0.00053047424],"domain_scores_gemma":[0.9968751,0.00078597263,0.0003916722,0.0013764211,0.00031328353,0.00025752795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016568655,0.00039073487,0.0013985977,0.00037688954,0.00006695928,0.000054771368,0.00032422665,0.00024923033,0.00008169957],"category_scores_gemma":[0.0032322584,0.00029501636,0.00064551295,0.00029949777,0.00048509688,0.00013373942,0.00020658855,0.0006413784,0.00001797032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015596615,0.00017356769,0.0056708725,0.001458426,0.001813797,0.0010219134,0.001778657,0.000046583777,0.000040166156,0.0000040401987,0.9501635,0.036268834],"study_design_scores_gemma":[0.0138653405,0.0017555725,0.01819914,0.038744427,0.00046049,0.0013646471,0.0042442116,0.00019122547,0.0016230613,0.0017094256,0.9162609,0.0015815338],"about_ca_topic_score_codex":0.001109629,"about_ca_topic_score_gemma":0.000026471997,"teacher_disagreement_score":0.059513498,"about_ca_system_score_codex":0.00003605858,"about_ca_system_score_gemma":0.00054870604,"threshold_uncertainty_score":0.9999502},"labels":[],"label_agreement":null},{"id":"W2162235829","doi":"10.1136/annrheumdis-2012-201795","title":"Long-term safety of pegloticase in chronic gout refractory to conventional treatment","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Savient Pharmaceuticals","keywords":"Medicine; Gout; Internal medicine; Tophus; Randomized controlled trial; Refractory (planetary science); Placebo; Uric acid; Adverse effect; Surgery; Hyperuricemia; Pathology","score_opus":0.05409944100895533,"score_gpt":0.350948335862527,"score_spread":0.2968488948535717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162235829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924413,0.00493562,0.000022532533,0.0012415926,0.00013564537,0.00063968246,0.00010732613,0.000015175722,0.0004611385],"genre_scores_gemma":[0.9985932,0.00048254672,0.000052259817,0.00019999861,0.000059857364,0.00003600925,0.000029163773,0.000018827443,0.0005281025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984724,0.00010451439,0.00054407254,0.00014986997,0.00041411084,0.0003150572],"domain_scores_gemma":[0.998608,0.00022013088,0.00022417231,0.000593776,0.000084331215,0.00026958477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021128064,0.00016816791,0.00046676074,0.00010926819,0.000033047592,0.000003964638,0.00016585842,0.000048634443,0.00057111436],"category_scores_gemma":[0.0004351544,0.000110418296,0.00027168708,0.00020587706,0.00012393329,0.00010377981,0.0000879763,0.00006609991,0.00006494258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012204361,0.0067550987,0.9292073,0.002212122,0.0011478096,0.00002252396,0.0014706232,0.00015400459,0.00092815206,0.0006501433,0.0023183592,0.053913396],"study_design_scores_gemma":[0.0015091095,0.00041478648,0.9939116,0.0014455053,0.00034433466,0.000019204725,0.00008522221,0.000047199635,0.0017688726,0.000067276706,0.0002802591,0.00010658272],"about_ca_topic_score_codex":0.000081656945,"about_ca_topic_score_gemma":0.000010152183,"teacher_disagreement_score":0.064704314,"about_ca_system_score_codex":0.00020629981,"about_ca_system_score_gemma":0.00031621847,"threshold_uncertainty_score":0.6253302},"labels":[],"label_agreement":null},{"id":"W2162417173","doi":"10.1136/ard.62.6.556","title":"Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Lupus nephritis; Lupus anticoagulant; Anti-dsDNA antibodies; Systemic lupus erythematosus; Immunology; Antibody; Lupus erythematosus; Internal medicine; Disease","score_opus":0.050787403354597555,"score_gpt":0.2978724925464141,"score_spread":0.24708508919181657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162417173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815,0.0074779163,0.00001615395,0.0015336865,0.00035941775,0.0014833023,0.00014208164,0.000069498645,0.0007679648],"genre_scores_gemma":[0.9958599,0.002873395,0.000017131817,0.00021730643,0.000019278903,0.0000316771,0.000026100424,0.000060379785,0.0008947856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621594,0.0007618027,0.0007252675,0.00041647616,0.0012048257,0.0006757091],"domain_scores_gemma":[0.99626654,0.0015117695,0.0005099692,0.0010183722,0.0003855221,0.00030780488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095609005,0.0004021871,0.001315126,0.00015619851,0.00035480422,0.00010565267,0.00043122837,0.000110522196,0.0000919604],"category_scores_gemma":[0.0036470713,0.0001890411,0.0003322625,0.0005872993,0.0013214457,0.00014898504,0.00013706551,0.00024288673,0.0000083868845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018395836,0.0004347213,0.98746043,0.0011109508,0.0011477831,0.0000328915,0.0014058095,0.000012027998,0.00019482909,0.0016145888,0.005988674,0.00041333114],"study_design_scores_gemma":[0.01632152,0.00047741944,0.9434098,0.01618032,0.0016118468,0.002998134,0.008445566,0.0007833273,0.0057462147,0.002445403,0.000677015,0.00090342556],"about_ca_topic_score_codex":0.00019325298,"about_ca_topic_score_gemma":0.000017485243,"teacher_disagreement_score":0.044050626,"about_ca_system_score_codex":0.000034150202,"about_ca_system_score_gemma":0.0003143812,"threshold_uncertainty_score":0.7708872},"labels":[],"label_agreement":null},{"id":"W2162563654","doi":"10.1136/annrheumdis-2012-201357","title":"Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Krembil Foundation","keywords":"Medicine; Confounding; Psoriatic arthritis; Quality of life (healthcare); Internal medicine; Multivariate analysis; Radiography; Disease; Physical therapy; Surgery","score_opus":0.02235859046225622,"score_gpt":0.2627179433392797,"score_spread":0.2403593528770235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162563654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908643,0.008063592,0.000002162529,0.00020396776,0.000070439244,0.00064262556,0.00011051935,0.0000151487575,0.000027292415],"genre_scores_gemma":[0.99839836,0.0013260999,0.000029474739,0.00009632549,0.000013818717,0.00008832891,0.000023478664,0.000014556236,0.000009554983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987955,0.00009736844,0.0002842884,0.00018805347,0.00033845592,0.00029629792],"domain_scores_gemma":[0.99891675,0.00012289561,0.00013268663,0.00044433665,0.000058491147,0.00032485373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007707332,0.00017993533,0.00037232265,0.000047260193,0.00009950256,0.000011728416,0.000082108694,0.000023689394,0.000049889666],"category_scores_gemma":[0.0002685451,0.00010205179,0.000110526475,0.00019793953,0.0004366687,0.00015813601,0.00009484343,0.00006001433,0.0000011280373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023487613,0.0017939529,0.98747873,0.00028123302,0.000101307094,0.0000024406318,0.00043668583,0.0000010522829,6.154267e-7,0.000047812777,0.00008893202,0.00953236],"study_design_scores_gemma":[0.0024280478,0.00008513377,0.9948002,0.0015964014,0.00013814513,6.073128e-7,0.00016806906,0.000011285879,0.000010468696,0.0006475968,0.0000059974745,0.00010803319],"about_ca_topic_score_codex":0.000073779105,"about_ca_topic_score_gemma":0.00002422461,"teacher_disagreement_score":0.009424327,"about_ca_system_score_codex":0.000010927203,"about_ca_system_score_gemma":0.000020820764,"threshold_uncertainty_score":0.41615513},"labels":[],"label_agreement":null},{"id":"W2162839224","doi":"10.1136/ard.59.11.870","title":"Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud's phenomenon","year":2000,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Vasospasm; Provocation test; Cardiology; Plethysmograph; Reactive hyperemia; Internal medicine; Blood flow; Pathology","score_opus":0.017952031625967396,"score_gpt":0.25004106585031105,"score_spread":0.23208903422434365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162839224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579086,0.03744159,9.5305234e-7,0.0010021507,0.000032260272,0.00041121987,0.00030677472,0.000021277105,0.0028751793],"genre_scores_gemma":[0.9865719,0.0116521325,0.000010351005,0.0005645035,0.000016024665,0.00001746096,0.000016528424,0.0000137551415,0.0011373579],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989543,0.00009241102,0.00037848303,0.00018430548,0.00021581378,0.00017470762],"domain_scores_gemma":[0.99918544,0.00023291678,0.000091152186,0.00028827152,0.000038898783,0.00016333789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012416807,0.00013475519,0.00033819568,0.0000619719,0.0000774243,0.00004426785,0.00007906618,0.000045121935,0.00028896763],"category_scores_gemma":[0.00018791304,0.000087688815,0.00011644764,0.000116717216,0.0002364535,0.00016270642,0.0000389234,0.00007057396,0.0000068480604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010828216,0.0012006619,0.28084484,0.0018115233,0.0007452923,0.000017485998,0.0014505095,0.000044665343,0.0008078968,0.0003339436,0.0017531329,0.70990723],"study_design_scores_gemma":[0.001925801,0.00009897363,0.9928952,0.0028088207,0.000173779,0.000024864576,0.0005204468,0.00013316503,0.00024397013,0.00051949563,0.000523449,0.00013205667],"about_ca_topic_score_codex":0.00001617175,"about_ca_topic_score_gemma":9.026144e-7,"teacher_disagreement_score":0.7120503,"about_ca_system_score_codex":0.0000114149525,"about_ca_system_score_gemma":0.00015182437,"threshold_uncertainty_score":0.3575846},"labels":[],"label_agreement":null},{"id":"W2162925641","doi":"10.1136/ard.2010.138792","title":"SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital; University of Toronto; Nova Scotia Cancer Centre; Toronto Western Hospital; Nova Scotia Health Authority","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; National Center for Research Resources; Wellcome Trust","keywords":"Medicine; Internal medicine; Confidence interval; Quality of life (healthcare); Cohort; Systemic lupus erythematosus; Disease","score_opus":0.05260674812044971,"score_gpt":0.29967450531063305,"score_spread":0.24706775719018334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162925641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98638785,0.01133473,0.000002763966,0.00031331112,0.00032151918,0.0010383194,0.000045315257,0.00003095495,0.0005252613],"genre_scores_gemma":[0.9969427,0.0019235694,0.0000525942,0.00007164544,0.000012237955,0.000054586162,0.0000035058067,0.00004218664,0.00089698186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973845,0.00023251466,0.0009655321,0.00030293025,0.0007251516,0.00038936897],"domain_scores_gemma":[0.99767506,0.00035365025,0.000591675,0.0009653299,0.00020891518,0.00020535069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049333135,0.00024788195,0.0010154967,0.00034580074,0.000050533097,0.000006308899,0.00042908455,0.00007605146,0.00004634197],"category_scores_gemma":[0.00091956876,0.00015521327,0.0002769164,0.00053454516,0.00019817623,0.0001196689,0.00023330149,0.00013516657,0.000012123406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004074929,0.0006009869,0.98728216,0.008195017,0.00018344563,0.000012918897,0.00079813134,0.0000037130972,0.000032502598,0.00013030379,0.002117629,0.00023571689],"study_design_scores_gemma":[0.0020078325,0.00015225195,0.97994745,0.012123634,0.00016392983,0.0012935845,0.0017273959,0.00011955859,0.00033887938,0.0019602948,0.0000043758523,0.00016082366],"about_ca_topic_score_codex":0.00034375337,"about_ca_topic_score_gemma":0.00002391513,"teacher_disagreement_score":0.010554869,"about_ca_system_score_codex":0.000022059672,"about_ca_system_score_gemma":0.00015048531,"threshold_uncertainty_score":0.63294137},"labels":[],"label_agreement":null},{"id":"W2163154920","doi":"10.1136/ard.2010.130658","title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":498,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"Actelion Pharmaceuticals; National Center for Research Resources","keywords":"Medicine; Bosentan; Placebo; Double blind; Scleroderma (fungus); Internal medicine; Randomized controlled trial; Dermatology; Physical therapy; Alternative medicine; Pathology","score_opus":0.061917648427589136,"score_gpt":0.30963064318146766,"score_spread":0.24771299475387853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163154920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788826,0.0057799965,0.0000011962105,0.0029873,0.0012494241,0.009571752,0.00072307495,0.00006545859,0.0007391634],"genre_scores_gemma":[0.99683523,0.0015768175,0.0000063325565,0.00011953413,0.00014924972,0.00061606505,0.00010585089,0.00004175078,0.00054916943],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99624294,0.00027076976,0.0019226483,0.0004201403,0.00079325336,0.0003502206],"domain_scores_gemma":[0.9947179,0.0020963415,0.0010890489,0.0014360737,0.000258458,0.00040220626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051640917,0.00038842898,0.0014762386,0.00012045096,0.00016764442,0.00008071776,0.0004846598,0.00017701928,0.00010237365],"category_scores_gemma":[0.0020096053,0.00017929032,0.0014597528,0.00038138934,0.00025932078,0.00011702509,0.00007553285,0.00014097226,0.000044877448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.981031,0.0017289128,0.00082598894,0.00009253773,0.0032748708,0.000002213193,0.0013858303,0.0001130646,0.0013892616,0.000053756263,0.0042677354,0.005834801],"study_design_scores_gemma":[0.9822923,0.00079661666,0.0034662825,0.006265012,0.002680385,0.000009785742,0.0017629233,0.00015467619,0.002163355,0.00014376683,0.000041299634,0.00022362373],"about_ca_topic_score_codex":0.0003040283,"about_ca_topic_score_gemma":0.000008968176,"teacher_disagreement_score":0.017952595,"about_ca_system_score_codex":0.000038127324,"about_ca_system_score_gemma":0.00033004285,"threshold_uncertainty_score":0.7311247},"labels":[],"label_agreement":null},{"id":"W2163463767","doi":"10.1136/annrheumdis-2012-201620","title":"Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Institute on Aging","keywords":"Medicine; Rheumatoid arthritis; Adalimumab; Methotrexate; Disease; Internal medicine; Antirheumatic drugs; Physical therapy; Antirheumatic Agents","score_opus":0.010168143502417595,"score_gpt":0.2357996987236047,"score_spread":0.2256315552211871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163463767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940022,0.0036541438,0.00010329514,0.00059519324,0.000032990352,0.0014781096,0.00010931427,0.000015771977,0.000008931678],"genre_scores_gemma":[0.99912137,0.0006552703,0.000033631663,0.000018224999,0.0000091363945,0.00011730942,0.000014585751,0.000020104218,0.000010361427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978633,0.00036075548,0.00044513904,0.00018179828,0.00082762446,0.0003213655],"domain_scores_gemma":[0.99846095,0.00017444804,0.00053092756,0.00030033579,0.00029557484,0.00023774045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005242055,0.00018360588,0.0006154467,0.00009575598,0.000066550405,0.00001545656,0.00006421021,0.00003633042,0.000015361114],"category_scores_gemma":[0.00048922497,0.000115202805,0.00013320202,0.00027538618,0.00020651823,0.0003409081,0.000033679436,0.00012330801,7.422814e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008983813,0.0027247316,0.9753435,0.00055988395,0.00058163016,3.1242553e-7,0.0012328152,0.00009330316,0.00022120608,0.000072081566,0.00013641127,0.01005026],"study_design_scores_gemma":[0.00747522,0.0015787112,0.9856983,0.0035254033,0.000048108053,4.7434187e-7,0.00022211985,0.00016119532,0.0007791397,0.0003879929,0.0000070842257,0.000116266456],"about_ca_topic_score_codex":0.00019960072,"about_ca_topic_score_gemma":0.000009564724,"teacher_disagreement_score":0.010354734,"about_ca_system_score_codex":0.00006088065,"about_ca_system_score_gemma":0.000121703844,"threshold_uncertainty_score":0.4697834},"labels":[],"label_agreement":null},{"id":"W2164096595","doi":"10.1136/annrheumdis-2013-204424","title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2876,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Toronto Western Hospital; Jewish General Hospital; St Joseph's Health Care; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research","keywords":"Medicine; Rheumatism; Rheumatology; Internal medicine; Scleroderma (fungus); Dermatology; Pathology","score_opus":0.08095854744517135,"score_gpt":0.3199430099495822,"score_spread":0.23898446250441086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164096595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594683,0.006322684,0.00010119658,0.0028527556,0.0002217572,0.0028211954,0.001363734,0.00007732638,0.00029253133],"genre_scores_gemma":[0.9913722,0.0071956892,0.00026819512,0.00043844368,0.000019389388,0.000444855,0.00013912817,0.00006187692,0.000060217088],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99654007,0.0008677511,0.0014014196,0.0003956592,0.00044032454,0.0003547594],"domain_scores_gemma":[0.9951201,0.0005816032,0.001668957,0.0008875375,0.0014194105,0.00032240205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043852677,0.00033360405,0.0011200197,0.00019339053,0.00018569466,0.00003176391,0.00044344398,0.0000873443,0.00007571093],"category_scores_gemma":[0.0010593876,0.00022396652,0.00038809192,0.00059691083,0.0007097039,0.00033633498,0.000072584735,0.00009733956,0.00003843491],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002927315,0.0105629945,0.10900401,0.020419069,0.0090594925,0.0000097193815,0.017276501,0.00045697024,0.0601952,0.011068612,0.61205274,0.14696737],"study_design_scores_gemma":[0.004411192,0.0013071364,0.87400955,0.057888173,0.00094723876,0.00006439737,0.047740195,0.008432643,0.003293141,0.0011649664,0.00006157958,0.00067980017],"about_ca_topic_score_codex":0.00020817741,"about_ca_topic_score_gemma":0.0000055266173,"teacher_disagreement_score":0.7650055,"about_ca_system_score_codex":0.000037688387,"about_ca_system_score_gemma":0.0003162792,"threshold_uncertainty_score":0.913309},"labels":[],"label_agreement":null},{"id":"W2164323898","doi":"10.1136/ard.2003.015974","title":"Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HEC Montréal","funders":"Novartis Pharma","keywords":"Medicine; Celecoxib; Placebo; WOMAC; Tolerability; Osteoarthritis; Visual analogue scale; Adverse effect; Internal medicine; Anesthesia; Physical therapy","score_opus":0.04119343835791871,"score_gpt":0.3141799739020727,"score_spread":0.272986535544154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164323898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644,0.0051366277,5.279553e-7,0.00076662865,0.00014915495,0.0070708045,0.00007442866,0.000008284029,0.0003535675],"genre_scores_gemma":[0.9985791,0.00060360343,0.0000112907,0.00006360556,0.000016342772,0.0005869066,0.000005502732,0.000016481748,0.00011717818],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984385,0.00023071172,0.0004712921,0.00021061713,0.00043473218,0.00021415601],"domain_scores_gemma":[0.9983794,0.0005323712,0.00031125787,0.00061314617,0.00009130621,0.000072499286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002418027,0.00022909352,0.00065204303,0.00007946409,0.000091517904,0.000014009164,0.00018362496,0.000048582453,0.00003240849],"category_scores_gemma":[0.0001326335,0.00011045666,0.00035940032,0.00027492826,0.00021766858,0.000069065216,0.000051074378,0.000063148276,0.0000026654002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41545352,0.053930476,0.03652891,0.0015970395,0.0036869731,0.000091879534,0.084892854,0.00014435193,0.0013287591,0.0009527791,0.00040314783,0.4009893],"study_design_scores_gemma":[0.8078369,0.035231866,0.07334415,0.0029129311,0.0024587696,0.000024829897,0.011886829,0.000011592609,0.06417217,0.0017681348,0.000074460164,0.00027737892],"about_ca_topic_score_codex":0.00031944277,"about_ca_topic_score_gemma":0.00027607576,"teacher_disagreement_score":0.40071192,"about_ca_system_score_codex":0.000030002057,"about_ca_system_score_gemma":0.0001149877,"threshold_uncertainty_score":0.4504292},"labels":[],"label_agreement":null},{"id":"W2164427325","doi":"10.1136/ard.2008.097527","title":"Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; McGill University; University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Internal medicine; Rheumatoid arthritis; Population; Breast cancer; Incidence (geometry); Oncology; Malignancy; Cancer registry; Epidemiology; Cancer; Lymphoma; Rituximab","score_opus":0.15990448939416543,"score_gpt":0.4100699393139614,"score_spread":0.25016544991979595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164427325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97951674,0.013521081,0.000052075644,0.005306617,0.00012919506,0.0010503046,0.000021574739,0.000052564657,0.00034986608],"genre_scores_gemma":[0.91246116,0.084862344,0.0012665108,0.0010357592,0.00003455413,0.00023795778,0.000039487357,0.000018587025,0.00004361354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546736,0.0012584695,0.0013324933,0.0003566711,0.0009176505,0.00066733814],"domain_scores_gemma":[0.9972591,0.0010654421,0.00031148724,0.00083668815,0.00019596591,0.0003313409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026289134,0.0002649882,0.00085427845,0.000093234594,0.0003339912,0.000040249437,0.00064791105,0.000092375114,0.00017787791],"category_scores_gemma":[0.0026772271,0.00013466644,0.00040185478,0.00032706422,0.0010059357,0.00020350804,0.00015876982,0.00035100573,0.000027213493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002470562,0.0037930424,0.6333992,0.0001336043,0.00024669038,0.000098981094,0.0018550807,0.000011843384,0.000009820763,0.0029679027,0.011507301,0.34572947],"study_design_scores_gemma":[0.0015324019,0.0005780933,0.98489887,0.0014858231,0.0000038497355,0.00020666631,0.0013052878,0.0001279585,0.0000820456,0.0019473853,0.0076552248,0.00017638477],"about_ca_topic_score_codex":0.00008835596,"about_ca_topic_score_gemma":0.00006058395,"teacher_disagreement_score":0.35149968,"about_ca_system_score_codex":0.00002138633,"about_ca_system_score_gemma":0.0006743024,"threshold_uncertainty_score":0.5491538},"labels":[],"label_agreement":null},{"id":"W2164450075","doi":"10.1136/ard.2009.127993","title":"Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Osteoarthritis; Cartilage; Bone marrow; Randomized controlled trial; Knee pain; Clinical trial; Physical therapy; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.07655006510911604,"score_gpt":0.3483182793771093,"score_spread":0.27176821426799325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164450075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929099,0.0017881406,0.000010846572,0.0014857614,0.00031218128,0.0030895409,0.0002987692,0.00002955482,0.000075286654],"genre_scores_gemma":[0.9988609,0.00008399878,0.0004148781,0.00013366084,0.0001616835,0.00009898708,0.00009959984,0.000022493985,0.00012379649],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968599,0.00086854264,0.0013739336,0.00030550925,0.00033872883,0.00025335667],"domain_scores_gemma":[0.992995,0.0056284037,0.00049764564,0.0005415792,0.00008478243,0.00025259197],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002244069,0.00020767379,0.0011093599,0.00010830311,0.00011829113,0.000032989057,0.00010170307,0.00016735378,0.000033316453],"category_scores_gemma":[0.014870399,0.00014287197,0.0004370049,0.00014022115,0.00021190393,0.00011314312,0.0000637069,0.00025331235,0.000004741956],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58425534,0.0016163132,0.25351825,0.00017554176,0.0002559496,0.00011583596,0.0006266771,0.000005302319,0.0006464614,0.0003330101,0.00062371464,0.15782759],"study_design_scores_gemma":[0.8985367,0.002427571,0.08912483,0.0018951498,0.0008908599,0.0000068300396,0.00021782513,0.00015862436,0.00037343128,0.006106121,0.000044313303,0.0002177885],"about_ca_topic_score_codex":0.000078044526,"about_ca_topic_score_gemma":0.000110847024,"teacher_disagreement_score":0.3142813,"about_ca_system_score_codex":0.000008104339,"about_ca_system_score_gemma":0.0001732884,"threshold_uncertainty_score":0.99342775},"labels":[],"label_agreement":null},{"id":"W2164744373","doi":"10.1136/ard.2005.039164","title":"TNFα polymorphisms and risk of psoriatic arthritis","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Memorial University of Newfoundland","funders":"","keywords":"Psoriatic arthritis; Medicine; Odds ratio; Arthritis; Psoriasis; Immunology; Tumor necrosis factor alpha; Internal medicine; Single-nucleotide polymorphism; Genotype; Meta-analysis; Oncology; Genetics; Gene; Biology","score_opus":0.05353655235836905,"score_gpt":0.34421842403849096,"score_spread":0.2906818716801219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164744373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032544902,0.9945235,5.222017e-7,0.00012738832,0.00014711173,0.00085452606,0.000865285,0.000014884958,0.0002122753],"genre_scores_gemma":[0.0033883706,0.9960958,0.00005626239,0.0000348589,0.00005754897,0.00007139208,0.000035812463,0.000036960882,0.00022302434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822307,0.00014344718,0.00082143466,0.00023507724,0.0003482029,0.00022874339],"domain_scores_gemma":[0.99790585,0.00032291305,0.0009235703,0.00062002003,0.00008516522,0.00014245811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011726843,0.00033940346,0.0023021637,0.00010595947,0.00008760241,0.000009376381,0.0001587742,0.00009094769,0.00013388833],"category_scores_gemma":[0.00054277666,0.0001980087,0.00091816025,0.00020054763,0.00025386293,0.00003973945,0.0001458033,0.00011057446,0.000015802152],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001826754,0.0003240682,0.0004507667,0.008411865,0.0021121826,0.0000061730398,0.000055743847,1.201195e-7,5.8952114e-9,0.00008437968,0.0013149435,0.9872215],"study_design_scores_gemma":[0.0044871434,0.0009957139,0.02441516,0.36900812,0.028161256,0.00026678247,0.0001771375,0.00000780258,0.000005433899,0.0016498559,0.57006294,0.0007626839],"about_ca_topic_score_codex":0.00013443023,"about_ca_topic_score_gemma":0.000014590469,"teacher_disagreement_score":0.9864588,"about_ca_system_score_codex":0.000013212268,"about_ca_system_score_gemma":0.00014779871,"threshold_uncertainty_score":0.807456},"labels":[],"label_agreement":null},{"id":"W2166077573","doi":"10.1136/annrheumdis-2013-205056","title":"Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":441,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Genentech; Celgene; Servier; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Apremilast; Medicine; Psoriatic arthritis; Placebo; Leflunomide; Internal medicine; Adverse effect; Psoriasis; Rheumatology; Discontinuation; Rheumatoid arthritis; Dermatology; Alternative medicine; Pathology","score_opus":0.026148470588898985,"score_gpt":0.31212507105393084,"score_spread":0.28597660046503187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166077573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198794,0.002987274,0.000009648112,0.00033701284,0.00017375348,0.004205425,0.00007809063,0.000019112007,0.00020172696],"genre_scores_gemma":[0.99757844,0.001224334,0.00010175861,0.00006720795,0.0000577897,0.0008283179,0.00002337944,0.000023275798,0.00009546484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980912,0.00024937378,0.0007798673,0.00024137092,0.00036409116,0.0002740477],"domain_scores_gemma":[0.9983684,0.00043157357,0.00041513087,0.0005037693,0.00011009619,0.00017105172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018378516,0.00027723442,0.001576529,0.000095416035,0.00007062801,0.000013926254,0.000094568524,0.000040265284,0.00006994974],"category_scores_gemma":[0.0004871477,0.00015062837,0.0003897175,0.00016167779,0.00016829137,0.000093572424,0.000024100436,0.0000380266,0.0000031825243],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8525697,0.010846529,0.0022484253,0.00014542992,0.0009198324,0.000025779274,0.00076058786,0.000025654752,0.000013260988,0.00003991047,0.00013911807,0.13226576],"study_design_scores_gemma":[0.981081,0.012472395,0.0020341757,0.001403737,0.00069238036,0.000012440695,0.0002729859,0.00047710718,0.0011341848,0.00020803434,0.00006886155,0.00014268099],"about_ca_topic_score_codex":0.00020965023,"about_ca_topic_score_gemma":0.0001480924,"teacher_disagreement_score":0.13212308,"about_ca_system_score_codex":0.000028949884,"about_ca_system_score_gemma":0.000118716074,"threshold_uncertainty_score":0.61424464},"labels":[],"label_agreement":null},{"id":"W2166266370","doi":"10.1136/ard.2010.130559","title":"Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis","year":2010,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Axial spondyloarthritis; Spondylarthritis; Clinical significance; Sacroiliitis; Back pain; Physical therapy; Ankylosing spondylitis; Intensive care medicine; Internal medicine; Pathology; Alternative medicine","score_opus":0.07250380199673974,"score_gpt":0.36014273644435285,"score_spread":0.2876389344476131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166266370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047984134,0.94672346,0.000010293271,0.00004534753,0.00011817108,0.002883995,0.002204426,0.0000072516737,0.000022928914],"genre_scores_gemma":[0.009321894,0.98950845,0.0005107935,0.000035677036,0.000042072865,0.00036506113,0.00014132044,0.000046293677,0.000028463126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976186,0.00024208167,0.0012645713,0.00029004677,0.00036288096,0.00022179566],"domain_scores_gemma":[0.99554586,0.0020155567,0.0014242878,0.0005307542,0.00033734084,0.0001461712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046095456,0.00032461956,0.0024415266,0.00008374446,0.00006286921,0.000006660589,0.00018539917,0.00014992901,0.00004948167],"category_scores_gemma":[0.0017185232,0.00019219969,0.00083346415,0.00014537164,0.0005878011,0.0000493789,0.00010919105,0.00014064337,0.000001077186],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025314794,0.00064482476,0.11187359,0.027347034,0.00088566885,0.0000016068266,0.000022559689,1.1622022e-7,1.0023831e-8,0.000021520955,0.0005790068,0.8583709],"study_design_scores_gemma":[0.01048637,0.0050082053,0.30142412,0.31587055,0.007710051,0.0000061432984,0.000104676124,0.000007218731,0.000011732498,0.00022872664,0.35842597,0.00071622885],"about_ca_topic_score_codex":0.00002109112,"about_ca_topic_score_gemma":0.0000144636415,"teacher_disagreement_score":0.8576547,"about_ca_system_score_codex":0.0000053774625,"about_ca_system_score_gemma":0.00018233275,"threshold_uncertainty_score":0.7837676},"labels":[],"label_agreement":null},{"id":"W2166476511","doi":"10.1136/annrheumdis-2014-205862","title":"Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Janssen Scientific Affairs; Oregon Health and Science University; Celltrion; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Golimumab; Medicine; Ankylosing spondylitis; Placebo; Spondylitis; Internal medicine; Surgery; Adalimumab; Disease","score_opus":0.03405460300183315,"score_gpt":0.3060174834501663,"score_spread":0.27196288044833317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166476511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419475,0.0013458959,4.3791576e-7,0.0013718609,0.00018660838,0.0009317109,0.00047065754,0.000018073442,0.0014800372],"genre_scores_gemma":[0.9990765,0.00018376617,0.000021193277,0.0001824653,0.000023575274,0.000030391175,0.000015488324,0.00002250343,0.00044415757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793535,0.00028624755,0.0007207177,0.00025631953,0.00051270856,0.00028863922],"domain_scores_gemma":[0.9980398,0.00040107607,0.00038086734,0.0009492355,0.00013112386,0.00009790011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030177235,0.00020705411,0.00061233,0.00007656386,0.000109005465,0.000014972608,0.0002946696,0.000040952105,0.00005166737],"category_scores_gemma":[0.0015221799,0.000119859644,0.00030441114,0.00030365054,0.00020387676,0.00005938691,0.00021191315,0.000093074625,0.0000094334755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01379413,0.015560902,0.89294064,0.0017413405,0.0021808827,0.0002002891,0.009621216,0.000074130425,0.000088399305,0.00084621325,0.009313,0.053638827],"study_design_scores_gemma":[0.007978321,0.0016495866,0.98158586,0.0035957466,0.00038640414,0.000039277154,0.0025300332,0.000055777513,0.00031015332,0.0011831624,0.00052264554,0.00016301124],"about_ca_topic_score_codex":0.00036853366,"about_ca_topic_score_gemma":0.00019340529,"teacher_disagreement_score":0.08864521,"about_ca_system_score_codex":0.000024637182,"about_ca_system_score_gemma":0.00009439848,"threshold_uncertainty_score":0.48877344},"labels":[],"label_agreement":null},{"id":"W2166562378","doi":"10.1136/annrheumdis-2013-204882","title":"A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"National Institute for Health and Care Research; Versus Arthritis; Pfizer","keywords":"Medicine; Etanercept; Methotrexate; Clinical endpoint; Rheumatoid arthritis; Internal medicine; Placebo; Gastroenterology; Arthritis; Surgery; Synovitis; Randomized controlled trial; Pathology","score_opus":0.029933647671336713,"score_gpt":0.3225408620302128,"score_spread":0.2926072143588761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166562378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868124,0.0041152323,0.000009882669,0.0033285187,0.00016439796,0.0051795756,0.0000105848585,0.00001577194,0.00036362078],"genre_scores_gemma":[0.9933594,0.005826664,0.000033064982,0.00022141391,0.00006543073,0.00037121086,0.0000020607688,0.000018470533,0.00010230788],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99673593,0.0012349195,0.0009211702,0.00020088899,0.0006274769,0.00027959148],"domain_scores_gemma":[0.99698716,0.0017025594,0.00035538024,0.00055440766,0.00016106118,0.00023940133],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020754132,0.00018390946,0.0010526787,0.0001511612,0.000095374024,0.00003419402,0.00025770967,0.00006544775,0.00005666684],"category_scores_gemma":[0.009398074,0.000095007126,0.00035251956,0.00021923274,0.00027812467,0.00009692618,0.000100783735,0.0001606579,0.000003922468],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9064911,0.0004236442,0.00052759796,0.00012812135,0.00023833654,0.0000025847025,0.0015725187,0.000008156484,0.0005072545,0.00025082362,0.0007076666,0.08914221],"study_design_scores_gemma":[0.9789209,0.0016183653,0.0123999,0.002941117,0.000035395973,0.0000045728025,0.00030623615,0.00015945564,0.0009799994,0.0021286833,0.0003833934,0.00012202837],"about_ca_topic_score_codex":0.000093360126,"about_ca_topic_score_gemma":0.00002201431,"teacher_disagreement_score":0.089020185,"about_ca_system_score_codex":0.000006749394,"about_ca_system_score_gemma":0.00019188157,"threshold_uncertainty_score":0.9989462},"labels":[],"label_agreement":null},{"id":"W2166854766","doi":"10.1136/annrheumdis-2012-201669","title":"The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; British Society for Rheumatology","keywords":"Medicine; Pulmonary embolism; Deep vein; Cohort; Population; Internal medicine; Rheumatoid arthritis; Relative risk; Body mass index; Thrombosis; Cohort study; Incidence (geometry); Surgery; Confidence interval","score_opus":0.019076852050935397,"score_gpt":0.2843924558948498,"score_spread":0.2653156038439144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166854766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573506,0.011381908,0.000009290991,0.0006386052,0.00016807656,0.0018709592,0.000035548943,0.000016380212,0.00014419711],"genre_scores_gemma":[0.987586,0.011940144,0.00002530211,0.00016136022,0.000014942867,0.00022772502,0.000014172923,0.00002138539,0.000008917028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787176,0.00031247703,0.00073470536,0.00019258428,0.000560031,0.0003284165],"domain_scores_gemma":[0.9981245,0.00047435646,0.00048328473,0.0006702147,0.00010237712,0.00014529013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083978137,0.00019692404,0.000719024,0.00010780127,0.00017773686,0.000020978974,0.00019916493,0.000040199007,0.000049215934],"category_scores_gemma":[0.00074517314,0.00011740507,0.00019571932,0.0002340133,0.0001371657,0.00009747854,0.00014136957,0.000096948024,0.0000032311261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055124823,0.0037223648,0.97443724,0.00018411333,0.00039975723,6.929388e-7,0.0009949567,0.00013268224,0.0000011853933,0.00035739486,0.00031651193,0.019397996],"study_design_scores_gemma":[0.0007112644,0.00017287461,0.9944164,0.0010112475,0.00026327427,8.931587e-7,0.0018289239,0.0007487789,0.000028291512,0.00067336933,0.000029438033,0.000115207804],"about_ca_topic_score_codex":0.0021718505,"about_ca_topic_score_gemma":0.00019899447,"teacher_disagreement_score":0.019979218,"about_ca_system_score_codex":0.000021844422,"about_ca_system_score_gemma":0.00004246284,"threshold_uncertainty_score":0.47876397},"labels":[],"label_agreement":null},{"id":"W2166868893","doi":"10.1136/annrheumdis-2012-201844","title":"NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms?","year":2012,"lang":"en","type":"editorial","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Radiography; Spondylitis; Internal medicine; Physical therapy; Radiology","score_opus":0.0318288147966012,"score_gpt":0.30080323967821315,"score_spread":0.26897442488161194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166868893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7365773,0.1572469,0.0000041280887,0.0007172562,0.10272322,0.0015127262,0.0009443081,0.0000631713,0.00021104378],"genre_scores_gemma":[0.9050452,0.031645156,0.00039721996,0.000098169556,0.06160427,0.00024888804,0.0005808964,0.00014500535,0.0002351727],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978547,0.0001280368,0.00048475267,0.00035653665,0.0006926424,0.00048331489],"domain_scores_gemma":[0.99818873,0.00049011316,0.0004213231,0.0005130722,0.0001667444,0.00022003186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024709868,0.00040446964,0.0009933789,0.00030714204,0.000102009784,0.000040066665,0.00015611839,0.00019077567,0.000033042725],"category_scores_gemma":[0.00061319047,0.00023676374,0.000252549,0.0003950157,0.00033373982,0.00008066404,0.00014598876,0.0002826567,0.0000016767561],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029726643,0.002370757,0.4058603,0.007330246,0.002419361,0.00023487999,0.0016153575,0.0000027227397,0.0000036282868,0.00003647854,0.11741947,0.45973414],"study_design_scores_gemma":[0.014385919,0.002587367,0.7092056,0.12395187,0.003984454,0.0001138523,0.0008671331,0.00003663509,0.00010209754,0.000907062,0.14260468,0.00125333],"about_ca_topic_score_codex":0.00026687855,"about_ca_topic_score_gemma":0.000079009864,"teacher_disagreement_score":0.4584808,"about_ca_system_score_codex":0.000029316318,"about_ca_system_score_gemma":0.00016969517,"threshold_uncertainty_score":0.9654945},"labels":[],"label_agreement":null},{"id":"W2167029668","doi":"10.1136/annrheumdis-2014-206484","title":"Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Toronto Western Hospital; Hospital for Sick Children; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Genetics; Exome sequencing; Medicine; Genotyping; Ankylosing spondylitis; Biology; Genotype; Gene; Immunology; Mutation","score_opus":0.05601685017120297,"score_gpt":0.3098504111061151,"score_spread":0.25383356093491216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167029668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971474,0.0066890153,0.0000056778294,0.0021524439,0.00016390956,0.00062018615,0.00032365866,0.000016086184,0.00031429378],"genre_scores_gemma":[0.99753267,0.0018714212,0.00013720288,0.00020610169,0.000028964329,0.000052923137,0.000028549537,0.000017586943,0.0001245563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998555,0.00008837209,0.00045516554,0.00026564032,0.00033749515,0.00029832174],"domain_scores_gemma":[0.9990981,0.00008978981,0.0001246757,0.00041612217,0.000085118234,0.0001861456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019354938,0.00017622169,0.00046359972,0.00012470907,0.00005662929,0.000015515274,0.00011818025,0.000052814874,0.000038698236],"category_scores_gemma":[0.0006368358,0.00013090408,0.00012801621,0.00029237915,0.00017839325,0.00009627073,0.00019196409,0.000091286645,0.00000841602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020357051,0.004555373,0.9195799,0.00050151226,0.00046000615,0.0006116809,0.002912928,0.00011376915,0.0003158835,0.002309038,0.0025629697,0.06404123],"study_design_scores_gemma":[0.006847444,0.00024610068,0.9881522,0.0014073752,0.00007231113,0.00007751406,0.0006401958,0.00012226685,0.000056853492,0.0020007768,0.00024497704,0.00013198418],"about_ca_topic_score_codex":0.00053193694,"about_ca_topic_score_gemma":0.00027560425,"teacher_disagreement_score":0.06857229,"about_ca_system_score_codex":0.000031787065,"about_ca_system_score_gemma":0.000116875555,"threshold_uncertainty_score":0.5338114},"labels":[],"label_agreement":null},{"id":"W2167061160","doi":"10.1136/ard.2010.132134","title":"Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis","year":2010,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Abatacept; Tocilizumab; Medicine; Rheumatoid arthritis; Rituximab; TNF inhibitor; Rheumatology; Internal medicine; Antirheumatic drugs; Methotrexate; Antirheumatic Agents; Adalimumab; Tofacitinib; Immunology; Pharmacology; Lymphoma","score_opus":0.18616352548080636,"score_gpt":0.3998710492460894,"score_spread":0.21370752376528304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167061160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73835754,0.2552019,0.000007799999,0.00021254914,0.000081432336,0.004084733,0.0020271342,0.000024301144,0.0000026121988],"genre_scores_gemma":[0.61846274,0.38078925,0.00015140478,0.000050059312,0.0000036304498,0.00028222578,0.0001858618,0.000063254345,0.000011604992],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98897445,0.0036823829,0.0034730108,0.00094460417,0.0020303838,0.0008951407],"domain_scores_gemma":[0.99214303,0.0020503153,0.002157808,0.0021969012,0.0004945002,0.00095741125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018234478,0.00096686865,0.0079126675,0.0018837193,0.00020467454,0.000104781335,0.0017240369,0.00023491665,0.00045680412],"category_scores_gemma":[0.004857378,0.0004974691,0.0030058222,0.0039212243,0.00068063714,0.000316983,0.0005192137,0.0006130695,0.0000138350615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022026397,0.028987732,0.3035658,0.029547833,0.083268926,0.000058335812,0.006563199,0.0009622821,0.000020076373,0.00012249012,0.00042508694,0.52445185],"study_design_scores_gemma":[0.004561465,0.0015781315,0.93441695,0.050910633,0.00601412,0.0000072916223,0.00029173787,0.00020253978,0.000036033143,0.000079111276,0.0010724214,0.00082956615],"about_ca_topic_score_codex":0.00047842268,"about_ca_topic_score_gemma":0.00028770982,"teacher_disagreement_score":0.63085115,"about_ca_system_score_codex":0.00007689076,"about_ca_system_score_gemma":0.0011257721,"threshold_uncertainty_score":0.9997477},"labels":[],"label_agreement":null},{"id":"W2167230918","doi":"10.1136/ard.2007.073023","title":"Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Magnetic resonance imaging; Cartilage; Lesion; Knee cartilage; Radiology; Nuclear medicine; Pathology; Anatomy; Articular cartilage","score_opus":0.013802579440091294,"score_gpt":0.26413092364198015,"score_spread":0.2503283442018889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167230918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98607117,0.012199033,0.000009877381,0.000537826,0.000060132545,0.00086771545,0.00016782206,0.000010301933,0.00007609424],"genre_scores_gemma":[0.9994326,0.00010310126,0.000053963286,0.00008273566,0.0000066270927,0.000018903002,0.000036871574,0.000018701496,0.00024646445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987923,0.000085179316,0.00030981685,0.0001799039,0.00041983547,0.0002129623],"domain_scores_gemma":[0.9991358,0.00013007027,0.0002610934,0.0002722471,0.00012279215,0.00007799988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016588384,0.0001567789,0.0003552152,0.000071812625,0.00007673603,0.000013365111,0.0000656021,0.000037122332,0.000025686326],"category_scores_gemma":[0.00020003598,0.000096860975,0.000069766415,0.00020995534,0.00020434624,0.00012802093,0.000058622412,0.00007016399,0.0000014944335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062993047,0.00028298958,0.89414877,0.00013414602,0.000010303073,0.000007943196,0.0008689051,9.961726e-7,0.00026881273,0.00006782847,0.00012487119,0.1034545],"study_design_scores_gemma":[0.0044245957,0.0021941955,0.987027,0.003028706,0.00014152526,0.0000033620167,0.00049930596,0.000035763365,0.0022606791,0.0002218815,0.00005544601,0.00010753541],"about_ca_topic_score_codex":0.00008744295,"about_ca_topic_score_gemma":0.00013514016,"teacher_disagreement_score":0.103346966,"about_ca_system_score_codex":0.000017349377,"about_ca_system_score_gemma":0.000047060905,"threshold_uncertainty_score":0.39498758},"labels":[],"label_agreement":null},{"id":"W2167388949","doi":"10.1136/ard.2010.133561","title":"High resolution mapping in the major histocompatibility complex region identifies multiple independent novel loci for psoriatic arthritis","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Memorial University of Newfoundland; Ontario Institute for Cancer Research; University of Toronto; Public Health Ontario; Hospital for Sick Children; Toronto Western Hospital","funders":"Krembil Foundation","keywords":"Psoriatic arthritis; Medicine; Major histocompatibility complex; Computational biology; Arthritis; Immunology; Genetics; Antigen; Biology","score_opus":0.14472336371435007,"score_gpt":0.30827861894633557,"score_spread":0.1635552552319855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167388949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294037,0.002593625,0.00046105444,0.0014499056,0.00019626597,0.00211797,0.0001354395,0.000023065635,0.00008229807],"genre_scores_gemma":[0.99850833,0.00028458762,0.00047103243,0.00026045612,0.000027163456,0.0003332824,0.00005168308,0.000013296901,0.000050147824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985526,0.000096841046,0.000536707,0.00022683377,0.0003329068,0.00025408308],"domain_scores_gemma":[0.9987087,0.00025965253,0.0002885334,0.00054556236,0.00014295916,0.000054555218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028361139,0.00016314705,0.00042425928,0.00007226176,0.00020796219,0.000015253408,0.00021176242,0.000038773735,0.000035920155],"category_scores_gemma":[0.00066832535,0.00010065011,0.0002612559,0.00016758012,0.0001775256,0.00008983328,0.00007967938,0.00006619641,0.0000044164185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045562806,0.019961162,0.71908313,0.0056622066,0.0030093547,0.00008485001,0.03763125,0.00009918931,0.00033099225,0.011539536,0.05526778,0.14277428],"study_design_scores_gemma":[0.004082351,0.00017716493,0.984474,0.0011126552,0.0001370839,0.000014601384,0.001999958,0.0004066592,0.00009549966,0.007283648,0.000110729095,0.00010563946],"about_ca_topic_score_codex":0.0022971975,"about_ca_topic_score_gemma":0.00082550064,"teacher_disagreement_score":0.2653909,"about_ca_system_score_codex":0.00004406074,"about_ca_system_score_gemma":0.000039990326,"threshold_uncertainty_score":0.41043925},"labels":[],"label_agreement":null},{"id":"W2167795826","doi":"10.1136/annrheumdis-2013-203696","title":"Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":458,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Nexus Clinical Research (Canada)","funders":"UCB Pharma; Astellas Pharma; Celgene; Biogen; Sanofi; National Center for Advancing Translational Sciences; Chugai Pharmaceutical; Amgen; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Certolizumab pegol; Psoriatic arthritis; Placebo; Double blind; Arthritis; Internal medicine; Psoriasis; Dermatology; Gastroenterology; Rheumatoid arthritis; Adalimumab; Pathology; Alternative medicine","score_opus":0.021959206891646176,"score_gpt":0.29856530183209096,"score_spread":0.2766060949404448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167795826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725504,0.0017372752,4.1724968e-7,0.0001904882,0.000073877156,0.010441728,0.00013005981,0.000012568834,0.00015857234],"genre_scores_gemma":[0.99876285,0.00026556643,0.000005260606,0.000016863916,0.000008670905,0.0008612933,0.000024424819,0.000023948654,0.000031127638],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974907,0.00037095696,0.0009650337,0.00028551623,0.0006143611,0.0002734279],"domain_scores_gemma":[0.9972376,0.0012020634,0.0006747163,0.0005175334,0.0002245173,0.0001435195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002081248,0.0003122907,0.0016465838,0.00018825805,0.00006562133,0.000014488329,0.00012893674,0.000042579075,0.000050323633],"category_scores_gemma":[0.0008271254,0.00016931156,0.00024396308,0.00023708603,0.00018105867,0.00009711752,0.000058696183,0.000078182595,0.0000032924427],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8935471,0.015244927,0.031453002,0.00064682105,0.0026624184,0.000020614376,0.0012073348,0.000016791797,0.000008648903,0.0000075506914,0.00020924378,0.054975525],"study_design_scores_gemma":[0.8927785,0.03647957,0.0650386,0.0036596816,0.0009853169,0.0000031785976,0.00035750752,0.000081860126,0.00043009527,0.000041336534,6.8065106e-7,0.00014363803],"about_ca_topic_score_codex":0.0002968134,"about_ca_topic_score_gemma":0.000028809305,"teacher_disagreement_score":0.054831885,"about_ca_system_score_codex":0.000015487403,"about_ca_system_score_gemma":0.000056679924,"threshold_uncertainty_score":0.6904325},"labels":[],"label_agreement":null},{"id":"W2167939282","doi":"10.1136/annrheumdis-2011-200726","title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","year":2012,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":946,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Arthritis Research Centre of Canada","funders":"","keywords":"Medicine; Internal medicine; Relative risk; Meta-analysis; Observational study; Rheumatoid arthritis; Heart failure; Myocardial infarction; Population; Cohort study; Hazard ratio; Subgroup analysis; Confidence interval","score_opus":0.2066834870611325,"score_gpt":0.38049143098595967,"score_spread":0.17380794392482718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167939282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05681894,0.94026166,0.0000036330362,0.000027761293,0.0000505861,0.0015429957,0.0012772367,0.000008296381,0.000008863246],"genre_scores_gemma":[0.113064334,0.88633907,0.000054417254,0.000010499325,0.0000062645845,0.00026874547,0.00020603543,0.000038456907,0.000012158118],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99398834,0.0011489097,0.0020526785,0.00034494768,0.0020789902,0.0003861613],"domain_scores_gemma":[0.994533,0.00090841413,0.002042177,0.0013656552,0.00097489444,0.00017583172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013500663,0.00048894534,0.008940149,0.0007572261,0.00006246451,0.0000064150145,0.00047360096,0.00010113016,0.00013941021],"category_scores_gemma":[0.0017119928,0.00026034896,0.007516067,0.0015335586,0.00040062756,0.00017925924,0.00023864214,0.00022116766,0.0000037744273],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012398332,0.0013129963,0.09686785,0.0127016045,0.6982537,0.0000012669998,0.00028376316,0.000095350726,4.9718882e-9,0.0000861007,0.00008617108,0.19018723],"study_design_scores_gemma":[0.0029373423,0.00049077906,0.5863568,0.054021504,0.34160262,0.0000056802983,0.00026883787,0.000011353025,0.0000038515022,0.000534321,0.013132663,0.00063419115],"about_ca_topic_score_codex":0.0002301489,"about_ca_topic_score_gemma":0.00006213921,"teacher_disagreement_score":0.489489,"about_ca_system_score_codex":0.000036933932,"about_ca_system_score_gemma":0.0003794093,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W2168157584","doi":"10.1136/ard.2003.011056","title":"Autoantibodies against granulocyte−macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Granulocyte macrophage colony-stimulating factor; Antibody; Rheumatoid arthritis; Immunology; Felty's syndrome; Internal medicine; Autoantibody; Gastroenterology; Cytokine; Chemotherapy; Neutropenia","score_opus":0.016750306896958233,"score_gpt":0.27058661865101485,"score_spread":0.25383631175405663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168157584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454165,0.0037401959,0.0000054552024,0.00069022755,0.00004865513,0.0007161468,0.00016759372,0.000035216388,0.000054838594],"genre_scores_gemma":[0.99816394,0.0014725598,0.00008123911,0.00017096043,0.0000052865616,0.000022799948,0.000024663168,0.000026152427,0.000032392414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984901,0.0000794993,0.0003717369,0.00022256369,0.00049488666,0.00034123837],"domain_scores_gemma":[0.9989871,0.00012852976,0.00019972767,0.00033617843,0.00016123742,0.00018724022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007772203,0.0002080608,0.0005296391,0.00014171461,0.00012713567,0.00004832911,0.00016620528,0.00003943932,0.000036066675],"category_scores_gemma":[0.0004992041,0.00012780483,0.00010748657,0.00020468379,0.0003205102,0.00019563804,0.00011264835,0.0001425616,0.0000052860128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067289936,0.00072325696,0.98203075,0.000768792,0.0002587718,0.00009485376,0.0011275153,0.00022020515,0.000026754853,0.00006981308,0.00010380394,0.01390258],"study_design_scores_gemma":[0.004101174,0.0005191475,0.98736644,0.006841194,0.000009585971,0.000012726216,0.00033655768,0.0000656862,0.00017444654,0.00041262992,0.000019380283,0.00014101095],"about_ca_topic_score_codex":0.000105918305,"about_ca_topic_score_gemma":0.00005228816,"teacher_disagreement_score":0.01376157,"about_ca_system_score_codex":0.000030427258,"about_ca_system_score_gemma":0.000099910525,"threshold_uncertainty_score":0.52117294},"labels":[],"label_agreement":null},{"id":"W2168200807","doi":"10.1136/ard.2007.072157","title":"EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine; Glucocorticoid; Systemic therapy; Immunology; Internal medicine","score_opus":0.08874313693834711,"score_gpt":0.354642161473087,"score_spread":0.2658990245347399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168200807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571629,0.031490035,0.00010671038,0.00880145,0.00014989456,0.0019806577,0.000052110492,0.000030485437,0.00022572845],"genre_scores_gemma":[0.9327213,0.06637678,0.00006038855,0.00058336376,0.000010631888,0.00012785937,0.000013106564,0.000025751064,0.00008079793],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972013,0.0003396644,0.00092087535,0.00023766296,0.00088972895,0.00041075057],"domain_scores_gemma":[0.9965143,0.0016834536,0.00040910675,0.0010369042,0.00019269284,0.00016351385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009898442,0.00022771991,0.00054262584,0.00023539597,0.00011783221,0.000031184314,0.00050269224,0.000037011083,0.00034330832],"category_scores_gemma":[0.00065872085,0.00012622455,0.0003744467,0.0005934763,0.00027262635,0.00014353648,0.0000794082,0.00013725065,0.000030308134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005679775,0.007552542,0.13796541,0.010574294,0.0034150279,0.00006425951,0.002131245,0.0011624799,0.00078481034,0.024571477,0.009812909,0.79628575],"study_design_scores_gemma":[0.005767881,0.0014975526,0.83417803,0.1359362,0.00013487836,0.000018165192,0.006058167,0.0018699775,0.007892614,0.0057113105,0.00046313312,0.00047207627],"about_ca_topic_score_codex":0.00008171462,"about_ca_topic_score_gemma":0.000006349759,"teacher_disagreement_score":0.7958137,"about_ca_system_score_codex":0.000040759016,"about_ca_system_score_gemma":0.00017562984,"threshold_uncertainty_score":0.5147288},"labels":[],"label_agreement":null},{"id":"W2168536859","doi":"10.1136/annrheumdis-2014-206149","title":"Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Bristol-Myers Squibb","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Internal medicine; Erythrocyte sedimentation rate; Gastroenterology; Arthritis; Surgery; Rituximab","score_opus":0.01101268063491969,"score_gpt":0.25245853327286494,"score_spread":0.24144585263794524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168536859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591,0.0029353118,0.000008681942,0.00030078206,0.000023827615,0.00070506043,0.00005506435,0.000010686781,0.00005061555],"genre_scores_gemma":[0.9892226,0.010416193,0.00026604842,0.000009562445,0.0000034824295,0.000034981163,0.000010234203,0.000019443743,0.000017486786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860096,0.00011275561,0.00037470122,0.00017670839,0.0005265779,0.00020832129],"domain_scores_gemma":[0.99907655,0.000091549016,0.00026650808,0.00028400886,0.000163208,0.00011816341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019178158,0.00013968929,0.0005226182,0.00010838004,0.00004146357,0.000012768685,0.0000910368,0.000027949209,0.000010382232],"category_scores_gemma":[0.00022441246,0.000079737954,0.000106048836,0.00018691127,0.0002577704,0.00014901892,0.000033139026,0.000050689803,4.012578e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004293236,0.0009390696,0.53356856,0.0002836708,0.0003996092,0.000002743794,0.0017719461,0.00001279569,0.00014059953,0.000118493524,0.00015054717,0.45831874],"study_design_scores_gemma":[0.008418041,0.004019725,0.96497047,0.016841907,0.000021237269,0.000005273412,0.00060331856,0.000033052762,0.0044197864,0.0004381043,0.000101057994,0.00012801886],"about_ca_topic_score_codex":0.0002117831,"about_ca_topic_score_gemma":0.000014604893,"teacher_disagreement_score":0.4581907,"about_ca_system_score_codex":0.000016922995,"about_ca_system_score_gemma":0.000097575066,"threshold_uncertainty_score":0.32516196},"labels":[],"label_agreement":null},{"id":"W2168567533","doi":"10.1136/ard.2009.119222","title":"Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate","year":2010,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; Genentech; National Institutes of Health; Versus Arthritis; National Institute for Health and Care Research; Biogen","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Methotrexate; Internal medicine; Placebo; Gastroenterology; Arthritis; Population; Leflunomide; Surgery; Pathology; Lymphoma","score_opus":0.008819963658137834,"score_gpt":0.2589102368355886,"score_spread":0.2500902731774508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168567533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983814,0.00042358742,0.000002905305,0.00017178757,0.000020395382,0.0008234111,0.00008652868,0.000017290711,0.000072722156],"genre_scores_gemma":[0.9989826,0.0006237844,0.00020323257,0.00002874378,0.000002588732,0.00003568139,0.0000844431,0.000026635636,0.000012275186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983667,0.00014574506,0.00041859117,0.00019734648,0.00060355186,0.00026806162],"domain_scores_gemma":[0.99884796,0.00011614227,0.00029759188,0.00036500258,0.00026781723,0.000105471554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018595668,0.00018151604,0.0005545413,0.00024778183,0.000037411133,0.000024437632,0.0001151258,0.000046712707,0.000096162905],"category_scores_gemma":[0.00019432067,0.00010777671,0.000062400824,0.0004598724,0.00040948135,0.00028345268,0.00003268756,0.00019954193,0.0000015010032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031315181,0.00129559,0.97761536,0.00014377171,0.00013123438,0.000015836125,0.0004928484,0.000018106566,0.00018742074,0.00039980025,0.000059458194,0.016509032],"study_design_scores_gemma":[0.02018145,0.00090496213,0.97206056,0.0040105106,0.000007298585,0.0000058796536,0.00013065738,0.00013989197,0.0019560636,0.000462738,0.000008880451,0.00013112836],"about_ca_topic_score_codex":0.0005851405,"about_ca_topic_score_gemma":0.0009228891,"teacher_disagreement_score":0.017049931,"about_ca_system_score_codex":0.000012008983,"about_ca_system_score_gemma":0.000106941414,"threshold_uncertainty_score":0.4395007},"labels":[],"label_agreement":null},{"id":"W2168887237","doi":"10.1136/annrheumdis-2013-203906","title":"First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"NIH Clinical Center; National Institutes of Health","keywords":"Medicine; Osteoarthritis; WOMAC; Analgesic; Cohort; Arthropathy; Internal medicine; Chondroitin sulfate; Surgery; Anesthesia; Pathology","score_opus":0.03522134770676362,"score_gpt":0.31757741521262145,"score_spread":0.28235606750585784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168887237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410934,0.009533156,5.6757244e-7,0.0008590063,0.00020689641,0.003654475,0.0015757706,0.000012702379,0.000048104877],"genre_scores_gemma":[0.9979995,0.0010418182,0.00005467284,0.00009424262,0.000026829473,0.00034356077,0.00038094007,0.000022722235,0.000035747606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976979,0.00032740913,0.0006850718,0.00034339278,0.0006899407,0.00025629258],"domain_scores_gemma":[0.9963603,0.0009769098,0.0008702269,0.0015115093,0.00018854022,0.00009250954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014229867,0.0003047676,0.0010206072,0.00015241459,0.00009405989,0.000014508959,0.0004573984,0.00008791277,0.00017847997],"category_scores_gemma":[0.0006544579,0.00013940461,0.0003904107,0.00061208685,0.0003450429,0.00015778054,0.000301622,0.0000928889,0.000001845289],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088220596,0.0013917909,0.470366,0.00063517643,0.002011576,0.0000088875995,0.0020000793,0.00004439478,0.0013565866,0.00006201277,0.00027210696,0.5209692],"study_design_scores_gemma":[0.0056184693,0.00956271,0.90962666,0.015321686,0.0031982185,0.0000017778698,0.0004701763,0.00064441387,0.054616086,0.0007537986,0.000017549824,0.00016844281],"about_ca_topic_score_codex":0.0006915647,"about_ca_topic_score_gemma":0.0013650864,"teacher_disagreement_score":0.52080077,"about_ca_system_score_codex":0.00003268582,"about_ca_system_score_gemma":0.00010264191,"threshold_uncertainty_score":0.5684755},"labels":[],"label_agreement":null},{"id":"W2169242706","doi":"10.1136/ard.62.10.999","title":"Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension","year":2003,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Lupus Research Alliance","keywords":"Medicine; Renal artery stenosis; Antiphospholipid syndrome; Renal artery; Internal medicine; Secondary hypertension; Cardiology; Stenosis; Renal Artery Obstruction; Renovascular hypertension; Gastroenterology; Kidney; Thrombosis; Blood pressure","score_opus":0.05344067284753982,"score_gpt":0.27717158216481147,"score_spread":0.22373090931727166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169242706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926121,0.004155247,0.0000047505196,0.0025826395,0.000051984283,0.0002762931,0.000008218853,0.000011089194,0.00029763542],"genre_scores_gemma":[0.9974045,0.0015692747,0.000048647158,0.00087648263,0.000005597135,0.000015062363,0.0000023940283,0.000007469983,0.00007056333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990148,0.00018765022,0.00023852263,0.00013497437,0.00026101148,0.00016306569],"domain_scores_gemma":[0.99923694,0.00018194749,0.00008262806,0.00040305735,0.000043808435,0.00005160867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027929575,0.0001103329,0.00029944352,0.000048785365,0.000060026698,0.000015958325,0.0001282384,0.0000321829,0.000021739103],"category_scores_gemma":[0.00063310144,0.000050014052,0.0001658538,0.000173749,0.00014690422,0.000058494476,0.00003800375,0.00007602344,0.0000066117145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00111483,0.0070651406,0.7945856,0.004971246,0.0018203104,0.0021602635,0.0056314734,0.0001814424,0.004298665,0.0074895993,0.04468853,0.12599292],"study_design_scores_gemma":[0.00059156306,0.00016319341,0.99311894,0.0010215626,0.0001343504,0.00083919254,0.0005655583,0.00004149017,0.0009651564,0.0022335956,0.00024289668,0.000082502],"about_ca_topic_score_codex":0.000022386343,"about_ca_topic_score_gemma":0.0000012190286,"teacher_disagreement_score":0.19853337,"about_ca_system_score_codex":0.000002932199,"about_ca_system_score_gemma":0.00003165796,"threshold_uncertainty_score":0.20395137},"labels":[],"label_agreement":null},{"id":"W2169313581","doi":"10.1136/annrheumdis-2013-204581","title":"Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Gene; Rheumatoid arthritis; Phosphoprotein; Identification (biology); Immunology; Genetics; Biology","score_opus":0.02319148075469311,"score_gpt":0.286422019489785,"score_spread":0.2632305387350919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169313581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98638403,0.010272635,0.00038510872,0.0017235758,0.000108418484,0.0008139863,0.000052388375,0.00004324641,0.00021658458],"genre_scores_gemma":[0.9958795,0.0030779964,0.00017863973,0.0003308151,0.000026335512,0.000036801906,0.00001986717,0.00001977737,0.00043029117],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980651,0.00011677279,0.00082520593,0.00025524417,0.00052675384,0.00021091578],"domain_scores_gemma":[0.99799436,0.000114872026,0.00053909695,0.0008762762,0.00026034215,0.0002150761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003969851,0.00018034576,0.00059317885,0.000058385875,0.00009526839,0.000015628659,0.00021186945,0.000056579258,0.00020136949],"category_scores_gemma":[0.0024210543,0.00012955614,0.00034938272,0.0002539505,0.00026386796,0.00009652705,0.00014165159,0.00007374401,0.000051828705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028774687,0.003735716,0.07782785,0.0047531645,0.0025993986,0.000010565555,0.0031823583,0.00010329755,0.24139912,0.004045756,0.046638764,0.6128265],"study_design_scores_gemma":[0.0017718511,0.00038745778,0.18472531,0.0018242291,0.00012348626,0.000025219733,0.00030088934,0.0003077483,0.7888244,0.021259874,0.00022754428,0.00022199492],"about_ca_topic_score_codex":0.0009574064,"about_ca_topic_score_gemma":0.000024292616,"teacher_disagreement_score":0.61260456,"about_ca_system_score_codex":0.000012131534,"about_ca_system_score_gemma":0.0001645084,"threshold_uncertainty_score":0.5283146},"labels":[],"label_agreement":null},{"id":"W2169389668","doi":"10.1136/ard.2008.094839","title":"Cardiovascular morbidity in psoriatic arthritis","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":304,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Angina; Myocardial infarction; Diabetes mellitus; Population; Heart failure; Psoriasis; Disease; Cardiology; Dermatology","score_opus":0.05310247159574994,"score_gpt":0.28796048156037823,"score_spread":0.2348580099646283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169389668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556849,0.042538464,0.0000027574736,0.0006054868,0.0001405032,0.0003429435,0.00003507386,0.000017848988,0.0006320478],"genre_scores_gemma":[0.9793395,0.020277852,0.000037313857,0.00015887096,0.00002453305,0.000040845694,0.000005896247,0.000011274342,0.00010392728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998938,0.00006097657,0.00028565695,0.00014699818,0.0003689769,0.0001993682],"domain_scores_gemma":[0.99921745,0.000060221384,0.000072166236,0.00050074793,0.000066447916,0.00008297508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000869591,0.00011913681,0.0005084342,0.00005067675,0.00008978388,0.0000033663512,0.0000924738,0.000025789428,0.00006984991],"category_scores_gemma":[0.00036116777,0.00008039748,0.00050683453,0.00020260333,0.00014049311,0.000049715407,0.00006105992,0.000051510087,0.000022976868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032700726,0.0032393776,0.6529697,0.00081585266,0.004256499,0.00072199135,0.0016992458,0.00022608344,0.0000072742378,0.00046075814,0.017129833,0.31814638],"study_design_scores_gemma":[0.0022980003,0.0001037995,0.9944519,0.0010306461,0.0001503534,0.000078576384,0.0001234273,0.000027605862,0.00017471878,0.00078777963,0.0006861919,0.00008701371],"about_ca_topic_score_codex":0.00047595598,"about_ca_topic_score_gemma":0.000031004143,"teacher_disagreement_score":0.3414822,"about_ca_system_score_codex":0.000013684081,"about_ca_system_score_gemma":0.00006477629,"threshold_uncertainty_score":0.3278514},"labels":[],"label_agreement":null},{"id":"W2169532722","doi":"10.1136/annrheumdis-2015-207526","title":"Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Versus Arthritis","keywords":"Medicine; MEDLINE; Systematic review; Rheumatoid arthritis; Evidence-based medicine; Intensive care medicine; Physical therapy; Clinical trial; Disease; Inclusion and exclusion criteria; Randomized controlled trial; Alternative medicine; Internal medicine; Pathology","score_opus":0.17165359232471186,"score_gpt":0.42243804645319505,"score_spread":0.25078445412848316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169532722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019782444,0.9874499,0.000055270688,0.0006868686,0.00017887549,0.00800545,0.003296534,0.00004522687,0.00008403859],"genre_scores_gemma":[0.0010244693,0.9962428,0.00082562416,0.00006535635,0.00006079072,0.0011347646,0.00026554038,0.00010299659,0.0002776225],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99204254,0.0016901346,0.0034634352,0.000578015,0.001536168,0.00068971375],"domain_scores_gemma":[0.98957914,0.004452567,0.00178087,0.0018238673,0.0016939357,0.0006695956],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004747305,0.00064810895,0.0067097517,0.0005508716,0.00015084747,0.00014304272,0.0010111228,0.00020890152,0.000039816317],"category_scores_gemma":[0.03387176,0.0003680804,0.002383366,0.001085143,0.00025290134,0.00023804832,0.0003147716,0.00032998485,0.000040937688],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041863567,0.00024462873,0.0000053021176,0.51564074,0.0012732283,0.00001277865,0.00082380156,0.0000059133513,6.3350524e-7,0.00023891687,0.01219708,0.46913835],"study_design_scores_gemma":[0.0010285267,0.00053225784,0.00000879866,0.94577605,0.00021493825,0.00015935519,0.0001980826,0.000062558436,0.000031791475,0.00050611346,0.05117933,0.0003022312],"about_ca_topic_score_codex":0.00004157253,"about_ca_topic_score_gemma":0.0000055395885,"teacher_disagreement_score":0.46883613,"about_ca_system_score_codex":0.00005863643,"about_ca_system_score_gemma":0.0014262266,"threshold_uncertainty_score":0.9998771},"labels":[],"label_agreement":null},{"id":"W2169537705","doi":"10.1136/annrheumdis-2011-201087","title":"Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Mount Sinai Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Tocilizumab; Rheumatoid arthritis; Rheumatology; Internal medicine; Adverse effect; TNF inhibitor; Tumor necrosis factor alpha; Physical therapy; Adalimumab","score_opus":0.06343954309124501,"score_gpt":0.4085865289842006,"score_spread":0.3451469858929556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169537705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755395,0.004888237,0.000003964972,0.0032893876,0.00011686612,0.0038319174,0.00020528265,0.000022337437,0.00008804927],"genre_scores_gemma":[0.98799586,0.010155138,0.0003726672,0.0010274597,0.000027640093,0.00030504365,0.0000081497565,0.000037961683,0.00007005009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964087,0.00094989035,0.00080614875,0.0004012757,0.000811296,0.0006226624],"domain_scores_gemma":[0.99639124,0.0014015258,0.0002569799,0.0006111612,0.0005019244,0.0008371645],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016675325,0.0002783495,0.0008299684,0.00021907222,0.00018693352,0.00012472562,0.00030479612,0.00005846553,0.00003939308],"category_scores_gemma":[0.01460567,0.0001720384,0.00004734594,0.0006084661,0.00019709405,0.00087094645,0.0007724512,0.00022868851,0.000015710875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040264066,0.014118967,0.46749687,0.00010940571,0.00049094093,0.000021475465,0.006483637,2.8567945e-7,0.0000011664052,0.00019352256,0.004512096,0.46630755],"study_design_scores_gemma":[0.018444268,0.007541556,0.96014476,0.0041690245,0.000022287613,0.000021799566,0.0066790553,0.000005724884,0.000040737516,0.000113962415,0.0025592765,0.00025756698],"about_ca_topic_score_codex":0.00039550598,"about_ca_topic_score_gemma":0.00027195268,"teacher_disagreement_score":0.49264786,"about_ca_system_score_codex":0.000028138269,"about_ca_system_score_gemma":0.00033993332,"threshold_uncertainty_score":0.9936947},"labels":[],"label_agreement":null},{"id":"W2169713004","doi":"10.1136/ard.2008.090019","title":"Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Methotrexate; Infliximab; Rheumatoid arthritis; TNF inhibitor; Blockade; Internal medicine; Tumor necrosis factor alpha; Arthritis; Antirheumatic Agents; Etanercept; Immunology; Gastroenterology","score_opus":0.03063950296592316,"score_gpt":0.29215128248307015,"score_spread":0.261511779517147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169713004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659325,0.03076356,0.000011119252,0.0020977585,0.000026893089,0.00091130874,0.0002264552,0.000025340858,0.0000050890003],"genre_scores_gemma":[0.7441161,0.25565314,0.00004718375,0.00007174919,0.0000054263674,0.00005584525,0.000012241677,0.000029802306,0.000008495479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975698,0.0005187916,0.0004520459,0.00032879531,0.0006781115,0.00045247952],"domain_scores_gemma":[0.99774927,0.0007284001,0.0004246166,0.00047598165,0.00017306572,0.00044865682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002795538,0.00034756534,0.00085978827,0.00026812052,0.00024824397,0.000041987532,0.00020134058,0.000048899703,0.000028822637],"category_scores_gemma":[0.0005822665,0.00018074538,0.00016322733,0.00038950722,0.0008051501,0.00020497991,0.00013152603,0.00019818012,2.362768e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004296915,0.00081729895,0.9112337,0.0006365855,0.00051409437,0.000016244509,0.005710017,0.00003165225,0.0018079132,0.000017515242,0.00011993418,0.074798115],"study_design_scores_gemma":[0.004790225,0.00058982935,0.9792874,0.004502581,0.00001936078,0.000018004088,0.00034793874,0.0006852015,0.009058333,0.00046793587,0.000031499192,0.00020171446],"about_ca_topic_score_codex":0.00046954548,"about_ca_topic_score_gemma":0.00010688487,"teacher_disagreement_score":0.22488959,"about_ca_system_score_codex":0.000019162315,"about_ca_system_score_gemma":0.00014063746,"threshold_uncertainty_score":0.7370583},"labels":[],"label_agreement":null},{"id":"W2169773326","doi":"10.1136/annrheumdis-2014-206624","title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":890,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Memorial University of Newfoundland; Innovaderm (Canada); St Joseph's Health Care; Western University; University of Toronto; University of British Columbia; Hôpital Saint-Luc; Hôpital du Sacré-Cœur de Montréal; Lynde Centre for Dermatology; University of Alberta; Université de Montréal; Hôpital Notre-Dame","funders":"British Association of Dermatologists","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Rheumatoid arthritis; Methotrexate; Dermatology; Etanercept; Meta-analysis; Arthritis; Tumor necrosis factor alpha; Inflammatory arthritis; Antirheumatic Agents; Internal medicine; Immunology","score_opus":0.036377180542002285,"score_gpt":0.31864808034910186,"score_spread":0.2822708998070996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169773326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016729077,0.9757345,0.0000021333935,0.00016697895,0.000120406,0.0069092927,0.00030995943,0.000022188106,0.0000055132605],"genre_scores_gemma":[0.035350945,0.9632368,0.000014960711,0.000068473964,0.000013539895,0.0011752617,0.000027860326,0.00008431125,0.000027826714],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9910447,0.0031111073,0.0029104576,0.00073742593,0.0015807375,0.000615583],"domain_scores_gemma":[0.9930625,0.0026297693,0.0017696383,0.001653119,0.00036659313,0.0005183553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026746052,0.0009406689,0.013154258,0.00055189966,0.00020589167,0.00011203556,0.00048183696,0.00019891534,0.000010817134],"category_scores_gemma":[0.003837725,0.00050648005,0.0037099873,0.00088877697,0.00054625166,0.00022130014,0.0003777703,0.0004229973,0.000004057104],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004015015,0.00023959271,0.00011024673,0.70608693,0.14050883,0.00001931445,0.00040570548,7.7134723e-7,6.8958747e-7,0.00002060242,0.00019252417,0.15237463],"study_design_scores_gemma":[0.0030866219,0.0006005155,0.0017288745,0.79790395,0.19342092,0.00016459095,0.00025282794,0.000017159824,0.00003532881,0.00034914076,0.001560529,0.0008795678],"about_ca_topic_score_codex":0.00012466768,"about_ca_topic_score_gemma":0.000027593833,"teacher_disagreement_score":0.15149505,"about_ca_system_score_codex":0.00004188048,"about_ca_system_score_gemma":0.00031060973,"threshold_uncertainty_score":0.9997387},"labels":[],"label_agreement":null},{"id":"W2170079635","doi":"10.1136/annrheumdis-2011-200972","title":"A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Rottapharm|Madaus; McMaster University","keywords":"Medicine; Osteoarthritis; WOMAC; Population; Viscosupplementation; Randomized controlled trial; Hyaluronic acid; Internal medicine; Intention-to-treat analysis; Surgery; Physical therapy; Intra articular; Gastroenterology; Pathology","score_opus":0.029363126258520618,"score_gpt":0.2986104061503155,"score_spread":0.26924727989179487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170079635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791665,0.012832731,0.00007351675,0.00040092788,0.0003417848,0.0065939715,0.000025937745,0.000063066116,0.00050157355],"genre_scores_gemma":[0.9976215,0.00012413797,0.00005051357,0.00013763786,0.000059603924,0.0018157907,0.00006005668,0.000039211587,0.00009158646],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99751985,0.00029277685,0.00093549996,0.00024308154,0.00044463293,0.00056414027],"domain_scores_gemma":[0.9984018,0.0002529316,0.0003509957,0.0006217023,0.000075945434,0.00029659653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038935296,0.00034223028,0.0012216517,0.00013869797,0.00012050152,0.000048193815,0.00018861171,0.000069616515,0.000108561166],"category_scores_gemma":[0.00025358482,0.00022738641,0.00062720745,0.00023388582,0.000107919775,0.00025524365,0.00008978873,0.00013054286,0.000018334966],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9252939,0.008258844,0.0066466257,0.0007982144,0.0022175277,0.000031065298,0.0029564,0.00018670669,0.016192775,0.0032230916,0.0004379075,0.033756923],"study_design_scores_gemma":[0.95831245,0.0013523633,0.0003819088,0.0016303936,0.00087932515,0.000023959756,0.0001963005,0.0008199629,0.035484172,0.0006152587,0.000029366629,0.0002745315],"about_ca_topic_score_codex":0.000017035693,"about_ca_topic_score_gemma":0.000013436236,"teacher_disagreement_score":0.03348239,"about_ca_system_score_codex":0.000039944338,"about_ca_system_score_gemma":0.00009873844,"threshold_uncertainty_score":0.92725486},"labels":[],"label_agreement":null},{"id":"W2170350220","doi":"10.1136/ard.2008.101675","title":"Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; Genentech; National Institutes of Health; Versus Arthritis; National Institute for Health and Care Research; Biogen","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Internal medicine; Rheumatology; Surgery; Immunology; Lymphoma","score_opus":0.03306602984099796,"score_gpt":0.3077833391413956,"score_spread":0.2747173093003976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170350220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675478,0.029634267,0.000004897252,0.001576575,0.000084536376,0.0006860744,0.00007710968,0.0000266722,0.00036210075],"genre_scores_gemma":[0.9016459,0.09804655,0.000073728144,0.00014399368,0.000007425889,0.00002501629,0.000026278922,0.000010941276,0.000020156724],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99804974,0.00020105833,0.0007110123,0.00021066383,0.00046421145,0.00036333254],"domain_scores_gemma":[0.9988509,0.0002296556,0.00020769337,0.00045217108,0.00011518481,0.000144405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020837197,0.00021422707,0.0008135863,0.00014105989,0.000085197156,0.0000152418515,0.00021808951,0.00005842321,0.000119037955],"category_scores_gemma":[0.00055630587,0.00012654907,0.0005269468,0.0002705271,0.00020768947,0.00012247656,0.000043268148,0.000076802346,0.000008899966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012470019,0.006445314,0.34290066,0.000069159505,0.00048583042,0.000013385827,0.0014296421,0.000009058436,0.00018729219,0.0013135589,0.00049637374,0.6454027],"study_design_scores_gemma":[0.008520288,0.0018105957,0.9762266,0.0033674983,0.000007038638,0.0000056914037,0.00040257737,0.00003716653,0.0021077206,0.006641171,0.00070534734,0.00016830693],"about_ca_topic_score_codex":0.00011700082,"about_ca_topic_score_gemma":0.000017058785,"teacher_disagreement_score":0.6452344,"about_ca_system_score_codex":0.000026813705,"about_ca_system_score_gemma":0.00011715802,"threshold_uncertainty_score":0.5160521},"labels":[],"label_agreement":null},{"id":"W2170503153","doi":"10.1136/ard.2007.082784","title":"A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Single-nucleotide polymorphism; Genotype; SNP; TLR2; Allele; Haplotype; Genotype frequency; Medicine; Immunology; Population; Allele frequency; Pathogenesis; Innate immune system; Immune system; Genetics; Biology; Gene","score_opus":0.03833242038209197,"score_gpt":0.27320747709532345,"score_spread":0.23487505671323147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170503153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485445,0.0017743418,0.000027275419,0.0014771108,0.000087319684,0.0006484201,0.0004085462,0.00002818617,0.000694332],"genre_scores_gemma":[0.99866956,0.0000588704,0.0001331899,0.00045230528,0.0000411214,0.000039942926,0.000037265552,0.000025968578,0.00054178387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824935,0.00004815312,0.00048443416,0.00020733547,0.00067264814,0.00033807053],"domain_scores_gemma":[0.9986634,0.0001850822,0.0004055571,0.0003313269,0.00026489986,0.00014973368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002432862,0.00020553153,0.0005443154,0.00009619587,0.00014559452,0.000008374175,0.00010549948,0.000055820547,0.00028489903],"category_scores_gemma":[0.00037669862,0.00013521423,0.00028602275,0.00027535713,0.00026438912,0.00007235193,0.000065440596,0.00008245361,0.0000070472324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06312733,0.017982578,0.567285,0.0021824108,0.021836488,0.0010099403,0.00839381,0.00002268198,0.011636188,0.011682397,0.029136363,0.2657048],"study_design_scores_gemma":[0.008399223,0.002022794,0.96272564,0.004990505,0.00039477693,0.000044227876,0.0010012757,0.0000107865035,0.019095037,0.00084521074,0.00022986144,0.00024067958],"about_ca_topic_score_codex":0.00015544656,"about_ca_topic_score_gemma":0.00005395544,"teacher_disagreement_score":0.39544064,"about_ca_system_score_codex":0.00003067613,"about_ca_system_score_gemma":0.00015266411,"threshold_uncertainty_score":0.5513876},"labels":[],"label_agreement":null},{"id":"W2170524712","doi":"10.1136/annrheumdis-2011-200831","title":"Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources","keywords":"Belimumab; Medicine; Mucocutaneous zone; Placebo; Internal medicine; Systemic lupus erythematosus; B-cell activating factor; Clinical trial; Lupus erythematosus; Immunology; Gastroenterology; Disease; B cell; Antibody; Pathology","score_opus":0.03945405308968634,"score_gpt":0.3378727717348145,"score_spread":0.29841871864512814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170524712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890114,0.0034299793,0.000023538538,0.00010919261,0.0005513934,0.0052167703,0.0015758771,0.00006910104,0.000012721768],"genre_scores_gemma":[0.9990879,0.00027443547,0.000024363004,0.00004203518,0.00010831515,0.00017713393,0.00013471124,0.00009755134,0.000053547054],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9933028,0.00144652,0.0018706648,0.0005789185,0.0019081768,0.0008928785],"domain_scores_gemma":[0.9887231,0.006636769,0.0016223098,0.0017796286,0.00043774044,0.0008004517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017728116,0.0005663505,0.0023363333,0.00026503383,0.00015508525,0.00004033133,0.0005273039,0.00012216662,0.000020566253],"category_scores_gemma":[0.0065360395,0.0003439177,0.00053724553,0.0007017238,0.00036782864,0.00031921294,0.00027515643,0.00021592475,0.000023191169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2636253,0.015568816,0.69839776,0.0076772384,0.001337708,0.00003519673,0.006370497,0.00019304219,0.0012752679,0.00005135977,0.0010014713,0.00446639],"study_design_scores_gemma":[0.5080668,0.0022003527,0.3975124,0.05621329,0.00089427654,0.00006499931,0.0014021798,0.0010296545,0.031546164,0.00019808939,0.000023644896,0.00084816973],"about_ca_topic_score_codex":0.0002706787,"about_ca_topic_score_gemma":0.000010018895,"teacher_disagreement_score":0.30088532,"about_ca_system_score_codex":0.00027970358,"about_ca_system_score_gemma":0.00037712097,"threshold_uncertainty_score":0.9999013},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2170961028","doi":"10.1136/annrheumdis-2011-201063","title":"A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis","year":2012,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sunnybrook Health Science Centre; Health Sciences Centre; Centre Hospitalier de l’Université de Montréal","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Referral; Triage; Rheumatology; Rheumatism; Family medicine; Internal medicine; MEDLINE; Systematic review; Physical therapy; Intensive care medicine; Medical emergency","score_opus":0.06518033683504501,"score_gpt":0.3556229483372776,"score_spread":0.2904426115022326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170961028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0121947555,0.9837711,2.9715153e-7,0.00016964338,0.000032888944,0.0036669069,0.0000764178,0.0000072827083,0.00008074732],"genre_scores_gemma":[0.019355386,0.97987425,0.000032936357,0.000025938785,0.00001339154,0.0006482223,0.00001686479,0.000025354651,0.000007637587],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965641,0.0008695482,0.0014988622,0.00020617721,0.0005844941,0.00027685653],"domain_scores_gemma":[0.997495,0.00054764433,0.0010507208,0.00065313815,0.00014806967,0.00010540229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014631496,0.00030806195,0.002247751,0.00017850287,0.00005723529,0.000057565165,0.00031558512,0.00007833868,0.000011549889],"category_scores_gemma":[0.00046123224,0.0001571176,0.00040245015,0.00039624554,0.00028047845,0.00022303105,0.00016950355,0.00022324352,7.0864706e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007876762,0.00011775134,0.00012704045,0.757402,0.0005311724,0.000011551931,0.0012507022,3.86039e-8,6.661688e-8,0.000716862,0.00007452321,0.23976041],"study_design_scores_gemma":[0.00024512826,0.00011765197,0.001469569,0.9956311,0.0004869493,0.00010752815,0.0006347951,0.0000014709204,0.0000012555038,0.00022098512,0.00096375943,0.00011980954],"about_ca_topic_score_codex":0.000021451306,"about_ca_topic_score_gemma":0.0000036972483,"teacher_disagreement_score":0.2396406,"about_ca_system_score_codex":0.000008713449,"about_ca_system_score_gemma":0.00011278845,"threshold_uncertainty_score":0.640707},"labels":[],"label_agreement":null},{"id":"W2171108647","doi":"10.1136/ard.2007.069609","title":"Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Antagonism; Connective tissue disease; Pulmonary hypertension; Pharmacology; Connective tissue; Receptor; Internal medicine; Disease; Pathology; Autoimmune disease","score_opus":0.03773525095748122,"score_gpt":0.308317861028312,"score_spread":0.2705826100708308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171108647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939181,0.0006171463,0.00011178042,0.0022796872,0.00009733866,0.002030462,0.0006818732,0.000056639194,0.00020694661],"genre_scores_gemma":[0.9983863,0.000109345296,0.00013913253,0.000503979,0.00005687772,0.00010312171,0.00025232683,0.00004731616,0.00040158883],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99810165,0.00010615785,0.00031415536,0.00035412365,0.0006233094,0.0005006086],"domain_scores_gemma":[0.9974257,0.0006824586,0.00024887096,0.00041995867,0.00070095086,0.00052211236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020361741,0.00027348805,0.00054150436,0.000112255926,0.0002448528,0.000017396904,0.00014796988,0.000054058753,0.000044943794],"category_scores_gemma":[0.00092537573,0.00014540661,0.00017846927,0.00029755972,0.00022352382,0.00013273337,0.000048850226,0.00009617374,0.000008774113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36842772,0.063229255,0.31341076,0.0034374543,0.020210259,0.007844375,0.0010966782,0.000105026214,0.0993763,0.001135858,0.02862495,0.093101345],"study_design_scores_gemma":[0.008559278,0.0042850743,0.92634827,0.0030336156,0.001281603,0.00018102342,0.00076104875,0.00053451775,0.05260509,0.001703772,0.00024862756,0.00045805768],"about_ca_topic_score_codex":0.000054828648,"about_ca_topic_score_gemma":0.0000112364305,"teacher_disagreement_score":0.61293757,"about_ca_system_score_codex":0.000055663695,"about_ca_system_score_gemma":0.0003221758,"threshold_uncertainty_score":0.59295094},"labels":[],"label_agreement":null},{"id":"W2171240688","doi":"10.1136/ard.2003.018184","title":"Dactylitis in psoriatic arthritis: a marker for disease severity?","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Dactylitis; Medicine; Psoriatic arthritis; Population; Dermatology; Radiological weapon; Internal medicine; Psoriasis; Surgery; Enthesitis","score_opus":0.029245908553658908,"score_gpt":0.3057810801382336,"score_spread":0.2765351715845747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171240688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977649,0.014362488,0.00002359203,0.005915635,0.00018137877,0.0011559168,0.00042460253,0.000026221906,0.00026120673],"genre_scores_gemma":[0.9958206,0.0028512874,0.00017460877,0.00066475203,0.000028520539,0.00026732677,0.000033033226,0.000020420586,0.00013945892],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99885523,0.00003256218,0.00036886192,0.00019725131,0.00025703717,0.00028903247],"domain_scores_gemma":[0.9990935,0.00011629398,0.00012041269,0.00039579134,0.000086777756,0.00018728082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088961126,0.00016081189,0.00041572785,0.00006272199,0.000085834,0.000013573424,0.00010950144,0.000026515121,0.00007004533],"category_scores_gemma":[0.00064622925,0.000114325754,0.00032291978,0.00017300855,0.00010830683,0.00008967581,0.00006030352,0.00004358957,0.000010524098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00518792,0.010038434,0.31691083,0.0048280857,0.002146603,0.00032753038,0.001607475,0.00017702137,0.000010788697,0.008737049,0.00960436,0.6404239],"study_design_scores_gemma":[0.006449966,0.00018135365,0.957021,0.004409562,0.00019743251,0.000010401049,0.00019361927,0.000051459974,0.00006213104,0.030791556,0.0004913419,0.00014018978],"about_ca_topic_score_codex":0.0001394394,"about_ca_topic_score_gemma":0.00007026206,"teacher_disagreement_score":0.6402837,"about_ca_system_score_codex":0.000031608186,"about_ca_system_score_gemma":0.00015698391,"threshold_uncertainty_score":0.46620688},"labels":[],"label_agreement":null},{"id":"W2171249245","doi":"10.1136/ard.2009.108217","title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":943,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Toronto Western Hospital","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Axial spondyloarthritis; Expert opinion; Ankylosing spondylitis; Family medicine; Sacroiliitis; Medical physics; Intensive care medicine; Surgery","score_opus":0.07912323226440239,"score_gpt":0.3997982788249223,"score_spread":0.3206750465605199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171249245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901726,0.0030890992,0.0003000278,0.003057315,0.0007933342,0.0011934825,0.0010074631,0.000016654245,0.00036999283],"genre_scores_gemma":[0.9943127,0.0031979885,0.0015100496,0.000092686685,0.000050027036,0.00015034131,0.0006427697,0.000015178573,0.000028242976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975672,0.00008462359,0.0011801242,0.00024790093,0.00069251837,0.00022765061],"domain_scores_gemma":[0.997416,0.0004114689,0.0009777268,0.00039606148,0.00072311726,0.00007561336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003893736,0.0002047295,0.0005045133,0.000052375868,0.00024162016,0.00001602295,0.00027542544,0.000070337854,0.00003886481],"category_scores_gemma":[0.0005213458,0.00014121011,0.00039292942,0.00016755049,0.0002716309,0.00015150958,0.00008435733,0.000059940972,4.2818294e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023297693,0.007268649,0.051048428,0.00085879327,0.0017794911,3.753114e-7,0.003972243,0.000017101236,0.019998765,0.005170821,0.06437873,0.84317684],"study_design_scores_gemma":[0.0059865983,0.0009453527,0.9635411,0.0031178948,0.00011194813,0.0000016661493,0.0020822743,0.0010504412,0.0059914007,0.0006607205,0.016279137,0.00023146588],"about_ca_topic_score_codex":0.00001811101,"about_ca_topic_score_gemma":0.0000086149175,"teacher_disagreement_score":0.9124927,"about_ca_system_score_codex":0.000062893356,"about_ca_system_score_gemma":0.00021170516,"threshold_uncertainty_score":0.57583815},"labels":[],"label_agreement":null},{"id":"W2171632731","doi":"10.1136/ard.2008.092288","title":"Hsp90β and p130cas: novel regulatory factors of MMP-13 expression in human osteoarthritic chondrocytes","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Gene silencing; Small interfering RNA; Chondrocyte; Molecular biology; Matrix metalloproteinase; Gene expression; Cell biology; Transfection; Biology; Gene; In vitro; Biochemistry","score_opus":0.04554755020667528,"score_gpt":0.2861397436180294,"score_spread":0.24059219341135413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171632731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455124,0.0045848745,0.0000022034476,0.000099303434,0.00006767833,0.0004183267,0.0000535694,0.000020163885,0.00020263872],"genre_scores_gemma":[0.9990781,0.00045235985,0.00007695569,0.000056762947,0.000011753423,0.000018352275,0.000020577128,0.000018909628,0.00026625718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883807,0.00004418022,0.00041810484,0.00018059042,0.0003222718,0.0001967785],"domain_scores_gemma":[0.9990647,0.00014001588,0.0001983649,0.00039651035,0.00006834627,0.00013208493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006870055,0.0001728233,0.00047340422,0.00012367124,0.00008978421,0.0000047812982,0.000107608386,0.000058406433,0.000055611777],"category_scores_gemma":[0.0002233376,0.000115909956,0.00016438811,0.00012359915,0.0002429363,0.000119810116,0.000071922266,0.000061246355,0.000001416009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007430434,0.00514723,0.6520144,0.00347915,0.0002527948,0.000070828995,0.00757233,0.000028424593,0.30377772,0.0019021326,0.0013907705,0.02362122],"study_design_scores_gemma":[0.0047514946,0.0010959285,0.66521484,0.0065256916,0.00012094415,0.00003806297,0.0009115264,0.000011047689,0.31981507,0.001290141,0.000029326238,0.0001959588],"about_ca_topic_score_codex":0.000038491187,"about_ca_topic_score_gemma":0.000019683066,"teacher_disagreement_score":0.02342526,"about_ca_system_score_codex":0.000009399102,"about_ca_system_score_gemma":0.00006909146,"threshold_uncertainty_score":0.47266707},"labels":[],"label_agreement":null},{"id":"W2173403513","doi":"10.1136/annrheumdis-2015-207980","title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Waterloo; Toronto Western Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psoriatic arthritis; Incidence (geometry); Internal medicine; Dermatology; Arthritis; Psoriasis","score_opus":0.02307923712219121,"score_gpt":0.2602273872894322,"score_spread":0.23714815016724097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173403513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668796,0.012021381,0.00001030572,0.00018395118,0.00008258352,0.00091307744,0.00006968902,0.000008964912,0.00002211516],"genre_scores_gemma":[0.9989705,0.0007174367,0.0000983959,0.000061561754,0.000010280559,0.00009863268,0.000014412049,0.000011758673,0.000017017244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908,0.00003698128,0.0002103623,0.00014380387,0.0003692275,0.00015964602],"domain_scores_gemma":[0.99930006,0.000060124134,0.0000838125,0.00027567288,0.00015855233,0.000121799814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011878515,0.00011059503,0.00038577142,0.000040758485,0.000040720897,0.0000039314714,0.0000615201,0.00002002599,0.0000031104191],"category_scores_gemma":[0.00050521357,0.00006683865,0.00016207682,0.00010898389,0.00007194525,0.00007491856,0.00005096787,0.000025537789,0.0000010830067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036262398,0.00036965567,0.9732683,0.00016686048,0.0007386481,0.0000020672592,0.00025603065,0.000020451545,2.2907773e-8,0.000032352054,0.000338286,0.02444473],"study_design_scores_gemma":[0.0070433705,0.0006050084,0.98902625,0.0016398825,0.00027301663,0.000002260452,0.00015678635,0.00001566759,0.0000067587325,0.0010993335,0.00006391649,0.00006772544],"about_ca_topic_score_codex":0.00009908401,"about_ca_topic_score_gemma":0.000023843113,"teacher_disagreement_score":0.024377003,"about_ca_system_score_codex":0.000015236561,"about_ca_system_score_gemma":0.000059086302,"threshold_uncertainty_score":0.2725601},"labels":[],"label_agreement":null},{"id":"W2178132676","doi":"10.1136/annrheumdis-2015-208174","title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Comorbidity; Cross-sectional study; Osteoporosis; Internal medicine; Risk factor; Physical therapy; Pathology","score_opus":0.1454583651299389,"score_gpt":0.3821347507967657,"score_spread":0.23667638566682678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178132676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939727,0.0041429517,7.7182943e-7,0.00019911659,0.00015740347,0.00062377093,0.0005883133,0.0000035540754,0.00031139026],"genre_scores_gemma":[0.9995225,0.00031350786,0.000025901583,0.0000138904725,0.000011720659,0.000029532623,0.000008513504,0.0000061873525,0.00006824342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998113,0.00016800573,0.00059481285,0.00013580032,0.0008979929,0.000090424895],"domain_scores_gemma":[0.99825746,0.00021906402,0.00047139148,0.00030714256,0.00070732465,0.000037635993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092068367,0.0001003249,0.00029641675,0.00006438681,0.000039746184,0.000007113764,0.00018930466,0.000022687289,0.000024313835],"category_scores_gemma":[0.0014468713,0.000060059807,0.000115188064,0.00014218487,0.0003280682,0.0000902947,0.00017124637,0.000047120808,2.1427891e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071134797,0.0008930445,0.9919839,0.00018120682,0.00026587103,6.8246294e-7,0.0015427654,0.00022834279,0.000018200806,0.000057789628,0.00012211701,0.0039947294],"study_design_scores_gemma":[0.0052480255,0.0003384721,0.9877803,0.0015483559,0.000117782816,0.0000060972807,0.0023733408,0.0004384801,0.0010613422,0.0010417423,0.000004240767,0.00004186301],"about_ca_topic_score_codex":0.00033554347,"about_ca_topic_score_gemma":0.00008073294,"teacher_disagreement_score":0.005549775,"about_ca_system_score_codex":0.000013928382,"about_ca_system_score_gemma":0.00012503543,"threshold_uncertainty_score":0.24491678},"labels":[],"label_agreement":null},{"id":"W2206432491","doi":"10.1136/annrheumdis-2015-207524","title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1458,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; Montreal Clinical Research Institute","funders":"Versus Arthritis; Medizinische Universität Wien; Universität Wien","keywords":"Medicine; Task force; Rheumatoid arthritis; Task (project management); Physical therapy; Immunology; Management","score_opus":0.05683045475796395,"score_gpt":0.3824648529613987,"score_spread":0.32563439820343476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2206432491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014986371,0.9910217,0.000031236323,0.0022505347,0.00039974632,0.0015650986,0.0024987438,0.000021896385,0.0007124172],"genre_scores_gemma":[0.0033169982,0.99525076,0.0004920609,0.00009991898,0.00004113257,0.0001540397,0.00031175144,0.00005527747,0.0002780394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571836,0.00085606804,0.0018409878,0.00030057025,0.000966203,0.00031783432],"domain_scores_gemma":[0.9955598,0.00054650014,0.0016315642,0.0012568326,0.00068838696,0.00031688274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012748799,0.0003558231,0.002361762,0.0002686858,0.00011500649,0.0000377166,0.0011325087,0.00009763329,0.00037906348],"category_scores_gemma":[0.003502503,0.000197354,0.0012236723,0.0004136079,0.00030420945,0.0002228681,0.00037904992,0.0002206809,0.00002915664],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050167513,0.00041451355,0.00010464781,0.0031303244,0.001006255,0.000001312514,0.00031818077,0.000010522725,0.0000016810075,0.0008469501,0.021989323,0.9721261],"study_design_scores_gemma":[0.00082827493,0.00027332926,0.00030309713,0.10963277,0.00012946514,0.00008734498,0.00031680716,0.00008895969,0.00009609376,0.002704597,0.88526404,0.00027523603],"about_ca_topic_score_codex":0.0001308526,"about_ca_topic_score_gemma":0.000020530675,"teacher_disagreement_score":0.9718509,"about_ca_system_score_codex":0.000033803877,"about_ca_system_score_gemma":0.000762618,"threshold_uncertainty_score":0.80478626},"labels":[],"label_agreement":null},{"id":"W2209763605","doi":"10.1136/annrheumdis-2015-eular.3592","title":"SAT0560 Serious Infection Events in the Psoriasis Longitudinal Assessment and Registry Study: Current Status of Observations","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Manitoba","funders":"","keywords":"Medicine; Ustekinumab; Adalimumab; Etanercept; Infliximab; Psoriatic arthritis; Internal medicine; Psoriasis; Hazard ratio; Incidence (geometry); Population; Cohort; Cumulative incidence; Proportional hazards model; Cohort study; Disease; Rheumatoid arthritis; Immunology; Confidence interval; Environmental health","score_opus":0.12902274584544143,"score_gpt":0.36466315501737656,"score_spread":0.23564040917193513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209763605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325246,0.0054459902,0.0000075416274,0.00022836296,0.00042536322,0.0004884662,0.000101908496,0.000009340763,0.000040559906],"genre_scores_gemma":[0.9985459,0.0012628296,0.000010338342,0.000016528616,0.000007990342,0.0000767767,0.000041536656,0.0000055393884,0.000032604727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870557,0.000531857,0.0003346548,0.00014113812,0.00010072287,0.00018606304],"domain_scores_gemma":[0.99902016,0.00020151459,0.0002787507,0.00037190766,0.00009894936,0.000028746828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034434753,0.00012533074,0.00025540363,0.000060638766,0.00009020401,0.0000056011218,0.00017690336,0.00003907143,0.000011516775],"category_scores_gemma":[0.00024840835,0.00007343527,0.00009403461,0.00020518292,0.00009501199,0.000090133,0.00008136112,0.00007096547,0.000003082709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008853869,0.0015190089,0.95550656,0.000066325025,0.00028996915,4.2409408e-7,0.0010984108,0.000033133747,0.000019111843,0.00015313065,0.0006756294,0.04054976],"study_design_scores_gemma":[0.0011903502,0.00021912274,0.9957409,0.00015195552,0.00025280198,0.0000030552626,0.0010005125,0.0000057785464,0.0000901131,0.0010591837,0.0002182225,0.0000680214],"about_ca_topic_score_codex":0.0008678238,"about_ca_topic_score_gemma":0.00019844521,"teacher_disagreement_score":0.040481735,"about_ca_system_score_codex":0.000022879642,"about_ca_system_score_gemma":0.00014898651,"threshold_uncertainty_score":0.29946035},"labels":[],"label_agreement":null},{"id":"W2217064679","doi":"10.1136/annrheumdis-2015-208237","title":"2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":895,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging; National Cancer Institute; National Institutes of Health; Agency for Healthcare Research and Quality; Faculty of Medical and Health Sciences, University of Auckland; European League Against Rheumatism; Arthritis New Zealand","keywords":"Medicine; Tophus; Gout; Rheumatology; Rheumatism; Internal medicine; Gold standard (test); Synovial fluid; Radiology; Physical therapy; Hyperuricemia; Pathology; Osteoarthritis; Uric acid; Alternative medicine","score_opus":0.13438101695369384,"score_gpt":0.408770922938034,"score_spread":0.2743899059843402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217064679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005441935,0.97916687,0.000029217872,0.0008946307,0.00046137668,0.0031998504,0.0077187307,0.00012263196,0.002964772],"genre_scores_gemma":[0.035095908,0.9626185,0.00043789635,0.00023767886,0.000041235147,0.00019765763,0.000991138,0.00019087516,0.00018909163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915229,0.0032766974,0.0027227842,0.00077720924,0.0011334064,0.00056697003],"domain_scores_gemma":[0.9896321,0.0009086668,0.0049771476,0.0022505387,0.0016306472,0.00060087105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001302578,0.0009370614,0.0052965023,0.000490624,0.00015527259,0.000031082258,0.0012159755,0.0002563733,0.000074130796],"category_scores_gemma":[0.0037414639,0.00063978054,0.00091513764,0.0017653551,0.0015951588,0.00034346772,0.0003889354,0.0005095528,0.000105208295],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002615599,0.0023814852,0.000598963,0.04231947,0.004682483,0.00004495323,0.0029616437,0.0000058299593,0.0000036709562,0.0010351726,0.1187205,0.8269843],"study_design_scores_gemma":[0.0060063717,0.0040915017,0.014152205,0.34538925,0.021794764,0.0007238552,0.025300505,0.00085722096,0.000043760992,0.0020412093,0.57556266,0.0040366873],"about_ca_topic_score_codex":0.00008228596,"about_ca_topic_score_gemma":0.000009249542,"teacher_disagreement_score":0.82294756,"about_ca_system_score_codex":0.00016789169,"about_ca_system_score_gemma":0.0027188545,"threshold_uncertainty_score":0.99960536},"labels":[],"label_agreement":null},{"id":"W2226515367","doi":"10.1136/annrheumdis-2015-eular.3594","title":"OP0169 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase 3, Randomized, Controlled Trials","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Dactylitis; Medicine; Apremilast; Enthesitis; Psoriatic arthritis; Enthesopathy; Internal medicine; Randomized controlled trial; Placebo; Surgery; Dermatology; Arthritis; Pathology","score_opus":0.0313836493141773,"score_gpt":0.2849350386890698,"score_spread":0.25355138937489247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226515367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947946,0.0019159757,0.000064995045,0.00014941575,0.0001472541,0.0020709117,0.00083006587,0.0000108813465,0.000015899488],"genre_scores_gemma":[0.9982826,0.00030459097,0.000034799617,0.00024842014,0.000028852699,0.00016280987,0.00087542407,0.00002500739,0.000037469134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966824,0.0009901283,0.0012234873,0.00040712394,0.00043204674,0.00026483307],"domain_scores_gemma":[0.9977221,0.00040547366,0.0010069621,0.00042857614,0.0002492074,0.00018770802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014583395,0.00031496625,0.0016026098,0.000092427,0.000055031498,0.00007483594,0.00016386257,0.00011014187,0.000016820217],"category_scores_gemma":[0.0031656844,0.00018324787,0.00019970957,0.00013458196,0.00019169049,0.000056497254,0.00007610733,0.000073223295,6.576184e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7266573,0.006498708,0.20292644,0.00008687117,0.0032032426,0.000016591848,0.0013844924,0.00020475165,0.00030156694,0.000009006278,0.0007925626,0.057918496],"study_design_scores_gemma":[0.65709585,0.001546993,0.33252388,0.0020914844,0.0005061424,8.8588985e-7,0.00013555131,0.00066419214,0.0046780743,0.00038645262,0.0000032972305,0.00036718714],"about_ca_topic_score_codex":0.00032800247,"about_ca_topic_score_gemma":0.0010711948,"teacher_disagreement_score":0.12959746,"about_ca_system_score_codex":0.00002510214,"about_ca_system_score_gemma":0.00014331976,"threshold_uncertainty_score":0.74726313},"labels":[],"label_agreement":null},{"id":"W2230966900","doi":"10.1136/annrheumdis-2015-eular.3324","title":"OP0186 5-Year Organ Damage Accrual and Safety in Patients with Sle Treated with Belimumab Plus Standard of Care","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Belimumab; Internal medicine; Interim analysis; Population; Clinical trial; B-cell activating factor; Immunology","score_opus":0.02360246737543311,"score_gpt":0.2903850696841096,"score_spread":0.2667826023086765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2230966900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728584,0.0007428924,0.0000033649258,0.00020701122,0.00001814334,0.00095715333,0.00023549727,0.000015993297,0.00053412927],"genre_scores_gemma":[0.9996309,0.00006368451,0.00006984006,0.000020504136,0.0000055137334,0.000014119502,0.000039507264,0.000029268067,0.00012664415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819654,0.00013405904,0.00036575837,0.00018556342,0.0008885328,0.00022957113],"domain_scores_gemma":[0.9982359,0.00011647181,0.00019903063,0.0005355105,0.00069165934,0.00022146593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019817929,0.00015971625,0.00063066196,0.00012081707,0.00003465503,0.000012019009,0.00017983554,0.000040233037,0.000029154851],"category_scores_gemma":[0.0004389761,0.000083959625,0.000047028843,0.00034763053,0.00024156291,0.00009557518,0.00011083243,0.00007781625,0.0000021629432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010592672,0.00021382021,0.9815569,0.0018442092,0.00019029064,0.0000060243256,0.0038117776,0.000035592475,0.0000023424134,0.000037255006,0.00064355845,0.0010655461],"study_design_scores_gemma":[0.02934339,0.0046288655,0.9302581,0.01330389,0.00027140163,0.000041011233,0.02064603,0.000085069274,0.0010250917,0.00008975144,0.00005020617,0.0002572064],"about_ca_topic_score_codex":0.0001686369,"about_ca_topic_score_gemma":0.00006350986,"teacher_disagreement_score":0.051298827,"about_ca_system_score_codex":0.00007726756,"about_ca_system_score_gemma":0.0005125037,"threshold_uncertainty_score":0.3423774},"labels":[],"label_agreement":null},{"id":"W2239811432","doi":"10.1136/annrheumdis-2015-eular.3573","title":"SAT0271 Development of a Novel SI Joint CT Score for Diagnosis of Axial Spondylitis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Sacroiliitis; Radiology; Ankylosing spondylitis; Sacroiliac joint; Gold standard (test); Enthesitis; Pelvis; Abdomen; Spondylitis; Radiography; Surgery; Internal medicine; Disease; Psoriatic arthritis","score_opus":0.1643190144286065,"score_gpt":0.33992882265255703,"score_spread":0.17560980822395053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239811432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329716,0.004506062,0.00003921468,0.00061935355,0.00013801457,0.00073297555,0.00048383896,0.000009949914,0.00017341752],"genre_scores_gemma":[0.9977721,0.00028746933,0.0015128491,0.00009354943,0.000017687287,0.00017401864,0.0000326451,0.000016241029,0.0000934133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986855,0.00001994103,0.000576611,0.00014235673,0.00038462284,0.00019098505],"domain_scores_gemma":[0.9986848,0.00016001925,0.00035998653,0.00031404407,0.00033990966,0.00014121621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001661609,0.00014598711,0.0005934792,0.00006635175,0.000051771458,0.000003784294,0.00011479388,0.000019265943,0.00004148853],"category_scores_gemma":[0.0010491959,0.000095371644,0.0002998839,0.00013267485,0.00014555824,0.000041544154,0.000105614185,0.00002429638,0.000002062868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003441035,0.016959278,0.57995415,0.009787281,0.0064260624,0.000026507443,0.0074275746,0.000060644456,0.0002960523,0.0029606568,0.031411637,0.3412491],"study_design_scores_gemma":[0.015445617,0.0015441377,0.91510123,0.012361918,0.0010210066,0.00002905969,0.0019769126,0.00010305093,0.04737133,0.0018279848,0.0028795293,0.00033819894],"about_ca_topic_score_codex":0.000116102674,"about_ca_topic_score_gemma":0.000024590432,"teacher_disagreement_score":0.3409109,"about_ca_system_score_codex":0.000018897515,"about_ca_system_score_gemma":0.0002814169,"threshold_uncertainty_score":0.38891426},"labels":[],"label_agreement":null},{"id":"W2252636341","doi":"10.1136/annrheumdis-2015-207656","title":"Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Ministry of Economic Development and Innovation; Ministero dello Sviluppo Economico; Diamond Light Source; Genome Canada; Wellcome Trust; GlaxoSmithKline; European Commission; Pfizer; Eli Lilly and Company","keywords":"Citrullination; Porphyromonas gingivalis; Autoantibody; Periodontal pathogen; Citrulline; Periodontitis; Autoimmunity; Microbiology; Medicine; Biology; Arginine; Immunology; Biochemistry; Amino acid; Antibody","score_opus":0.054907306226777995,"score_gpt":0.33316384771961033,"score_spread":0.27825654149283235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2252636341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747947,0.018918172,0.00007612669,0.004181482,0.00008590769,0.00088764046,0.00089628657,0.00004307229,0.000116629286],"genre_scores_gemma":[0.990315,0.008885675,0.0004478597,0.0001075527,0.000015561374,0.00006290932,0.00008455528,0.00003703408,0.00004383051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821186,0.00014094701,0.00068519823,0.00019297337,0.00040693747,0.00036207828],"domain_scores_gemma":[0.99785703,0.00028343374,0.00031617814,0.00073409034,0.0005476473,0.00026160074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003100633,0.00019343832,0.000628332,0.00019143806,0.00009348346,0.000021415457,0.0003572801,0.00006198832,0.000077621036],"category_scores_gemma":[0.0019341888,0.00014351326,0.00029371385,0.00037369248,0.0003992761,0.00017195044,0.00012361936,0.00013439075,0.0000023445782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050993017,0.007940177,0.4912669,0.004431359,0.0029031392,0.00002058838,0.014290347,0.00092419406,0.04114777,0.061459467,0.100874595,0.26964214],"study_design_scores_gemma":[0.00765315,0.0010031272,0.88003933,0.0056240163,0.000030872572,0.000104944855,0.0024083906,0.0004724,0.012507153,0.087715656,0.002036697,0.00040423987],"about_ca_topic_score_codex":0.00034417943,"about_ca_topic_score_gemma":0.00008163104,"teacher_disagreement_score":0.38877246,"about_ca_system_score_codex":0.000022449398,"about_ca_system_score_gemma":0.0004639746,"threshold_uncertainty_score":0.5852301},"labels":[],"label_agreement":null},{"id":"W2254729675","doi":"10.1136/annrheumdis-2014-207164","title":"The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Janeway Children's Health and Rehabilitation Centre; University of Toronto; Memorial University of Newfoundland; McMaster University; University of Calgary; SickKids Foundation; London Health Sciences Centre; Western University; Hospital for Sick Children; University of Saskatchewan; Université de Sherbrooke; Izaak Walton Killam Health Centre; Royal University Hospital; BC Children's Hospital; Centre hospitalier de l'Université Laval; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; University of Manitoba; Children's Hospital of Eastern Ontario; McGill University Health Centre; Dalhousie University; University of Ottawa; Alberta Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Juvenile; Cohort; Arthritis; Internal medicine; Genetics","score_opus":0.03153973845795021,"score_gpt":0.3094039139377729,"score_spread":0.2778641754798227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254729675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88749254,0.10514077,0.0000010987645,0.005936646,0.00008515038,0.0005183136,0.00020193867,0.000011410465,0.00061215146],"genre_scores_gemma":[0.98108125,0.018454162,0.0000053540766,0.00019527056,0.000023924325,0.000028852171,0.000017248763,0.000012569574,0.00018135873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790144,0.0004180255,0.00069516053,0.00016832234,0.0006011293,0.00021593248],"domain_scores_gemma":[0.9976912,0.00077203993,0.00037155717,0.0008439274,0.00022546212,0.00009577883],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016638079,0.00012774934,0.00044791293,0.00003694787,0.00013341337,0.000028155902,0.00038635338,0.00008741685,0.000008799248],"category_scores_gemma":[0.009393113,0.000058160203,0.00014021456,0.00016787459,0.0004235398,0.00008848221,0.00019327168,0.00036020836,0.0000067428587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044717337,0.0008080848,0.5949851,0.00046186414,0.0011107335,0.000027446433,0.012518767,0.00007726506,0.00012709711,0.0008898914,0.13458607,0.24993593],"study_design_scores_gemma":[0.0024583745,0.00017328207,0.9737562,0.0029928912,0.00011755862,0.0000039057722,0.0047526094,0.00035276508,0.0008736574,0.010768801,0.0036381816,0.0001117831],"about_ca_topic_score_codex":0.000991268,"about_ca_topic_score_gemma":0.00027824682,"teacher_disagreement_score":0.37877107,"about_ca_system_score_codex":0.000010342893,"about_ca_system_score_gemma":0.00032887096,"threshold_uncertainty_score":0.9989512},"labels":[],"label_agreement":null},{"id":"W2256374136","doi":"10.1136/annrheumdis-2015-eular.2907","title":"THU0420 Long-Term (104-Week) Efficacy and Safety Profile of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomised, Controlled Trial and Open-Label Extension (Palace 1)","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Apremilast; Psoriatic arthritis; Randomized controlled trial; Internal medicine; Placebo; Psoriasis; Rheumatology; Gastroenterology; Rheumatoid arthritis; Dermatology","score_opus":0.05224593430081605,"score_gpt":0.33392307293213785,"score_spread":0.2816771386313218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256374136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800677,0.011237676,0.000006616945,0.0003211381,0.00012486824,0.0077099083,0.00047121127,0.000018855913,0.00004202745],"genre_scores_gemma":[0.99378216,0.005497262,0.00015357877,0.00007237323,0.000029463923,0.00019810829,0.00020724007,0.000029098746,0.00003073651],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968121,0.0005579536,0.0011606786,0.0004224093,0.0007111411,0.0003357172],"domain_scores_gemma":[0.9970839,0.0008066266,0.0005816611,0.0006245391,0.00041251112,0.0004907306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009152463,0.0002998782,0.0015237135,0.00011882711,0.000100279794,0.00009049576,0.00025128742,0.00006739524,0.00002871907],"category_scores_gemma":[0.003026917,0.00018223427,0.00008054957,0.00018458912,0.00041317075,0.00047583712,0.0002164669,0.00014264316,0.0000011288711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91543776,0.009234548,0.0054554306,0.00010849678,0.00036469672,0.0000132288615,0.0011781211,0.0000041650082,0.000028234554,0.0000114246905,0.00070116663,0.06746274],"study_design_scores_gemma":[0.93447983,0.006659751,0.051769454,0.005685615,0.0000824567,0.0000033433378,0.00027348023,0.00039878348,0.00026559466,0.00017972571,0.000007602516,0.00019434711],"about_ca_topic_score_codex":0.00036596638,"about_ca_topic_score_gemma":0.00009823952,"teacher_disagreement_score":0.0672684,"about_ca_system_score_codex":0.000016739446,"about_ca_system_score_gemma":0.00032059767,"threshold_uncertainty_score":0.7431298},"labels":[],"label_agreement":null},{"id":"W2259159922","doi":"10.1136/annrheumdis-2014-206644","title":"MICL controls inflammation in rheumatoid arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; Université Laval","funders":"Division of Materials Research; Medical Research Council; Versus Arthritis; University of Aberdeen; Canadian Arthritis Network; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Society; Wellcome Trust","keywords":"Medicine; Autoantibody; Inflammation; Arthritis; Immunology; Myeloid; Antibody; Rheumatoid arthritis; Autoimmunity; Pathogenesis","score_opus":0.030418259047834358,"score_gpt":0.26599139509421804,"score_spread":0.2355731360463837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259159922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579514,0.008982059,0.00002978874,0.0015312174,0.0016989963,0.00024991267,0.000008934513,0.00003285121,0.0016711225],"genre_scores_gemma":[0.9976261,0.00094088475,0.0000038427,0.00019274834,0.0000070079973,0.000023693,0.000033543096,0.000007439543,0.0011647017],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902856,0.00023806616,0.0004171177,0.00010218617,0.00005262037,0.00016147083],"domain_scores_gemma":[0.9992504,0.00012493736,0.00022739473,0.0002534612,0.000121988836,0.000021814882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023128423,0.000098653465,0.00023028914,0.00008399699,0.00004833133,0.0000130820745,0.0001676294,0.000063709194,0.00035323988],"category_scores_gemma":[0.0007694856,0.00007177257,0.00011625672,0.000114520444,0.00009849716,0.00019022427,0.000047951766,0.000095197945,0.0003537397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032778315,0.0018835657,0.059642427,0.00027981232,0.0010694275,0.0000047978356,0.0069424193,0.0012779427,0.07188938,0.015878586,0.46478844,0.37306538],"study_design_scores_gemma":[0.020044647,0.0009028495,0.36976966,0.005448114,0.000090062014,0.00016025674,0.009179449,0.0006900702,0.3801134,0.0254439,0.18695913,0.0011984863],"about_ca_topic_score_codex":0.0002131854,"about_ca_topic_score_gemma":0.000027399334,"teacher_disagreement_score":0.37186688,"about_ca_system_score_codex":0.000014744958,"about_ca_system_score_gemma":0.000064556356,"threshold_uncertainty_score":0.45467266},"labels":[],"label_agreement":null},{"id":"W2262165924","doi":"10.1136/annrheumdis-2015-eular.2000","title":"SAT0559 Malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Study: Current Status of Observations","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Cognition; Medicine; Audiology; Comprehension; Cognitive psychology; Psychology; Psychiatry","score_opus":0.15537927818480918,"score_gpt":0.3572144170035453,"score_spread":0.2018351388187361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262165924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804182,0.018102245,0.0000069071707,0.00041198634,0.000323536,0.0004302073,0.00022179884,0.000009097721,0.00007603538],"genre_scores_gemma":[0.99843454,0.0013275347,0.0000295163,0.000027735121,0.000008110217,0.000073844254,0.000037226913,0.0000062496374,0.00005526077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858296,0.00050982396,0.0003893135,0.00016156478,0.00011870958,0.00023765609],"domain_scores_gemma":[0.9987442,0.0003387089,0.0002847958,0.00047627298,0.00012264679,0.000033413162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004175461,0.0001462896,0.00031890118,0.000059586826,0.00009907586,0.000012109218,0.0003086525,0.00004044388,0.00001719188],"category_scores_gemma":[0.0003365673,0.00008217585,0.00011022445,0.00021017028,0.00019527184,0.000092917275,0.000112773574,0.000074164345,0.000003336717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001093122,0.001717906,0.9610548,0.00010498103,0.00038629698,0.0000015251688,0.0026058138,0.000017539494,0.00006952064,0.00092973927,0.002732701,0.030269882],"study_design_scores_gemma":[0.0010737607,0.0001986888,0.9916453,0.00020287979,0.00027780925,0.00000313667,0.004600525,0.000004005703,0.00021300683,0.0012466299,0.0004508841,0.00008341718],"about_ca_topic_score_codex":0.0003716731,"about_ca_topic_score_gemma":0.00009555431,"teacher_disagreement_score":0.030590475,"about_ca_system_score_codex":0.000016987451,"about_ca_system_score_gemma":0.00020051672,"threshold_uncertainty_score":0.3351034},"labels":[],"label_agreement":null},{"id":"W2263473847","doi":"10.1136/annrheumdis-2015-208730","title":"Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cohort; Axial spondyloarthritis; Predictive value; Internal medicine; Ankylosing spondylitis; Sacroiliitis","score_opus":0.07006128833981154,"score_gpt":0.3344420247713695,"score_spread":0.2643807364315579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263473847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246615,0.0016354223,0.000067275854,0.0035497113,0.0001449169,0.000991253,0.0010346898,0.000006945106,0.000103645005],"genre_scores_gemma":[0.9985108,0.0006650605,0.000028473487,0.00012520587,0.000033307693,0.00037472666,0.000014792211,0.000010156001,0.00023751106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860233,0.00023063927,0.00039474908,0.00021611832,0.0003601003,0.0001960729],"domain_scores_gemma":[0.9986574,0.0003951701,0.0002340698,0.0004906072,0.00016975927,0.000052989097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030015557,0.00015694594,0.00045485626,0.000061532824,0.0001245836,0.000017670394,0.0001735901,0.00004315347,0.00012277738],"category_scores_gemma":[0.0006970441,0.000067159985,0.000463772,0.00027178944,0.00034633116,0.00008916141,0.000074220516,0.000041867985,7.8957333e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021017808,0.0005791028,0.973047,0.00017834251,0.0014718359,0.000003987467,0.0013732701,0.0000017353816,0.000060318303,0.00019662017,0.0022771258,0.018708862],"study_design_scores_gemma":[0.002630086,0.00033129644,0.9924454,0.00068866526,0.0014324576,0.0000053827425,0.00045204177,0.00014703636,0.00011345027,0.0014637015,0.00021795933,0.000072517105],"about_ca_topic_score_codex":0.0000969357,"about_ca_topic_score_gemma":0.00017827739,"teacher_disagreement_score":0.019398388,"about_ca_system_score_codex":0.000021435391,"about_ca_system_score_gemma":0.00006099769,"threshold_uncertainty_score":0.27387047},"labels":[],"label_agreement":null},{"id":"W2276452272","doi":"10.1136/annrheumdis-2015-207596","title":"Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Medicine; Etanercept; Axial spondyloarthritis; Internal medicine; Sacroiliac joint; Gastroenterology; Ankylosing spondylitis; Nuclear medicine; Physical therapy; Surgery; Sacroiliitis; Rheumatoid arthritis","score_opus":0.08529294235137276,"score_gpt":0.3612316145739862,"score_spread":0.2759386722226135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276452272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748964,0.004986007,0.0000012931608,0.0049655065,0.0003452929,0.0014523111,0.0005660995,0.000024452396,0.00016936919],"genre_scores_gemma":[0.9974357,0.00136662,0.00008477041,0.00071215734,0.000094207644,0.00008541153,0.000016978976,0.000024076704,0.00018008456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720323,0.0005593567,0.0008973374,0.00042762977,0.00058393576,0.00032848306],"domain_scores_gemma":[0.9973055,0.0010922819,0.00020515257,0.00086489215,0.00016506197,0.00036707844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009530936,0.00025086434,0.00073915184,0.00012241231,0.0001407685,0.00004798486,0.00029432942,0.00006134031,0.0000157183],"category_scores_gemma":[0.003181153,0.0001448158,0.0002625079,0.0004934321,0.00038617177,0.00009208703,0.00025674314,0.0001673983,0.000032454394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007645503,0.0023761638,0.95250547,0.000017982778,0.0005100356,0.00013481878,0.0062545524,0.0000042678644,0.0000012655262,0.000016005564,0.013615414,0.01691851],"study_design_scores_gemma":[0.008953583,0.0020610397,0.9811705,0.0010279436,0.00025416745,0.00000955451,0.0053153373,0.00001346872,0.0000047577346,0.00070831185,0.00033996408,0.00014141528],"about_ca_topic_score_codex":0.0022308335,"about_ca_topic_score_gemma":0.0007945351,"teacher_disagreement_score":0.028664978,"about_ca_system_score_codex":0.000011047193,"about_ca_system_score_gemma":0.00013129387,"threshold_uncertainty_score":0.59054166},"labels":[],"label_agreement":null},{"id":"W2279827378","doi":"10.1136/annrheumdis-2015-eular.1097","title":"FRI0289 Denosumab Treatment in Postmenopausal Women with Osteoporosis for Up to 9 Years: Results Through Year 6 of the Freedom Extension","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Denosumab; Medicine; Bristol-Myers; Osteoporosis; Postmenopausal women; Placebo; Incidence (geometry); Internal medicine; Surgery; Alternative medicine","score_opus":0.0891447200918796,"score_gpt":0.36727988270862344,"score_spread":0.27813516261674387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279827378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223346,0.0004397843,0.0000013724301,0.0042286906,0.000103474755,0.0025902314,0.00024755465,0.000010954078,0.00014445468],"genre_scores_gemma":[0.998484,0.00008141554,0.00021885181,0.00039829698,0.000021717331,0.00024192281,0.000010564275,0.000023427741,0.00051977695],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9981265,0.00014701941,0.0004978276,0.0002329344,0.00062275125,0.00037295945],"domain_scores_gemma":[0.9981443,0.00023833169,0.00020547393,0.00081691804,0.00031434177,0.00028061392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004347428,0.0001485975,0.0004697054,0.00007464868,0.000049627033,0.000011267627,0.0002345305,0.00004321922,0.000017277465],"category_scores_gemma":[0.0011467984,0.00007387404,0.00008719661,0.00037064328,0.000121662924,0.000066683686,0.00010748289,0.00006395859,0.000008284015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17299798,0.023188485,0.25385648,0.0045605022,0.0018193749,0.000053662177,0.2613798,0.0014579836,0.0012525977,0.00048379618,0.18046393,0.09848542],"study_design_scores_gemma":[0.014725471,0.015057066,0.93960994,0.0019101292,0.00016767127,0.000007254302,0.02429836,0.000060029073,0.0017651703,0.0009056993,0.0013078366,0.00018535742],"about_ca_topic_score_codex":0.001565564,"about_ca_topic_score_gemma":0.00024839048,"teacher_disagreement_score":0.68575346,"about_ca_system_score_codex":0.000102866994,"about_ca_system_score_gemma":0.00064827455,"threshold_uncertainty_score":0.3012496},"labels":[],"label_agreement":null},{"id":"W2282202229","doi":"10.1136/annrheumdis-2015-eular.1864","title":"FRI0341 Influence of Tapering Etanercept on Work Productivity Outcomes in Patients with Early Rheumatoid Arthritis Tapered: 117 Week Results from the Prize Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Medicine; Etanercept; Rheumatoid arthritis; Placebo; Work productivity; Presenteeism; Internal medicine; Absenteeism; Physical therapy; Productivity; Alternative medicine","score_opus":0.03642167681710036,"score_gpt":0.28002785177093126,"score_spread":0.2436061749538309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282202229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466836,0.0014673424,7.381815e-7,0.0016313284,0.00008777799,0.0018080701,0.00023484816,0.00003217123,0.00006937379],"genre_scores_gemma":[0.9986394,0.0010366454,0.00004413277,0.000091705086,0.000012764275,0.000084574196,0.00001716971,0.000032831347,0.000040753504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964523,0.00047203733,0.0008205763,0.000403307,0.0014492114,0.0004026165],"domain_scores_gemma":[0.9968033,0.00080673705,0.00043756317,0.0012808699,0.0004409509,0.000230588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067876163,0.0002934727,0.0008227974,0.00010816614,0.00011444754,0.00005220546,0.00052898505,0.00004438493,0.000020348261],"category_scores_gemma":[0.00476442,0.00015333485,0.00015464313,0.00048721881,0.0004405472,0.0002816666,0.00019105655,0.00026199396,0.0000147847295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042374614,0.003803399,0.9674609,0.000035135687,0.00037294152,0.0000058216247,0.0065338677,0.00031673178,0.000005980451,0.000025323603,0.00036536204,0.016837114],"study_design_scores_gemma":[0.006792662,0.0017021587,0.9855219,0.0038069184,0.00001068523,8.225743e-7,0.0014739777,0.0000067402107,0.000118306496,0.00036211658,0.0000428217,0.00016085609],"about_ca_topic_score_codex":0.0015219116,"about_ca_topic_score_gemma":0.00020178531,"teacher_disagreement_score":0.018061073,"about_ca_system_score_codex":0.000025932464,"about_ca_system_score_gemma":0.00021678071,"threshold_uncertainty_score":0.6252814},"labels":[],"label_agreement":null},{"id":"W2285826736","doi":"10.1136/annrheumdis-2015-eular.2852","title":"THU0418 Secukinumab Significantly Reduces Psoriasis Burden in Patients with Psoriatic Arthritis: Results from the Phase 3 Future 2 Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Psoriasis; Psoriasis Area and Severity Index; Clinical endpoint; Internal medicine; Dermatology Life Quality Index; Rheumatology; Dermatology; Placebo; Ustekinumab; Randomized controlled trial; Adalimumab; Disease; Pathology","score_opus":0.029915895439353496,"score_gpt":0.268604237032849,"score_spread":0.23868834159349553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285826736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881232,0.0070687286,7.154091e-7,0.000969868,0.0009266618,0.0010968505,0.0016966152,0.000035751462,0.00008165886],"genre_scores_gemma":[0.9989531,0.0003012856,0.000013782681,0.00007378471,0.00010147128,0.00009674327,0.0003355381,0.000022505765,0.00010180649],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997511,0.0009119298,0.0006408322,0.00037791525,0.00021645703,0.0003418128],"domain_scores_gemma":[0.9979128,0.00052211626,0.00047305663,0.00083871605,0.00019116938,0.00006211068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039733204,0.0003064969,0.00054041715,0.000070046655,0.00017756091,0.000035494122,0.0006631261,0.0000993589,0.00007373567],"category_scores_gemma":[0.00054167194,0.00015588726,0.00015503308,0.0003285632,0.00018006423,0.00014970575,0.00011278023,0.00013161016,0.000057269608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020194989,0.013896872,0.06247795,0.000044197033,0.005179698,0.000019911222,0.040940296,0.00016444313,0.00004894468,0.0000948526,0.03591728,0.82102054],"study_design_scores_gemma":[0.066349335,0.0032510092,0.881793,0.0012662826,0.0013832009,0.000002758821,0.039693855,0.000010522032,0.0021407816,0.0021215228,0.0012738063,0.0007138845],"about_ca_topic_score_codex":0.0008067615,"about_ca_topic_score_gemma":0.0002128206,"teacher_disagreement_score":0.82030666,"about_ca_system_score_codex":0.000021674161,"about_ca_system_score_gemma":0.00015992325,"threshold_uncertainty_score":0.63568985},"labels":[],"label_agreement":null},{"id":"W2290444582","doi":"10.1136/annrheumdis-2015-208742","title":"Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Chugai Pharmaceutical","keywords":"Medicine; Tocilizumab; Prednisone; Polymyalgia rheumatica; Adverse effect; Clinical endpoint; Internal medicine; Neutropenia; Surgery; Randomized controlled trial; Giant cell arteritis; Chemotherapy; Rheumatoid arthritis","score_opus":0.045401283798501973,"score_gpt":0.3201112355576798,"score_spread":0.2747099517591778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290444582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993944,0.0015362118,0.000031425578,0.002628996,0.00006466464,0.0015225436,0.000063923915,0.000025792278,0.00018244721],"genre_scores_gemma":[0.9985753,0.001046114,0.000018928762,0.000023696886,0.000011904037,0.000097753065,0.0000026732291,0.000019405012,0.00020420607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835217,0.00010819033,0.0006379284,0.00022613384,0.00043943347,0.00023612542],"domain_scores_gemma":[0.9984018,0.00037912827,0.0002719227,0.00062706997,0.00020815906,0.00011191867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017549694,0.00018042898,0.0005672121,0.00013320791,0.000071141796,0.000008978331,0.0002244228,0.000053115196,0.0002827954],"category_scores_gemma":[0.00066867674,0.00008762585,0.0003457015,0.00036370664,0.00022822987,0.00009688492,0.00006756526,0.000088944566,0.000015210395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011112544,0.0069764154,0.9615515,0.00023966099,0.0013485271,0.000012929954,0.0023370225,0.000013843597,0.000033542005,0.0011228902,0.000383762,0.024868662],"study_design_scores_gemma":[0.008044902,0.0014022118,0.9825082,0.0030910706,0.00015983058,0.000008101439,0.00023937004,0.000019649773,0.00038810563,0.004029866,0.000003003039,0.000105708554],"about_ca_topic_score_codex":0.0003178037,"about_ca_topic_score_gemma":0.000035046836,"teacher_disagreement_score":0.024762953,"about_ca_system_score_codex":0.000026084808,"about_ca_system_score_gemma":0.000107958134,"threshold_uncertainty_score":0.35732782},"labels":[],"label_agreement":null},{"id":"W2305355596","doi":"10.1136/annrheumdis-2015-eular.4852","title":"SAT0404 Spot Urine Protein/Creatinine Ratio is Useful in Screening for Proteinuria but Should Not Substitute 24 hours Urine Collection Sample to Quantify Proteinuria in Lupus","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proteinuria; Medicine; Urine; Creatinine; Urine sample; Urology; Dipstick; Internal medicine; Kidney","score_opus":0.20979641737868654,"score_gpt":0.3864733027305716,"score_spread":0.17667688535188508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305355596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97609717,0.0006898136,0.0010039536,0.0065133353,0.0002390334,0.015047479,0.00024057536,0.000078712954,0.0000899029],"genre_scores_gemma":[0.9877945,0.000037972477,0.0041187312,0.00027288724,0.000121308345,0.0041516423,0.00005468991,0.00009685455,0.0033513745],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956329,0.00034361187,0.0013014707,0.00061953004,0.0013459225,0.00075656443],"domain_scores_gemma":[0.99684834,0.00046653187,0.00045326893,0.0010543056,0.0006739116,0.0005036602],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017444304,0.00042674542,0.0011399171,0.00062967464,0.00011095487,0.00007657585,0.0005112878,0.00015631807,0.000096914286],"category_scores_gemma":[0.009633218,0.00031679423,0.00028454483,0.0013664834,0.00015036692,0.00026233072,0.00022056526,0.0002719702,0.000018142991],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022512821,0.003214585,0.9211735,0.010208646,0.00067437463,0.00006718968,0.007531596,0.0012999158,0.0057218513,0.00066124735,0.020760335,0.006173918],"study_design_scores_gemma":[0.061472207,0.008148336,0.38705274,0.091360666,0.0006973502,0.0014012998,0.0105619375,0.023175824,0.40166986,0.007932517,0.0034933337,0.0030339318],"about_ca_topic_score_codex":0.00438812,"about_ca_topic_score_gemma":0.0011029068,"teacher_disagreement_score":0.5341208,"about_ca_system_score_codex":0.00020705807,"about_ca_system_score_gemma":0.0008982401,"threshold_uncertainty_score":0.9999284},"labels":[],"label_agreement":null},{"id":"W2312493484","doi":"10.1136/annrheumdis-2014-eular.3777","title":"SAT0373 Anti-Tumor Necrosis Factor Therapy May Influence Structural Progression in the Sacroiliac Joints of Patients with Axial Spondyloarthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cilag","keywords":"Medicine; Sacroiliac joint; SSS*; Ankylosis; Coronal plane; Prospective cohort study; Axial spondyloarthritis; Radiography; Radiology; Nuclear medicine; Sacroiliitis; Surgery; Internal medicine; Magnetic resonance imaging","score_opus":0.017797843320702424,"score_gpt":0.29170839878196375,"score_spread":0.2739105554612613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312493484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970552,0.001132811,4.1385294e-7,0.00049476494,0.00008001886,0.0009229943,0.00025978076,0.0000128608,0.00004119902],"genre_scores_gemma":[0.99916965,0.0003553204,0.000045991495,0.0003166327,0.000013997838,0.000049981896,0.00002153931,0.000018074537,0.00000883736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827313,0.00016225419,0.00043615152,0.00021054663,0.0006359479,0.00028195782],"domain_scores_gemma":[0.99867064,0.00017651124,0.00035733904,0.0005190374,0.00019911364,0.000077350094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011273091,0.00022471926,0.000530914,0.00006349696,0.00012911225,0.000021218495,0.00024565897,0.00003190389,0.0000630689],"category_scores_gemma":[0.00032180327,0.00010337675,0.00018105087,0.0002513302,0.0003329718,0.00012538974,0.00006944225,0.00008569538,0.0000032250664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007101604,0.0005946463,0.9231651,0.00016090636,0.00012718554,0.0000042154466,0.00067547464,0.000006017277,0.000038330993,0.00004783696,0.000107863256,0.07436228],"study_design_scores_gemma":[0.0038859257,0.00090165733,0.99197274,0.0017285681,0.00004942621,0.000004200288,0.00012625265,0.000015516873,0.0008794487,0.00026306225,0.00006513549,0.00010804344],"about_ca_topic_score_codex":0.00015825756,"about_ca_topic_score_gemma":0.000028009765,"teacher_disagreement_score":0.07425423,"about_ca_system_score_codex":0.000010534071,"about_ca_system_score_gemma":0.000049265698,"threshold_uncertainty_score":0.42155814},"labels":[],"label_agreement":null},{"id":"W2312580319","doi":"10.1136/annrheumdis-2014-eular.1138","title":"SAT0372 Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 48-Week Treatment Data","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Medicine; BASDAI; BASFI; Etanercept; Ankylosing spondylitis; Internal medicine; Clinical endpoint; Placebo; Population; Sacroiliitis; Sacroiliac joint; Gastroenterology; Axial spondyloarthritis; Clinical trial; Surgery; Arthritis; Rheumatoid arthritis; Psoriatic arthritis; Pathology","score_opus":0.06951731161183314,"score_gpt":0.35600481296148323,"score_spread":0.28648750134965006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312580319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898812,0.008001126,0.000005952751,0.0009091267,0.00018043732,0.0005378245,0.00023471483,0.000015808342,0.00023377142],"genre_scores_gemma":[0.99307084,0.0064993924,0.00011456682,0.00013023971,0.00005130471,0.000018880399,0.000047616137,0.000021339802,0.00004583499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981472,0.00017063452,0.0007391508,0.00037065713,0.00029527806,0.00027707318],"domain_scores_gemma":[0.9980253,0.00046304023,0.00025422053,0.0010186165,0.00006746842,0.00017133851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032675054,0.0002213925,0.0008323481,0.00013713165,0.00007427324,0.000016462975,0.0002486851,0.000042694715,0.000031447355],"category_scores_gemma":[0.0006278713,0.00014751162,0.000283913,0.00024576962,0.00054279,0.00011650106,0.00021200033,0.0000776164,0.0000068930317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049566844,0.0020227863,0.741808,0.00013591381,0.00038199534,0.000022801178,0.00030467162,0.000001565339,0.0000056726353,0.00009980838,0.0005627147,0.25415838],"study_design_scores_gemma":[0.007451331,0.0007683805,0.9885035,0.0015564752,0.00037857078,0.000018859093,0.00015278149,0.0002763144,0.000030400306,0.00046268528,0.00028252474,0.00011816546],"about_ca_topic_score_codex":0.0006517324,"about_ca_topic_score_gemma":0.00010379375,"teacher_disagreement_score":0.2540402,"about_ca_system_score_codex":0.000007759212,"about_ca_system_score_gemma":0.00006662691,"threshold_uncertainty_score":0.6015349},"labels":[],"label_agreement":null},{"id":"W2312711202","doi":"10.1136/annrheumdis-2012-eular.2608","title":"FRI0151 Steroids and leflunomide, not biologics, are the major risk factors for infection following total joint arthroplasty","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Leflunomide; Rheumatoid arthritis; Internal medicine; Surgery; Urinary system; Orthopedic surgery; Arthritis","score_opus":0.05458807545757571,"score_gpt":0.30945947221720493,"score_spread":0.2548713967596292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312711202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876579,0.009674589,0.000089901085,0.0011068141,0.00042425524,0.0007716752,0.00020969943,0.00003356458,0.000031607196],"genre_scores_gemma":[0.9938541,0.0057383417,0.00003583271,0.00013818376,0.00006482631,0.000063933105,0.000014522929,0.000018359815,0.00007187072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870634,0.00017639343,0.00033365196,0.00014534753,0.00026300424,0.00037527533],"domain_scores_gemma":[0.99860954,0.0005275184,0.00025140974,0.00033004815,0.000088512636,0.0001929806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004493946,0.00017574546,0.00037779278,0.0000617253,0.0003576129,0.000046549736,0.00008150629,0.0000482554,0.00003336972],"category_scores_gemma":[0.0020777122,0.00008638074,0.00038861707,0.00009022756,0.00024033045,0.00021689001,0.000102735474,0.000116311756,0.000005757545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002812631,0.00037931956,0.96783924,0.0002596662,0.0008691444,5.5022144e-7,0.0010482597,0.000010636463,0.000264203,0.00032015482,0.002765216,0.025962329],"study_design_scores_gemma":[0.0010566605,0.00027874092,0.9931272,0.00055444514,0.0000686521,0.000009267029,0.0011167588,0.00012311497,0.0021938775,0.0007263291,0.000624578,0.00012033961],"about_ca_topic_score_codex":0.00019594168,"about_ca_topic_score_gemma":0.000015172127,"teacher_disagreement_score":0.025841989,"about_ca_system_score_codex":0.000010895837,"about_ca_system_score_gemma":0.00003981816,"threshold_uncertainty_score":0.35225043},"labels":[],"label_agreement":null},{"id":"W2312717678","doi":"10.1136/annrheumdis-2014-eular.4753","title":"FRI0212 What Are the Effects of Interventions Targetting Medication Adherence in Rheumatic Diseases: A Systematic Review","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Psychological intervention; Internal medicine; Physical therapy; Psoriatic arthritis; PsycINFO; CINAHL; Randomized controlled trial; Rheumatoid arthritis; MEDLINE; Rheumatology; Meta-analysis; Psychiatry","score_opus":0.02677081702622219,"score_gpt":0.3319753607646403,"score_spread":0.3052045437384181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312717678","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25717726,0.73143107,0.0001805286,0.0068222363,0.0003052268,0.003969946,0.000028786748,0.000040568655,0.000044377142],"genre_scores_gemma":[0.8000832,0.19886158,0.000020702371,0.0004703866,0.000010838704,0.000481124,0.000014569201,0.000018030802,0.000039527273],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961843,0.0011451184,0.0013025313,0.00021263893,0.00084375823,0.00031165994],"domain_scores_gemma":[0.99509597,0.0022413847,0.0011146404,0.0010882252,0.00026701664,0.0001927371],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011699612,0.0002163218,0.0011610459,0.00013142411,0.00011983375,0.000052736366,0.0006065762,0.000037593636,0.00008874351],"category_scores_gemma":[0.020735007,0.00011524477,0.00064746983,0.00044751755,0.00033839667,0.00032234832,0.00014386202,0.00015467044,0.00002167015],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046875506,0.0009506302,0.005413174,0.9720698,0.00054756546,0.0000028478205,0.00083891075,0.000005561272,0.000022162389,0.00084810297,0.0028292253,0.01642515],"study_design_scores_gemma":[0.00083062093,0.0002307387,0.0411408,0.9517113,0.00030554034,0.000009602176,0.0013752843,0.00063827453,0.00015805807,0.003461762,0.000012336019,0.00012566835],"about_ca_topic_score_codex":0.000065996566,"about_ca_topic_score_gemma":0.00002124347,"teacher_disagreement_score":0.542906,"about_ca_system_score_codex":0.000019524769,"about_ca_system_score_gemma":0.00011262062,"threshold_uncertainty_score":0.9875138},"labels":[],"label_agreement":null},{"id":"W2312852273","doi":"10.1136/annrheumdis-2013-eular.2159","title":"SAT0435 A1G T-Type Calcium Channel is Expressed in Human Fetal Hearts and Has an Extracellular Epitope Bound by Autoantibodies from Congenital Heart Block Maternal Sera","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Fetus; Autoantibody; Western blot; Epitope; Medicine; Antibody; Immunofluorescence; Molecular biology; Internal medicine; Endocrinology; Andrology; Immunology; Biology; Pregnancy; Gene; Biochemistry","score_opus":0.06973911860163068,"score_gpt":0.33331615788110386,"score_spread":0.2635770392794732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312852273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97977036,0.0101113105,0.0000011651425,0.008849393,0.00011525476,0.00060854387,0.00045601765,0.000027459337,0.000060505477],"genre_scores_gemma":[0.99660593,0.00050145166,0.000050588056,0.00059646525,0.00007748641,0.000029199246,0.000096569354,0.00003146297,0.0020108437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787986,0.00016883328,0.00052164093,0.000361801,0.0005896029,0.00047823926],"domain_scores_gemma":[0.99869186,0.00014857831,0.00012607219,0.00045859316,0.00018316123,0.00039173354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015758684,0.0002829815,0.0006005574,0.000097699645,0.00024328964,0.00016847024,0.00025369687,0.00008547153,0.000744038],"category_scores_gemma":[0.00009232802,0.0001945685,0.00017255289,0.00012048052,0.0005398668,0.00028699657,0.00020277711,0.00019303786,0.000050414594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012772765,0.0031702474,0.60688263,0.0018443,0.0013242607,0.00010158901,0.004071659,0.000027054703,0.24597935,0.00016112934,0.12975493,0.005405543],"study_design_scores_gemma":[0.0012292336,0.0004965503,0.93847764,0.0009595809,0.0001048103,0.000034802506,0.00039467233,0.0025971318,0.051400457,0.002196459,0.0017575716,0.00035106717],"about_ca_topic_score_codex":0.01308386,"about_ca_topic_score_gemma":0.00007967668,"teacher_disagreement_score":0.331595,"about_ca_system_score_codex":0.00001102879,"about_ca_system_score_gemma":0.00009187221,"threshold_uncertainty_score":0.9934881},"labels":[],"label_agreement":null},{"id":"W2312892771","doi":"10.1136/annrheumdis-2014-eular.4253","title":"THU0273 Changes in Patient-Reported Joint Counts and Composite Indices Can Identify Flare of Disease Activity in Recent Onset","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université de Sherbrooke; Southlake Regional Health Center; University of Manitoba; Mount Sinai Hospital; McGill University","funders":"","keywords":"Medicine; Flare; Cohort; Wilcoxon signed-rank test; Rheumatoid arthritis; Internal medicine; Severity of illness; Physical therapy; Mann–Whitney U test","score_opus":0.041457319454494164,"score_gpt":0.31644535642426264,"score_spread":0.2749880369697685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312892771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929377,0.0038681158,7.5005966e-7,0.0025762934,0.000053845764,0.00034039572,0.00010778327,0.000008003947,0.00010714238],"genre_scores_gemma":[0.986198,0.013605047,0.000005622324,0.0001241569,0.0000048794104,0.00002100318,0.00001744524,0.000008642832,0.000015197854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988988,0.0001747328,0.00027164977,0.00012975717,0.00035394897,0.00017109158],"domain_scores_gemma":[0.9991889,0.00010897742,0.00019918989,0.00027047584,0.00008456555,0.00014786444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021947025,0.00009787195,0.00032078204,0.00014925409,0.000030016281,0.0000135723785,0.000082029306,0.000022740687,0.00007382971],"category_scores_gemma":[0.0005763607,0.00006846534,0.000055300126,0.00016661239,0.0001652935,0.000056563073,0.00007375985,0.00007446346,0.0000017612194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011745745,0.0013504084,0.7611174,0.0016218818,0.00022853866,0.000028973574,0.0015949399,0.000010232933,0.0008153523,0.00010412077,0.001946527,0.23000704],"study_design_scores_gemma":[0.00074224634,0.00013066521,0.9927335,0.002563967,0.000010747509,0.000003424129,0.00013631153,0.00014232211,0.0022403486,0.0010193023,0.00020690715,0.000070256785],"about_ca_topic_score_codex":0.00033879187,"about_ca_topic_score_gemma":0.0003391704,"teacher_disagreement_score":0.23161608,"about_ca_system_score_codex":0.0000107641545,"about_ca_system_score_gemma":0.000090954214,"threshold_uncertainty_score":0.27919355},"labels":[],"label_agreement":null},{"id":"W2313042510","doi":"10.1136/annrheumdis-2014-eular.1114","title":"FRI0407 The Impact of Lupus Nephritis at Inception on Health Related Quality of Life: Results from an International Cohort Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Capital District Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Lupus nephritis; Cohort; Quality of life (healthcare); Internal medicine; Systemic lupus erythematosus; Cohort study; Renal function; Disease","score_opus":0.08663216233567742,"score_gpt":0.42219254847277915,"score_spread":0.3355603861371017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313042510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479437,0.00034708556,0.000004790787,0.002264876,0.00019830035,0.0013376999,0.00065519975,0.000020221001,0.00037746143],"genre_scores_gemma":[0.99920917,0.000302447,0.0000101867645,0.00009735779,0.00003619681,0.000025897867,0.0001354497,0.000018504034,0.00016478809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99523526,0.0015587355,0.0014522019,0.0002630692,0.0012873112,0.00020340817],"domain_scores_gemma":[0.9953603,0.0014557152,0.0012790591,0.001298281,0.0003981226,0.0002085271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027079869,0.0001593493,0.00077977264,0.0001051623,0.00008481185,0.000011615387,0.0005206335,0.000052320247,0.00015658987],"category_scores_gemma":[0.0067925584,0.000084044055,0.00031816345,0.0002229723,0.00022201084,0.00009645551,0.00016769509,0.00012811819,0.000011542923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027092576,0.0016069757,0.9819435,0.000266405,0.00091134495,4.4205092e-7,0.0037330308,0.00018782323,0.00007132552,0.0000959256,0.005639388,0.0028345732],"study_design_scores_gemma":[0.0028602018,0.00101404,0.9907823,0.0017156388,0.000049723767,0.000015425225,0.0013662081,0.0011198408,0.00006926292,0.0009344277,0.0000054613633,0.00006744957],"about_ca_topic_score_codex":0.012966421,"about_ca_topic_score_gemma":0.00016057501,"teacher_disagreement_score":0.0128058465,"about_ca_system_score_codex":0.000104579914,"about_ca_system_score_gemma":0.00026311475,"threshold_uncertainty_score":0.9936063},"labels":[],"label_agreement":null},{"id":"W2313088731","doi":"10.1136/annrheumdis-2012-eular.2754","title":"FRI0297 What is the contribution of the antero-posterior radiograph of the lumbar spine to the assessment of radiographic severity and progression using the modified stoke ankylosing spondylitis spine score?","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Radiography; Ankylosing spondylitis; Lumbar spine; Radiology; Lumbar; Physical therapy; Nuclear medicine; Surgery","score_opus":0.03600707249318906,"score_gpt":0.3407150837947191,"score_spread":0.30470801130153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313088731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533219,0.03594923,0.000044858356,0.0076307463,0.00037792663,0.0022922314,0.00036212918,0.00000791628,0.000013057493],"genre_scores_gemma":[0.993986,0.0052777226,0.0000619763,0.0005335106,0.000041674088,0.000059125054,0.000010210886,0.000019057223,0.00001073193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744314,0.0005055702,0.00069785974,0.0002028266,0.00078477425,0.00036583166],"domain_scores_gemma":[0.9974559,0.00016042839,0.00084381516,0.0011268692,0.00031630273,0.00009669045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008146444,0.00026928168,0.0006523459,0.00007805829,0.0005500793,0.00004329584,0.0004894539,0.000053365027,0.000022572636],"category_scores_gemma":[0.0002566923,0.00009513652,0.00061475765,0.00079440523,0.00096917595,0.00021048583,0.00043067444,0.00014408425,1.2519284e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060590013,0.0018126115,0.93436986,0.0010900944,0.0026028517,0.0000019745582,0.004513993,0.000070686205,0.004735898,0.0008653529,0.0005807166,0.048750035],"study_design_scores_gemma":[0.0012793088,0.00025606292,0.9844306,0.006364363,0.00092757633,0.000034989167,0.0011995217,0.0004271708,0.0047131656,0.00018382644,0.000085497464,0.000097891214],"about_ca_topic_score_codex":0.00024388786,"about_ca_topic_score_gemma":0.000026686592,"teacher_disagreement_score":0.05006074,"about_ca_system_score_codex":0.00002468677,"about_ca_system_score_gemma":0.000074789845,"threshold_uncertainty_score":0.42308208},"labels":[],"label_agreement":null},{"id":"W2313218045","doi":"10.1136/annrheumdis-2012-eular.495","title":"AB0495 Functional outcome in response to treatment with dmards compared to anti-TNF agents in a cohort with rheumatoid arthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Physical therapy; Cohort; Adalimumab; Cohort study; Rheumatology","score_opus":0.0642867878695567,"score_gpt":0.33923439883017176,"score_spread":0.27494761096061504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313218045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99147034,0.0031536114,0.000022678118,0.0033138676,0.000082578925,0.0016876818,0.00010153505,0.00003135928,0.0001363647],"genre_scores_gemma":[0.9940175,0.0046997624,0.0001887669,0.0004435371,0.000013475305,0.0004136294,0.000021990858,0.000036959358,0.00016440162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729234,0.0003012073,0.0005991823,0.0002850201,0.00085304846,0.00066922815],"domain_scores_gemma":[0.9982341,0.0002796815,0.00012183985,0.00059757556,0.00014661672,0.00062017026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005938358,0.0002893838,0.00081834366,0.00039025568,0.00008652599,0.00003619045,0.00018690403,0.00003740109,0.00022779731],"category_scores_gemma":[0.0004077879,0.00017255399,0.0001352626,0.00065995276,0.00015092747,0.00020004188,0.0000795653,0.000103939754,0.00006830838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008797221,0.0016776222,0.974624,0.00005781257,0.00028146806,0.000032541437,0.001165402,0.00022299952,0.000056616707,0.000040810995,0.0012734196,0.011770117],"study_design_scores_gemma":[0.0044598747,0.0010885994,0.9882023,0.0031066237,0.0000082549095,0.00006323087,0.00063261547,0.00003619376,0.00022556784,0.000025741801,0.0019491045,0.0002019067],"about_ca_topic_score_codex":0.0007710833,"about_ca_topic_score_gemma":0.00048572937,"teacher_disagreement_score":0.013578317,"about_ca_system_score_codex":0.00011020187,"about_ca_system_score_gemma":0.0002743363,"threshold_uncertainty_score":0.70365477},"labels":[],"label_agreement":null},{"id":"W2313262182","doi":"10.1136/annrheumdis-2014-eular.2635","title":"AB0251 The Impact of Missing Anti-Citrullinated Protein Antibody (ACPA) Serology on Outcomes in Early Rheumatoid Arthritis: Results from Catch (Canadian Early Arthritis Cohort)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Manitoba; Southlake Regional Health Center; Université de Montréal; Université de Sherbrooke; Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Rheumatoid factor; Internal medicine; Cohort; Biomarker; Immunology; Arthritis; Physical therapy","score_opus":0.020647524025048266,"score_gpt":0.31060617774472277,"score_spread":0.2899586537196745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313262182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98683774,0.0052305767,0.0000066752086,0.004953896,0.000116847856,0.0015362881,0.00091730617,0.000045556495,0.00035509228],"genre_scores_gemma":[0.9896479,0.00982652,0.000040707328,0.0001870893,0.000025136575,0.000063986095,0.000116020856,0.000056291658,0.00003633699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956719,0.00083117,0.0013200644,0.00048750982,0.0008110933,0.0008782139],"domain_scores_gemma":[0.9962351,0.00096044707,0.0005945788,0.0013301487,0.00034498825,0.0005347766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010094823,0.0004307866,0.0014195202,0.0004021653,0.00025328205,0.00010311749,0.00067242637,0.0001640615,0.0001226365],"category_scores_gemma":[0.0035259973,0.00026195534,0.0006070051,0.0005084796,0.0007123868,0.00022422725,0.00010217439,0.00042521153,0.000041649615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001535032,0.0010673107,0.9252373,0.00010057794,0.0012622982,0.000055225042,0.0018944319,0.00011810961,0.0011961054,0.00051596906,0.0011883373,0.06582929],"study_design_scores_gemma":[0.0042367014,0.0008967545,0.97933125,0.006913301,0.000009642537,0.000016116219,0.00013157722,0.00041272215,0.0022732557,0.0054816124,0.000053470634,0.0002435967],"about_ca_topic_score_codex":0.18332405,"about_ca_topic_score_gemma":0.007692007,"teacher_disagreement_score":0.17563204,"about_ca_system_score_codex":0.000049219983,"about_ca_system_score_gemma":0.0006036152,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W2313344922","doi":"10.1136/annrheumdis-2015-208941","title":"Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Rheumatology; Etanercept; Erythrocyte sedimentation rate; Rheumatoid factor; Methotrexate; Physical therapy; Surgery","score_opus":0.053755185650055354,"score_gpt":0.358397020268935,"score_spread":0.3046418346188796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313344922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98513556,0.00609239,0.0000043165755,0.004959616,0.00037729973,0.0031458,0.000113648224,0.000021627418,0.00014976146],"genre_scores_gemma":[0.96726215,0.03224596,0.000011615118,0.000113798334,0.00006444087,0.00012098321,0.0000037571176,0.000025021971,0.00015227737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943776,0.0019145259,0.0019129419,0.00032206293,0.0010522548,0.0004206299],"domain_scores_gemma":[0.99266756,0.004886073,0.00079700357,0.0011996139,0.00025702888,0.00019272314],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003787127,0.00022980342,0.00085430307,0.00007908245,0.00021026531,0.00003863292,0.0007274009,0.00007485713,0.00009548917],"category_scores_gemma":[0.027938934,0.0000849326,0.0006582685,0.0003629855,0.0007721073,0.00014875663,0.00021983514,0.00024837878,0.000010805462],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48668808,0.010128945,0.26041096,0.00028833235,0.0017585595,0.000025534368,0.006309076,0.00001981039,0.0017492789,0.00033023302,0.05817805,0.17411312],"study_design_scores_gemma":[0.49647683,0.0023643263,0.47299552,0.016645776,0.000046645095,0.00002097261,0.0027422514,0.000044407512,0.0025329294,0.003984711,0.0018050577,0.00034059142],"about_ca_topic_score_codex":0.00024466054,"about_ca_topic_score_gemma":0.000045489287,"teacher_disagreement_score":0.21258456,"about_ca_system_score_codex":0.000013896543,"about_ca_system_score_gemma":0.00033281522,"threshold_uncertainty_score":0.98024917},"labels":[],"label_agreement":null},{"id":"W2313376315","doi":"10.1136/annrheumdis-2013-eular.2587","title":"AB0264 Comparison of drug survival, safety and doses of etanercept, infliximab and adalimumab in rheumatoid arthritis patients: thirteen years canadian clinical practice experience.","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Credit Valley Hospital","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Rheumatoid arthritis; Infliximab; Drug; Internal medicine; Antirheumatic Agents; Physical therapy; Intensive care medicine; Pharmacology; Tumor necrosis factor alpha","score_opus":0.0327264314325027,"score_gpt":0.35375142147229693,"score_spread":0.32102499003979423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313376315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763592,0.020913476,0.0000011812317,0.0014394051,0.000093887706,0.00068678183,0.00011752978,0.000008985324,0.00037954163],"genre_scores_gemma":[0.90312886,0.09654141,0.00012026186,0.00013388264,0.0000063181196,0.000022286451,0.000014627391,0.00001654857,0.000015829852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718523,0.00041745513,0.0012384356,0.0002339391,0.00059278356,0.00033218483],"domain_scores_gemma":[0.9971988,0.0010649632,0.0004883746,0.00044174728,0.00040956723,0.00039649903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005452596,0.00017591822,0.00091593916,0.00017745254,0.00007266775,0.00003162336,0.00021987801,0.00006845696,0.00019466736],"category_scores_gemma":[0.0034842526,0.00013376455,0.00013293998,0.00023191086,0.00090302655,0.0003891038,0.00012881297,0.00017734677,0.0000045481606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056333444,0.00097389985,0.7819075,0.00028020688,0.00022195654,0.0000034992754,0.0077414983,0.0000050238045,0.000012871231,0.0004325418,0.0026810893,0.2051766],"study_design_scores_gemma":[0.0031945456,0.00036534856,0.98241264,0.0025771537,0.000010423005,0.000007358375,0.009204327,0.00017987104,0.00010972371,0.00043844632,0.0013565525,0.00014358562],"about_ca_topic_score_codex":0.053290848,"about_ca_topic_score_gemma":0.0076588877,"teacher_disagreement_score":0.20503302,"about_ca_system_score_codex":0.000014862918,"about_ca_system_score_gemma":0.00030873742,"threshold_uncertainty_score":0.95301336},"labels":[],"label_agreement":null},{"id":"W2313460482","doi":"10.1136/annrheumdis-2014-eular.1885","title":"THU0262 Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada","funders":"","keywords":"Medicine; Adalimumab; Abatacept; Etanercept; Infliximab; Rheumatoid arthritis; Internal medicine; Cohort; TNF inhibitor; Rheumatology; Visual analogue scale; Discontinuation; Clinical trial; Physical therapy; Surgery; Disease","score_opus":0.062103097693860826,"score_gpt":0.34851651123730426,"score_spread":0.2864134135434434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313460482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924207,0.0047120387,0.000017763148,0.0014810477,0.00008315721,0.0008150047,0.00035166866,0.000024023224,0.00009460603],"genre_scores_gemma":[0.98006606,0.01840109,0.00014781336,0.0010975675,0.000028230985,0.000058105565,0.000117288604,0.00002949001,0.000054331907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974665,0.0002713405,0.0007572543,0.0004606472,0.0006514946,0.00039278663],"domain_scores_gemma":[0.99712294,0.0009840026,0.00026349505,0.0010679996,0.00013200338,0.00042956838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044800056,0.00027299213,0.00072225975,0.00006729451,0.00026986533,0.0001255796,0.00044853362,0.000047716298,0.00040741634],"category_scores_gemma":[0.0024564685,0.00014799989,0.00007669446,0.00020115539,0.0007887454,0.00033598204,0.00048839935,0.00024463207,0.000013854208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028421963,0.00073830306,0.9442056,0.00018157483,0.00019729814,0.000011004254,0.0024472785,0.000010863046,0.0000033683668,0.00011198978,0.007124334,0.042126205],"study_design_scores_gemma":[0.006468992,0.00066575373,0.9809538,0.006109596,0.000010572978,0.000015820082,0.0010100686,0.00041961556,0.000056600118,0.00021052313,0.0038505644,0.00022807231],"about_ca_topic_score_codex":0.0007994005,"about_ca_topic_score_gemma":0.0017164615,"teacher_disagreement_score":0.04189813,"about_ca_system_score_codex":0.000010314142,"about_ca_system_score_gemma":0.000104613,"threshold_uncertainty_score":0.60352606},"labels":[],"label_agreement":null},{"id":"W2313587247","doi":"10.1136/annrheumdis-2013-eular.1499","title":"FRI0372 Early mortality in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (the insync study)","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Cause of death; Cohort study; Internal medicine; Mortality rate; Scleroderma (fungus); Disease; Survival analysis; Pediatrics; Pathology","score_opus":0.045452432034933425,"score_gpt":0.28001458477401386,"score_spread":0.23456215273908043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313587247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371827,0.0007153303,0.000038635695,0.00019902243,0.000068531044,0.0051071197,0.00011871734,0.0000148333775,0.000019552275],"genre_scores_gemma":[0.9987121,0.00007904558,0.000032107524,0.00009325898,0.00001791183,0.0009710841,0.000051871273,0.000017372882,0.000025250165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979901,0.0001473421,0.000775083,0.00020189809,0.000706278,0.00017933469],"domain_scores_gemma":[0.99792135,0.0002981648,0.00056629017,0.00041957467,0.0007124888,0.00008212566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034363763,0.00015757399,0.0004191456,0.00009834614,0.00011312063,0.000022601926,0.0002084678,0.000046839752,0.000043984026],"category_scores_gemma":[0.0005156356,0.00008219225,0.00018553379,0.00027623933,0.0001362006,0.00023666974,0.000053564003,0.000061552724,0.000004272273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015180567,0.0016237289,0.99300295,0.0005252943,0.00040065745,7.16901e-8,0.00086766836,0.00030110296,0.00008474081,0.00006299776,0.00026575784,0.0027132062],"study_design_scores_gemma":[0.0024901803,0.00019675735,0.9880396,0.0057784654,0.0003195955,5.1916885e-7,0.0016978951,0.0010873587,0.00012293618,0.0001748846,4.4458992e-7,0.00009134391],"about_ca_topic_score_codex":0.00041825481,"about_ca_topic_score_gemma":0.000016245702,"teacher_disagreement_score":0.005253171,"about_ca_system_score_codex":0.000032747415,"about_ca_system_score_gemma":0.00013169086,"threshold_uncertainty_score":0.33517027},"labels":[],"label_agreement":null},{"id":"W2313622309","doi":"10.1136/annrheumdis-2014-eular.2283","title":"SAT0396 Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Adverse effect; Internal medicine; Concomitant; Placebo; Clinical endpoint; Randomization; Dosing; Psoriasis; Randomized controlled trial; Arthritis; Rheumatoid arthritis; Adalimumab; Dermatology","score_opus":0.027580727669619234,"score_gpt":0.3192333291753375,"score_spread":0.29165260150571826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313622309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947147,0.0005211821,0.000005935933,0.00025109318,0.00003862716,0.0041015763,0.00017367523,0.000014174178,0.00017905825],"genre_scores_gemma":[0.9994359,0.00028091064,0.000024624751,0.00004218457,0.000010384544,0.00008868541,0.000063638356,0.000022067661,0.000031576456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99745,0.00037113522,0.0009756185,0.00028557525,0.0006584263,0.000259247],"domain_scores_gemma":[0.9976578,0.0007490831,0.000561276,0.0006523049,0.00025284145,0.00012672295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047069273,0.00021406339,0.0010177975,0.00015671855,0.00007157055,0.000018847857,0.0002110238,0.000048749007,0.00004799131],"category_scores_gemma":[0.0016779314,0.00013225414,0.00012762276,0.00021711456,0.00018750184,0.0001553676,0.00011533961,0.00015349721,0.0000049514556],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8263485,0.012606505,0.03637637,0.0002595319,0.0012116045,0.0000030312694,0.0038607062,0.00005599564,0.0000055256623,0.00002401872,0.00012978414,0.11911844],"study_design_scores_gemma":[0.5133151,0.0017748318,0.4804494,0.0019069677,0.00022542974,1.4846958e-7,0.0016041193,0.00044604568,0.000088062574,0.00005482706,0.000021561149,0.000113498725],"about_ca_topic_score_codex":0.00034827166,"about_ca_topic_score_gemma":0.00004947798,"teacher_disagreement_score":0.44407302,"about_ca_system_score_codex":0.000016296079,"about_ca_system_score_gemma":0.00012863959,"threshold_uncertainty_score":0.5393167},"labels":[],"label_agreement":null},{"id":"W2313829353","doi":"10.1136/annrheumdis-2013-eular.1921","title":"SAT0195 Alexithymia: Unspeakable Suffering, a Prevalence Study in Systemic Sclerosis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Medicine; Toronto Alexithymia Scale; Mood; Beck Depression Inventory; Depression (economics); Mood disorders; Somatization; Psychiatry; Clinical psychology; Internal medicine; Anxiety","score_opus":0.06501942274196133,"score_gpt":0.3186111199350124,"score_spread":0.2535916971930511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313829353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912533,0.0057673343,0.0000024441529,0.000724076,0.000058616723,0.001882207,0.000012288572,0.000032602118,0.00026710462],"genre_scores_gemma":[0.9973679,0.0013562351,0.000019059957,0.00001993016,0.0000062412682,0.00023043466,0.000002533156,0.000022827295,0.00097480975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794185,0.0002093023,0.0005098969,0.00025964822,0.0006667687,0.00041255713],"domain_scores_gemma":[0.9985439,0.0001681106,0.0001457056,0.00081500696,0.0001464523,0.00018078304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031183165,0.00017679782,0.00046943058,0.00013210173,0.00006425381,0.000034686742,0.00040978476,0.00004676723,0.00080097734],"category_scores_gemma":[0.0004547235,0.00011388955,0.00017923067,0.00041709133,0.00015709916,0.00016142517,0.00018196204,0.00015434026,0.00015039802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009355794,0.002293154,0.9652247,0.021866916,0.00033028133,0.000011647317,0.0010817167,0.000085707194,0.0007185285,0.00010894942,0.0048480625,0.0033367793],"study_design_scores_gemma":[0.0009974682,0.0004210526,0.97708285,0.0191207,0.000056796962,0.000018170502,0.0010031887,0.0005284973,0.00041373033,0.00024236826,0.0000020941857,0.00011307795],"about_ca_topic_score_codex":0.00081281347,"about_ca_topic_score_gemma":0.000004723482,"teacher_disagreement_score":0.011858153,"about_ca_system_score_codex":0.000054018667,"about_ca_system_score_gemma":0.00023371635,"threshold_uncertainty_score":0.87701404},"labels":[],"label_agreement":null},{"id":"W2314174082","doi":"10.1136/annrheumdis-2014-eular.1054","title":"THU0173 Achievement and Maintenance of Remission/Low Disease Activity over 24 Months in Patients with Rheumatoid Arthritis Treated with Etanercept or Etanercept + Methotrexate in the Canadian Methotrexate and Etanercept Outcome (CAMEO) Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Southlake Regional Health Center; Amgen (Canada); Université de Montréal; Mount Sinai Hospital; Western University","funders":"","keywords":"Etanercept; Medicine; Methotrexate; Rheumatoid arthritis; Internal medicine; Combination therapy; Gastroenterology; Surgery; Arthritis; Antifolate; Randomized controlled trial; Antimetabolite","score_opus":0.027129352333569653,"score_gpt":0.2984612869861081,"score_spread":0.2713319346525384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314174082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436617,0.0014127691,0.000008789672,0.0015973457,0.00002510714,0.0022955553,0.0001697981,0.000018054117,0.000106382824],"genre_scores_gemma":[0.99435055,0.00493737,0.00012150383,0.00027825884,0.0000054700527,0.00013595741,0.000019644802,0.000046824433,0.00010441445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957208,0.0013124294,0.0007455257,0.0005242129,0.0010532932,0.0006437195],"domain_scores_gemma":[0.9972011,0.0006282326,0.00040082945,0.0009377738,0.00021226515,0.0006198071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00120732,0.0004506427,0.001110511,0.0003324512,0.00021674496,0.00008141327,0.00036078336,0.00006781057,0.00010704247],"category_scores_gemma":[0.0010818004,0.00021510011,0.00012008558,0.00058219023,0.00063514756,0.00027508673,0.00011436084,0.00033097793,0.0000013438864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005268092,0.001682428,0.9448628,0.00033458846,0.00028379075,0.000051379768,0.0023873236,0.00005071731,0.000014185516,0.00006550649,0.00013891135,0.04486031],"study_design_scores_gemma":[0.007863535,0.0015436332,0.9844055,0.0037178951,0.000049447775,0.000009722874,0.0013827152,0.0004678786,0.000037040423,0.00017890685,0.00007125747,0.00027247125],"about_ca_topic_score_codex":0.025829835,"about_ca_topic_score_gemma":0.08051545,"teacher_disagreement_score":0.054685615,"about_ca_system_score_codex":0.00005684979,"about_ca_system_score_gemma":0.0003039469,"threshold_uncertainty_score":0.9806572},"labels":[],"label_agreement":null},{"id":"W2314325724","doi":"10.1136/annrheumdis-2014-eular.3436","title":"FRI0582-HPR A Critical Review on Measurement Properties of Instruments Used to Evaluate Body Function in People with Knee Osteoarthritis","year":2014,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Sherbrooke","funders":"","keywords":"Medicine; Osteoarthritis; Physical therapy; Reliability (semiconductor); Visual analogue scale; Population; Physical medicine and rehabilitation; Alternative medicine; Pathology","score_opus":0.15384504008305566,"score_gpt":0.3451485593848033,"score_spread":0.19130351930174766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314325724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008028794,0.986156,0.000002395103,0.0005289274,0.0002004873,0.0048490795,0.00007019374,0.000024125535,0.00014001585],"genre_scores_gemma":[0.10544079,0.8928128,0.000019372383,0.0003819776,0.000027252227,0.0011407492,0.000035884696,0.00006327315,0.000077911645],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961672,0.0005038509,0.0011410842,0.00039964973,0.0014403948,0.00034785448],"domain_scores_gemma":[0.99792266,0.000092699134,0.00047946468,0.0008697266,0.00040617367,0.00022925054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059904746,0.00049031817,0.002824474,0.0002251727,0.000054482018,0.000017413204,0.00021669638,0.00009925244,0.00008510217],"category_scores_gemma":[0.001449033,0.0002679482,0.0006252595,0.00041629167,0.000093114315,0.00007691107,0.00008995164,0.00015762389,0.000054961227],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003134649,0.00072458835,0.00006330571,0.13527106,0.0002659166,0.0000030935366,0.000057550056,3.9150345e-7,0.0000038203234,0.00010524477,0.00024043038,0.86295116],"study_design_scores_gemma":[0.0021589105,0.009291467,0.0002672837,0.9648559,0.00486656,0.000021918926,0.00003608248,0.000001858691,0.00012318003,0.00009974361,0.017952628,0.0003244397],"about_ca_topic_score_codex":0.000029878744,"about_ca_topic_score_gemma":0.00006335277,"teacher_disagreement_score":0.8626267,"about_ca_system_score_codex":0.00008203443,"about_ca_system_score_gemma":0.0005279402,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W2314387514","doi":"10.1136/annrheumdis-2014-eular.2535","title":"THU0156 Impact of Golimumab on Physical Function and Employability of Patients with Rheumatoid Arthritis: 5-Year Data from 3 Phase III Clinical Trials","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Employability; Placebo; Internal medicine; Physical therapy; Population; Methotrexate; Concomitant; Clinical trial; Adalimumab; Alternative medicine","score_opus":0.13422698196043062,"score_gpt":0.4520920778046343,"score_spread":0.31786509584420364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314387514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672323,0.00042791944,0.00005523628,0.00009121224,0.000063920554,0.00086519466,0.0017119141,0.000015875947,0.000045462733],"genre_scores_gemma":[0.9990323,0.00053029857,0.000029923041,0.00003688589,0.000050376653,0.000011399469,0.00027944017,0.000023353246,0.000006025745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625784,0.0009846939,0.0012356393,0.0003962144,0.00089056056,0.00023504572],"domain_scores_gemma":[0.99259686,0.0040461365,0.0008729757,0.0018889147,0.00033149883,0.00026358216],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0019728418,0.00020807846,0.0015047003,0.00006478868,0.000041449173,0.000013108436,0.0003848801,0.00006991947,0.00016659961],"category_scores_gemma":[0.011194159,0.00011208992,0.00040371125,0.00016862061,0.00065593567,0.00014782608,0.0002733149,0.00014245977,0.0000060276902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096177645,0.03048757,0.5367805,0.0018248494,0.0058648586,0.0000021912927,0.00058083533,0.000119700504,0.00010331687,0.00036283935,0.014678632,0.31301707],"study_design_scores_gemma":[0.08336953,0.0064530126,0.8952034,0.003550743,0.00046023857,0.0000011422907,0.00007753872,0.007117563,0.00039940822,0.0031674418,0.00002143124,0.0001785147],"about_ca_topic_score_codex":0.00066187815,"about_ca_topic_score_gemma":0.000010294119,"teacher_disagreement_score":0.35842294,"about_ca_system_score_codex":0.0001318635,"about_ca_system_score_gemma":0.0014491573,"threshold_uncertainty_score":0.997135},"labels":[],"label_agreement":null},{"id":"W2314407063","doi":"10.1136/annrheumdis-2014-eular.3295","title":"FRI0165 The Molecular Convergence of Non-Hla Ankylosing Spondylitis Risk Genes with Autoimmune Diseases","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Memorial University of Newfoundland; Hospital for Sick Children","funders":"","keywords":"Ankylosing spondylitis; Genome-wide association study; Medicine; Disease; Rheumatoid arthritis; Human leukocyte antigen; Gene; Immunology; Genetics; Computational biology; Biology; Single-nucleotide polymorphism; Internal medicine","score_opus":0.012415944706741452,"score_gpt":0.2669760068897636,"score_spread":0.25456006218302213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314407063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97562414,0.021740092,0.00014085165,0.000992431,0.00011364357,0.00050276966,0.00057332695,0.000023722869,0.00028904434],"genre_scores_gemma":[0.9964453,0.0029926724,0.00011372551,0.00023260355,0.000019531715,0.000046452016,0.000030750816,0.000024898132,0.00009405058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984899,0.00015357697,0.00040237524,0.00020959684,0.00047392663,0.00027058204],"domain_scores_gemma":[0.9981708,0.00028631202,0.00040466196,0.0008129188,0.00020872783,0.00011659175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013563839,0.00022057667,0.00054482545,0.00004584517,0.0002144017,0.0000150211,0.0002583397,0.000028016115,0.00016340698],"category_scores_gemma":[0.00041856684,0.00011051779,0.00031918348,0.00024062164,0.00048658656,0.00006808816,0.00012781372,0.00006478798,0.000008129961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020775832,0.002605472,0.82369083,0.002075014,0.0047256984,0.00006738643,0.0013420724,0.00051745627,0.00075041683,0.002880534,0.002804814,0.15646271],"study_design_scores_gemma":[0.0019077779,0.0005710971,0.9863196,0.0022873303,0.0013024119,0.000019408482,0.00041506471,0.0007150089,0.004167338,0.0012988078,0.00082387705,0.0001723037],"about_ca_topic_score_codex":0.00038690877,"about_ca_topic_score_gemma":0.000008655942,"teacher_disagreement_score":0.16262873,"about_ca_system_score_codex":0.000008839758,"about_ca_system_score_gemma":0.00008106661,"threshold_uncertainty_score":0.45067847},"labels":[],"label_agreement":null},{"id":"W2314463542","doi":"10.1136/annrheumdis-2014-eular.2385","title":"AB0302 Profile of Joint Involvement over Time in Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Anti-TNF in A Real-World Setting","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of Alberta; University of Saskatchewan; Université de Montréal; McMaster University; Hôpital Notre-Dame; Montreal General Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Infliximab; Oligoarthritis; Polyarthritis; Arthritis; Adalimumab; Surgery; Ankylosing spondylitis; Rheumatology; BASDAI; Gastroenterology; Disease","score_opus":0.016060631520612996,"score_gpt":0.26338703320205525,"score_spread":0.24732640168144227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314463542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929561,0.004950368,0.0000016504611,0.00041454352,0.000028354665,0.0011327309,0.00009278706,0.000025864743,0.0003976245],"genre_scores_gemma":[0.9614793,0.038089786,0.00009883962,0.00008975352,0.000008215577,0.00010165017,0.000049400605,0.00003348235,0.000049588598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973365,0.00030656563,0.00094253395,0.00030630638,0.0006584796,0.0004496113],"domain_scores_gemma":[0.99849397,0.0002544596,0.00040555204,0.00047227874,0.0001802582,0.00019349714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051762915,0.0002576615,0.0009347878,0.00039507626,0.00006513619,0.00003169741,0.00014879514,0.0000455224,0.00018407137],"category_scores_gemma":[0.0006269724,0.0001801672,0.00012648867,0.0005151509,0.00030858145,0.00020098337,0.00011272822,0.00014297418,0.000007867856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037331422,0.0012866536,0.8009965,0.0006868212,0.0001781604,0.000008978406,0.00083355553,0.00001929034,0.0001248443,0.00029905836,0.0010230778,0.19416976],"study_design_scores_gemma":[0.0065945294,0.00065398816,0.9665858,0.021823283,0.0000069032862,0.000004875693,0.00013627495,0.0012744674,0.0018647197,0.00080429704,0.00005542332,0.00019539929],"about_ca_topic_score_codex":0.0014868707,"about_ca_topic_score_gemma":0.0007827347,"teacher_disagreement_score":0.19397436,"about_ca_system_score_codex":0.000027461829,"about_ca_system_score_gemma":0.0001222418,"threshold_uncertainty_score":0.7347005},"labels":[],"label_agreement":null},{"id":"W2314906058","doi":"10.1136/annrheumdis-2014-eular.1890","title":"AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Infliximab; Rituximab; Rheumatoid arthritis; Internal medicine; TNF inhibitor; Visual analogue scale; Rheumatology; Cohort; Clinical trial; Database; Physical therapy; Tumor necrosis factor alpha","score_opus":0.06414060930602469,"score_gpt":0.3404344388877495,"score_spread":0.27629382958172477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314906058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045646,0.006286233,0.000015481783,0.0013548956,0.000075896394,0.0009906559,0.0007660201,0.000017467362,0.00003686295],"genre_scores_gemma":[0.9601237,0.03848408,0.00021417152,0.00084721483,0.000018482659,0.000028064956,0.00022436885,0.00002687776,0.000032994933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972042,0.00038954982,0.0010036674,0.00041449323,0.0006797066,0.00030841157],"domain_scores_gemma":[0.9966379,0.0010205286,0.00048492654,0.0012674831,0.00026302537,0.00032612667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007179838,0.00024557105,0.0009227132,0.00008165661,0.0001311454,0.00008170856,0.00030593242,0.000056156416,0.00009729455],"category_scores_gemma":[0.002684073,0.00013888312,0.00011810498,0.00019064003,0.0007491115,0.00028866666,0.0002542327,0.0002099994,0.0000047565027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023467925,0.0017073675,0.93099606,0.00011963269,0.00041167607,0.000022730334,0.00043101312,0.0000034800184,0.000018967696,0.0000803662,0.012256194,0.05160573],"study_design_scores_gemma":[0.007770553,0.0006372917,0.9826734,0.0041955835,0.000010603993,0.000025345493,0.00015663104,0.00013678645,0.00015952626,0.0004720033,0.0036017806,0.00016050419],"about_ca_topic_score_codex":0.000933613,"about_ca_topic_score_gemma":0.00024761402,"teacher_disagreement_score":0.05167734,"about_ca_system_score_codex":0.000005142439,"about_ca_system_score_gemma":0.00013670084,"threshold_uncertainty_score":0.5663489},"labels":[],"label_agreement":null},{"id":"W2315076668","doi":"10.1136/annrheumdis-2013-eular.659","title":"THU0131 Correlation of Individual HAQ Questions with Outcome Measures in Rheumatoid Arthritis: Implications for Instrument Reduction","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hôpital Notre-Dame; University of Ottawa; Arthritis Research Centre of Canada; University of Alberta; Université de Montréal; Memorial University of Newfoundland; Southlake Regional Health Center","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Physical therapy; Infliximab; Correlation; Patient-reported outcome; Internal medicine; Logistic regression; Severity of illness; Adalimumab; Quality of life (healthcare); Disease","score_opus":0.057808259418450685,"score_gpt":0.32419346385285935,"score_spread":0.26638520443440866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315076668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98447734,0.006213992,0.00041895252,0.0066568097,0.00008185496,0.0018456804,0.00015677685,0.000030836643,0.000117778545],"genre_scores_gemma":[0.9895656,0.009123091,0.00051433285,0.00005513661,0.000010883757,0.00061365403,0.000064110594,0.000019121437,0.0000340501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983789,0.0001001302,0.00068967894,0.00017205937,0.0004125634,0.00024672426],"domain_scores_gemma":[0.9985242,0.00017680776,0.00031398094,0.00042258605,0.00043328115,0.00012912898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029640394,0.00014342603,0.00040020182,0.00019514463,0.00011714938,0.00003490174,0.00019256529,0.000046152025,0.000050123494],"category_scores_gemma":[0.0006672676,0.000096162716,0.00015945383,0.00028888765,0.0002835935,0.0002846358,0.00004360776,0.00009480522,0.000005957213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004713988,0.0018621903,0.5253186,0.00054947415,0.00066203653,3.5555175e-7,0.0016260482,0.00054674485,0.0005463206,0.017723756,0.005941272,0.4447518],"study_design_scores_gemma":[0.0019686574,0.0003733059,0.9774693,0.0028460086,0.00001632117,0.000029817249,0.0008028006,0.00019254415,0.0006822787,0.015356542,0.00014023967,0.0001221867],"about_ca_topic_score_codex":0.00038961836,"about_ca_topic_score_gemma":0.000068279856,"teacher_disagreement_score":0.4521507,"about_ca_system_score_codex":0.000019274537,"about_ca_system_score_gemma":0.00018327995,"threshold_uncertainty_score":0.39214018},"labels":[],"label_agreement":null},{"id":"W2315305182","doi":"10.1136/annrheumdis-2013-eular.1127","title":"THU0599 From Bad to Worse? The Impact of Switching Biologic Agents Multiple Times on Work Productivity and Health-Related Quality of Life for Patients with RA.","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Golimumab; Adalimumab; Abatacept; Etanercept; Rheumatoid arthritis; Tocilizumab; Physical therapy; Infliximab; Internal medicine; Cohort; Work productivity; Quality of life (healthcare); Certolizumab pegol; Rheumatology; Productivity; Rituximab; Disease","score_opus":0.0866449699528848,"score_gpt":0.3585350082056694,"score_spread":0.2718900382527846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315305182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943649,0.0012017605,0.000041041352,0.0028409364,0.00008783242,0.0010878724,0.0003583563,0.000008260227,0.000009052333],"genre_scores_gemma":[0.99945986,0.000032806915,0.00017547427,0.00023103002,0.000003839344,0.000027279459,0.000019841431,0.000007238984,0.00004261434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837536,0.0006214764,0.0005267983,0.00020353962,0.0000617512,0.00021104995],"domain_scores_gemma":[0.99746937,0.0013390253,0.0005862884,0.00040546758,0.00014510241,0.000054756114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057803106,0.00015387802,0.000564941,0.000035499404,0.000106443294,0.0000073059437,0.00024751198,0.00007373003,0.000117000855],"category_scores_gemma":[0.0021670249,0.00006347658,0.0001966198,0.00016035755,0.00023854277,0.000044431974,0.00010117927,0.0000864101,0.0000031020588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017527587,0.0014361524,0.9522723,0.0001498452,0.0013549442,1.26438175e-8,0.00048505777,0.000061581864,0.000589926,0.00007200116,0.007674961,0.034150448],"study_design_scores_gemma":[0.00067839294,0.00061264634,0.99503726,0.00035136874,0.000041123516,4.4504247e-8,0.0000796418,0.000018486517,0.0010718814,0.0020205986,0.0000068470026,0.00008172512],"about_ca_topic_score_codex":0.0019491024,"about_ca_topic_score_gemma":0.000016541513,"teacher_disagreement_score":0.042764932,"about_ca_system_score_codex":0.00000749274,"about_ca_system_score_gemma":0.000051214098,"threshold_uncertainty_score":0.29464728},"labels":[],"label_agreement":null},{"id":"W2315559512","doi":"10.1136/annrheumdis-2014-eular.1827","title":"OP0078 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-WEEK) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Apremilast; Psoriatic arthritis; Randomized controlled trial; Internal medicine; Placebo; Clinical endpoint; Gastroenterology; Psoriasis; Surgery; Rheumatoid arthritis; Dermatology; Pathology","score_opus":0.040219577723373735,"score_gpt":0.3114789602206468,"score_spread":0.27125938249727305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315559512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895932,0.003429397,0.00004293162,0.00049791194,0.00010120233,0.004906901,0.001383267,0.000027122913,0.00001802997],"genre_scores_gemma":[0.9961595,0.0029395584,0.00002710849,0.00015169829,0.000026461274,0.0004033751,0.00023519681,0.000040985524,0.000016120755],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99261695,0.0028425981,0.0020608583,0.0004770786,0.0014957731,0.0005067304],"domain_scores_gemma":[0.9930502,0.0034060501,0.00168926,0.00085705065,0.00053245435,0.00046496873],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0041500693,0.0004484558,0.0043408284,0.0002780892,0.000079425045,0.0000709834,0.00029375055,0.0000759235,0.000073226736],"category_scores_gemma":[0.016575685,0.00024230196,0.0005836548,0.0003265453,0.00049171905,0.00040491612,0.00007690794,0.00020501176,0.0000013389366],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.829362,0.013635809,0.06650872,0.00022640069,0.0021819316,0.000013566549,0.0009428301,0.000052035102,0.000060905044,0.000014522821,0.00015440663,0.0868469],"study_design_scores_gemma":[0.71355635,0.0031355883,0.26613775,0.013071995,0.00030670816,2.4050257e-7,0.00009408849,0.0008329247,0.001945688,0.00062621786,0.0000017923787,0.00029067954],"about_ca_topic_score_codex":0.0007647047,"about_ca_topic_score_gemma":0.0006235285,"teacher_disagreement_score":0.19962902,"about_ca_system_score_codex":0.00005063421,"about_ca_system_score_gemma":0.0003663974,"threshold_uncertainty_score":0.9917081},"labels":[],"label_agreement":null},{"id":"W2315621400","doi":"10.1136/annrheumdis-2014-eular.5893","title":"SAT0286 Paediatric Vasculitis Damage Index: A New Tool for Standardised Disease Assessment","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Vasculitis; Medicine; Systemic vasculitis; Rheumatology; Disease; Pediatrics; Internal medicine","score_opus":0.020204405884374346,"score_gpt":0.3086747029468668,"score_spread":0.28847029706249244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315621400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92849463,0.005553213,0.020250766,0.036190636,0.00085587613,0.0040460676,0.0021465144,0.00023001054,0.0022322931],"genre_scores_gemma":[0.9965542,0.0006557314,0.0003814615,0.0010387064,0.00015717073,0.0001197937,0.00013786634,0.00003294532,0.0009221173],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99827605,0.00011930908,0.00047955706,0.00025100418,0.00055866764,0.00031538447],"domain_scores_gemma":[0.99798155,0.00032295656,0.00022247683,0.00077657995,0.00021383545,0.0004826194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026615473,0.00020155883,0.0004658941,0.000102872364,0.00018897583,0.00004357184,0.00022697236,0.000060369817,0.00033211906],"category_scores_gemma":[0.0010913565,0.00013065226,0.0008809079,0.00025031745,0.00010902935,0.00011348707,0.0000790556,0.0001096651,0.000011297001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010198349,0.0028288392,0.1529256,0.005365974,0.0040737926,0.000020599786,0.000538177,0.0017799436,0.000030364303,0.040737342,0.43555158,0.35512796],"study_design_scores_gemma":[0.0045305574,0.00022868798,0.95133954,0.0010986115,0.0015270901,0.0000037718266,0.00007603981,0.0031949575,0.00002728969,0.030176774,0.007554168,0.00024249146],"about_ca_topic_score_codex":0.000037229758,"about_ca_topic_score_gemma":0.0000018712813,"teacher_disagreement_score":0.798414,"about_ca_system_score_codex":0.000028102082,"about_ca_system_score_gemma":0.0006213551,"threshold_uncertainty_score":0.5327844},"labels":[],"label_agreement":null},{"id":"W2315625975","doi":"10.1136/annrheumdis-2012-eular.2128","title":"THU0163 Predictors of metabolic syndrome at enrolment into a multicentre international inception cohort of patients with SLE","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Cohort; Metabolic syndrome; Internal medicine; Cohort study; Logistic regression; Disease; Obesity","score_opus":0.016258499843720436,"score_gpt":0.2882345222252525,"score_spread":0.27197602238153207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315625975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682766,0.0014477164,0.000010294276,0.00015668274,0.00025698714,0.000968957,0.00012818458,0.000010745545,0.00019274723],"genre_scores_gemma":[0.99922425,0.00024275463,0.000080232996,0.00002431319,0.000018697601,0.00005017778,0.000060273538,0.000016959906,0.00028234956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775517,0.000120646124,0.00055996916,0.00012872046,0.0012161807,0.00021928498],"domain_scores_gemma":[0.9982757,0.00015897129,0.0005073174,0.0004601048,0.0004279304,0.0001699627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029651093,0.00013586805,0.00049238786,0.00013158927,0.000032131153,0.000003579717,0.0002584449,0.000037685895,0.0003252755],"category_scores_gemma":[0.0005041001,0.00007801746,0.00017002746,0.00017723178,0.00019612486,0.0001437882,0.00019381102,0.000049372156,0.00001277076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045489892,0.001236966,0.9928042,0.0012154472,0.00102602,4.0177045e-7,0.0018075074,0.0000137139705,0.00006252875,0.00006934789,0.00064580434,0.0006631092],"study_design_scores_gemma":[0.0015272564,0.00012414041,0.99386966,0.0019231281,0.00028515438,0.000024097499,0.0004144461,0.000096433316,0.0015456723,0.000035266596,0.0000879729,0.00006675716],"about_ca_topic_score_codex":0.00008904635,"about_ca_topic_score_gemma":0.000004334761,"teacher_disagreement_score":0.0023965556,"about_ca_system_score_codex":0.00004362606,"about_ca_system_score_gemma":0.00007969466,"threshold_uncertainty_score":0.35615388},"labels":[],"label_agreement":null},{"id":"W2315632856","doi":"10.1136/annrheumdis-2012-eular.2243","title":"THU0278 The effect of anti-tumor necrosis factor therapy with golimumab on radiographic progression in definite ankylosing spondylitis: 4-year results","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Golimumab; BASDAI; BASFI; Internal medicine; Surgery; Radiography; Adalimumab; Tumor necrosis factor alpha; Rheumatoid arthritis; Psoriatic arthritis","score_opus":0.03012435094838036,"score_gpt":0.3120500816017624,"score_spread":0.28192573065338206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315632856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98769873,0.0098393755,3.139959e-7,0.00059351407,0.000089943394,0.0011126784,0.00042967597,0.000021208842,0.00021454098],"genre_scores_gemma":[0.9974569,0.002225508,0.000022694054,0.00012293589,0.000022143973,0.00008493137,0.000026780976,0.000026371627,0.000011710515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828154,0.0002723755,0.00040967966,0.00018618567,0.0004805271,0.00036969548],"domain_scores_gemma":[0.99829906,0.0006142008,0.00034136503,0.00057327905,0.00006454295,0.00010754583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003007954,0.00024522722,0.0005871846,0.0001334204,0.00012984495,0.000015467564,0.00016210596,0.000034840916,0.000028666773],"category_scores_gemma":[0.0003180408,0.000104110724,0.0002822662,0.0004764041,0.0002760082,0.00009964131,0.000050073577,0.00010264107,0.000003634901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008948581,0.0012823007,0.9602355,0.00036802288,0.0005791548,0.000011054383,0.0010061051,0.000006123027,0.00008328274,0.00010033696,0.00031552123,0.027064048],"study_design_scores_gemma":[0.0066084103,0.002751407,0.97854835,0.005360232,0.00015300029,0.000012919855,0.00018417081,0.000008231568,0.006097656,0.000055825432,0.00010559688,0.000114176735],"about_ca_topic_score_codex":0.00011645961,"about_ca_topic_score_gemma":0.000006109276,"teacher_disagreement_score":0.026949871,"about_ca_system_score_codex":0.000013657577,"about_ca_system_score_gemma":0.000031551022,"threshold_uncertainty_score":0.42455122},"labels":[],"label_agreement":null},{"id":"W2315748669","doi":"10.1136/annrheumdis-2012-eular.1339","title":"AB1345 The number needed to offend: Beliefs and feelings in patients and rheumatologists","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Feeling; Medicine; Offensive; Rheumatology; Outpatient clinic; Family medicine; Harm; Physical therapy; Medical diagnosis; Internal medicine; Psychiatry; Clinical psychology; Social psychology; Psychology; Pathology","score_opus":0.032972983916337205,"score_gpt":0.32336200264293014,"score_spread":0.29038901872659295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315748669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904186,0.0021394202,0.0000013796897,0.006603707,0.0000631555,0.0005058624,0.000013867122,0.000011295089,0.00024267565],"genre_scores_gemma":[0.999054,0.00048036352,0.00003714961,0.0002291431,0.000005419761,0.000027732192,0.000005335798,0.000014139266,0.00014669153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987029,0.00010451552,0.00029846356,0.00014059298,0.00038340586,0.0003701638],"domain_scores_gemma":[0.9989996,0.0002512824,0.00008585658,0.00034138892,0.00007683193,0.00024505978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030705307,0.00013545211,0.0003166247,0.000058498776,0.00008309193,0.00002065935,0.00016209277,0.00004474113,0.00006656293],"category_scores_gemma":[0.0008125093,0.00007199535,0.00007046273,0.00021050741,0.0002277293,0.00010117113,0.00021709556,0.00010921703,0.000023437335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017108096,0.00049370417,0.97418594,0.0021070035,0.000114022114,9.1732613e-7,0.002052842,0.0000020113548,0.000014755431,0.00071174535,0.011087126,0.009058866],"study_design_scores_gemma":[0.0008684429,0.00009904081,0.99615455,0.0015327295,0.000031822572,0.000014480013,0.00049119006,0.00003915132,0.00017107886,0.0004177347,0.00009210836,0.000087652756],"about_ca_topic_score_codex":0.0003468918,"about_ca_topic_score_gemma":0.000002639999,"teacher_disagreement_score":0.021968642,"about_ca_system_score_codex":0.000015023886,"about_ca_system_score_gemma":0.000058026315,"threshold_uncertainty_score":0.29358852},"labels":[],"label_agreement":null},{"id":"W2315817472","doi":"10.1136/annrheumdis-2013-eular.1617","title":"FRI0490 The four finger examination technique is superior to the standard two finger technique to detect metacarpal phalangeal joint swelling in rheumatoid arthritis - a validation by power doppler ultrasound","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Synovitis; Rheumatoid arthritis; Palpation; Physical examination; Power doppler; Ultrasound; Grey scale; Nuclear medicine; Radiology; Surgery; Internal medicine","score_opus":0.02726926070060002,"score_gpt":0.29450214030615496,"score_spread":0.2672328796055549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315817472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963865,0.006215363,0.0061179185,0.017338758,0.00011835766,0.0057873256,0.0002703195,0.00008353707,0.0002034661],"genre_scores_gemma":[0.98756903,0.007812773,0.0010187887,0.0013173083,0.000030565407,0.0020556757,0.000021968744,0.000057150864,0.00011673099],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996589,0.00057540595,0.0008004136,0.0003920898,0.0010485308,0.0005945498],"domain_scores_gemma":[0.9975586,0.0006435597,0.0002141717,0.0008910757,0.00042695928,0.0002656118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016729772,0.00033911414,0.0006035656,0.00025645466,0.0003386479,0.0002348108,0.0005319313,0.00008570597,0.0009667031],"category_scores_gemma":[0.0018743381,0.00018808566,0.0003021834,0.0006444262,0.00019873088,0.00037180353,0.00017085501,0.00032590175,0.000079172314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011723008,0.0012504027,0.013104921,0.0007107122,0.001419883,0.000029856565,0.02213345,0.00042606227,0.14598048,0.00081253774,0.33084714,0.48211223],"study_design_scores_gemma":[0.0043289806,0.0022238523,0.10492168,0.014506799,0.00006814167,0.0004735977,0.00390061,0.000388606,0.82473755,0.013584175,0.029422542,0.0014434373],"about_ca_topic_score_codex":0.00088042,"about_ca_topic_score_gemma":0.00009391222,"teacher_disagreement_score":0.6787571,"about_ca_system_score_codex":0.0000650631,"about_ca_system_score_gemma":0.00014832319,"threshold_uncertainty_score":0.99994653},"labels":[],"label_agreement":null},{"id":"W2315890402","doi":"10.1136/annrheumdis-2013-eular.1928","title":"SAT0202 Early Accrual of Organ Damage in Systemic Sclerosis: Rationale for Forming a Multinational Inception Cohort of Patients with Scleroderma (The Insync Study)","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Scleroderma (fungus); Disease; Organ dysfunction; Organ system; Internal medicine; Pathology","score_opus":0.032196515632945864,"score_gpt":0.26137337141230854,"score_spread":0.22917685577936267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315890402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948604,0.0005623895,0.000026433137,0.0001835941,0.000054182467,0.004152047,0.0001352958,0.000010782889,0.000014883824],"genre_scores_gemma":[0.99925256,0.00008134057,0.000047410944,0.000057054192,0.000014687281,0.00044478706,0.00005271268,0.000019786869,0.000029661707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980063,0.00014412454,0.00083812035,0.00017916232,0.0006704499,0.00016187612],"domain_scores_gemma":[0.99766976,0.00036665527,0.0007031253,0.0003842278,0.0008126306,0.0000635925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003007398,0.00015303676,0.0004593853,0.00013065676,0.000083398445,0.000015584908,0.00023445445,0.00004752292,0.00005935926],"category_scores_gemma":[0.0006333731,0.00008226048,0.00016252618,0.00033717128,0.00015584046,0.00022761339,0.00006738998,0.000059016256,0.0000027899855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028296286,0.0018978358,0.9892297,0.00082684995,0.00039231515,7.958013e-8,0.0017976018,0.00027732982,0.0006379452,0.00007071523,0.00035456533,0.004232144],"study_design_scores_gemma":[0.0029822604,0.00029908857,0.9844497,0.007585967,0.00027409664,5.2209896e-7,0.002976698,0.00073344837,0.0005233786,0.00008996651,3.4805734e-7,0.000084526255],"about_ca_topic_score_codex":0.0002279125,"about_ca_topic_score_gemma":0.00001251762,"teacher_disagreement_score":0.006759117,"about_ca_system_score_codex":0.00002702293,"about_ca_system_score_gemma":0.00015536524,"threshold_uncertainty_score":0.3354485},"labels":[],"label_agreement":null},{"id":"W2315984390","doi":"10.1136/annrheumdis-2012-eular.1853","title":"OP0170 Achieving ASDAS-CRP major improvement and inactive disease in patients with ankylosing spondylitis after treatment with golimumab is associated with normalized health related quality of life: Two-year results from the go-raise trial","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Placebo; Ankylosing spondylitis; Quality of life (healthcare); Physical therapy; Visual analogue scale; Internal medicine; Minimal clinically important difference; Disease; Randomized controlled trial; Adalimumab","score_opus":0.031519381027550544,"score_gpt":0.3021827593323895,"score_spread":0.27066337830483894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315984390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865917,0.0031642187,6.4348023e-7,0.0012713863,0.000049744966,0.0025455991,0.0063134646,0.000017734017,0.00004552671],"genre_scores_gemma":[0.9986994,0.00031195272,0.000046636975,0.00028838703,0.000018441788,0.00016879675,0.00039760472,0.00003361752,0.000035144152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972427,0.00042159972,0.00086035917,0.00033376264,0.0006891886,0.00045238336],"domain_scores_gemma":[0.99728763,0.0005430101,0.0010203021,0.00059715763,0.00020225566,0.00034964478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003969603,0.00034483708,0.0009784227,0.000062077816,0.0001754353,0.000023693741,0.00009531479,0.000040821073,0.000044434288],"category_scores_gemma":[0.000549642,0.00016288403,0.00014697354,0.000283981,0.00027772234,0.00021606302,0.0000885678,0.00010722809,0.0000010573017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20116284,0.003821915,0.78674847,0.000106556414,0.0019477158,0.00000608221,0.0033692769,0.000003512821,7.241778e-7,0.000015377462,0.000045497163,0.0027720109],"study_design_scores_gemma":[0.11588284,0.0038108942,0.87569755,0.002947178,0.0006287423,4.0453529e-7,0.00080394786,0.0000072288744,0.000018275547,0.0000350322,0.000009169689,0.0001587546],"about_ca_topic_score_codex":0.0077705993,"about_ca_topic_score_gemma":0.0005901769,"teacher_disagreement_score":0.08894905,"about_ca_system_score_codex":0.00016536038,"about_ca_system_score_gemma":0.00028159207,"threshold_uncertainty_score":0.99883676},"labels":[],"label_agreement":null},{"id":"W2316011782","doi":"10.1136/annrheumdis-2012-eular.2873","title":"FRI0416 Remission definitions affect cost savings estimates in anti-TNF treated rheumatoid arthritis patients","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Propensity score matching; Confounding; Cohort; Internal medicine; Physical therapy; Pediatrics","score_opus":0.049547572380212235,"score_gpt":0.31637556821766766,"score_spread":0.2668279958374554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316011782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757598,0.021489823,0.00000675976,0.0007857194,0.00014586205,0.00093250227,0.00016700516,0.00007113415,0.0006413918],"genre_scores_gemma":[0.932392,0.06705019,0.00009593987,0.0001536542,0.000016761842,0.00010257499,0.00012520823,0.000037585007,0.000026067222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976804,0.00020189665,0.00061997626,0.00021958197,0.0006045812,0.00067354686],"domain_scores_gemma":[0.99807537,0.00049416855,0.00023876055,0.00054234435,0.00020339376,0.00044595127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003313289,0.00026933954,0.0006542791,0.00022375115,0.000203285,0.000043468663,0.00023257382,0.00007642678,0.00034315817],"category_scores_gemma":[0.002481521,0.00018533396,0.00029568563,0.00044454873,0.00027964558,0.00038323793,0.00012401745,0.00017095098,0.00007804891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018979944,0.0021526956,0.9060193,0.00028095406,0.00015732794,0.000004968266,0.00048557544,0.000006817133,0.0002037165,0.00049328106,0.00895416,0.08105144],"study_design_scores_gemma":[0.0026233266,0.0001901878,0.9802897,0.009279244,0.000013218375,0.000025692327,0.00017411385,0.00011604566,0.0050541763,0.0012741741,0.00073663215,0.00022347628],"about_ca_topic_score_codex":0.0002278614,"about_ca_topic_score_gemma":0.000015191339,"teacher_disagreement_score":0.08082796,"about_ca_system_score_codex":0.000032038395,"about_ca_system_score_gemma":0.000101958685,"threshold_uncertainty_score":0.75576997},"labels":[],"label_agreement":null},{"id":"W2316060747","doi":"10.1136/annrheumdis-2012-eular.133","title":"AB0133 New evidence linking the in vivo implication of 4-hydroxynonenal in osteoarthritis pathogenesis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biochemical effects in animals","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Cartilage; 4-Hydroxynonenal; Pathogenesis; Pathology; In vivo; Lipid peroxidation; Internal medicine; Oxidative stress; Anatomy; Biology","score_opus":0.053291226172242454,"score_gpt":0.3341171342668131,"score_spread":0.28082590809457064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316060747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97902656,0.01753224,0.000017002245,0.0027128295,0.000052222207,0.0005144283,0.000014824563,0.00000916569,0.00012073992],"genre_scores_gemma":[0.9984123,0.0009711579,0.00012179542,0.00036964158,0.000044188,0.000034257155,0.0000017754329,0.0000121849025,0.000032689455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986709,0.00015649965,0.00048329326,0.00012412627,0.00032626264,0.00023895677],"domain_scores_gemma":[0.998295,0.0007972801,0.00024443195,0.00049766735,0.000058934696,0.00010666395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057344866,0.00011342709,0.00032414938,0.000067058114,0.000022457492,0.000006341896,0.00027134956,0.0000582526,0.00006817471],"category_scores_gemma":[0.0020670253,0.00006769352,0.00014336138,0.00036263262,0.00013922967,0.00012273388,0.00011048585,0.000095283365,0.0000054358247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006194556,0.0012428408,0.48380932,0.002935529,0.00010928424,0.0000029484975,0.002373929,0.000072724404,0.25250152,0.0011952086,0.0029376089,0.25219962],"study_design_scores_gemma":[0.0006213103,0.00013966413,0.81221706,0.010588723,0.00008927711,0.000011263172,0.00012656383,0.00015564387,0.17421748,0.0016761663,0.000044755518,0.00011207972],"about_ca_topic_score_codex":0.0002161609,"about_ca_topic_score_gemma":0.000012401494,"teacher_disagreement_score":0.32840773,"about_ca_system_score_codex":0.000018109522,"about_ca_system_score_gemma":0.00010011134,"threshold_uncertainty_score":0.2760462},"labels":[],"label_agreement":null},{"id":"W2316188757","doi":"10.1136/annrheumdis-2014-eular.3360","title":"FRI0249 Case Definition for Erosions Imaged with High Resolution Peripheral Quantitative Computed Tomography (HR-PQCT): an International Spectra Reliability Exercise-1 (RELEX-1)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Quantitative computed tomography; Cortical bone; Peripheral; Kappa; Radiology; Image quality; Rheumatoid arthritis; Nuclear medicine; Bone erosion; Reproducibility; Anatomy; Pathology; Internal medicine; Osteoporosis; Image (mathematics); Bone mineral","score_opus":0.03981548065851222,"score_gpt":0.31605051225355624,"score_spread":0.27623503159504403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316188757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900316,0.0008685536,0.0050102994,0.002083182,0.00017082882,0.0010620039,0.0005259218,0.00008201871,0.00016557213],"genre_scores_gemma":[0.9871167,0.0010998121,0.01115466,0.00014242099,0.00004008331,0.00014709614,0.0002525172,0.000027927957,0.000018802173],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9982066,0.0002579181,0.00042135426,0.00031057568,0.0004921959,0.00031135333],"domain_scores_gemma":[0.9979302,0.00042492268,0.00022045903,0.00054890796,0.00063502614,0.00024044675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042065978,0.00019899858,0.00040864773,0.00014642447,0.00032118673,0.000065689186,0.00022704956,0.000046533605,0.00011297986],"category_scores_gemma":[0.00079177856,0.00013211665,0.00026691437,0.0002463427,0.00045271107,0.00037098097,0.000048713726,0.00012918713,0.0000040001587],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07619345,0.032811336,0.16517721,0.007931805,0.006546824,0.0003747826,0.017452605,0.0070790485,0.006754177,0.3911705,0.050875574,0.23763268],"study_design_scores_gemma":[0.014082711,0.008620927,0.796312,0.009280233,0.00030934962,0.0005496493,0.00354531,0.05886941,0.005760506,0.10091926,0.00074745005,0.0010032248],"about_ca_topic_score_codex":0.00040687883,"about_ca_topic_score_gemma":0.00009898981,"teacher_disagreement_score":0.63113475,"about_ca_system_score_codex":0.000023775632,"about_ca_system_score_gemma":0.00010216195,"threshold_uncertainty_score":0.5387561},"labels":[],"label_agreement":null},{"id":"W2316233576","doi":"10.1136/annrheumdis-2014-eular.4489","title":"FRI0103 The Omeract Preliminary Flare Questionnaire (PFQ) is Responsive to Change and Able to Detect Clinically Important Worsening Indicating Need for Treatment Change in the Canadian Early Arthritis Cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Manitoba; Southlake Regional Health Center; University of Toronto; McGill University; Arthritis Research Centre of Canada; Université de Sherbrooke","funders":"","keywords":"Medicine; Cohort; Flare; Rheumatoid arthritis; Physical therapy; Internal medicine","score_opus":0.06144762883945225,"score_gpt":0.35113973107319946,"score_spread":0.2896921022337472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316233576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.930455,0.012772692,0.00000717625,0.052548163,0.00006831361,0.0039361157,0.0001605244,0.000016437816,0.00003557132],"genre_scores_gemma":[0.9833758,0.007827098,0.00014718568,0.006694737,0.00009284472,0.0017906621,0.000013401628,0.000026827536,0.00003145179],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977867,0.00038868358,0.00060282,0.00028208602,0.00042537943,0.00051431474],"domain_scores_gemma":[0.99756277,0.00097545236,0.00021845508,0.0006097596,0.00018180464,0.00045176275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014374255,0.0002098158,0.0004568711,0.00021058533,0.00045298462,0.000103547725,0.00030769836,0.000059771133,0.00002568263],"category_scores_gemma":[0.0034949754,0.00011265886,0.00017320228,0.0003424473,0.00014321593,0.00013190585,0.000073583535,0.000114941584,0.000009284787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013951784,0.00017406075,0.31228185,0.00016038261,0.00027692487,0.000020898298,0.029539432,0.0000032173123,0.000019079136,0.0001478825,0.0024866217,0.6534945],"study_design_scores_gemma":[0.0009856079,0.00272608,0.98670834,0.0042671966,0.000034086584,0.000026200665,0.0011375668,0.00028112423,0.00011839689,0.00074911886,0.0028082377,0.00015805532],"about_ca_topic_score_codex":0.047424678,"about_ca_topic_score_gemma":0.04684082,"teacher_disagreement_score":0.6744265,"about_ca_system_score_codex":0.0000431064,"about_ca_system_score_gemma":0.00025722213,"threshold_uncertainty_score":0.97055185},"labels":[],"label_agreement":null},{"id":"W2316417823","doi":"10.1136/annrheumdis-2015-eular.2771","title":"THU0419 Integrated Safety of Ustekinumab in Psoriatic Arthritis: 2 Year Follow-Up from the Psoriatic Arthritis Clinical Development Program","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Concomitant; Internal medicine; Psoriasis; Arthritis; Gastroenterology; Pediatrics; Dermatology; Rheumatoid arthritis; Adalimumab","score_opus":0.08173107485383593,"score_gpt":0.3640126373384116,"score_spread":0.2822815624845757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316417823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820331,0.013491296,0.000026313965,0.0017881246,0.00041117516,0.0016592847,0.00008391852,0.000048836788,0.00045796554],"genre_scores_gemma":[0.99394923,0.0049226023,0.00037806964,0.00023160822,0.000043117434,0.00014513472,0.000095453426,0.000032058193,0.0002027314],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99598444,0.0006072905,0.0018125672,0.00027652565,0.0009268203,0.0003923597],"domain_scores_gemma":[0.9973902,0.00060341205,0.0005182828,0.0008652239,0.00041365504,0.00020924042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014444616,0.00023992319,0.0009916676,0.00009246952,0.00008189607,0.00003249614,0.0005535556,0.00011685588,0.00022597978],"category_scores_gemma":[0.0049866103,0.00014142775,0.00036810862,0.00050645176,0.00035175306,0.00013906005,0.00022193948,0.00032063003,0.00006407232],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011770617,0.001496768,0.05393213,0.00022871315,0.0005852851,0.000009226868,0.0022852237,0.000017494176,0.000002026204,0.00021911068,0.012575684,0.9274713],"study_design_scores_gemma":[0.015964106,0.00088193367,0.939665,0.01175191,0.00020039041,0.0000063905018,0.009101046,0.0010380262,0.0003297307,0.00462252,0.01604796,0.0003909645],"about_ca_topic_score_codex":0.00038712157,"about_ca_topic_score_gemma":0.0002419173,"teacher_disagreement_score":0.92708033,"about_ca_system_score_codex":0.000040988012,"about_ca_system_score_gemma":0.0015771295,"threshold_uncertainty_score":0.59697986},"labels":[],"label_agreement":null},{"id":"W2316494699","doi":"10.1136/annrheumdis-2012-eular.2729","title":"FRI0272 How much does the spondyloarthritis research consortium of canada (SPARCC)-score of the SI-joints change over a 3-month period in patients on non-biological treatment?","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axial spondyloarthritis; Cohort; Internal medicine; Surgery; Nuclear medicine; Arthritis","score_opus":0.10037124058565725,"score_gpt":0.329519310059273,"score_spread":0.22914806947361574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316494699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047744,0.002922989,2.3840537e-8,0.0037314096,0.00025844912,0.0014853068,0.0007869998,0.000004335256,0.00033304226],"genre_scores_gemma":[0.9983435,0.000965522,0.0000027801618,0.00021491037,0.00003917797,0.0001927103,0.000019698795,0.00001613192,0.0002055502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771833,0.00033238143,0.00040672603,0.000206026,0.0008027608,0.0005337964],"domain_scores_gemma":[0.9981362,0.00046994814,0.00029215112,0.00073313987,0.00022728568,0.00014126647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027683086,0.00022764795,0.0006157149,0.00006961102,0.00020955523,0.0000093329745,0.00028578145,0.000057366724,0.00013698534],"category_scores_gemma":[0.00088799174,0.00008956317,0.00026966317,0.00032155454,0.0005660638,0.000069213915,0.00020325294,0.00012570954,0.0000016475547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006650817,0.002236017,0.9845373,0.00013960646,0.0003041954,0.000006765844,0.0015006922,5.327299e-7,0.000014415652,0.00013677539,0.0021321059,0.008326513],"study_design_scores_gemma":[0.0026470823,0.00092722545,0.99164236,0.0014279796,0.00007683523,0.000002135138,0.0015748849,0.000006878943,0.0011751617,0.00014527896,0.00028919565,0.00008501217],"about_ca_topic_score_codex":0.035509117,"about_ca_topic_score_gemma":0.031472083,"teacher_disagreement_score":0.008241501,"about_ca_system_score_codex":0.00009280669,"about_ca_system_score_gemma":0.00021762178,"threshold_uncertainty_score":0.98620105},"labels":[],"label_agreement":null},{"id":"W2316774930","doi":"10.1136/annrheumdis-2012-eular.2640","title":"FRI0183 Sustained inhibition of structural damage in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors prior to rituximab treatment: 5-year data from the reflex study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Rheumatoid arthritis; Placebo; Gastroenterology; Population; Methotrexate; Surgery; Pathology; Lymphoma","score_opus":0.039757620991026726,"score_gpt":0.3310390019624469,"score_spread":0.2912813809714202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316774930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930315,0.0015097514,0.0000017895018,0.001417731,0.000050951774,0.0022769887,0.0016856411,0.000021166688,0.000004463823],"genre_scores_gemma":[0.99874485,0.0007453995,0.0001266964,0.000101680875,0.000021554322,0.000064034364,0.0001510041,0.000034460056,0.00001030678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972968,0.0006574293,0.0005821359,0.00033395062,0.0006830305,0.00044663498],"domain_scores_gemma":[0.99761987,0.00041348845,0.00021585987,0.0011149029,0.00020730628,0.0004285719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000467108,0.0002689098,0.0006110102,0.00018023376,0.00017346698,0.00007058513,0.00034380797,0.000036751844,0.00007590073],"category_scores_gemma":[0.0012459266,0.00014935085,0.00006608707,0.00039108022,0.00018933912,0.00062838936,0.00034640753,0.000103107275,0.0000065049885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015381505,0.0032814154,0.9051757,0.000066545064,0.00029962597,0.0000054104084,0.015357023,0.0000046487125,0.0003529681,0.00003163846,0.00054095505,0.05950259],"study_design_scores_gemma":[0.008022696,0.0026649013,0.98009056,0.0016729137,0.000016910368,0.0000011273946,0.005971497,0.000020491836,0.0012054079,0.00013034308,0.000040729097,0.00016240892],"about_ca_topic_score_codex":0.001634502,"about_ca_topic_score_gemma":0.0006551275,"teacher_disagreement_score":0.074914895,"about_ca_system_score_codex":0.000042458665,"about_ca_system_score_gemma":0.00014644896,"threshold_uncertainty_score":0.6090351},"labels":[],"label_agreement":null},{"id":"W2316813582","doi":"10.1136/annrheumdis-2013-eular.1569","title":"FRI0442 Commonalities and differences in subsets of axial spondyloarthritis: analysis of a longitudinal observational cohort","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Ankylosing spondylitis; Axial spondyloarthritis; Internal medicine; Cohort; Cohort study; Physical therapy; Gastroenterology","score_opus":0.07491839333148063,"score_gpt":0.3081523118812461,"score_spread":0.23323391854976544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316813582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922531,0.006233727,0.0000012325632,0.00062760705,0.000031423155,0.00035142087,0.00036571556,0.0000048649495,0.00013090952],"genre_scores_gemma":[0.9984378,0.0012982988,0.000042650663,0.0000515343,0.0000059078757,0.000054339896,0.00005222706,0.0000056662125,0.00005155076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987028,0.00006634397,0.0005478224,0.00014361339,0.00038904438,0.00015033814],"domain_scores_gemma":[0.99886656,0.00032528545,0.00027766463,0.00024608674,0.00021813189,0.00006625639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105142455,0.0001304429,0.00081512524,0.00017448506,0.00004217864,0.000008160847,0.00010236029,0.000030595074,0.00031445117],"category_scores_gemma":[0.0002621021,0.00008766102,0.00024378065,0.00043773922,0.00037459977,0.00009195704,0.00007913443,0.000039150087,0.000001089622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010458606,0.0004814049,0.9938453,0.00027089674,0.0019618666,0.0000024424305,0.00026678166,0.0000043278123,0.000011531435,0.00081316294,0.0002058706,0.0020318474],"study_design_scores_gemma":[0.00085214915,0.0001377343,0.9948945,0.0008390081,0.00088054634,0.0000024530498,0.00042978628,0.00018061516,0.0000917088,0.001623401,0.0000025847846,0.000065510656],"about_ca_topic_score_codex":0.0020100067,"about_ca_topic_score_gemma":0.0003090149,"teacher_disagreement_score":0.0061847256,"about_ca_system_score_codex":0.0000066597877,"about_ca_system_score_gemma":0.00004618754,"threshold_uncertainty_score":0.3574713},"labels":[],"label_agreement":null},{"id":"W2316874297","doi":"10.1136/annrheumdis-2012-eular.1744","title":"OP0061 Seizures in systemic lupus erythematosus: A prospective study of predictors and outcomes in a large, international, disease inception cohort","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Internal medicine; Systemic lupus erythematosus; Cohort; Univariate analysis; Proportional hazards model; Disease; Multivariate analysis; Pediatrics","score_opus":0.027272238717069262,"score_gpt":0.33884195852845245,"score_spread":0.3115697198113832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316874297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345565,0.0027856294,0.0000048296783,0.00022760253,0.00023286168,0.0030930087,0.00008770361,0.000022120592,0.000090591195],"genre_scores_gemma":[0.99893624,0.00040529203,0.0000061065252,0.000027050553,0.000021306858,0.00038449734,0.000008959466,0.000024504308,0.00018603168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973318,0.000311318,0.00085355307,0.00024617204,0.0009159946,0.0003411652],"domain_scores_gemma":[0.99835426,0.00033275626,0.00035849822,0.0005439245,0.00019290288,0.00021766612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008646869,0.00020232309,0.0007541928,0.0003984201,0.000033899534,0.000014782649,0.000270964,0.000047711703,0.000034224286],"category_scores_gemma":[0.0015814559,0.00012994636,0.00013154699,0.00037222911,0.0001269878,0.00024105592,0.00020410311,0.00012319052,0.0000034335997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047774267,0.0040824227,0.982044,0.0021934947,0.00040249494,0.000009887657,0.010329028,0.000018007364,0.000009783718,0.00015942138,0.00018734937,0.00008639745],"study_design_scores_gemma":[0.0032382896,0.000118603675,0.97672325,0.004632803,0.00012725155,0.00021190457,0.014261068,0.0003219091,0.000017222546,0.00024510256,0.000001929503,0.00010064623],"about_ca_topic_score_codex":0.00017573436,"about_ca_topic_score_gemma":0.00005808066,"teacher_disagreement_score":0.0054805987,"about_ca_system_score_codex":0.000093710354,"about_ca_system_score_gemma":0.00011578274,"threshold_uncertainty_score":0.5299059},"labels":[],"label_agreement":null},{"id":"W2316925332","doi":"10.1136/annrheumdis-2014-eular.2365","title":"THU0241 Predictors of Acr/Eular Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: an Analysis from the Prospective, Observational Registry, Biotrac","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Montreal General Hospital; Nexus Clinical Research (Canada); University of Victoria; Arthritis Research Centre of Canada; University of Saskatchewan; Université de Montréal","funders":"","keywords":"Medicine; Golimumab; Infliximab; Internal medicine; Rheumatoid arthritis; Psoriatic arthritis; Univariate analysis; Rheumatology; Ankylosing spondylitis; Confounding; Etanercept; Observational study; Prospective cohort study; Adalimumab; Multivariate analysis; Disease","score_opus":0.014663589708851621,"score_gpt":0.25275901566063363,"score_spread":0.238095425951782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316925332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582934,0.0022789815,0.00003384347,0.00071084214,0.000016597496,0.0007301138,0.0003139703,0.000028123935,0.000058187787],"genre_scores_gemma":[0.9946533,0.004759661,0.00012577488,0.00006772955,0.000012910886,0.000031831634,0.0003035282,0.00002686275,0.000018394296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975929,0.0002999556,0.0005481681,0.000363341,0.000906668,0.00028894152],"domain_scores_gemma":[0.9977577,0.00034674394,0.00042059357,0.00083490676,0.00041850118,0.00022160044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034097987,0.00024732001,0.0007311973,0.00016022655,0.00015354008,0.00006615096,0.00029980362,0.000059860115,0.00006752505],"category_scores_gemma":[0.00080599444,0.00012469401,0.00013751726,0.00077811617,0.0005921495,0.00034991695,0.000070936585,0.00014538079,5.6453564e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010607626,0.00073499896,0.9898209,0.000070150956,0.000902327,0.0000016644659,0.00045120975,0.00012478286,0.000028541474,0.0001229847,0.00029553808,0.0063861655],"study_design_scores_gemma":[0.003328894,0.0007114807,0.99050653,0.0028480028,0.00008207442,0.0000018775567,0.00035889918,0.0010821323,0.00049023196,0.0003774325,0.00006841178,0.00014406015],"about_ca_topic_score_codex":0.0012132899,"about_ca_topic_score_gemma":0.00028534388,"teacher_disagreement_score":0.0062421057,"about_ca_system_score_codex":0.000014918351,"about_ca_system_score_gemma":0.00013325256,"threshold_uncertainty_score":0.5084874},"labels":[],"label_agreement":null},{"id":"W2317098257","doi":"10.1136/annrheumdis-2012-eular.523","title":"AB0523 Lower than expected levels of DMARD acquisition immediately pre and post biologic initiation in RA patients","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Cohort; Rheumatoid arthritis; Internal medicine; Concomitant; Hydroxychloroquine; Biologic Agents; Rheumatology; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.04458665874057759,"score_gpt":0.312101203567964,"score_spread":0.2675145448273864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317098257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955551,0.003205659,0.000009164849,0.00035738456,0.0002461922,0.0002121038,0.00034948744,0.0000084824405,0.000056435998],"genre_scores_gemma":[0.99941367,0.00017825648,0.000044908895,0.00025055144,0.000007654025,0.000008160552,0.000041424246,0.0000052633254,0.0000501252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989141,0.00035814068,0.00035903492,0.00011043504,0.00004761004,0.00021067544],"domain_scores_gemma":[0.99914575,0.000287118,0.00024508263,0.00017712315,0.00011487798,0.000030037807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025759373,0.00011260188,0.00027686232,0.00007127591,0.00003882358,0.0000041820604,0.00013263924,0.00012618053,0.0002087201],"category_scores_gemma":[0.0006179873,0.00006791077,0.000101617035,0.00013395419,0.00022567873,0.00011629542,0.00009386225,0.000066376866,0.0000048458382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096236856,0.0025281878,0.90112174,0.00037415803,0.0003567987,3.166853e-7,0.0015623186,0.0000017794063,0.028001625,0.00062822975,0.0011070931,0.06335537],"study_design_scores_gemma":[0.0004908757,0.00017941502,0.9781432,0.00022035334,0.00004986794,7.11768e-7,0.00014882119,0.0000022944807,0.020021603,0.0006431116,0.000018572264,0.00008117433],"about_ca_topic_score_codex":0.000029473786,"about_ca_topic_score_gemma":0.0000022361128,"teacher_disagreement_score":0.07702145,"about_ca_system_score_codex":0.000005689715,"about_ca_system_score_gemma":0.000015906313,"threshold_uncertainty_score":0.2769321},"labels":[],"label_agreement":null},{"id":"W2317357049","doi":"10.1136/annrheumdis-2012-eular.2085","title":"THU0120 Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial programme","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Rituximab; Internal medicine; Population; Adverse effect; Placebo; Methotrexate; Clinical trial; Rheumatology; Pathology; Lymphoma","score_opus":0.117532149327895,"score_gpt":0.41234445610826037,"score_spread":0.29481230678036535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317357049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869259,0.0077738794,0.000012124964,0.0013721812,0.0005102161,0.0022265275,0.00011696578,0.000030928244,0.0010312995],"genre_scores_gemma":[0.9947321,0.004567564,0.000045813224,0.00022626214,0.00015282207,0.000105207226,0.000037576523,0.000025783136,0.00010689976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99519837,0.000784692,0.0015538702,0.00028823523,0.0013506489,0.0008241939],"domain_scores_gemma":[0.99632454,0.0012673966,0.0005031332,0.0013150097,0.0002228376,0.00036708105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027239674,0.00026439189,0.0010369848,0.000068204805,0.0000863495,0.000033243618,0.00082501874,0.0001488353,0.00043775112],"category_scores_gemma":[0.005409055,0.00015100269,0.00087504234,0.00056159473,0.000741176,0.0001864353,0.00030856478,0.00023486333,0.00007973203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07702711,0.016590452,0.47504187,0.002294006,0.001287725,0.00004661115,0.0016226589,0.0000045679662,0.0000022544045,0.002981012,0.021989265,0.40111247],"study_design_scores_gemma":[0.2629477,0.0011941565,0.7280778,0.0048676603,0.00021402429,0.000119058095,0.0007100134,0.00016136047,0.0000889997,0.0006938042,0.00062461314,0.0003007644],"about_ca_topic_score_codex":0.00027902448,"about_ca_topic_score_gemma":0.00007125346,"teacher_disagreement_score":0.40081173,"about_ca_system_score_codex":0.00043697754,"about_ca_system_score_gemma":0.0026971316,"threshold_uncertainty_score":0.6475535},"labels":[],"label_agreement":null},{"id":"W2317614509","doi":"10.1136/annrheumdis-2013-eular.909","title":"THU0381 Up to Half of First Fragility Fractures (FF), and a Third of Recurrent FF, Occur in Patients with Low or Moderate Estimated Frax® 10-Year Fracture Risk: Results from the Optimus Initiative","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; FRAX; Osteoporosis; Cohort; Hip fracture; Internal medicine; Prospective cohort study; Physical therapy; Bone mineral; Osteoporotic fracture","score_opus":0.02971874778636404,"score_gpt":0.2984042585024464,"score_spread":0.2686855107160824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317614509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286336,0.0006863598,0.000056194684,0.00295567,0.000059760994,0.0014141506,0.0018440156,0.000017945125,0.0001025472],"genre_scores_gemma":[0.99853545,0.00022930077,0.00024929942,0.0007576459,0.00001594762,0.000045421006,0.000121472585,0.000021671412,0.000023808128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774206,0.00025352451,0.0007900727,0.00034038955,0.00060441316,0.0002695233],"domain_scores_gemma":[0.99607,0.0015451072,0.00080378464,0.000818105,0.0005639776,0.00019898846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025277975,0.0003115186,0.00079035736,0.00009067785,0.00010757842,0.000029806159,0.00032678695,0.00011665983,0.00040464755],"category_scores_gemma":[0.004417677,0.00014076936,0.00013932597,0.00030023785,0.0002946085,0.0001802275,0.00013139388,0.00027895826,0.0000070607457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037955973,0.0033295348,0.84205383,0.0012049982,0.001435884,0.000005492351,0.037396803,0.007754643,0.0000069179205,0.000014325574,0.05321705,0.015624519],"study_design_scores_gemma":[0.0029817196,0.0006277417,0.98785,0.0035297086,0.00020402935,3.305214e-7,0.000801287,0.0020752568,0.000722027,0.00096807163,0.00007357297,0.00016626735],"about_ca_topic_score_codex":0.0032365443,"about_ca_topic_score_gemma":0.0002727863,"teacher_disagreement_score":0.14579614,"about_ca_system_score_codex":0.000014552205,"about_ca_system_score_gemma":0.0001399141,"threshold_uncertainty_score":0.57404083},"labels":[],"label_agreement":null},{"id":"W2317736009","doi":"10.1136/annrheumdis-2014-eular.2737","title":"THU0256 Does Socioeconomic Status Affect Outcomes in Early Rheumatoid Arthritis? Data from A Multi-Site Canadian Inception Cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Manitoba; Southlake Regional Health Center; Université de Sherbrooke; Université de Montréal; Western University","funders":"","keywords":"Medicine; Socioeconomic status; Cohort; Rheumatoid arthritis; Household income; Physical therapy; Cohort study; Odds ratio; Demography; Internal medicine; Environmental health; Population","score_opus":0.03373451038004639,"score_gpt":0.31560966813722413,"score_spread":0.28187515775717775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317736009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895479,0.0051830336,0.000021055068,0.0020823563,0.00024744074,0.0008684808,0.0018741621,0.00004548121,0.00013007838],"genre_scores_gemma":[0.96518964,0.03361144,0.00014216937,0.00043603644,0.000026903383,0.00006406163,0.0004276787,0.000038565428,0.0000635035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973823,0.0003707665,0.00065760256,0.00046292203,0.0004302782,0.0006961677],"domain_scores_gemma":[0.997058,0.00052967516,0.00023886768,0.0014948669,0.00009838938,0.0005802141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006128065,0.0002769352,0.00083126273,0.00024748538,0.00016974671,0.000105394254,0.000619626,0.00008732461,0.0005289174],"category_scores_gemma":[0.0013569093,0.00018159476,0.00022335436,0.00012519961,0.00034561328,0.00045898667,0.00024372204,0.0002134749,0.00022926199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009432401,0.00025810028,0.96964294,0.000061496685,0.0003229054,0.0000045461475,0.0006660177,0.000007567658,0.000030923326,0.0001125684,0.0017889465,0.027009686],"study_design_scores_gemma":[0.0023591889,0.00009142395,0.99126494,0.0014704247,0.0000109561015,0.0000026140576,0.00026908086,0.0019899027,0.00008609068,0.001392772,0.00085450406,0.00020809032],"about_ca_topic_score_codex":0.18513896,"about_ca_topic_score_gemma":0.22072431,"teacher_disagreement_score":0.035585366,"about_ca_system_score_codex":0.00006837976,"about_ca_system_score_gemma":0.00046542293,"threshold_uncertainty_score":0.8202873},"labels":[],"label_agreement":null},{"id":"W2317798338","doi":"10.1136/annrheumdis-2013-eular.1352","title":"FRI0225 Use of abatacept in patients with rheumatoid arthritis from the rhumadata® database: experience as first or second line agent compared with adalimumab and etanercept.","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Abatacept; Rheumatoid arthritis; Cohort; Internal medicine; Infliximab; Rheumatology; Biosimilar; Database; Physical therapy; Disease","score_opus":0.039752261044805524,"score_gpt":0.2794857182874968,"score_spread":0.23973345724269127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317798338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996025,0.0062591205,0.000013106147,0.0010632873,0.000038237475,0.0013489205,0.0012760598,0.000019457802,0.00002158059],"genre_scores_gemma":[0.98221797,0.016658124,0.00023579116,0.0003616881,0.00000833785,0.00014094595,0.00027359702,0.000032383425,0.00007119294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976296,0.00017294334,0.0006255916,0.00034251306,0.00085047336,0.00037886915],"domain_scores_gemma":[0.9972904,0.0007580636,0.0003355473,0.0010620144,0.0002963555,0.00025766864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012220792,0.000285794,0.0006767051,0.00008146025,0.00017304505,0.00010557912,0.0003951136,0.00003750544,0.0027745184],"category_scores_gemma":[0.00059439766,0.00013519963,0.0000792315,0.00028301938,0.0008560658,0.0006875665,0.00023112909,0.00016354487,0.000014677032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009421416,0.003811017,0.883726,0.0008152099,0.0013518616,0.000041514068,0.014321025,0.0000970215,0.00008606134,0.00019759013,0.033015765,0.053115495],"study_design_scores_gemma":[0.007386909,0.0011723109,0.9734044,0.010632394,0.000017579967,0.000020363392,0.004001573,0.00036112478,0.0006234596,0.00013386933,0.0019517635,0.00029425463],"about_ca_topic_score_codex":0.004203134,"about_ca_topic_score_gemma":0.0026479452,"teacher_disagreement_score":0.08967838,"about_ca_system_score_codex":0.0000132088435,"about_ca_system_score_gemma":0.00016975433,"threshold_uncertainty_score":0.99813706},"labels":[],"label_agreement":null},{"id":"W2317900691","doi":"10.1136/annrheumdis-2014-eular.1750","title":"FRI0318 Two-Year Retention and Effectiveness of IV Abatacept in Real-Life Setting: Results from the Action Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Abatacept; Internal medicine; Retention rate; Cohort; Surgery","score_opus":0.05294223653561911,"score_gpt":0.3396118354689946,"score_spread":0.2866695989333755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317900691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977713,0.00028780958,0.0000027183073,0.0008247143,0.000068451554,0.00076516194,0.000093610564,0.000011161676,0.00017505453],"genre_scores_gemma":[0.9995103,0.00031082373,0.0000120407985,0.000052273568,0.000020191343,0.000043768356,0.000034361383,0.000008493985,0.000007759161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854046,0.0005693911,0.00034555723,0.0001787944,0.00026369104,0.00010211249],"domain_scores_gemma":[0.99770314,0.0014560673,0.000258207,0.00044966541,0.00007188784,0.00006105575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070230453,0.0001065638,0.00031745338,0.000034921133,0.000052938045,0.00001221085,0.00008968459,0.00002358216,0.000007930058],"category_scores_gemma":[0.001485112,0.00005594921,0.00010234443,0.00011359577,0.00006973019,0.00006117688,0.000060678864,0.00003683943,0.000002555645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017090671,0.0020928928,0.98101234,0.00031962793,0.00040971054,0.0000015891558,0.0010818556,0.00006522355,0.00009992974,0.00031548974,0.0006094782,0.012282802],"study_design_scores_gemma":[0.004750317,0.00032976025,0.98950106,0.0016153542,0.000271626,5.257472e-7,0.0014202857,0.00028808278,0.00093818735,0.00082922063,0.000006105571,0.000049462193],"about_ca_topic_score_codex":0.002271353,"about_ca_topic_score_gemma":0.00007649085,"teacher_disagreement_score":0.01223334,"about_ca_system_score_codex":0.000017750197,"about_ca_system_score_gemma":0.00004238464,"threshold_uncertainty_score":0.34336215},"labels":[],"label_agreement":null},{"id":"W2317934975","doi":"10.1136/annrheumdis-2012-eular.2888","title":"FRI0431 Why the findings of published rheumatoid arthritis multiple treatment comparisons are so different – an overview of recurrent methodological shortcomings","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rheumatoid arthritis; MEDLINE; Clinical trial; Systematic review; Inclusion and exclusion criteria; Intensive care medicine; Alternative medicine; Internal medicine; Pathology","score_opus":0.25948717440336827,"score_gpt":0.41159172656656273,"score_spread":0.15210455216319446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317934975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8831438,0.11228375,0.00006422193,0.003041192,0.0002053868,0.000890823,0.0002920506,0.000029405675,0.000049382736],"genre_scores_gemma":[0.88293296,0.11645943,0.00024714813,0.00015817236,0.000025235637,0.00009038255,0.000045564586,0.000024386234,0.000016718075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630237,0.0009505495,0.0010562362,0.00026996445,0.0008504219,0.00057045533],"domain_scores_gemma":[0.9959613,0.0016255443,0.00065947516,0.0010428258,0.00029183464,0.0004190034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009425095,0.00033928666,0.0014295989,0.00013273273,0.00020351999,0.000053174204,0.00053672603,0.0000813083,0.00048038567],"category_scores_gemma":[0.0025918626,0.00016749612,0.0007479176,0.0002748951,0.0007790658,0.00030741384,0.00021419128,0.00017593695,0.0000046067003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013267768,0.009661099,0.8229109,0.0011492409,0.0017224799,0.0000026447467,0.0038723885,0.000014114112,0.00052571495,0.004622292,0.021843089,0.13234924],"study_design_scores_gemma":[0.0027521946,0.0012604365,0.96787375,0.005957928,0.000077205405,0.000031031017,0.0019268128,0.00036208757,0.0128875505,0.0016854678,0.0049170568,0.00026845583],"about_ca_topic_score_codex":0.00037394132,"about_ca_topic_score_gemma":0.00010637,"teacher_disagreement_score":0.14496286,"about_ca_system_score_codex":0.000029267032,"about_ca_system_score_gemma":0.00010833477,"threshold_uncertainty_score":0.68302935},"labels":[],"label_agreement":null},{"id":"W2318093985","doi":"10.1136/annrheumdis-2014-eular.2945","title":"THU0266 Determining the Absolute Change in the Clinical Disease Activity Index (CDAI) to Define A Minimally Important Difference","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier de l’Université de Montréal; University of Manitoba; Southlake Regional Health Center; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cohort; Rheumatoid arthritis; Internal medicine; Rheumatology; Fibromyalgia; Percentile; Concomitant; Receiver operating characteristic; Physical therapy; Statistics","score_opus":0.11650573511024417,"score_gpt":0.39506005292562607,"score_spread":0.27855431781538187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318093985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760323,0.0019329666,0.000020165715,0.020556765,0.00012360922,0.001122216,0.000063121865,0.00002295495,0.00012587055],"genre_scores_gemma":[0.9919892,0.003809061,0.00001843944,0.0037756262,0.00009806023,0.00024015772,0.0000061366113,0.000022798113,0.00004050382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970414,0.0007114885,0.0006551196,0.00029824546,0.0008022402,0.0004914789],"domain_scores_gemma":[0.996587,0.001526095,0.00027926912,0.0010946072,0.00013375974,0.00037927745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014190186,0.00023417475,0.0005289419,0.00008710585,0.00019231749,0.000074690644,0.00080257026,0.000044859917,0.00005355882],"category_scores_gemma":[0.004602249,0.000105964486,0.0003737274,0.00031032515,0.0003882576,0.000116818046,0.0002679582,0.0002684491,0.00001705707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012838844,0.0012019939,0.78170335,0.00020598227,0.0001286113,0.000012511462,0.0012894413,0.0000023928035,0.000013748237,0.00050690403,0.0021360058,0.21151514],"study_design_scores_gemma":[0.0010267777,0.0004139788,0.993378,0.0011986424,0.000025289008,0.0000043260075,0.000117092946,0.0015402427,0.000013128527,0.0014971449,0.0006571422,0.00012827902],"about_ca_topic_score_codex":0.00019108728,"about_ca_topic_score_gemma":0.00024782977,"teacher_disagreement_score":0.21167459,"about_ca_system_score_codex":0.000010398133,"about_ca_system_score_gemma":0.00018352977,"threshold_uncertainty_score":0.5509654},"labels":[],"label_agreement":null},{"id":"W2318267216","doi":"10.1136/annrheumdis-2012-eular.460","title":"AB0460 Long-term remission with golimumab in active rheumatoid arthritis patients despite methotrexate through 2 years","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methotrexate; Medicine; Rheumatoid arthritis; Internal medicine; Golimumab; Gastroenterology; Complete remission; Adalimumab; Chemotherapy","score_opus":0.03869301267534495,"score_gpt":0.33954150178728226,"score_spread":0.3008484891119373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318267216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940453,0.004057837,0.000021775346,0.00024969276,0.000101559395,0.0008194619,0.00004440039,0.00003274183,0.0006272244],"genre_scores_gemma":[0.99459285,0.0046756323,0.0002089902,0.00020677093,0.000024620478,0.000055455443,0.000034380075,0.000048504342,0.00015282715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974069,0.00024375095,0.0005090926,0.00026804119,0.00091720134,0.0006549927],"domain_scores_gemma":[0.9980634,0.00035375752,0.00029981302,0.0007764889,0.00018981523,0.000316744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003030791,0.00024408632,0.0005803336,0.000115112496,0.00006841956,0.000021178235,0.0003071489,0.00008318154,0.00021192928],"category_scores_gemma":[0.0008861631,0.00015695208,0.00019675803,0.00046101765,0.00027851673,0.00042126598,0.00021040888,0.00019305017,0.00004582181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040668417,0.0042499127,0.64211035,0.0018217061,0.0008144828,0.00008215864,0.0071807555,0.000072336465,0.00009337845,0.00021072885,0.0035962858,0.33570105],"study_design_scores_gemma":[0.011095515,0.00026391115,0.9758424,0.0076110703,0.00005961918,0.000047862683,0.00020342073,0.0001055475,0.0040783905,0.00033731243,0.00012711808,0.00022783678],"about_ca_topic_score_codex":0.00033554094,"about_ca_topic_score_gemma":0.000023244731,"teacher_disagreement_score":0.3354732,"about_ca_system_score_codex":0.0007914171,"about_ca_system_score_gemma":0.0011966821,"threshold_uncertainty_score":0.64003205},"labels":[],"label_agreement":null},{"id":"W2318359473","doi":"10.1136/annrheumdis-2014-eular.3328","title":"THU0176 Golimumab 5-Year Safety: an Analysis of Pooled Data from the Long Term Extensions of Randomized, Double-Blind, Placebo-Controlled Studies in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"AstraZeneca; Pfizer; Genentech; Amgen","keywords":"Medicine; Golimumab; Psoriatic arthritis; Placebo; Rheumatoid arthritis; Ankylosing spondylitis; Internal medicine; Incidence (geometry); Concomitant; Pathology; Adalimumab","score_opus":0.0833797178581337,"score_gpt":0.37678194755046285,"score_spread":0.29340222969232915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318359473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250692,0.07057509,0.000066355926,0.00081594015,0.00009996988,0.0023363822,0.0009654926,0.00001970741,0.0000518784],"genre_scores_gemma":[0.92117983,0.07802173,0.00010125947,0.0001028805,0.000036680558,0.0000969223,0.0004103751,0.000032265005,0.000018074334],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942247,0.0015939578,0.002084165,0.0005558652,0.0010901738,0.0004511143],"domain_scores_gemma":[0.9870436,0.008675566,0.0010539397,0.0025358237,0.00047369275,0.00021736583],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0039039291,0.0003482667,0.003778145,0.0004123435,0.00015673917,0.00004857985,0.0008347105,0.00009873972,0.00017416668],"category_scores_gemma":[0.01045658,0.00020452375,0.00063974265,0.00082032837,0.001431538,0.00029860644,0.0006729122,0.00019680348,0.0000025497152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8698784,0.001927347,0.016407683,0.0016754196,0.03310443,0.000044552653,0.005325576,0.00079593813,0.000070921444,0.002304232,0.0005833986,0.06788208],"study_design_scores_gemma":[0.87345266,0.00019406102,0.044271413,0.014465586,0.0055842665,0.000028237806,0.0024607037,0.05643777,0.00023766383,0.0025632102,0.000006699954,0.00029771368],"about_ca_topic_score_codex":0.0025377139,"about_ca_topic_score_gemma":0.0014900443,"teacher_disagreement_score":0.06758437,"about_ca_system_score_codex":0.00019270842,"about_ca_system_score_gemma":0.0010988265,"threshold_uncertainty_score":0.9978788},"labels":[],"label_agreement":null},{"id":"W2318413177","doi":"10.1136/annrheumdis-2014-eular.3912","title":"THU0012 Elevated Risk of Chronic Obstructive Pulmonary Disease in Systemic Lupus Erythematosus: A Population-Based Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; COPD; Population; Diagnosis code; Cohort; Retrospective cohort study; Internal medicine; Pediatrics; Emergency medicine; Environmental health","score_opus":0.013873757427837552,"score_gpt":0.268467544237011,"score_spread":0.2545937868091735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318413177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951283,0.0025602477,0.00004851802,0.00018129368,0.00024095648,0.0013843452,0.00035461207,0.000039431343,0.00006230191],"genre_scores_gemma":[0.99953616,0.00007419057,0.000013330669,0.000055366116,0.00005170355,0.00010303127,0.000068863206,0.00003568201,0.00006168203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973714,0.00051392225,0.00088126055,0.00032725948,0.0005979002,0.00030830968],"domain_scores_gemma":[0.99761397,0.00034547187,0.0006645498,0.0008944085,0.00022634558,0.00025527767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033127688,0.00027604622,0.00075213576,0.00020306271,0.00008861244,0.00001243129,0.000302531,0.000053764645,0.00006353629],"category_scores_gemma":[0.0009844467,0.00019104268,0.0004948708,0.00041468616,0.00011748863,0.00012207119,0.000088408924,0.00013433883,0.0000063397556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033922694,0.003082174,0.984721,0.0035576634,0.0002313627,0.000019412442,0.00017972886,0.0024203951,0.00005629122,0.0003211744,0.00005203072,0.0019665079],"study_design_scores_gemma":[0.0012774874,0.00085558166,0.9606535,0.0055894013,0.00085298397,0.000015026345,0.0004367156,0.02802275,0.000047350997,0.0020512992,0.0000036439767,0.00019429027],"about_ca_topic_score_codex":0.0007889207,"about_ca_topic_score_gemma":0.000017739898,"teacher_disagreement_score":0.025602354,"about_ca_system_score_codex":0.00008711733,"about_ca_system_score_gemma":0.00028039873,"threshold_uncertainty_score":0.77904946},"labels":[],"label_agreement":null},{"id":"W2318445579","doi":"10.1136/annrheumdis-2012-eular.2446","title":"THU0481-HPR Lessons from patient reported outcomes of biologic treatment: Improvements in quality of life and health status are stable over time despite declining physical function","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Internal medicine; Physical therapy","score_opus":0.5241523834361353,"score_gpt":0.48718425080869865,"score_spread":0.0369681326274367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318445579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904505,0.004476963,0.000036892307,0.0025458334,0.00014075889,0.0005718556,0.0017356641,0.00001006909,0.000031452884],"genre_scores_gemma":[0.9981434,0.00045749117,0.00009689388,0.0011564507,0.000017801396,0.000042672673,0.00005283906,0.000012412467,0.000020068914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953573,0.00046537805,0.0034741187,0.00025702987,0.00011669914,0.00032952076],"domain_scores_gemma":[0.9918323,0.0011749124,0.006255551,0.0004890615,0.000056245826,0.00019192377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003286969,0.0001639929,0.0014299694,0.00012891763,0.00006645151,0.00001129623,0.00010779056,0.00005056332,0.00007092527],"category_scores_gemma":[0.0032502112,0.00013484068,0.00018843797,0.00013279027,0.00008837081,0.00028862758,0.00007043188,0.000046744848,0.000011030025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000520981,0.0008955846,0.99347055,0.0003341366,0.00028897173,1.7238532e-8,0.0016058407,0.00006691324,0.000004545416,0.0012560147,0.00027244992,0.0017528993],"study_design_scores_gemma":[0.0007926151,0.00017206334,0.9908665,0.00020383834,0.000017300597,2.8081935e-8,0.00078771147,0.0005761012,0.000019219151,0.0064057447,0.00004866305,0.00011025843],"about_ca_topic_score_codex":0.012035201,"about_ca_topic_score_gemma":0.00017487479,"teacher_disagreement_score":0.011860326,"about_ca_system_score_codex":0.00011530097,"about_ca_system_score_gemma":0.0001563533,"threshold_uncertainty_score":0.99454373},"labels":[],"label_agreement":null},{"id":"W2318743788","doi":"10.1136/annrheumdis-2012-eular.459","title":"AB0459 Analysis of integrated radiographic data for two long-term, open-label extension studies of adalimumab","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adalimumab; Radiography; Rheumatoid arthritis; Placebo; Clinical trial; Post-hoc analysis; Internal medicine; Nuclear medicine; Surgery; Pathology","score_opus":0.2830504771859936,"score_gpt":0.4622822381015675,"score_spread":0.1792317609155739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318743788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561508,0.041015342,0.0000315334,0.00052581093,0.00009177027,0.00082228286,0.001334446,0.000009200363,0.000018796045],"genre_scores_gemma":[0.9950741,0.003897288,0.00027153603,0.00014512768,0.000010847989,0.000065766784,0.0004856422,0.000013907904,0.000035784236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985149,0.00010220396,0.0006355872,0.00021468684,0.0003194559,0.00021319231],"domain_scores_gemma":[0.99681705,0.00058944017,0.00057205284,0.0014538213,0.0004446942,0.00012292377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043036943,0.00017802908,0.001094518,0.00024322607,0.000059887207,0.000009800393,0.000535471,0.000027637121,0.00003845456],"category_scores_gemma":[0.0009190955,0.000097557866,0.00033535733,0.00081804086,0.00022808115,0.0002067656,0.000377473,0.000023051405,8.310457e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008245018,0.009415671,0.90742046,0.0014215527,0.028356703,0.0000020048672,0.00036449044,0.00002672723,0.0001487825,0.00040188016,0.008141014,0.04347623],"study_design_scores_gemma":[0.004568229,0.00037231334,0.96991354,0.0024426826,0.018130789,0.000002533323,0.0003643354,0.0009031839,0.0029481926,0.00020572825,0.000028241111,0.000120245706],"about_ca_topic_score_codex":0.00029821045,"about_ca_topic_score_gemma":0.000034600787,"teacher_disagreement_score":0.062493086,"about_ca_system_score_codex":0.000016969701,"about_ca_system_score_gemma":0.00009381961,"threshold_uncertainty_score":0.39782944},"labels":[],"label_agreement":null},{"id":"W2319007535","doi":"10.1136/annrheumdis-2014-eular.2511","title":"AB1133 Comparison of Canadian and Israeli Rheumatologists' Understanding of Cannabinoid Use as A Therapy for Rheumatic Diseases","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Medical prescription; Cannabis; Cannabinoid; Family medicine; Internal medicine; Confidence interval; Alternative medicine; Rheumatology; Psychiatry; Pharmacology","score_opus":0.11687980126094265,"score_gpt":0.364323491210922,"score_spread":0.24744368994997934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319007535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98232275,0.0055437963,0.00011177099,0.009776612,0.000115724455,0.0013943885,0.0004620685,0.000022347731,0.0002505538],"genre_scores_gemma":[0.9971497,0.0018419038,0.000064132415,0.00030785686,0.000011928543,0.000092438015,0.000036494643,0.000040629835,0.00045491377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743795,0.00018924894,0.00091622275,0.00030448637,0.00063751556,0.00051459705],"domain_scores_gemma":[0.9971963,0.0003864615,0.00057787105,0.00078065146,0.00046583623,0.0005928817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004143747,0.00028086535,0.0011370407,0.00057123695,0.00019548797,0.000046449975,0.00035519057,0.000095740754,0.0000779429],"category_scores_gemma":[0.0029122685,0.00019256107,0.00044393673,0.00055444613,0.0008373117,0.00013798889,0.00008880517,0.000114309085,0.0000014452734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031584608,0.0027943475,0.5742219,0.01579916,0.00196462,0.0000040760633,0.0040912074,0.00023185264,0.0004988625,0.06677903,0.27400908,0.05644741],"study_design_scores_gemma":[0.0073658475,0.0033093374,0.9227317,0.007851595,0.0008097498,0.00003920319,0.007932187,0.007829085,0.007349288,0.025058402,0.008896442,0.0008271838],"about_ca_topic_score_codex":0.046832014,"about_ca_topic_score_gemma":0.0047937306,"teacher_disagreement_score":0.3485098,"about_ca_system_score_codex":0.000064017775,"about_ca_system_score_gemma":0.00086612214,"threshold_uncertainty_score":0.9595152},"labels":[],"label_agreement":null},{"id":"W2319264256","doi":"10.1136/annrheumdis-2014-eular.4755","title":"AB0236 What Level of Disease Activity at 6 Months Predicts Achieving or Sustaining Remission at 12 Months?","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; University of Alberta; Arthritis Research Centre of Canada; Université de Montréal; University of Toronto","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Rheumatoid arthritis; Infliximab; Internal medicine; Ankylosing spondylitis; Receiver operating characteristic; Logistic regression; Adalimumab; Physical therapy; Surgery; Disease","score_opus":0.09657553197162094,"score_gpt":0.34054627789462616,"score_spread":0.24397074592300522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319264256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98519766,0.009738874,0.00005819491,0.0035466999,0.00015462312,0.0007495026,0.00013629951,0.00005260076,0.00036552764],"genre_scores_gemma":[0.9753916,0.021934899,0.000051495423,0.00016215359,0.000045737084,0.000042565607,0.00002377821,0.00004250171,0.0023052609],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997175,0.00036063435,0.00054895366,0.00033055904,0.001057857,0.00052704214],"domain_scores_gemma":[0.99675304,0.00084073684,0.00044518028,0.0010027811,0.0002478934,0.00071034464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005546988,0.00027923964,0.0006983576,0.0001289529,0.0003251665,0.000053106003,0.00038382754,0.000065320746,0.00037714452],"category_scores_gemma":[0.0045464984,0.00016984064,0.0004091699,0.00019201882,0.00039767392,0.00054241705,0.000530331,0.00013491891,0.000011927831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034568295,0.0029356268,0.1610563,0.008078379,0.0013763073,0.000048471084,0.0036236364,0.00042612804,0.0052709267,0.00049003604,0.034347042,0.74777883],"study_design_scores_gemma":[0.0047327545,0.0012340939,0.94124067,0.024365269,0.0001495016,0.000019688197,0.0013062081,0.0064403103,0.014720734,0.0015161047,0.003784905,0.0004897697],"about_ca_topic_score_codex":0.000113940245,"about_ca_topic_score_gemma":0.000053543798,"teacher_disagreement_score":0.7801844,"about_ca_system_score_codex":0.0000623323,"about_ca_system_score_gemma":0.00026498435,"threshold_uncertainty_score":0.69259006},"labels":[],"label_agreement":null},{"id":"W2319342693","doi":"10.1136/annrheumdis-2013-eular.308","title":"OP0103 Efficacy of Brodalumab, an Anti-IL-17R Antibody, in Subjects with Psoriatic Arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Clinical endpoint; Psoriasis; Adverse effect; Rheumatology; Randomized controlled trial; Immunology","score_opus":0.02035229992375236,"score_gpt":0.26873687599887963,"score_spread":0.24838457607512726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319342693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923779,0.0063269953,0.0000039969354,0.00023320486,0.00022031588,0.0005563386,0.00011978562,0.000027071095,0.00013442744],"genre_scores_gemma":[0.99816924,0.0014349292,0.00004049748,0.00005807065,0.000009860106,0.000040380695,0.00009055708,0.000019458017,0.00013700449],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99846005,0.00037700636,0.00047368612,0.00023900588,0.00008868101,0.00036159332],"domain_scores_gemma":[0.99860865,0.00029921974,0.00032605868,0.00061059714,0.000110440764,0.00004504876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001647396,0.00022041825,0.0005767301,0.00012704432,0.00008588191,0.000014660545,0.0003866926,0.00009404943,0.00042596136],"category_scores_gemma":[0.00019814615,0.00014040305,0.00017331606,0.00027464138,0.00027523597,0.00020983293,0.00007354466,0.00007073939,0.00008666343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094609265,0.0073426026,0.27944344,0.0007699712,0.002364758,0.000014366692,0.0027258892,0.00022067405,0.024114113,0.0014451772,0.0033536141,0.67725927],"study_design_scores_gemma":[0.0028903582,0.0004053967,0.96934116,0.0010080506,0.00014982176,0.000011659902,0.00025621825,0.000011529223,0.02435758,0.001341666,0.000029729594,0.00019683105],"about_ca_topic_score_codex":0.0008420926,"about_ca_topic_score_gemma":0.000071159,"teacher_disagreement_score":0.6898977,"about_ca_system_score_codex":0.000006554646,"about_ca_system_score_gemma":0.00009335302,"threshold_uncertainty_score":0.572547},"labels":[],"label_agreement":null},{"id":"W2319390006","doi":"10.1136/annrheumdis-2014-eular.3681","title":"FRI0312 Biological Therapy Survival Rate in A Canadian Cohort of Rheumatoid Arthritis Patients","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Rimouski","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Abatacept; Rheumatoid arthritis; Tocilizumab; Internal medicine; TNF inhibitor; Discontinuation; Rituximab; Infliximab; Log-rank test; Golimumab; Tumor necrosis factor alpha; Proportional hazards model; Lymphoma","score_opus":0.030996958427027217,"score_gpt":0.28779440618640817,"score_spread":0.25679744775938096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319390006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985136,0.007116332,0.0000031676793,0.00116242,0.00015453808,0.00066277065,0.0001155983,0.000016828226,0.0009170066],"genre_scores_gemma":[0.89995307,0.099630244,0.000013435057,0.00027951482,0.000011306807,0.000042490516,0.00003798242,0.000017662092,0.000014296891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772346,0.00047379965,0.000618415,0.0002199456,0.00043668985,0.0005277167],"domain_scores_gemma":[0.9982657,0.00034935828,0.00020008234,0.0005081852,0.00026062483,0.00041607578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007936054,0.00018935287,0.0006892077,0.00020397965,0.00008186579,0.00001819559,0.00031055498,0.000070750546,0.00032628095],"category_scores_gemma":[0.0019518895,0.000121795376,0.00024815212,0.00030358927,0.00037444217,0.00008960912,0.00005826818,0.00012360577,0.000017756254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022400067,0.0004931449,0.9225792,0.0000447307,0.00015284948,0.0000021022418,0.00016536447,0.00000566362,0.000042454056,0.001210124,0.0012015632,0.07387874],"study_design_scores_gemma":[0.0022463228,0.00038522534,0.98962075,0.0013001631,0.0000011299578,0.0000019952818,0.00006892456,0.000112106936,0.000657642,0.0024663964,0.003013758,0.00012557406],"about_ca_topic_score_codex":0.03482263,"about_ca_topic_score_gemma":0.0127295125,"teacher_disagreement_score":0.09251391,"about_ca_system_score_codex":0.000020622148,"about_ca_system_score_gemma":0.00031848572,"threshold_uncertainty_score":0.9716046},"labels":[],"label_agreement":null},{"id":"W2319668926","doi":"10.1136/annrheumdis-2012-eular.1336","title":"AB1342 Impact of obesity and hyper-triglyceridemia on gout development with or without hyperuricemia –a prospective study in chinese","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hyperuricemia; Medicine; Gout; Internal medicine; Hazard ratio; Uric acid; Body mass index; Metabolic syndrome; Proportional hazards model; Prospective cohort study; Obesity; Confidence interval; Endocrinology; Physical therapy","score_opus":0.03619614747930426,"score_gpt":0.3525183614451192,"score_spread":0.31632221396581495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319668926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968169,0.00084471115,0.0000035985959,0.000108794804,0.00004497007,0.0018080688,0.000022854661,0.000029470388,0.0003206797],"genre_scores_gemma":[0.99926746,0.00006872753,0.0002540744,0.00008703167,0.000029248307,0.00008628737,0.0000042265506,0.000037310336,0.00016566306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786955,0.00014564983,0.0006107655,0.0002898166,0.0006638225,0.00042039622],"domain_scores_gemma":[0.99820375,0.00028638344,0.0004065361,0.0006546536,0.00015278636,0.00029589407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045047273,0.00036198506,0.0009801119,0.00017594562,0.000079430356,0.000011408607,0.00022429727,0.00006622551,0.000065065215],"category_scores_gemma":[0.00090930366,0.00017002321,0.00014301506,0.00056596333,0.00021689004,0.00020139485,0.0001491555,0.00020121931,0.000008437371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025505754,0.003920633,0.9847314,0.00037385247,0.000600311,0.0000054461407,0.0051052505,0.00003120099,0.000046510468,0.000006876257,0.00010598284,0.002521961],"study_design_scores_gemma":[0.0028809484,0.0012596585,0.99266076,0.000995383,0.00029970426,0.000040114635,0.0010686151,0.00006025783,0.0004737579,0.000050301875,0.000005554406,0.00020496795],"about_ca_topic_score_codex":0.00036065167,"about_ca_topic_score_gemma":0.00004087757,"teacher_disagreement_score":0.007929336,"about_ca_system_score_codex":0.00012603367,"about_ca_system_score_gemma":0.00045172145,"threshold_uncertainty_score":0.6933346},"labels":[],"label_agreement":null},{"id":"W2319909929","doi":"10.1136/annrheumdis-2014-eular.2728","title":"FRI0371 A Comparison of Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) TRIAL Design: Ways to Improve Positive Trials in Sle","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Randomized controlled trial; Internal medicine; Clinical trial; Methotrexate; Concomitant; Rheumatology; Hydroxychloroquine; Physical therapy; Disease","score_opus":0.07883867541139963,"score_gpt":0.34628323411167306,"score_spread":0.2674445587002734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319909929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599813,0.025384078,0.008104392,0.0014648697,0.001960404,0.0025440615,0.00036182237,0.00003352869,0.00016554266],"genre_scores_gemma":[0.9980308,0.0009585431,0.00067032495,0.00017452388,0.000014160856,0.000065482775,0.00000623153,0.000015486592,0.000064465734],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995612,0.0021115937,0.0015114967,0.0003087169,0.00011027897,0.0003458627],"domain_scores_gemma":[0.9944078,0.004164232,0.0007722427,0.00045102896,0.0001264094,0.00007829739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029553564,0.0002473373,0.0018325015,0.00014260493,0.00008903052,0.000021783757,0.00034616503,0.00019600555,0.00007386079],"category_scores_gemma":[0.006198409,0.00015815353,0.00036528287,0.00021512008,0.00031622525,0.00005995904,0.00014383321,0.00014573906,0.000010676454],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12347841,0.007931598,0.015924403,0.0032995502,0.005269977,0.0000071649706,0.0077131866,0.00024225512,0.12073381,0.03723357,0.07486343,0.60330266],"study_design_scores_gemma":[0.11909054,0.013639068,0.011661067,0.027216101,0.001010774,0.00029741763,0.0051346733,0.001954849,0.76478165,0.051254936,0.0017602943,0.0021986447],"about_ca_topic_score_codex":0.000092089474,"about_ca_topic_score_gemma":0.000012333259,"teacher_disagreement_score":0.6440478,"about_ca_system_score_codex":0.000011630465,"about_ca_system_score_gemma":0.000063638305,"threshold_uncertainty_score":0.74205226},"labels":[],"label_agreement":null},{"id":"W2320118044","doi":"10.1136/annrheumdis-2014-eular.3947","title":"FRI0207 Prevalence of Femoroacetabular Impingement in Caucasians Compared to Chinese in Vancouver, Canada: A Population-Based Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hip disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Femoroacetabular impingement; Medicine; Population; Ethnic group; Physical therapy; Demography; Osteoarthritis; Pathology; Environmental health","score_opus":0.02011361574469574,"score_gpt":0.3047448596586997,"score_spread":0.28463124391400396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320118044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759966,0.00031093773,0.000013635764,0.0007413637,0.00008431911,0.0011424315,0.000045053996,0.000005357499,0.00005721208],"genre_scores_gemma":[0.99952865,0.000009585721,0.000050060004,0.00026936023,0.0000033553897,0.00006033986,0.000008016749,0.000009909992,0.00006073385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987288,0.00011766839,0.0004443251,0.00015912545,0.00038360915,0.00016648007],"domain_scores_gemma":[0.9991689,0.000100291945,0.00015246465,0.00042204457,0.00005966512,0.000096682474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014949002,0.00013166082,0.000435455,0.0001036232,0.00002471552,0.0000031700715,0.00014868208,0.000013637349,0.000041909392],"category_scores_gemma":[0.0003457023,0.00008757095,0.00007120598,0.0003077993,0.000014513219,0.00002765808,0.000036763275,0.00003591311,7.106949e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012808274,0.0020303272,0.9913745,0.0006982575,0.0000642936,0.0000031495513,0.00045612568,0.0033649995,0.0000015071926,0.000003863966,0.00061978755,0.0012551039],"study_design_scores_gemma":[0.0019623556,0.00016001465,0.9939609,0.0009571146,0.000069958805,1.232381e-7,0.0003415301,0.0023130605,0.000017827862,0.00013918638,0.0000063540733,0.00007157768],"about_ca_topic_score_codex":0.2938091,"about_ca_topic_score_gemma":0.6095726,"teacher_disagreement_score":0.3157635,"about_ca_system_score_codex":0.00005708252,"about_ca_system_score_gemma":0.00022953881,"threshold_uncertainty_score":0.7108935},"labels":[],"label_agreement":null},{"id":"W2320121061","doi":"10.1136/annrheumdis-2012-eular.3146","title":"SAT0199 An estimate of the proportion of patients with sle receiving off-label treatment with rituximab in european countries","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; European union; Rituximab; Rheumatology; Population; Internal medicine; Specialty; Family medicine; Demography; Pediatrics; Environmental health","score_opus":0.027780369814081413,"score_gpt":0.292356506755357,"score_spread":0.2645761369412756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320121061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974652,0.0011991212,0.0000012591822,0.0003426859,0.000043891516,0.00069816236,0.000092344235,0.000008621979,0.000148697],"genre_scores_gemma":[0.999437,0.00029051382,0.0001202146,0.00004483811,0.000008508508,0.000030433925,0.000023565328,0.000017000255,0.000027960263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884826,0.00011967208,0.0003442633,0.0001090326,0.00040559925,0.00017316842],"domain_scores_gemma":[0.9988169,0.000057477337,0.00043630012,0.00045450413,0.00015650247,0.000078303485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013749674,0.0001467449,0.00036192982,0.000041035284,0.00004619676,0.000006290814,0.00010187564,0.000014451897,0.000017208084],"category_scores_gemma":[0.000056992987,0.00005986626,0.00007011784,0.00014209631,0.00016429991,0.00014751148,0.000033658533,0.000019512141,0.0000020281677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045552454,0.00966208,0.9572687,0.00029372572,0.0002192114,0.0000010177914,0.00076875463,0.000016195258,0.0000028956952,0.00009434093,0.000053098953,0.03116447],"study_design_scores_gemma":[0.0046690986,0.0011119366,0.98946327,0.001864483,0.0003805054,0.0000018857605,0.00014116609,0.00004194483,0.0021884057,0.000026282589,0.00004510285,0.000065920656],"about_ca_topic_score_codex":0.0001694609,"about_ca_topic_score_gemma":0.000036932724,"teacher_disagreement_score":0.03219458,"about_ca_system_score_codex":0.000041700638,"about_ca_system_score_gemma":0.0001020269,"threshold_uncertainty_score":0.24412751},"labels":[],"label_agreement":null},{"id":"W2320130322","doi":"10.1136/annrheumdis-2014-eular.2537","title":"OP0200 Thromboembolism in Rheumatology: Investigation of the Risks of Deep Vein Thrombosis and Pulmonary Embolism in Inflammatory Arthritis, Connective Tissue Diseases, Vasculitis and Myositis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Pulmonary embolism; Antiphospholipid syndrome; Rheumatology; Myositis; Deep vein; Incidence (geometry); Thrombosis; Population; Cumulative incidence; Vasculitis; Arthritis; Gastroenterology; Cohort; Disease","score_opus":0.036998991466426254,"score_gpt":0.2975504732722362,"score_spread":0.26055148180580995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320130322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96316713,0.03460076,0.000004378534,0.0010526414,0.00013320698,0.0008157294,0.00013040783,0.000015255728,0.00008046414],"genre_scores_gemma":[0.98359793,0.01613918,0.00001622752,0.00013300692,0.000012203298,0.0000579369,0.000015861611,0.000023661665,0.0000040162645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974277,0.00062238926,0.0009844087,0.00030991418,0.00040105075,0.00025456172],"domain_scores_gemma":[0.99786395,0.0006349159,0.0006049651,0.0005527844,0.00014868868,0.00019471072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036105915,0.0002425426,0.0010414225,0.000183958,0.000075423675,0.000014586552,0.0002208954,0.00015327525,0.000028262433],"category_scores_gemma":[0.001178889,0.00016130213,0.00018365204,0.0003593714,0.0009473558,0.00016048668,0.00018303082,0.00013982989,9.327979e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007381168,0.00033494117,0.9714157,0.0023267386,0.00025482939,0.0000020365796,0.0017801281,0.000071381495,0.00068257423,0.0022188085,0.00018997505,0.020649092],"study_design_scores_gemma":[0.0014737081,0.00007607097,0.9739575,0.0138377715,0.00024589707,0.000019710262,0.0010122089,0.00072016206,0.0014045592,0.0070969253,0.0000053603135,0.00015014643],"about_ca_topic_score_codex":0.0012927457,"about_ca_topic_score_gemma":0.000070351394,"teacher_disagreement_score":0.020498946,"about_ca_system_score_codex":0.000019029536,"about_ca_system_score_gemma":0.00014078681,"threshold_uncertainty_score":0.657771},"labels":[],"label_agreement":null},{"id":"W2320153283","doi":"10.1136/annrheumdis-2014-eular.4011","title":"SAT0316 Key Role of Cardiac Biomarkers in the Assessment of Systemic Sclerosis: Contribution of High Sensitivity Cardiac Troponin","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Troponin; Troponin T; Troponin complex; Myocardial infarction","score_opus":0.017734650852466404,"score_gpt":0.27079203173981886,"score_spread":0.25305738088735247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320153283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795664,0.01828407,0.000019194373,0.00034726068,0.00021074177,0.00094218994,0.00045863513,0.000012169402,0.0001593503],"genre_scores_gemma":[0.9966543,0.003161938,0.000019467534,0.000040145864,0.000026728534,0.00004108463,0.000036942132,0.000015403379,0.000004039948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622566,0.0015231334,0.0010333065,0.00020204323,0.0007854898,0.00023038861],"domain_scores_gemma":[0.99673676,0.0009591257,0.000985654,0.00081292697,0.00040869543,0.000096808464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017620723,0.00019717522,0.0012393516,0.00013172839,0.00004583532,0.0000075928424,0.00021412408,0.00010009723,0.000008711782],"category_scores_gemma":[0.001041788,0.00011072784,0.0007423736,0.00039421415,0.0003029449,0.00006136074,0.00006904517,0.00008628631,0.0000010894973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088522583,0.0029065313,0.7633834,0.006222576,0.006094783,0.0000013033422,0.0020398265,0.00091001816,0.17818683,0.0073742513,0.0031488598,0.028846404],"study_design_scores_gemma":[0.0009363514,0.00018533124,0.9530313,0.01887978,0.0010905691,0.00000262286,0.0032974773,0.00076045876,0.021475174,0.00022576358,0.00000635143,0.0001088203],"about_ca_topic_score_codex":0.001115544,"about_ca_topic_score_gemma":0.0000036691108,"teacher_disagreement_score":0.18964791,"about_ca_system_score_codex":0.000036427715,"about_ca_system_score_gemma":0.00020049789,"threshold_uncertainty_score":0.45153502},"labels":[],"label_agreement":null},{"id":"W2320222267","doi":"10.1136/annrheumdis-2013-eular.241","title":"OP0036 An Evidence-Based Tool for Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The Detect Study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; DLCO; Pulmonary hypertension; Diffusing capacity; Internal medicine; Cardiology; Medical diagnosis; Cohort; False positive paradox; Lung; Radiology","score_opus":0.10186130500119352,"score_gpt":0.29715899725924383,"score_spread":0.19529769225805033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320222267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867377,0.008493323,0.000041963467,0.000436563,0.0002974206,0.0039345054,0.000025842255,0.000029692237,0.0000029691457],"genre_scores_gemma":[0.9984726,0.00053864234,0.000011070944,0.00019163915,0.000055292203,0.0006912721,0.0000042469283,0.000024330284,0.00001092234],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99779946,0.00043100462,0.00082994206,0.00025430898,0.0004620272,0.00022325806],"domain_scores_gemma":[0.9976328,0.0006769076,0.0004374127,0.0007937887,0.00035570178,0.00010341147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005457386,0.00019068812,0.0005451526,0.00011784997,0.00011267057,0.000030861716,0.0002976372,0.000074920405,0.000029065699],"category_scores_gemma":[0.0013279286,0.000096318916,0.00033377725,0.00029509084,0.00011676827,0.00022367726,0.000046637324,0.00007076962,0.0000056957574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057318294,0.00864899,0.096377246,0.0060574086,0.0009400122,0.000005951152,0.0011562031,0.0015258157,0.57650346,0.00001280236,0.0012734758,0.3017668],"study_design_scores_gemma":[0.0020556406,0.00082756724,0.94011414,0.026905578,0.00062496006,0.00001534216,0.0027253581,0.010659296,0.01576807,0.0001495353,8.181217e-7,0.00015368541],"about_ca_topic_score_codex":0.00044961317,"about_ca_topic_score_gemma":0.0000061627024,"teacher_disagreement_score":0.8437369,"about_ca_system_score_codex":0.00002458487,"about_ca_system_score_gemma":0.0001389905,"threshold_uncertainty_score":0.39277714},"labels":[],"label_agreement":null},{"id":"W2320352679","doi":"10.1136/annrheumdis-2014-eular.1199","title":"THU0464 Lsd1-Mediated Demethylation of Histone H3 Lysine 9 Contributes to Interleukin 1-Induced Microsomal Prostaglandin E Synthase-1 Expression","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Histone H3; Demethylase; Demethylation; Chromatin immunoprecipitation; Histone methylation; Molecular biology; Histone; Epigenetics; Regulation of gene expression; Gene expression; Biology; Chemistry; Biochemistry; DNA methylation; Promoter; Gene","score_opus":0.021916806348942247,"score_gpt":0.32504386203023033,"score_spread":0.30312705568128806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320352679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996469,0.00064151105,0.000257387,0.001274278,0.0003060707,0.00087210594,0.00007794017,0.00003909727,0.00006258526],"genre_scores_gemma":[0.99923664,0.000030924813,0.000103813974,0.00036012038,0.000058017587,0.00005307148,0.000057344205,0.000025694913,0.00007436331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998197,0.0002475314,0.00064415747,0.00021333444,0.00040774464,0.00029023664],"domain_scores_gemma":[0.99786043,0.0006498116,0.00045195202,0.0005376566,0.0002803712,0.00021975503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000582493,0.00020804693,0.0006590186,0.0001834739,0.00007399962,0.000011460178,0.00020660942,0.00007627853,0.000058252175],"category_scores_gemma":[0.0046550483,0.00013365233,0.00023231113,0.00028377815,0.00011196807,0.00008192243,0.00009984704,0.00009585571,0.000020810086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022370683,0.0009993655,0.063423455,0.0026120131,0.00034861796,0.0000061776864,0.00092990434,0.000049243037,0.9025366,0.00026662473,0.011439084,0.015151905],"study_design_scores_gemma":[0.0020160717,0.00050669146,0.20817445,0.0042013857,0.00023264602,0.000003354728,0.00007922342,0.00075686513,0.7831322,0.00032407697,0.00040218237,0.00017083691],"about_ca_topic_score_codex":0.000047336325,"about_ca_topic_score_gemma":0.0000060380758,"teacher_disagreement_score":0.14475101,"about_ca_system_score_codex":0.000033626668,"about_ca_system_score_gemma":0.000114474766,"threshold_uncertainty_score":0.5572864},"labels":[],"label_agreement":null},{"id":"W2320607657","doi":"10.1136/annrheumdis-2014-eular.6245","title":"SP0140 Outcome Measures in Rheumatology (OMERACT): Status on the Flare Assessment Work","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Observational study; Delphi method; Rheumatology; Delphi; Flare; Clinical trial; Physical therapy; Family medicine; Medical physics; Internal medicine; Artificial intelligence","score_opus":0.0659827987776855,"score_gpt":0.36030272789309664,"score_spread":0.29431992911541116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320607657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97554415,0.003375562,0.00003089737,0.018605923,0.00022870836,0.0006896263,0.000029618548,0.00003877165,0.0014567327],"genre_scores_gemma":[0.9940135,0.0046827192,0.000052938853,0.00094987324,0.000014370656,0.00009707094,0.0000112746575,0.000028823699,0.00014942663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689156,0.0006922966,0.00069003564,0.00025093416,0.0008784754,0.0005966718],"domain_scores_gemma":[0.99690723,0.0015030036,0.00025638213,0.0009321569,0.0001601972,0.00024101134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009160216,0.00023983663,0.00066647993,0.00015909599,0.00017123166,0.000051527713,0.00043314428,0.000058651684,0.00032580606],"category_scores_gemma":[0.0035030947,0.00012316329,0.00030697553,0.0003691115,0.000340026,0.000089006295,0.00012695258,0.00031589248,0.00006859058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005075532,0.00091780483,0.8853882,0.00038874813,0.00035610484,0.0000068460317,0.00060938817,0.00008830401,0.000021332038,0.018120373,0.012881355,0.080713995],"study_design_scores_gemma":[0.0014189883,0.00028928486,0.9819118,0.0028275007,0.000015001732,0.000010848907,0.0006065344,0.00019799617,0.00021722224,0.007940499,0.0043857736,0.00017857309],"about_ca_topic_score_codex":0.00019770658,"about_ca_topic_score_gemma":0.00004200196,"teacher_disagreement_score":0.09652358,"about_ca_system_score_codex":0.000030813655,"about_ca_system_score_gemma":0.00019294154,"threshold_uncertainty_score":0.5022453},"labels":[],"label_agreement":null},{"id":"W2320813552","doi":"10.1136/annrheumdis-2012-eular.901","title":"AB0901 Spondyloarthritis research consortium of canada (SAPRCC) enthesitis index in turkish as patients","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"BASDAI; Enthesitis; BASFI; Medicine; Ankylosing spondylitis; Visual analogue scale; Physical therapy; Internal medicine; Erythrocyte sedimentation rate; Disease; Psoriatic arthritis","score_opus":0.045798218924416004,"score_gpt":0.3349741424070312,"score_spread":0.2891759234826152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320813552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883841,0.0070025907,1.167042e-7,0.0008181073,0.00022556588,0.0005897696,0.0002592341,0.000007051332,0.0027134405],"genre_scores_gemma":[0.9983578,0.00096296,0.000007995422,0.00022254437,0.000024928771,0.00005362485,0.000021851902,0.00001913051,0.0003291623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975752,0.00019355815,0.0005251752,0.00016543666,0.00095617835,0.00058442436],"domain_scores_gemma":[0.9983736,0.00038235186,0.00019334695,0.00045709376,0.00034104937,0.00025253693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003138338,0.00016070162,0.000512546,0.00013350825,0.00011110069,0.0000072482444,0.0001816699,0.00004643014,0.00034662054],"category_scores_gemma":[0.0014295761,0.00011801312,0.00015107976,0.00039197417,0.0002645561,0.00010308191,0.000155154,0.00012465805,0.000009616848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028787777,0.0014163299,0.96966755,0.00026938034,0.00019329345,0.000019164634,0.00043730566,0.0000016864373,0.000005435891,0.00024651203,0.010275737,0.017179709],"study_design_scores_gemma":[0.0019336474,0.00020250281,0.9932892,0.0015209068,0.000046273915,0.000007674859,0.0006898432,0.000004098696,0.0009357995,0.0004022077,0.0008712506,0.00009663569],"about_ca_topic_score_codex":0.1115062,"about_ca_topic_score_gemma":0.027120147,"teacher_disagreement_score":0.08438606,"about_ca_system_score_codex":0.00007020324,"about_ca_system_score_gemma":0.00044301405,"threshold_uncertainty_score":0.99063236},"labels":[],"label_agreement":null},{"id":"W2320840145","doi":"10.1136/annrheumdis-2012-eular.685","title":"AB0685 The systemic lupus erythematosus activity scoring tool (LAST) and the simplified clinical index (C-LAST) are simple and sensitive indices of disease activity as compared to the sledai selena modification","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Rheumatology; Disease; Internal medicine; Systemic lupus erythematosus; Physical therapy","score_opus":0.08055143465329791,"score_gpt":0.3759042969239297,"score_spread":0.2953528622706318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320840145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891113,0.001789916,0.00018283984,0.005133369,0.0002383322,0.003318436,0.00012960116,0.000036953476,0.00005924741],"genre_scores_gemma":[0.9987082,0.000557087,0.0000053174895,0.0002530005,0.00013500468,0.00021505928,0.000004966234,0.000038497685,0.000082907965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952851,0.0018291487,0.00084432296,0.00040309026,0.0011039688,0.0005343812],"domain_scores_gemma":[0.9907338,0.005857986,0.0010829618,0.0014815346,0.00039862085,0.00044510304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003110799,0.00034726798,0.0010612726,0.00010989259,0.00045552565,0.00008537196,0.00052619044,0.00009185026,0.000008389501],"category_scores_gemma":[0.005111147,0.00014248052,0.0003384299,0.0004375025,0.0010843616,0.00027082156,0.00057925767,0.00037313532,0.0000118562275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077897822,0.00082817057,0.96673715,0.004321307,0.0011063004,0.000003090805,0.0069067013,0.00017447938,0.00020289845,0.0007177908,0.0016926506,0.009519676],"study_design_scores_gemma":[0.0035620334,0.00012873836,0.97254276,0.0043554646,0.0007140519,0.00066423183,0.00987666,0.0063287313,0.0007758111,0.000740325,0.000049463146,0.00026172024],"about_ca_topic_score_codex":0.00022630577,"about_ca_topic_score_gemma":0.000043742482,"teacher_disagreement_score":0.009596854,"about_ca_system_score_codex":0.000046712717,"about_ca_system_score_gemma":0.00030511405,"threshold_uncertainty_score":0.61188895},"labels":[],"label_agreement":null},{"id":"W2320982755","doi":"10.1136/annrheumdis-2012-eular.2520","title":"FRI0063 Comparison of disease characteristics of RA patients in remission according to the DAS criteria versus the new ACR/EULAR criteria in a real-world patient population","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Victoria; Arthritis Research Centre of Canada; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Infliximab; Population; Gastroenterology; Disease","score_opus":0.06883146431166912,"score_gpt":0.40807763346961884,"score_spread":0.3392461691579497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320982755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948498,0.0017243705,0.0000062681142,0.0019583625,0.00035358177,0.0009284007,0.000121569814,0.0000084041885,0.00004921297],"genre_scores_gemma":[0.99836546,0.001314409,0.000041392806,0.00009429564,0.000039787938,0.000033019147,0.000075306496,0.000019667208,0.000016680768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756503,0.00037853143,0.00091578637,0.00014977272,0.000646956,0.0003439066],"domain_scores_gemma":[0.9980896,0.0003938557,0.00043535564,0.00064367446,0.00015928,0.0002782397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041977558,0.00017297624,0.00054118934,0.00017956019,0.000081686594,0.00002372172,0.00032109034,0.000030312198,0.00009321405],"category_scores_gemma":[0.002259987,0.00009474884,0.00016384343,0.00044498986,0.00009807124,0.00019456765,0.00020540724,0.000108832064,0.0000029049315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035363226,0.0011412074,0.9295723,0.0003726026,0.0000679224,6.224084e-7,0.0045051514,0.000023082604,0.00017526656,0.00017072682,0.0038260361,0.05660877],"study_design_scores_gemma":[0.0012134111,0.00023043466,0.9923731,0.0033734355,0.000025335634,1.5837524e-7,0.0010843356,0.00046363825,0.0005406158,0.0002738091,0.00032812968,0.00009356145],"about_ca_topic_score_codex":0.0017201804,"about_ca_topic_score_gemma":0.00015460086,"teacher_disagreement_score":0.06280085,"about_ca_system_score_codex":0.00003613362,"about_ca_system_score_gemma":0.0000966283,"threshold_uncertainty_score":0.38637453},"labels":[],"label_agreement":null},{"id":"W2320986231","doi":"10.1136/annrheumdis-2014-eular.5560","title":"THU0255 Methotrexate Parenteral Administration versus Oral Delivery: A Comparison of Treatment Survival Using Ontario Best Practice Research Initiative (OBRI) Cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; University Health Network; Toronto General Hospital; University of Calgary","funders":"","keywords":"Medicine; Methotrexate; Discontinuation; Rheumatoid arthritis; Cohort; Internal medicine; Route of administration; Cohort study; Surgery","score_opus":0.30448025748744484,"score_gpt":0.4828934394308529,"score_spread":0.17841318194340805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320986231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947993,0.0015784907,0.000057574947,0.00072123687,0.0002061357,0.0007359308,0.00007176646,0.000014235277,0.0018153263],"genre_scores_gemma":[0.99715376,0.0019730378,0.000616204,0.000030446896,0.000030714167,0.00003927637,0.000053306485,0.000019588677,0.00008369096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963829,0.0013882827,0.0006025195,0.00024814456,0.0009863412,0.00039179894],"domain_scores_gemma":[0.9960938,0.0018374056,0.00038793395,0.00052145135,0.0009294011,0.0002300173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010528831,0.00019800245,0.0007139408,0.00014730023,0.00021240384,0.000052236595,0.00021879199,0.00005020334,0.0001380598],"category_scores_gemma":[0.0024407462,0.00013647253,0.00025039027,0.00025464204,0.00043635964,0.00028535497,0.00010110552,0.00018709895,0.00001150585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038620953,0.016405238,0.75508016,0.0009570329,0.008758858,0.000034151333,0.020701194,0.00051073456,0.00081629487,0.0044749407,0.0032549358,0.15038553],"study_design_scores_gemma":[0.034998074,0.061908983,0.745701,0.014648131,0.0019263328,0.00010330282,0.051441938,0.027642626,0.040566776,0.0044805235,0.015073904,0.0015084171],"about_ca_topic_score_codex":0.016196093,"about_ca_topic_score_gemma":0.0069901166,"teacher_disagreement_score":0.1488771,"about_ca_system_score_codex":0.00015225563,"about_ca_system_score_gemma":0.0010639497,"threshold_uncertainty_score":0.99035513},"labels":[],"label_agreement":null},{"id":"W2320997019","doi":"10.1136/annrheumdis-2014-eular.3828","title":"FRI0153 Validation of the New Concept of Backfill on Mri: A Distinct Reparative Tissue That Follows Resolution of Inflammation at Sites of Sacroiliac Joint Erosion in Axial Spondyloarthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliac joint; Coronal plane; Magnetic resonance imaging; Metaplasia; Radiology; Nuclear medicine; Prospective cohort study; Lesion; Pathology","score_opus":0.04133241607992812,"score_gpt":0.2978516319909426,"score_spread":0.2565192159110145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320997019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968821,0.0007465421,0.00005180392,0.0008631385,0.00008018887,0.0007242171,0.0002646089,0.0000085206075,0.00037888726],"genre_scores_gemma":[0.9994408,0.00017021681,0.00006721724,0.000029013592,0.000024505522,0.000012082101,0.000079028185,0.000011645777,0.00016549927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977316,0.00035776198,0.0009411252,0.00018048125,0.000643468,0.00014551256],"domain_scores_gemma":[0.997385,0.00036243864,0.0012805321,0.0006131265,0.00027839895,0.00008047364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003214383,0.00016486888,0.00068924285,0.00011341723,0.000042602267,0.00000411439,0.00015039781,0.000069779744,0.00014235628],"category_scores_gemma":[0.0020552895,0.000105611616,0.0003444033,0.00027107308,0.00031220712,0.00014104196,0.00011496007,0.00006582304,0.0000024107612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016320346,0.0056992513,0.37213013,0.012453899,0.0010034082,0.000005479681,0.017343188,0.006792702,0.42382059,0.006478022,0.063440986,0.07451202],"study_design_scores_gemma":[0.0014106149,0.00055201876,0.3847185,0.004850294,0.0001717504,0.0000012922922,0.00020805086,0.00051341654,0.6055128,0.0019156139,0.000062392406,0.00008326093],"about_ca_topic_score_codex":0.0005257218,"about_ca_topic_score_gemma":0.0001269283,"teacher_disagreement_score":0.1816922,"about_ca_system_score_codex":0.000025215451,"about_ca_system_score_gemma":0.00013194057,"threshold_uncertainty_score":0.43067166},"labels":[],"label_agreement":null},{"id":"W2321014483","doi":"10.1136/annrheumdis-2013-eular.2410","title":"AB0087 Tissue localisation of acid sensing proteins in synovial biopsies from patients with rheumatoid arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Pathology; Synovial membrane; Synovial joint; Synovial fluid; Cartilage; Arthritis; Immunology; Osteoarthritis; Anatomy; Articular cartilage","score_opus":0.01457428246624726,"score_gpt":0.2403265916082915,"score_spread":0.22575230914204425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321014483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613094,0.0012184938,0.00011937915,0.00090235804,0.00007715618,0.0013215756,0.000110611894,0.000030338313,0.000089172885],"genre_scores_gemma":[0.99849534,0.00027308354,0.00091523764,0.00015153906,0.000016984,0.000032851953,0.00006716081,0.000030012761,0.000017784652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981175,0.00011501473,0.000647206,0.00022940781,0.0006338625,0.00025700915],"domain_scores_gemma":[0.9983911,0.0001251437,0.00045445617,0.0005913927,0.00031176506,0.00012614556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010741137,0.00021152354,0.00058061845,0.00012762644,0.000049742946,0.000021046199,0.00017050067,0.000073193805,0.0001835811],"category_scores_gemma":[0.0008000522,0.00013917513,0.00010219099,0.00032190472,0.0002654239,0.00024984294,0.00008585057,0.00010531996,0.000028938946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000990841,0.0035036309,0.66011894,0.0018768966,0.0011203571,0.00001883173,0.007017151,0.00036983544,0.0076524834,0.00010430544,0.0041805445,0.31304616],"study_design_scores_gemma":[0.0028867072,0.00040565486,0.9426399,0.007597303,0.000100184334,0.000007378119,0.0009024896,0.0008077545,0.04299685,0.0013550618,0.000040533887,0.00026019063],"about_ca_topic_score_codex":0.0030676292,"about_ca_topic_score_gemma":0.000053023883,"teacher_disagreement_score":0.31278598,"about_ca_system_score_codex":0.000024655059,"about_ca_system_score_gemma":0.00012811371,"threshold_uncertainty_score":0.5675397},"labels":[],"label_agreement":null},{"id":"W2321027235","doi":"10.1136/annrheumdis-2014-eular.4816","title":"FRI0194 Identifying Patients with Rheumatoid Arthritis in Primary Care Electronic Medical Records","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; McGill University; Southlake Regional Health Center; University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Rheumatology; Rheumatoid arthritis; Medical record; Internal medicine; Medical prescription; Diagnosis code; Retrospective cohort study; Gold standard (test); MEDLINE; Primary care; Family medicine; Population","score_opus":0.011529984904076588,"score_gpt":0.26657555694562773,"score_spread":0.25504557204155115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321027235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772043,0.02002139,0.0000436851,0.0008597697,0.00011954208,0.00056956854,0.000029503039,0.000044347096,0.0011078987],"genre_scores_gemma":[0.9581656,0.04114367,0.00004533297,0.00041333796,0.000021298427,0.00006010795,0.00008109187,0.000036501697,0.000033086388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687904,0.0002593868,0.00059390813,0.00028088526,0.0013723975,0.00061440124],"domain_scores_gemma":[0.9983731,0.0002469459,0.00020577904,0.00058747653,0.00026891948,0.000317766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040317109,0.00022220134,0.0006295487,0.00017432975,0.00012561749,0.00004042108,0.00038270687,0.000072827774,0.00029658407],"category_scores_gemma":[0.0010047574,0.00014461944,0.00020005014,0.00033405746,0.00024461737,0.00021053477,0.000137967,0.0002856442,0.000025737721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006632719,0.0007619128,0.5686042,0.0009311514,0.00022758853,0.000007874171,0.00076310994,0.000006660675,0.000005275787,0.001016743,0.001766532,0.4252457],"study_design_scores_gemma":[0.006107772,0.0006950609,0.97374666,0.014429676,0.000008393506,0.000020442982,0.00035907698,0.00011567703,0.00020072339,0.0019915758,0.0020665177,0.00025843497],"about_ca_topic_score_codex":0.00017712363,"about_ca_topic_score_gemma":0.00026137845,"teacher_disagreement_score":0.4249873,"about_ca_system_score_codex":0.000055413628,"about_ca_system_score_gemma":0.00058230956,"threshold_uncertainty_score":0.58974093},"labels":[],"label_agreement":null},{"id":"W2321059112","doi":"10.1136/annrheumdis-2013-eular.2610","title":"AB0288 Safety, effectiveness, work and household productivity of anti-tnf alpha therapy with certolizumab pegol observed in adult rheumatoid arthritis patients in daily practice in canada: first interim analysis of the non-interventional fast can study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Certolizumab pegol; Rheumatoid arthritis; Interim analysis; Bristol-Myers; Clinical endpoint; Internal medicine; Physical therapy; Concomitant; Interim; Adalimumab; Clinical trial","score_opus":0.029607495159471354,"score_gpt":0.28317671013945545,"score_spread":0.2535692149799841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321059112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938187,0.00079454336,8.0601325e-7,0.003298609,0.000041896463,0.001812956,0.00021436613,0.0000027621018,0.000015335274],"genre_scores_gemma":[0.99822414,0.0015631996,0.000009055408,0.000032499276,0.000003360917,0.000120671,0.000019955643,0.00001595052,0.000011189166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972448,0.00060497556,0.000790309,0.0003032776,0.00078150607,0.00027513833],"domain_scores_gemma":[0.9977862,0.0007534888,0.0004901452,0.00048109534,0.00039879224,0.00009025478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024751123,0.00021763875,0.0009212581,0.00023923116,0.00005881025,0.000014827993,0.00031774875,0.000030187368,0.000034585097],"category_scores_gemma":[0.00079899974,0.00012450377,0.0001865138,0.0012402091,0.00023479003,0.00018034421,0.00020344056,0.00019044938,1.7800039e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023598708,0.004106682,0.982397,0.00051199604,0.0009291015,0.000013865881,0.00091240765,0.0003478743,0.000011653639,0.000010810647,0.000059087208,0.008339646],"study_design_scores_gemma":[0.0029693653,0.0004779687,0.9906913,0.004088571,0.00007990799,0.0000054194816,0.0010359756,0.00023452526,0.00026734997,0.000030249792,0.0000033880267,0.000115957],"about_ca_topic_score_codex":0.72993004,"about_ca_topic_score_gemma":0.687954,"teacher_disagreement_score":0.04197604,"about_ca_system_score_codex":0.00009291758,"about_ca_system_score_gemma":0.0005138654,"threshold_uncertainty_score":0.50771165},"labels":[],"label_agreement":null},{"id":"W2321144882","doi":"10.1136/annrheumdis-2012-eular.526","title":"AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Rheumatoid arthritis; Methotrexate; Placebo; Gastroenterology; Surgery; Lymphoma; Pathology","score_opus":0.029019696137970473,"score_gpt":0.328246413055332,"score_spread":0.2992267169173615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321144882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457335,0.000897945,3.2468347e-7,0.0007519345,0.000015891597,0.0036200278,0.000110855945,0.000017410484,0.000012229588],"genre_scores_gemma":[0.99921274,0.00030118547,0.00004492918,0.00012761012,0.000007873568,0.00019896096,0.000011863467,0.000033778942,0.0000610549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967969,0.0010588104,0.0005229398,0.0003531432,0.00075903453,0.0005091703],"domain_scores_gemma":[0.9977321,0.00093089655,0.00017011428,0.0007230218,0.00012157467,0.00032227425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000908896,0.00027606188,0.0006079765,0.0002524299,0.00010459656,0.000059881437,0.00016369777,0.00004348447,0.000018844663],"category_scores_gemma":[0.0012905493,0.00014252611,0.00005860169,0.00046869926,0.00028210614,0.00021775479,0.00013860212,0.00011617517,0.0000022323986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10732003,0.01159245,0.7984871,0.0002503453,0.00030449574,0.00011700529,0.031718485,0.000013375506,0.000030568353,0.000021640735,0.00017939844,0.04996508],"study_design_scores_gemma":[0.03619726,0.0048054038,0.9512574,0.0017097753,0.000050486156,0.000021723608,0.005598733,0.000034053024,0.00011604966,0.000010217257,0.000029553581,0.00016932005],"about_ca_topic_score_codex":0.0013040664,"about_ca_topic_score_gemma":0.00033962473,"teacher_disagreement_score":0.15277031,"about_ca_system_score_codex":0.00084026676,"about_ca_system_score_gemma":0.0012047002,"threshold_uncertainty_score":0.5812046},"labels":[],"label_agreement":null},{"id":"W2321379642","doi":"10.1136/annrheumdis-2014-eular.5973","title":"OP0173 Anti-Carbamylated Antibodies in Canadian First Nation RA Patients, First Degree Relatives and Controls in Relation to ACPA and RF Presence and ACPA Epitope Spread","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Rheumatoid arthritis; Antibody; Rheumatoid factor; First-degree relatives; Population; Autoantibody; Internal medicine; Immunology; Epitope; Gastroenterology; Family history","score_opus":0.049942690340455904,"score_gpt":0.30077331216353204,"score_spread":0.25083062182307614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321379642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98143035,0.0025712638,0.0000023039918,0.014787287,0.000034945388,0.0007267026,0.00007595283,0.0000069671655,0.00036422402],"genre_scores_gemma":[0.9967343,0.002770952,0.0000361492,0.00021439939,0.000013427681,0.000020608562,0.000024976413,0.000011019397,0.0001741176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986736,0.00012753384,0.00034579946,0.00024984128,0.00028964563,0.00031356176],"domain_scores_gemma":[0.9985248,0.0007360347,0.00011235222,0.00018801156,0.00013205672,0.0003067562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034875682,0.00016144845,0.00040412115,0.00027640065,0.00015300523,0.000037395155,0.00010727503,0.00006647448,0.0000147163055],"category_scores_gemma":[0.0020009342,0.00011403406,0.00004022283,0.0002388597,0.00022356716,0.000210739,0.000114252776,0.00012430319,0.0000026875045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023257465,0.00009661233,0.98353887,0.0004418369,0.000046112076,0.0000030676413,0.0013268589,0.000055693505,0.000049946648,0.00039597662,0.0005471918,0.0132652335],"study_design_scores_gemma":[0.0010297176,0.00017135093,0.99151707,0.0016908854,0.000025631458,0.0000023793157,0.00010806503,0.003927487,0.00007432171,0.0006609705,0.00067344296,0.000118690914],"about_ca_topic_score_codex":0.056365572,"about_ca_topic_score_gemma":0.060768876,"teacher_disagreement_score":0.015303997,"about_ca_system_score_codex":0.000024052328,"about_ca_system_score_gemma":0.000072401395,"threshold_uncertainty_score":0.95636964},"labels":[],"label_agreement":null},{"id":"W2321615460","doi":"10.1136/annrheumdis-2014-eular.2701","title":"FRI0186 Epidemiology of Rheumatic Diseases in Maya-Yucateco People: A Community-Based Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Indigenous; Epidemiology; Latin Americans; Family medicine; Census; Population; Demography; Gerontology; Physical therapy; Environmental health; Internal medicine","score_opus":0.05548845657275757,"score_gpt":0.3616736921316207,"score_spread":0.3061852355588631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321615460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939942,0.0011610477,0.00013305257,0.0032244953,0.00009725968,0.001178662,0.000049575046,0.000028515247,0.00013322025],"genre_scores_gemma":[0.9989488,0.00008025687,0.00011499661,0.00062390184,0.000008131944,0.00011699228,0.000052195748,0.00002312794,0.00003157839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956947,0.0024051757,0.0010898925,0.00019382808,0.00032607163,0.0002903566],"domain_scores_gemma":[0.9942222,0.003808481,0.00054481707,0.0010841794,0.00017668302,0.00016359698],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001358822,0.00022530176,0.0010974292,0.00021817374,0.00011205487,0.0000042777597,0.00037912797,0.00006119623,0.00012391292],"category_scores_gemma":[0.008618928,0.00014373436,0.0004482268,0.00044503965,0.00028536597,0.00007243295,0.00011131616,0.00019378561,0.000009182974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022748607,0.006724189,0.9715875,0.006121063,0.0001729661,2.619317e-7,0.0016249698,0.0005989971,0.0000064008577,0.00052041886,0.00074522983,0.011670512],"study_design_scores_gemma":[0.001743683,0.0009920291,0.9782145,0.0019350321,0.00023568803,5.182367e-7,0.0023223415,0.002608386,0.000008629846,0.011797588,0.000011265527,0.00013034567],"about_ca_topic_score_codex":0.0014164239,"about_ca_topic_score_gemma":0.0002910086,"teacher_disagreement_score":0.011540167,"about_ca_system_score_codex":0.000016555749,"about_ca_system_score_gemma":0.00013219549,"threshold_uncertainty_score":0.9997319},"labels":[],"label_agreement":null},{"id":"W2321653606","doi":"10.1136/annrheumdis-2012-eular.3145","title":"SAT0198 A comprehensive behavioral intervention in systemic lupus erythematosus demonstrates improvement in endothelial function, mental health but not in physical health or cardiovascular risks at one year","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; McGill University Health Centre; Montreal Heart Institute; St Joseph's Health Centre; Toronto Western Hospital; McGill University; St Joseph's Health Care; University Health Network; University of Toronto; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Randomized controlled trial; Physical therapy; Internal medicine; Framingham Risk Score; Mental health; Bonferroni correction; Clinical trial; Disease; Psychiatry","score_opus":0.10717947032234924,"score_gpt":0.3781262654881201,"score_spread":0.27094679516577086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321653606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853899,0.010381092,0.000013182769,0.00068689993,0.00036118535,0.002949051,0.0001804233,0.000027092385,0.000011163773],"genre_scores_gemma":[0.9982235,0.0011003945,0.000026018692,0.00012465434,0.00006085524,0.00026644676,0.00004834992,0.0000401213,0.00010964878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958469,0.00079976884,0.001227089,0.0003448231,0.0010194599,0.0007619555],"domain_scores_gemma":[0.99828136,0.00018115215,0.0004549601,0.00066751253,0.00010381903,0.00031119763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011696136,0.00028233996,0.0013333302,0.0003359658,0.000079308484,0.000017419645,0.00022188402,0.00006712992,0.000036954294],"category_scores_gemma":[0.00014539342,0.0001994968,0.0005540327,0.0004302022,0.00014616789,0.0001572175,0.00022019853,0.00023978685,0.000027563945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036685842,0.006946484,0.94302785,0.013724497,0.00070399354,0.000012897598,0.009103991,0.000097491094,0.0009004877,0.00010623065,0.0008794508,0.02082805],"study_design_scores_gemma":[0.03800478,0.0048035826,0.8124228,0.06827186,0.0004843867,0.0034586226,0.06422813,0.0017167646,0.005120155,0.00035043215,0.000121157726,0.0010173357],"about_ca_topic_score_codex":0.0060906396,"about_ca_topic_score_gemma":0.00060132064,"teacher_disagreement_score":0.13060504,"about_ca_system_score_codex":0.0007320536,"about_ca_system_score_gemma":0.00037770162,"threshold_uncertainty_score":0.9207266},"labels":[],"label_agreement":null},{"id":"W2321753973","doi":"10.1136/annrheumdis-2014-eular.6068","title":"AB0221 Does Etanercept Maintain Its Efficacy in the Elderly Population. A Single Center Retrospective Analysis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Etanercept; Medicine; Retrospective cohort study; Discontinuation; Rheumatoid arthritis; Single Center; Internal medicine; Pharmacy; Adverse effect; Incidence (geometry); Population; Rheumatology; Surgery","score_opus":0.024263537012655986,"score_gpt":0.30779578989944323,"score_spread":0.28353225288678724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321753973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185824,0.0011117194,0.00004355851,0.005684884,0.00005865056,0.000499579,0.00005793474,0.000023861072,0.0006615763],"genre_scores_gemma":[0.9982177,0.0011283407,0.000030334999,0.00037936197,0.00003483739,0.000031109143,0.000041375344,0.000014860267,0.000122065285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978215,0.0005052518,0.00043393264,0.00022251163,0.00068361004,0.00033316162],"domain_scores_gemma":[0.99849945,0.0004095474,0.00018068019,0.00064276875,0.00015049477,0.00011708338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005384312,0.00016344356,0.0004963594,0.0002209705,0.00013140604,0.00006650896,0.0003504037,0.000038626516,0.0003276117],"category_scores_gemma":[0.0016926208,0.000077771045,0.00044721772,0.0007390405,0.00014831824,0.00012380753,0.00006107366,0.00014025543,0.000016806527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057973387,0.0057001044,0.8498889,0.0003600025,0.0026574028,0.000014896892,0.0039163725,0.00033654738,0.0001454058,0.013899581,0.0033934219,0.11910758],"study_design_scores_gemma":[0.0011339595,0.00040055419,0.9900706,0.00056013593,0.000087422835,0.000007014357,0.0006440667,0.00065397186,0.000116238494,0.005858048,0.00035588915,0.00011210753],"about_ca_topic_score_codex":0.00020480451,"about_ca_topic_score_gemma":0.00022052405,"teacher_disagreement_score":0.14018165,"about_ca_system_score_codex":0.000025805082,"about_ca_system_score_gemma":0.000028829068,"threshold_uncertainty_score":0.35871184},"labels":[],"label_agreement":null},{"id":"W2321798153","doi":"10.1136/annrheumdis-2012-eular.3183","title":"SAT0236 Role of serological markers at baseline and follow-up in predicting biopsy proven lupus nephritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Lupus nephritis; Internal medicine; Serology; Biopsy; Systemic lupus erythematosus; Crithidia; Gastroenterology; Renal biopsy; Anti-dsDNA antibodies; Antibody; Immunology; Disease","score_opus":0.035022130748254165,"score_gpt":0.3045024265054061,"score_spread":0.26948029575715193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321798153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868435,0.010893397,0.0000020537623,0.00082667003,0.0001446872,0.0007524565,0.00006988325,0.000022336511,0.00044499597],"genre_scores_gemma":[0.9985879,0.0006319111,0.0000926768,0.000085841886,0.00003691887,0.000051480496,0.000010615439,0.000020802647,0.0004818192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795276,0.0002983427,0.00059883535,0.00018330418,0.0005489491,0.0004178345],"domain_scores_gemma":[0.99830073,0.00064077845,0.00024756673,0.0004428484,0.00011475307,0.00025330557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010359344,0.00015830285,0.00055113406,0.00012079306,0.000050228857,0.0000075438,0.000188642,0.00008184703,0.00013103237],"category_scores_gemma":[0.0025291978,0.00010044286,0.00017216992,0.0002503828,0.00022030987,0.000114777984,0.000288007,0.00010638763,0.0000064042947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007225743,0.0002820134,0.98700637,0.0017848868,0.00013465509,0.0000032895432,0.00086582743,0.0000023104012,0.0008969641,0.0000417962,0.0017199864,0.006539321],"study_design_scores_gemma":[0.004167809,0.00032623942,0.9753897,0.00764022,0.00021007909,0.0017437249,0.0042009745,0.002625396,0.0026079703,0.00063255255,0.00023435002,0.00022095605],"about_ca_topic_score_codex":0.0001650963,"about_ca_topic_score_gemma":0.000014360138,"teacher_disagreement_score":0.011744414,"about_ca_system_score_codex":0.000031367785,"about_ca_system_score_gemma":0.00007410426,"threshold_uncertainty_score":0.4095941},"labels":[],"label_agreement":null},{"id":"W2321974265","doi":"10.1136/annrheumdis-2014-eular.2521","title":"SAT0330 Juvenile Onset Raynaud's Predicts Good Survival in the Canadian Scleroderma Research Group Cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cohort; Proportional hazards model; Internal medicine; Survival analysis; Hazard ratio; Age of onset; Cohort study; Pediatrics; Surgery; Disease; Confidence interval","score_opus":0.08984519648139636,"score_gpt":0.33826581006646467,"score_spread":0.2484206135850683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321974265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781354,0.003702609,0.0000017753111,0.008163836,0.00032618718,0.0012284773,0.00016700401,0.000030030624,0.008244664],"genre_scores_gemma":[0.9976391,0.00073934975,0.000006159164,0.0010960887,0.000087182816,0.00011958499,0.00006154103,0.000029135967,0.00022184919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956094,0.0014142767,0.000643014,0.00031473004,0.0013829384,0.0006356271],"domain_scores_gemma":[0.99678904,0.0011202446,0.00017713931,0.0011625587,0.00026580412,0.00048520844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031734032,0.00020575627,0.00052981044,0.00025700137,0.00037333582,0.00007585001,0.00071065145,0.000110186076,0.00012896747],"category_scores_gemma":[0.0028420058,0.000111893336,0.000291061,0.00068826095,0.00043026754,0.000086147826,0.00009889297,0.00032771396,0.000058143978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017442385,0.0009992602,0.86056745,0.00069591415,0.00040390622,0.00001495924,0.0010999879,0.000071214774,0.000027829527,0.0023200072,0.12332387,0.010301154],"study_design_scores_gemma":[0.00091873936,0.00011960076,0.9912979,0.0036773824,0.00016071048,0.000015549975,0.0008702859,0.0004177024,0.000035563506,0.0014397898,0.0009221392,0.00012464645],"about_ca_topic_score_codex":0.05628879,"about_ca_topic_score_gemma":0.026179312,"teacher_disagreement_score":0.13073042,"about_ca_system_score_codex":0.00007176383,"about_ca_system_score_gemma":0.00065237563,"threshold_uncertainty_score":0.9915904},"labels":[],"label_agreement":null},{"id":"W2322227652","doi":"10.1136/annrheumdis-2012-eular.3408","title":"SAT0462 Case definition of serious infection affects incidence and predictors in an inception cohort of rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Incidence (geometry); Cohort; Marital status; Cohort study; Physical therapy; Population","score_opus":0.028697420314842625,"score_gpt":0.2955590493006526,"score_spread":0.26686162898580995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322227652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930368,0.0057502543,0.00000727993,0.00003971072,0.00012257458,0.000886808,0.00011351695,0.000023348159,0.000019692197],"genre_scores_gemma":[0.93160725,0.068210125,0.000046457,0.000024621024,0.000010085253,0.000050934377,0.000028986273,0.000020942023,6.158074e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981192,0.00033539868,0.00057808147,0.0001765941,0.00048983545,0.00030091184],"domain_scores_gemma":[0.9985051,0.00023833342,0.0004645597,0.0003371829,0.0002478379,0.00020700014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039669426,0.00018395948,0.0005567617,0.00022480101,0.00009106913,0.000019715935,0.000088497014,0.000058881873,0.000053260002],"category_scores_gemma":[0.00085082033,0.0001404097,0.0001294878,0.00030004015,0.00031549326,0.00070042274,0.000064653395,0.00010809341,0.0000010802622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021334189,0.00095750723,0.94123405,0.0003016176,0.000089117966,0.0000029921862,0.0014159774,0.0000056270555,0.00077972957,0.00004276722,0.000031452717,0.054925833],"study_design_scores_gemma":[0.0015497984,0.00065971696,0.9892864,0.0032728366,0.0000060803436,0.00006159854,0.00018367554,0.000073812604,0.004542651,0.00024551887,0.0000039621114,0.00011392129],"about_ca_topic_score_codex":0.0010553278,"about_ca_topic_score_gemma":0.00016661786,"teacher_disagreement_score":0.062459867,"about_ca_system_score_codex":0.00002188493,"about_ca_system_score_gemma":0.00007767678,"threshold_uncertainty_score":0.57257414},"labels":[],"label_agreement":null},{"id":"W2322330499","doi":"10.1136/annrheumdis-2012-eular.2882","title":"FRI0425 Longitudinal analysis of direct medical costs for systemic lupus erythematosus in british columbia, canada: A population-based study","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Population; Diagnosis code; Psoriatic arthritis; Cohort; Rheumatology; Rheumatoid arthritis; Connective tissue disease; Systemic lupus erythematosus; Spondyloarthropathy; Lupus erythematosus; Health care; Medical prescription; Medical record; Internal medicine; Disease; Immunology; Autoimmune disease; Environmental health","score_opus":0.03600834587465982,"score_gpt":0.3248631029639718,"score_spread":0.28885475708931196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322330499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364454,0.0033582074,0.00002165508,0.00024204166,0.00020316493,0.002205304,0.0002663694,0.000019205094,0.000039517294],"genre_scores_gemma":[0.99914795,0.000036468387,0.000018963307,0.00006378302,0.000029080671,0.00030390007,0.00006822256,0.0000305887,0.0003010228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572265,0.00041029454,0.0012211342,0.00027969523,0.0018501683,0.00051605667],"domain_scores_gemma":[0.99621505,0.001676608,0.0005139976,0.0007612412,0.00043235478,0.00040076885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014930122,0.00016423989,0.0014319917,0.00025622413,0.000086925975,0.000032919364,0.00040573542,0.00008063712,0.00020641259],"category_scores_gemma":[0.0042099976,0.00016166968,0.00045964163,0.0012660905,0.0000805865,0.000084292886,0.00008066209,0.000103023514,8.6959653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010959986,0.0015386231,0.98966557,0.0028744636,0.0018820163,0.000019642574,0.00019063853,0.000078772704,0.0000011045923,0.000008065082,0.0028886022,0.0007429039],"study_design_scores_gemma":[0.0020953373,0.00010728142,0.9857799,0.0056184228,0.001510168,0.00038574444,0.0017143758,0.0026203906,0.000007301697,0.000013005118,0.000005385357,0.00014273304],"about_ca_topic_score_codex":0.7485815,"about_ca_topic_score_gemma":0.87363863,"teacher_disagreement_score":0.12505709,"about_ca_system_score_codex":0.00024113365,"about_ca_system_score_gemma":0.001310528,"threshold_uncertainty_score":0.6592698},"labels":[],"label_agreement":null},{"id":"W2322527211","doi":"10.1136/annrheumdis-2013-eular.422","title":"OP0217 Frequent Detection of Inflammation and Fat Infiltration Suggestive of Spondyloarthritis on MRI of the Entire Spine in Healthy Subjects and Patients with Mechanical Back Pain","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Cohort; Back pain; Magnetic resonance imaging; Radiography; Low back pain; Lesion; Internal medicine; Radiology; Physical therapy; Surgery; Pathology","score_opus":0.012243015551845489,"score_gpt":0.24284422926347038,"score_spread":0.2306012137116249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322527211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755704,0.0007368188,0.00001002626,0.000534,0.000033286324,0.0010522425,0.000050626553,0.0000028068841,0.000023128101],"genre_scores_gemma":[0.9991444,0.0007088597,0.000041237538,0.000042428943,0.000004845786,0.00003392145,0.000012164376,0.0000072546463,0.0000049005434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893355,0.0001579289,0.00040719926,0.00011964856,0.00027800712,0.00010366629],"domain_scores_gemma":[0.9990237,0.00013466446,0.00039735736,0.00019802355,0.00019786615,0.0000484105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013772729,0.00010994274,0.00033405918,0.000064638276,0.000039827333,0.000004302274,0.00004446257,0.000034506513,0.00001676582],"category_scores_gemma":[0.00039116922,0.00006295419,0.000058195765,0.00016099018,0.00015668236,0.000087795044,0.000038163187,0.00004517692,4.005893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002374208,0.0017685533,0.77615124,0.0027743767,0.0003880439,0.0000013245767,0.001299515,0.00004777813,0.0032076868,0.0006731323,0.000073753166,0.21124038],"study_design_scores_gemma":[0.0028347992,0.0023265006,0.97350085,0.003116526,0.00005604784,0.0000012305424,0.00024962638,0.0001359968,0.017145239,0.0005803072,0.0000018647889,0.000051019222],"about_ca_topic_score_codex":0.00050053955,"about_ca_topic_score_gemma":0.0003128302,"teacher_disagreement_score":0.21118936,"about_ca_system_score_codex":0.000013112535,"about_ca_system_score_gemma":0.000027965678,"threshold_uncertainty_score":0.25671974},"labels":[],"label_agreement":null},{"id":"W2322595648","doi":"10.1136/annrheumdis-2014-eular.2541","title":"FRI0375 A Delphi Exercise for Treatment Algorithms for Systemic Lupus Erythematosus","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rituximab; Hydroxychloroquine; Abatacept; Azathioprine; Mycophenolic acid; Methotrexate; Internal medicine; Dermatomyositis; Belimumab; Golimumab; Adalimumab; Rheumatoid arthritis; Immunology; Transplantation","score_opus":0.07625391005273022,"score_gpt":0.35676722231532404,"score_spread":0.2805133122625938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322595648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686513,0.010668714,0.005731413,0.0036192904,0.0006788333,0.009880135,0.0003706047,0.0001533271,0.00024639894],"genre_scores_gemma":[0.99153405,0.00086111436,0.0011550064,0.00014681109,0.00014654586,0.0026617507,0.000051033956,0.00009255768,0.0033511403],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99756575,0.00011346671,0.00079450104,0.0003787143,0.0005781685,0.00056941714],"domain_scores_gemma":[0.9962656,0.0013127321,0.0004011005,0.0011594986,0.00054293114,0.00031813918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005998651,0.0003217777,0.0011172475,0.000153505,0.00017402114,0.00003613412,0.00040580018,0.00009636302,0.000028030336],"category_scores_gemma":[0.00134051,0.00018864733,0.0008804214,0.00020034834,0.00014177011,0.000074749034,0.00006766072,0.000037454673,0.000023640945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01307436,0.00965453,0.081228524,0.16064167,0.007918591,0.000029169592,0.015625639,0.0004618091,0.0013032514,0.014337065,0.27493617,0.4207892],"study_design_scores_gemma":[0.14079034,0.019781226,0.005934651,0.24296308,0.016893974,0.050676413,0.032866344,0.29105988,0.048125535,0.10816313,0.03732543,0.005419996],"about_ca_topic_score_codex":0.00004149602,"about_ca_topic_score_gemma":0.000002895847,"teacher_disagreement_score":0.41536924,"about_ca_system_score_codex":0.00008227081,"about_ca_system_score_gemma":0.00025574642,"threshold_uncertainty_score":0.7692815},"labels":[],"label_agreement":null},{"id":"W2322760244","doi":"10.1136/annrheumdis-2012-eular.1854","title":"OP0171 A data driven approach to the definition of a positive MRI of the sacroiliac joints in spondyloarthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Gold standard (test); Magnetic resonance imaging; Radiology; Confidence interval; Sacroiliac joint; Radiography; Population; Axial spondyloarthritis; Physical examination; Physical therapy; Sacroiliitis; Surgery; Internal medicine","score_opus":0.08407542184007881,"score_gpt":0.3175739246195686,"score_spread":0.2334985027794898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322760244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98574126,0.00650934,0.000011276984,0.002724628,0.00013176489,0.0010660986,0.0016950257,0.0000061424134,0.0021144398],"genre_scores_gemma":[0.9983014,0.00088795833,0.00030221266,0.00031256105,0.000022665912,0.00005676553,0.00006504724,0.00001382376,0.000037597867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985339,0.00017658043,0.0004435131,0.00016991176,0.00041868893,0.0002574261],"domain_scores_gemma":[0.9982008,0.00020177098,0.00027897672,0.0011144181,0.00011785742,0.00008622987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028014788,0.00014753392,0.0004494539,0.000055819073,0.00009124081,0.0000061272945,0.00045059348,0.00003220299,0.00002869129],"category_scores_gemma":[0.00067314727,0.00007382261,0.00020238143,0.00035262367,0.00023892734,0.000114637514,0.0005051493,0.00007394513,0.000007456446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002750616,0.019777993,0.79709375,0.0028598728,0.0037783217,0.000013496281,0.024820592,0.00017387483,0.0003987964,0.015977118,0.042703964,0.08965162],"study_design_scores_gemma":[0.0014376394,0.0001690652,0.9915462,0.0029339213,0.00029685342,0.000021184596,0.0016584081,0.00008519092,0.0007561419,0.0008877618,0.000116090734,0.000091547736],"about_ca_topic_score_codex":0.00034469142,"about_ca_topic_score_gemma":0.00006991105,"teacher_disagreement_score":0.19445246,"about_ca_system_score_codex":0.000014455443,"about_ca_system_score_gemma":0.00006498016,"threshold_uncertainty_score":0.30103987},"labels":[],"label_agreement":null},{"id":"W2322800322","doi":"10.1136/annrheumdis-2013-eular.2606","title":"AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Internal medicine; Safety profile; Adverse effect; Rheumatoid arthritis; Physical therapy; Adalimumab","score_opus":0.043190332442442594,"score_gpt":0.3280958714096306,"score_spread":0.284905538967188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322800322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993015,0.0019179392,0.000029681103,0.0043516955,0.00008492961,0.002390594,0.0005883908,0.000023806891,0.0006827826],"genre_scores_gemma":[0.9979486,0.0013578329,0.00007054784,0.00010424756,0.000023660597,0.00009100169,0.00015446148,0.000030013676,0.0002196542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959935,0.0005072504,0.001793989,0.0004001078,0.00089325,0.0004118822],"domain_scores_gemma":[0.99320453,0.0034966883,0.0011757509,0.0015554143,0.00037704548,0.00019056999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010237454,0.00028538046,0.0011666485,0.0001187129,0.00011161292,0.000026218486,0.0005175518,0.00011444776,0.00028946507],"category_scores_gemma":[0.0035249426,0.00014899985,0.0002579221,0.0004098184,0.0013031865,0.00016751586,0.00027171624,0.000227145,0.00001366826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27182662,0.012823013,0.5535803,0.0065138317,0.009160047,0.0005384171,0.020478174,0.0020987787,0.00035012644,0.0020808424,0.08714436,0.03340551],"study_design_scores_gemma":[0.09623868,0.0005660965,0.89000624,0.006807909,0.00035112223,0.00016126843,0.0014745251,0.00224164,0.000559696,0.0012910286,0.000062114974,0.00023966022],"about_ca_topic_score_codex":0.004826825,"about_ca_topic_score_gemma":0.00030781014,"teacher_disagreement_score":0.336426,"about_ca_system_score_codex":0.00033861556,"about_ca_system_score_gemma":0.0023725042,"threshold_uncertainty_score":0.72967476},"labels":[],"label_agreement":null},{"id":"W2322841545","doi":"10.1136/annrheumdis-2015-eular.2389","title":"FRI0036 What is the Level of Agreement Between Disease Activity Indices and Response Criteria Among Rheumatoid Arthritis Patients Treated with TNF Inhibitors?","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Oakville Public Library; University of Alberta; University of Saskatchewan; McGill University; Arthritis Research Centre of Canada; University of Toronto","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Internal medicine; Infliximab; Cohen's kappa; Adalimumab; Physical therapy; Disease; Statistics","score_opus":0.07448075653575234,"score_gpt":0.32228780204536145,"score_spread":0.2478070455096091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322841545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811642,0.013794458,0.000004863695,0.0032798795,0.00006635702,0.0010328824,0.00061099685,0.000021492855,0.00002484701],"genre_scores_gemma":[0.9785432,0.021093126,0.000015713056,0.00013636128,0.000018065883,0.000070445865,0.000029948947,0.000028719403,0.00006442622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997074,0.00061219296,0.0005249566,0.00029413804,0.0011224634,0.00037224163],"domain_scores_gemma":[0.9972043,0.0005117702,0.00045751993,0.0007335004,0.00048208842,0.00061079225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006683795,0.00028435004,0.00063411443,0.00014526593,0.00019053064,0.00013345969,0.00028995782,0.000050747956,0.000074305426],"category_scores_gemma":[0.000969093,0.00015378465,0.00018786425,0.00029910178,0.0010080732,0.0007065868,0.00021050696,0.00013329441,0.000005598199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074844873,0.000917898,0.863554,0.0003232514,0.0007251934,0.000008390623,0.0038717769,0.0000016174776,0.000038294296,0.000017240549,0.005824848,0.117232986],"study_design_scores_gemma":[0.0032724899,0.00097412756,0.98319495,0.006786038,0.000041409246,0.0000029038724,0.0012399177,0.00003728643,0.0035367839,0.0005349694,0.00020135476,0.00017776884],"about_ca_topic_score_codex":0.0004987599,"about_ca_topic_score_gemma":0.0000379934,"teacher_disagreement_score":0.11964094,"about_ca_system_score_codex":0.000023050501,"about_ca_system_score_gemma":0.000299338,"threshold_uncertainty_score":0.6271156},"labels":[],"label_agreement":null},{"id":"W2322975071","doi":"10.1136/annrheumdis-2014-eular.4664","title":"OP0270-HPR Should A Successful Early Inflammatory Arthritis Clinic Also Address Cardiac Risk?","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Dyslipidemia; Framingham Risk Score; Internal medicine; Cohort; Family history; Obesity; Disease; Physical therapy; Pediatrics; Environmental health","score_opus":0.0357764576810654,"score_gpt":0.3215334443235637,"score_spread":0.28575698664249827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322975071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717459,0.022711571,0.00001894257,0.0018018052,0.00041482912,0.0007874355,0.00024539983,0.00010717176,0.0021669192],"genre_scores_gemma":[0.93774706,0.061077293,0.00004033946,0.00036089338,0.00014292984,0.0001085306,0.000020783014,0.00005344146,0.00044871325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963814,0.00072967535,0.00085014466,0.0003639711,0.0010536334,0.000621185],"domain_scores_gemma":[0.996622,0.0008418993,0.00044935965,0.0012133836,0.00035042784,0.00052289694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000996457,0.00031243663,0.00093482947,0.0001613481,0.00027492546,0.00009653558,0.00055052293,0.0001107445,0.0006918316],"category_scores_gemma":[0.0030534437,0.00021826116,0.000786015,0.0002704261,0.0006221868,0.00027966703,0.00022285657,0.00033609354,0.0002566914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000783972,0.0007895382,0.5532915,0.0008461267,0.0015170192,0.00001576147,0.0010436141,0.000019024075,0.000115024915,0.0014171561,0.050549127,0.38961214],"study_design_scores_gemma":[0.0030885953,0.0009274397,0.9614797,0.0056965426,0.00009593075,0.00001494304,0.0004354292,0.00019789419,0.0022539715,0.007303913,0.018034631,0.0004710055],"about_ca_topic_score_codex":0.00035759783,"about_ca_topic_score_gemma":0.000035518642,"teacher_disagreement_score":0.4081882,"about_ca_system_score_codex":0.00001262958,"about_ca_system_score_gemma":0.00022095932,"threshold_uncertainty_score":0.8900432},"labels":[],"label_agreement":null},{"id":"W2323187591","doi":"10.1136/annrheumdis-2014-eular.1348","title":"THU0412 Cardiovascular Outcomes in Patients with Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-Analyses","year":2014,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Centre Hospitalier de l’Université de Montréal; Memorial University of Newfoundland; Western University; University of Toronto; SKiN Health; University of British Columbia; Hôpital du Sacré-Cœur de Montréal; Lynde Centre for Dermatology; University of Alberta; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Observational study; Rheumatoid arthritis; Meta-analysis; Psoriasis; Myocardial infarction; MEDLINE; Stroke (engine); Intensive care medicine; Physical therapy; Dermatology","score_opus":0.06801976241211781,"score_gpt":0.3501850305059368,"score_spread":0.282165268093819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323187591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005625059,0.9920517,0.0000045537276,0.00025990285,0.00005840663,0.0066747135,0.00032775712,0.000038564125,0.000021898792],"genre_scores_gemma":[0.0029213883,0.9952113,0.000051644798,0.00024570784,0.000009767455,0.0013473347,0.00007090983,0.0001048011,0.00003715819],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.992784,0.001847727,0.0024961757,0.0007137442,0.0015526327,0.00060570095],"domain_scores_gemma":[0.9949426,0.0010175299,0.0012823419,0.0019790428,0.0003557655,0.0004227237],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001454238,0.0009812857,0.016533496,0.00041543233,0.00015252334,0.00012403488,0.00046844574,0.00016135159,0.00008178805],"category_scores_gemma":[0.003723496,0.00048226307,0.0030445945,0.0005739658,0.0004650658,0.00023280234,0.00025297902,0.00035914773,0.000014621597],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002351942,0.00036595608,0.0003467956,0.77728087,0.054492142,0.000009340588,0.00005565457,5.0794364e-7,1.1864412e-9,0.00008853726,0.00033647998,0.16700017],"study_design_scores_gemma":[0.0027752207,0.00036321196,0.0016907053,0.9385328,0.04826678,0.00010785211,0.000049829338,0.0000025780005,2.6117263e-7,0.0002770033,0.0072205723,0.00071315415],"about_ca_topic_score_codex":0.00011112147,"about_ca_topic_score_gemma":0.000028865788,"teacher_disagreement_score":0.16628702,"about_ca_system_score_codex":0.000027350874,"about_ca_system_score_gemma":0.00025957933,"threshold_uncertainty_score":0.9997629},"labels":[],"label_agreement":null},{"id":"W2323233940","doi":"10.1136/annrheumdis-2014-eular.4515","title":"FRI0002 Lower Levels of 14-3-3Eta PREDICT DMARD Associated DAS Remission at 1 Year Follow Up","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cohort; Univariate analysis; Gastroenterology; Multivariate analysis; Stepwise regression","score_opus":0.02965759949111678,"score_gpt":0.30333322092438536,"score_spread":0.27367562143326857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323233940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960118,0.0004404675,0.000101065474,0.00047798024,0.00052956847,0.00025679093,0.00035176193,0.00001523454,0.001815344],"genre_scores_gemma":[0.992496,0.000114202296,0.000053837426,0.0001253944,0.000039939227,0.000017052638,0.000055935223,0.000023545008,0.007074066],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871933,0.00019492964,0.0003716624,0.00022224213,0.00029328596,0.00019855984],"domain_scores_gemma":[0.9984397,0.000089763525,0.00038831454,0.00075251755,0.00022752548,0.00010217005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025028302,0.00015117408,0.00025556094,0.00003271112,0.00008491735,0.000011593968,0.0003950168,0.00010780855,0.00034395768],"category_scores_gemma":[0.0031229272,0.00011107622,0.00033812583,0.0000914055,0.00011163836,0.000008593211,0.00027551668,0.000059663067,0.000020625177],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012632057,0.0016805185,0.04108551,0.0007156559,0.0021176005,0.0000014956947,0.0003395459,0.00042928566,0.34262288,0.00034063347,0.5883459,0.021057779],"study_design_scores_gemma":[0.0023753233,0.00092748547,0.20423765,0.0023753974,0.00037425666,0.0000059135355,0.00011057611,0.00054321974,0.7565929,0.0033933846,0.028458739,0.0006051361],"about_ca_topic_score_codex":0.000024522502,"about_ca_topic_score_gemma":0.000011725043,"teacher_disagreement_score":0.5598872,"about_ca_system_score_codex":0.000011331464,"about_ca_system_score_gemma":0.000058814818,"threshold_uncertainty_score":0.45295566},"labels":[],"label_agreement":null},{"id":"W2323265688","doi":"10.1136/annrheumdis-2014-eular.2731","title":"SAT0008 Low Socioeconomic Status (SES) as Measured by Education is (NOT) Associated with Worse Outcome in Sle: Data from the 1000 Canadian Faces of Lupus","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Socioeconomic status; Cohort; Logistic regression; Cohort study; Health care; Demography; Prospective cohort study; Disease; Gerontology; Pediatrics; Internal medicine; Population; Environmental health","score_opus":0.05735848034478968,"score_gpt":0.3371768825327347,"score_spread":0.279818402187945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323265688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98580223,0.0027320697,0.0000023247726,0.008355433,0.00022254186,0.0008704724,0.0016433825,0.000014697078,0.00035685464],"genre_scores_gemma":[0.996355,0.0003262453,0.000011105516,0.0013037032,0.000022394774,0.000040883588,0.0003618738,0.0000345885,0.0015441872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973923,0.00047539402,0.0006972301,0.00032298427,0.00066957815,0.0004425337],"domain_scores_gemma":[0.9961508,0.0010984776,0.00050492847,0.0016617225,0.00025270545,0.00033138477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009244669,0.00020899938,0.00065932074,0.00012449366,0.00009256713,0.000038546146,0.00092023454,0.00008388828,0.00040969843],"category_scores_gemma":[0.0031680886,0.000119974145,0.000112010195,0.00022944932,0.0002636902,0.0001623944,0.00013349476,0.0001601859,0.000052781663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014172455,0.0002822188,0.88048154,0.0003449087,0.00042709164,6.111518e-7,0.002088332,0.000013140914,0.000028704544,0.000026027601,0.11238279,0.003782877],"study_design_scores_gemma":[0.0043627513,0.00024492727,0.9631625,0.01085345,0.00059518206,0.000045263147,0.011632339,0.0029558882,0.0009610039,0.0013135182,0.0033369171,0.0005362541],"about_ca_topic_score_codex":0.16152781,"about_ca_topic_score_gemma":0.043604966,"teacher_disagreement_score":0.11792285,"about_ca_system_score_codex":0.00020795834,"about_ca_system_score_gemma":0.002463353,"threshold_uncertainty_score":0.97384673},"labels":[],"label_agreement":null},{"id":"W2323364690","doi":"10.1136/annrheumdis-2013-eular.1854","title":"SAT0128 Prolonged Exposure to Subcutaneous and Intravenous Abatacept in Patients with Rheumatoid Arthritis does not Affect Rates of Infection, Malignancy and Autoimmune Events: Results from Pooled Clinical Trial Data","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Rheumatoid arthritis; Adverse effect; Cumulative dose; Incidence (geometry); Clinical trial; MedDRA; Discontinuation; Abatacept; Gastroenterology; Cohort; Rituximab","score_opus":0.043077330683503626,"score_gpt":0.3355547840796279,"score_spread":0.2924774533961243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323364690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373025,0.0014272971,0.0000024036515,0.000862884,0.0001409703,0.003080596,0.0007283774,0.000020941525,0.000006288922],"genre_scores_gemma":[0.9960001,0.0034566056,0.00009379635,0.000085435815,0.000024759907,0.00007999149,0.00020274597,0.00002818439,0.00002834807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968988,0.00044314435,0.0012136016,0.0005101316,0.00060685014,0.00032752453],"domain_scores_gemma":[0.99637127,0.0013743531,0.00046659165,0.0012816231,0.0002742388,0.00023192646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068506814,0.00023702437,0.0008987825,0.0001206272,0.00006366758,0.000037430833,0.0003124284,0.00010308136,0.000049679886],"category_scores_gemma":[0.005822795,0.00013636891,0.00008437244,0.00023638172,0.00030468643,0.00023475023,0.00045776996,0.00016286818,0.0000061411415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15274821,0.006153048,0.5656609,0.0013597767,0.001794319,0.000043381875,0.0021135656,0.000033387692,0.000082202125,0.000015827176,0.0018153421,0.26818],"study_design_scores_gemma":[0.08795003,0.0038478568,0.90270656,0.0043728612,0.00009175073,0.000012825968,0.00007847902,0.00032083725,0.00021430591,0.0002355015,0.000007749837,0.00016121876],"about_ca_topic_score_codex":0.003905853,"about_ca_topic_score_gemma":0.000289557,"teacher_disagreement_score":0.33704567,"about_ca_system_score_codex":0.00010790484,"about_ca_system_score_gemma":0.0009032209,"threshold_uncertainty_score":0.697085},"labels":[],"label_agreement":null},{"id":"W2323647093","doi":"10.1136/annrheumdis-2014-eular.1808","title":"SAT0245 Decreased Use of Glucocorticoids in PTS with RA Who Initiated IV Abatacept and Previously Failed at Least One Biologic Agent: Results from the 2-Year Action Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Concomitant; Abatacept; Internal medicine; Surgery; Rituximab","score_opus":0.12985102030288045,"score_gpt":0.32204101857825984,"score_spread":0.1921899982753794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323647093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638706,0.0004681453,0.000006131492,0.0011255473,0.000030441157,0.0016995566,0.00022980596,0.000017993603,0.00003529786],"genre_scores_gemma":[0.99838036,0.001020066,0.000058659723,0.00023333133,0.000015086982,0.00011970346,0.000110069705,0.000016433512,0.000046285775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980566,0.0005347639,0.0005621522,0.00030139147,0.00034772512,0.00019738123],"domain_scores_gemma":[0.9972516,0.0014269396,0.00043370933,0.0006050972,0.00015059751,0.00013208325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027915696,0.00021550093,0.000601498,0.00005984363,0.00009515217,0.000028058528,0.000121296354,0.000044245917,0.00005867994],"category_scores_gemma":[0.0020117678,0.00010399417,0.000100599376,0.00020782526,0.00019225413,0.00010571132,0.00010018624,0.00007915856,0.0000056453237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039654947,0.0028601794,0.983292,0.00012866463,0.0007359259,0.0000055507967,0.0017482755,0.000055416283,0.000064038475,0.000036429206,0.00053479784,0.0065732454],"study_design_scores_gemma":[0.006294818,0.0013833985,0.98739827,0.0020284064,0.00050417683,0.0000017361126,0.0007312806,0.00033515523,0.0010655026,0.00012379729,0.000028114175,0.00010531862],"about_ca_topic_score_codex":0.0012838612,"about_ca_topic_score_gemma":0.00100459,"teacher_disagreement_score":0.006467927,"about_ca_system_score_codex":0.00002857973,"about_ca_system_score_gemma":0.00006667791,"threshold_uncertainty_score":0.4240759},"labels":[],"label_agreement":null},{"id":"W2323721573","doi":"10.1136/annrheumdis-2013-eular.3090","title":"AB0768 Relationship between das28 1.2 and sdai50 responses in rheumatoid arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St Joseph's Health Centre; Université de Sherbrooke; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cohort; Internal medicine; Methotrexate; Rheumatology; Physical therapy","score_opus":0.05623161246704262,"score_gpt":0.32573247982452136,"score_spread":0.26950086735747875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323721573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967334,0.024313001,0.0000062245845,0.0071680867,0.000047661328,0.0006648967,0.000051415278,0.000043209926,0.00037153368],"genre_scores_gemma":[0.9725227,0.026860395,0.00008244293,0.00017390806,0.000017471657,0.00007520093,0.000014739061,0.000026172005,0.0002270023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980823,0.00029289152,0.0005813557,0.00022094883,0.00045390762,0.00036859512],"domain_scores_gemma":[0.99763536,0.0012724795,0.00016083418,0.00051333464,0.00013827188,0.00027971438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003687864,0.00017842167,0.00049633556,0.00022856484,0.0001538426,0.000070192116,0.00020464582,0.0000643212,0.0002725845],"category_scores_gemma":[0.0033505878,0.00012680519,0.0001513505,0.0003114657,0.00043711223,0.0003150692,0.0001229499,0.00018493968,0.00007722351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115811374,0.00016443376,0.92545354,0.00016681946,0.000085231826,0.0000043103046,0.0005285328,0.0000014972524,0.000034172124,0.0017605923,0.0045950357,0.06708999],"study_design_scores_gemma":[0.0011903347,0.000113965805,0.9743925,0.0027869213,0.000003880095,0.00002641795,0.00043965786,0.00003296926,0.0002025266,0.020273611,0.00041277098,0.00012446106],"about_ca_topic_score_codex":0.00040170702,"about_ca_topic_score_gemma":0.000024810082,"teacher_disagreement_score":0.066965535,"about_ca_system_score_codex":0.000011764776,"about_ca_system_score_gemma":0.00012477384,"threshold_uncertainty_score":0.5170966},"labels":[],"label_agreement":null},{"id":"W2323784951","doi":"10.1136/annrheumdis-2014-eular.4950","title":"SAT0427 Multicentric Osteoarthritis Intervention Study with Sysadoa (MOVES): Effects of Combined Glucosamine Hydrochloride and Chondroitin Sulfate VS Celecoxib for Painful Knee Osteoarthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Tolerability; WOMAC; Chondroitin sulfate; Celecoxib; Placebo; Internal medicine; Knee pain; Randomized controlled trial; Gastroenterology; Adverse effect; Pathology","score_opus":0.007881661902689104,"score_gpt":0.24359746349033826,"score_spread":0.23571580158764915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323784951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915689,0.0029644326,0.00013359734,0.00025220323,0.00023382125,0.0046335855,0.000099146106,0.000058993206,0.000055269637],"genre_scores_gemma":[0.9986222,0.00014866654,0.00019694248,0.00010496831,0.000039587114,0.00045348328,0.00008675104,0.000056008437,0.00029140402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99779844,0.00023390663,0.00072212634,0.0003793074,0.00046361622,0.00040262446],"domain_scores_gemma":[0.9975653,0.00079797755,0.00054625334,0.0005883675,0.00026267435,0.00023941227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033775246,0.00035293767,0.0009663075,0.00017893263,0.00012813235,0.00003499875,0.00016361075,0.00006875783,0.000019864658],"category_scores_gemma":[0.0010228946,0.000253776,0.00034218628,0.000258564,0.00017433063,0.000169294,0.00010015158,0.000088931265,0.000003683264],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012014391,0.007113927,0.03870311,0.008704834,0.00087484345,0.000047573754,0.001036355,0.000011449766,0.0024508224,0.0007681181,0.0001996032,0.92807496],"study_design_scores_gemma":[0.20071083,0.26181105,0.31651667,0.033945844,0.0058601415,0.00013869791,0.00266563,0.0010662185,0.17129867,0.0042744926,0.00028960695,0.0014221447],"about_ca_topic_score_codex":0.000055300978,"about_ca_topic_score_gemma":0.00008521536,"teacher_disagreement_score":0.92665285,"about_ca_system_score_codex":0.000017651488,"about_ca_system_score_gemma":0.00004418981,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W2323815622","doi":"10.1136/annrheumdis-2013-eular.731","title":"THU0203 Equal Retention and Drug Survival Between Females and Males Requiring Biologic Therapy for Rheumatoid Arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Etanercept; Adalimumab; Internal medicine; Rheumatoid arthritis; Infliximab; Population; Rheumatology; Survival analysis; Drug; Disease; Pharmacology","score_opus":0.10996718372254957,"score_gpt":0.33125836062105857,"score_spread":0.221291176898509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323815622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96049994,0.03546715,0.0001597555,0.003015184,0.00015194294,0.00048160687,0.00015352975,0.00002628815,0.00004458055],"genre_scores_gemma":[0.98258,0.016716678,0.00029972152,0.00015798263,0.000013373237,0.000041206204,0.000021071844,0.000010490386,0.00015947495],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987282,0.0003507701,0.0003773328,0.00023419151,0.000043013988,0.00026649947],"domain_scores_gemma":[0.9984635,0.0009821047,0.00020269217,0.00022031034,0.000086759,0.000044603574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048731308,0.00016870142,0.00042992923,0.000043805605,0.00020077701,0.00003867393,0.00018242953,0.000111628906,0.000116351184],"category_scores_gemma":[0.00044948526,0.00009910808,0.00016066975,0.00006616844,0.0006243204,0.00011324443,0.00012531887,0.00007707213,0.0000055909745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002331345,0.00025016116,0.28205374,0.0004162412,0.001046193,3.2968399e-7,0.00034145868,6.454419e-7,0.010024209,0.0077325,0.005273855,0.69262755],"study_design_scores_gemma":[0.0016406578,0.00040625318,0.91106373,0.000907328,0.00007188829,0.000008786561,0.00077151274,0.000029390518,0.01724153,0.06616364,0.0013212262,0.0003740685],"about_ca_topic_score_codex":0.00006381689,"about_ca_topic_score_gemma":0.000005281767,"teacher_disagreement_score":0.6922535,"about_ca_system_score_codex":0.0000024379756,"about_ca_system_score_gemma":0.000015959055,"threshold_uncertainty_score":0.40415102},"labels":[],"label_agreement":null},{"id":"W2324087599","doi":"10.1136/annrheumdis-2014-eular.4315","title":"AB1082 High-Resolution Peripheral Quantitative CT (HRPQCT) in Ankylosing Spondylitis Reveals Diminished Bone Strength and Volumetric Bmd","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Quantitative computed tomography; Trabecular bone score; BASDAI; Osteoporosis; Ankylosing spondylitis; Bone mineral; Internal medicine; Bone density; Surgery; Nuclear medicine; Rheumatoid arthritis; Psoriatic arthritis","score_opus":0.042237934131491475,"score_gpt":0.34515892764302575,"score_spread":0.3029209935115343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324087599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98814046,0.006862608,0.000026885744,0.0038856636,0.00008999316,0.0006091787,0.00016184303,0.000024463716,0.00019888006],"genre_scores_gemma":[0.99714345,0.0013703686,0.00058613834,0.0005205598,0.000028215198,0.000034948698,0.000051877578,0.000022401155,0.00024201773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975494,0.0004642035,0.00065531617,0.00028756668,0.0005697006,0.00047378973],"domain_scores_gemma":[0.99799395,0.0007848774,0.00025898035,0.00044243934,0.00018045703,0.0003392787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008425798,0.0001836872,0.0006304455,0.0003004804,0.00013984188,0.000037822978,0.0001379355,0.000047708247,0.00015042762],"category_scores_gemma":[0.004573142,0.00013305471,0.00013599766,0.00067110383,0.00026540618,0.00016864712,0.000101733356,0.00018355616,0.0000070230203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044998736,0.0033556882,0.5273503,0.0105258515,0.00035360653,0.00006040005,0.0024246727,0.00011370648,0.00063142524,0.013656718,0.020391716,0.41663605],"study_design_scores_gemma":[0.0017354393,0.0006530971,0.98785037,0.0018639944,0.000065083026,0.00001754079,0.00043003212,0.004507193,0.00017105204,0.0021646388,0.00039504492,0.00014651912],"about_ca_topic_score_codex":0.0015816318,"about_ca_topic_score_gemma":0.00010438765,"teacher_disagreement_score":0.46050006,"about_ca_system_score_codex":0.000044675166,"about_ca_system_score_gemma":0.00016307694,"threshold_uncertainty_score":0.5474809},"labels":[],"label_agreement":null},{"id":"W2324404021","doi":"10.1136/annrheumdis-2012-eular.1852","title":"OP0169 Sarilumab for the treatment of ankylosing spondylitis: Results of a phase 2, randomized. Double-blind, placebo-controlled, international study (align)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Ankylosing spondylitis; Placebo; Clinical endpoint; Concomitant; Internal medicine; Regimen; Adverse effect; Gastroenterology; Randomized controlled trial","score_opus":0.08510372261674753,"score_gpt":0.3927855748835677,"score_spread":0.30768185226682015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324404021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97339594,0.015256015,0.000029938145,0.0011237478,0.00048221485,0.0076476396,0.0015828642,0.000012742467,0.000468899],"genre_scores_gemma":[0.9961619,0.0021231277,0.0000662323,0.00003899851,0.00008953291,0.0010324233,0.00008234658,0.000018750978,0.00038669925],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978882,0.00017007419,0.0010255292,0.00017352392,0.0004773242,0.00026534084],"domain_scores_gemma":[0.9964523,0.001825256,0.0007728016,0.00053406996,0.00031461177,0.00010097337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068204594,0.00023178727,0.001304748,0.000099720084,0.00012646327,0.000013248572,0.00019641545,0.00003254468,0.00007961731],"category_scores_gemma":[0.00084109814,0.00011089617,0.0009316746,0.000128803,0.00025257407,0.000102774866,0.000052911084,0.000029341176,0.000001759165],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94896907,0.01788907,0.002394297,0.00012959426,0.00945781,0.0000024585238,0.003753781,0.000015051667,0.000009712573,0.0004599902,0.00066216,0.016257033],"study_design_scores_gemma":[0.9857844,0.0021300477,0.0026642494,0.0006766379,0.0040712147,0.0000074610875,0.0027523667,0.00024046171,0.000874775,0.00019148605,0.0005061378,0.000100777885],"about_ca_topic_score_codex":0.00037036728,"about_ca_topic_score_gemma":0.000018519257,"teacher_disagreement_score":0.03681534,"about_ca_system_score_codex":0.000033175536,"about_ca_system_score_gemma":0.000073209216,"threshold_uncertainty_score":0.45222148},"labels":[],"label_agreement":null},{"id":"W2324457823","doi":"10.1136/annrheumdis-2012-eular.2636","title":"FRI0179 Comparison of tocilizumab as monotherapy or in combination with non-biological disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to anti-TNF agents","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Tocilizumab; Leflunomide; Internal medicine; Combination therapy; Rheumatoid arthritis; TNF inhibitor; Methotrexate; Rheumatology; Adalimumab; Hydroxychloroquine; Gastroenterology; Disease","score_opus":0.04304142709805488,"score_gpt":0.3455407365479506,"score_spread":0.3024993094498957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324457823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364173,0.0034794882,0.000027629187,0.00070029905,0.00004841942,0.0019776707,0.00007703041,0.00002775887,0.000019942074],"genre_scores_gemma":[0.9908081,0.0086494675,0.00014882747,0.0001489418,0.000005530541,0.00013995807,0.00004648559,0.000043538108,0.000009102662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651617,0.00064557017,0.00089301757,0.00036404436,0.0009337195,0.0006474676],"domain_scores_gemma":[0.9976958,0.00047086496,0.00040166144,0.0006101093,0.00023799378,0.0005835527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007743725,0.00035885733,0.0011086108,0.00041924466,0.00013326755,0.000051026593,0.00030378846,0.00007583364,0.00006835867],"category_scores_gemma":[0.00084097224,0.00021771395,0.00009883149,0.0005965867,0.00038931254,0.0005369139,0.0001150916,0.00019248984,0.000006767108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02156189,0.0043196618,0.9015361,0.0003685033,0.00013938009,0.000008131985,0.005401166,0.00012763198,0.000046130368,0.00008294881,0.00009159039,0.066316836],"study_design_scores_gemma":[0.0119160395,0.002693154,0.97450364,0.0074794786,0.000009601833,0.000005143863,0.0017215464,0.0008023531,0.00036793572,0.0001968851,0.000024872732,0.0002793718],"about_ca_topic_score_codex":0.0003767582,"about_ca_topic_score_gemma":0.00006295347,"teacher_disagreement_score":0.07296749,"about_ca_system_score_codex":0.000051053597,"about_ca_system_score_gemma":0.00024297959,"threshold_uncertainty_score":0.8878117},"labels":[],"label_agreement":null},{"id":"W2324484179","doi":"10.1136/annrheumdis-2014-eular.3404","title":"AB0975 Power and Colour Doppler Findings in Lower Extremity Entheses of Healthy Children – Effect of Measurement Distance from Bone and Joint Position","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone fractures and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Enthesis; Medicine; Achilles tendon; Ankle; Tendon; Power doppler; Ultrasound; Quadriceps tendon; Surgery; Radiology","score_opus":0.018395094785342507,"score_gpt":0.2706152425053695,"score_spread":0.252220147720027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324484179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942489,0.0039047855,0.000011632765,0.0011646688,0.000032737666,0.0004741069,0.000121507066,0.0000047335975,0.00003689479],"genre_scores_gemma":[0.999424,0.00036596286,0.00003172074,0.00013662345,0.000004729693,0.000011004041,0.000011773977,0.000008616623,0.00000558537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892837,0.000120427954,0.0003570559,0.00014849867,0.00032704585,0.0001186194],"domain_scores_gemma":[0.9991572,0.00019695098,0.00025431966,0.00024290409,0.00006195749,0.000086688735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003058649,0.00012736855,0.0005303171,0.000048666447,0.000027808372,0.000005514502,0.000038163846,0.000034856246,0.000032575404],"category_scores_gemma":[0.00041155732,0.00007571221,0.00010486649,0.00005814516,0.00011535185,0.00004503832,0.000041166186,0.000046274152,3.809922e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018769379,0.0010615825,0.9871591,0.000764149,0.00033455298,0.0000016499977,0.00029522358,0.000003715317,0.00061823684,0.000070781025,0.00079919,0.0070149167],"study_design_scores_gemma":[0.0017115279,0.0005538034,0.989685,0.0024351715,0.00018543612,0.0000036169108,0.000014247741,0.0000355676,0.0046572,0.00065685844,0.0000048861134,0.00005665936],"about_ca_topic_score_codex":0.00056714437,"about_ca_topic_score_gemma":0.000030029036,"teacher_disagreement_score":0.0069582574,"about_ca_system_score_codex":0.000015220612,"about_ca_system_score_gemma":0.000022902586,"threshold_uncertainty_score":0.30874544},"labels":[],"label_agreement":null},{"id":"W2324623105","doi":"10.1136/annrheumdis-2012-eular.1447","title":"AB1456-HPR Where the needs of mothers with rheumatoid arthritis meet arthritis-related health care","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Health care; Outpatient clinic; Arthritis; Gerontology; Family medicine; Nursing; Internal medicine","score_opus":0.01941940498964478,"score_gpt":0.29357052689346386,"score_spread":0.2741511219038191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324623105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66614825,0.31669188,0.00003960158,0.013897719,0.00020628567,0.0009539981,0.00017063557,0.00006057323,0.0018310996],"genre_scores_gemma":[0.9679208,0.030848308,0.00004235646,0.00094107626,0.00002114332,0.000041857613,0.000020829417,0.000030673116,0.00013298975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99808675,0.00020171229,0.0006301744,0.00010813815,0.0005534045,0.0004198168],"domain_scores_gemma":[0.9978606,0.00019721113,0.0006033787,0.0007949196,0.00017244798,0.00037140757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035320854,0.00020028178,0.000576172,0.00009231066,0.00014703853,0.000010123304,0.0002735443,0.000058730286,0.00026997636],"category_scores_gemma":[0.00039095388,0.00010539895,0.0002396375,0.00039408318,0.0004396839,0.0001722468,0.00004792909,0.00012635691,0.000012597082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000816352,0.0023031733,0.111536495,0.00479897,0.0024830708,0.0000052295104,0.08824866,0.00012951589,0.0000788427,0.009650922,0.12418955,0.6557592],"study_design_scores_gemma":[0.013686634,0.002614496,0.7131635,0.14832625,0.0005590592,0.0006883722,0.10026691,0.00014385991,0.005110056,0.002506054,0.011843509,0.0010912932],"about_ca_topic_score_codex":0.00023996142,"about_ca_topic_score_gemma":0.000033720586,"teacher_disagreement_score":0.6546679,"about_ca_system_score_codex":0.00002239824,"about_ca_system_score_gemma":0.00046238292,"threshold_uncertainty_score":0.42980444},"labels":[],"label_agreement":null},{"id":"W2324697623","doi":"10.1136/annrheumdis-2014-eular.1198","title":"THU0423 The Impact of Etanercept and Methotrexate Treatment on Work Productivity in Patients with Rheumatoid Arthritis: Results from Phase 2 of the Prize Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes","funders":"","keywords":"Medicine; Etanercept; Rheumatoid arthritis; Presenteeism; Absenteeism; Placebo; Work productivity; Physical therapy; Methotrexate; Internal medicine; Productivity; Randomized controlled trial; Rheumatology; Alternative medicine","score_opus":0.034191322217600455,"score_gpt":0.33091536490476225,"score_spread":0.2967240426871618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324697623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994567,0.0022156085,0.0000016847562,0.00072338094,0.000037498565,0.001974419,0.0003957418,0.000009860622,0.00007480832],"genre_scores_gemma":[0.996629,0.0032098896,0.000020061461,0.00001699307,0.000009455559,0.000054855194,0.000015956264,0.00002039708,0.000023388118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972268,0.00093011983,0.00061446434,0.0002889657,0.0006803291,0.0002593278],"domain_scores_gemma":[0.9971457,0.00088062615,0.000520344,0.0011577334,0.00018225911,0.00011334765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006302344,0.0002459317,0.0007300602,0.00007893718,0.00010608248,0.00002076146,0.00028248894,0.00002923161,0.000027443286],"category_scores_gemma":[0.0017000921,0.000094671836,0.00023352906,0.00035972203,0.00050204305,0.000092408234,0.00009729951,0.00012272681,0.0000012012715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014319629,0.01444672,0.7275272,0.00007462375,0.0015072867,0.0000015696561,0.007662898,0.00020996612,0.00006401361,0.00004854258,0.00044865272,0.23368889],"study_design_scores_gemma":[0.012738945,0.00427611,0.97753316,0.0030246226,0.000026190015,9.389158e-7,0.00049428537,0.000058741098,0.0010985716,0.00063624565,0.000016218031,0.00009595176],"about_ca_topic_score_codex":0.0014426282,"about_ca_topic_score_gemma":0.00012243328,"teacher_disagreement_score":0.250006,"about_ca_system_score_codex":0.00002178492,"about_ca_system_score_gemma":0.00013857377,"threshold_uncertainty_score":0.38606054},"labels":[],"label_agreement":null},{"id":"W2325131409","doi":"10.1136/annrheumdis-2012-eular.2166","title":"THU0201 Cognitive impairment in behçet's disease is not associated to systemic disease activity, cumulative prednisone dose or white-matter lesions","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuropsychology; White matter; Hyperintensity; Montreal Cognitive Assessment; Cognition; Neuropsychological assessment; Executive dysfunction; Prednisone; Internal medicine; Pediatrics; Disease; Dementia; Psychiatry; Magnetic resonance imaging; Radiology","score_opus":0.07019636542666499,"score_gpt":0.3549458903960419,"score_spread":0.2847495249693769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325131409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837756,0.0014028705,0.000022743401,0.008734616,0.0002063315,0.002830851,0.0028667888,0.00006498694,0.000095187206],"genre_scores_gemma":[0.99375653,0.00015979819,0.000012287841,0.0036370598,0.00005880968,0.00035772682,0.000103453596,0.000070908754,0.0018434126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964125,0.00042472145,0.0007358803,0.00049481296,0.0010747534,0.0008573206],"domain_scores_gemma":[0.99600756,0.00042514465,0.00045265333,0.0008889254,0.00028882857,0.0019368676],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035581648,0.00048813564,0.00090119656,0.0002608191,0.00017825935,0.00005368344,0.00034275535,0.00008527414,0.0014762006],"category_scores_gemma":[0.0014238363,0.00031662578,0.00071452,0.0006571735,0.00017647112,0.00044238815,0.00041779896,0.000178374,0.00024348916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077426755,0.010715351,0.960687,0.0020345957,0.0008268261,0.00006777555,0.002028294,0.000111971916,0.00003101894,0.00001828167,0.013721588,0.0020146687],"study_design_scores_gemma":[0.0024407615,0.0002792275,0.98556215,0.008442167,0.0014662591,0.0000069632238,0.0005992761,0.0005595412,0.00009368264,0.00012931284,0.000024122492,0.00039655526],"about_ca_topic_score_codex":0.00012570724,"about_ca_topic_score_gemma":0.000011037859,"teacher_disagreement_score":0.024875177,"about_ca_system_score_codex":0.00014091618,"about_ca_system_score_gemma":0.0004988667,"threshold_uncertainty_score":0.9999286},"labels":[],"label_agreement":null},{"id":"W2325250307","doi":"10.1136/annrheumdis-2013-eular.1989","title":"SAT0264 Ustekinumab Improves Physical Function, Quality of Life and Work Productivity of Patients With Active Psoriatic Arthritis who were NaÏVe To MTX, Despite MTX Therapy or Previously Treated with Anti-Tnf: Results from Psummit I and Psummit II","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Ustekinumab; Quality of life (healthcare); Internal medicine; Placebo; Physical therapy; Rheumatology; Psoriasis; Minimal clinically important difference; Arthritis; Randomized controlled trial; Infliximab; Disease; Dermatology; Pathology; Alternative medicine","score_opus":0.021773344829550335,"score_gpt":0.2437459372954986,"score_spread":0.22197259246594825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325250307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943618,0.0026957158,0.000003408872,0.00027648744,0.00006462968,0.0014980069,0.0010656867,0.000022445134,0.000011789944],"genre_scores_gemma":[0.9988239,0.00070852455,0.00004285003,0.000046190125,0.00001563026,0.00010983252,0.00011097633,0.000021879616,0.00012023646],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981485,0.00047002872,0.0005354934,0.0004429624,0.00014122631,0.00026178185],"domain_scores_gemma":[0.9975847,0.0005533484,0.00075015466,0.0006822046,0.0003476937,0.00008190459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013770492,0.00032005954,0.0009353684,0.000070130875,0.00016784106,0.000018215436,0.00020309318,0.000089992245,0.000034080025],"category_scores_gemma":[0.0005291217,0.00017141085,0.00011315003,0.00026684676,0.00039000963,0.00024890047,0.00011384046,0.000075358774,0.0000035171267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03435247,0.003732601,0.3052361,0.0003120786,0.0050365557,4.350018e-7,0.004574807,0.00001273888,0.0014469689,0.000028588396,0.0011878941,0.6440788],"study_design_scores_gemma":[0.00588625,0.0022156807,0.97992533,0.0008534979,0.00030597713,3.195274e-7,0.00033161283,0.0000011892165,0.0099673895,0.00027080454,0.00002436661,0.00021756884],"about_ca_topic_score_codex":0.0008493153,"about_ca_topic_score_gemma":0.000107242406,"teacher_disagreement_score":0.67468923,"about_ca_system_score_codex":0.000009227683,"about_ca_system_score_gemma":0.00009116463,"threshold_uncertainty_score":0.6989932},"labels":[],"label_agreement":null},{"id":"W2325406501","doi":"10.1136/annrheumdis-2012-eular.1307","title":"AB1311 Healthcare costs of systemic lupus erythematosus (SLE) patients in canada: The impact of disease severity and flares","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; GlaxoSmithKline (Canada); University of Toronto; McGill University","funders":"","keywords":"Medicine; Disease; Severity of illness; Systemic lupus erythematosus; Health care; Internal medicine; Indirect costs; Rheumatology; Pediatrics; Physical therapy","score_opus":0.032158780531481884,"score_gpt":0.321735103284766,"score_spread":0.28957632275328415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325406501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98146224,0.01589589,8.315986e-7,0.0005270692,0.00018555709,0.0013458992,0.0005448228,0.0000068347763,0.000030844236],"genre_scores_gemma":[0.99883336,0.0009867218,0.0000030380786,0.000046410332,0.000015218744,0.000043026535,0.000015184074,0.000023653418,0.000033385786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970962,0.00045987047,0.0008663885,0.00017057729,0.00094093697,0.00046603824],"domain_scores_gemma":[0.99702436,0.00066769595,0.00056537107,0.0008666821,0.00040779138,0.00046812632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053537515,0.00021860519,0.000800344,0.000111686015,0.000056682657,0.000006332048,0.00034259373,0.000042283376,0.000025698211],"category_scores_gemma":[0.0015279576,0.0001128268,0.00025018657,0.00033486428,0.00022649641,0.000111433146,0.0001961691,0.00012336022,0.0000011999483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005274126,0.00039378728,0.98617893,0.007299798,0.00021464347,0.0000019411498,0.0014348796,0.000018466591,0.000009770946,0.000070004724,0.0026197855,0.0012305729],"study_design_scores_gemma":[0.0011165838,0.00009487115,0.9848971,0.010282289,0.00009105967,0.00016501964,0.0027751853,0.00022774027,0.00010649628,0.00013973012,0.0000014871703,0.00010244615],"about_ca_topic_score_codex":0.4324028,"about_ca_topic_score_gemma":0.027085217,"teacher_disagreement_score":0.40531757,"about_ca_system_score_codex":0.00031476878,"about_ca_system_score_gemma":0.0018960746,"threshold_uncertainty_score":0.99066794},"labels":[],"label_agreement":null},{"id":"W2325435208","doi":"10.1136/annrheumdis-2013-eular.1887","title":"SAT0161 The Role of Biological Agents in the Management of Large Vessel Vasculitis (LVV): A Systematic Review","year":2013,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Tocilizumab; Infliximab; Adalimumab; Etanercept; Ustekinumab; Rituximab; Internal medicine; Randomized controlled trial; Anakinra; Abatacept; Vasculitis; TNF inhibitor; Rheumatoid arthritis; Disease","score_opus":0.08400640763982613,"score_gpt":0.36978861499407034,"score_spread":0.2857822073542442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325435208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016771213,0.99197,0.0000018306396,0.000620685,0.00005735378,0.006115035,0.00030184104,0.000008868178,0.0007566835],"genre_scores_gemma":[0.005549526,0.9928755,0.000009560735,0.000286066,0.00001074793,0.0010210484,0.00010054259,0.000020228217,0.00012677975],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959586,0.0011467696,0.0017622341,0.00021838413,0.000625481,0.00028849454],"domain_scores_gemma":[0.9964705,0.0005028712,0.0013366076,0.0014875091,0.00013340147,0.00006911152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011411614,0.00032221962,0.0028181807,0.00008603654,0.000077487086,0.0000121635385,0.0009858074,0.00012406064,0.00029240857],"category_scores_gemma":[0.0003442354,0.0001114982,0.0019998022,0.0005552456,0.00020271829,0.000035644123,0.00022557653,0.00022615018,0.00004493625],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000019377349,0.00058716105,0.00000767166,0.94539475,0.0032630102,0.0000057366938,0.000114853785,2.873431e-7,2.1414756e-8,0.0035997462,0.003455634,0.043569196],"study_design_scores_gemma":[0.00028651298,0.00006210853,0.0005977324,0.9614632,0.012238903,0.000039115374,0.0005904718,0.000007284048,4.4982227e-7,0.0013798376,0.023207016,0.00012736008],"about_ca_topic_score_codex":0.00003432743,"about_ca_topic_score_gemma":6.137462e-7,"teacher_disagreement_score":0.043441836,"about_ca_system_score_codex":0.000015996244,"about_ca_system_score_gemma":0.000091820395,"threshold_uncertainty_score":0.45467648},"labels":[],"label_agreement":null},{"id":"W2325624679","doi":"10.1136/annrheumdis-2013-eular.2589","title":"AB0267 Five-year safety and efficacy of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate: final study results of the phase 3, randomized placebo-controlled go-forward trial","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Placebo; Internal medicine; Randomized controlled trial; Methotrexate; Adalimumab","score_opus":0.021600468137041973,"score_gpt":0.31379600676777936,"score_spread":0.2921955386307374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325624679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830595,0.0004972958,0.000005093505,0.00025401663,0.000035174107,0.015826292,0.00019629818,0.0000110744295,0.00011523696],"genre_scores_gemma":[0.99830747,0.0008879735,0.00008127145,0.000014729631,0.000008369891,0.0004794313,0.000016685472,0.000030337722,0.00017376375],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956551,0.0012644647,0.0013270742,0.0003583259,0.0010359542,0.00035904636],"domain_scores_gemma":[0.9937566,0.0036200846,0.0011005142,0.00089437416,0.00044888907,0.00017954088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093201816,0.00033892764,0.0022336473,0.00015879472,0.000087604785,0.000021617772,0.00029100524,0.00005825052,0.000058080648],"category_scores_gemma":[0.003536644,0.00014580542,0.00039002666,0.00032507937,0.00069631153,0.0001380523,0.00013295794,0.00012707541,0.000002521343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9525525,0.0074643907,0.0011955546,0.00016522995,0.0021773695,0.000003690843,0.0031704109,0.00014249895,0.0000030709318,0.000008477207,0.000052516167,0.03306428],"study_design_scores_gemma":[0.94182307,0.007345169,0.04525273,0.0025542048,0.0005583291,0.0000034174964,0.00079562113,0.0010694339,0.00040929913,0.00004784685,0.0000030899869,0.0001378195],"about_ca_topic_score_codex":0.0016559334,"about_ca_topic_score_gemma":0.000093693554,"teacher_disagreement_score":0.044057176,"about_ca_system_score_codex":0.0004630989,"about_ca_system_score_gemma":0.0020900164,"threshold_uncertainty_score":0.59457725},"labels":[],"label_agreement":null},{"id":"W2325701386","doi":"10.1136/annrheumdis-2012-eular.275","title":"AB0275 14-3-3 eta is an independent marker of joint damage that complements CRP and anti-CCP","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Joint disease; Surrogate endpoint; Disease; Gastroenterology; Immunology; Pathology; Osteoarthritis","score_opus":0.08253765128187597,"score_gpt":0.3362402254098228,"score_spread":0.25370257412794683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325701386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972236,0.0012691125,0.000076154414,0.00034683992,0.0001400967,0.00026535074,0.0002702541,0.000005108934,0.00040346556],"genre_scores_gemma":[0.9987991,0.00041219982,0.00011815218,0.00032799947,0.000027201946,0.000018178245,0.0000466169,0.000016521099,0.00023404554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894845,0.00013599492,0.0002923669,0.00016718928,0.00023786775,0.00021810608],"domain_scores_gemma":[0.9988603,0.000023941553,0.00027952268,0.0005970828,0.000106214145,0.00013293888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022954404,0.00014044602,0.00021304982,0.00003961682,0.00007243246,0.000019544448,0.00025271572,0.000051440682,0.00029567492],"category_scores_gemma":[0.00015846023,0.00010441056,0.00014334795,0.000046743113,0.00013525014,0.000025919862,0.00029242915,0.000052709132,0.00000546725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029757444,0.0032344456,0.76727617,0.0011425107,0.0018044098,0.0000013427301,0.0013611225,0.000037883416,0.15959816,0.0007113165,0.05145543,0.013079616],"study_design_scores_gemma":[0.00036080892,0.00010054911,0.8088775,0.00021883141,0.00008498955,0.000005724171,0.00038799923,0.00005622784,0.18788143,0.0003682931,0.0014978842,0.00015976763],"about_ca_topic_score_codex":0.000086517604,"about_ca_topic_score_gemma":0.000008325406,"teacher_disagreement_score":0.049957547,"about_ca_system_score_codex":0.000003421874,"about_ca_system_score_gemma":0.000031105905,"threshold_uncertainty_score":0.4257739},"labels":[],"label_agreement":null},{"id":"W2325761823","doi":"10.1136/annrheumdis-2014-eular.3775","title":"FRI0398 Disease Specific Quality of Life in Patients with Lupus Nephritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Medicine; Quality of life (healthcare); Lupus nephritis; Internal medicine; Pyuria; Disease; Systemic lupus erythematosus; Physical therapy; Proteinuria; Urinary system","score_opus":0.051125050018924666,"score_gpt":0.31267748788238264,"score_spread":0.261552437863458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325761823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960014,0.001628234,0.000019889792,0.0008269689,0.00011161532,0.00081624114,0.00010604951,0.000018262665,0.00047129273],"genre_scores_gemma":[0.9993235,0.0001857071,0.000043146345,0.00017024759,0.000023239128,0.000032904914,0.000021280295,0.000026426409,0.00017353507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711853,0.0004101893,0.0008093222,0.00023483827,0.0011263987,0.00030074173],"domain_scores_gemma":[0.9973385,0.0004965376,0.00039924492,0.001030348,0.0003445546,0.0003908625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053473597,0.00017222499,0.000728378,0.0001422875,0.00003765329,0.000012338753,0.00033280413,0.000037617585,0.00014071462],"category_scores_gemma":[0.0024017503,0.00010382158,0.00021111849,0.00035662492,0.00027203315,0.00009256369,0.00011726478,0.000095479256,0.000016844266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014148909,0.00092672516,0.9873363,0.0032236387,0.00009651549,9.937831e-7,0.00022722472,0.000016282918,0.000004170845,0.0005370596,0.0034249087,0.0027913158],"study_design_scores_gemma":[0.0034435464,0.00015870937,0.9907807,0.004237726,0.000036532856,0.000003357079,0.0001981918,0.000072549374,0.000032312557,0.0008043719,0.0001178615,0.000114126924],"about_ca_topic_score_codex":0.00013531328,"about_ca_topic_score_gemma":0.000012250991,"teacher_disagreement_score":0.0034444411,"about_ca_system_score_codex":0.000023213746,"about_ca_system_score_gemma":0.00020649687,"threshold_uncertainty_score":0.42337212},"labels":[],"label_agreement":null},{"id":"W2325805069","doi":"10.1136/annrheumdis-2013-eular.1744","title":"SAT0018 Establishing the Content Validity of Omeract Preliminary Flare Questions (PFQ) for Detecting and Measuring Disease Exacerbations in Rheumatoid Arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Southlake Regional Health Center; University of Manitoba; Western University; Université de Sherbrooke; McGill University","funders":"","keywords":"Medicine; Physical therapy; Rheumatoid arthritis; Rating scale; Cohort; Convergent validity; Internal medicine; Psychometrics; Clinical psychology","score_opus":0.12018309781395516,"score_gpt":0.3095895104898904,"score_spread":0.18940641267593528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325805069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672129,0.026252039,0.00013424555,0.004347505,0.00009375115,0.0017628396,0.00013184495,0.000028764542,0.000036108588],"genre_scores_gemma":[0.97588825,0.02339897,0.00015623885,0.000086957814,0.00002019746,0.00037516735,0.000013822437,0.000024593337,0.000035799152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980503,0.0002780144,0.00064688333,0.0002188064,0.00045760762,0.00034838726],"domain_scores_gemma":[0.99670887,0.0017713971,0.0002872149,0.00052394695,0.00045082503,0.0002577666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006348172,0.0001802899,0.00044040335,0.0001402596,0.00029672286,0.00009539125,0.00024072122,0.000036243528,0.00004949814],"category_scores_gemma":[0.008506148,0.000114798706,0.00024118391,0.00023776805,0.0003328215,0.00047853342,0.00013946852,0.0001519417,0.0000026619941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013624341,0.0020870205,0.5041491,0.0036192038,0.00076353364,0.000009345201,0.0056278794,0.00045035608,0.0018449578,0.0035950583,0.004013811,0.47247732],"study_design_scores_gemma":[0.0016381046,0.0003010559,0.97330344,0.00984495,0.000025085475,0.00001824531,0.0028093623,0.0027584585,0.0012506947,0.007738114,0.00013853042,0.00017395389],"about_ca_topic_score_codex":0.0008446082,"about_ca_topic_score_gemma":0.00011356917,"teacher_disagreement_score":0.4723034,"about_ca_system_score_codex":0.000019043095,"about_ca_system_score_gemma":0.00019531234,"threshold_uncertainty_score":0.9998456},"labels":[],"label_agreement":null},{"id":"W2325823893","doi":"10.1136/annrheumdis-2013-eular.360","title":"OP0155 A Novel Model of Systemic Sclerosis?: Loss of PTEN in Fibroblasts Results in Lung Fibrosis in A CCN2/CTGF-Dependent Fashion","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"PTEN; Fibrosis; Medicine; CTGF; Pathology; Sirius Red; Cancer research; Connective tissue; Growth factor; Biology; Internal medicine; PI3K/AKT/mTOR pathway; Signal transduction; Cell biology","score_opus":0.05189075860341109,"score_gpt":0.2778594238642141,"score_spread":0.225968665260803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325823893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241877,0.005020155,0.000019089275,0.0005738963,0.00006752731,0.0014031712,0.00035727886,0.000015668587,0.00012441872],"genre_scores_gemma":[0.99727315,0.0023523555,0.000052255058,0.000060104576,0.0000086732925,0.0001279413,0.000020547846,0.000029294542,0.00007565114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642473,0.00018171157,0.001961525,0.00035047604,0.00070967944,0.00037187312],"domain_scores_gemma":[0.99763733,0.00035392717,0.00083782827,0.0007661908,0.00023509256,0.00016961271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049514225,0.00026768242,0.0010551158,0.0004566172,0.000020844182,0.000013779316,0.00039796912,0.000155649,0.000025319687],"category_scores_gemma":[0.00096427544,0.00018381818,0.00033498203,0.00066497445,0.00015825372,0.00020174589,0.0001722604,0.00014894055,0.000005556519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046350975,0.012440992,0.5646596,0.031713475,0.0009319854,0.000012188852,0.011078635,0.17170338,0.18961653,0.00050464476,0.0042325538,0.008470919],"study_design_scores_gemma":[0.0072425813,0.00015711316,0.75091785,0.13997914,0.0001675646,0.00000942851,0.0026790008,0.092425756,0.005932536,0.00022800322,1.3852615e-7,0.00026089113],"about_ca_topic_score_codex":0.0016845107,"about_ca_topic_score_gemma":0.000067894296,"teacher_disagreement_score":0.18625826,"about_ca_system_score_codex":0.00007952033,"about_ca_system_score_gemma":0.00026807078,"threshold_uncertainty_score":0.7495888},"labels":[],"label_agreement":null},{"id":"W2325909579","doi":"10.1136/annrheumdis-2015-eular.3507","title":"OP0176 Improved Survival in Rheumatoid Arthritis: A General Population-Based Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Arthritis Research Centre of Canada","funders":"","keywords":"Medicine; Hazard ratio; Cohort; Proportional hazards model; Population; Rheumatoid arthritis; Body mass index; Context (archaeology); Comorbidity; Mortality rate; Internal medicine; Demography; Cohort study; Confounding; Confidence interval; Environmental health","score_opus":0.07466646673398385,"score_gpt":0.3486572406348146,"score_spread":0.27399077390083076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325909579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432284,0.0016942678,0.000017929086,0.0014562763,0.00026615435,0.0013344612,0.000043758235,0.00007123962,0.00079310377],"genre_scores_gemma":[0.9991999,0.00010180408,0.000059309583,0.00025830808,0.00003012157,0.00010774161,0.00005749275,0.000028169952,0.00015709572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979088,0.00021006989,0.0006420443,0.00027661966,0.0006480232,0.00031446136],"domain_scores_gemma":[0.9984719,0.0001097611,0.00025029486,0.0007725209,0.00015079406,0.0002447223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042732674,0.00022332008,0.0005531365,0.00016368173,0.000051448314,0.00004914503,0.00029227717,0.000033582764,0.00011131303],"category_scores_gemma":[0.00083340064,0.000165393,0.00021592782,0.00036645777,0.00007126835,0.0001555941,0.00012872736,0.00008590972,0.000013392586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006867872,0.0047851736,0.9731706,0.0005335837,0.0003991112,0.000030697727,0.00046146417,0.0025187137,0.000005773416,0.0013706522,0.0042116097,0.011825863],"study_design_scores_gemma":[0.0055866917,0.00030972977,0.9807269,0.0010507018,0.00008483889,0.000001248896,0.0021825253,0.0069072703,0.000020423226,0.002878249,0.00005099469,0.00020040773],"about_ca_topic_score_codex":0.0017291483,"about_ca_topic_score_gemma":0.00035179112,"teacher_disagreement_score":0.011625455,"about_ca_system_score_codex":0.000060670332,"about_ca_system_score_gemma":0.0004792079,"threshold_uncertainty_score":0.6744531},"labels":[],"label_agreement":null},{"id":"W2326125948","doi":"10.1136/annrheumdis-2015-207259.116","title":"A5.10 Increases in serum cholesterol with baricitinib treatment are associated with favourable changes in apolipoprotein content and with improvement in DAS28-CRP in patients with rheumatoid arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Apolipoprotein B; Medicine; Internal medicine; Rheumatoid arthritis; Triglyceride; Endocrinology; Cholesterol; Apolipoprotein A1; Very low-density lipoprotein; Placebo; Lipoprotein; Pathology","score_opus":0.04040915596739722,"score_gpt":0.2509010163450564,"score_spread":0.21049186037765918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326125948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941103,0.0010695911,4.793766e-7,0.0014737247,0.000008220959,0.0030494838,0.00022053746,0.00001829179,0.000049401737],"genre_scores_gemma":[0.9976749,0.0008004998,0.000034915396,0.0002684565,0.0000038767494,0.0010306195,0.0000940563,0.000043223492,0.00004946702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767536,0.00020192111,0.0005354068,0.0004552821,0.00062738376,0.00050464366],"domain_scores_gemma":[0.99849415,0.0001630144,0.00045358104,0.00039560138,0.00022846047,0.0002651995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022118312,0.00045432177,0.0011018523,0.0003030096,0.000046825353,0.00004570531,0.00011081992,0.00006403176,0.000027989581],"category_scores_gemma":[0.00020446695,0.00023405583,0.000040105257,0.0005099984,0.00017643216,0.0001907761,0.00005382339,0.00012656412,0.0000013403095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034425375,0.006440761,0.9782365,0.00014585305,0.00030708156,0.00007328953,0.00093171786,0.00015490566,0.0000011666498,0.000012212989,0.000028808987,0.010225177],"study_design_scores_gemma":[0.029457835,0.008014133,0.9431892,0.016081156,0.000064712134,0.00000779128,0.0021816979,0.000090385474,0.0006039092,0.000036839185,0.000005560459,0.0002667969],"about_ca_topic_score_codex":0.008001202,"about_ca_topic_score_gemma":0.060764633,"teacher_disagreement_score":0.052763432,"about_ca_system_score_codex":0.00027641075,"about_ca_system_score_gemma":0.00025462566,"threshold_uncertainty_score":0.9986046},"labels":[],"label_agreement":null},{"id":"W2326242517","doi":"10.1136/annrheumdis-2014-eular.3688","title":"AB0751 Efficacy of Ustekinumab in Patients with Active Psoriatic Arthritis: 1 Year Results","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski","funders":"","keywords":"Medicine; Ustekinumab; Dactylitis; Psoriatic arthritis; BASDAI; BASFI; Enthesitis; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Adalimumab; Arthritis; Physical therapy; Dermatology; Disease","score_opus":0.013830013355231924,"score_gpt":0.2603014841708453,"score_spread":0.24647147081561338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326242517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750584,0.00047251946,0.0000012487388,0.00029711807,0.00006892109,0.00053451385,0.00016216212,0.000010562768,0.000947107],"genre_scores_gemma":[0.9995175,0.00024146959,0.00005447718,0.00006485182,0.000012080605,0.000018624325,0.000028880964,0.00001452256,0.00004756442],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988091,0.00007314383,0.00039684627,0.0001642956,0.00037073204,0.00018588637],"domain_scores_gemma":[0.9988444,0.00022201086,0.00028443453,0.00042347258,0.00015222315,0.00007346295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083202925,0.0001359004,0.00047074983,0.00006817011,0.000038915074,0.0000047167237,0.00010379632,0.000027454835,0.00002526694],"category_scores_gemma":[0.00088160933,0.00008254419,0.00012517918,0.00019942949,0.00012662805,0.00005651707,0.00005337284,0.000051554245,0.000008887752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013243877,0.007916986,0.39321554,0.0007002087,0.0014262547,0.000007918562,0.0021669765,0.000086644446,0.0000017593288,0.00066885,0.0024881396,0.57807684],"study_design_scores_gemma":[0.014624142,0.00088200945,0.9803883,0.0032191647,0.00011679745,6.175552e-7,0.0001709398,0.000012966677,0.00015152416,0.00029981346,0.000055926317,0.00007779463],"about_ca_topic_score_codex":0.00009925824,"about_ca_topic_score_gemma":0.000027961694,"teacher_disagreement_score":0.58717275,"about_ca_system_score_codex":0.000013786467,"about_ca_system_score_gemma":0.000043861353,"threshold_uncertainty_score":0.33660543},"labels":[],"label_agreement":null},{"id":"W2326335301","doi":"10.1136/annrheumdis-2012-eular.2867","title":"FRI0410 Rheumatoid arthritis (RA) care: Geographic disparities and impact of primary care physicians on access to rheumatologists","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Rheumatology; Referral; Internal medicine; Cohort; Family medicine; Population; Rheumatoid arthritis; Logistic regression; Health care; Primary care; Physical therapy","score_opus":0.0334400733560654,"score_gpt":0.3304538661584507,"score_spread":0.29701379280238527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326335301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86598,0.13114993,0.0000075882936,0.0007004593,0.00016056602,0.0008494887,0.0004572155,0.00005084171,0.00064387004],"genre_scores_gemma":[0.89668596,0.10271889,0.000036072823,0.0003182321,0.000024567355,0.000094100076,0.00006927777,0.000042338685,0.000010542092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973545,0.00019815622,0.0006241465,0.0002942159,0.00080630294,0.0007226711],"domain_scores_gemma":[0.9976129,0.0003480083,0.0003170198,0.00083331513,0.000399913,0.00048887875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017988427,0.00036547025,0.0010801536,0.00030467488,0.00021128755,0.00008086246,0.00047259912,0.000081787395,0.000055152774],"category_scores_gemma":[0.00052159023,0.00024909517,0.00062101416,0.00042082122,0.0006617383,0.00043129793,0.00032298366,0.00018327331,0.000010721935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006775386,0.00070416334,0.7868115,0.0021532509,0.00064756366,0.0000034999712,0.00331405,0.00003350627,0.00008294904,0.0010274594,0.0043631475,0.20018142],"study_design_scores_gemma":[0.001310141,0.00071671733,0.9852993,0.008957215,0.000019699213,0.000029093335,0.0013373926,0.0000070541164,0.0013615595,0.00041626548,0.00027876406,0.00026680657],"about_ca_topic_score_codex":0.0010544355,"about_ca_topic_score_gemma":0.00005357724,"teacher_disagreement_score":0.19991462,"about_ca_system_score_codex":0.00004483315,"about_ca_system_score_gemma":0.00021023849,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W2326552639","doi":"10.1136/annrheumdis-2012-eular.840","title":"AB0840 Scleroderma classification criteria: Disease-specific methods for valid case comparisons","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; University of Toronto","funders":"","keywords":"Medicine; Interstitial lung disease; Intraclass correlation; Dermatology; Surgery; Physical therapy; Internal medicine; Lung","score_opus":0.3263524439061633,"score_gpt":0.45561163724370995,"score_spread":0.12925919333754665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326552639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84518886,0.12729193,0.010283341,0.009629245,0.0022289134,0.0035243405,0.00087299227,0.0002232127,0.0007571611],"genre_scores_gemma":[0.9943472,0.0017340231,0.0025604803,0.0006173589,0.00019917882,0.00024420192,0.00007764721,0.000046355046,0.00017351059],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99778384,0.00041353435,0.00076513167,0.0002709829,0.00031648576,0.00045003404],"domain_scores_gemma":[0.99687666,0.0007419888,0.00043102127,0.000960082,0.00030203714,0.000688199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063866016,0.00025686025,0.00059383584,0.000109021355,0.0002661797,0.000041915693,0.0002303008,0.000086555294,0.00023426459],"category_scores_gemma":[0.0009769216,0.00016509608,0.0006800559,0.00026683757,0.00021905979,0.00019589478,0.00007653277,0.000087979024,0.000023877687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001934521,0.00795782,0.06642115,0.00571053,0.0022528898,0.000022010274,0.001732858,0.00006648653,0.0039706156,0.0099416515,0.6716785,0.22831099],"study_design_scores_gemma":[0.003065339,0.00015977795,0.95192367,0.0070491703,0.0032601557,0.00034730363,0.003066943,0.0083746845,0.0033259522,0.0016332986,0.017128775,0.0006649116],"about_ca_topic_score_codex":0.000016790573,"about_ca_topic_score_gemma":2.425425e-7,"teacher_disagreement_score":0.8855025,"about_ca_system_score_codex":0.000029761373,"about_ca_system_score_gemma":0.00011395871,"threshold_uncertainty_score":0.6732423},"labels":[],"label_agreement":null},{"id":"W2326589759","doi":"10.1136/annrheumdis-2014-eular.4084","title":"THU0321 A Randomized Controlled Study of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Pregabalin; Medicine; Fibromyalgia; Depression (economics); Brief Pain Inventory; Randomized controlled trial; Hospital Anxiety and Depression Scale; Internal medicine; Serotonin reuptake inhibitor; Antidepressant; Anxiety; Clinical Global Impression; Placebo; Physical therapy; Anesthesia; Chronic pain; Psychiatry","score_opus":0.01902423865089135,"score_gpt":0.30288937085959056,"score_spread":0.2838651322086992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326589759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949403,0.0014721494,0.000043760658,0.00018414026,0.000039665712,0.0032357762,0.000009303683,0.00001109813,0.00006383889],"genre_scores_gemma":[0.99963695,0.00015616041,0.000021181886,0.000004641239,0.0000024701064,0.00013166234,0.000014932372,0.000014344455,0.00001764409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721235,0.00076630304,0.0007582716,0.00022123162,0.0008372531,0.00020457666],"domain_scores_gemma":[0.9975164,0.0009802405,0.00071791053,0.00045804135,0.0002094312,0.00011800105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085632113,0.00017016285,0.0013765097,0.0001358387,0.00004943363,0.0000121317,0.00017872952,0.0000406969,0.000054040112],"category_scores_gemma":[0.0021552197,0.00008494733,0.00015474782,0.00016638529,0.0002977256,0.00007466247,0.000109429144,0.000109612694,6.208502e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06328857,0.003707073,0.9180235,0.0067328927,0.00091836444,0.0000015347105,0.0012523066,0.000074297066,0.000023584646,0.00013062442,0.00016233734,0.0056848754],"study_design_scores_gemma":[0.23619509,0.00059360225,0.75054896,0.0080643445,0.000301413,0.0000012370858,0.00018971563,0.0038138495,0.00011640644,0.00009968208,2.916267e-7,0.00007541494],"about_ca_topic_score_codex":0.00020093418,"about_ca_topic_score_gemma":0.000002542286,"teacher_disagreement_score":0.17290652,"about_ca_system_score_codex":0.000010679557,"about_ca_system_score_gemma":0.000096099684,"threshold_uncertainty_score":0.34640515},"labels":[],"label_agreement":null},{"id":"W2326689699","doi":"10.1136/annrheumdis-2014-eular.2248","title":"THU0220 Impact of Meniscal Extrusion on the Progression of Knee Osteoarthritis Structural Changes and the Effects of Treatment: Data from the Osteoarthritis Initiative Progression Cohort","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Cartilage; Cohort; Internal medicine; Magnetic resonance imaging; Cohort study; Surgery; Pathology; Radiology","score_opus":0.03382801866113028,"score_gpt":0.32853953176441125,"score_spread":0.294711513103281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326689699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98267335,0.011440235,0.0000014395333,0.0013406301,0.0001473138,0.0032369213,0.0009840323,0.000015291327,0.00016078023],"genre_scores_gemma":[0.9979427,0.0014411288,0.000037913862,0.000087748434,0.000054929293,0.00017092853,0.00021960105,0.000026061789,0.000019009207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99750364,0.00079633645,0.00051847915,0.000304032,0.00062932697,0.0002481916],"domain_scores_gemma":[0.994817,0.002760148,0.00083111005,0.0013355704,0.00015582415,0.0001003471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041109737,0.00032263045,0.0008411805,0.000050977545,0.00021760484,0.000022000548,0.00043554715,0.000078350844,0.000061849765],"category_scores_gemma":[0.0011107662,0.000113815346,0.0003167024,0.00017100747,0.0009437081,0.00012119136,0.00034623788,0.00010610563,0.0000012472831],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037392294,0.00047571948,0.042963598,0.00039460647,0.0006901329,0.0000041231892,0.0023744383,0.0000016159457,0.0025204597,0.0008929495,0.00027877622,0.94566435],"study_design_scores_gemma":[0.039480507,0.07718212,0.6336048,0.043686606,0.0043750466,0.00005639687,0.002082382,0.0010714339,0.1870739,0.010696989,0.00011184956,0.0005779668],"about_ca_topic_score_codex":0.0001756445,"about_ca_topic_score_gemma":0.00006467346,"teacher_disagreement_score":0.94508636,"about_ca_system_score_codex":0.000013839103,"about_ca_system_score_gemma":0.00010425196,"threshold_uncertainty_score":0.4641255},"labels":[],"label_agreement":null},{"id":"W2326751576","doi":"10.1136/annrheumdis-2014-eular.5713","title":"FRI0092 Lung Disease among Rheumatoid Arthritis Patients – Results from Ontario BIOLOGICS Research Initiative (OBRI)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; COPD; Interstitial lung disease; Asthma; Cohort; Population; Prospective cohort study; Cohort study; Obstructive lung disease; Physical therapy; Lung","score_opus":0.05842292859204297,"score_gpt":0.3133637441089295,"score_spread":0.2549408155168865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326751576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915786,0.0019763252,0.000026306196,0.0015297575,0.000400429,0.0009425619,0.0025342493,0.000063481166,0.0033690217],"genre_scores_gemma":[0.9967239,0.0013436137,0.0000407949,0.0005956778,0.00010727306,0.00007125655,0.00077514356,0.00003770288,0.0003046368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961784,0.00066626637,0.0009204795,0.00056342606,0.0010693099,0.0006021281],"domain_scores_gemma":[0.99597484,0.00092738005,0.00044719139,0.0011312468,0.00082307233,0.000696249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006223622,0.00032787037,0.00067677576,0.0001646584,0.0003670448,0.00006753281,0.0005080601,0.00011461909,0.00029169786],"category_scores_gemma":[0.0046787565,0.00022833567,0.00057701726,0.0003188321,0.0007178251,0.00026262735,0.00038183518,0.00036571757,0.0000614066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021475568,0.004663602,0.83480716,0.0008124764,0.0010010387,0.00006039358,0.0030321907,0.00008691924,0.000022419568,0.002759138,0.103272185,0.028006883],"study_design_scores_gemma":[0.002227905,0.00092173845,0.9766205,0.0070881895,0.00013476604,0.0000011461543,0.00022919143,0.0013993864,0.00008827043,0.009494126,0.0014955063,0.0002992652],"about_ca_topic_score_codex":0.010162724,"about_ca_topic_score_gemma":0.00058773044,"teacher_disagreement_score":0.14181332,"about_ca_system_score_codex":0.000110232766,"about_ca_system_score_gemma":0.0004938306,"threshold_uncertainty_score":0.99642867},"labels":[],"label_agreement":null},{"id":"W2326772258","doi":"10.1136/annrheumdis-2013-eular.2636","title":"AB0314 The survival rates of biologics treated patients at the centre de rhumatologie de l'est du quebec : description of the real world, canadian patient cohort.","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Rimouski","funders":"","keywords":"Medicine; Abatacept; Tocilizumab; Rheumatoid arthritis; Erythrocyte sedimentation rate; Etanercept; Internal medicine; Rituximab; Cohort; TNF inhibitor; Rheumatoid factor; Infliximab; Antirheumatic drugs; Tumor necrosis factor alpha; Antirheumatic Agents","score_opus":0.02978294415448031,"score_gpt":0.26938820986853984,"score_spread":0.23960526571405955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326772258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989,0.0017739054,6.001429e-7,0.007250291,0.000117508695,0.0011828257,0.00021376467,0.000013268057,0.00044783697],"genre_scores_gemma":[0.9935261,0.0057065147,0.0000054956777,0.00025036404,0.000009349437,0.000060533093,0.00004257478,0.000015348847,0.00038373037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977215,0.00072970195,0.0005144277,0.00014849914,0.00042964562,0.0004562387],"domain_scores_gemma":[0.99770266,0.0005845883,0.0003944591,0.00067096064,0.0004452886,0.00020202281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036363213,0.000181277,0.00038892348,0.0000697421,0.00030849606,0.00003256294,0.00050239795,0.000051766958,0.00030671532],"category_scores_gemma":[0.0013916575,0.00007249964,0.0002701754,0.0002953096,0.0008527549,0.000079729485,0.00015409758,0.00011577454,0.000010879567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116548625,0.00026315154,0.97550625,0.00008718575,0.00028443118,7.837364e-7,0.0009967231,0.000032206277,0.00009411417,0.00034913697,0.0137656415,0.008503857],"study_design_scores_gemma":[0.0004896655,0.00010781574,0.99350655,0.0006381942,0.000040967232,0.0000020789091,0.0012782452,0.00019066555,0.0023537865,0.00096826185,0.00034694653,0.000076824326],"about_ca_topic_score_codex":0.40231284,"about_ca_topic_score_gemma":0.28363886,"teacher_disagreement_score":0.11867397,"about_ca_system_score_codex":0.00010121964,"about_ca_system_score_gemma":0.0005187334,"threshold_uncertainty_score":0.7294329},"labels":[],"label_agreement":null},{"id":"W2326840341","doi":"10.1136/annrheumdis-2014-eular.4848","title":"AB0831 Management of Primary Hyperparathyroidism with Cinacalcet","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Cinacalcet; Medicine; Primary hyperparathyroidism; Parathyroid adenoma; Adenoma; Hyperparathyroidism; Parathyroid carcinoma; Urology; Parathyroid neoplasm; Hyperplasia; Internal medicine; Surgery; Secondary hyperparathyroidism; Parathyroid hormone; Calcium","score_opus":0.027137013560927476,"score_gpt":0.2785354165200936,"score_spread":0.25139840295916616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326840341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97390044,0.006016566,0.00011911889,0.00077161426,0.000031050255,0.00041762303,0.000025691692,0.000018638553,0.018699251],"genre_scores_gemma":[0.9975759,0.0010935054,0.0003248215,0.00033879647,0.000006039898,0.000027519096,0.00001683959,0.000014503439,0.00060209085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902993,0.00004471832,0.00026703757,0.00014823843,0.00034201142,0.0001680704],"domain_scores_gemma":[0.99903655,0.00005313794,0.00019302662,0.00054831884,0.00006969608,0.000099247394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008314365,0.00014192676,0.0004024471,0.000046853085,0.00004325729,0.0000052963815,0.00015702163,0.000022356566,0.000014626116],"category_scores_gemma":[0.000026457663,0.00007713928,0.00016630239,0.00016786346,0.00013004873,0.000049001796,0.0000634527,0.000034087276,0.000015591584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059266817,0.021350732,0.42966145,0.007264391,0.011298714,0.00008716264,0.0014161777,0.0005997186,0.0006389148,0.039989844,0.17085528,0.3109109],"study_design_scores_gemma":[0.0048669227,0.00076039304,0.9858636,0.0009280573,0.00093413406,0.000012952335,0.00024354334,0.00020803974,0.0018838956,0.0031601845,0.0009633328,0.00017489484],"about_ca_topic_score_codex":0.000027960234,"about_ca_topic_score_gemma":6.499878e-7,"teacher_disagreement_score":0.5562022,"about_ca_system_score_codex":0.0000076061656,"about_ca_system_score_gemma":0.00003997876,"threshold_uncertainty_score":0.31456485},"labels":[],"label_agreement":null},{"id":"W2326868400","doi":"10.1136/annrheumdis-2014-eular.3108","title":"OP0212 The Risk of Myocardial Infarction and Cerebrovascular Accident in Patients with SjÖGren's Syndrome: A General Population-Based Cohort Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Cohort; Population; Myocardial infarction; Diagnosis code; Retrospective cohort study; Cohort study; Emergency medicine; Relative risk; Internal medicine; Pediatrics; Confidence interval","score_opus":0.007014155827874309,"score_gpt":0.23215446157550332,"score_spread":0.225140305747629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326868400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985775,0.000096915646,0.000040922172,0.00021430005,0.00006595764,0.0009555361,0.000018002062,0.000008093336,0.000022823939],"genre_scores_gemma":[0.9997136,0.00003336838,0.000019104411,0.00012403271,0.000009582888,0.000047171292,0.000034887093,0.000009461221,0.0000088051775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890596,0.00020588817,0.00027618362,0.00013131055,0.0003793174,0.00010131675],"domain_scores_gemma":[0.99912196,0.00013079263,0.00019149916,0.00040350095,0.00009937975,0.000052862506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025507662,0.00010353128,0.00030198376,0.00007274735,0.00008367249,0.0000106011075,0.00007488303,0.000021585918,0.000025930703],"category_scores_gemma":[0.00033597855,0.00005155606,0.0001189596,0.00016658327,0.000056650442,0.00005299952,0.000030127083,0.000055881872,6.4426195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016885536,0.00070716155,0.996039,0.000046687695,0.00037222498,9.2063246e-8,0.00008407965,0.0014547764,5.2447486e-8,0.000022400738,0.000102958766,0.0010017428],"study_design_scores_gemma":[0.0022937767,0.00047880496,0.9950949,0.0001553435,0.00057406863,7.676277e-7,0.00011573852,0.0009309347,0.0000010432079,0.00028979962,0.000004220393,0.00006062123],"about_ca_topic_score_codex":0.0023011558,"about_ca_topic_score_gemma":0.00007174654,"teacher_disagreement_score":0.0022294093,"about_ca_system_score_codex":0.0000074124428,"about_ca_system_score_gemma":0.000035930338,"threshold_uncertainty_score":0.34786746},"labels":[],"label_agreement":null},{"id":"W2327126636","doi":"10.1136/annrheumdis-2014-eular.4013","title":"AB1059 Assessing Treatment Durability of Infliximab in the Management of Psoriatic Arthritis and Rheumatoid Arthritis Patients in A Canadian Setting","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Credit Valley Hospital; Hôpital Maisonneuve-Rosemont; McMaster University; McGill University; University of Ottawa; Montreal General Hospital; Memorial University of Newfoundland; Université de Montréal; University of Saskatchewan; University of Alberta; Arthritis Research Centre of Canada","funders":"","keywords":"Medicine; Psoriatic arthritis; Infliximab; Golimumab; Rheumatoid arthritis; Internal medicine; Surgery; Adalimumab; Tumor necrosis factor alpha","score_opus":0.016790094225197554,"score_gpt":0.291045573420457,"score_spread":0.27425547919525944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327126636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877059,0.009776877,0.00000213024,0.0011275582,0.000045473862,0.00088272284,0.00006222759,0.000005711768,0.0003913934],"genre_scores_gemma":[0.94857043,0.05115405,0.00010654519,0.000065570486,0.0000042063625,0.00006960481,0.000013789786,0.000012633393,0.0000031614402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976956,0.0003993634,0.00081870327,0.0002023347,0.00048484988,0.00039913278],"domain_scores_gemma":[0.9985385,0.0003787167,0.00028639345,0.0005126411,0.000117728545,0.00016605084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008241311,0.00017722874,0.0006005009,0.00021456064,0.00008012945,0.00003142806,0.0002052837,0.000038847134,0.00002750332],"category_scores_gemma":[0.0005817965,0.00011394179,0.0001439121,0.0003196277,0.00028705815,0.00015746226,0.000059148562,0.00008544732,0.000001076145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074888645,0.00075212284,0.3807315,0.00068279356,0.00014513778,0.000006582667,0.0019204739,0.000016487265,0.000003930316,0.0010714827,0.00005307717,0.61454153],"study_design_scores_gemma":[0.003598503,0.00028375533,0.9800584,0.010333537,0.000008904281,0.0000076085726,0.0014084547,0.00039401962,0.00017559752,0.0035093946,0.00012242502,0.00009941626],"about_ca_topic_score_codex":0.037909187,"about_ca_topic_score_gemma":0.024273643,"teacher_disagreement_score":0.6144421,"about_ca_system_score_codex":0.000048760576,"about_ca_system_score_gemma":0.00018660318,"threshold_uncertainty_score":0.9935308},"labels":[],"label_agreement":null},{"id":"W2327138975","doi":"10.1136/annrheumdis-2014-eular.4744","title":"SAT0458 How Does Non-Compliance to Prolia ® (DENOSUMAB) Affect the Change in Bone Mineral Density (BMD)?","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hip disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; University of Ottawa; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Bone mineral; Femoral neck; Denosumab; Osteoporosis; Cohort; Retrospective cohort study; Population; Surgery; Lumbar; Internal medicine","score_opus":0.058846761280643145,"score_gpt":0.33371114498730253,"score_spread":0.2748643837066594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327138975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97593987,0.0007255413,0.000014456986,0.021583676,0.00012593207,0.0012890206,0.000027344575,0.000019435935,0.0002747364],"genre_scores_gemma":[0.99697727,0.00011248831,0.000050731516,0.002022999,0.000048300422,0.00016695226,0.000008039661,0.000018824154,0.00059440854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882936,0.00011712657,0.00021078091,0.00021571641,0.0003234087,0.00030358136],"domain_scores_gemma":[0.9988498,0.00014721087,0.00013309256,0.0006479761,0.00007672476,0.00014520138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019933189,0.00019165671,0.0004472706,0.0000641522,0.000092574206,0.000026498825,0.00022704086,0.00003509274,0.00003186325],"category_scores_gemma":[0.00045085032,0.00008709249,0.00019979756,0.00023350993,0.00010467165,0.000078616205,0.000100423764,0.00007177477,0.00003701495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066582224,0.0021027622,0.85906446,0.001563948,0.00038648827,0.000024819341,0.0029497494,0.000015067855,0.00020458933,0.00038525806,0.014338747,0.11829828],"study_design_scores_gemma":[0.0010244506,0.0002077658,0.99507785,0.0013190922,0.00011210149,0.0000060375646,0.000097403,0.00046662914,0.0004491602,0.00090977043,0.00021294596,0.00011679298],"about_ca_topic_score_codex":0.0004221694,"about_ca_topic_score_gemma":0.0002694903,"teacher_disagreement_score":0.13601337,"about_ca_system_score_codex":0.000014999259,"about_ca_system_score_gemma":0.000032566073,"threshold_uncertainty_score":0.35515288},"labels":[],"label_agreement":null},{"id":"W2327313988","doi":"10.1136/annrheumdis-2014-eular.3413","title":"FRI0147 Data Driven Lesion-Based Criteria for Defining A Positive Sacroiliac Joint MRI in 2 Cohorts with Axial Spondyloarthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Sacroiliac joint; Cohort; BASDAI; Sacroiliitis; Radiography; Radiology; Concomitant; Ankylosing spondylitis; Magnetic resonance imaging; Internal medicine; Nuclear medicine; Arthritis; Psoriatic arthritis","score_opus":0.058991630905590994,"score_gpt":0.3324103449591368,"score_spread":0.2734187140535458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327313988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911284,0.0016272624,0.00027341617,0.0034762088,0.00014087852,0.0011529251,0.0019093724,0.0000316494,0.0002598742],"genre_scores_gemma":[0.99683136,0.00026647613,0.0015886803,0.00061855733,0.000032618882,0.00012263471,0.00048269675,0.000032444743,0.000024511699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984219,0.00011161853,0.00042830617,0.00036697436,0.00033197645,0.00033919417],"domain_scores_gemma":[0.99822694,0.00041538605,0.00021971631,0.0008416653,0.00015999738,0.00013632374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021637714,0.00022686526,0.0006689504,0.00009190338,0.0001578872,0.000027368473,0.00022332318,0.00004277285,0.00006328576],"category_scores_gemma":[0.000655665,0.00015028768,0.00016485232,0.00016403296,0.00019027204,0.000113539565,0.00015792336,0.00006666108,0.000006908152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015098792,0.009745598,0.6774239,0.0049845553,0.0036714054,0.00027737324,0.0030195639,0.00086995366,0.0006592084,0.0034753114,0.058747858,0.2220265],"study_design_scores_gemma":[0.013204048,0.0022210644,0.95661205,0.013626522,0.00068203383,0.00003542822,0.00040137678,0.009265192,0.0013287852,0.0013624436,0.0008285015,0.00043253915],"about_ca_topic_score_codex":0.00029040963,"about_ca_topic_score_gemma":0.00024720584,"teacher_disagreement_score":0.2791882,"about_ca_system_score_codex":0.000020295884,"about_ca_system_score_gemma":0.00013460776,"threshold_uncertainty_score":0.6128554},"labels":[],"label_agreement":null},{"id":"W2327586239","doi":"10.1136/annrheumdis-2014-eular.4443","title":"THU0247 What is More Predictive of Achieving Remission at 12 Months: the Percentage of Baseline Improvement or the Actual Disease State Achieved?","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Arthritis Research Centre of Canada; Montreal General Hospital; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Golimumab; Infliximab; Logistic regression; Internal medicine; Rheumatoid arthritis; Disease; Physical therapy","score_opus":0.024716240746049098,"score_gpt":0.3065204364155008,"score_spread":0.2818041956694517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327586239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97067595,0.010291322,0.000087400585,0.016910333,0.00012410468,0.0013473989,0.00048425444,0.000022018552,0.000057222507],"genre_scores_gemma":[0.9517758,0.046413142,0.000018746829,0.00094455783,0.000038258557,0.00006262635,0.000030971525,0.000031713855,0.00068421906],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969869,0.0004540652,0.0007383679,0.00026563852,0.0011710115,0.00038400668],"domain_scores_gemma":[0.99643344,0.0012355413,0.00052900304,0.0012238628,0.00025330356,0.00032484333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094495824,0.00026477806,0.0005501434,0.00006579919,0.00028395493,0.000044336753,0.00061614555,0.000034895485,0.00041203882],"category_scores_gemma":[0.0019795417,0.00009931621,0.00044071616,0.00014787575,0.0007871975,0.00028406337,0.00043943428,0.00016484076,0.000004112433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023406502,0.0035937838,0.0397201,0.004441804,0.002784995,0.0000110832725,0.029140102,0.00045670362,0.0070993192,0.00019402457,0.036687322,0.85246426],"study_design_scores_gemma":[0.010110939,0.0053110886,0.7922375,0.03897783,0.0008115905,0.00002469848,0.04449843,0.036111113,0.054470904,0.0039736712,0.012541204,0.0009310343],"about_ca_topic_score_codex":0.00013080539,"about_ca_topic_score_gemma":0.000019121979,"teacher_disagreement_score":0.85153323,"about_ca_system_score_codex":0.000025154222,"about_ca_system_score_gemma":0.00021156977,"threshold_uncertainty_score":0.4511536},"labels":[],"label_agreement":null},{"id":"W2327658707","doi":"10.1136/annrheumdis-2013-eular.2708","title":"AB0386 Sjögren's syndrome associated with mpo-anca-positive polyangiitis.","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine and Dentistry, University of Alberta; Univerzita Palackého v Olomouci","keywords":"Medicine; Microscopic polyangiitis; Autoantibody; Vasculitis; Pathology; Biopsy; Renal biopsy; Cyclophosphamide; Myeloperoxidase; Gastroenterology; Internal medicine; Immunology; Antibody; Disease; Chemotherapy","score_opus":0.019438324352047877,"score_gpt":0.24923485361125766,"score_spread":0.2297965292592098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327658707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899862,0.0011600689,0.000026473257,0.0043389457,0.00008854962,0.0005353036,0.00012657458,0.00005855116,0.0036793656],"genre_scores_gemma":[0.9968732,0.00010692469,0.000024096824,0.0012708982,0.000012689905,0.000058262463,0.00006762431,0.000020895783,0.0015653857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989807,0.000059331996,0.00024232476,0.00015259007,0.00031890813,0.0002461163],"domain_scores_gemma":[0.998896,0.00019811855,0.00016999934,0.0003663732,0.00020320207,0.00016630258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005926954,0.00015347573,0.00035059298,0.0000639125,0.000118731594,0.000025522068,0.00012543148,0.000044069784,0.0008507142],"category_scores_gemma":[0.00036615736,0.00008632464,0.00018572717,0.00027300382,0.0001551762,0.00013568508,0.0000426404,0.0000732769,0.00007453975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009224732,0.0064858347,0.6926114,0.0007890646,0.006063865,0.000099758014,0.0015932663,0.00010538502,0.000078528064,0.0025454976,0.25978294,0.02892197],"study_design_scores_gemma":[0.00096897274,0.00038137613,0.9946449,0.0010524607,0.0003166582,0.00004273323,0.0003209325,0.00011547136,0.00006036271,0.0019358615,0.000031710224,0.00012858235],"about_ca_topic_score_codex":0.0003285402,"about_ca_topic_score_gemma":0.000009633557,"teacher_disagreement_score":0.30203345,"about_ca_system_score_codex":0.000010782992,"about_ca_system_score_gemma":0.00009478108,"threshold_uncertainty_score":0.9314724},"labels":[],"label_agreement":null},{"id":"W2327692489","doi":"10.1136/annrheumdis-2014-eular.4747","title":"SAT0589-HPR Body Mass Index and Its Relationship to Disease Activity in Early Rheumatoid Arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Overweight; Body mass index; Underweight; Internal medicine; Rheumatoid arthritis; Obesity; Polyarthritis; Physical therapy; Disease; Arthritis; Pediatrics","score_opus":0.02985329887778118,"score_gpt":0.3015664825120701,"score_spread":0.27171318363428887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327692489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851484,0.0061477874,0.00007321967,0.0073976764,0.000086252316,0.00078617426,0.0000697244,0.000045050823,0.00024572082],"genre_scores_gemma":[0.988444,0.010914058,0.000026903024,0.00032572818,0.000022036988,0.00009887235,0.000006695301,0.000031025134,0.00013073796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978439,0.00033480022,0.0004371199,0.00031456636,0.00062726816,0.0004423419],"domain_scores_gemma":[0.9978773,0.0005577285,0.0001477104,0.00057323644,0.00014853103,0.00069551496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004528443,0.00022282316,0.0005104433,0.0002512192,0.00015888839,0.00006685434,0.00023267488,0.000056056313,0.00007031499],"category_scores_gemma":[0.0035961156,0.00017090829,0.0001722192,0.00038508014,0.00016880925,0.0002964538,0.00013718301,0.00019980877,0.00004813972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013774591,0.00053644937,0.9418051,0.00044022268,0.00011989041,0.0000122028105,0.0005050132,0.000051604908,0.00018970038,0.005610618,0.0016142637,0.047737442],"study_design_scores_gemma":[0.0015690462,0.00020961819,0.9838917,0.0029846355,0.00000533596,0.0000059988306,0.00006216641,0.0012739314,0.0003057009,0.009071136,0.0004425582,0.00017813694],"about_ca_topic_score_codex":0.00014260456,"about_ca_topic_score_gemma":0.00004579869,"teacher_disagreement_score":0.047559306,"about_ca_system_score_codex":0.000017862672,"about_ca_system_score_gemma":0.00015130694,"threshold_uncertainty_score":0.69694376},"labels":[],"label_agreement":null},{"id":"W2327773781","doi":"10.1136/annrheumdis-2012-eular.2162","title":"THU0197 Time to recovery from proteinuria in lupus nephritis patients receiving standard of care treatment","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proteinuria; Medicine; Lupus nephritis; Pyuria; Systemic lupus erythematosus; Internal medicine; Gastroenterology; Urology; Urinary system; Kidney; Disease","score_opus":0.0257894766633409,"score_gpt":0.3049526856489802,"score_spread":0.2791632089856393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327773781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226356,0.0039045482,0.0000022345976,0.0003498958,0.00017301593,0.001901837,0.00054418837,0.000016300279,0.00084440695],"genre_scores_gemma":[0.9985975,0.00026525732,0.0001322968,0.000053539978,0.000035863228,0.0001381826,0.0000434357,0.000029267763,0.00070467533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980072,0.00022741847,0.00055774476,0.00017540893,0.0006802022,0.0003520362],"domain_scores_gemma":[0.9983332,0.0003168445,0.00021916431,0.000642053,0.00025350318,0.00023524156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020001797,0.00017203721,0.0006776581,0.00013837752,0.000032949774,0.000011227979,0.00020368141,0.000054519707,0.00048324303],"category_scores_gemma":[0.0011959954,0.00011112751,0.00022195025,0.00025679928,0.000055906185,0.00012619184,0.00011616169,0.000052931315,0.00009779089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016424363,0.0008348211,0.8882129,0.001612093,0.00032831592,0.0000023299885,0.0072657997,0.000015746535,0.00014353545,0.0000054666516,0.0062708785,0.09366566],"study_design_scores_gemma":[0.008786656,0.0039569912,0.9162508,0.04400498,0.00039783973,0.00004925997,0.004792917,0.000053818632,0.018256363,0.0006787041,0.0022504998,0.0005211488],"about_ca_topic_score_codex":0.00034020422,"about_ca_topic_score_gemma":0.000035478068,"teacher_disagreement_score":0.093144506,"about_ca_system_score_codex":0.00017579651,"about_ca_system_score_gemma":0.00018333347,"threshold_uncertainty_score":0.5291172},"labels":[],"label_agreement":null},{"id":"W2327800753","doi":"10.1136/annrheumdis-2014-eular.2883","title":"SAT0099 Preferences of Patients with Spondyloarthritis for the Items of the ASAS Health Index: A Best Worst Scaling","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Health care; Physical therapy; Gerontology; Family medicine; Nursing","score_opus":0.04423784139027495,"score_gpt":0.32142859387277334,"score_spread":0.27719075248249836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327800753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275786,0.0027666772,0.00008888299,0.0020052393,0.00012398786,0.001878134,0.0002242109,0.000008463348,0.00014656351],"genre_scores_gemma":[0.9992896,0.0002619165,0.000037533846,0.000108467975,0.00002616407,0.0000861139,0.000008209725,0.000021276272,0.00016076627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976595,0.00028309642,0.0006548396,0.0001660693,0.00095605024,0.00028043255],"domain_scores_gemma":[0.996388,0.0014110313,0.00074270216,0.0008697617,0.00047627214,0.00011222003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007837463,0.00015015839,0.00057255634,0.00006910037,0.00014733007,0.000014140764,0.0005511222,0.000038648745,0.00002931053],"category_scores_gemma":[0.0018162552,0.00006107158,0.00024374243,0.00031924885,0.00045190108,0.000055308574,0.00012908428,0.0000932439,0.0000015911481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072553934,0.0007259959,0.94457495,0.006029995,0.00038475476,7.706465e-8,0.002162395,0.00008370017,0.000008367262,0.00041492278,0.0025233456,0.042365942],"study_design_scores_gemma":[0.005062708,0.0015816297,0.9444633,0.03750662,0.00030551388,0.0000258619,0.004400734,0.0016794608,0.0010636344,0.003011378,0.00067711907,0.00022204802],"about_ca_topic_score_codex":0.00038190177,"about_ca_topic_score_gemma":0.00008050557,"teacher_disagreement_score":0.042143896,"about_ca_system_score_codex":0.000015337213,"about_ca_system_score_gemma":0.00032593062,"threshold_uncertainty_score":0.24904266},"labels":[],"label_agreement":null},{"id":"W2327964202","doi":"10.1136/annrheumdis-2013-eular.1362","title":"FRI0235 Adherence to the recommended dosing regimen of abatacept: results from the international, real-world action study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Abatacept; Medicine; Regimen; Dosing; Internal medicine; Surgery","score_opus":0.11140975648166797,"score_gpt":0.37267999138484154,"score_spread":0.2612702349031736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327964202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694445,0.00014839486,0.0000036037065,0.026942067,0.00021168232,0.0011497104,0.00019432069,0.000016268694,0.0018894167],"genre_scores_gemma":[0.9979029,0.0005187248,0.00004971536,0.0006452931,0.000029463321,0.0000790663,0.00004594117,0.000010924859,0.00071796734],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987392,0.00012517121,0.00042454162,0.00017712568,0.00039835522,0.00013560201],"domain_scores_gemma":[0.998115,0.0005882552,0.0003516221,0.00072420976,0.0001533799,0.00006752738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021118596,0.00012619732,0.00026927088,0.000041869513,0.000112358,0.000037896214,0.00043919674,0.000017605904,0.00020710891],"category_scores_gemma":[0.0006162222,0.00005666044,0.00013107435,0.00020681396,0.00004797435,0.0001170314,0.00014114773,0.00007196144,0.00004609152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021300185,0.0052037737,0.090907596,0.00009912709,0.0037038482,0.000009528844,0.011519988,0.00013693226,0.0002758711,0.00011419893,0.50314236,0.38275677],"study_design_scores_gemma":[0.0025482199,0.0004708505,0.9812856,0.0012226026,0.00038959002,0.0000020738648,0.008231212,0.00039398635,0.0012369485,0.0027176284,0.0013746902,0.00012662243],"about_ca_topic_score_codex":0.011028245,"about_ca_topic_score_gemma":0.0008686535,"teacher_disagreement_score":0.890378,"about_ca_system_score_codex":0.000019280733,"about_ca_system_score_gemma":0.000049285845,"threshold_uncertainty_score":0.9955574},"labels":[],"label_agreement":null},{"id":"W2328176970","doi":"10.1136/annrheumdis-2012-eular.2770","title":"FRI0313 Prediction of total knee replacement in a 6-month multicentre clinical trial with chondroitin sulfate in knee osteoarthritis: Results from a 4-year observation","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Incidence (geometry); Placebo; Physical therapy; Population; Body mass index; Retrospective cohort study; Cohort; Internal medicine; Surgery","score_opus":0.0622614689908656,"score_gpt":0.31312831444345046,"score_spread":0.25086684545258486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328176970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956484,0.0008919343,0.000003867892,0.00033381642,0.00038735085,0.0020443934,0.0004937898,0.00002287704,0.00017360479],"genre_scores_gemma":[0.99880636,0.00012405789,0.00030879743,0.000051391475,0.000093096554,0.00011866499,0.000269914,0.000019757634,0.00020793416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748176,0.00031093933,0.0011827896,0.00025470226,0.0004691592,0.00030066326],"domain_scores_gemma":[0.9983247,0.00039912542,0.00051890925,0.00050171016,0.00010031419,0.00015523653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006428641,0.00018210064,0.00058196374,0.00010532555,0.000030577394,0.000009978934,0.000069094734,0.000094455725,0.000048836664],"category_scores_gemma":[0.0013952481,0.00012897163,0.00018844969,0.00023023611,0.00007988195,0.00023905978,0.00005300224,0.00014369117,0.000006334405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25221965,0.009111982,0.63075775,0.00029668285,0.00031637793,0.000020069483,0.0038442635,0.00006370908,0.00020604553,0.00018642929,0.0004501728,0.10252689],"study_design_scores_gemma":[0.18331657,0.009867334,0.7970837,0.005529337,0.00030840503,0.0000038573994,0.0019652888,0.00033312297,0.0012149325,0.0001820974,0.00003888012,0.00015651593],"about_ca_topic_score_codex":0.00029149215,"about_ca_topic_score_gemma":0.0001686256,"teacher_disagreement_score":0.16632591,"about_ca_system_score_codex":0.00003319734,"about_ca_system_score_gemma":0.0001171109,"threshold_uncertainty_score":0.525931},"labels":[],"label_agreement":null},{"id":"W2328364255","doi":"10.1136/annrheumdis-2013-eular.1828","title":"SAT0102 Rituximab-Induced T-Cell Depletion in Patients with Rheumatoid Arthritis: Association With Clinical Response","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Rituximab; Medicine; CD20; Rheumatoid arthritis; CD8; CD19; Immunology; Lymphocyte; Internal medicine; CD3; Flow cytometry; Antibody; Antigen","score_opus":0.012327945668984267,"score_gpt":0.24128851056743955,"score_spread":0.2289605648984553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328364255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522305,0.0032195356,0.0000075786384,0.00058394123,0.00019114332,0.00060370885,0.000022599525,0.000033071265,0.0001153716],"genre_scores_gemma":[0.99918514,0.00033982564,0.000008078792,0.00019036946,7.270715e-7,0.00006155427,0.00004313693,0.00001834648,0.00015281122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977316,0.0008832549,0.00064547674,0.0002340127,0.00014377381,0.00036183526],"domain_scores_gemma":[0.9981927,0.000543463,0.00058519014,0.00044659924,0.00021788017,0.00001412563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006202906,0.00019229071,0.00043992442,0.00008615836,0.00016306982,0.00002538719,0.00032108693,0.00014640354,0.00016858084],"category_scores_gemma":[0.0007253049,0.000120961675,0.000138848,0.00024061455,0.0001913925,0.00023482041,0.00006431238,0.00022703513,0.00021540708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033623413,0.005177539,0.9475073,0.00006642387,0.00032117032,6.3377536e-7,0.00089373277,0.000042285526,0.00080356724,0.00006842559,0.0015192516,0.040237285],"study_design_scores_gemma":[0.0054486096,0.00047221954,0.99090326,0.0006078285,0.000020442269,9.1101845e-7,0.00052998646,0.000007302809,0.0015317131,0.00016416205,0.00013234466,0.00018124141],"about_ca_topic_score_codex":0.00040316532,"about_ca_topic_score_gemma":0.000014862499,"teacher_disagreement_score":0.043395896,"about_ca_system_score_codex":0.000026751184,"about_ca_system_score_gemma":0.00012949588,"threshold_uncertainty_score":0.4932674},"labels":[],"label_agreement":null},{"id":"W2328657304","doi":"10.1136/annrheumdis-2014-eular.4010","title":"FRI0579-HPR Feasibility of Using Fitbit Flex to Motivate People with Rheumatoid Arthritis to BE Physically Active","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Rheumatoid arthritis; FLEX; Table (database); Physical therapy; Physical activity; Internal medicine; Statistics; Data mining; Computer science","score_opus":0.040393453716966274,"score_gpt":0.3142727880572626,"score_spread":0.2738793343402963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328657304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928905,0.00020623635,0.0006833949,0.0041739433,0.00008869955,0.001251403,0.00016691779,0.000046941066,0.0004919716],"genre_scores_gemma":[0.99657613,0.00007911586,0.0013307462,0.0018515213,0.000036996236,0.00004035575,0.0000118021235,0.000043031232,0.000030320054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760544,0.00019233904,0.00060797756,0.00035103282,0.00084706885,0.00039611448],"domain_scores_gemma":[0.9971033,0.00038547724,0.0003731781,0.0011475234,0.0005645464,0.0004259719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035431428,0.0002909731,0.0009863855,0.000178853,0.00010122382,0.0000123621985,0.00038046908,0.000052177093,0.00017148134],"category_scores_gemma":[0.001906176,0.00018853447,0.00032343986,0.0008045895,0.00025541088,0.00011452208,0.00015777543,0.00013532554,0.000009179197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016092496,0.011803081,0.5713415,0.008844468,0.005647577,0.000026710732,0.04250585,0.0050376407,0.049471516,0.0054992717,0.024826057,0.2589038],"study_design_scores_gemma":[0.0025266854,0.0015818542,0.95235807,0.0103248395,0.0002366512,0.000020307016,0.0013012489,0.00062585674,0.027942235,0.0025896037,0.00011077464,0.0003818758],"about_ca_topic_score_codex":0.0002746912,"about_ca_topic_score_gemma":0.000031643714,"teacher_disagreement_score":0.38101655,"about_ca_system_score_codex":0.000027822234,"about_ca_system_score_gemma":0.00015715114,"threshold_uncertainty_score":0.76882124},"labels":[],"label_agreement":null},{"id":"W2328684823","doi":"10.1136/annrheumdis-2012-eular.1363","title":"AB1369 What is the evidence-based for future policy decisions regarding biologics in sle? A structured review of the literature","year":2012,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Reimbursement; Evidence-based medicine; Intensive care medicine; Evidence-based practice; Alternative medicine; Health care; Economic growth","score_opus":0.17991787852311159,"score_gpt":0.4281669185035638,"score_spread":0.24824903998045222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328684823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013980588,0.97832584,0.00000846134,0.017418426,0.0010810625,0.0020279821,0.0011042742,0.000008115286,0.000011826605],"genre_scores_gemma":[0.0002210528,0.99412364,0.00012666117,0.005041004,0.0000985448,0.00013039606,0.000047169426,0.000022922093,0.00018863533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955478,0.0023258608,0.0012160445,0.00033922077,0.00013449167,0.00043663388],"domain_scores_gemma":[0.99181867,0.004933723,0.0013677531,0.0015513122,0.00028294994,0.00004556791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015821885,0.00047164512,0.002031996,0.00013203785,0.00020370487,0.00004798755,0.001854236,0.0005904949,0.00013227105],"category_scores_gemma":[0.006754169,0.00016117781,0.0025412436,0.0011259449,0.0005412414,0.00014334646,0.00036003735,0.00053177157,0.0000030422163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038177783,0.00008847823,0.000015809608,0.04762856,0.00047726167,1.2832801e-7,0.000076087366,2.0527847e-7,0.0000022526915,0.0010735397,0.013062723,0.9375368],"study_design_scores_gemma":[0.00013303231,0.00004245634,0.00016550552,0.47922838,0.0016659285,0.000008542136,0.00005435774,7.061474e-7,0.00006528503,0.0028480145,0.51560676,0.0001810414],"about_ca_topic_score_codex":0.000008518003,"about_ca_topic_score_gemma":0.0000034922657,"teacher_disagreement_score":0.93735576,"about_ca_system_score_codex":0.000028970217,"about_ca_system_score_gemma":0.0004683938,"threshold_uncertainty_score":0.8085859},"labels":[],"label_agreement":null},{"id":"W2328740639","doi":"10.1136/annrheumdis-2014-eular.1816","title":"SAT0227 Two-Year Retention and Effectiveness of IV Abatacept Monotherapy and Combination in PTS with RA Previously Treated with at Least One Biologic Agent in A Real-Life Setting: Subgroup Analysis from the Action Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Abatacept; Combination therapy; Internal medicine; Cohort; Population; Surgery","score_opus":0.040333413424293876,"score_gpt":0.30344804423062227,"score_spread":0.2631146308063284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328740639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784476,0.0005404191,0.000011060751,0.00023864995,0.000006683454,0.0013184226,0.000021226942,0.000009316094,0.000009486082],"genre_scores_gemma":[0.9988063,0.0009517043,0.000013305184,0.000025670613,0.00000296125,0.00012374444,0.000063778396,0.000008662219,0.0000038659446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985374,0.00066696014,0.00026119864,0.00022170428,0.0002076217,0.000105079635],"domain_scores_gemma":[0.9987711,0.0005535132,0.0002797935,0.00028177848,0.00006235915,0.00005146541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045094977,0.00013674035,0.00047810085,0.00010525966,0.000049819635,0.000013986198,0.000052575262,0.00002496592,0.0000072914477],"category_scores_gemma":[0.000110643065,0.0000658158,0.000062721556,0.00035289832,0.00009564938,0.00006157515,0.00002863557,0.00003064781,2.6101097e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00243262,0.002126802,0.98923105,0.00015504015,0.0011417269,0.0000014569711,0.0007427102,0.00015003867,0.00008806825,0.000033842665,0.0000040833024,0.0038925337],"study_design_scores_gemma":[0.0077990354,0.0014743035,0.9859858,0.0011975537,0.0011421817,8.022397e-7,0.000883705,0.00093990524,0.0004118737,0.00009689918,2.0863789e-7,0.00006772928],"about_ca_topic_score_codex":0.0035912374,"about_ca_topic_score_gemma":0.001346273,"teacher_disagreement_score":0.0053664153,"about_ca_system_score_codex":0.000051937288,"about_ca_system_score_gemma":0.000022818844,"threshold_uncertainty_score":0.5428901},"labels":[],"label_agreement":null},{"id":"W2328774052","doi":"10.1136/annrheumdis-2012-eular.2644","title":"FRI0187 The effectiveness of abatacept in a large RA real world database including durability and changes in haq over time: Post DMARDs and post TNF","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); McGill University; St Joseph's Health Care","funders":"","keywords":"Abatacept; Medicine; Internal medicine; Randomized controlled trial; Physical therapy","score_opus":0.029589761190132943,"score_gpt":0.32791498286120346,"score_spread":0.2983252216710705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328774052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926836,0.0045582247,2.0232514e-7,0.0013417673,0.000035713056,0.0007109037,0.00053916866,0.000006506463,0.00012391302],"genre_scores_gemma":[0.99856037,0.0011007517,0.000007252954,0.00017952769,0.000012349177,0.00006761208,0.000048170088,0.000010335774,0.000013632884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987114,0.0004059356,0.00026305908,0.00015989676,0.0002206698,0.00023903504],"domain_scores_gemma":[0.99788433,0.0014150465,0.00013573183,0.0003969172,0.000061422936,0.00010654008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011075448,0.00014935568,0.0004347498,0.000106184416,0.000054275428,0.000010840634,0.00009055837,0.000026894579,0.00006778344],"category_scores_gemma":[0.0008486265,0.000080411155,0.00007182554,0.00021105909,0.00015867494,0.00015846202,0.00025569854,0.000053159638,0.0000014735464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006290963,0.0015686882,0.99103266,0.0012456768,0.00012287161,0.0000035558312,0.0006388777,7.2633026e-7,0.00032900268,0.0003190861,0.00014314472,0.003966585],"study_design_scores_gemma":[0.0019717459,0.00010313278,0.99291164,0.0024542073,0.00013461048,0.000004157925,0.00021225502,0.00006541469,0.0019375195,0.00011372485,0.000015838315,0.000075769596],"about_ca_topic_score_codex":0.0018566495,"about_ca_topic_score_gemma":0.0007655623,"teacher_disagreement_score":0.0058767665,"about_ca_system_score_codex":0.000038453883,"about_ca_system_score_gemma":0.000053451924,"threshold_uncertainty_score":0.32790717},"labels":[],"label_agreement":null},{"id":"W2328928577","doi":"10.1136/annrheumdis-2016-209429","title":"Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease","year":2016,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council; National Institute for Health and Care Research; Endocyte; Celgene; Servier; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Rheumatism; Rheumatoid arthritis; Clinical trial; Physical therapy; Guideline; Rheumatology; Disease; Internal medicine; Clinical endpoint; Clinical disease; Pathology","score_opus":0.21999612358457113,"score_gpt":0.47351578130517574,"score_spread":0.2535196577206046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328928577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012685962,0.98765254,0.00003182552,0.0018362686,0.00045194812,0.005646017,0.0030242705,0.000025138701,0.000063403066],"genre_scores_gemma":[0.0036804574,0.99485254,0.000031527805,0.000042035623,0.00020178276,0.00059544883,0.000049448197,0.00008858871,0.00045817601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924455,0.001565506,0.004033435,0.00045992612,0.0009941455,0.00050145126],"domain_scores_gemma":[0.9791903,0.014823144,0.003077128,0.0018825822,0.0003502025,0.0006766377],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023076646,0.00060446176,0.005945295,0.00022190911,0.00012685095,0.000032900713,0.00075909606,0.00017108243,0.00026588087],"category_scores_gemma":[0.009235705,0.00024816356,0.0068091433,0.0002537587,0.00079638365,0.00007858029,0.00008944641,0.00014652325,0.000030592255],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014905487,0.0017294843,0.0000935012,0.0053779087,0.0038195583,0.0000023369519,0.00017073171,2.9559544e-7,9.949828e-8,0.0013008966,0.010906145,0.9751085],"study_design_scores_gemma":[0.0062053967,0.0032014397,0.0008075051,0.22546408,0.0006841006,0.0000056720837,0.00007531806,0.0000053111635,0.000034595865,0.008080111,0.7551164,0.00032006644],"about_ca_topic_score_codex":0.00012339027,"about_ca_topic_score_gemma":0.0000047504686,"teacher_disagreement_score":0.9747884,"about_ca_system_score_codex":0.000031092062,"about_ca_system_score_gemma":0.0019207823,"threshold_uncertainty_score":0.9999971},"labels":[],"label_agreement":null},{"id":"W2328961942","doi":"10.1136/annrheumdis-2014-eular.1846","title":"AB0848 Canakinumab Pre-Filled Syringe VS Triamcinolone Acetonide in the Treatment of Acute Gouty Arthritis Attacks: Results from A Post-Hoc Analysis in Difficult-To-Treat Patients","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Canakinumab; Triamcinolone acetonide; Contraindication; Internal medicine; Post-hoc analysis; European union; Surgery; Gout; Pathology; Anakinra","score_opus":0.01621642720333235,"score_gpt":0.28505222973749944,"score_spread":0.2688358025341671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328961942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919303,0.0007230843,0.0000037062566,0.004041049,0.00006112146,0.0010360893,0.0020382395,0.000017105294,0.00014928941],"genre_scores_gemma":[0.9970101,0.0019210258,0.00003324936,0.00024113634,0.000015376467,0.000109178756,0.00053869985,0.000014990016,0.00011621637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771094,0.00033752364,0.0009074187,0.0003081196,0.00043529324,0.00030069757],"domain_scores_gemma":[0.9977073,0.0006678566,0.0003473041,0.00093878683,0.00019026882,0.0001485061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014351029,0.00023582348,0.0008954395,0.00031778836,0.00006940484,0.00001782809,0.00028278786,0.00008788972,0.000050860686],"category_scores_gemma":[0.00066347496,0.00012505599,0.00046300923,0.0010197471,0.00011377287,0.000059271468,0.000045335895,0.0000918955,0.000009884379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04510545,0.04529597,0.6207206,0.0003839002,0.04579117,0.00017911194,0.092654794,0.0052328594,0.00064220565,0.0004548249,0.0077225454,0.13581653],"study_design_scores_gemma":[0.009583049,0.0017928302,0.9802508,0.00096834404,0.0055673122,0.0000012959116,0.0004396211,0.0006623022,0.00038753691,0.00016053714,0.00004756855,0.00013885401],"about_ca_topic_score_codex":0.0066591664,"about_ca_topic_score_gemma":0.002345846,"teacher_disagreement_score":0.35953012,"about_ca_system_score_codex":0.00006733273,"about_ca_system_score_gemma":0.000091605536,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W2328991175","doi":"10.1136/annrheumdis-2014-eular.2375","title":"SAT0336 Change over Time in the Profile of Ankylosing Spondylitis Patients Treated with Infliximab in A REAL World Routine Care","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Arthritis Research Centre of Canada; Nexus Clinical Research (Canada); Hôpital Notre-Dame; McMaster University; Montreal General Hospital","funders":"","keywords":"Medicine; Infliximab; Golimumab; Ankylosing spondylitis; Internal medicine; Psoriatic arthritis; Demographics; Rheumatoid arthritis; Cohort; Prospective cohort study; Physical therapy; Disease; Demography","score_opus":0.026807168918949503,"score_gpt":0.2957722110780864,"score_spread":0.26896504215913686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328991175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956261,0.0014513669,2.3610048e-7,0.0005226902,0.00001374463,0.00097515504,0.00025161504,0.000012939551,0.0011461648],"genre_scores_gemma":[0.9987233,0.0007701225,0.000018828207,0.00015743118,0.0000153664,0.000102104386,0.00012874718,0.000018360717,0.0000657026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982866,0.0003225369,0.00039442713,0.00015632722,0.00054200453,0.00029807567],"domain_scores_gemma":[0.9988853,0.00025470162,0.00018590392,0.00044043394,0.00015724525,0.000076464516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025313487,0.00015323989,0.00044239577,0.00021322642,0.000042704927,0.000017746772,0.000217016,0.000026672848,0.00018316985],"category_scores_gemma":[0.00035820715,0.000080870814,0.00010559693,0.00052656396,0.0001974166,0.00013758638,0.00005554035,0.00010180877,0.0000047065846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012569557,0.0007468784,0.9623575,0.0004931405,0.000073206655,0.0000052658324,0.0046242005,0.000003408669,0.000017762586,0.00021848138,0.00047239632,0.029730786],"study_design_scores_gemma":[0.003134275,0.00053588394,0.9905163,0.0044883657,0.00001259692,0.0000014326882,0.00037791036,0.00026540953,0.00025420752,0.00014192594,0.0001829438,0.000088723675],"about_ca_topic_score_codex":0.0017668672,"about_ca_topic_score_gemma":0.00051081285,"teacher_disagreement_score":0.029642062,"about_ca_system_score_codex":0.000022242744,"about_ca_system_score_gemma":0.00006183636,"threshold_uncertainty_score":0.3297816},"labels":[],"label_agreement":null},{"id":"W2328999000","doi":"10.1136/annrheumdis-2014-eular.1661","title":"THU0233 Differences in the Burden of Rheumatoid Arthritis (RA) on Patients' Health-Related Quality-Of-Life (HRQOL) and Work Productivity across Disease Activity: Results from the PROSE-RA Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Presenteeism; Medicine; Absenteeism; Quality of life (healthcare); Observational study; Rheumatoid arthritis; Disease burden; Disease; Productivity; Physical therapy; Burden of disease; Internal medicine","score_opus":0.06925651634854153,"score_gpt":0.340929353465969,"score_spread":0.27167283711742746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328999000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729931,0.008088013,0.000002342361,0.015528192,0.00011721779,0.0025164562,0.0007092528,0.000023219822,0.000022226113],"genre_scores_gemma":[0.9909514,0.008645685,0.000005612564,0.0001604114,0.000034472225,0.0001271303,0.000034525958,0.000023623756,0.000017135908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99358535,0.0028216455,0.001277715,0.00046847446,0.0013827278,0.00046409832],"domain_scores_gemma":[0.993416,0.0036076265,0.0010715374,0.001401991,0.00023610928,0.0002667532],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0027170975,0.00030545343,0.001136666,0.000075126314,0.00032277947,0.000065155844,0.000597988,0.00005014388,0.000014300376],"category_scores_gemma":[0.01108467,0.00015282052,0.00023649452,0.0004979201,0.00091694645,0.00017697833,0.00023240372,0.0003137557,0.0000029432454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010374007,0.0064854706,0.77368873,0.0004575563,0.00056414877,0.0000015039185,0.036397118,0.000038093425,0.000009699055,0.0003401358,0.001443141,0.1702004],"study_design_scores_gemma":[0.0045191436,0.0009972026,0.98361874,0.0041811103,0.000008822724,4.5906322e-7,0.0039848574,0.000052468265,0.000040753537,0.0024041,0.00004671791,0.00014565457],"about_ca_topic_score_codex":0.005404395,"about_ca_topic_score_gemma":0.00029387829,"teacher_disagreement_score":0.20992997,"about_ca_system_score_codex":0.000013344647,"about_ca_system_score_gemma":0.00022388883,"threshold_uncertainty_score":0.9972454},"labels":[],"label_agreement":null},{"id":"W2329148939","doi":"10.1136/annrheumdis-2014-eular.2379","title":"AB0234 Differential Relative Contribution of Individual Components on DAS28 over Time. an Analysis from the Prospective, Observational Registry, Biotrac","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of Victoria; Southlake Regional Health Center; Montreal General Hospital; Université du Québec à Rimouski; Université de Montréal; University of Saskatchewan; University of Alberta; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Infliximab; Psoriatic arthritis; Internal medicine; Ankylosing spondylitis; Observational study; Prospective cohort study; Physical therapy; Adalimumab; Tumor necrosis factor alpha","score_opus":0.047898422356646736,"score_gpt":0.3207970740811929,"score_spread":0.2728986517245462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329148939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589336,0.000617601,0.00019169746,0.0016753521,0.000056873258,0.00044900304,0.001007453,0.000019335228,0.00008930082],"genre_scores_gemma":[0.998401,0.00036176888,0.000026793272,0.00018053326,0.000046469668,0.000018125713,0.00089618063,0.000011969811,0.000057169957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977613,0.00041420915,0.00043136423,0.00021614043,0.000976986,0.00020001271],"domain_scores_gemma":[0.9977835,0.00077380217,0.00040769184,0.00062007713,0.0002862532,0.00012868697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031181477,0.0001577724,0.0004973972,0.0000852212,0.00017539218,0.000041860636,0.00037649687,0.0000526129,0.00044861896],"category_scores_gemma":[0.0012924556,0.000088423694,0.00035894412,0.00030776908,0.00040448096,0.00016276976,0.000087644534,0.00013257461,0.000011073259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021331601,0.0025818024,0.9532727,0.000062482526,0.0075757066,0.0000011632771,0.00097551325,0.00016097592,0.0012972996,0.019234585,0.004631464,0.008073161],"study_design_scores_gemma":[0.0013674237,0.0002913594,0.98425543,0.0005445397,0.00024646497,5.117004e-7,0.00005524846,0.0035416097,0.0012256388,0.008309942,0.000076418255,0.000085419124],"about_ca_topic_score_codex":0.00030350682,"about_ca_topic_score_gemma":0.000019848132,"teacher_disagreement_score":0.030982738,"about_ca_system_score_codex":0.000015687072,"about_ca_system_score_gemma":0.000058886468,"threshold_uncertainty_score":0.4912063},"labels":[],"label_agreement":null},{"id":"W2329324114","doi":"10.1136/annrheumdis-2012-eular.3259","title":"SAT0312 Psoriasis and psoriatic arthritis among natives and mestizos from the andean mountains region of peru","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Epidemiology; Ethnic group; Psoriasis; Population; Demography; Disease; Internal medicine; Dermatology; Environmental health","score_opus":0.03100127219215618,"score_gpt":0.25696159930774115,"score_spread":0.22596032711558497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329324114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93163913,0.067070566,0.0000065800746,0.0004524335,0.00026761694,0.00025934615,0.00021119947,0.000015001111,0.00007814646],"genre_scores_gemma":[0.9918497,0.007853719,0.00001725535,0.00007125576,0.000031664902,0.000024994975,0.000033871398,0.000011953132,0.00010555046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882877,0.00041620262,0.00030513565,0.00015503386,0.000066198176,0.000228633],"domain_scores_gemma":[0.99846876,0.00079317135,0.00029587408,0.00034425434,0.000054419503,0.00004354893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001935072,0.00017904719,0.0003816644,0.000044210425,0.00020146294,0.000013095848,0.00018520607,0.00008274608,0.00006448508],"category_scores_gemma":[0.00035146996,0.00010092697,0.00013635319,0.000101475795,0.00055525574,0.00017217813,0.00011115514,0.00005970202,0.0000049334258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026532848,0.0004808188,0.5457821,0.00012012712,0.0018125579,0.0000010926061,0.008022249,0.0000017417742,0.0003483628,0.0021489023,0.003505923,0.43751082],"study_design_scores_gemma":[0.0009720769,0.00007633687,0.98976755,0.00042854907,0.0004169285,0.000008063852,0.0015784603,0.000004713704,0.0039853044,0.0024695299,0.00016727253,0.00012522383],"about_ca_topic_score_codex":0.00043881172,"about_ca_topic_score_gemma":0.000046488298,"teacher_disagreement_score":0.44398546,"about_ca_system_score_codex":0.0000051975626,"about_ca_system_score_gemma":0.000022175078,"threshold_uncertainty_score":0.41156825},"labels":[],"label_agreement":null},{"id":"W2329422884","doi":"10.1136/annrheumdis-2012-eular.3281","title":"SAT0335 Semi-quantitative assessment of bone marrow edema and synovitis-effusion in osteoarthritis with the knee inflammation MRI scoring system (KIMRISS): A target lesion based methodology","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Synovitis; Osteoarthritis; Coronal plane; Sagittal plane; Effusion; Magnetic resonance imaging; Joint effusion; Radiology; Patella; Knee Joint; Edema; Lesion; Nuclear medicine; Arthritis; Pathology; Surgery; Internal medicine","score_opus":0.06516180648846731,"score_gpt":0.34517551110900796,"score_spread":0.28001370462054065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329422884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98865867,0.0059367693,0.0017951276,0.0022167314,0.00007844793,0.0010139421,0.00006478897,0.000025925037,0.00020961954],"genre_scores_gemma":[0.9962073,0.00020307864,0.0032642174,0.00013564652,0.00002686642,0.000096189266,0.000023764835,0.000021460019,0.00002147776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774593,0.0007580556,0.00058116997,0.00018402451,0.00045198674,0.00027883495],"domain_scores_gemma":[0.99763864,0.0011071432,0.00053656456,0.00040272577,0.00016709839,0.00014781996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011231678,0.0001971793,0.00066956156,0.00016506732,0.00010223794,0.0000141114015,0.00008019549,0.00005976224,0.00003194255],"category_scores_gemma":[0.0005615377,0.0001116203,0.00014802699,0.00028187115,0.00023192709,0.00021692207,0.00009094242,0.00010939857,0.000001448178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004939116,0.0022157116,0.85536027,0.024416406,0.0008217698,0.000071454364,0.004398562,0.0020388353,0.018759567,0.015331744,0.0027053985,0.06894115],"study_design_scores_gemma":[0.002749739,0.0009109154,0.96529084,0.013359185,0.000472546,0.000043914242,0.0048238942,0.00400331,0.0077072,0.00037148636,0.000052072002,0.00021489183],"about_ca_topic_score_codex":0.00015740059,"about_ca_topic_score_gemma":0.000027767388,"teacher_disagreement_score":0.10993057,"about_ca_system_score_codex":0.000028116328,"about_ca_system_score_gemma":0.00017067944,"threshold_uncertainty_score":0.45517436},"labels":[],"label_agreement":null},{"id":"W2329442309","doi":"10.1136/annrheumdis-2014-eular.3835","title":"THU0098 The Baseline Characteristics of A Canadian Ankylosing Spondylitis Cohort, the Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiviness in Ankylosing Spondylitis (COMPLETE- AS)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); McMaster University; Memorial University of Newfoundland; Centre Hospitalier de l’Université de Montréal; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Ankylosing spondylitis; BASDAI; BASFI; Adalimumab; Observational study; Quality of life (healthcare); Cohort; Epidemiology; Internal medicine; Cohort study; Physical therapy; Psoriatic arthritis; Disease","score_opus":0.08136532659733174,"score_gpt":0.33124620534576693,"score_spread":0.24988087874843518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329442309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829767,0.00089506106,0.0000046307878,0.011763835,0.00020561417,0.0014978326,0.0020530196,0.000015773585,0.00058757176],"genre_scores_gemma":[0.99691784,0.0001215427,0.00006089315,0.0023020261,0.0000972213,0.00009823043,0.00033965043,0.000032353317,0.000030255136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953103,0.0020854962,0.0009946519,0.00037781603,0.00055776245,0.0006739566],"domain_scores_gemma":[0.99264497,0.005237949,0.00053047534,0.00074501213,0.0004985708,0.00034305462],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004216967,0.0003480558,0.0009870173,0.00032284175,0.00087441184,0.00009535835,0.0004100249,0.000084952786,0.00030058553],"category_scores_gemma":[0.01773351,0.00019021025,0.00030582456,0.00082990434,0.00042378448,0.00012095874,0.0001306148,0.00027103454,0.000004307712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024019925,0.00032588368,0.9798704,0.00020946175,0.00033872502,0.000051174564,0.00039097064,0.000023442872,0.000013928725,0.00060463365,0.00029529165,0.017635923],"study_design_scores_gemma":[0.0008758586,0.00021915742,0.9929029,0.0021674545,0.00029469034,0.000046035006,0.00079908903,0.0010779464,0.00000918004,0.00045138426,0.0009841253,0.00017221303],"about_ca_topic_score_codex":0.6166917,"about_ca_topic_score_gemma":0.5199395,"teacher_disagreement_score":0.09675226,"about_ca_system_score_codex":0.00017260114,"about_ca_system_score_gemma":0.0007230244,"threshold_uncertainty_score":0.99054056},"labels":[],"label_agreement":null},{"id":"W2329591082","doi":"10.1136/annrheumdis-2014-eular.3672","title":"AB0382 Factors Associated with the Incidence of Infusion Reactions to Infliximab: Results from “Remitrac Infusion”, A Prospective Real-World Community Registry","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Infliximab; Concomitant; Incidence (geometry); Clinical endpoint; Logistic regression; Prospective cohort study; Internal medicine; Observational study; Cohort; Clinical trial; Disease","score_opus":0.029366037155871577,"score_gpt":0.27516425668661976,"score_spread":0.24579821953074818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329591082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570453,0.0006465845,0.000018949373,0.001041398,0.00014974103,0.00046415493,0.00044251938,0.000050966584,0.0014811463],"genre_scores_gemma":[0.99882245,0.000096796124,0.0000041934736,0.0002011799,0.0000016616499,0.0000280153,0.00016243233,0.000014824854,0.0006684599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976612,0.0010548262,0.0006513257,0.00019826702,0.00015535005,0.0002790713],"domain_scores_gemma":[0.99478555,0.0026821345,0.0009763721,0.0012207073,0.00031702706,0.00001819784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077852776,0.00022758669,0.0004525192,0.0000962351,0.00076557865,0.00001913205,0.00094180316,0.00010522118,0.000051280935],"category_scores_gemma":[0.0052569187,0.00012563769,0.00019179234,0.0005701032,0.0007045618,0.00014137184,0.00033833028,0.00044521518,0.000011719428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0128668975,0.016940126,0.43716705,0.0008852426,0.007773565,0.0000023898235,0.21896704,0.007815174,0.19306897,0.010511323,0.033277404,0.06072481],"study_design_scores_gemma":[0.000961434,0.00020847213,0.97704184,0.0014060584,0.00012239543,4.68221e-7,0.0038860054,0.000021091453,0.013784067,0.0015769107,0.0008081541,0.00018312575],"about_ca_topic_score_codex":0.01607956,"about_ca_topic_score_gemma":0.00090061827,"teacher_disagreement_score":0.53987473,"about_ca_system_score_codex":0.000028130014,"about_ca_system_score_gemma":0.000129386,"threshold_uncertainty_score":0.99047244},"labels":[],"label_agreement":null},{"id":"W2329619961","doi":"10.1136/annrheumdis-2013-eular.811","title":"THU0283 Two Year Follow-Up on Biologics Use in 13 Centers - Data from the International Registry for Biologics in SLE (IRBIS)","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Nova Scotia Research and Innovation Trust","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Abatacept; Belimumab; Internal medicine; Rituximab; Infliximab; Biologic Agents; Golimumab; Tocilizumab; Lupus nephritis; Hydroxychloroquine; Rheumatoid arthritis; Disease; Immunology; Infectious disease (medical specialty)","score_opus":0.09416431753763538,"score_gpt":0.3075665771863953,"score_spread":0.21340225964875992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329619961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896379,0.0041361237,0.000012312876,0.002880314,0.0012448884,0.0005339775,0.0013558718,0.000018117524,0.00018051206],"genre_scores_gemma":[0.9967122,0.00066752365,0.00001326528,0.0010999192,0.0000038774183,0.000053151944,0.0010121725,0.000009450505,0.00042845213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987086,0.00022673947,0.00043457327,0.0002860465,0.000056083943,0.00028792894],"domain_scores_gemma":[0.99760103,0.0010746502,0.0002565861,0.0010059571,0.000055136126,0.000006648408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031586856,0.00016538728,0.0002648511,0.000054945816,0.00010412916,0.000041220217,0.0019131836,0.00009700585,0.00023086384],"category_scores_gemma":[0.0019434216,0.00009205955,0.00014657143,0.00012333671,0.00031271807,0.00019517979,0.00042344505,0.00016902362,0.00008822278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035418544,0.0050020395,0.6471116,0.00016160413,0.0018365158,0.0000033627944,0.0030735992,0.0012674452,0.016344486,0.011887589,0.24374774,0.066022195],"study_design_scores_gemma":[0.006856882,0.00024580004,0.94370073,0.001298379,0.00008222741,0.0000023278383,0.0068171225,0.0010081301,0.002662217,0.019267535,0.017494591,0.0005640832],"about_ca_topic_score_codex":0.0033889909,"about_ca_topic_score_gemma":0.00014591042,"teacher_disagreement_score":0.29658914,"about_ca_system_score_codex":0.000012567711,"about_ca_system_score_gemma":0.000050242725,"threshold_uncertainty_score":0.5123163},"labels":[],"label_agreement":null},{"id":"W2329703565","doi":"10.1136/annrheumdis-2014-eular.3061","title":"THU0120 Is Early DMARD Use Associated with Less Joint Replacement Surgery? an Analysis of 5,199 Incident Rheumatoid Arthritis (RA) Patients","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université Laval; University of Alberta; Université de Montréal; Université de Sherbrooke; University of Toronto; Dalhousie University; University of Calgary; McGill University; Institute for Clinical Evaluative Sciences; University of British Columbia","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Proportional hazards model; Rheumatology; Cohort; Methotrexate; Hazard ratio; Joint replacement; Cumulative incidence; Osteoarthritis; TNF inhibitor; Hydroxychloroquine; Cumulative dose; Etanercept; Surgery; Disease; Arthroplasty; Confidence interval","score_opus":0.04788436075639491,"score_gpt":0.2825274625633635,"score_spread":0.23464310180696857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329703565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676543,0.0014359598,0.000038593935,0.00059619936,0.000080925754,0.00060640107,0.00037930103,0.000048961803,0.000048235856],"genre_scores_gemma":[0.9900154,0.009235561,0.000034615776,0.0003277073,0.000008679936,0.000054430155,0.00020050729,0.00004299914,0.000080128346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568105,0.0006024058,0.0011313207,0.00040601,0.0016532845,0.0005259596],"domain_scores_gemma":[0.9956946,0.0007246754,0.000972574,0.0012214574,0.0009490973,0.00043760793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009198395,0.00032150303,0.0014766058,0.00050082186,0.0001731053,0.00009001615,0.00030263458,0.00007433953,0.0002544057],"category_scores_gemma":[0.0028908132,0.0002149258,0.00073761446,0.0009067231,0.00039673792,0.0003293004,0.00014184727,0.00013804143,0.000006632523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007405205,0.001847187,0.96147084,0.00012937833,0.004031494,0.0000028143309,0.0011741027,0.00007749267,0.000018192448,0.00015024038,0.0029127407,0.027444985],"study_design_scores_gemma":[0.0017693379,0.0008786613,0.9899858,0.004003476,0.000188119,0.0000019796178,0.0003258283,0.0011817102,0.0011136545,0.00023397373,0.00008070209,0.00023676212],"about_ca_topic_score_codex":0.0016750195,"about_ca_topic_score_gemma":0.0004365185,"teacher_disagreement_score":0.028514944,"about_ca_system_score_codex":0.000040554532,"about_ca_system_score_gemma":0.0001759873,"threshold_uncertainty_score":0.876442},"labels":[],"label_agreement":null},{"id":"W2329881241","doi":"10.1136/annrheumdis-2015-eular.1628","title":"THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Placebo; Internal medicine; Gastroenterology; TNF inhibitor; Cartilage oligomeric matrix protein; Urology; Osteoarthritis; Pathology; Adalimumab","score_opus":0.05182186504130101,"score_gpt":0.324490089834696,"score_spread":0.27266822479339503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329881241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927167,0.0039524315,0.00000522647,0.00033131518,0.00009213157,0.0026529615,0.00019406766,0.0000190945,0.000036057554],"genre_scores_gemma":[0.99659526,0.0030713293,0.000010652929,0.00011377778,0.000005213786,0.00014579577,0.000019344814,0.00003017225,0.000008448516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973458,0.0005980207,0.0005943781,0.00036227927,0.0006931148,0.00040642644],"domain_scores_gemma":[0.9978078,0.00060492015,0.0002142187,0.0005737969,0.00020749566,0.00059177313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004061271,0.0003047088,0.0008830553,0.00035780956,0.00006447492,0.000034099263,0.00024043521,0.000040456118,0.000011597123],"category_scores_gemma":[0.0023768907,0.00020324577,0.0001461071,0.00037558968,0.00021012344,0.00021162796,0.00021374217,0.00014995784,0.0000050637886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019934926,0.025515318,0.82725453,0.00077020866,0.00032907093,0.000053645443,0.004427686,0.00014399133,0.00019871649,0.000038004797,0.00052927865,0.120804645],"study_design_scores_gemma":[0.021555332,0.0020153644,0.9640157,0.0077414443,0.0000068432637,0.000002084132,0.00049061875,0.0018764145,0.0012958006,0.0007882639,0.000009178983,0.00020293999],"about_ca_topic_score_codex":0.00065141154,"about_ca_topic_score_gemma":0.00014783247,"teacher_disagreement_score":0.1367612,"about_ca_system_score_codex":0.000030731004,"about_ca_system_score_gemma":0.0001672787,"threshold_uncertainty_score":0.82881224},"labels":[],"label_agreement":null},{"id":"W2330062298","doi":"10.1136/annrheumdis-2014-eular.4840","title":"THU0224 Knee Effusion is A Risk Factor for Prevalence and Progression of Bone Marrow Lesions: A Population-Based Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Osteoarthritis; Effusion; Knee pain; Population; Cohort; Cartilage; Stage (stratigraphy); Internal medicine; Bone marrow; Incidence (geometry); Physical therapy; Surgery; Pathology","score_opus":0.029795125049475183,"score_gpt":0.3232571576921787,"score_spread":0.29346203264270354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330062298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952934,0.0018369156,0.000049663482,0.00030334544,0.000053341955,0.002103831,0.0003314224,0.000020049582,0.0000080574755],"genre_scores_gemma":[0.99905366,0.00011404379,0.0005032123,0.00006675449,0.000010820297,0.00011935667,0.000010766803,0.000013988254,0.000107403226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989333,0.00011251431,0.00035211054,0.00016999264,0.0003081431,0.00012390125],"domain_scores_gemma":[0.99876374,0.00031219627,0.0003652023,0.00035381393,0.00011321156,0.00009185567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019371591,0.00012796716,0.00034854925,0.00006411852,0.00010186576,0.000008519014,0.00006039058,0.00003264932,0.00006722916],"category_scores_gemma":[0.0008174757,0.00007564437,0.0001586639,0.00007680413,0.000036179386,0.00005108076,0.00004155974,0.00003089237,9.776985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006633501,0.0016157045,0.57733554,0.0019611788,0.00007531806,5.057957e-7,0.00047667391,0.0000028461238,0.00028396258,0.00005842544,0.00008830627,0.41743818],"study_design_scores_gemma":[0.0041545206,0.0050624553,0.97841287,0.004811816,0.0005799229,0.0000010361288,0.0001439695,0.0009480882,0.0039248,0.0018396524,0.000013477287,0.00010741358],"about_ca_topic_score_codex":0.000021885202,"about_ca_topic_score_gemma":0.000005732345,"teacher_disagreement_score":0.41733077,"about_ca_system_score_codex":0.0000049990613,"about_ca_system_score_gemma":0.000036651832,"threshold_uncertainty_score":0.3084688},"labels":[],"label_agreement":null},{"id":"W2330082233","doi":"10.1136/annrheumdis-2014-eular.2874","title":"SAT0091 Towards A Patient Global Measure to Assess At-Work Productivity Loss in Patients with Inflammatory Arthritis and Osteoarthritis: A Qualitative Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Presenteeism; Medicine; Physical therapy; Quality of life (healthcare); Debriefing; Attribution; Population; Rheumatoid arthritis; Gerontology; Absenteeism; Internal medicine; Psychology","score_opus":0.036741564288130836,"score_gpt":0.3735346572177118,"score_spread":0.33679309292958093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330082233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932221,0.0005926974,0.000014480055,0.0017140864,0.00023531486,0.0037887413,0.000118653385,0.000039233862,0.00027467677],"genre_scores_gemma":[0.9987556,0.000030328589,0.000053495398,0.0005642488,0.000030691976,0.00050407246,0.000008057653,0.00002345683,0.00003010091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993913,0.00343938,0.0008326358,0.0004235904,0.00077945273,0.00061192707],"domain_scores_gemma":[0.9975081,0.0006105076,0.0004996701,0.00058752624,0.0004089799,0.00038521545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015182587,0.00026742026,0.0006186376,0.00007690393,0.00043166056,0.000016306456,0.00021820549,0.00007867865,0.000020846079],"category_scores_gemma":[0.0021529144,0.00018613624,0.00006546669,0.00050936337,0.00014238575,0.00018332768,0.00034175633,0.0002447795,0.000020194744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012046888,0.0006939679,0.87291205,0.00056585786,0.00004806473,0.0000017405625,0.040626664,0.00003599143,8.7868834e-8,0.00018370312,0.0008858206,0.08284137],"study_design_scores_gemma":[0.002419268,0.00096645753,0.97802234,0.006011429,0.000026530266,3.3003238e-7,0.010846543,0.000002880245,0.0000029313906,0.0013983533,0.000088041495,0.00021490137],"about_ca_topic_score_codex":0.00028305594,"about_ca_topic_score_gemma":0.0010937328,"teacher_disagreement_score":0.10511029,"about_ca_system_score_codex":0.000107245614,"about_ca_system_score_gemma":0.0003281617,"threshold_uncertainty_score":0.75904155},"labels":[],"label_agreement":null},{"id":"W2330257268","doi":"10.1136/annrheumdis-2014-eular.2513","title":"SAT0561 In Vivo Cartilage-Specific Deletion of Ephrin-B2 in Mice Results in Bone Development Leading to Osteoarthritis Features","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ephrin; Osteoarthritis; Cartilage; Erythropoietin-producing hepatocellular (Eph) receptor; Medicine; In vivo; Endocrinology; Internal medicine; Pathology; Receptor; Anatomy; Biology; Genetics","score_opus":0.04611778823661326,"score_gpt":0.2844131369418697,"score_spread":0.23829534870525645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330257268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978538,0.0006173779,0.000016542246,0.0007471176,0.00008152163,0.00032278916,0.000023997043,0.000010693741,0.00032614064],"genre_scores_gemma":[0.99906933,0.00021633581,0.00008484722,0.0005125201,0.000009551045,0.000029405612,0.0000010593923,0.000012767943,0.00006415347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979495,0.00028793982,0.0007609645,0.0003107405,0.00038827094,0.0003025744],"domain_scores_gemma":[0.9988149,0.00058150844,0.00023993256,0.0002566406,0.000034580575,0.000072474926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048609526,0.00014546464,0.00034235118,0.00025191062,0.0000475232,0.000018617397,0.0003295221,0.0000368148,0.000011912568],"category_scores_gemma":[0.0016560418,0.0001227236,0.00007208276,0.000585046,0.00007444812,0.00013301124,0.00011678922,0.000102371734,0.000009996523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019818705,0.00086312956,0.009157166,0.00060427043,0.0000058855862,0.00004255199,0.007235741,0.015759984,0.80038434,0.0011339072,0.002842717,0.15998846],"study_design_scores_gemma":[0.0008588188,0.000118728305,0.071350574,0.0027970448,0.0000027704032,0.0000035271453,0.00018708741,0.000091273534,0.92306197,0.0005757357,0.0007710918,0.0001814077],"about_ca_topic_score_codex":0.00007441697,"about_ca_topic_score_gemma":0.00042562222,"teacher_disagreement_score":0.15980706,"about_ca_system_score_codex":0.000027161064,"about_ca_system_score_gemma":0.000050745053,"threshold_uncertainty_score":0.50045234},"labels":[],"label_agreement":null},{"id":"W2330309815","doi":"10.1136/annrheumdis-2014-eular.2768","title":"FRI0072 Prevalence of Malignancies in Patients with Rheumatoid Arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Nexus Clinical Research (Canada)","funders":"","keywords":"Medicine; Internal medicine; Malignancy; Cohort; Psoriatic arthritis; Rheumatoid arthritis; Dysplasia; Cancer; Cervical cancer","score_opus":0.013209181631875854,"score_gpt":0.2536764325888558,"score_spread":0.24046725095697996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330309815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145883,0.0071189683,0.000017790084,0.0004537399,0.00004981337,0.00049634627,0.00007319713,0.00001791573,0.00031337165],"genre_scores_gemma":[0.98189753,0.017791163,0.000095441144,0.000091217684,0.0000057738166,0.000030051024,0.0000074566456,0.000018864066,0.000062511215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981652,0.00015178835,0.00050208747,0.00018094575,0.00069439993,0.00030555972],"domain_scores_gemma":[0.998541,0.00020725145,0.00025373395,0.0005696922,0.0002898376,0.0001384933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002637934,0.00015858213,0.0004993,0.00012545167,0.00005179881,0.000013026575,0.00026845018,0.00003325877,0.00017168677],"category_scores_gemma":[0.0009287346,0.000097673525,0.00014620504,0.00025396008,0.00041010417,0.00015343571,0.00008142658,0.000084193845,0.000009198489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005131551,0.00085465773,0.950123,0.0011281159,0.000111711954,0.0000010143007,0.00041303027,0.000019838848,0.000024239027,0.0013574559,0.0009369317,0.04451686],"study_design_scores_gemma":[0.00248359,0.00058571174,0.9844529,0.009373493,0.000004983434,0.0000028294394,0.00008944718,0.000052193533,0.00115611,0.0014996878,0.00018955824,0.00010947871],"about_ca_topic_score_codex":0.000078894096,"about_ca_topic_score_gemma":0.000017588593,"teacher_disagreement_score":0.044407383,"about_ca_system_score_codex":0.0000070970264,"about_ca_system_score_gemma":0.00010455049,"threshold_uncertainty_score":0.39830106},"labels":[],"label_agreement":null},{"id":"W2330414892","doi":"10.1136/annrheumdis-2012-eular.2737","title":"FRI0280 Structural progression of ankylosing spondylitis associated with elevation in two novel, inflammatory biomarkers; matrix metalloproteinase and cathepsin-derived CRP","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Cohort; Internal medicine; Biomarker; C-reactive protein; Gastroenterology; Sacroiliitis; Lumican; Pathology; Inflammation","score_opus":0.02750777554294643,"score_gpt":0.3332844712386035,"score_spread":0.3057766956956571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330414892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203664,0.0067529567,0.0000032843623,0.00023203938,0.000044040033,0.00070830167,0.00017493221,0.000015945823,0.00003185741],"genre_scores_gemma":[0.99939024,0.00013913144,0.00030767595,0.000024419394,0.00001026947,0.00003621415,0.00006008191,0.000017018689,0.000014963253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883544,0.000082504754,0.00037249294,0.00013328991,0.00032552052,0.0002507305],"domain_scores_gemma":[0.99904,0.00011816298,0.00038722143,0.00021896616,0.00013431023,0.00010135516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020045131,0.00016768859,0.00041225814,0.000100019395,0.00008305013,0.000009889822,0.000060851744,0.000031476444,0.000037632202],"category_scores_gemma":[0.00044734665,0.00010189653,0.000090403046,0.00023005363,0.00020460528,0.0001920969,0.00006644024,0.000050323677,4.3512222e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010860056,0.00079621014,0.97741234,0.0006174146,0.0010009304,0.000011106269,0.0011986017,0.0000049504843,0.004550266,0.00034438906,0.00002618508,0.0129516125],"study_design_scores_gemma":[0.003303061,0.00021062138,0.98609525,0.0033237303,0.00027359516,0.000016029635,0.00039134634,0.000098354394,0.0059452816,0.00022628688,0.000007751976,0.00010868181],"about_ca_topic_score_codex":0.00017186708,"about_ca_topic_score_gemma":0.000040508934,"teacher_disagreement_score":0.01284293,"about_ca_system_score_codex":0.000027775308,"about_ca_system_score_gemma":0.000054802,"threshold_uncertainty_score":0.41552198},"labels":[],"label_agreement":null},{"id":"W2330498796","doi":"10.1136/annrheumdis-2013-eular.1353","title":"FRI0226 Rituximab versus abatacept in rheumatoid arthritis patients with an inadequate response to prior biologic therapy: a retrospective single-center study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Abatacept; TNF inhibitor; Rituximab; Internal medicine; Rheumatoid arthritis; Single Center; Retrospective cohort study; Log-rank test; Cohort; Surgery; Survival analysis; Etanercept; Lymphoma","score_opus":0.03722704614638195,"score_gpt":0.29891153998176306,"score_spread":0.2616844938353811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330498796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992428,0.0018159099,0.0000036364484,0.00152486,0.0001276993,0.0038532657,0.00012764391,0.00006208688,0.000056876543],"genre_scores_gemma":[0.9965872,0.002482913,0.00010662753,0.0002480445,0.000011817694,0.0004633644,0.00002671186,0.000046516438,0.000026815766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967074,0.00076462445,0.000614942,0.0004763418,0.0008265701,0.00061016885],"domain_scores_gemma":[0.99761474,0.00034095574,0.00023154714,0.0009101027,0.0004994975,0.00040318028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004629532,0.00033737757,0.0007749686,0.00030303013,0.00017256339,0.00011071262,0.00043478073,0.00005757922,0.00039936486],"category_scores_gemma":[0.0014780523,0.00020592763,0.00015694385,0.0005797723,0.00027763797,0.00045177073,0.0001645902,0.00019873232,0.000088436966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042099167,0.022402275,0.74243057,0.000050709175,0.00057386694,0.000020678985,0.0049893297,0.000007422761,0.00011414566,0.000044168417,0.0010653634,0.18620227],"study_design_scores_gemma":[0.0246944,0.013789223,0.9569222,0.00142447,0.000004203067,0.000004450187,0.0021695727,0.000023121951,0.0001627361,0.00041307247,0.00013512206,0.0002574566],"about_ca_topic_score_codex":0.00046326904,"about_ca_topic_score_gemma":0.0002427786,"teacher_disagreement_score":0.21449158,"about_ca_system_score_codex":0.00007540345,"about_ca_system_score_gemma":0.00015883919,"threshold_uncertainty_score":0.8397485},"labels":[],"label_agreement":null},{"id":"W2331313534","doi":"10.1136/annrheumdis-2014-eular.3406","title":"FRI0168 Comprehensive Analysis of the Oral Microbiome in Axial Spondyloarthritis Reveals Associations with Disease Activity and Periodontitis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Ankylosing spondylitis; Medicine; BASDAI; Periodontitis; Oral Microbiome; Microbiome; Bleeding on probing; Pathogenesis; Chronic periodontitis; Dysbiosis; Internal medicine; Disease; Immunology; Gastroenterology; Psoriatic arthritis; Bioinformatics","score_opus":0.02412423041849476,"score_gpt":0.28570953061406257,"score_spread":0.2615853001955678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331313534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504167,0.0015934164,0.0000039310985,0.0017575995,0.00004852677,0.00042507058,0.0010566202,0.000008025791,0.00006515703],"genre_scores_gemma":[0.9991363,0.000467997,0.000033112698,0.00020728481,0.000007889289,0.000025789574,0.000030570198,0.000010585042,0.00008045455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885017,0.00019741763,0.00029036088,0.00018783395,0.00028320507,0.00019102555],"domain_scores_gemma":[0.9987823,0.00022168292,0.00029647673,0.0004262991,0.00016520367,0.00010804087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086741544,0.00015348048,0.0006815981,0.00013163614,0.00014171778,0.000015798187,0.00011619638,0.00002854523,0.000041335607],"category_scores_gemma":[0.0003304001,0.00008834346,0.00031121998,0.0006812751,0.0003193066,0.00007350147,0.00011441961,0.00005961466,9.540903e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003763881,0.0006335739,0.9889933,0.00018471124,0.001954809,0.0000060510456,0.00037959855,0.000042459822,0.00018027388,0.00015039332,0.0003108085,0.0067876466],"study_design_scores_gemma":[0.0015956404,0.00013570419,0.9951738,0.0007356036,0.0016783008,0.0000027687445,0.000119131524,0.00011768548,0.0001153402,0.00018470785,0.00005582443,0.00008549241],"about_ca_topic_score_codex":0.0006430672,"about_ca_topic_score_gemma":0.00065003044,"teacher_disagreement_score":0.0067021544,"about_ca_system_score_codex":0.000019886422,"about_ca_system_score_gemma":0.000058916696,"threshold_uncertainty_score":0.36025417},"labels":[],"label_agreement":null},{"id":"W2331438532","doi":"10.1136/annrheumdis-2014-eular.3285","title":"SAT0178 Rheumatoid Arthritis Erosion Detection and Measurement in Longitudinal Datasets Using High-Resolution Peripheral Quantitative Computed Tomography (HR-PQCT): Reliability Exercise-2 (RELEX-2)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Quantitative computed tomography; Nuclear medicine; Rheumatoid arthritis; Bone erosion; Kappa; Reproducibility; Radiology; Biomedical engineering; Internal medicine; Mathematics; Osteoporosis; Geometry; Bone density","score_opus":0.04622102448936871,"score_gpt":0.3009875784692421,"score_spread":0.2547665539798734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331438532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796243,0.017019812,0.0016817398,0.00044034395,0.00017644945,0.0008530765,0.00012896057,0.00006845453,0.0000068944087],"genre_scores_gemma":[0.9819121,0.017124511,0.00078005693,0.0000461197,0.000015193428,0.00004390719,0.00004628954,0.000030800817,0.0000010386999],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970227,0.00048932177,0.0006913273,0.00042233567,0.00094270014,0.0004316193],"domain_scores_gemma":[0.9983361,0.00019368145,0.00028334116,0.0005900361,0.00035272219,0.00024412629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010635721,0.0002702907,0.0006683146,0.0002449685,0.0002474085,0.00006706399,0.00018554932,0.00007399682,0.000027202901],"category_scores_gemma":[0.001081603,0.00020749668,0.000203032,0.0004473221,0.0004907842,0.00034091133,0.00014725208,0.00019319866,0.000002489677],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085760765,0.0051067984,0.37200707,0.0037379113,0.0009288251,0.000025295334,0.002335045,0.004196617,0.016302288,0.003024696,0.0027753706,0.580984],"study_design_scores_gemma":[0.003386676,0.0007402184,0.9448904,0.010286762,0.000025281437,0.000033452347,0.00026811147,0.03228559,0.004033017,0.0036143733,0.00013345358,0.00030271255],"about_ca_topic_score_codex":0.0018393842,"about_ca_topic_score_gemma":0.00046999138,"teacher_disagreement_score":0.5806813,"about_ca_system_score_codex":0.00006212421,"about_ca_system_score_gemma":0.00009995734,"threshold_uncertainty_score":0.84614694},"labels":[],"label_agreement":null},{"id":"W2331618367","doi":"10.1136/annrheumdis-2014-eular.2382","title":"AB0760 Real-World Validation of the Minimal Disease Activity Index in Psoriatic Arthritis: an Analysis from the Prospective, Observational Registry, Biotrac","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Saskatchewan; McMaster University; Hôpital Notre-Dame; Montreal General Hospital; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Infliximab; Internal medicine; Rheumatoid arthritis; Ankylosing spondylitis; Erythrocyte sedimentation rate; Observational study; Adalimumab; BASDAI; Physical therapy; Disease","score_opus":0.04560022604283796,"score_gpt":0.32882761894817863,"score_spread":0.28322739290534066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331618367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919535,0.0012549205,0.00005839286,0.0054947883,0.000087770626,0.0007077102,0.00030143946,0.000018788374,0.00012270322],"genre_scores_gemma":[0.9971941,0.0023059396,0.000035842848,0.00016349829,0.00006118503,0.00008087196,0.00007012456,0.00001681795,0.00007160119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723613,0.0007036673,0.0005624687,0.00029079366,0.00094625365,0.00026066767],"domain_scores_gemma":[0.99710506,0.00078686577,0.0005059672,0.0011691299,0.0002521271,0.00018087598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000594184,0.00018911362,0.0005257841,0.00013737558,0.00017551109,0.00005587401,0.0005306412,0.000039739436,0.00013633122],"category_scores_gemma":[0.002269121,0.00010315738,0.0004308303,0.0010256064,0.00046804082,0.0002720541,0.000118516415,0.00016800374,0.0000025195077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007648066,0.00083788665,0.9793882,0.0001004078,0.0005878655,9.1297227e-7,0.00036349075,0.00043585515,0.00008303152,0.0015657522,0.00046253853,0.015409277],"study_design_scores_gemma":[0.0009915599,0.00007645165,0.9804523,0.0010311096,0.00012458007,3.879443e-7,0.0001639503,0.0056725205,0.0010325265,0.010298011,0.000052764954,0.00010384437],"about_ca_topic_score_codex":0.0030558459,"about_ca_topic_score_gemma":0.0017831012,"teacher_disagreement_score":0.0153054325,"about_ca_system_score_codex":0.000029846957,"about_ca_system_score_gemma":0.0002981004,"threshold_uncertainty_score":0.4619545},"labels":[],"label_agreement":null},{"id":"W2331964856","doi":"10.1136/annrheumdis-2014-eular.5589","title":"SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Apremilast; Tolerability; Psoriatic arthritis; Placebo; Adverse effect; Randomized controlled trial; Internal medicine; Nausea; Gastroenterology; Surgery; Arthritis","score_opus":0.0190196144959197,"score_gpt":0.293338388482158,"score_spread":0.2743187739862383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331964856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743355,0.008097837,0.0009292228,0.00010504549,0.000063147156,0.002917685,0.000416684,0.000016198532,0.000020625526],"genre_scores_gemma":[0.99752915,0.0020558913,0.00005141045,0.000105717634,0.000015965627,0.000061985236,0.00015519404,0.000020699397,0.0000039784245],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99356174,0.0024147679,0.0026297602,0.000349467,0.00079070503,0.00025355784],"domain_scores_gemma":[0.99469084,0.0021867997,0.001534468,0.0009323429,0.0004303063,0.000225227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046234443,0.00034808877,0.0076619186,0.00027363215,0.000064521395,0.00001794826,0.0001936703,0.000081017635,0.00013404388],"category_scores_gemma":[0.004695624,0.00019191983,0.002314596,0.00050972245,0.0005950531,0.00018709575,0.00005928931,0.000091295326,2.8216513e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5185022,0.003908131,0.31167698,0.0006881509,0.020435454,0.0000022021593,0.00026646673,0.0005056757,0.0000074313602,0.000090300025,0.000007723454,0.14390928],"study_design_scores_gemma":[0.36662918,0.0006193463,0.61230445,0.0018862769,0.016120331,7.6479995e-7,0.00005862174,0.00168709,0.0002219552,0.0002987466,0.0000013369483,0.00017188444],"about_ca_topic_score_codex":0.00009807773,"about_ca_topic_score_gemma":0.00009245568,"teacher_disagreement_score":0.3006275,"about_ca_system_score_codex":0.00001579104,"about_ca_system_score_gemma":0.00013761861,"threshold_uncertainty_score":0.78262633},"labels":[],"label_agreement":null},{"id":"W2331997489","doi":"10.1136/annrheumdis-2014-eular.4348","title":"AB1069 Burden of Refractory Gouty Arthritis among Difficult-To-Treat Patients over One Year: Post- HOC Analysis from Motion Observational Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Gout; Internal medicine; Quality of life (healthcare); Physical therapy; Population; Observational study; Post-hoc analysis; Refractory (planetary science); Arthritis","score_opus":0.03969786795917406,"score_gpt":0.2888963493575668,"score_spread":0.24919848139839273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331997489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779075,0.00024192313,0.000058487134,0.00045789158,0.000077108336,0.0007204373,0.0005326682,0.00003211653,0.0000885883],"genre_scores_gemma":[0.99887383,0.000079134,0.00014540413,0.00025177028,0.0000616629,0.000031485248,0.00036933518,0.000025285564,0.00016208099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744546,0.0002296087,0.0007099702,0.00032445413,0.0010747605,0.00021573588],"domain_scores_gemma":[0.997375,0.00034434756,0.00052255654,0.0009181137,0.00062531116,0.00021464992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021218571,0.00021576979,0.00074662094,0.00019311295,0.00007050631,0.000018488392,0.0002863551,0.00006906595,0.0003823352],"category_scores_gemma":[0.0019135781,0.00015757562,0.0003706829,0.00066036056,0.000104067425,0.00016644158,0.00015258443,0.00009903505,0.00002838335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029988596,0.002946442,0.98008215,0.000116615236,0.0017439394,8.5337695e-7,0.0015400047,0.0004447306,0.00014043099,0.000015705236,0.0012903541,0.011378875],"study_design_scores_gemma":[0.0016848661,0.0005819363,0.99356395,0.00049802574,0.0020586874,7.328025e-8,0.00060161663,0.0005493213,0.0001290003,0.00017460871,0.000014703194,0.00014318596],"about_ca_topic_score_codex":0.0022357837,"about_ca_topic_score_gemma":0.000065708286,"teacher_disagreement_score":0.013481811,"about_ca_system_score_codex":0.000038421935,"about_ca_system_score_gemma":0.0000552241,"threshold_uncertainty_score":0.6425747},"labels":[],"label_agreement":null},{"id":"W2332077206","doi":"10.1136/annrheumdis-2014-eular.3012","title":"THU0577-HPR A Study to Determine Patient Satisfaction with A Nurse Injection Clinic in Rheumatology","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Family medicine; Patient satisfaction; Health care; Physical therapy; Nursing","score_opus":0.026743501394801774,"score_gpt":0.32437207880289426,"score_spread":0.2976285774080925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332077206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967369,0.00043023512,0.000036418267,0.0011355951,0.00013780018,0.001307872,0.0000093778535,0.000035959594,0.0001698356],"genre_scores_gemma":[0.99911636,0.0004219533,0.000055519708,0.00017713907,0.000007842589,0.0001457794,0.0000029453058,0.000022566011,0.000049915845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801326,0.00038416262,0.0005561694,0.000254905,0.00047873642,0.00031278204],"domain_scores_gemma":[0.9985938,0.00029597877,0.00020289043,0.0005463885,0.00015641126,0.00020450339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003313477,0.00017534812,0.0005278956,0.00023677005,0.00008588199,0.000022638898,0.00012544602,0.000031025284,0.00013191532],"category_scores_gemma":[0.0010606067,0.000108317,0.00011490238,0.00037515844,0.00012410211,0.000114968345,0.000056900622,0.00012746954,0.000045210127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015708895,0.0017950019,0.8210067,0.00019143587,0.00017251377,0.0000061304995,0.0031633324,0.00007176089,0.000021629065,0.000065910586,0.0010397105,0.17089498],"study_design_scores_gemma":[0.002407396,0.00561182,0.9854113,0.0019514655,0.000020016967,0.00006567618,0.0031776938,0.00029335957,0.00014904428,0.0006900097,0.00007961984,0.00014262472],"about_ca_topic_score_codex":0.0010033634,"about_ca_topic_score_gemma":0.0012783639,"teacher_disagreement_score":0.17075236,"about_ca_system_score_codex":0.000020922393,"about_ca_system_score_gemma":0.00010408854,"threshold_uncertainty_score":0.4417039},"labels":[],"label_agreement":null},{"id":"W2332254935","doi":"10.1136/annrheumdis-2014-eular.2408","title":"THU0024 High Mortality in North American Indigenous People with Systemic Lupus Erythematosus (SLE):","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Ethnic group; Rheumatology; Hazard ratio; Proportional hazards model; Internal medicine; Systemic lupus erythematosus; Medical record; Retrospective cohort study; Demography; Pediatrics; Disease; Confidence interval","score_opus":0.023331342428665587,"score_gpt":0.29568988349713266,"score_spread":0.2723585410684671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332254935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967338,0.0006967784,0.000042898257,0.0003782901,0.00019303981,0.0014905202,0.000060198126,0.00007502089,0.00032945562],"genre_scores_gemma":[0.9989141,0.000287363,0.000045888126,0.00015255793,0.000042838168,0.00017343162,0.000021834274,0.00006011857,0.00030186542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650383,0.00041816058,0.0008188803,0.0004048191,0.0012165247,0.00063779857],"domain_scores_gemma":[0.9967782,0.0005153592,0.0005748475,0.0015382505,0.00027486408,0.00031846517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059748656,0.00032389056,0.001226009,0.00024082052,0.00010218533,0.000035146357,0.0005775938,0.00004717902,0.000033980337],"category_scores_gemma":[0.0006523889,0.00018850368,0.00023595823,0.0012248013,0.00035869103,0.000102041115,0.00016447887,0.00020087215,0.000046477166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026890828,0.00047592114,0.9885821,0.004355929,0.0003334523,0.00001474329,0.0032176296,0.0001049294,0.0000079086885,0.00014794465,0.0005105398,0.0019800249],"study_design_scores_gemma":[0.0018295151,0.00043787458,0.9865299,0.004341227,0.00021523399,0.0027828375,0.0027347493,0.00047208805,0.00012433075,0.00025073288,0.000014615144,0.00026688082],"about_ca_topic_score_codex":0.002792133,"about_ca_topic_score_gemma":0.0031909198,"teacher_disagreement_score":0.0027680944,"about_ca_system_score_codex":0.000078047124,"about_ca_system_score_gemma":0.0003533856,"threshold_uncertainty_score":0.76869565},"labels":[],"label_agreement":null},{"id":"W2332306083","doi":"10.1136/annrheumdis-2013-eular.1121","title":"THU0593 Frequency and Impact of Disease Symptoms Experienced by Patients with Systemic Sclerosis: A Comparison among Five European Countries","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Quality of life (healthcare); Physical therapy; Rheumatology; Disease; Confidence interval; Internal medicine; Pediatrics","score_opus":0.015539746129375484,"score_gpt":0.25511357185896816,"score_spread":0.23957382572959268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332306083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813272,0.016792718,0.0000046417817,0.00009324054,0.000055928536,0.0012182281,0.00036555677,0.0000399369,0.00010256687],"genre_scores_gemma":[0.99877864,0.000907935,0.0000055163305,0.000081854516,0.000011382334,0.00008364038,0.00004766708,0.000034530764,0.000048802853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789584,0.00022186812,0.0007213109,0.00027392068,0.0006034495,0.00028363784],"domain_scores_gemma":[0.9976216,0.00014758,0.0006955721,0.00059967226,0.00044588078,0.0004897026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010682735,0.00028295742,0.0006694214,0.00008021933,0.000113247,0.00005262551,0.00025415828,0.000042756263,0.00011619827],"category_scores_gemma":[0.00029711265,0.00014566857,0.00027960178,0.0002084985,0.0005937911,0.00026250543,0.00008419209,0.000071233975,0.000010803984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025044422,0.00065614335,0.98902684,0.0008452389,0.00056960963,5.342433e-7,0.0012593421,0.000039536848,0.00015653578,0.00001572846,0.005729394,0.0014506357],"study_design_scores_gemma":[0.0015638066,0.00043327484,0.9770764,0.018700702,0.00045877194,0.0000011656763,0.0012120786,0.00022343958,0.00012669644,0.00003115569,5.6204817e-7,0.00017192177],"about_ca_topic_score_codex":0.00058242114,"about_ca_topic_score_gemma":7.6526015e-7,"teacher_disagreement_score":0.017855464,"about_ca_system_score_codex":0.00002795352,"about_ca_system_score_gemma":0.00013094797,"threshold_uncertainty_score":0.5940192},"labels":[],"label_agreement":null},{"id":"W2332346805","doi":"10.1136/annrheumdis-2014-eular.1499","title":"AB0752 Efficacy and Safety of Brodalumab over One Year in Patients with Psoriatic Arthritis with and without Prior Exposure to A Biologic","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Université Laval","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Internal medicine; Rheumatology; Psoriasis; Ustekinumab; Enthesitis; Placebo; Arthritis; Surgery; Adalimumab; Dermatology; Rheumatoid arthritis; Pathology","score_opus":0.012049945015239644,"score_gpt":0.2263392746583248,"score_spread":0.21428932964308514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332346805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731743,0.0019001899,0.000006833895,0.000087531065,0.00003683815,0.00050696905,0.00010067599,0.000010117834,0.000033414493],"genre_scores_gemma":[0.99944216,0.00029179148,0.000117933814,0.00006379354,0.0000034851078,0.000020179968,0.000018469571,0.000010291142,0.00003191522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991301,0.00019212291,0.00025521155,0.00019179432,0.000059061047,0.00017171062],"domain_scores_gemma":[0.999293,0.00016847884,0.00017850507,0.00027153405,0.00005379972,0.000034627254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011944829,0.00014943304,0.00041810604,0.0000669129,0.00005775529,0.000006341927,0.00010888749,0.000057625173,0.000036171637],"category_scores_gemma":[0.00016408406,0.00008487404,0.000034555575,0.000118791475,0.000184905,0.000048855778,0.000059943603,0.000039950864,0.000004261359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031323656,0.0006885593,0.83734363,0.00013017865,0.00043235515,1.4567031e-7,0.0005030351,0.0000115416515,0.00009435462,0.00016780989,0.000049599967,0.15744641],"study_design_scores_gemma":[0.0064548748,0.0014703715,0.9901366,0.0009876646,0.0001268464,9.124966e-7,0.00005191939,9.548118e-7,0.00048571415,0.00013709185,0.000031345433,0.00011567173],"about_ca_topic_score_codex":0.000049675582,"about_ca_topic_score_gemma":0.00004108908,"teacher_disagreement_score":0.15733074,"about_ca_system_score_codex":0.0000041597714,"about_ca_system_score_gemma":0.000024723866,"threshold_uncertainty_score":0.3461063},"labels":[],"label_agreement":null},{"id":"W2332361110","doi":"10.1136/annrheumdis-2014-eular.5399","title":"THU0415 Changing Patterns in Prescribing in Rheumatoid Arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Hydroxychloroquine; Sulfasalazine; Rheumatoid arthritis; Internal medicine; Leflunomide; Rheumatology; Azathioprine; Cohort; Abatacept; Methotrexate; Tocilizumab; Combination therapy; Infliximab; Disease; Rituximab","score_opus":0.028968245136454664,"score_gpt":0.29077502155294765,"score_spread":0.26180677641649297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332361110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872808,0.009358878,0.000053046824,0.0020944912,0.00011819749,0.0004835072,0.000024171162,0.000032553155,0.00055436254],"genre_scores_gemma":[0.96659684,0.0329094,0.000026908,0.0002939065,0.000021485172,0.00006477374,0.000009981379,0.000026097463,0.000050629485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997934,0.00024329085,0.00056982215,0.00019948099,0.0004892948,0.00056410383],"domain_scores_gemma":[0.9988322,0.00026909585,0.00014190488,0.00052004977,0.00007264041,0.00016407088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006136891,0.00017910455,0.00053263485,0.0003900463,0.00007064723,0.000036676112,0.0002745028,0.00004605386,0.0001537451],"category_scores_gemma":[0.0011861541,0.00013223043,0.00019311786,0.00042644434,0.00012888595,0.0001864797,0.00015173742,0.00017150574,0.000018097853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000214411,0.00072313595,0.7074375,0.00056874653,0.00009599985,0.0000175615,0.0036076943,0.00010348272,0.00012023686,0.002803256,0.00087032176,0.2834376],"study_design_scores_gemma":[0.004271068,0.00025290003,0.95395005,0.025632974,0.0000036388435,0.000050707342,0.0025115476,0.0031299558,0.0020136957,0.006891714,0.0009648588,0.00032689114],"about_ca_topic_score_codex":0.00039873648,"about_ca_topic_score_gemma":0.0002617899,"teacher_disagreement_score":0.28311074,"about_ca_system_score_codex":0.000017657569,"about_ca_system_score_gemma":0.000079343044,"threshold_uncertainty_score":0.53922004},"labels":[],"label_agreement":null},{"id":"W2332713223","doi":"10.1136/annrheumdis-2013-eular.1611","title":"FRI0484 One year results of treatment efficacy on bone microarchitecture and joint space width in early inflammatory arthritis measured with hr-pqct","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Quantitative computed tomography; Nuclear medicine; Arthritis; Rheumatology; Internal medicine; Radiology; Bone density; Osteoporosis","score_opus":0.02772087846128483,"score_gpt":0.25568337947253644,"score_spread":0.22796250101125162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332713223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987251,0.0077298456,0.0000014964967,0.0034654562,0.000020102485,0.0011320874,0.00008905318,0.000021863458,0.00028910142],"genre_scores_gemma":[0.9882648,0.011280102,0.00016917347,0.000057327834,0.000015194554,0.00006064765,0.000009704283,0.00002637539,0.00011665753],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99824154,0.00017911411,0.0005215344,0.0002445466,0.00049784034,0.00031542606],"domain_scores_gemma":[0.99857414,0.00022256272,0.00024418236,0.00056855654,0.0001599871,0.00023054873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020858322,0.00021593283,0.00064962014,0.00019364915,0.000055232,0.000030178298,0.00010169111,0.000047411653,0.000048113867],"category_scores_gemma":[0.00056765584,0.00012958968,0.00015078485,0.00018089087,0.00040107092,0.000087459215,0.000048306498,0.00012548768,0.00001655886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02583205,0.011777323,0.17309208,0.002887687,0.0040573934,0.000119066106,0.023114817,0.0004581328,0.027481036,0.0018684398,0.009073613,0.7202384],"study_design_scores_gemma":[0.010899089,0.0030831792,0.9581703,0.010097986,0.000023096361,0.000018695344,0.00033160433,0.000027921384,0.01577282,0.0011713136,0.00020755114,0.00019646743],"about_ca_topic_score_codex":0.00091191806,"about_ca_topic_score_gemma":0.00014257048,"teacher_disagreement_score":0.7850782,"about_ca_system_score_codex":0.000023860674,"about_ca_system_score_gemma":0.00016582609,"threshold_uncertainty_score":0.5284514},"labels":[],"label_agreement":null},{"id":"W2332829298","doi":"10.1136/annrheumdis-2012-eular.3077","title":"SAT0130 Long-term safety of adalimumab in patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, and crohn's disease","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Psoriatic arthritis; Adalimumab; Ankylosing spondylitis; Psoriasis; Internal medicine; Infliximab; BASDAI; Rheumatoid arthritis; Population; Arthritis; Etanercept; Adverse effect; Dermatology; Disease","score_opus":0.05782023959083216,"score_gpt":0.3684292947082618,"score_spread":0.31060905511742964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332829298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79018015,0.20561063,0.000014018708,0.00046029867,0.00042546575,0.0015494914,0.0016930324,0.000028649882,0.000038235667],"genre_scores_gemma":[0.8726925,0.1265834,0.000043092117,0.00017395921,0.00008184568,0.000060167014,0.000313633,0.000044081018,0.0000073314445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98908263,0.0030790856,0.005159427,0.00056419516,0.0011897662,0.000924912],"domain_scores_gemma":[0.9950123,0.0013087549,0.0015919162,0.0010996244,0.00026862798,0.0007188203],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005800812,0.00049240503,0.003290441,0.00025870252,0.00013653004,0.000060853585,0.00043272538,0.0002472477,0.00038788485],"category_scores_gemma":[0.014377276,0.00041367253,0.0007862967,0.00059229886,0.00062268355,0.00066321716,0.00037228558,0.00044028863,0.00001618843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003179687,0.0022893508,0.66825396,0.0006146152,0.00018693197,0.000037123125,0.0002601981,0.0000050069884,0.0000024802862,0.00026984126,0.00034383408,0.32455695],"study_design_scores_gemma":[0.013831457,0.0002480536,0.9635691,0.019426966,0.00010061349,0.0000073158876,0.0002464036,0.0000631072,0.000054197008,0.0019703829,0.00013179386,0.000350586],"about_ca_topic_score_codex":0.00058688654,"about_ca_topic_score_gemma":0.00021196694,"teacher_disagreement_score":0.32420635,"about_ca_system_score_codex":0.00010166063,"about_ca_system_score_gemma":0.00078968954,"threshold_uncertainty_score":0.9998315},"labels":[],"label_agreement":null},{"id":"W2333209791","doi":"10.1136/annrheumdis-2014-eular.2250","title":"SAT0429 The OA TRIAL Bank: Meta-Analysis of Individual Patient Data Show That Patients with Severe Pain or with Inflammatory Signs Detected by Ultrasound Especially Benefit from Intra-Articular Glucocorticoids for Knee or Hip Oa","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Osteoarthritis; Placebo; Internal medicine; Clinical trial; Randomized controlled trial; Physical therapy; Rheumatology; Pathology","score_opus":0.06418169025158796,"score_gpt":0.2722143474205737,"score_spread":0.20803265716898575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333209791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063116,0.0005981876,0.0005399083,0.00027406047,0.000062285755,0.0033613485,0.004492556,0.00003272982,0.000007763989],"genre_scores_gemma":[0.9964256,0.000023666484,0.00054570293,0.00046225623,0.000033757893,0.00037150306,0.0020364623,0.000047782167,0.000053217682],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966827,0.00044290887,0.0007971356,0.00047201128,0.0012341411,0.00037107876],"domain_scores_gemma":[0.9943992,0.0025644137,0.0008887782,0.0016501821,0.0002844478,0.00021296409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062078744,0.00040753555,0.0014208946,0.00012186817,0.00016515957,0.000079800826,0.00061850605,0.000087984794,0.0005454019],"category_scores_gemma":[0.0016420912,0.00016823903,0.0006078003,0.00042650197,0.00021702652,0.000221489,0.00014808166,0.00009410761,0.0000014107584],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19352499,0.008527313,0.037359763,0.0008683246,0.4136863,0.000019943775,0.0046216114,0.00045729688,0.0006730784,0.00023083838,0.005912087,0.33411846],"study_design_scores_gemma":[0.099814266,0.05316142,0.05273103,0.0010561126,0.7691588,0.000007181169,0.0029552835,0.0010932845,0.016494995,0.0013733496,0.00069680787,0.0014574672],"about_ca_topic_score_codex":0.00006006623,"about_ca_topic_score_gemma":0.0006236186,"teacher_disagreement_score":0.3554725,"about_ca_system_score_codex":0.000019025749,"about_ca_system_score_gemma":0.00019328245,"threshold_uncertainty_score":0.6860589},"labels":[],"label_agreement":null},{"id":"W2333274499","doi":"10.1136/annrheumdis-2012-eular.1940","title":"OP0257 IL-6 in scleroderma; potential implications for targeted therapy: A systematic analysis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Scleroderma (fungus); Cytokine; Interleukin; Fibrosis; Rheumatology; Interleukin 8; Immunology; Internal medicine","score_opus":0.07050123480926233,"score_gpt":0.33251142518632487,"score_spread":0.2620101903770625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333274499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573798,0.037567418,0.0002460051,0.0021268378,0.00018246926,0.0021023792,0.00028669077,0.000042174466,0.00006623133],"genre_scores_gemma":[0.99737746,0.0014900812,0.000051465435,0.00041567083,0.00004381103,0.0004453973,0.00006086748,0.000022551985,0.00009269629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819237,0.00019280279,0.0007996818,0.00018274166,0.00027922675,0.000353152],"domain_scores_gemma":[0.9980858,0.0003245359,0.00041480636,0.00073901186,0.00020064079,0.00023519919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039633195,0.00018305841,0.00079861254,0.00027362735,0.00010156216,0.00002117552,0.0002449068,0.000074512165,0.00006035546],"category_scores_gemma":[0.00072551885,0.00010694343,0.00090300874,0.00086948054,0.00008091303,0.00012044247,0.000042910553,0.00005380703,0.000008174667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011358078,0.011321286,0.85881066,0.05104336,0.026026448,0.0000015440244,0.0034003886,0.0026575876,0.0058778967,0.0033471757,0.021589113,0.014788705],"study_design_scores_gemma":[0.0010872835,0.000044087694,0.9855143,0.00763259,0.0030672846,0.0000048776487,0.0004826704,0.0011460165,0.00046602034,0.00040514822,0.000008857907,0.00014087888],"about_ca_topic_score_codex":0.000054699063,"about_ca_topic_score_gemma":0.0000020188297,"teacher_disagreement_score":0.1267036,"about_ca_system_score_codex":0.00002222585,"about_ca_system_score_gemma":0.000092075345,"threshold_uncertainty_score":0.43610263},"labels":[],"label_agreement":null},{"id":"W2333505098","doi":"10.1136/annrheumdis-2013-eular.1832","title":"SAT0106 Predictors of Retention with Abatacept in Patients Who have Failed One or More Biologic Agents: Results from the International, Real-World Action Study","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Abatacept; Medicine; Internal medicine; Discontinuation; Hazard ratio; Proportional hazards model; Multivariate analysis; Interim analysis; Concomitant; Randomized controlled trial; Confidence interval","score_opus":0.0782400364116686,"score_gpt":0.3339934027681172,"score_spread":0.2557533663564486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333505098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528563,0.00015008278,0.0000019512224,0.0022157712,0.00010227593,0.0016465733,0.0003393516,0.00001780062,0.00024054182],"genre_scores_gemma":[0.994589,0.0046504037,0.000020708818,0.00009072397,0.000025476054,0.000106887324,0.00020705244,0.000014110227,0.00029563936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800533,0.00023711116,0.0006003768,0.00022371276,0.0007448714,0.00018859081],"domain_scores_gemma":[0.9982273,0.00036217208,0.00042613776,0.00054852624,0.000350486,0.00008538662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025808555,0.00014698396,0.00036185328,0.00012629063,0.00006902851,0.00003734482,0.00035026664,0.000029968303,0.00030817772],"category_scores_gemma":[0.0012143173,0.000068448746,0.00010487568,0.00023885515,0.00021866648,0.00024930385,0.000116559946,0.000112575945,0.000007811039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029200222,0.0019095866,0.9695507,0.00004753912,0.00064952753,0.0000011930481,0.0017764402,0.000021096752,0.000019224875,0.000007109223,0.009096031,0.014001482],"study_design_scores_gemma":[0.0038558287,0.0008058481,0.9887034,0.0018193228,0.00002691016,1.7659731e-7,0.00401401,0.00024666658,0.00020231711,0.00018663621,0.00006773658,0.00007110363],"about_ca_topic_score_codex":0.0052740397,"about_ca_topic_score_gemma":0.0014056535,"teacher_disagreement_score":0.019152697,"about_ca_system_score_codex":0.000028963555,"about_ca_system_score_gemma":0.000069697824,"threshold_uncertainty_score":0.7972806},"labels":[],"label_agreement":null},{"id":"W2333614414","doi":"10.1136/annrheumdis-2014-eular.2522","title":"THU0319 Lower Socioeconomic Status Associates with Increased Symptom Severity and Functional Impairment in Fibromyalgia","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Fibromyalgia; Visual analogue scale; Physical therapy; Cohort; Anxiety; Psychosocial; Hospital Anxiety and Depression Scale; McGill Pain Questionnaire; Depression (economics); Socioeconomic status; Cohort study; Internal medicine; Population; Psychiatry","score_opus":0.01548314011277074,"score_gpt":0.26732443689925656,"score_spread":0.2518412967864858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333614414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666333,0.0006698775,0.000006159767,0.0020182782,0.000041578907,0.0003666386,0.000048590515,0.000020973854,0.000164571],"genre_scores_gemma":[0.999443,0.00017281693,0.000047243073,0.000049459144,0.000007071539,0.000029504854,0.000030351226,0.000018214536,0.0002023611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853724,0.00016257234,0.00030626784,0.00022235318,0.00038659223,0.00038498582],"domain_scores_gemma":[0.9988352,0.0003663086,0.00014824599,0.0003420738,0.000086441694,0.0002217013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003446379,0.00016704091,0.00040318593,0.000082676175,0.000079815414,0.000025611585,0.00009974631,0.000057158846,0.00043693793],"category_scores_gemma":[0.00024026282,0.00010625557,0.00012704497,0.000109509405,0.00025008392,0.00010309752,0.00009212453,0.00013362059,0.000019279476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080316426,0.0009750347,0.98061293,0.0057362225,0.0005603428,0.0000050233016,0.00036364273,0.000062942,0.00007762344,0.0003497098,0.008673548,0.001779812],"study_design_scores_gemma":[0.001798515,0.00048874016,0.9927955,0.001792702,0.00006867515,0.000011951824,0.00016809745,0.0013010739,0.00013262469,0.0012911113,0.000027219246,0.00012373616],"about_ca_topic_score_codex":0.00039307913,"about_ca_topic_score_gemma":0.0000068128097,"teacher_disagreement_score":0.0121826185,"about_ca_system_score_codex":0.00008789931,"about_ca_system_score_gemma":0.00038424725,"threshold_uncertainty_score":0.47841638},"labels":[],"label_agreement":null},{"id":"W2333724311","doi":"10.1136/annrheumdis-2012-eular.2698","title":"FRI0241 Association of gastroesophageal factors and progression of interstitial lung disease in the canadian scleroderma research group (CSRG); a large, multi-center database","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McMaster University; Western University","funders":"","keywords":"Medicine; Interstitial lung disease; Internal medicine; Dysphagia; Pulmonary function testing; Scleroderma (fungus); DLCO; Swallowing; Lung; Gastroenterology; Surgery; Pathology; Diffusing capacity; Lung function","score_opus":0.10108382001052336,"score_gpt":0.38705206227733135,"score_spread":0.285968242266808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333724311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017113,0.0072321715,0.000005435614,0.0007209366,0.00013345107,0.00079327845,0.0009019853,0.0000061513965,0.000035446665],"genre_scores_gemma":[0.99919504,0.00047447672,0.00001627283,0.00009544464,0.000035128134,0.000033383338,0.000119123106,0.000014308935,0.000016834236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974433,0.0006258742,0.00051293604,0.00015616436,0.00081207906,0.00044963308],"domain_scores_gemma":[0.99823856,0.0003826061,0.00031912228,0.0004248839,0.00021294942,0.00042187623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001276003,0.0001436707,0.00034560173,0.00022571956,0.0001326672,0.000019050836,0.00023751985,0.000065476735,0.000038150112],"category_scores_gemma":[0.0018244872,0.000075769494,0.00017844462,0.0002924188,0.00018698716,0.00018220679,0.0001173353,0.0001744477,0.0000013186409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018854818,0.0018627853,0.9918207,0.0009396645,0.00013551708,0.000002439629,0.0015876646,0.0000021283765,0.00005027024,0.00007810169,0.00288978,0.00044238043],"study_design_scores_gemma":[0.0015639196,0.000058365924,0.98944813,0.0065877563,0.0001761239,0.00000119914,0.0012622809,0.00063949096,0.00017102479,0.000016102253,0.000016555878,0.000059078768],"about_ca_topic_score_codex":0.006155833,"about_ca_topic_score_gemma":0.0022308545,"teacher_disagreement_score":0.009023884,"about_ca_system_score_codex":0.00006092275,"about_ca_system_score_gemma":0.00021589677,"threshold_uncertainty_score":0.930582},"labels":[],"label_agreement":null},{"id":"W2333795773","doi":"10.1136/annrheumdis-2012-eular.1310","title":"AB1314 Involvement in medical decisions and alexithymia among patients with rheumatoid arthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Medicine; Clinical psychology; Dysfunctional family; Logistic regression; Marital status; Rheumatoid arthritis; Psychiatry; Internal medicine; Population","score_opus":0.023060745726820917,"score_gpt":0.28265699641177994,"score_spread":0.259596250684959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333795773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408203,0.0040016663,0.000013520941,0.0006165132,0.00008885586,0.00055024656,0.000032650692,0.00001490509,0.00059958437],"genre_scores_gemma":[0.9953818,0.0039811293,0.00008382243,0.00041662165,0.000006948429,0.000056179935,0.000025324076,0.000017832343,0.000030390476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983755,0.00006287374,0.0004176949,0.0001504315,0.0006880917,0.0003054175],"domain_scores_gemma":[0.99875647,0.00024201862,0.00016669388,0.00039562237,0.00005727201,0.00038192785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017849515,0.00017164684,0.0003927331,0.00008805187,0.00006271368,0.000012374796,0.00013923238,0.0000485785,0.0002240634],"category_scores_gemma":[0.00060789194,0.000095231786,0.000092053306,0.00018721164,0.0002345703,0.00016097896,0.00008763449,0.00007175159,0.000009127068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008752473,0.002218425,0.9710245,0.000084725296,0.00017703544,0.000002142849,0.0005487079,7.0973925e-7,1.4149526e-7,0.00028646432,0.0009212784,0.024648318],"study_design_scores_gemma":[0.0030390534,0.00014064193,0.9811685,0.013677425,0.00002747085,0.0000041080816,0.00033173774,0.000042450192,0.000011108721,0.001397979,0.000059873917,0.00009965964],"about_ca_topic_score_codex":0.00013184715,"about_ca_topic_score_gemma":0.000062033214,"teacher_disagreement_score":0.02454866,"about_ca_system_score_codex":0.00001162015,"about_ca_system_score_gemma":0.00006505436,"threshold_uncertainty_score":0.38834396},"labels":[],"label_agreement":null},{"id":"W2333967381","doi":"10.1136/annrheumdis-2014-eular.1636","title":"SAT0351 Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Outcomes of the Rapid-Axspa Trial","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Certolizumab pegol; Medicine; Axial spondyloarthritis; Ankylosing spondylitis; Bristol-Myers; BASDAI; Internal medicine; Randomized controlled trial; Interim analysis; Physical therapy; Pediatrics; Surgery; Adalimumab; Sacroiliitis; Arthritis; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.021000856320439267,"score_gpt":0.27142003158627476,"score_spread":0.2504191752658355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333967381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918609,0.004164954,0.0000050146073,0.00062343007,0.00030283668,0.0020882415,0.0008197597,0.000018775958,0.00011607881],"genre_scores_gemma":[0.9976162,0.0020466074,0.00004478133,0.000064462365,0.000049346116,0.000038636244,0.0000755271,0.000047966518,0.000016516737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666464,0.00033973646,0.0011816934,0.00047457375,0.0008324678,0.0005068711],"domain_scores_gemma":[0.99729115,0.0007315576,0.00077864,0.0007663558,0.00022195427,0.00021035383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025150832,0.00046364477,0.0015566585,0.00031330707,0.0002800026,0.00003378205,0.00028531364,0.00011334121,0.00007641934],"category_scores_gemma":[0.00093516306,0.00029071918,0.00044763664,0.00056608923,0.0010194094,0.00020323301,0.00034060777,0.00018894934,6.0519653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029722942,0.0019727857,0.9058873,0.0005984336,0.00059154356,0.00002482362,0.0006670176,0.0000036789477,0.000008633966,0.0001378041,0.000025068757,0.060359962],"study_design_scores_gemma":[0.07783389,0.0024957592,0.91380596,0.0046880706,0.00045457005,0.00004281026,0.00011706695,0.000014462981,0.00012191522,0.00015399279,0.000026875347,0.000244616],"about_ca_topic_score_codex":0.00027697405,"about_ca_topic_score_gemma":0.00019459633,"teacher_disagreement_score":0.060115345,"about_ca_system_score_codex":0.000028353166,"about_ca_system_score_gemma":0.000109134475,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W2334040872","doi":"10.1136/annrheumdis-2013-eular.2984","title":"AB0662 Frequencies of cognitive impairment and vitamin d deficiency and determination of apoe allells in the patients with fibromyalgia syndrome","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Fibromyalgia; Internal medicine; Cognition; Apolipoprotein E; Vitamin D and neurology; Dementia; Physical therapy; Psychiatry; Disease","score_opus":0.010246001622736544,"score_gpt":0.23808422821974748,"score_spread":0.22783822659701095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334040872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978963,0.00095265073,0.0000035688024,0.00030138888,0.000009666273,0.00071840786,0.000032718388,0.0000025468023,0.0000827098],"genre_scores_gemma":[0.99963105,0.0002424119,0.00004863795,0.0000326717,4.5682162e-7,0.000016595492,0.000008187419,0.000004759017,0.000015224757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992108,0.00007375587,0.00026423458,0.000090901114,0.00025736957,0.00010298266],"domain_scores_gemma":[0.9992032,0.00026596416,0.00021438209,0.00013336478,0.00014184575,0.000041256368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012513956,0.00008923919,0.00021563929,0.00006892243,0.000026479562,0.000006277372,0.000073089155,0.000030936375,0.000019229832],"category_scores_gemma":[0.00017636773,0.000041055813,0.00004471226,0.00013236079,0.0003255227,0.00007791225,0.00003179261,0.00003623841,6.331956e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041978908,0.0025036684,0.95726347,0.005659846,0.00031606568,0.000006736654,0.008579058,0.0000037900004,0.00032230525,0.00007914992,0.0003591556,0.024486983],"study_design_scores_gemma":[0.0010126554,0.00077251665,0.99186385,0.0032830809,0.00013514236,0.0000107187025,0.001991905,0.000095925854,0.00034980534,0.00043500005,1.3768468e-7,0.00004926152],"about_ca_topic_score_codex":0.00015052373,"about_ca_topic_score_gemma":0.0000018202895,"teacher_disagreement_score":0.0346004,"about_ca_system_score_codex":0.0000037695117,"about_ca_system_score_gemma":0.00003122669,"threshold_uncertainty_score":0.16742074},"labels":[],"label_agreement":null},{"id":"W2334118180","doi":"10.1136/annrheumdis-2012-eular.3064","title":"SAT0117 Early RA patients reporting a flare identify more tender than swollen joints","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Sherbrooke; McGill University; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Concordance; Cohort; Rheumatoid arthritis; Internal medicine; Physical therapy; Surgery","score_opus":0.06738383226424452,"score_gpt":0.36111726428490143,"score_spread":0.29373343202065694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334118180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990136,0.00726918,0.0000040251634,0.0011110358,0.00023384491,0.0005966586,0.000048891132,0.000052561398,0.0007824588],"genre_scores_gemma":[0.99720144,0.0018200611,0.000051298477,0.00025970288,0.00007019436,0.000044801207,0.000030813793,0.000036613437,0.00048508288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708563,0.0001541064,0.0009783754,0.00020135358,0.0009795432,0.000600971],"domain_scores_gemma":[0.9974403,0.00012733311,0.00087624736,0.00072800106,0.00039438598,0.00043377726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056279195,0.00021074445,0.0005310901,0.000119413555,0.0001999511,0.000057113073,0.00026558086,0.0000557727,0.0002876079],"category_scores_gemma":[0.0044602365,0.00013295976,0.00044849524,0.0002176423,0.00021883381,0.000426365,0.00021040018,0.00015256941,0.00006954547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000162451,0.0008334449,0.95458895,0.00038468637,0.00045836926,0.0000075357048,0.0021550464,8.4199326e-7,0.00006912009,0.00011324574,0.013819782,0.027406547],"study_design_scores_gemma":[0.0009532438,0.00010787477,0.99369586,0.001865937,0.000031028172,0.000015319445,0.0007152016,0.000013126133,0.0012288283,0.0008649778,0.00036700408,0.00014161946],"about_ca_topic_score_codex":0.0001934531,"about_ca_topic_score_gemma":0.0000049411924,"teacher_disagreement_score":0.03910691,"about_ca_system_score_codex":0.00001680851,"about_ca_system_score_gemma":0.00012287879,"threshold_uncertainty_score":0.5421941},"labels":[],"label_agreement":null},{"id":"W2334126784","doi":"10.1136/annrheumdis-2013-eular.202","title":"SP0202 Advanced Case Presentations: Interaction and Discussion","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Interpretation (philosophy); Presentation (obstetrics); Medical physics; Pediatrics; Surgery; Computer science","score_opus":0.04001415032116859,"score_gpt":0.3442706344329926,"score_spread":0.30425648411182404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334126784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98823184,0.0011469799,0.000015766414,0.009423452,0.000083902305,0.0005218483,0.000022489307,0.000026579235,0.00052716007],"genre_scores_gemma":[0.9982355,0.00036248847,0.00007956121,0.00044941987,0.00001667915,0.000060754777,0.000010919751,0.000009651114,0.0007749791],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993351,0.00004983562,0.00023642377,0.000115491006,0.00015393223,0.000109187626],"domain_scores_gemma":[0.99925405,0.00010771823,0.00012430873,0.0002684021,0.0000983534,0.00014717576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033549022,0.00009043446,0.000182846,0.00004696396,0.00008007054,0.000022929655,0.000042229505,0.000018004648,0.00036775603],"category_scores_gemma":[0.00042652662,0.000044110497,0.00011813289,0.00009683852,0.000086507425,0.0002932682,0.00005883899,0.00004456056,0.000026031172],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044461712,0.001755798,0.07070757,0.0022989241,0.0004612406,0.000103868224,0.001207571,0.00006199606,0.00064546097,0.0006370758,0.114772536,0.80690336],"study_design_scores_gemma":[0.0017721349,0.00027618767,0.9691068,0.0027197457,0.0005680088,0.0006171488,0.008311421,0.0019650685,0.0021811556,0.011119538,0.0011039304,0.00025887767],"about_ca_topic_score_codex":0.00017983657,"about_ca_topic_score_gemma":0.0000055194587,"teacher_disagreement_score":0.89839923,"about_ca_system_score_codex":0.0000036166768,"about_ca_system_score_gemma":0.00003072697,"threshold_uncertainty_score":0.40266708},"labels":[],"label_agreement":null},{"id":"W2334128926","doi":"10.1136/annrheumdis-2012-eular.2047","title":"THU0082 An evaluation of flare in patients with early rheumatoid arthritis using the omeract preliminary flare questionnaire","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Sherbrooke; McGill University; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Flare; Concordance; Rheumatoid arthritis; Physical therapy; Cohort; Internal medicine; Arthritis","score_opus":0.04501790142735262,"score_gpt":0.3284637750125704,"score_spread":0.2834458735852178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334128926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755743,0.022710424,0.00000899354,0.0003307921,0.00010012364,0.0011485106,0.00006120736,0.00001741084,0.000048223697],"genre_scores_gemma":[0.9963472,0.0034045915,0.000051211304,0.000052569987,0.000021867594,0.00004866198,0.000038945836,0.00002910309,0.000005858839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968585,0.0006434351,0.0005260594,0.00017221182,0.0014148585,0.00038497968],"domain_scores_gemma":[0.9978966,0.00013199385,0.00034418772,0.00068172836,0.0007493955,0.00019608239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009564824,0.00019536077,0.00041681554,0.00013928441,0.0001518998,0.0000288877,0.00025600556,0.000050502735,0.000110856665],"category_scores_gemma":[0.0008896162,0.000108631546,0.00014506404,0.00033993588,0.000305807,0.0006844856,0.000078021716,0.00014515381,0.000004877775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008385501,0.0014729754,0.90188944,0.00020955426,0.0001956247,7.326743e-7,0.0026686327,0.00017863582,0.000023976623,0.00014259781,0.000172536,0.09220677],"study_design_scores_gemma":[0.0022636259,0.00061350036,0.9871694,0.0072488966,0.000029941892,0.000008912867,0.00073412305,0.00092653703,0.00042319583,0.00044295064,0.000013227222,0.00012571864],"about_ca_topic_score_codex":0.00036504868,"about_ca_topic_score_gemma":0.000045939523,"teacher_disagreement_score":0.09208105,"about_ca_system_score_codex":0.000032878794,"about_ca_system_score_gemma":0.0002983319,"threshold_uncertainty_score":0.4429866},"labels":[],"label_agreement":null},{"id":"W2334337629","doi":"10.1136/annrheumdis-2014-eular.1174","title":"SAT0404 Fifty-Two Week Clinical Response to Brodalumab, an Anti-IL-17R Antibody, in Subjects with Psoriatic Arthritis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Rheumatology; Adverse effect; Psoriasis; Placebo; Psoriasis Area and Severity Index; Rheumatoid arthritis; Immunology; Pathology","score_opus":0.03669345411588095,"score_gpt":0.3284316581926772,"score_spread":0.2917382040767963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334337629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520767,0.0022112534,0.000029510273,0.0012676873,0.0004946927,0.0004963443,0.00016864178,0.000052496976,0.00007169059],"genre_scores_gemma":[0.99831015,0.0007550305,0.0001054602,0.0004709279,0.0000338802,0.00004171778,0.00007163739,0.000029639694,0.00018155253],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996073,0.0022046997,0.000708298,0.0004234934,0.000117117685,0.00047339406],"domain_scores_gemma":[0.99731785,0.0012676454,0.00029627286,0.0009046981,0.00009963714,0.000113891154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011729288,0.00028816,0.0007629775,0.00016856537,0.00015634033,0.000026804128,0.0005122677,0.00012583655,0.00014149939],"category_scores_gemma":[0.0013656715,0.00019333861,0.00024293481,0.00034121925,0.00027247623,0.00015320072,0.00011592293,0.00012932677,0.00019441498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01282095,0.005720143,0.28548208,0.00022560194,0.0013636064,0.000035397054,0.0018755394,0.00026150994,0.00499187,0.00089377485,0.004213328,0.6821162],"study_design_scores_gemma":[0.004403178,0.0017458915,0.9868353,0.0010114241,0.0001732894,0.00002010357,0.00019985558,0.00002166391,0.003530019,0.0009211939,0.00082614674,0.00031190657],"about_ca_topic_score_codex":0.000249,"about_ca_topic_score_gemma":0.00026941707,"teacher_disagreement_score":0.70135325,"about_ca_system_score_codex":0.000011448384,"about_ca_system_score_gemma":0.00015804496,"threshold_uncertainty_score":0.788412},"labels":[],"label_agreement":null},{"id":"W2334724180","doi":"10.1136/annrheumdis-2012-eular.1922","title":"OP0239 What constitutes the characteristic fat lesion on MRI of the sacroiliac joints in early spondyloarthritis?","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cohort; Ankylosing spondylitis; Rheumatology; Sacroiliac joint; Sacroiliitis; BASDAI; Radiology; Internal medicine; Arthritis; Psoriatic arthritis","score_opus":0.05370105711905281,"score_gpt":0.3098613803773452,"score_spread":0.25616032325829236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334724180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840163,0.008326175,0.0000014590081,0.0061101494,0.00044838362,0.00067153113,0.00013196774,0.00001560428,0.00027841743],"genre_scores_gemma":[0.99571556,0.0025516038,0.000006922961,0.0014182403,0.0000621738,0.00003235473,0.000009790053,0.0000175053,0.00018582371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982099,0.00024291367,0.00054612785,0.00015537335,0.00051469344,0.0003310058],"domain_scores_gemma":[0.9980799,0.00046903052,0.00035133873,0.0008434266,0.000102521604,0.00015379375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031024835,0.00019864623,0.00048101105,0.00007204309,0.000121395504,0.000038106115,0.0003098446,0.00005174646,0.00016185915],"category_scores_gemma":[0.0011528132,0.00009386066,0.00038822,0.00024881255,0.0005329393,0.00034550205,0.00014831094,0.0001436662,0.000042861713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021868155,0.0064763506,0.8054364,0.0029559024,0.00064538076,0.000023221646,0.0047271224,0.000036566667,0.0020383936,0.0075927046,0.030436162,0.137445],"study_design_scores_gemma":[0.00070640433,0.00011314613,0.9836246,0.007744454,0.00018506,0.000009874549,0.0006973975,0.00001665639,0.005070119,0.0012473284,0.00046736308,0.00011760151],"about_ca_topic_score_codex":0.00011778398,"about_ca_topic_score_gemma":0.00001207815,"teacher_disagreement_score":0.17818822,"about_ca_system_score_codex":0.000013759311,"about_ca_system_score_gemma":0.00010483744,"threshold_uncertainty_score":0.38275266},"labels":[],"label_agreement":null},{"id":"W2334820410","doi":"10.1136/annrheumdis-2012-eular.486","title":"AB0486 New, provisional american college of rheumatology and european league against rheumatism remission criteria: Results from 2 randomized, controlled golimumab trials in patients with rheumatoid arthritis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Rheumatism; Rheumatoid arthritis; Rheumatology; Internal medicine; Methotrexate; Randomized controlled trial; Physical therapy; Etanercept","score_opus":0.025430768003247076,"score_gpt":0.3076862996416509,"score_spread":0.28225553163840383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334820410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872433,0.0062797945,0.00003056716,0.0012387641,0.0001786949,0.003660515,0.0009658981,0.000032644137,0.00036981475],"genre_scores_gemma":[0.9896319,0.009311394,0.0005189011,0.000131837,0.000022921433,0.000069371905,0.00015781561,0.000061047285,0.000094848736],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9904931,0.0038088656,0.0034230486,0.00045239917,0.0011884877,0.00063406694],"domain_scores_gemma":[0.9860128,0.009610062,0.0024870655,0.0009351538,0.0003692565,0.0005856279],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0053015267,0.00044059087,0.0053180815,0.0003063741,0.00009737841,0.000024885145,0.00037734705,0.00009586816,0.00009482092],"category_scores_gemma":[0.033756077,0.00024739036,0.0006033988,0.00041310352,0.0011046653,0.00025581731,0.00029427558,0.00022731042,0.000009428485],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8338134,0.0034000666,0.051115356,0.0010348203,0.003083216,0.00002589953,0.0034948965,0.0000644452,0.00007847158,0.0005853508,0.018322736,0.08498133],"study_design_scores_gemma":[0.8717106,0.00047046383,0.10727437,0.016805822,0.00025360635,0.00003429429,0.0006042515,0.0015539451,0.0002427235,0.00060952106,0.00007925419,0.00036117574],"about_ca_topic_score_codex":0.0020994393,"about_ca_topic_score_gemma":0.00003712986,"teacher_disagreement_score":0.084620155,"about_ca_system_score_codex":0.00027549465,"about_ca_system_score_gemma":0.0020907444,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W2334991599","doi":"10.1136/annrheumdis-2013-eular.2012","title":"SAT0287 Long-Term Safety Of Ustekinumab: 5 Years of Follow-Up from the Psoriasis Clinical Development Program Including Patients with Psoriatic Arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Discontinuation; Adverse effect; Psoriasis; Population; Internal medicine; Dermatology; Rheumatoid arthritis","score_opus":0.043655645000211914,"score_gpt":0.29381732660925947,"score_spread":0.25016168160904756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334991599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438775,0.0035243202,0.000009910138,0.00010380644,0.0006234257,0.001066213,0.00023608904,0.00002386508,0.000024652598],"genre_scores_gemma":[0.99848264,0.0009024664,0.00018745588,0.000044631674,0.000016042017,0.00011526499,0.00017255568,0.000019829627,0.000059106787],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99785066,0.00045996477,0.0010014392,0.00023993842,0.00017158671,0.00027641325],"domain_scores_gemma":[0.9972838,0.0010047216,0.00082705385,0.00060583354,0.00023484348,0.000043731154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026922234,0.00021884475,0.0006658479,0.000047365203,0.00013953535,0.000013022967,0.0005260679,0.00011930789,0.000328811],"category_scores_gemma":[0.00044200744,0.0001245999,0.00033292975,0.00018390085,0.0003719202,0.00010972856,0.00020641884,0.000088464585,0.000046508136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003383325,0.00087362755,0.3901808,0.000056161705,0.0015546757,2.8442005e-7,0.0006112247,0.0000015688072,0.000011114403,0.000020151532,0.00049896055,0.6058531],"study_design_scores_gemma":[0.0034271723,0.00026993066,0.99294764,0.0011605232,0.00038027685,5.431277e-7,0.00016474734,0.00000104497,0.0011747195,0.00021570185,0.00011484427,0.0001428771],"about_ca_topic_score_codex":0.00024860975,"about_ca_topic_score_gemma":0.00008116103,"teacher_disagreement_score":0.6057102,"about_ca_system_score_codex":0.0000130898725,"about_ca_system_score_gemma":0.00014291672,"threshold_uncertainty_score":0.5081036},"labels":[],"label_agreement":null},{"id":"W2335050608","doi":"10.1136/annrheumdis-2014-eular.2540","title":"OP0277 Effect of Disease Modifying Drugs on Bone Mineral Density in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis: A Meta-Analysis","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Centre hospitalier universitaire de Québec; Memorial University of Newfoundland; Western University; University of Toronto; SKiN Health; University of British Columbia; Hôpital du Sacré-Cœur de Montréal; Lynde Centre for Dermatology; University of Alberta; Université de Montréal; Hôpital Notre-Dame; Université Laval; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Ankylosing spondylitis; Bone mineral; Internal medicine; Psoriasis; Osteoporosis; Placebo; Arthritis; Gastroenterology; Dermatology; Pathology","score_opus":0.018643060987876162,"score_gpt":0.2609789950036147,"score_spread":0.24233593401573855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335050608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336565,0.014543197,0.000016798447,0.0004987289,0.000046038236,0.0009104051,0.0005550526,0.000031641393,0.000032502274],"genre_scores_gemma":[0.9977099,0.0015741796,0.000095609634,0.00032606832,0.000015792672,0.00007413411,0.00015428581,0.000036180852,0.00001388918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965457,0.00066673034,0.0009566531,0.00048675487,0.0009356671,0.0004084942],"domain_scores_gemma":[0.9970725,0.00075040624,0.00059633487,0.0009212127,0.00021217561,0.00044733062],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000622393,0.00043065666,0.0024167858,0.0004188179,0.0001112795,0.00004198931,0.00015266606,0.000061016755,0.000101167076],"category_scores_gemma":[0.001458405,0.0002710954,0.0011623309,0.0006654454,0.00028509364,0.00021237698,0.00010177107,0.00014058549,0.0000027214128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016843896,0.004480246,0.83677113,0.004630991,0.048891492,0.000039767605,0.00070235593,0.00092970213,0.00001349716,0.0009901029,0.00087124156,0.0848356],"study_design_scores_gemma":[0.007473017,0.0011678284,0.95192635,0.0030776565,0.03365754,0.0000033633528,0.00006342937,0.00075376144,0.00036049855,0.0011040056,0.000016397627,0.00039617674],"about_ca_topic_score_codex":0.00022690215,"about_ca_topic_score_gemma":0.00003359171,"teacher_disagreement_score":0.11515522,"about_ca_system_score_codex":0.000018122277,"about_ca_system_score_gemma":0.00008745415,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W2335092371","doi":"10.1136/annrheumdis-2014-eular.2300","title":"THU0219 Prevalence of Joint Pain and Self-Reported Osteoarthritis in British Columbia, Canada","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Osteoarthritis; Ankle; Physical therapy; Population; Foot (prosody); Knee pain; Family medicine; Demography; Alternative medicine; Surgery; Environmental health","score_opus":0.021888440767316338,"score_gpt":0.24059561519370962,"score_spread":0.21870717442639329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335092371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965796,0.0014359882,0.0000023241587,0.0015299596,0.000040873678,0.0002095496,0.000030411291,0.000007298538,0.00016400524],"genre_scores_gemma":[0.9983977,0.00059397885,0.000033993856,0.00078118214,0.000008418654,0.0000080434575,0.0000020281173,0.0000018521087,0.00017280271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883395,0.00017774676,0.00036560165,0.00013233359,0.00034508997,0.00014528567],"domain_scores_gemma":[0.9991883,0.00027909703,0.0001638671,0.00015424137,0.000061130224,0.00015335172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006850156,0.000047468646,0.00026986812,0.0000086137115,0.000032269538,0.000012331593,0.00011077484,0.00002598313,0.00022366381],"category_scores_gemma":[0.0037722397,0.00003641831,0.000051294614,0.00012676176,0.00022386097,0.000024640978,0.000057301495,0.00004307931,1.9933208e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059014087,0.00022272153,0.7882093,0.001146816,0.000023676339,0.0000069522252,0.000025151778,5.335471e-7,0.000030749463,0.000009312959,0.0028278013,0.20749104],"study_design_scores_gemma":[0.00028064084,0.00028652584,0.9955882,0.0019887867,0.000029067145,0.000011719122,0.000059306774,0.00019931163,0.00004250614,0.0013226296,0.0001434856,0.000047856687],"about_ca_topic_score_codex":0.42836082,"about_ca_topic_score_gemma":0.49040854,"teacher_disagreement_score":0.2074432,"about_ca_system_score_codex":0.000005286488,"about_ca_system_score_gemma":0.00018137353,"threshold_uncertainty_score":0.5754458},"labels":[],"label_agreement":null},{"id":"W2335453945","doi":"10.1136/annrheumdis-2012-eular.1205","title":"AB1207 Increasing quality of JIA treatment: The pediatric rheumatology care and outcomes improvement network (PR-COIN)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Quality management; Coaching; Multidisciplinary approach; Quality (philosophy); Health care; Medical education; Management system; Operations management","score_opus":0.1190212476026718,"score_gpt":0.453857747950262,"score_spread":0.3348365003475902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335453945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970266,0.02537386,0.0000073356478,0.002128693,0.0006502599,0.0011394221,0.00018246863,0.000030086972,0.00022190069],"genre_scores_gemma":[0.99228835,0.0067756386,0.000048109137,0.00052431884,0.00018554952,0.00007380113,0.00001725444,0.000021879569,0.00006507596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958731,0.001711334,0.0012016776,0.00017766554,0.00033954202,0.0006966792],"domain_scores_gemma":[0.9944236,0.0033103419,0.001169028,0.000641814,0.000205803,0.00024937987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001177765,0.00024199263,0.0007425117,0.00005671236,0.0007070198,0.0000059686895,0.00029783678,0.00012987088,0.00008005423],"category_scores_gemma":[0.001088076,0.00012419431,0.00026327072,0.00024183773,0.00014148686,0.00011734837,0.00023900506,0.00019251152,0.000013452691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009683514,0.00014988254,0.9751344,0.0029741488,0.000095520154,8.392541e-8,0.005635855,0.0000040957866,3.9796106e-7,0.0012853277,0.0018536483,0.012769826],"study_design_scores_gemma":[0.0006715643,0.000091639806,0.9910948,0.00032355648,0.00020480904,6.9049696e-7,0.00636517,0.00001019737,0.0000031292207,0.00087091926,0.00023541128,0.00012808248],"about_ca_topic_score_codex":0.003463328,"about_ca_topic_score_gemma":0.00012955,"teacher_disagreement_score":0.0220224,"about_ca_system_score_codex":0.00004567733,"about_ca_system_score_gemma":0.00035265627,"threshold_uncertainty_score":0.5437896},"labels":[],"label_agreement":null},{"id":"W2335457996","doi":"10.1136/annrheumdis-2014-eular.5680","title":"AB0857 Medicolegal Implications of the 2012 Canadian Fibromyalgia Guidelines","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Fibromyalgia; Adjudication; Family medicine; Psychiatry; Law","score_opus":0.06654618676439293,"score_gpt":0.35191071348839564,"score_spread":0.2853645267240027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335457996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8251918,0.006388129,0.00006576473,0.1589995,0.00038155474,0.0013347827,0.00041874478,0.000041469844,0.007178267],"genre_scores_gemma":[0.9984131,0.00017796227,0.00008852446,0.0001406057,0.00001846404,0.000029168232,0.000015157244,0.000015424106,0.0011015852],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982803,0.00013704023,0.00052616437,0.00015869345,0.000546085,0.00035175786],"domain_scores_gemma":[0.9975969,0.00024865664,0.0002115283,0.0011318175,0.0004641164,0.000346939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036258707,0.00013778999,0.00033872356,0.00009184155,0.00016733629,0.000014411628,0.00062049035,0.000062419866,0.00049848476],"category_scores_gemma":[0.0022968017,0.00007376176,0.00032779155,0.00036696048,0.00038240975,0.00008830178,0.00009458049,0.00011676071,0.000021095768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008375461,0.00053796556,0.05574257,0.013107591,0.0008608935,0.0000014338735,0.00052306167,0.00012889068,0.0009346094,0.019615691,0.84629834,0.062165197],"study_design_scores_gemma":[0.00051971315,0.0001257322,0.9860128,0.004222263,0.00016800356,0.00002334092,0.000106214415,0.0005845435,0.0012355632,0.0041220207,0.0027621475,0.00011766732],"about_ca_topic_score_codex":0.010116611,"about_ca_topic_score_gemma":0.0004738742,"teacher_disagreement_score":0.9302702,"about_ca_system_score_codex":0.000032917804,"about_ca_system_score_gemma":0.0011934427,"threshold_uncertainty_score":0.9964751},"labels":[],"label_agreement":null},{"id":"W2335487027","doi":"10.1136/annrheumdis-2014-eular.5515","title":"SAT0576 Creating New Rheumatologists: the Canadian Experience","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Manitoba; Western University; McGill University; University of Alberta; Université Laval; Dalhousie University; McMaster University","funders":"","keywords":"Medicine; Subspecialty; Accreditation; Economic shortage; Medical education; Family medicine; Thematic analysis; Curriculum; Internal medicine; Qualitative research; Psychology; Pedagogy","score_opus":0.03333809663544887,"score_gpt":0.31791788783233227,"score_spread":0.28457979119688337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335487027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689973,0.0014510192,0.000081838676,0.019198773,0.00014863735,0.0004421804,0.000007252256,0.00002637478,0.0096466495],"genre_scores_gemma":[0.9980254,0.00011211414,0.00010455376,0.0012807716,0.000020056485,0.000020542155,0.0000051674906,0.0000101685,0.00042121668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897367,0.00010503322,0.00028862694,0.00013447627,0.00028100435,0.00021721103],"domain_scores_gemma":[0.9986987,0.00031280512,0.00014146257,0.0005209569,0.00009565679,0.00023039205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019151423,0.00010988487,0.00022983638,0.000042287662,0.00027461164,0.000027935384,0.00024356623,0.00003775391,0.0001428317],"category_scores_gemma":[0.003065103,0.00005309682,0.00021530269,0.00018103833,0.0002956177,0.00005929486,0.00003766199,0.00006905569,0.000017440723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012268289,0.00044379293,0.4583636,0.0019420608,0.00033601685,0.0000014597804,0.013607002,0.00029081752,0.000046326277,0.06819609,0.060354378,0.3962958],"study_design_scores_gemma":[0.00038811786,0.00011626144,0.97787905,0.0010194652,0.00006451474,0.0000053569133,0.0018672097,0.0011032391,0.000069788824,0.014096325,0.003271487,0.0001192092],"about_ca_topic_score_codex":0.073050335,"about_ca_topic_score_gemma":0.011305742,"teacher_disagreement_score":0.51951545,"about_ca_system_score_codex":0.000016362834,"about_ca_system_score_gemma":0.00028175302,"threshold_uncertainty_score":0.9331223},"labels":[],"label_agreement":null},{"id":"W2335579102","doi":"10.1136/annrheumdis-2015-208642","title":"Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group","year":2016,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":528,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliitis; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine","score_opus":0.0636124992782591,"score_gpt":0.3553155276802312,"score_spread":0.29170302840197215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335579102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046587177,0.99182326,0.000033444852,0.0009092474,0.00037164413,0.0022085668,0.0036589182,0.000026606294,0.0005024453],"genre_scores_gemma":[0.009926574,0.98840773,0.000052385316,0.0001136839,0.00008255641,0.0007181131,0.00042332918,0.0000715054,0.00020410397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974915,0.00023852604,0.00095008226,0.00042365183,0.0005042642,0.00039200633],"domain_scores_gemma":[0.9961316,0.0014004614,0.0013402494,0.00085632224,0.00016046334,0.000110932095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026519696,0.00046426742,0.001808313,0.000105964646,0.0002776009,0.000026309739,0.00040282213,0.00014488221,0.0000773883],"category_scores_gemma":[0.000598334,0.00023256289,0.0012938115,0.0002528112,0.00034037346,0.000068670386,0.00012974866,0.00015191975,0.000032370306],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002746349,0.00037855707,0.00003884246,0.004036485,0.0014002015,0.0000025436289,0.00005571826,1.3382979e-7,4.4184128e-7,0.0030025223,0.0114826895,0.9793272],"study_design_scores_gemma":[0.0022086727,0.00063838396,0.0010837351,0.17234674,0.002749714,0.000028278297,0.00016899232,0.0000047298076,0.000024323364,0.0013729457,0.81903327,0.00034021502],"about_ca_topic_score_codex":0.00001943548,"about_ca_topic_score_gemma":0.000009588997,"teacher_disagreement_score":0.97898704,"about_ca_system_score_codex":0.00005983974,"about_ca_system_score_gemma":0.00016507294,"threshold_uncertainty_score":0.9483639},"labels":[],"label_agreement":null},{"id":"W2335590421","doi":"10.1136/annrheumdis-2012-eular.3231","title":"SAT0284 Disease activity in patients with ankylosing spondylitis considered candidates for anti-TNF therapy: How often and when should it be assessed?","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; BASDAI; Ankylosing spondylitis; Internal medicine; Adalimumab; Cohort; Refractory (planetary science); Disease; Rheumatology; Etanercept; Spondylitis; Tumor necrosis factor alpha; Cohort study; Physical therapy; Surgery; Psoriatic arthritis","score_opus":0.07540559291683671,"score_gpt":0.3176360019378006,"score_spread":0.2422304090209639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335590421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818632,0.0053350884,0.0000043633927,0.009576783,0.00006932822,0.0012147811,0.001886267,0.000017491144,0.000032699736],"genre_scores_gemma":[0.9978767,0.00080546294,0.00008614811,0.00088943477,0.00002029411,0.000104813684,0.00012709835,0.00002862656,0.000061397775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878556,0.00008149561,0.00020414776,0.000215871,0.00032572323,0.0003871901],"domain_scores_gemma":[0.9987359,0.00032647618,0.00018847316,0.00035343878,0.00013621962,0.00025950294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012170206,0.00023192109,0.0005250318,0.00007376326,0.00014006777,0.000038095954,0.00007659298,0.00003591343,0.000054813576],"category_scores_gemma":[0.00038278388,0.00014086884,0.00012959182,0.00010771037,0.00020092548,0.00029903007,0.000066801804,0.000055501423,4.4380587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021430193,0.0015429207,0.9785123,0.00035644346,0.0004426224,0.0000040983964,0.00041185957,5.9786254e-7,0.0000076537945,0.000046614485,0.0028065853,0.013725319],"study_design_scores_gemma":[0.0054397434,0.00035329498,0.9910872,0.0010753389,0.00026124265,0.0000017315788,0.00023240065,0.000022556496,0.00027843876,0.0003434012,0.0007470797,0.00015760232],"about_ca_topic_score_codex":0.00015806338,"about_ca_topic_score_gemma":0.00003977518,"teacher_disagreement_score":0.016013525,"about_ca_system_score_codex":0.000021964703,"about_ca_system_score_gemma":0.00008638293,"threshold_uncertainty_score":0.57444644},"labels":[],"label_agreement":null},{"id":"W2335723138","doi":"10.1136/annrheumdis-2014-eular.3755","title":"FRI0154 The Spondyloarthritis Research Consortium of Canada MRI Sacroiliac Joint Structural Score: Reliable Detection of Structural Progression Even over One Year","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosis; Sacroiliac joint; Radiography; SSS*; Radiology; Axial spondyloarthritis; Nuclear medicine; Magnetic resonance imaging; Physical therapy; Orthodontics; Internal medicine; Sacroiliitis","score_opus":0.04352392732875473,"score_gpt":0.32456813852956873,"score_spread":0.281044211200814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335723138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938054,0.003821894,0.0000013707929,0.0010172968,0.00024295395,0.00068097917,0.00019870786,0.000009438847,0.00022195218],"genre_scores_gemma":[0.999308,0.0003541744,0.000050070976,0.000050902396,0.000038855484,0.000028284458,0.000013467811,0.00001778905,0.00013847392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767905,0.00020925367,0.0005445377,0.00019781163,0.001020581,0.0003487489],"domain_scores_gemma":[0.9981915,0.00023528538,0.00037147704,0.00061388186,0.0004697723,0.00011813717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003374936,0.00015870671,0.00051446166,0.00006601543,0.0002669215,0.000011261578,0.00019362675,0.000045009598,0.0001524506],"category_scores_gemma":[0.0008634274,0.00008980899,0.00018397071,0.00028882702,0.0004921194,0.00006759891,0.00016487611,0.00014963497,0.0000013345137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006631201,0.0011960473,0.7351963,0.0065761977,0.0035383357,0.000031542328,0.0025634516,0.00033784853,0.014436922,0.004107821,0.03232037,0.19306397],"study_design_scores_gemma":[0.0019419164,0.0006709971,0.9482522,0.0028658914,0.0001552735,0.000013794229,0.00048386812,0.0003207898,0.041921947,0.0030403598,0.00021425103,0.00011871653],"about_ca_topic_score_codex":0.038916104,"about_ca_topic_score_gemma":0.0141725065,"teacher_disagreement_score":0.2130559,"about_ca_system_score_codex":0.000044272667,"about_ca_system_score_gemma":0.0002973628,"threshold_uncertainty_score":0.9674838},"labels":[],"label_agreement":null},{"id":"W2336136362","doi":"10.1136/annrheumdis-2015-209068","title":"Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; BASDAI; Ustekinumab; Dactylitis; Psoriatic arthritis; Ankylosing spondylitis; Enthesitis; Spondylitis; Placebo; Internal medicine; Post-hoc analysis; Arthritis; Psoriasis; Gastroenterology; Adalimumab; Dermatology; Rheumatoid arthritis; Pathology","score_opus":0.04667483071468284,"score_gpt":0.3528422889791418,"score_spread":0.306167458264459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336136362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9376525,0.05808217,0.000004632236,0.0005248299,0.0001151485,0.0026272298,0.0009226744,0.000027996964,0.0000427974],"genre_scores_gemma":[0.9738698,0.025512224,0.00010274727,0.00012944416,0.000038912316,0.00016276815,0.00009394305,0.000036983376,0.000053188833],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99697435,0.00018979094,0.001249482,0.00052187504,0.00061612466,0.00044837806],"domain_scores_gemma":[0.9969264,0.00090126507,0.0008632562,0.00056355016,0.0005290367,0.00021645156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016341549,0.00047491636,0.0019857322,0.00017754553,0.00017148264,0.000028882901,0.0001281931,0.00005913318,0.00008179045],"category_scores_gemma":[0.00063393835,0.00026497795,0.00027600164,0.0002946353,0.00059107755,0.00027509712,0.00014760987,0.0000887435,0.0000019340594],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37405494,0.0048402455,0.07144856,0.0003376673,0.010638439,0.00012863886,0.0023052257,0.000019044259,0.00009255163,0.0000625545,0.00015378455,0.53591835],"study_design_scores_gemma":[0.7224194,0.0020820377,0.25485578,0.01508979,0.0019214897,0.000008060672,0.0024536226,0.000054704084,0.00042452777,0.00026435492,0.000029725528,0.00039654027],"about_ca_topic_score_codex":0.0005564426,"about_ca_topic_score_gemma":0.000864103,"teacher_disagreement_score":0.5355218,"about_ca_system_score_codex":0.000045829896,"about_ca_system_score_gemma":0.00009978386,"threshold_uncertainty_score":0.9999803},"labels":[],"label_agreement":null},{"id":"W2336227340","doi":"10.1136/annrheumdis-2015-eular.6285","title":"OP0144 The Effect of TNF Inhibition on Radiographic Progression in Ankylosing Spondylitis: An Observational Cohort Study of 384 Patients","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Cohort; Internal medicine; Propensity score matching; BASDAI; Observational study; Ankylosing spondylitis; Cohort study; Rheumatology; Logistic regression; Univariate analysis; Surgery; Disease; Multivariate analysis; Psoriatic arthritis","score_opus":0.0715999351272921,"score_gpt":0.3573252753169703,"score_spread":0.2857253401896782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336227340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672353,0.00091055856,2.2276171e-7,0.00018034512,0.00008515055,0.0018890963,0.00013369533,0.000008825414,0.00006856991],"genre_scores_gemma":[0.99960715,0.00007873644,0.00000967835,0.000039850707,0.000010501358,0.00012307415,0.00011475339,0.0000115400335,0.0000046934374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815404,0.00035432464,0.00047475492,0.00016281036,0.00071404484,0.00014000978],"domain_scores_gemma":[0.99875456,0.00022577951,0.00034568622,0.00038369757,0.00021403767,0.000076251476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043707865,0.0001437233,0.0004571693,0.00011829128,0.000064147105,0.0000063260786,0.00010058622,0.000027986924,0.000012235588],"category_scores_gemma":[0.00057041,0.000074756324,0.00013652963,0.00037370098,0.0001390057,0.00009903878,0.000057865564,0.00005647679,6.2518745e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013489452,0.0034209976,0.9847647,0.0001875064,0.00022142583,0.0000034381737,0.00062292954,0.000039979794,0.0000044869057,0.000042496544,0.00019652036,0.009146583],"study_design_scores_gemma":[0.0047770385,0.0060836663,0.98501056,0.0025012663,0.00021581857,0.0000012033215,0.00048300333,0.000055109416,0.00050585653,0.00030587555,0.0000040494356,0.00005654044],"about_ca_topic_score_codex":0.00020800924,"about_ca_topic_score_gemma":0.000027694412,"teacher_disagreement_score":0.009090043,"about_ca_system_score_codex":0.000018238015,"about_ca_system_score_gemma":0.000043157,"threshold_uncertainty_score":0.30484745},"labels":[],"label_agreement":null},{"id":"W2337006501","doi":"10.1136/annrheumdis-2015-eular.3489","title":"OP0175 Two-Year Clinical Response to Brodalumab, An Anti-IL-17 Receptor Antibody, in Patients with Psoriatic Arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Psoriasis; Rheumatology; Psoriasis Area and Severity Index; Placebo; Rheumatoid arthritis; Immunology; Gastroenterology; Pathology","score_opus":0.04251572921150886,"score_gpt":0.3289120101862254,"score_spread":0.28639628097471653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337006501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966221,0.0008755511,0.000003354612,0.0007214892,0.0006628763,0.00058467925,0.00043087205,0.00003674333,0.00006232586],"genre_scores_gemma":[0.9989017,0.00022316973,0.00012672483,0.00023818371,0.00002306758,0.00003104653,0.00017899141,0.000024791305,0.00025232797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971351,0.0013785948,0.0006276002,0.0003452478,0.00014336722,0.00037006842],"domain_scores_gemma":[0.9982557,0.00038105302,0.00027390604,0.0007421501,0.00020035163,0.00014681298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082809525,0.00023617834,0.0006044918,0.0001349144,0.000092338654,0.000021527449,0.00045039138,0.00011041189,0.00016307343],"category_scores_gemma":[0.0011745176,0.00014377556,0.00016793291,0.00028751115,0.00020424667,0.00017765348,0.00012455051,0.00010065407,0.00026400745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01288026,0.003788835,0.8465822,0.00004026509,0.0006416879,0.0000047516314,0.0009543398,0.00006898673,0.00016906748,0.00011744431,0.014296155,0.12045603],"study_design_scores_gemma":[0.007252395,0.0015944785,0.9881339,0.0005767342,0.00010633993,0.0000016051424,0.0003603738,0.000002079407,0.00053479424,0.00023401939,0.0009650005,0.0002382437],"about_ca_topic_score_codex":0.0001162781,"about_ca_topic_score_gemma":0.00004352188,"teacher_disagreement_score":0.14155176,"about_ca_system_score_codex":0.000020154486,"about_ca_system_score_gemma":0.00020159999,"threshold_uncertainty_score":0.5862997},"labels":[],"label_agreement":null},{"id":"W2337142758","doi":"10.1136/annrheumdis-2015-eular.3155","title":"FRI0132 Long Term Safety of Intravenous Golimumab and Comparison with Subcutaneous Golimumab in Rheumatoid Arthritis: Results Through 2 Years","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Internal medicine; Population; Incidence (geometry); Adalimumab","score_opus":0.04562457894680351,"score_gpt":0.32324592043897116,"score_spread":0.27762134149216766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337142758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863996,0.011243781,0.000018147777,0.00056204514,0.00006001868,0.0007756641,0.00012233558,0.000030666644,0.0007877752],"genre_scores_gemma":[0.9935535,0.0060613994,0.00013849273,0.00007712527,0.00001596443,0.00001800722,0.000031646476,0.00003709097,0.000066740075],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99712366,0.0001849436,0.0009856616,0.00032695793,0.0009121686,0.00046659372],"domain_scores_gemma":[0.99778694,0.00043410846,0.00041841666,0.00083599536,0.00024317873,0.00028137848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043025007,0.00024034794,0.0009268465,0.000121486715,0.000044052125,0.0000253478,0.00033209738,0.00008984982,0.000020648376],"category_scores_gemma":[0.00087464735,0.00016818462,0.000119614924,0.0003880591,0.00064525125,0.00014635907,0.0002160428,0.00020033034,0.000009913884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12287252,0.013404211,0.16685091,0.012507805,0.0040795286,0.00368785,0.090284474,0.006327366,0.00016741008,0.0026083,0.019170161,0.5580395],"study_design_scores_gemma":[0.15091646,0.008046629,0.7539897,0.04950249,0.0004431991,0.0052251364,0.010342639,0.009665462,0.004740637,0.005083202,0.0005722367,0.001472245],"about_ca_topic_score_codex":0.0015118595,"about_ca_topic_score_gemma":0.0003190531,"teacher_disagreement_score":0.5871388,"about_ca_system_score_codex":0.00056730356,"about_ca_system_score_gemma":0.0027082341,"threshold_uncertainty_score":0.685837},"labels":[],"label_agreement":null},{"id":"W2337852073","doi":"10.1136/annrheumdis-2015-208982","title":"2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children; University of Calgary","funders":"","keywords":"Macrophage activation syndrome; Medicine; Consensus conference; Arthritis; Internal medicine","score_opus":0.06945819423854739,"score_gpt":0.34722946173895014,"score_spread":0.27777126750040276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337852073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507345,0.0040068324,0.0023888652,0.0067678103,0.00009405234,0.0013067356,0.000113662085,0.00006157681,0.00018701698],"genre_scores_gemma":[0.99801123,0.00080563687,0.0000506905,0.00013824675,0.000022591366,0.0002743862,0.000017617762,0.00002590262,0.0006536751],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984391,0.00013011578,0.00067004934,0.00020064808,0.0003118449,0.00024825058],"domain_scores_gemma":[0.9983472,0.00023067994,0.00042917533,0.00060739793,0.000294981,0.00009052474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044288763,0.00013064631,0.00044858005,0.00008120834,0.00015826285,0.000021700534,0.00023507836,0.00005834878,0.00011042311],"category_scores_gemma":[0.0013168533,0.00007532264,0.00022006436,0.00013927533,0.00013065085,0.00019996731,0.000062158855,0.000053866555,0.000049249527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000671071,0.0008137604,0.007858084,0.007767144,0.00040929465,0.0000057379225,0.00053806236,0.000005030237,0.29896468,0.0033879762,0.026070727,0.6535084],"study_design_scores_gemma":[0.00721913,0.0010575566,0.85212964,0.070675455,0.00024315779,0.00026361615,0.0015159519,0.0030343574,0.048993707,0.011708876,0.002465327,0.00069319597],"about_ca_topic_score_codex":0.000016129687,"about_ca_topic_score_gemma":3.8429596e-7,"teacher_disagreement_score":0.8442716,"about_ca_system_score_codex":0.000037439004,"about_ca_system_score_gemma":0.00021801086,"threshold_uncertainty_score":0.3071568},"labels":[],"label_agreement":null},{"id":"W2338311228","doi":"10.1136/annrheumdis-2015-eular.2291","title":"OP0251 Effects of 2 Years of Treatment with Romosozumab Followed by 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bone mineral; Femoral neck; Denosumab; Sclerostin; Placebo; Postmenopausal women; Urology; Osteoporosis; Lumbar spine; Internal medicine; Surgery; Chemistry","score_opus":0.027252637847661573,"score_gpt":0.3156595177510587,"score_spread":0.28840687990339714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338311228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766123,0.00086286356,0.0000028868362,0.00017514422,0.000024895064,0.001064053,0.000102407794,0.000008677352,0.00009783922],"genre_scores_gemma":[0.9991246,0.00015669533,0.0001701988,0.000028975986,0.000006751432,0.00007825007,0.000010959739,0.0000291763,0.00039437631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981446,0.0001749903,0.00042584835,0.00018985191,0.0007599926,0.00030469283],"domain_scores_gemma":[0.9982956,0.00034789482,0.00030960492,0.00057413196,0.00023764516,0.00023512998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025786107,0.00017760716,0.00083386,0.00012292856,0.000011596203,0.0000047529297,0.0001931191,0.000046226163,0.00004253643],"category_scores_gemma":[0.00049004715,0.000100558325,0.000070229034,0.0003543076,0.00030609846,0.00005786986,0.00006961646,0.00006789127,0.000002291708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24334499,0.027084047,0.5470708,0.028230026,0.00783205,0.00083330064,0.025085213,0.00081550126,0.029925676,0.00015331853,0.030617135,0.059007917],"study_design_scores_gemma":[0.079306245,0.104222566,0.5691597,0.025153046,0.0014789209,0.0001270909,0.0048446697,0.0004313224,0.21369767,0.00048651465,0.00018225583,0.0009100307],"about_ca_topic_score_codex":0.0009954973,"about_ca_topic_score_gemma":0.000097130694,"teacher_disagreement_score":0.183772,"about_ca_system_score_codex":0.00015771191,"about_ca_system_score_gemma":0.0011820538,"threshold_uncertainty_score":0.41006494},"labels":[],"label_agreement":null},{"id":"W2339340768","doi":"10.1136/annrheumdis-2015-eular.2920","title":"SAT0563 Long Term Improvements in Physical Function are Associated with Improvements in Dactylitis, Enthesitis, Tender and Swollen Joint Counts, and Psoriasis Skin Involvement: Results from a Phase 3 Study of Ustekinumab in Psoriatic Arthritis Patients","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Dactylitis; Medicine; Enthesitis; Ustekinumab; Psoriasis; Internal medicine; Psoriatic arthritis; Physical therapy; Dermatology; Rheumatoid arthritis; Adalimumab","score_opus":0.039294410734568005,"score_gpt":0.29348542851993625,"score_spread":0.25419101778536823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339340768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961096,0.0019896904,0.0000010400908,0.00006101478,0.0000615603,0.001300016,0.00044546658,0.000007967461,0.00002364748],"genre_scores_gemma":[0.99739957,0.0023210456,0.000005572218,0.000041435786,0.000011985118,0.00006487375,0.00012574323,0.0000184125,0.00001137056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979024,0.00024552245,0.00063765596,0.00029082576,0.00065871724,0.00026487134],"domain_scores_gemma":[0.9989167,0.00014391572,0.00037244396,0.000279929,0.00014436775,0.00014265811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034132617,0.00018946335,0.00059146975,0.00020671377,0.000031353266,0.000028423374,0.00009148776,0.000040102725,0.000012284609],"category_scores_gemma":[0.000665347,0.00013823004,0.000045532914,0.00024247362,0.00010425636,0.0001983033,0.00009769945,0.00011776484,8.2949447e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027398814,0.011940592,0.80538636,0.00022133299,0.00050024944,0.000020063855,0.005951728,0.000005652117,0.000020540463,0.0000076136744,0.0002410831,0.17296489],"study_design_scores_gemma":[0.03616593,0.0018803492,0.9534176,0.0043654055,0.000031124797,3.993009e-7,0.0031535935,0.00021333892,0.000114509836,0.00052949175,0.0000031224984,0.00012514241],"about_ca_topic_score_codex":0.0021403998,"about_ca_topic_score_gemma":0.0018389411,"teacher_disagreement_score":0.17283975,"about_ca_system_score_codex":0.00006244857,"about_ca_system_score_gemma":0.00010142156,"threshold_uncertainty_score":0.5636857},"labels":[],"label_agreement":null},{"id":"W2340621084","doi":"10.1136/annrheumdis-2015-eular.1791","title":"OP0171 Achievement of Remission of Inflammation in the Spine and Sacroiliac Joints Measured by Magnetic Resonance Imaging (MRI) in Patients with Axial Spondyloarthritis, and Associations Between MRI and Clinical Remission, Over 96 Weeks of Treatment with Certolizumab Pegol","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Certolizumab pegol; Ankylosing spondylitis; Magnetic resonance imaging; Spondylarthritis; Randomized controlled trial; Nuclear medicine; Internal medicine; Etanercept; Radiology; Rheumatoid arthritis; Sacroiliitis","score_opus":0.026429998007884554,"score_gpt":0.2993132763316091,"score_spread":0.27288327832372455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340621084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034995,0.007104521,0.0000015982702,0.0014640751,0.000012629713,0.0007869576,0.00024476505,0.0000029590162,0.000032528093],"genre_scores_gemma":[0.99677145,0.0030116034,0.000112530965,0.000010168706,0.000006885381,0.000017010332,0.000049339345,0.00001016605,0.000010829183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983526,0.00018756575,0.0006761837,0.00019213352,0.0004471884,0.0001443135],"domain_scores_gemma":[0.9988469,0.00014218487,0.00047315456,0.00025122316,0.00018986866,0.00009665145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021293097,0.00015825428,0.0005955737,0.00007130136,0.000045120814,0.000006979817,0.00006105944,0.000037338832,0.0000038346234],"category_scores_gemma":[0.00031281865,0.000086040716,0.000048986534,0.00016609885,0.00021777571,0.00008352807,0.000055608918,0.00005705223,5.2731046e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061965146,0.00067593995,0.94831634,0.000111190675,0.00007867194,0.0000034799398,0.00070806785,9.368712e-7,0.000016432492,0.0000059294975,0.00013440539,0.049328946],"study_design_scores_gemma":[0.011211608,0.0023793767,0.9826295,0.0027822752,0.00021662455,0.0000034438426,0.000301578,0.00004388844,0.00019058755,0.00012447419,0.00004255233,0.000074098665],"about_ca_topic_score_codex":0.00044671659,"about_ca_topic_score_gemma":0.00011681305,"teacher_disagreement_score":0.049254846,"about_ca_system_score_codex":0.000035175286,"about_ca_system_score_gemma":0.00009281576,"threshold_uncertainty_score":0.35086387},"labels":[],"label_agreement":null},{"id":"W2340731655","doi":"10.1136/annrheumdis-2015-eular.6461","title":"THU0428 Validation of the Toronto Psoriatic Arthritis Screen II (Topas II) Questionnaire in a Turkish Population","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Rheumatology; Turkish population; Internal medicine; Turkish; Psoriasis; Population; Receiver operating characteristic; Physical therapy; Arthritis; Dermatology","score_opus":0.03497849232083143,"score_gpt":0.30684388470037716,"score_spread":0.2718653923795457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340731655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984296,0.012298169,0.0000025585655,0.0022313623,0.00023761722,0.0005820816,0.00006415256,0.00001657295,0.0002714867],"genre_scores_gemma":[0.9988227,0.000781516,0.00003652457,0.0001240661,0.000033581164,0.000038977105,0.000029306862,0.000011697385,0.00012165281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870485,0.00011738751,0.00044688612,0.00013620152,0.00044159213,0.00015310243],"domain_scores_gemma":[0.9990048,0.000032693155,0.00028835033,0.00041559467,0.00017846066,0.00008009426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018153239,0.00012920432,0.00035409236,0.000031181455,0.00013910279,0.000007687583,0.00013226103,0.000038310656,0.00003625217],"category_scores_gemma":[0.0008862381,0.00007795119,0.00017647755,0.0001721112,0.000077488796,0.00016101166,0.00014741223,0.000036590416,0.0000015917511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005513805,0.0026413647,0.83940214,0.00049352396,0.00053736096,0.000005963891,0.006051228,0.00027471248,0.000020438143,0.0024456799,0.0065301447,0.14104606],"study_design_scores_gemma":[0.0023810298,0.00036301182,0.9850476,0.004845538,0.00015706377,0.000007062661,0.00051325886,0.00013068166,0.00034284912,0.006011252,0.000109296685,0.00009135524],"about_ca_topic_score_codex":0.005019192,"about_ca_topic_score_gemma":0.0029133372,"teacher_disagreement_score":0.14564545,"about_ca_system_score_codex":0.00005148508,"about_ca_system_score_gemma":0.00007960294,"threshold_uncertainty_score":0.758755},"labels":[],"label_agreement":null},{"id":"W2342059615","doi":"10.1136/annrheumdis-2015-eular.5334","title":"SAT0570 Joint Damage is Not Associated with Smoking Status in Patients with Psoriatic Arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Rheumatoid factor; Cohort; Psoriasis; Arthritis; Surgery; Dermatology","score_opus":0.04352300452716712,"score_gpt":0.27072156844510403,"score_spread":0.2271985639179369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342059615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687284,0.001177463,0.0000011132412,0.0006792203,0.000072685405,0.0005928243,0.0002278785,0.000024464165,0.00035153108],"genre_scores_gemma":[0.99895394,0.0002809895,0.000040481915,0.00052643847,0.000008007928,0.00003786016,0.000054630593,0.000026784437,0.00007089297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831206,0.000075314834,0.0003556946,0.000201205,0.00069362065,0.00036211903],"domain_scores_gemma":[0.99875677,0.00008116139,0.00028086506,0.0003836821,0.00028787006,0.0002096435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011663604,0.00020062912,0.0005464818,0.000080271966,0.00007107265,0.000019627956,0.00008297047,0.000033271906,0.000057334622],"category_scores_gemma":[0.0006324514,0.00011537637,0.000094070114,0.00029818,0.00012915232,0.0001095189,0.00006895584,0.00008003934,0.0000058257065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067185226,0.0013805982,0.9780551,0.00008180987,0.0006933136,0.000024127126,0.0011638029,0.000018212158,1.9560606e-7,0.000030492956,0.0018015042,0.01607899],"study_design_scores_gemma":[0.010852388,0.0010644195,0.98263574,0.0042111017,0.00020480603,0.0000012241987,0.0005376844,0.0000252316,0.00005447751,0.00024282701,0.000035610865,0.00013451334],"about_ca_topic_score_codex":0.0003447279,"about_ca_topic_score_gemma":0.0001742552,"teacher_disagreement_score":0.015944477,"about_ca_system_score_codex":0.000064294836,"about_ca_system_score_gemma":0.00015168442,"threshold_uncertainty_score":0.47049117},"labels":[],"label_agreement":null},{"id":"W2342101480","doi":"10.1136/annrheumdis-2015-eular.3346","title":"FRI0159 Results of a Single Dose Ascending First-in-Man Trial of a Novel Biologic, Human Stress Protein Rasolvir (BIP) in Rheumatoid Arthritis (RA): The Ragulo Trial","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Placebo; Adverse effect; Internal medicine; Arthritis; Surgery; Gastroenterology; Immunology; Pathology","score_opus":0.09061393387671213,"score_gpt":0.3441725201651541,"score_spread":0.25355858628844197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342101480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938784,0.0027656085,0.0000058579835,0.00059452065,0.00011661564,0.002136177,0.000386044,0.0000070340934,0.0001097016],"genre_scores_gemma":[0.9987541,0.00080931996,0.000027389753,0.000030428215,0.000053513904,0.00019415504,0.00006854981,0.000024323997,0.000038252987],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99704576,0.0006070141,0.0011077046,0.00034481625,0.0005038,0.00039091602],"domain_scores_gemma":[0.9978702,0.00020028999,0.0006845242,0.00094567245,0.0001883209,0.00011097437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015624048,0.00023821539,0.0005795528,0.00013926195,0.00007509217,0.000022967764,0.00087401364,0.00013479586,0.000014321569],"category_scores_gemma":[0.0028540026,0.00015633728,0.00030995804,0.00031172088,0.0004469695,0.00001430018,0.00031101066,0.00013092405,0.0000011624578],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76748246,0.009350812,0.0010195446,0.00038728598,0.00042357124,0.0000049840605,0.0011537423,0.0020791357,0.20257288,0.00012650476,0.0018115359,0.013587558],"study_design_scores_gemma":[0.29130596,0.01706932,0.0016742513,0.0028875044,0.00002517043,0.0000027280205,0.0010837059,0.00025070814,0.683776,0.0011569145,0.0002894279,0.00047827707],"about_ca_topic_score_codex":0.0004596316,"about_ca_topic_score_gemma":0.0011200397,"teacher_disagreement_score":0.48120314,"about_ca_system_score_codex":0.000020305082,"about_ca_system_score_gemma":0.00025797213,"threshold_uncertainty_score":0.63752496},"labels":[],"label_agreement":null},{"id":"W2343043961","doi":"10.1136/annrheumdis-2015-eular.3653","title":"AB0573 Neutrophil-Lymphocyte Ratio is not Superior to Lymphocyte Count Alone in Differentiating Disease Activity in SLE","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Medicine; Neutrophilia; Internal medicine; Biomarker; Neutrophil to lymphocyte ratio; Lymphocyte; Immunology; Gastroenterology; Absolute neutrophil count; Disease; Neutropenia; Chemotherapy","score_opus":0.08506887076388776,"score_gpt":0.3466248620657346,"score_spread":0.26155599130184687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343043961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065167,0.0019635407,0.000022460777,0.0053732656,0.00023963385,0.0014566928,0.00014119231,0.000036418896,0.000115117444],"genre_scores_gemma":[0.9978934,0.00031922036,0.00003266335,0.000893605,0.000049435763,0.00020994214,0.00001150332,0.000049451453,0.00054077344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965479,0.00037032072,0.00077060104,0.0004428506,0.0012637937,0.00060453714],"domain_scores_gemma":[0.99727994,0.00034952263,0.00022828497,0.0010828958,0.00027715616,0.0007821774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006539234,0.00030977768,0.0008889429,0.00034451863,0.000065842476,0.000057864665,0.00046854038,0.00006925358,0.000078299345],"category_scores_gemma":[0.0022162073,0.00022208772,0.000251422,0.0007046314,0.00013201294,0.0002267456,0.0003393205,0.00013720992,0.0000718621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012643546,0.003333467,0.9357682,0.0067093894,0.0003906945,0.00020438882,0.012010649,0.0011228123,0.0034760265,0.00018019215,0.0077740056,0.01638666],"study_design_scores_gemma":[0.016833205,0.00042839872,0.920172,0.013915116,0.00022351032,0.00015408653,0.0024224992,0.026986703,0.017091548,0.0007678023,0.00025895913,0.00074620394],"about_ca_topic_score_codex":0.001360164,"about_ca_topic_score_gemma":0.000113945964,"teacher_disagreement_score":0.025863891,"about_ca_system_score_codex":0.00046551393,"about_ca_system_score_gemma":0.0013360358,"threshold_uncertainty_score":0.90564746},"labels":[],"label_agreement":null},{"id":"W2343866616","doi":"10.1136/annrheumdis-2016-209131","title":"Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":290,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; Amgen; Pfizer; Eli Lilly and Company; Genentech","keywords":"Tofacitinib; Medicine; Abatacept; Tocilizumab; Rheumatoid arthritis; Internal medicine; Concomitant; Incidence (geometry); Gastroenterology; Rituximab","score_opus":0.06727845581169782,"score_gpt":0.34744970715512274,"score_spread":0.2801712513434249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343866616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511933,0.0028125022,0.000005032515,0.00042708087,0.000027085145,0.0006182776,0.00045379568,0.000027857026,0.0005090263],"genre_scores_gemma":[0.9448401,0.05498017,0.000028976418,0.000024230165,0.0000033419446,0.00005530608,0.000017949951,0.000011807108,0.000038144666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985715,0.00019819848,0.0004723725,0.00019659619,0.00029681664,0.00026451505],"domain_scores_gemma":[0.9985613,0.00045624515,0.0002589233,0.0003199411,0.00025578594,0.00014777975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013657483,0.00017827215,0.0006023991,0.00020487516,0.00008592312,0.000013205283,0.00011394442,0.0000355227,0.00013610025],"category_scores_gemma":[0.0003360458,0.000087929424,0.00010528835,0.0003461797,0.0007356936,0.00015949215,0.00006963321,0.00005957103,0.000005885828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006042973,0.0010554907,0.93733114,0.00007958719,0.00025442484,0.0000018760695,0.00033328793,0.0000027857272,0.00014067141,0.0005946671,0.00049123523,0.05911055],"study_design_scores_gemma":[0.0038892617,0.0006552728,0.9852011,0.004923237,0.000006628034,0.0000038862318,0.00017179883,0.000007837093,0.0031041391,0.0016651818,0.00024884107,0.00012277819],"about_ca_topic_score_codex":0.0014846486,"about_ca_topic_score_gemma":0.0010438819,"teacher_disagreement_score":0.05898777,"about_ca_system_score_codex":0.000012483249,"about_ca_system_score_gemma":0.00008092499,"threshold_uncertainty_score":0.35856578},"labels":[],"label_agreement":null},{"id":"W2344059050","doi":"10.1136/annrheumdis-2015-eular.3144","title":"SAT0368 How Patients Self-Manage Rheumatoid Arthritis Flares: Findings from Catch","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Southlake Regional Health Center; University of Manitoba; Université de Montréal; Université de Sherbrooke; University of Toronto; McGill University","funders":"","keywords":"Medicine; Flare; Rheumatoid arthritis; Internal medicine; Physical therapy","score_opus":0.03169421652504243,"score_gpt":0.2771949110847775,"score_spread":0.24550069455973508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344059050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753389,0.01765021,0.000016365884,0.0048912973,0.00034373536,0.0007190986,0.00034789633,0.00013501859,0.0005574901],"genre_scores_gemma":[0.96468455,0.034222472,0.00020623021,0.00041668408,0.00003893092,0.000059200574,0.00013404507,0.000048723472,0.00018916796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971088,0.00021330036,0.00051131577,0.00035135623,0.001262234,0.0005529751],"domain_scores_gemma":[0.99741,0.00026764048,0.00023596994,0.0009097433,0.0005148487,0.00066180265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029103854,0.0003056023,0.00070071995,0.00014934837,0.00017475439,0.00012722837,0.0005170757,0.00008306652,0.00017988609],"category_scores_gemma":[0.0019602845,0.00021458213,0.00037488565,0.00033148902,0.00027112558,0.00036868668,0.00025801518,0.00018177494,0.00013454467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010013139,0.0037354613,0.46236455,0.0005820664,0.002300223,0.000051667415,0.009543078,0.000010300957,0.000076424294,0.0010545468,0.36649024,0.15279011],"study_design_scores_gemma":[0.018737243,0.0017315295,0.8539274,0.0138797,0.00009141281,0.00004009581,0.0057304245,0.0006901814,0.005151699,0.022807172,0.07593473,0.0012784244],"about_ca_topic_score_codex":0.0004709613,"about_ca_topic_score_gemma":0.000047807014,"teacher_disagreement_score":0.39156282,"about_ca_system_score_codex":0.000040318133,"about_ca_system_score_gemma":0.0002651688,"threshold_uncertainty_score":0.87504053},"labels":[],"label_agreement":null},{"id":"W2344731223","doi":"10.1136/annrheumdis-2015-eular.4726","title":"OP0209 Soluble Ephrin-B2 Ectodomain Contributes to the Pathogenesis of Systemic Sclerosis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Jewish General Hospital; Université de Montréal","funders":"","keywords":"Fibroblast; Western blot; Fibrosis; CTGF; Medicine; Immunology; Molecular biology; Bleomycin; Receptor; Pathology; Biology; Internal medicine; Cell culture; Growth factor","score_opus":0.0898431014147665,"score_gpt":0.31846838558526763,"score_spread":0.22862528417050115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344731223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861829,0.010888441,0.0002627586,0.0016345865,0.00013863243,0.00058866234,0.00021079592,0.00000723339,0.0000859556],"genre_scores_gemma":[0.99912107,0.0003524395,0.000023060857,0.00016727026,0.000029368037,0.00007407889,0.000013828696,0.000018467057,0.00020039023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848837,0.00035334396,0.00032808146,0.00021171011,0.0003485478,0.0002699669],"domain_scores_gemma":[0.99827945,0.00015182278,0.00017217774,0.0007936109,0.0004488124,0.00015412734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006186164,0.0001418991,0.00027847543,0.000049559847,0.000077627694,0.000023483984,0.00073174504,0.000050643743,0.000015614083],"category_scores_gemma":[0.002489263,0.00008609568,0.00020783165,0.00024331974,0.00015280934,0.000005057761,0.0004595054,0.00003967882,0.000015631107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012383198,0.0007988381,0.126062,0.001034697,0.0016743962,0.0000025743716,0.0009544988,0.0015833622,0.7189436,0.0016758436,0.10795167,0.038080208],"study_design_scores_gemma":[0.0016962931,0.0007179071,0.38634166,0.0019143398,0.00021848972,0.000011579266,0.0020836366,0.00015494894,0.6006337,0.0023784267,0.0033852106,0.0004638401],"about_ca_topic_score_codex":0.00016503032,"about_ca_topic_score_gemma":0.00003415111,"teacher_disagreement_score":0.26027966,"about_ca_system_score_codex":0.000012644484,"about_ca_system_score_gemma":0.0001986143,"threshold_uncertainty_score":0.351088},"labels":[],"label_agreement":null},{"id":"W2388516114","doi":"10.1136/annrheumdis-2015-208902","title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":267,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Toronto","funders":"","keywords":"Immunology; Medicine; Interleukin 17; Antigen; Ankylosing spondylitis; Priming (agriculture); Interleukin-7 receptor; Inflammation; T cell; Immune system; Biology; IL-2 receptor","score_opus":0.018775998307614058,"score_gpt":0.2535474068522607,"score_spread":0.23477140854464662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2388516114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98065114,0.0019607525,0.000045104418,0.0140747065,0.0015082215,0.0005904669,0.00052088144,0.00003723217,0.0006114886],"genre_scores_gemma":[0.99285096,0.00050047296,0.0000030479246,0.0009436884,0.000010026239,0.000043153912,0.00006927426,0.000014841921,0.0055645173],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979595,0.0007289577,0.00059545785,0.00023156503,0.00008295799,0.00040156662],"domain_scores_gemma":[0.99826664,0.00077230757,0.0002908337,0.00046650952,0.00017246867,0.000031239557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064217474,0.00018681814,0.0003730343,0.00015377442,0.00013811702,0.00002607567,0.00040995743,0.00012017406,0.0010986989],"category_scores_gemma":[0.0020155532,0.000098434975,0.00015413557,0.0004032544,0.00010682049,0.00018225411,0.00015832754,0.00016673842,0.00023813361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040578847,0.003601242,0.031719644,0.0002466345,0.0014353319,0.000012466145,0.005169081,0.00027246593,0.1975233,0.0035606963,0.7010785,0.051322803],"study_design_scores_gemma":[0.0047430014,0.00045956243,0.6801806,0.0042495998,0.0001415101,0.000018590736,0.001302972,0.00007856198,0.1715246,0.002071781,0.13461293,0.0006162644],"about_ca_topic_score_codex":0.00085964956,"about_ca_topic_score_gemma":0.0005429825,"teacher_disagreement_score":0.648461,"about_ca_system_score_codex":0.000069484406,"about_ca_system_score_gemma":0.00012176042,"threshold_uncertainty_score":0.99981445},"labels":[],"label_agreement":null},{"id":"W2395974963","doi":"10.1136/annrheumdis-2015-eular.1980","title":"SAT0061 Comparison of Outcomes Between Studies of Intensive Treatment Strategies in Early RA from a Single Centre Over 20 Years","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Synovitis; Physical therapy","score_opus":0.1772363604398987,"score_gpt":0.4114543306084037,"score_spread":0.23421797016850499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395974963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97815126,0.020031203,0.0000015550969,0.0010497791,0.000065790475,0.00036088246,0.00025960515,0.000010322155,0.0000695868],"genre_scores_gemma":[0.99809384,0.001709921,0.000055746663,0.000033581677,0.000012070971,0.00000833032,0.000021371128,0.0000124642465,0.00005269166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984483,0.00014712033,0.00058766647,0.0001347806,0.00047744522,0.00020468888],"domain_scores_gemma":[0.9981888,0.00051925634,0.0002993467,0.0003520916,0.0005108341,0.00012964991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108224696,0.00015332388,0.0010033903,0.00011103326,0.000017591075,0.000013056084,0.0001543583,0.00003297612,0.00002686701],"category_scores_gemma":[0.001086526,0.000094715404,0.00022464126,0.00014533417,0.00038634753,0.000121823534,0.00008566906,0.000055890232,0.0000043438313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037008483,0.0008981299,0.9595942,0.00013906133,0.0016416056,0.000004533991,0.017142888,0.000028992505,0.00012068579,0.0000979415,0.0022401847,0.017721713],"study_design_scores_gemma":[0.002857528,0.0008559081,0.94540846,0.0021682065,0.00006928535,2.714301e-7,0.039800942,0.000031574302,0.0039257184,0.0046903035,0.00009691625,0.00009489242],"about_ca_topic_score_codex":0.0018140904,"about_ca_topic_score_gemma":0.00027463425,"teacher_disagreement_score":0.022658052,"about_ca_system_score_codex":0.000030484667,"about_ca_system_score_gemma":0.00017566145,"threshold_uncertainty_score":0.3862382},"labels":[],"label_agreement":null},{"id":"W2407731553","doi":"10.1136/annrheumdis-2016-eular.1163","title":"OP0100 Superior Gains in Bone Mineral Density and Estimated Strength at The Hip for Romosozumab Compared with Teriparatide in Women with Postmenopausal Osteoporosis Transitioning from Bisphosphonate Therapy: Results of The Phase 3 Open-Label Structure Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Teriparatide; Femoral neck; Bone mineral; Osteoporosis; FRAX; Internal medicine; Clinical endpoint; Urology; Randomized controlled trial; Osteoporotic fracture","score_opus":0.07098216695213957,"score_gpt":0.36960294837532065,"score_spread":0.29862078142318105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407731553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896026,0.0009505911,0.0000012992846,0.003962649,0.000021489937,0.0036495079,0.0017991103,0.000009241518,0.0000034982434],"genre_scores_gemma":[0.998917,0.00018206969,0.00014460398,0.00039314717,0.000004514719,0.00023117698,0.00005164625,0.00002679462,0.00004908496],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99779063,0.00032438833,0.00064648606,0.00034091788,0.0004865758,0.00041098535],"domain_scores_gemma":[0.9980875,0.00058825593,0.00031102108,0.0006410043,0.00019718701,0.00017502677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004356453,0.0002470445,0.00071063713,0.000067337525,0.00020043463,0.00004087308,0.0003309795,0.000046136982,0.000033622036],"category_scores_gemma":[0.00025352938,0.00009462176,0.00003336279,0.0003567888,0.00039216765,0.00015041513,0.0001351097,0.00012615399,2.2950641e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4590957,0.01865281,0.2503878,0.0012592934,0.0015761207,0.00007238567,0.06177275,0.00026041115,0.09396131,0.000019705998,0.0017760436,0.11116567],"study_design_scores_gemma":[0.07054404,0.0058859144,0.89498746,0.0028469488,0.00012270812,0.000016006936,0.0040732953,0.0006780493,0.020416062,0.00020445674,0.000012970593,0.0002120668],"about_ca_topic_score_codex":0.0033464944,"about_ca_topic_score_gemma":0.0043342668,"teacher_disagreement_score":0.6445997,"about_ca_system_score_codex":0.00007048145,"about_ca_system_score_gemma":0.0003918268,"threshold_uncertainty_score":0.5058921},"labels":[],"label_agreement":null},{"id":"W2408844222","doi":"10.1136/annrheumdis-2015-eular.4503","title":"THU0200 Sustained and Similar Clinical Response to Etanercept After 6 Years of Treatment in Patients with Non-radiographic Axial Spondyloarthritis and Ankylosing Spondylitis: Long-term Results of the Esther Trial","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; BASDAI; Ankylosing spondylitis; BASFI; Etanercept; Sulfasalazine; Spondylitis; Internal medicine; Clinical trial; Surgery; Physical therapy; Arthritis; Rheumatoid arthritis; Disease; Psoriatic arthritis","score_opus":0.029705722718833875,"score_gpt":0.32279275550391595,"score_spread":0.2930870327850821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408844222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441576,0.0024661229,7.1835075e-7,0.0010527548,0.00006615791,0.0015421,0.0004377569,0.000005955894,0.000012696122],"genre_scores_gemma":[0.99788713,0.0018691687,0.00004328027,0.00007256539,0.000017950488,0.000039810446,0.000013025856,0.000020155247,0.00003689143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976661,0.00062403455,0.00070335617,0.0002391589,0.0005086534,0.00025868224],"domain_scores_gemma":[0.99826306,0.00047738606,0.00023836512,0.00053224334,0.00021337534,0.0002755759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082314626,0.00017204988,0.0006237918,0.00019415213,0.00003365126,0.000020545463,0.00014463658,0.00005870358,0.000017676017],"category_scores_gemma":[0.0015126702,0.000099079356,0.00018302616,0.00033254368,0.0006501049,0.000096638934,0.00009602501,0.00008520096,4.6297262e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32636663,0.0010839598,0.63850087,0.00011092423,0.00022161583,0.000025370273,0.0022081456,0.000005056298,0.000007748597,0.000008043495,0.00013599923,0.03132563],"study_design_scores_gemma":[0.047829516,0.0063068382,0.94293916,0.0022049837,0.000039139108,0.0000057477228,0.00032695886,0.000009504716,0.00004433307,0.000107330874,0.00009092046,0.00009558925],"about_ca_topic_score_codex":0.00013585499,"about_ca_topic_score_gemma":0.00009109427,"teacher_disagreement_score":0.30443826,"about_ca_system_score_codex":0.00001887575,"about_ca_system_score_gemma":0.00029149753,"threshold_uncertainty_score":0.4040339},"labels":[],"label_agreement":null},{"id":"W2408862352","doi":"10.1136/annrheumdis-2015-eular.4380","title":"OP0019 Osteoarthritis, Drug Use and Risk of Cardiac Ischaemic Events: A Case-Control Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Drug; Ischaemic heart disease; Internal medicine; Intensive care medicine; Pharmacology; Alternative medicine; Pathology","score_opus":0.026807790269696923,"score_gpt":0.28279186935531864,"score_spread":0.2559840790856217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408862352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904772,0.007353093,0.0000022899108,0.00014878462,0.00020233271,0.0013671455,0.00041416124,0.000019517889,0.000015484631],"genre_scores_gemma":[0.999135,0.00057861797,0.000017323437,0.00008111576,0.000041594292,0.00004720121,0.0000037803488,0.000020352207,0.000074998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982211,0.00056461844,0.00043084568,0.00016778364,0.0004167735,0.00019885035],"domain_scores_gemma":[0.998058,0.0005221141,0.00032644,0.0005446113,0.00024925577,0.00029956852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081431295,0.00016955932,0.00063680415,0.00007344142,0.00005974785,0.000011119152,0.000101929654,0.000036308866,0.000013408051],"category_scores_gemma":[0.0023115568,0.00010979305,0.00021786231,0.0001202675,0.00011994582,0.00015926974,0.00007269742,0.00010105041,0.000005546055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005731012,0.00058420125,0.9727842,0.00049050315,0.0008500993,0.000084284504,0.002843787,0.00002065575,0.000021181098,0.000019484218,0.004411893,0.017316608],"study_design_scores_gemma":[0.0069468,0.0012598756,0.9802742,0.0018044901,0.0026384515,0.00013802398,0.004939577,0.00028901285,0.00078681094,0.00052175083,0.00014774968,0.00025327492],"about_ca_topic_score_codex":0.0006479877,"about_ca_topic_score_gemma":0.00003485999,"teacher_disagreement_score":0.017063333,"about_ca_system_score_codex":0.000009599813,"about_ca_system_score_gemma":0.00012997672,"threshold_uncertainty_score":0.44772306},"labels":[],"label_agreement":null},{"id":"W2408863428","doi":"10.1136/annrheumdis-2015-eular.6199","title":"SAT0062 What is the Effect of TNF Inhibitors on Employment Status in Rheumatoid Arthritis Patients and what are the Predictors of Progression to Unemployment?","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Penticton Regional Hospital; University of Ottawa; Oakville Public Library; Credit Valley Hospital; Mount Sinai Hospital; University of Victoria; Arthritis Research Centre of Canada; Université de Montréal; University of Saskatchewan; McMaster University","funders":"","keywords":"Medicine; Golimumab; Internal medicine; Rheumatoid arthritis; Infliximab; Proportional hazards model; Unemployment; Demography; Adalimumab; Disease","score_opus":0.020264715034521832,"score_gpt":0.3069948553524515,"score_spread":0.2867301403179297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408863428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363451,0.05651061,3.6749157e-7,0.0046701543,0.00030833637,0.0020651661,0.000071611255,0.00001388655,0.000014755643],"genre_scores_gemma":[0.88892287,0.11060188,0.0000046340747,0.00026320046,0.000012295332,0.00014861513,0.000011364713,0.000025115492,0.000010038918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673694,0.0005498915,0.0007282357,0.00025156583,0.0013229226,0.00041043418],"domain_scores_gemma":[0.99764305,0.00065519696,0.00044445504,0.00067530095,0.00025109516,0.00033087918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007347321,0.00026092914,0.0006588249,0.00015784499,0.00009972687,0.000114156865,0.00031000067,0.000051310475,0.000019137004],"category_scores_gemma":[0.0011510656,0.00011895342,0.00020513829,0.00036494862,0.00049868395,0.0004670477,0.0002541824,0.00014426962,0.0000046670093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016901636,0.00070680503,0.57560307,0.000363845,0.000264824,0.0000024268454,0.0047955397,0.000036358364,0.000021111473,0.000027211508,0.0061461725,0.41034248],"study_design_scores_gemma":[0.010306646,0.010659352,0.83055264,0.08357818,0.000045675428,0.000008592561,0.016249966,0.00010073278,0.045209993,0.0009312279,0.0019813394,0.000375667],"about_ca_topic_score_codex":0.00017214917,"about_ca_topic_score_gemma":0.00003249694,"teacher_disagreement_score":0.40996683,"about_ca_system_score_codex":0.000029731586,"about_ca_system_score_gemma":0.000102048245,"threshold_uncertainty_score":0.48507798},"labels":[],"label_agreement":null},{"id":"W2408916981","doi":"10.1136/annrheumdis-2015-eular.4974","title":"SAT0030 Release of Secondary Mediators of Inflammation by Human Secretory Phospholipases A2 (SPLA2's)","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proinflammatory cytokine; Inflammation; Vascular smooth muscle; Medicine; Internal medicine; Endocrinology; Biochemistry; Chemistry; Smooth muscle","score_opus":0.019426684987106396,"score_gpt":0.2700237507044228,"score_spread":0.25059706571731644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408916981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393415,0.0048599043,0.000029882436,0.00010129784,0.000115903,0.00022923059,0.00035973327,0.000007191172,0.0003626908],"genre_scores_gemma":[0.99924535,0.00025157258,0.000031915206,0.00009791082,0.000048055725,0.00001923234,0.00017564424,0.000016672706,0.00011363129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879,0.00011919489,0.00047577362,0.00015892678,0.0003080621,0.00014799813],"domain_scores_gemma":[0.9985871,0.000024776671,0.0005142296,0.0005022168,0.00022533193,0.00014640225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022633022,0.00014270395,0.00026220432,0.00003891837,0.000038200327,0.0000054239013,0.00030686377,0.00008449752,0.00005253797],"category_scores_gemma":[0.0005530709,0.00011033098,0.0001940684,0.00008447759,0.00017022691,0.000015046404,0.00013723523,0.0000478433,0.0000023575349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033544484,0.0004497667,0.0015586899,0.0008611519,0.00032399356,9.61507e-7,0.0003240649,0.00006295078,0.89354515,0.0009392382,0.09382501,0.00777358],"study_design_scores_gemma":[0.0005077263,0.00027155902,0.0006683268,0.00022957713,0.000054788547,9.1175644e-7,0.00018997933,0.000023657944,0.99433553,0.002792489,0.00080625154,0.0001192012],"about_ca_topic_score_codex":0.00008704145,"about_ca_topic_score_gemma":0.00000455173,"teacher_disagreement_score":0.10079038,"about_ca_system_score_codex":0.000005112515,"about_ca_system_score_gemma":0.00021862864,"threshold_uncertainty_score":0.44991666},"labels":[],"label_agreement":null},{"id":"W2408957377","doi":"10.1136/annrheumdis-2015-eular.5089","title":"THU0348 The Influence of Drug Exposures and Comorbidity on Survival in Patients with Rheumatoid Arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; McGill University","funders":"","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Hazard ratio; Comorbidity; Proportional hazards model; Population; Cohort; Retrospective cohort study; Discontinuation; Cohort study; Diabetes mellitus; Confidence interval; Environmental health; Endocrinology","score_opus":0.026644439922837455,"score_gpt":0.2780272969843823,"score_spread":0.25138285706154484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408957377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298346,0.0049363025,6.049219e-7,0.0012596643,0.00005141616,0.00053361314,0.00006715588,0.000012453139,0.00015534763],"genre_scores_gemma":[0.9889107,0.010880532,0.0000113865135,0.00013003664,0.000005515779,0.00002381886,0.0000071605605,0.000014218667,0.000016660579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981285,0.0002632748,0.00039276166,0.00015896716,0.00081732415,0.00023919232],"domain_scores_gemma":[0.9984331,0.00036552988,0.00020404969,0.0005106149,0.00030461827,0.00018207326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045830096,0.00015486116,0.00043556807,0.00007975596,0.00006994671,0.00002270016,0.0002448308,0.000024159606,0.000015259928],"category_scores_gemma":[0.0010792644,0.00007799703,0.000076971126,0.00020619847,0.00060656905,0.00013931569,0.00010227215,0.00012556197,0.0000035514274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011682796,0.00069933635,0.9812554,0.00012448391,0.00012152861,0.0000024958842,0.001525665,0.0001835641,0.0000040361947,0.00062018936,0.0017805232,0.012514463],"study_design_scores_gemma":[0.0030205955,0.0005332144,0.9910181,0.0028133094,0.0000035962098,0.0000027585527,0.00064197584,0.000020892247,0.00019401268,0.0015553576,0.00010948731,0.000086700704],"about_ca_topic_score_codex":0.0005618023,"about_ca_topic_score_gemma":0.00016325334,"teacher_disagreement_score":0.012427762,"about_ca_system_score_codex":0.000008401657,"about_ca_system_score_gemma":0.00015256232,"threshold_uncertainty_score":0.31806263},"labels":[],"label_agreement":null},{"id":"W2409159966","doi":"10.1136/annrheumdis-2015-eular.4962","title":"THU0371 Compliance with Allopurinol Among Hypertensive Patients with Gout Diagnosis and the Relationship to Onset of End-Stage Renal Disease","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Allopurinol; Gout; Internal medicine; Kidney disease; End stage renal disease; Dyslipidemia; Cohort; Risk factor; Hemodialysis; Aspirin; Disease","score_opus":0.1332728337734345,"score_gpt":0.341414986189241,"score_spread":0.2081421524158065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409159966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926416,0.00057652785,0.000019035342,0.004486157,0.000016934537,0.0015031216,0.0004952829,0.00001511259,0.00024621055],"genre_scores_gemma":[0.99869484,0.00011825403,0.000098739256,0.000583135,0.000008225126,0.00020709296,0.000032536183,0.0000239813,0.00023321483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979852,0.00026670602,0.0003344236,0.00021382344,0.0009506191,0.00024925388],"domain_scores_gemma":[0.9968658,0.0009638964,0.00023082223,0.00070181745,0.0007089638,0.00052870985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024817805,0.00017050414,0.0004460554,0.000082699975,0.00010692642,0.000023736591,0.0002512423,0.000023991784,0.000038467482],"category_scores_gemma":[0.00403437,0.00007996677,0.000086490945,0.00030148862,0.0008839872,0.00012704034,0.00014706433,0.000116135205,0.000008851021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024832503,0.00034702994,0.9900952,0.00030445104,0.00020604495,0.000010073385,0.0006371998,0.00009428592,1.8862545e-7,0.00021745535,0.0035713534,0.0020334974],"study_design_scores_gemma":[0.002681827,0.00035033884,0.9931922,0.0025688098,0.00020948813,0.0000011386915,0.00021239016,0.00022596426,0.000046348712,0.00029077395,0.00011486277,0.00010586793],"about_ca_topic_score_codex":0.00048578272,"about_ca_topic_score_gemma":0.000097377444,"teacher_disagreement_score":0.0060532037,"about_ca_system_score_codex":0.000019313447,"about_ca_system_score_gemma":0.00027084368,"threshold_uncertainty_score":0.48298097},"labels":[],"label_agreement":null},{"id":"W2409212569","doi":"10.1136/annrheumdis-2015-eular.1896","title":"AB0616 Biomarkers for Neuropsychiatric Manifestations in Systemic Lupus Erythematosus","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Autoantibody; Lupus nephritis; Immunology; Anti-nuclear antibody; Systemic lupus erythematosus; Antibody; Gastroenterology; Disease","score_opus":0.07931744319663543,"score_gpt":0.3526662654234564,"score_spread":0.273348822226821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409212569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883803,0.0050368807,0.00011960766,0.0024915244,0.00067662523,0.0021989825,0.00009208202,0.000053480184,0.00095051806],"genre_scores_gemma":[0.99816537,0.000244503,0.00021611877,0.0001408068,0.00004112719,0.0002528853,0.00001637202,0.000045768993,0.0008770561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768543,0.00021758783,0.0007631224,0.00026499544,0.00066959765,0.0003992558],"domain_scores_gemma":[0.9975964,0.00059172435,0.00031515298,0.0007880683,0.00040384795,0.00030479784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068515603,0.00019541563,0.00051213586,0.000348914,0.0000600862,0.000023906223,0.00038121533,0.00005871002,0.000016261763],"category_scores_gemma":[0.002374868,0.00012921679,0.00030540346,0.00065649394,0.00012645317,0.000098818455,0.00009187833,0.000082602826,0.00003463065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014403715,0.0012459402,0.8701743,0.014927067,0.0006190507,0.000051121428,0.0027343847,0.00019707839,0.00010769952,0.0023853332,0.10208037,0.004037292],"study_design_scores_gemma":[0.08809846,0.00489519,0.4152553,0.09717735,0.003756107,0.1461947,0.09561526,0.04799073,0.0016480054,0.092474796,0.0030917926,0.003802323],"about_ca_topic_score_codex":0.00007557559,"about_ca_topic_score_gemma":0.000011588518,"teacher_disagreement_score":0.45491898,"about_ca_system_score_codex":0.000061989515,"about_ca_system_score_gemma":0.00053649815,"threshold_uncertainty_score":0.52693075},"labels":[],"label_agreement":null},{"id":"W2409941847","doi":"10.1136/annrheumdis-2015-eular.4293","title":"FRI0336 Disease Activity Patterns in Rheumatoid Arthritis in the First 3-Years of Follow-Up in Usual Care: Markov Modeling Shows Rapid Improvement in DAS28 States in the 1st Year Followed by Stable States in the Last 2 Years. Results from the Ontario Best Practices Research Initiative (OBRI)","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Disease; Rheumatoid arthritis; Physical therapy; Internal medicine","score_opus":0.10300185678304045,"score_gpt":0.34821103622976396,"score_spread":0.2452091794467235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409941847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783755,0.010914918,0.0000019309182,0.00667042,0.00007671057,0.0024752095,0.0013582201,0.0000072967487,0.0001197936],"genre_scores_gemma":[0.9671431,0.031719282,0.0000099887975,0.0003436498,0.000016088889,0.00047141404,0.00025015487,0.000034396257,0.000011932719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923684,0.003017209,0.0012294824,0.00052739115,0.001975288,0.00088221463],"domain_scores_gemma":[0.99307764,0.004919335,0.0004998087,0.0011307227,0.00021766058,0.00015484382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006567544,0.00033113724,0.00074783806,0.00038426084,0.00012939153,0.00022641233,0.0013433741,0.00008772923,0.00004128482],"category_scores_gemma":[0.0048492923,0.00018847991,0.00017778181,0.0010730792,0.00041204097,0.00065203203,0.0003471724,0.0010902495,0.000004816899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010428298,0.0049304003,0.64622575,0.00030953388,0.00018894835,0.00025162354,0.30168205,0.0018734399,0.000027467764,0.000057779613,0.0059851054,0.028039621],"study_design_scores_gemma":[0.013840654,0.0008863247,0.67094886,0.008233795,0.000014709246,0.0000031843285,0.298932,0.0032048705,0.000087537745,0.0028757572,0.00063527306,0.00033708173],"about_ca_topic_score_codex":0.30607435,"about_ca_topic_score_gemma":0.6469345,"teacher_disagreement_score":0.3408602,"about_ca_system_score_codex":0.00023357988,"about_ca_system_score_gemma":0.0009298689,"threshold_uncertainty_score":0.7685988},"labels":[],"label_agreement":null},{"id":"W2410105860","doi":"10.1136/annrheumdis-2015-eular.2400","title":"SAT0507 Growth and Weight Gain in Children with Juvenile Idiopathic Arthritis: Results from the Reacch-Out Cohort","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Memorial University of Newfoundland; University of Toronto; Université de Sherbrooke; McGill University; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Body mass index; Cohort; Weight gain; Percentile; Obesity; Pediatrics; Short stature; Demography; Juvenile; Internal medicine; Body weight; Statistics","score_opus":0.03066337201353378,"score_gpt":0.2810205336984042,"score_spread":0.25035716168487043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410105860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701176,0.021298636,0.0000041286958,0.006585692,0.000031171414,0.0007730187,0.00012883959,0.000025122175,0.0010357599],"genre_scores_gemma":[0.995426,0.0038050513,0.000016633936,0.00047758146,0.000032818272,0.00004624084,0.000054495053,0.000021303647,0.00011987004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980374,0.00026067824,0.0005826572,0.00024364551,0.0006031819,0.00027243275],"domain_scores_gemma":[0.99860704,0.00018538813,0.00023364631,0.0006754741,0.00013362829,0.00016482355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079187285,0.00016934083,0.0005172566,0.000060212355,0.0000852159,0.00003297974,0.00029365008,0.000054424392,0.000016683409],"category_scores_gemma":[0.0019224338,0.00008715037,0.00008998038,0.00020169388,0.00032670386,0.00014190204,0.00014821453,0.00020128569,0.000015411573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010507834,0.0003545503,0.9633503,0.00009237071,0.00037736967,0.000013048538,0.0020549686,0.000012148626,0.000019889105,0.00018538379,0.014934166,0.01755505],"study_design_scores_gemma":[0.0035615272,0.00020665633,0.9894363,0.002503319,0.00008792002,0.000015999816,0.00067708414,0.00012113734,0.00043222247,0.0026696657,0.00015554878,0.00013260999],"about_ca_topic_score_codex":0.0013736604,"about_ca_topic_score_gemma":0.00010333964,"teacher_disagreement_score":0.02608604,"about_ca_system_score_codex":0.000013543576,"about_ca_system_score_gemma":0.00038179322,"threshold_uncertainty_score":0.3553889},"labels":[],"label_agreement":null},{"id":"W2410446387","doi":"10.1136/annrheumdis-2015-eular.3270","title":"THU0598 Course and Predictors of Pain and Physical Functioning in Patients with HIP Osteoarthritis: Systematic Review","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; CINAHL; Physical therapy; Psychosocial; Osteoarthritis; Quality of life (healthcare); MEDLINE; Psychological intervention; Alternative medicine; Psychiatry; Pathology","score_opus":0.016994655329014195,"score_gpt":0.2543720357746907,"score_spread":0.2373773804456765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410446387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660247,0.032367602,0.0000017864149,0.00020341888,0.000030274972,0.001293828,0.000027193695,0.000010788823,0.000040381205],"genre_scores_gemma":[0.99921787,0.00049364154,0.000015316256,0.00014619475,0.000006853492,0.00006148037,0.000014289661,0.000010899584,0.000033479373],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989818,0.0001599363,0.00030467365,0.000116881834,0.00032239675,0.00011431796],"domain_scores_gemma":[0.99915045,0.00013702811,0.0002176424,0.00023167841,0.00013139752,0.00013181742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030348502,0.000120311175,0.0006058267,0.00003524606,0.000021676087,0.000006723277,0.00004544981,0.000019264307,0.0000030682925],"category_scores_gemma":[0.0006005749,0.0000685996,0.00005827109,0.00011039848,0.00010525599,0.000087522065,0.000032587785,0.00003764425,7.403116e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000746571,0.0024211286,0.68713117,0.27979562,0.000507469,0.0000099134495,0.0020878564,0.0000040003524,0.000011176536,0.00027578772,0.00075277453,0.026256505],"study_design_scores_gemma":[0.01069533,0.010344151,0.2518147,0.720849,0.0030080725,0.000014385779,0.0016521197,0.00007480891,0.00022346868,0.0010548102,0.000004336165,0.00026487184],"about_ca_topic_score_codex":0.000006873394,"about_ca_topic_score_gemma":0.0000041307417,"teacher_disagreement_score":0.44105333,"about_ca_system_score_codex":0.0000063210314,"about_ca_system_score_gemma":0.000055271215,"threshold_uncertainty_score":0.27974105},"labels":[],"label_agreement":null},{"id":"W2410976872","doi":"10.1136/annrheumdis-2015-eular.3527","title":"OP0141-HPR Modifiable Lifestyle Factors Negatively Impact Treating to Target and HAQ Scores in Early Rheumatoid Arthritis Patients","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Body mass index; Rheumatoid arthritis; Internal medicine; Overweight; Physical therapy; Population; Cohort; Obesity; Disease","score_opus":0.03785046925508183,"score_gpt":0.31358188200159465,"score_spread":0.2757314127465128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410976872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906157,0.0073350733,0.000008433988,0.000576209,0.00008116034,0.0008430553,0.00022925685,0.000038642047,0.00027242128],"genre_scores_gemma":[0.994553,0.0049516237,0.00019769675,0.000099990546,0.00001372044,0.00005484449,0.000031141873,0.000037791055,0.000060155075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976232,0.0002185371,0.0005816989,0.00029830664,0.0007218653,0.00055639306],"domain_scores_gemma":[0.9980651,0.00030073515,0.00020359542,0.0004198019,0.00022554213,0.0007852243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031435594,0.00029064645,0.0007012513,0.00025460048,0.00012718077,0.000100111,0.00023988089,0.00005526258,0.000056771645],"category_scores_gemma":[0.003046374,0.00019071931,0.0001959888,0.0004086899,0.00023174885,0.0003994327,0.00017984549,0.00014294487,0.000016230635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044515872,0.0006097405,0.97511053,0.00009968724,0.00017405943,0.000008302078,0.005111856,0.0002052044,0.000022594371,0.00011807524,0.0033322396,0.0147625655],"study_design_scores_gemma":[0.0032250406,0.0010537906,0.9866126,0.0037330592,0.00000478927,0.000009168332,0.0010492124,0.000494532,0.0009685887,0.0024326507,0.00017739086,0.00023917221],"about_ca_topic_score_codex":0.0031764663,"about_ca_topic_score_gemma":0.0000589714,"teacher_disagreement_score":0.014523393,"about_ca_system_score_codex":0.000041598007,"about_ca_system_score_gemma":0.00027341125,"threshold_uncertainty_score":0.77773076},"labels":[],"label_agreement":null},{"id":"W2410990138","doi":"10.1136/annrheumdis-2015-eular.2404","title":"THU0073 14-3-3ETA as a Novel RA Drug Target: Anti-14-3-3ETA Monoclonal Antibody Delays the Onset and Mitigates the Severity of Arthritis in CIA MICE","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; National Research Council Canada","funders":"","keywords":"Medicine; Dexamethasone; Monoclonal antibody; Arthritis; Internal medicine; Placebo; Biomarker; Rheumatoid arthritis; Immunology; In vivo; Drug; Pharmacology; Antibody; Pathology","score_opus":0.021742355556661326,"score_gpt":0.30000142040844835,"score_spread":0.27825906485178703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410990138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845707,0.009807753,0.000056924026,0.004082226,0.0001587253,0.0005127801,0.000566112,0.00000782583,0.00023696518],"genre_scores_gemma":[0.9972892,0.0015711269,0.00019154664,0.0005988076,0.00003681818,0.000049263956,0.000067915695,0.0000224387,0.00017291447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983268,0.00028234124,0.00050305534,0.00028799006,0.00031853968,0.00028131172],"domain_scores_gemma":[0.9983167,0.00020862337,0.0003673949,0.0007147898,0.000274144,0.00011835827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004970759,0.0002297157,0.00034096697,0.00004624222,0.00014283745,0.000048886726,0.0006509916,0.00007876132,0.0000350375],"category_scores_gemma":[0.001348425,0.00013645848,0.0002237886,0.00017897997,0.000549473,0.000027006861,0.00038383502,0.0001555575,0.0000071654395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003055769,0.008234448,0.45331395,0.0017926828,0.0053379843,0.00003758231,0.011084995,0.004752881,0.24901336,0.0030773743,0.2359121,0.024386851],"study_design_scores_gemma":[0.00390635,0.00053892634,0.52059144,0.0025170639,0.00034433318,0.00037506572,0.0052532456,0.0027198312,0.4363141,0.018361302,0.007929828,0.0011485202],"about_ca_topic_score_codex":0.0008193642,"about_ca_topic_score_gemma":0.00017166736,"teacher_disagreement_score":0.22798227,"about_ca_system_score_codex":0.0000071546638,"about_ca_system_score_gemma":0.00023813629,"threshold_uncertainty_score":0.5564615},"labels":[],"label_agreement":null},{"id":"W2411005995","doi":"10.1136/annrheumdis-2015-eular.3704","title":"AB0460 Remission After Discontinuation of Abatacept for Good Response: Results from the ORA Registry","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Abatacept; Medicine; Discontinuation; Rheumatoid arthritis; Internal medicine; Methotrexate; Arthritis; Surgery; Rituximab","score_opus":0.08334310221856803,"score_gpt":0.36507399932640705,"score_spread":0.28173089710783905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411005995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833669,0.002445958,0.00007424913,0.011888587,0.00011824761,0.00090854167,0.0008865828,0.000018477578,0.00029246454],"genre_scores_gemma":[0.9969438,0.00011877632,0.00020485873,0.00019442794,0.00007605238,0.000068951864,0.000097960045,0.000022833661,0.0022723952],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99787474,0.0003065973,0.0006248376,0.00023704105,0.00071868586,0.00023810849],"domain_scores_gemma":[0.9952414,0.0023312673,0.0004382549,0.0013524325,0.00043961292,0.0001970509],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013135521,0.00014525345,0.0003613087,0.00003792864,0.000056106852,0.000022158723,0.00042908502,0.00007059527,0.000040173083],"category_scores_gemma":[0.01789403,0.000074101714,0.00025562118,0.00020090569,0.00028227046,0.00010386858,0.0001792509,0.00008825694,0.000008573958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19426575,0.0025937671,0.0074690157,0.0018996339,0.0014512453,0.00004181007,0.013906158,0.00032339423,0.0017579356,0.00047219353,0.6862881,0.08953099],"study_design_scores_gemma":[0.11768576,0.0036573461,0.6455195,0.03609097,0.0023667593,0.00007382436,0.014588608,0.027612943,0.08133378,0.03039212,0.039453045,0.0012253666],"about_ca_topic_score_codex":0.0005157641,"about_ca_topic_score_gemma":0.000017561028,"teacher_disagreement_score":0.6468351,"about_ca_system_score_codex":0.0003350508,"about_ca_system_score_gemma":0.003265124,"threshold_uncertainty_score":0.9903787},"labels":[],"label_agreement":null},{"id":"W2411201675","doi":"10.1136/annrheumdis-2015-eular.2434","title":"SAT0272 Increased Risk of Vascular Mortality in Axial Spondyloarthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cohort; Internal medicine; Population; Hazard ratio; Proportional hazards model; Cohort study; Kidney disease; Retrospective cohort study; Diabetes mellitus; Environmental health; Confidence interval","score_opus":0.05019092087537993,"score_gpt":0.31562700035910063,"score_spread":0.2654360794837207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411201675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890805,0.009168601,0.0000023172624,0.00019924772,0.00011822252,0.00044905161,0.00032283014,0.000015623016,0.00064362556],"genre_scores_gemma":[0.99761003,0.002128293,0.000056185476,0.00008864325,0.000021245767,0.000030347404,0.000024440094,0.000014217577,0.000026610238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983888,0.00018782166,0.00049961853,0.00017531465,0.0005270074,0.00022143834],"domain_scores_gemma":[0.99864686,0.0001200491,0.0002713281,0.000585551,0.0001871475,0.00018905869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003537119,0.0001589666,0.000621615,0.000080869846,0.00004149806,0.0000056991253,0.00014211527,0.00004288435,0.00007529923],"category_scores_gemma":[0.0014903528,0.00010862426,0.00036253943,0.00027270132,0.00021591414,0.00006761552,0.00010362368,0.000071243005,0.000010106093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034669435,0.0012135388,0.982783,0.00021970144,0.0006975947,0.000028764773,0.00035130675,0.000023994764,0.000008848197,0.000169769,0.0010954614,0.013061299],"study_design_scores_gemma":[0.0043803668,0.0002774805,0.9900776,0.0009994603,0.00038802304,0.0000057744933,0.0003643468,0.000050459086,0.00044112225,0.002764665,0.00015687812,0.00009380403],"about_ca_topic_score_codex":0.0037887548,"about_ca_topic_score_gemma":0.00027126115,"teacher_disagreement_score":0.012967495,"about_ca_system_score_codex":0.000019620426,"about_ca_system_score_gemma":0.00015431036,"threshold_uncertainty_score":0.57274896},"labels":[],"label_agreement":null},{"id":"W2411490644","doi":"10.1136/annrheumdis-2015-eular.3538","title":"SAT0557 Predictors of Response in Patients with Psoriatic Arthritis Treated with Anti-TNF in a Real-World Setting","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Rimouski; McMaster University; Research Canada; Université de Montréal; University of Alberta; University of Saskatchewan; Nexus Clinical Research (Canada); Arthritis Research Centre of Canada","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Internal medicine; Infliximab; Ankylosing spondylitis; Adalimumab; Multivariate analysis; Gastroenterology; Rheumatoid arthritis; Physical therapy; Disease","score_opus":0.022427352705528297,"score_gpt":0.27777461471776,"score_spread":0.2553472620122317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411490644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758875,0.00090595364,2.538556e-7,0.0003306102,0.000036216607,0.0007846733,0.000116876115,0.000018090133,0.00021859053],"genre_scores_gemma":[0.9994558,0.0002846034,0.000057085217,0.000046238165,0.0000063674374,0.000047879388,0.000026781883,0.000022950147,0.000052256557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983623,0.00018868818,0.0004976718,0.00019514665,0.00049388345,0.00026231527],"domain_scores_gemma":[0.998783,0.00020633162,0.00029813978,0.00038454795,0.00019374986,0.00013425993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000237057,0.00019002752,0.0006371844,0.00022590953,0.000031266693,0.0000068095005,0.00009711229,0.000027353262,0.000012989964],"category_scores_gemma":[0.0005496549,0.00011077592,0.00007553468,0.0006448069,0.00015677152,0.00009364452,0.000049858292,0.00006491447,0.0000017407524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007409674,0.0012783374,0.9842737,0.00013993522,0.0002599444,0.00004035446,0.0007096193,0.000065587396,7.94309e-7,0.000010435123,0.0002595309,0.005552132],"study_design_scores_gemma":[0.011137993,0.0017162281,0.97984713,0.006394082,0.000123658,0.0000027205913,0.00047637723,0.000026470309,0.00010217989,0.00006314316,0.0000087752505,0.00010121015],"about_ca_topic_score_codex":0.0010271193,"about_ca_topic_score_gemma":0.0006141593,"teacher_disagreement_score":0.0062541473,"about_ca_system_score_codex":0.000045915196,"about_ca_system_score_gemma":0.00017506395,"threshold_uncertainty_score":0.4517311},"labels":[],"label_agreement":null},{"id":"W2411553295","doi":"10.1136/annrheumdis-2015-eular.6517","title":"OP0250 The Regulatory Role of the C-Terminal Domain of Connexin 43 in Articular Cartilage","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Connexin; Chondrocyte; Cartilage; Cell biology; Immunohistochemistry; Western blot; Immunostaining; Gap junction; Biology; Pathology; Medicine; Anatomy; Genetics; Gene","score_opus":0.02842512287306948,"score_gpt":0.2765669252399315,"score_spread":0.248141802366862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411553295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399304,0.0036381558,0.0000017109477,0.0011224753,0.00009070783,0.00054897385,0.00003633682,0.000006845569,0.00056177715],"genre_scores_gemma":[0.99954677,0.000033295124,0.000029606306,0.00015457306,0.000014005996,0.000025839576,0.0000032292344,0.000011236122,0.00018146963],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986779,0.00019739966,0.00041231737,0.00010693181,0.00043685833,0.00016860323],"domain_scores_gemma":[0.9987156,0.00011494878,0.00027296343,0.00069378625,0.000112574526,0.000090162226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036016415,0.00011919018,0.00035592617,0.000039605882,0.000034943365,0.000005014548,0.0002518398,0.00003696251,0.0000345237],"category_scores_gemma":[0.00032493775,0.00005600462,0.00025292608,0.00016182597,0.0003079329,0.000052119838,0.000103651546,0.000055095876,0.000003763042],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008818644,0.016216613,0.37215668,0.006419578,0.002069538,0.0002484621,0.057521462,0.00076236844,0.17979653,0.15043911,0.019873532,0.18567747],"study_design_scores_gemma":[0.0075287693,0.001671168,0.17853692,0.006923849,0.0008219796,0.000076951925,0.014164249,0.00021120328,0.6963087,0.092939675,0.0005192004,0.00029733722],"about_ca_topic_score_codex":0.000053685293,"about_ca_topic_score_gemma":0.000030038185,"teacher_disagreement_score":0.51651216,"about_ca_system_score_codex":0.000012801234,"about_ca_system_score_gemma":0.00016903701,"threshold_uncertainty_score":0.22838022},"labels":[],"label_agreement":null},{"id":"W2411700716","doi":"10.1136/annrheumdis-2015-eular.6024","title":"SAT0493 Farber Disease: First Natural History Cohort Demonstrates a Broad Clinical Spectrum with Implications for Juvenile Idiopathic Arthritis Patients","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Medicine; Arthritis; Cohort; Internal medicine; Disease; Enzyme replacement therapy; Pathology","score_opus":0.04487279133637327,"score_gpt":0.3041665893437645,"score_spread":0.2592937980073912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411700716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553174,0.03363519,0.0000541541,0.008386338,0.00036766025,0.0016305695,0.00018034129,0.000081828126,0.00034651067],"genre_scores_gemma":[0.9976405,0.00084484415,0.000060020408,0.0006929735,0.000041575757,0.00022295609,0.00009441196,0.000034726527,0.00036802806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981896,0.000085782034,0.0008031857,0.00028552898,0.00033511542,0.0003007524],"domain_scores_gemma":[0.9979439,0.00015593185,0.00047190953,0.0007163832,0.00035326846,0.00035861583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003069134,0.00021704305,0.0006146292,0.000058609574,0.00012678334,0.000015032245,0.00025346474,0.000056822955,0.000036184414],"category_scores_gemma":[0.0013439805,0.00014470493,0.00039693265,0.00012185625,0.0003985034,0.00017430671,0.0000647709,0.00013321081,0.000015990752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006922337,0.000990469,0.9224149,0.00037873338,0.0003309547,0.0000017015877,0.00013082197,0.00001923173,8.652114e-7,0.00054862036,0.060140885,0.014350567],"study_design_scores_gemma":[0.002336332,0.00037973386,0.9836815,0.0012329262,0.0003663218,0.0000041564595,0.000086734486,0.00019487565,0.000010166882,0.001977518,0.009534025,0.00019570654],"about_ca_topic_score_codex":0.00004685888,"about_ca_topic_score_gemma":0.000034105957,"teacher_disagreement_score":0.061266586,"about_ca_system_score_codex":0.00007215976,"about_ca_system_score_gemma":0.00094011973,"threshold_uncertainty_score":0.59008956},"labels":[],"label_agreement":null},{"id":"W2411747197","doi":"10.1136/annrheumdis-2015-eular.1524","title":"SAT0564 Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Certolizumab pegol; Psoriatic arthritis; Physical therapy; Internal medicine; Work productivity; Placebo; Minimal clinically important difference; Population; Clinical trial; Randomized controlled trial; Adalimumab; Arthritis; Productivity; Rheumatoid arthritis; Alternative medicine; Environmental health","score_opus":0.04769324522907203,"score_gpt":0.3058013804692308,"score_spread":0.25810813524015874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411747197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329406,0.0023259849,4.088735e-8,0.0027996146,0.000027124493,0.0014305194,0.000086870255,0.00001470387,0.000021063388],"genre_scores_gemma":[0.9991062,0.00056744256,0.000012378791,0.00012504555,0.000002994973,0.00012020725,0.000019307725,0.000020086525,0.000026290458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745804,0.0006702814,0.00071406405,0.0003784276,0.00048370444,0.00029548968],"domain_scores_gemma":[0.99793106,0.00087313,0.0005016793,0.00038730996,0.00014967204,0.00015715134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028692893,0.0002876259,0.0010417019,0.00015496694,0.00008032348,0.00002910119,0.00006551898,0.00006259924,0.0000028124139],"category_scores_gemma":[0.0042546834,0.00014287172,0.00006630256,0.00036586344,0.00036757012,0.00012992539,0.00011699834,0.00013631259,3.62665e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031556257,0.0019654473,0.98400986,0.0000752878,0.00028290678,0.0002736077,0.0014066313,9.951785e-7,1.12121164e-7,0.000003332384,0.00008591225,0.008740303],"study_design_scores_gemma":[0.017222326,0.0010857357,0.9774536,0.0022829832,0.00017167762,0.00006786289,0.0013844826,0.000014555924,0.000006194567,0.00014727682,0.0000023224222,0.0001610131],"about_ca_topic_score_codex":0.0012261181,"about_ca_topic_score_gemma":0.0049404223,"teacher_disagreement_score":0.014066701,"about_ca_system_score_codex":0.000059492,"about_ca_system_score_gemma":0.00009253416,"threshold_uncertainty_score":0.582614},"labels":[],"label_agreement":null},{"id":"W2411753617","doi":"10.1136/annrheumdis-2015-eular.4798","title":"SAT0347 Comparisons of Reporting and Level of Agreement of Co-Morbidities Ascertained from Rheumatologists, Patients and Health Administrative Data: A Data Linkage Study Among Patients with Rheumatoid Arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Toronto; Western University; Institute for Clinical Evaluative Sciences; McGill University","funders":"","keywords":"Medicine; Comorbidity; Rheumatoid arthritis; Confounding; Internal medicine; Diabetes mellitus; Record linkage; Family medicine; Physical therapy; Population; Environmental health","score_opus":0.48990069607819303,"score_gpt":0.44613113367799356,"score_spread":0.04376956240019947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411753617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878428,0.003042026,0.000034336772,0.00024231605,0.00005184444,0.0016849576,0.0069787833,0.0000147435785,0.00010819384],"genre_scores_gemma":[0.99626917,0.0012789376,0.00027214896,0.000028395532,0.000003879562,0.000018088225,0.0021009522,0.000019120092,0.000009313761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598724,0.00023269764,0.0020877854,0.00047604635,0.00097257394,0.0002436628],"domain_scores_gemma":[0.99285555,0.00028343656,0.0043983664,0.0017708364,0.0004405667,0.00025121975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008547955,0.0002739497,0.001357616,0.000106845255,0.000073799696,0.000025798527,0.00055003713,0.000035026285,0.000019650333],"category_scores_gemma":[0.0019925116,0.00019114529,0.000060856637,0.000171711,0.0008541698,0.00036535884,0.0009306496,0.00009093082,2.579599e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043860922,0.0034038876,0.97988695,0.0017308842,0.0011393349,0.0000031943052,0.001803066,0.000007913882,3.121087e-7,0.00007183128,0.00802871,0.0034853173],"study_design_scores_gemma":[0.0051528076,0.0014136545,0.97183347,0.0051592803,0.00023629199,8.111568e-7,0.015592188,0.00029035233,0.000033637745,0.0001258404,0.000013900558,0.00014775812],"about_ca_topic_score_codex":0.005997962,"about_ca_topic_score_gemma":0.0009952834,"teacher_disagreement_score":0.013789121,"about_ca_system_score_codex":0.000021399963,"about_ca_system_score_gemma":0.0006101667,"threshold_uncertainty_score":0.9067164},"labels":[],"label_agreement":null},{"id":"W2411836947","doi":"10.1136/annrheumdis-2015-eular.2265","title":"THU0425 Secukinumab Improves Signs and Symptoms of Active Psoriatic Arthritis in a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Using a Subcutaneous Dosing Regimen (Future 2)","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Secukinumab; Psoriatic arthritis; Clinical endpoint; Placebo; Placebo-controlled study; Internal medicine; Psoriasis Area and Severity Index; Regimen; Dactylitis; Dosing; Enthesitis; Randomized controlled trial; Gastroenterology; Rheumatoid arthritis; Psoriasis; Immunology; Double blind; Pathology","score_opus":0.038396197517986244,"score_gpt":0.3107881325951577,"score_spread":0.27239193507717147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411836947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746075,0.021036768,0.000007072398,0.000089477304,0.00047199382,0.0036181093,0.000113458285,0.000021745014,0.000033871533],"genre_scores_gemma":[0.99911416,0.0005826449,0.000023641103,0.000022563863,0.00002453183,0.00012526574,0.000022596632,0.000022137669,0.000062457555],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722004,0.0011491919,0.0008662349,0.00030682285,0.00012911927,0.0003285724],"domain_scores_gemma":[0.99771094,0.0008501308,0.0008103338,0.0004078758,0.00015512967,0.000065594075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006348104,0.0003261535,0.001591392,0.00019687306,0.00010977194,0.00002634861,0.00025496757,0.00012582084,0.00002254995],"category_scores_gemma":[0.0004142691,0.0002110241,0.00034548083,0.00019932343,0.00027431935,0.00016702175,0.00011818209,0.00010942139,0.0000031316233],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84319335,0.003942596,0.00029792168,0.00012447462,0.004052343,0.000020230415,0.013810915,0.000040499322,0.0015564349,0.000053287164,0.000026152922,0.13288179],"study_design_scores_gemma":[0.97968686,0.001408785,0.0002533476,0.00082782196,0.0019409569,0.00004153479,0.010310739,0.00033115363,0.0044542034,0.00045897768,0.000005503435,0.00028011724],"about_ca_topic_score_codex":0.00045092934,"about_ca_topic_score_gemma":0.00008136137,"teacher_disagreement_score":0.1364935,"about_ca_system_score_codex":0.000031358733,"about_ca_system_score_gemma":0.00015988368,"threshold_uncertainty_score":0.86053133},"labels":[],"label_agreement":null},{"id":"W2411876523","doi":"10.1136/annrheumdis-2015-eular.1840","title":"THU0427 Sustained Improvements in Skin Outcomes Following Certolizumab Pegol Treatment of Psoriatic Arthritis Patients with Prior Anti-TNF Exposure or Severe Skin Involvement at Baseline","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Certolizumab pegol; Psoriatic arthritis; Psoriasis; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Internal medicine; Placebo; Clinical endpoint; Randomized controlled trial; Adalimumab; Body surface area; Gastroenterology; Surgery; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.02869060349835092,"score_gpt":0.28664010458515204,"score_spread":0.25794950108680115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411876523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931266,0.0032162997,0.0000025519278,0.00080211123,0.00019403378,0.002285659,0.0003016552,0.000023339351,0.000047779904],"genre_scores_gemma":[0.9980908,0.0007493316,0.00016086968,0.000100427846,0.000014452839,0.00022092958,0.00014275173,0.000042847052,0.00047760055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972667,0.00013477427,0.0008900125,0.00035964543,0.00088402285,0.00046485924],"domain_scores_gemma":[0.99811554,0.00017942775,0.00048260108,0.0006785363,0.00029809936,0.0002457793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009416181,0.000415763,0.0011967021,0.00014982371,0.00011011569,0.000015539274,0.00016801171,0.000056513323,0.00007955207],"category_scores_gemma":[0.00040326355,0.00022527327,0.00040009915,0.00032344437,0.00009456965,0.00013862077,0.0001528782,0.000044342447,0.000005493219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017969214,0.0061916863,0.90847385,0.00040192943,0.0016950866,0.00014223286,0.0020477576,0.000023412314,0.0000016326476,0.0000105619365,0.00035539677,0.07885951],"study_design_scores_gemma":[0.044490512,0.004877649,0.94347745,0.0024862865,0.0006868084,0.000009532237,0.0029125537,0.000051764095,0.0004997921,0.00011570737,0.00009274375,0.0002991877],"about_ca_topic_score_codex":0.0007085434,"about_ca_topic_score_gemma":0.00074683694,"teacher_disagreement_score":0.07856032,"about_ca_system_score_codex":0.00024156245,"about_ca_system_score_gemma":0.00027694416,"threshold_uncertainty_score":0.9186377},"labels":[],"label_agreement":null},{"id":"W2411929631","doi":"10.1136/annrheumdis-2016-209835","title":"The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Perspective (graphical); Disease; Physical therapy; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.027981026034754043,"score_gpt":0.33183072438154537,"score_spread":0.3038496983467913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411929631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903715,0.0049719573,0.000010377865,0.0030208554,0.00011122055,0.0009881605,0.00040169098,0.000014558175,0.00010966782],"genre_scores_gemma":[0.9669043,0.032887373,0.000012231689,0.000073089905,0.000004939663,0.00006740667,0.0000035237156,0.000022017086,0.000025143578],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99683046,0.00072164985,0.000698653,0.00030966784,0.0010450823,0.00039448103],"domain_scores_gemma":[0.9961623,0.0014953489,0.00044098412,0.00091250805,0.0005969164,0.00039197571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053313054,0.00021955177,0.0005709604,0.00016681929,0.00013767416,0.000019313715,0.00036483826,0.00003981245,0.00006524866],"category_scores_gemma":[0.007543508,0.00010966497,0.0003025476,0.00038901728,0.00053465174,0.00015375743,0.00018851235,0.000106994674,0.000011079395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039556906,0.008629825,0.30441082,0.0008892626,0.0010293516,0.000038228034,0.014338783,0.00011971231,0.023988158,0.0048709153,0.009053451,0.59307456],"study_design_scores_gemma":[0.0015012427,0.0009693119,0.96807337,0.015102273,0.0000039772012,0.0000020226164,0.0014432305,0.000022253178,0.0090516275,0.0036001876,0.00008501343,0.00014551902],"about_ca_topic_score_codex":0.000877713,"about_ca_topic_score_gemma":0.0002222774,"teacher_disagreement_score":0.6636625,"about_ca_system_score_codex":0.00006362397,"about_ca_system_score_gemma":0.00030914883,"threshold_uncertainty_score":0.90308285},"labels":[],"label_agreement":null},{"id":"W2412367122","doi":"10.1136/annrheumdis-2015-eular.4396","title":"AB0926 Long-Term Safety and Maintenance of Efficacy of Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Results From a 36 Week Extension Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Canakinumab; Adverse effect; Internal medicine; Safety profile; European union; Incidence (geometry); Surgery; Pediatrics; Anakinra","score_opus":0.038019377625178145,"score_gpt":0.31331819492142526,"score_spread":0.2752988172962471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412367122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356586,0.0042462917,0.000013526871,0.0004213657,0.00006154097,0.0010539115,0.0005906277,0.000010875831,0.000036012225],"genre_scores_gemma":[0.99013835,0.009634183,0.000040366762,0.00003589484,0.0000082246,0.000012300655,0.00009633992,0.000015491847,0.000018856137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775887,0.0001981527,0.0009327853,0.00023516604,0.0006367315,0.00023831772],"domain_scores_gemma":[0.99794424,0.00033461687,0.00046575413,0.0005507435,0.00050855055,0.00019611341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039225398,0.000158775,0.00064126344,0.00012687252,0.00004121835,0.000010306658,0.00016820058,0.000038539234,0.000014171447],"category_scores_gemma":[0.0023031342,0.0001088193,0.00012103582,0.00021490605,0.0001910782,0.00018263105,0.00013787212,0.000085329135,0.0000014447263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08876274,0.011933412,0.64564854,0.0005226227,0.0012859806,0.000059775073,0.01584901,0.00013799354,0.00026385023,0.00018847844,0.0015843038,0.2337633],"study_design_scores_gemma":[0.013827556,0.002409893,0.97640026,0.005660786,0.000027295237,0.0000030034496,0.0005769183,0.00015757399,0.00046235367,0.0003671886,0.000010392468,0.000096771226],"about_ca_topic_score_codex":0.0022143866,"about_ca_topic_score_gemma":0.00073507265,"teacher_disagreement_score":0.33075175,"about_ca_system_score_codex":0.000024431889,"about_ca_system_score_gemma":0.0001647034,"threshold_uncertainty_score":0.44375223},"labels":[],"label_agreement":null},{"id":"W2412564260","doi":"10.1136/annrheumdis-2015-eular.3075","title":"SAT0388 Mood Disorders in Systemic Lupus Erythematosus (SLE): Results from an International, Inception Cohort Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"","keywords":"Medicine; Mood disorders; Internal medicine; Mood; Lupus anticoagulant; Systemic lupus erythematosus; Cohort; Psychiatry; Disease; Anxiety; Thrombosis","score_opus":0.055264258775748455,"score_gpt":0.3585990461996018,"score_spread":0.30333478742385334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412564260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929953,0.00055765494,0.000016472166,0.0011909648,0.0008825161,0.0025263533,0.00019299537,0.00007014547,0.0015675979],"genre_scores_gemma":[0.9987266,0.00036385705,0.000038780123,0.000044343484,0.00007129384,0.00018726525,0.00011752491,0.00004136848,0.0004089899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959218,0.000579496,0.0011300163,0.00047933552,0.0015548408,0.00033453663],"domain_scores_gemma":[0.9970119,0.00039463592,0.00047554588,0.0014074933,0.0003801257,0.00033031986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013626814,0.00025413348,0.00071300403,0.00027282353,0.00005249329,0.00005182464,0.00073733006,0.00008080515,0.000043778404],"category_scores_gemma":[0.0030744693,0.00017384712,0.00018198078,0.0004117562,0.00014431101,0.00032754423,0.00024889817,0.000164386,0.00005755801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011658102,0.0020129236,0.98652405,0.00027527782,0.0003900224,0.000006632213,0.005857079,0.00019474604,0.000015386862,0.00004224532,0.0019893171,0.0015265202],"study_design_scores_gemma":[0.01174501,0.00060477643,0.939838,0.0058538844,0.00024188984,0.0005390416,0.033296622,0.0038458898,0.00006212536,0.0036002726,0.000042574266,0.00032992568],"about_ca_topic_score_codex":0.0021007108,"about_ca_topic_score_gemma":0.000700537,"teacher_disagreement_score":0.046686053,"about_ca_system_score_codex":0.00015377962,"about_ca_system_score_gemma":0.0002895546,"threshold_uncertainty_score":0.708928},"labels":[],"label_agreement":null},{"id":"W2412587704","doi":"10.1136/annrheumdis-2015-eular.2374","title":"AB1163 Prevalence of Smoking and Impact on Disease Parameters Among Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Infliximab or Golimumab","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Rimouski; University of Victoria; Université de Montréal; Arthritis Research Centre of Canada; McMaster University","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Infliximab; Ankylosing spondylitis; Statistical significance; Adalimumab; Physical therapy; Surgery; Disease","score_opus":0.02874038932596073,"score_gpt":0.2921265419540693,"score_spread":0.26338615262810855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412587704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648135,0.033011258,0.0000034351212,0.00019210631,0.0000473087,0.0009926084,0.000858911,0.000041048293,0.000039856153],"genre_scores_gemma":[0.925761,0.07393826,0.000060747807,0.00006443942,0.000008639822,0.00005601929,0.00004500027,0.000042502794,0.000023423629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972093,0.00028096934,0.00067427394,0.00038333223,0.00096305826,0.00048905663],"domain_scores_gemma":[0.99727297,0.00045497398,0.00044124402,0.00060430606,0.000375061,0.0008514277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031256358,0.0003730153,0.00082434906,0.00021913575,0.00013924977,0.00008983892,0.00018715658,0.00005095759,0.00007324915],"category_scores_gemma":[0.0018007733,0.0002205725,0.00017890568,0.00031538436,0.00093288225,0.0004269018,0.00011521282,0.00015094146,0.0000015121437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0083135795,0.00086994027,0.8531789,0.0011845903,0.00059722073,0.000047414796,0.0008606005,0.000060959253,0.000002427275,0.000103335784,0.00041409617,0.13436694],"study_design_scores_gemma":[0.007966573,0.0026921271,0.9616705,0.02534068,0.000057720332,0.000052235482,0.00030321127,0.0004986653,0.00030465363,0.0008111241,0.00002448903,0.00027800718],"about_ca_topic_score_codex":0.00032364146,"about_ca_topic_score_gemma":0.000022076818,"teacher_disagreement_score":0.13408893,"about_ca_system_score_codex":0.00003521989,"about_ca_system_score_gemma":0.00029792057,"threshold_uncertainty_score":0.89946854},"labels":[],"label_agreement":null},{"id":"W2412621561","doi":"10.1136/annrheumdis-2015-eular.1339","title":"AB0822 Therapeutic Response in Adalimumab-Treated Patients with Psoriatic Arthritis in Relation to Weight","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Internal medicine; Psoriasis; Gastroenterology; Psoriasis Area and Severity Index; Quartile; Placebo; Body mass index; Arthritis; Rheumatoid arthritis; Immunology; Pathology","score_opus":0.027472200514693155,"score_gpt":0.2565416920185186,"score_spread":0.22906949150382547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412621561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448705,0.0040749656,0.0000038745334,0.00054918654,0.00017775605,0.0005351956,0.00007894969,0.000019942374,0.00007307759],"genre_scores_gemma":[0.9993923,0.00014088796,0.000015203949,0.00013425527,0.0000034470308,0.00007499763,0.00005755959,0.000014595176,0.00016679981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838316,0.0007212666,0.00037365482,0.00018730368,0.000091820446,0.00024276033],"domain_scores_gemma":[0.9990579,0.00029993794,0.00015924369,0.00034756315,0.00009098794,0.00004435508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030124778,0.00016530325,0.00032576954,0.00019147858,0.000044514087,0.000008155985,0.00019148832,0.00007892115,0.0000622041],"category_scores_gemma":[0.00034350972,0.00010572797,0.00006969031,0.0004060903,0.00006557347,0.00010869903,0.00004178656,0.00005962408,0.00008813423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016418142,0.0018918831,0.8117225,0.0000457481,0.00045292612,0.0000073432916,0.0029321134,0.00036067519,0.00012679954,0.00022966093,0.0011853755,0.1646268],"study_design_scores_gemma":[0.0043093534,0.00046297375,0.9923153,0.00058674155,0.00006182215,0.0000012092946,0.00014410894,0.0000074259124,0.0008919867,0.00091240247,0.00017162284,0.00013506526],"about_ca_topic_score_codex":0.00018675497,"about_ca_topic_score_gemma":0.00011946049,"teacher_disagreement_score":0.18059276,"about_ca_system_score_codex":0.00003872204,"about_ca_system_score_gemma":0.00009829886,"threshold_uncertainty_score":0.43114617},"labels":[],"label_agreement":null},{"id":"W2412762464","doi":"10.1136/annrheumdis-2015-eular.3602","title":"FRI0324 Does High Serum URIC Acid Increase the Risk of Renal Disease in Patients with Gout? Results from a Retrospective Analysis of Electronic Health Record Data","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Internal medicine; Kidney disease; Gout; Hyperuricemia; Retrospective cohort study; Proportional hazards model; Disease; Uric acid","score_opus":0.023574208362789662,"score_gpt":0.2808201823891798,"score_spread":0.2572459740263901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412762464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808142,0.0015809506,0.000027381766,0.002198926,0.00005888226,0.0008517122,0.014422016,0.000021167509,0.000024748555],"genre_scores_gemma":[0.9978969,0.00058330636,0.0001245877,0.00022213625,0.000025340649,0.000020192914,0.0010614105,0.000029876574,0.000036250378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957649,0.0007533578,0.0011928128,0.000562582,0.0012669883,0.00045935527],"domain_scores_gemma":[0.9935555,0.00052200916,0.0018921498,0.0031299465,0.00046437795,0.00043604025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011723484,0.00030399775,0.0012332515,0.00030779853,0.00007435965,0.000013982905,0.0009693892,0.00005523425,0.00004706121],"category_scores_gemma":[0.005867692,0.00014627521,0.00028301222,0.0017984721,0.00031340047,0.00022639793,0.00042895655,0.000279607,0.0000025604688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060949023,0.0015756232,0.98269784,0.00014973675,0.004341597,0.0000025016368,0.00084387074,0.00042027645,0.0000014597343,0.00003424559,0.0018607763,0.0019771857],"study_design_scores_gemma":[0.0035717392,0.00060589396,0.98471457,0.000899649,0.005474834,1.8315333e-7,0.0003551447,0.0021168368,0.000047745736,0.0020403063,0.000019015944,0.00015405656],"about_ca_topic_score_codex":0.016275484,"about_ca_topic_score_gemma":0.0011111614,"teacher_disagreement_score":0.017082684,"about_ca_system_score_codex":0.00014067371,"about_ca_system_score_gemma":0.0011415315,"threshold_uncertainty_score":0.9902752},"labels":[],"label_agreement":null},{"id":"W2412832182","doi":"10.1136/annrheumdis-2015-eular.1610","title":"AB0474 Identification of Tuberculosis Incidence Through the Use of a Validated Claims-Based Algorithm Among Rheumatoid Arthritis Patients Treated with Disease-Modifying Antirheumatic Drugs","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Diagnosis code; Rheumatoid arthritis; Algorithm; Incidence (geometry); Internal medicine; Tuberculosis; Pediatrics; Population; Pathology","score_opus":0.08011177952809961,"score_gpt":0.33315291914254014,"score_spread":0.2530411396144405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412832182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360955,0.0022864337,0.0006209625,0.00154169,0.000056178007,0.0013679358,0.00045324265,0.00004473843,0.000019263898],"genre_scores_gemma":[0.9958432,0.0029685749,0.0005440869,0.0002449117,0.0000074437316,0.00012501785,0.00019486433,0.000041575633,0.00003033543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954451,0.0008952943,0.0015217763,0.00038162465,0.0012840946,0.00047211],"domain_scores_gemma":[0.9943738,0.0012294436,0.0012728721,0.0013380169,0.001385503,0.0004003383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075360126,0.00032991587,0.0010221315,0.00017391802,0.0001467085,0.00003958369,0.000506065,0.000087478504,0.00003328679],"category_scores_gemma":[0.0044728285,0.00018364131,0.0004067193,0.0008641796,0.0011141084,0.0005111069,0.0001435547,0.00018002647,0.000007882875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017415609,0.0025651562,0.93799686,0.0017840569,0.0013025794,0.0000072522407,0.0014611146,0.00294828,0.000094442075,0.00012229879,0.0070441877,0.04293218],"study_design_scores_gemma":[0.0033266956,0.0005557577,0.933295,0.007974063,0.0004016368,0.0000055000282,0.0005101561,0.048261713,0.0044487636,0.00088108587,0.000057788202,0.000281813],"about_ca_topic_score_codex":0.0026540717,"about_ca_topic_score_gemma":0.000024888575,"teacher_disagreement_score":0.045313437,"about_ca_system_score_codex":0.000045633456,"about_ca_system_score_gemma":0.00040120678,"threshold_uncertainty_score":0.7488675},"labels":[],"label_agreement":null},{"id":"W2412895688","doi":"10.1136/annrheumdis-2015-eular.2053","title":"OP0051 Relationship Between Physical Activity and Hip Pain in Persons with and Without Femoroacetabular Impingement: A Population-Based Case-Control Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hip disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Research Canada; University of British Columbia","funders":"","keywords":"Femoroacetabular impingement; Medicine; Physical therapy; Groin; Squatting position; Population; Pelvis; Physical medicine and rehabilitation; Surgery","score_opus":0.07791247926416184,"score_gpt":0.34721963868302086,"score_spread":0.269307159418859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412895688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727786,0.00032973656,0.000067533954,0.0011461839,0.0000054743286,0.0010925295,0.000052159972,0.000014379246,0.000014149081],"genre_scores_gemma":[0.9997958,0.0000015456447,0.00004635418,0.000055187844,0.000008385317,0.000055130484,0.0000068300246,0.000013429314,0.0000173611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899685,0.0003119622,0.00013857512,0.00017398321,0.00024004518,0.00013855317],"domain_scores_gemma":[0.9990833,0.00036429937,0.00011571777,0.00023656766,0.000041069365,0.00015909302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034191067,0.0001377045,0.00036293,0.00007082693,0.00008457228,0.000018914141,0.000038217106,0.000021774174,0.000002319003],"category_scores_gemma":[0.000537378,0.00008451964,0.00004742197,0.00013912628,0.0000649561,0.00008701071,0.000018692108,0.000067076,4.6908713e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024541531,0.0010939111,0.9885841,0.000118366734,0.00019861732,0.000016667815,0.0011029149,0.00005231132,2.3564603e-7,0.000012601141,0.000014998492,0.008559872],"study_design_scores_gemma":[0.0049042203,0.0006053823,0.9881254,0.0002744676,0.0005705275,0.0000073626634,0.0013484231,0.0036691518,0.0000025631327,0.00040823274,4.0284272e-7,0.00008390396],"about_ca_topic_score_codex":0.0009442466,"about_ca_topic_score_gemma":0.00013812691,"teacher_disagreement_score":0.008475969,"about_ca_system_score_codex":0.000017280892,"about_ca_system_score_gemma":0.000071516566,"threshold_uncertainty_score":0.34466112},"labels":[],"label_agreement":null},{"id":"W2412981802","doi":"10.1136/annrheumdis-2015-eular.3046","title":"AB0757 Quality of life in Patients with Active Nonradiographic Axial Spondyloarthritis After 16 Weeks of Golimumab Treatment","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; BASDAI; Golimumab; Quality of life (healthcare); Ankylosing spondylitis; Physical therapy; Placebo; Internal medicine; BASFI; Dermatology Life Quality Index; Population; Randomized controlled trial; Back pain; Minimal clinically important difference; Arthritis; Adalimumab; Disease; Psoriatic arthritis","score_opus":0.03902610533570463,"score_gpt":0.29815707536314606,"score_spread":0.25913097002744145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412981802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940931,0.0037464872,0.0000011206905,0.00025429853,0.00007524289,0.0007683128,0.00075599377,0.000008827741,0.0002966164],"genre_scores_gemma":[0.9991546,0.00055510295,0.00003585339,0.00006315853,0.000010021539,0.00008683977,0.000044063065,0.000018371955,0.000031939362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820757,0.00014491896,0.0006429266,0.00020501399,0.00056301005,0.0002365809],"domain_scores_gemma":[0.99838424,0.00013214571,0.0004514926,0.0004944701,0.00033375877,0.00020391765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011015865,0.00022208385,0.0009260226,0.00014993107,0.000027089733,0.0000041139347,0.000107251515,0.00004597177,0.00006122106],"category_scores_gemma":[0.0003037012,0.00013352848,0.00031737977,0.00034153764,0.00031815944,0.000090686066,0.00005851399,0.000045698845,0.000002494663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009610824,0.0046162875,0.9654299,0.00025319838,0.0009502956,0.0000055927358,0.0009873312,0.000008903001,9.127127e-7,0.000046824425,0.00013707059,0.017952835],"study_design_scores_gemma":[0.0135674765,0.0027923733,0.9809444,0.0012947764,0.00022487121,9.377605e-7,0.00057616225,0.0000025621043,0.0001422469,0.00031799465,0.000024511048,0.00011168953],"about_ca_topic_score_codex":0.0014234126,"about_ca_topic_score_gemma":0.00040362033,"teacher_disagreement_score":0.017841145,"about_ca_system_score_codex":0.000049432092,"about_ca_system_score_gemma":0.00018713818,"threshold_uncertainty_score":0.54451334},"labels":[],"label_agreement":null},{"id":"W2413050166","doi":"10.1136/annrheumdis-2015-eular.4296","title":"AB0771 The Prevalence of Inflammatory Eye Diseases in Rheumatologic Conditions: Results From a Meta-Analysis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Episcleritis; Scleritis; Retinal vasculitis; Psoriatic arthritis; Spondyloarthropathy; Etanercept; Rheumatoid arthritis; Uveitis; Ankylosing spondylitis; Dermatology; Ophthalmology; Internal medicine; Disease; Vasculitis","score_opus":0.12467513331161313,"score_gpt":0.35581583346922013,"score_spread":0.23114070015760702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413050166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415165,0.050951645,0.0000016737158,0.002765777,0.00006334179,0.0005872732,0.0039021738,0.00002100695,0.00019061733],"genre_scores_gemma":[0.9969608,0.0022813424,0.000025739717,0.0002078535,0.0000068425966,0.00014520125,0.000085208274,0.000010103062,0.00027690167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978169,0.00029025192,0.00084558147,0.00026562985,0.00057040434,0.00021124133],"domain_scores_gemma":[0.99722826,0.0007972241,0.0005837165,0.0009914391,0.0002516152,0.0001477494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026872594,0.00020733461,0.0011267732,0.00013049411,0.00007830102,0.0000124067,0.00032463038,0.000038848473,0.00020756832],"category_scores_gemma":[0.0024453003,0.000101732374,0.0011317546,0.00054925657,0.0004072845,0.000098477765,0.00015377163,0.00006727415,0.000013487196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001306272,0.0024694288,0.86316895,0.0008868815,0.11915197,0.000046273824,0.0020379892,0.0007463593,0.0000043563427,0.00069075293,0.008684392,0.00080638437],"study_design_scores_gemma":[0.001840122,0.00011320805,0.9185912,0.00034397788,0.07306246,0.0000017197908,0.00080907566,0.00013715222,0.00007453477,0.004858982,0.00005982279,0.000107754466],"about_ca_topic_score_codex":0.000645047,"about_ca_topic_score_gemma":0.00009126596,"teacher_disagreement_score":0.05544432,"about_ca_system_score_codex":0.000016687196,"about_ca_system_score_gemma":0.0001347296,"threshold_uncertainty_score":0.4148526},"labels":[],"label_agreement":null},{"id":"W2413103353","doi":"10.1136/annrheumdis-2015-eular.2727","title":"FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor)","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Tocilizumab; Polymyalgia rheumatica; Giant cell arteritis; Clinical endpoint; Internal medicine; Corticosteroid; Rheumatology; Surgery; Randomized controlled trial; Rheumatoid arthritis; Vasculitis; Disease","score_opus":0.03077399209369642,"score_gpt":0.28548228316403995,"score_spread":0.25470829107034354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413103353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228954,0.0008615732,0.0000020814073,0.0038075305,0.00006886596,0.0024152691,0.00014395699,0.000012687524,0.0003984665],"genre_scores_gemma":[0.9991751,0.00063397276,0.000014180224,0.000044220553,0.0000059220797,0.00004141482,0.000014471844,0.00001803086,0.00005269857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998003,0.0001278794,0.0007810976,0.00023674626,0.0006489522,0.00020234466],"domain_scores_gemma":[0.99778813,0.00031610258,0.00050242915,0.0007103077,0.00054251705,0.00014053305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023640519,0.00020354449,0.00056415336,0.000086233864,0.000112195616,0.000009627807,0.0002462593,0.000059631187,0.000034786564],"category_scores_gemma":[0.001213921,0.000099149445,0.00011167801,0.00050085416,0.0003804913,0.0000734591,0.00012288816,0.00014963683,0.0000021189035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01632983,0.011844609,0.9551807,0.00023816744,0.0022293986,0.0000028598754,0.008789421,0.00024713518,0.0000018150024,0.0002527357,0.0007009168,0.0041824337],"study_design_scores_gemma":[0.01666318,0.0036830786,0.97501576,0.0023380017,0.0005148577,0.000002662861,0.00070225523,0.000056036723,0.00014415284,0.00075795123,0.00001570965,0.00010633322],"about_ca_topic_score_codex":0.0003356217,"about_ca_topic_score_gemma":0.00008407333,"teacher_disagreement_score":0.019835101,"about_ca_system_score_codex":0.00003586068,"about_ca_system_score_gemma":0.00024923545,"threshold_uncertainty_score":0.4043197},"labels":[],"label_agreement":null},{"id":"W2413122152","doi":"10.1136/annrheumdis-2015-eular.1912","title":"FRI0391 GLYCA, A Novel Marker of Inflammation, Is Elevated in Systemic Lupus Erythematosus","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Erythrocyte sedimentation rate; Acute-phase protein; Haptoglobin; Internal medicine; Systemic inflammation; C-reactive protein; Inflammation; Population; Coronary artery disease; Serum amyloid A; Immunology","score_opus":0.04070693017185361,"score_gpt":0.3034671751526252,"score_spread":0.2627602449807716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413122152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971184,0.0013153277,0.00011987281,0.0005515889,0.00007168536,0.0003850386,0.00007620986,0.000005248923,0.0003566139],"genre_scores_gemma":[0.99898666,0.00013930423,0.000056004086,0.00006671178,0.000015419257,0.00003340005,0.0000301599,0.000012686439,0.0006596275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875325,0.00010557926,0.00045083716,0.00015683436,0.00035457432,0.00017894513],"domain_scores_gemma":[0.9987519,0.000030046804,0.00024096385,0.0004970129,0.0003806534,0.000099454155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034478202,0.00011428811,0.00021657486,0.00008239188,0.000022993261,0.000012338746,0.00031477638,0.000069606445,0.000041273302],"category_scores_gemma":[0.000942137,0.000082998624,0.00012071661,0.00023889927,0.00009367354,0.000008890273,0.00014076226,0.00004486012,0.000010156001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004350932,0.0025383444,0.34869716,0.0056021414,0.0013423465,0.000009540698,0.0036186911,0.004119313,0.52397877,0.0031561907,0.079918005,0.022668602],"study_design_scores_gemma":[0.009598352,0.00072767946,0.095993236,0.003925728,0.00011276691,0.00019560845,0.002612078,0.010215284,0.8639367,0.0055239685,0.006228174,0.0009304054],"about_ca_topic_score_codex":0.00008813233,"about_ca_topic_score_gemma":0.000018376682,"teacher_disagreement_score":0.33995798,"about_ca_system_score_codex":0.000008015246,"about_ca_system_score_gemma":0.00019659231,"threshold_uncertainty_score":0.33845857},"labels":[],"label_agreement":null},{"id":"W2413174267","doi":"10.1136/annrheumdis-2015-eular.3807","title":"OP0035 Tolerance of Rituximab, Abatacept and Tocilizumab in Common Practice: Analysis of the 3 Registries of the French Society of Rheumatology (Air, Ora and Regate)","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Tocilizumab; Abatacept; Rituximab; Internal medicine; Rheumatoid arthritis; Discontinuation; Rheumatology; Lymphoma","score_opus":0.04577598675378617,"score_gpt":0.3493294515922446,"score_spread":0.3035534648384584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413174267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559743,0.009507247,0.000006232383,0.0038950387,0.000039475213,0.00060358347,0.00015019234,0.000004063857,0.00019671126],"genre_scores_gemma":[0.99752384,0.0021466997,0.00010808997,0.00008481162,0.0000024048986,0.000016262691,0.000005437256,0.000010562091,0.000101902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744743,0.00042027596,0.00092916575,0.00020523218,0.00078684074,0.00021107263],"domain_scores_gemma":[0.9957215,0.0013118252,0.0011429803,0.0011732137,0.000558674,0.00009179679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007931554,0.00015950412,0.0011406605,0.000090254085,0.00005000444,0.0000060064126,0.00049237453,0.000090712565,0.000016782205],"category_scores_gemma":[0.003588341,0.000084738145,0.00035108675,0.001028436,0.001877161,0.00012232565,0.00046362483,0.00014608336,1.8084015e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003336691,0.004492221,0.8848619,0.019174522,0.008616998,0.0000056387603,0.025917396,0.0022525466,0.0003332412,0.002989934,0.03347936,0.014539553],"study_design_scores_gemma":[0.03292497,0.00078520825,0.85584587,0.011946884,0.0053721014,0.00014581904,0.023165297,0.042918485,0.019963648,0.0059369975,0.00055654196,0.00043815232],"about_ca_topic_score_codex":0.008672715,"about_ca_topic_score_gemma":0.00056385336,"teacher_disagreement_score":0.04066594,"about_ca_system_score_codex":0.0001746512,"about_ca_system_score_gemma":0.0019820752,"threshold_uncertainty_score":0.9979286},"labels":[],"label_agreement":null},{"id":"W2413516833","doi":"10.1136/annrheumdis-2015-eular.2369","title":"AB1029 Serum 14-3-3ETA is Present in JIA and is not Associated with RF+ Polyarthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Saskatchewan","funders":"","keywords":"Medicine; Polyarthritis; Oligoarthritis; Arthritis; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Rheumatoid factor; Enthesitis; Rheumatology","score_opus":0.063621284613068,"score_gpt":0.3066270151905692,"score_spread":0.2430057305775012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413516833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97314095,0.0055653034,2.8450324e-7,0.019997297,0.000044122087,0.00042295342,0.0002600714,0.000018276329,0.00055073726],"genre_scores_gemma":[0.99644583,0.0009215548,0.00001409232,0.0019590298,0.000015588295,0.000042485834,0.000012872799,0.000015365136,0.0005731663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878186,0.0000603741,0.00028003956,0.00019357895,0.00045418923,0.00022998296],"domain_scores_gemma":[0.9989459,0.00014498772,0.00015674815,0.00037529352,0.00013412477,0.00024294094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012986279,0.00016152259,0.00041172263,0.000057784644,0.00003932236,0.000026059515,0.00009994071,0.00004252527,0.00008306663],"category_scores_gemma":[0.00029185246,0.000094197974,0.00010549819,0.00016745557,0.00011558923,0.000088342684,0.00007958771,0.00004050762,0.000011552633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031822713,0.002232428,0.8872634,0.0001985909,0.0007524862,0.0000487385,0.0018633367,0.000007458767,0.0000031254856,0.000085982305,0.072718844,0.03450738],"study_design_scores_gemma":[0.0040590055,0.0004094185,0.9895413,0.0021890695,0.00022908511,0.000011542569,0.00025794006,0.00015882173,0.0018000253,0.0007652566,0.00045928112,0.000119232966],"about_ca_topic_score_codex":0.0005557602,"about_ca_topic_score_gemma":0.00007021741,"teacher_disagreement_score":0.10227792,"about_ca_system_score_codex":0.0000352595,"about_ca_system_score_gemma":0.00016197808,"threshold_uncertainty_score":0.38412818},"labels":[],"label_agreement":null},{"id":"W2414016622","doi":"10.1136/annrheumdis-2015-eular.1904","title":"AB1021 Prevalence and Neuroimaging Correlates of Central Ataxia In Childhood-Onset Systemic Lupus Erythematosus","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Ataxia; Systemic lupus erythematosus; Cerebellar ataxia; Magnetic resonance imaging; Internal medicine; Pediatrics; Disease; Radiology","score_opus":0.039348074100063454,"score_gpt":0.3057607685367217,"score_spread":0.2664126944366582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414016622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761117,0.022005878,0.000006048374,0.0004647987,0.00023971962,0.0009217195,0.00007374738,0.000026303855,0.00015007694],"genre_scores_gemma":[0.99809676,0.0014737232,0.000027761991,0.000047764748,0.00001522877,0.00002725133,0.0000057859634,0.000028666645,0.00027702624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975094,0.0002880975,0.00077246473,0.00027311404,0.0007385717,0.0004183248],"domain_scores_gemma":[0.99787587,0.00045348858,0.00038716575,0.00073942146,0.0002255818,0.00031850074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000554998,0.00020563752,0.0006918117,0.00017684848,0.000034521967,0.00001969472,0.0003492823,0.000053226333,0.000020724168],"category_scores_gemma":[0.0024625408,0.00013790437,0.00015769202,0.00034707965,0.00030285429,0.00013785942,0.00023185083,0.00015006395,0.000008309654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017298273,0.00032029007,0.9862989,0.0075373957,0.0000940176,0.000017441727,0.0030768295,0.000044390825,0.000027480595,0.000076600234,0.0017539364,0.0005797382],"study_design_scores_gemma":[0.0035840736,0.00020850592,0.93827873,0.034157205,0.00022129953,0.014786998,0.003962472,0.0025655103,0.00045193755,0.001530437,0.000010939507,0.00024188518],"about_ca_topic_score_codex":0.00009031324,"about_ca_topic_score_gemma":0.0000031954785,"teacher_disagreement_score":0.048020158,"about_ca_system_score_codex":0.000034782533,"about_ca_system_score_gemma":0.00034815786,"threshold_uncertainty_score":0.56235766},"labels":[],"label_agreement":null},{"id":"W2414073010","doi":"10.1136/annrheumdis-2015-eular.1627","title":"AB0492 Evaluation of Potential Drug-Drug Interactions with Baricitinib","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Pharmacology; Organic anion transporter 1; CYP2C19; CYP3A4; CYP3A; Ketoconazole; CYP2C9; Rheumatoid arthritis; Drug; Cmax; Pharmacokinetics; TNF inhibitor; Methotrexate; Transporter; Internal medicine; Cytochrome P450; Chemistry; Biochemistry; Etanercept; Metabolism","score_opus":0.27020762959871036,"score_gpt":0.4873810910400886,"score_spread":0.21717346144137822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414073010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98829484,0.0037047397,0.000044720688,0.0018999681,0.0011226821,0.0004834992,0.0002175983,0.000021230864,0.004210716],"genre_scores_gemma":[0.99852526,0.0002883086,0.00006146244,0.0005698094,0.00007814502,0.000051050545,0.000018878176,0.000016852375,0.0003902036],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762374,0.00091019954,0.00045045486,0.00016613219,0.00061943673,0.000230034],"domain_scores_gemma":[0.99795413,0.00021912612,0.0004381641,0.00030705924,0.0008387538,0.00024277972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012700113,0.0001651391,0.00029668648,0.000090317575,0.000106133295,0.00001157214,0.00038422365,0.00003187827,0.00067817396],"category_scores_gemma":[0.0003460005,0.000111328576,0.00017206625,0.00024004735,0.00025041695,0.0001271007,0.000111057154,0.00018581466,0.000024308634],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003425909,0.007563472,0.025204036,0.0008447481,0.0044459514,0.0000108594395,0.010995107,0.23709397,0.0073325485,0.0039651697,0.25482824,0.44428998],"study_design_scores_gemma":[0.023651134,0.00033353962,0.14467916,0.0012151771,0.015787965,0.00008002887,0.007395116,0.27410644,0.3994396,0.05962944,0.071907766,0.0017746189],"about_ca_topic_score_codex":0.00007129034,"about_ca_topic_score_gemma":0.000014096655,"teacher_disagreement_score":0.44251537,"about_ca_system_score_codex":0.000014069197,"about_ca_system_score_gemma":0.0003590877,"threshold_uncertainty_score":0.7425529},"labels":[],"label_agreement":null},{"id":"W2414149218","doi":"10.1136/annrheumdis-2015-eular.1065","title":"FRI0613-HPR Assessing Reporting Bias in Trials of Exercise Interventions for Pain Management in Rheumatic Diseases: An Application of the Test for Excess Significance","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Reporting bias; Context (archaeology); Publication bias; Funnel plot; Psychological intervention; Physical therapy; Meta-analysis; MEDLINE; Clinical psychology; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.8851861581963015,"score_gpt":0.6095608025844746,"score_spread":0.2756253556118269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414149218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8514035,0.005871917,0.12650336,0.0014455242,0.0002833083,0.013790448,0.000542933,0.000009814989,0.00014924239],"genre_scores_gemma":[0.9954746,0.00006697383,0.0028074088,0.00003266811,0.000008508828,0.0014099452,0.000016216576,0.0000147637475,0.00016895853],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97018874,0.0076746102,0.019149123,0.00055916165,0.0021846157,0.0002437518],"domain_scores_gemma":[0.8937163,0.036996204,0.060762975,0.0060100323,0.0022581648,0.00025633717],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.15356947,0.00023838427,0.003706331,0.0003803015,0.00008597032,0.00020816376,0.0019808058,0.00004301541,0.000058242338],"category_scores_gemma":[0.34140185,0.00010897289,0.0028913512,0.0014424986,0.0001308546,0.00037797424,0.00018078176,0.000048049227,0.000002429487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014579999,0.003813177,0.2802315,0.022253258,0.0006508658,6.1554215e-7,0.0022384082,0.010479695,0.00004342153,0.0028787774,0.011579349,0.6656851],"study_design_scores_gemma":[0.0020251207,0.00019677557,0.4049102,0.028816272,0.0024221807,8.5956077e-7,0.02103957,0.21514808,0.00034566817,0.3243978,0.00023281475,0.00046466195],"about_ca_topic_score_codex":0.00009901205,"about_ca_topic_score_gemma":0.00007180016,"teacher_disagreement_score":0.66522044,"about_ca_system_score_codex":0.000027262196,"about_ca_system_score_gemma":0.00015219007,"threshold_uncertainty_score":0.87157834},"labels":[],"label_agreement":null},{"id":"W2414322210","doi":"10.1136/annrheumdis-2015-eular.4179","title":"SAT0566 Impact of Disease Management by Rheumatologists and Dermatologists on Patients' Attitude Toward Medication in Psoriatic Arthritis: Results from the Global Align Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Disease; Rheumatology; Psoriasis; Rheumatoid arthritis; Physical therapy; Dermatology","score_opus":0.03953200847345099,"score_gpt":0.30642019330252945,"score_spread":0.26688818482907845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414322210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98532003,0.010829177,0.00000404949,0.0006836467,0.00023935945,0.00084025296,0.0019925195,0.000019890798,0.00007105735],"genre_scores_gemma":[0.99775434,0.0017200431,0.000007582825,0.00007725314,0.0000032935072,0.00007301004,0.00034649737,0.000007551885,0.000010423785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792105,0.000737113,0.00064125797,0.00029015105,0.0001732655,0.0002371752],"domain_scores_gemma":[0.9983414,0.00044037297,0.00046211146,0.0006008211,0.000075409116,0.00007992836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031603346,0.0002263188,0.00044665523,0.000043057906,0.000071728005,0.000014629253,0.00043043893,0.000066313194,0.000012400521],"category_scores_gemma":[0.00082337944,0.00012513052,0.00015310131,0.00016968475,0.00027062674,0.00007370045,0.00016381653,0.000053340664,0.000017502633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024461516,0.0033897308,0.91353595,0.00006173859,0.0013998223,0.0000048365578,0.0012913801,0.00004758364,0.0000010649288,0.00032095253,0.014931014,0.062569745],"study_design_scores_gemma":[0.005402186,0.00032745829,0.99019796,0.0005092562,0.00024189304,8.83922e-7,0.00065240375,0.000007022444,0.00005386405,0.0024528045,0.00003130287,0.0001229561],"about_ca_topic_score_codex":0.0012418531,"about_ca_topic_score_gemma":0.00008770077,"teacher_disagreement_score":0.07666199,"about_ca_system_score_codex":0.000043451524,"about_ca_system_score_gemma":0.00007933328,"threshold_uncertainty_score":0.51026744},"labels":[],"label_agreement":null},{"id":"W2414332145","doi":"10.1136/annrheumdis-2015-eular.3525","title":"THU0365 Do Patterns of Joint Swelling or Tenderness in Rheumatoid Arthritis Patients Impact Disease Activity Outcomes and Pain? Implications for Clinical Practice","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Rimouski; University of Ottawa; Research Canada; Nexus Clinical Research (Canada); Arthritis Research Centre of Canada; University of Saskatchewan","funders":"","keywords":"Medicine; Tenderness; Rheumatoid arthritis; Golimumab; Wrist; Joint pain; Interphalangeal Joint; Internal medicine; Osteoarthritis; Adalimumab; Physical therapy; Surgery; Pathology","score_opus":0.1515101325316591,"score_gpt":0.4385754180435292,"score_spread":0.28706528551187005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414332145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855616,0.007246898,0.00036322503,0.0046621202,0.00009233109,0.0013885077,0.00064230565,0.000021284663,0.000021747574],"genre_scores_gemma":[0.95224833,0.047155004,0.00015457228,0.00021038782,0.000014084357,0.00014436933,0.000031363616,0.000028123015,0.000013780042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740607,0.00053623016,0.0009093801,0.00029672083,0.0004913717,0.00036022963],"domain_scores_gemma":[0.9951968,0.0023193199,0.00056053273,0.00064671173,0.00067059457,0.00060602906],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0015668729,0.0002230065,0.00081379316,0.00013510355,0.00008556141,0.0000449361,0.0002076455,0.000055926954,0.000019550762],"category_scores_gemma":[0.01891531,0.00013359198,0.00039625802,0.00017540659,0.00024017032,0.0003634483,0.0001337043,0.00014149897,0.0000014364765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020945247,0.0022769112,0.84055376,0.00036743513,0.00029545889,0.0000022216914,0.00032183473,0.000012415701,0.0000018819917,0.00019196866,0.0011202134,0.1527614],"study_design_scores_gemma":[0.00413622,0.00072211534,0.9884955,0.0023727883,0.000023064955,0.0000054634024,0.0005190309,0.00027989066,0.000025024976,0.0030905919,0.00018493348,0.00014534632],"about_ca_topic_score_codex":0.00026195354,"about_ca_topic_score_gemma":0.00002981399,"teacher_disagreement_score":0.15261605,"about_ca_system_score_codex":0.00002476029,"about_ca_system_score_gemma":0.00050371594,"threshold_uncertainty_score":0.98934877},"labels":[],"label_agreement":null},{"id":"W2414374240","doi":"10.1136/annrheumdis-2015-eular.4680","title":"FRI0423 Impact of Disease Activity on Organ Damage Risk Over Time in Systemic Lupus Erythematosus – The Hopkins Lupus Cohort","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Cohort; Systemic lupus erythematosus; Internal medicine; Proportional hazards model; Hazard ratio; Disease; Cohort study; Hydroxychloroquine; Confidence interval","score_opus":0.03741544698411645,"score_gpt":0.33489429482544564,"score_spread":0.29747884784132916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414374240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942414,0.0014019043,0.0000051903053,0.0005785911,0.00031172973,0.0022680562,0.00048448754,0.00005403899,0.00065458386],"genre_scores_gemma":[0.9980805,0.0006170999,0.0000043398854,0.000053903346,0.000050848153,0.00009795651,0.000018165767,0.00007352212,0.0010036875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953095,0.0010646014,0.00086316734,0.0004251629,0.0017400593,0.0005975321],"domain_scores_gemma":[0.99454594,0.0012628152,0.00082782697,0.0022886686,0.0004024817,0.00067228725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016311517,0.00042204396,0.0011866934,0.00035179622,0.00009924104,0.00004048132,0.0008214216,0.00010424026,0.00017650277],"category_scores_gemma":[0.004816975,0.00021572858,0.0007411817,0.0009014664,0.00041787763,0.0001819061,0.00032388075,0.00033159577,0.00011790102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028567435,0.0011995335,0.97347003,0.0018701402,0.0007620386,0.00003044854,0.0014166703,0.00045827322,0.000117119365,0.000051396073,0.0172561,0.0005115201],"study_design_scores_gemma":[0.005996746,0.0009094812,0.9669045,0.013538141,0.0007925149,0.0011892248,0.00096786243,0.0074000345,0.0006603926,0.0011468235,0.000032131695,0.00046213984],"about_ca_topic_score_codex":0.0012527792,"about_ca_topic_score_gemma":0.000021458189,"teacher_disagreement_score":0.017223967,"about_ca_system_score_codex":0.00026649318,"about_ca_system_score_gemma":0.0011249799,"threshold_uncertainty_score":0.87971556},"labels":[],"label_agreement":null},{"id":"W2414382940","doi":"10.1136/annrheumdis-2015-eular.2286","title":"THU0473 Diacerein Reduces Antagonists of WNT Enabling this System's Activity in Human Osteoarthritic Subchondral Bone Osteoblasts","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"ZonMw","keywords":"Wnt signaling pathway; Bone remodeling; Osteoarthritis; Medicine; Internal medicine; Endocrinology; Pharmacology; Cancer research; Cell biology; Signal transduction; Pathology; Biology","score_opus":0.05004536174241638,"score_gpt":0.3178743112514105,"score_spread":0.26782894950899416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414382940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900296,0.0064854794,0.0000017598087,0.0009826977,0.00035207457,0.0006030248,0.000062683845,0.00004010518,0.001442601],"genre_scores_gemma":[0.99931544,0.00024349704,0.000022052092,0.00007706714,0.00006024251,0.00003199449,0.000014032662,0.00002644442,0.00020923266],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978478,0.00026675712,0.00064702675,0.00025268132,0.00063530664,0.00035045831],"domain_scores_gemma":[0.99828345,0.00019563833,0.00042690936,0.00060105894,0.00022124904,0.00027170888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005022255,0.00022768808,0.00084656273,0.00019672084,0.000070062764,0.000023283508,0.00024780995,0.000071957744,0.00003212874],"category_scores_gemma":[0.0012261785,0.00015844032,0.00029061653,0.00036809593,0.00026929218,0.00023963494,0.00013609794,0.00012106311,0.000009272547],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012120011,0.0195647,0.41296422,0.06119474,0.0018109505,0.00024017904,0.039090574,0.0012319245,0.27255887,0.021226251,0.048488777,0.10950879],"study_design_scores_gemma":[0.020427382,0.0019731664,0.333218,0.03039076,0.0015070623,0.00009879439,0.02127572,0.00041925767,0.58487296,0.0037645742,0.0006159852,0.0014363334],"about_ca_topic_score_codex":0.0005264414,"about_ca_topic_score_gemma":0.00006122118,"teacher_disagreement_score":0.3123141,"about_ca_system_score_codex":0.000029307468,"about_ca_system_score_gemma":0.0003733471,"threshold_uncertainty_score":0.6461009},"labels":[],"label_agreement":null},{"id":"W2414402038","doi":"10.1136/annrheumdis-2015-eular.4061","title":"SAT0337 Opioids Use and Risk of Fractures in Rheumatoid Arthritis Patients: Results Of a Canadian Epidemiological Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Odds ratio; Internal medicine; Confidence interval; Rheumatoid arthritis; Epidemiology; Cohort; Medical prescription; Quartile; Osteoporosis; Comorbidity; Physical therapy; Emergency medicine","score_opus":0.09930499664567354,"score_gpt":0.366487293913779,"score_spread":0.26718229726810544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414402038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935273,0.0038082562,3.186036e-7,0.0010803186,0.000039409962,0.0009350386,0.00052171556,0.000005177534,0.00008249514],"genre_scores_gemma":[0.98845476,0.011212849,0.000065809974,0.00019789355,0.000004614922,0.000021878493,0.000021544909,0.000008878195,0.000011785715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974283,0.00064826355,0.0009636611,0.00018942126,0.00046051323,0.00030983248],"domain_scores_gemma":[0.9970082,0.0010520527,0.00041603195,0.00047325733,0.0004264603,0.00062397664],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012954301,0.00013340854,0.0007504335,0.00034061872,0.000041242125,0.0000072712783,0.00015319377,0.00007114469,0.000016635495],"category_scores_gemma":[0.027384454,0.00008007074,0.00010634492,0.0004116325,0.000255134,0.00009138201,0.00008826547,0.00016479177,0.0000013122749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090303994,0.00096393446,0.97342664,0.00018822768,0.0000744544,0.0000029190921,0.0010488116,0.000019978726,7.060543e-7,0.000022743368,0.0064310743,0.01691748],"study_design_scores_gemma":[0.0034086632,0.0011380322,0.99218816,0.0012593146,0.00002349208,0.000001227388,0.0010747554,0.00006496465,0.000052364085,0.00057986536,0.00014673361,0.00006243865],"about_ca_topic_score_codex":0.29288822,"about_ca_topic_score_gemma":0.0574379,"teacher_disagreement_score":0.23545033,"about_ca_system_score_codex":0.000020451702,"about_ca_system_score_gemma":0.0005161108,"threshold_uncertainty_score":0.9808083},"labels":[],"label_agreement":null},{"id":"W2414429658","doi":"10.1136/annrheumdis-2015-eular.2479","title":"SAT0490 Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Juvenile dermatomyositis; Medicine; Dermatomyositis; Juvenile; Dermatology","score_opus":0.3487757458145318,"score_gpt":0.4840425579083993,"score_spread":0.13526681209386748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414429658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350613,0.0004774364,0.00027248333,0.0013331759,0.00013488767,0.0009945405,0.0032479975,0.000010858752,0.000022475266],"genre_scores_gemma":[0.9867959,0.000096351934,0.0110759055,0.00051523774,0.00006576978,0.00013897064,0.0012091417,0.000024191368,0.00007851264],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9980431,0.00015890844,0.00084495003,0.00020366716,0.000514018,0.00023530962],"domain_scores_gemma":[0.997278,0.00088516646,0.0002654274,0.00041216143,0.00087071635,0.00028852798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013686643,0.00012126154,0.00043795182,0.000104371626,0.000116494135,0.000037457557,0.00024327186,0.00006086142,0.000010549007],"category_scores_gemma":[0.0023549818,0.00008734583,0.00014028118,0.000087260836,0.00032288468,0.00023738462,0.00017574006,0.000070279144,0.0000024636754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075468323,0.0026902044,0.09627004,0.005738785,0.0012956796,0.000027951935,0.0050771944,0.000012904135,0.00016262638,0.003669366,0.74794155,0.12956683],"study_design_scores_gemma":[0.01242433,0.0018380855,0.8347621,0.0040217494,0.00048710365,0.00013248657,0.0028122892,0.0074034617,0.011516284,0.0074560493,0.116576016,0.0005700442],"about_ca_topic_score_codex":0.00002583529,"about_ca_topic_score_gemma":0.000015415882,"teacher_disagreement_score":0.7384921,"about_ca_system_score_codex":0.00001244735,"about_ca_system_score_gemma":0.0005501517,"threshold_uncertainty_score":0.35618594},"labels":[],"label_agreement":null},{"id":"W2414507880","doi":"10.1136/annrheumdis-2015-eular.3582","title":"THU0432 Long-Term (104-Week) Safety Profile of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Synthesis of β-Lactam Compounds","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"IC Design Education Center; AbbVie; Genentech; Celgene; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Apremilast; Tolerability; Psoriatic arthritis; Internal medicine; Placebo; Adverse effect; Nausea; Randomized controlled trial; Gastroenterology; Surgery; Arthritis; Pathology","score_opus":0.043792624403634815,"score_gpt":0.3056959914613972,"score_spread":0.2619033670577624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414507880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931885,0.0027554603,0.00012451703,0.0001110926,0.00012161643,0.0019461936,0.0014223,0.000040161794,0.00029018434],"genre_scores_gemma":[0.9989275,0.00024308589,0.00017523837,0.00003302612,0.000031389605,0.00020727402,0.00030169782,0.0000492041,0.000031592237],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920293,0.0015264001,0.004114298,0.00047331705,0.0014111592,0.00044550994],"domain_scores_gemma":[0.9885896,0.0047608754,0.00402754,0.0014725532,0.0008273106,0.00032215012],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004251152,0.00056450506,0.007479236,0.0004096419,0.00007142467,0.00005233723,0.0008442851,0.00014055622,0.0006574243],"category_scores_gemma":[0.01210856,0.0003432443,0.0018574907,0.00072091125,0.00052408845,0.0004240006,0.00018165413,0.00014831542,0.0000022846027],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73481506,0.015076505,0.17573363,0.0011466033,0.024095044,0.000006506271,0.0011138202,0.0016439335,0.00015943477,0.00008040029,0.00027245464,0.045856632],"study_design_scores_gemma":[0.84160745,0.0007533745,0.10196201,0.0074505233,0.020919407,0.0000011905842,0.00056817016,0.009115638,0.015466242,0.001233428,0.0000031691256,0.0009194037],"about_ca_topic_score_codex":0.00023583834,"about_ca_topic_score_gemma":0.00021912108,"teacher_disagreement_score":0.10679241,"about_ca_system_score_codex":0.000066018736,"about_ca_system_score_gemma":0.0004177539,"threshold_uncertainty_score":0.99990195},"labels":[],"label_agreement":null},{"id":"W2414549220","doi":"10.1136/annrheumdis-2015-eular.2841","title":"FRI0371 Autoimmune Diseases in Patients with Rheumatoid Arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Population; Rheumatology; Cohort; Autoimmune disease; Concomitant; Disease; Immunology","score_opus":0.024314593266101733,"score_gpt":0.27509703695700616,"score_spread":0.2507824436909044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414549220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972251,0.024618806,0.0000068822633,0.0015824948,0.00013887601,0.000768642,0.00014514918,0.000062763254,0.00042536744],"genre_scores_gemma":[0.9893151,0.010123283,0.000058990205,0.00022567362,0.000014032871,0.00006873269,0.000062453844,0.00003902355,0.00009274545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743587,0.00018033152,0.0005724506,0.0002629826,0.001056568,0.00049180613],"domain_scores_gemma":[0.9979915,0.00014331931,0.00022030741,0.0007629955,0.00040792624,0.0004739682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020702508,0.0002527784,0.00067020033,0.00018636389,0.00009031546,0.00004826395,0.00033807146,0.000046396897,0.00016224879],"category_scores_gemma":[0.0011310981,0.00015676097,0.00020569541,0.00044392172,0.00040979392,0.00029416126,0.00014530809,0.00014794453,0.000046090303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015036012,0.0021484452,0.92139846,0.0001638926,0.000267793,0.000014563265,0.00057627674,0.00004105151,0.000002282209,0.00061504706,0.009624284,0.06364429],"study_design_scores_gemma":[0.006703437,0.00065939105,0.9840256,0.0040648077,0.000008793832,0.000007599106,0.0003788682,0.00008835208,0.00006740755,0.0024382658,0.0013511492,0.00020634106],"about_ca_topic_score_codex":0.0001924289,"about_ca_topic_score_gemma":0.000029847797,"teacher_disagreement_score":0.06343795,"about_ca_system_score_codex":0.000030081317,"about_ca_system_score_gemma":0.00042539288,"threshold_uncertainty_score":0.63925266},"labels":[],"label_agreement":null},{"id":"W2414595475","doi":"10.1136/annrheumdis-2015-eular.2399","title":"SAT0090 Exploring The Das: What is the Level of Agreement in the Classification of Remission and Low Disease Activity Among the Various Versions of the Disease Activity Score (DAS) and Their Correlation? An Analysis from a Prospective, Observational Registry","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Université de Montréal; University of Saskatchewan; Arthritis Research Centre of Canada; Mount Sinai Hospital; McMaster University","funders":"","keywords":"Medicine; Golimumab; Cohen's kappa; Internal medicine; Infliximab; Kappa; Correlation; Severity of illness; Physical therapy; Disease; Statistics","score_opus":0.20309388526141392,"score_gpt":0.35367098337448544,"score_spread":0.15057709811307152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414595475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830175,0.0042264527,0.00010259229,0.011003743,0.000054745175,0.0011442071,0.00043152052,0.0000055494274,0.000013699224],"genre_scores_gemma":[0.994816,0.004880312,0.0000065046506,0.00010265536,0.000016981086,0.00011601258,0.00002546977,0.000010359658,0.000025679537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973419,0.0008716779,0.0004087163,0.0002644341,0.00093547266,0.00017783711],"domain_scores_gemma":[0.9961598,0.0013528854,0.0006267732,0.0013497572,0.00032811516,0.00018270308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000978237,0.00019095793,0.00037384455,0.00007176812,0.00035503664,0.000072344345,0.00056708104,0.000032926237,0.000016541973],"category_scores_gemma":[0.0015144978,0.00007150597,0.0002625543,0.0005976979,0.001108479,0.00059926166,0.00023023096,0.00020988678,2.2566907e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017730184,0.0010431017,0.9692174,0.00020723241,0.0007225865,8.153121e-7,0.010990825,0.0004788378,0.00031787233,0.0005500124,0.0002998896,0.014398397],"study_design_scores_gemma":[0.0006653397,0.00007431481,0.9667697,0.0014136109,0.0002398834,5.70686e-7,0.008992033,0.016641513,0.0003575298,0.004762821,0.000010107156,0.0000725985],"about_ca_topic_score_codex":0.001055933,"about_ca_topic_score_gemma":0.00020062194,"teacher_disagreement_score":0.016162675,"about_ca_system_score_codex":0.000030330453,"about_ca_system_score_gemma":0.00036550226,"threshold_uncertainty_score":0.4084237},"labels":[],"label_agreement":null},{"id":"W2414669970","doi":"10.1136/annrheumdis-2015-eular.3087","title":"THU0198 Risk of Hospitalized Serious Infection in Spondylitis Ankylosing (AS) Patients Using Nbdmard or Anti-TNF","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Alberta","funders":"","keywords":"Medicine; Cohort; Ankylosing spondylitis; Medical prescription; Diagnosis code; Internal medicine; Cohort study; Retrospective cohort study; Drug; Etanercept; Tumor necrosis factor alpha; Emergency medicine; Population; Pharmacology","score_opus":0.045965860799764266,"score_gpt":0.3284641607517854,"score_spread":0.28249829995202114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414669970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971857,0.0013586838,0.000002734276,0.00010079999,0.00023561706,0.0006222764,0.00027474406,0.000018243303,0.00020119615],"genre_scores_gemma":[0.9978535,0.001889861,0.00007858681,0.0000660092,0.000013724907,0.000010160727,0.000030134373,0.000019854098,0.000038164595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985828,0.00014077897,0.0004866828,0.000170854,0.0003924441,0.00022648937],"domain_scores_gemma":[0.9987781,0.000087215834,0.00040194238,0.0003375172,0.00026856462,0.00012666378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016290594,0.00017074068,0.00057174993,0.00011628715,0.00006963941,0.000011307272,0.00007905193,0.000044032167,0.00005758733],"category_scores_gemma":[0.0014593248,0.00010907191,0.00021037376,0.00034497835,0.00012589249,0.00013504262,0.000098701974,0.00005687329,0.000005161123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086750137,0.001277922,0.9870253,0.00024653034,0.00032161968,0.000013785425,0.00051593356,0.000077551354,0.000003857612,0.000014907717,0.0002366093,0.0093984725],"study_design_scores_gemma":[0.00598227,0.00071944896,0.98922557,0.0021465295,0.00033882973,0.00001055002,0.00019308951,0.00017409057,0.00027545853,0.0007597835,0.00006479507,0.00010960042],"about_ca_topic_score_codex":0.0036825847,"about_ca_topic_score_gemma":0.00008196416,"teacher_disagreement_score":0.009288872,"about_ca_system_score_codex":0.0000457263,"about_ca_system_score_gemma":0.0001310464,"threshold_uncertainty_score":0.5566991},"labels":[],"label_agreement":null},{"id":"W2414748186","doi":"10.1136/annrheumdis-2015-eular.2396","title":"FRI0499 Using Patient-Relevant Variables to Describe the Disease Course in Children with Juvenile Idiopathic Arthritis: Results from the Reacch-Out Cohort","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Saskatchewan; Simon Fraser University","funders":"","keywords":"Medicine; Arthritis; Cohort; Quality of life (healthcare); Physical therapy; Disease; Juvenile rheumatoid arthritis; Pediatrics; Psoriatic arthritis; Cohort study; Internal medicine","score_opus":0.04876938179599082,"score_gpt":0.30192481708714924,"score_spread":0.2531554352911584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414748186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748054,0.0146959685,0.000029942692,0.007907871,0.000083783416,0.0018275584,0.00046963885,0.000031723997,0.00014811214],"genre_scores_gemma":[0.9979023,0.00060761627,0.000047551996,0.0011195929,0.000044393117,0.000107268526,0.00006844668,0.000036970596,0.000065863554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686867,0.00047114128,0.00084045256,0.00033382102,0.0010428767,0.00044304525],"domain_scores_gemma":[0.9972929,0.0002830542,0.0003551887,0.0013971552,0.00031374267,0.00035797368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010575065,0.00025143437,0.0005726521,0.00006043044,0.00021994913,0.000072604234,0.00059126946,0.000049856917,0.000028630777],"category_scores_gemma":[0.0033040927,0.00011775317,0.00016596192,0.00037517695,0.00032712397,0.00017804492,0.00027625894,0.00025174097,0.000027668037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055108974,0.0020203304,0.8964969,0.00015339865,0.0012542885,0.000060255417,0.009217708,0.0039881044,0.000059049824,0.00026624705,0.0405505,0.04042234],"study_design_scores_gemma":[0.003165983,0.00031550802,0.9817831,0.0063432436,0.00042411988,0.000014354481,0.0032181046,0.0017166508,0.00016425592,0.0020490547,0.0005324054,0.00027319932],"about_ca_topic_score_codex":0.0023634573,"about_ca_topic_score_gemma":0.00014821927,"teacher_disagreement_score":0.08528624,"about_ca_system_score_codex":0.000045445984,"about_ca_system_score_gemma":0.0012695215,"threshold_uncertainty_score":0.48018348},"labels":[],"label_agreement":null},{"id":"W2415226296","doi":"10.1136/annrheumdis-2015-eular.2821","title":"FRI0204 What is the Correlation of Individual HAQ and Basdai Questions with Disease Activity Measures in Ankylosing Spondylitis? Implications for Instrument Reduction","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; University of Toronto; McMaster University; University of Alberta; University of Saskatchewan; Hôpital Maisonneuve-Rosemont; University of Victoria; Nexus Clinical Research (Canada); Memorial University of Newfoundland","funders":"","keywords":"BASDAI; BASFI; Medicine; Ankylosing spondylitis; Physical therapy; Correlation; Golimumab; Infliximab; Disease; Internal medicine","score_opus":0.08341088889276957,"score_gpt":0.3311227602302676,"score_spread":0.24771187133749803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415226296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783933,0.0059028496,0.00008733626,0.013905355,0.00007009087,0.0009540191,0.0006582675,0.00000872891,0.000020030833],"genre_scores_gemma":[0.9983033,0.0012416675,0.000099985824,0.00009881605,0.000012463929,0.00016255009,0.000048734797,0.000009045782,0.000023432029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992017,0.000072884744,0.00021954704,0.0001421018,0.00024304996,0.00012072673],"domain_scores_gemma":[0.9990868,0.00012924649,0.0001920063,0.00028487947,0.000197074,0.000109988774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019204819,0.00010443142,0.00021290102,0.000057025423,0.00013285849,0.00003078104,0.000067557165,0.00002094915,0.000004727737],"category_scores_gemma":[0.00029032317,0.000060374852,0.0000759962,0.00016861214,0.00020286301,0.00026112897,0.000044000404,0.00004121573,2.6656204e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043846886,0.0028259817,0.5178033,0.0007121067,0.001102761,0.0000017868111,0.006496044,0.00033291557,0.0000531782,0.004519896,0.0025558933,0.45921144],"study_design_scores_gemma":[0.0016665038,0.00028739963,0.9873586,0.0017087348,0.00044005705,0.000009524226,0.0016946823,0.00014547087,0.00017406676,0.0063438755,0.00010394024,0.00006714118],"about_ca_topic_score_codex":0.0001491944,"about_ca_topic_score_gemma":0.00003586632,"teacher_disagreement_score":0.4695553,"about_ca_system_score_codex":0.000025284635,"about_ca_system_score_gemma":0.00014667261,"threshold_uncertainty_score":0.2462015},"labels":[],"label_agreement":null},{"id":"W2415357747","doi":"10.1136/annrheumdis-2015-eular.6079","title":"FRI0238 Reliability of Sacroiliac Joint MRI Assessment in a Population-Based Cohort of Patients with Possible Inflammatory Back Pain","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliac joint; Cohort; Population; Ankylosing spondylitis; Sacroiliitis; Axial spondyloarthritis; Physical therapy; Kappa; Radiology; Nuclear medicine; Internal medicine","score_opus":0.02303604478556266,"score_gpt":0.2855944604861469,"score_spread":0.26255841570058425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415357747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980182,0.00029670272,0.000011031884,0.00036967022,0.00004156869,0.00092072785,0.00015481889,0.0000074839627,0.0001798189],"genre_scores_gemma":[0.9993556,0.000036583522,0.0003879512,0.00006627072,0.0000033425947,0.000042552656,0.00007312474,0.00001234204,0.000022197146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829364,0.0001788303,0.0006411673,0.00016184029,0.00056612474,0.0001584057],"domain_scores_gemma":[0.9983557,0.00016759492,0.00043640207,0.0005072261,0.0004217245,0.00011134175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044357916,0.00014220852,0.0005733845,0.0000753602,0.00002553082,0.0000035308178,0.00008696303,0.000031812113,0.000055218385],"category_scores_gemma":[0.00065727415,0.0000870257,0.00014783195,0.00020340997,0.00012790883,0.00006194212,0.00004905678,0.000050888677,0.0000015958587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003961507,0.0016865585,0.9950205,0.00076476805,0.00015323146,0.000001206473,0.00010961469,0.00045323328,0.0000011523515,0.000024082794,0.0005184685,0.00087105396],"study_design_scores_gemma":[0.0030933407,0.0005577399,0.99308324,0.0019895309,0.000104793755,1.2878046e-7,0.00014582273,0.00034926189,0.00012417001,0.00047132585,0.0000074568,0.00007319231],"about_ca_topic_score_codex":0.0008357568,"about_ca_topic_score_gemma":0.00008102858,"teacher_disagreement_score":0.0026971898,"about_ca_system_score_codex":0.00005669112,"about_ca_system_score_gemma":0.00027513868,"threshold_uncertainty_score":0.3548805},"labels":[],"label_agreement":null},{"id":"W2415464014","doi":"10.1136/annrheumdis-2015-eular.1792","title":"THU0201 Factors Associated with Structural Damage in the Spine, as Measured by X-ray, in Patients with Axial Spondyloarthritis Treated with Certolizumab Pegol Over 96 Weeks","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Certolizumab pegol; Medicine; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine; Sacroiliitis; Adalimumab; Rheumatoid arthritis","score_opus":0.02887788563079061,"score_gpt":0.2686418267119881,"score_spread":0.2397639410811975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415464014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652267,0.0007097372,3.8066435e-7,0.0006786358,0.000040399038,0.0012924401,0.00040575917,0.000029711884,0.00032027203],"genre_scores_gemma":[0.99930686,0.000039328057,0.00000810131,0.000100051766,0.000008899505,0.00006518481,0.00033127103,0.000042244134,0.00009804505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974534,0.00024170667,0.00040479336,0.00031823467,0.0011199313,0.0004619495],"domain_scores_gemma":[0.99859494,0.000101643636,0.0003133986,0.0005170391,0.00028075,0.00019225199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007325741,0.00039840653,0.00072912994,0.00011207643,0.00011583218,0.00004356112,0.0002555631,0.00006886076,0.00006521323],"category_scores_gemma":[0.00042205153,0.00017841546,0.00010850125,0.00059631496,0.00028630544,0.00020232511,0.000053103053,0.00016817251,0.0000026517605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023812288,0.0011747199,0.99229985,0.00004201788,0.0004776877,0.00014294252,0.0012421368,0.000018134177,0.0000014628913,0.000016717253,0.0011117449,0.0010913456],"study_design_scores_gemma":[0.01841321,0.0027087973,0.9753791,0.0016661771,0.0002585501,0.00001455602,0.0011755937,0.000024957639,0.000034601755,0.0000696528,0.000024266727,0.0002305554],"about_ca_topic_score_codex":0.0017818951,"about_ca_topic_score_gemma":0.0017574307,"teacher_disagreement_score":0.01692078,"about_ca_system_score_codex":0.00008480815,"about_ca_system_score_gemma":0.00017885953,"threshold_uncertainty_score":0.7275571},"labels":[],"label_agreement":null},{"id":"W2415642736","doi":"10.1136/annrheumdis-2015-eular.4217","title":"THU0086 The Survival Impact of Statins in Rheumatoid Arthritis: A General Population-Based Cohort Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Propensity score matching; Cohort; Internal medicine; Population; Rheumatoid arthritis; Context (archaeology); Statin; Proportional hazards model; Body mass index; Confounding; Cohort study; Physical therapy; Environmental health; Confidence interval","score_opus":0.047541145668527206,"score_gpt":0.3575025194643915,"score_spread":0.3099613737958643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415642736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914074,0.0058388654,0.000011780343,0.00075028016,0.00011745348,0.0015504906,0.00014954065,0.000025101801,0.00014907026],"genre_scores_gemma":[0.9966847,0.0029882265,0.000036782472,0.00006268506,0.000017863586,0.00010906843,0.000042360094,0.000027620932,0.00003073206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684787,0.0006333882,0.0007998565,0.00021528378,0.0011290363,0.00037457666],"domain_scores_gemma":[0.99780786,0.0004323479,0.0003354309,0.00079887226,0.0003668312,0.0002586623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011208182,0.00022026664,0.0007391519,0.00016296977,0.00008921609,0.000036655,0.0003694163,0.00003589456,0.00012538845],"category_scores_gemma":[0.0018526335,0.00011925313,0.00037417005,0.00045857544,0.0002329956,0.00013569281,0.00008912147,0.00014750195,0.0000072050475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004899031,0.0015016271,0.98762167,0.000053898824,0.00040021367,0.000005988655,0.00086812,0.0012344468,0.000008256503,0.00019705422,0.0015043897,0.006114453],"study_design_scores_gemma":[0.0031094167,0.00070528244,0.99058396,0.0009376596,0.000010711368,0.000005733667,0.0011610318,0.0017162943,0.000055589124,0.001582962,0.000015124346,0.0001162634],"about_ca_topic_score_codex":0.009598493,"about_ca_topic_score_gemma":0.00079149666,"teacher_disagreement_score":0.008806996,"about_ca_system_score_codex":0.00004509335,"about_ca_system_score_gemma":0.00070432475,"threshold_uncertainty_score":0.9969967},"labels":[],"label_agreement":null},{"id":"W2415685259","doi":"10.1136/annrheumdis-2015-eular.5235","title":"AB0276 Characteristics of Patients with Early Rheumatoid Arthritis (ERA) Over Time: Data from the Catch Cohort Demonstrate that More Patients Achieve Remission in Recent Years","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Southlake Regional Health Center; University of Toronto; University of Winnipeg; Université de Sherbrooke; Western University","funders":"","keywords":"Medicine; Cohort; Rheumatoid arthritis; Internal medicine; Retrospective cohort study; Cohort study; Pediatrics; Physical therapy","score_opus":0.03909670639538801,"score_gpt":0.28831657378105624,"score_spread":0.24921986738566823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415685259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286324,0.0030583995,0.000002077123,0.00095897965,0.00011117064,0.0009627591,0.0019658303,0.00001868428,0.000058835987],"genre_scores_gemma":[0.9708949,0.027667075,0.00004896337,0.00014533928,0.000013228084,0.000022000442,0.0011523496,0.00003573992,0.000020438669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712884,0.0002607967,0.00063257874,0.00032725107,0.001298503,0.00035203795],"domain_scores_gemma":[0.99720484,0.00027312117,0.00047559637,0.0013369193,0.00041207805,0.00029745925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004027558,0.00023461756,0.00062918535,0.00007012961,0.000070676404,0.000047567748,0.0006965015,0.00006571212,0.00015023284],"category_scores_gemma":[0.0011189177,0.0001359089,0.000092025366,0.0002680972,0.00039730716,0.00031026162,0.00034137492,0.00021452665,0.000018281735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011443917,0.00086616207,0.9193802,0.000038128623,0.00023158014,0.000003983171,0.00054260116,0.0000011303216,0.0000049650616,0.0000053153904,0.0089821275,0.06879941],"study_design_scores_gemma":[0.0031399555,0.00029286052,0.99167997,0.0035389885,0.000017818957,0.0000010446946,0.00014671887,0.00011865657,0.00010184354,0.00028432548,0.00053121406,0.00014660522],"about_ca_topic_score_codex":0.00082867435,"about_ca_topic_score_gemma":0.000051243835,"teacher_disagreement_score":0.072299756,"about_ca_system_score_codex":0.000028775159,"about_ca_system_score_gemma":0.0003331422,"threshold_uncertainty_score":0.5542204},"labels":[],"label_agreement":null},{"id":"W2415738923","doi":"10.1136/annrheumdis-2015-eular.3537","title":"FRI0523 Clinical Value of Serum Anti-C1Q Antibodies as a Marker for Nephritis Activity in Pediatric Patients with SLE in Comparison to Anti-DSDNA","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Lupus nephritis; Antibody; Rheumatology; Internal medicine; Autoantibody; Nephritis; Immunology; Proteinuria; Gastroenterology; Disease; Kidney","score_opus":0.08459855892147154,"score_gpt":0.40309373373164986,"score_spread":0.3184951748101783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415738923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574107,0.00079371035,0.000017126744,0.00088780484,0.00017938827,0.0020253886,0.00017269762,0.00001500058,0.00016782487],"genre_scores_gemma":[0.99931616,0.0002302224,0.0001646046,0.00009401047,0.000031081112,0.00005635763,0.000009189337,0.000031380612,0.00006699729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701315,0.00041500427,0.0009710822,0.00031479693,0.0008708064,0.00041513942],"domain_scores_gemma":[0.9972753,0.0009248793,0.0004242976,0.00061275356,0.00046638492,0.00029636294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001230635,0.00020344194,0.0011788183,0.00031814646,0.000030044632,0.00001529253,0.00033407577,0.00008798607,0.000014898243],"category_scores_gemma":[0.0043512024,0.00013414078,0.00020966449,0.00063893845,0.00014503919,0.00014068687,0.00019767351,0.00015087807,0.000010196363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001189739,0.0021675467,0.98696005,0.0023827564,0.00010874983,0.000003743494,0.0006329715,0.00009637085,0.0000038438375,0.000028891876,0.0036996182,0.0027257244],"study_design_scores_gemma":[0.0046486296,0.00072051276,0.9894206,0.0030496167,0.000093394774,0.000007731321,0.00056435907,0.0008884024,0.00018217448,0.0002623255,0.000024822919,0.00013746484],"about_ca_topic_score_codex":0.00029749962,"about_ca_topic_score_gemma":0.00006447584,"teacher_disagreement_score":0.0036747954,"about_ca_system_score_codex":0.00003698848,"about_ca_system_score_gemma":0.00045821397,"threshold_uncertainty_score":0.5470102},"labels":[],"label_agreement":null},{"id":"W2415767628","doi":"10.1136/annrheumdis-2015-eular.2629","title":"SAT0407 Musculoskeletal Complications of Systemic Lupus Erythematosus: Risk Factors for and Prevalence of Avascular Necrosis and Osteoporosis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Avascular necrosis; Osteoporosis; Population; Systemic lupus erythematosus; Lupus erythematosus; Internal medicine; Disease; Pediatrics; Surgery; Immunology; Femoral head","score_opus":0.04357927516774549,"score_gpt":0.30577394208878184,"score_spread":0.2621946669210363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415767628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835274,0.01434127,0.000067212524,0.00026016904,0.00004059733,0.0008297035,0.00089488225,0.000014789128,0.000023935378],"genre_scores_gemma":[0.9969238,0.0027145413,0.00020168281,0.000024681256,0.000005455989,0.000047691246,0.000015957186,0.000014873262,0.000051287498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988274,0.00008236486,0.0004976652,0.00017348713,0.00028276417,0.00013632199],"domain_scores_gemma":[0.9980709,0.00041351104,0.00048870797,0.0004959433,0.00032039476,0.00021053044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021019696,0.00014453364,0.00053675356,0.00006910599,0.00005452813,0.0000074747477,0.00011458361,0.000038521994,0.000008221113],"category_scores_gemma":[0.0013240637,0.00009370955,0.00031093342,0.00011297804,0.00034071616,0.00008902552,0.00008044213,0.00003342449,5.0572334e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020230938,0.000656826,0.96762055,0.021763584,0.0006395075,2.1099471e-7,0.002215134,0.000020876127,0.00030993423,0.0003602889,0.002273119,0.003937673],"study_design_scores_gemma":[0.0021493123,0.0005478702,0.97689456,0.0062219067,0.002921341,0.000037616675,0.004035235,0.00038322387,0.0023145883,0.0042824727,0.000022126573,0.00018973433],"about_ca_topic_score_codex":0.00017900483,"about_ca_topic_score_gemma":0.0000025216507,"teacher_disagreement_score":0.015541677,"about_ca_system_score_codex":0.0000059079784,"about_ca_system_score_gemma":0.000095635216,"threshold_uncertainty_score":0.38213643},"labels":[],"label_agreement":null},{"id":"W2415828555","doi":"10.1136/annrheumdis-2015-eular.1973","title":"OP0178 Body Mass Index is an Independent Risk Factor for not Achieving Sustained Remission in Early Rheumatoid Arthritis: Results from the Catch Observational Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Manitoba; Southlake Regional Health Center; Université de Sherbrooke; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Body mass index; Underweight; Overweight; Internal medicine; Rheumatoid arthritis; Obesity; Cohort","score_opus":0.12951030733086571,"score_gpt":0.36076868003003887,"score_spread":0.23125837269917315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415828555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866621,0.0030003998,0.00006957748,0.005518888,0.00016284897,0.0023095575,0.0022040447,0.000045603043,0.000026989952],"genre_scores_gemma":[0.9936719,0.005430264,0.00011057111,0.00030739547,0.00006464645,0.00016805426,0.0001079974,0.000043430144,0.00009576221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995866,0.00064687064,0.0010610395,0.00047466834,0.0014384801,0.00051296735],"domain_scores_gemma":[0.9960657,0.0012201153,0.00052960246,0.001092401,0.00064312137,0.00044909836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014609154,0.00030235146,0.0006470332,0.000124576,0.0002938282,0.00015176802,0.00068333384,0.00009418153,0.000058520174],"category_scores_gemma":[0.0071680583,0.00018444091,0.00025088232,0.0003113007,0.00017592171,0.00045251468,0.00019392034,0.00032507267,0.000007450236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006326636,0.0017689195,0.9359057,0.00006553015,0.0004921716,0.000012510224,0.014623192,0.00008260156,0.00010581181,0.00011089227,0.004173142,0.03633287],"study_design_scores_gemma":[0.00874104,0.0008014567,0.9701896,0.0017059344,0.000013247901,0.0000028630386,0.011517493,0.0016701685,0.00033720766,0.0044901934,0.00031788068,0.00021292274],"about_ca_topic_score_codex":0.0037761435,"about_ca_topic_score_gemma":0.00040219957,"teacher_disagreement_score":0.03611995,"about_ca_system_score_codex":0.000058816313,"about_ca_system_score_gemma":0.00065511063,"threshold_uncertainty_score":0.85813534},"labels":[],"label_agreement":null},{"id":"W2415874162","doi":"10.1136/annrheumdis-2015-eular.4064","title":"FRI0353 Association of Attitudes Toward Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs and Tumor Necrosis Factor Inhibitors and Treatment Adherence in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: Results from the Global Align Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Ankylosing spondylitis; Internal medicine; Psoriasis; Logistic regression; Tumor necrosis factor alpha; Infliximab; Physical therapy; Immunology","score_opus":0.07148128078639802,"score_gpt":0.32851787917436875,"score_spread":0.2570365983879707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415874162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97680503,0.018750072,0.0000105595145,0.0018789384,0.00012473394,0.0011207158,0.0012704402,0.000021138849,0.000018352092],"genre_scores_gemma":[0.9899859,0.009637406,0.000070716225,0.0001114286,0.000017844324,0.00009350263,0.000053531297,0.000012016787,0.0000176724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729514,0.00039386243,0.00095006987,0.00038539805,0.00072376523,0.00025177188],"domain_scores_gemma":[0.9975536,0.00080934697,0.0007328137,0.00040737502,0.00018706739,0.0003098059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005623565,0.00025308717,0.0006989311,0.00005479459,0.00011602993,0.000080718775,0.00015449236,0.000044245317,0.000041115858],"category_scores_gemma":[0.0024789749,0.00017194176,0.00010511173,0.00022423168,0.00028036532,0.00020172587,0.000108389955,0.000082304476,0.0000047354893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050193764,0.001184672,0.94968337,0.0003223439,0.0003432689,0.0000076187807,0.0039794226,0.000006203024,0.000009537926,0.00018946246,0.00039731618,0.043374877],"study_design_scores_gemma":[0.0056943893,0.0003366404,0.973774,0.01081877,0.00013555634,0.000008574508,0.004653091,0.0005157473,0.000071301176,0.0037969758,0.000022757315,0.00017215629],"about_ca_topic_score_codex":0.001381484,"about_ca_topic_score_gemma":0.00009196778,"teacher_disagreement_score":0.04320272,"about_ca_system_score_codex":0.00008556501,"about_ca_system_score_gemma":0.0003083775,"threshold_uncertainty_score":0.70115817},"labels":[],"label_agreement":null},{"id":"W2416237431","doi":"10.1136/annrheumdis-2015-eular.2812","title":"THU0196 Is the Basdai Score Driven by Pain in Ankylosing Spondylitis Patients Treated with Anti-TNF?","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Saskatchewan; McMaster University; University of Ottawa; Memorial University of Newfoundland","funders":"","keywords":"BASDAI; Medicine; Ankylosing spondylitis; BASFI; Enthesitis; Physical therapy; Internal medicine; Arthritis; Psoriatic arthritis","score_opus":0.035010322717148816,"score_gpt":0.2767837570008888,"score_spread":0.24177343428373999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416237431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920609,0.0031877775,0.0000016411767,0.0027808747,0.000044550157,0.0007238107,0.0006449927,0.000018868937,0.0005365641],"genre_scores_gemma":[0.9980221,0.00041904068,0.000020649848,0.001044734,0.000011257643,0.00003904034,0.00011939157,0.000024450444,0.00029935676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847615,0.00018529806,0.0003284471,0.00021635937,0.00047862536,0.0003151038],"domain_scores_gemma":[0.998816,0.00016816577,0.00018694781,0.00047713358,0.00019734062,0.0001543732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002090158,0.00021207127,0.00044104792,0.000055694996,0.00010551331,0.000024032806,0.00017478922,0.000035094075,0.00009765332],"category_scores_gemma":[0.0004207903,0.00010419534,0.00014265566,0.00033529877,0.00020906184,0.00009419428,0.000079824495,0.00007260348,0.00001305048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003413384,0.00096370635,0.9539122,0.00009828178,0.00030356244,0.000016666787,0.0007196512,0.0000066692483,0.0000023664068,0.000018797828,0.022921229,0.02069555],"study_design_scores_gemma":[0.004923585,0.0011299283,0.98720646,0.003101069,0.00025626793,0.0000070759006,0.0008836674,0.00016865635,0.00033739637,0.0002547007,0.001553486,0.0001776962],"about_ca_topic_score_codex":0.0005193683,"about_ca_topic_score_gemma":0.000038381622,"teacher_disagreement_score":0.03329429,"about_ca_system_score_codex":0.000033589815,"about_ca_system_score_gemma":0.000078216246,"threshold_uncertainty_score":0.42489624},"labels":[],"label_agreement":null},{"id":"W2416438187","doi":"10.1136/annrheumdis-2015-eular.1847","title":"THU0417 Improvements in Extra-Articular Manifestations of Psoriatic Arthritis Over 96 Weeks of Certolizumab Pegol Treatment","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Dactylitis; Psoriatic arthritis; Psoriasis; Certolizumab pegol; Enthesitis; Psoriasis Area and Severity Index; Internal medicine; Clinical endpoint; Placebo; Placebo-controlled study; Surgery; Dermatology; Gastroenterology; Clinical trial; Double blind; Etanercept; Rheumatoid arthritis; Pathology","score_opus":0.04890140752926477,"score_gpt":0.29021960478177783,"score_spread":0.24131819725251305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416438187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926353,0.009125568,0.000008565864,0.00026391548,0.00027298267,0.00046066998,0.00038199383,0.000010894788,0.00021184723],"genre_scores_gemma":[0.99834174,0.0011707919,0.000027863853,0.000013840019,0.000005520565,0.00007642624,0.00006361533,0.000012178941,0.0002880407],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99866766,0.00024399451,0.00059741543,0.0001632931,0.00010070731,0.0002269089],"domain_scores_gemma":[0.9988336,0.00017329118,0.00039868764,0.00044532816,0.000107882435,0.000041227257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074578216,0.0001790461,0.0004696463,0.00010722032,0.000041649433,0.0000045463444,0.00020559641,0.00007060863,0.00016676301],"category_scores_gemma":[0.0001791573,0.00012255104,0.0002521475,0.00015592929,0.00014705448,0.00009227258,0.000050585568,0.000031206448,0.000020051624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019607958,0.013199028,0.117822304,0.00089365785,0.0061300835,0.00010078968,0.011080348,0.00025992573,0.012706211,0.0042196023,0.004144908,0.82748234],"study_design_scores_gemma":[0.023822844,0.003055704,0.70466226,0.002498008,0.0020429112,0.00011681302,0.0038581064,0.00014417613,0.23895893,0.019628663,0.0005108382,0.000700736],"about_ca_topic_score_codex":0.00063731737,"about_ca_topic_score_gemma":0.00010608132,"teacher_disagreement_score":0.82678163,"about_ca_system_score_codex":0.000026580927,"about_ca_system_score_gemma":0.00014300083,"threshold_uncertainty_score":0.49974865},"labels":[],"label_agreement":null},{"id":"W2416494790","doi":"10.1136/annrheumdis-2015-eular.6284","title":"THU0582 Readability of Online Ankylosing Spondylitis Patient Education Material","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Readability; Medicine; Intraclass correlation; Ankylosing spondylitis; The Internet; Reading (process); Patient education; Test (biology); Grade level; Medical education; Medical physics; Family medicine; Physical therapy; World Wide Web; Internal medicine; Computer science; Psychology; Mathematics education","score_opus":0.0508583560012589,"score_gpt":0.34067681258848675,"score_spread":0.2898184565872278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416494790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171525,0.004317864,0.0000032229298,0.0020097126,0.00030000304,0.0004225838,0.00079669367,0.000019530175,0.00041513497],"genre_scores_gemma":[0.9979735,0.0013604569,0.00022358946,0.00015276491,0.000042644155,0.000016708052,0.00015551518,0.000013168434,0.000061676226],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984807,0.00017865127,0.0004725767,0.00013667929,0.00054022163,0.00019121669],"domain_scores_gemma":[0.9984354,0.00008923158,0.00022784378,0.00052258896,0.00049503363,0.0002298954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022240473,0.00011333711,0.00034983415,0.00007153097,0.00004154249,0.000016302734,0.00015732736,0.00003054861,0.00025832627],"category_scores_gemma":[0.0013905121,0.000074023665,0.00016233817,0.00015540015,0.00026449354,0.00012251233,0.000088107976,0.00005347317,0.000004237733],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002925229,0.006232503,0.045039468,0.0015023857,0.00035867843,0.0000035933535,0.0027369126,0.000017188673,0.00090497214,0.0012322849,0.023805859,0.91524094],"study_design_scores_gemma":[0.0023984716,0.004913391,0.65851396,0.019050842,0.00017724354,0.00016393879,0.013576106,0.0005132781,0.19470511,0.0809764,0.024163136,0.000848116],"about_ca_topic_score_codex":0.00040842997,"about_ca_topic_score_gemma":0.000011993992,"teacher_disagreement_score":0.9143928,"about_ca_system_score_codex":0.000019591724,"about_ca_system_score_gemma":0.00066802045,"threshold_uncertainty_score":0.30185974},"labels":[],"label_agreement":null},{"id":"W2416499912","doi":"10.1136/annrheumdis-2015-eular.2429","title":"THU0443 The Levels of the Adipokines Leptin, Adipsin and Adiponectin Predict Knee Osteoarthritis Progression as Assessed by MRI and Total Knee Replacement Occurrence in Symptomatic Patients","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Adipokine; Resistin; Adiponectin; Osteoarthritis; Leptin; Internal medicine; Population; Body mass index; Obesity; Pathology; Insulin resistance","score_opus":0.023143832517180916,"score_gpt":0.289952699847442,"score_spread":0.26680886733026105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416499912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889261,0.007410955,0.0000015845708,0.0010330747,0.00021201745,0.0018972231,0.0003313367,0.000021179894,0.00016652547],"genre_scores_gemma":[0.99936694,0.00010727229,0.00003750364,0.00013909744,0.000011794861,0.00014514006,0.000026978418,0.00001599898,0.00014928928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979708,0.00031322739,0.00054850813,0.00026207694,0.00064863893,0.00025674765],"domain_scores_gemma":[0.9983777,0.00029869203,0.0004264244,0.00053885556,0.00018208938,0.00017628564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004146401,0.00024169432,0.00045016553,0.000060573715,0.00012446663,0.0000345429,0.00015617021,0.000061826795,0.000027787732],"category_scores_gemma":[0.0011892681,0.000121995865,0.00011381253,0.00022231856,0.00029145245,0.00016071057,0.00021856418,0.000119069395,0.0000023110624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014975742,0.002624631,0.5591955,0.0014540856,0.00037136316,0.000007470877,0.0036757542,0.000012879804,0.00059958675,0.00029923258,0.0065008607,0.42376104],"study_design_scores_gemma":[0.020810844,0.014041901,0.9226018,0.02078595,0.0010809066,0.00010584157,0.0027740519,0.00047718547,0.013429222,0.003090243,0.00026189734,0.0005401346],"about_ca_topic_score_codex":0.000041583928,"about_ca_topic_score_gemma":0.000018395125,"teacher_disagreement_score":0.4232209,"about_ca_system_score_codex":0.000018915009,"about_ca_system_score_gemma":0.00015764944,"threshold_uncertainty_score":0.49748468},"labels":[],"label_agreement":null},{"id":"W2416618882","doi":"10.1136/annrheumdis-2020-eular.1235","title":"OP0197 THE INITIAL TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: AN INTERNATIONAL COLLABORATION AMONG 10 REGISTRIES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Agricultural Research Institute of Ontario","funders":"","keywords":"Medicine; Anakinra; Rheumatology; Internal medicine; Arthritis; Bristol-Myers; Interquartile range; Pediatrics; Disease","score_opus":0.06654668516877009,"score_gpt":0.35036136828423803,"score_spread":0.2838146831154679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416618882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98391885,0.007944084,0.000013669656,0.0067227967,0.0000949396,0.00061709207,0.00012052093,0.000024535637,0.0005435051],"genre_scores_gemma":[0.99662936,0.002828852,0.000004253698,0.00014205484,0.000056214598,0.000061597384,0.00004741031,0.000012160827,0.0002180854],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99851274,0.00018163466,0.00057979143,0.0001334265,0.00046717827,0.00012523677],"domain_scores_gemma":[0.99872154,0.00007075293,0.00037271754,0.00040369885,0.00034221428,0.000089056826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001712677,0.00011355085,0.00040262952,0.000039255843,0.00009367609,0.000035703924,0.0002719232,0.00003825044,0.00017720368],"category_scores_gemma":[0.0008414033,0.00006535669,0.00016320395,0.00021200883,0.0002682102,0.00024261039,0.000051997784,0.000050473165,0.000012306845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011606778,0.008399478,0.22722183,0.009314839,0.0057503628,0.00015334804,0.077320434,0.0025417623,0.0056241457,0.011649777,0.063929096,0.57648814],"study_design_scores_gemma":[0.022101633,0.015627231,0.7078381,0.027903069,0.0015606288,0.00014080104,0.096367754,0.02682619,0.07610074,0.003689782,0.020476999,0.0013670543],"about_ca_topic_score_codex":0.00009580402,"about_ca_topic_score_gemma":0.000012076524,"teacher_disagreement_score":0.5751211,"about_ca_system_score_codex":0.000021749574,"about_ca_system_score_gemma":0.00045558476,"threshold_uncertainty_score":0.26651683},"labels":[],"label_agreement":null},{"id":"W2416816419","doi":"10.1136/annrheumdis-2015-eular.1892","title":"THU0483 Relation of Synovitis, Effusions, Bone Marrow Lesions and Cartilage Damage to Pain Sensitisation in People with Knee Osteoarthritis Presenting for Total Knee Replacement: An Observational Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Osteoarthritis; Synovitis; Magnetic resonance imaging; Effusion; Cartilage; Knee pain; Surgery; Arthritis; Radiology; Internal medicine; Pathology; Anatomy","score_opus":0.07142060527205843,"score_gpt":0.31420565344942586,"score_spread":0.24278504817736743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416816419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596894,0.0002870344,0.00006991876,0.000657625,0.00005193987,0.0027776668,0.00012943603,0.000020390746,0.0000370287],"genre_scores_gemma":[0.99841774,0.000008400532,0.0008715258,0.00008413463,0.000017449176,0.00020578121,0.00017802216,0.000020018448,0.00019690928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984742,0.0002805708,0.00043903998,0.00022327463,0.00040683543,0.00017611308],"domain_scores_gemma":[0.99872226,0.00032282353,0.00021707364,0.00033232462,0.00023432756,0.00017117626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072392606,0.00014048039,0.00035510366,0.00012207568,0.0001022857,0.000019379619,0.00003959152,0.000035885216,0.000010850563],"category_scores_gemma":[0.0011718946,0.00010858549,0.000060747916,0.00022044484,0.000039090814,0.00022656431,0.00006385359,0.000047865247,6.595407e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028375455,0.002588794,0.9229578,0.00060438586,0.00010244707,0.000025191277,0.011020326,0.00049408636,0.0035911654,0.00077724474,0.00053327665,0.05446777],"study_design_scores_gemma":[0.008261435,0.010890961,0.9632344,0.002108448,0.0002727793,0.00001899485,0.011196195,0.0013487883,0.0016223615,0.0008423382,0.0000112453745,0.00019202234],"about_ca_topic_score_codex":0.00013018242,"about_ca_topic_score_gemma":0.00076134823,"teacher_disagreement_score":0.05427575,"about_ca_system_score_codex":0.000020603666,"about_ca_system_score_gemma":0.00012315284,"threshold_uncertainty_score":0.4427988},"labels":[],"label_agreement":null},{"id":"W2417137723","doi":"10.1136/annrheumdis-2015-eular.5368","title":"AB0946 Association of Cognitive Function with Serum Uric Acid and Mean Platelet Volume Levels Between Fibromyalgia Syndrome and Healthy Subjects","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mean platelet volume; Fibromyalgia; Internal medicine; Beck Depression Inventory; Outpatient clinic; Physical therapy; Montreal Cognitive Assessment; Quality of life (healthcare); Trail Making Test; Platelet activation; Cognition; Visual analogue scale; Platelet; Dementia; Cognitive impairment; Anxiety; Psychiatry; Disease","score_opus":0.05173147448166945,"score_gpt":0.3069534172441642,"score_spread":0.25522194276249477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417137723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940547,0.0032167742,0.000027997843,0.0017893986,0.0000335084,0.00057636265,0.00022614175,0.00002233699,0.00005282449],"genre_scores_gemma":[0.99933887,0.0001859835,0.000030053836,0.000017947848,0.000006629912,0.000014989837,0.000040644787,0.00002226217,0.0003426183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998141,0.00019898481,0.00036783278,0.00022598187,0.00074716256,0.00031907106],"domain_scores_gemma":[0.9983395,0.00035280647,0.00035433378,0.00023737187,0.0003845288,0.0003314566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050519645,0.00017471862,0.0005588944,0.00012360931,0.000080925936,0.000020086563,0.000089894056,0.000090066,0.00005117249],"category_scores_gemma":[0.00072021905,0.00011777075,0.000075688855,0.00030387205,0.0002049455,0.00017239874,0.00008515846,0.0001420523,0.0000071264108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017875966,0.00048502392,0.95789325,0.020149617,0.00240347,0.000021917487,0.0023923973,0.0000072742964,0.000082292296,0.000073487885,0.0035718135,0.011131863],"study_design_scores_gemma":[0.00260048,0.002756803,0.9870167,0.0049023842,0.00039232546,0.00006399256,0.00071566075,0.000091960355,0.0006473542,0.0006807026,0.0000045630923,0.00012708688],"about_ca_topic_score_codex":0.00010760164,"about_ca_topic_score_gemma":0.0000025808877,"teacher_disagreement_score":0.02912344,"about_ca_system_score_codex":0.0000500136,"about_ca_system_score_gemma":0.00042082294,"threshold_uncertainty_score":0.4802552},"labels":[],"label_agreement":null},{"id":"W2417322539","doi":"10.1136/annrheumdis-2015-eular.2776","title":"THU0337 Worse Disease Trajectory in Early RA Patients is Associated with Lower Improvements in Health Related Quality of Life; Results from a Multicenter Early RA Cohort","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Montréal; Southlake Regional Health Center; University of Manitoba; Mount Sinai Hospital; University of Calgary; McGill University; Université de Sherbrooke","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Cohort study; Internal medicine; Physical therapy; Demography; Pediatrics","score_opus":0.05068943298480148,"score_gpt":0.31542271982171743,"score_spread":0.26473328683691594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417322539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332356,0.0025872057,7.8909267e-7,0.0011025089,0.00011005873,0.0015871084,0.0012107376,0.000025799005,0.00005224491],"genre_scores_gemma":[0.9982569,0.0009663019,0.000014726718,0.00035358823,0.0000067978267,0.000057856527,0.00018421732,0.000033101656,0.00012648264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534005,0.00088082184,0.0016333691,0.00037979876,0.0012604673,0.0005054899],"domain_scores_gemma":[0.9968054,0.0003949678,0.0009173627,0.00071970443,0.00043012667,0.00073243346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012346258,0.00025888142,0.0009495964,0.00020367863,0.000047346748,0.000026560752,0.00029524398,0.00006885413,0.000053855834],"category_scores_gemma":[0.005659199,0.000176431,0.00021225963,0.00046239348,0.00027992393,0.00026909795,0.00010179188,0.00023626964,0.000008969137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012313125,0.0039421087,0.9750742,0.00017359047,0.0005315726,0.000009843921,0.0050353794,0.000021506585,0.000005372711,0.000006539098,0.001059904,0.0018268568],"study_design_scores_gemma":[0.017669214,0.0006940811,0.97528654,0.005230227,0.000017676555,6.369755e-8,0.00035336395,0.00021620773,0.000026624868,0.00033717832,0.00000857731,0.00016026296],"about_ca_topic_score_codex":0.017764803,"about_ca_topic_score_gemma":0.00064953126,"teacher_disagreement_score":0.01711527,"about_ca_system_score_codex":0.0000953508,"about_ca_system_score_gemma":0.0006964058,"threshold_uncertainty_score":0.98877597},"labels":[],"label_agreement":null},{"id":"W2417600579","doi":"10.1136/annrheumdis-2015-eular.3482","title":"SAT0115 Rheumatoid Arthritis Also Disadvantages Female and Younger Patients for Cardiovascular Disease: Results of a Systematic Review with Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Meta-analysis; Population; Internal medicine; Incidence (geometry); Rheumatoid arthritis; Cochrane Library; Mortality rate; Coronary artery disease; Rate ratio; Observational study; Stroke (engine); Confidence interval","score_opus":0.13122784785103486,"score_gpt":0.37142023849963746,"score_spread":0.2401923906486026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417600579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064603446,0.98327357,0.000020460082,0.00018332229,0.00004466838,0.009403909,0.006950976,0.000029879315,0.000028640514],"genre_scores_gemma":[0.0010305782,0.9955773,0.0001007311,0.00007040094,0.00001170937,0.0021807947,0.0007907871,0.00009767682,0.00014007404],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99274355,0.0011761338,0.0027150915,0.00073757756,0.0021066507,0.00052099064],"domain_scores_gemma":[0.99150527,0.0010263883,0.0025925664,0.0028664842,0.001342068,0.00066720526],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019416487,0.0008151777,0.014591149,0.00039063278,0.00013265427,0.00006187767,0.0006185861,0.00010819006,0.000034071578],"category_scores_gemma":[0.0054848753,0.00040632064,0.011604701,0.00095288357,0.00054148724,0.0002332726,0.00021904061,0.00017433304,0.0000057425686],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017164263,0.00036948564,0.000027999438,0.662111,0.302648,0.0000046364025,0.00005506421,0.0000035268781,2.4411773e-9,0.000046221656,0.0018540773,0.032708343],"study_design_scores_gemma":[0.001556513,0.00032741207,0.000057831858,0.57331884,0.3831668,0.000022716304,0.00006174044,0.000006650556,4.9261797e-7,0.000120323806,0.04091764,0.0004430606],"about_ca_topic_score_codex":0.00007182594,"about_ca_topic_score_gemma":0.0000085136535,"teacher_disagreement_score":0.08879218,"about_ca_system_score_codex":0.00002890612,"about_ca_system_score_gemma":0.0005582712,"threshold_uncertainty_score":0.9998389},"labels":[],"label_agreement":null},{"id":"W2417672353","doi":"10.1136/annrheumdis-2015-eular.3822","title":"FRI0154 Incidence of Cancers in Patients with Rheumatoid Arthritis and a History of Cancer Treated with Rituximab or Abatacept","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Abatacept; Rituximab; Cancer; Internal medicine; Rheumatoid arthritis; Incidence (geometry); Oncology; Lymphoma","score_opus":0.0348785620371985,"score_gpt":0.3009865286675026,"score_spread":0.26610796663030406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417672353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818934,0.01715368,0.000001767198,0.00011043304,0.000027530074,0.000576593,0.000096614145,0.000008794541,0.00013114681],"genre_scores_gemma":[0.9959654,0.003655896,0.00005597097,0.000053251675,0.00000330252,0.00005421318,0.000008159247,0.000020867572,0.00018293233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982842,0.0000811203,0.0004349345,0.00019290965,0.00077345816,0.00023336505],"domain_scores_gemma":[0.9983681,0.00015593763,0.0003583789,0.0004481846,0.00046861832,0.00020077596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016068359,0.00015909997,0.0006432878,0.0001272648,0.000013508026,0.0000035600087,0.00017911466,0.00003794377,0.00008527592],"category_scores_gemma":[0.00047851357,0.0000869861,0.000049753748,0.00029891537,0.00066787377,0.0001352689,0.00007947694,0.00007468673,7.9978423e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01484954,0.0015667682,0.93194824,0.0026873373,0.0006190104,0.000030888412,0.004124273,0.00043225987,0.000011446648,0.000030219571,0.007947061,0.035752933],"study_design_scores_gemma":[0.08878124,0.0033738858,0.8636447,0.037277866,0.00022257233,0.000031957814,0.0014459454,0.002750835,0.0017122517,0.000091887276,0.0002638763,0.0004029569],"about_ca_topic_score_codex":0.021232963,"about_ca_topic_score_gemma":0.0021000833,"teacher_disagreement_score":0.073931694,"about_ca_system_score_codex":0.0020355654,"about_ca_system_score_gemma":0.010795068,"threshold_uncertainty_score":0.9948128},"labels":[],"label_agreement":null},{"id":"W2417953706","doi":"10.1136/annrheumdis-2015-eular.1900","title":"SAT0476 Cognitive Impairment and Mood Disorders are Associated with Hippocampal and Amigdala Volumes in Systemic Sclerosis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; Mood disorders; Internal medicine; Depression (economics); Mood; Anxiety; Cognitive impairment; Disease; Psychiatry","score_opus":0.040789494033870305,"score_gpt":0.264228372643664,"score_spread":0.2234388786097937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417953706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784421,0.019482316,0.0000021588476,0.0008884626,0.000056081197,0.00084799854,0.00012313083,0.000034665252,0.00012314139],"genre_scores_gemma":[0.9965122,0.0031687447,0.0000037531133,0.00014106133,0.000010262307,0.00006764633,0.000016301286,0.000023552555,0.000056503053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844533,0.00020585561,0.00040985062,0.00025246732,0.00043136475,0.000255146],"domain_scores_gemma":[0.99864525,0.00027354676,0.0003543881,0.0002218485,0.00017833812,0.00032664769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027251997,0.00021398623,0.0005624479,0.00010358846,0.00006549278,0.000031742322,0.000086922664,0.000076997654,0.000007728345],"category_scores_gemma":[0.00094765687,0.00012613737,0.00010136165,0.00026713137,0.00028555098,0.00009744826,0.00007855881,0.00008680574,0.0000021022076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045956814,0.00077307114,0.9887114,0.0006386292,0.0005511275,0.0000024840508,0.0012325656,0.000026657985,0.000014455391,0.000015088808,0.0008323041,0.006742631],"study_design_scores_gemma":[0.003950919,0.00034428117,0.9460963,0.037432943,0.0004839819,0.000015943022,0.010710177,0.00051069167,0.00004031175,0.0002585255,4.9873796e-7,0.0001553985],"about_ca_topic_score_codex":0.00018016872,"about_ca_topic_score_gemma":0.000079246565,"teacher_disagreement_score":0.04261509,"about_ca_system_score_codex":0.000034716344,"about_ca_system_score_gemma":0.00013718974,"threshold_uncertainty_score":0.51437324},"labels":[],"label_agreement":null},{"id":"W2418013315","doi":"10.1136/annrheumdis-2015-eular.5805","title":"AB0258 Predictors of Maladaptive Coping Strategies in Patients with Rheumatoid Arthritis","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Visual analogue scale; McGill Pain Questionnaire; Beck Depression Inventory; Physical therapy; Coping (psychology); Anxiety; Rheumatoid arthritis; Pain catastrophizing; Internal medicine; Chronic pain; Clinical psychology; Psychiatry","score_opus":0.026462223961796393,"score_gpt":0.27752353791034173,"score_spread":0.25106131394854536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418013315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990948,0.0072032646,0.000017449716,0.00040111525,0.00009141896,0.0006225949,0.000073892676,0.000023624423,0.0006186384],"genre_scores_gemma":[0.99280906,0.0069686035,0.00007416554,0.00004698811,0.0000085211395,0.000030552965,0.000017624325,0.000021511309,0.00002299906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980208,0.00013536224,0.0005286137,0.0001740602,0.0008282373,0.0003129155],"domain_scores_gemma":[0.9984878,0.00013240242,0.0002687145,0.00041117202,0.00046517586,0.00023473565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002205971,0.00017677792,0.0005633384,0.00015196454,0.000041085932,0.000025567178,0.00021976783,0.000039916486,0.00004622639],"category_scores_gemma":[0.0005158815,0.000111667156,0.00012541021,0.00030534153,0.00044370818,0.00030934208,0.00008250784,0.000109351095,0.000004751802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015922282,0.0010493903,0.9790352,0.00032044674,0.00037785977,0.000005474264,0.0020752458,0.00018718005,0.000005833753,0.001965681,0.0025311052,0.010854328],"study_design_scores_gemma":[0.0053558685,0.0011358791,0.9804622,0.0073946356,0.0000069400544,0.0000045949687,0.002665059,0.000048885737,0.0003540346,0.002231207,0.00019411229,0.00014660714],"about_ca_topic_score_codex":0.00017492218,"about_ca_topic_score_gemma":0.0000502817,"teacher_disagreement_score":0.010707721,"about_ca_system_score_codex":0.000018073293,"about_ca_system_score_gemma":0.0004921498,"threshold_uncertainty_score":0.45536545},"labels":[],"label_agreement":null},{"id":"W2418442723","doi":"10.1136/annrheumdis-2015-eular.3179","title":"THU0223 Serum Biomarkers Associated with Changes in Asdas and MRI Following Treatment of Ankylosing Spondylitis with Golimumab","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Instituto de Salud Carlos III","keywords":"Medicine; Ankylosing spondylitis; Golimumab; Magnetic resonance imaging; Internal medicine; Haptoglobin; Biomarker; Serum amyloid A; Gastroenterology; Imaging biomarker; Inflammation; Radiology; Adalimumab; Disease","score_opus":0.04806705687268151,"score_gpt":0.2984891679709047,"score_spread":0.2504221110982232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418442723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975354,0.0076322467,7.428141e-7,0.0015013479,0.000038172562,0.0005156239,0.000266728,0.00001640788,0.00027515838],"genre_scores_gemma":[0.9987869,0.00090311223,0.000066659384,0.00005617558,0.000005887545,0.00003639961,0.00003516739,0.000019448473,0.00009024057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896646,0.00007315187,0.0002189904,0.00017701049,0.00032522093,0.00023915301],"domain_scores_gemma":[0.99920017,0.00013572206,0.00019141585,0.00024872983,0.000091533584,0.00013242605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010468958,0.00018682524,0.0005628479,0.000093507144,0.00005405471,0.000010592091,0.000052804542,0.000030339806,0.000012771979],"category_scores_gemma":[0.00014194628,0.000101249214,0.00009500129,0.00028089774,0.00015221824,0.000065283246,0.00003384535,0.000022714099,4.5297017e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016974292,0.0015178741,0.9708394,0.00018323239,0.0030214183,0.00014572349,0.0027297572,0.000012304073,0.00001027638,0.000035393838,0.00016388373,0.019643337],"study_design_scores_gemma":[0.010500787,0.0036301375,0.9760237,0.005233304,0.0007710881,0.000025675705,0.0025832453,0.00006364763,0.00073407555,0.0002079228,0.00007475243,0.00015166811],"about_ca_topic_score_codex":0.0005013159,"about_ca_topic_score_gemma":0.0007999724,"teacher_disagreement_score":0.019491669,"about_ca_system_score_codex":0.000056151246,"about_ca_system_score_gemma":0.000099333454,"threshold_uncertainty_score":0.4128823},"labels":[],"label_agreement":null},{"id":"W2418763169","doi":"10.1136/annrheumdis-2015-eular.4039","title":"SAT0415 Performance of Anti-Nuclear Antibodies (ANA) for Classifying Systemic Lupus Erythematosus (SLE): A Systematic Literature Review and Meta-Regression of Diagnostic Data","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; IIf; Population; Meta-analysis; Gold standard (test); Systematic review; Titer; MEDLINE; Internal medicine; Indirect immunofluorescence; Immunology; Antibody","score_opus":0.1491823522325431,"score_gpt":0.37651595113255715,"score_spread":0.22733359890001406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418763169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52670527,0.46952862,0.000004561014,0.0014954134,0.000092828035,0.0015040602,0.00062076247,0.000011592364,0.00003691622],"genre_scores_gemma":[0.85220003,0.14703493,0.0001752117,0.00017162568,0.00001595572,0.000044701505,0.00006353109,0.000023097089,0.00027093332],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976089,0.00024006494,0.00094682415,0.00026241507,0.00069025875,0.00025151795],"domain_scores_gemma":[0.9958318,0.0014895033,0.0008002663,0.0010546122,0.00062462303,0.00019922457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009436145,0.00027086522,0.0020696071,0.00011476252,0.00008065194,0.000020034295,0.0005555849,0.00005902063,0.000013303327],"category_scores_gemma":[0.0055812737,0.00012450962,0.00036513348,0.00027789068,0.0002933603,0.00021381796,0.00043055252,0.00010565747,0.0000022072556],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002946282,0.0002831685,0.0128086,0.9680645,0.0026820695,0.000006997219,0.00047541846,0.000008696616,0.00012339358,0.00034565976,0.014439,0.00046788424],"study_design_scores_gemma":[0.00198596,0.0010220405,0.009365822,0.95180607,0.025162723,0.0013368833,0.0010572746,0.006034102,0.001050413,0.00039703332,0.00031720256,0.00046446628],"about_ca_topic_score_codex":0.000016315933,"about_ca_topic_score_gemma":9.4280864e-7,"teacher_disagreement_score":0.32549477,"about_ca_system_score_codex":0.0000077074865,"about_ca_system_score_gemma":0.00012348576,"threshold_uncertainty_score":0.6681709},"labels":[],"label_agreement":null},{"id":"W2418807167","doi":"10.1136/annrheumdis-2015-eular.2281","title":"OP0054 Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 48 Data from the Fasscinate Trial","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Medicine; Tocilizumab; Internal medicine; Multiple sclerosis; Clinical trial; Dermatology; Immunology; Rheumatoid arthritis","score_opus":0.10390714737541781,"score_gpt":0.2989464735270519,"score_spread":0.19503932615163408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418807167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604048,0.03571996,0.0000039009656,0.0011224231,0.00021276763,0.0016286593,0.00076364435,0.000025074694,0.000118782635],"genre_scores_gemma":[0.99498516,0.0046365736,0.000013879348,0.00011974949,0.000052591604,0.000025777832,0.000096664684,0.000024167048,0.000045436347],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974974,0.00034649562,0.0008789095,0.00035638685,0.0006809213,0.00023988572],"domain_scores_gemma":[0.99669784,0.00084406754,0.0005509442,0.0014758263,0.0001936822,0.00023764365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004979098,0.00022540281,0.00075754424,0.000058014626,0.000064858556,0.000026184924,0.0006662134,0.000080812875,0.00002701064],"category_scores_gemma":[0.0016720139,0.00010648785,0.00013660971,0.0002930947,0.00029780532,0.000118909746,0.00028050735,0.00011898897,0.000007717493],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72421795,0.009712421,0.08354593,0.0060030725,0.0050459104,0.00011883565,0.01342486,0.0011383153,0.00028887956,0.00036907181,0.04728451,0.10885022],"study_design_scores_gemma":[0.20270361,0.0032039825,0.5744784,0.19050772,0.0032275724,0.00022645385,0.0193853,0.0047280956,0.0002840662,0.0004776782,0.000072573894,0.0007045756],"about_ca_topic_score_codex":0.0013384118,"about_ca_topic_score_gemma":0.000056869707,"teacher_disagreement_score":0.52151436,"about_ca_system_score_codex":0.000026738453,"about_ca_system_score_gemma":0.00037198036,"threshold_uncertainty_score":0.43424487},"labels":[],"label_agreement":null},{"id":"W2419212055","doi":"10.1136/annrheumdis-2015-eular.4375","title":"SAT0233 Acute Anterior Uveitis in Ankylosing Spondylitis: Association with Inflammatory Bowel Disease and Psoriasis Independent of HLA-B27","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriasis; Uveitis; Internal medicine; Cohort; Psoriatic arthritis; Inflammatory bowel disease; Spondylitis; HLA-B27; Logistic regression; Cohort study; Disease; Dermatology; Immunology; Human leukocyte antigen","score_opus":0.021534755309878976,"score_gpt":0.2810186188263307,"score_spread":0.25948386351645175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419212055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990231,0.0076111946,0.0000017882554,0.0009769275,0.00009316293,0.00046045973,0.00050432177,0.000015548447,0.000105618776],"genre_scores_gemma":[0.9976444,0.0019761221,0.000043503413,0.00013078324,0.000018384408,0.00003899353,0.000025346928,0.000017467317,0.000104974475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853134,0.000093041985,0.00042050917,0.00018386866,0.00054517353,0.00022606224],"domain_scores_gemma":[0.99881965,0.00009555388,0.00036594967,0.00028966248,0.00019741066,0.00023178128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021127111,0.00016586813,0.0004518213,0.00010455642,0.000049669194,0.000017265262,0.00008466396,0.000040756306,0.00002481766],"category_scores_gemma":[0.00048430858,0.00011260752,0.000117184405,0.00015320115,0.000113167385,0.00015014794,0.00009718269,0.000062198276,0.0000019562442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015652516,0.00045717193,0.98951143,0.00044709555,0.00081448356,0.000094141324,0.0009629177,0.000008061547,0.000015718002,0.000057632715,0.000491402,0.005574671],"study_design_scores_gemma":[0.0038993673,0.0003086499,0.9899947,0.0034319584,0.0005589026,0.000013324478,0.00077205495,0.000045253273,0.00024913266,0.000573058,0.00004451635,0.00010910503],"about_ca_topic_score_codex":0.0001368365,"about_ca_topic_score_gemma":0.000070521724,"teacher_disagreement_score":0.0074134464,"about_ca_system_score_codex":0.00006693497,"about_ca_system_score_gemma":0.00016632453,"threshold_uncertainty_score":0.45920014},"labels":[],"label_agreement":null},{"id":"W2419229113","doi":"10.1136/annrheumdis-2015-eular.3159","title":"THU0349 Analysis of Real Costs of Biologic Therapy for the Treatment of Chronic Inflammatory Arthropaties in a Tertiary University Hospital. A Pilot Study","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IBI Group (Canada)","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Adverse effect; Rheumatology; Observational study; Retrospective cohort study; Pediatrics","score_opus":0.055510783595355245,"score_gpt":0.32056363152898515,"score_spread":0.26505284793362993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419229113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193264,0.015990099,0.000008880062,0.00030061245,0.000033756045,0.001551909,0.00015512583,0.000007344938,0.00001965786],"genre_scores_gemma":[0.93721926,0.06268778,0.0000069829166,0.000007069148,0.0000062339354,0.000036505135,0.000011278445,0.0000069970824,0.000017874256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868125,0.0002561469,0.00043535398,0.00013066687,0.00031566067,0.00018090077],"domain_scores_gemma":[0.9982349,0.0005353146,0.00036708353,0.0005031815,0.00028810572,0.00007140678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003380176,0.0001311394,0.0006415513,0.00023196187,0.00003935246,0.0000036028562,0.00023677803,0.000019370504,0.000020566085],"category_scores_gemma":[0.00019841369,0.00006790383,0.0003023119,0.0004132397,0.00047886683,0.00006186851,0.00004296382,0.000031179155,3.0826288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003412567,0.010497096,0.9320299,0.00014516064,0.005674478,0.0000027902527,0.005193502,0.00027640542,0.000109166605,0.00035176871,0.0001504322,0.04215675],"study_design_scores_gemma":[0.004645623,0.018989114,0.9670312,0.00040807252,0.0002368491,2.7112776e-7,0.00683509,0.000688519,0.0007033806,0.0003376905,0.000050468265,0.000073743264],"about_ca_topic_score_codex":0.0020978565,"about_ca_topic_score_gemma":0.0010310734,"teacher_disagreement_score":0.046697676,"about_ca_system_score_codex":0.000052924726,"about_ca_system_score_gemma":0.00031191972,"threshold_uncertainty_score":0.31713453},"labels":[],"label_agreement":null},{"id":"W2419294655","doi":"10.1136/annrheumdis-2015-eular.3211","title":"THU0369 Costs of Early Spondyloarthritis: Estimates from the First Three Years of the Desir Cohort","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Medicine; Cohort; Indirect costs; Emergency medicine; Pediatrics; Cohort study; Total cost; Medical costs; Public health; Health care; Internal medicine","score_opus":0.049929875280746716,"score_gpt":0.292205700321741,"score_spread":0.24227582504099426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419294655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98082274,0.015421125,0.0000032810544,0.0019035069,0.00021492378,0.0007409954,0.00052034535,0.000015462252,0.00035764772],"genre_scores_gemma":[0.9988437,0.00072382763,0.00006251392,0.00023158277,0.00002516723,0.000041275194,0.0000132537125,0.000020270563,0.000038388534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984904,0.00006459526,0.00045321952,0.00016553917,0.00061592564,0.00021032755],"domain_scores_gemma":[0.9978656,0.00054864166,0.00037243473,0.0008695269,0.0002433251,0.000100469515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019017787,0.00017030282,0.0005289636,0.000025133113,0.00010383316,0.000013076008,0.00042447814,0.000042247248,0.000052213873],"category_scores_gemma":[0.001054812,0.00008606216,0.0003395901,0.00022479195,0.00054727093,0.000064780594,0.00023432501,0.00007258171,0.000012002256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033279715,0.00048842054,0.9739564,0.00008062473,0.0009135029,0.000007222188,0.00070080307,0.00001824796,0.0000100357765,0.0003541065,0.0064991964,0.01663865],"study_design_scores_gemma":[0.0015166269,0.00024407903,0.9903349,0.002566458,0.00048092596,0.0000052688843,0.00033373872,0.000029763718,0.0006023066,0.0036618419,0.00014614602,0.000077896635],"about_ca_topic_score_codex":0.0023897272,"about_ca_topic_score_gemma":0.00044606667,"teacher_disagreement_score":0.018021008,"about_ca_system_score_codex":0.000018466919,"about_ca_system_score_gemma":0.00012774135,"threshold_uncertainty_score":0.36125684},"labels":[],"label_agreement":null},{"id":"W2419464122","doi":"10.1136/annrheumdis-2015-eular.3172","title":"OP0200 Global DNA Methylation Patterns Differ Between Responders and Non-Responders in Psoriatic Arthritis Patients Treated with Tumor Necrosis Factor-α Inhibitors","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Etanercept; CpG site; Internal medicine; DNA methylation; Oncology; Tumor necrosis factor alpha; Methylation; Arthritis; Gene; Gene expression; Genetics","score_opus":0.025567294473335753,"score_gpt":0.27782022340690965,"score_spread":0.2522529289335739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419464122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825656,0.0007566159,0.00010391964,0.0001488817,0.000052536387,0.00035538737,0.00029295703,0.0000062340087,0.00002689955],"genre_scores_gemma":[0.9994528,0.00025315458,0.000030088102,0.000053588523,0.000022212596,0.000017001743,0.00013627054,0.000017366643,0.000017479657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986693,0.00020612458,0.00036156655,0.00025588222,0.00029690706,0.00021021352],"domain_scores_gemma":[0.99912035,0.00005255815,0.0002347759,0.00029349918,0.0001389194,0.00015988763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015766422,0.00018980465,0.00026119364,0.000062006424,0.00004778058,0.000035147837,0.00014223576,0.00007203262,0.000004019985],"category_scores_gemma":[0.00035802444,0.0001369364,0.00007971748,0.00018637431,0.00008988599,0.000017001601,0.00008488555,0.000041768584,9.391312e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002518293,0.0001220734,0.9793676,0.000050388466,0.00008691782,5.955106e-7,0.00016937738,0.00007894656,0.00086135534,0.0000031293555,0.00011065496,0.018897139],"study_design_scores_gemma":[0.0014366722,0.00039783717,0.96031946,0.00023284231,0.00004046964,1.7849537e-7,0.0001161661,0.000051866784,0.036724236,0.00048105046,0.000025212343,0.00017400441],"about_ca_topic_score_codex":0.00021448234,"about_ca_topic_score_gemma":0.00010357171,"teacher_disagreement_score":0.03586288,"about_ca_system_score_codex":0.000019824545,"about_ca_system_score_gemma":0.000080787475,"threshold_uncertainty_score":0.55841047},"labels":[],"label_agreement":null},{"id":"W2474595142","doi":"10.1136/annrheumdis-2015-209058","title":"Improved survival in rheumatoid arthritis: a general population-based cohort study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Rheumatoid arthritis; Cohort; Population; Internal medicine; Cohort study; Environmental health","score_opus":0.0235468220571097,"score_gpt":0.30527388197288247,"score_spread":0.28172705991577274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474595142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925116,0.0033997628,0.000041333285,0.0021038111,0.00019242705,0.0015219665,0.00007691693,0.000053489824,0.00009872786],"genre_scores_gemma":[0.99295443,0.0064590145,0.000049888837,0.00013227866,0.00002535055,0.00020366101,0.000015179599,0.000032610063,0.0001275884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746495,0.00034879858,0.000713779,0.00030912904,0.00072493294,0.00043843198],"domain_scores_gemma":[0.99825346,0.00036899443,0.00021156539,0.000749005,0.000188484,0.00022846935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058845535,0.0002211508,0.000665732,0.00018749056,0.00010086194,0.000032741853,0.00028442265,0.00004525499,0.00031674458],"category_scores_gemma":[0.0013512571,0.00012385895,0.00026667677,0.00029844287,0.00015875077,0.00016325363,0.00008249094,0.00009135253,0.000017496428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034994085,0.0012301499,0.9562367,0.00005599564,0.00020023891,0.000008005448,0.00008724392,0.000010722048,0.00014012649,0.00025566656,0.00040098626,0.041024175],"study_design_scores_gemma":[0.0043288376,0.00032480122,0.9910435,0.0020271968,0.0000063339808,0.000004689517,0.0001469868,0.00038908527,0.00036232013,0.001149548,0.00005781268,0.00015885559],"about_ca_topic_score_codex":0.0014361574,"about_ca_topic_score_gemma":0.0004896558,"teacher_disagreement_score":0.04086532,"about_ca_system_score_codex":0.000033737168,"about_ca_system_score_gemma":0.00024297825,"threshold_uncertainty_score":0.50508213},"labels":[],"label_agreement":null},{"id":"W2478788944","doi":"10.1136/annrheumdis-2016-209442","title":"Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Burroughs Wellcome Fund","keywords":"Progenitor cell; Medicine; Immunology; Endothelial dysfunction; Peripheral blood mononuclear cell; Antiphospholipid syndrome; Endothelium; Endothelial stem cell; Interferon; Antibody; Internal medicine; Stem cell; Biology; Cell biology; In vitro","score_opus":0.023325639575752122,"score_gpt":0.27869482512197247,"score_spread":0.25536918554622035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478788944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582875,0.0014501038,0.000008252341,0.0012967418,0.0002153443,0.000819961,0.00005282329,0.000039190938,0.00028883704],"genre_scores_gemma":[0.9979612,0.00027008643,0.000023928069,0.000117918935,0.000035825855,0.000052257248,0.00000653509,0.000032054428,0.0015001904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836147,0.00013986397,0.0003603431,0.0002150006,0.00061892625,0.00030440278],"domain_scores_gemma":[0.998682,0.00030775115,0.00021124189,0.0004524336,0.00023412702,0.000112397276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002798004,0.00016445668,0.00045780817,0.000120861514,0.00003549985,0.0000139547865,0.00022559246,0.00007754007,0.000115062925],"category_scores_gemma":[0.00077472016,0.0000742691,0.00013045892,0.0003322048,0.00013910134,0.000115947085,0.000088917746,0.00011026911,0.000043983033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043631396,0.0010281948,0.9574132,0.0031952197,0.0007042496,0.00006165659,0.00060664956,0.0000027601993,0.012491075,0.00006853385,0.007239306,0.01282602],"study_design_scores_gemma":[0.011728165,0.0038300762,0.8837091,0.053524245,0.00043156682,0.0023873392,0.0009819699,0.000057686328,0.040952425,0.001322729,0.0004264307,0.0006483161],"about_ca_topic_score_codex":0.00003410979,"about_ca_topic_score_gemma":0.0000059433187,"teacher_disagreement_score":0.073704146,"about_ca_system_score_codex":0.00010195285,"about_ca_system_score_gemma":0.00030920308,"threshold_uncertainty_score":0.3028606},"labels":[],"label_agreement":null},{"id":"W2504775069","doi":"10.1136/annrheumdis-2016-210002","title":"Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; McMaster University","funders":"Genentech; Versus Arthritis; Rosetrees Trust","keywords":"Medicine; Toxicity; Ranking (information retrieval); Multiple-criteria decision analysis; Judgement; Composite index; Internal medicine; Computer science; Operations research; Mathematics; Machine learning; Composite indicator","score_opus":0.05663940111377146,"score_gpt":0.3473482054513041,"score_spread":0.29070880433753266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504775069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988208,0.0005148445,0.010691177,0.00024100483,0.00003862032,0.00023280251,0.000025096804,0.000009656446,0.00003881932],"genre_scores_gemma":[0.9973607,0.000081345606,0.0023900939,0.00010464339,0.000004938711,0.0000044892085,0.0000028331758,0.000009696681,0.00004123724],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99866,0.00003310075,0.00058107724,0.00015001642,0.00040614608,0.00016965816],"domain_scores_gemma":[0.9988089,0.00018815979,0.00030444717,0.00042240074,0.00016361318,0.00011243956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013154405,0.00012303816,0.00046558966,0.00014723538,0.000046613066,0.0000054329794,0.00015181622,0.000034955796,0.00018082201],"category_scores_gemma":[0.00055554055,0.00006152344,0.00035299652,0.0004087749,0.00009863322,0.000070335096,0.00011509243,0.00002235956,0.000005497933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002188703,0.0022831822,0.36994523,0.0010617365,0.0043584574,0.000004817068,0.0012789224,0.00070603145,0.025312828,0.00019701844,0.00037898912,0.5922841],"study_design_scores_gemma":[0.0013030196,0.000068691545,0.973193,0.0017344251,0.0010387285,0.0000024407125,0.0003868816,0.0057403934,0.01567295,0.0006437084,0.00006261756,0.00015318135],"about_ca_topic_score_codex":0.000049060047,"about_ca_topic_score_gemma":0.000013474192,"teacher_disagreement_score":0.6032477,"about_ca_system_score_codex":0.000016689528,"about_ca_system_score_gemma":0.0001598526,"threshold_uncertainty_score":0.2508853},"labels":[],"label_agreement":null},{"id":"W2512436288","doi":"10.1136/annrheumdis-2016-209709","title":"Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":568,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"UCB Pharma; Genentech; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Santen; Pfizer; Abbott Japan; Novo Nordisk; Sanofi; GlaxoSmithKline; Amgen; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ixekizumab; Medicine; Placebo; Psoriatic arthritis; Adalimumab; Internal medicine; Psoriasis; Adverse effect; Immunology; Arthritis; Secukinumab; Pharmacology; Gastroenterology; Rheumatoid arthritis; Pathology","score_opus":0.05109430224959261,"score_gpt":0.3221726779938731,"score_spread":0.2710783757442805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512436288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97233117,0.004870378,0.00002187163,0.0024038667,0.00042994102,0.015785607,0.0040952335,0.000014537729,0.000047382695],"genre_scores_gemma":[0.99274,0.005232751,0.000029219205,0.00006179745,0.00013127414,0.0015739001,0.0001167939,0.000031102594,0.00008315807],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968862,0.00046605815,0.001235324,0.00047483042,0.0005601135,0.00037745858],"domain_scores_gemma":[0.99228805,0.0045084856,0.0016651656,0.0009449383,0.00046427053,0.00012908825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032934986,0.000491559,0.0019980103,0.0000660384,0.00042922143,0.000036566642,0.00039142865,0.000085014486,0.000054551205],"category_scores_gemma":[0.0007953305,0.00015602956,0.0009929262,0.00016009486,0.0009257451,0.00015306313,0.00009114399,0.00008132252,0.000001028981],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87980616,0.0060037505,0.00051892333,0.000022242222,0.006524158,0.0000026993646,0.0029205438,0.000005748291,0.00003969261,0.000060915718,0.0001278779,0.1039673],"study_design_scores_gemma":[0.9634958,0.011096095,0.016681388,0.0014093645,0.0024806352,0.0000027984825,0.0025851543,0.000060585677,0.0014714319,0.00043654445,0.00009762543,0.00018257776],"about_ca_topic_score_codex":0.00038634115,"about_ca_topic_score_gemma":0.00017606826,"teacher_disagreement_score":0.103784725,"about_ca_system_score_codex":0.00006218621,"about_ca_system_score_gemma":0.00019874866,"threshold_uncertainty_score":0.6362701},"labels":[],"label_agreement":null},{"id":"W2514573576","doi":"10.1136/annrheumdis-2016-210242","title":"International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials","year":2016,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Toronto Western Hospital; Women's College Hospital; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute for Health and Care Research","keywords":"Medicine; Psoriatic arthritis; Quality of life (healthcare); Physical therapy; Rheumatology; Clinical trial; Disease; Family medicine; MEDLINE; Internal medicine; Nursing","score_opus":0.4926044732083754,"score_gpt":0.5429225170633315,"score_spread":0.050318043854956085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514573576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012363885,0.9878316,0.0000011003079,0.0011348135,0.0012057513,0.0027374215,0.0055809594,0.000017462633,0.000254482],"genre_scores_gemma":[0.0018090652,0.99680424,0.000037495778,0.0004910693,0.00019677331,0.00035896388,0.000132481,0.000036854664,0.00013306874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683833,0.00035805706,0.0019052512,0.00033055292,0.00035138213,0.00021639731],"domain_scores_gemma":[0.9931178,0.00457069,0.001532378,0.00046191746,0.00016358812,0.00015361368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000610514,0.00034827017,0.0032803277,0.00007962769,0.00008851108,0.000018701234,0.00015069246,0.000104946535,0.00004887433],"category_scores_gemma":[0.007261664,0.00017110532,0.0018115983,0.00006461488,0.000210626,0.000017443266,0.00011102298,0.00009307088,0.000022272789],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020695727,0.00044413607,0.00014946336,0.0039039373,0.0025749765,0.0000092465,0.000022818123,1.9666313e-8,4.3323753e-9,0.0002707477,0.014957611,0.9774601],"study_design_scores_gemma":[0.0055736057,0.0012640732,0.00085072714,0.13393693,0.003510699,0.000035939327,0.00007253301,0.0000045174934,4.7164195e-7,0.00161133,0.8528487,0.0002904616],"about_ca_topic_score_codex":0.0000050545623,"about_ca_topic_score_gemma":0.000001065577,"teacher_disagreement_score":0.97716963,"about_ca_system_score_codex":0.00002342709,"about_ca_system_score_gemma":0.00012782092,"threshold_uncertainty_score":0.86934143},"labels":[],"label_agreement":null},{"id":"W2517958812","doi":"10.1136/annrheumdis-2016-209247","title":"Consensus-based recommendations for the management of juvenile dermatomyositis","year":2016,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":319,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Executive Agency for Health and Consumers; Medac; Swedish Orphan Biovitrum; National Institute for Health and Care Research; Medical Research Council; Myositis Association; Chugai Pharmaceutical; Pfizer","keywords":"Medicine; Juvenile dermatomyositis; Best practice; Family medicine; MEDLINE; Dermatomyositis; Alternative medicine; Physical therapy; Rheumatism; Intensive care medicine; Pediatrics; Pathology; Internal medicine","score_opus":0.08985515088608344,"score_gpt":0.3856989137148151,"score_spread":0.29584376282873165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517958812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022139533,0.9878649,0.00022728379,0.0066268276,0.00032243488,0.0026907963,0.0018450026,0.00003011486,0.00037049904],"genre_scores_gemma":[0.00040113472,0.997538,0.0004019052,0.0004921338,0.000037628735,0.0005631521,0.00009962859,0.000050905768,0.00041556984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782026,0.00016697528,0.0012100275,0.00020310392,0.00033413194,0.00026548965],"domain_scores_gemma":[0.9960331,0.0013767021,0.0011814485,0.0010633841,0.00024541907,0.0000999762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003008731,0.0003122213,0.001468188,0.00010633138,0.00018532109,0.000017181173,0.00043881923,0.00009305754,0.00019883343],"category_scores_gemma":[0.00012772626,0.00014650416,0.0014963653,0.00020168426,0.00026127376,0.0000280112,0.0001239944,0.000087246684,0.000021210148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003504502,0.000129828,0.000007016951,0.08197189,0.0014011441,0.000005645947,0.000022326887,0.0000010443719,3.4138527e-8,0.0018175353,0.08834359,0.8262649],"study_design_scores_gemma":[0.00059540494,0.000043339955,0.0001026271,0.12470838,0.0037546176,0.000038853912,0.00006575985,0.000042872325,0.000020978407,0.00046117336,0.86999947,0.00016652604],"about_ca_topic_score_codex":0.0000069351927,"about_ca_topic_score_gemma":4.963989e-7,"teacher_disagreement_score":0.8260984,"about_ca_system_score_codex":0.000024064588,"about_ca_system_score_gemma":0.0003479988,"threshold_uncertainty_score":0.5974266},"labels":[],"label_agreement":null},{"id":"W2520379025","doi":"10.1136/annrheumdis-2016-209768","title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Task force; Scleroderma (fungus); Physical therapy; Pathology","score_opus":0.2124305034721688,"score_gpt":0.3903012544553823,"score_spread":0.17787075098321348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520379025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98026824,0.008967833,0.0033327348,0.0025812401,0.00007859603,0.0045369575,0.00020804915,0.000015730164,0.000010623551],"genre_scores_gemma":[0.9932472,0.0061139297,0.00009978646,0.000027376736,0.00004881761,0.0003786431,0.000008650131,0.000031107757,0.00004448228],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995999,0.0017496552,0.0010908584,0.00029778582,0.00057922147,0.0002835229],"domain_scores_gemma":[0.990566,0.00665335,0.0012054257,0.00063232944,0.0008215325,0.000121349396],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008328075,0.00020152982,0.0007342683,0.0001030674,0.00047638846,0.000056146146,0.00028793915,0.00007276744,0.0000038018668],"category_scores_gemma":[0.009654031,0.00008665017,0.00027158027,0.00022029481,0.0004141251,0.00018828212,0.00014606783,0.00006688167,2.3474155e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009959417,0.00077101885,0.0040309783,0.015901398,0.0017728239,1.99078e-7,0.0025783945,0.000010708803,0.40575,0.0002961096,0.0045329765,0.554396],"study_design_scores_gemma":[0.0074614454,0.00063293066,0.8217428,0.068272404,0.0013438636,0.0000068673685,0.0020347557,0.0011288506,0.09604738,0.0009633692,0.00009306461,0.00027228956],"about_ca_topic_score_codex":0.000022366605,"about_ca_topic_score_gemma":0.0000016810808,"teacher_disagreement_score":0.8177118,"about_ca_system_score_codex":0.000035719047,"about_ca_system_score_gemma":0.00022266677,"threshold_uncertainty_score":0.9986881},"labels":[],"label_agreement":null},{"id":"W2527759663","doi":"10.1136/annrheumdis-2016-209686","title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","year":2016,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Internal medicine","score_opus":0.042862072415930375,"score_gpt":0.34844940931358226,"score_spread":0.3055873368976519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527759663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037287697,0.9932052,0.00001748897,0.00011211507,0.0003832416,0.0011210891,0.0013151375,0.000012945785,0.00010399523],"genre_scores_gemma":[0.006454149,0.9913689,0.000007183986,0.0001001325,0.000048385016,0.00043420529,0.00058686855,0.00007126654,0.0009289055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817073,0.00023072313,0.00069191196,0.0003414058,0.00017549054,0.00038971772],"domain_scores_gemma":[0.99795383,0.00032401478,0.0006534165,0.0008255911,0.00016084961,0.000082324004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021563694,0.00040495358,0.0010955192,0.000065329295,0.00013944256,0.000039045975,0.0007761814,0.00023520185,0.00012238072],"category_scores_gemma":[0.0035248627,0.00024445905,0.0014520418,0.00010859528,0.00018830199,0.000006678862,0.00024232556,0.000062825355,0.000033514436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000490424,0.00047056907,0.00005263325,0.026659343,0.0026660403,0.0000036757117,0.00004611465,0.0000010640051,0.000027401526,0.00009403089,0.065461986,0.9044681],"study_design_scores_gemma":[0.0005218048,0.00032506767,0.0005465711,0.032377437,0.0010706199,0.000016039161,0.000025985291,0.0000018587817,0.00009623451,0.0005907206,0.9638204,0.000607281],"about_ca_topic_score_codex":0.00000548894,"about_ca_topic_score_gemma":0.0000020532934,"teacher_disagreement_score":0.9038608,"about_ca_system_score_codex":0.000010570659,"about_ca_system_score_gemma":0.00031495965,"threshold_uncertainty_score":0.9968751},"labels":[],"label_agreement":null},{"id":"W2548885112","doi":"10.1136/annrheumdis-2016-210092","title":"Development of the autoinflammatory disease damage index (ADDI)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Alberta Children's Hospital","funders":"National Institute of Allergy and Infectious Diseases; Swedish Orphan Biovitrum; Rosetrees Trust; Executive Agency for Health and Consumers; Novartis Pharma; Regeneron Pharmaceuticals","keywords":"Medicine; Index (typography); Disease; Internal medicine; World Wide Web","score_opus":0.015047023325614313,"score_gpt":0.24814581612804396,"score_spread":0.23309879280242965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548885112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744153,0.001025445,0.00006158601,0.00078369456,0.00011841042,0.0001973708,0.000050948198,0.0000059156077,0.00031511253],"genre_scores_gemma":[0.9987758,0.000174047,0.000027206857,0.00017443269,0.000013312428,0.000022664713,0.000006971468,0.00001411929,0.00079144083],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99901026,0.00008039407,0.00035784175,0.00014399858,0.00022544488,0.00018204482],"domain_scores_gemma":[0.99882114,0.000023640872,0.00026043056,0.0007320681,0.00009708831,0.00006564497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013192873,0.00013146226,0.00014510445,0.000022510132,0.00010274507,0.0000065408894,0.00056559534,0.00003886357,0.000057547924],"category_scores_gemma":[0.00038503713,0.00006258012,0.00024356964,0.000074013056,0.00023996088,0.000007816638,0.00032613354,0.000025949348,0.000007292173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013191235,0.0015292614,0.29519233,0.0017012914,0.00197274,0.000002578909,0.0014417145,0.00025568824,0.29670498,0.0028132068,0.04650218,0.35056493],"study_design_scores_gemma":[0.00052614324,0.000021799076,0.82032,0.00054984714,0.000042094867,3.4627072e-7,0.00013243724,0.000016645248,0.1641756,0.0007615991,0.013272479,0.00018101638],"about_ca_topic_score_codex":0.0000031128234,"about_ca_topic_score_gemma":0.000006564098,"teacher_disagreement_score":0.52512765,"about_ca_system_score_codex":0.00000416727,"about_ca_system_score_gemma":0.00032491816,"threshold_uncertainty_score":0.2551943},"labels":[],"label_agreement":null},{"id":"W2549083603","doi":"10.1136/annrheumdis-2016-eular.2937","title":"FRI0066 The 28-Joint Disease Activity Score (DAS28) Using C-Reactive Protein Yields Lower Thresholds Compared To Conventional DAS28 with Erythrocyte Sedimentation Rate in Early Rheumatoid Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Sherbrooke; St Joseph's Health Care; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Erythrocyte sedimentation rate; Medicine; Rheumatoid arthritis; C-reactive protein; Receiver operating characteristic; Internal medicine; Cohort; Sample size determination; Physical therapy; Statistics","score_opus":0.05522764018745422,"score_gpt":0.305602527524027,"score_spread":0.25037488733657276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549083603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870506,0.0018001156,0.00029532853,0.008202683,0.00011806774,0.0022205873,0.00021701203,0.00004540059,0.00005021682],"genre_scores_gemma":[0.9978348,0.0014596912,0.00005214161,0.00026461738,0.00003053249,0.00021941378,0.000015429488,0.000045745306,0.0000776224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723464,0.00036638728,0.0005461182,0.00040563708,0.00091855816,0.00052866404],"domain_scores_gemma":[0.9979127,0.00026698146,0.00034616838,0.0007148856,0.00032163915,0.00043764233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045906944,0.00032106263,0.00058697036,0.00018341065,0.00028526687,0.00009617972,0.00031626903,0.000051933413,0.00028772638],"category_scores_gemma":[0.0005134968,0.00016570085,0.00027772557,0.0003877812,0.0005908877,0.00055388256,0.00016958569,0.00018081062,0.000033332424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.086102836,0.015309771,0.59088975,0.0024549367,0.005856521,0.00054952456,0.009246827,0.0014591032,0.09075455,0.010328572,0.0101263635,0.17692122],"study_design_scores_gemma":[0.006909926,0.00083272404,0.94389516,0.023606177,0.000033608423,0.000037409183,0.00059014,0.00045250176,0.01842873,0.0045390446,0.00020780337,0.00046678988],"about_ca_topic_score_codex":0.00046438488,"about_ca_topic_score_gemma":0.0001234264,"teacher_disagreement_score":0.35300538,"about_ca_system_score_codex":0.000080101134,"about_ca_system_score_gemma":0.00041746587,"threshold_uncertainty_score":0.6757085},"labels":[],"label_agreement":null},{"id":"W2549255362","doi":"10.1136/annrheumdis-2016-eular.4214","title":"AB0251 Early Onset of Benefit by Patient-Reported Outcomes (PROs) with Sarilumab Treatment in RA","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Visual analogue scale; Rheumatoid arthritis; Placebo; Adverse effect; Internal medicine; TNF inhibitor; Neutropenia; Physical therapy; Adalimumab; Chemotherapy","score_opus":0.021465825815186516,"score_gpt":0.28988454879636233,"score_spread":0.2684187229811758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549255362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923189,0.0035551966,0.00000440751,0.0029476564,0.000034453766,0.00070736685,0.00028719896,0.000019725903,0.00012507204],"genre_scores_gemma":[0.99549735,0.0038243688,0.000030463638,0.00008416878,0.0000029686519,0.00008313434,0.000012581938,0.000020852138,0.0004441089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998314,0.00007536308,0.00056190445,0.0001936434,0.0005483138,0.00030674465],"domain_scores_gemma":[0.9984861,0.00027822683,0.00030437618,0.0006020144,0.00015925698,0.00017001118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010089872,0.00019112017,0.00059728354,0.000113431204,0.000043855336,0.000012277333,0.00015289386,0.00003442062,0.0001621113],"category_scores_gemma":[0.00034538537,0.00008347933,0.00020825172,0.00017321795,0.0002718293,0.00012274932,0.00004491985,0.000039307197,0.000008058494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012295676,0.0016599677,0.8576061,0.000114475595,0.00078200066,0.000017736382,0.00067044864,0.0000021296767,0.0002649988,0.00011564647,0.0015466987,0.13599025],"study_design_scores_gemma":[0.005546348,0.0019062476,0.97612995,0.0030161333,0.000036547313,0.000017533268,0.00023800485,0.0000061700202,0.011073855,0.0015819285,0.00029780902,0.00014946898],"about_ca_topic_score_codex":0.0011119833,"about_ca_topic_score_gemma":0.00009905646,"teacher_disagreement_score":0.13584077,"about_ca_system_score_codex":0.000027921773,"about_ca_system_score_gemma":0.0001641475,"threshold_uncertainty_score":0.34041885},"labels":[],"label_agreement":null},{"id":"W2549269809","doi":"10.1136/annrheumdis-2016-209519","title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)","year":2016,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Arthritis Society; University of Calgary","funders":"Medical Research Council; Karolinska Institutet; National Institute for Health and Care Research","keywords":"Medicine; Task force; Doris (gastropod); Complete remission; Task (project management); Internal medicine; Chemotherapy; Virology","score_opus":0.1593191091914506,"score_gpt":0.43651892429756933,"score_spread":0.27719981510611874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549269809","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011148408,0.9778766,0.0001640538,0.001845392,0.00070507673,0.0034931854,0.0041042822,0.000029052355,0.00063393835],"genre_scores_gemma":[0.010427884,0.9875144,0.0004710298,0.000075369564,0.00006975702,0.0003751016,0.0002804564,0.00007259521,0.000713442],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963906,0.00035821804,0.0015511769,0.0004365659,0.0008568154,0.00040667097],"domain_scores_gemma":[0.9916232,0.0061266264,0.000896211,0.00090840616,0.00025160477,0.00019391911],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008334569,0.00035573923,0.0018855046,0.00054744026,0.000053797776,0.000015056324,0.0006091228,0.00034562286,0.00022439672],"category_scores_gemma":[0.015843198,0.00020437982,0.0007905181,0.0004503733,0.00011817102,0.000042854106,0.00022098642,0.00034760247,0.000022143377],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038833998,0.006330969,0.014896426,0.27049133,0.0028918595,0.000104666404,0.0027271719,0.0000068303607,0.00008467142,0.026279707,0.13993485,0.5323681],"study_design_scores_gemma":[0.0024137301,0.00015781277,0.00024729312,0.89951473,0.00034981934,0.0000893323,0.00033069958,0.00011471434,0.00007829575,0.039854594,0.05654442,0.00030454792],"about_ca_topic_score_codex":0.000056798675,"about_ca_topic_score_gemma":0.0000047896415,"teacher_disagreement_score":0.62902343,"about_ca_system_score_codex":0.00017188591,"about_ca_system_score_gemma":0.00070518465,"threshold_uncertainty_score":0.9924468},"labels":[],"label_agreement":null},{"id":"W2549330247","doi":"10.1136/annrheumdis-2016-eular.3766","title":"FRI0172 Primary and Secondary Non-Response in RA Patients Treated with An anti-TNF: An Analysis from A Prospective, Observational Registry","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; University of Victoria","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Infliximab; Rheumatoid arthritis; Internal medicine; Adalimumab; Concomitant; Ankylosing spondylitis; TNF inhibitor; Etanercept; Rheumatology; Observational study; BASDAI; Physical therapy; Surgery; Disease","score_opus":0.024991646970817835,"score_gpt":0.28915550551657215,"score_spread":0.2641638585457543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549330247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719167,0.000831047,0.0000153233,0.00077437714,0.000012190263,0.00048429673,0.0006205262,0.000022875389,0.000047682643],"genre_scores_gemma":[0.99820733,0.0011438074,0.0001226188,0.00018220297,0.000010538018,0.00005055318,0.00017828384,0.000019184137,0.00008550378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998316,0.00028033092,0.00035476478,0.00031501133,0.00049112516,0.00024280162],"domain_scores_gemma":[0.998398,0.00032587966,0.00019179659,0.00058701826,0.00024512253,0.0002521609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023296826,0.0001795311,0.00051947904,0.00020258411,0.00008893821,0.00003911775,0.00019215351,0.000044069162,0.00017858611],"category_scores_gemma":[0.00039257263,0.00009484902,0.00011433676,0.00039661623,0.00032819703,0.0005012124,0.000059455342,0.000078354526,0.0000025162158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006054206,0.0009899151,0.9769024,0.00005915482,0.00067506055,0.00000969417,0.00034719237,0.000005210335,0.00033337442,0.000023027887,0.00012753315,0.01447323],"study_design_scores_gemma":[0.0036866635,0.0007944347,0.9930193,0.00094775116,0.00006822089,0.0000019921747,0.00015137056,0.00023166217,0.0004851675,0.00046383354,0.000018313862,0.0001313111],"about_ca_topic_score_codex":0.000506224,"about_ca_topic_score_gemma":0.0001058942,"teacher_disagreement_score":0.016116876,"about_ca_system_score_codex":0.000028273298,"about_ca_system_score_gemma":0.00026120376,"threshold_uncertainty_score":0.3867831},"labels":[],"label_agreement":null},{"id":"W2549411495","doi":"10.1136/annrheumdis-2016-eular.1597","title":"THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Adalimumab; Internal medicine; Gastroenterology; Clinical disease; Disease","score_opus":0.03323607436085807,"score_gpt":0.31726530584343865,"score_spread":0.2840292314825806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549411495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97081023,0.014741293,0.0000036663737,0.01031272,0.00015169576,0.0013849005,0.002465145,0.00008253875,0.000047829708],"genre_scores_gemma":[0.97327524,0.025435172,0.00007924411,0.00039675785,0.000022011214,0.0001187921,0.000043817286,0.000055411718,0.00057352136],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9954385,0.0010957823,0.0010083114,0.000634915,0.0011254066,0.0006970918],"domain_scores_gemma":[0.9935573,0.0039996454,0.00035862354,0.001086024,0.00037665086,0.0006218006],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012538366,0.00041291627,0.0009628394,0.00032296783,0.00027615725,0.000042118114,0.0003317745,0.00007108445,0.00011261527],"category_scores_gemma":[0.010930415,0.00022743197,0.0001700738,0.0003141793,0.0007381566,0.0002804487,0.00057237095,0.00013210684,0.00006107407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6599723,0.0023432178,0.18558481,0.00018710145,0.0014699002,0.000116817435,0.007803341,0.000014553241,0.002364177,0.000043014254,0.042913113,0.09718767],"study_design_scores_gemma":[0.061986376,0.004791877,0.9027924,0.02130324,0.000027011552,0.00002059134,0.0007905333,0.000027293121,0.003271996,0.00072955986,0.0037871501,0.0004719759],"about_ca_topic_score_codex":0.00013791246,"about_ca_topic_score_gemma":0.00028527185,"teacher_disagreement_score":0.7172076,"about_ca_system_score_codex":0.00012036285,"about_ca_system_score_gemma":0.00022777432,"threshold_uncertainty_score":0.99740094},"labels":[],"label_agreement":null},{"id":"W2549602975","doi":"10.1136/annrheumdis-2016-eular.3419","title":"SAT0002 Specific Premature Epigenetic Aging of Cartilage in Osteoarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Biomarker; Cartilage; Osteoarthritis; Epigenetics; Internal medicine; DNA methylation; Oncology; Bioinformatics; Pathology; Gene; Genetics","score_opus":0.017743425688241866,"score_gpt":0.2760575133497532,"score_spread":0.2583140876615113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549602975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802684,0.01710898,0.00072221673,0.00081853353,0.00014094084,0.00043808564,0.00014057464,0.0000064399123,0.0003558374],"genre_scores_gemma":[0.99631345,0.0031803497,0.000049697934,0.00005623271,0.00002433113,0.000024652798,0.0000073317588,0.000021571394,0.00032237274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987474,0.00015122173,0.00033186623,0.00022634462,0.00028612092,0.00025702672],"domain_scores_gemma":[0.9989793,0.000037618007,0.00015156563,0.00064758654,0.00010800432,0.00007593177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016883304,0.00012626193,0.00021372252,0.000069101116,0.00002768426,0.000008350316,0.0003736535,0.000080294296,0.00008415282],"category_scores_gemma":[0.0002853533,0.00008252373,0.00019175785,0.00016381941,0.00015409572,0.00000508547,0.00019866886,0.00004956655,0.0000057137113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013652444,0.00013970614,0.00047515077,0.00022492338,0.000053948796,0.000003819202,0.000087574736,0.000115316514,0.9237939,0.00018075587,0.0022656487,0.07252269],"study_design_scores_gemma":[0.0006258217,0.00015646203,0.005817404,0.0010321795,0.000012459187,0.0000038113212,0.000048907772,0.000006290627,0.99005944,0.0010538531,0.0010642352,0.00011916411],"about_ca_topic_score_codex":0.000014976888,"about_ca_topic_score_gemma":0.000033035634,"teacher_disagreement_score":0.07240353,"about_ca_system_score_codex":0.000008474758,"about_ca_system_score_gemma":0.00009161372,"threshold_uncertainty_score":0.336522},"labels":[],"label_agreement":null},{"id":"W2549701246","doi":"10.1136/annrheumdis-2016-eular.1488","title":"THU0201 Weak Correlation between A Multi-Biomarker Disease Activity Score and Clinical Response with Baricitinib in A Phase 2b Study in Rheumatoid Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Rheumatoid arthritis; Medicine; Erythrocyte sedimentation rate; Methotrexate; Biomarker; Internal medicine; Placebo; C-reactive protein; Gastroenterology; Post-hoc analysis; Nuclear medicine; Pathology; Inflammation","score_opus":0.09067736120830998,"score_gpt":0.39531882304693355,"score_spread":0.30464146183862356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549701246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913121,0.003610694,0.000121031764,0.0028447553,0.000049995768,0.001837803,0.00017818954,0.000033495286,0.000011978277],"genre_scores_gemma":[0.98668355,0.013017362,0.0000331936,0.000045083,0.000011286095,0.000120917655,0.0000073507854,0.00003267476,0.00004859304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963403,0.0013219672,0.0008461087,0.0004447551,0.0006093156,0.0004375805],"domain_scores_gemma":[0.99638134,0.0020428307,0.00030189304,0.00064684177,0.00013831472,0.000488806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015564534,0.00026914768,0.00081923517,0.00029697592,0.00009789431,0.0000392255,0.00017876031,0.00006605191,0.00006959082],"category_scores_gemma":[0.004039969,0.00015031324,0.00017478006,0.0004055605,0.0006033375,0.00036220357,0.0001493796,0.00019971034,0.000009796552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02261872,0.004057005,0.8232103,0.00006639224,0.00019186798,0.00006892977,0.00035159677,0.0000012522933,0.000032852022,0.000014976512,0.00013125745,0.14925484],"study_design_scores_gemma":[0.022098575,0.0014464497,0.9683006,0.006771003,0.000017935085,0.000011988704,0.0004330667,0.00042496086,0.000025244055,0.00024075566,0.000041475494,0.00018797877],"about_ca_topic_score_codex":0.00019056317,"about_ca_topic_score_gemma":0.00033201952,"teacher_disagreement_score":0.14906687,"about_ca_system_score_codex":0.00002916453,"about_ca_system_score_gemma":0.0003895106,"threshold_uncertainty_score":0.61295956},"labels":[],"label_agreement":null},{"id":"W2549718159","doi":"10.1136/annrheumdis-2016-eular.6204","title":"LB0002 Does Adding Azathioprine To Glucocorticoid Induction Increase The Remission Rate and Prevent Relapses in Patients with Systemic Necrotizing Vasculitides without Poor-Prognosis Factors? A Multicenter, Double-Blind Randomized Controlled Trial","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Granulomatosis with polyangiitis; Internal medicine; Microscopic polyangiitis; Azathioprine; Gastroenterology; Concomitant; Placebo; Clinical endpoint; Adverse effect; Randomized controlled trial; Giant cell arteritis; Polyarteritis nodosa; Systemic vasculitis; Surgery; Vasculitis; Pathology","score_opus":0.021072624816989564,"score_gpt":0.27765908441376197,"score_spread":0.2565864595967724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549718159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850679,0.0007864338,0.000018219718,0.002054984,0.00020798476,0.0117769,0.000031791384,0.000031406347,0.000024355122],"genre_scores_gemma":[0.99776596,0.00095976004,0.000023454788,0.00009115466,0.00003143114,0.0008934261,0.000016168646,0.000026607748,0.00019204913],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972508,0.00072413497,0.0009827606,0.0003134793,0.00045979355,0.0002690419],"domain_scores_gemma":[0.9973855,0.0011093984,0.0006299237,0.00040301456,0.00025996173,0.00021219006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008845939,0.00027402537,0.0012851577,0.00017178325,0.00016884271,0.000052296076,0.00013071964,0.00007925406,0.000048099697],"category_scores_gemma":[0.002858802,0.00008990575,0.00044242654,0.00022449634,0.00016757008,0.00020290763,0.00009821091,0.00013149301,0.0000030444346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9519341,0.0009961306,0.04170064,0.0004304872,0.0016172865,0.0000023316807,0.00068115565,0.000033301225,0.00035665164,0.00010605761,0.000038242124,0.0021036286],"study_design_scores_gemma":[0.9331694,0.00032925393,0.048216447,0.0150115285,0.0015710138,0.0000054257557,0.00048364347,0.00008921841,0.0008337364,0.000109891975,0.0000058601354,0.00017457975],"about_ca_topic_score_codex":0.00022464078,"about_ca_topic_score_gemma":0.000010160088,"teacher_disagreement_score":0.018764686,"about_ca_system_score_codex":0.000040474795,"about_ca_system_score_gemma":0.000110357774,"threshold_uncertainty_score":0.366625},"labels":[],"label_agreement":null},{"id":"W2549779699","doi":"10.1136/annrheumdis-2016-eular.4957","title":"SAT0578 The Association of Arthritis and Lung Disease: A Population-Based Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; COPD; Body mass index; Asthma; Population; Overweight; Physical therapy; Rheumatoid arthritis; Internal medicine; Underweight; Arthritis; Chronic bronchitis; Fibromyalgia; Environmental health","score_opus":0.03060920249611967,"score_gpt":0.3450942117427582,"score_spread":0.3144850092466385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549779699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666674,0.0029792548,0.0000169218,0.02955247,0.000037192436,0.00059551856,0.00010716577,0.000011417529,0.00003263084],"genre_scores_gemma":[0.9986133,0.00069448707,0.0000068926097,0.0004763772,0.000019481922,0.000043884647,0.0000068315103,0.0000077064105,0.00013106038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984928,0.00044524408,0.0003604115,0.00012379288,0.00039716894,0.00018063314],"domain_scores_gemma":[0.99744093,0.0016260042,0.00025644913,0.00038460476,0.00015042612,0.00014159674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006287283,0.00008426661,0.00031385585,0.000048903083,0.000075356176,0.0000062832437,0.00011851606,0.000024240766,0.000070958384],"category_scores_gemma":[0.007810466,0.000035837857,0.00014958941,0.00011630622,0.00007425624,0.00005167223,0.000051859897,0.000041956206,0.0000028204024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016195794,0.00032730738,0.96905637,0.00014569248,0.00021939052,7.550271e-7,0.00004755423,0.000008370335,0.00001606917,0.00021854292,0.004400066,0.02539793],"study_design_scores_gemma":[0.0008505013,0.000099259414,0.9961509,0.0008519847,0.00013909518,3.4879645e-7,0.00006820088,0.00033351316,0.00003353981,0.0013941757,0.000036934012,0.00004151282],"about_ca_topic_score_codex":0.00022297355,"about_ca_topic_score_gemma":0.000047700865,"teacher_disagreement_score":0.03194585,"about_ca_system_score_codex":0.000021901857,"about_ca_system_score_gemma":0.000091207134,"threshold_uncertainty_score":0.93504214},"labels":[],"label_agreement":null},{"id":"W2550015412","doi":"10.1136/annrheumdis-2016-eular.5738","title":"AB0792 Knowledge about Osteoporosis and It's Risk Factors among Elderly Participants of Healthy Aging Academy","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Nutrition and Health Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Medicine; Osteoporosis; Gerontology; Physical therapy; Intervention (counseling); Disease; Population ageing; Elderly people; Population; Family medicine; Internal medicine; Environmental health; Nursing","score_opus":0.11214819659529003,"score_gpt":0.4004966792585092,"score_spread":0.28834848266321916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550015412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767527,0.008875794,0.0000044527765,0.013601484,0.000083628496,0.0003916277,0.00012597258,0.0000248415,0.0001395285],"genre_scores_gemma":[0.9807841,0.018408062,0.00001874534,0.00052713393,0.00002493785,0.000025999449,0.0000016197604,0.000013765804,0.00019558969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850935,0.00014059163,0.0005995999,0.00017232927,0.00024315444,0.00033496894],"domain_scores_gemma":[0.9982689,0.00062499655,0.00044174428,0.00023077946,0.00012919068,0.0003044089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029784197,0.00015034692,0.00054465386,0.00008778223,0.0001605745,0.000006018453,0.00010852013,0.000051823867,0.0000671693],"category_scores_gemma":[0.00084767747,0.000077742036,0.00016389508,0.0001385176,0.0003825144,0.0000989885,0.00008192768,0.00008260141,0.0000059668396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017453755,0.0005691225,0.93619674,0.0034903549,0.00029757002,4.003638e-7,0.00349171,3.6341297e-7,0.00006802298,0.00015216139,0.018182114,0.03737691],"study_design_scores_gemma":[0.0011574243,0.00025975928,0.9898852,0.004506988,0.0002260675,5.93485e-7,0.0013051594,0.000013485429,0.0011361768,0.0008435901,0.0005777818,0.00008774535],"about_ca_topic_score_codex":0.00015739285,"about_ca_topic_score_gemma":0.000026013504,"teacher_disagreement_score":0.053688496,"about_ca_system_score_codex":0.000012302901,"about_ca_system_score_gemma":0.00007982207,"threshold_uncertainty_score":0.31702283},"labels":[],"label_agreement":null},{"id":"W2550228164","doi":"10.1136/annrheumdis-2016-eular.4338","title":"FRI0187 A Randomized Crossover Comparison of Injection Site Pain with 40 Mg/0.8 Ml and 40 mg/0.4 ml Formulations of Adalimumab in Patients with Rheumatoid Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Visual analogue scale; Tolerability; Randomized controlled trial; Crossover study; McGill Pain Questionnaire; Anesthesia; Clinical endpoint; Arthritis; Surgery; Adverse effect; Placebo; Internal medicine","score_opus":0.014000680863987676,"score_gpt":0.2770941748673668,"score_spread":0.2630934940033791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550228164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923001,0.005022692,0.00046018712,0.0005410367,0.000030750845,0.0013469929,0.00020069782,0.00002209781,0.00007542543],"genre_scores_gemma":[0.99360144,0.005995656,0.00018318194,0.000041390114,0.0000055506953,0.000078623336,0.00002747935,0.000030045707,0.00003664179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972975,0.00043026113,0.00093293656,0.00023634052,0.00077493384,0.00032799292],"domain_scores_gemma":[0.99731106,0.0009311606,0.0006569951,0.00047154893,0.00046124175,0.00016802442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064845604,0.00023912497,0.0012174264,0.00024214268,0.00010498629,0.00002459463,0.00014034784,0.00005840558,0.000102806116],"category_scores_gemma":[0.0013345142,0.00012315178,0.0001939837,0.00032784836,0.0008202692,0.00034071264,0.00007092282,0.000095549985,0.0000022169993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13569978,0.0020687508,0.7931102,0.0007307289,0.0008770912,0.0000017513353,0.0029217566,0.00007811511,0.00015083395,0.0009127538,0.0007511247,0.0626971],"study_design_scores_gemma":[0.20465519,0.0023052862,0.76655275,0.020034652,0.000050878527,0.000008960837,0.00062355795,0.001053946,0.0013349486,0.0029711346,0.000088313835,0.0003204136],"about_ca_topic_score_codex":0.00045525303,"about_ca_topic_score_gemma":0.00026907958,"teacher_disagreement_score":0.0689554,"about_ca_system_score_codex":0.000019706804,"about_ca_system_score_gemma":0.00016426589,"threshold_uncertainty_score":0.5021984},"labels":[],"label_agreement":null},{"id":"W2550252965","doi":"10.1136/annrheumdis-2016-eular.2306","title":"SAT0396 Secukinumab Provides Sustained Improvements in The Signs and Symptoms of Active Ankylosing Spondylitis: 2-Year Results from A Phase 3 Trial with Subcutaneous Loading and Maintenance Dosing (Measure 2)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Secukinumab; Ankylosing spondylitis; Clinical endpoint; Placebo; Internal medicine; Dosing; Gastroenterology; Clinical trial; Psoriatic arthritis; Rheumatoid arthritis; Pathology","score_opus":0.021752008556324767,"score_gpt":0.28439876418345633,"score_spread":0.2626467556271316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550252965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942862,0.001435549,0.0000074980744,0.0011902971,0.000036287525,0.0013535315,0.0016061363,0.0000110476285,0.00007344873],"genre_scores_gemma":[0.99944365,0.00030122153,0.000038944436,0.0000828727,0.000022487131,0.000042638134,0.000020722926,0.000016425625,0.000031061092],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985317,0.00013615435,0.00042616518,0.00027661026,0.00035638,0.00027297094],"domain_scores_gemma":[0.9984291,0.0006732939,0.00035411204,0.00033088657,0.00013532002,0.00007729001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021595723,0.00019752498,0.00046931018,0.00006431613,0.000112385474,0.00002630333,0.000106218205,0.000035608464,0.0000100353445],"category_scores_gemma":[0.00088861183,0.000088828456,0.000084869964,0.00015145808,0.00031921422,0.00013378874,0.00006984515,0.00005947987,2.3085902e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41732916,0.0028493223,0.012418926,0.000687499,0.0019657488,0.0003493549,0.011101527,0.0000013816762,0.0027038096,0.00034314537,0.00020839785,0.55004174],"study_design_scores_gemma":[0.69736975,0.036644533,0.14148961,0.05520116,0.002738815,0.00028602398,0.044369437,0.00015716247,0.010976362,0.0094901435,0.0002074525,0.0010695275],"about_ca_topic_score_codex":0.00048403186,"about_ca_topic_score_gemma":0.000069271664,"teacher_disagreement_score":0.5489722,"about_ca_system_score_codex":0.00003443073,"about_ca_system_score_gemma":0.000091138914,"threshold_uncertainty_score":0.3622319},"labels":[],"label_agreement":null},{"id":"W2550369872","doi":"10.1136/annrheumdis-2016-eular.2794","title":"AB0419 Aurion Study: Preliminary Results of Voclosporin in Lupus Nephritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Lupus nephritis; Renal function; Internal medicine; Proteinuria; Calcineurin; Creatinine; Urology; Immunosuppression; Gastroenterology; Pharmacodynamics; Systemic lupus erythematosus; Kidney; Pharmacokinetics; Transplantation","score_opus":0.04873398366371672,"score_gpt":0.33821650420215266,"score_spread":0.28948252053843593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550369872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928837,0.0020828997,0.0000029867638,0.0026956943,0.00018637742,0.0013075686,0.000103614744,0.000023273202,0.00071387447],"genre_scores_gemma":[0.9967553,0.0005941782,0.000022203474,0.000030398567,0.000025236719,0.000058643054,0.0000036916051,0.000023477178,0.002486898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973812,0.00028911696,0.00092500856,0.00025457673,0.00084751146,0.00030260274],"domain_scores_gemma":[0.99750954,0.00074837694,0.0003584951,0.001004375,0.00023461123,0.00014461824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006729563,0.00015910588,0.00060235005,0.00019128027,0.000029364255,0.0000059691697,0.0003781912,0.00005367121,0.00005773356],"category_scores_gemma":[0.0025865103,0.00008353462,0.0002043717,0.00036839017,0.00018600313,0.00010552079,0.00020995959,0.00007379969,0.000027439286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066837347,0.003368907,0.90719277,0.002992726,0.0003286047,0.000068284266,0.004035865,0.0000060338652,0.0003840008,0.00012722424,0.02465784,0.050153997],"study_design_scores_gemma":[0.014135264,0.0030603448,0.9377376,0.031038688,0.00018152069,0.0005310073,0.0065947995,0.00009249604,0.0043652295,0.0017318923,0.00026341766,0.00026777323],"about_ca_topic_score_codex":0.0002714336,"about_ca_topic_score_gemma":0.000029696139,"teacher_disagreement_score":0.049886223,"about_ca_system_score_codex":0.000037360947,"about_ca_system_score_gemma":0.00020605304,"threshold_uncertainty_score":0.3406443},"labels":[],"label_agreement":null},{"id":"W2550403306","doi":"10.1136/annrheumdis-2016-eular.3529","title":"FRI0269 Diffuse Cutaneous Systemic Sclerosis (dcSSc) Referral and Diagnosis: Results of A Survey of Healthcare Providers","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Referral; Family medicine; Health care; Rheumatology; Quality of life (healthcare); Presentation (obstetrics); Pediatrics; Internal medicine; Surgery; Nursing","score_opus":0.11490250398124999,"score_gpt":0.3097527684376528,"score_spread":0.19485026445640283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550403306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625847,0.031655643,0.000002621247,0.00306858,0.00013559389,0.000841672,0.0016523391,0.000029780664,0.000029105468],"genre_scores_gemma":[0.9767414,0.022907931,0.000008753965,0.00012554358,0.000014451219,0.000059747552,0.000017936205,0.000028603887,0.00009563696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709725,0.00047328696,0.0012602402,0.00031110464,0.0005808499,0.00027724623],"domain_scores_gemma":[0.9960036,0.0013039304,0.001009024,0.0008483032,0.0005441869,0.000290948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042274906,0.00022969677,0.0009262339,0.00012635319,0.00006011189,0.000009903115,0.00025791678,0.000114055445,0.000015635505],"category_scores_gemma":[0.0041944575,0.00011559502,0.00029946235,0.00029426833,0.00038322716,0.0000889126,0.000114393224,0.00006163781,0.0000028776994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005549568,0.003092476,0.83521074,0.015772419,0.0018850114,0.00001008887,0.0017942078,0.00001925048,0.0051045497,0.0001693467,0.023939101,0.10745323],"study_design_scores_gemma":[0.004121203,0.0006069077,0.89103323,0.09636497,0.0005705665,0.000044886874,0.000792791,0.000038709935,0.0060508577,0.00015538784,0.000013593685,0.00020691453],"about_ca_topic_score_codex":0.004071489,"about_ca_topic_score_gemma":0.00006515888,"teacher_disagreement_score":0.10724631,"about_ca_system_score_codex":0.000023800061,"about_ca_system_score_gemma":0.0002449428,"threshold_uncertainty_score":0.61549},"labels":[],"label_agreement":null},{"id":"W2550461501","doi":"10.1136/annrheumdis-2016-eular.5279","title":"SAT0322 Prevalence and Risk Factors for Cognitive Impairment in Systemic Lupus Erythematosus","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; Internal medicine; Dementia; Systemic lupus erythematosus; Overweight; Dyslipidemia; Disease; Obesity","score_opus":0.04008764970973178,"score_gpt":0.3259481621510465,"score_spread":0.2858605124413147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550461501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909425,0.0052976287,0.00007391669,0.00042120306,0.00014101535,0.00258606,0.00045969023,0.000029237744,0.00004874075],"genre_scores_gemma":[0.9942634,0.00461179,0.000017201297,0.000023992277,0.000017222015,0.0002585648,0.0000031792317,0.000029229215,0.0007753853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979844,0.00023895373,0.0005842503,0.00030209793,0.0005024955,0.0003878064],"domain_scores_gemma":[0.99617183,0.0025667665,0.00035589855,0.00046718758,0.00023312778,0.0002051841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005872256,0.00020998326,0.00058213144,0.00014898302,0.00007120633,0.000015104306,0.0002118944,0.0000600735,0.000044036275],"category_scores_gemma":[0.0037014964,0.00010069501,0.00022791648,0.00016988993,0.0002470174,0.00010468425,0.00013167929,0.00006384595,0.000009045656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005106324,0.00025833285,0.9852204,0.00845678,0.000259212,0.0000028051163,0.0013995034,7.701212e-7,0.000058514335,0.00008287347,0.000797011,0.0029531822],"study_design_scores_gemma":[0.011983023,0.0010438445,0.86485755,0.10129307,0.00081918435,0.002590586,0.008478716,0.0003340889,0.00393558,0.0041602887,0.00002205943,0.00048199602],"about_ca_topic_score_codex":0.00006289259,"about_ca_topic_score_gemma":0.000006973773,"teacher_disagreement_score":0.12036282,"about_ca_system_score_codex":0.000053939,"about_ca_system_score_gemma":0.00016281403,"threshold_uncertainty_score":0.44313043},"labels":[],"label_agreement":null},{"id":"W2550484150","doi":"10.1136/annrheumdis-2016-eular.3590","title":"FRI0446 Treatment with Tildrakizumab, An Anti-IL-23P19 Monoclonal Antibody, Improves Health-Related Quality of Life in Patients with Chronic Plaque Psoriasis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Medicine; Dermatology Life Quality Index; Psoriasis; Psoriasis Area and Severity Index; Quality of life (healthcare); Internal medicine; Placebo; Physical therapy; Gastroenterology; Dermatology; Pathology","score_opus":0.029809757481912204,"score_gpt":0.2868373016328367,"score_spread":0.2570275441509245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550484150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327105,0.0041789026,0.0000076101032,0.0006115324,0.00014336374,0.00071771274,0.0010180683,0.000032076317,0.00001966468],"genre_scores_gemma":[0.9983347,0.0011711012,0.000027346226,0.000039225793,0.000008003361,0.000049366026,0.00021619379,0.000025901505,0.0001281396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976026,0.00064714934,0.0008303953,0.00036103968,0.00013368553,0.00042513083],"domain_scores_gemma":[0.9979496,0.0002973827,0.0008674898,0.00067208975,0.00012498719,0.00008844638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020994361,0.0003317763,0.00092901604,0.00012575825,0.00012154169,0.000007730862,0.0003105068,0.00011837582,0.00011494203],"category_scores_gemma":[0.00007542924,0.00015453623,0.00018999664,0.00021672843,0.0003485871,0.0002016809,0.00005241458,0.00005303703,0.000017499511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043627624,0.004154448,0.8029842,0.00023040248,0.0023832268,0.0000012019982,0.00061615865,0.000024782727,0.0014837292,0.00028372608,0.00013682827,0.18333855],"study_design_scores_gemma":[0.008901869,0.0031783688,0.9816871,0.0007290701,0.00015263013,0.0000013979198,0.000076643286,0.0000024763008,0.004851692,0.00016341275,0.00003659553,0.00021868618],"about_ca_topic_score_codex":0.0021073145,"about_ca_topic_score_gemma":0.0004191987,"teacher_disagreement_score":0.18311988,"about_ca_system_score_codex":0.00007747592,"about_ca_system_score_gemma":0.00051618525,"threshold_uncertainty_score":0.6301804},"labels":[],"label_agreement":null},{"id":"W2550511177","doi":"10.1136/annrheumdis-2016-eular.1921","title":"THU0450 All-Cause Mortality and Malignancies in Psoriasis Patients with Psoriatic Arthritis in The Psoriasis Longitudinal Assessment and Registry Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ustekinumab; Adalimumab; Psoriatic arthritis; Etanercept; Internal medicine; Infliximab; Cohort; Psoriasis; Hazard ratio; Incidence (geometry); Proportional hazards model; Disease; Rheumatoid arthritis; Dermatology; Confidence interval","score_opus":0.3359048772144245,"score_gpt":0.43657783905289593,"score_spread":0.10067296183847141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550511177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865594,0.0018507827,0.000035882,0.009759667,0.00014136003,0.0012274982,0.000339221,0.000009109366,0.000077073884],"genre_scores_gemma":[0.99741226,0.0015193479,0.000077694705,0.0007135206,0.000027658005,0.00021285264,0.000004855613,0.000015554542,0.00001627108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961373,0.00068176474,0.00220263,0.0004319544,0.00023364772,0.00031269333],"domain_scores_gemma":[0.9961418,0.0014576823,0.0014807193,0.00075864984,0.000063039646,0.000098130884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059698224,0.0002087477,0.0008294496,0.00015918667,0.00010970427,0.000083214305,0.00034351554,0.000049885693,0.00004483122],"category_scores_gemma":[0.0024242313,0.00013033468,0.00006955712,0.00020139903,0.00019019307,0.0004424049,0.00010254628,0.00008308005,0.000008467949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002640551,0.00063625793,0.98883384,0.00023402758,0.0002394087,0.000001239286,0.0015438679,0.000009367997,3.2997708e-8,0.006086787,0.00078954705,0.0015991937],"study_design_scores_gemma":[0.001998255,0.00015847817,0.9814309,0.00072705303,0.000044735494,0.0000010792546,0.0023992942,0.00005854987,4.3371176e-7,0.012966011,0.00004187239,0.00017332817],"about_ca_topic_score_codex":0.0014821237,"about_ca_topic_score_gemma":0.0015349666,"teacher_disagreement_score":0.010852839,"about_ca_system_score_codex":0.00008298769,"about_ca_system_score_gemma":0.00009795223,"threshold_uncertainty_score":0.53148943},"labels":[],"label_agreement":null},{"id":"W2550566425","doi":"10.1136/annrheumdis-2016-eular.4740","title":"AB0684 Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Memorial University of Newfoundland; McGill University","funders":"","keywords":"Medicine; Golimumab; BASDAI; BASFI; Ankylosing spondylitis; Infliximab; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Spondylitis; Physical therapy; Surgery; Disease","score_opus":0.0725482826873975,"score_gpt":0.2888157022000375,"score_spread":0.21626741951264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550566425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970001,0.0012103047,7.0611475e-7,0.00036029253,0.000039721217,0.00071102614,0.0003189632,0.000017824521,0.00034107035],"genre_scores_gemma":[0.99723804,0.0022908433,0.000017691396,0.0000603763,0.000010268184,0.00009314124,0.000049350198,0.000018980194,0.00022129477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861884,0.00009313318,0.00041963076,0.00025131716,0.00031891902,0.00029817325],"domain_scores_gemma":[0.9991153,0.00019599937,0.00018811597,0.0003267015,0.000085068925,0.00008883551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042670315,0.00022953228,0.0005131928,0.00014848364,0.00006932403,0.000011577199,0.0000790387,0.000038863574,0.00033496736],"category_scores_gemma":[0.00009861956,0.00009855599,0.00010524465,0.00027423442,0.00010744716,0.00012304337,0.00005020188,0.00002623088,0.000012908948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032991176,0.0016611976,0.9661873,0.00006871521,0.00018343315,0.000037570186,0.0004926254,8.526104e-7,0.000007816356,0.000034950215,0.000074920456,0.027951475],"study_design_scores_gemma":[0.011632577,0.0011908616,0.9840481,0.0021074484,0.00008435013,0.0000057744705,0.00014405568,0.0000050844915,0.00043673892,0.00014740857,0.00007453404,0.0001230665],"about_ca_topic_score_codex":0.0002028667,"about_ca_topic_score_gemma":0.0002939822,"teacher_disagreement_score":0.027828408,"about_ca_system_score_codex":0.00021305076,"about_ca_system_score_gemma":0.000060164155,"threshold_uncertainty_score":0.40189964},"labels":[],"label_agreement":null},{"id":"W2550567080","doi":"10.1136/annrheumdis-2016-eular.3974","title":"SAT0559 The Anatomical Distribution of Inflammation, Fat, Erosion and New Bone Formation in The Spine Assessed According To The Canada-Denmark MRI Definitions in Patients with Axial Spondyloarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Soft tissue; Radiology; Lesion; Axial skeleton; Axial spondyloarthritis; Magnetic resonance imaging; Anatomy; Surgery","score_opus":0.0244603379012981,"score_gpt":0.2504153000674729,"score_spread":0.22595496216617483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550567080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726758,0.0002522351,0.00019068779,0.025783112,0.00003290006,0.0007701466,0.00026965505,0.0000047853446,0.00002069146],"genre_scores_gemma":[0.99917567,0.00021878352,0.000013497834,0.00043276945,0.000024318571,0.000040238512,0.000082156614,0.000007034072,0.000005517189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986393,0.0001705472,0.0004562134,0.00010937818,0.00045532794,0.00016924086],"domain_scores_gemma":[0.9989177,0.00029954553,0.00021951765,0.00034136197,0.00014048717,0.0000813882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023826807,0.00011720786,0.00023657855,0.000054634584,0.00011307396,0.000022885752,0.00015081721,0.000025559602,0.000014751355],"category_scores_gemma":[0.0010219426,0.00004509132,0.000062751686,0.00035810383,0.0001004994,0.00020935122,0.000058672118,0.000065419365,0.0000012266452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026835217,0.001295357,0.79937786,0.0008115793,0.00017951561,0.0000142335875,0.0019661586,0.00023246242,0.0005332691,0.0068842876,0.04838772,0.13763407],"study_design_scores_gemma":[0.0015965006,0.00011689307,0.99409854,0.0017904012,0.00007516575,0.0000042911543,0.00059934176,0.000072533156,0.00032323293,0.0011349483,0.00011874015,0.00006943745],"about_ca_topic_score_codex":0.00984339,"about_ca_topic_score_gemma":0.026485326,"teacher_disagreement_score":0.19472069,"about_ca_system_score_codex":0.000038614624,"about_ca_system_score_gemma":0.00022695266,"threshold_uncertainty_score":0.9967502},"labels":[],"label_agreement":null},{"id":"W2550586814","doi":"10.1136/annrheumdis-2016-eular.4126","title":"SAT0166 An Analysis of Laboratory Results from 2 Randomized, Double-Blind Studies of Sirukumab in Patients with Active Rheumatoid Arthritis Refractory To Disease-Modifying Anti-Rheumatic Drug Treatment","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Rheumatoid arthritis; Concomitant; Methotrexate; Internal medicine; Placebo; Gastroenterology; Alanine transaminase; Refractory (planetary science); Pharmacology; Pathology","score_opus":0.05779955863381384,"score_gpt":0.3560743928772639,"score_spread":0.29827483424345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550586814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073374,0.004104684,0.00001177384,0.00042283023,0.00005929901,0.0023159424,0.0023081352,0.000023755663,0.000019851437],"genre_scores_gemma":[0.9927955,0.00668316,0.00007903468,0.000037126058,0.000009709068,0.00019057696,0.00012900447,0.00004178312,0.000034099714],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952053,0.000688454,0.0016971051,0.00058455794,0.0013763866,0.00044820865],"domain_scores_gemma":[0.9924556,0.0032911072,0.0011675888,0.0016170605,0.0010261578,0.00044246193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007568181,0.0004144395,0.0028094521,0.00075125066,0.00007575272,0.000016004118,0.0004067815,0.00006304514,0.000056198543],"category_scores_gemma":[0.0034737643,0.00021172126,0.000560378,0.0012557907,0.0007856565,0.0003378888,0.00018208228,0.00008048201,0.000005460341],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8534776,0.0074318317,0.059955716,0.0011582031,0.023934852,0.000026576607,0.012627512,0.001752933,0.00008600353,0.00009503231,0.00020331028,0.03925041],"study_design_scores_gemma":[0.66311705,0.00074161374,0.30911565,0.016338678,0.0026818975,4.071337e-7,0.0021792045,0.00081849255,0.004271537,0.00034202842,0.000006254532,0.0003872036],"about_ca_topic_score_codex":0.0023505862,"about_ca_topic_score_gemma":0.0004203636,"teacher_disagreement_score":0.24915995,"about_ca_system_score_codex":0.0013572815,"about_ca_system_score_gemma":0.0025685169,"threshold_uncertainty_score":0.86337423},"labels":[],"label_agreement":null},{"id":"W2550644244","doi":"10.1136/annrheumdis-2016-eular.3359","title":"THU0140 Efficacy and Safety Analysis by Overall anti-Drug Antibody Results Up To Week 30 in Patients with Rheumatoid Arthritis Treated with Sb2 (An Infliximab Biosimilar) or Infliximab Reference Product in Phase III Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Biosimilar; Infliximab; Internal medicine; Methotrexate; Immunogenicity; Gastroenterology; Clinical efficacy; Safety profile; Drug; Surgery; Antibody; Adverse effect; Pharmacology; Immunology; Disease","score_opus":0.026809171790200426,"score_gpt":0.3187931148104403,"score_spread":0.2919839430202399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550644244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521244,0.00088946545,0.00001944672,0.0010070436,0.000035220237,0.0014792889,0.0012991986,0.000034457265,0.000023443976],"genre_scores_gemma":[0.99819905,0.0011667503,0.000066206485,0.00019139932,0.0000025388315,0.000038434067,0.00014078892,0.000023598039,0.00017125397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965032,0.00090041576,0.0010690624,0.0007823145,0.00020549458,0.0005395573],"domain_scores_gemma":[0.9977795,0.00049191224,0.00044469134,0.00093014067,0.0002222406,0.00013153713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006387439,0.00043226746,0.0012632844,0.00036839143,0.00013514186,0.000041140225,0.0004728235,0.00010186423,0.00014867864],"category_scores_gemma":[0.00069193146,0.00020001022,0.00009088154,0.0010963937,0.0004344558,0.00027928565,0.00018900876,0.00017491104,0.000005229327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060949977,0.020411968,0.8406995,0.00010540955,0.003375405,0.000016066067,0.002137834,0.000040133225,0.0017194563,0.00004304908,0.0019575346,0.06854367],"study_design_scores_gemma":[0.041390356,0.0036151079,0.94794995,0.0016117609,0.0003342206,0.000002337844,0.0003462873,0.00001498914,0.0039421474,0.000028627108,0.00026652068,0.0004977192],"about_ca_topic_score_codex":0.0005823613,"about_ca_topic_score_gemma":0.00051504845,"teacher_disagreement_score":0.10725043,"about_ca_system_score_codex":0.000026344072,"about_ca_system_score_gemma":0.00009493505,"threshold_uncertainty_score":0.81561804},"labels":[],"label_agreement":null},{"id":"W2550805759","doi":"10.1136/annrheumdis-2016-eular.1275","title":"SAT0150 Comparative Risk of Malignancy with Initiaton of Abatacept and Other Biologics in Patients with Rheumatoid Arthritis: A Cohort Analysis of A United States Claims Database","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Population; Oncology; Database; Physical therapy; Rituximab","score_opus":0.02627795943970613,"score_gpt":0.28922794674145885,"score_spread":0.26294998730175273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550805759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999935,0.0050426675,0.00006211605,0.00007934657,0.0000072307885,0.00067465054,0.0040964386,0.00000881507,0.00002937024],"genre_scores_gemma":[0.96070486,0.038933016,0.00012746238,0.00003066643,0.000001070957,0.000028963828,0.00015586567,0.000014245633,0.000003856942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794143,0.00033803674,0.0007244473,0.00022376963,0.0005331827,0.00023910774],"domain_scores_gemma":[0.9974422,0.00058232807,0.0008003095,0.00054253964,0.0005059681,0.00012669651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032631535,0.00020350823,0.0011109005,0.0005162628,0.00003617166,0.0000062838785,0.00017433052,0.000036601792,0.00009744672],"category_scores_gemma":[0.00030314905,0.00009619323,0.00013393845,0.0010048319,0.0010611855,0.00014468076,0.00007993423,0.000069404094,5.722578e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023936832,0.0010402276,0.98810273,0.00023702595,0.0035262061,0.0000015258811,0.0010022452,0.000056117005,0.000036386744,0.00021949864,0.00008491725,0.0032994412],"study_design_scores_gemma":[0.0044746576,0.0013303969,0.9812792,0.008889696,0.00016664017,0.0000013810102,0.0010690261,0.00017974284,0.0021004337,0.00035687996,0.000018860312,0.000133076],"about_ca_topic_score_codex":0.00085924315,"about_ca_topic_score_gemma":0.0003071567,"teacher_disagreement_score":0.033890348,"about_ca_system_score_codex":0.000007692611,"about_ca_system_score_gemma":0.00010409045,"threshold_uncertainty_score":0.39226463},"labels":[],"label_agreement":null},{"id":"W2550819725","doi":"10.1136/annrheumdis-2016-eular.2021","title":"THU0138 Secondary Efficacy Results Up To Week 24 from A Phase III Study Comparing SB5 (An Adalimumab Biosimiar) with Adalimumab Reference Product in Patients with Moderate To Severe Rheumatoid Arthritis despite Methotrexate Therapy","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Clinical endpoint; Internal medicine; Methotrexate; Surrogate endpoint; Physical therapy; Clinical trial","score_opus":0.06699277095954076,"score_gpt":0.3212752334356977,"score_spread":0.25428246247615693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550819725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932134,0.0013884366,0.00012467032,0.0015951357,0.00018296798,0.0020391378,0.0013404156,0.0000635755,0.000052264728],"genre_scores_gemma":[0.9980449,0.00035028317,0.00060468883,0.0006226479,0.000008825077,0.00010146647,0.00006759571,0.000045338053,0.00015425912],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959779,0.0012673567,0.00095391663,0.00091336,0.00025190925,0.00063558214],"domain_scores_gemma":[0.9971434,0.0006031757,0.00043113416,0.0012863212,0.00032997294,0.0002060247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055810704,0.00051240105,0.0011166318,0.00019680918,0.00022110737,0.00006672202,0.00079310004,0.00010555013,0.00018748498],"category_scores_gemma":[0.00041808034,0.00025383072,0.00012080678,0.00050133804,0.00026767814,0.00029011627,0.00025348237,0.00025132508,0.00002509324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1965766,0.021434646,0.05529324,0.000104506544,0.0038179364,0.00001875001,0.010789396,0.00030059856,0.0033336983,0.000102819984,0.0052807387,0.7029471],"study_design_scores_gemma":[0.12375866,0.016577758,0.8007909,0.008073902,0.00026633698,0.000010045744,0.0024147467,0.00005469154,0.044126663,0.0008737465,0.0011461884,0.0019063835],"about_ca_topic_score_codex":0.0005743366,"about_ca_topic_score_gemma":0.00043820275,"teacher_disagreement_score":0.74549764,"about_ca_system_score_codex":0.000031729487,"about_ca_system_score_gemma":0.00017562309,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W2550836250","doi":"10.1136/annrheumdis-2016-eular.4786","title":"OP0033 European Scleroderma Study Group Activity Index Captures Variations in Disease Activity over Time and Predicts Organ Damage in Early Systemic Sclerosis: Data from The Canadian Scleroderma Research Group","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Western University","funders":"","keywords":"Medicine; Internal medicine; Scleroderma (fungus); Cohort; Disease; Severity of illness; Systemic scleroderma; Rheumatology; Pathology","score_opus":0.13111683327094117,"score_gpt":0.32697096280843835,"score_spread":0.19585412953749717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550836250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882637,0.003888552,0.0000058307146,0.002907626,0.00013270909,0.0023969195,0.0022806276,0.000047019716,0.00007700934],"genre_scores_gemma":[0.9982252,0.0011884564,0.0000022925442,0.00021129551,0.00009330657,0.00009107345,0.00006770517,0.00006700975,0.000053659212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993061,0.0034901036,0.0006999209,0.0008404785,0.001217099,0.00069142116],"domain_scores_gemma":[0.99461496,0.0014935097,0.00033011535,0.0025676768,0.00018589062,0.00080786383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024723788,0.00036832577,0.0006559456,0.00037910306,0.00045959715,0.00019092133,0.0012560368,0.000119041,0.000103667815],"category_scores_gemma":[0.0024930227,0.00019986149,0.00013069519,0.00087625266,0.0005128258,0.0006894621,0.00085986225,0.0004204153,0.000034867568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006651513,0.0020788226,0.98081255,0.00019902614,0.00041280515,0.00003880482,0.0016838092,0.000020337313,0.0015752634,0.000024985018,0.0033490746,0.009139369],"study_design_scores_gemma":[0.003073247,0.00010507822,0.9800794,0.014049129,0.0002600871,0.000002492664,0.00039121273,0.001659718,0.000014047,0.00013382634,0.000006717214,0.00022501663],"about_ca_topic_score_codex":0.15876196,"about_ca_topic_score_gemma":0.07577386,"teacher_disagreement_score":0.082988106,"about_ca_system_score_codex":0.00018806748,"about_ca_system_score_gemma":0.0006631111,"threshold_uncertainty_score":0.9410909},"labels":[],"label_agreement":null},{"id":"W2550932522","doi":"10.1136/annrheumdis-2016-eular.4414","title":"FRI0181 Changing Use of Methotrexate (MTX) and Biologics in The Treatment of Rheumatoid Arthritis (RA) in The United States (US): Results of A Comprehensive Pharmaceutical Claims Analysis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Concomitant; Dosing; Combination therapy","score_opus":0.11257117432041908,"score_gpt":0.3717952961883916,"score_spread":0.2592241218679725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550932522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97961485,0.0155906845,0.000023820003,0.0034409112,0.00001760677,0.00066678866,0.0006273811,0.000006457369,0.000011471709],"genre_scores_gemma":[0.71237993,0.28735146,0.000052946896,0.00013405697,0.0000028780782,0.000030407457,0.00003706412,0.0000067403594,0.0000045186453],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969723,0.0011434174,0.0008724862,0.00019852881,0.00048201918,0.00033123317],"domain_scores_gemma":[0.9949072,0.003765945,0.00042680342,0.00057453674,0.00024636506,0.000079176345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072449975,0.00019613719,0.00084948586,0.0005846434,0.000055550176,0.000015178256,0.0002727637,0.000045675242,0.000024261486],"category_scores_gemma":[0.0006407377,0.000079736725,0.00031516099,0.0013465551,0.00081201084,0.00009425044,0.00006451646,0.00007483996,5.7644127e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012781977,0.011386078,0.4378788,0.0014085505,0.0101399645,0.00009958675,0.06645387,0.0013275757,0.0049687047,0.003674891,0.0015411075,0.4483389],"study_design_scores_gemma":[0.019484892,0.0039829593,0.8995461,0.010972257,0.00036036366,0.00004897268,0.023943486,0.0075283903,0.023507018,0.005165813,0.005001516,0.00045824013],"about_ca_topic_score_codex":0.0011349322,"about_ca_topic_score_gemma":0.00014252693,"teacher_disagreement_score":0.4616673,"about_ca_system_score_codex":0.0000115273515,"about_ca_system_score_gemma":0.00005203523,"threshold_uncertainty_score":0.32515693},"labels":[],"label_agreement":null},{"id":"W2550954506","doi":"10.1136/annrheumdis-2016-eular.2694","title":"AB0183 Long Term Outcome of Early Arthritis: from Remission through Rheumatoid Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Arthritis; Internal medicine; Outpatient clinic; Physical therapy; Pediatrics","score_opus":0.04763529136458061,"score_gpt":0.3294657982968649,"score_spread":0.2818305069322843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550954506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94332236,0.051203795,0.00015254303,0.0036013774,0.000248752,0.00056937453,0.00041739302,0.00007390841,0.00041051733],"genre_scores_gemma":[0.8301054,0.16918944,0.00015475664,0.00019220074,0.00003984372,0.000034784203,0.000016896156,0.000042532458,0.00022411672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664617,0.00021767251,0.0012011292,0.00037431202,0.0010285527,0.0005321636],"domain_scores_gemma":[0.9970725,0.0005661316,0.0005429807,0.0011532146,0.00032322196,0.0003419157],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027615193,0.00031485435,0.0010097453,0.00011114771,0.00014706024,0.00003789672,0.00050411734,0.00010361034,0.0011196918],"category_scores_gemma":[0.001484085,0.00017783546,0.0006092564,0.00024114308,0.00069939037,0.0004469557,0.00022174898,0.0001392734,0.00008123679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007173901,0.00072589883,0.50770295,0.00027429732,0.0005660202,0.000031152955,0.0007732859,5.937917e-7,0.0030723566,0.0009047805,0.0060921437,0.47913912],"study_design_scores_gemma":[0.004992608,0.00053139287,0.9187327,0.033103775,0.000018011597,0.000046282097,0.00020418134,0.0000047800872,0.02659375,0.014314556,0.0011120442,0.00034592944],"about_ca_topic_score_codex":0.0004924689,"about_ca_topic_score_gemma":0.000039474136,"teacher_disagreement_score":0.47879317,"about_ca_system_score_codex":0.000018713283,"about_ca_system_score_gemma":0.00017410432,"threshold_uncertainty_score":0.9997934},"labels":[],"label_agreement":null},{"id":"W2550973753","doi":"10.1136/annrheumdis-2016-eular.3741","title":"SAT0145 Efficacy and Safety of Sirukumab in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of A Randomized, Double-Blind, Placebo-Controlled Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Rheumatoid arthritis; Drug; Placebo; Randomized controlled trial; Internal medicine; Pharmacology; Alternative medicine","score_opus":0.02404135419784575,"score_gpt":0.2948679784413491,"score_spread":0.27082662424350334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550973753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815066,0.008006138,0.00001532446,0.00059641985,0.000052449544,0.009318931,0.00040015625,0.000029450768,0.00007453471],"genre_scores_gemma":[0.9647424,0.034636233,0.000039865357,0.000012827068,0.000006657441,0.0004455326,0.000026878757,0.000047143352,0.000042440934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948717,0.000976794,0.0020142505,0.00048990786,0.0011273498,0.00051999465],"domain_scores_gemma":[0.9936063,0.0032512199,0.0013159497,0.0009410155,0.00049804116,0.00038742216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010969894,0.0004833331,0.003082691,0.00045324792,0.00014110045,0.00003253189,0.0003022165,0.00005340591,0.000042492415],"category_scores_gemma":[0.0028586336,0.00023872752,0.00053243863,0.00040472928,0.00095159677,0.0003436026,0.00013891661,0.000110337285,0.0000033493184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8742826,0.006095795,0.055761654,0.00036913733,0.0028051045,0.000007937577,0.0031602185,0.00003496823,0.000013448684,0.0001526195,0.00002676897,0.05728976],"study_design_scores_gemma":[0.76863796,0.00119496,0.21439342,0.013822439,0.00014978026,0.000002469676,0.0006422768,0.000059788286,0.000434156,0.00043949654,0.0000038122848,0.00021944511],"about_ca_topic_score_codex":0.00042151372,"about_ca_topic_score_gemma":0.00010042759,"teacher_disagreement_score":0.15863177,"about_ca_system_score_codex":0.00005071249,"about_ca_system_score_gemma":0.000354386,"threshold_uncertainty_score":0.9735026},"labels":[],"label_agreement":null},{"id":"W2551016060","doi":"10.1136/annrheumdis-2016-eular.3567","title":"FRI0120 The Incidence of Herpes Zoster (HZ) in A Population of Patients with Inflammatory Arthritis: A 12-Year Analysis from The Rhumadata Clinical Database and Registry","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada","funders":"","keywords":"Medicine; Psoriatic arthritis; Incidence (geometry); Ankylosing spondylitis; Rheumatoid arthritis; Population; Internal medicine; Postherpetic neuralgia; Immunosuppression; Univariate analysis; Rheumatology; Pediatrics; Surgery; Multivariate analysis; Pathology","score_opus":0.030968054792345018,"score_gpt":0.31278415760625466,"score_spread":0.2818161028139097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551016060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977482,0.0006695447,0.000018786312,0.00048338436,0.000021355621,0.00031691985,0.00072061294,0.000004395438,0.000016826274],"genre_scores_gemma":[0.99902934,0.0007455073,0.000040193623,0.000083004124,0.000009106486,0.00001542013,0.0000578865,0.0000067124183,0.00001282334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987013,0.00022012612,0.0005496247,0.00014795303,0.00028877053,0.000092249786],"domain_scores_gemma":[0.9978887,0.0006974148,0.0004467149,0.0008150078,0.00010074669,0.000051426003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002947886,0.00009679626,0.0003493028,0.000050080176,0.00005197488,0.000007641591,0.00015754475,0.000031338885,0.000063391424],"category_scores_gemma":[0.0008422241,0.000036759924,0.00012830232,0.00019937313,0.00033300705,0.00014789231,0.000111319096,0.000046360565,0.0000013151329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027050346,0.00038539723,0.96167916,0.000047096724,0.0006474945,0.0000011276985,0.00010029504,0.0000024307342,9.187402e-7,0.000034916444,0.00016886088,0.036661804],"study_design_scores_gemma":[0.0012939767,0.00007205886,0.9956029,0.0018910638,0.0005714485,3.7939088e-7,0.00008371686,0.00002975085,0.000030146612,0.00032361815,0.00005814223,0.000042778127],"about_ca_topic_score_codex":0.00130087,"about_ca_topic_score_gemma":0.0008492443,"teacher_disagreement_score":0.036619026,"about_ca_system_score_codex":0.000006690785,"about_ca_system_score_gemma":0.00005618667,"threshold_uncertainty_score":0.19665349},"labels":[],"label_agreement":null},{"id":"W2551140749","doi":"10.1136/annrheumdis-2016-eular.1999","title":"OP0096 Meniscal Extrusion and Bone Marrow Lesions Are Independently Associated with Incident and Progressive Knee Osteoarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Cartilage; Magnetic resonance imaging; Tibia; Prospective cohort study; Knee Joint; Surgery; Internal medicine; Pathology; Radiology; Anatomy","score_opus":0.020639812794303835,"score_gpt":0.2616066208323242,"score_spread":0.2409668080380204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551140749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982483,0.0068194233,0.000003620866,0.0022438096,0.000050602932,0.00076283823,0.00014611898,0.000036862602,0.00011188148],"genre_scores_gemma":[0.9984148,0.00047126997,0.000048569455,0.0001449036,0.0000141301925,0.000077029224,0.000014170974,0.000022244707,0.00079287915],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987554,0.0000904318,0.0002632172,0.00023113075,0.00042419854,0.00023560184],"domain_scores_gemma":[0.99889886,0.00016273475,0.0003013254,0.00026942985,0.00013249314,0.00023512491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011168942,0.00018878952,0.00040192268,0.00006764475,0.00014781658,0.00002714083,0.00006211244,0.00006633513,0.00008034586],"category_scores_gemma":[0.00039192004,0.00009415084,0.000085450505,0.000091892216,0.00023228783,0.00014799349,0.00014302002,0.000054197022,0.0000037832224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010293811,0.00092079013,0.22096388,0.00025758642,0.00032412104,0.00025368197,0.00041534824,1.976539e-7,0.0021075818,0.000506096,0.00066165,0.7725597],"study_design_scores_gemma":[0.013257378,0.005684699,0.9455515,0.020988256,0.00078348053,0.00030577657,0.0009045398,0.000008980492,0.0082160765,0.0038636774,0.000067529676,0.00036807597],"about_ca_topic_score_codex":0.000008409579,"about_ca_topic_score_gemma":0.000045871944,"teacher_disagreement_score":0.7721916,"about_ca_system_score_codex":0.000015724192,"about_ca_system_score_gemma":0.00006535037,"threshold_uncertainty_score":0.383936},"labels":[],"label_agreement":null},{"id":"W2551184473","doi":"10.1136/annrheumdis-2016-eular.1846","title":"THU0174 A Safety Analysis of Tofacitinib 5 mg Twice Daily Administered as Monotherapy or in Combination with Background Conventional Synthetic Dmards in A Phase 3 Rheumatoid Arthritis Population","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Tofacitinib; Adverse effect; Rheumatoid arthritis; Internal medicine; Combination therapy; Methotrexate; Population; Gastroenterology","score_opus":0.04997734749271165,"score_gpt":0.3691876380807219,"score_spread":0.31921029058801026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551184473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966611,0.00061946,0.00017809293,0.0011858561,0.000027605896,0.0007986078,0.0003798987,0.000015078081,0.00013427497],"genre_scores_gemma":[0.9972508,0.0021561708,0.000063366664,0.00009791048,0.0000043036007,0.00008055112,0.00013586732,0.000023055702,0.00018794961],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972274,0.00030220658,0.0009993542,0.0003073413,0.0008664147,0.00029729045],"domain_scores_gemma":[0.9976909,0.00084799883,0.000480529,0.00061222055,0.00023452511,0.00013382817],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006007638,0.00019844862,0.00084503944,0.0005599816,0.000042074436,0.000018669618,0.00023284998,0.00006921207,0.0011080387],"category_scores_gemma":[0.00084811426,0.00011237439,0.00027966595,0.0011670497,0.00027057625,0.00021114772,0.00005634592,0.00006354272,0.000005630118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11778284,0.022316156,0.30448276,0.0038827187,0.010313452,0.0002630388,0.0037621479,0.0007834554,0.0013457235,0.011969751,0.000765666,0.5223323],"study_design_scores_gemma":[0.13638677,0.0029254672,0.80675745,0.021067249,0.0006921558,0.0001220224,0.0012700072,0.02466705,0.002070524,0.0032196157,0.0002652258,0.00055648654],"about_ca_topic_score_codex":0.0012323329,"about_ca_topic_score_gemma":0.00071538845,"teacher_disagreement_score":0.5217758,"about_ca_system_score_codex":0.0007299079,"about_ca_system_score_gemma":0.0017554687,"threshold_uncertainty_score":0.9998051},"labels":[],"label_agreement":null},{"id":"W2551258084","doi":"10.1136/annrheumdis-2016-eular.4351","title":"FRI0456 Association between Improvement in Enthesopathy and Quality of Life: Results from Anti-Tnf-Naïve Patients with Psoriatic Arthritis in Two Phase 3 Ustekinumab Trials","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Enthesopathy; Medicine; Ustekinumab; Psoriatic arthritis; Internal medicine; Physical therapy; Quality of life (healthcare); Randomization; Post-hoc analysis; Arthritis; Randomized controlled trial; Disease","score_opus":0.052288334874194244,"score_gpt":0.3170246519870126,"score_spread":0.2647363171128183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551258084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064493,0.0025172902,0.0000053163517,0.00029836094,0.0001672751,0.00065376627,0.0056896294,0.000009600567,0.000013832342],"genre_scores_gemma":[0.99875045,0.00092261,0.000012454254,0.00002677221,0.000014658705,0.00004179786,0.00019145828,0.00001024058,0.000029537408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967017,0.0013016823,0.0013481897,0.0002638344,0.00013970351,0.0002448532],"domain_scores_gemma":[0.99506986,0.00299832,0.0014416532,0.00035135896,0.00010173167,0.000037058253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013305157,0.0001915864,0.0010223257,0.00011198657,0.000043884407,0.000008646972,0.0001750261,0.00008808257,0.00005196884],"category_scores_gemma":[0.0041343444,0.00010684134,0.00014867891,0.00014309718,0.000090329915,0.0001307396,0.00006722653,0.000050019295,0.000006642341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018962821,0.0011973012,0.67446965,0.00005032538,0.00082151685,3.2433215e-7,0.0005736514,0.0000016083811,0.0008400276,0.000027178985,0.00009661642,0.3200255],"study_design_scores_gemma":[0.032038826,0.00029793664,0.9533198,0.0010777191,0.00021106438,3.1609062e-8,0.000120547375,6.7624205e-7,0.011908885,0.0008733004,0.000011838731,0.00013936368],"about_ca_topic_score_codex":0.0014066054,"about_ca_topic_score_gemma":0.00029187772,"teacher_disagreement_score":0.31988612,"about_ca_system_score_codex":0.000040547733,"about_ca_system_score_gemma":0.000081862054,"threshold_uncertainty_score":0.4949495},"labels":[],"label_agreement":null},{"id":"W2551418231","doi":"10.1136/annrheumdis-2016-eular.4314","title":"FRI0184 Increasing Treatment Time on Infliximab Is Predictive of Incrementally Better Long-Term Retention in Stable Infliximab Rheumatology Patients in Canada","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Infliximab; Discontinuation; Internal medicine; Biosimilar; Confidence interval; Population; Cohort; Odds ratio; Rheumatology; Surgery; Demography; Disease","score_opus":0.022186357770935874,"score_gpt":0.26327808073861825,"score_spread":0.2410917229676824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551418231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973809,0.00044728504,0.0000043414398,0.0009854961,0.00012040834,0.0003894766,0.0005139558,0.0000060387547,0.0001520695],"genre_scores_gemma":[0.9991854,0.00029358215,0.000024756917,0.00033048852,0.0000017359166,0.000022209859,0.00002700158,0.000010806915,0.000104064195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979521,0.0006310316,0.0007184857,0.0002458481,0.000116491756,0.00033605174],"domain_scores_gemma":[0.99854404,0.0005899148,0.00038407935,0.000350594,0.00009495191,0.000036433652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024222519,0.00020498697,0.0005692772,0.0001342614,0.00004107729,0.0000047521953,0.0002560646,0.000109157925,0.00049500103],"category_scores_gemma":[0.00040849292,0.00011488704,0.00013200592,0.00016655622,0.00022788908,0.00010826458,0.00012116918,0.000076272714,0.00001017983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011477708,0.0008594549,0.9726351,0.00010737983,0.00030401067,0.0000016002115,0.00013382923,0.000002830356,0.0012537946,0.000032870368,0.00074657926,0.022774775],"study_design_scores_gemma":[0.0026748606,0.00039515982,0.9625564,0.0016461,0.000061653765,0.0000019076454,0.000042194693,0.00001684319,0.032023735,0.0004229543,0.000023338262,0.00013485433],"about_ca_topic_score_codex":0.13673969,"about_ca_topic_score_gemma":0.031055609,"teacher_disagreement_score":0.10568407,"about_ca_system_score_codex":0.0002211968,"about_ca_system_score_gemma":0.00028949068,"threshold_uncertainty_score":0.9866251},"labels":[],"label_agreement":null},{"id":"W2551613250","doi":"10.1136/annrheumdis-2016-eular.2103","title":"OP0179 Comparing Initial Treatment Strategies with Methotrexate on First Use of Biologic Therapy: Results from The Canadian Early Arthritis Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Southlake Regional Health Center; University of Manitoba; University of British Columbia; Mount Sinai Hospital; University of Calgary; St Joseph's Health Care; University of Toronto; Université de Sherbrooke; London Health Sciences Centre","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cohort; Combination therapy; Internal medicine; Methotrexate; Cohort study; Rheumatology; Prospective cohort study; Arthritis; Physical therapy","score_opus":0.13136303262216112,"score_gpt":0.3284676153913264,"score_spread":0.1971045827691653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551613250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886857,0.003177858,0.0000048103266,0.005662817,0.00005778299,0.0007395537,0.0011472678,0.000022865912,0.00050130044],"genre_scores_gemma":[0.9671058,0.032479778,0.000045535267,0.00018162596,0.00002787814,0.00005597126,0.00003590082,0.000018459918,0.0000490708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982868,0.0002820631,0.00042817008,0.00023739858,0.00041665608,0.00034894],"domain_scores_gemma":[0.997185,0.0014242901,0.00024433812,0.0007263681,0.00018450023,0.00023552112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021979284,0.00021718573,0.0005281076,0.00008030727,0.00027945897,0.0000851474,0.00026340823,0.00004494559,0.000088887646],"category_scores_gemma":[0.0005383169,0.00008220357,0.00019046904,0.00013958338,0.00065519364,0.00017659356,0.000033051972,0.00007076947,0.000012208173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0111623285,0.0012455954,0.6504872,0.000055517994,0.004737736,0.00007579096,0.003289439,0.00024708934,0.00020108886,0.003236752,0.003547823,0.32171363],"study_design_scores_gemma":[0.0043060277,0.0019418439,0.98213625,0.004150551,0.000027396243,0.000006771598,0.00027142864,0.000028345346,0.003176231,0.001254081,0.00254561,0.00015547317],"about_ca_topic_score_codex":0.20986265,"about_ca_topic_score_gemma":0.16494076,"teacher_disagreement_score":0.33164904,"about_ca_system_score_codex":0.000034989167,"about_ca_system_score_gemma":0.00042663142,"threshold_uncertainty_score":0.8502969},"labels":[],"label_agreement":null},{"id":"W2551672151","doi":"10.1136/annrheumdis-2016-eular.5111","title":"AB0822 Hospitalization Trends of Gout and Rheumatoid Arthritis in The United States: A Tale of Two Arthritides","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Rheumatoid arthritis; Epidemiology; Internal medicine; Demography; Emergency medicine","score_opus":0.022444300553308472,"score_gpt":0.3057862453873498,"score_spread":0.2833419448340413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551672151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788789,0.016980302,0.00004729514,0.0033466853,0.000033918866,0.00031574257,0.00022537018,0.000013689452,0.00015810673],"genre_scores_gemma":[0.8628401,0.13691577,0.000029660803,0.00009824101,0.0000057840257,0.000031775824,0.000025993073,0.000014907173,0.000037740192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981029,0.00026086616,0.0006815622,0.000160274,0.0005368121,0.0002575539],"domain_scores_gemma":[0.9983667,0.00047364068,0.0003319283,0.00048019047,0.0002476794,0.0000998608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044245546,0.00015918874,0.0005124693,0.0003136094,0.000057666748,0.000018204626,0.00023961354,0.000032360662,0.00014919492],"category_scores_gemma":[0.0007341808,0.0000798958,0.0001715209,0.0005860621,0.00075394445,0.00017849174,0.00007294681,0.000057478133,0.0000019583895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013637621,0.0026014291,0.27765402,0.0013259897,0.00073179347,0.000020045456,0.012233355,0.000081117374,0.0018234364,0.0194396,0.0077119083,0.67501354],"study_design_scores_gemma":[0.014654891,0.0020129287,0.8775754,0.036754847,0.000036192283,0.00010896763,0.006227141,0.000961178,0.012721008,0.046708472,0.0017536994,0.00048528207],"about_ca_topic_score_codex":0.0004705428,"about_ca_topic_score_gemma":0.000118133095,"teacher_disagreement_score":0.6745283,"about_ca_system_score_codex":0.0000063869784,"about_ca_system_score_gemma":0.000074808704,"threshold_uncertainty_score":0.32580563},"labels":[],"label_agreement":null},{"id":"W2551757606","doi":"10.1136/annrheumdis-2016-eular.4307","title":"FRI0316 Assessing Attribution of Neuropsychiatric Events in Systemic Lupus Erythematosus. Performance of A New Algorithm in An International Multicenter Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Attribution; Cohort; Algorithm; Systemic lupus erythematosus; Blinding; Cohort study; Internal medicine; Clinical trial; Disease; Computer science; Psychology","score_opus":0.040456928155832066,"score_gpt":0.34357615868440294,"score_spread":0.30311923052857087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551757606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974597,0.0006449442,0.00023499137,0.00032747624,0.00039212892,0.00084285956,0.000051672057,0.000011716654,0.000034480898],"genre_scores_gemma":[0.99887097,0.0007096139,0.00018186292,0.00001759224,0.00002968888,0.0000278205,0.000010593155,0.000021906435,0.0001299238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973022,0.00025551236,0.0010868855,0.00023961396,0.00084566534,0.00027013553],"domain_scores_gemma":[0.99812996,0.00022591486,0.0006143393,0.00058695045,0.00031654743,0.000126263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006589942,0.00016287407,0.0006061627,0.0004122691,0.000018574949,0.0000064675874,0.00043929007,0.00006039272,0.000040054903],"category_scores_gemma":[0.00057889376,0.000096489144,0.0001699693,0.0004552539,0.00009186811,0.00038923434,0.00012500031,0.00008715058,0.0000057931243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002685893,0.00062338007,0.98325086,0.0019141803,0.00009109027,0.0000024656217,0.0003039165,0.000023364188,0.00079230434,0.00002494978,0.00005567994,0.012649252],"study_design_scores_gemma":[0.0034736232,0.00013960166,0.96955407,0.018771492,0.000054853765,0.0003752051,0.00031472932,0.0056818505,0.001415721,0.00011736302,0.0000029200005,0.00009860434],"about_ca_topic_score_codex":0.000122009194,"about_ca_topic_score_gemma":0.000006014478,"teacher_disagreement_score":0.016857311,"about_ca_system_score_codex":0.00008663345,"about_ca_system_score_gemma":0.0003010323,"threshold_uncertainty_score":0.39347133},"labels":[],"label_agreement":null},{"id":"W2551904347","doi":"10.1136/annrheumdis-2016-eular.4483","title":"SAT0055 Treatment Response To Conventional Disease Modifying Anti-Rheumatic Drugs (Dmards) and Biologics in Seropositive and Seronegative Patients with Early Rheumatoid Arthritis: Results from Catch (Canadian Early Arthritis Cohort)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Southlake Regional Health Center; University of Manitoba; Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Rheumatoid factor; Cohort; Methotrexate; Prospective cohort study; Rheumatology; Arthritis","score_opus":0.015863583445587262,"score_gpt":0.25624617223527757,"score_spread":0.24038258878969032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551904347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825802,0.0063142325,0.000008913828,0.0044585927,0.000059620274,0.0018802419,0.0046366137,0.000034099714,0.000027506761],"genre_scores_gemma":[0.9583708,0.040977288,0.00011299138,0.00016368764,0.000010012343,0.00017473094,0.00010546232,0.000038725055,0.000046311263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967368,0.0005945712,0.0007581246,0.0006279149,0.0006412459,0.000641308],"domain_scores_gemma":[0.9965471,0.0011047464,0.00027603656,0.0005698907,0.00034508595,0.0011571094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004347352,0.00040647524,0.00083359523,0.0003324643,0.00026913852,0.00010581877,0.00018664666,0.00007860441,0.000051208033],"category_scores_gemma":[0.001467605,0.00024280018,0.00014089824,0.0002868239,0.00068443647,0.0003681103,0.00011783869,0.000111959824,0.000020835649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011109445,0.00059725257,0.8905805,0.000058423393,0.00066164206,0.00004983503,0.0033656517,0.0000047844856,0.00007193247,0.00012707498,0.00018710493,0.09318638],"study_design_scores_gemma":[0.011167801,0.0012124156,0.97331697,0.011775128,0.000019649184,0.0000054805378,0.00048530317,0.000026874253,0.00027188307,0.0013474004,0.00006622307,0.00030486297],"about_ca_topic_score_codex":0.021096902,"about_ca_topic_score_gemma":0.0040190914,"teacher_disagreement_score":0.092881516,"about_ca_system_score_codex":0.00012732447,"about_ca_system_score_gemma":0.0005452336,"threshold_uncertainty_score":0.9901104},"labels":[],"label_agreement":null},{"id":"W2551975643","doi":"10.1136/annrheumdis-2016-eular.5878","title":"THU0265 B Cell Phenotypic Changes in anti-Nuclear Antibody Positive Individuals Prior To The Onset of Systemic Autoimmune Rheumatic Disease","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lakeridge Health; University Health Network","funders":"","keywords":"Medicine; Antibody; Immunology; Anti-nuclear antibody; Asymptomatic; Memory B cell; B-cell activating factor; Autoimmunity; Autoantibody; B cell; Internal medicine","score_opus":0.02213434951419645,"score_gpt":0.2821355389906894,"score_spread":0.2600011894764929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551975643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732158,0.015562114,0.0000110964875,0.008136177,0.00024295406,0.0018820053,0.0007915539,0.000048501726,0.000109780696],"genre_scores_gemma":[0.99429584,0.0046432326,0.000015298823,0.0006365498,0.000027280115,0.000071314826,0.000022185528,0.000053769905,0.00023454282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685204,0.00048648525,0.0010276239,0.00037011597,0.00080219033,0.00046153553],"domain_scores_gemma":[0.9966657,0.00074699,0.00074367423,0.0012601367,0.00023463691,0.0003488163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005831044,0.00034363315,0.00096816197,0.00026377267,0.00014258202,0.000029158593,0.0007078195,0.000091578586,0.00017768101],"category_scores_gemma":[0.0013242359,0.0001570785,0.00042432314,0.000590338,0.0002884556,0.00010973463,0.00028385277,0.00010686127,0.00008815389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039058044,0.011509984,0.74351174,0.023749074,0.0045460165,0.00008316424,0.023962324,0.0005917109,0.053217337,0.0022296573,0.032298498,0.100394666],"study_design_scores_gemma":[0.0016128874,0.00018782103,0.9385526,0.055009834,0.0006076158,0.0000162264,0.0016643058,0.000080844875,0.001813441,0.00018723091,0.000034213484,0.0002329511],"about_ca_topic_score_codex":0.0001704507,"about_ca_topic_score_gemma":0.000005192662,"teacher_disagreement_score":0.19504087,"about_ca_system_score_codex":0.00004346354,"about_ca_system_score_gemma":0.00027884744,"threshold_uncertainty_score":0.6405475},"labels":[],"label_agreement":null},{"id":"W2552087653","doi":"10.1136/annrheumdis-2016-eular.5190","title":"FRI0256 Significance of Cognitive Impairment in Systemic Sclerosis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; Internal medicine; Cognition; Cognitive impairment; Physical therapy; Disease; Rheumatology; Psychiatry","score_opus":0.05165432442154732,"score_gpt":0.2921260417695096,"score_spread":0.2404717173479623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552087653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858064,0.011838324,0.000016675629,0.0008671656,0.00012313467,0.00088691013,0.0002220283,0.000020715472,0.00021866417],"genre_scores_gemma":[0.99547416,0.004097126,0.000005226471,0.00013672658,0.000016838123,0.00008721071,0.0000033313486,0.000016749063,0.0001626616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982579,0.00016420442,0.0007202916,0.00020251972,0.00042906008,0.00022606211],"domain_scores_gemma":[0.99816513,0.000626007,0.0004373056,0.00041044885,0.00021386071,0.00014722791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023422272,0.0001566533,0.0005469126,0.0001133982,0.000029396928,0.0000049930704,0.0001881044,0.000059853926,0.00013699375],"category_scores_gemma":[0.00096320646,0.000075537326,0.00033646618,0.00028469553,0.00022383247,0.00006799457,0.000062163956,0.000041548876,0.000019665367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029580647,0.00652609,0.7647065,0.008190704,0.0021839628,0.000014628805,0.0024516117,0.000060506198,0.040883232,0.0008301295,0.012245024,0.15894955],"study_design_scores_gemma":[0.0025136063,0.00021451716,0.84641194,0.12855506,0.0003118251,0.0000079717365,0.0012650994,0.00003065691,0.020239715,0.00031825007,0.0000022060601,0.00012916102],"about_ca_topic_score_codex":0.00010066735,"about_ca_topic_score_gemma":0.0000017967832,"teacher_disagreement_score":0.15882039,"about_ca_system_score_codex":0.000029547575,"about_ca_system_score_gemma":0.00018348925,"threshold_uncertainty_score":0.30803227},"labels":[],"label_agreement":null},{"id":"W2552121629","doi":"10.1136/annrheumdis-2016-eular.4359","title":"FRI0599 Clinician Training in Motivational Communication Skills: The Impact of The Language of Change Program among Rheumatologists from across Canada","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; University of Saskatchewan; Dalhousie University","funders":"","keywords":"Medicine; Popularity; Trial registration; Self-efficacy; Physical therapy; Family medicine; Randomized controlled trial; Internal medicine; Psychology","score_opus":0.2979616190843893,"score_gpt":0.4888997241309039,"score_spread":0.1909381050465146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552121629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869586,0.0022844044,0.0000014120133,0.007432216,0.00016177767,0.001723527,0.0013263536,0.000019146766,0.00009251476],"genre_scores_gemma":[0.9986623,0.00037214984,0.000052052335,0.0003366397,0.000013005638,0.0004817523,0.000041148793,0.00001794447,0.000023029168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529207,0.0024252904,0.0013108869,0.0001511809,0.00045727304,0.0003633146],"domain_scores_gemma":[0.98969,0.005885261,0.0020033338,0.001964746,0.0003770403,0.000079589736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006136154,0.00015927225,0.00044205817,0.0000304991,0.00041036095,0.000005127716,0.0017116121,0.000096862736,0.00006930567],"category_scores_gemma":[0.0051992205,0.0000698824,0.00022338335,0.0003673838,0.0005822575,0.00016019841,0.0005808597,0.00028687544,0.0000014436506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003889064,0.00021050677,0.9207165,0.00022407608,0.00008397909,7.404896e-8,0.04763977,0.000023428318,0.000004055149,0.00021190589,0.0006887,0.030158078],"study_design_scores_gemma":[0.00045896057,0.000029828965,0.9697708,0.005441546,0.000011575686,1.2949064e-7,0.022284811,0.00018887532,0.000048310598,0.0016652568,0.000026246364,0.00007368452],"about_ca_topic_score_codex":0.61001277,"about_ca_topic_score_gemma":0.41381577,"teacher_disagreement_score":0.19619697,"about_ca_system_score_codex":0.00012125367,"about_ca_system_score_gemma":0.0011994524,"threshold_uncertainty_score":0.62243277},"labels":[],"label_agreement":null},{"id":"W2552188862","doi":"10.1136/annrheumdis-2016-eular.4676","title":"FRI0467 Predictors of Early Minimal Disease Activity in PSA Patients Treated with Anti-TNF in A Real-World Registry","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Research Canada; Arthritis Society; St. Paul's Hospital; Arthritis Research Centre of Canada; McGill University; Memorial University of Newfoundland; Penticton Regional Hospital; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Infliximab; Internal medicine; Rheumatoid arthritis; Ankylosing spondylitis; Logistic regression; Adalimumab; Physical therapy; Surgery; Disease","score_opus":0.025368537539187355,"score_gpt":0.2940228349337622,"score_spread":0.26865429739457486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552188862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724156,0.0006981145,0.0000010071334,0.00083747157,0.000030418529,0.0006475781,0.00030709698,0.000021178172,0.00021556894],"genre_scores_gemma":[0.9950577,0.0046244306,0.000007473943,0.000021453887,0.000009805049,0.000053646672,0.000010046893,0.000023044406,0.00019237502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811393,0.00020672183,0.00045562428,0.00024506153,0.0006187386,0.00035993356],"domain_scores_gemma":[0.99839926,0.00027473722,0.00028053633,0.00060230464,0.00015845956,0.00028469978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016316994,0.00019178346,0.000549884,0.00026865248,0.000032600154,0.00001151042,0.00023843996,0.00003423216,0.00006735644],"category_scores_gemma":[0.0006746483,0.00009965766,0.00015550246,0.0004722727,0.00043190378,0.00022834685,0.00007590525,0.0000872755,0.0000037169264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003884543,0.0016457704,0.98148906,0.0003326066,0.00013608078,0.00001845167,0.0001623692,0.0000022703405,0.00012661038,0.00004139441,0.0004673925,0.011693471],"study_design_scores_gemma":[0.0035347657,0.00051680004,0.9853912,0.008919196,0.000016721073,5.953277e-7,0.00003223419,0.000018201652,0.0012418879,0.00019426171,0.000023858263,0.00011028029],"about_ca_topic_score_codex":0.0013337843,"about_ca_topic_score_gemma":0.00032386542,"teacher_disagreement_score":0.011583191,"about_ca_system_score_codex":0.00003038934,"about_ca_system_score_gemma":0.00025988978,"threshold_uncertainty_score":0.40639213},"labels":[],"label_agreement":null},{"id":"W2552299156","doi":"10.1136/annrheumdis-2016-eular.1505","title":"THU0614 Forewarned Is Forearmed? Risk Communication during The Commencement of Methotrexate; Presenting The Clinicians' & Patients' Perspectives","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Perspective (graphical); Descriptive statistics; Family medicine; Internal medicine","score_opus":0.04121330211678722,"score_gpt":0.3440059281103527,"score_spread":0.3027926259935655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552299156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751076,0.007833631,0.00007430077,0.01546274,0.000045919198,0.0009346411,0.0001524199,0.000018619387,0.00037012305],"genre_scores_gemma":[0.95352757,0.045813918,0.00010341027,0.000169089,0.000016955804,0.00007885532,0.0000063062043,0.000018263114,0.00026562702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748576,0.0008014223,0.0005864602,0.00017031046,0.0006563778,0.00029965516],"domain_scores_gemma":[0.9956326,0.0018525865,0.00063521985,0.0013557909,0.0004368977,0.00008691643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096496346,0.00015592574,0.00035247672,0.00005596233,0.0004563663,0.000029340232,0.00070577755,0.000030444506,0.00023355163],"category_scores_gemma":[0.0029319914,0.000059261423,0.00037951002,0.00019166527,0.00085717026,0.00014752644,0.00034423446,0.0001357472,0.000010540975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009720513,0.0016961459,0.81430227,0.00048466364,0.0021252914,3.6128574e-7,0.027557662,0.000010605924,0.00026099087,0.0022466471,0.013697058,0.13664627],"study_design_scores_gemma":[0.0024954856,0.00019425356,0.9648859,0.0027349712,0.000093495655,0.0000022160136,0.007919026,0.000096423166,0.0047103087,0.01422035,0.0025019548,0.00014563848],"about_ca_topic_score_codex":0.00029928292,"about_ca_topic_score_gemma":0.00004630901,"teacher_disagreement_score":0.15058362,"about_ca_system_score_codex":0.000017543058,"about_ca_system_score_gemma":0.00006543755,"threshold_uncertainty_score":0.3510079},"labels":[],"label_agreement":null},{"id":"W2552333695","doi":"10.1136/annrheumdis-2016-eular.1719","title":"THU0616 Treatment Adherence and Attitudes towards Systemic Medications in Patients with Rheumatoid Arthritis in Different Geographical Regions","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cross-sectional study; Demography; Pathology","score_opus":0.03561695508137648,"score_gpt":0.2978225722786365,"score_spread":0.26220561719726004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552333695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916514,0.0023659673,0.00004405125,0.005111412,0.000033163447,0.000655724,0.00003709471,0.000017123228,0.0000840776],"genre_scores_gemma":[0.9882939,0.01118983,0.000021235579,0.00012718527,0.0000054862635,0.00024383551,0.000009247465,0.00000833744,0.000100979465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986966,0.00008963306,0.00043433474,0.00022154856,0.00036577604,0.00019206695],"domain_scores_gemma":[0.9989196,0.000164833,0.00019194829,0.00046265186,0.00009047958,0.00017050488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008373398,0.00015288893,0.0004132163,0.00011600872,0.000041117084,0.0000080477785,0.00015361587,0.000038736267,0.00012345161],"category_scores_gemma":[0.00022250134,0.000067965164,0.00007090428,0.00023048086,0.00029820477,0.00007459232,0.000039924227,0.0000500078,0.00001284451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009760388,0.0009090826,0.94865847,0.0001320944,0.000071928414,0.0000012216732,0.00013553521,4.9609514e-7,0.000005272752,0.00055481977,0.00029346615,0.049140036],"study_design_scores_gemma":[0.0026418727,0.0003233812,0.9836379,0.012341045,0.000022842718,0.0000059044023,0.00009362682,0.000013950864,0.00003628191,0.00077417144,0.000024780342,0.00008419731],"about_ca_topic_score_codex":0.00013806247,"about_ca_topic_score_gemma":0.0000774199,"teacher_disagreement_score":0.049055837,"about_ca_system_score_codex":0.000028988648,"about_ca_system_score_gemma":0.0001476549,"threshold_uncertainty_score":0.27715388},"labels":[],"label_agreement":null},{"id":"W2552475238","doi":"10.1136/annrheumdis-2016-eular.3760","title":"AB1040 Comparison of Adherence and Dosing Interval of Subcutaneous anti-TNF Biologics in Inflammatory Arthritis from A Canadian Administrative Database","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Université Laval","funders":"","keywords":"Medicine; Golimumab; Adalimumab; Psoriatic arthritis; Certolizumab pegol; Etanercept; Rheumatoid arthritis; Infliximab; Dosing; Internal medicine; Database; Arthritis; Vial; Ankylosing spondylitis; Tumor necrosis factor alpha","score_opus":0.07874937164161133,"score_gpt":0.3501252070028586,"score_spread":0.27137583536124726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552475238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902674,0.0071880203,0.0000205761,0.00055390224,0.000097538876,0.00014200794,0.0016784495,0.0000041938733,0.000047919602],"genre_scores_gemma":[0.9988556,0.0008960211,0.00013960426,0.00007281511,0.000002636649,0.0000029456662,0.0000125073,0.0000041174776,0.000013767532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874675,0.00032853396,0.0005374924,0.0001598601,0.000039220886,0.00018815616],"domain_scores_gemma":[0.99856275,0.00073589274,0.00031777206,0.0002610771,0.00007124404,0.00005126416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019601393,0.00011912191,0.00048256398,0.00006921687,0.000034346886,0.0000047032236,0.00024012962,0.000102244594,0.00019750322],"category_scores_gemma":[0.0007256403,0.00006677735,0.00009168376,0.000085877924,0.0008206656,0.000051018924,0.00009755076,0.00007724943,0.0000020823595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007703046,0.0007055431,0.5679182,0.00037121726,0.0006285318,0.000020922847,0.0011085244,0.0000016612023,0.08617231,0.0018525205,0.0017239153,0.33872637],"study_design_scores_gemma":[0.0017063635,0.0011941182,0.5979787,0.008758244,0.00016886706,0.000024129911,0.0021085106,0.00005514477,0.38174164,0.0054758606,0.00038515805,0.00040323831],"about_ca_topic_score_codex":0.0059266808,"about_ca_topic_score_gemma":0.007419869,"teacher_disagreement_score":0.33832315,"about_ca_system_score_codex":0.0000074437207,"about_ca_system_score_gemma":0.000141989,"threshold_uncertainty_score":0.89594084},"labels":[],"label_agreement":null},{"id":"W2552719386","doi":"10.1136/annrheumdis-2016-eular.1843","title":"THU0424 Treatment with Tnf Alpha Blockers Is Associated with Reduced Progression of Atherosclerotic Plaques in Patients with Psoriatic Disease – A Prospective Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Waterloo; Women's College Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Psoriasis; Disease; Statin; Gastroenterology; Immunology","score_opus":0.019642548451263387,"score_gpt":0.2591230787110639,"score_spread":0.23948053025980048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552719386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963318,0.0007184202,0.0000011231238,0.00019956607,0.000051349984,0.0022908675,0.0003606695,0.000032275453,0.000013937814],"genre_scores_gemma":[0.99925303,0.00007428808,0.0000133897,0.000014189066,0.0000030348,0.0003728234,0.00003261214,0.000029422248,0.00020718553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984051,0.00037701824,0.00036622002,0.00034763658,0.00018968985,0.00031431593],"domain_scores_gemma":[0.9984526,0.00023921742,0.0005478708,0.00050890836,0.00019111352,0.000060287155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098087956,0.0003279115,0.0005922734,0.000100521705,0.0001061387,0.00000884654,0.00021764796,0.00005438046,0.000064769556],"category_scores_gemma":[0.00010974721,0.00012874977,0.00011238309,0.000278452,0.0002851674,0.00012171194,0.00004244169,0.00003735707,0.0000059623308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006796315,0.009877879,0.95310175,0.00005121186,0.0030032052,0.0000040132145,0.0019524716,0.0000029927735,0.00006693169,0.000012864352,0.000071040246,0.025059314],"study_design_scores_gemma":[0.011932523,0.0066379616,0.9715414,0.0029590416,0.0010382503,4.3113178e-7,0.00037089715,0.0000011217098,0.005187745,0.00012859383,0.0000018226016,0.00020021266],"about_ca_topic_score_codex":0.00006790618,"about_ca_topic_score_gemma":0.0000630156,"teacher_disagreement_score":0.0248591,"about_ca_system_score_codex":0.00007094612,"about_ca_system_score_gemma":0.00018044861,"threshold_uncertainty_score":0.5250263},"labels":[],"label_agreement":null},{"id":"W2552722867","doi":"10.1136/annrheumdis-2016-eular.4701","title":"SAT0394 Impact of Disease Duration on Patient Reported and Clinical Outcomes in Patients with Ankylosing Spondylitis Treated with Anti-TNF: An Analysis from A Prospective, Observational Registry","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Institut de Readaptation Gingras Lindsay de Montreal; Université Laval; University of Saskatchewan; University of Alberta; Hôpital Maisonneuve-Rosemont; McGill University","funders":"","keywords":"Medicine; BASDAI; Golimumab; BASFI; Ankylosing spondylitis; Internal medicine; Psoriatic arthritis; Infliximab; Rheumatoid arthritis; Observational study; Prospective cohort study; Logistic regression; Confounding; Disease; Physical therapy","score_opus":0.042556326054117986,"score_gpt":0.34381578262820733,"score_spread":0.30125945657408937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552722867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973181,0.00016271818,0.000010997703,0.0003602434,0.0000097398815,0.00066164986,0.0014522478,0.000015819816,0.000008512687],"genre_scores_gemma":[0.9991325,0.0004043016,0.00006199782,0.00003601589,0.000005449669,0.00002277937,0.0003100092,0.000015786094,0.000011160633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978928,0.00022458045,0.00072044454,0.00031499728,0.000654836,0.00019236807],"domain_scores_gemma":[0.99776036,0.00039862457,0.00058371795,0.00059690414,0.0003921954,0.00026821662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001571217,0.00018600504,0.0006560555,0.00018064532,0.00005652026,0.00002366344,0.00009028277,0.00003448442,0.00008967644],"category_scores_gemma":[0.0011986529,0.00008290969,0.00024391094,0.00038829478,0.0003374112,0.00027300796,0.00002847253,0.00006273818,3.4839056e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007829442,0.002030996,0.98111296,0.000032099382,0.0021337671,0.000010117306,0.00008774814,0.000028792161,0.0000069431594,0.00003343179,0.000021146892,0.0066725537],"study_design_scores_gemma":[0.003836842,0.0020642204,0.9916162,0.0016281672,0.0002052519,6.260499e-7,0.000045722216,0.0001376433,0.000057585727,0.0002954933,0.0000011517322,0.00011112405],"about_ca_topic_score_codex":0.0007083258,"about_ca_topic_score_gemma":0.000081687496,"teacher_disagreement_score":0.010503209,"about_ca_system_score_codex":0.000036073045,"about_ca_system_score_gemma":0.00021452,"threshold_uncertainty_score":0.3380959},"labels":[],"label_agreement":null},{"id":"W2552806269","doi":"10.1136/annrheumdis-2016-eular.1513","title":"THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; CD8; Internal medicine; Immunology; Phlebotomy; Lymphocyte; Placebo; Gastroenterology; Immune system; Pathology","score_opus":0.020004280640442944,"score_gpt":0.2856849034924401,"score_spread":0.2656806228519971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552806269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959402,0.0015341523,0.0000025468423,0.00057073066,0.000036405567,0.0016372495,0.00022883876,0.000018249973,0.000031592295],"genre_scores_gemma":[0.9785498,0.021113554,0.0000043486248,0.000053011558,0.0000048029297,0.00017384838,0.00005506644,0.000028804456,0.000016759339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764407,0.00027866644,0.00077656924,0.00027844709,0.00061682815,0.00040539622],"domain_scores_gemma":[0.9986497,0.00020506131,0.00034523685,0.00045884735,0.00020787427,0.00013329253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033863957,0.00023011587,0.00078776607,0.000492789,0.00003289402,0.000015143073,0.00022345256,0.000047959416,0.0001324557],"category_scores_gemma":[0.0005594869,0.00013216202,0.00008000477,0.0007106081,0.00020199182,0.00024024012,0.000075209464,0.00007473023,0.000005634714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023590398,0.005799358,0.8815453,0.00013954651,0.00009576171,0.000022201368,0.0013452418,0.0000017818409,0.0012920058,0.00001984173,0.000017758008,0.10736216],"study_design_scores_gemma":[0.022517636,0.0012076665,0.95913994,0.009863311,0.000004290138,0.0000030913304,0.0003836907,0.0000329845,0.0065814387,0.00009706004,0.000018803501,0.00015009537],"about_ca_topic_score_codex":0.0005327668,"about_ca_topic_score_gemma":0.0010293965,"teacher_disagreement_score":0.10721207,"about_ca_system_score_codex":0.00004602017,"about_ca_system_score_gemma":0.00017142706,"threshold_uncertainty_score":0.5389411},"labels":[],"label_agreement":null},{"id":"W2552814813","doi":"10.1136/annrheumdis-2016-eular.3753","title":"FRI0421 What Is The Location of Enthesitis in Ankylosing Spondylitis and Psoriatic Arthritis Patients and How Do They Respond To Anti-TNF Treatment?","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Université du Québec à Rimouski; Memorial University of Newfoundland; University of Saskatchewan; Université de Montréal; Penticton Regional Hospital; St. Paul's Hospital","funders":"","keywords":"Medicine; Enthesitis; Psoriatic arthritis; Ankylosing spondylitis; Rheumatoid arthritis; Internal medicine; Infliximab; Golimumab; Spondyloarthropathy; Surgery; Etanercept; Disease","score_opus":0.02095281619050847,"score_gpt":0.28389583296290954,"score_spread":0.26294301677240106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552814813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94619346,0.037480194,0.00000535753,0.015243742,0.00006169792,0.0007639111,0.00022055091,0.000008015585,0.000023056726],"genre_scores_gemma":[0.85922253,0.14043458,0.000021868453,0.00018495941,0.000011675712,0.00004155276,0.000005639488,0.000014922508,0.000062265855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99851584,0.0002756242,0.00032043256,0.00022377395,0.00040088058,0.0002634633],"domain_scores_gemma":[0.9983898,0.00063202437,0.000168992,0.00042522768,0.00022443596,0.0001595164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027875276,0.00016867886,0.00042643794,0.00015450736,0.00009804006,0.000098626486,0.00013104532,0.00003618748,0.00005577894],"category_scores_gemma":[0.0009992558,0.00008320592,0.00008644982,0.00022640316,0.0002679143,0.0004012487,0.000078847224,0.00003693649,0.0000030423018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004265076,0.00031962612,0.05840394,0.00021275175,0.00016158944,0.0000033624078,0.0039093755,7.0090965e-7,0.00019970658,0.0003892786,0.00039816226,0.935575],"study_design_scores_gemma":[0.0045068343,0.0012222797,0.9584672,0.01928256,0.000038003313,0.00001848662,0.0024985415,0.000032310174,0.006903281,0.0055974517,0.0012316782,0.00020138257],"about_ca_topic_score_codex":0.00015796129,"about_ca_topic_score_gemma":0.000060464918,"teacher_disagreement_score":0.9353736,"about_ca_system_score_codex":0.000020042866,"about_ca_system_score_gemma":0.00008112913,"threshold_uncertainty_score":0.33930388},"labels":[],"label_agreement":null},{"id":"W2552841720","doi":"10.1136/annrheumdis-2016-eular.1234","title":"THU0407 Baseline Results from Proof – A 5-Year Observational Study of Long-Term Disease Outcome in Axial Spondyloarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; BASDAI; BASFI; Ankylosing spondylitis; Observational study; Axial spondyloarthritis; Internal medicine; Physical therapy; Quality of life (healthcare); Rheumatology; Disease; Sacroiliitis; Psoriatic arthritis","score_opus":0.122377590779879,"score_gpt":0.3551703887496438,"score_spread":0.2327927979697648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552841720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913485,0.0014205778,0.0000053311483,0.002941429,0.00015052319,0.0011640149,0.002902675,0.000018026254,0.000048929676],"genre_scores_gemma":[0.9989746,0.00032559797,0.00003655404,0.00013527536,0.00005098772,0.00009224873,0.0001146559,0.000021732556,0.0002483006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760604,0.00016612938,0.0009910851,0.0003316034,0.00065052445,0.00025462476],"domain_scores_gemma":[0.99789757,0.0005924178,0.00038466696,0.0007225279,0.00021452743,0.00018831926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023843443,0.00021943361,0.00063891005,0.00010182571,0.000062275394,0.000008442879,0.00021108994,0.000034189114,0.00021378329],"category_scores_gemma":[0.0024013165,0.00012375078,0.00025638586,0.0002386326,0.00015721652,0.00012416462,0.00016007676,0.000054217424,0.000012223274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035750603,0.0045826524,0.96676284,0.00012335897,0.00030508687,0.00009276253,0.00030770618,0.0000046565615,0.000016231052,0.000040125396,0.00043692265,0.02375258],"study_design_scores_gemma":[0.013010034,0.00047773708,0.9827328,0.0025427886,0.00022615952,0.0000014980917,0.00019874508,0.000014175036,0.000118611606,0.00054292206,0.000012668421,0.00012190628],"about_ca_topic_score_codex":0.00033231048,"about_ca_topic_score_gemma":0.0002805995,"teacher_disagreement_score":0.023630675,"about_ca_system_score_codex":0.000024876828,"about_ca_system_score_gemma":0.00012434403,"threshold_uncertainty_score":0.50464106},"labels":[],"label_agreement":null},{"id":"W2552863535","doi":"10.1136/annrheumdis-2016-eular.6084","title":"SAT0072 Ultrasound Is Associated with Late Phases Preceding The Clinical Onset of Rheumatoid Arthritis in Individuals Genetically at Risk","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Rheumatoid arthritis; Synovitis; Internal medicine; Logistic regression; Cohort; Arthritis; Rheumatology","score_opus":0.04096948380345173,"score_gpt":0.334252802115486,"score_spread":0.2932833183120343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552863535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854302,0.009796201,0.000011462844,0.0029354445,0.0000732503,0.00071110704,0.0008151409,0.000028618293,0.00019859333],"genre_scores_gemma":[0.8120007,0.18746828,0.000040158888,0.00024567088,0.000012394891,0.000040442486,0.000012828205,0.0000271096,0.00015244955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963977,0.0007062466,0.0011482644,0.00031163223,0.00092387135,0.00051233557],"domain_scores_gemma":[0.9932559,0.0047694948,0.00070915866,0.0007288404,0.0002833384,0.00025326683],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012986575,0.00025128576,0.00086051296,0.00010254428,0.00026769395,0.000051659,0.00044560753,0.00009352999,0.0005345205],"category_scores_gemma":[0.008806059,0.00011340422,0.00037923924,0.00034893618,0.0013292405,0.00013522878,0.00016801036,0.0001899989,0.00001786946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005517641,0.0009478573,0.91097206,0.00005289914,0.001066735,0.000005832031,0.00060349377,0.0000049677096,0.00015886768,0.00007645867,0.009836985,0.075722106],"study_design_scores_gemma":[0.0055706417,0.00083056936,0.9716862,0.011283334,0.000031931446,0.00003946687,0.00021518455,0.000027453452,0.005414282,0.003982063,0.00070283073,0.00021603801],"about_ca_topic_score_codex":0.0001496841,"about_ca_topic_score_gemma":0.00025460872,"teacher_disagreement_score":0.17767207,"about_ca_system_score_codex":0.00002398093,"about_ca_system_score_gemma":0.0002792977,"threshold_uncertainty_score":0.9995432},"labels":[],"label_agreement":null},{"id":"W2552918916","doi":"10.1136/annrheumdis-2016-eular.3586","title":"FRI0270 Patient Perception of Disease Burden in Diffuse Cutaneous Systemic Sclerosis (DcSSc)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Seriousness; Quality of life (healthcare); Family medicine; Physical therapy; Nursing","score_opus":0.035904053360177504,"score_gpt":0.2626806192438801,"score_spread":0.2267765658837026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552918916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895629,0.0076092156,0.000010673214,0.0014560095,0.00019160878,0.0007836029,0.0002572321,0.000038489186,0.00009022307],"genre_scores_gemma":[0.9925502,0.007006288,0.00000859264,0.00013357762,0.000036439997,0.00006117342,0.000009477978,0.000029886176,0.00016436486],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99765337,0.0002065532,0.0009201937,0.0002857037,0.00064706797,0.00028712003],"domain_scores_gemma":[0.99785846,0.00029254818,0.00048704952,0.00081846386,0.00020697988,0.00033646883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011989546,0.0002271025,0.0006119777,0.00017057794,0.000050999395,0.000010459319,0.00025904205,0.000077512486,0.00019742023],"category_scores_gemma":[0.00092035794,0.00011529811,0.00049444335,0.00027718634,0.00021649584,0.00009818995,0.000107326014,0.00005761313,0.000035524103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004884286,0.009155226,0.34713796,0.00970739,0.0012881366,0.000058271482,0.00431842,0.0005045368,0.072674274,0.0004420746,0.012212802,0.5376166],"study_design_scores_gemma":[0.005824023,0.0005414312,0.833261,0.15071757,0.0012086451,0.000051573505,0.003856058,0.0004696091,0.002666036,0.0008601406,0.00004642827,0.0004974702],"about_ca_topic_score_codex":0.00015540882,"about_ca_topic_score_gemma":0.0000016072912,"teacher_disagreement_score":0.53711915,"about_ca_system_score_codex":0.000058554415,"about_ca_system_score_gemma":0.00016157786,"threshold_uncertainty_score":0.47017208},"labels":[],"label_agreement":null},{"id":"W2553082272","doi":"10.1136/annrheumdis-2016-eular.1448","title":"AB0390 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance To Anti-TNF Biologic Therapy","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; TNF inhibitor; Internal medicine; Methotrexate; Placebo; Clinical endpoint; Gastroenterology; Pharmacology; Tumor necrosis factor alpha; Randomized controlled trial; Adalimumab","score_opus":0.020578046673543147,"score_gpt":0.27519098601038106,"score_spread":0.25461293933683793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553082272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950747,0.0016098993,0.000008175233,0.0019277866,0.000024199617,0.0010976327,0.00023531711,0.000012076764,0.0000102415115],"genre_scores_gemma":[0.99155456,0.008057944,0.00007067069,0.00022168206,0.0000037978193,0.000060574315,0.0000041823887,0.000014833833,0.000011754877],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987049,0.00015348637,0.0004025309,0.00028401674,0.00023633035,0.00021869762],"domain_scores_gemma":[0.9981941,0.0009387082,0.00025683577,0.0002889135,0.00017763478,0.00014382208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001775488,0.0002123301,0.0006105828,0.00012220252,0.00005725906,0.000009511108,0.000086709595,0.00004611377,0.000013279475],"category_scores_gemma":[0.0008621856,0.00009394775,0.00006807035,0.00027666244,0.00024177409,0.00010948196,0.0000696779,0.00003719007,0.0000014818532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04897871,0.0031969317,0.36789772,0.00008425793,0.00039162344,0.0000048209645,0.0014142813,0.000005501366,0.00030321957,0.000058315392,0.00009749405,0.5775671],"study_design_scores_gemma":[0.014724865,0.0025049718,0.9687101,0.0055645015,0.000022269289,0.000005015305,0.00009836658,0.0000044419753,0.008116518,0.00007886102,0.000041368272,0.0001287109],"about_ca_topic_score_codex":0.00014140946,"about_ca_topic_score_gemma":0.000026302412,"teacher_disagreement_score":0.6008124,"about_ca_system_score_codex":0.00004161045,"about_ca_system_score_gemma":0.0001645619,"threshold_uncertainty_score":0.38310778},"labels":[],"label_agreement":null},{"id":"W2553126827","doi":"10.1136/annrheumdis-2016-eular.3192","title":"FRI0471 Certolizumab Pegol for The Treatment of Psoriatic Arthritis: 4-Year Outcomes from The Rapid-Psa Trial","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Certolizumab pegol; Psoriatic arthritis; Adverse effect; Internal medicine; Randomized controlled trial; Placebo; Psoriasis; Surgery; Adalimumab; Arthritis; Rheumatoid arthritis; Dermatology","score_opus":0.05568773566595063,"score_gpt":0.2893052181650443,"score_spread":0.23361748249909364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553126827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393223,0.042896148,0.000043361055,0.010776927,0.0019224307,0.0020583617,0.0028758529,0.0000338493,0.00007076687],"genre_scores_gemma":[0.98846143,0.010287888,0.000014146662,0.0000657486,0.00007231873,0.0004217891,0.000039892013,0.000018610417,0.00061816507],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99851644,0.00038139807,0.00052011525,0.00020864171,0.000091579415,0.0002818202],"domain_scores_gemma":[0.9939299,0.0046989033,0.00041032681,0.0008536729,0.000081505386,0.000025672545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009439777,0.00024353302,0.0005717279,0.000029669252,0.00026129687,0.000013328695,0.00052561675,0.00008956763,0.0007112885],"category_scores_gemma":[0.00052880676,0.00008334087,0.0008033168,0.00007676319,0.00030948198,0.000059152208,0.000048133224,0.00002541326,0.000064244516],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009924635,0.001542923,0.0036172923,0.000030407386,0.0052860174,0.0000010751108,0.0011681438,0.000001431401,0.00025830616,0.00095125457,0.009627372,0.96759117],"study_design_scores_gemma":[0.3052925,0.007979904,0.5079547,0.0026025728,0.010785606,0.000023054397,0.004212759,0.00001760098,0.08164433,0.034603562,0.043562457,0.0013209522],"about_ca_topic_score_codex":0.00020075976,"about_ca_topic_score_gemma":0.000040759154,"teacher_disagreement_score":0.9662702,"about_ca_system_score_codex":0.000015740981,"about_ca_system_score_gemma":0.000092187394,"threshold_uncertainty_score":0.778811},"labels":[],"label_agreement":null},{"id":"W2553129727","doi":"10.1136/annrheumdis-2016-eular.1807","title":"THU0434 Serious Infections in Psoriasis Patients with Psoriatic Arthritis in The Psoriasis Longitudinal Assessment and Registry Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Etanercept; Ustekinumab; Adalimumab; Psoriatic arthritis; Psoriasis; Infliximab; Internal medicine; Hazard ratio; Observational study; Rheumatoid arthritis; Dermatology; Disease; Confidence interval","score_opus":0.02156932866329865,"score_gpt":0.2789648345852418,"score_spread":0.25739550592194316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553129727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961149,0.0016976494,0.000008093249,0.000715995,0.00031492286,0.00091808976,0.00012930216,0.000018088405,0.000082933795],"genre_scores_gemma":[0.9985518,0.001030917,0.000012114982,0.000045408848,0.000012375042,0.00025793217,0.0000152099865,0.000013983313,0.000060284474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980629,0.0007224176,0.00047027558,0.00030062726,0.00013718031,0.0003065832],"domain_scores_gemma":[0.99836516,0.0006463334,0.00028283862,0.0006019593,0.00007570168,0.000028016673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037192294,0.0002388808,0.0004354135,0.00013540148,0.00017958887,0.00002646246,0.00031880036,0.00007492776,0.000081774335],"category_scores_gemma":[0.00024201865,0.000110768975,0.000107223845,0.00033524327,0.00020636688,0.00016542242,0.00009233801,0.00009694322,0.00001126876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017914419,0.002565772,0.85404795,0.000031639367,0.00038328493,0.0000042938946,0.0006583417,0.0000041466383,0.0000063519346,0.00018137606,0.0003193183,0.14161839],"study_design_scores_gemma":[0.005221175,0.0005930659,0.9915327,0.0005284519,0.00020552102,0.00000835098,0.00085315725,6.135674e-7,0.000059044272,0.00078931166,0.00005533306,0.00015330885],"about_ca_topic_score_codex":0.00033870045,"about_ca_topic_score_gemma":0.00088584394,"teacher_disagreement_score":0.14146508,"about_ca_system_score_codex":0.000030846277,"about_ca_system_score_gemma":0.00009014058,"threshold_uncertainty_score":0.45170277},"labels":[],"label_agreement":null},{"id":"W2553191232","doi":"10.1136/annrheumdis-2016-eular.3717","title":"AB0090 Reactivity To Citrullinated Peptide of 14-3-3eta Protein Is Associated with Worse Radiographic Outcomes in Patients with Recent-Onset Inflammatory Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Alberta; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Rheumatoid arthritis; Citrullination; Internal medicine; Confidence interval; Receiver operating characteristic; Cohort; Gastroenterology; Arthritis; Serology; Odds ratio; Autoantibody; Immunology; Antibody; Biochemistry; Citrulline; Biology; Amino acid","score_opus":0.010067288099830646,"score_gpt":0.24050404205177542,"score_spread":0.23043675395194477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553191232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973598,0.00014035411,0.000023448312,0.0009408665,0.00003357988,0.0010029234,0.00045429516,0.000012535761,0.00003217743],"genre_scores_gemma":[0.99920547,0.0001606736,0.00006307607,0.00012596691,0.000004245331,0.00014909501,0.000034837594,0.000027615013,0.00022902117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984454,0.00025434,0.000416859,0.00028174624,0.0003397164,0.0002619672],"domain_scores_gemma":[0.99825686,0.00009334477,0.0004703652,0.00065282435,0.0004151231,0.00011148179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002089122,0.00021318438,0.0003680583,0.00013822188,0.000055629687,0.000011980986,0.00029326804,0.00007745376,0.0000457575],"category_scores_gemma":[0.0015110214,0.00012177817,0.00014205702,0.0003377418,0.00018993615,0.000024929288,0.000100498,0.00008047242,0.0000033469782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012578197,0.0011387267,0.9803703,0.000067142086,0.0006342306,0.0000018434936,0.000107732696,0.000016796606,0.006023296,0.000008397125,0.0016227979,0.008750948],"study_design_scores_gemma":[0.0016017715,0.0004986041,0.93713087,0.0022887876,0.000034519417,7.628982e-7,0.00003211745,0.000001184786,0.057866577,0.00017982564,0.00015885067,0.00020611042],"about_ca_topic_score_codex":0.00006696353,"about_ca_topic_score_gemma":0.00021782806,"teacher_disagreement_score":0.051843278,"about_ca_system_score_codex":0.000016042226,"about_ca_system_score_gemma":0.000115648,"threshold_uncertainty_score":0.49659693},"labels":[],"label_agreement":null},{"id":"W2553209517","doi":"10.1136/annrheumdis-2016-eular.4463","title":"FRI0594 Association of Gout Diagnosis with Increased Risk of Joint Replacement: A Population-Based Cohort Study of over 250,000 Patients","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Gout; Internal medicine; Cohort; Population; Cohort study; Surgery; Physical therapy","score_opus":0.013692658085477106,"score_gpt":0.2578850917341779,"score_spread":0.2441924336487008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553209517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739754,0.00009381841,0.000012110367,0.00017326954,0.000044655226,0.0016071473,0.0005959504,0.00001567649,0.000059821698],"genre_scores_gemma":[0.9995913,0.00007071309,0.000047009198,0.00006561236,0.000008522259,0.00011453684,0.000030529707,0.000025144582,0.0000466665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969992,0.0003614143,0.0010225655,0.00023468722,0.0011913765,0.00019073384],"domain_scores_gemma":[0.99506825,0.00089325325,0.002462633,0.00085891766,0.000605293,0.00011165832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060475594,0.0001943376,0.00082087907,0.00015108516,0.00004447943,0.0000037861332,0.00017663675,0.00006014596,0.00023796434],"category_scores_gemma":[0.004699188,0.000106543106,0.00023000024,0.00031200287,0.00007121731,0.00008041866,0.00006297849,0.000057784295,0.000001867704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067546626,0.0046873605,0.990392,0.00046177403,0.001467855,3.1926152e-7,0.0003056238,0.0000937292,0.000027894173,0.0000056948556,0.0010409302,0.0008413457],"study_design_scores_gemma":[0.005167533,0.0012568793,0.987126,0.0020465755,0.0020399457,1.2321092e-7,0.00015428713,0.00016519926,0.001830066,0.00010054857,0.000003132583,0.00010972596],"about_ca_topic_score_codex":0.004566934,"about_ca_topic_score_gemma":0.000054678643,"teacher_disagreement_score":0.004512255,"about_ca_system_score_codex":0.00008918577,"about_ca_system_score_gemma":0.00012443148,"threshold_uncertainty_score":0.69038683},"labels":[],"label_agreement":null},{"id":"W2553333000","doi":"10.1136/annrheumdis-2016-eular.4373","title":"OP0173 How Much of A Barrier Is Excess Weight and Smoking for Achieving Sustained Remission in Early RA? Results from The Canadian Early Arthritis Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of British Columbia; Southlake Regional Health Center; University of Manitoba; Université de Montréal; Université de Sherbrooke; University of Toronto","funders":"","keywords":"Medicine; Overweight; Cohort; Internal medicine; Prospective cohort study; Body mass index; Cohort study; Smoking cessation; Obesity; Demography; Physical therapy; Pediatrics","score_opus":0.025127750061792794,"score_gpt":0.27146983238268785,"score_spread":0.24634208232089505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553333000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678055,0.002732928,0.0000029307562,0.027505154,0.00005346281,0.0007897702,0.0010079248,0.000006741831,0.00009555765],"genre_scores_gemma":[0.9979457,0.0013813691,0.000030928895,0.00032780532,0.000028574368,0.000072251765,0.00001638185,0.000015362159,0.00018158698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987714,0.00008839681,0.00036559306,0.00022782755,0.00028807807,0.00025865607],"domain_scores_gemma":[0.9979493,0.00094358454,0.00023240794,0.00048315158,0.00015908868,0.00023246142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030413806,0.00015121057,0.00039671137,0.00007128074,0.00014198023,0.000039977196,0.00016805549,0.000058256617,0.000023994437],"category_scores_gemma":[0.0016720621,0.00006883348,0.00015696677,0.00011158855,0.0001344381,0.00011876281,0.000056749457,0.00003466131,4.868552e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037789755,0.00012704654,0.92991763,0.00009829979,0.0003080302,0.000010281275,0.0014260176,1.8010432e-7,0.00004749502,0.00012597535,0.005290395,0.06227075],"study_design_scores_gemma":[0.003588046,0.00013560972,0.98542035,0.0056622275,0.00016564807,0.0000017377773,0.00028363918,0.000021101494,0.0027498838,0.0014658034,0.0004161969,0.00008978578],"about_ca_topic_score_codex":0.058591675,"about_ca_topic_score_gemma":0.00887289,"teacher_disagreement_score":0.062180962,"about_ca_system_score_codex":0.000060307517,"about_ca_system_score_gemma":0.00031421022,"threshold_uncertainty_score":0.94767725},"labels":[],"label_agreement":null},{"id":"W2553398933","doi":"10.1136/annrheumdis-2016-eular.4769","title":"AB0661 Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in A Real-World Setting","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut de Readaptation Gingras Lindsay de Montreal; Hôpital Maisonneuve-Rosemont; McGill University; Ottawa Hospital; University of Saskatchewan; Université Laval","funders":"","keywords":"Medicine; Golimumab; BASDAI; Psoriatic arthritis; BASFI; Ankylosing spondylitis; Internal medicine; Infliximab; Rheumatoid arthritis; Univariate analysis; Adalimumab; Spondylitis; Multivariate analysis; Gastroenterology; Physical therapy; Disease","score_opus":0.01844271055713981,"score_gpt":0.28840012100732026,"score_spread":0.26995741045018046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553398933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973235,0.00040415005,0.000001969935,0.0009259321,0.000015367523,0.000784706,0.0003928202,0.00002580289,0.00012571987],"genre_scores_gemma":[0.9985973,0.0010253408,0.000060858114,0.0000425727,0.0000061496444,0.000045943016,0.000019610208,0.000031901527,0.00017029776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773514,0.0003936018,0.00059775315,0.00022643346,0.0006420944,0.00040497875],"domain_scores_gemma":[0.99802506,0.0008030799,0.00029215068,0.00049785496,0.00022204706,0.00015979305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042092698,0.00020158546,0.0005707881,0.0004392372,0.000042825468,0.000014736924,0.00018955779,0.00003409067,0.0001579579],"category_scores_gemma":[0.0011912906,0.00008997086,0.00008399152,0.00072482537,0.00038202206,0.00023684585,0.0000619341,0.00008607795,0.0000018014318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055820905,0.0007979667,0.9307037,0.0002611899,0.00017473617,0.000026127647,0.0006612008,0.000010295193,0.000054737546,0.000039131817,0.00014579775,0.011304187],"study_design_scores_gemma":[0.009437764,0.0017328835,0.97086924,0.016411196,0.000015102307,0.000004296126,0.00020046995,0.000023625102,0.0010034365,0.00010198097,0.00007680357,0.0001232094],"about_ca_topic_score_codex":0.0005160462,"about_ca_topic_score_gemma":0.00038933224,"teacher_disagreement_score":0.04638314,"about_ca_system_score_codex":0.000055450982,"about_ca_system_score_gemma":0.0003586886,"threshold_uncertainty_score":0.36689052},"labels":[],"label_agreement":null},{"id":"W2553478815","doi":"10.1136/annrheumdis-2016-eular.1314","title":"OP0306 Ten Years of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Results from The Freedom Extension Trial","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval","funders":"","keywords":"Medicine; Denosumab; Osteoporosis; Lumbar spine; Bristol-Myers; Postmenopausal women; Surgery; Physical therapy; Internal medicine","score_opus":0.22418970409167022,"score_gpt":0.3799391418210731,"score_spread":0.15574943772940286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553478815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812125,0.0010973791,0.000006376335,0.013766026,0.00020972121,0.0014487575,0.0021575526,0.000011900028,0.00008981368],"genre_scores_gemma":[0.9986547,0.00026479724,0.00007935792,0.0005870525,0.000064779655,0.00018760709,0.0000126950845,0.00002060353,0.00012837519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959035,0.0005089492,0.002770599,0.00036485834,0.00016550637,0.00028661333],"domain_scores_gemma":[0.99329364,0.0031548708,0.0023330408,0.0010509606,0.000063426356,0.00010408209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037766509,0.00016708788,0.00089150283,0.00011232938,0.000069507645,0.000025308193,0.00044780504,0.000051870153,0.00010812639],"category_scores_gemma":[0.0046096025,0.000095124815,0.00010589527,0.00016399559,0.00015816368,0.00020894817,0.00007476475,0.000040501833,0.00008578613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1227136,0.021498835,0.48482198,0.000903943,0.0056063244,0.000019660169,0.1930821,0.0025957457,0.000066054585,0.013227751,0.0646459,0.09081809],"study_design_scores_gemma":[0.031504236,0.0021247142,0.94521767,0.0009245057,0.000041779396,7.402489e-7,0.007476443,0.00012109081,0.000017890694,0.011854499,0.00047779185,0.0002386163],"about_ca_topic_score_codex":0.005919239,"about_ca_topic_score_gemma":0.00037351868,"teacher_disagreement_score":0.46039572,"about_ca_system_score_codex":0.0001758194,"about_ca_system_score_gemma":0.00020829408,"threshold_uncertainty_score":0.8948158},"labels":[],"label_agreement":null},{"id":"W2553508787","doi":"10.1136/annrheumdis-2016-eular.4099","title":"SAT0438 Magnetic Resonance Imaging Markers as Predictors for Total Knee Replacement over 10.7 Years in Older Adults","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Magnetic resonance imaging; Osteoarthritis; Cartilage; Knee pain; Total knee replacement; Nuclear medicine; Surgery; Radiology; Pathology; Anatomy","score_opus":0.009113881503267779,"score_gpt":0.25927299999068665,"score_spread":0.2501591184874189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553508787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896336,0.007372252,0.0000031162201,0.0010912869,0.00017325352,0.0012393144,0.0001263294,0.0000276197,0.0003331804],"genre_scores_gemma":[0.99359244,0.0002647143,0.000074431715,0.00023159909,0.0000240745,0.00017883316,0.000011708353,0.00002527501,0.0055969493],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881613,0.000051253828,0.00032397127,0.00023236577,0.0002977312,0.00027851883],"domain_scores_gemma":[0.99910754,0.00019553013,0.000117734366,0.00040314,0.000058980593,0.00011705882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015278386,0.00014764673,0.0002628356,0.00007466102,0.000034480345,0.000009806388,0.000086696564,0.000029358738,0.0008213002],"category_scores_gemma":[0.00047807166,0.00009014374,0.00019354091,0.00009049868,0.00007912413,0.00009659171,0.000057446345,0.000031014308,0.00002484462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004362863,0.0006600421,0.0749075,0.0003443347,0.00005362821,0.00001797301,0.00043089193,5.9473155e-7,0.00013274411,0.00021569988,0.015436936,0.9034368],"study_design_scores_gemma":[0.01300415,0.0018569987,0.97053367,0.010046928,0.00016177564,0.000014053759,0.00035389047,0.00007580235,0.0010965143,0.001053345,0.0016038867,0.00019899807],"about_ca_topic_score_codex":0.000030738673,"about_ca_topic_score_gemma":0.0000065073696,"teacher_disagreement_score":0.9032378,"about_ca_system_score_codex":0.000029928071,"about_ca_system_score_gemma":0.00008104098,"threshold_uncertainty_score":0.8992661},"labels":[],"label_agreement":null},{"id":"W2553538764","doi":"10.1136/annrheumdis-2016-eular.3002","title":"THU0022 Hyperglycemia-Related Advanced Glycation End-Products Is Associated with The Altered Phosphytidylcholine Metabolism in Osteoarthritis Patients","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Methylglyoxal; Glycation; Internal medicine; Endocrinology; Medicine; Phosphatidylcholine; Osteoarthritis; Metabolism; Diabetes mellitus; Synovial fluid; Hypertriglyceridemia; Chemistry; Biochemistry; Triglyceride; Phospholipid; Cholesterol; Pathology","score_opus":0.01418155491910482,"score_gpt":0.24466286668660678,"score_spread":0.23048131176750195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553538764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866265,0.0033846619,0.0000019565398,0.00809535,0.00024962245,0.0011409464,0.00026188648,0.000044368317,0.00019467318],"genre_scores_gemma":[0.9972362,0.00063774374,0.000026278332,0.00061072264,0.000022712422,0.00011915284,0.00009256137,0.00003571589,0.0012189113],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99820423,0.00015012517,0.00045858248,0.0003048139,0.00054306496,0.00033917133],"domain_scores_gemma":[0.99828273,0.00020406618,0.00040983604,0.0006545263,0.00034305485,0.00010576218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017058557,0.0002468091,0.0004863136,0.000079052246,0.00010323218,0.00001467503,0.00021694176,0.000068173016,0.00016447336],"category_scores_gemma":[0.000795436,0.00011207236,0.00016117023,0.00043980728,0.00016896629,0.00022554341,0.00006501442,0.00009776153,0.000022569115],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032565505,0.0033701505,0.03581689,0.00019568404,0.00077704125,0.000016813472,0.0021435309,0.000013385503,0.005520667,0.00094142917,0.0042769616,0.94367087],"study_design_scores_gemma":[0.05319424,0.0039201425,0.77554,0.01078046,0.0012197313,0.000021053074,0.0004851364,0.000027557156,0.14859104,0.0037308906,0.0017078285,0.0007819319],"about_ca_topic_score_codex":0.000021353067,"about_ca_topic_score_gemma":0.000026408232,"teacher_disagreement_score":0.942889,"about_ca_system_score_codex":0.00003165907,"about_ca_system_score_gemma":0.000112959744,"threshold_uncertainty_score":0.4570178},"labels":[],"label_agreement":null},{"id":"W2553817392","doi":"10.1136/annrheumdis-2016-eular.3332","title":"FRI0068 Contributions of Social Determinants of Health on Remission in Rheumatoid Arthritis Patients","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Confounding; Logistic regression; Univariate analysis; Physical therapy; Marital status; Multivariate analysis; Population; Environmental health","score_opus":0.03033367766775547,"score_gpt":0.3452814502053783,"score_spread":0.31494777253762285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553817392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919102,0.0040548737,0.000007832153,0.0028139644,0.00007413143,0.00048538976,0.0005439571,0.000010133097,0.00009950152],"genre_scores_gemma":[0.9754575,0.024377448,0.000010675285,0.000073017975,0.0000059818294,0.000018446452,0.0000108130425,0.000013031741,0.000033089356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776626,0.00028321883,0.00091199885,0.00014891544,0.00057911547,0.00031046872],"domain_scores_gemma":[0.9983472,0.00030862787,0.00056876655,0.0003300029,0.00031026264,0.0001351347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041464804,0.00013100241,0.00071207323,0.00015066256,0.00009174154,0.0000041400285,0.0001842614,0.0000466293,0.00013867057],"category_scores_gemma":[0.0020234005,0.000074356896,0.0002374966,0.00020044309,0.0003240407,0.00008806378,0.00006922951,0.00006267986,0.0000067166916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088534324,0.002539192,0.324758,0.0005611517,0.00011911002,0.0000018244183,0.0007412486,9.612907e-7,0.00051290187,0.0014474296,0.0067535583,0.66167927],"study_design_scores_gemma":[0.0050528767,0.000849655,0.95352805,0.019368842,0.0000028381685,0.0000025726886,0.00016382962,0.000014822536,0.017162576,0.0033213778,0.0004245894,0.000107977045],"about_ca_topic_score_codex":0.00013327994,"about_ca_topic_score_gemma":0.000021258491,"teacher_disagreement_score":0.6615713,"about_ca_system_score_codex":0.000026623027,"about_ca_system_score_gemma":0.00028191836,"threshold_uncertainty_score":0.30321863},"labels":[],"label_agreement":null},{"id":"W2553857278","doi":"10.1136/annrheumdis-2016-eular.1770","title":"FRI0160 Anti-TNF Therapy in Patients with Rheumatoid Arthritis Does Not Attenuate Cutaneous TNF Activity Following A Tuberculin Skin Test","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Etanercept; Immunology; ELISPOT; Tuberculin; Adalimumab; Immune system; Interferon gamma; Tumor necrosis factor alpha; Methotrexate; Antigen; Tuberculosis; T cell; Pathology","score_opus":0.018133890881981887,"score_gpt":0.2659755705086502,"score_spread":0.24784167962666834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553857278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583304,0.0002542644,0.000015357755,0.0026492495,0.00019579392,0.00061225955,0.00029176055,0.00004914065,0.00009915055],"genre_scores_gemma":[0.9978356,0.0016282202,0.000030107507,0.0003017248,0.00002321231,0.000043079715,0.000009946776,0.000039807714,0.00008833697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982534,0.00010130269,0.00047644443,0.0003043493,0.0005162596,0.00034823385],"domain_scores_gemma":[0.99817926,0.0006280275,0.00029022974,0.0005794323,0.00017284523,0.00015018735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013406806,0.00026532146,0.000598832,0.00013224626,0.00011757857,0.00003217205,0.00020417043,0.000052676136,0.00021445352],"category_scores_gemma":[0.0008234892,0.00012161921,0.00036623064,0.00023198016,0.0001285898,0.00025604435,0.000063522806,0.00012202537,0.000027049477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014027711,0.0045622396,0.6500897,0.00015625416,0.00062077894,0.00004496964,0.000503729,0.0000269841,0.008773448,0.000028204262,0.0011106617,0.33268026],"study_design_scores_gemma":[0.005399072,0.0011229871,0.91311765,0.009995285,0.000060701295,0.000027473223,0.00008366055,0.000102388534,0.06919373,0.0002773254,0.00025953047,0.00036022006],"about_ca_topic_score_codex":0.0002827938,"about_ca_topic_score_gemma":0.00004946619,"teacher_disagreement_score":0.33232006,"about_ca_system_score_codex":0.000031520933,"about_ca_system_score_gemma":0.000121703306,"threshold_uncertainty_score":0.49594876},"labels":[],"label_agreement":null},{"id":"W2553966075","doi":"10.1136/annrheumdis-2016-eular.1146","title":"SAT0477 Lysophosphatidylcholines To Phosphatidylcholines Ratio Predicts Advanced Knee Osteoarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Osteoarthritis; Cohort; Internal medicine; Synovial fluid; Knee replacement; Cohort study; Biomarker; Retrospective cohort study; Surgery; Arthroplasty; Pathology","score_opus":0.02214788220762236,"score_gpt":0.2849900842325773,"score_spread":0.26284220202495495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553966075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818379,0.00784339,0.0001099724,0.0065299985,0.0008121139,0.0016893481,0.0003154081,0.00012966186,0.00073216093],"genre_scores_gemma":[0.9923084,0.00054198265,0.00051806343,0.0013406497,0.00010602073,0.00027683537,0.000020998164,0.000047628575,0.0048394348],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797326,0.00006459931,0.0005989461,0.0003620492,0.00056862645,0.00043251575],"domain_scores_gemma":[0.9979251,0.00021544224,0.00024662944,0.0008598854,0.00033278594,0.00042015576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118851865,0.00030698668,0.00056835904,0.00010991774,0.00012409371,0.000025400099,0.0002435902,0.00006929777,0.00042338093],"category_scores_gemma":[0.00094126776,0.00016904289,0.00035295374,0.0003196178,0.00013179367,0.0002707531,0.00012864788,0.000048314265,0.00016422966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066703104,0.00048407065,0.005558273,0.00012859075,0.00014426466,0.000013357597,0.00032956334,0.0000063761304,0.0019862985,0.0014634705,0.0031074442,0.9861113],"study_design_scores_gemma":[0.039241295,0.017179435,0.31455377,0.032883123,0.0018303482,0.00017555707,0.0013098731,0.00003577119,0.5619918,0.013521377,0.01539059,0.0018870478],"about_ca_topic_score_codex":0.000011350279,"about_ca_topic_score_gemma":0.000007733008,"teacher_disagreement_score":0.9842242,"about_ca_system_score_codex":0.000023007271,"about_ca_system_score_gemma":0.00013577139,"threshold_uncertainty_score":0.6893369},"labels":[],"label_agreement":null},{"id":"W2553970710","doi":"10.1136/annrheumdis-2016-eular.1144","title":"SAT0378 Modification of Structural Lesions on Magnetic Resonance Imaging by Etanercept: A 12-Week Randomized Placebo-Controlled Trial","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical; University of Alberta","funders":"","keywords":"Medicine; Etanercept; Placebo; Magnetic resonance imaging; BASDAI; Randomized controlled trial; Clinical endpoint; Population; Nuclear medicine; Internal medicine; Surgery; Gastroenterology; Rheumatoid arthritis; Radiology; Pathology; Psoriatic arthritis","score_opus":0.03225024502213817,"score_gpt":0.30461422967058277,"score_spread":0.2723639846484446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553970710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97587126,0.016476847,0.0000114591,0.0036832269,0.000207848,0.0030106544,0.00017546825,0.000022233884,0.0005410039],"genre_scores_gemma":[0.99661666,0.0017655602,0.000033392942,0.0001308595,0.00002326191,0.00030011576,0.000010136388,0.000015440315,0.0011045899],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99833953,0.0002540334,0.0006165083,0.00019405066,0.0003951363,0.00020074123],"domain_scores_gemma":[0.99790823,0.0010729135,0.00037878606,0.00043863224,0.00011443968,0.00008699948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020499267,0.00018081158,0.0009739338,0.000058021877,0.00010046831,0.000007806182,0.00013469714,0.000026366326,0.00021626838],"category_scores_gemma":[0.0017885745,0.000083397004,0.0005115254,0.00007823049,0.00031285477,0.00005304175,0.000039313272,0.0000368651,0.000008738685],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8697954,0.0005644393,0.0005672879,0.000060240964,0.00023232371,0.0000021026904,0.00015909929,0.0000021073963,0.00021084285,0.00038750836,0.0035524473,0.12446625],"study_design_scores_gemma":[0.97899455,0.00053519517,0.015387852,0.0016085511,0.0005725217,0.0000034370464,0.000097210956,0.00024331527,0.0004508808,0.0019342887,0.00006396251,0.000108214],"about_ca_topic_score_codex":0.00006350468,"about_ca_topic_score_gemma":0.0000031861875,"teacher_disagreement_score":0.12435803,"about_ca_system_score_codex":0.000017153498,"about_ca_system_score_gemma":0.0000472924,"threshold_uncertainty_score":0.34008312},"labels":[],"label_agreement":null},{"id":"W2554015286","doi":"10.1136/annrheumdis-2016-eular.1805","title":"THU0186 Does Early Steroid Use Increase The Likelihood of Achieving Remission at 6 Months in Early RA? Results from The Canadian Early Arthritis Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Public Health Ontario; University of British Columbia; Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; University of Toronto","funders":"","keywords":"Medicine; Cohort; Logistic regression; Internal medicine; Observational study; Cohort study; Rheumatology; Single Center; Physical therapy; Prospective cohort study; Pediatrics","score_opus":0.022082228716754426,"score_gpt":0.2616206569272277,"score_spread":0.23953842821047328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554015286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774082,0.0070476145,0.0000014381328,0.012554504,0.00012911015,0.0011270873,0.0014832073,0.000024318084,0.00022454599],"genre_scores_gemma":[0.98646486,0.0126078315,0.000017833632,0.00032253595,0.000052047504,0.000058901118,0.000024491277,0.000038193062,0.00041328208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638647,0.000702474,0.0009092579,0.0003670914,0.0009927959,0.000641924],"domain_scores_gemma":[0.9950176,0.0022805629,0.00040637064,0.001461391,0.00028631525,0.0005477775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000996948,0.000286698,0.0006079585,0.00013660254,0.00039301816,0.00012338252,0.0007418496,0.00009624575,0.00012736848],"category_scores_gemma":[0.0052051074,0.0001094801,0.00032873356,0.00028952438,0.0006683469,0.00040390794,0.0002707304,0.0002195876,0.000027690372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016505705,0.00022889425,0.9099261,0.000048566995,0.0004149229,0.000029899786,0.0033988669,0.0000016334841,0.0009600648,0.00007963631,0.0061494904,0.07711132],"study_design_scores_gemma":[0.0024521349,0.00022020082,0.98586565,0.007501786,0.00002742766,0.000005526756,0.00021908461,0.000013429059,0.0012937628,0.0012542526,0.0009925775,0.00015415558],"about_ca_topic_score_codex":0.44625288,"about_ca_topic_score_gemma":0.18426938,"teacher_disagreement_score":0.26198348,"about_ca_system_score_codex":0.00007251754,"about_ca_system_score_gemma":0.00049914717,"threshold_uncertainty_score":0.8306156},"labels":[],"label_agreement":null},{"id":"W2554016289","doi":"10.1136/annrheumdis-2016-eular.2081","title":"THU0048 Testing of 14-3-3eta in Early Undifferentiated Polyarthritis Can Assist with Prioritizing Referrals of High Joint Damage Risk Patients To Rheumatologists","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Polyarthritis; Referral; Internal medicine; Rheumatology; Radiography; Physical therapy; Arthritis; Surgery; Family medicine","score_opus":0.045144789484438626,"score_gpt":0.28127369288397747,"score_spread":0.23612890339953885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554016289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966536,0.0010927848,0.000024964897,0.00072688004,0.000066042456,0.00075727666,0.00054915634,0.000030244124,0.0000990072],"genre_scores_gemma":[0.9975665,0.0019580105,0.00030834906,0.000035170717,0.0000055334217,0.00003618451,0.00001423717,0.000034780478,0.00004118596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709123,0.0003274687,0.0009822474,0.0002939485,0.00079261215,0.0005124911],"domain_scores_gemma":[0.9972023,0.0005231214,0.00069488067,0.0007059843,0.0006043139,0.00026944868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033793633,0.00024945138,0.0009628158,0.00030053366,0.00009040848,0.000021938085,0.00032360177,0.00005925617,0.000046333364],"category_scores_gemma":[0.004034234,0.00013829596,0.00017558454,0.0005419504,0.00045234888,0.00014929005,0.0001969282,0.00012427091,0.0000040892382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005229716,0.0007186082,0.95399904,0.00045555094,0.00026271486,0.0000068692207,0.00043196446,0.000004481732,0.0007526583,0.00045174072,0.00015118263,0.042242203],"study_design_scores_gemma":[0.0033118483,0.0010422587,0.96922183,0.01667019,0.00002395076,0.0000052564997,0.00011371644,0.0000073711913,0.008060567,0.001376543,0.0000069254675,0.00015954928],"about_ca_topic_score_codex":0.0039435453,"about_ca_topic_score_gemma":0.0005436565,"teacher_disagreement_score":0.042082656,"about_ca_system_score_codex":0.000028239781,"about_ca_system_score_gemma":0.00018105243,"threshold_uncertainty_score":0.5961487},"labels":[],"label_agreement":null},{"id":"W2554180402","doi":"10.1136/annrheumdis-2016-eular.3304","title":"SAT0424 Trends in Osteoarthritis Incidence in British Columbia, Canada, 2001-2012","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Poisson regression; Incidence (geometry); Population; Demography; Epidemiology; Public health; Confidence interval; Obesity; Gerontology; Environmental health; Internal medicine","score_opus":0.031612503715757315,"score_gpt":0.29125714713414314,"score_spread":0.25964464341838583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554180402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782814,0.0034126868,0.0000015502781,0.004982616,0.000143797,0.00033075115,0.00024190321,0.000021398617,0.0030371344],"genre_scores_gemma":[0.9923786,0.0007354064,0.000008177682,0.00055905676,0.000020318272,0.000052424544,0.0000147250075,0.000017633833,0.006213645],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998207,0.000093442744,0.0005074223,0.0002456073,0.00052012067,0.00042642624],"domain_scores_gemma":[0.99892825,0.00016084926,0.00015824515,0.0005115603,0.00006236966,0.00017872198],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018605222,0.00011966399,0.00040175128,0.00010361727,0.000038075665,0.000052689,0.00029241285,0.000033498418,0.0023410765],"category_scores_gemma":[0.0004846011,0.000116583695,0.00012568932,0.00046281845,0.0001843643,0.00025268985,0.0001429368,0.00006360327,0.0000075662283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004447933,0.00036507033,0.39468598,0.0003755017,0.00005545623,0.00016526102,0.000038041257,0.000008962263,0.000007417117,0.000057862733,0.18321186,0.4209841],"study_design_scores_gemma":[0.0017218349,0.000066290144,0.99036115,0.0050144526,0.000046565587,0.000011049305,0.00023106919,0.000017356446,0.000011751253,0.0012313707,0.0011434774,0.0001436159],"about_ca_topic_score_codex":0.75594866,"about_ca_topic_score_gemma":0.9869496,"teacher_disagreement_score":0.5956752,"about_ca_system_score_codex":0.00013274621,"about_ca_system_score_gemma":0.00071686524,"threshold_uncertainty_score":0.9985709},"labels":[],"label_agreement":null},{"id":"W2554230685","doi":"10.1136/annrheumdis-2016-eular.3245","title":"FRI0434 Prevalence of Structural Cardiac Disease and Diastolic Dysfunction in Axial Spondyloarthritis: A Prospective Case-Control Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital","funders":"","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Cardiology; Population; Ascending aorta; Spondylitis; Prospective cohort study; Cohort; Univariate analysis; Diastole; Multivariate analysis; Aorta; Blood pressure","score_opus":0.015848526273790877,"score_gpt":0.2784261684901875,"score_spread":0.2625776422163966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554230685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983709,0.0129414145,0.00000283875,0.00034770713,0.0001422518,0.0017405414,0.0010841682,0.000014876057,0.000017225073],"genre_scores_gemma":[0.99891174,0.0007632604,0.00000672718,0.000023230916,0.000029255283,0.00016707432,0.0000012937872,0.000014342638,0.000083055806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865687,0.00016073552,0.00038884304,0.00026444407,0.00030982506,0.00021929057],"domain_scores_gemma":[0.99891335,0.00023319654,0.00019271631,0.00037675683,0.00013279931,0.00015120968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012513116,0.00018423493,0.0005244383,0.00008455303,0.00008412551,0.0000075490125,0.000071676055,0.000024201607,0.000066233166],"category_scores_gemma":[0.00065449794,0.0001018807,0.00018471127,0.00015308494,0.00023953021,0.00013353604,0.00007593215,0.000044021537,0.0000019101265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014146658,0.0005344115,0.95312697,0.00039687485,0.00047181334,0.00016245224,0.0006150655,0.0000017383751,0.000019203795,0.000102386795,0.00003601357,0.04311843],"study_design_scores_gemma":[0.006024788,0.0006943153,0.98939276,0.0015157802,0.00063139683,0.00004378688,0.0005835539,0.000013268815,0.00005316805,0.00094687485,0.0000015074659,0.000098819255],"about_ca_topic_score_codex":0.00018155448,"about_ca_topic_score_gemma":0.00005421947,"teacher_disagreement_score":0.04301961,"about_ca_system_score_codex":0.000024742498,"about_ca_system_score_gemma":0.000066019005,"threshold_uncertainty_score":0.41545746},"labels":[],"label_agreement":null},{"id":"W2554259115","doi":"10.1136/annrheumdis-2016-eular.3011","title":"SAT0388 Long-Term Efficacy and Tolerability of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results of The Open-Label Extension of A Randomized, Double-Blind Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tolerability; Placebo; Population; Internal medicine; Adverse effect","score_opus":0.0800724299875214,"score_gpt":0.37074978150058097,"score_spread":0.29067735151305957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554259115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860395,0.007977396,0.0000031016586,0.0009997908,0.0000770442,0.0046118516,0.0002208773,0.000006544271,0.00006388038],"genre_scores_gemma":[0.9896897,0.010125086,0.000014933829,0.000017402539,0.000009415597,0.00009887882,0.0000040609825,0.000016711376,0.000023809765],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99632764,0.0009655433,0.0013670507,0.00032587376,0.00074287475,0.00027103478],"domain_scores_gemma":[0.9957618,0.0017525897,0.00083137315,0.0010542572,0.0004609512,0.00013898994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017316454,0.00021441646,0.0015792649,0.00022451849,0.000069534995,0.000017676528,0.00056408485,0.000056851113,0.0000330863],"category_scores_gemma":[0.0033616184,0.0001021232,0.00031040906,0.00048416317,0.00154609,0.00021667054,0.00041560424,0.00011741385,5.278323e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81533927,0.011722757,0.07573224,0.00071576465,0.0011810528,0.000008132463,0.003179511,0.0000040029554,0.0017421397,0.00026273407,0.00010250881,0.09000986],"study_design_scores_gemma":[0.42521748,0.0010295664,0.55946815,0.008301885,0.00007923901,0.00000868531,0.00033266755,0.000011236791,0.0043180347,0.001132948,0.0000016529901,0.00009849085],"about_ca_topic_score_codex":0.0006163243,"about_ca_topic_score_gemma":0.00021339375,"teacher_disagreement_score":0.4837359,"about_ca_system_score_codex":0.000011140121,"about_ca_system_score_gemma":0.00022139809,"threshold_uncertainty_score":0.5696633},"labels":[],"label_agreement":null},{"id":"W2554268613","doi":"10.1136/annrheumdis-2016-eular.1386","title":"FRI0548 Responsiveness of A New MRI Scoring Method Based on The Canada-Denmark Definitions of Lesions in The Spine and The SPARCC MRI Spine Inflammation Index in Patients with Axial Spondyloarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axial spondyloarthritis; Sagittal plane; Adalimumab; Ankylosis; Spondylarthritis; Magnetic resonance imaging; Radiology; Ankylosing spondylitis; Surgery; Pathology; Disease","score_opus":0.03024670665599778,"score_gpt":0.2753036797533536,"score_spread":0.24505697309735586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554268613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981474,0.0006992232,0.00009427181,0.016294923,0.000042331667,0.0011018148,0.00016042919,0.0000030510612,0.00012999862],"genre_scores_gemma":[0.9986931,0.0007641411,0.0001326433,0.00027182454,0.000012998618,0.00008538623,0.000009452559,0.000011891012,0.000018551471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815357,0.0004557033,0.0004902903,0.00015667823,0.0005523935,0.00019138199],"domain_scores_gemma":[0.9977663,0.0011651751,0.00033548017,0.0005118941,0.00016529555,0.00005582899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051873614,0.0001649542,0.00044183992,0.00009883542,0.0001224985,0.000008444909,0.00019485754,0.000027760761,0.000040888615],"category_scores_gemma":[0.0014804407,0.00006215501,0.00009876059,0.0003992114,0.0002914801,0.000059194692,0.000067782785,0.00008077605,4.3782873e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015285703,0.0022011232,0.82977504,0.00080438534,0.0008062113,0.000045567096,0.0030381633,0.0013225409,0.00007022552,0.01812253,0.0017381542,0.12679039],"study_design_scores_gemma":[0.008190967,0.00034759034,0.9832707,0.0052789585,0.000114541035,0.0000022997417,0.00047376272,0.000115053976,0.00028757262,0.0018094769,0.00003640066,0.00007268045],"about_ca_topic_score_codex":0.018542388,"about_ca_topic_score_gemma":0.03552244,"teacher_disagreement_score":0.15349568,"about_ca_system_score_codex":0.000028437355,"about_ca_system_score_gemma":0.00040946182,"threshold_uncertainty_score":0.98799324},"labels":[],"label_agreement":null},{"id":"W2554300481","doi":"10.1136/annrheumdis-2016-eular.2394","title":"THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Psoriasis; Internal medicine; Randomized controlled trial; Adverse effect; Psoriatic arthritis; Rheumatoid arthritis; Clinical trial; Adalimumab; Surgery; Dermatology","score_opus":0.38836668055030127,"score_gpt":0.5214376873914496,"score_spread":0.1330710068411483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554300481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93622214,0.008781121,0.00040152628,0.030150844,0.00050513603,0.00079706154,0.022840789,0.00004134698,0.00026005507],"genre_scores_gemma":[0.98892915,0.009474404,0.000100809215,0.0009094427,0.00022812307,0.000011710554,0.00030932933,0.000011422183,0.00002558808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944411,0.002547763,0.0017004542,0.0004229136,0.00059139787,0.00029637388],"domain_scores_gemma":[0.9886924,0.0077854204,0.0011105239,0.0018458449,0.00025245277,0.00031333222],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004199314,0.00024292462,0.001457145,0.00003318298,0.00013535284,0.00003078334,0.00097608904,0.000094033705,0.0011922282],"category_scores_gemma":[0.020040112,0.0000950925,0.00080120016,0.00061177654,0.0005895535,0.0003072707,0.00053461397,0.00015400434,0.000015167132],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073626125,0.0019056861,0.20252772,0.00016081163,0.016236622,0.000007866376,0.00011889203,0.00001407908,0.000067174966,0.000544766,0.02538652,0.7456672],"study_design_scores_gemma":[0.010708957,0.0010550324,0.86114264,0.0027566035,0.03190159,0.000004860132,0.0012177665,0.0029125875,0.001971097,0.005798119,0.07999713,0.00053363055],"about_ca_topic_score_codex":0.0013262327,"about_ca_topic_score_gemma":0.0004403381,"teacher_disagreement_score":0.74513364,"about_ca_system_score_codex":0.000039511822,"about_ca_system_score_gemma":0.00034769767,"threshold_uncertainty_score":0.9997208},"labels":[],"label_agreement":null},{"id":"W2554485042","doi":"10.1136/annrheumdis-2016-eular.4257","title":"FRI0159 Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from An Ontario Rheumatoid Arthritis Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cohort; Methotrexate; Concomitant; Internal medicine; Combination therapy; Antirheumatic drugs; Physical therapy; Antirheumatic Agents","score_opus":0.030070912795035137,"score_gpt":0.272756749222915,"score_spread":0.24268583642787986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554485042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779666,0.0074720983,0.00007086456,0.0013829761,0.000051150906,0.002728137,0.00031508628,0.00010051755,0.000082525556],"genre_scores_gemma":[0.95101213,0.04782289,0.00033122176,0.00015323775,0.0000070776928,0.00028818645,0.00026389147,0.00009430451,0.0000270533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99461347,0.0005464473,0.0012980008,0.0009784708,0.0016390888,0.00092452095],"domain_scores_gemma":[0.9960815,0.0005927375,0.00087206124,0.0013760759,0.00052364933,0.00055402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005665935,0.00072157686,0.0015648945,0.0004310945,0.0002681494,0.00014467473,0.0006033172,0.0001116923,0.00014527315],"category_scores_gemma":[0.00019586786,0.0003578739,0.0001635099,0.000660338,0.0010606862,0.0009948452,0.00006996789,0.0003554128,0.000012105072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027271524,0.003420596,0.92016315,0.00006599365,0.00052687724,0.000025688472,0.0035898124,0.0001423957,0.000014078449,0.000103039834,0.00006942841,0.044607405],"study_design_scores_gemma":[0.04007896,0.0041111656,0.9273133,0.025751894,0.000010932764,0.000012837076,0.0010956292,0.00024982565,0.00022555036,0.00048341686,0.000059335714,0.00060709997],"about_ca_topic_score_codex":0.009044188,"about_ca_topic_score_gemma":0.017370844,"teacher_disagreement_score":0.044000305,"about_ca_system_score_codex":0.00017722708,"about_ca_system_score_gemma":0.0008125596,"threshold_uncertainty_score":0.99988735},"labels":[],"label_agreement":null},{"id":"W2555072770","doi":"10.1136/annrheumdis-2017-211708","title":"Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Tocilizumab; Internal medicine; Endocrinology; Catabolism; Cholesterol; Lipoprotein; Blockade; Low-density lipoprotein; Metabolism; Receptor","score_opus":0.03899042941028379,"score_gpt":0.30306110402132636,"score_spread":0.26407067461104256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555072770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97623414,0.012364648,0.00019251311,0.008178991,0.00038797763,0.0020336157,0.00039750597,0.00008528126,0.00012531751],"genre_scores_gemma":[0.9348061,0.06340942,0.00013919748,0.00030572477,0.00011845117,0.0010232368,0.000025363935,0.00009670901,0.0000757759],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968,0.00026227106,0.0008281634,0.0005560506,0.00072482054,0.00082868827],"domain_scores_gemma":[0.9961502,0.000510447,0.0006888348,0.001858003,0.00036972936,0.00042279632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060580723,0.00048561709,0.0011998991,0.00033403627,0.0005317771,0.00022632553,0.0011021469,0.00013905864,0.00017689847],"category_scores_gemma":[0.002231362,0.00036067565,0.000517658,0.00015821608,0.0005720292,0.0003622034,0.00029163508,0.00022954601,0.000028327348],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007225715,0.0052025714,0.018149558,0.0025695858,0.0024707424,0.00011393474,0.006184406,0.000007583778,0.113737844,0.005291555,0.009139505,0.829907],"study_design_scores_gemma":[0.017724989,0.0012007433,0.2748975,0.0430989,0.000097526274,0.0003514179,0.001858483,0.00118714,0.61417496,0.0387902,0.004990403,0.0016277612],"about_ca_topic_score_codex":0.0010870721,"about_ca_topic_score_gemma":0.0007422462,"teacher_disagreement_score":0.82827926,"about_ca_system_score_codex":0.00003576942,"about_ca_system_score_gemma":0.00018769655,"threshold_uncertainty_score":0.99988455},"labels":[],"label_agreement":null},{"id":"W2555093064","doi":"10.1136/annrheumdis-2016-eular.5138","title":"OP0038 Improved Survival in Dermatomyositis and Polymyositis: A General Population-Base Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Polymyositis; Dermatomyositis; Population; Proportional hazards model; Internal medicine; Context (archaeology); Comorbidity; Confounding; Mortality rate; Demography; Confidence interval; Environmental health","score_opus":0.01866575263149002,"score_gpt":0.28643492760778333,"score_spread":0.2677691749762933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555093064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950018,0.0009163762,0.000030889118,0.002982829,0.00014193724,0.0007417791,0.00006896495,0.00003796403,0.00007749526],"genre_scores_gemma":[0.9990219,0.00014380872,0.000051369672,0.00052775536,0.000039101084,0.000055224762,0.00000667848,0.000024307203,0.00012989073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983805,0.00020130779,0.00056810904,0.00023372445,0.0003262723,0.00029012802],"domain_scores_gemma":[0.99885404,0.00018650643,0.00019723662,0.0004854153,0.00009734936,0.00017945396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020680355,0.00019643301,0.0004873533,0.00012654075,0.00009596709,0.000026763917,0.00014078303,0.00004807089,0.00006344487],"category_scores_gemma":[0.00027075506,0.00011336487,0.00014707324,0.00017875408,0.00010997688,0.00017486242,0.000119567245,0.000059682698,0.0000055719706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025495453,0.00051081245,0.97479147,0.0002773604,0.00014213874,0.000065383414,0.00044137728,0.0000033363028,0.00032365188,0.00062690774,0.0005273882,0.022035245],"study_design_scores_gemma":[0.00239285,0.00014614407,0.99389243,0.00089897413,0.00010150174,0.000054274864,0.00032097823,0.00037457407,0.0006100985,0.0010372807,0.000013418298,0.00015746756],"about_ca_topic_score_codex":0.0008067715,"about_ca_topic_score_gemma":0.00009131353,"teacher_disagreement_score":0.021877777,"about_ca_system_score_codex":0.000021661248,"about_ca_system_score_gemma":0.0000814892,"threshold_uncertainty_score":0.46228853},"labels":[],"label_agreement":null},{"id":"W2555297192","doi":"10.1136/annrheumdis-2016-eular.1398","title":"THU0430 Ixekizumab Provides Improvements through 52 Weeks in Physical Function, Quality of Life, and Work Productivity in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Ixekizumab; Adalimumab; Quality of life (healthcare); Enthesitis; BASDAI; Internal medicine; Dermatology Life Quality Index; Ankylosing spondylitis; Placebo; Psoriasis; Presenteeism; Physical therapy; Arthritis; Rheumatoid arthritis; Immunology; Disease; Absenteeism; Secukinumab; Alternative medicine","score_opus":0.02890524886302692,"score_gpt":0.2673986003624654,"score_spread":0.23849335149943846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555297192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425256,0.0036422778,0.000014892648,0.00040481726,0.00018683852,0.0011159673,0.00035044653,0.000021859181,0.000010315579],"genre_scores_gemma":[0.99904233,0.0006366795,0.000014914821,0.000035410583,0.000009546486,0.00017433689,0.000038328635,0.000016210548,0.000032250784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976548,0.0007866846,0.00062458107,0.00043920657,0.00013752248,0.0003572205],"domain_scores_gemma":[0.9979727,0.00069783995,0.0006620591,0.00048109947,0.00013726215,0.00004900682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025745848,0.00030057193,0.0007703549,0.000105109815,0.00010575843,0.000010202288,0.00022559019,0.00006808328,0.000022661627],"category_scores_gemma":[0.001087105,0.00016075533,0.00015278289,0.0003427098,0.00048554846,0.00037526464,0.00013533038,0.000085442254,0.000007679619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036175568,0.0025214558,0.68481576,0.00045086636,0.00056169817,5.027114e-7,0.0011437641,0.000007737255,0.00016367229,0.00021078956,0.00006376277,0.3064424],"study_design_scores_gemma":[0.004585413,0.00024815457,0.98402363,0.0017214922,0.00011111575,1.6858674e-7,0.00028670067,0.0000015026569,0.0011360499,0.0076687317,0.000003819728,0.00021319823],"about_ca_topic_score_codex":0.00023026881,"about_ca_topic_score_gemma":0.000066068205,"teacher_disagreement_score":0.30622923,"about_ca_system_score_codex":0.00003180719,"about_ca_system_score_gemma":0.00013336101,"threshold_uncertainty_score":0.65554124},"labels":[],"label_agreement":null},{"id":"W2555339381","doi":"10.1136/annrheumdis-2016-eular.3610","title":"THU0304 Adherence To Hydroxychloroquine as Assessed by Measurements of Drug and Metabolite Blood Levels in An International Prospective Study of Sle Patients in Flare","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Hydroxychloroquine; Internal medicine; Prospective cohort study; Lupus nephritis; Gastroenterology; Systemic lupus erythematosus; Disease","score_opus":0.07151887619430734,"score_gpt":0.372101899735303,"score_spread":0.30058302354099564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555339381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742156,0.00035589706,0.0000014484281,0.00015654476,0.000067712666,0.0017243403,0.0001625335,0.000005667539,0.00010429976],"genre_scores_gemma":[0.99963766,0.00005222032,0.000018432158,0.00002136365,0.0000048939237,0.00010659447,0.000004801667,0.000014468371,0.00013956126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753696,0.000257725,0.0006930252,0.00025699005,0.0010674606,0.00018782046],"domain_scores_gemma":[0.9983342,0.00018871446,0.0003126024,0.00045057104,0.0005873749,0.00012648274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056993595,0.00014113859,0.0005447693,0.00021171954,0.00001487523,0.000008377295,0.00036436954,0.000025584117,0.000047681347],"category_scores_gemma":[0.0016720131,0.00008172499,0.000057655423,0.00031126232,0.000077626224,0.00022162858,0.000166848,0.0000419054,0.0000019738832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038386285,0.0049706395,0.98454356,0.00041023752,0.00025700653,0.000001253046,0.003779344,0.000002462331,0.0039328123,0.0000133877575,0.00007556588,0.0016298551],"study_design_scores_gemma":[0.006055827,0.0008925109,0.96167773,0.0037210518,0.00006642982,0.0000033812287,0.0016890174,0.0000133692865,0.025489282,0.000308169,6.733273e-7,0.00008253842],"about_ca_topic_score_codex":0.0006027735,"about_ca_topic_score_gemma":0.00015236034,"teacher_disagreement_score":0.022865823,"about_ca_system_score_codex":0.000031220523,"about_ca_system_score_gemma":0.00011721353,"threshold_uncertainty_score":0.33326483},"labels":[],"label_agreement":null},{"id":"W2555384512","doi":"10.1136/annrheumdis-2016-eular.3142","title":"SAT0375 Certolizumab Pegol for The Treatment of Axial Spondyloarthritis: 4-Year Outcomes from The Rapid-AXSPA Trial","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Certolizumab pegol; Medicine; Axial spondyloarthritis; Physical therapy; Internal medicine; Adalimumab; Ankylosing spondylitis; Intensive care medicine; Rheumatoid arthritis; Sacroiliitis","score_opus":0.06922076240192718,"score_gpt":0.32582870539945363,"score_spread":0.25660794299752643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555384512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946829,0.017757758,0.000017686742,0.02867031,0.0008268656,0.0031780584,0.0024958379,0.000029562289,0.0001949224],"genre_scores_gemma":[0.98815256,0.0104837,0.00003342208,0.00016877224,0.00019084848,0.00043897753,0.000022511236,0.000028617478,0.0004805658],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983341,0.000117925316,0.0005579372,0.00023820778,0.0004383351,0.0003135139],"domain_scores_gemma":[0.99575305,0.0027354734,0.00034133234,0.00092489674,0.00015023498,0.00009500824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069627495,0.0002677258,0.000732279,0.000031401945,0.00025955346,0.00001765674,0.00029988933,0.000048873448,0.00049974164],"category_scores_gemma":[0.0007921567,0.000090631744,0.0009816748,0.000103018545,0.00038527462,0.000057184345,0.000065730404,0.000029906589,0.000017646524],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05057218,0.0049308278,0.04222311,0.00012921926,0.0069607804,0.00002733112,0.0018493626,0.0000014707773,0.000047247646,0.00141074,0.01779421,0.87405354],"study_design_scores_gemma":[0.2653527,0.009938562,0.67850864,0.002994511,0.004596621,0.00003077554,0.002755441,0.000023825007,0.0027530673,0.007351365,0.025190134,0.00050440506],"about_ca_topic_score_codex":0.00036481008,"about_ca_topic_score_gemma":0.00007909692,"teacher_disagreement_score":0.8735491,"about_ca_system_score_codex":0.00003081166,"about_ca_system_score_gemma":0.00011389323,"threshold_uncertainty_score":0.547182},"labels":[],"label_agreement":null},{"id":"W2555389255","doi":"10.1136/annrheumdis-2016-eular.4308","title":"AB0341 Favorable Effects of Sirukumab Treatment on Physical Function and Reductions in Morning Stiffness in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Disease-Modifying Anti-Rheumatic Drugs","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Rheumatoid arthritis; Morning stiffness; Disease; Morning; Arthritis; Internal medicine; Physical therapy","score_opus":0.04739448132875973,"score_gpt":0.3801218099309517,"score_spread":0.33272732860219195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555389255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686795,0.000560915,0.000005015229,0.0009658801,0.0001563416,0.0013002803,0.00010699756,0.00002882505,0.000007776333],"genre_scores_gemma":[0.9989664,0.00064477924,0.0000095878895,0.0001524754,0.000009912705,0.00017738692,0.0000067545297,0.000021289226,0.000011397525],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971581,0.0014254298,0.00038649366,0.00038828055,0.00027203257,0.00036967095],"domain_scores_gemma":[0.9959494,0.0030992746,0.000271846,0.00025661048,0.00009396554,0.00032891575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000345522,0.00030070654,0.0005967439,0.0002603541,0.00016266335,0.00001846955,0.00018146145,0.000076554956,0.000012953105],"category_scores_gemma":[0.0007259302,0.00017625919,0.00007762583,0.0003627287,0.0003286681,0.00035499656,0.000104597435,0.0002059129,0.0000029094806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049557935,0.007853057,0.052996,0.0007597774,0.0004882437,0.000016217224,0.002443517,0.0021004204,0.011101822,0.00029426574,0.00006331556,0.8723254],"study_design_scores_gemma":[0.008539712,0.0020558853,0.9754486,0.0028834254,0.00010570396,9.310456e-7,0.00013845574,0.0009518848,0.0075915097,0.0020131788,0.00001303695,0.00025767196],"about_ca_topic_score_codex":0.000034182605,"about_ca_topic_score_gemma":0.000009134936,"teacher_disagreement_score":0.9224526,"about_ca_system_score_codex":0.000082920065,"about_ca_system_score_gemma":0.000087462984,"threshold_uncertainty_score":0.7187641},"labels":[],"label_agreement":null},{"id":"W2555495946","doi":"10.1136/annrheumdis-2016-eular.3875","title":"SAT0196 Impress 2 (International Multicentric Prospective Study on Pregnancy in Systemic Sclerosis). Prospective, Case-Control Study of Pregnancy in Systemic Sclerosis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Intrauterine growth restriction; Prospective cohort study; Live birth; Pediatrics; Scleroderma (fungus); Population; Gestation; Low birth weight; Internal medicine; Immunology","score_opus":0.046082198514474565,"score_gpt":0.2961418037186846,"score_spread":0.25005960520421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555495946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642501,0.02311583,0.0000061815913,0.00010842899,0.0004775901,0.01149013,0.00037257618,0.00006314938,0.00011603719],"genre_scores_gemma":[0.99571735,0.0024657266,0.0000029603764,0.000021669312,0.00003671804,0.00156796,0.0000021047704,0.00006537391,0.00012011995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945062,0.00085149513,0.0020232974,0.000835272,0.0012426663,0.000541112],"domain_scores_gemma":[0.99593055,0.0008272491,0.0012135562,0.0012403891,0.0005617333,0.00022650749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049587566,0.0005137311,0.0014421043,0.0006129885,0.0001034635,0.000038017813,0.0006424561,0.00014083042,0.0000557635],"category_scores_gemma":[0.0015321472,0.00029280028,0.00041319442,0.0008437781,0.00015256582,0.00027528743,0.00018273861,0.00020822445,0.000015444757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013323519,0.017620588,0.9579229,0.00129181,0.0014292825,0.00012894718,0.0049296347,0.00032924325,0.0015804351,0.000041577347,0.00004914041,0.013344094],"study_design_scores_gemma":[0.017579282,0.0011507825,0.77788347,0.19091699,0.00060472655,0.000069105154,0.010725051,0.00016265713,0.0006262358,0.000036141962,3.13344e-8,0.00024551392],"about_ca_topic_score_codex":0.0006204948,"about_ca_topic_score_gemma":0.00007771504,"teacher_disagreement_score":0.18962517,"about_ca_system_score_codex":0.00032056918,"about_ca_system_score_gemma":0.00020293042,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W2555503896","doi":"10.1136/annrheumdis-2016-eular.1554","title":"OP0024-PARE Development and Use of A Canadian Arthritis Patient Charter","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Medicine; Charter; Arthritis; General partnership; Health care; Family medicine; Physical therapy; Public relations; Internal medicine; Political science; Business; Finance","score_opus":0.2336852393106777,"score_gpt":0.4166334845013452,"score_spread":0.1829482451906675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555503896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820367,0.0015087614,0.0000034515144,0.0147499,0.00025486684,0.0005748824,0.00035275877,0.000009446984,0.00050920877],"genre_scores_gemma":[0.9972502,0.0011519513,0.00008763977,0.00094860257,0.000015145944,0.000070340044,0.0000026068356,0.000010485553,0.00046303606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99818593,0.00056639715,0.0006259858,0.00011893625,0.000205097,0.00029764223],"domain_scores_gemma":[0.99780345,0.00093947735,0.0004328769,0.00030107016,0.0002109138,0.00031222994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033067737,0.00009503966,0.00025990032,0.00013165206,0.00026713635,0.000006601684,0.00010397083,0.00005442503,0.00034606887],"category_scores_gemma":[0.0011844607,0.000049565835,0.000048432503,0.00012864468,0.000060714694,0.00019335197,0.00006425675,0.00006015378,0.00003183308],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005085539,0.00008035967,0.12269129,0.0016726061,0.00013652288,0.0000030746103,0.012963096,4.3323394e-7,0.000015229402,0.0019629225,0.05520205,0.80522156],"study_design_scores_gemma":[0.0003950002,0.00007990477,0.5045905,0.01235829,0.000017012804,0.0000020377443,0.0023901889,0.000004667672,0.00019651781,0.00045771446,0.4793492,0.00015893334],"about_ca_topic_score_codex":0.0437602,"about_ca_topic_score_gemma":0.049506117,"teacher_disagreement_score":0.80506265,"about_ca_system_score_codex":0.000020130701,"about_ca_system_score_gemma":0.00079932547,"threshold_uncertainty_score":0.9678379},"labels":[],"label_agreement":null},{"id":"W2555579595","doi":"10.1136/annrheumdis-2016-eular.4364","title":"AB0512 Use of Nominal Group Technique To Facilitate Item Reduction for Sle Classification Criteria Development","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Delphi method; Delphi; Weighting; Cohort; Nominal group technique; Artificial intelligence; Computer science; Internal medicine","score_opus":0.18533945375446312,"score_gpt":0.3457614445919002,"score_spread":0.1604219908374371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555579595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97084844,0.0003034286,0.017442934,0.0069537843,0.0023444847,0.0017604186,0.0002457727,0.0000467228,0.000054040862],"genre_scores_gemma":[0.984803,0.00014568836,0.008731187,0.000090218535,0.000030962747,0.00027017665,0.000021339107,0.00001750074,0.0058898963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990001,0.000048827842,0.00043396075,0.00015918053,0.00020293226,0.00015503849],"domain_scores_gemma":[0.9989853,0.0001969333,0.00018848205,0.00032041117,0.00018670168,0.00012220794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015624527,0.000103379665,0.00025409367,0.000101100086,0.00005232542,0.000008404226,0.000101077276,0.000045954446,0.000039740276],"category_scores_gemma":[0.0009323638,0.000059351285,0.00013654286,0.00010715573,0.00011376478,0.00013311485,0.000029728748,0.000024898383,0.000007591729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011297973,0.0011241395,0.0036215305,0.002509672,0.000305171,0.0000013070268,0.0018883854,0.0000016070524,0.5151136,0.00097462913,0.15878583,0.31454435],"study_design_scores_gemma":[0.0027280387,0.0013230954,0.40428576,0.021636005,0.0004471614,0.000072995805,0.0006783457,0.00009486021,0.48574528,0.0034479534,0.07898519,0.0005553184],"about_ca_topic_score_codex":0.000020611886,"about_ca_topic_score_gemma":0.000002843174,"teacher_disagreement_score":0.4006642,"about_ca_system_score_codex":0.000025683625,"about_ca_system_score_gemma":0.000088658446,"threshold_uncertainty_score":0.24202752},"labels":[],"label_agreement":null},{"id":"W2555741025","doi":"10.1136/annrheumdis-2016-eular.4335","title":"AB0378 Improvements in Measures of Work Productivity/interference and General Health Status with Sirukumab Treatment in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Rheumatoid arthritis; Visual analogue scale; Placebo; Physical therapy; Internal medicine; Quality of life (healthcare); Alternative medicine","score_opus":0.03049772427265678,"score_gpt":0.2847638864242749,"score_spread":0.2542661621516181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555741025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98346573,0.012549701,0.000021911908,0.0011256186,0.00003944472,0.0024902201,0.00027436623,0.00002285988,0.000010168268],"genre_scores_gemma":[0.94149727,0.057979602,0.000097706004,0.000027809294,0.00000579032,0.00029011793,0.000022243505,0.00004091174,0.000038527243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969341,0.00035577914,0.0007459175,0.0005153155,0.0007307718,0.0007181126],"domain_scores_gemma":[0.99793583,0.00022943893,0.0005093479,0.0006729081,0.00021426009,0.00043822938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021546695,0.00042757526,0.0011031269,0.00030957864,0.000109306384,0.000034368284,0.00016133105,0.00002923831,0.000021389109],"category_scores_gemma":[0.00024977437,0.00021084845,0.00013061136,0.00039127286,0.00048184715,0.00035867508,0.000073737014,0.00007804803,0.0000015748473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035984144,0.002494469,0.5904306,0.0002525539,0.00038138757,0.000004922886,0.0015954144,0.000024961353,0.000025092488,0.000022333503,0.000018452072,0.4011514],"study_design_scores_gemma":[0.012952995,0.0026531972,0.96487755,0.01727183,0.00001665242,0.0000023399473,0.00031818432,0.0000248999,0.0013365478,0.0002870138,0.000025997491,0.00023280294],"about_ca_topic_score_codex":0.0020064379,"about_ca_topic_score_gemma":0.0011572206,"teacher_disagreement_score":0.40091857,"about_ca_system_score_codex":0.00024287992,"about_ca_system_score_gemma":0.0007234284,"threshold_uncertainty_score":0.859815},"labels":[],"label_agreement":null},{"id":"W2555804000","doi":"10.1136/annrheumdis-2016-eular.4242","title":"AB0191 Durability of First Biologic Disease-Modifying Antirheumatic Drug Is Not Influenced by Initial/early DAS28","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Medicine; Antirheumatic drugs; Internal medicine; Population; Drug; Rheumatology; Antirheumatic Agents; Surgery; Pharmacology","score_opus":0.051465725922420984,"score_gpt":0.3293689553802522,"score_spread":0.2779032294578312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555804000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841646,0.0040027653,0.00009389483,0.009499834,0.00024209688,0.00037710503,0.001490715,0.000043354543,0.0000856353],"genre_scores_gemma":[0.99790955,0.00093781704,0.000053860877,0.0007220186,0.0000056833546,0.000018383003,0.000010408281,0.000015287189,0.0003269987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976177,0.0005658609,0.00088499393,0.00037243596,0.00013574198,0.0004232218],"domain_scores_gemma":[0.9967355,0.0014999242,0.0005742532,0.0008957011,0.00019116815,0.0001034262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005443004,0.00028142935,0.00069764646,0.000071869836,0.00019016828,0.00001563724,0.00078007975,0.00014274231,0.0008837274],"category_scores_gemma":[0.0021832304,0.00014012327,0.0004943239,0.000194638,0.0014286661,0.00015601832,0.0002763557,0.00011500602,0.000044286204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042673815,0.0056847804,0.5751442,0.006197906,0.0042859167,0.000005934263,0.0021811863,0.000010380114,0.09633438,0.0038897914,0.112581804,0.1894164],"study_design_scores_gemma":[0.0023727755,0.00033547054,0.6926719,0.004226331,0.0005493332,0.0000044699195,0.00019767198,0.000037781214,0.268601,0.028813908,0.0014818168,0.0007075355],"about_ca_topic_score_codex":0.000111523215,"about_ca_topic_score_gemma":0.0000036888266,"teacher_disagreement_score":0.18870886,"about_ca_system_score_codex":0.000013711855,"about_ca_system_score_gemma":0.0000652128,"threshold_uncertainty_score":0.96761954},"labels":[],"label_agreement":null},{"id":"W2555859840","doi":"10.1136/annrheumdis-2016-eular.3342","title":"FRI0445 Tildrakizumab Treatment Improved Measures of Psoriatic Arthritis in Adults with Chronic Plaque Psoriasis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Internal medicine; Secukinumab; Placebo; Ustekinumab; Arthritis; Clinical endpoint; Gastroenterology; Dermatology; Randomized controlled trial; Rheumatoid arthritis; Adalimumab; Pathology","score_opus":0.022646265567451532,"score_gpt":0.24113012263039724,"score_spread":0.2184838570629457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555859840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97542584,0.022514027,0.000016228898,0.0005661208,0.00028608443,0.00062947307,0.0004447107,0.000028641798,0.00008886915],"genre_scores_gemma":[0.99040246,0.009019685,0.000022292092,0.000016877246,0.000018453016,0.00016567472,0.000023411152,0.000021759843,0.00030937864],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984176,0.00029655086,0.00055296754,0.00028173404,0.0000912638,0.00035987198],"domain_scores_gemma":[0.9984546,0.00038332402,0.0004144097,0.000607423,0.00010047215,0.00003978596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001221309,0.00028399547,0.0006494159,0.000123479,0.000074655974,0.0000057294656,0.00030377513,0.000113207054,0.00023314239],"category_scores_gemma":[0.00016852334,0.00013741197,0.00026987167,0.000188178,0.0002589763,0.00011069428,0.000047987996,0.00003852311,0.00003763918],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002218234,0.0010624289,0.008397027,0.00018886964,0.0014389112,0.000003538124,0.00071392825,0.0000098298315,0.0024987042,0.0002833725,0.00037322505,0.9828119],"study_design_scores_gemma":[0.046589456,0.006137694,0.4593401,0.01622199,0.0013348212,0.000050277187,0.0006730481,0.000021539568,0.46415672,0.002977493,0.0014499035,0.0010469619],"about_ca_topic_score_codex":0.00064080366,"about_ca_topic_score_gemma":0.000957167,"teacher_disagreement_score":0.981765,"about_ca_system_score_codex":0.000066359535,"about_ca_system_score_gemma":0.00025693112,"threshold_uncertainty_score":0.56034976},"labels":[],"label_agreement":null},{"id":"W2555940180","doi":"10.1136/annrheumdis-2016-eular.3997","title":"FRI0593 A Systematic Literature Review of The Prevalence of Psoriatic Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Psoriatic arthritis; Systematic review; CINAHL; Population; MEDLINE; Prevalence; Dactylitis; Family medicine; Disease; Internal medicine; Epidemiology; Enthesitis; Environmental health; Psychological intervention","score_opus":0.01951095878553258,"score_gpt":0.28840384695138355,"score_spread":0.268892888165851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555940180","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1950826,0.7990695,0.000002530832,0.003409328,0.00018726327,0.0015933783,0.0004486641,0.00001033217,0.00019640848],"genre_scores_gemma":[0.6710643,0.3281487,0.000014816752,0.00023355547,0.000009032466,0.00006402503,0.0000010103386,0.00000835844,0.000456215],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99828196,0.00019104626,0.0007384281,0.00013610028,0.00049960095,0.0001528927],"domain_scores_gemma":[0.9977037,0.0003240675,0.0007010821,0.0008903242,0.00032001053,0.000060847753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021192792,0.00015192377,0.0008076788,0.000031709184,0.000049271377,0.0000038785824,0.00027297327,0.000028471852,0.00012770543],"category_scores_gemma":[0.00258627,0.000058073114,0.00051706325,0.0002808406,0.0001949492,0.000061655046,0.00011386232,0.00003565786,0.000005890587],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006039818,0.000551553,0.010953575,0.970218,0.0007841394,0.0000049882433,0.0003657484,1.3940819e-7,0.000042196592,0.00074111874,0.004210417,0.012067746],"study_design_scores_gemma":[0.00088005903,0.00015149736,0.07396496,0.9226003,0.0008239138,0.000026084552,0.00004070365,0.0000014116721,0.00063082523,0.0007914023,0.000027415252,0.000061409286],"about_ca_topic_score_codex":0.000006744505,"about_ca_topic_score_gemma":0.0000016329797,"teacher_disagreement_score":0.4759817,"about_ca_system_score_codex":0.00000921695,"about_ca_system_score_gemma":0.00006795199,"threshold_uncertainty_score":0.30961934},"labels":[],"label_agreement":null},{"id":"W2556163619","doi":"10.1136/annrheumdis-2016-eular.3729","title":"SAT0446 Reference Curves for The Australian/canadian Hand Osteoarthritis Index (AUSCAN) in The General Population","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Physical therapy; Epidemiology; Rheumatology; Logistic regression; Odds ratio; Internal medicine","score_opus":0.056512367321286824,"score_gpt":0.3199659237475449,"score_spread":0.26345355642625806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556163619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551056,0.0034512128,0.000009726129,0.038989272,0.00018878849,0.001608365,0.00039851412,0.000012309228,0.00023620023],"genre_scores_gemma":[0.9958406,0.00088319316,0.000021052287,0.0012578792,0.00005087931,0.00020251425,0.000048318107,0.00001324501,0.0016822926],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988861,0.00010429481,0.0002921775,0.00015115115,0.0002765709,0.00028967363],"domain_scores_gemma":[0.9988892,0.00031709616,0.00012567143,0.00047134046,0.00008263752,0.0001140188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025634523,0.00014063805,0.00023215405,0.00006251169,0.00017861945,0.00003159637,0.00025237093,0.000047378577,0.000116046045],"category_scores_gemma":[0.0003780384,0.000057144523,0.00016203811,0.0001357871,0.00013107013,0.00011264044,0.000022427208,0.00004591108,0.000007908007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038100523,0.00029556672,0.09662376,0.0005429385,0.00015554667,0.00001196205,0.0005478505,0.000008229279,0.0003502578,0.0074161943,0.031313863,0.86235285],"study_design_scores_gemma":[0.0045933304,0.0011354618,0.96189445,0.007747209,0.0003490807,0.000031318134,0.00046047312,0.000030858235,0.0016621107,0.013117815,0.008723473,0.00025441722],"about_ca_topic_score_codex":0.0052691144,"about_ca_topic_score_gemma":0.023429198,"teacher_disagreement_score":0.8652707,"about_ca_system_score_codex":0.000022297281,"about_ca_system_score_gemma":0.000121361714,"threshold_uncertainty_score":0.99439067},"labels":[],"label_agreement":null},{"id":"W2556203638","doi":"10.1136/annrheumdis-2016-eular.2088","title":"THU0045 14-3-3eta Positivity Is Associated with Radiographic Progression despite Patients Achieving Clinical Remission","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cohort; Rheumatoid arthritis; Internal medicine; Radiography; Gastroenterology; Surgery","score_opus":0.028012805986409876,"score_gpt":0.3393344478119936,"score_spread":0.31132164182558375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556203638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971657,0.00064450165,0.00015451029,0.0011768951,0.00016260406,0.0003931821,0.00015666775,0.00001911771,0.00012681764],"genre_scores_gemma":[0.99871975,0.0005843954,0.00008183828,0.00027123786,0.000033374934,0.000031589363,0.00003443178,0.000023765673,0.00021962708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836206,0.00038367716,0.00039823566,0.00030602954,0.0003171768,0.00023279061],"domain_scores_gemma":[0.9983003,0.0001643685,0.00049968896,0.0005978362,0.00029745986,0.0001403168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031971396,0.00017441658,0.0002395003,0.000045034387,0.00015085432,0.000022361568,0.00032374542,0.00011028305,0.000033789718],"category_scores_gemma":[0.0020911624,0.00008787136,0.00031938424,0.0001505456,0.00022250945,0.000020061147,0.00019088715,0.00007825626,0.000004441229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060562755,0.0016073467,0.8646797,0.000084088715,0.0006963584,0.0000010352703,0.00004403802,0.0000028335633,0.010978921,0.000015728665,0.015358599,0.105925746],"study_design_scores_gemma":[0.001183546,0.0008006501,0.95102817,0.0046587577,0.00011239763,0.0000025543638,0.000011622477,0.000015270027,0.040463448,0.00029991474,0.0011644405,0.00025922118],"about_ca_topic_score_codex":0.0000062445565,"about_ca_topic_score_gemma":0.000004770725,"teacher_disagreement_score":0.105666526,"about_ca_system_score_codex":0.000008340046,"about_ca_system_score_gemma":0.000074069285,"threshold_uncertainty_score":0.35832903},"labels":[],"label_agreement":null},{"id":"W2556238235","doi":"10.1136/annrheumdis-2016-eular.1095","title":"THU0222 The Diagnosis of Familial Mediterranean Fever Following The Initial Presentation of Monoarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"MEFV; Familial Mediterranean fever; Medicine; Monoarthritis; Abdominal pain; Arthritis; Internal medicine; Population; Pediatrics; Gene mutation; Mutation; Disease; Genetics","score_opus":0.03326979582327793,"score_gpt":0.3068413600689322,"score_spread":0.27357156424565426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556238235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473476,0.0027335675,0.000033530778,0.0017586375,0.00021546423,0.00024239579,0.00009713339,0.000002307702,0.00018219721],"genre_scores_gemma":[0.99803686,0.0016345691,0.000004229424,0.0001504553,0.000039307426,0.000046846715,0.000015079416,0.000009277079,0.000063392115],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999086,0.00015993694,0.0003146199,0.00009730568,0.00021757474,0.00012452214],"domain_scores_gemma":[0.99907124,0.00015727669,0.0002334015,0.00043423363,0.00008469584,0.000019180528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017196684,0.000092071896,0.00014906166,0.000016620137,0.000076257726,0.0000062752233,0.00040427278,0.00003619827,0.000034749315],"category_scores_gemma":[0.00056753034,0.00003980555,0.00032431734,0.000066316294,0.0002670502,0.00001174568,0.00012550213,0.000023984876,0.0000013091316],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010844424,0.0010962858,0.13173887,0.0006046368,0.0029395423,0.0000022475442,0.0054845205,0.00023569069,0.13156153,0.0008138363,0.06391885,0.66051954],"study_design_scores_gemma":[0.001559595,0.00030316444,0.16278897,0.00073565164,0.00021599399,0.000001486679,0.0017638925,0.000033619468,0.82798904,0.002710547,0.0016959241,0.00020212849],"about_ca_topic_score_codex":0.000083136765,"about_ca_topic_score_gemma":0.000020271133,"teacher_disagreement_score":0.6964275,"about_ca_system_score_codex":0.0000012661336,"about_ca_system_score_gemma":0.000048425492,"threshold_uncertainty_score":0.16232231},"labels":[],"label_agreement":null},{"id":"W2556298093","doi":"10.1136/annrheumdis-2016-eular.2402","title":"FRI0268 Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from The Open-Label Period of The Fasscinate Trial","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Tocilizumab; Placebo; Internal medicine; Gastroenterology; Adverse effect; Randomized controlled trial; Open label; Clinical trial; Rheumatoid arthritis; Pathology","score_opus":0.07402716531058635,"score_gpt":0.3010191833609156,"score_spread":0.22699201805032926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556298093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940695,0.013588902,0.0000012419958,0.003270171,0.0002858329,0.0022093093,0.0010520824,0.0000129570335,0.00017255229],"genre_scores_gemma":[0.9960252,0.003606029,0.000005361166,0.000094387724,0.00003372549,0.000034577777,0.0000054127527,0.000022180386,0.00017310664],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99686015,0.0005735,0.0013933171,0.0003169114,0.00060906785,0.0002470667],"domain_scores_gemma":[0.995641,0.0017786088,0.0010172157,0.0012408452,0.00019883514,0.00012348144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000630114,0.00022538906,0.0008411666,0.00005048016,0.0001215662,0.000031498803,0.00091710297,0.000107006534,0.000027037897],"category_scores_gemma":[0.0028213947,0.00008536655,0.0002747582,0.00031330303,0.00046954822,0.000098863624,0.00040796027,0.00010196651,0.000003582812],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56762713,0.01254616,0.07177405,0.0037299003,0.0060139247,0.000035142206,0.021518618,0.00015457698,0.029339414,0.0021989753,0.008653005,0.2764091],"study_design_scores_gemma":[0.122219145,0.0010833011,0.7835537,0.08648329,0.0012524447,0.00003408084,0.0021066547,0.00010706816,0.0022723002,0.0005922971,0.000023408016,0.00027229433],"about_ca_topic_score_codex":0.0013029834,"about_ca_topic_score_gemma":0.000027298282,"teacher_disagreement_score":0.71177965,"about_ca_system_score_codex":0.000031545424,"about_ca_system_score_gemma":0.0002740758,"threshold_uncertainty_score":0.3481147},"labels":[],"label_agreement":null},{"id":"W2556469126","doi":"10.1136/annrheumdis-2016-eular.5731","title":"OP0003 Development of A Glucocorticoid Toxicity Index Using Multi-Criteria Decision Analysis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Toxicity; Limiting; Clinical trial; Internal medicine","score_opus":0.4763934643158192,"score_gpt":0.4816172165723984,"score_spread":0.005223752256579228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556469126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93226653,0.0010333196,0.06413163,0.0015872687,0.0001969416,0.00040006728,0.00032730118,0.000011440185,0.00004551889],"genre_scores_gemma":[0.99271166,0.000085664564,0.006375658,0.0006856125,0.000014376762,0.000020411848,0.00000426613,0.000015531812,0.00008681562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951107,0.00022628192,0.0039074104,0.00032079755,0.00016830592,0.00026648864],"domain_scores_gemma":[0.99492246,0.0010721721,0.0029869261,0.0007495339,0.00013474333,0.00013414516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004034467,0.00016086751,0.0011128966,0.00038482703,0.000107064436,0.000024439969,0.00044397943,0.000064246386,0.0005352957],"category_scores_gemma":[0.005269175,0.00012205483,0.0003742869,0.00045023445,0.000099143814,0.00028866742,0.00014594563,0.00003325605,0.000113288035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001253949,0.001142745,0.9638527,0.0015428485,0.0026670636,3.2882403e-7,0.0026857718,0.002136817,0.00016526258,0.004587202,0.0018601248,0.019233717],"study_design_scores_gemma":[0.0009163318,0.000026851652,0.96131164,0.0010905078,0.00009921191,5.5604227e-7,0.0003437013,0.027491659,0.0006376055,0.007404045,0.0003834724,0.00029440646],"about_ca_topic_score_codex":0.00021630414,"about_ca_topic_score_gemma":0.000058004574,"teacher_disagreement_score":0.060445152,"about_ca_system_score_codex":0.000114728,"about_ca_system_score_gemma":0.00024028221,"threshold_uncertainty_score":0.6308075},"labels":[],"label_agreement":null},{"id":"W2556747255","doi":"10.1136/annrheumdis-2016-eular.1858","title":"SAT0405 No Radiological Sacroiliac Joint Progression after 2 Years of Etanercept Treatment in Non-Radiographic Axial Spondyloarthritis: Data from The Embark Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Etanercept; Sacroiliac joint; Radiography; Radiological weapon; Sacroiliitis; Internal medicine; Axial spondyloarthritis; Grading (engineering); Placebo; Ankylosing spondylitis; Concomitant; Surgery; Nuclear medicine; Radiology; Tumor necrosis factor alpha; Pathology","score_opus":0.05920385663461138,"score_gpt":0.3320506954867499,"score_spread":0.27284683885213856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556747255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705935,0.00903238,0.000001118205,0.0009458394,0.00018151621,0.0015285984,0.0011881959,0.000016534916,0.000046470483],"genre_scores_gemma":[0.99454814,0.0048929513,0.00006027381,0.00009520865,0.00006551524,0.00021042296,0.00005407341,0.000019656589,0.000053727428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794465,0.00026634737,0.0006142833,0.00041031733,0.00046026643,0.0003041613],"domain_scores_gemma":[0.9977216,0.000416809,0.00024606558,0.001424751,0.00007724507,0.00011348861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021523511,0.00024745218,0.00075851794,0.000071958755,0.00007020624,0.000012701054,0.000378845,0.000057073245,0.00031172897],"category_scores_gemma":[0.0004793534,0.00010490893,0.00031323184,0.0002300653,0.0004067137,0.000094048526,0.00031960316,0.0000651597,0.000031212257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00206333,0.004822202,0.806133,0.00005073861,0.0009925071,0.00017026364,0.0011217911,7.3803415e-7,0.00011486513,0.0000058949327,0.0020194168,0.18250526],"study_design_scores_gemma":[0.005191179,0.0016506675,0.9891318,0.0024357934,0.00033628667,0.000008019391,0.0006642136,0.000010342898,0.00006668513,0.00022496298,0.00016453824,0.000115484014],"about_ca_topic_score_codex":0.000534393,"about_ca_topic_score_gemma":0.00026114148,"teacher_disagreement_score":0.18299884,"about_ca_system_score_codex":0.000026606174,"about_ca_system_score_gemma":0.000071525385,"threshold_uncertainty_score":0.42780623},"labels":[],"label_agreement":null},{"id":"W2556816460","doi":"10.1136/annrheumdis-2016-eular.3020","title":"SAT0423 Patient-Reported Quality of Life in Patients with Baseline Objective Signs of Inflammation and Active Nonradiographic Axial Spondyloarthritis Treated with Golimumab: Results of The Open-Label Extension of A Randomized, Double-Blind Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Golimumab; Placebo; Quality of life (healthcare); Physical therapy; Ankylosing spondylitis; Internal medicine; Dermatology Life Quality Index; Randomized controlled trial; Adalimumab; Disease","score_opus":0.053405005891387566,"score_gpt":0.31665959159755586,"score_spread":0.2632545857061683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556816460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324673,0.00052808085,0.000003620495,0.00013770537,0.00002523878,0.0053551234,0.0006605994,0.000005244159,0.000037642938],"genre_scores_gemma":[0.9994757,0.00029643107,0.000030186764,0.000008875783,0.0000038135581,0.00012999306,0.00002988098,0.000017566612,0.0000075486178],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99648184,0.0007011282,0.0016051163,0.00029857393,0.0007427718,0.00017055482],"domain_scores_gemma":[0.9945301,0.00092932663,0.002590713,0.0006508841,0.0012140675,0.00008493721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070513407,0.00024499756,0.0016629694,0.00020546277,0.000058766684,0.0000050820568,0.00015882256,0.000048000646,0.000007610204],"category_scores_gemma":[0.002013396,0.000107205946,0.00017313474,0.0006477932,0.0006335301,0.0001742825,0.00015516374,0.00005652798,7.575744e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5679771,0.0057600406,0.41491637,0.00021531283,0.0019989805,0.000002424576,0.0016651833,0.000009878601,0.00019571323,0.00002277965,0.000008463874,0.007227821],"study_design_scores_gemma":[0.38461417,0.003385625,0.6038051,0.0037528763,0.0006021659,9.3186947e-7,0.00087691826,0.000007467635,0.0027861525,0.000083787345,1.2785317e-7,0.0000846529],"about_ca_topic_score_codex":0.0030510123,"about_ca_topic_score_gemma":0.000661904,"teacher_disagreement_score":0.18888877,"about_ca_system_score_codex":0.000017155264,"about_ca_system_score_gemma":0.00016464188,"threshold_uncertainty_score":0.46122384},"labels":[],"label_agreement":null},{"id":"W2556851961","doi":"10.1136/annrheumdis-2016-eular.3697","title":"AB0748 Novel Biomarkers Distinguish Psoriatic Arthritis from Psoriasis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Internal medicine; Gastroenterology; Arthritis; Immunology","score_opus":0.03587489225925086,"score_gpt":0.2978954038677882,"score_spread":0.26202051160853734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556851961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966252,0.017828232,0.0002966714,0.012420454,0.0006719355,0.00057727844,0.0009133459,0.000098195684,0.00094185385],"genre_scores_gemma":[0.97503906,0.023810627,0.00029598622,0.00038739791,0.0001279687,0.000048878293,0.000018970317,0.000035822515,0.00023528408],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978599,0.000114624476,0.0005736688,0.00029316166,0.00072049384,0.00043815598],"domain_scores_gemma":[0.9975629,0.0007741453,0.00026399508,0.00081399415,0.00024349734,0.00034147268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023328312,0.00022522632,0.00054625486,0.000099996985,0.00014370639,0.000042281234,0.00036777416,0.00005523871,0.0008654421],"category_scores_gemma":[0.0043088463,0.0001209633,0.0004249939,0.00023906204,0.0004460512,0.00016223968,0.0001354385,0.00006961509,0.00008798691],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005515489,0.0008225998,0.016338948,0.00017276441,0.0014825636,0.000011886908,0.0003183421,6.6236976e-7,0.0016352701,0.0015146494,0.039363693,0.93778706],"study_design_scores_gemma":[0.015694039,0.00074385985,0.8643068,0.027978571,0.0001715196,0.000056885256,0.0007545172,0.00018697172,0.017613119,0.043123253,0.028477915,0.0008925284],"about_ca_topic_score_codex":0.00036751828,"about_ca_topic_score_gemma":0.000032658736,"teacher_disagreement_score":0.93689454,"about_ca_system_score_codex":0.000018951361,"about_ca_system_score_gemma":0.00017454682,"threshold_uncertainty_score":0.94759846},"labels":[],"label_agreement":null},{"id":"W2556872993","doi":"10.1136/annrheumdis-2016-eular.3013","title":"SAT0399 Efficacy of Golimumab for Nonradiographic Axial Spondyloarthritis: Subgroup Analysis by Baseline MRI and C-Reactive Protein Status","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; C-reactive protein; Internal medicine; Golimumab; Clinical endpoint; Gastroenterology; Sacroiliitis; Placebo; Randomized controlled trial; Adalimumab; Ankylosing spondylitis; Nuclear medicine; Disease; Inflammation; Pathology","score_opus":0.016929691803918373,"score_gpt":0.28540775959153847,"score_spread":0.26847806778762007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556872993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98186916,0.012216126,0.0002329689,0.00143068,0.000041423737,0.0013448597,0.0028036616,0.000021522497,0.000039572566],"genre_scores_gemma":[0.9965946,0.002711435,0.0001987025,0.00006922429,0.000023122106,0.00016569563,0.00008075478,0.000023460158,0.00013301623],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983674,0.00010220869,0.0005156856,0.0003064416,0.00035117648,0.00035704786],"domain_scores_gemma":[0.9981079,0.000602143,0.00036324127,0.00047425102,0.00024506415,0.00020737396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001952424,0.00023215103,0.000818489,0.00020755202,0.00010594376,0.000010366792,0.00011158174,0.000050564955,0.000076794284],"category_scores_gemma":[0.00081720366,0.00013170428,0.0006388451,0.00050568715,0.00037704632,0.00009517061,0.000066712644,0.00003835102,0.0000016717681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0157606,0.010261506,0.45516056,0.0023169455,0.032943618,0.00003205277,0.0013800679,0.000010280062,0.008274867,0.0016134598,0.010871658,0.46137437],"study_design_scores_gemma":[0.026586758,0.0030428506,0.93586224,0.004906891,0.008026684,0.000013255439,0.0005964595,0.00013070258,0.016175944,0.0024307775,0.001685803,0.0005416516],"about_ca_topic_score_codex":0.00024859884,"about_ca_topic_score_gemma":0.00005428748,"teacher_disagreement_score":0.48070166,"about_ca_system_score_codex":0.000016036774,"about_ca_system_score_gemma":0.000065136184,"threshold_uncertainty_score":0.53707445},"labels":[],"label_agreement":null},{"id":"W2556888886","doi":"10.1136/annrheumdis-2016-eular.4865","title":"FRI0503 Efficacy and Safety of Canakinumab in Patients with Cryopyrin Associated Periodic Syndromes: An Open-Label, Phase-III, Extension Study","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Canakinumab; Internal medicine; Rheumatology; Adverse effect; Pediatrics; Anakinra; Disease","score_opus":0.02603817161413529,"score_gpt":0.30525184950451056,"score_spread":0.27921367789037527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556888886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858683,0.00041755318,0.0000034113057,0.00008162919,0.000026873318,0.00075366086,0.00009758075,0.0000035152252,0.000028924404],"genre_scores_gemma":[0.9996392,0.00016476942,0.0000072055896,0.000049996037,0.0000020909156,0.000017871613,0.00005005975,0.000015591133,0.000053188825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885494,0.00017561163,0.00036577042,0.00023331282,0.00018757804,0.0001827641],"domain_scores_gemma":[0.9989943,0.00003255646,0.00026990147,0.00048892846,0.00015712217,0.00005720941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019442732,0.00014880461,0.0003158537,0.000043404667,0.00007406939,0.000016809587,0.00036585238,0.000043302836,0.000023572138],"category_scores_gemma":[0.00031707564,0.00008349309,0.000029475377,0.00011171314,0.0001420582,0.000022664117,0.00022036501,0.000029011579,5.392058e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017990567,0.04203554,0.7930102,0.0002571538,0.0019498601,0.0000064748147,0.002513662,0.000048047434,0.01704893,0.00006047181,0.001619098,0.12346004],"study_design_scores_gemma":[0.021657271,0.003946793,0.97137845,0.0005876747,0.00007075293,4.0282652e-7,0.00045765997,0.000010256603,0.0016231347,0.000051453666,0.000034353943,0.00018179498],"about_ca_topic_score_codex":0.0002532869,"about_ca_topic_score_gemma":0.00017109544,"teacher_disagreement_score":0.1783683,"about_ca_system_score_codex":0.0000069791076,"about_ca_system_score_gemma":0.00009554403,"threshold_uncertainty_score":0.34047493},"labels":[],"label_agreement":null},{"id":"W2556895356","doi":"10.1136/annrheumdis-2016-eular.3644","title":"THU0421 Serum-Based Soluble Markers May Differentiate Psoriatic Arthritis from Osteoarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Krembil Foundation","funders":"Ministerul Cercetării, Inovării şi Digitalizării","keywords":"Medicine; Psoriatic arthritis; Internal medicine; BASDAI; Adiponectin; Resistin; Receiver operating characteristic; Osteoarthritis; Arthritis; Oncology; Gastroenterology; Pathology; Insulin resistance; Insulin","score_opus":0.024779453395109306,"score_gpt":0.27842523750953807,"score_spread":0.2536457841144288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556895356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641629,0.019196087,0.00013248413,0.0138819525,0.0005861618,0.0007342013,0.000755404,0.00010583517,0.00044498127],"genre_scores_gemma":[0.9764059,0.021956706,0.000111953916,0.00066095626,0.00007091941,0.00009181929,0.00003481791,0.0000515838,0.00061529584],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971837,0.00030068372,0.00065246195,0.00036368967,0.0008814193,0.0006180399],"domain_scores_gemma":[0.99743336,0.00065458025,0.00027833518,0.0009900801,0.00022034389,0.00042328495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022654301,0.00030596848,0.0007049907,0.00013117181,0.00019247606,0.00006858158,0.00041691383,0.000076782504,0.002964236],"category_scores_gemma":[0.00095832144,0.0001740111,0.000557496,0.00021646399,0.0004842527,0.00023126052,0.00013895865,0.00011320258,0.0001658684],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009693427,0.00064300984,0.03310488,0.00026256638,0.00066364097,0.000027462936,0.00014474617,0.000003114512,0.00069606217,0.00047578837,0.023627454,0.93938196],"study_design_scores_gemma":[0.023927856,0.0017416994,0.8627114,0.035423767,0.00015578954,0.00003501123,0.00043407234,0.00037024848,0.032764137,0.030264301,0.011164512,0.0010071623],"about_ca_topic_score_codex":0.00020238265,"about_ca_topic_score_gemma":0.0000826835,"teacher_disagreement_score":0.93837476,"about_ca_system_score_codex":0.000021683318,"about_ca_system_score_gemma":0.00025516187,"threshold_uncertainty_score":0.9979472},"labels":[],"label_agreement":null},{"id":"W2557038733","doi":"10.1136/annrheumdis-2016-eular.4199","title":"AB0206 Treatment Patterns in Rheumatoid Arthritis after Methotrexate: Data from The Ontario Best Practice Research Initiatives Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; St Joseph's Health Centre","funders":"","keywords":"Medicine; Hydroxychloroquine; Discontinuation; Rheumatoid arthritis; Internal medicine; Leflunomide; Sulfasalazine; Methotrexate; Cohort; Disease","score_opus":0.16683013144668365,"score_gpt":0.43019678875837863,"score_spread":0.26336665731169495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557038733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97886074,0.0074950885,0.000023692979,0.00987192,0.00010429926,0.0014128265,0.001123868,0.000019390889,0.0010881566],"genre_scores_gemma":[0.9651591,0.033113834,0.0001016511,0.00036522152,0.000055934262,0.00031664828,0.00009518113,0.00003951111,0.0007529155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950824,0.0014403483,0.00072373566,0.0006050389,0.0014978831,0.0006506107],"domain_scores_gemma":[0.9871241,0.008919921,0.00024635042,0.0030578782,0.00040100585,0.00025073465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018362926,0.00027160216,0.00061919005,0.0001252948,0.00013733674,0.000073017225,0.0010877108,0.00008446358,0.0013771352],"category_scores_gemma":[0.0074204803,0.00012166666,0.00018057524,0.00035125267,0.00062922196,0.00060915545,0.00092144543,0.00026243425,0.00019732029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004756263,0.0056542684,0.7757789,0.00030269907,0.0030828244,0.00057138636,0.010389174,0.000007716581,0.000045857018,0.00017743696,0.015706385,0.18352708],"study_design_scores_gemma":[0.0124316,0.0006549306,0.9591349,0.013068256,0.00022599557,0.000084382256,0.003390186,0.0002457563,0.0012117655,0.0018600133,0.007384703,0.0003075106],"about_ca_topic_score_codex":0.18525265,"about_ca_topic_score_gemma":0.060026973,"teacher_disagreement_score":0.183356,"about_ca_system_score_codex":0.0023488821,"about_ca_system_score_gemma":0.0059046275,"threshold_uncertainty_score":0.99973094},"labels":[],"label_agreement":null},{"id":"W2557069156","doi":"10.1136/annrheumdis-2016-eular.2102","title":"SAT0520 Indications and Clinical Impacts of Magnetic Resonance Imaging of The Knee in Older Patients: Are We Choosing Wisely?","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Knee injuries and reconstruction techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Magnetic resonance imaging; Osteoarthritis; Orthopedic surgery; Radiography; Retrospective cohort study; Medical record; Radiology; Specialty; Population; Physical therapy; Surgery; Pathology","score_opus":0.021673982002253327,"score_gpt":0.3260987299682372,"score_spread":0.30442474796598384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557069156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98699117,0.005987645,0.000007467353,0.006414457,0.000069896356,0.0003683433,0.00007921007,0.000010037979,0.00007179184],"genre_scores_gemma":[0.9967541,0.0029241806,0.00010099245,0.0001587972,0.000008982721,0.000007591902,7.045623e-7,0.000008219613,0.000036416477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988647,0.00009256261,0.0006418796,0.00010746301,0.000185798,0.00010755979],"domain_scores_gemma":[0.99862915,0.00024009057,0.0005592367,0.00036930016,0.0001421586,0.00006008449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001819818,0.00008069786,0.00031218457,0.00007831076,0.00003491382,0.0000039053502,0.00012417119,0.00003215325,0.000047714533],"category_scores_gemma":[0.0010497037,0.000037100253,0.00015792697,0.00016256202,0.0005971536,0.00007377227,0.00008521903,0.000057184534,3.6499978e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030123274,0.00022539195,0.833932,0.00019983025,0.000013361135,6.508274e-8,0.00008666159,4.318989e-8,0.000016562932,0.00007533707,0.0011009229,0.1643197],"study_design_scores_gemma":[0.0006984044,0.00007605123,0.98886627,0.0065986123,0.000057515503,0.0000021036856,0.00017624756,0.000009290834,0.0010057555,0.0023899365,0.00007564063,0.000044161974],"about_ca_topic_score_codex":0.00003272038,"about_ca_topic_score_gemma":0.000005952971,"teacher_disagreement_score":0.16427553,"about_ca_system_score_codex":0.00000864256,"about_ca_system_score_gemma":0.00007216763,"threshold_uncertainty_score":0.22002372},"labels":[],"label_agreement":null},{"id":"W2557091385","doi":"10.1136/annrheumdis-2016-eular.4093","title":"FRI0562 Attrition and Participant Characteristics in A Rheumatoid Arthritis Cohort","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Generalizability theory; Rheumatoid arthritis; Cohort; Attrition; Physical therapy; Internal medicine; Observational study; Cohort study; Surgery","score_opus":0.052332581925954226,"score_gpt":0.30975735804566196,"score_spread":0.2574247761197077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557091385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98051715,0.013052165,0.00001847312,0.005599115,0.00008029749,0.0004904062,0.00012421692,0.000027573615,0.000090603666],"genre_scores_gemma":[0.8438735,0.15577906,0.000023503377,0.00015688986,0.000014441782,0.000073603056,0.000006710296,0.000015707099,0.000056562792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830335,0.00013864135,0.0005955863,0.00020418206,0.00039550758,0.00036272564],"domain_scores_gemma":[0.99879724,0.00029220182,0.00017244737,0.00038628516,0.00012362382,0.00022821224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036767992,0.00015090728,0.00056437746,0.00011104257,0.00007327201,0.000026441843,0.00012266828,0.000043363787,0.00020476055],"category_scores_gemma":[0.0014756068,0.00008515834,0.00012910523,0.00015379794,0.00037584544,0.00016089954,0.00008649589,0.00007094128,0.000023637316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003726045,0.0005568148,0.72620934,0.00025749792,0.00022097613,0.000022334558,0.00033290585,1.8062339e-7,0.0008918844,0.0016579918,0.0022654166,0.26721203],"study_design_scores_gemma":[0.0018955941,0.00016954937,0.984295,0.007745438,0.000007785575,0.000048479378,0.00011119335,0.00004553493,0.001262605,0.0034332206,0.00085791154,0.00012768377],"about_ca_topic_score_codex":0.00008373847,"about_ca_topic_score_gemma":0.00002828799,"teacher_disagreement_score":0.26708436,"about_ca_system_score_codex":0.000011311266,"about_ca_system_score_gemma":0.00011024837,"threshold_uncertainty_score":0.34726563},"labels":[],"label_agreement":null},{"id":"W2557139856","doi":"10.1136/annrheumdis-2016-eular.1848","title":"THU0444 Subclinical Ultrasonographic Enthesitis in Patients with Psoriasis Is Associated with Risk Markers for Psoriatic Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Women's College Hospital","funders":"","keywords":"Enthesitis; Medicine; Psoriatic arthritis; Enthesis; Subclinical infection; Psoriasis; Enthesopathy; Spondyloarthropathy; Plantar fascia; Dermatology; Internal medicine; Arthritis; Pathology; Tendon; Plantar fasciitis","score_opus":0.01716287657264265,"score_gpt":0.2604114050599314,"score_spread":0.24324852848728873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557139856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532723,0.0009629358,0.000010255355,0.0012570028,0.00008896468,0.0012114163,0.0010583529,0.000026116364,0.00005769756],"genre_scores_gemma":[0.9962472,0.003115952,0.00007263051,0.00022731164,0.000014527022,0.0001856072,0.000029421739,0.000034218792,0.000073133204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824053,0.00012963875,0.00048599098,0.00029771586,0.00046585104,0.00038024382],"domain_scores_gemma":[0.99762756,0.0011103633,0.0004354675,0.0004334158,0.00024496176,0.00014822377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020357592,0.00024152455,0.0006785964,0.00009755372,0.00012324881,0.00001282929,0.00013581499,0.000059835238,0.00009692878],"category_scores_gemma":[0.0015634026,0.00011512281,0.00029938715,0.0003066972,0.00025254476,0.000102973405,0.000030349334,0.00005970875,0.0000045289557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022680066,0.001360708,0.885221,0.00006471691,0.0013811459,0.000004250778,0.00013630505,5.2440276e-7,1.7653063e-7,0.00002327966,0.001204734,0.10833516],"study_design_scores_gemma":[0.016009985,0.0019473004,0.9748186,0.005749882,0.000555298,0.0000013764483,0.000120589,0.000005043204,0.000039823684,0.0005412797,0.00004780769,0.00016301378],"about_ca_topic_score_codex":0.0000867006,"about_ca_topic_score_gemma":0.0001619143,"teacher_disagreement_score":0.10817215,"about_ca_system_score_codex":0.000029080693,"about_ca_system_score_gemma":0.00007591588,"threshold_uncertainty_score":0.4694572},"labels":[],"label_agreement":null},{"id":"W2557156928","doi":"10.1136/annrheumdis-2016-eular.1776","title":"THU0394 MRI Assessment of Axial Involvement in Inflammatory Bowel Disease-Related SPA: Age at Disease Diagnosis, Not Extent and Severity of Axial Disease, Relates To HLA-B27","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Ankylosing spondylitis; Sacroiliitis; Spondyloarthropathy; Inflammatory bowel disease; Rheumatology; Psoriatic arthritis; Magnetic resonance imaging; Axial skeleton; HLA-B27; Enthesitis; Spondylitis; Dactylitis; Internal medicine; BASDAI; Radiology; Disease; Human leukocyte antigen","score_opus":0.0250946487672756,"score_gpt":0.2975299714804842,"score_spread":0.2724353227132086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557156928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98395956,0.0071444497,0.0000041548237,0.005431929,0.00020881329,0.0016981809,0.0014745982,0.000028404755,0.000049893933],"genre_scores_gemma":[0.99101275,0.0080060065,0.000043213222,0.00024427904,0.000025300105,0.0003656195,0.000057943176,0.000037859016,0.0002070224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968644,0.0001994807,0.0010971846,0.00049551844,0.0008999162,0.00044353158],"domain_scores_gemma":[0.9971129,0.00039650724,0.00051319407,0.0008759061,0.00018575086,0.00091574964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026303035,0.00039511573,0.0008173922,0.00018219922,0.00012804543,0.000014268791,0.00025392426,0.000056089262,0.00018988899],"category_scores_gemma":[0.00080824853,0.00024598022,0.00046265265,0.00021851304,0.0004991878,0.00015798287,0.00061336544,0.00008180203,0.0000070363444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024098312,0.00259053,0.9860087,0.0014922243,0.00064976676,0.00014593871,0.00029737933,0.00006207749,0.00006928756,0.000652806,0.0017260143,0.003895416],"study_design_scores_gemma":[0.0040385164,0.0002831387,0.9854851,0.006842555,0.0007160709,9.461231e-7,0.00010476204,0.0000857436,0.00025808054,0.0018161002,0.0001217536,0.00024726195],"about_ca_topic_score_codex":0.00016068801,"about_ca_topic_score_gemma":0.00007977381,"teacher_disagreement_score":0.007053182,"about_ca_system_score_codex":0.00013000207,"about_ca_system_score_gemma":0.00028390615,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W2557167765","doi":"10.1136/annrheumdis-2016-eular.5764","title":"THU0644-HPR E-Learning: An Effective Method To Improve Disease Knowledge and Self-Efficacy for Patients with Axial Spondyloarthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Ankylosing spondylitis; Physical therapy; Axial spondyloarthritis; Disease; Spondylitis; Patient education; Family medicine; Internal medicine","score_opus":0.012619804771223517,"score_gpt":0.318260904358307,"score_spread":0.30564109958708346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557167765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218816,0.0024020828,0.00076245447,0.001188314,0.0000889732,0.0028829663,0.0003378456,0.00007746484,0.000071748706],"genre_scores_gemma":[0.9971886,0.0011262526,0.0008929768,0.00010970557,0.000057595542,0.00039445778,0.000020639472,0.000047336995,0.0001624274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99816585,0.00036174402,0.00029048094,0.00038042897,0.00038324227,0.000418252],"domain_scores_gemma":[0.99699986,0.0011497692,0.00013857706,0.00045477378,0.00046536908,0.0007916669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033425115,0.00023960158,0.00046957,0.00011913096,0.00020533906,0.000043631324,0.00019796668,0.000036845893,0.000049698458],"category_scores_gemma":[0.002044013,0.00012306048,0.00018569554,0.00016030946,0.00018272742,0.0002383002,0.00011950086,0.00007422166,0.000012683242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051776166,0.0036525475,0.04257898,0.0004975842,0.00045473897,0.0000031325665,0.0009218518,0.0000029622302,0.00012401112,0.00067215087,0.00097535906,0.9449391],"study_design_scores_gemma":[0.010531419,0.0060197315,0.9702314,0.0031266497,0.000098398836,0.000003671435,0.00009151186,0.00014533549,0.0010661094,0.0018787266,0.006488359,0.0003186934],"about_ca_topic_score_codex":0.000013878444,"about_ca_topic_score_gemma":0.0000062404765,"teacher_disagreement_score":0.9446204,"about_ca_system_score_codex":0.000019593894,"about_ca_system_score_gemma":0.00016436468,"threshold_uncertainty_score":0.5018261},"labels":[],"label_agreement":null},{"id":"W2557230747","doi":"10.1136/annrheumdis-2016-eular.1595","title":"THU0198 Baricitinib Effects on Lipid and NMR-Measured Lipoprotein Profiles in A Phase 3 Study in Patients with Rheumatoid Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Lipoprotein; Placebo; Very low-density lipoprotein; Lipid profile; Methotrexate; Adalimumab; Endocrinology; Gastroenterology; Nuclear medicine; Cholesterol; Pathology","score_opus":0.01738263826612206,"score_gpt":0.284696211762759,"score_spread":0.2673135734966369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557230747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238664,0.0030647044,0.00000286228,0.0011425775,0.00004759073,0.0031842918,0.000069929025,0.000031066516,0.000070361864],"genre_scores_gemma":[0.993965,0.0054599843,0.000019625055,0.00010305479,0.000014763974,0.0003714224,0.0000066850125,0.000035436013,0.00002402229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973612,0.00042287598,0.00056222506,0.00036155648,0.0008353816,0.00045680246],"domain_scores_gemma":[0.9983666,0.0004935946,0.00019536725,0.00055931695,0.00015585727,0.00022924272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042449715,0.0002782434,0.0007234615,0.0002955306,0.000079156875,0.000035813937,0.00020057803,0.000047189187,0.000051685856],"category_scores_gemma":[0.0016244657,0.0001430454,0.000096017575,0.00035091318,0.00023782617,0.000204195,0.0000896371,0.00014058422,0.000012240946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035421508,0.006358982,0.5895353,0.00025387178,0.00015865114,0.000022783199,0.00076389534,0.0000010822158,0.000052904743,0.00008613106,0.00027541278,0.39894882],"study_design_scores_gemma":[0.031326618,0.004784026,0.94524777,0.016335161,0.0000054201323,0.0000036941187,0.00029116098,0.000012396224,0.0012538821,0.00049449364,0.000046023826,0.00019933721],"about_ca_topic_score_codex":0.00019589525,"about_ca_topic_score_gemma":0.00014440373,"teacher_disagreement_score":0.39874947,"about_ca_system_score_codex":0.000024292507,"about_ca_system_score_gemma":0.00013486191,"threshold_uncertainty_score":0.58332217},"labels":[],"label_agreement":null},{"id":"W2559250903","doi":"10.1136/annrheumdis-2016-209632","title":"GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes","year":2016,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Japan Society for the Promotion of Science; Ministry of Defense; Jikei University School of Medicine; Gout Research Foundation of Japan; University of Tokyo; Université Paris Diderot; Ministry of Health, Labour and Welfare; Health Research Council of New Zealand; Radboud Universitair Medisch Centrum; Centre Hospitalier Universitaire Vaudois; Radboud Universiteit; Ministry of Education, Culture, Sports, Science and Technology; Université de Lausanne; National Defense Medical College; Institut National de la Santé et de la Recherche Médicale; University of Otago","keywords":"Gout; Genome-wide association study; Single-nucleotide polymorphism; Medicine; Hyperuricemia; Genetics; Genetic association; Uric acid; Internal medicine; Biology; Genotype; Gene","score_opus":0.11141123410233494,"score_gpt":0.3745124787239848,"score_spread":0.26310124462164985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559250903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05980993,0.9368267,0.000022192797,0.0003885719,0.00019021043,0.001377367,0.001275367,0.000045006305,0.00006465638],"genre_scores_gemma":[0.12731287,0.87186915,0.00008970001,0.00009646091,0.00004470681,0.000055540022,0.00013938987,0.000052414656,0.00033976045],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99579287,0.000409514,0.0021506231,0.000569987,0.00069167593,0.0003853052],"domain_scores_gemma":[0.99431413,0.0017907175,0.0018027975,0.0015508332,0.00027073766,0.0002707985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087738625,0.00057265256,0.0031779546,0.00014537318,0.0000879553,0.000023372282,0.00060449843,0.0002939368,0.00023809749],"category_scores_gemma":[0.0023264885,0.0003010595,0.0015033489,0.00022377414,0.0008239147,0.00013665097,0.00025495517,0.00021829113,0.000030558418],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004188845,0.0008816425,0.052403677,0.11285369,0.0029989309,0.000013910718,0.0003638094,7.764704e-7,0.000013315598,0.000023993754,0.0028109716,0.8272164],"study_design_scores_gemma":[0.00858402,0.0016488753,0.27289447,0.40927377,0.052514568,0.0003029672,0.00087414007,0.00005592488,0.0008670325,0.006471176,0.2427256,0.0037874593],"about_ca_topic_score_codex":0.0000795172,"about_ca_topic_score_gemma":0.000023170302,"teacher_disagreement_score":0.8234289,"about_ca_system_score_codex":0.000024919114,"about_ca_system_score_gemma":0.0004794366,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W2559330783","doi":"10.1136/annrheumdis-2016-210726","title":"Response to: ‘Criteria for CAPS, is it all in the name?‘ by Touitou and Sarrabay","year":2016,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Medicine","score_opus":0.0656740706773399,"score_gpt":0.3637304167647382,"score_spread":0.29805634608739834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559330783","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05806946,0.002240738,0.000009771803,0.93546534,0.00020689465,0.001117364,0.0027039857,0.000011890442,0.00017458366],"genre_scores_gemma":[0.054974288,0.0008713494,0.00003180911,0.93453807,0.0002566578,0.00030101294,0.00023277724,0.000047545047,0.00874651],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983269,0.000310357,0.0004277361,0.00025474612,0.00034464203,0.0003355974],"domain_scores_gemma":[0.9974528,0.0014547559,0.00016142029,0.00070447364,0.00012663288,0.0000999303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034293605,0.00023333606,0.00045606148,0.000114497045,0.00008172939,0.000038085363,0.00035680513,0.0002461763,0.00036847498],"category_scores_gemma":[0.0011458879,0.00010950551,0.00027876193,0.00009842229,0.00017833413,0.000048316306,0.000064973414,0.00027457543,0.000025696692],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030642573,0.000075590266,0.000029618595,0.00023607956,0.0005527381,0.000013643089,0.0012263278,6.849134e-8,0.00020419518,0.000013615274,0.9957806,0.0015611285],"study_design_scores_gemma":[0.0010926272,0.00036424713,0.004042255,0.0038509043,0.0014494781,0.000031075044,0.00033103325,0.000011467858,0.00017539767,0.0019049254,0.9865062,0.00024037303],"about_ca_topic_score_codex":0.00004679242,"about_ca_topic_score_gemma":0.0000018415051,"teacher_disagreement_score":0.009274353,"about_ca_system_score_codex":0.000014950359,"about_ca_system_score_gemma":0.00014218845,"threshold_uncertainty_score":0.44655052},"labels":[],"label_agreement":null},{"id":"W2560661426","doi":"10.1136/annrheumdis-2016-210324","title":"Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Saskatchewan; University of Toronto","funders":"Sanofi; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; NHS Blood and Transplant; National Institute for Health and Care Research; National Institute on Aging; Canadian Institutes of Health Research; National Institutes of Health; Swedish Orphan Biovitrum; Servier; Bundesministerium für Bildung und Forschung; Arthritis Society; Cincinnati Children's Hospital Medical Center; Marcus Foundation; Sparks; Versus Arthritis; F. Hoffmann-La Roche; Medical Research Council; Celgene; Canadian Arthritis Network; National Human Genome Research Institute; Wellcome Trust; GlaxoSmithKline; Pfizer","keywords":"Medicine; Arthritis; Genome-wide association study; Genetic architecture; Single-nucleotide polymorphism; Juvenile; Disease; Bioinformatics; Genetics; Immunology; Genotype; Population; Biology; Internal medicine; Gene; Quantitative trait locus","score_opus":0.03964005571334484,"score_gpt":0.3211837784889096,"score_spread":0.2815437227755648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560661426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8756192,0.11938674,0.00034960007,0.0033921585,0.000080051,0.0006912014,0.00032683235,0.000043127682,0.000111137764],"genre_scores_gemma":[0.98886883,0.0104330145,0.000039534694,0.00033116475,0.00006496154,0.00010940189,0.0000060843795,0.00004471665,0.00010231701],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99686193,0.0003466412,0.0016365054,0.00035240906,0.00044705553,0.00035544758],"domain_scores_gemma":[0.997409,0.00040793608,0.00071094977,0.001030895,0.00024524293,0.00019600018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000674398,0.00024318835,0.0011701992,0.00009382871,0.00014104832,0.000023272649,0.000377961,0.000130409,0.00012712975],"category_scores_gemma":[0.0016944961,0.00013692456,0.00042297435,0.00018601817,0.00068415294,0.00007207514,0.0001649538,0.00018738044,0.000020094843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023975344,0.0004992672,0.21310809,0.0011309976,0.0004250916,0.0000064078295,0.00056557375,0.000006752324,0.0022725693,0.00068786397,0.0006090918,0.78044856],"study_design_scores_gemma":[0.0035594287,0.0006159997,0.91979355,0.025728805,0.0002514575,0.00009936921,0.00046448744,0.000091194386,0.0015492822,0.046557367,0.0009345258,0.00035455622],"about_ca_topic_score_codex":0.00014935037,"about_ca_topic_score_gemma":0.00004680176,"teacher_disagreement_score":0.78009397,"about_ca_system_score_codex":0.000014683283,"about_ca_system_score_gemma":0.000407278,"threshold_uncertainty_score":0.5583621},"labels":[],"label_agreement":null},{"id":"W2561358587","doi":"10.1136/annrheumdis-2016-209562","title":"Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population—closing the mortality gap","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; McGill University; University of British Columbia","funders":"University of British Columbia; Ministry of Health, British Columbia","keywords":"Medicine; Rheumatoid arthritis; Closing (real estate); Population; Internal medicine; Demography; Environmental health","score_opus":0.04792045022803588,"score_gpt":0.33244421282580267,"score_spread":0.2845237625977668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561358587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98682415,0.004110285,0.000016598291,0.007654119,0.00007918831,0.0010953251,0.000064840024,0.000022973294,0.00013251619],"genre_scores_gemma":[0.9876406,0.011740515,0.000017559647,0.00035126792,0.000024873236,0.00015121521,0.000013100251,0.000022114195,0.000038739865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724275,0.00038480625,0.0007089932,0.00026775996,0.0009349229,0.00046075165],"domain_scores_gemma":[0.9982251,0.00030162575,0.000299844,0.00092458236,0.00011139378,0.00013746854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089730514,0.00022221207,0.0005100166,0.00009215971,0.00018093163,0.00006113607,0.00041801968,0.000036323192,0.00012542587],"category_scores_gemma":[0.0004265093,0.00008828449,0.00018933491,0.00033851952,0.0004804298,0.00020788147,0.00015712823,0.00015431002,0.000007847543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002634017,0.00042574728,0.9693375,0.00008032424,0.00023650793,0.000009807668,0.00057163823,0.00008666076,0.0001784731,0.0012902363,0.0009020492,0.026617644],"study_design_scores_gemma":[0.0021933194,0.00011673698,0.98876107,0.0026966536,0.000008272014,0.000009129693,0.0005828563,0.0001955513,0.0005441511,0.004661137,0.00009912979,0.00013198519],"about_ca_topic_score_codex":0.0047925613,"about_ca_topic_score_gemma":0.004802528,"teacher_disagreement_score":0.02648566,"about_ca_system_score_codex":0.000057510457,"about_ca_system_score_gemma":0.0001670385,"threshold_uncertainty_score":0.7244951},"labels":[],"label_agreement":null},{"id":"W2561521221","doi":"10.1136/annrheumdis-2016-210786","title":"Response to: ‘Why CAPS criteria are not diagnostic criteria?‘ by Landewé and van der Heijde","year":2016,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Medicine; Gold standard (test); League; Privilege (computing); Rheumatism; Family medicine; Internal medicine","score_opus":0.016243844182804362,"score_gpt":0.2826280862182432,"score_spread":0.26638424203543887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561521221","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45127892,0.0081845075,0.000043865573,0.5367796,0.00044643297,0.00056929264,0.0025646286,0.000017762988,0.00011499317],"genre_scores_gemma":[0.37335983,0.0033264707,0.000022747428,0.6175883,0.00048197678,0.00017120977,0.00063107,0.000121030134,0.0042973873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979703,0.00045457872,0.00042618567,0.0004373355,0.00026412652,0.00044747195],"domain_scores_gemma":[0.99814725,0.00034713413,0.00029421327,0.0009293118,0.00017522549,0.000106875355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002366844,0.0003865309,0.00046504743,0.00007053253,0.000118807824,0.00007587557,0.0005671134,0.00032138493,0.00018518243],"category_scores_gemma":[0.0026622873,0.00026075036,0.0002694751,0.000062118575,0.00020865347,0.000010812509,0.00034985182,0.00015244284,0.000026716647],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042278774,0.00004384978,0.00029005134,0.00032692408,0.0002461936,0.000009058487,0.00006440751,4.989362e-7,0.011813854,7.220223e-7,0.9851126,0.0016690404],"study_design_scores_gemma":[0.0006129159,0.0002443926,0.0070033814,0.0014027926,0.00015946862,0.000009929604,0.000060983548,0.000001773458,0.023562849,0.00035222154,0.9660285,0.0005607553],"about_ca_topic_score_codex":0.000030675725,"about_ca_topic_score_gemma":0.0000044325084,"teacher_disagreement_score":0.08080871,"about_ca_system_score_codex":0.0000060381335,"about_ca_system_score_gemma":0.00008465593,"threshold_uncertainty_score":0.99998444},"labels":[],"label_agreement":null},{"id":"W2567225699","doi":"10.1136/annrheumdis-2016-210025","title":"Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of Saskatchewan","funders":"Canadian Arthritis Network; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; Norwegian Institute of Public Health; Medical Research Council; Wake Forest School of Medicine; National Institutes of Health; Doris Duke Charitable Foundation; Arthritis Foundation; Helse Midt-Norge; National Institute of Allergy and Infectious Diseases; Versus Arthritis; Ministry of Education, India; Ministerio de Economía y Competitividad; Great Ormond Street Hospital for Children; University of Manchester; Arthritis Society; Cincinnati Children's Hospital Medical Center; Marcus Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; Norges Teknisk-Naturvitenskapelige Universitet; National Institute for Health and Care Research; NHS Blood and Transplant; Bundesministerium für Bildung und Forschung; Fundación Bechara; University of Utah; Wellcome Trust; University College London; Emory University; Canadian Institutes of Health Research; Juvenile Diabetes Research Foundation International; Sparks","keywords":"Polyarthritis; Oligoarthritis; Medicine; Arthritis; PTPN22; Human leukocyte antigen; Immunology; Disease; Single-nucleotide polymorphism; Genotype; Genetics; Antigen; Biology; Internal medicine; Gene","score_opus":0.03770455386113351,"score_gpt":0.29693605551305785,"score_spread":0.2592315016519243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567225699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746101,0.015496425,0.00010836312,0.008026148,0.00017323083,0.0012995091,0.00014263166,0.000063712796,0.000079896854],"genre_scores_gemma":[0.9974553,0.0011648752,0.0000144444275,0.00061917177,0.000084170904,0.0003010874,0.000006946559,0.000051177347,0.00030282748],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960382,0.0005168491,0.0013665007,0.0004494358,0.00088446215,0.0007445611],"domain_scores_gemma":[0.996899,0.0006484554,0.00040667717,0.0013404699,0.0003331495,0.00037223185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006950615,0.0003567008,0.00092633005,0.00029591992,0.00027433032,0.000057944857,0.0006959128,0.00008586623,0.00017298594],"category_scores_gemma":[0.006686785,0.00019699991,0.0004708388,0.00063136494,0.0004139757,0.00020959569,0.0004015795,0.00020083602,0.00014107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009826346,0.00086486724,0.480467,0.0021820113,0.00032954378,0.00018840414,0.001418961,0.00014930646,0.004707161,0.00031943084,0.010222085,0.4981686],"study_design_scores_gemma":[0.001979895,0.00021333499,0.97577465,0.015579697,0.000079564474,0.00003743982,0.00047522658,0.00013001403,0.0018638942,0.002722364,0.0007806145,0.0003632976],"about_ca_topic_score_codex":0.000068285524,"about_ca_topic_score_gemma":0.00010752392,"teacher_disagreement_score":0.4978053,"about_ca_system_score_codex":0.00007280923,"about_ca_system_score_gemma":0.00045302065,"threshold_uncertainty_score":0.80334234},"labels":[],"label_agreement":null},{"id":"W2572897530","doi":"10.1136/annrheumdis-2016-210770","title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1563,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European League Against Rheumatism","keywords":"Medicine; Axial spondyloarthritis; Physical therapy; Sacroiliitis; Ankylosing spondylitis; Internal medicine","score_opus":0.15897712543659714,"score_gpt":0.41901352539332015,"score_spread":0.260036399956723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572897530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066650624,0.98946303,0.0000047718745,0.002412422,0.000759364,0.0029928512,0.003273487,0.000013862101,0.0010135791],"genre_scores_gemma":[0.00036005332,0.99563485,0.0001278245,0.00010784957,0.00006362429,0.00052378373,0.00022521759,0.000045426597,0.002911358],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980869,0.00013195594,0.00085715053,0.00028104,0.0003564282,0.0002865239],"domain_scores_gemma":[0.9967594,0.00020613491,0.0012422712,0.0015357538,0.00016329,0.00009313228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020530625,0.00035137596,0.001684548,0.00009157308,0.00037906558,0.000026580396,0.0006494408,0.000084470885,0.00015994062],"category_scores_gemma":[0.0003691231,0.00018269558,0.0018779109,0.00013538642,0.00026540397,0.000062807274,0.00040529526,0.00009248879,0.00002235719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003656677,0.0003612023,0.00003526514,0.014423803,0.0021410347,0.0000034577552,0.000018394521,1.1217654e-7,8.881822e-9,0.000805261,0.0634232,0.9187517],"study_design_scores_gemma":[0.0010909527,0.00010268586,0.0005213554,0.07767791,0.004119869,0.000012414606,0.000037466005,8.4907356e-7,0.000002260504,0.0011290443,0.91515833,0.00014688187],"about_ca_topic_score_codex":0.000038130132,"about_ca_topic_score_gemma":0.0000094868,"teacher_disagreement_score":0.9186048,"about_ca_system_score_codex":0.000025233541,"about_ca_system_score_gemma":0.00018104434,"threshold_uncertainty_score":0.745011},"labels":[],"label_agreement":null},{"id":"W2587219500","doi":"10.1136/annrheumdis-2016-210503","title":"Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Pharmacyclics; Genentech; Medac; Gilead Sciences; European League Against Rheumatism; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Array BioPharma; Sanofi; Scleroderma and Raynaud's UK; Pfizer; Active Biotech; Celgene","keywords":"Medicine; Scleroderma (fungus); Observational study; Dermatology; Outcome (game theory); Internal medicine; Pathology","score_opus":0.2372845424958659,"score_gpt":0.35338935852590625,"score_spread":0.11610481603004036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587219500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907247,0.0041116364,0.0000011830092,0.00242812,0.00029530228,0.0016644623,0.00007934387,0.000045169905,0.0006500979],"genre_scores_gemma":[0.997846,0.0011929302,0.0000031839652,0.00023295858,0.00007887451,0.00010929042,0.000007821007,0.000040537467,0.0004884098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721086,0.0005659998,0.00094319344,0.00032090192,0.00064671267,0.0003123126],"domain_scores_gemma":[0.99678755,0.00028829495,0.0006967863,0.0018891908,0.00015148746,0.00018668517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039638535,0.0002901624,0.0006312931,0.000076385586,0.0004964974,0.00014905706,0.0008095516,0.000046418547,0.000024466795],"category_scores_gemma":[0.00092853897,0.00013972311,0.000437638,0.00012614437,0.0002375739,0.00014087472,0.00020467705,0.00011035755,0.000055398596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014167411,0.0027007158,0.9807096,0.00018533929,0.00050199876,0.00003515527,0.0013553882,0.00008050351,0.00007712178,0.000051727362,0.00044958267,0.0137111675],"study_design_scores_gemma":[0.0028514073,0.00025090706,0.98924327,0.0053825364,0.00051464024,0.000043577485,0.0012559233,0.00020690553,0.0000358609,0.00006110211,0.000009572748,0.00014428624],"about_ca_topic_score_codex":0.0008911643,"about_ca_topic_score_gemma":0.000026956312,"teacher_disagreement_score":0.013566881,"about_ca_system_score_codex":0.000057489913,"about_ca_system_score_gemma":0.00011639536,"threshold_uncertainty_score":0.56977427},"labels":[],"label_agreement":null},{"id":"W2588274024","doi":"10.1136/annrheumdis-2016-210146","title":"Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990–2013: findings from the Global Burden of Disease Study 2013","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; Public Health Agency of Canada; Hospital for Sick Children; University of Toronto","funders":"Bill and Melinda Gates Foundation","keywords":"Medicine; Burden of disease; Disease; Disease burden; Physical therapy; Gerontology; Family medicine; Internal medicine","score_opus":0.03356509872432559,"score_gpt":0.33172278382597464,"score_spread":0.2981576851016491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588274024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567575,0.0020731082,0.000010599837,0.038838062,0.00019599171,0.0017612358,0.00015585525,0.000010044091,0.00019764052],"genre_scores_gemma":[0.99894863,0.00069665833,0.000008229648,0.00009452006,0.000079289246,0.00006845804,0.000033405966,0.000018328827,0.000052461368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973393,0.0004218451,0.0007583815,0.00029467218,0.0009244135,0.00026135202],"domain_scores_gemma":[0.9966659,0.0005299175,0.00067806576,0.0018241316,0.00016643199,0.000135576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049238827,0.00025892636,0.00056902884,0.000055167726,0.00022229356,0.00003877365,0.0012619398,0.00005525031,0.00006551209],"category_scores_gemma":[0.0017983237,0.00012325333,0.0006458166,0.00019233089,0.000888233,0.00019447826,0.00024807837,0.00012882215,0.0000063077687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091237645,0.0026026568,0.93179256,0.0018632555,0.0007129906,0.0000037979373,0.01705767,0.0003313454,0.000010732239,0.00031969306,0.009081473,0.03531147],"study_design_scores_gemma":[0.0016104726,0.00041229808,0.97334564,0.0014985427,0.00048685123,4.7279542e-7,0.01322306,0.0012210107,0.0000014140804,0.007930592,0.00013488943,0.00013477208],"about_ca_topic_score_codex":0.022526579,"about_ca_topic_score_gemma":0.0008820784,"teacher_disagreement_score":0.042191185,"about_ca_system_score_codex":0.0000130582575,"about_ca_system_score_gemma":0.00010408704,"threshold_uncertainty_score":0.9839825},"labels":[],"label_agreement":null},{"id":"W2588775504","doi":"10.1136/annrheumdis-2016-210534","title":"Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Patient-reported outcome; Multiple sclerosis; Scleroderma (fungus); Systemic disease; Dermatology; Intensive care medicine; Physical therapy; Internal medicine; Immunopathology; Quality of life (healthcare); Immunology","score_opus":0.08320474810124168,"score_gpt":0.28927726877910837,"score_spread":0.2060725206778667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588775504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997531,0.00063717284,0.000006306853,0.00015057385,0.00008766909,0.0015186617,0.000040242754,0.000007664944,0.000020715777],"genre_scores_gemma":[0.99945027,0.0001170276,0.00019582463,0.000044503824,0.0000038741227,0.00013432953,0.0000277557,0.000013598069,0.000012828679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983608,0.00003578346,0.0008473233,0.00017993852,0.00042402546,0.00015212325],"domain_scores_gemma":[0.99803984,0.000053348096,0.0010615338,0.00052259123,0.00022140399,0.00010128228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018433553,0.0001432808,0.00043930355,0.000087255554,0.0001187812,0.000023223061,0.00013897181,0.000041037718,0.0000053114645],"category_scores_gemma":[0.00035755427,0.00008255987,0.00010865458,0.00006134517,0.00009744548,0.00009639789,0.000087126435,0.000029452769,4.3300307e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038222913,0.00075973244,0.97090685,0.0015798572,0.00036154667,2.3387129e-7,0.0006438376,0.000020725087,0.000051290303,0.00003981186,0.00006468109,0.025189174],"study_design_scores_gemma":[0.0033382778,0.00018615878,0.9741691,0.014977173,0.00023369137,7.090451e-7,0.0006956226,0.00003439179,0.0062312325,0.00003249939,0.000005120116,0.00009607713],"about_ca_topic_score_codex":0.00007850934,"about_ca_topic_score_gemma":0.000003867081,"teacher_disagreement_score":0.025093097,"about_ca_system_score_codex":0.000032375323,"about_ca_system_score_gemma":0.00011490297,"threshold_uncertainty_score":0.33666936},"labels":[],"label_agreement":null},{"id":"W2590926956","doi":"10.1136/annrheumdis-2016-210275","title":"Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Institute for Work & Health; Institute for Clinical Evaluative Sciences; St. Michael's Hospital; University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Meta-analysis; Psoriatic arthritis; Relative risk; Internal medicine; Population; Rheumatoid arthritis; Arthritis; Ankylosing spondylitis; Myocardial infarction; Gout; Physical therapy; Confidence interval; Environmental health","score_opus":0.12324196215369873,"score_gpt":0.39579619549836176,"score_spread":0.272554233344663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590926956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005249584,0.99555165,9.3296075e-7,0.0006053841,0.000017899343,0.0029797147,0.0002738973,0.0000075664834,0.000038029957],"genre_scores_gemma":[0.01945004,0.97959566,0.0000071706063,0.0001567922,0.000009927249,0.0005270035,0.0001417412,0.000020481943,0.00009120102],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99599177,0.001439598,0.0012938037,0.00022521109,0.0008429326,0.00020668034],"domain_scores_gemma":[0.99630475,0.0005094891,0.0018063113,0.0010544339,0.00023962147,0.00008537346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013827243,0.00031060734,0.0065551205,0.0002530681,0.00012000543,0.000060877544,0.0004058853,0.00007719994,0.00007967973],"category_scores_gemma":[0.002568456,0.00013236966,0.0021486576,0.00054419757,0.00021151696,0.00011283896,0.00008528884,0.00017127756,0.0000022008353],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002569832,0.00029181977,0.0005038586,0.7052931,0.2677877,0.000011537999,0.0001768835,0.000004179909,8.906772e-9,0.00024083906,0.00052642403,0.025137937],"study_design_scores_gemma":[0.00053203997,0.00020465121,0.010240797,0.42853844,0.55847,0.00008097016,0.00005776271,0.000012715723,1.3537486e-7,0.00031227508,0.0012618499,0.00028836945],"about_ca_topic_score_codex":0.00047099253,"about_ca_topic_score_gemma":0.00024989276,"teacher_disagreement_score":0.29068232,"about_ca_system_score_codex":0.000018409168,"about_ca_system_score_gemma":0.00017010837,"threshold_uncertainty_score":0.5397878},"labels":[],"label_agreement":null},{"id":"W2592896056","doi":"10.1136/annrheumdis-2017-211157","title":"Commentary on the recent international multicentre study (EUVAS) on antineutrophil cytoplasmic antibodies","year":2017,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Vasculitis; Anti-neutrophil cytoplasmic antibody; Context (archaeology); Immunology; Intensive care medicine; Differential diagnosis; Serology; Clinical trial; Antibody; Pathology; Disease","score_opus":0.050352923096130806,"score_gpt":0.3252361289816905,"score_spread":0.2748832058855597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592896056","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17305733,0.0004002873,1.5576225e-7,0.82214165,0.0010769366,0.0010995622,0.0006564379,0.000027998023,0.0015396194],"genre_scores_gemma":[0.45220086,0.005363365,0.0000030904635,0.53927404,0.0007944356,0.00006415358,0.00054061087,0.00004925723,0.001710193],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779063,0.0002580606,0.0004775053,0.00031625252,0.0008810938,0.00027646005],"domain_scores_gemma":[0.9972085,0.0004992758,0.0005864826,0.0014239083,0.0002131588,0.000068698646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015153701,0.00034288125,0.00056126533,0.00012558344,0.0004232895,0.0000755243,0.00083213876,0.00014886983,0.00056705106],"category_scores_gemma":[0.000524458,0.00016799306,0.00055852806,0.00006238933,0.00025428776,0.00005142161,0.00019275595,0.000876847,0.00010057127],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010072904,0.0013409397,0.0025963385,0.00016688384,0.0024880606,0.00013938882,0.00021908247,0.000019558805,0.00000104955,0.000038379967,0.9907021,0.002187506],"study_design_scores_gemma":[0.005881711,0.0013056672,0.23517442,0.020116821,0.0039945445,0.00006912298,0.0012841868,0.00030769184,0.00020473874,0.0013913251,0.7294586,0.00081119686],"about_ca_topic_score_codex":0.00007066556,"about_ca_topic_score_gemma":0.0000036161573,"teacher_disagreement_score":0.28286764,"about_ca_system_score_codex":0.000033812736,"about_ca_system_score_gemma":0.000072894894,"threshold_uncertainty_score":0.68505585},"labels":[],"label_agreement":null},{"id":"W2595556343","doi":"10.1136/annrheumdis-2016-210645","title":"Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Agence Nationale de la Recherche","keywords":"Medicine; Gene; Multiple sclerosis; Genetics; Meta-analysis; Bioinformatics; Computational biology; Immunology; Internal medicine; Biology","score_opus":0.44656227378290275,"score_gpt":0.4448491147501775,"score_spread":0.001713159032725231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595556343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064677456,0.9887142,0.000004366206,0.0004522881,0.0002200082,0.002859833,0.001133701,0.000059517868,0.000088342276],"genre_scores_gemma":[0.059707552,0.9380447,0.000009162457,0.00013226415,0.00004735557,0.0004449357,0.00008249737,0.00006659662,0.0014649356],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945708,0.001068679,0.0020403662,0.0008943436,0.000980519,0.000445277],"domain_scores_gemma":[0.9933014,0.0008773713,0.0016962303,0.0031188403,0.0003722786,0.000633888],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001256725,0.00078375294,0.007983542,0.0004920878,0.00032387063,0.00018706561,0.0009869086,0.0003267309,0.00041109163],"category_scores_gemma":[0.0018315834,0.00040850614,0.009953568,0.0007516474,0.00039366767,0.00013330005,0.0002848005,0.00020294392,0.00008366154],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008953089,0.0004902368,0.00020405337,0.10214068,0.3513794,0.0000061184896,0.000271802,0.000013822671,0.0000062439535,0.000026639604,0.0033714669,0.542],"study_design_scores_gemma":[0.00028977467,0.00010492553,0.0043022935,0.07643559,0.9110302,0.000046458164,0.00021302352,0.0000067744572,0.000018745162,0.00008748206,0.0069338395,0.00053090986],"about_ca_topic_score_codex":0.0003806911,"about_ca_topic_score_gemma":0.000029080951,"teacher_disagreement_score":0.5596508,"about_ca_system_score_codex":0.000039235085,"about_ca_system_score_gemma":0.00047989996,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W2604690153","doi":"10.1136/annrheumdis-2017-211401","title":"2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"National Institutes of Health; European League Against Rheumatism; Cure JM Foundation; Myositis Association","keywords":"Medicine; Juvenile dermatomyositis; Rheumatism; Rheumatology; Dermatomyositis; League; Internal medicine; Juvenile; Dermatology; Physical therapy","score_opus":0.044415801140214727,"score_gpt":0.3581935731911961,"score_spread":0.3137777720509814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604690153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047595,0.0012190829,0.0000553393,0.005792452,0.00021533069,0.00087068166,0.0010495562,0.000028162645,0.0002934676],"genre_scores_gemma":[0.9965298,0.0019121945,0.00074093224,0.0005697982,0.000014046126,0.00005641278,0.000016234917,0.000048991413,0.00011157838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672395,0.0007547618,0.0015325638,0.0003405339,0.00026139268,0.00038682096],"domain_scores_gemma":[0.99604416,0.0010400518,0.0013067948,0.00112304,0.00024988933,0.00023608973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013006742,0.0002786794,0.0013389734,0.00015615151,0.0003238023,0.000045180273,0.00047044185,0.000081638835,0.000020401802],"category_scores_gemma":[0.0030229248,0.00021103953,0.0003824559,0.00009282228,0.0012949468,0.0002385106,0.00029189308,0.00013668105,0.000006866943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051331904,0.00330793,0.58931553,0.01261248,0.0018506461,0.00073921605,0.0036284772,0.000032996137,0.001050607,0.0036624477,0.23400992,0.098457836],"study_design_scores_gemma":[0.0049316525,0.00056468125,0.97953254,0.0075061163,0.00016497227,0.00025968315,0.000768909,0.0031181204,0.0011526579,0.0010544012,0.00061240507,0.00033386663],"about_ca_topic_score_codex":0.00012713835,"about_ca_topic_score_gemma":0.000020099606,"teacher_disagreement_score":0.39021698,"about_ca_system_score_codex":0.00001334632,"about_ca_system_score_gemma":0.0002788989,"threshold_uncertainty_score":0.8605942},"labels":[],"label_agreement":null},{"id":"W2611413478","doi":"10.1136/annrheumdis-2016-211001","title":"European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council; Versus Arthritis; Rosetrees Trust","keywords":"Medicine; Antiphospholipid syndrome; Pediatrics; Observational study; Intensive care medicine; Rheumatology; Systematic review; MEDLINE; Internal medicine; Thrombosis","score_opus":0.4905713055315824,"score_gpt":0.469864987230721,"score_spread":0.020706318300861393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611413478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010617283,0.98880666,0.0000034320472,0.0029504863,0.00016067714,0.004708339,0.0022140709,0.00001530505,0.0000793056],"genre_scores_gemma":[0.0072460053,0.9908547,0.000038181483,0.000062923245,0.00005906781,0.0013345721,0.0001499,0.00006228094,0.00019236062],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971462,0.00084200676,0.0009778666,0.00032222652,0.0004387878,0.0002729044],"domain_scores_gemma":[0.99018896,0.0062796515,0.0015806772,0.0014227928,0.00036966873,0.00015826355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007462493,0.0003638883,0.0019399202,0.00019888044,0.00025719978,0.000053397587,0.0006470377,0.00007480452,0.00009153219],"category_scores_gemma":[0.0056612752,0.0001697771,0.0011422766,0.00026381225,0.00031571722,0.00010244944,0.00016625345,0.00009426204,0.000013026269],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004267019,0.00048273578,0.002866222,0.06881246,0.0011392229,0.000007563977,0.00026859873,3.213613e-7,8.730016e-9,0.000017692733,0.013859748,0.91250277],"study_design_scores_gemma":[0.0017668743,0.0014976173,0.0035338106,0.55224895,0.008558092,0.00047166136,0.00041463927,0.00004119068,0.000012007519,0.00013752576,0.43090656,0.0004110722],"about_ca_topic_score_codex":0.000036650934,"about_ca_topic_score_gemma":0.0000021845854,"teacher_disagreement_score":0.9120917,"about_ca_system_score_codex":0.0000637732,"about_ca_system_score_gemma":0.0007703103,"threshold_uncertainty_score":0.6923309},"labels":[],"label_agreement":null},{"id":"W2611495101","doi":"10.1136/annrheumdis-2016-210942","title":"Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Research Canada","funders":"","keywords":"Medicine; Observational study; Internal medicine; Granulomatosis with polyangiitis; Population; Meta-analysis; Microscopic polyangiitis; Vasculitis; Rheumatology; Epidemiology; Subgroup analysis; Disease; Environmental health","score_opus":0.5597691346708064,"score_gpt":0.5096656680922793,"score_spread":0.050103466578527045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611495101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068435515,0.9898418,6.753338e-7,0.0003353178,0.00012291678,0.00071980455,0.001920925,0.000013541735,0.00020146699],"genre_scores_gemma":[0.012829367,0.9857518,0.000009700662,0.000059907154,0.000014270216,0.00012074083,0.00079774106,0.00002071128,0.00039572964],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99664176,0.00044044064,0.0016942286,0.00029945746,0.00069764245,0.0002264629],"domain_scores_gemma":[0.99530375,0.00066322496,0.0021528967,0.0013294813,0.00045327432,0.00009739793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006932536,0.00032102314,0.0051579755,0.00040595315,0.00010940501,0.000016059685,0.00045504054,0.00018272172,0.0001839965],"category_scores_gemma":[0.004900405,0.00018389513,0.0050643445,0.0010067316,0.00036282954,0.00008732804,0.00014355381,0.00021708073,0.0000056000094],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012530129,0.0022911732,0.022539146,0.05413884,0.45494807,0.00002329418,0.0004095032,0.0001266394,3.5038486e-8,0.0022752474,0.0066945096,0.45654103],"study_design_scores_gemma":[0.00071755314,0.00005722384,0.65741366,0.07156289,0.24915056,0.0000031562506,0.00013213114,0.00007283097,3.8340443e-7,0.0025870868,0.017969152,0.0003333893],"about_ca_topic_score_codex":0.00016006062,"about_ca_topic_score_gemma":0.00009009677,"teacher_disagreement_score":0.63487446,"about_ca_system_score_codex":0.000052918844,"about_ca_system_score_gemma":0.0005010354,"threshold_uncertainty_score":0.7499026},"labels":[],"label_agreement":null},{"id":"W2611521096","doi":"10.1136/annrheumdis-2016-210724","title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Psoriatic arthritis; Placebo; Double blind; Arthritis; Rheumatoid arthritis; Internal medicine; Dermatology; Alternative medicine; Pathology","score_opus":0.04274807420956792,"score_gpt":0.34557724349011776,"score_spread":0.3028291692805498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611521096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98385483,0.009395082,0.000001449207,0.00039184827,0.00010225873,0.005761042,0.000053719712,0.00000859243,0.000431186],"genre_scores_gemma":[0.9955533,0.003908964,0.0000137874085,0.000027546928,0.000015874524,0.00036487426,0.0000065045847,0.000018361896,0.00009076609],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99802446,0.00013275455,0.000934252,0.0002748301,0.00035883678,0.0002748625],"domain_scores_gemma":[0.9980133,0.00036923087,0.0006013867,0.00080719375,0.000080542566,0.00012829974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045497745,0.00024227331,0.0014418523,0.00014670764,0.00016567176,0.00002978443,0.00022418314,0.0000436797,0.000046697205],"category_scores_gemma":[0.00067642226,0.00016329224,0.00024362332,0.00011557762,0.00020568229,0.00012696203,0.00016532891,0.00009433294,0.0000026200128],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84078026,0.017697861,0.07610074,0.0005038308,0.0013286971,0.00010973163,0.0033662247,0.00006384318,0.000021446198,0.00007098456,0.0001603137,0.05979608],"study_design_scores_gemma":[0.8552678,0.0007761183,0.13993953,0.0020978665,0.0003684082,0.000004933457,0.0009595832,0.00019930121,0.00008710686,0.00016869551,0.0000058496794,0.00012477605],"about_ca_topic_score_codex":0.00076235674,"about_ca_topic_score_gemma":0.0004191812,"teacher_disagreement_score":0.0638388,"about_ca_system_score_codex":0.000017822804,"about_ca_system_score_gemma":0.00008769085,"threshold_uncertainty_score":0.6658864},"labels":[],"label_agreement":null},{"id":"W2612549667","doi":"10.1136/annrheumdis-2016-210963","title":"Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Incidence (geometry); Register (sociolinguistics); Linkage (software); Epidemiology; Dermatology; Pediatrics; Psoriasis; Internal medicine; Genetics","score_opus":0.04235277896378635,"score_gpt":0.3404235780365972,"score_spread":0.2980707990728108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612549667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888061,0.009331863,0.0000013112584,0.0008269685,0.00006856232,0.00064035924,0.000034548648,0.0000041352964,0.00028611903],"genre_scores_gemma":[0.993551,0.005992116,0.000044824315,0.00006114401,0.000008947473,0.000047260164,6.7111256e-7,0.000007007519,0.00028698586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899966,0.000061846535,0.00036887903,0.00015536552,0.00028882877,0.00012544538],"domain_scores_gemma":[0.99867415,0.00014985332,0.00037622618,0.0006323931,0.00011190355,0.00005548856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019994703,0.00010232671,0.00036933465,0.00005006031,0.00012943045,0.000019165978,0.0001832969,0.000019735791,0.000034527722],"category_scores_gemma":[0.0019892626,0.00007026274,0.00008025257,0.000056574532,0.00021282391,0.00012943594,0.00017993322,0.00004272064,0.0000027040392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009739054,0.0007298823,0.96274465,0.00073069875,0.00013515558,0.000021151322,0.00082923763,9.324758e-7,0.0000032902321,0.00007579872,0.0001255898,0.034506246],"study_design_scores_gemma":[0.0020669522,0.00028188818,0.9914745,0.004314855,0.00012281153,0.000007443859,0.0003405258,0.00003047901,0.00007829349,0.0012217017,0.0000054366897,0.000055128578],"about_ca_topic_score_codex":0.00027839595,"about_ca_topic_score_gemma":0.00023066431,"teacher_disagreement_score":0.034451116,"about_ca_system_score_codex":0.000006216934,"about_ca_system_score_gemma":0.000045135865,"threshold_uncertainty_score":0.28652313},"labels":[],"label_agreement":null},{"id":"W2615525468","doi":"10.1136/annrheumdis-2016-210456","title":"Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Janssen Research and Development; National Institutes of Health; Celgene; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Golimumab; Medicine; Placebo; Clinical endpoint; Adverse effect; Internal medicine; Arthritis; Rheumatology; Clinical trial; Rheumatoid arthritis; Etanercept","score_opus":0.03782567756802102,"score_gpt":0.3359269238272286,"score_spread":0.2981012462592076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615525468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899573,0.0031199488,0.000017574032,0.0018651946,0.00009965237,0.0053459434,0.00027454266,0.000026670268,0.00025475794],"genre_scores_gemma":[0.9986073,0.0005880418,0.000032325726,0.00005185896,0.00006042918,0.00029087474,0.000043847933,0.00003805746,0.0002872728],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99744016,0.0001286793,0.0009809317,0.0003057905,0.0007032505,0.00044117912],"domain_scores_gemma":[0.9964723,0.00022121238,0.0012733514,0.0013622256,0.0004764787,0.00019445899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055654504,0.00025553134,0.0010888978,0.000081725884,0.0003804688,0.00006164493,0.0005485515,0.00009335616,0.00003063607],"category_scores_gemma":[0.002004835,0.00015917844,0.0005627592,0.000097132535,0.00054353214,0.00023141905,0.00013111549,0.00016613057,0.000007011686],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9483255,0.0019918473,0.0011125593,0.0004658294,0.001441827,0.000017821318,0.0007373473,0.00005174836,0.00006636835,0.00007310095,0.00089707784,0.044818982],"study_design_scores_gemma":[0.93284625,0.0032004763,0.046113074,0.0040914863,0.0010336097,0.000064705084,0.00068050786,0.00047680803,0.010776291,0.0003430572,0.000055377877,0.00031837964],"about_ca_topic_score_codex":0.00028850808,"about_ca_topic_score_gemma":0.000060972598,"teacher_disagreement_score":0.045000512,"about_ca_system_score_codex":0.000017679306,"about_ca_system_score_gemma":0.00078404223,"threshold_uncertainty_score":0.64911085},"labels":[],"label_agreement":null},{"id":"W2616087671","doi":"10.1136/annrheumdis-2017-211172","title":"Arthroscopic partial meniscectomy versus placebo surgery for a degenerative meniscus tear: a 2-year follow-up of the randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Knee injuries and reconstruction techniques","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Academy of Finland; Sigrid Juséliuksen Säätiö; Jane ja Aatos Erkon Säätiö; Kela","keywords":"Medicine; Placebo; Osteoarthritis; Medial meniscus; Surgery; Meniscus; Knee pain; Randomized controlled trial; Adverse effect; Clinical trial; Arthroscopy; Incidence (geometry); Internal medicine","score_opus":0.05590702020751619,"score_gpt":0.3452556349070221,"score_spread":0.2893486146995059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616087671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98744184,0.0002994043,0.00004491802,0.0034180852,0.0019244781,0.006174909,0.00010134587,0.000030862182,0.0005641843],"genre_scores_gemma":[0.9978639,0.00014591256,0.00011802887,0.00006406998,0.00013445328,0.000847668,0.0000045734423,0.000018238627,0.0008031408],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983165,0.0002123589,0.0007592806,0.00016952107,0.00033095223,0.00021135402],"domain_scores_gemma":[0.9967506,0.0009854626,0.0011333019,0.0008052493,0.00023343558,0.00009196029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005730075,0.00017822675,0.0011176659,0.00005402326,0.0004014828,0.00004202718,0.00028878372,0.00007120364,0.00012240959],"category_scores_gemma":[0.004964118,0.000085102285,0.0014075944,0.00005127283,0.00054927694,0.000084517684,0.00008685091,0.000072971816,0.0000012591504],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9682621,0.0003349704,0.0011694023,0.00032853475,0.0014472245,4.4659728e-7,0.00022447927,0.0000027269937,0.0003237977,0.0007106369,0.023281053,0.0039146394],"study_design_scores_gemma":[0.91524,0.0007300516,0.0009948825,0.00096758397,0.0013211336,0.000002464806,0.00033291706,0.00015715552,0.077778764,0.0017772779,0.00052032975,0.0001774626],"about_ca_topic_score_codex":0.000030773776,"about_ca_topic_score_gemma":0.000011329727,"teacher_disagreement_score":0.07745496,"about_ca_system_score_codex":0.000011689855,"about_ca_system_score_gemma":0.0003738771,"threshold_uncertainty_score":0.5942871},"labels":[],"label_agreement":null},{"id":"W2619315233","doi":"10.1136/annrheumdis-2017-211108","title":"Learning the hard way: clinical trials in juvenile idiopathic arthritis","year":2017,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Western University; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Arthritis; Juvenile; Clinical trial; Physical therapy; Family medicine; Internal medicine","score_opus":0.1849434549857575,"score_gpt":0.42972057605605224,"score_spread":0.24477712107029473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619315233","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07460288,0.041142516,0.0000040620403,0.88020724,0.0007001103,0.0019175243,0.000086502136,0.000051602452,0.0012875947],"genre_scores_gemma":[0.6862827,0.060738187,0.000014590282,0.22694372,0.002440594,0.0004996441,0.00023431474,0.00022089157,0.022625381],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899185,0.0050002616,0.0030137785,0.00040326724,0.0010973109,0.00056691974],"domain_scores_gemma":[0.9921508,0.003056312,0.0024459483,0.0019899032,0.0002467965,0.000110229026],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0126230605,0.00035594116,0.003108898,0.0001670667,0.00035126158,0.00012373895,0.0012029742,0.0005226372,0.00040104592],"category_scores_gemma":[0.057197906,0.00018920968,0.0018600425,0.0001438186,0.0007287804,0.00012967065,0.0003848227,0.0029427134,0.00015071643],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001531023,0.00015401261,0.0060113086,0.0013057134,0.00039238995,0.00014612202,0.00021669472,0.000007171231,0.0000018632486,0.0000131965335,0.8348914,0.15670705],"study_design_scores_gemma":[0.0036457651,0.00063446607,0.14620815,0.028707037,0.0005639779,0.00004840129,0.0004985623,0.00034686358,0.000043338976,0.0033572612,0.8154219,0.0005243013],"about_ca_topic_score_codex":0.00017387762,"about_ca_topic_score_gemma":0.000008595265,"teacher_disagreement_score":0.6532635,"about_ca_system_score_codex":0.000023276392,"about_ca_system_score_gemma":0.001001344,"threshold_uncertainty_score":0.9993575},"labels":[],"label_agreement":null},{"id":"W2619991145","doi":"10.1136/annrheumdis-2017-211123","title":"Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Genentech; Sanofi","keywords":"Medicine; Azathioprine; Prednisolone; Internal medicine; Gastroenterology; Clinical endpoint; Vasculitis; Cyclophosphamide; Microscopic polyangiitis; Randomized controlled trial; Maintenance therapy; Surgery; Creatinine; Chemotherapy; Disease","score_opus":0.05384392333692033,"score_gpt":0.361238919077691,"score_spread":0.30739499574077067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619991145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901423,0.001161849,0.0000015702091,0.0035390188,0.0001057723,0.003928906,0.00010003473,0.0000071255117,0.0010134382],"genre_scores_gemma":[0.9980228,0.0013906065,0.0000052028477,0.000042053754,0.000018045848,0.00025988652,0.000027311282,0.0000081409,0.00022598449],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99827635,0.00038076707,0.00070739776,0.00011589684,0.0003721954,0.0001473979],"domain_scores_gemma":[0.99755806,0.00049656007,0.00092713046,0.00079207105,0.0001599548,0.00006622454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056877895,0.00012928378,0.0009215652,0.00005732536,0.00014308964,0.000011871132,0.00026336504,0.00006847267,0.00008760341],"category_scores_gemma":[0.0037049225,0.000057063076,0.00088386214,0.000083294784,0.00021066071,0.000054317123,0.000025001164,0.00006603753,9.1387994e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8497537,0.03887061,0.004359184,0.0009427722,0.010210758,0.0000391369,0.005870757,0.00006827382,0.0012366029,0.00078513427,0.005435416,0.08242764],"study_design_scores_gemma":[0.95289177,0.0014466519,0.039193943,0.0017645691,0.0015294056,0.0000025988747,0.00022745274,0.00030779708,0.0012477409,0.0012898612,0.000028975275,0.000069225745],"about_ca_topic_score_codex":0.00019139137,"about_ca_topic_score_gemma":0.000010701321,"teacher_disagreement_score":0.103138074,"about_ca_system_score_codex":0.000013907071,"about_ca_system_score_gemma":0.00018345584,"threshold_uncertainty_score":0.4435406},"labels":[],"label_agreement":null},{"id":"W2620020700","doi":"10.1136/annrheumdis-2001.922","title":"THU0068 N-acylation and sulfation of glucosamine (glcn) differentially modulate chondrocyte (ch) proliferation and proteoglycan (pg) synthesis","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Sulfation; Glucosamine; Acylation; Biochemistry; Galactosamine; Proteoglycan; Cell growth; DNA synthesis; Chemistry; DNA; Catalysis","score_opus":0.024700304133113568,"score_gpt":0.26496719248265616,"score_spread":0.24026688834954257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620020700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968772,0.00096237997,0.000106812295,0.00090255175,0.0000471286,0.0009511188,0.000031933723,0.000021704858,0.00009918326],"genre_scores_gemma":[0.99850637,0.00095266016,0.00016924152,0.00003818248,0.000021526794,0.000067645895,0.00004185677,0.000014473283,0.00018807435],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990855,0.00006348632,0.00032401533,0.00015581693,0.00024704746,0.00012416385],"domain_scores_gemma":[0.9992621,0.000070238675,0.00024380282,0.00022239976,0.00011510138,0.000086351174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008848459,0.00013618446,0.00031278748,0.000076177574,0.00007372986,0.000019366267,0.000046836452,0.00004311804,0.00003507522],"category_scores_gemma":[0.00026465475,0.0000925902,0.00007691853,0.000099426754,0.00008155707,0.00015861607,0.00003605466,0.000031173753,0.0000010892865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002718181,0.001505918,0.11916218,0.0024162587,0.00049965444,0.000007894202,0.0011451754,0.000043885735,0.05813872,0.002551913,0.00010817979,0.811702],"study_design_scores_gemma":[0.0034157208,0.00133498,0.8077611,0.002912346,0.00078608585,0.000046094206,0.00015233777,0.003407435,0.17437302,0.005544538,0.00003306928,0.00023331033],"about_ca_topic_score_codex":0.00002788979,"about_ca_topic_score_gemma":0.000022116152,"teacher_disagreement_score":0.8114687,"about_ca_system_score_codex":0.000007204543,"about_ca_system_score_gemma":0.000035083987,"threshold_uncertainty_score":0.37757188},"labels":[],"label_agreement":null},{"id":"W2623521568","doi":"10.1136/annrheumdis-2016-210459","title":"Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Amgen","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Clinical endpoint; Internal medicine; Adverse effect; Bioequivalence; Pharmacokinetics; Gastroenterology; Randomized controlled trial","score_opus":0.04817295763684427,"score_gpt":0.32983176028224587,"score_spread":0.2816588026454016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623521568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946144,0.001138724,0.000031839772,0.0009839928,0.000083344145,0.0028596953,0.00021084277,0.000010846543,0.00006627565],"genre_scores_gemma":[0.99932444,0.00030628947,0.00006432802,0.00016866626,0.0000023827834,0.000065205786,0.000005867579,0.0000152462635,0.00004758706],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980921,0.00043433733,0.00063650974,0.0003364708,0.00017348918,0.00032710168],"domain_scores_gemma":[0.9977791,0.00030325144,0.000595966,0.0010534606,0.00019486614,0.00007336909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004728189,0.0002737736,0.00084013934,0.00006441187,0.0004200886,0.00004917543,0.00077719893,0.00007733958,0.000057642854],"category_scores_gemma":[0.000289148,0.0001316971,0.000121822806,0.00016118404,0.0007523947,0.00013361497,0.00036980564,0.00016066029,0.0000015978092],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80253524,0.011619073,0.14647503,0.00033294552,0.0026165445,0.000004426699,0.002239121,0.00036852114,0.000171693,0.00019875955,0.00088624604,0.03255238],"study_design_scores_gemma":[0.45723638,0.0018733362,0.52995294,0.004701073,0.0003077409,0.000006915646,0.00064364035,0.00006926011,0.004459323,0.00025643545,0.00004324521,0.00044971853],"about_ca_topic_score_codex":0.00013351544,"about_ca_topic_score_gemma":0.0001092484,"teacher_disagreement_score":0.38347793,"about_ca_system_score_codex":0.000008738381,"about_ca_system_score_gemma":0.00008863415,"threshold_uncertainty_score":0.5370452},"labels":[],"label_agreement":null},{"id":"W2625972055","doi":"10.1136/annrheumdis-2017-211396","title":"Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Services and Delivery Research Programme; Rosetrees Trust","keywords":"Medicine; Osteoarthritis; Pathology; Bone marrow; WOMAC; Internal medicine","score_opus":0.026659337046610176,"score_gpt":0.2882583281963716,"score_spread":0.26159899114976143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625972055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953669,0.0034371826,0.0000033444664,0.0005293753,0.000032255728,0.00045540763,0.00012722962,0.000006249382,0.000042110754],"genre_scores_gemma":[0.9991146,0.00066004787,0.00009912066,0.000009656041,0.000004926013,0.000022741166,0.000053489162,0.000009612522,0.0000258047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881417,0.000080053724,0.0006053096,0.00016548588,0.00019451119,0.00014045446],"domain_scores_gemma":[0.9986471,0.00010036144,0.0005747953,0.0005013468,0.000113942995,0.00006244327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001365027,0.00012952134,0.00059082947,0.0003357349,0.000059046386,0.000015188412,0.00011153044,0.0000578954,0.000019489798],"category_scores_gemma":[0.00027424135,0.000101222984,0.00020688269,0.00031013065,0.00017549805,0.0001690196,0.0000649307,0.000034773297,3.7818847e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029459328,0.00027752598,0.6174866,0.00033263923,0.00021568121,0.0000058192486,0.00026118552,0.00012375445,0.16452388,0.00019296845,0.000008188892,0.21627718],"study_design_scores_gemma":[0.0014768925,0.00020925737,0.81043655,0.000864658,0.00056358724,0.0000043169584,0.00011274392,0.0002487886,0.18548517,0.00053053675,0.0000015168715,0.00006597623],"about_ca_topic_score_codex":0.00025619307,"about_ca_topic_score_gemma":0.00082856015,"teacher_disagreement_score":0.2162112,"about_ca_system_score_codex":0.0000074299714,"about_ca_system_score_gemma":0.000053762527,"threshold_uncertainty_score":0.41277534},"labels":[],"label_agreement":null},{"id":"W2704261773","doi":"10.1136/annrheumdis-2016-210960","title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council; Versus Arthritis; Rosetrees Trust","keywords":"Medicine; Lupus erythematosus; Intensive care medicine; Pediatrics; Dermatology; Immunology; Antibody","score_opus":0.20183076236549322,"score_gpt":0.38917552160952407,"score_spread":0.18734475924403085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2704261773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96298885,0.010728396,0.000023359631,0.021849131,0.0001688225,0.0029977546,0.0010331146,0.000023514463,0.00018702832],"genre_scores_gemma":[0.99281484,0.006022882,0.00006639687,0.00019064671,0.000040668576,0.0006335931,0.00003191929,0.00003386732,0.00016521258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810994,0.0004399154,0.00059095386,0.00023826402,0.00037772048,0.0002432387],"domain_scores_gemma":[0.9943628,0.002892317,0.0008163652,0.0014010657,0.0003861118,0.0001413644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005954263,0.00020659005,0.0005804514,0.000088564884,0.00047129925,0.000071757386,0.0005207192,0.00003301147,0.000058880378],"category_scores_gemma":[0.005107759,0.000104502615,0.00035580454,0.00009126479,0.00037890096,0.00016368473,0.0001358194,0.00005026241,0.000007728254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045255164,0.0015745611,0.9173482,0.006133612,0.0012639062,0.000005776319,0.007725495,0.000010433582,0.000012956802,0.00023565748,0.030194392,0.03504247],"study_design_scores_gemma":[0.014105999,0.003728413,0.73909223,0.20432805,0.002986432,0.0025259126,0.020148374,0.0017286482,0.0061666635,0.0027836382,0.0016248635,0.0007808044],"about_ca_topic_score_codex":0.000060162445,"about_ca_topic_score_gemma":0.000007836588,"teacher_disagreement_score":0.19819443,"about_ca_system_score_codex":0.00003981532,"about_ca_system_score_gemma":0.00024581997,"threshold_uncertainty_score":0.61148334},"labels":[],"label_agreement":null},{"id":"W2724955338","doi":"10.1136/annrheumdis-2017-211734","title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":676,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Sun Pharma; Versus Arthritis; National Institute for Health and Care Research; AbbVie; Samsung; Celgene; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Ankylosing spondylitis; Axial spondyloarthritis; Expert opinion; Physical therapy; Task force; Disease; Set (abstract data type); Family medicine; Internal medicine; Sacroiliitis; Intensive care medicine","score_opus":0.023892883012181346,"score_gpt":0.3241380528006267,"score_spread":0.30024516978844534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724955338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777438,0.0075424192,0.00007196399,0.008012786,0.000745071,0.0008375442,0.0032988498,0.00003400471,0.0017135671],"genre_scores_gemma":[0.9862387,0.010975956,0.0013093019,0.0004172523,0.00015573409,0.00008333061,0.0002876265,0.000037426977,0.000494678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979556,0.00009787942,0.0007052539,0.0003968522,0.00047970057,0.00036466494],"domain_scores_gemma":[0.99778295,0.00009521033,0.00061489013,0.00090785685,0.0002843222,0.00031476605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021027598,0.0002946941,0.00071100215,0.000100564765,0.0006633006,0.00014542356,0.0004715411,0.000067080524,0.00052866543],"category_scores_gemma":[0.0009633247,0.00024915216,0.0002528409,0.000081286424,0.00035767583,0.00054988574,0.0002800782,0.000099745885,0.000010071212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012873645,0.0018417912,0.05096732,0.0002360014,0.0011252854,0.000093248156,0.0015623539,0.00002094171,0.0005198475,0.0026948652,0.020963572,0.9186874],"study_design_scores_gemma":[0.024846667,0.003947616,0.89123523,0.012029513,0.00076739857,0.00052122294,0.0020584126,0.0006676227,0.0047162557,0.011176757,0.04660516,0.001428164],"about_ca_topic_score_codex":0.0002899,"about_ca_topic_score_gemma":0.00021701476,"teacher_disagreement_score":0.9172592,"about_ca_system_score_codex":0.000027576158,"about_ca_system_score_gemma":0.000100911624,"threshold_uncertainty_score":0.99999607},"labels":[],"label_agreement":null},{"id":"W2726607957","doi":"10.1136/annrheumdis-2017-eular.5524","title":"FRI0187 Radiographic progression by disease activity states in patients with rheumatoid arthritis treated with sb2 or reference infliximab","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Infliximab; Rheumatoid arthritis; Methotrexate; Internal medicine; Biosimilar; Adalimumab; Etanercept; Gastroenterology; Rheumatology; Clinical disease; Disease; Surgery","score_opus":0.026793230850410066,"score_gpt":0.3026051223582627,"score_spread":0.2758118915078526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726607957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951534,0.0026519955,0.000010471588,0.0009360283,0.00004073803,0.00052586093,0.00059759675,0.000028145625,0.000055717654],"genre_scores_gemma":[0.9971807,0.0024188121,0.000059379025,0.00008883297,0.0000015604379,0.000050398387,0.000064941356,0.000017060811,0.000118298325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853057,0.00033709238,0.00030721942,0.00031760216,0.00013901349,0.00036852775],"domain_scores_gemma":[0.9982462,0.00019151164,0.00049502513,0.0008313113,0.00013606479,0.00009987762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016932724,0.00026312613,0.0004992648,0.000080640144,0.00033990346,0.00006102494,0.00052880344,0.00009858134,0.00015227804],"category_scores_gemma":[0.00033757483,0.00012247032,0.000101693455,0.0001713714,0.00096948957,0.00025610055,0.00014088672,0.00017366163,0.000004356201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089786695,0.0020568622,0.88947874,0.00015958732,0.00039520994,0.000004842137,0.00004856103,0.0000027410756,0.00007260956,0.000049203856,0.0025322654,0.096220694],"study_design_scores_gemma":[0.0032845382,0.00074372394,0.9896117,0.0024807549,0.00006579973,0.0000012668949,0.00002573679,0.000020392099,0.002873025,0.0002644249,0.00038124132,0.00024738847],"about_ca_topic_score_codex":0.0001827465,"about_ca_topic_score_gemma":0.00006098839,"teacher_disagreement_score":0.10013296,"about_ca_system_score_codex":0.000008862791,"about_ca_system_score_gemma":0.00008330794,"threshold_uncertainty_score":0.49941945},"labels":[],"label_agreement":null},{"id":"W2732727310","doi":"10.1136/annrheumdis-2017-211313","title":"Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study","year":2017,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Pfizer","keywords":"Medicine; Etanercept; Sacroiliitis; Internal medicine; Post-hoc analysis; Sacroiliac joint; C-reactive protein; Placebo; Magnetic resonance imaging; BASDAI; Ankylosing spondylitis; Gastroenterology; Physical therapy; Surgery; Tumor necrosis factor alpha; Arthritis; Inflammation; Radiology; Pathology; Psoriatic arthritis","score_opus":0.027530271157439893,"score_gpt":0.3317270622820487,"score_spread":0.3041967911246088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732727310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97520936,0.005241131,1.2647578e-7,0.010033689,0.0001083419,0.006187041,0.003181347,0.0000052108494,0.000033786357],"genre_scores_gemma":[0.9977778,0.00084040343,0.000004148884,0.0005725777,0.00003672426,0.00055838266,0.00009970695,0.000035844543,0.00007437868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99270797,0.0037151384,0.0009546008,0.0004712809,0.0018133809,0.00033760327],"domain_scores_gemma":[0.9944636,0.0012942211,0.0016625548,0.0019164637,0.00059329276,0.000069832415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019366661,0.0004976451,0.0019715682,0.0005611217,0.00018546109,0.000016603317,0.0003752834,0.00016890136,0.000048115988],"category_scores_gemma":[0.0030019693,0.00024185487,0.0012803588,0.00081864645,0.0006667836,0.000058535894,0.00016680513,0.00028251027,5.342111e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08394614,0.013394168,0.6485276,0.0039793346,0.08673604,0.00034811752,0.011975693,0.0005809077,0.0009701105,0.0000062204163,0.008548491,0.14098714],"study_design_scores_gemma":[0.009342511,0.010577846,0.9509843,0.006996904,0.020223625,0.0000067310884,0.0004901074,0.00015116265,0.00094230485,0.00004578548,0.000055930956,0.00018277566],"about_ca_topic_score_codex":0.0021452273,"about_ca_topic_score_gemma":0.00077601516,"teacher_disagreement_score":0.30245668,"about_ca_system_score_codex":0.00011688635,"about_ca_system_score_gemma":0.00033763575,"threshold_uncertainty_score":0.9862555},"labels":[],"label_agreement":null},{"id":"W2734988234","doi":"10.1136/annrheumdis-2017-211792","title":"Response to: ‘Mortality in ANCA-associated vasculitis: mission incomplete’ by Moiseev et al","year":2017,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Observational study; Medicine; Confounding; Comparability; Selection bias; Intensive care medicine; Vasculitis; Limiting; Internal medicine; Pathology; Disease","score_opus":0.05264724557847199,"score_gpt":0.35254722312199976,"score_spread":0.29989997754352776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734988234","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28157896,0.0022705689,0.0000022308204,0.71226287,0.00027712915,0.0008121017,0.0023180845,0.00004727189,0.00043081227],"genre_scores_gemma":[0.3426311,0.0017009918,0.000016941382,0.6502033,0.00007757098,0.00009408405,0.0017637439,0.00008700502,0.0034252745],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9963039,0.000987743,0.00080507033,0.00046157805,0.0009496171,0.0004920518],"domain_scores_gemma":[0.99682814,0.00050581904,0.0006296517,0.0015886443,0.00019687899,0.00025087118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008433135,0.00039040294,0.001075006,0.0001981774,0.00020623337,0.00006609041,0.0006271492,0.0004185741,0.00028657637],"category_scores_gemma":[0.0033024845,0.00026742116,0.0008456412,0.0002153166,0.00020784147,0.00010975347,0.0002087637,0.0009340546,0.000046584795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014886481,0.00038306075,0.001817994,0.0002885026,0.00082375616,0.00013579483,0.00015080906,0.000010022768,0.00004609446,0.000006799404,0.99517506,0.0010132464],"study_design_scores_gemma":[0.0024339096,0.00026863138,0.5258263,0.01658495,0.0007809014,0.000026053673,0.00005247188,0.000060314793,0.00007915528,0.0017865635,0.45157823,0.00052258425],"about_ca_topic_score_codex":0.0007952421,"about_ca_topic_score_gemma":0.000021138518,"teacher_disagreement_score":0.54359686,"about_ca_system_score_codex":0.00007660415,"about_ca_system_score_gemma":0.00045368905,"threshold_uncertainty_score":0.9999778},"labels":[],"label_agreement":null},{"id":"W2735120995","doi":"10.1136/annrheumdis-2018-213271","title":"Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Incyte; Eli Lilly and Company","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Adverse effect; Internal medicine; Prospective cohort study; Hazard ratio; Surgery; Gastroenterology; Confidence interval","score_opus":0.01356919667232581,"score_gpt":0.2811139419683195,"score_spread":0.2675447452959937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735120995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461395,0.002006072,0.000009841243,0.000452456,0.000063108186,0.0024235912,0.00026586078,0.000021345855,0.00014379386],"genre_scores_gemma":[0.99825835,0.0015250484,0.00003418245,0.000019130957,0.00001711194,0.00007789116,0.000019589272,0.000026204812,0.000022504297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972604,0.00031408746,0.00093110296,0.00029184986,0.0008672025,0.0003353723],"domain_scores_gemma":[0.9972406,0.00020251668,0.00059213326,0.0006730323,0.0010794001,0.00021229636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004738066,0.00020971506,0.0007466847,0.00025217008,0.00009403936,0.000015760974,0.00022733242,0.00003055041,0.000038987964],"category_scores_gemma":[0.0023967023,0.0001363767,0.00017199859,0.00054799655,0.0007149798,0.00021504473,0.00008522005,0.000112134374,0.0000019139147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033755228,0.0073727756,0.9361918,0.00039385332,0.0006476239,0.0000065042386,0.0031993494,0.000027191629,0.00004261306,0.00035656057,0.00036877702,0.01763775],"study_design_scores_gemma":[0.019516664,0.0035634928,0.96854573,0.0046551516,0.00002474071,0.0000017603502,0.0023390327,0.00006381906,0.00038189837,0.00077575364,0.000007763167,0.00012418187],"about_ca_topic_score_codex":0.0002690955,"about_ca_topic_score_gemma":0.00004460715,"teacher_disagreement_score":0.032353967,"about_ca_system_score_codex":0.000023293082,"about_ca_system_score_gemma":0.00030960765,"threshold_uncertainty_score":0.556128},"labels":[],"label_agreement":null},{"id":"W2735919225","doi":"10.1136/annrheumdis-2017-eular.1335","title":"FRI0092 Effects of baricitinib on haemoglobin and related laboratory parameters in rheumatoid arthritis patients","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Phlebotomy; Medicine; Rheumatoid arthritis; Placebo; Internal medicine; Erythropoietin; Methotrexate; Adalimumab; Gastroenterology; Anemia; Pathology","score_opus":0.015426850204907994,"score_gpt":0.2821655732377155,"score_spread":0.26673872303280755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735919225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883108,0.009429612,5.2468977e-7,0.0008414518,0.0001787957,0.0007114962,0.00009514224,0.0000166372,0.00041549694],"genre_scores_gemma":[0.9615141,0.038244087,0.000028620996,0.00012065746,0.000003277484,0.000035750913,0.000008802981,0.000021266591,0.000023424122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998249,0.00020171297,0.00052951067,0.0002218407,0.00049529306,0.00030266301],"domain_scores_gemma":[0.9979271,0.00047841092,0.0004254468,0.0008009656,0.00017509137,0.0001929407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025195925,0.00018751434,0.0006094001,0.00014830462,0.00016900426,0.000043243745,0.00029784342,0.000067142915,0.000027851544],"category_scores_gemma":[0.004412055,0.00013423398,0.00015956964,0.0001263788,0.0006110743,0.00018702445,0.00013448102,0.0001516909,0.000009994964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013095558,0.003172753,0.6893554,0.0021101658,0.00081007765,0.00007035214,0.0016755386,0.000026680907,0.00032518755,0.0027296261,0.0052971463,0.29311755],"study_design_scores_gemma":[0.004750691,0.00066335115,0.96938074,0.01209546,0.000007723991,0.0000042145757,0.0000917553,0.000065584645,0.009334222,0.0033680617,0.00009112719,0.00014705744],"about_ca_topic_score_codex":0.00017471604,"about_ca_topic_score_gemma":0.0000130221215,"teacher_disagreement_score":0.29297048,"about_ca_system_score_codex":0.000010867882,"about_ca_system_score_gemma":0.000100294885,"threshold_uncertainty_score":0.5473903},"labels":[],"label_agreement":null},{"id":"W2737567623","doi":"10.1136/annrheumdis-2017-212004","title":"GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies","year":2017,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"National Institute for Health and Care Research","keywords":"Dactylitis; Medicine; Psoriatic arthritis; Enthesitis; Observational study; Clinical trial; Physical therapy; Medical physics; Disease; Internal medicine","score_opus":0.5306006645642909,"score_gpt":0.5288818931098576,"score_spread":0.0017187714544333321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737567623","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37416208,0.044828534,0.0000021503865,0.5740008,0.0012506904,0.00239105,0.0031871148,0.000025857049,0.00015176047],"genre_scores_gemma":[0.6918934,0.08711966,0.00025879344,0.21716568,0.0012718571,0.0008634083,0.00040416158,0.00012173981,0.0009012724],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99547374,0.00081003184,0.0019186466,0.0005276617,0.00086050574,0.0004094412],"domain_scores_gemma":[0.99210787,0.0050388887,0.0013850037,0.0008270174,0.00047282473,0.00016837535],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015665385,0.00049096666,0.0038059677,0.00020820758,0.0002590616,0.00006244401,0.00027487427,0.0002070727,0.000061343264],"category_scores_gemma":[0.027013747,0.0003014659,0.0009601243,0.0001424484,0.0005033609,0.00015252447,0.0003210725,0.00048074205,0.000012092013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046798226,0.0005257977,0.32245117,0.0009597478,0.0064038425,0.00041787614,0.0003792537,0.0000011893504,5.311351e-8,0.00004470721,0.61254424,0.05580417],"study_design_scores_gemma":[0.004764965,0.0006487044,0.965523,0.010757095,0.0012254998,0.0000158962,0.00024148294,0.0000024222654,0.0000025678112,0.0042606965,0.012251767,0.00030591615],"about_ca_topic_score_codex":0.00007949824,"about_ca_topic_score_gemma":0.00008075252,"teacher_disagreement_score":0.64307183,"about_ca_system_score_codex":0.000045526536,"about_ca_system_score_gemma":0.00029270252,"threshold_uncertainty_score":0.99994373},"labels":[],"label_agreement":null},{"id":"W2739017157","doi":"10.1136/annrheumdis-2017-eular.1741","title":"OP0023 Four-year imaging outcomes in axial spondyloarthritis patients treated with certolizumab pegol, including patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Momenta Pharmaceuticals; Amgen; Pfizer; Genentech; Horizon Pharma; Eli Lilly and Company","keywords":"Certolizumab pegol; Medicine; Ankylosing spondylitis; Axial spondyloarthritis; Sacroiliitis; Bristol-Myers; Internal medicine; Spondylarthritis; Nuclear medicine; Mallinckrodt; Radiography; Surgery; Radiology; Rheumatoid arthritis; Adalimumab","score_opus":0.02221090532463449,"score_gpt":0.27115906367217885,"score_spread":0.24894815834754436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739017157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940332,0.000981308,0.0000021177211,0.001087931,0.00018086466,0.0015353272,0.0017123059,0.000051502753,0.00041541728],"genre_scores_gemma":[0.9984289,0.0008123513,0.00014230616,0.00008197504,0.000039840997,0.00010881046,0.00023262703,0.00009376296,0.0000594631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667937,0.00012701825,0.00074343215,0.00068319053,0.0009479792,0.00081900466],"domain_scores_gemma":[0.9972359,0.00019385098,0.0007060271,0.0011011814,0.00040951703,0.00035350825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009063409,0.00062954146,0.0013055926,0.00041799314,0.0009777624,0.00021712614,0.0003883194,0.000089311055,0.00009809379],"category_scores_gemma":[0.0005098713,0.00042299487,0.0003126097,0.0003635588,0.00088225707,0.0006974053,0.00035598944,0.00021957926,0.0000052885425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00260171,0.0011097908,0.9680525,0.00022251309,0.00045111537,0.00048482136,0.0003208928,0.0000011794084,0.000002091344,0.000036769747,0.00009712686,0.026619466],"study_design_scores_gemma":[0.022047307,0.0011968509,0.9702448,0.005067251,0.00036953716,0.00010998036,0.00020625944,0.00002958056,0.00004048279,0.00016546306,0.00007349908,0.00044899082],"about_ca_topic_score_codex":0.0013610591,"about_ca_topic_score_gemma":0.0005199868,"teacher_disagreement_score":0.026170475,"about_ca_system_score_codex":0.0000653194,"about_ca_system_score_gemma":0.00010448104,"threshold_uncertainty_score":0.9998222},"labels":[],"label_agreement":null},{"id":"W2739416456","doi":"10.1136/annrheumdis-2017-eular.3390","title":"OP0274 Fibromyalgia in real life: a national french web-based survey in 4516 patients","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Fibromyalgia; Medicine; Population; Physical therapy; Chronic pain; Feeling; Family medicine; Socioeconomic status","score_opus":0.2778479970381669,"score_gpt":0.5039312849049845,"score_spread":0.22608328786681758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739416456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969746,0.00016389771,8.5967537e-7,0.0053224238,0.0006390653,0.00081637874,0.000631392,0.000015293677,0.0027132176],"genre_scores_gemma":[0.9989348,0.00013365036,0.00001794182,0.0003700498,0.000027062351,0.000121985424,0.000051710987,0.000015764015,0.00032705913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948096,0.0030422155,0.0009482724,0.00021169876,0.0005959353,0.00039227144],"domain_scores_gemma":[0.99442863,0.0031148088,0.0011434964,0.0006573369,0.0004664199,0.00018929738],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030228195,0.00014625875,0.00040456172,0.0001341021,0.0005163724,0.00002930246,0.00060462963,0.00012498915,0.00028373342],"category_scores_gemma":[0.01949338,0.00010334866,0.00008929188,0.00016377794,0.00008594228,0.00031797666,0.00015639297,0.000282543,0.000063267624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081060214,0.00025923437,0.97692657,0.001334888,0.000017500008,6.2958503e-7,0.00039879314,0.000022447859,4.3649243e-7,0.00023240606,0.019660879,0.0010651742],"study_design_scores_gemma":[0.0011317594,0.000039605853,0.99356574,0.0032293012,0.0000047754143,3.142561e-8,0.00009552714,0.0005313037,0.0000011332248,0.00076969503,0.0005278905,0.00010323731],"about_ca_topic_score_codex":0.04081692,"about_ca_topic_score_gemma":0.009441297,"teacher_disagreement_score":0.031375624,"about_ca_system_score_codex":0.00005764561,"about_ca_system_score_gemma":0.002045621,"threshold_uncertainty_score":0.98876584},"labels":[],"label_agreement":null},{"id":"W2742515995","doi":"10.1136/annrheumdis-2017-211259","title":"Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Incyte; Eli Lilly and Company","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Placebo; Physical therapy; Internal medicine; Visual analogue scale","score_opus":0.12076640274954911,"score_gpt":0.4092374494778227,"score_spread":0.2884710467282736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742515995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601705,0.009011098,0.0000020746531,0.0006538987,0.000364971,0.002948392,0.00081833836,0.000040496503,0.00014368337],"genre_scores_gemma":[0.9936505,0.005806859,0.000020641006,0.00010762751,0.000024025048,0.00025513215,0.0000612909,0.000044412198,0.00002950195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953306,0.0006793942,0.0016161298,0.0005094528,0.0013828102,0.0004816377],"domain_scores_gemma":[0.99309224,0.0024000285,0.001314471,0.002623093,0.00031629376,0.0002538973],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005374498,0.00042117617,0.0015204585,0.00017008938,0.0005105248,0.00016778683,0.0010175888,0.00006461942,0.0010502066],"category_scores_gemma":[0.0061665974,0.00022802464,0.00043166333,0.0002554035,0.00050613936,0.00037187853,0.0004953497,0.0003197011,0.000010919789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03417083,0.032869983,0.70398694,0.000099514844,0.010744827,0.00034926782,0.023824807,0.000044375265,0.0001500584,0.000014020289,0.0035399045,0.19020545],"study_design_scores_gemma":[0.065599605,0.004077166,0.8679122,0.002448092,0.00016583073,0.0000052432924,0.05782742,0.00010947397,0.0009053796,0.00056204473,0.000087791304,0.00029979437],"about_ca_topic_score_codex":0.016670115,"about_ca_topic_score_gemma":0.004068517,"teacher_disagreement_score":0.18990566,"about_ca_system_score_codex":0.000023152086,"about_ca_system_score_gemma":0.00046945375,"threshold_uncertainty_score":0.99986297},"labels":[],"label_agreement":null},{"id":"W2742751361","doi":"10.1136/annrheumdis-2017-eular.4085","title":"FRI0047 Elevated 14-3-3eta levels predict worse radiographic outcomes in patients with recent-onset inflammatory arthritis in clinical remission","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Concomitant; Mann–Whitney U test","score_opus":0.04339232119212708,"score_gpt":0.3407526690085314,"score_spread":0.2973603478164043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742751361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306303,0.0031132896,0.000001250106,0.0022975763,0.00018786773,0.0010456708,0.00015215455,0.00003382191,0.00010536385],"genre_scores_gemma":[0.9733948,0.026205765,0.00004122069,0.00015333768,0.0000150612495,0.00004860507,0.000035214613,0.000032130334,0.000073844974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966297,0.0005159399,0.001142135,0.00034701484,0.0008592164,0.0005059837],"domain_scores_gemma":[0.9970191,0.00040239614,0.0005795312,0.0013620072,0.00027673418,0.00036024232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010721452,0.0002671302,0.0009202174,0.00029799668,0.0002323296,0.0000739506,0.0005796964,0.00011240855,0.00018305806],"category_scores_gemma":[0.006076913,0.00016635867,0.00028692765,0.00026190074,0.00069004967,0.0003650833,0.0001840849,0.00040521417,0.000011206453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011950755,0.0011850881,0.9222234,0.00013141969,0.0002132495,0.000023470218,0.00011960056,0.0000035967519,0.0000022875877,0.00002039379,0.0014256845,0.07345675],"study_design_scores_gemma":[0.00822131,0.00039147315,0.98172295,0.008153094,0.000011534329,0.0000031397894,0.00006219604,0.00004764291,0.000055924203,0.0008443075,0.0003126681,0.00017374803],"about_ca_topic_score_codex":0.00011317116,"about_ca_topic_score_gemma":0.0001836649,"teacher_disagreement_score":0.073283,"about_ca_system_score_codex":0.000018311337,"about_ca_system_score_gemma":0.00029656873,"threshold_uncertainty_score":0.7275071},"labels":[],"label_agreement":null},{"id":"W2743735384","doi":"10.1136/annrheumdis-2017-211300","title":"Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Health and Medical Research Council; Australian Research Council; Canadian Institutes of Health Research","keywords":"Immunology; Human leukocyte antigen; Vimentin; Citrulline; Medicine; Allele; Citrullination; Rheumatoid arthritis; Major histocompatibility complex; HLA-DRB1; Antigen; Genetics; Arginine; Biology; Gene; Immunohistochemistry","score_opus":0.032455803043566135,"score_gpt":0.33019747787705134,"score_spread":0.2977416748334852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743735384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205446,0.0029723651,0.00026209358,0.0017683511,0.00007565048,0.001693512,0.0010147454,0.000026294361,0.00013254698],"genre_scores_gemma":[0.99108714,0.007907563,0.00043329125,0.00032244268,0.000013832031,0.00015174173,0.00003020525,0.0000343071,0.00001946289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791044,0.00014672178,0.0005838999,0.00030445855,0.00059687585,0.00045759606],"domain_scores_gemma":[0.9966563,0.0003155346,0.0005000794,0.0014582257,0.0006519741,0.0004178726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003085503,0.00022694124,0.0008006958,0.00011912649,0.00041248472,0.000056399516,0.00064324803,0.000042403644,0.00007375575],"category_scores_gemma":[0.0039062195,0.00016866706,0.0005247088,0.0001589847,0.0006920153,0.00015082704,0.0002063904,0.000088344605,0.000008832559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003383093,0.0028164196,0.66656154,0.0015437969,0.0021347709,0.000027503267,0.00500575,0.000091911585,0.004836174,0.00089442305,0.0033044072,0.30940017],"study_design_scores_gemma":[0.00182488,0.0011767419,0.95653373,0.0032373758,0.000027966948,0.000013215166,0.0007084331,0.000067254994,0.03448004,0.0014731435,0.00021888592,0.0002383388],"about_ca_topic_score_codex":0.0022582184,"about_ca_topic_score_gemma":0.00053288374,"teacher_disagreement_score":0.30916184,"about_ca_system_score_codex":0.000022404558,"about_ca_system_score_gemma":0.00039202542,"threshold_uncertainty_score":0.68780434},"labels":[],"label_agreement":null},{"id":"W2743772575","doi":"10.1136/annrheumdis-2017-eular.4146","title":"THU0440 Temporal trends of venous thromboembolism risk before and after diagnosis of gout. a general population-based study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Research Canada","funders":"Simon Fraser University; University of British Columbia; Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Medicine; Gout; Pulmonary embolism; Cohort; Population; Diagnosis code; Internal medicine; Hazard ratio; Deep vein; Venous thrombosis; Cohort study; Incidence (geometry); Thrombosis; Confidence interval; Environmental health","score_opus":0.024868217064412494,"score_gpt":0.3179072622181471,"score_spread":0.2930390451537346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743772575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974045,0.0008636406,0.0000028673355,0.0006616868,0.00009475278,0.00047079846,0.0004239847,0.000014849615,0.00006289757],"genre_scores_gemma":[0.9994571,0.00007836974,0.00014898447,0.000083514045,0.00003734699,0.00007438914,0.000021320531,0.000025934982,0.00007304543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835825,0.0001222876,0.00058624934,0.00021894235,0.0005161931,0.0001980973],"domain_scores_gemma":[0.99742687,0.00013069031,0.000952563,0.0012134205,0.00014328473,0.0001331906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023825272,0.00020226618,0.00083823776,0.00012831521,0.00014265097,0.000019499932,0.00031830263,0.00005837521,0.00010393745],"category_scores_gemma":[0.0008470124,0.00013138357,0.0002843878,0.00011912909,0.00021868364,0.000119882694,0.00014820676,0.00008579311,0.0000012030196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017193022,0.0020001244,0.97907484,0.00042127524,0.00051687413,0.0000045157885,0.0010638993,0.00003245718,0.0000040564073,0.000015703266,0.00024165734,0.016452666],"study_design_scores_gemma":[0.0013137069,0.0006420069,0.9946536,0.00064421684,0.001225893,0.0000016494373,0.00021464196,0.00037785375,0.0001461084,0.00066891726,0.00000639483,0.00010505654],"about_ca_topic_score_codex":0.0030763578,"about_ca_topic_score_gemma":0.00016453883,"teacher_disagreement_score":0.01634761,"about_ca_system_score_codex":0.00001179464,"about_ca_system_score_gemma":0.000083563995,"threshold_uncertainty_score":0.5357666},"labels":[],"label_agreement":null},{"id":"W2744088480","doi":"10.1136/annrheumdis-2016-211049.25","title":"03.25 Three enzymes co-expressed on the outer membrane of p.gingivalis, collaborate in breaking tolerance to citrullinated proteins","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citrullination; Porphyromonas gingivalis; Antibody; Autoimmunity; Citrulline; Autoantibody; Microbiology; Immunology; Adjuvant; Medicine; Biology; Arginine; Periodontitis; Biochemistry; Amino acid","score_opus":0.06831445765720744,"score_gpt":0.3584225409410628,"score_spread":0.29010808328385534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744088480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921506,0.0005718974,0.0000073857877,0.004536909,0.00018582195,0.00086095225,0.0008445023,0.000014641955,0.0008272722],"genre_scores_gemma":[0.99882936,0.00009865944,0.000022455732,0.00027934535,0.000022626527,0.00007796019,0.000009975701,0.000017050872,0.0006425762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984543,0.0002896225,0.00042409272,0.00023481617,0.00028496445,0.0003122493],"domain_scores_gemma":[0.99780554,0.00031640782,0.00038972922,0.0011913554,0.0002295546,0.00006741123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047531127,0.00017299685,0.0004180488,0.00008142427,0.00030993938,0.00012126184,0.0013745428,0.00007693693,0.00041907976],"category_scores_gemma":[0.0014019948,0.00010295198,0.0001485746,0.00018556428,0.0003620719,0.00014712238,0.0002469809,0.00015567172,0.00008202884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056999787,0.0035863325,0.62330514,0.0049839513,0.0019410717,0.0002000145,0.004817201,0.0023287758,0.20616117,0.01976039,0.10286291,0.024353037],"study_design_scores_gemma":[0.00078972854,0.000111785455,0.74599534,0.0029684936,0.00002699986,0.0000033476745,0.00011384985,0.00022554628,0.24693386,0.0017205618,0.0008964027,0.00021410015],"about_ca_topic_score_codex":0.00068387965,"about_ca_topic_score_gemma":0.00040328765,"teacher_disagreement_score":0.12269015,"about_ca_system_score_codex":0.000010020684,"about_ca_system_score_gemma":0.00009709739,"threshold_uncertainty_score":0.45886296},"labels":[],"label_agreement":null},{"id":"W2744608496","doi":"10.1136/annrheumdis-2017-211388","title":"Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"UCB Pharma; Biogen","keywords":"Medicine; Placebo; Internal medicine; Adverse effect; Certolizumab pegol; Lupus erythematosus; Gastroenterology; Immunology; Antibody; Rheumatoid arthritis; Pathology","score_opus":0.04789686287682976,"score_gpt":0.338746928104959,"score_spread":0.29085006522812923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744608496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923104,0.0021852802,0.0000015183058,0.00055977755,0.000040084647,0.0045790193,0.00030010534,0.000010766172,0.000013039117],"genre_scores_gemma":[0.9992763,0.0003476081,0.0000040131276,0.000011951225,0.0000047346375,0.00024510483,0.000018457875,0.000023867706,0.000067967216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972844,0.00052189233,0.0009282805,0.00037665464,0.00060215505,0.00028658242],"domain_scores_gemma":[0.99795157,0.00019527724,0.00076758437,0.0007468138,0.00016308733,0.00017567702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006357796,0.00026973494,0.0012048765,0.00027655024,0.00006867938,0.000043827626,0.00029761568,0.000065738874,0.000009271773],"category_scores_gemma":[0.0004501527,0.00019818879,0.0001034659,0.00017704426,0.0002415799,0.0001726961,0.00010326079,0.00012829446,2.678885e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04753599,0.008064115,0.8278118,0.010455246,0.0004884821,0.000064386724,0.007705783,0.000006313821,0.09648329,0.0000023827424,0.00008989159,0.0012923391],"study_design_scores_gemma":[0.22587244,0.0021242457,0.6316283,0.027409565,0.0008345123,0.0005220145,0.0073944014,0.00870822,0.09487933,0.00012871102,6.9316275e-7,0.0004975754],"about_ca_topic_score_codex":0.0008832421,"about_ca_topic_score_gemma":0.0003155232,"teacher_disagreement_score":0.19618349,"about_ca_system_score_codex":0.000032156473,"about_ca_system_score_gemma":0.00022296944,"threshold_uncertainty_score":0.8081904},"labels":[],"label_agreement":null},{"id":"W2745656122","doi":"10.1136/annrheumdis-2017-eular.2484","title":"FRI0066 Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocyte invasiveness over the pi3k/akt pathway","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Instituto de Salud Carlos III; Hospital de Clínicas de Porto Alegre; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação Instituto de Pesquisas Econômicas; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Gastrin-releasing peptide; Protein kinase B; Arthritis; LY294002; Chemistry; Internal medicine; Cancer research; PI3K/AKT/mTOR pathway; Western blot; Medicine; Endocrinology; Signal transduction; Receptor; Bombesin; Biochemistry","score_opus":0.03397476697320668,"score_gpt":0.2906698480514027,"score_spread":0.25669508107819605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745656122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928562,0.0015644699,0.0000117366335,0.004239533,0.000052174113,0.0003657479,0.00022286359,0.00003460975,0.00065267313],"genre_scores_gemma":[0.996294,0.0013559937,0.000030558203,0.0011692692,0.00007848165,0.000029959017,0.000028409613,0.00002689323,0.0009864296],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99826247,0.0001888883,0.00046309456,0.00028438328,0.00048948743,0.0003116786],"domain_scores_gemma":[0.997646,0.00030156935,0.00054916355,0.0009783,0.00022219945,0.00030277547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002416982,0.00024669818,0.00050288986,0.00008473165,0.00070798676,0.00015719097,0.00037487346,0.00005766121,0.00060862687],"category_scores_gemma":[0.0020515644,0.00014934882,0.00039462745,0.00012411033,0.000377632,0.00029319784,0.00029041193,0.00014909389,0.000059315025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005425005,0.006688923,0.14221956,0.012761438,0.0070670466,0.00049609673,0.004017649,0.00038260664,0.055431455,0.00791996,0.22007103,0.5375192],"study_design_scores_gemma":[0.0056819418,0.0004652892,0.87882227,0.05888632,0.0007795941,0.00017686524,0.0013319587,0.0018075741,0.043463275,0.0023734146,0.005318162,0.00089331344],"about_ca_topic_score_codex":0.00029753364,"about_ca_topic_score_gemma":0.000042217223,"teacher_disagreement_score":0.7366027,"about_ca_system_score_codex":0.000016062902,"about_ca_system_score_gemma":0.00018371454,"threshold_uncertainty_score":0.6664038},"labels":[],"label_agreement":null},{"id":"W2746208055","doi":"10.1136/annrheumdis-2017-eular.6062","title":"THU0462 Mortality in patients with gout: a systematic review","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Gout; Medicine; Internal medicine; Uric acid; Hazard ratio; Cochrane Library; MEDLINE; Kidney disease; Cause of death; Disease; Intensive care medicine; Hyperuricemia; Meta-analysis; Confidence interval","score_opus":0.1375537653680652,"score_gpt":0.40903710385293557,"score_spread":0.2714833384848704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746208055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005354228,0.9907029,6.8911794e-7,0.00013412077,0.00009297656,0.007906985,0.00022870368,0.00003105719,0.0003671307],"genre_scores_gemma":[0.0014338979,0.9972318,0.00001312034,0.0003091241,0.000019212965,0.00055833824,0.00013541547,0.00007772877,0.00022140385],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99535537,0.000601019,0.0019797299,0.00045513656,0.0012011603,0.00040761623],"domain_scores_gemma":[0.99233186,0.00034416068,0.0031008266,0.0037255066,0.00025740493,0.0002402439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077450013,0.00065033586,0.0066356137,0.0001522258,0.00008900537,0.000044211472,0.0011425313,0.00015696508,0.00006891698],"category_scores_gemma":[0.0046733473,0.00031147196,0.0012856323,0.00037417476,0.00021985389,0.00016953108,0.00026791717,0.000333487,0.00007708704],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010725234,0.0005540859,0.0019657093,0.9690558,0.0015718512,0.000009787419,0.000026319121,1.09538114e-7,3.6075593e-10,0.000010760398,0.00091502344,0.025879886],"study_design_scores_gemma":[0.00045011993,0.00007718731,0.0103984745,0.9662132,0.019539788,0.00001366718,0.000008666118,0.0000013922537,4.0759968e-8,0.0000374748,0.0029587548,0.00030123498],"about_ca_topic_score_codex":0.00006527477,"about_ca_topic_score_gemma":0.0000043341206,"teacher_disagreement_score":0.02557865,"about_ca_system_score_codex":0.00007490609,"about_ca_system_score_gemma":0.00066401606,"threshold_uncertainty_score":0.9999337},"labels":[],"label_agreement":null},{"id":"W2746582800","doi":"10.1136/annrheumdis-2017-eular.2512","title":"FRI0173 Correlation between assymetric dimethylarginine and homocysteine levels in patients with rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Methylenetetrahydrofolate reductase; Medicine; Internal medicine; Asymmetric dimethylarginine; Homocysteine; Endothelial dysfunction; Interquartile range; Diabetes mellitus; Rheumatoid arthritis; Endocrinology; Gastroenterology; Genotype; Biology; Arginine","score_opus":0.04189210254584254,"score_gpt":0.315672126686086,"score_spread":0.2737800241402435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746582800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643564,0.0016792505,0.000017807457,0.0009335236,0.000042143904,0.0005152901,0.00011198847,0.00001205159,0.00025228068],"genre_scores_gemma":[0.9988251,0.0008383688,0.000048915503,0.00003519689,0.000012606088,0.000012686624,0.00003103396,0.000018321049,0.00017779708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855167,0.00008052572,0.0003615154,0.00019286477,0.00056297705,0.00025045357],"domain_scores_gemma":[0.99844897,0.00021247158,0.00029799104,0.00068398897,0.00020043648,0.00015616024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028413645,0.00014857182,0.00046750638,0.00022543356,0.00019468671,0.000059249534,0.00020328803,0.000055960263,0.00005041029],"category_scores_gemma":[0.0014138574,0.000091935675,0.00007876125,0.00023593061,0.00023693683,0.0002822925,0.00016451896,0.0001425665,0.000010574996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012287039,0.0002497781,0.92083204,0.00015814643,0.00012908925,0.0000039838146,0.00008998335,0.0000031557192,0.0000031129389,0.000037617127,0.0002562023,0.078114],"study_design_scores_gemma":[0.0033424504,0.00042053097,0.9935718,0.0019064293,0.00003674726,0.0000023377474,0.000031485346,0.00014881509,0.00016915466,0.00022813771,0.000036823974,0.00010527755],"about_ca_topic_score_codex":0.0002152206,"about_ca_topic_score_gemma":0.000016847564,"teacher_disagreement_score":0.078008726,"about_ca_system_score_codex":0.0000125044,"about_ca_system_score_gemma":0.00007862132,"threshold_uncertainty_score":0.37490278},"labels":[],"label_agreement":null},{"id":"W2746830037","doi":"10.1136/annrheumdis-2017-eular.3404","title":"AB0115 Comparison of the bacterial stool microbiota in established psoriatic arthritis (PSA) and psoriasis (PSC) - exploratory analysis of pilot data","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Glenmark Pharmaceuticals; Pfizer; Eli Lilly and Company","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Gut flora; Dysbiosis; Microbiome; Alpha diversity; Internal medicine; Gastroenterology; Immunology; Bioinformatics; Biology; Ecology; Species diversity","score_opus":0.08140414731934113,"score_gpt":0.3493087921145033,"score_spread":0.26790464479516213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746830037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949892,0.0027499793,0.000008011507,0.00041475036,0.00023397536,0.0002638319,0.0013161309,0.0000020314847,0.000022044325],"genre_scores_gemma":[0.9979247,0.001745238,0.000056134395,0.000059579696,0.000025917952,0.0000060738553,0.00015508059,0.000011466117,0.000015813182],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985316,0.0002189223,0.00062650634,0.00027879496,0.00015263948,0.00019153782],"domain_scores_gemma":[0.996798,0.000057739475,0.0008895501,0.0020820478,0.00010939995,0.00006327521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003641746,0.00015181964,0.0005859839,0.00008002051,0.00013855576,0.000041608975,0.0011915857,0.00006593755,0.000028568613],"category_scores_gemma":[0.0007724065,0.0001044664,0.00016123617,0.00016217963,0.00037007063,0.000026078218,0.00079339975,0.00006206551,4.24527e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012860042,0.0030994667,0.37568668,0.0020141362,0.00409424,9.3796405e-7,0.0016647406,0.0002044766,0.54855067,0.00018664099,0.028278735,0.0349333],"study_design_scores_gemma":[0.0011340528,0.0001842225,0.9617934,0.0005491017,0.00060139655,6.83248e-7,0.00031651102,0.0002178234,0.03460564,0.00009017905,0.00034099194,0.00016600112],"about_ca_topic_score_codex":0.00046976027,"about_ca_topic_score_gemma":0.0012676922,"teacher_disagreement_score":0.5861067,"about_ca_system_score_codex":0.0000043653426,"about_ca_system_score_gemma":0.00017072973,"threshold_uncertainty_score":0.42600164},"labels":[],"label_agreement":null},{"id":"W2747313723","doi":"10.1136/annrheumdis-2017-eular.1791","title":"AB0286 14 cases study of macrophage activation syndrome (MAS) in systemic onset juvenile idiopathic arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Japan; Ono Pharmaceutical; AbbVie Canada; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Tanabe Pharma Corporation; Japan Blood Products Organization; Chugai Pharmaceutical; Teijin Pharma; Pfizer","keywords":"Macrophage activation syndrome; Medicine; Hepatosplenomegaly; Hemophagocytosis; Internal medicine; Arthritis; Retrospective cohort study; Immunology; Pediatrics; Bone marrow; Pancytopenia","score_opus":0.04963062336469869,"score_gpt":0.3380899538126767,"score_spread":0.288459330447978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747313723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459016,0.003632553,0.0000019916804,0.00045642108,0.000069799455,0.001055843,0.00004325354,0.000016240772,0.00013374507],"genre_scores_gemma":[0.9989028,0.00071744906,0.0000020600635,0.000034606634,0.000006412332,0.000081605016,0.000006607207,0.000020505213,0.00022795373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978735,0.000243759,0.00084909314,0.00019609515,0.00059051125,0.00024707805],"domain_scores_gemma":[0.9976493,0.00014847427,0.00070504623,0.0012282892,0.00018450545,0.00008436656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005894128,0.00015864147,0.00079574075,0.00016281399,0.0002080279,0.00003459163,0.00045994265,0.0000578695,0.0000853614],"category_scores_gemma":[0.0026855809,0.000115898656,0.00017595445,0.00014578267,0.0001848011,0.0002493553,0.00019831417,0.00015687064,0.000016061149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014815616,0.008871659,0.8855271,0.009675016,0.0008505027,0.0009416687,0.0055821678,0.00020001388,0.0014071674,0.00015341978,0.0025280244,0.08278173],"study_design_scores_gemma":[0.0024565603,0.0007691771,0.9820326,0.009217768,0.00006269601,0.0001447567,0.0034349442,0.00014577976,0.001344207,0.0002541733,0.000012198378,0.00012512309],"about_ca_topic_score_codex":0.0012095437,"about_ca_topic_score_gemma":0.00007597073,"teacher_disagreement_score":0.096505545,"about_ca_system_score_codex":0.000025778516,"about_ca_system_score_gemma":0.00026298664,"threshold_uncertainty_score":0.472621},"labels":[],"label_agreement":null},{"id":"W2747836692","doi":"10.1136/annrheumdis-2017-eular.2165","title":"THU0006 Trans-ethnic meta-analysis of genome-wide association studies identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Genome-wide association study; Genetics; Biology; Single-nucleotide polymorphism; Genetic association; Gene; Locus (genetics); SNP; Genotype","score_opus":0.2269056832654786,"score_gpt":0.384576276500883,"score_spread":0.1576705932354044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747836692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84537107,0.14967138,0.000006489137,0.003670863,0.000118968426,0.0007830849,0.00029499648,0.00002418017,0.000058960235],"genre_scores_gemma":[0.9765697,0.022179617,0.00001228296,0.00035456076,0.000018897817,0.00009240189,0.000012693549,0.000019081948,0.0007407712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970142,0.00041778237,0.0010745453,0.00039859148,0.00082308945,0.00027176068],"domain_scores_gemma":[0.99474776,0.0015247139,0.001335975,0.0014208917,0.0007449918,0.00022565211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013708507,0.00027098926,0.002096014,0.00022730145,0.00031117533,0.00007137981,0.00044507207,0.00010086404,0.00012060607],"category_scores_gemma":[0.008104631,0.00015989461,0.0019227889,0.00038551778,0.0002673101,0.00017688215,0.00018254947,0.00006769364,0.000008175934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046299916,0.00089152553,0.49575675,0.00522933,0.47848892,0.0000021090605,0.00463267,0.0007858759,0.005271951,0.000054718625,0.0038822684,0.004540898],"study_design_scores_gemma":[0.00036993626,0.000078578145,0.82431555,0.001325741,0.16965164,8.209334e-7,0.0019509117,0.000040603427,0.0019094527,0.00021230945,0.0000051471707,0.00013932356],"about_ca_topic_score_codex":0.00041040286,"about_ca_topic_score_gemma":0.00010030151,"teacher_disagreement_score":0.3285588,"about_ca_system_score_codex":0.000051122777,"about_ca_system_score_gemma":0.00009486573,"threshold_uncertainty_score":0.97025853},"labels":[],"label_agreement":null},{"id":"W2748681743","doi":"10.1136/annrheumdis-2017-eular.1747","title":"AB0199 Methotrexate response in early rheumatoid arthritis assessed using a somamer proteomic assay","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Methotrexate; Rheumatoid arthritis; Logistic regression; Weighting; Population; Internal medicine; Hierarchical clustering; Oncology; Cluster analysis; Statistics; Mathematics","score_opus":0.09408622365418562,"score_gpt":0.39698115112767246,"score_spread":0.30289492747348684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748681743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918284,0.0014751911,0.000020790347,0.0052992622,0.00010551946,0.0007449973,0.000087140375,0.00001960514,0.0004190864],"genre_scores_gemma":[0.9967779,0.001703638,0.00052898924,0.00019627393,0.000026444532,0.000046016296,0.000004471852,0.000030972387,0.00068530027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973291,0.0006533735,0.00057174085,0.00028315862,0.0006932771,0.00046931134],"domain_scores_gemma":[0.99751866,0.0005504622,0.00044613704,0.0010572674,0.00019203042,0.00023547068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013549728,0.00022787435,0.00065842865,0.00017636507,0.0003450777,0.00011517556,0.00059339456,0.00007439804,0.00015681512],"category_scores_gemma":[0.0039533265,0.00015163222,0.00036535785,0.0001528484,0.00046987872,0.0002622453,0.00031116695,0.00023197387,0.000038166854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018539486,0.0021990924,0.8723012,0.001658391,0.0010120639,0.00032563214,0.0013748837,0.000089134584,0.029566346,0.0009546024,0.0021942484,0.0697849],"study_design_scores_gemma":[0.0013164672,0.0002007694,0.98051983,0.0042658867,0.000028177876,0.000033871973,0.00006277242,0.001704492,0.009442756,0.0020371866,0.00020438597,0.00018338082],"about_ca_topic_score_codex":0.0018261049,"about_ca_topic_score_gemma":0.00002674559,"teacher_disagreement_score":0.10821863,"about_ca_system_score_codex":0.000025963935,"about_ca_system_score_gemma":0.00042084,"threshold_uncertainty_score":0.6183383},"labels":[],"label_agreement":null},{"id":"W2749517741","doi":"10.1136/annrheumdis-2017-eular.4992","title":"SAT0149 Comparative effectiveness of tofacitinib, biologic drugs and traditional disease-modifying antirheumatic drugs in rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Celltrion","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Methotrexate; Antirheumatic drugs; Internal medicine; Janus kinase inhibitor; Cohort; Pharmacy; Antirheumatic Agents; Pharmacology","score_opus":0.08376000932739558,"score_gpt":0.3470339129770998,"score_spread":0.2632739036497042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749517741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977628,0.019508276,0.0000101259075,0.00075948826,0.00012251009,0.000979685,0.0005490453,0.00002569752,0.00041715658],"genre_scores_gemma":[0.959675,0.040025976,0.00005506127,0.00003912024,0.000011039659,0.00010462686,0.000057895882,0.000020107178,0.000011151519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971872,0.00064373604,0.00073733943,0.00035972317,0.00064886437,0.00042313675],"domain_scores_gemma":[0.9965731,0.0015099617,0.0005610424,0.0008238864,0.00020961136,0.00032237908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010346781,0.00029951523,0.0011452772,0.00020185701,0.00037852032,0.00008614857,0.0004578815,0.000063635176,0.000104754035],"category_scores_gemma":[0.0017589363,0.00021419769,0.0003348242,0.0001501599,0.0015607667,0.00038091175,0.00020321688,0.00018829167,0.0000075057224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006950484,0.0037494947,0.85048324,0.008503988,0.001513341,0.000040061925,0.007265411,0.00010079974,0.0010790522,0.025458008,0.0008861366,0.09396997],"study_design_scores_gemma":[0.00397997,0.00022514419,0.95425636,0.017919863,0.000012722107,0.000018581797,0.0010561108,0.00055641826,0.0016462815,0.02007116,0.00003329481,0.00022412719],"about_ca_topic_score_codex":0.00021578731,"about_ca_topic_score_gemma":0.000010783728,"teacher_disagreement_score":0.10377308,"about_ca_system_score_codex":0.0000196704,"about_ca_system_score_gemma":0.00024529928,"threshold_uncertainty_score":0.8734728},"labels":[],"label_agreement":null},{"id":"W2750331265","doi":"10.1136/annrheumdis-2017-eular.5161","title":"FRI0722 Cross-sectional associations between demographic, job related, health related and psychosocial factors and three different measures of presenteeism: results from eular-pro at-work productivity study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Presenteeism; Psychosocial; Medicine; Attribution; Productivity; Scale (ratio); Physical therapy; Gerontology; Demography; Psychology; Absenteeism; Psychiatry; Social psychology","score_opus":0.15372711476958348,"score_gpt":0.4268826687528806,"score_spread":0.27315555398329716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750331265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861747,0.0014753154,0.0000044336894,0.0077724066,0.0006525431,0.0022514276,0.0014556788,0.000049672693,0.00016383611],"genre_scores_gemma":[0.99901724,0.00044506218,0.000011250823,0.000042002757,0.000091568734,0.000057337802,0.00008533373,0.000029996365,0.00022021717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949515,0.0015485774,0.0016626194,0.00053382607,0.0007656865,0.00053782953],"domain_scores_gemma":[0.99323016,0.0023299297,0.0028501796,0.0009418134,0.00029353207,0.0003543753],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0021072743,0.00028527065,0.000879249,0.00010942095,0.003685947,0.00005165487,0.00043091338,0.00022880775,0.000025434263],"category_scores_gemma":[0.0050511607,0.00019700662,0.00020169945,0.00019439397,0.00043784187,0.00022741723,0.00045102902,0.00059214525,0.0000027440205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003319675,0.00033551687,0.9904215,0.00023696588,0.00056105846,2.7330304e-7,0.005047974,0.0000055357345,0.0000011686261,0.00011310862,0.0019048735,0.0010400858],"study_design_scores_gemma":[0.0018430578,0.00011890534,0.9777248,0.000798427,0.00012273702,1.268109e-7,0.00040327088,0.0000111763975,0.0000058636397,0.018803895,0.000016696631,0.00015106869],"about_ca_topic_score_codex":0.007432903,"about_ca_topic_score_gemma":0.0018955038,"teacher_disagreement_score":0.018690785,"about_ca_system_score_codex":0.000064767584,"about_ca_system_score_gemma":0.00025596362,"threshold_uncertainty_score":0.9991767},"labels":[],"label_agreement":null},{"id":"W2750410794","doi":"10.1136/annrheumdis-2017-211585","title":"The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Agence Nationale de la Recherche; National Institute for Health and Care Research","keywords":"Medicine; Rheumatology; Internal medicine; Rheumatism; Wrist; Physical therapy; Delphi; Radiology","score_opus":0.034333522864009126,"score_gpt":0.3598468552876055,"score_spread":0.32551333242359637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750410794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94785887,0.031534024,0.000054378233,0.017993137,0.0002974538,0.001409121,0.00015489773,0.000029268534,0.0006688416],"genre_scores_gemma":[0.972171,0.027302086,0.000041934065,0.00010529957,0.000015065826,0.00015530501,0.000007684542,0.000022136042,0.0001794992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839616,0.00009851793,0.0004360363,0.00019994451,0.00040326407,0.00046610675],"domain_scores_gemma":[0.9973537,0.000837107,0.0003494104,0.0010665851,0.00024923956,0.00014400437],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006055956,0.00016278608,0.00042270657,0.00006251993,0.00095737644,0.00018780804,0.00071935385,0.000031172043,0.000027787417],"category_scores_gemma":[0.010536455,0.00008871349,0.0002862866,0.000050764706,0.00086339633,0.00019549635,0.00012062986,0.000098743025,0.000005513817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035634956,0.00092645147,0.7059306,0.0028981066,0.000890668,0.000024573417,0.0016751536,0.000026092668,0.00054108654,0.015737329,0.1381517,0.12963472],"study_design_scores_gemma":[0.005559087,0.00020816344,0.9174325,0.0058661764,0.000037778056,0.00012645392,0.0013943448,0.0005294578,0.0020695105,0.058089245,0.008382222,0.00030506167],"about_ca_topic_score_codex":0.00013252156,"about_ca_topic_score_gemma":0.000099030585,"teacher_disagreement_score":0.21150188,"about_ca_system_score_codex":0.000013411507,"about_ca_system_score_gemma":0.00037736577,"threshold_uncertainty_score":0.9977982},"labels":[],"label_agreement":null},{"id":"W2751178115","doi":"10.1136/annrheumdis-2017-eular.2444","title":"SAT0469 Integrated efficacy analysis of tofacitinib, an oral janus kinase inhibitor, in patients with active psoriatic arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Dactylitis; Adalimumab; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Janus kinase inhibitor; Internal medicine; Psoriasis; Enthesitis; Tolerability; Placebo; Methotrexate; Gastroenterology; Arthritis; Dermatology; Adverse effect; Rheumatoid arthritis","score_opus":0.03308478355887003,"score_gpt":0.32860026088970057,"score_spread":0.29551547733083056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751178115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839723,0.00027537614,0.0000041746816,0.0002494375,0.000036030968,0.00059147924,0.00026531392,0.00001249778,0.00016847],"genre_scores_gemma":[0.99951446,0.00016802616,0.000024545263,0.000051905143,0.000004827307,0.00002234543,0.00015777154,0.000016786318,0.00003933531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981492,0.00017466338,0.0005860507,0.00022074855,0.0006014151,0.00026790463],"domain_scores_gemma":[0.99767447,0.000103483355,0.00055952364,0.0011130401,0.00041021855,0.00013924533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022361714,0.00018443225,0.00086210837,0.0003250933,0.0001382402,0.00003793789,0.00040192588,0.000055810528,0.00021680721],"category_scores_gemma":[0.0015821665,0.00011610255,0.00027240865,0.00048955827,0.00041383712,0.00034161008,0.00011198298,0.00014390616,0.0000040908335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021303822,0.0030182248,0.5483652,0.00021743285,0.0020355957,0.00000783558,0.0009993424,0.00010690294,0.00001619566,0.0000689062,0.00018597719,0.442848],"study_design_scores_gemma":[0.0037840616,0.00054352375,0.9915831,0.0011723323,0.0005354875,1.9862271e-7,0.0005704456,0.0005403982,0.0010029116,0.000110967194,0.00003317699,0.0001233613],"about_ca_topic_score_codex":0.00071521185,"about_ca_topic_score_gemma":0.00017304184,"teacher_disagreement_score":0.44321793,"about_ca_system_score_codex":0.000019431036,"about_ca_system_score_gemma":0.00027193865,"threshold_uncertainty_score":0.47345245},"labels":[],"label_agreement":null},{"id":"W2751269869","doi":"10.1136/annrheumdis-2017-211328","title":"Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"Janssen Research and Development; Regeneron Pharmaceuticals; Genentech; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Rheumatoid arthritis; Placebo; Internal medicine; Adverse effect; Clinical endpoint; Rheumatology; Gastroenterology; Methotrexate; Arthritis; Clinical trial; Pathology","score_opus":0.07247113780770482,"score_gpt":0.39159478649063734,"score_spread":0.3191236486829325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751269869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701279,0.017687244,0.00009048201,0.007800844,0.00038338848,0.0031880147,0.00017629747,0.00005688734,0.0004889673],"genre_scores_gemma":[0.98076874,0.017903924,0.000037154092,0.00030653118,0.00006788607,0.00043391302,0.000013522605,0.000041686097,0.00042662796],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997554,0.00017196407,0.00066542573,0.00030740094,0.0007744655,0.0005267433],"domain_scores_gemma":[0.99618,0.0004986736,0.00053853507,0.0021494206,0.00037642012,0.00025696607],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00075282226,0.00026872623,0.00070647825,0.00007085557,0.0015663381,0.00029611497,0.0011167257,0.000044850985,0.00016925193],"category_scores_gemma":[0.0026951553,0.00014629023,0.0005493478,0.00009213868,0.0007798924,0.00031872702,0.0002878463,0.0001583231,0.000025131827],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005815071,0.012491843,0.020462437,0.00059713423,0.003540906,0.000037563274,0.005243624,0.000011910744,0.00016675991,0.008251817,0.062451147,0.88092977],"study_design_scores_gemma":[0.17886962,0.014936584,0.5615533,0.021691233,0.00040906292,0.00040804074,0.035018686,0.0037916708,0.00713625,0.11027411,0.06350766,0.002403752],"about_ca_topic_score_codex":0.0002768355,"about_ca_topic_score_gemma":0.00009564191,"teacher_disagreement_score":0.87852603,"about_ca_system_score_codex":0.000012650653,"about_ca_system_score_gemma":0.00025146912,"threshold_uncertainty_score":0.9997335},"labels":[],"label_agreement":null},{"id":"W2751453946","doi":"10.1136/annrheumdis-2017-211898","title":"European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council; Versus Arthritis; Rosetrees Trust","keywords":"Medicine; Azathioprine; Lupus nephritis; Prednisone; Rheumatology; Nephrology; Systemic lupus erythematosus; Internal medicine; Pediatrics; Intensive care medicine; Disease","score_opus":0.24917116503957545,"score_gpt":0.40435616735393265,"score_spread":0.1551850023143572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751453946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8346316,0.025390584,0.000028477763,0.13391091,0.00023731876,0.0039275778,0.0015602863,0.00002241401,0.00029082043],"genre_scores_gemma":[0.98516303,0.013421109,0.000043994663,0.0005144216,0.000046522066,0.0006075235,0.00002132626,0.000022582344,0.00015947859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854904,0.00037317918,0.00039056913,0.00017035956,0.00032119025,0.00019563528],"domain_scores_gemma":[0.9934366,0.004504117,0.00048443038,0.0012016963,0.00027754606,0.000095637726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052061316,0.00015068715,0.00034850647,0.000046167574,0.00063110085,0.00007890299,0.0005317067,0.000021729677,0.00009168807],"category_scores_gemma":[0.005666453,0.00006489655,0.00027880678,0.00007603729,0.0004568377,0.00013391663,0.0001320862,0.000050776387,0.000005120797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051082403,0.0015837577,0.61624295,0.0019554275,0.0017682663,0.0000051626535,0.009599447,0.000014340033,0.0000067810993,0.00027076976,0.111134075,0.25690818],"study_design_scores_gemma":[0.0036759146,0.0010928352,0.9559448,0.025528356,0.0009953983,0.00015941626,0.0059189517,0.0006873423,0.0011106658,0.0011632163,0.0035317931,0.00019131973],"about_ca_topic_score_codex":0.0001302512,"about_ca_topic_score_gemma":0.0000229995,"teacher_disagreement_score":0.33970183,"about_ca_system_score_codex":0.000021514943,"about_ca_system_score_gemma":0.00018444346,"threshold_uncertainty_score":0.6783683},"labels":[],"label_agreement":null},{"id":"W2751686928","doi":"10.1136/annrheumdis-2017-eular.1571","title":"OP0049 Systematic review of randomized controlled trials evaluating bisphosphonates for the prevention and treatment of glucocorticoid- induced osteoporosis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Queen's University","funders":"UCB Pharma; Astellas Pharma; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Cochrane Library; Osteoporosis; Randomized controlled trial; Placebo; MEDLINE; Internal medicine; Meta-analysis; Prednisone; Physical therapy; Alternative medicine; Pathology","score_opus":0.1622742524840805,"score_gpt":0.4539380274889285,"score_spread":0.29166377500484797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751686928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6138975,0.34645444,0.0000122012125,0.0036853463,0.00020043459,0.035604104,0.00008896727,0.000007745247,0.000049235754],"genre_scores_gemma":[0.93437725,0.062058806,0.000079631995,0.0001119426,0.000005509844,0.0028140892,0.000009752279,0.000012461758,0.000530527],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958683,0.0009977001,0.002438929,0.00013812937,0.00041255026,0.00014433685],"domain_scores_gemma":[0.9842878,0.008771072,0.0055649336,0.0008666557,0.0004280935,0.000081435326],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0048479843,0.0001882515,0.005779447,0.000040668423,0.00013665365,0.000016915455,0.00014845232,0.000037247246,0.000022556143],"category_scores_gemma":[0.046556477,0.00007122193,0.0017543823,0.00004726282,0.00014798863,0.000056528224,0.000031734082,0.000020604517,6.967002e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09662838,0.0020912292,0.0015084745,0.8387772,0.016960772,5.012822e-7,0.00073925947,0.000003919258,0.00017194057,0.0002904163,0.00014137066,0.04268653],"study_design_scores_gemma":[0.4088715,0.002144513,0.0075167194,0.513118,0.059438497,0.0000044905273,0.00029966127,0.00234865,0.004010438,0.002112447,0.0000012402696,0.00013384483],"about_ca_topic_score_codex":0.0003064138,"about_ca_topic_score_gemma":0.000005479212,"teacher_disagreement_score":0.3256592,"about_ca_system_score_codex":0.000018882072,"about_ca_system_score_gemma":0.000334304,"threshold_uncertainty_score":0.9614748},"labels":[],"label_agreement":null},{"id":"W2751997314","doi":"10.1136/annrheumdis-2017-eular.2934","title":"THU0061 Regulation of osteoclast recruitment and activation by resolvin d1","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Università di Pisa; Canadian Institutes of Health Research; Ohio State University","keywords":"Viability assay; Chemistry; Osteocalcin; Cathepsin K; Bone resorption; Osteoclast; Inflammation; Bone remodeling; Internal medicine; Endocrinology; Andrology; Molecular biology; Apoptosis; Alkaline phosphatase; Medicine; Biochemistry; In vitro; Biology; Enzyme","score_opus":0.06587026659939343,"score_gpt":0.3360272904164206,"score_spread":0.27015702381702716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751997314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642825,0.00043702705,0.000011309547,0.0019198175,0.00008673999,0.0005746603,0.000024010029,0.000008743834,0.0005094509],"genre_scores_gemma":[0.99933314,0.0001903868,0.000023680544,0.00008370311,0.000024144347,0.000024630493,0.000012119403,0.000009049482,0.0002991198],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992443,0.000060159706,0.00024044466,0.00010010518,0.0002552542,0.000099786776],"domain_scores_gemma":[0.998738,0.0001238794,0.00044640357,0.0005233835,0.000093368115,0.00007498074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021785311,0.00008711924,0.00023687443,0.00003318929,0.00012998057,0.000015244679,0.00010829668,0.0000371224,0.00003603723],"category_scores_gemma":[0.0009075877,0.00005601244,0.000080465674,0.000029806337,0.00015894094,0.00012723518,0.00005962307,0.000036936126,0.0000020568682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002529885,0.0013608062,0.26483402,0.007836457,0.0008682434,0.000003573666,0.0026084092,0.000033926066,0.075211,0.003018994,0.1418433,0.49985138],"study_design_scores_gemma":[0.0007772786,0.00016729816,0.8788744,0.0018487051,0.000097840086,0.0000014880017,0.00006574965,0.000359832,0.1160935,0.0010744331,0.0005696885,0.000069744434],"about_ca_topic_score_codex":0.00005221084,"about_ca_topic_score_gemma":0.000002484563,"teacher_disagreement_score":0.61404043,"about_ca_system_score_codex":0.000008104183,"about_ca_system_score_gemma":0.000047009333,"threshold_uncertainty_score":0.22841209},"labels":[],"label_agreement":null},{"id":"W2752032723","doi":"10.1136/annrheumdis-2017-eular.4867","title":"OP0183 Cordycepin, a novel compound, reduces knee joint pathology and pain in the monosodium iodoacetate (MIA) rat model of osteoarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Université de Montréal; Arthritis Society","keywords":"Cordycepin; Medicine; Osteoarthritis; Inflammation; Arthritis; Pathology; Internal medicine; Endocrinology; Chemistry","score_opus":0.07367787831994102,"score_gpt":0.3011819389839867,"score_spread":0.2275040606640457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752032723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991452,0.0028406584,0.00003936923,0.004199982,0.00012795613,0.0008157409,0.0001373473,0.000011756738,0.0003752144],"genre_scores_gemma":[0.998147,0.0008066396,0.00036323044,0.00042138365,0.000016499762,0.000074703894,0.000015565485,0.000016572869,0.00013840057],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859935,0.000175286,0.0004667161,0.00021790035,0.00028841707,0.00025230052],"domain_scores_gemma":[0.9983753,0.00017847147,0.00044583913,0.00080462557,0.00010213417,0.00009365314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005895582,0.00019286486,0.0005832047,0.000072898714,0.0001906891,0.000044477896,0.00029429514,0.000058978578,0.000011023001],"category_scores_gemma":[0.00071823754,0.00011717938,0.00019597834,0.000055255812,0.00047733457,0.00013387208,0.00014648214,0.0000944097,0.0000022888269],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022412157,0.00455847,0.015220524,0.0021682843,0.00038088954,0.00026130988,0.008624068,0.00027745348,0.07228665,0.0063546696,0.0033729037,0.88425356],"study_design_scores_gemma":[0.08941167,0.037486333,0.27936813,0.04270906,0.0038612455,0.0018182925,0.023361072,0.030403785,0.3068249,0.18095867,0.0005967931,0.0032000758],"about_ca_topic_score_codex":0.000055158987,"about_ca_topic_score_gemma":0.00004336721,"teacher_disagreement_score":0.8810535,"about_ca_system_score_codex":0.000006842821,"about_ca_system_score_gemma":0.00009310145,"threshold_uncertainty_score":0.4778436},"labels":[],"label_agreement":null},{"id":"W2752063004","doi":"10.1136/annrheumdis-2001.1216","title":"OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial)","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Methotrexate; Placebo; Internal medicine; Adverse effect; Dose-ranging study; Refractory (planetary science); Gastroenterology; Surgery; Double blind; Pathology","score_opus":0.14078556034577666,"score_gpt":0.4322839467827096,"score_spread":0.29149838643693293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752063004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98682564,0.0005312665,0.0000039599427,0.00652011,0.00023434217,0.005438127,0.00006715641,0.00003480917,0.0003446124],"genre_scores_gemma":[0.9970849,0.0010508272,0.000009870266,0.0011662857,0.00014340821,0.00016959889,0.00003905568,0.000059009835,0.00027702627],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9928056,0.0026622813,0.0013322079,0.0005694709,0.0019267763,0.0007036728],"domain_scores_gemma":[0.99183285,0.0047136154,0.0007897676,0.0021061304,0.00036018118,0.00019747116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036230849,0.00042845926,0.00094035064,0.00014473622,0.00057551917,0.00009833475,0.0013445816,0.000085420324,0.000071965136],"category_scores_gemma":[0.0023777164,0.00016160407,0.0005132326,0.00087603123,0.000851407,0.00015843278,0.0003193917,0.00065612927,0.000019501847],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58174443,0.036844324,0.07337539,0.00025326008,0.007512697,0.00023318974,0.013663576,0.0023280533,0.00002587226,0.00023649112,0.009671559,0.27411115],"study_design_scores_gemma":[0.20050278,0.004688419,0.7878844,0.0010126868,0.00038029486,0.000010267204,0.002930174,0.0013196013,0.000118420096,0.00041899647,0.0004569086,0.00027703837],"about_ca_topic_score_codex":0.0012062244,"about_ca_topic_score_gemma":0.000079773425,"teacher_disagreement_score":0.714509,"about_ca_system_score_codex":0.00044107132,"about_ca_system_score_gemma":0.0019091285,"threshold_uncertainty_score":0.65900224},"labels":[],"label_agreement":null},{"id":"W2753090874","doi":"10.1136/annrheumdis-2017-211735","title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Musculoskeletal Health and Arthritis; University of Manitoba","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Myocardial infarction; Cohort; Population; Angina; Incidence (geometry); Cohort study; Stroke (engine); Rheumatology; Disease; Attributable risk; Epidemiology; Environmental health","score_opus":0.0259693259209759,"score_gpt":0.2918983534911836,"score_spread":0.2659290275702077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753090874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955611,0.003133316,0.000003325196,0.00006887228,0.00003680205,0.00061469886,0.00049466395,0.000018491484,0.00006872783],"genre_scores_gemma":[0.99205965,0.007827574,0.000010244784,0.000005740832,0.0000027095102,0.000018054045,0.000034447017,0.00003211618,0.0000094816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769187,0.00019033588,0.00044375024,0.00021473729,0.0010765485,0.00038275679],"domain_scores_gemma":[0.9971502,0.00027348057,0.0006210348,0.0013698002,0.00038579223,0.00019968822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029976215,0.00025516626,0.0011423253,0.00013637346,0.00021332758,0.00005137799,0.000403004,0.000049903563,0.000063463034],"category_scores_gemma":[0.0033319723,0.00012611384,0.000708359,0.00014233509,0.00054734683,0.00027403393,0.00009733885,0.0001496622,0.0000018970284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004330136,0.00104111,0.98264945,0.000045862267,0.0038642478,0.0000032579342,0.00036878375,0.000108995344,5.2977134e-7,0.000015056154,0.00009237997,0.011377342],"study_design_scores_gemma":[0.0057765394,0.0007348169,0.98933727,0.003572612,0.000034876655,7.8012863e-7,0.00011412799,0.000017364338,0.00006738026,0.0001937659,0.0000044039857,0.00014609627],"about_ca_topic_score_codex":0.0021135611,"about_ca_topic_score_gemma":0.00018395674,"teacher_disagreement_score":0.0112312455,"about_ca_system_score_codex":0.000028079812,"about_ca_system_score_gemma":0.00020931262,"threshold_uncertainty_score":0.5142773},"labels":[],"label_agreement":null},{"id":"W2753864954","doi":"10.1136/annrheumdis-2017-eular.3227","title":"SAT0063 A prospective study on comparison of composite indices with ultrasound for detecting remission and prediction of flare in 2 years","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Synovitis; Internal medicine; Prospective cohort study; Gold standard (test)","score_opus":0.0527298077937177,"score_gpt":0.3667067987889057,"score_spread":0.313976990995188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753864954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975003,0.0011451201,0.0000067406063,0.00008547429,0.000019913357,0.0011087552,0.00006320609,0.0000060680586,0.00006443521],"genre_scores_gemma":[0.9995323,0.00035148356,0.000051644383,0.0000039232473,0.0000060178554,0.000034423305,0.0000034034167,0.0000089636615,0.000007881752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909306,0.00006249453,0.00029384927,0.00012374017,0.00031496165,0.00011188876],"domain_scores_gemma":[0.9988129,0.00029053798,0.00040280743,0.0003116795,0.00012502639,0.00005701742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002310738,0.00008186338,0.0003732634,0.00008390309,0.00011830317,0.000019384013,0.00012515271,0.000021113972,0.0000032958258],"category_scores_gemma":[0.00085977465,0.00005130708,0.000055205026,0.000058294045,0.00020983469,0.00009224001,0.000039580398,0.00006739082,1.0647558e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001689331,0.0009425398,0.97746944,0.0004049322,0.00018944048,7.475558e-7,0.0041786893,0.000013428413,0.0014320399,0.000019816345,0.00003555247,0.01362405],"study_design_scores_gemma":[0.0023399643,0.0021640798,0.9745758,0.0043441416,0.000022652184,0.0000023267219,0.003913538,0.00014352176,0.012102333,0.00034900365,0.0000029155901,0.000039681832],"about_ca_topic_score_codex":0.00017407788,"about_ca_topic_score_gemma":0.000059723814,"teacher_disagreement_score":0.013584368,"about_ca_system_score_codex":0.000006964605,"about_ca_system_score_gemma":0.00004701598,"threshold_uncertainty_score":0.20922421},"labels":[],"label_agreement":null},{"id":"W2753909342","doi":"10.1136/annrheumdis-2017-eular.1719","title":"SAT0463 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years: long-term data from the future 1 and future 2 studies","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Secukinumab; Placebo; Psoriatic arthritis; Discontinuation; Internal medicine; Plaque psoriasis; Randomized controlled trial; Minimal clinically important difference; Physical therapy; TNF inhibitor; Psoriasis; Gastroenterology; Tumor necrosis factor alpha; Arthritis; Adalimumab; Dermatology; Pathology","score_opus":0.047887894986296524,"score_gpt":0.30788697030965284,"score_spread":0.2599990753233563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753909342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674161,0.02895177,3.9218045e-7,0.0017574021,0.00053001096,0.0006197001,0.0007036378,0.000009882408,0.000011094645],"genre_scores_gemma":[0.9916808,0.0077478834,0.000014512912,0.000038411476,0.00008778135,0.00004620702,0.00034582277,0.0000117365735,0.000026837399],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99889016,0.00028284104,0.0002595638,0.00028731153,0.00007615882,0.0002039491],"domain_scores_gemma":[0.9983808,0.00017604488,0.0003662632,0.0009895372,0.00007372797,0.000013650833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011368879,0.00018685863,0.00037172434,0.000033424567,0.00024903487,0.00004019568,0.0005519802,0.00008436701,0.000025892443],"category_scores_gemma":[0.00020996548,0.000101591075,0.000050029954,0.00007572543,0.00032648738,0.00046281828,0.00027726864,0.000103682345,0.0000032178991],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013688513,0.00057922385,0.26496366,0.00012910095,0.0014052975,0.0000058459627,0.0078101074,0.0000018239748,0.000008263257,0.00009928294,0.0016987001,0.72192985],"study_design_scores_gemma":[0.0027478528,0.00010109748,0.9891993,0.0008230971,0.00016197028,0.0000013633954,0.0053479965,6.0922275e-7,0.00019195737,0.0012246292,0.00007852241,0.000121614656],"about_ca_topic_score_codex":0.0002861564,"about_ca_topic_score_gemma":0.0009664518,"teacher_disagreement_score":0.72423565,"about_ca_system_score_codex":0.000018928495,"about_ca_system_score_gemma":0.00006268251,"threshold_uncertainty_score":0.4142764},"labels":[],"label_agreement":null},{"id":"W2753952014","doi":"10.1136/annrheumdis-2017-eular.1578","title":"FRI0435 Comparison between central and local assessment of radiographic sacroiliitis in patients with recently diagnosed axial spondyloarthritis in proof study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Ankylosing spondylitis; Sacroiliitis; Radiography; Sacroiliac joint; Axial spondyloarthritis; Internal medicine; Cohort; Observational study; Radiology; Cohort study; Physical therapy","score_opus":0.026540853762682785,"score_gpt":0.3238419887925455,"score_spread":0.2973011350298627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753952014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965051,0.0012692683,0.0000044353105,0.00021466191,0.00006759173,0.0016626511,0.00022307271,0.0000062389718,0.000047017948],"genre_scores_gemma":[0.999369,0.00044731935,0.000038360165,0.000015163579,0.000010021777,0.000069672715,0.000030265935,0.000016541806,0.0000036150345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981842,0.00013371752,0.00059423834,0.00026362293,0.0004988518,0.00032533624],"domain_scores_gemma":[0.9986554,0.00013420254,0.0004269681,0.000549163,0.0001018925,0.00013236604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001557228,0.00020727969,0.00088597357,0.00014429353,0.00013684672,0.00002533658,0.0001941958,0.00003985496,0.000015913238],"category_scores_gemma":[0.00017982059,0.00014202754,0.00011181999,0.00017332697,0.00041307547,0.00012898707,0.00014124275,0.00011201838,2.1481546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044743842,0.004404035,0.9438146,0.00017993501,0.0003114544,0.000027336015,0.00038470866,0.000014803989,2.4807852e-7,0.000019270065,0.000033951197,0.050362222],"study_design_scores_gemma":[0.014171881,0.002037575,0.980496,0.002371612,0.0001861664,7.6732283e-7,0.00045486062,0.000041711613,0.000023214863,0.00009098062,0.0000054275797,0.0001198123],"about_ca_topic_score_codex":0.0010425647,"about_ca_topic_score_gemma":0.0012611138,"teacher_disagreement_score":0.05024241,"about_ca_system_score_codex":0.00002892111,"about_ca_system_score_gemma":0.00007521914,"threshold_uncertainty_score":0.5791715},"labels":[],"label_agreement":null},{"id":"W2754001224","doi":"10.1136/annrheumdis-2017-eular.2007","title":"THU0629 The perspectives of patients, their first degree relatives, and rheumatologists around preventative treatments for rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Centre for Advancing Health Outcomes; McGill University; University of British Columbia","funders":"National Institute on Aging; National Institutes of Health; Reumatikerförbundet; Umeå Universitet; Karolinska Institutet","keywords":"Rheumatoid arthritis; Medicine; Focus group; Physical therapy; Rheumatology; Family medicine; Randomized controlled trial; Internal medicine","score_opus":0.15656994219294043,"score_gpt":0.40603282674365754,"score_spread":0.2494628845507171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754001224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98200303,0.0071525504,0.000012872335,0.006829015,0.0006700456,0.0025808723,0.00027149235,0.000016082127,0.0004640155],"genre_scores_gemma":[0.9753292,0.023836985,0.00007983714,0.000023264063,0.000030819767,0.00063862075,0.000007647625,0.000013653118,0.00003994059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982836,0.0004216746,0.00043291508,0.00021958214,0.00035476804,0.00028743572],"domain_scores_gemma":[0.99327934,0.0044730627,0.0012111567,0.0005358562,0.00038535142,0.000115222414],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.00054262247,0.00016216573,0.00038520008,0.000038146733,0.0021246911,0.0000802751,0.0006627911,0.000068028,0.000020725449],"category_scores_gemma":[0.012823522,0.00009857631,0.00019100944,0.00009674087,0.0021965492,0.00036884588,0.00010902011,0.00006791955,0.0000014618787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012963219,0.00072890334,0.5911117,0.00022146195,0.00041519222,7.913406e-8,0.27058703,0.000001914459,3.2147594e-7,0.024843467,0.0011341233,0.11082617],"study_design_scores_gemma":[0.00060202857,0.00010592481,0.90007687,0.00083791744,0.00003899443,1.7400352e-7,0.06750373,0.000012450003,0.00003304989,0.030250035,0.00043216234,0.00010665255],"about_ca_topic_score_codex":0.0036763544,"about_ca_topic_score_gemma":0.0012630576,"teacher_disagreement_score":0.30896518,"about_ca_system_score_codex":0.000053273983,"about_ca_system_score_gemma":0.00030042956,"threshold_uncertainty_score":0.9991744},"labels":[],"label_agreement":null},{"id":"W2754037720","doi":"10.1136/annrheumdis-2017-eular.3575","title":"FRI0133 Is there incremental mental health burden associated with rheumatoid arthritis?","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Mental health; Depression (economics); Comorbidity; Medicine; Rheumatoid arthritis; Population; SF-36; National Comorbidity Survey; Psychiatry; Gerontology; Internal medicine; Environmental health; Health related quality of life; Disease","score_opus":0.03658950279609774,"score_gpt":0.3253138638169284,"score_spread":0.28872436102083066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754037720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94704574,0.023259996,0.0000030635056,0.02706668,0.00013062071,0.0008401251,0.00043909354,0.000055565153,0.0011590938],"genre_scores_gemma":[0.9256297,0.07310973,0.000033434622,0.0007234768,0.000026940828,0.00003765947,0.000056493867,0.000039214163,0.00034339004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975091,0.00017091312,0.0005037032,0.00027371867,0.000989098,0.0005534407],"domain_scores_gemma":[0.99757814,0.00009198279,0.0006653689,0.0010873248,0.00018940873,0.0003877835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003958002,0.00026145537,0.0006734219,0.000073096,0.0010470247,0.0001698723,0.0006048922,0.000049486152,0.00069218094],"category_scores_gemma":[0.0005945909,0.00016486019,0.00028832298,0.00009403401,0.00068011007,0.00032967178,0.0002408168,0.0001714992,0.000042629126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002087962,0.0033168842,0.36907324,0.00083491084,0.005677344,0.00004540233,0.009638909,0.000007056306,0.00029913863,0.0021451097,0.25296524,0.3539088],"study_design_scores_gemma":[0.010010706,0.001626436,0.9453111,0.026140692,0.000018921499,0.00008232155,0.0031837372,0.0002826681,0.003021131,0.002567206,0.007215027,0.00054004014],"about_ca_topic_score_codex":0.0009869874,"about_ca_topic_score_gemma":0.00016006602,"teacher_disagreement_score":0.57623786,"about_ca_system_score_codex":0.00004100773,"about_ca_system_score_gemma":0.00038627413,"threshold_uncertainty_score":0.8052973},"labels":[],"label_agreement":null},{"id":"W2754043363","doi":"10.1136/annrheumdis-2017-eular.2445","title":"AB0794 Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: results from two phase 3 studies","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Zynerba Pharmaceuticals; Dermira; Genentech; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Ankylosing spondylitis; Janus kinase inhibitor; Adalimumab; Placebo; Internal medicine; Visual analogue scale; Psoriasis; Arthritis; Dermatology; Surgery; Rheumatoid arthritis; Alternative medicine; Pathology","score_opus":0.04343408846701979,"score_gpt":0.3805636743739268,"score_spread":0.337129585906907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754043363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654025,0.00073877606,3.16781e-7,0.00050220423,0.00009530665,0.0011916753,0.00065273343,0.000013966227,0.0002647858],"genre_scores_gemma":[0.9993827,0.00035235996,0.000006983476,0.000061696664,0.0000064034843,0.00005490571,0.00007578103,0.00001837026,0.000040803952],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99771005,0.00020352745,0.0008380513,0.00025000706,0.00074963283,0.0002487399],"domain_scores_gemma":[0.99660003,0.0007170427,0.0011214847,0.0011816631,0.00029429464,0.000085491614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025072804,0.00022639768,0.0010278816,0.00011239026,0.00014899604,0.000019208204,0.0002778896,0.000036344587,0.00003381325],"category_scores_gemma":[0.007850392,0.00012376245,0.00021787919,0.000090192225,0.0003751397,0.00019952984,0.00013639157,0.00013033231,0.000006050452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018092852,0.002385748,0.46848103,0.00044687,0.0022232656,0.000021486067,0.0018498556,0.000032278822,0.000008615067,0.000017411427,0.00057405577,0.5058665],"study_design_scores_gemma":[0.030162605,0.0026607648,0.95713645,0.0048824516,0.00017995357,2.4358633e-7,0.0004772665,0.000038536204,0.003973518,0.00033016628,0.000023472725,0.00013459851],"about_ca_topic_score_codex":0.000274487,"about_ca_topic_score_gemma":0.000018275807,"teacher_disagreement_score":0.50573194,"about_ca_system_score_codex":0.000018528908,"about_ca_system_score_gemma":0.000108990316,"threshold_uncertainty_score":0.9398219},"labels":[],"label_agreement":null},{"id":"W2754051493","doi":"10.1136/annrheumdis-2017-eular.3821","title":"SAT0448 Apremilast treatment and long-term (up to 156 weeks) improvements in dactylitis and enthesitis in patients with psoriatic arthritis: analysis of a large database of the phase iii clinical development program","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Dactylitis; Enthesitis; Medicine; Psoriatic arthritis; Apremilast; Psoriasis; Internal medicine; Enthesis; Arthritis; Surgery; Dermatology","score_opus":0.03811603164717551,"score_gpt":0.3825612080199088,"score_spread":0.34444517637273325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754051493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954706,0.0020334388,0.00000367083,0.00021293001,0.00003936198,0.00177087,0.0004543659,0.000005015096,0.000009791083],"genre_scores_gemma":[0.99297357,0.0067104595,0.000073662275,0.000038514387,0.0000044148496,0.00011377893,0.000055837536,0.000012423526,0.000017327524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796915,0.00016994815,0.0008277179,0.0002763529,0.00045540702,0.00030142366],"domain_scores_gemma":[0.99823517,0.00016027206,0.0004787132,0.0007895628,0.00012749487,0.00020881074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041489006,0.00018715559,0.00083808653,0.00020607424,0.0001140666,0.000036604048,0.0002539338,0.00003340445,0.000031548992],"category_scores_gemma":[0.0005768493,0.00010718286,0.00014585802,0.0002347759,0.00032621782,0.00015522387,0.0002549002,0.00007030569,3.4061281e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087228563,0.0031392223,0.65777904,0.00021048763,0.00092140434,0.0000030159738,0.0007992256,6.779065e-7,0.000004548798,0.000010856029,0.000015937683,0.3362433],"study_design_scores_gemma":[0.014164299,0.0011685918,0.97889894,0.0048389174,0.00013766627,7.328381e-7,0.00019316506,0.000087436456,0.00037726175,0.00001794896,0.000016078306,0.00009896488],"about_ca_topic_score_codex":0.0003425321,"about_ca_topic_score_gemma":0.0014502339,"teacher_disagreement_score":0.33614433,"about_ca_system_score_codex":0.000021894772,"about_ca_system_score_gemma":0.00016065434,"threshold_uncertainty_score":0.437079},"labels":[],"label_agreement":null},{"id":"W2754055218","doi":"10.1136/annrheumdis-2017-eular.2085","title":"THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Ottawa; McMaster University","funders":"","keywords":"Guideline; Antiphospholipid syndrome; Clinical Practice; Catastrophic antiphospholipid syndrome; Medicine; Intensive care medicine; Internal medicine; Physical therapy; Thrombosis; Pathology","score_opus":0.1255665061095725,"score_gpt":0.45965913587247487,"score_spread":0.3340926297629023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754055218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729513,0.005649264,0.000108036875,0.018447598,0.0002759579,0.001860445,0.00021477696,0.0000148126355,0.0004778259],"genre_scores_gemma":[0.98272806,0.013140397,0.0032276239,0.0004173888,0.000034617096,0.00015665634,0.000012563756,0.000025306881,0.00025739433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787027,0.00010805667,0.0009903228,0.00024131699,0.00055105146,0.00023897385],"domain_scores_gemma":[0.9960871,0.00090496946,0.0009195712,0.0014485125,0.00046224977,0.0001776446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014072922,0.00013934226,0.000629245,0.000050766077,0.00015459293,0.000033223867,0.0005096717,0.000049075756,0.000028714141],"category_scores_gemma":[0.006388961,0.00008868009,0.00028742815,0.00006238958,0.00041012635,0.0001501945,0.00039501424,0.00007056247,0.000005898432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016345471,0.0027357393,0.66610926,0.026199719,0.0038390642,0.000091784364,0.00026777873,0.000008256787,0.000008500717,0.0026768034,0.20857167,0.08785687],"study_design_scores_gemma":[0.010444076,0.0018564352,0.90803045,0.036052525,0.0036327348,0.0020983266,0.002537023,0.0012101857,0.001019396,0.0033542737,0.029267354,0.00049720134],"about_ca_topic_score_codex":0.00009439151,"about_ca_topic_score_gemma":0.0000012682262,"teacher_disagreement_score":0.2419212,"about_ca_system_score_codex":0.000008792627,"about_ca_system_score_gemma":0.000096155076,"threshold_uncertainty_score":0.76486444},"labels":[],"label_agreement":null},{"id":"W2754064060","doi":"10.1136/annrheumdis-2017-eular.4317","title":"OP0212 Endothelin-1 induces a profibrotic phenotype in cultured human microvascular endothelial and circulating monocyte/macrophage cells","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi di Genova; Universitair Ziekenhuis Gent; University of Aberdeen; Arthritis Society","keywords":"Monocyte; Scavenger receptor; Fibrosis; Fibrocyte; CD163; Immunology; Macrophage; Medicine; Biology; Cell biology; Cancer research; Internal medicine; Pathology; In vitro","score_opus":0.053486201102283984,"score_gpt":0.3191509649318482,"score_spread":0.2656647638295642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754064060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872897,0.010763357,0.0000025539848,0.0003878893,0.00017546317,0.00090891274,0.0000673917,0.00002880394,0.000375925],"genre_scores_gemma":[0.9983851,0.0009729829,0.00007787845,0.00014490158,0.000070879236,0.000041165862,0.0000070805204,0.000032964334,0.00026707677],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99825394,0.00014554987,0.0005948282,0.0003228282,0.0003686346,0.00031420717],"domain_scores_gemma":[0.998124,0.00009235673,0.0005409587,0.00093392853,0.0001084439,0.0002003163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002636163,0.00024673826,0.00060393865,0.00008850793,0.00037818874,0.00010839499,0.0003326159,0.00010733742,0.000050437906],"category_scores_gemma":[0.00064390036,0.00015531997,0.00033121606,0.00008241745,0.00030139694,0.00015210806,0.00018909323,0.00013969831,0.00001084905],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039080303,0.0018829186,0.10464257,0.0053631756,0.0016868736,0.00008197035,0.0037214293,0.00016390675,0.8451537,0.0006297718,0.00087104406,0.035411865],"study_design_scores_gemma":[0.006246118,0.00018472451,0.7157062,0.018006733,0.0009294751,0.00005142999,0.0014702469,0.0006575129,0.25457814,0.0015810335,0.000047501024,0.0005408682],"about_ca_topic_score_codex":0.00042710602,"about_ca_topic_score_gemma":0.0000056599893,"teacher_disagreement_score":0.61106366,"about_ca_system_score_codex":0.000018718645,"about_ca_system_score_gemma":0.00009935843,"threshold_uncertainty_score":0.6333765},"labels":[],"label_agreement":null},{"id":"W2754068533","doi":"10.1136/annrheumdis-2017-eular.5163","title":"AB0771 Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment in the liberate study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Apremilast; Medicine; Etanercept; Psoriasis; Dermatology; Placebo; Dermatology Life Quality Index; Psoriatic arthritis; Psoriasis Area and Severity Index; Clinical endpoint; Internal medicine; Mucocutaneous zone; Nail disease; Clinical trial; Surgery; Disease; Pathology; Tumor necrosis factor alpha","score_opus":0.03525518595697935,"score_gpt":0.2823813366102179,"score_spread":0.24712615065323856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754068533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967229,0.00032451536,0.0000018747617,0.00040986648,0.00011403584,0.0016113237,0.0006231927,0.000009790946,0.00018249561],"genre_scores_gemma":[0.99917424,0.0002245551,0.000016810738,0.0001064019,0.000008189299,0.000092399714,0.000057385903,0.000018736562,0.00030127598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982002,0.0005431494,0.00050222944,0.0003581607,0.00011991658,0.0002763515],"domain_scores_gemma":[0.9978369,0.0006863447,0.00041292643,0.0009618952,0.000069864276,0.000032097752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017493071,0.00032079485,0.0007577563,0.000061925355,0.0002417006,0.000040393476,0.0005050069,0.000088153975,0.000058156027],"category_scores_gemma":[0.00024838562,0.00015347668,0.00011491024,0.00011546036,0.00015392536,0.00012998354,0.00011429052,0.00008073203,0.000010671414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052945822,0.012485874,0.7812184,0.00008721795,0.0028465756,0.000012370905,0.037348986,0.0005922372,0.00013154099,0.000055949684,0.00053094636,0.11174404],"study_design_scores_gemma":[0.012575206,0.0014974818,0.9822124,0.00066533906,0.0003216745,6.039421e-7,0.0012697871,0.0000067821834,0.0011061163,0.00013145666,0.0000335407,0.00017960228],"about_ca_topic_score_codex":0.001095254,"about_ca_topic_score_gemma":0.000752376,"teacher_disagreement_score":0.20099397,"about_ca_system_score_codex":0.000025489822,"about_ca_system_score_gemma":0.00006016089,"threshold_uncertainty_score":0.62585974},"labels":[],"label_agreement":null},{"id":"W2754089339","doi":"10.1136/annrheumdis-2017-eular.5796","title":"OP0048 Romosozumab rapidly reduces clinical vertebral fracture incidence: results from the frame study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"UCB Pharma; Astellas Pharma; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Sclerostin; Postmenopausal women; Incidence (geometry); Bone mineral; Osteoporosis; Internal medicine; Nuclear medicine; Urology","score_opus":0.12924726939831616,"score_gpt":0.45851643974575423,"score_spread":0.3292691703474381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754089339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350866,0.0022527704,0.0000014424813,0.060376137,0.00041988294,0.0012401686,0.0002449088,0.00002876466,0.0003492958],"genre_scores_gemma":[0.9943032,0.0011174505,0.00004469427,0.003742998,0.00027271872,0.000041109826,0.000031920208,0.000022958478,0.00042294431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962867,0.000630235,0.0010724575,0.0004151722,0.0011559029,0.00043953912],"domain_scores_gemma":[0.9936453,0.0019512575,0.00082521554,0.0027889314,0.00033145965,0.00045782098],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016750499,0.00022000608,0.0007043128,0.000034355013,0.000840304,0.00015571134,0.0014281546,0.00013445962,0.0002084222],"category_scores_gemma":[0.02052805,0.00010692656,0.0004150597,0.00010840288,0.0006606419,0.00021646463,0.00047545988,0.0005865246,0.00007230503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054374645,0.004411566,0.5122042,0.00024725692,0.00092066475,0.00004278495,0.0034030636,0.000010499286,0.000015895432,0.000036633257,0.3410547,0.13221526],"study_design_scores_gemma":[0.002983977,0.00065971486,0.99041885,0.0011208338,0.00019409087,0.0000028149113,0.0014025815,0.00017477412,0.00015937597,0.0019646154,0.00080376695,0.000114607225],"about_ca_topic_score_codex":0.0025659797,"about_ca_topic_score_gemma":0.00012152555,"teacher_disagreement_score":0.47821465,"about_ca_system_score_codex":0.000015282389,"about_ca_system_score_gemma":0.0007243869,"threshold_uncertainty_score":0.98772246},"labels":[],"label_agreement":null},{"id":"W2754102303","doi":"10.1136/annrheumdis-2017-eular.6369","title":"SAT0122 Which multimorbid conditions are more prevalent around the time of early ra diagnosis and have the greatest impact on trajectories of disease activity in the first year? results from the canadian early arthritis cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Western University; Southlake Regional Health Center; University of Manitoba; McGill University; University of Toronto","funders":"","keywords":"Medicine; Disease; Cohort; Logistic regression; Comorbidity; Internal medicine; Retrospective cohort study; Rheumatoid arthritis; Pediatrics","score_opus":0.04190647025713573,"score_gpt":0.3275073762258928,"score_spread":0.2856009059687571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754102303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576467,0.002815281,1.355747e-7,0.030453121,0.000047690588,0.0015412036,0.0073484406,0.0000071192894,0.00014030446],"genre_scores_gemma":[0.99103284,0.0084394775,0.0000012386582,0.0001564789,0.000041751206,0.00020911089,0.000049050494,0.000019926485,0.00005012258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978079,0.00042753495,0.00041654348,0.00024205731,0.0007631335,0.0003428354],"domain_scores_gemma":[0.9948309,0.0025525047,0.00048644523,0.0016527598,0.0002470452,0.00023034505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071153545,0.00023484624,0.00046990122,0.00006127726,0.0009128468,0.0002138049,0.00083485816,0.000049779046,0.0000778648],"category_scores_gemma":[0.0033380054,0.00009546752,0.00027539075,0.00014248042,0.0014938472,0.0002107428,0.00010523422,0.00025744547,0.0000079800475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011238931,0.00039789954,0.9849882,0.00007401118,0.0005107202,0.000008885528,0.0047567836,0.00003825052,0.0000040956597,0.00007132145,0.005993577,0.0020323447],"study_design_scores_gemma":[0.0012472993,0.000298484,0.9934606,0.0027505404,0.00007899906,0.0000022606,0.0010206191,0.00013790795,0.000111146386,0.00071180117,0.00008141143,0.00009891868],"about_ca_topic_score_codex":0.15024485,"about_ca_topic_score_gemma":0.104658745,"teacher_disagreement_score":0.045586098,"about_ca_system_score_codex":0.00003160155,"about_ca_system_score_gemma":0.00035713724,"threshold_uncertainty_score":0.9116789},"labels":[],"label_agreement":null},{"id":"W2754126020","doi":"10.1136/annrheumdis-2017-eular.2316","title":"THU0083 The relevance of elevated crp as an inclusion criterion in clinical trials in patients with rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Methotrexate; C-reactive protein; Inclusion and exclusion criteria; Clinical trial; Post-hoc analysis; Placebo; Physical therapy; Pathology; Inflammation","score_opus":0.07133469089353192,"score_gpt":0.409855818990497,"score_spread":0.3385211280969651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754126020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072206,0.0048349258,0.000003215979,0.002893114,0.00013540433,0.0012270473,0.00006572605,0.000013905281,0.00010461091],"genre_scores_gemma":[0.9502827,0.049372606,0.000036767764,0.00018642294,0.000016066488,0.000043373384,0.000021126118,0.000024036022,0.000016916061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950927,0.0016611461,0.0017286071,0.00028414064,0.0008859734,0.00034746967],"domain_scores_gemma":[0.99533707,0.0014577748,0.0012119547,0.0014547404,0.00035174782,0.0001866963],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0045286636,0.0002060943,0.0012115842,0.00013913479,0.00034780367,0.00006424928,0.0007569393,0.00008207038,0.00009866214],"category_scores_gemma":[0.02335417,0.000107102955,0.00028962066,0.00018353404,0.00078428455,0.00042042966,0.000491614,0.00025894024,0.000006354286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047406983,0.0022045851,0.7763482,0.00018604037,0.00014591054,0.000008938555,0.0011179977,0.000008854667,0.0000524451,0.00045829124,0.00049915223,0.21422891],"study_design_scores_gemma":[0.0068156887,0.0010808357,0.97609365,0.009163401,0.0000069857792,0.0000032749228,0.00021910819,0.0001608735,0.00053960277,0.0055921227,0.00019951358,0.00012497019],"about_ca_topic_score_codex":0.00074810913,"about_ca_topic_score_gemma":0.00031579245,"teacher_disagreement_score":0.21410394,"about_ca_system_score_codex":0.000014487111,"about_ca_system_score_gemma":0.000256258,"threshold_uncertainty_score":0.9848725},"labels":[],"label_agreement":null},{"id":"W2754128858","doi":"10.1136/annrheumdis-2017-eular.5464","title":"OP0002 Multicriteria decision analysis for developing new classification criteria for systemic lupus erythematosus","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Serositis; Multiple-criteria decision analysis; Delphi method; Ranking (information retrieval); Statistics; Internal medicine; Machine learning; Computer science; Arthritis; Operations research; Mathematics","score_opus":0.17756545642528004,"score_gpt":0.43264595657401506,"score_spread":0.255080500148735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754128858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92760646,0.0017487821,0.061342258,0.0050240257,0.00061678665,0.0033731626,0.00017028161,0.000054191158,0.00006402401],"genre_scores_gemma":[0.9895543,0.00028888232,0.008043985,0.00011183381,0.000114963914,0.00039577798,0.000056144465,0.00005061066,0.0013835396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974794,0.00009537564,0.00097247714,0.00042254207,0.0005936488,0.00043659026],"domain_scores_gemma":[0.99483025,0.001186816,0.00089349056,0.0019897334,0.0008515226,0.0002481627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083731266,0.00025935154,0.0009948683,0.00029104127,0.00049798086,0.00020897116,0.0008948433,0.000108598586,0.000042131946],"category_scores_gemma":[0.007003157,0.00017292812,0.0008587479,0.0002489222,0.00015072669,0.0002207263,0.00016398064,0.000055683264,0.00001282914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007930348,0.0012090915,0.64316463,0.05033418,0.013126654,0.000013900974,0.005343438,0.00010604307,0.008649583,0.009136704,0.16496988,0.09601555],"study_design_scores_gemma":[0.035190597,0.0011227324,0.54001033,0.09168406,0.016461752,0.0060903905,0.009717356,0.22282961,0.017779553,0.052444298,0.0040558777,0.002613421],"about_ca_topic_score_codex":0.00006405754,"about_ca_topic_score_gemma":0.000012710258,"teacher_disagreement_score":0.22272357,"about_ca_system_score_codex":0.00007709854,"about_ca_system_score_gemma":0.00043298246,"threshold_uncertainty_score":0.83839387},"labels":[],"label_agreement":null},{"id":"W2754141291","doi":"10.1136/annrheumdis-2017-eular.2447","title":"THU0352 Tofacitinib treatment is associated with attainment of the minimally important reduction in axial mri inflammation in patients with ankylosing spondylitis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Astellas Pharma; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Tofacitinib; Ankylosing spondylitis; BASDAI; Medicine; Internal medicine; Placebo; BASFI; Spondylitis; Clinical trial; Physical therapy; Surgery; Disease; Rheumatoid arthritis; Psoriatic arthritis; Pathology","score_opus":0.021918816130428318,"score_gpt":0.2758462404509518,"score_spread":0.25392742432052345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754141291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967025,0.00022226793,2.2123778e-7,0.0013456491,0.000056998157,0.0010190106,0.00051590276,0.000005876661,0.0001316062],"genre_scores_gemma":[0.99953955,0.00020830092,0.000022255997,0.000024021525,0.000008264515,0.000057004105,0.00006859606,0.000013260531,0.000058717073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863994,0.00006951814,0.00046457793,0.00018305311,0.0004391852,0.00020370712],"domain_scores_gemma":[0.9984993,0.000043158816,0.0007392397,0.00053489936,0.00013457013,0.00004883259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010910294,0.00017398613,0.0004218446,0.000058115733,0.00015657314,0.000019676474,0.00012697578,0.000034792956,0.000039826467],"category_scores_gemma":[0.00021515613,0.00008718725,0.00011904608,0.00012276562,0.00020360049,0.0001277066,0.00005569004,0.000044411092,4.3956751e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013348206,0.001334546,0.985398,0.00007249591,0.00036864972,0.000008326837,0.0011522567,0.000016800725,0.000011912595,0.000030284007,0.000040392933,0.010231544],"study_design_scores_gemma":[0.0063637043,0.0010374475,0.9869644,0.0032582756,0.00019203563,0.000002567291,0.0003357855,0.000031688567,0.0015797848,0.00013341314,0.000016356762,0.00008453175],"about_ca_topic_score_codex":0.00049178506,"about_ca_topic_score_gemma":0.00031279182,"teacher_disagreement_score":0.010147013,"about_ca_system_score_codex":0.00011242923,"about_ca_system_score_gemma":0.00009094652,"threshold_uncertainty_score":0.3555393},"labels":[],"label_agreement":null},{"id":"W2754190914","doi":"10.1136/annrheumdis-2017-eular.3348","title":"OP0203 Impact of adalimumab serum concentration on efficacy and association between ANTI-DRUG antibodies and serum concentration: 24 week results from a phase III study comparing SB5 (an adalimumab biosimilar) with reference adalimumab in patients with rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Pfizer; Amgen","keywords":"Adalimumab; Medicine; Biosimilar; Rheumatoid arthritis; Trough level; Internal medicine; Gastroenterology","score_opus":0.05134418831104503,"score_gpt":0.332393368620422,"score_spread":0.281049180309377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754190914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948437,0.00096412725,0.000004210289,0.0004686375,0.00007607378,0.00096924783,0.002607477,0.000022267055,0.000044209766],"genre_scores_gemma":[0.99883235,0.00082794036,0.000045416324,0.000042430336,0.000008233798,0.000008577148,0.00020419592,0.000018075061,0.000012797632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732375,0.0006771975,0.0008522482,0.0004997186,0.00025666578,0.00039044386],"domain_scores_gemma":[0.9969307,0.00064640667,0.001369397,0.00069186126,0.00026384357,0.00009774693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046142447,0.0003587646,0.001032588,0.00006173756,0.00042655243,0.0001281555,0.00036503794,0.0001436867,0.000027615084],"category_scores_gemma":[0.00049398973,0.00022465411,0.00008319915,0.00012002823,0.00052524934,0.0004336984,0.00013948821,0.00024045334,8.8566804e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004609791,0.0024992437,0.981871,0.000049610222,0.0011950484,0.0000017962398,0.0014263077,0.000030323828,0.00012577209,0.00003261805,0.00014892677,0.008009566],"study_design_scores_gemma":[0.028520608,0.0028442743,0.962939,0.0017531314,0.0002305109,7.8106774e-7,0.00069633126,0.00010696812,0.002533008,0.00009297649,0.0000060282405,0.0002763424],"about_ca_topic_score_codex":0.0010732963,"about_ca_topic_score_gemma":0.0003031684,"teacher_disagreement_score":0.023910819,"about_ca_system_score_codex":0.000041163563,"about_ca_system_score_gemma":0.00012381749,"threshold_uncertainty_score":0.9161129},"labels":[],"label_agreement":null},{"id":"W2754193952","doi":"10.1136/annrheumdis-2017-eular.1860","title":"THU0382 Change in sacroiliac joint structural radiographic damage after two years of etanercept therapy in comparison to a contemporary control cohort in non-radiographic axial spondyloarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer; Eli Lilly and Company","keywords":"Medicine; Etanercept; Sacroiliac joint; Cohort; Sacroiliitis; Radiography; Internal medicine; Axial spondyloarthritis; Clinical endpoint; Physical therapy; Cohort study; Ankylosing spondylitis; Surgery; Clinical trial; Rheumatoid arthritis","score_opus":0.05099719232432352,"score_gpt":0.3386668433208861,"score_spread":0.28766965099656255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754193952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848004,0.011324114,5.207441e-7,0.0010255714,0.00018756866,0.002251406,0.000314806,0.000010507762,0.00008508301],"genre_scores_gemma":[0.9967678,0.0023734537,0.00002525256,0.0003592923,0.00003182513,0.0003866549,0.000019821167,0.00002867139,0.000007236351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977947,0.0001697447,0.00085170724,0.00034200965,0.00043690347,0.00040492715],"domain_scores_gemma":[0.9983662,0.00011103533,0.0004029829,0.00087852695,0.00008110403,0.00016019012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003033666,0.000286775,0.0013205743,0.00058648904,0.00007283362,0.000031687676,0.0003232127,0.000070455666,0.00006532059],"category_scores_gemma":[0.00019064313,0.00022423126,0.0004296071,0.00044152085,0.00040581237,0.00019623092,0.00010848514,0.00017123186,0.0000027474148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001950026,0.0005702938,0.96942216,0.00009689719,0.00027536668,0.00019925067,0.0018669049,0.000011352127,0.000056211407,0.000013711776,0.00010513207,0.025432667],"study_design_scores_gemma":[0.01164196,0.000562556,0.98390293,0.0028709595,0.000053887397,0.000007675804,0.00025864624,0.00022233912,0.000058994097,0.00021947645,0.000015677744,0.00018489982],"about_ca_topic_score_codex":0.008445058,"about_ca_topic_score_gemma":0.004185872,"teacher_disagreement_score":0.025247768,"about_ca_system_score_codex":0.00002471778,"about_ca_system_score_gemma":0.00006311222,"threshold_uncertainty_score":0.9981578},"labels":[],"label_agreement":null},{"id":"W2754228505","doi":"10.1136/annrheumdis-2017-eular.6530","title":"SAT0746-HPR Towards measurement of person-centered care outcomes in outpatient nurse-led clinics","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent","funders":"","keywords":"Context (archaeology); Content validity; Medicine; Outpatient clinic; Nursing; Quality (philosophy); Content analysis; Family medicine; Psychometrics; Clinical psychology","score_opus":0.17536703538580697,"score_gpt":0.39085197518046527,"score_spread":0.2154849397946583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754228505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846187,0.0025495018,0.000005383501,0.004149847,0.00047845705,0.0011838208,0.00016521427,0.000029157634,0.006819888],"genre_scores_gemma":[0.9991881,0.0002817843,0.000035524965,0.00018465958,0.000017643246,0.0000439531,0.000017289474,0.000024104764,0.00020690485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751353,0.00010471658,0.0007032146,0.0002699131,0.0010971777,0.0003114612],"domain_scores_gemma":[0.9970427,0.00006170534,0.0007733696,0.001583071,0.00038324654,0.00015587246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032828422,0.00025262666,0.0007900864,0.00011821768,0.00011443294,0.00004710885,0.0006767665,0.00005147843,0.0001301362],"category_scores_gemma":[0.001854633,0.00017094275,0.0005784937,0.000075712145,0.00031050455,0.00014974663,0.00018115836,0.000099220575,0.000008785002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008098283,0.003907606,0.8846869,0.0076526185,0.0015720837,0.000018325918,0.004525747,0.00009545666,0.000014561478,0.0009855476,0.0063776006,0.08935374],"study_design_scores_gemma":[0.0030830328,0.00025889458,0.98340315,0.0034985358,0.00048331748,3.9481438e-7,0.008241787,0.00017242276,0.00020655124,0.00036136855,0.0001393052,0.00015123693],"about_ca_topic_score_codex":0.00036049617,"about_ca_topic_score_gemma":0.00009712221,"teacher_disagreement_score":0.09871627,"about_ca_system_score_codex":0.00009928006,"about_ca_system_score_gemma":0.00040331364,"threshold_uncertainty_score":0.6970843},"labels":[],"label_agreement":null},{"id":"W2754332575","doi":"10.1136/annrheumdis-2017-eular.5944","title":"FRI0154 The tolerability of vaccination against pneumococcus in children with juvenile idiopathic arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Vaccination; Arthritis; Adverse effect; Tolerability; Internal medicine; Incidence (geometry); Pediatrics; Immunology","score_opus":0.01499046898840558,"score_gpt":0.25395421277974917,"score_spread":0.23896374379134358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754332575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97022164,0.02775751,0.000004438007,0.0010933942,0.00012850836,0.0004034515,0.00006258777,0.000011063645,0.00031742686],"genre_scores_gemma":[0.99902356,0.0007933817,9.4880346e-7,0.00007265801,0.0000011227454,0.000031244195,0.000014801879,0.000007876215,0.000054428707],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988103,0.00026046342,0.0004828837,0.00015725722,0.00007318739,0.00021589718],"domain_scores_gemma":[0.9980281,0.00008585771,0.0008097725,0.0009807606,0.00009018,0.0000053351714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047819532,0.00013581685,0.00037694117,0.000041347685,0.00041936236,0.000021245629,0.0008473029,0.000063576445,0.00006739532],"category_scores_gemma":[0.00071466214,0.00007553601,0.00015530021,0.00008740172,0.00040715322,0.00015873063,0.00014688096,0.00014902765,0.000010784563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002937434,0.0016933884,0.47638515,0.00022534079,0.0004444974,6.659503e-7,0.0025389688,0.00062238425,0.0037250824,0.0013319483,0.00021913862,0.5125197],"study_design_scores_gemma":[0.00086277624,0.000074109186,0.98919284,0.00055510865,0.000027613629,0.000003842228,0.0003166042,0.000017649818,0.0076599773,0.0011420756,0.000048715898,0.00009868422],"about_ca_topic_score_codex":0.0005215186,"about_ca_topic_score_gemma":0.00003937197,"teacher_disagreement_score":0.51280767,"about_ca_system_score_codex":0.00000732253,"about_ca_system_score_gemma":0.000098626166,"threshold_uncertainty_score":0.32254386},"labels":[],"label_agreement":null},{"id":"W2754343433","doi":"10.1136/annrheumdis-2017-eular.4451","title":"OP0041 All-cause, cardiovascular and malignancy related mortality in systemic lupus erythematosus (SLE): a population-based study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Comorbidity; Population; Context (archaeology); Cohort; Proportional hazards model; Cause of death; Mortality rate; Confounding; Incidence (geometry); Disease; Confidence interval","score_opus":0.08020988360202912,"score_gpt":0.3606217647951024,"score_spread":0.28041188119307325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754343433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878909,0.008263908,0.0000063967095,0.00040612798,0.0003095826,0.002845545,0.000040029714,0.000049995735,0.0001875443],"genre_scores_gemma":[0.9991321,0.00029060742,0.000015861986,0.000031980573,0.000017437878,0.00019153993,0.0000135963255,0.000047328387,0.00025956117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963125,0.00055006845,0.0010218528,0.00047400265,0.0012155239,0.00042608095],"domain_scores_gemma":[0.99570644,0.00029171747,0.00057643565,0.0029539373,0.00022782908,0.00024362231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014535233,0.00030012286,0.0012120446,0.00020412836,0.00023522908,0.00010495735,0.00059440976,0.00010623518,0.000030441639],"category_scores_gemma":[0.0022737805,0.00020317374,0.000506756,0.0002082457,0.00016398724,0.00017910637,0.00025821448,0.00017251151,0.000012058827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011424705,0.0006373198,0.99114245,0.003828778,0.0025378012,0.00010731868,0.00066430465,0.00014746036,0.000009190581,0.00015469248,0.00015194724,0.00050447386],"study_design_scores_gemma":[0.0045127496,0.00013001569,0.9794208,0.009834475,0.0011216343,0.0010702098,0.001555339,0.0011752731,0.00004005189,0.00090536603,0.000004930605,0.00022914947],"about_ca_topic_score_codex":0.001612606,"about_ca_topic_score_gemma":0.000082784674,"teacher_disagreement_score":0.01172166,"about_ca_system_score_codex":0.00006893754,"about_ca_system_score_gemma":0.00022175391,"threshold_uncertainty_score":0.82851845},"labels":[],"label_agreement":null},{"id":"W2754346163","doi":"10.1136/annrheumdis-2017-eular.2389","title":"FRI0618 Adalimumab in non-infectious uveitis – efficacy across different etiologies in the visual i and visual ii trials","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Adalimumab; Uveitis; Prednisone; Etiology; Clinical endpoint; Visual acuity; Internal medicine; Clinical trial; Surgery; Ophthalmology; Disease","score_opus":0.06865046669864493,"score_gpt":0.4182696184445134,"score_spread":0.34961915174586844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754346163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935718,0.0018863135,0.000004308258,0.0031437133,0.00018043435,0.0010067276,0.00009254891,0.000021063535,0.000093096634],"genre_scores_gemma":[0.9981389,0.001326433,0.0000028333748,0.000303209,0.00005136953,0.00007756383,0.000016077915,0.000017878334,0.000065756234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978305,0.0003918896,0.0006893829,0.00028400845,0.00041536478,0.00038882156],"domain_scores_gemma":[0.9978949,0.0007716732,0.00048382397,0.0006639311,0.000060742026,0.00012497131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088789366,0.000255815,0.0009573682,0.00008019176,0.0004069532,0.00013196115,0.00040141976,0.000086442145,0.000063975516],"category_scores_gemma":[0.0042835474,0.00013021681,0.00041477408,0.00010613995,0.00041118983,0.00014003388,0.00038917022,0.00015642605,0.000004710084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017054654,0.008967957,0.7477402,0.0014951046,0.00073936075,0.00013632407,0.0037670408,0.000041778818,0.0002743087,0.00018195952,0.0022778085,0.23267269],"study_design_scores_gemma":[0.0036484178,0.00062101637,0.9914876,0.0013898794,0.00018547759,0.000021541817,0.0008804618,0.00032684498,0.00017918674,0.0010692575,0.000036265734,0.00015403373],"about_ca_topic_score_codex":0.00046443017,"about_ca_topic_score_gemma":0.0001329169,"teacher_disagreement_score":0.24374741,"about_ca_system_score_codex":0.000018131896,"about_ca_system_score_gemma":0.000067927314,"threshold_uncertainty_score":0.5310088},"labels":[],"label_agreement":null},{"id":"W2754357527","doi":"10.1136/annrheumdis-2017-eular.6891","title":"AB1130 Relapse risk assessment in young aps patients with previous stroke event using the adjusted global antiphospholipid syndrome score (AGAPSS)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"UCB Pharma; GlaxoSmithKline","keywords":"Medicine; Antiphospholipid syndrome; Thrombosis; Internal medicine; Stroke (engine); Cohort; Magnetic resonance imaging; Cerebral venous sinus thrombosis; Retrospective cohort study; Cardiology; Surgery; Radiology","score_opus":0.042230473896105236,"score_gpt":0.3474362165494166,"score_spread":0.30520574265331135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754357527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949468,0.0012524755,0.00003536221,0.0005147864,0.00030013252,0.0022069917,0.00034306291,0.000025785814,0.00037462165],"genre_scores_gemma":[0.99906707,0.00046020036,0.00009582877,0.000044184137,0.000020299942,0.00006560215,0.000015542551,0.000036382848,0.0001948776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964924,0.000384618,0.0007348256,0.000364374,0.0014954804,0.00052830036],"domain_scores_gemma":[0.99597806,0.00018638602,0.001044862,0.002176721,0.0003929134,0.00022104343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074738805,0.00029954297,0.0007297405,0.000077908095,0.00043184313,0.00011936256,0.0009675208,0.00007677014,0.00004757703],"category_scores_gemma":[0.0014383562,0.0001530121,0.00028028345,0.00023373369,0.00040754367,0.00025308,0.00044256932,0.00028367114,0.000008860446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033209033,0.0007219722,0.99468136,0.0010475817,0.00043230664,0.000024608997,0.0002502296,0.00013731832,0.0000032148123,0.00005686495,0.00046240835,0.0018500548],"study_design_scores_gemma":[0.0029782187,0.00024466708,0.983948,0.009684814,0.0003504523,0.0003473866,0.0005243677,0.0015152544,0.00002852692,0.00020786567,0.000005999831,0.00016445518],"about_ca_topic_score_codex":0.0016423436,"about_ca_topic_score_gemma":0.00016709763,"teacher_disagreement_score":0.010733358,"about_ca_system_score_codex":0.00019831129,"about_ca_system_score_gemma":0.00052123953,"threshold_uncertainty_score":0.6239652},"labels":[],"label_agreement":null},{"id":"W2754373759","doi":"10.1136/annrheumdis-2017-eular.5816","title":"THU0063 IL-1 family cytokines and receptors in IGG4-related disease","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Immunology; Receptor; Cytokine; Internal medicine; Endocrinology","score_opus":0.0334781247029386,"score_gpt":0.3014187541189993,"score_spread":0.2679406294160607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754373759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874165,0.00546028,5.4003846e-7,0.0043104696,0.00032476077,0.0005297727,0.00013967004,0.000054321896,0.0017636523],"genre_scores_gemma":[0.9961397,0.0024069494,0.000010342221,0.0004970611,0.00003378311,0.000030890347,0.000023410861,0.000032605105,0.00082528125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827117,0.000104175524,0.0005932503,0.00030019242,0.00039656388,0.00033465432],"domain_scores_gemma":[0.99774647,0.00012675207,0.00043173943,0.001135463,0.00012962904,0.00042995167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019885604,0.0002627992,0.0005200259,0.00013520893,0.00030325618,0.000073352814,0.00041293504,0.00008077945,0.0001277089],"category_scores_gemma":[0.0019554223,0.00017499054,0.00029377156,0.0001271717,0.00056466856,0.00034317301,0.0002160537,0.0001464515,0.000032402146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014946854,0.0015315887,0.90039146,0.0022707775,0.000647461,0.000116273164,0.0006346249,0.00008331117,0.00018952918,0.005455479,0.026963145,0.060221665],"study_design_scores_gemma":[0.0013961053,0.00006588508,0.98748547,0.002934832,0.00029749054,0.000004079839,0.00018030951,0.00044120333,0.00020215107,0.005834095,0.00094813365,0.00021026954],"about_ca_topic_score_codex":0.000100019286,"about_ca_topic_score_gemma":0.0000050026456,"teacher_disagreement_score":0.08709398,"about_ca_system_score_codex":0.000014355487,"about_ca_system_score_gemma":0.00020943044,"threshold_uncertainty_score":0.7135907},"labels":[],"label_agreement":null},{"id":"W2754379238","doi":"10.1136/annrheumdis-2017-eular.6544","title":"SAT0384 Risk of myocardial infarction and cerebrovascular accident in ankylosing spondylitis: a general population-based study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Ankylosing spondylitis; Cohort; Myocardial infarction; Retrospective cohort study; Population; Diagnosis code; Emergency medicine; Relative risk; Cohort study; Stroke (engine); Confounding; Internal medicine; Pediatrics; Confidence interval; Environmental health","score_opus":0.02642959439332866,"score_gpt":0.31741079327655936,"score_spread":0.2909811988832307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754379238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975072,0.0012963527,0.000002167927,0.00029398923,0.000101118436,0.00065166387,0.00010945536,0.000007453779,0.000030583375],"genre_scores_gemma":[0.9994152,0.00039049768,0.000055040957,0.000042287673,0.000022622613,0.000032154992,0.000019408648,0.000010527389,0.000012270292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989245,0.00012125621,0.0003477567,0.00016185081,0.0003057085,0.00013895518],"domain_scores_gemma":[0.998864,0.00007507369,0.00035257026,0.00056391215,0.0000822166,0.000062225925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019581645,0.000122040365,0.0004235639,0.000079025696,0.00020843782,0.000025867783,0.00009745503,0.000025298697,0.000027406704],"category_scores_gemma":[0.00069893757,0.00008612758,0.00020169906,0.000055403998,0.00007323368,0.00009556956,0.00008837049,0.000047923826,6.64187e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019119479,0.00059713103,0.9885175,0.00008626488,0.00051503064,0.0000030865226,0.00021207941,0.000078562225,0.00000246851,0.000029467541,0.000024291698,0.009742897],"study_design_scores_gemma":[0.0032601452,0.00025239866,0.99421835,0.0006861445,0.00045291721,0.0000021341743,0.00023754498,0.00017639776,0.000050168637,0.0005890782,0.000007123594,0.00006762539],"about_ca_topic_score_codex":0.0069769174,"about_ca_topic_score_gemma":0.00037107774,"teacher_disagreement_score":0.009675272,"about_ca_system_score_codex":0.000018804814,"about_ca_system_score_gemma":0.00004056579,"threshold_uncertainty_score":0.9996357},"labels":[],"label_agreement":null},{"id":"W2754409937","doi":"10.1136/annrheumdis-2017-eular.1874","title":"SAT0461 Characterisation of different low disease activity measurements in patients with psoriatic arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Visual analogue scale; Dermatology; Physical therapy","score_opus":0.03926473635492046,"score_gpt":0.28472698589139567,"score_spread":0.24546224953647522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754409937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798775,0.00040482322,0.0000013226986,0.0005287821,0.00012354057,0.00074184337,0.0001441294,0.000007477517,0.00006032482],"genre_scores_gemma":[0.99943787,0.0003973109,0.000006484048,0.00003868748,0.000010993598,0.00005204643,0.000022974664,0.000014080523,0.000019568457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872786,0.000059764207,0.00029756097,0.00017160006,0.0005564266,0.0001867758],"domain_scores_gemma":[0.9984249,0.000038045142,0.000529741,0.00071870483,0.0001604206,0.00012818491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066401895,0.00016794392,0.0004806249,0.000053121483,0.00014459433,0.000018888299,0.00015770014,0.000021373617,0.000040384344],"category_scores_gemma":[0.0004505629,0.00010146345,0.00015081408,0.0000494156,0.00015535578,0.00016264462,0.0000875138,0.000044239674,0.0000026123694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014017626,0.0025264756,0.92135024,0.00038116073,0.00028152112,0.0000019671818,0.00009438517,0.00000133979,0.000008947498,0.000012805751,0.000038751554,0.07390066],"study_design_scores_gemma":[0.005158965,0.00031795923,0.9895965,0.0039809383,0.00017253992,1.7283075e-7,0.000017289414,0.000014482389,0.00042011053,0.00023229682,0.0000014886116,0.0000872425],"about_ca_topic_score_codex":0.00011211353,"about_ca_topic_score_gemma":0.000052573432,"teacher_disagreement_score":0.07381342,"about_ca_system_score_codex":0.00002538452,"about_ca_system_score_gemma":0.00005380562,"threshold_uncertainty_score":0.41375592},"labels":[],"label_agreement":null},{"id":"W2754439958","doi":"10.1136/annrheumdis-2017-eular.2590","title":"THU0632 Validation of internet-based reporting of patient reported outcomes within the swedish rheumatology quality register","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; National Institutes of Health; Canadian Rheumatology Association","keywords":"Medicine; BASDAI; Psoriatic arthritis; Visual analogue scale; BASFI; Rheumatology; Ankylosing spondylitis; Physical therapy; Internal medicine; Rheumatoid arthritis; Gold standard (test); Quality of life (healthcare)","score_opus":0.10951926505197403,"score_gpt":0.39648114411384466,"score_spread":0.28696187906187065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754439958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918592,0.0008433378,0.000041732834,0.0059900098,0.00026053877,0.0005724739,0.00003510333,0.000019157833,0.00037847646],"genre_scores_gemma":[0.9993603,0.00026564903,0.00008237673,0.00010735892,0.000004627464,0.000032021104,0.000013587432,0.000017512664,0.00011657287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955473,0.00034892294,0.0028723225,0.00021943511,0.000788675,0.00022335562],"domain_scores_gemma":[0.98734725,0.00055930566,0.009409174,0.0019573742,0.00062072644,0.00010614765],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0017440022,0.00017512504,0.0009508891,0.00007698421,0.0001734941,0.000038813676,0.0005100206,0.000048647435,0.00007653886],"category_scores_gemma":[0.0284006,0.00009193289,0.00050982647,0.00008476498,0.000944827,0.00014454564,0.00019774179,0.00012653593,0.0000014111678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054206554,0.0005715882,0.9836113,0.0011973497,0.0007636139,0.000008457105,0.001307461,0.000043211312,0.0001964351,0.0024317836,0.0013189774,0.008007752],"study_design_scores_gemma":[0.0013917428,0.00028230555,0.94497055,0.0039033482,0.000057914556,0.000037318496,0.0009632753,0.00033812935,0.04359356,0.004260863,0.00006112463,0.00013990035],"about_ca_topic_score_codex":0.0011773008,"about_ca_topic_score_gemma":0.00004297829,"teacher_disagreement_score":0.043397125,"about_ca_system_score_codex":0.000009745779,"about_ca_system_score_gemma":0.00027447686,"threshold_uncertainty_score":0.9797836},"labels":[],"label_agreement":null},{"id":"W2754445098","doi":"10.1136/annrheumdis-2017-eular.3718","title":"AB0627 Rise-ssc: a double-blind, randomised study evaluating the efficacy and safety of riociguat for the treatment of patients with diffuse cutaneous systemic sclerosis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Riociguat; Medicine; Connective tissue disease; Fibrosis; Internal medicine; Placebo; Scleroderma (fungus); Gastroenterology; Clinical endpoint; Connective tissue; Surgery; Clinical trial; Pathology; Disease; Pulmonary hypertension; Autoimmune disease","score_opus":0.11645460587077382,"score_gpt":0.3576456307765168,"score_spread":0.24119102490574296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754445098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97798127,0.011607696,0.000008116676,0.00040443864,0.00013247173,0.009631948,0.00020103162,0.000012834454,0.00002017769],"genre_scores_gemma":[0.9952599,0.004106831,0.000009097448,0.000021136777,0.00002876868,0.00046515703,0.000008852554,0.000030247953,0.000070036105],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99765784,0.00024695921,0.000904649,0.00026090638,0.0007038851,0.0002257858],"domain_scores_gemma":[0.9942031,0.0022101626,0.0015258951,0.0014821116,0.00045409327,0.00012467286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004866858,0.0002723984,0.0009142942,0.00004893394,0.0005983024,0.000050129547,0.0004556906,0.00005194708,0.000013425681],"category_scores_gemma":[0.0009888796,0.00010079023,0.0004243563,0.00009507756,0.00046322687,0.000059506187,0.00007941707,0.000049863036,7.2039876e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40807596,0.025187084,0.3546251,0.003371495,0.0141924685,0.000002362067,0.013615348,0.001058277,0.00041852755,0.000046213576,0.00039334098,0.17901382],"study_design_scores_gemma":[0.25710794,0.0054955957,0.7090608,0.013336222,0.009411062,0.0000069704106,0.0037213822,0.0010806216,0.0005361183,0.00003445994,0.000004957038,0.00020384425],"about_ca_topic_score_codex":0.0002311827,"about_ca_topic_score_gemma":0.0000072750836,"teacher_disagreement_score":0.3544357,"about_ca_system_score_codex":0.00002511363,"about_ca_system_score_gemma":0.00013586684,"threshold_uncertainty_score":0.46017188},"labels":[],"label_agreement":null},{"id":"W2754453190","doi":"10.1136/annrheumdis-2017-eular.6432","title":"SAT0688 Joint involvement in patients with knee and hip oa scheduled for surgery: multi-joint oa, the rule not the exception?","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Taichung Veterans General Hospital; Pfizer","keywords":"Medicine; Osteoarthritis; Physical therapy; Body mass index; Joint pain; Ankle; WOMAC; Surgery; Internal medicine","score_opus":0.07697727748651857,"score_gpt":0.29527069601953954,"score_spread":0.21829341853302098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754453190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095625,0.00047040268,0.00002004791,0.006362612,0.00014055773,0.0019267347,0.00008761421,0.000013277784,0.00002249544],"genre_scores_gemma":[0.99845034,0.000083177976,0.00015698207,0.00081234897,0.000022534234,0.0002886407,0.000028555613,0.000020827045,0.00013657703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998815,0.000075500335,0.0003456179,0.00019021715,0.0003295578,0.00024413023],"domain_scores_gemma":[0.998385,0.00019907698,0.0003791157,0.00080458936,0.00013739626,0.000094822106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036436948,0.0001807684,0.00039210625,0.000049019287,0.00037868947,0.00007021564,0.00016609077,0.00002907055,0.000032509866],"category_scores_gemma":[0.0005870148,0.000077935925,0.00019287578,0.000043405413,0.00023421444,0.000117345975,0.00012490776,0.00006432734,0.000005646247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022941856,0.0040565496,0.6503724,0.0012287972,0.00080619944,0.000006519585,0.002537266,0.0000119752995,0.00025547328,0.0012160193,0.002240655,0.334974],"study_design_scores_gemma":[0.0050706845,0.00060590194,0.9880871,0.0015491863,0.00024744245,0.0000011626142,0.00043238906,0.0001462071,0.0022115172,0.0014410387,0.00007980125,0.00012755523],"about_ca_topic_score_codex":0.00010335172,"about_ca_topic_score_gemma":0.00006596262,"teacher_disagreement_score":0.33771473,"about_ca_system_score_codex":0.00001735853,"about_ca_system_score_gemma":0.000073567535,"threshold_uncertainty_score":0.31781346},"labels":[],"label_agreement":null},{"id":"W2754453650","doi":"10.1136/annrheumdis-2017-eular.6132","title":"OP0181 Deletion of the prostaglandin D2 receptor DP1 exacerbates aging-associated and instability-induced osteoarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; University of Leeds; Arthritis Society","keywords":"Medicine; Osteoarthritis; Cartilage; Internal medicine; Endocrinology; Agonist; Pathogenesis; Receptor; Pathology; Anatomy","score_opus":0.02910080144692843,"score_gpt":0.29204183452337384,"score_spread":0.2629410330764454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754453650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955795,0.00076294056,4.6436043e-7,0.0022971847,0.00030556912,0.0008037372,0.00007884371,0.000018863548,0.0001529036],"genre_scores_gemma":[0.99944836,0.0002214635,0.00000692008,0.00011332306,0.000033413362,0.000032740103,0.000008669793,0.000016164691,0.0001189564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987049,0.00020226123,0.0003670055,0.0001630848,0.0003598844,0.00020282643],"domain_scores_gemma":[0.9981225,0.00021145913,0.00059274386,0.0007703907,0.00019090838,0.00011197729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005056359,0.0001496575,0.0004066494,0.000035257188,0.0003107417,0.000032807093,0.00025803316,0.000068680565,0.00004496506],"category_scores_gemma":[0.003893431,0.00008437888,0.00019000692,0.000076528166,0.00032938452,0.00012602484,0.00016645153,0.00010432309,0.0000033107215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004228708,0.0006044237,0.918057,0.0024855866,0.00030925169,0.000003012839,0.0022262265,0.0000022893691,0.009655883,0.00023995315,0.0031629235,0.06283058],"study_design_scores_gemma":[0.0015517324,0.0002732734,0.9459979,0.00334359,0.0001437144,0.0000029234855,0.00019993217,0.000086708096,0.04765942,0.0005154234,0.000111331254,0.000114038],"about_ca_topic_score_codex":0.00017401659,"about_ca_topic_score_gemma":0.000050204686,"teacher_disagreement_score":0.06271654,"about_ca_system_score_codex":0.00001736857,"about_ca_system_score_gemma":0.000121617784,"threshold_uncertainty_score":0.4661082},"labels":[],"label_agreement":null},{"id":"W2754468333","doi":"10.1136/annrheumdis-2017-eular.2986","title":"SAT0602 Management of epicondylitis with single local injection of sodium hyaluronate","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tendon Structure and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Epicondylitis; Medicine; Tennis elbow; Elbow; Placebo; Grip strength; Physical therapy; Adverse effect; Randomized controlled trial; Prolotherapy; Anesthesia; Surgery; Internal medicine","score_opus":0.03839550531292467,"score_gpt":0.3007135136519008,"score_spread":0.2623180083389761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754468333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942756,0.00069602125,0.0001111072,0.0008015884,0.000079252226,0.00032430855,0.000060348655,0.000010489918,0.0036412762],"genre_scores_gemma":[0.99928284,0.00009957489,0.00016633846,0.000043501837,0.000006876523,0.000009569104,0.0000063573225,0.000009704039,0.00037525143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99921316,0.000023543822,0.0002578354,0.00011002156,0.0002823116,0.000113130896],"domain_scores_gemma":[0.9987237,0.000030646257,0.00042572644,0.00065758015,0.00010369797,0.00005865076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048336147,0.000103726314,0.00031763886,0.000037294354,0.000062737614,0.0000071359755,0.00015149494,0.000020039803,0.000061674735],"category_scores_gemma":[0.00003115794,0.000058502323,0.00014456152,0.00004363458,0.00030957148,0.000059918915,0.000073880656,0.000027878103,0.0000018530628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023102455,0.0023970164,0.119715735,0.007296239,0.0051774243,0.00006320548,0.000739864,0.00012121439,0.00030527392,0.008440361,0.00229819,0.85113525],"study_design_scores_gemma":[0.0021047946,0.0010712831,0.95189077,0.0026086483,0.0009059864,0.000028393793,0.0004440364,0.000040649,0.036749776,0.003966349,0.000099651224,0.00008966505],"about_ca_topic_score_codex":0.00020530142,"about_ca_topic_score_gemma":0.000009220122,"teacher_disagreement_score":0.85104555,"about_ca_system_score_codex":0.00000926124,"about_ca_system_score_gemma":0.000031690495,"threshold_uncertainty_score":0.23856555},"labels":[],"label_agreement":null},{"id":"W2754477812","doi":"10.1136/annrheumdis-2017-eular.1040","title":"SAT0520 Marked reduction of osteoarthritis pain with a hydrogen sulfide-releasing naproxen derivative","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Naproxen; Osteoarthritis; Hydrogen sulfide; Reduction (mathematics); Derivative (finance); Hydrogen; Medicine; Chemistry; Organic chemistry; Business; Mathematics; Pathology; Sulfur; Alternative medicine","score_opus":0.022451727366926418,"score_gpt":0.2790127131309804,"score_spread":0.256560985764054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754477812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966183,0.001012841,0.00002001338,0.0011198551,0.000098995624,0.0006487585,0.00002632779,0.000020453035,0.00043448343],"genre_scores_gemma":[0.9994051,0.00017169458,0.00010988156,0.00008289804,0.00005219636,0.000032487143,0.000008030356,0.000023605224,0.00011409146],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986581,0.00022788938,0.00034919777,0.00016487075,0.00039258046,0.00020732853],"domain_scores_gemma":[0.9980641,0.00017806934,0.0006415852,0.0007754899,0.00020626847,0.00013450377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044606984,0.00015941875,0.00044875464,0.000060108283,0.0002173841,0.00002025707,0.00022363117,0.00004695843,0.00004365947],"category_scores_gemma":[0.0020936485,0.000100595695,0.00018893278,0.000081919505,0.00042431077,0.00015950702,0.0000690515,0.000076303324,0.000003827653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006273631,0.0012062347,0.16441642,0.007348096,0.0018292778,0.00007668266,0.003957762,0.00007233618,0.015546361,0.0008660257,0.0072944327,0.7911127],"study_design_scores_gemma":[0.004780677,0.001957363,0.74833715,0.017173314,0.00067939964,0.000091625625,0.0011627431,0.00064320484,0.22189,0.0025209682,0.0003099477,0.00045363748],"about_ca_topic_score_codex":0.00011959119,"about_ca_topic_score_gemma":0.0000067426154,"teacher_disagreement_score":0.79065907,"about_ca_system_score_codex":0.000013111541,"about_ca_system_score_gemma":0.00016356383,"threshold_uncertainty_score":0.41021734},"labels":[],"label_agreement":null},{"id":"W2754514945","doi":"10.1136/annrheumdis-2017-eular.5600","title":"FRI0171 Obesity contributes to suboptimal physical function in rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Patient-Centered Outcomes Research Institute; U.S. Department of State","keywords":"Medicine; Overweight; Rheumatoid arthritis; Internal medicine; Obesity; Depression (economics); Physical therapy; Confounding; Observational study; Weight loss","score_opus":0.029467440592682633,"score_gpt":0.31904687861374936,"score_spread":0.2895794380210667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754514945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98591244,0.00554528,0.00004754645,0.00689918,0.0002142001,0.0006596921,0.00006822393,0.000034635632,0.00061878806],"genre_scores_gemma":[0.9892572,0.010131585,0.000028719718,0.00035393416,0.00003727446,0.00007043714,0.000009335591,0.000020032185,0.00009144927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983192,0.00010957232,0.00039049727,0.00024943784,0.00049689197,0.0004344126],"domain_scores_gemma":[0.99815005,0.00017753604,0.00020684827,0.0009847558,0.0002157692,0.0002650265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030020328,0.00018978074,0.0006144944,0.00013070524,0.00037111956,0.00012611976,0.0004542922,0.000046040426,0.00009518367],"category_scores_gemma":[0.002166419,0.00013595399,0.00029720677,0.00014085554,0.00035776896,0.00028154813,0.00024176751,0.00015227811,0.000085464664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024693336,0.0031211595,0.7492892,0.00038085022,0.00063622,0.000034232286,0.0009411829,0.00006251119,0.00079462247,0.011726282,0.02295659,0.2075878],"study_design_scores_gemma":[0.0022048657,0.000304554,0.9801343,0.003222474,0.000007373101,0.000008639506,0.00018097676,0.00029352008,0.0024314208,0.009666111,0.00139905,0.00014668018],"about_ca_topic_score_codex":0.00037221413,"about_ca_topic_score_gemma":0.000111811896,"teacher_disagreement_score":0.23084512,"about_ca_system_score_codex":0.00001929045,"about_ca_system_score_gemma":0.0001455249,"threshold_uncertainty_score":0.5544043},"labels":[],"label_agreement":null},{"id":"W2754606331","doi":"10.1136/annrheumdis-2017-eular.6083","title":"AB0367 The prophylactic effect of sulfasalazine against pneumocystis pneumonia: an analysis of incidence for pneumocystis pneumonia in patients with rheumatoid arthritis in japan","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Patient-Centered Outcomes Research Institute","keywords":"Sulfasalazine; Medicine; Rheumatoid arthritis; Internal medicine; Pneumocystis pneumonia; Incidence (geometry); Rheumatology; Tocilizumab; Arthritis; Retrospective cohort study; Pneumonia; Pneumocystis jirovecii; Disease; Ulcerative colitis","score_opus":0.013176028524837517,"score_gpt":0.28784382936040276,"score_spread":0.27466780083556525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754606331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499154,0.0006540205,0.000010996105,0.00084850093,0.00014208407,0.0028422773,0.00043331183,0.00002938157,0.000047883448],"genre_scores_gemma":[0.99873555,0.00061250385,0.000036358088,0.000056486457,0.000010710256,0.00038650876,0.00006888467,0.00006160239,0.00003139534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568105,0.00043893052,0.0015878731,0.00064178644,0.0010621914,0.00058817357],"domain_scores_gemma":[0.99387527,0.00095823244,0.0020648383,0.002363439,0.0004790007,0.0002592114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008405438,0.0005656707,0.0021895303,0.00071233284,0.00029965342,0.00006851725,0.0009478351,0.00013406956,0.000015918977],"category_scores_gemma":[0.0023623055,0.00032919343,0.0007006502,0.0010196955,0.0007242183,0.00044604036,0.00021244162,0.00026009258,0.0000027186677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00250445,0.0019207272,0.9534282,0.0009992975,0.0012344695,0.00001641752,0.00042455253,0.0012980945,0.0021629122,0.000061461826,0.0000061842884,0.035943206],"study_design_scores_gemma":[0.0054047154,0.0031243723,0.9801162,0.0027267213,0.0009741652,0.000010291696,0.000107666725,0.0029465973,0.0041996166,0.00009763727,0.000005059966,0.00028698138],"about_ca_topic_score_codex":0.0012028591,"about_ca_topic_score_gemma":0.0015366583,"teacher_disagreement_score":0.035656225,"about_ca_system_score_codex":0.00010873785,"about_ca_system_score_gemma":0.00023356995,"threshold_uncertainty_score":0.999916},"labels":[],"label_agreement":null},{"id":"W2754632726","doi":"10.1136/annrheumdis-2017-eular.1818","title":"AB0289 Predictor of the simplified disease activity index 50 (SDAI 50) at month 6 during bdmards treatment in patients with long-established rheumatoid arthritis: a single-center, retrospective study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Japan; Ono Pharmaceutical; AbbVie Canada; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Tanabe Pharma Corporation; Japan Blood Products Organization; Chugai Pharmaceutical; Teijin Pharma; Pfizer","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Methotrexate; Single Center; Antirheumatic drugs; Odds ratio; Body mass index; Tocilizumab; Retrospective cohort study; Physical therapy; Antirheumatic Agents","score_opus":0.02146073027347704,"score_gpt":0.2760304804239141,"score_spread":0.25456975015043704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754632726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930712,0.0019054125,0.000002317754,0.0004996098,0.00015897663,0.0035457453,0.00068403623,0.00003577488,0.00009693911],"genre_scores_gemma":[0.9964728,0.003038948,0.000003896228,0.000019478432,0.000017866527,0.00025901408,0.000018147937,0.000051570263,0.00011833168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652636,0.0003576725,0.00064970093,0.00049527414,0.0013917983,0.0005792055],"domain_scores_gemma":[0.99614614,0.0001252524,0.0008503775,0.0021209065,0.00034574693,0.00041156367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023167505,0.00041452458,0.0009754267,0.00015499929,0.0005975552,0.00012726366,0.00069131,0.00005631367,0.00007942103],"category_scores_gemma":[0.0012771485,0.00023368656,0.00038223187,0.0001975928,0.00070622994,0.0004973112,0.0005183363,0.00018092018,0.0000026826322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009108989,0.012212324,0.97210443,0.00023645198,0.00075995165,0.000015207082,0.00089250086,0.000023241459,0.000024852001,0.0000108272825,0.00011956233,0.0044916538],"study_design_scores_gemma":[0.015931712,0.0016586537,0.9767791,0.004541207,0.000035957564,0.0000035249568,0.00024592114,0.000046856076,0.0003534176,0.00018465948,0.00001447345,0.0002044963],"about_ca_topic_score_codex":0.00097436615,"about_ca_topic_score_gemma":0.001535331,"teacher_disagreement_score":0.01055367,"about_ca_system_score_codex":0.00023081104,"about_ca_system_score_gemma":0.00031178942,"threshold_uncertainty_score":0.9529461},"labels":[],"label_agreement":null},{"id":"W2754644128","doi":"10.1136/annrheumdis-2017-eular.3151","title":"FRI0505 Residual disease activity in psoriatic arthritis triggers treatment adjustment in only a quarter of patients in daily clinical practice","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriatic arthritis; Residual; Quarter (Canadian coin); Medicine; Clinical Practice; Disease; Computer science; Internal medicine; Physical therapy; Algorithm; History","score_opus":0.05357209459711481,"score_gpt":0.3800204442597939,"score_spread":0.3264483496626791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754644128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105865,0.0038198172,2.1860365e-7,0.0030385775,0.00023555104,0.0012441969,0.00025380126,0.0000064788055,0.00034268477],"genre_scores_gemma":[0.9896971,0.009891542,0.000050790233,0.0001348029,0.000025763089,0.00012498723,0.000019990583,0.00001604769,0.000039000934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975558,0.00036123407,0.0009391364,0.00033266042,0.0004848797,0.00032630406],"domain_scores_gemma":[0.99744767,0.00058796036,0.0007390479,0.00092521973,0.00011096461,0.00018915017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033888893,0.00023933942,0.0009082408,0.00014098815,0.000078847006,0.000017885885,0.00020437856,0.00005843763,0.0000428097],"category_scores_gemma":[0.0033617397,0.00016650169,0.00030030697,0.0001326359,0.00022390102,0.00027878443,0.000112612994,0.000110308676,0.000006762411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004254778,0.012825147,0.76260096,0.00017716992,0.00026739007,0.00008744786,0.0005460635,0.000007109642,2.897054e-7,0.000043866225,0.00037577457,0.218814],"study_design_scores_gemma":[0.014788526,0.0012880774,0.98008764,0.0026474001,0.00022430762,0.0000011215612,0.0003754066,0.000043135013,0.000018263447,0.00033218678,0.000072492425,0.00012145969],"about_ca_topic_score_codex":0.0025205659,"about_ca_topic_score_gemma":0.0017702474,"teacher_disagreement_score":0.21869254,"about_ca_system_score_codex":0.00010053654,"about_ca_system_score_gemma":0.00032004758,"threshold_uncertainty_score":0.6789742},"labels":[],"label_agreement":null},{"id":"W2754667420","doi":"10.1136/annrheumdis-2017-eular.2311","title":"FRI0132 High disease activity is a predictor of depression and persistent depression in early rheumatoid arthritis: results from the ontario best practices research initiative (OBRI)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; University of Toronto; University Health Network; Toronto General Hospital; William Osler Health System; Brampton Civic Hospital","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Depression (economics); Medicine; Rheumatoid arthritis; Logistic regression; Internal medicine; Disease; Physical therapy","score_opus":0.13981739523463235,"score_gpt":0.3771130075288303,"score_spread":0.23729561229419796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754667420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707106,0.020351123,0.0000014955048,0.006376594,0.00011151636,0.0010912307,0.0009822015,0.000013725071,0.00036151303],"genre_scores_gemma":[0.9477634,0.051830124,0.000037574384,0.00007544194,0.000033543773,0.000102717175,0.000025156722,0.0000245274,0.000107519256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960996,0.0007974717,0.00064920174,0.00051312195,0.0014567117,0.0004839131],"domain_scores_gemma":[0.99412495,0.0020878846,0.0011752284,0.0017051047,0.00048706162,0.00041978457],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011407284,0.00025438055,0.0006214182,0.00013630133,0.0007852907,0.00021171047,0.00075881515,0.000090457645,0.00009168775],"category_scores_gemma":[0.010002192,0.00015105201,0.000273059,0.00014036265,0.0012426396,0.00083540374,0.0007482367,0.00052702706,0.000007604916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010485771,0.0015461422,0.9236838,0.00022985887,0.00052113546,0.00003228356,0.011194178,0.0000046436217,0.00016734086,0.000042938107,0.002551643,0.04954027],"study_design_scores_gemma":[0.0039908634,0.00034278035,0.9754752,0.0144003965,0.00002893649,0.00000517178,0.0015951894,0.0001964371,0.0017243703,0.0018484041,0.0002504368,0.00014180757],"about_ca_topic_score_codex":0.096320406,"about_ca_topic_score_gemma":0.009105378,"teacher_disagreement_score":0.08721503,"about_ca_system_score_codex":0.000043152337,"about_ca_system_score_gemma":0.00061885436,"threshold_uncertainty_score":0.998337},"labels":[],"label_agreement":null},{"id":"W2754680496","doi":"10.1136/annrheumdis-2017-eular.5890","title":"OP0237 Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: combined evidence from 5 randomized controlled trials","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"Universidad de Córdoba; Santen; Omeros Corporation; Allergan; Shire","keywords":"Medicine; Rheumatoid arthritis; Placebo; Randomized controlled trial; Internal medicine; Gastroenterology; Ophthalmology; Surgery; Pathology","score_opus":0.12271303735262398,"score_gpt":0.39904211781432963,"score_spread":0.2763290804617057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754680496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95940953,0.01957498,0.00064627494,0.01155883,0.0005702664,0.007044684,0.0010197774,0.00003442982,0.00014122065],"genre_scores_gemma":[0.9931405,0.004700393,0.00014647578,0.000043655396,0.00006968918,0.00087080593,0.00010459201,0.00001907531,0.00090480817],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99721456,0.00062838016,0.0013555691,0.00022189069,0.00036647756,0.00021312646],"domain_scores_gemma":[0.9900598,0.006508065,0.0017689314,0.0010977443,0.00032942853,0.00023604951],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008891538,0.00023948861,0.0034367817,0.00008594772,0.0003109004,0.000048480582,0.00029917943,0.00007660914,0.00018858984],"category_scores_gemma":[0.024950191,0.00011672921,0.002724139,0.00004984341,0.00051912584,0.00013959303,0.000044391934,0.000035068053,0.00000688887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8847658,0.00665995,0.042554867,0.0008357232,0.043536074,0.000014617545,0.000852021,0.00013600466,0.0036464608,0.002695278,0.0017940742,0.01250911],"study_design_scores_gemma":[0.59608036,0.00092329347,0.27558064,0.010535082,0.058070604,4.4698012e-7,0.000115336596,0.020426055,0.0033737205,0.034568768,0.000017545872,0.00030810887],"about_ca_topic_score_codex":0.00028418165,"about_ca_topic_score_gemma":0.0000022444128,"teacher_disagreement_score":0.28868544,"about_ca_system_score_codex":0.000022661534,"about_ca_system_score_gemma":0.00031855048,"threshold_uncertainty_score":0.9832631},"labels":[],"label_agreement":null},{"id":"W2754728260","doi":"10.1136/annrheumdis-2017-eular.6928","title":"FRI0294 Ultrasound of the salivary glands helps to distinguish between primary and secondary sjÖgren syndrome","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; SSS*; Internal medicine; Sicca syndrome; Gastroenterology; Connective tissue disease; Salivary gland; Ultrasound; Antibody; Systemic disease; Pathology; Autoimmune disease; Disease; Immunology; Radiology","score_opus":0.038238024495541784,"score_gpt":0.3005151244941107,"score_spread":0.26227709999856896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754728260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889271,0.0012433553,0.000013116582,0.0033665048,0.00020159503,0.00038874848,0.00048289585,0.000016985203,0.005359658],"genre_scores_gemma":[0.9984497,0.00014748886,0.00004203004,0.00064914406,0.000050940173,0.000012889113,0.000030774063,0.00001639581,0.0006006353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894387,0.000055848355,0.00033979854,0.00017480126,0.00030094845,0.00018473949],"domain_scores_gemma":[0.99806845,0.0003465116,0.0003036306,0.0010183521,0.00009412742,0.00016893129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017235371,0.0001483741,0.00043888864,0.000043445565,0.00036746098,0.000039829112,0.00040036326,0.000044735378,0.00011085848],"category_scores_gemma":[0.0015471888,0.00008148501,0.00021764699,0.00009100023,0.00029877288,0.00008919602,0.00027069895,0.00009458526,0.000004090612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000954531,0.00019561406,0.9769796,0.00071512157,0.00030287908,0.000002758863,0.0003051647,0.0000016462683,0.00003415334,0.00016228089,0.0139857475,0.007219575],"study_design_scores_gemma":[0.00060189917,0.0001380185,0.9944637,0.0009891859,0.00030033197,0.000029597417,0.00014256946,0.0000033369229,0.00009882258,0.0026805846,0.00045434517,0.00009759686],"about_ca_topic_score_codex":0.00029533062,"about_ca_topic_score_gemma":0.000011627314,"teacher_disagreement_score":0.017484106,"about_ca_system_score_codex":0.0000061136416,"about_ca_system_score_gemma":0.00012894328,"threshold_uncertainty_score":0.3322862},"labels":[],"label_agreement":null},{"id":"W2754728664","doi":"10.1136/annrheumdis-2017-eular.1274","title":"OP0222 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 104 weeks results from a phase 3 trial, future 2","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Dactylitis; Placebo; Internal medicine; Ankylosing spondylitis; Gastroenterology; Enthesitis; Rheumatoid arthritis; Pathology","score_opus":0.02937615795444619,"score_gpt":0.331369886370903,"score_spread":0.3019937284164568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754728664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872767,0.004858439,7.5834197e-7,0.0037702292,0.00021148102,0.002102999,0.0015550915,0.000010328604,0.00021402923],"genre_scores_gemma":[0.99742794,0.001966261,0.000016814165,0.00017918508,0.000096714306,0.00017235227,0.00006838751,0.000015641093,0.000056675686],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982771,0.00014404555,0.0006090876,0.00027304667,0.00043550075,0.00026116366],"domain_scores_gemma":[0.9977048,0.0003571464,0.00076398277,0.0009448908,0.00014210827,0.00008705319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024302835,0.00022266437,0.0006445952,0.0000582846,0.0002884856,0.000057633126,0.00034045955,0.000054827407,0.000024869885],"category_scores_gemma":[0.0016153306,0.00012442541,0.00020977855,0.00008989297,0.00028692168,0.00017869746,0.0001681064,0.00009864477,0.0000011864269],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05479645,0.0053371526,0.0017417389,0.00045303558,0.0018753998,0.000070213726,0.0077446313,0.000001196626,0.000065868364,0.00031744316,0.001889085,0.92570776],"study_design_scores_gemma":[0.5656906,0.016756468,0.34141162,0.010869133,0.0020120016,0.000015501162,0.04104225,0.00021855641,0.0022233357,0.018316505,0.00078269746,0.0006613515],"about_ca_topic_score_codex":0.0011286812,"about_ca_topic_score_gemma":0.00017269551,"teacher_disagreement_score":0.92504644,"about_ca_system_score_codex":0.000019553172,"about_ca_system_score_gemma":0.00012923586,"threshold_uncertainty_score":0.5073921},"labels":[],"label_agreement":null},{"id":"W2754758374","doi":"10.1136/annrheumdis-2017-eular.3906","title":"THU0438 Lack of predictive value of the NIAID/FAAN criteria to identify subjects with evidence of immune activation after receiving pegloticase for chronic refractory gout","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Simon Fraser University; University of British Columbia; Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Medicine; Internal medicine; Refractory (planetary science); Gout","score_opus":0.0979302259242577,"score_gpt":0.41659768999578406,"score_spread":0.31866746407152635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754758374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605334,0.00046383412,0.0001220829,0.0015128137,0.00015921806,0.0012765625,0.00013721702,0.000010590299,0.00026435466],"genre_scores_gemma":[0.9994035,0.00014966997,0.00011587405,0.000051439903,0.000030487061,0.00008114495,0.0000030881895,0.000026618485,0.00013820759],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983575,0.00013730561,0.0005894697,0.00020441959,0.00051396573,0.00019739187],"domain_scores_gemma":[0.9959465,0.00070077286,0.0012091185,0.0014456575,0.0006037472,0.000094166455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004160431,0.00016706753,0.00052021816,0.000091869384,0.00013041712,0.000017574228,0.0004482836,0.000052958323,0.000015288777],"category_scores_gemma":[0.005900091,0.000099351215,0.00030813392,0.00015466152,0.00036486692,0.00044488694,0.0001793454,0.000102693804,0.0000015721108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011905371,0.0066398387,0.1348783,0.043677293,0.006008383,0.0000094988245,0.017362636,0.0015437715,0.7051112,0.0014314802,0.0010932279,0.07033899],"study_design_scores_gemma":[0.0006373489,0.0003094068,0.8970316,0.02345599,0.00052972673,0.0000037342122,0.0004987705,0.00026869535,0.07687412,0.0002870982,0.000015581867,0.00008789856],"about_ca_topic_score_codex":0.00036135231,"about_ca_topic_score_gemma":0.000027156924,"teacher_disagreement_score":0.7621533,"about_ca_system_score_codex":0.00006940023,"about_ca_system_score_gemma":0.0004518014,"threshold_uncertainty_score":0.7063386},"labels":[],"label_agreement":null},{"id":"W2754761751","doi":"10.1136/annrheumdis-2017-eular.2446","title":"FRI0484 Impact of psoriatic arthritis on patient-reported outcomes in 5 european union countries","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Genentech; Astellas Pharma; Incyte; Dermira; Baxalta; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Celgene; Novo Nordisk; Teva Pharmaceutical Industries; Amgen; Meiji Seika Pharma; Pfizer; GlaxoSmithKline","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Physical therapy; Rheumatology; Ustekinumab; Cross-sectional study; Tocilizumab; European union; Adalimumab; Arthritis; Disease; Pathology","score_opus":0.03619323963684104,"score_gpt":0.3358264879944852,"score_spread":0.29963324835764416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754761751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951181,0.0016228677,4.7267253e-7,0.0010866043,0.00015632724,0.00039354365,0.00015647942,0.000012037315,0.0014535912],"genre_scores_gemma":[0.99784404,0.0019449433,0.000008196538,0.00007918981,0.0000090507465,0.000011367091,0.000010993523,0.000016589041,0.00007560972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869454,0.000124582,0.00051372004,0.00014223553,0.0003348278,0.00019010005],"domain_scores_gemma":[0.9982239,0.00011877059,0.0006459638,0.00081047823,0.00012064807,0.00008022433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017018031,0.00016358995,0.0005751052,0.00007191016,0.00014652176,0.000020570045,0.00016267173,0.000020698079,0.000069886286],"category_scores_gemma":[0.0012613878,0.0000958801,0.0003366063,0.00005574494,0.0001888971,0.00008647166,0.000099369696,0.00004844023,0.000012049306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019317404,0.00096009404,0.92495346,0.00011617088,0.0006854481,0.00005175977,0.00034802564,0.000014323739,0.0000035514327,0.00009617212,0.0009300567,0.07164775],"study_design_scores_gemma":[0.0025341255,0.0006264288,0.99327624,0.0025768387,0.00010372726,0.0000052992777,0.0001026722,0.000007953703,0.00015122523,0.0005019325,0.000036868376,0.0000767144],"about_ca_topic_score_codex":0.0008007317,"about_ca_topic_score_gemma":0.00006314218,"teacher_disagreement_score":0.07157104,"about_ca_system_score_codex":0.000020308093,"about_ca_system_score_gemma":0.00006254401,"threshold_uncertainty_score":0.39098772},"labels":[],"label_agreement":null},{"id":"W2754766765","doi":"10.1136/annrheumdis-2017-eular.2751","title":"SAT0372 Clinical and serological associations of autoantibodies to BICD2 as a novel marker for systemic sclerosis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Autoantibody; Scleroderma (fungus); Serology; Receiver operating characteristic; Medicine; Antibody; Titer; Internal medicine; Immunology; Pathology","score_opus":0.24814227904210265,"score_gpt":0.423659718623706,"score_spread":0.17551743958160335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754766765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895768,0.0033880996,0.000033913064,0.005268944,0.00020335594,0.00097339717,0.00035845864,0.000024253179,0.00017273857],"genre_scores_gemma":[0.9969729,0.0018477417,0.00019746744,0.00062459783,0.000046105557,0.000063730244,0.000008649875,0.00001621681,0.00022257966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983228,0.0000873445,0.00081296574,0.00024135625,0.00032446516,0.00021107637],"domain_scores_gemma":[0.99727374,0.0006713258,0.00073801534,0.0007261446,0.0003434099,0.0002473431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061576633,0.00015432546,0.00074884924,0.000059575075,0.00026572327,0.000043049826,0.00030818087,0.00012346695,0.000023752256],"category_scores_gemma":[0.007654039,0.0000910424,0.0005092862,0.00006711429,0.00033440176,0.00007283363,0.00016167307,0.00006270088,0.000006903456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065833656,0.0012814773,0.96212596,0.001547546,0.0015888176,9.861313e-7,0.00030593935,0.000017622957,0.0012579436,0.0013128719,0.014403447,0.015499066],"study_design_scores_gemma":[0.0013319232,0.00024244112,0.9880104,0.00848378,0.0006512157,0.000010047522,0.000265359,0.0002109121,0.00020948083,0.00045230912,0.00003397561,0.000098123695],"about_ca_topic_score_codex":0.00009979765,"about_ca_topic_score_gemma":0.0000026716982,"teacher_disagreement_score":0.025884487,"about_ca_system_score_codex":0.000008322828,"about_ca_system_score_gemma":0.00013158118,"threshold_uncertainty_score":0.91631526},"labels":[],"label_agreement":null},{"id":"W2754780777","doi":"10.1136/annrheumdis-2017-eular.6141","title":"THU0677 Outcome measurement instruments for safety in rheumatology: a scoping review of available instruments to inform the omeract safety working group","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Ottawa","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Adverse effect; Clinical trial; Patient safety; MEDLINE; Medical physics; Family medicine; Physical therapy; Health care","score_opus":0.5918507672081825,"score_gpt":0.5440570933910943,"score_spread":0.04779367381708821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754780777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004986899,0.9807899,0.000014387836,0.0026011583,0.00047160054,0.012745577,0.00018769597,0.000036782687,0.0031030523],"genre_scores_gemma":[0.0015663956,0.9963754,0.00015206465,0.00022895602,0.000016243039,0.0014182735,0.000022669232,0.000047241472,0.00017277799],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.991739,0.0012881267,0.003264101,0.0004770024,0.0023497897,0.0008820053],"domain_scores_gemma":[0.99265844,0.0015474213,0.0032131413,0.0018520937,0.0004969204,0.00023199258],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012906127,0.00049685413,0.003093728,0.00033504076,0.0009798452,0.00013383674,0.004265067,0.00022138255,0.00018909293],"category_scores_gemma":[0.019342905,0.00030238702,0.0012293799,0.0009794099,0.00059969816,0.00034455783,0.0010689398,0.00038091026,0.00003793168],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003635403,0.00013292524,0.00089511153,0.1857849,0.0002504614,2.9501695e-7,0.00022211739,4.805982e-7,8.963525e-9,0.0008900786,0.0018746738,0.8099126],"study_design_scores_gemma":[0.00019641926,0.000039546398,0.00021654055,0.7103883,0.00021807963,0.000001198376,0.000108682805,0.0000026246337,5.934593e-7,0.00045788154,0.28811705,0.0002530649],"about_ca_topic_score_codex":0.0012813114,"about_ca_topic_score_gemma":0.0006695974,"teacher_disagreement_score":0.80965954,"about_ca_system_score_codex":0.0004038037,"about_ca_system_score_gemma":0.0021577128,"threshold_uncertainty_score":0.99994284},"labels":[],"label_agreement":null},{"id":"W2754781315","doi":"10.1136/annrheumdis-2017-eular.1858","title":"OP0211-PARE Who cares? an investigation of the health and perceived social care needs of people with rheumatoid arthritis living in scotland","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"Università degli Studi di Genova; Universitair Ziekenhuis Gent; University of Aberdeen; Arthritis Society","keywords":"Medicine; Comorbidity; Quality of life (healthcare); Thematic analysis; Gerontology; Health care; Rheumatoid arthritis; Depression (economics); Cross-sectional study; Social support; Family medicine; Demography; Psychiatry; Qualitative research; Nursing; Internal medicine; Psychology","score_opus":0.03997194121942831,"score_gpt":0.32023841002184295,"score_spread":0.2802664688024146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754781315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932977,0.0036246628,9.833882e-7,0.002105121,0.000043803597,0.000615206,0.00007662483,0.0000100692405,0.00022581074],"genre_scores_gemma":[0.99805075,0.0017328333,0.0000088204615,0.00011592146,0.000013405412,0.000019625568,0.000018372915,0.00001615775,0.000024109211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987339,0.00015784052,0.00039769974,0.00013805182,0.00038578987,0.00018673882],"domain_scores_gemma":[0.9983319,0.000077822406,0.0006545197,0.00064435665,0.00016440114,0.00012698953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016247891,0.00014782231,0.0005133711,0.000088340974,0.0002638253,0.00004959416,0.00031321088,0.000030478386,0.000019910745],"category_scores_gemma":[0.0003424427,0.00009265493,0.000103729835,0.00014658456,0.0005474052,0.00024431752,0.00018534793,0.0000682976,1.7228152e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014245846,0.00012931807,0.9418844,0.004322147,0.000113016045,6.687652e-7,0.04689746,0.00003342746,0.000013622178,0.00068344496,0.00070757227,0.0050724535],"study_design_scores_gemma":[0.00088954327,0.00020064983,0.93986243,0.0116271535,0.000047389945,0.0000017413579,0.046735495,0.00012887114,0.000058075366,0.0003628307,0.00000336739,0.00008243352],"about_ca_topic_score_codex":0.0022549285,"about_ca_topic_score_gemma":0.0020253137,"teacher_disagreement_score":0.0073050065,"about_ca_system_score_codex":0.000024641577,"about_ca_system_score_gemma":0.0005721732,"threshold_uncertainty_score":0.37783584},"labels":[],"label_agreement":null},{"id":"W2754791514","doi":"10.1136/annrheumdis-2017-eular.2887","title":"FRI0129 Comparative safety of biologic dmard initiation in ra: a population-based observational study of malignancy risk","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Janssen Pharmaceuticals; Pfizer Japan; Samsung; Astellas Pharma; Santen; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Celltrion; Kissei; Celgene; Biogen; GlaxoSmithKline; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Etanercept; Discontinuation; Internal medicine; Population; Observational study; Golimumab; Abatacept; Oncology; Rheumatoid arthritis; Rituximab","score_opus":0.27340327890147753,"score_gpt":0.43841175122348647,"score_spread":0.16500847232200894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754791514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979555,0.00023403109,0.00001592411,0.00035465398,0.000045796438,0.0010432673,0.00018365815,0.0000067233996,0.00016043372],"genre_scores_gemma":[0.99966305,0.0000859629,0.00007484182,0.000037063288,0.000010807783,0.000041470532,0.00006016782,0.000007487747,0.000019137224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801624,0.0003208163,0.0007754694,0.00016616374,0.0005624194,0.00015888442],"domain_scores_gemma":[0.9968489,0.0008529269,0.0010859299,0.00078393455,0.0003691148,0.00005922232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050764583,0.00012386244,0.00058192166,0.000117350864,0.000114145114,0.000008956842,0.00035960064,0.000045330034,0.00007949586],"category_scores_gemma":[0.0031435227,0.000082409366,0.00015381043,0.00018045508,0.00018587131,0.00011913808,0.000116533076,0.000079809484,0.000002375291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008749158,0.0015438261,0.9924441,0.00046221894,0.00016540335,0.0000019299941,0.0006306796,0.002432978,0.000022051114,0.00026721923,0.00011450285,0.001040176],"study_design_scores_gemma":[0.0072414037,0.00033945055,0.97821677,0.0012637954,0.00009930097,5.7994544e-7,0.0004190913,0.010209477,0.0005048656,0.0016368291,0.0000013031273,0.000067117755],"about_ca_topic_score_codex":0.004106232,"about_ca_topic_score_gemma":0.000343561,"teacher_disagreement_score":0.014227312,"about_ca_system_score_codex":0.00027778195,"about_ca_system_score_gemma":0.0013069533,"threshold_uncertainty_score":0.62074214},"labels":[],"label_agreement":null},{"id":"W2754798244","doi":"10.1136/annrheumdis-2017-eular.2809","title":"AB0882 Efficacy of intralesionnal sodium thiosulfate in disabling tumoral calcinosis: about two cases","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Manitoba Health Research Council","keywords":"Medicine; Tumoral calcinosis; Sodium thiosulfate; Calciphylaxis; Dermatomyositis; Surgery; Internal medicine; Urology; Calcinosis; Calcification","score_opus":0.056713633713405945,"score_gpt":0.35882108741857033,"score_spread":0.3021074537051644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754798244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514073,0.0014382383,0.0000046856485,0.0023050015,0.00021437858,0.0003794842,0.000059587073,0.000022502949,0.0004353679],"genre_scores_gemma":[0.9990536,0.00041298123,0.00005294088,0.00030603405,0.000066376975,0.000017261036,0.000007885775,0.000021245109,0.0000616614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982111,0.00010191609,0.00073518156,0.00019751416,0.00041985913,0.00033444236],"domain_scores_gemma":[0.9977785,0.0002542434,0.0006288768,0.0010090058,0.00016482649,0.00016457858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027461475,0.0002029292,0.000646409,0.00010508936,0.0002350982,0.000051735868,0.00046063858,0.000046285277,0.00007408921],"category_scores_gemma":[0.0016329292,0.00013613394,0.00035608353,0.00009727237,0.00044206533,0.00021807411,0.00021215774,0.0001341189,0.000012270318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021359425,0.0019291821,0.94285697,0.004726411,0.0004163339,0.0005025917,0.0025564528,0.00028987575,0.0007042852,0.0039502345,0.007161305,0.03277042],"study_design_scores_gemma":[0.002085906,0.00009753579,0.9806554,0.0059522036,0.00015685824,0.00007195095,0.00028749116,0.0006345853,0.0090592895,0.0007911855,0.000048052763,0.00015955545],"about_ca_topic_score_codex":0.00051787286,"about_ca_topic_score_gemma":0.00003888038,"teacher_disagreement_score":0.037798423,"about_ca_system_score_codex":0.000014311587,"about_ca_system_score_gemma":0.00015189426,"threshold_uncertainty_score":0.5551381},"labels":[],"label_agreement":null},{"id":"W2754814058","doi":"10.1136/annrheumdis-2017-eular.3138","title":"AB0444 Effect of rituximab on a salivary gland ultrasound score in primary sjÖgren's syndrome: results of the tractiss multicentre randomised trial sub-study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Echogenicity; Internal medicine; Population; Clinical endpoint; Rituximab; Placebo; Ultrasound; Gastroenterology; Pathology; Randomized controlled trial; Radiology","score_opus":0.030243314880048753,"score_gpt":0.30467825554886263,"score_spread":0.27443494066881385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754814058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940403,0.0005308863,7.963367e-7,0.000581517,0.00038695353,0.0034031875,0.0002348803,0.000011338397,0.0008101425],"genre_scores_gemma":[0.9995119,0.0002028575,0.0000045633506,0.00006554296,0.00002603267,0.00006984315,0.000024206458,0.000018168143,0.00007687505],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997742,0.00046040304,0.00078808033,0.00023971949,0.0005577712,0.0002120399],"domain_scores_gemma":[0.99535596,0.0022572407,0.0008730229,0.0013356558,0.0000869895,0.00009112654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006789349,0.00022558589,0.0009848753,0.000088790526,0.00018315743,0.000022696393,0.0004402133,0.00006584587,0.000027742688],"category_scores_gemma":[0.0057106297,0.0001141343,0.000517242,0.00015123992,0.00027027284,0.00010619492,0.00008697352,0.00015273978,0.0000025513789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5225506,0.012858363,0.45170805,0.001604555,0.00087638566,0.000029802633,0.0010452834,0.00007600187,0.000121261706,0.000011873473,0.0031477252,0.0059700795],"study_design_scores_gemma":[0.24635148,0.0015526249,0.7488468,0.0017599504,0.00055237894,0.00001105037,0.00020943522,0.000037069996,0.00048200568,0.0001025848,0.0000048853612,0.00008971209],"about_ca_topic_score_codex":0.0005679026,"about_ca_topic_score_gemma":0.000057549078,"teacher_disagreement_score":0.29713875,"about_ca_system_score_codex":0.000013269486,"about_ca_system_score_gemma":0.0001426985,"threshold_uncertainty_score":0.683657},"labels":[],"label_agreement":null},{"id":"W2754837162","doi":"10.1136/annrheumdis-2017-eular.5151","title":"SAT0428 Which criteria for inflammatory back pain in spondyloarthritis are optimal? data from the screening for axial spondyloarthritis in psoriasis, iritis, and colitis study (SASPIC)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; University of Calgary; Université de Sherbrooke; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Psoriasis; Triage; Gold standard (test); Rheumatology; Ankylosing spondylitis; Internal medicine; Uveitis; Back pain; Axial spondyloarthritis; Physical therapy; Sacroiliitis; Dermatology; Pathology; Ophthalmology; Emergency medicine; Alternative medicine","score_opus":0.11195243819850967,"score_gpt":0.3673324369555649,"score_spread":0.2553799987570552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754837162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711592,0.011458342,0.00003654974,0.004343482,0.00032809505,0.0043246113,0.008297852,0.0000195708,0.00003225986],"genre_scores_gemma":[0.9945062,0.0026308913,0.0010927595,0.00032588813,0.00020009007,0.00072451495,0.00040697725,0.000057625944,0.00005508948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711186,0.000348953,0.0008867261,0.00067371794,0.00040018905,0.0005785275],"domain_scores_gemma":[0.99565035,0.0014473973,0.00054599287,0.0019438651,0.00024281908,0.00016954709],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013517165,0.0003771106,0.001024293,0.00009770537,0.0006265416,0.00021828244,0.0008813914,0.00010060009,0.00009744442],"category_scores_gemma":[0.0061226957,0.00028164586,0.00019606182,0.00014106753,0.0003435587,0.00042552946,0.00071306864,0.0001485541,0.0000033748006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045662066,0.0017897397,0.76353645,0.00081351254,0.0007603033,0.00016332784,0.0015035563,0.000009614238,0.000011242008,0.000105407424,0.01741713,0.20932351],"study_design_scores_gemma":[0.014439587,0.0008192324,0.9709207,0.006029596,0.0002125616,0.00001562965,0.00393935,0.0006170792,0.000021494378,0.0009185877,0.0017867025,0.00027947058],"about_ca_topic_score_codex":0.002050296,"about_ca_topic_score_gemma":0.016975483,"teacher_disagreement_score":0.20904404,"about_ca_system_score_codex":0.0000251849,"about_ca_system_score_gemma":0.00012300536,"threshold_uncertainty_score":0.9999636},"labels":[],"label_agreement":null},{"id":"W2754855780","doi":"10.1136/annrheumdis-2017-eular.4485","title":"AB0287 Mutual assent towards comprehensive disease control: the relationship between us measures and patient reported outcomes in early rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Japan; Ono Pharmaceutical; AbbVie Canada; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Tanabe Pharma Corporation; Japan Blood Products Organization; Chugai Pharmaceutical; Teijin Pharma; Pfizer","keywords":"Medicine; Rheumatoid arthritis; Synovitis; Internal medicine; Physical therapy; Cohort; Disease","score_opus":0.08835789917907229,"score_gpt":0.3441415833036445,"score_spread":0.25578368412457225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754855780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969695,0.014891105,0.000008587064,0.013747557,0.00014239854,0.0011729936,0.00020438469,0.00003506601,0.00010294379],"genre_scores_gemma":[0.98945224,0.010002673,0.000014047886,0.00031654077,0.000020276111,0.00011116288,0.000012893576,0.000029478853,0.000040678286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693894,0.00041066486,0.0008749087,0.00031914876,0.001017776,0.00043855916],"domain_scores_gemma":[0.9959749,0.0012462586,0.0006513121,0.0013674255,0.00032608357,0.000434013],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00039150723,0.00028456157,0.0007989247,0.00012487173,0.00067223696,0.00021150448,0.0004292551,0.000060919752,0.000021182928],"category_scores_gemma":[0.008595904,0.00016494187,0.0003472181,0.00010304538,0.00095288316,0.00029715683,0.000223137,0.00026500068,0.000008839155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038091227,0.00023451558,0.9634001,0.00008470779,0.0004128275,0.00003678058,0.00066139124,0.0000064602273,0.00000402538,0.0005983724,0.0006525595,0.033527337],"study_design_scores_gemma":[0.0028570744,0.0001819973,0.98851675,0.0021072475,0.000030938743,0.000015284602,0.0003112907,0.000048415077,0.000033724413,0.0053343964,0.00039278556,0.0001700846],"about_ca_topic_score_codex":0.0009687877,"about_ca_topic_score_gemma":0.00009463775,"teacher_disagreement_score":0.03335725,"about_ca_system_score_codex":0.000019842448,"about_ca_system_score_gemma":0.00027319603,"threshold_uncertainty_score":0.9997551},"labels":[],"label_agreement":null},{"id":"W2754903693","doi":"10.1136/annrheumdis-2017-eular.4710","title":"FRI0180 Multiple sclerosis risk-alleles study in patients with demyelinating side effects on anti tnf alpha therapy","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Genentech; UCB Pharma; Pfizer","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Multiple sclerosis; Rheumatology; Single-nucleotide polymorphism; Tumor necrosis factor alpha; Cohort; Clinically isolated syndrome; Immunology; Genotype","score_opus":0.04943423555750202,"score_gpt":0.3081594460564358,"score_spread":0.25872521049893377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754903693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589425,0.0015963194,0.0000027248982,0.00052576885,0.000078115765,0.0017061722,0.00004735453,0.000029078354,0.000120188284],"genre_scores_gemma":[0.9944206,0.0052393484,0.000051382696,0.00011666614,0.000023226363,0.00008983631,0.000007626802,0.000035581994,0.000015769274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781495,0.00034108525,0.0003827811,0.00028013144,0.000797804,0.0003832246],"domain_scores_gemma":[0.99749947,0.00066867424,0.00046159988,0.0010013025,0.00019702829,0.00017194725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038844548,0.00024004123,0.0005640273,0.00012562687,0.00051290967,0.000101250866,0.00048053733,0.00003603417,0.000020185513],"category_scores_gemma":[0.0024114181,0.00013741972,0.00016376472,0.000107775304,0.0002105099,0.00021540603,0.00012883851,0.00018329598,0.000012940726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008223133,0.00219919,0.76601386,0.00009558032,0.00030327486,0.000004259092,0.0006000558,0.000022832226,0.000012917175,0.000011262446,0.00015633399,0.22975814],"study_design_scores_gemma":[0.009152656,0.0017830944,0.9836933,0.0034315041,0.000015543019,3.0306074e-7,0.0003463438,0.000119515214,0.001086348,0.0002035132,0.000021763142,0.00014609408],"about_ca_topic_score_codex":0.00056138105,"about_ca_topic_score_gemma":0.00012222958,"teacher_disagreement_score":0.22961205,"about_ca_system_score_codex":0.000013444776,"about_ca_system_score_gemma":0.00006968531,"threshold_uncertainty_score":0.56038135},"labels":[],"label_agreement":null},{"id":"W2754919740","doi":"10.1136/annrheumdis-2017-eular.4074","title":"FRI0522 The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Cohort; Internal medicine; Ankylosing spondylitis; Confounding; Retrospective cohort study; Peripheral; Radiography; Univariate analysis; Physical therapy; Multivariate analysis; Surgery; Arthritis","score_opus":0.0320736464529388,"score_gpt":0.31472086405351835,"score_spread":0.28264721760057954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754919740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902348,0.0037546882,0.000001059151,0.005047435,0.00011615855,0.0004304068,0.00020722802,0.0000114475915,0.00019678948],"genre_scores_gemma":[0.9956144,0.004111256,0.000013741036,0.000088805515,0.000025569425,0.00003224834,0.000025685204,0.000009697088,0.000078585115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887,0.00010627038,0.00034018082,0.00014737021,0.00035325543,0.00018288524],"domain_scores_gemma":[0.9985641,0.00041399087,0.0003938807,0.00047576506,0.000081953156,0.00007028901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024977818,0.00011939894,0.00036105534,0.000055219887,0.00036635983,0.000047980357,0.00018301031,0.000053758995,0.00003847047],"category_scores_gemma":[0.001502337,0.0000709743,0.00016108873,0.00010798382,0.00013443358,0.000101837446,0.00011751016,0.000093481285,0.000004284532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041784027,0.0001814482,0.97746253,0.00006997029,0.00058558094,0.0000051337724,0.00016545647,0.0000018130047,8.4503034e-7,0.0008476889,0.0004887709,0.020148978],"study_design_scores_gemma":[0.0019943404,0.000077979406,0.9898681,0.0012694431,0.00024655106,0.000001549261,0.00012514903,0.00005748408,0.00003738421,0.0062299687,0.000027850385,0.000064181986],"about_ca_topic_score_codex":0.00030838474,"about_ca_topic_score_gemma":0.0002021273,"teacher_disagreement_score":0.020084795,"about_ca_system_score_codex":0.000017820415,"about_ca_system_score_gemma":0.00003850925,"threshold_uncertainty_score":0.2894248},"labels":[],"label_agreement":null},{"id":"W2754920324","doi":"10.1136/annrheumdis-2017-eular.1574","title":"FRI0375 Real-life treatment strategies for systemic sclerosis according to experts","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital","funders":"","keywords":"Medicine; cGMP-specific phosphodiesterase type 5; Internal medicine; Algorithm; Sildenafil; Computer science","score_opus":0.18190267747364444,"score_gpt":0.37714754383310795,"score_spread":0.1952448663594635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754920324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868663,0.0069873533,0.00006023423,0.0033363688,0.0003482637,0.0015750566,0.00011585187,0.00006344197,0.00064716017],"genre_scores_gemma":[0.99379355,0.004867512,0.00004228267,0.00040539555,0.00011445436,0.00040958548,0.000009340037,0.000036660163,0.0003212099],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984006,0.00006041031,0.0005637021,0.00029772604,0.00034546285,0.00033209805],"domain_scores_gemma":[0.9972903,0.00021997718,0.0004983636,0.0013423213,0.00022253717,0.00042647053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015036583,0.00025364477,0.00068426615,0.00008059787,0.00049837056,0.00017379105,0.00044298253,0.00007724858,0.00003097573],"category_scores_gemma":[0.00083572144,0.00014452447,0.00059659436,0.00007210813,0.000113913375,0.00018733043,0.000089636414,0.000026761518,0.000015226266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076641724,0.009013155,0.30517682,0.018187588,0.014593756,0.00004224913,0.015047141,0.00233799,0.04866576,0.018560596,0.20095728,0.3597535],"study_design_scores_gemma":[0.0089620305,0.0019515757,0.80925083,0.10527734,0.0034921214,0.00006213313,0.053191725,0.0014460055,0.012839047,0.0020062886,0.00041236007,0.0011085469],"about_ca_topic_score_codex":0.0006374842,"about_ca_topic_score_gemma":0.0000062295057,"teacher_disagreement_score":0.504074,"about_ca_system_score_codex":0.00004766468,"about_ca_system_score_gemma":0.00036623408,"threshold_uncertainty_score":0.5893537},"labels":[],"label_agreement":null},{"id":"W2754936199","doi":"10.1136/annrheumdis-2017-eular.3001","title":"SAT0436 Durability of apremilast response in patients with psoriatic arthritis: long-term (208-week) results from the palace 1 trial","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"School of Medicine, University of California, San Diego; European Regional Development Fund; University of Washington; Université d'Orléans; University of Melbourne; Monash University; Instituto de Salud Carlos III","keywords":"Apremilast; Medicine; Psoriatic arthritis; Randomized controlled trial; Placebo; Internal medicine; Psoriasis; Gastroenterology; Surgery; Dermatology; Disease; Pathology","score_opus":0.03669287233529942,"score_gpt":0.2971676991719139,"score_spread":0.26047482683661444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754936199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932184,0.0016000594,5.912449e-7,0.0022664058,0.00024067059,0.0015332785,0.001050778,0.000011636372,0.00007816125],"genre_scores_gemma":[0.9991014,0.0005882087,0.000021946811,0.00008184123,0.00003541811,0.00006147579,0.000048794376,0.000017659644,0.00004328115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977939,0.00031390355,0.0007393696,0.0002993583,0.0005894933,0.00026395867],"domain_scores_gemma":[0.9960559,0.0010763704,0.000803431,0.0017507749,0.00020945737,0.000104038234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046820517,0.00021984766,0.0006778514,0.000035811612,0.00025374632,0.000033877164,0.00041072562,0.00005011973,0.00004513339],"category_scores_gemma":[0.0064529283,0.00011453043,0.00023564935,0.000097167635,0.00049185817,0.0001218173,0.00018889211,0.00010070425,0.0000058156224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21723425,0.0026661044,0.7568451,0.000096023614,0.00045567754,0.000010300819,0.0005940065,0.0000039081297,0.0000014310385,0.000008868854,0.0005290841,0.021555204],"study_design_scores_gemma":[0.06490553,0.0014889111,0.92904186,0.003770069,0.00019628362,6.444711e-7,0.00012547319,0.0000043980845,0.000070871145,0.00028881175,0.000007872869,0.000099295576],"about_ca_topic_score_codex":0.00057739805,"about_ca_topic_score_gemma":0.00036533945,"teacher_disagreement_score":0.1721967,"about_ca_system_score_codex":0.000026812697,"about_ca_system_score_gemma":0.0001369448,"threshold_uncertainty_score":0.7725224},"labels":[],"label_agreement":null},{"id":"W2754946657","doi":"10.1136/annrheumdis-2017-eular.2170","title":"THU0653 Preventing rheumatoid arthritis: a general population pilot study on perspectives of the risk of developing the disease and potential preventative interventions","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; McGill University; University of British Columbia","funders":"","keywords":"Rheumatoid arthritis; Medicine; Disease; Psychological intervention; Population; Intensive care medicine; Risk analysis (engineering); Environmental health; Immunology; Internal medicine; Psychiatry","score_opus":0.058700793070853095,"score_gpt":0.36554292607843825,"score_spread":0.30684213300758517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754946657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868921,0.00975405,0.00004929323,0.0015205051,0.00010985326,0.0014779505,0.0001498645,0.000010449843,0.000035922112],"genre_scores_gemma":[0.98536426,0.014385815,0.00005075974,0.000017146895,0.000020440504,0.00007672072,0.000004474414,0.00001753923,0.00006287297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976917,0.0006727415,0.0006139084,0.00021624274,0.00060004357,0.00020535363],"domain_scores_gemma":[0.9975347,0.00020835624,0.0010500785,0.00086315704,0.0002468297,0.00009686592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005887648,0.0001732772,0.00042397768,0.00007224576,0.00075805385,0.00006620478,0.00047370742,0.000015391364,0.000028242486],"category_scores_gemma":[0.0027125704,0.00008978444,0.00040597309,0.00010119681,0.00063443766,0.00020024092,0.00035345252,0.00013956346,7.915921e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018447686,0.0052314145,0.9291844,0.0010361854,0.003258007,0.000004670987,0.010765931,0.00019183531,0.00016685536,0.0061651673,0.0003119983,0.041838795],"study_design_scores_gemma":[0.0014090938,0.00065440347,0.9766617,0.0074309525,0.00008310506,0.00000438669,0.0057059065,0.00018841037,0.00028640576,0.0074882894,0.0000015234567,0.000085846004],"about_ca_topic_score_codex":0.0006038329,"about_ca_topic_score_gemma":0.000108940745,"teacher_disagreement_score":0.04747731,"about_ca_system_score_codex":0.00001312686,"about_ca_system_score_gemma":0.00012148037,"threshold_uncertainty_score":0.5830414},"labels":[],"label_agreement":null},{"id":"W2754948728","doi":"10.1136/annrheumdis-2017-eular.4842","title":"FRI0011 Targeting neutrophil microvesicles to damaged cartilage using antibodies to post translationally modified collagen ii","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Advanced Chemical Sensor Technologies","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Université de Montréal; Arthritis Society","keywords":"Chemistry; Microvesicles; Molecular biology; Antibody; Reactive oxygen species; Avidity; Cartilage; Immunology; Biochemistry; Biology; microRNA","score_opus":0.04126889637919047,"score_gpt":0.29197893310147194,"score_spread":0.2507100367222815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754948728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587905,0.00051726523,0.0004116119,0.002193514,0.00009671307,0.00032608813,0.00021091834,0.0002064675,0.00015837973],"genre_scores_gemma":[0.99676603,0.00005651528,0.002925627,0.0001474876,0.000020246562,0.0000108054655,0.000005175826,0.000036429206,0.000031686635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989375,0.000018188191,0.00033547307,0.00018220361,0.00021431944,0.0003123],"domain_scores_gemma":[0.99887997,0.00009268335,0.00011871948,0.00067213573,0.00012217293,0.0001143208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005142357,0.00020080988,0.00030635166,0.00007004451,0.0004517108,0.000066111366,0.00078527984,0.000051905707,0.000011850636],"category_scores_gemma":[0.00092411763,0.00016327342,0.00014088798,0.0001113415,0.00011987504,0.00019958189,0.00024631922,0.000056704466,0.0000062755585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003102542,0.000036716305,0.00044183029,0.00016091559,0.000057109464,0.0000018145057,0.00038136358,0.111586615,0.883883,0.00015111506,0.00090571586,0.0023627765],"study_design_scores_gemma":[0.00021100027,0.000034956094,0.021955762,0.00050147716,0.00005467387,0.0000010655422,0.0002932036,0.003675138,0.96954656,0.0032437185,0.00013761364,0.00034482442],"about_ca_topic_score_codex":0.000035408117,"about_ca_topic_score_gemma":0.000009345552,"teacher_disagreement_score":0.107911475,"about_ca_system_score_codex":0.00001898381,"about_ca_system_score_gemma":0.000010359714,"threshold_uncertainty_score":0.6658097},"labels":[],"label_agreement":null},{"id":"W2754957831","doi":"10.1136/annrheumdis-2017-eular.6184","title":"FRI0009 Accelerated development of aging-associated and instability-induced osteoarthritis in 12/15-lipoxygenase deficient mice","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Université de Montréal; Arthritis Society","keywords":"Osteoarthritis; Cartilage; Pathogenesis; Chemistry; Lipoxygenase; Inflammation; Arachidonate 5-lipoxygenase; Immunohistochemistry; Internal medicine; Endocrinology; Medicine; Pathology; Biochemistry; Enzyme; Anatomy","score_opus":0.05605155044934118,"score_gpt":0.3127219405003305,"score_spread":0.2566703900509893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754957831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767876,0.00093144283,8.653442e-7,0.00044384986,0.00013988224,0.0005796231,0.000030112189,0.000015967711,0.00017950074],"genre_scores_gemma":[0.9996849,0.00008964514,0.000035823745,0.00010108703,0.000009384347,0.000028036311,0.000010443344,0.000014956811,0.000025743544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984686,0.00012981021,0.00058534375,0.00019969128,0.0003546118,0.0002619459],"domain_scores_gemma":[0.9984614,0.00016484351,0.0004977803,0.00054721214,0.00017266009,0.00015607406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005743812,0.00017174106,0.0005143631,0.00009592514,0.00021364898,0.000028141545,0.00023129482,0.0000675521,0.000032069725],"category_scores_gemma":[0.002100076,0.00012431141,0.00010792737,0.00009937697,0.00016939391,0.000115513976,0.00015793323,0.00010126821,0.0000037509215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008307884,0.002982494,0.71003014,0.005533555,0.00051265606,0.00005591159,0.009695909,0.00001980959,0.016278226,0.00014192698,0.0008277001,0.25309092],"study_design_scores_gemma":[0.0019104726,0.00014131615,0.93162,0.0029344654,0.000054700195,0.000002384777,0.00021671914,0.00012434454,0.062712654,0.00011742861,0.000033360433,0.00013216048],"about_ca_topic_score_codex":0.000136296,"about_ca_topic_score_gemma":0.0002601742,"teacher_disagreement_score":0.25295874,"about_ca_system_score_codex":0.000028949691,"about_ca_system_score_gemma":0.00031020542,"threshold_uncertainty_score":0.50692725},"labels":[],"label_agreement":null},{"id":"W2754964888","doi":"10.1136/annrheumdis-2017-eular.4659","title":"OP0120 The role of smoking in the development and progression of structural damage in patients with ankylosing spondylitis: the preliminary results of a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Bundesministerium für Bildung und Forschung; Amgen","keywords":"Medicine; Meta-analysis; Ankylosing spondylitis; Cohort study; Odds ratio; Cross-sectional study; Physical therapy; Checklist; Systematic review; Observational study; Internal medicine; MEDLINE; Pathology","score_opus":0.11452172060209047,"score_gpt":0.3857596411142154,"score_spread":0.2712379205121249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754964888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037260022,0.95794666,5.7410237e-8,0.00014887733,0.000006370525,0.00403312,0.0005764091,0.0000015143636,0.000026989785],"genre_scores_gemma":[0.36229292,0.6373119,0.000029575258,0.000019729194,0.0000013551262,0.0002562022,0.0000692584,0.000011437947,0.0000076186952],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966955,0.00076551666,0.001561883,0.00021786551,0.000600019,0.00015921876],"domain_scores_gemma":[0.9953768,0.00074244756,0.002662574,0.0010275225,0.000158964,0.000031695945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001074485,0.0003027472,0.0039617294,0.00012508892,0.00012414293,0.000017471917,0.00042152702,0.000043351545,0.0000064397536],"category_scores_gemma":[0.00085867353,0.00009314122,0.0005937804,0.00038287166,0.0003262284,0.000060027185,0.00023033774,0.00011253547,4.520679e-8],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003777793,0.00046241513,0.008942398,0.857516,0.0587501,0.0000059661556,0.0031741157,0.0000014580339,6.581262e-9,0.00005457452,0.000016027909,0.070699185],"study_design_scores_gemma":[0.00097152527,0.0003995321,0.120978735,0.49144188,0.38486022,0.000009516151,0.00092541805,0.0000060219904,0.0000017672565,0.00009009142,0.0001695706,0.00014573922],"about_ca_topic_score_codex":0.000089977824,"about_ca_topic_score_gemma":0.000044385968,"teacher_disagreement_score":0.3660741,"about_ca_system_score_codex":0.0000127424755,"about_ca_system_score_gemma":0.00009553172,"threshold_uncertainty_score":0.3798189},"labels":[],"label_agreement":null},{"id":"W2754977895","doi":"10.1136/annrheumdis-2017-eular.4279","title":"SAT0277 Cognitive dysfunction in patients with systemic lupus erythematosus in dominican republic","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Cognition; Rheumatology; Comorbidity; Internal medicine; Pediatrics; Cognitive impairment; Psychiatry","score_opus":0.037646131966205754,"score_gpt":0.31741001481301245,"score_spread":0.2797638828468067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754977895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958478,0.00054783036,0.0000035693727,0.0005860264,0.00022351414,0.0017711015,0.00005018914,0.000022628408,0.0009473236],"genre_scores_gemma":[0.99907625,0.00011656917,0.00000905783,0.00007140909,0.000019252335,0.0001434172,0.00001928498,0.000035526267,0.0005092586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739397,0.0002437523,0.0007392165,0.00034361726,0.0008679205,0.00041153556],"domain_scores_gemma":[0.99703515,0.00043224898,0.0007118264,0.0013109166,0.000333065,0.00017681965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065508886,0.00022181528,0.00075844413,0.00029042363,0.000128643,0.000065938984,0.00046818415,0.00007821656,0.000046297537],"category_scores_gemma":[0.003812604,0.0001331716,0.00016056547,0.00026898715,0.00033056986,0.0002717713,0.00020228163,0.00018198333,0.000018860641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017256144,0.00070699106,0.98788875,0.0020268862,0.0001594524,0.000014495078,0.0006388848,0.0000040075774,0.0000023940406,0.00008295223,0.00051271095,0.0062368815],"study_design_scores_gemma":[0.009014462,0.00026893258,0.9657233,0.022559535,0.00008101617,0.00031489728,0.0015063948,0.00008530239,0.000054378947,0.00023982998,0.000006439841,0.00014555712],"about_ca_topic_score_codex":0.00028277133,"about_ca_topic_score_gemma":0.00009600879,"teacher_disagreement_score":0.022165475,"about_ca_system_score_codex":0.00008610095,"about_ca_system_score_gemma":0.0002739221,"threshold_uncertainty_score":0.54305804},"labels":[],"label_agreement":null},{"id":"W2754989230","doi":"10.1136/annrheumdis-2017-eular.2155","title":"SAT0548 Plasma CGRP concentrations were not associated with patient OA symptoms or response to galcanezumab, a monoclonal antibody against CGRP","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Calcitonin gene-related peptide; Celecoxib; Medicine; Osteoarthritis; Placebo; WOMAC; Internal medicine; Gastroenterology; Interim analysis; Randomized controlled trial; Pathology; Receptor","score_opus":0.03058403615896824,"score_gpt":0.3188972271753703,"score_spread":0.288313191016402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754989230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938934,0.00008348439,0.00000904826,0.00385028,0.00028248568,0.0011560721,0.0003587324,0.00005725316,0.000309273],"genre_scores_gemma":[0.99792486,0.000056281173,0.00004028729,0.0012906947,0.000047246598,0.00008289687,0.00005437552,0.000039117414,0.00046422257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977545,0.00028344637,0.0005182685,0.0002945012,0.0006947962,0.00045446682],"domain_scores_gemma":[0.99679327,0.00072506646,0.0006228292,0.0010625245,0.00032569442,0.0004705901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041220488,0.00029422017,0.0006147328,0.00009632203,0.0005376061,0.00009601869,0.000410757,0.000084897365,0.00011183862],"category_scores_gemma":[0.005763241,0.00017079996,0.0002394865,0.00013662607,0.00029885833,0.00017673816,0.00013857504,0.00014433841,0.000038687413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14404316,0.0093914,0.5674094,0.003515655,0.009151577,0.0016434535,0.018104,0.0020388428,0.018073687,0.0014865045,0.08753065,0.13761167],"study_design_scores_gemma":[0.0039231665,0.0020231875,0.9730341,0.005786763,0.00042817972,0.000020774833,0.00039470597,0.002311762,0.010774301,0.000044404715,0.00083055935,0.00042811976],"about_ca_topic_score_codex":0.00004257981,"about_ca_topic_score_gemma":0.000044928856,"teacher_disagreement_score":0.4056247,"about_ca_system_score_codex":0.000063707776,"about_ca_system_score_gemma":0.0006729594,"threshold_uncertainty_score":0.69650203},"labels":[],"label_agreement":null},{"id":"W2755009226","doi":"10.1136/annrheumdis-2017-eular.4177","title":"THU0442 Ehealth supported collaborative care model for gout involving rheumatology, pharmacy, and dietetics: proof-of-concept observational study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Providence Health Care; University of British Columbia","funders":"","keywords":"Medicine; Rheumatology; Observational study; eHealth; Gout; Internal medicine; Pharmacy; Family medicine; Physical therapy; Pharmacist; Health care","score_opus":0.1844451122187801,"score_gpt":0.42155161860735785,"score_spread":0.23710650638857775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755009226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674065,0.004949702,0.00024136584,0.0041580615,0.00015067426,0.0029221422,0.00075664814,0.000024603185,0.000056174937],"genre_scores_gemma":[0.99825126,0.00024186456,0.0008387437,0.00023894013,0.000017063589,0.00020016795,0.00006689462,0.000031808904,0.00011327321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980952,0.00011136258,0.0007198618,0.00031573005,0.0004547718,0.0003030305],"domain_scores_gemma":[0.9965594,0.00040838827,0.0010068947,0.0008662461,0.0009635798,0.0001955225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028761468,0.00024345513,0.000775907,0.00006758047,0.00041268655,0.00003663336,0.00044317852,0.000054889726,0.000019302592],"category_scores_gemma":[0.0023457129,0.00017312569,0.00016371251,0.0001086927,0.0004958568,0.00024109232,0.00024945228,0.00011087888,5.489965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010311753,0.0021309224,0.9255536,0.0057381373,0.0017617395,0.000004563913,0.037098855,0.00080134807,0.00006357869,0.0009239502,0.010395246,0.014496868],"study_design_scores_gemma":[0.013846426,0.0017538341,0.74840057,0.0043091294,0.0028363857,0.000021030455,0.03492132,0.17754032,0.006679022,0.008795872,0.00014552799,0.0007505772],"about_ca_topic_score_codex":0.00017394683,"about_ca_topic_score_gemma":0.00003554648,"teacher_disagreement_score":0.17715307,"about_ca_system_score_codex":0.000027504688,"about_ca_system_score_gemma":0.00096784317,"threshold_uncertainty_score":0.7059861},"labels":[],"label_agreement":null},{"id":"W2755024679","doi":"10.1136/annrheumdis-2017-eular.6278","title":"THU0496 Pulmonary symptoms as the first presentation of kawasaki disease in children","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Kawasaki Disease and Coronary Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Hospital for Sick Children; University of Toronto; National Natural Science Foundation of China; Centre Hospitalier Universitaire Vaudois; Cliniques Universitaires Saint-Luc; Novartis","keywords":"Medicine; Kawasaki disease; Erythrocyte sedimentation rate; Pediatrics; Thrombocytosis; Internal medicine; Dermatology; Rheumatology; Surgery","score_opus":0.029349056266576346,"score_gpt":0.32660924774146016,"score_spread":0.2972601914748838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755024679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97782075,0.0021764815,0.0000033805532,0.01714383,0.000054321168,0.0009318716,0.00013593958,0.00001774464,0.0017156812],"genre_scores_gemma":[0.9984654,0.0004469469,0.00000419368,0.0005909564,0.00003628494,0.00011964456,0.000044197077,0.0000171835,0.0002751886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869484,0.00006891605,0.00041706816,0.00020305823,0.00042018236,0.00019596715],"domain_scores_gemma":[0.99736977,0.00014282948,0.00044506972,0.001746323,0.00012545293,0.00017056915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001138691,0.00015269456,0.0002811793,0.0000668044,0.00031644962,0.000031875716,0.0007901631,0.000027533659,0.00011702195],"category_scores_gemma":[0.0005872191,0.00009047209,0.00031155755,0.00012821461,0.00039151276,0.00020416675,0.00023257248,0.00007714464,0.000022038173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000287518,0.0010425557,0.98395807,0.00026206908,0.00019674296,0.0000035160244,0.00014038557,0.00011220609,0.000010431995,0.0017016936,0.0015433225,0.010741483],"study_design_scores_gemma":[0.00043259157,0.000046035915,0.98931175,0.0008627036,0.00028435866,0.0000060812818,0.000065383974,0.0006650253,0.000112484035,0.008042621,0.00008085348,0.000090129186],"about_ca_topic_score_codex":0.0005094288,"about_ca_topic_score_gemma":0.00001304867,"teacher_disagreement_score":0.020644655,"about_ca_system_score_codex":0.000010565384,"about_ca_system_score_gemma":0.00019584864,"threshold_uncertainty_score":0.36893445},"labels":[],"label_agreement":null},{"id":"W2755029581","doi":"10.1136/annrheumdis-2017-eular.5382","title":"AB0364 Characteristics of blood pressure phehotypes in patients with rheumatoid arthritis - eular","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Dyslipidemia; Blood pressure; Rheumatology; Gastroenterology; Disease","score_opus":0.015117963858990245,"score_gpt":0.2658208701529183,"score_spread":0.25070290629392805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755029581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98422366,0.013998838,0.0000017080076,0.00056694594,0.000081141145,0.00057462486,0.00026508066,0.000014577807,0.00027342187],"genre_scores_gemma":[0.973356,0.026395386,0.000047889283,0.000045533598,0.000011807586,0.000024849325,0.000024550807,0.000025759853,0.000068229616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822366,0.00008642199,0.00052848255,0.00019663446,0.000652354,0.0003124636],"domain_scores_gemma":[0.9977601,0.00009703086,0.00056592363,0.0010843353,0.00033206987,0.00016054038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018961976,0.00018663795,0.00066449225,0.00009385939,0.00016688852,0.00005218965,0.00047376452,0.000048673268,0.00016625291],"category_scores_gemma":[0.0011754852,0.000119780445,0.00016678112,0.00008537321,0.0005321113,0.0002319008,0.00014565459,0.0001227743,0.0000059766107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089665584,0.0017806002,0.92055327,0.00063761295,0.00092251605,0.000009146213,0.00031216777,0.0000034423158,0.00003618207,0.00047469573,0.0005986097,0.073775105],"study_design_scores_gemma":[0.0036602225,0.00044358664,0.98718745,0.006261562,0.000041874544,0.000004071746,0.00004313467,0.0000272915,0.0012171512,0.00050158164,0.0004841171,0.00012794673],"about_ca_topic_score_codex":0.00017783378,"about_ca_topic_score_gemma":0.000017398557,"teacher_disagreement_score":0.07364716,"about_ca_system_score_codex":0.0000023524415,"about_ca_system_score_gemma":0.00013578171,"threshold_uncertainty_score":0.48845047},"labels":[],"label_agreement":null},{"id":"W2755049090","doi":"10.1136/annrheumdis-2017-eular.2443","title":"OP0202 Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: opal beyond, a randomised, double-blind, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"AbbVie; Celgene; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Janus kinase inhibitor; Discontinuation; Internal medicine; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Placebo; Clinical endpoint; Rheumatoid arthritis; Gastroenterology; Surgery; Randomized controlled trial; Dermatology","score_opus":0.04150119976932149,"score_gpt":0.3519479655918908,"score_spread":0.3104467658225693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755049090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912564,0.0003531884,0.0000029852015,0.000734865,0.000087241395,0.007089946,0.00042505356,0.000016371274,0.000033909517],"genre_scores_gemma":[0.99922985,0.00019724439,0.000028953624,0.000065836204,0.00003531681,0.00031335797,0.000054348413,0.000037351852,0.00003776882],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965938,0.0007015357,0.0010964358,0.00043438078,0.00074155885,0.0004323263],"domain_scores_gemma":[0.9970357,0.0005280313,0.000756821,0.00086336216,0.00032411516,0.0004919893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010400756,0.0003609129,0.0014793454,0.000312273,0.00032842965,0.00014365315,0.00034118968,0.00010337492,0.00005381682],"category_scores_gemma":[0.0034454095,0.0002432276,0.00018479372,0.00018184615,0.00049591844,0.0007685221,0.00021851045,0.00022106706,0.000001917944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8315339,0.0027288126,0.0023069137,0.00018048198,0.0002384873,0.000010293255,0.0018075486,0.000010532535,0.00018086743,0.000009978595,0.000035112247,0.16095704],"study_design_scores_gemma":[0.8577595,0.0070681935,0.12962545,0.0018721074,0.00018150269,0.0000017522661,0.0006354197,0.00013694748,0.0023427722,0.000086956876,0.00002291642,0.00026650875],"about_ca_topic_score_codex":0.0003533757,"about_ca_topic_score_gemma":0.00007496633,"teacher_disagreement_score":0.16069053,"about_ca_system_score_codex":0.000028763894,"about_ca_system_score_gemma":0.00043405237,"threshold_uncertainty_score":0.99185336},"labels":[],"label_agreement":null},{"id":"W2755059505","doi":"10.1136/annrheumdis-2017-eular.3552","title":"SAT0603 An innovative treatment modality for acute ilio-tibial band syndrome in runners: local hyaluronate + botulinum toxin in a prospective cohort of 45 athletes","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lower Extremity Biomechanics and Pathologies","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Botulinum toxin; Visual analogue scale; Physical therapy; Tendinopathy; Fibromyalgia; Treadmill; Cohort; Anesthesia; Physical medicine and rehabilitation; Internal medicine; Surgery; Tendon","score_opus":0.03593742628417633,"score_gpt":0.30757529874056594,"score_spread":0.2716378724563896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755059505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996494,0.00026861363,0.00020924046,0.00016947753,0.00011865104,0.00089557393,0.0017001199,0.000028478667,0.000115833805],"genre_scores_gemma":[0.99936813,0.00020749039,0.00014177934,0.000012723085,0.0000064836872,0.00017744645,0.00004271255,0.000019295887,0.000023908668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988441,0.000052101983,0.00044190235,0.00022999232,0.00017139105,0.00026050527],"domain_scores_gemma":[0.99885184,0.00012868304,0.00024997978,0.00060825766,0.000107896005,0.000053349322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002704566,0.00021000023,0.0005340542,0.00011288438,0.000067702065,0.000036240657,0.00041802865,0.00007385508,0.000015747506],"category_scores_gemma":[0.00029087107,0.00015168499,0.00013426425,0.00017305271,0.00019479962,0.00023175977,0.00007953617,0.00006445449,9.147616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031094174,0.008249582,0.6352908,0.00429458,0.00623785,0.00020794498,0.016732238,0.027689217,0.005652928,0.011721098,0.0011855535,0.27962878],"study_design_scores_gemma":[0.0019040406,0.0007374116,0.9225906,0.001045364,0.00011328387,0.000004903536,0.00039880592,0.024405535,0.014162282,0.03427382,0.000012495184,0.0003514308],"about_ca_topic_score_codex":0.00030964933,"about_ca_topic_score_gemma":0.00026400056,"teacher_disagreement_score":0.2872998,"about_ca_system_score_codex":0.00006579719,"about_ca_system_score_gemma":0.00006349433,"threshold_uncertainty_score":0.6185534},"labels":[],"label_agreement":null},{"id":"W2755078555","doi":"10.1136/annrheumdis-2017-eular.5828","title":"FRI0134 Cluster analysis of pulmonary lesions in rheumatoid arthritis (ra); airway disease is shared and critical pulmonary abnormality in ra","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Bronchiectasis; Abnormality; Lung; Internal medicine; COPD; Ground-glass opacity; Interstitial lung disease; Pathology","score_opus":0.04656644805885878,"score_gpt":0.3518827240087528,"score_spread":0.305316275949894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755078555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616311,0.01666556,0.000023428598,0.019860463,0.00006993835,0.00047486543,0.0007243428,0.000015054135,0.00053523836],"genre_scores_gemma":[0.9860066,0.012823518,0.000027950633,0.000932435,0.000009415895,0.000056511606,0.000054353455,0.000013828315,0.00007535003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978438,0.00020314421,0.00083754933,0.0003036935,0.0004852543,0.00032654006],"domain_scores_gemma":[0.9973189,0.00048181828,0.00036391726,0.0012446713,0.00013032147,0.00046037335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047859515,0.000199749,0.0008015606,0.00035414114,0.00015216935,0.000029884477,0.00038683435,0.00007705523,0.00035927948],"category_scores_gemma":[0.0043734843,0.0001489717,0.0003735966,0.00034948616,0.0006196219,0.00042385072,0.00025401128,0.00015727269,0.0000040187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007130111,0.0020920648,0.9182694,0.0014739324,0.00043968362,0.00009661358,0.00078178075,0.000036234702,0.000024531726,0.00027131813,0.0015195817,0.074281864],"study_design_scores_gemma":[0.00071973325,0.000028829858,0.9816761,0.0074884174,0.00033489894,0.000009859507,0.00017834234,0.007697996,0.000084884356,0.0016052949,0.000037409656,0.0001382103],"about_ca_topic_score_codex":0.00046699552,"about_ca_topic_score_gemma":0.000042983836,"teacher_disagreement_score":0.074143656,"about_ca_system_score_codex":0.000017636854,"about_ca_system_score_gemma":0.00022033876,"threshold_uncertainty_score":0.60748893},"labels":[],"label_agreement":null},{"id":"W2755130106","doi":"10.1136/annrheumdis-2017-eular.2148","title":"AB0756 Primary efficacy and safety of adalimumab in nail psoriasis from the first 26 weeks of a phase-3, randomized, placebo-controlled trial with subanalysis in patients with and without psoriatic arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Incyte; Valeant Pharmaceuticals International; AbbVie; Celgene; Amgen; Pfizer; Allergan; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Concomitant; Psoriasis; Adalimumab; Placebo; Adverse effect; Internal medicine; Randomized controlled trial; Clinical endpoint; Psoriasis Area and Severity Index; Surgery; Dermatology; Gastroenterology; Rheumatoid arthritis; Pathology","score_opus":0.012470468457135654,"score_gpt":0.24575878918402258,"score_spread":0.23328832072688693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755130106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897945,0.0067993035,0.000004621891,0.0003378603,0.00009780415,0.0026356636,0.00028420956,0.00000724994,0.000038797385],"genre_scores_gemma":[0.99754655,0.0021130436,0.000026518615,0.000025949712,0.000008862222,0.0001958852,0.000043070457,0.00001785776,0.000022270342],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977905,0.0007114593,0.0008611976,0.0002721227,0.00014501499,0.0002196896],"domain_scores_gemma":[0.99591017,0.0020384125,0.0012225132,0.0007012103,0.00009726112,0.000030412706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006256416,0.00027159316,0.0018502137,0.000110750676,0.00020620279,0.000023076267,0.00036169388,0.00009604137,0.000035526486],"category_scores_gemma":[0.00090503186,0.00013348763,0.00023107092,0.000118017204,0.0007969579,0.00013380512,0.00009920788,0.00008758068,8.9074734e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8559024,0.0016879351,0.091801524,0.00008258576,0.0034143352,7.0788644e-7,0.0010487562,0.000015664356,0.0000055233436,0.00002764107,0.000028181934,0.04598478],"study_design_scores_gemma":[0.66570437,0.0005095099,0.33078963,0.0010547545,0.0014630302,5.022722e-7,0.00010848208,0.0000151523745,0.000098114826,0.00013956179,0.000003808068,0.00011308029],"about_ca_topic_score_codex":0.0010906075,"about_ca_topic_score_gemma":0.0009285543,"teacher_disagreement_score":0.2389881,"about_ca_system_score_codex":0.000010852834,"about_ca_system_score_gemma":0.00009747254,"threshold_uncertainty_score":0.54434675},"labels":[],"label_agreement":null},{"id":"W2755153724","doi":"10.1136/annrheumdis-2017-eular.3905","title":"THU0437 Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Simon Fraser University; University of British Columbia; Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Gout; Medicine; Retrospective cohort study; Febuxostat; Thiazide; Internal medicine; Diuretic; Cohort; Benzbromarone; Allopurinol; Renal function; Uric acid; Hyperuricemia","score_opus":0.032687794129609996,"score_gpt":0.33155951252032273,"score_spread":0.29887171839071275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755153724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988261,0.00009454279,0.0000068826644,0.0002541246,0.000024499195,0.00052370434,0.000100355865,0.00000675334,0.00016305094],"genre_scores_gemma":[0.9996545,0.00018786582,0.000013731732,0.00007089291,0.0000066513494,0.000011679465,0.000024813886,0.000015859301,0.000014047165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985805,0.00009958123,0.00042158613,0.00015682654,0.0005743617,0.00016715206],"domain_scores_gemma":[0.99734485,0.00014948417,0.0008030465,0.0014082681,0.00021545369,0.0000788724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031405844,0.00016302211,0.0005797073,0.00014933293,0.0000811586,0.000017693505,0.0004357031,0.000040182455,0.000082250735],"category_scores_gemma":[0.00056482054,0.000074712254,0.0003129286,0.00031470752,0.0002824481,0.00013621064,0.000063279054,0.00008829443,0.0000010559113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072919816,0.0009614112,0.98907834,0.00006498855,0.002213516,6.317208e-7,0.0005636832,0.0012805341,0.000069767215,0.000019368741,0.000043387558,0.0049751676],"study_design_scores_gemma":[0.0008455746,0.00081817724,0.9941711,0.0005783485,0.00091694016,1.8594694e-7,0.00010773116,0.0014812783,0.0008865859,0.00011655835,4.914149e-7,0.000077058314],"about_ca_topic_score_codex":0.00046901798,"about_ca_topic_score_gemma":0.000016127411,"teacher_disagreement_score":0.0050927238,"about_ca_system_score_codex":0.00002572437,"about_ca_system_score_gemma":0.00008362922,"threshold_uncertainty_score":0.3046677},"labels":[],"label_agreement":null},{"id":"W2755161965","doi":"10.1136/annrheumdis-2017-eular.1464","title":"OP0278-PARE The french patient's association (AFLAR: french league against rheumatism) has generated the french national alliance against osteoarthritis and the first general convention of osteoarthritis in france: a campaign to create a national lobbying tool to improve the management of osteoarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Société Française de Medecine physique et de Réadaptation; Les Laboratories Pierre Fabre; Chugai Pharmaceutical; Pfizer","keywords":"Convention; Alliance; Medicine; League; Rheumatism; Order (exchange); White paper; Health care; Public relations; Political science; Business; Law","score_opus":0.05499470295988919,"score_gpt":0.3614548858686878,"score_spread":0.3064601829087986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755161965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453975,0.006637337,0.00003648006,0.038295407,0.00094880443,0.005438461,0.0016960818,0.00001962536,0.0015302802],"genre_scores_gemma":[0.99253327,0.001967968,0.000114993134,0.0024325883,0.00013279723,0.00188261,0.0000647864,0.000030741878,0.0008402353],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9932388,0.0021768312,0.0018677997,0.00043914857,0.0016958405,0.0005815996],"domain_scores_gemma":[0.9923275,0.0023261805,0.0027413622,0.0009789856,0.001496463,0.00012949115],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0047631976,0.00034123397,0.0006952231,0.000092659255,0.0029083595,0.0002269432,0.0011373721,0.00016875642,0.0000679616],"category_scores_gemma":[0.003684306,0.00018415086,0.00026417404,0.00043241002,0.00041682654,0.00045441656,0.0005384417,0.00045615938,0.000016972268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004602677,0.0006453341,0.12742111,0.004955346,0.0012998391,0.000011485122,0.057505302,0.00476358,0.00021460225,0.008386141,0.06197102,0.73236597],"study_design_scores_gemma":[0.0067659537,0.0005221975,0.9408415,0.01742068,0.00014806169,0.000004217607,0.005951131,0.0018180948,0.00022552538,0.0039211023,0.021824995,0.0005565313],"about_ca_topic_score_codex":0.005208876,"about_ca_topic_score_gemma":0.0076417574,"teacher_disagreement_score":0.8134204,"about_ca_system_score_codex":0.00013598976,"about_ca_system_score_gemma":0.0005212137,"threshold_uncertainty_score":0.9983897},"labels":[],"label_agreement":null},{"id":"W2755162095","doi":"10.1136/annrheumdis-2017-eular.3031","title":"THU0698 Measurement properties of presenteeism measures with dual answer keys in inflammatory arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; Institute for Work & Health; Research Canada","funders":"","keywords":"Presenteeism; Scale (ratio); Construct validity; Medicine; Physical therapy; Absenteeism; Statistics; Psychology; Mathematics; Psychometrics; Social psychology; Geography","score_opus":0.14655036495440174,"score_gpt":0.35914112208507315,"score_spread":0.2125907571306714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755162095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985297,0.00593714,0.000007996552,0.0053119883,0.00030888835,0.0013140521,0.000018021954,0.000025987061,0.0017788731],"genre_scores_gemma":[0.9981052,0.0011132169,0.000014858774,0.00030378313,0.00005283536,0.00018723917,9.538388e-7,0.00002450646,0.00019736728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684453,0.00066889124,0.000862256,0.00020202031,0.00091333844,0.00050894404],"domain_scores_gemma":[0.9972882,0.00013172218,0.000919451,0.0009988624,0.00048680868,0.00017490305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001394445,0.00019048834,0.0004900278,0.00008786543,0.0007508655,0.000022113834,0.0005041895,0.00008420815,0.00004962596],"category_scores_gemma":[0.0019707289,0.00011267281,0.00011558797,0.000075087926,0.00034792908,0.0002604591,0.00021062822,0.0002601549,0.000015739986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008522165,0.00044154932,0.9598281,0.0058680153,0.00019512641,0.0000069360594,0.0062572,0.00015733318,0.00013570477,0.0012801163,0.008684119,0.016293619],"study_design_scores_gemma":[0.0018257742,0.00011586298,0.95484227,0.035049602,0.00004852232,8.8016697e-7,0.0029633087,0.00008384651,0.001714695,0.0022980617,0.0008316359,0.0002255504],"about_ca_topic_score_codex":0.0012333473,"about_ca_topic_score_gemma":0.0013722152,"teacher_disagreement_score":0.029181587,"about_ca_system_score_codex":0.00003155484,"about_ca_system_score_gemma":0.0008208635,"threshold_uncertainty_score":0.5775126},"labels":[],"label_agreement":null},{"id":"W2755163724","doi":"10.1136/annrheumdis-2017-eular.1478","title":"SAT0472 Utilization of the psoriasis epidemiology screening tool to identify signs and symptoms of early psoriatic arthritis among those with psoriasis: analysis from the corrona psoriasis registry","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Horizon Pharma; Pfizer Pharmaceuticals; Janssen Pharmaceuticals; Momenta Pharmaceuticals; Valeant Pharmaceuticals International; Genentech; Novartis Pharmaceuticals Corporation; Celgene; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Psoriasis; Psoriatic arthritis; Dermatology; Epidemiology; Medicine; Internal medicine","score_opus":0.07103453564537741,"score_gpt":0.323078800177517,"score_spread":0.2520442645321396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755163724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98620534,0.010084043,0.00048261264,0.00073942135,0.0006143638,0.0007513366,0.0010557367,0.000023634439,0.000043516688],"genre_scores_gemma":[0.99770045,0.0016415799,0.00013450433,0.00012401235,0.0000478958,0.00009784207,0.000072303505,0.000028919556,0.00015247753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965148,0.0012073112,0.0011128623,0.00051305204,0.00021961467,0.00043239148],"domain_scores_gemma":[0.9929069,0.002117185,0.0022747822,0.0023387957,0.00029112544,0.00007118777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009250289,0.00039912216,0.0012796037,0.00013946938,0.00075024273,0.00005205196,0.001430644,0.00023370817,0.00011633942],"category_scores_gemma":[0.00351694,0.00021400885,0.0007099381,0.00048577605,0.0011674727,0.00025201193,0.00043794847,0.00015683485,0.0000063896905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068708876,0.00022504762,0.7408432,0.000085022235,0.0068526673,8.250455e-7,0.0013811663,0.0001929922,0.00030940372,0.0003998522,0.00064420555,0.24837855],"study_design_scores_gemma":[0.0014421941,0.00028655544,0.98563206,0.0012324966,0.0046316623,0.000002729801,0.00067428156,0.000041688683,0.004414639,0.0013463948,0.000053006388,0.00024231231],"about_ca_topic_score_codex":0.0038521937,"about_ca_topic_score_gemma":0.0005698222,"teacher_disagreement_score":0.24813622,"about_ca_system_score_codex":0.000013702726,"about_ca_system_score_gemma":0.000103211,"threshold_uncertainty_score":0.8727028},"labels":[],"label_agreement":null},{"id":"W2755164839","doi":"10.1136/annrheumdis-2017-eular.3105","title":"SAT0437 Ixekizumab improves nail and skin lesions in patients with active psoriatic arthritis and prior tnf inadequate response","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ixekizumab; Medicine; Psoriatic arthritis; Psoriasis; Mallinckrodt; Placebo; Internal medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Dermatology; Secukinumab; Pathology","score_opus":0.017095471045233863,"score_gpt":0.25304477465024733,"score_spread":0.23594930360501346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755164839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496764,0.0036707711,6.689545e-7,0.0005603108,0.0001348722,0.00040815648,0.00021811886,0.000010666279,0.000028793538],"genre_scores_gemma":[0.9984477,0.0012120866,0.00001767091,0.00004026028,0.0000038503094,0.000041623407,0.000016363983,0.000012334753,0.00020810931],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989572,0.0003036816,0.00023675266,0.00021872109,0.000057078447,0.00022653701],"domain_scores_gemma":[0.99877363,0.00034233433,0.00031514588,0.0004708888,0.00005799158,0.00004000287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015915885,0.00017816074,0.0003440782,0.00007637992,0.00040885,0.000037104,0.00021543991,0.00007671167,0.000020556963],"category_scores_gemma":[0.0006561512,0.000112727656,0.00006337592,0.00004756088,0.00039549283,0.0002025426,0.00015315716,0.000067145695,0.000007729292],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002623421,0.00028381063,0.003217303,0.000046003628,0.0002544763,0.0000016020807,0.0006886252,3.506126e-7,0.000011401543,0.000054041728,0.00011497896,0.992704],"study_design_scores_gemma":[0.0035341133,0.00034040393,0.9922128,0.00067455467,0.00011377616,0.0000025051552,0.00020815017,0.000001959391,0.002062773,0.00065187516,0.00006177845,0.00013535946],"about_ca_topic_score_codex":0.00018894278,"about_ca_topic_score_gemma":0.00010060231,"teacher_disagreement_score":0.9925686,"about_ca_system_score_codex":0.000009765708,"about_ca_system_score_gemma":0.00007123724,"threshold_uncertainty_score":0.45969003},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2755201572","doi":"10.1136/annrheumdis-2017-eular.1803","title":"THU0613 Exploring the impact of health status and well-being of people with inflammatory arthritis on presenteeism in the workplace: a qualitative study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Employment and Welfare Studies","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Collaboration for Leadership in Applied Health Research and Care - Greater Manchester; UCB Pharma; University of British Columbia; Health Canada; Keele University; University of Toronto","keywords":"Presenteeism; Arthritis; Qualitative research; Inflammatory arthritis; Medicine; Psychology; Absenteeism; Internal medicine; Sociology; Social psychology","score_opus":0.12018696337237318,"score_gpt":0.4699370038856504,"score_spread":0.34975004051327724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755201572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991677,0.0015019445,0.0000012355727,0.0046027023,0.00006298584,0.001686788,0.000029575656,0.000007476414,0.0004303126],"genre_scores_gemma":[0.9973065,0.0022586563,0.0000019257784,0.00007487398,0.0000132537525,0.00027678523,0.0000014210375,0.000013169372,0.000053416607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632263,0.0021123956,0.0006582821,0.0001432468,0.00042135103,0.0003420786],"domain_scores_gemma":[0.9955589,0.002424085,0.0010979068,0.0007429713,0.00012309276,0.000053022948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019166303,0.00016129528,0.0005212229,0.000062375046,0.0010056437,0.000016230184,0.0004143478,0.000017740382,0.00001469801],"category_scores_gemma":[0.00088224845,0.00006757942,0.00010759551,0.000115122864,0.00028965276,0.0001797194,0.0002503074,0.0001886619,0.0000011963137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018890639,0.0002722975,0.6049671,0.00035700545,0.00019497804,3.0557376e-7,0.39078364,0.000035206387,1.7257008e-7,0.0007372245,0.0008227385,0.0016403856],"study_design_scores_gemma":[0.00067005696,0.00040369888,0.7298141,0.003041062,0.000018807927,6.846898e-8,0.2634443,0.000007422673,0.0000022990766,0.0025432124,0.0000052463174,0.00004974091],"about_ca_topic_score_codex":0.0069021196,"about_ca_topic_score_gemma":0.0016826413,"teacher_disagreement_score":0.12733933,"about_ca_system_score_codex":0.00001712917,"about_ca_system_score_gemma":0.00018760911,"threshold_uncertainty_score":0.999711},"labels":[],"label_agreement":null},{"id":"W2755215691","doi":"10.1136/annrheumdis-2017-eular.3391","title":"FRI0293 Characterization and risk estimate of cancer in primary sjÖgren syndrome: analysis in 1300 patients","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Cancer; Incidence (geometry); Univariate analysis; Cancer registry; Lymphoma; Oncology; Cohort; Proportional hazards model; Gastroenterology; Multivariate analysis","score_opus":0.01781587707816416,"score_gpt":0.3063127402664976,"score_spread":0.2884968631883334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755215691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984151,0.0005699826,0.000016762568,0.00032754254,0.00004508516,0.00020689519,0.00031446584,0.000003879861,0.000100265934],"genre_scores_gemma":[0.9976348,0.0021647313,0.000012799454,0.00004632479,0.0000025536856,0.000017456852,0.00006737202,0.000005406307,0.000048553597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993391,0.000037042628,0.00027924936,0.00010631162,0.00014540384,0.00009287613],"domain_scores_gemma":[0.9991668,0.00004501771,0.0003451483,0.00034146596,0.000056318742,0.00004525006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008594125,0.000074679236,0.0003407153,0.00015233639,0.00006026582,0.000011648698,0.00009452465,0.00002548435,0.000065045715],"category_scores_gemma":[0.00031274182,0.00005013488,0.000090890266,0.00018499338,0.00008081811,0.00011350551,0.000056043325,0.000038251692,5.939424e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009758795,0.0003372688,0.9811045,0.00021047842,0.00024319139,8.3052015e-7,0.00012475385,0.000081815786,0.000006211882,0.000006582212,0.000027356175,0.01775945],"study_design_scores_gemma":[0.0008294284,0.000045196768,0.9961882,0.00052893953,0.0005250977,2.497402e-7,0.000021227288,0.0016026619,0.000013521273,0.00019359903,0.000003351585,0.000048527523],"about_ca_topic_score_codex":0.0017847343,"about_ca_topic_score_gemma":0.00020465997,"teacher_disagreement_score":0.017710922,"about_ca_system_score_codex":0.0000072529497,"about_ca_system_score_gemma":0.00004206424,"threshold_uncertainty_score":0.26979965},"labels":[],"label_agreement":null},{"id":"W2755218319","doi":"10.1136/annrheumdis-2017-eular.5065","title":"AB0743 Low rates of major adverse cardiac events, malignancies, and serious infections in patients with psoriasis and psoriatic arthritis treated with apremilast for ≥156 weeks: pooled analysis from the esteem and palace 1-3 phase 3 trials","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Probity Medical Research","funders":"","keywords":"Medicine; Mace; Psoriatic arthritis; Incidence (geometry); Psoriasis; Apremilast; Internal medicine; Concomitant; Placebo; Surgery; Dermatology; Gastroenterology; Myocardial infarction; Pathology","score_opus":0.03932922814143805,"score_gpt":0.3528632269620152,"score_spread":0.3135339988205772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755218319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053156,0.0057000043,0.0000110050605,0.0014791051,0.000037362042,0.0012581585,0.0009644981,0.000006441904,0.000011885785],"genre_scores_gemma":[0.9931802,0.006508352,0.000044846558,0.00009145143,0.000017024107,0.00009599203,0.00003459991,0.000011837279,0.000015662597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998698,0.00025034568,0.0004426253,0.00021492854,0.00022207019,0.0001720341],"domain_scores_gemma":[0.9970273,0.0016163655,0.00069030555,0.00037704525,0.00016726836,0.00012172627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004538914,0.00018650565,0.0009474819,0.000055543314,0.00028561137,0.000040924955,0.000094787036,0.00003539295,0.000015766542],"category_scores_gemma":[0.0021078442,0.00009193587,0.00014748474,0.00017664439,0.00027372275,0.00019589385,0.00007346273,0.00006123988,1.5747909e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036565994,0.0007983417,0.95899457,0.00033800516,0.0064434223,0.0000011344431,0.00035786856,0.000013423447,0.0000160642,0.000011301617,0.00018419535,0.0291851],"study_design_scores_gemma":[0.01170375,0.00075372483,0.97575545,0.0013665266,0.009180053,7.933008e-7,0.00042575173,0.00016582862,0.00029992335,0.00014365536,0.00008279575,0.000121750294],"about_ca_topic_score_codex":0.00090221904,"about_ca_topic_score_gemma":0.00028214778,"teacher_disagreement_score":0.029063348,"about_ca_system_score_codex":0.00000776085,"about_ca_system_score_gemma":0.000045100347,"threshold_uncertainty_score":0.3749036},"labels":[],"label_agreement":null},{"id":"W2755229160","doi":"10.1136/annrheumdis-2017-eular.5629","title":"OP0122 Venous thromboembolism in systemic sclerosis: prevalence, risk factors and impact on survival","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Pulmonary embolism; Thrombosis; Cumulative incidence; Incidence (geometry); Deep vein; Venous thrombosis; Surgery; Cardiology; Cohort","score_opus":0.06771413947700711,"score_gpt":0.3285789962538607,"score_spread":0.2608648567768536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755229160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98191607,0.01615727,4.297505e-7,0.00019704325,0.0003518312,0.00067384826,0.00030982195,0.000029629042,0.00036405565],"genre_scores_gemma":[0.9816583,0.01814303,0.0000016044235,0.000042442432,0.000038831353,0.000023570134,0.0000052184364,0.000026662958,0.00006038665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981674,0.0002237171,0.00051543006,0.00028944615,0.0004918637,0.00031214827],"domain_scores_gemma":[0.99753493,0.0003117937,0.00064811605,0.0011516501,0.00008980645,0.00026373175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034635415,0.0002738647,0.0008483849,0.000113964394,0.00029565813,0.000080785714,0.0004159514,0.00010008127,0.000051565487],"category_scores_gemma":[0.0014319626,0.00014135527,0.00038931813,0.00009610392,0.00027520265,0.00014654102,0.00013058662,0.0001506889,0.000011368732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022798065,0.0009521527,0.9874967,0.0014604589,0.0005628084,0.0000035175683,0.000604284,0.00011547936,0.00013619811,0.00008477122,0.0007535929,0.0076021105],"study_design_scores_gemma":[0.0010029994,0.00023610883,0.97188586,0.025040142,0.00044734596,0.000006990337,0.0005130649,0.00016787864,0.00029799505,0.00025686412,0.0000010723674,0.00014368145],"about_ca_topic_score_codex":0.00097122055,"about_ca_topic_score_gemma":0.000004957465,"teacher_disagreement_score":0.023579683,"about_ca_system_score_codex":0.00003135278,"about_ca_system_score_gemma":0.00013142437,"threshold_uncertainty_score":0.5764301},"labels":[],"label_agreement":null},{"id":"W2755229746","doi":"10.1136/annrheumdis-2017-eular.3840","title":"AB0785 Consistent safety profile with up to 4 years of apremilast treatment: analysis of data from 1493 patients with psoriatic arthritis in 3 large, phase iii, long-term studies","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Momenta Pharmaceuticals; Janssen Pharmaceuticals; Genentech; Horizon Pharma; AstraZeneca; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Apremilast; Medicine; Psoriatic arthritis; Adverse effect; Placebo; Nausea; Internal medicine; Upper respiratory tract infection; Randomized controlled trial; Tolerability; Psoriasis; Arthritis; Gastroenterology; Dermatology","score_opus":0.07738426380436773,"score_gpt":0.3734743654847418,"score_spread":0.29609010168037403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755229746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856917,0.0050028316,0.0000051729817,0.00013949005,0.000057061985,0.0010497192,0.007991048,0.0000070237115,0.000055900666],"genre_scores_gemma":[0.995342,0.0037207066,0.0001120542,0.00003228375,0.0000075098997,0.00006306802,0.0006468746,0.000016523863,0.000058957507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829143,0.000054597815,0.0006194604,0.00033830697,0.00046085255,0.00023535443],"domain_scores_gemma":[0.9970625,0.00017042208,0.0007162945,0.0016678598,0.00026699636,0.000115932045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096208634,0.00022159757,0.0013430843,0.00014952618,0.00011584389,0.00001218955,0.00032965056,0.00002575557,0.00009891793],"category_scores_gemma":[0.00034306062,0.0001322194,0.00018318887,0.0002768106,0.0002789886,0.00014895869,0.00027825154,0.000033492583,0.0000022214595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034447012,0.0038744186,0.91983926,0.00020184963,0.015819395,0.000022446797,0.0014741061,0.000017704819,0.0000021674412,0.000008929575,0.0001710242,0.055123974],"study_design_scores_gemma":[0.01855369,0.0012613002,0.97092545,0.0040393616,0.0042410586,4.7173137e-7,0.0006942702,0.00005492782,0.0000900071,0.000013467125,0.0000091501315,0.00011687014],"about_ca_topic_score_codex":0.0006584717,"about_ca_topic_score_gemma":0.0024766636,"teacher_disagreement_score":0.055007104,"about_ca_system_score_codex":0.00003180134,"about_ca_system_score_gemma":0.00008499835,"threshold_uncertainty_score":0.53917503},"labels":[],"label_agreement":null},{"id":"W2755245455","doi":"10.1136/annrheumdis-2017-eular.5655","title":"THU0509 Improvement of disease activity in patients with colchicine-resistant FMF, HIDS/MKD and traps assessed by autoinflammatory disease activity index (AIDAI): results from the cluster trial","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Familial Mediterranean fever; Internal medicine; Canakinumab; Gastroenterology; Immunology; Disease; Anakinra","score_opus":0.01004002824101978,"score_gpt":0.2465343670285086,"score_spread":0.23649433878748882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755245455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506265,0.00041734806,0.000014821985,0.0013880172,0.000098894976,0.0011855905,0.0017842676,0.000005457824,0.000042931173],"genre_scores_gemma":[0.99934113,0.00018478338,0.0000021297997,0.00013631998,0.000024484403,0.00006847762,0.00015054898,0.000022384347,0.00006974326],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983152,0.00021763418,0.00042765687,0.00037278046,0.00040008704,0.0002666153],"domain_scores_gemma":[0.9973827,0.00013154058,0.00081071595,0.0013882135,0.00013326464,0.0001535925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028438322,0.0002677998,0.00035997623,0.000028662278,0.0002537957,0.00006899442,0.000588006,0.000067413865,0.00000625571],"category_scores_gemma":[0.00089930935,0.00015998891,0.00017920174,0.00005351772,0.00045264635,0.000050303497,0.00031230855,0.000103164275,3.7918133e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6261558,0.005856556,0.2937208,0.00075758016,0.0012934735,0.000003487239,0.00042971742,0.00013979452,0.018939825,0.00002939331,0.008099235,0.044574346],"study_design_scores_gemma":[0.0227801,0.00061065925,0.96904194,0.00033339264,0.00014039279,1.2757526e-8,0.00006305754,0.00014903484,0.0063042617,0.00016140568,0.00018983854,0.00022589542],"about_ca_topic_score_codex":0.00044592246,"about_ca_topic_score_gemma":0.00014245101,"teacher_disagreement_score":0.67532116,"about_ca_system_score_codex":0.000010292891,"about_ca_system_score_gemma":0.00028415234,"threshold_uncertainty_score":0.6524158},"labels":[],"label_agreement":null},{"id":"W2755259675","doi":"10.1136/annrheumdis-2017-eular.5459","title":"THU0458 Ready or not? changes in the clinical profile of gout patients over the last 25 years","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; Faculty of Pharmaceutical Sciences, University of British Columbia; Korea Health Industry Development Institute; University of Exeter; Massachusetts General Hospital; Faculty of Medicine, University of British Columbia; AstraZeneca; Amgen","keywords":"Medicine; Gout; Cohort; Internal medicine; Population; Bonferroni correction; Cohort study; Prospective cohort study; Rheumatoid arthritis; Rheumatology; Pediatrics; Physical therapy; Environmental health","score_opus":0.12071833118312808,"score_gpt":0.4007183133847292,"score_spread":0.2799999822016011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755259675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926282,0.00022029427,4.75332e-7,0.0048321187,0.00022443474,0.0008897685,0.00017576708,0.000010909079,0.001018041],"genre_scores_gemma":[0.99723905,0.00041215325,0.00002386876,0.001709307,0.00007299789,0.000053579435,0.000012573049,0.000019620229,0.00045683596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980537,0.00027523658,0.0005503666,0.00019293449,0.0006805419,0.0002472168],"domain_scores_gemma":[0.9965508,0.0008041938,0.00072341406,0.0017129614,0.00012991994,0.00007871029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080483133,0.00015564449,0.00046865098,0.000042864544,0.00012744956,0.000032384185,0.0010232865,0.0000724735,0.00015736307],"category_scores_gemma":[0.0051230364,0.00006476768,0.00021717937,0.000115524,0.00050164456,0.00009370392,0.00029031772,0.0001879785,0.000032756052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097606826,0.0023873365,0.8653773,0.0006568204,0.00047293043,0.000012440635,0.002919455,0.0000027680285,0.000015157734,0.0002599373,0.06803401,0.058885742],"study_design_scores_gemma":[0.0011057288,0.00027254145,0.9955622,0.0008189881,0.00022938898,0.0000023407156,0.00045619876,0.00005982881,0.00009134351,0.00015754873,0.0011656237,0.00007830065],"about_ca_topic_score_codex":0.00021148975,"about_ca_topic_score_gemma":0.00008189248,"teacher_disagreement_score":0.13018483,"about_ca_system_score_codex":0.00000923665,"about_ca_system_score_gemma":0.00013666072,"threshold_uncertainty_score":0.6133123},"labels":[],"label_agreement":null},{"id":"W2755264841","doi":"10.1136/annrheumdis-2017-eular.6332","title":"SAT0745-HPR Impact of an interdisciplinary intervention on ra patients","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré de Santé et de Services Sociaux des Laurentides; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université du Québec à Rimouski; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent","funders":"","keywords":"Medicine; Physical therapy; Psychological intervention; Intervention (counseling); Quality of life (healthcare); Rheumatoid arthritis; Cohort; Family medicine; Nursing; Internal medicine","score_opus":0.04218296614775742,"score_gpt":0.41996545496775955,"score_spread":0.37778248882000215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755264841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997593,0.0006234708,0.0000028734553,0.000535906,0.00013192258,0.00036085007,0.0001323133,0.0000134009815,0.0006062841],"genre_scores_gemma":[0.99902654,0.0007395357,0.000013179053,0.000026590567,0.000019624516,0.000013406946,0.000032251843,0.000016216874,0.000112655565],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998728,0.000117982076,0.00037627242,0.00014407275,0.0004306696,0.00020303845],"domain_scores_gemma":[0.9981047,0.00007214571,0.0004248101,0.0010039374,0.00021166693,0.00018274282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020183905,0.00013467374,0.00036191774,0.0000928565,0.00022147837,0.00004421572,0.00044522647,0.000030636304,0.00022678841],"category_scores_gemma":[0.00081094203,0.000078031946,0.0005708013,0.000043531174,0.00031173314,0.0002793269,0.00029564652,0.00008201195,0.000015199492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034283986,0.0062251408,0.27126977,0.00073159544,0.0010456096,0.0000063457974,0.0012588496,0.000033488217,0.00013538019,0.00034538365,0.0073571494,0.7081629],"study_design_scores_gemma":[0.0017680246,0.0023812423,0.9870918,0.0037425137,0.000014737199,0.0000023070343,0.00016251022,0.00025546306,0.0012006094,0.0032918218,0.000013574104,0.00007541779],"about_ca_topic_score_codex":0.00021020618,"about_ca_topic_score_gemma":0.0000149268,"teacher_disagreement_score":0.71582204,"about_ca_system_score_codex":0.000015934069,"about_ca_system_score_gemma":0.000061296785,"threshold_uncertainty_score":0.31820506},"labels":[],"label_agreement":null},{"id":"W2755276796","doi":"10.1136/annrheumdis-2017-eular.1864","title":"THU0353 Change in mri structural lesions in the sacroiliac joint after two years of etanercept therapy in comparison to a contemporary control cohort in non-radiographic axial spondyloarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Astellas Pharma; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Etanercept; Cohort; Axial spondyloarthritis; Sacroiliac joint; Ankylosis; Radiography; Internal medicine; Target lesion; Lesion; Radiology; Physical therapy; Nuclear medicine; Surgery; Rheumatoid arthritis; Ankylosing spondylitis; Sacroiliitis","score_opus":0.06490604427449491,"score_gpt":0.35177539413144393,"score_spread":0.286869349856949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755276796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856796,0.008865329,4.1663924e-7,0.0027806717,0.000118542375,0.0022388923,0.00022103528,0.0000050694607,0.00009039479],"genre_scores_gemma":[0.99685323,0.002030826,0.000015116349,0.00057519856,0.000023825804,0.00046677727,0.000012947882,0.000017061087,0.0000049995356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980878,0.00022444723,0.0007187164,0.00025358354,0.00038961432,0.00032581124],"domain_scores_gemma":[0.9986753,0.00017550995,0.0002806248,0.000732935,0.000051387266,0.00008424802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003717766,0.00021536036,0.0009454726,0.0003166285,0.00007098535,0.000026444286,0.00033316208,0.00005333813,0.000045407993],"category_scores_gemma":[0.0002140271,0.00014048695,0.00026007637,0.00031249798,0.00029021112,0.00013491546,0.000089267625,0.00016780595,0.0000027747458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012493343,0.00060915994,0.96367747,0.00005156406,0.00010515366,0.00015713368,0.0047088107,0.000016830109,0.000019281424,0.000019693356,0.00015167384,0.029233918],"study_design_scores_gemma":[0.008296542,0.00039076197,0.9872218,0.0025320966,0.0000294745,0.0000072602343,0.00089996227,0.00018017896,0.000023518644,0.00027876042,0.000018322062,0.00012134564],"about_ca_topic_score_codex":0.009666894,"about_ca_topic_score_gemma":0.009304021,"teacher_disagreement_score":0.029112572,"about_ca_system_score_codex":0.000024173367,"about_ca_system_score_gemma":0.00006140404,"threshold_uncertainty_score":0.9969278},"labels":[],"label_agreement":null},{"id":"W2755277521","doi":"10.1136/annrheumdis-2017-eular.4561","title":"FRI0727 Impact of maternal systemic autoimmune rheumatic diseases on neonatal outcomes: a population-level analysis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ironwood Pharmaceuticals, Incorporated; AstraZeneca","keywords":"Medicine; Population; Live birth; Cohort; Pediatrics; Pregnancy; Obstetrics; Internal medicine","score_opus":0.0614283221752481,"score_gpt":0.35631509234370473,"score_spread":0.29488677016845666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755277521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899967,0.006566006,0.000024186373,0.00037704204,0.00030501292,0.00074801786,0.0018252797,0.000057445974,0.000100366175],"genre_scores_gemma":[0.99840593,0.00088645885,0.000018926936,0.0000682321,0.000026648373,0.00004835397,0.00013407011,0.00004310286,0.00036825374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965446,0.0001979924,0.001413194,0.00037132014,0.0010754783,0.00039743757],"domain_scores_gemma":[0.99449265,0.00039018027,0.0020344493,0.0024132049,0.00030130136,0.00036821727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024927454,0.00043363552,0.0017366109,0.0003915996,0.0003626231,0.00010408622,0.00088554213,0.00011771345,0.00036561125],"category_scores_gemma":[0.00202161,0.00024009065,0.0026352683,0.0003441261,0.0002701622,0.00022760314,0.00020234064,0.00012082435,0.00003989404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039785137,0.0007287648,0.9721056,0.0014884656,0.00931725,0.000007696536,0.0001765755,0.0015988284,0.00003939795,0.000108953776,0.0009179983,0.013112588],"study_design_scores_gemma":[0.0014824361,0.00017025684,0.97814196,0.012208404,0.0047632474,0.000017061067,0.00016784866,0.0024835444,0.0000623341,0.00027864974,0.000001005736,0.00022326125],"about_ca_topic_score_codex":0.0030563164,"about_ca_topic_score_gemma":0.000009463206,"teacher_disagreement_score":0.012889327,"about_ca_system_score_codex":0.00007655368,"about_ca_system_score_gemma":0.00023713853,"threshold_uncertainty_score":0.97906125},"labels":[],"label_agreement":null},{"id":"W2755291424","doi":"10.1136/annrheumdis-2017-211480","title":"Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Pulmonary hypertension; Cohort; Internal medicine; Cardiology; Scleroderma (fungus); Disease; Cohort study; Longitudinal data; Pathology","score_opus":0.15867330517605782,"score_gpt":0.3100058505294995,"score_spread":0.1513325453534417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755291424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98939973,0.006560024,0.0000017889854,0.0006390046,0.000246696,0.0017581707,0.0012945269,0.00007841014,0.00002162511],"genre_scores_gemma":[0.99831235,0.0006641807,0.0000019249467,0.00011127346,0.000061622166,0.000115589646,0.0006490162,0.000058626752,0.000025400019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965693,0.000478432,0.0006961808,0.000633447,0.0011682548,0.00045438856],"domain_scores_gemma":[0.9944079,0.0009764433,0.001278485,0.0027164395,0.00029240386,0.00032835288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005003126,0.0004259782,0.0009242007,0.00006973753,0.0007012021,0.00023497807,0.0012331629,0.0001425165,0.00003245802],"category_scores_gemma":[0.0050080717,0.00018329619,0.00022885088,0.00023592982,0.00060271955,0.0003842425,0.00038930407,0.00022394214,0.000004776737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012797426,0.0011703111,0.993284,0.00011562127,0.00123396,0.00007218507,0.000111911744,0.000025973428,0.00017776096,0.0000011701374,0.0011387106,0.0013886386],"study_design_scores_gemma":[0.0026135307,0.00015304956,0.9187624,0.075013794,0.0018590582,0.0000035382652,0.00024427308,0.0009789666,0.000097580145,0.000028693765,0.000001086961,0.00024402425],"about_ca_topic_score_codex":0.0007809081,"about_ca_topic_score_gemma":0.00013989129,"teacher_disagreement_score":0.07489817,"about_ca_system_score_codex":0.00006348752,"about_ca_system_score_gemma":0.000417317,"threshold_uncertainty_score":0.7474601},"labels":[],"label_agreement":null},{"id":"W2755296718","doi":"10.1136/annrheumdis-2017-eular.2326","title":"FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Bristol-Myers Squibb (Canada); Montreal Clinical Research Institute","funders":"","keywords":"Adalimumab; Medicine; Golimumab; Abatacept; Infliximab; Etanercept; Internal medicine; Rheumatoid arthritis; Discontinuation; Certolizumab pegol; Tumor necrosis factor alpha; Rituximab","score_opus":0.0626517723474842,"score_gpt":0.33962508072311764,"score_spread":0.27697330837563344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755296718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95633525,0.04120041,0.0000011944037,0.0014311464,0.00008140697,0.0005966291,0.00030538408,0.0000057579814,0.00004282249],"genre_scores_gemma":[0.8204186,0.17942895,0.000016585747,0.000023197876,0.000012929041,0.000054161104,0.000025552423,0.0000084026005,0.000011611439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832875,0.00021597996,0.000602263,0.00019816958,0.0004557189,0.0001991004],"domain_scores_gemma":[0.9972092,0.0007479133,0.00069850544,0.0011727975,0.000105474515,0.0000661436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032512713,0.00015591868,0.00054894044,0.000052963725,0.00016169783,0.000036975867,0.00054170046,0.00005128928,0.000053524334],"category_scores_gemma":[0.0016051764,0.00008002118,0.00022589134,0.00010126562,0.0013896195,0.00016766795,0.00010795204,0.00006796288,0.0000016691885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001902023,0.003357888,0.71278834,0.0005894663,0.000971042,0.000030008392,0.040058695,0.000013810577,0.0030633758,0.0011611182,0.0043164557,0.23174779],"study_design_scores_gemma":[0.002665204,0.0010332481,0.9577317,0.0073482473,0.000016576018,0.000012125606,0.010236405,0.00004480804,0.016469184,0.0036500401,0.00067000865,0.00012243094],"about_ca_topic_score_codex":0.0039963103,"about_ca_topic_score_gemma":0.00037755037,"teacher_disagreement_score":0.2449434,"about_ca_system_score_codex":0.000008054244,"about_ca_system_score_gemma":0.00008388892,"threshold_uncertainty_score":0.60412526},"labels":[],"label_agreement":null},{"id":"W2755299652","doi":"10.1136/annrheumdis-2017-eular.5707","title":"FRI0172 Prevalence and features of the “masked” arterial hypertension in women with rheumatoid arthritis without cardiovascular diseases based to ambulatory blood pressure monitoring","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Rheumatoid arthritis; Medicine; Ambulatory blood pressure; Blood pressure; Ambulatory; Cardiology; Internal medicine; Arterial stiffness; Physical therapy","score_opus":0.025824987164951334,"score_gpt":0.2886638650766974,"score_spread":0.26283887791174604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755299652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748505,0.02129117,0.0000022998781,0.0022040117,0.00023124006,0.00121551,0.00015571078,0.00001859054,0.00003101692],"genre_scores_gemma":[0.99736875,0.0021210762,0.000041912393,0.00021956312,0.000073341515,0.00011148435,0.0000012182741,0.000026296855,0.000036343095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772066,0.00033753397,0.00049838156,0.00031127597,0.0007533794,0.00037879744],"domain_scores_gemma":[0.99724543,0.00012314807,0.00037726696,0.0015921328,0.00023952856,0.00042250214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051539735,0.00021632815,0.0008568719,0.0000771652,0.00028193192,0.000054398144,0.00038281048,0.00007267599,0.0000093490535],"category_scores_gemma":[0.0010960491,0.00011894783,0.00018872012,0.00011626572,0.00024086771,0.00015401862,0.00014817624,0.00013881162,4.9428536e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008738306,0.00048102808,0.94400376,0.008337941,0.0008019344,0.000013301837,0.001140675,0.00013631294,0.0001304359,0.000027563387,0.00043348785,0.043619726],"study_design_scores_gemma":[0.0016699763,0.00021678534,0.98144007,0.015387495,0.00017878095,0.000025200288,0.00021459283,0.00003749427,0.00035144523,0.00004133494,0.00031123435,0.00012561114],"about_ca_topic_score_codex":0.0020161083,"about_ca_topic_score_gemma":0.000035782883,"teacher_disagreement_score":0.043494113,"about_ca_system_score_codex":0.00001355717,"about_ca_system_score_gemma":0.000652819,"threshold_uncertainty_score":0.48505518},"labels":[],"label_agreement":null},{"id":"W2755347934","doi":"10.1136/annrheumdis-2017-eular.3409","title":"THU0463 Epidemiology of gout and hyperuricemia in new caledonia","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Hyperuricemia; Gout; Polynesians; Medicine; Internal medicine; Demography; Ethnic group; Epidemiology; Odds ratio; Population; Uric acid; Environmental health","score_opus":0.11108474481442226,"score_gpt":0.3833684354393417,"score_spread":0.2722836906249194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755347934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833498,0.0067413524,0.00001629356,0.008254102,0.00011803999,0.00034439773,0.000030517464,0.000013919724,0.0011315688],"genre_scores_gemma":[0.9969978,0.0012424982,0.00033885895,0.00063299853,0.00004098419,0.000007754524,0.000002974467,0.000017796525,0.0007183548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984497,0.00014325476,0.00065563445,0.00023201268,0.00022139304,0.0002979935],"domain_scores_gemma":[0.9970165,0.0007834414,0.0006612603,0.0012323705,0.000076101765,0.00023032514],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0004948183,0.00017712812,0.0008455713,0.00008487294,0.00008714816,0.000006301207,0.00044846852,0.00009746008,0.00007294426],"category_scores_gemma":[0.0095356675,0.000114543676,0.00019671155,0.00008749419,0.00046251636,0.00011633243,0.00026892917,0.00014084319,0.000010048806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021671802,0.000236071,0.97163707,0.0006841562,0.0002048244,0.0000071121544,0.00040454717,0.00001315041,0.00010292678,0.0007810193,0.0057517528,0.019960651],"study_design_scores_gemma":[0.0010730657,0.00010399141,0.9902236,0.0011734243,0.00022808788,0.000024165585,0.00011756336,0.00027122727,0.00032353873,0.0061628637,0.00019522202,0.00010326624],"about_ca_topic_score_codex":0.0012211652,"about_ca_topic_score_gemma":0.000032838114,"teacher_disagreement_score":0.019857384,"about_ca_system_score_codex":0.000013069647,"about_ca_system_score_gemma":0.0002676489,"threshold_uncertainty_score":0.99880743},"labels":[],"label_agreement":null},{"id":"W2755379306","doi":"10.1136/annrheumdis-2017-eular.3772","title":"OP0076 Risk of developing additional immune mediated manifestations for patients with systemic arthritides","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medac; AbbVie; Novo Nordisk; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Ankylosing spondylitis; Psoriasis; Rheumatoid arthritis; Internal medicine; Incidence (geometry); Immunology","score_opus":0.047103584134463264,"score_gpt":0.3295527659427491,"score_spread":0.2824491818082859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755379306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927292,0.00035512616,0.00006957235,0.0008862649,0.000037957805,0.00073038455,0.005070926,0.000009825773,0.000110751265],"genre_scores_gemma":[0.9984292,0.00041171402,0.0005216442,0.000036453748,0.00001523135,0.00011747415,0.00038764958,0.0000140888005,0.000066588655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880975,0.000057510028,0.0003780585,0.000118664735,0.00046533346,0.00017069012],"domain_scores_gemma":[0.9974071,0.0006884402,0.0005780491,0.00048293985,0.00076638185,0.0000771212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019105464,0.00010158353,0.00032269335,0.00006616204,0.00030410953,0.000026921261,0.00025850843,0.000028337103,0.00020597495],"category_scores_gemma":[0.003628112,0.000060352144,0.00017213271,0.00006523624,0.00024318771,0.00012634303,0.00006980601,0.00005143512,0.0000050234044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017863599,0.0027119904,0.9404628,0.006736252,0.0025462038,0.000004198577,0.0005591126,0.000048945683,0.00033175442,0.0019914692,0.014480506,0.028340394],"study_design_scores_gemma":[0.0013750192,0.00019776456,0.9906766,0.0054029184,0.00015149295,0.0000034293937,0.00013761435,0.00019165114,0.00084152824,0.00091417023,0.00002882539,0.00007897435],"about_ca_topic_score_codex":0.00007355828,"about_ca_topic_score_gemma":0.00001299204,"teacher_disagreement_score":0.050213795,"about_ca_system_score_codex":0.0000111504505,"about_ca_system_score_gemma":0.00023145528,"threshold_uncertainty_score":0.4343451},"labels":[],"label_agreement":null},{"id":"W2755443573","doi":"10.1136/annrheumdis-2017-eular.4298","title":"THU0460 Barriers to gout care: a systematic review and thematic synthesis of 120 providers and 480 gout patients from qualitative studies","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Korea Health Industry Development Institute; AstraZeneca; Amgen","keywords":"Gout; Medicine; Computer science; Intensive care medicine; Internal medicine","score_opus":0.13820688946186319,"score_gpt":0.44627132280018456,"score_spread":0.30806443333832134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755443573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014004288,0.98789346,0.000001155824,0.0005747399,0.00009288788,0.008712024,0.001207755,0.000024799305,0.0000927483],"genre_scores_gemma":[0.0071899667,0.9908059,0.000113166476,0.00040348683,0.000014078247,0.0012478508,0.000033286393,0.00008046061,0.00011180212],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99448335,0.001414107,0.00226086,0.0005882862,0.00089260226,0.00036082245],"domain_scores_gemma":[0.98901105,0.0044481065,0.003406067,0.00200938,0.00058785744,0.00053752377],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095695886,0.0007756845,0.008537012,0.00019093372,0.00020756565,0.000046144476,0.00071564777,0.00014836664,0.000023876277],"category_scores_gemma":[0.06428614,0.0004190727,0.00092858134,0.00023898955,0.00062239374,0.0001605333,0.00053094764,0.00019135943,0.000013162155],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016276575,0.00009625399,0.00006467766,0.9435212,0.0061000106,0.0000021715039,0.012364449,4.694527e-8,2.2585953e-8,0.000013869266,0.0015787401,0.036242303],"study_design_scores_gemma":[0.0002944199,0.00015689779,0.00009104764,0.93093634,0.0556043,0.0000069864013,0.011651638,0.0000011309995,0.0000021091914,0.00024777467,0.00062806235,0.00037927242],"about_ca_topic_score_codex":0.00011446228,"about_ca_topic_score_gemma":0.000005015153,"teacher_disagreement_score":0.06332919,"about_ca_system_score_codex":0.00007895276,"about_ca_system_score_gemma":0.0005058493,"threshold_uncertainty_score":0.99982613},"labels":[],"label_agreement":null},{"id":"W2755445691","doi":"10.1136/annrheumdis-2017-eular.3032","title":"FRI0449 Analysis of the canadian adalimumab post-marketing observational epidemiological study assessing effectiveness in ankylosing spondylitis (complete-as): association between baseline extra articular manifestations and patient-reported outcomes","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); University of British Columbia; McMaster University; Memorial University of Newfoundland; Centre Hospitalier de l’Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"BASDAI; BASFI; Medicine; Ankylosing spondylitis; Observational study; Quality of life (healthcare); Physical therapy; Internal medicine; Adalimumab; Multivariate analysis; Disease; Psoriatic arthritis","score_opus":0.11522921150237653,"score_gpt":0.38046551176623816,"score_spread":0.26523630026386164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755445691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513316,0.00031493025,0.0000039002434,0.0030286338,0.000054949258,0.00076403073,0.0006498641,0.0000066887756,0.00004382492],"genre_scores_gemma":[0.9996006,0.000020210136,0.00005523498,0.00016695278,0.000006244032,0.00004029948,0.000093537186,0.00000880557,0.000008098821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973914,0.0009849004,0.00070386846,0.00023071267,0.00044881858,0.00024029726],"domain_scores_gemma":[0.9950171,0.0030747254,0.00092699216,0.00048499295,0.00038335225,0.00011285084],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014649819,0.00016423297,0.00076081115,0.00014911154,0.00067975774,0.000054870303,0.00014137206,0.000050125574,0.00003715517],"category_scores_gemma":[0.020521196,0.00009938521,0.00030449787,0.00028499027,0.00011962955,0.00012454344,0.0001091112,0.00009071705,3.2110702e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006479315,0.00033981857,0.99261653,0.00006449984,0.0027055533,0.000020951753,0.00023533877,0.00009136897,0.000009324799,0.000036656154,0.0000070921333,0.0038080493],"study_design_scores_gemma":[0.0010744517,0.000095166535,0.99397254,0.0006916891,0.0024921808,0.000002311158,0.0007018227,0.0005355369,0.000012645594,0.0003348682,0.0000033377373,0.000083430554],"about_ca_topic_score_codex":0.056363165,"about_ca_topic_score_gemma":0.030135361,"teacher_disagreement_score":0.026227806,"about_ca_system_score_codex":0.00011958123,"about_ca_system_score_gemma":0.0001770772,"threshold_uncertainty_score":0.9877294},"labels":[],"label_agreement":null},{"id":"W2755477575","doi":"10.1136/annrheumdis-2017-eular.4479","title":"AB0365 Henoch-schÖnlein purpura in tunisian adults: monocentric study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Henoch-Schonlein purpura; Rheumatology; Purpura (gastropod); Internal medicine; Palpable purpura; Rheumatism; Vasculitis; Arthritis; Retrospective cohort study; Dermatology; Population; Gastroenterology; Surgery; Disease","score_opus":0.03558903051291585,"score_gpt":0.3285808962232305,"score_spread":0.29299186571031466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755477575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888644,0.0022670939,0.0000035237244,0.00612265,0.00015759583,0.0009011107,0.00005463211,0.000024577854,0.0016044148],"genre_scores_gemma":[0.99847394,0.0008340589,0.000019804293,0.00017549649,0.000025467521,0.000049576276,0.000011253081,0.000016541799,0.00039383688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873084,0.00007999681,0.00041920616,0.00019433194,0.00033114685,0.00024449313],"domain_scores_gemma":[0.9982347,0.000055583616,0.0002811298,0.0011575796,0.00010918453,0.00016182076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014670168,0.00014589369,0.0003878058,0.00011543058,0.00026583934,0.000052454114,0.00043895442,0.000049112845,0.0001783016],"category_scores_gemma":[0.00070439506,0.00009160285,0.00025794993,0.000145601,0.00014169974,0.00014665393,0.00013542535,0.00014056588,0.000040587474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007135925,0.011055955,0.8062665,0.0011827343,0.0018844814,0.00026739037,0.005012341,0.00012390885,0.000015389965,0.003288453,0.013921679,0.15626758],"study_design_scores_gemma":[0.0025826748,0.00025353982,0.99091375,0.0019309609,0.00021900509,0.000009759759,0.0013798231,0.00030786797,0.00003801945,0.0021306062,0.00012198935,0.00011197567],"about_ca_topic_score_codex":0.00040057543,"about_ca_topic_score_gemma":0.00005889201,"teacher_disagreement_score":0.18464729,"about_ca_system_score_codex":0.000014128745,"about_ca_system_score_gemma":0.00009435794,"threshold_uncertainty_score":0.3735456},"labels":[],"label_agreement":null},{"id":"W2755487753","doi":"10.1136/annrheumdis-2017-eular.5021","title":"SAT0423 Increased prevalence of extra-articular manifestations among individuals with ankylosing spondylitis in canada: results from the rhumadata® multicentre registry","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute; Novartis (Canada)","funders":"","keywords":"Ankylosing spondylitis; Dactylitis; Medicine; BASDAI; Enthesitis; Cohort; Internal medicine; BASFI; Population; Retrospective cohort study; TNF inhibitor; Inflammatory bowel disease; Surgery; Adalimumab; Disease; Psoriatic arthritis","score_opus":0.03237436931765715,"score_gpt":0.2769959222536866,"score_spread":0.24462155293602944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755487753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848099,0.0023761413,0.0000014823406,0.0020855898,0.000050001232,0.00062299334,0.009894575,0.0000063536845,0.00015296253],"genre_scores_gemma":[0.99883544,0.0006557515,0.00009054043,0.00010757547,0.000013361965,0.00002963698,0.00016983636,0.0000132851055,0.00008458646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983661,0.00012270079,0.0005062799,0.00023424333,0.0005266081,0.00024405024],"domain_scores_gemma":[0.9971651,0.00059968384,0.00070461124,0.0012847595,0.00013505165,0.000110791945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017160249,0.00016780257,0.0003731746,0.00002517077,0.00029691722,0.000033123662,0.00039732162,0.000025085696,0.00007148462],"category_scores_gemma":[0.0021243945,0.000095232994,0.00009497709,0.00008186402,0.00037163743,0.00015996724,0.00013062854,0.000081630526,8.8769366e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039729575,0.0002652338,0.99466324,0.00027438538,0.00038234793,0.000107743734,0.0006707729,0.000026089496,0.000008174883,0.00003452438,0.0012502143,0.0019199519],"study_design_scores_gemma":[0.0028679194,0.000053458803,0.9888028,0.005454274,0.00043906592,0.000008179274,0.0015153075,0.00007866337,0.0004951989,0.00013474002,0.00005761506,0.00009280108],"about_ca_topic_score_codex":0.7067678,"about_ca_topic_score_gemma":0.41905633,"teacher_disagreement_score":0.2877115,"about_ca_system_score_codex":0.00005053643,"about_ca_system_score_gemma":0.0005444128,"threshold_uncertainty_score":0.5915444},"labels":[],"label_agreement":null},{"id":"W2755505764","doi":"10.1136/annrheumdis-2017-eular.6119","title":"THU0388 Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results from the 28-week open-label period of the ability-3 study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Pfizer; Amgen","keywords":"Medicine; Adalimumab; BASDAI; Ankylosing spondylitis; Axial spondyloarthritis; Placebo; Internal medicine; Bristol-Myers; Randomized controlled trial; Physical therapy; Rheumatoid arthritis; Psoriatic arthritis; Sacroiliitis; Pathology","score_opus":0.037599440514228845,"score_gpt":0.3034550495326321,"score_spread":0.2658556090184032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755505764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924088,0.0015940575,1.8307063e-7,0.0015544326,0.000114528135,0.0028119069,0.0013567607,0.0000049480036,0.00015435283],"genre_scores_gemma":[0.999304,0.00048932445,0.000023926714,0.000061233004,0.000012605297,0.000052163457,0.000020831909,0.000018404628,0.00001749283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979033,0.0002250459,0.00072840595,0.00032752845,0.00058415555,0.0002315472],"domain_scores_gemma":[0.99666876,0.0004677414,0.00078105804,0.001782375,0.00021811065,0.00008197591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036494192,0.00023720207,0.00077978143,0.00004382549,0.00045814912,0.00004845226,0.00082930294,0.000038710354,0.000016065902],"category_scores_gemma":[0.0012672909,0.00010970172,0.00014053697,0.00020142188,0.00093136594,0.00014544881,0.00064344774,0.00011642677,6.629966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010183975,0.008874659,0.96108466,0.00009392188,0.00085891975,0.0000052894416,0.0032095532,0.00000362474,0.0000041702897,0.000027338343,0.00019237085,0.015461514],"study_design_scores_gemma":[0.03765059,0.0019464229,0.955348,0.0029555573,0.00038881638,0.0000011040521,0.0013204837,0.000008590336,0.000025085166,0.00024028054,0.000013640305,0.00010143615],"about_ca_topic_score_codex":0.0028696274,"about_ca_topic_score_gemma":0.00083824375,"teacher_disagreement_score":0.027466614,"about_ca_system_score_codex":0.0000116032215,"about_ca_system_score_gemma":0.00010953746,"threshold_uncertainty_score":0.44735065},"labels":[],"label_agreement":null},{"id":"W2755554734","doi":"10.1136/annrheumdis-2017-eular.5597","title":"AB0366 “i just want my life back”: physical function and fatigue are critical targets for improving participation and hrql in rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Immunovaccine (Canada)","funders":"Canadian Institutes of Health Research; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Mood; Anxiety; Rheumatoid arthritis; Physical therapy; Quality of life (healthcare); Depression (economics); Confounding; Sleep disorder; Internal medicine; Psychiatry; Cognition","score_opus":0.07425419619411423,"score_gpt":0.36721351414661096,"score_spread":0.29295931795249675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755554734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804729,0.011336154,0.00023372222,0.0069712834,0.00013458892,0.000691607,0.00009447153,0.00001875725,0.000046499037],"genre_scores_gemma":[0.9893223,0.0101839295,0.00008992745,0.00016079053,0.000050393704,0.00014097203,0.000011747649,0.000022620829,0.000017304163],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99853903,0.000092853945,0.00039358548,0.0002741867,0.00032280575,0.00037752077],"domain_scores_gemma":[0.99839145,0.00042102893,0.0002301546,0.00044840403,0.0001847051,0.0003242759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026250118,0.00018051578,0.0005117218,0.00007673044,0.0004078937,0.00015455692,0.00013703256,0.000051373354,0.000034226596],"category_scores_gemma":[0.005455791,0.00013210399,0.0001328408,0.000048620328,0.00059233175,0.00040860413,0.00012869916,0.000113526075,0.0000040091777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033732366,0.0029692152,0.39100346,0.00622975,0.00055840815,0.000017155293,0.0040137577,0.000027860266,0.0016424413,0.015728766,0.005480559,0.56895536],"study_design_scores_gemma":[0.0034658154,0.0005136222,0.968249,0.0038610646,0.000025321517,0.000008422499,0.001058995,0.0073276614,0.0007632355,0.014380074,0.00013137267,0.00021536817],"about_ca_topic_score_codex":0.00013474592,"about_ca_topic_score_gemma":0.00006497625,"teacher_disagreement_score":0.5772456,"about_ca_system_score_codex":0.000008440915,"about_ca_system_score_gemma":0.00009236347,"threshold_uncertainty_score":0.6531486},"labels":[],"label_agreement":null},{"id":"W2755590020","doi":"10.1136/annrheumdis-2017-eular.6147","title":"SAT0540 The reduction in adrenergic and inflammatory serum markers in osteoarthritis patients after treatment with chondroitin sulfate/glucosamine hydrochloride and celecoxib is different according to the presence of bacterial dna in blood","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cairo University; McMaster University","keywords":"Chondroitin sulfate; Osteoarthritis; Immune system; Internal medicine; Medicine; Endocrinology; Immunology; Pharmacology; Pathology","score_opus":0.009369127589931437,"score_gpt":0.2335575019158538,"score_spread":0.22418837432592237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755590020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738204,0.00051423296,9.4063935e-8,0.00076599984,0.00013775942,0.0011338504,0.00004512627,0.0000038103155,0.00001710399],"genre_scores_gemma":[0.998918,0.0007639354,0.000002624842,0.000039656246,0.000035857334,0.0002007107,0.000005567019,0.000014659201,0.0000189893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876696,0.00014810084,0.0003925854,0.00021041385,0.00024956552,0.00023236219],"domain_scores_gemma":[0.99894494,0.00015509863,0.00026024575,0.0005073792,0.000040461502,0.00009188968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022564812,0.00019177773,0.00039222863,0.000105965686,0.00008346184,0.000034895646,0.00015499709,0.00004056233,0.000014320664],"category_scores_gemma":[0.00026452346,0.00009393832,0.000057262187,0.000088655615,0.00019425576,0.00014533335,0.00012288759,0.0000776789,4.128481e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002451473,0.00030028672,0.96968883,0.00035111644,0.00006322699,0.0000136298495,0.0018138208,0.000013548381,0.0005179087,0.0000054249244,0.000022270691,0.02475846],"study_design_scores_gemma":[0.003639181,0.0006029932,0.97737443,0.0024423068,0.00007863017,0.0000052228884,0.00036557153,0.0000741787,0.015265029,0.00004738344,0.0000070197243,0.000098030956],"about_ca_topic_score_codex":0.00031227487,"about_ca_topic_score_gemma":0.0008252262,"teacher_disagreement_score":0.024660429,"about_ca_system_score_codex":0.000023421158,"about_ca_system_score_gemma":0.000052272328,"threshold_uncertainty_score":0.38306934},"labels":[],"label_agreement":null},{"id":"W2755612746","doi":"10.1136/annrheumdis-2017-eular.3328","title":"SAT0039 Large tender joints have the greatest impact on longitudinal trajectories of function in early rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Sherbrooke; McGill University; University of Manitoba; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Gee; Rheumatoid arthritis; Shoulders; Joint (building); Physical therapy; Cohort; Arthritis; Generalized estimating equation; Physical medicine and rehabilitation; Internal medicine; Surgery; Statistics; Mathematics; Structural engineering","score_opus":0.04692338230713149,"score_gpt":0.3344727553854234,"score_spread":0.2875493730782919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755612746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908743,0.0060167764,0.000009577057,0.0016061707,0.00018335514,0.0005731816,0.00018740601,0.000019673234,0.00052959035],"genre_scores_gemma":[0.9840905,0.01562907,0.0000038376293,0.00006412097,0.000030861094,0.000044190423,0.000010250787,0.000027467846,0.00009967866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978017,0.0001773853,0.0005617405,0.00023914016,0.000748918,0.00047107154],"domain_scores_gemma":[0.9976186,0.00029503755,0.00046078904,0.0012058958,0.00024547224,0.00017420281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005057677,0.0002544507,0.0006412114,0.00014454355,0.00040896676,0.0001083226,0.00046924475,0.000061336905,0.00024054977],"category_scores_gemma":[0.0015022032,0.00013297818,0.00046225454,0.00012449041,0.00063319696,0.0003061371,0.00012837794,0.00021971807,0.00001950384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014045417,0.0007587177,0.96943235,0.00014188942,0.00045421318,0.0000121494195,0.0008673826,0.00001492575,0.000039053186,0.00108585,0.0017898225,0.023999102],"study_design_scores_gemma":[0.0021364742,0.00069536583,0.9880099,0.003517326,0.000010680172,0.000021323816,0.0004844234,0.00010095273,0.00070833095,0.0041064303,0.00008549298,0.00012324158],"about_ca_topic_score_codex":0.0013892526,"about_ca_topic_score_gemma":0.00038955896,"teacher_disagreement_score":0.02387586,"about_ca_system_score_codex":0.000022000278,"about_ca_system_score_gemma":0.00018217218,"threshold_uncertainty_score":0.5422693},"labels":[],"label_agreement":null},{"id":"W2755614830","doi":"10.1136/annrheumdis-2017-eular.5664","title":"FRI0050 Type ii collagen secreted from articular chondrocytes is mainly destroyed by cathepsin s in ra mice","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Canadian Institutes of Health Research; Instituto Nacional De Salud Pública; Universidad de León; Amgen Canada; Amgen; Instituto de Seguriidad y Servicios Sociales de los Trabadores del Estado; Consejo Nacional de Ciencia y Tecnología","keywords":"Type II collagen; Chemistry; Cartilage; Synovial membrane; Cell biology; Cathepsin S; Type I collagen; Molecular biology; Synovial fluid; Arthritis; Cathepsin; Immunology; Pathology; Osteoarthritis; Biology; Medicine; Anatomy; Biochemistry","score_opus":0.033072132781992246,"score_gpt":0.3170423389652386,"score_spread":0.28397020618324637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755614830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779545,0.015220431,0.00000681083,0.0055351253,0.000119947785,0.00050383026,0.000298716,0.00002579173,0.00033481652],"genre_scores_gemma":[0.98981076,0.008738827,0.00011027955,0.00060125004,0.000024713556,0.000029783185,0.000050016835,0.00002816496,0.00060619134],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982907,0.0001354642,0.0004067924,0.0002550072,0.00051046634,0.00040152846],"domain_scores_gemma":[0.99805963,0.00018219133,0.0002682309,0.001054429,0.00017959905,0.00025590256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020312391,0.00020154774,0.00050249323,0.00007127301,0.00037825713,0.00009925975,0.00057117245,0.0000657008,0.00067868625],"category_scores_gemma":[0.0016703872,0.00014037188,0.00020226376,0.0001339226,0.00034884855,0.00019368982,0.0002200141,0.00009899438,0.000055322085],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007056001,0.005656484,0.3425955,0.0012821441,0.004645612,0.00021983692,0.012292065,0.000045161436,0.12630211,0.00084017485,0.42275137,0.07631354],"study_design_scores_gemma":[0.009944851,0.0010904059,0.7462237,0.008274514,0.00015476551,0.000025738811,0.0015174765,0.002487212,0.20467481,0.0127103925,0.012069862,0.000826257],"about_ca_topic_score_codex":0.0014376761,"about_ca_topic_score_gemma":0.00007374152,"teacher_disagreement_score":0.41068152,"about_ca_system_score_codex":0.000019767955,"about_ca_system_score_gemma":0.00020908016,"threshold_uncertainty_score":0.7431138},"labels":[],"label_agreement":null},{"id":"W2755704235","doi":"10.1136/annrheumdis-2017-eular.1580","title":"SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"","keywords":"Ixekizumab; Psoriatic arthritis; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Presenteeism; Placebo; Psoriasis; Internal medicine; Visual analogue scale; Physical therapy; Adalimumab; Tumor necrosis factor alpha; Arthritis; Secukinumab; Absenteeism; Dermatology; Pathology; Alternative medicine; Psychology","score_opus":0.017133957347561166,"score_gpt":0.2559271969964671,"score_spread":0.23879323964890592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755704235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672645,0.0009296323,5.9466674e-7,0.0005999578,0.00033711738,0.0009531454,0.00041201382,0.000023962713,0.000017107282],"genre_scores_gemma":[0.9994247,0.00017706201,0.000014469308,0.00007392772,0.000003838235,0.00010288561,0.000023350485,0.000022564212,0.00015717723],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983265,0.0003616699,0.0005042091,0.00033076762,0.00012131245,0.00035558784],"domain_scores_gemma":[0.99804175,0.0003409521,0.0006874443,0.0007305385,0.00012388367,0.00007543356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012801893,0.0002978755,0.00060663436,0.00013201674,0.00035309664,0.000057358735,0.00032147972,0.00009232125,0.00002660947],"category_scores_gemma":[0.0015095809,0.00018678869,0.0001540331,0.00008968909,0.00021487291,0.00025144298,0.00020608136,0.00008216194,0.000015364505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037737007,0.0006395606,0.18007196,0.000047347763,0.00071437954,0.0000042394463,0.0014509758,0.000002010269,0.00025571164,0.0000059203544,0.00015546197,0.8128787],"study_design_scores_gemma":[0.0034670543,0.00072092627,0.98411846,0.0007118417,0.00015275544,0.0000017170746,0.00016450077,5.8185907e-7,0.010222142,0.00018679685,0.00003062438,0.00022257722],"about_ca_topic_score_codex":0.00041177552,"about_ca_topic_score_gemma":0.000093352864,"teacher_disagreement_score":0.81265616,"about_ca_system_score_codex":0.00002667783,"about_ca_system_score_gemma":0.000088794324,"threshold_uncertainty_score":0.7617022},"labels":[],"label_agreement":null},{"id":"W2755728786","doi":"10.1136/annrheumdis-2017-eular.5695","title":"THU0085 Time to remission and the achievement of sustained remission in patients with early rheumatoid arthritis: site variation analysis in therapeutic strategy from the canadian early arthritis cohort (CATCH)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université de Sherbrooke; University of Calgary; McGill University; Southlake Regional Health Center; University of Manitoba; Western University; University of Toronto","funders":"","keywords":"Methotrexate; Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Combination therapy; Physical therapy","score_opus":0.010970414867760736,"score_gpt":0.25393271355689045,"score_spread":0.24296229868912972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755728786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877529,0.0039764,0.000008871496,0.006388132,0.000019403917,0.0015643878,0.00014814473,0.000008830248,0.00013292732],"genre_scores_gemma":[0.9943246,0.0052718273,0.000018033285,0.00018362507,0.000008382143,0.00006127805,0.000048993337,0.000021562371,0.00006166729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973557,0.0004501587,0.00066499965,0.00030972186,0.00081550813,0.0004039117],"domain_scores_gemma":[0.99752104,0.000349632,0.00043751235,0.0010991468,0.00029537678,0.00029730628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094109576,0.00022771528,0.0007148953,0.00023977496,0.00044820734,0.0001921111,0.00048021835,0.00007051696,0.00012877307],"category_scores_gemma":[0.0007576005,0.000116743286,0.00016571149,0.00043439757,0.0004312859,0.00025026317,0.00012446009,0.00019326938,0.000006977911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016519759,0.00024059882,0.965572,0.000027044518,0.00065368484,0.00000412509,0.0020331352,0.00005755503,0.000027916416,0.00028286877,0.00012024697,0.029328855],"study_design_scores_gemma":[0.004487329,0.00029114366,0.9892466,0.0028646186,0.000047132242,6.240827e-7,0.00025029737,0.00035596197,0.000046757592,0.0022477533,0.000031786367,0.00012997299],"about_ca_topic_score_codex":0.18372768,"about_ca_topic_score_gemma":0.06642504,"teacher_disagreement_score":0.11730264,"about_ca_system_score_codex":0.00006014165,"about_ca_system_score_gemma":0.00038403756,"threshold_uncertainty_score":0.9506103},"labels":[],"label_agreement":null},{"id":"W2755814119","doi":"10.1136/annrheumdis-2017-eular.5115","title":"FRI0719 Burden of hepatitis e virus infection in patients with rheumatic diseases","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Hepatitis E virus; Rheumatology; Hepatitis E; Seroprevalence; Gastroenterology; Arthritis; Immunology; Hepatitis; Antibody; Serology","score_opus":0.0383392685133728,"score_gpt":0.31792612519061914,"score_spread":0.27958685667724636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755814119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711746,0.0006666335,0.000017747343,0.0008754111,0.00017170684,0.0005706383,0.00021618418,0.00001852642,0.0003456868],"genre_scores_gemma":[0.98887,0.010732187,0.00003766282,0.00019239097,0.000023621038,0.000046070985,0.000023368866,0.000021437703,0.000053252046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983323,0.00014331668,0.0006640493,0.00021078694,0.0003596377,0.00028987965],"domain_scores_gemma":[0.99761164,0.00027365686,0.0008013931,0.0009404948,0.00023606888,0.0001367514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001644151,0.00020232423,0.00084781315,0.000098815544,0.00019913065,0.00001611469,0.0002649766,0.000055090706,0.00011596359],"category_scores_gemma":[0.003469931,0.0001248099,0.00022963325,0.00010844607,0.00041792283,0.00017880161,0.00019161888,0.0000889442,0.000011742419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026230127,0.0005526822,0.9818871,0.0008081973,0.00028927164,0.0000018247954,0.0001965478,0.000117648175,0.0000012561817,0.00010511266,0.0020313018,0.013746727],"study_design_scores_gemma":[0.0013789248,0.00043945163,0.9935606,0.0028238404,0.00022399116,7.536985e-7,0.000021793941,0.00035735933,0.000035714795,0.0009712482,0.00006057061,0.00012574765],"about_ca_topic_score_codex":0.04917037,"about_ca_topic_score_gemma":0.0026500213,"teacher_disagreement_score":0.046520352,"about_ca_system_score_codex":0.000027521231,"about_ca_system_score_gemma":0.000093383605,"threshold_uncertainty_score":0.9571613},"labels":[],"label_agreement":null},{"id":"W2755846149","doi":"10.1136/annrheumdis-2017-eular.5125","title":"THU0689 Moderate to good construct validity of global presenteeism measures with multi-item presenteeism measure and patient reported health outcomes: eular-pro worker productivity study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Presenteeism; Construct validity; Medicine; Observational study; Physical therapy; Quality of life (healthcare); Scale (ratio); Absenteeism; Clinical psychology; Psychometrics; Psychology; Social psychology; Internal medicine; Nursing","score_opus":0.1609883975937335,"score_gpt":0.43359662275269134,"score_spread":0.27260822515895783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755846149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97978467,0.0008199235,0.0002665838,0.011355172,0.00048426943,0.0067982366,0.00019603058,0.00006467506,0.00023044506],"genre_scores_gemma":[0.998559,0.0000714029,0.0002829683,0.00055716414,0.00003130448,0.00030802994,0.0000039679167,0.00003578858,0.00015036012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99348,0.0023420656,0.0014905907,0.00066590105,0.001196679,0.00082476187],"domain_scores_gemma":[0.9931693,0.000576637,0.0025719306,0.0021850227,0.00084616983,0.00065090624],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0020779236,0.00041473456,0.0012272539,0.00006400063,0.0019381933,0.000055478587,0.0006101795,0.000105031504,0.000011799472],"category_scores_gemma":[0.0057163606,0.00025267122,0.0001763909,0.00021702694,0.00033958323,0.00030703095,0.0006200064,0.00037847031,0.0000032334815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009416161,0.001246844,0.98000365,0.0011992739,0.00045253185,0.0000051625952,0.0036674943,0.00012435541,0.000001538818,0.0001240794,0.0025835978,0.009649828],"study_design_scores_gemma":[0.0019664487,0.00041426465,0.9894657,0.0030901732,0.0001471956,0.0000043036307,0.0034844766,0.00022632374,0.000043389533,0.00085017,0.00007727588,0.00023026353],"about_ca_topic_score_codex":0.0038284922,"about_ca_topic_score_gemma":0.0012394711,"teacher_disagreement_score":0.01877435,"about_ca_system_score_codex":0.0000724378,"about_ca_system_score_gemma":0.0011696643,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W2755866409","doi":"10.1136/annrheumdis-2017-eular.1522","title":"OP0337-HPR Predictors of patient reported decision to discontinue anti-rheumatic medication in rheumatoid arthritis patients: data from a rheumatoid arthritis cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; William Osler Health System; Brampton Civic Hospital","funders":"Instituto de Salud Carlos III","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Cohort; Internal medicine; Comorbidity; Physical therapy; Cohort study; Retrospective cohort study","score_opus":0.03415988078075126,"score_gpt":0.31720813382060137,"score_spread":0.2830482530398501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755866409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778059,0.015778255,0.000091288486,0.0015322602,0.0007832742,0.0023936003,0.0013936722,0.000061525876,0.0001602124],"genre_scores_gemma":[0.8280828,0.17065157,0.000332758,0.00010993949,0.000023899658,0.00015870991,0.00056482333,0.000063935666,0.000011541894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992885,0.00034225272,0.002828593,0.000935219,0.0022666182,0.0007423036],"domain_scores_gemma":[0.9905419,0.0006954314,0.0021176136,0.0053132107,0.0006603764,0.0006715106],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010877793,0.0005151044,0.0017964873,0.00041518756,0.00042799985,0.00015261164,0.002041011,0.00016028158,0.00034195444],"category_scores_gemma":[0.016725775,0.0003943626,0.00037890443,0.00038203443,0.0008152772,0.0010074835,0.0013970877,0.00030291447,0.000042348027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005180775,0.0016492808,0.76363665,0.00016690485,0.0006713234,0.000021322969,0.000937049,0.00002208567,0.00005224082,0.000063274834,0.012852236,0.21940956],"study_design_scores_gemma":[0.004633781,0.0004045695,0.9579727,0.03167266,0.000021403617,0.00002189232,0.00037763134,0.00043855913,0.0010270758,0.0019886335,0.0010708658,0.00037020803],"about_ca_topic_score_codex":0.0033599813,"about_ca_topic_score_gemma":0.0006905579,"teacher_disagreement_score":0.21903934,"about_ca_system_score_codex":0.000052782023,"about_ca_system_score_gemma":0.00047774977,"threshold_uncertainty_score":0.9998508},"labels":[],"label_agreement":null},{"id":"W2755891845","doi":"10.1136/annrheumdis-2017-eular.1498","title":"FRI0008 Effects of the human il4-10 fusion protein in the canine groove model of osteoarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Université de Montréal; Arthritis Society","keywords":"Osteoarthritis; Proteoglycan; Cartilage; Chemistry; Glycosaminoglycan; Type II collagen; Pathology; Inflammation; Medicine; Internal medicine; Anatomy; Biochemistry","score_opus":0.03308626682814573,"score_gpt":0.2969427728521292,"score_spread":0.2638565060239835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755891845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460536,0.0012745459,0.0000019223733,0.0012358373,0.00007667777,0.0017453099,0.00008585849,0.000007726177,0.0009667642],"genre_scores_gemma":[0.99879974,0.00008834118,0.00003204542,0.0001023151,0.000017412252,0.00010798839,0.000008077631,0.000016767783,0.00082733715],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860126,0.00014634068,0.0004078483,0.00014930319,0.0004973259,0.00019792741],"domain_scores_gemma":[0.99793214,0.0001109742,0.00054493145,0.0012403711,0.000113704045,0.000057859954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021808913,0.00016785692,0.00045099948,0.000046709218,0.00021851456,0.000016206966,0.00057991734,0.000054054173,0.00004180889],"category_scores_gemma":[0.0006382167,0.00008180604,0.00030943425,0.00008144659,0.00028436113,0.00009517919,0.00019075465,0.00008595674,0.0000026393204],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002460158,0.012596385,0.07322981,0.017880144,0.0009706527,0.000108600456,0.019047353,0.00027465765,0.34285575,0.0443364,0.0077192304,0.47852087],"study_design_scores_gemma":[0.014422746,0.0050579705,0.23506176,0.03345535,0.00093025545,0.000019905327,0.0009693043,0.0006660372,0.6657381,0.043183252,0.000058459587,0.00043687454],"about_ca_topic_score_codex":0.00029611427,"about_ca_topic_score_gemma":0.0001988387,"teacher_disagreement_score":0.478084,"about_ca_system_score_codex":0.0000086512,"about_ca_system_score_gemma":0.00009469821,"threshold_uncertainty_score":0.33359537},"labels":[],"label_agreement":null},{"id":"W2755901387","doi":"10.1136/annrheumdis-2017-eular.4594","title":"THU0064 ADAM-10 as a tocilizumab treatment predictive factor in rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; St. Olavs Hospital Universitetssykehuset i Trondheim","keywords":"Tocilizumab; Medicine; Rheumatoid arthritis; Adalimumab; Internal medicine; CX3CL1; Rheumatology; Cytokine; Tumor necrosis factor alpha; Gastroenterology; Receptor; Immunology; Chemokine; Chemokine receptor","score_opus":0.09281284942180426,"score_gpt":0.40234021715342017,"score_spread":0.30952736773161593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755901387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794289,0.0061036455,0.000002869526,0.005883112,0.00016730372,0.0013855761,0.000416072,0.000041530984,0.006570996],"genre_scores_gemma":[0.9855991,0.012002131,0.000020652205,0.00013431326,0.00003393701,0.0002617023,0.000012583858,0.00003340956,0.0019021718],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997753,0.00014864684,0.00050458434,0.00033004262,0.00079989544,0.00046381372],"domain_scores_gemma":[0.99732286,0.0002602931,0.00031532958,0.001592377,0.0002021099,0.00030701305],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018536272,0.00025000045,0.0006605656,0.000114397175,0.0002342758,0.000081981285,0.00058431795,0.00007808116,0.0016482655],"category_scores_gemma":[0.0025491454,0.00016348202,0.00034823598,0.00011254537,0.00042137306,0.00019032315,0.00022064718,0.00013723834,0.00014905604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031657366,0.0036982084,0.239465,0.0011070832,0.0012829828,0.00017769892,0.004447883,0.000045829656,0.00010251846,0.0007428471,0.028598076,0.7171661],"study_design_scores_gemma":[0.0047255675,0.0017538028,0.9747203,0.0073504415,0.00005178316,0.00003397905,0.000675685,0.0004203908,0.003442963,0.003822834,0.002744867,0.00025740714],"about_ca_topic_score_codex":0.0032026495,"about_ca_topic_score_gemma":0.0003370339,"teacher_disagreement_score":0.7352553,"about_ca_system_score_codex":0.00015288198,"about_ca_system_score_gemma":0.0008326122,"threshold_uncertainty_score":0.99926436},"labels":[],"label_agreement":null},{"id":"W2755961259","doi":"10.1136/annrheumdis-2017-eular.2871","title":"THU0025 Il-6 trans-signaling causes accelerated atherosclerosis in disease prone animals","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Inflammation; Medicine; Rheumatoid arthritis; Immune system; Apolipoprotein E; Immunology; Acute-phase protein; Arthritis; Internal medicine; Endocrinology; Disease","score_opus":0.14759972619765704,"score_gpt":0.36520176315509134,"score_spread":0.2176020369574343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755961259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260426,0.0005696433,0.00002246786,0.0054724836,0.00014016386,0.0006013105,0.00027698878,0.00004250271,0.00027015517],"genre_scores_gemma":[0.99887866,0.00041018653,0.00004092117,0.00031063284,0.000046976736,0.00006702687,0.000013523774,0.00003092833,0.00020112378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851096,0.000081875725,0.00051961036,0.0002519218,0.0003463592,0.00028928634],"domain_scores_gemma":[0.9981672,0.00013137727,0.00037322537,0.0009124084,0.00018402559,0.00023175578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019340077,0.0002084022,0.00046143358,0.00010154262,0.00031739575,0.00010861455,0.00040546505,0.000042155127,0.00037264757],"category_scores_gemma":[0.0010929818,0.00012736443,0.0003504644,0.00013180223,0.00019787505,0.00023469541,0.00008286878,0.00013457601,0.00001284171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036819621,0.00767117,0.72530144,0.0044324743,0.0016463277,0.000066513494,0.0040544686,0.0011557615,0.19765873,0.0016639209,0.007772984,0.044894252],"study_design_scores_gemma":[0.0011357316,0.0001349137,0.9539405,0.004908306,0.00026873022,0.0000027282415,0.00015801382,0.00072578096,0.037222065,0.0009267503,0.00038322248,0.00019325504],"about_ca_topic_score_codex":0.0002818917,"about_ca_topic_score_gemma":0.000029515699,"teacher_disagreement_score":0.22863907,"about_ca_system_score_codex":0.000019295045,"about_ca_system_score_gemma":0.00019354212,"threshold_uncertainty_score":0.51937705},"labels":[],"label_agreement":null},{"id":"W2755976988","doi":"10.1136/annrheumdis-2017-eular.5087","title":"AB0712 Clinical characteristics of spondylarthritis (SPA) with and without peripheral enthesitis – data from the desir cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Montreal Clinical Research Institute","funders":"","keywords":"Enthesitis; Medicine; Cohort; Population; Internal medicine; Plantar fascia; Peripheral; Incidence (geometry); Enthesopathy; Prospective cohort study; Plantar fasciitis; Heel; Disease; Psoriatic arthritis; Arthritis; Anatomy","score_opus":0.11701942144833773,"score_gpt":0.37941489917440063,"score_spread":0.2623954777260629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755976988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907784,0.0043241205,0.000008838834,0.002169566,0.00012918914,0.0004941598,0.0018753642,0.000010428124,0.00020995062],"genre_scores_gemma":[0.99108225,0.008151198,0.00016554829,0.0002747948,0.0000703099,0.000016904321,0.00010672282,0.000019293066,0.00011294916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986628,0.000092450944,0.00044503305,0.00027031737,0.00034710963,0.00018226473],"domain_scores_gemma":[0.99700713,0.000306669,0.00053655426,0.0019009281,0.00012886056,0.00011984452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026085833,0.00017146938,0.00067154656,0.000011667794,0.0003300537,0.000052941818,0.00052075874,0.000039937993,0.00010529523],"category_scores_gemma":[0.0010388966,0.00008738712,0.00012496393,0.000029912282,0.00093960005,0.00013683549,0.00041579382,0.000082901985,0.0000034009288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004952174,0.0003213428,0.9359018,0.00006584048,0.0009372604,0.0000151445,0.00009007757,5.440093e-8,0.0000027712572,0.00003698843,0.0012693317,0.060864136],"study_design_scores_gemma":[0.0018558487,0.0002801652,0.9944165,0.0018171938,0.00072372326,0.000018002447,0.00013932609,0.000042641608,0.000039393428,0.00015414655,0.00042244152,0.00009063777],"about_ca_topic_score_codex":0.00055763876,"about_ca_topic_score_gemma":0.00015042705,"teacher_disagreement_score":0.060773496,"about_ca_system_score_codex":0.000004239651,"about_ca_system_score_gemma":0.000083282896,"threshold_uncertainty_score":0.35635433},"labels":[],"label_agreement":null},{"id":"W2755994026","doi":"10.1136/annrheumdis-2017-eular.5593","title":"SAT0132 The rheumatoid arthritis flare questionnaire (RA-FQ): results of rasch analysis and feedback on real-world applications from international RA patients and clinicians","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"U.S. Department of State","keywords":"Interpretability; Rasch model; Differential item functioning; Medicine; Rheumatoid arthritis; Reliability (semiconductor); Item response theory; Psychometrics; Physical therapy; Clinical psychology; Psychology; Internal medicine; Artificial intelligence; Computer science; Developmental psychology","score_opus":0.025071666862935514,"score_gpt":0.3329970611902248,"score_spread":0.3079253943272893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755994026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831513,0.004875842,0.000021897526,0.0090810135,0.000105987616,0.00066669524,0.0012523796,0.000020769216,0.00082411454],"genre_scores_gemma":[0.89531076,0.104095824,0.000050216535,0.00015516246,0.000030948835,0.00006332798,0.00013397909,0.000014588752,0.00014516593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980286,0.0001659746,0.0006895105,0.00030393933,0.0006112028,0.00020077438],"domain_scores_gemma":[0.9971998,0.0005117084,0.00067513454,0.0010487331,0.00038823686,0.00017642436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035445992,0.0001809365,0.0005319496,0.0001737792,0.00047409124,0.00012120304,0.00047504972,0.00004728458,0.000050232717],"category_scores_gemma":[0.0016267783,0.00011271005,0.00025879586,0.00018978669,0.00076805725,0.00017919685,0.00021431613,0.00013865369,0.0000071761588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093740516,0.0006977382,0.62126833,0.00009861364,0.002185009,0.00000165058,0.00075046095,0.0000149752395,0.000013218772,0.0011164987,0.005407517,0.3675086],"study_design_scores_gemma":[0.0022640156,0.00012399882,0.990945,0.002197388,0.00006998443,0.0000010555108,0.00021121673,0.0002751357,0.00020804099,0.0025312214,0.0010659639,0.00010697585],"about_ca_topic_score_codex":0.002844414,"about_ca_topic_score_gemma":0.0018397555,"teacher_disagreement_score":0.36967668,"about_ca_system_score_codex":0.000011694371,"about_ca_system_score_gemma":0.000080095095,"threshold_uncertainty_score":0.45961824},"labels":[],"label_agreement":null},{"id":"W2756020569","doi":"10.1136/annrheumdis-2017-eular.3537","title":"SAT0530 Central sensitisation in hand osteoarthritis: the anterior cingulate cortex is involved in pain processing","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Pregabalin; Anterior cingulate cortex; Duloxetine; Cingulate cortex; Insular cortex; Medicine; Placebo; Grey matter; Secondary somatosensory cortex; Anesthesia; Thalamus; Psychology; Internal medicine; Neuroscience; Functional magnetic resonance imaging; Magnetic resonance imaging; Psychiatry; Central nervous system; Cognition; Radiology; Pathology","score_opus":0.04535798762434582,"score_gpt":0.29603563242233677,"score_spread":0.25067764479799093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756020569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580914,0.0004772647,0.000055275876,0.0027629551,0.000114106864,0.00056045403,0.00001862835,0.000013413969,0.00018875713],"genre_scores_gemma":[0.99842614,0.0002300868,0.0000046778664,0.0012193715,0.00001452357,0.000018743935,0.0000013690984,0.000009765857,0.00007530121],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977556,0.0011807965,0.00030345377,0.00020928522,0.00026268457,0.00028822166],"domain_scores_gemma":[0.99840415,0.00072048337,0.00033740597,0.00047559402,0.000020207333,0.00004214951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017533684,0.00012745187,0.00021057841,0.00006659826,0.00036175473,0.00028901346,0.00048426128,0.000026467156,0.000017930186],"category_scores_gemma":[0.004644707,0.00008291074,0.00008994308,0.0001264215,0.0002871877,0.0003177218,0.0001325369,0.000079311016,0.000004872776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029082556,0.00025984237,0.29196104,0.0009918077,0.000018652854,0.000049971328,0.0055746045,0.00027020398,0.010143905,0.00012441677,0.0015209414,0.6887938],"study_design_scores_gemma":[0.0006665828,0.000037304337,0.9439615,0.003170889,0.000015257718,0.0000010733373,0.0002673494,0.04176543,0.007432083,0.0024888448,0.00005160338,0.00014205667],"about_ca_topic_score_codex":0.00021121197,"about_ca_topic_score_gemma":0.0003170688,"teacher_disagreement_score":0.68865174,"about_ca_system_score_codex":0.000010902874,"about_ca_system_score_gemma":0.00004123338,"threshold_uncertainty_score":0.55604833},"labels":[],"label_agreement":null},{"id":"W2756023907","doi":"10.1136/annrheumdis-2017-eular.2629","title":"FRI0439 Psychiatric disorders associated with ankylosing spondylitis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ankylosing spondylitis; Anxiety; Medicine; Alexithymia; Enthesitis; Toronto Alexithymia Scale; Fibromyalgia; Physical therapy; Depression (economics); Visual analogue scale; Quality of life (healthcare); Internal medicine; Psychiatry; Disease; Psoriatic arthritis","score_opus":0.031111357240494148,"score_gpt":0.3086595176634189,"score_spread":0.2775481604229248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756023907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867529,0.0037648831,0.0000033911651,0.0047408394,0.00016880178,0.00038313493,0.00038844958,0.000030867257,0.0037666755],"genre_scores_gemma":[0.9979563,0.0012721275,0.000046970705,0.00019964454,0.00002095146,0.000022275979,0.000036932,0.000020832887,0.00042397206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896973,0.000039117247,0.00022590274,0.00017428792,0.00033499772,0.0002559704],"domain_scores_gemma":[0.9985871,0.00009047809,0.0003700103,0.00074103655,0.000100695564,0.000110727386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007785795,0.00016163009,0.00037223988,0.000045981298,0.00058619096,0.00004472906,0.00022084838,0.000032057575,0.00015663337],"category_scores_gemma":[0.00072629907,0.000094858464,0.00022838371,0.00010253565,0.00026496913,0.00011167488,0.00009097126,0.00005757628,0.000007944272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046890104,0.0013498664,0.9408832,0.00021037491,0.0013719088,0.000017887198,0.00019322113,0.0000047561675,0.0000020422979,0.0005816541,0.00591524,0.049000923],"study_design_scores_gemma":[0.002245477,0.00032278747,0.99277776,0.001348147,0.00042386222,0.0000060210136,0.00012822672,0.00002531802,0.000031840063,0.002051518,0.00052850635,0.000110532834],"about_ca_topic_score_codex":0.00023709414,"about_ca_topic_score_gemma":0.00013538667,"teacher_disagreement_score":0.051894538,"about_ca_system_score_codex":0.00001338113,"about_ca_system_score_gemma":0.00006644784,"threshold_uncertainty_score":0.4508566},"labels":[],"label_agreement":null},{"id":"W2756038537","doi":"10.1136/annrheumdis-2017-eular.1291","title":"AB0588 Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise; Hotel Dieu Hospital","funders":"","keywords":"Medicine; Malignancy; Internal medicine; Concomitant; Hairy cell leukemia; Cancer; Retrospective cohort study; Gastroenterology; Pathology; Leukemia","score_opus":0.015614662990354109,"score_gpt":0.28154041323692447,"score_spread":0.26592575024657034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756038537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994995,0.00090814824,0.000009397832,0.0021611187,0.00011990829,0.00079080305,0.00056317996,0.000010009988,0.0004424408],"genre_scores_gemma":[0.99919194,0.00034743408,0.000018762883,0.00008978404,0.000015704292,0.000026113901,0.000002440101,0.000010436336,0.00029738134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902135,0.00010347585,0.0003463297,0.00014013292,0.00024599416,0.00014270887],"domain_scores_gemma":[0.99848443,0.00011990741,0.0005891052,0.00048683462,0.00023169855,0.00008803059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020435546,0.00010509435,0.0004141112,0.00003476668,0.00021827527,0.00003248711,0.0001046757,0.00004726623,0.000085988875],"category_scores_gemma":[0.00064465555,0.00006873521,0.00019856208,0.0000318853,0.00010906038,0.000095056595,0.0000491389,0.00007918029,0.0000032110784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021255904,0.0028243142,0.98043156,0.00060556864,0.0026090008,0.00040805308,0.0031013049,0.000005319914,0.00047607132,0.0003037943,0.0028166436,0.00620579],"study_design_scores_gemma":[0.004202558,0.00032056108,0.99145955,0.0008597262,0.0009097181,0.00004868573,0.0009315658,0.00035320624,0.00024533528,0.0005931172,0.0000041343333,0.000071825634],"about_ca_topic_score_codex":0.00019918526,"about_ca_topic_score_gemma":0.000036991878,"teacher_disagreement_score":0.011027985,"about_ca_system_score_codex":0.000022396092,"about_ca_system_score_gemma":0.000040785606,"threshold_uncertainty_score":0.28029403},"labels":[],"label_agreement":null},{"id":"W2756136256","doi":"10.1136/annrheumdis-2017-eular.3777","title":"FRI0115 Ever-smoking is associated with disease severity and opioid use in rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Rheumatoid arthritis; Medicine; Disease; Opioid; Internal medicine; Receptor","score_opus":0.04138878654438099,"score_gpt":0.3012481063653005,"score_spread":0.25985931982091953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756136256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98472875,0.011362974,0.0000042150855,0.0028293189,0.0000770178,0.0005568848,0.00028375819,0.00003569052,0.00012136284],"genre_scores_gemma":[0.9453519,0.05398165,0.000027677788,0.00039615773,0.000010597664,0.000043893826,0.00001910693,0.000030956628,0.00013803405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979414,0.00015013092,0.00043166187,0.00031784733,0.0006949734,0.00046403555],"domain_scores_gemma":[0.99765253,0.0002811519,0.00037139302,0.001034742,0.00021200097,0.0004481615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000318999,0.000249814,0.00061245146,0.00011355404,0.00046204933,0.00025050325,0.00036722975,0.00005650614,0.00013753393],"category_scores_gemma":[0.0033724087,0.00017119395,0.00017519057,0.00012253883,0.00070240063,0.0006844353,0.00024997076,0.00019460738,0.000004920121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005960245,0.0005377347,0.9673093,0.00020403162,0.0003633666,0.00007859405,0.0006574802,0.0000042969473,0.000008381422,0.00025780156,0.0029051371,0.027077826],"study_design_scores_gemma":[0.0026118017,0.000100946454,0.9837438,0.009453883,0.0000137679635,0.000018675375,0.00014486251,0.0004024464,0.00015953924,0.0027454996,0.0004025961,0.00020218967],"about_ca_topic_score_codex":0.0007553505,"about_ca_topic_score_gemma":0.00029777846,"teacher_disagreement_score":0.042618677,"about_ca_system_score_codex":0.00002163655,"about_ca_system_score_gemma":0.0002527137,"threshold_uncertainty_score":0.6981087},"labels":[],"label_agreement":null},{"id":"W2756142879","doi":"10.1136/annrheumdis-2017-eular.6146","title":"THU0697 Feasibility and reliability of the sparcc sacroiliac joint structural score for children with spondyloarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"SSS*; Intraclass correlation; Medicine; Sacroiliac joint; Physical therapy; Ankylosis; Reliability (semiconductor); Orthodontics; Radiology; Internal medicine; Psychometrics","score_opus":0.05337870738402244,"score_gpt":0.31473995020993495,"score_spread":0.2613612428259125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756142879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926883,0.0025558588,0.0000015106197,0.002164007,0.00010283437,0.0015811905,0.0008230634,0.000010241039,0.00007298352],"genre_scores_gemma":[0.9991914,0.0004491129,0.0001269614,0.000080108395,0.000020139252,0.000041567888,0.000010592557,0.0000142135505,0.00006591046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988205,0.000052571813,0.000341331,0.00026012244,0.0003050416,0.00022045986],"domain_scores_gemma":[0.99778306,0.00009557554,0.00044719802,0.0013494988,0.00022507487,0.00009960577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001497973,0.0001832831,0.00053289905,0.000017045319,0.0005114142,0.000027330132,0.0002530364,0.00003423182,0.000026648093],"category_scores_gemma":[0.001202845,0.000086695356,0.00030117529,0.000048902548,0.0010280003,0.0001022133,0.00023561415,0.00006370512,4.302432e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004940728,0.00019372738,0.98794866,0.00036193713,0.00022800309,7.020586e-7,0.00013570474,0.0000027338394,0.000009704984,0.00014343123,0.0003639128,0.010117388],"study_design_scores_gemma":[0.0026625183,0.0003858002,0.9892311,0.0012982416,0.0002931385,0.000023980887,0.00007769638,0.000016135527,0.0011445585,0.0047693434,0.00001046931,0.00008702427],"about_ca_topic_score_codex":0.000355121,"about_ca_topic_score_gemma":0.00013676377,"teacher_disagreement_score":0.010030364,"about_ca_system_score_codex":0.000014373887,"about_ca_system_score_gemma":0.00008494045,"threshold_uncertainty_score":0.39334363},"labels":[],"label_agreement":null},{"id":"W2756145887","doi":"10.1136/annrheumdis-2017-eular.6921","title":"THU0695 The RA FLARE questionnaire (RA-FQ) is responsive to change in ra symptoms and impacts in clinical and observational trials","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Observational study; Medicine; Flare; Clinical trial; Internal medicine; Randomized controlled trial","score_opus":0.2603968844254673,"score_gpt":0.47151296405001086,"score_spread":0.21111607962454354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756145887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93968034,0.010363073,3.101571e-7,0.048633963,0.00012512045,0.0010124644,0.00014925709,0.000006042564,0.000029451627],"genre_scores_gemma":[0.99117774,0.0057483898,0.000013792621,0.002803464,0.00006264732,0.00011540149,0.0000068578647,0.000009882087,0.00006183443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844676,0.00031950066,0.0005854586,0.00020680802,0.0002497586,0.00019169583],"domain_scores_gemma":[0.9981042,0.00083126005,0.00031554778,0.00049160706,0.00011574957,0.00014163133],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010685544,0.00014755366,0.00062847324,0.000060624858,0.00020978169,0.000048516627,0.00015173118,0.000052629104,0.000025322322],"category_scores_gemma":[0.010996578,0.000079121215,0.00014066706,0.000088126784,0.00026923316,0.00014287257,0.0001986039,0.00008093183,0.000003881212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094725913,0.00023895939,0.9436378,0.00010213422,0.0001897874,0.000016427108,0.0015000463,3.8501912e-7,0.0000020127766,0.00029217987,0.0022857198,0.050787326],"study_design_scores_gemma":[0.0029431933,0.00025462772,0.99086374,0.0036197545,0.000107164095,0.000006129354,0.00026092996,0.000038865997,0.000018226634,0.001704744,0.000107675776,0.00007494522],"about_ca_topic_score_codex":0.00057123665,"about_ca_topic_score_gemma":0.0004058015,"teacher_disagreement_score":0.051497415,"about_ca_system_score_codex":0.00001324724,"about_ca_system_score_gemma":0.00009180556,"threshold_uncertainty_score":0.99733424},"labels":[],"label_agreement":null},{"id":"W2756159746","doi":"10.1136/annrheumdis-2017-eular.1639","title":"FRI0010 Metabolic dysregulation accelerates joint degeneration upon mechanically induced cartilage damage, driven by local inflammation; an in vivo rat study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Université de Montréal; Arthritis Society","keywords":"Osteoarthritis; Internal medicine; Medicine; Inflammation; Endocrinology; Cartilage; Immunostaining; Metabolic syndrome; Histopathology; Systemic inflammation; Pathology; Obesity; Immunohistochemistry; Anatomy","score_opus":0.04905098002720244,"score_gpt":0.3224195583502805,"score_spread":0.2733685783230781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756159746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743086,0.000112892754,0.00007766816,0.00064471405,0.00026147213,0.0013742766,0.000020436422,0.000036367615,0.000041298077],"genre_scores_gemma":[0.9994992,0.000036167174,0.00004912724,0.00009892399,0.00009540826,0.000110903435,0.000035698973,0.000029023027,0.000045571236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978792,0.00034824183,0.0006753979,0.00027848015,0.0005566168,0.0002620399],"domain_scores_gemma":[0.997912,0.000080133585,0.00056094676,0.0010327486,0.00020852398,0.00020565097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067044393,0.00023698193,0.000559977,0.00012834874,0.0003085053,0.00012155619,0.00033490264,0.00009694378,0.000091985086],"category_scores_gemma":[0.00090676354,0.00016815118,0.00017057662,0.0001283786,0.00007706164,0.0006339064,0.00012449893,0.00013031627,0.000009234262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001212941,0.0034056513,0.06463659,0.0008058297,0.00045119083,0.000046246834,0.0044108015,0.0022531739,0.85987854,0.0017139612,0.002049418,0.059135683],"study_design_scores_gemma":[0.0019024393,0.00041730632,0.28833458,0.0003627008,0.00023358718,0.0000018159798,0.00042504666,0.0132191675,0.6943292,0.00055316323,0.000018171175,0.00020281017],"about_ca_topic_score_codex":0.00015011495,"about_ca_topic_score_gemma":0.00043742385,"teacher_disagreement_score":0.22369798,"about_ca_system_score_codex":0.000026140713,"about_ca_system_score_gemma":0.00013582448,"threshold_uncertainty_score":0.6857006},"labels":[],"label_agreement":null},{"id":"W2756207122","doi":"10.1136/annrheumdis-2017-eular.1436","title":"SAT0115 Effect of biological disease modifying anti-rheumatic drugs (BDMARDS) on cardio vascular disease (CVD) risk in ra patients:three years results from a canadian cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Internal medicine; Cohort; Incidence (geometry); Prospective cohort study; Framingham Risk Score; Population; Disease; Cohort study","score_opus":0.025549563768472863,"score_gpt":0.2803023893263353,"score_spread":0.25475282555786244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756207122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139655,0.0027040208,0.0000060466864,0.0004698799,0.00024051669,0.0023794821,0.0026386606,0.000026087606,0.00013874265],"genre_scores_gemma":[0.99706197,0.0023092856,0.00001745471,0.00014699236,0.000059059214,0.00012154412,0.00023318201,0.00004133272,0.0000092038745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960022,0.0007634317,0.00089024485,0.0005876115,0.0011894874,0.00056700007],"domain_scores_gemma":[0.99429154,0.00041755574,0.000690007,0.0032356633,0.00017649216,0.0011887623],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015406936,0.00038041925,0.0014073092,0.00021076026,0.00029538228,0.000054181623,0.0006701272,0.000109098415,0.000029005136],"category_scores_gemma":[0.00901093,0.00024930062,0.0013757268,0.00017245908,0.00034958447,0.00013477437,0.00020029355,0.0002532899,0.00002136835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016018726,0.00043019745,0.94072974,0.0008907558,0.0011868934,0.000046716716,0.00018838324,0.00040048608,0.0000011316008,0.000021856256,0.00035205486,0.054149907],"study_design_scores_gemma":[0.0046681818,0.00022529911,0.9882069,0.0042017736,0.0009829028,2.931131e-7,0.000032143555,0.0007611294,0.000038022954,0.00058430905,0.000054500753,0.00024454054],"about_ca_topic_score_codex":0.15495665,"about_ca_topic_score_gemma":0.0019892443,"teacher_disagreement_score":0.15296741,"about_ca_system_score_codex":0.00011414289,"about_ca_system_score_gemma":0.0006034697,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W2756224343","doi":"10.1136/annrheumdis-2017-eular.6442","title":"AB0833 Bone mineral density in tunisian patients with autoimmune hepatitis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Osteopenia; Autoimmune hepatitis; Osteoporosis; Bone mineral; Femoral neck; Internal medicine; Gastroenterology; Azathioprine; Bone density; Cirrhosis; Hepatitis; Disease","score_opus":0.02257366206032637,"score_gpt":0.2753301377747013,"score_spread":0.25275647571437493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756224343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969881,0.0004217511,0.0000023977939,0.0014640399,0.00009185236,0.0004046107,0.000094992734,0.000016771182,0.00051549444],"genre_scores_gemma":[0.9989603,0.00023323164,0.000042944215,0.00030922395,0.000011776572,0.0000116049805,0.000037635687,0.000015884352,0.00037735762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887323,0.00008951962,0.00030169776,0.0001479934,0.00035870212,0.0002288434],"domain_scores_gemma":[0.9980616,0.000056092173,0.0003284746,0.0012244141,0.0001869065,0.00014250829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113496724,0.00015498583,0.00041174085,0.000055984656,0.00027994887,0.00004405351,0.0003403427,0.000032635413,0.000103927225],"category_scores_gemma":[0.00061061926,0.00009493216,0.00017952517,0.000072602605,0.00027533347,0.00022897456,0.00020301265,0.00011173384,0.000010265359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035786926,0.001030533,0.98804706,0.00025316302,0.00012713701,0.000010279869,0.00016422913,0.0000031689635,0.0000073327265,0.00009924827,0.0011468126,0.008753158],"study_design_scores_gemma":[0.0017898277,0.00018683178,0.99580413,0.0012879778,0.00015023383,0.0000022654383,0.000047008514,0.00015258169,0.00006263747,0.00036256658,0.00003811799,0.00011582901],"about_ca_topic_score_codex":0.0025526527,"about_ca_topic_score_gemma":0.00008180218,"teacher_disagreement_score":0.008637329,"about_ca_system_score_codex":0.000017052847,"about_ca_system_score_gemma":0.00011573082,"threshold_uncertainty_score":0.38712212},"labels":[],"label_agreement":null},{"id":"W2756230760","doi":"10.1136/annrheumdis-2017-eular.3219","title":"OP0265 Validation of a definition for attack (FLARE) in patients with established gout","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Odense Universitetshospital; University of Auckland; Parker Institute for Cancer Immunotherapy; Ironwood Pharmaceuticals, Incorporated; AstraZeneca; University of Alabama at Birmingham; Sjællands Universitetshospital; Fonterra Co-Operative Group; University of Otago; Pfizer","keywords":"Medicine; Gout; Flare; Internal medicine","score_opus":0.06949234921562124,"score_gpt":0.3230522887528289,"score_spread":0.2535599395372076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756230760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973769,0.00010119803,0.00006416111,0.0007699,0.00006548263,0.0008881717,0.00014317577,0.000010949547,0.0005800388],"genre_scores_gemma":[0.99912894,0.00003114658,0.0004917705,0.00010530442,0.000011643898,0.000050343704,0.000097443786,0.000018651283,0.00006475543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988587,0.000045402714,0.00038134112,0.00015539049,0.0003894415,0.00016973536],"domain_scores_gemma":[0.998036,0.0001623019,0.00061645533,0.0007961207,0.00031653733,0.000072562805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019363887,0.00012357312,0.0003696465,0.00007780301,0.00008806823,0.000026017113,0.00026106747,0.0000443238,0.000033095428],"category_scores_gemma":[0.0022644429,0.00007880465,0.00013086149,0.000088895686,0.0001297284,0.00026774924,0.00006789257,0.00004919531,0.0000034954621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011192976,0.0013512857,0.98447305,0.0015710826,0.0002491652,8.0515775e-7,0.00045219483,0.00006408558,0.00003440751,0.00020358144,0.0031479201,0.0073331455],"study_design_scores_gemma":[0.0029902065,0.00032057124,0.991574,0.0017954983,0.000285825,6.5535266e-7,0.00009087546,0.00019451168,0.001446116,0.0011652504,0.000041390882,0.000095110845],"about_ca_topic_score_codex":0.0001070255,"about_ca_topic_score_gemma":0.0000060501675,"teacher_disagreement_score":0.0072380346,"about_ca_system_score_codex":0.000016669095,"about_ca_system_score_gemma":0.00011119391,"threshold_uncertainty_score":0.32135606},"labels":[],"label_agreement":null},{"id":"W2756275983","doi":"10.1136/annrheumdis-2017-eular.3955","title":"AB0438 Rheumatoid arthritis drug therapy in the perioperative period of large joints arthroplasty, its impact on the long-term results of surgery","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"Pfizer","keywords":"Medicine; Rheumatoid arthritis; Leflunomide; Perioperative; Arthroplasty; Prednisone; Methotrexate; Arthritis; Surgery; Internal medicine; Osteoarthritis","score_opus":0.057066961526033445,"score_gpt":0.35763654730541566,"score_spread":0.3005695857793822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756275983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679552,0.019514624,8.197953e-7,0.010065014,0.00014725153,0.0011282467,0.00067637063,0.000012312095,0.0005002013],"genre_scores_gemma":[0.87310976,0.1264336,0.0000024366702,0.0002243866,0.000024322208,0.000071525865,0.000021838832,0.00002890614,0.00008325925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961467,0.0008071699,0.0010681434,0.00029667682,0.0011351091,0.0005462351],"domain_scores_gemma":[0.9950512,0.001578506,0.0009510622,0.0018399047,0.00042704144,0.0001522703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018871552,0.00035013125,0.0010497429,0.00016311358,0.0005246502,0.0001325151,0.00088196265,0.00006194699,0.00040136703],"category_scores_gemma":[0.0040283855,0.00015608389,0.0008054724,0.00021984296,0.0010376909,0.00029258095,0.00017753188,0.00028719,0.000019173898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013927154,0.009524157,0.70455384,0.0011517312,0.003044184,0.00014852446,0.038158692,0.000056894376,0.001269199,0.004328473,0.043572035,0.18026511],"study_design_scores_gemma":[0.0034822952,0.0005321543,0.97818184,0.007551812,0.0000067803803,0.000041781306,0.0015632998,0.000061636565,0.0078526195,0.00034217793,0.0001990683,0.00018454186],"about_ca_topic_score_codex":0.00029259248,"about_ca_topic_score_gemma":0.00018280902,"teacher_disagreement_score":0.273628,"about_ca_system_score_codex":0.000015158165,"about_ca_system_score_gemma":0.00043292023,"threshold_uncertainty_score":0.6364916},"labels":[],"label_agreement":null},{"id":"W2756291183","doi":"10.1136/annrheumdis-2017-eular.3681","title":"FRI0474 Does axial spondyloarthritis phenotype correlate with imaging morphotype?","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Pfizer","keywords":"Axial spondyloarthritis; Medicine; Sacroiliitis; Ankylosing spondylitis; Psoriasis; Radiography; Internal medicine; Radiology; Dermatology","score_opus":0.02050910820100078,"score_gpt":0.28750821880856525,"score_spread":0.2669991106075645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756291183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864947,0.004366811,0.0000064416745,0.0034491417,0.00038411756,0.00042940577,0.00017260054,0.000039673447,0.0046570944],"genre_scores_gemma":[0.9976117,0.0010338029,0.00009296131,0.00030697958,0.00004945678,0.000028923738,0.000013862403,0.00002887278,0.0008334203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880445,0.000031369727,0.0002641426,0.00022965996,0.0003695484,0.00030083425],"domain_scores_gemma":[0.99829733,0.00006951484,0.00033688662,0.0009886908,0.0001607479,0.00014681705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007617747,0.00020815333,0.00044676528,0.000040777057,0.00056835054,0.000066215005,0.00027800584,0.000027391936,0.00029084738],"category_scores_gemma":[0.00034496133,0.00010732004,0.00021787069,0.000059438058,0.00044649126,0.00016892221,0.00016859111,0.000083330786,0.000045902514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024640579,0.0013995316,0.7744076,0.00055800047,0.0017175039,0.0004586917,0.0007580478,0.000013046636,0.00008900554,0.0019292316,0.007123897,0.20908137],"study_design_scores_gemma":[0.003638618,0.0002506252,0.98888206,0.002587699,0.00045467698,0.000058308215,0.00030730054,0.000067673056,0.0004519671,0.0018008703,0.0013011855,0.00019901463],"about_ca_topic_score_codex":0.00041870872,"about_ca_topic_score_gemma":0.00007849022,"teacher_disagreement_score":0.21447445,"about_ca_system_score_codex":0.0000111410145,"about_ca_system_score_gemma":0.00007890612,"threshold_uncertainty_score":0.43763843},"labels":[],"label_agreement":null},{"id":"W2756322479","doi":"10.1136/annrheumdis-2017-eular.1576","title":"OP0201 A phase 3 study of the efficacy and safety of ixekizumab in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitor(s)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Psoriasis; Internal medicine; Adalimumab; Ixekizumab; Gastroenterology; Tumor necrosis factor alpha; Clinical endpoint; Surgery; Clinical trial; Immunology; Pathology; Secukinumab","score_opus":0.023090348047180503,"score_gpt":0.28203488290901696,"score_spread":0.25894453486183644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756322479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973819,0.00061999285,4.4677978e-7,0.0002390332,0.000113316884,0.0010735384,0.00056167966,0.0000041462918,0.00000593455],"genre_scores_gemma":[0.9997709,0.0001292523,0.000003831147,0.000013790503,0.0000024192836,0.000033351647,0.0000047586495,0.000009968686,0.000031750806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986755,0.000505337,0.00037091877,0.00019067476,0.00009031185,0.00016721894],"domain_scores_gemma":[0.9983752,0.00043096323,0.000518205,0.0005454237,0.00009417525,0.00003602728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016475887,0.00016855107,0.00046699203,0.000075062315,0.00022198375,0.0000142380695,0.00029370264,0.00004797314,0.00001541325],"category_scores_gemma":[0.00093936286,0.00009395704,0.00006625913,0.00009264501,0.00026299586,0.00011127767,0.00022135742,0.000055676428,0.0000013355801],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045239512,0.0067560747,0.1469686,0.00014135744,0.0011232271,0.0000015772514,0.011535168,0.00000925562,0.0011668277,0.000015634883,0.00009216891,0.7869506],"study_design_scores_gemma":[0.014105373,0.0017193607,0.97254324,0.00093068916,0.00016011986,6.296829e-7,0.00061024976,8.390545e-7,0.009770342,0.000055448134,0.0000060351886,0.000097696764],"about_ca_topic_score_codex":0.00026688096,"about_ca_topic_score_gemma":0.00008971714,"teacher_disagreement_score":0.82557464,"about_ca_system_score_codex":0.000009536087,"about_ca_system_score_gemma":0.00005889123,"threshold_uncertainty_score":0.3831457},"labels":[],"label_agreement":null},{"id":"W2756326039","doi":"10.1136/annrheumdis-2017-eular.5948","title":"OP0317-PARE An independent review of people with rheumatoid arthritis (RA) and their caregiver's lost work time","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"Medac; Servicio Gallego de Salud; Pfizer; Merck Sharp and Dohme; Assistance publique-Hôpitaux de Paris; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Indirect costs; Socioeconomic status; Health care; Work (physics); Family medicine; Gerontology; Environmental health; Economic growth; Population; Business; Immunology","score_opus":0.022758523046535167,"score_gpt":0.288967341869598,"score_spread":0.2662088188230628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756326039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7828128,0.21216562,0.0000062742965,0.0032491111,0.000048942176,0.0007616008,0.00019020084,0.000021510241,0.0007439491],"genre_scores_gemma":[0.6401882,0.35946605,0.000026848415,0.00013843058,0.000010632452,0.000024790148,0.000019785808,0.000021899385,0.000103330225],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99808526,0.00016738039,0.00047185097,0.00028332663,0.00061999116,0.00037218965],"domain_scores_gemma":[0.9971231,0.00015043629,0.00054389023,0.0014519036,0.00039410611,0.00033656272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040271628,0.00025785214,0.0009300399,0.00007061773,0.00030224197,0.00007690958,0.0005615097,0.00004745178,0.00043922226],"category_scores_gemma":[0.0007368335,0.00014947454,0.00021837557,0.00012599802,0.00064356485,0.00034006004,0.00024285838,0.00014172556,0.000020339636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023948543,0.00251579,0.2869198,0.022027483,0.0029170057,0.000052937965,0.006652568,0.000008133986,0.00019497435,0.0014598655,0.036577653,0.6382789],"study_design_scores_gemma":[0.0045794933,0.001516968,0.7324413,0.25142643,0.000059801285,0.00024685316,0.0022281974,0.00007818666,0.0022460632,0.0023600166,0.0022160548,0.00060062745],"about_ca_topic_score_codex":0.00024661302,"about_ca_topic_score_gemma":0.00008668778,"teacher_disagreement_score":0.6376783,"about_ca_system_score_codex":0.000009506864,"about_ca_system_score_gemma":0.00023755932,"threshold_uncertainty_score":0.60953945},"labels":[],"label_agreement":null},{"id":"W2756372715","doi":"10.1136/annrheumdis-2017-eular.1458","title":"SAT0462 Secukinumab provides sustained pasdas related low disease activity in psoriatic arthritis: 2 year results from the future 2 study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Secukinumab; Medicine; Dactylitis; Psoriatic arthritis; Placebo; Population; Internal medicine; Enthesitis; Disease; Alternative medicine; Pathology","score_opus":0.020718524693384966,"score_gpt":0.30519199468208696,"score_spread":0.284473469988702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756372715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710948,0.008212463,9.2386665e-7,0.017592369,0.00032025983,0.0020698349,0.0005066084,0.00004996975,0.00015279633],"genre_scores_gemma":[0.98865247,0.010694044,0.000009582426,0.00011857863,0.00013772474,0.00011901068,0.00003721908,0.00003632454,0.00019506042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997019,0.0006074294,0.00065767515,0.00042104727,0.0008070433,0.00048780747],"domain_scores_gemma":[0.9960364,0.00061329524,0.00055079075,0.0022560228,0.00021468507,0.00032880265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007135265,0.0002893371,0.0006266171,0.00008175664,0.00057325495,0.00022731189,0.00087059103,0.00006564108,0.0000992945],"category_scores_gemma":[0.005723849,0.0001661022,0.00032139366,0.00018745224,0.00047367116,0.00039993555,0.00033136076,0.0003377217,0.00002751886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025020763,0.0096472455,0.33040303,0.00090602506,0.002889027,0.00046056483,0.015001061,0.00010225247,0.000048254893,0.001610559,0.026238484,0.58767277],"study_design_scores_gemma":[0.008650917,0.00039577708,0.97206044,0.0034935148,0.000053192973,0.000002457254,0.005151359,0.00041878998,0.000053248306,0.0090713445,0.00043969523,0.0002092823],"about_ca_topic_score_codex":0.0012560157,"about_ca_topic_score_gemma":0.0007264542,"teacher_disagreement_score":0.6416574,"about_ca_system_score_codex":0.00004194969,"about_ca_system_score_gemma":0.0005490764,"threshold_uncertainty_score":0.68523955},"labels":[],"label_agreement":null},{"id":"W2756395113","doi":"10.1136/annrheumdis-2017-eular.4682","title":"OP0190 Histological characterization of rotator cuff calcific tendinopathy","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Shoulder Injury and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Pathology; Calcification; Von Kossa stain; Staining; Tendinopathy; Rotator cuff; H&E stain; Bone decalcification; Soft tissue; Histology; Immunohistochemistry; Cadaveric spasm; Anatomy; Tendon; Chemistry; Alkaline phosphatase","score_opus":0.0758957792779398,"score_gpt":0.3577849854324355,"score_spread":0.28188920615449564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756395113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633944,0.00035835983,0.000015529447,0.0018693487,0.0001737956,0.0003273235,0.0001147789,0.000016078353,0.0007853645],"genre_scores_gemma":[0.9991448,0.00020832043,0.00002848338,0.0001397074,0.000020214884,0.000024562542,0.000030431436,0.000008575452,0.00039489305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991762,0.00004511126,0.00029298177,0.00012684545,0.00023399545,0.00012486413],"domain_scores_gemma":[0.998598,0.00005021721,0.00043205864,0.0007327559,0.00009374833,0.0000932211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007952222,0.00010689268,0.0003390963,0.000034569952,0.00014080515,0.0000133385365,0.00022934454,0.00003794771,0.00014327033],"category_scores_gemma":[0.00048966595,0.00006123493,0.00020802756,0.000037068858,0.00022695883,0.00008557162,0.00007313345,0.00004066595,0.000011770192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002303344,0.00838395,0.7393595,0.0027833066,0.0017802493,0.00009270548,0.001169698,0.000005141644,0.021938382,0.011912924,0.005156788,0.205114],"study_design_scores_gemma":[0.00051133626,0.00021458331,0.95546085,0.00041685152,0.00033678306,0.000010388957,0.000034017467,0.00003399131,0.041669387,0.000990825,0.0002580932,0.00006292215],"about_ca_topic_score_codex":0.000027001524,"about_ca_topic_score_gemma":5.0876423e-7,"teacher_disagreement_score":0.21610132,"about_ca_system_score_codex":0.000009638729,"about_ca_system_score_gemma":0.00007553608,"threshold_uncertainty_score":0.2497088},"labels":[],"label_agreement":null},{"id":"W2756411158","doi":"10.1136/annrheumdis-2017-eular.2865","title":"OP0223 Abatacept in the treatment of active psoriatic arthritis: 1-year results from a phase iii study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Abatacept; Internal medicine; Psoriatic arthritis; Population; Clinical endpoint; Placebo; Psoriasis Area and Severity Index; Psoriasis; Gastroenterology; Rheumatoid arthritis; Randomized controlled trial; Rituximab; Immunology; Lymphoma","score_opus":0.07425897810562103,"score_gpt":0.39155831659763984,"score_spread":0.3172993384920188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756411158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931551,0.0023007258,0.000001191876,0.0016982855,0.00006049197,0.001558649,0.00042302077,0.000008218815,0.00079430075],"genre_scores_gemma":[0.9963424,0.0032547351,0.0000077133855,0.00004287999,0.000023430157,0.00011162771,0.00003713674,0.000012128867,0.00016791318],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981533,0.00024529334,0.000643339,0.00019800405,0.0005481152,0.00021193488],"domain_scores_gemma":[0.99736786,0.00035469217,0.00052337564,0.0015814462,0.000109285655,0.000063338506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032296102,0.00015627938,0.00060122827,0.000070397065,0.00019636429,0.000037334867,0.0005457791,0.000033099757,0.0001145786],"category_scores_gemma":[0.0012546557,0.00008288548,0.00023599189,0.000099141296,0.00025535116,0.00015586292,0.00008135157,0.000080791244,0.000013595307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010606493,0.03137053,0.0136189945,0.00018956352,0.0016948007,0.000066024186,0.053644404,0.00001794746,0.000051373892,0.00014428847,0.0040557757,0.8845398],"study_design_scores_gemma":[0.04247612,0.0034690215,0.9110136,0.0016256439,0.00031140074,0.0000015062619,0.036960628,0.00024633188,0.0013226022,0.0018235411,0.0005882416,0.00016133279],"about_ca_topic_score_codex":0.0019606757,"about_ca_topic_score_gemma":0.00013333751,"teacher_disagreement_score":0.89739466,"about_ca_system_score_codex":0.000017089345,"about_ca_system_score_gemma":0.00018633461,"threshold_uncertainty_score":0.3379972},"labels":[],"label_agreement":null},{"id":"W2756411629","doi":"10.1136/annrheumdis-2017-eular.2563","title":"OP0072-PARE Pregnancy and parenting with arthritis – developing an educational resource for patient by patients","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Medicine; Pregnancy; Resource (disambiguation); Arthritis; Educational resources; Obstetrics; Immunology; Pediatrics; Computer science; Pedagogy","score_opus":0.03902738169866258,"score_gpt":0.3296495225587171,"score_spread":0.2906221408600545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756411629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872371,0.0052213245,0.00009816774,0.006030941,0.0000774253,0.0008072311,0.00023718215,0.00001426504,0.00027637702],"genre_scores_gemma":[0.9982106,0.0004924954,0.0004039621,0.00047945604,0.000015950385,0.00011967462,0.00013623046,0.000014093212,0.00012754792],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991031,0.00003251516,0.00025634197,0.00016836096,0.00026166928,0.00017798007],"domain_scores_gemma":[0.9986199,0.00010781076,0.00042712718,0.0004796792,0.0001900395,0.00017540842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006899274,0.00011034715,0.00020629667,0.000027516855,0.0003810862,0.000041617557,0.00017265423,0.000025276075,0.000017162194],"category_scores_gemma":[0.0014012103,0.00007133342,0.000054508142,0.000030280366,0.0001581184,0.00021540123,0.000059739195,0.00003679474,6.349903e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017882095,0.00078743085,0.30578274,0.0011921792,0.00017832434,4.5333624e-7,0.0013829117,0.000002042028,0.000008209382,0.0005596665,0.016400684,0.6735265],"study_design_scores_gemma":[0.0016888031,0.0003892876,0.9657053,0.027419502,0.00010009018,0.0000051529914,0.0003702716,0.00006105511,0.00093894615,0.0013404754,0.0018127261,0.0001684165],"about_ca_topic_score_codex":0.000017301041,"about_ca_topic_score_gemma":0.0000045859224,"teacher_disagreement_score":0.67335814,"about_ca_system_score_codex":0.000008938062,"about_ca_system_score_gemma":0.00020778344,"threshold_uncertainty_score":0.29310453},"labels":[],"label_agreement":null},{"id":"W2756415381","doi":"10.1136/annrheumdis-2017-eular.4717","title":"OP0296 Autoimmune associated gene PTPN22 negatively regulates DECTIN-1 signalling in dendritic cells","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Menzies Centre for Australian Studies, King's College London, University of London; Canadian Institutes of Health Research; Eli Lilly and Company; University of Washington; King's College London; Seattle Children's Research Institute; Research Manitoba","keywords":"Syk; Curdlan; Biology; PTPN22; Cytokine; Molecular biology; Cell biology; Immunology; Tyrosine kinase; Signal transduction; Biochemistry","score_opus":0.03543727729891408,"score_gpt":0.2858609821917909,"score_spread":0.2504237048928768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756415381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917655,0.006159786,0.0000074634027,0.00077444274,0.0006452526,0.00023587172,0.00009786512,0.000029034984,0.00028475813],"genre_scores_gemma":[0.99808294,0.0005363871,0.000016137714,0.00013733983,0.000009091739,0.000025867457,0.000023203906,0.000016489907,0.0011525257],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846756,0.00034860187,0.00046665367,0.00024833303,0.00005653318,0.00041231918],"domain_scores_gemma":[0.9983142,0.00033463436,0.0006101708,0.00059172255,0.00012239562,0.000026855676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033164132,0.00019291387,0.00048401416,0.00007154259,0.00047445524,0.00003825315,0.0008186908,0.00015405963,0.0002397744],"category_scores_gemma":[0.0009790484,0.00014015727,0.00022528942,0.000091907095,0.00047027244,0.0001066727,0.00023283374,0.00017840955,0.000043261847],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057144166,0.0018726318,0.08288272,0.0003194457,0.0022434066,0.000015862664,0.0019269539,0.0005802652,0.85613406,0.0012801144,0.005745026,0.046428047],"study_design_scores_gemma":[0.0010296383,0.00011905165,0.6170612,0.0005223273,0.00008127931,0.0000062992517,0.00017680823,0.000049994058,0.37560898,0.0049906014,0.00014209472,0.00021172076],"about_ca_topic_score_codex":0.0008524321,"about_ca_topic_score_gemma":0.00014457047,"teacher_disagreement_score":0.5341785,"about_ca_system_score_codex":0.000024196803,"about_ca_system_score_gemma":0.00011208622,"threshold_uncertainty_score":0.57154477},"labels":[],"label_agreement":null},{"id":"W2756418051","doi":"10.1136/annrheumdis-2018-eular.4605","title":"AB0571 Factors related to alexithymia in systemic lupus erythematosus","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Medicine; Mood; Anxiety; Mood disorders; Quality of life (healthcare); Internal medicine; Lupus erythematosus; Systemic lupus erythematosus; Psychiatry; Disease; Immunology; Antibody","score_opus":0.04052069515090549,"score_gpt":0.3330223353919502,"score_spread":0.2925016402410447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756418051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951259,0.0014453839,0.000003985556,0.0015776663,0.00023848328,0.00069197046,0.000024319625,0.000039765353,0.0008525427],"genre_scores_gemma":[0.9979723,0.00012107801,0.000025782861,0.000032945543,0.000007427072,0.000025697589,0.000008633496,0.000026964755,0.001779189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981487,0.00012031991,0.00052403985,0.00023296398,0.00056226784,0.0004117336],"domain_scores_gemma":[0.9985572,0.00017565797,0.00012935675,0.00072449975,0.00015109785,0.000262164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024356543,0.00017678042,0.00047574763,0.00019806794,0.000068219735,0.00001596951,0.00033936137,0.00007311222,0.00046084478],"category_scores_gemma":[0.000770039,0.00010915793,0.00020993614,0.00061728415,0.00023824883,0.00006910841,0.00013855609,0.0001245255,0.00019480457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075739826,0.0012984198,0.9156257,0.02019213,0.00089324807,0.00006145083,0.008186299,0.00007314721,0.0014869595,0.0026902312,0.04485255,0.0038824684],"study_design_scores_gemma":[0.0023491343,0.0011184153,0.9452084,0.038002547,0.00012881953,0.0005221535,0.0025594353,0.00065517216,0.0054324334,0.0035453113,0.00010260427,0.00037563097],"about_ca_topic_score_codex":0.00012313809,"about_ca_topic_score_gemma":0.000003766459,"teacher_disagreement_score":0.044749945,"about_ca_system_score_codex":0.00005503734,"about_ca_system_score_gemma":0.0002567938,"threshold_uncertainty_score":0.5045927},"labels":[],"label_agreement":null},{"id":"W2756423462","doi":"10.1136/annrheumdis-2017-eular.1930","title":"THU0089 M-DAS28, DAS28 (CRP) and RAPID3 scores at baseline are good predictors of radiographic disease progression at 1 and 2 years: data from the ample trial","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); University of Toronto","funders":"","keywords":"Adalimumab; Medicine; Internal medicine; Logistic regression; Abatacept; Post-hoc analysis; Radiography; Randomized controlled trial; Rheumatoid arthritis; Surgery","score_opus":0.43409638846583687,"score_gpt":0.4464728565880018,"score_spread":0.012376468122164919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756423462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94076353,0.031763792,0.000013546818,0.014847143,0.00039346018,0.0010994415,0.011066268,0.000017364919,0.000035468413],"genre_scores_gemma":[0.9938612,0.004744305,0.000061734376,0.00072525855,0.00018487181,0.00004584817,0.0002834639,0.000027547992,0.00006574969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966165,0.00047511113,0.0019328712,0.0005200639,0.00020332108,0.000252147],"domain_scores_gemma":[0.991312,0.001887586,0.003956193,0.0025164692,0.000052136696,0.00027560652],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004593228,0.00020050161,0.0008527297,0.000095954325,0.00059148966,0.00013284963,0.0011778784,0.000066505294,0.00018950853],"category_scores_gemma":[0.011303554,0.00015058309,0.00017458954,0.00007241943,0.0006410195,0.0004979483,0.0010438841,0.00007605317,0.00002145007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013198155,0.00026615348,0.9368362,0.00063020136,0.00034164893,6.641428e-7,0.0005484289,0.000011455607,6.311425e-7,0.00080934813,0.057900928,0.0013345493],"study_design_scores_gemma":[0.00412671,0.000069501606,0.9810464,0.0011223664,0.00010039314,6.4694547e-7,0.00020317292,0.0023808912,0.0000040725986,0.0072565232,0.0035072681,0.00018209047],"about_ca_topic_score_codex":0.00080515735,"about_ca_topic_score_gemma":0.00022722779,"teacher_disagreement_score":0.05439366,"about_ca_system_score_codex":0.000026514459,"about_ca_system_score_gemma":0.00007457155,"threshold_uncertainty_score":0.99702466},"labels":[],"label_agreement":null},{"id":"W2756446998","doi":"10.1136/annrheumdis-2017-eular.2344","title":"AB1226-HPR Vaccination compliance in autoimmune inflammatory rheumatic diseases (AIRDS): role of specialist nurse","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine and Dentistry, University of Alberta; Institute of Psychology, Chinese Academy of Sciences; University of Leeds; Pfizer","keywords":"Medicine; Vaccination; Rheumatoid arthritis; Rheumatology; Spondyloarthropathy; Population; Internal medicine; Disease; Quality of life (healthcare); Physical therapy; Immunology; Nursing","score_opus":0.035793869763311524,"score_gpt":0.33807651649528975,"score_spread":0.30228264673197824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756446998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97372806,0.02005555,0.000006765219,0.0023812305,0.00023687971,0.00091980596,0.0001554652,0.000044976212,0.002471286],"genre_scores_gemma":[0.9901873,0.009304038,0.000043219625,0.00005990934,0.00003878695,0.000072258874,0.000028056525,0.00003552576,0.00023092139],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973332,0.00019731936,0.00093955384,0.00027115806,0.0008243005,0.00043441085],"domain_scores_gemma":[0.99672085,0.00026524955,0.00088425446,0.0015618156,0.00033603236,0.00023177797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034525717,0.00026905723,0.00084857165,0.000205859,0.00031815708,0.000092983304,0.0008734076,0.000063941545,0.00040067235],"category_scores_gemma":[0.0024983315,0.00020225151,0.00038290062,0.00016668566,0.000552693,0.00048120716,0.00019119997,0.00016094733,0.000038337253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014449329,0.0032652533,0.42416865,0.004072412,0.0007293176,0.000028248289,0.0020775122,0.000093913906,0.0007331916,0.0104090925,0.005345567,0.5476319],"study_design_scores_gemma":[0.002151297,0.00013417273,0.9753707,0.0069943597,0.000030741165,0.000007836612,0.00062580657,0.0013541878,0.0012196272,0.011552031,0.0003721541,0.00018706097],"about_ca_topic_score_codex":0.00038133626,"about_ca_topic_score_gemma":0.00010826381,"teacher_disagreement_score":0.55120206,"about_ca_system_score_codex":0.000039193117,"about_ca_system_score_gemma":0.00030655874,"threshold_uncertainty_score":0.8247577},"labels":[],"label_agreement":null},{"id":"W2756448545","doi":"10.1136/annrheumdis-2017-eular.5246","title":"THU0615 Participants' experience of the making it work program, an online program to help people with inflammatory arthritis remain employed","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Research Canada","funders":"Merck Sharp and Dohme","keywords":"Session (web analytics); Vocational education; Descriptive statistics; Scale (ratio); Work (physics); Medicine; Sample (material); Medical education; Family medicine; Psychology; Physical therapy; Computer science; World Wide Web; Engineering; Pedagogy","score_opus":0.15553513972316807,"score_gpt":0.4390923439866442,"score_spread":0.28355720426347614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756448545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703978,0.00040120285,0.0000096242675,0.025689535,0.00014614356,0.0031266534,0.000059267008,0.00007469609,0.000095104064],"genre_scores_gemma":[0.9974831,0.00008288099,0.0005522059,0.0011187831,0.00007668852,0.0005443847,0.000006816749,0.00003284703,0.000102324244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717426,0.00033972537,0.00083244813,0.00029055038,0.00075361656,0.00060937915],"domain_scores_gemma":[0.9962983,0.00009967577,0.00076514843,0.0019581048,0.00039175304,0.00048699562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007601944,0.00021322709,0.0006535715,0.000054889442,0.00041775295,0.00008665966,0.0007013653,0.00006883294,0.000034188466],"category_scores_gemma":[0.0017855846,0.00011276611,0.0001767841,0.0003148585,0.0003204389,0.00020381976,0.00019367006,0.00015214705,0.0000029777666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028258708,0.001408976,0.5532057,0.0017566456,0.00010249667,0.0000063700527,0.009526633,0.000012279377,0.00000592637,0.00017679704,0.0017150055,0.43180054],"study_design_scores_gemma":[0.00054143765,0.0008898531,0.97942406,0.012586271,0.000042702748,0.000012178343,0.003352665,0.000119127915,0.00006219333,0.00010351057,0.002715884,0.00015011134],"about_ca_topic_score_codex":0.0009154162,"about_ca_topic_score_gemma":0.0027453504,"teacher_disagreement_score":0.43165043,"about_ca_system_score_codex":0.000022176526,"about_ca_system_score_gemma":0.00097176875,"threshold_uncertainty_score":0.45984685},"labels":[],"label_agreement":null},{"id":"W2756450767","doi":"10.1136/annrheumdis-2017-eular.5855","title":"AB0829 Bone metabolism in liver transplant patients two-year study. influence of medical intervention prior to surgery and antiresorptive treatment","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Osteoporosis; Bone remodeling; Liver transplantation; Internal medicine; Vitamin D and neurology; Surgery; Cohort; Transplantation","score_opus":0.05406195634054952,"score_gpt":0.37294830739343465,"score_spread":0.31888635105288515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756450767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784434,0.000687331,5.9353334e-7,0.00062428106,0.000032618464,0.0007180711,0.00006351084,0.000004260181,0.000024984765],"genre_scores_gemma":[0.9982989,0.00156597,0.000004886006,0.00003761889,0.0000074732748,0.000029849769,0.000005170839,0.000008016519,0.000042154308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984181,0.00013876549,0.0004202783,0.0001623936,0.0006914141,0.00016907514],"domain_scores_gemma":[0.9989028,0.00018654036,0.00018403615,0.00042158936,0.00013285191,0.00017219392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004423032,0.000112498485,0.00048574645,0.00014843588,0.000063568186,0.000018720217,0.00019909955,0.00003186827,0.00004385791],"category_scores_gemma":[0.0010650847,0.00006688363,0.00016159813,0.000085424836,0.00016114183,0.00011988632,0.00012035175,0.000057016106,0.000004454525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008892634,0.0043434436,0.90396285,0.00047503773,0.00031040492,0.000036442205,0.00200641,0.0000040426758,0.00003590791,0.00003095449,0.00011166618,0.08779356],"study_design_scores_gemma":[0.0021991218,0.00046877714,0.99365306,0.0023962783,0.00013025782,0.0000016916955,0.00025748392,0.00007893489,0.0007159306,0.00003085093,0.000009073559,0.00005852489],"about_ca_topic_score_codex":0.0025651802,"about_ca_topic_score_gemma":0.00020813735,"teacher_disagreement_score":0.0896902,"about_ca_system_score_codex":0.0000111600075,"about_ca_system_score_gemma":0.000085284184,"threshold_uncertainty_score":0.38778022},"labels":[],"label_agreement":null},{"id":"W2756472435","doi":"10.1136/annrheumdis-2017-eular.3942","title":"THU0144 Cognitive function of patients with rheumatoid arthritis is associated with disease activity but not carotid atherosclerotic changes","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cognition; Rheumatoid arthritis; Internal medicine; Verbal fluency test; Erythrocyte sedimentation rate; Recall; Verbal memory; Cardiology; Neuropsychology; Montreal Cognitive Assessment; Intima-media thickness; Disease; Audiology; Cognitive impairment; Carotid arteries; Psychiatry; Psychology","score_opus":0.03723251945310472,"score_gpt":0.29421483573930923,"score_spread":0.2569823162862045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756472435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959361,0.00018901197,0.000034073953,0.0011247937,0.00005081805,0.0014016052,0.0009846188,0.00002506382,0.0002539103],"genre_scores_gemma":[0.99860877,0.00054790254,0.0000034631676,0.00029061624,0.000010628042,0.00012469008,0.00006402348,0.000033021963,0.00031690436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782443,0.00016261847,0.00024640927,0.0002957478,0.0011140255,0.00035677906],"domain_scores_gemma":[0.99717164,0.00021961353,0.00071442255,0.0006286007,0.0009827777,0.00028292873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002054257,0.00024688418,0.00054021797,0.00008858375,0.00034218718,0.000058503883,0.00024190098,0.000041728996,0.0002599696],"category_scores_gemma":[0.0012231718,0.00014820868,0.00018088262,0.0001276161,0.00064544566,0.00026369005,0.00014210917,0.0001189441,0.0000080453965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050837146,0.0024259433,0.9651361,0.0004368772,0.0013121959,0.0000040832615,0.00016691582,8.4303826e-7,0.00006195853,0.000014419005,0.00025477173,0.025102155],"study_design_scores_gemma":[0.004652901,0.001664688,0.97915894,0.0071714795,0.0004751526,5.383823e-7,0.00015951555,0.00003219329,0.006415884,0.00009803571,0.0000042508395,0.0001664528],"about_ca_topic_score_codex":0.00011456741,"about_ca_topic_score_gemma":0.000048410537,"teacher_disagreement_score":0.024935702,"about_ca_system_score_codex":0.000017577484,"about_ca_system_score_gemma":0.0002255931,"threshold_uncertainty_score":0.60437745},"labels":[],"label_agreement":null},{"id":"W2758393126","doi":"10.1136/annrheumdis-2017-212008","title":"Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer; Eli Lilly and Company","keywords":"Medicine; Etanercept; Sacroiliac joint; Internal medicine; Clinical endpoint; Cohort; Surgery; Randomized controlled trial; Rheumatoid arthritis","score_opus":0.09713218596847482,"score_gpt":0.3593486250072924,"score_spread":0.2622164390388176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758393126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833397,0.010017024,2.5835956e-7,0.0008045843,0.0002655515,0.0051808227,0.00031645634,0.000005935368,0.00006962252],"genre_scores_gemma":[0.99762183,0.0015047127,0.000010972019,0.00028224426,0.000029852792,0.0005074766,0.00002093197,0.00001793331,0.0000040527475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967455,0.00084250985,0.0009949364,0.0002577146,0.00090406596,0.00025527022],"domain_scores_gemma":[0.998455,0.00016291026,0.0004162381,0.00056985306,0.00031584347,0.000080166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012128094,0.00020455029,0.0009928076,0.00028764896,0.000033619228,0.000008317977,0.0001841551,0.000065893466,0.00016586576],"category_scores_gemma":[0.00071547984,0.00013692696,0.0002718866,0.0007198119,0.0003720163,0.00008078649,0.000068002984,0.00010743877,0.0000016216852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014905172,0.0008373687,0.9487916,0.0000667173,0.00035226753,0.000009704801,0.002114882,0.000014905315,0.000051790925,0.000009431399,0.00018232837,0.03266379],"study_design_scores_gemma":[0.033206236,0.00089645013,0.9625164,0.0018953236,0.0001635324,0.0000027901083,0.0002768136,0.0003475168,0.00025703805,0.00030899182,0.000020756062,0.00010813347],"about_ca_topic_score_codex":0.002321856,"about_ca_topic_score_gemma":0.002372791,"teacher_disagreement_score":0.032555655,"about_ca_system_score_codex":0.000065192966,"about_ca_system_score_gemma":0.00020637168,"threshold_uncertainty_score":0.5583719},"labels":[],"label_agreement":null},{"id":"W2758911649","doi":"10.1136/annrheumdis-2017-211605","title":"Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Sanofi; Pfizer; Eli Lilly and Company; Amgen","keywords":"Etanercept; Medicine; Placebo; SSS*; Internal medicine; Axial spondyloarthritis; Sacroiliac joint; Randomized controlled trial; Magnetic resonance imaging; Surgery; Ankylosing spondylitis; Rheumatoid arthritis; Radiology; Pathology; Sacroiliitis","score_opus":0.028483508278267587,"score_gpt":0.2917734727078707,"score_spread":0.2632899644296031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758911649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992354,0.00048350834,5.595334e-7,0.0008876353,0.0002563275,0.007966616,0.0002740178,0.000004816585,0.00020296597],"genre_scores_gemma":[0.9990195,0.00034767136,0.000008244997,0.000061822546,0.000022472632,0.0004541298,0.000028514478,0.000017634004,0.00003999552],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99741685,0.0004553457,0.00089692,0.00023896762,0.00073896284,0.0002529446],"domain_scores_gemma":[0.9970792,0.0005634037,0.0010791101,0.0010861269,0.00012905081,0.00006312459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047121558,0.0002499658,0.0011005626,0.00012840315,0.00026142798,0.000025400903,0.0004901805,0.00006407169,0.000032103468],"category_scores_gemma":[0.0013961009,0.00011319865,0.00057651935,0.00019801896,0.00047139218,0.00009288974,0.00006451207,0.00013618336,8.292788e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95437723,0.0026542956,0.03610782,0.000095857235,0.00045609992,0.000002360018,0.0009355238,0.000034247343,0.000017469367,0.000037663725,0.0005945963,0.0046868566],"study_design_scores_gemma":[0.55642325,0.0014433344,0.44026926,0.0010395136,0.00023710975,5.719784e-7,0.00020206906,0.000047906622,0.00006170965,0.00020312276,0.0000022542038,0.00006992034],"about_ca_topic_score_codex":0.00039029212,"about_ca_topic_score_gemma":0.00018221523,"teacher_disagreement_score":0.40416142,"about_ca_system_score_codex":0.000017711824,"about_ca_system_score_gemma":0.000098757766,"threshold_uncertainty_score":0.46161067},"labels":[],"label_agreement":null},{"id":"W2763284518","doi":"10.1136/ard.2009.123976","title":"Evidence for treating rheumatoid arthritis to target: results of a systematic literature search","year":2010,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; MEDLINE; Rheumatoid arthritis; Clinical trial; Randomized controlled trial; Systematic review; Meta-analysis; Physical therapy; Internal medicine; Intensive care medicine","score_opus":0.13576789892394112,"score_gpt":0.41191866390644,"score_spread":0.2761507649824989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763284518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003982585,0.98789597,0.000050119103,0.00056971365,0.00023155897,0.008249533,0.0024721392,0.00004254126,0.000090154645],"genre_scores_gemma":[0.0013973382,0.99562013,0.0010021633,0.00005189458,0.00007237683,0.0012743108,0.00015846177,0.000102003185,0.00032132733],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9928739,0.0012296033,0.0033788707,0.00057010556,0.0012756733,0.00067182805],"domain_scores_gemma":[0.9868507,0.007786791,0.0017454983,0.001913329,0.0011663303,0.0005373661],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034447974,0.0006312467,0.006195766,0.0005484554,0.00019074028,0.00014092641,0.0010134645,0.00028533736,0.000052553678],"category_scores_gemma":[0.045586888,0.00035681104,0.002849594,0.0009575886,0.0002929077,0.00019914412,0.0002620693,0.000522995,0.00002475752],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000259246,0.0002357793,0.000006981188,0.48076883,0.0008126645,0.000008577482,0.00069509237,0.0000017587323,0.000003533055,0.00023022247,0.0025938759,0.51438344],"study_design_scores_gemma":[0.00081034936,0.00048384318,0.000023072247,0.9614664,0.00018413036,0.0001755108,0.00013309794,0.000041506722,0.000091820955,0.0003015458,0.035996623,0.0002921306],"about_ca_topic_score_codex":0.000043950848,"about_ca_topic_score_gemma":0.000010518215,"teacher_disagreement_score":0.5140913,"about_ca_system_score_codex":0.000030916268,"about_ca_system_score_gemma":0.0010356072,"threshold_uncertainty_score":0.99988836},"labels":[],"label_agreement":null},{"id":"W2763480891","doi":"10.1136/annrheumdis-2017-211904","title":"Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Executive Agency for Health and Consumers; Medical Research Council; Versus Arthritis","keywords":"Medicine; Biobank; Rheumatology; Family medicine; Internal medicine; Bioinformatics","score_opus":0.7683604048975122,"score_gpt":0.6184038125079957,"score_spread":0.14995659238951653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763480891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049106864,0.9758491,0.000034666038,0.006742706,0.0007488787,0.011407111,0.0043790727,0.000034009077,0.0003134232],"genre_scores_gemma":[0.0050742542,0.9910476,0.00013330596,0.00021756973,0.0002235894,0.002577586,0.0005197339,0.00011336352,0.00009299618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98901,0.006080336,0.0025972591,0.00072161347,0.0004223179,0.0011685026],"domain_scores_gemma":[0.97445846,0.018935733,0.002946661,0.00077623175,0.0026276486,0.00025528652],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0049619144,0.0005146934,0.0024458473,0.0015763941,0.0015964492,0.00010023773,0.0013847434,0.00043456798,0.00003782637],"category_scores_gemma":[0.041517165,0.00038101227,0.00027375322,0.0038673673,0.00022992506,0.00047592117,0.0014691498,0.0011397783,0.000014292723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020925874,0.0005665423,0.018040646,0.1651554,0.00016669986,0.000004520869,0.00498172,0.0000026522614,1.5154077e-8,0.0013417946,0.07424935,0.7352814],"study_design_scores_gemma":[0.0027451,0.00040019138,0.005589706,0.122849114,0.0005668634,0.0000033806655,0.0034985635,0.00011327377,2.4420245e-7,0.006177146,0.85712385,0.00093255],"about_ca_topic_score_codex":0.00024505923,"about_ca_topic_score_gemma":0.0005229167,"teacher_disagreement_score":0.7828745,"about_ca_system_score_codex":0.00020288347,"about_ca_system_score_gemma":0.0049875835,"threshold_uncertainty_score":0.99986416},"labels":[],"label_agreement":null},{"id":"W2765743865","doi":"10.1136/annrheumdis-2017-211468","title":"2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1525,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Izaak Walton Killam Health Centre; Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; European League Against Rheumatism; National Institute for Health and Care Research; Medical Research Council; Myositis Association; Versus Arthritis; Horizon Pharmaceuticals","keywords":"Medicine; Rheumatology; Rheumatism; Internal medicine; Biopsy; Juvenile dermatomyositis; Neurology; Physical therapy; Dermatology; Dermatomyositis","score_opus":0.03240055367031087,"score_gpt":0.295328204138496,"score_spread":0.2629276504681851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765743865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148285,0.0025702615,0.00010947399,0.0036007909,0.00020511202,0.00088685995,0.00076199067,0.00004374886,0.0003389228],"genre_scores_gemma":[0.9956881,0.0035734358,0.00019599657,0.00032526927,0.000024104043,0.00007499106,0.000024011179,0.000048714046,0.000045413904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977634,0.0003214763,0.0010212028,0.0003357857,0.00023025252,0.00032789528],"domain_scores_gemma":[0.996138,0.00029723532,0.0016494455,0.0011455832,0.0005635705,0.00020621768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007642552,0.0003187966,0.0010738033,0.00013381867,0.0006143664,0.000060436938,0.00041468284,0.00007716105,0.0000062262816],"category_scores_gemma":[0.0022876817,0.00022514253,0.0002470244,0.00006782387,0.0016088106,0.00028279447,0.00026730838,0.00012421128,0.0000032026867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033396212,0.0012100887,0.64965177,0.040785544,0.0018720286,0.00009104883,0.011065312,0.000008242485,0.011526169,0.05442092,0.037099775,0.18892951],"study_design_scores_gemma":[0.0022198535,0.00033426017,0.97917986,0.006301261,0.00019607728,0.0002265145,0.0033520965,0.0027570538,0.0024412028,0.0023390248,0.0003064551,0.00034635072],"about_ca_topic_score_codex":0.00007642649,"about_ca_topic_score_gemma":0.00002439791,"teacher_disagreement_score":0.32952812,"about_ca_system_score_codex":0.00001112123,"about_ca_system_score_gemma":0.00013618056,"threshold_uncertainty_score":0.9181046},"labels":[],"label_agreement":null},{"id":"W2765960457","doi":"10.1136/annrheumdis-2017-212141","title":"Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; National Institutes of Health; Versus Arthritis; Arthritis Research UK; National Institute for Health and Care Research; Wellcome Trust","keywords":"Juvenile dermatomyositis; Medicine; Delphi method; Dermatomyositis; Nominal group technique; MEDLINE; Family medicine; Artificial intelligence; Pathology; Computer science","score_opus":0.47718695279173634,"score_gpt":0.5300368338420174,"score_spread":0.052849881050281045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765960457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939842,0.00015275838,0.0000110175915,0.0028081038,0.000113415015,0.0010930778,0.0017249655,0.000008365517,0.00010405692],"genre_scores_gemma":[0.99629676,0.000094504554,0.0025768834,0.00064382126,0.000019435724,0.00009913146,0.00017479502,0.00001624047,0.00007839735],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99783325,0.00007677927,0.0010906837,0.00017482473,0.0004971841,0.00032726052],"domain_scores_gemma":[0.99687856,0.0008045159,0.00041660867,0.001138239,0.000538896,0.00022319108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012393304,0.00012532162,0.0005670974,0.00013833243,0.0002919644,0.00004775641,0.00045701623,0.00006665371,0.000027240096],"category_scores_gemma":[0.0060979505,0.00008979614,0.0001518106,0.00014066095,0.000366038,0.00012080441,0.00039329464,0.000120298966,0.000016987398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001874466,0.0010599681,0.34222844,0.0041387468,0.00038354006,0.000081788945,0.0030467352,0.000009726785,0.000082719744,0.0019631595,0.5736333,0.07149741],"study_design_scores_gemma":[0.0018232372,0.00013511848,0.94093066,0.0031360427,0.00005219932,0.000026488286,0.00049128884,0.00028144187,0.0021515018,0.00045105667,0.050376102,0.00014486679],"about_ca_topic_score_codex":0.00009223476,"about_ca_topic_score_gemma":0.00006339635,"teacher_disagreement_score":0.5987022,"about_ca_system_score_codex":0.000018327126,"about_ca_system_score_gemma":0.0006145557,"threshold_uncertainty_score":0.73002565},"labels":[],"label_agreement":null},{"id":"W2766145635","doi":"10.1136/annrheumdis-2017-211682","title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University; Jewish General Hospital","funders":"Roche; U.S. Department of Veterans Affairs","keywords":"Tocilizumab; Medicine; Placebo; Adverse effect; Clinical endpoint; Internal medicine; Surgery; Clinical trial; Gastroenterology; Rheumatoid arthritis","score_opus":0.07693841705835605,"score_gpt":0.34067269859184784,"score_spread":0.26373428153349177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766145635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723753,0.017790476,9.203762e-7,0.0015904258,0.000256561,0.006895152,0.0007232409,0.000011888998,0.00035608953],"genre_scores_gemma":[0.99469894,0.0048789163,0.000007199858,0.00006489125,0.000037477486,0.00013876783,0.00002272055,0.000021016762,0.00013008401],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963236,0.0005567508,0.001990202,0.00033618958,0.00054959697,0.00024365024],"domain_scores_gemma":[0.9935926,0.0021800373,0.002261839,0.0015521569,0.00024699763,0.00016637574],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011381365,0.00026328606,0.0019677528,0.00006682301,0.00034472716,0.0000679325,0.0009793887,0.00011461228,0.000034718334],"category_scores_gemma":[0.009327824,0.00013166116,0.00041845764,0.00012231771,0.00051101454,0.00012276493,0.0003926293,0.00011846624,0.000001132243],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97150373,0.004859036,0.00028489024,0.0003944199,0.0013065308,0.00000990654,0.0017854547,0.000025100317,0.0021071215,0.00007937474,0.0006027568,0.017041674],"study_design_scores_gemma":[0.9523818,0.0015465983,0.015325592,0.02649729,0.0014478295,0.000017054874,0.0010289205,0.000906347,0.000561413,0.00013635427,0.0000034042926,0.00014742736],"about_ca_topic_score_codex":0.0011722896,"about_ca_topic_score_gemma":0.000019939605,"teacher_disagreement_score":0.02610287,"about_ca_system_score_codex":0.000022102999,"about_ca_system_score_gemma":0.00034422768,"threshold_uncertainty_score":0.999017},"labels":[],"label_agreement":null},{"id":"W2769532298","doi":"10.1136/annrheumdis-2017-212046","title":"Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Fonterra Co-Operative Group; AstraZeneca; Pfizer","keywords":"Gout; Allopurinol; Medicine; Uric acid; Deposition (geology); Internal medicine; Tophus; Surgery; Urology; Hyperuricemia","score_opus":0.013339003415929024,"score_gpt":0.24570126513268212,"score_spread":0.2323622617167531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769532298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815875,0.00027617707,0.000027436914,0.0004604614,0.000021714375,0.00043363118,0.00011707836,0.000018833032,0.0004858971],"genre_scores_gemma":[0.99940217,0.00008678268,0.00005955717,0.00007374151,0.000006597479,0.000037429145,0.000051974388,0.000024213223,0.000257514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853694,0.00007604216,0.0003681223,0.00022434519,0.0005485103,0.00024603115],"domain_scores_gemma":[0.9981044,0.000071011076,0.00059596373,0.00090473035,0.00019409033,0.00012982912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060983177,0.00020060809,0.00043344323,0.00006519085,0.00010282121,0.000026472024,0.00029003914,0.00003182295,0.000019937732],"category_scores_gemma":[0.00023718608,0.00011457119,0.0000832861,0.00011843862,0.00027925798,0.00025834952,0.00009671293,0.00007011056,0.0000016491301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016208594,0.0018060177,0.98994446,0.00048681392,0.00047675357,0.000023812288,0.00020135439,0.00011773947,0.00035320752,0.0000327004,0.0019509798,0.002985282],"study_design_scores_gemma":[0.002754207,0.000735816,0.98103774,0.001915429,0.00032329405,0.000009747535,0.000081427694,0.00038425357,0.01251843,0.000065772845,0.000012313769,0.00016157693],"about_ca_topic_score_codex":0.0013109767,"about_ca_topic_score_gemma":0.0000281722,"teacher_disagreement_score":0.012165223,"about_ca_system_score_codex":0.000018533445,"about_ca_system_score_gemma":0.00009288087,"threshold_uncertainty_score":0.46720776},"labels":[],"label_agreement":null},{"id":"W2770849948","doi":"10.1136/annrheumdis-2017-211912","title":"Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"European League Against Rheumatism; Scleroderma and Raynaud's UK","keywords":"Medicine; Scleroderma (fungus); Observational study; Dermatology; Internal medicine; Pathology","score_opus":0.17037480996569537,"score_gpt":0.3048701966001782,"score_spread":0.13449538663448285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770849948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285895,0.0047955457,0.000001850553,0.0005330945,0.00020933028,0.0011932522,0.00035098993,0.000022440772,0.000034559616],"genre_scores_gemma":[0.9981306,0.0012422566,0.0000027365625,0.00032393693,0.00018276252,0.00005541665,0.000020552541,0.000028031844,0.000013678257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977595,0.00055761886,0.0006999037,0.0002522061,0.00053888,0.00019186737],"domain_scores_gemma":[0.9982687,0.00034676146,0.000409511,0.0006565471,0.00018858747,0.00012987148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004202395,0.00018783256,0.0004445659,0.000072971365,0.00009521826,0.000026786758,0.0003410001,0.000041341755,0.000035905337],"category_scores_gemma":[0.00039307433,0.0000998819,0.00016574765,0.00026092769,0.00022858786,0.00011718084,0.00018785703,0.00008272434,0.0000062474733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009173862,0.00089781516,0.9874789,0.00022587784,0.00031017332,0.0000013553639,0.005577142,0.0000015287914,0.00010330792,0.000009959905,0.00047704348,0.0048251664],"study_design_scores_gemma":[0.0016479456,0.0001994024,0.97802776,0.017676685,0.00032459214,0.0000021259877,0.0017778771,0.000091327965,0.00012316044,0.000035969242,0.0000011196723,0.00009205911],"about_ca_topic_score_codex":0.0024573668,"about_ca_topic_score_gemma":0.000079042075,"teacher_disagreement_score":0.017450806,"about_ca_system_score_codex":0.000012085698,"about_ca_system_score_gemma":0.000050016148,"threshold_uncertainty_score":0.40730658},"labels":[],"label_agreement":null},{"id":"W2773576586","doi":"10.1136/annrheumdis-2017-212078","title":"Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Sanofi","keywords":"Leflunomide; Medicine; Pregnancy; Obstetrics; Abortion; Low birth weight; Teratology; Pediatrics; Gestation; Internal medicine; Rheumatoid arthritis","score_opus":0.05007792492802624,"score_gpt":0.33072076028925884,"score_spread":0.2806428353612326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773576586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848561,0.010673199,0.000010604066,0.0029629602,0.000117768184,0.000742851,0.00010491738,0.000018830657,0.000512762],"genre_scores_gemma":[0.9886651,0.009875135,0.00004165406,0.00008185446,0.0000076505285,0.000027481889,0.0000020555135,0.000013434936,0.0012856186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987664,0.00013208916,0.0004424115,0.00015029193,0.00031799436,0.00019078293],"domain_scores_gemma":[0.99687743,0.0004686303,0.0009369218,0.0014656606,0.000108828,0.00014252997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015941745,0.0001518861,0.0004884231,0.000043434302,0.00031007826,0.000017068629,0.00039897326,0.00003891651,0.00003730644],"category_scores_gemma":[0.008111049,0.00007233272,0.00033371217,0.00004309072,0.00081423396,0.00030783747,0.0001905356,0.00009834595,0.0000033825027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028808418,0.0002778539,0.9718459,0.0015490125,0.0007467875,0.0000042561633,0.0012243488,0.000007308808,0.00002350407,0.0009671598,0.00019908304,0.022866681],"study_design_scores_gemma":[0.003069364,0.00003380067,0.9736801,0.019731427,0.0005573448,0.00000608719,0.00012467014,0.000058573638,0.001042506,0.0016133924,0.000010387531,0.00007238239],"about_ca_topic_score_codex":0.00020666524,"about_ca_topic_score_gemma":0.0000075238545,"teacher_disagreement_score":0.022794299,"about_ca_system_score_codex":0.0000054772386,"about_ca_system_score_gemma":0.00009878375,"threshold_uncertainty_score":0.97102696},"labels":[],"label_agreement":null},{"id":"W2777155781","doi":"10.1136/annrheumdis-2017-212819","title":"Simultaneous inhibition of α4/β7 integrin and tumour necrosis factor-α in concomitant spondyloarthritis and inflammatory bowel disease","year":2017,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McGill University Health Centre; University Health Network; Montreal General Hospital","funders":"","keywords":"Medicine; Vedolizumab; Certolizumab pegol; Sacroiliitis; Inflammatory bowel disease; Inflammatory arthritis; Internal medicine; Tumor necrosis factor alpha; Concomitant; Arthritis; Adalimumab; Gastroenterology; Disease","score_opus":0.014289800008758716,"score_gpt":0.2537611750132881,"score_spread":0.2394713750045294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777155781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833217,0.0049064746,0.0000023038888,0.008464973,0.00013375265,0.000647625,0.0024570336,0.000010516701,0.000055576154],"genre_scores_gemma":[0.9900149,0.0018882515,0.000010802398,0.007370735,0.00014609212,0.00005433466,0.0002724211,0.000058087364,0.0001843636],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99782383,0.0002816635,0.00070391566,0.00048163222,0.00035594113,0.00035298904],"domain_scores_gemma":[0.9976828,0.00016366587,0.0008106945,0.00094256236,0.00019013858,0.00021012737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016574691,0.0004391961,0.0005371548,0.00012649475,0.000111096,0.00006939026,0.0004133344,0.00033140552,0.000023294982],"category_scores_gemma":[0.0017641902,0.00036568005,0.0002943231,0.00003664078,0.00076526724,0.000024096049,0.0004391476,0.0003204354,0.0000021487485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076308427,0.00141836,0.4140692,0.049244992,0.0024846357,0.009583346,0.0017013679,0.00061131164,0.01924887,0.0005223955,0.4597245,0.033760183],"study_design_scores_gemma":[0.0025798131,0.00021728878,0.971451,0.008300876,0.00036841782,0.00003062599,0.000114757924,0.00030972916,0.006136148,0.0031451723,0.0061187427,0.0012274354],"about_ca_topic_score_codex":0.00005335579,"about_ca_topic_score_gemma":0.00004547414,"teacher_disagreement_score":0.5573818,"about_ca_system_score_codex":0.000013475485,"about_ca_system_score_gemma":0.00029379927,"threshold_uncertainty_score":0.99987954},"labels":[],"label_agreement":null},{"id":"W2778717374","doi":"10.1136/annrheumdis-2017-212089","title":"ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Adalimumab; Uveitis; Placebo; Arthritis; Internal medicine; Adverse effect; Surgery; Ophthalmology; Rheumatoid arthritis; Pathology","score_opus":0.034455011490244096,"score_gpt":0.3132077401071657,"score_spread":0.2787527286169216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778717374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791852,0.013380891,0.000002381845,0.0012799164,0.00039948657,0.0052440725,0.0002298485,0.00003444757,0.00024374647],"genre_scores_gemma":[0.9965944,0.0022450094,0.0000062894883,0.00007916948,0.00007046998,0.00053155655,0.000022515274,0.00004448545,0.00040606764],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963664,0.00036393615,0.0015998625,0.00035882,0.0008103584,0.00050062896],"domain_scores_gemma":[0.99602866,0.0002578356,0.0017586136,0.0014195067,0.00024986887,0.00028552263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010291161,0.00034988738,0.00234969,0.00019417457,0.00023499795,0.00009192776,0.0006635112,0.00015654547,0.00022081731],"category_scores_gemma":[0.0024992405,0.00024995522,0.0014248912,0.0001694483,0.00034264658,0.0002572133,0.00020012264,0.00020810406,0.000014947341],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9762083,0.0031893647,0.00670508,0.0007935091,0.0010189551,0.00009801097,0.00024202873,0.000014684737,0.000089107896,0.00002312748,0.00039622566,0.011221563],"study_design_scores_gemma":[0.9232655,0.0014907984,0.061937965,0.01115392,0.000776479,0.000020612593,0.00006301815,0.0002918495,0.00037412692,0.00035664928,0.000013294987,0.00025575774],"about_ca_topic_score_codex":0.0009229933,"about_ca_topic_score_gemma":0.00030542567,"teacher_disagreement_score":0.055232886,"about_ca_system_score_codex":0.000069053596,"about_ca_system_score_gemma":0.00083091616,"threshold_uncertainty_score":0.9999953},"labels":[],"label_agreement":null},{"id":"W2782911007","doi":"10.1136/annrheumdis-2017-212403","title":"A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":231,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Gottfried und Julia Bangerter-Rhyner-Stiftung; Starr Foundation","keywords":"Medicine; Haploinsufficiency; Disease; Phenotype; Clinical phenotype; Rheumatology; Bioinformatics; Immunology; Genetics; Internal medicine; Gene; Biology","score_opus":0.021243388096778587,"score_gpt":0.2852689184970251,"score_spread":0.26402553040024657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782911007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593,0.0018743468,0.00011072577,0.00031561058,0.00014565901,0.00046850325,0.0010829916,0.000023688204,0.000048439633],"genre_scores_gemma":[0.99890596,0.00022913615,0.00013555842,0.00039366033,0.0000687262,0.000020805848,0.00016157929,0.000036343543,0.00004825102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809647,0.0002287885,0.00061525695,0.00040698078,0.0003658879,0.0002866491],"domain_scores_gemma":[0.99749535,0.00013735628,0.00053387776,0.00079310715,0.0004657542,0.0005745683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002758786,0.00025310053,0.00036297715,0.00004299191,0.0001171862,0.000019821871,0.00040085218,0.000066323955,0.000042185162],"category_scores_gemma":[0.0020468158,0.00016827813,0.00022365543,0.0001399695,0.0010554824,0.000014996693,0.0002093626,0.00006516775,0.000007299104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004703586,0.003914767,0.9617516,0.0007510306,0.0006434379,0.000004737647,0.0002006685,0.000089988236,0.0009612804,0.00013666824,0.008143623,0.018698635],"study_design_scores_gemma":[0.0019092445,0.0007472853,0.99221814,0.0005808439,0.00031858953,2.8533398e-7,0.000045793124,0.00060491654,0.00184644,0.00078316854,0.00062079617,0.00032452802],"about_ca_topic_score_codex":0.000008225297,"about_ca_topic_score_gemma":0.0000066653206,"teacher_disagreement_score":0.030466532,"about_ca_system_score_codex":0.0000035893324,"about_ca_system_score_gemma":0.0006197735,"threshold_uncertainty_score":0.68621826},"labels":[],"label_agreement":null},{"id":"W2782992211","doi":"10.1136/annrheumdis-2017-212377","title":"Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"UCB Pharma","keywords":"Medicine; Axial spondyloarthritis; Certolizumab pegol; Ankylosing spondylitis; Internal medicine; Placebo; Bristol-Myers; Spondylitis; Physical therapy; Gastroenterology; Sacroiliitis; Disease; Adalimumab; Pathology; Alternative medicine","score_opus":0.015166633008936021,"score_gpt":0.29302788731410684,"score_spread":0.27786125430517084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782992211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235094,0.0016954378,0.0000030614042,0.0028577074,0.00017003647,0.0027701291,0.00008041265,0.000021849808,0.00005045255],"genre_scores_gemma":[0.9989327,0.00055574067,0.000054774253,0.00008186823,0.000069691945,0.00018918229,0.0000911409,0.000016737466,0.000008144549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984516,0.00020554801,0.00051996973,0.00022815328,0.00035298246,0.00024173563],"domain_scores_gemma":[0.9988405,0.00028875488,0.00027224023,0.00034989818,0.00016815386,0.000080415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022316637,0.00019231584,0.00050003984,0.00018199981,0.00020653072,0.00003356922,0.00010199554,0.000033373297,0.000061742576],"category_scores_gemma":[0.0006260141,0.00010177303,0.00014223772,0.00044069404,0.00042791417,0.00016492417,0.00006124999,0.0000865059,0.0000010753931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20531759,0.002146592,0.6853252,0.000058650385,0.00047801653,0.000013452171,0.0018723628,0.0000024593983,0.000008955746,0.00004634553,0.0005089437,0.10422146],"study_design_scores_gemma":[0.35272968,0.00072788977,0.6435748,0.0013229606,0.00018907603,0.0000011015127,0.00094670214,0.00006819333,0.00005707888,0.00025616275,0.000027628359,0.000098716555],"about_ca_topic_score_codex":0.00016784543,"about_ca_topic_score_gemma":0.0000838428,"teacher_disagreement_score":0.1474121,"about_ca_system_score_codex":0.00001832127,"about_ca_system_score_gemma":0.00006388996,"threshold_uncertainty_score":0.41501838},"labels":[],"label_agreement":null},{"id":"W2783179629","doi":"10.1136/annrheumdis-2017-211568","title":"Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"AbbVie; Celgene","keywords":"Medicine; Apremilast; Psoriatic arthritis; Internal medicine; Arthritis; Randomized controlled trial; Dermatology","score_opus":0.018532781923374347,"score_gpt":0.2899030603222618,"score_spread":0.2713702783988875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783179629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198365,0.0015325799,0.000009029551,0.00029419785,0.00006090126,0.0059082494,0.000056864024,0.000023818713,0.00013067939],"genre_scores_gemma":[0.9984501,0.0008095825,0.00004236871,0.00015057507,0.00003808493,0.00044154323,0.000015097846,0.000020616952,0.00003201345],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998507,0.00016291672,0.00046237255,0.00027123714,0.00030074184,0.00029568255],"domain_scores_gemma":[0.9985181,0.00046652145,0.00032473056,0.00030355607,0.0002485598,0.00013854237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012335052,0.00025631353,0.0010227732,0.00008689506,0.00012653519,0.000021338052,0.00009026189,0.00004405307,0.00006336174],"category_scores_gemma":[0.0006224778,0.00012227334,0.00015951281,0.00021329173,0.0004268681,0.0000844193,0.00003324054,0.0000649232,0.0000021238661],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9326995,0.0048893536,0.016670724,0.000042563723,0.001227705,0.0000134055135,0.00077285676,8.9669027e-7,0.000003923409,0.000036613725,0.000060351525,0.043582093],"study_design_scores_gemma":[0.79098535,0.009249412,0.19785036,0.0010734638,0.00021688378,0.0000018029842,0.00026101718,0.000023597871,0.00004577281,0.0001582671,0.000010045858,0.00012402076],"about_ca_topic_score_codex":0.000060460276,"about_ca_topic_score_gemma":0.000021218331,"teacher_disagreement_score":0.18117964,"about_ca_system_score_codex":0.000017199922,"about_ca_system_score_gemma":0.00007647586,"threshold_uncertainty_score":0.49861622},"labels":[],"label_agreement":null},{"id":"W2783466784","doi":"10.1136/annrheumdis-2017-212478","title":"Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Biotest; AbbVie","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Placebo; Antirheumatic Agents; Internal medicine; Physical therapy; Randomized controlled trial; Clinical trial; Alternative medicine; Surgery; Pathology","score_opus":0.021065482312351815,"score_gpt":0.3265432012661672,"score_spread":0.30547771895381537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783466784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912995,0.002792872,0.000013341462,0.00068101124,0.000045900822,0.004846098,0.00023713235,0.000013766529,0.00007036105],"genre_scores_gemma":[0.99349076,0.006103117,0.00015976124,0.000040778512,0.000012003018,0.0001234565,0.00001617333,0.000024978797,0.000028968741],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963519,0.0011757966,0.0011974965,0.00031341295,0.0006345876,0.00032680208],"domain_scores_gemma":[0.9964906,0.0016284119,0.0005391304,0.00059493433,0.00039264726,0.00035425162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017695054,0.00024417407,0.0013672182,0.00032989203,0.000091504524,0.000023499268,0.00018752353,0.00005532324,0.00003674505],"category_scores_gemma":[0.006956442,0.0001511418,0.00014243515,0.0003524685,0.0007060511,0.0001856075,0.00009014662,0.00009369768,0.0000010274752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8891331,0.0021458513,0.00060377247,0.00010543641,0.00034794433,0.0000029464527,0.0019115551,0.0000037488642,0.00012345488,0.000045966037,0.00015415392,0.105422065],"study_design_scores_gemma":[0.94152975,0.012974712,0.038163107,0.0047883894,0.000030660714,0.000004586212,0.00023647193,0.00014295931,0.0017204384,0.00017714883,0.00007500787,0.00015677672],"about_ca_topic_score_codex":0.00018072444,"about_ca_topic_score_gemma":0.00006556346,"teacher_disagreement_score":0.10526528,"about_ca_system_score_codex":0.000011067439,"about_ca_system_score_gemma":0.00023497638,"threshold_uncertainty_score":0.83280134},"labels":[],"label_agreement":null},{"id":"W2784510548","doi":"10.1136/annrheumdis-2017-212224","title":"Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Medicine; Antiphospholipid syndrome; Pregnancy; Preeclampsia; Complement system; Gestation; Internal medicine; Systemic lupus erythematosus; Antibody; Immunology; Gastroenterology; Obstetrics; Disease","score_opus":0.04855170918041103,"score_gpt":0.326337468477944,"score_spread":0.27778575929753296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784510548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996464,0.0006441788,0.000021088768,0.00027204133,0.00017985329,0.0020893607,0.00007080635,0.000041132458,0.00021754204],"genre_scores_gemma":[0.9991155,0.00022652256,0.00007686261,0.00007929164,0.000023837621,0.00007127735,0.000020077967,0.00003332778,0.00035325458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975535,0.00013924853,0.00075139466,0.00029955752,0.000868196,0.00038810284],"domain_scores_gemma":[0.99807745,0.00022756973,0.0004234708,0.0006959036,0.00041460257,0.00016100897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002460322,0.00024152978,0.00066537777,0.0001893383,0.00010526151,0.00001797817,0.00023912507,0.000051848234,0.000072181596],"category_scores_gemma":[0.0006720694,0.00012881054,0.00009896988,0.00035892153,0.00034069092,0.00018790156,0.00018581044,0.00009175156,0.000013380446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012041541,0.00052269496,0.9892639,0.005174472,0.00019305755,0.0000039270803,0.0012783201,0.0000031029901,0.000012299792,0.0000888413,0.00076137396,0.0014938352],"study_design_scores_gemma":[0.006283442,0.00077613624,0.9495728,0.040355362,0.00011593878,0.0002701372,0.001543323,0.00020138329,0.00057294447,0.00009946968,0.00002109794,0.00018798096],"about_ca_topic_score_codex":0.00006618735,"about_ca_topic_score_gemma":0.000013591437,"teacher_disagreement_score":0.03969114,"about_ca_system_score_codex":0.000054322525,"about_ca_system_score_gemma":0.00015159744,"threshold_uncertainty_score":0.5252741},"labels":[],"label_agreement":null},{"id":"W2785614344","doi":"10.1136/annrheumdis-2017-212902","title":"Response to: ‘Statins in systemic lupus erythematosus’ by Abud-Mendoza","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Rijksinstituut voor Volksgezondheid en Milieu","keywords":"Medicine; Statin; Disease; Clinical Practice; Systemic therapy; Internal medicine; Lupus erythematosus; Systemic lupus erythematosus; Clinical trial; Medical record; Physical therapy; Intensive care medicine; Immunology","score_opus":0.025391641986925916,"score_gpt":0.2986443463231878,"score_spread":0.2732527043362619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785614344","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5018741,0.00957059,0.00003183711,0.4835399,0.0007654026,0.0029325266,0.0008833776,0.00006862083,0.00033364896],"genre_scores_gemma":[0.29014927,0.0018517794,0.0001624412,0.6919119,0.0011654907,0.0007489261,0.00032681818,0.0002851725,0.013398234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99573207,0.00089968817,0.00096383947,0.00047426808,0.0013161291,0.0006140188],"domain_scores_gemma":[0.9965734,0.000448167,0.00046649444,0.0020216107,0.0002441624,0.0002461777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012442413,0.00042361385,0.0014280522,0.0002627088,0.00008024641,0.000034651424,0.0005419813,0.0002999881,0.00013380755],"category_scores_gemma":[0.0015440651,0.0002769182,0.0008584437,0.00041098782,0.00015413716,0.000056609315,0.0001349914,0.0005049602,0.00012608561],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006501529,0.00014540907,0.0005345281,0.0053508035,0.00047820038,0.00009310292,0.00043742647,0.0000026728146,0.00003352207,0.0000050396134,0.9897561,0.002513016],"study_design_scores_gemma":[0.006296356,0.0016042099,0.011306845,0.07330723,0.0015931905,0.0022579348,0.001269816,0.000074085016,0.0010297665,0.0009648163,0.8987931,0.0015026346],"about_ca_topic_score_codex":0.00031458764,"about_ca_topic_score_gemma":0.000005118506,"teacher_disagreement_score":0.21172482,"about_ca_system_score_codex":0.000098259035,"about_ca_system_score_gemma":0.00057022827,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W2786205567","doi":"10.1136/annrheumdis-2018-213153","title":"Detection of myositis-specific antibodies: additional notes","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Health Sciences Centre","funders":"","keywords":"Medicine; Autoantibody; Myositis; Medical diagnosis; Dermatomyositis; Immunology; Polymyositis; Antibody; Pathology","score_opus":0.03347070720890428,"score_gpt":0.27611735632860795,"score_spread":0.24264664911970368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786205567","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2664924,0.017702777,0.00039312372,0.65554076,0.0044225887,0.0035574653,0.04572199,0.00037021513,0.00579864],"genre_scores_gemma":[0.6430835,0.004273286,0.0003588222,0.3401656,0.005673112,0.00018880566,0.004570214,0.00023639027,0.0014502901],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776214,0.00013509304,0.00075561326,0.00025687806,0.0007939839,0.0002963062],"domain_scores_gemma":[0.99717623,0.0005953027,0.0007963276,0.0007861211,0.00057092035,0.000075108874],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011005899,0.000302929,0.00078696513,0.00018308224,0.00013637064,0.000022574923,0.00028164877,0.0002935052,0.0027364464],"category_scores_gemma":[0.00043795572,0.00021434114,0.0007099729,0.00017938885,0.0005752248,0.0000949128,0.000103821265,0.00034735238,0.000083970175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008478545,0.00008028991,0.00017031713,0.0025618495,0.00031854276,0.000041851337,0.000090949216,9.386351e-7,0.000072733885,0.000028895347,0.9918734,0.004675488],"study_design_scores_gemma":[0.001021183,0.0004886098,0.07015792,0.019523973,0.0008287375,0.00034544896,0.00012023134,0.00010360561,0.0185806,0.0037301227,0.88441837,0.00068117795],"about_ca_topic_score_codex":0.000025455649,"about_ca_topic_score_gemma":0.0000013139116,"teacher_disagreement_score":0.3765911,"about_ca_system_score_codex":0.000019878133,"about_ca_system_score_gemma":0.00015333564,"threshold_uncertainty_score":0.9981752},"labels":[],"label_agreement":null},{"id":"W2786778392","doi":"10.1136/annrheumdis-2017-212647","title":"Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; Deutsche Forschungsgemeinschaft; National Institute on Aging; Praespero; U.S. Department of Veterans Affairs","keywords":"Medicine; Rheumatoid arthritis; GSK-3; Coronary artery disease; Glycogen synthase; Arthritis; Internal medicine; Immunology; Glycogen; Cardiology; Kinase; Biochemistry","score_opus":0.02248964646670074,"score_gpt":0.2919406045105789,"score_spread":0.26945095804387814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786778392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668229,0.0278596,0.000020929872,0.0039016034,0.00014204989,0.00089743565,0.00018901959,0.000044036493,0.00012237218],"genre_scores_gemma":[0.964813,0.03402788,0.000085479296,0.0007798235,0.000053191703,0.00012201737,0.000022675491,0.000036189947,0.00005975231],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978829,0.00021232927,0.0005362214,0.00035760153,0.00053980545,0.00047112047],"domain_scores_gemma":[0.99813104,0.00023002342,0.00014281835,0.000644067,0.00021767378,0.00063438836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002678707,0.00025792638,0.00058541726,0.00029197146,0.00018552913,0.000059957485,0.00023242876,0.00004598174,0.00027181566],"category_scores_gemma":[0.0015457559,0.00019455297,0.00016241822,0.00043517663,0.00053787767,0.000291835,0.00019710421,0.000118768156,0.000060751754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045131515,0.0020816617,0.10339901,0.00064429303,0.00044334284,0.00049304153,0.0016638213,0.00001084495,0.0031867637,0.001524517,0.0069514476,0.8750881],"study_design_scores_gemma":[0.0023359223,0.00045932067,0.9805742,0.0051798983,0.000013717446,0.00017931059,0.00042082672,0.00022583618,0.0055028163,0.0037711582,0.0010633846,0.00027359257],"about_ca_topic_score_codex":0.00014201981,"about_ca_topic_score_gemma":0.00005301738,"teacher_disagreement_score":0.8771752,"about_ca_system_score_codex":0.000020232255,"about_ca_system_score_gemma":0.00020780256,"threshold_uncertainty_score":0.7933639},"labels":[],"label_agreement":null},{"id":"W2789710874","doi":"10.1136/annrheumdis-2017-212687","title":"Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Secukinumab; Psoriatic arthritis; Internal medicine; Double blind; Dermatology; Arthritis; Physical therapy; Placebo; Alternative medicine; Pathology","score_opus":0.02539280914381398,"score_gpt":0.3226251448150906,"score_spread":0.2972323356712766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789710874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687068,0.023337146,0.0000011469948,0.0025808294,0.00044857888,0.0042103096,0.00045945385,0.00004855938,0.00020718422],"genre_scores_gemma":[0.9934479,0.0051628365,0.000024287092,0.00037901595,0.00043312222,0.00037321114,0.000101782454,0.000030225487,0.00004763357],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99764895,0.00020408457,0.0007144358,0.00045985033,0.0006294345,0.00034325497],"domain_scores_gemma":[0.99771804,0.00045909843,0.00053467334,0.0008222917,0.0002654872,0.00020041071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027331646,0.00035275405,0.0008394818,0.00008207649,0.0005485357,0.00006426532,0.00023781542,0.00007115183,0.00003849602],"category_scores_gemma":[0.00024033025,0.00017916354,0.00032409307,0.00041041334,0.0005755714,0.00016558779,0.00022510729,0.00015286672,0.00000535316],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22274034,0.0057301545,0.0036477286,0.0001398228,0.0048301728,0.000042705553,0.009693976,2.3759897e-7,0.00004539912,0.000041143936,0.0046194713,0.7484689],"study_design_scores_gemma":[0.7567271,0.005308345,0.2190151,0.0048942184,0.002434412,0.000045921992,0.0080628535,0.00003338994,0.001454615,0.0010681674,0.0005151827,0.00044071433],"about_ca_topic_score_codex":0.00019761878,"about_ca_topic_score_gemma":0.00008844491,"teacher_disagreement_score":0.74802816,"about_ca_system_score_codex":0.000016715006,"about_ca_system_score_gemma":0.000111904206,"threshold_uncertainty_score":0.73060775},"labels":[],"label_agreement":null},{"id":"W2790131456","doi":"10.1136/annrheumdis-2018-213359","title":"Response to: ‘A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease’ by Aeschlimann et al","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Disease; Haploinsufficiency; Phenotype; Rheumatology; Clinical phenotype; Behcet's disease; Presentation (obstetrics); Cohort; Inheritance (genetic algorithm); Autoimmunity; Penetrance; Genetics; Internal medicine; Gene","score_opus":0.0193512651656968,"score_gpt":0.2916296982068602,"score_spread":0.2722784330411634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790131456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8803856,0.002601144,0.000068848014,0.10408487,0.00026895248,0.001098033,0.011437761,0.000038053717,0.000016755825],"genre_scores_gemma":[0.6075824,0.0007647822,0.00026986233,0.38589355,0.00024313456,0.00015809765,0.004432677,0.00024804886,0.0004074579],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99559987,0.0011123182,0.0010553221,0.0008821471,0.0008214604,0.0005289153],"domain_scores_gemma":[0.99559426,0.0005458616,0.0010514664,0.0014632843,0.0006255708,0.00071957934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078686466,0.0006016494,0.0008028664,0.000105839004,0.00012615482,0.000051625804,0.0008596222,0.00026405026,0.00004251517],"category_scores_gemma":[0.0044840495,0.00042553304,0.00045429275,0.00018467875,0.0009725838,0.00001837249,0.00043664098,0.00033135625,0.000014033075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073390147,0.0010694036,0.018631555,0.00046233836,0.00048778972,0.000013478592,0.0000602596,0.000022653056,0.00034100402,0.0000018726499,0.97060335,0.0009672849],"study_design_scores_gemma":[0.0067940284,0.004457734,0.41841108,0.0057012886,0.0017463114,0.0000022477432,0.00006294318,0.00030988737,0.0015033615,0.0005028498,0.55804193,0.0024663128],"about_ca_topic_score_codex":0.000010933607,"about_ca_topic_score_gemma":0.0000034950517,"teacher_disagreement_score":0.4125614,"about_ca_system_score_codex":0.000010873656,"about_ca_system_score_gemma":0.0013968663,"threshold_uncertainty_score":0.99981964},"labels":[],"label_agreement":null},{"id":"W2790156447","doi":"10.1136/annrheumdis-2018-213023","title":"Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes; Research Canada","funders":"Arthritis Society","keywords":"Medicine; Pregnancy; Small for gestational age; Obstetrics; Population; Premature birth; Gestational age; Live birth; Propensity score matching; Pediatrics; Internal medicine","score_opus":0.03923466201873562,"score_gpt":0.31413216992006765,"score_spread":0.27489750790133205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790156447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969139,0.00073757005,0.00008623186,0.000114423994,0.000027743314,0.0018700211,0.00022556094,0.000020648957,0.0000038768344],"genre_scores_gemma":[0.9991986,0.00016029549,0.0003307501,0.0000537114,0.000009748433,0.00017352855,0.000027647866,0.000015623888,0.0000300813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878764,0.00012439115,0.00044324753,0.00019653777,0.0002458592,0.00020235205],"domain_scores_gemma":[0.9985849,0.00024331971,0.00044749456,0.00040183333,0.00017280187,0.00014960517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002174869,0.00014641328,0.0003835616,0.00013049367,0.000106281215,0.000008733414,0.00012037899,0.000030032437,0.00002358765],"category_scores_gemma":[0.001441714,0.00008309496,0.000060546077,0.00022724834,0.00021890238,0.000084951585,0.000040233266,0.000050079663,1.8459477e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025448175,0.00063832954,0.9902248,0.0011531449,0.00024614308,0.0000056522344,0.0012159438,0.00020352242,0.000020901345,0.00001013999,0.0000021391427,0.0037345018],"study_design_scores_gemma":[0.0021707127,0.0007478763,0.98583466,0.007320655,0.0003050558,0.000002082322,0.00031939725,0.0026337418,0.0000672402,0.0005063904,4.1920012e-7,0.00009174142],"about_ca_topic_score_codex":0.00018113601,"about_ca_topic_score_gemma":0.000052400188,"teacher_disagreement_score":0.00616751,"about_ca_system_score_codex":0.00003525901,"about_ca_system_score_gemma":0.00033099353,"threshold_uncertainty_score":0.3388514},"labels":[],"label_agreement":null},{"id":"W2791011575","doi":"10.1136/annrheumdis-2017-212681","title":"‘Deep Koebner’ phenomenon of the flexor tendon-associated accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Dactylitis; Medicine; Pulley; Psoriatic arthritis; Tenosynovitis; Numerical digit; Psoriasis; Rheumatoid arthritis; Tendon; Arthritis; Fibrocyte; Surgery; Dermatology; Internal medicine; Pathology; Enthesitis","score_opus":0.03551269363780975,"score_gpt":0.3052165486579193,"score_spread":0.2697038550201096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791011575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898606,0.006312363,0.0000012657972,0.0016588038,0.00017332086,0.00085935544,0.00029241134,0.000013383236,0.0008284885],"genre_scores_gemma":[0.99636644,0.0029812525,0.000020164409,0.000336838,0.000024770934,0.00007871659,0.000011071745,0.000023352062,0.00015741683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826026,0.00011175729,0.000621112,0.00025541298,0.00039554233,0.00035590908],"domain_scores_gemma":[0.9986457,0.00027465844,0.00037055585,0.00046043674,0.00014777867,0.00010086212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014066885,0.00022219763,0.00068592926,0.00012162865,0.00011016172,0.00001938075,0.00023410561,0.00006252672,0.00017624935],"category_scores_gemma":[0.0014035305,0.00013763676,0.00017660472,0.00046609974,0.00039250654,0.00011677305,0.00021215112,0.00010275554,0.000005621476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006617394,0.006310297,0.7782012,0.0009072659,0.001337093,0.000042715783,0.0066346093,0.00000872407,0.00037609498,0.0009165681,0.0008949223,0.20370875],"study_design_scores_gemma":[0.004799844,0.00047036746,0.9869528,0.0038150914,0.00009892092,0.0000130501285,0.0008049292,0.00008894731,0.00050398026,0.0022541406,0.00006221491,0.00013572414],"about_ca_topic_score_codex":0.0020609035,"about_ca_topic_score_gemma":0.0017002,"teacher_disagreement_score":0.20875157,"about_ca_system_score_codex":0.000047791556,"about_ca_system_score_gemma":0.00011944095,"threshold_uncertainty_score":0.5612664},"labels":[],"label_agreement":null},{"id":"W2793263939","doi":"10.1136/annrheumdis-2018-ewrr2018.108","title":"P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Incyte; Eli Lilly and Company","keywords":"Janus kinase; Rheumatoid arthritis; Adalimumab; STAT protein; Transcriptome; Medicine; STAT1; STAT3; Microarray; stat; Cancer research; Signal transduction; Gene expression; Gene; Receptor; Interferon; Immunology; Internal medicine; Biology; Cell biology","score_opus":0.040127701313779504,"score_gpt":0.33059260617062586,"score_spread":0.29046490485684634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793263939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98870647,0.008529116,0.00012892167,0.0010215465,0.00007000656,0.0010065667,0.00031428892,0.00004176247,0.00018132331],"genre_scores_gemma":[0.9946387,0.004572746,0.00016692148,0.00039672613,0.000027975984,0.00008371427,0.00004306755,0.000029258057,0.00004088796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737555,0.00032215446,0.00076162914,0.000460118,0.000598922,0.00048163038],"domain_scores_gemma":[0.9980784,0.0003107582,0.00018951097,0.0007538493,0.00025563058,0.0004118238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039777544,0.0002827653,0.0010787335,0.00041422332,0.0002112933,0.00011586234,0.00030684654,0.000045707835,0.00034583436],"category_scores_gemma":[0.00070373516,0.00021068787,0.00025131513,0.00092244596,0.00028038342,0.00018348882,0.00023693098,0.00014800343,0.000026206237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008712078,0.011410016,0.65625453,0.00020945126,0.009502042,0.0001229734,0.028449168,0.00034510856,0.0013805287,0.00033467117,0.0046552406,0.27862418],"study_design_scores_gemma":[0.030182853,0.00351655,0.9208626,0.007491869,0.00023981152,0.000045720175,0.011725195,0.012620216,0.006641518,0.004865624,0.00080132834,0.0010067287],"about_ca_topic_score_codex":0.0020417438,"about_ca_topic_score_gemma":0.001624667,"teacher_disagreement_score":0.27761745,"about_ca_system_score_codex":0.000019322337,"about_ca_system_score_gemma":0.00014283943,"threshold_uncertainty_score":0.8591602},"labels":[],"label_agreement":null},{"id":"W2797862713","doi":"10.1136/annrheumdis-2018-213030","title":"Treating juvenile idiopathic arthritis to target: recommendations of an international task force","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; SickKids Foundation; Hospital for Sick Children; London Health Sciences Centre; University of Toronto","funders":"AbbVie","keywords":"Medicine; Timeline; Task force; Delphi method; Set (abstract data type); Arthritis; Task (project management); Delphi; Physical therapy; Internal medicine; Computer science","score_opus":0.0361719460296801,"score_gpt":0.3496269498093818,"score_spread":0.3134550037797017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797862713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983997,0.0010370796,0.0002594502,0.008812007,0.0001629201,0.00044522775,0.00013035325,0.000028497336,0.005127501],"genre_scores_gemma":[0.9978746,0.0002760567,0.0004136521,0.00040290348,0.000046963138,0.000032368556,0.000031936062,0.000014495597,0.0009070091],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998744,0.00008640614,0.0005288106,0.00013299631,0.00034210298,0.00016566706],"domain_scores_gemma":[0.9987987,0.000057608366,0.00022334962,0.00044603567,0.00036150022,0.00011275711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003099504,0.00009037078,0.00031299004,0.00011266134,0.000106894535,0.000014323618,0.00028921498,0.000028063338,0.0004089138],"category_scores_gemma":[0.0012335463,0.00006701025,0.00014425619,0.00020188586,0.00013360099,0.00019536632,0.00010999684,0.00005959901,0.000035956014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006375081,0.0020238636,0.01583197,0.0006997574,0.00059410755,0.000008010883,0.0051744166,0.00010181246,0.0045926105,0.002625242,0.021809671,0.94590104],"study_design_scores_gemma":[0.009091931,0.007182147,0.707382,0.026362574,0.0003888419,0.00013002513,0.011226673,0.02608297,0.12577595,0.029392773,0.055775255,0.0012088441],"about_ca_topic_score_codex":0.00008424083,"about_ca_topic_score_gemma":0.000011545011,"teacher_disagreement_score":0.9446922,"about_ca_system_score_codex":0.000012603327,"about_ca_system_score_gemma":0.00017292213,"threshold_uncertainty_score":0.44773194},"labels":[],"label_agreement":null},{"id":"W2799626438","doi":"10.1136/annrheumdis-2018-213519","title":"Response to: ‘Time to personalise the treatment of anti-MDA-5 associated lung disease’ by Lake et al","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Disease; Lung; Lung disease; Internal medicine; Gerontology; Intensive care medicine","score_opus":0.01909576829776462,"score_gpt":0.29928351079134224,"score_spread":0.28018774249357764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799626438","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3389399,0.0014382103,0.000002090194,0.6517555,0.00016339937,0.0012467594,0.006305855,0.0000408966,0.000107384956],"genre_scores_gemma":[0.05308871,0.00057675684,0.000016430255,0.9340529,0.00022594914,0.00023207552,0.0009129889,0.00012819894,0.010766018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964469,0.0008629505,0.0007248401,0.00038678033,0.001082803,0.0004957396],"domain_scores_gemma":[0.9965129,0.000923824,0.0005519313,0.0012692856,0.00040543906,0.0003366135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004778981,0.00048275126,0.0010780996,0.00014722736,0.00017665178,0.000054423508,0.00050426525,0.000160789,0.0008834271],"category_scores_gemma":[0.0012307483,0.0002702601,0.0008766619,0.00029110088,0.0002634455,0.00007710755,0.00012907285,0.00019935133,0.00017334518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014289981,0.000479957,0.00088179467,0.0003437688,0.0008817924,0.00009568051,0.0009246728,0.000005560825,0.000056002136,0.000002678771,0.9945219,0.00037715537],"study_design_scores_gemma":[0.000991191,0.00064704235,0.04013998,0.0040177917,0.0010995273,0.000012350912,0.000066610875,0.00014223561,0.00022497404,0.00004153926,0.9522566,0.000360149],"about_ca_topic_score_codex":0.000050126768,"about_ca_topic_score_gemma":0.0000039517176,"teacher_disagreement_score":0.28585118,"about_ca_system_score_codex":0.00007312985,"about_ca_system_score_gemma":0.00040186488,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W2800113614","doi":"10.1136/annrheumdis-2017-212768","title":"Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Assistance publique-Hôpitaux de Paris; Genentech; Université Paris Descartes; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Microscopic polyangiitis; Rituximab; Azathioprine; Internal medicine; Anti-neutrophil cytoplasmic antibody; Granulomatosis with polyangiitis; Maintenance therapy; Gastroenterology; Vasculitis; Adverse effect; Clinical endpoint; Surgery; Randomized controlled trial; Chemotherapy; Lymphoma; Disease","score_opus":0.0357831577958527,"score_gpt":0.32568980047439244,"score_spread":0.2899066426785397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800113614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304175,0.0015758659,0.00010312829,0.0033971488,0.00017407392,0.00067745143,0.00022145077,0.00003890588,0.000770238],"genre_scores_gemma":[0.9975511,0.00062746665,0.00008424267,0.0002470487,0.000046453726,0.000024442548,0.000056624,0.000019116758,0.0013435078],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99882317,0.000058502643,0.00044595302,0.00016793379,0.00026490338,0.00023955155],"domain_scores_gemma":[0.9980744,0.00034078216,0.00035424056,0.0005423902,0.00054603856,0.00014211699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018145805,0.00012915708,0.00042142684,0.00005562895,0.00013379662,0.0000074461077,0.00018649039,0.000069822265,0.0001800732],"category_scores_gemma":[0.0026135445,0.00007735737,0.0005850802,0.00020833149,0.0003519954,0.000053804328,0.000047253445,0.000060950155,0.000008253846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002782499,0.013578033,0.1257227,0.008639034,0.016636053,0.000030203762,0.004691838,0.00009518034,0.00409402,0.015858913,0.6193065,0.18856503],"study_design_scores_gemma":[0.0039571947,0.00055848423,0.9705296,0.011341321,0.0010131397,0.000012494189,0.000133367,0.0001951736,0.006027386,0.0057128426,0.00034095708,0.0001780194],"about_ca_topic_score_codex":0.000022050863,"about_ca_topic_score_gemma":0.0000033269794,"teacher_disagreement_score":0.8448069,"about_ca_system_score_codex":0.000014450417,"about_ca_system_score_gemma":0.00013709199,"threshold_uncertainty_score":0.3154542},"labels":[],"label_agreement":null},{"id":"W2800156208","doi":"10.1136/annrheumdis-2018-213413","title":"Imputation-based analysis of MICA alleles in the susceptibility to ankylosing spondylitis","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences","keywords":"Imputation (statistics); Allele; Genotyping; Ankylosing spondylitis; Human leukocyte antigen; Genetics; Major histocompatibility complex; Genetic association; Medicine; Genotype; Immunology; Biology; Gene; Single-nucleotide polymorphism; Antigen; Missing data","score_opus":0.04464971265563155,"score_gpt":0.33685522759645836,"score_spread":0.2922055149408268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800156208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77004945,0.0016551156,0.000010933186,0.2243984,0.00008505845,0.0009055163,0.0027282927,0.00001217528,0.00015505438],"genre_scores_gemma":[0.8889006,0.00014353747,0.00012804412,0.10960588,0.00010822175,0.00007363613,0.0009418908,0.00002384442,0.00007438206],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976338,0.0003090071,0.00072038156,0.00033280192,0.00069666427,0.0003073111],"domain_scores_gemma":[0.9972659,0.00091867417,0.00042643133,0.001019251,0.00031130022,0.00005846286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026427052,0.00027272716,0.0010561608,0.00037918688,0.000088226785,0.00002037782,0.00036923282,0.000120956014,0.00037589888],"category_scores_gemma":[0.0008753857,0.00015425059,0.00087627966,0.0010726283,0.00029563002,0.000029935043,0.00007811094,0.00017528773,0.000006470402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073653983,0.0016799012,0.13682535,0.0025763311,0.009649168,0.00012373121,0.0024449113,0.00026548377,0.000010409824,0.000028204888,0.83497125,0.010688703],"study_design_scores_gemma":[0.0012992045,0.00062691374,0.9743292,0.0033034391,0.0070849773,0.000003745064,0.0005558096,0.0003643252,0.00010271335,0.0008572761,0.011186753,0.00028569484],"about_ca_topic_score_codex":0.0008657395,"about_ca_topic_score_gemma":0.00033695795,"teacher_disagreement_score":0.8375038,"about_ca_system_score_codex":0.000034861012,"about_ca_system_score_gemma":0.00014351169,"threshold_uncertainty_score":0.6290157},"labels":[],"label_agreement":null},{"id":"W2800543283","doi":"10.1136/annrheumdis-2017-212713","title":"Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; Department of Medicine, Ottawa Hospital; Rare Diseases Clinical Research Network; National Institutes of Health; National Institute for Health and Care Research; University of Oxford; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Society","keywords":"Rasch model; Medicine; Intraclass correlation; Construct validity; Patient-reported outcome; Physical therapy; Convergent validity; Quality of life (healthcare); Clinical psychology; Psychometrics; Psychology","score_opus":0.029338319985452024,"score_gpt":0.2996623054348267,"score_spread":0.2703239854493747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800543283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927766,0.0005545117,0.000012883505,0.0050322744,0.00038799815,0.0005120533,0.000098658325,0.000041764768,0.00058330223],"genre_scores_gemma":[0.99901205,0.00013999418,0.0000145217555,0.00036278382,0.000019835577,0.000024949046,0.00003577007,0.000015019512,0.00037510283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839973,0.00017163559,0.0005946455,0.00014790829,0.0005119891,0.0001740974],"domain_scores_gemma":[0.99798757,0.000081533784,0.00059338455,0.0006677261,0.0005840278,0.00008573335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015922828,0.00013410416,0.00035289797,0.0000539693,0.000191227,0.000011612271,0.00017837198,0.00007511191,0.00021994393],"category_scores_gemma":[0.0020850783,0.000069539245,0.0005476363,0.00035256727,0.0003292348,0.00008858785,0.00007478128,0.000084724714,0.0000124905055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110817564,0.0029620188,0.90314573,0.0007951933,0.006236567,0.000006218757,0.0033052624,0.00009872884,0.000418847,0.003265413,0.03373612,0.045919105],"study_design_scores_gemma":[0.00097080733,0.00014053575,0.9854512,0.0022671653,0.0007264929,0.0000084894555,0.00016096327,0.00008909252,0.005528453,0.0044935555,0.00007265646,0.0000905511],"about_ca_topic_score_codex":0.00020060026,"about_ca_topic_score_gemma":0.000010234381,"teacher_disagreement_score":0.08230553,"about_ca_system_score_codex":0.000020026051,"about_ca_system_score_gemma":0.00015623622,"threshold_uncertainty_score":0.28357282},"labels":[],"label_agreement":null},{"id":"W2801618299","doi":"10.1136/annrheumdis-2018-213440","title":"Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Anti-nuclear antibody; Medicine; Confusion; Immunofluorescence; Indirect immunofluorescence; Inclusion (mineral); Immunology; Antibody; Autoantibody; Chemistry; Psychology","score_opus":0.10603149923509124,"score_gpt":0.3125762090021263,"score_spread":0.20654470976703504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801618299","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2998478,0.047322318,0.000030148718,0.64005893,0.0029010847,0.006635844,0.0006791801,0.00014406053,0.0023806416],"genre_scores_gemma":[0.8254484,0.011282149,0.00016789752,0.10924297,0.0023246459,0.00033936527,0.00011622513,0.00043509062,0.050643247],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958624,0.0010391034,0.0007005867,0.0003891253,0.0014765832,0.0005321999],"domain_scores_gemma":[0.9954914,0.0015238312,0.0008764672,0.0016903057,0.0002784161,0.00013960923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012771818,0.00036387716,0.0009203178,0.00024090942,0.00025955,0.000034789682,0.00092355715,0.00028230876,0.000113485294],"category_scores_gemma":[0.002313709,0.0001956843,0.0004807017,0.0003684895,0.0007697595,0.00006899781,0.00045365392,0.00096808403,0.000028447077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061760205,0.00012544864,0.0035131506,0.007963671,0.0005725497,0.0000047429153,0.001015881,0.000004453957,0.0002762417,0.0000222774,0.98435545,0.0020843882],"study_design_scores_gemma":[0.008569287,0.0028965776,0.05822591,0.5835828,0.004829749,0.0019656685,0.0029172979,0.0012027869,0.038441643,0.008561464,0.28568593,0.003120877],"about_ca_topic_score_codex":0.00029715188,"about_ca_topic_score_gemma":0.0000049726336,"teacher_disagreement_score":0.6986695,"about_ca_system_score_codex":0.00008579071,"about_ca_system_score_gemma":0.0006279262,"threshold_uncertainty_score":0.79797745},"labels":[],"label_agreement":null},{"id":"W2806261101","doi":"10.1136/annrheumdis-2017-212076","title":"Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Assessment of SpondyloArthritis international Society","keywords":"Medicine; Intraclass correlation; Cronbach's alpha; Construct validity; BASDAI; Internal medicine; Physical therapy; Axial spondyloarthritis; BASFI; Disease; Ankylosing spondylitis; Surgery; Psychometrics; Patient satisfaction; Psoriatic arthritis; Clinical psychology; Sacroiliitis","score_opus":0.051975733371297725,"score_gpt":0.2851909590549987,"score_spread":0.23321522568370096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806261101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994262,0.0033398585,2.9566985e-7,0.00084735383,0.00007272174,0.0012555358,0.00014611545,0.000004758694,0.00007138895],"genre_scores_gemma":[0.9997866,0.000080543155,0.000006703798,0.0000734463,0.000009528997,0.000024067778,0.0000011311907,0.0000075339217,0.000010400159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982958,0.00014528124,0.00049236085,0.00016173982,0.00072372076,0.00018111117],"domain_scores_gemma":[0.99885356,0.00001015209,0.0003366149,0.00037018224,0.00036414235,0.000065354914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021604223,0.00013820225,0.00046333816,0.000023383905,0.00009110274,0.0000058605774,0.00011684055,0.00001759967,0.000005376784],"category_scores_gemma":[0.00029901887,0.00006681844,0.0000807061,0.00020835634,0.0004140477,0.000045984256,0.00012001804,0.000037015478,2.507129e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038030199,0.0026181373,0.98011136,0.00025758226,0.0002951413,8.172314e-7,0.0015873609,0.0000022714719,0.000001561352,0.000012871234,0.00017339588,0.011136499],"study_design_scores_gemma":[0.009005503,0.0030241872,0.9824545,0.004225874,0.00007024997,0.0000013789573,0.0010237829,0.0000053413023,0.000073469775,0.00004977312,0.000010206057,0.000055744746],"about_ca_topic_score_codex":0.00138932,"about_ca_topic_score_gemma":0.0019347112,"teacher_disagreement_score":0.011080754,"about_ca_system_score_codex":0.000042206742,"about_ca_system_score_gemma":0.0001987683,"threshold_uncertainty_score":0.27247766},"labels":[],"label_agreement":null},{"id":"W2807731611","doi":"10.1136/annrheumdis-2018-eular.1334","title":"SAT0090 Evaluation of the use of ultrasound to manage patients with rheumatoid arthritis over time: results from the corrona registry","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Momenta Pharmaceuticals; Valeant Pharmaceuticals International; Genentech; Russian Foundation for Basic Research; Horizon Pharma; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Physical therapy","score_opus":0.04672276163166645,"score_gpt":0.2979426186157436,"score_spread":0.2512198569840772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807731611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931965,0.0021334589,0.000008130286,0.0014464784,0.00012696028,0.0013276559,0.0015129631,0.000013676849,0.00023418022],"genre_scores_gemma":[0.9961497,0.0031692295,0.00006834663,0.0003351833,0.00002470261,0.000030335097,0.000077236116,0.000025219097,0.00012003796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965918,0.00041875738,0.0006744472,0.00025185756,0.001795886,0.0002672701],"domain_scores_gemma":[0.99554795,0.0011131581,0.0006104301,0.0015328244,0.0010590705,0.00013657978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006119551,0.00019376846,0.0004390438,0.00005504945,0.0001734262,0.000041214156,0.0005192318,0.00004550234,0.0003456328],"category_scores_gemma":[0.006181372,0.000092643946,0.0002181781,0.00037170932,0.0008844258,0.0001816757,0.00016501354,0.00010475846,0.000021671583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009060199,0.0026433659,0.5254108,0.00027575102,0.0022683714,0.0000016158236,0.0073003005,0.0003490393,0.0008172991,0.00037589835,0.27633667,0.17516072],"study_design_scores_gemma":[0.0037354522,0.00042123205,0.98307204,0.006881825,0.00005496767,0.0000029590046,0.00019335822,0.00028285224,0.0023715703,0.0011495425,0.0017050136,0.00012919429],"about_ca_topic_score_codex":0.0010529554,"about_ca_topic_score_gemma":0.00018134619,"teacher_disagreement_score":0.45766127,"about_ca_system_score_codex":0.000019459576,"about_ca_system_score_gemma":0.00020467851,"threshold_uncertainty_score":0.7400126},"labels":[],"label_agreement":null},{"id":"W2807787512","doi":"10.1136/annrheumdis-2018-eular.4269","title":"THU0298 Peritenon extensor tendon inflammation, synovitis and enthesopathy in psoriatic arthritis: what is the connexion?","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Celgene; Gilead Sciences; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Enthesis; Medicine; Enthesitis; Synovitis; Psoriatic arthritis; Tenosynovitis; Intraclass correlation; Enthesopathy; Tendon; Arthritis; Psoriasis; Radiology; Pathology; Surgery; Dermatology; Internal medicine","score_opus":0.021118465200215424,"score_gpt":0.2882132328753216,"score_spread":0.26709476767510615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807787512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93528587,0.048620332,0.0000016032654,0.01491719,0.00020200844,0.00070282083,0.000047803733,0.000019059351,0.00020333033],"genre_scores_gemma":[0.9698687,0.028495068,0.000023679515,0.0013183508,0.00007210395,0.000092245195,0.0000066880552,0.00001687016,0.00010628502],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99870116,0.000104902545,0.000423467,0.0002123427,0.0003113094,0.00024684242],"domain_scores_gemma":[0.9988346,0.00023575184,0.00019111713,0.0004704133,0.0001815293,0.00008657023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017414252,0.00017863813,0.00039414613,0.00006536889,0.00021670222,0.00006859856,0.00013161477,0.000036487778,0.00017388487],"category_scores_gemma":[0.0004556453,0.00010012191,0.00013931464,0.00019147093,0.00043605664,0.00023520555,0.00010441112,0.00006210845,0.000026604008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005075267,0.0007391502,0.061860632,0.00048155183,0.00063253555,0.00004455591,0.010115189,0.0000015394822,0.0000657838,0.0018655155,0.0033868097,0.92029923],"study_design_scores_gemma":[0.0045369407,0.0008944248,0.9570123,0.010291734,0.0003257587,0.00011893309,0.009299074,0.00025763997,0.002487955,0.013019171,0.0014867545,0.0002693434],"about_ca_topic_score_codex":0.00012490315,"about_ca_topic_score_gemma":0.000077173725,"teacher_disagreement_score":0.9200299,"about_ca_system_score_codex":0.00001284201,"about_ca_system_score_gemma":0.000043732485,"threshold_uncertainty_score":0.40828532},"labels":[],"label_agreement":null},{"id":"W2807800334","doi":"10.1136/annrheumdis-2018-eular.3132","title":"THU0294 5-year efficacy and safety of apremilast treatment in subjects with psoriatic arthritis: pooled analysis of the palace studies","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Apremilast; Psoriatic arthritis; Placebo; Internal medicine; Adverse effect; Tolerability; Arthritis; Alternative medicine","score_opus":0.03308156230402172,"score_gpt":0.3277649653153326,"score_spread":0.2946834030113109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807800334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98800766,0.010351622,0.0000020835937,0.0007159757,0.000019140403,0.0006153667,0.000031842017,0.00000589432,0.00025042996],"genre_scores_gemma":[0.9934247,0.0063741105,0.000014085381,0.000040756757,0.000006065106,0.000021343656,0.0000032590901,0.000009573531,0.00010607286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858505,0.00018351292,0.00051964336,0.00014806447,0.00038853177,0.00017521251],"domain_scores_gemma":[0.99848765,0.00033319532,0.00031767332,0.0005788596,0.00023367973,0.00004893244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024824293,0.00013798848,0.0007994491,0.000158049,0.000067622634,0.0000049329637,0.00015895662,0.000027511996,0.00004859521],"category_scores_gemma":[0.0007521824,0.00006570914,0.00020045154,0.000789062,0.00067222706,0.000049657385,0.00010052391,0.000048337533,0.000001162028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004848254,0.0028629177,0.8779224,0.0022235045,0.022449428,0.0000050375315,0.0140865315,0.00046267943,0.00028238274,0.0006509575,0.000645281,0.07356062],"study_design_scores_gemma":[0.0028081143,0.0006596,0.98618406,0.0025173435,0.00166026,9.250027e-7,0.0034089095,0.00030449225,0.0021868236,0.00017891928,0.000019608482,0.00007091539],"about_ca_topic_score_codex":0.00013064349,"about_ca_topic_score_gemma":0.00020271658,"teacher_disagreement_score":0.10826168,"about_ca_system_score_codex":0.000016627682,"about_ca_system_score_gemma":0.00017464902,"threshold_uncertainty_score":0.26795408},"labels":[],"label_agreement":null},{"id":"W2807845149","doi":"10.1136/annrheumdis-2018-eular.5723","title":"SAT0322 The effect of guselkumab on dactylitis: results from a phase 2 study in patients with active psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation","funders":"","keywords":"Dactylitis; Medicine; Psoriatic arthritis; Psoriasis; Tolerability; Internal medicine; Surgery; Dermatology; Adverse effect; Enthesitis","score_opus":0.017262814402632356,"score_gpt":0.3171502949072817,"score_spread":0.29988748050464936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807845149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953364,0.0009712346,9.883111e-7,0.0004901459,0.00009896904,0.0020939598,0.0008037858,0.000017047993,0.00018742969],"genre_scores_gemma":[0.99899495,0.0007085388,0.0000064310248,0.00007338915,0.000034640525,0.00009232791,0.000050678165,0.000023543718,0.000015494345],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972742,0.00065556867,0.00057601905,0.0002717212,0.0009172408,0.0003052411],"domain_scores_gemma":[0.99712455,0.0012614814,0.0003514274,0.0009066201,0.0002254024,0.0001305428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041017839,0.00022040211,0.00063995173,0.000117024116,0.00012015584,0.00002512706,0.00033274066,0.00003152594,0.000113366485],"category_scores_gemma":[0.002360038,0.0001057489,0.00015135846,0.0003249433,0.0004658751,0.00012825994,0.000084639134,0.00014975654,0.000015854934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06709799,0.009458545,0.120797485,0.00017811761,0.001945356,0.000016241567,0.010367964,0.00001135476,0.000010931136,0.000050464536,0.0027120325,0.7873535],"study_design_scores_gemma":[0.03810004,0.022203036,0.930129,0.0051336396,0.000059636935,9.487782e-7,0.0010861162,0.000043730884,0.0026221261,0.00041584336,0.00006722805,0.00013867521],"about_ca_topic_score_codex":0.0007040655,"about_ca_topic_score_gemma":0.00017590856,"teacher_disagreement_score":0.8093315,"about_ca_system_score_codex":0.000019067178,"about_ca_system_score_gemma":0.00010323556,"threshold_uncertainty_score":0.4312315},"labels":[],"label_agreement":null},{"id":"W2807850784","doi":"10.1136/annrheumdis-2018-eular.3820","title":"SAT0565 Adjusting for the intra-articular placebo effect in knee osteoarthritis therapies","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Placebo; Osteoarthritis; Minimal clinically important difference; Saline; Meta-analysis; Intra articular; Randomized controlled trial; Anesthesia; Physical therapy; Internal medicine; Pathology","score_opus":0.03872998822870849,"score_gpt":0.30088856515183343,"score_spread":0.26215857692312494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807850784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911492,0.0018975725,0.0006756796,0.002657257,0.00044715684,0.002427926,0.000038866885,0.000059749458,0.0006465787],"genre_scores_gemma":[0.9982367,0.00012549241,0.000020374007,0.0011251735,0.000063511216,0.00026456334,0.0000011247016,0.000017597058,0.00014543987],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760514,0.0012357399,0.00028726555,0.0002303278,0.00029391344,0.00034759112],"domain_scores_gemma":[0.98849577,0.010765041,0.00017381282,0.0004817627,0.00003608985,0.00004751798],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002066317,0.00017317754,0.00024938866,0.000066156106,0.00028794716,0.000076393095,0.00053219975,0.000029440294,0.00006970883],"category_scores_gemma":[0.009668765,0.000094488336,0.00021413006,0.00030923393,0.00035655205,0.00014823383,0.00012494098,0.000071484654,0.00002996742],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013980226,0.00021365535,0.009884601,0.0009876821,0.00014323585,0.0000054286247,0.0023949197,0.0004932381,0.0054182545,0.0026726,0.011764352,0.964624],"study_design_scores_gemma":[0.017188476,0.0065477616,0.20251332,0.009799012,0.0012035416,0.000016230904,0.002654433,0.17689925,0.5045521,0.0618772,0.014432094,0.002316569],"about_ca_topic_score_codex":0.000026391632,"about_ca_topic_score_gemma":0.000025847787,"teacher_disagreement_score":0.96230745,"about_ca_system_score_codex":0.000006853665,"about_ca_system_score_gemma":0.000021871012,"threshold_uncertainty_score":0.9986732},"labels":[],"label_agreement":null},{"id":"W2807893669","doi":"10.1136/annrheumdis-2018-eular.2053","title":"SAT0291 Creation of a european database of patients with axial spondyloarthritis treated in clinical practice– initial, preliminary findings from the eurospa research network collaboration","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"Samsung; Celgene; Biogen; Pfizer; Celltrion; Eli Lilly and Company","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Axial spondyloarthritis; Disease; Biologic Agents; Clinical Practice; Physical therapy","score_opus":0.07442482159046844,"score_gpt":0.40480058718519213,"score_spread":0.3303757655947237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807893669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947022,0.0016682138,0.000002588076,0.0009307407,0.00011004583,0.0010018874,0.0008815493,0.0000087911185,0.00069394195],"genre_scores_gemma":[0.99800646,0.0011599419,0.00018254135,0.00014828924,0.000099898876,0.000023623392,0.00033600532,0.00002244087,0.000020815769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969242,0.001102964,0.0007969988,0.00023878826,0.000691533,0.0002455059],"domain_scores_gemma":[0.9959816,0.0017064415,0.0004756126,0.0005954326,0.0011638325,0.00007712997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010423703,0.00014190565,0.00043050532,0.00006738131,0.00017411224,0.000017088254,0.00019347163,0.00003746831,0.00007043768],"category_scores_gemma":[0.004945594,0.00008265125,0.00011718952,0.0007336292,0.000792095,0.00019950676,0.00018908025,0.00012838304,0.0000079993315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015211731,0.0035232692,0.9470766,0.00012883308,0.00054798386,0.000031683772,0.0012719316,0.000013900469,0.0000108001705,0.00012480328,0.010115195,0.02194326],"study_design_scores_gemma":[0.00431656,0.0035329224,0.98716635,0.003335603,0.00029233386,0.0000015010065,0.0006609092,0.000042817206,0.00018074377,0.00009004476,0.00031130403,0.00006894213],"about_ca_topic_score_codex":0.00058977096,"about_ca_topic_score_gemma":0.00019534191,"teacher_disagreement_score":0.04008971,"about_ca_system_score_codex":0.000014853406,"about_ca_system_score_gemma":0.00013577586,"threshold_uncertainty_score":0.5920695},"labels":[],"label_agreement":null},{"id":"W2807919770","doi":"10.1136/annrheumdis-2018-eular.4121","title":"THU0667 Disease, work and personal related factors associated with presenteeism in patients with rheumatoid arthritis: results from the national rheumatoid arthritis society survey (NRAS)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Presenteeism; Medicine; Rheumatoid arthritis; Absenteeism; Psychological intervention; Physical therapy; Family medicine; Internal medicine; Psychiatry; Psychology","score_opus":0.045487075158628626,"score_gpt":0.31910435802554565,"score_spread":0.273617282866917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807919770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892881,0.0021063876,0.0000041373733,0.003704487,0.00024719164,0.0014589208,0.0029457663,0.00007410868,0.00017088241],"genre_scores_gemma":[0.9948104,0.0029445528,0.000014545722,0.0010738261,0.00003147128,0.00009866986,0.00086729793,0.000057314817,0.00010194447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941938,0.0019323409,0.0012239198,0.00055362156,0.0012666166,0.0008296832],"domain_scores_gemma":[0.99111146,0.0060370276,0.0011164054,0.0004677223,0.000843108,0.0004242873],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0016805074,0.0004018082,0.0006487212,0.0000693027,0.0014419265,0.00005452222,0.00043737006,0.00018643685,0.00015426322],"category_scores_gemma":[0.0051855342,0.00022740728,0.00015751815,0.0007977572,0.0007320225,0.00032470655,0.00022414197,0.0006132395,0.000016641612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014826996,0.00035704888,0.9605219,0.000052980533,0.0002840716,5.562219e-7,0.0059981034,0.000016524269,5.0259672e-8,0.00007061852,0.030246383,0.000969081],"study_design_scores_gemma":[0.0051447675,0.000115715506,0.97978765,0.011988425,0.000015339756,1.2359392e-7,0.0012595757,0.00022487147,0.0000010097127,0.0010389228,0.00014507887,0.00027850922],"about_ca_topic_score_codex":0.0014966252,"about_ca_topic_score_gemma":0.0016922536,"teacher_disagreement_score":0.030101303,"about_ca_system_score_codex":0.00009143634,"about_ca_system_score_gemma":0.00086567283,"threshold_uncertainty_score":0.9998581},"labels":[],"label_agreement":null},{"id":"W2807941420","doi":"10.1136/annrheumdis-2018-eular.5248","title":"SAT0513 Progressive skin fibrosis is associated with a decline in lung function and poorer survival in patients with diffuse cutaneous systemic sclerosis: a european scleroderma trials and research (EUSTAR) analysis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Internal medicine; Ejection fraction; Scleroderma (fungus); Proportional hazards model; Interstitial lung disease; Vital capacity; Fibrosis; Cardiology; Lung; Pathology; Heart failure; Diffusing capacity; Lung function","score_opus":0.06009139800521496,"score_gpt":0.3168844056328202,"score_spread":0.25679300762760526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807941420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139524,0.006316027,0.0000040993223,0.0004336674,0.000039471266,0.0015546789,0.00019979246,0.00002737062,0.000029661094],"genre_scores_gemma":[0.9987562,0.00085387024,0.000008982745,0.00017031058,0.00002886257,0.00006363021,0.000052857944,0.000042039002,0.000023263703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504834,0.0019883148,0.0009870703,0.00049872976,0.0010442476,0.00043329672],"domain_scores_gemma":[0.99701166,0.0008668271,0.00063775614,0.0005264361,0.00069742795,0.00025988475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018170509,0.00028660882,0.0012097368,0.0006088122,0.00016216101,0.000096956916,0.00017816799,0.00009669224,0.000038646194],"category_scores_gemma":[0.002078313,0.00015615129,0.00017323074,0.0017595071,0.00051910005,0.00013507555,0.00016717405,0.00018098939,0.0000018758166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037659695,0.0013424614,0.98558,0.00049398,0.0022875655,0.000009485028,0.0011942401,0.000024438506,0.000037553036,0.0000044414173,0.00028099626,0.004978844],"study_design_scores_gemma":[0.006707327,0.0008303017,0.96420836,0.024124635,0.002060362,0.0000049584755,0.0010720375,0.000728844,0.00005069891,0.000030800442,6.143764e-7,0.0001810534],"about_ca_topic_score_codex":0.0004804459,"about_ca_topic_score_gemma":0.00011582527,"teacher_disagreement_score":0.023630656,"about_ca_system_score_codex":0.000062538806,"about_ca_system_score_gemma":0.00012514948,"threshold_uncertainty_score":0.63676643},"labels":[],"label_agreement":null},{"id":"W2807978154","doi":"10.1136/annrheumdis-2018-eular.3646","title":"SAT0271 Secukinumab, a fully human anti-interleukin-17a monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52-week treatment period","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Myriad Genetics; UCB Pharma; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Psoriatic arthritis; Ankylosing spondylitis; Secukinumab; Immunogenicity; Concomitant; BASDAI; Internal medicine; Rheumatoid arthritis; Gastroenterology; Pharmacokinetics; Psoriasis Area and Severity Index; Methotrexate; Adalimumab; Adverse effect; Pharmacology; Immunology; Antibody; Psoriasis","score_opus":0.009129718896250853,"score_gpt":0.24014444326050666,"score_spread":0.2310147243642558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807978154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768142,0.021884188,0.0000038935473,0.00010274042,0.00021216933,0.0005817871,0.00030247643,0.000038473623,0.00006006568],"genre_scores_gemma":[0.99914324,0.00048947474,0.000008337599,0.000049631893,0.0000050816184,0.00003014981,0.00015802856,0.000029789244,0.00008625885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978933,0.0002930163,0.00068028487,0.00041939414,0.00012703896,0.0005869677],"domain_scores_gemma":[0.9987893,0.00008121381,0.00039546742,0.0005631627,0.00014723712,0.000023631423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015524476,0.00038097004,0.0006711104,0.00017576721,0.00059395423,0.000057121848,0.00035343016,0.00010703017,0.00030084496],"category_scores_gemma":[0.00010525741,0.00027429342,0.00021616796,0.00025550916,0.0008831616,0.00025020033,0.00017899327,0.00014381479,0.000020119645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012516927,0.021346988,0.5633205,0.002185186,0.0050754505,0.00006758424,0.040721394,0.00009744865,0.05588834,0.0013851719,0.00012065198,0.29727432],"study_design_scores_gemma":[0.0062681423,0.0014550545,0.97536135,0.0028763416,0.00009561015,0.00003029138,0.0007738614,0.000014367799,0.0124042,0.00028567956,0.00006421986,0.0003708702],"about_ca_topic_score_codex":0.0006087409,"about_ca_topic_score_gemma":0.00005669865,"teacher_disagreement_score":0.41204083,"about_ca_system_score_codex":0.000049389328,"about_ca_system_score_gemma":0.00010670993,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W2807998682","doi":"10.1136/annrheumdis-2018-eular.5563","title":"FRI0158 Prostaglandin e2 and its receptor subtype ep4 are involved in ankylosing spondylitis disease progression","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Single-nucleotide polymorphism; Rheumatology; Peripheral blood mononuclear cell; Spondylitis; Prostaglandin E2; Immunology; Gastroenterology; Biology","score_opus":0.03478220123667775,"score_gpt":0.3168825149666984,"score_spread":0.28210031373002065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807998682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916895,0.0051913233,0.0000010006036,0.001649279,0.0002469138,0.00093678315,0.00018438978,0.00003639765,0.000064383654],"genre_scores_gemma":[0.9988839,0.00042001856,0.000026884438,0.00031337942,0.00012606687,0.00005196469,0.000042501415,0.00002499042,0.000110316876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985235,0.00018311822,0.0003693619,0.00024116482,0.00037602367,0.00030687748],"domain_scores_gemma":[0.9987099,0.00014341326,0.00026485338,0.0003529157,0.0001740764,0.00035482834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033961693,0.00018969609,0.00038943585,0.00012176282,0.000109646084,0.000023418248,0.00012370382,0.000058478745,0.00019111905],"category_scores_gemma":[0.001644947,0.000121380064,0.000108293425,0.0002532388,0.00020716286,0.00015256091,0.00010393376,0.00009911633,0.000022451519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033392766,0.0006859015,0.96658856,0.0044690333,0.00009565089,0.000056401113,0.001050793,0.0000012422278,0.0007765868,0.0003279252,0.0070873136,0.015521312],"study_design_scores_gemma":[0.0016341568,0.00035590952,0.97455704,0.0109085925,0.00011870963,0.0000041021844,0.0001969683,0.0009615813,0.009221548,0.0007280043,0.0010954195,0.00021796352],"about_ca_topic_score_codex":0.000014200339,"about_ca_topic_score_gemma":0.000011738347,"teacher_disagreement_score":0.015303349,"about_ca_system_score_codex":0.000020387084,"about_ca_system_score_gemma":0.00015351157,"threshold_uncertainty_score":0.49497354},"labels":[],"label_agreement":null},{"id":"W2808011810","doi":"10.1136/annrheumdis-2018-eular.2039","title":"AB0294 Treatment modes in rheumatoid arthritis: factors influencing patient preference","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"UCB Pharma; Sanofi Genzyme; Genentech; Celgene; Biogen; Celltrion; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Preference; Coding (social sciences); Internal medicine; Physical therapy; Family medicine","score_opus":0.061557971472836155,"score_gpt":0.3094025394136426,"score_spread":0.24784456794080645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808011810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862374,0.011830182,0.0000075961266,0.00037474654,0.000096067044,0.00062734145,0.00006784902,0.000045979792,0.0007128063],"genre_scores_gemma":[0.96094036,0.03874656,0.000049030063,0.00010559487,0.000016411877,0.00007319583,0.000011061422,0.000022798607,0.000034978344],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99801856,0.00014440165,0.00058706175,0.000261692,0.00053115457,0.00045712976],"domain_scores_gemma":[0.9985658,0.00017658381,0.00019558215,0.0006091594,0.00020832715,0.00024455838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109417495,0.00024467398,0.0005368877,0.00017150115,0.00014400043,0.00004087064,0.00022657494,0.00004973936,0.00025237023],"category_scores_gemma":[0.000534627,0.00015019254,0.00023581802,0.00028257634,0.00042928124,0.00020852353,0.00010088925,0.00008879071,0.000033804045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001055834,0.0036140934,0.44244874,0.00035991703,0.000771058,0.000022728547,0.016178876,0.00009314648,0.0010304932,0.0023940306,0.002426266,0.52960485],"study_design_scores_gemma":[0.0059815734,0.0054190303,0.86242926,0.019439457,0.000021313997,0.0000520082,0.008931731,0.001208148,0.08054436,0.012924919,0.0023196274,0.0007285756],"about_ca_topic_score_codex":0.00081142597,"about_ca_topic_score_gemma":0.00022922854,"teacher_disagreement_score":0.52887625,"about_ca_system_score_codex":0.00004803647,"about_ca_system_score_gemma":0.00025778954,"threshold_uncertainty_score":0.61246747},"labels":[],"label_agreement":null},{"id":"W2808042837","doi":"10.1136/annrheumdis-2018-eular.1840","title":"PARE0003 Providing patient and family education and support for children with rheumatic diseases and their families: cassie and friends annual family day in bc","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Family medicine; Rheumatic disease; Recreation; Pediatrics; Disease; Internal medicine","score_opus":0.019586054774004026,"score_gpt":0.2933213573472374,"score_spread":0.27373530257323336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808042837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786587,0.009760425,0.000024511,0.0004561169,0.000039030776,0.0014113018,0.0002502862,0.000020402182,0.00017203308],"genre_scores_gemma":[0.99614316,0.003072078,0.00005508068,0.0003588062,0.00001653925,0.00018458786,0.000044255405,0.000028197215,0.000097273696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852395,0.00010617012,0.00046039693,0.00033292032,0.00025882473,0.0003177648],"domain_scores_gemma":[0.99876857,0.00025330597,0.00021699368,0.000338457,0.00020605089,0.00021660015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002348899,0.00025170133,0.0005256251,0.00017504835,0.00021736432,0.000060851842,0.000105628875,0.000052511896,0.00000983711],"category_scores_gemma":[0.00043655344,0.00015200369,0.000054402757,0.00017833352,0.00070400414,0.00030843512,0.00015002517,0.00008197727,8.4479143e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004593942,0.00077652076,0.6196005,0.0019711321,0.000406536,0.000001320841,0.010238955,0.0000018528938,0.000076028664,0.0002258933,0.00343065,0.36281127],"study_design_scores_gemma":[0.001352919,0.0010353038,0.9783938,0.0016010947,0.00013597556,0.000013214036,0.01577684,0.00044960293,0.000093182425,0.00073662016,0.00021832735,0.00019313152],"about_ca_topic_score_codex":0.00021682029,"about_ca_topic_score_gemma":0.000010516789,"teacher_disagreement_score":0.36261812,"about_ca_system_score_codex":0.000013497019,"about_ca_system_score_gemma":0.00040960795,"threshold_uncertainty_score":0.619853},"labels":[],"label_agreement":null},{"id":"W2808047780","doi":"10.1136/annrheumdis-2018-eular.1406","title":"OP0345 Denosumab compared with risedronate in glucocorticoid-treated subjects: results from the final 24-month analysis of a randomised, double-blind, double-dummy study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Celgene; Astellas Pharma; Alexion Pharmaceuticals; Daiichi-Sankyo; McMaster University; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Denosumab; Osteoporosis; Glucocorticoid; Adverse effect; Internal medicine; Population; Femoral neck; Prednisone; Urology","score_opus":0.1095772070930975,"score_gpt":0.36136589538156716,"score_spread":0.2517886882884697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808047780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312943,0.0012097606,0.000004897276,0.0009474109,0.00006741642,0.0039107697,0.00036731386,0.00002794301,0.00033507732],"genre_scores_gemma":[0.99894303,0.00012995076,0.000034913897,0.00023133392,0.000015420374,0.0002021247,0.00021188808,0.000025777807,0.00020554401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967614,0.0003281169,0.0012750737,0.0004403472,0.00077751296,0.00041758537],"domain_scores_gemma":[0.9962773,0.0008614784,0.0009048526,0.001340813,0.00039209434,0.00022349828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048044504,0.00032858617,0.0013923984,0.00028381345,0.00014429253,0.000029003271,0.00039949623,0.000060671806,0.00009289199],"category_scores_gemma":[0.00025740577,0.00016378473,0.00039070635,0.0016750194,0.00032966974,0.00010434641,0.00009867314,0.00014183039,0.000015703676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41790193,0.0045850743,0.5648221,0.000118892676,0.007803225,0.000024169885,0.0025959099,0.00042765308,0.000004486629,0.000009946522,0.00048284617,0.0012237958],"study_design_scores_gemma":[0.23502342,0.0010090481,0.75262535,0.000814434,0.0070832735,0.0000018771196,0.0011068109,0.0017407765,0.00038513556,0.000052565552,0.00001281298,0.00014449368],"about_ca_topic_score_codex":0.023759698,"about_ca_topic_score_gemma":0.008140067,"teacher_disagreement_score":0.18780327,"about_ca_system_score_codex":0.00004578654,"about_ca_system_score_gemma":0.00037434688,"threshold_uncertainty_score":0.9827412},"labels":[],"label_agreement":null},{"id":"W2808072355","doi":"10.1136/annrheumdis-2018-eular.6190","title":"AB0125 Anti-dengue igg antibody positivity and risk of developing rheumatoid arthritis: evidence from the malaysian epidemiological investigation of rheumatoid arthritis (MYEIRA) case-control study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada","funders":"European Regional Development Fund; Instituto de Salud Carlos III; Guangdong Provincial Hospital of Traditional Chinese Medicine","keywords":"Medicine; Dengue fever; Malay; Rheumatoid arthritis; Immunology; Odds ratio; Antibody; Internal medicine; Population; Dengue virus; Chikungunya; Confidence interval","score_opus":0.04020359833723088,"score_gpt":0.32160126884796314,"score_spread":0.2813976705107323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808072355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95678973,0.03765897,0.00065126305,0.0022145875,0.000132554,0.0016489943,0.0008547617,0.00004010741,0.000009017062],"genre_scores_gemma":[0.96217775,0.03698803,0.00020115929,0.0004589469,0.000059768856,0.00006513178,0.000018952658,0.000028285687,0.0000019556028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951878,0.00172833,0.0015046643,0.00053300813,0.0006277369,0.00041842696],"domain_scores_gemma":[0.9928109,0.0037720336,0.0014231467,0.0011168849,0.00059834437,0.0002787124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001798736,0.00039484003,0.0015257745,0.00009214011,0.0003387625,0.00004316928,0.0004305789,0.000112723654,0.00009700732],"category_scores_gemma":[0.008298655,0.00024071989,0.00045231878,0.00036256976,0.0011541249,0.00029078286,0.00023023348,0.00021399662,0.000005110709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044129058,0.0004134267,0.9639347,0.00019681474,0.0011116771,0.000042101696,0.0011005878,0.000023879593,0.00050410547,0.00027593665,0.00037544235,0.031580016],"study_design_scores_gemma":[0.0024782598,0.0005859022,0.9786078,0.010288498,0.00032351277,0.00011790461,0.0017378103,0.0020585898,0.0010542762,0.0025095558,0.0000046002524,0.00023331383],"about_ca_topic_score_codex":0.0034882545,"about_ca_topic_score_gemma":0.00029865262,"teacher_disagreement_score":0.0313467,"about_ca_system_score_codex":0.00001577682,"about_ca_system_score_gemma":0.0002826458,"threshold_uncertainty_score":0.9934864},"labels":[],"label_agreement":null},{"id":"W2808077593","doi":"10.1136/annrheumdis-2018-eular.2676","title":"SAT0111 Efficacy of tofacitinib in patients with moderate to severe rheumatoid arthritis by baseline c-reactive protein levels and erythrocyte sedimentation rates","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Tofacitinib; Erythrocyte sedimentation rate; Rheumatoid arthritis; Internal medicine; Methotrexate; C-reactive protein; Gastroenterology; Adverse effect; Placebo; Inflammation; Pathology","score_opus":0.020380871942461624,"score_gpt":0.2924875563265393,"score_spread":0.27210668438407765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808077593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949186,0.0017173317,0.000086430024,0.00097480905,0.0000264259,0.0015688647,0.0006358971,0.000017948385,0.000053690732],"genre_scores_gemma":[0.99862385,0.0007167174,0.00024540888,0.00019408212,0.000008920716,0.00007549593,0.00007126064,0.000025998137,0.000038286667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998182,0.00018128865,0.000513216,0.00026554236,0.0005517396,0.00030619485],"domain_scores_gemma":[0.9985646,0.00019264618,0.0002408133,0.00032460832,0.00046080197,0.00021652239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025602026,0.00020928553,0.00052153895,0.00013754985,0.00009511523,0.00002930944,0.00012753198,0.000038536324,0.00015727064],"category_scores_gemma":[0.00067566853,0.00014240509,0.000073740695,0.00028949478,0.00036725978,0.0002517813,0.00007768525,0.00008639715,0.0000076070723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03640245,0.00808594,0.53059703,0.0015639323,0.0018850624,0.0000108220975,0.010417845,0.00008834953,0.0058233533,0.0010242681,0.012321248,0.39177972],"study_design_scores_gemma":[0.017503213,0.0030853304,0.8330889,0.013141568,0.000016652039,0.000009598583,0.0008265549,0.0003217539,0.12972939,0.0015971449,0.00024724202,0.00043264785],"about_ca_topic_score_codex":0.00020536935,"about_ca_topic_score_gemma":0.000040800325,"teacher_disagreement_score":0.39134708,"about_ca_system_score_codex":0.000015842073,"about_ca_system_score_gemma":0.00013458324,"threshold_uncertainty_score":0.58071107},"labels":[],"label_agreement":null},{"id":"W2808088865","doi":"10.1136/annrheumdis-2018-eular.4041","title":"PARE0014 Getting the pulse on workplace experiences and accommodations","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"Sanofi Genzyme; Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. Prof. dr hab. med. Eleonory Reicher","keywords":"Arthritis; Outreach; Medicine; Promotion (chess); Public relations; Business; Family medicine; Political science","score_opus":0.05593694995273274,"score_gpt":0.3546067640637168,"score_spread":0.29866981411098403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808088865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833622,0.0013040886,0.000008566739,0.013462,0.000068862566,0.00029526177,0.000007532376,0.00001701805,0.0014744628],"genre_scores_gemma":[0.9990455,0.00018503932,0.000028959013,0.00016573489,0.00002430928,0.000050814535,0.00000318897,0.000008957179,0.00048751244],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989732,0.00010861351,0.0001982801,0.00013469676,0.0003732072,0.00021202752],"domain_scores_gemma":[0.99881315,0.0004169265,0.00008989651,0.00048461184,0.00009709204,0.00009829746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023016386,0.000094719675,0.00016980601,0.000038363014,0.00028919213,0.00003524643,0.00024144523,0.000024672092,0.0005040059],"category_scores_gemma":[0.0008230462,0.000045729965,0.00008613675,0.00019823678,0.00060002896,0.0000650863,0.000111601184,0.00008530056,0.000024854631],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018498183,0.0033476858,0.11814771,0.011389044,0.0021955199,0.000023795314,0.073971815,0.00008686037,0.0006404616,0.01659163,0.28713247,0.48462316],"study_design_scores_gemma":[0.0018443133,0.0016691812,0.92993677,0.013305802,0.00027019143,0.00007949468,0.032145627,0.004790581,0.0075413096,0.006877744,0.0011011515,0.0004378435],"about_ca_topic_score_codex":0.0000417573,"about_ca_topic_score_gemma":0.000001417358,"teacher_disagreement_score":0.81178904,"about_ca_system_score_codex":0.000008018788,"about_ca_system_score_gemma":0.000108004104,"threshold_uncertainty_score":0.5518511},"labels":[],"label_agreement":null},{"id":"W2808209724","doi":"10.1136/annrheumdis-2018-eular.2140","title":"OP0307 Efficacy and safety of risankizumab, a selective il-23p19 inhibitor, in patients with active psoriatic arthritis over 24 weeks: results from a phase 2 trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Enthesitis; Internal medicine; Placebo; Clinical endpoint; Golimumab; Synovitis; Gastroenterology; Arthritis; Surgery; Rheumatoid arthritis; Randomized controlled trial; Etanercept; Pathology","score_opus":0.017582912759857173,"score_gpt":0.26635962034093,"score_spread":0.24877670758107284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808209724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929907,0.001291565,0.0000022354081,0.000072809555,0.00043333767,0.0010218451,0.004078629,0.00001566789,0.00009326303],"genre_scores_gemma":[0.999142,0.00041566778,0.000021608344,0.000030426467,0.000036134657,0.000037856502,0.00025761884,0.000015721394,0.00004300036],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982568,0.00045212283,0.000600257,0.00032156508,0.00011165454,0.00025758584],"domain_scores_gemma":[0.9981105,0.0007795356,0.00053861673,0.00038372792,0.00014749754,0.000040167877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014498345,0.00023664777,0.0005983029,0.00010910864,0.00011735079,0.000009457173,0.00018525952,0.00012008251,0.00008820124],"category_scores_gemma":[0.0006704841,0.00015576824,0.00012548147,0.00025142496,0.00041188352,0.00014289223,0.000086129585,0.000091355374,0.000011718125],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45023453,0.0071722586,0.004631778,0.00004738391,0.0025554711,0.0000020122372,0.0054353736,0.0000030474891,0.00021300316,0.000053672673,0.0026104422,0.527041],"study_design_scores_gemma":[0.30651772,0.0058975276,0.6625402,0.0018114973,0.00057785463,9.728773e-7,0.00031624438,0.0000062921,0.020815087,0.00096691423,0.00022129851,0.00032840326],"about_ca_topic_score_codex":0.00047091406,"about_ca_topic_score_gemma":0.0001160637,"teacher_disagreement_score":0.6579084,"about_ca_system_score_codex":0.000021524282,"about_ca_system_score_gemma":0.00012937174,"threshold_uncertainty_score":0.63520443},"labels":[],"label_agreement":null},{"id":"W2808262647","doi":"10.1136/annrheumdis-2018-eular.4107","title":"SAT0570 Resting-state fmri brain connectivity in hand osteoarthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Gaziantep Üniversitesi; Marmara Üniversitesi; Necmettin Erbakan Üniversitesi; Dicle Üniversitesi; Sakarya Üniversitesi; Akdeniz Üniversitesi; Sivas Cumhuriyet Üniversitesi; Karadeniz Teknik Üniversitesi; Adnan Menderes Üniversitesi; National Institute for Health and Care Research","keywords":"Resting state fMRI; Medicine; Osteoarthritis; Functional connectivity; Neuroscience; Physical medicine and rehabilitation; Pathology","score_opus":0.05574447150028101,"score_gpt":0.3280217433286149,"score_spread":0.2722772718283339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808262647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783367,0.0005166006,0.000010872387,0.01960528,0.00010445162,0.00022165051,0.000020118812,0.000015465035,0.001168839],"genre_scores_gemma":[0.9973684,0.00006729957,0.000029357949,0.002155265,0.000042087584,0.000008347382,0.0000020768273,0.0000027757146,0.00032436833],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998891,0.00014588362,0.00026717706,0.00016767824,0.00029976235,0.00022852731],"domain_scores_gemma":[0.99885565,0.00057708815,0.00010874754,0.00020805374,0.000075375625,0.0001750915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048483143,0.00008540421,0.00026487742,0.000031124837,0.000090588044,0.000015542246,0.0001781941,0.00003215825,0.00032817607],"category_scores_gemma":[0.006561552,0.000041257998,0.00009449104,0.00027486196,0.0010115387,0.00004824826,0.00009247507,0.00006741968,0.000023416045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047214993,0.00084917754,0.3129573,0.00035212803,0.000044337667,0.00002149765,0.0005688311,0.0000028759578,0.0015655563,0.0005407475,0.01667459,0.66595083],"study_design_scores_gemma":[0.00071517524,0.0008212359,0.9720351,0.001394349,0.00001329681,0.000007661701,0.000083575964,0.000169092,0.002654697,0.021334881,0.00068717357,0.00008375451],"about_ca_topic_score_codex":0.00021161104,"about_ca_topic_score_gemma":0.00017434882,"teacher_disagreement_score":0.6658671,"about_ca_system_score_codex":0.000004742421,"about_ca_system_score_gemma":0.00007199173,"threshold_uncertainty_score":0.78552645},"labels":[],"label_agreement":null},{"id":"W2808310542","doi":"10.1136/annrheumdis-2018-eular.2638","title":"AB0415 Disease flares among early rheumatoid arthritis patients treated with continued methotrexate either alone or in combination with adalimumab","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Japan; Ono Pharmaceutical; AbbVie Canada; Amgen; Astellas Foundation for Research on Metabolic Disorders; Teijin Pharma; Novo Nordisk; GlaxoSmithKline; Pfizer; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Methotrexate; Rheumatoid arthritis; Placebo; Internal medicine; Flare; Surgery; Pathology","score_opus":0.023588056656982322,"score_gpt":0.2935004729738323,"score_spread":0.26991241631685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808310542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713534,0.00055509893,0.000017623,0.0003904969,0.00003327915,0.0014913392,0.00009187051,0.00006191737,0.00022304385],"genre_scores_gemma":[0.9983658,0.00044945712,0.00008341019,0.00016274846,0.000015309204,0.00014369063,0.00006197857,0.0000674042,0.0006501841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970166,0.00033537962,0.00060939824,0.00039877312,0.0011216935,0.00051812106],"domain_scores_gemma":[0.9972905,0.00035649174,0.0003976182,0.000854165,0.000712368,0.00038887208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002960341,0.00031906329,0.0007084112,0.00020592981,0.00012116951,0.000056883466,0.0003189906,0.0000629695,0.00025780027],"category_scores_gemma":[0.0010548292,0.0001703589,0.00012229975,0.00073095434,0.00088030257,0.00029111205,0.00010753149,0.00012940583,0.000026256253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019814951,0.002917915,0.9497038,0.0007356443,0.00083437643,0.00016693979,0.0013428315,0.000020705222,0.000015686359,0.000100317695,0.0020288704,0.02231793],"study_design_scores_gemma":[0.03216759,0.0019211047,0.9541647,0.007905057,0.00013109604,0.000011481763,0.00017721328,0.0012857519,0.0017203325,0.00021219517,0.00003659285,0.00026689016],"about_ca_topic_score_codex":0.0018382978,"about_ca_topic_score_gemma":0.00068637705,"teacher_disagreement_score":0.022051038,"about_ca_system_score_codex":0.00041556978,"about_ca_system_score_gemma":0.0016309039,"threshold_uncertainty_score":0.69470346},"labels":[],"label_agreement":null},{"id":"W2808313322","doi":"10.1136/annrheumdis-2018-eular.2720","title":"AB0943 Sustained improvements with up to 104 weeks of apremilast monotherapy in biologic-naÏve subjects with active psoriatic arthritis: results from a phase 3b, randomised, controlled trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Apremilast; Adverse effect; Internal medicine; Placebo; Randomized controlled trial; Surgery; Arthritis; Physical therapy","score_opus":0.022762261221380576,"score_gpt":0.3165732447492673,"score_spread":0.2938109835278867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808313322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879953,0.0017943971,0.00007383582,0.0011688109,0.00014827959,0.008031254,0.0005364312,0.00003201822,0.00021964128],"genre_scores_gemma":[0.99526095,0.003378692,0.00012222314,0.00025281895,0.00008498707,0.00070467306,0.000053248317,0.00003632191,0.00010610354],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968534,0.00043722472,0.0010414186,0.00042607784,0.00071731006,0.0005245473],"domain_scores_gemma":[0.9966078,0.001089039,0.00067976513,0.000724912,0.00059629674,0.0003021828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005766083,0.00034567152,0.0014884628,0.00024959323,0.0001030755,0.000036905585,0.0003407872,0.00007287427,0.00013293029],"category_scores_gemma":[0.0026881665,0.00018576892,0.0002690832,0.0004580865,0.0005159266,0.00016694203,0.00006496763,0.0001385854,0.0000061550295],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9262795,0.0018356196,0.00019830308,0.00007058539,0.0014371519,0.00001285828,0.0030948294,0.000009002365,0.0007235368,0.00003766423,0.0004956036,0.06580533],"study_design_scores_gemma":[0.96078366,0.014833952,0.002626792,0.0040012393,0.00006592191,0.000003131462,0.0029059912,0.00022482895,0.013248148,0.0010119395,0.000050791492,0.00024361452],"about_ca_topic_score_codex":0.00071838073,"about_ca_topic_score_gemma":0.0003230282,"teacher_disagreement_score":0.06556172,"about_ca_system_score_codex":0.00003241514,"about_ca_system_score_gemma":0.0004901589,"threshold_uncertainty_score":0.7575437},"labels":[],"label_agreement":null},{"id":"W2808388887","doi":"10.1136/annrheumdis-2018-eular.5304","title":"FRI0556 Automated scoring of knee osteoarthritis (OA) on routine radiographs identifies disease severity in oa","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"WOMAC; Osteoarthritis; Medicine; Radiography; Knee Joint; Body mass index; Physical therapy; Internal medicine; Surgery; Pathology","score_opus":0.025594085305097568,"score_gpt":0.296006312572208,"score_spread":0.27041222726711045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808388887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952477,0.0022736401,0.0000029389341,0.0005493694,0.00035141836,0.00073854945,0.00019115314,0.00012809558,0.00051710365],"genre_scores_gemma":[0.9992266,0.00017361886,0.000056092973,0.00018315519,0.000045585322,0.00005101308,0.000038508257,0.000027531798,0.0001978801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981957,0.00012847663,0.0005712123,0.00027696384,0.00049944874,0.0003282002],"domain_scores_gemma":[0.9985,0.00012740435,0.0002734442,0.0006872711,0.00017409027,0.00023781759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020309401,0.00023506868,0.0005654154,0.00025755615,0.00009375164,0.000021853042,0.00019469384,0.000052165502,0.00015538138],"category_scores_gemma":[0.0005207704,0.00017609612,0.00037644844,0.0004694945,0.0003168987,0.00015532254,0.000101848666,0.00007728067,0.000025745085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008123675,0.008067042,0.53784835,0.0046543665,0.0011128769,0.00029799348,0.003005791,0.00007137134,0.0037038852,0.0038669638,0.0057496666,0.423498],"study_design_scores_gemma":[0.0074720653,0.0037778756,0.9340883,0.012490226,0.0005619737,0.000015511616,0.0005019143,0.0006926928,0.034283973,0.005659546,0.000059376594,0.00039655453],"about_ca_topic_score_codex":0.00009286611,"about_ca_topic_score_gemma":0.00004851762,"teacher_disagreement_score":0.42310145,"about_ca_system_score_codex":0.000016987124,"about_ca_system_score_gemma":0.00008973907,"threshold_uncertainty_score":0.7180991},"labels":[],"label_agreement":null},{"id":"W2808406427","doi":"10.1136/annrheumdis-2018-eular.4851","title":"THU0697 Risk of major congenital malformations associated with exposure to conventional synthetic disease modifying antirheumatic drugs in women with inflammatory arthritis: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Psoriatic arthritis; Sulfasalazine; Leflunomide; Pregnancy; Population; Cohort; Internal medicine; Azathioprine; Retrospective cohort study; Hydroxychloroquine; Arthritis; Odds ratio; Pediatrics; Rheumatoid arthritis; Obstetrics; Disease","score_opus":0.013395015087406845,"score_gpt":0.2698075644103223,"score_spread":0.2564125493229154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808406427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966278,0.0003218412,0.00014815724,0.00036124059,0.000039215534,0.0021294807,0.0002962334,0.000038483406,0.00003753239],"genre_scores_gemma":[0.9992307,0.00003466004,0.000054464475,0.00014711633,0.000008620655,0.00041937194,0.000051276937,0.000023086875,0.000030730247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976672,0.0002757065,0.00073609984,0.00021139637,0.000820661,0.00028896652],"domain_scores_gemma":[0.99772674,0.00033809972,0.0006398707,0.0005731475,0.00038016622,0.00034199248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006103428,0.00020131569,0.0005252789,0.0002464368,0.00013611293,0.00001771566,0.00018989986,0.00003526616,0.00014734386],"category_scores_gemma":[0.0019775385,0.00013128782,0.00009839898,0.00048159497,0.00024623546,0.00019721077,0.0000360218,0.0000995686,0.000007002553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012612562,0.0015114311,0.99179786,0.00038076245,0.00067518896,0.000003225152,0.0023824333,0.00044510321,0.0000025760419,0.000037995454,0.000052439922,0.001449717],"study_design_scores_gemma":[0.0038160596,0.0008015722,0.9816039,0.010153273,0.00039029928,0.0000021025269,0.0016924789,0.0010706144,0.000032635646,0.00028719625,6.653106e-7,0.00014920716],"about_ca_topic_score_codex":0.00010888418,"about_ca_topic_score_gemma":0.000078458055,"teacher_disagreement_score":0.010193976,"about_ca_system_score_codex":0.000062525156,"about_ca_system_score_gemma":0.00052942865,"threshold_uncertainty_score":0.5353762},"labels":[],"label_agreement":null},{"id":"W2808407775","doi":"10.1136/annrheumdis-2018-eular.5579","title":"SAT0112 Guideline-based care improves outcomes that matter to patients: tighter control, less suffering, and greater well-being over the past decade in canadian ra patients","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; University of Toronto; McGill University","funders":"Sanofi Genzyme; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Guideline; Cohort; Internal medicine; Physical therapy; Clinical Practice; Pediatrics","score_opus":0.013946495556427624,"score_gpt":0.28116766236796575,"score_spread":0.2672211668115381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808407775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188954,0.00062242284,0.0000049023943,0.0059180553,0.0001575888,0.00096706423,0.00012737904,0.000012324325,0.0003007228],"genre_scores_gemma":[0.9909275,0.00012468628,0.000022336157,0.008692248,0.00003229992,0.00006821204,0.000026205063,0.000032624575,0.0000738786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981356,0.00014127167,0.00044682785,0.00024762246,0.00047001787,0.00055862725],"domain_scores_gemma":[0.9984743,0.00013454647,0.00011927369,0.00051126635,0.00034211407,0.00041848968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016356661,0.00023986345,0.00042536424,0.00020080151,0.0001879315,0.0000864305,0.00028732122,0.000049532813,0.0003128098],"category_scores_gemma":[0.00025641854,0.00012666748,0.0001512543,0.00012759348,0.00026453412,0.00014465618,0.00009355638,0.00009787541,0.000050916133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019054287,0.00009180604,0.97972125,0.00012898596,0.00010967961,0.0000017205446,0.0012622849,0.0000029734952,0.0000034625864,0.000013088018,0.009444954,0.009029257],"study_design_scores_gemma":[0.0026435477,0.00016034019,0.99392456,0.0009571776,0.000020548145,5.421533e-7,0.00029746574,0.00008512177,0.00015907985,0.000078637306,0.0015230912,0.00014990082],"about_ca_topic_score_codex":0.03570571,"about_ca_topic_score_gemma":0.02040795,"teacher_disagreement_score":0.015297762,"about_ca_system_score_codex":0.00004674167,"about_ca_system_score_gemma":0.00013195182,"threshold_uncertainty_score":0.99746704},"labels":[],"label_agreement":null},{"id":"W2808434235","doi":"10.1136/annrheumdis-2018-eular.3769","title":"SAT0290 Canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs. non-biologic dmards in ankylosing spondylitis (COMPLETE-AS): 12-month effectiveness data","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Penticton Regional Hospital; University of British Columbia; Etobicoke General Hospital; McMaster University; University of Toronto; Memorial University of Newfoundland; Centre hospitalier de l'Université Laval","funders":"Celltrion; Samsung; Celgene; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"BASDAI; Medicine; Adalimumab; BASFI; Ankylosing spondylitis; Enthesitis; Observational study; Internal medicine; Physical therapy; Psoriatic arthritis; Quality of life (healthcare); Arthritis; Disease","score_opus":0.12673242389522263,"score_gpt":0.398724339576588,"score_spread":0.2719919156813654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808434235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923615,0.0026205922,0.00002487391,0.0011920622,0.00020728329,0.0022310389,0.0010346955,0.000025331907,0.00030265495],"genre_scores_gemma":[0.99854314,0.0005104482,0.00007808815,0.00034396883,0.000061998835,0.00010868604,0.00031611422,0.00003227441,0.0000052581627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98947626,0.0074890377,0.00094645756,0.00060054124,0.0007495186,0.0007381692],"domain_scores_gemma":[0.98339635,0.013698074,0.00043316005,0.0014993574,0.0006599083,0.00031316018],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011670058,0.00036728705,0.0012179024,0.00023444222,0.0004674243,0.00007714589,0.001177942,0.00010706688,0.0002053903],"category_scores_gemma":[0.025221113,0.0002101231,0.00027144328,0.00056052976,0.000990907,0.00031622846,0.0005442529,0.00030988423,0.0000068597874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005711263,0.00109729,0.97243315,0.0010181909,0.0006409884,0.00003962289,0.00034614105,0.00007244021,0.0005724238,0.00036042783,0.0002089214,0.017499123],"study_design_scores_gemma":[0.0023243935,0.0013576661,0.98461366,0.0063219443,0.00004773468,0.000028698514,0.0011203984,0.0017771401,0.00020066,0.0019108299,0.00008911803,0.00020778821],"about_ca_topic_score_codex":0.05334768,"about_ca_topic_score_gemma":0.009496754,"teacher_disagreement_score":0.043850925,"about_ca_system_score_codex":0.00011653634,"about_ca_system_score_gemma":0.0010985291,"threshold_uncertainty_score":0.98298985},"labels":[],"label_agreement":null},{"id":"W2808480446","doi":"10.1136/annrheumdis-2018-eular.2055","title":"THU0647 Longitudinal study of long-term poverty and persistent depressive symptoms in sle","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cognitive and psychological constructs research","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"","keywords":"Medicine; Term (time); Depressive symptoms; Poverty; Pediatrics; Psychiatry; Anxiety","score_opus":0.12963268868218875,"score_gpt":0.41898676894708275,"score_spread":0.289354080264894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808480446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939403,0.0020901314,0.0000051886373,0.00020555816,0.00016439281,0.0005168373,0.00004943991,0.0000074540562,0.003020707],"genre_scores_gemma":[0.9994702,0.000078607634,0.0000015868386,0.0001488419,0.000018008725,0.000030374918,0.0000019745034,0.000007987805,0.00024243748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984607,0.00036611882,0.00034416097,0.00028179152,0.0002920178,0.00025522654],"domain_scores_gemma":[0.99870276,0.00036424564,0.00018192107,0.0004475821,0.00020610941,0.00009739519],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017929178,0.00013138895,0.00031567307,0.0001005911,0.00007075224,0.000016820935,0.00034860993,0.000043948745,0.0012744358],"category_scores_gemma":[0.00027746582,0.00008150683,0.00013385447,0.00024629838,0.00047887347,0.0000609699,0.00021154586,0.000097364886,0.000017018168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036967406,0.0015486544,0.9361301,0.00007068508,0.00039185956,0.000012598908,0.0015497423,3.9297078e-7,0.00000769398,0.00015371329,0.00069413934,0.059070755],"study_design_scores_gemma":[0.0011316898,0.0010078822,0.99554056,0.00030693188,0.000077469165,0.000009148883,0.0012067903,0.000007909593,0.00005274177,0.0005649788,0.000003683411,0.00009023496],"about_ca_topic_score_codex":0.00020574918,"about_ca_topic_score_gemma":0.0000883636,"teacher_disagreement_score":0.05941045,"about_ca_system_score_codex":0.000004862956,"about_ca_system_score_gemma":0.000022003567,"threshold_uncertainty_score":0.99963856},"labels":[],"label_agreement":null},{"id":"W2808502374","doi":"10.1136/annrheumdis-2018-eular.3158","title":"OP0233 Long-term safety of adalimumab in adult patients from global clinical trials across multiple indications: an updated analysis in 29,987 patients representing 56,951 patient-years","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Adalimumab; Medicine; Psoriatic arthritis; Ankylosing spondylitis; Psoriasis; Ulcerative colitis; Internal medicine; Rheumatoid arthritis; Population; Hidradenitis suppurativa; Dermatology; Disease","score_opus":0.09696121735880978,"score_gpt":0.4536993820513461,"score_spread":0.3567381646925363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808502374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954132,0.00020891202,0.000020088404,0.00011837429,0.00022325035,0.0019057891,0.002042064,0.000025724088,0.000042585845],"genre_scores_gemma":[0.99830514,0.00016465498,0.000102561076,0.00010779193,0.000045264598,0.00006151434,0.0011734666,0.000027708342,0.000011919776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99083465,0.0026498346,0.0039151516,0.0006429162,0.001404214,0.0005532278],"domain_scores_gemma":[0.99300003,0.0015657446,0.002215099,0.0016853444,0.0011920354,0.00034177527],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0024904711,0.00027876705,0.0017923858,0.00033521105,0.000091268164,0.000038835555,0.0007453407,0.00019618095,0.0001897077],"category_scores_gemma":[0.023392025,0.00020512952,0.0008149527,0.002014627,0.0004968555,0.00027712135,0.000478202,0.00020325437,0.000018532695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020929128,0.0040377774,0.96582764,0.00022740298,0.0013049147,0.0000031670904,0.0018457292,0.000022161903,0.0000034443806,0.0000055174078,0.00036849288,0.024260823],"study_design_scores_gemma":[0.008400116,0.00033022533,0.985604,0.0024947464,0.00046232954,0.0000010838769,0.0009316116,0.0013495027,0.00011194421,0.00014491305,0.0000023230384,0.00016723483],"about_ca_topic_score_codex":0.0025510725,"about_ca_topic_score_gemma":0.0014101173,"teacher_disagreement_score":0.024093589,"about_ca_system_score_codex":0.00011562877,"about_ca_system_score_gemma":0.00025238513,"threshold_uncertainty_score":0.9848344},"labels":[],"label_agreement":null},{"id":"W2808531399","doi":"10.1136/annrheumdis-2018-eular.5435","title":"AB0633 Measuring what matters to lupus patients: translating patient views into novel patient-reported outcomes","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Systemic lupus erythematosus; Medical physics; Internal medicine; Disease","score_opus":0.08285980960226755,"score_gpt":0.3427929271781173,"score_spread":0.2599331175758498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808531399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875945,0.0009679209,0.00013595812,0.0077330456,0.0010865825,0.0021363476,0.000029875544,0.00007283289,0.00024297317],"genre_scores_gemma":[0.99516124,0.000073984884,0.00056156557,0.0038046364,0.00003563261,0.00014991431,0.000014549774,0.00006835122,0.00013015536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956817,0.00018171064,0.001437586,0.00045559264,0.0016522999,0.0005910797],"domain_scores_gemma":[0.9964789,0.00028280567,0.0006225612,0.0012469592,0.0008937343,0.0004750442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039222016,0.0003647933,0.0008641906,0.00026015818,0.00021786107,0.00009885521,0.00042458242,0.000070800284,0.0001366265],"category_scores_gemma":[0.0019404897,0.00023030995,0.0004839255,0.0005213337,0.0002193366,0.0003941495,0.0002572192,0.00012944755,0.00009000605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000685602,0.0022666934,0.6890893,0.0038897842,0.0013439305,0.000009507007,0.039763633,0.00004181461,0.0010075232,0.000033566423,0.018375915,0.24349275],"study_design_scores_gemma":[0.027274279,0.008810749,0.639173,0.16442387,0.0028961746,0.0014878381,0.07754179,0.0025461174,0.05133516,0.0032290467,0.016665637,0.0046163783],"about_ca_topic_score_codex":0.0001978105,"about_ca_topic_score_gemma":0.000037653466,"teacher_disagreement_score":0.23887637,"about_ca_system_score_codex":0.00009360178,"about_ca_system_score_gemma":0.00016039473,"threshold_uncertainty_score":0.9391767},"labels":[],"label_agreement":null},{"id":"W2808552148","doi":"10.1136/annrheumdis-2018-eular.2294","title":"THU0526 Acute paraspinal muscle necrosis with crack cocaine and heroin; a case report","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Muscle and Compartmental Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rhabdomyolysis; Creatine kinase; Heroin; Internal medicine; Muscle biopsy; Surgery; Drug; Biopsy; Pharmacology","score_opus":0.034262815922355146,"score_gpt":0.3237175635662448,"score_spread":0.2894547476438897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808552148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950858,0.000574703,0.000022419807,0.0028117574,0.000044759767,0.00037903033,0.00003125062,0.00003136872,0.0010189414],"genre_scores_gemma":[0.9980506,0.0001323563,0.00011465031,0.0011393894,0.000023630766,0.000027410697,0.000011495548,0.000016843456,0.0004836755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898404,0.000038809554,0.00029508845,0.00020653685,0.00026663422,0.00020888331],"domain_scores_gemma":[0.99891996,0.00004877686,0.00019260899,0.00052208494,0.00012947935,0.00018711154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009438176,0.00015346032,0.00031801438,0.000036950772,0.00014047636,0.000023796305,0.00009154984,0.000023982151,0.0001518595],"category_scores_gemma":[0.00009302794,0.00009016289,0.00011529027,0.0001688504,0.00042082256,0.00009234736,0.0000757061,0.000047946753,0.000010480826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092837615,0.01084129,0.38588172,0.004968044,0.009241638,0.032534108,0.0068574995,0.000025416486,0.0021936812,0.001895577,0.25657883,0.27969843],"study_design_scores_gemma":[0.003526777,0.0026183168,0.963073,0.0020574408,0.0014491092,0.018347453,0.0016370724,0.0005872522,0.0028201432,0.002416442,0.0010752415,0.00039176116],"about_ca_topic_score_codex":0.00028285157,"about_ca_topic_score_gemma":0.00007117012,"teacher_disagreement_score":0.57719123,"about_ca_system_score_codex":0.000005912252,"about_ca_system_score_gemma":0.00007661265,"threshold_uncertainty_score":0.3676736},"labels":[],"label_agreement":null},{"id":"W2808556353","doi":"10.1136/annrheumdis-2018-eular.3955","title":"PARE0005 Development & dissemination of a resource about methotrexate use for and by patients with inflammatory arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Methotrexate; Arthritis; Inflammatory arthritis; Resource (disambiguation); Medicine; Computer science; Business; Immunology","score_opus":0.022495616548317363,"score_gpt":0.30230432425479814,"score_spread":0.27980870770648075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808556353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480057,0.003822863,0.00018348431,0.0002583725,0.000020781503,0.00068700383,0.0001831161,0.000014063812,0.00002977151],"genre_scores_gemma":[0.99583906,0.0027011475,0.0010277572,0.00007136399,0.000008975474,0.00007354686,0.0000737933,0.000019588473,0.0001847403],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988097,0.000081242106,0.0003611392,0.00014909032,0.00039676248,0.00020206092],"domain_scores_gemma":[0.99846905,0.0004507276,0.00023794014,0.00027607966,0.0004251948,0.00014098723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020157362,0.00012393515,0.0003018211,0.000069800735,0.0001157899,0.000025621497,0.000100816505,0.000027479398,0.000037625174],"category_scores_gemma":[0.0013663329,0.00007821735,0.000065931636,0.000098328375,0.00038753852,0.00014582938,0.000052399584,0.000036097194,0.0000017876497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023980325,0.00096405245,0.42907766,0.0011765676,0.0007715675,6.142819e-7,0.0041406928,0.0000011354834,0.00044899422,0.00030973912,0.04031162,0.52039933],"study_design_scores_gemma":[0.002458727,0.00058211485,0.9514016,0.009447772,0.00002726835,0.0000026907585,0.0002734597,0.000029796121,0.007428948,0.00039964146,0.027757645,0.00019035736],"about_ca_topic_score_codex":0.000014238181,"about_ca_topic_score_gemma":0.000029517008,"teacher_disagreement_score":0.5223239,"about_ca_system_score_codex":0.0000070950864,"about_ca_system_score_gemma":0.000080755046,"threshold_uncertainty_score":0.3189611},"labels":[],"label_agreement":null},{"id":"W2808618638","doi":"10.1136/annrheumdis-2018-eular.3097","title":"AB1481-PARE Canadian arthritis patient alliance: who are we? what have we been up to?","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Medicine; Alliance; Arthritis; Dermatology; Immunology","score_opus":0.046364096007663815,"score_gpt":0.31780313276998523,"score_spread":0.2714390367623214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808618638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80550873,0.11525509,0.000009530834,0.075531945,0.00076444226,0.0013904234,0.0005547248,0.000058860674,0.00092625176],"genre_scores_gemma":[0.8179206,0.17867932,0.00004405472,0.0023039598,0.00009423911,0.00008496002,0.000018523791,0.000036476817,0.0008178475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756694,0.00013358232,0.000499788,0.00032791687,0.0007424246,0.0007293468],"domain_scores_gemma":[0.99717367,0.00011656519,0.00019086438,0.00085091434,0.00052536826,0.0011426065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015423493,0.00026159224,0.00060863094,0.00016011288,0.00032293258,0.00016732814,0.0004191806,0.00006709993,0.0010380324],"category_scores_gemma":[0.00062691694,0.0001900909,0.00028391258,0.00027293916,0.000415911,0.00035196822,0.00013167105,0.00013458113,0.00023113804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026073065,0.0002037107,0.009157802,0.0003518612,0.0003897555,0.000037822236,0.0060585006,0.000010411489,0.000019308305,0.0002797843,0.36026385,0.62296647],"study_design_scores_gemma":[0.0050883144,0.0034196267,0.2233861,0.13161987,0.000072023984,0.0001306947,0.042765822,0.000583561,0.011049141,0.015289235,0.5651348,0.00146076],"about_ca_topic_score_codex":0.006770419,"about_ca_topic_score_gemma":0.03109521,"teacher_disagreement_score":0.6215057,"about_ca_system_score_codex":0.000047453614,"about_ca_system_score_gemma":0.0005258076,"threshold_uncertainty_score":0.9998751},"labels":[],"label_agreement":null},{"id":"W2808632434","doi":"10.1136/annrheumdis-2018-eular.2131","title":"SAT0196 Time to discontinuation of biologic therapy by mechanism of action in rheumatoid arthritis: results from the ontario best practice research initiative (OBRI) cohort","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Adalimumab; Golimumab; Discontinuation; Abatacept; Rheumatoid arthritis; Etanercept; Tofacitinib; Infliximab; Internal medicine; Adverse effect; Tocilizumab; TNF inhibitor; Cohort; Physical therapy; Rituximab; Tumor necrosis factor alpha","score_opus":0.10095219462665443,"score_gpt":0.3785237141540789,"score_spread":0.2775715195274245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808632434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98554283,0.005696756,0.000025128504,0.005395259,0.00008454489,0.0015597112,0.0005407203,0.000013562173,0.0011415128],"genre_scores_gemma":[0.9606249,0.038611602,0.000114867384,0.00023588985,0.000029241055,0.00009465765,0.0001031135,0.000019467625,0.00016629172],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961972,0.0011316502,0.000926184,0.00032472413,0.001046091,0.00037411565],"domain_scores_gemma":[0.99497306,0.0024870024,0.0005565701,0.00075235416,0.0010944813,0.00013655798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022665006,0.00018857211,0.00059592834,0.00017379085,0.00015873539,0.000034639743,0.00043760223,0.00008205315,0.00038440418],"category_scores_gemma":[0.006921196,0.00011305155,0.00016492019,0.000552333,0.00071294594,0.0003141692,0.00015737211,0.0002632579,0.00007075989],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042633902,0.015356323,0.07926435,0.00021614392,0.00442239,0.000017391701,0.069449216,0.000031487314,0.04279611,0.0033308244,0.10619396,0.6362879],"study_design_scores_gemma":[0.015208141,0.014487818,0.6060157,0.025070013,0.00006144539,0.000030920677,0.022903942,0.000422187,0.2717308,0.029427407,0.013831788,0.0008098362],"about_ca_topic_score_codex":0.03232263,"about_ca_topic_score_gemma":0.0073877675,"teacher_disagreement_score":0.6354781,"about_ca_system_score_codex":0.000053333682,"about_ca_system_score_gemma":0.0004280729,"threshold_uncertainty_score":0.9741212},"labels":[],"label_agreement":null},{"id":"W2808641721","doi":"10.1136/annrheumdis-2018-eular.3146","title":"THU0614 Interstitial lung disease in patients with antisynthetase syndrome and anti-ro52 antibodies positive","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Medicine; Anakinra; Antisynthetase syndrome; Colchicine; Dermatology; Interstitial lung disease; Adverse effect; Amyloidosis; Internal medicine; Gastroenterology; Disease; Lung","score_opus":0.007983547536269585,"score_gpt":0.2526391468283229,"score_spread":0.2446555992920533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808641721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974586,0.0006232154,0.000014985716,0.00075147935,0.00010796973,0.00053072366,0.00029191963,0.000024233068,0.00019692598],"genre_scores_gemma":[0.99927765,0.00011621952,0.00002800591,0.0004737682,0.000020354651,0.000009234341,0.000031161017,0.000020965148,0.000022622642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987672,0.000088524925,0.0003323266,0.00021865628,0.00033150474,0.00026176387],"domain_scores_gemma":[0.99896836,0.000082427214,0.00017430652,0.00037438277,0.00019765944,0.00020288056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088470835,0.00019785717,0.0004325002,0.00012229278,0.00012435611,0.000030583487,0.00012448367,0.000031263633,0.000057224668],"category_scores_gemma":[0.00018908305,0.00012242704,0.00010662036,0.0001571335,0.00059721345,0.00021010468,0.00012863762,0.00007245934,0.000008102395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010229221,0.00043456786,0.99455476,0.0007273497,0.00018710064,0.0001219414,0.0004073597,0.0000027643666,0.0000053335293,0.00031770204,0.0008551965,0.0013630093],"study_design_scores_gemma":[0.0012973358,0.0002265417,0.99297154,0.004225595,0.00020334724,0.000024201863,0.000118695134,0.00039228075,0.00021077244,0.00016145383,0.000012524071,0.00015573233],"about_ca_topic_score_codex":0.00006446672,"about_ca_topic_score_gemma":0.0000057121074,"teacher_disagreement_score":0.0034982453,"about_ca_system_score_codex":0.000016026876,"about_ca_system_score_gemma":0.00007721423,"threshold_uncertainty_score":0.499243},"labels":[],"label_agreement":null},{"id":"W2808690586","doi":"10.1136/annrheumdis-2018-eular.2637","title":"SAT0324 Certolizumab pegol provides sustained remission and minimal disease activity in patients with psoriatic arthritis over 4 years' treatment","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Internal medicine; Ustekinumab; Placebo; Gastroenterology; Arthritis; Disease; Etanercept; Rheumatoid arthritis; Adalimumab; Alternative medicine","score_opus":0.015082793615920144,"score_gpt":0.27478884226825934,"score_spread":0.2597060486523392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808690586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612516,0.0016854793,5.466277e-7,0.00094126223,0.00005341296,0.0009719176,0.00013000972,0.000018559513,0.00007366726],"genre_scores_gemma":[0.9989074,0.0007640628,0.000027167298,0.000042291278,0.000027260357,0.00006366327,0.000015894628,0.00002024753,0.00013200015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988534,0.0000666447,0.00023086063,0.0002551043,0.00032985554,0.000264123],"domain_scores_gemma":[0.99907947,0.00008325378,0.00014972822,0.00036422655,0.00010566537,0.0002176385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002285685,0.00020218872,0.0004098839,0.00007003362,0.000102125356,0.000018444096,0.000060104812,0.00002827344,0.00006917071],"category_scores_gemma":[0.0002430436,0.00011964869,0.00010526069,0.00014912913,0.00023018397,0.000114320486,0.00007253944,0.000035302073,0.0000033590559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069273924,0.002630807,0.71852595,0.0002839277,0.00031038182,0.000085030755,0.0005137398,3.548006e-7,0.0000028174156,0.00003932702,0.00045613918,0.27022412],"study_design_scores_gemma":[0.008127291,0.0020197837,0.9871896,0.0017256851,0.00020850495,0.000004448084,0.00013144505,0.000045074965,0.00006998228,0.0002737167,0.00008466673,0.00011979909],"about_ca_topic_score_codex":0.00019874085,"about_ca_topic_score_gemma":0.00007265753,"teacher_disagreement_score":0.27010432,"about_ca_system_score_codex":0.00005564981,"about_ca_system_score_gemma":0.0001350922,"threshold_uncertainty_score":0.48791322},"labels":[],"label_agreement":null},{"id":"W2809077997","doi":"10.1136/annrheumdis-2018-212964","title":"Connective tissue growth factor contributes to joint homeostasis and osteoarthritis severity by controlling the matrix sequestration and activation of latent TGFβ","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Versus Arthritis; Arthritis Research UK; Kennedy Trust for Rheumatology Research","keywords":"CTGF; Cartilage; Growth factor; Connective tissue; Cell biology; Osteoarthritis; Conditional gene knockout; Transforming growth factor; Cartilage oligomeric matrix protein; Extracellular matrix; Medicine; Immunology; Pathology; Biology; Internal medicine; Anatomy; Biochemistry; Receptor","score_opus":0.028030171809970073,"score_gpt":0.3118764873922104,"score_spread":0.2838463155822403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809077997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270034,0.0031377017,0.00060793397,0.0023460086,0.00003309188,0.0006810501,0.0004766248,0.000005052083,0.000012181237],"genre_scores_gemma":[0.99922884,0.00052808656,0.00001884246,0.000116959345,0.0000219393,0.000031051433,0.00002301421,0.00001002743,0.000021218288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903846,0.00019024112,0.00023941901,0.00019923043,0.00017279631,0.00015987166],"domain_scores_gemma":[0.9989295,0.0001706324,0.00016151037,0.00022048558,0.00044349855,0.0000743881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020070934,0.000121087745,0.00022165358,0.000036941026,0.0001253356,0.000036435715,0.00012816832,0.000050965467,0.000013499956],"category_scores_gemma":[0.0014869997,0.00008106916,0.000051769308,0.00010386706,0.0002999304,0.000015468162,0.000145973,0.000043066488,8.742417e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091945834,0.0001849571,0.027016869,0.00035098207,0.00052994624,4.2990052e-7,0.0008313861,0.000006731479,0.8931204,0.0009246433,0.002427463,0.07368671],"study_design_scores_gemma":[0.0005470078,0.0005547034,0.16319315,0.00015759662,0.000029249653,0.0000014275538,0.00015962907,0.000046429996,0.83373106,0.0013316695,0.00015225068,0.000095845644],"about_ca_topic_score_codex":0.00021015632,"about_ca_topic_score_gemma":0.00002609081,"teacher_disagreement_score":0.13617629,"about_ca_system_score_codex":0.000008293788,"about_ca_system_score_gemma":0.000049776278,"threshold_uncertainty_score":0.33059046},"labels":[],"label_agreement":null},{"id":"W2883590012","doi":"10.1136/annrheumdis-2018-eular.5825","title":"AB0912 Two-year efficacy and safety of guselkumab for treatment of moderate-to-severe psoriasis: phase 3 voyage 1 trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Clinical trial; Phase (matter); Dermatology; Internal medicine","score_opus":0.13876714708623106,"score_gpt":0.4467224896793756,"score_spread":0.30795534259314455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883590012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922402,0.0021330717,0.00004982215,0.0026076785,0.00015793729,0.001690372,0.00038722894,0.000010621133,0.0007230712],"genre_scores_gemma":[0.997468,0.0018414469,0.00020274849,0.00018886176,0.00010614993,0.00004808104,0.0000068494137,0.000012409724,0.0001254867],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988922,0.00008103372,0.00046842248,0.00015648668,0.00022449059,0.00017737293],"domain_scores_gemma":[0.9982195,0.00082609936,0.00028464175,0.0003000465,0.00020960179,0.00016012302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019510541,0.0001413582,0.0006017573,0.000037002057,0.00009362223,0.0000076250985,0.000101695514,0.000026193402,0.00012160583],"category_scores_gemma":[0.0010169426,0.00008237633,0.00020473855,0.000110521105,0.00018670758,0.00006355451,0.00005479993,0.000020518857,0.00000302557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6851844,0.012526496,0.0005578321,0.0017754937,0.0041420716,0.0000018913197,0.0026269504,0.000056306693,0.0005121407,0.0015911506,0.008735942,0.2822893],"study_design_scores_gemma":[0.7852243,0.0544801,0.018589841,0.004590616,0.01046493,0.000014047743,0.0026040338,0.00390145,0.077851556,0.006421005,0.034996685,0.0008614338],"about_ca_topic_score_codex":0.00005797809,"about_ca_topic_score_gemma":0.0000038599746,"teacher_disagreement_score":0.28142786,"about_ca_system_score_codex":0.000010535756,"about_ca_system_score_gemma":0.00006536003,"threshold_uncertainty_score":0.33592093},"labels":[],"label_agreement":null},{"id":"W2883877973","doi":"10.1136/annrheumdis-2018-eular.7892","title":"LB0002 Biomechanical therapy for osteoarthritis of the knee: a randomised controlled trial (BIOTOK)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Biomechanics; Physical therapy; Physical medicine and rehabilitation; Gait; Randomized controlled trial; Rehabilitation; Knee pain; Surgery","score_opus":0.03795349886015399,"score_gpt":0.311821207635244,"score_spread":0.27386770877509004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883877973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814854,0.0028366838,0.000023267965,0.002043874,0.0009139176,0.0121094175,0.00017893054,0.000030735166,0.00037774933],"genre_scores_gemma":[0.997296,0.0002685156,0.000073965275,0.00052045414,0.00016805487,0.0009219537,0.000011820519,0.000027614893,0.0007116366],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998209,0.00020820764,0.0006874182,0.00020341817,0.00042018984,0.00027173935],"domain_scores_gemma":[0.9978144,0.00060360733,0.0004733477,0.00067755126,0.00030964907,0.00012142205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037360316,0.00021214668,0.0009309657,0.00006142112,0.00014926714,0.000015766607,0.0002661266,0.0000854872,0.00024100885],"category_scores_gemma":[0.0012141602,0.0001030628,0.0012364779,0.00018785454,0.00032558606,0.000053723823,0.00006214707,0.000051592837,0.0000069987727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74409133,0.001783965,0.00007191351,0.00016974214,0.0006857588,0.000001133666,0.0002638444,1.7076586e-7,0.005451129,0.0014791726,0.0024730973,0.24352877],"study_design_scores_gemma":[0.9170381,0.010875637,0.00021889595,0.0010903352,0.0005393829,0.0000061616993,0.000101271726,0.0000749736,0.06511861,0.004293243,0.00051175355,0.00013166509],"about_ca_topic_score_codex":0.000009881874,"about_ca_topic_score_gemma":0.000005762402,"teacher_disagreement_score":0.2433971,"about_ca_system_score_codex":0.000008141724,"about_ca_system_score_gemma":0.00019161095,"threshold_uncertainty_score":0.42027786},"labels":[],"label_agreement":null},{"id":"W2884094456","doi":"10.1136/annrheumdis-2018-213625","title":"Epidemiology and socioeconomic impact of the rheumatic diseases on indigenous people: an invisible syndemic public health problem","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Consejo Nacional de Ciencia y Tecnología, Paraguay","keywords":"Medicine; Epidemiology; Socioeconomic status; Population; Rheumatoid arthritis; Physical therapy; Public health; Internal medicine; Environmental health; Pathology","score_opus":0.0605136272599509,"score_gpt":0.3834420812909026,"score_spread":0.3229284540309517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884094456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852327,0.0034816656,0.000014290256,0.0096576,0.000093493756,0.0012798198,0.00013804597,0.0000271382,0.00007526154],"genre_scores_gemma":[0.9975249,0.0010708111,0.00004961147,0.0011813792,0.000027235454,0.000049111026,0.000031673197,0.000026523636,0.000038721486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974008,0.00076688826,0.00086669845,0.00029254393,0.00022769894,0.00044533762],"domain_scores_gemma":[0.99699897,0.0008152316,0.0008545371,0.0008140366,0.00016434302,0.00035291014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008791687,0.00023573537,0.0008799156,0.00013083125,0.00028040115,0.00001191924,0.0003250057,0.00008027179,0.000150021],"category_scores_gemma":[0.0018968772,0.00012028082,0.00051113,0.00022032298,0.0007975197,0.00016449078,0.000112251095,0.00012895952,0.000010569279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014966099,0.0014995841,0.9117227,0.0037449622,0.000540783,8.5421476e-8,0.005280109,0.00007936125,0.0000118439575,0.0013906806,0.0033854025,0.07219484],"study_design_scores_gemma":[0.0005674754,0.0018620442,0.9764891,0.0010364028,0.00009528382,0.000004770681,0.00068187754,0.00068629935,0.000004534937,0.018451866,0.0000070379892,0.00011330875],"about_ca_topic_score_codex":0.0010445361,"about_ca_topic_score_gemma":0.00011998054,"teacher_disagreement_score":0.07208153,"about_ca_system_score_codex":0.00006846471,"about_ca_system_score_gemma":0.0008009563,"threshold_uncertainty_score":0.49049094},"labels":[],"label_agreement":null},{"id":"W2884688806","doi":"10.1136/annrheumdis-2018-eular.2024","title":"THU0311 Impact of secukinumab treatment on psoriatic arthritis patients with or without enthesitis at baseline: pooled data from two phase 3 studies (FUTURE 2 AND FUTURE 3)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Children's Hospital; Children’s Hospital of Wisconsin Research Institute; Brigham and Women's Hospital; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Enthesitis; Psoriatic arthritis; Secukinumab; Internal medicine; Psoriasis; Ankylosing spondylitis; Arthritis; Physical therapy; Gastroenterology; Immunology","score_opus":0.05870140561695615,"score_gpt":0.39423313143404476,"score_spread":0.3355317258170886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884688806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435944,0.011563601,0.0000019619386,0.0009109728,0.000098675046,0.00088572106,0.002115208,0.000019833878,0.00004457892],"genre_scores_gemma":[0.9869155,0.012133487,0.00004938814,0.00013418362,0.00022775821,0.000025982104,0.00036185852,0.00003101342,0.00012083061],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998108,0.00020611906,0.0004987774,0.00033462705,0.000583319,0.00026912807],"domain_scores_gemma":[0.9975827,0.00026527172,0.0003837153,0.0012661207,0.00034749132,0.00015473191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016144168,0.00029847582,0.0008971078,0.00008579544,0.00016529935,0.000017615921,0.00028509586,0.000045781948,0.00064653717],"category_scores_gemma":[0.00036719162,0.00013800635,0.00016321152,0.00017214539,0.0003847311,0.00017187586,0.00020600099,0.0000718514,0.000013419199],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023503607,0.0051977527,0.14474013,0.0008175069,0.009110726,0.00002180728,0.0055342843,0.0000057060433,0.00007387997,0.000024691484,0.022269242,0.78870064],"study_design_scores_gemma":[0.07653666,0.030778605,0.85475045,0.011760177,0.0036318582,0.000019115723,0.008480903,0.0037503433,0.0047070202,0.00062182517,0.003968109,0.000994898],"about_ca_topic_score_codex":0.0002209109,"about_ca_topic_score_gemma":0.00013373635,"teacher_disagreement_score":0.7877058,"about_ca_system_score_codex":0.00004888049,"about_ca_system_score_gemma":0.00027061906,"threshold_uncertainty_score":0.70791286},"labels":[],"label_agreement":null},{"id":"W2885442772","doi":"10.1136/annrheumdis-2018-213725","title":"In silico validation of the Autoinflammatory Disease Damage Index","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Western University; Alberta Children's Hospital","funders":"Executive Agency for Health and Consumers; Novartis Pharma; National Institutes of Health; Universitair Medisch Centrum Utrecht; Rosetrees Trust","keywords":"Medicine; In silico; Index (typography); Disease; Computational biology; Pathology; World Wide Web; Genetics; Biology","score_opus":0.011976928359170753,"score_gpt":0.26749987075884,"score_spread":0.2555229423996693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885442772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978839,0.00060149154,0.000009625246,0.00074246916,0.00014466798,0.00020283193,0.00003084607,0.0000031888108,0.00038094746],"genre_scores_gemma":[0.99923295,0.000104819424,0.0000031351883,0.0002878353,0.000027415774,0.000013510622,0.000013041132,0.0000103723605,0.00030692964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991454,0.00012413209,0.00029439083,0.00012525864,0.00016906013,0.00014178304],"domain_scores_gemma":[0.9989791,0.000017311993,0.00021195968,0.00064770825,0.000106309315,0.000037636502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014220584,0.000100369194,0.00012531113,0.00003196237,0.000061673556,0.000008016859,0.00042075352,0.0000393396,0.000048026446],"category_scores_gemma":[0.00046063983,0.00006340448,0.00018005443,0.00013412836,0.0003097566,0.000011317908,0.00019638852,0.000035403336,0.000004744342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012495145,0.0014292396,0.8413353,0.0012142182,0.0005292599,0.0000019052485,0.0013978641,0.0018895102,0.10259978,0.0020802252,0.032619882,0.013653294],"study_design_scores_gemma":[0.00037943013,0.00004646179,0.7627257,0.00021079941,0.000030048666,2.5960307e-7,0.00012939307,0.00021429472,0.23295039,0.0020287111,0.00117149,0.000112999594],"about_ca_topic_score_codex":0.000027850276,"about_ca_topic_score_gemma":0.000011364967,"teacher_disagreement_score":0.13035062,"about_ca_system_score_codex":0.000002891304,"about_ca_system_score_gemma":0.00013588926,"threshold_uncertainty_score":0.25855595},"labels":[],"label_agreement":null},{"id":"W2885757481","doi":"10.1136/annrheumdis-2018-eular.6713","title":"THU0276 Mri lesion definitions in axial spondyloarthritis: a consensus reappraisal from the assessments in spondyloarthritis international society (ASAS)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Fundación Española de Reumatología; Bundesministerium für Bildung und Forschung; Amgen","keywords":"Medicine; Axial spondyloarthritis; Consensus conference; Ankylosing spondylitis; Medical physics; Radiology; Internal medicine; Sacroiliitis","score_opus":0.08342892752439739,"score_gpt":0.36518410861443584,"score_spread":0.28175518109003844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885757481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816567,0.0033785736,0.0000075771604,0.008265646,0.0006640191,0.0006726961,0.0013360297,0.000032748667,0.003986029],"genre_scores_gemma":[0.9944663,0.003694305,0.00038801166,0.00091244245,0.00015626456,0.000115558316,0.0001455181,0.000025906533,0.00009566953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997679,0.00017581347,0.0006733368,0.0003686358,0.00072001864,0.00038322114],"domain_scores_gemma":[0.99811316,0.000702997,0.0002477366,0.0005643028,0.0002635646,0.00010826634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033420045,0.00025794414,0.0004954767,0.000084815554,0.00021855964,0.000044745015,0.00032946776,0.000089446774,0.00036010717],"category_scores_gemma":[0.0007947946,0.00017410169,0.0003824672,0.00039466663,0.00063026353,0.00011352335,0.00023862837,0.00019659378,0.000046922687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031604676,0.006116278,0.7534401,0.00017754645,0.0017826059,0.0003730415,0.0050164284,0.000029216126,0.0002431314,0.0063424897,0.12525512,0.09806361],"study_design_scores_gemma":[0.007669189,0.00040663657,0.9738926,0.004006634,0.00014215824,0.000052196192,0.0025267887,0.00036544626,0.00018991422,0.0057192356,0.0047908737,0.00023831164],"about_ca_topic_score_codex":0.0013944602,"about_ca_topic_score_gemma":0.0017086164,"teacher_disagreement_score":0.22045255,"about_ca_system_score_codex":0.000052239047,"about_ca_system_score_gemma":0.00025781433,"threshold_uncertainty_score":0.70996606},"labels":[],"label_agreement":null},{"id":"W2885772073","doi":"10.1136/annrheumdis-2018-eular.2891","title":"OP0344 Frame study: the foundation effect of rebuilding bone with one year of romosozumab leads to continued lower fracture risk after transition to denosumab","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Sclerostin; Denosumab; Medicine; Bone mineral; Osteoporosis; Urology; Internal medicine; Chemistry","score_opus":0.008647307224593013,"score_gpt":0.27083237129037285,"score_spread":0.26218506406577985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885772073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705535,0.0007279023,0.0007706789,0.0004012543,0.00006287105,0.0007933958,0.00015661474,0.0000059779186,0.000025972611],"genre_scores_gemma":[0.99933344,0.000053025375,0.0001185411,0.00031152772,0.000062050545,0.000059434213,0.00001838245,0.000019368445,0.000024255232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875236,0.0002691753,0.0003064296,0.00021147488,0.00030421687,0.00015635371],"domain_scores_gemma":[0.9987359,0.00007213747,0.00023930687,0.0006399355,0.00022607406,0.00008667111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028121882,0.00015800241,0.00033152365,0.00004365767,0.00007123094,0.000018887718,0.00024615365,0.000048206213,0.000051939856],"category_scores_gemma":[0.000476135,0.000089728484,0.00016282995,0.00017196819,0.0001599221,0.000011674643,0.00008183383,0.000045048233,0.0000055218675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13385102,0.016604427,0.39685637,0.0040423577,0.008656267,0.000012030513,0.021640416,0.0054613296,0.24935746,0.0002548745,0.03392748,0.12933597],"study_design_scores_gemma":[0.002654596,0.006388574,0.68576354,0.0009531876,0.0013761026,0.0000018321643,0.0005272897,0.000025523052,0.30098101,0.0002776923,0.0006786172,0.00037202644],"about_ca_topic_score_codex":0.00011326377,"about_ca_topic_score_gemma":0.000047353147,"teacher_disagreement_score":0.28890717,"about_ca_system_score_codex":0.0000030259835,"about_ca_system_score_gemma":0.00004682799,"threshold_uncertainty_score":0.36590213},"labels":[],"label_agreement":null},{"id":"W2886546589","doi":"10.1136/annrheumdis-2018-eular.6880","title":"FRI0597 Validation of web-based calibration modules for imaging scoring systems based on principles of artificial intelligence: the sparcc mri sacroiliac joint inflammation score","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Medical physics; DICOM; Artificial intelligence; Quadrant (abdomen); Calibration; Computer science; Machine learning; Physical therapy; Radiology; Pathology; Statistics","score_opus":0.06798254035158761,"score_gpt":0.3275498075948006,"score_spread":0.259567267243213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886546589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8754584,0.0001987201,0.11779825,0.005089443,0.00031404805,0.0009776596,0.000045946203,0.000028625785,0.00008886726],"genre_scores_gemma":[0.99841785,0.000027624103,0.0011704438,0.00012896757,0.00013775012,0.000046416884,0.000040716004,0.000020173058,0.000010053263],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981739,0.00016778179,0.00080544717,0.00017075341,0.00051602145,0.00016610867],"domain_scores_gemma":[0.99782395,0.0004960166,0.0007603942,0.00046625684,0.00038576947,0.000067613524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008971728,0.00013902149,0.00035094057,0.00014648675,0.00013525579,0.000034711346,0.00017344717,0.000031946456,0.000018211293],"category_scores_gemma":[0.0026569867,0.00008383705,0.00020931462,0.00020287288,0.0003547006,0.00009682602,0.000033791654,0.000089601126,0.0000010041231],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018368851,0.0011747926,0.042806774,0.0135414265,0.00041566006,0.0000020539721,0.0015501502,0.7157467,0.032494333,0.032228805,0.0015560393,0.15664637],"study_design_scores_gemma":[0.0002426279,0.00014017687,0.006922883,0.0042872904,0.000117040196,7.9708155e-7,0.000170038,0.86264825,0.123547316,0.001824097,0.000030102407,0.00006935759],"about_ca_topic_score_codex":0.00007913632,"about_ca_topic_score_gemma":0.0000023292714,"teacher_disagreement_score":0.15657702,"about_ca_system_score_codex":0.000019549561,"about_ca_system_score_gemma":0.0002001382,"threshold_uncertainty_score":0.34187755},"labels":[],"label_agreement":null},{"id":"W2886701099","doi":"10.1136/annrheumdis-2018-213590","title":"Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Medical Research Council; British Society for Rheumatology; Versus Arthritis; Arthritis Research UK; Pfizer","keywords":"Medicine; Rheumatology; Axial spondyloarthritis; Internal medicine; Register (sociolinguistics); Physical therapy; Oncology; Family medicine; Ankylosing spondylitis","score_opus":0.1562014930247843,"score_gpt":0.38349440578313454,"score_spread":0.22729291275835023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886701099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33656824,0.6545752,4.988229e-7,0.00020036365,0.00003938056,0.0017380919,0.006859031,0.000009515458,0.000009653943],"genre_scores_gemma":[0.10522045,0.89338964,0.00006463561,0.00018674515,0.000011647688,0.00025737018,0.000797018,0.000028830864,0.000043677843],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99714386,0.00035339405,0.0012160942,0.00058863155,0.00033626414,0.00036172356],"domain_scores_gemma":[0.99493736,0.0025329692,0.0012942345,0.0009035224,0.00023465818,0.000097258984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030985943,0.00053986406,0.0053201504,0.000073131036,0.00019914284,0.000049804545,0.00035530372,0.00023980293,0.000076677854],"category_scores_gemma":[0.00103203,0.00021398708,0.005847424,0.00050539104,0.00075234985,0.000035979276,0.0001429157,0.00015059872,0.0000024854085],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044214446,0.0031639442,0.29831603,0.0010151088,0.44158018,0.000009093454,0.0003131485,0.000001956795,3.3741203e-9,0.000022176415,0.0052847355,0.24587217],"study_design_scores_gemma":[0.009489931,0.0049388744,0.84280646,0.007258464,0.12802592,0.0000096563,0.000082768325,9.16563e-7,1.9921886e-7,0.00055345934,0.006310015,0.00052332773],"about_ca_topic_score_codex":0.0013000029,"about_ca_topic_score_gemma":0.00015099137,"teacher_disagreement_score":0.54449046,"about_ca_system_score_codex":0.000026377087,"about_ca_system_score_gemma":0.00012059179,"threshold_uncertainty_score":0.872614},"labels":[],"label_agreement":null},{"id":"W2887136713","doi":"10.1136/annrheumdis-2018-eular.1114","title":"OP0199 Sustained remission of inflammation is associated with reduced structural damage on sacroiliac joint magnetic resonance imaging in patients with early axial spondyloarthritis: evidence to support the concept of treat-to-target","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Genentech; Dermira; F. Hoffmann-La Roche; Sanofi; GlaxoSmithKline; Amgen; Pfizer; UCB Pharma; Seqirus; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ankylosing spondylitis; Etanercept; Axial spondyloarthritis; Sacroiliitis; Cohort; Sacroiliac joint; Magnetic resonance imaging; Internal medicine; Physical therapy; Surgery; Radiology; Rheumatoid arthritis","score_opus":0.0182063842423393,"score_gpt":0.27796293791750576,"score_spread":0.2597565536751665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887136713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613905,0.0007259585,9.761683e-7,0.0014802366,0.000043053955,0.0012765375,0.0002414967,0.000011751667,0.00008093471],"genre_scores_gemma":[0.99949306,0.000033091972,0.00007762861,0.00017475054,0.00001602415,0.000034770437,0.00002520115,0.000021014455,0.00012444629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809945,0.00013000546,0.0005485382,0.00025756814,0.00067547715,0.00028898235],"domain_scores_gemma":[0.99817795,0.00015688226,0.00039508584,0.0005181134,0.0006303544,0.00012161685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015810458,0.0002160889,0.00052667054,0.00011314204,0.000109351895,0.000014189818,0.0001824354,0.00002878556,0.000095995616],"category_scores_gemma":[0.0011618722,0.000116696596,0.000094721516,0.0004674682,0.00032239227,0.00013570965,0.00009065421,0.000065615226,0.0000022796294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012723578,0.0006823867,0.89014673,0.00023759622,0.00017743283,0.00003987945,0.0109425215,0.000052232626,0.00068485056,0.0000761024,0.001845472,0.08239122],"study_design_scores_gemma":[0.0035193905,0.005151193,0.97102106,0.008683242,0.00010421364,0.0000020820846,0.00051903515,0.00003806293,0.010728227,0.00010233204,0.0000100865145,0.00012105395],"about_ca_topic_score_codex":0.00024502887,"about_ca_topic_score_gemma":0.000042520347,"teacher_disagreement_score":0.08227016,"about_ca_system_score_codex":0.000051538893,"about_ca_system_score_gemma":0.00013774773,"threshold_uncertainty_score":0.4758749},"labels":[],"label_agreement":null},{"id":"W2887140526","doi":"10.1136/annrheumdis-2018-213334","title":"Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Ankylosing spondylitis; Back pain; Sacroiliitis; Axial spondyloarthritis; Internal medicine; Radiological weapon; Kappa; Physical therapy; Rheumatoid arthritis; Surgery; Pathology","score_opus":0.019083228205774936,"score_gpt":0.27274443603902754,"score_spread":0.2536612078332526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887140526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843791,0.014176925,0.0000033713306,0.00027133388,0.0001806049,0.0006613772,0.000119699675,0.000010166522,0.00019738574],"genre_scores_gemma":[0.9740593,0.025244333,0.0002347134,0.00024083952,0.00004384484,0.000067794266,0.000017869985,0.000025667521,0.00006567992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761754,0.00039201038,0.0010155445,0.0002734123,0.00031793377,0.00038354387],"domain_scores_gemma":[0.9984642,0.00041657593,0.0004117927,0.00044135607,0.00014579747,0.00012025757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010117209,0.00025744617,0.00081364776,0.0001616708,0.0000751208,0.000020910462,0.00015298212,0.000069874885,0.0003786261],"category_scores_gemma":[0.0016229564,0.00020888084,0.000120845965,0.00029565484,0.00037368023,0.00016878688,0.00012061685,0.0001008481,0.000038741036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041701877,0.0005494109,0.6614266,0.004885889,0.0001498326,0.000015067953,0.001317384,0.0000013256285,0.000014488736,0.00008432857,0.0008405295,0.33029813],"study_design_scores_gemma":[0.0034359263,0.0013407294,0.9618584,0.030610772,0.00005939643,0.000013035586,0.00041106387,0.0014292694,0.00011119979,0.00042464037,0.00009648247,0.00020906857],"about_ca_topic_score_codex":0.00006315695,"about_ca_topic_score_gemma":0.00009937115,"teacher_disagreement_score":0.33008906,"about_ca_system_score_codex":0.000023662962,"about_ca_system_score_gemma":0.000099294484,"threshold_uncertainty_score":0.8517914},"labels":[],"label_agreement":null},{"id":"W2887209502","doi":"10.1136/annrheumdis-2018-eular.7144","title":"FRI0169 First validation of consensus definitions for mri lesions in the sacroiliac joint by the assessments in spondyloarthritis international society (ASAS) mri group","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"NIHR Sheffield Biomedical Research Centre; King's Health Partners; Medical Research Council; Novo Nordisk; National Institute for Health and Care Research; University of Alberta; Eli Lilly and Company","keywords":"DICOM; Medicine; Axial spondyloarthritis; Intraclass correlation; Kappa; Cohen's kappa; Radiology; Magnetic resonance imaging; Nuclear medicine; Medical physics; Computer science; Sacroiliitis; Machine learning","score_opus":0.0912693989950599,"score_gpt":0.34983046994558475,"score_spread":0.25856107095052483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887209502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96542114,0.0008798688,0.00018504885,0.029715275,0.00018116845,0.0010893705,0.0017077079,0.000014294035,0.00080611074],"genre_scores_gemma":[0.99706745,0.0010421165,0.00030115075,0.0011085466,0.00003955995,0.00017029373,0.00018670838,0.000012780082,0.00007138298],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9984915,0.00014068713,0.0005906992,0.00016870683,0.0004089672,0.0001994431],"domain_scores_gemma":[0.9981581,0.0008608376,0.0002923565,0.0004237202,0.00020804389,0.00005696758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046807123,0.00013698303,0.00029159192,0.00006295782,0.00016798361,0.000026346484,0.0002638973,0.000046044646,0.00011889418],"category_scores_gemma":[0.0006893969,0.000077704484,0.00037484206,0.00025065328,0.0004093997,0.00008734124,0.000076155025,0.00009470019,0.0000056554586],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078533764,0.0055909534,0.054149676,0.0010051137,0.00067313545,0.000005760693,0.0036853005,0.00009492482,0.00052288617,0.007680031,0.91538393,0.010422974],"study_design_scores_gemma":[0.007932723,0.0009987968,0.9009651,0.007529846,0.00077054225,0.00004228041,0.012998576,0.004088257,0.0053937067,0.04847884,0.010313933,0.00048740636],"about_ca_topic_score_codex":0.00024888714,"about_ca_topic_score_gemma":0.00015242903,"teacher_disagreement_score":0.90506995,"about_ca_system_score_codex":0.000023530227,"about_ca_system_score_gemma":0.00013978759,"threshold_uncertainty_score":0.31686968},"labels":[],"label_agreement":null},{"id":"W2887404297","doi":"10.1136/annrheumdis-2020-eular.6304","title":"FRI0317 CONSENSUS DEFINITIONS FOR MRI LESIONS IN THE SPINE OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS: FIRST ANALYSIS FROM THE ASSESSMENTS IN SPONDYLOARTHRITIS INTERNATIONAL SOCIETY CLASSIFICATION COHORT","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Consensus conference; Ankylosing spondylitis; Cohort; Physical therapy; Pathology; Internal medicine; Sacroiliitis","score_opus":0.06770281687522979,"score_gpt":0.3172806101485634,"score_spread":0.24957779327333363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887404297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97698003,0.0010141522,0.00008348452,0.015921956,0.00007608805,0.0014340961,0.0043236827,0.000010597799,0.0001559279],"genre_scores_gemma":[0.9957796,0.0014580438,0.00044506232,0.00089062785,0.00003059686,0.00029882265,0.0010762754,0.000014184233,0.0000068163436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982154,0.000112102985,0.00062388193,0.00027816842,0.00056213,0.00020834812],"domain_scores_gemma":[0.9982875,0.00059417717,0.0003717994,0.0004137618,0.00026441587,0.000068355635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019255071,0.00018650646,0.0005125137,0.00006835963,0.00018340127,0.00002609728,0.00031247683,0.000048158316,0.00007436515],"category_scores_gemma":[0.00050282246,0.00010426222,0.00043982334,0.00072116486,0.000282012,0.000068112895,0.000077097706,0.00011453796,0.000002080805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005411471,0.0014518839,0.98679614,0.00006861447,0.0017402122,0.000005584423,0.0011020091,0.00012259414,0.000003809972,0.00059046096,0.0033889867,0.0041885497],"study_design_scores_gemma":[0.0044108024,0.0002798173,0.99014324,0.0006542967,0.0009071051,8.697108e-7,0.0018633346,0.0008788557,0.000012254663,0.0004577921,0.0002947112,0.00009690667],"about_ca_topic_score_codex":0.00032905562,"about_ca_topic_score_gemma":0.0008031358,"teacher_disagreement_score":0.018799555,"about_ca_system_score_codex":0.000030033043,"about_ca_system_score_gemma":0.00010626777,"threshold_uncertainty_score":0.425169},"labels":[],"label_agreement":null},{"id":"W2887432271","doi":"10.1136/annrheumdis-2018-eular.3699","title":"AB1301 Cardiovascular risk age and vascular age estimations in predicting cardiovascular events in rheumatoid arthritis patients","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Quartile; Diabetes mellitus; Blood pressure; Risk factor; Framingham Risk Score; Disease; Cardiology; Confidence interval; Endocrinology","score_opus":0.020506423749132356,"score_gpt":0.27088406835676876,"score_spread":0.2503776446076364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887432271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94268566,0.055536658,0.00007240093,0.000099000375,0.00014421361,0.0011396527,0.00008252877,0.000040922296,0.0001989873],"genre_scores_gemma":[0.89721304,0.10235817,0.00016765998,0.000039699167,0.00002907842,0.00011230921,0.000032086577,0.000038823902,0.000009134521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641484,0.00060646987,0.00079877896,0.00043958836,0.0011738689,0.00056644494],"domain_scores_gemma":[0.9980133,0.00019651653,0.00017863305,0.001116865,0.00022889988,0.00026577179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011731888,0.00028971973,0.0010610694,0.00033532784,0.00021730417,0.000038187227,0.00029241104,0.000088882276,0.000040598556],"category_scores_gemma":[0.0026879923,0.00022907807,0.00092301733,0.0005659722,0.00049432454,0.000283011,0.00022366231,0.00025422903,0.000016522737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010230698,0.00073014444,0.8310883,0.00035811675,0.002433192,0.000053853466,0.0016598878,0.0003960622,0.0000035704925,0.00007491177,0.00022074544,0.1628789],"study_design_scores_gemma":[0.0045458083,0.00019783445,0.98593265,0.005044729,0.00005309047,0.000011902102,0.0002529244,0.0007918195,0.00006981735,0.0021279592,0.0007553444,0.00021611011],"about_ca_topic_score_codex":0.0017499295,"about_ca_topic_score_gemma":0.00029674338,"teacher_disagreement_score":0.16266279,"about_ca_system_score_codex":0.000037507984,"about_ca_system_score_gemma":0.00011350288,"threshold_uncertainty_score":0.93415326},"labels":[],"label_agreement":null},{"id":"W2889330860","doi":"10.1136/annrheumdis-2018-eular.2347","title":"THU0313 Ixekizumab improves nail and skin lesions through 52 weeks in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Ixekizumab; Psoriasis; Adalimumab; Placebo; Secukinumab; Internal medicine; Population; Erythema; Etanercept; Gastroenterology; Tumor necrosis factor alpha; Dermatology; Surgery; Pathology","score_opus":0.016110046367408152,"score_gpt":0.24929206478676103,"score_spread":0.23318201841935288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889330860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963346,0.0017117873,0.0000029762866,0.00067303126,0.00020059361,0.0005861127,0.00044661597,0.000019942647,0.000024306555],"genre_scores_gemma":[0.99916637,0.00041143972,0.00004168072,0.0001371254,0.000010843438,0.00006123934,0.000019738969,0.000019339615,0.0001322021],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99856156,0.00040404504,0.0003318716,0.00030263458,0.00008320102,0.00031670832],"domain_scores_gemma":[0.99891824,0.00040633988,0.00020773713,0.0002972576,0.00011005726,0.00006039456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011713432,0.0002465379,0.00041148748,0.00011418444,0.00023565671,0.000027379521,0.0001645358,0.00009443992,0.000042389293],"category_scores_gemma":[0.0004521209,0.00015889757,0.000077248056,0.00022123338,0.0003605939,0.00021413642,0.00015319054,0.000074378855,0.000021490081],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004425539,0.0004719491,0.0055830725,0.000050799066,0.00033574595,0.0000011446394,0.004991897,6.530471e-7,0.00049037056,0.000036404123,0.0005683175,0.9830441],"study_design_scores_gemma":[0.0027969521,0.0011255984,0.9723969,0.00073560973,0.000096233176,0.0000020046675,0.00058693596,0.0000011109898,0.021334164,0.00062242954,0.00010015112,0.00020189425],"about_ca_topic_score_codex":0.0003367684,"about_ca_topic_score_gemma":0.00014984867,"teacher_disagreement_score":0.9828422,"about_ca_system_score_codex":0.000018614375,"about_ca_system_score_gemma":0.000078749785,"threshold_uncertainty_score":0.6479655},"labels":[],"label_agreement":null},{"id":"W2889761813","doi":"10.1136/annrheumdis-2018-eular.2149","title":"FRI0669 Physician global assessments for disease activity in rheumatoid arthritis are all over the map!","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Health and Medical Research Fund","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Internal medicine; Disease; Physical therapy; Kappa; Family medicine","score_opus":0.04463843860683064,"score_gpt":0.3701722117332462,"score_spread":0.32553377312641557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889761813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796124,0.010017267,0.00009281058,0.0074333255,0.00031322852,0.0014093594,0.0007716875,0.00004304222,0.00030686462],"genre_scores_gemma":[0.9866266,0.011409387,0.000042157368,0.0014927754,0.00009018756,0.00022023883,0.000024177589,0.00002941075,0.00006503721],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997686,0.00023440589,0.00042563627,0.00032669908,0.00073152944,0.00059571734],"domain_scores_gemma":[0.99794364,0.00030071332,0.00030895826,0.0008653208,0.00024908906,0.00033226638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003441005,0.0002657509,0.0005408054,0.00006320256,0.00022671263,0.0000741921,0.0004747997,0.000047311933,0.000125832],"category_scores_gemma":[0.00051903527,0.00016180782,0.00043944316,0.00029033003,0.00061311544,0.0002753586,0.00018593397,0.00012757584,0.000033013515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077127614,0.005412617,0.26478577,0.0014450069,0.0017390759,0.00003667676,0.00066425983,0.000020845717,0.0001734336,0.006400944,0.1237677,0.5878409],"study_design_scores_gemma":[0.0031130482,0.0004530829,0.96108836,0.004462795,0.000021085874,0.000004045265,0.00030465852,0.0014380892,0.00038279025,0.023466084,0.0050232373,0.00024272475],"about_ca_topic_score_codex":0.00021119493,"about_ca_topic_score_gemma":0.00017844462,"teacher_disagreement_score":0.6963026,"about_ca_system_score_codex":0.000045499757,"about_ca_system_score_gemma":0.0002807227,"threshold_uncertainty_score":0.65983313},"labels":[],"label_agreement":null},{"id":"W2890914790","doi":"10.1136/annrheumdis-2018-eular.6215","title":"SAT0739-HPR Occupational exposure to pesticides increases the risk of rheumatoid arthritis: results from the malaysian population-based case-control study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada","funders":"Radboud Universiteit; Universiteit Utrecht","keywords":"Medicine; Rheumatoid arthritis; Population; Case-control study; Internal medicine; Immunology; Risk factor; Environmental health","score_opus":0.025973607929110354,"score_gpt":0.30582354823532465,"score_spread":0.2798499403062143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890914790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98398876,0.00590151,0.00011180576,0.0037576086,0.00014639278,0.0019583576,0.004053905,0.000043975568,0.00003771021],"genre_scores_gemma":[0.9971273,0.0016502088,0.00012636677,0.00070673996,0.00013434968,0.00014240968,0.0000666424,0.00003336258,0.000012633087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586827,0.0011898631,0.0010902584,0.00035387202,0.001108016,0.00038973],"domain_scores_gemma":[0.99215716,0.004860002,0.0006328233,0.0014109572,0.00067513844,0.00026389593],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011848187,0.00029560196,0.0006423922,0.00011464462,0.00065135024,0.0000846895,0.0005838715,0.000052007028,0.0003264689],"category_scores_gemma":[0.0117010195,0.00014770048,0.0003776067,0.00043692163,0.0005301463,0.00013436623,0.00012182062,0.00018198034,0.000030780182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040026316,0.0013956698,0.95107937,0.00003787295,0.0010264826,0.000031503558,0.0020990903,0.00076992286,0.000016264994,0.00017997436,0.0061282553,0.033232946],"study_design_scores_gemma":[0.003910199,0.0010583522,0.98761576,0.001759509,0.00007599704,0.000043039352,0.002636162,0.00097418233,0.0001483803,0.0015394256,0.00008082133,0.00015816733],"about_ca_topic_score_codex":0.014794244,"about_ca_topic_score_gemma":0.0028932656,"teacher_disagreement_score":0.036536377,"about_ca_system_score_codex":0.000017287524,"about_ca_system_score_gemma":0.00033112578,"threshold_uncertainty_score":0.9966238},"labels":[],"label_agreement":null},{"id":"W2891190175","doi":"10.1136/annrheumdis-2018-eular.6685","title":"OP0004 Cognitive impairment in rheumatoid arthritispatients: a case-control study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Rheumatology Research Foundation","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Internal medicine; Montreal Cognitive Assessment; Outpatient clinic; Depression (economics); Physical therapy; Anxiety; Disease; Cognitive impairment; Psychiatry","score_opus":0.026944617985463718,"score_gpt":0.3255928568072898,"score_spread":0.29864823882182606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891190175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053717,0.0054458976,0.000024567045,0.0007525692,0.00017256789,0.0024736566,0.00023085403,0.000042474745,0.0003202179],"genre_scores_gemma":[0.99663526,0.00262584,0.000019085719,0.00037598854,0.000034698158,0.00022240134,0.0000056400345,0.000030499587,0.000050562452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736995,0.00041321965,0.0007019627,0.00031224938,0.0006850479,0.0005175793],"domain_scores_gemma":[0.9981413,0.0003826033,0.00021829054,0.00053706614,0.0004410855,0.0002796511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049436995,0.00024485754,0.0006337905,0.00021874049,0.00019233569,0.000044781907,0.00022054747,0.000042586096,0.00062866753],"category_scores_gemma":[0.0012135537,0.00016757855,0.00025245472,0.0004102969,0.0005084583,0.00019118037,0.00012584173,0.00015185277,0.00007561561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038408132,0.012112342,0.7538599,0.0003489387,0.0015707106,0.0009836874,0.008402763,0.0000072877806,0.000017950837,0.00029270616,0.0032592942,0.21530363],"study_design_scores_gemma":[0.016970813,0.005394659,0.95704734,0.0068455283,0.00004827195,0.0006819993,0.0098268865,0.00047153578,0.00042419395,0.0018827007,0.00008473291,0.00032134473],"about_ca_topic_score_codex":0.00053186767,"about_ca_topic_score_gemma":0.00040483693,"teacher_disagreement_score":0.21498229,"about_ca_system_score_codex":0.000025063664,"about_ca_system_score_gemma":0.0002052077,"threshold_uncertainty_score":0.68834686},"labels":[],"label_agreement":null},{"id":"W2891970367","doi":"10.1136/annrheumdis-2018-eular.1202","title":"SAT0254 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from select-next","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Regeneron Pharmaceuticals; Celltrion; Sanofi; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Rheumatic disease; Antirheumatic Agents; Disease; Internal medicine","score_opus":0.02030599282964591,"score_gpt":0.2802099168111502,"score_spread":0.2599039239815043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891970367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914318,0.0025354598,0.000012624861,0.0032522571,0.0001558071,0.0017255229,0.00077314395,0.00007155665,0.000041831743],"genre_scores_gemma":[0.9955822,0.0034182512,0.0002113537,0.00042469497,0.000013622315,0.00013018028,0.0001144839,0.00006144244,0.000043766184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995359,0.00055336975,0.001395317,0.0006706008,0.0013098936,0.0007118071],"domain_scores_gemma":[0.99581486,0.0012928622,0.0006105209,0.0009917241,0.0005810298,0.00070902857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006372486,0.0004536527,0.0010544829,0.00040156147,0.00029960892,0.0001476723,0.00031673658,0.00007156982,0.00010169115],"category_scores_gemma":[0.0062816087,0.00031113756,0.00024102883,0.00052533165,0.00074899,0.00041654112,0.00023786063,0.00019542755,0.000032247062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053540785,0.0039364845,0.55415165,0.0005569708,0.0019979472,0.00006140854,0.0073642605,0.00002145742,0.000313745,0.00015466838,0.0018995194,0.37600112],"study_design_scores_gemma":[0.010316576,0.0011260884,0.97385806,0.0111810975,0.00003076872,0.000007426096,0.0007484152,0.00024133376,0.0006788623,0.0012192121,0.00020619256,0.0003859504],"about_ca_topic_score_codex":0.0005340765,"about_ca_topic_score_gemma":0.000050631712,"teacher_disagreement_score":0.41970646,"about_ca_system_score_codex":0.000045888348,"about_ca_system_score_gemma":0.00042447686,"threshold_uncertainty_score":0.9999341},"labels":[],"label_agreement":null},{"id":"W2892791765","doi":"10.1136/annrheumdis-2018-eular.2641","title":"OP0334 Efficacy and safety of continuing versus withdrawing adalimumab (ADA) in maintaining remission in patients with non-radiographic axial spondyloarthritis (NR-AXSPA)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adalimumab; Axial spondyloarthritis; Internal medicine; BASDAI; Clinical endpoint; Etanercept; Placebo; Gastroenterology; Ankylosing spondylitis; Randomized controlled trial; Arthritis; Disease; Tumor necrosis factor alpha; Psoriatic arthritis","score_opus":0.01373599523036244,"score_gpt":0.2686657211245,"score_spread":0.25492972589413754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892791765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726385,0.00143388,0.000002920736,0.00018101484,0.00010794673,0.0006537516,0.00003900255,0.000011152535,0.00030648624],"genre_scores_gemma":[0.99916726,0.0005828116,0.00013090346,0.00003352694,0.000023178336,0.000014538328,0.000015706537,0.000022191003,0.00000985715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984331,0.00007689734,0.0005056075,0.0002560447,0.00041705946,0.00031127868],"domain_scores_gemma":[0.9989137,0.0002332904,0.00026641611,0.00032501295,0.00014586622,0.00011568393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018450292,0.00020394898,0.00061243953,0.00021036707,0.00009462633,0.000011174892,0.00010865531,0.000049179824,0.000024069728],"category_scores_gemma":[0.00041359253,0.0001414452,0.000100797355,0.00046855642,0.00037679245,0.00011120687,0.000108300344,0.000094717754,7.243912e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012021464,0.0006815874,0.9289743,0.00016881066,0.0002160817,0.000016666932,0.0013421183,0.000010868465,0.000014559732,0.000041170828,0.0000489909,0.056463394],"study_design_scores_gemma":[0.024289051,0.0018812333,0.96165526,0.01097681,0.00011636363,0.0000031544394,0.0006303106,0.00005691693,0.00017334244,0.00006077536,0.000024707108,0.00013204712],"about_ca_topic_score_codex":0.00017856067,"about_ca_topic_score_gemma":0.00010381898,"teacher_disagreement_score":0.056331348,"about_ca_system_score_codex":0.000023398563,"about_ca_system_score_gemma":0.000052659416,"threshold_uncertainty_score":0.5767968},"labels":[],"label_agreement":null},{"id":"W2893246991","doi":"10.1136/annrheumdis-2018-eular.5146","title":"AB0954 A randomised, double-blind trial comparing the efficacy, safety and immunogenicity of msb11022, a proposed biosimilar of adalimumab, versus adalimumab originator in patients with moderate-to-severe plaque psoriasis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Psoriasis Area and Severity Index; Biosimilar; Psoriatic arthritis; Tolerability; Clinical endpoint; Bioequivalence; Internal medicine; Psoriasis; Interim analysis; Clinical trial; Adverse effect; Rheumatoid arthritis; Dermatology; Pharmacokinetics","score_opus":0.05245146854743497,"score_gpt":0.3175573006045067,"score_spread":0.2651058320570717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893246991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600816,0.00070174865,0.000034226843,0.00052799354,0.00031429002,0.0021126138,0.00019032347,0.000011047085,0.00009961054],"genre_scores_gemma":[0.99960643,0.00011270809,0.00011596352,0.00007960775,0.000013053285,0.00002328675,0.000012756207,0.000016227195,0.000019981648],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99765253,0.00063126895,0.000905273,0.0002986665,0.00018215408,0.00033012283],"domain_scores_gemma":[0.9974744,0.000979402,0.0005717462,0.00060393335,0.00031302831,0.000057519577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007305533,0.00027113446,0.0009629517,0.00011132074,0.00017103353,0.00001650472,0.00054332166,0.00015136822,0.000089730274],"category_scores_gemma":[0.0005113623,0.00014021661,0.0002445409,0.000396454,0.00094781624,0.00007797106,0.00023188816,0.00017158435,0.00000214168],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9907688,0.0013368163,0.0029481244,0.0001523166,0.0012726281,2.2386895e-7,0.00049389753,0.000050787123,0.00021437557,0.00039875173,0.00017617122,0.0021871263],"study_design_scores_gemma":[0.88235575,0.0038809662,0.059680782,0.001210816,0.000965677,0.0000017992676,0.00026916742,0.0001953319,0.0504246,0.00036244403,0.00021253982,0.00044011624],"about_ca_topic_score_codex":0.00027062677,"about_ca_topic_score_gemma":0.0000742078,"teacher_disagreement_score":0.10841302,"about_ca_system_score_codex":0.000021463922,"about_ca_system_score_gemma":0.00016759512,"threshold_uncertainty_score":0.57178676},"labels":[],"label_agreement":null},{"id":"W2893892798","doi":"10.1136/annrheumdis-2018-213150","title":"Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Canakinumab; Discontinuation; Macrophage activation syndrome; Internal medicine; Rheumatology; Arthritis; Bristol-Myers; Population; Pediatrics; Surgery; Disease; Anakinra","score_opus":0.030960257551667793,"score_gpt":0.31279045244675696,"score_spread":0.28183019489508915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893892798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987879,0.0090970835,0.0000021602307,0.0004835697,0.00011961848,0.0018145824,0.0005425698,0.000011066996,0.000050355196],"genre_scores_gemma":[0.9989449,0.0007604465,0.000001572337,0.000106539876,0.000036800702,0.000040010935,0.000031389605,0.000021018759,0.000057316054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682325,0.00082328456,0.0010947735,0.0002677766,0.00073480856,0.00025608708],"domain_scores_gemma":[0.99701273,0.0005425725,0.0009874296,0.00097146013,0.00040121673,0.00008457339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010556425,0.00020082224,0.0009940297,0.00007121196,0.00017924578,0.000024836469,0.00036348918,0.00007735585,0.000023644878],"category_scores_gemma":[0.0031336858,0.000088312765,0.00019737332,0.0002768794,0.00048762278,0.00012133687,0.00017446809,0.00019768272,0.0000031944978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.100649126,0.0054689855,0.532792,0.00568817,0.0033075223,0.000057145673,0.030594366,0.00005437861,0.0024054316,0.00023540796,0.01330723,0.30544028],"study_design_scores_gemma":[0.01835676,0.0007216204,0.9442879,0.032651946,0.00021476079,0.000016395526,0.0021098307,0.000041284067,0.0013737235,0.000087890745,0.0000065505665,0.0001313253],"about_ca_topic_score_codex":0.0012879783,"about_ca_topic_score_gemma":0.0002655175,"teacher_disagreement_score":0.41149595,"about_ca_system_score_codex":0.00003731438,"about_ca_system_score_gemma":0.0004394638,"threshold_uncertainty_score":0.3751541},"labels":[],"label_agreement":null},{"id":"W2894900585","doi":"10.1136/annrheumdis-2018-eular.4823","title":"THU0300 Network meta-analysis of tofacitinib vs bdmards or apremilast for the treatment of tnf inhibitor-naÏve patients with psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Regeneron Pharmaceuticals; Celgene; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Apremilast; TNF inhibitor; Internal medicine; Rheumatoid arthritis; Dactylitis; Randomized controlled trial; Tocilizumab; Golimumab; Etanercept; Enthesitis","score_opus":0.09620446080829122,"score_gpt":0.346140263883117,"score_spread":0.24993580307482582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894900585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98600817,0.009468215,0.00014127359,0.00091574696,0.00008846555,0.0021811528,0.0009994478,0.000015500375,0.00018203753],"genre_scores_gemma":[0.99730736,0.0017256971,0.00009800695,0.00012936845,0.000039359067,0.0002304864,0.00007152696,0.000023540917,0.00037462957],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9977724,0.00014497865,0.00085390196,0.00020786046,0.0007114854,0.00030938207],"domain_scores_gemma":[0.99677926,0.00077470276,0.00066494313,0.00093447126,0.0007557977,0.00009080273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003083905,0.00022698045,0.001600624,0.000121634155,0.00014992172,0.000013350407,0.00027685513,0.000047368703,0.0009116888],"category_scores_gemma":[0.00048256383,0.00009452994,0.0014074193,0.00072168227,0.0005372319,0.000080810714,0.000055699064,0.00004175032,0.0000029425653],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014925891,0.008646229,0.10383221,0.0022739857,0.57870424,0.0000029642556,0.0056385654,0.0019036118,0.0000152273915,0.0007104545,0.026307063,0.25703955],"study_design_scores_gemma":[0.010815876,0.014906595,0.6636861,0.0013194972,0.28935504,0.0000017344379,0.00205545,0.004341124,0.0039957864,0.0011040237,0.007869808,0.00054893823],"about_ca_topic_score_codex":0.00009203994,"about_ca_topic_score_gemma":0.0000621646,"teacher_disagreement_score":0.5598539,"about_ca_system_score_codex":0.000014476713,"about_ca_system_score_gemma":0.00022686273,"threshold_uncertainty_score":0.9982353},"labels":[],"label_agreement":null},{"id":"W2895378661","doi":"10.1136/annrheumdis-2018-eular.6782","title":"THU0291 Incidence of serious gastrointestinal events and inflammatory bowel disease among tildrakizumab-treated patients with moderate to severe plaque psoriasis: data from 3 large randomised clinical trials","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Abdominal pain; Inflammatory bowel disease; Exacerbation; Disease","score_opus":0.052684517315116475,"score_gpt":0.3235493271148486,"score_spread":0.2708648097997321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895378661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206984,0.0008314274,0.00006264982,0.000095767595,0.00021753211,0.0013581598,0.0053170184,0.000033053144,0.000014550346],"genre_scores_gemma":[0.99874926,0.00017025793,0.00009286708,0.00010094043,0.00003496375,0.00006154207,0.0006867735,0.000024898905,0.00007848332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610156,0.0017372748,0.001157935,0.0004980474,0.00016000509,0.00034518758],"domain_scores_gemma":[0.99597174,0.0014352441,0.0009696972,0.0011415464,0.0003013601,0.00018040683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010701905,0.0003240942,0.00095210155,0.00007925678,0.00019335067,0.0000196942,0.0006993637,0.00009048936,0.00017419159],"category_scores_gemma":[0.0036729644,0.00019780737,0.00021794264,0.00012217741,0.00038693365,0.0002655233,0.00045261625,0.00009463324,0.000036011923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044566024,0.0009606343,0.94470274,0.00009838129,0.0013874024,0.0000046067257,0.00017890098,0.00001516205,0.000047945516,0.000013964864,0.0019556426,0.0060685794],"study_design_scores_gemma":[0.019893968,0.00036571623,0.9757904,0.001627217,0.0010273331,0.000002216375,0.000058346883,0.0001286773,0.0005544063,0.00032703075,0.00001603718,0.00020868985],"about_ca_topic_score_codex":0.0001788899,"about_ca_topic_score_gemma":0.000087953435,"teacher_disagreement_score":0.031087603,"about_ca_system_score_codex":0.000009446267,"about_ca_system_score_gemma":0.00019400263,"threshold_uncertainty_score":0.806635},"labels":[],"label_agreement":null},{"id":"W2895598841","doi":"10.1136/annrheumdis-2018-213629","title":"microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Calgary; Alberta Bone and Joint Health Institute; University of Toronto; University Health Network; Toronto Western Hospital","funders":"Canadian Institutes of Health Research; Krembil Foundation","keywords":"Medicine; Osteoarthritis; microRNA; Facet (psychology); Oligonucleotide; Knee Joint; Bioinformatics; Surgery; Pathology; Gene; Genetics; Biology","score_opus":0.028636240330259456,"score_gpt":0.2870556529068549,"score_spread":0.25841941257659545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895598841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364734,0.0029958377,0.0000012375876,0.0016958531,0.00018813284,0.0005861327,0.000085194915,0.000033927157,0.0007663724],"genre_scores_gemma":[0.9978794,0.0007382237,0.00016831067,0.0005674031,0.000042644948,0.000020265268,0.000013188043,0.000026227133,0.0005443552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99874526,0.00008103434,0.000380763,0.00024048529,0.00023590059,0.00031657083],"domain_scores_gemma":[0.9990746,0.00006391894,0.00015494111,0.0004211415,0.00011292941,0.00017248007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013194956,0.00019878261,0.00045933304,0.00011394907,0.000092482405,0.00002763489,0.00009922463,0.000052304917,0.00015559595],"category_scores_gemma":[0.00026363772,0.00014314734,0.00015092087,0.00017672077,0.0003363041,0.00012298046,0.00011304196,0.00006720011,0.000092268005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077395403,0.0011617183,0.08995656,0.0008850552,0.00028159752,0.0001756682,0.0021053527,0.0000010465145,0.021908412,0.000863747,0.0050194627,0.8768674],"study_design_scores_gemma":[0.013705976,0.0057648895,0.8035149,0.0117467735,0.00052186236,0.0003249502,0.0014086481,0.00007363065,0.15234378,0.008641264,0.0012874375,0.0006658553],"about_ca_topic_score_codex":0.00006205812,"about_ca_topic_score_gemma":0.00008153806,"teacher_disagreement_score":0.87620157,"about_ca_system_score_codex":0.000009360836,"about_ca_system_score_gemma":0.00005495807,"threshold_uncertainty_score":0.5837379},"labels":[],"label_agreement":null},{"id":"W2895642842","doi":"10.1136/annrheumdis-2018-eular.2727","title":"SAT0575 Safety and efficacy of lutikizumab (ABT-981), an anti–interleukin-1 alpha/beta dual variable domain (DVD) immunoglobulin, in subjects with knee osteoarthritis: results from the randomised, double-blind, placebo-controlled, parallel-group phase 2 trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; WOMAC; Osteoarthritis; Synovitis; Placebo; Visual analogue scale; Knee pain; Clinical endpoint; Internal medicine; Gastroenterology; Urology; Randomized controlled trial; Arthritis; Surgery; Pathology","score_opus":0.025575288839578825,"score_gpt":0.2934223971733086,"score_spread":0.26784710833372977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895642842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985602,0.00442565,0.0000459572,0.00070671225,0.00035793864,0.007446466,0.00071922253,0.0000486219,0.0006474372],"genre_scores_gemma":[0.9978054,0.0005596377,0.00046260896,0.00017732044,0.00021478655,0.00025784926,0.0003355277,0.000053284057,0.00013357372],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958881,0.000658946,0.0015769226,0.0005993407,0.00071250665,0.00056415034],"domain_scores_gemma":[0.99557894,0.0017475707,0.00089942216,0.0012579276,0.00023955668,0.00027658083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011540292,0.00051029434,0.0017372334,0.00014065624,0.00025348988,0.000084371546,0.00038317378,0.00015264105,0.00011735248],"category_scores_gemma":[0.0006363707,0.00028760146,0.00039658893,0.00035708587,0.0006641104,0.00030775697,0.00015359776,0.00021100591,0.000007879016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9753262,0.002790106,0.00013950285,0.00007332959,0.0008117736,0.000044482884,0.001492685,0.000016548423,0.0004510624,0.00059246586,0.00016042394,0.018101428],"study_design_scores_gemma":[0.97490364,0.015467434,0.0013323671,0.003104555,0.001109781,0.00004598303,0.0009967879,0.000067554494,0.0016209122,0.0009122898,0.0001272166,0.00031150327],"about_ca_topic_score_codex":0.0005988217,"about_ca_topic_score_gemma":0.00040669364,"teacher_disagreement_score":0.017789925,"about_ca_system_score_codex":0.000034454693,"about_ca_system_score_gemma":0.00033752524,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W2895726712","doi":"10.1136/annrheumdis-2018-eular.4382","title":"THU0201 A pooled analysis of three tnf-Α inhibitor biosimilar studies in patients with rheumatoid arthritis comparing radiographic progression by disease activity states","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Rheumatoid arthritis; Internal medicine; Biosimilar; TNF inhibitor; Disease","score_opus":0.038792196765815586,"score_gpt":0.3229218672946032,"score_spread":0.2841296705287876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895726712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801572,0.018248111,0.000041558586,0.0005025632,0.000128839,0.000432339,0.00045820634,0.000022456325,0.000008752189],"genre_scores_gemma":[0.99729884,0.0024442552,0.00006664044,0.00009118909,0.0000039822903,0.000026318266,0.000047413818,0.00001344829,0.0000079253405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981123,0.00044883607,0.0005721417,0.00033320862,0.00017894588,0.0003545209],"domain_scores_gemma":[0.9981933,0.0003597364,0.0005310531,0.0005301916,0.00030885026,0.00007687398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036124923,0.00026447471,0.0010040744,0.0003246574,0.00015194,0.0000140010725,0.00034117617,0.00008501605,0.00007154085],"category_scores_gemma":[0.0003899117,0.00015068428,0.00035875526,0.0011945444,0.0017033614,0.0001290355,0.00020431781,0.00012450226,0.0000018425108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002143721,0.002005885,0.96230114,0.00023937604,0.0068700383,7.081324e-7,0.0002256681,0.000014759774,0.00031949382,0.000040479365,0.0029869615,0.022851791],"study_design_scores_gemma":[0.0016739158,0.000535639,0.9840185,0.0021759847,0.0011523489,2.081528e-7,0.00012310868,0.0003097643,0.00910043,0.00062110217,0.000045903453,0.00024307286],"about_ca_topic_score_codex":0.000062702304,"about_ca_topic_score_gemma":0.00012063249,"teacher_disagreement_score":0.022608718,"about_ca_system_score_codex":0.000011696468,"about_ca_system_score_gemma":0.000043241587,"threshold_uncertainty_score":0.6276106},"labels":[],"label_agreement":null},{"id":"W2896211924","doi":"10.1136/annrheumdis-2018-eular.2705","title":"OP0309 Characterisation of clinical benefits in subjects classified as acr20 non-responders at week 104 of apremilast treatment: subanalysis of 3 long-term, phase iii trials","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Janssen Research and Development; KU Leuven","keywords":"Apremilast; Medicine; Internal medicine; Clinical trial; Term (time); Intensive care medicine; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.7321362683283751,"score_gpt":0.6138100759340432,"score_spread":0.11832619239433184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896211924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961371,0.00016851621,0.00073545333,0.00025044204,0.00034511278,0.0012264189,0.0009544694,0.000014867422,0.00016765375],"genre_scores_gemma":[0.9945351,0.00077307614,0.004321585,0.000051874635,0.00009059146,0.000049018527,0.000020218715,0.000038461236,0.00012010479],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9882475,0.00372019,0.0063779904,0.00045435064,0.0008538429,0.00034613442],"domain_scores_gemma":[0.9217926,0.06988231,0.0061472612,0.001340446,0.00060513255,0.00023221874],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007929154,0.00036133357,0.003980946,0.00027862968,0.000056634257,0.000013580127,0.0006800134,0.00024348006,0.00071736425],"category_scores_gemma":[0.16203582,0.00024096805,0.0015156891,0.00063051865,0.0010157744,0.00012645888,0.00021451295,0.00011344812,0.000009981271],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08165924,0.04710106,0.15808308,0.008454823,0.013126543,0.000021389245,0.0055202716,0.00007266776,0.009625717,0.011505623,0.0020680453,0.6627615],"study_design_scores_gemma":[0.029893318,0.006202159,0.5719866,0.00699468,0.0055447947,0.0000028901645,0.00045366542,0.0015285767,0.21921836,0.15751089,0.000005718551,0.0006583418],"about_ca_topic_score_codex":0.00011544586,"about_ca_topic_score_gemma":0.00006902083,"teacher_disagreement_score":0.6621032,"about_ca_system_score_codex":0.00004104292,"about_ca_system_score_gemma":0.0002911754,"threshold_uncertainty_score":0.98263913},"labels":[],"label_agreement":null},{"id":"W2896633702","doi":"10.1136/annrheumdis-2018-213718","title":"Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre for Global Health Research; University of Toronto; CReATe Fertility Centre; Centre Hospitalier Universitaire Sainte-Justine; St. Michael's Hospital; Université de Montréal","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Hydroxychloroquine; In utero; Rash; Pregnancy; Gestation; Internal medicine; Pediatrics; Obstetrics; Fetus; Disease; Coronavirus disease 2019 (COVID-19)","score_opus":0.029707204845871388,"score_gpt":0.3206859302392688,"score_spread":0.2909787253933974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896633702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963647,0.0010291357,0.000010303326,0.00058256,0.00020150974,0.0011586754,0.000029184921,0.000016170401,0.0006077747],"genre_scores_gemma":[0.9993536,0.00006334245,0.000056619458,0.000057044264,0.000028381484,0.00006411519,0.0000050267586,0.000029560577,0.000342309],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970806,0.00037019365,0.000961103,0.00022337602,0.0010304918,0.00033422318],"domain_scores_gemma":[0.9965239,0.0016483559,0.0004559789,0.0010261356,0.00023184309,0.000113767645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010289085,0.00023484539,0.00079717644,0.00018214343,0.00006501129,0.0000074595077,0.00056918146,0.00006680886,0.00016534748],"category_scores_gemma":[0.0019335025,0.00011453584,0.00026205805,0.000399382,0.00046940934,0.000041533967,0.0002092913,0.0001236819,0.000029425802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018697394,0.004073935,0.67868185,0.050275136,0.003488962,0.00021938492,0.04701589,0.00009546447,0.005371549,0.0016810927,0.015398891,0.17500043],"study_design_scores_gemma":[0.0100990785,0.009671142,0.0255171,0.06264168,0.00044718548,0.0067609674,0.004139396,0.0016492666,0.8760965,0.0018447589,0.0004332253,0.0006997368],"about_ca_topic_score_codex":0.000026823773,"about_ca_topic_score_gemma":0.000018379484,"teacher_disagreement_score":0.8707249,"about_ca_system_score_codex":0.000034278553,"about_ca_system_score_gemma":0.00023162246,"threshold_uncertainty_score":0.46706358},"labels":[],"label_agreement":null},{"id":"W2896812857","doi":"10.1136/annrheumdis-2018-eular.3115","title":"SAT0293 Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of opal balance, an open-label, long-term extension study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Toronto Western Hospital; University of Toronto","funders":"Sun Pharma; Genentech; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Psoriatic arthritis; Tolerability; Adverse effect; Internal medicine; Discontinuation; Interim analysis; Clinical endpoint; Gastroenterology; Surgery; Arthritis; Randomized controlled trial; Rheumatoid arthritis","score_opus":0.06990249752259424,"score_gpt":0.3735381835484743,"score_spread":0.30363568602588004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896812857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944182,0.001103083,0.00001099259,0.00016528946,0.00007847825,0.001931181,0.0022695176,0.0000108243585,0.0000124044345],"genre_scores_gemma":[0.99793226,0.0013038565,0.00007201858,0.00011129568,0.000019463527,0.000026489617,0.0005084494,0.000021489202,0.000004697309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716073,0.0005819484,0.0007601747,0.00048296188,0.0007274886,0.00028671251],"domain_scores_gemma":[0.9967742,0.00035797592,0.00038947008,0.0017651614,0.00045057907,0.00026262217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054130924,0.00023872641,0.0010283209,0.00019962102,0.00012401397,0.00006983821,0.00095761963,0.000037279977,0.00009208672],"category_scores_gemma":[0.0010261136,0.0001379587,0.00005915107,0.0006828106,0.00048761928,0.0006062169,0.0007946224,0.00011725252,0.0000017440601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024691127,0.009679984,0.75072217,0.000086083855,0.0023493154,0.000008305839,0.0066620014,0.000010148616,0.00008437892,0.000017301682,0.0001912653,0.20549792],"study_design_scores_gemma":[0.010245216,0.0052878954,0.97820574,0.0027059366,0.00024410049,6.260694e-7,0.002335734,0.000480176,0.0002753837,0.000067307636,0.000006440467,0.00014546617],"about_ca_topic_score_codex":0.0023287304,"about_ca_topic_score_gemma":0.003178953,"teacher_disagreement_score":0.22748356,"about_ca_system_score_codex":0.000015849671,"about_ca_system_score_gemma":0.000121278055,"threshold_uncertainty_score":0.5625793},"labels":[],"label_agreement":null},{"id":"W2897014420","doi":"10.1136/annrheumdis-2018-eular.1770","title":"AB0825 Managing systemic sclerosis: assessing the educational needs of rheumatologists","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Rheumatology; Multiple sclerosis; Intensive care medicine; Physical therapy; Internal medicine; Immunology","score_opus":0.06641226476984105,"score_gpt":0.33880530581053786,"score_spread":0.27239304104069684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897014420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966214,0.025656726,0.000036293804,0.005054533,0.0005787498,0.0004903314,0.000030393518,0.000035932102,0.0019030203],"genre_scores_gemma":[0.99691385,0.0022212078,0.000026987413,0.00043280504,0.00008762259,0.000039667742,0.000008496194,0.000022730086,0.00024664964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980161,0.00021251138,0.00079981005,0.00016060747,0.0005487664,0.0002621924],"domain_scores_gemma":[0.9973631,0.00050961215,0.00070839433,0.00083656306,0.00044513872,0.00013718147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041046835,0.00019063153,0.0005081117,0.00014818566,0.0002378443,0.00004496041,0.00046728144,0.00006966291,0.00013505017],"category_scores_gemma":[0.0009387448,0.00009712098,0.00039677156,0.00056676345,0.00070306385,0.00012549963,0.00012721459,0.000089399524,0.000028772292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005066978,0.0035542557,0.72936237,0.013114929,0.0048187026,0.000002537832,0.00851043,0.00029055952,0.0065950966,0.025985489,0.10569027,0.101568684],"study_design_scores_gemma":[0.0009306473,0.000114278686,0.91975695,0.062731,0.0008500923,0.00010435458,0.008634865,0.00076827354,0.0032536967,0.0025913944,0.000040999443,0.00022346285],"about_ca_topic_score_codex":0.00011417666,"about_ca_topic_score_gemma":8.811119e-7,"teacher_disagreement_score":0.1903946,"about_ca_system_score_codex":0.000022133812,"about_ca_system_score_gemma":0.0003495594,"threshold_uncertainty_score":0.39604786},"labels":[],"label_agreement":null},{"id":"W2897014939","doi":"10.1136/annrheumdis-2018-eular.5848","title":"OP0106 Who is not reaching remission in early ra and why? predictors for persistent disease activity in the first year differ in men and women and are related to lifestyle and treatment","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Western University; Université de Sherbrooke; University of Manitoba; Southlake Regional Health Center; University of Toronto; McGill University","funders":"Sanofi Genzyme; National Institutes of Health; Northeast Ohio Medical University; Amgen; Pfizer; Eli Lilly and Company; Università Cattolica del Sacro Cuore","keywords":"Medicine; Logistic regression; Cohort; Internal medicine; Disease; Odds; Physical therapy; Guideline; Odds ratio; Pediatrics; Demography","score_opus":0.033852163149385384,"score_gpt":0.30431842619633376,"score_spread":0.2704662630469484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897014939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936194,0.0011416599,5.019525e-7,0.008402613,0.000007226362,0.000995748,0.000039743987,0.000005258759,0.000045334473],"genre_scores_gemma":[0.9981663,0.0012787685,0.0000035586072,0.00026254705,0.0000053922545,0.00010394265,0.0000022109803,0.000011105885,0.00016617618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904376,0.000117317344,0.0002282978,0.00021189255,0.00018752697,0.00021121083],"domain_scores_gemma":[0.99928534,0.00021018198,0.00007540701,0.00024245144,0.000027839444,0.00015877865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036189606,0.00012737716,0.0003147914,0.00011323078,0.00010366433,0.000033560966,0.000073593146,0.000039729228,0.000007174543],"category_scores_gemma":[0.00045526135,0.00007289399,0.00004361195,0.00011835868,0.00016270611,0.00011604253,0.00010196627,0.0000744903,3.1055322e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019022019,0.00036047923,0.9543261,0.00051612203,0.000078108744,0.0000048529073,0.032033037,0.0000020429802,0.00004412439,0.000011898713,0.0007220785,0.00999895],"study_design_scores_gemma":[0.0019574051,0.0005242944,0.9910268,0.0013434085,0.00003394499,0.0000011802343,0.0033040228,0.0012480493,0.000040806317,0.0002404389,0.00020381801,0.000075809185],"about_ca_topic_score_codex":0.00020636518,"about_ca_topic_score_gemma":0.000036459773,"teacher_disagreement_score":0.03670072,"about_ca_system_score_codex":0.00003576072,"about_ca_system_score_gemma":0.000042916425,"threshold_uncertainty_score":0.29725307},"labels":[],"label_agreement":null},{"id":"W2899230583","doi":"10.1136/annrheumdis-2018-eular.2137","title":"THU0333 Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: three year results from a phase 3 study (SPIRIT-P1)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation","funders":"NordForsk; Oak Foundation","keywords":"Medicine; Ixekizumab; Discontinuation; Psoriatic arthritis; Internal medicine; Adverse effect; Placebo; Rheumatology; Psoriasis; Physical therapy; Arthritis; Secukinumab; Dermatology; Alternative medicine","score_opus":0.0212153636489128,"score_gpt":0.2711073827062123,"score_spread":0.24989201905729952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899230583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955587,0.0013419824,0.0000026987718,0.00009664304,0.0001509993,0.0008455125,0.0019167378,0.00001370153,0.00007306612],"genre_scores_gemma":[0.99957603,0.00018423569,0.000017697761,0.000019259438,0.000011652485,0.000023190541,0.00013320381,0.000012635394,0.00002209975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99868935,0.00027073288,0.00048159974,0.00026188788,0.0000943685,0.00020206017],"domain_scores_gemma":[0.9986137,0.00040015831,0.000362412,0.0004758457,0.00011802208,0.000029859615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001326846,0.0001857502,0.00047175307,0.00007701164,0.000097844655,0.000007648403,0.00022032697,0.00006437411,0.00008769441],"category_scores_gemma":[0.0003287497,0.00011776611,0.00007624532,0.00016961966,0.0003056554,0.00009756371,0.000092336864,0.000059452886,0.000019141615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033577953,0.010204024,0.07054622,0.000043685097,0.0022999765,0.0000025031475,0.005554219,0.0000041155618,0.000035975107,0.00004334811,0.0004603079,0.87722766],"study_design_scores_gemma":[0.029965,0.0022561448,0.9639566,0.0007150749,0.00028057667,3.008043e-7,0.00059826055,0.0000023583523,0.001590125,0.00047153927,0.000030912088,0.00013308517],"about_ca_topic_score_codex":0.0003413281,"about_ca_topic_score_gemma":0.00023543948,"teacher_disagreement_score":0.8934104,"about_ca_system_score_codex":0.000009152892,"about_ca_system_score_gemma":0.000057519046,"threshold_uncertainty_score":0.48023626},"labels":[],"label_agreement":null},{"id":"W2899817624","doi":"10.1136/annrheumdis-2018-eular.1932","title":"AB0240 Reduction in fatigue and pain are associated with improved work productivity in patients with ra","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Medicine; Reduction (mathematics); Productivity; Work productivity; Work (physics); Physical therapy; Physical medicine and rehabilitation","score_opus":0.027870145690457326,"score_gpt":0.28038910366091335,"score_spread":0.25251895797045604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899817624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744743,0.00023911135,0.000005406819,0.0014092727,0.00003057948,0.0008157476,0.0000112914295,0.0000143972975,0.000026784364],"genre_scores_gemma":[0.99973613,0.000020345493,0.000033251774,0.000009927033,0.0000067529827,0.000037552592,0.000016136395,0.00001708685,0.00012283296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860233,0.0002668784,0.00023889591,0.00023897173,0.000380608,0.0002722958],"domain_scores_gemma":[0.9990477,0.000110511566,0.0001888956,0.00034926142,0.00021392811,0.00008967979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005193182,0.00013682366,0.00033361372,0.00011796161,0.00005152778,0.000014366152,0.000095306204,0.000045135967,0.000024738096],"category_scores_gemma":[0.0012077068,0.00007883457,0.000035056382,0.0006331898,0.00036812463,0.000119949,0.000043984404,0.00013280916,8.925047e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001209489,0.0010806468,0.98842984,0.0011263478,0.0001364266,0.0000019790475,0.00047818228,0.000009822308,0.000016787923,0.0000055171117,0.0006373622,0.00686762],"study_design_scores_gemma":[0.001980403,0.0009144804,0.98768914,0.008525957,0.00003190775,0.0000011938694,0.00022193285,0.0001671681,0.00023430666,0.00013416074,0.0000012801208,0.00009804544],"about_ca_topic_score_codex":0.0001178927,"about_ca_topic_score_gemma":0.000036544167,"teacher_disagreement_score":0.00739961,"about_ca_system_score_codex":0.000053319884,"about_ca_system_score_gemma":0.00016231328,"threshold_uncertainty_score":0.32147804},"labels":[],"label_agreement":null},{"id":"W2899867903","doi":"10.1136/annrheumdis-2018-eular.4510","title":"FRI0183 Clinical peripheral enthesitis in the desir prospective longitudinal axial spondyloarthritis cohort","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Pfizer","keywords":"Medicine; Enthesitis; Dactylitis; Internal medicine; BASDAI; Prospective cohort study; Psoriatic arthritis; Sacroiliitis; BASFI; Peripheral; Plantar fascia; Ankylosing spondylitis; Arthritis; Surgery; Pathology; Plantar fasciitis","score_opus":0.07418433741519735,"score_gpt":0.3799119487617852,"score_spread":0.3057276113465878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899867903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99164927,0.0005364205,0.000009974921,0.004107649,0.00021082727,0.0009769693,0.0000857627,0.000021683638,0.0024014618],"genre_scores_gemma":[0.99888223,0.00026497198,0.000058424102,0.00022509345,0.00018703648,0.0000878035,0.000015973003,0.0000169913,0.00026145682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980272,0.00038759562,0.00054064096,0.00026144917,0.000490764,0.0002923707],"domain_scores_gemma":[0.99868715,0.00034119628,0.00017035393,0.0005233816,0.00015647187,0.00012145167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014467025,0.00018785808,0.00047621407,0.000050610735,0.00016083529,0.000034307486,0.0002721031,0.000059838978,0.00054434856],"category_scores_gemma":[0.0007235874,0.00010247128,0.00034042212,0.00024300099,0.00069081236,0.00013508069,0.00006177073,0.00014075842,0.00006431439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041730588,0.0011769232,0.9757155,0.000049841485,0.0002850553,0.0002950148,0.0009540001,1.3161373e-7,0.000003024131,0.00046120922,0.0020106263,0.018631373],"study_design_scores_gemma":[0.0014760726,0.0007600306,0.9942585,0.00063662895,0.00020455425,0.0003956137,0.0003236683,0.00003438419,0.00022065848,0.001436272,0.0001500397,0.00010354154],"about_ca_topic_score_codex":0.00011671889,"about_ca_topic_score_gemma":0.00007466916,"teacher_disagreement_score":0.01854304,"about_ca_system_score_codex":0.000024947585,"about_ca_system_score_gemma":0.00015263123,"threshold_uncertainty_score":0.59602344},"labels":[],"label_agreement":null},{"id":"W2899933472","doi":"10.1136/annrheumdis-2018-eular.1023","title":"AB0843 Effect of tnf inhibitors on bone microarchitecture in patients with ankylosing spondylitis: a longitudinal study based on high-resolution peripheral quantitative based (HRPQCT)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada); University of Toronto; NOSM University","funders":"","keywords":"Medicine; Femoral neck; BASDAI; Ankylosing spondylitis; Quantitative computed tomography; Infliximab; Internal medicine; Osteoporosis; Adalimumab; Bone mineral; Surgery; Urology; Psoriatic arthritis; Rheumatoid arthritis; Tumor necrosis factor alpha","score_opus":0.018197336555423008,"score_gpt":0.2942533857826045,"score_spread":0.2760560492271815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899933472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971442,0.00029658037,0.000012802886,0.00028782347,0.00010817553,0.0016352818,0.00045053352,0.000019005049,0.00004554577],"genre_scores_gemma":[0.99951804,0.0000040581435,0.00013538588,0.00013996342,0.000020393922,0.00006891412,0.00007771729,0.000027784297,0.000007735107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979537,0.00035019388,0.00042732828,0.00032571278,0.0006490108,0.00029402698],"domain_scores_gemma":[0.998548,0.0003944845,0.0003041074,0.00045344429,0.00020662109,0.00009335013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002115566,0.00029923732,0.0006928932,0.00022217956,0.00013691875,0.000012797137,0.000102677186,0.00004042416,0.000078745215],"category_scores_gemma":[0.00044283172,0.00017333195,0.00019056568,0.00039752573,0.00033965788,0.000050710394,0.00003816207,0.00010811964,0.000003475672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028710317,0.0066403914,0.956832,0.0004420289,0.00039158776,0.000027870452,0.00056087633,0.000523639,0.00001257504,0.000033211756,0.00020815112,0.00561737],"study_design_scores_gemma":[0.012906668,0.02881808,0.9509249,0.0052984045,0.00027355916,7.069023e-7,0.0001393813,0.0004053728,0.001056826,0.00002886318,0.0000047359913,0.00014252528],"about_ca_topic_score_codex":0.00042042942,"about_ca_topic_score_gemma":0.0001297681,"teacher_disagreement_score":0.022177689,"about_ca_system_score_codex":0.00006377026,"about_ca_system_score_gemma":0.000073756455,"threshold_uncertainty_score":0.7068272},"labels":[],"label_agreement":null},{"id":"W2900290728","doi":"10.1136/annrheumdis-2018-eular.5536","title":"OP0312 International league of associations for rheumatology (ILAR) treatment recommendations for psoriatic arthritis in resource-poor countries","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"KU Leuven; Celgene; Pfizer","keywords":"Medicine; Psoriatic arthritis; Guideline; League; Resource (disambiguation); Rheumatism; Family medicine; Medical education; Internal medicine; Arthritis; Pathology; Computer science","score_opus":0.08814511728975306,"score_gpt":0.40836964031793466,"score_spread":0.3202245230281816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900290728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7004319,0.0024748317,0.0007875402,0.28755057,0.00065058796,0.0030008033,0.0045263967,0.00003681391,0.00054059067],"genre_scores_gemma":[0.9936291,0.0028820704,0.001002878,0.0012289152,0.00006436566,0.00051441806,0.00038474868,0.000017143951,0.00027638374],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9984875,0.00016186711,0.0007396471,0.0001669295,0.0001670858,0.00027697696],"domain_scores_gemma":[0.99658406,0.0022648296,0.00037563356,0.00026740824,0.00042061365,0.00008746531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005255342,0.000114698356,0.00058053865,0.0001648779,0.00010511881,0.000008391797,0.00018780629,0.00006732927,0.000134518],"category_scores_gemma":[0.007830261,0.00008176184,0.00028721374,0.0001278897,0.00024464302,0.00006812217,0.000042403044,0.00004155139,0.000005755307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023816319,0.0031309824,0.17561562,0.001048579,0.0030398061,9.457886e-7,0.0020893838,0.00006781243,0.000053804164,0.031639334,0.6204085,0.16052362],"study_design_scores_gemma":[0.022467516,0.0059581487,0.5572578,0.0062431325,0.00085911347,0.000039090242,0.0030599781,0.016697252,0.00563566,0.07326641,0.30786237,0.00065354945],"about_ca_topic_score_codex":0.00024852323,"about_ca_topic_score_gemma":0.00034187915,"teacher_disagreement_score":0.38164216,"about_ca_system_score_codex":0.000061358216,"about_ca_system_score_gemma":0.00021003703,"threshold_uncertainty_score":0.937412},"labels":[],"label_agreement":null},{"id":"W2900492392","doi":"10.1136/annrheumdis-2018-eular.2862","title":"AB0731 Treatment algorithms for systemic sclerosis according to experts","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"","keywords":"Medicine; Rituximab; Tocilizumab; Hydroxychloroquine; Internal medicine; Scleroderma (fungus); Cyclophosphamide; Interstitial lung disease; Mycophenolate; Gastroenterology; Algorithm; Transplantation; Immunology; Rheumatoid arthritis; Lung; Disease; Chemotherapy; Lymphoma","score_opus":0.16836126368151547,"score_gpt":0.3689852875787754,"score_spread":0.20062402389725995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900492392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98554516,0.009199222,0.00020772712,0.002391097,0.0004876809,0.0017847022,0.00010805424,0.00007671018,0.00019964363],"genre_scores_gemma":[0.99644387,0.0013347635,0.0001906029,0.00091474166,0.00023620907,0.00036678233,0.000010279356,0.000037170903,0.00046556574],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843717,0.00006248525,0.00054026325,0.00029229728,0.00033537426,0.00033240704],"domain_scores_gemma":[0.998194,0.00022480762,0.00022772206,0.0006850524,0.00032669463,0.0003417418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013469343,0.0002270052,0.000563677,0.00010805508,0.00018760492,0.000033172084,0.00023633502,0.00006658041,0.000057632693],"category_scores_gemma":[0.0004355707,0.00012726332,0.0005387275,0.00025564313,0.00012055773,0.00006546777,0.000058311387,0.000020399779,0.000040670013],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024721522,0.0042039873,0.0386981,0.0035610993,0.0046625366,0.0000083162895,0.006202351,0.00013618996,0.02058241,0.00061835523,0.17026019,0.7485943],"study_design_scores_gemma":[0.023842204,0.013241389,0.3768617,0.2702556,0.009128404,0.00046668225,0.04387496,0.009005421,0.24291418,0.0021369192,0.005328532,0.002944037],"about_ca_topic_score_codex":0.00011074644,"about_ca_topic_score_gemma":0.0000014172449,"teacher_disagreement_score":0.7456503,"about_ca_system_score_codex":0.000057607205,"about_ca_system_score_gemma":0.00013673106,"threshold_uncertainty_score":0.51896477},"labels":[],"label_agreement":null},{"id":"W2900514407","doi":"10.1136/annrheumdis-2018-eular.4362","title":"THU0184 Impact of immunogenicity on clinical efficacy and administration related reaction in tnf inhibitors: a pooled-analysis from three biosimilar studies in patients with rheumatoid arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Biosimilar; Adalimumab; Etanercept; Infliximab; Immunogenicity; Rheumatoid arthritis; Clinical endpoint; Internal medicine; Discontinuation; TNF inhibitor; Clinical efficacy; Clinical trial; Antibody; Immunology; Tumor necrosis factor alpha","score_opus":0.05998855447232843,"score_gpt":0.37815480077710734,"score_spread":0.3181662463047789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900514407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498165,0.0040998245,0.000003892658,0.00026813362,0.00011896329,0.00032024027,0.00018299448,0.000009878403,0.000014455899],"genre_scores_gemma":[0.9980558,0.001796824,0.00004035033,0.000048901387,0.0000052655996,0.000005373563,0.00003512978,0.000008133836,0.000004210909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977725,0.0006334422,0.0009974106,0.0002966055,0.000100529214,0.0001995125],"domain_scores_gemma":[0.9979424,0.000868438,0.00056162523,0.0004160494,0.00017813561,0.000033356348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059345766,0.00019550197,0.00081516406,0.0001901484,0.000062435094,0.000008606842,0.0001675862,0.00018161126,0.00005782313],"category_scores_gemma":[0.0013134067,0.00011338545,0.00031430574,0.0005743647,0.0009186598,0.000091879534,0.0000861556,0.00018384168,0.0000033241272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036311871,0.001992458,0.9663012,0.000027778473,0.006602329,8.383749e-7,0.00031350914,0.000008942403,0.00032408847,0.00003857175,0.00027492183,0.020484162],"study_design_scores_gemma":[0.0023322438,0.0019647903,0.99072874,0.001061272,0.00043969307,5.3622443e-7,0.00010119325,0.000028687897,0.0022707696,0.0009439359,0.0000029095306,0.00012523033],"about_ca_topic_score_codex":0.0003095623,"about_ca_topic_score_gemma":0.00042533752,"teacher_disagreement_score":0.024427526,"about_ca_system_score_codex":0.000020980799,"about_ca_system_score_gemma":0.000064472304,"threshold_uncertainty_score":0.46237245},"labels":[],"label_agreement":null},{"id":"W2900570140","doi":"10.1136/annrheumdis-2018-eular.1281","title":"SAT0217 Identification of distinct disease activity trajectories in patients with rheumatoid arthritis receiving tofacitinib over 12 months","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Pfizer (Canada)","funders":"","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Identification (biology); Disease; Internal medicine; Physical therapy","score_opus":0.019113769000904227,"score_gpt":0.2826113057787568,"score_spread":0.2634975367778526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900570140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961532,0.0019209789,0.000028053539,0.00036738513,0.00012830055,0.0007997942,0.00044770446,0.000030727686,0.00012387986],"genre_scores_gemma":[0.99621487,0.003548122,0.000018871977,0.00003157853,0.000021173977,0.00005837238,0.000042841642,0.000029889567,0.000034261666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764603,0.00019947106,0.0006397064,0.00029115673,0.0008520505,0.00037159747],"domain_scores_gemma":[0.9979474,0.00022710071,0.00045621995,0.0007228058,0.0003856911,0.00026078944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030253906,0.00022331737,0.000551208,0.00015413403,0.00014080263,0.000040814626,0.0002513335,0.000040324965,0.00022972294],"category_scores_gemma":[0.0016229021,0.00015372511,0.00019695921,0.0003422108,0.0007590496,0.0003849041,0.00008717718,0.00011075015,0.0000069483885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028770792,0.0012784228,0.9281298,0.00035272512,0.00017866996,0.0000022531262,0.0006198195,0.000005750592,0.00008293933,0.00018423639,0.00048784274,0.065800466],"study_design_scores_gemma":[0.0024558024,0.00036752442,0.9899569,0.0037618503,0.000011072152,0.0000010350465,0.00010519894,0.0001365325,0.0021473425,0.00081551925,0.0000854433,0.00015575389],"about_ca_topic_score_codex":0.00029524718,"about_ca_topic_score_gemma":0.00020669147,"teacher_disagreement_score":0.06564471,"about_ca_system_score_codex":0.000024483794,"about_ca_system_score_gemma":0.0002216641,"threshold_uncertainty_score":0.62687284},"labels":[],"label_agreement":null},{"id":"W2900596103","doi":"10.1136/annrheumdis-2018-eular.3008","title":"FRI0324 Immunosuppression for primary sjogren's syndrome: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Immunosuppression; Meta-analysis; Immunology; Intensive care medicine; Internal medicine","score_opus":0.13428173377224767,"score_gpt":0.38674365261435995,"score_spread":0.2524619188421123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900596103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027694991,0.9928156,0.000040108713,0.00055628753,0.00006296295,0.005363398,0.001017948,0.000027601682,0.00011333092],"genre_scores_gemma":[0.000038727994,0.9956009,0.00007242598,0.00085832854,0.00001060092,0.0015466242,0.0003776671,0.00004183068,0.0014529203],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972441,0.0003555136,0.0014084568,0.00037383285,0.00038516484,0.00023292658],"domain_scores_gemma":[0.99608594,0.0008085714,0.0012695289,0.0014410559,0.00023425352,0.00016065838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049811543,0.00046446547,0.009199354,0.00023793458,0.0001473547,0.000031737756,0.0003420878,0.00012283912,0.0003852357],"category_scores_gemma":[0.0011257142,0.000207351,0.006971539,0.0006911942,0.0001464659,0.000069786096,0.00015648302,0.00010053798,0.000014248269],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007357592,0.00015979863,0.0000019179931,0.82355726,0.16467528,0.0000010717799,0.0000086009995,6.1327356e-8,1.1939552e-9,0.000021689433,0.010186919,0.0013800601],"study_design_scores_gemma":[0.000113253074,0.00009740716,0.000032849195,0.1882029,0.8004765,0.00005639123,0.000011571211,0.0000028057902,2.3390495e-8,0.00016819588,0.010668496,0.00016961023],"about_ca_topic_score_codex":0.0000117175,"about_ca_topic_score_gemma":5.972331e-7,"teacher_disagreement_score":0.6358012,"about_ca_system_score_codex":0.0000116058345,"about_ca_system_score_gemma":0.00018847633,"threshold_uncertainty_score":0.84555286},"labels":[],"label_agreement":null},{"id":"W2900635510","doi":"10.1136/annrheumdis-2018-eular.1275","title":"THU0323 Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Allergan; Incyte; Momenta Pharmaceuticals; Dermira; Genentech; Valeant Pharmaceuticals International; Sanofi; Sun Pharma; Zynerba Pharmaceuticals; Regeneron Pharmaceuticals; Novartis Pharma; Novartis; Amgen; Pfizer; Horizon Pharma; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Internal medicine; Adalimumab; Clinical endpoint; Janus kinase inhibitor; Psoriasis; Psoriasis Area and Severity Index; Placebo; Arthritis; Rheumatoid arthritis; Clinical trial; Gastroenterology; Surgery; Dermatology; Pathology","score_opus":0.0273525534853502,"score_gpt":0.2841176598579625,"score_spread":0.2567651063726123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900635510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965117,0.0016665857,0.000011825911,0.000573965,0.00004958743,0.0007403277,0.0001278661,0.000017073458,0.00030107843],"genre_scores_gemma":[0.9993322,0.00032424007,0.00003277466,0.00015708388,0.00001339393,0.000031290914,0.000029894161,0.000020286623,0.000058820562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980955,0.00012495049,0.00059226365,0.0001826744,0.0007248858,0.00027973452],"domain_scores_gemma":[0.99844015,0.000088449764,0.00028885074,0.0006095345,0.00040888463,0.00016413767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019821154,0.00016666089,0.00051776343,0.00013352821,0.00006896108,0.0000133482445,0.0002436689,0.000030848707,0.00016371765],"category_scores_gemma":[0.00059870916,0.00010284702,0.00017743603,0.00027322894,0.00052457995,0.00014423174,0.00010376505,0.000088959416,0.000011427254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00486404,0.0023980788,0.8514752,0.0016081398,0.00042613555,0.0000043353107,0.0010149233,0.000019641047,0.00012673083,0.0003878088,0.0012822676,0.1363927],"study_design_scores_gemma":[0.0024672383,0.00056770875,0.99189484,0.002204788,0.00007240763,2.2890633e-7,0.00014950993,0.00012367664,0.0013639239,0.0009203057,0.00012012445,0.00011522559],"about_ca_topic_score_codex":0.00008354425,"about_ca_topic_score_gemma":0.00001203854,"teacher_disagreement_score":0.14041966,"about_ca_system_score_codex":0.00001103373,"about_ca_system_score_gemma":0.00024645965,"threshold_uncertainty_score":0.41939798},"labels":[],"label_agreement":null},{"id":"W2900816366","doi":"10.1136/annrheumdis-2018-eular.7268","title":"SAT0080 Secular trends prior to-and after dissemination of best practice recommendations showed earlier intensified medication strategies and improved outcomes in canadians with early inflammatory arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Toronto; University of Winnipeg; Western University; McGill University; Southlake Regional Health Center","funders":"Sanofi; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Cohort; Internal medicine; Cohort study; Prospective cohort study; Pediatrics; Physical therapy","score_opus":0.01301640820211231,"score_gpt":0.3122802754574951,"score_spread":0.2992638672553828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900816366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834946,0.0015266575,0.000028297889,0.014312714,0.000035216937,0.0003912038,0.00006118956,0.000009258927,0.00014087737],"genre_scores_gemma":[0.99625885,0.003045033,0.00026880583,0.00021361971,0.000009980617,0.000082663624,0.000011253076,0.000014003832,0.0000957749],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891025,0.00010857855,0.00035914098,0.00016413962,0.0002723975,0.00018552478],"domain_scores_gemma":[0.9986377,0.00035942972,0.00016918303,0.0002741972,0.0003654322,0.0001941041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024610944,0.00012295513,0.00030301567,0.00023092332,0.00006876564,0.000051729785,0.00008022374,0.00003741248,0.00006314694],"category_scores_gemma":[0.001592284,0.00008371257,0.00004253276,0.00019913477,0.00038986953,0.00041438645,0.000044185534,0.00007949456,0.0000013595561],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028995143,0.0011799778,0.2584362,0.000681618,0.0010827011,0.000025680616,0.03780237,0.0000020449534,0.0013205205,0.0017756048,0.0016791403,0.69311464],"study_design_scores_gemma":[0.00097075466,0.0008132045,0.9841316,0.0032722966,0.000035139263,0.000020169296,0.00958607,0.000092831084,0.0004341235,0.00026317654,0.0002593902,0.00012125498],"about_ca_topic_score_codex":0.0019276381,"about_ca_topic_score_gemma":0.006436417,"teacher_disagreement_score":0.7256954,"about_ca_system_score_codex":0.000012489009,"about_ca_system_score_gemma":0.00018069589,"threshold_uncertainty_score":0.35916716},"labels":[],"label_agreement":null},{"id":"W2900877048","doi":"10.1136/annrheumdis-2018-eular.5665","title":"SAT0560 From a 2-year multicentre clinical trial in knee osteoarthritis, a metabolomic analysis reveals that over activation of the conversion pathway of phosphatidylcholine to lysophosphatidylcholine is associated with knee cartilage volume loss over time","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Osteoarthritis; Metabolite; Internal medicine; Metabolomics; Cartilage; Rheumatology; Magnetic resonance imaging; Lysophosphatidylcholine; Metabolome; Pathology; Phosphatidylcholine; Bioinformatics; Radiology; Phospholipid; Biochemistry; Biology","score_opus":0.03314796820682456,"score_gpt":0.3123808831993665,"score_spread":0.279232914992542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900877048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603707,0.0005573238,0.00002042536,0.000824153,0.00010239535,0.0014977469,0.0009060428,0.000014182686,0.000040668587],"genre_scores_gemma":[0.99820626,0.0001436417,0.00009548929,0.0012558659,0.00002872121,0.000023288121,0.00008620362,0.00002066718,0.00013986965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704653,0.00040230766,0.0011775856,0.00034493502,0.0007451081,0.0002835593],"domain_scores_gemma":[0.996212,0.0013679513,0.0010700779,0.00077471515,0.00039056368,0.00018471014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048301503,0.00024582687,0.0013769384,0.00012572084,0.000055608645,0.000013914654,0.0002697372,0.00016790898,0.0010754867],"category_scores_gemma":[0.0072864187,0.0001409772,0.00064144336,0.0010260338,0.00038994304,0.00011912416,0.0001655807,0.00014169415,0.000014176921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031104533,0.003570512,0.9551073,0.00018246804,0.0017135805,0.000005297084,0.001079832,0.00007353693,0.00039431851,0.000039480197,0.004066752,0.0026624096],"study_design_scores_gemma":[0.028687054,0.0013430171,0.9507318,0.0022283667,0.0018725313,2.629547e-7,0.00020828823,0.0011564099,0.013254416,0.00026427806,0.00005815674,0.00019539938],"about_ca_topic_score_codex":0.00037905233,"about_ca_topic_score_gemma":0.00006509582,"teacher_disagreement_score":0.012860098,"about_ca_system_score_codex":0.000024334693,"about_ca_system_score_gemma":0.00016229981,"threshold_uncertainty_score":0.99983764},"labels":[],"label_agreement":null},{"id":"W2900885871","doi":"10.1136/annrheumdis-2018-eular.6131","title":"OP0306 Subcutaneous secukinumab inhibits radiographic progression in psoriatic arthritis: analysis by prior anti-tnf therapy and concomitant methotrexate use","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Concomitant; Psoriatic arthritis; Secukinumab; Methotrexate; Internal medicine; Placebo; Synovitis; Urology; Psoriasis; Rheumatoid arthritis; Gastroenterology; Nuclear medicine; Surgery; Pathology; Immunology","score_opus":0.03260126968607537,"score_gpt":0.32300131298497214,"score_spread":0.2904000432988968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900885871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92636806,0.07133118,0.000016634816,0.001051565,0.00008734487,0.0009432036,0.00012511913,0.000045776982,0.0000310946],"genre_scores_gemma":[0.8605434,0.13889922,0.00017544568,0.0002188871,0.000022867887,0.00005437972,0.000026490268,0.00002998562,0.000029366296],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971297,0.00051351317,0.0007363053,0.00040408192,0.0007015078,0.00051493105],"domain_scores_gemma":[0.9979172,0.00050761236,0.0003380945,0.00065494893,0.00027070745,0.00031144594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053959247,0.0002999382,0.0009843226,0.00051181926,0.00019457588,0.00012454511,0.00024790803,0.000084784035,0.0001311111],"category_scores_gemma":[0.0008089472,0.0001950882,0.00039039724,0.0013613394,0.0008227434,0.0002756869,0.00010232683,0.00017067957,0.0000055850273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022462183,0.0016636496,0.16587515,0.00033080846,0.0037461359,0.0000913753,0.002716643,0.000007247987,0.0016160378,0.0002494835,0.0031317265,0.8183255],"study_design_scores_gemma":[0.016130064,0.0043954016,0.9241955,0.013905566,0.0004829073,0.00032869048,0.0011231038,0.004647827,0.025899561,0.004948393,0.0027863414,0.0011566379],"about_ca_topic_score_codex":0.00023400178,"about_ca_topic_score_gemma":0.00008779416,"teacher_disagreement_score":0.8171689,"about_ca_system_score_codex":0.000013837344,"about_ca_system_score_gemma":0.00011196881,"threshold_uncertainty_score":0.7955466},"labels":[],"label_agreement":null},{"id":"W2900960610","doi":"10.1136/annrheumdis-2018-eular.6009","title":"THU0615 Immune related adverse events (IRAES) associated with checkpoint inhibitors: 12 cases from a single centre","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Immunology; Internal medicine","score_opus":0.03060352778655538,"score_gpt":0.2698284226833359,"score_spread":0.23922489489678053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900960610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442595,0.001957291,0.0000020536356,0.002113657,0.00026431773,0.000489126,0.00020262168,0.000070458875,0.00047449773],"genre_scores_gemma":[0.99835855,0.00013712973,0.000027746588,0.00041659252,0.00005001763,0.000009774823,0.000093707604,0.00003338223,0.00087309093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982293,0.00014151176,0.0006308484,0.00023460595,0.00046781253,0.0002958803],"domain_scores_gemma":[0.9982857,0.00020807072,0.0005713069,0.00058190554,0.00022368439,0.00012934553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019936025,0.0002281755,0.00045191435,0.000064247484,0.00012892211,0.000009711329,0.00019866176,0.00008028841,0.00072144694],"category_scores_gemma":[0.0007931492,0.00013797362,0.00040934383,0.00031539882,0.00035282667,0.00012473017,0.000074447686,0.00009082025,0.000027937696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049217924,0.024065053,0.6294063,0.0016324387,0.03273916,0.0003162934,0.019466035,0.00005204378,0.04441986,0.00009378673,0.075245276,0.12334583],"study_design_scores_gemma":[0.0075920373,0.0015362991,0.92742264,0.015571352,0.0011014229,0.000025635345,0.0018741362,0.00020071976,0.04277193,0.00082060735,0.0006142539,0.00046894557],"about_ca_topic_score_codex":0.00085570005,"about_ca_topic_score_gemma":0.00016168499,"teacher_disagreement_score":0.29801637,"about_ca_system_score_codex":0.00006513012,"about_ca_system_score_gemma":0.0001623267,"threshold_uncertainty_score":0.7899338},"labels":[],"label_agreement":null},{"id":"W2900973517","doi":"10.1136/annrheumdis-2018-eular.1755","title":"OP0031 The importance of assessing multiplicative and additive interaction: examining the effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritisand concomitant type ii diabetes","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Pfizer","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Diabetes mellitus; Glucocorticoid; Concomitant; Relative risk; Proportional hazards model; Absolute risk reduction; Multiplicative function; Hazard ratio; Endocrinology; Confidence interval; Mathematics","score_opus":0.03197670308734101,"score_gpt":0.3283590964388915,"score_spread":0.2963823933515505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900973517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944041,0.003856112,0.00000115957,0.0002693447,0.000071001225,0.0011564234,0.00006810873,0.000007773468,0.00016599361],"genre_scores_gemma":[0.9962051,0.00357636,0.000008796493,0.00010588777,0.000011153616,0.00005993975,0.000011423519,0.000016934373,0.000004411451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819565,0.00041602692,0.0004931743,0.0002027957,0.00047066982,0.00022165978],"domain_scores_gemma":[0.9968266,0.0016806384,0.00055091816,0.00055184367,0.0003272575,0.000062756466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051076384,0.0001847075,0.00055204856,0.00005774131,0.00016120251,0.000023793844,0.0002027748,0.00003051235,0.00006502591],"category_scores_gemma":[0.001077467,0.00008006843,0.000087362416,0.00026814788,0.0011346411,0.00017030074,0.000092968134,0.00014650075,0.000001049176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013169461,0.00028794206,0.95881575,0.00011293585,0.00040814816,4.5859215e-7,0.0011593828,0.000004585121,0.00015870381,0.00005591603,0.00010311395,0.037576128],"study_design_scores_gemma":[0.0028167479,0.0038502705,0.9730267,0.0040303837,0.00001444062,0.0000012241684,0.00056412956,0.00015642897,0.01531768,0.00011475275,0.000025341902,0.000081905346],"about_ca_topic_score_codex":0.00005301237,"about_ca_topic_score_gemma":0.000021995056,"teacher_disagreement_score":0.037494224,"about_ca_system_score_codex":0.000011259963,"about_ca_system_score_gemma":0.000088308814,"threshold_uncertainty_score":0.41806322},"labels":[],"label_agreement":null},{"id":"W2901122096","doi":"10.1136/annrheumdis-2018-214140","title":"Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Ottawa Hospital; University of Ottawa","funders":"National Institute for Health and Care Research; Pfizer","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Disease; Kappa; Physical therapy","score_opus":0.022253367772408772,"score_gpt":0.2833946302085506,"score_spread":0.26114126243614183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901122096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967018,0.0023051123,0.0000012577639,0.00012928757,0.00006063461,0.00037772945,0.00038322518,0.000012089927,0.000028905803],"genre_scores_gemma":[0.99775153,0.0019650923,0.000020382337,0.000144408,0.000014099937,0.000017345308,0.000070620896,0.000012329117,0.0000042010133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868965,0.000119214346,0.00037145306,0.00028105694,0.00034616212,0.00019246688],"domain_scores_gemma":[0.9988022,0.00014491472,0.00027168548,0.0003853278,0.00019461388,0.00020124647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005306353,0.00018898136,0.00075187715,0.00012724151,0.00012873046,0.000019311714,0.00007671653,0.000031052783,0.000030992065],"category_scores_gemma":[0.00026345134,0.00013558737,0.00013791567,0.00025952898,0.00034762008,0.0001820197,0.000102516795,0.000046869794,0.0000010374612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012582645,0.0015017161,0.94948536,0.00020627267,0.0010250537,0.0000038095247,0.0021228641,0.000011934461,0.00008209842,0.000009050616,0.00005225449,0.044241313],"study_design_scores_gemma":[0.002456387,0.00036773153,0.9891591,0.0024849523,0.0011636552,1.2219446e-7,0.0004961105,0.0032892968,0.00017921593,0.00028393828,0.000003715158,0.0001157596],"about_ca_topic_score_codex":0.0007059451,"about_ca_topic_score_gemma":0.00027355144,"teacher_disagreement_score":0.044125553,"about_ca_system_score_codex":0.00001809527,"about_ca_system_score_gemma":0.00003657764,"threshold_uncertainty_score":0.55290926},"labels":[],"label_agreement":null},{"id":"W2901315913","doi":"10.1136/annrheumdis-2018-eular.2983","title":"AB0955 Tildrakizumab efficacy over time by week 28 response levels in two phase 3 clinical trials in patients with chronic plaque psoriasis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research","funders":"Sanofi Genzyme; Allergan; LEO Pharma; Astellas Pharma; Dermira; Regeneron Pharmaceuticals; Genentech; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Active Biotech; Biogen; Celgene; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Placebo; Internal medicine; Psoriasis; Gastroenterology; Clinical trial; Randomized controlled trial; Dermatology; Pathology","score_opus":0.0742742728827114,"score_gpt":0.389371472254729,"score_spread":0.31509719937201763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901315913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511194,0.002219319,0.0000041301037,0.00038817863,0.0004078528,0.00090968865,0.00089898444,0.00002767926,0.00003219977],"genre_scores_gemma":[0.9989205,0.000151016,0.000012553871,0.00014017725,0.000037502854,0.000053520223,0.00012777229,0.000027856806,0.00052912306],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9930141,0.004635024,0.0013718647,0.00040091632,0.00012637922,0.00045170495],"domain_scores_gemma":[0.9943872,0.0040848944,0.0006992617,0.0006654482,0.00009813006,0.00006507167],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026387454,0.0003125113,0.0011497184,0.00018142656,0.00010528307,0.000018146671,0.00045660092,0.00015620643,0.0010561218],"category_scores_gemma":[0.0032536949,0.00019539033,0.00036839972,0.00032513024,0.00049034384,0.00014699047,0.00010496339,0.00014778775,0.00031442504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14321946,0.030980403,0.21019647,0.00018965654,0.0041733473,0.000015408263,0.0014091542,0.00003104456,0.0022991414,0.0000953465,0.064354524,0.54303604],"study_design_scores_gemma":[0.045199975,0.0025964915,0.9434179,0.00097214873,0.00035661948,0.0000015191224,0.000021389078,0.000018315692,0.0058427216,0.00018565178,0.0010604301,0.00032681972],"about_ca_topic_score_codex":0.0001296688,"about_ca_topic_score_gemma":0.000057432448,"teacher_disagreement_score":0.7332215,"about_ca_system_score_codex":0.000054796008,"about_ca_system_score_gemma":0.00029576718,"threshold_uncertainty_score":0.99985707},"labels":[],"label_agreement":null},{"id":"W2901363487","doi":"10.1136/annrheumdis-2018-eular.4877","title":"FRI0339 Sledai-2k responder index-50 is effective in demonstrating partial response in a phase 2, randomised placebo-controlled study of ustekinumab in patients with active systemic lupus erythematosus","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation","funders":"Janssen Research and Development","keywords":"Medicine; Ustekinumab; Internal medicine; Randomized controlled trial; Placebo; Gastroenterology; Immunology; Disease; Adalimumab; Pathology","score_opus":0.021343863175711308,"score_gpt":0.33439345315061475,"score_spread":0.31304958997490345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901363487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219,0.00022192851,0.0000061724254,0.00017757609,0.00006243689,0.007180452,0.00007048916,0.000009379563,0.00008153365],"genre_scores_gemma":[0.9992762,0.000012408123,0.000010236818,0.00007077387,0.000016466167,0.0005135476,0.000004296111,0.000024526093,0.00007153071],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950465,0.0020848073,0.0011453026,0.0003607717,0.00091617776,0.0004464675],"domain_scores_gemma":[0.99553937,0.002952084,0.0005633822,0.00046940803,0.000324685,0.00015104483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014858475,0.00030041556,0.0014374541,0.0005612685,0.000071630384,0.00001621157,0.00026588776,0.00008130032,0.00006613588],"category_scores_gemma":[0.0027123014,0.00017744728,0.00020819297,0.0006803523,0.00029880388,0.00013602935,0.00012000232,0.0002632654,0.0000040664418],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60650146,0.004808627,0.37905127,0.00036265815,0.0003924485,0.000026781163,0.0066544213,0.000058808462,0.00008516589,0.0000042444226,0.000035303718,0.002018791],"study_design_scores_gemma":[0.34602535,0.0060568294,0.63289046,0.005402333,0.00016030122,0.000016881815,0.0053304234,0.0026472358,0.0011604228,0.00010300126,0.000001303079,0.0002054672],"about_ca_topic_score_codex":0.0005581557,"about_ca_topic_score_gemma":0.00020672804,"teacher_disagreement_score":0.2604761,"about_ca_system_score_codex":0.00007659987,"about_ca_system_score_gemma":0.00035332702,"threshold_uncertainty_score":0.72360903},"labels":[],"label_agreement":null},{"id":"W2901752294","doi":"10.1136/annrheumdis-2018-eular.3895","title":"THU0038 Increase of circulating memory b cells after glucocorticoid-induced remission identifies patients at risk of igg4-related disease relapse","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Rituximab; B cell; CD20; IgG4-related disease; Glucocorticoid; CD19; Internal medicine; Flow cytometry; Immunology; Corticosteroid; Antibody; Lymphoma; Disease","score_opus":0.013613094846075275,"score_gpt":0.2576855336370146,"score_spread":0.2440724387909393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901752294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960361,0.0015780427,0.0000012309346,0.00008813354,0.0004083252,0.0009924643,0.00038854562,0.000050462393,0.0004566957],"genre_scores_gemma":[0.9988878,0.00027099915,0.000014697781,0.00013129857,0.00003410552,0.000026500868,0.00006047781,0.000054499826,0.0005196298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638784,0.00038164243,0.0015145798,0.0003941757,0.0009486803,0.0003730926],"domain_scores_gemma":[0.9954477,0.0003448676,0.0015884591,0.0013121077,0.000800527,0.0005063433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033101928,0.00035135474,0.0008027599,0.00020049703,0.00016492631,0.000013404147,0.00032977207,0.00013040974,0.0007258168],"category_scores_gemma":[0.003282264,0.00024423623,0.0007612798,0.00041884644,0.0004954647,0.00025668743,0.0003265894,0.00015662983,0.00006726066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064379387,0.003226452,0.9528114,0.0062997225,0.0014481997,0.000033673394,0.0020979724,0.00017765947,0.017858325,0.00006300333,0.0039550224,0.005590619],"study_design_scores_gemma":[0.0022214665,0.00028949566,0.91535556,0.0067004114,0.0018607092,0.0000020842556,0.0002602454,0.0010680509,0.071252875,0.0006938238,0.000015645204,0.00027961985],"about_ca_topic_score_codex":0.0001422172,"about_ca_topic_score_gemma":0.0000028515137,"teacher_disagreement_score":0.053394552,"about_ca_system_score_codex":0.000041850337,"about_ca_system_score_gemma":0.00031188785,"threshold_uncertainty_score":0.99596643},"labels":[],"label_agreement":null},{"id":"W2904618547","doi":"10.1136/annrheumdis-2018-eular.4347","title":"THU0582 A systematic review of employment outcomes of adults with childhood-onset systemic autoimmune rheumatic diseases","year":2018,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; MEDLINE; Systemic vasculitis; Rheumatology; Critical appraisal; Polyarteritis nodosa; Disease; Pediatrics; Intensive care medicine; Internal medicine; Vasculitis; Alternative medicine; Pathology","score_opus":0.03781355293829989,"score_gpt":0.34717565239318604,"score_spread":0.30936209945488613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904618547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021989448,0.9855169,0.0000049675414,0.00016598076,0.00011316706,0.011053622,0.000784306,0.00006620539,0.000095911244],"genre_scores_gemma":[0.008993362,0.98885936,0.000021171496,0.00013556122,0.000011521434,0.0011832418,0.00026688643,0.0001470123,0.00038187118],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9897538,0.0013143657,0.0055276123,0.0005756931,0.0021969844,0.0006315771],"domain_scores_gemma":[0.98739797,0.0012221945,0.0063624564,0.0037325842,0.0009917439,0.00029306053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011225902,0.0010404781,0.012169063,0.00047297816,0.00013176748,0.00002595326,0.0016450123,0.00020086677,0.00025456824],"category_scores_gemma":[0.0048555895,0.00051915844,0.00321823,0.001021727,0.0008250954,0.00016576248,0.00048303007,0.00032161173,0.00006577286],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008505445,0.0013955438,0.0004298127,0.97183555,0.0060264436,0.0000058607316,0.00032046443,5.500277e-7,3.3808835e-8,0.000041792522,0.0020408612,0.017818013],"study_design_scores_gemma":[0.0009259884,0.0005824086,0.0044904733,0.97688746,0.015623259,0.00011505138,0.0003807826,0.000010744537,0.0000022856475,0.00004241853,0.0004954762,0.00044363525],"about_ca_topic_score_codex":0.00007798863,"about_ca_topic_score_gemma":0.0000018102606,"teacher_disagreement_score":0.017374378,"about_ca_system_score_codex":0.00007593325,"about_ca_system_score_gemma":0.0021997879,"threshold_uncertainty_score":0.999726},"labels":[],"label_agreement":null},{"id":"W2904726109","doi":"10.1136/annrheumdis-2018-eular.6534","title":"SAT0086 Evaluation of diagnostic performance of magnetic resonance imaging (MRI) and ultrasound (US) toward early rheumatoid arthritis from nagasaki early arthritis cohort","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Regional Development Fund; Amgen; Instituto de Salud Carlos III; Gilead Sciences; Momenta Pharmaceuticals; Valeant Pharmaceuticals International; Genentech; Horizon Pharma; Celgene; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Synovitis; Magnetic resonance imaging; Rheumatoid arthritis; Cohort; Arthritis; Univariate analysis; Internal medicine; Rheumatology; Radiology; Multivariate analysis","score_opus":0.020784790976189037,"score_gpt":0.28207948420914325,"score_spread":0.26129469323295423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904726109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8312106,0.16691299,0.000010683804,0.0002972293,0.00014532654,0.0008828616,0.00029790198,0.000024869385,0.00021750959],"genre_scores_gemma":[0.7837232,0.21593896,0.000101192614,0.00006557566,0.00003547841,0.00007219886,0.00001909906,0.000030270226,0.000014024566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964004,0.00030123017,0.0009594632,0.0003760913,0.0015269017,0.00043590946],"domain_scores_gemma":[0.99625456,0.0012033612,0.00044197254,0.00076241,0.0011000357,0.0002376424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089245744,0.00027687833,0.0008118945,0.00016492122,0.00015753538,0.00005155402,0.00032398727,0.000060405207,0.00052103755],"category_scores_gemma":[0.0040917867,0.00022484334,0.00021780141,0.00032699626,0.001532372,0.0003735405,0.00013120321,0.00014162625,0.000019440306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031746775,0.00024891447,0.6612661,0.0001808711,0.00014057731,0.0000027221633,0.0013490549,0.0000041137905,0.00054393377,0.00010455423,0.0008246359,0.33501706],"study_design_scores_gemma":[0.0026267655,0.00082831294,0.9739083,0.010848463,0.00004640332,0.00003573691,0.00023384803,0.00089168595,0.0075700963,0.0026329218,0.00017741714,0.00020003215],"about_ca_topic_score_codex":0.0016025475,"about_ca_topic_score_gemma":0.000061626735,"teacher_disagreement_score":0.33481702,"about_ca_system_score_codex":0.000018567165,"about_ca_system_score_gemma":0.0002760308,"threshold_uncertainty_score":0.91688454},"labels":[],"label_agreement":null},{"id":"W2904798486","doi":"10.1136/annrheumdis-2018-213336","title":"Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer; AbbVie; Bristol-Myers Squibb; GlaxoSmithKline; Amgen","keywords":"Medicine; Placebo; Clinical endpoint; Internal medicine; Pharmacodynamics; Osteoarthritis; Pharmacokinetics; Adverse effect; Randomized controlled trial; Gastroenterology; Surgery; Anesthesia; Pathology","score_opus":0.01225408008750231,"score_gpt":0.2816255934890825,"score_spread":0.2693715134015802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904798486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99230695,0.0028156755,0.000019366515,0.00015175978,0.000141934,0.004222779,0.00018827953,0.00002534336,0.00012790332],"genre_scores_gemma":[0.9987297,0.0007796698,0.00007792526,0.000080363374,0.00003462411,0.00017009035,0.000034555433,0.000045409364,0.000047652],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964402,0.00062961975,0.0010866588,0.0004509783,0.0008322447,0.0005603183],"domain_scores_gemma":[0.9972325,0.00044857524,0.00054481137,0.0008185901,0.0006456588,0.00030984476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064864714,0.00039693515,0.0016224709,0.00027853544,0.00025471536,0.00011282293,0.0003397209,0.00006929809,0.00019876368],"category_scores_gemma":[0.0007273071,0.00024987038,0.00019704721,0.0003392457,0.0010747719,0.00039060466,0.0001743696,0.00017558361,0.00000442284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63318145,0.052088767,0.23274806,0.0010870674,0.005063584,0.00012226145,0.026804494,0.000037632155,0.004224779,0.00037375576,0.0011563877,0.043111753],"study_design_scores_gemma":[0.7648668,0.027867477,0.18885009,0.0061849155,0.00019825489,0.000036939844,0.006579146,0.00017686798,0.004003093,0.0006762198,0.000057703877,0.00050247944],"about_ca_topic_score_codex":0.00042497355,"about_ca_topic_score_gemma":0.00018662585,"teacher_disagreement_score":0.13168536,"about_ca_system_score_codex":0.000028743318,"about_ca_system_score_gemma":0.00023242245,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W2905341752","doi":"10.1136/annrheumdis-2018-214294","title":"Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Research UK; Versus Arthritis; Kennedy Trust for Rheumatology Research; National Institute for Health and Care Research; Ontario Genomics; Genome Canada; Chugai Pharmaceutical; Wellcome Trust; Roche; University Hospitals Birmingham NHS Foundation Trust; Pfizer; Ontario Genomics Institute; Merck KGaA; Birmingham Biomedical Research Centre; Eli Lilly and Company","keywords":"Medicine; Proinflammatory cytokine; Synovitis; Immunology; Immune system; Arthritis; Rheumatoid arthritis; Cytokine; Synovial fluid; Inflammation; Pathology; Osteoarthritis","score_opus":0.03269123392471438,"score_gpt":0.29157826002980086,"score_spread":0.25888702610508646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905341752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698395,0.024758672,0.000006315163,0.00456884,0.00008663323,0.0005129688,0.000023648769,0.000009872375,0.0001935268],"genre_scores_gemma":[0.9821773,0.017022038,0.0000333041,0.0005492536,0.00008268473,0.000020460779,0.00000470766,0.000017288628,0.00009294902],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99849916,0.00021303768,0.00035470183,0.0001453613,0.0004909814,0.00029674373],"domain_scores_gemma":[0.9989461,0.00018010651,0.00019978668,0.0005220842,0.00006593167,0.00008602709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003903505,0.00014081503,0.000331697,0.0000883451,0.00009025187,0.000020412244,0.00041191606,0.000034917604,0.00024505056],"category_scores_gemma":[0.0002844236,0.0000767419,0.00016754323,0.00019438149,0.0005402647,0.00008036121,0.00008225079,0.00010549749,0.000016854701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005644525,0.0050243363,0.2179438,0.0011834248,0.0023005616,0.000028179362,0.04435694,0.00003264373,0.068135045,0.0027738078,0.06230052,0.59027624],"study_design_scores_gemma":[0.0037428674,0.0019334756,0.9505371,0.0030854943,0.000024305478,0.000017653134,0.002147763,0.00015848533,0.025262162,0.004144049,0.008696282,0.000250388],"about_ca_topic_score_codex":0.0003673462,"about_ca_topic_score_gemma":0.000026165948,"teacher_disagreement_score":0.7325933,"about_ca_system_score_codex":0.000008669861,"about_ca_system_score_gemma":0.00011020853,"threshold_uncertainty_score":0.31294438},"labels":[],"label_agreement":null},{"id":"W2905445983","doi":"10.1136/annrheumdis-2018-214764","title":"Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cohort; Clinical trial; Cohort study; Physical therapy; Emergency medicine; Internal medicine","score_opus":0.21195088759047134,"score_gpt":0.3831162644559732,"score_spread":0.17116537686550184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905445983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477637,0.0011987104,0.000015403957,0.0011623844,0.00043448,0.0022399162,0.00008646098,0.000019994335,0.00006625614],"genre_scores_gemma":[0.99875706,0.00059463334,0.00005529338,0.00039482486,0.00002136293,0.000052604228,0.00001217636,0.00002623269,0.000085779415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560297,0.00076457363,0.002322255,0.00035671992,0.00069020863,0.00026327823],"domain_scores_gemma":[0.9966992,0.00084455067,0.0011359081,0.0008679467,0.00020779727,0.00024459104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026854181,0.00024450538,0.0011862462,0.00016688251,0.00007624798,0.0000355106,0.00037762584,0.00013867421,0.00006180972],"category_scores_gemma":[0.003374925,0.00013403267,0.00036006977,0.00049528596,0.00017539029,0.00010042176,0.00029510484,0.00015000538,0.00001459654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066473655,0.0013220555,0.967214,0.0020455846,0.0006325881,6.950158e-7,0.0013257925,0.0002847681,0.01285497,0.00021700775,0.0007516769,0.012686138],"study_design_scores_gemma":[0.0029944356,0.00009424028,0.9533644,0.025361812,0.00027132308,0.0000048074294,0.0016413457,0.00043566668,0.015638802,0.000021720352,0.00001794014,0.00015355927],"about_ca_topic_score_codex":0.00008923087,"about_ca_topic_score_gemma":0.000009155499,"teacher_disagreement_score":0.023316227,"about_ca_system_score_codex":0.000039304807,"about_ca_system_score_gemma":0.00046261385,"threshold_uncertainty_score":0.54656935},"labels":[],"label_agreement":null},{"id":"W2906044230","doi":"10.1136/annrheumdis-2018-eular.3797","title":"THU0264 Impact of extra-articular manifestations on patient-reported outcomes in ankylosing spondylitis and psoriatic arthritis: interim results from the complete studies","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ABB (Canada); Penticton Regional Hospital; South Bruce Grey Health Centre; University of Toronto; University of British Columbia; Memorial University of Newfoundland; Centre hospitalier de l'Université Laval","funders":"Sanofi Genzyme; Celgene; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Interim; Spondylitis; Dermatology; Psoriasis; Arthritis; Surgery; Physical therapy; Internal medicine","score_opus":0.09853263985878127,"score_gpt":0.376453991927528,"score_spread":0.2779213520687467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906044230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988429,0.007421701,0.0000016878629,0.001529772,0.00013579156,0.0005746832,0.001809225,0.000013038427,0.00008508186],"genre_scores_gemma":[0.99783254,0.0017630308,0.00006970564,0.00021003048,0.000017411216,0.00003000104,0.000053682354,0.00001344335,0.000010165538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836326,0.00014637898,0.0007553224,0.00021350551,0.00031062917,0.00021089344],"domain_scores_gemma":[0.9978991,0.0008913267,0.00042205476,0.00050467305,0.0002130209,0.00006979713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001438306,0.00019233221,0.0005929917,0.0000636243,0.00014378062,0.000016335083,0.00009150867,0.000023435961,0.00003712259],"category_scores_gemma":[0.002174977,0.00010035497,0.00023633188,0.00016612472,0.00044425877,0.00007366331,0.00009657749,0.00005754485,0.0000030541023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005734992,0.0043547396,0.8081167,0.0004050081,0.012700032,0.00031649336,0.03554483,0.0000431666,0.0002252232,0.00093476917,0.0050908923,0.12653317],"study_design_scores_gemma":[0.0033114022,0.001165133,0.98369485,0.004055806,0.0002924845,0.000017492543,0.003035426,0.000068791356,0.00019079077,0.0040504206,0.000022094346,0.00009532233],"about_ca_topic_score_codex":0.00090131763,"about_ca_topic_score_gemma":0.0002179023,"teacher_disagreement_score":0.17557815,"about_ca_system_score_codex":0.000025181935,"about_ca_system_score_gemma":0.00004564953,"threshold_uncertainty_score":0.4092357},"labels":[],"label_agreement":null},{"id":"W2906204560","doi":"10.1136/annrheumdis-2018-214434","title":"Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Calgary; University Health Network; Dalhousie University; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Centre hospitalier universitaire de Québec; Toronto Western Hospital; McGill University Health Centre","funders":"National Institutes of Health; National Research Foundation; National Institute for Health and Care Research; McGill University Health Centre; McGill University; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Gigtforeningen; Arthritis Society; Ministry of Science and ICT, South Korea; Johns Hopkins University","keywords":"Medicine; Aspirin; Cohort; Obstetrics; Eclampsia; Pregnancy; Cohort study; Preeclampsia; Internal medicine; Demography","score_opus":0.028841477393378497,"score_gpt":0.2780375766334245,"score_spread":0.249196099240046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906204560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911199,0.0021342018,0.000011699113,0.004126797,0.00016850911,0.0013798118,0.0010045515,0.000024717465,0.000029818417],"genre_scores_gemma":[0.9909164,0.0051795365,0.000049672934,0.002597975,0.00008630668,0.00022697849,0.00011994598,0.000033078577,0.00079013576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973646,0.00038024777,0.00074688037,0.00040092057,0.000707886,0.00039947673],"domain_scores_gemma":[0.99717385,0.00084481755,0.0009608207,0.000676811,0.0002493657,0.00009431619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003803648,0.00035348107,0.0008789157,0.00018576313,0.000090457426,0.000021325453,0.00030573594,0.0002551312,0.0001036002],"category_scores_gemma":[0.0019109175,0.00023472906,0.00022098736,0.00018059963,0.0007943446,0.00026488453,0.000261473,0.00042270767,0.0000018842035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000159331,0.00031052245,0.9628922,0.00926094,0.0006330716,0.000005035537,0.002198683,0.000021864187,0.000002721406,0.0000075278695,0.02334358,0.0011645423],"study_design_scores_gemma":[0.0006122591,0.0002247808,0.9735579,0.023091793,0.00038821046,0.0000016854939,0.00006851758,0.00017855139,0.00018160367,0.0013264861,0.00015810473,0.00021009664],"about_ca_topic_score_codex":0.0005288414,"about_ca_topic_score_gemma":0.000021928881,"teacher_disagreement_score":0.023185475,"about_ca_system_score_codex":0.000054801963,"about_ca_system_score_gemma":0.00013445615,"threshold_uncertainty_score":0.9571973},"labels":[],"label_agreement":null},{"id":"W2906835839","doi":"10.1136/annrheumdis-2018-214603","title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"European League Against Rheumatism; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Academy of Medical Sciences; Rheumatology Research Foundation","keywords":"Medicine; Cross-sectional study; Internal medicine; Pathology","score_opus":0.037784362408600496,"score_gpt":0.3944983721272741,"score_spread":0.3567140097186736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906835839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965093,0.001000019,0.000007563262,0.00015404828,0.0005164879,0.000365612,0.00061937707,0.000032978503,0.00079462916],"genre_scores_gemma":[0.9986669,0.00023501809,0.000026053945,0.00015595714,0.00003952417,0.000008361498,0.00032288602,0.000020346783,0.00052494707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701065,0.0001871249,0.0014623209,0.00031758467,0.00082915643,0.00019314025],"domain_scores_gemma":[0.99696225,0.00032182306,0.00091890123,0.0008328764,0.0006612402,0.00030290132],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044851477,0.00019158862,0.00083857134,0.000299967,0.000046819023,0.000017111806,0.00041899006,0.00008238852,0.002548455],"category_scores_gemma":[0.00085993274,0.00013519615,0.0012022731,0.0005258164,0.00045023108,0.00024573167,0.00011301085,0.0001223912,0.000023938384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081853627,0.0014591722,0.9834918,0.00031458674,0.0049491376,0.0000027028339,0.00005916046,0.004292849,0.000054419896,0.0028918092,0.00021008894,0.0014557461],"study_design_scores_gemma":[0.001223088,0.00012833763,0.98283,0.00048548795,0.0024134999,0.0000012336468,0.000041189043,0.011100792,0.00016353025,0.0014423184,0.000045166886,0.00012533981],"about_ca_topic_score_codex":0.00005172979,"about_ca_topic_score_gemma":0.000002545782,"teacher_disagreement_score":0.006807944,"about_ca_system_score_codex":0.000015517504,"about_ca_system_score_gemma":0.0002979385,"threshold_uncertainty_score":0.9983634},"labels":[],"label_agreement":null},{"id":"W2907178835","doi":"10.1136/annrheumdis-2018-214043","title":"Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Propensity score matching; Belimumab; Standard of care; Internal medicine; Comparative effectiveness research; Surgery; Intensive care medicine; Pathology; Immunology; Alternative medicine; Antibody","score_opus":0.15319989295402298,"score_gpt":0.3906774340809608,"score_spread":0.2374775411269378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907178835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42515185,0.56988066,6.9782806e-7,0.000016018888,0.00004172729,0.0038638248,0.0007009276,0.000016046597,0.00032822698],"genre_scores_gemma":[0.47842973,0.5207955,0.0000141490045,0.0000054775223,0.000007007252,0.0000939787,0.0004672534,0.000048184505,0.00013871126],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957991,0.0007234593,0.0012545256,0.00045256838,0.0014025226,0.00036782582],"domain_scores_gemma":[0.9951684,0.0005888395,0.0013527472,0.0015675507,0.0011420434,0.00018042073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003018912,0.00049104344,0.006057534,0.000632211,0.000044897002,0.00002188676,0.0005849914,0.0001394088,0.000079290265],"category_scores_gemma":[0.0005564431,0.00025459164,0.0009663557,0.0023988127,0.00030024102,0.0000804899,0.0002451818,0.00024285242,0.000016332566],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015008014,0.0018202432,0.5370324,0.35363477,0.025853517,0.000021702033,0.003991969,0.000042548738,1.4764593e-7,0.000031373103,0.0009721291,0.06159115],"study_design_scores_gemma":[0.03194525,0.011708805,0.12965064,0.73080724,0.08472191,0.000045990568,0.004510661,0.00008482698,0.00011217149,0.000020062404,0.00461397,0.0017784595],"about_ca_topic_score_codex":0.00023744632,"about_ca_topic_score_gemma":0.00016332597,"teacher_disagreement_score":0.4073818,"about_ca_system_score_codex":0.00022290576,"about_ca_system_score_gemma":0.0012568127,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W2907239699","doi":"10.1136/annrheumdis-2018-eular.5970","title":"FRI0656 Predictive validity of presenteeism measures with dual answer keys in inflammatory arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Research Canada; Simon Fraser University; Institute for Work & Health; University of Ottawa; University of British Columbia","funders":"","keywords":"Presenteeism; Medicine; Physical therapy; Construct validity; Arthritis; Predictive validity; Logistic regression; Psoriatic arthritis; Work (physics); Absenteeism; Internal medicine; Psychometrics; Clinical psychology; Psychology; Social psychology","score_opus":0.05944572360525597,"score_gpt":0.3706323148288178,"score_spread":0.31118659122356185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907239699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928654,0.0010056699,0.00006874952,0.0017899253,0.00038535584,0.001124811,0.000109386536,0.000039255654,0.0026114783],"genre_scores_gemma":[0.9983486,0.00067810464,0.00004105738,0.00046123026,0.00013161487,0.00011794945,0.0000059678355,0.00002336854,0.0001920946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670446,0.0011522778,0.000843245,0.0002163925,0.00057229586,0.0005113288],"domain_scores_gemma":[0.9972236,0.0009745915,0.00059777306,0.00055243226,0.00044380984,0.00020779988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096063846,0.00017694166,0.00045873257,0.00011524981,0.00033054588,0.0000060832567,0.00027496507,0.00010661967,0.0002181426],"category_scores_gemma":[0.001286713,0.00011606763,0.000108787564,0.00027072543,0.00043391125,0.00018264633,0.00014954392,0.00027848687,0.000029689996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008140668,0.0003434288,0.9573054,0.001642583,0.00011537119,0.0000042816637,0.007898047,0.000089549525,0.000009939341,0.0010633024,0.025415007,0.0052990634],"study_design_scores_gemma":[0.0013963716,0.00036937965,0.9759306,0.009554584,0.000046865578,0.0000012880814,0.0028215237,0.00025326727,0.00045634597,0.007859884,0.0011394155,0.0001704771],"about_ca_topic_score_codex":0.00053613196,"about_ca_topic_score_gemma":0.00045774196,"teacher_disagreement_score":0.024275592,"about_ca_system_score_codex":0.000024063482,"about_ca_system_score_gemma":0.00066324975,"threshold_uncertainty_score":0.47331008},"labels":[],"label_agreement":null},{"id":"W2907351969","doi":"10.1136/annrheumdis-2018-eular.3834","title":"THU0321 Acute phase markers in psoriatic arthritis identify patients with a more severe phenotype","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Incyte; Dermira; Valeant Pharmaceuticals International; Celgene; Novartis; Amgen; Pfizer; Allergan; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Rheumatology; Rheumatoid arthritis; Cohort; Psoriasis; Comorbidity; Arthritis; C-reactive protein; Inflammatory arthritis; Rheumatoid factor; Gastroenterology; Immunology; Inflammation","score_opus":0.016816763562524695,"score_gpt":0.3150505739464026,"score_spread":0.2982338103838779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907351969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958188,0.0017660551,0.000002773975,0.0007889147,0.00017560784,0.0007157359,0.00024681058,0.000022248067,0.00046304427],"genre_scores_gemma":[0.9984443,0.00074072654,0.00008586776,0.00044285462,0.000028717332,0.00005113122,0.000048501868,0.000023975836,0.00013388996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986347,0.000050846807,0.0003528848,0.00022300275,0.00044231018,0.00029624207],"domain_scores_gemma":[0.9989214,0.000065535314,0.00019719238,0.0004666914,0.000222364,0.00012682374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065488384,0.00019844358,0.00045563385,0.00007874668,0.00011347194,0.00001808016,0.00014196419,0.000033411146,0.00026445728],"category_scores_gemma":[0.00020277039,0.000122038284,0.00014748964,0.00031029363,0.00026682107,0.00012288892,0.000086001804,0.0000599933,0.00003293041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006662049,0.0072851293,0.5434643,0.00055301347,0.0036241028,0.0001149882,0.0021999544,0.0000037544307,0.000007023275,0.0001196343,0.017515164,0.4184509],"study_design_scores_gemma":[0.013324871,0.0013200404,0.9805406,0.0030996,0.00041275853,0.000008611128,0.00034006668,0.000039830415,0.000067954184,0.0005668073,0.00011780998,0.00016107359],"about_ca_topic_score_codex":0.00011102943,"about_ca_topic_score_gemma":0.00007591811,"teacher_disagreement_score":0.43707627,"about_ca_system_score_codex":0.000021846257,"about_ca_system_score_gemma":0.00007432512,"threshold_uncertainty_score":0.4976577},"labels":[],"label_agreement":null},{"id":"W2908053107","doi":"10.1136/annrheumdis-2001.420","title":"OP0053 Success-1 in osteoarthritis (oa) trial: celecoxib significantly reduces risk of serious upper gi complications compared to nsaids while providing similar efficacy in 13,274 randomised patients","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Celecoxib; Diclofenac; Tolerability; Osteoarthritis; Internal medicine; Naproxen; Nausea; WOMAC; Rofecoxib; Abdominal pain; Clinical trial; Adverse effect; Gastroenterology; Anesthesia","score_opus":0.0277367949179346,"score_gpt":0.2983562031786001,"score_spread":0.27061940826066555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908053107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310356,0.000564993,0.0000064737073,0.00070333085,0.00019459122,0.005032249,0.0001568715,0.000032248936,0.00020565352],"genre_scores_gemma":[0.9989531,0.0002865213,0.000059720034,0.00016923448,0.00003324818,0.00038157645,0.000055985765,0.0000345996,0.000026034437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996994,0.0005515814,0.0011903497,0.0003296099,0.0005218626,0.00041256828],"domain_scores_gemma":[0.9973506,0.0009429904,0.00057473645,0.00062351895,0.00024450832,0.0002636624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067844195,0.0002671704,0.0010285852,0.00033719203,0.000098491866,0.000024359584,0.00036241958,0.00007512035,0.00006778511],"category_scores_gemma":[0.00236333,0.00020293018,0.00031083642,0.00071658054,0.0001389757,0.00014086146,0.00007215769,0.000157976,0.000011540763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1092797,0.01163012,0.7154622,0.0018800141,0.00048760293,0.00003097605,0.0059308293,0.0025654805,0.0021290877,0.000046465848,0.0040901466,0.14646739],"study_design_scores_gemma":[0.12107727,0.0010573913,0.8653623,0.0030841115,0.0002177491,0.000002021039,0.0003793815,0.0006944144,0.0074844584,0.00014349585,0.00018717555,0.00031027122],"about_ca_topic_score_codex":0.00031269665,"about_ca_topic_score_gemma":0.00013171935,"teacher_disagreement_score":0.14990006,"about_ca_system_score_codex":0.000041774703,"about_ca_system_score_gemma":0.00018175425,"threshold_uncertainty_score":0.82752526},"labels":[],"label_agreement":null},{"id":"W2908325363","doi":"10.1136/annrheumdis-2018-eular.1094","title":"THU0344 Assessment of the psychometric properties of patient-reported outcomes of depression in SLE","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Hospital Anxiety and Depression Scale; Depression (economics); Youden's J statistic; Gold standard (test); Receiver operating characteristic; Internal medicine; Mini-international neuropsychiatric interview; Anxiety; Mood; Physical therapy; Psychiatry","score_opus":0.076169930287798,"score_gpt":0.3752150421569398,"score_spread":0.2990451118691418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908325363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590063,0.0018163105,0.000004588079,0.00045556907,0.0001968042,0.00096528005,0.000019409074,0.000007033553,0.00063436775],"genre_scores_gemma":[0.9995161,0.00015031316,0.00005017066,0.000037117472,0.0000064195274,0.00003572279,0.0000011426766,0.000015242677,0.00018775409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716836,0.00025538728,0.0010938277,0.00015573627,0.0011344705,0.00019220269],"domain_scores_gemma":[0.9970436,0.00025032193,0.0009815444,0.0011031919,0.00055619195,0.000065136286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004905751,0.00013285902,0.00069448544,0.0002914159,0.0000333854,0.0000038317226,0.00042099672,0.000046519028,0.00006090914],"category_scores_gemma":[0.002757218,0.00005880223,0.00028906894,0.0009145174,0.00042086802,0.00006053418,0.00023632491,0.00007694404,9.673141e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015271563,0.0009802835,0.9892614,0.002675233,0.0002850646,3.293424e-7,0.0009303829,0.000009220957,0.0022307741,0.000031679425,0.0007715154,0.0026714331],"study_design_scores_gemma":[0.0010308523,0.00020669625,0.93457246,0.00843678,0.00010196629,0.000018857485,0.0011053664,0.0002820728,0.053940672,0.0002359547,0.000008424424,0.000059923474],"about_ca_topic_score_codex":0.00025333615,"about_ca_topic_score_gemma":0.000009637306,"teacher_disagreement_score":0.054688938,"about_ca_system_score_codex":0.000020336585,"about_ca_system_score_gemma":0.0002683771,"threshold_uncertainty_score":0.33008465},"labels":[],"label_agreement":null},{"id":"W2908342189","doi":"10.1136/annrheumdis-2018-214245","title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Vifor Pharma; National Institute for Health and Care Research; Wellcome Trust; F. Hoffmann-La Roche","keywords":"Medicine; Cyclophosphamide; Internal medicine; Azathioprine; Gastroenterology; Regimen; Clinical endpoint; Mycophenolate; Mycophenolic acid; Surgery; Randomized controlled trial; Chemotherapy; Transplantation; Disease","score_opus":0.030264215126965744,"score_gpt":0.30874786383601827,"score_spread":0.2784836487090525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908342189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928932,0.0010244441,0.000012375473,0.0011375716,0.0011874553,0.0029916135,0.00008735426,0.00003690409,0.00062904274],"genre_scores_gemma":[0.9980381,0.0010537807,0.0000351192,0.00009422316,0.00005308579,0.00018812166,0.00008914896,0.000023068345,0.00042535173],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983909,0.00012016892,0.0006203957,0.000243224,0.00033864932,0.0002866661],"domain_scores_gemma":[0.9985478,0.00036473255,0.00032677955,0.00045443964,0.00016491061,0.00014136582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004058642,0.0001775044,0.00062581233,0.00009462798,0.00010036547,0.000018101322,0.00014431901,0.00013399089,0.00021172214],"category_scores_gemma":[0.001607179,0.00012128872,0.0006487887,0.0003151851,0.00005961298,0.00012899659,0.00004412983,0.00016773268,0.000017840934],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.832648,0.009284779,0.0218585,0.004535038,0.0079130335,0.000029213048,0.0033456592,0.0018683923,0.0018917513,0.0014864678,0.029297145,0.08584205],"study_design_scores_gemma":[0.7527524,0.0013876862,0.23002173,0.0056242305,0.0011054825,0.000006269841,0.00058249617,0.0019138793,0.0010373384,0.0047645443,0.00041370853,0.0003901979],"about_ca_topic_score_codex":0.00017828298,"about_ca_topic_score_gemma":0.000007874457,"teacher_disagreement_score":0.20816322,"about_ca_system_score_codex":0.000057682828,"about_ca_system_score_gemma":0.00024126895,"threshold_uncertainty_score":0.49460104},"labels":[],"label_agreement":null},{"id":"W2908545013","doi":"10.1136/annrheumdis-2018-eular.2125","title":"THU0601 Carrier rate of familial mediterranean gene (MEFV) mutation in parents of children with familial mediterranean fever","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Familial Mediterranean fever; MEFV; Medicine; Pyrin domain; Genetics; Mutation; Mediterranean climate; Gene; Gene mutation; Internal medicine; Biology; Disease; Ecology","score_opus":0.04049976195510057,"score_gpt":0.31716364829524407,"score_spread":0.2766638863401435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908545013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976157,0.0006598712,0.000018870462,0.0003416959,0.0001392813,0.00072017603,0.00022889739,0.000013335993,0.00026219175],"genre_scores_gemma":[0.99921334,0.00027760846,0.000034066,0.00014657022,0.0000696232,0.000023672412,0.0001158699,0.000026933112,0.00009230532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977185,0.00022289461,0.00081545726,0.00022098134,0.00072323374,0.00029892952],"domain_scores_gemma":[0.9983333,0.00010417784,0.00045380046,0.0005981125,0.00038857415,0.00012203735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041905363,0.0002034401,0.0006585196,0.00019765072,0.00005944382,0.000006924616,0.00035371573,0.0000734748,0.00021475054],"category_scores_gemma":[0.00057193375,0.0001286238,0.00018879831,0.00037757654,0.00079233927,0.00017016957,0.00010186474,0.00012042921,0.0000060268644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082558235,0.0032350873,0.8196613,0.0033327478,0.0028130894,0.00003378936,0.020222038,0.00026682098,0.009163095,0.00010062217,0.01157513,0.12134041],"study_design_scores_gemma":[0.0034292382,0.0007314751,0.961813,0.0014476166,0.00017343304,0.0000083397135,0.0009681563,0.0009037291,0.029975481,0.00036152205,0.000030097008,0.00015793325],"about_ca_topic_score_codex":0.00063776376,"about_ca_topic_score_gemma":0.00006540239,"teacher_disagreement_score":0.14215162,"about_ca_system_score_codex":0.000014162418,"about_ca_system_score_gemma":0.00033148358,"threshold_uncertainty_score":0.52451265},"labels":[],"label_agreement":null},{"id":"W2908580319","doi":"10.1136/annrheumdis-2018-eular.2124","title":"FRI0216 Detection of structural lesions on t1 weighted mri versus radiography of the si joints in early axial spondyloarthritis: 2-year data","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliitis; Radiography; McNemar's test; Nuclear medicine; Concordance; Sacroiliac joint; Magnetic resonance imaging; Radiology; Kappa; Internal medicine","score_opus":0.0485537401561667,"score_gpt":0.31282021787692016,"score_spread":0.26426647772075346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908580319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960796,0.0015326885,0.000001414384,0.0004374823,0.0005532488,0.00048000712,0.00067775405,0.000011221467,0.00022656075],"genre_scores_gemma":[0.9991926,0.00060442154,0.000046260648,0.000043152562,0.000047953523,0.000010430063,0.000023679215,0.000014857667,0.000016625154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985446,0.00012246566,0.00046093762,0.00022170098,0.00044333213,0.00020698617],"domain_scores_gemma":[0.9982688,0.00017652877,0.0003162403,0.0010141582,0.00015451913,0.000069772126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011328282,0.00016085936,0.0004391107,0.00014079179,0.00012880504,0.000007202683,0.0003579494,0.00004839304,0.00008107448],"category_scores_gemma":[0.00042101397,0.000094174306,0.0002670837,0.0004985395,0.00048387036,0.00009674297,0.00021875686,0.000085551896,0.000005359703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025506832,0.004145499,0.74314266,0.0012969911,0.0050143986,0.00003659875,0.003988061,0.000016294653,0.0022332405,0.0019765177,0.0069418107,0.20570111],"study_design_scores_gemma":[0.0048015118,0.001080009,0.984986,0.0019720602,0.00023327977,0.0000037907373,0.00032879825,0.00007560001,0.005542426,0.0008149967,0.00007094373,0.00009056334],"about_ca_topic_score_codex":0.00051046716,"about_ca_topic_score_gemma":0.00027537844,"teacher_disagreement_score":0.24184337,"about_ca_system_score_codex":0.000012067831,"about_ca_system_score_gemma":0.000056438326,"threshold_uncertainty_score":0.38403165},"labels":[],"label_agreement":null},{"id":"W2908664375","doi":"10.1136/annrheumdis-2018-eular.5620","title":"SAT0614 New variant in the il1rn-gene associated with late onset and atypical presentation of dira","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Presentation (obstetrics); Gene; Genetics; Obstetrics; Biology","score_opus":0.020575349954180894,"score_gpt":0.25964208971957203,"score_spread":0.23906673976539114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908664375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998735,0.00029421298,0.000051059524,0.00059694395,0.000020964635,0.00012943585,0.000075587246,0.0000017461175,0.00009505904],"genre_scores_gemma":[0.999463,0.00010586237,0.000052593834,0.00014949383,0.000019754676,0.000006000591,0.000038170132,0.000004827756,0.0001602666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942636,0.00011452261,0.00017394866,0.000088036504,0.000104367406,0.000092733404],"domain_scores_gemma":[0.99952537,0.000046920573,0.00013247556,0.00020556393,0.00006211502,0.000027537764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012581302,0.0000663486,0.000103614766,0.000015148917,0.00004475606,0.000012160246,0.00014928111,0.000030541632,0.000015774645],"category_scores_gemma":[0.00018057725,0.0000367049,0.000040680978,0.00007404442,0.00013303477,0.0000049102277,0.000054303637,0.000021124091,5.976765e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048466907,0.0034315058,0.89332134,0.00072325475,0.002982298,0.000014139834,0.018110411,0.0013798113,0.018108198,0.0072180727,0.030375531,0.019488756],"study_design_scores_gemma":[0.0004345084,0.0002601797,0.9855594,0.000113017915,0.000055653472,0.000006461088,0.00030582363,0.000112021036,0.010757493,0.0022500395,0.0000734923,0.00007190299],"about_ca_topic_score_codex":0.0001181812,"about_ca_topic_score_gemma":0.000105349325,"teacher_disagreement_score":0.092238076,"about_ca_system_score_codex":0.0000017848109,"about_ca_system_score_gemma":0.00007172316,"threshold_uncertainty_score":0.14967825},"labels":[],"label_agreement":null},{"id":"W2908702800","doi":"10.1136/annrheumdis-2018-eular.2071","title":"OP0105 Zcchc6 deletion downregulates il-6 and reduces the severity of experimental osteoarthritis in mice","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Northeast Ohio Medical University; McGill University; University of Toronto; Johns Hopkins University","keywords":"Pathogenesis; Osteoarthritis; Medicine; Proinflammatory cytokine; Arthritis; Cytokine; microRNA; Cartilage; Aggrecanase; In vivo; Gene expression; Molecular biology; Immunology; Pathology; Inflammation; Gene; Biology; Genetics; Articular cartilage; Anatomy","score_opus":0.022039273782298932,"score_gpt":0.29065626063065403,"score_spread":0.2686169868483551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908702800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914096,0.006555862,5.323277e-7,0.0010744384,0.00010135297,0.0004635878,0.000049136313,0.000011742035,0.00033377606],"genre_scores_gemma":[0.9992924,0.0003305133,0.000072896575,0.00012198048,0.000028935203,0.000028676104,0.000010507317,0.000009729908,0.000104401006],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991288,0.00008312904,0.0002857146,0.00013923233,0.00021187287,0.00015124615],"domain_scores_gemma":[0.999388,0.000085235915,0.00014640261,0.0002378787,0.00007908932,0.000063426836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001301799,0.00011841835,0.0002692455,0.000044363125,0.00007539753,0.000011685704,0.00010805485,0.00003647747,0.00007193539],"category_scores_gemma":[0.00011085134,0.000069861206,0.0001019527,0.0001176719,0.00038785706,0.00009432303,0.00007532172,0.000039279654,0.0000036763745],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019805608,0.0026579518,0.019040588,0.00061243906,0.0003024486,0.00001525953,0.008964639,0.000002653426,0.20845751,0.0024735585,0.0018397213,0.7536527],"study_design_scores_gemma":[0.0021998987,0.0018185681,0.07734444,0.0019100645,0.00011133102,0.000044045995,0.0024240306,0.000040670766,0.91195434,0.0019525869,0.00007922666,0.00012078625],"about_ca_topic_score_codex":0.000071519906,"about_ca_topic_score_gemma":0.000025174144,"teacher_disagreement_score":0.7535319,"about_ca_system_score_codex":0.000007522251,"about_ca_system_score_gemma":0.000039891376,"threshold_uncertainty_score":0.2848857},"labels":[],"label_agreement":null},{"id":"W2908716519","doi":"10.1136/annrheumdis-2018-eular.3003","title":"PARE0009 Canadian arthritis patient alliance: understanding member profiles and needs","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Government (linguistics); Alliance; Strategic planning; Public relations; Plan (archaeology); Business; Medicine; Political science; Medical education; Marketing; Geography","score_opus":0.3386183097663687,"score_gpt":0.4183044508630263,"score_spread":0.07968614109665761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908716519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98190254,0.0025093067,0.000011015161,0.0028459479,0.0008510626,0.0013680815,0.00042273095,0.000024480669,0.010064842],"genre_scores_gemma":[0.993318,0.0011026222,0.000034187142,0.005012239,0.000056745608,0.0001064595,0.000037483616,0.000014194573,0.00031806168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998233,0.00027940414,0.00052759907,0.00014074521,0.00028745786,0.0005317719],"domain_scores_gemma":[0.9985626,0.0002271247,0.00028218442,0.00030412627,0.0001197213,0.00050427875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002566609,0.0001336982,0.00022917274,0.00007457691,0.0009726417,0.000009854916,0.00014880698,0.000058443853,0.0007669425],"category_scores_gemma":[0.00010842392,0.00009241157,0.000058550628,0.00018760914,0.0001945163,0.00009138131,0.00008930579,0.00010605235,0.00007160735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030406585,0.0004268612,0.5585591,0.0073715914,0.00025219138,0.000004142669,0.035060477,0.0000064729,0.0000072194152,0.046933517,0.26528826,0.085786104],"study_design_scores_gemma":[0.006387811,0.0038080495,0.38415262,0.09079078,0.00030657623,0.000007381883,0.20116965,0.0017526671,0.0018238993,0.1939803,0.11369533,0.0021249326],"about_ca_topic_score_codex":0.016000245,"about_ca_topic_score_gemma":0.015355288,"teacher_disagreement_score":0.17440647,"about_ca_system_score_codex":0.00010072296,"about_ca_system_score_gemma":0.00045273663,"threshold_uncertainty_score":0.9905523},"labels":[],"label_agreement":null},{"id":"W2908742799","doi":"10.1136/annrheumdis-2018-eular.2130","title":"AB0906 Ixekizumab improves fatigue in a subset of patients with psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celgene; Pfizer","keywords":"Medicine; Dactylitis; Psoriatic arthritis; Ixekizumab; Placebo; Minimal clinically important difference; Physical therapy; Mallinckrodt; Enthesitis; Internal medicine; Arthritis; Clinical endpoint; Clinical trial; Randomized controlled trial; Alternative medicine; Secukinumab","score_opus":0.0270707519919961,"score_gpt":0.30264798122968634,"score_spread":0.27557722923769024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908742799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973031,0.001175548,0.000009100358,0.0005223487,0.00006183288,0.0006330221,0.00008946093,0.000012638792,0.00019294325],"genre_scores_gemma":[0.999471,0.00024735177,0.000094812836,0.000019242581,0.000009135066,0.000029866453,0.000028892393,0.000020997528,0.00007871094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821734,0.000097090706,0.0004933971,0.00019251656,0.00067383825,0.0003258293],"domain_scores_gemma":[0.9985494,0.00013591566,0.00023874165,0.00060057093,0.00034481258,0.00013055067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015797127,0.00015798575,0.0004918986,0.00014016806,0.000046272587,0.0000099723175,0.00025355798,0.000047532485,0.00025617663],"category_scores_gemma":[0.00055099773,0.00009598726,0.00014267328,0.0004301356,0.0005056921,0.0001071831,0.000083061816,0.00009525908,0.000011245246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042041442,0.008225159,0.58956856,0.030574761,0.0017915043,0.000025630194,0.0049881455,0.000031672644,0.00024219013,0.0017135207,0.01584022,0.34279448],"study_design_scores_gemma":[0.0029158457,0.0014404082,0.9854348,0.007093382,0.0000592833,0.0000029442251,0.00021184866,0.00020766498,0.0014832238,0.0010191201,0.000014537224,0.000116965486],"about_ca_topic_score_codex":0.00018963541,"about_ca_topic_score_gemma":0.000017163504,"teacher_disagreement_score":0.39586622,"about_ca_system_score_codex":0.000022637176,"about_ca_system_score_gemma":0.0003212223,"threshold_uncertainty_score":0.39142472},"labels":[],"label_agreement":null},{"id":"W2908761228","doi":"10.1136/annrheumdis-2018-eular.2099","title":"AB1124 A uk study: vocational experiences of young adults with juvenile idiopathic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"Leids Universitair Medisch Centrum; Erasmus Medisch Centrum; Universiteit Leiden","keywords":"Young adult; Medicine; Vocational education; Arthritis; Gerontology; Family medicine; Psychology; Pedagogy","score_opus":0.026960857173418923,"score_gpt":0.31233643063995437,"score_spread":0.2853755734665354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908761228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409753,0.0039839954,0.000012992048,0.00041682296,0.000062748266,0.0006078251,0.000011756258,0.000015971042,0.0007903833],"genre_scores_gemma":[0.99927866,0.00025490095,0.00002181234,0.00007041629,0.00002726829,0.0001302508,0.0000044882345,0.000012187477,0.00020003458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998299,0.000094270676,0.0005229544,0.00016649268,0.0007222055,0.00019504898],"domain_scores_gemma":[0.9985882,0.00005403296,0.0002841186,0.0005095197,0.00048060974,0.000083533545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028815056,0.00011961832,0.00043579514,0.00007884643,0.00012166104,0.00001263228,0.00026813624,0.00002640957,0.0004516078],"category_scores_gemma":[0.0005320779,0.000071922674,0.00011765167,0.00028080528,0.0005585809,0.00010524458,0.00008645136,0.00006639825,0.000016919661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005403758,0.007974707,0.48887703,0.0030258007,0.001457703,0.00003598548,0.27489692,0.000016214428,0.00029800675,0.0008776498,0.012090487,0.20504574],"study_design_scores_gemma":[0.0033829296,0.0038408015,0.84560907,0.006828948,0.00011150519,0.000028775277,0.13540271,0.00029992915,0.0035784815,0.0006005311,0.00009451917,0.00022178539],"about_ca_topic_score_codex":0.00016098605,"about_ca_topic_score_gemma":0.0000478137,"teacher_disagreement_score":0.35673207,"about_ca_system_score_codex":0.0000071632235,"about_ca_system_score_gemma":0.00041547228,"threshold_uncertainty_score":0.49447888},"labels":[],"label_agreement":null},{"id":"W2908811978","doi":"10.1136/annrheumdis-2018-eular.4882","title":"THU0345 Sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with systemic lupus eritamatosus and rheumatoid arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; University Health Network","keywords":"Medicine; Rheumatoid arthritis; Autoantibody; Antibody; Internal medicine; Cohort; Immunology; Connective tissue disease; Gastroenterology; Systemic lupus erythematosus; Population; Pathogenesis; Rheumatology; Autoimmune disease; Arthritis; Disease","score_opus":0.01591667783872558,"score_gpt":0.25848320886006143,"score_spread":0.24256653102133585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908811978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915739,0.005879871,0.000005903216,0.0000716567,0.00005686449,0.0021018237,0.00019825883,0.00001797053,0.000093738265],"genre_scores_gemma":[0.9951466,0.0047107,0.000047354744,0.000011906108,0.000007509808,0.00002555055,0.000010921852,0.000025220335,0.00001429275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975964,0.0003064978,0.00080370274,0.00029185863,0.0006945939,0.0003069777],"domain_scores_gemma":[0.99776226,0.00029221099,0.00055386964,0.0005512236,0.00068904686,0.0001513653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051677815,0.00022740696,0.0010577758,0.00024510434,0.00006036307,0.000013510636,0.00011546391,0.00007140344,0.00000744412],"category_scores_gemma":[0.00077061454,0.00014689939,0.00009146433,0.00045758183,0.00084761326,0.00008655981,0.00016145017,0.000095276555,9.96677e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070753734,0.00044962415,0.98973835,0.0047072857,0.0002814642,0.000009224801,0.0014139246,0.0000046340238,0.0004817891,0.000028778908,0.00007643336,0.0021009792],"study_design_scores_gemma":[0.0029110934,0.00032637335,0.97066706,0.0202525,0.000050190036,0.0004166955,0.0012055325,0.00073498837,0.0032235242,0.000059949278,0.0000015343476,0.0001505572],"about_ca_topic_score_codex":0.00034770157,"about_ca_topic_score_gemma":0.000083718274,"teacher_disagreement_score":0.019071262,"about_ca_system_score_codex":0.000027250237,"about_ca_system_score_gemma":0.00015804256,"threshold_uncertainty_score":0.59903836},"labels":[],"label_agreement":null},{"id":"W2908836806","doi":"10.1136/annrheumdis-2018-eular.3772","title":"OP0130 Risk of cancer in patients with psoriasis/psoriatic arthritis: a population-based study in the province of british columbia","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Population; Dermatology; Environmental health","score_opus":0.011561708438780823,"score_gpt":0.24899515476277337,"score_spread":0.23743344632399255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908836806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556214,0.0021996084,8.372236e-7,0.000029165307,0.00015520689,0.0011004679,0.00093305955,0.0000061689307,0.00001335473],"genre_scores_gemma":[0.99962187,0.000128901,0.000009151621,0.000025498153,0.0000065038525,0.00012279357,0.000031545573,0.000009941504,0.000043819873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983342,0.00065400824,0.0005276361,0.00017534598,0.00012654053,0.00018225033],"domain_scores_gemma":[0.9985984,0.00030109056,0.0005419784,0.00040012418,0.0001459577,0.0000124544995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028020097,0.000109411856,0.0004166592,0.000057260404,0.00007189484,0.0000121183775,0.0003204618,0.00005092315,0.00012448743],"category_scores_gemma":[0.00024489136,0.000085882195,0.00009939455,0.00029719333,0.00016321377,0.00006722412,0.00003413472,0.000056365374,0.0000021983706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030080584,0.0023462619,0.9196267,0.00007578033,0.00028930177,7.3644185e-7,0.0003884675,0.00004958552,0.0000016786838,0.0000030217684,0.0002602018,0.076657474],"study_design_scores_gemma":[0.0037839308,0.00063549407,0.99355865,0.001058154,0.00022256598,1.7888323e-7,0.0003653533,0.000006842792,0.000074717434,0.00020081208,0.000003973992,0.00008932342],"about_ca_topic_score_codex":0.049203433,"about_ca_topic_score_gemma":0.15226996,"teacher_disagreement_score":0.10306652,"about_ca_system_score_codex":0.000012879121,"about_ca_system_score_gemma":0.00012974639,"threshold_uncertainty_score":0.957128},"labels":[],"label_agreement":null},{"id":"W2909008322","doi":"10.1136/annrheumdis-2018-eular.3380","title":"THU0567 Testing performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Arthritis; Juvenile; Physical therapy; Internal medicine","score_opus":0.13138407111950984,"score_gpt":0.4055761626550346,"score_spread":0.27419209153552476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909008322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786384,0.017161211,0.0000061055216,0.0014835075,0.0007841466,0.00065640424,0.00007872048,0.000066164444,0.0011253003],"genre_scores_gemma":[0.9967174,0.0020383145,0.000027313261,0.0005588805,0.0003522717,0.0000678147,0.000007714196,0.000024406732,0.00020586398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970983,0.0006671278,0.00095541944,0.00023055794,0.00048099904,0.0005675394],"domain_scores_gemma":[0.99773324,0.00043581208,0.0004992163,0.0005164928,0.0006589496,0.0001563075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008429512,0.0001782282,0.0004529342,0.0001198646,0.0007710859,0.000013761064,0.00042164652,0.0001148242,0.00010967833],"category_scores_gemma":[0.00281982,0.00013136699,0.00011515063,0.00049196987,0.00016681687,0.00019372988,0.00019645989,0.0003403235,0.00015185757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065208165,0.00008285444,0.8164999,0.005224307,0.000016754537,0.0000022498969,0.011742879,0.000012303924,0.000011013249,0.000057700345,0.009537212,0.15674764],"study_design_scores_gemma":[0.0006736328,0.00012193692,0.9687861,0.017882712,0.00003265357,0.0000014409956,0.009416219,0.00021077036,0.00018520992,0.0014277396,0.001011206,0.00025037894],"about_ca_topic_score_codex":0.0007024082,"about_ca_topic_score_gemma":0.0008627752,"teacher_disagreement_score":0.15649725,"about_ca_system_score_codex":0.0000467175,"about_ca_system_score_gemma":0.0007448144,"threshold_uncertainty_score":0.5930647},"labels":[],"label_agreement":null},{"id":"W2909030224","doi":"10.1136/annrheumdis-2018-eular.6028","title":"THU0132 The patient global assessment rating varies minimally if using arthritis or global health condition and agreement is high between common composite disease activitymeasures and remission classification using either: results from a national early ra cohort study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Sherbrooke; McGill University; Southlake Regional Health Center; University of Winnipeg; University of Toronto","funders":"Sanofi Genzyme; Karolinska Institutet; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Kappa; Wilcoxon signed-rank test; Intraclass correlation; Internal medicine; Physical therapy; Cohort; Cohen's kappa; Statistics; Psychometrics; Mann–Whitney U test; Clinical psychology; Mathematics","score_opus":0.07955138995183796,"score_gpt":0.4038726144896903,"score_spread":0.32432122453785234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909030224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045086,0.0017140696,0.0001593017,0.0033089407,0.00007747719,0.0016337469,0.0025928533,0.000023874341,0.000038874143],"genre_scores_gemma":[0.9977126,0.001224568,0.00051584473,0.00031482134,0.000062713865,0.000031143118,0.00012285983,0.0000126333225,0.0000027749234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650675,0.0007657834,0.00072894234,0.00039048961,0.0013166398,0.00029141677],"domain_scores_gemma":[0.99779207,0.00040990987,0.0006425165,0.00039734202,0.00042928202,0.00032887998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072557025,0.00023656567,0.00050976477,0.000037171623,0.00084680144,0.00020784688,0.00015159033,0.000039032577,0.000032249543],"category_scores_gemma":[0.00048373052,0.0001459534,0.00008671806,0.00021368891,0.00053704955,0.0002756658,0.0001850329,0.00010356721,0.0000011244305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001965244,0.00076418044,0.9396068,0.000084598934,0.0006795948,0.000004211201,0.0012180696,0.000014074608,0.00010043597,0.0002545222,0.00050277746,0.054805506],"study_design_scores_gemma":[0.0021796746,0.00070509844,0.9846235,0.002320202,0.00008499696,0.000008428574,0.0010681987,0.0036895324,0.000069840215,0.005094439,0.000019248115,0.00013684481],"about_ca_topic_score_codex":0.0031857844,"about_ca_topic_score_gemma":0.00015581581,"teacher_disagreement_score":0.05466866,"about_ca_system_score_codex":0.00017709754,"about_ca_system_score_gemma":0.00072139077,"threshold_uncertainty_score":0.6512998},"labels":[],"label_agreement":null},{"id":"W2909067215","doi":"10.1136/annrheumdis-2018-eular.7349","title":"THU0523 Do we need steroid injection after ultrasound guided percutaneous lavage of a rotator cuff calcification ? results at 3 months of a double blinded randomised controlled study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Shoulder Injury and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Minia University","keywords":"Medicine; Rotator cuff; Methylprednisolone acetate; Calcific tendinitis; Calcification; Surgery; Percutaneous; Saline; Prospective cohort study; Methylprednisolone; Anesthesia; Radiology","score_opus":0.05205953351213422,"score_gpt":0.34969600908290643,"score_spread":0.2976364755707722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909067215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928254,0.0011628352,0.000009244073,0.0004862996,0.00013253835,0.0048017506,0.00016648545,0.000029666962,0.00038581848],"genre_scores_gemma":[0.9987983,0.0002221852,0.000040090807,0.000057501416,0.000033578362,0.00028951457,0.000017317527,0.000023033677,0.0005184797],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974518,0.00029952129,0.0011717292,0.00028008674,0.00059084664,0.00020603713],"domain_scores_gemma":[0.9969816,0.00062351924,0.0008135988,0.0008966999,0.000555187,0.00012937539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046631586,0.00024064694,0.0009664179,0.00014762039,0.00008977953,0.000016208456,0.00017790061,0.00006664225,0.00014751306],"category_scores_gemma":[0.0009822823,0.00014480286,0.00043501647,0.0002634495,0.00023842302,0.000082727325,0.000056108795,0.000058219775,0.000009888001],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9137148,0.012275352,0.023457076,0.00094091985,0.0054829493,0.000029762097,0.022192948,0.00009441,0.014017107,0.00005054041,0.004637586,0.0031065152],"study_design_scores_gemma":[0.55729145,0.01082363,0.19558491,0.0031318637,0.009424353,0.0002960635,0.012589021,0.00057592994,0.20791927,0.0016907074,0.00006176722,0.00061101234],"about_ca_topic_score_codex":0.00024995033,"about_ca_topic_score_gemma":0.00004673233,"teacher_disagreement_score":0.35642335,"about_ca_system_score_codex":0.000039671977,"about_ca_system_score_gemma":0.00011441834,"threshold_uncertainty_score":0.590489},"labels":[],"label_agreement":null},{"id":"W2909098770","doi":"10.1136/annrheumdis-2018-eular.4644","title":"AB0436 Consolidated long-term safety of infliximab in inflammatory arthritis from a prospective, observational registry","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Credit Valley Hospital; Memorial University of Newfoundland","funders":"McMaster University","keywords":"Medicine; Psoriatic arthritis; Golimumab; Infliximab; Ustekinumab; Internal medicine; Rheumatoid arthritis; Observational study; Ankylosing spondylitis; Adverse effect; Incidence (geometry); Concomitant; Discontinuation; Surgery; Etanercept; Adalimumab; Disease","score_opus":0.040533433680144434,"score_gpt":0.3202668309470482,"score_spread":0.27973339726690377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909098770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988867,0.008216114,0.000012252328,0.0014178054,0.000089451576,0.0006169108,0.00034162714,0.000027699469,0.0004111782],"genre_scores_gemma":[0.9909725,0.00842798,0.00008553322,0.00024173815,0.000046824272,0.00004454926,0.00007639516,0.000019497704,0.00008494214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804306,0.00013039591,0.000738386,0.00022064846,0.0005892049,0.0002782806],"domain_scores_gemma":[0.99813485,0.00027618275,0.00034274225,0.0006179107,0.0004791983,0.00014914166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020716284,0.00016900053,0.0005190749,0.00011091633,0.000074338044,0.000020923435,0.00028705306,0.00006336936,0.000570831],"category_scores_gemma":[0.001256051,0.00012754192,0.00018690962,0.0002856027,0.0010532599,0.0002022508,0.00012529086,0.00013011014,0.00001744456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001703966,0.0006505733,0.97027785,0.00029155097,0.00038800534,0.000017476059,0.0009214095,0.0000040215805,0.0006644366,0.0012052571,0.0021404007,0.021735027],"study_design_scores_gemma":[0.002744956,0.00015906364,0.9825408,0.0052920748,0.000009406825,0.000009935672,0.0001528014,0.00007664297,0.0058356123,0.0029050538,0.00015917467,0.000114470466],"about_ca_topic_score_codex":0.0001802404,"about_ca_topic_score_gemma":0.00011053189,"teacher_disagreement_score":0.021620557,"about_ca_system_score_codex":0.000022225695,"about_ca_system_score_gemma":0.0004124046,"threshold_uncertainty_score":0.62501997},"labels":[],"label_agreement":null},{"id":"W2909167076","doi":"10.1136/annrheumdis-2018-eular.6533","title":"FRI0615 Normalised toxicity to pregabalin did not increase with changes in approval mechanism and use in australia","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centers for Disease Control and Prevention; University of Melbourne; McMaster University; GlaxoSmithKline","keywords":"Pregabalin; Medicine; Adverse effect; Neuropathic pain; Medical prescription; Anesthesia; Internal medicine; Pharmacology","score_opus":0.05407085751452425,"score_gpt":0.3163862935805246,"score_spread":0.2623154360660004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909167076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581444,0.000083893916,0.000007305819,0.0027519437,0.000036350986,0.0011313863,0.00011980717,0.000020521156,0.000034368084],"genre_scores_gemma":[0.99829245,0.00006796741,0.0004459601,0.0008274963,0.000016699201,0.00011959306,0.0000138496835,0.000019368998,0.0001966159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873495,0.00010534873,0.00028441325,0.0002676607,0.00031770882,0.0002899279],"domain_scores_gemma":[0.9990114,0.00010569492,0.00011371733,0.0004648548,0.00008880782,0.00021554029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016659628,0.00020442372,0.0004145339,0.00016884577,0.000035084973,0.000024639576,0.00014089483,0.0000458477,0.000060938382],"category_scores_gemma":[0.0003855006,0.00012908319,0.000054370597,0.00030868364,0.00012485424,0.00012601788,0.000115889256,0.00006619832,0.0000091985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009850097,0.008634695,0.94270486,0.003088797,0.0007449653,0.00013010032,0.016757865,0.000061098624,0.002412835,0.0031240412,0.0024354486,0.010055227],"study_design_scores_gemma":[0.0024136177,0.00096003735,0.9716451,0.0022228996,0.00013367085,0.000007952298,0.000560746,0.0002392664,0.020692322,0.0009115526,0.000021237438,0.00019155568],"about_ca_topic_score_codex":0.0032384594,"about_ca_topic_score_gemma":0.0025916386,"teacher_disagreement_score":0.02894031,"about_ca_system_score_codex":0.00002594849,"about_ca_system_score_gemma":0.000077193974,"threshold_uncertainty_score":0.52638596},"labels":[],"label_agreement":null},{"id":"W2909199597","doi":"10.1136/annrheumdis-2018-eular.6751","title":"THU0301 A novel role for the psoriatic arthritis impact of disease questionnaire (PSAID)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Celgene; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Prom; Internal medicine; Disease; Arthritis; Dermatology","score_opus":0.02872317409925323,"score_gpt":0.2966166982352564,"score_spread":0.26789352413600315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909199597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95928144,0.036857087,0.00027034228,0.0007553803,0.00059352326,0.00073470536,0.0014147477,0.000033354743,0.000059417882],"genre_scores_gemma":[0.99848795,0.0009449607,0.000025300507,0.000076876444,0.000052436117,0.00012106878,0.00003962702,0.000016585316,0.00023516707],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99899167,0.00013259418,0.00037433612,0.0001693555,0.0000683192,0.00026374473],"domain_scores_gemma":[0.99834657,0.00046685323,0.00033781596,0.0005942487,0.00020664299,0.000047853493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018790054,0.0001869614,0.00033274412,0.000048517453,0.00026503863,0.000009766287,0.00040952236,0.000060178696,0.00018596982],"category_scores_gemma":[0.00072815164,0.000096729476,0.00062825135,0.0001454492,0.0004485442,0.00008397808,0.000073959665,0.00003746622,0.000036009442],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037993551,0.003081146,0.04205065,0.00048130626,0.006919967,6.6619225e-7,0.0019361906,0.00013972985,0.0032428354,0.005014419,0.021438494,0.9118952],"study_design_scores_gemma":[0.0028719557,0.0007878902,0.9732649,0.0014222114,0.0012053179,0.000005655986,0.00021849593,0.00023823854,0.008899862,0.010279331,0.0005421416,0.00026404051],"about_ca_topic_score_codex":0.00021994529,"about_ca_topic_score_gemma":0.00002966398,"teacher_disagreement_score":0.9312142,"about_ca_system_score_codex":0.00001123012,"about_ca_system_score_gemma":0.0001817017,"threshold_uncertainty_score":0.39445135},"labels":[],"label_agreement":null},{"id":"W2909287229","doi":"10.1136/annrheumdis-2018-eular.1576","title":"THU0423 Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Toronto Western Hospital; University Health Network; University of Toronto; Institute of Health Services and Policy Research; Mount Sinai Hospital","funders":"","keywords":"Medicine; Overlap syndrome; Internal medicine; Lupus anticoagulant; Interstitial lung disease; Antiphospholipid syndrome; Gastroenterology; Rheumatology; Hazard ratio; Connective tissue disease; Proportional hazards model; Scleroderma (fungus); Epidemiology; Systemic disease; Immunopathology; Disease; Immunology; Autoimmune disease; Lung; Thrombosis","score_opus":0.08035409916740612,"score_gpt":0.3141625220843067,"score_spread":0.23380842291690057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909287229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93817407,0.05926515,0.000021192975,0.00048071265,0.00090877997,0.00071342743,0.00014283636,0.00005457805,0.00023923005],"genre_scores_gemma":[0.9919233,0.0074320124,0.000024225003,0.00021451904,0.000070118665,0.00003743299,0.000009527177,0.000037941976,0.00025094525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967959,0.0005553686,0.0013850655,0.00037580496,0.00046030962,0.00042757645],"domain_scores_gemma":[0.9962039,0.001093686,0.0010111735,0.0009885738,0.00036757241,0.00033512324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009241982,0.0003024798,0.0015048506,0.00014753175,0.00012707346,0.000010682893,0.00033875712,0.00017068516,0.00008522503],"category_scores_gemma":[0.0021491752,0.00018097229,0.00050391874,0.00032075122,0.00082123745,0.00008795013,0.00018151598,0.000104549516,0.000032471253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000624575,0.0007065752,0.96817803,0.009250501,0.0018732365,0.000010949034,0.0009989123,0.000026625214,0.0033469563,0.002958179,0.007267104,0.004758373],"study_design_scores_gemma":[0.003194478,0.00082378706,0.8844389,0.0977889,0.001522238,0.004414388,0.0039924122,0.00047117617,0.0011429213,0.0017737302,0.000013842943,0.00042326303],"about_ca_topic_score_codex":0.00012021948,"about_ca_topic_score_gemma":0.0000022046684,"teacher_disagreement_score":0.08853839,"about_ca_system_score_codex":0.00002307,"about_ca_system_score_gemma":0.00017212957,"threshold_uncertainty_score":0.7379836},"labels":[],"label_agreement":null},{"id":"W2909340062","doi":"10.1136/annrheumdis-2018-eular.2127","title":"FRI0714-HPR The patient's journey from onset of back pain to diagnosis of axial spondyloarthritis: results from a qualitative study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Krembil Foundation; University of Toronto","funders":"","keywords":"Medicine; Back pain; Ankylosing spondylitis; Physical therapy; Surgery; Alternative medicine; Pathology","score_opus":0.04653409703938528,"score_gpt":0.35859778139895465,"score_spread":0.3120636843595694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909340062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892671,0.00070670346,0.000032739554,0.005757346,0.00016457538,0.0014122613,0.0025568625,0.000010034627,0.00009238076],"genre_scores_gemma":[0.9988534,0.000068853224,0.00025121763,0.0005688494,0.000059472695,0.000071489434,0.000071910974,0.000016842863,0.000037990452],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99566877,0.002178821,0.0010456198,0.00025263045,0.0006745721,0.00017957923],"domain_scores_gemma":[0.99200547,0.005853519,0.0006363366,0.00084326766,0.0005048423,0.00015654428],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001421535,0.00017898591,0.0005895545,0.000085616186,0.00008022028,0.000011724169,0.00029967827,0.000046579124,0.00036638166],"category_scores_gemma":[0.014067967,0.000098462566,0.000355627,0.00032557602,0.00047297223,0.00007253167,0.0001189733,0.000084197774,0.00002704665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009877952,0.012070566,0.07482931,0.0014987523,0.0028448305,0.000004023922,0.6563187,0.000043368054,0.0005162092,0.0001519395,0.14382124,0.09802308],"study_design_scores_gemma":[0.0033406527,0.0056617614,0.8335342,0.0075198608,0.0003218863,2.4588076e-7,0.13918027,0.00012866453,0.0022907113,0.0075839777,0.00022064423,0.00021714251],"about_ca_topic_score_codex":0.003094531,"about_ca_topic_score_gemma":0.00025127645,"teacher_disagreement_score":0.75870484,"about_ca_system_score_codex":0.000011492881,"about_ca_system_score_gemma":0.000098145276,"threshold_uncertainty_score":0.99423695},"labels":[],"label_agreement":null},{"id":"W2909352902","doi":"10.1136/annrheumdis-2018-eular.6787","title":"FRI0634 Cost savings of using hla-b*27 tag snp genotyping to determine hla-b*27 status in a canadian population","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Human leukocyte antigen; SNP; Genotyping; HLA-B; Locus (genetics); Population; Gold standard (test); Immunology; Genetic testing; Internal medicine; Single-nucleotide polymorphism; Genetics; Genotype; Antigen; Biology; Gene","score_opus":0.044348526262509444,"score_gpt":0.3050606328984339,"score_spread":0.2607121066359244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909352902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090445,0.0073676053,0.000032882162,0.00027664567,0.000573387,0.00045289006,0.00015980803,0.000014204749,0.00021813044],"genre_scores_gemma":[0.99928415,0.000092439725,0.000033933076,0.00035597172,0.0000033019405,0.000008629321,0.00005443907,0.000018179222,0.00014896998],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99829805,0.00018291919,0.00060505647,0.00021241141,0.00007340621,0.00062816043],"domain_scores_gemma":[0.99893236,0.00011480248,0.00030827007,0.0004610487,0.00014419378,0.00003934274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028887574,0.0001860906,0.0003976896,0.00029031048,0.00021374974,0.000014896313,0.000403239,0.00010147533,0.00027359626],"category_scores_gemma":[0.000716104,0.00015452104,0.00014620693,0.0004107789,0.00026569446,0.0001393653,0.000114070295,0.00009008345,0.000042461492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013136703,0.0017119158,0.42273483,0.0012237862,0.00096422737,0.0000073936717,0.022743521,0.0037384073,0.10898416,0.0023700665,0.0036936468,0.4305144],"study_design_scores_gemma":[0.0012025086,0.00020126863,0.9707928,0.0020784454,0.00012634817,0.000009794338,0.0016094787,0.00081806566,0.016692951,0.0013143764,0.004657006,0.00049698073],"about_ca_topic_score_codex":0.27378505,"about_ca_topic_score_gemma":0.025566509,"teacher_disagreement_score":0.548058,"about_ca_system_score_codex":0.000061151106,"about_ca_system_score_gemma":0.00029290852,"threshold_uncertainty_score":0.9922144},"labels":[],"label_agreement":null},{"id":"W2909368329","doi":"10.1136/annrheumdis-2018-eular.2139","title":"THU0312 Risk of infection in patients with psoriasis/psoriatic arthritis: a population-based study in the province of british columbia","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Population; Cohort; Diagnosis code; Internal medicine; Poisson regression; Disease; Immunology","score_opus":0.011754637477370175,"score_gpt":0.26771510101462404,"score_spread":0.2559604635372539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909368329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689144,0.0006525237,0.000004813644,0.00006215469,0.00005681624,0.0021633788,0.00013052474,0.000008842785,0.00002953574],"genre_scores_gemma":[0.99912274,0.00066780235,0.000023456516,0.00003368848,0.0000129088785,0.000100806574,0.000014706458,0.000013475903,0.00001040588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977359,0.0005311981,0.0006267333,0.00016314698,0.0007422078,0.00020079299],"domain_scores_gemma":[0.9984469,0.00028360245,0.0004366939,0.00046591583,0.00031518747,0.00005169037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005945625,0.000097455675,0.00044314138,0.00010468089,0.00006655357,0.000032005108,0.00017227362,0.000028998742,0.00005547465],"category_scores_gemma":[0.0011758643,0.00007745344,0.00010846745,0.00048134217,0.00020746811,0.00013278276,0.00003301496,0.00010112209,0.000001098452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042565266,0.0032164871,0.9619104,0.0002381762,0.000112088426,0.0000018226631,0.00042825798,0.000033611974,2.5879712e-7,0.000006272354,0.0002786951,0.033348236],"study_design_scores_gemma":[0.0046562213,0.0019579246,0.9883041,0.003928031,0.000024388573,7.5260215e-7,0.0002900548,0.000115108276,0.000010674852,0.0006364563,0.0000045161455,0.00007181359],"about_ca_topic_score_codex":0.04386616,"about_ca_topic_score_gemma":0.115926236,"teacher_disagreement_score":0.07206007,"about_ca_system_score_codex":0.000014646761,"about_ca_system_score_gemma":0.00019066349,"threshold_uncertainty_score":0.9625008},"labels":[],"label_agreement":null},{"id":"W2909398159","doi":"10.1136/annrheumdis-2018-eular.4696","title":"THU0151 Assessment of compliance of rheumatoid arthritis patients in cognitive dysfunction","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Horizon Pharma; Celgene; Momenta Pharmaceuticals; Gilead Sciences; Genentech; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Cognition; Compliance (psychology); Arthritis; Clinical psychology; Internal medicine; Psychiatry; Psychology","score_opus":0.05578878079151912,"score_gpt":0.363514313395943,"score_spread":0.30772553260442387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909398159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940363,0.0034058217,0.00006584321,0.0002765718,0.00014482233,0.00061863905,0.00018263693,0.000011368077,0.0012579997],"genre_scores_gemma":[0.9761121,0.023615759,0.00008513008,0.000077915,0.00001086179,0.00003067402,0.000028238479,0.000014596789,0.00002468202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806595,0.00015731384,0.0006959089,0.0001733632,0.0006600102,0.0002474507],"domain_scores_gemma":[0.9979995,0.00026068022,0.00043109446,0.0003545328,0.00084465917,0.00010955142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026551733,0.0001426821,0.0005702721,0.00015163478,0.000056955985,0.00000812718,0.00017936582,0.00003803902,0.00029168162],"category_scores_gemma":[0.0009081361,0.00010347324,0.00019219048,0.00033450138,0.00071631785,0.00014260664,0.00009419393,0.00009008892,0.0000069563325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007584932,0.0026131049,0.83833134,0.0006995689,0.0003600344,0.0000016518184,0.0007403618,0.000004991617,0.00023123121,0.00087707373,0.001897221,0.1534849],"study_design_scores_gemma":[0.003100019,0.0009309736,0.9733118,0.015032235,0.000005701106,0.0000028408983,0.00046951458,0.00032484066,0.0050189975,0.0016451738,0.00006577981,0.00009217024],"about_ca_topic_score_codex":0.00025611807,"about_ca_topic_score_gemma":0.0000680993,"teacher_disagreement_score":0.15339273,"about_ca_system_score_codex":0.0000134225575,"about_ca_system_score_gemma":0.00018807185,"threshold_uncertainty_score":0.42195162},"labels":[],"label_agreement":null},{"id":"W2909428870","doi":"10.1136/annrheumdis-2018-eular.4863","title":"OP0044 After how long of disease duration does the increased mortality risk appear in recent onset rheumatoid arthritis?","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Institute for Clinical Evaluative Sciences; McGill University; Sunnybrook Hospital","funders":"NIHR Newcastle Biomedical Research Centre; Wellcome Trust","keywords":"Medicine; Rheumatoid arthritis; Proportional hazards model; Hazard ratio; Cohort; Population; Internal medicine; Cohort study; Demography; Pediatrics; Confidence interval; Environmental health","score_opus":0.03984515286910329,"score_gpt":0.33536897295415297,"score_spread":0.2955238200850497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909428870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889098,0.0026211946,0.000024827448,0.006449963,0.000102796854,0.0011030011,0.00066248234,0.000024019304,0.0001019217],"genre_scores_gemma":[0.9818221,0.017557755,0.0000200269,0.0002997152,0.000037071022,0.00014305995,0.00004010618,0.000026143536,0.00005404436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682474,0.00082868343,0.0006967861,0.00028093628,0.0009983752,0.00037048172],"domain_scores_gemma":[0.99724036,0.00036772026,0.00041989176,0.0012055803,0.00045411236,0.0003123103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009976191,0.0002086182,0.0004887029,0.00013476645,0.00012622081,0.000047668622,0.00037023253,0.000054748125,0.0006536758],"category_scores_gemma":[0.0060740924,0.00011027578,0.0002588578,0.00046491463,0.00085529266,0.00020624504,0.00019305381,0.00018223668,0.000027512842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010063853,0.0006878,0.9570748,0.00047944626,0.00021209304,0.000014949141,0.00043519033,0.0000039533393,0.000021278178,0.000041720607,0.0022594084,0.03776295],"study_design_scores_gemma":[0.00090364006,0.00012579747,0.99208236,0.0026701689,0.00007207259,0.0000017401459,0.00019117637,0.00067175075,0.0014452084,0.0014031264,0.00030727562,0.0001257002],"about_ca_topic_score_codex":0.0015252025,"about_ca_topic_score_gemma":0.0014651263,"teacher_disagreement_score":0.037637252,"about_ca_system_score_codex":0.000033893317,"about_ca_system_score_gemma":0.0004101555,"threshold_uncertainty_score":0.72716945},"labels":[],"label_agreement":null},{"id":"W2909485289","doi":"10.1136/annrheumdis-2018-eular.2317","title":"THU0435 Long-term outcome and prognosis factors of complications in thromboangiitis obliterans (BUERGER'S DISEASE): a multicenter study of 224 patients","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Buerger's disease; Amputation; Surgery; Claudication; Thrombosis; Retrospective cohort study; Internal medicine; Cohort; Gangrene; Vascular disease; Disease","score_opus":0.06464630995188847,"score_gpt":0.3496319626836844,"score_spread":0.28498565273179594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909485289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688226,0.0002467302,0.000008474193,0.0005822233,0.00006354007,0.0018351164,0.00031537263,0.000016795642,0.000049485992],"genre_scores_gemma":[0.99956244,0.000052060117,0.000017118113,0.00017587646,0.000008054324,0.000091056834,0.000050513645,0.000017850403,0.000025002497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998196,0.00012173441,0.0007712644,0.0002500287,0.0004552152,0.00020575956],"domain_scores_gemma":[0.9984902,0.000087722896,0.00036111142,0.0006175014,0.00025208225,0.00019134198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008164716,0.00019188435,0.0005191417,0.00016501662,0.000052797994,0.000013649619,0.00024977367,0.000019478544,0.00009571029],"category_scores_gemma":[0.00020477014,0.00012840022,0.00018835132,0.00027297894,0.0002558941,0.00014384584,0.00019540582,0.00004198653,0.000002567475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019008567,0.008198762,0.98570555,0.0011767126,0.00031457015,0.0000010881037,0.0016595301,0.00000538005,0.00000839981,0.000018265047,0.00020551472,0.0025161307],"study_design_scores_gemma":[0.0017511694,0.0004365117,0.9952358,0.0013433662,0.00040184625,7.716241e-8,0.00041615922,0.00021428164,0.000039924624,0.000050197195,0.000005329614,0.00010532352],"about_ca_topic_score_codex":0.000115977804,"about_ca_topic_score_gemma":0.000074213676,"teacher_disagreement_score":0.009530253,"about_ca_system_score_codex":0.000015422109,"about_ca_system_score_gemma":0.000029220575,"threshold_uncertainty_score":0.5236009},"labels":[],"label_agreement":null},{"id":"W2909563401","doi":"10.1136/annrheumdis-2018-eular.4212","title":"OP0302 An evaluation of utilisation patterns and appropriateness of laboratory tests among new referrals to rheumatologists: choosing unwisely!","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rheumatology; Referral; Audit; Anti-nuclear antibody; Internal medicine; Medical laboratory; Family medicine; Physical therapy; Autoantibody; Pathology; Immunology","score_opus":0.11347892625373261,"score_gpt":0.3848433263491859,"score_spread":0.27136440009545326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909563401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958418,0.0025342489,0.00006972255,0.00052180234,0.00008804433,0.0007621664,0.00008122961,0.000020791545,0.000080175894],"genre_scores_gemma":[0.9981655,0.0015246809,0.00014222182,0.000065775894,0.000024731848,0.00002630979,0.000018488083,0.000018683162,0.000013591599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977641,0.00037201465,0.0005825212,0.00021701885,0.0008497199,0.0002146117],"domain_scores_gemma":[0.99743044,0.00014487194,0.00039107056,0.00057518657,0.001195768,0.0002626492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009884593,0.00014904031,0.00047835734,0.00016383165,0.00007633374,0.000023119173,0.00021096853,0.0000540926,0.00012045985],"category_scores_gemma":[0.0024010574,0.00010457478,0.0000849589,0.00030762315,0.00040942358,0.00027632923,0.00008670709,0.000056837045,0.0000025752922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007377395,0.0008313818,0.7817441,0.0013563519,0.00041922892,8.086314e-7,0.004889608,0.00006563629,0.004482757,0.00091299356,0.0013142192,0.20324516],"study_design_scores_gemma":[0.0012533276,0.00050326274,0.9615501,0.0037819734,0.000052522897,0.0000031066836,0.0009520451,0.0010103728,0.028143398,0.0026132597,0.000023813313,0.00011280732],"about_ca_topic_score_codex":0.0009210265,"about_ca_topic_score_gemma":0.00016387152,"teacher_disagreement_score":0.20313236,"about_ca_system_score_codex":0.000016258307,"about_ca_system_score_gemma":0.00040156962,"threshold_uncertainty_score":0.42644358},"labels":[],"label_agreement":null},{"id":"W2909622563","doi":"10.1136/annrheumdis-2018-eular.6001","title":"FRI0655 Title: the consistency of outcomes reported in trials of systemic sclerosis. improving over time?","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Clinical trial; Rheumatology; Meta-analysis; Randomized controlled trial; MEDLINE; Physical therapy; Internal medicine; Psychological intervention; Trial registration","score_opus":0.10311250657577607,"score_gpt":0.3463573488882886,"score_spread":0.24324484231251253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909622563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775194,0.01925326,0.0000019276126,0.0003193066,0.00030872857,0.0005727828,0.000084162835,0.000014695395,0.0019257568],"genre_scores_gemma":[0.99792975,0.0012904378,0.000009076304,0.00006614897,0.000024257175,0.00001294082,0.0000035244102,0.000012531338,0.0006513077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978241,0.00022402612,0.0013471226,0.00012033317,0.0003480222,0.00013643502],"domain_scores_gemma":[0.997128,0.00081278174,0.0011491441,0.00061529403,0.00023206678,0.000062726984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010208654,0.000110790286,0.00075565965,0.00007245838,0.00004610929,0.0000074777627,0.00017898397,0.000058941794,0.00030962616],"category_scores_gemma":[0.0055002435,0.000052274234,0.00041295838,0.00020290131,0.00029141761,0.000030363168,0.00005596984,0.000044234675,0.000021250911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001693221,0.0030055414,0.5376657,0.009996097,0.0072193397,0.000010577661,0.0019569932,0.000023373364,0.06415886,0.0034202712,0.19927736,0.17157264],"study_design_scores_gemma":[0.0023126607,0.00020717294,0.9499373,0.033452112,0.001280766,0.00001560432,0.00076860556,0.0004934752,0.010484393,0.0007638937,0.000089825735,0.00019419527],"about_ca_topic_score_codex":0.00013631454,"about_ca_topic_score_gemma":0.000002002944,"teacher_disagreement_score":0.41227156,"about_ca_system_score_codex":0.0000105183835,"about_ca_system_score_gemma":0.00021954051,"threshold_uncertainty_score":0.6584702},"labels":[],"label_agreement":null},{"id":"W2909652654","doi":"10.1136/annrheumdis-2018-eular.7249","title":"OP0249 The contribution of structural mri lesions to detection of sacroiliitis in patients in the assessments in spondyloarthritis international society (ASAS) classification cohort","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Novo Nordisk; Ablynx; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Axial spondyloarthritis; Cohort; Sacroiliitis; DICOM; Radiology; Lesion; Target lesion; Ankylosing spondylitis; Nuclear medicine; Magnetic resonance imaging; Internal medicine; Surgery","score_opus":0.025989767496557785,"score_gpt":0.3386480262173103,"score_spread":0.31265825872075254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909652654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714655,0.00026087963,0.000019620144,0.0011737397,0.0001797621,0.0009518612,0.00017045738,0.0000034979403,0.00009363025],"genre_scores_gemma":[0.99929464,0.00038018482,0.000032094533,0.00012678398,0.000014952767,0.00008339009,0.000051092844,0.0000059058166,0.000010986164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986018,0.00013242746,0.0005254714,0.00014714304,0.00043978004,0.00015337899],"domain_scores_gemma":[0.9989771,0.00016041988,0.00026184926,0.00028789815,0.0002840327,0.000028659762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030802828,0.00010557988,0.0002748061,0.000081932325,0.00007151824,0.000008907233,0.00020317662,0.000038765527,0.00002295102],"category_scores_gemma":[0.0004030257,0.000060708564,0.00014064152,0.00039929955,0.00019266702,0.000090209855,0.00007205907,0.00007581274,0.0000016453394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003128248,0.00051427167,0.978265,0.00003240992,0.00011402716,6.9846504e-7,0.0007248931,0.000016116508,0.00012028477,0.00023421086,0.0002574007,0.019407874],"study_design_scores_gemma":[0.0019867644,0.0003177565,0.99439985,0.0007436927,0.000042829404,0.0000015353698,0.00076582335,0.00045293465,0.0006991095,0.00049847655,0.000043894754,0.000047327707],"about_ca_topic_score_codex":0.00058931723,"about_ca_topic_score_gemma":0.0009392638,"teacher_disagreement_score":0.019360546,"about_ca_system_score_codex":0.000068689,"about_ca_system_score_gemma":0.00005293416,"threshold_uncertainty_score":0.24756233},"labels":[],"label_agreement":null},{"id":"W2909658960","doi":"10.1136/annrheumdis-2018-eular.6087","title":"SAT0384 Evolving patterns of reactive arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Hospital for Sick Children; Western University","funders":"Hospital for Sick Children; Vedecká Grantová Agentúra MŠVVaŠ SR a SAV","keywords":"Medicine; Reactive arthritis; Arthritis; Immunology","score_opus":0.03238662441837182,"score_gpt":0.31872158926664995,"score_spread":0.28633496484827814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909658960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883347,0.008379579,0.000038698916,0.0013031822,0.00012924592,0.00031607924,0.00011798025,0.000023860113,0.0013566861],"genre_scores_gemma":[0.9907815,0.008766946,0.000054931752,0.00015089511,0.00005625056,0.000015598755,0.000006955838,0.000017793445,0.0001491374],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986005,0.00010218539,0.00038758898,0.00014792127,0.0005001998,0.00026164926],"domain_scores_gemma":[0.99844146,0.0001992099,0.00021878563,0.00052971876,0.00045339536,0.00015745475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018519333,0.00012324235,0.000402485,0.00009006406,0.000089619505,0.000015379066,0.0002155803,0.0000314933,0.0007341602],"category_scores_gemma":[0.001131841,0.00008219413,0.00025106018,0.00015714439,0.0004110526,0.00014202317,0.00010377136,0.00007577349,0.00002776187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001072391,0.0019185214,0.37075552,0.0013148198,0.0016463381,0.000020587064,0.005728573,0.0000021157373,0.0037706548,0.0038116665,0.028211975,0.5817468],"study_design_scores_gemma":[0.0018634835,0.000992765,0.9298573,0.010866333,0.000027737333,0.00004200591,0.0014955661,0.00012960016,0.046383355,0.0068809832,0.0012662425,0.00019459757],"about_ca_topic_score_codex":0.00027622483,"about_ca_topic_score_gemma":0.00004314514,"teacher_disagreement_score":0.58155227,"about_ca_system_score_codex":0.000007693586,"about_ca_system_score_gemma":0.00013266136,"threshold_uncertainty_score":0.8038539},"labels":[],"label_agreement":null},{"id":"W2909665751","doi":"10.1136/annrheumdis-2018-eular.5346","title":"FRI0016 No relationships between acpa and periodontitis in early rheumatoid arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lachine Hospital","funders":"","keywords":"Medicine; Periodontitis; Rheumatoid arthritis; Citrullination; Internal medicine; Porphyromonas gingivalis; Gastroenterology; Case-control study; Arthritis; Population; Rheumatology; Immunology; Odds ratio; Chronic periodontitis; Citrulline; Arginine","score_opus":0.044163831175188656,"score_gpt":0.3021004067440838,"score_spread":0.25793657556889515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909665751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847539,0.010605162,0.000010392373,0.002733697,0.00010974655,0.00045278913,0.000091018046,0.000036757792,0.0012065148],"genre_scores_gemma":[0.96095484,0.038484983,0.00013339409,0.00008673069,0.0000646351,0.000033273693,0.000012006802,0.000025193624,0.00020492761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981558,0.00024534896,0.00052862853,0.00024007299,0.00045298188,0.00037718978],"domain_scores_gemma":[0.9984781,0.00034364482,0.00015079313,0.00048733535,0.00026301792,0.00027712263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042426452,0.00017620814,0.00049973506,0.00017366266,0.0002424427,0.00006633357,0.00020957041,0.000071836985,0.00028569545],"category_scores_gemma":[0.0018708108,0.00012935698,0.00014979493,0.00029253706,0.00073833467,0.00026677625,0.00013520445,0.00020700437,0.00014006348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016118112,0.0001724302,0.9322846,0.0001398317,0.00017132463,0.0000073673955,0.0018642775,2.355263e-7,0.0000349938,0.0012731381,0.0050229914,0.05886766],"study_design_scores_gemma":[0.0013864601,0.00033974618,0.98613757,0.0036546162,0.0000052838845,0.000020545227,0.00031007416,0.00003977281,0.00028092525,0.005451108,0.002231928,0.00014198261],"about_ca_topic_score_codex":0.00035538277,"about_ca_topic_score_gemma":0.0001269755,"teacher_disagreement_score":0.058725677,"about_ca_system_score_codex":0.000011603992,"about_ca_system_score_gemma":0.00013137294,"threshold_uncertainty_score":0.5275025},"labels":[],"label_agreement":null},{"id":"W2909710445","doi":"10.1136/annrheumdis-2018-eular.1887","title":"FRI0448 Mda5 antibody positive clinical amyopathic dermatomyositis (CADM): a single tertiary centre case series of 13 patients","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dermatomyositis; Series (stratigraphy); Antibody; Immunology; Dermatology","score_opus":0.02522123130539285,"score_gpt":0.32214716321394077,"score_spread":0.29692593190854794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909710445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952987,0.0007004271,0.000028059809,0.001382992,0.0004314563,0.0006715091,0.00062467565,0.000055843335,0.00080633175],"genre_scores_gemma":[0.9978308,0.00020308392,0.0001326191,0.0014817589,0.0001129386,0.0000086974605,0.00008543676,0.00004129961,0.000103349994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703157,0.00041406025,0.0012758089,0.000313789,0.0005449583,0.00041978585],"domain_scores_gemma":[0.99698865,0.0002793734,0.00072209374,0.00079062156,0.0009116661,0.00030761183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002753352,0.00030519447,0.0008285791,0.0001160298,0.00023134475,0.000030991447,0.00025614962,0.00013828762,0.00019397428],"category_scores_gemma":[0.00076664257,0.00021636035,0.00057350233,0.0002545583,0.0009440033,0.00030824973,0.00025444,0.0001643543,0.00005134025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011954563,0.0032797803,0.9451026,0.00226027,0.0008529256,0.001299472,0.002872675,0.0000018990543,0.00028644848,0.00042414875,0.02494054,0.017483832],"study_design_scores_gemma":[0.00252339,0.0011711471,0.96658456,0.006001455,0.0007318409,0.0025015508,0.0011118471,0.00025288912,0.017440483,0.0007230717,0.0005330167,0.0004247306],"about_ca_topic_score_codex":0.00015709031,"about_ca_topic_score_gemma":0.000035079673,"teacher_disagreement_score":0.024407523,"about_ca_system_score_codex":0.000018080678,"about_ca_system_score_gemma":0.00016865345,"threshold_uncertainty_score":0.8822919},"labels":[],"label_agreement":null},{"id":"W2909757543","doi":"10.1136/annrheumdis-2018-eular.5944","title":"AB1297 High prevalence of seronegative rheumatoid arthritisin a maya-yucateco indigenous population: a cohort community-based study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Consejo Nacional de Ciencia y Tecnología","keywords":"Medicine; Cohort; Rheumatoid arthritis; Internal medicine; Rheumatoid factor; Population; Physical therapy; Quality of life (healthcare); Incidence (geometry); Environmental health","score_opus":0.038309212770924216,"score_gpt":0.33058918566618484,"score_spread":0.29227997289526064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909757543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391484,0.0028412123,0.000031054948,0.000535566,0.00013933257,0.0021025594,0.00027611217,0.00006230511,0.00009702064],"genre_scores_gemma":[0.996681,0.0026302366,0.00013778769,0.00019310946,0.000025324693,0.00013939076,0.000048742484,0.000038293645,0.00010611983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645317,0.0009860917,0.0008717145,0.000253572,0.0010058241,0.00042963884],"domain_scores_gemma":[0.9967115,0.000499642,0.0005305619,0.001303721,0.0007143043,0.00024026961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087841065,0.00027813815,0.0008035005,0.0002074461,0.0004945601,0.00003880084,0.00060133496,0.000061737046,0.0004374643],"category_scores_gemma":[0.0008754151,0.00018560696,0.00026363938,0.00048593176,0.00074719853,0.0001945008,0.00018533197,0.00026451264,0.000030461868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011792504,0.0053037675,0.96403265,0.0017965258,0.0009052605,0.0000069454427,0.006065401,0.000024199673,0.00005005242,0.00023589717,0.00080866995,0.019591391],"study_design_scores_gemma":[0.002345649,0.002855032,0.98344123,0.004195618,0.000050392126,0.000013543597,0.0013919165,0.000057832523,0.0018361876,0.0035770994,0.000044857876,0.00019065538],"about_ca_topic_score_codex":0.0025797908,"about_ca_topic_score_gemma":0.00028087766,"teacher_disagreement_score":0.019408576,"about_ca_system_score_codex":0.000030065476,"about_ca_system_score_gemma":0.0003189996,"threshold_uncertainty_score":0.7568832},"labels":[],"label_agreement":null},{"id":"W2909874369","doi":"10.1136/annrheumdis-2018-eular.5849","title":"AB0331 Incidence of malignancy in psoriatic and rheumatoid arthritis patients living in newfoundland and labrador","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Malignancy; Internal medicine; Rheumatoid arthritis; Population; Breast cancer; Incidence (geometry); Cohort; Cancer registry; Lung cancer; Cancer; Rheumatology; Epidemiology; Oncology","score_opus":0.014866763698923029,"score_gpt":0.28060128670555023,"score_spread":0.2657345230066272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909874369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97598207,0.023042109,0.0000026026237,0.0003548634,0.00006519697,0.00041982392,0.000022482096,0.000008171066,0.00010266408],"genre_scores_gemma":[0.9268602,0.07294372,0.0000613114,0.000074160016,0.000009243657,0.000019991134,0.0000021935778,0.000013173864,0.000015970094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984657,0.00014931546,0.0005548771,0.00019315032,0.00036226155,0.00027470474],"domain_scores_gemma":[0.9988429,0.00038643272,0.00019495461,0.0002886245,0.00015146023,0.00013560992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003296121,0.00014184488,0.00048523402,0.00019531902,0.0000556671,0.000024519284,0.00013465766,0.00003995268,0.000068585156],"category_scores_gemma":[0.0018203808,0.00010468925,0.000057058234,0.00027670714,0.00049305015,0.00021655303,0.00015075666,0.000081383805,0.0000029597395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012373125,0.00032950583,0.8981463,0.000372945,0.00003862884,0.0000031178122,0.001951316,6.054196e-7,0.000027519536,0.00034388382,0.00012172814,0.098540746],"study_design_scores_gemma":[0.0016132584,0.0003447379,0.9805071,0.014086147,0.0000027009614,0.000010337027,0.00027712953,0.00019713813,0.00012728215,0.0027114532,0.000027463582,0.00009526422],"about_ca_topic_score_codex":0.0020916623,"about_ca_topic_score_gemma":0.0021302248,"teacher_disagreement_score":0.09844548,"about_ca_system_score_codex":0.000013075927,"about_ca_system_score_gemma":0.00009415516,"threshold_uncertainty_score":0.42691037},"labels":[],"label_agreement":null},{"id":"W2909973729","doi":"10.1136/annrheumdis-2018-eular.5649","title":"THU0271 Emergence of severe spondyloarthropathy related entheseal pathology following vedolizumab therapy for inflammatory bowel disease","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Vedolizumab; Medicine; Enthesopathy; Spondyloarthropathy; Inflammatory bowel disease; Sacroiliitis; Internal medicine; Enthesitis; Dermatology; Gastroenterology; Disease; Arthritis; Psoriatic arthritis","score_opus":0.02998807794777261,"score_gpt":0.3145021254963619,"score_spread":0.28451404754858933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909973729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985219,0.01166583,0.000008000942,0.00093246845,0.00052935595,0.0010468619,0.00028343804,0.000036491794,0.0002785647],"genre_scores_gemma":[0.99683875,0.0024120081,0.00006756841,0.00021709634,0.00005117959,0.00012095435,0.000030880245,0.000034319386,0.00022723738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983003,0.000112113776,0.0005892242,0.0002782115,0.00036800597,0.0003521561],"domain_scores_gemma":[0.9983152,0.00019074902,0.000350678,0.0006668772,0.00028195293,0.00019451634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019225288,0.00023389509,0.00051909813,0.00008193889,0.00020929775,0.0000066327407,0.00022706793,0.00005829426,0.00025205713],"category_scores_gemma":[0.00076916703,0.00015553639,0.00068698253,0.00017940246,0.00044011534,0.00010125115,0.000105463914,0.00005739168,0.000014394368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016092746,0.0060586487,0.77790505,0.0026597087,0.006030183,0.0003252639,0.008319012,0.000050673843,0.0011458303,0.003917144,0.01956882,0.15792693],"study_design_scores_gemma":[0.0073424354,0.0017197822,0.97606206,0.0023436472,0.00064556726,0.000025401732,0.0009966708,0.00016140642,0.0020969536,0.0077089793,0.0005894014,0.00030771884],"about_ca_topic_score_codex":0.0000148325735,"about_ca_topic_score_gemma":0.000005411247,"teacher_disagreement_score":0.198157,"about_ca_system_score_codex":0.000010448122,"about_ca_system_score_gemma":0.00017155647,"threshold_uncertainty_score":0.634259},"labels":[],"label_agreement":null},{"id":"W2909981543","doi":"10.1136/annrheumdis-2018-eular.5263","title":"AB0693 Demographic, clinical, laboratory and imaging characteristics of an incidence cohort of 93 patients with large vessel gca","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; Celgene; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; University of California, San Francisco; European League Against Rheumatism; Medpace; Genentech; National Center for Advancing Translational Sciences; Vasculitis Foundation; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Cohort; Incidence (geometry); Rheumatology; Internal medicine; Retrospective cohort study; Radiology; Pediatrics","score_opus":0.012001662941198317,"score_gpt":0.3017141151445191,"score_spread":0.2897124522033208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909981543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984061,0.00049125165,0.000017313188,0.00022333664,0.00006825507,0.00026108327,0.00047308538,0.0000106641455,0.00004889281],"genre_scores_gemma":[0.9986647,0.00091728644,0.0000928621,0.00024114914,0.00001779067,0.0000056693075,0.000042376458,0.0000116845595,0.0000065226204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885297,0.00008881614,0.000517756,0.00013468994,0.00027707624,0.00012872105],"domain_scores_gemma":[0.9981545,0.000112457805,0.00045938144,0.00041993722,0.00071923126,0.00013445891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002316238,0.00009667118,0.00038994144,0.00006547669,0.00007184566,0.0000066840835,0.00012021803,0.000037618433,0.000048240414],"category_scores_gemma":[0.00047028414,0.00005893153,0.00009925464,0.00020742914,0.0006540763,0.000119238124,0.000052123414,0.000073915035,0.0000011675656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008404839,0.0007655162,0.9947604,0.0002840669,0.00029848682,0.0000012643483,0.00011787444,1.6288004e-7,0.000016055199,0.00014301541,0.0005498072,0.0029793344],"study_design_scores_gemma":[0.0008774362,0.00033385408,0.99593854,0.0016663938,0.0004270388,0.0000016032327,0.00008988283,0.00012298749,0.00015756238,0.00027081455,0.000047822592,0.00006605126],"about_ca_topic_score_codex":0.000022186901,"about_ca_topic_score_gemma":0.0000023627308,"teacher_disagreement_score":0.0029132832,"about_ca_system_score_codex":0.0000020350374,"about_ca_system_score_gemma":0.00011306633,"threshold_uncertainty_score":0.24099712},"labels":[],"label_agreement":null},{"id":"W2909983580","doi":"10.1136/annrheumdis-2018-eular.4192","title":"AB0413 Nodular polyarteritis as an unforeseeable adverse reaction in ra patient treated with tofacitinib","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ono Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; AbbVie Canada; Astellas Foundation for Research on Metabolic Disorders; Pfizer Japan; Chugai Pharmaceutical; Pfizer","keywords":"Medicine; Tofacitinib; Adverse effect; Dermatology; Polyarteritis nodosa; Immunology; Rheumatoid arthritis; Internal medicine; Vasculitis; Disease","score_opus":0.019900111108539478,"score_gpt":0.2894513192624036,"score_spread":0.26955120815386413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909983580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574643,0.00039820507,0.0000012224759,0.00046202555,0.000063968786,0.00045976788,0.00012933818,0.000045765377,0.0026932599],"genre_scores_gemma":[0.99884593,0.00018278536,0.000014781067,0.00055551145,0.00002473532,0.000030797128,0.000063247,0.00002196364,0.00026022902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986813,0.00008371166,0.00035859228,0.00021587784,0.0003727204,0.00028781893],"domain_scores_gemma":[0.9988147,0.000035125766,0.0001890066,0.00052842026,0.0001593209,0.00027343337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000638309,0.00017602493,0.0003231318,0.00011926409,0.00009610836,0.000012607038,0.00012375305,0.000063273525,0.0004276052],"category_scores_gemma":[0.00015586584,0.000105599254,0.00014116711,0.00031544873,0.00027578467,0.00023163325,0.000028186685,0.000078080615,0.000053716023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023438847,0.01995844,0.67202944,0.0022139437,0.0029876442,0.00060826034,0.0076055233,0.0003523302,0.0050792224,0.0016688885,0.016036877,0.24802059],"study_design_scores_gemma":[0.005095081,0.004264311,0.951963,0.0058414605,0.0006814589,0.00011352859,0.0029415032,0.0013423266,0.024169197,0.001827025,0.0012689909,0.0004921006],"about_ca_topic_score_codex":0.0012583957,"about_ca_topic_score_gemma":0.000042194966,"teacher_disagreement_score":0.2799336,"about_ca_system_score_codex":0.000019310368,"about_ca_system_score_gemma":0.00015624263,"threshold_uncertainty_score":0.46819773},"labels":[],"label_agreement":null},{"id":"W2909991553","doi":"10.1136/annrheumdis-2018-eular.2134","title":"AB0939 Off-label secukinumab dose escalation in the treatment of moderate-to-severe psoriasis: a multicenter, retrospective study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; NOSM University; Sunnybrook Health Science Centre; Western University; McMaster University; University of Toronto","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Psoriatic arthritis; Dosing; Psoriasis Area and Severity Index; Retrospective cohort study; Adverse effect; Internal medicine; Dermatology","score_opus":0.10592112926419756,"score_gpt":0.41219164729362445,"score_spread":0.3062705180294269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909991553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255276,0.001501694,0.000005483099,0.0036016924,0.000118691016,0.0015768635,0.000051824347,0.000010878664,0.000580114],"genre_scores_gemma":[0.99801767,0.0012027612,0.000038666618,0.00052412745,0.000054466098,0.000089755005,0.0000027415595,0.000010269606,0.00005955254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848837,0.00026785277,0.0004112348,0.00019363366,0.00043851248,0.000200392],"domain_scores_gemma":[0.99869776,0.00034094817,0.000230032,0.00042403498,0.00022173037,0.000085504194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000280231,0.00016024239,0.0004210974,0.000053253803,0.00011708981,0.00001844936,0.00018256683,0.00002508207,0.0000745659],"category_scores_gemma":[0.00058979425,0.00007942512,0.00012878861,0.00031424154,0.00011701806,0.0001016854,0.00005623217,0.00006130123,0.000013478509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025832228,0.076663084,0.48106936,0.00071259745,0.004551213,0.000028314547,0.09771279,0.00015743826,0.00012253567,0.0005661122,0.0052259862,0.30735835],"study_design_scores_gemma":[0.0071344073,0.004041619,0.9756183,0.00049188826,0.00074197096,0.0000027580795,0.0061548925,0.0037205627,0.00045546147,0.0009943777,0.0005168401,0.00012693397],"about_ca_topic_score_codex":0.00030928524,"about_ca_topic_score_gemma":0.0001168237,"teacher_disagreement_score":0.49454892,"about_ca_system_score_codex":0.000044306875,"about_ca_system_score_gemma":0.00004117898,"threshold_uncertainty_score":0.32388625},"labels":[],"label_agreement":null},{"id":"W2910073867","doi":"10.1136/annrheumdis-2018-eular.3433","title":"SAT0074 Identification of a protein panel useful for the prediction of response to methotrexate in rheumatoid arthritis patients","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; National Natural Science Foundation of China; Ontario Ministry of Health and Long-Term Care; Celgene; Sanofi; Amgen; Pfizer; Natural Science Foundation of Guangdong Province; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Identification (biology); Arthritis; Immunology; Internal medicine","score_opus":0.040624096501430305,"score_gpt":0.3001951283375929,"score_spread":0.2595710318361626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910073867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954205,0.00078212377,0.0013191623,0.00057401904,0.00005749646,0.0013450742,0.0004914643,0.0000034942125,0.000006643617],"genre_scores_gemma":[0.9992767,0.00023674892,0.00012041365,0.000040174444,0.000007266677,0.00025086463,0.000024658008,0.000007891154,0.000035287492],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987106,0.00028249974,0.0005602988,0.0001663501,0.00017402225,0.00010627284],"domain_scores_gemma":[0.9984584,0.00010461213,0.00038128713,0.00060627237,0.0004130364,0.000036397294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084741553,0.00007977682,0.00015587661,0.000043906093,0.00005131905,0.0000068433446,0.00028593093,0.000042478427,0.000007819244],"category_scores_gemma":[0.0036285738,0.000053922813,0.000119725366,0.0001539574,0.00018607615,0.0000072418356,0.000067747664,0.000021174768,0.000001064833],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011865475,0.0026185869,0.07420975,0.0009696666,0.0003983765,6.326608e-8,0.0026230582,0.00016899427,0.7247545,0.0008037681,0.0017123116,0.17987546],"study_design_scores_gemma":[0.0004674292,0.0002769631,0.5282466,0.00022487075,0.000008147336,1.326383e-7,0.00010887945,0.00015694331,0.4689926,0.0008253255,0.00064207026,0.000050089027],"about_ca_topic_score_codex":0.000039162012,"about_ca_topic_score_gemma":0.000015655498,"teacher_disagreement_score":0.4540368,"about_ca_system_score_codex":0.0000060881107,"about_ca_system_score_gemma":0.00007299402,"threshold_uncertainty_score":0.43440038},"labels":[],"label_agreement":null},{"id":"W2910095732","doi":"10.1136/annrheumdis-2018-eular.1832","title":"OP0128 The phenotype of axial psoriatic arthritis: is it dependent on hla-b27 status?","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Health and Medical Research Fund","keywords":"Medicine; BASDAI; HLA-B27; Ankylosing spondylitis; Psoriatic arthritis; Internal medicine; BASFI; Psoriasis; Sacroiliitis; Disease; Dermatology; Human leukocyte antigen; Immunology; Antigen","score_opus":0.04631038910448132,"score_gpt":0.3292983003566994,"score_spread":0.28298791125221806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910095732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817627,0.008001035,0.0000037704394,0.0054482273,0.00048011864,0.00063943025,0.00029355584,0.000017745715,0.0033533827],"genre_scores_gemma":[0.99362427,0.0041127643,0.000027730866,0.0016456594,0.000105334766,0.000036288387,0.000008768636,0.00001942808,0.0004197538],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838424,0.00008127857,0.000441539,0.00019265528,0.0005870234,0.00031327448],"domain_scores_gemma":[0.99846584,0.00021094971,0.00028228393,0.0006919314,0.0002292379,0.00011973248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012939889,0.00018539617,0.00044875772,0.000044861037,0.00018628912,0.000014706892,0.00020892615,0.00003543033,0.0008068845],"category_scores_gemma":[0.0005329712,0.00009911109,0.00027154785,0.00016668408,0.00035669713,0.000049714927,0.000117897565,0.00006734246,0.00011066192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003708733,0.0061518103,0.03565095,0.0011226329,0.0054133334,0.000033307828,0.011810319,0.000018551473,0.00010354951,0.0042397226,0.16706268,0.7646844],"study_design_scores_gemma":[0.013960502,0.0071071936,0.9181314,0.012398501,0.002016344,0.000032550844,0.007855319,0.00021787608,0.012897425,0.017327938,0.0073997253,0.0006552188],"about_ca_topic_score_codex":0.0002475195,"about_ca_topic_score_gemma":0.00007534546,"teacher_disagreement_score":0.88248044,"about_ca_system_score_codex":0.00001644992,"about_ca_system_score_gemma":0.00010653931,"threshold_uncertainty_score":0.883482},"labels":[],"label_agreement":null},{"id":"W2910101882","doi":"10.1136/annrheumdis-2018-eular.7226","title":"THU0334 Patterns of aspirin use in sle pregnancies within a multinational inception cohort and relationship to preeclampsia risk factors","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"NordForsk; Oak Foundation","keywords":"Medicine; Preeclampsia; Aspirin; Pregnancy; Obstetrics; Risk factor; Cohort; Lupus nephritis; Antiphospholipid syndrome; Cohort study; Internal medicine; Disease; Thrombosis","score_opus":0.07652092693136321,"score_gpt":0.3428619983974846,"score_spread":0.2663410714661214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910101882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982079,0.0001667585,0.000119015014,0.00019790753,0.00006595166,0.0010165686,0.0001604461,0.000014601185,0.00005080168],"genre_scores_gemma":[0.99934995,0.000049956132,0.00016061863,0.000027260046,0.000010384286,0.000053651725,0.000015732438,0.000014050808,0.00031839748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835676,0.00022810527,0.00049825705,0.00018218353,0.0005583454,0.00017633894],"domain_scores_gemma":[0.9981734,0.0007352381,0.00029797683,0.00038826655,0.00029472177,0.000110406494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005249526,0.00011589113,0.00030360234,0.00019062661,0.00006147701,0.000015339429,0.0001439255,0.000049092545,0.000036389887],"category_scores_gemma":[0.0049389536,0.0000762888,0.00007902301,0.00025221045,0.00018270318,0.00016044755,0.00011890418,0.00009142839,0.0000063432926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001056126,0.00017592117,0.993295,0.00061843777,0.00007570946,3.5453562e-7,0.004794757,0.00003895758,0.000043020038,0.00040624067,0.00017558695,0.00027040148],"study_design_scores_gemma":[0.0005089687,0.00016170213,0.9911461,0.004625332,0.000044040113,0.000012500392,0.0014935622,0.00061427057,0.0007049675,0.00061696465,0.000003577279,0.00006801737],"about_ca_topic_score_codex":0.00076418475,"about_ca_topic_score_gemma":0.00024759234,"teacher_disagreement_score":0.004414001,"about_ca_system_score_codex":0.00003170174,"about_ca_system_score_gemma":0.00011989878,"threshold_uncertainty_score":0.59127456},"labels":[],"label_agreement":null},{"id":"W2910120474","doi":"10.1136/annrheumdis-2018-eular.2499","title":"THU0588 Reduction in the utilisation of prednisone and/or methotrexate following the initiation of etanercept in paediatric patients","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Etanercept; Psoriatic arthritis; Internal medicine; Prednisone; Pediatrics; Retrospective cohort study; Cohort; Medical prescription; Antirheumatic drugs; Methotrexate; Arthritis; Antirheumatic Agents; Pharmacology; Rheumatoid arthritis","score_opus":0.1261571671219561,"score_gpt":0.4085927484820485,"score_spread":0.2824355813600924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910120474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470925,0.0014904687,0.0000058325522,0.002897446,0.00009191395,0.00045498394,0.000012358932,0.0000028657987,0.00033486338],"genre_scores_gemma":[0.9980688,0.0016663466,0.000028456605,0.00018051678,0.000023600578,0.000016421493,0.000004044596,0.000004259507,0.0000075702014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870884,0.00042232906,0.00038899772,0.00008401402,0.00029740008,0.0000984319],"domain_scores_gemma":[0.99863744,0.00080247957,0.00026472032,0.0001796191,0.000094196235,0.000021527387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008254406,0.00007098732,0.0002111342,0.000054970766,0.000055338995,0.000005841238,0.00011110555,0.000023619752,0.000023402841],"category_scores_gemma":[0.0020863903,0.000031152533,0.000082571445,0.0003875609,0.0001457095,0.00013754061,0.000051519724,0.00006914637,5.219953e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033419193,0.0029177857,0.52575135,0.0017770365,0.00056400034,0.0000017199989,0.034816656,0.00007349872,0.0005692953,0.00050146977,0.0015913488,0.4280939],"study_design_scores_gemma":[0.00083535264,0.0002985361,0.99105954,0.00045785637,0.00030718997,0.0000012081142,0.0033111551,0.0008345271,0.0013720187,0.0013970869,0.00007883094,0.000046667155],"about_ca_topic_score_codex":0.00013165092,"about_ca_topic_score_gemma":0.000021396672,"teacher_disagreement_score":0.46530822,"about_ca_system_score_codex":0.0000070763263,"about_ca_system_score_gemma":0.000031248157,"threshold_uncertainty_score":0.24977547},"labels":[],"label_agreement":null},{"id":"W2910131159","doi":"10.1136/annrheumdis-2018-eular.2343","title":"THU0290 Effects of biologic dmards on physical function in patients with active psoriatic arthritis: results of network meta-analyses","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; Novo Nordisk; Actelion Pharmaceuticals; Dermira; Valeant Pharmaceuticals International; Merck Sharp and Dohme; DUSA Pharmaceuticals; Celgene; Galderma; Ortho Dermatologics; Bristol-Myers Squibb; Eli Lilly and Company; Pfizer; Amgen; Sun Pharma; Abbott Laboratories; Regeneron Pharmaceuticals; Sanofi Genzyme; Incyte; American Academy of Dermatology; AbbVie; Sanofi","keywords":"Medicine; Psoriatic arthritis; Adalimumab; Golimumab; Secukinumab; Ustekinumab; Infliximab; Physical therapy; Internal medicine; Ixekizumab; Etanercept; Certolizumab pegol; Population; Rheumatoid arthritis; Disease","score_opus":0.06129275247769898,"score_gpt":0.33433137713432526,"score_spread":0.27303862465662626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910131159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969813,0.0018098769,0.0000028099848,0.00009891761,0.00010740798,0.0006379068,0.00013580684,0.000008466992,0.00021750311],"genre_scores_gemma":[0.99946135,0.00029503417,0.000025800233,0.00008100144,0.000036103876,0.0000473688,0.00002713193,0.000010424162,0.000015761922],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986368,0.00017594072,0.0004156724,0.00019634156,0.00038668117,0.00018857192],"domain_scores_gemma":[0.9982903,0.0004943616,0.0005017488,0.00040051583,0.0002606444,0.000052437506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009681579,0.00018214577,0.0009926775,0.00006786649,0.0000483244,0.000002809355,0.00008735346,0.000030875155,0.000018077677],"category_scores_gemma":[0.0007480338,0.000089345274,0.00036550296,0.0003411403,0.00026101753,0.0000494189,0.000048964324,0.000049457372,0.0000035565663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076667614,0.033366274,0.32263654,0.002964344,0.087027065,0.000022543241,0.0025113919,0.000880538,0.0000889046,0.0011368943,0.008312598,0.46438527],"study_design_scores_gemma":[0.005416486,0.006941249,0.97823673,0.0018952452,0.0037123512,2.3569903e-7,0.000062372084,0.00002167965,0.0024871842,0.0011373503,0.000007556382,0.00008156672],"about_ca_topic_score_codex":0.0001216146,"about_ca_topic_score_gemma":0.00004054842,"teacher_disagreement_score":0.6556002,"about_ca_system_score_codex":0.000011097213,"about_ca_system_score_gemma":0.000034007215,"threshold_uncertainty_score":0.36433944},"labels":[],"label_agreement":null},{"id":"W2910166059","doi":"10.1136/annrheumdis-2018-214530","title":"Current challenges in the development of new treatments for lupus","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Community Based Research Centre","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Clinical trial; Drug development; Intensive care medicine; Systemic lupus erythematosus; Pace; Disease; Quality of life (healthcare); Drug approval; Immunology; Drug; Internal medicine; Pharmacology","score_opus":0.4745656181598905,"score_gpt":0.48366084152548305,"score_spread":0.009095223365592542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910166059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086183264,0.9932238,0.0000040406726,0.00031802597,0.00033876565,0.004969708,0.00008319653,0.000007658537,0.00019295665],"genre_scores_gemma":[0.00023423447,0.9983098,0.000071499,0.000009229618,0.000039380713,0.0005343843,0.00005367893,0.00004117098,0.0007066407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970415,0.0002895887,0.0012446379,0.00028783077,0.000807619,0.00032877488],"domain_scores_gemma":[0.99671113,0.0011587797,0.0007770676,0.0011101644,0.00013142219,0.00011140663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069186755,0.00034511945,0.0021398081,0.00021145881,0.000036272235,0.000010190683,0.00078644376,0.000094925446,0.000023530985],"category_scores_gemma":[0.00074583956,0.0001519806,0.0009152995,0.00025179054,0.000066288005,0.000032545497,0.00014551543,0.0001292135,0.000029183582],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030734234,0.00046600917,0.00023682766,0.18045388,0.00073339726,4.586937e-7,0.0017519934,1.594848e-7,1.4222298e-8,0.000085775035,0.003754686,0.81248605],"study_design_scores_gemma":[0.0016493887,0.00018752048,0.00050948624,0.39963734,0.0025132592,0.00020056004,0.0011840704,0.0000068910676,0.000004435766,0.00059327163,0.59325653,0.00025723263],"about_ca_topic_score_codex":0.000008559579,"about_ca_topic_score_gemma":0.000007071917,"teacher_disagreement_score":0.81222886,"about_ca_system_score_codex":0.000072969204,"about_ca_system_score_gemma":0.0019826284,"threshold_uncertainty_score":0.6197589},"labels":[],"label_agreement":null},{"id":"W2910215620","doi":"10.1136/annrheumdis-2018-eular.3343","title":"OP0349 Remaining pain and widespread pain distribution during the first 12 months after ra diagnosis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; McGill University; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Fibromyalgia; Chronic pain; Cohort; Physical therapy; Logistic regression; Internal medicine; Incidence (geometry); Arthritis; Depression (economics)","score_opus":0.02411036421212753,"score_gpt":0.2882324695813517,"score_spread":0.26412210536922415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910215620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839667,0.003652608,0.000077235876,0.011523589,0.00005838096,0.0005502612,0.000081537335,0.000031437885,0.00005822612],"genre_scores_gemma":[0.99879485,0.00058217644,0.000019537873,0.00017015962,0.000033662196,0.00017516759,0.000019752237,0.000020149457,0.00018456207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982057,0.00039326976,0.00033439728,0.00022719397,0.00046456076,0.00037484872],"domain_scores_gemma":[0.9977939,0.0011745483,0.00013143843,0.00063692936,0.00012403852,0.00013914917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013993907,0.00016820633,0.00029404528,0.000040949806,0.0003096995,0.000046572513,0.00022640548,0.000053499363,0.00026785146],"category_scores_gemma":[0.003154197,0.00009350631,0.00017965118,0.0001711194,0.00056407816,0.00010122837,0.00018535531,0.00011797325,0.000012744036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011203896,0.00072576216,0.8680103,0.017470306,0.00087943976,0.000039170383,0.0031232107,0.000016609325,0.00007106158,0.0002625362,0.055726707,0.05255454],"study_design_scores_gemma":[0.0007491367,0.0005227713,0.98339117,0.009714356,0.00013271524,0.000017998082,0.0006601098,0.0019527288,0.0009999974,0.00068112096,0.0010098848,0.00016804445],"about_ca_topic_score_codex":0.00012384026,"about_ca_topic_score_gemma":0.000015782658,"teacher_disagreement_score":0.115380876,"about_ca_system_score_codex":0.00003856559,"about_ca_system_score_gemma":0.00008812062,"threshold_uncertainty_score":0.38130763},"labels":[],"label_agreement":null},{"id":"W2910239587","doi":"10.1136/annrheumdis-2018-eular.1461","title":"AB0691 Instertitial lung disease and mycroscopic polyangiitis in chilean patients","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; University of California, San Francisco; National Institutes of Health; Canadian Institutes of Health Research; InflaRx; European League Against Rheumatism; Medpace; Alexion Pharmaceuticals; Genentech; National Center for Advancing Translational Sciences; Vasculitis Foundation; Bristol-Myers Squibb; AstraZeneca; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; Medical Research Council; Celgene; Sanofi","keywords":"Medicine; Microscopic polyangiitis; Interstitial lung disease; Internal medicine; Gastroenterology; Usual interstitial pneumonia; Lung; Granulomatosis with polyangiitis; Vasculitis; Retrospective cohort study; Pathology; Disease","score_opus":0.013002555587717981,"score_gpt":0.2844440376113386,"score_spread":0.2714414820236206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910239587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529344,0.0017416273,0.000005962964,0.0012092926,0.00029544643,0.0004800653,0.00030186324,0.000022246815,0.0006500353],"genre_scores_gemma":[0.99831295,0.0002595454,0.00001112129,0.0010709686,0.00012009888,0.000021403173,0.000038216793,0.000020211008,0.0001454753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987424,0.00007407902,0.00037138964,0.0002284041,0.00031150226,0.00027224785],"domain_scores_gemma":[0.99900514,0.00004339934,0.00012991842,0.00038530212,0.00012469373,0.00031154347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006958146,0.00016995522,0.0003092748,0.00010115044,0.00010335511,0.000024511897,0.00015341582,0.000037535185,0.00015546863],"category_scores_gemma":[0.00030402743,0.00012029364,0.00018612934,0.00016577174,0.0003659536,0.00014847502,0.00014946253,0.000069597656,0.000011536656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058740433,0.002295587,0.94883275,0.0028355173,0.00026745055,0.000039790917,0.0006739324,0.0000031525415,0.00006084233,0.0012244097,0.0102663,0.027626233],"study_design_scores_gemma":[0.0010118993,0.00059822167,0.99303615,0.0032951753,0.00019594707,0.0000029330306,0.000044676995,0.00068485085,0.00009265074,0.0007835905,0.00011811448,0.00013580972],"about_ca_topic_score_codex":0.0001600131,"about_ca_topic_score_gemma":0.00000975335,"teacher_disagreement_score":0.04420339,"about_ca_system_score_codex":0.00002003131,"about_ca_system_score_gemma":0.00011279803,"threshold_uncertainty_score":0.49054322},"labels":[],"label_agreement":null},{"id":"W2910242780","doi":"10.1136/annrheumdis-2018-eular.5566","title":"THU0275 The relationship between maastricht ankylosing spondylitis enthesitis score and the spondyloarthritis research consortium of canada enthesitis index in ankylosing spondylitis: friends or enemies?","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enthesitis; Medicine; Ankylosing spondylitis; Enthesis; Spondylitis; Erythrocyte sedimentation rate; Internal medicine; Surgery; Tendon; Arthritis; Psoriatic arthritis","score_opus":0.11815414355527028,"score_gpt":0.36005926752199385,"score_spread":0.2419051239667236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910242780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97545016,0.013151214,0.0000064289393,0.006141326,0.00017208376,0.001257175,0.002594243,0.00001918805,0.0012081558],"genre_scores_gemma":[0.99735785,0.0015965635,0.000039922346,0.00027982634,0.00014167426,0.000113862734,0.00006999428,0.000043490985,0.0003568281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99503016,0.0011991842,0.0011147857,0.00045954145,0.001366652,0.00082968647],"domain_scores_gemma":[0.99000674,0.007692435,0.0004957273,0.0010350944,0.0005305209,0.00023946167],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0017824058,0.0003609898,0.00097496033,0.00028775624,0.0009427636,0.000081362465,0.0004870126,0.00011269489,0.00049133337],"category_scores_gemma":[0.0049822265,0.00019863748,0.00024545327,0.0013356908,0.0029415218,0.0001955232,0.0003832413,0.00039075976,0.0000027534172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024578306,0.00021472204,0.97141683,0.0004263253,0.0004388753,0.00012083326,0.002199495,0.0000033042425,0.0000034580944,0.0033060587,0.0021337317,0.017278511],"study_design_scores_gemma":[0.003795062,0.0003586101,0.9807451,0.004895108,0.00030799213,0.00013633838,0.0040040673,0.00008695216,0.0003315754,0.003918521,0.0012213043,0.00019939833],"about_ca_topic_score_codex":0.060231525,"about_ca_topic_score_gemma":0.038046014,"teacher_disagreement_score":0.022185512,"about_ca_system_score_codex":0.0001249158,"about_ca_system_score_gemma":0.00095040654,"threshold_uncertainty_score":0.9997719},"labels":[],"label_agreement":null},{"id":"W2910264956","doi":"10.1136/annrheumdis-2018-eular.1505","title":"FRI0139 Comparative safety of abatacept in rheumatoid arthritis with copd: a real-world population-based observational study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Abatacept; Internal medicine; Etanercept; Tocilizumab; Infliximab; Adalimumab; Golimumab; COPD; Rheumatoid arthritis; Population; Propensity score matching; Physical therapy; Rituximab; Disease","score_opus":0.07583341983889443,"score_gpt":0.3487248038542037,"score_spread":0.27289138401530927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910264956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963907,0.000548623,0.00005089407,0.00091701583,0.00007738347,0.0010379502,0.00034242365,0.000022745277,0.0006122765],"genre_scores_gemma":[0.9991395,0.00015011714,0.0001976541,0.00021998117,0.000027847029,0.0000379784,0.00013450194,0.000016732583,0.00007571351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981594,0.00016016084,0.00068251864,0.00022820216,0.00056509173,0.00020460348],"domain_scores_gemma":[0.9983618,0.00023145556,0.000406291,0.0004749033,0.000402431,0.0001230871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019577397,0.00018934933,0.00064470025,0.00013053733,0.00011415464,0.00001212178,0.00019038035,0.000028895984,0.00045052572],"category_scores_gemma":[0.00013006457,0.00013217963,0.00018930149,0.0004398271,0.00028066488,0.00013341746,0.00005166136,0.00008068075,0.000009843212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008273314,0.002918078,0.9816742,0.00038639898,0.00028247735,0.000008756467,0.0013729987,0.00045968272,0.000017152235,0.0010064532,0.002117116,0.0014833749],"study_design_scores_gemma":[0.0019457223,0.0018487112,0.9864796,0.004899447,0.00007531387,0.0000025031918,0.0009905815,0.0029500152,0.00007179271,0.0005594876,0.000037446105,0.00013938989],"about_ca_topic_score_codex":0.0038924247,"about_ca_topic_score_gemma":0.0016783585,"teacher_disagreement_score":0.0063275914,"about_ca_system_score_codex":0.000032496017,"about_ca_system_score_gemma":0.00031266134,"threshold_uncertainty_score":0.58842075},"labels":[],"label_agreement":null},{"id":"W2910270132","doi":"10.1136/annrheumdis-2018-eular.6758","title":"AB0903 Efficacy of tildrakizumab in etanercept partial or nonresponders","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"Merck Sharp and Dohme; EMD Serono; Kyowa Hakko Kirin; Dermira; Meiji Seika Pharma; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; Genentech; Valeant Pharmaceuticals International; Sanofi; Amgen; Eli Lilly and Company; GlaxoSmithKline; Sun Pharma; Regeneron Pharmaceuticals; American Academy of Dermatology","keywords":"Medicine; Etanercept; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Placebo; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.05526279902356336,"score_gpt":0.317720676704457,"score_spread":0.2624578776808936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910270132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970579,0.0016590419,0.0000047644407,0.00026939943,0.0003539806,0.00022855695,0.00009723592,0.00001601746,0.00031308024],"genre_scores_gemma":[0.9987769,0.00016448204,0.000016586639,0.00008428927,0.000016042835,0.000013840964,0.000018897734,0.000010512102,0.00089844124],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881655,0.00032776358,0.00039316897,0.00016219226,0.00005975448,0.00024055084],"domain_scores_gemma":[0.9988077,0.00045885678,0.00021911733,0.0004277657,0.0000629389,0.000023583234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016915485,0.00014385373,0.00035286884,0.000090975605,0.000069024674,0.000004484092,0.00033103183,0.00008686265,0.0013154829],"category_scores_gemma":[0.00048271366,0.00008491705,0.00020235103,0.00021852441,0.00041635789,0.00005490562,0.00007737112,0.00004464908,0.00014614534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024692433,0.006800457,0.046515517,0.00057253,0.0037856987,0.000018698423,0.0093147205,0.00008346352,0.017701842,0.00239628,0.032307744,0.85581064],"study_design_scores_gemma":[0.0052468926,0.0008227171,0.8146074,0.00082254637,0.00043524773,0.000014409816,0.0006931188,0.0000180337,0.1742439,0.0007369389,0.002050903,0.00030793488],"about_ca_topic_score_codex":0.00012490041,"about_ca_topic_score_gemma":0.000056335015,"teacher_disagreement_score":0.85550267,"about_ca_system_score_codex":0.00000737561,"about_ca_system_score_gemma":0.000106020394,"threshold_uncertainty_score":0.99959743},"labels":[],"label_agreement":null},{"id":"W2910347821","doi":"10.1136/annrheumdis-2018-eular.3210","title":"AB0921 Impact of baseline demographics, disease activity and concomitant medication on american college of rheumatology 20 response rate and health assessment questionnaire-disability index score with tofacitinib in active psoriatic arthritis: a pooled subgroup analysis of 2 phase 3 studies","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Adalimumab; Internal medicine; Concomitant; Rheumatology; Janus kinase inhibitor; Rheumatoid arthritis; Placebo; Psoriasis; Gastroenterology; Surgery; Dermatology","score_opus":0.038096072972838645,"score_gpt":0.4079524138006296,"score_spread":0.36985634082779095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910347821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841083,0.0047470923,0.00007636237,0.003764327,0.000019107398,0.00093029276,0.0020408228,0.000010217918,9.611794e-7],"genre_scores_gemma":[0.9808926,0.018911906,0.000045009427,0.00004623511,0.0000031134516,0.00005831051,0.000029625631,0.00001261884,6.070174e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960152,0.001971223,0.0008975085,0.00032004577,0.0005283014,0.00026775742],"domain_scores_gemma":[0.99565554,0.0017692716,0.0011562564,0.0005323404,0.00055660674,0.00032999035],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0022216882,0.00023208123,0.0016098823,0.0004703014,0.00008724626,0.0000051330794,0.00011843302,0.000033423683,0.000021113863],"category_scores_gemma":[0.0034905486,0.0001505846,0.0002323382,0.0011219347,0.0038014408,0.00013298726,0.000057807527,0.00012582248,5.7918214e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039519038,0.003260806,0.9094077,0.001032057,0.00478581,0.0000043081554,0.0011332007,0.000049037546,0.00011645536,0.00024648392,0.000045533616,0.040399615],"study_design_scores_gemma":[0.005123567,0.0043983706,0.9769575,0.005103659,0.00022941816,0.0000043759537,0.0017176727,0.0050816154,0.0002604523,0.0010143244,3.364443e-7,0.00010871705],"about_ca_topic_score_codex":0.0013939609,"about_ca_topic_score_gemma":0.0017180637,"teacher_disagreement_score":0.06754984,"about_ca_system_score_codex":0.000060799463,"about_ca_system_score_gemma":0.00093674805,"threshold_uncertainty_score":0.99890965},"labels":[],"label_agreement":null},{"id":"W2910355860","doi":"10.1136/annrheumdis-2019-eular.1364","title":"AB0768 BASELINE PAIN SEVERITY AS A PREDICTOR OF PAIN IMPROVEMENT FOLLOWING TREATMENT WITH TOFACITINIB IN PSORIATIC ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Gilead Sciences; Sanofi; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Janus kinase inhibitor; Placebo; Internal medicine; Arthritis; Visual analogue scale; Ankylosing spondylitis; Surgery; Rheumatoid arthritis","score_opus":0.014932540611533844,"score_gpt":0.2757741779865268,"score_spread":0.260841637374993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910355860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149144,0.0052579367,0.00005336382,0.0013010222,0.00007552451,0.0014812655,0.00016110991,0.000022420245,0.00015589327],"genre_scores_gemma":[0.99314886,0.006084799,0.00007716764,0.00031474713,0.000015257365,0.00014310009,0.0000406446,0.000025752506,0.00014965836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974169,0.00062613306,0.000631585,0.00025178777,0.0006940316,0.00037954614],"domain_scores_gemma":[0.9979698,0.0008819773,0.00023693682,0.0005959242,0.00011495908,0.00020040163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015584654,0.00022916267,0.0007356804,0.00012556845,0.000045258323,0.000017370832,0.00017433705,0.00004152508,0.0005386615],"category_scores_gemma":[0.001524345,0.00014108475,0.00034401318,0.00025374943,0.000117737734,0.00012561989,0.000041557192,0.00008221363,0.000012304221],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015336336,0.0028211002,0.26753098,0.0013267358,0.0012904136,0.000036087535,0.0020352185,0.000067077664,0.00038800668,0.00016922268,0.0006321969,0.72216934],"study_design_scores_gemma":[0.09967692,0.06729214,0.56739986,0.12610489,0.00049256126,0.00010434286,0.02803152,0.041928653,0.03723824,0.022037225,0.006862886,0.0028307422],"about_ca_topic_score_codex":0.00054714846,"about_ca_topic_score_gemma":0.00010240426,"teacher_disagreement_score":0.7193386,"about_ca_system_score_codex":0.00003578377,"about_ca_system_score_gemma":0.00033698932,"threshold_uncertainty_score":0.5897966},"labels":[],"label_agreement":null},{"id":"W2910397536","doi":"10.1136/annrheumdis-2018-eular.4474","title":"SAT0270 Low incidence of both new-onset and flares of uveitis in secukinumab-treated patients with ankylosing spondylitis: clinical trial and post-marketing safety analysis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Secukinumab; Ankylosing spondylitis; Uveitis; Incidence (geometry); Clinical trial; Internal medicine; Pediatrics; Ophthalmology; Disease; Psoriatic arthritis","score_opus":0.020973514845916398,"score_gpt":0.31879471847936036,"score_spread":0.29782120363344394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910397536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967972,0.0013049659,0.000006231265,0.00017944475,0.00003308486,0.0005869322,0.001065855,0.000008968814,0.000017329065],"genre_scores_gemma":[0.99925375,0.00035903772,0.00013265744,0.00009744687,0.000018365234,0.0000036988063,0.00010386028,0.0000142235585,0.000016946968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767077,0.00039276213,0.0009747954,0.00028770027,0.00046194386,0.00021204271],"domain_scores_gemma":[0.9977054,0.0006737663,0.0006152235,0.00045227725,0.00032470786,0.00022862187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006300028,0.00018244288,0.0009144052,0.0002169314,0.00005583057,0.000015927853,0.00013753783,0.00006494235,0.00018551506],"category_scores_gemma":[0.0025596383,0.00011862602,0.00027410706,0.0005713781,0.000559312,0.000108194545,0.0001291859,0.00007422575,3.1691476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027134174,0.0007105205,0.95657253,0.0005250693,0.000846814,0.0000050834637,0.00020627613,0.000004572481,0.000008127271,0.0000037043337,0.00007551269,0.013907621],"study_design_scores_gemma":[0.010942666,0.0013659084,0.9820735,0.003309569,0.0015534562,0.000004363527,0.00019289255,0.00029096144,0.00006383362,0.00007977502,0.0000052172945,0.0001178682],"about_ca_topic_score_codex":0.0010092783,"about_ca_topic_score_gemma":0.00015743465,"teacher_disagreement_score":0.025500964,"about_ca_system_score_codex":0.000010347717,"about_ca_system_score_gemma":0.0001903885,"threshold_uncertainty_score":0.4837429},"labels":[],"label_agreement":null},{"id":"W2910528685","doi":"10.1136/annrheumdis-2018-eular.3654","title":"SAT0072 Mirna-146a is a key player in bone metabolism and osteoporosis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; West China Hospital, Sichuan University; Ontario Ministry of Health and Long-Term Care; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Osteoclast; Bone remodeling; Osteoporosis; Osteoblast; Medicine; Internal medicine; Endocrinology; microRNA; Ex vivo; In vivo; Biology; In vitro; Receptor","score_opus":0.018607739151795845,"score_gpt":0.2777449335963412,"score_spread":0.25913719444454536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910528685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001133,0.008536244,0.000011943077,0.0008980349,0.00007086228,0.00019329706,0.000101207464,0.000005382119,0.00017170972],"genre_scores_gemma":[0.99835116,0.0006229084,0.00010594326,0.0006444929,0.000054159238,0.000015542602,0.000018699231,0.000015041206,0.00017207311],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99911004,0.0000755001,0.00026970948,0.00021371801,0.00015318893,0.00017781749],"domain_scores_gemma":[0.9992097,0.000018379718,0.00015514749,0.00043101917,0.00009828052,0.00008748911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001221396,0.00013099494,0.00018939945,0.000047706046,0.00005553191,0.000019582994,0.00017561868,0.00006213385,0.00008221406],"category_scores_gemma":[0.00021026112,0.00009844188,0.0001218418,0.00010880573,0.00021348853,0.000008491682,0.00016227728,0.000027060209,0.000008507195],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018337809,0.0022318645,0.08110812,0.0017416966,0.0015230252,0.0000070710803,0.0051929206,0.00008358533,0.58698845,0.001685729,0.20010775,0.11749603],"study_design_scores_gemma":[0.0009434172,0.00011076918,0.68459547,0.00035060104,0.00012351583,0.000006804087,0.00018483493,0.00015150169,0.30311716,0.0030871502,0.00702774,0.00030101938],"about_ca_topic_score_codex":0.00006879409,"about_ca_topic_score_gemma":0.00002991647,"teacher_disagreement_score":0.6034874,"about_ca_system_score_codex":0.000003075685,"about_ca_system_score_gemma":0.000052837444,"threshold_uncertainty_score":0.40143433},"labels":[],"label_agreement":null},{"id":"W2910563880","doi":"10.1136/annrheumdis-2018-eular.1943","title":"FRI0537 Neurophysiological data in patients with chronic pain in knee osteoarthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Medicine; Hyperalgesia; Neuropathic pain; Osteoarthritis; Chronic pain; Nociception; Fibromyalgia; Anesthesia; Neurological examination; Physical examination; Referred pain; Neurophysiology; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Surgery; Pathology","score_opus":0.02839013507320305,"score_gpt":0.2736781735594044,"score_spread":0.24528803848620134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910563880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791163,0.0007183213,0.0000020138464,0.0003144862,0.00007876847,0.00069962314,0.000108842774,0.000017956314,0.00014837636],"genre_scores_gemma":[0.99930274,0.00005222292,0.000062276464,0.0003243953,0.000034326742,0.000028516912,0.00013005147,0.000015752366,0.000049729206],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987328,0.00016852812,0.00029395503,0.0002662099,0.0002765678,0.00026194283],"domain_scores_gemma":[0.9988066,0.000102506034,0.00010524049,0.00083129114,0.00006652103,0.0000878189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015959478,0.00014808266,0.00034142716,0.00007285599,0.000037083475,0.000010055408,0.00025749777,0.00003877897,0.00013327641],"category_scores_gemma":[0.0004158703,0.000087747685,0.000056804627,0.00023408525,0.00017946225,0.00012429658,0.0001826698,0.00007553713,0.000023175257],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012817619,0.0018667089,0.30979046,0.00023143941,0.000047486505,0.000030016525,0.00011668185,0.000003971114,0.00008307346,0.00014092757,0.00055365096,0.68585384],"study_design_scores_gemma":[0.0061084977,0.013809578,0.97614086,0.0025479686,0.000050219376,0.0000016116167,0.0000373295,0.000105249164,0.00022446178,0.00068368297,0.0001555868,0.00013494935],"about_ca_topic_score_codex":0.000041499214,"about_ca_topic_score_gemma":0.00014350929,"teacher_disagreement_score":0.6857189,"about_ca_system_score_codex":0.000016161664,"about_ca_system_score_gemma":0.00009356388,"threshold_uncertainty_score":0.35782468},"labels":[],"label_agreement":null},{"id":"W2910604099","doi":"10.1136/annrheumdis-2018-eular.3956","title":"SAT0077 Change in frequency of arthroplasty surgery in rheumatoid arthritis: a 13 year population health study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Arthroplasty; Cohort; Retrospective cohort study; Population; Internal medicine; Surgery; Physical therapy","score_opus":0.06070366114599811,"score_gpt":0.3479799511861022,"score_spread":0.2872762900401041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910604099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814154,0.015714582,0.0000017532933,0.0013657755,0.00015419035,0.0012291977,0.000049549166,0.000022252607,0.00004729964],"genre_scores_gemma":[0.9678707,0.03172831,0.000044411125,0.00017682511,0.000031667892,0.00009924939,0.000019837997,0.000023431721,0.000005564953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726284,0.00043746643,0.0010138253,0.00024076753,0.0006192846,0.00042584367],"domain_scores_gemma":[0.9985005,0.0002552867,0.00037981456,0.0005338954,0.00016132231,0.00016913563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000902847,0.00017777905,0.00083479774,0.00042162175,0.00006892176,0.000015202115,0.00015123161,0.000042852735,0.00020700505],"category_scores_gemma":[0.00095384277,0.00013511929,0.00018576349,0.0006367659,0.0002581065,0.00022883732,0.0000732653,0.00012383096,0.000016413831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018900933,0.0015087398,0.93437374,0.00023716997,0.000067911016,0.000006097914,0.002361413,9.1141493e-7,0.00000457144,0.00030054414,0.00059028604,0.06035963],"study_design_scores_gemma":[0.0015065916,0.0005013673,0.98755294,0.0064228433,0.0000016401477,0.000007252346,0.0011765135,0.00004083346,0.00004038844,0.0026243369,0.000020654532,0.00010466093],"about_ca_topic_score_codex":0.010949759,"about_ca_topic_score_gemma":0.008997175,"teacher_disagreement_score":0.06025497,"about_ca_system_score_codex":0.00003075576,"about_ca_system_score_gemma":0.00025849877,"threshold_uncertainty_score":0.9956364},"labels":[],"label_agreement":null},{"id":"W2910686623","doi":"10.1136/annrheumdis-2018-eular.1740","title":"THU0150 Impact of comorbidity burden and obesity on the effectiveness of tocilizumab in patients with rheumatoid arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Horizon Pharma; Celgene; Momenta Pharmaceuticals; Gilead Sciences; Genentech; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Comorbidity; Tocilizumab; Rheumatoid arthritis; Internal medicine; Minimal clinically important difference; Obesity; Physical therapy; Randomized controlled trial","score_opus":0.018521604409432582,"score_gpt":0.29266418755146784,"score_spread":0.27414258314203527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910686623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640363,0.002013101,0.0000025312645,0.00022715268,0.000029424109,0.000926522,0.00014559709,0.0000077852965,0.0002442275],"genre_scores_gemma":[0.9958018,0.0041202935,0.0000067543606,0.000013242802,0.000008169054,0.000023076085,0.000008142613,0.000014098549,0.000004400422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981521,0.00052437704,0.0003619712,0.00016421186,0.00056314777,0.0002342186],"domain_scores_gemma":[0.99785817,0.00090984907,0.0002351729,0.00054673123,0.00034088985,0.00010916353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061748707,0.00016705788,0.0005828696,0.000093962764,0.00008024974,0.000012037615,0.00021562446,0.00003543215,0.00010050078],"category_scores_gemma":[0.0010654924,0.000081469734,0.00017704227,0.00024563234,0.0009460588,0.00009501723,0.00009800516,0.000101151934,0.0000028388872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005854988,0.001049555,0.9656363,0.00052260724,0.00048647667,0.0000014711371,0.00081315427,0.000019576857,0.000054448366,0.0011901548,0.0003513993,0.024019856],"study_design_scores_gemma":[0.0031508645,0.0024006148,0.98281264,0.007252361,0.000005892528,0.000002798937,0.00013957809,0.000051770938,0.0019214575,0.0021756396,0.000006837493,0.00007955005],"about_ca_topic_score_codex":0.00091442233,"about_ca_topic_score_gemma":0.00006163586,"teacher_disagreement_score":0.023940306,"about_ca_system_score_codex":0.000018462462,"about_ca_system_score_gemma":0.00015862386,"threshold_uncertainty_score":0.3485793},"labels":[],"label_agreement":null},{"id":"W2910723474","doi":"10.1136/annrheumdis-2018-eular.7258","title":"SAT0306 Finger flexor tendon pulley complex involvement in psa dactylitis: an ultrasonography study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Dactylitis; Pulley; Medicine; Tendon; Numerical digit; Surgery; Psoriatic arthritis; Enthesitis; Arthritis; Internal medicine; Physics","score_opus":0.08875274804215007,"score_gpt":0.36538250825301166,"score_spread":0.2766297602108616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910723474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938697,0.002796936,0.00000575286,0.0012784443,0.00011026554,0.0012352428,0.00008142928,0.0000497565,0.00057247275],"genre_scores_gemma":[0.9963089,0.002707138,0.00009436967,0.0005920879,0.000062573854,0.00011350662,0.00003708359,0.000027719523,0.000056595403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975703,0.00033381552,0.0005847073,0.00031162976,0.0007136437,0.0004859178],"domain_scores_gemma":[0.9982491,0.000164233,0.00017029009,0.00085901964,0.00025362533,0.00030372592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047138112,0.00022452373,0.00052203576,0.00025628041,0.00017473492,0.00006354174,0.00042246646,0.00003438898,0.00067967514],"category_scores_gemma":[0.0004293674,0.00015074218,0.00021912098,0.00045808306,0.00049398805,0.0002219193,0.00011385614,0.0001268077,0.00003273453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011437747,0.01277022,0.8417458,0.0004682877,0.00093302235,0.000025864778,0.007927459,0.0000062426284,0.0006663693,0.0006779649,0.015465804,0.11816921],"study_design_scores_gemma":[0.0027082022,0.0023199164,0.9838921,0.0013577717,0.000023461744,0.0000077699115,0.0049379705,0.00014861985,0.0008311506,0.0021691674,0.0014166189,0.00018729494],"about_ca_topic_score_codex":0.00089136604,"about_ca_topic_score_gemma":0.0005876458,"teacher_disagreement_score":0.14214627,"about_ca_system_score_codex":0.000015993644,"about_ca_system_score_gemma":0.0001261054,"threshold_uncertainty_score":0.7441966},"labels":[],"label_agreement":null},{"id":"W2910773388","doi":"10.1136/annrheumdis-2018-eular.2325","title":"SAT0321 Ixekizumab treatment significantly improves enthesitis and dactylitis in patients with active psoriatic arthritis: results from the spirit trials","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dactylitis; Medicine; Psoriatic arthritis; Enthesitis; Internal medicine; Psoriasis; Physical therapy; Visual analogue scale; Ixekizumab; Arthritis; Dermatology","score_opus":0.04275974475903819,"score_gpt":0.3098327364342033,"score_spread":0.2670729916751651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910773388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992153,0.002298334,0.0000019959068,0.0028188042,0.000059025035,0.0015612037,0.0007991281,0.000016445461,0.00029205176],"genre_scores_gemma":[0.9976365,0.0017874632,0.000023202267,0.00021387638,0.000050911178,0.00008707937,0.00008067124,0.000021604663,0.00009868024],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99755776,0.00050268276,0.000824097,0.00029842398,0.0005086286,0.00030839327],"domain_scores_gemma":[0.9972511,0.0012616413,0.00047544792,0.0006919946,0.00020413638,0.000115688825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046397262,0.0002257623,0.00080790336,0.00007112301,0.000159802,0.000049403756,0.00020913998,0.000054051157,0.00013270353],"category_scores_gemma":[0.0028731467,0.00010902366,0.00017306102,0.000194327,0.0004966228,0.0001704057,0.00007802451,0.000092730304,0.000013642489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006416471,0.0009496172,0.012513846,0.00007484853,0.0007310724,0.0000055187566,0.0034303167,0.0000011175025,0.000021507938,0.000045802393,0.0017887728,0.97402114],"study_design_scores_gemma":[0.009191817,0.0017019887,0.98237896,0.0017823575,0.00019803569,9.07187e-7,0.0015706666,0.0000466645,0.0016938472,0.00086017774,0.0004376707,0.000136893],"about_ca_topic_score_codex":0.0013363604,"about_ca_topic_score_gemma":0.00019611116,"teacher_disagreement_score":0.9738842,"about_ca_system_score_codex":0.000035131794,"about_ca_system_score_gemma":0.0002760825,"threshold_uncertainty_score":0.4445856},"labels":[],"label_agreement":null},{"id":"W2910793117","doi":"10.1136/annrheumdis-2018-eular.6474","title":"AB0692 Belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: effect on biomarkers","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; University of California, San Francisco; National Institutes of Health; Canadian Institutes of Health Research; InflaRx; European League Against Rheumatism; Medpace; Alexion Pharmaceuticals; Genentech; National Center for Advancing Translational Sciences; Vasculitis Foundation; Bristol-Myers Squibb; AstraZeneca; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; Medical Research Council; Celgene; Sanofi","keywords":"Medicine; Granulomatosis with polyangiitis; Microscopic polyangiitis; Rituximab; Azathioprine; Internal medicine; Gastroenterology; B-cell activating factor; Immunology; Vasculitis; Antibody; B cell","score_opus":0.00945603689777595,"score_gpt":0.2712616510775186,"score_spread":0.26180561417974263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910793117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394417,0.0009795119,0.000051484487,0.0037561185,0.000040669303,0.0009857295,0.000055050732,0.000019720612,0.00016751795],"genre_scores_gemma":[0.999037,0.0003435509,0.00014263054,0.00023494723,0.000008221587,0.00009135484,0.000028196771,0.000021160373,0.00009288357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990316,0.00007236824,0.0002584967,0.00021000198,0.00019704115,0.00023046313],"domain_scores_gemma":[0.9992458,0.00016875812,0.00013321149,0.00026969195,0.00009074562,0.000091744594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017140042,0.00015423473,0.0003341057,0.00018232969,0.0000901058,0.000014942276,0.00008277751,0.000055943063,0.000016383861],"category_scores_gemma":[0.00017892364,0.000084893734,0.000078821104,0.00032944055,0.00024281084,0.00006894667,0.00002364397,0.00007100684,0.0000017787717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016295873,0.0051605087,0.72191006,0.008246181,0.0023012636,0.00013082456,0.0031389894,0.00005155521,0.006043714,0.0060228687,0.008491221,0.22220694],"study_design_scores_gemma":[0.010532541,0.0040530693,0.9527461,0.021335725,0.00020384017,0.0000632522,0.0001868096,0.00040006972,0.009079974,0.0011724074,0.000043205764,0.00018301024],"about_ca_topic_score_codex":0.00019675441,"about_ca_topic_score_gemma":0.000074835785,"teacher_disagreement_score":0.23083603,"about_ca_system_score_codex":0.000025528036,"about_ca_system_score_gemma":0.000058217127,"threshold_uncertainty_score":0.3461866},"labels":[],"label_agreement":null},{"id":"W2910807962","doi":"10.1136/annrheumdis-2018-eular.5168","title":"THU0303 The early psoriatic arthritis screening questionnaireidentifies patients with psoriatic arthritis amongst treated patients with psoriasis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Enthesitis; Cohort; Arthritis; Quality of life (healthcare); Dermatology; Dermatology Life Quality Index; Physical therapy; Outpatient clinic","score_opus":0.013355457189942833,"score_gpt":0.24132210413929375,"score_spread":0.22796664694935093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910807962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936878,0.0028567032,0.000029204568,0.00072069117,0.00037424004,0.0017362152,0.00029979975,0.00009296232,0.00020238425],"genre_scores_gemma":[0.99791825,0.0010161577,0.00014601227,0.00025711258,0.00011841134,0.0002055761,0.000110347755,0.00006953796,0.00015859547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687,0.00020224316,0.0007090569,0.00046306878,0.0011814015,0.00057423796],"domain_scores_gemma":[0.99682367,0.00023770421,0.0006308283,0.000978293,0.0010981719,0.00023132404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015143251,0.0004763152,0.00080322206,0.00012515808,0.0007775446,0.000118653246,0.0003200381,0.000071492585,0.00016264369],"category_scores_gemma":[0.0006178178,0.00024456676,0.00027480858,0.00061724905,0.0008644949,0.00034632944,0.00013554927,0.00014042894,0.000046833342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011893766,0.0013341886,0.80922234,0.00012589399,0.0016386674,0.000009170163,0.0008577506,0.0000045386982,2.4124532e-7,0.000110800225,0.0021045604,0.18340248],"study_design_scores_gemma":[0.009187055,0.002265672,0.9801715,0.0064429203,0.00074779696,0.000004693932,0.00027828867,0.000019483574,0.000100034325,0.00040116813,0.00009451742,0.00028686874],"about_ca_topic_score_codex":0.0008845001,"about_ca_topic_score_gemma":0.0005028731,"teacher_disagreement_score":0.18311562,"about_ca_system_score_codex":0.00003535605,"about_ca_system_score_gemma":0.00008623749,"threshold_uncertainty_score":0.9973143},"labels":[],"label_agreement":null},{"id":"W2910824208","doi":"10.1136/annrheumdis-2018-eular.6191","title":"SAT0671 Initial development of a whole-body magnetic resonance imaging inflammation index for active disease of peripheral joints and entheses in patients with inflammatory arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of Alberta","funders":"Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; Rigshospitalet","keywords":"Medicine; Enthesis; Synovitis; Magnetic resonance imaging; Wrist; Rheumatoid arthritis; Radiology; Enthesitis; Arthritis; Nuclear medicine; Surgery; Tendon; Internal medicine; Psoriatic arthritis","score_opus":0.013831877083069946,"score_gpt":0.2745831935903512,"score_spread":0.2607513165072813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910824208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421024,0.004334386,0.000026127547,0.00026708344,0.000030729425,0.00095988705,0.00013783258,0.00000826967,0.000025445002],"genre_scores_gemma":[0.9990776,0.0005024697,0.00022997193,0.000028128621,0.000017659615,0.000095376905,0.000021477703,0.00001818784,0.000009086772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847597,0.00008867504,0.00055542425,0.00017267127,0.00047406094,0.00023318049],"domain_scores_gemma":[0.99865913,0.0001342331,0.00028445086,0.00031025597,0.00047016065,0.00014177412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016315572,0.00015117688,0.00038043593,0.00015613048,0.00007834035,0.0000145516615,0.00014682625,0.00002218412,0.00004212306],"category_scores_gemma":[0.0008741523,0.00010827316,0.000073450734,0.0001388822,0.00062986073,0.00023051751,0.000102195234,0.000053622265,6.972717e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049586515,0.00041160636,0.5608769,0.00068173296,0.000070651164,0.000001638284,0.002608024,0.0000021079784,0.00014466501,0.00009152026,0.00007190705,0.43008062],"study_design_scores_gemma":[0.0040373052,0.00039408822,0.9829101,0.0059957104,0.000010318278,8.6193506e-7,0.00041518014,0.00021383094,0.004919901,0.00084354513,0.00015101628,0.00010813904],"about_ca_topic_score_codex":0.000019414767,"about_ca_topic_score_gemma":0.00004422516,"teacher_disagreement_score":0.42997247,"about_ca_system_score_codex":0.00001709716,"about_ca_system_score_gemma":0.00034363623,"threshold_uncertainty_score":0.44152513},"labels":[],"label_agreement":null},{"id":"W2910843803","doi":"10.1136/annrheumdis-2018-eular.5296","title":"FRI0456 Predictors for disease worsening defined by organ failure in diffuse systemic sclerosis: a european scleroderma trials and research (EUSTAR) analysis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"Medac; Actelion Pharmaceuticals; IC Design Education Center; Sanofi; Genentech; Bayer; Pfizer; Biogen; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; Clinical trial; Internal medicine; Scleroderma (fungus); Population; Cardiology; Surrogate endpoint; Intensive care medicine; Heart failure; Pathology","score_opus":0.14028194128255816,"score_gpt":0.36099463646425045,"score_spread":0.2207126951816923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910843803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745433,0.020293022,0.000072065915,0.0021559221,0.00013035814,0.0018755917,0.0008034988,0.00007097185,0.00005530588],"genre_scores_gemma":[0.99638224,0.0027068094,0.000042567364,0.00021794383,0.00013705593,0.0001690708,0.000103145954,0.000065752094,0.00017539835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99445117,0.0019398902,0.0014870231,0.000600966,0.0009042157,0.00061673],"domain_scores_gemma":[0.9953839,0.0016867552,0.00059801596,0.0010043726,0.0006168485,0.00071007235],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0033806595,0.00033819722,0.0013517446,0.00066321105,0.00033887397,0.00011913056,0.00043802528,0.00010402833,0.00006909927],"category_scores_gemma":[0.008848466,0.00021322415,0.00072437595,0.0017296206,0.0005782952,0.00015455084,0.0002267629,0.00018227138,0.000009608703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053208447,0.006079355,0.7882105,0.007030053,0.011643993,0.000021038635,0.0055526746,0.00012585128,0.007869245,0.0003315514,0.1408622,0.026952684],"study_design_scores_gemma":[0.009013525,0.0004263479,0.9373867,0.036049742,0.007479502,0.000007567166,0.004282461,0.0031200626,0.0011180509,0.0004448381,0.0001629655,0.00050822645],"about_ca_topic_score_codex":0.00011376542,"about_ca_topic_score_gemma":0.000020273283,"teacher_disagreement_score":0.1491762,"about_ca_system_score_codex":0.0000480033,"about_ca_system_score_gemma":0.0002296053,"threshold_uncertainty_score":0.99950045},"labels":[],"label_agreement":null},{"id":"W2910856619","doi":"10.1136/annrheumdis-2018-eular.2142","title":"FRI0657 Construct validity and responsiveness of three stiffness items in rheumatoid arthritis: an application of the omeract filter 2.1","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Construct validity; Construct (python library); Stiffness; Physical therapy; Internal medicine; Psychometrics; Clinical psychology; Computer science; Structural engineering","score_opus":0.03393816551487667,"score_gpt":0.29842622210047975,"score_spread":0.2644880565856031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910856619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974908,0.0010689088,0.000057445533,0.00044573957,0.00011530556,0.000595587,0.0001254719,0.000010627459,0.00009009403],"genre_scores_gemma":[0.9992456,0.0004889223,0.000045586567,0.0001454492,0.000019494939,0.000028920827,0.000007213313,0.000013660788,0.0000051761294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998482,0.00022773161,0.00062616245,0.00016923051,0.0003355938,0.00015930415],"domain_scores_gemma":[0.99807143,0.00027864642,0.00050462014,0.0007399567,0.00032666794,0.000078651814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035257472,0.00013990472,0.00048218324,0.000081918,0.00008467694,0.000011130894,0.00023381079,0.000056911147,0.000038502218],"category_scores_gemma":[0.00042921316,0.00008716701,0.00013370132,0.00023851734,0.0007751079,0.00014039651,0.00011819702,0.000074289,0.0000018940178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029961779,0.0008690471,0.8615865,0.002855677,0.00021662806,0.0000070244705,0.002392595,0.000036438774,0.0055349655,0.003942513,0.001002087,0.118560344],"study_design_scores_gemma":[0.001129597,0.000116526004,0.97201216,0.0027887751,0.000037787788,0.00004700924,0.0003917104,0.0010279467,0.017593145,0.0046458477,0.00010504898,0.00010447133],"about_ca_topic_score_codex":0.00025734902,"about_ca_topic_score_gemma":0.000063403975,"teacher_disagreement_score":0.11845588,"about_ca_system_score_codex":0.0000069664334,"about_ca_system_score_gemma":0.000133715,"threshold_uncertainty_score":0.35545674},"labels":[],"label_agreement":null},{"id":"W2910872480","doi":"10.1136/annrheumdis-2018-eular.6166","title":"SAT0740-HPR Parity and the risk of developing rheumatoid arthritis: evidence from the malaysian epidemiological investigation of rheumatoid arthritis case-control study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada","funders":"","keywords":"Medicine; Rheumatoid arthritis; Odds ratio; Parity (physics); Epidemiology; Internal medicine; Population; Case-control study; Confidence interval; Immunology; Environmental health","score_opus":0.06964287522419761,"score_gpt":0.33481004404662956,"score_spread":0.26516716882243196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910872480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95387316,0.03780994,0.0003462962,0.005056044,0.00012466143,0.0025194862,0.00022234055,0.000030358036,0.000017733555],"genre_scores_gemma":[0.95540625,0.04379168,0.00026811162,0.0003035039,0.00004452754,0.00015286024,0.000003905158,0.000024573406,0.000004583923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924537,0.0039723986,0.001803091,0.000427973,0.00093512674,0.00040770424],"domain_scores_gemma":[0.98288786,0.013352628,0.0014658024,0.0013856163,0.0007071425,0.00020094847],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.005865596,0.00032189192,0.0015237726,0.00008369154,0.00038291223,0.000039584374,0.00064305036,0.00011076925,0.000089262736],"category_scores_gemma":[0.02908005,0.00015062548,0.00037240627,0.00043682824,0.0029300328,0.00019182762,0.00036103438,0.00029321882,0.000009499738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008223034,0.00016142137,0.9783774,0.00035739018,0.0009670672,0.000015356172,0.00623992,0.0000145302,0.000034350272,0.00059374963,0.0011122581,0.01130426],"study_design_scores_gemma":[0.005927505,0.0004865517,0.9345339,0.025924647,0.00017898068,0.0014034157,0.01061703,0.0028131492,0.0007016301,0.017182587,0.00000801356,0.00022257533],"about_ca_topic_score_codex":0.0039372114,"about_ca_topic_score_gemma":0.00046592942,"teacher_disagreement_score":0.043843478,"about_ca_system_score_codex":0.000025960539,"about_ca_system_score_gemma":0.00035297134,"threshold_uncertainty_score":0.9997834},"labels":[],"label_agreement":null},{"id":"W2910953330","doi":"10.1136/annrheumdis-2018-eular.2001","title":"FRI0013 Converting patient-reported physical function outcomes scores to promis metric scores in phase 3 trials of baricitinib in rheumatoid arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Medicine; Physical therapy; Rheumatoid arthritis; Metric (unit); Adalimumab; Population; Schema crosswalk; Internal medicine","score_opus":0.06618926938334381,"score_gpt":0.3732779084433429,"score_spread":0.3070886390599991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910953330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210465,0.004818763,0.00003022961,0.00085701176,0.00020789511,0.001724084,0.000101390084,0.000034552726,0.00012143114],"genre_scores_gemma":[0.99586946,0.0035930772,0.00006391596,0.00020539649,0.000031376454,0.00016952616,0.000020360781,0.00003119694,0.000015695976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563456,0.0005676194,0.0020318176,0.00035071513,0.000913982,0.000501298],"domain_scores_gemma":[0.99663365,0.0012117488,0.0008453467,0.0006010442,0.00044196387,0.00026626608],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012561072,0.00027759533,0.0016684706,0.0008028805,0.00008387823,0.00003360054,0.0002523291,0.00005942127,0.00025549924],"category_scores_gemma":[0.018477378,0.00018618042,0.00046833232,0.0013330517,0.00037680488,0.00023547321,0.00014490825,0.00015269915,0.000019507277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005135861,0.0060450397,0.49543613,0.0006077925,0.00090850034,0.00003196623,0.0049308874,0.00004006849,0.00332192,0.00057380984,0.0023274214,0.48064062],"study_design_scores_gemma":[0.019044636,0.004573722,0.9002936,0.015680665,0.000053181488,0.000028034625,0.0022359053,0.0012945934,0.049269523,0.006808123,0.000211603,0.0005064096],"about_ca_topic_score_codex":0.00088033656,"about_ca_topic_score_gemma":0.000120010875,"teacher_disagreement_score":0.4801342,"about_ca_system_score_codex":0.000026602522,"about_ca_system_score_gemma":0.00026281373,"threshold_uncertainty_score":0.9897904},"labels":[],"label_agreement":null},{"id":"W2910957854","doi":"10.1136/annrheumdis-2018-eular.7006","title":"THU0343 How patients ability beliefs about math matter to sle patients disease","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Canadian Rheumatology Association; University Health Network","keywords":"Medicine; Numeracy; Logistic regression; Disease; Systemic lupus erythematosus; Population; Harm; Stepwise regression; Physical therapy; Family medicine; Internal medicine; Environmental health; Literacy; Psychology","score_opus":0.029594747185110848,"score_gpt":0.3150176292755206,"score_spread":0.2854228820904098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910957854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907134,0.00021294231,0.000017863333,0.005553211,0.00047606006,0.0018870748,0.0003970894,0.00004762561,0.00069473736],"genre_scores_gemma":[0.99576986,0.000030255356,0.000064443906,0.0018740911,0.00009127823,0.0001290261,0.00004720474,0.000049866387,0.0019439955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688363,0.00021860721,0.00056101807,0.00043292786,0.0013496223,0.00055419764],"domain_scores_gemma":[0.9960724,0.00020565192,0.00026768932,0.0016085288,0.0010696263,0.0007760723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002939218,0.00028193239,0.0005530716,0.00013709554,0.00016898346,0.00005845682,0.000580075,0.00005609308,0.0004902413],"category_scores_gemma":[0.0025827028,0.00017394428,0.00035281433,0.00036949728,0.0003467215,0.00018055941,0.00042385302,0.00009764742,0.0007908803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040926688,0.0013280135,0.8892288,0.0018163961,0.00012903495,0.0000010382875,0.00069568603,6.905787e-7,0.000007392747,0.00004995324,0.10281904,0.003514682],"study_design_scores_gemma":[0.0013051082,0.00030750025,0.99305934,0.0029770974,0.00010432975,0.0000033671563,0.00010753019,0.00008712725,0.00015986654,0.00060996367,0.0010951535,0.00018359027],"about_ca_topic_score_codex":0.000049039016,"about_ca_topic_score_gemma":0.0000042116017,"teacher_disagreement_score":0.10383056,"about_ca_system_score_codex":0.00006487396,"about_ca_system_score_gemma":0.00021109845,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2910971363","doi":"10.1136/annrheumdis-2018-eular.6478","title":"SAT0003 Synovial tissue cd1c+ dendritic cells in rheumatoid arthritis express high levels of the epigenetic regulator of inflammation, microrna-155 and inflammatory cytokines","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; Università Cattolica del Sacro Cuore; Magyar Tudományos Akadémia; Semmelweis Egyetem; University of Glasgow","keywords":"Immune system; Inflammation; Immunology; Biology; Medicine","score_opus":0.013179479823037146,"score_gpt":0.24161411549405581,"score_spread":0.22843463567101868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910971363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755039,0.022865986,0.0000130805865,0.0002946295,0.0005413007,0.000497759,0.00024669143,0.000013446321,0.000023187504],"genre_scores_gemma":[0.99656963,0.0030234628,0.000029362276,0.00004836101,0.000014806676,0.000025402822,0.000005232727,0.000024270492,0.0002594641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975691,0.00072379224,0.0010575601,0.00021549079,0.00012169659,0.0003123518],"domain_scores_gemma":[0.99771583,0.0005193522,0.00071032153,0.0007767052,0.00025409585,0.000023716882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036373007,0.00024595007,0.0006158024,0.00014997447,0.00016747274,0.000014000151,0.0006198466,0.00015909296,0.000315794],"category_scores_gemma":[0.000516451,0.0001682757,0.0001748769,0.00023801308,0.0017693088,0.00014355089,0.00023155619,0.00011696018,0.000014548371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050807314,0.00017221195,0.0041100974,0.00039693562,0.0002927704,7.512486e-7,0.0015292687,0.000020233541,0.97010624,0.0007749268,0.000512732,0.021575773],"study_design_scores_gemma":[0.0010095688,0.00012470265,0.23072486,0.0019225696,0.000024598,0.000017627697,0.00017087781,0.0000024824521,0.7638987,0.001263988,0.0007003852,0.00013968827],"about_ca_topic_score_codex":0.00018519613,"about_ca_topic_score_gemma":0.00005012265,"teacher_disagreement_score":0.22661476,"about_ca_system_score_codex":0.00001022136,"about_ca_system_score_gemma":0.00017850405,"threshold_uncertainty_score":0.6862084},"labels":[],"label_agreement":null},{"id":"W2911064014","doi":"10.1136/annrheumdis-2018-eular.4985","title":"SAT0562 Hip shape predicts knee osteoarthritis outcomes over a decade in older-adults","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Osteoarthritis; WOMAC; Knee replacement; Knee pain; Physical therapy; Radiography; Arthroplasty; Surgery","score_opus":0.02169926693418082,"score_gpt":0.29159724882902294,"score_spread":0.2698979818948421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911064014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348116,0.0027059251,0.0000014242942,0.0012562467,0.00032602999,0.0011109542,0.00011287236,0.000064805965,0.0009405706],"genre_scores_gemma":[0.9978725,0.00015848698,0.00007742517,0.0010433249,0.000066547276,0.00009856811,0.000025779687,0.00003350424,0.00062388263],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982201,0.00008031328,0.0005063908,0.0002882983,0.00049866986,0.0004062157],"domain_scores_gemma":[0.99868935,0.00015843105,0.00019650842,0.00060115266,0.0001238369,0.0002307118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012811784,0.0002530535,0.0005572383,0.0001442711,0.00009257928,0.00002210807,0.00020115764,0.00008904237,0.0006582346],"category_scores_gemma":[0.00052024156,0.00017109366,0.00031228072,0.00025118593,0.00020762015,0.00015755257,0.0001188933,0.000092225106,0.000079356745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097436947,0.001697707,0.2402736,0.0005942556,0.00019567573,0.000057546844,0.0018909632,6.088243e-7,0.0001688023,0.00057994,0.0030398278,0.7505267],"study_design_scores_gemma":[0.010723556,0.0029991341,0.97134674,0.007264731,0.0002203818,0.000024461537,0.00045161817,0.00011064005,0.0043085553,0.002100497,0.00019990122,0.0002498031],"about_ca_topic_score_codex":0.00007092748,"about_ca_topic_score_gemma":0.00010612607,"teacher_disagreement_score":0.7502769,"about_ca_system_score_codex":0.000020185269,"about_ca_system_score_gemma":0.00010968793,"threshold_uncertainty_score":0.7207207},"labels":[],"label_agreement":null},{"id":"W2911078931","doi":"10.1136/annrheumdis-2018-eular.1890","title":"THU0106 Converting patient-reported outcome measures of fatigue and pain to promis scores: data from phase 3 baricitinib rheumatoid arthritis trials","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"National Institute for Health and Care Research","keywords":"Medicine; Physical therapy; Population; Adalimumab; Placebo; Rheumatoid arthritis; Schema crosswalk; Internal medicine","score_opus":0.30132205023622405,"score_gpt":0.41931605681829087,"score_spread":0.11799400658206682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911078931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770579,0.01707208,0.00045044764,0.0017417006,0.00019043838,0.0016496779,0.0016476556,0.00005386316,0.00013626824],"genre_scores_gemma":[0.9879317,0.01077933,0.00040997862,0.00052212755,0.00005187484,0.00006592502,0.0001847455,0.000038963975,0.00001531302],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99491614,0.0010148576,0.0020997028,0.000489428,0.0010337739,0.00044609004],"domain_scores_gemma":[0.9943379,0.0019061392,0.0010367022,0.0016083333,0.000634343,0.00047658113],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030289723,0.00030280923,0.001476706,0.00018514179,0.00019690784,0.000068229776,0.0005724003,0.00007002427,0.00048906007],"category_scores_gemma":[0.04017498,0.00020130411,0.00026394535,0.00032574043,0.00065713696,0.0002688744,0.0004461397,0.00012560203,0.000011230742],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032439395,0.0017771877,0.09918511,0.0005708467,0.0022567224,0.000024575224,0.0034268268,0.000002602548,0.004213211,0.00017714445,0.02286277,0.8622591],"study_design_scores_gemma":[0.093532704,0.01991967,0.37433162,0.12804143,0.00087119656,0.00033008913,0.01899065,0.014136636,0.2938576,0.028953115,0.022774793,0.004260473],"about_ca_topic_score_codex":0.0010088896,"about_ca_topic_score_gemma":0.00008846158,"teacher_disagreement_score":0.8579986,"about_ca_system_score_codex":0.000009573115,"about_ca_system_score_gemma":0.00026969044,"threshold_uncertainty_score":0.96791005},"labels":[],"label_agreement":null},{"id":"W2911099940","doi":"10.1136/annrheumdis-2018-eular.5716","title":"SAT0198 Drug survival and efficacy of abatacept in rheumatoid arthritis patients in routine care – 7 year experience from a single centre in the united kingdom","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Discontinuation; Internal medicine; Tolerability; Rheumatism; Infliximab; Disease; Adverse effect; Rituximab","score_opus":0.0328359066596759,"score_gpt":0.30068310582339874,"score_spread":0.26784719916372285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911099940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408466,0.004411793,7.7060764e-7,0.0005921756,0.000080935635,0.00057663507,0.00013550163,0.000009674871,0.00010784029],"genre_scores_gemma":[0.994537,0.0052500567,0.000026737684,0.00006885409,0.000012543436,0.000016443764,0.00006776541,0.000016153646,0.000004469331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979354,0.0003947512,0.0005714796,0.0002281288,0.00054329645,0.00032689993],"domain_scores_gemma":[0.99856216,0.00053239043,0.0001759026,0.0004630539,0.00016968965,0.00009681648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023968444,0.00016669265,0.00046383395,0.00022227754,0.00005465039,0.000029818983,0.00031082652,0.0000386867,0.00009003924],"category_scores_gemma":[0.0013643865,0.00010904805,0.000090012174,0.000584195,0.00050896127,0.00012723233,0.00013454056,0.00013103875,0.000004302479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005796173,0.0011902194,0.94053143,0.00010951271,0.00003828233,0.0000070416068,0.038932495,0.0000063677676,0.00004432277,0.00020144785,0.0002751854,0.018084062],"study_design_scores_gemma":[0.005278692,0.00018601188,0.96900064,0.0058488753,0.0000025172026,0.0000010166342,0.018258382,0.000091860085,0.0007270128,0.0003052418,0.00018212502,0.00011761475],"about_ca_topic_score_codex":0.0067539327,"about_ca_topic_score_gemma":0.0031686379,"teacher_disagreement_score":0.028469209,"about_ca_system_score_codex":0.000020253869,"about_ca_system_score_gemma":0.00007100797,"threshold_uncertainty_score":0.99986017},"labels":[],"label_agreement":null},{"id":"W2911158691","doi":"10.1136/annrheumdis-2018-214930","title":"Altered DNA methylation in children born to mothers with rheumatoid arthritis during pregnancy","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; ReumaNederland; Arthritis Society; Erasmus Universiteit Rotterdam; ZonMw; European Commission; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Dutch Arthritis Society","keywords":"Medicine; DNA methylation; CpG site; Pregnancy; Methylation; Population; Rheumatoid arthritis; Confounding; Immunology; Internal medicine; Genetics; Biology; Gene","score_opus":0.015462595482833427,"score_gpt":0.2774556132014548,"score_spread":0.2619930177186214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911158691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921847,0.0042241416,0.00003183729,0.0018279797,0.000058714704,0.0011921086,0.000033498767,0.000034632663,0.0004123699],"genre_scores_gemma":[0.99750835,0.0018554783,0.00007681185,0.00024310057,0.000009745676,0.00005630308,0.000014067228,0.000022205264,0.0002139469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876666,0.000071245435,0.00036223006,0.0001970516,0.00036093377,0.00024188349],"domain_scores_gemma":[0.998925,0.00006154631,0.00019917572,0.00056685857,0.00006174455,0.00018572557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000959802,0.00014268984,0.00035151362,0.00013863736,0.000035764042,0.000011012882,0.000146075,0.000035537825,0.0001775078],"category_scores_gemma":[0.00033806934,0.00009316985,0.000104908235,0.00030646074,0.000051595107,0.00015471873,0.000041615403,0.0000769761,0.000041198207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005673087,0.0007080262,0.8922296,0.0008595742,0.0004574913,0.0000042084844,0.0023576145,0.0003893203,0.0010636607,0.00020932655,0.00062778644,0.10052604],"study_design_scores_gemma":[0.0018476346,0.00014713286,0.9704322,0.02060343,0.000022543301,0.000032443837,0.00011822675,0.000049159145,0.006370915,0.00024639687,0.000015123395,0.00011475365],"about_ca_topic_score_codex":0.000062467756,"about_ca_topic_score_gemma":0.000007713948,"teacher_disagreement_score":0.10041129,"about_ca_system_score_codex":0.000018845596,"about_ca_system_score_gemma":0.00012294094,"threshold_uncertainty_score":0.37993562},"labels":[],"label_agreement":null},{"id":"W2911175757","doi":"10.1136/annrheumdis-2018-eular.5519","title":"FRI0395 Sle disease activity index glucocorticoid index (SLEDAI-2KG) identifies more responders than sledai-2k","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Index (typography); Glucocorticoid; Immunology; Internal medicine; Computer science","score_opus":0.04224121047749377,"score_gpt":0.3243632026587405,"score_spread":0.2821219921812468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911175757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867798,0.005982668,0.00007600864,0.003705544,0.0011689545,0.0012905388,0.00020459265,0.00015131687,0.0006405715],"genre_scores_gemma":[0.9950866,0.00087683956,0.0000069318694,0.0009704752,0.0002052908,0.000087398985,0.000027110495,0.000074688665,0.0026646808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962038,0.0003326715,0.000862303,0.0006221353,0.0013271392,0.00065195124],"domain_scores_gemma":[0.99577725,0.00040086024,0.00069935806,0.0018187116,0.00050889066,0.0007949063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003723461,0.0004789349,0.00088717684,0.00028595177,0.00032383026,0.000100263795,0.00064264826,0.00017606259,0.000621386],"category_scores_gemma":[0.00195142,0.00031380513,0.00091644505,0.0007044293,0.00087971793,0.00035537512,0.0003357949,0.00023338068,0.00017382794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013480419,0.005062464,0.8415689,0.005028387,0.0039051457,0.00007201373,0.0023046585,0.00039120656,0.002813142,0.00044191437,0.0938585,0.031073242],"study_design_scores_gemma":[0.001981268,0.00022085881,0.9810639,0.006324941,0.00089688745,0.0000118643975,0.0014364567,0.0032675422,0.0029533922,0.0012089888,0.00022959567,0.00040430645],"about_ca_topic_score_codex":0.0002899597,"about_ca_topic_score_gemma":0.000015537062,"teacher_disagreement_score":0.139495,"about_ca_system_score_codex":0.00005761507,"about_ca_system_score_gemma":0.00063139485,"threshold_uncertainty_score":0.9999314},"labels":[],"label_agreement":null},{"id":"W2911198252","doi":"10.1136/annrheumdis-2018-eular.3821","title":"SAT0336 Measurement properties of the minimal disease activity criteria for psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Dactylitis; Psoriatic arthritis; Enthesitis; Psoriasis; Observational study; Internal medicine; Disease; Physical therapy; Clinical trial; MEDLINE; Rheumatology; Ustekinumab; Dermatology; Adalimumab","score_opus":0.14938761777604723,"score_gpt":0.326457194544335,"score_spread":0.1770695767682878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911198252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98466194,0.0094221635,0.000008915219,0.0040050377,0.00038204485,0.001214839,0.0002123979,0.000015107537,0.0000775325],"genre_scores_gemma":[0.998934,0.00044961827,0.00003645971,0.000220169,0.000081593695,0.00017505404,0.000001607496,0.0000177301,0.00008381769],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861044,0.000091635906,0.00033428447,0.00017680263,0.00055059843,0.00023623844],"domain_scores_gemma":[0.9985347,0.000044315173,0.00025194182,0.0005765572,0.00047345366,0.00011904679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017434916,0.00016812971,0.00041901608,0.000028465012,0.00021435246,0.000013273654,0.00018549187,0.000022182021,0.000048760303],"category_scores_gemma":[0.0013220081,0.00008622815,0.0004227214,0.000114920054,0.000441977,0.000068352536,0.00012194648,0.00003153768,0.000003907931],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030571537,0.018696964,0.12569344,0.01875065,0.010083494,0.000014952022,0.0068766945,0.0000084907515,0.015134887,0.002015737,0.07318636,0.6989668],"study_design_scores_gemma":[0.0045351433,0.0011771041,0.9418433,0.011291113,0.0010847825,0.0000047920366,0.00041530942,0.0001753604,0.036525395,0.0021214776,0.0006099002,0.00021636861],"about_ca_topic_score_codex":0.00006933803,"about_ca_topic_score_gemma":0.000037973474,"teacher_disagreement_score":0.81614983,"about_ca_system_score_codex":0.000022180648,"about_ca_system_score_gemma":0.00018145892,"threshold_uncertainty_score":0.35162818},"labels":[],"label_agreement":null},{"id":"W2911200769","doi":"10.1136/annrheumdis-2018-eular.5960","title":"AB0864 The impact of disease activity, structural damage, and fatigue on physical function in patients with ankylosing spondylitis: differences in early and late disease","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Western University","funders":"Foundation for Research in Rheumatology","keywords":"BASFI; BASDAI; Medicine; Ankylosing spondylitis; Disease; Physical therapy; Internal medicine","score_opus":0.029933589960510775,"score_gpt":0.30867152351734317,"score_spread":0.2787379335568324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911200769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838567,0.00035543842,3.7061895e-7,0.00027309448,0.000024622286,0.0004951519,0.00044559105,0.000005587904,0.000014487569],"genre_scores_gemma":[0.9998345,0.00006773305,0.0000017019316,0.000032940592,0.000013650278,0.000015937037,0.000015995767,0.000009745637,0.000007824386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991261,0.000095474854,0.00016286147,0.00018002374,0.00026137766,0.00017416065],"domain_scores_gemma":[0.99926674,0.00014109025,0.00013544201,0.00024734248,0.00006660897,0.00014274582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004190694,0.00016513077,0.00032434662,0.00006868317,0.00008841014,0.000020284604,0.000061567574,0.000013561907,0.000013527259],"category_scores_gemma":[0.00013017078,0.0000771543,0.0000811602,0.0001643413,0.00041641164,0.00013429063,0.00007000142,0.000059982736,2.9535832e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067208647,0.0006477502,0.9844415,0.00012067702,0.0001449629,0.0000033117929,0.00046807015,0.0000083099985,0.0000022615814,0.00005118041,0.000009385283,0.0073817284],"study_design_scores_gemma":[0.002329521,0.0016157713,0.9922354,0.0014976597,0.00014082987,1.6412756e-7,0.00004963613,0.00045845684,0.000008773263,0.001587332,2.1466786e-7,0.00007620637],"about_ca_topic_score_codex":0.00046317893,"about_ca_topic_score_gemma":0.00003766587,"teacher_disagreement_score":0.007793937,"about_ca_system_score_codex":0.000014185078,"about_ca_system_score_gemma":0.000042230597,"threshold_uncertainty_score":0.3146261},"labels":[],"label_agreement":null},{"id":"W2911764694","doi":"10.1136/annrheumdis-2018-214685","title":"Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McMaster University; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; National Institute for Health and Care Research; Gigtforeningen; Lupus Foundation of America","keywords":"Multiple-criteria decision analysis; Medicine; Ranking (information retrieval); Pairwise comparison; Rheumatism; Statistics; Machine learning; Computer science; Mathematics; Operations research; Internal medicine","score_opus":0.07640682826083822,"score_gpt":0.3997196485713566,"score_spread":0.3233128203105184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911764694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882314,0.00085866085,0.004964018,0.002027527,0.00036950485,0.0033252155,0.00006860197,0.00006035084,0.000094685965],"genre_scores_gemma":[0.9955186,0.00006767618,0.0017687017,0.00024315402,0.000049128437,0.00024170516,0.000047452875,0.000048442445,0.002015115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708587,0.00013287428,0.0009950189,0.00046693368,0.00088913296,0.0004301621],"domain_scores_gemma":[0.99569577,0.0007943278,0.0003986941,0.0012795313,0.0014233482,0.0004083481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067968795,0.00026186687,0.0009803051,0.0004701095,0.00008642967,0.000071230046,0.0005902672,0.00009380209,0.00022178373],"category_scores_gemma":[0.0036591403,0.00017022807,0.00042732965,0.00190708,0.000050448103,0.0001423487,0.000117393036,0.00006743983,0.00014790513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005769399,0.0012688445,0.80604947,0.035733696,0.0056533744,0.000008870858,0.011574027,0.0006218659,0.009308794,0.0009618204,0.09305257,0.029997254],"study_design_scores_gemma":[0.032377765,0.002619586,0.5527108,0.122901686,0.014707858,0.011972704,0.04258023,0.1700737,0.026635911,0.016301382,0.0031708155,0.003947587],"about_ca_topic_score_codex":0.000033549186,"about_ca_topic_score_gemma":0.000005725248,"teacher_disagreement_score":0.2533387,"about_ca_system_score_codex":0.00007035871,"about_ca_system_score_gemma":0.0006046546,"threshold_uncertainty_score":0.69416994},"labels":[],"label_agreement":null},{"id":"W2911911582","doi":"10.1136/annrheumdis-2018-214388","title":"Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Research Canada; University of British Columbia","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research","keywords":"Medicine; Ankylosing spondylitis; Venous thromboembolism; Spondylitis; Population; Venous thrombosis; Intensive care medicine; Internal medicine; Thrombosis; Environmental health","score_opus":0.019363771113480154,"score_gpt":0.3011863666853638,"score_spread":0.28182259557188366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911911582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684364,0.00070521055,0.00000498272,0.0003360487,0.00016794645,0.0015315223,0.00013658704,0.00002003726,0.00025401908],"genre_scores_gemma":[0.99934745,0.00010942693,0.00008774706,0.00029652382,0.000019975303,0.000037382935,0.00003333544,0.000022726857,0.00004544971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982579,0.00021012207,0.0005997344,0.00021989057,0.00047444805,0.00023793177],"domain_scores_gemma":[0.9985495,0.00017106204,0.0004035211,0.00070020097,0.00009847424,0.00007722217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035488294,0.00016400489,0.00088830356,0.00017655513,0.000045673874,0.000012675535,0.0002108762,0.000034741846,0.00030044437],"category_scores_gemma":[0.00030037572,0.00011697073,0.00025528573,0.0003067317,0.000039100058,0.00007541901,0.00008273909,0.00008160201,0.000009783563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012768265,0.006999982,0.9808232,0.0008198711,0.00042747208,0.0000044015924,0.0008457223,0.0031551633,0.000019028957,0.00069557613,0.00032977157,0.0057521216],"study_design_scores_gemma":[0.0013156228,0.00052046357,0.9930256,0.0011662054,0.00044044288,5.1661357e-7,0.0005327358,0.0011499192,0.00013472773,0.0015831749,0.000021168751,0.00010940921],"about_ca_topic_score_codex":0.0029372142,"about_ca_topic_score_gemma":0.00007211976,"teacher_disagreement_score":0.012202406,"about_ca_system_score_codex":0.000025662797,"about_ca_system_score_gemma":0.00009434529,"threshold_uncertainty_score":0.47699282},"labels":[],"label_agreement":null},{"id":"W2912810442","doi":"10.1136/annrheumdis-2018-214273","title":"Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Secukinumab; Ankylosing spondylitis; Psoriatic arthritis; Inflammatory bowel disease; Internal medicine; Incidence (geometry); Gastroenterology; Ulcerative colitis; Cumulative incidence; Psoriasis; Arthritis; Surgery; Disease; Dermatology; Cohort","score_opus":0.04788716359656981,"score_gpt":0.35146266645036717,"score_spread":0.30357550285379736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912810442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665863,0.0055211163,0.0000025812867,0.00009748036,0.000048542915,0.0012055024,0.0064430274,0.000010621436,0.000012507681],"genre_scores_gemma":[0.996563,0.0025129162,0.00007857232,0.00003900153,0.000012747836,0.000024708615,0.00073820277,0.00002177105,0.000009063872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966276,0.0005852997,0.001412662,0.0004944684,0.00065224036,0.00022770812],"domain_scores_gemma":[0.9957188,0.0012147729,0.0013015157,0.0011973606,0.00037624125,0.00019132641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007452716,0.00027088064,0.0020254634,0.00024572763,0.000045466684,0.000017326045,0.00024110342,0.000056242476,0.00016075233],"category_scores_gemma":[0.0028056484,0.00016284964,0.00027254093,0.00068909966,0.0003522765,0.00024053646,0.00019472175,0.00009548502,0.0000012360949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007517492,0.001155499,0.9785691,0.00025205308,0.006688046,0.00001642471,0.00021875302,0.000021152226,0.0000017789196,0.000028058048,0.000037595048,0.0054940586],"study_design_scores_gemma":[0.010863331,0.0008575657,0.97530806,0.005890783,0.005813833,3.9961083e-7,0.00023322954,0.0005810748,0.00005066667,0.00024918836,0.0000016414297,0.00015021405],"about_ca_topic_score_codex":0.0009020509,"about_ca_topic_score_gemma":0.00031287217,"teacher_disagreement_score":0.009904396,"about_ca_system_score_codex":0.000025850732,"about_ca_system_score_gemma":0.00018450462,"threshold_uncertainty_score":0.6640816},"labels":[],"label_agreement":null},{"id":"W2913650270","doi":"10.1136/annrheumdis-2019-215108","title":"Response to: ‘Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis’ by Cutolo et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; Versus Arthritis; Kennedy Trust for Rheumatology Research; Ontario Genomics; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; Chugai Pharmaceutical; Wellcome Trust; Roche; University Hospitals Birmingham NHS Foundation Trust; Pfizer; Novartis Pharma; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Birmingham Biomedical Research Centre; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Arthritis; Internal medicine; Dermatology; Surgery","score_opus":0.032978924346344494,"score_gpt":0.3301067485235929,"score_spread":0.2971278241772484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913650270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5763612,0.007081822,0.000010281947,0.41345948,0.00006639498,0.0019141653,0.0010848653,0.000010883378,0.000010920161],"genre_scores_gemma":[0.59384894,0.099272914,0.00028751066,0.30082038,0.00007134725,0.001855188,0.0005736483,0.00024347105,0.003026601],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970075,0.0005387884,0.0007217432,0.00046315213,0.000809585,0.00045925993],"domain_scores_gemma":[0.99649847,0.002032013,0.00031631617,0.0008011409,0.0002005187,0.00015151972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039745503,0.00036048252,0.0011612168,0.0003812889,0.000042587526,0.000039146937,0.00030059606,0.00019796628,0.000074368596],"category_scores_gemma":[0.0015689387,0.00024637865,0.0004942641,0.00021444209,0.00019818514,0.00006039891,0.00015976117,0.00022374818,0.000013738934],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030903278,0.0007497305,0.004847195,0.00055875676,0.00034037983,0.000049711154,0.0002565076,0.000008307705,0.0006735227,0.0000027676153,0.9687528,0.020669993],"study_design_scores_gemma":[0.015315511,0.011742629,0.12981223,0.02635124,0.0003466673,0.000069211215,0.00032874776,0.00033186044,0.022491675,0.0007781311,0.7912071,0.0012250125],"about_ca_topic_score_codex":0.00040206636,"about_ca_topic_score_gemma":0.000019730362,"teacher_disagreement_score":0.17754571,"about_ca_system_score_codex":0.000048265418,"about_ca_system_score_gemma":0.00034073243,"threshold_uncertainty_score":0.99999887},"labels":[],"label_agreement":null},{"id":"W2921652873","doi":"10.1136/annrheumdis-2018-214436","title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Anti-nuclear antibody; Context (archaeology); Relevance (law); Pathology; Autoantibody; Immunology; Antibody; Biology; Political science","score_opus":0.0690074511666344,"score_gpt":0.38221239250645184,"score_spread":0.31320494133981747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921652873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542666,0.001542056,0.0000038215053,0.00989346,0.00061826356,0.0010311804,0.00022461338,0.000020852845,0.001239111],"genre_scores_gemma":[0.9970014,0.0017448397,0.0000135948885,0.00055731414,0.00006676583,0.000029060593,0.000009472468,0.000026636957,0.0005508913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970156,0.00041643318,0.0008441418,0.0003033629,0.0011565915,0.00026387855],"domain_scores_gemma":[0.9954166,0.002156076,0.0005615934,0.0011753862,0.00057977554,0.00011056761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085399224,0.00018412834,0.0006162311,0.00010318169,0.000048002486,0.000018386176,0.00075121236,0.00006338479,0.00036472667],"category_scores_gemma":[0.0033631013,0.00009637997,0.0005066319,0.00015573653,0.00027265915,0.00003536398,0.00024187357,0.00025797886,0.00007913618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010154012,0.00093320763,0.97812146,0.0010400697,0.0011797255,0.0000079203355,0.0012491497,0.000020491165,0.000102682745,0.0008290451,0.008838532,0.0066623404],"study_design_scores_gemma":[0.00289704,0.0007034358,0.96625686,0.014377171,0.00017919092,0.00018228762,0.009374887,0.0010077277,0.003341762,0.0010913609,0.00037234937,0.00021594083],"about_ca_topic_score_codex":0.00027412653,"about_ca_topic_score_gemma":0.000010685088,"teacher_disagreement_score":0.013337102,"about_ca_system_score_codex":0.00007189731,"about_ca_system_score_gemma":0.00023903491,"threshold_uncertainty_score":0.40261894},"labels":[],"label_agreement":null},{"id":"W2922032370","doi":"10.1136/annrheumdis-2018-213455","title":"Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"Bayer","keywords":"Medicine; Scleroderma (fungus); Internal medicine; Proportional hazards model; Cohort; Fibrosis; Vital capacity; Hazard ratio; Pulmonary fibrosis; Idiopathic pulmonary fibrosis; Gastroenterology; Lung; Diffusing capacity; Pathology; Lung function; Confidence interval","score_opus":0.05066124165525567,"score_gpt":0.3013338977939897,"score_spread":0.2506726561387341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922032370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039906,0.005556657,5.47579e-7,0.0005210221,0.000047884252,0.0032868094,0.00011273968,0.000015484748,0.000059808608],"genre_scores_gemma":[0.9985596,0.0010686269,0.0000028223394,0.0001478895,0.000014039421,0.000101372796,0.000039989056,0.000036315334,0.000029369054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99425954,0.003013401,0.00087880454,0.00040677225,0.0010535581,0.00038795677],"domain_scores_gemma":[0.99702007,0.0015573436,0.00048499095,0.00051828,0.00028208544,0.00013722673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00321896,0.00024843134,0.0009179803,0.00030490832,0.00008781015,0.00008473903,0.00021825694,0.00008420946,0.000020415357],"category_scores_gemma":[0.0016603256,0.000120018965,0.00009509842,0.0008884727,0.0002406231,0.0001335772,0.0001321338,0.00025453029,0.0000022841448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023550019,0.001328599,0.99080634,0.00064637465,0.00032044295,0.000013182088,0.0013011693,0.000046355522,0.00002599291,0.000005583146,0.00025907805,0.002891888],"study_design_scores_gemma":[0.007512197,0.0004892303,0.95386666,0.035446715,0.00028647573,0.00000917819,0.0019011578,0.00029535632,0.000013900621,0.000035104076,6.2863694e-7,0.00014340927],"about_ca_topic_score_codex":0.00037153775,"about_ca_topic_score_gemma":0.00006478271,"teacher_disagreement_score":0.036939684,"about_ca_system_score_codex":0.000057453504,"about_ca_system_score_gemma":0.00011325647,"threshold_uncertainty_score":0.48942316},"labels":[],"label_agreement":null},{"id":"W2937087541","doi":"10.1136/annrheumdis-2018-214802","title":"All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971–2013)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Systemic lupus erythematosus; Cause of death; Malignancy; Population; Epidemiology; Standardized mortality ratio; Internal medicine; Lupus erythematosus; Pediatrics; Disease; Immunology; Antibody","score_opus":0.048043642697621396,"score_gpt":0.2879994984740661,"score_spread":0.23995585577644468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937087541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947146,0.0022193983,0.0000025482248,0.00009735231,0.0002964219,0.002183597,0.0002655785,0.000016971759,0.00020349938],"genre_scores_gemma":[0.9987184,0.0005179255,0.000013790901,0.000048871312,0.000010763366,0.00003893201,0.000052965144,0.000049048314,0.00054932537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962756,0.00021194105,0.0009765694,0.00041521774,0.0016681754,0.00045246314],"domain_scores_gemma":[0.99737734,0.00030945987,0.00053093996,0.0011855761,0.0003348878,0.00026182662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038746078,0.00030683013,0.001083455,0.0001686448,0.000039234823,0.00003354065,0.00033293496,0.00007913105,0.00035759216],"category_scores_gemma":[0.00011348781,0.00020492385,0.00014400971,0.0003091827,0.00021005316,0.00014621679,0.00014609587,0.00020381097,0.00000678528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006851124,0.00029280738,0.9834297,0.0027286783,0.00076673843,0.000045982393,0.0015271053,0.00007572321,0.00003361498,0.00012175086,0.010199102,0.00009369189],"study_design_scores_gemma":[0.004668033,0.00014725109,0.9864945,0.006281617,0.00016046478,0.00014295976,0.0012775543,0.000037305104,0.00007021102,0.000077863406,0.00040867375,0.0002335796],"about_ca_topic_score_codex":0.16967708,"about_ca_topic_score_gemma":0.33413926,"teacher_disagreement_score":0.1644622,"about_ca_system_score_codex":0.0003334317,"about_ca_system_score_gemma":0.0011613569,"threshold_uncertainty_score":0.8358521},"labels":[],"label_agreement":null},{"id":"W2940679238","doi":"10.1136/annrheumdis-2019-215048","title":"Classification criteria for autoinflammatory recurrent fevers","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":561,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Western Ontario; SickKids Foundation; Western University","funders":"Executive Agency for Health and Consumers; Rosetrees Trust; Swedish Orphan Biovitrum; E-Rare; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Familial Mediterranean fever; Pharyngitis; Consensus conference; Internal medicine; Disease","score_opus":0.12138335941753849,"score_gpt":0.3950284691247774,"score_spread":0.27364510970723893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940679238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031664397,0.9971615,0.000033238095,0.00008691228,0.0006103947,0.0012042699,0.00034799182,0.0000085915635,0.00023046738],"genre_scores_gemma":[0.00040423614,0.99745667,0.000023372053,0.00006200485,0.000059775895,0.00024125639,0.0008242757,0.00004522514,0.0008831766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859107,0.0001545434,0.0005958631,0.00028914885,0.00014362417,0.00022575555],"domain_scores_gemma":[0.99823344,0.00005851861,0.00066347496,0.00086611946,0.00013312329,0.000045355777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019138797,0.00028478727,0.0007136244,0.000055208562,0.000073151234,0.000025121963,0.0005824851,0.00017826517,0.000027891658],"category_scores_gemma":[0.0003878807,0.00019595699,0.0011220833,0.00008005133,0.00009536409,0.0000057591046,0.00013735711,0.00006439688,0.000024804167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000328775,0.00007891638,0.0000049617875,0.020980988,0.00040910605,5.1134627e-8,0.000016889933,0.0000013228123,0.000021256936,0.00016812568,0.03985297,0.9384325],"study_design_scores_gemma":[0.00017072241,0.000087380016,0.0001283789,0.005875648,0.00051860826,0.0000012119945,0.00003638971,0.000024839723,0.000076733166,0.00012418706,0.99270314,0.00025277675],"about_ca_topic_score_codex":0.000001687151,"about_ca_topic_score_gemma":7.9366646e-7,"teacher_disagreement_score":0.95285016,"about_ca_system_score_codex":0.000008833433,"about_ca_system_score_gemma":0.00037987603,"threshold_uncertainty_score":0.79908943},"labels":[],"label_agreement":null},{"id":"W2942307919","doi":"10.1136/annrheumdis-2018-214737","title":"Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Actua; Toronto Western Hospital; University of Waterloo; University of Toronto","funders":"","keywords":"Medicine; Resistin; Internal medicine; Cartilage oligomeric matrix protein; Adiponectin; Psoriatic arthritis; Leptin; Adipokine; Gastroenterology; Endocrinology; Receiver operating characteristic; Osteoarthritis; Arthritis; Oncology; Insulin; Insulin resistance; Pathology; Obesity","score_opus":0.018054896718003643,"score_gpt":0.25892787470956696,"score_spread":0.24087297799156332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942307919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839055,0.0110611655,0.000005458056,0.0020186035,0.00077080535,0.00083585444,0.00049821613,0.00005487491,0.0008495018],"genre_scores_gemma":[0.996632,0.0015786692,0.00008265408,0.0008625313,0.000034751876,0.000060659233,0.000088329936,0.000035323927,0.00062510854],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982829,0.00009124788,0.00045910498,0.00029976896,0.0004974149,0.00036953323],"domain_scores_gemma":[0.99848276,0.00022164418,0.0002454597,0.0007532655,0.000117957774,0.00017891698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000696377,0.00025434204,0.000678096,0.00006411605,0.00012253023,0.000031887826,0.00019123562,0.000055640536,0.0019282373],"category_scores_gemma":[0.00017710972,0.00018015079,0.0004858202,0.00017829344,0.00012366757,0.00009214338,0.00010940605,0.00008363297,0.00021428509],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001527464,0.0020885856,0.4189137,0.00096298853,0.0022988275,0.000060178558,0.00033310175,0.000047846403,0.00011997938,0.00027262446,0.016907027,0.5564677],"study_design_scores_gemma":[0.011210218,0.0008384277,0.97509694,0.006230947,0.00046300943,0.0000071624963,0.00031192356,0.00035240437,0.0017514743,0.0025299324,0.00090341136,0.00030412304],"about_ca_topic_score_codex":0.00028226894,"about_ca_topic_score_gemma":0.000062776955,"teacher_disagreement_score":0.5561833,"about_ca_system_score_codex":0.000018214065,"about_ca_system_score_gemma":0.000096136435,"threshold_uncertainty_score":0.99898416},"labels":[],"label_agreement":null},{"id":"W2942761763","doi":"10.1136/annrheumdis-2019-215509","title":"Response to: ‘Regarding microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints’ by Liebling","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"","keywords":"Osteoarthritis; microRNA; Oligonucleotide; Medicine; Locked nucleic acid; Facet (psychology); Bioinformatics; Cancer research; Pathology; Alternative medicine; Biology; Biochemistry; Gene; Psychology","score_opus":0.01705039445949057,"score_gpt":0.2606841217970211,"score_spread":0.24363372733753053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942761763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9161768,0.0066978666,0.000011421771,0.075118676,0.00022243544,0.0008050282,0.00091675174,0.000013997551,0.00003703167],"genre_scores_gemma":[0.91606486,0.0011437342,0.00011885313,0.08036025,0.00020910906,0.00005753876,0.00056434923,0.0001380404,0.0013432475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974162,0.00053118216,0.0006281956,0.0006116601,0.0003308908,0.00048187465],"domain_scores_gemma":[0.9981791,0.00016084757,0.00044072027,0.00096374494,0.00014273694,0.00011289643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039731406,0.00042398015,0.00059727486,0.00018668185,0.00008441767,0.00009477622,0.00042107774,0.000346014,0.0000271586],"category_scores_gemma":[0.0011182383,0.00037234614,0.00031423333,0.00017461383,0.00017597358,0.000015219211,0.00045136703,0.0002532658,0.000033086955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045941316,0.000061001145,0.0013874507,0.0007397493,0.00020221456,0.000019779922,0.00008921064,0.00009413765,0.1804045,9.078607e-7,0.81159645,0.0049451613],"study_design_scores_gemma":[0.0059415116,0.0011910073,0.09528217,0.017345965,0.0006075918,0.00014069793,0.00035064394,0.00016980842,0.31057292,0.0005001831,0.5645294,0.0033680846],"about_ca_topic_score_codex":0.00004115819,"about_ca_topic_score_gemma":0.000006920924,"teacher_disagreement_score":0.24706705,"about_ca_system_score_codex":0.0000201737,"about_ca_system_score_gemma":0.00013716417,"threshold_uncertainty_score":0.99987286},"labels":[],"label_agreement":null},{"id":"W2942777319","doi":"10.1136/annrheumdis-2018-214529","title":"Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Institute for Health and Care Research; Incyte; Eli Lilly and Company","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Placebo; Adverse effect; Internal medicine; Surgery","score_opus":0.05603932408168234,"score_gpt":0.3706559969297201,"score_spread":0.3146166728480378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942777319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262166,0.0003636381,0.000041863033,0.0007910488,0.00013807722,0.0054031797,0.0006108871,0.000023614799,0.000006021724],"genre_scores_gemma":[0.99803334,0.0006998827,0.00031503724,0.00062633725,0.0000071238787,0.00014159961,0.00009946599,0.000047288184,0.000029947378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99562275,0.0008026169,0.0012856033,0.00068724115,0.0010604874,0.0005413059],"domain_scores_gemma":[0.99544036,0.0018196469,0.00025660454,0.0017000949,0.00023511593,0.00054817606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012478267,0.000350433,0.0014378233,0.0003304776,0.00007079794,0.00006667809,0.0007394854,0.00006558409,0.00019676553],"category_scores_gemma":[0.0039870753,0.0002162025,0.000107222964,0.00051057996,0.000116215815,0.0003320724,0.00065963983,0.00021522546,0.00005572125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048372794,0.009849604,0.889287,0.000038380625,0.00033141277,0.000021952788,0.0016217036,0.000017249382,0.0000023289695,0.0000013339256,0.00067700027,0.049779236],"study_design_scores_gemma":[0.04607352,0.007121967,0.9423505,0.0029493389,0.000011914492,7.816721e-7,0.0010101569,0.00012670926,0.000015039555,0.000048677273,0.000038679613,0.00025269506],"about_ca_topic_score_codex":0.0009101444,"about_ca_topic_score_gemma":0.00036323618,"teacher_disagreement_score":0.05306352,"about_ca_system_score_codex":0.000026824307,"about_ca_system_score_gemma":0.00031282715,"threshold_uncertainty_score":0.88164824},"labels":[],"label_agreement":null},{"id":"W2944143667","doi":"10.1136/annrheumdis-2019-215443","title":"Antinuclear antibodies by indirect immunofluorescence and solid phase assays","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Anti-nuclear antibody; Immunofluorescence; Antibody; Indirect immunofluorescence; Pathology; Immunology; Autoantibody","score_opus":0.04332923238365785,"score_gpt":0.36316713924384764,"score_spread":0.31983790686018976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944143667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6068794,0.04857713,0.0000053861213,0.33705735,0.00068205077,0.002829498,0.00164934,0.00013522251,0.0021846055],"genre_scores_gemma":[0.63312495,0.038476713,0.00012238164,0.2921377,0.0011083644,0.00015960439,0.001022796,0.00057622185,0.033271234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644226,0.0003725928,0.00077087316,0.00048768337,0.0013003887,0.0006261896],"domain_scores_gemma":[0.9966188,0.00087298645,0.0006487328,0.0014209722,0.00031555007,0.00012293416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046020048,0.00045586354,0.0014705701,0.00022736898,0.0001241469,0.00008274326,0.0006882172,0.00035167157,0.00020427785],"category_scores_gemma":[0.0015931706,0.00028864457,0.0004520794,0.00023502392,0.00057111436,0.00011901397,0.00040813186,0.00077984435,0.00011351414],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013115924,0.00023522653,0.008515745,0.010562817,0.00083347777,0.000045690515,0.00031421357,1.343953e-7,0.00046415563,0.000003491106,0.9756915,0.003202387],"study_design_scores_gemma":[0.021817198,0.0035180766,0.0200058,0.21229707,0.0052202973,0.007952151,0.002370622,0.0016087865,0.02855995,0.0016846155,0.6905476,0.004417852],"about_ca_topic_score_codex":0.00008132704,"about_ca_topic_score_gemma":3.3894543e-7,"teacher_disagreement_score":0.2851439,"about_ca_system_score_codex":0.000028861616,"about_ca_system_score_gemma":0.00030184796,"threshold_uncertainty_score":0.99995655},"labels":[],"label_agreement":null},{"id":"W2946847163","doi":"10.1136/annrheumdis-2019-eular.3249","title":"SAT0098 ANTIBODIES AGAINST CITRULLINATED ANTIGENS ARE ASSOCIATED WITH TREATMENT RESPONSE IN ACPA-NEGATIVE RHEUMATOID ARTHRITIS PATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Sheffield Biomedical Research Centre; Canadian Institutes of Health Research; Eli Lilly Canada; University of Manchester; Bristol-Myers Squibb; Manchester Biomedical Research Centre; Bristol-Myers Squibb Canada","keywords":"Medicine; Autoantibody; Rheumatoid arthritis; Internal medicine; Immunology; Antigen; Rheumatology; Antibody; Adalimumab; Gastroenterology","score_opus":0.02953123121134983,"score_gpt":0.2987882637972616,"score_spread":0.26925703258591177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946847163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465746,0.0014432861,2.8396065e-7,0.0017075259,0.000070615264,0.0010802837,0.00054344797,0.000033792814,0.0004633279],"genre_scores_gemma":[0.99220145,0.0062450673,0.000018847282,0.00028471465,0.000006593751,0.00003101076,0.000105382285,0.000031055955,0.0010758705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975048,0.00042477556,0.00053376524,0.00032154587,0.00073246384,0.0004826494],"domain_scores_gemma":[0.9976665,0.00086925924,0.00039020125,0.0004649272,0.0004141109,0.00019499508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026350984,0.000308197,0.0008316866,0.00021228827,0.00011557764,0.000026383887,0.00021663232,0.000075947755,0.00014142024],"category_scores_gemma":[0.0012905065,0.00017803526,0.00027625976,0.0004927964,0.0002890079,0.00011992732,0.0001025022,0.00014772252,0.00005652261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006543742,0.0019134985,0.9815457,0.00018365467,0.00064390677,0.000040810584,0.00088122144,0.00007467712,0.00011406741,0.000028866472,0.0006124046,0.0074174777],"study_design_scores_gemma":[0.003604773,0.0011963752,0.9852789,0.006287747,0.000027068618,0.000003339007,0.00048654346,0.0002575881,0.0023352269,0.00020112998,0.00011661515,0.00020469174],"about_ca_topic_score_codex":0.00025092406,"about_ca_topic_score_gemma":0.00011566064,"teacher_disagreement_score":0.007212786,"about_ca_system_score_codex":0.00007780437,"about_ca_system_score_gemma":0.00025896687,"threshold_uncertainty_score":0.72600675},"labels":[],"label_agreement":null},{"id":"W2946988370","doi":"10.1136/annrheumdis-2019-eular.794","title":"AB0307 A.P.R.A.N. ASSESSMENTS OF TENDER AND SWOLLEN JOINTS COUNT SCORE PERFORMED BY A RHEUMATOLOGIST AND RHEUMATOLOGY NURSES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski; Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent","funders":"Sanofi; Pfizer; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Rheumatology; Internal medicine; Arthritis; Psoriasis; Physical therapy; Dermatology","score_opus":0.012252898925373224,"score_gpt":0.27384640023005785,"score_spread":0.2615935013046846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946988370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558549,0.041706383,0.0000030045312,0.00051888666,0.00014796425,0.0013989183,0.00024147503,0.000024546893,0.000103927254],"genre_scores_gemma":[0.82929295,0.17037502,0.000073594616,0.0000695461,0.0000017634485,0.000060390328,0.000045181023,0.000036200043,0.000045363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970007,0.00022084924,0.0009582022,0.0004915876,0.0007647,0.0005639534],"domain_scores_gemma":[0.99790764,0.00044251955,0.00051888084,0.000543729,0.0002777437,0.00030951586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034534596,0.00039199248,0.0014251127,0.00025596755,0.00012878778,0.00006266514,0.00020042194,0.000120743665,0.00012301424],"category_scores_gemma":[0.00054018624,0.00026882475,0.00010293156,0.00026123907,0.0011226895,0.00036679817,0.00019429045,0.00022327315,0.0000046559467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090012787,0.00070401997,0.9170863,0.0011011955,0.0003765072,0.0000036809454,0.00060284283,0.0000012786269,0.000016158847,0.00050025986,0.0011129454,0.077594705],"study_design_scores_gemma":[0.012120218,0.0013909702,0.96828544,0.014757303,0.000017253364,0.0001251112,0.0012214064,0.00019417328,0.00017367868,0.0012293792,0.00015289386,0.00033216985],"about_ca_topic_score_codex":0.00042677953,"about_ca_topic_score_gemma":0.00009334197,"teacher_disagreement_score":0.12866864,"about_ca_system_score_codex":0.0000197831,"about_ca_system_score_gemma":0.00021381836,"threshold_uncertainty_score":0.9999764},"labels":[],"label_agreement":null},{"id":"W2947003717","doi":"10.1136/annrheumdis-2019-eular.3581","title":"AB1343 EFFECTIVENESS OF A RHEUMATOLOGY EDUCATIONAL PROGRAM TO IMPROVE METHOTREXATE PRESCRIBING PRACTICES FOR RHEUMATOID ARTHRITISIN THE SOLE PUBLIC ADULT RHEUMATOLOGY CLINIC IN ETHIOPIA","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Manitoba","funders":"Versus Arthritis; Pfizer","keywords":"Medicine; Rheumatology; Internal medicine; Rheumatoid arthritis; Specialty; Physical therapy; Family medicine; Health care","score_opus":0.05462256692734438,"score_gpt":0.4005478052739723,"score_spread":0.3459252383466279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947003717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759611,0.003334597,0.0000651197,0.014036488,0.0003661772,0.0056985365,0.000060139027,0.000035166053,0.00044267508],"genre_scores_gemma":[0.9959007,0.0015322629,0.00032120256,0.0002128597,0.0000044938356,0.001593608,0.000040681185,0.00004631525,0.00034791042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561936,0.0012655974,0.001423411,0.00048508772,0.0005579321,0.00064861967],"domain_scores_gemma":[0.99018866,0.0062038987,0.0014119635,0.0010917062,0.0009382052,0.0001655385],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026825943,0.00029472605,0.0012766537,0.00029773338,0.00014283964,0.000049887614,0.00075049134,0.00017152543,0.00018614426],"category_scores_gemma":[0.018523667,0.00019040263,0.00046803194,0.0006022266,0.00042217213,0.00032374,0.00029591963,0.0003467136,0.000055013064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006276901,0.006488016,0.7655866,0.026852332,0.0019550545,0.0000021737962,0.0029242388,0.00015436624,0.001384773,0.031003477,0.0057004406,0.15167162],"study_design_scores_gemma":[0.015936108,0.0047673937,0.8931975,0.028092135,0.00033623332,0.00020067698,0.0068481583,0.0077163484,0.0069324863,0.029758317,0.0050553563,0.0011593337],"about_ca_topic_score_codex":0.0007164561,"about_ca_topic_score_gemma":0.00007993064,"teacher_disagreement_score":0.1505123,"about_ca_system_score_codex":0.000031818003,"about_ca_system_score_gemma":0.0013525051,"threshold_uncertainty_score":0.9897437},"labels":[],"label_agreement":null},{"id":"W2947084022","doi":"10.1136/annrheumdis-2019-eular.3082","title":"FRI0132 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS: RESULTS AT 60 WEEKS FROM THE SELECT-NEXT STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Rheumatoid arthritis; Adverse effect; Internal medicine; Placebo; Randomized controlled trial; Safety profile; Surgery; Gastroenterology","score_opus":0.02221680218042602,"score_gpt":0.29951382890431155,"score_spread":0.2772970267238855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947084022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943814,0.0018181952,0.0000010251998,0.0012581262,0.000023571014,0.0022361425,0.00022172117,0.000013906968,0.000045861903],"genre_scores_gemma":[0.99823344,0.0013629925,0.00000951745,0.00018266575,0.000004269012,0.000025029318,0.00004925374,0.000025899099,0.00010695066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972783,0.00065930234,0.0007669918,0.00034254944,0.00065032445,0.00030257352],"domain_scores_gemma":[0.997407,0.0010387796,0.0003016894,0.0008838443,0.00019337212,0.00017531039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008463568,0.00021689065,0.00068273727,0.00011494067,0.00012370892,0.00003580645,0.00028558218,0.000048127582,0.000086680804],"category_scores_gemma":[0.0014249538,0.00012433845,0.000071106515,0.00030017857,0.00023020672,0.0002084016,0.00030502034,0.00014962234,0.00001214909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044392,0.0013511054,0.8919039,0.00013996966,0.00024289712,0.000006527373,0.005446086,0.000022376138,0.000039372964,0.000005239081,0.0003195741,0.056130953],"study_design_scores_gemma":[0.011426853,0.0023811692,0.9818631,0.0025803456,0.000033699445,0.0000015642598,0.0012913578,0.000051825125,0.0001339778,0.000026334248,0.000066945126,0.0001428712],"about_ca_topic_score_codex":0.00042891243,"about_ca_topic_score_gemma":0.00014254458,"teacher_disagreement_score":0.08995916,"about_ca_system_score_codex":0.000020687678,"about_ca_system_score_gemma":0.00016183243,"threshold_uncertainty_score":0.50703746},"labels":[],"label_agreement":null},{"id":"W2947126667","doi":"10.1136/annrheumdis-2019-eular.2325","title":"THU0117 PHARMACOKINETICS AND SHORT-TERM SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Pfizer Japan; AbbVie Canada; Astellas Foundation for Research on Metabolic Disorders; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Bristol-Myers Squibb; AstraZeneca; Teijin Pharma; Pfizer; Japan Blood Products Organization; Ono Pharmaceutical","keywords":"Medicine; Pharmacokinetics; Janus kinase inhibitor; Term (time); Pharmacology; Internal medicine; Janus kinase","score_opus":0.018262813676154774,"score_gpt":0.28580252139100093,"score_spread":0.26753970771484614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947126667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652517,0.0012853992,0.000004417444,0.00027186272,0.000048400794,0.0014448644,0.00009013372,0.000015701742,0.00031407748],"genre_scores_gemma":[0.998845,0.00074336916,0.00008234861,0.00011057665,0.000010269451,0.000043862463,0.000020496369,0.00002631624,0.00011780861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845725,0.000113514034,0.00048044298,0.0002601001,0.00040752967,0.00028116285],"domain_scores_gemma":[0.9988315,0.00022119924,0.00022891852,0.00044073042,0.00013311928,0.0001445286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000144722,0.0002389017,0.000614733,0.000105202824,0.00003153561,0.000009432403,0.000120919394,0.00004124034,0.0000698583],"category_scores_gemma":[0.00010379276,0.0001495649,0.0001162875,0.00024713526,0.00013488285,0.0000886325,0.00009688183,0.00010955912,0.0000037273403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063600494,0.0030140313,0.9662539,0.0041807448,0.0011917796,0.000051314626,0.002859857,0.001137412,0.0013647722,0.00005326257,0.00047010288,0.013062794],"study_design_scores_gemma":[0.00815471,0.0014829037,0.9363997,0.0054570897,0.0005152764,0.00003501785,0.00024966314,0.008043173,0.03917464,0.00024887887,0.00000653341,0.0002324436],"about_ca_topic_score_codex":0.00017401976,"about_ca_topic_score_gemma":0.00003187973,"teacher_disagreement_score":0.037809864,"about_ca_system_score_codex":0.00011541082,"about_ca_system_score_gemma":0.00044446715,"threshold_uncertainty_score":0.609908},"labels":[],"label_agreement":null},{"id":"W2947169687","doi":"10.1136/annrheumdis-2019-eular.5945","title":"AB0281 UTILIZATION OF SMART PHONE APPLICATION TO ASSESS THE DISEASE OUTCOMES IN RHEUMATOID ARTHRITIS: SMART- RA STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Diverse Scientific Research Studies","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Medicine; Rheumatoid arthritis; Quality of life (healthcare); Physical therapy; Checklist; Disease management; Disease; Internal medicine; Nursing","score_opus":0.16878254577959276,"score_gpt":0.45857397101007363,"score_spread":0.28979142523048085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947169687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945063,0.00069981965,0.000090616806,0.0031960274,0.00055737636,0.005180943,0.00024152073,0.00003367391,0.00054935983],"genre_scores_gemma":[0.99701697,0.0007468211,0.0000117486325,0.00029898895,0.000007439486,0.0007163546,0.000013469248,0.000018786466,0.0011694342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597657,0.001157507,0.0009704898,0.00035480922,0.0010891642,0.00045147762],"domain_scores_gemma":[0.9959971,0.0014970355,0.00052457175,0.0013062949,0.0004816654,0.00019333915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019483615,0.00019520141,0.0005717511,0.00019603259,0.0003843194,0.000025726977,0.00086746935,0.000036605234,0.00032719524],"category_scores_gemma":[0.003176549,0.00011284867,0.00017763156,0.0008269996,0.00018619646,0.0002648161,0.00069932995,0.00017224438,0.0003684125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018857625,0.001245221,0.9768771,0.0005097628,0.00014031,6.214214e-7,0.004232358,0.00023315208,0.00002077582,0.0009321765,0.009412665,0.0062073064],"study_design_scores_gemma":[0.0008858838,0.000065474764,0.97770464,0.0012145666,0.000021366026,4.7981615e-8,0.017312702,0.00046578236,0.0000336043,0.0016720394,0.00050499605,0.00011888518],"about_ca_topic_score_codex":0.0005975822,"about_ca_topic_score_gemma":0.00039595988,"teacher_disagreement_score":0.013080343,"about_ca_system_score_codex":0.000038580205,"about_ca_system_score_gemma":0.0003096446,"threshold_uncertainty_score":0.47353202},"labels":[],"label_agreement":null},{"id":"W2947177224","doi":"10.1136/annrheumdis-2019-eular.7637","title":"FRI0189 POOLED ANALYSIS OF THE REAL-WORLD EFFECTIVENESS OF BELIMUMAB IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS USING MULTI-COUNTRY DATA FROM THE OBSERVE STUDIES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Pfizer","keywords":"Belimumab; Medicine; Post-hoc analysis; Observational study; Internal medicine; Clinical trial; Retrospective cohort study; Physical therapy; Immunology; B-cell activating factor; Antibody","score_opus":0.15924575398911203,"score_gpt":0.4078621792130511,"score_spread":0.2486164252239391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947177224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711939,0.024967447,0.000006657836,0.00010466388,0.0002403211,0.0022282333,0.0012250909,0.0000098457285,0.00002384027],"genre_scores_gemma":[0.9972876,0.0024187537,0.00003207902,0.00001159355,0.000012703774,0.000047705962,0.00006164672,0.00003074741,0.00009721121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954943,0.0014129593,0.0013517186,0.00039369127,0.0010444999,0.000302795],"domain_scores_gemma":[0.9896499,0.0050528357,0.0012741671,0.0034667512,0.00048970454,0.000066628396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001342597,0.00029853053,0.0021779323,0.00028585954,0.00006260986,0.000009797675,0.001174302,0.0000648528,0.000027295186],"category_scores_gemma":[0.0014380902,0.00013517188,0.0006185053,0.0017653112,0.0004048849,0.000107715605,0.00060436194,0.00009009239,0.0000022837196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007930583,0.0010505378,0.96911424,0.0082006855,0.013365029,0.0000026027683,0.003252656,0.0016189967,0.002333554,0.000058246642,0.00004532772,0.00016508944],"study_design_scores_gemma":[0.006589792,0.00022245871,0.88026714,0.054364663,0.011559395,0.000061525054,0.016577082,0.022465877,0.0074304934,0.00023796932,0.00000189236,0.00022170931],"about_ca_topic_score_codex":0.008254325,"about_ca_topic_score_gemma":0.0009445313,"teacher_disagreement_score":0.08884707,"about_ca_system_score_codex":0.00016467493,"about_ca_system_score_gemma":0.00037706972,"threshold_uncertainty_score":0.9983498},"labels":[],"label_agreement":null},{"id":"W2947220159","doi":"10.1136/annrheumdis-2019-eular.431","title":"FRI0166 RADIOSYNOVIOTHESIS WITH YTTRIUM90: A CANADIAN EXPERIENCE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Southlake Regional Health Center","funders":"Eli Lilly Japan; Pfizer Japan; Astellas Foundation for Research on Metabolic Disorders; Novartis Pharma; Astellas Pharma; Sanofi; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; AstraZeneca; Bristol-Myers Squibb; Takeda Pharmaceutical Company; Daiichi-Sankyo; Pfizer","keywords":"Medicine; Adverse effect; Refractory (planetary science); Surgery; Synovectomy; Synovitis; Arthritis; Internal medicine; Rheumatoid arthritis","score_opus":0.01857805555015154,"score_gpt":0.2659495329145065,"score_spread":0.24737147736435497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947220159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906099,0.00053828093,0.0000017483046,0.0023099345,0.00007495095,0.00047709848,0.00005945384,0.000016665985,0.0059119966],"genre_scores_gemma":[0.99708223,0.00008335154,0.000042952935,0.0008258435,0.000013550815,0.000026701886,0.00000790816,0.000015677968,0.0019017868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904823,0.000031833508,0.00019718362,0.00014768553,0.00030131917,0.00027374353],"domain_scores_gemma":[0.99896675,0.00006049695,0.00009917777,0.0005022437,0.000074227435,0.00029712523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044613767,0.00013744543,0.00029938476,0.00006221666,0.00007411307,0.000014728538,0.00016777981,0.00002789871,0.0010470038],"category_scores_gemma":[0.00007347631,0.00007340906,0.00017802563,0.00018064985,0.00010688057,0.0000927274,0.000028669723,0.000040546478,0.000076413635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045771862,0.0006706614,0.95734584,0.0014011288,0.0010420902,0.000035568388,0.0017565116,0.000037519312,0.00004374352,0.0025167745,0.0044029406,0.030289492],"study_design_scores_gemma":[0.0013163213,0.00043811937,0.98978734,0.001531782,0.00021416257,0.00003808886,0.00083266536,0.00009832888,0.001152245,0.0003476387,0.004024262,0.00021901981],"about_ca_topic_score_codex":0.033761345,"about_ca_topic_score_gemma":0.0014082594,"teacher_disagreement_score":0.032441515,"about_ca_system_score_codex":0.000028495657,"about_ca_system_score_gemma":0.00025068244,"threshold_uncertainty_score":0.9998662},"labels":[],"label_agreement":null},{"id":"W2947323381","doi":"10.1136/annrheumdis-2019-eular.3524","title":"AB1345 CONTEXTUAL FACTORS IMPACTING OSTEOARTHRITIS MANAGEMENT IN URBAN AND RURAL COMMUNITY-DWELLING SENIORS: AN ANALYSIS BASED ON THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING DISABILITY AND HEALTH","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; Western University","funders":"Pfizer","keywords":"Medicine; International Classification of Functioning, Disability and Health; Osteoarthritis; Gerontology; Physical therapy; Alternative medicine; Pathology; Rehabilitation","score_opus":0.08711091277968455,"score_gpt":0.35637402160646,"score_spread":0.2692631088267754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947323381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958164,0.00019786171,0.000023822466,0.002718982,0.00004646353,0.0006044167,0.000056172095,0.000014459589,0.00052139774],"genre_scores_gemma":[0.99956644,0.000063322324,0.000010130359,0.00021331957,0.0000067669175,0.000013130381,0.00009981708,0.000007781275,0.000019310664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986832,0.0002919495,0.00040651386,0.00014171495,0.00033807821,0.00013850101],"domain_scores_gemma":[0.9986197,0.0004493676,0.0003158257,0.00048799155,0.00004923446,0.0000779244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007294857,0.00012461728,0.00031979836,0.00013226915,0.00012154506,0.00004596639,0.00014428512,0.000018024999,0.0000887727],"category_scores_gemma":[0.00014114135,0.00008029443,0.00012189337,0.00024912498,0.00018347401,0.00015117985,0.000085980195,0.000115616655,4.5911634e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020571772,0.00054846145,0.98195153,0.0007073875,0.00048898667,2.3217584e-7,0.0012684553,0.0021841023,0.000008909261,0.0019762982,0.00005230673,0.010607621],"study_design_scores_gemma":[0.0007306437,0.0001880509,0.9247794,0.0008166133,0.00022000638,1.856823e-7,0.029677108,0.043271616,0.000014032583,0.00023588186,0.000005246707,0.000061212144],"about_ca_topic_score_codex":0.0010183193,"about_ca_topic_score_gemma":0.00020007868,"teacher_disagreement_score":0.05717212,"about_ca_system_score_codex":0.00005923447,"about_ca_system_score_gemma":0.000040942716,"threshold_uncertainty_score":0.32743117},"labels":[],"label_agreement":null},{"id":"W2947366750","doi":"10.1136/annrheumdis-2019-eular.907","title":"PARE0009 THE PHYSICAL AND EMOTIONAL BURDEN OF RHEUMATOID ARTHRITIS: DATA FROM RA MATTERS, A WEB-BASED SURVEY OF PATIENTS AND PHYSICIANS IN EUROPE AND CANADA","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Quality of life (healthcare); Health care; Health professionals; Family medicine; Physical therapy; Gerontology; Internal medicine; Nursing","score_opus":0.02436547564086618,"score_gpt":0.26975804730758823,"score_spread":0.24539257166672204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947366750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881956,0.006286334,0.0000010805034,0.0020756407,0.00003573448,0.0003914645,0.0029979954,0.0000036434083,0.00001249572],"genre_scores_gemma":[0.9870983,0.012379677,0.000008150078,0.0002510275,0.0000057620273,0.000005250393,0.000233359,0.00001331009,0.0000051653683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849224,0.00029738364,0.00034887737,0.00020928615,0.00048055293,0.00017166976],"domain_scores_gemma":[0.99818784,0.00080393086,0.00021314636,0.000512746,0.00019781102,0.00008454303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023130047,0.0001318457,0.00048716727,0.00004172544,0.000040257077,0.000017594108,0.00024787482,0.00001699173,0.00003122864],"category_scores_gemma":[0.00059228187,0.00008331866,0.000031610165,0.000143854,0.00035629113,0.00010924112,0.00020972217,0.00008032329,8.031292e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005215141,0.0005159657,0.96815634,0.0004540876,0.00027079182,0.000002639293,0.00047790149,0.000025702768,0.00016231582,0.000046337605,0.0064676558,0.022898762],"study_design_scores_gemma":[0.0022289853,0.00011448594,0.9911866,0.002666204,0.000005340024,0.0000011793566,0.00022336147,0.003068452,0.00013035118,0.000173162,0.00012357267,0.00007831118],"about_ca_topic_score_codex":0.1854115,"about_ca_topic_score_gemma":0.035081357,"teacher_disagreement_score":0.15033014,"about_ca_system_score_codex":0.00000456947,"about_ca_system_score_gemma":0.00031643346,"threshold_uncertainty_score":0.9825259},"labels":[],"label_agreement":null},{"id":"W2947464563","doi":"10.1136/annrheumdis-2019-eular.1832","title":"FRI0351 DISTINCTION BETWEEN TELANGIECTASIA SECONDARY TO CONNECTIVE TISSUE DISEASE AND CUTANEOUS COLLAGENOUS VASCULOPATHY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; CTD; Dermatomyositis; Connective tissue disease; Pathology; Telangiectasia; Connective tissue; Dermatology; Undifferentiated connective tissue disease; Disease; Autoimmune disease","score_opus":0.016127339601589612,"score_gpt":0.2781892649395357,"score_spread":0.2620619253379461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947464563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898473,0.0045798183,0.000042402833,0.0017167599,0.00018433743,0.0018913813,0.0006270596,0.000104782834,0.0010061461],"genre_scores_gemma":[0.9981371,0.00014488745,0.00005009009,0.00061353715,0.000058139103,0.000061496925,0.000077795914,0.000052781277,0.000804182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981363,0.00014168116,0.0004582002,0.00040385744,0.0004963268,0.000363634],"domain_scores_gemma":[0.9976888,0.00043732297,0.00023893561,0.0008866509,0.00020032632,0.00054799387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012601666,0.0002913436,0.00066793436,0.0001250482,0.00015593703,0.000036178804,0.0002550129,0.00005721808,0.0005542913],"category_scores_gemma":[0.0011504077,0.0002141729,0.00025599683,0.0002923892,0.00016143887,0.000096506854,0.00024767197,0.00010588811,0.00018097743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003588247,0.0023266885,0.7736163,0.0075526945,0.003099233,0.0002706039,0.003446284,0.00035739728,0.0006746602,0.00072124193,0.020916827,0.18342982],"study_design_scores_gemma":[0.0008537273,0.0005328027,0.99182546,0.001286267,0.0009606172,0.000054369277,0.0005422937,0.000054620825,0.00075878203,0.0016067686,0.0012267175,0.0002975656],"about_ca_topic_score_codex":0.00011568381,"about_ca_topic_score_gemma":0.000004124546,"teacher_disagreement_score":0.21820918,"about_ca_system_score_codex":0.000042157564,"about_ca_system_score_gemma":0.00033533227,"threshold_uncertainty_score":0.8733718},"labels":[],"label_agreement":null},{"id":"W2947471477","doi":"10.1136/annrheumdis-2019-eular.4239","title":"FRI0256 ASSESSING THE PREVALENCE AND USE OF VALIDATED SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY METRICS IN REAL WORLD PRACTICE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"EMD Serono; National Institutes of Health; Glenmark Pharmaceuticals; Brigham and Women's Hospital; Johns Hopkins University; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Disease; Medicine; Systemic lupus erythematosus; Computer science; Intensive care medicine; Internal medicine","score_opus":0.08372029135838253,"score_gpt":0.38204787118661343,"score_spread":0.2983275798282309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947471477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917682,0.0043790243,0.000016345275,0.00130786,0.00020346633,0.0019099299,0.000080746315,0.000030838542,0.000303633],"genre_scores_gemma":[0.9955922,0.0027565195,0.0000688163,0.00008320233,0.0000145503545,0.00005284529,0.0000038470125,0.000035423953,0.0013926419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615276,0.0011056279,0.0007691303,0.0003618569,0.0012293484,0.0003812693],"domain_scores_gemma":[0.99121785,0.005772655,0.00086371775,0.0014237856,0.0004784134,0.00024356702],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0015228128,0.0002468541,0.0007606827,0.0003678162,0.00007754795,0.00009561047,0.00043515442,0.000057701694,0.000040699637],"category_scores_gemma":[0.008988672,0.00013956723,0.00021898773,0.0013381531,0.00027586048,0.00068716507,0.00033542365,0.00024037638,0.00000957878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072855956,0.0005955171,0.97541106,0.02005523,0.000254909,0.000017147016,0.0006216917,0.00006581491,0.00028784017,0.00030829752,0.000587455,0.0010664981],"study_design_scores_gemma":[0.0031275554,0.000190038,0.93762463,0.042522844,0.0012076321,0.0015842109,0.0025679786,0.00895966,0.0011599436,0.000534889,0.00011511562,0.00040550262],"about_ca_topic_score_codex":0.00042172923,"about_ca_topic_score_gemma":0.0000099180015,"teacher_disagreement_score":0.03778641,"about_ca_system_score_codex":0.00007154224,"about_ca_system_score_gemma":0.0004755674,"threshold_uncertainty_score":0.999359},"labels":[],"label_agreement":null},{"id":"W2947496942","doi":"10.1136/annrheumdis-2019-eular.7272","title":"AB0283 IDENTIFICATION OF NEW AUTOANTIBODIES FOR RHEUMATOID ARTHRITIS USING HUMAN PROTEOME MICROARRAYS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Anhui Province; University of British Columbia; National Natural Science Foundation of China","keywords":"Medicine; Autoantibody; Rheumatoid arthritis; Identification (biology); Proteome; Computational biology; DNA microarray; Arthritis; Immunology; Bioinformatics; Antibody; Genetics; Gene expression; Biology; Gene","score_opus":0.07472407226452016,"score_gpt":0.37444916572156933,"score_spread":0.2997250934570492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947496942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262726,0.0038173103,0.00010485929,0.0015368606,0.00012465105,0.0014257119,0.00019549663,0.000018904138,0.0001489156],"genre_scores_gemma":[0.99515736,0.0011720002,0.0004325135,0.00008664205,0.00003574342,0.00002267943,0.000043428634,0.000023807352,0.003025806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982747,0.000051567346,0.0007172337,0.00021254612,0.00046809987,0.00027584765],"domain_scores_gemma":[0.99846876,0.00013953207,0.00044517138,0.00050254824,0.0003083713,0.0001356007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027636733,0.000160367,0.00053546013,0.000120867866,0.000120906436,0.000022895409,0.00027930434,0.00004846288,0.00020448027],"category_scores_gemma":[0.00031584018,0.000110342655,0.00042342654,0.00017328627,0.00019592128,0.00011447149,0.00010057108,0.00007333081,0.000021134849],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019512385,0.0018845437,0.15072119,0.01579441,0.0018831433,0.0000037979937,0.0022799394,0.00029801132,0.7274236,0.011747895,0.025527472,0.060484737],"study_design_scores_gemma":[0.003532481,0.0008253587,0.48258123,0.011341221,0.00018827242,0.00005242661,0.00057166204,0.0029201042,0.4723003,0.022525182,0.0026455305,0.00051623856],"about_ca_topic_score_codex":0.00038893303,"about_ca_topic_score_gemma":0.0000061351984,"teacher_disagreement_score":0.33186004,"about_ca_system_score_codex":0.000011357659,"about_ca_system_score_gemma":0.00023248,"threshold_uncertainty_score":0.44996428},"labels":[],"label_agreement":null},{"id":"W2947572061","doi":"10.1136/annrheumdis-2019-eular.1176","title":"OP0254 CANAKINUMAB IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RECURRENT FEVER SYNDROMES: RESULTS FROM A PHASE 3 TRIAL (CLUSTER)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"EMD Serono; Celgene; Sandwell and West Birmingham Hospitals NHS Trust; Eli Lilly and Company","keywords":"Medicine; Canakinumab; Quality of life (healthcare); Psychosocial; Familial Mediterranean fever; Internal medicine; Pediatrics; Physical therapy; Disease; Psychiatry; Anakinra","score_opus":0.013815859733137023,"score_gpt":0.2686010292850212,"score_spread":0.2547851695518842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947572061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741197,0.00029971084,0.0000012473068,0.00017813008,0.00034084255,0.0011295191,0.00054093497,0.0000067669057,0.00009088869],"genre_scores_gemma":[0.9988984,0.000052628628,0.000013097585,0.00018975587,0.000008504156,0.000041316798,0.0006312338,0.000020543399,0.00014453044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834096,0.00010951021,0.00065581244,0.0003263617,0.0003059315,0.00026143307],"domain_scores_gemma":[0.99845797,0.000051781222,0.0005109485,0.00078607013,0.0001301029,0.000063140775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083682695,0.00022164028,0.00037010192,0.000056713758,0.000040350365,0.000022084543,0.00030496914,0.00006906899,0.000024809762],"category_scores_gemma":[0.0005012011,0.00013969956,0.0002007144,0.00011162087,0.00006795396,0.000017262231,0.00015094128,0.000064345404,0.000006252139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3203768,0.019260313,0.4740758,0.0005677914,0.0055486537,0.000011294044,0.0034036837,0.0005335988,0.002169361,0.000025447256,0.015043203,0.15898404],"study_design_scores_gemma":[0.19251487,0.0055307588,0.7917723,0.0009438039,0.00023017802,8.797466e-7,0.00082886324,0.00011625976,0.00545857,0.00023158597,0.0015417922,0.0008301276],"about_ca_topic_score_codex":0.0004718877,"about_ca_topic_score_gemma":0.00007384614,"teacher_disagreement_score":0.3176965,"about_ca_system_score_codex":0.0000101301175,"about_ca_system_score_gemma":0.00015167643,"threshold_uncertainty_score":0.5696783},"labels":[],"label_agreement":null},{"id":"W2947616753","doi":"10.1136/annrheumdis-2019-eular.2886","title":"OP0029 SWITCHING BETWEEN THE JAK1-SELECTIVE INHIBITOR-UPADACITINIB AND ADALIMUMAB FOLLOWING INITIAL NON-RESPONSE: CLINICAL AND FUNCTIONAL OUTCOMES AMONG RHEUMATOID ARTHRITIS PATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"Sanofi Genzyme; Genentech; Regeneron Pharmaceuticals; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Methotrexate; Placebo; Adverse effect; Gastroenterology; Pathology","score_opus":0.03605637087655619,"score_gpt":0.34789586733678785,"score_spread":0.3118394964602317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947616753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996447,0.00080025895,0.000015898206,0.0010369491,0.00032441254,0.0011417258,0.00006976882,0.000029716111,0.00013426317],"genre_scores_gemma":[0.99896395,0.0003924225,0.000019326975,0.00035519848,0.00006953431,0.000042667783,0.000021034777,0.000039907416,0.00009597323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966757,0.00051423826,0.0009005504,0.00042389444,0.00104313,0.0004424396],"domain_scores_gemma":[0.9943879,0.0041868463,0.00033106928,0.00057998515,0.00021578722,0.00029837774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012869678,0.00028524295,0.00083868793,0.000114016846,0.0003007913,0.000084400424,0.00023075477,0.00012394378,0.000053254564],"category_scores_gemma":[0.0039052148,0.00016902067,0.00042614512,0.0002288439,0.0005047826,0.0002775038,0.0004344762,0.00035380494,0.00001782336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012168862,0.00020016491,0.97563624,0.0001758093,0.00073706656,0.0000061449737,0.00046626714,0.000005560438,0.000008322258,0.000023048502,0.0011172302,0.02040728],"study_design_scores_gemma":[0.013788748,0.00034789473,0.9818414,0.0018285358,0.00011538121,0.000012633918,0.0004164214,0.00070373074,0.00015254694,0.0005672902,0.00004103563,0.00018438968],"about_ca_topic_score_codex":0.00024886033,"about_ca_topic_score_gemma":0.000015160945,"teacher_disagreement_score":0.02022289,"about_ca_system_score_codex":0.00019448524,"about_ca_system_score_gemma":0.0015228345,"threshold_uncertainty_score":0.6892463},"labels":[],"label_agreement":null},{"id":"W2947756907","doi":"10.1136/annrheumdis-2019-eular.1440","title":"SAT0393 EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Ottawa; University of Toronto; Université de Montréal; University of Saskatchewan; Lakeridge Health; Nexus Clinical Research (Canada); Memorial University of Newfoundland","funders":"AstraZeneca; Amgen","keywords":"Medicine; Psoriatic arthritis; Ustekinumab; Golimumab; Internal medicine; Infliximab; Dactylitis; Population; Incidence (geometry); Enthesitis; Arthritis; Disease","score_opus":0.01653192858621517,"score_gpt":0.2436608507875698,"score_spread":0.22712892220135464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947756907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912602,0.007182155,0.0000015876672,0.000052093368,0.00018925553,0.0006340895,0.0006049275,0.000008099563,0.00006764905],"genre_scores_gemma":[0.998927,0.00084939,0.000016808093,0.000023627348,0.0000041488884,0.000041758787,0.00008706951,0.000009105354,0.000041077932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892247,0.00029168194,0.00035223755,0.00021692793,0.00006870448,0.00014799065],"domain_scores_gemma":[0.99862623,0.0007169994,0.00027981465,0.00026781048,0.000089352194,0.000019808236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013039209,0.00015215825,0.00044767265,0.000053009393,0.000050507024,0.0000072642624,0.00012761001,0.000086965054,0.00006124172],"category_scores_gemma":[0.00029253511,0.00011213191,0.000085694395,0.00011414807,0.00017122246,0.00011764417,0.000101115074,0.000056725603,0.0000075811035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010910741,0.0003981788,0.9279275,0.00024048513,0.00042499206,3.9941287e-7,0.00050523825,0.000010310219,0.00025914656,0.00057480106,0.000039655613,0.068528235],"study_design_scores_gemma":[0.0049148933,0.00014301643,0.9868496,0.0011690948,0.00008093381,0.0000012394291,0.00010277606,0.000007879415,0.0024744114,0.0041301,0.000018758745,0.00010731921],"about_ca_topic_score_codex":0.0002583567,"about_ca_topic_score_gemma":0.000026663785,"teacher_disagreement_score":0.06842092,"about_ca_system_score_codex":0.000016701306,"about_ca_system_score_gemma":0.00005660438,"threshold_uncertainty_score":0.45726064},"labels":[],"label_agreement":null},{"id":"W2947841996","doi":"10.1136/annrheumdis-2019-eular.4603","title":"SAT0369 SECUKINUMAB IMPROVES GRAPPA-OMERACT CORE DOMAINS OF PSORIATIC ARTHRITIS REGARDLESS OF PREVIOUS EXPOSURE TO A TNF INHIBITOR","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Horizon Pharma; Celgene; Galápagos; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Internal medicine; Rheumatology; Placebo; Ankylosing spondylitis; Clinical trial; Psoriasis; Arthritis; Oncology; Physical therapy; Immunology; Pathology; Alternative medicine","score_opus":0.019037231011136725,"score_gpt":0.25644664402496503,"score_spread":0.2374094130138283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947841996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98173094,0.015786534,0.0000031230186,0.00016198397,0.0006982841,0.0008518728,0.00058789586,0.000022368784,0.00015702612],"genre_scores_gemma":[0.9978873,0.0013464673,0.000040587176,0.0000701162,0.000016366812,0.000053857686,0.000053309253,0.000022589407,0.0005094149],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838,0.0002294233,0.00070821575,0.00025946152,0.00012806758,0.0002948295],"domain_scores_gemma":[0.99798244,0.0003729415,0.00063535216,0.0007871146,0.00017140599,0.000050744402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018964997,0.00025078826,0.0008112409,0.00013193683,0.00006585425,0.0000072597354,0.0004310235,0.00012469885,0.00021957983],"category_scores_gemma":[0.0002816075,0.00017332908,0.00046648172,0.00026113453,0.00016998913,0.00009078289,0.00013908622,0.00006986596,0.00006516857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028374232,0.0035315894,0.03426857,0.0031517104,0.0056130425,0.0000062168133,0.0064125243,0.00007717728,0.1117127,0.0024097299,0.010895825,0.8190835],"study_design_scores_gemma":[0.010514353,0.00439167,0.5335637,0.009026112,0.001568302,0.000043040254,0.002508606,0.00000839147,0.42957938,0.006091198,0.0017064317,0.0009988546],"about_ca_topic_score_codex":0.0001082788,"about_ca_topic_score_gemma":0.000022545173,"teacher_disagreement_score":0.81808466,"about_ca_system_score_codex":0.000010388419,"about_ca_system_score_gemma":0.000111787806,"threshold_uncertainty_score":0.7068155},"labels":[],"label_agreement":null},{"id":"W2948013745","doi":"10.1136/annrheumdis-2019-eular.792","title":"SAT0109 SMOKING CESSATION IN PATIENTS WITH RA IS ASSOCIATED WITH REDUCED CVD EVENT RATES AND IMPROVED LIPID PROFILES AND PREDICTS LOWER RA DISEASE ACTIVITY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Rheumatoid arthritis; Quartile; Internal medicine; Disease; Proportional hazards model; Smoking cessation; Risk factor; Logistic regression; Confidence interval; Pathology","score_opus":0.013092856010053817,"score_gpt":0.2551185580780044,"score_spread":0.24202570206795057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948013745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964302,0.0005208471,5.4819833e-7,0.0010864014,0.00005287662,0.0015956652,0.0002742749,0.00001966689,0.000019496707],"genre_scores_gemma":[0.9993368,0.00018297078,0.0000055334067,0.00019563215,0.000008437949,0.00010651043,0.00008335264,0.00002215222,0.000058618807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987513,0.000103100225,0.00022699583,0.00030522447,0.00039969652,0.0002136723],"domain_scores_gemma":[0.9988085,0.00017274279,0.00029683806,0.0003270065,0.00015833213,0.00023656595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101160236,0.0002180333,0.00039438746,0.000070986134,0.00006395895,0.000036771155,0.00006641636,0.00003671137,0.00004415271],"category_scores_gemma":[0.00020192754,0.000121973644,0.00007245882,0.00015502183,0.00010442969,0.00023988629,0.000063366264,0.00006486592,8.747042e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023263695,0.0024346309,0.9895915,0.0005096899,0.0005744691,0.0000029812122,0.0002734424,0.000009918447,0.000016491638,0.000006738108,0.00019746777,0.0040563173],"study_design_scores_gemma":[0.0053583165,0.0007195418,0.9881043,0.00363234,0.0006041299,2.500833e-7,0.00006709554,0.0005871489,0.0007071628,0.000073084164,0.00000197487,0.0001446452],"about_ca_topic_score_codex":0.00006655688,"about_ca_topic_score_gemma":0.0000060897682,"teacher_disagreement_score":0.003911672,"about_ca_system_score_codex":0.000038408525,"about_ca_system_score_gemma":0.00015176873,"threshold_uncertainty_score":0.49739408},"labels":[],"label_agreement":null},{"id":"W2949071363","doi":"10.1136/annrheumdis-2019-eular.7901","title":"THU0366 MAGNETIC RESONANCE IMAGING IN COMPARISON WITH CONVENTIONAL RADIOGRAPHY FOR DETECTION OF STRUCTURAL CHANGES TYPICAL FOR SPA – DATA FROM THE ASSESSMENT OF SPONDYLOARTHRITIS INTERNATIONAL SOCIETY (ASAS) COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiography; Sacroiliitis; Magnetic resonance imaging; Radiology; Axial spondyloarthritis; Ankylosis; Kappa; Nuclear medicine; Ankylosing spondylitis; Cohort; Orthodontics; Surgery; Internal medicine","score_opus":0.03567962280117447,"score_gpt":0.337250784514797,"score_spread":0.3015711617136225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949071363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824005,0.011458347,0.00017686651,0.0013732216,0.0001970782,0.0012856153,0.0030796733,0.0000051429984,0.000023581895],"genre_scores_gemma":[0.9979111,0.00047580703,0.0010257885,0.000066734625,0.000027078193,0.00009614728,0.00036727363,0.000009665264,0.000020393483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990263,0.00003083796,0.00032001024,0.00019216212,0.00030552555,0.0001251661],"domain_scores_gemma":[0.9987872,0.00038437088,0.00026779276,0.00036378246,0.00017093857,0.000025892465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015503222,0.000106988286,0.0003660425,0.000034654888,0.000049898026,0.000008430273,0.00023335357,0.000019896373,0.000049640657],"category_scores_gemma":[0.00007828918,0.00006404721,0.00019052411,0.00010610512,0.00018184917,0.000065994645,0.000087746004,0.000042548814,1.828499e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008233587,0.00021905957,0.9730835,0.00015374206,0.00031701731,2.8014935e-7,0.00009240316,0.000010928665,0.00012316622,0.00017283708,0.0011126283,0.023891095],"study_design_scores_gemma":[0.0036322374,0.00033916452,0.9843318,0.0010502075,0.00020831684,0.0000025942993,0.00044956076,0.008682816,0.00031329656,0.00049108715,0.00043923114,0.000059720685],"about_ca_topic_score_codex":0.00014002268,"about_ca_topic_score_gemma":0.00017166787,"teacher_disagreement_score":0.023831375,"about_ca_system_score_codex":0.000013619745,"about_ca_system_score_gemma":0.000053481446,"threshold_uncertainty_score":0.26117694},"labels":[],"label_agreement":null},{"id":"W2949086036","doi":"10.1136/annrheumdis-2019-eular.3341","title":"OP0204 EMAPALUMAB, AN INTERFERON GAMMA (IFN-Y)-BLOCKING MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Macrophage activation syndrome; Hemophagocytosis; Arthritis; Internal medicine; Immunology; Hepatosplenomegaly; Gastroenterology; Tocilizumab; Adverse effect; Rheumatoid arthritis; Pancytopenia; Bone marrow; Disease","score_opus":0.02041723704868489,"score_gpt":0.29227520109567656,"score_spread":0.2718579640469917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949086036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682486,0.0012736215,0.000040128147,0.00023300883,0.00005842153,0.001353713,0.000029813731,0.000044070704,0.00014236143],"genre_scores_gemma":[0.999481,0.00010373997,0.000028280856,0.00010052285,0.0000097546745,0.00005612786,0.000098310375,0.00004495274,0.00007727383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973924,0.00024517032,0.00086787104,0.00035165664,0.00073733565,0.00040554666],"domain_scores_gemma":[0.9981799,0.00008785261,0.00053068466,0.00081258995,0.00025347262,0.0001355142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041955867,0.00024555236,0.00080343825,0.00020221047,0.00011397686,0.000047082292,0.00038831562,0.00007983466,0.00012338714],"category_scores_gemma":[0.00020758137,0.00017923159,0.00015203048,0.00035995536,0.000117031836,0.00041544068,0.00016581191,0.00026675133,0.00004436825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012778533,0.0014596864,0.9432178,0.0038987936,0.0002372192,0.000018483548,0.0011476525,0.0005494534,0.0020047226,0.00012475904,0.00008603083,0.04597753],"study_design_scores_gemma":[0.0030313022,0.0011730143,0.9730598,0.018064057,0.000034322948,0.000034559132,0.0007492779,0.002565633,0.00091238925,0.00013676328,0.000008727075,0.00023020047],"about_ca_topic_score_codex":0.00016660376,"about_ca_topic_score_gemma":0.0000074337,"teacher_disagreement_score":0.04574733,"about_ca_system_score_codex":0.00006536352,"about_ca_system_score_gemma":0.00021139673,"threshold_uncertainty_score":0.7308852},"labels":[],"label_agreement":null},{"id":"W2949141411","doi":"10.1136/annrheumdis-2019-eular.3388","title":"FRI0334 PERFORMANCE OF THE SCLERODERMA SKIN PATIENT-REPORTED OUTCOME (SSPRO) IN A PHASE 2 TRIAL WITH LENABASUM","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Scleroderma (fungus); Outcome (game theory); Dermatology; Pathology","score_opus":0.05393691450906222,"score_gpt":0.3047402630489404,"score_spread":0.2508033485398782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949141411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950151,0.0015684174,4.728877e-7,0.00064320257,0.00033576647,0.001973809,0.00004331933,0.000016750815,0.0004031513],"genre_scores_gemma":[0.99920726,0.00022776186,0.000006785865,0.0002753582,0.000019140407,0.000057729816,0.0000070230135,0.000022542727,0.0001763945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976044,0.0001489795,0.0010471916,0.00022842929,0.00071631535,0.00025463925],"domain_scores_gemma":[0.9977992,0.00013551446,0.00084221596,0.0009666763,0.00014130042,0.000115079536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002135231,0.00020259545,0.00065650296,0.00009703213,0.00005312786,0.000010631482,0.0002892993,0.00006625785,0.00013332027],"category_scores_gemma":[0.00041211062,0.00009181115,0.0003792132,0.00042867332,0.00017293732,0.000108041844,0.00009378144,0.00012595074,0.0000091304455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02840683,0.0055154567,0.9356353,0.002502277,0.0009134631,0.000005265834,0.0011323605,0.000449114,0.0010735273,0.000046831305,0.0016499306,0.022669632],"study_design_scores_gemma":[0.053052343,0.0014889566,0.9177586,0.015602703,0.0006007753,0.000019249079,0.00087535713,0.0012285277,0.00907073,0.000031782536,0.00003613716,0.00023487843],"about_ca_topic_score_codex":0.00010389149,"about_ca_topic_score_gemma":0.000002841222,"teacher_disagreement_score":0.024645513,"about_ca_system_score_codex":0.000015403375,"about_ca_system_score_gemma":0.0002516086,"threshold_uncertainty_score":0.37439498},"labels":[],"label_agreement":null},{"id":"W2949219841","doi":"10.1136/annrheumdis-2019-eular.330","title":"SAT0349 HIGHER DISEASE ACTIVITY IS ASSOCIATED WITH MORE SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Bundesministerium für Bildung und Forschung","keywords":"Medicine; Ankylosing spondylitis; Cohort; Axial spondyloarthritis; Internal medicine; Observational study; Radiography; Cohort study; Confidence interval; Physical therapy; Surgery; Sacroiliitis","score_opus":0.014926795935471861,"score_gpt":0.2775618683162935,"score_spread":0.2626350723808216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949219841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952685,0.0016884912,2.600366e-7,0.0012379027,0.00009618244,0.0012976354,0.00026878764,0.000031788404,0.00011044354],"genre_scores_gemma":[0.99923426,0.00016283966,0.00001353438,0.0002615172,0.000012188204,0.000074868876,0.00005984412,0.00003270902,0.00014825018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982036,0.000083411884,0.0002523652,0.0003237818,0.0007756201,0.00036124903],"domain_scores_gemma":[0.99877125,0.000055476787,0.00027487814,0.0005039312,0.00017450612,0.00021996665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006794012,0.00027160993,0.0005697686,0.00012833157,0.00009697432,0.000019360476,0.00012999137,0.000046514517,0.00018075247],"category_scores_gemma":[0.00007908093,0.0001515319,0.00020507263,0.000511104,0.00022936749,0.00016309414,0.000072068535,0.000110907305,0.000008846414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077108284,0.0026465827,0.9717975,0.00021505011,0.00047352698,0.000041168198,0.000083895335,0.0000038221283,0.000001378512,0.000017406508,0.00031676496,0.016692039],"study_design_scores_gemma":[0.009129712,0.0019682876,0.9814329,0.0068406137,0.00025846603,0.0000014385479,0.000030572584,0.0000138716005,0.00003458098,0.00007570648,0.00003490517,0.00017892144],"about_ca_topic_score_codex":0.000065652675,"about_ca_topic_score_gemma":0.0000187364,"teacher_disagreement_score":0.016513117,"about_ca_system_score_codex":0.000032630753,"about_ca_system_score_gemma":0.00010410728,"threshold_uncertainty_score":0.61792916},"labels":[],"label_agreement":null},{"id":"W2949232069","doi":"10.1136/annrheumdis-2019-eular.3403","title":"THU0167 SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Rheumatoid arthritis; Discontinuation; Adverse effect; Placebo; Adalimumab; Internal medicine; Methotrexate; Phases of clinical research; Clinical trial; Pharmacology; Gastroenterology; Pathology","score_opus":0.04611880106264763,"score_gpt":0.39903815208864907,"score_spread":0.3529193510260014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949232069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180627,0.0038179483,0.00002032859,0.0010257154,0.000090187445,0.0021500422,0.0005474629,0.00004760883,0.00049444713],"genre_scores_gemma":[0.994973,0.0040176506,0.00018624403,0.00020860245,0.000022285076,0.00010660578,0.00025792548,0.000027750419,0.00019992467],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99597657,0.00068774563,0.0015649238,0.0004041846,0.0009149245,0.0004516756],"domain_scores_gemma":[0.99524677,0.002205489,0.000567089,0.0013962152,0.00038926143,0.0001951901],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001252873,0.0002470405,0.0012746843,0.00016809205,0.000054489792,0.000029179846,0.00067302235,0.00011689089,0.0015371937],"category_scores_gemma":[0.0032467819,0.00013197317,0.0008785639,0.0018056157,0.00052214426,0.00010608884,0.00021099298,0.0003285538,0.000069577385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007912832,0.011191049,0.3657556,0.0010677427,0.009762825,0.00003431958,0.0015160241,0.00030590163,0.0001349448,0.0003541644,0.014340081,0.58762455],"study_design_scores_gemma":[0.07348173,0.0029234493,0.7398046,0.015089068,0.0018418867,0.00003333078,0.0035914343,0.15200396,0.0055519645,0.0016345194,0.0032673876,0.0007766579],"about_ca_topic_score_codex":0.002041739,"about_ca_topic_score_gemma":0.00019612774,"teacher_disagreement_score":0.5868479,"about_ca_system_score_codex":0.0002874024,"about_ca_system_score_gemma":0.0038919058,"threshold_uncertainty_score":0.9993755},"labels":[],"label_agreement":null},{"id":"W2949251889","doi":"10.1136/annrheumdis-2019-eular.1539","title":"OP0342 IDENTIFYING CANDIDATE ITEMS TOWARDS THE DEVELOPMENT OF CLASSIFICATION CRITERIA FOR CHRONIC NONBACTERIAL OSTEOMYELITIS (CNO) AND CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS (CRMO)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteomyelitis and Bone Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"Childhood Arthritis and Rheumatology Research Alliance","keywords":"Chronic recurrent multifocal osteomyelitis; Medicine; Osteomyelitis; Chronic disease; Osteitis; Intensive care medicine; Surgery","score_opus":0.10642705739121303,"score_gpt":0.38233043107276643,"score_spread":0.2759033736815534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949251889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868704,0.0055874446,0.00012338406,0.0038746807,0.0005402643,0.0024417373,0.0004027451,0.000020176354,0.00013916564],"genre_scores_gemma":[0.997435,0.0013052529,0.00019272757,0.000031147873,0.00023762956,0.0002504323,0.0002069883,0.000036883448,0.000303963],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973521,0.00017925688,0.0009571034,0.0003856613,0.00064635044,0.00047950982],"domain_scores_gemma":[0.9980161,0.00026101194,0.00043865677,0.00069374667,0.00042370212,0.00016677241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062672124,0.00026199763,0.00062323455,0.0001190275,0.00021266323,0.00008772075,0.00037775276,0.000086455635,0.00032297592],"category_scores_gemma":[0.00037060742,0.00016404245,0.00028835627,0.00021562075,0.00029340977,0.00017343262,0.00024744868,0.00013614967,0.000014957197],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000670203,0.00012461224,0.0018764132,0.005994024,0.0003204249,7.371249e-7,0.0017646567,0.0000030232486,0.018156469,0.00016721616,0.0006076338,0.97031456],"study_design_scores_gemma":[0.012315427,0.003043527,0.86536866,0.014696792,0.0006453106,0.00004704285,0.004704811,0.008786699,0.07025695,0.0011614313,0.01803489,0.0009384294],"about_ca_topic_score_codex":0.00017910043,"about_ca_topic_score_gemma":0.00016153514,"teacher_disagreement_score":0.96937615,"about_ca_system_score_codex":0.00011800405,"about_ca_system_score_gemma":0.0010395601,"threshold_uncertainty_score":0.66894567},"labels":[],"label_agreement":null},{"id":"W2949252282","doi":"10.1136/annrheumdis-2019-eular.4166","title":"AB0738 DUAL NEUTRALISATION OF INTERLEUKIN (IL)–17A AND IL–17F WITH BIMEKIZUMAB IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: 60-WEEK RESULTS FROM A RANDOMISED, DOUBLE-BLINDED, PHASE 2B EXTENSION STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Placebo; Ankylosing spondylitis; Internal medicine; Immune system; Dithranol; Interleukin 17; Psoriasis Area and Severity Index; Arthritis; Interleukin; Gastroenterology; Inflammation; Dermatology; Immunology; Pathology; Cytokine","score_opus":0.05462284286593391,"score_gpt":0.29499905037272445,"score_spread":0.24037620750679053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949252282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521327,0.0010796097,0.0000087138005,0.0003455482,0.0002822017,0.0020407997,0.00096146273,0.00002594749,0.00004241837],"genre_scores_gemma":[0.9991425,0.00022257287,0.000035964316,0.00006209224,0.0000124833305,0.00011090652,0.00021141072,0.000023354738,0.00017871158],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977548,0.00051628187,0.00084590673,0.00046734788,0.00013226086,0.00028336892],"domain_scores_gemma":[0.9980457,0.0006022323,0.00050259236,0.00064732134,0.0001436741,0.000058513968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038618574,0.00031432757,0.00080043863,0.0002116744,0.00008430965,0.000026181195,0.0002524859,0.00012384326,0.00007310669],"category_scores_gemma":[0.00014513453,0.00020164512,0.00015283284,0.00025103777,0.00011434187,0.00020159918,0.00011372978,0.000108095854,0.00003208251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8608351,0.013824248,0.016629841,0.00032013224,0.0043143616,0.00004440145,0.020901546,0.002478637,0.00990356,0.00017034274,0.0017039313,0.06887394],"study_design_scores_gemma":[0.61710304,0.0066944286,0.28978,0.00360164,0.0019476681,0.000048287162,0.0097514875,0.00031786054,0.06800106,0.0016166414,0.00007891635,0.0010589684],"about_ca_topic_score_codex":0.0011012268,"about_ca_topic_score_gemma":0.00026023312,"teacher_disagreement_score":0.27315015,"about_ca_system_score_codex":0.00001847708,"about_ca_system_score_gemma":0.000104615785,"threshold_uncertainty_score":0.82228494},"labels":[],"label_agreement":null},{"id":"W2949268801","doi":"10.1136/annrheumdis-2019-eular.3110","title":"SAT0120 COMPARATIVE EFFECTIVENESS OF TOFACITINIB AND TNF INHIBITORS SINCE 2014. IMPACT OF COMBINATION WITH METHOTREXATE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Adalimumab; Golimumab; Tofacitinib; Etanercept; Infliximab; Certolizumab pegol; Ustekinumab; Internal medicine; Rheumatoid arthritis; Concomitant; Abatacept; Discontinuation; Methotrexate; Psoriatic arthritis; Oncology; Tumor necrosis factor alpha; Rituximab","score_opus":0.028530485257976156,"score_gpt":0.34540469496090004,"score_spread":0.3168742097029239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949268801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462163,0.004024078,0.000015925714,0.000103887374,0.000028821107,0.0007724779,0.00014818108,0.00000840857,0.00027660228],"genre_scores_gemma":[0.9982307,0.0016505342,0.000046146244,0.000007670382,0.000002659823,0.000013111564,0.000018028055,0.000010344582,0.000020805368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986424,0.0003700184,0.00030024216,0.00013546164,0.00039523115,0.00015667386],"domain_scores_gemma":[0.99819016,0.00076127646,0.00030730892,0.00029645767,0.00034088184,0.000103914324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039660741,0.00013662461,0.0006461011,0.00009845087,0.000031262774,0.000009217439,0.000105486266,0.00002601971,0.00007061719],"category_scores_gemma":[0.00021391505,0.00007654281,0.00017712773,0.00017920478,0.00038966394,0.00014684189,0.00005115679,0.00006375551,0.000003570009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00618887,0.0017525938,0.9491427,0.0048584044,0.002254296,0.0000023434718,0.0020795166,0.0002551694,0.010517101,0.00408802,0.00072205655,0.018138919],"study_design_scores_gemma":[0.0026379188,0.0016731394,0.93977714,0.005137842,0.000028009861,0.0000074667746,0.00031771394,0.000240714,0.048423626,0.0016558414,0.000010730099,0.00008984827],"about_ca_topic_score_codex":0.0002250715,"about_ca_topic_score_gemma":0.0000031274037,"teacher_disagreement_score":0.037906528,"about_ca_system_score_codex":0.000009900178,"about_ca_system_score_gemma":0.00014512529,"threshold_uncertainty_score":0.31213254},"labels":[],"label_agreement":null},{"id":"W2949292483","doi":"10.1136/annrheumdis-2019-eular.4179","title":"FRI0519 IDENTIFICATION OF CELLULAR TARGETS FOR ANTI-CITRULLINATED PROTEIN ANTIBODIES (ACPAS)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Research in Rheumatology; Dutch Arthritis Society; Arthritis Society; Eli Lilly and Company","keywords":"Autoantibody; Citrullination; Medicine; Neutrophil extracellular traps; Antigen; Antibody; clone (Java method); Molecular biology; Immunology; Biology; Cell biology; Inflammation; Citrulline; Biochemistry","score_opus":0.033118083286173,"score_gpt":0.3265349959192767,"score_spread":0.2934169126331037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949292483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940851,0.0017846985,0.00035229546,0.0012325677,0.000077599114,0.0021812068,0.000118647564,0.000021886652,0.00014601188],"genre_scores_gemma":[0.99706346,0.00018349866,0.00015628085,0.000051353316,0.000010684885,0.0000545521,0.000060313458,0.000025762096,0.002394083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998301,0.00009424353,0.00059640367,0.0002172599,0.0005566134,0.00023443304],"domain_scores_gemma":[0.99807763,0.00016374512,0.00039985456,0.00070783024,0.00055618933,0.0000947736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036240648,0.0001360066,0.00044752314,0.0001311515,0.000051135477,0.00001456144,0.00030605315,0.0000518482,0.00023927697],"category_scores_gemma":[0.0010876815,0.000092712944,0.00033249962,0.00022367838,0.00013943356,0.000074460135,0.000105111096,0.000067719615,0.000056472712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004695654,0.0011065428,0.015073334,0.008226576,0.00038656578,0.0000020729608,0.00024521712,0.00007885863,0.96382195,0.0011897002,0.0038965305,0.00550309],"study_design_scores_gemma":[0.0008688185,0.00019624889,0.092349686,0.0012473703,0.000103269296,9.954467e-7,0.0001720533,0.0030690427,0.8993646,0.0022577231,0.0002565976,0.00011357547],"about_ca_topic_score_codex":0.000025524356,"about_ca_topic_score_gemma":3.3033646e-7,"teacher_disagreement_score":0.07727636,"about_ca_system_score_codex":0.0000094487905,"about_ca_system_score_gemma":0.00012216,"threshold_uncertainty_score":0.3780724},"labels":[],"label_agreement":null},{"id":"W2949319789","doi":"10.1136/annrheumdis-2019-eular.7640","title":"THU0133 TENDERNESS CAN BE REGARDED AS A SIGN OF INFLAMMATION IN RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Rheumatoid arthritis; Synovitis; Tenderness; Interphalangeal Joint; Osteoarthritis; Physical examination; Arthritis; Swelling; Internal medicine; Rheumatology; Surgery; Gastroenterology; Pathology","score_opus":0.023905296469051818,"score_gpt":0.29158478448319985,"score_spread":0.26767948801414804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949319789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852679,0.00736268,0.00000327931,0.004546041,0.00010853269,0.0009392654,0.00005940951,0.000029186478,0.0016837016],"genre_scores_gemma":[0.9692268,0.030206116,0.000024875046,0.0001528359,0.000011347745,0.0000505857,0.000025406656,0.0000260999,0.0002759397],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977055,0.00020736323,0.00073354493,0.000222352,0.0007767207,0.0003545005],"domain_scores_gemma":[0.9982483,0.00028369212,0.00034253165,0.0006887348,0.00026839733,0.0001683767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038001288,0.00019230595,0.0006788042,0.00022028366,0.00004830324,0.000024224093,0.0003030489,0.00006505584,0.00053726236],"category_scores_gemma":[0.0011002364,0.00013780087,0.00027079205,0.00035021282,0.00024442488,0.00017468663,0.000105625084,0.00013761382,0.000034532088],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038827062,0.0029467638,0.38222402,0.0052174465,0.0017237195,0.000063126965,0.013707031,0.00049345643,0.013643048,0.029045632,0.010772659,0.5362804],"study_design_scores_gemma":[0.015863637,0.0018756047,0.7885345,0.035091687,0.000029886634,0.0001713331,0.00834296,0.0015245866,0.09824494,0.046235044,0.00317806,0.0009077458],"about_ca_topic_score_codex":0.00073980447,"about_ca_topic_score_gemma":0.00016620515,"teacher_disagreement_score":0.5353726,"about_ca_system_score_codex":0.000018914418,"about_ca_system_score_gemma":0.00036446893,"threshold_uncertainty_score":0.5882646},"labels":[],"label_agreement":null},{"id":"W2949395959","doi":"10.1136/annrheumdis-2019-eular.798","title":"FRI0452 TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DERMATOLOGIC ENDPOINTS FROM 2 PHASE 3 STUDIES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Dermatology; Arthritis; Rheumatoid arthritis; Psoriasis; Internal medicine","score_opus":0.02667997768072668,"score_gpt":0.28420306581718113,"score_spread":0.25752308813645447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949395959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823634,0.015307406,0.0000016664479,0.00006652684,0.00019234193,0.000352642,0.0016614686,0.000013808299,0.00004071511],"genre_scores_gemma":[0.99864864,0.00076711876,0.00001807808,0.00006072634,0.0000018115935,0.00002862214,0.0004304248,0.000008071323,0.000036495494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867743,0.00028233504,0.00051543844,0.00021766943,0.00009190727,0.00021519321],"domain_scores_gemma":[0.9985154,0.00044727314,0.0004334163,0.00046541286,0.00011838929,0.000020062374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009285114,0.0001881468,0.0008842254,0.00019771022,0.000044174045,0.00000471915,0.00024903615,0.00006667465,0.0005179343],"category_scores_gemma":[0.00017231921,0.000113311864,0.00027216162,0.00044885356,0.00015826049,0.000092164744,0.00007398872,0.000047481408,0.0000443674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000957606,0.002443845,0.9192166,0.0001524929,0.015223459,0.0000025274296,0.001228634,0.0000842168,0.00007720497,0.00012020302,0.00046319817,0.060030013],"study_design_scores_gemma":[0.006723092,0.00029018772,0.98181397,0.00082006806,0.0022486825,4.3315882e-7,0.000847585,0.000014464283,0.00623055,0.0007833572,0.00004332777,0.00018426486],"about_ca_topic_score_codex":0.000091254595,"about_ca_topic_score_gemma":0.00003499444,"teacher_disagreement_score":0.06259739,"about_ca_system_score_codex":0.000008517933,"about_ca_system_score_gemma":0.0000334022,"threshold_uncertainty_score":0.5671018},"labels":[],"label_agreement":null},{"id":"W2949466731","doi":"10.1136/annrheumdis-2019-eular.4258","title":"FRI0147 SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-COMPARE STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Rheumatoid arthritis; Adalimumab; Medicine; Internal medicine; Oncology; Computer science","score_opus":0.03250115161430618,"score_gpt":0.32335986826359203,"score_spread":0.29085871664928586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949466731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319863,0.0036207729,9.110941e-7,0.00067481364,0.00007100032,0.001732646,0.00046783336,0.000011594358,0.00022179105],"genre_scores_gemma":[0.9976455,0.0020874643,0.000007688611,0.00015843956,0.0000062776408,0.000026527538,0.000031076186,0.000014982727,0.0000220206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978834,0.00060407113,0.00053715747,0.00025334358,0.0005003743,0.00022166074],"domain_scores_gemma":[0.99571973,0.0032115944,0.00037152506,0.00044202825,0.00015971297,0.000095403724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055061403,0.000191274,0.0006905259,0.000027617667,0.000115576055,0.000014784247,0.00019664061,0.000025391973,0.0001100817],"category_scores_gemma":[0.00094056193,0.000087704444,0.00008130787,0.00023358926,0.00015818748,0.00012048641,0.00021204106,0.00013436732,0.000007824309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041460916,0.0015557992,0.9463468,0.0004114779,0.0007149079,0.0000026308098,0.0011447405,0.000029439681,0.0000047494777,0.000016313068,0.00047657618,0.007835656],"study_design_scores_gemma":[0.012303729,0.0008401693,0.9809355,0.0037281485,0.00012967229,0.0000014710979,0.0012402388,0.00006917391,0.0001713322,0.00008924693,0.00037541176,0.00011588616],"about_ca_topic_score_codex":0.0006812252,"about_ca_topic_score_gemma":0.00024731684,"teacher_disagreement_score":0.034588728,"about_ca_system_score_codex":0.000019611321,"about_ca_system_score_gemma":0.000066414905,"threshold_uncertainty_score":0.35764834},"labels":[],"label_agreement":null},{"id":"W2949487292","doi":"10.1136/annrheumdis-2019-eular.704","title":"THU0304 PREVALENCE AND MANAGEMENT OF CARDIOVASCULAR RISK FACTORS IN ANCA-ASSOCIATED VASCULITIS: A CROSS-SECTIONAL STUDY IN THE NETHERLANDS AND CANADA","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Microscopic polyangiitis; Granulomatosis with polyangiitis; Dyslipidemia; Internal medicine; Cross-sectional study; Kidney disease; Renal function; Body mass index; Vasculitis; Risk factor; Gastroenterology; Disease; Pathology","score_opus":0.019719316773796708,"score_gpt":0.27410096084297214,"score_spread":0.2543816440691754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949487292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928459,0.005854447,4.7147586e-7,0.0000905587,0.000053148353,0.0009119126,0.000130566,0.0000039225,0.00010905249],"genre_scores_gemma":[0.9944975,0.0053753727,0.0000015419014,0.000024088646,0.0000030363817,0.00003059781,0.000008652152,0.0000062033923,0.000053007254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986688,0.00023275598,0.00033172662,0.00016538285,0.00046298243,0.00013838486],"domain_scores_gemma":[0.99928373,0.00015411232,0.00012497905,0.0003464681,0.000047569672,0.00004313105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047617653,0.00010294654,0.00031543706,0.00004676394,0.000053783297,0.0000145994145,0.00012296563,0.000033111137,0.000027236809],"category_scores_gemma":[0.000101235564,0.000057161156,0.00015597524,0.0001780444,0.00007907922,0.000049206217,0.000053084303,0.00010595769,2.4972607e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001854841,0.0002975585,0.9961423,0.0005421655,0.0014534385,0.0000061267983,0.00062736426,0.0005103653,1.563942e-7,0.000032005977,0.000058872618,0.00031106707],"study_design_scores_gemma":[0.0018740648,0.00009693847,0.9950031,0.00077183574,0.0003639651,0.0000029283722,0.0015075023,0.000095703814,0.000002750932,0.00021089776,0.000010047127,0.0000602832],"about_ca_topic_score_codex":0.1242812,"about_ca_topic_score_gemma":0.015242358,"teacher_disagreement_score":0.10903884,"about_ca_system_score_codex":0.00002138126,"about_ca_system_score_gemma":0.00007572065,"threshold_uncertainty_score":0.8815503},"labels":[],"label_agreement":null},{"id":"W2949513703","doi":"10.1136/annrheumdis-2019-eular.4547","title":"SAT0131 SAFETY AND EFFECTIVENESS OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) IN OLDER ADULTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Retrospective cohort study; Cohort; Adverse effect; Population; Physical therapy; Rheumatology; Arthritis","score_opus":0.007600938972062284,"score_gpt":0.2672667394570664,"score_spread":0.25966580048500415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949513703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98033637,0.013635191,0.000015398111,0.00017443576,0.00009094603,0.0054160166,0.00012472861,0.000044068118,0.00016285562],"genre_scores_gemma":[0.9678702,0.031773534,0.00002334619,0.00002863418,0.000005954283,0.0002025346,0.000022905439,0.000055549917,0.000017378808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959666,0.0007340269,0.0009153457,0.00059151376,0.0012603103,0.00053220504],"domain_scores_gemma":[0.9970304,0.00077211176,0.0004454553,0.0010006302,0.0004072006,0.00034420847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012797731,0.0004016829,0.0016598279,0.00029781592,0.00012467729,0.00004587469,0.0003096054,0.000058703932,0.00012132878],"category_scores_gemma":[0.00078533695,0.0002699162,0.00024906328,0.0005926889,0.0004744499,0.000329533,0.00020704143,0.00024838746,0.000010484985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059490353,0.0020835262,0.9783323,0.0030764318,0.0007725999,0.000014598678,0.0025237578,0.000047307174,0.000023661358,0.00029411598,0.000024788285,0.006857888],"study_design_scores_gemma":[0.0104081845,0.0008482549,0.94515795,0.038982272,0.000033334687,0.000016321672,0.003147776,0.00032487995,0.00019761878,0.0006132053,0.0000030975623,0.000267078],"about_ca_topic_score_codex":0.0006004177,"about_ca_topic_score_gemma":0.000048833106,"teacher_disagreement_score":0.03590584,"about_ca_system_score_codex":0.000057165595,"about_ca_system_score_gemma":0.00029435309,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2949519416","doi":"10.1136/annrheumdis-2019-eular.2458","title":"FRI0065 PATIENT-REPORTED PALINDROMIC SYMPTOMS IN EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Université Laval; University of Calgary; McGill University; University of Toronto; Southlake Regional Health Center; University of Manitoba; Western University","funders":"Janssen Biotech; Eli Lilly Canada; Amgen; AbbVie Canada; Sanofi Genzyme; Bristol-Myers Squibb Canada; Merck Canada; Pfizer Canada; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Cohort; Internal medicine; Logistic regression; Arthritis; Joint pain; Physical therapy; Pediatrics","score_opus":0.01668986185249314,"score_gpt":0.25432271580590055,"score_spread":0.2376328539534074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949519416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97257,0.019617388,5.5729953e-7,0.0034703156,0.0004380393,0.0019255367,0.0009782923,0.00005573848,0.0009441238],"genre_scores_gemma":[0.96923,0.029672919,0.000020856554,0.000603853,0.000032897387,0.000114929666,0.00016163752,0.000057026642,0.000105908104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955703,0.00038168038,0.0014145928,0.00055301783,0.0011959948,0.000884431],"domain_scores_gemma":[0.9962721,0.00066391856,0.0005091809,0.0016278977,0.00031938148,0.0006075575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006066038,0.0003729854,0.0009004924,0.00023460914,0.00028543273,0.00018457424,0.00062208745,0.0001494932,0.00042643625],"category_scores_gemma":[0.0016518184,0.00024864278,0.00037407587,0.00052390475,0.0004458056,0.0003040968,0.00015025842,0.00042779773,0.00029476793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007808434,0.00036105962,0.911054,0.00004238169,0.00093656307,0.00011116044,0.0029243687,0.000025155892,0.000060887483,0.0003804373,0.0062470757,0.07707608],"study_design_scores_gemma":[0.0044525643,0.00041372178,0.9826325,0.007253642,0.000012711728,0.00004839998,0.00039691452,0.000097920594,0.00030812086,0.0022582754,0.001828452,0.00029674493],"about_ca_topic_score_codex":0.2885817,"about_ca_topic_score_gemma":0.08376541,"teacher_disagreement_score":0.20481628,"about_ca_system_score_codex":0.00007364566,"about_ca_system_score_gemma":0.0009887477,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2949577349","doi":"10.1136/annrheumdis-2019-eular.2136","title":"THU0118 TREATMENT OF RHEUMATOID ARTHRITIS WITH COMBINATION THERAPY USING A BIOLOGIC AGENT AND METHOTREXATE LOWERS THE RISK OF DECREASING KIDNEY FUNCTION COMPARED TO METHOTREXATE MONOTHERAPY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Pfizer Japan; AbbVie Canada; Astellas Foundation for Research on Metabolic Disorders; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Bristol-Myers Squibb; AstraZeneca; Teijin Pharma; Pfizer; Japan Blood Products Organization; Ono Pharmaceutical","keywords":"Medicine; Renal function; Internal medicine; Rheumatoid arthritis; Methotrexate; Kidney disease; Prednisolone; Dyslipidemia; Body mass index; Combination therapy; Disease","score_opus":0.0503432257528172,"score_gpt":0.3181175293198915,"score_spread":0.2677743035670743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949577349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97718096,0.019666992,0.00040727915,0.000868151,0.00008919871,0.0016133649,0.000103438346,0.000021105028,0.000049514565],"genre_scores_gemma":[0.8569344,0.14203396,0.00072813994,0.00020095857,0.0000055016794,0.00003912034,0.00001364651,0.000024748188,0.000019514502],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977703,0.0006744288,0.0005568766,0.00026074192,0.0004613813,0.0002762701],"domain_scores_gemma":[0.9977287,0.00052046945,0.0006014801,0.0006006253,0.00029591873,0.00025281962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005320565,0.00025859705,0.0008016757,0.00017268452,0.00014189367,0.00002866107,0.00016975043,0.000043138687,0.00013157891],"category_scores_gemma":[0.00029886662,0.00012816614,0.0002671383,0.00032952067,0.00030825593,0.00011512015,0.00003850057,0.000065470624,0.0000029934506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017160542,0.0036495102,0.40968883,0.00047202536,0.0066912146,0.0000044179624,0.007882922,0.001159202,0.02603319,0.0012118982,0.00040103812,0.5256452],"study_design_scores_gemma":[0.028243745,0.015108061,0.8028497,0.012281225,0.00022555605,0.000089863715,0.005166094,0.012271189,0.11196976,0.008238681,0.00275729,0.0007988184],"about_ca_topic_score_codex":0.00087868155,"about_ca_topic_score_gemma":0.000018296534,"teacher_disagreement_score":0.5248464,"about_ca_system_score_codex":0.000025233854,"about_ca_system_score_gemma":0.0001939258,"threshold_uncertainty_score":0.52264637},"labels":[],"label_agreement":null},{"id":"W2949592566","doi":"10.1136/annrheumdis-2019-eular.4888","title":"THU0126 FACTORS AFFECTING THE DISCREPANCY BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OVER TIME","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Rheumatoid arthritis; Medicine; Disease; Internal medicine; Physical therapy","score_opus":0.010345743224994286,"score_gpt":0.2773730911505356,"score_spread":0.26702734792554134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949592566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966485,0.0011604927,0.000002725675,0.00028335393,0.000043854758,0.0012854354,0.00041716738,0.000017812099,0.00014064462],"genre_scores_gemma":[0.9988624,0.0010074915,0.00001270447,0.00003925674,0.0000070270776,0.0000183889,0.000023891576,0.000021065249,0.000007808387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978677,0.0002668389,0.000385192,0.0002626322,0.0008617885,0.0003558316],"domain_scores_gemma":[0.9983444,0.00036217368,0.0003644578,0.0005820077,0.00012426105,0.00022268717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016969742,0.00023979656,0.00062306324,0.00006061486,0.00010500733,0.000041610594,0.00019590906,0.00003101422,0.000050378738],"category_scores_gemma":[0.00017295589,0.00012718771,0.00019654918,0.00027943737,0.00028868404,0.00028836544,0.00017629465,0.00014028883,0.000003456119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043267093,0.00065350643,0.9652914,0.00019927736,0.00025862936,7.426026e-7,0.00036299307,0.0000072420385,0.000009561095,0.00011611025,0.0000496187,0.032618277],"study_design_scores_gemma":[0.0019355156,0.0007585392,0.9928747,0.0034167743,0.000015955542,2.3326943e-7,0.00016876565,0.000077132114,0.00011909672,0.0004871648,0.000008130501,0.00013800412],"about_ca_topic_score_codex":0.00031891247,"about_ca_topic_score_gemma":0.000017000928,"teacher_disagreement_score":0.032480273,"about_ca_system_score_codex":0.000030375382,"about_ca_system_score_gemma":0.00015753425,"threshold_uncertainty_score":0.5186565},"labels":[],"label_agreement":null},{"id":"W2949663727","doi":"10.1136/annrheumdis-2019-eular.1460","title":"FRI0109 EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND GOLIMUMAB-IV IN RHEUMATOID ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health; University of British Columbia; McMaster University; University of Saskatchewan; University of Alberta; Université Laval; Canadian Rheumatology Association; Université de Montréal; Ontario Rheumatology Association; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Internal medicine; Infliximab; Cohort; Incidence (geometry); Population; Cohort study; Physical therapy; Etanercept; Disease","score_opus":0.0203366777362768,"score_gpt":0.2902031857695247,"score_spread":0.2698665080332479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949663727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938913,0.003931312,0.0000035163182,0.00019249895,0.00006372148,0.0013725772,0.0002853297,0.00001341993,0.0002463327],"genre_scores_gemma":[0.9969951,0.0027187378,0.000048645972,0.00007184348,0.000009058258,0.000056372428,0.00004412824,0.0000229421,0.000033172888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979902,0.00019348932,0.0005855627,0.00033631342,0.00062854734,0.00026592542],"domain_scores_gemma":[0.9975712,0.0011473846,0.00030641115,0.00055084657,0.00028291644,0.00014129166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003016012,0.00019996606,0.0007038878,0.00009823865,0.00004580741,0.0000183409,0.00018746413,0.000085849984,0.000070692884],"category_scores_gemma":[0.0013729241,0.00014976654,0.000118424985,0.0002604029,0.00036815656,0.00019383444,0.00026932918,0.00014170865,0.0000058725755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002738156,0.000630005,0.98152745,0.0017630506,0.00028136818,0.000004344412,0.0008239299,0.000049579292,0.00009578704,0.0006679596,0.00015620887,0.011262167],"study_design_scores_gemma":[0.018979855,0.0002182698,0.96772605,0.0064917365,0.000025900452,0.000008416594,0.00020513416,0.0014434155,0.0008084565,0.003939675,0.000020746033,0.00013231821],"about_ca_topic_score_codex":0.0012295007,"about_ca_topic_score_gemma":0.00003623258,"teacher_disagreement_score":0.0162417,"about_ca_system_score_codex":0.00044575156,"about_ca_system_score_gemma":0.0012181175,"threshold_uncertainty_score":0.61073023},"labels":[],"label_agreement":null},{"id":"W2949691522","doi":"10.1136/annrheumdis-2019-eular.3525","title":"AB1328 MEASUREMENT PROPERTIES OF THE BRIEF PAIN INVENTORY-SHORT FORM (BPI-SF) AND THE REVISED SHORT-FORM MCGILL PAIN QUESTIONNAIRE-VERSION-2 (SF-MPQ-2) IN PAIN-RELATED MUSCULOSKELETAL CONDITIONS: A SYSTEMATIC REVIEW","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Brief Pain Inventory; Medicine; CINAHL; McGill Pain Questionnaire; Physical therapy; Interpretability; Quality of life (healthcare); Reliability (semiconductor); Musculoskeletal pain; Chronic pain; Psychiatry; Artificial intelligence; Visual analogue scale; Computer science","score_opus":0.08290032752511332,"score_gpt":0.32149675109725545,"score_spread":0.2385964235721421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949691522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000916443,0.97871524,0.000009107288,0.0023780381,0.00016322544,0.017602189,0.000085373846,0.000040603147,0.000089790694],"genre_scores_gemma":[0.114947066,0.8822677,0.00000458348,0.0010038624,0.000019276884,0.001492062,0.00006605385,0.00006578627,0.00013361829],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9835796,0.010521515,0.0032879617,0.00050860096,0.0016874564,0.0004148629],"domain_scores_gemma":[0.99405175,0.0016444558,0.0015972219,0.0018351519,0.0006838366,0.00018757793],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022342645,0.0007159068,0.0040526674,0.0002299942,0.00025870197,0.000028768298,0.000741807,0.00024590813,0.00003728296],"category_scores_gemma":[0.033578128,0.00030097368,0.0027602466,0.0007984567,0.00092347024,0.00017546366,0.00021795894,0.00045240758,0.000007676711],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003506877,0.00035398084,0.00010232373,0.94549876,0.0010876431,5.921768e-7,0.00018230539,0.0000019723116,0.0000012962099,0.0003536847,0.0018616434,0.050520733],"study_design_scores_gemma":[0.0006647407,0.0002329339,0.00075176224,0.9885502,0.005560706,0.000007309511,0.00030216057,0.000495035,0.0000011166635,0.0006009047,0.0024706784,0.00036244257],"about_ca_topic_score_codex":0.000116939125,"about_ca_topic_score_gemma":0.000030867042,"teacher_disagreement_score":0.11403063,"about_ca_system_score_codex":0.00024237763,"about_ca_system_score_gemma":0.0005285099,"threshold_uncertainty_score":0.9999442},"labels":[],"label_agreement":null},{"id":"W2949772916","doi":"10.1136/annrheumdis-2019-eular.790","title":"FRI0408 EARLIER TREATMENT OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WITH CERTOLIZUMAB PEGOL RESULTS IN IMPROVED CLINICAL OUTCOMES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; University of Toronto; University of Alberta","funders":"UCB Pharma","keywords":"Medicine; Certolizumab pegol; BASDAI; Ankylosing spondylitis; Axial spondyloarthritis; Internal medicine; Clinical endpoint; Placebo; Adalimumab; Bristol-Myers; Physical therapy; Gastroenterology; Clinical trial; Arthritis; Disease; Sacroiliitis; Psoriatic arthritis; Pathology","score_opus":0.03391134011866367,"score_gpt":0.33181804420568495,"score_spread":0.2979067040870213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949772916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933448,0.0020826254,6.9363267e-7,0.001991716,0.00022272371,0.0013544025,0.00035560332,0.000017529333,0.0006299413],"genre_scores_gemma":[0.9958722,0.0033236542,0.00009948142,0.000053854972,0.000023078876,0.00007059034,0.000035469362,0.000028066812,0.0004935967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788004,0.000100241625,0.00093469216,0.00035229302,0.00038771165,0.00034504096],"domain_scores_gemma":[0.9980661,0.00038739477,0.00041831398,0.0008312138,0.00013890653,0.00015804789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006685616,0.00028721578,0.0012091603,0.00016365758,0.000050825263,0.000010064921,0.0001568897,0.00007606833,0.000080313665],"category_scores_gemma":[0.00021662039,0.0001597795,0.00068419735,0.00034224766,0.00027367318,0.00007715457,0.000058139114,0.000075682554,0.000017609507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045860666,0.003244853,0.9484159,0.00017784418,0.0011455207,0.00011926305,0.00042594149,0.0000036535093,0.000010599609,0.000029706109,0.00022138548,0.041619275],"study_design_scores_gemma":[0.019795332,0.0043564932,0.9732694,0.0013062041,0.00030239092,0.00005414636,0.00029809444,0.000066308436,0.00013816146,0.0000936232,0.00016706283,0.00015277554],"about_ca_topic_score_codex":0.0008882395,"about_ca_topic_score_gemma":0.00026406551,"teacher_disagreement_score":0.0414665,"about_ca_system_score_codex":0.000023676304,"about_ca_system_score_gemma":0.00014453259,"threshold_uncertainty_score":0.6515619},"labels":[],"label_agreement":null},{"id":"W2949797841","doi":"10.1136/annrheumdis-2019-eular.3543","title":"AB1216 CHECKING IN WITH IMMUNE CHECKPOINT INHIBITORS: RESULTS FROM A NEEDS ASSESSMENT SURVEY OF CANADIAN RHEUMATOLOGISTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Ottawa; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Polymyalgia rheumatica; Adverse effect; Family medicine; Myositis; Descriptive statistics; Physical therapy; Oncology; Disease; Vasculitis","score_opus":0.053470866286697664,"score_gpt":0.3239665947684579,"score_spread":0.27049572848176023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949797841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423033,0.0010533796,0.0000018456658,0.0011981548,0.000102931815,0.0008558857,0.0003812182,0.0000148836525,0.0021613585],"genre_scores_gemma":[0.99907666,0.00039485496,0.00009288066,0.000068053836,0.000008102683,0.000022423694,0.00015094843,0.000030353116,0.00015570973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970124,0.00028694555,0.0010972576,0.00028857935,0.0008164968,0.0004983421],"domain_scores_gemma":[0.9967385,0.000903939,0.00051954103,0.0011962368,0.00035452849,0.00028724957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012399924,0.00022530266,0.0008592361,0.00063455204,0.000037446443,0.000022561655,0.00045204393,0.000095659794,0.00010919876],"category_scores_gemma":[0.0020361731,0.00014319619,0.0001830519,0.001450961,0.00026211396,0.000106710046,0.00016873704,0.00020412944,0.00001781306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045341686,0.0013787663,0.9750898,0.0027098928,0.0012841864,0.00007851013,0.0035319475,0.0012187463,0.00063413027,0.000418226,0.0020973114,0.0070243306],"study_design_scores_gemma":[0.009923531,0.00021419094,0.9742064,0.006910137,0.000047528625,0.000012700732,0.00066380965,0.003394536,0.0043042777,0.00011656414,0.000038447884,0.00016790193],"about_ca_topic_score_codex":0.7734553,"about_ca_topic_score_gemma":0.095493734,"teacher_disagreement_score":0.6779616,"about_ca_system_score_codex":0.0012456448,"about_ca_system_score_gemma":0.010876229,"threshold_uncertainty_score":0.9947312},"labels":[],"label_agreement":null},{"id":"W2949828273","doi":"10.1136/annrheumdis-2019-eular.6354","title":"THU0393 PERFORMANCE OF THE ASAS CLASSIFICATION CRITERIA PRESENTING WITH UNDIAGNOSED BACK PAIN? DATA FROM THE SCREENING IN AXIAL SPONDYLOARTHRITIS IN PSORIASIS, IRITIS, AND COLITIS (SASPIC) COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; University of Ottawa; McMaster University; Université de Sherbrooke; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Psoriasis; Cohort; Back pain; Uveitis; Ankylosing spondylitis; Internal medicine; Physical therapy; Disease; Axial spondyloarthritis; Inflammatory bowel disease; Psoriatic arthritis; Sacroiliitis; Dermatology; Pathology; Ophthalmology; Alternative medicine","score_opus":0.058581715569471636,"score_gpt":0.30634595001413967,"score_spread":0.24776423444466802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949828273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926238,0.0031701413,0.0000014200322,0.0020589775,0.000107131986,0.0012227017,0.00056658837,0.0000068165227,0.00024244393],"genre_scores_gemma":[0.99703914,0.0023823,0.000088690846,0.00016346962,0.00002982166,0.000052901487,0.00014230108,0.00001722475,0.00008417018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982472,0.00029642234,0.0004683701,0.00029402497,0.0004532023,0.0002407456],"domain_scores_gemma":[0.9979112,0.00068649085,0.00028110886,0.00096912787,0.0001028044,0.00004924636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005405901,0.0001642732,0.00043388884,0.000041018593,0.00010452847,0.00003364933,0.00039190706,0.00004167886,0.000119853044],"category_scores_gemma":[0.00072151324,0.00009015385,0.000067595625,0.00027133996,0.00025965218,0.00019823553,0.00030245684,0.00011058413,0.0000036918548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003809593,0.00021831393,0.987034,0.00021098008,0.00015706457,0.000004056539,0.00030311366,0.000005804394,0.000010194145,0.000039909137,0.0014428477,0.010192719],"study_design_scores_gemma":[0.002527259,0.00014352458,0.98981535,0.0046287663,0.000095213625,0.0000072689304,0.00091892236,0.0014218967,0.000062054976,0.00011915365,0.00016921536,0.000091351765],"about_ca_topic_score_codex":0.0020934816,"about_ca_topic_score_gemma":0.0012519772,"teacher_disagreement_score":0.010101368,"about_ca_system_score_codex":0.000011816738,"about_ca_system_score_gemma":0.00007549342,"threshold_uncertainty_score":0.36763674},"labels":[],"label_agreement":null},{"id":"W2949925324","doi":"10.1136/annrheumdis-2019-eular.5820","title":"SAT0169 RISK OF SERIOUS INFECTIONS IN OFFSPRING ACCORDING TO TNFI SUBTYPES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Psoriatic arthritis; Pregnancy; Offspring; Internal medicine; Rheumatoid arthritis; Immunology; Tumor necrosis factor alpha","score_opus":0.021593336508194866,"score_gpt":0.3161748472060204,"score_spread":0.29458151069782557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949925324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964776,0.0008302987,0.000034128727,0.0010690851,0.00013218829,0.00043389972,0.000020965006,0.000017747681,0.0009840814],"genre_scores_gemma":[0.9989684,0.0005716842,0.000040267176,0.00022521631,0.000009677177,0.000014893449,0.0000020879827,0.000008824621,0.00015891813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991784,0.00006060951,0.00031402207,0.000101625476,0.00020148636,0.00014381816],"domain_scores_gemma":[0.998989,0.00020592244,0.00020091164,0.0004223373,0.00006900831,0.00011284028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020786482,0.00007886787,0.00028591487,0.00013556237,0.000025685691,0.000004119221,0.00012754672,0.000026641148,0.00009342626],"category_scores_gemma":[0.0018793506,0.000053615015,0.00013498082,0.00030774763,0.000038790175,0.00007805212,0.000060123235,0.0000722764,0.000032599542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079526086,0.00031912146,0.96675056,0.0005648151,0.000118641445,4.5908988e-7,0.000523235,0.00028081978,0.0004688226,0.00019675655,0.0003750202,0.030322194],"study_design_scores_gemma":[0.00051673525,0.00012143815,0.9894905,0.003955464,0.000086694396,0.0000037477646,0.00035371952,0.00015011411,0.0045911972,0.0005350336,0.00013494997,0.000060410544],"about_ca_topic_score_codex":0.00029034453,"about_ca_topic_score_gemma":0.000016311516,"teacher_disagreement_score":0.030261785,"about_ca_system_score_codex":0.000012146538,"about_ca_system_score_gemma":0.00012944727,"threshold_uncertainty_score":0.2249894},"labels":[],"label_agreement":null},{"id":"W2949956868","doi":"10.1136/annrheumdis-2019-eular.1241","title":"AB0755 REGIONAL AND TEMPORAL VARIATION IN THE BASELINE PROFILE OF PSORIATIC ARTHRITIS PATIENTS INITIATING ADALIMUMAB FOLLOWING FAILURE OF NON-BIOLOGIC TREATMENT IN CANADIAN ROUTINE CARE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); South Bruce Grey Health Centre; University of Toronto; Centre Hospitalier de l’Université de Montréal; Etobicoke General Hospital; Université Laval; Memorial University of Newfoundland","funders":"Celgene; Sanofi; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Internal medicine; Observational study; Reimbursement; Infliximab; Multivariate analysis; Rheumatology; Univariate analysis; Physical therapy; Disease; Health care","score_opus":0.01832762304957736,"score_gpt":0.2731213744222216,"score_spread":0.25479375137264426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949956868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953117,0.0026077458,4.5711158e-7,0.00059856137,0.000054431144,0.0010706539,0.00025594633,0.0000027136534,0.00009782611],"genre_scores_gemma":[0.9992621,0.00030462875,0.00007908111,0.00009977806,0.000008265226,0.000063712745,0.00016748045,0.000008178712,0.000006773256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881595,0.00012911997,0.00047764054,0.00014965842,0.00022757813,0.00020005806],"domain_scores_gemma":[0.9991372,0.0002071629,0.00026417215,0.00023358357,0.00010060885,0.000057239908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017795658,0.00013751282,0.00045783745,0.000109552784,0.000045916877,0.000004934176,0.000079889294,0.000040064868,0.000024188457],"category_scores_gemma":[0.00029674137,0.00008045241,0.00013430184,0.00021168627,0.000043247586,0.00005822415,0.000026474829,0.000042377116,9.672915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009263589,0.00040644978,0.98570144,0.00026454002,0.00013277636,0.0000060019456,0.0035099352,0.000016886444,0.000006213014,0.000039049966,0.000042941378,0.00978112],"study_design_scores_gemma":[0.0045163785,0.0006904353,0.9887245,0.0022397044,0.00008714194,0.0000016176305,0.0032474124,0.00024244403,0.000045422934,0.00012631215,0.00001100893,0.000067609486],"about_ca_topic_score_codex":0.06072251,"about_ca_topic_score_gemma":0.038236957,"teacher_disagreement_score":0.022485552,"about_ca_system_score_codex":0.00005628501,"about_ca_system_score_gemma":0.0001985947,"threshold_uncertainty_score":0.9793127},"labels":[],"label_agreement":null},{"id":"W2949995868","doi":"10.1136/annrheumdis-2019-eular.6381","title":"THU0157 REASONS FOR NON-PARTICIPATION IN A RANDOMIZED CONTROLLED TRIAL COMPARING TWO SEASONAL INFLUENZA VACCINES IN RHEUMATOID ARTHRITISPATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Technische Universität Dresden; Arthritis Society; Bristol-Myers Squibb","keywords":"Medicine; Randomized controlled trial; Rheumatoid arthritis; Influenza vaccine; Vaccination; Seasonal influenza; Internal medicine; Family medicine; Informed consent; Pediatrics; Physical therapy; Immunology; Alternative medicine; Disease; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.03875243724559844,"score_gpt":0.3685129586706187,"score_spread":0.3297605214250202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949995868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652333,0.0017635953,0.000018425846,0.00052882725,0.00017636926,0.010429021,0.000017498329,0.000017804356,0.0005251286],"genre_scores_gemma":[0.99731123,0.00038235862,0.000021754793,0.00018786406,0.000012810783,0.001923182,0.000032406962,0.000019349756,0.000109060624],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99692935,0.00044456552,0.0014603181,0.00023616143,0.0005213669,0.00040823067],"domain_scores_gemma":[0.99721485,0.0014618745,0.0005462701,0.00044058257,0.00023046944,0.000105948675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015827583,0.00021475741,0.0023367135,0.0002637679,0.000056325523,0.000030369447,0.00022518367,0.000058486457,0.00012938915],"category_scores_gemma":[0.0049265805,0.00014169968,0.0006879394,0.00030199336,0.00009804245,0.00020998095,0.000090204565,0.0001420319,0.000022583017],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81394476,0.0012995806,0.17864795,0.0005329221,0.00029994565,0.0000011191726,0.0005456851,0.00075360114,0.00002037203,0.0003842303,0.00043506545,0.0031347491],"study_design_scores_gemma":[0.847367,0.00022389986,0.11264624,0.002664687,0.000073931486,7.903563e-7,0.00017207506,0.035574112,0.000066071734,0.00105317,0.000024253468,0.00013376953],"about_ca_topic_score_codex":0.00017582011,"about_ca_topic_score_gemma":0.00007196483,"teacher_disagreement_score":0.06600172,"about_ca_system_score_codex":0.000026672691,"about_ca_system_score_gemma":0.00034659953,"threshold_uncertainty_score":0.5897933},"labels":[],"label_agreement":null},{"id":"W2950010805","doi":"10.1136/annrheumdis-2019-eular.3998","title":"FRI0063 EFFECTS OF MALALIGNMENT AND DISEASE ACTIVITY ON SECONDARY OSTEOARTHRITIS PROGRESSION IN KNEES OF RHEUMATOID ARTHRITIS PATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Eli Lilly Canada; Sanofi Genzyme; Bristol-Myers Squibb Canada; Dutch Arthritis Association; Merck Canada; Pfizer Canada; Sanofi; European Commission; AbbVie Canada; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Osteoarthritis; Radiography; Tibia; Femur; Knee Joint; Surgery; Arthritis; Internal medicine; Pathology","score_opus":0.007734371455655033,"score_gpt":0.25612669828135576,"score_spread":0.24839232682570073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950010805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038327,0.0074186353,6.064195e-7,0.00040916482,0.000105522944,0.0012868759,0.00022752666,0.000012529561,0.00015585197],"genre_scores_gemma":[0.99655426,0.0031534536,0.00001691269,0.00015475463,0.000004804195,0.00005189152,0.000020784788,0.000019421479,0.00002370503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983817,0.00015241234,0.00048904656,0.00023515933,0.0005320552,0.00020966918],"domain_scores_gemma":[0.99841475,0.0003216341,0.0004022258,0.0004984862,0.0000996618,0.00026321207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010644009,0.00019593308,0.0006705805,0.00013304348,0.000028383529,0.000007180006,0.000103706465,0.00004537608,0.00009232411],"category_scores_gemma":[0.00064405845,0.00013861572,0.0002381732,0.0001515618,0.00018729996,0.00013867523,0.00012233305,0.00008523682,0.000005164976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002196052,0.0040122657,0.6522242,0.006256658,0.0001161651,0.0000101723135,0.00021620037,0.0000067398455,0.00043764396,0.00016667091,0.00088266307,0.33347458],"study_design_scores_gemma":[0.0038413266,0.001361056,0.95806354,0.022685705,0.00004528648,0.0000010771658,0.000060325554,0.000023549095,0.012844424,0.0009173188,0.000028605416,0.00012776871],"about_ca_topic_score_codex":0.000044894456,"about_ca_topic_score_gemma":0.000003678454,"teacher_disagreement_score":0.3333468,"about_ca_system_score_codex":0.00001070471,"about_ca_system_score_gemma":0.00015820288,"threshold_uncertainty_score":0.56525856},"labels":[],"label_agreement":null},{"id":"W2950083834","doi":"10.1136/annrheumdis-2019-eular.1719","title":"OP0068 ABATACEPT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS— RESULTS OF A PHASE 2 INVESTIGATOR-INITIATED, MULTICENTER, DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"National Institutes of Health; CSL Behring; Genentech; Acceleron; United Therapeutics Corporation; Sanofi; National Institute of Allergy and Infectious Diseases; Amgen; Pfizer; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Double blind; Abatacept; Placebo; Randomized controlled trial; Scleroderma (fungus); Internal medicine; Multicenter study; Systemic scleroderma; Pathology; Alternative medicine; Rituximab","score_opus":0.06634695926808125,"score_gpt":0.32626721223427546,"score_spread":0.2599202529661942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950083834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773655,0.005507564,0.0000035574571,0.000501397,0.00044399977,0.015477867,0.00028680253,0.00007695512,0.00033637357],"genre_scores_gemma":[0.9974743,0.0009838016,0.00002533882,0.00020466205,0.00003795413,0.0006876458,0.000076660326,0.00006623571,0.0004433821],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99429655,0.0010513031,0.0026836856,0.00047985557,0.0009777887,0.000510791],"domain_scores_gemma":[0.9931069,0.0028103413,0.0018834207,0.0014476954,0.0003396881,0.0004119246],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010704629,0.0004761569,0.0031091885,0.00036887234,0.00006187354,0.000045051493,0.0006210847,0.00014998457,0.0001187095],"category_scores_gemma":[0.009166864,0.00031135854,0.0012718488,0.000419064,0.0005192747,0.00018988425,0.00019332122,0.00022040514,0.00005784861],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.988233,0.0059948093,0.00063028414,0.0011995216,0.001179966,0.000025203286,0.0010593566,0.00010826966,0.0004081691,0.000054774846,0.000536601,0.00057004986],"study_design_scores_gemma":[0.9819223,0.0007516201,0.00067894434,0.011519148,0.0013581039,0.000021145212,0.00030777344,0.001844709,0.0011869727,0.0001281117,0.000006300471,0.00027484298],"about_ca_topic_score_codex":0.00058484427,"about_ca_topic_score_gemma":0.0000061098153,"teacher_disagreement_score":0.020108836,"about_ca_system_score_codex":0.000050441835,"about_ca_system_score_gemma":0.0006852841,"threshold_uncertainty_score":0.99993384},"labels":[],"label_agreement":null},{"id":"W2950121360","doi":"10.1136/annrheumdis-2019-eular.8808","title":"LB0006 SUBCUTANEOUS SECUKINUMAB 300MG AND 150MG PROVIDES SUSTAINED INHIBITION OF RADIOGRAPHIC PROGRESSION IN PSORIATIC ARTHRITIS OVER 2 YEARS: RESULTS FROM THE PHASE 3 FUTURE-5 TRIAL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Secukinumab; Psoriatic arthritis; Internal medicine; Placebo; Concomitant; Dactylitis; Rheumatoid arthritis; Gastroenterology; Surgery; Enthesitis; Pathology","score_opus":0.01308040620576175,"score_gpt":0.3009215113707179,"score_spread":0.28784110516495615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950121360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713882,0.02378778,0.0000010625272,0.001945046,0.00020750584,0.0022247052,0.0003790493,0.000023194207,0.000043438424],"genre_scores_gemma":[0.9764513,0.023121739,0.000028698745,0.00009128687,0.00010639828,0.00005902339,0.00009646666,0.0000222709,0.000022832466],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99759424,0.00036211204,0.0007597783,0.00027847395,0.00069616805,0.00030923387],"domain_scores_gemma":[0.9980784,0.00065491576,0.00040882814,0.00059425115,0.00013684569,0.00012673228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049943296,0.00019163032,0.00057123695,0.00016367728,0.000066602675,0.00005171934,0.00018083125,0.0000749865,0.00009151639],"category_scores_gemma":[0.0009738758,0.00011381916,0.00024339253,0.00038740085,0.00031967965,0.00018677136,0.00009166364,0.00017063477,0.0000034792515],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1657795,0.004143497,0.011133424,0.0011024901,0.0008282361,0.00013350822,0.0076909694,0.00001583476,0.0011115257,0.0011340816,0.007563692,0.79936326],"study_design_scores_gemma":[0.56034464,0.017262612,0.30021682,0.04900977,0.00026289633,0.00016539168,0.014024463,0.002655233,0.006361507,0.044082977,0.004328332,0.0012853267],"about_ca_topic_score_codex":0.00038624514,"about_ca_topic_score_gemma":0.00008061902,"teacher_disagreement_score":0.7980779,"about_ca_system_score_codex":0.00001339998,"about_ca_system_score_gemma":0.00018432915,"threshold_uncertainty_score":0.46414104},"labels":[],"label_agreement":null},{"id":"W2950176872","doi":"10.1136/annrheumdis-2019-eular.1368","title":"AB1170 A PHASE IV, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE IMPACT OF APREMILAST ON HAND AND WHOLE-BODY MRI OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS (MOSAIC): RATIONALE, DESIGN AND METHODS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dactylitis; Apremilast; Psoriatic arthritis; Enthesitis; Clinical trial; Internal medicine; Surgery; Radiology; Arthritis","score_opus":0.0637199519468009,"score_gpt":0.4113460323766914,"score_spread":0.34762608042989046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950176872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097294,0.0018530745,0.0001383503,0.00074212335,0.00004548328,0.0060816673,0.00014326617,0.000006895446,0.000016182341],"genre_scores_gemma":[0.9981329,0.00072408677,0.00079124933,0.0001244365,0.0000042350275,0.00014277175,0.000014336173,0.00002520834,0.000040779676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997355,0.0009019178,0.0005356114,0.00029274533,0.00062985776,0.00028489556],"domain_scores_gemma":[0.9975505,0.0012120061,0.00021132015,0.0005477393,0.00027096304,0.00020750178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001022366,0.00024921342,0.0007524776,0.00015202288,0.000118664255,0.00012330519,0.0002918915,0.000022826931,0.000057332774],"category_scores_gemma":[0.0011929924,0.00012341705,0.0000747869,0.00023718028,0.00023194344,0.00023418898,0.0001973706,0.00010645099,0.000004466229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02488629,0.07128819,0.64634514,0.00048520672,0.003137487,0.000007591515,0.0096278675,0.00064765854,0.0010274036,0.0001048216,0.0016140402,0.24082834],"study_design_scores_gemma":[0.06498851,0.025373412,0.89803034,0.0043793903,0.000081896134,0.0000034696943,0.0012396141,0.0041106013,0.00088980707,0.00062461494,0.000017218068,0.0002611455],"about_ca_topic_score_codex":0.00018984692,"about_ca_topic_score_gemma":0.000024269937,"teacher_disagreement_score":0.2516852,"about_ca_system_score_codex":0.00002206289,"about_ca_system_score_gemma":0.00013595197,"threshold_uncertainty_score":0.5032801},"labels":[],"label_agreement":null},{"id":"W2950197984","doi":"10.1136/annrheumdis-2019-eular.4721","title":"THU0200 DRUG UTILISATION IN PEOPLE WITH EARLY RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Roche Nederland; Foundation for Research in Rheumatology; Dutch Arthritis Society; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Regimen; Combination therapy; Internal medicine; Comorbidity; Demographics; Drug; Epidemiology; Pharmacotherapy; Physical therapy; Pharmacology; Demography","score_opus":0.02813554398207487,"score_gpt":0.2869358190128902,"score_spread":0.2588002750308154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950197984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053746,0.0032007017,0.0000028711852,0.004603987,0.000065231485,0.0010670108,0.000022588694,0.000024054916,0.00047607062],"genre_scores_gemma":[0.9887293,0.010635261,0.000016892242,0.00041060694,0.000008943431,0.00007753681,0.00002917538,0.000022960781,0.00006931679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978114,0.00035866248,0.00048042854,0.00021319845,0.0007486077,0.00038772455],"domain_scores_gemma":[0.99846816,0.00046947895,0.0001746049,0.00066140736,0.00012856994,0.00009777314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005865606,0.00018387745,0.0004611262,0.00029302714,0.000071797134,0.00006158779,0.0003752816,0.00003709898,0.00022171714],"category_scores_gemma":[0.00039048892,0.000100039506,0.00013428666,0.00097394054,0.00018382489,0.00022868582,0.000059978058,0.0002174621,0.000046581426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007411811,0.00074779027,0.9728035,0.00025908594,0.000112579924,0.0000147760575,0.0076111658,0.00014793669,0.00003297953,0.0040236874,0.001729127,0.011776228],"study_design_scores_gemma":[0.0030078546,0.00023724613,0.98581487,0.004986647,0.0000034991035,0.00003018054,0.0024637124,0.00064948614,0.00016814786,0.001667638,0.00082700007,0.00014369255],"about_ca_topic_score_codex":0.0037198993,"about_ca_topic_score_gemma":0.0011554115,"teacher_disagreement_score":0.013011434,"about_ca_system_score_codex":0.000017526869,"about_ca_system_score_gemma":0.00018287644,"threshold_uncertainty_score":0.56234},"labels":[],"label_agreement":null},{"id":"W2950198302","doi":"10.1136/annrheumdis-2019-eular.6353","title":"AB0617 CUTANEOUS POLYARTERITIS NODOSA TREATMENT: A RETROSPECTIVE CASE SERIES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Hydroxychloroquine; Prednisone; Methotrexate; Livedo reticularis; Dapsone; Azathioprine; Retrospective cohort study; Polyarteritis nodosa; Surgery; Dermatology; Skin biopsy; Internal medicine; Biopsy; Vasculitis; Disease","score_opus":0.01720948296623099,"score_gpt":0.27544933900084706,"score_spread":0.2582398560346161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950198302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909241,0.0008695718,0.0000019790339,0.0036883284,0.0001994255,0.0004922029,0.00030709477,0.000052265048,0.0034650264],"genre_scores_gemma":[0.9945831,0.0005200117,0.00002609487,0.00020536248,0.000023124758,0.000022176724,0.000020169387,0.000017966015,0.0045820135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991778,0.000044507742,0.00024107662,0.00016014666,0.00018096226,0.00019549359],"domain_scores_gemma":[0.9990754,0.00007163361,0.000110744375,0.000510922,0.000097731536,0.00013356548],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000205075,0.00014256347,0.00034294932,0.000054247655,0.00010533902,0.000018385306,0.00007736184,0.000053338816,0.0009468114],"category_scores_gemma":[0.000102625265,0.000086279586,0.0002871547,0.00015454761,0.00014774955,0.000089259156,0.00003144945,0.00006338722,0.0001310345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061236476,0.020256283,0.5836399,0.0034731436,0.054694816,0.035133217,0.035498038,0.0002745508,0.008825734,0.058896482,0.056448773,0.1367354],"study_design_scores_gemma":[0.013626208,0.0138676595,0.6712596,0.009133509,0.01905958,0.1881168,0.009518094,0.0020056777,0.018660214,0.0496495,0.0032053257,0.001897835],"about_ca_topic_score_codex":0.0001885631,"about_ca_topic_score_gemma":0.000012408879,"teacher_disagreement_score":0.15298358,"about_ca_system_score_codex":0.000028076547,"about_ca_system_score_gemma":0.0000930052,"threshold_uncertainty_score":0.99996644},"labels":[],"label_agreement":null},{"id":"W2950207837","doi":"10.1136/annrheumdis-2019-eular.8657","title":"LB0004 METHOTREXATE WITHDRAWAL IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ACHIEVE LOW DISEASE ACTIVITY WITH TOFACITINIB MODIFIED-RELEASE 11 MG ONCE DAILY + METHOTREXATE: A RANDOMISED NON-INFERIORITY PHASE 3B/4 STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Montreal Clinical Research Institute; Western University","funders":"","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Methotrexate; Clinical endpoint; Internal medicine; Placebo; Phases of clinical research; Gastroenterology; Clinical trial; Pathology","score_opus":0.015312071392517338,"score_gpt":0.2951889365168673,"score_spread":0.27987686512434995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950207837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900136,0.0012583627,0.00020633054,0.0005205911,0.000117802745,0.006986512,0.0006634649,0.00009163319,0.0001417088],"genre_scores_gemma":[0.9966188,0.002304899,0.00011898712,0.0001652651,0.000016690545,0.0004865636,0.0000853566,0.000111490815,0.00009196089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99380034,0.001199606,0.0010292605,0.0009370826,0.0019841525,0.0010495726],"domain_scores_gemma":[0.9951394,0.0007168731,0.0007484482,0.0017494877,0.00060967106,0.001036089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096643454,0.00078719534,0.0020567852,0.0003579167,0.00027449298,0.00015389774,0.00062921445,0.000091001224,0.0002829417],"category_scores_gemma":[0.0009775808,0.000498975,0.00045918903,0.00089394924,0.000577229,0.0008706159,0.0002026804,0.00051051367,0.000028871447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16132684,0.018450458,0.76338774,0.0010874657,0.0016259676,0.00016052848,0.00265879,0.0009575855,0.000072493494,0.00007529747,0.0001776508,0.05001916],"study_design_scores_gemma":[0.15913767,0.004418311,0.8215025,0.009088998,0.00011332891,0.000009050642,0.0010032561,0.002957481,0.0006116134,0.00036389162,0.000022187505,0.00077173667],"about_ca_topic_score_codex":0.0006776359,"about_ca_topic_score_gemma":0.00019677053,"teacher_disagreement_score":0.058114726,"about_ca_system_score_codex":0.00006761439,"about_ca_system_score_gemma":0.0009151644,"threshold_uncertainty_score":0.9997462},"labels":[],"label_agreement":null},{"id":"W2950243234","doi":"10.1136/annrheumdis-2019-eular.1174","title":"SAT0422 URATE VOLUME AND DISTRIBUTION BY DUAL ENERGY CT: CLINICAL AND RADIOLOGICAL CORRELATION IN GOUT PATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Gout; Radiological weapon; Nuclear medicine; Radiology; Internal medicine","score_opus":0.018153707700008237,"score_gpt":0.28198561091287155,"score_spread":0.2638319032128633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950243234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968191,0.001632701,0.000040673272,0.0008739964,0.00013573344,0.000278958,0.00013393733,0.000015147313,0.0000697589],"genre_scores_gemma":[0.9983972,0.00071282225,0.00001156365,0.000344709,0.000015281736,0.000008827911,0.00020587782,0.000008729136,0.00029499788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986748,0.00019112516,0.0004930533,0.00022734689,0.00023850884,0.00017515851],"domain_scores_gemma":[0.99906707,0.0002669416,0.00021704362,0.00024963883,0.00006001206,0.00013931183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002388965,0.0001293513,0.0003939399,0.00002674059,0.000035790334,0.000012329554,0.0000693006,0.000067512396,0.000045622408],"category_scores_gemma":[0.0010660538,0.0000842865,0.00008637267,0.00010839789,0.00021496331,0.00009947895,0.00009830318,0.00011038305,0.000010185535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015775069,0.0003794749,0.9765581,0.00008914192,0.000059886468,0.0000018114247,0.000051669773,0.000010260522,0.0000067676233,0.00013262978,0.010207512,0.01234499],"study_design_scores_gemma":[0.0015344096,0.00030139883,0.99253714,0.00023617447,0.00010609973,0.000010151631,0.000066767476,0.004003219,0.000016737353,0.0005945245,0.0004983557,0.00009502955],"about_ca_topic_score_codex":0.0000697351,"about_ca_topic_score_gemma":0.0000010879983,"teacher_disagreement_score":0.015979027,"about_ca_system_score_codex":0.000013857995,"about_ca_system_score_gemma":0.000036350208,"threshold_uncertainty_score":0.34371036},"labels":[],"label_agreement":null},{"id":"W2950290561","doi":"10.1136/annrheumdis-2019-eular.4316","title":"THU0511 COMPARISON OF PAXGENE AND TEMPUS WHOLE BLOOD RNA COLLECTION AND ISOLATION SYSTEMS FOR THE QUANTIFICATION OF TYPE I INTERFERON-STIMULATED GENE EXPRESSION","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"TEMPUS; Interferon; Whole blood; Gene expression; Immunology; Biology; Medicine; Gene; Molecular biology; Genetics","score_opus":0.07371354093883108,"score_gpt":0.3582997785911421,"score_spread":0.284586237652311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950290561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848106,0.012545903,0.0005583706,0.00021972082,0.00016570755,0.0016348442,0.000036332265,0.000009578022,0.000018978626],"genre_scores_gemma":[0.9989562,0.0006744978,0.00005442298,0.0000050172002,0.000011181901,0.000030368603,0.000018510811,0.0000138778105,0.00023591587],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987995,0.00012648775,0.00053070695,0.00014443202,0.0002946977,0.00010419402],"domain_scores_gemma":[0.9979789,0.00064807956,0.00049142074,0.00040597995,0.00042899177,0.00004658107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038616927,0.000095850046,0.00040964966,0.000085040694,0.00006549637,0.000013628565,0.00011010905,0.000053860364,0.000007436164],"category_scores_gemma":[0.00045406932,0.00005362532,0.00006758441,0.0001935769,0.00009817256,0.00005731026,0.00005695959,0.000044369983,0.000001142956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025850001,0.0007393761,0.46895316,0.012899859,0.0007293924,1.1991763e-7,0.0030997782,0.0019280682,0.50389636,0.00012681456,0.00306,0.001982049],"study_design_scores_gemma":[0.0046201707,0.0020376407,0.10603343,0.013500938,0.0008696832,0.00007101605,0.0057161567,0.45718977,0.4094413,0.00026985508,0.000043462882,0.0002065909],"about_ca_topic_score_codex":0.00008923836,"about_ca_topic_score_gemma":0.0000017441045,"teacher_disagreement_score":0.4552617,"about_ca_system_score_codex":0.000008394151,"about_ca_system_score_gemma":0.00006277544,"threshold_uncertainty_score":0.2186777},"labels":[],"label_agreement":null},{"id":"W2950341266","doi":"10.1136/annrheumdis-2019-eular.6080","title":"SAT0339 WHAT IS THE IMPACT OF IMAGING ON DIAGNOSTIC ASCERTAINMENT OF PATIENTS PRESENTING WITH UNDIAGNOSED BACK PAIN AND WHAT IS THE IMPACT OF CENTRAL EVALUATION? DATA FROM THE SCREENING IN AXIAL SPONDYLOARTHRITIS IN PSORIASIS, IRITIS, AND COLITIS (SASPIC) COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; University of Ottawa; McMaster University; Université de Sherbrooke; University of Calgary; University of Alberta","funders":"Baylor Scott and White Health; University of Texas at Austin; Novartis Pharmaceuticals Corporation; Eli Lilly and Company","keywords":"Medicine; Cohort; Ankylosing spondylitis; Radiography; Back pain; Psoriatic arthritis; Psoriasis; Sacroiliitis; Radiology; Axial spondyloarthritis; Physical therapy; Internal medicine; Pathology; Dermatology","score_opus":0.03001635840102298,"score_gpt":0.3259071703152642,"score_spread":0.29589081191424127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950341266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97077984,0.02401452,8.396885e-7,0.0012638799,0.000057696885,0.0025266388,0.0013410993,0.0000025287532,0.000012934326],"genre_scores_gemma":[0.9813545,0.01818336,0.0000119829065,0.00015485735,0.00001590844,0.000052322324,0.00020414001,0.000020053092,0.0000029142964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972626,0.0006152504,0.00063967553,0.00032877072,0.00081152166,0.00034215674],"domain_scores_gemma":[0.9943969,0.0038650332,0.00053075195,0.0009177988,0.00020736085,0.000082109385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010108828,0.0002533375,0.00063794124,0.000063842774,0.00009453105,0.000100768186,0.0003248245,0.000033224398,0.00019479178],"category_scores_gemma":[0.001573526,0.00011831637,0.00018626278,0.0002413416,0.00037188173,0.00051342935,0.00027109508,0.00011069893,7.426678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060607516,0.00055967196,0.9370113,0.00010648645,0.0007511927,0.0000033829929,0.002254771,0.0001458239,0.0000012406799,0.0000037139946,0.0006548681,0.057901453],"study_design_scores_gemma":[0.004957584,0.00062255637,0.97831225,0.0075193467,0.0002776882,0.0000024227743,0.0052902703,0.0025438876,0.000043067157,0.00032442063,0.000002958297,0.00010353766],"about_ca_topic_score_codex":0.012781784,"about_ca_topic_score_gemma":0.00046348476,"teacher_disagreement_score":0.057797916,"about_ca_system_score_codex":0.00004421317,"about_ca_system_score_gemma":0.00012917673,"threshold_uncertainty_score":0.9937922},"labels":[],"label_agreement":null},{"id":"W2950426289","doi":"10.1136/annrheumdis-2019-eular.8676","title":"LB0001 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH1 PRIMARY OUTCOME RESULTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Institute for Health and Care Research","keywords":"Medicine; Rheumatoid arthritis; Adalimumab; Internal medicine; Clinical endpoint; Methotrexate; Adverse effect; Placebo; Clinical trial","score_opus":0.026615921402139427,"score_gpt":0.3138811237535323,"score_spread":0.28726520235139286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950426289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938883,0.0004442731,0.00004299239,0.0016588233,0.000041187126,0.0030375523,0.0006568723,0.000024677884,0.00020532437],"genre_scores_gemma":[0.9971894,0.0003640712,0.0013658797,0.00029313145,0.000006227852,0.00006912484,0.00007100192,0.00004797993,0.00059317466],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99728435,0.00022135123,0.0008318113,0.0003864252,0.00085426,0.0004218267],"domain_scores_gemma":[0.99483943,0.002930114,0.00044182918,0.0010017318,0.00048150675,0.00030540768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092540524,0.00025505203,0.00088060054,0.0001569213,0.000073612086,0.000019158448,0.0002950443,0.000059179656,0.000042911583],"category_scores_gemma":[0.003897953,0.00014640538,0.00013818215,0.00037227388,0.00025487866,0.00011351226,0.00019653107,0.00010128728,0.00001187113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68534184,0.0043455223,0.10796987,0.010173149,0.0022555701,0.000026809637,0.0035535942,0.00085130363,0.0002727719,0.00027352525,0.009006047,0.17593],"study_design_scores_gemma":[0.08387703,0.0054469486,0.8967888,0.010229145,0.00013772283,0.00002368802,0.0001867122,0.00049266464,0.0013841068,0.00010760333,0.0009766105,0.00034900114],"about_ca_topic_score_codex":0.00012379844,"about_ca_topic_score_gemma":0.000009886782,"teacher_disagreement_score":0.7888189,"about_ca_system_score_codex":0.00030193495,"about_ca_system_score_gemma":0.0019918764,"threshold_uncertainty_score":0.5970238},"labels":[],"label_agreement":null},{"id":"W2950456275","doi":"10.1136/annrheumdis-2019-eular.1146","title":"THU0688 ASSESSMENT OF THE QRISK2, QRISK3, SLE CARDIOVASCULAR RISK EQUATION, FRAMINGHAM AND MODIFIED FRAMINGHAM RISK CALCULATORS AS PREDICTORS OF CARDIOVASCULAR DISEASE EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi","keywords":"Framingham Risk Score; Medicine; Disease; Risk assessment; Internal medicine; Systemic risk; Cardiology; Computer science; Economics","score_opus":0.02321613852136021,"score_gpt":0.287282596130944,"score_spread":0.26406645760958375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950456275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95433813,0.04026294,0.00031531134,0.000062987834,0.00071784056,0.0038423783,0.00028165616,0.00003138723,0.0001473347],"genre_scores_gemma":[0.9938428,0.005613819,0.000037669684,0.000013557283,0.000038261696,0.00017171321,0.000014287041,0.0000777214,0.00019019343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920052,0.001767955,0.0016976646,0.00066995225,0.003291374,0.0005678164],"domain_scores_gemma":[0.99330306,0.0009051522,0.001272514,0.0035487604,0.00058948074,0.00038105802],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031340555,0.00048074347,0.0020638648,0.0003442747,0.00014729188,0.000020011019,0.00082390266,0.00019265493,0.000031149604],"category_scores_gemma":[0.003698521,0.00029636294,0.002291295,0.00086634664,0.00040253648,0.0001798967,0.0005267704,0.00042818327,0.000009142652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019318993,0.00047806092,0.95092237,0.0078021456,0.0071009076,0.00000528628,0.0012323358,0.030996846,0.00001361475,0.00017536127,0.0000996338,0.0009802569],"study_design_scores_gemma":[0.0066183563,0.0002514269,0.9252841,0.018903114,0.0060257064,0.00033155543,0.0032135476,0.03609772,0.00053910934,0.0021824844,0.00005574355,0.0004971713],"about_ca_topic_score_codex":0.0023236435,"about_ca_topic_score_gemma":0.0000067041956,"teacher_disagreement_score":0.039504614,"about_ca_system_score_codex":0.00013859136,"about_ca_system_score_gemma":0.0007710652,"threshold_uncertainty_score":0.99994886},"labels":[],"label_agreement":null},{"id":"W2950469873","doi":"10.1136/annrheumdis-2019-eular.172","title":"AB0745 ASSESSMENT OF DISEASE ACTIVITY USING RAPID3 AND EVALUATION OF TREATMENT EFFECT OF GUSELKUMAB IN PATIENTS WITH PSA: RESULTS FROM A RANDOMIZED PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Physical therapy; Psoriasis; Arthritis; Surgery; Dermatology; Pathology","score_opus":0.06153507801289493,"score_gpt":0.38723954002909833,"score_spread":0.3257044620162034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950469873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253637,0.0011089139,0.000004293013,0.000021775912,0.00022769917,0.005144098,0.00093473686,0.000004408146,0.000017690969],"genre_scores_gemma":[0.9995024,0.00018145499,0.000019635221,0.0000025771608,0.000005364511,0.00012917204,0.0001397976,0.000009266957,0.000010333515],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99374545,0.004612194,0.0010583096,0.0002557124,0.00018754473,0.00014078645],"domain_scores_gemma":[0.9927822,0.005006622,0.0015254281,0.00047676297,0.00017241288,0.000036626625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021777025,0.00022385322,0.0019519777,0.00010598318,0.000030116898,0.000003779103,0.00012312255,0.00008347911,0.00005332824],"category_scores_gemma":[0.0014633569,0.000114388895,0.00052649167,0.00009847074,0.00024211705,0.00008134542,0.000041502575,0.000043922017,6.891223e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9188705,0.0044179843,0.040221505,0.00009971119,0.003511281,1.3445995e-7,0.00013160362,0.00023919666,0.00026109657,0.000004331966,0.0000054222014,0.03223722],"study_design_scores_gemma":[0.83897537,0.003955506,0.14708513,0.00056457694,0.0048480076,4.351129e-8,0.000016153752,0.001754383,0.0026504092,0.00006389839,2.598657e-7,0.000086240434],"about_ca_topic_score_codex":0.000288137,"about_ca_topic_score_gemma":0.000008100862,"teacher_disagreement_score":0.106863625,"about_ca_system_score_codex":0.000033609074,"about_ca_system_score_gemma":0.0003259695,"threshold_uncertainty_score":0.46646437},"labels":[],"label_agreement":null},{"id":"W2950495050","doi":"10.1136/annrheumdis-2019-eular.1626","title":"OP0082 TEMPORAL TRENDS OF BISPHOSPHONATE DISCONTINUATION AND FACTORS ASSOCIATED WITH ALENDRONATE DISCONTINUATION AND RESTART AT POPULATION LEVEL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi; Chugai Pharmaceutical; Pfizer; Eli Lilly and Company; Amgen","keywords":"Discontinuation; Medicine; Bisphosphonate; Osteoporosis; Cohort; Internal medicine; Population; Pediatrics; Retrospective cohort study; Cohort study","score_opus":0.06415880827326918,"score_gpt":0.3093111549833753,"score_spread":0.2451523467101061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950495050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978166,0.00057973375,0.0000022187628,0.0008566331,0.000044511413,0.00040347548,0.00022258428,0.000013212948,0.000060995702],"genre_scores_gemma":[0.9977332,0.0001092159,0.00002366816,0.000039548373,0.000001527995,0.0000094936795,0.00039447745,0.0000143744355,0.0016744907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899447,0.000067696696,0.0003460402,0.00016744058,0.00027460785,0.0001497168],"domain_scores_gemma":[0.99904406,0.00011373406,0.00045927297,0.00020595065,0.00008318505,0.000093795534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012617838,0.00013967152,0.00036783298,0.00008370037,0.00006476573,0.000008882446,0.00003823434,0.00004204841,0.000033032633],"category_scores_gemma":[0.0001577579,0.00008131396,0.00006497818,0.00015408234,0.00007966919,0.00016904608,0.000037733425,0.000039097682,6.8793145e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030311197,0.0002634698,0.9842642,0.00014136496,0.00016941589,3.275571e-7,0.00033131833,0.000006545976,0.000022064258,0.000060300586,0.000097252785,0.014340658],"study_design_scores_gemma":[0.0016630895,0.0003600666,0.99534965,0.00094155467,0.0001912838,0.0000010892917,0.00010238199,0.00068681815,0.00040182512,0.00021667859,0.0000074601257,0.000078078934],"about_ca_topic_score_codex":0.0013486596,"about_ca_topic_score_gemma":0.00063578784,"teacher_disagreement_score":0.014262578,"about_ca_system_score_codex":0.000023640669,"about_ca_system_score_gemma":0.000038273993,"threshold_uncertainty_score":0.33158872},"labels":[],"label_agreement":null},{"id":"W2950539728","doi":"10.1136/annrheumdis-2019-eular.7595","title":"FRI0669 DEPRESSION AND ANXIETY AND THEIR CLINICAL CORRELATES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Anxiety; Depression (economics); Internal medicine; Systemic lupus erythematosus; Hospital Anxiety and Depression Scale; Cohort; Beck Depression Inventory; Epidemiology; Comorbidity; Disease; Psychiatry","score_opus":0.0347408903847897,"score_gpt":0.33074904370118224,"score_spread":0.2960081533163925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950539728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97315013,0.024421934,0.000005652994,0.0004073864,0.00038758386,0.0011749528,0.000022931832,0.000031193398,0.0003982061],"genre_scores_gemma":[0.9912181,0.00796343,0.000017029399,0.00010720532,0.000022269132,0.000031754305,0.0000044864364,0.000030059997,0.0006056928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776894,0.00033900896,0.00081755145,0.00037008812,0.00038200244,0.00032241156],"domain_scores_gemma":[0.9974748,0.0011200439,0.0002966104,0.00076291466,0.000107151165,0.00023847539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009342231,0.00022178622,0.00085677794,0.000121490586,0.000048366153,0.000024463041,0.00022634838,0.0001334875,0.000048761423],"category_scores_gemma":[0.0008316606,0.0001207048,0.00019759247,0.00017679173,0.00023480844,0.000109259396,0.0003110462,0.0002184271,0.000025776351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031624275,0.00019477188,0.9825962,0.0036980591,0.00012932805,0.0000036545118,0.0008067473,0.0000050519284,0.00011431629,0.00009578827,0.0013142008,0.010725633],"study_design_scores_gemma":[0.00955192,0.00048766215,0.89453375,0.05331749,0.00022781761,0.014778236,0.010378916,0.011205916,0.00089160027,0.0038780689,0.00019361639,0.0005550005],"about_ca_topic_score_codex":0.00004009376,"about_ca_topic_score_gemma":0.000003845733,"teacher_disagreement_score":0.08806245,"about_ca_system_score_codex":0.000016664291,"about_ca_system_score_gemma":0.000114559516,"threshold_uncertainty_score":0.4922199},"labels":[],"label_agreement":null},{"id":"W2950572195","doi":"10.1136/annrheumdis-2019-eular.230","title":"THU0250 EARLY IMPROVEMENT IN SLEDAI-2K RESPONDER INDEX-50 PREDICTS SRI-4 RESPONSE IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF USTEKINUMAB (UST) IN SYSTEMIC LUPUS ERYTHEMATOSUS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation","funders":"","keywords":"Ustekinumab; Medicine; Internal medicine; Placebo; Randomized controlled trial; Gastroenterology; Immunology; Disease; Pathology","score_opus":0.018733296211888666,"score_gpt":0.30157886613954216,"score_spread":0.2828455699276535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950572195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980549,0.001967611,0.000005473189,0.0005575709,0.00038070613,0.01616014,0.000030776984,0.00002468902,0.00032404825],"genre_scores_gemma":[0.9969325,0.0003286014,0.000012082233,0.00008856038,0.000024843217,0.0013183769,0.0000056101135,0.000045546432,0.0012438503],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9915496,0.0028458228,0.0027056492,0.0005129121,0.0016394206,0.0007466026],"domain_scores_gemma":[0.9891836,0.0080111325,0.0009492847,0.0014267211,0.00022016284,0.00020908435],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007546444,0.00040170795,0.003265144,0.001102528,0.00002608932,0.000030550807,0.0006433807,0.00021965311,0.00013407257],"category_scores_gemma":[0.0133613255,0.00025938248,0.000763164,0.0008617076,0.0003087987,0.00017964248,0.0003081893,0.00035760138,0.000022655791],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9862859,0.0014740719,0.0042137527,0.0024024427,0.00046343822,0.000057071775,0.0031880355,0.00090696046,0.00034473478,0.00009324563,0.00014454099,0.00042576098],"study_design_scores_gemma":[0.96596545,0.0012005423,0.0047780816,0.00949903,0.00016797757,0.00005697918,0.0013680442,0.015767267,0.00036272148,0.00062081846,0.000003042573,0.00021004985],"about_ca_topic_score_codex":0.0014997385,"about_ca_topic_score_gemma":0.00009765248,"teacher_disagreement_score":0.0203205,"about_ca_system_score_codex":0.0019786935,"about_ca_system_score_gemma":0.0068870215,"threshold_uncertainty_score":0.9999858},"labels":[],"label_agreement":null},{"id":"W2950577066","doi":"10.1136/annrheumdis-2019-eular.1659","title":"SAT0395 RESPONSIVENESS AND CLINICAL TRIAL DISCRIMINATION OF SWOLLEN AND TENDER JOINT COUNTS FOR THE MEASUREMENT OF MSK DISEASE ACTIVITY IN PSORIATIC ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Toronto Western Hospital; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Placebo; Randomized controlled trial; Physical therapy; Arthritis; Pathology; Alternative medicine","score_opus":0.12620975500474485,"score_gpt":0.3792082199426977,"score_spread":0.25299846493795286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950577066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98531497,0.011490912,0.000019531824,0.0015680088,0.00013903111,0.0013505493,0.00007756605,0.0000029559951,0.000036499925],"genre_scores_gemma":[0.9757691,0.024097165,0.000013401573,0.000028628538,0.000014237943,0.000042542528,0.0000021489457,0.0000073834835,0.000025384768],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987564,0.00019187189,0.0003930162,0.00011941138,0.0004279576,0.000111351495],"domain_scores_gemma":[0.99857056,0.00067528454,0.00020702275,0.000268008,0.00019963656,0.00007946125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009986196,0.0000780035,0.00037231372,0.000056988913,0.00003191356,0.000008806864,0.00007395714,0.00002395252,0.000027578988],"category_scores_gemma":[0.0024253004,0.00004416832,0.00014064473,0.00006487216,0.00022865566,0.00006394637,0.000048937272,0.000051220475,6.809487e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10549243,0.0027754677,0.04553492,0.0045035714,0.0010418083,0.0000022460958,0.001036693,0.00001594552,0.00036424657,0.0031923202,0.0018444177,0.8341959],"study_design_scores_gemma":[0.019206857,0.0008840109,0.9679913,0.003965394,0.0000673202,0.0000010163131,0.00041913023,0.0009488605,0.00043833506,0.005832855,0.00016338855,0.00008154765],"about_ca_topic_score_codex":0.00004020083,"about_ca_topic_score_gemma":0.000019186746,"teacher_disagreement_score":0.9224564,"about_ca_system_score_codex":0.0000073962065,"about_ca_system_score_gemma":0.00018956306,"threshold_uncertainty_score":0.29034862},"labels":[],"label_agreement":null},{"id":"W2950607588","doi":"10.1136/annrheumdis-2019-eular.8105","title":"SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Quality of life (healthcare); Internal medicine; Visual analogue scale; McGill Pain Questionnaire; Chronic pain; Arthritis; Physical therapy; Disease","score_opus":0.03576933087659685,"score_gpt":0.27194837233206237,"score_spread":0.23617904145546553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950607588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95759326,0.039430473,0.0000069042567,0.000202818,0.000056637826,0.0025854355,0.00006448085,0.00001928159,0.00004068899],"genre_scores_gemma":[0.9969474,0.0027572156,0.000016943133,0.000075781296,0.000009762959,0.00011880936,0.000031291325,0.000030002953,0.000012771294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731475,0.00040955146,0.0006573456,0.00030551743,0.0010398059,0.00027300412],"domain_scores_gemma":[0.9980996,0.00019102954,0.00043065287,0.0006430913,0.0004433718,0.00019222566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008308137,0.00022998486,0.00074756675,0.0001583698,0.00004572743,0.000018484881,0.0001649654,0.000060600272,0.00008479903],"category_scores_gemma":[0.00028234653,0.00013264065,0.00011137336,0.000422734,0.00012695706,0.0001082716,0.000059228747,0.00007884926,0.000008921878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009774946,0.0010190681,0.9031296,0.0026174148,0.0004272746,3.8618077e-7,0.000643863,0.004163453,0.00025570925,0.000026790247,0.0006667577,0.08607223],"study_design_scores_gemma":[0.006748224,0.0012632794,0.8892799,0.09913746,0.00018846575,0.000004247755,0.0005277892,0.0023899698,0.00027205897,0.000019108693,0.0000032521687,0.00016621251],"about_ca_topic_score_codex":0.00023443166,"about_ca_topic_score_gemma":0.00006677549,"teacher_disagreement_score":0.096520044,"about_ca_system_score_codex":0.00013393766,"about_ca_system_score_gemma":0.00056997035,"threshold_uncertainty_score":0.54089284},"labels":[],"label_agreement":null},{"id":"W2950613183","doi":"10.1136/annrheumdis-2019-eular.2677","title":"OP0018 MIR-34A IS A POTENTIAL THERAPEUTIC TARGET IN OSTEOARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Osteoarthritis; Synovial fluid; In vivo; Cartilage; Histology; microRNA; Pathogenesis; Pathology; Western blot; Arthritis; Medial meniscus; Internal medicine; Anatomy; Biology; Gene","score_opus":0.019008545336208937,"score_gpt":0.27649086735536665,"score_spread":0.2574823220191577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950613183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987621,0.007120806,0.0000058837973,0.002545006,0.0003226733,0.00094499876,0.00009940565,0.00003103551,0.0013091876],"genre_scores_gemma":[0.99665755,0.00019680022,0.00008976161,0.0014134416,0.00002403009,0.000040791685,0.000026215108,0.000025923242,0.0015254938],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986618,0.000074824784,0.0003571191,0.00022135294,0.00038137342,0.00030352603],"domain_scores_gemma":[0.99908584,0.00005366969,0.00013865986,0.0005283209,0.000073646435,0.00011988047],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010194053,0.00018327456,0.0004445455,0.00009631841,0.000040365092,0.000018946952,0.00017720602,0.000061516395,0.0013162352],"category_scores_gemma":[0.000048176746,0.00012682287,0.00032174998,0.00019168902,0.00007128718,0.000112782414,0.00006900433,0.00008048192,0.00019838389],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004416953,0.008149498,0.14079289,0.0036310407,0.0013903993,0.000285489,0.005027443,0.00009335969,0.031888053,0.006965469,0.014221683,0.78313774],"study_design_scores_gemma":[0.056549218,0.016951872,0.57963693,0.021606246,0.0017535696,0.00037218668,0.0044004163,0.001470224,0.20346923,0.10209381,0.009496054,0.00220023],"about_ca_topic_score_codex":0.000035058776,"about_ca_topic_score_gemma":0.000006550555,"teacher_disagreement_score":0.7809375,"about_ca_system_score_codex":0.000012760482,"about_ca_system_score_gemma":0.00009991223,"threshold_uncertainty_score":0.9995967},"labels":[],"label_agreement":null},{"id":"W2950744902","doi":"10.1136/annrheumdis-2019-215658","title":"Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al‘ by Vandergheynst et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Mycophenolate; ANCA-Associated Vasculitis; Vasculitis; Immunology; Mycophenolic acid; Dermatology; Internal medicine; Transplantation; Disease","score_opus":0.03334168226370591,"score_gpt":0.30950844008805717,"score_spread":0.27616675782435124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950744902","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31380442,0.0010968534,0.0000055932965,0.68247026,0.00014027671,0.0012816822,0.0010969697,0.000015612619,0.00008835572],"genre_scores_gemma":[0.33107367,0.0025290968,0.000004530375,0.6650449,0.000014473172,0.00023197911,0.0004651278,0.000037175945,0.00059902767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614716,0.001727318,0.0006514823,0.00030474656,0.0008166148,0.0003526742],"domain_scores_gemma":[0.9966558,0.0017116661,0.0004623253,0.00097163406,0.00012922205,0.00006932664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079976703,0.00033753327,0.00069601275,0.00010762603,0.00012428538,0.000043760065,0.0003215414,0.0001596321,0.00013081759],"category_scores_gemma":[0.00054555305,0.00016012986,0.0005817774,0.0003050912,0.00013279167,0.000069409936,0.000054609143,0.00047169274,0.000029791567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043904516,0.0013473434,0.00015979081,0.00006347617,0.0012755875,0.000009397382,0.0013006098,0.00005877215,0.00007515574,0.0000533709,0.99416775,0.0010496841],"study_design_scores_gemma":[0.007260408,0.0030059027,0.020529056,0.0059410976,0.0012648295,0.000023668419,0.0018268267,0.00018980559,0.0004745806,0.001400971,0.957614,0.00046886396],"about_ca_topic_score_codex":0.0005893136,"about_ca_topic_score_gemma":0.000014322593,"teacher_disagreement_score":0.036553778,"about_ca_system_score_codex":0.00009721532,"about_ca_system_score_gemma":0.00015335664,"threshold_uncertainty_score":0.65299064},"labels":[],"label_agreement":null},{"id":"W2950872861","doi":"10.1136/annrheumdis-2019-eular.542","title":"AB0287 BENEFITS OF PAIN RELIEF ON FATIGUE, FUNCTION, AND QUALITY OF LIFE WHEN JOINT INFLAMMATION IS CONTROLLED IN PATIENTS WITH RA","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Medicine; Rheumatoid arthritis; Minimal clinically important difference; Quality of life (healthcare); Physical therapy; Visual analogue scale; Population; Internal medicine; Arthritis; SF-36; Randomized controlled trial; Disease; Health related quality of life","score_opus":0.03758229220091868,"score_gpt":0.27598417638129435,"score_spread":0.23840188418037567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950872861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491835,0.0024514948,0.000012756767,0.0013134138,0.000034277662,0.0010686843,0.000058076137,0.00000718812,0.00013578536],"genre_scores_gemma":[0.99801993,0.0016169071,0.000020824073,0.00023298213,0.000005369907,0.000024460753,0.000017020853,0.000010727724,0.00005177414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805665,0.00031511314,0.0007213645,0.00013642709,0.0006259988,0.00014445237],"domain_scores_gemma":[0.99820614,0.00043142308,0.00051739946,0.00037543185,0.0003683659,0.00010123985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075848907,0.00012135193,0.0006963446,0.00013483052,0.000025458585,0.000008660202,0.00008281831,0.000034189594,0.0001422373],"category_scores_gemma":[0.0018891047,0.00007148248,0.000119463715,0.000120099176,0.00012514074,0.00011089316,0.000033236567,0.00006353142,0.0000026396526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011958742,0.0009543193,0.95790017,0.0015290214,0.0004879763,6.226309e-8,0.00091357087,0.00016446774,0.0000736466,0.0018540024,0.0013167701,0.022847269],"study_design_scores_gemma":[0.012061482,0.0012764003,0.9808288,0.0034270992,0.000012349792,5.329265e-8,0.00018569351,0.00015223092,0.00044270832,0.001522885,0.000018863246,0.000071433526],"about_ca_topic_score_codex":0.00019721974,"about_ca_topic_score_gemma":0.000017919354,"teacher_disagreement_score":0.02292865,"about_ca_system_score_codex":0.0000066316898,"about_ca_system_score_gemma":0.000092031645,"threshold_uncertainty_score":0.29149708},"labels":[],"label_agreement":null},{"id":"W2950880342","doi":"10.1136/annrheumdis-2019-eular.1921","title":"FRI0462 UNDERSTANDING MEDIATORS OF PAIN REDUCTION IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH TOFACITINIB: ROLE OF INFLAMMATION","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Gilead Sciences; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Placebo; Janus kinase inhibitor; Internal medicine; Visual analogue scale; Psoriasis; Arthritis; Population; Physical therapy; Dermatology; Rheumatoid arthritis; Pathology; Alternative medicine","score_opus":0.01663464922587403,"score_gpt":0.2433698150448088,"score_spread":0.22673516581893477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950880342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981549,0.0007531825,0.000002263972,0.00013655765,0.00004937048,0.000613708,0.00007466886,0.000009052729,0.00020630934],"genre_scores_gemma":[0.9994529,0.00043008427,0.000015261612,0.0000079804595,0.0000065029744,0.000020316575,0.000045512323,0.000011784718,0.00000967047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998866,0.000092906565,0.0004483126,0.000116360905,0.00034390492,0.0001324995],"domain_scores_gemma":[0.99910235,0.00010891878,0.0003946438,0.00022497117,0.00012355598,0.00004555269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013327661,0.00011372544,0.00042154314,0.000115427254,0.000025032305,0.0000029759358,0.00005434424,0.000031707517,0.00006487417],"category_scores_gemma":[0.00024715185,0.000075962824,0.00010250264,0.000265443,0.0000850607,0.000090350026,0.00001795491,0.00003424315,0.0000019314286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054068136,0.00056934694,0.9694565,0.0004697255,0.00033785758,9.608502e-7,0.001271424,0.000075255855,0.000107898595,0.00036462452,0.000049848306,0.026755879],"study_design_scores_gemma":[0.007803197,0.0014767232,0.95996666,0.008082179,0.00021950067,0.0000025645181,0.00693606,0.000294813,0.0113070225,0.0037504376,0.0000072962,0.00015353554],"about_ca_topic_score_codex":0.00012099266,"about_ca_topic_score_gemma":0.000022227001,"teacher_disagreement_score":0.026602343,"about_ca_system_score_codex":0.000031164913,"about_ca_system_score_gemma":0.000045007648,"threshold_uncertainty_score":0.3097674},"labels":[],"label_agreement":null},{"id":"W2950932724","doi":"10.1136/annrheumdis-2019-eular.1694","title":"FRI0410 TNF INHIBITORS REDUCE SPINAL RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITIS (PARTIALLY) BY DECREASING DISEASE ACTIVITY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ankylosing spondylitis; Axial spondyloarthritis; Observational study; Internal medicine; Cohort; Gee; Radiography; Physical therapy; Surgery; Generalized estimating equation","score_opus":0.023348100690529297,"score_gpt":0.3161259948055842,"score_spread":0.2927778941150549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950932724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789359,0.017127218,0.0000016390384,0.0020648926,0.0003433927,0.0011758257,0.00013808213,0.000041983163,0.00017106182],"genre_scores_gemma":[0.9974979,0.002033407,0.00003994854,0.00013568754,0.000051815812,0.0000860924,0.000033676588,0.000032606255,0.00008887499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790114,0.00017192513,0.00046023028,0.00039349953,0.0006207235,0.0004524757],"domain_scores_gemma":[0.99859065,0.00009294756,0.0002795091,0.00058473524,0.00009215924,0.00036002442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017972654,0.0002902126,0.0006174766,0.00016523107,0.0001376178,0.000032304524,0.00017814034,0.00006278013,0.00013249756],"category_scores_gemma":[0.00037237504,0.00020768416,0.00044618986,0.00050502794,0.0002347342,0.00020827478,0.00013621799,0.00014448303,0.000022412847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072665154,0.003988891,0.705775,0.0010016973,0.00039462245,0.000114778,0.00016490935,0.000008826803,0.00093729026,0.00014526998,0.0038090157,0.27639318],"study_design_scores_gemma":[0.0047442745,0.0008530643,0.9799597,0.009403207,0.0002448422,0.00001984761,0.00011311091,0.0001120418,0.0030761785,0.00062217185,0.00056265894,0.0002888638],"about_ca_topic_score_codex":0.00020122185,"about_ca_topic_score_gemma":0.00002517552,"teacher_disagreement_score":0.2761043,"about_ca_system_score_codex":0.000033565975,"about_ca_system_score_gemma":0.00016849238,"threshold_uncertainty_score":0.84691143},"labels":[],"label_agreement":null},{"id":"W2950962041","doi":"10.1136/annrheumdis-2019-eular.643","title":"AB0753 COMPARING COMPOSITE MEASURES OF DISEASE ACTIVITY IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 2 TRIAL WITH GUSELKUMAB","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; University of Toronto","funders":"Celgene; Pfizer; British Society for Rheumatology; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Ustekinumab; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Arthritis; Gastroenterology; Disease; Immunology; Adalimumab; Pathology","score_opus":0.0517268126852062,"score_gpt":0.31590468947587713,"score_spread":0.26417787679067095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950962041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906312,0.005339455,0.000008259814,0.00056148856,0.00017193044,0.0025207393,0.0005000108,0.000022367667,0.00024451085],"genre_scores_gemma":[0.99834025,0.0013071933,0.00005549375,0.000052385218,0.00002477213,0.000107551474,0.000058624686,0.000019847908,0.00003385667],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977523,0.00033496396,0.00076353893,0.00029103376,0.00061300764,0.00024517404],"domain_scores_gemma":[0.99756485,0.0008755723,0.0005931741,0.0006614748,0.000136232,0.00016872246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003273809,0.00024108165,0.001680313,0.000099278186,0.00005577493,0.000016765249,0.00016058041,0.000032023923,0.000036817597],"category_scores_gemma":[0.0008742202,0.0001461789,0.00041966652,0.00021523316,0.00022995738,0.0001132961,0.000079721205,0.00009099331,0.000007317027],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97207195,0.0042662127,0.007700646,0.00025828782,0.001458032,0.000018425371,0.00051602675,0.00010748812,0.00004224709,0.00004930824,0.0001278768,0.01338351],"study_design_scores_gemma":[0.9116895,0.00089973514,0.077025965,0.007012667,0.00084905734,0.0000013347454,0.00014422777,0.0008585501,0.00066634495,0.0006735611,0.000009535763,0.00016952422],"about_ca_topic_score_codex":0.0010453354,"about_ca_topic_score_gemma":0.0001096211,"teacher_disagreement_score":0.06932532,"about_ca_system_score_codex":0.00002117207,"about_ca_system_score_gemma":0.00014483588,"threshold_uncertainty_score":0.5961003},"labels":[],"label_agreement":null},{"id":"W2950975041","doi":"10.1136/annrheumdis-2019-eular.6357","title":"OP0269 HPR PATTERNS OF FATIGUE AND PREDICTORS OF SIGNIFICANT IMPROVEMENT IN THE 1ST YEAR OF RA: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT (CATCH)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Université de Sherbrooke; Université Laval; University of Toronto; University of Calgary; McGill University; Southlake Regional Health Center; University of Manitoba; Western University; Centre for Advancing Health Outcomes","funders":"","keywords":"Medicine; Cohort; Internal medicine; Depression (economics); Physical therapy; Logistic regression; Chronic fatigue; Chronic fatigue syndrome","score_opus":0.02975822829085077,"score_gpt":0.2772900343914023,"score_spread":0.24753180610055153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950975041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406046,0.0009322612,8.04861e-7,0.002123566,0.000053787455,0.001085168,0.0015631453,0.000002800674,0.0001780153],"genre_scores_gemma":[0.9989046,0.0009118223,0.0000063782745,0.000024725781,0.0000066297466,0.000019920799,0.000055379056,0.00001233398,0.000058205613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980782,0.00017061779,0.0006411015,0.00017813963,0.0006911661,0.00024077167],"domain_scores_gemma":[0.99810284,0.0005439116,0.00030815657,0.00078381045,0.00014264545,0.00011863702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059765007,0.00012773082,0.00045057517,0.00007515004,0.000037001297,0.000011636434,0.00041414882,0.000051707284,0.000107482054],"category_scores_gemma":[0.00045385255,0.00006486106,0.00014529383,0.0001772627,0.0002912103,0.00004709521,0.000081562735,0.00012866901,0.0000021143599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024211634,0.0002873363,0.98816943,0.0018563936,0.00047408434,0.000003731883,0.0034809557,0.000021531801,0.00060833816,0.00019136093,0.0019807278,0.0026839653],"study_design_scores_gemma":[0.0013126193,0.0005130372,0.98897624,0.004427736,0.00007593962,0.0000010222425,0.0018865397,0.000065744964,0.0024339703,0.00023446791,0.0000115132525,0.00006118049],"about_ca_topic_score_codex":0.22969608,"about_ca_topic_score_gemma":0.0050077974,"teacher_disagreement_score":0.22468828,"about_ca_system_score_codex":0.000023916382,"about_ca_system_score_gemma":0.00049882993,"threshold_uncertainty_score":0.7754334},"labels":[],"label_agreement":null},{"id":"W2950980122","doi":"10.1136/annrheumdis-2019-eular.2680","title":"FRI0512 RETRO-INVERSO TAT-BECLIN-1 INDUCES SYNOVIAL FIBROSIS AND DOES NOT PROTECT CARTILAGE FROM DEGENERATION IN A MOUSE MODEL OF OA","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Autophagy; Medicine; Osteoarthritis; Fibrosis; Synovitis; Cartilage; Inflammation; PI3K/AKT/mTOR pathway; Myofibroblast; Pathology; Cancer research; Arthritis; Internal medicine; Cell biology; Chemistry; Apoptosis; Signal transduction; Biology; Anatomy","score_opus":0.02762156535013427,"score_gpt":0.25575970403163417,"score_spread":0.2281381386814999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950980122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980004,0.00048984843,0.00004742033,0.0001890049,0.000042438092,0.00045315857,0.000720372,0.00000538796,0.00005196696],"genre_scores_gemma":[0.99902445,0.00017906747,0.00033158498,0.00013569741,0.000021695498,0.00003826075,0.000042161155,0.000013109343,0.0002139939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905723,0.00012068218,0.00029575624,0.0002193786,0.00016688307,0.00014008525],"domain_scores_gemma":[0.9992881,0.000036322654,0.00020759476,0.00035410788,0.00006119778,0.000052718875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015985835,0.0001286719,0.00023102562,0.000035842797,0.000029694367,0.000017232765,0.00019101151,0.00008926264,0.000024168805],"category_scores_gemma":[0.00022174472,0.00008638289,0.00010811473,0.000050910614,0.00008142706,0.000012980127,0.00013079091,0.000050500417,0.000002514919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020651658,0.00008287082,0.003523762,0.00019938407,0.000031256994,8.9951286e-8,0.00025730516,0.00038628827,0.99429786,0.000053467593,0.000082669845,0.00087853265],"study_design_scores_gemma":[0.00036997738,0.00012117949,0.0012360954,0.00015815896,0.00001994337,1.3716485e-7,0.00012453285,0.002001527,0.99509436,0.0007538759,0.000007361793,0.00011287205],"about_ca_topic_score_codex":0.00017241425,"about_ca_topic_score_gemma":0.000046254194,"teacher_disagreement_score":0.0022876665,"about_ca_system_score_codex":0.0000036466004,"about_ca_system_score_gemma":0.000071944276,"threshold_uncertainty_score":0.3522592},"labels":[],"label_agreement":null},{"id":"W2950981519","doi":"10.1136/annrheumdis-2019-eular.5693","title":"SAT0318 PREVALENCE AND PREDICTORS OF DEPRESSION AMONG PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN A CANADIAN REAL WORLD OBSERVATIONAL COHORT: RESULTS FROM THE COMPLETE STUDIES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Penticton Regional Hospital; McMaster University; University of British Columbia; Memorial University of Newfoundland; Centre hospitalier de l'Université Laval","funders":"Karolinska Institutet; Samsung; Pfizer; Eli Lilly and Company","keywords":"Medicine; BASDAI; BASFI; Psoriatic arthritis; Internal medicine; Depression (economics); Adalimumab; Ankylosing spondylitis; Physical therapy; Cohort; Arthritis; Disease","score_opus":0.03316873429034036,"score_gpt":0.2731964186554102,"score_spread":0.24002768436506985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950981519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860972,0.00874635,4.098462e-8,0.00044500898,0.000077765006,0.0009142631,0.0036281738,0.0000054773977,0.00008567518],"genre_scores_gemma":[0.9944036,0.0052381433,0.000028858944,0.000086747335,0.00001128193,0.000028727407,0.00015204777,0.00000994046,0.00004063173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987202,0.000093572045,0.00041633897,0.00022529603,0.00034338617,0.00020118352],"domain_scores_gemma":[0.99852806,0.0006398379,0.00026386004,0.0003004003,0.00015233632,0.00011553182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015551948,0.00014298341,0.00043120765,0.00006359243,0.00010770769,0.000012410191,0.00008021694,0.000021308242,0.000021729944],"category_scores_gemma":[0.0005288819,0.000079858735,0.000044970184,0.00017373834,0.00030091856,0.0001103884,0.00008118238,0.000055514265,4.0822755e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004072588,0.00008874846,0.994778,0.00020799982,0.0003646771,0.0000031158952,0.00090837793,0.000007996961,4.6520393e-7,0.00002750822,0.0002189004,0.0029869624],"study_design_scores_gemma":[0.003043918,0.0001526611,0.98763853,0.008341328,0.0001724057,7.884201e-7,0.00023949357,0.000069793045,0.0000063028797,0.00022752746,0.00003456781,0.00007268004],"about_ca_topic_score_codex":0.07210712,"about_ca_topic_score_gemma":0.09490807,"teacher_disagreement_score":0.022800954,"about_ca_system_score_codex":0.000028374248,"about_ca_system_score_gemma":0.00008909989,"threshold_uncertainty_score":0.9340718},"labels":[],"label_agreement":null},{"id":"W2950989573","doi":"10.1136/annrheumdis-2019-eular.6737","title":"THU0525 DEVELOPMENT OF A PREDICTIVE TOOL FOR RESPONSE TO ANTI-TNF-ALPHA THERAPY IN JIA USING GENE EXPRESSION PROFILES IN PERIPHERAL DERIVED MONONUCLEAR CELLS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Peripheral blood mononuclear cell; Whole blood; Gene expression; Immunology; Internal medicine; Gene; Biology; In vitro","score_opus":0.04472255078598385,"score_gpt":0.33077857363768937,"score_spread":0.2860560228517055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950989573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643147,0.00068584864,0.00012833296,0.00022842998,0.000041124604,0.0024268618,0.000031687538,0.00001011144,0.000016156397],"genre_scores_gemma":[0.9974794,0.00016216536,0.002031762,0.000092135044,0.0000059606646,0.00011281555,0.0000060319053,0.00002597148,0.00008378118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983071,0.00021569362,0.00063035864,0.00020863397,0.0003592696,0.00027894432],"domain_scores_gemma":[0.9990122,0.0001868483,0.00019683996,0.0003859522,0.00015371846,0.00006447045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005787421,0.00015327749,0.0005116462,0.00020015055,0.000048879778,0.000010776068,0.00023132707,0.000055967947,0.00008337928],"category_scores_gemma":[0.00034370707,0.0001054954,0.00013664788,0.0002401489,0.0000675585,0.00012626253,0.000119545606,0.00007502246,0.0000039383444],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014030326,0.0009268405,0.05015547,0.00084306,0.000121532124,0.000002394876,0.009033167,0.00223208,0.9063049,0.000003370916,0.00020628484,0.016140558],"study_design_scores_gemma":[0.002193801,0.00037871173,0.5210026,0.0022044438,0.000008601124,5.5380343e-7,0.0014205595,0.002658449,0.46987686,0.0000696342,0.00006935745,0.00011645595],"about_ca_topic_score_codex":0.000026485655,"about_ca_topic_score_gemma":0.00000138371,"teacher_disagreement_score":0.4708471,"about_ca_system_score_codex":0.000046590903,"about_ca_system_score_gemma":0.0006178336,"threshold_uncertainty_score":0.43019775},"labels":[],"label_agreement":null},{"id":"W2951028259","doi":"10.1136/annrheumdis-2019-eular.5123","title":"THU0463  EXPECTATIONS OF TREATMENT RESULT OF KNEE OSTEOARTHRITIS PATIENTS TREATED WITH A TOTAL KNEE ARTHROPLASTY. THE INFLUENCE OF DEMOGRAPHIC FACTORS, PAIN, PERSONALITY TRAITS, PHYSICAL AND PSYCHOLOGICAL STATUS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Erasmus Universitair Medisch Centrum Rotterdam; Universidade Estadual de Campinas; Radboud Universitair Medisch Centrum; Universidade de São Paulo; Erasmus Medisch Centrum; Erasmus+; University of Calgary","keywords":"Physical therapy; Osteoarthritis; Anxiety; Mood; Medicine; Squatting position; Arthroplasty; Body mass index; Optimism; Quality of life (healthcare); Psychology; Clinical psychology; Surgery; Internal medicine; Psychiatry","score_opus":0.020350056884928844,"score_gpt":0.2764327759111369,"score_spread":0.25608271902620805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951028259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974078,0.0006043974,9.002246e-7,0.00015045144,0.000019031824,0.0010279753,0.0007308687,0.00001569419,0.000042894026],"genre_scores_gemma":[0.99973273,0.00010240882,0.000028499224,0.000024316838,0.0000043961486,0.00003252707,0.000030074143,0.00001450322,0.00003055571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982349,0.00029534046,0.0005299773,0.00024062942,0.0004634006,0.0002357068],"domain_scores_gemma":[0.9976807,0.0009483023,0.0005073253,0.00045101845,0.0002811778,0.0001314407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009404392,0.00023524182,0.0007031013,0.00008003733,0.00006293816,0.000006631407,0.000077109245,0.000044556222,0.00002861894],"category_scores_gemma":[0.0005747493,0.000114104754,0.0003063467,0.00032456423,0.0008146748,0.0001055973,0.000043482945,0.00008088054,0.0000011171951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009029393,0.0021262353,0.9806201,0.0002973609,0.00044063522,6.9791423e-7,0.004297205,0.000103253406,0.00023065892,0.00006924123,0.00003127282,0.010880387],"study_design_scores_gemma":[0.0033871457,0.008610873,0.9836221,0.00077930285,0.00024977996,0.000004306334,0.002783534,0.00004527885,0.00034081744,0.00006940102,0.0000040621157,0.000103422906],"about_ca_topic_score_codex":0.00021496307,"about_ca_topic_score_gemma":0.000037485523,"teacher_disagreement_score":0.010776965,"about_ca_system_score_codex":0.000011606989,"about_ca_system_score_gemma":0.00007839206,"threshold_uncertainty_score":0.4653057},"labels":[],"label_agreement":null},{"id":"W2951060310","doi":"10.1136/annrheumdis-2019-eular.3429","title":"AB0666 ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY TREND IN PATIENTS WITH SYSTEMIC SCLEROSIS: A POPULATION-BASED STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Population; Cause of death; Intensive care medicine; Internal medicine; Disease; Environmental health","score_opus":0.06886897980071788,"score_gpt":0.29523578599464684,"score_spread":0.22636680619392896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951060310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425143,0.003381244,5.536624e-7,0.00012223965,0.00010950565,0.001973418,0.00010491859,0.0000366874,0.000019975205],"genre_scores_gemma":[0.99945647,0.00022016991,0.000004373386,0.00012907115,0.000010525966,0.00006856444,0.000054865723,0.000030009543,0.000025983232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786353,0.00020637411,0.0006721219,0.0003442972,0.0006684329,0.0002452135],"domain_scores_gemma":[0.998372,0.00015788552,0.00037042005,0.0008012213,0.000108766544,0.00018970041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020103427,0.00023921185,0.0006174064,0.00015278927,0.000052763513,0.000033760345,0.00016018277,0.000060682352,0.000065738226],"category_scores_gemma":[0.00009903501,0.00013769131,0.00013811563,0.00031688967,0.00005419692,0.00010790785,0.00004774022,0.000085837266,0.000009524001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003652393,0.0019780938,0.9949058,0.00058590074,0.00074430456,0.0000019331476,0.0002745268,0.00023862367,0.000011996415,0.000018223116,0.00025499793,0.00062031875],"study_design_scores_gemma":[0.004659552,0.00033603545,0.9824007,0.010659791,0.00068088237,0.000001095667,0.00093443855,0.00013665212,0.000011567168,0.000017985963,0.0000011199055,0.00016018465],"about_ca_topic_score_codex":0.00019523973,"about_ca_topic_score_gemma":0.000046812856,"teacher_disagreement_score":0.012505147,"about_ca_system_score_codex":0.00003786247,"about_ca_system_score_gemma":0.0000713784,"threshold_uncertainty_score":0.5614889},"labels":[],"label_agreement":null},{"id":"W2951084767","doi":"10.1136/annrheumdis-2019-eular.5824","title":"THU0516 LONG-TERM SAFETY OF SUBCUTANEOUS TOCILIZUMAB ADMINISTRATION IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"GlaxoSmithKline","keywords":"Medicine; Tocilizumab; Adverse effect; Body weight; Internal medicine; Rheumatoid arthritis","score_opus":0.017704822966367672,"score_gpt":0.2876255108741461,"score_spread":0.26992068790777846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951084767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97697514,0.021347545,0.0000056866907,0.00060159405,0.00004345418,0.0007902703,0.000023870398,0.000012321459,0.00020010005],"genre_scores_gemma":[0.99690133,0.0028048803,0.0000032496919,0.00004710603,0.000005405153,0.000018821987,0.000010755511,0.000013038832,0.00019540673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835795,0.00013836237,0.00074542983,0.00016010033,0.0003941408,0.00020400494],"domain_scores_gemma":[0.9989893,0.000088593115,0.00026663652,0.00046813715,0.000110467736,0.00007687497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031850903,0.000122041056,0.00058776996,0.000085867745,0.000035484052,0.00001191589,0.0001390968,0.000059230693,0.00013008027],"category_scores_gemma":[0.0003169696,0.00008820172,0.00014929254,0.0001631367,0.00012795736,0.00010347795,0.00007216425,0.00009755848,0.000015890535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004243808,0.0015008765,0.8240041,0.017737059,0.0004472094,0.0002342204,0.0023292634,0.0001119519,0.008488284,0.0015058473,0.00027088023,0.13912646],"study_design_scores_gemma":[0.0029337066,0.0011636853,0.97268933,0.014492927,0.00008962131,0.0004233097,0.00095982087,0.0005812273,0.005938895,0.0005091493,0.000015648124,0.00020268108],"about_ca_topic_score_codex":0.000055120418,"about_ca_topic_score_gemma":0.000023576777,"teacher_disagreement_score":0.1486852,"about_ca_system_score_codex":0.000019658959,"about_ca_system_score_gemma":0.00032759603,"threshold_uncertainty_score":0.35967615},"labels":[],"label_agreement":null},{"id":"W2951090692","doi":"10.1136/annrheumdis-2019-eular.4873","title":"OP0157 HPR EUROPEAN PATIENT VOICE IN GOUT SURVEY – SUBJECTIVE SATISFACTION IN GOUT PATIENTS VERSUS OBJECTIVE SUBOPTIMAL GOUT CARE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fundación Española de Reumatología; British Society for Rheumatology; Arthritis Society; Celgene","keywords":"Medicine; Gout; Internal medicine; Physical therapy; Overweight; Rheumatology; Dyslipidemia; Disease; Obesity","score_opus":0.024214251347539014,"score_gpt":0.2831256580056824,"score_spread":0.2589114066581434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951090692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296904,0.0007525946,0.0000023240357,0.00010959237,0.00068477576,0.0016561811,0.00036809078,0.000043344517,0.0034140896],"genre_scores_gemma":[0.9992863,0.0001242916,0.000034598415,0.00017262372,0.000022497145,0.00004200692,0.00016156764,0.00006614544,0.00008998418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962462,0.0009557986,0.0008357068,0.000554925,0.0008869099,0.000520431],"domain_scores_gemma":[0.9969942,0.00087027706,0.0005310513,0.0008781103,0.0005250794,0.00020129212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004983957,0.0003860054,0.00074096915,0.00028190803,0.00006983512,0.000029596555,0.00032282993,0.0001091995,0.00008618326],"category_scores_gemma":[0.0029147128,0.00030185978,0.00026466258,0.0006882825,0.00013154892,0.00029896645,0.0002705062,0.00040490107,0.00020865089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019564363,0.00062834757,0.97886556,0.00037637123,0.00021201457,0.000009471166,0.0066456185,0.0004875114,0.000017686963,0.000009208757,0.00031543756,0.010476336],"study_design_scores_gemma":[0.0043152166,0.000846794,0.98844796,0.0011928829,0.00013397641,0.0000020174693,0.0042728945,0.0001781116,0.00025745475,0.000039803435,0.00002086094,0.00029204699],"about_ca_topic_score_codex":0.006369953,"about_ca_topic_score_gemma":0.0014717098,"teacher_disagreement_score":0.010184289,"about_ca_system_score_codex":0.00036340771,"about_ca_system_score_gemma":0.00030653455,"threshold_uncertainty_score":0.9999434},"labels":[],"label_agreement":null},{"id":"W2951120056","doi":"10.1136/annrheumdis-2019-eular.2823","title":"SAT0140 COMPARATIVE EFFECTIVENESS OF TOFACITINIB AND NON-TNF AGENTS SINCE 2014. IMPACT OF COMBINATION WITH METHOTREXATE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"","keywords":"Tofacitinib; Medicine; Abatacept; Tocilizumab; Rheumatoid arthritis; Psoriatic arthritis; Internal medicine; Ustekinumab; Rituximab; Infliximab; Golimumab; Adalimumab; Methotrexate; Concomitant; Oncology; Tumor necrosis factor alpha","score_opus":0.03548218083640778,"score_gpt":0.3618279112857658,"score_spread":0.326345730449358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951120056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608135,0.0023830566,0.000032004165,0.000072280505,0.000025698408,0.0008610389,0.00017462489,0.000006573115,0.0003633455],"genre_scores_gemma":[0.99734306,0.0025161759,0.00005062636,0.000010546618,0.0000019274712,0.000014904466,0.000022705319,0.000010674655,0.000029396539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868697,0.00031975025,0.00028703123,0.00014077994,0.00040053672,0.00016494236],"domain_scores_gemma":[0.9983044,0.0006172094,0.00030504182,0.0003284736,0.00033671752,0.00010812555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003762725,0.00013978886,0.00066236756,0.00009281132,0.000032939613,0.000009531845,0.00012577127,0.000024984727,0.00009081198],"category_scores_gemma":[0.00016788281,0.00007938696,0.0001751664,0.00016237822,0.0003315677,0.00013938926,0.000054931697,0.00005966636,0.000005462401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00603184,0.0018787797,0.95940083,0.004412082,0.0026463808,0.0000030877802,0.0020116738,0.00030432604,0.006949602,0.0013957948,0.00094359653,0.014021994],"study_design_scores_gemma":[0.0028401841,0.0014307299,0.96757406,0.0042634574,0.000028277474,0.000005752873,0.00021304277,0.00056110346,0.021977296,0.0010161336,0.000009044568,0.00008093608],"about_ca_topic_score_codex":0.00023344453,"about_ca_topic_score_gemma":0.000002813406,"teacher_disagreement_score":0.0150276935,"about_ca_system_score_codex":0.000009911741,"about_ca_system_score_gemma":0.00013571222,"threshold_uncertainty_score":0.32373065},"labels":[],"label_agreement":null},{"id":"W2951132233","doi":"10.1136/annrheumdis-2019-eular.568","title":"THU0464 PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Naproxen; Medicine; Osteoarthritis; Placebo; Celecoxib; Evening; Internal medicine; Antipyretic; Gastroenterology; Pharmacology; Analgesic; Pathology","score_opus":0.035814368834908863,"score_gpt":0.35090196671351825,"score_spread":0.3150875978786094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951132233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944678,0.0012413204,0.000002972722,0.000766352,0.001044915,0.0019525341,0.00009054697,0.000025548026,0.00040804222],"genre_scores_gemma":[0.9988065,0.00052254414,0.000015902959,0.0002306933,0.00015337516,0.00001584116,0.000008271305,0.000036654634,0.00021024932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609715,0.0006957877,0.0017168614,0.00027206203,0.0008861018,0.0003320119],"domain_scores_gemma":[0.99553555,0.0012243169,0.0013793764,0.0013932768,0.0002526304,0.00021482389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014495639,0.00026606667,0.0012036473,0.00008983587,0.0000847944,0.000008145011,0.0005585636,0.00011487123,0.0001630065],"category_scores_gemma":[0.0026877113,0.00014812434,0.001256282,0.00027504086,0.0004967112,0.000113151844,0.00021218511,0.00022581966,0.000025718324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16968489,0.018466944,0.60613185,0.022039253,0.006687369,0.0000502175,0.0048608207,0.0005826452,0.013290899,0.005069978,0.02991481,0.12322031],"study_design_scores_gemma":[0.21540964,0.0036624589,0.57121927,0.021968288,0.0037501797,0.000037600894,0.0011774217,0.0041010454,0.17101018,0.002869312,0.0036454482,0.0011491377],"about_ca_topic_score_codex":0.00004096772,"about_ca_topic_score_gemma":0.0000023610353,"teacher_disagreement_score":0.15771928,"about_ca_system_score_codex":0.000016678374,"about_ca_system_score_gemma":0.00058583566,"threshold_uncertainty_score":0.6040335},"labels":[],"label_agreement":null},{"id":"W2951160933","doi":"10.1136/annrheumdis-2019-eular.3132","title":"AB0740 USE OF SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS. IMPACTS OF COMBINATION WITH METHOTREXATE","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Methotrexate; Dermatology; Psoriasis; Arthritis; Immunology","score_opus":0.016975044362148882,"score_gpt":0.23522776407099918,"score_spread":0.2182527197088503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951160933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791193,0.001209157,0.0000028976199,0.000054087,0.00009841687,0.00048811908,0.00019400675,0.0000072702856,0.00003408632],"genre_scores_gemma":[0.9995199,0.00021868871,0.000050060946,0.000019431438,9.0299693e-7,0.000011800735,0.000076179545,0.000012012288,0.00009106295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897563,0.00025719625,0.00036641574,0.00013274603,0.000098193326,0.00016982315],"domain_scores_gemma":[0.9986361,0.000290317,0.0005217067,0.00036860674,0.00016464083,0.000018614372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011685675,0.00014552109,0.0004645076,0.0001114917,0.000022676033,0.0000045835586,0.00015438507,0.000055078268,0.0001027518],"category_scores_gemma":[0.00012711673,0.0000841449,0.00009562739,0.00021724046,0.00009131055,0.0001653266,0.00003524299,0.000041629217,0.000010600307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023356155,0.0021560912,0.93886006,0.00042986075,0.0011266132,6.6519056e-7,0.0007362592,0.000126089,0.00032740599,0.00043789076,0.00019523967,0.053268194],"study_design_scores_gemma":[0.005144511,0.0008264228,0.980036,0.0014391132,0.00016189263,8.4173064e-7,0.00006901741,0.000005746417,0.011881253,0.00031761124,0.000012365885,0.00010522587],"about_ca_topic_score_codex":0.00026374537,"about_ca_topic_score_gemma":0.000052795956,"teacher_disagreement_score":0.053162966,"about_ca_system_score_codex":0.000012702205,"about_ca_system_score_gemma":0.0000644218,"threshold_uncertainty_score":0.34313294},"labels":[],"label_agreement":null},{"id":"W2951164170","doi":"10.1136/annrheumdis-2019-eular.7869","title":"FRI0358 ROLE OF MIRNA-21-5PAS A POTENTIAL BIOMARKER FOR THE INFLAMMATION PATHWAY IN PSORIATIC DISEASE AND RESPONSE TO METHOTREXATE TREATMENT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Memorial University of Newfoundland; University Health Network","funders":"","keywords":"Medicine; Methotrexate; Biomarker; Inflammation; microRNA; Disease; Psoriatic arthritis; Psoriasis; Bioinformatics; Immunology; Internal medicine; Gene","score_opus":0.02629998834831441,"score_gpt":0.30565352167566634,"score_spread":0.2793535333273519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951164170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98704684,0.0065110605,0.000012135629,0.0040267524,0.00008964646,0.002031651,0.0002460939,0.0000080153,0.000027797409],"genre_scores_gemma":[0.99869126,0.0006308048,0.00007658044,0.000081357844,0.000012814841,0.00026322075,0.000012039175,0.000014904679,0.00021698716],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989089,0.00014688952,0.00036065825,0.00017356726,0.00022683556,0.00018315468],"domain_scores_gemma":[0.9986091,0.0005783714,0.00018276989,0.0004188889,0.00009231478,0.00011852674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024703998,0.00015428895,0.0003769073,0.00009192794,0.00006564879,0.000011933094,0.00009018131,0.000023096349,0.000035314577],"category_scores_gemma":[0.00062994333,0.00008180518,0.00022067255,0.00015791741,0.00006198541,0.000052833537,0.00006560417,0.000019773961,0.0000060644925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079321876,0.0038290925,0.13561302,0.0020897374,0.005342858,0.00003609819,0.007650426,0.0006571257,0.013082395,0.0012713921,0.0006845985,0.75042135],"study_design_scores_gemma":[0.0049583297,0.0008207866,0.98386556,0.0011105154,0.00054180715,0.0000027779083,0.0008815999,0.0019702625,0.0034139403,0.0017889886,0.0005319541,0.00011348984],"about_ca_topic_score_codex":0.00016098554,"about_ca_topic_score_gemma":0.000026288859,"teacher_disagreement_score":0.84825253,"about_ca_system_score_codex":0.000026461428,"about_ca_system_score_gemma":0.00009832588,"threshold_uncertainty_score":0.33359185},"labels":[],"label_agreement":null},{"id":"W2951196418","doi":"10.1136/annrheumdis-2019-eular.1474","title":"FRI0430 IXEKIZUMAB IMPROVES THE SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS REGARDLESS OF SEX, DURATION OF DISEASE, OR BODY MASS INDEX IN TWO RANDOMIZED, PHASE 3 CLINICAL TRIALS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"UCB Pharma; British Heart Foundation; Prothena; Gilead Sciences; Novo Nordisk; Sanofi; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ixekizumab; Internal medicine; Psoriatic arthritis; Placebo; Rheumatology; Psoriasis; Body mass index; Psoriasis Area and Severity Index; Arthritis; Secukinumab; Immunology; Pathology","score_opus":0.055610966463744374,"score_gpt":0.40664316586456495,"score_spread":0.3510321994008206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951196418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678195,0.00939388,0.000021340045,0.0005375427,0.0001996576,0.0026464132,0.00034565976,0.0000071282348,0.00006642737],"genre_scores_gemma":[0.9935065,0.006140854,0.000022386253,0.00006108609,0.00002978031,0.000093469585,0.000022288024,0.000017585257,0.00010606854],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957109,0.0010994045,0.002272382,0.00023676718,0.00048588277,0.0001946423],"domain_scores_gemma":[0.99347746,0.0039854213,0.0016066842,0.00060516904,0.00020532242,0.00011996421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021093404,0.00021450117,0.002316371,0.00010031992,0.00004186052,0.000010311285,0.0001718675,0.000048538303,0.00008001059],"category_scores_gemma":[0.0064327004,0.00010672687,0.0006507267,0.0002089001,0.00054728414,0.0000977998,0.000091016336,0.00008537497,0.0000012179019],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.306771,0.007831027,0.16805163,0.004612064,0.006640638,0.000020539037,0.0016973525,0.0000630505,0.0005336188,0.0016570226,0.00047147306,0.5016506],"study_design_scores_gemma":[0.64549553,0.0045282883,0.31188476,0.014085995,0.003610776,0.000008854862,0.0031515558,0.003904812,0.0028256313,0.01008419,0.000026244612,0.00039335224],"about_ca_topic_score_codex":0.00021009633,"about_ca_topic_score_gemma":0.000031550375,"teacher_disagreement_score":0.50125724,"about_ca_system_score_codex":0.000008741586,"about_ca_system_score_gemma":0.00020282985,"threshold_uncertainty_score":0.7701008},"labels":[],"label_agreement":null},{"id":"W2951198932","doi":"10.1136/annrheumdis-2019-eular.6455","title":"THU0361 DIAGNOSTIC PERFORMANCE OF MRI LESIONS IN THE SACROILIAC JOINTS ACCORDING TO UPDATED ASAS LESION DEFINITIONS: A CENTRAL READER ASSESSMENT OF MRI SCANS FROM THE ASSESSMENTS IN SPONDYLOARTHRITIS CLASSIFICATION COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Cohort; Quadrant (abdomen); Axial spondyloarthritis; Lesion; Radiology; Gold standard (test); Magnetic resonance imaging; Internal medicine; Sacroiliitis; Surgery","score_opus":0.07365954213307674,"score_gpt":0.3495802443430664,"score_spread":0.27592070220998965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951198932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295986,0.0010966451,0.0000150102815,0.0029982962,0.00014984138,0.0018015974,0.0005319661,0.000009279971,0.00043753223],"genre_scores_gemma":[0.99322325,0.0058826664,0.00018730138,0.0002576176,0.000012393567,0.00020290366,0.00019606481,0.000017467373,0.000020347765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976462,0.00030286695,0.00079257804,0.0002802715,0.00065601896,0.00032204005],"domain_scores_gemma":[0.997407,0.0011963575,0.00039130804,0.0007750998,0.0001564191,0.00007378248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042559605,0.00020668042,0.0005745726,0.00012062274,0.000120140205,0.000019934521,0.0003428816,0.00005394773,0.00011047751],"category_scores_gemma":[0.0004963893,0.000117689495,0.00018941959,0.00057906576,0.00014664297,0.0001509465,0.00013110795,0.00015325817,0.000010272022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016292134,0.0011491523,0.98992,0.00013791057,0.00019022544,0.0000045549264,0.0006843826,0.0002666311,0.00014036613,0.00033323318,0.00092164526,0.006088933],"study_design_scores_gemma":[0.0015782188,0.00031130775,0.9859916,0.0052893385,0.00018985802,0.000003733517,0.004962517,0.0009687038,0.00025675798,0.00031563896,0.000030133493,0.00010222185],"about_ca_topic_score_codex":0.0010965917,"about_ca_topic_score_gemma":0.00026879023,"teacher_disagreement_score":0.005986711,"about_ca_system_score_codex":0.00006625938,"about_ca_system_score_gemma":0.00019482977,"threshold_uncertainty_score":0.4799238},"labels":[],"label_agreement":null},{"id":"W2951206277","doi":"10.1136/annrheumdis-2019-eular.3751","title":"OP0170 USE OF THE PROVISIONAL EULAR/ACR IGG4-RD CLASSIFICATION CRITERIA IN A COHORT OF SPANISH PATIENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Internal medicine; IgG4-related disease; Disease","score_opus":0.03974752607038922,"score_gpt":0.2960055773270297,"score_spread":0.2562580512566405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951206277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972368,0.00022124019,0.0000011250507,0.00077911274,0.00018471877,0.0011537682,0.00023575935,0.000011137295,0.00017636221],"genre_scores_gemma":[0.9993276,0.00008326591,0.000020029893,0.00026964062,0.000008530388,0.000022990396,0.0000412009,0.000018077273,0.00020865347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980474,0.00021658906,0.00075322355,0.0001858121,0.000621761,0.00017518585],"domain_scores_gemma":[0.99793226,0.00026221364,0.00058672513,0.00076418713,0.0003671152,0.00008748699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022324124,0.00015254738,0.000443128,0.00008742746,0.00003544414,0.000012303156,0.00029470932,0.00006479386,0.00023151992],"category_scores_gemma":[0.0016226501,0.00008874766,0.0003077782,0.00024929288,0.00019317504,0.00021698054,0.00012157064,0.00008718829,0.000013155974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007414508,0.0013520214,0.98726535,0.001043925,0.00016783233,5.125389e-7,0.00023791556,0.000053962678,0.001305231,0.0003646737,0.0057270117,0.0017401346],"study_design_scores_gemma":[0.0009212977,0.00013287058,0.9918375,0.0027995242,0.00016385279,7.099449e-7,0.00010913767,0.0008661135,0.0024899517,0.00038349957,0.00020793726,0.00008758474],"about_ca_topic_score_codex":0.00005867744,"about_ca_topic_score_gemma":0.0000016165019,"teacher_disagreement_score":0.0055190744,"about_ca_system_score_codex":0.000018886336,"about_ca_system_score_gemma":0.00024407945,"threshold_uncertainty_score":0.36190245},"labels":[],"label_agreement":null},{"id":"W2951242625","doi":"10.1136/annrheumdis-2019-eular.8571","title":"SP0045 CAN IMAGING PREDICT PROGRESSORS?","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Osteoarthritis; Synovitis; Magnetic resonance imaging; Clinical trial; Joint replacement; Joint effusion; Physical therapy; Intensive care medicine; Physical medicine and rehabilitation; Radiology; Internal medicine; Arthritis; Pathology; Arthroplasty","score_opus":0.017584759843718337,"score_gpt":0.27916059627429585,"score_spread":0.2615758364305775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951242625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911098,0.0025454024,0.0000012317017,0.002910907,0.0002381914,0.0007604958,0.000062356354,0.000055175446,0.0023164365],"genre_scores_gemma":[0.997597,0.00009493423,0.00005779304,0.00042558217,0.00002497933,0.000029190227,0.000022509366,0.000018532022,0.0017295089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990787,0.00003505832,0.0002155368,0.00014581552,0.00031098933,0.00021392135],"domain_scores_gemma":[0.99916434,0.000046160945,0.00012840523,0.00045845754,0.000077819896,0.00012479162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007378178,0.00012417424,0.0002732399,0.000045764333,0.00004165095,0.000015071433,0.0001320399,0.000019881929,0.0002776047],"category_scores_gemma":[0.00010544388,0.00007651029,0.00021525899,0.000101355945,0.00006499279,0.00006886603,0.000062146166,0.000045563695,0.000059650414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038503774,0.0013096073,0.57678545,0.0014587084,0.00041027128,0.000032358086,0.0006589704,0.0000090795465,0.0008028694,0.0028649303,0.007743349,0.40753934],"study_design_scores_gemma":[0.016854195,0.0043637003,0.84826815,0.022763224,0.00222946,0.00022521346,0.002321735,0.0013286582,0.073378384,0.021856545,0.0053363917,0.0010743522],"about_ca_topic_score_codex":0.000019706216,"about_ca_topic_score_gemma":0.000002664123,"teacher_disagreement_score":0.406465,"about_ca_system_score_codex":0.000008923914,"about_ca_system_score_gemma":0.000089167785,"threshold_uncertainty_score":0.3119999},"labels":[],"label_agreement":null},{"id":"W2951268098","doi":"10.1136/annrheumdis-2019-eular.331","title":"SAT0157 REAL-WORLD EVALUATION OF PERSISTENCE WITH EARLY-LINE ABATACEPT VERSUS TUMOR NECROSIS FACTOR-INHIBITORS FOR RHEUMATOID ARTHRITIS COMPLICATED BY POOR PROGNOSTIC FACTORS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Celgene; Biogen; Gilead Sciences; Momenta Pharmaceuticals; Genentech; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Tumor necrosis factor alpha; Immunology; Rheumatoid factor; Arthritis; Oncology; Internal medicine; Antibody; Rituximab","score_opus":0.07382460127520298,"score_gpt":0.32891286114893153,"score_spread":0.2550882598737286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951268098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899168,0.0049059708,0.000012748354,0.00069920527,0.00018312965,0.0031308804,0.000904919,0.000058049896,0.00018827443],"genre_scores_gemma":[0.9951817,0.004127929,0.00006466142,0.000037164275,0.000012824473,0.00019662535,0.00021144343,0.000054669636,0.00011299415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668306,0.00021225275,0.00073854346,0.00040063943,0.0014665617,0.0004989274],"domain_scores_gemma":[0.99642783,0.0008785256,0.00059268135,0.0007007031,0.0011027654,0.0002974803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040284923,0.00033290716,0.00084342854,0.00018336522,0.00015108014,0.000052310512,0.00035335135,0.000048661477,0.00032826044],"category_scores_gemma":[0.0012089614,0.00021972194,0.00041112961,0.00046525343,0.00042277956,0.00025797426,0.00007860152,0.00012804745,0.0000152949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010055903,0.003472126,0.88146406,0.0027655659,0.0035359326,0.000002760028,0.0029725689,0.00022812508,0.007931568,0.00061839505,0.014668042,0.07228492],"study_design_scores_gemma":[0.021821337,0.006041029,0.88283074,0.0150907105,0.00024877614,0.000012260392,0.002771644,0.004157465,0.0649389,0.00071364164,0.00052314624,0.0008503335],"about_ca_topic_score_codex":0.0006980859,"about_ca_topic_score_gemma":0.00013143159,"teacher_disagreement_score":0.071434595,"about_ca_system_score_codex":0.000050636158,"about_ca_system_score_gemma":0.00039234047,"threshold_uncertainty_score":0.8960001},"labels":[],"label_agreement":null},{"id":"W2951283876","doi":"10.1136/annrheumdis-2019-eular.6134","title":"THU0158 IMPAIRED OLFACTORY FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Technische Universität Dresden; Arthritis Society; Bristol-Myers Squibb","keywords":"Odor; Medicine; Rheumatoid arthritis; Olfaction; Taste; Olfactory system; Internal medicine; Sensory threshold; Audiology; Gastroenterology; Psychology; Neuroscience","score_opus":0.07196028573738941,"score_gpt":0.24153765157136772,"score_spread":0.1695773658339783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951283876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980848,0.00018515052,0.0000042079114,0.00018412141,0.00045467154,0.0004365411,0.00005594782,0.00004556121,0.00054901],"genre_scores_gemma":[0.9990609,0.00024151512,0.0000015325172,0.0004151413,0.000005537358,0.00001419166,0.0000031065777,0.000015612235,0.00024243578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985061,0.00020003707,0.0003351569,0.00026974015,0.00044960628,0.00023934382],"domain_scores_gemma":[0.9989132,0.0002712717,0.00024251874,0.00042937513,0.00007751306,0.0000660894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000875945,0.00017023622,0.00030577535,0.00008987287,0.000116163996,0.000024842544,0.00020654414,0.000031665135,0.00029385518],"category_scores_gemma":[0.00043723418,0.00010570987,0.00012542469,0.00027995705,0.00014550591,0.00032583097,0.00007615181,0.00008826459,0.000118243726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011830188,0.0007814654,0.9852947,0.00014441136,0.000056732213,8.692192e-7,0.00059636263,0.00036200124,0.0002435038,0.00059925084,0.0015267675,0.009210911],"study_design_scores_gemma":[0.001149068,0.00025677934,0.9952937,0.00041308324,0.0000068094246,5.577414e-7,0.0002297463,0.00003811532,0.0015311434,0.0005733399,0.0003552819,0.00015237844],"about_ca_topic_score_codex":0.000013155162,"about_ca_topic_score_gemma":0.000008016557,"teacher_disagreement_score":0.00999899,"about_ca_system_score_codex":0.000012196838,"about_ca_system_score_gemma":0.000040191422,"threshold_uncertainty_score":0.43107235},"labels":[],"label_agreement":null},{"id":"W2951304013","doi":"10.1136/annrheumdis-2019-eular.4185","title":"OP0203 CHARACTERIZING THE EPIGENOMIC LANDSCAPE OF PSORIASIS PATIENTS DESTINED TO DEVELOP PSORIATIC ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Memorial University of Newfoundland; University Health Network","funders":"","keywords":"Psoriasis; Medicine; Epigenomics; DNA methylation; Epigenome; Psoriatic arthritis; Epigenetics; Internal medicine; Oncology; Bioinformatics; Immunology; Genetics; Biology; Gene expression; Gene","score_opus":0.019760450481450392,"score_gpt":0.24042252941687298,"score_spread":0.22066207893542258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951304013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474037,0.002714956,0.0000039479264,0.0005012937,0.00095025415,0.0006451876,0.00027744044,0.000020649015,0.00014591293],"genre_scores_gemma":[0.99872124,0.0005021642,0.000040932136,0.0002370675,0.000015011907,0.00005138352,0.00008371295,0.000018602603,0.0003298916],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859864,0.00028654528,0.00052393274,0.00020600126,0.00009069642,0.00029421135],"domain_scores_gemma":[0.9983479,0.0004328031,0.0003999219,0.000568251,0.00021367078,0.00003745353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022512028,0.00020199532,0.00046421165,0.00007809635,0.00013372986,0.000012660336,0.00051246124,0.00007178547,0.00040446862],"category_scores_gemma":[0.000611858,0.00011798373,0.00019483395,0.00032547492,0.000077516765,0.000076001794,0.00016464107,0.000055345627,0.0003686037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082385156,0.0010150243,0.33868873,0.00036825426,0.0020412842,8.3554255e-7,0.0035521574,0.000039267477,0.006139054,0.0004214994,0.006336182,0.64057386],"study_design_scores_gemma":[0.0014955925,0.00019705163,0.97405857,0.00060871,0.00020040153,0.0000021599953,0.00025147703,0.00000339868,0.021920554,0.00026902367,0.0008061097,0.00018695508],"about_ca_topic_score_codex":0.00005174733,"about_ca_topic_score_gemma":0.000008191212,"teacher_disagreement_score":0.64038694,"about_ca_system_score_codex":0.00000939641,"about_ca_system_score_gemma":0.00010845581,"threshold_uncertainty_score":0.4811237},"labels":[],"label_agreement":null},{"id":"W2951315292","doi":"10.1136/annrheumdis-2019-eular.6299","title":"THU0392 DESCRIPTION AND PREVALENCE: OF SPONDYLOARTHRITIS IN UNSELECTED PATIENTS WITH PSORIASIS, ACUTE ANTERIOR UVEITIS, AND INFLAMMATORY BOWEL DISEASE PRESENTING WITH UNDIAGNOSED BACK PAIN","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; University of Ottawa; McMaster University; Université de Sherbrooke; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Psoriasis; Inflammatory bowel disease; Ankylosing spondylitis; Internal medicine; Axial spondyloarthritis; Disease; Back pain; Physical therapy; Uveitis; Psoriatic arthritis; Sacroiliitis; Dermatology; Immunology; Pathology; Alternative medicine","score_opus":0.00891223099326572,"score_gpt":0.23385875559893524,"score_spread":0.22494652460566952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951315292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241525,0.005831438,0.0000014447162,0.00012098123,0.000035084424,0.0013039842,0.0002496382,0.000012612638,0.000029568078],"genre_scores_gemma":[0.99580544,0.0038614068,0.000060436083,0.0000632643,0.000006041448,0.00005103121,0.00004044608,0.000021962098,0.00008994868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986581,0.00013939956,0.00036023927,0.0002587788,0.00034518205,0.00023824995],"domain_scores_gemma":[0.99896497,0.0001508972,0.000277621,0.00030332385,0.0001578373,0.00014534614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012010893,0.00020082682,0.00041868121,0.00009621215,0.0000574061,0.000020447082,0.00007559697,0.00003131007,0.000053434327],"category_scores_gemma":[0.00018079176,0.00012769006,0.00006105813,0.00017064862,0.00022603055,0.00020395475,0.00006884053,0.00005925503,0.0000015384862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017413761,0.0005467709,0.9907753,0.0026089668,0.00031406313,0.000021523023,0.0002718703,0.0000027247447,0.000013557046,0.000019110406,0.000070845424,0.0036138964],"study_design_scores_gemma":[0.0062225973,0.00083895196,0.9841971,0.007943977,0.00027864886,0.0000054833763,0.00013814365,0.00006941664,0.00007172938,0.000097214855,0.0000071630975,0.00012959861],"about_ca_topic_score_codex":0.000056535868,"about_ca_topic_score_gemma":0.000042726842,"teacher_disagreement_score":0.00657822,"about_ca_system_score_codex":0.000011672156,"about_ca_system_score_gemma":0.000072044415,"threshold_uncertainty_score":0.5207049},"labels":[],"label_agreement":null},{"id":"W2951323886","doi":"10.1136/annrheumdis-2019-eular.1360","title":"FRI0450 PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH APREMILAST","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"UCB Pharma; Genentech; Celgene; Gilead Sciences; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Internal medicine; Physical therapy; Disease; Enthesitis","score_opus":0.021864966867556748,"score_gpt":0.2696159590939036,"score_spread":0.2477509922263469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951323886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670583,0.0008573885,0.0000024126564,0.00039533246,0.000028005536,0.0016258772,0.00013694818,0.000023463284,0.00022472815],"genre_scores_gemma":[0.99911773,0.00054272014,0.000058334674,0.00003387438,0.0000073270644,0.00008008148,0.000014045979,0.000024200765,0.00012165503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847883,0.0001322938,0.00032495108,0.00032295627,0.00046322768,0.00027774772],"domain_scores_gemma":[0.99839926,0.00026478263,0.00034259752,0.000634856,0.00016610126,0.00019238051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009786922,0.00024956503,0.00073544105,0.00007578786,0.00006478666,0.000008914555,0.000118449614,0.000037180005,0.00010343162],"category_scores_gemma":[0.0004469632,0.00012577251,0.00014612863,0.000410071,0.00018294717,0.000163326,0.00007359579,0.000096270756,0.0000033799793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032744505,0.0044601792,0.8577669,0.0031896527,0.0007633604,0.000065450135,0.00056923355,0.00012976507,0.00017209994,0.000026433747,0.00006578105,0.10004664],"study_design_scores_gemma":[0.0055310456,0.0013848138,0.973447,0.01543828,0.00025193964,0.000008535648,0.00026034858,0.00010216344,0.0032855559,0.00013643148,0.00000418252,0.00014969465],"about_ca_topic_score_codex":0.00024067635,"about_ca_topic_score_gemma":0.00017150784,"teacher_disagreement_score":0.115680106,"about_ca_system_score_codex":0.000048258127,"about_ca_system_score_gemma":0.00027211194,"threshold_uncertainty_score":0.51288545},"labels":[],"label_agreement":null},{"id":"W2951330810","doi":"10.1136/annrheumdis-2019-eular.6084","title":"SAT0334 DOES DEPRESSION PREDICT FUTURE DISEASE STATUS AND IMPROVEMENTS IN DISEASE PARAMETERS? RESULTS FROM THE COMPLETE STUDIES, A CANADIAN REAL WORLD OBSERVATIONAL COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; ABB (Canada); Memorial University of Newfoundland","funders":"Celgene; Sanofi; Pfizer; Eli Lilly and Company; Amgen","keywords":"BASDAI; Medicine; BASFI; Psoriatic arthritis; Internal medicine; Depression (economics); Cohort; Observational study; Ankylosing spondylitis; Physical therapy; Logistic regression; Comorbidity; Disease","score_opus":0.0532328860527841,"score_gpt":0.3071212008182538,"score_spread":0.2538883147654697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951330810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727462,0.010737872,6.036725e-8,0.0072265123,0.0003422983,0.0015109227,0.007349827,0.000015707003,0.00007059824],"genre_scores_gemma":[0.99055195,0.0070133107,0.000026214466,0.001335369,0.000054442145,0.00012669826,0.000652851,0.000018588295,0.00022060501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981023,0.00012314462,0.000486456,0.00039085382,0.00050700747,0.00039023807],"domain_scores_gemma":[0.99786574,0.00052192766,0.00022701616,0.0006973657,0.00012851878,0.0005594202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014652495,0.00023914731,0.00045161817,0.00007429438,0.00019925472,0.000029913128,0.0001715875,0.000021631513,0.00004210654],"category_scores_gemma":[0.0006357655,0.000118346106,0.00014927027,0.00021349087,0.00018232598,0.00011750555,0.00017304317,0.00010011055,0.000005094701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015745878,0.00021264543,0.99007976,0.00014300656,0.0006552189,0.000025186408,0.00037808114,0.000018963927,0.0000010832999,0.000067260706,0.0027897218,0.0040544868],"study_design_scores_gemma":[0.003594367,0.00005517872,0.990639,0.0018844487,0.00037550475,2.2655028e-7,0.0006938248,0.00020554231,0.0000023483412,0.0016613469,0.0007643539,0.00012388939],"about_ca_topic_score_codex":0.060911637,"about_ca_topic_score_gemma":0.051324397,"teacher_disagreement_score":0.01780572,"about_ca_system_score_codex":0.00008545197,"about_ca_system_score_gemma":0.00033407324,"threshold_uncertainty_score":0.96598643},"labels":[],"label_agreement":null},{"id":"W2951332961","doi":"10.1136/annrheumdis-2019-eular.761","title":"AB0247 INSIGHTS INTO ADHERENCE AND PATIENT-INITIATED MONOTHERAPY FOR RHEUMATOID ARTHRITIS VIA A GLOBAL SURVEY OF PATIENTS, CAREGIVERS AND PHYSICIANS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada","funders":"","keywords":"Medicine; Rheumatoid arthritis; Medication adherence; Arthritis; Alternative medicine; Family medicine; Physical therapy; Intensive care medicine; Internal medicine; Pathology","score_opus":0.02342415076198776,"score_gpt":0.28837442372248906,"score_spread":0.2649502729605013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951332961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97007805,0.027971815,0.00003064411,0.00016955048,0.00010318996,0.0011259416,0.0004579155,0.000017714476,0.00004518666],"genre_scores_gemma":[0.9536092,0.046078857,0.0000557837,0.00012009278,0.0000030105166,0.000040281415,0.00006837326,0.000018432782,0.000005922568],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985108,0.00016361673,0.00043786375,0.00025021957,0.00038299168,0.0002545159],"domain_scores_gemma":[0.9983609,0.00031091558,0.00030201918,0.0003511735,0.00052208937,0.0001529226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100693884,0.00019510931,0.0005877392,0.000062951854,0.00009206127,0.000025278228,0.00014492367,0.000049024628,0.00003386924],"category_scores_gemma":[0.000351977,0.00014295695,0.00013623344,0.00021144861,0.0003616379,0.00018002537,0.000079456644,0.000055028733,0.0000028190166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020012576,0.000814101,0.45656115,0.0007645013,0.00064289157,0.0000011188687,0.0044652256,0.000005911849,0.00013917683,0.00040258645,0.001771897,0.5324302],"study_design_scores_gemma":[0.005570547,0.0020752843,0.981015,0.003417766,0.00001121737,0.000003080063,0.0011164427,0.0004985743,0.0012510987,0.0044739,0.00033372306,0.00023336119],"about_ca_topic_score_codex":0.0014445746,"about_ca_topic_score_gemma":0.00025294462,"teacher_disagreement_score":0.5321968,"about_ca_system_score_codex":0.000012054852,"about_ca_system_score_gemma":0.000107234686,"threshold_uncertainty_score":0.5829615},"labels":[],"label_agreement":null},{"id":"W2951399722","doi":"10.1136/annrheumdis-2019-eular.4161","title":"FRI0084 THE IMPACT OF IL-6 AND TNF INHIBITORS ON HEMOGLOBIN LEVELS: AN ANALYSIS FROM RHUMADATA® CLINICAL DATABASE AND REGISTRY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Apelin-related biomedical research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"","keywords":"Hemoglobin; Tumor necrosis factor alpha; Computer science; Database; Medicine; Internal medicine","score_opus":0.09936078143370007,"score_gpt":0.43703431388221636,"score_spread":0.3376735324485163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951399722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408036,0.0014979227,0.00001106523,0.0019321921,0.000047879068,0.00041195788,0.0019202287,0.000012480148,0.000085923486],"genre_scores_gemma":[0.9981583,0.001142501,0.000045588422,0.00025381596,0.00004307191,0.000004056091,0.00018908703,0.000015619604,0.00014798173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749917,0.00038102976,0.0007069655,0.00036376488,0.0007990379,0.00025000528],"domain_scores_gemma":[0.99581647,0.0017769266,0.00037275584,0.0014493169,0.0001438823,0.00044063583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010216262,0.00018833933,0.00070339197,0.0001275674,0.00007413298,0.000025860487,0.00039697104,0.000110584435,0.00044548555],"category_scores_gemma":[0.0038154267,0.00008916428,0.00039078254,0.00047037928,0.00089955993,0.00012928015,0.0003279777,0.00030485558,0.000014412234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027568557,0.0029552495,0.8497763,0.0007319412,0.008063055,0.000022972585,0.00053153955,0.00007045372,0.0011231635,0.00021780578,0.021957474,0.11179315],"study_design_scores_gemma":[0.0010866291,0.00061744306,0.9883478,0.0009863579,0.0008345804,0.0000025035736,0.00045057177,0.006703926,0.00027774685,0.0005414811,0.000045053148,0.0001058572],"about_ca_topic_score_codex":0.0014553093,"about_ca_topic_score_gemma":0.000014386138,"teacher_disagreement_score":0.13857152,"about_ca_system_score_codex":0.000015220324,"about_ca_system_score_gemma":0.00025242384,"threshold_uncertainty_score":0.48777544},"labels":[],"label_agreement":null},{"id":"W2951409490","doi":"10.1136/annrheumdis-2019-eular.4414","title":"OP0315 ACHIEVING A LOW DISEASE STATE WITHIN FIRST 3 MONTHS IN EARLY RHEUMATOID ARTHRITIS RESULTS IN LOWER FATIGUE OVER 5 YEARS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; Université Laval; University of Calgary; McGill University; Public Health Ontario; University of Toronto; Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Cohort; Internal medicine; Rating scale; Arthritis; Adverse effect; Repeated measures design; Cohort study","score_opus":0.020120690792998393,"score_gpt":0.28255412310083233,"score_spread":0.26243343230783395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951409490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520285,0.011048519,0.000001971897,0.0016775933,0.00024334721,0.0012777206,0.00028524306,0.00004149117,0.00022124112],"genre_scores_gemma":[0.971352,0.028032484,0.000029383635,0.00020082429,0.000012480404,0.00007883171,0.00002719291,0.00004991099,0.0002168937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672395,0.00023289595,0.0010578765,0.00044542112,0.0009003822,0.0006394654],"domain_scores_gemma":[0.9977662,0.00038766736,0.00032493623,0.0009821884,0.000110442415,0.0004285443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005912434,0.0002990523,0.00074389356,0.00034430771,0.00006623236,0.00008617912,0.00042197443,0.00006097314,0.00018531206],"category_scores_gemma":[0.0016219123,0.00023478677,0.00031000524,0.00055692415,0.0002486989,0.00043217183,0.00020161647,0.00030357676,0.000083364575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008214142,0.002592404,0.9407886,0.0011430946,0.00033620157,0.0003446903,0.006792126,0.0021362233,0.00007409234,0.00050075486,0.0040726345,0.03300503],"study_design_scores_gemma":[0.006107397,0.00026707913,0.9713919,0.018236673,0.0000037865639,0.000005341572,0.00026314257,0.0014427392,0.00010681786,0.0016291494,0.00027084656,0.00027509444],"about_ca_topic_score_codex":0.0012448922,"about_ca_topic_score_gemma":0.0007693439,"teacher_disagreement_score":0.032729935,"about_ca_system_score_codex":0.000044272314,"about_ca_system_score_gemma":0.00032589893,"threshold_uncertainty_score":0.9574327},"labels":[],"label_agreement":null},{"id":"W2951415329","doi":"10.1136/annrheumdis-2019-215145","title":"Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"Peking Union Medical College; Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu; Peking Union Medical College Hospital; Bayer; Sapienza Università di Roma; Ege Üniversitesi; Medicinski Fakultet, Sveučilište u Zagrebu; University of Leeds; University of Bern; Universidad de Buenos Aires; Università degli Studi di Cagliari; Sveučilište u Zagrebu; School of Medicine, Stanford University; University of Otago","keywords":"Medicine; Internal medicine; Scleroderma (fungus); Interstitial lung disease; Clinical trial; Imputation (statistics); Pulmonary hypertension; Systemic scleroderma; Cohort; Population; Disease; Lung; Pathology; Missing data","score_opus":0.09217164975021941,"score_gpt":0.3527032368942012,"score_spread":0.2605315871439818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951415329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97125435,0.026425358,0.00000306165,0.00032138973,0.000082630766,0.0014312039,0.00037074025,0.00002592753,0.00008531119],"genre_scores_gemma":[0.99492407,0.0047812993,0.000013214669,0.000028687049,0.000018036431,0.00003440684,0.00005815581,0.000038994072,0.0001031618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99396855,0.0023759175,0.0017411712,0.00040463367,0.0011476242,0.0003620985],"domain_scores_gemma":[0.99591666,0.0011938118,0.0010744844,0.0010068659,0.0004093715,0.00039877972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031033868,0.00024988604,0.0015404056,0.0006738672,0.000072400515,0.000028889714,0.00037928674,0.00007913131,0.00007384582],"category_scores_gemma":[0.0044818344,0.00015115069,0.0005681566,0.0017120091,0.0003738179,0.00012675255,0.00026721894,0.00016853499,0.0000036947804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013683889,0.002320978,0.9698884,0.0046861502,0.0020419287,0.0000036739475,0.0010831006,0.00016267246,0.012236948,0.000035968693,0.0019979684,0.0041738176],"study_design_scores_gemma":[0.0036187368,0.00022317213,0.9438918,0.04445808,0.0023229637,0.0000012224565,0.0018367139,0.00088670186,0.002565717,0.000040270734,0.0000033205365,0.00015124961],"about_ca_topic_score_codex":0.00011296098,"about_ca_topic_score_gemma":0.000002377119,"teacher_disagreement_score":0.039771933,"about_ca_system_score_codex":0.000025398052,"about_ca_system_score_gemma":0.00019844457,"threshold_uncertainty_score":0.6163746},"labels":[],"label_agreement":null},{"id":"W2951589667","doi":"10.1136/annrheumdis-2019-eular.6275","title":"AB0726 WHAT IS THE IMPACT OF MRI ON THE PERFORMANCE OF THE ASAS CLASSIFICATION CRITERIA IN PATIENTS PRESENTING WITH UNDIAGNOSED BACK PAIN?","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; University of Ottawa; McMaster University; Université de Sherbrooke; University of Calgary; University of Alberta","funders":"Pfizer; Eli Lilly and Company","keywords":"Medicine; Gold standard (test); Magnetic resonance imaging; Radiography; Uveitis; Radiology; Physical therapy; Ophthalmology","score_opus":0.03190478151174244,"score_gpt":0.3149805264494112,"score_spread":0.2830757449376688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951589667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359494,0.0009970537,4.2847645e-7,0.003839346,0.00006682807,0.0012301193,0.000034497363,0.000004170003,0.00023262823],"genre_scores_gemma":[0.9947587,0.0048748273,0.0000035568694,0.00018970639,0.000008247477,0.000032544835,0.0000060595853,0.000015158675,0.00011117016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981185,0.00046344416,0.00041198387,0.00013630436,0.0006397518,0.00023000536],"domain_scores_gemma":[0.99747986,0.00085746986,0.0004108544,0.00090705685,0.00029429028,0.000050449537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006607336,0.00014066604,0.000300031,0.00005413288,0.000089205474,0.00004391679,0.00047999367,0.000027393276,0.00032150338],"category_scores_gemma":[0.00068013713,0.00004989872,0.0002262582,0.00029708145,0.0003275105,0.00023102386,0.00008650956,0.000122036756,0.0000132028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006492724,0.0007357998,0.9825872,0.00047264784,0.00029717444,1.09239686e-7,0.0018693788,0.000112935915,0.000102015794,0.00012691335,0.006162677,0.0068838294],"study_design_scores_gemma":[0.0009190468,0.00061453367,0.987892,0.0042809923,0.0000093298395,4.2435093e-7,0.0010755532,0.0030632692,0.0017893594,0.0002549715,0.000041418538,0.000059112714],"about_ca_topic_score_codex":0.00015068092,"about_ca_topic_score_gemma":0.000006737651,"teacher_disagreement_score":0.006824717,"about_ca_system_score_codex":0.000015389003,"about_ca_system_score_gemma":0.00012833774,"threshold_uncertainty_score":0.35202366},"labels":[],"label_agreement":null},{"id":"W2951710839","doi":"10.1136/annrheumdis-2019-eular.2320","title":"THU0153 PATTERNS OF SUSTAINED REMISSION AND SUBSEQUENT DMARD TAPERING IN EARLY RHEUMATOID ARTHRITIS: DATA FROM THE CANADIAN EARLY ARTHRITIS COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; Université Laval; University of Calgary; McGill University; Western University; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Rheumatology; Arthritis; Combination therapy; Cohort study; Physical therapy; Observational study; Pediatrics","score_opus":0.03065265621166534,"score_gpt":0.2844459008083941,"score_spread":0.25379324459672875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951710839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621199,0.03285971,0.0000025038441,0.0027463913,0.00011898125,0.0010765671,0.0008673974,0.000018761048,0.00018982973],"genre_scores_gemma":[0.9038178,0.09574263,0.000020982086,0.0001636371,0.000018326167,0.00002859237,0.0001225924,0.000031256634,0.00005423324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738187,0.00025416844,0.00070679287,0.00039297398,0.0007390397,0.00052514],"domain_scores_gemma":[0.9972348,0.00041903954,0.00024027277,0.0015098042,0.00019346707,0.00040257405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064595736,0.0002356983,0.00070554775,0.0001414156,0.00015275425,0.00010057938,0.0007059881,0.00008034138,0.00032990854],"category_scores_gemma":[0.0009263733,0.00015427747,0.0001379541,0.00022160714,0.0002760772,0.00033130625,0.00035944744,0.0002397581,0.000015811596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019327483,0.00011055089,0.95989573,0.00014917913,0.00021988766,0.000022676457,0.0010689206,0.0000034166771,0.00012166654,0.00028995832,0.00090626534,0.037018485],"study_design_scores_gemma":[0.0018462593,0.00016468696,0.9824451,0.011965983,0.000008178379,0.000016531767,0.0011020907,0.00022183357,0.00040297656,0.0011054066,0.0005514272,0.00016948306],"about_ca_topic_score_codex":0.18708842,"about_ca_topic_score_gemma":0.071299486,"teacher_disagreement_score":0.11578892,"about_ca_system_score_codex":0.000036473026,"about_ca_system_score_gemma":0.00052423077,"threshold_uncertainty_score":0.9456469},"labels":[],"label_agreement":null},{"id":"W2951735415","doi":"10.1136/annrheumdis-2019-eular.3158","title":"THU0359 WHAT IS THE LEVEL OF AGREEMENT BETWEEN LOCAL AND CENTRAL READERS IN THE DETECTION OF ACTIVE AND STRUCTURAL LESIONS ON MRI TYPICAL OF AXIAL SPONDYLOARTHRITIS? DATA FROM THE ASAS CLASSIFICATION COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Axial spondyloarthritis; Medicine; Cohort; Kappa; Lesion; Radiology; Cohen's kappa; Magnetic resonance imaging; Nuclear medicine; Internal medicine; Pathology; Computer science; Sacroiliitis","score_opus":0.15122335207820367,"score_gpt":0.35212337031766106,"score_spread":0.20090001823945738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951735415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346215,0.0010414947,0.00002813051,0.0032258867,0.000050671595,0.0012322214,0.0009468295,0.0000023956331,0.000010253623],"genre_scores_gemma":[0.9989584,0.0007949171,0.000005461251,0.00013966636,0.00001809617,0.000011401563,0.000059683098,0.0000061646288,0.000006205323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984632,0.00033077408,0.00041167333,0.00019665193,0.00047636038,0.00012133638],"domain_scores_gemma":[0.9978902,0.0008851765,0.00030598984,0.0007962469,0.00007476165,0.000047662168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026142967,0.00011681131,0.00034984844,0.000033666827,0.00006433658,0.000016421958,0.00028168363,0.000036033463,0.000036743244],"category_scores_gemma":[0.00024447823,0.000052303792,0.000082330414,0.00012299942,0.00042629274,0.00016756674,0.000127655,0.000110280904,7.243078e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002019933,0.0007629189,0.84112334,0.00021769638,0.0007048136,8.166775e-7,0.0075632,0.000013111388,0.00025576804,0.00010101064,0.00066434446,0.14657302],"study_design_scores_gemma":[0.0008687858,0.00033226344,0.96206325,0.0007386116,0.00043209185,9.765025e-7,0.03360534,0.00041830546,0.0008309723,0.0006531761,0.000007679994,0.00004855417],"about_ca_topic_score_codex":0.00088906125,"about_ca_topic_score_gemma":0.0002035719,"teacher_disagreement_score":0.14652447,"about_ca_system_score_codex":0.00000842099,"about_ca_system_score_gemma":0.00006825366,"threshold_uncertainty_score":0.21328868},"labels":[],"label_agreement":null},{"id":"W2951769538","doi":"10.1136/annrheumdis-2019-eular.4236","title":"AB0233 ASSESSMENT OF THE RESPONSE TO THERAPY WITH CSDMARDS AND BDMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Research in Rheumatology; Sun Pharma; Arthritis Society; Roche Nederland; Universiteit Utrecht; F. Hoffmann-La Roche; Dutch Arthritis Society; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Physical therapy; Intensive care medicine","score_opus":0.011424178058101033,"score_gpt":0.2851460651801122,"score_spread":0.2737218871220112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951769538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296826,0.0025794692,0.0000041654025,0.0025260793,0.000054352284,0.0015813673,0.00008181275,0.000012384342,0.0001921322],"genre_scores_gemma":[0.99191356,0.0075096297,0.0001046432,0.00028949376,0.0000033767183,0.000060145856,0.000004463858,0.00002860736,0.00008607128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774086,0.0003335368,0.00040872578,0.00023516921,0.0009657657,0.00031593873],"domain_scores_gemma":[0.9982567,0.00029170598,0.000211899,0.0007810528,0.00028333423,0.00017534243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004947057,0.00020247867,0.0005571806,0.00013855463,0.00007206571,0.000029470975,0.00028406904,0.000034388922,0.000117854775],"category_scores_gemma":[0.00027243333,0.00009575423,0.00011432125,0.00041004838,0.00030113378,0.00012929241,0.00012696948,0.00013115352,0.0000032776024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006333638,0.00072224106,0.9617147,0.00013391512,0.00023568631,0.0000015398391,0.00062570866,0.00004388498,0.00008842389,0.00018757707,0.00041048744,0.029502213],"study_design_scores_gemma":[0.0056194817,0.0019736735,0.9857138,0.0052212803,0.0000035855448,0.000005558741,0.00029352756,0.000033061264,0.00041289712,0.00017126743,0.0004275366,0.00012432248],"about_ca_topic_score_codex":0.00012669989,"about_ca_topic_score_gemma":0.000044777727,"teacher_disagreement_score":0.02937789,"about_ca_system_score_codex":0.000019898314,"about_ca_system_score_gemma":0.00037662341,"threshold_uncertainty_score":0.3904744},"labels":[],"label_agreement":null},{"id":"W2951791231","doi":"10.1136/annrheumdis-2019-eular.1613","title":"OP0238 WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT AMONG PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND TREATED WITH IXEKIZUMAB FOR 16 WEEKS: RESULTS FROM COAST-V AND COAST-W","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Cilag; Sanofi Genzyme; Foundation for Research in Rheumatology; Biogen; Samsung; Celgene; Sanofi; Karolinska Institutet; Pfizer; NordForsk; Eli Lilly and Company","keywords":"Ankylosing spondylitis; Medicine; BASDAI; Adalimumab; Ixekizumab; Placebo; Work productivity; Internal medicine; Physical therapy; Productivity; Disease; Psoriatic arthritis; Secukinumab; Alternative medicine; Pathology","score_opus":0.012142059045353145,"score_gpt":0.234550396654075,"score_spread":0.22240833760872186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951791231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976207,0.001490007,0.0000043537148,0.00041771185,0.00005952213,0.0027702642,0.005424673,0.00003552641,0.00003590072],"genre_scores_gemma":[0.9988578,0.00047626684,0.000087469634,0.000037488677,0.000025731968,0.0001264411,0.00028798505,0.000040355448,0.000060469592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815065,0.00011906328,0.0003109012,0.00063949043,0.00039467643,0.00038523175],"domain_scores_gemma":[0.99828535,0.0004019779,0.00037298037,0.0004678568,0.00023005999,0.00024178642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012788072,0.00038329326,0.00080119877,0.00011535587,0.00026263733,0.00005717165,0.000071687115,0.000067200264,0.000014681839],"category_scores_gemma":[0.00018004821,0.00023931124,0.00011170507,0.00029279658,0.0005684873,0.00032188298,0.00012054269,0.0001081141,3.8136298e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029471949,0.001253234,0.8671008,0.00029098213,0.0011673013,0.00001108731,0.0008322292,0.00000252452,0.0000072949915,0.00000799356,0.00017303789,0.09968156],"study_design_scores_gemma":[0.016754856,0.0035087338,0.9744661,0.0032539882,0.000596117,0.000013018669,0.00057754165,0.000018150515,0.000349851,0.0001615174,0.00004204759,0.0002580804],"about_ca_topic_score_codex":0.0015342092,"about_ca_topic_score_gemma":0.0006687662,"teacher_disagreement_score":0.107365295,"about_ca_system_score_codex":0.0000313559,"about_ca_system_score_gemma":0.000058088535,"threshold_uncertainty_score":0.9758829},"labels":[],"label_agreement":null},{"id":"W2951820023","doi":"10.1136/annrheumdis-2019-eular.2515","title":"SAT0097 ASSOCIATION BETWEEN PHYSICAL ACTIVITY AND SUBSEQUENT CHANGES IN DISEASE ACTIVITY IN PEOPLE LIVING WITH RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Visual analogue scale; Population; Cohort; Physical therapy; Body mass index; Internal medicine; Cohort study; Disease; Arthritis; Environmental health","score_opus":0.020662501520295386,"score_gpt":0.2871534414333129,"score_spread":0.26649093991301753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951820023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368775,0.0017789506,0.0000023002067,0.003539865,0.00003502586,0.0008022315,0.00007819846,0.0000246545,0.000051032814],"genre_scores_gemma":[0.98296267,0.016822638,0.000005441456,0.000041887644,0.000018930634,0.000070759874,0.000005926051,0.000022624734,0.000049110397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981457,0.00031055234,0.00019087578,0.00028441506,0.00064824376,0.0004201966],"domain_scores_gemma":[0.9982435,0.00083812926,0.00021991292,0.00037496665,0.000081233375,0.00024222152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039178133,0.00019938269,0.0006650235,0.00016284057,0.000059018254,0.000045076828,0.00013323914,0.000045385335,0.000045654306],"category_scores_gemma":[0.0007498849,0.00014198387,0.00011352931,0.000345957,0.00010309514,0.00029622036,0.000120617166,0.00021270686,0.000008830596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034714022,0.000719933,0.9567735,0.0003845099,0.00012099396,0.0000038988674,0.0010695953,0.00001140059,0.00017203767,0.000059466096,0.000034019246,0.040303484],"study_design_scores_gemma":[0.0014478627,0.00022498354,0.9915055,0.0051386957,0.000008166709,0.00000214404,0.00021596563,0.00040813765,0.00051476125,0.0003675474,0.00001616935,0.0001500335],"about_ca_topic_score_codex":0.00086999754,"about_ca_topic_score_gemma":0.0014274998,"teacher_disagreement_score":0.040153448,"about_ca_system_score_codex":0.000078401,"about_ca_system_score_gemma":0.00019569296,"threshold_uncertainty_score":0.57899344},"labels":[],"label_agreement":null},{"id":"W2951842881","doi":"10.1136/annrheumdis-2019-eular.7271","title":"THU0371 PREVALENCE OF WORK DISABILITY AND PREDICTORS OF WORK PRODUCTIVITY AMONG EMPLOYABLE PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN A CANADIAN REAL WORLD OBSERVATIONAL COHORT: INTERIM RESULTS FROM THE COMPLETE STUDIES","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; McMaster University; Etobicoke General Hospital; ABB (Canada); Centre hospitalier de l'Université Laval","funders":"","keywords":"Ankylosing spondylitis; Psoriatic arthritis; Observational study; Interim; Work productivity; Medicine; Work (physics); Cohort study; Productivity; Cohort; Physical therapy; Arthritis; Internal medicine; Geography; Engineering; Economics","score_opus":0.044007322070353454,"score_gpt":0.2815791250035862,"score_spread":0.2375718029332327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951842881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047834,0.0040847785,7.2483836e-8,0.0007508171,0.00009841141,0.0013329426,0.0032161924,0.0000061213864,0.000032305696],"genre_scores_gemma":[0.99843574,0.0012990405,0.000049168615,0.000026523756,0.000013796451,0.00004300438,0.000085836975,0.000011046394,0.000035836954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998402,0.0001643821,0.00056674884,0.00030495648,0.00033131058,0.00023062454],"domain_scores_gemma":[0.9979988,0.00083161524,0.00037988173,0.0004758158,0.00020739397,0.00010654128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031281356,0.00017340276,0.0006213783,0.00004513163,0.00008844625,0.000011102951,0.00010792313,0.000022812303,0.000024227968],"category_scores_gemma":[0.0010135418,0.00010242832,0.00006476756,0.0003642875,0.00086620986,0.00013636696,0.00011620764,0.00007283559,2.2047276e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001010315,0.00026880894,0.99357516,0.0005307067,0.000508589,8.9428164e-7,0.0014367863,0.000012635391,4.3900178e-7,0.000020348463,0.00014997227,0.0024853772],"study_design_scores_gemma":[0.0018430195,0.00025424655,0.9876691,0.009360667,0.00018875835,2.8200517e-7,0.0002694313,0.000008085459,0.000011036726,0.0002986722,0.0000137914485,0.00008287152],"about_ca_topic_score_codex":0.06146797,"about_ca_topic_score_gemma":0.06370079,"teacher_disagreement_score":0.008829961,"about_ca_system_score_codex":0.00005941914,"about_ca_system_score_gemma":0.00010842041,"threshold_uncertainty_score":0.9533842},"labels":[],"label_agreement":null},{"id":"W2951880153","doi":"10.1136/annrheumdis-2019-eular.6356","title":"THU0658 WHO IS AT RISK FOR PERSISTENT FATIGUE IN THE FIRST YEAR OF RA? CHARACTERISTICS OF PATIENTS WITH PERSISTENT FATIGUE IN THE FIRST YEAR BY SEX IN THE CANADIAN EARLY ARTHRITIS COHORT (CATCH)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Université de Sherbrooke; Université Laval; Southlake Regional Health Center; University of Manitoba; Western University; University of Toronto; University of Calgary; McGill University","funders":"","keywords":"Medicine; Cohort; Logistic regression; Physical therapy; Internal medicine","score_opus":0.024896067638899285,"score_gpt":0.2613319819201017,"score_spread":0.23643591428120242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951880153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911102,0.00068955676,7.5399817e-7,0.0042484226,0.000032274096,0.002516315,0.0011958346,0.0000027080307,0.00020393956],"genre_scores_gemma":[0.99890786,0.00056177913,0.000007961828,0.00013975706,0.0000054335087,0.00013005605,0.00012296333,0.000023459275,0.000100736645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750173,0.00024314836,0.0005906671,0.00024935606,0.000978707,0.00043637407],"domain_scores_gemma":[0.997996,0.0005235031,0.0003280524,0.0008883813,0.00017004642,0.00009404591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081031496,0.00021237836,0.0005619572,0.00013611997,0.00013788848,0.00003418218,0.0007601511,0.0000818838,0.00012902138],"category_scores_gemma":[0.00029198124,0.000105936444,0.00034246652,0.00038003,0.00031482178,0.00007238242,0.00006607729,0.00023126585,0.0000071204186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002238562,0.000513988,0.9770198,0.0017772868,0.00022345588,0.0000026538025,0.012955393,0.000033053886,5.8876094e-7,0.000046109693,0.006881315,0.00032252734],"study_design_scores_gemma":[0.0019903774,0.00090984954,0.98702675,0.0032589717,0.00012358243,0.0000025507854,0.0060097026,0.00029190286,0.000016363652,0.00004302535,0.00020542061,0.0001214814],"about_ca_topic_score_codex":0.023965215,"about_ca_topic_score_gemma":0.008605458,"teacher_disagreement_score":0.015359758,"about_ca_system_score_codex":0.0001178077,"about_ca_system_score_gemma":0.0002976419,"threshold_uncertainty_score":0.9825343},"labels":[],"label_agreement":null},{"id":"W2951901351","doi":"10.1136/annrheumdis-2019-eular.2696","title":"AB0282 SYSTEMATIC REVIEW OF STUDIES REPORTING ON COGNITIVE FUNCTION IN RHEUMATOID ARTHRITISCOMPARED TO THE GENERAL POPULATION","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Research Canada","funders":"Natural Science Foundation of Anhui Province; University of British Columbia; National Natural Science Foundation of China","keywords":"Medicine; Rheumatoid arthritis; Cognition; Population; Systematic review; MEDLINE; Internal medicine; Psychiatry; Environmental health","score_opus":0.06768541505018637,"score_gpt":0.3794357406636946,"score_spread":0.31175032561350824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951901351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8118708,0.18355608,0.000005624592,0.0015924943,0.00016780902,0.0026445768,0.000021161499,0.000015739932,0.00012567143],"genre_scores_gemma":[0.9081695,0.09073719,0.000010867244,0.0007666851,0.000012706105,0.00018227453,0.000019400894,0.000015995261,0.00008538631],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99666536,0.00040573248,0.0017277821,0.00020832398,0.00075055566,0.00024226545],"domain_scores_gemma":[0.99706197,0.0005361244,0.0013257146,0.00057731254,0.0004115556,0.00008735185],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013097798,0.00017418746,0.0011836865,0.00013788715,0.000075748154,0.00001560345,0.00016898892,0.000024384028,0.000054151256],"category_scores_gemma":[0.008900628,0.00009322317,0.00030213196,0.0003993991,0.0000982197,0.00010515439,0.00008218825,0.00009685546,0.000030853276],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013424951,0.0011116264,0.10412767,0.8653391,0.002408854,0.000012713744,0.0025312542,0.00032195245,0.00012310421,0.0033461761,0.0056797373,0.013655324],"study_design_scores_gemma":[0.0008114174,0.0003762469,0.13397734,0.8617212,0.00007113623,0.000020101013,0.001599004,0.00013763187,0.00024345948,0.0009099627,0.000010723479,0.000121765974],"about_ca_topic_score_codex":0.00009553102,"about_ca_topic_score_gemma":0.000033513537,"teacher_disagreement_score":0.09629866,"about_ca_system_score_codex":0.000020502574,"about_ca_system_score_gemma":0.000072556904,"threshold_uncertainty_score":0.9994478},"labels":[],"label_agreement":null},{"id":"W2951905258","doi":"10.1136/annrheumdis-2019-eular.6478","title":"THU0112 SECULAR TRENDS IN THE INCIDENT RISK OF ACUTE MYOCARDIAL INFARCTION IN RHEUMATOID ARTHRITIS RELATIVE TO THE GENERAL POPULATION","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"Northwestern University; Pfizer; University of Alabama at Birmingham; Bristol-Myers Squibb","keywords":"Medicine; Population; Myocardial infarction; Relative risk; Incidence (geometry); Hazard ratio; Cohort; Internal medicine; Diagnosis code; Demography; Proportional hazards model; Confidence interval; Environmental health","score_opus":0.015656123525947415,"score_gpt":0.30440496998470645,"score_spread":0.28874884645875903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951905258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896956,0.004617659,0.00001312424,0.0041910764,0.00016641968,0.00090178585,0.00011823108,0.000011162968,0.00028490458],"genre_scores_gemma":[0.9796067,0.019805433,0.00003104878,0.0003158889,0.000024624984,0.00008984758,0.000051356325,0.000017362167,0.000057760335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724627,0.00075750955,0.0006614886,0.00020978846,0.0008268719,0.00029808094],"domain_scores_gemma":[0.99852663,0.00026538412,0.00030816934,0.00069379125,0.00011875992,0.00008725111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008304296,0.00017790006,0.0004894425,0.00030081687,0.00009230237,0.00003155473,0.00035470954,0.000055166885,0.00010946632],"category_scores_gemma":[0.00049094885,0.00009395958,0.00041171085,0.0007686413,0.00012003984,0.00023324128,0.00011591746,0.0002162949,0.000018752004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092713017,0.000530349,0.89603585,0.00008050536,0.0010473396,0.0000075262283,0.007420441,0.001924778,0.0001412542,0.003838743,0.003666041,0.08438007],"study_design_scores_gemma":[0.0013993513,0.00026814782,0.9917713,0.0011445244,0.000022020879,0.00001938111,0.00066358165,0.00061648164,0.0001239503,0.0035971312,0.00027250857,0.00010164783],"about_ca_topic_score_codex":0.0023962737,"about_ca_topic_score_gemma":0.00050593005,"teacher_disagreement_score":0.09573545,"about_ca_system_score_codex":0.000031820375,"about_ca_system_score_gemma":0.000068715184,"threshold_uncertainty_score":0.38315603},"labels":[],"label_agreement":null},{"id":"W2951919715","doi":"10.1136/annrheumdis-2019-eular.4395","title":"FRI0550 JIA DISEASE ACTIVITY OUTCOMES ACROSS A MULTI-CENTER COHORT: ANALYSIS OF THE PEDIATRIC RHEUMATOLOGY CARE AND OUTCOMES IMPROVEMENT NETWORK (PR-COIN) REGISTRY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Cohort; Disease; Physical therapy; Single Center; Severity of illness; Arthritis; Pediatrics","score_opus":0.020854155934037496,"score_gpt":0.33194162995428494,"score_spread":0.31108747402024745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951919715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930731,0.0036171093,0.0000113852775,0.0013979665,0.0001864869,0.0012624562,0.000368057,0.000023791585,0.000059642192],"genre_scores_gemma":[0.9976789,0.0013012232,0.000014335705,0.00028509766,0.0000067201236,0.000066343615,0.000029137362,0.000025732461,0.00059251796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974151,0.00021757014,0.00077529874,0.0003750473,0.00071074464,0.0005062145],"domain_scores_gemma":[0.99681884,0.0003594337,0.0007595152,0.0015957879,0.00025793246,0.00020847635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003347654,0.0003031112,0.0013511904,0.00011881345,0.00019661566,0.000030632284,0.000532743,0.000087987326,0.000113355105],"category_scores_gemma":[0.00080476434,0.00016485057,0.0010682615,0.0006292862,0.00033952034,0.00013539525,0.00062140875,0.0002022307,0.000008077428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002627218,0.0006711055,0.98939043,0.0019502452,0.0026237231,0.0000016503925,0.0005079343,0.0001566237,0.000006106559,0.00004198245,0.0005171959,0.0038702562],"study_design_scores_gemma":[0.001987081,0.00008266158,0.9939743,0.00026320553,0.0016126134,9.2325007e-7,0.0007725831,0.0010287459,0.000023589995,0.00004657042,0.00004938065,0.00015829028],"about_ca_topic_score_codex":0.00031178974,"about_ca_topic_score_gemma":0.00004717021,"teacher_disagreement_score":0.004605787,"about_ca_system_score_codex":0.000027455788,"about_ca_system_score_gemma":0.00027905853,"threshold_uncertainty_score":0.6722411},"labels":[],"label_agreement":null},{"id":"W2951965981","doi":"10.1136/annrheumdis-2019-eular.4474","title":"THU0104 HIGH-PERFORMANCE CHEMICAL ISOTOPE LABELING LIQUID CHROMATOGRAPHY MASS SPECTROMETRY FOR DISCOVERY OF METABOLITE BIOMARKERS OF RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metabolite; Metabolome; Rheumatoid arthritis; Mass spectrometry; Cohort; Liquid chromatography–mass spectrometry; Chemistry; Metabolomics; Chromatography; Internal medicine; Medicine","score_opus":0.013824634943836464,"score_gpt":0.2656606680870263,"score_spread":0.25183603314318986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951965981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96058595,0.036924012,0.00010207356,0.00049196946,0.00020511923,0.0010683545,0.00046664162,0.000029611405,0.00012625549],"genre_scores_gemma":[0.908705,0.08992906,0.0011040128,0.000066315,0.0000189271,0.000058265756,0.00004818289,0.000040555373,0.000029688974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740076,0.00008854998,0.0009753833,0.00029704627,0.0007523194,0.00048591886],"domain_scores_gemma":[0.9976966,0.00041417938,0.0005638643,0.00082009356,0.00034092824,0.00016435521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004362152,0.00027164695,0.0011275979,0.00031921017,0.000061586215,0.000025946763,0.0004523667,0.00007780611,0.00011775865],"category_scores_gemma":[0.0005156067,0.00019238108,0.0006751964,0.000631809,0.0004942269,0.00037440594,0.00012363191,0.00011505575,0.0000067063543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010743382,0.0028016444,0.11806442,0.011413639,0.00756691,0.00000399883,0.00079565233,0.00007181985,0.8004112,0.011158638,0.002698869,0.0342698],"study_design_scores_gemma":[0.0048685134,0.0013737229,0.044964585,0.009722954,0.00004644038,0.000019444153,0.00046794754,0.00034100897,0.93521154,0.0023936431,0.00024859508,0.00034157652],"about_ca_topic_score_codex":0.000072282994,"about_ca_topic_score_gemma":9.814888e-7,"teacher_disagreement_score":0.13480034,"about_ca_system_score_codex":0.000010259011,"about_ca_system_score_gemma":0.00019945893,"threshold_uncertainty_score":0.7845073},"labels":[],"label_agreement":null},{"id":"W2952060191","doi":"10.1136/annrheumdis-2019-eular.7669","title":"AB0919 EFFECTS OF ALEXITHYMIA ON ACTIVITY PAIN, UPPER EXTREMITY FUNCTION, SYMPTOM AND DEPRESSION LEVELS IN PATIENTS WITH THORACIC OUTLET SYNDROME","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Orthopedic Surgery and Rehabilitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Medicine; Physical therapy; Depression (economics); Anxiety; Visual analogue scale; Dash; Physical medicine and rehabilitation; Clinical psychology; Psychiatry","score_opus":0.011949855225024106,"score_gpt":0.26291312767921143,"score_spread":0.2509632724541873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952060191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850464,0.00029422948,0.000018530724,0.00016958037,0.00013440542,0.00079548167,0.000019927538,0.000011187977,0.00005198944],"genre_scores_gemma":[0.99969286,0.00002363373,0.0000109531875,0.00014152123,0.000005035185,0.000017528393,0.0000069026873,0.000012361023,0.0000892097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874705,0.00031330384,0.00023913829,0.00019103545,0.00037631398,0.0001331514],"domain_scores_gemma":[0.99826324,0.00095738564,0.0002192253,0.00036790912,0.000113124894,0.00007912127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003698917,0.00013309794,0.0003796914,0.000103128245,0.000031581436,0.0000045689735,0.000052569132,0.00005370809,0.000036450852],"category_scores_gemma":[0.0010941876,0.00007362874,0.00009701279,0.00016921616,0.00010068173,0.00013322315,0.000034348515,0.0000825437,0.0000035158916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080479676,0.00087873964,0.94617015,0.002514767,0.00007918732,8.658801e-7,0.00015364855,0.000022819708,0.000048295817,0.0000052573428,0.00005844235,0.049263008],"study_design_scores_gemma":[0.00089522765,0.00066358416,0.9894679,0.007965087,0.000077376215,8.641783e-7,0.000054152162,0.00006903319,0.0005847543,0.00014204034,0.000003853517,0.000076127326],"about_ca_topic_score_codex":0.000019329182,"about_ca_topic_score_gemma":0.0000010034721,"teacher_disagreement_score":0.04918688,"about_ca_system_score_codex":0.000010681826,"about_ca_system_score_gemma":0.000047339614,"threshold_uncertainty_score":0.30024928},"labels":[],"label_agreement":null},{"id":"W2952066725","doi":"10.1136/annrheumdis-2019-eular.7067","title":"OP0295 N-LINKED GLYCANS IN THE VARIABLE DOMAIN OF ACPA-IGG IN THE DEVELOPMENT OF RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Fondation Saint Luc; Fédération Wallonie-Bruxelles; Celltrion; Sanofi; Fonds De La Recherche Scientifique - FNRS; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Rheumatoid arthritis; Medicine; Antibody; Glycan; Immunology; Autoantibody; Somatic hypermutation; Arthritis; Glycosylation; Population; B cell; Glycoprotein; Biology; Molecular biology; Genetics","score_opus":0.04188972432986785,"score_gpt":0.3243410594835062,"score_spread":0.28245133515363835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952066725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942304,0.0027694325,0.000008888387,0.0042095436,0.000051917472,0.0008153058,0.000058179052,0.000003904408,0.002659787],"genre_scores_gemma":[0.99693453,0.002003171,0.00036818627,0.00042511764,0.000008822681,0.00004559613,0.000018291226,0.000010429829,0.0001858318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748886,0.0003448656,0.00082078873,0.00015821205,0.00087943365,0.00030786163],"domain_scores_gemma":[0.99808186,0.0009019607,0.0002569582,0.00058377156,0.00011825768,0.000057169433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013307048,0.00015407462,0.0005333614,0.00011905391,0.00005582643,0.000011902807,0.0007284684,0.000047430553,0.00027194686],"category_scores_gemma":[0.0003709386,0.00007275871,0.00018048173,0.0005251386,0.00022718833,0.00006534925,0.00014281673,0.0001768769,0.00001634711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050640972,0.010165471,0.69036514,0.010280185,0.0014608725,0.000051935036,0.079807475,0.00057745335,0.0051582647,0.062104065,0.018042123,0.11692293],"study_design_scores_gemma":[0.0025103837,0.0003472333,0.95829046,0.007672549,0.000022991195,0.00003079152,0.009453313,0.00028254974,0.0020973193,0.014165862,0.0049128346,0.00021374002],"about_ca_topic_score_codex":0.00058263127,"about_ca_topic_score_gemma":0.00013242319,"teacher_disagreement_score":0.2679253,"about_ca_system_score_codex":0.000012127738,"about_ca_system_score_gemma":0.00040462878,"threshold_uncertainty_score":0.29776272},"labels":[],"label_agreement":null},{"id":"W2952098942","doi":"10.1136/annrheumdis-2019-eular.1253","title":"FRI0401 EFFECT OF LONG-TERM TREATMENT WITH SECUKINUMAB ON LIPID PROFILE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: POOLED 4 YEAR ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celgene; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Secukinumab; Ankylosing spondylitis; Psoriatic arthritis; Internal medicine; Lipid profile; Adalimumab; Gastroenterology; Placebo; Population; Concomitant; Statin; Adverse effect; Rheumatoid arthritis; Cholesterol; Pathology","score_opus":0.006685494126029679,"score_gpt":0.24941666719245556,"score_spread":0.2427311730664259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952098942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680936,0.00093465776,5.30138e-7,0.00006492464,0.000030818825,0.0014714594,0.0005190888,0.000010569378,0.0001585638],"genre_scores_gemma":[0.99927455,0.0003970989,0.000019722416,0.000022676308,0.0000073905367,0.00007737628,0.00013097191,0.00002011403,0.000050126848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987302,0.00011481616,0.00028592398,0.0002681784,0.00037795815,0.00022292885],"domain_scores_gemma":[0.9989519,0.00019735297,0.00026124247,0.00040964954,0.00009161276,0.00008822499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056194946,0.00024206,0.0008935125,0.00018029782,0.000045370136,0.00001183862,0.00006050873,0.000032379154,0.00015423034],"category_scores_gemma":[0.00005062971,0.00012746389,0.00017446719,0.00039944085,0.00010299538,0.00007932963,0.00003330386,0.00004696262,0.00000515812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062048584,0.0011470332,0.90868205,0.00035359876,0.003504609,0.000013753921,0.00035877127,0.000013830035,0.0000012967039,0.000009717308,0.000006288442,0.07970417],"study_design_scores_gemma":[0.012759671,0.009659285,0.97080874,0.0037943567,0.0018351221,0.000002173051,0.00011265006,0.00001895545,0.0008809011,0.0000099808185,0.0000015919164,0.00011658758],"about_ca_topic_score_codex":0.0001271988,"about_ca_topic_score_gemma":0.000074394455,"teacher_disagreement_score":0.079587586,"about_ca_system_score_codex":0.000046492576,"about_ca_system_score_gemma":0.000044078053,"threshold_uncertainty_score":0.5197827},"labels":[],"label_agreement":null},{"id":"W2952141990","doi":"10.1136/annrheumdis-2019-eular.6994","title":"THU0574 DOES THE USE OF CHOLCHICINE EFFECT COGNITIVE FUNCTIONS IN FAMILIAL MEDITERRANEAN FEVER? PRELIMINARY STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial Mediterranean fever; Montreal Cognitive Assessment; Verbal fluency test; Cognition; Rating scale; Medicine; Fluency; Trail Making Test; Executive functions; Cognitive test; Memory span; Quality of life (healthcare); Clinical psychology; Audiology; Internal medicine; Working memory; Psychiatry; Psychology; Disease; Neuropsychology; Developmental psychology; Cognitive impairment","score_opus":0.02689028807711881,"score_gpt":0.2816099676868858,"score_spread":0.254719679609767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952141990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976903,0.0007658075,0.00000554044,0.00020956268,0.00022912354,0.0009351712,0.00008368663,0.0000036665801,0.000077139644],"genre_scores_gemma":[0.9992268,0.000107365086,0.0000012241203,0.00015513242,0.000019258816,0.000047128797,0.00005387048,0.000012067986,0.00037712144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989181,0.0002935701,0.00029592955,0.00016466927,0.0001797719,0.00014792735],"domain_scores_gemma":[0.9990451,0.00020739423,0.0001667628,0.00046618216,0.000091077745,0.000023517954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019633751,0.00013679656,0.00022782326,0.000040522176,0.000053823263,0.00001032924,0.00025362696,0.000040405805,0.000035901914],"category_scores_gemma":[0.00054372015,0.0000667479,0.0001790897,0.0001183455,0.00013792714,0.000012608053,0.00015918638,0.00006727484,0.0000060782863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004352492,0.0026559199,0.9348236,0.00062421366,0.0013798771,0.0000025439624,0.003066558,0.0011269067,0.011134244,0.000015876349,0.003990822,0.03682699],"study_design_scores_gemma":[0.0018689125,0.001900018,0.9769042,0.0004377696,0.00017561292,0.0000011677778,0.0031680658,0.00013318073,0.015040935,0.00005799305,0.00016364938,0.00014850334],"about_ca_topic_score_codex":0.00012284727,"about_ca_topic_score_gemma":0.000045698405,"teacher_disagreement_score":0.042080633,"about_ca_system_score_codex":0.0000018884497,"about_ca_system_score_gemma":0.00003997304,"threshold_uncertainty_score":0.27219006},"labels":[],"label_agreement":null},{"id":"W2952182954","doi":"10.1136/annrheumdis-2019-eular.3083","title":"FRI0171 CLINICAL RESPONSES IN PATIENTS WITH INADEQUATE RESPONSE TO BDMARDS UPON TREATMENT WITH UPADACITINIB","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"Regeneron Pharmaceuticals; Gilead Sciences; AbbVie; Sanofi; Amgen; Pfizer; Samsung; Genentech; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Placebo; Adverse effect; Gastroenterology","score_opus":0.04816730546240868,"score_gpt":0.3694457898233973,"score_spread":0.32127848436098866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952182954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489135,0.00014248192,0.000003224042,0.002635188,0.00005830228,0.0019202912,0.00009621639,0.000025464922,0.00022749357],"genre_scores_gemma":[0.9974578,0.00007808726,0.0001227909,0.0004810595,0.000014395679,0.00008094914,0.000015587126,0.000040217477,0.0017090861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996837,0.0006968566,0.0006257626,0.0003889121,0.0009796922,0.000471753],"domain_scores_gemma":[0.9963269,0.0016330805,0.00021099605,0.0011943933,0.00026646504,0.00036813333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008451489,0.00025329957,0.00070843165,0.00021787485,0.000045737645,0.000023616405,0.00029786534,0.00006601145,0.00015819399],"category_scores_gemma":[0.0016788006,0.00012885763,0.00017643764,0.0004877807,0.00017554362,0.000102172824,0.00013177653,0.00012390532,0.00011067791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24867094,0.0033100077,0.6965616,0.00048884674,0.0006279203,0.00007323178,0.0008120527,0.00023658408,0.000011081767,0.000046702207,0.0011865057,0.047974564],"study_design_scores_gemma":[0.02897323,0.009484907,0.95692015,0.0025236162,0.00011846971,0.00000878341,0.00018863865,0.00035585588,0.00034025963,0.000044298133,0.00085194956,0.00018981981],"about_ca_topic_score_codex":0.0003130913,"about_ca_topic_score_gemma":0.000056765293,"teacher_disagreement_score":0.2603586,"about_ca_system_score_codex":0.0010719035,"about_ca_system_score_gemma":0.005090094,"threshold_uncertainty_score":0.90296084},"labels":[],"label_agreement":null},{"id":"W2952183138","doi":"10.1136/annrheumdis-2019-eular.808","title":"FRI0467 THE DISTRIBUTION OF PREVALENT AND INCIDENT VERTEBRAL FRACTURES IN THE TERIPARATIDE VERSUS RISEDRONATE “VERO” CLINICAL TRIAL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Osteoporosis; Teriparatide; Incidence (geometry); Population; Lumbar; Clinical trial; Surgery; Bone mineral; Internal medicine","score_opus":0.10853563975113832,"score_gpt":0.4527811654009166,"score_spread":0.3442455256497783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952183138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883717,0.0023316904,0.0000013493255,0.0072257603,0.0002723411,0.0016061838,0.0000805926,0.000004755906,0.000105631734],"genre_scores_gemma":[0.99786115,0.0014126981,0.0000033142617,0.0005472846,0.000042200387,0.000047024518,0.000026871156,0.0000063915786,0.000053074305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766296,0.0006193344,0.00069297245,0.00015713001,0.00063774735,0.00022985923],"domain_scores_gemma":[0.99755275,0.0013669682,0.00029724045,0.0005836903,0.00008976942,0.00010956801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013923377,0.000110961744,0.00039139198,0.0000277586,0.000069877875,0.000018322551,0.0002971494,0.00005887616,0.00009252592],"category_scores_gemma":[0.0020685915,0.000047834204,0.00020873813,0.00013959743,0.00025982596,0.000066388624,0.00011858312,0.00022786636,0.000009555054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18387622,0.005300873,0.64112145,0.00426447,0.00067677494,0.000009331532,0.0028919254,0.00009383901,0.00004300332,0.0014399127,0.06160242,0.098679766],"study_design_scores_gemma":[0.014793612,0.001181164,0.9815856,0.0004300275,0.00009436057,0.0000018608954,0.00038799227,0.00037412127,0.00009555045,0.00047729677,0.00052713946,0.000051282164],"about_ca_topic_score_codex":0.00024730022,"about_ca_topic_score_gemma":0.000036021953,"teacher_disagreement_score":0.34046412,"about_ca_system_score_codex":0.000014886982,"about_ca_system_score_gemma":0.00022630994,"threshold_uncertainty_score":0.24764466},"labels":[],"label_agreement":null},{"id":"W2952212829","doi":"10.1136/annrheumdis-2019-eular.1725","title":"FRI0118 INFECTION OUTCOMES IN PATIENTS WITH RA TREATED WITH ABATACEPT AND OTHER DMARDS: RESULTS FROM A 10-YEAR INTERNATIONAL POST-APPROVAL STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; McGill University","funders":"Bristol-Myers Squibb","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Incidence (geometry); Epidemiology; Healthcare delivery; Population; Rheumatology; Retrospective cohort study; Health care; Physical therapy; Environmental health","score_opus":0.01854146662557498,"score_gpt":0.29382671692915213,"score_spread":0.27528525030357714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952212829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757457,0.000030144314,7.2684185e-7,0.00026212574,0.000044549914,0.0012902273,0.00028327532,0.000020969432,0.0004934201],"genre_scores_gemma":[0.9989649,0.000012173228,0.000024668092,0.00010501273,0.000009806918,0.000028456963,0.00007935624,0.0000236289,0.00075198954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841785,0.00010572263,0.0003244691,0.00027218007,0.0006991083,0.00018069388],"domain_scores_gemma":[0.9987662,0.00024199345,0.00018082722,0.0004840669,0.00023702717,0.00008987541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016291914,0.00016157594,0.00036294138,0.00012687132,0.00002665995,0.00002936688,0.00014797415,0.000034061788,0.00024106506],"category_scores_gemma":[0.00046998498,0.000084307685,0.0000582457,0.0001729516,0.0001006821,0.0001377684,0.00010576261,0.000080836,0.000026160635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073619746,0.0016254828,0.9880792,0.00007375587,0.00062165374,0.0000039465813,0.0007001605,0.000038464827,0.00000251325,0.000004885885,0.00027291916,0.0012150315],"study_design_scores_gemma":[0.034042884,0.0012375021,0.96290857,0.00065514474,0.00009570119,0.0000014652544,0.0004830777,0.00037568048,0.000046324643,0.000016179987,0.000036533445,0.00010093435],"about_ca_topic_score_codex":0.004731003,"about_ca_topic_score_gemma":0.00020990646,"teacher_disagreement_score":0.02668091,"about_ca_system_score_codex":0.00029437157,"about_ca_system_score_gemma":0.0004959203,"threshold_uncertainty_score":0.7151893},"labels":[],"label_agreement":null},{"id":"W2952246874","doi":"10.1136/annrheumdis-2019-eular.343","title":"THU0711-HPR COMPARISON OF FEMALE SEXUAL FUNCTION INDEX IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS AND HEALTHY CONTROLS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Association of Friendship Centres; Ottawa Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Psoriatic arthritis; Sexual function; Internal medicine; Psoriasis; Dermatology; Immunology","score_opus":0.01446575097444809,"score_gpt":0.27067548376772205,"score_spread":0.25620973279327397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952246874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948645,0.003679957,0.000014080433,0.0005451543,0.000074626274,0.000685143,0.000038713762,0.0000101206515,0.000087673114],"genre_scores_gemma":[0.99929315,0.00048995524,0.000011235258,0.00013032297,0.0000038351213,0.000014788392,0.000020422583,0.000010249417,0.000026030708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989838,0.00007047615,0.00040533807,0.00014044401,0.00025370967,0.00014624988],"domain_scores_gemma":[0.9991588,0.00016704666,0.00024292925,0.00023243706,0.0000984299,0.000100385245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008201786,0.00010859176,0.00047251928,0.00008667058,0.000042399188,0.000009220755,0.00004605631,0.000052457446,0.00004483306],"category_scores_gemma":[0.00010953982,0.00006824614,0.00003778953,0.00013605747,0.00013792305,0.00008899984,0.000030571875,0.000096649084,0.0000029294927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009157422,0.0006693798,0.9800461,0.00031170432,0.00035032863,2.714043e-7,0.0004641195,0.000043554744,0.00000747428,0.00034715905,0.0001159341,0.01672825],"study_design_scores_gemma":[0.005165621,0.0012093633,0.9897625,0.0015408378,0.0001765568,0.0000021714695,0.0006789051,0.0008803375,0.000017711924,0.00048685417,0.000006686639,0.00007245214],"about_ca_topic_score_codex":0.00008535218,"about_ca_topic_score_gemma":0.000014854536,"teacher_disagreement_score":0.016655797,"about_ca_system_score_codex":0.000006119207,"about_ca_system_score_gemma":0.000068564776,"threshold_uncertainty_score":0.2782997},"labels":[],"label_agreement":null},{"id":"W2952258757","doi":"10.1136/annrheumdis-2019-eular.7248","title":"SAT0360 REMISSION IN PSORIATIC ARTHRITIS: DEFINITION AND PREDICTORS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto","funders":"","keywords":"Medicine; Confidence interval; Psoriatic arthritis; Visual analogue scale; Internal medicine; Hazard ratio; Cohort; Physical therapy; Arthritis","score_opus":0.02648308297235141,"score_gpt":0.2749033016661543,"score_spread":0.24842021869380287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952258757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857361,0.011686805,4.1998865e-7,0.0008638987,0.00012146305,0.00039763507,0.000030853822,0.000014183634,0.001148685],"genre_scores_gemma":[0.99256426,0.0070828707,0.000037714257,0.00016944796,0.000009866075,0.000019165618,0.000012106331,0.000009076976,0.00009548941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992468,0.00003781405,0.00024617094,0.00013000706,0.00020053252,0.0001387031],"domain_scores_gemma":[0.9994771,0.00009104365,0.000096437594,0.00022569686,0.000036532718,0.00007320978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070468,0.000096297525,0.00028263903,0.000050594466,0.000037234,0.000007180754,0.00004369758,0.00002838069,0.00008702083],"category_scores_gemma":[0.000255487,0.00006261257,0.0000837523,0.000112003225,0.000054561147,0.000058471192,0.00005117436,0.000041863907,0.00001583969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032234163,0.0007110611,0.85860825,0.0007680653,0.00023318506,0.000014353341,0.00054490904,0.0000047642816,0.00004461109,0.0009866549,0.0018586523,0.13590316],"study_design_scores_gemma":[0.0023754353,0.0002364991,0.9874535,0.0046036993,0.00006708491,0.000012759192,0.00028793846,0.000043106942,0.00016218961,0.004559864,0.00013021754,0.00006766983],"about_ca_topic_score_codex":0.000054498305,"about_ca_topic_score_gemma":0.000010654256,"teacher_disagreement_score":0.13583548,"about_ca_system_score_codex":0.000009399923,"about_ca_system_score_gemma":0.0000319364,"threshold_uncertainty_score":0.25532666},"labels":[],"label_agreement":null},{"id":"W2952308726","doi":"10.1136/annrheumdis-2019-eular.7968","title":"AB0537 CHRONIC DAMAGE CONTRIBUTION TO COGNITIVE IMPAIRMENT IN PRIMARY ANTIPHOSPHOLIPID SYNDROME","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; Depression (economics); Population; Montreal Cognitive Assessment; Anxiety; Dementia; Physical therapy; Disease; Psychiatry","score_opus":0.018671497468420936,"score_gpt":0.3117395114317996,"score_spread":0.29306801396337867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952308726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931509,0.0018189455,0.000010900666,0.0013457813,0.00016804675,0.0028377546,0.0001137851,0.000028297334,0.00052559376],"genre_scores_gemma":[0.9984615,0.00023269582,0.000008412276,0.00044737128,0.000016795146,0.00010351611,0.000040200346,0.00002377783,0.0006657432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979141,0.00016549046,0.00051387737,0.00026226958,0.00071060075,0.0004336997],"domain_scores_gemma":[0.99844277,0.0003373378,0.00017192753,0.00058108167,0.00025257448,0.00021430098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005266674,0.00017259127,0.000624431,0.0001792431,0.000035654775,0.000017566064,0.0002586935,0.00005456528,0.00031689167],"category_scores_gemma":[0.0006805304,0.00011665401,0.00020887631,0.0004634773,0.00008895034,0.00010267432,0.00021212708,0.000121598234,0.00038214462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013409426,0.0014404602,0.97912806,0.007562629,0.0004703085,0.00006799609,0.00089228014,0.000062143255,0.0011009051,0.00027834464,0.0043212683,0.0033346768],"study_design_scores_gemma":[0.0036065998,0.00072972436,0.975535,0.01608071,0.00007518424,0.00036569257,0.00043586126,0.000268435,0.0024868532,0.00019286678,0.000062422376,0.0001606973],"about_ca_topic_score_codex":0.00007475606,"about_ca_topic_score_gemma":0.0000046913724,"teacher_disagreement_score":0.00851808,"about_ca_system_score_codex":0.00021253289,"about_ca_system_score_gemma":0.00046497994,"threshold_uncertainty_score":0.49118236},"labels":[],"label_agreement":null},{"id":"W2952372713","doi":"10.1136/annrheumdis-2019-eular.3547","title":"THU0598 ROLE OF DUAL-ENERGY CT AS A SCREENING TOOL FOR CORONARY GOUT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Gout; Hyperuricemia; Asymptomatic; Uric acid; Internal medicine; Radiology; Surgery","score_opus":0.02178006449621785,"score_gpt":0.29433449972230474,"score_spread":0.2725544352260869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952372713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990346,0.0055566337,0.00011387707,0.0010609712,0.00014973978,0.00040926752,0.00019094087,0.00002847969,0.0021441004],"genre_scores_gemma":[0.9978575,0.0001864116,0.00016819684,0.00077094627,0.000032438562,0.000027489796,0.000035678182,0.000022107539,0.0008992154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901885,0.000037141774,0.00031569312,0.00013682005,0.00030515372,0.00018634264],"domain_scores_gemma":[0.9982344,0.0008153026,0.00019895531,0.00049498305,0.00017248874,0.00008389181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014309505,0.00012190106,0.00042694793,0.000052325948,0.00003586641,0.0000098476585,0.00011387632,0.00001965457,0.00008657431],"category_scores_gemma":[0.0013027522,0.00008512034,0.00045106947,0.00009460117,0.00008126399,0.00006166978,0.00008351745,0.00003811896,0.000013577362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013191502,0.0012883007,0.726622,0.0023457096,0.0014714902,0.000012038524,0.00047362337,0.0008439852,0.0008942862,0.007123424,0.048346207,0.20925978],"study_design_scores_gemma":[0.0029260183,0.00059699046,0.95781136,0.0047618104,0.0009647399,0.00007641597,0.0009887661,0.0027529418,0.01377314,0.009310313,0.0057230736,0.00031445213],"about_ca_topic_score_codex":0.00015911814,"about_ca_topic_score_gemma":6.308545e-7,"teacher_disagreement_score":0.23118934,"about_ca_system_score_codex":0.0000054544207,"about_ca_system_score_gemma":0.00012439031,"threshold_uncertainty_score":0.34711066},"labels":[],"label_agreement":null},{"id":"W2952397982","doi":"10.1136/annrheumdis-2019-eular.3307","title":"SAT0308 CLUSTER-BASED SPONDYLOARTHRITIS PHENOTYPES DEFINED AT BASELINE ARE PREDICTIVE OF 5-YEAR SEVERITY OUTCOME IN THE DESIR COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Celgene; UCB Pharma; Dutch Arthritis Society; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Cohort; Cluster (spacecraft); Baseline (sea); Outcome (game theory); Internal medicine; Axial spondyloarthritis; Cohort study; Ankylosing spondylitis; Sacroiliitis","score_opus":0.028537986144265136,"score_gpt":0.27926342840463403,"score_spread":0.2507254422603689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952397982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461854,0.0011276145,0.000015968259,0.0015327435,0.00013828113,0.0015419044,0.00051533774,0.000025294632,0.00048433378],"genre_scores_gemma":[0.998458,0.00010902195,0.000144221,0.0008258184,0.000017393473,0.000063583924,0.000089034984,0.000021489823,0.00027142485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998137,0.00029019284,0.0005462433,0.00022769038,0.00054918794,0.00024970697],"domain_scores_gemma":[0.99816144,0.0005526583,0.00034351673,0.0007053664,0.00014698305,0.0000900499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049612654,0.00020745418,0.0006267343,0.00008866618,0.000056044057,0.000009275124,0.00024191813,0.000066050285,0.00029357112],"category_scores_gemma":[0.0006151962,0.00012318643,0.00032189372,0.00022848474,0.00013367676,0.00007709846,0.000082829785,0.000094132796,0.00003861783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017023609,0.0010417924,0.9892884,0.0007091427,0.00013241741,0.000013043254,0.00029097736,0.00008600891,0.000116539646,0.00024858274,0.0008391843,0.0055315318],"study_design_scores_gemma":[0.0055833724,0.0011746857,0.98483026,0.0023898485,0.00037749336,0.000010271,0.00058801717,0.00048491126,0.0033613774,0.0009289391,0.000098040466,0.00017280247],"about_ca_topic_score_codex":0.000061436775,"about_ca_topic_score_gemma":0.00007885478,"teacher_disagreement_score":0.0053587295,"about_ca_system_score_codex":0.000029396066,"about_ca_system_score_gemma":0.000100043464,"threshold_uncertainty_score":0.5023397},"labels":[],"label_agreement":null},{"id":"W2952422947","doi":"10.1136/annrheumdis-2019-eular.1466","title":"FRI0398 IXEKIZUMAB IS EFFECTIVE IN THE TREATMENT OF RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS REGARDLESS OF THE LEVEL OF C-REACTIVE PROTEIN OR MAGNETIC RESONANCE IMAGING SCORES: 16-WEEK DATA FROM COAST-V AND COAST-W","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Pfizer; Eli Lilly and Company","keywords":"Medicine; Ankylosing spondylitis; Adalimumab; BASDAI; Sacroiliitis; Internal medicine; Ixekizumab; Placebo; Back pain; Population; Axial spondyloarthritis; Magnetic resonance imaging; Secukinumab; Visual analogue scale; Gastroenterology; Physical therapy; Tumor necrosis factor alpha; Disease; Pathology; Radiology","score_opus":0.06489042340462008,"score_gpt":0.3073104009727469,"score_spread":0.24241997756812683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952422947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94618946,0.044797804,0.0000017635313,0.0005960242,0.000076478784,0.0027162358,0.005562121,0.0000047101867,0.0000554023],"genre_scores_gemma":[0.99616873,0.0033838719,0.000042923446,0.00007236511,0.000015193264,0.00015096174,0.000057935624,0.000021218677,0.000086800355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979268,0.0003200363,0.00058673625,0.00036477775,0.0005572201,0.0002444605],"domain_scores_gemma":[0.9971028,0.00080540497,0.0005297277,0.001334273,0.00017196994,0.000055798286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019989727,0.00027190175,0.0008925453,0.00010474836,0.00008004768,0.000011352916,0.0004670015,0.00004024597,0.000060503404],"category_scores_gemma":[0.00034483787,0.0001323746,0.00027136685,0.00042422372,0.0006592385,0.00011574436,0.00022020638,0.00008136222,0.0000011067057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008516266,0.006965345,0.61051494,0.0011463915,0.0011591251,0.00004014559,0.01055019,0.000003587313,0.0004882793,0.00013449708,0.001237173,0.35924408],"study_design_scores_gemma":[0.0083943475,0.002341373,0.9706655,0.0078092525,0.0005227579,0.000018773671,0.0040463177,0.00008142194,0.0047904095,0.0010187589,0.00017326484,0.00013782889],"about_ca_topic_score_codex":0.0066596176,"about_ca_topic_score_gemma":0.0015095975,"teacher_disagreement_score":0.36015058,"about_ca_system_score_codex":0.000024979696,"about_ca_system_score_gemma":0.00013250815,"threshold_uncertainty_score":0.9999551},"labels":[],"label_agreement":null},{"id":"W2952488859","doi":"10.1136/annrheumdis-2019-eular.1988","title":"THU0545 A PROSPECTIVE OUTCOME OF ALL 17 CONSECUTIVE PEDIATRIC PATIENTS WITH CHRONIC NONBACTERIAL OSTEOMYELITIS TREATED WITH INTRAVENOUS PAMIDRONATE AND FOLLOWED AT A SINGLE CENTER OVER 15 YEARS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Orthopedic Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Single Center; Prospective cohort study; Magnetic resonance imaging; Surgery; Gastroenterology; Radiology","score_opus":0.010090389372618367,"score_gpt":0.24032126471410264,"score_spread":0.2302308753414843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952488859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759024,0.0001669771,7.449848e-7,0.000053435248,0.000061694234,0.0013351863,0.00043525454,0.000016940461,0.00033952997],"genre_scores_gemma":[0.99933714,0.00004804044,0.00001488119,0.000046072517,0.000020503012,0.000031829724,0.00007231884,0.000024467578,0.0004047344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989542,0.000042194293,0.00028508098,0.00021668588,0.0002891208,0.00021271994],"domain_scores_gemma":[0.99906725,0.00006288558,0.00031283835,0.00029337415,0.00016187532,0.000101753445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036586574,0.0001882615,0.0004518672,0.00008175413,0.00004092805,0.000011451019,0.0000458227,0.00003924935,0.00019376047],"category_scores_gemma":[0.000031899872,0.00010587365,0.00010923366,0.00014911407,0.00014311487,0.000086941414,0.000064671185,0.000050962342,0.0000071195386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016437544,0.0010030695,0.9948667,0.000287181,0.0006967335,0.00000972229,0.00032717906,0.0000024881244,0.000011068073,0.000008339204,0.000057579124,0.0010861768],"study_design_scores_gemma":[0.008766281,0.00329048,0.98652464,0.00040387112,0.00070654985,0.0000132583655,0.000029052242,0.000007314392,0.00010196318,0.000015322277,0.000026666783,0.00011462382],"about_ca_topic_score_codex":0.00022039861,"about_ca_topic_score_gemma":0.00006729847,"teacher_disagreement_score":0.008342093,"about_ca_system_score_codex":0.0000749055,"about_ca_system_score_gemma":0.00009006821,"threshold_uncertainty_score":0.43174022},"labels":[],"label_agreement":null},{"id":"W2952555221","doi":"10.1136/annrheumdis-2019-eular.5469","title":"THU0156 NO CONFIRMATION OF INCREASED RISK OF IDIOPATHIC FACIAL NERVE PALSY UNDER TOCILIZUMAB","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Facial Nerve Paralysis Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Samsung; Genentech; Arthritis Society; Celltrion; Sanofi; McGill University Health Centre; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tocilizumab; Incidence (geometry); Palsy; Pediatrics; Rate ratio; Internal medicine; Cohort; Retrospective cohort study; Surgery; Confidence interval; Rheumatoid arthritis","score_opus":0.034479971687856395,"score_gpt":0.3203468042415629,"score_spread":0.28586683255370654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952555221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953316,0.00184819,0.000008916609,0.00041710562,0.00007649976,0.0007020998,0.0001676214,0.000012220936,0.0014357626],"genre_scores_gemma":[0.99886775,0.0005401246,0.00001785256,0.000045029206,0.000015868749,0.000015152086,0.00004011835,0.000011858988,0.00044626833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979992,0.00033139042,0.0006236223,0.00015005472,0.00070674485,0.00018897753],"domain_scores_gemma":[0.99806714,0.00024289382,0.0005421717,0.0005612962,0.0004775939,0.00010889688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041194246,0.00015000909,0.0006812165,0.00011853031,0.000047293768,0.000007512834,0.00020941522,0.000067777764,0.0004544648],"category_scores_gemma":[0.00083442585,0.00008811155,0.00052885426,0.00026803062,0.00021974972,0.00008359631,0.00007634399,0.00008890618,0.00009370061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058768187,0.0056235297,0.91291517,0.00998817,0.005421915,0.0000062188597,0.0016380438,0.0009555146,0.012820379,0.0031565677,0.0034880177,0.038109645],"study_design_scores_gemma":[0.004032496,0.00093522103,0.9565138,0.002505202,0.0009508835,0.0000023737803,0.0004883368,0.002156916,0.029949209,0.002236495,0.000055597444,0.00017345209],"about_ca_topic_score_codex":0.0008955157,"about_ca_topic_score_gemma":0.000010100506,"teacher_disagreement_score":0.043598637,"about_ca_system_score_codex":0.000013639937,"about_ca_system_score_gemma":0.00020904251,"threshold_uncertainty_score":0.49760708},"labels":[],"label_agreement":null},{"id":"W2952589990","doi":"10.1136/annrheumdis-2019-eular.5217","title":"SAT0406 COMPUTED TOMOGRAPHIC MAPPING OF SPINAL AND VASCULAR URATE DEPOSITION IN THE ABDOMEN WITH CORRELATION TO URIC ACID LEVEL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Gout; Lumbosacral joint; Abdomen; Uric acid; Radiology; Pelvis; Tophus; Nuclear medicine; Internal medicine; Surgery; Hyperuricemia","score_opus":0.03407245228619036,"score_gpt":0.26749150738567856,"score_spread":0.2334190550994882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952589990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951451,0.0011534839,0.0013471011,0.0013084377,0.00003882661,0.0008966078,0.0000140847815,0.000013175705,0.00008318351],"genre_scores_gemma":[0.9989326,0.00008730393,0.00047269047,0.0004383721,0.000009640037,0.000021183056,0.000012808205,0.000012289801,0.0000130880035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987174,0.00013431326,0.00034958703,0.00017111313,0.00045661995,0.00017095677],"domain_scores_gemma":[0.999037,0.00010845627,0.00022758344,0.00044293946,0.00011041722,0.00007360427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030990803,0.00013866073,0.00034158662,0.00018888836,0.000044626155,0.000014987551,0.00017338553,0.000038661612,0.00001192525],"category_scores_gemma":[0.00010954573,0.00007799202,0.00010349861,0.00067928474,0.00008121071,0.00010454214,0.000057842637,0.000093390016,0.0000056030262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001499042,0.0016180343,0.92833817,0.004864158,0.0015935967,0.000018164195,0.00862456,0.004311056,0.005768138,0.0007579131,0.00085245137,0.041754734],"study_design_scores_gemma":[0.0010003857,0.00041699444,0.99157476,0.002367611,0.00021531204,0.00002768693,0.000794182,0.002748191,0.00049851194,0.0002488302,0.000008055615,0.00009948936],"about_ca_topic_score_codex":0.000107720705,"about_ca_topic_score_gemma":0.0000053336935,"teacher_disagreement_score":0.063236594,"about_ca_system_score_codex":0.000011268744,"about_ca_system_score_gemma":0.000055489105,"threshold_uncertainty_score":0.31804222},"labels":[],"label_agreement":null},{"id":"W2952617971","doi":"10.1136/annrheumdis-2019-eular.1873","title":"FRI0470 EFFECT OF DISCONTINUATION OF DENOSUMAB IN SUBJECTS WITH RHEUMATOID ARTHRITIS TREATED WITH GLUCOCORTICOIDS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Denosumab; Medicine; Discontinuation; Rheumatoid arthritis; Internal medicine; Placebo; Osteoporosis; N-terminal telopeptide; Urology; Interim analysis; Gastroenterology; Randomized controlled trial; Pathology","score_opus":0.010982873034163601,"score_gpt":0.2715929719001931,"score_spread":0.2606100988660295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952617971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603355,0.0020834953,0.000002932927,0.00017414642,0.000020093406,0.001328153,0.000035850015,0.000013058854,0.00030871536],"genre_scores_gemma":[0.99903744,0.00070433953,0.00003366153,0.000026092986,0.0000015297117,0.000046128214,0.000026634454,0.000020351983,0.000103805934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985929,0.00013164544,0.00050513586,0.00016559425,0.00038824012,0.00021650096],"domain_scores_gemma":[0.9985825,0.00026526794,0.00046306825,0.000459158,0.00012279583,0.00010720595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001448037,0.0001750051,0.00077276095,0.00011711828,0.000020237027,0.000004208867,0.00008830603,0.000039247298,0.00004605255],"category_scores_gemma":[0.00017346974,0.000090035355,0.00011358694,0.00033639438,0.00013074873,0.00009650093,0.000020856538,0.00005744786,0.0000056292483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033670703,0.0008007245,0.97289515,0.0012798628,0.00026908386,0.0000062687686,0.00020743176,0.000031509095,0.0000798245,0.00007490436,0.00003210689,0.020956056],"study_design_scores_gemma":[0.00820288,0.0038584373,0.9543989,0.009407469,0.00013266347,0.000016040936,0.00008481388,0.000110618945,0.023621574,0.00007370307,0.000002304521,0.00009063825],"about_ca_topic_score_codex":0.0010579968,"about_ca_topic_score_gemma":0.00019935059,"teacher_disagreement_score":0.02354175,"about_ca_system_score_codex":0.000015247794,"about_ca_system_score_gemma":0.00021219999,"threshold_uncertainty_score":0.36715353},"labels":[],"label_agreement":null},{"id":"W2952640064","doi":"10.1136/annrheumdis-2019-eular.2998","title":"FRI0376 DIFFERENCES IN PHYSICAL ACTIVITY BETWEEN AXIAL SPONDYLOARTHRITIS PATIENTS WITH AND WITHOUT PHYSICAL THERAPY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Sanofi Genzyme; Foundation for Research in Rheumatology; Arthritis Society; Samsung; Dutch Arthritis Society; Biogen; Celgene; Celltrion; AbbVie; Karolinska Institutet; Pfizer; NordForsk; Eli Lilly and Company","keywords":"Medicine; Physical therapy; Guideline; Aerobic exercise; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine","score_opus":0.029155042164809943,"score_gpt":0.2937469911945175,"score_spread":0.26459194902970756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952640064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982692,0.00038020342,3.7451017e-7,0.00033526425,0.000037755348,0.00069506996,0.00013206097,0.000014168486,0.0001359082],"genre_scores_gemma":[0.99958247,0.00023146665,0.0000064745964,0.000044413093,0.000035163328,0.000029951543,0.000010878858,0.000015235942,0.000043949534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989775,0.00006722634,0.00012693623,0.00022718908,0.0003809351,0.00022021633],"domain_scores_gemma":[0.9993011,0.00014514613,0.00011816269,0.00027943336,0.000060674844,0.00009549708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003148,0.00019399414,0.00064810814,0.000042132415,0.000057351383,0.000014837078,0.000088723005,0.000025050014,0.00001977763],"category_scores_gemma":[0.000045664903,0.00010352066,0.00012466898,0.00013580624,0.00019260081,0.00010623028,0.00006860211,0.00008375946,0.000007463632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060804945,0.0015794915,0.9227206,0.00007204555,0.0002112871,0.0000011074707,0.00035517325,2.5769666e-7,0.000008506387,0.000034919685,0.000019767787,0.07438879],"study_design_scores_gemma":[0.0049851863,0.0010433672,0.99225265,0.0007297701,0.00007151694,7.3226494e-7,0.00006323568,0.000031909873,0.00023463838,0.0004634894,0.00001144935,0.00011208147],"about_ca_topic_score_codex":0.00010067556,"about_ca_topic_score_gemma":0.000008926508,"teacher_disagreement_score":0.07427671,"about_ca_system_score_codex":0.000008426355,"about_ca_system_score_gemma":0.000033743814,"threshold_uncertainty_score":0.42214498},"labels":[],"label_agreement":null},{"id":"W2952653384","doi":"10.1136/annrheumdis-2019-eular.344","title":"AB0763 SAFETY OF ABATACEPT TREATMENT OVER 2 YEARS IN A PHASE III ACTIVE PSORIATIC ARTHRITIS RANDOMIZED TRIAL (ASTRAEA)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Abatacept; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Dermatology","score_opus":0.021669453992262323,"score_gpt":0.32341202493495647,"score_spread":0.30174257094269413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952653384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078125,0.0043993583,0.0000017764751,0.00027453247,0.00028327783,0.0032503163,0.00038403485,0.000012282168,0.00061317673],"genre_scores_gemma":[0.9930226,0.0063592945,0.000025797845,0.000056260273,0.00002690331,0.0001712895,0.000042950745,0.000017575392,0.0002773227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99824756,0.00017302025,0.0007581699,0.00021249354,0.00036884643,0.00023991491],"domain_scores_gemma":[0.9984833,0.00048710944,0.00042064738,0.00044925028,0.00006420391,0.00009546438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017561579,0.00020836506,0.0014989695,0.00009955339,0.000032594315,0.00000684812,0.000100405625,0.000044767945,0.0006486876],"category_scores_gemma":[0.00034353122,0.00013299787,0.0006889071,0.00018731634,0.00017149786,0.00008186037,0.000049411294,0.00005117063,0.000016833324],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77173823,0.004988593,0.0009468584,0.00014535639,0.0020668146,0.00002098707,0.0014630175,0.000016180285,0.0000143514,0.0002648016,0.00031497024,0.21801983],"study_design_scores_gemma":[0.96860164,0.0016711524,0.02562943,0.0018662176,0.0004921371,0.000003931153,0.000493839,0.00008020151,0.0003734775,0.0005726999,0.0000992916,0.000115998235],"about_ca_topic_score_codex":0.0005194722,"about_ca_topic_score_gemma":0.000046414127,"teacher_disagreement_score":0.21790382,"about_ca_system_score_codex":0.000046866287,"about_ca_system_score_gemma":0.00013363779,"threshold_uncertainty_score":0.7102674},"labels":[],"label_agreement":null},{"id":"W2952669912","doi":"10.1136/annrheumdis-2019-eular.7561","title":"OP0343 LONGITUDINAL ASSESSMENT OF MRI OF THE SACROILIAC JOINTS IN THE ASAS CLASSIFICATION COHORT: EVOLUTION OF DIAGNOSTIC FEATURES AND PREDICTIVE UTILITY FOR AXIAL SPONDYLOARTHRITIS:","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Axial spondyloarthritis; Medicine; Cohort; Quadrant (abdomen); Predictive value; Radiology; Magnetic resonance imaging; Internal medicine; Surgery; Sacroiliitis","score_opus":0.02768597648521954,"score_gpt":0.31986889792536916,"score_spread":0.2921829214401496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952669912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901099,0.0056685945,0.000029574396,0.000867391,0.00013715633,0.002095413,0.0008655908,0.0000035762298,0.00022278844],"genre_scores_gemma":[0.99868447,0.0010569523,0.000041650103,0.000019601048,0.000011528928,0.00012783604,0.000023569217,0.000007854194,0.000026546963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985068,0.00018137007,0.00050889637,0.00019044674,0.00046054018,0.00015195378],"domain_scores_gemma":[0.9976118,0.0010785667,0.0005026408,0.0005155742,0.00025708028,0.00003429953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040765535,0.00013637787,0.0004911388,0.000050207687,0.00006899199,0.000005782138,0.00017499836,0.00004621467,0.000020869405],"category_scores_gemma":[0.0013343373,0.00007228573,0.00023875962,0.00019196395,0.000386642,0.00007228157,0.00008507937,0.00007301544,2.915244e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043874048,0.0009591283,0.9922142,0.0007707197,0.00033384396,5.0037784e-7,0.0003749845,0.000021894448,0.000076990735,0.001067125,0.00072375836,0.0030181056],"study_design_scores_gemma":[0.0017992255,0.00053669227,0.9912355,0.002065254,0.00037187673,0.0000058507335,0.0011240367,0.00036527362,0.00039812882,0.0020360553,0.000011222545,0.000050881412],"about_ca_topic_score_codex":0.00022532353,"about_ca_topic_score_gemma":0.00008178429,"teacher_disagreement_score":0.008574546,"about_ca_system_score_codex":0.000027641563,"about_ca_system_score_gemma":0.00013018743,"threshold_uncertainty_score":0.29477262},"labels":[],"label_agreement":null},{"id":"W2952717710","doi":"10.1136/annrheumdis-2019-eular.418","title":"AB0454 FREQUENCY AND DURATION OF EARLY NON-SERIOUS ADVERSE EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB 5 MG TWICE DAILY AS MONOTHERAPY AND COMBINATION THERAPY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Université Laval; Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Tolerability; Tofacitinib; Internal medicine; Adverse effect; Rheumatoid arthritis; Placebo; Combination therapy","score_opus":0.012848850966468492,"score_gpt":0.27323195870729433,"score_spread":0.26038310774082585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952717710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731183,0.0008688986,0.0000019742513,0.00015258288,0.000022763434,0.001439228,0.00004035831,0.000012382892,0.00014995887],"genre_scores_gemma":[0.9938364,0.005899158,0.000019572708,0.0000877836,0.0000022830154,0.0000448408,0.00003615473,0.00002361773,0.000050189592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847084,0.00010998331,0.0004686348,0.00022798909,0.0005165706,0.00020600905],"domain_scores_gemma":[0.99883646,0.00015026354,0.00030758223,0.00036430702,0.00023541682,0.00010595982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016492118,0.00017282201,0.00042961384,0.00013099822,0.00003923328,0.00000782996,0.00011408445,0.000058841273,0.00006146669],"category_scores_gemma":[0.00013403929,0.00011737919,0.00006462365,0.00024835236,0.0001526932,0.00024891336,0.000029528323,0.0000731027,0.000005575594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023856398,0.00080251426,0.97437406,0.00038930814,0.00020295965,0.000003836515,0.001805764,0.000013109132,0.00040592824,0.00010504573,0.000015984424,0.019495828],"study_design_scores_gemma":[0.028432375,0.0017041662,0.96329683,0.0023463166,0.000014302214,0.00001151776,0.00022818666,0.0008804987,0.002180391,0.0007771942,0.0000028976767,0.00012533167],"about_ca_topic_score_codex":0.0017247496,"about_ca_topic_score_gemma":0.000028729159,"teacher_disagreement_score":0.026046734,"about_ca_system_score_codex":0.00014505509,"about_ca_system_score_gemma":0.0005549424,"threshold_uncertainty_score":0.47865844},"labels":[],"label_agreement":null},{"id":"W2952720151","doi":"10.1136/annrheumdis-2019-eular.1144","title":"AB0277 EFFECT OF DISEASE DURATION AND OTHER PATIENT BASELINE CHARACTERISTICS ON OUTCOMES IN TOCILIZUMAB-TREATED RHEUMATOID ARTHRITIS PATIENTS: A POOLED ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Research in Rheumatology; Arthritis Society; Genentech; Roche Nederland; F. Hoffmann-La Roche; Dutch Arthritis Society; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Tocilizumab; Internal medicine; Observational study; Methotrexate; Logistic regression; Disease; Physical therapy","score_opus":0.00937800465936037,"score_gpt":0.27035314841859215,"score_spread":0.26097514375923175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952720151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954304,0.0020956667,0.0000036155207,0.00043300103,0.000061331324,0.001273547,0.00061552157,0.000021004389,0.000065925815],"genre_scores_gemma":[0.99439794,0.0051206527,0.000007600347,0.00022001252,0.000004005125,0.00007126133,0.00011884727,0.000024236635,0.0000354389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974364,0.0004217767,0.00092471443,0.0002781661,0.0006617068,0.00027722496],"domain_scores_gemma":[0.99786854,0.0006191749,0.00045347126,0.0006049927,0.00021886593,0.00023497139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003214798,0.0002590731,0.0010330029,0.00036980433,0.000049728777,0.000027922724,0.00013301802,0.000046186793,0.00027683814],"category_scores_gemma":[0.002070027,0.0001618438,0.0003926678,0.00046682238,0.00015295748,0.00012076795,0.000070156755,0.00009774601,0.000015518943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025106713,0.0009926632,0.9458383,0.00038155355,0.0010194543,0.0000031048012,0.00021674669,0.000028404036,0.000033496082,0.00009532441,0.00011679442,0.048763517],"study_design_scores_gemma":[0.0039674877,0.0013853312,0.989281,0.0026936587,0.00011281559,6.670568e-7,0.00005766374,0.0013138691,0.000842549,0.00012225957,0.00006467461,0.00015802833],"about_ca_topic_score_codex":0.00020583549,"about_ca_topic_score_gemma":0.000030215258,"teacher_disagreement_score":0.04860549,"about_ca_system_score_codex":0.00002073245,"about_ca_system_score_gemma":0.00006090435,"threshold_uncertainty_score":0.6599799},"labels":[],"label_agreement":null},{"id":"W2952746195","doi":"10.1136/annrheumdis-2019-eular.8709","title":"LB0005 MULTICENTRE, RANDOMISED, OPEN-LABEL, ASSESSOR-BLINDED, PARALLEL-GROUP HEAD-TO-HEAD COMPARISON OF THE EFFICACY AND SAFETY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS NAIVE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: 24-WEEK RESULTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Psoriatic arthritis; Ixekizumab; Adalimumab; Internal medicine; Psoriasis; Population; Clinical trial; Placebo; Physical therapy; Arthritis; Rheumatoid arthritis; Secukinumab; Immunology; Alternative medicine","score_opus":0.06988501346317202,"score_gpt":0.36053726891123433,"score_spread":0.2906522554480623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952746195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432386,0.0061798543,0.000019012045,0.0014315102,0.00029015448,0.00718685,0.0004664084,0.000023689236,0.000078664714],"genre_scores_gemma":[0.99544084,0.003746732,0.000396774,0.0001302655,0.000010521664,0.00014254036,0.000066800545,0.000045531277,0.00001998462],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9948781,0.0008088675,0.0018209243,0.00059244764,0.0012213282,0.0006783359],"domain_scores_gemma":[0.9945476,0.00219617,0.001004568,0.0012968417,0.00043318627,0.0005216113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074476755,0.0004570745,0.0018899745,0.0002719662,0.00019414257,0.00008005018,0.00095495913,0.00008623129,0.000046669076],"category_scores_gemma":[0.0040041427,0.0002714942,0.0002170387,0.00078598125,0.00040251325,0.00029409715,0.00060944067,0.00026608264,0.00001542746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48321623,0.016907934,0.29826182,0.002953423,0.0020133653,0.000006481048,0.007659756,0.0034522202,0.000086045824,0.000363482,0.0007972352,0.184282],"study_design_scores_gemma":[0.22262138,0.0035876317,0.75057197,0.01878147,0.00011165294,0.000001177257,0.0019788195,0.0015904569,0.00013218107,0.00019536522,0.000056509925,0.00037140065],"about_ca_topic_score_codex":0.00041819463,"about_ca_topic_score_gemma":0.0001628663,"teacher_disagreement_score":0.45231014,"about_ca_system_score_codex":0.00005708906,"about_ca_system_score_gemma":0.0003124783,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W2952793585","doi":"10.1136/annrheumdis-2019-eular.1607","title":"THU0116   COMPARATIVE SAFETY OF BIOLOGIC DMARDS AND ABATACEPT IN RHEUMATOID ARTHRITIS WITH COPD: A REAL-WORLD POPULATION-BASED OBSERVATIONAL STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Japan Society for the Promotion of Science; Pfizer Japan; Ono Pharmaceutical; AbbVie Canada; Amgen; Astellas Foundation for Research on Metabolic Disorders; Japan Blood Products Organization; McGill University; Gilead Sciences; Teijin Pharma; Pfizer; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Abatacept; Medicine; COPD; Internal medicine; Rheumatoid arthritis; Adverse effect; Hazard ratio; Observational study; Population; Propensity score matching; Physical therapy; Confidence interval","score_opus":0.08153348263112065,"score_gpt":0.34337049019174487,"score_spread":0.2618370075606242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952793585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648654,0.001110961,0.0000014321739,0.0006502665,0.00002733606,0.0013000973,0.0001707388,0.000011949532,0.00024065339],"genre_scores_gemma":[0.9987204,0.00081467413,0.00010883504,0.00012794758,0.0000029691637,0.000075238866,0.00010691123,0.000007835242,0.000035167246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873465,0.00013264673,0.0004856164,0.00019567844,0.00031769674,0.00013372998],"domain_scores_gemma":[0.99861574,0.0005379626,0.00031378568,0.00033609744,0.00012913268,0.000067265806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155196,0.00015725763,0.0006331404,0.00010027542,0.00003870892,0.000007928771,0.00008562019,0.000021891246,0.000119776705],"category_scores_gemma":[0.00008333004,0.00008920591,0.00009165098,0.0002736096,0.00009043034,0.00007377774,0.000038123984,0.000034999706,0.0000036033584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005964735,0.001989261,0.99310917,0.0001378619,0.00023069711,0.000002371397,0.00028471192,0.00035931222,0.0000032232495,0.0008992104,0.00015953416,0.0022281674],"study_design_scores_gemma":[0.0041774735,0.00064800587,0.99179435,0.0019650175,0.000047915684,0.0000015404034,0.00047703952,0.00045116004,0.00010785612,0.00022964935,0.000009636794,0.00009038163],"about_ca_topic_score_codex":0.002525676,"about_ca_topic_score_gemma":0.0011863094,"teacher_disagreement_score":0.0035810003,"about_ca_system_score_codex":0.000026902773,"about_ca_system_score_gemma":0.00016329515,"threshold_uncertainty_score":0.38180834},"labels":[],"label_agreement":null},{"id":"W2952816198","doi":"10.1136/annrheumdis-2019-eular.8097","title":"SAT0411 COMORBIDITY PATTERNS IN GOUT USING THE US GENERAL POPULATION – CLUSTER ANALYSIS OF THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2007-2016","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Comorbidity; Gout; National Health and Nutrition Examination Survey; Internal medicine; Population; Kidney disease; Diabetes mellitus; Type 2 diabetes; Hypertriglyceridemia; Obesity; Physical therapy; Environmental health; Endocrinology; Cholesterol","score_opus":0.09650187605185383,"score_gpt":0.3894386082671541,"score_spread":0.29293673221530026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952816198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973583,0.0004584664,0.000016607853,0.0012724032,0.000057679423,0.00058317184,0.0002300225,0.0000028679974,0.000020439602],"genre_scores_gemma":[0.9988313,0.00040290802,0.0000110275405,0.00047301193,0.000017102833,0.000006929499,0.0001557998,0.0000062950717,0.00009565955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981272,0.0006623599,0.00036460065,0.00012384033,0.0005875375,0.00013442445],"domain_scores_gemma":[0.99894637,0.00026371385,0.0002607692,0.0002505181,0.000230324,0.00004831319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011200418,0.00008039855,0.0002818691,0.00017734159,0.00007287415,0.000015894875,0.00012974355,0.000033235785,0.000053617914],"category_scores_gemma":[0.00042120612,0.00004107373,0.0001332381,0.00052466104,0.000065633576,0.00010199598,0.000077307726,0.00007410763,9.754693e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077073346,0.00024776228,0.9956377,0.00033231874,0.00019582409,5.975988e-8,0.00019473594,0.0005986066,0.000038226306,0.00002267059,0.0005367388,0.002118258],"study_design_scores_gemma":[0.0004518178,0.00005266967,0.95217377,0.000491819,0.00008060369,0.0000010083534,0.00007507728,0.046477083,0.00005064446,0.00009874988,0.0000072829675,0.000039496997],"about_ca_topic_score_codex":0.0057313074,"about_ca_topic_score_gemma":0.00079072185,"teacher_disagreement_score":0.045878477,"about_ca_system_score_codex":0.000049811762,"about_ca_system_score_gemma":0.00012124475,"threshold_uncertainty_score":0.866406},"labels":[],"label_agreement":null},{"id":"W2952866196","doi":"10.1136/annrheumdis-2019-eular.1820","title":"OP0252 NEUROPATHIES IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL, INCEPTION COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Autoantibody; Internal medicine; Placebo; Incidence (geometry); Disease; Immunology; Population; Cohort; Serology; Demography; Antibody; Pathology","score_opus":0.038742921181212045,"score_gpt":0.34129193405701475,"score_spread":0.3025490128758027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952866196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449545,0.00051713636,0.0000039047036,0.000559009,0.0008233772,0.0027115766,0.00016810026,0.000059853694,0.0006615859],"genre_scores_gemma":[0.99849254,0.00043119636,0.000017891587,0.00010418144,0.00005625015,0.00010573951,0.00007384311,0.00003781706,0.0006805539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963307,0.00059275056,0.0010655823,0.0004822806,0.0012439005,0.00028478628],"domain_scores_gemma":[0.99701023,0.00052695477,0.00046211568,0.0015345677,0.00031209772,0.0001540232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010496,0.0002250998,0.0007132901,0.00027198243,0.000044554836,0.000053200496,0.00070552866,0.00006385857,0.00013257077],"category_scores_gemma":[0.0017544297,0.00015029864,0.0001808725,0.00035407138,0.00009543973,0.00032006405,0.00025463157,0.00017044938,0.00015038179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008609296,0.0012005108,0.9919618,0.00058197655,0.00024546374,0.000020618147,0.0033135496,0.00011482529,0.00017824407,0.00005159602,0.0006575895,0.00081289734],"study_design_scores_gemma":[0.0046835644,0.00037780707,0.9723233,0.007323174,0.00011752432,0.00064091675,0.0108673,0.0027431531,0.00016390832,0.00054282806,0.00001982035,0.00019670239],"about_ca_topic_score_codex":0.00067163503,"about_ca_topic_score_gemma":0.000036276102,"teacher_disagreement_score":0.019638497,"about_ca_system_score_codex":0.00007250933,"about_ca_system_score_gemma":0.00016690815,"threshold_uncertainty_score":0.6129001},"labels":[],"label_agreement":null},{"id":"W2952914994","doi":"10.1136/annrheumdis-2019-eular.6039","title":"FRI0533 ETHNICITY AND NEONATAL LUPUSRISK IN A LARGE MULTI-ETHNIC COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Ethnic group; Pediatrics; Cohort; Population; Demography; Internal medicine; Environmental health","score_opus":0.05266535859376767,"score_gpt":0.3595451342462052,"score_spread":0.3068797756524375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952914994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871153,0.01028762,0.000019907719,0.0007190662,0.0001321933,0.0013339743,0.000074458796,0.00002721813,0.00029022235],"genre_scores_gemma":[0.9966474,0.0015636197,0.000056416597,0.00023406379,0.000012605689,0.000044965185,0.000009435693,0.000025223906,0.0014062381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802005,0.00021944953,0.00047774776,0.00028157522,0.00060778024,0.00039341842],"domain_scores_gemma":[0.99837,0.00039947103,0.00016240687,0.00074893853,0.00012897718,0.00019023732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074911176,0.0001706424,0.00059412647,0.00013979315,0.00003703708,0.000012349007,0.0002637726,0.00007955723,0.00024442386],"category_scores_gemma":[0.0011359848,0.00010915119,0.00018511074,0.0003315707,0.00013633117,0.00010185477,0.000277702,0.0001936049,0.00008183757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015496282,0.0003319226,0.9909994,0.0023933318,0.00015124305,0.0000087109665,0.0010924857,0.0000052705695,0.00006071315,0.000097610005,0.00086137635,0.0038429734],"study_design_scores_gemma":[0.0029189358,0.00008919343,0.9873614,0.0035134917,0.00006933156,0.00024283183,0.0013467987,0.0035345634,0.00036601225,0.0003132001,0.000104374354,0.00013991835],"about_ca_topic_score_codex":0.00023694156,"about_ca_topic_score_gemma":0.000056524448,"teacher_disagreement_score":0.009532092,"about_ca_system_score_codex":0.000028738483,"about_ca_system_score_gemma":0.00014889377,"threshold_uncertainty_score":0.44510564},"labels":[],"label_agreement":null},{"id":"W2953007060","doi":"10.1136/annrheumdis-2019-eular.2434","title":"SAT0352 THE FREQUENCY OF OCULAR MANIFESTATIONS IN PATIENTS WITH ADULT VS. CHILDHOOD SPONDYLOARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Medicine; Episcleritis; Psoriatic arthritis; Ophthalmology; Spondyloarthropathy; Arthritis; Uveitis; Internal medicine; Surgery; Scleritis","score_opus":0.007089835697571958,"score_gpt":0.2318191766995126,"score_spread":0.22472934100194064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953007060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953992,0.0015722589,6.898328e-7,0.0010613472,0.000071853465,0.0009740745,0.00023913747,0.000009582548,0.0006718687],"genre_scores_gemma":[0.999048,0.00042352613,0.000055908913,0.00031121628,0.000006076437,0.00003907749,0.00004094845,0.000016527849,0.000058739155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882346,0.000060199593,0.0003544765,0.00015479024,0.00041221955,0.00019482803],"domain_scores_gemma":[0.99886113,0.00010677977,0.00021986902,0.00052730105,0.00022842278,0.000056510606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005929014,0.00014576573,0.00035435098,0.000060200535,0.00006564356,0.000007005927,0.00015517086,0.000025003017,0.00013288959],"category_scores_gemma":[0.00019999448,0.000075748634,0.00015995433,0.00023464294,0.0001406565,0.000079593236,0.00005274116,0.000065141554,0.000019580246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014920266,0.0011609663,0.99187416,0.00016504285,0.00027572687,0.0000061630476,0.00045896738,0.000010192149,0.0000013267121,0.0008384823,0.00021991615,0.0048398483],"study_design_scores_gemma":[0.0036109928,0.00048545626,0.9924244,0.001911114,0.00013072786,0.000004721108,0.00032442107,0.000004561219,0.000057296664,0.0009561846,0.000013393407,0.00007669897],"about_ca_topic_score_codex":0.00027916083,"about_ca_topic_score_gemma":0.00010191276,"teacher_disagreement_score":0.0047631497,"about_ca_system_score_codex":0.000011154457,"about_ca_system_score_gemma":0.00007054045,"threshold_uncertainty_score":0.30889398},"labels":[],"label_agreement":null},{"id":"W2953060083","doi":"10.1136/annrheumdis-2019-eular.6889","title":"OP0183 EFFICACY AND SAFETY OF RIOCIGUAT IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE (SSC-ILD): RESULTS FROM THE PHASE IIB RISE-SSC STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Riociguat; Medicine; DLCO; Interstitial lung disease; Vital capacity; Internal medicine; Clinical endpoint; Placebo; Population; Connective tissue disease; Gastroenterology; Pulmonary function testing; Scleroderma (fungus); Diffusing capacity; Pulmonary hypertension; Lung; Pathology; Clinical trial; Disease; Chronic thromboembolic pulmonary hypertension; Lung function; Autoimmune disease","score_opus":0.01947641673136575,"score_gpt":0.26200977664753505,"score_spread":0.2425333599161693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953060083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876239,0.007427297,0.0000024437118,0.0003898331,0.00014985629,0.0030957162,0.0012670144,0.000025370302,0.000018583789],"genre_scores_gemma":[0.9981137,0.0016037538,0.000003910007,0.00010144879,0.000024475454,0.000031038933,0.000054013304,0.000034840243,0.00003281231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972232,0.00037299428,0.0009789121,0.00045656308,0.0006932034,0.00027515623],"domain_scores_gemma":[0.9969928,0.0009631461,0.00059480715,0.0009453177,0.00017292553,0.00033095543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021406905,0.0003154284,0.00079159485,0.000097776014,0.000108552274,0.000047970156,0.0003035786,0.00006403564,0.000025134415],"category_scores_gemma":[0.00078611256,0.00016263618,0.00016449614,0.00024744633,0.00030174362,0.00012872556,0.00020194937,0.00014123983,0.0000037584978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025983151,0.0062324638,0.95362735,0.0007115643,0.0010209117,0.000013546079,0.0038870669,0.000096014766,0.000062106985,0.000008862071,0.00049125357,0.0078657],"study_design_scores_gemma":[0.028696053,0.00090731203,0.94334453,0.02374273,0.0012151251,0.0000033289743,0.0014681993,0.00038684873,0.000025655858,0.000018924015,0.000002094775,0.000189221],"about_ca_topic_score_codex":0.0006274669,"about_ca_topic_score_gemma":0.000009447746,"teacher_disagreement_score":0.023031166,"about_ca_system_score_codex":0.000030229588,"about_ca_system_score_gemma":0.00011112238,"threshold_uncertainty_score":0.66321105},"labels":[],"label_agreement":null},{"id":"W2953082572","doi":"10.1136/annrheumdis-2019-eular.4598","title":"AB0278 DISCRIMINANT VALIDITY OF THE HANDGRIP STRENGTH TEST IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Research in Rheumatology; Arthritis Society; Genentech; Roche Nederland; F. Hoffmann-La Roche; Dutch Arthritis Society; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Discriminant validity; Rheumatoid arthritis; Cohort; Physical therapy; Test (biology); Internal medicine; Psychometrics; Clinical psychology; Internal consistency","score_opus":0.018848453050601854,"score_gpt":0.27126937746899243,"score_spread":0.2524209244183906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953082572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479806,0.0015694683,0.0000010218225,0.00035571275,0.00013385933,0.002763407,0.00016170878,0.000016993794,0.00019977985],"genre_scores_gemma":[0.99593234,0.0037839653,0.000011236693,0.00004975866,0.000006155243,0.000087639564,0.000013598769,0.000027701759,0.00008760533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719834,0.00028993713,0.0006689621,0.00028333685,0.0011782856,0.00038115846],"domain_scores_gemma":[0.99767953,0.00039774858,0.00037953118,0.001105022,0.00029027474,0.0001479087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004448049,0.00023856008,0.00075962493,0.00010390022,0.000098337514,0.000029494196,0.00046549446,0.000037057536,0.00016128553],"category_scores_gemma":[0.0010974507,0.00011693429,0.00023080033,0.0003699782,0.00033946603,0.00016534221,0.00020677304,0.0001750238,0.000013088932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003759974,0.004710738,0.98747844,0.00021613648,0.00022662446,0.0000016483413,0.0006044898,0.00000821792,0.000008997482,0.000077371216,0.00053277356,0.0057585896],"study_design_scores_gemma":[0.0045092735,0.0012957822,0.98712534,0.0052007562,0.00001874827,0.0000026681116,0.0008903527,0.000043401596,0.000418245,0.00031691868,0.000041575684,0.0001369187],"about_ca_topic_score_codex":0.00039629568,"about_ca_topic_score_gemma":0.00018895895,"teacher_disagreement_score":0.005621671,"about_ca_system_score_codex":0.000018695546,"about_ca_system_score_gemma":0.00022143013,"threshold_uncertainty_score":0.4768442},"labels":[],"label_agreement":null},{"id":"W2953113425","doi":"10.1136/annrheumdis-2019-eular.5323","title":"SAT0309 CLINICAL, IMAGING AND BIOLOGIC FEATURES OF SPONDYLOARTHRITIS IN AN AT-RISK POPULATION: DATA FROM THE PRE-SPA COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; UCB Pharma; Dutch Arthritis Society; Pfizer","keywords":"Medicine; Ankylosing spondylitis; Axial spondyloarthritis; Cohort; Sacroiliitis; Internal medicine; Sacroiliac joint; Population; Back pain; Physical therapy; Radiology; Pathology","score_opus":0.06124795845538585,"score_gpt":0.3704801407189748,"score_spread":0.30923218226358895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953113425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96364075,0.03323028,3.2139172e-7,0.0009562999,0.00015065458,0.00065972045,0.0012719223,0.000011558074,0.00007851883],"genre_scores_gemma":[0.98694927,0.012226932,0.00006506794,0.00028889632,0.000031253607,0.000011780709,0.00036475877,0.000011110588,0.00005091186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856305,0.00023604993,0.00049995416,0.0003140141,0.00022565576,0.00016128391],"domain_scores_gemma":[0.9977232,0.0006440886,0.00033733647,0.0011660892,0.000057647852,0.00007160329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003412805,0.00014143025,0.0005198854,0.000028331866,0.0000912431,0.000014902793,0.00029940708,0.000037400136,0.00013223515],"category_scores_gemma":[0.0006939276,0.0000760215,0.00011450824,0.00011081579,0.0002295532,0.00012504973,0.00041609452,0.00008943689,0.0000055447613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030830136,0.00026933174,0.9599551,0.000043817712,0.00019053032,0.000004648381,0.0001028741,0.0000030974757,0.000004208027,0.000023657954,0.0018750995,0.03721932],"study_design_scores_gemma":[0.0014799864,0.00017517542,0.99587387,0.0008606344,0.00021067244,0.0000060723187,0.00026134204,0.0001358559,0.000011128529,0.00077232765,0.00013884484,0.00007410043],"about_ca_topic_score_codex":0.0026112513,"about_ca_topic_score_gemma":0.0008750628,"teacher_disagreement_score":0.03714522,"about_ca_system_score_codex":0.0000072836374,"about_ca_system_score_gemma":0.000026931528,"threshold_uncertainty_score":0.3947448},"labels":[],"label_agreement":null},{"id":"W2953196368","doi":"10.1136/annrheumdis-2019-eular.5529","title":"FRI0195 EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL (DZP) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A RANDOMISED, PLACEBO (PBO)-CONTROLLED STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; CD40; Systemic lupus erythematosus; Clinical endpoint; Placebo; Prednisone; Internal medicine; Interim analysis; Immunology; Gastroenterology; Randomized controlled trial; Chemistry; Pathology","score_opus":0.01669393433511525,"score_gpt":0.28573715507178193,"score_spread":0.2690432207366667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953196368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99015653,0.0005432514,0.0000044679973,0.00038552034,0.000075627206,0.008333925,0.00012432277,0.000012266206,0.0003640596],"genre_scores_gemma":[0.99902886,0.000089405854,0.000019177567,0.00009333791,0.00000910143,0.00014781501,0.000010445047,0.000026407499,0.0005754674],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9973449,0.00036050173,0.00076404103,0.0003199278,0.0008635703,0.00034704115],"domain_scores_gemma":[0.9976215,0.0009849841,0.0003421699,0.00050157396,0.0003104823,0.00023932435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029381787,0.00028211574,0.0014035205,0.00019181977,0.0000671051,0.000018741495,0.00025661124,0.000047240716,0.00008270068],"category_scores_gemma":[0.00049575744,0.00015288059,0.0001980341,0.00026304228,0.00010613224,0.00010141298,0.00018026699,0.0001480151,0.000016156933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70016056,0.0031332714,0.28730437,0.001652021,0.0013487287,0.0000110088295,0.0029275701,0.00056375883,0.000014063342,0.00007173814,0.00017691904,0.0026359877],"study_design_scores_gemma":[0.18000916,0.0020930397,0.81181395,0.0032749595,0.00028955663,0.00003791408,0.0012848845,0.00081080396,0.00009444843,0.000079719415,0.000006918446,0.00020463413],"about_ca_topic_score_codex":0.00018544159,"about_ca_topic_score_gemma":0.000016036242,"teacher_disagreement_score":0.5245096,"about_ca_system_score_codex":0.000028033472,"about_ca_system_score_gemma":0.00018255414,"threshold_uncertainty_score":0.62342894},"labels":[],"label_agreement":null},{"id":"W2953210514","doi":"10.1136/annrheumdis-2019-eular.1762","title":"FRI0435 INFLUENCE OF BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS ON EFFICACY OF AN ORAL, SELECTIVE TYK2 INHIBITOR, BMS-986165, IN PATIENTS WITH PLAQUE PSORIASIS IN A PHASE 2 TRIAL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Medac; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Placebo; Internal medicine; Psoriasis Area and Severity Index; Psoriasis; Dermatology Life Quality Index; Clinical endpoint; Body surface area; Gastroenterology; Randomized controlled trial; Disease; Immunology; Pathology","score_opus":0.015318172423611946,"score_gpt":0.26945421504190176,"score_spread":0.2541360426182898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953210514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759364,0.00035236994,7.2814703e-7,0.000048946316,0.00011321368,0.0009829542,0.0008964375,0.00000815619,0.0000035645794],"genre_scores_gemma":[0.9995265,0.00018417815,0.000013006357,0.00004621417,0.0000056528706,0.0000319779,0.00017125033,0.0000140919365,0.000007101359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983594,0.0004911788,0.0005836581,0.00025127974,0.00010982271,0.00020465109],"domain_scores_gemma":[0.99836713,0.0005522947,0.00047578773,0.000392796,0.00014894531,0.00006302369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023939552,0.00021213558,0.0006044368,0.00023843706,0.000033803768,0.0000051921866,0.0001960679,0.0000910385,0.000022324735],"category_scores_gemma":[0.0007586966,0.0001424683,0.00010800365,0.00036778205,0.00020124918,0.00013255473,0.000048861104,0.00009362005,0.0000027000503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15315881,0.014501026,0.80290866,0.00038122048,0.00052723836,0.0000027146798,0.00061935926,0.00015778479,0.0005620474,0.00013385335,0.00005796868,0.026989287],"study_design_scores_gemma":[0.046693355,0.0023664767,0.9470224,0.0010029408,0.00021638018,2.365429e-7,0.000051994768,0.000023459013,0.0023056553,0.00015478184,0.0000057505163,0.00015661692],"about_ca_topic_score_codex":0.00008585297,"about_ca_topic_score_gemma":0.000023911793,"teacher_disagreement_score":0.14411367,"about_ca_system_score_codex":0.00001019183,"about_ca_system_score_gemma":0.00014746583,"threshold_uncertainty_score":0.58096886},"labels":[],"label_agreement":null},{"id":"W2953217707","doi":"10.1136/annrheumdis-2019-eular.5401","title":"THU0427 THE LIFETIME RISK OF KNEE AND HIP REPLACEMENT FOLLOWING A GP DIAGNOSIS OF OSTEOARTHRITIS: REAL WORLD COHORT DATA FROM CATALONIA INCLUDING 48,311 PARTICIPANTS WITH UP TO 9 YEARS OF FOLLOW-UP","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"Universidade de Brasília","keywords":"Osteoarthritis; Cohort; Medicine; Physical therapy; Knee replacement; Arthroplasty; Internal medicine; Surgery; Alternative medicine; Pathology","score_opus":0.052180960077979066,"score_gpt":0.31480970063009545,"score_spread":0.2626287405521164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953217707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936187,0.0029178336,0.000001901401,0.00025985064,0.00026212167,0.0015840323,0.0012584241,0.000014112678,0.000082983825],"genre_scores_gemma":[0.99855804,0.00067939627,0.0001460371,0.00006826039,0.000014724575,0.000100351295,0.00012581806,0.000028841105,0.00027855547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979421,0.00014020441,0.0006605547,0.000345035,0.00063326355,0.00027883687],"domain_scores_gemma":[0.99701107,0.0006278567,0.00056667184,0.0015259174,0.00009931571,0.00016917905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000544315,0.00020014112,0.00081210816,0.00009801003,0.00005918336,0.000013586231,0.0003583647,0.000036836424,0.00007095554],"category_scores_gemma":[0.0006660846,0.0001269784,0.00018724911,0.0002695543,0.00012693275,0.00014477504,0.0004513568,0.000070942915,0.000008785922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015069183,0.00030779204,0.97479224,0.00028306982,0.001259315,0.000005684393,0.001778016,0.0000073926713,0.00048924016,0.000046858917,0.0013273286,0.018196153],"study_design_scores_gemma":[0.010517294,0.0037062764,0.9283295,0.016238917,0.004878914,0.0000031980721,0.0025932856,0.00008544048,0.032637287,0.0005611896,0.00011933449,0.000329333],"about_ca_topic_score_codex":0.0021275077,"about_ca_topic_score_gemma":0.0006693996,"teacher_disagreement_score":0.0464627,"about_ca_system_score_codex":0.00001276212,"about_ca_system_score_gemma":0.00012305456,"threshold_uncertainty_score":0.5178029},"labels":[],"label_agreement":null},{"id":"W2953226909","doi":"10.1136/annrheumdis-2019-eular.4302","title":"FRI0178 CLUSTER PROFILING OF PATIENTS IN A REAL-WORLD DATA SET WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THEIR ASSOCIATED TREATMENTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cluster (spacecraft); Internal medicine; Rheumatoid arthritis","score_opus":0.06282818663445129,"score_gpt":0.33480741057063507,"score_spread":0.2719792239361838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953226909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959907,0.00061041676,0.0000015505881,0.00015925197,0.00006992717,0.0022383928,0.0006319548,0.000022206994,0.0002756148],"genre_scores_gemma":[0.99881977,0.00030285548,0.000029199558,0.000033653418,0.000005817758,0.00004630602,0.00017704528,0.000037948368,0.00054739293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976848,0.00030000857,0.0007027681,0.00035582745,0.00061988103,0.00033673836],"domain_scores_gemma":[0.9970147,0.0005641509,0.00062872167,0.0014127359,0.0002513941,0.00012830623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000539767,0.00023966153,0.00093865744,0.00022288536,0.000033646742,0.00001696571,0.00044604257,0.000047117537,0.000015648433],"category_scores_gemma":[0.0005074805,0.00012550179,0.00008319201,0.00047848557,0.00015182115,0.00015964705,0.00036970474,0.000101763464,0.0000075935827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006721181,0.00056602,0.991277,0.004515937,0.000609298,0.0000024425624,0.0011168733,0.000011277997,0.00003013246,0.000019174577,0.0005648117,0.000614923],"study_design_scores_gemma":[0.013651971,0.0008656066,0.9335054,0.036826555,0.00044142097,0.00036100176,0.0065750536,0.006273732,0.00089418644,0.00023894553,0.000006583425,0.00035951057],"about_ca_topic_score_codex":0.00057310035,"about_ca_topic_score_gemma":0.0001773965,"teacher_disagreement_score":0.057771556,"about_ca_system_score_codex":0.00006225191,"about_ca_system_score_gemma":0.00019298185,"threshold_uncertainty_score":0.5117814},"labels":[],"label_agreement":null},{"id":"W2953232262","doi":"10.1136/annrheumdis-2019-eular.4977","title":"AB1304 THE RHEUMATOID ARTHRITIS FLARE QUESTIONNAIRE (RA-FQ) IS AN EASY TO ADMINISTER PATIENT-REPORTED OUTCOME MEASURE THAT TRACKS WELL WITH THE CLINICAL DISEASE ACTIVITY INDEX (CDAI) OVER TIME IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (ERA) IN 2 DIFFERENT HEALTH SETTINGS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Canadian Rheumatology Association; Université Laval; University of Manitoba; Université de Sherbrooke; University of Calgary; McGill University; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Concordance; Internal medicine; Physical therapy; Intraclass correlation; Rheumatology; Cohort; Observational study; Psychometrics","score_opus":0.029202061049656263,"score_gpt":0.30983753329645336,"score_spread":0.2806354722467971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953232262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748935,0.0038016967,0.000013255067,0.016312327,0.00016084441,0.0044253664,0.00028294578,0.000077718985,0.00003233512],"genre_scores_gemma":[0.99196553,0.0044734585,0.000013044108,0.0029910188,0.000022269607,0.0002927391,0.000060079525,0.00010995143,0.00007191742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992639,0.0014493194,0.0015579307,0.00090897986,0.0023832258,0.0010615418],"domain_scores_gemma":[0.99501425,0.0005016092,0.001032701,0.0020031878,0.00042285986,0.0010254086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001182037,0.00071858417,0.001603517,0.00025918664,0.0003558536,0.00022530342,0.00073069794,0.00014079724,0.0003095348],"category_scores_gemma":[0.00065138354,0.00035712728,0.0004576657,0.00062803377,0.00059738685,0.00066640496,0.0002540236,0.0008639859,0.00005872377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058168825,0.0024764657,0.91266066,0.00021267046,0.0003128907,0.000028586106,0.001876451,0.000024406268,0.0000013397888,0.000019702615,0.0019217243,0.07464821],"study_design_scores_gemma":[0.0075121014,0.0024148615,0.97523147,0.013230667,0.00001193897,0.00002035537,0.00039908095,0.00020887604,0.000024324625,0.0001630388,0.000336476,0.00044679057],"about_ca_topic_score_codex":0.00075316173,"about_ca_topic_score_gemma":0.0011525252,"teacher_disagreement_score":0.07420141,"about_ca_system_score_codex":0.000103526814,"about_ca_system_score_gemma":0.000773259,"threshold_uncertainty_score":0.99988806},"labels":[],"label_agreement":null},{"id":"W2953283032","doi":"10.1136/annrheumdis-2019-eular.6404","title":"AB0452 SYSTEMATIC REVIEW OF GUIDELINES ON THE USE OF METHOTREXATE IN RHEUMATOID ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Guideline; Rheumatoid arthritis; Methotrexate; Internal medicine; Family medicine; Pathology","score_opus":0.16022306344999146,"score_gpt":0.38500310103725277,"score_spread":0.2247800375872613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953283032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8670398,0.12317463,0.0000066332127,0.0053317645,0.00010381752,0.0039139413,0.000093309936,0.00001618867,0.00031991728],"genre_scores_gemma":[0.8296009,0.16766664,0.00015433299,0.0019435225,0.0000069270636,0.00010637735,0.000008020166,0.00003285787,0.00048046536],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961069,0.00060139596,0.0017455993,0.00020012815,0.0010827967,0.00026313405],"domain_scores_gemma":[0.99415743,0.0025537785,0.0008883755,0.0016822546,0.0006270046,0.00009116103],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016322203,0.00019722231,0.0014801569,0.00012506937,0.000021944561,0.0000100171155,0.0005126048,0.000046348214,0.0003197062],"category_scores_gemma":[0.017600443,0.000096413874,0.0004877562,0.00052601757,0.00020793232,0.00009025756,0.00016934576,0.00011338814,0.00004391918],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002695077,0.00061593944,0.001097299,0.9703308,0.00070473127,0.000008784016,0.00034532062,0.00027430308,0.00010584389,0.002320751,0.021196933,0.0027297998],"study_design_scores_gemma":[0.0023876554,0.00018154467,0.0015588637,0.9890697,0.00015925527,0.00002918803,0.00019563167,0.0034665074,0.0021928172,0.0005302002,0.00010621957,0.0001224046],"about_ca_topic_score_codex":0.000448761,"about_ca_topic_score_gemma":0.000009061333,"teacher_disagreement_score":0.044492006,"about_ca_system_score_codex":0.00018720276,"about_ca_system_score_gemma":0.0013755162,"threshold_uncertainty_score":0.99067473},"labels":[],"label_agreement":null},{"id":"W2953300791","doi":"10.1136/annrheumdis-2019-eular.6108","title":"SAT0373 EFFECT OF FILGOTINIB ON PATIENT-REPORTED OUTCOMES IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Randomized controlled trial; Internal medicine; Physical therapy; Arthritis","score_opus":0.022951180376594434,"score_gpt":0.32965062078744806,"score_spread":0.3066994404108536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953300791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245864,0.001526467,3.4037313e-7,0.00027429787,0.0003057561,0.0044502425,0.00067752186,0.000020380141,0.00028637468],"genre_scores_gemma":[0.99917656,0.00035577253,0.000010212776,0.00008955842,0.000009191905,0.00022101229,0.00006528433,0.00002118507,0.00005121733],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970617,0.00055638497,0.0011811833,0.00032998982,0.00062844815,0.00024224463],"domain_scores_gemma":[0.99499303,0.0031746353,0.000859684,0.0007667734,0.00010705007,0.00009881577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003827328,0.00028702008,0.0019427574,0.00012595774,0.000042933218,0.000008794022,0.00013039433,0.00004267495,0.00010247133],"category_scores_gemma":[0.00514259,0.00016211896,0.0005506646,0.00021014913,0.00011226194,0.000068547066,0.00008854118,0.00009578728,0.000023256127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48941514,0.021221064,0.20089923,0.00037971252,0.009477557,0.0001470956,0.00662233,0.000045313787,0.000018282417,0.000043970682,0.00050866307,0.27122164],"study_design_scores_gemma":[0.6771692,0.0073201796,0.3046552,0.005141669,0.0011634789,0.0000023208165,0.0016571115,0.00010579865,0.0019674122,0.0006039573,0.0000062410813,0.00020741014],"about_ca_topic_score_codex":0.0010804478,"about_ca_topic_score_gemma":0.000041850926,"teacher_disagreement_score":0.2710142,"about_ca_system_score_codex":0.000023873363,"about_ca_system_score_gemma":0.00005928547,"threshold_uncertainty_score":0.6611019},"labels":[],"label_agreement":null},{"id":"W2953377481","doi":"10.1136/annrheumdis-2019-eular.2122","title":"SAT0279 MULTICENTER DOUBLE-BLIND, PROOF-OF-CONCEPT, RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RIOCIGUAT IN SYSTEMIC SCLEROSIS-ASSOCIATED DIGITAL ULCERS (RESCUE)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; CSL Behring; University of Connecticut; Genentech; Acceleron; University of Michigan; Cumberland Pharmaceuticals; Pfizer","keywords":"Riociguat; Medicine; Proof of concept; Placebo; Double blind; Randomized controlled trial; Scleroderma (fungus); Internal medicine; Pulmonary hypertension; Pathology; Chronic thromboembolic pulmonary hypertension; Alternative medicine","score_opus":0.04173568707658423,"score_gpt":0.2919737310766453,"score_spread":0.2502380440000611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953377481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765575,0.009127907,0.0000029639828,0.0002743567,0.0005839295,0.012796062,0.00013428678,0.000031310334,0.0004916862],"genre_scores_gemma":[0.9982645,0.0007502525,0.0000037139969,0.000060255003,0.000030998206,0.00039779802,0.000045064742,0.000040666226,0.0004067595],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953574,0.00064432324,0.0023378695,0.00033501463,0.00094238104,0.00038302245],"domain_scores_gemma":[0.995477,0.0015148276,0.0016617521,0.0007689673,0.0003839958,0.00019344824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010982964,0.00035354178,0.0029578772,0.00025998498,0.000038418068,0.000030497265,0.00040937006,0.00019400625,0.000115639705],"category_scores_gemma":[0.0025322463,0.00020472784,0.0017353557,0.0004114452,0.0003503653,0.00019371715,0.00010695642,0.0001571951,0.00001073488],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98585266,0.0029989888,0.002481145,0.0013352623,0.0024698575,0.0000011238619,0.000913657,0.0006005433,0.00031078857,0.000037412603,0.00024359093,0.002754989],"study_design_scores_gemma":[0.962349,0.0003258017,0.0018235266,0.028181853,0.0012464443,0.0000018924391,0.0010430113,0.0013784523,0.0033933967,0.000059898295,8.3334663e-7,0.00019586738],"about_ca_topic_score_codex":0.00019347943,"about_ca_topic_score_gemma":0.0000039085216,"teacher_disagreement_score":0.02684659,"about_ca_system_score_codex":0.00005909452,"about_ca_system_score_gemma":0.0003564866,"threshold_uncertainty_score":0.8348559},"labels":[],"label_agreement":null},{"id":"W2953380780","doi":"10.1136/annrheumdis-2019-eular.7372","title":"OP0165 EULAR RECOMMENDATIONS FOR THE DIAGNOSIS AND THE MANAGEMENT OF RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS DUE TO CANCER IMMUNOTHERAPY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clinical trial; Referral; Intensive care medicine; Adverse effect; Population; Physical therapy; Internal medicine; Family medicine","score_opus":0.030474917689818005,"score_gpt":0.3306731788076109,"score_spread":0.30019826111779285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953380780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93643624,0.012436303,0.00015303574,0.045497864,0.00031586646,0.004897104,0.00012848797,0.000035387886,0.00009973558],"genre_scores_gemma":[0.9762905,0.020730408,0.00026320314,0.001291996,0.0000067646506,0.000724999,0.000010225467,0.00004975228,0.000632125],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983347,0.00015149488,0.00074430596,0.0001997145,0.00034030026,0.00022946208],"domain_scores_gemma":[0.9973317,0.0010238342,0.00049326336,0.0009391416,0.0001422571,0.000069842376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065202155,0.0002050998,0.00055513077,0.0000651221,0.0001406948,0.0000090096155,0.00044791106,0.000050778875,0.00049419596],"category_scores_gemma":[0.00016531079,0.0001017355,0.00044854285,0.00032734525,0.00018380779,0.00007436869,0.00012960141,0.000104415405,0.000010009826],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010752237,0.005443301,0.046369947,0.011853075,0.05144037,0.0000045743905,0.023301337,0.005949631,0.0007093798,0.014511674,0.040746618,0.78891784],"study_design_scores_gemma":[0.03886938,0.0007703379,0.8468442,0.038324285,0.00514934,0.000026819875,0.007295239,0.011424324,0.011920817,0.031274572,0.007110867,0.0009898127],"about_ca_topic_score_codex":0.0003156775,"about_ca_topic_score_gemma":0.000005531794,"teacher_disagreement_score":0.8004743,"about_ca_system_score_codex":0.000029628736,"about_ca_system_score_gemma":0.00005189863,"threshold_uncertainty_score":0.5411099},"labels":[],"label_agreement":null},{"id":"W2953889774","doi":"10.1136/annrheumdis-2019-215356","title":"The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Celgene; Novartis Pharmaceuticals Corporation; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Enthesitis; Ankylosing spondylitis; Psoriasis; Disease; Immunology; Interleukin 23; Interleukin 17; Dermatology; Immune system; Pathology","score_opus":0.025860194830817473,"score_gpt":0.2849888468299404,"score_spread":0.25912865199912294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953889774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048926678,0.9928247,9.707046e-8,0.000097314565,0.00046156862,0.0007189575,0.00089958153,0.0000073816987,0.00009778141],"genre_scores_gemma":[0.0050029582,0.9947081,0.0000024104932,0.000015693531,0.000013326769,0.00007111226,0.000055326833,0.000015083195,0.00011597787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829113,0.00054018176,0.0006278183,0.00022643885,0.00006530753,0.00024913836],"domain_scores_gemma":[0.9970814,0.0018576388,0.00061396457,0.0003708761,0.000051946703,0.000024196177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023319786,0.00027888617,0.0013510772,0.00008069911,0.00011875137,0.000018038363,0.0002694887,0.00014804552,0.000038937098],"category_scores_gemma":[0.0005867802,0.00015620871,0.000286029,0.00012517715,0.0004133192,0.000086443804,0.00013618123,0.00009923551,0.00001203526],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008952758,0.00008554916,0.00012989838,0.0027286534,0.00053488195,7.058123e-7,0.0000991113,1.9357742e-7,9.436503e-7,0.00043804492,0.00018755876,0.99570495],"study_design_scores_gemma":[0.001264506,0.00017228964,0.00088491116,0.017950092,0.0009871353,0.000022202832,0.00038471358,4.660782e-7,0.000051581716,0.0026049535,0.9754591,0.00021805313],"about_ca_topic_score_codex":0.000031277377,"about_ca_topic_score_gemma":0.000052758616,"teacher_disagreement_score":0.99548686,"about_ca_system_score_codex":0.000008353523,"about_ca_system_score_gemma":0.00012077401,"threshold_uncertainty_score":0.6370006},"labels":[],"label_agreement":null},{"id":"W2954920148","doi":"10.1136/annrheumdis-2019-eular.1800","title":"AB0752 DRUG RETENTION AND REMISSION RATES IN 14,261 BIOLOGIC-NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS STARTING TNF INHIBITOR TREATMENT IN ROUTINE CARE – RESULTS FROM 12 REGISTRIES IN THE EUROSPA RESEARCH COLLABORATION","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; University of Toronto; Janssen Research and Development; University of Leeds; University of Rochester; Hôpitaux Universitaires de Genève; Celgene; Sanofi; Pfizer; Medical Center, University of Rochester; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Internal medicine; TNF inhibitor; Observational study; Randomized controlled trial; Arthritis; Physical therapy; Adalimumab; Rheumatoid arthritis","score_opus":0.035020252617255825,"score_gpt":0.32501984120301736,"score_spread":0.2899995885857615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954920148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98503965,0.009535554,1.908784e-7,0.0031754372,0.00006438822,0.0018149875,0.0002539083,0.000011056958,0.00010483547],"genre_scores_gemma":[0.9843451,0.015137726,0.000029029028,0.000041261123,0.000018069666,0.0000835275,0.00027184407,0.000013949335,0.0000594846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969805,0.0010201479,0.00064422714,0.0003397788,0.00066807005,0.00034728614],"domain_scores_gemma":[0.99799716,0.0008743651,0.00024819153,0.0004702868,0.00032664792,0.00008335995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009473355,0.00017602085,0.0004183191,0.00020479376,0.000117930365,0.00008695407,0.0001541271,0.000052981537,0.000014759127],"category_scores_gemma":[0.0026211368,0.00009406541,0.00005141967,0.0005824047,0.00020749126,0.00022911889,0.00007070514,0.00018396409,0.0000035945857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069334228,0.0008527677,0.9281959,0.00024516287,0.000051985837,0.000017198954,0.017045109,0.00005132673,0.00010806271,0.00007358629,0.0009460366,0.045479473],"study_design_scores_gemma":[0.0097566815,0.0013023909,0.9569337,0.00913439,0.0000064587175,7.861024e-7,0.019332537,0.00019135697,0.0013709017,0.001697755,0.00013878725,0.00013424995],"about_ca_topic_score_codex":0.0022080103,"about_ca_topic_score_gemma":0.003130925,"teacher_disagreement_score":0.045345224,"about_ca_system_score_codex":0.00007868276,"about_ca_system_score_gemma":0.00019724967,"threshold_uncertainty_score":0.38358763},"labels":[],"label_agreement":null},{"id":"W2954962845","doi":"10.1136/annrheumdis-2019-215762","title":"Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?‘ by Tian et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Osteoarthritis; Interphalangeal Joint; Dermatology; Arthritis; Psoriasis; Pathology; Internal medicine; Surgery; Alternative medicine","score_opus":0.021280709007730728,"score_gpt":0.28605706219303517,"score_spread":0.26477635318530446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954962845","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24286029,0.015657026,0.000002890033,0.72716373,0.0010992283,0.0014752712,0.011504903,0.00006140708,0.00017527665],"genre_scores_gemma":[0.14435764,0.005834124,0.000056967277,0.8442711,0.00016559538,0.00022614676,0.0023697922,0.00016273536,0.0025559037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611926,0.00061028375,0.0008275582,0.0006886295,0.0010712565,0.0006829827],"domain_scores_gemma":[0.9965074,0.0011334273,0.0005188512,0.0014304457,0.00017368776,0.00023619825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002028618,0.0006550644,0.0014833655,0.00018435171,0.00015461247,0.00008441714,0.00045575688,0.00024898787,0.0005412651],"category_scores_gemma":[0.0010619377,0.000483657,0.00084112916,0.0002554777,0.00020943188,0.0000731093,0.00031164562,0.00044497338,0.00021520031],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011949771,0.00028484716,0.0006316544,0.00020060282,0.001988552,0.00015890693,0.00018765412,3.782399e-7,0.000049277995,0.0000020064397,0.964497,0.030804126],"study_design_scores_gemma":[0.00888776,0.0017523962,0.049815685,0.01890875,0.001150309,0.00003724928,0.00017250577,0.0000071893714,0.0004124028,0.0006372176,0.917329,0.000889513],"about_ca_topic_score_codex":0.0005544302,"about_ca_topic_score_gemma":0.000057945897,"teacher_disagreement_score":0.1171074,"about_ca_system_score_codex":0.000055915792,"about_ca_system_score_gemma":0.0002299245,"threshold_uncertainty_score":0.9997615},"labels":[],"label_agreement":null},{"id":"W2955724587","doi":"10.1136/annrheumdis-2019-eular.496","title":"SAT0605 BODY MASS INDEX AND SYSTEMIC CORTICOSTEROID USE AS INDICATORS OF DISEASE BURDEN AND THEIR INFLUENCE ON THE SAFETY PROFILE OF CERTOLIZUMAB PEGOL ACROSS INDICATIONS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Genentech; Medac; Gilead Sciences; Servier; Celltrion; Regeneron Pharmaceuticals; Mylan; Amgen; Atlantic Healthcare; Eli Lilly and Company; Purdue Pharma; Dermira; UCB Pharma; Valeant Pharmaceuticals International; Pfizer; Biogen; Celgene; Nordic Pharma Group; Purdue University; Sanofi; Tillotts Pharma; Allergan; Seres Therapeutics; Galderma; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Certolizumab pegol; Psoriatic arthritis; Internal medicine; Psoriasis; Adverse effect; Body mass index; Rheumatoid arthritis; Comorbidity; Etanercept; Immunology","score_opus":0.022899281835568372,"score_gpt":0.3096321335340153,"score_spread":0.2867328516984469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955724587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375623,0.0014497519,0.000005021137,0.0017693567,0.000040138584,0.002305311,0.0005501455,0.000017709785,0.00010634156],"genre_scores_gemma":[0.9988004,0.00075173686,0.000004007729,0.00006275659,0.000011165281,0.00009671913,0.000013489628,0.000029465637,0.00023027578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752927,0.00031215226,0.0008112584,0.00029179774,0.00074904424,0.00030649404],"domain_scores_gemma":[0.9959804,0.0014216999,0.0008067942,0.0012421206,0.00026339936,0.0002856103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002813148,0.00023021693,0.00065464515,0.00016862708,0.00011398804,0.000034053435,0.00044205418,0.00007194562,0.000059639344],"category_scores_gemma":[0.0022745149,0.00012005218,0.00016224135,0.00039201239,0.0006658948,0.00015490469,0.0002850457,0.00015909976,0.000012915977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013862406,0.00021207985,0.9825673,0.0068149366,0.0004475936,0.000003794966,0.0036959448,0.00001767146,0.0016597013,0.000831392,0.00014084762,0.002222482],"study_design_scores_gemma":[0.0017517402,0.00032266692,0.97421104,0.012640827,0.0001578625,0.00029000916,0.0066280775,0.0006044041,0.002466717,0.00072756375,0.000021139638,0.00017795386],"about_ca_topic_score_codex":0.00015224193,"about_ca_topic_score_gemma":0.0000014182377,"teacher_disagreement_score":0.008356277,"about_ca_system_score_codex":0.000030302175,"about_ca_system_score_gemma":0.00036114198,"threshold_uncertainty_score":0.48955858},"labels":[],"label_agreement":null},{"id":"W2961584204","doi":"10.1136/annrheumdis-2019-215211","title":"Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Macrophage activation syndrome; Arthritis; Receiver operating characteristic; Internal medicine; Population; Tocilizumab; Physical therapy; Rheumatoid arthritis","score_opus":0.041300777939439204,"score_gpt":0.3067967073491443,"score_spread":0.2654959294097051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961584204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961902,0.0022583948,0.000009978531,0.00031949425,0.00004392965,0.0011157517,0.00002591199,0.0000040925165,0.000032250457],"genre_scores_gemma":[0.99936885,0.00039886983,0.000016840364,0.000027742348,0.0000028059756,0.00012647238,0.000009751958,0.000009840711,0.00003884575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988002,0.00008845543,0.00059071527,0.00009903051,0.00030615326,0.00011542196],"domain_scores_gemma":[0.9990699,0.00014207087,0.00036956795,0.00026151608,0.00013017438,0.000026726872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003843079,0.00008021566,0.00039235997,0.000081327606,0.000037461225,0.0000057584293,0.00013145016,0.000040226132,0.000031380474],"category_scores_gemma":[0.0005869566,0.000050871295,0.0001005245,0.00016890804,0.00007761913,0.00009986003,0.000074066484,0.00005450339,0.0000015905091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008142441,0.0012422221,0.8085212,0.030568736,0.00041877487,0.0000036558226,0.005677362,0.00031771694,0.008031995,0.0008832863,0.00040257492,0.14311825],"study_design_scores_gemma":[0.0018707849,0.0002121222,0.78828895,0.020215012,0.000041730364,0.0000120068435,0.00092934654,0.00020196236,0.1875574,0.0005400904,0.000036266374,0.00009434626],"about_ca_topic_score_codex":0.00004485173,"about_ca_topic_score_gemma":0.000003023605,"teacher_disagreement_score":0.17952539,"about_ca_system_score_codex":0.00001622772,"about_ca_system_score_gemma":0.00024844208,"threshold_uncertainty_score":0.20744711},"labels":[],"label_agreement":null},{"id":"W2965035961","doi":"10.1136/annrheumdis-2019-215764","title":"Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"AbbVie","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Methotrexate; Antirheumatic Agents; Internal medicine; Arthritis; Surgery","score_opus":0.011760363529995608,"score_gpt":0.2755415480654439,"score_spread":0.2637811845354483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965035961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952931,0.0012116613,0.000016136812,0.00015450452,0.000043621578,0.0030236754,0.00020372334,0.000017095319,0.00003650913],"genre_scores_gemma":[0.9959913,0.003622574,0.0000920529,0.00010128889,0.0000020244029,0.00008548165,0.000027926428,0.000053572705,0.000023797822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658227,0.00078904734,0.0006288201,0.00042794907,0.0010867101,0.00048521056],"domain_scores_gemma":[0.99754524,0.0007722772,0.00032743142,0.0006603039,0.000448088,0.00024666847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008358725,0.00034610328,0.0010392022,0.00036583218,0.00005960348,0.000033699693,0.00025633318,0.000051577685,0.00009317559],"category_scores_gemma":[0.00041880013,0.0001807405,0.000074333984,0.0007585648,0.000259468,0.00023747176,0.000113583796,0.00017284178,0.0000045603906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22952001,0.0015702671,0.74946636,0.0003458009,0.00028795275,0.000008287077,0.00095160946,0.00031266682,0.000021389724,0.000048020527,0.000014398557,0.017453225],"study_design_scores_gemma":[0.036571607,0.0073540304,0.9405309,0.014295055,0.000005947653,0.0000037519637,0.00019244564,0.00006785925,0.00064314465,0.000049192524,0.00004398488,0.00024211155],"about_ca_topic_score_codex":0.00045626183,"about_ca_topic_score_gemma":0.0001427303,"teacher_disagreement_score":0.1929484,"about_ca_system_score_codex":0.000058848018,"about_ca_system_score_gemma":0.00038092353,"threshold_uncertainty_score":0.7370384},"labels":[],"label_agreement":null},{"id":"W2965479220","doi":"10.1136/annrheumdis-2019-215294","title":"Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Versus Arthritis; National Institute for Health and Care Research; Arthritis Society; Manchester Biomedical Research Centre; AbbVie","keywords":"Medicine; Rheumatoid arthritis; Sick leave; Physical therapy; Work (physics); Family medicine; Internal medicine","score_opus":0.019163887343405357,"score_gpt":0.2623872922033753,"score_spread":0.24322340485996996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965479220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942422,0.0024285659,0.000006442388,0.00022624871,0.00014328657,0.0024167378,0.00026150266,0.00008738604,0.00018762934],"genre_scores_gemma":[0.99606395,0.0035294553,0.00006434412,0.00007456404,0.000010345084,0.000061046376,0.00009666252,0.000056269804,0.0000433461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650097,0.00056802464,0.0008513185,0.00053489825,0.0010612994,0.00048347338],"domain_scores_gemma":[0.9970927,0.0007571681,0.00048583368,0.0009948325,0.00037228563,0.00029715567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037500824,0.00037915743,0.00089230866,0.000089304005,0.0003275001,0.00015447795,0.00032419618,0.000049550814,0.00025624706],"category_scores_gemma":[0.0010623574,0.00022704035,0.00015893075,0.000334597,0.000856377,0.00049217796,0.00029792578,0.00016333113,0.000030360732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015548532,0.0016440452,0.9773643,0.00019240406,0.0004967415,0.000004068208,0.002113366,0.000026383601,5.835826e-7,0.00004198838,0.00043302978,0.016128223],"study_design_scores_gemma":[0.0060080006,0.0007557532,0.98543036,0.0059975022,0.00002253285,0.000001906282,0.0010523984,0.000046926605,0.000025665078,0.00031170275,0.00007750639,0.00026976183],"about_ca_topic_score_codex":0.0005049058,"about_ca_topic_score_gemma":0.00015582626,"teacher_disagreement_score":0.015858462,"about_ca_system_score_codex":0.00003150609,"about_ca_system_score_gemma":0.0000930121,"threshold_uncertainty_score":0.92584366},"labels":[],"label_agreement":null},{"id":"W2965737655","doi":"10.1136/annrheumdis-2019-215724","title":"Risk of gout flares after vaccination: a prospective case cross-over study","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Medicine; Gout; Prospective cohort study; Vaccination; Reactive arthritis; Arthritis; Internal medicine; Immunology","score_opus":0.015052840911820691,"score_gpt":0.3263511965841137,"score_spread":0.311298355672293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965737655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955824,0.0015923063,0.00000703284,0.00016864958,0.00014403703,0.0017434756,0.00018204414,0.000029265793,0.00055079075],"genre_scores_gemma":[0.99863505,0.000062451036,0.000042673346,0.00012300628,0.000028720433,0.000087902496,0.000002826076,0.000026081923,0.0009912913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982563,0.00014901566,0.0005223739,0.00026914375,0.0005938549,0.00020929928],"domain_scores_gemma":[0.997821,0.00026502076,0.0004511735,0.000971538,0.00037551232,0.00011576998],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029834345,0.00019692522,0.0005248056,0.000090273934,0.000060926766,0.000021985985,0.00020802295,0.000050499366,0.001069269],"category_scores_gemma":[0.0011245945,0.00012320043,0.0003004862,0.0002908132,0.000082650186,0.00017965032,0.00017630451,0.00012678164,0.000055982768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006275724,0.0015026972,0.99119085,0.00055231666,0.0008832619,0.000073985815,0.0025990005,0.00004383554,0.000009000764,0.000030008641,0.0007517381,0.0017357131],"study_design_scores_gemma":[0.0022896205,0.0004956131,0.99301624,0.00035116402,0.00077121955,0.00007815758,0.0015455362,0.00021240606,0.00037655028,0.00072148343,0.000017049826,0.00012496444],"about_ca_topic_score_codex":0.0003075743,"about_ca_topic_score_gemma":0.000016790213,"teacher_disagreement_score":0.003052649,"about_ca_system_score_codex":0.000027851665,"about_ca_system_score_gemma":0.00011026629,"threshold_uncertainty_score":0.9998439},"labels":[],"label_agreement":null},{"id":"W2966041078","doi":"10.1136/annrheumdis-2018-214819","title":"2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1504,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research; McMaster University; University of Calgary; Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; European League Against Rheumatism; Academy of Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Rheumatism; Rheumatology; League; Internal medicine; Dermatology; Family medicine","score_opus":0.12211828306950487,"score_gpt":0.39504094902098286,"score_spread":0.27292266595147796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966041078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009251906,0.9771177,0.000105259074,0.00042262598,0.0009912665,0.008147129,0.0033296826,0.00009624314,0.00053816155],"genre_scores_gemma":[0.018260278,0.97818613,0.00017348072,0.000048517522,0.000039756054,0.0004867285,0.0004982261,0.00029187443,0.0020149825],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99147284,0.0020057622,0.0037686073,0.00084589317,0.0011034333,0.00080348016],"domain_scores_gemma":[0.98776484,0.0030015658,0.0049033808,0.003026574,0.0009587486,0.00034488246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017919083,0.0008907226,0.006900043,0.0006893551,0.00013425796,0.000031712905,0.0016180776,0.0002687515,0.000056073724],"category_scores_gemma":[0.0030061374,0.00058130786,0.002452832,0.0009478126,0.0007879576,0.0001211203,0.00037131776,0.00034179064,0.00021329352],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026480888,0.0006639776,0.001880743,0.6261421,0.0028993974,0.0000127322755,0.00039365154,0.0000028912716,0.000008571672,0.0018943407,0.09664452,0.26919228],"study_design_scores_gemma":[0.003806584,0.00078071805,0.00025258178,0.8482732,0.0051062284,0.03004836,0.0028461795,0.0007278566,0.000013389291,0.00031576576,0.10650861,0.0013205158],"about_ca_topic_score_codex":0.000055426735,"about_ca_topic_score_gemma":0.0000025764332,"teacher_disagreement_score":0.26787177,"about_ca_system_score_codex":0.00015619207,"about_ca_system_score_gemma":0.0015159621,"threshold_uncertainty_score":0.99966383},"labels":[],"label_agreement":null},{"id":"W2968387223","doi":"10.1136/annrheumdis-2019-215803","title":"2019 EULAR recommendations for the generic core competences of health professionals in rheumatology","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Leids Universitair Medisch Centrum; European League Against Rheumatism; Universiteit Leiden; King's College London","keywords":"Medicine; Rheumatology; Health professionals; Core (optical fiber); Internal medicine; Family medicine; Medical education; Physical therapy; Health care","score_opus":0.06734780256851619,"score_gpt":0.38586146000106586,"score_spread":0.31851365743254967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968387223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91758,0.008364958,0.00007784211,0.071880996,0.0002822001,0.0016932191,0.00007520402,0.000006716144,0.000038831393],"genre_scores_gemma":[0.99754345,0.0011267468,0.00026732346,0.00072124274,0.000002890971,0.000076181925,0.000050344148,0.000008309619,0.00020349558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988431,0.0001524225,0.00056183327,0.000116178795,0.00018081056,0.00014570069],"domain_scores_gemma":[0.9981632,0.00093079905,0.0004093723,0.00032801027,0.00013279221,0.000035830366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046660964,0.000083995204,0.00040500055,0.000064826294,0.00006815273,0.0000026910757,0.00016864511,0.000028980598,0.0001567366],"category_scores_gemma":[0.00048379303,0.000041295927,0.00021405464,0.00019731956,0.00012523143,0.00004346707,0.00004148136,0.000049533373,0.0000048486936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005744139,0.0046819337,0.514505,0.025575152,0.0008348953,1.52906e-7,0.006321797,0.00083312707,0.00020384579,0.03423209,0.2106337,0.2016039],"study_design_scores_gemma":[0.0013080287,0.00049130095,0.9731012,0.0042960253,0.00006063889,0.000001937528,0.005912971,0.0038483406,0.000041321404,0.010021124,0.000812916,0.00010417515],"about_ca_topic_score_codex":0.00024265413,"about_ca_topic_score_gemma":0.00001393713,"teacher_disagreement_score":0.45859623,"about_ca_system_score_codex":0.0000070154174,"about_ca_system_score_gemma":0.00021600188,"threshold_uncertainty_score":0.17161559},"labels":[],"label_agreement":null},{"id":"W2968744974","doi":"10.1136/annrheumdis-2019-215589","title":"MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":304,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Sacroiliac joint; Sacroiliitis; Magnetic resonance imaging; Radiology","score_opus":0.03130173509914627,"score_gpt":0.2679187463990347,"score_spread":0.2366170112998884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968744974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947901,0.0027567537,0.0000042554348,0.0010286693,0.00004288592,0.0007320814,0.0003787389,0.0000057830434,0.000260757],"genre_scores_gemma":[0.9975607,0.0020178293,0.0000634508,0.00015911777,0.0000045418583,0.00003941916,0.00012764118,0.000011928821,0.000015401649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987971,0.00016084172,0.0003643183,0.0001488799,0.0003719287,0.00015690895],"domain_scores_gemma":[0.9988541,0.0002488124,0.0002851785,0.0004634302,0.00010381829,0.000044636814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001933971,0.00013020067,0.00032896196,0.000051213272,0.000113643655,0.0000133368185,0.00015267843,0.000025930087,0.000052222313],"category_scores_gemma":[0.000100548124,0.000062824765,0.00009401924,0.00023354705,0.0002226739,0.00010511521,0.000063450876,0.0000642619,0.0000029736093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005694891,0.0026282656,0.96454674,0.00030618624,0.00037030282,0.0000024842818,0.001805443,0.000024586974,0.00002965727,0.0020514796,0.001827616,0.025837753],"study_design_scores_gemma":[0.0024484405,0.0005480065,0.9907336,0.0020786342,0.00020942988,0.0000038627404,0.0017326152,0.000018452885,0.00021081592,0.0017948959,0.00014109275,0.00008014738],"about_ca_topic_score_codex":0.00012388875,"about_ca_topic_score_gemma":0.00007183209,"teacher_disagreement_score":0.026186869,"about_ca_system_score_codex":0.000006055992,"about_ca_system_score_gemma":0.000026208381,"threshold_uncertainty_score":0.25619197},"labels":[],"label_agreement":null},{"id":"W2969697792","doi":"10.1136/annrheumdis-2018-214918","title":"Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"AbbVie","keywords":"Medicine; Rheumatoid arthritis; Antirheumatic drugs; Antirheumatic Agents; Drug; Disease; Arthritis; Internal medicine; Physical therapy; Pharmacology","score_opus":0.013932313737703933,"score_gpt":0.2805160448705515,"score_spread":0.26658373113284756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969697792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935074,0.003075453,0.000001377723,0.00061856594,0.00007433125,0.0024810105,0.00019897011,0.000028252653,0.000014667132],"genre_scores_gemma":[0.98663396,0.013007907,0.000018492377,0.000055971756,0.0000032496675,0.00010075478,0.000055667646,0.00003738883,0.00008658303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974523,0.00035440322,0.00070295733,0.0003341315,0.00080009433,0.00035611988],"domain_scores_gemma":[0.9973855,0.00095268135,0.0003759694,0.0007456535,0.00013320762,0.0004069666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026668137,0.00035004385,0.00095107965,0.00023436778,0.0000922983,0.000055579825,0.00014857207,0.000029644489,0.000059114922],"category_scores_gemma":[0.001123357,0.00018909734,0.0002602354,0.00020980353,0.00023454946,0.0003565033,0.00006596522,0.00009165093,0.000013079828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055477945,0.0013514431,0.9521178,0.001099086,0.00028295547,0.000005024893,0.00035327845,0.000056598285,0.000004809255,0.00013962055,0.000055257253,0.03898632],"study_design_scores_gemma":[0.009019917,0.0019280245,0.9779979,0.010037674,0.000030508745,8.4558275e-7,0.00005738253,0.00031727023,0.0002641091,0.00015205322,0.000015261354,0.00017906117],"about_ca_topic_score_codex":0.00016033805,"about_ca_topic_score_gemma":0.000018842471,"teacher_disagreement_score":0.038807258,"about_ca_system_score_codex":0.000037395064,"about_ca_system_score_gemma":0.00015237581,"threshold_uncertainty_score":0.77111655},"labels":[],"label_agreement":null},{"id":"W2970990577","doi":"10.1136/annrheumdis-2019-215349","title":"Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"CD8; Medicine; Cytotoxic T cell; Immunology; Synovial fluid; Peripheral blood mononuclear cell; Immune system; Population; Inflammation; Flow cytometry; Transcriptome; Ankylosing spondylitis; Cell biology; Biology; Pathology; Gene expression; Gene; Genetics","score_opus":0.02075794520292961,"score_gpt":0.290609252152208,"score_spread":0.2698513069492784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970990577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934811,0.004328138,0.000002652187,0.0005358876,0.00017538577,0.00086320075,0.00012386589,0.000016374783,0.00047336705],"genre_scores_gemma":[0.99887335,0.00067061395,0.000022555389,0.00007685345,0.000013502666,0.000047127174,0.00003261385,0.000015524172,0.0002478346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896693,0.00006499522,0.00033024687,0.0002116484,0.00023075525,0.0001954278],"domain_scores_gemma":[0.9994036,0.0000878699,0.00012945035,0.00024432124,0.00006203844,0.00007270044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008805838,0.00015477317,0.00040339064,0.00008522317,0.00005054971,0.000016339021,0.000077076606,0.00003987775,0.00013366525],"category_scores_gemma":[0.00011816398,0.00010769497,0.00015018012,0.0001583007,0.00010737161,0.00010632879,0.0000520464,0.00007834317,0.000020476788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078242086,0.00085542834,0.9712323,0.0008925679,0.0001551762,0.000021223785,0.001322593,0.0000065866343,0.00062354025,0.0003174119,0.00032940018,0.023461327],"study_design_scores_gemma":[0.0028208802,0.00024293573,0.991589,0.0016271723,0.000100560486,0.000012025467,0.0008337158,0.000094962656,0.0012511456,0.0012787585,0.000043180557,0.00010562512],"about_ca_topic_score_codex":0.00036346418,"about_ca_topic_score_gemma":0.00011397474,"teacher_disagreement_score":0.023355702,"about_ca_system_score_codex":0.000019379913,"about_ca_system_score_gemma":0.00003989339,"threshold_uncertainty_score":0.43916735},"labels":[],"label_agreement":null},{"id":"W2971752454","doi":"","title":"Variation of anti-CCP antibodies and IGM rheumatoid factor during follow-up of patients with recent-onset polyarthritis correlations with clinical outcomes","year":2005,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Polyarthritis; Rheumatoid factor; Rheumatoid arthritis; Antibody; Immunoglobulin M; Immunology; Internal medicine; Dermatology; Arthritis; Immunoglobulin G","score_opus":0.02942034478385678,"score_gpt":0.31221924796352146,"score_spread":0.28279890317966466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971752454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951841,0.0026797624,0.000029475095,0.0008732753,0.000079299134,0.0005894061,0.0005024175,0.000022702743,0.00003952107],"genre_scores_gemma":[0.97240824,0.027150322,0.0002661055,0.000039463517,0.000007986649,0.000011362393,0.00004401321,0.00002340866,0.000049117672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979231,0.00015732704,0.00080827007,0.00020741491,0.0006510992,0.00025282687],"domain_scores_gemma":[0.99785256,0.00044911334,0.0005791308,0.00043847944,0.0005073859,0.00017330807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001722762,0.00019748323,0.0007727515,0.00013897575,0.00013038452,0.000018827142,0.00014484071,0.000053029937,0.00014277078],"category_scores_gemma":[0.00096195255,0.000116945375,0.00017987112,0.0002155482,0.0005237063,0.00027733503,0.000072747454,0.0001130007,0.0000026750965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088756287,0.0007894526,0.9812866,0.00026158695,0.00066461135,6.8370764e-7,0.0005870886,0.000012054017,0.000020355403,0.00010609295,0.00012342907,0.015260473],"study_design_scores_gemma":[0.005271942,0.00044544644,0.99115354,0.002206426,0.00003817688,0.000005655224,0.00017570994,0.000042506384,0.00039052402,0.00010015912,0.000047656227,0.00012228906],"about_ca_topic_score_codex":0.000088969224,"about_ca_topic_score_gemma":0.000055428987,"teacher_disagreement_score":0.02447056,"about_ca_system_score_codex":0.000007514309,"about_ca_system_score_gemma":0.00015448937,"threshold_uncertainty_score":0.4768894},"labels":[],"label_agreement":null},{"id":"W2972414225","doi":"10.1136/annrheumdis-2019-215933","title":"Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; U.S. Department of Veterans Affairs","keywords":"Gout; Medicine; Tophus; Hyperuricemia; Asymptomatic; Internal medicine; Rheumatology; Disease; Physical therapy; Uric acid","score_opus":0.03788746503950297,"score_gpt":0.27392111174795797,"score_spread":0.236033646708455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972414225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705024,0.007520129,0.0000075015555,0.0024024283,0.000085748674,0.0009333635,0.0017419144,0.00003606919,0.00022261449],"genre_scores_gemma":[0.9953617,0.003711384,0.00014012463,0.00037760416,0.000015203065,0.000030349043,0.00009616354,0.000039314196,0.00022814682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748355,0.00023824457,0.00091540266,0.0003310079,0.0006257307,0.00040609096],"domain_scores_gemma":[0.9965781,0.0009871825,0.0008059912,0.0007296087,0.0003311374,0.0005679608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003868482,0.00028986108,0.0008547422,0.00010597405,0.00010513647,0.00001951866,0.00017601048,0.000053230608,0.00009155067],"category_scores_gemma":[0.001660812,0.00021266019,0.0002484009,0.00034449526,0.00048204153,0.00008253843,0.00024587428,0.00011764247,0.00000313228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016872286,0.0015534027,0.97097665,0.006452039,0.0019513266,0.000021580403,0.00096486654,0.0013319836,0.00042583718,0.0018374665,0.011138537,0.0016590849],"study_design_scores_gemma":[0.003526495,0.00035386163,0.9700696,0.0060619703,0.0027676532,0.000005947409,0.0010444642,0.0019937824,0.00021769332,0.013408133,0.0001755139,0.00037487812],"about_ca_topic_score_codex":0.0001099913,"about_ca_topic_score_gemma":0.0000047128315,"teacher_disagreement_score":0.011570667,"about_ca_system_score_codex":0.000030619056,"about_ca_system_score_gemma":0.00032923615,"threshold_uncertainty_score":0.8672031},"labels":[],"label_agreement":null},{"id":"W2972593257","doi":"10.1136/annrheumdis-2019-216515","title":"Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1680,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Burden of disease; Demography; Disease burden; Incidence (geometry); Population; Epidemiology; Prevalence; Confidence interval; Environmental health; Internal medicine","score_opus":0.04960525960140079,"score_gpt":0.31706035700966084,"score_spread":0.26745509740826007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972593257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98575234,0.008079343,0.0000053499703,0.0024301244,0.00006428673,0.0015735559,0.0018658199,0.000012904796,0.00021629897],"genre_scores_gemma":[0.99948806,0.00019590964,0.000027916847,0.00012385583,0.000027224174,0.000047321897,0.000039593222,0.000008656098,0.000041495918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724704,0.00025281147,0.00086869055,0.00025297434,0.0012087625,0.00016969292],"domain_scores_gemma":[0.99761206,0.0001979805,0.00089244207,0.0005893126,0.00046037862,0.00024784464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002183629,0.00021512399,0.001099856,0.00007574315,0.000073446325,0.000013206612,0.00037304344,0.000040828178,0.00004062137],"category_scores_gemma":[0.0011426071,0.00013123702,0.00067389186,0.00080579065,0.00029630418,0.00008823184,0.00020772497,0.000038243685,0.0000017535741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007823273,0.0097135985,0.78924745,0.09182249,0.03793118,0.00010031125,0.01380382,0.0038968404,0.000490663,0.021953668,0.011589698,0.011626973],"study_design_scores_gemma":[0.014529929,0.0060887653,0.86133665,0.04227045,0.045154896,0.00003856211,0.014170459,0.0047582323,0.00034432104,0.010586974,0.000042980675,0.00067779276],"about_ca_topic_score_codex":0.00025186432,"about_ca_topic_score_gemma":0.000037331836,"teacher_disagreement_score":0.07208915,"about_ca_system_score_codex":0.000024906944,"about_ca_system_score_gemma":0.0002806123,"threshold_uncertainty_score":0.535169},"labels":[],"label_agreement":null},{"id":"W2974471364","doi":"10.1136/annrheumdis-2019-216250","title":"Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS' by Assan et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatism; Rheumatology; Internal medicine; Dermatology; Immunology","score_opus":0.048701566377638374,"score_gpt":0.33837660301874345,"score_spread":0.28967503664110505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974471364","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7287793,0.0005210493,0.00031709412,0.25491464,0.00078210334,0.005793778,0.008738045,0.0000718991,0.0000820828],"genre_scores_gemma":[0.41359878,0.000103749786,0.002745936,0.5214353,0.0006637813,0.0012766296,0.025983114,0.0010070907,0.03318557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945494,0.00078237307,0.0008502281,0.0008148605,0.0023120185,0.0006911054],"domain_scores_gemma":[0.9929823,0.002278578,0.0012167384,0.0018647522,0.0013630646,0.00029453708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074721436,0.0005693221,0.0012391837,0.00021174004,0.00015015637,0.00017362644,0.00081757555,0.0002535098,0.00014131218],"category_scores_gemma":[0.005531818,0.00034763364,0.00028517927,0.00030408526,0.00011877437,0.00022582589,0.00020835164,0.0004948313,0.000058541067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041997475,0.00041020906,0.16490027,0.0014299869,0.00053007633,0.0000027751928,0.0004275199,0.000004527649,0.000020651703,8.9435434e-7,0.8277377,0.00033568553],"study_design_scores_gemma":[0.019015681,0.0033073486,0.4064541,0.0683493,0.0016136987,0.000017101782,0.000699496,0.00041771814,0.00023936633,0.0003654939,0.49774516,0.0017755436],"about_ca_topic_score_codex":0.0003944727,"about_ca_topic_score_gemma":0.000008093913,"teacher_disagreement_score":0.3299925,"about_ca_system_score_codex":0.00014933104,"about_ca_system_score_gemma":0.00068281236,"threshold_uncertainty_score":0.99989754},"labels":[],"label_agreement":null},{"id":"W2975383698","doi":"10.1136/annrheumdis-2019-215386","title":"A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Ixekizumab; Adalimumab; Psoriatic arthritis; Internal medicine; Adverse effect; Rheumatology; Psoriasis; Quality of life (healthcare); Physical therapy; Secukinumab; Disease; Dermatology","score_opus":0.08465387686902026,"score_gpt":0.365823190280827,"score_spread":0.28116931341180673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975383698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910476,0.002524303,9.177949e-7,0.0004598158,0.00010978558,0.0051780045,0.000584725,0.0000047251688,0.00009011281],"genre_scores_gemma":[0.99893355,0.0008013198,0.0000789078,0.000048630358,0.0000061834166,0.000084816464,0.000019301875,0.000013356894,0.000013929806],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976859,0.00029092192,0.0010831505,0.00029314577,0.00042625738,0.0002206416],"domain_scores_gemma":[0.9971322,0.0010805448,0.00093398103,0.0005058963,0.0002448455,0.000102568054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025943163,0.00022542095,0.00150158,0.00006948014,0.00006664727,0.0000111188765,0.00023893199,0.000060864615,0.000012497495],"category_scores_gemma":[0.0015966828,0.00011544513,0.00011041538,0.00032854255,0.0003067881,0.00008269026,0.00029400998,0.000094861,7.451706e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7273342,0.013091131,0.09097876,0.0005192586,0.0011861171,0.0000017326158,0.0024592008,0.00003097919,0.0000235694,0.000053565847,0.00012881121,0.16419269],"study_design_scores_gemma":[0.41426498,0.006885418,0.57216763,0.005080637,0.00023280339,0.0000011251199,0.00073218945,0.000038350543,0.00035009035,0.00013785041,0.000010451813,0.00009844919],"about_ca_topic_score_codex":0.0003466561,"about_ca_topic_score_gemma":0.000154145,"teacher_disagreement_score":0.4811889,"about_ca_system_score_codex":0.000016711834,"about_ca_system_score_gemma":0.00010894545,"threshold_uncertainty_score":0.47077158},"labels":[],"label_agreement":null},{"id":"W2975994788","doi":"10.1136/annrheumdis-2019-216040","title":"Emergent high fatality lung disease in systemic juvenile arthritis","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Children's Hospital of Eastern Ontario","funders":"National Institute of Allergy and Infectious Diseases; Life Sciences Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Bill and Melinda Gates Foundation","keywords":"Medicine; Juvenile; Arthritis; Disease; Juvenile rheumatoid arthritis; Lung; Immunology; Internal medicine","score_opus":0.023367331089546958,"score_gpt":0.3062257599552511,"score_spread":0.2828584288657041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975994788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820695,0.014529036,0.0000058420787,0.0017879256,0.00016837918,0.00096477626,0.00008838053,0.000027812244,0.0003583721],"genre_scores_gemma":[0.99645585,0.0022756213,0.000003488023,0.00020742278,0.0000124272365,0.00006322328,0.000038569862,0.000019659497,0.000923758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809325,0.00015768956,0.0006578572,0.00021696795,0.0005607644,0.00031345082],"domain_scores_gemma":[0.99857086,0.000077984245,0.00019571879,0.00085089804,0.000112738206,0.00019179346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029398166,0.00015178887,0.0005377149,0.00010318549,0.00004974596,0.000014589976,0.00028054786,0.000038267928,0.0010961874],"category_scores_gemma":[0.00046375304,0.00010636425,0.00028176207,0.0002644625,0.00010225928,0.00014086554,0.00015995753,0.00011973282,0.00013733564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006153011,0.001138824,0.95036054,0.0070269103,0.0002770025,0.000034481272,0.00048573216,0.00054632913,0.00023028681,0.0019172243,0.013699998,0.023667354],"study_design_scores_gemma":[0.0015016292,0.000060609033,0.9887912,0.005025195,0.000058692855,0.000004008155,0.0004216451,0.0021523947,0.00025929714,0.0011990685,0.00036146297,0.0001647542],"about_ca_topic_score_codex":0.0002742418,"about_ca_topic_score_gemma":0.0000062981635,"teacher_disagreement_score":0.038430687,"about_ca_system_score_codex":0.00002662773,"about_ca_system_score_gemma":0.0003122112,"threshold_uncertainty_score":0.99981695},"labels":[],"label_agreement":null},{"id":"W2977680555","doi":"10.1136/annrheumdis-2018-eular.1459","title":"THU0299 An integrated analysis of changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis across phase 3 and long-term extension studies","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Regeneron Pharmaceuticals; Celgene; Gilead Sciences; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Internal medicine; Incidence (geometry); Placebo; Adverse effect; Mace; Gastroenterology; Arthritis; Rheumatoid arthritis; Myocardial infarction; Conventional PCI","score_opus":0.053229426286665424,"score_gpt":0.3605337083282867,"score_spread":0.30730428204162125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977680555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821015,0.01683484,0.0000028718534,0.0000399152,0.000041173862,0.00062107557,0.00035298968,0.0000045483416,0.0000010617023],"genre_scores_gemma":[0.9942324,0.005615635,0.000037181635,0.00001649306,0.000005329406,0.000042447955,0.00003757361,0.000009643091,0.0000033056306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986611,0.00011869615,0.00042313474,0.00025945727,0.00034107149,0.00019655711],"domain_scores_gemma":[0.9989843,0.00010597318,0.00022626147,0.00037464325,0.00023735478,0.00007151634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019528331,0.00019361502,0.0011900264,0.00018341486,0.000062699764,0.0000055402475,0.000059678932,0.000029976669,0.0000076240467],"category_scores_gemma":[0.00025828014,0.00011639475,0.00020028814,0.00052716536,0.00025663243,0.00011028094,0.00007796488,0.00002785054,1.192137e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004906237,0.0013489082,0.8468067,0.00018527394,0.0062877256,0.000012539191,0.0036388247,0.000012560846,0.0000067226706,9.81731e-7,7.831812e-7,0.14120834],"study_design_scores_gemma":[0.00840465,0.002251629,0.98097825,0.004192207,0.0020182175,0.0000013148754,0.001479995,0.000062633815,0.00049515546,0.000022482052,9.2403394e-7,0.00009253264],"about_ca_topic_score_codex":0.00055885955,"about_ca_topic_score_gemma":0.002207825,"teacher_disagreement_score":0.14111581,"about_ca_system_score_codex":0.000025404608,"about_ca_system_score_gemma":0.000029102834,"threshold_uncertainty_score":0.47464404},"labels":[],"label_agreement":null},{"id":"W2977926703","doi":"10.1136/annrheumdis-2019-216338","title":"Response to: ‘Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?' by Chi et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.040693340506046366,"score_gpt":0.3522190882820545,"score_spread":0.31152574777600817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977926703","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3999702,0.001285444,0.000006289641,0.59324425,0.0007682393,0.0029417884,0.0014697306,0.000022946739,0.00029112003],"genre_scores_gemma":[0.4971197,0.0007937182,0.000018979856,0.4886582,0.00021902422,0.00040204002,0.00084095617,0.00019224951,0.011755147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924913,0.0030008873,0.0011170009,0.0005587372,0.0022565287,0.0005755427],"domain_scores_gemma":[0.99093366,0.004116354,0.00097615673,0.0032454873,0.00059494755,0.00013339714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023502128,0.00048352327,0.0009928481,0.00022045513,0.00016295518,0.000090960515,0.0016094663,0.00026214874,0.00025720548],"category_scores_gemma":[0.0053681275,0.00022634078,0.0006353463,0.00041834268,0.00035576316,0.00009253253,0.00036272238,0.0008058986,0.00024266075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021533943,0.00045070067,0.0024457697,0.0013301208,0.00043388872,0.000003322017,0.0013203847,0.0000032166981,0.00033879434,0.00007476434,0.99076885,0.0006767683],"study_design_scores_gemma":[0.004553727,0.0021244255,0.059973955,0.02327956,0.0007776786,0.00011970949,0.0020715466,0.0003959916,0.0014629584,0.0010487178,0.9032612,0.0009305572],"about_ca_topic_score_codex":0.00014374049,"about_ca_topic_score_gemma":0.0000023700266,"teacher_disagreement_score":0.104586065,"about_ca_system_score_codex":0.00008847938,"about_ca_system_score_gemma":0.00040778005,"threshold_uncertainty_score":0.9229909},"labels":[],"label_agreement":null},{"id":"W2979466167","doi":"10.1136/annrheumdis-2019-eular.7005","title":"SAT0571 IDENTIFYING DETERMINANTS OF PRESENTEEISM IN WORKERS WITH INFLAMMATORY ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"UCB Pharma; Celltrion; Celgene; Chugai Pharmaceutical; KineMed; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Presenteeism; Medicine; Absenteeism; Physical therapy; Quality of life (healthcare); Marital status; Social support; Rheumatoid arthritis; Job control; Gerontology; Internal medicine; Work (physics); Environmental health; Psychology; Population","score_opus":0.04073676740407948,"score_gpt":0.3817470387072666,"score_spread":0.3410102713031871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979466167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956759,0.0015031657,0.0000042936063,0.00051082263,0.0003129099,0.0010849087,0.000015534943,0.00001959483,0.0008728233],"genre_scores_gemma":[0.998286,0.0006758928,0.000033566695,0.00027550233,0.000018661372,0.000068124216,0.0000022509646,0.000022599828,0.00061739684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976273,0.0004734941,0.00087455113,0.00017798424,0.00036976536,0.00047687048],"domain_scores_gemma":[0.9977447,0.0007918758,0.0006796045,0.00053737423,0.00010769684,0.00013877294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059045694,0.00014205542,0.00046703895,0.00012416935,0.00015176217,0.000005718086,0.0003151909,0.00007868618,0.00020488501],"category_scores_gemma":[0.00035494118,0.00009598111,0.000104429324,0.000265581,0.00010189469,0.00018582329,0.0001518085,0.00023066087,0.00006787176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017955751,0.00006805749,0.9849976,0.0031493749,0.000023868957,0.0000027787075,0.0017396173,0.000093649964,0.000005154622,0.00014110949,0.0013378119,0.00826142],"study_design_scores_gemma":[0.0009809652,0.000048218873,0.9708638,0.022871953,0.000015265594,8.778533e-7,0.0030984478,0.00018058358,0.00011230378,0.0015938579,0.00012129937,0.000112435555],"about_ca_topic_score_codex":0.0004601298,"about_ca_topic_score_gemma":0.00037907966,"teacher_disagreement_score":0.019722577,"about_ca_system_score_codex":0.000018707382,"about_ca_system_score_gemma":0.00041167025,"threshold_uncertainty_score":0.3913996},"labels":[],"label_agreement":null},{"id":"W2979470999","doi":"10.1136/annrheumdis-2019-216337","title":"Response to: ‘Role of ANA testing in the classification of patients with systemic lupus erythematosus' by Pisetsky et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Immunology; Systemic lupus erythematosus; Lupus erythematosus; Dermatology; Internal medicine; Antibody; Disease","score_opus":0.0398680907952673,"score_gpt":0.31247895736239034,"score_spread":0.272610866567123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979470999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8848135,0.0011991273,0.000005489168,0.10995041,0.000102032696,0.0030128139,0.0007099169,0.000015816551,0.00019090633],"genre_scores_gemma":[0.96117765,0.00005766755,0.00004445923,0.037864532,0.000021686534,0.00018646156,0.00018405954,0.000082482984,0.00038100017],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9942421,0.0015366671,0.0012809146,0.0004008388,0.0021197358,0.0004197714],"domain_scores_gemma":[0.99140674,0.0044178576,0.0014428488,0.001855395,0.0008004769,0.0000767099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017558556,0.00036147263,0.0012151886,0.00038678342,0.000039370094,0.00002233463,0.000993921,0.0001873175,0.000017888731],"category_scores_gemma":[0.004651579,0.00019061915,0.00024999044,0.0007958223,0.00022765037,0.00008255132,0.0001562848,0.0004892933,0.000014380964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001644553,0.000451917,0.33604664,0.008508418,0.00025712236,0.0000052609394,0.0017534503,0.000016765063,0.00045788352,0.000009438328,0.65051615,0.00033241976],"study_design_scores_gemma":[0.017272774,0.0055017015,0.59442204,0.31823456,0.0017437842,0.0027422276,0.018924054,0.0015866901,0.0013043714,0.00067563594,0.035527393,0.0020647477],"about_ca_topic_score_codex":0.00012697265,"about_ca_topic_score_gemma":0.0000027667993,"teacher_disagreement_score":0.61498874,"about_ca_system_score_codex":0.00006868943,"about_ca_system_score_gemma":0.0006029444,"threshold_uncertainty_score":0.7773223},"labels":[],"label_agreement":null},{"id":"W2979929128","doi":"10.1136/annrheumdis-2019-216266","title":"Response to ‘Titre-specific positive predictive value of anti-nuclear antibody patterns' by Vulsteke et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Cohort; Context (archaeology); Titer; Relevance (law); Clinical significance; Disease; Internal medicine; Immunology; Antibody","score_opus":0.028064242033305452,"score_gpt":0.335999878626331,"score_spread":0.3079356365930256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979929128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5663629,0.0015843052,0.000042761403,0.42315397,0.0003809199,0.0023288226,0.0057658493,0.00004445579,0.00033598265],"genre_scores_gemma":[0.56572706,0.002049789,0.000047205966,0.42756343,0.00019212619,0.00007508321,0.000842781,0.00029912882,0.0032034053],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99339145,0.0017308508,0.0011428432,0.00071742345,0.0023347924,0.0006826334],"domain_scores_gemma":[0.99361813,0.0024449378,0.0008640167,0.0020960113,0.000745394,0.00023153411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011054936,0.00056792994,0.0017822183,0.00046619063,0.00007727234,0.000051510746,0.001076542,0.00034365698,0.00030137383],"category_scores_gemma":[0.0016729267,0.00039358862,0.00080105755,0.00041759544,0.00032306992,0.00012982744,0.0005529698,0.0008480717,0.000183004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026531022,0.00039782596,0.008976459,0.0035789262,0.0011852212,0.00007876337,0.0013602058,0.000014168639,0.0019335246,0.000016956978,0.9796232,0.00018167564],"study_design_scores_gemma":[0.009186526,0.006616416,0.16846114,0.18209133,0.0018085713,0.0020576348,0.0044029774,0.00070651696,0.008645358,0.00032495425,0.6131598,0.0025387704],"about_ca_topic_score_codex":0.0001538811,"about_ca_topic_score_gemma":3.380305e-7,"teacher_disagreement_score":0.36646336,"about_ca_system_score_codex":0.000097148484,"about_ca_system_score_gemma":0.00048205894,"threshold_uncertainty_score":0.9998516},"labels":[],"label_agreement":null},{"id":"W2980559721","doi":"10.1136/annrheumdis-2019-eular.3317","title":"AB0020B QUANTIFYING DIFFERENCES IN HERITABILITY AMONG PSORIATIC ARTHRITIS (PSA), CUTANEOUS PSORIASIS (PSC) AND PSORIASIS VULGARIS (PSV)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Memorial University of Newfoundland","funders":"Medical School, University of Michigan; Memorial University of Newfoundland; China Scholarship Council; St. John's University; University of Toronto; Deutsche Forschungsgemeinschaft; University of Michigan; Pfizer","keywords":"Heritability; Medicine; Imputation (statistics); Single-nucleotide polymorphism; Linkage disequilibrium; Psoriasis; Genome-wide association study; Psoriatic arthritis; Genotyping; Genetics; Biology; Genotype; Immunology; Statistics; Gene; Missing data","score_opus":0.05147770565574726,"score_gpt":0.29950043830683326,"score_spread":0.248022732651086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980559721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949825,0.0022381195,0.000011902772,0.0009924724,0.00053773733,0.0006880699,0.000087861685,0.00004774868,0.00041361537],"genre_scores_gemma":[0.9976209,0.0019129459,0.00007629631,0.00015466842,0.000050964143,0.00004076791,0.000009530025,0.000026293008,0.00010767472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997878,0.00018676209,0.0007751476,0.00037809272,0.00044323696,0.0003387687],"domain_scores_gemma":[0.997987,0.00070467446,0.00033657587,0.000639499,0.00014897523,0.00018331263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002631168,0.0002611055,0.0008098741,0.00015193799,0.00010784169,0.000062183586,0.00021006455,0.000085428794,0.00061685126],"category_scores_gemma":[0.0013513694,0.00018572788,0.00030557814,0.00032225787,0.00020425662,0.0002087791,0.000115882474,0.00021777645,0.000022631555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039203095,0.0011715622,0.9010263,0.0016434765,0.00043301762,0.00001668094,0.0022344464,0.000049466427,0.0006368343,0.00053794653,0.0008110092,0.091047205],"study_design_scores_gemma":[0.0014570288,0.00044154772,0.983659,0.004958985,0.00022848466,0.0000561666,0.0019915141,0.0026247904,0.0022750348,0.0018668002,0.00013037628,0.00031024043],"about_ca_topic_score_codex":0.0011909542,"about_ca_topic_score_gemma":0.00018792489,"teacher_disagreement_score":0.09073696,"about_ca_system_score_codex":0.000026650678,"about_ca_system_score_gemma":0.00009907421,"threshold_uncertainty_score":0.7573763},"labels":[],"label_agreement":null},{"id":"W2982479931","doi":"10.1136/annrheumdis-2019-216143","title":"Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"British Society for Rheumatology","keywords":"Medicine; Ankylosing spondylitis; Rheumatology; Quality of life (healthcare); Mood; Internal medicine; Sleep disorder; Physical therapy; Pittsburgh Sleep Quality Index; Fibromyalgia; Depression (economics); Disease; Axial spondyloarthritis; Sleep quality; Psychiatry; Insomnia","score_opus":0.03650871510013537,"score_gpt":0.29977454854674296,"score_spread":0.2632658334466076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982479931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423516,0.0009813743,0.000001529116,0.001077608,0.00018551676,0.0014973844,0.0019330005,0.00001838336,0.00007005579],"genre_scores_gemma":[0.99862754,0.00028290995,0.00011354668,0.0005825155,0.0000054217016,0.00004648374,0.00023282731,0.000021286742,0.00008746716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797153,0.00012964616,0.00092694757,0.00033657954,0.00032771454,0.00030759742],"domain_scores_gemma":[0.9973777,0.0011577233,0.00058615004,0.00053853705,0.00022628918,0.00011359618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002494967,0.00020310865,0.00085730344,0.00002638298,0.00014671232,0.000026063217,0.00023713801,0.000093372924,0.000036573354],"category_scores_gemma":[0.0025111127,0.00012071799,0.00041092178,0.00020246227,0.00021078173,0.000069981776,0.00013768543,0.00008924588,0.000006229841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023908971,0.0005057215,0.98899364,0.00015125067,0.00051794626,0.0000012134468,0.0010549664,0.0000098527935,0.000003135372,0.000040821127,0.0015530784,0.0047774916],"study_design_scores_gemma":[0.009884074,0.0008528207,0.984438,0.002623533,0.000090004345,0.0000016678241,0.0014290003,0.000012665452,0.00002861302,0.0004240978,0.00007651045,0.00013903462],"about_ca_topic_score_codex":0.0028024775,"about_ca_topic_score_gemma":0.00046082566,"teacher_disagreement_score":0.0074931765,"about_ca_system_score_codex":0.000018620412,"about_ca_system_score_gemma":0.00010863425,"threshold_uncertainty_score":0.49227366},"labels":[],"label_agreement":null},{"id":"W2982785161","doi":"10.1136/annrheumdis-2019-216118","title":"Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Placebo; Internal medicine; Disease; Secukinumab; Pathology; Psoriatic arthritis","score_opus":0.041292083805568765,"score_gpt":0.37474851048855057,"score_spread":0.3334564266829818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982785161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971796,0.004291977,0.000002750442,0.00030798354,0.00012090045,0.005098822,0.00036219068,0.00000891508,0.00008850905],"genre_scores_gemma":[0.9944949,0.0051711006,0.000037617378,0.00010453609,0.0000168943,0.00009984852,0.00004037451,0.000021264574,0.000013454894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963728,0.0009783522,0.0016191987,0.0003478222,0.00039387314,0.00028794107],"domain_scores_gemma":[0.9951536,0.0033651304,0.0008235397,0.00036884422,0.00014888786,0.00013998612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012006584,0.00028260687,0.0027971675,0.00016527272,0.000055503253,0.00001276148,0.00009953638,0.000062332525,0.000055159937],"category_scores_gemma":[0.0029832155,0.00016766791,0.0004202232,0.00029563464,0.00042726405,0.00014476923,0.000090935806,0.00014687433,0.0000010645567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3907671,0.0049570007,0.47767007,0.00022941479,0.0014891933,0.000014945478,0.00068451033,0.000010034742,0.0000032988064,0.00005773036,0.00008751351,0.1240292],"study_design_scores_gemma":[0.45614251,0.001895068,0.53912354,0.0018108123,0.00038167185,0.0000029359187,0.00029650825,0.000026227484,0.000020507972,0.00018714159,0.000011134972,0.0001019178],"about_ca_topic_score_codex":0.00035413064,"about_ca_topic_score_gemma":0.0002030836,"teacher_disagreement_score":0.12392728,"about_ca_system_score_codex":0.000012134234,"about_ca_system_score_gemma":0.000093414485,"threshold_uncertainty_score":0.6837299},"labels":[],"label_agreement":null},{"id":"W2989681134","doi":"10.1136/annrheumdis-2019-216535","title":"Anti-Ku antibodies: important points to consider","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Antibody; Immunology","score_opus":0.03614782774376746,"score_gpt":0.31373904605429304,"score_spread":0.2775912183105256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989681134","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15471438,0.003111235,0.000004547799,0.8360366,0.00119082,0.0016524481,0.000929309,0.00009250278,0.0022681495],"genre_scores_gemma":[0.05430338,0.000910701,0.000098234465,0.94049525,0.0005658334,0.00003631044,0.00018722209,0.000113616334,0.0032894625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969261,0.0001468556,0.0010641919,0.00040644084,0.0008898118,0.0005665938],"domain_scores_gemma":[0.9968159,0.00038215364,0.00069460325,0.0015742573,0.00036816872,0.00016491605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022132522,0.00046862886,0.0014442333,0.00020482017,0.00010603158,0.000053486518,0.00043414583,0.00031168372,0.0007313794],"category_scores_gemma":[0.00086488784,0.00030281994,0.00080117286,0.00019426875,0.00020514455,0.000088722525,0.00026617714,0.0005134926,0.00054190186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004427863,0.00006860456,0.008988887,0.0037606745,0.0004824971,0.00037072058,0.00017821333,0.0000017696548,0.000010899309,0.000057146706,0.9856564,0.00037993226],"study_design_scores_gemma":[0.0013559394,0.0002791168,0.07711332,0.019197825,0.0013368371,0.00054355897,0.00019527039,0.000083974366,0.0013882106,0.0016811567,0.895756,0.0010687796],"about_ca_topic_score_codex":0.000055714398,"about_ca_topic_score_gemma":8.668681e-7,"teacher_disagreement_score":0.10445863,"about_ca_system_score_codex":0.00002144165,"about_ca_system_score_gemma":0.00040172058,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W2990252958","doi":"10.1136/annrheumdis-2019-216078","title":"Retinal vasculometric characteristics and their associations with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Eye Study","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Moorfields Eye Hospital NHS Foundation Trust; Versus Arthritis; Queen's University; Queen's University Belfast; National Institute for Health and Care Research; Wellcome Trust; British Heart Foundation; Cancer Research UK","keywords":"Medicine; Polymyalgia rheumatica; Giant cell arteritis; EPIC; Prospective cohort study; Retinal; Ophthalmology; Cohort; Dermatology; Pathology; Vasculitis; Disease","score_opus":0.011852289419810738,"score_gpt":0.246264342348245,"score_spread":0.23441205292843428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990252958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9153419,0.0035068095,0.000016248756,0.07523015,0.00014247514,0.0036900246,0.0016038792,0.00003921659,0.00042929724],"genre_scores_gemma":[0.9882282,0.00268223,0.000041639716,0.0074927323,0.00007279264,0.00020281372,0.0003075326,0.00006455999,0.0009074998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762994,0.00028204304,0.0007165513,0.0004547114,0.0005388151,0.00037794968],"domain_scores_gemma":[0.99784476,0.0004955252,0.0006461797,0.0006583616,0.0002433407,0.00011180962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027301032,0.00040969718,0.0012507433,0.00040408628,0.00015338571,0.00008439919,0.00018388715,0.00025657137,0.00009807651],"category_scores_gemma":[0.00043507168,0.00024516703,0.00023549564,0.0005567829,0.00023624087,0.000091220805,0.00011883433,0.0007707161,0.000008779644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009375422,0.0018304444,0.9420972,0.0034781692,0.0036539703,0.0001393752,0.003219216,0.0000013417208,0.0000052342175,0.000038269038,0.04225044,0.0031926166],"study_design_scores_gemma":[0.0018186574,0.0006833686,0.9909113,0.0038132865,0.0012056836,0.00004711776,0.0006043727,0.00009571525,0.000005885949,0.00038210637,0.00014132964,0.00029114395],"about_ca_topic_score_codex":0.0001534704,"about_ca_topic_score_gemma":0.000008393411,"teacher_disagreement_score":0.0728863,"about_ca_system_score_codex":0.000050811967,"about_ca_system_score_gemma":0.00020795055,"threshold_uncertainty_score":0.99976206},"labels":[],"label_agreement":null},{"id":"W2990591993","doi":"10.1136/annrheumdis-2019-216452","title":"Risk of malignancy in patients treated for systemic necrotising vasculitis","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Malignancy; Cyclophosphamide; Vasculitis; Internal medicine; Population; Clinical endpoint; Systemic vasculitis; Dermatology; Clinical trial; Surgery; Disease; Chemotherapy","score_opus":0.019382986251098418,"score_gpt":0.26275686370073414,"score_spread":0.24337387744963573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990591993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9082099,0.0076558166,0.000029197752,0.07354063,0.0005301465,0.005165339,0.0045386357,0.00004312755,0.00028720405],"genre_scores_gemma":[0.971551,0.0028740114,0.000036310015,0.022023497,0.00010251493,0.0001876445,0.001661846,0.0000966344,0.0014665248],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979253,0.00019691531,0.000877113,0.0002638569,0.00043321194,0.0003035997],"domain_scores_gemma":[0.99757427,0.00037550693,0.00086876116,0.00077615277,0.00035706902,0.000048264308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012975032,0.0002633789,0.0010435351,0.00021052564,0.000052183812,0.000011357532,0.00024593872,0.0003398748,0.000073273266],"category_scores_gemma":[0.0005419275,0.00017022184,0.0010295376,0.00022078499,0.00009657474,0.00005575728,0.000042198557,0.00033192814,0.000012412298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011606022,0.00058511307,0.12856959,0.015826467,0.003041182,0.000019079582,0.00024362457,0.00009474386,0.0000027079652,0.000042780786,0.8467453,0.0047133407],"study_design_scores_gemma":[0.011270924,0.00094347494,0.85853934,0.113307826,0.00682813,0.0000484748,0.000115038805,0.0002977153,0.00019052534,0.0022678182,0.00547166,0.0007190636],"about_ca_topic_score_codex":0.0002743821,"about_ca_topic_score_gemma":0.0000014828324,"teacher_disagreement_score":0.84127367,"about_ca_system_score_codex":0.000032666507,"about_ca_system_score_gemma":0.00014710758,"threshold_uncertainty_score":0.69414455},"labels":[],"label_agreement":null},{"id":"W2993448153","doi":"10.1136/annrheumdis-2019-216561","title":"The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":739,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Academy of Medical Sciences","keywords":"Medicine; Rheumatism; Rheumatology; Radiological weapon; Internal medicine; Pathological; Cohort; Serology; Physical therapy; Radiology; Immunology","score_opus":0.0777348448428596,"score_gpt":0.36573520212469585,"score_spread":0.28800035728183626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993448153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00505118,0.97953355,0.000010642821,0.0012105693,0.000913233,0.0047897557,0.007843001,0.00010825316,0.00053984014],"genre_scores_gemma":[0.02098683,0.9757544,0.000027096487,0.00013932392,0.00002962371,0.00024582745,0.0011875264,0.0001968321,0.0014325692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99367684,0.001292887,0.0030073647,0.00066227274,0.00070086337,0.00065979664],"domain_scores_gemma":[0.9903791,0.002110883,0.004020397,0.002436758,0.00056984223,0.00048303485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008758054,0.00082874106,0.003403713,0.00029216532,0.0003795953,0.000045089146,0.0012990707,0.0001935054,0.00005910349],"category_scores_gemma":[0.0032833146,0.00047276038,0.0027671086,0.0006853559,0.0013200954,0.00017200963,0.0002677538,0.00036235317,0.00014717419],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005130386,0.00093053124,0.00042648852,0.07548179,0.0035303703,0.000009147186,0.00011495678,0.0000118099615,0.0000023849582,0.007956987,0.12047048,0.790552],"study_design_scores_gemma":[0.0034866475,0.00068630016,0.023482775,0.30074888,0.01743065,0.00007693323,0.0007031764,0.0015708848,0.000009155371,0.0022737675,0.6476686,0.001862238],"about_ca_topic_score_codex":0.000023393986,"about_ca_topic_score_gemma":0.000001606291,"teacher_disagreement_score":0.7886898,"about_ca_system_score_codex":0.000064679894,"about_ca_system_score_gemma":0.0014348471,"threshold_uncertainty_score":0.9997724},"labels":[],"label_agreement":null},{"id":"W2995304784","doi":"10.1136/annrheumdis-2019-216670","title":"Response to: ‘Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares' by Didierlaurent et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Kowa Company; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Gout; Vaccination; Adverse effect; Statement (logic); Pediatrics; Dermatology; Internal medicine; Immunology","score_opus":0.02859953723267244,"score_gpt":0.3064772339523396,"score_spread":0.27787769671966717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995304784","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23237446,0.0015328248,0.00002066947,0.7631238,0.0004319838,0.0019755596,0.00046011957,0.000016247497,0.00006434496],"genre_scores_gemma":[0.53556746,0.001743052,0.000025686626,0.45468396,0.00017541932,0.00019036974,0.00032448207,0.00010251347,0.007187061],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99470514,0.0019590554,0.0010543255,0.00039915257,0.0014740779,0.00040823035],"domain_scores_gemma":[0.9928103,0.0032052372,0.0017177641,0.0018539855,0.00033905558,0.00007365454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033822926,0.00037884212,0.0008032866,0.000088836685,0.0002216173,0.00007227203,0.00086057576,0.00023471018,0.00003139142],"category_scores_gemma":[0.0040799845,0.00015878909,0.0004289501,0.00030735045,0.00009120253,0.00009930237,0.00044551757,0.00085496984,0.000014769571],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030197817,0.00008610121,0.016326325,0.00036426968,0.0010991914,9.1542404e-7,0.0010054661,0.000007894472,0.00010803297,0.000006076501,0.979083,0.0016107743],"study_design_scores_gemma":[0.0015200466,0.00033809975,0.29921627,0.003818625,0.002519897,0.000007311999,0.0004897626,0.000058142912,0.0010100936,0.00039415818,0.6902919,0.00033574013],"about_ca_topic_score_codex":0.0001328171,"about_ca_topic_score_gemma":0.0000030265303,"teacher_disagreement_score":0.30843982,"about_ca_system_score_codex":0.000163337,"about_ca_system_score_gemma":0.00023799518,"threshold_uncertainty_score":0.6475231},"labels":[],"label_agreement":null},{"id":"W2995542662","doi":"10.1136/annrheumdis-2019-216368","title":"Dupilumab as a novel steroid-sparing treatment for IgG4-related disease","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Dupilumab; Asthma; IgG4-related disease; Immunology; Atopic dermatitis; Fibrosis; Internal medicine; Dermatology","score_opus":0.06018875627140293,"score_gpt":0.3154928110649834,"score_spread":0.2553040547935805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995542662","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30852434,0.018744862,0.00003398676,0.64739615,0.0028092128,0.011726029,0.007193182,0.00049568317,0.0030765731],"genre_scores_gemma":[0.43422866,0.002775591,0.00008969734,0.4842077,0.0017442581,0.0015746796,0.005204285,0.00070974586,0.069465384],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618167,0.00012748381,0.0012320112,0.00074598246,0.00089417875,0.0008186672],"domain_scores_gemma":[0.99561167,0.0006709768,0.0010034338,0.0019397534,0.00036986603,0.00040432438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001345752,0.0008565979,0.0015574705,0.00028219775,0.00021091355,0.00008018287,0.00061244477,0.00047301775,0.00042298366],"category_scores_gemma":[0.0010358625,0.0005613486,0.0021588183,0.000239749,0.00026714,0.00019166486,0.00016903157,0.00046862516,0.00025235803],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015033255,0.0016187428,0.0017000261,0.008589199,0.004236,0.00011577572,0.00022275494,0.00017920016,0.000025474705,0.00032154808,0.97585374,0.0056341956],"study_design_scores_gemma":[0.026409842,0.0034849066,0.055169746,0.050488003,0.026464881,0.0001334155,0.000303136,0.0048125517,0.00094493513,0.008229506,0.81995976,0.0035993215],"about_ca_topic_score_codex":0.00007778169,"about_ca_topic_score_gemma":0.0000010427931,"teacher_disagreement_score":0.16318843,"about_ca_system_score_codex":0.0001336138,"about_ca_system_score_gemma":0.0012511954,"threshold_uncertainty_score":0.9996838},"labels":[],"label_agreement":null},{"id":"W2995587627","doi":"10.1136/annrheumdis-2019-216472","title":"Response to: ‘Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients’ by Guggino et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Krembil Foundation","funders":"","keywords":"Medicine; Peripheral blood; Immunology; Cytotoxic T cell; CD8; Pathology; Immune system; Biology; In vitro","score_opus":0.015691229076488265,"score_gpt":0.25955128799461935,"score_spread":0.2438600589181311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995587627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84138507,0.0030561588,0.0000025429795,0.15277597,0.0015705269,0.0008265746,0.0002789657,0.000014745605,0.000089429945],"genre_scores_gemma":[0.722491,0.0005645689,0.000002720147,0.2680626,0.000015400263,0.000057926456,0.00031224353,0.000033925746,0.008459591],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969865,0.0016446604,0.0006167932,0.00030109214,0.00015758871,0.00029337805],"domain_scores_gemma":[0.9976311,0.0008806389,0.0006480078,0.00068381696,0.00013983222,0.000016653305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038473267,0.00030765796,0.0005923725,0.00013983766,0.00008281955,0.000031103446,0.0005033151,0.00024845757,0.0007973945],"category_scores_gemma":[0.00046576167,0.00019482838,0.00021091294,0.00010437412,0.00019479917,0.00010217928,0.00016384042,0.0005254275,0.00006967732],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00099516,0.0002873381,0.00044400725,0.0002040371,0.0002659306,0.0000025082372,0.0011630154,0.000007689671,0.049494848,0.0000010450951,0.94680154,0.0003328797],"study_design_scores_gemma":[0.0046365075,0.0017293674,0.08941348,0.0038495804,0.0005253459,0.00003288115,0.0029706084,0.0000042082347,0.12750264,0.000066437635,0.76838565,0.0008832924],"about_ca_topic_score_codex":0.00028686668,"about_ca_topic_score_gemma":0.000008021762,"teacher_disagreement_score":0.1784159,"about_ca_system_score_codex":0.00001621526,"about_ca_system_score_gemma":0.00007535091,"threshold_uncertainty_score":0.8730911},"labels":[],"label_agreement":null},{"id":"W2995945747","doi":"10.1136/annrheumdis-2019-216803","title":"Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion' by Sacre et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pericardial effusion; Internal medicine; Rheumatology; Surgery; Dermatology","score_opus":0.0643971569421218,"score_gpt":0.3678320396768077,"score_spread":0.30343488273468594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995945747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8037254,0.0004602639,0.0006566167,0.17538029,0.00150304,0.011247985,0.006936744,0.00006869725,0.0000209248],"genre_scores_gemma":[0.4832246,0.00029040547,0.0016391375,0.45161384,0.00085156976,0.004425548,0.020419031,0.001107824,0.03642805],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948466,0.00075859594,0.0010050683,0.0007935921,0.0018688377,0.0007273073],"domain_scores_gemma":[0.99333304,0.0020778922,0.0011655615,0.0015373303,0.0015743431,0.00031186087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008409371,0.000558879,0.0013421193,0.0003233837,0.00019032437,0.00014421262,0.00074315653,0.0003189439,0.00008471967],"category_scores_gemma":[0.005524127,0.00037833434,0.00072016555,0.00033060368,0.000111874375,0.00021914142,0.00024033274,0.00037220123,0.00004200883],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005212308,0.00035482788,0.07956114,0.0036939813,0.0005734734,0.0000016320971,0.0004791094,0.0000023659593,0.00009133257,7.174676e-7,0.909571,0.0004581112],"study_design_scores_gemma":[0.020442111,0.003002861,0.43966508,0.039552633,0.001723452,0.000021897713,0.0007642408,0.00051877677,0.00045570338,0.000160145,0.49211878,0.0015743119],"about_ca_topic_score_codex":0.00007764273,"about_ca_topic_score_gemma":0.0000017904421,"teacher_disagreement_score":0.41745222,"about_ca_system_score_codex":0.00014576085,"about_ca_system_score_gemma":0.00055383856,"threshold_uncertainty_score":0.99986684},"labels":[],"label_agreement":null},{"id":"W2996085778","doi":"10.1136/annrheumdis-2019-216807","title":"Response to: ‘Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus' by Wang et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Systemic disease; Systemic lupus; Systemic lupus erythematosus; Immunology; Computational biology; Internal medicine; Immunopathology; Disease","score_opus":0.041507123073295266,"score_gpt":0.34179761086963706,"score_spread":0.3002904877963418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996085778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7183909,0.006532989,0.00015237927,0.26955685,0.00042547093,0.004144929,0.00074253767,0.00003186121,0.000022105287],"genre_scores_gemma":[0.7131492,0.0010504173,0.00058423745,0.27760443,0.00022862531,0.0013809754,0.0012827591,0.0002870579,0.0044323215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995877,0.0007157864,0.0011269767,0.00047417657,0.0013401229,0.0004659096],"domain_scores_gemma":[0.98757744,0.01000843,0.00076340436,0.0009377043,0.00056492904,0.00014806459],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014297209,0.00041874463,0.0012713609,0.0003357871,0.00007509325,0.000043545766,0.00047754732,0.00030050776,0.00003085032],"category_scores_gemma":[0.009954399,0.0002851292,0.00033308737,0.00020868286,0.00014530246,0.000077959485,0.00022711715,0.00034996413,0.000017561317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013455013,0.00013315759,0.0015375101,0.015974361,0.00064574997,0.000023280118,0.0013017554,0.000020810663,0.000982104,0.000006375682,0.97761095,0.0004184263],"study_design_scores_gemma":[0.01976604,0.003563732,0.002338503,0.2764933,0.003077466,0.015293356,0.0034024408,0.0004561826,0.17663252,0.0011015332,0.49449098,0.0033839114],"about_ca_topic_score_codex":0.000017465745,"about_ca_topic_score_gemma":3.3269976e-7,"teacher_disagreement_score":0.48311996,"about_ca_system_score_codex":0.00007347688,"about_ca_system_score_gemma":0.00082386076,"threshold_uncertainty_score":0.99996006},"labels":[],"label_agreement":null},{"id":"W2996747123","doi":"10.1136/annrheumdis-2019-216700","title":"Response to: ‘European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view' by Infantino et al","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatism; Rheumatology; Internal medicine; League; Dermatology; Family medicine; Immunology","score_opus":0.03949035131608656,"score_gpt":0.3379068949338717,"score_spread":0.29841654361778513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996747123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5721231,0.0061421315,0.00012579208,0.40947026,0.00062677375,0.005079493,0.0062519484,0.0000654825,0.0001150326],"genre_scores_gemma":[0.87473196,0.005729446,0.00023057188,0.11635113,0.000041130093,0.00070427585,0.0005852021,0.00032659064,0.0012997037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98869073,0.0054472047,0.002972311,0.0007417988,0.001375994,0.00077198615],"domain_scores_gemma":[0.9840223,0.00696146,0.0038623065,0.003358066,0.0016526649,0.00014321104],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004762994,0.0007137869,0.0029974666,0.0005167778,0.00013745492,0.00003570037,0.0019221206,0.00029827203,0.000039852992],"category_scores_gemma":[0.009184151,0.0004426339,0.0008832492,0.00074601284,0.0014066348,0.00013032537,0.00046591082,0.0007213125,0.000047316295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024113844,0.00028539577,0.005669018,0.015778817,0.0012221468,0.000014303555,0.0013764881,0.000005014697,0.0048283082,0.00012342674,0.9678218,0.00046389157],"study_design_scores_gemma":[0.018762212,0.006474509,0.01679233,0.3037136,0.0025287538,0.019180829,0.03656211,0.0017112058,0.0075375685,0.00060855225,0.5822483,0.0038800456],"about_ca_topic_score_codex":0.000111959205,"about_ca_topic_score_gemma":0.0000027859048,"teacher_disagreement_score":0.3855735,"about_ca_system_score_codex":0.00011831386,"about_ca_system_score_gemma":0.0012000338,"threshold_uncertainty_score":0.99980253},"labels":[],"label_agreement":null},{"id":"W2997952011","doi":"10.1136/annrheumdis-2019-216827","title":"Do we need the PFAPA syndrome in adults with non-monogenic periodic fevers?","year":2019,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Pharyngitis; Stomatitis; Discontinuation; Adenitis; Adverse effect; Nonsteroidal; Dermatology; Internal medicine; Pediatrics","score_opus":0.009286568185623173,"score_gpt":0.22749749224092577,"score_spread":0.2182109240553026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997952011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81099415,0.014939688,0.0000031680781,0.17219345,0.000301038,0.0010028132,0.00016927136,0.000007834917,0.00038860508],"genre_scores_gemma":[0.93122935,0.006633085,0.0000071080713,0.059363168,0.00010828084,0.000121251454,0.00032808926,0.000076921206,0.0021327727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830866,0.00014747799,0.00041321994,0.00037147943,0.00033892624,0.00042026243],"domain_scores_gemma":[0.9981034,0.000057272613,0.00038507642,0.001324557,0.00009956689,0.000030152976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001286962,0.0003746579,0.00045413966,0.00007975045,0.000091047455,0.000049662052,0.0010392143,0.00029479404,0.00008430017],"category_scores_gemma":[0.00011122629,0.00020745855,0.0004283296,0.00017768198,0.0002602113,0.000008923307,0.00023671356,0.00036826576,0.000041984094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005049921,0.00017504011,0.0031111934,0.0020061794,0.0010449763,0.00003641097,0.0006655879,0.00018907445,0.00018516311,0.0000053062595,0.9872459,0.00483016],"study_design_scores_gemma":[0.010996072,0.003380472,0.123265415,0.028173463,0.0014817481,0.00031380003,0.007067542,0.00029868577,0.0066708224,0.0012751565,0.8124526,0.0046242313],"about_ca_topic_score_codex":0.00008824242,"about_ca_topic_score_gemma":0.000014946435,"teacher_disagreement_score":0.17479333,"about_ca_system_score_codex":0.000007785772,"about_ca_system_score_gemma":0.00024437057,"threshold_uncertainty_score":0.84599143},"labels":[],"label_agreement":null},{"id":"W2998116012","doi":"10.1136/annrheumdis-2019-216343","title":"Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Health Technology Assessment Programme; Vasculitis Foundation; Canadian Institutes of Health Research; National Institute for Health and Care Research; Medpace; Medical Research Council; Sanofi","keywords":"Medicine; Giant cell arteritis; Halo sign; Halo; Ultrasound; Radiology; Arteritis; Ischemia; Internal medicine; Pathology; Cardiology; Vasculitis; Disease","score_opus":0.02731214322131218,"score_gpt":0.28319844861125854,"score_spread":0.25588630538994633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998116012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98286915,0.002241159,0.0023288312,0.010970463,0.00004104431,0.0009185878,0.0005304083,0.000019947023,0.00008040627],"genre_scores_gemma":[0.9967379,0.0020476184,0.0005447781,0.0004902346,0.00001581189,0.000068630085,0.00006429707,0.000014243421,0.000016488706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910605,0.000032192173,0.0002993298,0.00014151906,0.00027775732,0.00014315832],"domain_scores_gemma":[0.9984109,0.0007392456,0.00033656886,0.0001825793,0.00019023054,0.00014048512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095928386,0.000111064764,0.00032941514,0.000036667603,0.000073108866,0.000016721322,0.000082788945,0.00004957044,0.000026869751],"category_scores_gemma":[0.0012821915,0.000070356386,0.00020339387,0.00016271236,0.00007939623,0.0000860251,0.00002275555,0.00008011482,5.653998e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051182264,0.0061132056,0.8584602,0.022869973,0.008905975,0.000037691152,0.00420788,0.0013702261,0.021727975,0.006802681,0.027179075,0.04181328],"study_design_scores_gemma":[0.0030182726,0.0007122435,0.9849786,0.0037616687,0.0014313285,0.000014637013,0.00050586887,0.0021652116,0.0025894898,0.0005528045,0.00010945283,0.00016042509],"about_ca_topic_score_codex":0.000021173604,"about_ca_topic_score_gemma":0.0000014966807,"teacher_disagreement_score":0.12651838,"about_ca_system_score_codex":0.000008331981,"about_ca_system_score_gemma":0.000112032336,"threshold_uncertainty_score":0.286905},"labels":[],"label_agreement":null},{"id":"W2998644011","doi":"10.1136/annrheumdis-2019-216487","title":"Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Tolerability; Internal medicine; Placebo; Adverse effect; Immunology; Population; Methotrexate; Rheumatism; Pharmacology; Pathology","score_opus":0.01592410041404283,"score_gpt":0.31939861613123544,"score_spread":0.3034745157171926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998644011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933937,0.002658199,0.0000057308994,0.00059266586,0.00008883197,0.0029149463,0.0003063211,0.00002622737,0.00001334059],"genre_scores_gemma":[0.9954358,0.0039985706,0.00020384215,0.00012430138,0.000006051374,0.000082281666,0.0000448128,0.00004614061,0.000058211408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965149,0.00080070854,0.0008460309,0.00045517416,0.0009057059,0.00047748373],"domain_scores_gemma":[0.9977409,0.00037331053,0.00028467938,0.0008735783,0.0003070623,0.0004204564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092948065,0.00032359388,0.0010232199,0.00036692756,0.000112588816,0.00003634861,0.00029986037,0.00005504905,0.00039554577],"category_scores_gemma":[0.0006911236,0.00021749156,0.00012363044,0.0005194576,0.00026455335,0.00031482274,0.0002546413,0.00017067307,0.000019019393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12188484,0.014617187,0.7636072,0.00030389344,0.0005941607,0.000022503,0.0053647715,0.000032025786,0.00082308485,0.0000312249,0.0003096829,0.09240941],"study_design_scores_gemma":[0.025643036,0.012290941,0.9555712,0.004565413,0.000014981977,0.0000066445577,0.00080012524,0.000055584125,0.0005377844,0.000051250696,0.00020427378,0.00025878957],"about_ca_topic_score_codex":0.00018172628,"about_ca_topic_score_gemma":0.000039821913,"teacher_disagreement_score":0.19196396,"about_ca_system_score_codex":0.000018592273,"about_ca_system_score_gemma":0.00021391328,"threshold_uncertainty_score":0.88690484},"labels":[],"label_agreement":null},{"id":"W2999809542","doi":"10.1136/annrheumdis-2019-216150","title":"Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; University of Manitoba; Toronto Western Hospital; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre","funders":"National Center for Research Resources; National Institutes of Health; Novo Nordisk; National Institute for Health and Care Research; Canadian Institutes of Health Research; Lupus Research Alliance; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Versus Arthritis; National Center for Chronic Disease Prevention and Health Promotion; University of Calgary; Wellcome Trust; Arthritis Society; Gigtforeningen; Johns Hopkins University; Eusko Jaurlaritza; Université Laval","keywords":"Medicine; Cohort; Cohort study; Systemic lupus erythematosus; Internal medicine; Disease","score_opus":0.09901226913539779,"score_gpt":0.37169586252993697,"score_spread":0.2726835933945392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999809542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971171,0.00028971295,0.0011029996,0.00025037638,0.00008119294,0.0010008626,0.000104780825,0.000018165088,0.000034819248],"genre_scores_gemma":[0.9991722,0.00015338656,0.00047057564,0.00005468881,0.00001109939,0.00005070423,0.000040784686,0.000025146675,0.000021378337],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99695754,0.0003114667,0.0011355341,0.00037375654,0.00096125423,0.00026045137],"domain_scores_gemma":[0.99838465,0.00013297428,0.00053777924,0.00054954935,0.00022697085,0.00016808925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047857608,0.00020415615,0.0010548373,0.00079975266,0.000026052705,0.000011799113,0.00048727836,0.000054496013,0.00001556233],"category_scores_gemma":[0.0006359873,0.00014537493,0.00039379302,0.001645729,0.00008258933,0.00022631786,0.00016085613,0.00013505487,0.0000016760927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003629666,0.00083657907,0.9215898,0.0017883305,0.00088764593,0.0000050877006,0.001588317,0.072661415,0.00009509179,0.000044546912,0.000009940128,0.00013029478],"study_design_scores_gemma":[0.0009236634,0.00003356553,0.46657667,0.0007272762,0.000368746,0.00008439988,0.0005666869,0.53058416,0.0000063765588,0.00005989062,3.0070066e-8,0.000068566005],"about_ca_topic_score_codex":0.0002359831,"about_ca_topic_score_gemma":0.000026900729,"teacher_disagreement_score":0.45792273,"about_ca_system_score_codex":0.000081199076,"about_ca_system_score_gemma":0.0001785322,"threshold_uncertainty_score":0.5928217},"labels":[],"label_agreement":null},{"id":"W3004755250","doi":"10.1136/annrheumdis-2019-216537","title":"Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Tocilizumab; Adalimumab; Rheumatoid arthritis; Methotrexate; Antirheumatic Agents; Clinical trial; Internal medicine; Biologic Agents; Prednisolone; Glucocorticoid; Physical therapy; Oncology","score_opus":0.14206391257664952,"score_gpt":0.43538432533920196,"score_spread":0.29332041276255244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004755250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880401,0.005512485,0.00001163583,0.0013930814,0.00020720878,0.0045682737,0.00019518915,0.000029493509,0.000042514137],"genre_scores_gemma":[0.8829014,0.116318196,0.00006347476,0.00052718725,0.000029081522,0.00008317624,0.000015181436,0.000047958147,0.000014360191],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9912941,0.003555967,0.0032254094,0.00046886658,0.0010435218,0.00041214755],"domain_scores_gemma":[0.98082995,0.016506948,0.0014675088,0.0006759845,0.00019702462,0.0003225969],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0038253667,0.00041360152,0.0033259199,0.00021474132,0.00007867888,0.000029610843,0.00035294617,0.00012976995,0.00025607736],"category_scores_gemma":[0.027876193,0.00021699436,0.0008950591,0.0004080987,0.0003399707,0.0001222317,0.0000871007,0.00028795836,0.0000059631116],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4056609,0.0022975698,0.029378483,0.0003993767,0.0010528825,0.0000064570204,0.00073979597,0.000070417715,0.00009360121,0.00007373373,0.0001349975,0.5600918],"study_design_scores_gemma":[0.5506329,0.09494136,0.31541824,0.018082026,0.00007660902,0.000004915181,0.00041124533,0.0008746904,0.018129876,0.00039100766,0.00041466134,0.000622468],"about_ca_topic_score_codex":0.00009868312,"about_ca_topic_score_gemma":0.000014226748,"teacher_disagreement_score":0.55946934,"about_ca_system_score_codex":0.000017595414,"about_ca_system_score_gemma":0.00033634654,"threshold_uncertainty_score":0.9803124},"labels":[],"label_agreement":null},{"id":"W3005060615","doi":"10.1136/annrheumdis-2020-216955","title":"Response to: ‘Dupilumab as a potential steroid-sparing treatment for IgG4-related disease’ by Della-Torre et al","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AllerGen","funders":"Regeneron Pharmaceuticals; Genentech; GlaxoSmithKline; AstraZeneca","keywords":"Dupilumab; Medicine; Dermatology; Internal medicine; Atopic dermatitis","score_opus":0.02994055366469405,"score_gpt":0.3119556149331076,"score_spread":0.2820150612684135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005060615","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1585616,0.0052214446,0.000033474164,0.8264817,0.0007114569,0.003590982,0.004999397,0.00023787639,0.0001620485],"genre_scores_gemma":[0.20327197,0.0009276244,0.000043560998,0.7850072,0.00028013677,0.0006339986,0.0025830688,0.00029840233,0.0069540627],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511445,0.000649577,0.0013102518,0.0009239735,0.0011325625,0.0008692161],"domain_scores_gemma":[0.99594736,0.00073150283,0.00077114097,0.0013790359,0.0003396688,0.00083131035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002343006,0.00093973655,0.0015548454,0.00025427272,0.0002884094,0.00013028772,0.0006962069,0.0003767053,0.00037086112],"category_scores_gemma":[0.001764086,0.00066997425,0.0018461229,0.00033685096,0.00023645385,0.00017841294,0.0002557615,0.00055779284,0.00021204671],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008236648,0.0006662663,0.0001455439,0.0010599907,0.002242402,0.0003028248,0.0003097593,0.00011443704,0.0002255151,0.0000146205175,0.9831509,0.0035310844],"study_design_scores_gemma":[0.008462744,0.003571683,0.0030559956,0.008565697,0.005955258,0.000077848366,0.00027099124,0.0010155012,0.0013145315,0.0010684421,0.965162,0.0014793272],"about_ca_topic_score_codex":0.000087521104,"about_ca_topic_score_gemma":0.0000012158008,"teacher_disagreement_score":0.04471037,"about_ca_system_score_codex":0.00015663085,"about_ca_system_score_gemma":0.0011705363,"threshold_uncertainty_score":0.99957514},"labels":[],"label_agreement":null},{"id":"W3007319208","doi":"10.1136/annrheumdis-2019-216819","title":"Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; McMaster University; Research Canada; Southlake Regional Health Center; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Toronto; Centre Hospitalier Universitaire de Sherbrooke; University of Alberta","funders":"AbbVie","keywords":"Medicine; Rheumatoid arthritis; Cohort; Physical therapy; Internal medicine; Cohort study; Arthritis; Intensive care medicine","score_opus":0.041842329167429304,"score_gpt":0.3196719241363454,"score_spread":0.27782959496891607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007319208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867497,0.008470051,0.000011460493,0.0031324904,0.000021509335,0.00086553965,0.00026903776,0.000017437833,0.00046277317],"genre_scores_gemma":[0.97083956,0.02848049,0.00018607096,0.00032417435,0.000005163577,0.00005396068,0.00007596608,0.000023883276,0.000010738829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667597,0.00033362478,0.0012817442,0.00037890565,0.0009237657,0.00040600402],"domain_scores_gemma":[0.99755734,0.0005247494,0.0006017714,0.0005634205,0.00043562098,0.00031707334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044724712,0.00025114146,0.0013851672,0.00070726214,0.0000411741,0.00002226137,0.0003401171,0.00006487714,0.00023256542],"category_scores_gemma":[0.0033110976,0.00019342263,0.00046123422,0.0029754057,0.0002131065,0.00020767718,0.00014045555,0.00015416039,0.0000067401734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002205006,0.0016730742,0.9761434,0.00022758407,0.0020584941,0.00002652909,0.0024363368,0.00018817215,0.00006032706,0.0000585853,0.00077900826,0.014143466],"study_design_scores_gemma":[0.002650534,0.0005690663,0.98986906,0.0036570115,0.00014065544,0.000002788219,0.0005674952,0.0010434784,0.0010903376,0.000101538666,0.00014934214,0.00015869335],"about_ca_topic_score_codex":0.001789469,"about_ca_topic_score_gemma":0.00022609577,"teacher_disagreement_score":0.02001044,"about_ca_system_score_codex":0.00002828498,"about_ca_system_score_gemma":0.00017845702,"threshold_uncertainty_score":0.7887546},"labels":[],"label_agreement":null},{"id":"W3009481934","doi":"10.1136/annrheumdis-2020-217105","title":"Response to: ‘Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?’ by Teng et al","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatism; Rheumatology; Internal medicine; Cohort; Disease; League; Systemic lupus erythematosus; Systemic disease; Lupus erythematosus; Dermatology; Physical therapy; Immunology; Antibody","score_opus":0.05133118986502631,"score_gpt":0.3446956915008542,"score_spread":0.2933645016358279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009481934","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38600585,0.0019332184,0.0002053683,0.59949785,0.00047289254,0.0045141564,0.0072308765,0.000093058414,0.000046750327],"genre_scores_gemma":[0.8326659,0.0024566907,0.00012960735,0.16159937,0.00008228427,0.00089817325,0.0006886363,0.0003778801,0.0011014468],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885591,0.0052563003,0.0021731665,0.0011112445,0.0019141746,0.0009860109],"domain_scores_gemma":[0.98621064,0.006330896,0.0029702703,0.0030512246,0.00078208046,0.0006549046],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027940443,0.00090801617,0.0026442672,0.00051933597,0.00031266527,0.000095374606,0.002192358,0.00025843794,0.000045142606],"category_scores_gemma":[0.009989269,0.0005832211,0.0011284542,0.00094779395,0.0012755835,0.0001620222,0.00059142476,0.0012756629,0.00008759149],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053055435,0.00035703531,0.0043290183,0.00998749,0.0010627782,0.000092277165,0.001083195,0.000005742771,0.0021284344,0.00007207551,0.9742162,0.0013602077],"study_design_scores_gemma":[0.022582179,0.0048535042,0.028563883,0.20869222,0.0056168297,0.02734527,0.015428594,0.008238855,0.0020753585,0.0019235243,0.6680848,0.0065949555],"about_ca_topic_score_codex":0.00008587249,"about_ca_topic_score_gemma":0.000002893657,"teacher_disagreement_score":0.44666007,"about_ca_system_score_codex":0.00012740244,"about_ca_system_score_gemma":0.0013867549,"threshold_uncertainty_score":0.9996619},"labels":[],"label_agreement":null},{"id":"W3010551274","doi":"10.1136/annrheumdis-2019-216846","title":"Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Rheumatology; Family medicine; Internal medicine","score_opus":0.12362840166495037,"score_gpt":0.38360686865834714,"score_spread":0.2599784669933968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010551274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008814404,0.9664533,0.00009023132,0.02230504,0.00035578568,0.0016959241,0.00019202598,0.000047404148,0.00004589229],"genre_scores_gemma":[0.12459913,0.8747471,0.00012843678,0.0002163045,0.0000130564495,0.000058397014,0.00014776459,0.000030615807,0.0000591746],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969828,0.00021990603,0.0016895728,0.00039190284,0.00036506273,0.00035075197],"domain_scores_gemma":[0.99660164,0.00017773887,0.0019877383,0.000787183,0.00027672088,0.00016895833],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041484897,0.00034969475,0.002382268,0.00036975864,0.00005529023,0.000017263326,0.0006700127,0.001327104,0.00002792409],"category_scores_gemma":[0.0021790604,0.00022346726,0.00047328134,0.004303263,0.00078623986,0.00008053095,0.00033176903,0.00087780156,0.0000060169705],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028510566,0.0008255639,0.0057808333,0.043548606,0.0015046776,0.000019163112,0.00023819057,0.0000114883605,5.938714e-7,0.0365473,0.009990173,0.9012483],"study_design_scores_gemma":[0.0037700648,0.001164144,0.0107749365,0.55767167,0.005311477,0.00019298108,0.0028142028,0.0004723239,0.00014553068,0.0074913325,0.40861788,0.0015734384],"about_ca_topic_score_codex":0.000016800908,"about_ca_topic_score_gemma":0.000009917988,"teacher_disagreement_score":0.8996749,"about_ca_system_score_codex":0.000033795408,"about_ca_system_score_gemma":0.00069771433,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W3010731257","doi":"10.1136/annrheumdis-2019-eular.576","title":"SAT0613 CHANGING TREATMENTS AND OUTCOMES FOR JUVENILE IDIOPATHIC ARTHRITIS: INITIAL FINDINGS FROM A NEW CANADIAN INCEPTION COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Arthritis Society; F. Hoffmann-La Roche","keywords":"Medicine; Cohort; Oligoarthritis; Rheumatology; Incidence (geometry); Pediatrics; Arthritis; Internal medicine; Adverse effect; Cumulative incidence; Cohort study; Physical therapy","score_opus":0.07112122782821684,"score_gpt":0.399709323063152,"score_spread":0.32858809523493515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010731257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896863,0.0022605313,0.000017086302,0.0048703467,0.0005668893,0.0017343373,0.00075904594,0.000025297693,0.00008013041],"genre_scores_gemma":[0.9965309,0.0006977723,0.00003265214,0.0017085386,0.00013757385,0.000092041526,0.00009180708,0.000020105892,0.0006885929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848336,0.00018654697,0.00048779958,0.00019009462,0.00019095886,0.00046122147],"domain_scores_gemma":[0.99870044,0.00037205956,0.00023913117,0.0002546513,0.00008043891,0.00035328235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030332364,0.00014536585,0.00043352979,0.00012479282,0.00041507097,0.00001119828,0.00014123089,0.00011042945,0.00024050746],"category_scores_gemma":[0.0004153031,0.00010644187,0.00012296572,0.00012199546,0.000025040808,0.0001236,0.00006148846,0.00012228517,0.0000671407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003810347,0.000026184327,0.9740802,0.0004162697,0.00006463719,4.974471e-7,0.0031143718,0.0000010148487,8.2225415e-7,0.00013731593,0.004395902,0.017724685],"study_design_scores_gemma":[0.0012229887,0.000060073788,0.99048054,0.0023667202,0.000085298285,2.2869561e-7,0.0017870526,0.0000933502,0.000005032839,0.003330893,0.0004393175,0.0001284896],"about_ca_topic_score_codex":0.07427669,"about_ca_topic_score_gemma":0.016816253,"teacher_disagreement_score":0.05746044,"about_ca_system_score_codex":0.000068902584,"about_ca_system_score_gemma":0.0009340704,"threshold_uncertainty_score":0.9383864},"labels":[],"label_agreement":null},{"id":"W3011433190","doi":"10.1136/annrheumdis-2019-216764","title":"Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Toronto","funders":"University of Toronto; University Health Network","keywords":"Medicine; Internal medicine; Blood pressure; Cardiology; Incidence (geometry); Connective tissue disease; Coronary artery disease; Systemic lupus erythematosus; Disease; Autoimmune disease","score_opus":0.06407285163702163,"score_gpt":0.31201497402221406,"score_spread":0.24794212238519242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011433190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650836,0.0005310078,0.000011819136,0.0014513414,0.00008301406,0.0011583336,0.0001961878,0.000011945056,0.00004798367],"genre_scores_gemma":[0.99941355,0.0003591701,0.0000333604,0.000097451244,0.000021633765,0.000020311922,0.0000056725853,0.000028420613,0.000020422593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967659,0.0008300105,0.0009094247,0.00021843794,0.0010015639,0.00027465416],"domain_scores_gemma":[0.9968692,0.00080459466,0.0011381395,0.00070191507,0.0003326765,0.00015348957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005399757,0.00019489479,0.0015147558,0.00013196246,0.000030740313,0.000001696271,0.0003281987,0.000056558903,0.000009015437],"category_scores_gemma":[0.0035228466,0.000111226494,0.0009027582,0.0009570979,0.00024052666,0.000039842085,0.00011252179,0.00013250863,0.0000048150396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046706115,0.00026544475,0.98920333,0.0017260496,0.0007275812,0.0000011859355,0.00054075784,0.0005215898,0.0036862604,0.000055199773,0.0026073155,0.0001982287],"study_design_scores_gemma":[0.002485708,0.0012482378,0.98099905,0.009887184,0.00035347062,0.00023485816,0.0021255855,0.0005396739,0.0015580262,0.00043148638,0.0000033238803,0.0001333663],"about_ca_topic_score_codex":0.00066998793,"about_ca_topic_score_gemma":0.000005819632,"teacher_disagreement_score":0.008204246,"about_ca_system_score_codex":0.00014058172,"about_ca_system_score_gemma":0.00044799197,"threshold_uncertainty_score":0.4535685},"labels":[],"label_agreement":null},{"id":"W3013790199","doi":"10.1136/annrheumdis-2020-eular.5010","title":"OP0277 AURORA PHASE 3 STUDY DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Placebo; Lupus nephritis; Internal medicine; Clinical endpoint; Phases of clinical research; Calcineurin; Proteinuria; Surrogate endpoint; Randomized controlled trial; Statistical significance; Clinical trial; Gastroenterology; Disease; Kidney; Transplantation; Pathology","score_opus":0.04649363614758237,"score_gpt":0.3739298829634106,"score_spread":0.3274362468158283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013790199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923721,0.0035409115,0.000020738296,0.0010896296,0.0001065001,0.0015945485,0.0011161317,0.000028651555,0.00013079679],"genre_scores_gemma":[0.99934417,0.00028042754,0.00012721686,0.00009451634,0.00002875819,0.00004250469,0.000026548605,0.000029705947,0.000026131962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969738,0.00035394682,0.0008886031,0.00031451095,0.0011158384,0.00035328275],"domain_scores_gemma":[0.99807084,0.00046977834,0.00019794883,0.00055657973,0.0003429405,0.00036194196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031223966,0.00022199393,0.0010346094,0.00009890978,0.000049814316,0.000023872099,0.00035129132,0.000056025798,0.00035572963],"category_scores_gemma":[0.0022512064,0.00015693894,0.0002031239,0.0004702541,0.00029700535,0.000107527965,0.0001899654,0.0001895791,0.000008013358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035020267,0.0015266364,0.9696297,0.005796135,0.0002767488,0.00014932771,0.007994765,0.00001316656,0.00012185917,0.0002832596,0.0023016883,0.008404705],"study_design_scores_gemma":[0.049894474,0.021893974,0.7401973,0.017571958,0.0013098893,0.0005897168,0.15427041,0.0027233816,0.0075373994,0.0022631634,0.0005936248,0.0011546925],"about_ca_topic_score_codex":0.00025331616,"about_ca_topic_score_gemma":0.00005909914,"teacher_disagreement_score":0.22943236,"about_ca_system_score_codex":0.00004693289,"about_ca_system_score_gemma":0.0005518819,"threshold_uncertainty_score":0.6399784},"labels":[],"label_agreement":null},{"id":"W3014194256","doi":"10.1136/annrheumdis-2019-216296","title":"Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer; Eli Lilly and Company","keywords":"WOMAC; Osteoarthritis; Medicine; Placebo; Internal medicine; Physical therapy; Surgery; Pathology","score_opus":0.046300373237771905,"score_gpt":0.2876616690346077,"score_spread":0.2413612957968358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014194256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851373,0.0023294103,0.000018835448,0.0031169513,0.00021653608,0.007057116,0.0020042227,0.00005081027,0.0000688322],"genre_scores_gemma":[0.998289,0.00018933469,0.0001457836,0.00034758,0.000050076273,0.00023543256,0.00010660138,0.00005082431,0.0005853587],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975087,0.00022469455,0.0008915855,0.0004539351,0.0005866992,0.00033440956],"domain_scores_gemma":[0.99712515,0.0010443451,0.00056475477,0.00072803354,0.00022494607,0.00031278856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019216747,0.00036515464,0.0011396619,0.00004674129,0.00023426118,0.00004704047,0.00028272116,0.00006467684,0.0000856936],"category_scores_gemma":[0.001807709,0.00018953404,0.00039630718,0.000266328,0.00023855198,0.00010780752,0.00012606729,0.0001150528,0.0000026584419],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79112154,0.0065691504,0.00027486106,0.0005704369,0.0015269539,0.0002289475,0.01616875,0.00001305469,0.001220336,0.000044965625,0.0014867109,0.18077429],"study_design_scores_gemma":[0.8785652,0.088031694,0.0015824203,0.005409087,0.0049225385,0.00015892589,0.012271173,0.00025485238,0.0073348847,0.00039195464,0.0005103178,0.0005669847],"about_ca_topic_score_codex":0.000076588796,"about_ca_topic_score_gemma":0.00008501667,"teacher_disagreement_score":0.18020731,"about_ca_system_score_codex":0.00001492792,"about_ca_system_score_gemma":0.000287752,"threshold_uncertainty_score":0.7728974},"labels":[],"label_agreement":null},{"id":"W3016646661","doi":"10.1136/annrheumdis-2019-216823","title":"Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital; Western University","funders":"Chugai Pharmaceutical; Genentech; Medac; Astellas Pharma; Ono Pharmaceutical; Eisai; Sanofi; Bayer HealthCare; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Alexion Pharmaceuticals; Immune Tolerance Network; GlaxoSmithKline; Bayer; Daiichi-Sankyo; Pfizer","keywords":"Medicine; Riociguat; Double blind; Placebo; Scleroderma (fungus); Double blinded; Placebo-controlled study; Randomized controlled trial; Internal medicine; Pathology; Pulmonary hypertension; Chronic thromboembolic pulmonary hypertension","score_opus":0.04725101955671286,"score_gpt":0.2643723640259998,"score_spread":0.21712134446928694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016646661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98382944,0.0048935683,0.000005146259,0.0009595629,0.00026457853,0.00975602,0.00008942038,0.000083144165,0.000119131066],"genre_scores_gemma":[0.9980532,0.0008588471,0.000009463083,0.00037216934,0.00008937717,0.0004287317,0.000028798044,0.000061576175,0.000097849],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962487,0.0003907218,0.0013700713,0.00046716852,0.0010509243,0.00047239618],"domain_scores_gemma":[0.9969863,0.0006305981,0.000838073,0.0006719293,0.000294766,0.00057833135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021528901,0.00043324594,0.0016599265,0.00014051143,0.00011821269,0.000068972695,0.00041077254,0.00015149824,0.00010600424],"category_scores_gemma":[0.0011767574,0.00023836805,0.00076858076,0.0004659073,0.00016097903,0.00014221242,0.000096845986,0.00020874482,0.000043077547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9522083,0.0030491916,0.038228,0.00082850945,0.0012683084,0.000011854221,0.0011262293,0.00030314398,0.00003432645,0.000007344032,0.0008467973,0.0020880408],"study_design_scores_gemma":[0.96033376,0.0010008854,0.02303937,0.012103375,0.001855975,0.0000046672653,0.0005397107,0.00067715376,0.00012886504,0.000007458475,0.0000039357255,0.00030482272],"about_ca_topic_score_codex":0.0001133499,"about_ca_topic_score_gemma":0.0000037631419,"teacher_disagreement_score":0.01518863,"about_ca_system_score_codex":0.00004814767,"about_ca_system_score_gemma":0.0002332889,"threshold_uncertainty_score":0.9720367},"labels":[],"label_agreement":null},{"id":"W3016704917","doi":"10.1136/annrheumdis-2020-217480","title":"Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance; McMaster University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Status quo; Medicine; Coronavirus disease 2019 (COVID-19); Economics","score_opus":0.06541760685145404,"score_gpt":0.31326924948202767,"score_spread":0.24785164263057363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016704917","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039115522,0.0050776503,0.0000018578309,0.95298034,0.00019955791,0.0009721051,0.0004993151,0.000027381866,0.0011262512],"genre_scores_gemma":[0.4014162,0.0053830566,0.000008143763,0.59266263,0.000084913394,0.00006551884,0.000031159136,0.000035775905,0.0003126042],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974917,0.00044669985,0.0006175327,0.0003088892,0.0007159994,0.00041914804],"domain_scores_gemma":[0.9967235,0.0011494033,0.0009590163,0.00093564106,0.000017690141,0.00021476203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033535485,0.00030624072,0.00064776983,0.000024050356,0.000361879,0.000037587542,0.0013184447,0.00013456651,0.0005962861],"category_scores_gemma":[0.0025366729,0.00013717597,0.00034282636,0.00025891882,0.0021468294,0.00008168213,0.0010210883,0.00043357906,0.000042869957],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007552723,0.000053677682,0.011061802,0.0012797375,0.000053248474,0.000004119439,0.0011213097,0.000041750143,0.0000029475923,0.00008901469,0.98367375,0.002543114],"study_design_scores_gemma":[0.0033769736,0.00030385348,0.077280715,0.00536667,0.0009953331,0.00014143923,0.0020603938,0.0025583107,0.00034140152,0.13530643,0.77106225,0.0012062357],"about_ca_topic_score_codex":0.0025545263,"about_ca_topic_score_gemma":0.00007728318,"teacher_disagreement_score":0.3623007,"about_ca_system_score_codex":0.000038425667,"about_ca_system_score_gemma":0.00009577165,"threshold_uncertainty_score":0.79100823},"labels":[],"label_agreement":null},{"id":"W3018517995","doi":"10.1136/annrheumdis-2020-217139","title":"EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cilag; Pharmacyclics; Chugai Pharmaceutical; LEO Pharma; Regeneron Pharmaceuticals; Gilead Sciences; European League Against Rheumatism; Celgene; Biogen; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Immunotherapy; Cancer immunotherapy; Adverse effect; Cancer; Ipilimumab; Immunology; Intensive care medicine; Oncology; Internal medicine","score_opus":0.04184898885750181,"score_gpt":0.3192135867304184,"score_spread":0.27736459787291656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018517995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396714,0.01028695,0.000126812,0.04635802,0.00012753351,0.00327872,0.00010398791,0.000029207591,0.000017366829],"genre_scores_gemma":[0.9883037,0.0068713133,0.00031835452,0.0037286947,0.00000995585,0.0006587031,0.000004174593,0.00004609034,0.0000589768],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984333,0.00006341454,0.00068238913,0.00022632416,0.00036759351,0.00022696517],"domain_scores_gemma":[0.99868506,0.00023226124,0.00033434795,0.0004551664,0.0001392226,0.00015392147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027553132,0.0002171152,0.0005188387,0.00005805009,0.00008935483,0.000008446963,0.00023532711,0.00003309079,0.00013620246],"category_scores_gemma":[0.00013562897,0.00011772063,0.00031441438,0.00038569918,0.00014739094,0.000058755897,0.00010025907,0.000054888056,0.0000028071893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060359225,0.0039390116,0.100597866,0.02748377,0.053677388,0.00004529924,0.03848535,0.003230158,0.006250898,0.0009196384,0.05275427,0.65225714],"study_design_scores_gemma":[0.012741424,0.0022079765,0.9101811,0.025486099,0.0018981303,0.000017786928,0.0054438175,0.00064402923,0.037023075,0.0007472089,0.002963939,0.0006453776],"about_ca_topic_score_codex":0.00033649194,"about_ca_topic_score_gemma":0.000012568609,"teacher_disagreement_score":0.80958325,"about_ca_system_score_codex":0.000025411056,"about_ca_system_score_gemma":0.000081075355,"threshold_uncertainty_score":0.4800508},"labels":[],"label_agreement":null},{"id":"W3020505526","doi":"10.1136/annrheumdis-2019-216841","title":"Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials?","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Pfizer UK; UCB UK; British Society for Rheumatology; AbbVie","keywords":"BASFI; BASDAI; Medicine; Ankylosing spondylitis; Clinical trial; Physical therapy; Internal medicine; Rheumatology; Infliximab; Cohort; Disease; Psoriatic arthritis","score_opus":0.2658216932135522,"score_gpt":0.431636843188721,"score_spread":0.16581514997516877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020505526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9343678,0.010182872,0.000001179248,0.05305353,0.00022658244,0.0008133987,0.001187707,0.000019229792,0.00014774122],"genre_scores_gemma":[0.9723762,0.025924588,0.000049720675,0.0012756276,0.00019993373,0.000042447293,0.00006122562,0.00001595039,0.00005427002],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99627286,0.00097324036,0.001740473,0.00030974115,0.0004853366,0.00021836144],"domain_scores_gemma":[0.99569535,0.0026272957,0.0007925517,0.0005576617,0.00014572278,0.00018144511],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011129138,0.00019039314,0.0010437001,0.000055968012,0.00007899513,0.000016413333,0.00017287207,0.000052882308,0.00009296128],"category_scores_gemma":[0.010558125,0.00010727642,0.0005663927,0.0004063823,0.00029993427,0.000089247624,0.00015387806,0.00014721531,0.0000086152295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05925573,0.0061774733,0.24955924,0.002056366,0.003984685,0.0006307168,0.013423174,0.0003197311,0.00093441043,0.0020330076,0.14674875,0.5148767],"study_design_scores_gemma":[0.018428382,0.0015520264,0.9447664,0.022036862,0.001165867,0.000006624617,0.0014617878,0.00042179727,0.003723653,0.0052579762,0.00084329117,0.00033530523],"about_ca_topic_score_codex":0.003483153,"about_ca_topic_score_gemma":0.001465739,"teacher_disagreement_score":0.6952072,"about_ca_system_score_codex":0.000017143791,"about_ca_system_score_gemma":0.00018284887,"threshold_uncertainty_score":0.9977764},"labels":[],"label_agreement":null},{"id":"W3021060361","doi":"10.1136/annrheumdis-2020-217232","title":"Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cohort; Sacroiliac joint; Radiology; Internal medicine","score_opus":0.07498199842648659,"score_gpt":0.32338166852821343,"score_spread":0.24839967010172684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021060361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773028,0.0016441752,0.000004326739,0.019431688,0.00006409568,0.0009775141,0.0004338016,0.0000049857354,0.00013663409],"genre_scores_gemma":[0.99901617,0.00062965025,0.000008116207,0.0002474044,0.000018087041,0.00003569223,0.000014745669,0.000012087439,0.000018071221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816823,0.00030699905,0.00038244892,0.00016252109,0.0008144997,0.00016531289],"domain_scores_gemma":[0.99823254,0.00032299923,0.0004883169,0.000651128,0.0002497073,0.00005532797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030657675,0.0001643841,0.0003537038,0.000012167234,0.0001862101,0.0000113740425,0.0002532378,0.000028855968,0.0000708395],"category_scores_gemma":[0.0005366196,0.00005368428,0.00020932994,0.00021028215,0.00091174553,0.00006624059,0.00008636265,0.000082245424,6.9322033e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017265371,0.00059225236,0.9650604,0.00041136722,0.0020884308,3.3327993e-7,0.010555992,0.00065294106,0.00051963574,0.00026175033,0.007105869,0.011024497],"study_design_scores_gemma":[0.0008377657,0.00030679893,0.9802854,0.0017977377,0.000903427,0.0000017402449,0.005918804,0.005798308,0.0039005266,0.00018141644,0.0000140014245,0.00005406965],"about_ca_topic_score_codex":0.0006628443,"about_ca_topic_score_gemma":0.000079868005,"teacher_disagreement_score":0.021713367,"about_ca_system_score_codex":0.000025697846,"about_ca_system_score_gemma":0.00017132988,"threshold_uncertainty_score":0.33593646},"labels":[],"label_agreement":null},{"id":"W3021149257","doi":"10.1136/annrheumdis-2020-217363","title":"Does cartilage loss cause pain in osteoarthritis and if so, how much?","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health; Amgen; Stryker; Sanofi; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Foundation for the National Institutes of Health","keywords":"Osteoarthritis; Medicine; WOMAC; Cartilage; Synovitis; Knee pain; Arthritis; Internal medicine; Surgery; Pathology; Anatomy","score_opus":0.02540190928047172,"score_gpt":0.2630557394623303,"score_spread":0.23765383018185857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021149257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700538,0.0032081215,0.0000059616323,0.025878234,0.00008100127,0.0005498747,0.00011232537,0.00003674308,0.000073941344],"genre_scores_gemma":[0.9971387,0.0007566665,0.00005206363,0.00168572,0.000035421064,0.000038985123,0.000017217852,0.00001997904,0.00025524566],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989259,0.00013605107,0.00024083428,0.00021156251,0.0002488195,0.0002368271],"domain_scores_gemma":[0.9991922,0.00013378648,0.0001051829,0.0002735409,0.000050226812,0.00024506496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014231406,0.00016726337,0.0004001566,0.000044969453,0.00006266334,0.000038181064,0.00010075331,0.00004526639,0.000067667774],"category_scores_gemma":[0.0006537668,0.00009248977,0.00014198272,0.0001491152,0.00015405322,0.00011502785,0.00008062842,0.00006848067,0.0000067489577],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010492704,0.001088042,0.115841635,0.0031079934,0.00023434815,0.00071655784,0.0074624317,0.000004858808,0.0055153146,0.0019890857,0.007987895,0.8550026],"study_design_scores_gemma":[0.07264737,0.037587766,0.23343275,0.042608608,0.003901963,0.00029842107,0.03763315,0.0014514874,0.48780483,0.055835284,0.02266868,0.0041296696],"about_ca_topic_score_codex":0.000018360508,"about_ca_topic_score_gemma":0.00005194509,"teacher_disagreement_score":0.8508729,"about_ca_system_score_codex":0.0000066206385,"about_ca_system_score_gemma":0.00006278826,"threshold_uncertainty_score":0.37716234},"labels":[],"label_agreement":null},{"id":"W3024016727","doi":"10.1136/annrheumdis-2020-217871","title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":1179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Canadian Arthritis Patient Alliance","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Internal medicine; Rheumatology; Odds ratio; Logistic regression; Hydroxychloroquine; Prednisone; Comorbidity; Coronavirus disease 2019 (COVID-19); Epidemiology; Disease; Infectious disease (medical specialty)","score_opus":0.17768799865497348,"score_gpt":0.43385671359188105,"score_spread":0.25616871493690757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024016727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7303339,0.0012396002,0.003790953,0.25196537,0.000082374514,0.0031009314,0.00933733,0.00013722527,0.000012314803],"genre_scores_gemma":[0.9688983,0.0014895664,0.00008637377,0.02712188,0.000034695455,0.0002941862,0.002002818,0.00003985414,0.00003233451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99593997,0.00045813946,0.0011090294,0.00080002274,0.0011386186,0.0005542149],"domain_scores_gemma":[0.9776122,0.016406504,0.0017250084,0.0024813148,0.000479349,0.0012956335],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008326348,0.00039320355,0.0012264925,0.000028246044,0.00029858283,0.000069733585,0.0012959129,0.00008600597,0.000058695878],"category_scores_gemma":[0.25524187,0.00022150982,0.00021910755,0.0008566559,0.0008854992,0.00021855597,0.0005461367,0.00024365821,0.0000073373667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004088324,0.0010158963,0.9455182,0.004441369,0.0016783751,0.000046753143,0.0009190479,0.0006355839,0.000001576319,0.00027786347,0.040360425,0.0010166158],"study_design_scores_gemma":[0.0040394044,0.0004145029,0.970589,0.002440419,0.0009269678,0.0000021058977,0.00058859686,0.016506264,0.000001823528,0.002871665,0.0012948964,0.0003243754],"about_ca_topic_score_codex":0.0015832756,"about_ca_topic_score_gemma":0.00066697935,"teacher_disagreement_score":0.25440922,"about_ca_system_score_codex":0.00026041013,"about_ca_system_score_gemma":0.0041204263,"threshold_uncertainty_score":0.9032908},"labels":[],"label_agreement":null},{"id":"W3024391321","doi":"10.1136/annrheumdis-2020-217309","title":"Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Pfizer UK; Novartis Pharmaceuticals UK Limited; Celgene; Pfizer","keywords":"Medicine; Tumor necrosis factor alpha; Enthesis; Immunology; Interleukin 17; CD8; Cell biology; Cytokine; Immune system; Pathology; Biology","score_opus":0.024725711867674145,"score_gpt":0.260040887576062,"score_spread":0.23531517570838784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024391321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991964,0.003965747,0.000006843401,0.0034236573,0.000017353601,0.00024270263,0.00004600086,0.000019837391,0.00031387503],"genre_scores_gemma":[0.9984351,0.00040672437,0.000067226414,0.0009223023,0.000019916644,0.00000959283,0.00000980599,0.000013262703,0.00011611542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916416,0.000051877178,0.00017407101,0.00019737256,0.00026164693,0.00015084916],"domain_scores_gemma":[0.9992924,0.00007882768,0.0001116994,0.00017310338,0.000045865647,0.00029815224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007912057,0.00013505602,0.0002579312,0.000044438737,0.0001283352,0.000026707095,0.000067269015,0.000041574385,0.0000692473],"category_scores_gemma":[0.000099587305,0.000084552456,0.000059737133,0.00007261571,0.00030092165,0.00011343977,0.00006464832,0.00007116605,9.785108e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006770539,0.0025165505,0.65864605,0.018109199,0.0019338722,0.00006347288,0.012193171,0.00009363576,0.05719655,0.008029757,0.1838471,0.050600123],"study_design_scores_gemma":[0.0024850809,0.00054278446,0.9557823,0.0019557849,0.0003235716,0.00001895381,0.0015642707,0.000094401985,0.035164874,0.0014939996,0.00033023124,0.00024374684],"about_ca_topic_score_codex":0.000021821215,"about_ca_topic_score_gemma":0.000002700978,"teacher_disagreement_score":0.29713628,"about_ca_system_score_codex":0.0000019467354,"about_ca_system_score_gemma":0.000049749866,"threshold_uncertainty_score":0.3447949},"labels":[],"label_agreement":null},{"id":"W3026709214","doi":"10.1136/annrheumdis-2020-217835","title":"Hydroxychloroquine shortages during the COVID-19 pandemic","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Toronto Western Hospital; Southlake Regional Health Center; Research Canada; University of British Columbia; McGill University Health Centre","funders":"","keywords":"Hydroxychloroquine; Medicine; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Economic shortage; Betacoronavirus; Pneumonia; Intensive care medicine; Internal medicine; Outbreak; Infectious disease (medical specialty)","score_opus":0.10614487550887095,"score_gpt":0.34731767576248895,"score_spread":0.241172800253618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026709214","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15268466,0.0028174343,0.000010364147,0.8419329,0.0003208052,0.0011610658,0.00042496028,0.00018139368,0.0004664097],"genre_scores_gemma":[0.34817797,0.00085314404,0.000010643139,0.6477828,0.0007674711,0.00007399333,0.0001394191,0.00009319594,0.0021013648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964884,0.00039841322,0.0008008968,0.0005210197,0.001241897,0.00054937956],"domain_scores_gemma":[0.99630815,0.00074752286,0.0006609795,0.0017839833,0.000116719944,0.00038266994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028794477,0.0005259806,0.0010836135,0.00011748567,0.00027006186,0.000051861938,0.0011593403,0.00028962098,0.00031655628],"category_scores_gemma":[0.0041645826,0.00028741098,0.0010211251,0.0003560536,0.0004934842,0.00008199584,0.0004451941,0.0012999998,0.000081381615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007938035,0.00012225969,0.009356191,0.0055411984,0.0011078651,0.00027829804,0.00033827874,0.000044115117,0.00010996493,0.0000096141075,0.9817709,0.0012419887],"study_design_scores_gemma":[0.003259569,0.0002887109,0.08713657,0.006724462,0.004840012,0.00076163776,0.00041846404,0.00041751433,0.0019350281,0.005966237,0.88650453,0.0017472574],"about_ca_topic_score_codex":0.0001323237,"about_ca_topic_score_gemma":0.0000082969345,"teacher_disagreement_score":0.19549333,"about_ca_system_score_codex":0.000094906245,"about_ca_system_score_gemma":0.0005603513,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W3032904473","doi":"10.1136/annrheumdis-2020-eular.2710","title":"SAT0440 METHOTREXATE SURVIVAL RATE IN PATIENTS WITH PSORIATIC ARTHRITIS FROM PSORIATIC ARTHRITIS –INTERNATIONAL DATABASE (PsArt-ID) COHORT","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Discontinuation; Psoriatic arthritis; Internal medicine; Methotrexate; Proportional hazards model; Cohort; Psoriasis; Prospective cohort study; Hazard ratio; Rheumatoid arthritis; Surgery; Confidence interval; Immunology","score_opus":0.026218103120828156,"score_gpt":0.27951527223839207,"score_spread":0.2532971691175639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032904473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98294276,0.0070001706,0.00008519265,0.0062423474,0.00044939335,0.0011274546,0.0018247995,0.000062800005,0.0002651016],"genre_scores_gemma":[0.97060823,0.027004626,0.0003695472,0.0010472103,0.000112756214,0.00008461417,0.0006949084,0.00005391924,0.00002416577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639827,0.0005176936,0.0008524544,0.00048356107,0.0012554446,0.00049259455],"domain_scores_gemma":[0.9976815,0.0005046461,0.00036461014,0.00066615664,0.000309449,0.00047361446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043352277,0.00033415382,0.0009074353,0.00014103668,0.00010719216,0.00008880541,0.00048726765,0.000054852615,0.0010998063],"category_scores_gemma":[0.0021192308,0.00023944487,0.00022094155,0.0004200964,0.00026715142,0.00041701616,0.00019927333,0.000250627,0.000084832966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004171245,0.0022375996,0.6921527,0.00042424933,0.0028145695,0.00011496912,0.0012729062,0.00009247063,0.000075650554,0.0010457168,0.012592062,0.28300586],"study_design_scores_gemma":[0.0105764605,0.0005122419,0.9795184,0.004241297,0.00005725453,0.000002447917,0.0002658482,0.00071346323,0.00043650807,0.0019917914,0.0013324653,0.00035179753],"about_ca_topic_score_codex":0.00057279854,"about_ca_topic_score_gemma":0.00016996986,"teacher_disagreement_score":0.28736573,"about_ca_system_score_codex":0.000025257583,"about_ca_system_score_gemma":0.00022663837,"threshold_uncertainty_score":0.9998133},"labels":[],"label_agreement":null},{"id":"W3032917529","doi":"10.1136/annrheumdis-2020-eular.3369","title":"FRI0501 CARDIOVASCULAR DISEASE RISK ASSESSMENT IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER RELATED AMYLOIDOSIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Familial Mediterranean fever; Amyloidosis; Internal medicine; Gastroenterology; AA amyloidosis; Risk factor; Prospective cohort study; Serum amyloid A; Disease; Proteinuria; Proportional hazards model; Inflammation; Kidney","score_opus":0.042909020630614574,"score_gpt":0.29281839793672915,"score_spread":0.24990937730611457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032917529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924967,0.0011894546,0.000013039196,0.0048635015,0.000067541296,0.0009514029,0.00022735226,0.000033323486,0.00015768573],"genre_scores_gemma":[0.99856293,0.0005671456,0.000050841227,0.00060771557,0.00003787528,0.00004501731,0.000061603634,0.0000337902,0.000033083055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968179,0.00035220606,0.0005087604,0.0003803684,0.0015857911,0.00035496184],"domain_scores_gemma":[0.99810624,0.00014597762,0.00017946154,0.00078430475,0.00023495163,0.0005490484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033502505,0.00023072324,0.00065953896,0.000097817705,0.00009469678,0.000027910799,0.0003206867,0.000054007338,0.00022721085],"category_scores_gemma":[0.001008638,0.00013630444,0.0006093255,0.00058490114,0.00019999425,0.00014730684,0.0001612142,0.00029814694,0.000018078588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008629589,0.0012376846,0.97450215,0.0005368991,0.0015155469,0.00001502625,0.00033411235,0.0006007339,0.00000566855,0.000012856964,0.0018172713,0.018559095],"study_design_scores_gemma":[0.0031493327,0.00027581278,0.9921341,0.0007691287,0.0007335634,3.3970105e-7,0.00011193232,0.002357598,0.000066046065,0.00012126716,0.00011946589,0.00016144298],"about_ca_topic_score_codex":0.00022872734,"about_ca_topic_score_gemma":0.000003353413,"teacher_disagreement_score":0.018397652,"about_ca_system_score_codex":0.000033933007,"about_ca_system_score_gemma":0.00024819255,"threshold_uncertainty_score":0.5558334},"labels":[],"label_agreement":null},{"id":"W3032917957","doi":"10.1136/annrheumdis-2020-eular.1374","title":"AB0755 REAL WORLD EFFECTIVENESS OF SECUKINUMAB IN PSORIATIC ARTHRITIS: FINDINGS FROM A RECENT CROSS SECTIONAL SURVEY OF RHEUMATOLOGISTS AND PATIENTS IN EUROPE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; Janssen Research and Development; Perelman School of Medicine, University of Pennsylvania; University of Birmingham","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Quality of life (healthcare); Concomitant; Cross-sectional study; Physical therapy; Internal medicine; Disease","score_opus":0.047087951767842105,"score_gpt":0.3186802247196823,"score_spread":0.27159227295184024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032917957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596715,0.0026058743,7.467296e-7,0.0000852111,0.00009704418,0.00051924546,0.00064678787,0.0000073009815,0.00007065573],"genre_scores_gemma":[0.99286425,0.0069426396,0.0000143440075,0.00003469393,0.0000030445224,0.000025910282,0.00009905001,0.000013342892,0.000002712675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982321,0.0003650932,0.0006703038,0.00024026085,0.0003195626,0.00017267307],"domain_scores_gemma":[0.9983917,0.0007552596,0.00027893647,0.00018916732,0.0003014487,0.000083494735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028003604,0.00015490057,0.00072992773,0.00009319748,0.000029987823,0.000008076303,0.00010845688,0.0000354237,0.000029896055],"category_scores_gemma":[0.0023385878,0.00011734962,0.00007840147,0.00065659033,0.00019566584,0.000064165506,0.00012849784,0.0000776403,0.0000015195853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001947451,0.0008365849,0.9912364,0.0006716831,0.00019244959,0.0000076102615,0.0003529143,0.000025732343,0.000005956175,0.000049143942,0.000036091238,0.004638006],"study_design_scores_gemma":[0.005703824,0.00029541925,0.9899678,0.0032383425,0.000024492416,8.522554e-7,0.000033928256,0.000050584626,0.00028908905,0.00031236126,0.0000027254248,0.00008056444],"about_ca_topic_score_codex":0.0051363935,"about_ca_topic_score_gemma":0.0014214772,"teacher_disagreement_score":0.0045574415,"about_ca_system_score_codex":0.000021685413,"about_ca_system_score_gemma":0.00008681352,"threshold_uncertainty_score":0.77647245},"labels":[],"label_agreement":null},{"id":"W3033193493","doi":"10.1136/annrheumdis-2020-eular.5872","title":"AB1170 THE IMPACT OF HIGH DISEASE ACTIVITY AS MEASURED BY SLEDAI AND DRUG BURDEN-ON HEALTHCARE UTILIZATION, QUALITY OF LIFE AND WORK PRODUCTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Propensity score matching; Disease; Quality of life (healthcare); Internal medicine; Health care; Physical therapy","score_opus":0.08104071539467608,"score_gpt":0.3608516801524519,"score_spread":0.2798109647577758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033193493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828264,0.0078016794,0.0000057197794,0.006730048,0.000066428016,0.002171689,0.00036879268,0.000019916157,0.000009330348],"genre_scores_gemma":[0.9990903,0.00067235867,0.0000021739695,0.00007460351,0.0000222365,0.000061520965,0.000017023955,0.000029966475,0.000029802983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959115,0.0013700225,0.00088071584,0.00040379964,0.0011382144,0.00029574783],"domain_scores_gemma":[0.99633044,0.0009141095,0.0008416732,0.00085215364,0.0005516053,0.00051001954],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010196927,0.00027170812,0.0010748858,0.00009502053,0.00008408359,0.000018317423,0.00028522944,0.00005800138,0.0000126289515],"category_scores_gemma":[0.009310644,0.00015202501,0.00022338283,0.00061931263,0.00037865803,0.0001266365,0.00018608554,0.00016960979,0.0000014027431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004829036,0.0007569167,0.97259206,0.013293812,0.0002784493,9.276e-7,0.0034849816,0.00007377075,0.000115011826,0.000092536895,0.0021519735,0.0023305512],"study_design_scores_gemma":[0.003485681,0.0004408996,0.9846555,0.00791142,0.000115693314,0.00002459214,0.001409939,0.0002804809,0.0006205238,0.00084565976,0.0000022536574,0.00020736484],"about_ca_topic_score_codex":0.0017320279,"about_ca_topic_score_gemma":0.000012658636,"teacher_disagreement_score":0.016263915,"about_ca_system_score_codex":0.00005544347,"about_ca_system_score_gemma":0.0005147358,"threshold_uncertainty_score":0.99903435},"labels":[],"label_agreement":null},{"id":"W3033195438","doi":"10.1136/annrheumdis-2020-eular.3974","title":"FRI0285 FILGOTINIB TREATMENT RESULTS IN REDUCTION OF BIOMARKERS ASSOCIATED WITH DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Biomarker; Ankylosing spondylitis; Internal medicine; Placebo; Gastroenterology; Pathology","score_opus":0.032370873224095896,"score_gpt":0.2691048078209133,"score_spread":0.23673393459681738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033195438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994631,0.0007238732,3.3980896e-7,0.0019396998,0.000025985328,0.0008028889,0.0017486227,0.000013998104,0.000113582566],"genre_scores_gemma":[0.99927795,0.00017157244,0.000034050172,0.000059198464,0.0000058410274,0.000033615033,0.00037943647,0.000016922155,0.000021387412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867606,0.0000974741,0.00043604907,0.0002347661,0.0003465647,0.00020908227],"domain_scores_gemma":[0.99907047,0.000096498945,0.00030615737,0.00025138783,0.00011816357,0.00015734801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006018969,0.00017871617,0.0004688193,0.00008721967,0.000040023035,0.0000061689034,0.00006606193,0.000024431405,0.000029012563],"category_scores_gemma":[0.0005274683,0.00010417991,0.000106489264,0.0005054319,0.00013981434,0.00008134218,0.000029055545,0.00003850696,8.625715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015728481,0.0029973977,0.9707542,0.00019066887,0.0006940077,0.000035642126,0.0010413284,0.00012037344,0.0000027153285,0.00001085796,0.0002079374,0.008216359],"study_design_scores_gemma":[0.011887184,0.0017705332,0.98177207,0.0036370275,0.00024636058,4.9715334e-7,0.00032074508,0.00007492799,0.00013800808,0.00003835373,0.000017911056,0.00009638001],"about_ca_topic_score_codex":0.00035240245,"about_ca_topic_score_gemma":0.000062010105,"teacher_disagreement_score":0.011017839,"about_ca_system_score_codex":0.00006122343,"about_ca_system_score_gemma":0.000110412315,"threshold_uncertainty_score":0.42483336},"labels":[],"label_agreement":null},{"id":"W3033240102","doi":"10.1136/annrheumdis-2020-eular.2377","title":"SAT0605 TRENDS OF TOTAL JOINT ARTHROPLASTY AMONG PATIENTS WITH OSTEOARTHRITIS, RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN BRITISH COLUMBIA, CANADA, 1998-2013","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; University of British Columbia; Research Canada","funders":"","keywords":"Medicine; Ankylosing spondylitis; Rheumatoid arthritis; Osteoarthritis; Arthroplasty; Population; Arthritis; Physical therapy; Joint replacement; Surgery; Internal medicine","score_opus":0.0073733090774631286,"score_gpt":0.20094425168339705,"score_spread":0.1935709426059339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033240102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216783,0.0052222423,0.0000019420845,0.0010082651,0.00006005736,0.0004842069,0.0009781471,0.000012186629,0.00006509513],"genre_scores_gemma":[0.9981401,0.0014254593,0.000045806843,0.00016634334,0.000007949921,0.000022543743,0.00013294951,0.000021810687,0.000037029975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829847,0.000098987155,0.00061170565,0.00025559944,0.0004940249,0.00024120022],"domain_scores_gemma":[0.99905896,0.00008871046,0.0002783589,0.00021462872,0.00012829571,0.00023103885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007563205,0.00013994689,0.0005815063,0.000049613063,0.00007572908,0.000041594107,0.00005887525,0.0000456198,0.00021097783],"category_scores_gemma":[0.00031740838,0.00014182721,0.00013931774,0.0003244798,0.0003749637,0.00015395021,0.00006317735,0.000095455034,4.309422e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091929156,0.0003025225,0.7279956,0.00086298125,0.000070140835,0.000008227573,0.00039186943,0.000021205708,0.00000578625,0.0000049513646,0.0027553933,0.2674894],"study_design_scores_gemma":[0.0025616859,0.00070040853,0.99030614,0.005315396,0.000026180594,0.00000814193,0.0006466147,0.0001236437,0.000010217402,0.000056946414,0.00009359759,0.00015104625],"about_ca_topic_score_codex":0.423098,"about_ca_topic_score_gemma":0.72963953,"teacher_disagreement_score":0.30654153,"about_ca_system_score_codex":0.000016983537,"about_ca_system_score_gemma":0.00020538435,"threshold_uncertainty_score":0.5807437},"labels":[],"label_agreement":null},{"id":"W3033266779","doi":"10.1136/annrheumdis-2020-eular.1917","title":"THU0270 ONLINE INTERACTION AND FREQUENT SELF-ASSESSMENTS PROMOTED TREAT-TO-TARGET FOR SLE VIA EMPOWERING PATIENTS: A COHORT STUDY FROM CHINA BY SMART SYSTEM OF DISEASE MANAGEMENT (SSDM)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Istituto Auxologico Italiano; Rigshospitalet; National Institutes of Health; Karl-Franzens-Universität Graz; Università degli Studi di Padova; University of Crete; Universidade do Porto; University of Leeds; Hospital for Special Surgery; Sveučilište u Zagrebu; Pécsi Tudományegyetem; York University; McMaster University","keywords":"Medicine; Cohort; Systemic lupus erythematosus; Demographics; Internal medicine; Disease; Physical therapy; Demography","score_opus":0.026647800809089964,"score_gpt":0.3405082223543402,"score_spread":0.31386042154525023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033266779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006087,0.00041185343,0.00056864414,0.0006333958,0.00015136995,0.006994044,0.0010341785,0.00006972118,0.00007594483],"genre_scores_gemma":[0.9986082,0.00006419754,0.00041131355,0.00006876176,0.00002195338,0.00045698095,0.00025604764,0.000043247357,0.000069336216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753875,0.00019986973,0.00077355705,0.00042411854,0.0008060408,0.00025769003],"domain_scores_gemma":[0.99819404,0.00014178662,0.00039301632,0.00058222015,0.00023591246,0.0004530273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022518169,0.00024971523,0.00070669316,0.00010183414,0.00007693522,0.00002752869,0.00027058422,0.00002893188,0.000023768698],"category_scores_gemma":[0.00024575723,0.00017247214,0.00018536436,0.0002380048,0.000032632768,0.00011668628,0.00024418932,0.00007137758,0.0000035178493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018415475,0.005180163,0.9716051,0.010683423,0.0021518613,0.00000881737,0.0019314543,0.00001757072,0.000094075476,0.000009311567,0.0030065437,0.0034700916],"study_design_scores_gemma":[0.005367585,0.0020503413,0.9685639,0.006585422,0.0013925085,0.000006105387,0.005109105,0.010121912,0.00039528546,0.000068164816,0.00008452433,0.0002551546],"about_ca_topic_score_codex":0.00022057588,"about_ca_topic_score_gemma":0.0000033903254,"teacher_disagreement_score":0.010104341,"about_ca_system_score_codex":0.000097814096,"about_ca_system_score_gemma":0.00006178475,"threshold_uncertainty_score":0.703321},"labels":[],"label_agreement":null},{"id":"W3033392335","doi":"10.1136/annrheumdis-2020-eular.2431","title":"AB0737 MEASUREMENT PROPERTIES OF RADIOGRAPHIC OUTCOME MEASURES IN PSORIATIC ARTHRITIS: A SYSTEMATIC REVIEW FROM THE GRAPPA-OMERACT INITIATIVE","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Psoriatic arthritis; Radiography; Medical physics; Arthritis; Physical therapy; Internal medicine; Radiology","score_opus":0.2931679541333469,"score_gpt":0.3546467407809349,"score_spread":0.06147878664758799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033392335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001632599,0.9901711,8.23894e-7,0.0011856324,0.00018048375,0.007820437,0.00041926483,0.000025481202,0.00003353603],"genre_scores_gemma":[0.033974577,0.96371734,0.000007473629,0.0005978907,0.00003177259,0.001577838,0.000029793613,0.00005862586,0.000004704093],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99322927,0.001428375,0.0029865315,0.00042302918,0.00158364,0.00034915988],"domain_scores_gemma":[0.9954193,0.00053190946,0.002279883,0.0011941136,0.00042456875,0.00015018744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008960024,0.0006939984,0.0070520993,0.00017512805,0.00011648117,0.000025703766,0.00064627215,0.00009633795,0.000026095788],"category_scores_gemma":[0.0061221165,0.00031470862,0.0024558697,0.0010441276,0.00029912035,0.000084731655,0.00017993679,0.00030073614,0.000017739956],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004415319,0.0005730683,0.00029954367,0.8499691,0.0069216117,0.000025924097,0.00041425202,1.7188252e-7,8.237706e-8,0.000028176464,0.000557094,0.14116685],"study_design_scores_gemma":[0.00087214186,0.0001609052,0.0010389473,0.98027813,0.014095824,0.000018060397,0.00029496642,0.0000013178144,0.000001805042,0.00015832749,0.002820882,0.000258694],"about_ca_topic_score_codex":0.0002798612,"about_ca_topic_score_gemma":0.0000817854,"teacher_disagreement_score":0.14090815,"about_ca_system_score_codex":0.00007432654,"about_ca_system_score_gemma":0.00046296604,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W3033413260","doi":"10.1136/annrheumdis-2020-eular.2175","title":"OP0264-HPR PERSPECTIVES ON APPROACHES TO PREDICT THE DEVELOPMENT OF RHEUMATOID ARTHRITIS: A QUANTITATIVE ASSESSMENT OF PATIENTS AND THEIR FIRST DEGREE RELATIVES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Psychological intervention; First-degree relatives; Predictive testing; Internal medicine; Family medicine; Disease; Family history; Psychiatry","score_opus":0.1595841330897995,"score_gpt":0.3201786895304782,"score_spread":0.1605945564406787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033413260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98083144,0.010955441,0.0002933632,0.00589212,0.000028302315,0.001186081,0.00020738215,0.000018485289,0.00058739044],"genre_scores_gemma":[0.98743945,0.011127091,0.0011939701,0.00010007328,0.000006042337,0.000092718146,0.000011934077,0.00002190776,0.000006831135],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99793756,0.00023546715,0.000674808,0.00027693948,0.0006333207,0.00024191017],"domain_scores_gemma":[0.99805146,0.00072691706,0.0003781407,0.00035054362,0.0002631349,0.00022978424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003359884,0.00023141775,0.0006352213,0.000096053,0.00019452018,0.000020694732,0.0003099361,0.00003438142,0.000040647647],"category_scores_gemma":[0.0013479254,0.00012275575,0.00019693591,0.0002899789,0.0005716866,0.00011788882,0.00021699515,0.00013821428,0.0000024800859],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047617685,0.006695985,0.2546583,0.0029157803,0.00567429,0.0000026400587,0.44182864,0.00032867506,0.00027479685,0.039715137,0.004272687,0.23887128],"study_design_scores_gemma":[0.0023435203,0.0023097503,0.91636664,0.006101987,0.000013236706,0.000001650031,0.06661186,0.0011596897,0.0033207387,0.0012070795,0.0003414253,0.00022244784],"about_ca_topic_score_codex":0.000013324668,"about_ca_topic_score_gemma":0.00001389362,"teacher_disagreement_score":0.6617083,"about_ca_system_score_codex":0.000015770314,"about_ca_system_score_gemma":0.00024988558,"threshold_uncertainty_score":0.50058347},"labels":[],"label_agreement":null},{"id":"W3033430185","doi":"10.1136/annrheumdis-2020-eular.1229","title":"OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Psoriasis; Internal medicine; Clinical endpoint; Adverse effect; Certolizumab pegol; Placebo; Randomized controlled trial; Psoriasis Area and Severity Index; Dermatology; Adalimumab","score_opus":0.036764983662214146,"score_gpt":0.32738921822603584,"score_spread":0.2906242345638217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033430185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783359,0.006645968,0.000041137915,0.0042406833,0.000053362015,0.0104304245,0.00020469734,0.000031380743,0.00001645593],"genre_scores_gemma":[0.98859787,0.010520491,0.0000623884,0.0002495363,0.000017090335,0.0004742662,0.000037813577,0.000032535827,0.0000080343325],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99554664,0.0014367355,0.0013658674,0.00043340595,0.00075360225,0.00046376025],"domain_scores_gemma":[0.9946781,0.003302428,0.0006629428,0.00038789294,0.00030025546,0.0006683802],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013092606,0.00037816734,0.0027382215,0.0003025058,0.00014707395,0.00006069716,0.00022425623,0.000060971495,0.00005479882],"category_scores_gemma":[0.009911999,0.00022361283,0.00032168836,0.00055674784,0.0006171802,0.00020704696,0.00014723462,0.00019175296,0.0000031839525],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9223849,0.0013592487,0.0005999313,0.00044027928,0.0009026137,0.0000068128434,0.0024883784,0.00002684463,0.0000252971,0.000087601584,0.000032946107,0.0716451],"study_design_scores_gemma":[0.9675056,0.002998031,0.022212973,0.0052640187,0.00015588332,0.0000016934044,0.00045354394,0.0006271369,0.00018981542,0.00033853907,0.000010856756,0.00024193978],"about_ca_topic_score_codex":0.00005259917,"about_ca_topic_score_gemma":0.0000036430833,"teacher_disagreement_score":0.07140316,"about_ca_system_score_codex":0.00001876416,"about_ca_system_score_gemma":0.00035854356,"threshold_uncertainty_score":0.9984279},"labels":[],"label_agreement":null},{"id":"W3033489031","doi":"10.1136/annrheumdis-2020-eular.3902","title":"FRI0032 REGIONAL AND WIDESPREAD PATTERNS OF NON-ARTICULAR PAIN ARE COMMON AT RA DIAGNOSIS AND CONTRIBUTE TO POOR OUTCOMES AT 12 MONTHS: A PROSPECTIVE STUDY OF PAIN PATTERNS IN CANADIANS WITH RA","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Southlake Regional Health Center; University of Manitoba; Osteoporosis Canada; Université de Sherbrooke; Université Laval; University of Calgary; McGill University; University of Toronto","funders":"","keywords":"Nap; Medicine; Gee; Physical therapy; Cohort; Fibromyalgia; Internal medicine; myalgia; Generalized estimating equation","score_opus":0.025626084513686215,"score_gpt":0.2807777738627197,"score_spread":0.2551516893490335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033489031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98183787,0.0020913177,0.000027757573,0.013396515,0.000010907128,0.0020481865,0.00057609595,0.000008997251,0.0000023633686],"genre_scores_gemma":[0.9966416,0.0016957192,0.000011033938,0.0013129149,0.0000054548686,0.00028333947,0.000013280038,0.00002178673,0.000014887057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979591,0.0004737966,0.00048627434,0.00027077,0.0005126178,0.00029744132],"domain_scores_gemma":[0.997857,0.0009940956,0.00025931437,0.0003185217,0.00015336121,0.00041773217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004913758,0.00020872148,0.0008605428,0.000102683705,0.00007771416,0.00001563552,0.00015134098,0.000031497813,0.000035075638],"category_scores_gemma":[0.0014479513,0.00013531263,0.00009791892,0.00015248159,0.00015117436,0.000076743425,0.00016400838,0.00008034203,5.136478e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010220816,0.00074817106,0.9846035,0.0006899553,0.0005677629,0.000046015964,0.007673226,0.000025159698,0.000032844953,0.0000065960126,0.0014595409,0.003125111],"study_design_scores_gemma":[0.0037036866,0.0020480426,0.98128515,0.0039195796,0.000045651108,0.000003652449,0.007876995,0.0003379015,0.00056423387,0.000051898467,0.000029229757,0.00013398333],"about_ca_topic_score_codex":0.013714591,"about_ca_topic_score_gemma":0.046324514,"teacher_disagreement_score":0.032609925,"about_ca_system_score_codex":0.000036387497,"about_ca_system_score_gemma":0.00006345638,"threshold_uncertainty_score":0.99285316},"labels":[],"label_agreement":null},{"id":"W3033627225","doi":"10.1136/annrheumdis-2020-eular.717","title":"FRI0031 OBSERVATIONS ON BIOMARKERS IN VERY EARLY RHEUMATOID ARTHRITIS CONSECUTIVELY RECRUITED OVER 20 YEARS, FROM BASELINE PRESENTATION TO FIVE-YEAR OUTCOMES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"Merck Canada; Celgene; Amgen Canada; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Cohort; Concomitant; Demographics; Comorbidity; Disease; Demography","score_opus":0.06777375875379452,"score_gpt":0.32228605144081574,"score_spread":0.25451229268702125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033627225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764844,0.0021492215,0.00002160043,0.018995997,0.000116508825,0.001020224,0.0010569906,0.000057155183,0.00009790945],"genre_scores_gemma":[0.98868793,0.007859881,0.00021964851,0.002851629,0.000024653968,0.00008854182,0.000175449,0.000034634617,0.000057650195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767333,0.0003178025,0.0006247399,0.00034100225,0.00070558296,0.00033756255],"domain_scores_gemma":[0.9979809,0.0008374134,0.00017599715,0.00044667363,0.00016663023,0.00039238896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020755707,0.0002205044,0.0005598943,0.00018524287,0.00007807176,0.000058654252,0.00028289217,0.000060073595,0.00041320358],"category_scores_gemma":[0.0035236331,0.00017598836,0.00025414515,0.000609704,0.00016139612,0.0002171845,0.00011520622,0.00015821759,0.00010292818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042768493,0.0013174667,0.8156024,0.00016357416,0.0018646542,0.00007083898,0.0054009994,0.00010845732,0.0011746606,0.0010568727,0.12913853,0.039824694],"study_design_scores_gemma":[0.0028703844,0.00035892965,0.9905537,0.0020734132,0.0000095191435,9.940782e-7,0.0006619255,0.00040082016,0.00077449356,0.0010014484,0.0011136234,0.00018076668],"about_ca_topic_score_codex":0.0010047784,"about_ca_topic_score_gemma":0.000116645126,"teacher_disagreement_score":0.17495129,"about_ca_system_score_codex":0.000021385427,"about_ca_system_score_gemma":0.00019090022,"threshold_uncertainty_score":0.7176597},"labels":[],"label_agreement":null},{"id":"W3033645402","doi":"10.1136/annrheumdis-2020-eular.3146","title":"SAT0585 GEO-EPIDEMIOLOGY OF AUTOANTIBODIES IN RA: DIFFERENT PREVALENCES IN FOUR ETHNICALLY DIVERSE RA POPULATIONS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Autoantibody; Cohort; Rheumatoid arthritis; Immunology; Internal medicine; Epidemiology; Population; Demography; Rheumatoid factor; Odds ratio; Antibody; Environmental health","score_opus":0.3440413551864976,"score_gpt":0.4371728737029556,"score_spread":0.09313151851645801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033645402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648466,0.0041163377,0.000014837303,0.030216828,0.000057937243,0.00040765287,0.00010319277,0.000010861294,0.00022575112],"genre_scores_gemma":[0.99580836,0.00296338,0.00014229595,0.000825785,0.000026612764,0.000016561124,0.000015449717,0.000007984232,0.00019358672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978121,0.00054008036,0.0007943061,0.00020813214,0.00034966617,0.00029570988],"domain_scores_gemma":[0.99795365,0.001280374,0.00024580574,0.00025275358,0.00009287506,0.00017456093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041611894,0.00015252976,0.00076932576,0.00011062135,0.00004630507,0.0000026734742,0.00030370968,0.00005772411,0.00024002012],"category_scores_gemma":[0.004738694,0.00008969145,0.00029819665,0.000264008,0.00033884353,0.00006174516,0.00025340944,0.0002114165,0.000007558746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000526803,0.0003632928,0.98445475,0.0015591423,0.00009984935,0.000009654831,0.0006076205,0.00035518725,0.00006241324,0.0018834115,0.0012855572,0.008792343],"study_design_scores_gemma":[0.00051434804,0.00020089341,0.9892818,0.0012962173,0.000053176707,0.0000023078717,0.00024021124,0.0018640575,0.00008289173,0.006331297,0.000052006668,0.00008082471],"about_ca_topic_score_codex":0.0010007853,"about_ca_topic_score_gemma":0.00023438853,"teacher_disagreement_score":0.030961743,"about_ca_system_score_codex":0.000010408751,"about_ca_system_score_gemma":0.00007891139,"threshold_uncertainty_score":0.5673002},"labels":[],"label_agreement":null},{"id":"W3033700636","doi":"10.1136/annrheumdis-2020-eular.4780","title":"AB0411 COGNITIVE IMPAIRMENT IN PRIMARY SJÖGREN'S SYNDROME: A CASE-CONTROL STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; Cognitive impairment; Internal medicine; Cognition; Neuropsychology; Rheumatology; Trail Making Test; Physical therapy; Pediatrics; Disease; Psychiatry","score_opus":0.03665042090114519,"score_gpt":0.29122592564171235,"score_spread":0.25457550474056717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033700636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205184,0.0012992998,0.0000388283,0.004480493,0.000061715415,0.0014256745,0.00019258058,0.000031971576,0.00041757573],"genre_scores_gemma":[0.9965128,0.000053504285,0.000008356116,0.0032449372,0.0000149893385,0.000089438145,0.00000994991,0.000013764431,0.000052277774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889165,0.00012445879,0.00035176764,0.00018512673,0.00026296417,0.00018405358],"domain_scores_gemma":[0.9991614,0.00024933968,0.00011413166,0.0002201803,0.00007404396,0.00018090774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121040495,0.00014018183,0.0004244327,0.000056861736,0.00006457485,0.0000114715385,0.000089156296,0.000024793771,0.00028304727],"category_scores_gemma":[0.00042595775,0.00008864299,0.0001950993,0.0002872973,0.00006286427,0.00006655005,0.000056639994,0.000088837456,0.000019388348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019510548,0.0061501223,0.9674685,0.00075436407,0.00097089633,0.0016634732,0.0034135191,0.00006674659,0.0000022090587,0.000029193985,0.006142198,0.0113877375],"study_design_scores_gemma":[0.004996399,0.001322933,0.98603445,0.00045773678,0.0005129636,0.00022053313,0.0056904773,0.00041455988,0.0000030330584,0.00023604854,0.000007679843,0.00010319936],"about_ca_topic_score_codex":0.00014330639,"about_ca_topic_score_gemma":0.000011333363,"teacher_disagreement_score":0.01856595,"about_ca_system_score_codex":0.000010087273,"about_ca_system_score_gemma":0.00011774632,"threshold_uncertainty_score":0.36147562},"labels":[],"label_agreement":null},{"id":"W3033748048","doi":"10.1136/annrheumdis-2020-eular.4339","title":"FRI0331 COMPARISON OF THE THERAPEUTIC TRAJECTORIES OF PATIENTS WITH OLIGO AND POLYARTICULAR PSORIATIC ARTHRITIS. A REPORT FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Psoriatic arthritis; Oligoarthritis; Polyarthritis; Cohort; Internal medicine; Database; Arthritis; Surgery; Dermatology","score_opus":0.056307159708479625,"score_gpt":0.3398344936533321,"score_spread":0.2835273339448525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033748048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592649,0.03474743,0.00002378904,0.004720535,0.00007156832,0.0005968923,0.0005496601,0.000010087279,0.000015183448],"genre_scores_gemma":[0.99192494,0.007532554,0.00006639572,0.00036519353,0.000029586488,0.000013235084,0.00004681993,0.000016220045,0.000005050672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778163,0.00031667226,0.00081308436,0.00023084284,0.0006708871,0.00018690476],"domain_scores_gemma":[0.99746114,0.0007138753,0.00061034167,0.0008513649,0.00018522659,0.0001780602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027996325,0.00016370178,0.00065874425,0.00001640348,0.00013878195,0.000027324377,0.000297865,0.000037545495,0.00003691239],"category_scores_gemma":[0.0019234682,0.000074840165,0.00015740923,0.0001701883,0.001346182,0.00011609935,0.00019398572,0.00016977622,4.941264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087198097,0.00060888124,0.96778697,0.0003605173,0.00079585006,0.000004562624,0.0015371726,0.0000019499366,0.00005267586,0.00028058287,0.0025336903,0.025165195],"study_design_scores_gemma":[0.002146946,0.00041334686,0.9915198,0.0021366428,0.00012900196,0.000006815477,0.0011546197,0.00016259178,0.0010490795,0.000751808,0.00043245152,0.00009688376],"about_ca_topic_score_codex":0.00028714893,"about_ca_topic_score_gemma":0.000045552646,"teacher_disagreement_score":0.03266009,"about_ca_system_score_codex":0.0000025976597,"about_ca_system_score_gemma":0.00016786458,"threshold_uncertainty_score":0.49600634},"labels":[],"label_agreement":null},{"id":"W3033763804","doi":"10.1136/annrheumdis-2020-eular.2495","title":"FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Placebo; Clinical endpoint; Rheumatoid arthritis; Randomized controlled trial; Surgery; Gastroenterology; Pathology","score_opus":0.028244051258446513,"score_gpt":0.31614458260548534,"score_spread":0.2879005313470388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033763804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443425,0.008758358,0.000046384135,0.0007395617,0.000065399814,0.005337589,0.00053216895,0.000024088664,0.000062221596],"genre_scores_gemma":[0.99485105,0.0044977786,0.000081409584,0.00014361738,0.00005413254,0.00026185525,0.000075613236,0.000030142948,0.000004398635],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962829,0.0009895265,0.0011496417,0.0003819668,0.0008358798,0.0003601159],"domain_scores_gemma":[0.99556404,0.0026996084,0.000689597,0.00035469135,0.0003280757,0.00036397902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041486212,0.00033204965,0.0023231413,0.00017911998,0.00009227423,0.000035693887,0.0001970261,0.00006821711,0.00012689125],"category_scores_gemma":[0.007504176,0.0002023602,0.00042965167,0.00047576244,0.0005167284,0.00022858965,0.0000907761,0.00022167731,0.000003286712],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9439138,0.0029029283,0.0011934376,0.00015386991,0.0021924383,0.000008902913,0.0024832613,0.000025699883,0.000029771652,0.00004889202,0.00021713457,0.046829857],"study_design_scores_gemma":[0.9747371,0.0031703974,0.0150906285,0.003099606,0.0002489777,8.102644e-7,0.00054669223,0.0007056738,0.0015877327,0.00059474277,0.000010337306,0.00020730654],"about_ca_topic_score_codex":0.0003955807,"about_ca_topic_score_gemma":0.0000409511,"teacher_disagreement_score":0.046622552,"about_ca_system_score_codex":0.000022163518,"about_ca_system_score_gemma":0.00033534618,"threshold_uncertainty_score":0.89837414},"labels":[],"label_agreement":null},{"id":"W3033767265","doi":"10.1136/annrheumdis-2020-eular.1127","title":"SAT0414 THE PERFORMANCE OF A MULTI-MARKER GENETIC TEST TO IDENTIFY PATIENTS WITH PSORIATIC ARTHRITIS AMONG PSORIASIS PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Logistic regression; Internal medicine; Psoriasis; Oncology; Outpatient clinic; Arthritis; Immunology","score_opus":0.020236547148137794,"score_gpt":0.2764983322686147,"score_spread":0.2562617851204769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033767265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496526,0.0020801697,0.000013782791,0.001247093,0.00009903333,0.0013592693,0.00018057284,0.000023332701,0.000031483174],"genre_scores_gemma":[0.995141,0.003992831,0.00015219302,0.00052156614,0.000024567047,0.00009101427,0.000018216362,0.000035187,0.000023384466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976471,0.00014279217,0.0006090651,0.00024921843,0.0009909366,0.00036085295],"domain_scores_gemma":[0.99790347,0.00030270586,0.0003214545,0.00058523664,0.0005339775,0.00035317143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013949603,0.00022474068,0.0005045823,0.00007326031,0.00015642858,0.000038338658,0.0004391539,0.000034410932,0.00014928158],"category_scores_gemma":[0.0021408107,0.00012212471,0.00020688954,0.00045138312,0.0003352794,0.00016422321,0.00017096073,0.00012092499,0.0000318908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043686424,0.00086548255,0.91063726,0.00042370262,0.00027782022,0.0000010469596,0.0010550048,0.00006306564,0.000012516242,0.000004573694,0.002134106,0.084088534],"study_design_scores_gemma":[0.0030361568,0.0012063395,0.991626,0.0024001973,0.00003995884,6.66109e-7,0.0001644087,0.0007778388,0.00046261327,0.000021177115,0.00012661132,0.00013800846],"about_ca_topic_score_codex":0.00007574502,"about_ca_topic_score_gemma":0.000019093095,"teacher_disagreement_score":0.08395053,"about_ca_system_score_codex":0.0000100832685,"about_ca_system_score_gemma":0.000100332254,"threshold_uncertainty_score":0.4980101},"labels":[],"label_agreement":null},{"id":"W3033800777","doi":"10.1136/annrheumdis-2020-eular.852","title":"SAT0402 EFFICACY AND SAFETY OF GUSELKUMAB, A MONOCLONAL ANTIBODY SPECIFIC TO THE P19-SUBUNIT OF INTERLEUKIN-23, THROUGH WEEK 52 OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Placebo; Axial spondyloarthritis; Internal medicine; Pathology; Alternative medicine","score_opus":0.11882644557337095,"score_gpt":0.3937381328853905,"score_spread":0.27491168731201954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033800777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859369,0.0030913225,0.00003345801,0.003508773,0.000058306498,0.0069686454,0.00026443403,0.000009547973,0.00012864705],"genre_scores_gemma":[0.9966901,0.002760748,0.000058467427,0.00030064865,0.000019656252,0.000121125,0.000027520768,0.0000152252105,0.0000065288086],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99697196,0.00076230353,0.0012386552,0.00028384727,0.0005065833,0.00023665733],"domain_scores_gemma":[0.9946464,0.0034026033,0.00108084,0.00034190557,0.00038339774,0.00014486171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064063154,0.00027574724,0.0020135464,0.000076905795,0.000072630566,0.000012646877,0.0002912202,0.000040865445,0.000104313476],"category_scores_gemma":[0.0021588644,0.000133608,0.00025770866,0.0005110891,0.00050379185,0.00014554395,0.00020437612,0.0001887181,0.000001840601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9658637,0.006852261,0.0027288909,0.00034050667,0.0034005798,0.000004222915,0.008709697,0.00008713783,0.000094678115,0.00006700721,0.00026695212,0.011584371],"study_design_scores_gemma":[0.95641863,0.005263446,0.02679004,0.0017784266,0.0016477441,0.0000019216961,0.0063100676,0.0003004554,0.00097373896,0.00015606155,0.00015931585,0.0002001778],"about_ca_topic_score_codex":0.00015053472,"about_ca_topic_score_gemma":0.000021544447,"teacher_disagreement_score":0.024061149,"about_ca_system_score_codex":0.000011918049,"about_ca_system_score_gemma":0.000087069275,"threshold_uncertainty_score":0.5448376},"labels":[],"label_agreement":null},{"id":"W3033809365","doi":"10.1136/annrheumdis-2020-eular.4328","title":"FRI0030 MORE THAN HALF OF NEWLY DIAGNOSED RA PATIENTS ARE NOT CONVINCED OF THE NECESSITY OF RA MEDICINES: ASSOCIATIONS WITH RA CHARACTERISTICS, SYMPTOMS, AND FUNCTION IN THE CANADIAN EARLY ARTHRITIS COHORT (CATCH)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pediatric health and respiratory diseases","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Western University; Université Laval; Southlake Regional Health Center; University of Manitoba; McGill University; University of Calgary; University of Toronto","funders":"Merck Canada; Celgene; Amgen Canada; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Cohort; Internal medicine; Depression (economics); Physical therapy","score_opus":0.03550752487554442,"score_gpt":0.31655214964809064,"score_spread":0.2810446247725462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033809365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858389,0.0007032836,0.000002624056,0.009039734,0.00016929851,0.0014566206,0.0027473758,0.000008985046,0.000033209],"genre_scores_gemma":[0.99467707,0.00043928644,0.000002123423,0.0046523036,0.000056456764,0.00008150444,0.000068434296,0.000014592829,0.000008218798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969059,0.00095075916,0.000985389,0.00018536478,0.0006458386,0.000326723],"domain_scores_gemma":[0.99587834,0.0012185387,0.0016128147,0.0004182796,0.00052341336,0.00034858705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005018828,0.00017189895,0.0006286417,0.00007953975,0.00041176166,0.000008411498,0.0003921265,0.000109908084,0.000038110258],"category_scores_gemma":[0.004074128,0.00009100126,0.00011955065,0.0004360624,0.00033728965,0.000110351815,0.000076540906,0.00024194809,0.0000014555332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015776038,0.00020346274,0.99130136,0.0011278207,0.000084877276,9.201166e-7,0.002818451,0.000005444236,0.0000017758642,0.000044348908,0.002697186,0.0015566006],"study_design_scores_gemma":[0.0013637729,0.00016345056,0.9938969,0.0016569804,0.00018563897,6.831507e-8,0.0024445108,0.000034439363,0.000008725564,0.00006616343,0.00009421958,0.00008511354],"about_ca_topic_score_codex":0.055310585,"about_ca_topic_score_gemma":0.018712051,"teacher_disagreement_score":0.036598533,"about_ca_system_score_codex":0.000039758903,"about_ca_system_score_gemma":0.0016022695,"threshold_uncertainty_score":0.9991939},"labels":[],"label_agreement":null},{"id":"W3033819416","doi":"10.1136/annrheumdis-2020-eular.4953","title":"FRI0547 THE EFFECT OF CORRECTED INFLAMMATION, OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION ON FMD LEVELS IN PATIENTS WITH SELECTED CHRONIC DISEASES: A QUASI-EXPERIMENTAL STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Endothelial dysfunction; Oxidative stress; Internal medicine; Malondialdehyde; Inflammation; Asymmetric dimethylarginine; Immunology; C-reactive protein; Gastroenterology; Endocrinology; Biochemistry; Arginine","score_opus":0.012008927804868008,"score_gpt":0.23499695659789224,"score_spread":0.22298802879302423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033819416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737513,0.00039437783,0.000013159832,0.00014064365,0.00011065512,0.0014257303,0.0005032285,0.000021109368,0.000015954389],"genre_scores_gemma":[0.9997345,0.000007517527,8.6296063e-7,0.000032388594,0.000011485512,0.00007883217,0.00011267793,0.000011164387,0.00001057716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983225,0.0008319243,0.00037366326,0.00019027393,0.00012267914,0.00015898005],"domain_scores_gemma":[0.9988073,0.00043648315,0.00037398018,0.00022160514,0.00013150729,0.000029104764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011614678,0.00018690243,0.0003361987,0.000057533693,0.00013550605,0.000013716796,0.0001920093,0.0000471144,0.00010316379],"category_scores_gemma":[0.00042128228,0.000097861914,0.00006512847,0.0002764857,0.00020045607,0.00010148178,0.0000679862,0.000094894865,0.000007826608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010919103,0.0031340574,0.9591396,0.0005512968,0.001426594,0.0000013063162,0.0097252885,0.00036510715,0.005625578,0.00011764421,0.0006559722,0.008338471],"study_design_scores_gemma":[0.005233958,0.007800454,0.8895951,0.00038128812,0.00012099979,2.9952398e-7,0.00089437596,0.000097268254,0.095728055,0.00001381259,0.000007991632,0.00012639193],"about_ca_topic_score_codex":0.000059316826,"about_ca_topic_score_gemma":0.00002149091,"teacher_disagreement_score":0.09010248,"about_ca_system_score_codex":0.000018958144,"about_ca_system_score_gemma":0.00007107853,"threshold_uncertainty_score":0.3990693},"labels":[],"label_agreement":null},{"id":"W3033829603","doi":"10.1136/annrheumdis-2020-eular.3913","title":"AB0211 DIFFERENTIAL INFLUENCE OF CDAI COMPONENTS BASED ON DISEASE STATE IN RHEUMATOID ARTHRITIS PATIENTS: REAL-WORLD RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (OBRI)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cronbach's alpha; Rheumatoid arthritis; Cohen's kappa; Construct validity; Physical therapy; Internal medicine; Cohort; Patient satisfaction; Surgery; Statistics; Psychometrics","score_opus":0.14462605071371892,"score_gpt":0.3677443688862568,"score_spread":0.22311831817253786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033829603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858699,0.001168011,0.0000028200905,0.008975184,0.00007771998,0.0013751747,0.0020983564,0.00002347227,0.00040937966],"genre_scores_gemma":[0.9838901,0.014856328,0.000021735023,0.00074027636,0.000023850434,0.00009142904,0.00029758934,0.00003490916,0.000043745546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942689,0.0013552671,0.0011959219,0.0005072505,0.0020964954,0.0005761827],"domain_scores_gemma":[0.9928532,0.003825389,0.0010029018,0.0009724754,0.00078359304,0.0005623888],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006372292,0.0003102602,0.0007442051,0.00022316647,0.00024356664,0.00009167472,0.00075246755,0.0000438986,0.00019583415],"category_scores_gemma":[0.010346633,0.00019764878,0.00027608828,0.00071371975,0.0008552011,0.0003804663,0.00030662064,0.00060438196,0.000034322646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033786483,0.0066376263,0.91517866,0.0005061223,0.0006282529,0.0000674024,0.013026459,0.0015191406,0.00011664011,0.00023283408,0.0069238064,0.021376584],"study_design_scores_gemma":[0.0060363323,0.00074309733,0.9791314,0.009843686,0.000014666828,2.503431e-7,0.00053934637,0.0010884111,0.0004835986,0.0014312406,0.0005023414,0.00018565245],"about_ca_topic_score_codex":0.0752189,"about_ca_topic_score_gemma":0.018605122,"teacher_disagreement_score":0.06395273,"about_ca_system_score_codex":0.00007172144,"about_ca_system_score_gemma":0.0008420381,"threshold_uncertainty_score":0.9993028},"labels":[],"label_agreement":null},{"id":"W3033835980","doi":"10.1136/annrheumdis-2020-eular.638","title":"OP0053 SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; University of Leeds; Perelman School of Medicine, University of Pennsylvania; Janssen Scientific Affairs; College of Medicine, Drexel University; University of Pennsylvania; Leids Universitair Medisch Centrum; Universiteit Leiden; Drexel University; Biogen; Celgene; Amgen; Pfizer; University of Washington; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Medicine; Secukinumab; Psoriatic arthritis; Clinical endpoint; BASDAI; Placebo; Axial spondyloarthritis; Mallinckrodt; Clinical trial; Internal medicine; Surgery; Arthritis; Sacroiliitis; Pathology","score_opus":0.03580724281123344,"score_gpt":0.3007715974809737,"score_spread":0.2649643546697403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033835980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97749984,0.0008605753,0.0000037265688,0.019408101,0.00007541946,0.0014409736,0.0006723764,0.000016875507,0.000022103122],"genre_scores_gemma":[0.9975608,0.00039039386,0.00021333437,0.0016750225,0.000029947718,0.00006712782,0.000030172001,0.000020328736,0.0000128441225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825084,0.00025880226,0.00059768243,0.00032550437,0.00035366093,0.00021353207],"domain_scores_gemma":[0.9979137,0.0012202746,0.00022484813,0.00032849508,0.00009697703,0.00021569208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002369205,0.00020375669,0.0005483508,0.000035709603,0.00015436462,0.000049305934,0.00010977368,0.000023726749,0.0000068665063],"category_scores_gemma":[0.002132423,0.000103087594,0.00008190117,0.00015575938,0.00029769778,0.00011439434,0.00012414149,0.00010195478,0.0000024544213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3465946,0.0017467053,0.45510253,0.00009303915,0.0009825656,0.00010409604,0.005129568,0.000007112742,0.0000011648207,0.00009453212,0.00079422886,0.18934985],"study_design_scores_gemma":[0.0763117,0.0027841376,0.91801333,0.0010112859,0.00024745023,0.0000025107793,0.0010700093,0.000042942665,0.0000044351373,0.00034292653,0.000048241687,0.00012100539],"about_ca_topic_score_codex":0.00060062687,"about_ca_topic_score_gemma":0.00025270766,"teacher_disagreement_score":0.46291083,"about_ca_system_score_codex":0.000008886106,"about_ca_system_score_gemma":0.00008449059,"threshold_uncertainty_score":0.420379},"labels":[],"label_agreement":null},{"id":"W3033837361","doi":"10.1136/annrheumdis-2020-eular.1230","title":"FRI0131 SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Methotrexate; Internal medicine; Discontinuation; Placebo; Pathology","score_opus":0.027652398403556214,"score_gpt":0.31035286013459906,"score_spread":0.28270046173104285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033837361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897505,0.0010088189,0.000050540642,0.0073166266,0.00001078359,0.0015623772,0.0002596895,0.000029273124,0.000011403716],"genre_scores_gemma":[0.9990338,0.0003588101,0.00019808301,0.0002674231,0.0000074788964,0.00004360062,0.000009354991,0.00003585955,0.000045560588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661964,0.0010471789,0.0006869418,0.00040814126,0.00082711276,0.00041097205],"domain_scores_gemma":[0.99523205,0.0024810724,0.00031996984,0.0006585251,0.000617614,0.0006907645],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012812404,0.00025140314,0.0008212547,0.00013949817,0.00011728428,0.000031573774,0.00024915373,0.000067282366,0.000033610417],"category_scores_gemma":[0.014787958,0.00016879043,0.00011957674,0.0004968882,0.0007716753,0.00016108081,0.00041539068,0.00014337586,0.0000020418893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16637893,0.00080078497,0.5567962,0.0061415425,0.0012120322,0.000072980416,0.012139499,0.00008718577,0.00013550195,0.00008581401,0.0016320987,0.25451747],"study_design_scores_gemma":[0.012042789,0.0017178119,0.97973233,0.002380882,0.00009966554,0.000006307826,0.0007936314,0.00033352614,0.0022164653,0.00035937905,0.000120866775,0.000196325],"about_ca_topic_score_codex":0.00032947055,"about_ca_topic_score_gemma":0.000008399015,"teacher_disagreement_score":0.42293617,"about_ca_system_score_codex":0.00031181876,"about_ca_system_score_gemma":0.0025928146,"threshold_uncertainty_score":0.9935109},"labels":[],"label_agreement":null},{"id":"W3033851042","doi":"10.1136/annrheumdis-2020-eular.2871","title":"AB1338-HPR GLOBAL PATIENT PERSPECTIVE ON TOP CHALLENGES IN LUPUS CARE AND RESEARCH PARTICIPATION","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"EMD Serono; AstraZeneca; Samsung; Celgene; Sanofi; Eli Lilly and Company","keywords":"Systemic lupus erythematosus; Medicine; Family medicine; Health care; Alternative medicine; Disease; Internal medicine; Pathology","score_opus":0.43320272369441953,"score_gpt":0.5295597354164258,"score_spread":0.09635701172200622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033851042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8351279,0.014391909,6.0942835e-7,0.14680332,0.00004141451,0.00060089794,0.000035131638,0.000010829965,0.0029879783],"genre_scores_gemma":[0.99021506,0.0067413235,0.000008701296,0.0029464774,0.000031096886,0.000040070918,0.000003171761,0.00000627339,0.000007793433],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99779123,0.00032782895,0.00023606126,0.00019937055,0.00094977487,0.0004957339],"domain_scores_gemma":[0.99708974,0.0003915075,0.000051852116,0.00023118521,0.00036012992,0.0018755599],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0004061694,0.00008643032,0.00024373244,0.000055304576,0.0000619138,0.00001071125,0.00009934603,0.000042800366,0.000034292832],"category_scores_gemma":[0.044425014,0.000053717955,0.00005933186,0.000285027,0.00017948651,0.000049266902,0.00009030376,0.00019215405,0.000013045588],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021066153,0.0009358844,0.02885117,0.0039428966,0.00008332056,0.000035755726,0.035616722,0.00002233321,0.000009430297,0.0063811257,0.017592559,0.90442216],"study_design_scores_gemma":[0.0038163355,0.010850621,0.8693032,0.0074351416,0.000074050775,0.000009387196,0.09083735,0.0010557212,0.00096777227,0.009590225,0.0058011427,0.00025903693],"about_ca_topic_score_codex":0.000224815,"about_ca_topic_score_gemma":0.000032636628,"teacher_disagreement_score":0.9041632,"about_ca_system_score_codex":0.00012451611,"about_ca_system_score_gemma":0.0009540435,"threshold_uncertainty_score":0.9636242},"labels":[],"label_agreement":null},{"id":"W3033903074","doi":"10.1136/annrheumdis-2020-eular.1751","title":"SAT0049 DIFFERENCES BETWEEN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS IN TIME TO ACHIEVING CDAI BUT NOT FATIGUE LOW DISEASE ACTIVITY AND REMISSION: DATA FROM THE OBRI REGISTRY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; University of Toronto; University Health Network; St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Log-rank test; Comorbidity; Disease; Physical therapy; Arthritis; Proportional hazards model","score_opus":0.08390056405250744,"score_gpt":0.31297303666041676,"score_spread":0.2290724726079093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033903074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486689,0.013265453,0.000024447649,0.03570779,0.000027157632,0.0006782436,0.0015595874,0.000037932827,0.000030502257],"genre_scores_gemma":[0.9776836,0.021336835,0.000046867914,0.0006995468,0.00005860617,0.000025468746,0.0000789783,0.000025201178,0.000044868302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975207,0.00036197613,0.00048149016,0.0005396821,0.00072735717,0.00036879332],"domain_scores_gemma":[0.99644727,0.0013004093,0.00021138962,0.0011080673,0.0000731757,0.0008597069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036821715,0.00026719391,0.00071742653,0.00005371747,0.00022224749,0.0002565915,0.0008370301,0.000055098393,0.00018672056],"category_scores_gemma":[0.0049321246,0.00016513889,0.00009709178,0.00025785613,0.00043944133,0.0004609818,0.00097319053,0.00026092466,0.000016312173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023010739,0.00033094388,0.78231496,0.000569234,0.00043449277,0.000042243748,0.0017559499,0.000003877729,0.00114434,0.000035781646,0.009805805,0.20126131],"study_design_scores_gemma":[0.001268446,0.0001416963,0.9901063,0.006385047,0.000019154986,0.0000032927437,0.00020575566,0.00064747117,0.00034468705,0.0003912687,0.00029222932,0.00019464351],"about_ca_topic_score_codex":0.0009513314,"about_ca_topic_score_gemma":0.00003755647,"teacher_disagreement_score":0.20779136,"about_ca_system_score_codex":0.000007943006,"about_ca_system_score_gemma":0.00019860122,"threshold_uncertainty_score":0.67341685},"labels":[],"label_agreement":null},{"id":"W3033951216","doi":"10.1136/annrheumdis-2020-eular.2494","title":"FRI0344 THE LONG-TERM EFFECT OF TREATING PSORIATIC ARTHRITIS WITH THE JANUS KINASE 1-SELECTIVE INHIBITOR FILGOTINIB ON LIPID PROFILES: AN ANALYSIS OF THE EQUATOR AND EQUATOR2 TRIALS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Galápagos; Gilead Sciences","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Mace; Dyslipidemia; Gastroenterology; Placebo; Body mass index; Lipid profile; Population; Arthritis; Surgery; Cholesterol; Obesity; Pathology; Percutaneous coronary intervention","score_opus":0.05113733063300098,"score_gpt":0.33163011201680753,"score_spread":0.28049278138380657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033951216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392205,0.0009248358,0.00004850031,0.003185152,0.00007726353,0.0014123122,0.00035909435,0.000015947631,0.00005481239],"genre_scores_gemma":[0.99922824,0.00011639564,0.000011620755,0.00036012722,0.00012429223,0.00010468641,0.000019760673,0.00002184552,0.000013060481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970463,0.0011918945,0.0007791606,0.0002474461,0.0005468757,0.00018834916],"domain_scores_gemma":[0.99409455,0.0037462106,0.001141621,0.0006745458,0.00021845399,0.00012460722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008818643,0.00024543432,0.0010806563,0.000089578454,0.00021778213,0.000036693204,0.00030549796,0.00004122586,0.000086289474],"category_scores_gemma":[0.0055230404,0.00008949662,0.000678712,0.0007940226,0.0003083132,0.000087463544,0.00008168189,0.00018046715,0.0000011995457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026908554,0.0067730425,0.40586263,0.00921011,0.046542678,0.00002736072,0.053556137,0.0064337943,0.04561412,0.002118455,0.008872291,0.3880808],"study_design_scores_gemma":[0.006399063,0.0117211025,0.49467576,0.011627721,0.020043282,0.000013586093,0.0033811568,0.01575089,0.4357447,0.0001451054,0.000033298667,0.00046433683],"about_ca_topic_score_codex":0.00014617816,"about_ca_topic_score_gemma":0.00003896329,"teacher_disagreement_score":0.39013058,"about_ca_system_score_codex":0.000014150331,"about_ca_system_score_gemma":0.00013520065,"threshold_uncertainty_score":0.66119945},"labels":[],"label_agreement":null},{"id":"W3033973761","doi":"10.1136/annrheumdis-2020-eular.536","title":"FRI0608-HPR SEVERITY AND PREDICTORS OF PAIN INTENSITY AND HAND DISABILITY IN PATIENTS WITH TRAPEZIOMETACARPAL OSTEOARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Orthopedic Surgery and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Biopsychosocial model; Medicine; Osteoarthritis; Physical therapy; Quality of life (healthcare); Thumb; Physical medicine and rehabilitation; Chronic pain; Psychiatry; Alternative medicine; Surgery","score_opus":0.01609660513100219,"score_gpt":0.2379264523902877,"score_spread":0.2218298472592855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033973761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689287,0.00060609274,0.000004887666,0.0019246333,0.00003238413,0.00043603443,0.00008295667,0.000007961255,0.000012184478],"genre_scores_gemma":[0.9996412,0.000068419045,0.000022132797,0.00023367046,0.000008123353,0.000006497712,0.000010991362,0.000006102749,0.0000028703732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989666,0.00019558748,0.00032520198,0.00016390198,0.00024631855,0.000102388716],"domain_scores_gemma":[0.99911445,0.00033689034,0.00012874555,0.0001644749,0.000110711204,0.00014474224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033005542,0.00010118724,0.00040440634,0.000029653584,0.000035797784,0.000006234618,0.000038977676,0.000034043678,0.0000130211965],"category_scores_gemma":[0.0017976182,0.00006145278,0.0000731984,0.0001994942,0.00072167173,0.000097834796,0.000046371413,0.0000651086,1.1673832e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008306017,0.00035611674,0.94015443,0.0010176145,0.000057550227,4.906737e-7,0.0011332022,0.0000017709493,0.000008224821,0.0000031194345,0.000040207287,0.056396674],"study_design_scores_gemma":[0.001132082,0.00081004266,0.9963985,0.00079603697,0.000082910636,6.098848e-7,0.0003831771,0.000079840065,0.00012668766,0.00011378045,0.000016429572,0.000059923645],"about_ca_topic_score_codex":0.000041116353,"about_ca_topic_score_gemma":0.000011373841,"teacher_disagreement_score":0.05633675,"about_ca_system_score_codex":0.0000040919267,"about_ca_system_score_gemma":0.00003329027,"threshold_uncertainty_score":0.26590297},"labels":[],"label_agreement":null},{"id":"W3033984439","doi":"10.1136/annrheumdis-2020-eular.2907","title":"SAT0345 IS THERE A DIFFERENCE BETWEEN THE SEXES IN THE RATE OF PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD)? DATA FROM THE SENSCIS TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Nintedanib; Placebo; Internal medicine; Vital capacity; Gastroenterology; Idiopathic pulmonary fibrosis; Diffusing capacity; Lung; Lung function; Pathology","score_opus":0.21359643082725321,"score_gpt":0.3503510226974161,"score_spread":0.13675459187016287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033984439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580932,0.025671951,0.0000029055773,0.0118798725,0.00012426436,0.0020127462,0.0021595706,0.000023605151,0.00003183836],"genre_scores_gemma":[0.99427545,0.004351993,0.0000034454383,0.0010381883,0.000111189394,0.000053251075,0.00012520299,0.000025281823,0.000016009311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956623,0.0015974893,0.0012187598,0.0003531028,0.000892822,0.00027554284],"domain_scores_gemma":[0.993449,0.0031273146,0.0013206344,0.0018184112,0.00016409914,0.00012059233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011724896,0.0002759481,0.00093505724,0.00003493703,0.0001654753,0.000043623153,0.0018737187,0.00012320152,0.00005938245],"category_scores_gemma":[0.0027986777,0.00010028488,0.00041230355,0.000600001,0.00042343888,0.00008238737,0.0004395898,0.00024422715,0.0000055658898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013056252,0.0034010625,0.81174016,0.003548995,0.0059176967,0.0000074233667,0.032078512,0.00007624692,0.0044798586,0.00011632672,0.085007556,0.04056988],"study_design_scores_gemma":[0.008683507,0.0003726154,0.9401683,0.03762425,0.0018090475,0.000001451195,0.008562316,0.00096072274,0.0012315443,0.00039284932,0.000016899867,0.00017645954],"about_ca_topic_score_codex":0.00080388325,"about_ca_topic_score_gemma":0.000014175199,"teacher_disagreement_score":0.12842815,"about_ca_system_score_codex":0.000012951306,"about_ca_system_score_gemma":0.00023496231,"threshold_uncertainty_score":0.40894988},"labels":[],"label_agreement":null},{"id":"W3033984526","doi":"10.1136/annrheumdis-2020-eular.1682","title":"FRI0087 DURABILITY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIASIS OVER THREE YEARS: AN ANALYSIS OF POOLED CLINICAL TRIAL DATA","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Gilead Sciences; LEO Pharma; Medac; Fresenius Medical Care North America; Celltrion; Astellas Pharma; Eisai; Daiichi-Sankyo; Chugai Pharmaceutical; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Pfizer; Biogen; Celgene; Bristol-Myers Squibb; Samsung; UCB Pharma; Valeant Pharmaceuticals International; Sanofi; Amgen; Galderma; Eli Lilly and Company; GlaxoSmithKline","keywords":"Certolizumab pegol; Medicine; Discontinuation; Internal medicine; Rheumatoid arthritis; Tolerability; Psoriasis; Placebo; Surgery; Adalimumab; Immunology; Adverse effect; Pathology","score_opus":0.23369549370840656,"score_gpt":0.44221587539132584,"score_spread":0.20852038168291928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033984526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524915,0.0007973893,0.000008035815,0.0022631825,0.00007341071,0.00071716425,0.0008525618,0.000010875921,0.000028234555],"genre_scores_gemma":[0.9973712,0.0022225222,0.0000675583,0.00020321237,0.000022440083,0.000009582828,0.000090033565,0.000012154071,0.000001322004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971919,0.0003721161,0.001225042,0.0003499755,0.0006679646,0.0001929817],"domain_scores_gemma":[0.9966562,0.0011445308,0.000763879,0.0010112288,0.00019100122,0.00023317151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003524331,0.00015842656,0.0012669968,0.000070465765,0.000030615716,0.000010886236,0.00050656596,0.000054571712,0.0005590141],"category_scores_gemma":[0.00604669,0.00009162137,0.00031378504,0.0007489015,0.00029198383,0.00026436694,0.00032181657,0.00014223318,0.000001607069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0931428,0.0040590838,0.8393496,0.00036670774,0.0040417733,0.00000691872,0.00030176257,0.000019925443,9.071442e-7,0.000023648736,0.00054012955,0.058146734],"study_design_scores_gemma":[0.024214007,0.0015419403,0.9682194,0.00043628822,0.0018862874,4.5089166e-7,0.0001758546,0.0032213198,0.000013406424,0.00008544703,0.00009975907,0.0001058392],"about_ca_topic_score_codex":0.00044361354,"about_ca_topic_score_gemma":0.00026817355,"teacher_disagreement_score":0.12886979,"about_ca_system_score_codex":0.000007851321,"about_ca_system_score_gemma":0.00015544357,"threshold_uncertainty_score":0.723889},"labels":[],"label_agreement":null},{"id":"W3033993458","doi":"10.1136/annrheumdis-2020-eular.4539","title":"OP0297 EFFICACY AND SAFETY OF ROMOSOZUMAB AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND MILD-TO-MODERATE CHRONIC KIDNEY DISEASE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; St. Joseph’s Healthcare Hamilton","funders":"UCB Pharma; Astellas Pharma; Amgen","keywords":"Medicine; Renal function; Osteoporosis; Internal medicine; Femoral neck; Kidney disease; Incidence (geometry); Urology","score_opus":0.029189633551714517,"score_gpt":0.3045998131570705,"score_spread":0.275410179605356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033993458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974021,0.0031057885,0.0000043500154,0.021082783,0.000018180483,0.0013258151,0.00035197422,0.000025522835,0.000064540174],"genre_scores_gemma":[0.9955339,0.0013403567,0.000070696035,0.0028369096,0.000026447708,0.00006790921,0.000025464324,0.000032849777,0.00006547605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798757,0.00013468064,0.0005010304,0.00034494002,0.0005688286,0.00046292384],"domain_scores_gemma":[0.99654585,0.00019694417,0.00020515596,0.00044795068,0.00018761381,0.0024164687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020401947,0.00022729053,0.0006509097,0.00007611524,0.00014379247,0.000027807364,0.00017430146,0.00004196152,0.000117378564],"category_scores_gemma":[0.001006733,0.00014341407,0.000058785212,0.00033528032,0.00040160902,0.00011769059,0.00021828944,0.00013520702,0.00000439772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18860629,0.0061250455,0.42928264,0.07994566,0.0039440407,0.00015617032,0.03581769,0.0008004151,0.0043143616,0.0007050148,0.03365489,0.21664777],"study_design_scores_gemma":[0.00511611,0.0035496862,0.9854623,0.002782511,0.0002473008,0.0000050374374,0.00052056124,0.0008788222,0.00089789584,0.000121342244,0.00021141462,0.00020698328],"about_ca_topic_score_codex":0.00010525352,"about_ca_topic_score_gemma":0.0000068120116,"teacher_disagreement_score":0.5561797,"about_ca_system_score_codex":0.000033332075,"about_ca_system_score_gemma":0.0008119786,"threshold_uncertainty_score":0.58482563},"labels":[],"label_agreement":null},{"id":"W3034051349","doi":"10.1136/annrheumdis-2020-eular.1889","title":"OP0191 ASSOCIATION OF TRAMADOL WITH ALL-CAUSE MORTALITY, CARDIOVASCULAR DISEASE, VENOUS THROMBOEMBOLISM AND HIP FRACTURES AMONG PATIENTS WITH OSTEOARTHRITIS. A POPULATION-BASED STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Tramadol; Propensity score matching; Hazard ratio; Codeine; Internal medicine; Osteoarthritis; Diclofenac; Cohort; Proportional hazards model; Population; Medical prescription; Cohort study; Analgesic; Anesthesia; Confidence interval; Morphine; Pharmacology","score_opus":0.02269000478283202,"score_gpt":0.2684570595162272,"score_spread":0.24576705473339522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034051349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688274,0.0008425603,0.000008312229,0.00024826996,0.00004233608,0.0018076994,0.00012924701,0.000030127569,0.000008699638],"genre_scores_gemma":[0.99949217,0.000027318914,0.000011449902,0.0002712641,0.000032208038,0.00005843567,0.00007373412,0.000030712792,0.0000027240624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978677,0.00023578097,0.00036085327,0.00024344656,0.0010923956,0.00019983065],"domain_scores_gemma":[0.9984619,0.00016683404,0.00039232595,0.00045231415,0.00023288566,0.00029375023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020522522,0.00021144845,0.00075059454,0.000048970905,0.000074705255,0.000021457345,0.00011135636,0.000045490095,0.000015690406],"category_scores_gemma":[0.0005595091,0.00012900266,0.00021268512,0.00017284023,0.00007508887,0.00012336427,0.00003405174,0.00009680854,7.5054623e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047528537,0.0009713841,0.9908588,0.00091061654,0.0034720062,0.000014102013,0.00067255564,0.000976779,0.0000012446593,0.0000054064826,0.00010007711,0.0015417644],"study_design_scores_gemma":[0.003413615,0.0010830951,0.9899279,0.0008055654,0.004188326,2.0091555e-7,0.00013212503,0.00019168755,0.00006856373,0.00003849519,0.000004776718,0.0001456778],"about_ca_topic_score_codex":0.00023195724,"about_ca_topic_score_gemma":0.000029580908,"teacher_disagreement_score":0.0029383295,"about_ca_system_score_codex":0.00001891775,"about_ca_system_score_gemma":0.00011834761,"threshold_uncertainty_score":0.52605754},"labels":[],"label_agreement":null},{"id":"W3034146407","doi":"10.1136/annrheumdis-2020-eular.2383","title":"OP0010 EFFECTIVENESS OF THE MAKING IT WORK™ PROGRAM AT IMPROVING PRESENTEEISM AND WORK CESSATION IN WORKERS WITH INFLAMMATORY ARTHRITIS – RESULTS OF A RANDOMIZED CONTROLLED TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Research Canada; Simon Fraser University; Institute for Work & Health; University of Toronto; University of British Columbia","funders":"","keywords":"Presenteeism; Medicine; Randomized controlled trial; Hazard ratio; Physical therapy; Proportional hazards model; Absenteeism; Gerontology; Internal medicine; Confidence interval; Psychology; Social psychology","score_opus":0.028205024195950924,"score_gpt":0.3523940596429163,"score_spread":0.32418903544696537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034146407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98017097,0.0016451175,0.000022320977,0.0036470625,0.00022152667,0.014001765,0.000013102316,0.000025802121,0.00025231112],"genre_scores_gemma":[0.9978724,0.00022507428,0.00004749469,0.00020016916,0.000037623264,0.0015543861,0.000003672159,0.00002078097,0.00003838061],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99243456,0.004860691,0.001655134,0.00023499914,0.00045776155,0.00035686843],"domain_scores_gemma":[0.9893806,0.007908729,0.0020635566,0.00035550012,0.00018265413,0.00010897538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00362137,0.00019572128,0.0015013878,0.00007647114,0.00025777207,0.0000115699295,0.00025762862,0.000110245346,0.000011802047],"category_scores_gemma":[0.007753362,0.00010361171,0.00030600498,0.0005390391,0.0003133476,0.00010469882,0.00022501619,0.00028525578,7.260715e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.884519,0.00015579966,0.10039673,0.003549656,0.00020767939,9.30295e-7,0.0036379818,0.0004662673,0.0000042792735,0.00007340251,0.0003243929,0.006663869],"study_design_scores_gemma":[0.8314659,0.00021530267,0.12376726,0.041705366,0.00023231785,2.386112e-7,0.0011349893,0.00073144864,0.000058422625,0.0005099393,0.000021071215,0.00015772543],"about_ca_topic_score_codex":0.00013623972,"about_ca_topic_score_gemma":0.00006585965,"teacher_disagreement_score":0.053053085,"about_ca_system_score_codex":0.000027996002,"about_ca_system_score_gemma":0.00041911408,"threshold_uncertainty_score":0.92820585},"labels":[],"label_agreement":null},{"id":"W3034202212","doi":"10.1136/annrheumdis-2020-eular.3668","title":"THU0189 EFFICACY AND SAFETY OF NINTEDANIB IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASE TREATED WITH DMARDS AND/OR GLUCOCORTICOIDS AT BASELINE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nintedanib; Azathioprine; Internal medicine; Interstitial lung disease; Rituximab; Placebo; Adverse effect; Population; Cyclophosphamide; Gastroenterology; Idiopathic pulmonary fibrosis; Lung; Disease; Chemotherapy; Pathology","score_opus":0.018261710222582824,"score_gpt":0.27621128980496884,"score_spread":0.257949579582386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034202212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395967,0.002050759,0.000020582022,0.0020760822,0.000017090677,0.0015059266,0.00028816372,0.000040609197,0.000041140036],"genre_scores_gemma":[0.9988394,0.0005587277,0.00002430353,0.00024152339,0.000009754219,0.000031245763,0.00013237288,0.000045132932,0.00011753465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997623,0.00020109449,0.0007001665,0.00039507952,0.0007318043,0.0003487993],"domain_scores_gemma":[0.9977998,0.00041657966,0.00028686452,0.0005458116,0.00023603156,0.0007149059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016369614,0.00029845483,0.00070144836,0.00011016132,0.000074152784,0.000016410135,0.00020611807,0.000040451563,0.00017438426],"category_scores_gemma":[0.0016856488,0.0001605805,0.00011030623,0.0005099421,0.0007166466,0.00012307958,0.00030663385,0.00014465835,0.0000022371646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20732039,0.002830536,0.75452,0.00693588,0.0016414847,0.00025605713,0.0012384553,0.00069326663,0.000032290263,0.000081422615,0.0011342514,0.02331597],"study_design_scores_gemma":[0.032351535,0.0010800236,0.9204189,0.0055646515,0.0007849974,0.000005483526,0.00007347267,0.039392643,0.00008246633,0.000015382402,0.000024270008,0.00020612765],"about_ca_topic_score_codex":0.00017931753,"about_ca_topic_score_gemma":0.000013005078,"teacher_disagreement_score":0.17496885,"about_ca_system_score_codex":0.0003878493,"about_ca_system_score_gemma":0.0017233605,"threshold_uncertainty_score":0.65482825},"labels":[],"label_agreement":null},{"id":"W3034345646","doi":"10.1136/annrheumdis-2020-eular.1746","title":"THU0179 PERSISTENCE IN RHEUMATOID ARTHRITIS PATIENTS ON BIOSIMILAR AND BIO-ORIGINATOR ETANERCEPT: A POOLED ANALYSIS OF PAN-CANADIAN COHORTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Université de Sherbrooke; Mount Sinai Hospital; McGill University; Public Health Ontario; Montreal Heart Institute; McGill University Health Centre","funders":"","keywords":"Medicine; Etanercept; Rheumatoid arthritis; Cohort; Discontinuation; Internal medicine; Proportional hazards model; Hazard ratio; Biosimilar; Persistence (discontinuity); Cohort study; Demography; Confidence interval","score_opus":0.034141930845011374,"score_gpt":0.2731696901167273,"score_spread":0.23902775927171593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034345646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98818177,0.0059639025,0.0000033286924,0.0045450167,0.00008825021,0.0002716468,0.000718601,0.0000104961455,0.00021697974],"genre_scores_gemma":[0.99507916,0.003027706,0.000033846503,0.0017929614,0.0000019800088,0.000007468708,0.000028703053,0.000008794183,0.000019379724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845433,0.00032857424,0.0005182615,0.0002966416,0.000100190824,0.00030201222],"domain_scores_gemma":[0.9989211,0.00027669835,0.00024331007,0.00032324035,0.00010477524,0.00013085087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021046161,0.00019213508,0.0007464343,0.00025828969,0.00008354821,0.00001290309,0.00031456054,0.00013349754,0.00038239948],"category_scores_gemma":[0.0008094375,0.00013185015,0.0003370138,0.0008052095,0.00044004072,0.000054976143,0.00008104033,0.00012913242,0.000008195417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005074473,0.0010839868,0.8740875,0.00034631958,0.0067337197,0.000007606627,0.0015540053,0.000044039243,0.001063627,0.0016256758,0.0065232506,0.10642281],"study_design_scores_gemma":[0.00082449376,0.00034417008,0.9908437,0.0005934292,0.00072147895,9.650707e-7,0.00036403604,0.00026555045,0.0045663025,0.0003337488,0.00089511374,0.00024698948],"about_ca_topic_score_codex":0.0015253103,"about_ca_topic_score_gemma":0.0011968846,"teacher_disagreement_score":0.11675621,"about_ca_system_score_codex":0.000012981826,"about_ca_system_score_gemma":0.00008222408,"threshold_uncertainty_score":0.53766924},"labels":[],"label_agreement":null},{"id":"W3034508941","doi":"10.1136/annrheumdis-2020-eular.1418","title":"THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Adverse effect; Internal medicine; Placebo; Randomized controlled trial; Methotrexate; Surgery; Pathology","score_opus":0.02631793133435877,"score_gpt":0.2858470353626134,"score_spread":0.25952910402825463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034508941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98750705,0.008392882,0.0000069838666,0.0009242821,0.000038955288,0.0022385567,0.00082491036,0.000028456292,0.000037931368],"genre_scores_gemma":[0.99025136,0.009385607,0.000010874821,0.00012604495,0.000012352489,0.00005832831,0.00011432561,0.000033308657,0.000007792617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967718,0.0008179149,0.00078201806,0.00039217644,0.0008505412,0.00038556638],"domain_scores_gemma":[0.99690866,0.0016005038,0.0003611815,0.00061607483,0.00026272907,0.00025085668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048060142,0.00028695256,0.00094030343,0.000057610134,0.00018555581,0.000037518992,0.00037319746,0.00003794297,0.00009615244],"category_scores_gemma":[0.0013378579,0.00014515835,0.00013479564,0.0003864416,0.00040861906,0.00015920957,0.00028310358,0.0001826943,0.0000055354003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042263385,0.0014213821,0.93811107,0.00042146453,0.0006755978,0.00001545411,0.00301835,0.000021019769,0.000012956786,0.000019368383,0.00039967237,0.013620301],"study_design_scores_gemma":[0.017179506,0.0020250492,0.9717878,0.007395481,0.000023424904,0.0000042645092,0.0008793669,0.000045415825,0.00039327884,0.00007457321,0.000028766217,0.00016309097],"about_ca_topic_score_codex":0.00041419038,"about_ca_topic_score_gemma":0.0005766321,"teacher_disagreement_score":0.033676732,"about_ca_system_score_codex":0.000020941648,"about_ca_system_score_gemma":0.0001886573,"threshold_uncertainty_score":0.5919386},"labels":[],"label_agreement":null},{"id":"W3034582727","doi":"10.1136/annrheumdis-2020-eular.6013","title":"AB0820 COMPARATIVE EFFICACY OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Adverse effect; Placebo; Psoriasis Area and Severity Index; Meta-analysis; Dactylitis; Psoriasis; Enthesitis; Rheumatoid arthritis; Physical therapy; Dermatology; Alternative medicine; Pathology","score_opus":0.05957431747440484,"score_gpt":0.27833955742827643,"score_spread":0.2187652399538716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034582727","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37598416,0.62076515,0.00000388296,0.00054948556,0.000038480885,0.0010863777,0.0015406552,0.000012334936,0.00001945421],"genre_scores_gemma":[0.9855501,0.013596875,0.000043229837,0.00030726407,0.0000048229867,0.000059025835,0.00041044218,0.000008289184,0.000019972927],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975376,0.00098162,0.00091487245,0.00028223562,0.00010440246,0.0001792542],"domain_scores_gemma":[0.99756825,0.0009197875,0.0008411363,0.0004828899,0.00014532621,0.000042589945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020521188,0.00024552934,0.0024362546,0.00006074211,0.00005690516,0.00001329188,0.00025957247,0.00006402926,0.000075159696],"category_scores_gemma":[0.00045536697,0.00013066537,0.0005853962,0.0007747078,0.00011047823,0.00008592824,0.00006717093,0.000076716366,0.000009388124],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005589722,0.0033232288,0.025074044,0.06060218,0.87325996,0.0000084935955,0.013784316,0.0018776783,0.0000093290455,0.00035657082,0.010794634,0.005319849],"study_design_scores_gemma":[0.009187688,0.00066405156,0.46214423,0.045261435,0.48128456,0.0000012663826,0.000265465,0.000036775575,0.0002740569,0.0003201725,0.000028219589,0.00053210347],"about_ca_topic_score_codex":0.00003198746,"about_ca_topic_score_gemma":0.00002227271,"teacher_disagreement_score":0.6095659,"about_ca_system_score_codex":0.000004060154,"about_ca_system_score_gemma":0.0000249525,"threshold_uncertainty_score":0.5328379},"labels":[],"label_agreement":null},{"id":"W3034596694","doi":"10.1136/annrheumdis-2020-eular.556","title":"FRI0623-HPR HEALTHCARE RESOURCE USE IN PATIENTS WITH TRAPEZIOMETACARPAL OSTEOARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Syddansk Universitet","keywords":"Medicine; Psychological intervention; Physical therapy; Psychosocial; Massage; Modalities; Health care; Manual therapy; Referral; Osteoarthritis; Health professionals; Alternative medicine; Family medicine; Nursing","score_opus":0.04066261415770734,"score_gpt":0.2620068452848018,"score_spread":0.22134423112709445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034596694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187255,0.0013738914,0.0000018167241,0.0054375185,0.000041100993,0.00089779764,0.00022198324,0.000038858896,0.00011450542],"genre_scores_gemma":[0.997154,0.000059762122,0.000098493896,0.002433809,0.000019814466,0.000033500484,0.000093012066,0.00002895431,0.00007867079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985254,0.0001117817,0.00036259508,0.00023924766,0.00048260888,0.00027835826],"domain_scores_gemma":[0.9989807,0.000092551854,0.00015762709,0.00035924796,0.0001106109,0.00029928228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053086565,0.00018714555,0.0004675103,0.00008112455,0.000057595316,0.00002191357,0.00013957261,0.00004816562,0.000060929455],"category_scores_gemma":[0.00023875012,0.00012099881,0.0001741662,0.00038090238,0.0000853949,0.0001576888,0.00005546101,0.00010432276,0.000012508262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029939362,0.0011568003,0.75746274,0.00077634375,0.00016584588,0.00004334141,0.001310327,0.000012874801,0.000021249216,0.00047935935,0.0015331735,0.23404403],"study_design_scores_gemma":[0.012459957,0.0076962463,0.97287303,0.003439177,0.0002587465,0.0000049831974,0.0005157836,0.0000195024,0.0009656923,0.00029428132,0.001189339,0.0002832679],"about_ca_topic_score_codex":0.000042722437,"about_ca_topic_score_gemma":0.000037060847,"teacher_disagreement_score":0.23376076,"about_ca_system_score_codex":0.000011585134,"about_ca_system_score_gemma":0.00008224722,"threshold_uncertainty_score":0.4934188},"labels":[],"label_agreement":null},{"id":"W3034621686","doi":"10.1136/annrheumdis-2020-eular.2059","title":"SAT0151 EFFICACY AND SAFETY OF UPADACITINIB VERSUS ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-CHOICE): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Internal medicine; Clinical endpoint; Adalimumab; Adverse effect; Methotrexate; Tofacitinib; Clinical trial; Gastroenterology; Rituximab","score_opus":0.059634229717229835,"score_gpt":0.3616093117384592,"score_spread":0.3019750820212294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034621686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98240966,0.002632997,0.000036388825,0.0021225782,0.00007390356,0.012483227,0.0001900643,0.000037369664,0.00001380228],"genre_scores_gemma":[0.9960586,0.0030283448,0.00007513257,0.0001977959,0.000018240939,0.00052885135,0.000038210153,0.000042557833,0.000012304546],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99508333,0.0012371336,0.0015907881,0.00059788435,0.0009423791,0.0005484707],"domain_scores_gemma":[0.98852485,0.008991554,0.0008476894,0.0005728957,0.0003490719,0.0007139352],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013123237,0.00045788143,0.003043324,0.00028485598,0.00014553861,0.000057431964,0.00032495116,0.00009223618,0.00005825531],"category_scores_gemma":[0.0219496,0.00026120883,0.00031559067,0.0007745132,0.00074241817,0.0002226937,0.00025553396,0.00023581169,0.000003377456],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94888943,0.0012446747,0.00023085387,0.0008784792,0.0009323325,0.000013514654,0.0027220172,0.00008803107,0.000015332156,0.000020548536,0.000039576324,0.044925187],"study_design_scores_gemma":[0.9778271,0.0033464797,0.00822339,0.0061766277,0.00030681037,0.0000028381119,0.0004372127,0.003100986,0.00025021913,0.00003197147,0.000009650467,0.00028673455],"about_ca_topic_score_codex":0.00017208901,"about_ca_topic_score_gemma":0.000017931761,"teacher_disagreement_score":0.04463845,"about_ca_system_score_codex":0.00031522184,"about_ca_system_score_gemma":0.0028884963,"threshold_uncertainty_score":0.999984},"labels":[],"label_agreement":null},{"id":"W3034843469","doi":"10.1136/annrheumdis-2020-eular.2819","title":"AB0551 CLINICAL SIGNIFICANCE OF COGNITIVE IMPAIRMENT AND MALNUTRITION IN PATIENTS WITH SYSTEMIC SCLEROSIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Depression (economics); Physical therapy; Anxiety; Malnutrition; Dysphagia; Montreal Cognitive Assessment; Cognition; Cognitive impairment; Disease; Surgery; Psychiatry","score_opus":0.06266083606081052,"score_gpt":0.2995903320159467,"score_spread":0.23692949595513618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034843469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318874,0.004730443,0.000005678171,0.0007018492,0.000036981826,0.0011147006,0.00018253668,0.000012644401,0.000026441607],"genre_scores_gemma":[0.9976399,0.0018882856,0.000012007038,0.00037439336,0.000014566898,0.00003625607,0.000018034581,0.000012327648,0.000004221132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847615,0.0001689149,0.00067389203,0.00020062711,0.00034879294,0.00013162124],"domain_scores_gemma":[0.99872863,0.00031315416,0.00038766392,0.00017213209,0.00020470312,0.00019371195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014969226,0.0001238569,0.0005212259,0.000043390573,0.00002500706,0.0000067408832,0.00008554883,0.00005048777,0.000020645006],"category_scores_gemma":[0.00056424807,0.00007209598,0.00015380101,0.00022385814,0.00020166271,0.000057771776,0.000043984113,0.00006882926,0.000002466346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019595553,0.0014429867,0.98722076,0.001955391,0.00028059926,0.0000010490027,0.00033916862,0.000011237392,0.0000311664,0.00001406724,0.00066410954,0.006079888],"study_design_scores_gemma":[0.0043089837,0.00082445896,0.9592845,0.03401905,0.00032477977,8.9967796e-7,0.00078774575,0.00010323118,0.00024482605,0.000023915365,4.0204355e-7,0.00007723171],"about_ca_topic_score_codex":0.00002630496,"about_ca_topic_score_gemma":4.3451234e-7,"teacher_disagreement_score":0.03206366,"about_ca_system_score_codex":0.000008235559,"about_ca_system_score_gemma":0.00008442001,"threshold_uncertainty_score":0.29399887},"labels":[],"label_agreement":null},{"id":"W3034862267","doi":"10.1136/annrheumdis-2020-eular.4512","title":"SAT0604 FAST FOOD HABITS AND SERUM URATE CHANGE IN YOUNG ADULTS: 15-YEAR PROSPECTIVE ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Nutrition, Health and Food Behavior","field":"Nursing","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Demography; Obesity; Insulin resistance; Animal science; Internal medicine","score_opus":0.044595938947880505,"score_gpt":0.30653346910196305,"score_spread":0.26193753015408255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034862267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98582524,0.002332353,0.0000026133819,0.0103049325,0.000103836224,0.0007652238,0.00058716745,0.000038868173,0.00003975146],"genre_scores_gemma":[0.99872905,0.00020930178,0.000032173444,0.000851246,0.000047450852,0.00009123315,0.000017597762,0.000017521821,0.000004398617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986398,0.00013387279,0.00039434835,0.00027197288,0.00026301664,0.00029699667],"domain_scores_gemma":[0.9991244,0.00006917849,0.00021479634,0.0002445281,0.000115071605,0.00023204055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096637785,0.00016357878,0.000411216,0.00013339982,0.000106057196,0.00003450457,0.0001841126,0.000048173708,0.000045002238],"category_scores_gemma":[0.00024026066,0.00012729394,0.00018125848,0.0008958269,0.00008873235,0.0002267039,0.000065726155,0.00010004829,0.00000720526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063321134,0.00035846018,0.9809398,0.00096285966,0.00016594789,0.000001157417,0.0054747867,0.000007836603,0.000009278685,0.00006108356,0.0003462402,0.011039313],"study_design_scores_gemma":[0.0008985934,0.00043467636,0.99459666,0.00062930724,0.0003575957,8.2362806e-7,0.0012871025,0.00063759054,0.0004631039,0.0005431268,0.000008452918,0.00014296471],"about_ca_topic_score_codex":0.00031026258,"about_ca_topic_score_gemma":0.0006232468,"teacher_disagreement_score":0.013656838,"about_ca_system_score_codex":0.000017311038,"about_ca_system_score_gemma":0.000020826157,"threshold_uncertainty_score":0.5190896},"labels":[],"label_agreement":null},{"id":"W3034888841","doi":"10.1136/annrheumdis-2020-eular.750","title":"SAT0503 SERIOUS INFECTION RISK IN PEDIATRIC PATIENTS WITH LOW IMMUNOGLOBULIN LEVELS FOLLOWING RITUXIMAB TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Concomitant; Granulomatosis with polyangiitis; Azathioprine; Internal medicine; Cyclophosphamide; Gastroenterology; Microscopic polyangiitis; Immunology; Antibody; Vasculitis; Disease; Chemotherapy","score_opus":0.0157790283464051,"score_gpt":0.24762259471689488,"score_spread":0.23184356637048978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034888841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435366,0.012812266,0.0001256921,0.0003661797,0.00023828512,0.0012822436,0.00073902676,0.0000650656,0.000017554288],"genre_scores_gemma":[0.99847144,0.0008351927,0.00004637471,0.00019062338,0.0000040198656,0.00017769633,0.0001610029,0.00004219231,0.00007145327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981926,0.00022515285,0.0005600565,0.00037144418,0.00011363124,0.00053711544],"domain_scores_gemma":[0.99876696,0.00023933341,0.00047773612,0.0004000853,0.00008904026,0.000026846701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010143733,0.00037714967,0.0006884855,0.00013044916,0.00038670716,0.0000377096,0.00031816892,0.00011608579,0.000068869624],"category_scores_gemma":[0.000231247,0.0002274795,0.00036526943,0.00055680727,0.00016662721,0.00021637767,0.00006998265,0.00012764614,0.000023738261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005086378,0.0052568247,0.8642467,0.0009796927,0.0018989281,0.000007362966,0.004187166,0.00038769338,0.00060294033,0.000037581245,0.0003263643,0.116982326],"study_design_scores_gemma":[0.012763795,0.0020182698,0.9782358,0.00061874767,0.0006015836,0.0000038519966,0.0003118929,0.000022908143,0.004749556,0.00006587472,0.00019047866,0.00041724712],"about_ca_topic_score_codex":0.0010031669,"about_ca_topic_score_gemma":0.000075144904,"teacher_disagreement_score":0.11656508,"about_ca_system_score_codex":0.000039142924,"about_ca_system_score_gemma":0.0002029306,"threshold_uncertainty_score":0.9276345},"labels":[],"label_agreement":null},{"id":"W3034926963","doi":"10.1136/annrheumdis-2020-eular.3394","title":"FRI0245 PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS IS NEARLY ALWAYS ACCOMPANIED BY A LOW DIFFUSING CAPACITY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University","funders":"","keywords":"DLCO; Medicine; Diffusing capacity; Pulmonary hypertension; Internal medicine; Cardiology; Pulmonary function testing; Pulmonary Diffusing Capacity; Scleroderma (fungus); Interstitial lung disease; Lung; Lung function; Pathology","score_opus":0.0876267566715717,"score_gpt":0.25176513060768774,"score_spread":0.16413837393611602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034926963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542947,0.009272682,0.000009914781,0.0038920895,0.00025807763,0.00072145264,0.00025498908,0.00007018118,0.000091128495],"genre_scores_gemma":[0.99531287,0.0015743278,0.000012013619,0.0028989036,0.00008743389,0.000030810228,0.000026591802,0.0000384085,0.000018639555],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976108,0.00020903448,0.0008210013,0.00038778727,0.0005844324,0.0003869428],"domain_scores_gemma":[0.9984243,0.00015784214,0.0003628635,0.00052729185,0.00013593888,0.00039179935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015433761,0.00028518154,0.0008343812,0.000076167,0.00012340948,0.00005101077,0.00030317772,0.00012723361,0.00012780524],"category_scores_gemma":[0.00045068996,0.00018680173,0.00043407734,0.00042417203,0.00015182798,0.00015205097,0.00013614059,0.00015266443,0.000041221818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035420265,0.0065059313,0.080125906,0.010556434,0.0015155247,0.00007172259,0.0066130855,0.00024671102,0.7259579,0.00006768583,0.12814443,0.036652688],"study_design_scores_gemma":[0.0062103425,0.00032917227,0.8761241,0.07243281,0.0011943177,0.00010590999,0.0034695568,0.01731699,0.02167921,0.00024155105,0.000060209393,0.00083582517],"about_ca_topic_score_codex":0.00025570655,"about_ca_topic_score_gemma":7.554777e-7,"teacher_disagreement_score":0.7959982,"about_ca_system_score_codex":0.000031244268,"about_ca_system_score_gemma":0.000116405856,"threshold_uncertainty_score":0.76175535},"labels":[],"label_agreement":null},{"id":"W3034961972","doi":"10.1136/annrheumdis-2020-eular.1233","title":"THU0207 SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Discontinuation; Placebo; Methotrexate; Post-hoc analysis; Gastroenterology; Pathology","score_opus":0.020795542196623648,"score_gpt":0.2992270094505657,"score_spread":0.278431467253942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034961972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826612,0.00046504484,0.00011398682,0.0155821545,0.000038828985,0.00092978147,0.00018886793,0.000012948138,0.0000071939107],"genre_scores_gemma":[0.99875134,0.00015154776,0.00014166713,0.00079813035,0.00000109614,0.00004422979,0.000005827752,0.000012409174,0.00009374666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997386,0.0014447662,0.00053082674,0.0002728568,0.00013128613,0.00023426885],"domain_scores_gemma":[0.9977679,0.0013299296,0.00021607148,0.00027498472,0.00030536432,0.000105722116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009867016,0.00016696582,0.00045955236,0.00011644854,0.0000759179,0.0000146966195,0.00023262217,0.00008562039,0.00020793302],"category_scores_gemma":[0.007316905,0.00010542424,0.00009942789,0.00037682452,0.0004167466,0.00007767223,0.00012683372,0.00009627163,0.000004189838],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37418196,0.0037526262,0.20444174,0.0008583064,0.00079742534,0.000011733614,0.005132592,0.00010049715,0.0025868744,0.0016170754,0.0024501905,0.40406898],"study_design_scores_gemma":[0.0033820178,0.0024085515,0.98344916,0.0010195517,0.000023401786,0.0000019174897,0.00058863347,0.000033195913,0.0068519944,0.0015036734,0.00055737543,0.00018053642],"about_ca_topic_score_codex":0.00007223553,"about_ca_topic_score_gemma":0.000015687801,"teacher_disagreement_score":0.77900743,"about_ca_system_score_codex":0.000022878026,"about_ca_system_score_gemma":0.00020319002,"threshold_uncertainty_score":0.8759547},"labels":[],"label_agreement":null},{"id":"W3034982030","doi":"10.1136/annrheumdis-2020-eular.1972","title":"AB0301 SARILUMAB AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 12-WEEK TREATMENT RESULTS FROM A MULTICENTER, OPEN-LABEL, PROSPECTIVE, SINGLE-ARM OBSERVATIONAL STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Interim analysis; Observational study; Clinical endpoint; Adverse effect; Internal medicine; Population; Rheumatoid arthritis; Clinical trial; Randomized controlled trial; Physical therapy","score_opus":0.1128154960863676,"score_gpt":0.3311556429888915,"score_spread":0.2183401469025239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034982030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072915,0.0013367448,0.00001150933,0.0027234827,0.00004252724,0.004573685,0.00046084623,0.00003209861,0.00008994565],"genre_scores_gemma":[0.99552613,0.0031191416,0.00026890478,0.00027782543,0.0000085803085,0.0004551958,0.00025612387,0.000043983793,0.000044088956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694836,0.0003354094,0.0008454935,0.0005255116,0.0009975153,0.0003477298],"domain_scores_gemma":[0.9981772,0.00042728253,0.00039384965,0.00043702486,0.0003398535,0.00022484569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020929518,0.00032356777,0.00076504046,0.00013723508,0.00011943323,0.00012338023,0.00036012474,0.000043240292,0.00018609322],"category_scores_gemma":[0.00073621864,0.0001954816,0.00007414521,0.00043312102,0.00022423886,0.00043144543,0.00010260432,0.00013801861,0.000011203397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07826892,0.07643655,0.8060265,0.00008203841,0.0010210369,0.000050018767,0.004687686,0.00008468702,0.000011294362,0.0002345145,0.00021146346,0.032885298],"study_design_scores_gemma":[0.10740801,0.020599268,0.8642293,0.0045165797,0.00001753185,0.000002824265,0.0013729604,0.0007412105,0.00014994333,0.0006353354,0.000087449844,0.00023955593],"about_ca_topic_score_codex":0.001672057,"about_ca_topic_score_gemma":0.0011358157,"teacher_disagreement_score":0.058202833,"about_ca_system_score_codex":0.000120510704,"about_ca_system_score_gemma":0.00047548345,"threshold_uncertainty_score":0.7971508},"labels":[],"label_agreement":null},{"id":"W3035011019","doi":"10.1136/annrheumdis-2020-eular.6349","title":"SAT0242 REGIONAL VARIATION IN CARDIOVASCULAR DISEASE AMONG SLE PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; Research Canada","funders":"","keywords":"Medicine; Myocardial infarction; Disease; Emergency medicine; Pediatrics; Demography; Internal medicine","score_opus":0.0778929162986036,"score_gpt":0.3117959891985126,"score_spread":0.23390307289990897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035011019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97277576,0.0022734553,0.00003904664,0.023561876,0.00014566815,0.0008857923,0.0000790426,0.000028478986,0.00021089775],"genre_scores_gemma":[0.996541,0.00018092322,0.00001944349,0.0030528249,0.00008023894,0.000036682297,0.00003651411,0.000016048578,0.00003627634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801517,0.00030957643,0.0005309218,0.00022065811,0.00068368687,0.00023997876],"domain_scores_gemma":[0.9984475,0.00008700553,0.00016952651,0.00046404713,0.00019963583,0.0006322984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037743023,0.00012047545,0.0004453378,0.000059027763,0.00005480039,0.000011616481,0.00014232044,0.000044432003,0.000048471225],"category_scores_gemma":[0.0012921735,0.00008277619,0.00036768575,0.00034050117,0.000054140706,0.000117703414,0.000047343212,0.00010264879,0.000012746841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025626805,0.0006055104,0.93003774,0.004421014,0.00045049423,0.000009562431,0.0019249928,0.0003362104,8.9213205e-7,0.0009862336,0.01572897,0.045242105],"study_design_scores_gemma":[0.0007183808,0.0000711737,0.9933621,0.0008565772,0.00007604498,4.6853393e-7,0.0000705316,0.0012304534,0.0000014955912,0.00040573793,0.0031311575,0.000075863485],"about_ca_topic_score_codex":0.0017222483,"about_ca_topic_score_gemma":0.000009412003,"teacher_disagreement_score":0.06332437,"about_ca_system_score_codex":0.000028844193,"about_ca_system_score_gemma":0.00061578443,"threshold_uncertainty_score":0.3375515},"labels":[],"label_agreement":null},{"id":"W3035069029","doi":"10.1136/annrheumdis-2020-eular.6339","title":"PARE0016 MINDFULNESS-BASED STRESS REDUCTION TO IMPROVE DEPRESSIVE SYMPTOMS AND RHEUMATOID ARTHRITIS-RELATED CLINICAL OUTCOMES: RESULTS FROM A FEASIBILITY AND ACCEPTABILITY TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski; McGill University; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Mindfulness; Mindfulness-based stress reduction; Rheumatoid arthritis; Randomized controlled trial; Physical therapy; Anxiety; Depression (economics); Visual analogue scale; Internal medicine; Clinical trial; Clinical psychology; Psychiatry","score_opus":0.06742969905249853,"score_gpt":0.368498560455348,"score_spread":0.3010688614028495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035069029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98603004,0.0016713836,0.000027065555,0.008438342,0.00021841757,0.002315135,0.0012328667,0.000051869625,0.000014861217],"genre_scores_gemma":[0.9993834,0.00022008287,0.00006213227,0.0000818748,0.000022897577,0.0001057447,0.0000871203,0.000023095512,0.000013682416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646884,0.00054667745,0.0012820432,0.0007445767,0.0006157534,0.00034208456],"domain_scores_gemma":[0.99655724,0.001238253,0.00040093187,0.00086168427,0.00021644142,0.00072545925],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.000559867,0.00027178958,0.0009743964,0.000052676627,0.0001298118,0.000055063916,0.00025221004,0.00015649194,0.00018001095],"category_scores_gemma":[0.00948212,0.00018216723,0.00036017323,0.00024741035,0.0005856877,0.00013804427,0.00024473324,0.00028117697,0.0000078987005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12268037,0.004449846,0.51382595,0.0052129803,0.0024974118,0.000030435645,0.0025740105,0.00007613909,0.000116571304,0.00006526505,0.0040560467,0.34441495],"study_design_scores_gemma":[0.06960344,0.0025437921,0.91559553,0.0033718066,0.00022222346,0.0000066834405,0.0006162809,0.0016408275,0.0035935843,0.0024427588,0.000013336771,0.00034971887],"about_ca_topic_score_codex":0.00035224797,"about_ca_topic_score_gemma":0.000005413171,"teacher_disagreement_score":0.40176958,"about_ca_system_score_codex":0.000030100698,"about_ca_system_score_gemma":0.00042530018,"threshold_uncertainty_score":0.99886143},"labels":[],"label_agreement":null},{"id":"W3035200754","doi":"10.1136/annrheumdis-2020-eular.2027","title":"THU0395 EFFICACY OF IXEKIZUMAB ON DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND OBJECTIVE SIGNS OF INFLAMMATION, STRATIFIED BY BASELINE CRP/SACROILIAC JOINT MRI STATUS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of California, San Francisco; National Institute for Health and Care Research; University of Leeds; NordForsk; University of Alberta; Brigham and Women's Hospital","keywords":"Medicine; Sacroiliitis; Internal medicine; Ankylosing spondylitis; Ixekizumab; Axial spondyloarthritis; Population; Placebo; Rheumatology; Gastroenterology; Physical therapy; Secukinumab; Disease; Psoriatic arthritis; Pathology","score_opus":0.026387396365007268,"score_gpt":0.27220757408565516,"score_spread":0.2458201777206479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035200754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440724,0.0010359597,0.000013542871,0.00055379287,0.000019587114,0.0011550914,0.0027843288,0.000007697088,0.000022770622],"genre_scores_gemma":[0.9987943,0.0009976629,0.000023854052,0.00005119729,0.000008494491,0.000028362629,0.0000780269,0.00001592726,0.0000021427782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980698,0.00023636383,0.0006754827,0.0002922988,0.00052130956,0.00020474913],"domain_scores_gemma":[0.9978999,0.00046119053,0.00072394806,0.00030496548,0.00031020722,0.00029978773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001320839,0.00023675385,0.00094098394,0.00011072673,0.000060408165,0.0000066338994,0.000068777066,0.000040654035,0.000018293838],"category_scores_gemma":[0.0013818318,0.00016523906,0.00016632103,0.00034653832,0.00048154694,0.0001349372,0.00006977445,0.00009274171,1.8705342e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052537993,0.005176134,0.8955452,0.0029221552,0.001529929,0.000004829914,0.004079438,0.000103291015,0.00087982626,0.00010698194,0.00017859341,0.036935616],"study_design_scores_gemma":[0.0105531365,0.0024277063,0.9801522,0.0014437501,0.00020983515,1.1814667e-7,0.00060819107,0.00007883299,0.004297799,0.00009721053,0.0000010460516,0.00013018999],"about_ca_topic_score_codex":0.00057549455,"about_ca_topic_score_gemma":0.00007233702,"teacher_disagreement_score":0.084606975,"about_ca_system_score_codex":0.000013649479,"about_ca_system_score_gemma":0.00016737086,"threshold_uncertainty_score":0.6738253},"labels":[],"label_agreement":null},{"id":"W3035340774","doi":"10.1136/annrheumdis-2020-eular.3138","title":"FRI0575 BIOMARKER ANALYSIS FROM THE RISE-SSC STUDY OF RIOCIGUAT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Riociguat; Medicine; Placebo; Internal medicine; Clinical endpoint; Biomarker; Gastroenterology; C-reactive protein; Fibrosis; Inflammation; Pathology; Chronic thromboembolic pulmonary hypertension; Pulmonary hypertension; Randomized controlled trial","score_opus":0.0835263571329782,"score_gpt":0.2899377659912241,"score_spread":0.20641140885824594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035340774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97460985,0.021600187,0.0000072573803,0.002044171,0.0001029385,0.0012386435,0.00031104306,0.000042511754,0.000043378226],"genre_scores_gemma":[0.99685764,0.002532115,0.000004753974,0.00043539878,0.000035218964,0.000060042563,0.000016132557,0.000032899945,0.000025798192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965157,0.00061701314,0.0012513027,0.0004179705,0.00090595224,0.00029207382],"domain_scores_gemma":[0.9968082,0.0008549038,0.0007190759,0.0011349568,0.0001973763,0.00028550992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023464413,0.0003016874,0.0012051568,0.000160811,0.000103462495,0.000039572325,0.00066779973,0.00009589277,0.0001411902],"category_scores_gemma":[0.0010190562,0.00015949973,0.00086294033,0.0017121867,0.00018765124,0.00007818067,0.00020305216,0.00014370878,0.00002052276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079461094,0.0035927778,0.968839,0.0004962301,0.00734412,0.000020449592,0.008582838,0.0006279779,0.0010170849,0.000008859,0.0028569507,0.0058191083],"study_design_scores_gemma":[0.002480294,0.0002778798,0.974985,0.005510472,0.006621474,0.0000033414192,0.0073235054,0.0022809128,0.0002783949,0.000046960035,0.0000062678882,0.00018548849],"about_ca_topic_score_codex":0.003137792,"about_ca_topic_score_gemma":0.00005350897,"teacher_disagreement_score":0.02224777,"about_ca_system_score_codex":0.00002383826,"about_ca_system_score_gemma":0.00010084727,"threshold_uncertainty_score":0.650421},"labels":[],"label_agreement":null},{"id":"W3035367631","doi":"10.1136/annrheumdis-2020-eular.2553","title":"THU0377 IMPACT OF FILGOTINIB ON STRUCTURAL LESIONS IN THE SACROILIAC JOINTS AT 12 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE DOUBLE-BLIND, RANDOMIZED TORTUGA TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Biogen; Gilead Sciences; Galápagos; Amgen","keywords":"Medicine; Magnetic resonance imaging; Ankylosing spondylitis; Post-hoc analysis; Randomization; Placebo; Internal medicine; Sacroiliac joint; Randomized controlled trial; Nuclear medicine; Physical therapy; Surgery; Radiology; Pathology","score_opus":0.06945419231117657,"score_gpt":0.3318452717819742,"score_spread":0.26239107947079765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035367631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855058,0.0058075665,1.7933479e-7,0.0023389051,0.00011564762,0.0032911643,0.0028103143,0.000009259223,0.00012113471],"genre_scores_gemma":[0.9984396,0.0005982545,0.000013525861,0.00038559787,0.000057459132,0.00010927895,0.00036444148,0.00002151902,0.000010306932],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99744207,0.00048805182,0.0006890815,0.00037311227,0.00069396273,0.0003137467],"domain_scores_gemma":[0.9970816,0.0013690168,0.0004084876,0.00095138175,0.000089583584,0.0000999492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002751596,0.000289725,0.0009635704,0.000049430655,0.0001471773,0.000026040154,0.00058983715,0.000036401507,0.00025294913],"category_scores_gemma":[0.0012465173,0.00012526601,0.0003351831,0.00028347314,0.00039463644,0.0001523004,0.00031419354,0.00018806884,0.0000054127577],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8571204,0.00070554635,0.105974026,0.00003232761,0.00026484142,0.00001824784,0.002119552,0.000015856343,0.0000016339228,0.000018215009,0.0014497598,0.032279626],"study_design_scores_gemma":[0.39289692,0.0007312771,0.60427815,0.0010615197,0.00020206608,0.0000012001385,0.0004802977,0.000103458086,0.0000147758865,0.00012986583,0.0000119042925,0.00008856498],"about_ca_topic_score_codex":0.0015352491,"about_ca_topic_score_gemma":0.0005050164,"teacher_disagreement_score":0.49830413,"about_ca_system_score_codex":0.000038099573,"about_ca_system_score_gemma":0.00013723511,"threshold_uncertainty_score":0.51082},"labels":[],"label_agreement":null},{"id":"W3035431445","doi":"10.1136/annrheumdis-2020-eular.1969","title":"FRI0286 IXEKIZUMAB TREATMENT IMPROVES FATIGUE, SPINAL PAIN, STIFFNESS, AND SLEEP IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Axial spondyloarthritis; Placebo; Physical therapy; Population; Ixekizumab; Internal medicine; Ankylosing spondylitis; Disease; Pathology","score_opus":0.022094252766380943,"score_gpt":0.25703830421803026,"score_spread":0.23494405145164932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035431445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959535,0.0070135556,0.0000066350394,0.0020560662,0.00006475342,0.0010013843,0.00017213455,0.000025450463,0.00006467256],"genre_scores_gemma":[0.9977441,0.0014717198,0.000067524175,0.00049769157,0.000033086682,0.000096668206,0.000049380942,0.000027823167,0.000012025643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851006,0.000076957615,0.00038444184,0.00033171396,0.00037398323,0.00032282312],"domain_scores_gemma":[0.9990578,0.00007700602,0.0001853204,0.00030844903,0.00011814347,0.00025325673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057631678,0.0002992928,0.0006453805,0.00009698668,0.00012657203,0.000025878011,0.000109082146,0.000043308377,0.00003516911],"category_scores_gemma":[0.00019471766,0.00018242156,0.000194692,0.00037361396,0.00024925638,0.00011280661,0.00006953499,0.00006851554,0.000003382598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040892777,0.0017234177,0.5352979,0.00044864166,0.00084606063,0.00005334029,0.0006407506,0.00000798241,0.0000068712784,0.000041020892,0.00050793635,0.45633683],"study_design_scores_gemma":[0.010124131,0.00365224,0.98395413,0.0011730713,0.00028728414,0.0000033397691,0.00023237559,0.00013168737,0.00004084714,0.000104648825,0.000119689845,0.00017657336],"about_ca_topic_score_codex":0.00023033776,"about_ca_topic_score_gemma":0.00005105354,"teacher_disagreement_score":0.45616025,"about_ca_system_score_codex":0.000020751526,"about_ca_system_score_gemma":0.000062390995,"threshold_uncertainty_score":0.7438935},"labels":[],"label_agreement":null},{"id":"W3035565261","doi":"10.1136/annrheumdis-2020-eular.3340","title":"SAT0175 IMPACT OF ANTIMALARIAL ADHERENCE ON MORTALITY AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A POPULATION-BASED COHORT STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Research Canada","funders":"","keywords":"Medicine; Hydroxychloroquine; Cohort; Population; Proportional hazards model; Systemic lupus erythematosus; Internal medicine; Cohort study; Lupus erythematosus; Immunology; Disease; Coronavirus disease 2019 (COVID-19); Environmental health","score_opus":0.04487843346933152,"score_gpt":0.3381098501171575,"score_spread":0.293231416647826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035565261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951618,0.000098247685,0.0000144401965,0.00007960165,0.00009768329,0.0042162626,0.00022305053,0.00004714565,0.00006179704],"genre_scores_gemma":[0.9996914,0.000007457341,0.000011970446,0.000046117144,0.000024694395,0.00010570562,0.00005517563,0.000041237956,0.000016214826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962502,0.00039292817,0.00091762905,0.0003841843,0.001738935,0.0003160968],"domain_scores_gemma":[0.9969142,0.00038642038,0.0008122723,0.0010305882,0.0005330731,0.00032341696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039773388,0.00030073072,0.0010994517,0.00011312791,0.000076633616,0.000024544364,0.00040937075,0.00005924273,0.00011380637],"category_scores_gemma":[0.0012604756,0.00016548495,0.00042753975,0.0005128037,0.00015870015,0.0001091936,0.00008878342,0.0001387737,0.000010269755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016526642,0.0017618175,0.990813,0.0028203195,0.0012006821,0.0000066468892,0.0005454337,0.00063414586,0.0000067847895,0.000011484898,0.0004566213,0.000090407884],"study_design_scores_gemma":[0.0038940269,0.002101056,0.9861329,0.005296711,0.000427162,0.000022280774,0.00042439706,0.0014777792,0.000053034542,0.000022486765,5.644424e-8,0.00014809714],"about_ca_topic_score_codex":0.0013662713,"about_ca_topic_score_gemma":0.00001570014,"teacher_disagreement_score":0.0046800794,"about_ca_system_score_codex":0.00006793529,"about_ca_system_score_gemma":0.00039108377,"threshold_uncertainty_score":0.67482805},"labels":[],"label_agreement":null},{"id":"W3035675951","doi":"10.1136/annrheumdis-2020-eular.5947","title":"SAT0383 ENHANCED PERFORMANCE OF THE ASAS CLASSIFICATION CRITERIA BY DELETION OF NON-DISCRIMINATORY CLINICAL ITEMS: DATA FROM THE SCREENING IN AXIAL SPONDYLOARTHRITIS IN PSORIASIS, IRITIS, AND COLITIS COHORT","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Ottawa Hospital; University of Alberta; Université de Sherbrooke; University of Calgary; St. Joseph’s Healthcare Hamilton","funders":"Pfizer","keywords":"Medicine; Dactylitis; Psoriasis; Enthesitis; Internal medicine; Cohort; Psoriatic arthritis; Prospective cohort study; Sacroiliitis; Ulcerative colitis; Logistic regression; Physical therapy; Arthritis; Dermatology; Disease","score_opus":0.10520643211428612,"score_gpt":0.3637092595586452,"score_spread":0.25850282744435904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035675951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889125,0.0062042708,0.000010751084,0.0025590647,0.00012750567,0.00071761705,0.0013941939,0.0000054466254,0.000068614594],"genre_scores_gemma":[0.99009717,0.009252632,0.00006349376,0.00029561663,0.000038357808,0.00003986628,0.0001928332,0.000012981999,0.0000070237575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807435,0.0002666457,0.00084760564,0.00028808133,0.0003546313,0.00016868452],"domain_scores_gemma":[0.9983619,0.0004357236,0.00040101045,0.0006332149,0.00009644616,0.000071709874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039198276,0.00014515771,0.0005601458,0.000026566217,0.000075791504,0.000011345296,0.0003602899,0.00005975448,0.000042208652],"category_scores_gemma":[0.0011122642,0.00009052446,0.00011269581,0.00022181918,0.00043394603,0.00014311442,0.00027942477,0.00012775922,0.0000010540618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001261137,0.0005324492,0.9174719,0.00037108886,0.00022098779,0.0000026633081,0.0008575827,0.0000022424324,0.0004751614,0.000027345726,0.006641901,0.07213553],"study_design_scores_gemma":[0.0023440141,0.00022542494,0.99084,0.0030261425,0.00015184011,0.0000016860804,0.00090398826,0.0013207727,0.0009385053,0.00006203388,0.00010954174,0.00007600404],"about_ca_topic_score_codex":0.0009717673,"about_ca_topic_score_gemma":0.00027782228,"teacher_disagreement_score":0.07336814,"about_ca_system_score_codex":0.000009391172,"about_ca_system_score_gemma":0.00008054188,"threshold_uncertainty_score":0.36914805},"labels":[],"label_agreement":null},{"id":"W3035689412","doi":"10.1136/annrheumdis-2020-eular.1832","title":"THU0392 PATIENT JOURNEY TO DIAGNOSIS OF ANKYLOSING SPONDYLITIS AND ITS TREATMENT PATTERNS ACROSS CENTRAL EASTERN EUROPE AND THE UNITED STATES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Ankylosing spondylitis; Sacroiliitis; Demographics; Test (biology); Axial spondyloarthritis; Exact test; Family medicine; Pediatrics; Demography; Physical therapy; Internal medicine","score_opus":0.06504837898234024,"score_gpt":0.31768591861537976,"score_spread":0.25263753963303953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035689412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97865325,0.006695489,0.000002109821,0.011966776,0.000043990745,0.0006837176,0.0019295459,0.000010907844,0.000014199465],"genre_scores_gemma":[0.98346436,0.014914454,0.0000072997427,0.0014725898,0.000015240762,0.000044682925,0.00004768419,0.000015769443,0.000017928716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888086,0.00012040126,0.00033868273,0.00017483867,0.00023149872,0.0002537365],"domain_scores_gemma":[0.9990073,0.00024609684,0.00017383024,0.00018854764,0.00012929176,0.00025494804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048213624,0.00017702825,0.00044213582,0.000027157135,0.00013449235,0.000029805611,0.00007814319,0.000015500083,0.000041408395],"category_scores_gemma":[0.00033379093,0.00008970254,0.00012136414,0.00018846069,0.00013733719,0.000046553316,0.0001697233,0.000034574106,0.0000018318918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023504503,0.00087058084,0.9029951,0.000709816,0.00130137,0.00005113813,0.033856142,0.000079762474,0.0000065921704,0.00013604303,0.0006587036,0.05698428],"study_design_scores_gemma":[0.006797346,0.0020937033,0.9777679,0.002639474,0.0006112056,0.000020592906,0.0057142205,0.00080826704,0.0016040031,0.00009117023,0.001681716,0.00017041147],"about_ca_topic_score_codex":0.00059596414,"about_ca_topic_score_gemma":0.000027604729,"teacher_disagreement_score":0.07477277,"about_ca_system_score_codex":0.000009474481,"about_ca_system_score_gemma":0.000019359873,"threshold_uncertainty_score":0.36579636},"labels":[],"label_agreement":null},{"id":"W3035751815","doi":"10.1136/annrheumdis-2020-eular.2848","title":"AB0752 PSORIATIC ARTHRITIS: OLIGOARTHRITIS AND POLYARTHRITIS PATTERN CHANGES OVER THE INITIAL YEAR OF THE PRESENTATION. A REAL-WORLD EVIDENCE REPORT FROM THE QUEBEC REGISTRY RHUMADATA®","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Oligoarthritis; Medicine; Psoriatic arthritis; Polyarthritis; Arthritis; Internal medicine; Surgery; Dermatology","score_opus":0.06898500744504539,"score_gpt":0.3385526728336013,"score_spread":0.2695676653885559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035751815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9099624,0.041451838,0.000004845027,0.045817114,0.00031163765,0.0011237848,0.0010704556,0.000028664772,0.00022923571],"genre_scores_gemma":[0.97558415,0.021476163,0.000013602621,0.0023157406,0.00023613201,0.00011314591,0.000040848507,0.000026077443,0.00019412865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781555,0.00025636033,0.00061322306,0.0003278791,0.0007260632,0.00026093217],"domain_scores_gemma":[0.9972339,0.0008270641,0.0006194068,0.001045306,0.00014776648,0.00012652882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017581222,0.00023775111,0.0005214753,0.00002313999,0.00031716964,0.00006833166,0.00042905228,0.000042898988,0.00020689706],"category_scores_gemma":[0.0015545816,0.000117883515,0.0002640341,0.00029919465,0.0006914029,0.0001533418,0.0003957767,0.00015683722,0.0000057578695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065580336,0.0005509911,0.5117885,0.0008178446,0.0020078132,0.00026787375,0.007799185,0.000007013551,0.00006131291,0.0005507989,0.10907016,0.3664227],"study_design_scores_gemma":[0.0017490337,0.00016773723,0.9864466,0.0067486605,0.00041189135,0.000046333604,0.0018112541,0.000028053539,0.0004501701,0.000750372,0.0012456557,0.00014424138],"about_ca_topic_score_codex":0.02752317,"about_ca_topic_score_gemma":0.022096358,"teacher_disagreement_score":0.4746581,"about_ca_system_score_codex":0.0000146841,"about_ca_system_score_gemma":0.00017250581,"threshold_uncertainty_score":0.99574786},"labels":[],"label_agreement":null},{"id":"W3036701919","doi":"10.1136/annrheumdis-2020-eular.449","title":"OP0331-HPR BARRIERS TO SHARED DECISION-MAKING WITH WOMEN OF REPRODUCTIVE AGE AFFECTED BY CHRONIC INFLAMMATORY DISEASES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Axdev Group (Canada)","funders":"","keywords":"Medicine; Family medicine; Psoriatic arthritis; Thematic analysis; Specialty; Alternative medicine; Physical therapy; Rheumatoid arthritis; Qualitative research; Internal medicine; Pathology","score_opus":0.017335127870468352,"score_gpt":0.29829984903534784,"score_spread":0.28096472116487947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036701919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898605,0.0046674255,0.00021824217,0.0036413537,0.00005615278,0.0009960063,0.000379103,0.00006741898,0.000113831906],"genre_scores_gemma":[0.9979202,0.000261283,0.000068908696,0.0014957712,0.0000452315,0.000105869716,0.000021993019,0.000027826387,0.0000528926],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981944,0.00010459109,0.0004449667,0.00032898475,0.0006023186,0.00032473673],"domain_scores_gemma":[0.9975534,0.0002896981,0.00034011004,0.0007674863,0.00018104738,0.0008682206],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.000155325,0.00019463644,0.0005355918,0.000078252815,0.00007741383,0.00001331511,0.000346098,0.00003675108,0.0005042814],"category_scores_gemma":[0.010621157,0.0001235326,0.00015712553,0.00046519042,0.00022913366,0.00016093814,0.00012878823,0.00009519275,0.000009439202],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017449,0.002855549,0.119354695,0.0168913,0.0064154407,0.00015162837,0.06320468,0.0017549802,0.006007102,0.0005334444,0.37000468,0.3953775],"study_design_scores_gemma":[0.00416915,0.0026440667,0.93976474,0.0352726,0.0009232396,0.0000147140945,0.00463707,0.0004839777,0.006789172,0.0020306644,0.0026162523,0.00065436756],"about_ca_topic_score_codex":0.0000076010137,"about_ca_topic_score_gemma":0.0000011693694,"teacher_disagreement_score":0.82041,"about_ca_system_score_codex":0.000058362923,"about_ca_system_score_gemma":0.00079892547,"threshold_uncertainty_score":0.9977128},"labels":[],"label_agreement":null},{"id":"W3037324625","doi":"10.1136/annrheumdis-2020-eular.3073","title":"OP0333 RISK FACTORS OF ANTIMALARIAL-INDUCED RETINOPATHY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER AUTOIMMUNE CONDITIONS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hydroxychloroquine; Retinopathy; Rheumatoid arthritis; Chloroquine; Systemic lupus erythematosus; Dermatology; Internal medicine; Lupus erythematosus; Immunology; Disease; Malaria; Antibody; Diabetes mellitus; Endocrinology","score_opus":0.04892791804767278,"score_gpt":0.2997028698628523,"score_spread":0.2507749518151795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037324625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966561,0.00088448875,0.000009920798,0.0010002916,0.00014434625,0.00070768053,0.0003320428,0.000039852715,0.00022525477],"genre_scores_gemma":[0.9995501,0.00011797185,0.00003239663,0.00020756724,0.000014061563,0.0000136744175,0.0000106564285,0.00003074358,0.000022819275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824375,0.00026270625,0.00068673235,0.00023064105,0.00035940783,0.00021674833],"domain_scores_gemma":[0.9984116,0.00026568078,0.0005523506,0.00050240103,0.000096954514,0.00017099302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024849974,0.00020242647,0.0007503862,0.00009989072,0.00005793314,0.000012750678,0.00021646108,0.00007952596,0.00005130782],"category_scores_gemma":[0.0021038817,0.00013960947,0.00024060061,0.0003223544,0.00016399837,0.00008343676,0.000119610864,0.00016012476,0.000006539913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031680154,0.0010079361,0.9512224,0.0039673652,0.0007298178,0.00002062822,0.0060442802,0.00014032195,0.03361904,0.0010405019,0.0005832154,0.0013076608],"study_design_scores_gemma":[0.0027079599,0.0002703285,0.94906384,0.005074294,0.00057026924,0.000084417174,0.002447589,0.0018639524,0.03666658,0.0009442517,0.000022609554,0.0002838899],"about_ca_topic_score_codex":0.00027227137,"about_ca_topic_score_gemma":0.0000035129353,"teacher_disagreement_score":0.0035966914,"about_ca_system_score_codex":0.000013528274,"about_ca_system_score_gemma":0.00012030291,"threshold_uncertainty_score":0.5693109},"labels":[],"label_agreement":null},{"id":"W3037338668","doi":"10.1136/annrheumdis-2019-216863","title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University; University of Toronto","funders":"National Institutes of Health; Canadian Institutes of Health Research; InflaRx; Vifor Pharma; Ministry of Health, Labour and Welfare; Genentech; University of Oxford; CSL Behring; National Institute for Health and Care Research; University of Utah; Insmed; Vasculitis Clinical Research Consortium; University of Pennsylvania; Kiniksa Pharmaceuticals; Mayo Clinic; Vasculitis Foundation; Medical Research Council; National Center for Research Resources; Versus Arthritis; Celgene; NIHR Cambridge Biomedical Research Centre; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; GlaxoSmithKline; University of Pittsburgh","keywords":"Medicine; Rituximab; Internal medicine; Granulomatosis with polyangiitis; Microscopic polyangiitis; Regimen; Vasculitis; Prednisone; Prospective cohort study; Population; Cohort; Cyclophosphamide; Surgery; Gastroenterology; Disease; Chemotherapy; Lymphoma","score_opus":0.038712418029306396,"score_gpt":0.3034553782608066,"score_spread":0.2647429602315002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037338668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95292526,0.0034420884,0.0000030843173,0.042192914,0.00007685712,0.00052377244,0.000067758425,0.000043245967,0.00072503],"genre_scores_gemma":[0.99085826,0.0019316341,0.000026370606,0.006802676,0.000025021407,0.00005744476,0.000024673987,0.000021700058,0.00025223885],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986491,0.00013155914,0.00039807367,0.00021884203,0.0003712267,0.00023114959],"domain_scores_gemma":[0.99901146,0.00008157026,0.000112659385,0.00036187502,0.00010268422,0.00032977748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001204696,0.00014869845,0.00042238564,0.00006848756,0.000059029513,0.000015947853,0.00016793846,0.00009202442,0.00064166967],"category_scores_gemma":[0.0012238588,0.00009565044,0.00033218667,0.0005218561,0.000053386266,0.0000803343,0.00006868534,0.00017408462,0.00010359106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00652126,0.018314665,0.15463257,0.0024241598,0.006325071,0.00071217376,0.03730237,0.00052293483,0.0038812817,0.0026830235,0.3256008,0.44107968],"study_design_scores_gemma":[0.007823567,0.0006612874,0.975158,0.0052393354,0.000228613,0.000014329166,0.00055663293,0.00016009768,0.0022717998,0.004260028,0.00331012,0.00031620075],"about_ca_topic_score_codex":0.00011196128,"about_ca_topic_score_gemma":0.000004513542,"teacher_disagreement_score":0.8205254,"about_ca_system_score_codex":0.00002049165,"about_ca_system_score_gemma":0.0001343464,"threshold_uncertainty_score":0.70258325},"labels":[],"label_agreement":null},{"id":"W3037553395","doi":"10.1136/annrheumdis-2020-218164","title":"Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Toronto Western Hospital; Centre for Advancing Health Outcomes; University of Calgary; McGill University Health Centre","funders":"","keywords":"Hydroxychloroquine; Medicine; Pandemic; Belimumab; Systemic lupus erythematosus; Coronavirus disease 2019 (COVID-19); Rheumatology; Economic shortage; Lupus erythematosus; Intensive care medicine; Immunology; Family medicine; Internal medicine; Disease; Antibody","score_opus":0.04649819119080465,"score_gpt":0.3296493320904768,"score_spread":0.28315114089967214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037553395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455039,0.0031521006,0.000017116903,0.043928698,0.0020506228,0.004276806,0.0008704715,0.000108681066,0.00009159843],"genre_scores_gemma":[0.97413105,0.0008248708,0.000012671644,0.021843653,0.00045097407,0.00053698086,0.00012345696,0.00015911889,0.0019172208],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99124116,0.0010705906,0.0024169101,0.000828387,0.003700863,0.000742115],"domain_scores_gemma":[0.9903911,0.0021807533,0.0033305187,0.0025456501,0.0012035536,0.0003484374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007565201,0.000773493,0.0018606912,0.0002248932,0.00044253137,0.00012505356,0.002961362,0.00038125698,0.00008430312],"category_scores_gemma":[0.0059718546,0.00036535875,0.00078098715,0.0010050328,0.0012907141,0.00020770448,0.0010023497,0.0012181529,0.000010768409],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041880997,0.00013907104,0.8909474,0.020040885,0.001239851,0.00006187979,0.0052572205,0.00018386699,0.00002423684,0.000008534675,0.08162263,0.000055634755],"study_design_scores_gemma":[0.0493728,0.0026437659,0.14880621,0.50878626,0.010515057,0.1293304,0.10619838,0.008800947,0.0010256156,0.0009837889,0.025887586,0.0076491903],"about_ca_topic_score_codex":0.00013932654,"about_ca_topic_score_gemma":0.000020192618,"teacher_disagreement_score":0.7421412,"about_ca_system_score_codex":0.00037241966,"about_ca_system_score_gemma":0.0012390427,"threshold_uncertainty_score":0.99987984},"labels":[],"label_agreement":null},{"id":"W3038113016","doi":"10.1136/ard.2011.154799","title":"Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Janssen Biotech","keywords":"Golimumab; Medicine; Ankylosing spondylitis; Placebo; Spondylitis; Internal medicine; Surgery; Gastroenterology; Etanercept; Rheumatoid arthritis","score_opus":0.09106185712770834,"score_gpt":0.3121873675547098,"score_spread":0.2211255104270015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038113016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921698,0.0029205994,2.5590072e-7,0.00056939473,0.00021315324,0.0011835821,0.0007034312,0.000021235091,0.0022185526],"genre_scores_gemma":[0.9988653,0.00031170415,0.00003132165,0.0001563936,0.000015190374,0.000046154975,0.000014779116,0.000026065281,0.00053306576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777603,0.00023687189,0.00085470325,0.00028766113,0.00050812814,0.0003365914],"domain_scores_gemma":[0.9980075,0.00025946624,0.00045783052,0.0010057937,0.0001539761,0.00011543689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024234537,0.0002446621,0.0006610949,0.0000935559,0.00011698124,0.000011233218,0.00035344035,0.00004643719,0.000120016324],"category_scores_gemma":[0.0009075165,0.00014258224,0.000354034,0.0003568513,0.00026422585,0.00008387546,0.00025146402,0.00010380922,0.000010001043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023850176,0.038673203,0.83904225,0.0017570839,0.0034580322,0.0009667495,0.03595388,0.000014538081,0.000072755734,0.00046411817,0.007075078,0.048672136],"study_design_scores_gemma":[0.0061309524,0.0021434964,0.9813758,0.0032469803,0.0004691177,0.00006898301,0.004530506,0.000014530407,0.00053588935,0.001174506,0.00014309213,0.00016610645],"about_ca_topic_score_codex":0.0009574669,"about_ca_topic_score_gemma":0.00032573214,"teacher_disagreement_score":0.14233358,"about_ca_system_score_codex":0.00002861744,"about_ca_system_score_gemma":0.00014175902,"threshold_uncertainty_score":0.5814335},"labels":[],"label_agreement":null},{"id":"W3039344762","doi":"10.1136/annrheumdis-2020-217237","title":"Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"Odense Universitetshospital; Oak Foundation","keywords":"Medicine; Epidemiology; Population; Meta-analysis; Physical therapy; Family medicine; Internal medicine; Gerontology; Environmental health","score_opus":0.4342632187980843,"score_gpt":0.4729137158865182,"score_spread":0.03865049708843388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039344762","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3189391,0.6776414,0.0000039315364,0.00012807659,0.00022011177,0.0025075416,0.00048113387,0.000074834374,0.000003875802],"genre_scores_gemma":[0.39433125,0.60407156,0.00001718313,0.00009477978,0.000082734536,0.00029254385,0.0010563931,0.00005169489,0.0000018496447],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98109233,0.011894457,0.004445974,0.0009115578,0.0010466621,0.0006090309],"domain_scores_gemma":[0.98869425,0.006441811,0.0027705997,0.0011752613,0.00012786368,0.00079018826],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045408625,0.0009866487,0.011924762,0.0002875377,0.00017367363,0.00013148908,0.0008617882,0.00033839475,0.0005076461],"category_scores_gemma":[0.025446588,0.0004829425,0.0025157225,0.0004818514,0.00025893733,0.00037596727,0.0002744062,0.0008191894,0.000018766155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084349414,0.005061229,0.08493754,0.0022530896,0.008458403,0.00017334461,0.0013819184,9.3089824e-7,5.0540064e-7,0.0003321359,0.00015946559,0.89639795],"study_design_scores_gemma":[0.008444112,0.012350182,0.71829396,0.11042976,0.01631878,0.00015013613,0.016576653,0.00043287635,0.0000047179833,0.011532053,0.101329826,0.004136932],"about_ca_topic_score_codex":0.00068229804,"about_ca_topic_score_gemma":0.00013858969,"teacher_disagreement_score":0.892261,"about_ca_system_score_codex":0.000059398164,"about_ca_system_score_gemma":0.00034269918,"threshold_uncertainty_score":0.99976224},"labels":[{"model":"gemma","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"observational","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch","metaepi_narrow","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W3039534321","doi":"10.1136/annrheumdis-2020-eular.364","title":"OP0302 IANALUMAB (VAY736), A DUAL MODE OF ACTION BIOLOGIC COMBINING BAFF RECEPTOR INHIBITION WITH B CELL DEPLETION, REACHES PRIMARY ENDPOINT FOR TREATMENT OF PRIMARY SJOGREN'S SYNDROME","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal; Mylan","keywords":"Medicine; B-cell activating factor; Clinical endpoint; Internal medicine; Belimumab; Gastroenterology; Rituximab; Surrogate endpoint; Placebo; Clinical trial; Immunology; Antibody; B cell; Pathology; Lymphoma","score_opus":0.07702378990611033,"score_gpt":0.2857495258716496,"score_spread":0.20872573596553926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039534321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940986,0.0012518539,0.00076056167,0.0021695376,0.000055501067,0.0008659592,0.0004755912,0.00003519856,0.00028717224],"genre_scores_gemma":[0.99769896,0.000745602,0.00064535637,0.00023154407,0.000019019384,0.00009046096,0.0005000147,0.000018478768,0.000050547886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888873,0.00007157076,0.00045680304,0.00019959843,0.0002334683,0.00014983676],"domain_scores_gemma":[0.9988672,0.000186951,0.00043124866,0.00025660815,0.00014996192,0.00010800081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006839386,0.00016983514,0.0005898615,0.00007482586,0.00006989589,0.000005753934,0.000057795907,0.000052294665,0.00006836241],"category_scores_gemma":[0.00010549535,0.00010275949,0.00028633754,0.00019980418,0.0001376331,0.00008772439,0.000025727364,0.000031921227,0.0000016093029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09286542,0.06803783,0.35116985,0.0675633,0.012867124,0.000064891,0.025028909,0.008851532,0.09730302,0.0026415605,0.06637915,0.20722742],"study_design_scores_gemma":[0.035421383,0.051643614,0.7875238,0.007512724,0.0065733884,0.00013921545,0.012185756,0.005174533,0.08336434,0.008182961,0.0009137618,0.0013644936],"about_ca_topic_score_codex":0.00007942367,"about_ca_topic_score_gemma":0.000002864872,"teacher_disagreement_score":0.43635398,"about_ca_system_score_codex":0.0000307441,"about_ca_system_score_gemma":0.00017273125,"threshold_uncertainty_score":0.41904104},"labels":[],"label_agreement":null},{"id":"W3040367438","doi":"10.1136/annrheumdis-2020-eular.3671","title":"OP0249 LONG-TERM EXTENSION RESULTS OF RISE-SSC, A RANDOMIZED TRIAL OF RIOCIGUAT IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Bayer","keywords":"Riociguat; Medicine; Placebo; Clinical endpoint; Internal medicine; Randomized controlled trial; Pulmonary hypertension; Chronic thromboembolic pulmonary hypertension; Pathology","score_opus":0.029574648662304893,"score_gpt":0.26823213629845866,"score_spread":0.23865748763615377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040367438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965911,0.0018013397,0.000021368085,0.00015228763,0.000050706116,0.0012043284,0.00014675665,0.0000043212885,0.000027773347],"genre_scores_gemma":[0.9984548,0.0013223204,0.000012446065,0.000036811354,0.00001840434,0.000032622684,0.00007357933,0.000016950604,0.000032053085],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99788713,0.00056412356,0.0007061321,0.00028477187,0.00035238024,0.00020544688],"domain_scores_gemma":[0.99844486,0.00017800799,0.00051082106,0.0005273338,0.00023546067,0.00010352839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031812082,0.00016847403,0.00068824866,0.00005068967,0.000029324177,0.000008248316,0.00040165184,0.00010140026,0.000007228549],"category_scores_gemma":[0.0016125008,0.00010215731,0.00031947682,0.00016373993,0.00037428664,0.0000051579477,0.00018287738,0.000070401125,0.0000015815809],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9407573,0.0016397164,0.034859058,0.00062061497,0.0005104784,0.0000061441665,0.00030321153,0.00006717431,0.016359292,0.00000661693,0.00023466883,0.004635738],"study_design_scores_gemma":[0.8092587,0.0035786922,0.088083684,0.0032254623,0.00032732257,0.000006984912,0.00008759935,0.00013909009,0.094854794,0.000072563176,0.0000029441564,0.00036216064],"about_ca_topic_score_codex":0.000052016796,"about_ca_topic_score_gemma":0.0000036390716,"teacher_disagreement_score":0.13149858,"about_ca_system_score_codex":0.0000037926636,"about_ca_system_score_gemma":0.000087161876,"threshold_uncertainty_score":0.41658542},"labels":[],"label_agreement":null},{"id":"W3042114005","doi":"10.1136/annrheumdis-2020-eular.3711","title":"THU0363 EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD) AND NORMAL VERSUS ELEVATED C-REACTIVE PROTEIN (CRP) AT BASELINE: ANALYSES FROM THE SENSCIS TRIAL","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nintedanib; Internal medicine; Vital capacity; Placebo; Gastroenterology; C-reactive protein; Scleroderma (fungus); Idiopathic pulmonary fibrosis; Pathology; Lung; Inflammation; Diffusing capacity; Lung function","score_opus":0.054991871884841795,"score_gpt":0.2798436474439691,"score_spread":0.22485177555912733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042114005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044234,0.0055431332,0.0000028986735,0.0006397588,0.00013927782,0.0027814065,0.0003924237,0.000039190807,0.000019587784],"genre_scores_gemma":[0.9991252,0.00034272543,0.000007543899,0.00022809733,0.000040411,0.000085870925,0.00012127473,0.000033998702,0.000014880181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697083,0.00073706853,0.0008373445,0.0003551828,0.00080642337,0.0002931268],"domain_scores_gemma":[0.9964933,0.0015281481,0.0008906158,0.0004931224,0.000349953,0.00024489686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025742454,0.00031633532,0.0009378812,0.0000737178,0.00011513692,0.00002340192,0.00026607406,0.000118837466,0.00003347082],"category_scores_gemma":[0.004221541,0.00016077026,0.0003112654,0.00061498926,0.00023548552,0.00010838251,0.0001508623,0.0001723886,0.000004831438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34944457,0.0074161603,0.57409096,0.0049045775,0.014656008,0.000024571847,0.0065425853,0.00045817604,0.026162475,0.000031397936,0.007899033,0.008369516],"study_design_scores_gemma":[0.0798546,0.0021384412,0.86018926,0.032873776,0.0027788084,8.380754e-7,0.0013511551,0.000993674,0.019482562,0.000013476392,0.0000024335193,0.00032095067],"about_ca_topic_score_codex":0.0008853826,"about_ca_topic_score_gemma":0.000028962928,"teacher_disagreement_score":0.28609833,"about_ca_system_score_codex":0.000054666572,"about_ca_system_score_gemma":0.00015808915,"threshold_uncertainty_score":0.65560204},"labels":[],"label_agreement":null},{"id":"W3042129498","doi":"10.1136/annrheumdis-2020-eular.2396","title":"THU0197 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Pfizer; Allergan; H. Lundbeck A/S; Eli Lilly and Company; Amgen","keywords":"Medicine; Adverse effect; Rheumatoid arthritis; Discontinuation; Internal medicine; Adalimumab; MedDRA; Gastroenterology; Surgery","score_opus":0.02056276654048842,"score_gpt":0.2662330432173505,"score_spread":0.24567027667686206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042129498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415505,0.0029475666,0.000010994117,0.0012493524,0.000045231092,0.0009716675,0.00044348836,0.00001609875,0.00016056484],"genre_scores_gemma":[0.9945519,0.004980009,0.00014308652,0.00020729259,0.000006878213,0.00002979052,0.000033236112,0.000024847704,0.000022984372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794346,0.00011976469,0.00069565536,0.00020040885,0.0007633077,0.00027737406],"domain_scores_gemma":[0.99861073,0.00015822619,0.00027618124,0.0004241847,0.0003028231,0.00022783497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015909293,0.00015430892,0.0006875388,0.00011008718,0.00002937336,0.000008660608,0.00027668095,0.00003711812,0.00028344878],"category_scores_gemma":[0.0010332193,0.00010942975,0.00017393321,0.00047154631,0.00023182349,0.000114280614,0.00011640353,0.0001007986,0.00001137228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008463086,0.0014388546,0.78138804,0.0015211332,0.0005297781,0.00000815246,0.008028391,0.00013425377,0.00020118275,0.0009705835,0.0065915985,0.19072497],"study_design_scores_gemma":[0.005035866,0.0016626992,0.98285186,0.006024794,0.0000063041066,0.0000016611688,0.00088661484,0.00002792003,0.0027127943,0.00022914584,0.00041616024,0.00014418284],"about_ca_topic_score_codex":0.00007920117,"about_ca_topic_score_gemma":0.000014586754,"teacher_disagreement_score":0.20146385,"about_ca_system_score_codex":0.0000071912896,"about_ca_system_score_gemma":0.00019158688,"threshold_uncertainty_score":0.44624156},"labels":[],"label_agreement":null},{"id":"W3042196480","doi":"10.1136/annrheumdis-2020-eular.474","title":"OP0054 EFFICACY OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF IL-23, ON ENDPOINTS RELATED TO AXIAL INVOLVEMENT IN PATIENTS WITH ACTIVE PSA WITH IMAGING-CONFIRMED SACROILIITIS: WEEK-24 RESULTS FROM TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Novartis Pharma; Celgene; Chugai Pharmaceutical; Pfizer","keywords":"Medicine; Sacroiliitis; BASDAI; Psoriatic arthritis; Axial spondyloarthritis; Internal medicine; Sacroiliac joint; Ankylosing spondylitis; Surgery; Nuclear medicine; Gastroenterology; Arthritis","score_opus":0.05550652916542601,"score_gpt":0.3145206718421891,"score_spread":0.2590141426767631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042196480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941773,0.0010077666,0.000010954494,0.002659829,0.0002146271,0.0044814716,0.002118522,0.000024778776,0.00006434197],"genre_scores_gemma":[0.99863946,0.00022471856,0.000046284484,0.00025742454,0.000015241834,0.00023214774,0.00049390807,0.000029577668,0.00006125015],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99671406,0.0009463962,0.0011331883,0.00051313045,0.0003151459,0.00037807375],"domain_scores_gemma":[0.9957377,0.0022485529,0.0009546182,0.00063069566,0.00032497552,0.00010349686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005090713,0.0004451348,0.0017113761,0.00020282848,0.00013158681,0.000019003315,0.0005941247,0.00007100118,0.0000663392],"category_scores_gemma":[0.00087413436,0.0002249461,0.00037666332,0.00045468507,0.000451212,0.00010681849,0.0001779423,0.00016338158,0.000031234817],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96950233,0.0033888917,0.002597608,0.000049938986,0.007543475,0.0000061967885,0.00789028,0.0006242285,0.0005394462,0.000062485735,0.00046019876,0.0073349196],"study_design_scores_gemma":[0.9310082,0.0024751816,0.030951153,0.001771849,0.0016433971,8.3406906e-7,0.0019585013,0.000036787802,0.029664855,0.000104463456,0.00004321895,0.0003415632],"about_ca_topic_score_codex":0.00022163027,"about_ca_topic_score_gemma":0.00007154211,"teacher_disagreement_score":0.038494136,"about_ca_system_score_codex":0.000032333526,"about_ca_system_score_gemma":0.00014669291,"threshold_uncertainty_score":0.91730356},"labels":[],"label_agreement":null},{"id":"W3042207082","doi":"10.1136/annrheumdis-2020-eular.4736","title":"FRI0340 COMPARISON OF SECUKINUMAB VERSUS ADALIMUMAB EFFICACY ON SKIN OUTCOMES IN PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM THE EXCEED STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada; AbbVie; Celgene; Gilead Sciences; Galápagos; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Adalimumab; Secukinumab; Etanercept; Psoriasis; Psoriatic arthritis; Ustekinumab; Plaque psoriasis; Internal medicine; Psoriasis Area and Severity Index; Clinical endpoint; Dosing; Dermatology; Clinical trial; Gastroenterology; Rheumatoid arthritis","score_opus":0.09139180522912485,"score_gpt":0.3222439612649051,"score_spread":0.23085215603578027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042207082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990754,0.0048952457,0.0000011399388,0.0019181488,0.0005927805,0.0008062982,0.00090555585,0.000031688458,0.00009514388],"genre_scores_gemma":[0.99937034,0.00023503663,0.000007625124,0.00015966063,0.000020427937,0.000041033385,0.000115328105,0.000017685565,0.000032891312],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974849,0.0008308718,0.00092149584,0.0003241252,0.00016564857,0.0002729434],"domain_scores_gemma":[0.9955993,0.0030821268,0.00055407826,0.00067593326,0.000047467696,0.000041083764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002184869,0.0002744133,0.0008594584,0.000053047163,0.0001313158,0.000015718024,0.0006665379,0.00007768747,0.00009249818],"category_scores_gemma":[0.0016587429,0.00016033513,0.00033043927,0.00025450005,0.00015909775,0.000058189522,0.00014647398,0.00014580405,0.00009200521],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059652604,0.040473733,0.19745079,0.00021271002,0.01495389,0.000026905276,0.09678303,0.0012751133,0.00043781797,0.00061588356,0.02394389,0.56417364],"study_design_scores_gemma":[0.025903558,0.0021525605,0.95525664,0.00060786464,0.00062561536,3.9269506e-7,0.00968054,0.000043320015,0.0049220137,0.00035295164,0.00018283246,0.0002717201],"about_ca_topic_score_codex":0.0007634013,"about_ca_topic_score_gemma":0.00025322847,"teacher_disagreement_score":0.7578058,"about_ca_system_score_codex":0.0000132750665,"about_ca_system_score_gemma":0.00006831279,"threshold_uncertainty_score":0.65382767},"labels":[],"label_agreement":null},{"id":"W3043011023","doi":"10.1136/annrheumdis-2020-eular.1709","title":"SAT0359 THE ASSOCIATION BETWEEN IMAGING SUB-PHENOTYPES OF PSORIATIC ARTHRITIS AND GENE EXPRESSION PROFILES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Krembil Foundation; University of Toronto","funders":"","keywords":"Medicine; Enthesitis; Psoriatic arthritis; Synovitis; Tenosynovitis; Pathology; Tendinopathy; Psoriasis; Arthritis; Internal medicine; Immunology; Tendon; Surgery","score_opus":0.02687157150990318,"score_gpt":0.2737268503488814,"score_spread":0.2468552788389782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043011023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708579,0.020924548,0.000008990085,0.007510487,0.00004917186,0.00039136087,0.0001529756,0.000015784952,0.00008873454],"genre_scores_gemma":[0.99505013,0.0044717635,0.00007461416,0.00028671592,0.00005371031,0.000021242782,0.000015687248,0.000010925987,0.000015181251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905497,0.00007838484,0.00029487017,0.00012334912,0.00031068933,0.00013772446],"domain_scores_gemma":[0.99907357,0.00026461502,0.0003021268,0.00018147218,0.00010364883,0.000074554424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103110644,0.000105897954,0.0003464323,0.000017705004,0.000114297756,0.000012161943,0.00008440607,0.000020104586,0.000019094297],"category_scores_gemma":[0.0007719295,0.000058684713,0.00012377017,0.00010893121,0.00008250715,0.00005813091,0.000098733326,0.000045663794,0.0000032184819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010781916,0.0001533373,0.828592,0.0004443992,0.0006066987,0.0000027623903,0.0012570136,0.0000031483949,0.00078584335,0.000078083474,0.0037089514,0.16425993],"study_design_scores_gemma":[0.0012548123,0.0001200304,0.9673564,0.0015286793,0.00038508725,0.000001607461,0.00043038264,0.000045501078,0.027740754,0.0009837704,0.0000789119,0.00007409802],"about_ca_topic_score_codex":0.000034696764,"about_ca_topic_score_gemma":0.0000018028297,"teacher_disagreement_score":0.16418582,"about_ca_system_score_codex":0.000008826676,"about_ca_system_score_gemma":0.00003129819,"threshold_uncertainty_score":0.23930931},"labels":[],"label_agreement":null},{"id":"W3043215792","doi":"10.1136/annrheumdis-2020-eular.1447","title":"FRI0416 COMBINATION OF SERUM ADIPOKINES/RELATED INFLAMMATORY FACTORS AND RATIOS AS PREDICTORS OF INFRAPATELLAR FAT PAD VOLUME IN KNEE OSTEOARTHRITIS PATIENTS: USAGE OF A COMPREHENSIVE MACHINE LEARNING APPROACH","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PerkinElmer Biosignal; Université de Montréal; Université Laval","funders":"Canada First Research Excellence Fund; Université Laval","keywords":"Medicine; Infrapatellar fat pad; Adipokine; Osteoarthritis; Internal medicine; Body mass index; Biomarker; Concordance; Physical therapy; Leptin; Obesity; Pathology","score_opus":0.016510303178143663,"score_gpt":0.22687745671615855,"score_spread":0.21036715353801488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043215792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995982,0.002480056,0.0000038173443,0.00008601195,0.000054508753,0.0010490281,0.00023972268,0.000019873854,0.00008499848],"genre_scores_gemma":[0.99936515,0.0003298165,0.000028699287,0.000035608933,0.00000427875,0.0000155514,0.00017090798,0.000021875467,0.000028081437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982498,0.00020768988,0.00080346427,0.00018295982,0.00040087578,0.00015518756],"domain_scores_gemma":[0.9985785,0.00014224598,0.00066836685,0.00020560045,0.00027768372,0.00012761548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007795867,0.00020823073,0.00072578195,0.00014333522,0.00003605333,0.000005260376,0.00010388114,0.00008423175,0.000055473516],"category_scores_gemma":[0.00049144763,0.00015635761,0.00017650878,0.00028940616,0.00019211131,0.00015173246,0.00009611757,0.00011653927,0.0000010632629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029594466,0.0006260641,0.9783675,0.0018161867,0.00022328571,0.0000023965986,0.004078023,0.00014680909,0.0010584099,0.00011791883,0.00001965137,0.013247823],"study_design_scores_gemma":[0.009331483,0.0065151034,0.95472026,0.0028491612,0.00040122107,0.0000024463914,0.002148651,0.0016446216,0.02179951,0.00036275922,0.000023710088,0.00020105284],"about_ca_topic_score_codex":0.000047644255,"about_ca_topic_score_gemma":0.0000048794664,"teacher_disagreement_score":0.023647208,"about_ca_system_score_codex":0.000009236917,"about_ca_system_score_gemma":0.00005620283,"threshold_uncertainty_score":0.6376079},"labels":[],"label_agreement":null},{"id":"W3043306280","doi":"10.1136/annrheumdis-2020-eular.346","title":"OP0231 COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Pfizer; Eli Lilly and Company","keywords":"Abatacept; Medicine; Rheumatoid arthritis; TNF inhibitor; Tofacitinib; Methotrexate; Arthritis; Internal medicine; Immunology; Pharmacology; Oncology; Adalimumab; Rituximab; Antibody","score_opus":0.04151861357584468,"score_gpt":0.32595042329920304,"score_spread":0.28443180972335835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043306280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967403,0.00053567183,0.000014397834,0.00063113036,0.00030853497,0.0012511892,0.00043352903,0.000011771477,0.0000734952],"genre_scores_gemma":[0.99940944,0.0003321807,0.000026180891,0.000051643405,0.0000328629,0.000041158393,0.00008623152,0.000017389824,0.0000029196483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997526,0.00046362903,0.0010298666,0.0002577359,0.0005878293,0.00013496116],"domain_scores_gemma":[0.9974095,0.00047134323,0.00090999325,0.00035811032,0.0007369904,0.00011403848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034637097,0.00020164289,0.0007410136,0.00014895924,0.0000601885,0.00002024751,0.00022842154,0.00004469898,0.00002570814],"category_scores_gemma":[0.00088711345,0.0001409643,0.00018323635,0.0005044059,0.00030866163,0.00032346701,0.00012678877,0.000120503726,7.8392304e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044205626,0.008663597,0.9157113,0.002127485,0.0011491353,0.000005318272,0.029406253,0.001684455,0.020027036,0.00055794284,0.0049048127,0.011342127],"study_design_scores_gemma":[0.0065414635,0.0040144073,0.74464685,0.011772688,0.00016248855,0.0000041290223,0.016192473,0.0016095799,0.21429847,0.0002310886,0.00021219066,0.0003141989],"about_ca_topic_score_codex":0.0002445019,"about_ca_topic_score_gemma":0.000056579254,"teacher_disagreement_score":0.19427143,"about_ca_system_score_codex":0.000025373223,"about_ca_system_score_gemma":0.00014506931,"threshold_uncertainty_score":0.5748357},"labels":[],"label_agreement":null},{"id":"W3043705891","doi":"10.1136/annrheumdis-2020-eular.1349","title":"FRI0351 DOES SEX OR BODY MASS INDEX IMPACT RESPONSE TO THERAPY IN PSORIATIC ARTHRITIS?: RESULTS FROM A PHASE 3, DOUBLE-BLIND, RANDOMIZED TRIAL EXAMINING METHOTREXATE AND ETANERCEPT AS MONOTHERAPY OR IN COMBINATION FOR TREATING PSORIATIC ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Etanercept; Methotrexate; Body mass index; Psoriatic arthritis; Internal medicine; Randomized controlled trial; Combination therapy; Rheumatoid arthritis","score_opus":0.09292621713179922,"score_gpt":0.399006282427661,"score_spread":0.3060800652958618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043705891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838836,0.0034009863,0.00008693916,0.003932815,0.00015967523,0.0078751575,0.0006029901,0.00004246029,0.00001535677],"genre_scores_gemma":[0.98677975,0.010599343,0.0005494664,0.00054812594,0.000083986626,0.001198086,0.000102667145,0.00005744988,0.00008113827],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959522,0.0010471209,0.0015160415,0.0005698934,0.00047458778,0.0004401407],"domain_scores_gemma":[0.9930463,0.005493608,0.00062711106,0.00041650952,0.00012565932,0.00029083205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013961622,0.0004424928,0.002003454,0.0002787191,0.00013789728,0.00009290603,0.00017651406,0.00011070222,0.00013902555],"category_scores_gemma":[0.0075347405,0.0002433516,0.0003499852,0.00058841135,0.00012141376,0.00019814899,0.000052488886,0.00013970889,0.0000027862231],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8087007,0.0011729817,0.0005025106,0.000062522064,0.0007616464,0.00005853567,0.0077295685,0.00004460645,0.0001462093,0.000008503858,0.000063113024,0.18074909],"study_design_scores_gemma":[0.97594494,0.007969849,0.004978549,0.0028314174,0.00018222896,0.000005238327,0.0027185269,0.0026821156,0.0007448605,0.0016335648,0.000022529566,0.00028618722],"about_ca_topic_score_codex":0.0012172647,"about_ca_topic_score_gemma":0.0002637124,"teacher_disagreement_score":0.18046291,"about_ca_system_score_codex":0.000058136364,"about_ca_system_score_gemma":0.00026868097,"threshold_uncertainty_score":0.99235904},"labels":[],"label_agreement":null},{"id":"W3043765668","doi":"10.1136/annrheumdis-2020-eular.6369","title":"SAT0384 REPLACEMENT OF RADIOGRAPHIC SACROILITIS BY MRI STRUCTURAL LESIONS: WHAT IS THE IMPACT ON CLASSIFICATION OF AXIAL SPONDYLOARTHRITIS IN THE ASAS CLASSIFICATION COHORT?","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Celgene; Chugai Pharmaceutical; Pfizer","keywords":"Medicine; Axial spondyloarthritis; Cohort; Radiography; Radiology; Magnetic resonance imaging; Pathology; Sacroiliitis","score_opus":0.045982519890146824,"score_gpt":0.33066462713802414,"score_spread":0.2846821072478773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043765668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622871,0.013976452,0.00000336804,0.02173479,0.0000781208,0.0012609423,0.0005401146,0.000010168708,0.00010893889],"genre_scores_gemma":[0.98345226,0.01567202,0.0000098006285,0.000623593,0.000021479173,0.00009278173,0.00009944104,0.000014621874,0.000014022947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978429,0.00030016663,0.0007119458,0.00026555415,0.00066598685,0.00021342793],"domain_scores_gemma":[0.9980102,0.0004451532,0.0005603229,0.00074550894,0.00015241334,0.000086412576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029521165,0.00021513632,0.0005147528,0.00007445383,0.00013870564,0.00002998992,0.000277864,0.000051547668,0.00013477112],"category_scores_gemma":[0.00034962923,0.00010424166,0.00044973157,0.00053881836,0.00038915957,0.00014285346,0.00005002441,0.00011687325,0.0000033572026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062197247,0.002594794,0.6688111,0.0010664045,0.0027729736,0.000013121964,0.012752194,0.000105862186,0.0015132483,0.002274848,0.08971529,0.21216045],"study_design_scores_gemma":[0.0017085996,0.0009865598,0.98818445,0.001354009,0.00022790048,0.000008547458,0.0051052175,0.0005162351,0.0009400087,0.0007018418,0.00017056384,0.000096093],"about_ca_topic_score_codex":0.00036146492,"about_ca_topic_score_gemma":0.000018105547,"teacher_disagreement_score":0.31937334,"about_ca_system_score_codex":0.000026221785,"about_ca_system_score_gemma":0.00007420082,"threshold_uncertainty_score":0.42508516},"labels":[],"label_agreement":null},{"id":"W3043886921","doi":"10.1136/annrheumdis-2020-eular.1728","title":"SAT0186 DEVELOPING PREDICTORS OF GLOBAL BILAG TREATMENT RESPONSE IN PATIENTS WITH LUPUS NEPHRITIS: MORE LESSONS FROM THE ASPREVA LUPUS MANAGEMENT STUDY GROUP (ALMS) DATA","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Internal medicine; Cohort; Odds ratio; Physical therapy; Disease","score_opus":0.08021598597082995,"score_gpt":0.3498803023264503,"score_spread":0.2696643163556203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043886921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565793,0.0017543392,0.000019084124,0.0073880926,0.00018213721,0.0033723093,0.0015611829,0.00003350055,0.000031404386],"genre_scores_gemma":[0.9988787,0.00036119646,0.00012424505,0.0002750594,0.000024303425,0.000120611214,0.00014747586,0.000030347781,0.000038027574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963211,0.00072118983,0.0007710989,0.0005081898,0.0013221087,0.00035632346],"domain_scores_gemma":[0.9968658,0.0006227103,0.00035309978,0.0018128046,0.00014592917,0.00019964155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048515032,0.00029331862,0.0007420314,0.000059577702,0.00008840241,0.000033139942,0.001139608,0.00004268851,0.000025950334],"category_scores_gemma":[0.00088478054,0.00014991337,0.00012525904,0.0007089775,0.00021139343,0.00015342396,0.00086543197,0.00008837925,0.0000065576533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070354817,0.0015765266,0.9787259,0.00069063285,0.0014740286,0.000032167754,0.0034598757,0.000022654685,0.0000012971866,0.000042726453,0.0033663209,0.003572386],"study_design_scores_gemma":[0.0063609653,0.0013144712,0.9759218,0.004593193,0.0005152003,0.000018342556,0.010757754,0.00017394211,0.000010417933,0.000074745316,0.00011394889,0.00014518219],"about_ca_topic_score_codex":0.00054338196,"about_ca_topic_score_gemma":0.00015814464,"teacher_disagreement_score":0.013220783,"about_ca_system_score_codex":0.00015462318,"about_ca_system_score_gemma":0.00027613825,"threshold_uncertainty_score":0.61132896},"labels":[],"label_agreement":null},{"id":"W3043919319","doi":"10.1136/annrheumdis-2020-eular.2479","title":"AB0337 TOFACITINIB MONOTHERAPY OR COMBINED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS SHOW SIMILAR RETENTION OVER FOUR YEARS. REPORT FROM RHUMADATA ®","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"Pfizer; Amgen","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Discontinuation; Internal medicine; Methotrexate; Cohort; Surgery","score_opus":0.047813938618065634,"score_gpt":0.28733842363539763,"score_spread":0.239524485017332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043919319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304235,0.0022512213,0.00008219721,0.002701677,0.000052331303,0.0011384508,0.0005850313,0.00006595009,0.00008076294],"genre_scores_gemma":[0.98706293,0.011019212,0.00058971514,0.00075973687,0.000017788401,0.000051570656,0.00036254278,0.00006471842,0.00007178191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711394,0.00023471245,0.00071002956,0.00046406087,0.0010638637,0.0004133628],"domain_scores_gemma":[0.99798465,0.00020988853,0.0004360415,0.00080967246,0.00021685181,0.00034288975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023615823,0.00030609628,0.0008286357,0.00010649777,0.00008705511,0.00007078084,0.00033472714,0.00006281674,0.00087813946],"category_scores_gemma":[0.0006757881,0.0001826513,0.00018502017,0.00043631362,0.00026089317,0.00033032254,0.000100474455,0.0002038026,0.000011792807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03681093,0.0017612809,0.8552727,0.00035827135,0.0019025045,0.0006172636,0.0016355892,0.000091423564,0.000081407576,0.00015122694,0.011256532,0.09006086],"study_design_scores_gemma":[0.014956813,0.0023549264,0.97347075,0.005105947,0.000025061207,0.000021541904,0.0002632763,0.0005420075,0.00052998244,0.0006780324,0.0016961207,0.0003555403],"about_ca_topic_score_codex":0.00026907734,"about_ca_topic_score_gemma":0.00013000375,"teacher_disagreement_score":0.11819804,"about_ca_system_score_codex":0.000017452378,"about_ca_system_score_gemma":0.00023862415,"threshold_uncertainty_score":0.9615011},"labels":[],"label_agreement":null},{"id":"W3044299144","doi":"10.1136/annrheumdis-2020-eular.4574","title":"SAT0638-HPR CHARACTERIZING THE IMPACT OF AXIAL SPONDYLOARTHRITIS ON DAILY LIFE: GENDER AND PATIENT-REPORTED OUTCOMES ASSOCIATED WITH FUNCTIONAL LIMITATION IN CANADA. RESULTS FROM THE IMAS SURVEY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of British Columbia; Université de Sherbrooke; Toronto Western Hospital; University of Ottawa; University of British Columbia Hospital; Canadian Standards Association; Western University; Memorial University of Newfoundland","funders":"","keywords":"Medicine; BASDAI; Mental health; Physical therapy; Activities of daily living; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine; Psychiatry; Arthritis","score_opus":0.08759703445102913,"score_gpt":0.28158661941995844,"score_spread":0.19398958496892932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044299144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114245,0.0010399239,3.2063664e-7,0.004349054,0.000061410945,0.00054852915,0.0028129043,0.0000073439282,0.000038063466],"genre_scores_gemma":[0.998044,0.00022714047,0.0000021384728,0.0012485494,0.000012939264,0.000024035633,0.0004219514,0.000013916784,0.0000053343947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838567,0.00024071713,0.00051181775,0.00019262255,0.00048893143,0.00018026371],"domain_scores_gemma":[0.99741155,0.0015304117,0.0005072163,0.00026532306,0.00017530538,0.00011020169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015589548,0.00017597647,0.00043083422,0.000022307671,0.000119736054,0.0000161318,0.00008552241,0.000024713909,0.000025292267],"category_scores_gemma":[0.004176644,0.000078815196,0.00012222114,0.0002249698,0.00010793003,0.00005930425,0.000053075375,0.00009578345,7.8260115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002438984,0.00022138136,0.9875337,0.000013353904,0.0013028891,0.0000151882305,0.0012234792,0.00007583592,0.000014202778,0.000004670017,0.0034892927,0.0036670421],"study_design_scores_gemma":[0.0033684906,0.00033117484,0.9945682,0.00042809703,0.00013006314,0.0000018092849,0.0009299007,0.00009822747,0.000028996901,0.000030539704,0.000008883609,0.00007558854],"about_ca_topic_score_codex":0.22902563,"about_ca_topic_score_gemma":0.080959454,"teacher_disagreement_score":0.14806618,"about_ca_system_score_codex":0.000050949384,"about_ca_system_score_gemma":0.0005790007,"threshold_uncertainty_score":0.9358106},"labels":[],"label_agreement":null},{"id":"W3044322808","doi":"10.1136/annrheumdis-2020-217101","title":"Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"GlaxoSmithKline","keywords":"Medicine; Belimumab; Placebo; Randomized controlled trial; Clinical trial; Lupus erythematosus; Internal medicine; Intensive care medicine; Immunology; Antibody; Alternative medicine; B-cell activating factor; Pathology","score_opus":0.022686787671168572,"score_gpt":0.27767002198226187,"score_spread":0.2549832343110933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044322808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984472,0.00424548,0.000026769338,0.0013981517,0.000071906026,0.009313565,0.00026564975,0.0000359258,0.00017059386],"genre_scores_gemma":[0.9986137,0.00090274634,0.00004356588,0.00008471943,0.00006856298,0.00014972946,0.00003594654,0.00004071789,0.000060310358],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99610466,0.0005905249,0.0016580154,0.00041884274,0.0008798251,0.00034815812],"domain_scores_gemma":[0.99543875,0.0024756053,0.0008542479,0.00074664084,0.00017754927,0.0003072068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008096743,0.0003011028,0.0020537183,0.00013911593,0.000057500576,0.000021849426,0.00037978817,0.000093205694,0.000028424596],"category_scores_gemma":[0.0054843514,0.00016946202,0.0003404152,0.00037555865,0.00026219917,0.000071690505,0.000145291,0.00018697773,0.000006108872],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9686291,0.00067385274,0.020917105,0.0012107908,0.0016880506,0.0000104631,0.0048062825,0.00014026485,0.00005251981,0.00003074561,0.00030314896,0.0015376398],"study_design_scores_gemma":[0.9807934,0.0009843612,0.005266152,0.008555154,0.00063390966,0.0008060458,0.0012496471,0.0012589566,0.00018089268,0.00008675147,0.0000020510713,0.00018265273],"about_ca_topic_score_codex":0.00024246663,"about_ca_topic_score_gemma":0.000008215015,"teacher_disagreement_score":0.015650954,"about_ca_system_score_codex":0.000031448457,"about_ca_system_score_gemma":0.0003964072,"threshold_uncertainty_score":0.691046},"labels":[],"label_agreement":null},{"id":"W3044502797","doi":"10.1136/annrheumdis-2020-eular.5998","title":"FRI0121 STEROID-SPARING EFFECT OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS FOLLOWED UP IN A REAL LIFE SETTING","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Internal medicine; Janus kinase inhibitor; Prednisone; Cohort; Adverse effect","score_opus":0.02255936462660734,"score_gpt":0.2902752797092193,"score_spread":0.26771591508261194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044502797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918563,0.008001924,0.0000020865718,0.0014092776,0.00014948638,0.00097527204,0.000058436508,0.000032363238,0.000185515],"genre_scores_gemma":[0.9814205,0.018220248,0.00001681694,0.00019761776,0.000018483073,0.000063346466,0.000022949447,0.000033762535,0.00000627283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969764,0.00045748096,0.0010614961,0.00028480467,0.000746802,0.00047307002],"domain_scores_gemma":[0.9982421,0.00053733337,0.00036057734,0.0003813914,0.00011545998,0.0003631684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005005495,0.00025539778,0.0009657053,0.00021315816,0.000058808622,0.0000274876,0.00030012178,0.000067718865,0.00005967294],"category_scores_gemma":[0.0040001106,0.00018893414,0.00032437977,0.00054276286,0.00017754437,0.00023176338,0.00022542154,0.00022933794,0.000010878102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013830743,0.00040912358,0.922332,0.0011940394,0.0001734347,0.000012608451,0.0028665168,0.00007933017,0.00021193102,0.000041291256,0.0017596554,0.069536984],"study_design_scores_gemma":[0.014452766,0.0015808619,0.95207393,0.020160971,0.000012740104,0.000004219458,0.00096278696,0.0016354929,0.00845696,0.0001976913,0.00011879494,0.00034279516],"about_ca_topic_score_codex":0.00047597586,"about_ca_topic_score_gemma":0.00007927552,"teacher_disagreement_score":0.06919419,"about_ca_system_score_codex":0.000021280988,"about_ca_system_score_gemma":0.00016963994,"threshold_uncertainty_score":0.77045107},"labels":[],"label_agreement":null},{"id":"W3044672311","doi":"10.1136/annrheumdis-2020-eular.5939","title":"FRI0358 USAGE OF C-REACTIVE PROTEIN TESTING IN THE DIAGNOSIS AND MONITORING OF PSORIATIC ARTHRITIS (PSA): RESULTS FROM A REAL-WORLD SURVEY IN THE US AND EUROPE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celgene; Biogen; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; C-reactive protein; Internal medicine; Disease; Inflammation","score_opus":0.12114716848762004,"score_gpt":0.3322654260550145,"score_spread":0.2111182575673945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044672311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869226,0.008806069,6.8503743e-7,0.0027942955,0.000018583049,0.00093379343,0.00034766036,0.0000063432917,0.00016994111],"genre_scores_gemma":[0.98452973,0.015191861,0.000069635425,0.000079377176,0.000022840539,0.000081006256,0.000009563878,0.000012789382,0.0000031966179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974229,0.0010410697,0.00063205557,0.00020062161,0.0004964848,0.0002069011],"domain_scores_gemma":[0.9949448,0.004137174,0.00033158012,0.00035503507,0.00014437217,0.00008702791],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011379928,0.00014301369,0.00047868732,0.00008481856,0.00005975891,0.00003460289,0.00027763695,0.000022994946,0.000006443954],"category_scores_gemma":[0.012466222,0.000078252815,0.00005967012,0.00067293755,0.00029241107,0.000121485085,0.00010558169,0.00017385453,6.597667e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077563047,0.0004243395,0.9413598,0.00035619552,0.000121878926,0.000020954014,0.00883781,0.000012896121,0.00029667537,0.000077462,0.00017503121,0.04754128],"study_design_scores_gemma":[0.0016038863,0.0003104885,0.9886852,0.0057140533,0.0000119683655,0.000001948894,0.0012382249,0.00016491607,0.0014962481,0.0006822767,0.000020786905,0.00007003972],"about_ca_topic_score_codex":0.012057971,"about_ca_topic_score_gemma":0.0008767749,"teacher_disagreement_score":0.04747124,"about_ca_system_score_codex":0.0000045329557,"about_ca_system_score_gemma":0.000082479666,"threshold_uncertainty_score":0.9958522},"labels":[],"label_agreement":null},{"id":"W3044737691","doi":"10.1136/annrheumdis-2020-eular.1544","title":"FRI0064 SAFETY OF LOW DOSE METHOTREXATE (MTX) AND TUBERCULOSIS (TB)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Canada; University of British Columbia; McGill University","funders":"Pfizer Canada; McGill University","keywords":"Medicine; Tuberculosis; Context (archaeology); Incidence (geometry); Internal medicine; Cohort; Cohort study; CINAHL; Pathology; Psychological intervention","score_opus":0.06553793685106808,"score_gpt":0.35436665809392603,"score_spread":0.28882872124285797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044737691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91970676,0.0051814034,0.000039609167,0.07353123,0.00003843109,0.00043872747,0.00017617558,0.000025577183,0.0008620883],"genre_scores_gemma":[0.98999214,0.0051965825,0.0002421344,0.00443646,0.000030185878,0.000013020886,0.000014149163,0.000016352085,0.000058946378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982388,0.00036741342,0.00055436575,0.00022158398,0.0003283958,0.0002894113],"domain_scores_gemma":[0.998033,0.0007746999,0.00020267908,0.00041672518,0.00015011746,0.0004228042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041356456,0.00015405285,0.0007113804,0.000057707304,0.000054953234,0.0000061669784,0.00021268951,0.00005762294,0.00029590042],"category_scores_gemma":[0.0055419225,0.00009354336,0.0003093921,0.00025947677,0.0003047714,0.00007133537,0.00019539642,0.00012623669,0.000017777445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008819467,0.0026598948,0.35496175,0.021604022,0.0067359675,0.000046533572,0.004018953,0.000548961,0.010011517,0.0053282874,0.23208328,0.35318136],"study_design_scores_gemma":[0.0018936918,0.00067385385,0.97667146,0.001672072,0.00046738723,0.000015430378,0.00038447976,0.005248445,0.00811291,0.0030379135,0.0016003007,0.00022207302],"about_ca_topic_score_codex":0.00015938179,"about_ca_topic_score_gemma":0.0000035774156,"teacher_disagreement_score":0.6217097,"about_ca_system_score_codex":0.0000062606223,"about_ca_system_score_gemma":0.00008992536,"threshold_uncertainty_score":0.66345996},"labels":[],"label_agreement":null},{"id":"W3045108370","doi":"10.1136/annrheumdis-2020-eular.4787","title":"THU0565 RESEARCHERS' PERSPECTIVES ON ADHERENCE INTERVENTION RESEARCH AND OUTCOMES IN RHEUMATOLOGY: AN INTERNATIONAL QUALITATIVE STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Psychological intervention; Family medicine; Qualitative research; Intervention (counseling); Thematic analysis; Alternative medicine; MEDLINE; Research design; Health services research; Public health; Nursing; Pathology","score_opus":0.25663342543566464,"score_gpt":0.5163316081600434,"score_spread":0.2596981827243788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045108370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855641,0.0019442718,0.000004078671,0.011171983,0.000047958132,0.0009012763,0.00004393295,0.000023107705,0.00029926214],"genre_scores_gemma":[0.99556255,0.004109443,0.000031424643,0.000069308946,0.00000877152,0.00009530968,0.000007586271,0.000015810503,0.00009980225],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9962927,0.0015581032,0.00044560208,0.00036597537,0.0010209642,0.00031665544],"domain_scores_gemma":[0.99777,0.0010019271,0.00011352111,0.00037800832,0.00046300475,0.0002735544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015765378,0.00014295589,0.00043732126,0.0002629596,0.00011663,0.00006867434,0.00044179757,0.000037309477,0.00019899853],"category_scores_gemma":[0.0067197727,0.00009464907,0.00011780924,0.0003698929,0.0006583793,0.00029826505,0.00025147988,0.00037318168,0.000018707013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042524165,0.009551924,0.5491574,0.00046736206,0.0008901216,0.00003097564,0.39235586,0.0000053434196,0.000042706462,0.015773246,0.000975539,0.026497152],"study_design_scores_gemma":[0.0028844613,0.0050121364,0.475815,0.0013314071,0.0000045050156,0.000003894204,0.5073279,0.00026750143,0.00009458909,0.007121058,0.000028828186,0.000108728666],"about_ca_topic_score_codex":0.00056487956,"about_ca_topic_score_gemma":0.00008093136,"teacher_disagreement_score":0.114972055,"about_ca_system_score_codex":0.000026798774,"about_ca_system_score_gemma":0.00010448611,"threshold_uncertainty_score":0.8044681},"labels":[],"label_agreement":null},{"id":"W3045546553","doi":"10.1136/annrheumdis-2020-eular.994","title":"AB0774 TIME TO RESPONSE FOR CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB, ADALIMUMAB OR PLACEBO","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); University of Toronto","funders":"","keywords":"Tofacitinib; Medicine; Adalimumab; Janus kinase inhibitor; Psoriatic arthritis; Internal medicine; Placebo; Clinical trial; Psoriasis; Clinical endpoint; Dermatology; Arthritis; Rheumatoid arthritis; Alternative medicine","score_opus":0.04316765185162938,"score_gpt":0.32935430671275734,"score_spread":0.28618665486112793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045546553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051684,0.0004941947,0.000007054888,0.006122993,0.00001746362,0.0024302208,0.00035018526,0.00003999356,0.000021062857],"genre_scores_gemma":[0.9978236,0.0004951412,0.00017672968,0.0011845409,0.0000071519707,0.00017490951,0.000030213521,0.000036967656,0.00007073355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775773,0.00028295149,0.0007435589,0.0003256471,0.0005499119,0.00034019933],"domain_scores_gemma":[0.9976692,0.00095956505,0.0002446203,0.00037200897,0.00027547567,0.00047912815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025316546,0.00023035286,0.00082172005,0.000097784934,0.000077707606,0.00003355665,0.0001332247,0.000044991855,0.00023039161],"category_scores_gemma":[0.0043202243,0.00012071519,0.00013144278,0.0002960254,0.00023894526,0.00012242363,0.000054734388,0.00009669068,0.000012510955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15724836,0.0013557923,0.73916054,0.00022415601,0.00090879586,0.00003557786,0.0010437891,0.000017024577,0.0000035297378,0.000009296024,0.004067201,0.095925935],"study_design_scores_gemma":[0.02544907,0.010845745,0.9593355,0.002668712,0.00005397259,0.000008489791,0.0004660502,0.00017730979,0.00012623258,0.000072022754,0.00054949604,0.00024740782],"about_ca_topic_score_codex":0.000019945823,"about_ca_topic_score_gemma":0.000010741214,"teacher_disagreement_score":0.22017497,"about_ca_system_score_codex":0.0000068064405,"about_ca_system_score_gemma":0.0002312932,"threshold_uncertainty_score":0.5172024},"labels":[],"label_agreement":null},{"id":"W3046452857","doi":"10.1136/annrheumdis-2020-eular.5912","title":"OP0304 METABOLOMICS PROFILING OF HUMAN SERUM FOR DISCOVERING BIOMARKERS TO DIAGNOSE PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS WITH HIGH SPECIFICITY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Biomarker; Metabolome; Metabolomics; Biomarker discovery; Metabolite; Internal medicine; Dansyl chloride; Ankylosing spondylitis; Psoriatic arthritis; Gastroenterology; Oncology; Disease; Bioinformatics; Chromatography; Mass spectrometry; Proteomics; Derivatization","score_opus":0.02677134953399003,"score_gpt":0.2746549012250184,"score_spread":0.24788355169102838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046452857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907469,0.005357285,0.0006408054,0.0013000503,0.00006065755,0.0005412653,0.0013246199,0.000006021261,0.000022381873],"genre_scores_gemma":[0.99498016,0.0023345824,0.002283817,0.00023624497,0.00005179288,0.00003851373,0.00004628146,0.000021045535,0.0000075728904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989971,0.00004900594,0.00033489012,0.00027363686,0.00013837163,0.00020699328],"domain_scores_gemma":[0.9992399,0.0000621426,0.00022630942,0.00026078426,0.00009600555,0.00011481217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014116881,0.0001665847,0.00040807118,0.00003705105,0.00010882132,0.000025725167,0.00018861565,0.000031798274,0.000009480349],"category_scores_gemma":[0.00052385713,0.00012106607,0.00013171512,0.00015189913,0.00012562411,0.000010221378,0.00019968192,0.000029572788,1.328824e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042373603,0.0011090823,0.065505445,0.005778841,0.0068558534,0.0000073011274,0.0019060574,0.0011724597,0.77460635,0.031208485,0.0048243273,0.10278841],"study_design_scores_gemma":[0.001456771,0.0012070184,0.048953027,0.00059568277,0.0002795498,0.0000026926693,0.0008224789,0.00013599193,0.9430097,0.0023349074,0.00080507336,0.0003971436],"about_ca_topic_score_codex":0.00004520423,"about_ca_topic_score_gemma":0.0000232257,"teacher_disagreement_score":0.1684033,"about_ca_system_score_codex":0.0000028799323,"about_ca_system_score_gemma":0.000033150627,"threshold_uncertainty_score":0.4936931},"labels":[],"label_agreement":null},{"id":"W3046619879","doi":"10.1136/annrheumdis-2020-217595","title":"DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Psoriatic arthritis; Internal medicine; Proportional hazards model; Cardiology; Confidence interval; Disease","score_opus":0.05814054854581336,"score_gpt":0.2992823382159213,"score_spread":0.24114178967010796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046619879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97348464,0.02384002,0.0000040917757,0.0013920773,0.00007253876,0.0010800031,0.00004318151,0.000017282038,0.00006617321],"genre_scores_gemma":[0.9962356,0.0033894572,0.000023126426,0.00019816302,0.000028278608,0.00009400548,0.0000047542644,0.000015387375,0.0000112398575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865085,0.00011551588,0.000351834,0.00026491104,0.00040875594,0.00020812395],"domain_scores_gemma":[0.99927396,0.00006725297,0.00008376735,0.00035698497,0.00005706286,0.00016099951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012240614,0.00016954553,0.0006730267,0.000042390337,0.00007358882,0.000007844372,0.000102377846,0.000023267707,0.000032900378],"category_scores_gemma":[0.00039475138,0.000118964446,0.00028438395,0.00021831784,0.00006679069,0.00006442628,0.000138932,0.00007178642,0.0000078772155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017128457,0.00097319507,0.97986937,0.00030315277,0.0019049795,0.00006893666,0.0012781805,0.000028195665,7.2507294e-7,0.00003450592,0.0003961993,0.014971289],"study_design_scores_gemma":[0.004684532,0.0005663107,0.99119985,0.0010809237,0.00043894825,0.000017364267,0.0015248017,0.000032903896,0.000022515187,0.0002976222,0.000032329706,0.00010190313],"about_ca_topic_score_codex":0.0003588411,"about_ca_topic_score_gemma":0.00007381545,"teacher_disagreement_score":0.022750955,"about_ca_system_score_codex":0.000009075831,"about_ca_system_score_gemma":0.000046986148,"threshold_uncertainty_score":0.48512295},"labels":[],"label_agreement":null},{"id":"W3046634842","doi":"10.1136/annrheumdis-2016-eular.1914","title":"THU0067 Is Treat-To-Target Really Working? A Longitudinal Analysis in Biodam","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University of Calgary; Université de Sherbrooke; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Clinical Practice; Cohort; Pediatrics; Physical therapy","score_opus":0.36289741219184984,"score_gpt":0.4350120875990584,"score_spread":0.07211467540720856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046634842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87267685,0.0034527793,0.0014573385,0.117565714,0.0002222497,0.00067792024,0.0011569631,0.000037218495,0.0027529707],"genre_scores_gemma":[0.9925105,0.00038633103,0.00044881317,0.005536396,0.000049613973,0.000081143706,0.000008255015,0.000021254538,0.0009577181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954795,0.00030578487,0.0031219677,0.00049864076,0.0001588313,0.00043522153],"domain_scores_gemma":[0.9958115,0.001180784,0.0016965254,0.0010025502,0.000072111245,0.0002365334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047978144,0.00020956776,0.0012162622,0.0007193194,0.000100379395,0.000049967377,0.00061193353,0.00007331909,0.0010393686],"category_scores_gemma":[0.0040062005,0.00015877059,0.0004911545,0.0009884482,0.00009907744,0.00024727976,0.00011620269,0.000054392458,0.0007600317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039608174,0.00025578472,0.95441896,0.00019366069,0.000556768,9.66803e-7,0.0009348411,0.00022200096,6.3556405e-7,0.012275293,0.029057954,0.0020435546],"study_design_scores_gemma":[0.0004727297,0.000049939248,0.9569239,0.00063394726,0.00006854484,8.605365e-7,0.00017543406,0.0007765236,0.000018702052,0.037277926,0.003329849,0.0002716338],"about_ca_topic_score_codex":0.0011457477,"about_ca_topic_score_gemma":0.00025962756,"teacher_disagreement_score":0.119833626,"about_ca_system_score_codex":0.0001281938,"about_ca_system_score_gemma":0.00012254721,"threshold_uncertainty_score":0.9998738},"labels":[],"label_agreement":null},{"id":"W3046653665","doi":"10.1136/annrheumdis-2020-eular.2719","title":"AB0824 WHICH PARAMETERS ARE RELEVANT IN THE IDENTIFYING AXIAL INVOLVEMENT IN PSORIATIC ARTHRITIS? – RESULTS OF A SURVEY AMONG ASAS AND GRAPPA MEMBERS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"UCB Pharma","keywords":"Axial spondyloarthritis; Medicine; Psoriatic arthritis; Population; Psoriasis; Family medicine; Observational study; Ranking (information retrieval); Physical therapy; Internal medicine; Dermatology; Arthritis; Artificial intelligence; Sacroiliitis","score_opus":0.0948184921765567,"score_gpt":0.3112388278645387,"score_spread":0.21642033568798202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046653665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894487,0.0060170004,9.299958e-7,0.0034497755,0.000078059675,0.0007468502,0.00019235352,0.000007434196,0.000058860343],"genre_scores_gemma":[0.9946765,0.004915891,0.00002892273,0.00027163664,0.0000080133095,0.000054124583,0.000027098698,0.000011825091,0.000006033752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804395,0.0003351072,0.00069753674,0.00023863917,0.0004572203,0.00022753564],"domain_scores_gemma":[0.99859035,0.00053007674,0.00036782795,0.00032140274,0.000096008225,0.00009431847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058128906,0.0001667922,0.0005600654,0.00007830661,0.000057657024,0.000021817934,0.00016446073,0.00003425413,0.0000070904493],"category_scores_gemma":[0.0026649947,0.00010329457,0.00012468098,0.00053400383,0.00019845563,0.00008252225,0.0001061763,0.00010361645,0.0000012072849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014754584,0.0009613122,0.97049075,0.0011331784,0.0005204267,0.00006612132,0.010068184,0.000118403965,0.000009719043,0.000057446818,0.0030558673,0.012043156],"study_design_scores_gemma":[0.0042009624,0.00026422445,0.9861257,0.003682878,0.00009388872,0.000002191867,0.004619068,0.00021173242,0.00009476398,0.0006008475,0.000012278742,0.000091447735],"about_ca_topic_score_codex":0.0039981483,"about_ca_topic_score_gemma":0.008719488,"teacher_disagreement_score":0.01563499,"about_ca_system_score_codex":0.00001268306,"about_ca_system_score_gemma":0.000046481495,"threshold_uncertainty_score":0.6044031},"labels":[],"label_agreement":null},{"id":"W3046861656","doi":"10.1136/annrheumdis-2020-eular.2997","title":"SAT0607-HPR MULTIDISCIPLINARY CARE CLINIC FOR PATIENTS WITH IMMUNITY MEDIATED INFLAMMATORY DISEASES. FIRST YEAR OF COORDINATED MANAGEMENT","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare during COVID-19 Pandemic","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Observational study; Internal medicine; Multidisciplinary approach; Family medicine; Physical therapy","score_opus":0.030354610845416245,"score_gpt":0.2955391099933616,"score_spread":0.26518449914794534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046861656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288523,0.0007423297,0.0013861479,0.0024297882,0.00016047091,0.0016733467,0.0005405146,0.00014633448,0.00003582606],"genre_scores_gemma":[0.99874026,0.00012805343,0.0006347106,0.00029654088,0.0000107337855,0.000087475935,0.00006673127,0.000023919647,0.000011579226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796396,0.0002028052,0.000661794,0.00034224024,0.00050925236,0.00031996064],"domain_scores_gemma":[0.99709105,0.000664115,0.00055688724,0.0009622415,0.0004307304,0.0002949632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016633354,0.000219663,0.0004335569,0.00008792988,0.0001937063,0.000026904516,0.001483824,0.00005117257,0.000013722108],"category_scores_gemma":[0.00075735577,0.0001576595,0.00022739687,0.00046120095,0.00016620463,0.00024834278,0.00077503227,0.00010003481,0.000012253296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009085921,0.0012152838,0.95733505,0.016353626,0.00069641985,0.000006868481,0.0061248993,0.00078948546,0.0000027475876,0.00061584474,0.004292787,0.011658411],"study_design_scores_gemma":[0.0023085945,0.00043709978,0.99083054,0.0013895805,0.000113652015,1.1540755e-7,0.0005948675,0.0033073602,0.00005421626,0.0005425414,0.00016236881,0.00025908966],"about_ca_topic_score_codex":0.00003890522,"about_ca_topic_score_gemma":0.000007835831,"teacher_disagreement_score":0.03349548,"about_ca_system_score_codex":0.00003686654,"about_ca_system_score_gemma":0.0002374377,"threshold_uncertainty_score":0.64291674},"labels":[],"label_agreement":null},{"id":"W3046879163","doi":"10.1136/annrheumdis-2020-eular.1530","title":"FRI0352 PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION WITH APREMILAST TREATMENT AMONG DMARD-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Dactylitis; Apremilast; Psoriatic arthritis; Internal medicine; Disease; Arthritis; Post-hoc analysis; Physical therapy; Gastroenterology; Enthesitis","score_opus":0.03993101138270144,"score_gpt":0.27543899913341874,"score_spread":0.2355079877507173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046879163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947549,0.0011667702,0.000019645695,0.0017425003,0.000033522683,0.0017793874,0.0003224328,0.0000446855,0.00013617353],"genre_scores_gemma":[0.9983644,0.0011256307,0.00013370128,0.00008540004,0.000029271814,0.00015544023,0.000020250765,0.000033591252,0.000052318122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982043,0.00014742507,0.00035661485,0.0004201389,0.00055850507,0.0003130541],"domain_scores_gemma":[0.9979806,0.00027185815,0.000467732,0.0005774843,0.00021811039,0.00048421955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057137044,0.00035180312,0.00088100333,0.000039468265,0.00016635231,0.000015124798,0.00013534259,0.000038836835,0.000083351],"category_scores_gemma":[0.0006737634,0.00017288177,0.00026952967,0.0003369299,0.0003783195,0.00018172458,0.000095514224,0.000087081855,0.0000023483435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06345863,0.008101855,0.5912628,0.0048987223,0.004254542,0.0002639264,0.004613768,0.0002816458,0.000131328,0.000041645133,0.0003921609,0.32229897],"study_design_scores_gemma":[0.006611363,0.004650239,0.9714309,0.009953862,0.0011350581,0.000008947424,0.0007341565,0.00018081738,0.0049163895,0.00012533314,0.000015635522,0.00023732678],"about_ca_topic_score_codex":0.00017278448,"about_ca_topic_score_gemma":0.00009140854,"teacher_disagreement_score":0.38016808,"about_ca_system_score_codex":0.000066203596,"about_ca_system_score_gemma":0.00036326452,"threshold_uncertainty_score":0.7049914},"labels":[],"label_agreement":null},{"id":"W3046965458","doi":"10.1136/annrheumdis-2020-eular.5910","title":"SAT0378 THE RELATIVE DIAGNOSTIC UTILITY OF INFLAMMATORY BACK PAIN CRITERIA IN AN INCEPTION COHORT OF PATIENTS WITH PSORIASIS, IRITIS, AND COLITIS PRESENTING WITH UNDIAGNOSED BACK PAIN","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Ottawa Hospital; University of Alberta; Université de Sherbrooke; University of Calgary; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Psoriasis; Back pain; Cohort; Dermatology; Physical therapy; Colitis; Cohort study; Internal medicine; Alternative medicine; Pathology","score_opus":0.03075607444715494,"score_gpt":0.2919201508796719,"score_spread":0.26116407643251693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046965458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966456,0.0005819007,0.000035761455,0.0009997607,0.000011935206,0.0015210174,0.00014542876,0.00000784882,0.00005069563],"genre_scores_gemma":[0.9994234,0.0002852623,0.00008891463,0.000043785425,0.0000063749853,0.000050194518,0.0000730122,0.000019951818,0.000009114142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969765,0.0013708399,0.0005620729,0.0002233317,0.000613997,0.0002532666],"domain_scores_gemma":[0.9964575,0.0022935201,0.000353672,0.0004234322,0.0002991877,0.00017265284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010019983,0.00017235076,0.00050823827,0.00005495347,0.000055370205,0.000016207505,0.00020576123,0.000053559685,0.00029933607],"category_scores_gemma":[0.004127652,0.000100105644,0.00007720662,0.0003224538,0.0006980847,0.00021325193,0.000101848724,0.00014507514,0.0000018293541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071463274,0.00043346675,0.985816,0.008575577,0.00019954261,0.0000036380407,0.0014662327,0.000010885629,0.0000066019047,0.000053728127,0.0009711658,0.0017485548],"study_design_scores_gemma":[0.0016730143,0.0010893721,0.9885471,0.005774652,0.00009100319,9.719433e-7,0.0009305023,0.0013081162,0.0001237003,0.00035436836,0.0000057822654,0.00010144102],"about_ca_topic_score_codex":0.0002260162,"about_ca_topic_score_gemma":0.000031084983,"teacher_disagreement_score":0.0031256536,"about_ca_system_score_codex":0.000017547674,"about_ca_system_score_gemma":0.00023318054,"threshold_uncertainty_score":0.49414828},"labels":[],"label_agreement":null},{"id":"W3047033768","doi":"10.1136/annrheumdis-2020-218615","title":"Response to: ''2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus' by Aringer et al' by Cui et al","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatism; Rheumatology; League; Internal medicine; Dermatology; Systemic lupus erythematosus; Family medicine; Disease","score_opus":0.05465663280084483,"score_gpt":0.35511635457123325,"score_spread":0.30045972177038843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047033768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.834764,0.0020391827,0.001219397,0.15678185,0.0002007539,0.0024051655,0.0023477958,0.00010385285,0.00013800929],"genre_scores_gemma":[0.9788737,0.0017383187,0.00031189708,0.018004756,0.0000053346153,0.00021934857,0.00019944992,0.00014189145,0.00050526054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938778,0.0021999367,0.0016893168,0.0006632217,0.00097515015,0.00059455243],"domain_scores_gemma":[0.9941885,0.00227495,0.0011651901,0.0012256785,0.0005749142,0.0005707714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024720945,0.0004371769,0.0015373011,0.00021172334,0.00011823325,0.000038583737,0.0008666129,0.000066839,0.00004035648],"category_scores_gemma":[0.0064661293,0.00033201513,0.00045245085,0.00065360806,0.00045442596,0.00016263526,0.00028784695,0.00021206935,0.000068876616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037779326,0.00047261416,0.014630706,0.0032158808,0.00047383606,0.000006761492,0.0024129862,0.00001537439,0.03489714,0.0005245188,0.93875617,0.00081608555],"study_design_scores_gemma":[0.07326651,0.019243438,0.042132013,0.22797707,0.0025653713,0.03460656,0.112617716,0.07479902,0.041358616,0.002010167,0.36035034,0.009073183],"about_ca_topic_score_codex":0.00008077326,"about_ca_topic_score_gemma":0.0000027524675,"teacher_disagreement_score":0.57840586,"about_ca_system_score_codex":0.00006669758,"about_ca_system_score_gemma":0.00042310986,"threshold_uncertainty_score":0.9999132},"labels":[],"label_agreement":null},{"id":"W3047042232","doi":"10.1136/annrheumdis-2020-eular.5901","title":"THU0275 SEVERE PREECLAMPSIA RELATED TO ANTIPHOSPHOLIPID SYNDROME: AN EUROPEAN STUDY OF 40 WOMEN","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Hydroxychloroquine; Antiphospholipid syndrome; Pregnancy; Preeclampsia; Aspirin; Live birth; Gestation; Eclampsia; Internal medicine; Rheumatology; Low molecular weight heparin; Obstetrics; Surgery; Heparin; Thrombosis; Disease","score_opus":0.020961538356189583,"score_gpt":0.2689746789776773,"score_spread":0.24801314062148772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047042232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816775,0.0005379857,0.000002225652,0.00029240624,0.000038685834,0.00044765454,0.00008123782,0.000011656432,0.00042038044],"genre_scores_gemma":[0.99935496,0.000075578704,0.00001741999,0.00037244929,0.000005823565,0.00001706972,0.000026149944,0.000024272185,0.00010630217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892205,0.00017824705,0.00029664816,0.0002486372,0.00017721759,0.00017717156],"domain_scores_gemma":[0.9990599,0.00000909243,0.00016088175,0.0005184913,0.00006279636,0.0001888207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088750676,0.00014531976,0.00024250448,0.00001771238,0.000052710104,0.000012410126,0.00040682743,0.000028709883,0.000037006987],"category_scores_gemma":[0.00012641112,0.000104315535,0.000102856575,0.00016242366,0.000044997752,0.0000071903055,0.00022856833,0.00003238016,0.000010936062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004100555,0.03444277,0.7775627,0.0016390787,0.010353937,0.00009226708,0.03900746,0.0050877323,0.008607199,0.00021301537,0.027833153,0.09106016],"study_design_scores_gemma":[0.004136059,0.008749554,0.968286,0.00026109166,0.00030758412,0.000015785665,0.0073617054,0.00008674243,0.0091634495,0.00053053163,0.0005686923,0.000532849],"about_ca_topic_score_codex":0.000026892683,"about_ca_topic_score_gemma":0.0000032669811,"teacher_disagreement_score":0.19072329,"about_ca_system_score_codex":0.0000020314744,"about_ca_system_score_gemma":0.000034251218,"threshold_uncertainty_score":0.4253864},"labels":[],"label_agreement":null},{"id":"W3047229059","doi":"10.1136/annrheumdis-2019-216761","title":"Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Genentech; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Janus kinase inhibitor; Incidence (geometry); Surgery","score_opus":0.0749860470472,"score_gpt":0.33419584380086725,"score_spread":0.2592097967536673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047229059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647246,0.031057943,0.0000054350285,0.0029053676,0.000067328336,0.00088552764,0.00030831364,0.000022898274,0.000022599332],"genre_scores_gemma":[0.8246077,0.17471196,0.00029534672,0.00019119972,0.000026047288,0.000050257484,0.00009936644,0.000016814327,0.0000013242525],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99741876,0.00028016244,0.00091959105,0.00042026312,0.0006348451,0.00032635103],"domain_scores_gemma":[0.9981614,0.0003742717,0.00043717847,0.0006896795,0.00009805854,0.00023942754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005524969,0.00023240746,0.0008523294,0.0000899327,0.00013890631,0.00007244354,0.00036815487,0.00003918569,0.000033472603],"category_scores_gemma":[0.0015080022,0.00015712803,0.00006160874,0.00032091432,0.00054360734,0.0002542421,0.00038571097,0.00014254452,0.0000014693957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006104886,0.0007514321,0.15608,0.00057799876,0.0005592829,0.000046022844,0.010332469,7.4088973e-7,0.00013300142,0.00035727792,0.0009679633,0.82958335],"study_design_scores_gemma":[0.0030143177,0.00034056153,0.9848956,0.0050040046,0.0000266194,0.00006044773,0.0018116588,0.00017652176,0.00046224555,0.0031465353,0.0008592081,0.00020232],"about_ca_topic_score_codex":0.0014703461,"about_ca_topic_score_gemma":0.0011250478,"teacher_disagreement_score":0.829381,"about_ca_system_score_codex":0.0000064907726,"about_ca_system_score_gemma":0.00024990216,"threshold_uncertainty_score":0.6407495},"labels":[],"label_agreement":null},{"id":"W3047343850","doi":"10.1136/annrheumdis-2019-eular.5700","title":"SAT0669 DISCRIMINANT ABILITY OF THE PARENT VERSION OF THE JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE IN A LARGE MULTINATION COHORT OF PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Arthritis; Cohort; Disease; Physical therapy; Oligoarthritis; Internal medicine; Juvenile; Polyarthritis","score_opus":0.01734636528468198,"score_gpt":0.2727576058875559,"score_spread":0.2554112406028739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047343850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951277,0.0018231495,0.0000036018262,0.00058886764,0.000086119246,0.001860812,0.00046086565,0.000005894931,0.000043001393],"genre_scores_gemma":[0.99938166,0.00046648178,0.000002538921,0.000030205205,0.000003040237,0.00004878381,0.000021373406,0.000015335148,0.000030570856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734026,0.00039032046,0.00076702336,0.00022165169,0.0010336732,0.00024706757],"domain_scores_gemma":[0.9975211,0.00013213325,0.0008163862,0.0010730528,0.0003777162,0.00007960211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005913154,0.00016794384,0.000713202,0.00007005175,0.00008462397,0.000005484359,0.0003783034,0.000048489128,0.000099859775],"category_scores_gemma":[0.001224792,0.00008568214,0.00036484373,0.00035355907,0.00038677614,0.00016824571,0.00030516976,0.00016408203,0.0000022288114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010230889,0.0023104367,0.9818096,0.0020392204,0.00006537752,5.5214656e-7,0.0005341074,0.00007428564,0.00027410302,0.000041691543,0.00012750569,0.011700039],"study_design_scores_gemma":[0.0026115282,0.00025763744,0.9850133,0.007912878,0.00007875104,2.916007e-7,0.00038748566,0.00043237707,0.0029809375,0.00021697576,0.00002108592,0.000086733446],"about_ca_topic_score_codex":0.0002717929,"about_ca_topic_score_gemma":0.000094961055,"teacher_disagreement_score":0.011613306,"about_ca_system_score_codex":0.000037543687,"about_ca_system_score_gemma":0.00047676568,"threshold_uncertainty_score":0.34940165},"labels":[],"label_agreement":null},{"id":"W3047674054","doi":"10.1136/annrheumdis-2020-eular.3207","title":"PARE0019 DON'T DELAY - TIME2WORK","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Feeling; Medicine; Retraining; Work (physics); Health care; Quarter (Canadian coin); Medical education; Public relations; Nursing; Psychology; Social psychology; Business; Political science","score_opus":0.11099330461668107,"score_gpt":0.36627201319907726,"score_spread":0.2552787085823962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047674054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67510015,0.0057929773,0.00017673352,0.3109903,0.0003095474,0.0012729309,0.0001759703,0.00014000664,0.0060414067],"genre_scores_gemma":[0.9828579,0.00029139014,0.00008992259,0.016283983,0.00014194075,0.00001692426,0.000013001192,0.000018862058,0.00028607945],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99841845,0.00018530905,0.00052242016,0.00017048055,0.0004124367,0.00029089182],"domain_scores_gemma":[0.99837834,0.00016254789,0.00020488728,0.00042526433,0.00016483032,0.00066410727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002877853,0.00012524021,0.00044750297,0.000029893305,0.00008183797,0.000014054552,0.00019900461,0.000054242126,0.00043021137],"category_scores_gemma":[0.0009451675,0.00007502581,0.00022654889,0.00032041967,0.000063623775,0.00006211368,0.000060724076,0.00011915988,0.00008878957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038796052,0.0006000217,0.08354822,0.010176413,0.0005373826,0.000027195922,0.003430852,0.000057571317,0.00001551795,0.0053275917,0.616263,0.27962834],"study_design_scores_gemma":[0.0029944,0.00158566,0.61460316,0.007935063,0.00037013763,0.000084771236,0.0022339986,0.0052691246,0.00026331536,0.003507456,0.36047986,0.0006730668],"about_ca_topic_score_codex":0.0005244594,"about_ca_topic_score_gemma":0.000005529772,"teacher_disagreement_score":0.5310549,"about_ca_system_score_codex":0.000010785174,"about_ca_system_score_gemma":0.0007156114,"threshold_uncertainty_score":0.47105128},"labels":[],"label_agreement":null},{"id":"W3048447337","doi":"10.1136/annrheumdis-2019-eular.5582","title":"SAT0612 FREQUENCY OF POLYAUTOIMMUNITY IN A TERTIARY HOSPITAL","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Arthritis Society; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Celgene; Biogen; Samsung; British Society for Rheumatology; Celltrion; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Antiphospholipid syndrome; Context (archaeology); Arthritis; Autoimmune hepatitis; Diabetes mellitus; Overlap syndrome; Immunology; Gastroenterology; Disease","score_opus":0.017195074411585253,"score_gpt":0.26918805077286684,"score_spread":0.2519929763612816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048447337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435056,0.012948176,5.3487105e-7,0.0009542641,0.00020620842,0.0005414887,0.00005092462,0.000017585582,0.0009302659],"genre_scores_gemma":[0.99889845,0.0006852731,0.000014784131,0.00021391493,0.000009166143,0.00001297683,0.000008632143,0.00001393035,0.00014289338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868685,0.000108819004,0.000564031,0.0001325627,0.00032768855,0.00018007144],"domain_scores_gemma":[0.99870324,0.00015131188,0.00029189303,0.00066294504,0.000097750795,0.00009283476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015766881,0.0001274338,0.00043995414,0.000101874815,0.00002067492,0.0000051904326,0.0002416886,0.000061560495,0.00027588726],"category_scores_gemma":[0.0004308873,0.000076841294,0.0003286955,0.00024056657,0.00011946434,0.000079919824,0.00007968943,0.0000849697,0.00002785676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006158145,0.0012319607,0.98775035,0.0010783528,0.00022869196,0.0000019777667,0.00047314947,0.000013689609,0.0015679916,0.00028359905,0.0010217547,0.0062869154],"study_design_scores_gemma":[0.0008480365,0.00011336582,0.9879464,0.007885611,0.00010736002,0.000003153457,0.0005662945,0.00006660856,0.0014847234,0.0008874619,0.0000047051544,0.00008630828],"about_ca_topic_score_codex":0.00052501453,"about_ca_topic_score_gemma":0.0000019583981,"teacher_disagreement_score":0.014547877,"about_ca_system_score_codex":0.000012585858,"about_ca_system_score_gemma":0.00015401685,"threshold_uncertainty_score":0.3133497},"labels":[],"label_agreement":null},{"id":"W3048560770","doi":"10.1136/annrheumdis-2020-eular.387","title":"FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Adverse effect; Discontinuation; Internal medicine; Placebo; Gastroenterology; Surgery; Arthritis; Pathology","score_opus":0.04106422336789942,"score_gpt":0.29787521990846044,"score_spread":0.256810996540561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048560770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98708475,0.0067639137,0.000023803663,0.0011114675,0.00021096932,0.0016198627,0.0029505016,0.000018290142,0.0002164618],"genre_scores_gemma":[0.99874717,0.00070527586,0.000043091135,0.00010833369,0.0000101140195,0.00007351023,0.00025098698,0.000015718144,0.000045796885],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99605566,0.0017200887,0.001615678,0.00022852798,0.00013776464,0.0002422783],"domain_scores_gemma":[0.99613684,0.0017683643,0.0013712178,0.0004907008,0.00020360535,0.000029288183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007084893,0.00025707445,0.0015290505,0.000058103942,0.00009796803,0.00000846195,0.0004456666,0.000082700106,0.00021395039],"category_scores_gemma":[0.0033115046,0.00012308816,0.00045835885,0.00036392116,0.00031840216,0.00010170734,0.000069774695,0.000099680685,0.000008952524],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42886874,0.009682405,0.012560941,0.00068499945,0.0151855275,0.000004642712,0.020929378,0.0010124845,0.0017311659,0.0015137409,0.008161948,0.499664],"study_design_scores_gemma":[0.7771304,0.007853984,0.1183462,0.007007631,0.0054730237,0.000004211726,0.0056467033,0.00018673333,0.07196506,0.003191845,0.0020989273,0.0010952285],"about_ca_topic_score_codex":0.0002702873,"about_ca_topic_score_gemma":0.000047427,"teacher_disagreement_score":0.4985688,"about_ca_system_score_codex":0.000010719321,"about_ca_system_score_gemma":0.0001638012,"threshold_uncertainty_score":0.50193894},"labels":[],"label_agreement":null},{"id":"W3048897341","doi":"10.1136/annrheumdis-2020-218015","title":"2019 EULAR points to consider for the assessment of competences in rheumatology specialty training","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European League Against Rheumatism","keywords":"Medicine; Rheumatology; Specialty; Internal medicine; Physical therapy; Rheumatism; Family medicine; Medical physics","score_opus":0.08299268678427801,"score_gpt":0.38522851799997176,"score_spread":0.30223583121569375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048897341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9080495,0.0010073707,0.00062641414,0.08871587,0.000120011726,0.0012231186,0.000059349804,0.0000081314365,0.00019019008],"genre_scores_gemma":[0.99767315,0.00017529972,0.00082690176,0.0012496843,0.000008633617,0.00003945887,0.000006687652,0.000007920687,0.0000122454685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896085,0.000101012636,0.000445669,0.00012990102,0.00022294269,0.0001396423],"domain_scores_gemma":[0.99846536,0.000957163,0.00017878557,0.00020333221,0.00011280281,0.00008255928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026558051,0.00008973853,0.00041369488,0.000039976705,0.000041819963,0.000005250853,0.00015432778,0.000024442294,0.00011058739],"category_scores_gemma":[0.0018033651,0.000047629364,0.00022480612,0.00017523138,0.00017019492,0.000034057142,0.000045351888,0.0000493201,0.0000021451008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014541253,0.0028125397,0.61692965,0.02116692,0.0019564477,0.000003807239,0.03623667,0.00517306,0.00091985904,0.07275913,0.098572694,0.14201508],"study_design_scores_gemma":[0.0010344897,0.0004359899,0.9804576,0.0011499282,0.00009914885,0.0000012755146,0.005580112,0.0046410225,0.00007120954,0.0061461567,0.00029735398,0.00008571239],"about_ca_topic_score_codex":0.00007920281,"about_ca_topic_score_gemma":0.000022463897,"teacher_disagreement_score":0.36352795,"about_ca_system_score_codex":0.000004866099,"about_ca_system_score_gemma":0.00016409959,"threshold_uncertainty_score":0.21589267},"labels":[],"label_agreement":null},{"id":"W3049003103","doi":"10.1136/annrheumdis-2020-217162","title":"Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; University Health Network; University of Toronto; Toronto Western Hospital; Mount Sinai Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; National Institutes of Health; European League Against Rheumatism; National Institute for Health and Care Research; Academy of Medical Sciences; American College of Rheumatology Research and Education Foundation","keywords":"Medicine; Disease; Ethnic group; Systemic lupus erythematosus; Systemic disease; Lupus erythematosus; Dermatology; Internal medicine; Immunology; Antibody","score_opus":0.08459352749775723,"score_gpt":0.35687205441121644,"score_spread":0.2722785269134592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049003103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868248,0.0059792297,0.00001296969,0.0049994844,0.00013454522,0.0017182825,0.00027844348,0.000022716687,0.000029497254],"genre_scores_gemma":[0.99818325,0.0009725609,0.000020492073,0.00022271906,0.00003517428,0.00013978223,0.000010918762,0.00003181429,0.00038330632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979187,0.00021029077,0.00071701204,0.00025732312,0.0005743743,0.00032230275],"domain_scores_gemma":[0.99807596,0.00042595816,0.00039885932,0.0006654899,0.0002447554,0.00018899729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004585545,0.00018984101,0.00058047794,0.000054846245,0.00010540978,0.000030767445,0.00043600117,0.0000590986,0.0000098691025],"category_scores_gemma":[0.0011352445,0.00010938257,0.00023542783,0.00031813112,0.00037446842,0.00014535846,0.0001856975,0.000105063875,0.0000033907143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015210159,0.00020619958,0.95015055,0.028465938,0.00019416513,0.0000020932014,0.010567623,0.000038972667,0.0019037167,0.00036375845,0.005511054,0.0010749192],"study_design_scores_gemma":[0.00403982,0.00041605363,0.93056935,0.025025526,0.000309856,0.00055568013,0.010232029,0.02444316,0.0032786618,0.0006908495,0.00009144438,0.00034756478],"about_ca_topic_score_codex":0.000048829097,"about_ca_topic_score_gemma":0.000003190022,"teacher_disagreement_score":0.024404189,"about_ca_system_score_codex":0.000023847937,"about_ca_system_score_gemma":0.00019419072,"threshold_uncertainty_score":0.44604918},"labels":[],"label_agreement":null},{"id":"W3062096295","doi":"10.1136/annrheumdis-2020-eular.3412","title":"FRI0545 A META-ANALYSIS OF GIANT CELL ARTERITIS TEMPORALLY AND ACROSS REGIONS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Epidemiology; Incidence (geometry); Giant cell arteritis; Mortality rate; Population; Strengthening the reporting of observational studies in epidemiology; Demography; Meta-analysis; Observational study; Cohort study; Polymyalgia rheumatica; Vasculitis; Disease; Internal medicine; Environmental health","score_opus":0.10922074403471604,"score_gpt":0.3294651406200188,"score_spread":0.22024439658530276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3062096295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92208564,0.018358141,0.00017732743,0.05647096,0.000030221592,0.00045023113,0.0016984615,0.00003462316,0.00069441996],"genre_scores_gemma":[0.9973001,0.0011848833,0.00008764444,0.0011430152,0.00000623784,0.000016051781,0.000039464856,0.000009258558,0.00021337227],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9989777,0.00006863708,0.00041492895,0.00015760769,0.0002449323,0.0001361634],"domain_scores_gemma":[0.9989785,0.00008878219,0.00024268929,0.00036850982,0.00012614302,0.000195379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008091602,0.000111520654,0.00084975665,0.00005280298,0.000075620774,0.00001391307,0.00012264248,0.000039233688,0.00038957907],"category_scores_gemma":[0.00016212201,0.00006514195,0.0013903178,0.0004783632,0.00018721395,0.0000534764,0.00006779942,0.00006519117,0.000004206469],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003356098,0.003379378,0.011065963,0.005311526,0.8532851,0.0001372204,0.020213177,0.0010626354,0.0025245678,0.0050271493,0.09003191,0.0076258187],"study_design_scores_gemma":[0.0022689537,0.00064342195,0.43677545,0.0005070007,0.54312587,0.000032746393,0.0044866093,0.004180336,0.0023036047,0.004287027,0.00093278807,0.0004562084],"about_ca_topic_score_codex":0.000077308905,"about_ca_topic_score_gemma":0.000007283626,"teacher_disagreement_score":0.4257095,"about_ca_system_score_codex":0.0000018332511,"about_ca_system_score_gemma":0.00004679114,"threshold_uncertainty_score":0.42656177},"labels":[],"label_agreement":null},{"id":"W3068188279","doi":"10.1136/annrheumdis-2020-217344","title":"EULAR definition of difficult-to-treat rheumatoid arthritis","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":539,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European League Against Rheumatism; Radboud Universiteit","keywords":"Medicine; Rheumatoid arthritis; Intensive care medicine; Immunology","score_opus":0.053243742621935625,"score_gpt":0.2927900079434731,"score_spread":0.23954626532153747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3068188279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97124994,0.015184593,0.00007095709,0.011730493,0.000060209793,0.00057833595,0.00020452941,0.000054384054,0.00086655887],"genre_scores_gemma":[0.95584196,0.04282104,0.00025565148,0.0009484461,0.000023274377,0.000034637393,0.000029080991,0.000026390768,0.000019530113],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812305,0.00012215132,0.0005675159,0.00021699235,0.0006658223,0.0003044693],"domain_scores_gemma":[0.9983896,0.00017052979,0.00019753943,0.00044515744,0.0003375996,0.000459584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012210126,0.00018459397,0.0005975163,0.00008353487,0.000088692665,0.000022002741,0.0002777275,0.00004115075,0.00036831576],"category_scores_gemma":[0.0018818446,0.00012647445,0.00033117027,0.00046305757,0.00023216057,0.000109010805,0.00013274455,0.00009731583,0.000088355715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006185111,0.005944112,0.09312754,0.0076126214,0.002501167,0.000118987555,0.015397335,0.00025019905,0.028401088,0.040113706,0.23656887,0.56377923],"study_design_scores_gemma":[0.021503411,0.0077477586,0.6516832,0.04468031,0.00016775334,0.00027840503,0.007905908,0.001108014,0.20897628,0.038396094,0.015531977,0.0020208494],"about_ca_topic_score_codex":0.00006268511,"about_ca_topic_score_gemma":0.0000035062073,"teacher_disagreement_score":0.5617584,"about_ca_system_score_codex":0.0000067661963,"about_ca_system_score_gemma":0.00013454129,"threshold_uncertainty_score":0.51574785},"labels":[],"label_agreement":null},{"id":"W3080703541","doi":"10.1136/annrheumdis-2020-eular.5828","title":"FRI0298 ASAS MODIFICATION OF THE BERLIN ALGORITHM AND THE DUET ALGORITHM FOR DIAGNOSING AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE SCREENING IN AXIAL SPONDYLOARTHRITIS FOR PSORIASIS, IRITIS, AND COLITIS COHORT","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Parkinson's Disease and Spinal Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Ottawa Hospital; University of Alberta; Université de Sherbrooke; University of Calgary; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Algorithm; Psoriasis; Axial spondyloarthritis; Cohort; Dermatology; Internal medicine; Ankylosing spondylitis; Computer science; Sacroiliitis","score_opus":0.04088825078404507,"score_gpt":0.296554333509554,"score_spread":0.25566608272550895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080703541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90129066,0.03209523,0.0038175664,0.041037463,0.00027813695,0.0056506256,0.015747493,0.000036498208,0.000046332458],"genre_scores_gemma":[0.9890949,0.006505615,0.0016195491,0.0017078723,0.00022516894,0.000503925,0.00028683743,0.000038195038,0.000017895405],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975257,0.00036603882,0.0008318401,0.00042785663,0.00050304964,0.00034553485],"domain_scores_gemma":[0.9963422,0.00228622,0.00046132415,0.0005119122,0.00021666501,0.00018170387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007003994,0.0002678495,0.00068948144,0.000046458095,0.00035782572,0.00007766166,0.00037782115,0.000093788105,0.000010830672],"category_scores_gemma":[0.0036218455,0.00015595781,0.00039836645,0.0002775193,0.00077977515,0.00015987901,0.00015016962,0.00015788309,5.2341494e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009559021,0.0006283856,0.01870571,0.00063408155,0.0009034016,0.000010286601,0.003917223,0.000096299096,0.000026976479,0.0013455731,0.015099774,0.94907326],"study_design_scores_gemma":[0.017847793,0.00038494932,0.9198432,0.003441591,0.0008933448,0.000012538127,0.002478173,0.043478098,0.00038073384,0.007603769,0.003329078,0.00030675303],"about_ca_topic_score_codex":0.0013048227,"about_ca_topic_score_gemma":0.00013877195,"teacher_disagreement_score":0.9487665,"about_ca_system_score_codex":0.000010512802,"about_ca_system_score_gemma":0.0001582512,"threshold_uncertainty_score":0.63597745},"labels":[],"label_agreement":null},{"id":"W3080901368","doi":"10.1136/annrheumdis-2020-218690","title":"Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; Eli Lilly and Company","keywords":"Medicine; Juvenile dermatomyositis; Dermatomyositis; Rash; Internal medicine; Janus kinase; Muscle weakness; Gastroenterology","score_opus":0.024367200605535842,"score_gpt":0.2596867928340036,"score_spread":0.23531959222846774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080901368","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20452383,0.004490195,0.000021991827,0.785126,0.00033249293,0.001645152,0.00083802006,0.00016457416,0.0028577945],"genre_scores_gemma":[0.45603058,0.0006861168,0.00007567546,0.54161876,0.0004648591,0.00014499568,0.000583709,0.0001190241,0.00027627838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968133,0.00028646487,0.000988187,0.00044146407,0.00094267656,0.0005279103],"domain_scores_gemma":[0.9976926,0.0002685904,0.000737006,0.0008681107,0.00023589916,0.00019777959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010784769,0.000510058,0.0012139691,0.00025501658,0.00012234252,0.000055014323,0.00028792213,0.0003260154,0.00026205642],"category_scores_gemma":[0.0002780696,0.0003522834,0.00046929784,0.00042976224,0.00030286566,0.00019797105,0.00015526291,0.0010517259,0.000070882794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002575143,0.000195604,0.002015413,0.0064601447,0.000213094,0.0049695983,0.00041593265,0.000008540439,0.000014955752,0.00003815559,0.9828133,0.00259776],"study_design_scores_gemma":[0.01151459,0.0018462578,0.12221616,0.10333909,0.0031257037,0.0030178437,0.0011453377,0.0007714248,0.007582382,0.0051933867,0.73681223,0.0034356017],"about_ca_topic_score_codex":0.00012900236,"about_ca_topic_score_gemma":0.000007712723,"teacher_disagreement_score":0.25150675,"about_ca_system_score_codex":0.00006092514,"about_ca_system_score_gemma":0.00048334908,"threshold_uncertainty_score":0.9998929},"labels":[],"label_agreement":null},{"id":"W3081489450","doi":"10.1136/annrheumdis-2001.890","title":"SAT0254 Patient characteristics and disease management of rheumatoid arthritis at baseline in the vigour (vioxx gi outcomes research) study: effects of disease duration","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Demographics; Surgery; Demography","score_opus":0.045838487240732154,"score_gpt":0.3614548952242073,"score_spread":0.3156164079834752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081489450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637134,0.004219525,0.0000037355996,0.0071916436,0.000057636695,0.0018508113,0.00021679605,0.00000797429,0.00008052123],"genre_scores_gemma":[0.97897774,0.020294258,0.000015483149,0.00031021386,0.000011871748,0.00011693558,0.000051314655,0.000017098391,0.00020507662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645585,0.0007233841,0.00082435133,0.00025368834,0.0014107258,0.00033201338],"domain_scores_gemma":[0.9973535,0.0010422481,0.0002950258,0.0006890394,0.00026768763,0.0003525286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008578484,0.00020086905,0.0005499356,0.000183353,0.0001499506,0.000018966899,0.00030240553,0.000023992237,0.000072791474],"category_scores_gemma":[0.0016949412,0.00011279737,0.00021690658,0.00038533602,0.00039102594,0.00008078826,0.00038849155,0.00013468471,0.000005714537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004141524,0.005675896,0.91634864,0.0050771213,0.00044451843,0.00033329384,0.0014498874,0.000010810161,0.00004286924,0.0007044304,0.0027001721,0.06307087],"study_design_scores_gemma":[0.0012312967,0.00045251692,0.9921796,0.0036231927,0.00008618873,0.0000043581285,0.00067642384,0.00027812796,0.00011071529,0.00096765935,0.00028696758,0.000102973056],"about_ca_topic_score_codex":0.00015812948,"about_ca_topic_score_gemma":0.00002377025,"teacher_disagreement_score":0.07583097,"about_ca_system_score_codex":0.000020434367,"about_ca_system_score_gemma":0.000095285744,"threshold_uncertainty_score":0.4599743},"labels":[],"label_agreement":null},{"id":"W3081969301","doi":"10.1136/annrheumdis-2020-217520","title":"EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Manchester Biomedical Research Centre; Versus Arthritis; National Institute for Health and Care Research; Arthritis Society","keywords":"Medicine; European union; Rheumatoid arthritis; Cross-sectional study; Rheumatism; Logistic regression; Family medicine; Physical therapy; Internal medicine; Pathology","score_opus":0.08537386186590276,"score_gpt":0.4206541231233591,"score_spread":0.33528026125745636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081969301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9176367,0.066565774,0.0000686523,0.00008975593,0.000043400956,0.00071472244,0.014840721,0.000013349334,0.000026954915],"genre_scores_gemma":[0.9622911,0.037122406,0.000098935925,0.00004766614,0.000005392939,0.00004083549,0.00036681592,0.000024607254,0.000002192977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974112,0.00013391828,0.001056833,0.0002863441,0.0008272172,0.0002845128],"domain_scores_gemma":[0.997155,0.00018657176,0.0007571302,0.0002563321,0.0014549673,0.00018997502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025709806,0.00021450513,0.0007779518,0.00006517739,0.00018007282,0.00004207963,0.00019527366,0.000043924818,0.000051574487],"category_scores_gemma":[0.00085814483,0.00016394825,0.00021587514,0.00017331098,0.0010455558,0.00021915596,0.00014293351,0.00006158426,1.6708415e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013065176,0.0001451875,0.96448505,0.00399921,0.00044496558,9.538327e-7,0.014313803,0.000011085998,0.0008190226,0.00016804255,0.001225791,0.013080355],"study_design_scores_gemma":[0.006942678,0.0015730858,0.90653634,0.0022930305,0.000026309366,0.0000066044354,0.029326582,0.000030553732,0.052419107,0.00015048392,0.00046255643,0.00023268601],"about_ca_topic_score_codex":0.00020825588,"about_ca_topic_score_gemma":0.000074376694,"teacher_disagreement_score":0.057948742,"about_ca_system_score_codex":0.000015542288,"about_ca_system_score_gemma":0.00021264225,"threshold_uncertainty_score":0.6685616},"labels":[],"label_agreement":null},{"id":"W3082103787","doi":"10.1136/annrheumdis-2020-eular.5136","title":"SAT0457 PREVALENCE OF OSTEOPOROSIS IN OSTEOARTHRITIC PATIENTS: A SYSTEMATIC REVIEW","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Osteoporosis; Internal medicine; Incidence (geometry); Odds ratio; Osteoarthritis; Meta-analysis; Population; Bone mineral; Epidemiology; Systematic review; Demography; Web of science; Prevalence; Physical therapy; MEDLINE; Alternative medicine; Pathology; Environmental health","score_opus":0.04127760909960295,"score_gpt":0.3280368155897612,"score_spread":0.2867592064901583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082103787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024201786,0.99063194,1.7335489e-7,0.00014218324,0.00012661937,0.0080668805,0.0006568662,0.000023963918,0.00010935102],"genre_scores_gemma":[0.0010442054,0.99760467,0.000024321918,0.00025603274,0.000011742163,0.00072448095,0.000106692925,0.00005805575,0.00016979537],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956501,0.0005816516,0.0023429526,0.00037953007,0.0007433814,0.00030239858],"domain_scores_gemma":[0.99608845,0.0005754365,0.0017766459,0.0011277406,0.00022736096,0.00020437701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002861135,0.00052235206,0.0054311147,0.00016608929,0.000030920495,0.000010147221,0.00051186705,0.00012565491,0.000114105525],"category_scores_gemma":[0.0036187773,0.00031150086,0.0016935878,0.0006267787,0.00012613456,0.00009258214,0.00017986001,0.00016944639,0.000050688497],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011618521,0.00040776076,0.000039864946,0.81679267,0.00019781628,0.0000072209723,0.000059411173,1.9360243e-8,4.7837517e-8,0.000034896904,0.00017339838,0.18227527],"study_design_scores_gemma":[0.00077110477,0.00087248895,0.000047063895,0.9842902,0.012235479,0.000015719526,0.00003063741,4.284183e-7,0.00000633455,0.000084347696,0.0014274125,0.00021877796],"about_ca_topic_score_codex":0.000006291362,"about_ca_topic_score_gemma":0.0000028017723,"teacher_disagreement_score":0.18205649,"about_ca_system_score_codex":0.0000442785,"about_ca_system_score_gemma":0.00047186477,"threshold_uncertainty_score":0.9999337},"labels":[],"label_agreement":null},{"id":"W3082398655","doi":"10.1136/annrheumdis-2020-eular.6350","title":"FRI0302 WHAT IS THE IMPACT OF DISCREPANCY BETWEEN CENTRAL AND LOCAL READERS IN EVALUATION OF MRI SCANS ON THE CLASSIFICATION OF AXIAL SPONDYLOARTHRITIS? DATA FROM THE ASAS CLASSIFICATION COHORT STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Cohort; Ankylosing spondylitis; Pathology; Internal medicine; Sacroiliitis","score_opus":0.20320444985121341,"score_gpt":0.39315956821532627,"score_spread":0.18995511836411286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082398655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799328,0.003925273,0.000020052767,0.012584045,0.000043290693,0.00215762,0.0012854007,0.000004982228,0.000046539866],"genre_scores_gemma":[0.9973027,0.0022839208,0.0000054959155,0.00008339266,0.000032146938,0.00005939616,0.00021793175,0.000012660404,0.0000023253137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738324,0.00060093816,0.00066867436,0.00028723292,0.0008927966,0.00016711194],"domain_scores_gemma":[0.997136,0.0008777327,0.0005962225,0.001105854,0.00021626141,0.00006790322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008025144,0.00017053416,0.00049103465,0.00003182284,0.000105662366,0.000022643297,0.0004284668,0.00003881541,0.00007157954],"category_scores_gemma":[0.0009046594,0.000076254946,0.00016870114,0.0003004794,0.0005118158,0.00018418289,0.00014452152,0.000103100836,0.0000012768224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005584164,0.00091000274,0.94508886,0.000061644285,0.0012088757,4.8401535e-7,0.0068044397,0.00007111626,0.000033232205,0.000117741234,0.0014469823,0.0436982],"study_design_scores_gemma":[0.0016510221,0.00047565275,0.96799266,0.0009790217,0.0009120268,4.055094e-7,0.021537138,0.005619843,0.000114643066,0.0006547588,0.000004069121,0.000058784743],"about_ca_topic_score_codex":0.0019000474,"about_ca_topic_score_gemma":0.00020818444,"teacher_disagreement_score":0.043639414,"about_ca_system_score_codex":0.000031484687,"about_ca_system_score_gemma":0.00016906876,"threshold_uncertainty_score":0.31095862},"labels":[],"label_agreement":null},{"id":"W3082456706","doi":"10.1136/annrheumdis-2020-eular.2229","title":"OP0015 SEX-SPECIFIC U-SHAPED RELATIONSHIP BETWEEN SERUM URATE AND MORTALITY IN THE UNITED STATES GENERAL POPULATION","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; National Health and Nutrition Examination Survey; Body mass index; Proportional hazards model; Population; Internal medicine; Diabetes mellitus; Demography; National Death Index; Gout; Hazard ratio; Mortality rate; Confidence interval; Endocrinology; Environmental health","score_opus":0.15242404817720318,"score_gpt":0.3488654173770773,"score_spread":0.19644136919987415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082456706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853874,0.00069815555,0.00003181422,0.013123658,0.000026828806,0.0005027713,0.00014318313,0.000034333218,0.0000518531],"genre_scores_gemma":[0.99766904,0.00020387078,0.0000539179,0.0016222907,0.00005945201,0.000015105501,0.00031483782,0.000016933189,0.000044576343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834144,0.00034576998,0.0004907695,0.00020141875,0.0004249443,0.0001956673],"domain_scores_gemma":[0.99866563,0.000496017,0.0002188149,0.00041396622,0.0000641383,0.0001414244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003595393,0.00015680693,0.00033263772,0.00007524088,0.00010325713,0.00003393829,0.00020842363,0.00005227557,0.000030479221],"category_scores_gemma":[0.00071982073,0.000094219264,0.00009682822,0.00060505816,0.000102122445,0.0001237438,0.00007571107,0.00014960975,0.000005730074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035861398,0.000067935754,0.995362,0.00022476638,0.00008715208,0.0000031745942,0.001637562,0.00030805473,0.000007826737,0.00025214234,0.0011954746,0.00081804756],"study_design_scores_gemma":[0.0005116939,0.00005677458,0.9892453,0.00016183872,0.00018790906,0.0000026705795,0.0007745247,0.0045056473,0.000028820847,0.0042913975,0.00013589865,0.00009752464],"about_ca_topic_score_codex":0.00033926955,"about_ca_topic_score_gemma":0.000007828951,"teacher_disagreement_score":0.0122816125,"about_ca_system_score_codex":0.000013269545,"about_ca_system_score_gemma":0.000036538673,"threshold_uncertainty_score":0.384215},"labels":[],"label_agreement":null},{"id":"W3083896324","doi":"10.1136/annrheumdis-2020-eular.1762","title":"SAT0046 MODIFIED DISEASE ACTIVITY SCORE AT 3 MONTHS IS A SIGNIFICANT PREDICTOR FOR RAPID RADIOGRAPHIC PROGRESSION AT 12 MONTHS COMPARED WITH OTHER MEASURES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Receiver operating characteristic; Methotrexate; Logistic regression; Confounding; Youden's J statistic; Area under the curve; Radiography; Gastroenterology; Surgery","score_opus":0.08275705078103843,"score_gpt":0.30950956324961654,"score_spread":0.2267525124685781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083896324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662888,0.01854128,0.00017471003,0.009694423,0.000067156085,0.003675357,0.0013352464,0.00013185806,0.00009115073],"genre_scores_gemma":[0.9934198,0.004858828,0.00008974262,0.0007067255,0.00007777229,0.0005897866,0.000051730112,0.00007553436,0.00013006318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969351,0.00024322368,0.00047075088,0.0005206186,0.0012436743,0.0005866296],"domain_scores_gemma":[0.9971689,0.0002975757,0.00037105795,0.0007905647,0.00028043258,0.0010914789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021699925,0.00039534495,0.000822115,0.000117928554,0.0003803928,0.000054650838,0.0004076898,0.000061610066,0.00020284158],"category_scores_gemma":[0.00059335,0.00023147822,0.0006326643,0.0003060298,0.0006445343,0.00018705777,0.00017692702,0.00012874758,0.0000082756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18660657,0.006232011,0.5113448,0.009147972,0.007099529,0.000070593225,0.0075395755,0.0006880524,0.007609873,0.0002705162,0.15582903,0.10756148],"study_design_scores_gemma":[0.02596782,0.005933625,0.8727931,0.015431928,0.00079325546,0.000020575599,0.0006174337,0.034523264,0.026989995,0.001797483,0.013574595,0.0015569321],"about_ca_topic_score_codex":0.00006731834,"about_ca_topic_score_gemma":0.00002705203,"teacher_disagreement_score":0.3614483,"about_ca_system_score_codex":0.000040180963,"about_ca_system_score_gemma":0.0002672017,"threshold_uncertainty_score":0.94394076},"labels":[],"label_agreement":null},{"id":"W3085311162","doi":"10.1136/annrheumdis-2020-217782","title":"Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada","funders":"Medical Research Council; National Health and Medical Research Council; National Natural Science Foundation of China","keywords":"Medicine; Osteoarthritis; Body mass index; Hazard ratio; Pulmonary embolism; Deep vein; Internal medicine; Knee replacement; Cohort; Cohort study; Proportional hazards model; Physical therapy; Rotterdam Study; Joint replacement; Venous thrombosis; Population; Thrombosis; Surgery; Arthroplasty; Confidence interval; Pathology","score_opus":0.022011488338027022,"score_gpt":0.28122273851258045,"score_spread":0.25921125017455343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085311162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949003,0.0020716125,0.000007926015,0.0010868098,0.00005952656,0.0017028808,0.000074021074,0.00001692188,0.000080018515],"genre_scores_gemma":[0.9987691,0.0003423059,0.000053971296,0.0006823652,0.000025713976,0.00008253851,0.000017265062,0.000019129462,0.0000075842554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853367,0.00016267931,0.00050947303,0.00022885622,0.00038341217,0.00018191941],"domain_scores_gemma":[0.9990159,0.0001214407,0.00029002965,0.0003539767,0.000078975434,0.00013967842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021678931,0.00015627118,0.0008624186,0.00008117355,0.00007938958,0.000019288173,0.00012454332,0.00003148461,0.000055717708],"category_scores_gemma":[0.00048067037,0.00011527012,0.0001432515,0.00022983525,0.00010929062,0.00005751372,0.000089762594,0.000075291,0.000002216948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010433121,0.0024347142,0.98089933,0.00059940986,0.00037452695,0.000006846268,0.0013711182,0.00061916653,0.000016479544,0.00012551657,0.00055897917,0.012889568],"study_design_scores_gemma":[0.0018115279,0.0009965382,0.9938571,0.0005708454,0.0006396032,5.9809906e-7,0.00045101854,0.00085187465,0.00014827852,0.0005582508,0.000011762639,0.00010262473],"about_ca_topic_score_codex":0.001795957,"about_ca_topic_score_gemma":0.000091404516,"teacher_disagreement_score":0.012957733,"about_ca_system_score_codex":0.000009327442,"about_ca_system_score_gemma":0.0000640534,"threshold_uncertainty_score":0.47005793},"labels":[],"label_agreement":null},{"id":"W3085646419","doi":"10.1136/annrheumdis-2020-eular.2289","title":"OP0084 PRESSURE PAIN THRESHOLDS AND THE ASSOCIATIONS WITH CHRONIC WIDESPREAD PAIN, KNEE OSTEOARTHRITIS AND OBESITY IN INDIVIDUALS WITH KNEE PAIN","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Commission; Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Osteoarthritis; Knee pain; Physical therapy; Obesity; Fibromyalgia; Chronic pain; Cross-sectional study; Logistic regression; Internal medicine; Pathology","score_opus":0.016110453088404416,"score_gpt":0.23974077168189756,"score_spread":0.22363031859349314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085646419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643334,0.020073626,0.000064249725,0.013003081,0.000020658263,0.0020973317,0.00022932066,0.000050040948,0.00012827452],"genre_scores_gemma":[0.9968445,0.00044405326,0.00011257585,0.0022038838,0.00003009007,0.000181849,0.000041423096,0.000026829575,0.00011480276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778384,0.0008975652,0.00032659373,0.00027330065,0.00042931002,0.00028937185],"domain_scores_gemma":[0.9978049,0.001328153,0.00024411727,0.0003357988,0.000091332186,0.00019573818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013415574,0.00024223019,0.000577546,0.000049216447,0.00017097298,0.000060994404,0.0001239333,0.000068059075,0.000033842614],"category_scores_gemma":[0.0016104353,0.00012801822,0.00009349998,0.00024850527,0.00035264075,0.00014950013,0.000092714814,0.00014461708,0.0000013159485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007214819,0.00039790536,0.805057,0.000965289,0.00063407386,0.000024671672,0.0032241333,0.00004382186,0.000022170834,0.0013386437,0.0017565107,0.1858143],"study_design_scores_gemma":[0.057870794,0.030152174,0.86758494,0.01925889,0.003532398,0.00006664938,0.0051103076,0.0024449013,0.0009223111,0.009766269,0.002095791,0.0011945599],"about_ca_topic_score_codex":0.000084666484,"about_ca_topic_score_gemma":0.00032898266,"teacher_disagreement_score":0.18461974,"about_ca_system_score_codex":0.000013341977,"about_ca_system_score_gemma":0.00016953665,"threshold_uncertainty_score":0.5220431},"labels":[],"label_agreement":null},{"id":"W3089023719","doi":"10.1136/annrheumdis-2020-218573","title":"Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update‘","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Medicine; Tofacitinib; Deep vein; Psoriatic arthritis; Rheumatism; Thrombosis; Psoriasis; Dermatology; Internal medicine; Intensive care medicine; Rheumatoid arthritis","score_opus":0.05937284809974449,"score_gpt":0.3350118183029112,"score_spread":0.27563897020316674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089023719","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003259874,0.01802319,0.00008476484,0.9732749,0.00050749304,0.0029953935,0.0016647114,0.000031278407,0.00015839642],"genre_scores_gemma":[0.102537245,0.1397886,0.0011630529,0.7499536,0.0005438446,0.0020366593,0.0009242292,0.00013611748,0.0029166196],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983798,0.00010822067,0.00045758937,0.00028269237,0.0005111332,0.0002605232],"domain_scores_gemma":[0.9980722,0.0007239995,0.00047007395,0.00052697875,0.0001498405,0.0000569214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009197823,0.00029151916,0.0006660556,0.00004884722,0.00019669562,0.000018408131,0.00036687698,0.0000689263,0.00049215055],"category_scores_gemma":[0.00007083655,0.0001400462,0.0003990524,0.00018814289,0.0002413372,0.000034665965,0.00010567309,0.00023512711,0.000025230833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007822337,0.00035843992,0.00005626117,0.00079139235,0.0053690565,0.00006126415,0.00012784099,0.000008116298,5.5137804e-7,0.00015333053,0.9390869,0.053204592],"study_design_scores_gemma":[0.010603099,0.0041107535,0.007273974,0.02073044,0.008965806,0.000031218224,0.0012287226,0.0001949746,0.00022155463,0.004126653,0.9419091,0.00060373923],"about_ca_topic_score_codex":0.00001565271,"about_ca_topic_score_gemma":0.0000011690236,"teacher_disagreement_score":0.22332127,"about_ca_system_score_codex":0.000017742906,"about_ca_system_score_gemma":0.000061185645,"threshold_uncertainty_score":0.5710919},"labels":[],"label_agreement":null},{"id":"W3089041431","doi":"10.1136/annrheumdis-2020-217646","title":"Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Birmingham Biomedical Research Centre; Medical Research Council; Versus Arthritis; National Institute for Health and Care Research; William Harvey Research Foundation; Cancer Research UK; Wellcome Trust","keywords":"Germinal center; CXCR5; FOXP3; MALT lymphoma; Immunology; Immunophenotyping; Medicine; Proinflammatory cytokine; Cytokine; Population; Immune system; Biology; B cell; Antibody; Flow cytometry; Lymphatic system; Inflammation","score_opus":0.01956463768581924,"score_gpt":0.24238102253241062,"score_spread":0.2228163848465914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089041431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929241,0.003657345,0.00018071388,0.0027122768,0.000034088545,0.0003002849,0.000119237586,0.000011596033,0.00006038528],"genre_scores_gemma":[0.9986017,0.0008488771,0.000029198443,0.00041049495,0.00000693555,0.000007146171,0.00000704827,0.00001004236,0.000078567835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991979,0.00005988176,0.00028150046,0.00013775605,0.00020759551,0.000115365365],"domain_scores_gemma":[0.9992081,0.00017712948,0.00019405881,0.00019816445,0.00009290806,0.00012964838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050166847,0.00011929534,0.00040688683,0.000048846403,0.000045376008,0.000009332401,0.00006833766,0.00002766192,0.00005951222],"category_scores_gemma":[0.00008486215,0.00007152129,0.000085332504,0.00011360722,0.00023224042,0.000068496694,0.000041947864,0.000028651344,6.7669635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009524588,0.004102069,0.8809171,0.025226222,0.0041072736,0.00016083784,0.0074673826,0.00054903113,0.008721271,0.005642529,0.014977038,0.03860469],"study_design_scores_gemma":[0.0041137896,0.00081402675,0.9787894,0.0019349671,0.0007800674,0.00006750519,0.0031143078,0.0008528916,0.007367041,0.0019659332,0.00003678885,0.00016329376],"about_ca_topic_score_codex":0.00015250975,"about_ca_topic_score_gemma":0.0000062236695,"teacher_disagreement_score":0.097872324,"about_ca_system_score_codex":0.0000023199266,"about_ca_system_score_gemma":0.0000827804,"threshold_uncertainty_score":0.29165536},"labels":[],"label_agreement":null},{"id":"W3089319728","doi":"10.1136/annrheumdis-2020-217895","title":"Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario; Ottawa Hospital; Institute for Work & Health; University of Toronto","funders":"Odense Universitetshospital; University of Leeds; National Institute for Health and Care Research; University of Bristol; Amsterdam University Medical Centers; School of Medicine, Duke University; University of Washington; Parker Institute for Cancer Immunotherapy; Université de Lorraine; Oak Foundation","keywords":"Medicine; Rheumatology; Internal medicine; Qualitative research; Family medicine; Alternative medicine; Physical therapy; Clinical trial; Pathology","score_opus":0.5109180140231975,"score_gpt":0.5595759363645055,"score_spread":0.04865792234130806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089319728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955695,0.00058746536,0.00005831962,0.0024016576,0.00014467436,0.0008928646,0.00013444296,0.00008240941,0.00012865869],"genre_scores_gemma":[0.99940073,0.00008550582,0.00023570399,0.0001712651,0.000023658034,0.000045386372,0.000015914666,0.000020404827,0.0000014158915],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98664856,0.010755519,0.0010611358,0.0003954441,0.0007642224,0.00037514456],"domain_scores_gemma":[0.9892228,0.009368967,0.00064084504,0.00028141445,0.0001449416,0.00034101825],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0068622767,0.00020491867,0.00091029156,0.00013449417,0.00035382502,0.000174933,0.0006460363,0.00009755002,0.00006601621],"category_scores_gemma":[0.032207485,0.00015351869,0.00012288966,0.00043478078,0.0007742802,0.00029202126,0.00020103919,0.00026306554,0.0000019014145],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068620505,0.0007262538,0.08922137,0.000058121095,0.0002399828,0.000015245227,0.87783706,0.000035417397,0.000018131552,0.006474576,0.00011605444,0.024571588],"study_design_scores_gemma":[0.0010966797,0.000526295,0.035565097,0.00059039594,0.000063901876,5.0844955e-7,0.94244033,0.0009073238,0.000097166085,0.018432215,0.000013448075,0.0002666589],"about_ca_topic_score_codex":0.028013572,"about_ca_topic_score_gemma":0.0054464103,"teacher_disagreement_score":0.06460326,"about_ca_system_score_codex":0.000025036263,"about_ca_system_score_gemma":0.0003535437,"threshold_uncertainty_score":0.97845894},"labels":[],"label_agreement":null},{"id":"W3089488138","doi":"10.1136/annrheumdis-2020-218004","title":"Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Queen Elizabeth II Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Blood–brain barrier; Cognition; Internal medicine; Neuroimaging; Pathology; Central nervous system; Psychiatry","score_opus":0.02581869362359201,"score_gpt":0.28858782929054666,"score_spread":0.26276913566695465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089488138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865317,0.0026219585,0.000009863375,0.008672324,0.00004467563,0.0016070731,0.00022923162,0.00004015662,0.00024302088],"genre_scores_gemma":[0.9960942,0.00013666353,0.000006979999,0.002820746,0.000019504954,0.00011850798,0.000016483391,0.000053691456,0.0007331682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973095,0.00035611272,0.00064527395,0.0003905807,0.00083236466,0.00046613516],"domain_scores_gemma":[0.99781144,0.0008004218,0.00033879187,0.00040600495,0.00024248337,0.00040083806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004325541,0.00029748253,0.00087961537,0.00012902371,0.000072432915,0.000040009105,0.00024124223,0.000084338215,0.00026421135],"category_scores_gemma":[0.001344338,0.0001783134,0.00018948063,0.00047578092,0.0003162622,0.00011031577,0.00017960551,0.00019039125,0.000048321675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006489468,0.00044659973,0.97555417,0.0051820483,0.00093147525,0.00016001423,0.0074774204,0.0000031959155,0.000105705396,0.000021966667,0.009333141,0.00013529535],"study_design_scores_gemma":[0.049657628,0.0038250084,0.669899,0.18191329,0.0038954616,0.029338757,0.04598541,0.0025759728,0.009161399,0.0016532579,0.00006511042,0.0020297312],"about_ca_topic_score_codex":0.0000487228,"about_ca_topic_score_gemma":0.000008213791,"teacher_disagreement_score":0.3056552,"about_ca_system_score_codex":0.000031239535,"about_ca_system_score_gemma":0.00020804339,"threshold_uncertainty_score":0.727141},"labels":[],"label_agreement":null},{"id":"W3091228368","doi":"10.1136/annrheumdis-2020-eular.276","title":"THU0198 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Adverse effect; Placebo; Methotrexate; Internal medicine","score_opus":0.0409407264005392,"score_gpt":0.3105212033318787,"score_spread":0.2695804769313395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091228368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878698,0.0006722266,0.00017676648,0.007928737,0.000020984084,0.002316351,0.00090243417,0.000031070198,0.00008161643],"genre_scores_gemma":[0.99713016,0.000581187,0.0014774826,0.00052018376,0.000011299569,0.000074873555,0.000059100577,0.000046784775,0.00009892491],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9973879,0.00027977978,0.00071599014,0.0004031571,0.0008129903,0.0004002136],"domain_scores_gemma":[0.99530995,0.002624764,0.0003776109,0.00067198003,0.0005254514,0.00049026514],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00059993775,0.00025211475,0.0007587827,0.00009898306,0.00010124555,0.000022119993,0.00030206033,0.000052395346,0.000028892538],"category_scores_gemma":[0.008672173,0.00014814136,0.00012590588,0.00050743995,0.00032345435,0.00009762161,0.00019346488,0.00010437337,0.000006032294],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7534397,0.004300062,0.005928251,0.0060373633,0.00222993,0.000044482094,0.010474028,0.0010894244,0.00021101284,0.00024272957,0.026607,0.18939601],"study_design_scores_gemma":[0.2889053,0.03476516,0.6151517,0.030922491,0.000609906,0.00006156731,0.0015371082,0.006938667,0.013966487,0.0003867061,0.005538251,0.0012166755],"about_ca_topic_score_codex":0.000111638525,"about_ca_topic_score_gemma":0.000011189823,"teacher_disagreement_score":0.6092234,"about_ca_system_score_codex":0.00015332502,"about_ca_system_score_gemma":0.0019996513,"threshold_uncertainty_score":0.9996782},"labels":[],"label_agreement":null},{"id":"W3092222387","doi":"10.1136/annrheumdis-2020-218992","title":"Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Internal medicine; Etanercept; Adalimumab; Incidence (geometry); Tocilizumab; Janus kinase inhibitor; Surgery","score_opus":0.0900191227390695,"score_gpt":0.3719142506461895,"score_spread":0.28189512790712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092222387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8799523,0.01471113,0.000022339551,0.10242291,0.00031180456,0.0017622146,0.0006529486,0.00005131096,0.00011302688],"genre_scores_gemma":[0.84088343,0.14226048,0.00003060085,0.016272537,0.00013058567,0.00022193302,0.0001407616,0.000039439332,0.000020229036],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99437976,0.0024197518,0.0015857753,0.00048723165,0.00070760224,0.000419873],"domain_scores_gemma":[0.99072754,0.006985547,0.0010023667,0.0007645691,0.00023286034,0.00028709567],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0017468921,0.00039820976,0.0022413477,0.00019629992,0.00019318385,0.00009321777,0.0003313387,0.00033130293,0.0001663951],"category_scores_gemma":[0.018398415,0.00022827725,0.000586131,0.0004141808,0.0035401422,0.00010910072,0.00018876175,0.0011785944,0.0000049252817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034688003,0.0028767623,0.38528964,0.004041043,0.005839351,0.0014073387,0.0015886778,0.00016016685,0.00003003169,0.000925774,0.4541642,0.10898902],"study_design_scores_gemma":[0.11905587,0.01775901,0.643315,0.05572652,0.000730835,0.0011687262,0.001315162,0.0010938271,0.00024594375,0.01021824,0.14687571,0.0024951352],"about_ca_topic_score_codex":0.00046944254,"about_ca_topic_score_gemma":0.0001744626,"teacher_disagreement_score":0.3072885,"about_ca_system_score_codex":0.00001772897,"about_ca_system_score_gemma":0.00074498955,"threshold_uncertainty_score":0.9991717},"labels":[],"label_agreement":null},{"id":"W3092285695","doi":"10.1136/annrheumdis-2020-217230","title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Sanofi; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Idiopathic pulmonary fibrosis; Nintedanib; Interstitial lung disease; Pirfenidone; Lymphangioleiomyomatosis; Connective tissue disease; Pathology; Pulmonary fibrosis; Fibrosis; Population; Connective tissue; Usual interstitial pneumonia; Lung; Disease; Internal medicine; Autoimmune disease; Tuberous sclerosis","score_opus":0.03736945009559668,"score_gpt":0.351324449296808,"score_spread":0.31395499920121134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092285695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045958062,0.9851008,0.000039081013,0.00057235133,0.000530645,0.003395738,0.009711785,0.000076316566,0.0001137097],"genre_scores_gemma":[0.17781639,0.8202545,0.000019440955,0.0002238698,0.00012852577,0.0004625521,0.0008544756,0.00013614417,0.00010408108],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9951976,0.0006743454,0.001815869,0.00076591474,0.00094937586,0.0005968931],"domain_scores_gemma":[0.9953805,0.0006150977,0.0018633849,0.00094554207,0.00038745458,0.0008080183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016541439,0.0008622717,0.003923934,0.00035557858,0.00010854155,0.000044222706,0.00081236276,0.00025491323,0.00030321293],"category_scores_gemma":[0.0022834179,0.0006040977,0.0025408787,0.00088138436,0.0004945736,0.00020056915,0.0005336161,0.00038036806,0.000019211899],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010900307,0.008956172,0.0004759047,0.3502357,0.007874185,0.0012717985,0.0006782812,0.000021352173,0.000009803325,0.004740278,0.010916829,0.6039194],"study_design_scores_gemma":[0.003711347,0.00613983,0.0061665922,0.8914836,0.041483235,0.000071891685,0.00068200275,0.0011272954,0.00010129003,0.010276692,0.036195543,0.0025606728],"about_ca_topic_score_codex":0.00011442373,"about_ca_topic_score_gemma":0.0000034465738,"teacher_disagreement_score":0.6013587,"about_ca_system_score_codex":0.00020630416,"about_ca_system_score_gemma":0.0015442173,"threshold_uncertainty_score":0.99964106},"labels":[],"label_agreement":null},{"id":"W3092889157","doi":"10.1136/annrheumdis-2020-eular.1432","title":"SAT0139 AGE-BASED (<65 VS ≥65 YEARS) INCIDENCE OF INFECTIONS AND SERIOUS INFECTIONS IN TOFACITINIB-, ADALIMUMAB- AND PLACEBO-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, PHASE 3 AND PHASE 3B/4 TOFACITINIB STUDIES","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Tofacitinib; Adalimumab; Etanercept; Internal medicine; Janus kinase inhibitor; Rheumatoid arthritis; Placebo; Post-hoc analysis; Adverse effect; Infliximab; Incidence (geometry); Surgery; Tumor necrosis factor alpha","score_opus":0.026645035647207948,"score_gpt":0.32764688730724856,"score_spread":0.3010018516600406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092889157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98390824,0.01171117,0.000021875996,0.00054129254,0.000018836341,0.0010726947,0.0026762448,0.000036339014,0.000013293038],"genre_scores_gemma":[0.9675502,0.031930666,0.00004761657,0.00016657944,0.000004506893,0.00009270141,0.00018099164,0.0000241972,0.0000025458771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771094,0.000256215,0.00083012984,0.0003699837,0.00051440974,0.00031834692],"domain_scores_gemma":[0.99767035,0.00061707915,0.00045964515,0.0003575484,0.0004932751,0.00040209104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023920654,0.0003014996,0.0012363245,0.00054191035,0.00015526373,0.000044605426,0.00011398401,0.000059503767,0.00009592739],"category_scores_gemma":[0.0019517009,0.0002310221,0.00019039202,0.0011589023,0.0010496449,0.00027924296,0.0001232567,0.00015174522,0.0000011746586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020746917,0.015251644,0.77489895,0.0025832155,0.009574998,0.0001037575,0.011536626,0.00025638347,0.0016372222,0.0001829465,0.00052912097,0.1626982],"study_design_scores_gemma":[0.22969963,0.04416272,0.6748705,0.021381008,0.002106247,0.0000958717,0.009687824,0.0073690866,0.0077561527,0.00058359274,0.00070778694,0.0015796163],"about_ca_topic_score_codex":0.0003188159,"about_ca_topic_score_gemma":0.00047667846,"teacher_disagreement_score":0.20895271,"about_ca_system_score_codex":0.000014491463,"about_ca_system_score_gemma":0.00020149766,"threshold_uncertainty_score":0.9420808},"labels":[],"label_agreement":null},{"id":"W3093000184","doi":"10.1136/annrheumdis-2020-eular.2230","title":"OP0247 PERSISTENT PREMATURE MORTALITY GAP IN IDIOPATHIC INFLAMMATORY MYOPATHY: A GENERAL POPULATION-BASED COHORT STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Cohort; Hazard ratio; Polymyositis; Population; Dermatomyositis; Internal medicine; Proportional hazards model; Mortality rate; Cohort study; Pediatrics; Surgery; Confidence interval","score_opus":0.040516772768484074,"score_gpt":0.3000890249130376,"score_spread":0.25957225214455354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093000184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994215,0.0012724156,0.000006939104,0.0022170497,0.00013063119,0.0018834049,0.000053839354,0.00007493939,0.00014577922],"genre_scores_gemma":[0.99753433,0.000035181958,0.0000251555,0.0021138506,0.000080695216,0.00012295635,0.00003509791,0.00003243403,0.00002030345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724823,0.00035894974,0.0009090078,0.00034832652,0.0008288818,0.00030661435],"domain_scores_gemma":[0.99836296,0.000065075685,0.00039106765,0.00071141217,0.00018589942,0.00028356776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004655477,0.00027615525,0.0007671429,0.000094235846,0.00011611369,0.000036032357,0.00028280527,0.00008657081,0.000070237635],"category_scores_gemma":[0.00064744434,0.00020024007,0.00050557224,0.00032931447,0.00008323447,0.0001335432,0.00011037577,0.0002211222,0.000012815689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023180069,0.0004978831,0.99366677,0.0014942486,0.00023184562,0.000076651595,0.0010435663,0.0017979917,0.000021537518,0.00013626648,0.0005397194,0.00026174245],"study_design_scores_gemma":[0.0011694098,0.00020940581,0.9854531,0.0010314866,0.0003680283,0.000007902222,0.00062064343,0.010658761,0.00011036361,0.00015702625,0.000015995394,0.00019785392],"about_ca_topic_score_codex":0.00021711437,"about_ca_topic_score_gemma":0.00002712823,"teacher_disagreement_score":0.008860769,"about_ca_system_score_codex":0.00004248163,"about_ca_system_score_gemma":0.00027624058,"threshold_uncertainty_score":0.8165553},"labels":[],"label_agreement":null},{"id":"W3093065321","doi":"10.1136/annrheumdis-2020-eular.401","title":"SAT0421 GUSELKUMAB DEMONSTRATED AN INDEPENDENT TREATMENT EFFECT ON FATIGUE AFTER ADJUSTMENT FOR CLINICAL RESPONSE (ACR20) IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM PHASE-3 TRIALS DISCOVER 1 & 2","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Internal medicine; Psoriasis; Clinical trial; Physical therapy; Concomitant; Clinical endpoint; Arthritis; Phases of clinical research; Rheumatology; Dermatology; Alternative medicine; Pathology","score_opus":0.12597946982937208,"score_gpt":0.3752623223085817,"score_spread":0.24928285247920962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093065321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831737,0.003029295,0.000017341692,0.00060917105,0.00043610035,0.0026065863,0.010085648,0.00003685011,0.00000526917],"genre_scores_gemma":[0.9965695,0.0005761918,0.000054211647,0.00023162107,0.000042656895,0.0005422208,0.0019174322,0.000031710242,0.00003445311],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99365133,0.0038693475,0.0013705029,0.000588966,0.00015634272,0.00036349884],"domain_scores_gemma":[0.9940017,0.0044188746,0.00069817994,0.0006783026,0.00008051586,0.00012242368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093645736,0.0004318434,0.0012902203,0.0000852731,0.000100642355,0.000028019032,0.00028737946,0.00018617517,0.00013898377],"category_scores_gemma":[0.0023921086,0.00023526797,0.0005286386,0.00016162588,0.0001479444,0.0001410577,0.00004712412,0.000102026934,0.00004538716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4736193,0.0124791,0.04098537,0.00007463121,0.0047512157,0.000008911811,0.0017327454,0.00010994881,0.00019570286,0.000016841634,0.0018632525,0.46416298],"study_design_scores_gemma":[0.08993195,0.019912612,0.8795034,0.0012663559,0.0015718999,5.914605e-7,0.00015176795,0.000015464873,0.006687068,0.00015781596,0.0003661613,0.0004348659],"about_ca_topic_score_codex":0.00010641438,"about_ca_topic_score_gemma":0.00010397179,"teacher_disagreement_score":0.8385181,"about_ca_system_score_codex":0.000047687285,"about_ca_system_score_gemma":0.00017628263,"threshold_uncertainty_score":0.95939493},"labels":[],"label_agreement":null},{"id":"W3093094066","doi":"10.1136/annrheumdis-2020-eular.1745","title":"OP0211 TIME TO DISCONTINUATION OF TOFACITINIB AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT METHOTREXATE: DATA FROM A RHEUMATOID ARTHRITIS COHORT","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; University of Toronto; University Health Network","funders":"Sanofi; Pfizer; Amgen","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Golimumab; Discontinuation; Adalimumab; Internal medicine; Infliximab; Methotrexate; Abatacept; Etanercept; Surgery; Tumor necrosis factor alpha; Rituximab","score_opus":0.030076856861144845,"score_gpt":0.2857505919026203,"score_spread":0.25567373504147545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093094066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97781724,0.015975282,0.000035478246,0.0025753675,0.000032020445,0.0014142272,0.0020289833,0.000033774384,0.00008762659],"genre_scores_gemma":[0.956247,0.042430934,0.0005168526,0.00025962322,0.000013667221,0.00005573512,0.00042035957,0.000042628333,0.000013248937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971163,0.00026542688,0.00088250113,0.00056800374,0.0007999197,0.00036783624],"domain_scores_gemma":[0.9978581,0.00029712354,0.00036639272,0.00075317494,0.00023120875,0.0004939771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003832283,0.00030927346,0.0010708648,0.00014874162,0.00008922508,0.00007354835,0.00035104537,0.0000632428,0.00029507204],"category_scores_gemma":[0.0018454337,0.0002232982,0.00008533731,0.00039245773,0.00043606985,0.0004893609,0.00046973868,0.00015830083,0.000018404471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011734808,0.00048366582,0.7924055,0.00015711747,0.0004071837,0.000004600435,0.0014222447,0.000006518911,0.00016693315,0.000040887142,0.0030201925,0.20071171],"study_design_scores_gemma":[0.007366345,0.000864829,0.9734052,0.012970225,0.000019844072,0.000011599325,0.0005616655,0.0009926647,0.0018001589,0.0004715081,0.001138091,0.00039789872],"about_ca_topic_score_codex":0.000547569,"about_ca_topic_score_gemma":0.00012507854,"teacher_disagreement_score":0.20031382,"about_ca_system_score_codex":0.000008593496,"about_ca_system_score_gemma":0.0001449788,"threshold_uncertainty_score":0.9105836},"labels":[],"label_agreement":null},{"id":"W3094526031","doi":"10.1136/annrheumdis-2020-eular.4506","title":"THU0134 COGNITIVE IMPAIRMENT IN RHEUMATOID ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi; Pfizer","keywords":"Medicine; Rheumatoid factor; Montreal Cognitive Assessment; Rheumatoid arthritis; Erythrocyte sedimentation rate; Internal medicine; Cognition; Incidence (geometry); Population; Cognitive impairment; Physical therapy; Disease; Gerontology; Psychiatry","score_opus":0.039434035320143064,"score_gpt":0.3095509761264995,"score_spread":0.27011694080635645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094526031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95960283,0.023937548,0.0000165785,0.014695071,0.00006954421,0.00082050497,0.00011030076,0.00004902349,0.00069858925],"genre_scores_gemma":[0.93469834,0.06348413,0.000027149792,0.0016357242,0.000022978964,0.00006467437,0.000016495529,0.000023287423,0.000027224536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99809104,0.00016263203,0.0005296982,0.00023967393,0.0005840646,0.0003928879],"domain_scores_gemma":[0.99879724,0.00023662798,0.00015351993,0.00028005984,0.00015705467,0.0003754985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017933597,0.00018842757,0.0005427331,0.00008731095,0.00007663144,0.000031092077,0.00022960154,0.000039917086,0.0005369149],"category_scores_gemma":[0.0012432043,0.0001307679,0.000298153,0.0003847693,0.00028059553,0.00014730603,0.00014192628,0.0001631611,0.000089598165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004949493,0.004446161,0.37107313,0.0019559748,0.0015715604,0.00022701394,0.01427554,0.000064773136,0.00037219873,0.0038195052,0.05639554,0.54084915],"study_design_scores_gemma":[0.012598606,0.0020020148,0.9413938,0.01959207,0.000020805446,0.000091757276,0.0064723035,0.0012521106,0.0069934796,0.0062329224,0.0027502135,0.0005999226],"about_ca_topic_score_codex":0.000094567724,"about_ca_topic_score_gemma":0.000018071105,"teacher_disagreement_score":0.57032067,"about_ca_system_score_codex":0.000010948347,"about_ca_system_score_gemma":0.00020893966,"threshold_uncertainty_score":0.5878842},"labels":[],"label_agreement":null},{"id":"W3094693153","doi":"10.1136/annrheumdis-2020-eular.3908","title":"OP0230 EFFICACY AND SAFETY OF TILDRAKIZUMAB, A HIGH-AFFINITY ANTI–INTERLEUKIN-23P19 MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 2B STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Celgene; GlaxoSmithKline; Pfizer","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Psoriatic arthritis; Internal medicine; Tolerability; Adverse effect; Psoriasis; Arthritis; Immunology; Alternative medicine","score_opus":0.028727753255920856,"score_gpt":0.28895007390383304,"score_spread":0.2602223206479122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094693153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287444,0.0016297034,0.0000053043145,0.00019520972,0.00013641894,0.0046391217,0.00048012292,0.000020460455,0.000019215968],"genre_scores_gemma":[0.9991301,0.0004085753,0.000018217888,0.000039575694,0.000009592477,0.00020110837,0.00015806628,0.00002344626,0.000011372455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99732685,0.0007683401,0.0009898446,0.0004157558,0.00015126806,0.0003479315],"domain_scores_gemma":[0.9975119,0.0012845028,0.0006496013,0.00035978272,0.00011930267,0.000074885145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029318058,0.00037050204,0.0014862748,0.0001873924,0.00010180367,0.000017205099,0.0003366612,0.000105180174,0.0000731913],"category_scores_gemma":[0.0006024955,0.0002455293,0.00021819612,0.0003471335,0.00022632266,0.00017632828,0.00014932612,0.00016480348,0.000008673736],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8024287,0.010239233,0.113735475,0.00013354293,0.002470993,0.000012594478,0.0034214053,0.00018802563,0.00014941026,0.000026298881,0.000035680558,0.06715862],"study_design_scores_gemma":[0.5495859,0.0013382517,0.446248,0.0005170811,0.00035990225,0.0000013259954,0.00047238357,0.000036401838,0.0012264069,0.000026102718,0.000002540976,0.00018572985],"about_ca_topic_score_codex":0.00034567737,"about_ca_topic_score_gemma":0.00016661915,"teacher_disagreement_score":0.33251253,"about_ca_system_score_codex":0.00002123565,"about_ca_system_score_gemma":0.00012886699,"threshold_uncertainty_score":0.9999997},"labels":[],"label_agreement":null},{"id":"W3095080509","doi":"10.1136/annrheumdis-2019-eular.2577","title":"SAT0628 VALIDATION OF METHODS FOR PREDICTING LONG-TERM OUTCOME IN JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FOR CANADIAN AND NORDIC PREDICTION MODELS IN THE NORDIC COHORT","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Receiver operating characteristic; Cohort; Medicine; Outcome (game theory); Prospective cohort study; Statistics; Artificial intelligence; Pediatrics; Internal medicine; Mathematics; Computer science","score_opus":0.06976649163572546,"score_gpt":0.3775872533319766,"score_spread":0.30782076169625117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095080509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033546,0.004068485,0.00053181156,0.0013669428,0.00007929438,0.0032108026,0.00025095357,0.000009329973,0.0001468926],"genre_scores_gemma":[0.9985032,0.00076084404,0.00013598953,0.000106855885,0.000012637857,0.00031902202,0.000086939355,0.000016698945,0.000057805995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979763,0.00027190996,0.0010070308,0.00020810713,0.00025065662,0.00028597374],"domain_scores_gemma":[0.9984509,0.0005357483,0.00032188048,0.00044136515,0.00017024392,0.00007990788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002960809,0.00012708292,0.00055233215,0.00024195804,0.00008054768,0.000018828146,0.00020559628,0.00007688494,0.000005892113],"category_scores_gemma":[0.0019453224,0.00008666174,0.00016260872,0.00023861263,0.00008497509,0.00021290014,0.00003938484,0.00012398609,6.289456e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048757004,0.00016305575,0.9549041,0.0022216502,0.00009284648,7.5509024e-7,0.0013581989,0.0008893772,0.00006754492,0.00011680848,0.00018913239,0.03950901],"study_design_scores_gemma":[0.0029216714,0.00033202334,0.96562845,0.0027776784,0.000086989334,0.0000049190207,0.00069547567,0.025122268,0.00029576517,0.0020171325,0.000028206498,0.00008943807],"about_ca_topic_score_codex":0.0038130006,"about_ca_topic_score_gemma":0.0016469897,"teacher_disagreement_score":0.039419573,"about_ca_system_score_codex":0.000039218026,"about_ca_system_score_gemma":0.00039303303,"threshold_uncertainty_score":0.57641417},"labels":[],"label_agreement":null},{"id":"W3095475399","doi":"10.1136/annrheumdis-2020-eular.1644","title":"SAT0019 HISTOPATHOLOGICAL CHANGES OF SYNOVIAL TISSUE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF INHIBITORS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sierra Oncology; Medizinische Universität Innsbruck","keywords":"Medicine; Etanercept; Golimumab; Synovitis; Rheumatoid arthritis; Fibrosis; Infliximab; Pathology; Arthritis; H&E stain; Tumor necrosis factor alpha; Immunohistochemistry; Internal medicine","score_opus":0.02903570486772907,"score_gpt":0.27444970750816283,"score_spread":0.24541400264043375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095475399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870611,0.0077867555,0.0000033668848,0.0040215272,0.00004841544,0.0007056335,0.00013087926,0.00003766946,0.00020469158],"genre_scores_gemma":[0.9826954,0.01681143,0.000042561252,0.00030614957,0.000019416515,0.0000440854,0.00003522585,0.000025036277,0.00002068943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805313,0.00018169484,0.0005308241,0.00025903297,0.0006396734,0.0003356339],"domain_scores_gemma":[0.99878615,0.0001390641,0.00026686653,0.00032967053,0.0002102983,0.00026797657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013241683,0.0002144612,0.00073667744,0.000120839235,0.000055351105,0.0000139745025,0.00022891871,0.00006197872,0.00017473016],"category_scores_gemma":[0.00089990644,0.00013255287,0.00013620447,0.00042609815,0.00047848225,0.000097754244,0.00010507596,0.00013876498,0.000012424546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030873278,0.0024668393,0.6992351,0.000942219,0.00024839866,0.00008873039,0.0023315882,0.000020991405,0.000925008,0.00037355482,0.006694108,0.28358614],"study_design_scores_gemma":[0.008453943,0.005717787,0.9480533,0.009057834,0.00002067137,0.000034781184,0.0006337641,0.00010716218,0.02498902,0.0003957821,0.0021200033,0.00041595992],"about_ca_topic_score_codex":0.00015680914,"about_ca_topic_score_gemma":0.000051370323,"teacher_disagreement_score":0.2831702,"about_ca_system_score_codex":0.000015069241,"about_ca_system_score_gemma":0.00010756724,"threshold_uncertainty_score":0.5405349},"labels":[],"label_agreement":null},{"id":"W3095584460","doi":"10.1136/annrheumdis-2020-eular.529","title":"OP0225 TOFACITINIB AS MONOTHERAPY FOLLOWING METHOTREXATE WITHDRAWAL IN PATIENTS WITH PSORIATIC ARTHRITIS PREVIOUSLY TREATED WITH OPEN-LABEL TOFACITINIB + METHOTREXATE: A RANDOMISED, PLACEBO-CONTROLLED SUBSTUDY OF OPAL BALANCE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); University of Toronto","funders":"Celgene; Gilead Sciences; Pfizer; Amgen","keywords":"Tofacitinib; Medicine; Placebo; Psoriatic arthritis; Internal medicine; Methotrexate; Clinical endpoint; Gastroenterology; Arthritis; Randomized controlled trial; Surgery; Rheumatoid arthritis","score_opus":0.03334244674960742,"score_gpt":0.31895581476280765,"score_spread":0.28561336801320025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095584460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877402,0.0027057745,0.000051784362,0.00083178096,0.00002369934,0.007931859,0.00010174805,0.000043311695,0.0005698527],"genre_scores_gemma":[0.99742603,0.00063050847,0.0004113435,0.00051419897,0.000008111506,0.00070365553,0.00007023627,0.000074704665,0.00016121258],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955575,0.00091573014,0.0013674148,0.00051281473,0.0010701253,0.0005764058],"domain_scores_gemma":[0.99710375,0.0006240848,0.0009048304,0.0007169838,0.00034872035,0.00030164013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088826497,0.00047930385,0.002547477,0.000162241,0.00012973564,0.00007380745,0.0007124341,0.000081251426,0.0002492118],"category_scores_gemma":[0.0015167216,0.00028435417,0.0003368363,0.00084574404,0.00024595467,0.00040225696,0.00015446266,0.00025214502,0.000008264564],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5055349,0.005553924,0.42424935,0.001472898,0.0064518363,0.00009864991,0.005574369,0.00034990985,0.00021833212,0.0001145374,0.00046007254,0.049921233],"study_design_scores_gemma":[0.80363125,0.006699686,0.1723507,0.007705975,0.0011416811,0.0000071761015,0.0016615203,0.0028260385,0.00285584,0.00024246435,0.00009838718,0.0007792639],"about_ca_topic_score_codex":0.00028790705,"about_ca_topic_score_gemma":0.000022739237,"teacher_disagreement_score":0.2980964,"about_ca_system_score_codex":0.000024440413,"about_ca_system_score_gemma":0.00051666773,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W3096035386","doi":"10.1136/annrheumdis-2019-eular.3382","title":"OP0128 SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE CHARACTERISTICS ASSOCIATED WITH THE TYPE I INTERFERON GENE SIGNATURE: BASELINE DATA OF THE SLE PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Observational study; Internal medicine; Cohort; Prospective cohort study; Cohort study; Systemic lupus erythematosus; Disease","score_opus":0.0647781183513655,"score_gpt":0.3252029898681976,"score_spread":0.26042487151683213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096035386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896768,0.0017269182,0.000017198287,0.0013881124,0.0005758607,0.005555354,0.00096620194,0.00003639281,0.000057176203],"genre_scores_gemma":[0.99710536,0.000099378965,0.000008235971,0.00017897354,0.00005437799,0.00012978676,0.00026401007,0.000057881203,0.002101992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995782,0.000751748,0.0008338231,0.00048456257,0.0017934942,0.00035435442],"domain_scores_gemma":[0.99329054,0.001212072,0.0009821756,0.003098549,0.0012417198,0.0001749431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016382012,0.00032033352,0.00088053616,0.0000727675,0.0001498883,0.000040643074,0.0015970098,0.00006872176,0.00013462179],"category_scores_gemma":[0.0043637473,0.00014094007,0.00020028697,0.00072868075,0.00028841337,0.00015501541,0.00076465355,0.00028186114,0.000020131036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013869677,0.0012910328,0.98711693,0.0014205412,0.0015532707,0.000006356708,0.00066612207,0.000050658313,0.00015175166,0.000082095044,0.006201164,0.00007312272],"study_design_scores_gemma":[0.0018569046,0.00037297135,0.9846464,0.0063446816,0.0010095827,0.00016179279,0.0016623767,0.0035017116,0.0001432376,0.00009631214,0.000017871173,0.00018620545],"about_ca_topic_score_codex":0.00003821111,"about_ca_topic_score_gemma":0.000013427693,"teacher_disagreement_score":0.007428578,"about_ca_system_score_codex":0.00009934791,"about_ca_system_score_gemma":0.0007861277,"threshold_uncertainty_score":0.57473695},"labels":[],"label_agreement":null},{"id":"W3096215873","doi":"10.1136/annrheumdis-2020-eular.5189","title":"THU0105 ISOTOPE-LABELING-LC-MS-BASED METABOLIC PROFILING OF MULTIPLE SERUM SAMPLE SETS FOR THE DISCOVERY OF HIGH-CONFIDENCE RHEUMATOID ARTHRITIS BIOMARKERS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cohort; Biomarker; Rheumatoid arthritis; Metabolite; Confidence interval; Biomarker discovery; Internal medicine; Immunology; Proteomics; Chemistry; Biochemistry","score_opus":0.032287068458343955,"score_gpt":0.28025662886741676,"score_spread":0.2479695604090728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096215873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.956042,0.032481767,0.005616933,0.002216789,0.00016456266,0.0008365323,0.002622687,0.000008583793,0.000010179496],"genre_scores_gemma":[0.9855567,0.011737456,0.00214858,0.00035127383,0.000024872103,0.000082892984,0.00006739571,0.00002299761,0.000007792907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984932,0.00009060894,0.0006170042,0.00028997028,0.00024891892,0.0002603273],"domain_scores_gemma":[0.9980197,0.0005197485,0.00059331144,0.0005625419,0.0002347195,0.00007001009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002977329,0.00021467882,0.0005643491,0.000040296098,0.00012624991,0.00002212844,0.0005570611,0.00005470271,0.00001119644],"category_scores_gemma":[0.0031297416,0.00013564037,0.0004348392,0.00022461049,0.00028952488,0.000014502614,0.00022601381,0.000048603008,4.4430678e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039044877,0.0017041935,0.08144057,0.0049927253,0.0099598,0.0000012279274,0.00077672204,0.0063285157,0.8052218,0.017511055,0.013182257,0.05497665],"study_design_scores_gemma":[0.0013569703,0.00028073348,0.015790971,0.000334636,0.00014455974,6.7367426e-7,0.00040880273,0.0027743378,0.97607136,0.001886768,0.00071372295,0.00023646899],"about_ca_topic_score_codex":0.00021758983,"about_ca_topic_score_gemma":0.000036848713,"teacher_disagreement_score":0.17084956,"about_ca_system_score_codex":0.000002082965,"about_ca_system_score_gemma":0.00016324918,"threshold_uncertainty_score":0.5531254},"labels":[],"label_agreement":null},{"id":"W3096532005","doi":"10.1136/annrheumdis-2020-218221","title":"Do autoantibody-responses mature between presentation with arthralgia suspicious for progression to rheumatoid arthritis and development of clinically apparent inflammatory arthritis? A longitudinal serological study","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Commission; H2020 European Research Council; Arthritis Society; ReumaNederland; Dutch Arthritis Society","keywords":"Autoantibody; Medicine; Rheumatoid arthritis; Arthritis; Immunology; Asymptomatic; Rheumatoid factor; Serology; Antibody; Internal medicine","score_opus":0.08686788881592371,"score_gpt":0.38916803531192395,"score_spread":0.30230014649600023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096532005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93034464,0.0048582153,0.00021516855,0.05605167,0.00010389718,0.008031123,0.00030996912,0.00007870797,0.000006607235],"genre_scores_gemma":[0.9901305,0.00137199,0.0018497704,0.0048031956,0.00023212816,0.001196864,0.00024673718,0.00011108432,0.000057764508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938367,0.0006581413,0.002214455,0.00081592577,0.0018739728,0.00060081703],"domain_scores_gemma":[0.995108,0.0016684165,0.0012965437,0.00085797196,0.0006908299,0.00037820888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082174764,0.0005912526,0.0020755534,0.00027777866,0.00020420806,0.00008785344,0.00053668476,0.0003404234,0.000032906457],"category_scores_gemma":[0.002132059,0.00035563848,0.0003147816,0.000275877,0.00039558046,0.00009668009,0.00046867842,0.00066971115,0.000007939968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005211134,0.00085061206,0.8365168,0.011206087,0.0019742707,0.00023700536,0.0040289047,0.000005710163,0.000021077794,0.000005777861,0.09444162,0.045500975],"study_design_scores_gemma":[0.0165813,0.013639185,0.8050191,0.14752279,0.0008068033,0.0014351471,0.0056153997,0.00006806722,0.0010950401,0.00066456624,0.0059253173,0.0016273136],"about_ca_topic_score_codex":0.000007273454,"about_ca_topic_score_gemma":0.000011687023,"teacher_disagreement_score":0.13631672,"about_ca_system_score_codex":0.00003735983,"about_ca_system_score_gemma":0.00082738645,"threshold_uncertainty_score":0.99988955},"labels":[],"label_agreement":null},{"id":"W3096555872","doi":"10.1136/annrheumdis-2019-eular.3711","title":"SAT0568 THE IMPACT OF ARTHRITIS ON UTILIZATION OF MENTAL HEALTH TREATMENT FOR COMORBID MENTAL DISORDERS: FINDINGS FROM A NATIONALLY REPRESENTATIVE MENTAL HEALTH SURVEY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Mental health; Anxiety; Psychiatry; Depression (economics); Bipolar disorder; Prevalence of mental disorders; Comorbidity; Mood disorders; Population; Mood; Clinical psychology; Environmental health","score_opus":0.18186838485920873,"score_gpt":0.4989000077141784,"score_spread":0.31703162285496966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096555872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951351,0.0032765507,0.000016840604,0.012401443,0.0003986033,0.0051887366,0.027298817,0.000014851911,0.000053176274],"genre_scores_gemma":[0.98745024,0.008842804,0.00002558788,0.00058798457,0.000032946664,0.00007924274,0.0028223388,0.00002551612,0.00013332244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961382,0.0015357549,0.0011171377,0.00026385474,0.00054166553,0.0004033982],"domain_scores_gemma":[0.99624944,0.001603765,0.0013634387,0.000431586,0.00018101312,0.00017073493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008628238,0.00022643752,0.0006659685,0.00009371174,0.00054047885,0.000006172237,0.00028160648,0.000060545186,0.00030431972],"category_scores_gemma":[0.00030418063,0.00013387288,0.0003846906,0.0002486954,0.00011825255,0.00011161845,0.00008992266,0.00011547908,0.000010266459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001792032,0.0016893691,0.8123646,0.00076950196,0.00047488647,3.6715235e-8,0.030708302,0.000059569298,0.000008734101,0.00045702676,0.12634233,0.025333643],"study_design_scores_gemma":[0.0029178981,0.0015599186,0.9846457,0.002094401,0.000014148885,1.6040167e-7,0.0069800024,0.0005298586,0.000040787236,0.00091543305,0.00018399916,0.000117643205],"about_ca_topic_score_codex":0.0216541,"about_ca_topic_score_gemma":0.0023671521,"teacher_disagreement_score":0.17228118,"about_ca_system_score_codex":0.000260304,"about_ca_system_score_gemma":0.0013178026,"threshold_uncertainty_score":0.9848608},"labels":[],"label_agreement":null},{"id":"W3096865564","doi":"10.1136/annrheumdis-2020-eular.6264","title":"OP0079 PRELIMINARY DEFINITION OF A POSITIVE MRI FOR STRUCTURAL LESIONS IN THE SACROILIAC JOINTS IN AXIAL SPONDYLOARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Celgene; Pfizer; Eli Lilly and Company","keywords":"Medicine; Axial spondyloarthritis; Lesion; Radiology; Quadrant (abdomen); Confidence interval; Sacroiliac joint; Target lesion; Gold standard (test); Magnetic resonance imaging; Sacroiliitis; Internal medicine; Surgery","score_opus":0.06028293117947602,"score_gpt":0.3165147656064234,"score_spread":0.25623183442694736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096865564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641694,0.0038596583,0.000004956797,0.0075242002,0.000057571477,0.0011076587,0.0008230856,0.000006962703,0.00019894385],"genre_scores_gemma":[0.9980512,0.0008644818,0.00018832737,0.0006833741,0.000021169024,0.0001056645,0.000069197326,0.000011295254,0.0000052844293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988718,0.00010619642,0.0004152133,0.00016117268,0.00024899727,0.00019661593],"domain_scores_gemma":[0.9991045,0.0003763254,0.00016378937,0.00020771426,0.000086111,0.00006153448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009953226,0.00013521417,0.00040598994,0.000054658736,0.000074900134,0.00000723442,0.00013927642,0.000033958604,0.0000345753],"category_scores_gemma":[0.00065360684,0.00008237188,0.00024319506,0.0002368677,0.00014558864,0.00006812251,0.00006910719,0.00007053133,0.0000023486962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040239997,0.009362867,0.4248865,0.008290728,0.0025552674,0.000617733,0.06977496,0.00031090857,0.0009262429,0.023841178,0.031170562,0.38802305],"study_design_scores_gemma":[0.0040669004,0.0014686619,0.9801954,0.0024288965,0.00015879226,0.000021229409,0.0026692308,0.00018327423,0.0006071476,0.008077984,0.000021954287,0.00010051103],"about_ca_topic_score_codex":0.00014569765,"about_ca_topic_score_gemma":0.000060458056,"teacher_disagreement_score":0.55530894,"about_ca_system_score_codex":0.000011627663,"about_ca_system_score_gemma":0.000062471874,"threshold_uncertainty_score":0.33590278},"labels":[],"label_agreement":null},{"id":"W3096902844","doi":"10.1136/annrheumdis-2020-218412","title":"Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Research Manitoba","funders":"Regeneron Pharmaceuticals; Genentech; Celgene; Gilead Sciences; AbbVie; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Adverse effect; Internal medicine; Placebo","score_opus":0.020069236617466506,"score_gpt":0.2698751059644152,"score_spread":0.2498058693469487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096902844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849046,0.009839718,0.000018009336,0.004083087,0.000038927432,0.0009378809,0.00011262834,0.000039932263,0.00002525618],"genre_scores_gemma":[0.9942515,0.0052779657,0.00007676889,0.00029748102,0.00001674311,0.000019788731,0.000021339369,0.00003432346,0.0000040748796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975997,0.00030697533,0.0006183749,0.00035721622,0.00070964143,0.00040806894],"domain_scores_gemma":[0.9982649,0.0006511961,0.0001893665,0.00032366166,0.00009965317,0.0004712106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041252104,0.0002574864,0.00069350854,0.00013710148,0.00021402328,0.000072264986,0.00016075168,0.000051783794,0.000019037025],"category_scores_gemma":[0.0019225186,0.00017659793,0.0001229899,0.00034892056,0.00022803627,0.00022055928,0.00020237493,0.0002139016,0.000003012161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011657848,0.0007246916,0.7923997,0.00039118994,0.00039078266,0.000038079666,0.004305096,0.000016886515,0.000098258184,0.0000942734,0.0002424541,0.18964073],"study_design_scores_gemma":[0.011500113,0.001254256,0.9795486,0.0060225273,0.000014419561,0.0000049653895,0.00059647975,0.00007593446,0.00027365636,0.00011180871,0.00038225806,0.00021498273],"about_ca_topic_score_codex":0.000057676156,"about_ca_topic_score_gemma":0.000008088251,"teacher_disagreement_score":0.18942575,"about_ca_system_score_codex":0.000016561056,"about_ca_system_score_gemma":0.00015820598,"threshold_uncertainty_score":0.72014546},"labels":[],"label_agreement":null},{"id":"W3096955495","doi":"10.1136/annrheumdis-2020-eular.809","title":"THU0614-HPR ASSESSING THE EFFECT OF INTERVENTIONS FOR AXIAL SPONDYLOARTHRITIS ACCORDING TO THE ENDORSED ASAS/OMERACT CORE OUTCOME SET: A META-RESEARCH STUDY OF TRIALS INCLUDED IN COCHRANE REVIEWS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Meta-analysis; Physical therapy; Outcome (game theory); Psychological intervention; Core (optical fiber); Randomized controlled trial; Family medicine; Internal medicine; Psychiatry","score_opus":0.6534601328205566,"score_gpt":0.5889375108664343,"score_spread":0.06452262195412228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096955495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96045643,0.025305232,0.000018576853,0.0052003385,0.00015486107,0.008449182,0.00036971128,0.000010249646,0.00003543594],"genre_scores_gemma":[0.99739146,0.00090339815,0.0000356913,0.00014965281,0.000050614522,0.0013970488,0.000019257455,0.000025756253,0.000027097476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939534,0.002543441,0.0020512696,0.0002973301,0.000817229,0.0003373047],"domain_scores_gemma":[0.9890094,0.008842112,0.0009869409,0.0007286561,0.0003067007,0.00012618295],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0070852395,0.00027490812,0.002840038,0.0001620989,0.00028525636,0.000039147948,0.0005402323,0.000036227826,0.00010606088],"category_scores_gemma":[0.03155157,0.0001172961,0.0017719915,0.0008736453,0.00017698415,0.000100832265,0.00040221584,0.00018899652,0.000005259112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012737413,0.009360183,0.5822896,0.025653025,0.026643937,0.00007768428,0.027644277,0.00035898277,0.0013504454,0.00024320107,0.011052794,0.30258846],"study_design_scores_gemma":[0.06551344,0.037020218,0.7423025,0.050749402,0.035301257,0.000062485116,0.057292435,0.0006684721,0.007818514,0.0010310588,0.0012495809,0.00099066],"about_ca_topic_score_codex":0.0004369135,"about_ca_topic_score_gemma":0.00016500667,"teacher_disagreement_score":0.3015978,"about_ca_system_score_codex":0.000022273465,"about_ca_system_score_gemma":0.000065417684,"threshold_uncertainty_score":0.9766061},"labels":[],"label_agreement":null},{"id":"W3097150570","doi":"10.1136/annrheumdis-2019-eular.6761","title":"SAT0664 RESPONSIVENESS OF PATIENT-REPORTED PHYSICAL FUNCTION OUTCOME MEASURES IN A REAL LIFE INTERNATIONAL COHORT OF 405 PATIENTS WITH PSORIATIC ARTHRITIS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Prom; Physical therapy; Quality of life (healthcare); Patient-reported outcome; Cohort; Longitudinal study; Internal medicine; Arthritis; Pathology","score_opus":0.024033703499425157,"score_gpt":0.2891555361830576,"score_spread":0.26512183268363243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097150570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816394,0.00038137962,0.0000017284724,0.0001468703,0.0002234059,0.00078978407,0.00010137806,0.00000892674,0.00018256278],"genre_scores_gemma":[0.9995485,0.0002573873,0.0000127809335,0.00005324875,0.000009943965,0.000040475163,0.000040299674,0.0000140400125,0.000023330374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982274,0.00008410795,0.00063502614,0.0001752951,0.00073802524,0.00014010747],"domain_scores_gemma":[0.99838006,0.00015293954,0.00057803723,0.0003559517,0.00046386514,0.00006912434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009944867,0.00014335217,0.0006304591,0.00011104161,0.000022139837,0.000003822327,0.00009271244,0.000028127157,0.000046913323],"category_scores_gemma":[0.00066738884,0.00009175749,0.00018711656,0.00020124705,0.00010764334,0.00008252323,0.00006144045,0.000049733233,0.0000030017263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003121343,0.0018170114,0.98102915,0.00019930322,0.0009825197,0.0000032878422,0.00031375783,0.000052828538,0.000015989172,0.00011707103,0.000057082903,0.01229067],"study_design_scores_gemma":[0.004180392,0.0009177018,0.99216104,0.0016902863,0.00023246421,0.0000012895335,0.00030542715,0.000032956883,0.00016667828,0.00022587794,0.000010167417,0.000075714794],"about_ca_topic_score_codex":0.0003129051,"about_ca_topic_score_gemma":0.000031457803,"teacher_disagreement_score":0.012214955,"about_ca_system_score_codex":0.000021107526,"about_ca_system_score_gemma":0.000102299215,"threshold_uncertainty_score":0.37417617},"labels":[],"label_agreement":null},{"id":"W3097200549","doi":"10.1136/annrheumdis-2020-eular.2002","title":"OP0065 INTER-RATER RELIABILITY AND VALIDITY OF MEDIAL AND LATERAL FEMORAL BONE MARROW LESIONS IN PATIENTS WITH OSTEOARTHRITIS UNDERGOING TIBIAL OSTEOTOMY USING THE KNEE INFLAMMATION MRI SCORING SYSTEM (KIMRISS)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Osteoarthritis; High tibial osteotomy; Intraclass correlation; Femur; Nuclear medicine; Confidence interval; Magnetic resonance imaging; Osteotomy; Sagittal plane; Surgery; Radiology; Pathology; Internal medicine","score_opus":0.03155705379813973,"score_gpt":0.2578510337683084,"score_spread":0.2262939799701687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097200549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761206,0.00024598732,0.000028255581,0.0008890555,0.00009541352,0.0010350082,0.00005697483,0.000018824163,0.000018418965],"genre_scores_gemma":[0.9996547,0.000031963587,0.00017069175,0.00005038899,0.00003525195,0.0000169711,0.000019230938,0.000015919073,0.000004887445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986791,0.00018967486,0.00045215228,0.00020453014,0.00029976398,0.00017478703],"domain_scores_gemma":[0.9990719,0.00015497477,0.0002977923,0.00024090313,0.000110265544,0.00012415266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018987944,0.00016497188,0.00042047084,0.000052324707,0.00009587254,0.000030271587,0.000068992405,0.000044453278,0.000008686428],"category_scores_gemma":[0.0002677132,0.00009756502,0.00007591499,0.00013061478,0.0001629448,0.00020859917,0.00013369958,0.00008484185,6.20811e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018412943,0.0001942341,0.96339273,0.002591822,0.0000732087,0.000014478017,0.0025539468,0.000090449445,0.00058780704,0.0001571094,0.000021055203,0.028481888],"study_design_scores_gemma":[0.017914478,0.0053349943,0.9418312,0.01834835,0.0007280785,0.000028434031,0.0024211723,0.0022071947,0.010111519,0.00064938416,0.00000953453,0.00041569705],"about_ca_topic_score_codex":0.000055199518,"about_ca_topic_score_gemma":0.00005445781,"teacher_disagreement_score":0.02806619,"about_ca_system_score_codex":0.000021570959,"about_ca_system_score_gemma":0.000073723124,"threshold_uncertainty_score":0.3978586},"labels":[],"label_agreement":null},{"id":"W3097229464","doi":"10.1136/annrheumdis-2020-218398","title":"Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Western University","funders":"National Institute for Health and Care Research; AbbVie; Eli Lilly and Company","keywords":"Medicine; Clinical trial; Task force; Adverse effect; Alternative medicine; Systematic review; Intensive care medicine; Family medicine; MEDLINE; Pharmacology; Internal medicine; Pathology","score_opus":0.07099216814092557,"score_gpt":0.3688703484656508,"score_spread":0.29787818032472524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097229464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003935961,0.9818689,0.0000056696967,0.0035287582,0.00014762605,0.0071514044,0.003307424,0.000039427414,0.000014813956],"genre_scores_gemma":[0.0045384266,0.9933639,0.00005862701,0.00015256004,0.00006240831,0.0014915881,0.00017979555,0.000083373125,0.00006932926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648863,0.00036373595,0.0015061107,0.0003816512,0.0007797052,0.0004801708],"domain_scores_gemma":[0.9941742,0.0028663746,0.0009678919,0.001036039,0.0004301292,0.0005253585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021785518,0.000579438,0.0024810405,0.00017468493,0.00016249454,0.000045282064,0.00036932877,0.00007330067,0.00009178671],"category_scores_gemma":[0.0017482132,0.00026277697,0.0013172786,0.00036262363,0.0006298175,0.000043700857,0.00011210067,0.00010950824,0.000026187223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017151467,0.0018554426,0.00026342613,0.031520437,0.0075017405,0.00007111865,0.0007896482,0.0000071486616,0.0000019670365,0.00014004817,0.015576096,0.9405578],"study_design_scores_gemma":[0.0032684703,0.0029714154,0.00057121966,0.06202664,0.0014827028,0.000025121335,0.00068896235,0.00002415668,0.00010964761,0.00019629125,0.9282533,0.0003821063],"about_ca_topic_score_codex":0.00009007029,"about_ca_topic_score_gemma":0.00001661858,"teacher_disagreement_score":0.94017565,"about_ca_system_score_codex":0.00007141196,"about_ca_system_score_gemma":0.0016099868,"threshold_uncertainty_score":0.9999824},"labels":[],"label_agreement":null},{"id":"W3097508704","doi":"10.1136/annrheumdis-2020-eular.4600","title":"AB0598 THE INCREASING USE OF IMMUNOSUPPRESSANTS IN EARLY SYSTEMIC SCLEROSIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University","funders":"","keywords":"Medicine; Azathioprine; Scleroderma (fungus); Cyclophosphamide; Internal medicine; Methotrexate; Interstitial lung disease; Systemic scleroderma; Connective tissue disease; Disease; Surgery; Gastroenterology; Chemotherapy; Autoimmune disease; Lung; Immunology","score_opus":0.13716685825887412,"score_gpt":0.2866724037319717,"score_spread":0.1495055454730976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097508704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778379,0.019289808,0.0000028125894,0.001901284,0.000100850906,0.00067835185,0.00010264984,0.00003654549,0.00004975595],"genre_scores_gemma":[0.9957832,0.0034958613,0.000012504621,0.0006080769,0.000025194342,0.000024662346,0.0000045864426,0.0000297391,0.000016185204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978754,0.00038443715,0.00081883615,0.00019242367,0.0005034454,0.00022547999],"domain_scores_gemma":[0.9979344,0.0006652077,0.00046468986,0.0006166532,0.00015464326,0.00016439133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026379555,0.00017415838,0.0005827543,0.000064793465,0.00006841088,0.00003095689,0.0003660157,0.00006706425,0.000031456544],"category_scores_gemma":[0.0021718927,0.00009006878,0.00038095933,0.00045484165,0.0002146664,0.00014184126,0.00014465667,0.00011811887,0.000011713385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021092151,0.0011625207,0.94143903,0.004789061,0.001448769,0.000009922053,0.005846985,0.0010131784,0.01716743,0.00023936917,0.008449023,0.016325474],"study_design_scores_gemma":[0.00094407395,0.00009403945,0.9695366,0.024213443,0.00035899892,0.000012183553,0.0009541425,0.00060366286,0.0031056704,0.0000570669,0.0000126920095,0.00010743031],"about_ca_topic_score_codex":0.00080752576,"about_ca_topic_score_gemma":0.0000013413472,"teacher_disagreement_score":0.028097544,"about_ca_system_score_codex":0.000012370945,"about_ca_system_score_gemma":0.000120598175,"threshold_uncertainty_score":0.36728984},"labels":[],"label_agreement":null},{"id":"W3097670425","doi":"10.1136/annrheumdis-2020-eular.1044","title":"OP0306 CD11C-SPECIFIC ABLATION OF SHP1 INDUCES AUTOIMMUNE SIALADENITIS SIMILAR TO SJÖGREN'S SYNDROME","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Pfizer","keywords":"CD11c; Protein tyrosine phosphatase; Conditional gene knockout; Immune system; Immunology; Autoimmunity; Biology; Medicine; Cell biology; Phenotype; Signal transduction; Genetics; Gene","score_opus":0.04607562992102936,"score_gpt":0.2679257322105422,"score_spread":0.22185010228951285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097670425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845796,0.007308104,0.000036052093,0.006864657,0.00039960875,0.00030814676,0.00020960848,0.000036217476,0.00025798887],"genre_scores_gemma":[0.99862117,0.0005086908,0.00002484115,0.00062880636,0.000013542935,0.00002231597,0.0000425201,0.000014319685,0.00012382014],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99874806,0.00021129368,0.0004939876,0.00022728782,0.00007011555,0.00024924875],"domain_scores_gemma":[0.9990148,0.00015503168,0.0003122861,0.00035255277,0.00011769615,0.000047643523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009808278,0.00016733726,0.00047879724,0.000066609944,0.00010443385,0.000009125861,0.00048393916,0.00011436885,0.0008711215],"category_scores_gemma":[0.00026584536,0.00012187623,0.00021568856,0.00029427922,0.00021963342,0.00006873097,0.00017138252,0.00011330749,0.00009689681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025181973,0.0021807074,0.02862271,0.0020285363,0.0044669183,0.000027332278,0.015140008,0.0014883945,0.49778253,0.008294728,0.17454998,0.26289997],"study_design_scores_gemma":[0.0014200144,0.0013482455,0.8695801,0.0008011707,0.00019912857,0.000052398005,0.0011697513,0.000019590327,0.10679766,0.0021686107,0.015954033,0.0004893405],"about_ca_topic_score_codex":0.00007144101,"about_ca_topic_score_gemma":0.0000032103942,"teacher_disagreement_score":0.84095734,"about_ca_system_score_codex":0.00000825349,"about_ca_system_score_gemma":0.000070513015,"threshold_uncertainty_score":0.95381695},"labels":[],"label_agreement":null},{"id":"W3097773625","doi":"10.1136/annrheumdis-2020-218510","title":"Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"AbbVie","keywords":"Medicine; Rheumatoid arthritis; Adalimumab; Adverse effect; Internal medicine; Placebo; Methotrexate; Surgery; Pathology","score_opus":0.06645929143838296,"score_gpt":0.36463657106777914,"score_spread":0.29817727962939616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097773625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96917707,0.019911302,0.00015951422,0.008303748,0.000060374052,0.0013391298,0.00083668117,0.00005451407,0.00015768898],"genre_scores_gemma":[0.9570502,0.04173188,0.0001736271,0.00061502215,0.00003197427,0.00008258906,0.00027036143,0.000024759154,0.00001958511],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960137,0.0007371652,0.00165783,0.00037209975,0.0007490064,0.00047022625],"domain_scores_gemma":[0.99685067,0.0011570611,0.0005497201,0.00070535694,0.00035429426,0.00038290958],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008493819,0.00025746896,0.0013501132,0.00011899016,0.00010647717,0.000042043604,0.00057063455,0.000082548715,0.0010204224],"category_scores_gemma":[0.004173473,0.00014482641,0.0009014758,0.0017511372,0.0006668005,0.0001332666,0.00015280953,0.00036003397,0.000019916277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007657717,0.0044584963,0.24547373,0.00027016876,0.006998309,0.000027727096,0.0037424741,0.000044137014,0.00014051868,0.00050946325,0.013922129,0.71675515],"study_design_scores_gemma":[0.05451775,0.003940463,0.86499673,0.014722012,0.0006628642,0.00002142455,0.012079618,0.027314084,0.0068389224,0.0026968904,0.011180612,0.0010286277],"about_ca_topic_score_codex":0.0009594661,"about_ca_topic_score_gemma":0.00018606515,"teacher_disagreement_score":0.7157265,"about_ca_system_score_codex":0.000011983537,"about_ca_system_score_gemma":0.00048171284,"threshold_uncertainty_score":0.9998928},"labels":[],"label_agreement":null},{"id":"W3097928759","doi":"10.1136/annrheumdis-2001.426","title":"SAT0051 Cox-2 specific inhibition with mk-0663 120 mg q. d. over 4 weeks did not increase faecal blood loss: a controlled study with placebo and ibuprofen 800 mg t.i.d","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Oral and gingival health research","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Placebo; Ibuprofen; Internal medicine; Gastroenterology; Osteoarthritis; Whole blood; Anesthesia; Pharmacology; Pathology","score_opus":0.08378156063364764,"score_gpt":0.41499265027907173,"score_spread":0.3312110896454241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097928759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872551,0.0009424555,0.000012408639,0.0052071963,0.00009713824,0.00532887,0.00022588685,0.0000818687,0.00084905425],"genre_scores_gemma":[0.99544513,0.0008995027,0.000032393196,0.0011049771,0.00012461394,0.00063069334,0.000026262658,0.000053059295,0.001683374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99482536,0.0016217793,0.00096587086,0.0005022515,0.0011487446,0.0009359992],"domain_scores_gemma":[0.99592227,0.0017161656,0.0005931169,0.0007455727,0.0003992565,0.00062363193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013886491,0.00038993687,0.0010118755,0.0001825574,0.0010703959,0.000050575884,0.00031887233,0.0001159672,0.0006539777],"category_scores_gemma":[0.0004960991,0.00020877337,0.00013906352,0.00048017708,0.0004019726,0.0002869613,0.00030776885,0.0005798943,0.000063950545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08367049,0.0069519426,0.8804354,0.003572176,0.0010275127,0.0002723341,0.0050268234,0.000024573104,0.00006107488,0.0010150836,0.012416797,0.005525775],"study_design_scores_gemma":[0.050998136,0.003837179,0.92629874,0.0061499365,0.00052469276,0.00003308532,0.008875371,0.00048310662,0.000057105448,0.001369297,0.0007870594,0.00058631715],"about_ca_topic_score_codex":0.001577969,"about_ca_topic_score_gemma":0.00042073554,"teacher_disagreement_score":0.045863297,"about_ca_system_score_codex":0.00004397936,"about_ca_system_score_gemma":0.0005397152,"threshold_uncertainty_score":0.8513531},"labels":[],"label_agreement":null},{"id":"W3098712408","doi":"10.1136/annrheumdis-2020-218467","title":"Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Tocilizumab; Clinical endpoint; Placebo; Internal medicine; Population; Placebo-controlled study; Rheumatology; Randomized controlled trial; Surgery; Rheumatoid arthritis; Double blind; Pathology","score_opus":0.05317174957570712,"score_gpt":0.296736064358537,"score_spread":0.2435643147828299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098712408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98385674,0.0008181119,0.000027960828,0.008695444,0.0002519251,0.005186755,0.000034931378,0.000043556047,0.0010845836],"genre_scores_gemma":[0.997491,0.00019760228,0.000030931686,0.0015082851,0.0000591394,0.0003972195,0.0000900824,0.000018754059,0.00020700417],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983993,0.00016525347,0.0006867544,0.00021655136,0.0003250845,0.00020703196],"domain_scores_gemma":[0.9988242,0.00036336525,0.00027211464,0.0002650821,0.00007833894,0.00019691854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021311281,0.00018139587,0.0007797205,0.00010072315,0.000057369634,0.000022861468,0.000100124525,0.00006412906,0.00054568355],"category_scores_gemma":[0.0009219764,0.00011404895,0.00046892627,0.00029954125,0.000072977215,0.00011550706,0.000060001334,0.00012667273,0.00003621305],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98755854,0.0011223337,0.0009318044,0.0003609284,0.0002969703,0.000010718393,0.00064705097,0.000060624065,0.000039535225,0.000025846935,0.007888695,0.0010569647],"study_design_scores_gemma":[0.99312115,0.0005174231,0.0034512077,0.0008524914,0.00036620433,0.000006965408,0.0004552672,0.00076720305,0.00010770012,0.0001357784,0.00008412365,0.00013448608],"about_ca_topic_score_codex":0.000041768624,"about_ca_topic_score_gemma":0.0000055733212,"teacher_disagreement_score":0.01363425,"about_ca_system_score_codex":0.000019894498,"about_ca_system_score_gemma":0.00018385016,"threshold_uncertainty_score":0.5974852},"labels":[],"label_agreement":null},{"id":"W3099993137","doi":"10.1136/annrheumdis-2020-eular.4566","title":"SAT0629-HPR FACTORS ASSOCIATED WITH USE OF BIOLOGICAL THERAPIES FOR AXIAL SPONDYLOARTHRITIS IN CANADA. RESULTS FROM THE IMAS SURVEY.","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Western University; Université de Sherbrooke; Novartis (Canada); University of British Columbia; University of Ottawa; Canadian Standards Association; University of British Columbia Hospital; Toronto Western Hospital","funders":"","keywords":"Medicine; Axial spondyloarthritis; BASDAI; Physical therapy; Ankylosing spondylitis; Family medicine; Internal medicine; Disease; Sacroiliitis","score_opus":0.18435079526209888,"score_gpt":0.29399873780578817,"score_spread":0.10964794254368929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099993137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800822,0.0025629073,0.0000013820056,0.0038307721,0.000058597674,0.0006410277,0.01280519,0.000009585923,0.00000831066],"genre_scores_gemma":[0.9982649,0.00064909144,0.000014781265,0.0005372905,0.000013368093,0.000024423367,0.00047205077,0.000013649265,0.000010428888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986098,0.00021595822,0.00044747733,0.00020012195,0.00030156915,0.00022507722],"domain_scores_gemma":[0.99611855,0.0030601788,0.00030096245,0.00026447445,0.00016215318,0.00009366115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012972759,0.00017460872,0.0005727384,0.000015654436,0.000081350765,0.000011460842,0.00015102782,0.000035210345,0.000030015259],"category_scores_gemma":[0.004979271,0.000081489445,0.00014871212,0.00022170981,0.00018210003,0.000046349887,0.000060603674,0.00006364649,3.2201243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002579863,0.0002635873,0.9871472,0.000024385145,0.000810281,0.000008191918,0.0009365049,0.00001810676,0.000013958432,0.00001707721,0.0044695167,0.0037112955],"study_design_scores_gemma":[0.003347131,0.00040737263,0.99402803,0.00063653756,0.00008779481,2.9588992e-7,0.0008840418,0.000034784905,0.00023080247,0.00008550553,0.00017041371,0.00008730047],"about_ca_topic_score_codex":0.39654523,"about_ca_topic_score_gemma":0.5048632,"teacher_disagreement_score":0.10831799,"about_ca_system_score_codex":0.000031644864,"about_ca_system_score_gemma":0.00035121688,"threshold_uncertainty_score":0.60747325},"labels":[],"label_agreement":null},{"id":"W3105464358","doi":"10.1136/annrheumdis-2020-eular.2508","title":"FRI0037 ALL-CAUSE MORTALITY IN EARLY RHEUMATOID ARTHRITIS PREDICTED BY HEALTH ASSESSMENT QUESTIONNAIRE AT ONE YEAR","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; Université Laval; University of Calgary; McGill University; University of Toronto; Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Population; Proportional hazards model; Hazard ratio; Physical therapy; Demography; Confidence interval","score_opus":0.06246592292664403,"score_gpt":0.3509440516463422,"score_spread":0.28847812871969813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105464358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557872,0.01780346,0.000038041082,0.02438394,0.00008167305,0.000980083,0.0006718607,0.00010096481,0.0001527731],"genre_scores_gemma":[0.8908777,0.107400574,0.000071644536,0.0013469539,0.0000215117,0.00007808948,0.00013519051,0.000033959488,0.000034348628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967857,0.00042121895,0.0008574705,0.00036197554,0.0010367937,0.00053685653],"domain_scores_gemma":[0.99812675,0.0001088991,0.00032368652,0.0005830474,0.0001558767,0.00070176314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003871644,0.00024502864,0.0007578579,0.00008046986,0.00014072197,0.000048106922,0.0003113646,0.00006498608,0.00032328363],"category_scores_gemma":[0.00073263503,0.00019533515,0.00023686359,0.000360464,0.00029001207,0.00020646534,0.00019959525,0.0002500379,0.0000310957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006511876,0.002388751,0.867757,0.0012447659,0.0021501675,0.000025352385,0.0027247805,0.000022569082,0.00023958266,0.0017791179,0.094060086,0.026956644],"study_design_scores_gemma":[0.0032447358,0.00079754426,0.986254,0.006018567,0.000017496446,0.000007731756,0.0002708737,0.00045219803,0.00048826847,0.0010155849,0.0012018685,0.00023117433],"about_ca_topic_score_codex":0.00089193566,"about_ca_topic_score_gemma":0.00016404173,"teacher_disagreement_score":0.11849696,"about_ca_system_score_codex":0.000072922594,"about_ca_system_score_gemma":0.00043478547,"threshold_uncertainty_score":0.7965536},"labels":[],"label_agreement":null},{"id":"W3109739095","doi":"10.1136/annrheumdis-2020-218870","title":"Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie; Genentech; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Placebo; Psoriatic arthritis; Internal medicine; Adverse effect; Rheumatology; Clinical endpoint; Arthritis; Pharmacology; Gastroenterology; Urology; Clinical trial; Pathology","score_opus":0.07046193175246603,"score_gpt":0.3277423721760776,"score_spread":0.2572804404236116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109739095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599394,0.012956284,0.00011073392,0.023635767,0.0002492256,0.0017376752,0.00071016134,0.000082327395,0.00057843205],"genre_scores_gemma":[0.9923464,0.0017981153,0.0003755886,0.0050658123,0.00009169863,0.00016156657,0.000033782915,0.000019403706,0.000107629574],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989334,0.000039216273,0.00034220022,0.00021913432,0.00020430538,0.0002617823],"domain_scores_gemma":[0.998976,0.00021421748,0.00014170866,0.00026968034,0.000158118,0.00024027593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063196654,0.00016050592,0.00047885207,0.00003075339,0.000115677976,0.000012194703,0.00014146967,0.000034860175,0.00012108175],"category_scores_gemma":[0.0017922315,0.00010329552,0.00029421772,0.00019785564,0.00006791403,0.00004092878,0.00007788656,0.00004532292,0.000041023643],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002217516,0.0016547227,0.016064623,0.0015324694,0.002116356,0.00002672749,0.002073022,0.000028127406,0.00030275478,0.0018995772,0.2036303,0.7684538],"study_design_scores_gemma":[0.034264907,0.026219515,0.66269284,0.013778991,0.002997956,0.000077363846,0.0053917416,0.00087566033,0.015408176,0.03038036,0.20571634,0.0021961324],"about_ca_topic_score_codex":0.000019637599,"about_ca_topic_score_gemma":0.000005464359,"teacher_disagreement_score":0.76625764,"about_ca_system_score_codex":0.0000101816495,"about_ca_system_score_gemma":0.00006999539,"threshold_uncertainty_score":0.42122692},"labels":[],"label_agreement":null},{"id":"W3111279864","doi":"10.1136/annrheumdis-2020-219174","title":"Anti-inflammatory therapy for COVID-19 infection: the case for colchicine","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; Colchicine; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Adverse effect; Internal medicine; Disease","score_opus":0.076335392822686,"score_gpt":0.38014487627844123,"score_spread":0.3038094834557552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111279864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012039202,0.99293095,0.00024143897,0.0013532515,0.00027130204,0.0032989366,0.00065637304,0.000014434885,0.000029393732],"genre_scores_gemma":[0.0015860236,0.99534327,0.000011663141,0.0012942537,0.00016867525,0.0010124749,0.0003602531,0.000056412115,0.00016696374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985406,0.00020549344,0.00060222886,0.0003020721,0.00010555418,0.00024404353],"domain_scores_gemma":[0.99810725,0.00028691918,0.0006234623,0.00073000626,0.00014655956,0.00010578827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003104191,0.0003442148,0.00084207446,0.000038563343,0.00033410397,0.00003571663,0.00048668307,0.00015837443,0.000018070219],"category_scores_gemma":[0.0012580812,0.0001873304,0.0014559393,0.00013221063,0.00018749546,0.0000050411595,0.00012800841,0.000081307546,0.000003045848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020602654,0.00017389312,0.000027261876,0.029614015,0.0020709578,0.000007048565,0.000101770296,0.00004753605,0.000013161189,0.0003651701,0.097409956,0.8699632],"study_design_scores_gemma":[0.0005780701,0.0002402694,0.000012911995,0.0010114898,0.0005088039,0.0000632054,0.000055940796,0.000015592437,0.00011882752,0.00029751268,0.99686074,0.00023665235],"about_ca_topic_score_codex":0.000023442224,"about_ca_topic_score_gemma":0.000013698786,"teacher_disagreement_score":0.8994508,"about_ca_system_score_codex":0.00000898639,"about_ca_system_score_gemma":0.0007419587,"threshold_uncertainty_score":0.7639112},"labels":[],"label_agreement":null},{"id":"W3111513911","doi":"10.1136/annrheumdis-2020-219314","title":"Response to: ‘Correspondence on ‘Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities’’ by Rönnelid et al","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Rheumatology; Ethnic group; Systemic lupus erythematosus; Disease; Systemic lupus; Internal medicine","score_opus":0.06423149082881675,"score_gpt":0.36879096173258114,"score_spread":0.3045594709037644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111513911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6650253,0.0024154333,0.000008922646,0.3275377,0.0003327391,0.002689605,0.0019568414,0.000025537953,0.0000079502715],"genre_scores_gemma":[0.8512214,0.001073288,0.000018751794,0.14319955,0.00008303183,0.00060152117,0.00012785764,0.00012663862,0.0035479781],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9944817,0.001381467,0.0012592814,0.0006781488,0.001554194,0.0006451977],"domain_scores_gemma":[0.99391687,0.0029148182,0.00084858673,0.0016777616,0.0003793992,0.00026257767],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001482696,0.0005093618,0.0012255905,0.00021671697,0.00014619507,0.000083391664,0.0010954617,0.00023027773,0.00001385353],"category_scores_gemma":[0.0041154,0.00031485126,0.00043241773,0.000544592,0.00046171033,0.00015181369,0.00036583078,0.000659305,0.00001559519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01094968,0.00016076765,0.020053532,0.012420756,0.00019373476,0.0000222897,0.0032454808,0.000017511165,0.0017696844,0.00001745559,0.9509418,0.00020733257],"study_design_scores_gemma":[0.022888424,0.007568168,0.29529297,0.5063152,0.0019622443,0.0062993206,0.011957083,0.015515228,0.011069705,0.0017378138,0.11472245,0.00467144],"about_ca_topic_score_codex":0.00006218998,"about_ca_topic_score_gemma":0.0000021234112,"teacher_disagreement_score":0.8362193,"about_ca_system_score_codex":0.00010670406,"about_ca_system_score_gemma":0.00060755905,"threshold_uncertainty_score":0.9999304},"labels":[],"label_agreement":null},{"id":"W3113999238","doi":"10.1136/annrheumdis-2020-219542","title":"Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases‘","year":2020,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Hydroxychloroquine; Rheumatoid arthritis; Immunology; Intensive care medicine; Internal medicine; Virology; Disease; Outbreak; Infectious disease (medical specialty)","score_opus":0.04407727063093206,"score_gpt":0.37681067932394124,"score_spread":0.33273340869300916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113999238","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39524257,0.00039220497,0.00003697476,0.592768,0.00039454058,0.007243053,0.0037394082,0.00016791954,0.000015342594],"genre_scores_gemma":[0.6954616,0.00063091645,0.00004370843,0.3006027,0.00007986905,0.000889532,0.000807353,0.00019098097,0.0012933554],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9938995,0.00062725396,0.0015704238,0.000905117,0.002148342,0.00084931],"domain_scores_gemma":[0.97236294,0.022870747,0.0011442137,0.0016670508,0.00048351326,0.0014715524],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037478833,0.00074933027,0.0018602501,0.00048435133,0.00032613127,0.000051376803,0.0010937976,0.00030144726,0.00033643327],"category_scores_gemma":[0.30244926,0.0004494576,0.00088410865,0.0008382042,0.00047698888,0.00012630776,0.00061732874,0.0013710435,0.00006434832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033742988,0.0014536175,0.24388437,0.0092318915,0.0012948768,0.000078307196,0.0012302483,0.00076264475,2.1530346e-7,0.00001760295,0.73650646,0.0021654794],"study_design_scores_gemma":[0.0044513713,0.0038195737,0.9442032,0.013230686,0.0009216368,1.7561358e-7,0.0001508963,0.00050535053,0.0000031845973,0.0018451496,0.030162983,0.00070581894],"about_ca_topic_score_codex":0.00014558031,"about_ca_topic_score_gemma":0.0000032893602,"teacher_disagreement_score":0.7063435,"about_ca_system_score_codex":0.00033943454,"about_ca_system_score_gemma":0.0031668842,"threshold_uncertainty_score":0.99979573},"labels":[],"label_agreement":null},{"id":"W3116542951","doi":"10.1136/annrheumdis-2020-eular.2063","title":"SAT0127 REAL-WORLD PREDICTORS OF STARTING DIFFERENT ADVANCED DMARD TREATMENTS IN RHEUMATOID ARTHRITIS: A PROSPECTIVE INVESTIGATION FROM THE CANADIAN EARLY ARTHRITIS COHORT (CATCH) GROUP","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Southlake Regional Health Center; University of Manitoba; Université de Sherbrooke; Université Laval; University of Calgary; McGill University; University of Toronto; Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cohort; Internal medicine; Logistic regression; Demography; Physical therapy","score_opus":0.02508431988633511,"score_gpt":0.26800309038108977,"score_spread":0.24291877049475466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116542951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816861,0.009940353,0.0000020020384,0.0055119093,0.000107528365,0.0018997091,0.0006125529,0.000044713863,0.00019514436],"genre_scores_gemma":[0.95963335,0.039497864,0.000043347267,0.0003817529,0.00003604984,0.00023611881,0.00011791111,0.00003920532,0.000014404089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970619,0.00033105488,0.0009085535,0.0003759639,0.0008184482,0.00050405343],"domain_scores_gemma":[0.9978733,0.0003815174,0.00041490636,0.0005327597,0.00019183895,0.0006056704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023072018,0.00029797156,0.00080726924,0.0001379185,0.00022071981,0.000060478866,0.00034285127,0.00005789027,0.00011210888],"category_scores_gemma":[0.0010679874,0.00019415883,0.00027081708,0.00053114106,0.00050287764,0.00025546417,0.00010116906,0.00023518801,0.000009042828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035749053,0.0002074939,0.97383314,0.00007426304,0.0005320015,0.000010665874,0.004048352,0.0000142789695,0.00020615259,0.00046374684,0.00082554127,0.019426877],"study_design_scores_gemma":[0.002590521,0.0004229925,0.98345,0.0058436445,0.000020306717,0.0000014912231,0.0007528238,0.00010366183,0.0017532225,0.004846307,0.000057895075,0.00015716637],"about_ca_topic_score_codex":0.12574413,"about_ca_topic_score_gemma":0.19096316,"teacher_disagreement_score":0.06521902,"about_ca_system_score_codex":0.000108350505,"about_ca_system_score_gemma":0.00041791424,"threshold_uncertainty_score":0.8800776},"labels":[],"label_agreement":null},{"id":"W3118297953","doi":"10.1136/annrheumdis-2020-218670","title":"New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Rheumatism; Rheumatology; Cohort; Systemic lupus erythematosus; Severity of illness; Disease; Physical therapy","score_opus":0.07565037062497808,"score_gpt":0.3710258320724012,"score_spread":0.2953754614474231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118297953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813598,0.008634265,0.00009445757,0.0069941,0.00040286162,0.00042226046,0.00004293756,0.000031857544,0.0020175015],"genre_scores_gemma":[0.99431324,0.00065964117,0.0003254314,0.00023665024,0.000036012563,0.000020968853,0.000034318353,0.000022616481,0.004351096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998111,0.00025711433,0.0005230791,0.00025224022,0.0005630971,0.00029348675],"domain_scores_gemma":[0.99821746,0.00034357424,0.00018402957,0.0008179804,0.00024034175,0.00019661298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039267243,0.00013737165,0.00045591127,0.00010473956,0.000059636805,0.00003467114,0.00023344952,0.00006539087,0.00041877528],"category_scores_gemma":[0.0021215712,0.000101002755,0.00020438393,0.00043144054,0.00006501656,0.000112490045,0.00016496233,0.00012337808,0.000105609484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033884626,0.0010073028,0.62354994,0.0040217293,0.00035258668,0.00005836074,0.0023213523,0.000021803096,0.004650821,0.0030483587,0.33304963,0.027579268],"study_design_scores_gemma":[0.003273758,0.00011471595,0.95641303,0.0108914245,0.00022544498,0.00064007955,0.0035557325,0.0022370678,0.013761675,0.007253816,0.0013006048,0.00033262555],"about_ca_topic_score_codex":0.00023468205,"about_ca_topic_score_gemma":0.000024594394,"teacher_disagreement_score":0.33286312,"about_ca_system_score_codex":0.000044635795,"about_ca_system_score_gemma":0.0006212701,"threshold_uncertainty_score":0.45852956},"labels":[],"label_agreement":null},{"id":"W3119683484","doi":"10.1136/annrheumdis-2020-218744","title":"Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Tenderness; Synovitis; Osteoarthritis; Internal medicine; Arthritis; Rheumatology; Surgery; Pathology","score_opus":0.015384457127121247,"score_gpt":0.25877672392288414,"score_spread":0.2433922667957629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119683484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86648285,0.13134827,0.000006073818,0.0014484524,0.000041705003,0.00050521595,0.000042036238,0.000011706007,0.00011367684],"genre_scores_gemma":[0.7823102,0.2174446,0.00008852346,0.000043567714,0.000008595466,0.00006154503,0.000015902842,0.000016511323,0.000010553234],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976396,0.00029422322,0.00090488466,0.00028321458,0.0005288995,0.0003491994],"domain_scores_gemma":[0.9988203,0.00017085152,0.00022956284,0.00042148514,0.00017107277,0.00018674547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004183879,0.00019865378,0.0007355389,0.00020651115,0.000058913225,0.000046598696,0.00009304616,0.000064678505,0.000090474445],"category_scores_gemma":[0.0009959077,0.00016886987,0.0001221001,0.00033757958,0.00033143602,0.0002420214,0.00017365317,0.00013952913,0.0000025671045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022247723,0.0006921614,0.09540346,0.00091475615,0.00016082799,0.000108980326,0.0024318793,0.000048869602,0.005943964,0.0044131954,0.000090634705,0.8895688],"study_design_scores_gemma":[0.0061628204,0.0003000496,0.8954823,0.020222431,0.000008933174,0.00018904456,0.0036141137,0.00074358494,0.051471032,0.021405414,0.0001511577,0.0002491424],"about_ca_topic_score_codex":0.00021948235,"about_ca_topic_score_gemma":0.0005144467,"teacher_disagreement_score":0.88931966,"about_ca_system_score_codex":0.000016050375,"about_ca_system_score_gemma":0.00017541005,"threshold_uncertainty_score":0.68863136},"labels":[],"label_agreement":null},{"id":"W3120019817","doi":"10.1136/annrheumdis-2020-eular.326","title":"FRI0106 RISK FACTORS FOR SERIOUS INFECTIONS IN PATIENTS WITH RA INITIATING TREATMENT WITH BIOLOGIC DMARDS: A REAL-WORLD POPULATION-BASED OBSERVATIONAL STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Genentech","keywords":"Medicine; Observational study; Internal medicine; Population; Hazard ratio; Proportional hazards model; Cohort study; Cohort; Abatacept; Intensive care medicine; Confidence interval; Environmental health","score_opus":0.06377550979311562,"score_gpt":0.2945819803512288,"score_spread":0.23080647055811315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120019817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748415,0.00033230765,0.000036309822,0.00024280394,0.00007679839,0.0013910707,0.00037991552,0.00003939746,0.000017278586],"genre_scores_gemma":[0.99905306,0.000020472939,0.000016534881,0.00012309679,0.000001124072,0.00017981461,0.0005755287,0.0000137304,0.000016645416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988777,0.00024480443,0.0003876933,0.00020999221,0.00006400562,0.00021580711],"domain_scores_gemma":[0.9987122,0.00054841756,0.00039799706,0.00022070193,0.00010949689,0.000011217412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076278506,0.0001977991,0.00034654082,0.000082988925,0.00031308888,0.000013512833,0.00016462531,0.0000384778,0.000043451535],"category_scores_gemma":[0.00032711026,0.000109999746,0.00011930963,0.00036228172,0.00008774234,0.00009907422,0.000026204154,0.00007756972,0.0000026336045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049152743,0.0020039706,0.9892162,0.000036393485,0.00030477362,9.995541e-8,0.0008913728,0.004836385,0.000005286676,0.00004515195,0.000016748929,0.0021521028],"study_design_scores_gemma":[0.003387955,0.0021561007,0.99271864,0.000113388014,0.00013719629,5.6445028e-8,0.0009802199,0.00015183933,0.000069112946,0.000097387514,0.000041587253,0.00014654676],"about_ca_topic_score_codex":0.002248102,"about_ca_topic_score_gemma":0.00021252727,"teacher_disagreement_score":0.0046845456,"about_ca_system_score_codex":0.000025961564,"about_ca_system_score_gemma":0.00012293669,"threshold_uncertainty_score":0.44856596},"labels":[],"label_agreement":null},{"id":"W3120355471","doi":"10.1136/annrheumdis-2020-eular.2053","title":"THU0396 IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE COAST-V AND COAST-W TRIALS AT 52 WEEKS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Memorial University of Newfoundland","funders":"Celgene; Gilead Sciences; Pfizer; Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Ankylosing spondylitis; Adalimumab; Placebo; Work productivity; Internal medicine; Presenteeism; Absenteeism; Physical therapy; Productivity; Secukinumab; Disease; Psoriatic arthritis; Pathology","score_opus":0.06039700618445116,"score_gpt":0.31015453346434335,"score_spread":0.2497575272798922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120355471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879554,0.0021275016,3.679356e-7,0.0035789236,0.000049971422,0.0011369087,0.0050875773,0.000012944279,0.000050400384],"genre_scores_gemma":[0.99926245,0.0002516823,0.000019025932,0.00019831538,0.0000355658,0.000021773223,0.00017542999,0.000018779338,0.000016987433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980423,0.00033934638,0.0006136874,0.0003119617,0.0004650667,0.0002276376],"domain_scores_gemma":[0.99764043,0.0010737306,0.0005307483,0.0004905047,0.0001309781,0.00013361695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031581018,0.00023071238,0.000885356,0.000034040233,0.000111635636,0.000016003394,0.00012953243,0.00003469576,0.00004474068],"category_scores_gemma":[0.0035859265,0.00010722324,0.00023762896,0.0002944029,0.00022273051,0.00007559461,0.00015290911,0.000090890295,0.0000020906082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03951951,0.0013946673,0.91219276,0.000133649,0.0011769233,0.0000095224295,0.003094899,0.00006960482,0.0000052731307,0.000009578695,0.004968834,0.037424754],"study_design_scores_gemma":[0.008741608,0.0016042821,0.98616296,0.002426999,0.0002923561,8.5317646e-7,0.0003182771,0.000010969104,0.00016759687,0.0001369752,0.000038996608,0.000098114484],"about_ca_topic_score_codex":0.0009501031,"about_ca_topic_score_gemma":0.0001027216,"teacher_disagreement_score":0.07397019,"about_ca_system_score_codex":0.00003259666,"about_ca_system_score_gemma":0.00007912954,"threshold_uncertainty_score":0.4372437},"labels":[],"label_agreement":null},{"id":"W3121213336","doi":"10.1136/annrheumdis-2020-eular.126","title":"THU0545 THE ASSOCIATION OF RHEUMATOID ARTHRITIS WITH HEALTH CARE COSTS FROM THE PAYERS PERSPECTIVE FROM 2001-2015","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Health care; Population; Rheumatoid arthritis; Demography; Public health; Family medicine; Pediatrics; Internal medicine; Environmental health","score_opus":0.02457514069319962,"score_gpt":0.30511158148169387,"score_spread":0.28053644078849427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121213336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6776145,0.1417786,0.000032700627,0.176705,0.00011681095,0.0012091738,0.0020124658,0.000049111462,0.0004816453],"genre_scores_gemma":[0.9336943,0.06255876,0.000058488953,0.0034472095,0.00006373491,0.00004324957,0.00008786324,0.000029177509,0.000017183565],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99711466,0.0005634236,0.0005104328,0.00027247972,0.0011450065,0.00039398362],"domain_scores_gemma":[0.99663126,0.0011969581,0.00062438997,0.00064316235,0.0006204859,0.00028372102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031885863,0.00022015776,0.000640694,0.000028382965,0.00028906498,0.000058337373,0.0005069033,0.00004818838,0.00028154725],"category_scores_gemma":[0.001955999,0.00010333233,0.000291744,0.00032215123,0.00036388836,0.00013557429,0.00012361676,0.00024855768,0.000021024716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031257453,0.0008594616,0.20132707,0.00026961422,0.004829221,0.000011672425,0.10929954,0.000079450794,0.00011965195,0.0027782272,0.57915044,0.09814993],"study_design_scores_gemma":[0.010345165,0.0023739133,0.7035627,0.0113036735,0.000111588335,0.000011137966,0.24856408,0.0005706243,0.0023306394,0.005218579,0.014973744,0.00063416787],"about_ca_topic_score_codex":0.009375998,"about_ca_topic_score_gemma":0.0011639032,"teacher_disagreement_score":0.5641767,"about_ca_system_score_codex":0.000109002794,"about_ca_system_score_gemma":0.00066463463,"threshold_uncertainty_score":0.99722064},"labels":[],"label_agreement":null},{"id":"W3121231912","doi":"10.1136/annrheumdis-2020-eular.4254","title":"FRI0025 CIRCADIAN RHYTHMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE PRODUCTION IN FEMALES WITH RHEUMATOID ARTHRITIS AND ARTERIAL HYPERTENSION DEPENDING ON NOS3 Т786С GENE POLYMORPHISM","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Amgen Canada; Merck Canada; Pfizer; Amgen","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Gene polymorphism; Evening; Endocrinology; Population; Gastroenterology; Genotype; Gene; Genetics","score_opus":0.05438986565751634,"score_gpt":0.2655450698124305,"score_spread":0.21115520415491412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121231912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455404,0.0012101104,0.000020339028,0.0034799979,0.000116951946,0.00042147315,0.000121714984,0.000024498095,0.000050854156],"genre_scores_gemma":[0.9977735,0.0016844386,0.00010861779,0.0002866079,0.00007684188,0.000020269887,0.000016229069,0.000023796294,0.000009679021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874574,0.000072203504,0.00045257175,0.00025600643,0.00029331865,0.00018013307],"domain_scores_gemma":[0.9990698,0.00013609907,0.00027244474,0.00026644891,0.00009583349,0.00015935168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009535244,0.00017145925,0.00047523188,0.00016665827,0.00007730611,0.000015749529,0.0000758858,0.000038502294,0.000049543047],"category_scores_gemma":[0.0008452641,0.00011853946,0.00012437279,0.00025203175,0.000121572186,0.000115505245,0.000036474838,0.000112215894,0.0000048266816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076927934,0.002459433,0.032848738,0.0015948281,0.00064267835,0.00018737158,0.0019230577,0.0008327891,0.8849129,0.0005009364,0.0021393807,0.06426509],"study_design_scores_gemma":[0.0045170626,0.0011271684,0.27853823,0.014024602,0.00018156045,0.0005900159,0.00088033313,0.0013800358,0.6979934,0.00027340493,0.00010452483,0.00038965006],"about_ca_topic_score_codex":0.00023762,"about_ca_topic_score_gemma":0.000015825206,"teacher_disagreement_score":0.2456895,"about_ca_system_score_codex":0.000011888501,"about_ca_system_score_gemma":0.00009735355,"threshold_uncertainty_score":0.48338988},"labels":[],"label_agreement":null},{"id":"W3121474974","doi":"10.1136/annrheumdis-2001.85","title":"SP0031 Genetic studies in familial ankylosing spondylitis: the north american spondylitis consortium experience","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ankylosing spondylitis; Genetics; Single-nucleotide polymorphism; Locus (genetics); Microsatellite; Allele; Spondylitis; Genetic association; Human leukocyte antigen; Major histocompatibility complex; Genetic linkage; Biology; Chromosome 16; SNP; Chromosome; Gene; Immunology; Genotype; Antigen","score_opus":0.07632533837584564,"score_gpt":0.36113417705156864,"score_spread":0.284808838675723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121474974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763319,0.020556523,0.0000019438587,0.0017374097,0.00023664419,0.0006214591,0.0002534873,0.000029767585,0.00023088096],"genre_scores_gemma":[0.9832007,0.015437155,0.000057478523,0.0008796035,0.000056809877,0.00013643657,0.000015885662,0.000021868462,0.00019401818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980131,0.00016291828,0.000585742,0.00030458745,0.0004665797,0.00046711866],"domain_scores_gemma":[0.99843925,0.00034253,0.00027426792,0.0006509176,0.00016705033,0.00012598952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010538292,0.00026065874,0.0006619604,0.00008777773,0.0002354184,0.000020569081,0.0002619601,0.000019569827,0.000093609044],"category_scores_gemma":[0.0007832978,0.0001499867,0.00025387178,0.0006910649,0.0013410425,0.000086036176,0.00017875708,0.0000989719,0.0000119042625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004820678,0.000514063,0.9477178,0.00014621252,0.00042470757,0.00025284066,0.0036333702,0.000029077215,0.000005419088,0.00007136755,0.0007985033,0.045924578],"study_design_scores_gemma":[0.0011369925,0.00028935462,0.9877118,0.0008802215,0.00016856444,0.00011661935,0.00813251,0.000037191963,0.00005523866,0.0002519817,0.0010700837,0.00014943304],"about_ca_topic_score_codex":0.00078940694,"about_ca_topic_score_gemma":0.0006142812,"teacher_disagreement_score":0.045775145,"about_ca_system_score_codex":0.000041089435,"about_ca_system_score_gemma":0.00008218087,"threshold_uncertainty_score":0.611628},"labels":[],"label_agreement":null},{"id":"W3122033829","doi":"10.1136/annrheumdis-2020-eular.708","title":"FRI0104 PERSISTENCE OF TOCILIZUMAB THERAPY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE US-BASED CORRONA RHEUMATOID ARTHRITIS REGISTRY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; McGill University; Bristol-Myers Squibb","keywords":"Medicine; Discontinuation; Tocilizumab; Rheumatoid arthritis; Persistence (discontinuity); Internal medicine; Hazard ratio; Proportional hazards model; Confidence interval","score_opus":0.07634263410370887,"score_gpt":0.29558734007224763,"score_spread":0.21924470596853876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122033829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96289855,0.023217821,0.000025599837,0.00925853,0.000078728845,0.0008985093,0.0033641448,0.00003715674,0.00022095388],"genre_scores_gemma":[0.9753559,0.022004455,0.0001155672,0.0017235747,0.000039462,0.000035335197,0.000648203,0.00003896418,0.000038540442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966342,0.00025835147,0.00076461304,0.0005008861,0.0014230895,0.00041887592],"domain_scores_gemma":[0.9961848,0.0007710428,0.0005784155,0.0016832324,0.00042393047,0.00035857476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021314742,0.00034514055,0.0008139095,0.000038642396,0.0002418394,0.000051494673,0.0014830208,0.00007459293,0.00071976724],"category_scores_gemma":[0.0010152295,0.00018386626,0.00034651122,0.00035463928,0.0011200239,0.00023174594,0.00040485203,0.00028123008,0.000024661897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003941019,0.001062167,0.9025553,0.00040534738,0.00081623776,0.000016260658,0.0007284209,0.00008936441,0.000045322584,0.000058519487,0.046004225,0.044277854],"study_design_scores_gemma":[0.0045737303,0.0008129032,0.97963804,0.007054021,0.00004336643,0.0000060604366,0.00064314035,0.0024046404,0.0010327132,0.00020216865,0.0032782955,0.00031093604],"about_ca_topic_score_codex":0.0015328171,"about_ca_topic_score_gemma":0.00011284569,"teacher_disagreement_score":0.07708276,"about_ca_system_score_codex":0.000011631006,"about_ca_system_score_gemma":0.00045413375,"threshold_uncertainty_score":0.78809464},"labels":[],"label_agreement":null},{"id":"W3122209248","doi":"10.1136/annrheumdis-2020-eular.6099","title":"THU0626-HPR IMPORTANCE OF A SYSTEMATIC COGNITIVE ASSESSMENT: IMPLEMENTATION OF A COGNITIVE EVALUATION AND REHABILITATION CLINIC IN RHEUMATIC PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Learning Styles and Cognitive Differences","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; Cognition; Rehabilitation; Wechsler Adult Intelligence Scale; Physical therapy; Cognitive rehabilitation therapy; Neuropsychological assessment; Descriptive statistics; Outpatient clinic; Anxiety; Hospital Anxiety and Depression Scale; Neuropsychology; Psychiatry; Clinical psychology; Cognitive impairment; Internal medicine","score_opus":0.0764424480746438,"score_gpt":0.4392757430379162,"score_spread":0.36283329496327243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122209248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958431,0.0008157568,0.00005130834,0.00029217353,0.000057770794,0.0023012955,0.00026690398,0.000007868947,0.0003638088],"genre_scores_gemma":[0.9993551,0.00007078871,0.000021939975,0.00013829114,0.000003797378,0.00031845336,0.00007288862,0.000012913169,0.000005840229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638766,0.0013869824,0.0012450028,0.00026396083,0.0005542452,0.0001621401],"domain_scores_gemma":[0.99374485,0.0035141588,0.0017014546,0.00016205422,0.00081710465,0.000060400962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085754105,0.00016467266,0.0006326528,0.00010799184,0.00004192219,0.000012392939,0.00015155437,0.000044603108,0.0004715653],"category_scores_gemma":[0.0052991537,0.00012208556,0.00016555964,0.00034491706,0.00023117986,0.00014830737,0.000060960112,0.000085338695,0.0000056774716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021379995,0.00064405816,0.94582456,0.011101677,0.00040245327,2.1155648e-7,0.024939401,0.0000021771432,0.000003033436,0.0005139493,0.00006149003,0.016293168],"study_design_scores_gemma":[0.0022620228,0.0007858685,0.9208918,0.013822805,0.00046924804,1.9513195e-7,0.058894683,0.00045103848,0.000027337754,0.0022908468,3.794584e-8,0.00010410816],"about_ca_topic_score_codex":0.00013062275,"about_ca_topic_score_gemma":0.000033532582,"teacher_disagreement_score":0.03395528,"about_ca_system_score_codex":0.000012327327,"about_ca_system_score_gemma":0.00011477868,"threshold_uncertainty_score":0.6343965},"labels":[],"label_agreement":null},{"id":"W3122258052","doi":"10.1136/annrheumdis-2020-eular.1052","title":"AB0838 IDENTIFYING MEDIATORS OF PAIN REDUCTION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB: ROLE OF INFLAMMATION ASSOCIATED WITH PERIPHERAL ARTHRITIS, ENTHESITIS AND SKIN DISEASE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Celgene; Pfizer; Eli Lilly and Company","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Enthesitis; Janus kinase inhibitor; Placebo; Internal medicine; Psoriasis; Arthritis; Psoriasis Area and Severity Index; Dermatology; Rheumatoid arthritis; Pathology","score_opus":0.010582490244189486,"score_gpt":0.22361583708541719,"score_spread":0.2130333468412277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122258052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588263,0.0026547299,0.0000041799967,0.00032791749,0.000013895597,0.00079461676,0.0002865468,0.00001987566,0.000015580024],"genre_scores_gemma":[0.99884164,0.0008510617,0.000031726697,0.000027437569,0.000011067792,0.000059087462,0.00014955555,0.000025793386,0.0000026393116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836016,0.00017460293,0.00050304347,0.00022447834,0.00053882657,0.00019888536],"domain_scores_gemma":[0.99875826,0.000098993616,0.0005306719,0.0001955606,0.00024090266,0.00017562143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011136194,0.00020904525,0.0006156205,0.00008237229,0.00006334386,0.000012545465,0.00006391029,0.000034000008,0.000038870763],"category_scores_gemma":[0.0004437821,0.00013643462,0.00008414041,0.00037214698,0.000231679,0.00018185731,0.000025031972,0.00005978496,3.0278497e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024991804,0.0006800296,0.91562223,0.00042926485,0.00066005584,0.000013425427,0.0019727652,0.00008875842,0.000023789265,0.00002359595,0.00001715637,0.07796975],"study_design_scores_gemma":[0.00791467,0.0014018627,0.9788613,0.0074948217,0.0002952844,0.000002040225,0.0017037406,0.00014206624,0.0019196564,0.00011962666,0.0000015059708,0.00014342465],"about_ca_topic_score_codex":0.000113366914,"about_ca_topic_score_gemma":0.00008364225,"teacher_disagreement_score":0.07782633,"about_ca_system_score_codex":0.000021557164,"about_ca_system_score_gemma":0.00008243989,"threshold_uncertainty_score":0.55636424},"labels":[],"label_agreement":null},{"id":"W3122291676","doi":"10.1136/annrheumdis-2020-eular.5021","title":"FRI0066 SUBCLINICAL CORONARY CALCIFICATION ASSOCIATED WITH LONG-TERM CARDIOVASCULAR OUTCOMES IN RHEUMATOID ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Inha University Hospital; Seoul National University Hospital; Seoul National University Bundang Hospital; McGill University","keywords":"Medicine; Internal medicine; Cardiology; Proportional hazards model; Framingham Risk Score; Asymptomatic; Myocardial infarction; Hazard ratio; Rheumatoid arthritis; Unstable angina; Disease; Confidence interval","score_opus":0.060018222626578896,"score_gpt":0.31683275892259655,"score_spread":0.25681453629601764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122291676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674468,0.025201738,0.000048515034,0.0062214597,0.00006041875,0.0007827261,0.00009059032,0.00006769386,0.0000800702],"genre_scores_gemma":[0.9582803,0.040961564,0.000023116952,0.0005173237,0.000014424155,0.00007018447,0.000070269474,0.00003594023,0.000026824267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722785,0.0003422014,0.0007104818,0.000335703,0.00098197,0.00040179133],"domain_scores_gemma":[0.99809355,0.00043586086,0.00022075279,0.0006706565,0.00021657583,0.0003625993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003953419,0.00023810781,0.0010350365,0.00008270867,0.000096585536,0.000036393652,0.00032533484,0.000078437995,0.00015711322],"category_scores_gemma":[0.00255258,0.00015492922,0.0006134126,0.00039045102,0.0003730479,0.00017652524,0.000102949656,0.00023114729,0.00003168663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047007398,0.00078272657,0.95389247,0.00015650214,0.0015857368,0.00007426742,0.0004470184,0.000051304607,0.000013881795,0.00012230394,0.0007092871,0.041694447],"study_design_scores_gemma":[0.0033292857,0.00038827924,0.9927052,0.0025982822,0.000025103789,0.00002085456,0.00016929198,0.00014956645,0.00016888673,0.00019000673,0.00008178464,0.00017342198],"about_ca_topic_score_codex":0.00007470425,"about_ca_topic_score_gemma":0.000049700247,"teacher_disagreement_score":0.041521028,"about_ca_system_score_codex":0.000021988972,"about_ca_system_score_gemma":0.00023179606,"threshold_uncertainty_score":0.631783},"labels":[],"label_agreement":null},{"id":"W3122322988","doi":"10.1136/annrheumdis-2001.472","title":"SAT0097 Success in osteoarthritis (oa) trial: celecoxib significantly reduces the risk of upper gastrointestinal (ugi) hospitalizations compared to diclofenac and naproxen in 13,274 randomised patients with oa","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Celecoxib; Diclofenac; Naproxen; Osteoarthritis; Internal medicine; Incidence (geometry); Clinical trial; Gastroenterology; Anesthesia","score_opus":0.011716483326840617,"score_gpt":0.25650931539661304,"score_spread":0.24479283206977243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122322988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567056,0.00038201225,0.000018486699,0.00062546297,0.00007455983,0.0030677281,0.000082911,0.000013738835,0.00006453196],"genre_scores_gemma":[0.9994387,0.00015129977,0.00004548849,0.000097052995,0.000022079066,0.00018374337,0.00002364527,0.00002160132,0.000016362805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800736,0.0003860763,0.00065782375,0.00021955515,0.00043599258,0.00029322127],"domain_scores_gemma":[0.99812144,0.0007516512,0.00039731554,0.0003648085,0.0001938692,0.00017092275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005058214,0.00020247215,0.0006311682,0.00016149231,0.00008337739,0.000022389047,0.0002115342,0.000029596087,0.00003643066],"category_scores_gemma":[0.0021657147,0.00011276288,0.00012308267,0.00046867025,0.00022944945,0.00010584024,0.00005799521,0.00011362729,0.0000017306471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029700307,0.00081367686,0.9631534,0.00023475869,0.00006673431,0.000008516391,0.0010329379,0.00040285185,0.000034707926,0.000013274144,0.0003075964,0.00423119],"study_design_scores_gemma":[0.06022516,0.0010350028,0.9340679,0.0026673316,0.00014245449,0.0000039554816,0.00045105212,0.00047444573,0.0006696378,0.00011916141,0.000007688026,0.00013619525],"about_ca_topic_score_codex":0.00038024748,"about_ca_topic_score_gemma":0.00020812897,"teacher_disagreement_score":0.030524852,"about_ca_system_score_codex":0.00001645951,"about_ca_system_score_gemma":0.00011465719,"threshold_uncertainty_score":0.45983368},"labels":[],"label_agreement":null},{"id":"W3122816672","doi":"10.1136/annrheumdis-2020-eular.1531","title":"SAT0207 ANTI-SSA/RO POSITIVITY AND CONGENITAL HEART BLOCK: OBSTETRIC AND FETAL OUTCOME IN A COHORT OF ANTI-SSA/RO POSITIVE PREGNANT WOMEN WITH AND WITHOUT AUTO-IMMUNE DISEASES FROM THREE ITALIAN TERTIARY REFERRAL CENTERS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Incidence (geometry); Fetus; Cohort; Pediatrics; Gestational age; Gestation; Prospective cohort study; Internal medicine","score_opus":0.03413424058079662,"score_gpt":0.29534405067208547,"score_spread":0.26120981009128885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122816672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98528314,0.009848689,0.0000060864627,0.0019852316,0.00005191001,0.0017728797,0.0009738082,0.000040328494,0.00003791],"genre_scores_gemma":[0.9990456,0.00047299245,0.00005131939,0.00023594835,0.000018390352,0.000056234287,0.000039714843,0.000050045564,0.00002973382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969541,0.00030623787,0.000833096,0.0005712979,0.00080565456,0.00052961084],"domain_scores_gemma":[0.9977734,0.0005425952,0.00035606467,0.000533366,0.0001957547,0.0005988166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025839123,0.00040529127,0.0014498794,0.00020337387,0.00010377886,0.00006402586,0.00022747947,0.00008619884,0.000018522102],"category_scores_gemma":[0.00088578474,0.00026521453,0.00013720122,0.00043714547,0.00080030627,0.0002819098,0.0004046002,0.0002059523,0.0000015706835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012762693,0.00049552915,0.9908581,0.0019439085,0.0010509166,0.00005614344,0.0021061879,0.0000028929312,0.0014051256,0.0000071616746,0.00006089258,0.000736894],"study_design_scores_gemma":[0.003734185,0.0005867686,0.98596585,0.005118363,0.0004408831,0.00030235262,0.0019332438,0.00096902065,0.000615887,0.00006260302,0.0000013729242,0.0002695009],"about_ca_topic_score_codex":0.00082059443,"about_ca_topic_score_gemma":0.000043700096,"teacher_disagreement_score":0.013762464,"about_ca_system_score_codex":0.0000544967,"about_ca_system_score_gemma":0.00020740482,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W3123163825","doi":"10.1136/annrheumdis-2020-eular.3415","title":"SAT0053 ESTIMATING REAL-WORLD UNMET NEEDS FOR REACHING REMISSION IN THE FIRST YEAR FOLLOWING EARLY RA DIAGNOSIS: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT (CATCH)","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Toronto; Southlake Regional Health Center; University of Manitoba; Université Laval; McGill University; University of Calgary; Université de Sherbrooke; Canadian Arthritis Network","funders":"","keywords":"Medicine; Cohort; Logistic regression; Internal medicine; Bristol-Myers; Rheumatoid arthritis; Disease; Clinical Practice; Physical therapy","score_opus":0.049849173296526106,"score_gpt":0.30965809992705806,"score_spread":0.25980892663053196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123163825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92282903,0.0035910916,0.000014651718,0.070781395,0.00015467021,0.0015329941,0.00048783087,0.000040739615,0.00056762394],"genre_scores_gemma":[0.9934505,0.0037064445,0.00040506892,0.0018917286,0.00015199427,0.00023102456,0.00008985215,0.000042287335,0.000031099855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973601,0.00031200383,0.0007239927,0.00030708642,0.0007599834,0.00053684495],"domain_scores_gemma":[0.99620605,0.002316437,0.0002473973,0.0007413666,0.00010037676,0.0003883791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011811233,0.00023436935,0.0005190804,0.00012280511,0.0006769547,0.00022504543,0.00069242535,0.00006103493,0.00002918941],"category_scores_gemma":[0.006317039,0.00013283604,0.00040118696,0.0005983284,0.00016249306,0.00021855622,0.00010060589,0.0003221295,0.000012705693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008761605,0.00022239238,0.8333609,0.00020770195,0.0006783866,0.00004826909,0.02974357,0.0001367683,0.000016296648,0.00083418743,0.0668852,0.066990145],"study_design_scores_gemma":[0.0031647217,0.00031740376,0.97142756,0.010323207,0.000077934565,0.0000026801483,0.0029589224,0.0016536429,0.00013429121,0.0038988683,0.0057623773,0.00027841455],"about_ca_topic_score_codex":0.23507856,"about_ca_topic_score_gemma":0.07565282,"teacher_disagreement_score":0.15942574,"about_ca_system_score_codex":0.000050528,"about_ca_system_score_gemma":0.00034504902,"threshold_uncertainty_score":0.9412141},"labels":[],"label_agreement":null},{"id":"W3123185003","doi":"10.1136/annrheumdis-2020-eular.6010","title":"SAT0213 IMPACT OF FLARES ON HEALTHCARE RESOURCE USAGE AND PROS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Konkuk University; Konkuk University Medical Center","keywords":"Medicine; Propensity score matching; Health care; Disease; Internal medicine; Physical therapy","score_opus":0.05218818521868886,"score_gpt":0.3401236739382637,"score_spread":0.28793548871957486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123185003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234766,0.0036893305,0.0000011924104,0.00193231,0.000040876923,0.0016466241,0.00016320815,0.000023877228,0.0001548954],"genre_scores_gemma":[0.9993048,0.00029134055,0.000009285126,0.00021953008,0.0000181139,0.0000451022,0.000013996885,0.000033356064,0.00006450626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974186,0.00035773756,0.00077374984,0.00028507685,0.0008233999,0.0003414333],"domain_scores_gemma":[0.9980098,0.0004359115,0.00040429964,0.0005906337,0.00021150826,0.00034784607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030822252,0.0002199655,0.0008260265,0.00015444943,0.00004504163,0.000014863973,0.00028337582,0.00007017644,0.000024543664],"category_scores_gemma":[0.0020554604,0.00013035655,0.0002743452,0.00041309473,0.00015633678,0.000063986234,0.00016586224,0.00015378566,0.0000084130525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010397058,0.0003689148,0.9741319,0.013811268,0.00017690838,0.000008605149,0.0045014294,0.000040787454,0.00010437739,0.00005580048,0.0037325344,0.0020277817],"study_design_scores_gemma":[0.011006797,0.004675129,0.89624465,0.07289856,0.00022174651,0.0011764781,0.008415345,0.0021693257,0.0019107959,0.0006797508,0.00004363155,0.00055781857],"about_ca_topic_score_codex":0.00019053667,"about_ca_topic_score_gemma":0.000004997615,"teacher_disagreement_score":0.07788727,"about_ca_system_score_codex":0.000058360045,"about_ca_system_score_gemma":0.00023249594,"threshold_uncertainty_score":0.5315786},"labels":[],"label_agreement":null},{"id":"W3123452764","doi":"10.1136/annrheumdis-2020-eular.949","title":"FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Tofacitinib; Janus kinase inhibitor; Placebo; Adalimumab; Internal medicine; Visual analogue scale; Gastroenterology; Surgery; Rheumatoid arthritis; Pathology","score_opus":0.017675874464468562,"score_gpt":0.271768722284153,"score_spread":0.25409284781968444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123452764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373835,0.00089204457,0.0000025789252,0.0041411947,0.00001721041,0.0008856535,0.000058328067,0.000011636532,0.00025297463],"genre_scores_gemma":[0.9991721,0.00014569605,0.000004015353,0.0005762131,0.000009766744,0.000037731752,0.00001880325,0.000015092899,0.000020563353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815387,0.00048700487,0.00041201842,0.00013380939,0.000616551,0.00019676017],"domain_scores_gemma":[0.9986789,0.00056983123,0.00019377017,0.00039937167,0.00007897469,0.00007915015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049906457,0.00013279145,0.00045702935,0.00004805662,0.00005088548,0.000008780384,0.00023729088,0.00002975031,0.00016225642],"category_scores_gemma":[0.002812929,0.00006259187,0.0001336352,0.0002715262,0.00018131876,0.000055256543,0.00006410431,0.00013483576,0.000011388182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004745108,0.00061111915,0.6223152,0.0022103998,0.00038665874,0.000006620331,0.0013561965,0.00018940617,0.000011094128,0.00020962258,0.012443281,0.35551527],"study_design_scores_gemma":[0.0047375555,0.0053058416,0.9841528,0.0030587178,0.00006838804,2.851659e-7,0.00036015187,0.00024893894,0.0014560643,0.00018674183,0.0003138055,0.00011070939],"about_ca_topic_score_codex":0.000028737246,"about_ca_topic_score_gemma":0.00000239055,"teacher_disagreement_score":0.3618376,"about_ca_system_score_codex":0.0000055268047,"about_ca_system_score_gemma":0.00008898237,"threshold_uncertainty_score":0.3367542},"labels":[],"label_agreement":null},{"id":"W3123866707","doi":"10.1136/annrheumdis-2020-eular.6668","title":"THU0599 PULMONARY ARTERY ANEURYSM, BUDD CHIARI SYNDROME, INTRACARDIAC AND INFERIOR VENA CAVA THROMBOSES: AN UNUSUAL CASE OF BEHÇET'S DISEASE","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Inferior vena cava; Thrombus; Surgery; Radiology; Budd–Chiari syndrome; Patent foramen ovale; Behcet's disease; Internal medicine; Cardiology; Disease; Percutaneous","score_opus":0.03909195595911738,"score_gpt":0.29911220658544985,"score_spread":0.2600202506263325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123866707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886204,0.0061004884,0.0000074509294,0.0028407157,0.00013601409,0.000811048,0.0010432064,0.00007099527,0.00012805357],"genre_scores_gemma":[0.9978844,0.0008288414,0.000040470542,0.0009702337,0.00006671094,0.00003303226,0.000093612005,0.00005788976,0.00002483583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975789,0.00021953906,0.00074899965,0.00049286376,0.00055824395,0.00040141147],"domain_scores_gemma":[0.9971576,0.0001536193,0.00038052027,0.0009131601,0.00017012001,0.0012249834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015970872,0.00038366744,0.0009784382,0.00011227562,0.00014461814,0.000045834644,0.00030095407,0.000083399296,0.00021582437],"category_scores_gemma":[0.0005858495,0.00027856557,0.0005678347,0.00037502332,0.00049853156,0.0004219736,0.00027030002,0.00017778094,0.000009653742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053727548,0.017495101,0.75254625,0.035221104,0.006022091,0.054358434,0.004728912,0.00045049246,0.0026253187,0.0021064584,0.0064578177,0.11261528],"study_design_scores_gemma":[0.001129157,0.0010221848,0.98557097,0.0014975114,0.00223033,0.0039005824,0.0010225485,0.001921634,0.00030399914,0.00086785574,0.00008044306,0.00045276995],"about_ca_topic_score_codex":0.00011552024,"about_ca_topic_score_gemma":0.000003260769,"teacher_disagreement_score":0.23302475,"about_ca_system_score_codex":0.000011316801,"about_ca_system_score_gemma":0.00030681113,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W3124192127","doi":"10.1136/annrheumdis-2021-219898","title":"Response to: ‘Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al","year":2021,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Colchicine; Medicine; Gout; Coronavirus disease 2019 (COVID-19); Rheumatology; Rheumatism; Internal medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Intensive care medicine; Disease; Infectious disease (medical specialty)","score_opus":0.03571017410450214,"score_gpt":0.33733163649775166,"score_spread":0.3016214623932495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124192127","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33122784,0.0026020317,0.0003052799,0.6620446,0.00047795178,0.0018467611,0.0014644328,0.000013351575,0.000017774017],"genre_scores_gemma":[0.055656757,0.0015080856,0.000012415704,0.9385712,0.00014409209,0.0010510704,0.0011071747,0.00006217203,0.0018870315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978298,0.00068793696,0.0004519226,0.00040523423,0.00024168428,0.00038342344],"domain_scores_gemma":[0.9973906,0.0008613318,0.0002921871,0.001054373,0.0003088629,0.0000926398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008470515,0.0003554865,0.00038760388,0.000075293254,0.00037032654,0.00008408332,0.000522573,0.00023788963,0.000055928493],"category_scores_gemma":[0.0032249046,0.00021162868,0.00065587193,0.000102865306,0.00017643388,0.0000103208995,0.00014517276,0.00022443305,0.000006206655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027769487,0.00009710377,0.00003207803,0.00024756178,0.00035309693,0.00001805559,0.00015513405,0.00021708885,0.005144693,0.000013190926,0.98999625,0.000948765],"study_design_scores_gemma":[0.0010408117,0.0007151071,0.0001415125,0.0001625728,0.00006856267,0.00005023403,0.00015288458,0.00001679036,0.017787123,0.00012488774,0.9794338,0.00030574517],"about_ca_topic_score_codex":0.00006943148,"about_ca_topic_score_gemma":0.000014648073,"teacher_disagreement_score":0.2765266,"about_ca_system_score_codex":0.000016059743,"about_ca_system_score_gemma":0.0006172246,"threshold_uncertainty_score":0.8629967},"labels":[],"label_agreement":null},{"id":"W3124339251","doi":"10.1136/annrheumdis-2020-219214","title":"Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Gilead Sciences; Sanofi; Chugai Pharmaceutical; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Methotrexate; Placebo; Internal medicine; Arthritis; Antirheumatic Agents; Clinical trial; Physical therapy; Alternative medicine; Pathology","score_opus":0.0710712141158208,"score_gpt":0.39166313549240006,"score_spread":0.32059192137657927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124339251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902738,0.004125742,0.00001890335,0.0025215715,0.00025737917,0.0025674817,0.0001423868,0.000031321593,0.00006143748],"genre_scores_gemma":[0.9817148,0.017223224,0.00028797012,0.00030749617,0.000022955146,0.0002165099,0.000037153088,0.00003810548,0.00015182921],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99541223,0.0017009912,0.0011672806,0.00043815767,0.00079445296,0.0004869137],"domain_scores_gemma":[0.9942343,0.0038198547,0.0003100334,0.00070479687,0.00036020039,0.00057078537],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016759284,0.00028044387,0.0011881273,0.00018333715,0.00013050313,0.00007216754,0.00021851105,0.00007996697,0.00038593693],"category_scores_gemma":[0.015493837,0.00017299959,0.00027341995,0.0005375577,0.0003323497,0.00016627238,0.00018054362,0.00022875577,0.000011879427],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8171288,0.0022406303,0.0014421439,0.000067011584,0.00042944695,0.000064154345,0.0004636528,0.000004345737,0.000007730074,0.000026887796,0.0015600093,0.1765652],"study_design_scores_gemma":[0.94880205,0.0074305637,0.036271036,0.0047260677,0.000031572734,0.0000148389845,0.0006077362,0.00009583444,0.0004895829,0.00011563545,0.0011581345,0.00025694896],"about_ca_topic_score_codex":0.00005700424,"about_ca_topic_score_gemma":0.00009935383,"teacher_disagreement_score":0.17630824,"about_ca_system_score_codex":0.00002052919,"about_ca_system_score_gemma":0.0008506939,"threshold_uncertainty_score":0.9927991},"labels":[],"label_agreement":null},{"id":"W3124449102","doi":"10.1136/annrheumdis-2020-eular.3421","title":"FRI0024 HOW OFTEN DOES REACHING TARGET MISS THE MARK? LONGITUDINAL PATTERNS OF REMISSION IN REAL-WORLD EARLY RHEUMATOID ARTHRITIS PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; Southlake Regional Health Center; University of Manitoba; Université Laval; University of Calgary; McGill University; Université de Sherbrooke; Canadian Arthritis Network","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Rheumatology; Cohort; Spontaneous remission; Comorbidity; Prospective cohort study; Pediatrics; Pathology","score_opus":0.03646654389199957,"score_gpt":0.2917791001689793,"score_spread":0.25531255627697974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124449102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97474587,0.0046152696,0.000014261629,0.019199371,0.00012044973,0.00073337887,0.00024992484,0.000036835816,0.0002846102],"genre_scores_gemma":[0.96724886,0.032083623,0.0000646469,0.00033549414,0.000033711956,0.000036538408,0.000037658046,0.000038099028,0.000121372614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706364,0.0003888912,0.0007684168,0.00033362175,0.0009890173,0.00045643657],"domain_scores_gemma":[0.9979214,0.00039157015,0.00045147832,0.00065332995,0.00024233485,0.00033987337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041834853,0.00027235446,0.00073952385,0.000143411,0.0001522921,0.00006558401,0.0005380856,0.000053307966,0.00021010908],"category_scores_gemma":[0.0016308642,0.00014291683,0.00036520476,0.0003988514,0.00024312,0.00025564496,0.00025449265,0.00029189896,0.0000072815556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007125323,0.0005286613,0.9490621,0.00067281845,0.000246814,0.000014793173,0.0023317938,0.000008335206,0.00012770796,0.00022330368,0.006383118,0.03968804],"study_design_scores_gemma":[0.0019669787,0.000343533,0.9834283,0.008349355,0.000011673723,0.0000036453573,0.00069564575,0.00024746088,0.0021573226,0.0015291893,0.0010737589,0.00019311193],"about_ca_topic_score_codex":0.0011069375,"about_ca_topic_score_gemma":0.0001326484,"teacher_disagreement_score":0.039494928,"about_ca_system_score_codex":0.000020192356,"about_ca_system_score_gemma":0.00012610754,"threshold_uncertainty_score":0.58279794},"labels":[],"label_agreement":null},{"id":"W3124526690","doi":"10.1136/annrheumdis-2020-eular.1178","title":"OP0085 THE CHANGING STATES OF FIBROMYALGIA IN A LONGITUDINAL COHORT OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; Medac; Arthritis Society; Dutch Arthritis Society; Celgene; Chugai Pharmaceutical; Celltrion; Sanofi; European Commission; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Fibromyalgia; Axial spondyloarthritis; Multivariate statistics; Multivariate analysis; Internal medicine; Univariate; Longitudinal study; Cohort; Physical therapy; Rheumatology; Univariate analysis; Ankylosing spondylitis; Sacroiliitis; Pathology","score_opus":0.02631866423236472,"score_gpt":0.2798575510936052,"score_spread":0.2535388868612405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124526690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957333,0.0014315029,0.000011335315,0.0019361922,0.000019835226,0.000654837,0.0001724553,0.000007663226,0.000032884713],"genre_scores_gemma":[0.9996307,0.00022020805,0.00003437333,0.000012792422,0.0000033842066,0.000019788584,0.000039213348,0.000016296315,0.000023283925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828327,0.00010587317,0.00044207176,0.00016610636,0.0007199291,0.00028275987],"domain_scores_gemma":[0.99885803,0.00021346768,0.00024017223,0.00036678018,0.00020661077,0.00011494447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019780466,0.00013502657,0.0004782116,0.00009160554,0.00004221348,0.000007064208,0.0002736214,0.000029584036,0.00023755808],"category_scores_gemma":[0.00039929978,0.0000726954,0.00016118992,0.00056063186,0.0003683984,0.000071769784,0.00013501135,0.00010925921,0.0000028789123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011142071,0.0005195847,0.98028654,0.012829411,0.00043659666,0.000008714905,0.0019748416,0.00012854196,0.000039700248,0.00015801135,0.0008674789,0.0016363973],"study_design_scores_gemma":[0.001526465,0.000849021,0.9891278,0.00595282,0.000106927335,0.0000027795083,0.00048235123,0.00052064884,0.0011544069,0.00019129655,0.0000050720714,0.00008038175],"about_ca_topic_score_codex":0.000119774624,"about_ca_topic_score_gemma":0.0000013312996,"teacher_disagreement_score":0.008841315,"about_ca_system_score_codex":0.000011756488,"about_ca_system_score_gemma":0.00020849744,"threshold_uncertainty_score":0.29644325},"labels":[],"label_agreement":null},{"id":"W3124666911","doi":"10.1136/annrheumdis-2020-eular.1862","title":"AB0876 THE BENEFIT AND SAFETY OF DIACEREIN IN AGED AND OBESE PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS: DATA FROM THE DISSCO CLINICAL STUDY","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Internal medicine; Adverse effect; Body mass index; Celecoxib; Population; Randomized controlled trial; Clinical trial; Physical therapy","score_opus":0.0452271629190168,"score_gpt":0.31135615530612565,"score_spread":0.26612899238710885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124666911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346703,0.0029986673,0.0000012857028,0.0014071417,0.00006981077,0.0016967484,0.000339339,0.000009810925,0.000010168893],"genre_scores_gemma":[0.9989543,0.00037850937,0.00001051159,0.00052167976,0.00004263446,0.000027472974,0.000045626995,0.000016100219,0.0000031548723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981334,0.00042236134,0.00062657986,0.00024860457,0.0004149265,0.00015412425],"domain_scores_gemma":[0.99669504,0.0019176722,0.0003029233,0.00088118744,0.000053579384,0.00014958823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006086749,0.00016321291,0.00055496977,0.000017297682,0.000086688684,0.0000198375,0.0003542873,0.000033399956,0.000025594181],"category_scores_gemma":[0.0019524369,0.00006968532,0.000060480834,0.00016160827,0.00033279354,0.00010804707,0.00038497968,0.00015084996,0.0000016632096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009974694,0.00047102734,0.97201693,0.0003095054,0.00023366371,0.000003930598,0.0026091223,0.0000041091835,0.000001133808,0.00001171041,0.0004446797,0.0228967],"study_design_scores_gemma":[0.0042956313,0.0009369605,0.9904704,0.0019383775,0.00035182107,5.1115853e-7,0.0013885833,0.00037102308,0.0000062726535,0.00014491666,0.000015326772,0.0000801821],"about_ca_topic_score_codex":0.00010819443,"about_ca_topic_score_gemma":0.00015915945,"teacher_disagreement_score":0.022816516,"about_ca_system_score_codex":0.000003040216,"about_ca_system_score_gemma":0.00006255666,"threshold_uncertainty_score":0.28416848},"labels":[],"label_agreement":null},{"id":"W3124718252","doi":"10.1136/annrheumdis-2020-218625","title":"10-Year natural course of early hip osteoarthritis in middle-aged persons with hip pain: a CHECK study","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"ReumaNederland; Dutch Arthritis Association; Universiteit Leiden; Leids Universitair Medisch Centrum; Medisch Spectrum Twente","keywords":"Medicine; Osteoarthritis; Physical therapy; Cohort; Rheumatology; Cohort study; Population; Hip pain; Internal medicine","score_opus":0.03422164972417646,"score_gpt":0.27507603318851515,"score_spread":0.24085438346433868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124718252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212855,0.005828299,6.7582005e-7,0.00070364727,0.00006808974,0.00090326974,0.00009524689,0.000024398796,0.00024782773],"genre_scores_gemma":[0.99733454,0.00005758433,0.00008076646,0.00012201683,0.000016961827,0.000068868314,0.000032422795,0.000027277241,0.0022595408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832267,0.00031062827,0.00037951884,0.00024603875,0.00046364183,0.00027751026],"domain_scores_gemma":[0.99871206,0.00019369251,0.00019588516,0.00055330165,0.00020692618,0.00013811616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000271957,0.00020929037,0.0005889262,0.00007517374,0.00005824444,0.000017560473,0.00014894606,0.000043547872,0.00039528354],"category_scores_gemma":[0.00037879276,0.00013906076,0.00023570404,0.00034253235,0.000128844,0.00009813021,0.00006456991,0.00011362122,0.00001265608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008294421,0.022715567,0.6477776,0.0030018883,0.0022127035,0.0012869607,0.023316734,0.000013964904,0.0030017337,0.00041971589,0.0033438522,0.28461483],"study_design_scores_gemma":[0.033385925,0.023934769,0.84092337,0.01726734,0.0015419866,0.00010552284,0.059838753,0.00004443062,0.021301989,0.00084223837,0.00008576972,0.0007278984],"about_ca_topic_score_codex":0.000057490248,"about_ca_topic_score_gemma":0.00018394695,"teacher_disagreement_score":0.28388694,"about_ca_system_score_codex":0.000014062624,"about_ca_system_score_gemma":0.0002570433,"threshold_uncertainty_score":0.5670733},"labels":[],"label_agreement":null},{"id":"W3124810175","doi":"10.1136/annrheumdis-2020-219498","title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":691,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Canadian Arthritis Patient Alliance","funders":"Cilag; UCB Pharma; Manchester Biomedical Research Centre; Brigham Research Institute; Chugai Pharmaceutical; Agency for Healthcare Research and Quality; Medac; Gilead Sciences; Servier; Nordic Pharma Group; Astellas Pharma; Eisai; Samsung; Bristol-Myers Squibb; Pfizer Australia; European League Against Rheumatism; University College London; Glenmark Pharmaceuticals; National Institutes of Health; Mylan; Amgen; Rheumatology Research Foundation; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Celgene; Actelion Pharmaceuticals; Pfizer; Biogen; University College London Hospitals NHS Foundation Trust; Childhood Arthritis and Rheumatology Research Alliance; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Rheumatology; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Betacoronavirus; Internal medicine; Family medicine; Virology; Disease; Outbreak; Infectious disease (medical specialty)","score_opus":0.13122844325172378,"score_gpt":0.41659946871410186,"score_spread":0.2853710254623781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124810175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296582,0.0028463397,0.0001664477,0.062221467,0.00011252443,0.0014670108,0.0032315946,0.00018127727,0.000115139854],"genre_scores_gemma":[0.98790205,0.0019423607,0.000024249279,0.008824881,0.0000126480245,0.00014990664,0.0008328211,0.00005285451,0.00025820814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930345,0.0013193444,0.0018252952,0.0010705094,0.0018176397,0.00093273254],"domain_scores_gemma":[0.96122646,0.032006726,0.0019904494,0.0026516134,0.0007087252,0.0014160016],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092515955,0.00064644124,0.0019511969,0.00006989682,0.00047621652,0.000088663895,0.0009700719,0.0001921901,0.00015018585],"category_scores_gemma":[0.27333537,0.00034110853,0.0005502297,0.0020754142,0.0012874807,0.00018905727,0.00052517746,0.00052569184,0.000011059203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024352071,0.0022583983,0.97157216,0.0016095205,0.00401209,0.00026951783,0.0018609867,0.003343409,0.0000021269736,0.00035870232,0.011763432,0.0005144411],"study_design_scores_gemma":[0.007950848,0.00031526433,0.9745494,0.0049865204,0.001097075,0.0000100981715,0.002356719,0.001251814,0.000014539518,0.00665328,0.00036423048,0.00045021053],"about_ca_topic_score_codex":0.006709194,"about_ca_topic_score_gemma":0.0035768931,"teacher_disagreement_score":0.27241018,"about_ca_system_score_codex":0.000602561,"about_ca_system_score_gemma":0.0074963397,"threshold_uncertainty_score":0.9999052},"labels":[],"label_agreement":null},{"id":"W3125751635","doi":"10.1136/annrheumdis-2020-eular.5862","title":"FRI0086 DISEASE ACTIVITY MEASURES AND OTHER POTENTIAL PREDICTORS OF SUCCESSFUL TNF INHIBITORS TAPERING IN RA PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Chugai Pharmaceutical; Gilead Sciences; LEO Pharma; Medac; Fresenius Medical Care North America; Celltrion; Astellas Pharma; Eisai; Daiichi-Sankyo; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Pfizer; Biogen; Celgene; Bristol-Myers Squibb; Samsung; Genentech; UCB Pharma; Valeant Pharmaceuticals International; Sanofi; Amgen; Galderma; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Internal medicine; Adverse effect; Logistic regression; Observational study; Tapering; Exact test; Statistical significance","score_opus":0.026692177838870988,"score_gpt":0.2746764209607541,"score_spread":0.24798424312188314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125751635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933338,0.004061523,0.0000070614815,0.0017685724,0.00009507366,0.00048062636,0.00019112971,0.000019505927,0.000042680214],"genre_scores_gemma":[0.99811894,0.0016195328,0.000007835121,0.00016382633,0.000032694166,0.000019345562,0.000005415746,0.000021311225,0.000011124457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983868,0.00015901613,0.00036076512,0.000206062,0.00064971717,0.0002376334],"domain_scores_gemma":[0.99896586,0.0000904799,0.00017442278,0.000261574,0.00012584867,0.00038181563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013460181,0.00015591945,0.00040408588,0.00008852003,0.00006760049,0.00002847357,0.0001704542,0.000032119915,0.00006846913],"category_scores_gemma":[0.0011508049,0.000107524014,0.00017591678,0.00020897415,0.00035466295,0.00018397365,0.00014313894,0.00010318724,0.0000019453441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017227564,0.0007280282,0.9612073,0.00091775606,0.00022193699,0.000005454028,0.0011689457,0.000057673667,0.00040532197,0.000039335348,0.00095323677,0.03257226],"study_design_scores_gemma":[0.0020656888,0.0002741224,0.9915552,0.0016564238,0.000028208939,6.7513196e-7,0.00022950415,0.00056550826,0.0028715548,0.00031397873,0.00031371973,0.0001254295],"about_ca_topic_score_codex":0.00020153256,"about_ca_topic_score_gemma":0.000017435024,"teacher_disagreement_score":0.032446828,"about_ca_system_score_codex":0.000007398589,"about_ca_system_score_gemma":0.00013439429,"threshold_uncertainty_score":0.4384702},"labels":[],"label_agreement":null},{"id":"W3128254628","doi":"10.1136/annrheumdis-2020-219373","title":"European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Institutes of Health; Academy of Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Rheumatism; Rheumatology; League; Internal medicine; Family medicine; Physical therapy; Dermatology","score_opus":0.05796894442684368,"score_gpt":0.33393702437464884,"score_spread":0.27596807994780514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128254628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904647,0.0024368593,0.000050253268,0.0028474305,0.0003171211,0.00055610173,0.0002487981,0.00005458439,0.0030241394],"genre_scores_gemma":[0.9940351,0.004347589,0.0002482492,0.00020494816,0.000014116671,0.00003582744,0.00006431959,0.000057472964,0.0009923262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963481,0.0008681307,0.0012085494,0.00036977243,0.00078051747,0.00042494433],"domain_scores_gemma":[0.9961604,0.0006454635,0.00081300404,0.0013819833,0.000764567,0.00023460352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000735855,0.00025590902,0.001009937,0.00017845037,0.00013215063,0.00001657451,0.00051802717,0.000057847978,0.00018272678],"category_scores_gemma":[0.0028217877,0.0001888731,0.00035453434,0.0007603035,0.00062148046,0.00013771409,0.00027251898,0.00017039127,0.00006637987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006033679,0.0021060705,0.8275105,0.022257416,0.0014879263,0.00007320344,0.0033072978,0.000046364996,0.008739782,0.0035616031,0.064697646,0.065608874],"study_design_scores_gemma":[0.00413187,0.000573794,0.9056794,0.03456576,0.00038062845,0.003629321,0.01369919,0.01595257,0.018448802,0.0005645815,0.0016465798,0.0007275137],"about_ca_topic_score_codex":0.00004372854,"about_ca_topic_score_gemma":0.0000067349974,"teacher_disagreement_score":0.078168936,"about_ca_system_score_codex":0.000041683652,"about_ca_system_score_gemma":0.0004681303,"threshold_uncertainty_score":0.7702022},"labels":[],"label_agreement":null},{"id":"W3129553355","doi":"10.1136/annrheumdis-2021-220057","title":"Response to: ‘Correspondence on ‘Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment’’ by Pamuk and Hasni","year":2021,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Gray (unit); Systemic lupus; Cognitive impairment; Blood–brain barrier; Cognition; Internal medicine; Psychiatry; Central nervous system; Disease","score_opus":0.021105252779726205,"score_gpt":0.29227460741165034,"score_spread":0.27116935463192415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129553355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81715137,0.004327073,0.0000030787978,0.17445442,0.00012898837,0.0022771442,0.0015656251,0.00003190401,0.000060419763],"genre_scores_gemma":[0.81904995,0.000302045,0.000005828469,0.16322175,0.000057114667,0.00039449913,0.00015841823,0.00016231625,0.016648097],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99324614,0.0021464706,0.0010040748,0.0009803632,0.0017446612,0.0008783196],"domain_scores_gemma":[0.9913681,0.006039791,0.00064225734,0.0010850339,0.00045603,0.00040879202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014815717,0.0007393633,0.0018196891,0.0005552219,0.00013707353,0.0001496375,0.00043312574,0.00046781424,0.00028162522],"category_scores_gemma":[0.0047177114,0.00048170664,0.00026863063,0.000688141,0.00056369766,0.00012084546,0.0003532464,0.0009270476,0.000046621444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004347044,0.00040251846,0.19480461,0.00664865,0.0012667414,0.0017303816,0.0038690022,7.479643e-7,0.0002002574,0.0000013192489,0.78663844,0.0000902657],"study_design_scores_gemma":[0.035766136,0.0072466573,0.08689116,0.7575288,0.0046322336,0.073803045,0.020029724,0.00016039275,0.0047115777,0.0005750628,0.0044904477,0.004164758],"about_ca_topic_score_codex":0.000089547386,"about_ca_topic_score_gemma":0.000009598981,"teacher_disagreement_score":0.782148,"about_ca_system_score_codex":0.000111771435,"about_ca_system_score_gemma":0.0005656011,"threshold_uncertainty_score":0.9997635},"labels":[],"label_agreement":null},{"id":"W3134517937","doi":"10.1136/annrheumdis-2021-220078","title":"Response to: ‘Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group’’ by Jibri et al","year":2021,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliac joint; Sacrum; Axial spondyloarthritis; Concordance; Radiology; Nuclear medicine; Magnetic resonance imaging; Surgery; Sacroiliitis; Internal medicine","score_opus":0.04333178994883475,"score_gpt":0.29507252975508924,"score_spread":0.2517407398062545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134517937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7787142,0.0032330302,0.000005721243,0.21361952,0.00009178915,0.0009963738,0.0032707893,0.00000897108,0.000059618924],"genre_scores_gemma":[0.8817182,0.0037476432,0.00008737657,0.11254454,0.000019700932,0.00019142042,0.0015346564,0.0000509337,0.000105529776],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99647826,0.0012001765,0.0006528392,0.00039363783,0.0009680841,0.00030703034],"domain_scores_gemma":[0.9966891,0.0015468092,0.00054378255,0.00092945184,0.00021133281,0.00007954105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005798571,0.0003367117,0.0006954351,0.00014688326,0.00019768791,0.000045759458,0.00034389866,0.00010431288,0.00005793542],"category_scores_gemma":[0.00073053007,0.00018283915,0.00019599803,0.00046427437,0.00035067057,0.000108473745,0.00014799916,0.0003663208,0.0000033576282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004219355,0.002047032,0.018995848,0.00026311216,0.0005103289,0.00006256333,0.0015626313,0.000017667668,0.000046996836,0.000091107024,0.9648692,0.007314174],"study_design_scores_gemma":[0.010244515,0.006054618,0.8162205,0.039672736,0.0015216636,0.000067274865,0.0038730958,0.0000208936,0.00103553,0.0015654614,0.118739195,0.0009844841],"about_ca_topic_score_codex":0.00014557876,"about_ca_topic_score_gemma":0.00006026508,"teacher_disagreement_score":0.84613,"about_ca_system_score_codex":0.000022167744,"about_ca_system_score_gemma":0.00011459755,"threshold_uncertainty_score":0.7455964},"labels":[],"label_agreement":null},{"id":"W3134759431","doi":"10.1136/annrheumdis-2021-220008","title":"Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group‘","year":2021,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Sacroiliitis; Axial spondyloarthritis; Natural history; Radiology; Sacroiliac joint; Ankylosing spondylitis; Magnetic resonance imaging; Surgery; Internal medicine","score_opus":0.05080670631140296,"score_gpt":0.2796866725699311,"score_spread":0.22887996625852816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134759431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9333825,0.006746189,0.0000055437536,0.056182936,0.00014542753,0.0011543641,0.0021494224,0.000010141825,0.00022343505],"genre_scores_gemma":[0.97465897,0.0053337617,0.000055871325,0.018386625,0.000041838444,0.0001293471,0.00128228,0.00003633743,0.00007497148],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975418,0.00048901036,0.0005938486,0.00030512916,0.00081377215,0.00025644255],"domain_scores_gemma":[0.9974946,0.0008011505,0.00061441876,0.0008303045,0.00021026174,0.00004930012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024008252,0.00028704802,0.00065634627,0.00011219618,0.0001989601,0.000031650612,0.00029923176,0.00010965539,0.00008403735],"category_scores_gemma":[0.0003182637,0.00014586354,0.00019672848,0.00037046248,0.00044381837,0.00008838526,0.000108067936,0.00033350452,0.0000026104271],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002494027,0.007517919,0.20236744,0.0023650299,0.0022063004,0.00022219283,0.004099557,0.000051396284,0.000016063494,0.0009695148,0.72465426,0.05303631],"study_design_scores_gemma":[0.006114211,0.002338282,0.940662,0.030973477,0.0017261679,0.00004408594,0.0026947227,0.000021651664,0.000308277,0.0030473827,0.011532466,0.0005372286],"about_ca_topic_score_codex":0.00012984546,"about_ca_topic_score_gemma":0.00007288552,"teacher_disagreement_score":0.7382946,"about_ca_system_score_codex":0.000015474607,"about_ca_system_score_gemma":0.000081465754,"threshold_uncertainty_score":0.59481424},"labels":[],"label_agreement":null},{"id":"W3139078631","doi":"10.1136/annrheumdis-2019-eular.1145","title":"SAT0600 COMPARATIVE CARDIOVASCULAR SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AMONG INDIVIDUALS WITH OSTEOARTHRITIS; FINDINGS FROM PROVINCIAL PRESCRIPTION CLAIM RECORDS IN BRITISH COLUMBIA, CANADA","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Medical prescription; Osteoarthritis; Internal medicine; Celecoxib; Cohort; Population; Cohort study; Observational study; Retrospective cohort study; Medical record; Emergency medicine; Alternative medicine; Environmental health; Pharmacology","score_opus":0.007132314495447269,"score_gpt":0.21091833945775404,"score_spread":0.20378602496230677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139078631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523884,0.001315185,0.0000036179795,0.000040659706,0.00035781364,0.002181987,0.0006682125,0.000018200995,0.0001754606],"genre_scores_gemma":[0.99936,0.00011648565,0.00003320303,0.000094328745,0.00005468859,0.000073896445,0.00009301063,0.000033154796,0.00014122383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970194,0.00031402463,0.0008205358,0.0003695745,0.001097542,0.00037890984],"domain_scores_gemma":[0.99825037,0.0002402159,0.000431861,0.00065058074,0.00022869818,0.00019829188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005167094,0.00022829745,0.0012677207,0.00007902636,0.000090034475,0.00005476661,0.00028035516,0.00010976315,0.00013551168],"category_scores_gemma":[0.00015916866,0.00023621271,0.00034466523,0.00025753008,0.00024845917,0.00027107773,0.00010489745,0.00022172305,0.0000047957064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022650837,0.00014498377,0.9881193,0.0010985456,0.00063275447,0.000031434345,0.0010212498,0.0001494568,0.000081435115,0.0000013573899,0.0022184986,0.0062745],"study_design_scores_gemma":[0.0035269181,0.00029262883,0.9862942,0.006355052,0.00027206488,0.000007085779,0.0011113078,0.00015067031,0.0015379702,0.000025628216,0.00017646182,0.00025000377],"about_ca_topic_score_codex":0.61140335,"about_ca_topic_score_gemma":0.6836308,"teacher_disagreement_score":0.07222745,"about_ca_system_score_codex":0.00009654395,"about_ca_system_score_gemma":0.0010931159,"threshold_uncertainty_score":0.9632475},"labels":[],"label_agreement":null},{"id":"W3145440935","doi":"10.1136/annrheumdis-2020-219523","title":"EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"Medical Research Council; Manchester Biomedical Research Centre; Versus Arthritis; European League Against Rheumatism; National Institute for Health and Care Research; Arthritis Society","keywords":"Medicine; Outcome (game theory); Multidisciplinary approach; Work (physics); Family medicine; Systematic review; MEDLINE; Medical physics; Physical therapy","score_opus":0.09066039456642377,"score_gpt":0.3915247451093043,"score_spread":0.3008643505428805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145440935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447405,0.0039409325,0.00009702653,0.0007664671,0.000015867792,0.0006780131,0.0000096567765,0.000010139774,0.000007837729],"genre_scores_gemma":[0.9970213,0.00048812488,0.002206905,0.00016758849,0.0000052715236,0.00007319872,0.000010133208,0.000017490853,0.000009998433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800986,0.00017494679,0.0009623188,0.00020611886,0.0004128442,0.00023391019],"domain_scores_gemma":[0.9979083,0.00028675416,0.00068471505,0.000322709,0.00064004294,0.00015751336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064128486,0.000131791,0.00064773654,0.000112396774,0.00008696362,0.000025117146,0.00005312643,0.000020774714,0.000011800659],"category_scores_gemma":[0.004700886,0.00008292862,0.00007509483,0.00028968064,0.00019923385,0.00015990052,0.000049219532,0.000051345807,4.1890775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086709746,0.0002952535,0.9862489,0.00044197144,0.00044704447,0.0000199444,0.002337954,0.00008299694,0.00003766952,0.00013059992,0.000044777313,0.009045804],"study_design_scores_gemma":[0.0025691062,0.0006749638,0.9820016,0.0074934363,0.000043151642,0.0000061170804,0.0029473333,0.000018423569,0.0018690131,0.0022484025,0.000010817869,0.00011763569],"about_ca_topic_score_codex":0.00002256331,"about_ca_topic_score_gemma":0.00011220665,"teacher_disagreement_score":0.008928169,"about_ca_system_score_codex":0.000011349748,"about_ca_system_score_gemma":0.00014751867,"threshold_uncertainty_score":0.56277394},"labels":[],"label_agreement":null},{"id":"W3153108455","doi":"10.1136/annrheumdis-2021-220202","title":"Primary and secondary non-response: in need of operational definitions in observational studies","year":2021,"lang":"en","type":"editorial","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Gilead Sciences; Pfizer; Eli Lilly and Company","keywords":"Medicine; Observational study; Immunogenicity; Biological response modifiers; Secondary care; Intensive care medicine; Primary care; Rheumatoid arthritis; Immunology; Internal medicine; Antibody; Immune system; Family medicine","score_opus":0.09647775118293042,"score_gpt":0.366254817892422,"score_spread":0.26977706670949153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153108455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85209215,0.10426347,0.0000016291257,0.005344531,0.03532937,0.0007312163,0.0020140684,0.000009321432,0.00021424159],"genre_scores_gemma":[0.57354957,0.3945457,0.00055855437,0.0008326046,0.026028488,0.00055545033,0.0031100207,0.00010095028,0.00071862113],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99762857,0.00032949093,0.0007578827,0.00021788596,0.00086134055,0.00020483506],"domain_scores_gemma":[0.9950836,0.003660045,0.00022538945,0.00030977078,0.00063651754,0.00008471921],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00062833616,0.00019459781,0.00087296165,0.0002722282,0.000060167047,0.000022492573,0.00016937022,0.0001295864,0.00010869632],"category_scores_gemma":[0.008449299,0.00014721716,0.00017324527,0.0003115632,0.000411168,0.00014404838,0.00018912547,0.0003311403,0.0000013943936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024373468,0.0010298127,0.008477497,0.0041319807,0.0008092787,0.000031405663,0.0012964699,0.000046551828,0.00013029604,0.00068552524,0.9774638,0.0034600312],"study_design_scores_gemma":[0.0070337947,0.00062273827,0.92401266,0.035072394,0.000062769504,0.000011932935,0.0024165702,0.00015990082,0.00022238074,0.007932749,0.022009842,0.00044225185],"about_ca_topic_score_codex":0.00008777416,"about_ca_topic_score_gemma":0.000065953776,"teacher_disagreement_score":0.955454,"about_ca_system_score_codex":0.000037632293,"about_ca_system_score_gemma":0.002514535,"threshold_uncertainty_score":0.99990296},"labels":[],"label_agreement":null},{"id":"W3154922502","doi":"10.1136/annrheumdis-2020-eular.3429","title":"THU0154 PERCEPTIONS ABOUT INTERVENTIONS TO ENHANCE INFLUENZA VACCINE UPTAKE DIFFER BETWEEN VACCINATED AND UNVACCINATED RA/JIA PATIENTS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Vaccination; Influenza vaccine; Rheumatology; Psychological intervention; Internal medicine; Rheumatoid arthritis; Immunization; Intervention (counseling); Immunology; Family medicine; Physical therapy; Antibody","score_opus":0.04901798439973461,"score_gpt":0.36682423932795577,"score_spread":0.3178062549282212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154922502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536,0.003836063,0.000088892746,0.009194311,0.000058455487,0.00096135173,0.00034592295,0.000078269106,0.000076706674],"genre_scores_gemma":[0.99539685,0.0027914362,0.000070218106,0.0014309229,0.000035695364,0.00006296428,0.00007078111,0.00003360537,0.00010750829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980329,0.00015653596,0.00070007064,0.0003108583,0.00043083748,0.000368761],"domain_scores_gemma":[0.99818903,0.00015075998,0.00018918508,0.00043774003,0.0004110436,0.00062223943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013583257,0.00023841513,0.0005817799,0.0001313583,0.0002032101,0.000059211412,0.0003101005,0.000053726268,0.0006599975],"category_scores_gemma":[0.0016416295,0.00016597075,0.000332154,0.00048811655,0.00005995277,0.000189563,0.00027263036,0.000172422,0.000076259246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088156486,0.001267192,0.78751534,0.0020348553,0.00096010114,0.000004266178,0.0033682864,0.000015861657,0.0006260477,0.0002108788,0.035136368,0.16797921],"study_design_scores_gemma":[0.0015175189,0.0006059042,0.99307853,0.0023304056,0.0000629719,0.0000013134693,0.0002711208,0.000059196474,0.00073365,0.00044363074,0.00073458964,0.0001611784],"about_ca_topic_score_codex":0.000043234813,"about_ca_topic_score_gemma":0.000011888165,"teacher_disagreement_score":0.20556316,"about_ca_system_score_codex":0.000014578849,"about_ca_system_score_gemma":0.0000592895,"threshold_uncertainty_score":0.72265095},"labels":[],"label_agreement":null},{"id":"W3154962230","doi":"10.1136/annrheumdis-2020-219483","title":"Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vitamin K Research Studies","field":"Nursing","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; ReumaNederland; Erasmus Medisch Centrum; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Society; Erasmus Universiteit Rotterdam; ZonMw; European Commission; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Dutch Arthritis Society","keywords":"Acenocoumarol; Vitamin K antagonist; Medicine; Matrix gla protein; Internal medicine; Vitamin D and neurology; Warfarin; VKORC1; Incidence (geometry); Gastroenterology; Cartilage oligomeric matrix protein; Osteoarthritis; Cohort; Vitamin; Anticoagulant; Cartilage; Endocrinology; Pathology; Ectopic calcification; Calcification; CYP2C9; Atrial fibrillation","score_opus":0.027866330178928488,"score_gpt":0.3231058803091094,"score_spread":0.29523955013018094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154962230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220407,0.005003906,0.000003623523,0.0019949162,0.0000551273,0.00032026035,0.00030653735,0.000021793645,0.000089761874],"genre_scores_gemma":[0.9990286,0.0006097268,0.00008579749,0.00017563788,0.0000070638407,0.000019330824,0.000017673741,0.000017468445,0.00003867197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800867,0.00037461251,0.00036291257,0.00023601616,0.00072325557,0.00029454168],"domain_scores_gemma":[0.9980131,0.00068847026,0.00034298276,0.00042351303,0.00041735897,0.00011456666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030780619,0.0001662229,0.00047558735,0.000058754715,0.00021502886,0.000051690964,0.00022538575,0.000039317896,0.000030280937],"category_scores_gemma":[0.0033190937,0.0001071767,0.000105229294,0.00037756198,0.0006300354,0.0001631383,0.00027567372,0.0000852894,0.0000013583074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090094795,0.0023868738,0.80264276,0.0030593984,0.00093987683,0.00016539702,0.0039764578,0.0000112458065,0.017749822,0.00010999172,0.008780373,0.15927686],"study_design_scores_gemma":[0.0011879054,0.00058655854,0.8553462,0.008955889,0.00013293554,0.000019677147,0.0008075211,0.00023432486,0.13189842,0.0006211085,0.000023280252,0.00018615964],"about_ca_topic_score_codex":0.0001276958,"about_ca_topic_score_gemma":0.000063530155,"teacher_disagreement_score":0.1590907,"about_ca_system_score_codex":0.000014415642,"about_ca_system_score_gemma":0.00009683703,"threshold_uncertainty_score":0.4370539},"labels":[],"label_agreement":null},{"id":"W3157319772","doi":"10.1136/annrheumdis-2020-219717","title":"Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Ixekizumab; Placebo; Clinical endpoint; Internal medicine; Ankylosing spondylitis; Clinical trial; Disease; Secukinumab","score_opus":0.01644860238706701,"score_gpt":0.26782222050810606,"score_spread":0.25137361812103903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157319772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240434,0.0025915094,0.0000013366763,0.0004620874,0.00016521261,0.003640893,0.0003883169,0.000030848674,0.00031542743],"genre_scores_gemma":[0.99877167,0.0005355084,0.00006955864,0.00003913787,0.000040369658,0.00016079294,0.00014633227,0.00003610068,0.00020055451],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99717927,0.00037848952,0.0008918718,0.0005678477,0.0005956556,0.00038688348],"domain_scores_gemma":[0.99728227,0.0011919877,0.00041085834,0.00065269053,0.00022773318,0.00023443552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019363135,0.0004168975,0.0015353137,0.00008368724,0.00022632815,0.000053855245,0.000111962065,0.000059628095,0.000044267825],"category_scores_gemma":[0.0015396867,0.00025083005,0.00025222942,0.000275322,0.00014874255,0.0001237775,0.00013844941,0.0001155778,0.0000020850348],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76428956,0.00569814,0.1429683,0.000049794693,0.0027072532,0.00027774903,0.004386563,0.00004247324,0.0000050151934,0.0000050455046,0.00008781772,0.07948231],"study_design_scores_gemma":[0.49326798,0.0023833232,0.4992123,0.0025524541,0.00076011004,0.0000036322165,0.0015252155,0.00003123137,0.000051652278,0.000012985673,0.000032932076,0.00016617862],"about_ca_topic_score_codex":0.00052439823,"about_ca_topic_score_gemma":0.0006153538,"teacher_disagreement_score":0.356244,"about_ca_system_score_codex":0.000063006315,"about_ca_system_score_gemma":0.00017116395,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W3157537176","doi":"10.1136/annrheumdis-2021-220249","title":"2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"European League Against Rheumatism","keywords":"Medicine; Inflammatory arthritis; Arthritis; Intensive care medicine; Physical therapy; Immunology; Internal medicine","score_opus":0.016369114312833156,"score_gpt":0.311979329735506,"score_spread":0.29561021542267285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157537176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893047,0.0047781966,0.00008318121,0.004389261,0.00006352396,0.0011175771,0.00015287736,0.000008995035,0.00010169149],"genre_scores_gemma":[0.9816673,0.017620564,0.00034181593,0.00008843927,0.000007890603,0.00015949603,0.00008069155,0.00001111848,0.000022689394],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99893194,0.00009101519,0.00036742367,0.00011295874,0.0003264797,0.00017015265],"domain_scores_gemma":[0.9989698,0.00018106346,0.0001625729,0.0003304814,0.00030834405,0.000047752983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016690085,0.00008975777,0.00021145139,0.00006215347,0.00008919162,0.000028876473,0.000118660726,0.000013596342,0.0002500016],"category_scores_gemma":[0.00006958674,0.000053516364,0.000109310786,0.0001990464,0.00008624008,0.00015513376,0.00005656115,0.000043968914,0.0000013985526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007508425,0.002451363,0.3779397,0.002105997,0.0029527186,0.000008448408,0.004558294,0.0001595344,0.000028823859,0.025013901,0.014596921,0.56943345],"study_design_scores_gemma":[0.0051443656,0.00029197786,0.9686708,0.002198728,0.000050047616,0.0000013632681,0.016199103,0.00005496791,0.00095901045,0.0033317753,0.0029924677,0.00010541353],"about_ca_topic_score_codex":0.0000342542,"about_ca_topic_score_gemma":0.000116532916,"teacher_disagreement_score":0.5907311,"about_ca_system_score_codex":0.000010043446,"about_ca_system_score_gemma":0.00019943458,"threshold_uncertainty_score":0.27373424},"labels":[],"label_agreement":null},{"id":"W3157578989","doi":"10.1136/annrheumdis-2021-220206","title":"Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Immunology; Internal medicine; Autoantibody; Anti-nuclear antibody; Serology; Antibody; ARDS; Gastroenterology; Lung","score_opus":0.047785974851993894,"score_gpt":0.3454444150712498,"score_spread":0.2976584402192559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157578989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069667,0.001110571,0.0000110966685,0.0062366133,0.0000729475,0.00037991037,0.00022296394,0.000015969355,0.0012532884],"genre_scores_gemma":[0.990122,0.0011790064,0.00016565138,0.0084368475,0.0000135653245,0.000009361964,0.000010472862,0.00001925338,0.000043843906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985938,0.00021482496,0.0003701522,0.00029838493,0.00025521306,0.00026758798],"domain_scores_gemma":[0.9983346,0.00050825946,0.00009797279,0.00032318415,0.0004221909,0.00031379322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014688261,0.00018694723,0.0006683319,0.000073658564,0.00010052496,0.00003430204,0.00008880054,0.00006126471,0.000070041875],"category_scores_gemma":[0.0057420954,0.00013409785,0.0001300937,0.0002322374,0.00045878644,0.00011271169,0.00020021139,0.00010234138,0.000004177867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018642769,0.00072254485,0.98713356,0.0008390259,0.00044752966,0.000024672201,0.0018447478,0.0000019500214,0.0003882612,0.0025894078,0.0006393844,0.0051824613],"study_design_scores_gemma":[0.0016577923,0.000113188435,0.987064,0.0011079982,0.00020155367,0.000018575576,0.00082450797,0.000050179286,0.005193803,0.003387697,0.00022446967,0.00015622342],"about_ca_topic_score_codex":0.00031259377,"about_ca_topic_score_gemma":0.000025583471,"teacher_disagreement_score":0.005595213,"about_ca_system_score_codex":0.000019561701,"about_ca_system_score_gemma":0.0002222964,"threshold_uncertainty_score":0.68742394},"labels":[],"label_agreement":null},{"id":"W3157994245","doi":"10.1136/annrheumdis-2020-219601","title":"Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Tofacitinib; Medicine; Placebo; Ankylosing spondylitis; Adverse effect; Internal medicine; Randomized controlled trial; Janus kinase inhibitor; Gastroenterology; Surgery; Rheumatoid arthritis","score_opus":0.09127472958911044,"score_gpt":0.3844357516029048,"score_spread":0.29316102201379435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157994245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96738493,0.02224229,0.000030673677,0.0012668946,0.00019534506,0.007787679,0.00084957224,0.000019185332,0.00022339677],"genre_scores_gemma":[0.9943197,0.0027069962,0.000043252086,0.000115403716,0.000048972837,0.0019179455,0.00008391413,0.000022823768,0.0007409849],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981965,0.00013004245,0.0007516846,0.00025592177,0.0003801354,0.0002857107],"domain_scores_gemma":[0.99716634,0.0013077378,0.0003881111,0.0006798977,0.00034585877,0.000112061774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022935959,0.0002583467,0.0012360862,0.000053840613,0.00025858975,0.000027342094,0.00013202654,0.00003180809,0.00030378994],"category_scores_gemma":[0.0003973152,0.00012902207,0.0010112543,0.00020399306,0.00014471366,0.000051447634,0.000044763055,0.000033584685,0.0000018939827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88935995,0.02749381,0.0034655693,0.00034652275,0.014016244,0.00007377376,0.0038007125,0.000036257778,0.0000470776,0.00027923932,0.00095879403,0.060122035],"study_design_scores_gemma":[0.97838134,0.0030236903,0.001969283,0.000713907,0.0052809506,0.000020968562,0.006298267,0.00018508737,0.0026635246,0.00030919476,0.001012939,0.0001408625],"about_ca_topic_score_codex":0.00010917791,"about_ca_topic_score_gemma":0.00003722024,"teacher_disagreement_score":0.08902136,"about_ca_system_score_codex":0.000025064368,"about_ca_system_score_gemma":0.00017755388,"threshold_uncertainty_score":0.5261367},"labels":[],"label_agreement":null},{"id":"W3158548019","doi":"10.1136/annrheumdis-2020-219181","title":"Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; Merck KGaA","keywords":"Medicine; Osteoarthritis; Knee Joint; Term (time); Physical therapy; Internal medicine; Surgery; Pathology; Alternative medicine","score_opus":0.00816619691987149,"score_gpt":0.24275156817234203,"score_spread":0.23458537125247053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158548019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627584,0.0017450122,0.0000012103588,0.00020819886,0.00008711198,0.0015377571,0.00012100492,0.000012134644,0.000011723225],"genre_scores_gemma":[0.99965984,0.000042980882,0.00006247394,0.000083690546,0.000011580053,0.00004197213,0.000060480084,0.000017113729,0.000019848878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984975,0.00020545373,0.0004468569,0.00022493153,0.00043211321,0.00019316477],"domain_scores_gemma":[0.99854743,0.00043609005,0.00021332958,0.0005747747,0.00013169103,0.000096673975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008440668,0.00018048409,0.0004905298,0.000037656446,0.000054658452,0.000022683053,0.00010908246,0.000033740947,0.000017465947],"category_scores_gemma":[0.0006157202,0.00009693065,0.000105955725,0.00017460743,0.00011477731,0.000093580114,0.000099010715,0.00007009835,0.0000018730517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001061318,0.0009850371,0.9479655,0.00041193498,0.0003375808,0.000062417195,0.0018139827,0.0000026835935,0.000054705306,0.00004170724,0.000022368748,0.047240768],"study_design_scores_gemma":[0.014243364,0.0028228448,0.97284764,0.0041574496,0.00052904367,0.0000035220332,0.0006253766,0.0000073303218,0.0042322767,0.0004319533,2.6259505e-7,0.000098912016],"about_ca_topic_score_codex":0.000036881727,"about_ca_topic_score_gemma":0.000092240676,"teacher_disagreement_score":0.047141854,"about_ca_system_score_codex":0.000009138599,"about_ca_system_score_gemma":0.00006853578,"threshold_uncertainty_score":0.39527172},"labels":[],"label_agreement":null},{"id":"W3158574496","doi":"10.1136/annrheumdis-2020-eular.2236","title":"THU0194 CHARACTERISATION OF DEPTH OF RESPONSE, INCLUDING 50% IMPROVEMENT IN ACR COMPONENTS AT WEEK 12 AND REMISSION AT WEEK 24, FOLLOWING TREATMENT WITH FILGOTINIB COMPARED WITH METHOTREXATE OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Adalimumab; Methotrexate; Internal medicine; Placebo; Post hoc; Gastroenterology; Rheumatoid arthritis; Pathology","score_opus":0.07062488236928202,"score_gpt":0.30035793096094127,"score_spread":0.22973304859165924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158574496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603516,0.0015388002,0.000008764572,0.0007720533,0.000021407272,0.0014410662,0.00014827639,0.000016666289,0.00001778534],"genre_scores_gemma":[0.99444354,0.0049073095,0.00034349578,0.00006083134,0.000002915263,0.00007172807,0.000105467036,0.00003763305,0.000027113878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730295,0.00037500542,0.00080449384,0.0003413611,0.00082641136,0.00034975077],"domain_scores_gemma":[0.99821085,0.0004187084,0.0006262193,0.00036578902,0.00012551456,0.000252918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031630555,0.00030334672,0.0010320559,0.00018145365,0.00010962325,0.000016990625,0.00015450509,0.000041107705,0.00004814232],"category_scores_gemma":[0.00024933912,0.00016745344,0.000108054046,0.00030953053,0.00021545826,0.00021082637,0.00017145797,0.000089411995,8.797584e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10067693,0.002130055,0.861482,0.0006774291,0.0006615816,0.000028475899,0.006760468,0.000077866775,0.0059780274,0.0000029254447,0.00006176041,0.021462435],"study_design_scores_gemma":[0.021298334,0.008598674,0.94380814,0.013158015,0.000029547058,0.000007715957,0.0011903906,0.00042191005,0.011209732,0.0000128361635,0.000058593345,0.00020611762],"about_ca_topic_score_codex":0.00042742753,"about_ca_topic_score_gemma":0.000525252,"teacher_disagreement_score":0.082326084,"about_ca_system_score_codex":0.000098043274,"about_ca_system_score_gemma":0.00018392087,"threshold_uncertainty_score":0.6828553},"labels":[],"label_agreement":null},{"id":"W3162222593","doi":"10.1136/annrheumdis-2020-219014","title":"Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Sun Pharma","keywords":"Medicine; Placebo; Internal medicine; Psoriatic arthritis; Adverse effect; Psoriasis; Clinical endpoint; Psoriasis Area and Severity Index; Enthesitis; Arthritis; Randomized controlled trial; Dermatology","score_opus":0.03058301587270064,"score_gpt":0.30904323014384716,"score_spread":0.27846021427114653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162222593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899174,0.003699046,0.000001646704,0.00018266065,0.00006708996,0.0055014417,0.00048524485,0.000010013407,0.00013544038],"genre_scores_gemma":[0.99861604,0.0009424078,0.000043713793,0.000023932009,0.000009290736,0.0002277265,0.00007247809,0.000022460814,0.00004196668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974621,0.00025197028,0.0011160922,0.0003303515,0.00058292603,0.00025656322],"domain_scores_gemma":[0.9970679,0.0010723349,0.0007385585,0.00054719124,0.0004430763,0.00013088528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024348492,0.00027315816,0.0015299472,0.00012747497,0.00008364573,0.000010427391,0.00011465705,0.000042407297,0.000025093903],"category_scores_gemma":[0.0016875428,0.0001722065,0.000236502,0.00035500788,0.00020027994,0.00010190398,0.0001148268,0.000093166185,0.0000010073458],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8899175,0.023817206,0.023323726,0.0002757097,0.0029528886,0.00003235007,0.002220692,0.000044042783,0.0000034755835,0.0000101790565,0.00005428833,0.05734797],"study_design_scores_gemma":[0.7281961,0.0027996812,0.26338285,0.0026841285,0.0007612003,0.0000029017533,0.0016711361,0.000031057716,0.00032647466,0.000031433938,0.0000030816752,0.00010997325],"about_ca_topic_score_codex":0.00018490029,"about_ca_topic_score_gemma":0.00018731847,"teacher_disagreement_score":0.24005914,"about_ca_system_score_codex":0.000020817175,"about_ca_system_score_gemma":0.00017853505,"threshold_uncertainty_score":0.7022378},"labels":[],"label_agreement":null},{"id":"W3163953444","doi":"10.1136/annrheumdis-2021-eular.2599","title":"AB0557 ACHIEVING TREATMENT TARGETS IN PSORIATIC ARTHRITIS WITH APREMILAST IN CANADIAN PRACTICE: REAL WORLD RESULTS FROM APPRAISE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Windsor Regional Hospital; Amgen (Canada); Memorial University of Newfoundland; Université Laval; Vancouver Island University; Southlake Regional Health Center; Arthritis Society","funders":"Celgene; Amgen","keywords":"Medicine; Apremilast; Tolerability; Psoriatic arthritis; Internal medicine; Concomitant; Interim analysis; Clinical trial; Clinical endpoint; Observational study; Adverse effect; Physical therapy; Disease","score_opus":0.03231272302563403,"score_gpt":0.31874104812914017,"score_spread":0.28642832510350613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163953444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91371185,0.0354301,0.000015386384,0.036109928,0.00069994456,0.00086569507,0.0023749112,0.000037980204,0.010754213],"genre_scores_gemma":[0.9944751,0.003617302,0.0006723224,0.0005497956,0.0000134204365,0.00002372556,0.000099030956,0.00001287719,0.0005364262],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978919,0.00073307444,0.00054424437,0.0003199408,0.00007163278,0.00043918932],"domain_scores_gemma":[0.9977915,0.0013305292,0.000217027,0.00048083678,0.00008070483,0.0000993955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003620919,0.00019215529,0.0004844743,0.00013628574,0.00007989301,0.000023431174,0.00020318676,0.00009851719,0.00020423817],"category_scores_gemma":[0.0020654795,0.00012386034,0.00012201504,0.00044570697,0.00016284816,0.00010775228,0.000058088215,0.00016358655,0.000012320552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062957257,0.0077497056,0.17362538,0.00036598477,0.0039720894,0.0009990297,0.0062659876,0.000558213,0.001935099,0.003783151,0.02002344,0.7744262],"study_design_scores_gemma":[0.007999333,0.00043749542,0.9397487,0.0048642955,0.00042236844,0.000031847725,0.0022130446,0.00017257368,0.012417975,0.0022291958,0.028784705,0.00067845726],"about_ca_topic_score_codex":0.16510242,"about_ca_topic_score_gemma":0.49594474,"teacher_disagreement_score":0.77374774,"about_ca_system_score_codex":0.00007235045,"about_ca_system_score_gemma":0.00053568376,"threshold_uncertainty_score":0.8404572},"labels":[],"label_agreement":null},{"id":"W3163968658","doi":"10.1136/annrheumdis-2021-eular.142","title":"POS1023 HOW DOES GENDER AFFECT SECUKINUMAB TREATMENT OUTCOMES AND RETENTION RATES IN PATIENTS WITH PSORIATIC ARTHRITIS? – REAL WORLD DATA FROM THE GERMAN AQUILA STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; University of Washington; Sorbonne Université; Memorial University of Newfoundland; University of Leeds; Janssen Scientific Affairs","keywords":"Medicine; Secukinumab; Psoriatic arthritis; Internal medicine; Psoriasis Area and Severity Index; Discontinuation; BASDAI; Ankylosing spondylitis; Beck Depression Inventory; Rheumatoid arthritis; Psoriasis; Physical therapy; Immunology; Anxiety; Psychiatry","score_opus":0.05637795383459359,"score_gpt":0.30647568855226137,"score_spread":0.2500977347176678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163968658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309635,0.0041321614,5.9131474e-7,0.00061862654,0.00025591816,0.0006987437,0.0011633416,0.000018321876,0.000015938931],"genre_scores_gemma":[0.9973717,0.0013160553,0.000012426259,0.00005070312,0.000010404374,0.000058523907,0.0009055547,0.000015367237,0.00025929522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823445,0.0008071423,0.00026872125,0.0003649872,0.00009988281,0.00022482847],"domain_scores_gemma":[0.9981614,0.000549415,0.00024042967,0.00096536963,0.000057808767,0.000025611433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015303289,0.00023765575,0.0004756354,0.00005024116,0.0001660036,0.000052159547,0.00030192488,0.00003642798,0.000075657445],"category_scores_gemma":[0.0001279584,0.00010521385,0.000099583034,0.00017417801,0.00013914422,0.00015911084,0.00020177593,0.000052582443,0.000009110737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003158505,0.0015692146,0.9542209,0.00002142501,0.0015590843,0.0000061243595,0.0009582911,9.936143e-7,0.000015126847,0.000029971317,0.00041573175,0.040887307],"study_design_scores_gemma":[0.0041800058,0.00021863988,0.9928184,0.00020139561,0.00058430224,6.632119e-7,0.00094531267,0.0000036045892,0.00034965755,0.0005375232,0.000026912057,0.00013356397],"about_ca_topic_score_codex":0.00064520765,"about_ca_topic_score_gemma":0.0047651264,"teacher_disagreement_score":0.040753745,"about_ca_system_score_codex":0.000017026627,"about_ca_system_score_gemma":0.000056750505,"threshold_uncertainty_score":0.4290496},"labels":[],"label_agreement":null},{"id":"W3163972164","doi":"10.1136/annrheumdis-2021-eular.544","title":"POS0594 MEANINGFUL IMPROVEMENT AND WORSENING IN PATIENTS WHO DO NOT ACHIEVE LDA AND SWITCH THERAPY TO A NEW BIOLOGIC OR TARGETED THERAPY: RESULTS FROM THE CORRONA REGISTRY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Instituto de Investigación Marqués de Valdecilla; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Patient-Centered Outcomes Research Institute; Gilead Sciences; Sanofi; Pfizer; Amgen","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Combination therapy; Physical therapy; Disease","score_opus":0.058254993974295156,"score_gpt":0.3206503309199542,"score_spread":0.26239533694565903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163972164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835841,0.0062114503,0.000005736488,0.0089347325,0.00007741947,0.0009433562,0.00018232889,0.000016835382,0.00004406132],"genre_scores_gemma":[0.99035746,0.005333622,0.00010529322,0.0035617533,0.000043979882,0.000030420215,0.00005255748,0.000024161502,0.00049072417],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99790233,0.00019563653,0.0005424721,0.00044560328,0.000547902,0.00036607502],"domain_scores_gemma":[0.9974385,0.001064948,0.0002334762,0.000842115,0.00017461175,0.00024634026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038201013,0.00023465217,0.00048341372,0.000052708205,0.000105931475,0.00007525819,0.00030429283,0.000073561714,0.00006960965],"category_scores_gemma":[0.0026047018,0.00011553482,0.0001018158,0.00036751412,0.00015336186,0.00006858951,0.00032896755,0.00016583741,0.0000029096238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044614293,0.0018126477,0.10686516,0.00037459476,0.0015723745,0.00008776915,0.019483943,0.00010164814,0.002980211,0.00007387729,0.03502304,0.78701043],"study_design_scores_gemma":[0.044878155,0.0021771577,0.9309894,0.0038645817,0.000094874435,0.000017375487,0.003241556,0.0009694711,0.010127141,0.0022013986,0.0010030149,0.00043590905],"about_ca_topic_score_codex":0.0024807586,"about_ca_topic_score_gemma":0.00011094795,"teacher_disagreement_score":0.8241242,"about_ca_system_score_codex":0.0002364508,"about_ca_system_score_gemma":0.001791474,"threshold_uncertainty_score":0.47113734},"labels":[],"label_agreement":null},{"id":"W3163976198","doi":"10.1136/annrheumdis-2021-eular.475","title":"AB0527 CORRELATIONS BETWEEN REDUCTIONS IN FATIGUE SEVERITY AND IMPROVEMENTS IN PHYSICAL FUNCTION AND CLINICAL RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE PHASE 3 DISCOVER PROGRAM","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Internal medicine; Physical therapy; Clinical trial; Post-hoc analysis; Post hoc; Arthritis; Pathology; Alternative medicine","score_opus":0.04066196266030002,"score_gpt":0.3634172688851685,"score_spread":0.3227553062248685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163976198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994306,0.0012939052,0.000006670241,0.0029378235,0.000063781445,0.0009494106,0.0004245463,0.0000102437425,0.0000076104416],"genre_scores_gemma":[0.997483,0.002155963,0.000041977542,0.000056117606,0.000025800453,0.00007016751,0.0001464743,0.000010432121,0.000010074497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803984,0.00059638324,0.00056508585,0.0002655119,0.00033266083,0.00020051596],"domain_scores_gemma":[0.99821156,0.0010864342,0.0001511942,0.00034528275,0.000094359166,0.000111161804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043955544,0.00012448564,0.0003696658,0.00006846345,0.000081809674,0.000043690874,0.000071965296,0.000039559665,0.000008036771],"category_scores_gemma":[0.0024141655,0.0000762815,0.00006694774,0.00035126592,0.00031955956,0.00022331766,0.000079756115,0.00023003528,8.2521e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006241297,0.003499144,0.8006358,0.00003060338,0.00015038626,0.000003916548,0.00079291064,0.000010115595,0.0000029439855,0.000032520613,0.00015112334,0.18844925],"study_design_scores_gemma":[0.014239146,0.0008267993,0.97944075,0.001913355,0.00002485436,6.5367124e-7,0.0005773547,0.00044469256,0.000011188327,0.002415056,0.000027601145,0.0000785488],"about_ca_topic_score_codex":0.0003931706,"about_ca_topic_score_gemma":0.0003969246,"teacher_disagreement_score":0.1883707,"about_ca_system_score_codex":0.00001581338,"about_ca_system_score_gemma":0.00018367611,"threshold_uncertainty_score":0.31106693},"labels":[],"label_agreement":null},{"id":"W3163987935","doi":"10.1136/annrheumdis-2021-eular.884","title":"POS1038 THE EFFECT OF FILGOTINIB ON ENTHESITIS: 100-WEEK DATA FROM AN OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Galápagos; Gilead Sciences","keywords":"Medicine; Enthesitis; Psoriatic arthritis; Internal medicine; Placebo; Surgery; Arthritis; Pathology","score_opus":0.07128501438015125,"score_gpt":0.3573001817615732,"score_spread":0.28601516738142196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163987935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537057,0.00084675156,7.853544e-7,0.0004133171,0.00009319078,0.002314624,0.00089819956,0.000011940805,0.000050645653],"genre_scores_gemma":[0.9989344,0.00013710394,0.000038703038,0.00020133983,0.000014739033,0.000072111194,0.00053690356,0.000031389947,0.000033312732],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972661,0.00084833405,0.00047944742,0.0004687143,0.0007150036,0.00022237317],"domain_scores_gemma":[0.99574953,0.001218045,0.00038344914,0.0023840433,0.00015247933,0.00011243428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002952546,0.0002466748,0.00075069064,0.000051829393,0.00008204371,0.00003326694,0.0007800023,0.00003630898,0.00016844716],"category_scores_gemma":[0.0015968805,0.00012711038,0.00005485467,0.00027493763,0.00010552618,0.00025660114,0.00054285163,0.00012918445,0.000012100562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013672731,0.04506883,0.44931254,0.00049760286,0.0032410896,0.00016815064,0.003116618,0.000091640664,0.000036367164,0.000014503081,0.0031645698,0.48161536],"study_design_scores_gemma":[0.018680554,0.0067653954,0.9667416,0.0047497326,0.0006262861,0.0000024244769,0.00070720917,0.00026738763,0.0012261348,0.00010696942,0.0000040065543,0.0001222652],"about_ca_topic_score_codex":0.0012226236,"about_ca_topic_score_gemma":0.00027091114,"teacher_disagreement_score":0.5174291,"about_ca_system_score_codex":0.00007263385,"about_ca_system_score_gemma":0.00032472634,"threshold_uncertainty_score":0.5183411},"labels":[],"label_agreement":null},{"id":"W3163991765","doi":"10.1136/annrheumdis-2021-eular.1620","title":"POS0918 EVALUATION OF SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING IXEKIZUMAB THERAPY OVER 2 YEARS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ixekizumab; Ankylosing spondylitis; Axial spondyloarthritis; Internal medicine; Logistic regression; Radiography; Placebo; Physical therapy; Surgery; Rheumatoid arthritis; Sacroiliitis; Secukinumab; Psoriatic arthritis; Pathology","score_opus":0.028642665917012436,"score_gpt":0.31735877200688406,"score_spread":0.28871610608987164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163991765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754556,0.023155555,5.637939e-7,0.00022027377,0.000130768,0.0008778899,0.00006759309,0.000013164254,0.000078636556],"genre_scores_gemma":[0.99602157,0.0036724315,0.00006479578,0.00006396259,0.000017128368,0.00006772903,0.00006144435,0.000023208226,0.000007710068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976597,0.00025002973,0.0004478651,0.00026304723,0.0011274136,0.0002519705],"domain_scores_gemma":[0.99858505,0.00005847413,0.0003085576,0.00046254607,0.00049642246,0.00008893124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028579507,0.00018878214,0.00050781015,0.00024386942,0.00007346873,0.000014547591,0.00011028855,0.000051066756,0.00015715654],"category_scores_gemma":[0.00025051017,0.0001284877,0.00030334367,0.0009423261,0.00020790478,0.000118520016,0.00005191689,0.00008462678,0.000001050142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015899137,0.0016090611,0.72949106,0.000115167066,0.00040563373,0.000014731507,0.00018524533,0.000011874401,0.000010103887,0.000023795597,0.00012967993,0.26641375],"study_design_scores_gemma":[0.012587613,0.0011075237,0.9805399,0.0046113203,0.00023968071,0.000007568245,0.000101998856,0.00003318601,0.0002479174,0.00037860268,0.000026340207,0.00011831485],"about_ca_topic_score_codex":0.000075354365,"about_ca_topic_score_gemma":0.00004007604,"teacher_disagreement_score":0.26629543,"about_ca_system_score_codex":0.000022895789,"about_ca_system_score_gemma":0.00018488156,"threshold_uncertainty_score":0.52395767},"labels":[],"label_agreement":null},{"id":"W3163993890","doi":"10.1136/annrheumdis-2021-eular.3582","title":"POS1375 THE EFFECT OF M694V HOMOZYGOSITY ON THE CAROTID INTIMA-MEDIA THICKNESS AND FLOW MEDIATED DILATATION IN PATIENTS WITH FMF RELATED AMYLOIDOSIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biomarkers in Disease Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; MEFV; Internal medicine; Amyloidosis; Endothelial dysfunction; Familial Mediterranean fever; Intima-media thickness; Gastroenterology; Diabetes mellitus; Risk factor; Cardiology; Pathology; Disease; Gene mutation; Endocrinology; Mutation; Carotid arteries","score_opus":0.007041725432700012,"score_gpt":0.2075395184925437,"score_spread":0.2004977930598437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163993890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960659,0.0014645921,0.0000045157954,0.0011963556,0.00025098948,0.00061655237,0.00033602677,0.000017017406,0.000048011978],"genre_scores_gemma":[0.9994215,0.00012384738,0.00000805121,0.00017479909,0.0000021713756,0.000045311856,0.00018662783,0.000015047984,0.000022675076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976643,0.0013824768,0.00036784777,0.0002209759,0.00015532461,0.00020912394],"domain_scores_gemma":[0.9965675,0.0023371084,0.00030847234,0.0006076753,0.00015097737,0.000028265924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049228634,0.00019666205,0.00036818418,0.00005967848,0.00016039038,0.000014183687,0.00036941445,0.00011501064,0.00012413735],"category_scores_gemma":[0.0019651446,0.000088446264,0.00012648969,0.00038521268,0.000526959,0.000068411166,0.0001788379,0.00019273497,0.0000116614265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005405553,0.0020834033,0.9429557,0.0012528625,0.0036775642,0.0000070186225,0.0062175826,0.00024787622,0.004677244,0.001462658,0.0050786,0.02693395],"study_design_scores_gemma":[0.0018888222,0.00028082955,0.96120775,0.0009187509,0.0002718891,0.000002658546,0.00033612212,0.00005754081,0.03397499,0.0009229118,0.000006131088,0.0001316022],"about_ca_topic_score_codex":0.000051995226,"about_ca_topic_score_gemma":0.000024644929,"teacher_disagreement_score":0.029297747,"about_ca_system_score_codex":0.000011547006,"about_ca_system_score_gemma":0.00006388936,"threshold_uncertainty_score":0.3606734},"labels":[],"label_agreement":null},{"id":"W3164005454","doi":"10.1136/annrheumdis-2021-eular.604","title":"POS0907 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Placebo; Ankylosing spondylitis; Clinical endpoint; Internal medicine; BASDAI; Exacerbation; Minimal clinically important difference; Randomized controlled trial; Back pain; Arthritis; Psoriatic arthritis","score_opus":0.00907366834452972,"score_gpt":0.2630155352134659,"score_spread":0.25394186686893616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164005454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765366,0.0005666401,8.8854495e-7,0.0007449,0.000042014395,0.0006448736,0.00027141324,0.000009372335,0.00006622698],"genre_scores_gemma":[0.9996218,0.000060992235,0.00004097637,0.00016952908,0.0000060399307,0.00002637326,0.00002427519,0.000019102828,0.000030931315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982806,0.00055084954,0.00033387748,0.00024277701,0.00035981185,0.00023211734],"domain_scores_gemma":[0.998364,0.0008586172,0.00017427269,0.00033990914,0.00013842284,0.00012478208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042194358,0.0001874227,0.00055018696,0.00012795874,0.000074538824,0.000011876926,0.00006218983,0.000030696792,0.000022763053],"category_scores_gemma":[0.0014471092,0.0001223079,0.0001033872,0.00025932732,0.00011691428,0.0000708952,0.00008895263,0.000069810434,0.0000014239332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03875119,0.0012257599,0.6097143,0.001444018,0.0007029293,0.00014167816,0.0034379521,0.000048161968,0.0002798348,0.000027718916,0.00014471365,0.3440817],"study_design_scores_gemma":[0.004841529,0.002533462,0.9720063,0.0090181595,0.00011741963,0.0000045178112,0.00044804657,0.000012324975,0.010864662,0.000022760812,0.000019522016,0.00011124841],"about_ca_topic_score_codex":0.000057109555,"about_ca_topic_score_gemma":0.0000072467333,"teacher_disagreement_score":0.36229202,"about_ca_system_score_codex":0.000027372665,"about_ca_system_score_gemma":0.00008880248,"threshold_uncertainty_score":0.49875712},"labels":[],"label_agreement":null},{"id":"W3164016623","doi":"10.1136/annrheumdis-2021-eular.2115","title":"OP0172 BRENTUXIMAB VEDONTIN FOR SKIN INVOLVEMENT IN REFRACTORY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS, INTERIM RESULTS OF A PHASE IIB OPEN-LABEL TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"Regeneron Pharmaceuticals; Samsung; Genentech; Acceleron; Cumberland Pharmaceuticals; Eli Lilly and Company; CSL Behring; Medpace; Biogen; Gilead Sciences; Amgen; Pfizer","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Rituximab; Clinical endpoint; Scleroderma (fungus); Gastroenterology; Surgery; Clinical trial; Lymphoma; CD30; Immunology","score_opus":0.1539483457360499,"score_gpt":0.37941299723752303,"score_spread":0.22546465150147313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164016623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748997,0.019510048,0.000016388489,0.0007763888,0.00060947525,0.002994383,0.0010406546,0.000024415825,0.00012851754],"genre_scores_gemma":[0.99318594,0.005491915,0.00006746392,0.00029438108,0.00006355177,0.00030912424,0.00017053986,0.000041096664,0.0003760174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99643177,0.00035220958,0.0018411834,0.0004571317,0.00056021643,0.00035747304],"domain_scores_gemma":[0.99662805,0.00060270424,0.0010228191,0.0010915629,0.00041785894,0.00023700872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052580214,0.00028966545,0.0011968993,0.00014860014,0.00007752896,0.000058204063,0.00059573265,0.00012368473,0.000039727085],"category_scores_gemma":[0.002684829,0.00019922099,0.00044345105,0.00037708957,0.00015109101,0.00012666332,0.00034699653,0.00012128241,0.000004047004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37227213,0.17775135,0.0014392554,0.020256562,0.005272983,0.00013842559,0.00640129,0.00009255645,0.07894309,0.0005536402,0.09481686,0.24206185],"study_design_scores_gemma":[0.75080216,0.0066041043,0.0044588014,0.17894168,0.0025179484,0.000120279896,0.007986677,0.002025007,0.044308838,0.00063346507,0.0007204943,0.0008805481],"about_ca_topic_score_codex":0.0002849214,"about_ca_topic_score_gemma":0.000024828572,"teacher_disagreement_score":0.37853003,"about_ca_system_score_codex":0.00007154171,"about_ca_system_score_gemma":0.0005846558,"threshold_uncertainty_score":0.81239957},"labels":[],"label_agreement":null},{"id":"W3164028019","doi":"10.1136/annrheumdis-2021-eular.1092","title":"OP0284 OUTCOME OF COVID-19 IN PATIENTS WITH RHEUMATIC AND INFLAMMATORY DISEASES TREATED WITH RITUXIMAB: DATA FROM DE FRENCH RMD COVID-19 COHORT","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Rituximab; Internal medicine; Comorbidity; Cohort; Population; Rheumatoid arthritis; Retrospective cohort study; Confounding; Propensity score matching; Intensive care unit; Cohort study; Mortality rate","score_opus":0.06650484761613192,"score_gpt":0.33351682769749297,"score_spread":0.26701198008136107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164028019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98998874,0.003961258,0.000078167504,0.003216056,0.000024111234,0.0008052738,0.0017989984,0.000059830625,0.000067551075],"genre_scores_gemma":[0.9949907,0.0006376487,0.00016047769,0.0035452596,0.0000066007656,0.00007080663,0.00050308974,0.000024320245,0.00006109566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726975,0.00031625782,0.00083337753,0.00051582634,0.00070841063,0.00035637862],"domain_scores_gemma":[0.9961402,0.0012326468,0.00048426192,0.0012761782,0.00019303474,0.0006736989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020785509,0.00034365908,0.0012427367,0.00011268048,0.00014143088,0.000030962998,0.00046285614,0.000070293725,0.00019247211],"category_scores_gemma":[0.005491072,0.00019305704,0.00011980278,0.00041849175,0.0006937696,0.00019108996,0.0004975973,0.0001263705,0.0000043079285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007325156,0.0018118441,0.99025065,0.0030075705,0.0008114258,0.00008819188,0.00032038073,0.00006205677,0.0000011996251,0.00005796442,0.0024015047,0.00045471574],"study_design_scores_gemma":[0.0059502088,0.00018116286,0.9891875,0.0013294155,0.0008690981,0.000010598377,0.00053590786,0.000271646,0.000020874242,0.0012524708,0.0001535295,0.00023759983],"about_ca_topic_score_codex":0.0016694851,"about_ca_topic_score_gemma":0.00032872934,"teacher_disagreement_score":0.0052832165,"about_ca_system_score_codex":0.00007096022,"about_ca_system_score_gemma":0.0009792296,"threshold_uncertainty_score":0.78726375},"labels":[],"label_agreement":null},{"id":"W3164028683","doi":"10.1136/annrheumdis-2021-eular.1002","title":"POS1042 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITOR, COMPARED WITH PLACEBO AND APREMILAST IN MODERATE TO SEVERE PLAQUE PSORIASIS: RESULTS FROM THE PHASE 3 POETYK PSO-1 STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"LEO Pharma; Foundation for Research in Rheumatology; Genentech; Celgene; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Apremilast; Medicine; Placebo; Psoriasis; Psoriatic arthritis; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Gastroenterology; Arthritis; Dermatology; Pathology","score_opus":0.035888513442331606,"score_gpt":0.2916870868243451,"score_spread":0.25579857338201345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164028683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220324,0.0034047258,0.0000074762756,0.0006508726,0.00007954921,0.0009816835,0.0026180882,0.000019412317,0.000034939345],"genre_scores_gemma":[0.9990593,0.00033784477,0.00007377004,0.00012180113,0.000011000549,0.00004782392,0.00027361172,0.000018575185,0.000056255252],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99769217,0.0009796234,0.0005427584,0.00043150832,0.00009757403,0.00025636062],"domain_scores_gemma":[0.99794537,0.0009999336,0.00026132105,0.0005342385,0.00018735586,0.00007179733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002805069,0.00028036142,0.00062610424,0.000062382176,0.00020529244,0.00003075309,0.00022042541,0.00007899584,0.000021331867],"category_scores_gemma":[0.00042139014,0.0001681827,0.00006396048,0.0003084324,0.00020026557,0.00012624197,0.0001542647,0.00011110597,0.000002663276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4802411,0.051476102,0.12755352,0.00058989244,0.014963181,0.00018283559,0.097705506,0.0043466752,0.033821788,0.0005069502,0.01138044,0.17723203],"study_design_scores_gemma":[0.08914719,0.0036185787,0.78247267,0.0027039493,0.0016363565,0.000053423733,0.01754366,0.00019451404,0.10104174,0.000641342,0.00015421187,0.0007923629],"about_ca_topic_score_codex":0.0006355223,"about_ca_topic_score_gemma":0.00095551735,"teacher_disagreement_score":0.65491915,"about_ca_system_score_codex":0.000013667903,"about_ca_system_score_gemma":0.00014099274,"threshold_uncertainty_score":0.68582916},"labels":[],"label_agreement":null},{"id":"W3164038827","doi":"10.1136/annrheumdis-2021-eular.1598","title":"POS1426 PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES ARE OVERREPRESENTED IN LOW- FREQUENCY VIRAL SYMPTOM CLUSTERS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universitätsklinikum Erlangen; Massachusetts General Hospital; Isfahan University of Medical Sciences; University of British Columbia; Friedrich-Alexander-Universität Erlangen-Nürnberg; Faculty of Medicine, University of British Columbia","keywords":"Medicine; Asymptomatic; Poisson regression; Population; Disease; Cluster (spacecraft); Immunology; Internal medicine; Pediatrics","score_opus":0.019562275108907907,"score_gpt":0.30300943327000274,"score_spread":0.28344715816109484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164038827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954533,0.0020652076,0.0000050329118,0.0010185039,0.00011462608,0.00078521646,0.00022237281,0.00005580075,0.00027992346],"genre_scores_gemma":[0.9988339,0.0001744791,0.000009202348,0.00054516393,0.000021162885,0.000085607746,0.00013986904,0.000040161696,0.00015047197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714553,0.0004092667,0.00071000966,0.00034249597,0.00096910755,0.0004236018],"domain_scores_gemma":[0.99735945,0.00032595405,0.00034495693,0.0010399725,0.0006430441,0.0002866223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001412934,0.00025674514,0.0005777472,0.0002568609,0.00010878096,0.000044888424,0.00029605627,0.000072844305,0.00030254805],"category_scores_gemma":[0.0028990225,0.00017156795,0.0002710737,0.00079834904,0.00034062308,0.00032619326,0.00023875645,0.00022803205,0.000035514244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045083853,0.001769267,0.9942581,0.0009366948,0.00034946197,0.00007086891,0.000089431094,0.00020415745,0.00015163096,0.000057368685,0.00079470227,0.00086746673],"study_design_scores_gemma":[0.0024892555,0.00017186608,0.9920699,0.003255905,0.00010910632,0.000003330873,0.00019806396,0.00028195902,0.00096833595,0.00024893443,0.00002413241,0.00017918505],"about_ca_topic_score_codex":0.0001582441,"about_ca_topic_score_gemma":0.000047704732,"teacher_disagreement_score":0.0033805652,"about_ca_system_score_codex":0.00007790462,"about_ca_system_score_gemma":0.0005340948,"threshold_uncertainty_score":0.69963384},"labels":[],"label_agreement":null},{"id":"W3164041117","doi":"10.1136/annrheumdis-2021-eular.1862","title":"POS1050 SECUKINUMAB LEADS TO IMPROVEMENT ACROSS PSORIATIC ARTHRITIS MANIFESTATIONS OVER 2 YEARS REGARDLESS OF PREVIOUS EXPOSURE TO A TNF INHIBITOR: A POST HOC ANALYSIS OF FUTURE 5","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation","funders":"Medac; Galápagos; Pfizer; Novartis Pharmaceuticals Corporation; Biogen; Celgene; Gilead Sciences; Regeneron Pharmaceuticals; Novartis; Amgen; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Secukinumab; Psoriatic arthritis; Dactylitis; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Enthesitis; Ustekinumab; Placebo; Clinical endpoint; Post-hoc analysis; Dermatology; Physical therapy; Surgery; Disease; Clinical trial; Adalimumab; Pathology","score_opus":0.013931697461441095,"score_gpt":0.31346266063075195,"score_spread":0.2995309631693109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164041117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274434,0.012282962,0.000020549318,0.0024823027,0.00016521775,0.0007537646,0.001497627,0.000018174343,0.00003506165],"genre_scores_gemma":[0.98954964,0.009368606,0.00020345434,0.00048303336,0.000047341982,0.00008088389,0.00008937247,0.000027744258,0.00014992538],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99736416,0.0001565606,0.0008478259,0.0003054438,0.0009385291,0.0003874496],"domain_scores_gemma":[0.99741936,0.00016254683,0.0003237328,0.00092345633,0.0008419276,0.00032900105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002675053,0.00020630813,0.00089656,0.00026389473,0.00008297572,0.000041933796,0.00028132307,0.000058351892,0.00027596517],"category_scores_gemma":[0.0007419926,0.00016448832,0.00063833484,0.0012705346,0.00012751785,0.00011129017,0.00022541227,0.00010210302,0.0000078113735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034731936,0.005282829,0.03310557,0.003939367,0.014567504,0.00016773418,0.043804634,0.001354981,0.017404605,0.001754015,0.016387906,0.8587577],"study_design_scores_gemma":[0.0047762366,0.0042935815,0.9465706,0.008315588,0.0007558763,0.000035301142,0.013039106,0.00010910605,0.019916777,0.00053379947,0.0011360997,0.0005179425],"about_ca_topic_score_codex":0.00021847276,"about_ca_topic_score_gemma":0.00070114096,"teacher_disagreement_score":0.913465,"about_ca_system_score_codex":0.000026815547,"about_ca_system_score_gemma":0.00031331487,"threshold_uncertainty_score":0.67076385},"labels":[],"label_agreement":null},{"id":"W3164067710","doi":"10.1136/annrheumdis-2021-eular.1797","title":"OP0141 EFFECTS OF FILGOTINIB ON SPINAL LESIONS IN ANKYLOSING SPONDYLITIS: MAGNETIC RESONANCE IMAGING DATA FROM THE TORTUGA TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Samsung; H. Lundbeck A/S; Galderma; Pfizer; Galápagos; Biogen; Gilead Sciences; Eli Lilly and Company","keywords":"Medicine; Ankylosing spondylitis; Magnetic resonance imaging; Post-hoc analysis; Nuclear medicine; Placebo; Confidence interval; Internal medicine; Radiology; Pathology","score_opus":0.0683690399473405,"score_gpt":0.34723793028431843,"score_spread":0.2788688903369779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164067710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8905668,0.10453302,0.0000013190819,0.0026141326,0.000286854,0.0005779255,0.0012199276,0.000009609284,0.00019038627],"genre_scores_gemma":[0.99618953,0.0028451553,0.00007704123,0.00052574667,0.00006485391,0.000032425265,0.00016578296,0.000015429257,0.00008403227],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984602,0.00021335846,0.00043172413,0.00028729814,0.0003864929,0.00022096724],"domain_scores_gemma":[0.9975096,0.0010155888,0.0001686827,0.0011598404,0.00007896727,0.00006731029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015032907,0.00015491663,0.0004545235,0.000033125532,0.000102381164,0.0000172184,0.00031888095,0.000022747006,0.0001878599],"category_scores_gemma":[0.002635447,0.000093484705,0.00016678634,0.00023189967,0.00015811545,0.00007066643,0.00031828924,0.00009039498,0.0000056958393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028177656,0.006225455,0.12166223,0.0011408584,0.00051633356,0.00077659125,0.0009915774,0.000009576837,0.00018750515,0.00086514326,0.021917874,0.8175292],"study_design_scores_gemma":[0.017974503,0.0005739514,0.9642689,0.013010139,0.00033917476,0.00001009097,0.00046390799,0.00012905095,0.00096825504,0.0010447856,0.0011038886,0.00011332517],"about_ca_topic_score_codex":0.00045733093,"about_ca_topic_score_gemma":0.0000721979,"teacher_disagreement_score":0.8426067,"about_ca_system_score_codex":0.000013248978,"about_ca_system_score_gemma":0.000142711,"threshold_uncertainty_score":0.38121957},"labels":[],"label_agreement":null},{"id":"W3164068973","doi":"10.1136/annrheumdis-2021-eular.2253","title":"POS1461-HPR THE DEVELOPMENT OF A NOVEL EPRO DELIVERY SYSTEM TO MEASURE PATIENT QUALITY OF LIFE IN ROUTINE CLINICAL CARE: AN ANALYSIS OF 5 YEARS OF EXPERIENCE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"Seqirus; Marmara Üniversitesi; Deakin University; Gilead Sciences; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Patient satisfaction; Quality of life (healthcare); Medical record; Health care; Patient experience; Family medicine; Physical therapy; Medical emergency; Internal medicine; Nursing","score_opus":0.1258790228163107,"score_gpt":0.39956933744679585,"score_spread":0.27369031463048515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164068973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368864,0.0054172813,0.00006641856,0.00016701617,0.000041273517,0.00039289574,0.00019680343,0.0000046202413,0.000025064925],"genre_scores_gemma":[0.99884176,0.0005652351,0.00048104342,0.00005134519,0.0000038116448,0.000028026117,0.000017825509,0.000008221524,0.0000027425558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630886,0.00053815724,0.0017945402,0.00020060083,0.0009811968,0.00017663787],"domain_scores_gemma":[0.99687576,0.0005074609,0.0006804688,0.0007847039,0.0009775488,0.00017407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010791263,0.00011289982,0.0010497741,0.0001568406,0.000029836388,0.0000053240947,0.00032768204,0.000039538663,0.00002732751],"category_scores_gemma":[0.0032756985,0.000073257674,0.00040398067,0.0007980112,0.0002729354,0.000056898487,0.00017849528,0.00006951523,3.8347818e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022035933,0.004802665,0.8322064,0.0031330725,0.0037165994,0.0000034023155,0.064005636,0.0010356887,0.0026404797,0.0006283506,0.00006470828,0.08555936],"study_design_scores_gemma":[0.0010357833,0.00024051522,0.952347,0.0028418226,0.00008013567,6.1501737e-7,0.03643935,0.00040255932,0.0065196254,0.0000073841625,0.000008188507,0.00007706082],"about_ca_topic_score_codex":0.0007824556,"about_ca_topic_score_gemma":0.00039862268,"teacher_disagreement_score":0.12014052,"about_ca_system_score_codex":0.00001928328,"about_ca_system_score_gemma":0.00070767,"threshold_uncertainty_score":0.39215538},"labels":[],"label_agreement":null},{"id":"W3164088341","doi":"10.1136/annrheumdis-2021-eular.755","title":"OP0149 RELIABILITY AND RESPONSIVENESS OF TWO OMERACT WHOLE-BODY MRI SCORES OF ENTHESEAL AND JOINT INFLAMMATION IN THE KNEE REGION IN SPONDYLOARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Leeds Biomedical Research Centre; National Institutes of Health; Pfizer","keywords":"Medicine; Synovitis; Enthesis; Psoriatic arthritis; Magnetic resonance imaging; Arthritis; Enthesitis; Knee arthritis; Joint effusion; Knee Joint; Intraclass correlation; Osteitis; Knee pain; Radiology; Physical therapy; Osteoarthritis; Surgery; Internal medicine; Pathology","score_opus":0.0347511226441421,"score_gpt":0.311884022300946,"score_spread":0.2771328996568039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164088341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98532027,0.010063819,0.0000018523377,0.0039615496,0.00003314335,0.0004913931,0.000057643974,0.0000031848544,0.0000671671],"genre_scores_gemma":[0.99499327,0.004834185,0.000033086166,0.000055284316,0.000008212663,0.00003554631,0.0000134146085,0.0000070833116,0.000019945788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849164,0.00036569088,0.00053770473,0.0001769812,0.00028875607,0.0001391995],"domain_scores_gemma":[0.9985598,0.00057101593,0.000250269,0.00040033134,0.00017510734,0.00004350285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041913652,0.00011834693,0.00048908795,0.00010488584,0.000042275948,0.000009617905,0.000061599996,0.000029632118,0.000011223267],"category_scores_gemma":[0.0015894374,0.00007478886,0.000104071616,0.0002769086,0.00028868412,0.00009996163,0.00010355451,0.000067962435,3.4613464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022498968,0.0014099076,0.92284316,0.0023998753,0.00020678557,0.00016575257,0.004112149,0.00009951221,0.0015503953,0.0013451168,0.00021648135,0.06340096],"study_design_scores_gemma":[0.0025367313,0.00026054535,0.9843305,0.00398206,0.0000725828,0.00003703399,0.0012818137,0.00009222088,0.0040622302,0.0032493281,0.00003465839,0.000060312435],"about_ca_topic_score_codex":0.00035667993,"about_ca_topic_score_gemma":0.00019519277,"teacher_disagreement_score":0.06334065,"about_ca_system_score_codex":0.0000115694975,"about_ca_system_score_gemma":0.00009094664,"threshold_uncertainty_score":0.30498013},"labels":[],"label_agreement":null},{"id":"W3164104205","doi":"10.1136/annrheumdis-2021-eular.2017","title":"POS0018 INVESTIGATING VIRTUAL IMMERSIVE EXPERIENCES IN THE MANAGEMENT OF CHRONIC PAIN – THE VIPA STUDY (PRELIMINARY RESULTS)","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Likert scale; McGill Pain Questionnaire; Visual analogue scale; Fibromyalgia; Virtual reality; Physical therapy; Rating scale; Chronic pain; Simulator sickness; Outpatient clinic; Psychology; Psychiatry; Artificial intelligence","score_opus":0.041857830091990705,"score_gpt":0.3270745654472309,"score_spread":0.28521673535524017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164104205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875573,0.002784766,0.0000082786955,0.008237855,0.00013305848,0.00077158137,0.000015012987,0.0000049731284,0.00048720412],"genre_scores_gemma":[0.99865365,0.00031693635,0.000030919946,0.00066797674,0.000020713518,0.00011246893,0.000006206978,0.0000066292614,0.0001844852],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9978667,0.0007909031,0.00051735167,0.00016941232,0.00050385034,0.00015179672],"domain_scores_gemma":[0.99746656,0.0015582547,0.00025153428,0.0005787567,0.00010122854,0.000043669188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010723004,0.000109820314,0.0002518406,0.000046614714,0.0000976881,0.000014214194,0.00031284624,0.00001958419,0.000047774807],"category_scores_gemma":[0.0013973294,0.000050457864,0.00020483378,0.00040768913,0.00031100886,0.000055056684,0.00013067413,0.00008472181,0.0000024341143],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002664704,0.015897866,0.09053342,0.0067019425,0.0041890326,0.00017611288,0.57682884,0.0036310956,0.00044506328,0.0043350714,0.03404174,0.2605551],"study_design_scores_gemma":[0.0009634076,0.0013493685,0.36114773,0.0022768702,0.00016554978,0.0000044365634,0.6325131,0.0006788908,0.00043982425,0.0003111512,0.00008047921,0.00006919721],"about_ca_topic_score_codex":0.00005621553,"about_ca_topic_score_gemma":0.0000075450193,"teacher_disagreement_score":0.27061433,"about_ca_system_score_codex":0.000016837204,"about_ca_system_score_gemma":0.00013860378,"threshold_uncertainty_score":0.2057612},"labels":[],"label_agreement":null},{"id":"W3164118400","doi":"10.1136/annrheumdis-2021-eular.1107","title":"OP0018 PREDICTING RESPONSES TO ANTI-TNF TREATMENTS IN RHEUMATOID ARTHRITIS PATIENTS FROM GENETIC AND CLINICAL DATA USING A MACHINE LEARNING APPROACH","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Linkage disequilibrium; Single-nucleotide polymorphism; Rheumatoid arthritis; Genome-wide association study; SNP; Genetic association; Internal medicine; Oncology; Bioinformatics; Genotype; Genetics; Gene; Biology","score_opus":0.09515230628081905,"score_gpt":0.36972063766214996,"score_spread":0.2745683313813309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164118400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96511847,0.033172112,0.000041581112,0.00031810213,0.000098358585,0.00055602414,0.00063864933,0.000027557608,0.000029168566],"genre_scores_gemma":[0.92310935,0.074285015,0.0020953587,0.00013829557,0.000023428538,0.000015949523,0.00026905452,0.000033609347,0.000029949391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968812,0.0007618949,0.0008527432,0.00054424215,0.0005697858,0.00039015868],"domain_scores_gemma":[0.99772567,0.0006154729,0.00022321822,0.0009169248,0.00017201444,0.0003466919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043887537,0.00022313342,0.00072983484,0.00013357104,0.00017673125,0.00007908145,0.00033001447,0.0000635145,0.00006262681],"category_scores_gemma":[0.0052499333,0.00017024946,0.00014212159,0.00033502732,0.00020001904,0.00019797041,0.00073006836,0.00021066096,0.0000052140317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038186501,0.0011537208,0.9135507,0.00008048606,0.0003874151,0.000028020293,0.00031259505,0.00006463578,0.000041360356,0.000004498072,0.00011574012,0.08387901],"study_design_scores_gemma":[0.0035533619,0.00026433982,0.9727014,0.003754979,0.000028610486,0.000025901103,0.00033638373,0.018697731,0.00015282157,0.00014151626,0.00018177682,0.00016123331],"about_ca_topic_score_codex":0.00085305277,"about_ca_topic_score_gemma":0.0000735299,"teacher_disagreement_score":0.08371777,"about_ca_system_score_codex":0.000016853193,"about_ca_system_score_gemma":0.00025639415,"threshold_uncertainty_score":0.69425714},"labels":[],"label_agreement":null},{"id":"W3164130008","doi":"10.1136/annrheumdis-2021-eular.3410","title":"AB0857 CERTOLIZUMAB PEGOL RELOADING SUCCESSFULLY CONTROLS INFLAMMATORY ARTHRITIS FLARES DURING PREGNANCY – A CASE REPORT","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Certolizumab pegol; Pregnancy; Etanercept; Sulfasalazine; Infliximab; Internal medicine; Adverse effect; Leflunomide; Arthritis; Population; Hydroxychloroquine; TNF inhibitor; Rheumatoid arthritis; Disease; Ulcerative colitis","score_opus":0.026887712611956084,"score_gpt":0.3084279067610688,"score_spread":0.2815401941491127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164130008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95635194,0.0351604,0.00003641151,0.0061575496,0.00024309407,0.0006090426,0.00007160462,0.000097609256,0.0012723461],"genre_scores_gemma":[0.9950848,0.0033402247,0.000046641344,0.00014323462,0.000056334666,0.000104595456,0.000026368183,0.000029448564,0.0011683403],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977678,0.00015794666,0.0008520531,0.00030712047,0.0005410275,0.00037407593],"domain_scores_gemma":[0.99740374,0.00023348673,0.00055247685,0.0010638474,0.00038062327,0.00036584755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085108186,0.00021573636,0.0005754808,0.000092285074,0.0002385577,0.00003723252,0.00017901308,0.000076995064,0.00029869966],"category_scores_gemma":[0.0052078837,0.00016020243,0.00039487018,0.00025027274,0.0001710957,0.0002530883,0.00012418586,0.0001576995,0.00001437563],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094878615,0.0023151748,0.09041412,0.014340069,0.002829425,0.68716145,0.0053201285,0.00005284034,0.0037747414,0.0017935028,0.007479822,0.18356995],"study_design_scores_gemma":[0.008660199,0.00020619029,0.24910225,0.105967164,0.001031572,0.57605207,0.002378472,0.00030862627,0.05204565,0.0027296257,0.0007590433,0.000759165],"about_ca_topic_score_codex":0.000054952845,"about_ca_topic_score_gemma":0.000023224544,"teacher_disagreement_score":0.1828108,"about_ca_system_score_codex":0.000028478515,"about_ca_system_score_gemma":0.00069074787,"threshold_uncertainty_score":0.6532866},"labels":[],"label_agreement":null},{"id":"W3164172015","doi":"10.1136/annrheumdis-2021-eular.1835","title":"POS0531 FACTORS ASSOCIATED WITH BASELINE HYPERTENSION IN EARLY RHEUMATOID ARTHRITIS: DATA FROM A REAL-WORLD LARGE INCIDENT COHORT","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Southlake Regional Health Center; University of Manitoba; Université Laval; Université de Sherbrooke; University of Calgary; McGill University; Lawson Health Research Institute; Sinai Health System; University of Toronto; Western University","funders":"Janssen Biotech; Eli Lilly Canada; Sandoz Canada; Sanofi Genzyme; Pfizer Canada; Amgen; AbbVie Canada; Bristol-Myers Squibb Canada; Gilead Sciences; Bristol-Myers Squibb; Eli Lilly and Company; Merck Canada","keywords":"Medicine; Internal medicine; Body mass index; Cohort; Rheumatoid arthritis; Logistic regression; Overweight; Diabetes mellitus; Prospective cohort study; Univariate analysis; Cohort study; Physical therapy; Multivariate analysis; Endocrinology","score_opus":0.06605144197997999,"score_gpt":0.31395806311409113,"score_spread":0.24790662113411116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164172015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817725,0.014033508,0.000012703703,0.001533407,0.00011314606,0.0005551568,0.0017536489,0.00006482609,0.00016110143],"genre_scores_gemma":[0.94158405,0.056031533,0.00004077015,0.00033112822,0.000018273207,0.00002722455,0.0017927389,0.000046539335,0.00012771477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649686,0.0005260755,0.0007734577,0.0005251666,0.0011178934,0.0005605619],"domain_scores_gemma":[0.99638325,0.00089128193,0.0003130553,0.00161427,0.00046550724,0.00033261866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067895197,0.00029416705,0.000949318,0.00017908386,0.00014962962,0.000078293626,0.00051031564,0.00006856302,0.0005082983],"category_scores_gemma":[0.004131917,0.000194478,0.00018531637,0.00071022386,0.0001963335,0.0003589015,0.00047169204,0.00025865773,0.000018894667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031260334,0.0016731247,0.986272,0.000059773905,0.0008208352,0.0001816717,0.00033992348,0.000005852567,0.000129943,0.00010531395,0.0067030997,0.0033958766],"study_design_scores_gemma":[0.0030753931,0.00011768434,0.98442847,0.008868399,0.00002985506,0.000010749357,0.00054892147,0.0008367874,0.00096862286,0.0005805518,0.00031587144,0.00021871728],"about_ca_topic_score_codex":0.0035618392,"about_ca_topic_score_gemma":0.009044584,"teacher_disagreement_score":0.041998025,"about_ca_system_score_codex":0.000038665938,"about_ca_system_score_gemma":0.0005481989,"threshold_uncertainty_score":0.7930583},"labels":[],"label_agreement":null},{"id":"W3164174907","doi":"10.1136/annrheumdis-2021-eular.900","title":"AB0531 THERAPIES FOR PERIPHERAL JOINT INVOLVEMENT IN PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Celgene; Biogen; Gilead Sciences; Chugai Pharmaceutical; Celltrion; Sanofi; Amgen; Pfizer; Samsung; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Leflunomide; Psoriatic arthritis; Systematic review; Internal medicine; Randomized controlled trial; Infliximab; Arthritis; Physical therapy; Rheumatoid arthritis; MEDLINE; Disease","score_opus":0.036532537979361644,"score_gpt":0.2765538748898031,"score_spread":0.24002133691044145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164174907","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11237259,0.88378173,0.000012287534,0.0018332871,0.00046007583,0.0012622015,0.00022198481,0.00002040653,0.0000354486],"genre_scores_gemma":[0.689235,0.30692646,0.00009105051,0.0015339789,0.000020307887,0.0010418402,0.00021339356,0.000023484405,0.00091449136],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981858,0.0005837619,0.0006822658,0.00021678398,0.0000729784,0.00025839152],"domain_scores_gemma":[0.9987373,0.0002526743,0.00030181103,0.0005136377,0.00017027388,0.00002435485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033919708,0.0002104855,0.0008042347,0.00005347274,0.000097765726,0.000026698623,0.00021547888,0.00007525575,0.00016514765],"category_scores_gemma":[0.0006041912,0.00013137226,0.0004748531,0.00025195995,0.000065872344,0.000085772685,0.00006113109,0.00006123754,0.000015903715],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044287846,0.004728903,0.0021915417,0.70675427,0.009420706,0.00006052161,0.012590877,0.000029773915,0.003210552,0.0076362714,0.04508533,0.2078484],"study_design_scores_gemma":[0.0058713327,0.00040194817,0.025088573,0.9339851,0.0018656648,0.00010176734,0.002673755,0.000027472262,0.016235093,0.011416114,0.0015484185,0.0007847391],"about_ca_topic_score_codex":0.00000828203,"about_ca_topic_score_gemma":0.000029613357,"teacher_disagreement_score":0.5768624,"about_ca_system_score_codex":0.000017454799,"about_ca_system_score_gemma":0.00010163812,"threshold_uncertainty_score":0.5357206},"labels":[],"label_agreement":null},{"id":"W3164178117","doi":"10.1136/annrheumdis-2021-eular.2513","title":"POS0474 SUBSTANTIAL IMPACT OF AUTOANTIBODY ENRICHMENT ON OUTCOMES IN EARLY RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT: DATA FROM A LARGE POOLED ANALYSIS OF 4 RCTS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Internal medicine; Adalimumab; Rheumatoid factor; Autoantibody; Methotrexate; Population; Clinical trial; Randomized controlled trial; Immunology; Rituximab; Antibody","score_opus":0.050130951589340375,"score_gpt":0.369493252303994,"score_spread":0.3193623007146536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164178117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842587,0.00313693,0.0000068088916,0.00063116965,0.000024227667,0.0003211465,0.011480929,0.000011450574,0.00012859714],"genre_scores_gemma":[0.9947337,0.003540853,0.000048011578,0.000064095024,0.000007306596,0.000006916405,0.0014487922,0.00001905664,0.0001312947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715424,0.00026331868,0.0008244933,0.0003782083,0.00100549,0.00037427794],"domain_scores_gemma":[0.99710923,0.00063627405,0.00041925788,0.001331402,0.0003105317,0.00019331895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002664573,0.00026410332,0.0014595641,0.00035722225,0.000047436406,0.000019274747,0.00048210804,0.000056756377,0.00059540465],"category_scores_gemma":[0.0005502495,0.00014811046,0.0006328463,0.0012961096,0.00017912629,0.00012566897,0.0002800348,0.00013795459,0.0000057552575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019687887,0.0029363125,0.98002934,0.00018420025,0.0108485995,0.00007770347,0.00030206633,0.0001180287,0.0008335951,0.00010635503,0.00046434806,0.0021306342],"study_design_scores_gemma":[0.0020445217,0.00050716475,0.98859507,0.0018707728,0.0008863306,0.0000033990457,0.00017567971,0.001989998,0.00369394,0.00008094675,0.000012311914,0.00013987774],"about_ca_topic_score_codex":0.0066291345,"about_ca_topic_score_gemma":0.0005884548,"teacher_disagreement_score":0.010474934,"about_ca_system_score_codex":0.00002109199,"about_ca_system_score_gemma":0.00037739417,"threshold_uncertainty_score":0.9999858},"labels":[],"label_agreement":null},{"id":"W3164196703","doi":"10.1136/annrheumdis-2021-eular.3321","title":"POS1323 SACROILIAC JOINT MRI ABNORMALITIES IN JUVENILE SPONDYLOARTHRITIS: AN UPDATE OF DEFINITIONS AND SCORING OF THE OMERACT JUVENILE IDIOPATHIC ARTHRITIS MRI SCORE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta; Hospital for Sick Children","funders":"University of Toronto; National and Kapodistrian University of Athens; Amsterdam University Medical Centers; Leeds Biomedical Research Centre; University of Alberta; Hospital for Special Surgery; Perelman School of Medicine, University of Pennsylvania; University of Leeds; National Institute for Health and Care Research; Hospital for Sick Children; University of Pennsylvania","keywords":"Medicine; Sacroiliac joint; Sacrum; Magnetic resonance imaging; Radiology; Radiography; Nuclear medicine; Surgery","score_opus":0.05000095958635391,"score_gpt":0.28859889244824277,"score_spread":0.23859793286188885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164196703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9174064,0.07848781,0.0000062767795,0.0027489127,0.00014051388,0.0003907738,0.00057173916,0.00001800043,0.00022959818],"genre_scores_gemma":[0.897379,0.102187924,0.00010660622,0.00015939667,0.000020429996,0.000044351797,0.000031424803,0.000026291815,0.000044583066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710995,0.0004475414,0.0011045429,0.00027476685,0.00066023075,0.0004029675],"domain_scores_gemma":[0.9979324,0.0002014544,0.00043755717,0.0008486276,0.00037845536,0.00020155405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057028304,0.00022097342,0.0009248985,0.00017010512,0.00017263391,0.000043199252,0.00026737564,0.00006240281,0.00021691517],"category_scores_gemma":[0.0010944654,0.00015936648,0.00035600102,0.0004757932,0.0006723948,0.00034811994,0.00025161362,0.00023145018,0.0000039676293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002705794,0.011551257,0.54440546,0.018886805,0.002345896,0.00061704655,0.025714824,0.0009704,0.023166215,0.06894092,0.0073896986,0.29330567],"study_design_scores_gemma":[0.0073316186,0.0011091522,0.71907073,0.073348336,0.00011328977,0.00072890817,0.0111058755,0.0004154294,0.13167998,0.053554494,0.0008342717,0.00070788956],"about_ca_topic_score_codex":0.00042645447,"about_ca_topic_score_gemma":0.00053793524,"teacher_disagreement_score":0.29259777,"about_ca_system_score_codex":0.00001608307,"about_ca_system_score_gemma":0.0005472624,"threshold_uncertainty_score":0.6498776},"labels":[],"label_agreement":null},{"id":"W3164198080","doi":"10.1136/annrheumdis-2021-eular.3550","title":"OP0048 DIAGNOSING AXIAL SPONDYLOARTHRITIS: ESTIMATION OF THE DISEASE PROBABILITY IN PATIENTS WITH A PRIORI DIFFERENT LIKELIHOODS OF THE DIAGNOSIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Valeant Pharmaceuticals International; Regeneron Pharmaceuticals; University of Pennsylvania; AbbVie; Celgene; Momenta Pharmaceuticals; Gilead Sciences; Amgen; Pfizer; University of Washington; Eli Lilly and Company; Bristol-Myers Squibb; Saint Joseph University; GlaxoSmithKline","keywords":"Medicine; Axial spondyloarthritis; Context (archaeology); Pre- and post-test probability; Calculator; Disease; Diagnostic test; Physical therapy; Internal medicine; Pediatrics; Sacroiliitis","score_opus":0.02098951209110831,"score_gpt":0.26835973341232977,"score_spread":0.24737022132122147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164198080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993011,0.003100239,0.0000022448196,0.0019438943,0.00017614495,0.0013617042,0.00037217484,0.000008107014,0.00002448481],"genre_scores_gemma":[0.9991846,0.00042668293,0.000039128914,0.00011061023,0.000009716272,0.00017903578,0.000020553225,0.00001637929,0.000013256612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804944,0.000241828,0.0005705444,0.00023526516,0.0006853337,0.00021758687],"domain_scores_gemma":[0.99803704,0.000306935,0.00042318171,0.00085864915,0.0002753803,0.00009880503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009369571,0.00020409338,0.0005278227,0.00003522697,0.00012322445,0.000012154243,0.00022276488,0.000032780557,0.000043716504],"category_scores_gemma":[0.001929522,0.00009578612,0.00037003309,0.00040745808,0.00034731103,0.00008054091,0.00027274564,0.000086736356,5.2969955e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000402771,0.0037792083,0.97374755,0.00074568397,0.00019362746,0.0000030215574,0.0003382933,0.00015792216,0.000001825033,0.000113281814,0.000101284146,0.020415558],"study_design_scores_gemma":[0.0028574918,0.00019382354,0.9859222,0.0074037286,0.00038001942,9.646758e-7,0.00009700016,0.000068330955,0.0011819721,0.0017996023,0.0000067980195,0.00008804807],"about_ca_topic_score_codex":0.00009529436,"about_ca_topic_score_gemma":0.00010835807,"teacher_disagreement_score":0.02032751,"about_ca_system_score_codex":0.000038710106,"about_ca_system_score_gemma":0.00021185701,"threshold_uncertainty_score":0.39060447},"labels":[],"label_agreement":null},{"id":"W3164214033","doi":"10.1136/annrheumdis-2021-eular.446","title":"OP0288 MACHINE LEARNING ALGORITHMS TO PREDICT COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES: RESULTS FROM THE GLOBAL RHEUMATOLOGY ALLIANCE PROVIDER REGISTRY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Metro North Hospital and Health Service; Swedish Orphan Biovitrum; Brigham and Women's Hospital; University College London; University of Otago; School of Medicine, Boston University; Biogen; Massachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical Center; University College London Hospitals NHS Foundation Trust; McMaster University","keywords":"Medicine; ARDS; Internal medicine; Logistic regression; Rheumatology; Algorithm; Comorbidity; Odds ratio; Machine learning; Population; Intensive care medicine","score_opus":0.04594436854534031,"score_gpt":0.37898871026749736,"score_spread":0.3330443417221571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164214033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94080234,0.0040005585,0.00024151383,0.042873528,0.00019208607,0.002158424,0.0095757935,0.00011808556,0.00003765906],"genre_scores_gemma":[0.9922712,0.00132802,0.00015939915,0.0051853233,0.000019475712,0.00025318662,0.00049485394,0.00004753361,0.00024104198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99394673,0.0010763068,0.0015023822,0.0009753423,0.0017114251,0.00078783656],"domain_scores_gemma":[0.9861541,0.009245986,0.0008147083,0.0021469279,0.00057489384,0.0010634294],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006956743,0.00049108634,0.0013327416,0.00006514498,0.00035864185,0.00009027397,0.0010764751,0.000120737255,0.00009546038],"category_scores_gemma":[0.12236388,0.00028284697,0.00038494068,0.0010778138,0.00083374366,0.00018986198,0.0011018261,0.00051679567,0.00002610147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039834976,0.001577303,0.97270876,0.0021280432,0.0014930377,0.00026937574,0.0004490869,0.001688428,4.727837e-7,0.00005871807,0.00679245,0.008850849],"study_design_scores_gemma":[0.0063116723,0.000665787,0.9820677,0.006027272,0.00046704538,0.000007677454,0.0003079806,0.0011973326,0.000005731013,0.0010415567,0.0015733741,0.00032686544],"about_ca_topic_score_codex":0.0015544578,"about_ca_topic_score_gemma":0.0002780207,"teacher_disagreement_score":0.121668205,"about_ca_system_score_codex":0.00027459284,"about_ca_system_score_gemma":0.0018346171,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W3164234380","doi":"10.1136/annrheumdis-2021-eular.359","title":"POS0652 SEX DIFFERENCES IN THE EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS: A POST HOC ANALYSIS OF PHASE 3 AND LONG-TERM EXTENSION TRIALS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Pfizer (Canada); University of Alberta","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Janus kinase inhibitor; Internal medicine; Discontinuation; Adalimumab; Post-hoc analysis; Placebo; Clinical trial; Methotrexate; Surgery; Alternative medicine; Pathology","score_opus":0.06071091670102527,"score_gpt":0.3499488817582679,"score_spread":0.28923796505724264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164234380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779542,0.019871525,0.000008930281,0.00082260906,0.00005211974,0.00027718244,0.0009996122,0.000002630266,0.000011188374],"genre_scores_gemma":[0.9843777,0.01528637,0.00002310244,0.0002127505,0.0000015511032,0.000005698948,0.000078583194,0.0000038113758,0.000010452453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969615,0.0015990417,0.0009682781,0.00021384661,0.00009072237,0.0001666626],"domain_scores_gemma":[0.99649507,0.0025301492,0.0004467147,0.00032840262,0.00017423641,0.000025457584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010198138,0.0001441294,0.0011209681,0.00016255879,0.000047768663,0.000012013633,0.0001829788,0.000094421826,0.00019892266],"category_scores_gemma":[0.0034994588,0.00007777037,0.00024729143,0.00050379557,0.00046702774,0.000049483628,0.0001240646,0.00009246588,2.2236979e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031160216,0.00561545,0.578617,0.00045913583,0.0028925266,0.000007628548,0.0021222362,0.0000032034134,0.0051509975,0.0005109355,0.0001859887,0.4013189],"study_design_scores_gemma":[0.003662366,0.00032307804,0.98969203,0.0010419516,0.00037043294,0.000003464403,0.0005727283,0.000018561304,0.003913137,0.00029655488,0.000010648274,0.000095056275],"about_ca_topic_score_codex":0.000055690605,"about_ca_topic_score_gemma":0.00006869704,"teacher_disagreement_score":0.41107506,"about_ca_system_score_codex":0.0000026966948,"about_ca_system_score_gemma":0.000039707356,"threshold_uncertainty_score":0.41894317},"labels":[],"label_agreement":null},{"id":"W3164258744","doi":"10.1136/annrheumdis-2021-eular.432","title":"POS1028 PATIENT CHARACTERISTICS & CLINICAL FEATURES ASSOCIATE WITH HEALTH-RELATED QUALITY OF LIFE IN BIO-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH WEEK 24 OF THE DISCOVER-2 STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital","funders":"","keywords":"Medicine; Visual analogue scale; Psoriatic arthritis; Dactylitis; Quality of life (healthcare); Internal medicine; Univariate analysis; EQ-5D; Placebo; Dermatology Life Quality Index; Psoriasis; Physical therapy; Rheumatoid arthritis; Multivariate analysis; Health related quality of life; Enthesitis; Immunology; Disease; Pathology","score_opus":0.07706283326798094,"score_gpt":0.36878658099225264,"score_spread":0.2917237477242717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164258744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416983,0.0015045425,0.0000025357733,0.0021445202,0.00014759635,0.0013844996,0.00061313785,0.000008393696,0.000024962274],"genre_scores_gemma":[0.9992568,0.0004004683,0.000055004984,0.00007078958,0.0000049263235,0.000029866547,0.00008894948,0.00002548571,0.000067720306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949471,0.0014975131,0.0015846209,0.00031227412,0.0013091579,0.0003493652],"domain_scores_gemma":[0.995984,0.00078352034,0.001605018,0.0008883427,0.00057923474,0.00015987607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054597744,0.00022878322,0.0013438124,0.00005057233,0.00008813572,0.000014556651,0.0002690716,0.00007733861,0.000061012077],"category_scores_gemma":[0.0033062648,0.000119133736,0.00029760596,0.00060849614,0.00043490375,0.00010970833,0.00020267871,0.00034845422,0.0000018831747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020158426,0.011949246,0.96724045,0.0032758056,0.0016903532,0.00000490135,0.0052310135,0.000016403961,0.0000020073862,0.000076324686,0.00071555795,0.007782079],"study_design_scores_gemma":[0.004394624,0.0022229597,0.9825977,0.0074862535,0.00013876862,0.0000019069776,0.0026089211,0.000005265067,0.00008914688,0.00032957149,0.000001908092,0.00012299354],"about_ca_topic_score_codex":0.0012050474,"about_ca_topic_score_gemma":0.0002393439,"teacher_disagreement_score":0.015357216,"about_ca_system_score_codex":0.00006562026,"about_ca_system_score_gemma":0.0016218595,"threshold_uncertainty_score":0.48581326},"labels":[],"label_agreement":null},{"id":"W3164273949","doi":"10.1136/annrheumdis-2021-eular.167","title":"POS1024 GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Sanofi Genzyme; University of Glasgow; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Clinical endpoint; Placebo; Randomized controlled trial; Gastroenterology; Surgery; Arthritis; Pathology","score_opus":0.022809360253828227,"score_gpt":0.29266312604098893,"score_spread":0.2698537657871607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164273949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803306,0.009755853,0.000015008076,0.00089120556,0.00006687996,0.0010347749,0.00007644166,0.000024868474,0.000101938305],"genre_scores_gemma":[0.99257696,0.006648952,0.00045239239,0.00017704804,0.000015543344,0.000022842352,0.000051870786,0.00003512372,0.000019282148],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997749,0.00034170997,0.00047193942,0.00033464152,0.00068598613,0.00041676406],"domain_scores_gemma":[0.99793357,0.00047343015,0.00022929035,0.0004778522,0.0006507185,0.00023515052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099683304,0.0002555273,0.00068723096,0.0001575713,0.00016676272,0.000094790565,0.00014718261,0.000046647277,0.00008503049],"category_scores_gemma":[0.00030648478,0.00017949879,0.00013980838,0.00040909476,0.0003650991,0.00025814192,0.000147181,0.00016605385,0.0000051032457],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024810087,0.017465288,0.26935455,0.004616272,0.0054195467,0.0008981278,0.014514839,0.0002669927,0.003935792,0.008241763,0.0016644729,0.64881223],"study_design_scores_gemma":[0.012182092,0.0006100772,0.9699939,0.0070257424,0.00003249446,0.0000504567,0.003339639,0.000061553015,0.0032297934,0.0028684123,0.00033496736,0.00027089444],"about_ca_topic_score_codex":0.00007157542,"about_ca_topic_score_gemma":0.00001771862,"teacher_disagreement_score":0.7006393,"about_ca_system_score_codex":0.000043498676,"about_ca_system_score_gemma":0.00036429282,"threshold_uncertainty_score":0.73197484},"labels":[],"label_agreement":null},{"id":"W3164287095","doi":"10.1136/annrheumdis-2021-eular.578","title":"POS0906 PREVALENCE OF SLEEP DISTURBANCE IN PATIENTS WITH ANKYLOSING SPONDYLITIS WITHIN THE AUSTRALIAN CLINICAL SETTING (ASLEEP STUDY): A REAL-WORLD OBSERVATIONAL STUDY USING THE OPAL DATASET","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Medicine; BASDAI; Ankylosing spondylitis; Sleep disorder; Population; Physical therapy; Cohort; Quality of life (healthcare); Insomnia; Pediatrics; Internal medicine; Disease; Psychiatry; Psoriatic arthritis","score_opus":0.1320833443328442,"score_gpt":0.3995152868979415,"score_spread":0.26743194256509734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164287095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279255,0.0005098443,9.182642e-7,0.0009045851,0.00012520535,0.0017012078,0.003942016,0.000008027683,0.000015631433],"genre_scores_gemma":[0.9991202,0.000051498748,0.00010460631,0.00020298983,0.000027937866,0.00005048639,0.00034602688,0.000018581766,0.000077721874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969127,0.0006526921,0.0009938707,0.00035955507,0.0008203428,0.00026084733],"domain_scores_gemma":[0.9973565,0.0006498973,0.00064283016,0.00096458604,0.00030829755,0.00007788667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007177969,0.00022520238,0.00055993616,0.000043312164,0.00027280627,0.000033919197,0.00033964546,0.000022466194,0.000057756995],"category_scores_gemma":[0.0007249729,0.000110880464,0.00014663133,0.000583579,0.0003263848,0.00014559984,0.00028574507,0.00017646352,7.5790444e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067136495,0.0048319376,0.9904832,0.00021844712,0.00067864347,0.000031659227,0.001297292,0.00013892169,5.648369e-7,0.0000505867,0.00031116174,0.0012861952],"study_design_scores_gemma":[0.0033967714,0.00063155626,0.98944813,0.0016541365,0.00073899457,0.000003715302,0.0037671446,0.00013132281,0.000011149473,0.00008985492,0.000019511346,0.00010770112],"about_ca_topic_score_codex":0.0009077927,"about_ca_topic_score_gemma":0.0007505837,"teacher_disagreement_score":0.0063275862,"about_ca_system_score_codex":0.000031916596,"about_ca_system_score_gemma":0.00015515857,"threshold_uncertainty_score":0.4521574},"labels":[],"label_agreement":null},{"id":"W3164306411","doi":"10.1136/annrheumdis-2021-eular.1297","title":"POS1068 Cardiac biomarkers are associated with the development of cardiovascular events in patients with psoriatic arthritis and psoriasis","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Waterloo; Women's College Hospital","funders":"Ministerio de Ciencia e Innovación; Arthritis Society; National Psoriasis Foundation","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Hazard ratio; Myocardial infarction; Proportional hazards model; Population; Biomarker; Framingham Risk Score; Cardiology; Cohort; Psoriasis; Quartile; Angina; Disease; Confidence interval; Immunology","score_opus":0.01459515990316901,"score_gpt":0.23814868527686764,"score_spread":0.22355352537369863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164306411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96916074,0.029583555,0.0000061687606,0.0005276871,0.000047684243,0.000556726,0.000071366514,0.0000088552815,0.000037232396],"genre_scores_gemma":[0.9929469,0.0068187765,0.000077324556,0.000034966095,0.0000050520066,0.00004964246,0.00003222596,0.00001963037,0.000015434489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979239,0.00033516833,0.00036940875,0.0001974587,0.00091245875,0.00026157615],"domain_scores_gemma":[0.9985929,0.00020803545,0.000219145,0.000463791,0.00040054394,0.00011557206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040560515,0.00016463814,0.0006418862,0.00007375435,0.00011031636,0.0000132316645,0.00013145742,0.000033326396,0.000018440156],"category_scores_gemma":[0.00067687774,0.0000868208,0.00020391487,0.0004119624,0.00020111552,0.00008376311,0.000082594604,0.00008068256,9.1112213e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005926089,0.0009022584,0.8190238,0.00038879985,0.009581444,0.000007802862,0.0014930837,0.000034572247,0.0000036298652,0.000025156372,0.0003713125,0.16757557],"study_design_scores_gemma":[0.0032084729,0.00014186179,0.98871994,0.0059354724,0.000089632806,0.000001467575,0.0011024557,0.000008187601,0.00048390235,0.00009197047,0.00010687342,0.00010978031],"about_ca_topic_score_codex":0.000046885754,"about_ca_topic_score_gemma":0.00009095504,"teacher_disagreement_score":0.16969615,"about_ca_system_score_codex":0.000020601663,"about_ca_system_score_gemma":0.00030225565,"threshold_uncertainty_score":0.35404494},"labels":[],"label_agreement":null},{"id":"W3164306653","doi":"10.1136/annrheumdis-2021-eular.473","title":"OP0144 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 1-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Friedrich-Alexander-Universität Erlangen-Nürnberg; Gilead Sciences; Sanofi; Chugai Pharmaceutical; Pfizer; Universitätsklinikum Erlangen; Eli Lilly and Company","keywords":"Medicine; BASDAI; Ankylosing spondylitis; Adverse effect; BASFI; Placebo; Internal medicine; Tolerability; Contraindication; Arthritis; Psoriatic arthritis","score_opus":0.04531372939620665,"score_gpt":0.3208458371285809,"score_spread":0.27553210773237424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164306653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059385,0.0014286689,0.0000022414463,0.00036472493,0.00003659494,0.006241417,0.0009820925,0.00000997112,0.00034041025],"genre_scores_gemma":[0.9989039,0.00033575005,0.00020499711,0.00006676044,0.000007814122,0.00017077729,0.00021553106,0.000024439041,0.00007007705],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99763525,0.00038821073,0.00078306475,0.00042367046,0.0005375295,0.00023225027],"domain_scores_gemma":[0.9970023,0.001294855,0.0005572544,0.000569801,0.0004548426,0.00012093778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036132563,0.00026435035,0.0017614808,0.000083613166,0.000120646204,0.000036900612,0.00014107999,0.000037700043,0.000045820114],"category_scores_gemma":[0.0011235985,0.00014270778,0.00009926789,0.00029792028,0.00023445553,0.00015941283,0.00022713073,0.000095753494,0.0000010640172],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96266896,0.007597035,0.021422956,0.00006901383,0.0025484685,0.000049748396,0.0013433687,0.0000152001785,0.0000020670527,0.000028583032,0.00003211826,0.0042224787],"study_design_scores_gemma":[0.7377406,0.0013045017,0.25372508,0.0038562214,0.0010384611,0.0000024490075,0.0020339175,0.000021050926,0.00009159349,0.000069433125,0.0000028679608,0.00011388509],"about_ca_topic_score_codex":0.00062088406,"about_ca_topic_score_gemma":0.00013421093,"teacher_disagreement_score":0.23230211,"about_ca_system_score_codex":0.000020795118,"about_ca_system_score_gemma":0.00015964276,"threshold_uncertainty_score":0.5819454},"labels":[],"label_agreement":null},{"id":"W3164311428","doi":"10.1136/annrheumdis-2021-eular.1725","title":"AB0821 PSYCHOMETRIC PROFILE OF PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Università degli Studi di Roma Tor Vergata","keywords":"Medicine; Psoriatic arthritis; Alexithymia; Internal medicine; Depression (economics); Toronto Alexithymia Scale; Beck Depression Inventory; Arthritis; Anxiety; Inflammatory arthritis; Physical therapy; Rheumatology; Clinical psychology; Psychiatry","score_opus":0.0222499122628767,"score_gpt":0.2870020229574717,"score_spread":0.264752110694595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164311428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934853,0.00915924,0.0000068883555,0.0005061009,0.00005973568,0.0004522503,0.000102198086,0.000015434425,0.00034963593],"genre_scores_gemma":[0.99801016,0.0013681053,0.000058906047,0.000014758123,0.000007864057,0.00003070037,0.000055780252,0.000021463073,0.000432237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822706,0.000090458016,0.000396004,0.00018658074,0.0007956731,0.00030420863],"domain_scores_gemma":[0.9983398,0.000118857846,0.00020966236,0.0006769745,0.00051035726,0.0001443618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113057846,0.00013453832,0.000411375,0.0001410889,0.00004979987,0.000009868037,0.00018826462,0.00004339137,0.0011199559],"category_scores_gemma":[0.00049555243,0.000084831154,0.0002051251,0.0007966112,0.00024231354,0.00008307835,0.00009261404,0.00011182068,0.000022550457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059852726,0.0033820935,0.8432637,0.030571222,0.0015040623,0.000025122758,0.00038500433,0.0000457658,0.0002141438,0.000950417,0.014638547,0.10442143],"study_design_scores_gemma":[0.0020805125,0.00052430166,0.9878125,0.006086653,0.000074022566,0.0000082526385,0.000087614426,0.00004516537,0.0027381466,0.00030004847,0.000139,0.000103772225],"about_ca_topic_score_codex":0.00001424077,"about_ca_topic_score_gemma":0.0000019281654,"teacher_disagreement_score":0.14454885,"about_ca_system_score_codex":0.000032939315,"about_ca_system_score_gemma":0.0010005397,"threshold_uncertainty_score":0.9997932},"labels":[],"label_agreement":null},{"id":"W3164343634","doi":"10.1136/annrheumdis-2021-eular.1573","title":"AB0285 EFFECTIVENESS OF IMMUNOSUPPRESSIVE THERAPY FOR CONNECTIVE TISSUE DISEASE–ASSOCIATED PULMONARY ARTERIAL HYPERTENSION","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Medicine; Pulmonary hypertension; Vascular resistance; Connective tissue disease; Mixed connective tissue disease; Internal medicine; Hemodynamics; Iloprost; Cardiology; Vasodilation; Bosentan; Pulmonary wedge pressure; Disease; Endothelin receptor","score_opus":0.048304946078971005,"score_gpt":0.3344698406722717,"score_spread":0.2861648945933007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164343634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873644,0.009052331,0.0000132264395,0.001032318,0.0002007823,0.0013780262,0.00085122394,0.000021406058,0.000086282795],"genre_scores_gemma":[0.9977321,0.001322101,0.000022570637,0.00019517094,0.000021784004,0.00016986119,0.00035057365,0.000027885344,0.00015794236],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816215,0.0004583271,0.0003501967,0.00028357096,0.00045947073,0.000286257],"domain_scores_gemma":[0.99664325,0.0013073708,0.00023242418,0.0005647744,0.00102557,0.00022659566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019141758,0.00020119452,0.00069537346,0.00006423083,0.000124951,0.000011286783,0.00016253012,0.000058783677,0.00008907737],"category_scores_gemma":[0.0024039312,0.0001263449,0.00044981873,0.00022523942,0.00019305422,0.00009342947,0.000099376346,0.00006138032,0.0000040385626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11919489,0.07252424,0.1288081,0.011336422,0.01951276,0.0038711736,0.0003972411,0.00018107978,0.48335564,0.0013315674,0.0118465135,0.14764038],"study_design_scores_gemma":[0.0041197715,0.00060403236,0.8738758,0.003025317,0.00037406664,0.000038618753,0.00012496297,0.00037656413,0.11206198,0.0051683923,0.000089718764,0.00014075656],"about_ca_topic_score_codex":0.000036941306,"about_ca_topic_score_gemma":6.2666066e-7,"teacher_disagreement_score":0.7450677,"about_ca_system_score_codex":0.000020892665,"about_ca_system_score_gemma":0.00040534014,"threshold_uncertainty_score":0.5152195},"labels":[],"label_agreement":null},{"id":"W3164370295","doi":"10.1136/annrheumdis-2021-eular.2114","title":"POS0671 CLINICAL RESPONSES TO UPADACITINIB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS BY TYPE OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG: DATA FROM THE PHASE 3 SELECT-CHOICE STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Genentech; CSL Behring; Gilead Sciences; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Internal medicine; TNF inhibitor; Tocilizumab; Golimumab; Post-hoc analysis; Gastroenterology; Etanercept; Rituximab","score_opus":0.1332728424230976,"score_gpt":0.4270048926955668,"score_spread":0.2937320502724692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164370295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97421134,0.018199908,0.000014783639,0.002117511,0.00015054818,0.0020869612,0.0031706158,0.000037830763,0.000010503128],"genre_scores_gemma":[0.9794758,0.019093275,0.0001542782,0.00044369427,0.00002086814,0.000060771446,0.0006222163,0.000047014288,0.000082101455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946048,0.0015865809,0.0014511542,0.0007111869,0.0011002381,0.0005460086],"domain_scores_gemma":[0.991793,0.004194053,0.0005217018,0.002391936,0.000640001,0.00045933208],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010532266,0.00036520435,0.0011782496,0.00011953726,0.00021866261,0.00008986943,0.0011420612,0.0000553959,0.00039220325],"category_scores_gemma":[0.017588189,0.00019452863,0.00018813895,0.0010055694,0.00046748074,0.000297627,0.0006654409,0.00029215327,0.00002306078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011800968,0.008907856,0.91737753,0.00017861226,0.00079768,0.000033673936,0.0008038668,0.0000041850417,0.000026729253,0.000012594974,0.016896391,0.04315993],"study_design_scores_gemma":[0.012645673,0.0020567942,0.97476864,0.006810582,0.000059170678,0.0000046067717,0.0020983005,0.00013159652,0.00015561302,0.00017012273,0.00080347824,0.00029544416],"about_ca_topic_score_codex":0.0005037267,"about_ca_topic_score_gemma":0.00044187537,"teacher_disagreement_score":0.057391103,"about_ca_system_score_codex":0.000018119146,"about_ca_system_score_gemma":0.0009895135,"threshold_uncertainty_score":0.9906871},"labels":[],"label_agreement":null},{"id":"W3164411024","doi":"10.1136/annrheumdis-2021-eular.2211","title":"POS0298 UNDERSERVED POPULATIONS IDENTIFY BARRIERS AND PROPOSE SOLUTIONS FOR SELF-MANAGING ARTHRITIS AND CHRONIC CONDITIONS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Centre for Social Innovation; Vancouver Native Health Society; Research Canada; University of British Columbia","funders":"Australian Government","keywords":"Medicine; Ethnic group; Health equity; Gerontology; Nursing; Sociology; Public health","score_opus":0.26291652323920517,"score_gpt":0.4487488154041465,"score_spread":0.18583229216494135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164411024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97262746,0.013314651,0.0002595083,0.009348773,0.0006419083,0.0021392102,0.0013231416,0.00006163398,0.00028368656],"genre_scores_gemma":[0.9946074,0.0030039542,0.00020546565,0.0012464003,0.000030480638,0.00032335267,0.00031328612,0.000014315277,0.00025536903],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99839354,0.0003155356,0.0005152875,0.00018886624,0.0001725578,0.00041419713],"domain_scores_gemma":[0.99864376,0.0003569576,0.00025180276,0.0002731377,0.00017941708,0.000294903],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.000298448,0.000113585076,0.00021875623,0.00005519847,0.0020520415,0.000017867642,0.000084968975,0.000047267153,0.00017954718],"category_scores_gemma":[0.00023534267,0.00009394428,0.00008971767,0.0001407019,0.00011226776,0.00015463517,0.00016233929,0.000095733994,0.000005857899],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020830597,0.0017348756,0.3215093,0.05786921,0.0012388105,0.000010352523,0.017493756,0.00036609295,0.00021231562,0.4772828,0.08485156,0.03722262],"study_design_scores_gemma":[0.00554856,0.0005245368,0.50132036,0.024093032,0.00065613544,0.000011370246,0.034455664,0.009807671,0.00023091846,0.4198056,0.002836894,0.00070929213],"about_ca_topic_score_codex":0.00014012032,"about_ca_topic_score_gemma":0.00067655987,"teacher_disagreement_score":0.17981105,"about_ca_system_score_codex":0.000048761736,"about_ca_system_score_gemma":0.0005410815,"threshold_uncertainty_score":0.99924713},"labels":[],"label_agreement":null},{"id":"W3164412668","doi":"10.1136/annrheumdis-2021-eular.1986","title":"POS0924 PREDICTORS OF 1-YEAR TREATMENT RESPONSE AMONG UPADACITINIB-TREATED PATIENTS WITH ANKYLOSING SPONDYLITIS: A POST HOC ANALYSIS OF SELECT-AXIS 1","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Confidence interval; Odds ratio; Logistic regression; Post-hoc analysis; Placebo; Spondylitis; Janus kinase inhibitor; Physical therapy; Surgery; Tofacitinib; Rheumatoid arthritis; Pathology","score_opus":0.013887729675483079,"score_gpt":0.26196213127167645,"score_spread":0.24807440159619337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164412668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916159,0.0020914772,8.73984e-7,0.00020019397,0.000035707235,0.00052025117,0.005385744,0.00002122651,0.0001286226],"genre_scores_gemma":[0.99845177,0.0004912321,0.00005932021,0.000038498405,0.000006073184,0.000030124647,0.0006757061,0.000024803569,0.00022246983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797773,0.00025109854,0.0006284935,0.00029134282,0.0005755066,0.00027582652],"domain_scores_gemma":[0.99743783,0.00035612262,0.0004926194,0.00065671885,0.0008971332,0.00015957857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010345046,0.0002608651,0.0010438603,0.0002689259,0.000089863446,0.000010822558,0.00010476308,0.000049816186,0.0003570246],"category_scores_gemma":[0.00055355066,0.0001610621,0.00059682486,0.001317366,0.00028525098,0.00008342095,0.00006668552,0.000041145937,0.0000013516965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010215882,0.0028102468,0.9703432,0.00019930577,0.013109392,0.000033337375,0.00084828405,0.000032229564,0.00006604558,0.000015991312,0.000109319284,0.0022168097],"study_design_scores_gemma":[0.0041455356,0.0030163631,0.9793468,0.0014494653,0.0064639538,0.0000026918315,0.0007980162,0.000028533294,0.0045793033,0.000012863923,0.000036838643,0.00011960196],"about_ca_topic_score_codex":0.0004184863,"about_ca_topic_score_gemma":0.00009459009,"teacher_disagreement_score":0.009003676,"about_ca_system_score_codex":0.00005059448,"about_ca_system_score_gemma":0.00021587235,"threshold_uncertainty_score":0.65679216},"labels":[],"label_agreement":null},{"id":"W3164415081","doi":"10.1136/annrheumdis-2021-eular.1790","title":"POS0734 EXTRAPOLATION OF LONG-TERM OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPLICATING A HOPKINS LUPUS COHORT ANALYSIS WITH THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC) INCEPTION COHORT","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Calgary","funders":"Gillings School of Public Health; Emory University; University of Toronto; University of Manitoba; Shanxi Medical University; Université Laval; National Natural Science Foundation of China; Northwestern University; McGill University; University of Calgary; Northwell Health; National Science Foundation","keywords":"Medicine; Cohort; Systemic lupus erythematosus; Prednisone; Internal medicine; Systemic lupus; Disease","score_opus":0.03491471654895213,"score_gpt":0.34794788411543154,"score_spread":0.3130331675664794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164415081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922065,0.0027713121,0.0005420252,0.0011268682,0.00052423443,0.002321605,0.00015663364,0.0000589199,0.00029188892],"genre_scores_gemma":[0.9968023,0.0015501704,0.000118309,0.000104736246,0.000051030187,0.00032582952,0.00016887262,0.00005739544,0.0008213571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99397784,0.0008360842,0.0021421225,0.00066219125,0.0019194006,0.00046236586],"domain_scores_gemma":[0.9926926,0.0014653408,0.0020067596,0.0019348516,0.0017241368,0.00017634753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002050721,0.00039815233,0.0016575922,0.0005901446,0.00016938247,0.00010031273,0.00074121595,0.00015530734,0.00006688447],"category_scores_gemma":[0.002543864,0.00023865949,0.00062938384,0.0027493262,0.0002936709,0.0002527352,0.000289874,0.00029173607,0.000007738305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002789311,0.0004391754,0.98725885,0.0033575243,0.0041378574,0.000034168806,0.0022278824,0.0008123034,0.00036602837,0.00014963956,0.00021182634,0.0007258055],"study_design_scores_gemma":[0.0029520157,0.00015589924,0.94217306,0.01726647,0.0031051016,0.011720846,0.011522445,0.01013152,0.0004990647,0.00006196644,0.0000066848665,0.0004048998],"about_ca_topic_score_codex":0.00019417594,"about_ca_topic_score_gemma":0.00024740267,"teacher_disagreement_score":0.04508577,"about_ca_system_score_codex":0.00026513616,"about_ca_system_score_gemma":0.00074230134,"threshold_uncertainty_score":0.9732251},"labels":[],"label_agreement":null},{"id":"W3164427644","doi":"10.1136/annrheumdis-2021-eular.1987","title":"POS1351 CAUSES OF HOSPITALIZATION IN BEHÇET SYNDROME","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Complication; Pediatrics; Retrospective cohort study; Medical record; Adverse effect; Internal medicine; Surgery","score_opus":0.02730413168346959,"score_gpt":0.3013579850438936,"score_spread":0.27405385336042404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164427644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235314,0.005392146,0.0000079154515,0.0015056805,0.00010398851,0.0002554798,0.00012430963,0.000014927967,0.0002424335],"genre_scores_gemma":[0.99860334,0.000704899,0.000041479314,0.00024455812,0.0000068692843,0.000011629549,0.000055187742,0.000017003998,0.00031503462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870014,0.000081340666,0.000463467,0.00017221711,0.00040072465,0.00018207886],"domain_scores_gemma":[0.99883556,0.00007297836,0.00020804319,0.00054376875,0.00022123916,0.00011841632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008941725,0.000127403,0.00045243694,0.000089228466,0.000027479902,0.000010153767,0.0001450067,0.00004326947,0.000410941],"category_scores_gemma":[0.0006700034,0.00009202058,0.00031490403,0.00043608138,0.00010798027,0.000096570024,0.00009669749,0.000047463058,0.0000069748953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017840858,0.00532417,0.9727664,0.0052542095,0.00084798574,0.0004298863,0.00055872806,0.0002938943,0.0007493548,0.0024440084,0.0041149124,0.007038059],"study_design_scores_gemma":[0.0006616786,0.00014779958,0.9901243,0.0025403716,0.00026705742,0.000084017156,0.00028679575,0.00011534344,0.0033312817,0.0022736678,0.000056742476,0.00011095682],"about_ca_topic_score_codex":0.00008100322,"about_ca_topic_score_gemma":0.0000123354675,"teacher_disagreement_score":0.017357904,"about_ca_system_score_codex":0.000011759362,"about_ca_system_score_gemma":0.00023321307,"threshold_uncertainty_score":0.44995156},"labels":[],"label_agreement":null},{"id":"W3164440162","doi":"10.1136/annrheumdis-2021-eular.211","title":"POS0901 IXEKIZUMAB SHOWS A DISTINCT PATTERN OF PAIN IMPROVEMENT BEYOND INFLAMMATION IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Janssen Research and Development; Janssen Scientific Affairs; McGovern Medical School; University of Pennsylvania","keywords":"Medicine; BASDAI; Ixekizumab; Axial spondyloarthritis; Adalimumab; Placebo; Clinical endpoint; Internal medicine; Randomized controlled trial; Physical therapy; Ankylosing spondylitis; Arthritis; Rheumatoid arthritis; Secukinumab; Pathology; Psoriatic arthritis","score_opus":0.016699854549792018,"score_gpt":0.26477884749930664,"score_spread":0.24807899294951463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164440162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99098915,0.00595819,0.000025781987,0.0017680895,0.0001423355,0.00054380833,0.00030940832,0.000015359312,0.00024786714],"genre_scores_gemma":[0.9982038,0.0012210053,0.000035560577,0.00021971551,0.00003393109,0.000078539495,0.000106346444,0.000018584718,0.00008251595],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99820584,0.0001734212,0.0006720504,0.00023181473,0.00044791697,0.00026897917],"domain_scores_gemma":[0.9987267,0.00019386398,0.00029102445,0.00048544368,0.00020141892,0.00010155175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002656234,0.00019384784,0.0005718935,0.00013262844,0.00006907281,0.000014132308,0.000120682715,0.000045930698,0.0002390006],"category_scores_gemma":[0.00057791726,0.00014577997,0.00039010195,0.00041484018,0.00014850665,0.00007971775,0.00011758459,0.000074132775,0.000003211164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003018961,0.0012149778,0.23762111,0.0009958777,0.00053500186,0.00011263634,0.00062644784,0.000008964917,0.0004960362,0.00012838499,0.00075706205,0.7572016],"study_design_scores_gemma":[0.0055542537,0.00082094653,0.9780021,0.0036423176,0.000282345,0.000029378041,0.00096279103,0.00021126773,0.0077280947,0.0023413575,0.00020553517,0.00021965665],"about_ca_topic_score_codex":0.0003296946,"about_ca_topic_score_gemma":0.0005975631,"teacher_disagreement_score":0.75698197,"about_ca_system_score_codex":0.000022412776,"about_ca_system_score_gemma":0.0001130962,"threshold_uncertainty_score":0.5944735},"labels":[],"label_agreement":null},{"id":"W3164457337","doi":"10.1136/annrheumdis-2021-eular.2000","title":"AB0547 ASSOCIATION BETWEEN ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH IMPROVEMENT IN QUALITY OF LIFE IN UPADACITINIB-TREATED PATIENTS IN THE PHASE 3 SELECT-PsA 1 AND 2 STUDIES","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Barrie Urology Group","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Visual analogue scale; Adalimumab; Placebo; Quality of life (healthcare); Clinical trial; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Physical therapy; Psoriasis; Disease; Immunology; Pathology","score_opus":0.067309451921762,"score_gpt":0.38349949164512903,"score_spread":0.316190039723367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164457337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948253,0.0024101026,0.0000014964342,0.0017629114,0.000010220127,0.00076429045,0.00021231001,0.0000037971784,0.000009539124],"genre_scores_gemma":[0.9922364,0.007558838,0.000008700575,0.000074987074,0.0000045394136,0.00005359844,0.000036289224,0.0000076086985,0.000019068159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763495,0.0006120425,0.00064345193,0.00017683917,0.0007175221,0.00021517926],"domain_scores_gemma":[0.9980458,0.0008130379,0.00045317019,0.00027969596,0.00029746222,0.000110806075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000816029,0.00013466594,0.00061869633,0.000100245816,0.000037415964,0.000010036729,0.000109315915,0.000027958773,0.000014335177],"category_scores_gemma":[0.00400011,0.00007037442,0.000075974196,0.00043374434,0.000116114905,0.00011208545,0.00008147166,0.000106447755,1.3518557e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032626914,0.0036989504,0.97033906,0.0014680215,0.00031914184,0.0000038486396,0.0012560701,0.0000061575097,0.00027591342,0.000015365222,0.00010011154,0.019254671],"study_design_scores_gemma":[0.006557003,0.0006241563,0.98322666,0.0035482,0.000024154268,8.550168e-8,0.0012833165,0.000043576274,0.0043704356,0.0002470238,0.0000041630897,0.000071250506],"about_ca_topic_score_codex":0.00048308546,"about_ca_topic_score_gemma":0.00040839537,"teacher_disagreement_score":0.01918342,"about_ca_system_score_codex":0.000050047413,"about_ca_system_score_gemma":0.00028961606,"threshold_uncertainty_score":0.47887942},"labels":[],"label_agreement":null},{"id":"W3164498262","doi":"10.1136/annrheumdis-2021-eular.3327","title":"POS1324 TREATMENT OF UVEITIS ASSOCIATED WITH JUVENILE IDIOPATHIC ARTHRITIS: A SEVEN YEARS' SINGLE-CENTRE EXPERIENCE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medac; Swedish Orphan Biovitrum; Hospital for Sick Children; Saint Petersburg State University; University of Toronto; Bundesministerium für Bildung und Forschung; Gilead Sciences; Sanofi; Pfizer","keywords":"Medicine; Adalimumab; Abatacept; Etanercept; Golimumab; Infliximab; Internal medicine; Tocilizumab; Uveitis; BASDAI; Arthritis; Psoriatic arthritis; Rituximab; Immunology; Rheumatoid arthritis; Tumor necrosis factor alpha; Lymphoma","score_opus":0.04019027133605954,"score_gpt":0.29529902566285654,"score_spread":0.255108754326797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164498262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98126596,0.016781647,0.0000040471714,0.0011002866,0.000034186196,0.00032450887,0.000065553126,0.000023037734,0.00040075774],"genre_scores_gemma":[0.99738777,0.0012487356,0.000021090025,0.00009937534,0.000007808558,0.000031659587,0.000026340025,0.000018863222,0.0011583333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984658,0.0001554022,0.00046007062,0.00017324586,0.00049861154,0.0002468649],"domain_scores_gemma":[0.99875695,0.00009570818,0.00026466194,0.00048341733,0.00029461537,0.00010466219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009305122,0.00013419602,0.000596049,0.0000469544,0.000058631118,0.000015535168,0.00012640838,0.000045490146,0.0003029057],"category_scores_gemma":[0.00073177944,0.00009147397,0.00023150502,0.0003089977,0.00019482846,0.000084266765,0.00005614687,0.00005113252,0.000008593257],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018155081,0.029664058,0.24138491,0.0027913223,0.004712708,0.0012780138,0.05062758,0.0001713749,0.009896946,0.00059332285,0.008087962,0.6489763],"study_design_scores_gemma":[0.011550166,0.0041699223,0.8217484,0.028404968,0.00062570785,0.00011320123,0.020366065,0.00039988838,0.10821668,0.0011037401,0.0026264293,0.00067487964],"about_ca_topic_score_codex":0.000054396893,"about_ca_topic_score_gemma":0.00003721894,"teacher_disagreement_score":0.6483014,"about_ca_system_score_codex":0.00003801931,"about_ca_system_score_gemma":0.0005250663,"threshold_uncertainty_score":0.37302002},"labels":[],"label_agreement":null},{"id":"W3164503965","doi":"10.1136/annrheumdis-2021-eular.274","title":"POS0200 CLINICAL CHARACTERISTICS & OUTCOMES ASSOCIATE WITH WORK PRODUCTIVITY IN BIO-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH WEEK 24 OF THE DISCOVER-2 STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Presenteeism; Internal medicine; Absenteeism; Golimumab; Placebo; Multivariate analysis; Physical therapy; Work productivity; Enthesitis; Arthritis; Productivity; Disease; Adalimumab","score_opus":0.0468209902511662,"score_gpt":0.2974974360181815,"score_spread":0.2506764457670153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164503965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963477,0.0007799426,0.0000030182753,0.0006293043,0.00065373274,0.0008378433,0.0007138309,0.000011960151,0.000022652066],"genre_scores_gemma":[0.9991633,0.00019157601,0.000030024172,0.000067694054,0.000011157267,0.000054433334,0.00008577822,0.000018784382,0.0003772092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974327,0.0011708281,0.00061654527,0.00033334983,0.0001703084,0.00027628004],"domain_scores_gemma":[0.99756527,0.00066952663,0.00077102514,0.0007527955,0.00021797617,0.00002342911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023849946,0.0002532317,0.0008294032,0.000030811432,0.00013730713,0.000015719976,0.0003127708,0.000082836654,0.00004831322],"category_scores_gemma":[0.0010604057,0.00012534765,0.0002518202,0.00040211252,0.0003204698,0.00014957628,0.00017203129,0.00015970242,0.000011632962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008467343,0.007597395,0.9530188,0.000046713587,0.0020556187,0.0000021539897,0.001364723,0.000004069785,0.0000036317358,0.000022127968,0.00017938824,0.03485869],"study_design_scores_gemma":[0.0028527668,0.0003656379,0.9938457,0.00068542926,0.0005228634,9.406151e-7,0.0004982615,7.357393e-8,0.0007056601,0.00033567694,0.00003152211,0.0001554875],"about_ca_topic_score_codex":0.0001038171,"about_ca_topic_score_gemma":0.0003800557,"teacher_disagreement_score":0.040826924,"about_ca_system_score_codex":0.000021060887,"about_ca_system_score_gemma":0.00021849436,"threshold_uncertainty_score":0.51115286},"labels":[],"label_agreement":null},{"id":"W3164504706","doi":"10.1136/annrheumdis-2021-eular.3420","title":"POS1372 EVALUATION OF E148Q AND CONCOMITANT AA AMYLOIDOSIS SECONDARY TO FAMILIAL MEDITERRANEAN FEVER AFTER ADJUSTED CLINICAL-DEMOGRAPHIC CHARACTERISTICS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Familial Mediterranean fever; Medicine; Amyloidosis; AA amyloidosis; Internal medicine; MEFV; Concomitant; Family history; Gastroenterology; Pathology; Gene mutation; Disease; Mutation; Genetics","score_opus":0.059077638523014675,"score_gpt":0.34776547144937336,"score_spread":0.2886878329263587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164504706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99230886,0.0045617144,0.00001531116,0.001519698,0.0003214166,0.00045040908,0.000760101,0.000007671308,0.000054832566],"genre_scores_gemma":[0.9941973,0.0037913441,0.00012152205,0.0014789653,0.000065721535,0.00010120254,0.0001622942,0.000024768658,0.000056879162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977173,0.00050291297,0.0007584664,0.0003696978,0.0004379888,0.00021361173],"domain_scores_gemma":[0.99797535,0.00020543,0.00039051712,0.0006882018,0.0005546696,0.00018582991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005280303,0.00022362007,0.00049906445,0.00006123653,0.000057513884,0.000020416986,0.00022765159,0.0001221117,0.00015206027],"category_scores_gemma":[0.0019047416,0.00016971391,0.00037508796,0.00017541202,0.0002455708,0.00001177088,0.00025688313,0.00006968333,0.0000040152686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005411786,0.0012232165,0.8628119,0.0004944638,0.001797573,0.0000065138665,0.00030454248,0.000019219164,0.0045546843,0.00002527151,0.008790267,0.11943117],"study_design_scores_gemma":[0.0011531276,0.00018667759,0.98142076,0.0003454974,0.00066307676,0.0000036916585,0.0001921142,0.00008651004,0.015302089,0.00019467775,0.00026352945,0.00018825353],"about_ca_topic_score_codex":0.000028717828,"about_ca_topic_score_gemma":0.00004557741,"teacher_disagreement_score":0.119242914,"about_ca_system_score_codex":0.000008032338,"about_ca_system_score_gemma":0.0002338818,"threshold_uncertainty_score":0.6920732},"labels":[],"label_agreement":null},{"id":"W3164519483","doi":"10.1136/annrheumdis-2021-eular.358","title":"POS0651 CLINICAL AND FUNCTIONAL RESPONSE TO TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: PROBABILITY PLOT ANALYSIS OF RESULTS FROM A 48-WEEK PHASE 3b/4 METHOTREXATE WITHDRAWAL STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Internal medicine; Methotrexate; Post-hoc analysis; Clinical endpoint; Abatacept; Phases of clinical research; Clinical trial; Rituximab","score_opus":0.05655714182587063,"score_gpt":0.353556543390873,"score_spread":0.2969994015650024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164519483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354714,0.0016450643,0.00003117583,0.0012273514,0.000062279374,0.0012180114,0.002228452,0.000022420278,0.000018123274],"genre_scores_gemma":[0.9977377,0.0013803791,0.00041324671,0.0001423957,0.0000075978337,0.0000691506,0.00020149827,0.0000213943,0.000026632868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99488986,0.0016602089,0.0014723827,0.00059519924,0.0010465541,0.00033577697],"domain_scores_gemma":[0.9958372,0.0016382161,0.00039590025,0.0009449594,0.00078554975,0.00039817023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016915097,0.0002511778,0.0012969517,0.0003278507,0.000094220246,0.00004430757,0.00017518824,0.000055205546,0.00017036915],"category_scores_gemma":[0.008308486,0.0001715736,0.00032560524,0.0012839917,0.0004564,0.00016756786,0.0001983658,0.0001893655,0.0000041772832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06724106,0.015772702,0.88424265,0.00006509272,0.004016105,0.000029945826,0.001994452,0.000092303686,0.000038479928,0.00003338425,0.00036093305,0.026112916],"study_design_scores_gemma":[0.019570343,0.002415726,0.9741205,0.0014502394,0.00015363439,0.000002071203,0.0011791466,0.00015179042,0.00020891514,0.0005387818,0.000044355187,0.00016448497],"about_ca_topic_score_codex":0.0003786472,"about_ca_topic_score_gemma":0.0004925785,"teacher_disagreement_score":0.08987788,"about_ca_system_score_codex":0.000015781947,"about_ca_system_score_gemma":0.0004788427,"threshold_uncertainty_score":0.9946634},"labels":[],"label_agreement":null},{"id":"W3164519882","doi":"10.1136/annrheumdis-2021-220418","title":"Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Canadian Arthritis Patient Alliance","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Tocilizumab; Internal medicine; Golimumab; Rheumatology; Tofacitinib; Logistic regression; Anakinra; Coronavirus disease 2019 (COVID-19); Odds ratio; Rituximab; Adalimumab; Disease","score_opus":0.08132615032310453,"score_gpt":0.34754742533234495,"score_spread":0.2662212750092404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164519882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432088,0.020048419,0.00022484452,0.021449395,0.00010874763,0.00080053875,0.014063636,0.00005449498,0.000041127103],"genre_scores_gemma":[0.9257265,0.07074051,0.00044031127,0.0024391285,0.000010144753,0.000054385688,0.00053415133,0.0000216997,0.0000332091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952723,0.0014937145,0.0014141739,0.0005011243,0.0008124077,0.0005063103],"domain_scores_gemma":[0.9911723,0.005224209,0.001204813,0.0013792616,0.00057154975,0.00044783062],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0009646514,0.00032406222,0.0013181347,0.0000621369,0.00020699146,0.000039158982,0.00056224957,0.00013841828,0.00017449046],"category_scores_gemma":[0.043008134,0.00019009633,0.0003580561,0.0009878735,0.0012653264,0.00018231953,0.0002166611,0.00023821478,0.0000047229673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0124518005,0.0061533106,0.88496137,0.0018026389,0.0031004176,0.00027193472,0.002751689,0.002099429,0.00034584053,0.0033221685,0.066555075,0.016184328],"study_design_scores_gemma":[0.0249544,0.0012568426,0.91393256,0.018195398,0.00016021363,0.00043650903,0.006797993,0.002192367,0.003331115,0.017536873,0.010087463,0.0011182587],"about_ca_topic_score_codex":0.008762003,"about_ca_topic_score_gemma":0.0056056795,"teacher_disagreement_score":0.05646761,"about_ca_system_score_codex":0.00011024087,"about_ca_system_score_gemma":0.003188678,"threshold_uncertainty_score":0.99783874},"labels":[],"label_agreement":null},{"id":"W3164548357","doi":"10.1136/annrheumdis-2021-eular.282","title":"AB0197 EFFICACY AND SAFETY OF HLX01 COMBINED WITH METHOTREXATE IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD INADEQUATE RESPONSES TO METHOTREXATE: RESULTS OF A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, Los Angeles; University of Toronto","keywords":"Medicine; Rheumatoid arthritis; Placebo; Methotrexate; Internal medicine; Clinical endpoint; Rituximab; Rheumatology; Tolerability; Adverse effect; Clinical trial; Surgery; Lymphoma","score_opus":0.03450348972195552,"score_gpt":0.3363933706583125,"score_spread":0.30188988093635694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164548357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924134,0.0013032375,0.00014141647,0.0010719283,0.00005756055,0.0041585546,0.00074169686,0.0000145630665,0.00009761607],"genre_scores_gemma":[0.9980828,0.0005217408,0.00078714394,0.00015379704,0.0000019782249,0.00017038331,0.000031970943,0.000027166083,0.00022299917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946923,0.0027651545,0.0013719609,0.0005396585,0.0002357396,0.00039515222],"domain_scores_gemma":[0.9940985,0.0036373264,0.0007756842,0.00068365835,0.00066296087,0.00014191036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015166928,0.00042219,0.0021401914,0.00028259656,0.000120823395,0.000025418722,0.00034859206,0.00012223235,0.000049099806],"category_scores_gemma":[0.0034879483,0.0002347564,0.0002117201,0.0009109389,0.00032202332,0.00012568681,0.00024108707,0.00021006954,0.0000017002197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96755445,0.005111155,0.0016166231,0.000113271075,0.002275225,0.000009271496,0.0022726455,0.00024207978,0.0003698838,0.000040503503,0.000083645995,0.020311248],"study_design_scores_gemma":[0.7683861,0.0067532663,0.18669882,0.002726649,0.00046719308,0.000007685361,0.0010345071,0.00008233355,0.03309954,0.0002442912,0.00002742654,0.0004721377],"about_ca_topic_score_codex":0.00022899658,"about_ca_topic_score_gemma":0.00020484693,"teacher_disagreement_score":0.19916831,"about_ca_system_score_codex":0.000015603877,"about_ca_system_score_gemma":0.00022831923,"threshold_uncertainty_score":0.9573088},"labels":[],"label_agreement":null},{"id":"W3164570473","doi":"10.1136/annrheumdis-2021-eular.805","title":"OP0047 IDENTIFICATION OF CLINICAL PHENOTYPES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, PERIPHERAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS ACCORDING TO PERIPHERAL MUSCULOSKELETAL MANIFESTATIONS: A CLUSTER ANALYSIS IN THE INTERNATIONAL ASAS-PERSPA STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cairo University; Università degli Studi di Pavia; Semmelweis Egyetem; Sun Yat-sen University; Universidade de Lisboa; Chonnam National University; Universiteit Leiden; Leids Universitair Medisch Centrum; School of Medicine, Kyorin University; Pfizer; Chang Gung Medical Foundation; Eli Lilly and Company","keywords":"Dactylitis; Medicine; Enthesitis; Psoriatic arthritis; Peripheral; Internal medicine; Cluster (spacecraft); Psoriasis; Arthritis; Hierarchical clustering; Physical therapy; Dermatology; Cluster analysis","score_opus":0.022095462017903533,"score_gpt":0.3370620960493079,"score_spread":0.3149666340314044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164570473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492776,0.0018542801,0.000021607122,0.0014924108,0.00021791454,0.0011850552,0.00023105725,0.000009195258,0.000060686292],"genre_scores_gemma":[0.99852604,0.0006755657,0.00018912442,0.00025238533,0.000041779927,0.00015097063,0.000110016816,0.000019181954,0.000034932735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684685,0.00044477373,0.001216303,0.00043793765,0.00079345424,0.00026068985],"domain_scores_gemma":[0.99829596,0.00032596884,0.00037608363,0.00051427813,0.00038727524,0.00010040423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060663244,0.00023205999,0.0008069058,0.00025206618,0.00011417874,0.00007503822,0.00024263507,0.000049627204,0.00011060869],"category_scores_gemma":[0.001163762,0.00016068891,0.00031847006,0.0009544835,0.00016908639,0.00022550311,0.00015124446,0.00014490317,0.000002102698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085771276,0.0032163702,0.9242166,0.0000702317,0.0009850685,0.000066012595,0.002735981,0.000150479,0.0000025148156,0.00008243616,0.000059319096,0.06755724],"study_design_scores_gemma":[0.0077777575,0.00076310145,0.98018795,0.00067899015,0.00051096996,0.000011961504,0.009579362,0.00017076351,0.0000072447215,0.0001400191,0.000024843743,0.00014703312],"about_ca_topic_score_codex":0.0003075265,"about_ca_topic_score_gemma":0.0026046394,"teacher_disagreement_score":0.0674102,"about_ca_system_score_codex":0.000035918303,"about_ca_system_score_gemma":0.00012331553,"threshold_uncertainty_score":0.6552704},"labels":[],"label_agreement":null},{"id":"W3164588808","doi":"10.1136/annrheumdis-2021-eular.711","title":"POS0595 ABATACEPT IN USUAL AND IN NON-SPECIFIC INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 190 PATIENTS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Ankara Universitesi; Gilead Sciences; Sanofi; Amgen; Pfizer; Patient-Centered Outcomes Research Institute; Eli Lilly and Company","keywords":"Medicine; DLCO; Usual interstitial pneumonia; Rheumatoid arthritis; Internal medicine; Interstitial lung disease; Abatacept; Rituximab; Rheumatoid factor; Vital capacity; Diffusing capacity; Gastroenterology; Lung","score_opus":0.019455842090480614,"score_gpt":0.28850774796526796,"score_spread":0.26905190587478733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164588808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726135,0.00094757916,0.0000021135222,0.0004241661,0.00018748379,0.0006849497,0.000359792,0.000007685187,0.00012490671],"genre_scores_gemma":[0.998947,0.00064293185,0.000011868229,0.0002353299,0.000013013892,0.00003806847,0.00006595973,0.000017829087,0.00002800191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798787,0.00016692087,0.00074504525,0.00027982084,0.000585165,0.00023519943],"domain_scores_gemma":[0.9988615,0.00013777148,0.00020537052,0.00024139005,0.00040534907,0.0001486144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018190047,0.00017590006,0.0005295181,0.00018987933,0.00004067767,0.000020984873,0.00014425225,0.00004908951,0.00006122755],"category_scores_gemma":[0.00072426675,0.00014777883,0.00015105205,0.00035312076,0.00008337095,0.00013064111,0.00020567756,0.00011585693,0.0000039565953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006251446,0.02278025,0.9500922,0.00069103803,0.00039647185,0.000112315756,0.0053862166,0.00021969082,0.00074435514,0.00008493807,0.0028577456,0.010383315],"study_design_scores_gemma":[0.0036575785,0.0011581031,0.98683953,0.005604697,0.0000243233,0.000002959297,0.001804569,0.000475801,0.00018408135,0.000090668174,0.000019604473,0.00013808112],"about_ca_topic_score_codex":0.00025103983,"about_ca_topic_score_gemma":0.0002383356,"teacher_disagreement_score":0.036747318,"about_ca_system_score_codex":0.00005986948,"about_ca_system_score_gemma":0.000108694316,"threshold_uncertainty_score":0.6026246},"labels":[],"label_agreement":null},{"id":"W3164610545","doi":"10.1136/annrheumdis-2021-eular.705","title":"POS0207 REAL-WORLD RETENTION OF JAK INHIBITORS IS LONGER THAN BDMARDS IN RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Tofacitinib; Abatacept; Discontinuation; Tocilizumab; Rheumatoid arthritis; Internal medicine; Janus kinase inhibitor; Hazard ratio; Certolizumab pegol; Rituximab; Adalimumab; Confidence interval","score_opus":0.03949495421658896,"score_gpt":0.3124648860336894,"score_spread":0.27296993181710044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164610545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785526,0.015085213,0.000010634956,0.003905302,0.0004988204,0.0001923372,0.00024980237,0.00001827465,0.0014870291],"genre_scores_gemma":[0.98812866,0.010075108,0.000111695816,0.0002888301,0.000007456873,0.000008390721,0.000024485607,0.000012439459,0.0013429292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981462,0.00050923176,0.00071600627,0.000245437,0.00010613919,0.0002769998],"domain_scores_gemma":[0.99867254,0.00028412987,0.00031739753,0.00050340436,0.00018349438,0.00003901469],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004182918,0.00016516654,0.00054516556,0.00011760927,0.000060584454,0.000011488671,0.00025088168,0.00013311605,0.0010766705],"category_scores_gemma":[0.00057781924,0.00011702895,0.0004169334,0.000490256,0.00035716512,0.00007835026,0.00017830789,0.00014716337,0.000016207183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009996735,0.0045978106,0.398494,0.0019274615,0.0027281328,0.00003706,0.0021069625,0.000015146359,0.055733643,0.014504297,0.14820425,0.37065154],"study_design_scores_gemma":[0.0012472689,0.000145015,0.5980244,0.0041804467,0.00009766262,0.000017095672,0.000662397,0.000021400116,0.38056245,0.012452885,0.002263265,0.00032571494],"about_ca_topic_score_codex":0.0002984898,"about_ca_topic_score_gemma":0.00020581255,"teacher_disagreement_score":0.37032583,"about_ca_system_score_codex":0.000010710513,"about_ca_system_score_gemma":0.000106380954,"threshold_uncertainty_score":0.9998365},"labels":[],"label_agreement":null},{"id":"W3164625274","doi":"10.1136/annrheumdis-2021-eular.108","title":"POS0896 PREDICTORS OF RESPONSE IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING CERTOLIZUMAB PEGOL IN THE C-AXSPAND STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Pfizer","keywords":"Medicine; Certolizumab pegol; Internal medicine; Axial spondyloarthritis; Placebo; Ankylosing spondylitis; BASDAI; Logistic regression; Physical therapy; Rheumatoid arthritis; Sacroiliitis; Etanercept; Psoriatic arthritis","score_opus":0.014922294089204967,"score_gpt":0.2653457453139972,"score_spread":0.2504234512247922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164625274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955833,0.0018463447,3.6185247e-7,0.0010221942,0.00010957553,0.0012075717,0.00013249485,0.000008307837,0.00008983915],"genre_scores_gemma":[0.99932265,0.00043869478,0.000012231066,0.000057394922,0.000011984952,0.000088043555,0.00002042657,0.000020275626,0.000028274753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977054,0.0004914368,0.0005634355,0.00026257633,0.00068567507,0.0002914862],"domain_scores_gemma":[0.9983844,0.00045644413,0.00022957461,0.00065234554,0.00020220819,0.00007501617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020420643,0.0002104898,0.0006174382,0.00021053791,0.00008996249,0.000017112,0.00020936246,0.000037930433,0.000043575885],"category_scores_gemma":[0.00079598505,0.000120824596,0.00019758365,0.00095582876,0.00018515276,0.00009121538,0.00009807693,0.00012120869,0.0000012911908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057043,0.004700475,0.98301905,0.00013360046,0.00034155798,0.00026440888,0.003182148,0.000009395537,0.0000036234023,0.0000062416707,0.00016940075,0.0024658057],"study_design_scores_gemma":[0.009578736,0.0021164417,0.9824877,0.002328459,0.0001993672,0.000028791952,0.0030330326,0.000007260882,0.0000357594,0.00007072561,0.000009426814,0.00010434466],"about_ca_topic_score_codex":0.00027533437,"about_ca_topic_score_gemma":0.0004201492,"teacher_disagreement_score":0.0038744356,"about_ca_system_score_codex":0.00002102384,"about_ca_system_score_gemma":0.00015849734,"threshold_uncertainty_score":0.49270838},"labels":[],"label_agreement":null},{"id":"W3164644841","doi":"10.1136/annrheumdis-2021-eular.1405","title":"OP0013 SEX DIFFERENCES IN AUTOIMMUNE DISEASE SUSCEPTIBILITY; A MULTI-OMIC APPROACH","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Manchester Biomedical Research Centre; National Institutes of Health; Versus Arthritis; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; LUPUS UK; University of Manchester; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Health Sciences Centre Foundation","keywords":"Medicine; Immune system; Internal medicine; Sex characteristics; Lipid metabolism; Cohort; Immunology; Sex hormone-binding globulin; Inflammation; Endocrinology; Hormone; Physiology; Androgen","score_opus":0.05624290308615588,"score_gpt":0.2676278183576903,"score_spread":0.2113849152715344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164644841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496849,0.04879104,0.00009173079,0.00042853187,0.00021127873,0.00034998477,0.00024684437,0.000043695636,0.00015197319],"genre_scores_gemma":[0.99678737,0.0013717754,0.00002949811,0.00022124375,0.000007852146,0.00008189617,0.000098533535,0.000020457073,0.0013813578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775714,0.00078972516,0.00051416864,0.00042358256,0.00012918458,0.00038619188],"domain_scores_gemma":[0.99839973,0.00016812446,0.00018254809,0.0010676013,0.000106811414,0.00007520879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025427286,0.00025190876,0.00064718624,0.000057019013,0.0001208563,0.000032260905,0.0005342611,0.000088971894,0.0003243099],"category_scores_gemma":[0.0005964947,0.00017269427,0.0008083531,0.00026526433,0.00042908083,0.00009966192,0.00030583923,0.00014257203,0.000044258806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004255062,0.011330665,0.9145536,0.0016361446,0.0030295807,0.000016077216,0.0017841802,0.0005275928,0.008255839,0.0015299928,0.006097905,0.050812915],"study_design_scores_gemma":[0.0011329888,0.00002110889,0.9945606,0.0004207803,0.00020309055,0.0000033918354,0.0009979021,0.00016711658,0.0015384849,0.00056333403,0.00016399831,0.00022717968],"about_ca_topic_score_codex":0.00011557702,"about_ca_topic_score_gemma":0.000014290993,"teacher_disagreement_score":0.080007024,"about_ca_system_score_codex":0.000016099095,"about_ca_system_score_gemma":0.00023813527,"threshold_uncertainty_score":0.7042268},"labels":[],"label_agreement":null},{"id":"W3164650005","doi":"10.1136/annrheumdis-2021-eular.3433","title":"AB0447 PREVALENCE OF PRIMARY BILIARY CIRRHOSIS IN SYSTEMIC SCLEROSIS AND SJÖGREN'S SYNDROME OVER TIME: A SYSTEMATIC REVIEW","year":2021,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Primary biliary cirrhosis; Overlap syndrome; Internal medicine; Gastroenterology; Rheumatology; Scleroderma (fungus); Interstitial lung disease; Autoimmune disease; Disease; Dermatology; Immunology; Lung","score_opus":0.06278304002187063,"score_gpt":0.3185152237337319,"score_spread":0.2557321837118613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164650005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057306974,0.98874706,2.5069792e-7,0.000063302374,0.00006629971,0.004608683,0.0007222228,0.000020134643,0.00004134291],"genre_scores_gemma":[0.0035461853,0.9954014,0.000009700329,0.00021484573,0.0000070714595,0.00037713116,0.00008404842,0.000054919077,0.00030472194],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9948856,0.0013738895,0.002274778,0.00043325935,0.00073142233,0.00030105273],"domain_scores_gemma":[0.994788,0.0010023908,0.0018644492,0.0018937184,0.00023026619,0.00022121312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079592434,0.0005372676,0.006568773,0.00021538923,0.000049532,0.000022218128,0.00062864315,0.00014947182,0.00024468914],"category_scores_gemma":[0.0018257807,0.0003255867,0.0016497154,0.00077549054,0.00023284362,0.00014915236,0.0004899458,0.00023710208,0.000016000222],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009019974,0.00047403484,0.00031917047,0.9828942,0.0011479083,0.0000145515,0.000033660464,1.243059e-7,4.820852e-7,0.0000072695093,0.00087692495,0.01422265],"study_design_scores_gemma":[0.00025425595,0.000090151676,0.0100657195,0.9684544,0.02054277,0.00021644826,0.000021827056,0.0000059224326,6.5764857e-7,0.000014837088,0.00007052412,0.00026248363],"about_ca_topic_score_codex":0.00006269857,"about_ca_topic_score_gemma":1.8783997e-7,"teacher_disagreement_score":0.019394862,"about_ca_system_score_codex":0.00008492348,"about_ca_system_score_gemma":0.00079419056,"threshold_uncertainty_score":0.9999196},"labels":[],"label_agreement":null},{"id":"W3164661700","doi":"10.1136/annrheumdis-2021-eular.2589","title":"AB0555 IMPACT OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY ON CLINICAL AND PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS OVER 24 MONTHS – RESULTS OF THE COMPLETE-PsA CANADIAN OBSERVATIONAL STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; South Bruce Grey Health Centre; ABB (Canada); Etobicoke General Hospital; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Dactylitis; Internal medicine; Golimumab; Concomitant; Etanercept; Enthesitis; Observational study; Population; Psoriasis; Physical therapy; Rheumatoid arthritis; Dermatology","score_opus":0.18730833062680727,"score_gpt":0.4036689281211126,"score_spread":0.21636059749430533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164661700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947707,0.0021530867,2.8840685e-8,0.0010031677,0.00029311547,0.00083385385,0.00086577336,0.000003739633,0.00007654738],"genre_scores_gemma":[0.99833995,0.0013362063,0.000009285472,0.0002190947,0.000007926094,0.000027043012,0.00003505602,0.000009440793,0.000016016107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980638,0.0002141944,0.0009401928,0.0002177035,0.00036875342,0.000195353],"domain_scores_gemma":[0.99788016,0.00077426306,0.00047053793,0.0005520857,0.00020868643,0.000114289105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017889494,0.00017085028,0.0007335896,0.000056693687,0.000075344,0.0000069029325,0.000114911985,0.000044008022,0.000043534234],"category_scores_gemma":[0.0019867579,0.000090473375,0.00037852844,0.00022938808,0.00018645468,0.000034984805,0.00007065719,0.000081729864,5.8500746e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017279892,0.0022204816,0.97792965,0.000023071301,0.0014831596,0.000025583817,0.0005508746,0.00003354036,0.000003172793,0.000019158233,0.00054679235,0.015436549],"study_design_scores_gemma":[0.013910961,0.002275581,0.9821141,0.0006121302,0.00010935056,0.0000020172224,0.00058758643,0.00004359044,0.0000216283,0.00023620417,0.000014614168,0.00007224224],"about_ca_topic_score_codex":0.03168069,"about_ca_topic_score_gemma":0.021483298,"teacher_disagreement_score":0.015364307,"about_ca_system_score_codex":0.0000328481,"about_ca_system_score_gemma":0.00041632692,"threshold_uncertainty_score":0.9963721},"labels":[],"label_agreement":null},{"id":"W3164687856","doi":"10.1136/annrheumdis-2021-eular.2344","title":"POS0299 SOCIOECONOMIC BACKGROUND IS ASSOCIATED WITH DISCORDANCE BETWEEN HEALTH LITERACY OF PEOPLE WITH RMDs AND ASSESSMENT OF HEALTH LITERACY BY THEIR TREATING HEALTH PROFESSIONAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Centre for Social Innovation; Vancouver Native Health Society; University of British Columbia","funders":"","keywords":"Medicine; Health literacy; Socioeconomic status; Family medicine; Health care; Literacy; Physical therapy; Internal medicine; Gerontology; Population; Environmental health","score_opus":0.08660357392167137,"score_gpt":0.4519826319248873,"score_spread":0.3653790580032159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164687856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92762846,0.005483138,0.000059411588,0.06455976,0.00023622107,0.0011715151,0.00080969324,0.00001746831,0.000034307945],"genre_scores_gemma":[0.99505436,0.0024707455,0.0007791376,0.0012614236,0.000050414168,0.00013192401,0.00016260603,0.00002413174,0.000065250664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955213,0.001915887,0.00111228,0.0003172995,0.00062187127,0.0005113756],"domain_scores_gemma":[0.9926854,0.0033282393,0.0028643769,0.00034329714,0.00045254274,0.00032616677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017710583,0.00020434558,0.0010122575,0.00006400953,0.0007394078,0.000056549452,0.00027648782,0.000051930903,0.00006592274],"category_scores_gemma":[0.0005080314,0.0001423398,0.00010937138,0.00048661785,0.00042294874,0.00042314248,0.00007186568,0.00017353176,3.3988164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026789327,0.0007139974,0.7531616,0.0017872973,0.00020707227,8.0362014e-8,0.10500494,0.000003672351,8.716673e-7,0.0006719571,0.0018214794,0.13660023],"study_design_scores_gemma":[0.00048571284,0.00038482054,0.974203,0.0046904944,0.0000257478,4.0590922e-7,0.018578647,0.00006471907,0.00001949181,0.0012741464,0.0001368287,0.00013598693],"about_ca_topic_score_codex":0.0121207265,"about_ca_topic_score_gemma":0.0010507765,"teacher_disagreement_score":0.22104138,"about_ca_system_score_codex":0.0002919394,"about_ca_system_score_gemma":0.008759851,"threshold_uncertainty_score":0.99685955},"labels":[],"label_agreement":null},{"id":"W3164726261","doi":"10.1136/annrheumdis-2021-eular.137","title":"OP0049 COMPARISON OF BASELINE DISEASE ACTIVITY AND PATIENT (PT)-REPORTED OUTCOMES (PROS) BETWEEN PTS WITH PSORIATIC ARTHRITIS AND AXIAL INVOLVEMENT (AXIAL PSA) AND AXIAL SPONDYLOARTHRITIS (AXIAL SPA) FROM THE CORRONA PSA/SPA REGISTRY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Momenta Pharmaceuticals; Valeant Pharmaceuticals International; Regeneron Pharmaceuticals; Genentech; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Axial spondyloarthritis; Internal medicine; Population; Psoriatic arthritis; Disease; Sacroiliitis","score_opus":0.04095905865174187,"score_gpt":0.3035787721721038,"score_spread":0.2626197135203619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164726261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96841127,0.023464149,0.000019737448,0.0033890922,0.00025899988,0.0011013603,0.003286674,0.000030180314,0.000038524166],"genre_scores_gemma":[0.9952439,0.0036057723,0.0001277228,0.00043080465,0.00011696666,0.00008811035,0.00032617303,0.000039352726,0.000021195536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968666,0.00027718444,0.0009029176,0.0006129905,0.00092531444,0.00041503238],"domain_scores_gemma":[0.99688494,0.00078912167,0.00075197394,0.0008358388,0.0002830702,0.0004550556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001995635,0.0004784,0.0013911974,0.000046255504,0.0004427132,0.000083934225,0.00014491436,0.00008730102,0.00007808512],"category_scores_gemma":[0.0007437694,0.0003053704,0.00025152473,0.00017820494,0.001011095,0.00018223516,0.0003878868,0.00019715878,0.0000011911172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029262905,0.0021956926,0.8322532,0.00060112035,0.0021896325,0.0001827946,0.0012763317,0.000007789327,0.00006986387,0.0003712814,0.0010710042,0.15685499],"study_design_scores_gemma":[0.010075681,0.0012231617,0.97819966,0.003693147,0.0017721952,0.000032797318,0.0014950751,0.00012168031,0.0013079938,0.0013592601,0.0003412608,0.000378092],"about_ca_topic_score_codex":0.0028957126,"about_ca_topic_score_gemma":0.0019852442,"teacher_disagreement_score":0.1564769,"about_ca_system_score_codex":0.000027805818,"about_ca_system_score_gemma":0.00021608773,"threshold_uncertainty_score":0.99993986},"labels":[],"label_agreement":null},{"id":"W3164740964","doi":"10.1136/annrheumdis-2021-eular.166","title":"POS1088 EFFICACY OF SUBCUTANEOUS TANEZUMAB FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE OR HIP: A POST-HOC SUBGROUP ANALYSIS OF PATIENTS FROM A RANDOMIZED, NSAID-CONTROLLED STUDY WITH A HISTORY OF DEPRESSION, ANXIETY, OR INSOMNIA","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Placebo; WOMAC; Internal medicine; Post-hoc analysis; Subgroup analysis; Randomized controlled trial; Knee pain; Clinical trial; Physical therapy; Confidence interval","score_opus":0.024111394512187783,"score_gpt":0.29145706981737707,"score_spread":0.26734567530518927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164740964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746621,0.019388646,0.000007704197,0.00016805922,0.00006241014,0.004719078,0.0009680308,0.000005721196,0.000018230397],"genre_scores_gemma":[0.9973195,0.0017827331,0.00005671644,0.00000852861,0.000004244357,0.00026900013,0.00006547632,0.000026075426,0.00046769297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996093,0.00074241904,0.0014664622,0.00029508877,0.0011534306,0.00024959666],"domain_scores_gemma":[0.99102926,0.004631339,0.0015064303,0.0013791918,0.0013523904,0.00010137317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003528604,0.00027852374,0.0027761322,0.00018773705,0.000055165874,0.0000056524486,0.0004329424,0.00006760199,0.00048087235],"category_scores_gemma":[0.00241629,0.00010968658,0.0015485256,0.00069970364,0.00067748345,0.000050332226,0.00011624932,0.00007005505,2.3133688e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86556995,0.021840617,0.037677784,0.0050457893,0.033894036,0.000024471427,0.009147866,0.00038404943,0.00095054036,0.00001802766,0.0003835956,0.0250633],"study_design_scores_gemma":[0.63037604,0.033154935,0.2684232,0.0088233985,0.043845743,0.00002516528,0.005955703,0.0026341213,0.006268732,0.00010670052,0.00002877528,0.00035750683],"about_ca_topic_score_codex":0.0013251422,"about_ca_topic_score_gemma":0.00018837549,"teacher_disagreement_score":0.2351939,"about_ca_system_score_codex":0.00009317968,"about_ca_system_score_gemma":0.0013141199,"threshold_uncertainty_score":0.5265215},"labels":[],"label_agreement":null},{"id":"W3164750661","doi":"10.1136/annrheumdis-2021-eular.3758","title":"OP0203 GENE-DIET INTERACTION ON THE RISK OF INCIDENT GOUT AMONG WOMEN – PROSPECTIVE COHORT STUDY OVER 32 YEARS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Nutrition, Health and Food Behavior","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Dash; Prospective cohort study; Refined grains; Relative risk; Environmental health; Cohort; Cohort study; Internal medicine; Single-nucleotide polymorphism; Lower risk; Whole grains; Confidence interval; Genotype; Food science; Genetics","score_opus":0.02776747765019819,"score_gpt":0.3267645523385503,"score_spread":0.29899707468835207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164750661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746835,0.0002548217,8.5589096e-7,0.00038204846,0.00046025793,0.0011815933,0.00015011063,0.000020396628,0.000081535516],"genre_scores_gemma":[0.9993363,0.00012516929,0.000005615405,0.00020282796,0.000034670473,0.00021633544,0.000007914527,0.000018636716,0.00005252472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812984,0.00048575373,0.00045174855,0.00021605368,0.00049272465,0.00022388034],"domain_scores_gemma":[0.9982996,0.00033449713,0.00048098518,0.000574865,0.00020874872,0.00010132917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043334498,0.00013471613,0.0003130918,0.000055847882,0.0001512862,0.000033440792,0.00022027828,0.00003350982,0.0001837564],"category_scores_gemma":[0.0007417221,0.00008798859,0.00018372743,0.00023801842,0.00010641192,0.00012590108,0.00008142199,0.00014417706,0.0000105156105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064900727,0.0021170513,0.99003583,0.00010921546,0.00021110309,0.000002310191,0.0031101413,0.000046952,0.000025511908,0.000015637737,0.0022187908,0.0014584245],"study_design_scores_gemma":[0.0004623195,0.00058131886,0.99029243,0.0003996908,0.00019686934,9.2883727e-7,0.004400322,0.000045870507,0.0022982992,0.0012146625,0.000019132214,0.00008817753],"about_ca_topic_score_codex":0.00051971513,"about_ca_topic_score_gemma":0.000092781374,"teacher_disagreement_score":0.0022727873,"about_ca_system_score_codex":0.000081736645,"about_ca_system_score_gemma":0.00005577992,"threshold_uncertainty_score":0.35880706},"labels":[],"label_agreement":null},{"id":"W3164778783","doi":"10.1136/annrheumdis-2021-eular.172","title":"POS0436 PATIENT CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB: THE OM1 RA REGISTRY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Genentech; Celgene; Gilead Sciences; Momenta Pharmaceuticals; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Medical prescription; Randomized controlled trial; Clinical trial; Pharmacy; Disease; Physical therapy; Family medicine; Pharmacology","score_opus":0.011921547885688367,"score_gpt":0.2490451790269996,"score_spread":0.23712363114131124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164778783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915139,0.0046099266,0.000002601277,0.0027669247,0.000036518173,0.00062829885,0.0002551875,0.000025304787,0.00016134854],"genre_scores_gemma":[0.9847831,0.014520598,0.000048812693,0.0003731784,0.0000058333676,0.00005751222,0.000082601335,0.000032569824,0.00009576494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998012,0.0001896817,0.0004856194,0.00026556195,0.00068152795,0.0003655741],"domain_scores_gemma":[0.99819446,0.00027080948,0.00027397147,0.0007000452,0.00036623247,0.00019451056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011601721,0.00024798934,0.0006283553,0.00006834731,0.0001606658,0.00008015776,0.00016621956,0.000041723215,0.00009260276],"category_scores_gemma":[0.00063541764,0.00011918026,0.0001116773,0.00028188262,0.00047757747,0.00013567947,0.0001060695,0.00016798929,0.0000038834787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008180992,0.00086111017,0.94032985,0.00014130695,0.00035717772,0.00004273899,0.0004403598,0.0000018983067,0.0000053631743,0.00017727308,0.00053724454,0.05628757],"study_design_scores_gemma":[0.003432452,0.0005482732,0.99048096,0.0037832633,0.000013846023,0.00004435963,0.00063443085,0.00001973815,0.0003444266,0.00015234888,0.0003841964,0.00016171533],"about_ca_topic_score_codex":0.000109382345,"about_ca_topic_score_gemma":0.00006294198,"teacher_disagreement_score":0.056125857,"about_ca_system_score_codex":0.000013487415,"about_ca_system_score_gemma":0.00020880904,"threshold_uncertainty_score":0.48600298},"labels":[],"label_agreement":null},{"id":"W3164781697","doi":"10.1136/annrheumdis-2021-eular.2644","title":"AB0558 CLINICAL EFFECTIVENESS AND SAFETY OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY IN PSORIATIC ARTHRITIS PATIENTS OVER 24 MONTHS – RESULTS OF THE COMPLETE-PsA CANADIAN OBSERVATIONAL STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; ABB (Canada); South Bruce Grey Health Centre; University of British Columbia; Memorial University of Newfoundland","funders":"Celgene; Sanofi; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Internal medicine; Ustekinumab; Golimumab; Rheumatology; Psoriasis; Observational study; Regimen; Clinical endpoint; Tocilizumab; Odds ratio; Physical therapy; Clinical trial; Arthritis; Disease; Dermatology","score_opus":0.11393910795423526,"score_gpt":0.3692297992159853,"score_spread":0.2552906912617501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164781697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925953,0.004390953,6.029959e-7,0.00063992885,0.00038092633,0.0012183887,0.0007035795,0.00000403533,0.000066273],"genre_scores_gemma":[0.98856384,0.011200091,0.000014292671,0.0001054431,0.000015511621,0.000035862216,0.00004513329,0.000011515071,0.000008336992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971555,0.00092989276,0.0008993084,0.00023877893,0.0005286764,0.00024787142],"domain_scores_gemma":[0.9967317,0.0018179694,0.0003235879,0.0005500281,0.00041657395,0.00016016474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007537596,0.00015551584,0.0006856357,0.00007358159,0.00009758371,0.0000120314035,0.00024233756,0.000055591943,0.000041349133],"category_scores_gemma":[0.003469095,0.00009450889,0.00023821063,0.00032831123,0.0003558501,0.00007649355,0.00011373025,0.00013893013,8.536788e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005309643,0.0019534293,0.93786925,0.00016335635,0.00058373285,0.0000054383295,0.0005965873,0.000031046242,0.000017105362,0.00012761158,0.00037198715,0.05297082],"study_design_scores_gemma":[0.016628878,0.0011440627,0.97898173,0.0017764226,0.000015390006,8.608208e-7,0.0004047338,0.00010352234,0.00010652312,0.00065119617,0.00010364798,0.00008304929],"about_ca_topic_score_codex":0.011335345,"about_ca_topic_score_gemma":0.0145105915,"teacher_disagreement_score":0.05288777,"about_ca_system_score_codex":0.00002800603,"about_ca_system_score_gemma":0.00062071066,"threshold_uncertainty_score":0.99524826},"labels":[],"label_agreement":null},{"id":"W3164784502","doi":"10.1136/annrheumdis-2021-eular.3477","title":"POS0184 URINE-GALECTINE 3 BINDING PROTEIN (U-GAL3BP) IS A SENSITIVE MARKER OF KIDNEY INFLAMMATION AND RESPONSE TO TREATMENT IN LUPUS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Lupus nephritis; Medicine; Lipocalin; Creatinine; Internal medicine; Biomarker; Systemic lupus erythematosus; Osteopontin; Gastroenterology; Renal biopsy; Urine; Population; Kidney; Proteinuria; Kidney disease; Urinary system; Immunology; Disease","score_opus":0.017516389748522158,"score_gpt":0.27329861974242176,"score_spread":0.2557822299938996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164784502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301237,0.00075658254,0.0000026083817,0.005416961,0.00012614511,0.00040535541,0.00017619501,0.000008183783,0.0000956036],"genre_scores_gemma":[0.9968255,0.00017368018,0.000027350052,0.00018248348,0.0000040880286,0.000050324277,0.000021711887,0.000007802164,0.0027070453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875295,0.00052000355,0.0003164643,0.00018969072,0.000036683996,0.00018423154],"domain_scores_gemma":[0.99922925,0.00018732213,0.0001690878,0.00024535033,0.00012310146,0.000045898683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002021868,0.00012719625,0.00031523182,0.000111215064,0.00005753027,0.0000062570875,0.00007563602,0.00006892565,0.00014883098],"category_scores_gemma":[0.0011971132,0.00008988766,0.000094079085,0.00023769146,0.00010424806,0.000037989998,0.0000917625,0.000049779814,0.000010359018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003654886,0.00035592765,0.024938107,0.0002070202,0.000468496,0.000008339173,0.0028641613,0.000006734568,0.9452037,0.00009939665,0.0018668657,0.020326363],"study_design_scores_gemma":[0.0012367654,0.000437905,0.10851895,0.00072792807,0.00005572284,0.00004788854,0.0006906212,0.00000563847,0.88637793,0.00021118412,0.0015635901,0.00012585783],"about_ca_topic_score_codex":0.0002183676,"about_ca_topic_score_gemma":0.000078168814,"teacher_disagreement_score":0.083580844,"about_ca_system_score_codex":0.00002676373,"about_ca_system_score_gemma":0.0002635752,"threshold_uncertainty_score":0.36655125},"labels":[],"label_agreement":null},{"id":"W3164788343","doi":"10.1136/annrheumdis-2021-eular.56","title":"POS0086 ANALYSIS OF DISEASE ACTIVITY MEASURES IN THE CONTEXT OF A METHOTREXATE WITHDRAWAL STUDY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB 11 MG ONCE DAILY + METHOTREXATE: POST HOC ANALYSIS OF DATA FROM ORAL SHIFT","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Université Laval; Montreal Clinical Research Institute","funders":"","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Post-hoc analysis; Placebo; Context (archaeology); Clinical endpoint; Confidence interval; Surgery; Clinical trial; Pathology","score_opus":0.04874233966477513,"score_gpt":0.3270796538001049,"score_spread":0.27833731413532975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164788343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830149,0.0039686984,0.00006713729,0.00031824378,0.00001306822,0.0010903897,0.011495183,0.000016575792,0.000015843469],"genre_scores_gemma":[0.9951438,0.0031521576,0.000121202545,0.000052893316,0.000002854852,0.0000585272,0.0014276684,0.000034892633,0.0000060558955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931543,0.002356208,0.0012297811,0.0006943574,0.0021244497,0.00044092257],"domain_scores_gemma":[0.99306417,0.0014775139,0.0012700256,0.002637632,0.0012443662,0.00030627457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011222605,0.00044061287,0.0025825473,0.0007730068,0.00011967633,0.000057530444,0.0009886536,0.000056689165,0.00024906168],"category_scores_gemma":[0.0015391865,0.0002475631,0.0006428299,0.0045846226,0.00093564315,0.0005608656,0.0002613467,0.00020651997,5.461995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009159966,0.005816203,0.93715847,0.00015074475,0.02852024,0.000043674423,0.00491544,0.0003738303,0.00006511095,0.000018868539,0.000032858356,0.013744595],"study_design_scores_gemma":[0.005332064,0.0010794632,0.9754747,0.0019435209,0.004521149,7.463086e-7,0.008955367,0.001648169,0.0007560765,0.00004472055,0.0000037187292,0.00024029608],"about_ca_topic_score_codex":0.012412411,"about_ca_topic_score_gemma":0.0274572,"teacher_disagreement_score":0.03831624,"about_ca_system_score_codex":0.000018447407,"about_ca_system_score_gemma":0.00050300104,"threshold_uncertainty_score":0.9999977},"labels":[],"label_agreement":null},{"id":"W3164788547","doi":"10.1136/annrheumdis-2021-eular.1434","title":"POS0406 miRNAs DEREGULATED IN RESPONSE TO IL17A INHIBITORS IN PSORIATIC ARTHRITIS REGULATE GENE PRODUCTS IN Rho-GTPase PATHWAYS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; University of Toronto; Memorial University of Newfoundland","funders":"UCB Pharma; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"MiRBase; Fold change; microRNA; Psoriatic arthritis; Transcriptome; Medicine; Gene; RNA extraction; RNA; Gene expression; Molecular biology; Cancer research; Biology; Immunology; Psoriasis; Genetics","score_opus":0.03934218975155715,"score_gpt":0.29160113029850715,"score_spread":0.25225894054695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164788547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844805,0.00226567,0.0000021793353,0.012130509,0.00027935894,0.0006885,0.000073590076,0.0000264718,0.00005322562],"genre_scores_gemma":[0.99853617,0.00029984803,0.00018053531,0.00066038035,0.000049386283,0.00006976271,0.00003313568,0.00003211473,0.00013867705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975374,0.0003810415,0.00094137056,0.00038359422,0.00038314334,0.000373481],"domain_scores_gemma":[0.99840105,0.00026944754,0.00019958042,0.00072554767,0.00024573933,0.00015864619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000573155,0.00021977809,0.0005888765,0.0004729436,0.00004381729,0.000029354796,0.00016271288,0.00007106393,0.000095198],"category_scores_gemma":[0.005023058,0.0001818525,0.00017971982,0.0014849539,0.00006409832,0.00014150194,0.00012688732,0.00019840445,0.000019398574],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012755291,0.012280519,0.048071735,0.0027782565,0.0004627159,0.00236515,0.012449251,0.011368301,0.73823303,0.0008935895,0.01516403,0.14317814],"study_design_scores_gemma":[0.0032652875,0.000297286,0.6554081,0.013285421,0.000055304885,0.00009382506,0.00082030945,0.00092423253,0.32295617,0.0021654936,0.00039071878,0.0003378774],"about_ca_topic_score_codex":0.00046524897,"about_ca_topic_score_gemma":0.0004875875,"teacher_disagreement_score":0.60733634,"about_ca_system_score_codex":0.00007634716,"about_ca_system_score_gemma":0.00053780957,"threshold_uncertainty_score":0.74157304},"labels":[],"label_agreement":null},{"id":"W3164790330","doi":"10.1136/annrheumdis-2021-eular.244","title":"POS1026 GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND NON-WORK ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS THROUGH 1 YEAR OF A PHASE 3 TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Sanofi Genzyme; Memorial University of Newfoundland; University of Glasgow; University of Pennsylvania; Celgene; Amgen; Pfizer; University of Washington; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Presenteeism; Medicine; Absenteeism; Psoriatic arthritis; Placebo; Work productivity; Productivity; Physical therapy; Demography; Internal medicine; Arthritis; Psychology; Alternative medicine","score_opus":0.019028202810161956,"score_gpt":0.26527330304651725,"score_spread":0.2462451002363553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164790330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965828,0.0015089768,0.0000018160373,0.00024222763,0.0002019133,0.0011958362,0.00022985406,0.000009469175,0.000027083757],"genre_scores_gemma":[0.99948984,0.00019396779,0.000038646212,0.000013670204,0.000009188259,0.00008718121,0.00006794564,0.000012885469,0.00008664886],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984246,0.00040839447,0.0004661519,0.0003253905,0.00010223664,0.00027324024],"domain_scores_gemma":[0.9987947,0.0002116066,0.00039189693,0.00045579052,0.00012635696,0.0000196983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025299302,0.00019467568,0.00054426136,0.00007215335,0.000058978072,0.000011994289,0.0001444288,0.00008198984,0.000016364786],"category_scores_gemma":[0.00079929334,0.00013529697,0.00009827891,0.00047907987,0.00016123289,0.0001972889,0.00010695154,0.00008807059,0.0000019928657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2319438,0.021222765,0.20095478,0.00072189054,0.0015563131,0.000012935952,0.0032682638,0.000018195142,0.0004474949,0.000054481578,0.00077402854,0.53902507],"study_design_scores_gemma":[0.118375786,0.0013579405,0.8607748,0.0018001832,0.00019607403,5.1200124e-7,0.0004087035,0.0000012314587,0.016230708,0.0005977291,0.000021122456,0.00023522487],"about_ca_topic_score_codex":0.00014110639,"about_ca_topic_score_gemma":0.00008000997,"teacher_disagreement_score":0.65982,"about_ca_system_score_codex":0.00002071238,"about_ca_system_score_gemma":0.00016175273,"threshold_uncertainty_score":0.55172503},"labels":[],"label_agreement":null},{"id":"W3164792926","doi":"10.1136/annrheumdis-2021-eular.3596","title":"POS0208 GENDER DIFFERENCES IN RESPONSE TO BIOLOGICALS. WOMEN FARE WORSE ACROSS INFLAMMATORY ARTHRITIS DISEASES - DATA FROM THE BIOREG","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psoriatic arthritis; Apremilast; BASDAI; Internal medicine; Rheumatoid arthritis; Etanercept; Tocilizumab; Ankylosing spondylitis; Physical therapy; Arthritis; Adalimumab","score_opus":0.09781830859423295,"score_gpt":0.3515714021463173,"score_spread":0.25375309355208436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164792926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93705934,0.0481399,0.0000048725797,0.0100199245,0.00013224687,0.0005273143,0.0040520597,0.00004308948,0.000021278423],"genre_scores_gemma":[0.9723211,0.025651665,0.00003171586,0.0014991388,0.000052228836,0.00012673905,0.0001892159,0.000022498552,0.000105713465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653184,0.0009970895,0.0006216445,0.000507534,0.00067698845,0.0006648968],"domain_scores_gemma":[0.9955184,0.0017168556,0.00016100297,0.0019479344,0.00020115424,0.00045465122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006393102,0.00026342567,0.0006618494,0.00006656234,0.00024133637,0.00014049503,0.0011049296,0.000068356116,0.00089126336],"category_scores_gemma":[0.007668191,0.00014345623,0.00019342678,0.0004922158,0.0005672594,0.00020865683,0.0011593405,0.00018798297,0.0000640164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059237224,0.0017071915,0.8376917,0.00025280684,0.0009274914,0.00030608336,0.008718406,0.000011335255,0.0010870082,0.00020166165,0.021774067,0.12139851],"study_design_scores_gemma":[0.0011933125,0.00013263509,0.9834867,0.0019838235,0.000009975911,0.000010776595,0.006887495,0.000043364384,0.00022211812,0.003171901,0.0026706983,0.00018719478],"about_ca_topic_score_codex":0.00014756282,"about_ca_topic_score_gemma":0.00016498251,"teacher_disagreement_score":0.14579499,"about_ca_system_score_codex":0.000025823203,"about_ca_system_score_gemma":0.00042110027,"threshold_uncertainty_score":0.97587085},"labels":[],"label_agreement":null},{"id":"W3164821397","doi":"10.1136/annrheumdis-2021-eular.1274","title":"AB0420 CIRCULATING MONOCYTES HAVE DISTINCT PHYSICAL PROPERTIES THAT CORRELATE WITH DISEASE ACTIVITY AND SEVERITY AND PREDICT PROGRESSION IN SYSTEMIC SCLEROSIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University","funders":"","keywords":"Medicine; Immunology; Immune system; Population; Peripheral blood mononuclear cell; Immunophenotyping; CD8; Disease; Antibody; Flow cytometry; Pathology; Biology","score_opus":0.03988735455282813,"score_gpt":0.26753651439618537,"score_spread":0.22764915984335723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164821397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523807,0.0041844887,0.0000857476,0.0001766537,0.000029588304,0.00021342322,0.000049020386,0.0000057816164,0.000017201379],"genre_scores_gemma":[0.9991534,0.0007025363,0.000011806173,0.00002166622,0.000012737465,0.000034326466,0.000016248141,0.000011362535,0.000035944937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930704,0.00010406067,0.000116693765,0.0002224326,0.00012885708,0.00012091902],"domain_scores_gemma":[0.9994695,0.00002618953,0.00011860648,0.00024033943,0.000058184087,0.00008717823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006023906,0.00011799995,0.0001670475,0.0000143479665,0.00009383053,0.000040017087,0.00006674866,0.000027286429,0.0000020635168],"category_scores_gemma":[0.00016615877,0.00007511602,0.00006488879,0.00004608146,0.00009200842,0.000016472115,0.0001738648,0.00005677582,1.552029e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018748321,0.0022982515,0.5155008,0.0040935487,0.0006700278,0.000030317105,0.0011493387,0.00059040193,0.36114368,0.00014610238,0.00020076137,0.11230198],"study_design_scores_gemma":[0.0006210599,0.00016838052,0.8400558,0.0054049734,0.00015547818,0.000034620156,0.0005491933,0.041595306,0.11083166,0.00030029606,0.000013060098,0.00027016885],"about_ca_topic_score_codex":0.00003692261,"about_ca_topic_score_gemma":0.0000222892,"teacher_disagreement_score":0.32455504,"about_ca_system_score_codex":0.0000050236335,"about_ca_system_score_gemma":0.000063278254,"threshold_uncertainty_score":0.30631423},"labels":[],"label_agreement":null},{"id":"W3164843014","doi":"10.1136/annrheumdis-2021-eular.2678","title":"AB0559 EFFICACY AND SAFETY OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AFTER INADEQUATE RESPONSE OR INTOLERANCE TO DMARDs: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND KEEPsAKE 1 TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Randomized controlled trial; Psoriasis; Double blind; Physical therapy; Internal medicine; Arthritis; Dermatology; Alternative medicine; Pathology; Placebo","score_opus":0.04448913930741695,"score_gpt":0.3339838451042612,"score_spread":0.2894947057968443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164843014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900757,0.0023251644,0.000015913149,0.003152687,0.00009580391,0.0036811195,0.0005973848,0.000010043942,0.00004617197],"genre_scores_gemma":[0.99774265,0.0014037093,0.000043433498,0.00029866007,0.000021991169,0.00026084413,0.00007719879,0.000024284827,0.00012719867],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962219,0.0011684493,0.0012094504,0.00034250712,0.0007578169,0.00029989943],"domain_scores_gemma":[0.99478084,0.0033189654,0.00046913812,0.00083800126,0.00044261428,0.00015046207],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011009418,0.00023951105,0.0011930198,0.00011348379,0.000095712065,0.00003618339,0.00024926767,0.00006614927,0.00020421948],"category_scores_gemma":[0.009489584,0.00012426879,0.000183469,0.00063600193,0.00041271985,0.00016073936,0.00018096974,0.00021420639,0.000006252663],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88379633,0.0018205734,0.0001800511,0.000112940004,0.0004642641,0.000018885408,0.003874528,0.00003569863,0.0000029271034,0.000008282656,0.00045379304,0.109231696],"study_design_scores_gemma":[0.8988575,0.001474702,0.09333683,0.004173447,0.00021872536,0.0000012955066,0.0008739624,0.000083347775,0.00044875572,0.00014743092,0.00022400987,0.00016000195],"about_ca_topic_score_codex":0.00024817768,"about_ca_topic_score_gemma":0.00009257949,"teacher_disagreement_score":0.109071694,"about_ca_system_score_codex":0.000025327872,"about_ca_system_score_gemma":0.0007753859,"threshold_uncertainty_score":0.9988539},"labels":[],"label_agreement":null},{"id":"W3164858320","doi":"10.1136/annrheumdis-2021-eular.3259","title":"OP0262-HPR THE NEURO-QOL UPPER EXTREMITY FUNCTION SCALE: NEW OPPORTUNITIES TO MORE RELIABLY AND PRECISELY MEASURE SELF-REPORTED HAND FUNCTION AND SELF-CARE ACTIVITIES IN PEOPLE WITH RA","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université Laval; Canadian Rheumatology Association; University of Toronto; Western University; University of Calgary; McGill University; Université de Sherbrooke; McGill University Health Centre","funders":"Janssen Biotech; Eli Lilly Canada; Sanofi Genzyme; Sandoz Canada; Merck Canada; Bristol-Myers Squibb Canada; Gilead Sciences; Pfizer Canada; Sanofi; AbbVie Canada; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Quality of life (healthcare); Physical therapy; Activities of daily living; Cohort; Physical medicine and rehabilitation; Internal medicine","score_opus":0.03226903269915032,"score_gpt":0.2692780695427753,"score_spread":0.23700903684362495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164858320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973852,0.017946448,0.000053614436,0.006938649,0.0001220557,0.00079173734,0.00003708667,0.00006458485,0.00019383554],"genre_scores_gemma":[0.9841239,0.0145393,0.000078602614,0.0006842565,0.000036589674,0.000077830235,0.000023633098,0.000031323256,0.00040459575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981153,0.00023252635,0.0003543932,0.00032777965,0.00066493475,0.00030507584],"domain_scores_gemma":[0.99836755,0.00029170685,0.00015773725,0.000519527,0.0003495903,0.0003139046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023999387,0.00023814301,0.00044530997,0.000118519354,0.00029303774,0.00016281242,0.00010820139,0.000056991044,0.000072949],"category_scores_gemma":[0.00045463679,0.00014126429,0.000099121484,0.00028595055,0.00020738597,0.00032171587,0.00012543265,0.00017673252,0.0000012649753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006188306,0.0014446281,0.7684014,0.0024143893,0.002168597,0.00006468477,0.028435087,0.000093821785,0.00079559674,0.00025253987,0.025018275,0.1647227],"study_design_scores_gemma":[0.002186311,0.00059392204,0.9728521,0.0023907283,0.000221432,0.00015337304,0.017164826,0.00017869331,0.00067417184,0.0005160177,0.0028442526,0.00022414357],"about_ca_topic_score_codex":0.00026958674,"about_ca_topic_score_gemma":0.0005268059,"teacher_disagreement_score":0.20445074,"about_ca_system_score_codex":0.000022649765,"about_ca_system_score_gemma":0.0006955929,"threshold_uncertainty_score":0.57605904},"labels":[],"label_agreement":null},{"id":"W3164871268","doi":"10.1136/annrheumdis-2021-eular.4150","title":"POS1268 COVID-19 VACCINE HESITANCY AMONG RHEUMATOLOGY PATIENTS RECEIVING INFLUENZA VACCINE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Vaccination; Influenza vaccine; Rheumatoid arthritis; Population; Pandemic; Hydroxychloroquine; Coronavirus disease 2019 (COVID-19); Family medicine; Immunology; Disease","score_opus":0.04114106099666703,"score_gpt":0.34178164602785094,"score_spread":0.3006405850311839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164871268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98207206,0.0044253464,0.00004532264,0.010719751,0.00048137768,0.00039763236,0.00004949327,0.00009619268,0.0017128095],"genre_scores_gemma":[0.9938939,0.0020591433,0.000046256795,0.0033062196,0.000042814663,0.000026105854,0.00001915536,0.000026694524,0.0005796824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968851,0.00073195325,0.00081617077,0.0003790873,0.0006180319,0.00056962203],"domain_scores_gemma":[0.99670327,0.00091813516,0.0005859685,0.0007472249,0.0005655979,0.00047977982],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005071575,0.00024785314,0.0006190081,0.00011186023,0.0007680843,0.000090871865,0.00074581424,0.000120353056,0.0014295891],"category_scores_gemma":[0.011500229,0.00019827255,0.0003160644,0.0007455451,0.000044270626,0.00048780063,0.00026822745,0.00014034945,0.000046748894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058841968,0.00039416616,0.94378847,0.00031715605,0.00014976716,0.0000090634185,0.0033570486,0.00004569239,0.0000029089474,0.0036028228,0.043282185,0.0049918904],"study_design_scores_gemma":[0.0011344792,0.00005067282,0.9762191,0.0005857755,0.0001058937,0.0000024171543,0.0014066317,0.000019361658,0.00008687616,0.014860323,0.0052478304,0.00028063921],"about_ca_topic_score_codex":0.0013211278,"about_ca_topic_score_gemma":0.0021462832,"teacher_disagreement_score":0.038034357,"about_ca_system_score_codex":0.00006975361,"about_ca_system_score_gemma":0.0008021509,"threshold_uncertainty_score":0.9994832},"labels":[],"label_agreement":null},{"id":"W3164941196","doi":"10.1136/annrheumdis-2021-eular.896","title":"AB0108 USING RNA SEQUENCING TO IDENTIFY GENE EXPRESSION SIGNATURES ASSOCIATED WITH RESPONSE TO ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; Pfizer; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Internal medicine; Biomarker; Immunology; Arthritis; Oncology; Rituximab; Antibody; Biology","score_opus":0.028148336889958016,"score_gpt":0.3007881771137593,"score_spread":0.27263984022380133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164941196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969137,0.0013597406,0.000019187606,0.00077048206,0.000053316704,0.0006969917,0.00014581221,0.000024098395,0.000016682005],"genre_scores_gemma":[0.9984158,0.00013672038,0.0006164898,0.00065773417,0.0000055311666,0.00005690655,0.0000476398,0.00003100677,0.00003213612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980599,0.00025004,0.0003896842,0.00031723018,0.0006761118,0.00030698473],"domain_scores_gemma":[0.99835616,0.000301256,0.00020515714,0.00052456796,0.00034874282,0.00026410082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019689299,0.00021911919,0.0004983742,0.00014164762,0.00010642137,0.000047264628,0.00013179598,0.000050541745,0.000059790767],"category_scores_gemma":[0.0013473798,0.00013300791,0.00011205275,0.00054873026,0.00004382819,0.00012812218,0.000121362915,0.00006452022,0.0000056084173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007487228,0.0041814763,0.9482243,0.00022301912,0.0008944106,0.00037059092,0.0032843924,0.0060665384,0.015609177,0.000013820422,0.002695758,0.010949262],"study_design_scores_gemma":[0.0032160408,0.00041889187,0.9207731,0.014130358,0.00006406969,0.00000596082,0.0003405216,0.00003177884,0.06080733,0.000032889973,0.0000090740505,0.00016997085],"about_ca_topic_score_codex":0.0001291045,"about_ca_topic_score_gemma":0.00006007537,"teacher_disagreement_score":0.04519815,"about_ca_system_score_codex":0.00017384478,"about_ca_system_score_gemma":0.00041418662,"threshold_uncertainty_score":0.5423905},"labels":[],"label_agreement":null},{"id":"W3164991770","doi":"10.1136/annrheumdis-2021-eular.1265","title":"AB0419 ACCESS TO TREATMENT FOR RAYNAUD'S PHENOMENON AND DIGITAL ULCERS FOR PATIENTS WITH SYSTEMIC SCLEROSIS DOESN'T FOLLOW EULAR/EUSTAR GUIDELINES","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University","funders":"","keywords":"Medicine; Iloprost; Tadalafil; Scleroderma (fungus); Health care; Ambulatory; Physical therapy; Internal medicine; Erectile dysfunction; Pathology","score_opus":0.10118089850136834,"score_gpt":0.3313950517083419,"score_spread":0.23021415320697353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164991770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831181,0.008955348,0.00019221472,0.002524674,0.00020966439,0.0030593658,0.0018596487,0.000038297272,0.000042643023],"genre_scores_gemma":[0.99624026,0.0015210615,0.00020765042,0.00080155116,0.000058202764,0.0005252776,0.00020611506,0.000049372782,0.00039048248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982566,0.000037760106,0.00063188316,0.0003880312,0.00037048964,0.00031522076],"domain_scores_gemma":[0.9975971,0.0003126738,0.00029801877,0.00053348433,0.000920886,0.00033783703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009300625,0.00028155418,0.00067215366,0.00007960509,0.00015177343,0.00014735396,0.00019102551,0.000057840833,0.000018035413],"category_scores_gemma":[0.0009299783,0.00015314906,0.00038966222,0.00022608199,0.00006686175,0.00019709108,0.000088830115,0.000023025746,0.0000017667122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009554117,0.0072278134,0.51628625,0.0131114395,0.01016883,0.000006927819,0.0018826427,0.0013343473,0.00071849895,0.00022456086,0.07086357,0.368621],"study_design_scores_gemma":[0.0408338,0.006314694,0.83657867,0.09038017,0.008325539,0.000029590732,0.006212957,0.0012073148,0.0049179136,0.0011868573,0.0024216252,0.0015908595],"about_ca_topic_score_codex":0.000026952166,"about_ca_topic_score_gemma":0.0000036460794,"teacher_disagreement_score":0.3670301,"about_ca_system_score_codex":0.00005753731,"about_ca_system_score_gemma":0.0002487651,"threshold_uncertainty_score":0.6245237},"labels":[],"label_agreement":null},{"id":"W3165027823","doi":"10.1136/annrheumdis-2021-eular.1296","title":"OP0202 DOES EXCESS WEIGHT AFFECT GOUT RISK DIFFERENTLY AMONG GENETICALLY PREDISPOSED INDIVIDUALS? – SEX-SPECIFIC PROSPECTIVE COHORT FINDINGS OVER >26 YEARS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"National Institutes of Health; Rheumatology Research Foundation","keywords":"Medicine; Overweight; Gout; Genome-wide association study; Obesity; Prospective cohort study; Internal medicine; Genetic predisposition; Population; Relative risk; Risk factor; Single-nucleotide polymorphism; Cohort; Cohort study; Demography; Environmental health; Disease; Confidence interval; Genetics; Genotype","score_opus":0.012615412151715645,"score_gpt":0.26216487223530627,"score_spread":0.24954946008359064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165027823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937136,0.002769486,0.000058583897,0.00044291196,0.0004051658,0.001480086,0.0004615268,0.00012505184,0.000543581],"genre_scores_gemma":[0.99564636,0.0021235915,0.00017491047,0.00021036007,0.00013762932,0.000148319,0.00006583876,0.00010043501,0.0013925486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961345,0.00037854075,0.00076414604,0.00073722034,0.0013780071,0.0006075824],"domain_scores_gemma":[0.99692506,0.00060461194,0.0004408912,0.0013510013,0.00025920654,0.00041922758],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039204519,0.00045855925,0.0010151904,0.00013773896,0.00018162081,0.00011562721,0.0005671514,0.00017826074,0.00097655813],"category_scores_gemma":[0.0012466254,0.00029264516,0.0006022235,0.00055368285,0.0004715393,0.00020349231,0.00045395814,0.00037121825,0.000055915196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012005492,0.00094051345,0.98640186,0.00041618393,0.001698062,0.000049943257,0.0014182898,0.00001336923,0.00049590366,0.00013630604,0.005785691,0.002523808],"study_design_scores_gemma":[0.0015658952,0.00014196309,0.98286897,0.0011229289,0.0012216767,0.000015056477,0.00030071175,0.000127508,0.010115515,0.0019706783,0.00020390749,0.00034517568],"about_ca_topic_score_codex":0.00005126578,"about_ca_topic_score_gemma":0.000010492487,"teacher_disagreement_score":0.009619611,"about_ca_system_score_codex":0.00007351795,"about_ca_system_score_gemma":0.00023488118,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W3165059913","doi":"10.1136/annrheumdis-2021-eular.952","title":"OP0252 ARTHRITIS AND ENTHESITIS IN THE HIP AND PELVIS REGION IN SPONDYLOARTHRITIS – VALIDATION OF TWO WHOLE-BODY MRI METHODS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Enthesis; Psoriatic arthritis; Pelvis; Synovitis; Enthesitis; Arthritis; Magnetic resonance imaging; Radiology; Intraclass correlation; Coronal plane; Oligoarthritis; Surgery; Internal medicine; Polyarthritis","score_opus":0.045668153334188284,"score_gpt":0.35975982673265644,"score_spread":0.31409167339846816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165059913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96095806,0.030626087,0.000046452245,0.0077176197,0.000036457273,0.00034810952,0.00006092841,0.000007709926,0.00019854995],"genre_scores_gemma":[0.98737144,0.011679909,0.0003540517,0.00045898685,0.000015277426,0.000028665032,0.000026243091,0.000011425588,0.000053972086],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99822927,0.000675318,0.00046837324,0.00020252434,0.00025657684,0.00016791603],"domain_scores_gemma":[0.9985992,0.00064984156,0.00017863307,0.00039323219,0.00009659275,0.000082509985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048717886,0.00013167839,0.00045415494,0.0001151094,0.000045509692,0.00002731105,0.000087590066,0.000038121296,0.00004425668],"category_scores_gemma":[0.0010679313,0.00009126301,0.0001289226,0.00032054834,0.00021464558,0.00014139299,0.00007589394,0.00008560146,9.3215266e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003286972,0.0012511194,0.13375995,0.001550468,0.00014118657,0.0002456557,0.0031236042,0.000017521197,0.0012720206,0.0022550193,0.0025828616,0.8534719],"study_design_scores_gemma":[0.0034091147,0.00021324358,0.94509125,0.008935628,0.00023686305,0.00025408214,0.0030546216,0.0002674325,0.019338738,0.01860146,0.00039075993,0.00020678192],"about_ca_topic_score_codex":0.00022425962,"about_ca_topic_score_gemma":0.000044071705,"teacher_disagreement_score":0.8532651,"about_ca_system_score_codex":0.0000060365082,"about_ca_system_score_gemma":0.000096434225,"threshold_uncertainty_score":0.37215975},"labels":[],"label_agreement":null},{"id":"W3165082155","doi":"10.1136/annrheumdis-2021-eular.106","title":"POS0895 EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Celgene; Gilead Sciences; Pfizer; Eli Lilly and Company","keywords":"Tofacitinib; Medicine; Ankylosing spondylitis; Physical therapy; Internal medicine; Janus kinase inhibitor; Quality of life (healthcare); Rheumatoid arthritis","score_opus":0.031388551478614905,"score_gpt":0.33959806266609116,"score_spread":0.30820951118747625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165082155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939199,0.00016976702,6.055862e-7,0.00035967454,0.00009029353,0.0012056262,0.004114402,0.0000137679035,0.00012595778],"genre_scores_gemma":[0.9989164,0.000021106021,0.000021289647,0.000020363832,0.000004569695,0.00003409311,0.0009054777,0.000020325553,0.000056372835],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99727136,0.00041988902,0.000760588,0.00031137906,0.0009487335,0.00028805135],"domain_scores_gemma":[0.99727607,0.0011398281,0.0004525781,0.0007201199,0.00026725285,0.00014418084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015185379,0.00021115557,0.0008113601,0.00012172872,0.00004070863,0.0000137198995,0.00013522792,0.000059951635,0.00023699713],"category_scores_gemma":[0.0039922753,0.00012312963,0.00028018185,0.00035585085,0.00015389176,0.00009447241,0.00007557669,0.0001527697,0.000002885375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70743513,0.01673028,0.19202991,0.003928386,0.0034043987,0.00024271481,0.0017411103,0.000045865047,0.0002546064,0.00003523182,0.0011125616,0.07303981],"study_design_scores_gemma":[0.19212346,0.011077209,0.757218,0.011424163,0.0003635041,0.0000036968672,0.00030145628,0.000047467915,0.02703854,0.0001806643,0.000016950085,0.00020486342],"about_ca_topic_score_codex":0.00019510972,"about_ca_topic_score_gemma":0.00000231057,"teacher_disagreement_score":0.5651881,"about_ca_system_score_codex":0.000041809275,"about_ca_system_score_gemma":0.00036012795,"threshold_uncertainty_score":0.50210804},"labels":[],"label_agreement":null},{"id":"W3165086674","doi":"10.1136/annrheumdis-2021-eular.3999","title":"POS0267-HPR IDENTIFYING MEANINGFUL AND DETECTABLE CHANGE FROM THE PATIENT PERSPECTIVE ACROSS COMMON FATIGUE MEASURES IN RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health; Diakonhjemmet; Universitetet i Oslo; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Likert scale; Quality of life (healthcare); Perspective (graphical); Chronic fatigue; Internal medicine; Chronic fatigue syndrome","score_opus":0.08962839703582699,"score_gpt":0.35001360188822184,"score_spread":0.26038520485239486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165086674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81974286,0.17399146,0.000010706644,0.0053293733,0.000119925506,0.00052162784,0.00014581239,0.00002775215,0.000110499626],"genre_scores_gemma":[0.8935126,0.10567058,0.000036334364,0.00062119233,0.00002718275,0.00007964382,0.000017278733,0.000023784662,0.000011386634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974951,0.00043066824,0.0005202486,0.00033625783,0.0007372088,0.00048052453],"domain_scores_gemma":[0.99805194,0.0005372017,0.0002127775,0.00064032193,0.00036764407,0.00019013317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034984123,0.00023203722,0.0005993338,0.000055372802,0.00033822708,0.00016235696,0.00026192897,0.000057108045,0.00009244953],"category_scores_gemma":[0.001653297,0.00015026472,0.00022765114,0.0003465907,0.0003420085,0.00028493154,0.00027513705,0.00024163864,0.0000063234947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008321441,0.0014843345,0.273696,0.00030498178,0.0011406598,0.00018468406,0.08902179,0.000028101244,0.0009479769,0.0028905296,0.0024602227,0.62700856],"study_design_scores_gemma":[0.0032059308,0.0003495706,0.8796292,0.014367398,0.000021345004,0.00011733323,0.05804911,0.00027972274,0.010941059,0.032033533,0.00061011914,0.00039566285],"about_ca_topic_score_codex":0.0038636408,"about_ca_topic_score_gemma":0.0033381188,"teacher_disagreement_score":0.6266129,"about_ca_system_score_codex":0.00002913455,"about_ca_system_score_gemma":0.00012968371,"threshold_uncertainty_score":0.61276174},"labels":[],"label_agreement":null},{"id":"W3165093839","doi":"10.1136/annrheumdis-2021-eular.556","title":"AB0528 COMPARABLE SAFETY PROFILE OF GUSELKUMAB IN PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM PHASE 3 TRIALS THROUGH 1 YEAR","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Dalhousie University","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Clinical trial; Arthritis; Internal medicine","score_opus":0.1840738089749834,"score_gpt":0.4356772386346589,"score_spread":0.2516034296596755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165093839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92872417,0.055736292,0.000016539196,0.009484272,0.0002688813,0.0006957409,0.0024829432,0.000017280989,0.0025738862],"genre_scores_gemma":[0.9546553,0.04431327,0.00042167617,0.00037687682,0.000051539188,0.00001867221,0.00007066162,0.000010288093,0.000081743965],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997657,0.0005162386,0.001067569,0.00022098246,0.00034234856,0.00019584928],"domain_scores_gemma":[0.99615604,0.0026697097,0.0005382099,0.00038590436,0.00014882094,0.00010131758],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0007849482,0.00014019464,0.0010149097,0.000026543352,0.00006421562,0.000017233382,0.00011073199,0.000042234544,0.00047046077],"category_scores_gemma":[0.00871531,0.00009345608,0.00020315757,0.00024305086,0.00013863448,0.00014796431,0.00011295928,0.00011062934,0.00000785424],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036141817,0.013031144,0.0058045057,0.0038971787,0.0060328073,0.000106656466,0.009272286,0.00012953335,0.0009501761,0.0032717823,0.08526744,0.8360947],"study_design_scores_gemma":[0.21160455,0.0028407974,0.33919305,0.05434586,0.008373187,0.000058716687,0.0220941,0.004830911,0.15365313,0.09504125,0.10610771,0.0018567307],"about_ca_topic_score_codex":0.00042888633,"about_ca_topic_score_gemma":0.000032755775,"teacher_disagreement_score":0.83423793,"about_ca_system_score_codex":0.000009355342,"about_ca_system_score_gemma":0.00012981668,"threshold_uncertainty_score":0.9996347},"labels":[],"label_agreement":null},{"id":"W3165112639","doi":"10.1136/annrheumdis-2021-eular.883","title":"POS1037 CORRELATION BETWEEN SKIN INVOLVEMENT, JOINT INVOLVEMENT AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POST-HOC ANALYSIS OF EQUATOR/EQUATOR2","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Enthesitis; Medicine; Psoriatic arthritis; Dactylitis; Post-hoc analysis; Psoriasis; Ankylosing spondylitis; Psoriasis Area and Severity Index; Internal medicine; Arthritis; Synovitis; Dermatology; Surgery; Physical therapy","score_opus":0.02314268714267475,"score_gpt":0.2672507535078982,"score_spread":0.24410806636522342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165112639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919469,0.006382559,0.000047974736,0.0005147732,0.000037195405,0.0006274294,0.0003883515,0.000011127358,0.000043710905],"genre_scores_gemma":[0.99287224,0.0065108286,0.00008014559,0.0001367506,0.000009861749,0.000039529306,0.00031298134,0.000018868152,0.000018821847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997574,0.0002916004,0.0007296504,0.00027683633,0.0008393709,0.00028858476],"domain_scores_gemma":[0.9980713,0.00029998386,0.00043194325,0.00046678618,0.00053715165,0.00019281932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027622297,0.00019867312,0.0008343562,0.00037568403,0.00007331747,0.000029618788,0.000102440295,0.000048301652,0.00015492171],"category_scores_gemma":[0.0005673892,0.00014394727,0.00024720666,0.0008217964,0.00020200966,0.00021356472,0.000120861834,0.00010880239,0.0000029086145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008863448,0.0015264758,0.7301851,0.00047395413,0.0048517445,0.000009238009,0.0028494864,0.000063551175,0.000026464719,0.0006204761,0.00012309727,0.25838405],"study_design_scores_gemma":[0.0031839816,0.0008481936,0.9890004,0.0027824754,0.00031831363,6.3330117e-7,0.0012288474,0.00041645567,0.0013265378,0.00073114195,0.000018929108,0.00014413462],"about_ca_topic_score_codex":0.00026879736,"about_ca_topic_score_gemma":0.000285026,"teacher_disagreement_score":0.25881523,"about_ca_system_score_codex":0.000041441366,"about_ca_system_score_gemma":0.00022721363,"threshold_uncertainty_score":0.5869999},"labels":[],"label_agreement":null},{"id":"W3165123004","doi":"10.1136/annrheumdis-2021-eular.1633","title":"POS1047 IMPACT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 TRIALS IN PATIENTS WITH INADEQUATE RESPONSE TO NON-BIOLOGIC OR BIOLOGIC DMARDs","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Samsung; Celgene; Biogen; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Adalimumab; Placebo; Internal medicine; Concomitant; Minimal clinically important difference; Certolizumab pegol; Golimumab; Psoriasis; Tofacitinib; BASDAI; Arthritis; Randomized controlled trial; Oncology; Rheumatoid arthritis; Dermatology","score_opus":0.04583795643492511,"score_gpt":0.35691944918772295,"score_spread":0.31108149275279784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165123004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935983,0.00039231195,0.0000022815204,0.00040659163,0.00007055958,0.0018644298,0.0036316128,0.000012922133,0.00002100425],"genre_scores_gemma":[0.99890333,0.00019143068,0.00015735971,0.0001725321,0.0000148182435,0.00009492248,0.00042570222,0.00002467563,0.000015203855],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99573237,0.0016536026,0.0012210218,0.00049441285,0.00047886133,0.00041971167],"domain_scores_gemma":[0.9950264,0.0029433593,0.00083291816,0.0006488695,0.00036914248,0.0001792756],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012542194,0.0003626505,0.0015983502,0.00023586232,0.00006883844,0.000016489666,0.0001607164,0.00006646497,0.000066146924],"category_scores_gemma":[0.01802308,0.00018001358,0.00026840018,0.0007293198,0.0001259337,0.00009381525,0.00009457218,0.00012872356,0.0000035429973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38901177,0.008864448,0.28103244,0.000114740666,0.0012702323,0.00010223897,0.0014126981,0.00043821626,0.000028445489,0.000002380738,0.0002687491,0.31745362],"study_design_scores_gemma":[0.056671295,0.01833486,0.91448575,0.009036278,0.0001466485,5.795716e-7,0.00046466992,0.000024887073,0.00052894355,0.00010598398,0.0000024585545,0.00019763561],"about_ca_topic_score_codex":0.000986735,"about_ca_topic_score_gemma":0.00018445868,"teacher_disagreement_score":0.6334533,"about_ca_system_score_codex":0.00012780837,"about_ca_system_score_gemma":0.0003863621,"threshold_uncertainty_score":0.9902485},"labels":[],"label_agreement":null},{"id":"W3165131817","doi":"10.1136/annrheumdis-2021-eular.1721","title":"POS1049 EFFECT OF FILGOTINIB ON PASDAS: DRIVERS OF LOW AND VERY LOW ACTIVITY UP TO WEEK 100","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Celgene; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Internal medicine; Disease; Enthesitis","score_opus":0.023244099567612125,"score_gpt":0.31385447755991275,"score_spread":0.2906103779923006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165131817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533325,0.002320828,0.0000058753362,0.0014279818,0.00011474284,0.00041382533,0.00015213189,0.000012098347,0.00021928322],"genre_scores_gemma":[0.9947837,0.0048291273,0.000017207269,0.00012621569,0.0000111534455,0.000015674206,0.000008227167,0.000015493024,0.00019320445],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847806,0.00027312723,0.00028891873,0.00018972585,0.00053818134,0.00023200248],"domain_scores_gemma":[0.9980667,0.0008508366,0.00016339435,0.000500121,0.00019433006,0.00022458498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024478475,0.00015620199,0.0006159605,0.000100261605,0.000053333875,0.000013094416,0.00015214003,0.000037166385,0.00018114653],"category_scores_gemma":[0.0019585425,0.00010419884,0.00026284938,0.00023174306,0.00025349384,0.00008577297,0.00012368915,0.00008815931,0.000009210588],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017321378,0.0068488764,0.10973093,0.02711165,0.004552541,0.00011815148,0.006255592,0.00030258228,0.045757864,0.0011395926,0.040024348,0.7408365],"study_design_scores_gemma":[0.0040268474,0.0037708709,0.34181383,0.017877547,0.00006503375,0.000017651919,0.0005828111,0.0002007251,0.6307227,0.0005105586,0.00018626117,0.00022513475],"about_ca_topic_score_codex":0.00006677577,"about_ca_topic_score_gemma":0.00000716097,"teacher_disagreement_score":0.7406114,"about_ca_system_score_codex":0.000007896739,"about_ca_system_score_gemma":0.00015874494,"threshold_uncertainty_score":0.42491055},"labels":[],"label_agreement":null},{"id":"W3165137534","doi":"10.1136/annrheumdis-2021-eular.2627","title":"POS0232 CLINICAL EFFECTIVENESS OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY IN THE MANAGEMENT OF EXTRA-ARTICULAR MANIFESTATIONS IN ANKYLOSING SPONDYLITIS PATIENTS OVER 24 MONTHS – RESULTS OF THE COMPLETE-AS CANADIAN OBSERVATIONAL STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; ABB (Canada); University of Toronto; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Adalimumab; Ankylosing spondylitis; Enthesitis; Hazard ratio; Internal medicine; Psoriasis; Psoriatic arthritis; Observational study; Surgery; Exacerbation; Etanercept; Disease; Rheumatoid arthritis; Dermatology; Confidence interval","score_opus":0.16405114528464027,"score_gpt":0.38930659718695804,"score_spread":0.22525545190231777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165137534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606794,0.00081812235,3.8920234e-7,0.00040965353,0.00015612131,0.001436116,0.0009281818,0.0000017567472,0.00018171336],"genre_scores_gemma":[0.99923486,0.0004551642,0.000025305351,0.000094214505,0.0000035686944,0.0000632393,0.000108565866,0.0000073321335,0.00000772617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978141,0.0006576557,0.00075172953,0.0001857121,0.0004185172,0.0001722489],"domain_scores_gemma":[0.99789065,0.0010270266,0.00030701235,0.0004968014,0.00023290563,0.000045573368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054510916,0.00012714048,0.00043098655,0.000058118596,0.000069554466,0.000005238496,0.00020521326,0.000029758321,0.000026064496],"category_scores_gemma":[0.0004918236,0.00007073793,0.00022518328,0.00039593366,0.00015958882,0.000041470634,0.000076916935,0.00006617554,4.6555365e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024951843,0.0043146955,0.9874879,0.00029481144,0.0008565413,0.00005359009,0.0010962154,0.00013160653,0.000008657669,0.00044559065,0.000059467162,0.0027557397],"study_design_scores_gemma":[0.01017245,0.0008649842,0.98362327,0.0017010684,0.00017590815,0.00000107244,0.0026550023,0.000042170694,0.00007352971,0.00062296476,0.000012334728,0.00005525466],"about_ca_topic_score_codex":0.016268365,"about_ca_topic_score_gemma":0.008822533,"teacher_disagreement_score":0.0076772654,"about_ca_system_score_codex":0.00003997443,"about_ca_system_score_gemma":0.00016303842,"threshold_uncertainty_score":0.9902824},"labels":[],"label_agreement":null},{"id":"W3165156384","doi":"10.1136/annrheumdis-2021-eular.3914","title":"OP0251 DATA-DRIVEN DEFINITIONS BASED ON INFLAMMATORY LESIONS FOR A POSITIVE MRI OF THE SPINE CONSISTENT WITH AXIAL SPONDYLOARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Gold standard (test); Radiology; Cohort; Back pain; Magnetic resonance imaging; Internal medicine; Sacroiliitis; Pathology; Alternative medicine","score_opus":0.08194589578130997,"score_gpt":0.3080915351217026,"score_spread":0.22614563934039267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165156384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452872,0.0023856375,0.00035365607,0.034070764,0.00020749599,0.0021062721,0.014167743,0.000049794533,0.0013714179],"genre_scores_gemma":[0.99669677,0.00022441446,0.00053658505,0.0019060228,0.000027129421,0.00007161669,0.00042085524,0.000021279136,0.00009532984],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986516,0.0001376834,0.00039601536,0.00022797458,0.00040348226,0.00018320659],"domain_scores_gemma":[0.9976467,0.00036432184,0.00026652226,0.0011743185,0.00040734574,0.00014080401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099066696,0.0001569236,0.00041028266,0.000053435702,0.00016336616,0.000014488068,0.00023579171,0.000034616212,0.00011571771],"category_scores_gemma":[0.0011780864,0.000089126166,0.00036461785,0.00020838594,0.0004163162,0.00007263586,0.00014548431,0.00007432261,0.0000031805334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021501664,0.056012295,0.16579956,0.030123575,0.014255898,0.0008303572,0.0029863587,0.014074613,0.0057825907,0.14178136,0.43454155,0.11231019],"study_design_scores_gemma":[0.0074962955,0.001255181,0.9427669,0.023526654,0.0032055744,0.00006755889,0.0011191226,0.004391443,0.010606017,0.0038935519,0.0012361428,0.00043555876],"about_ca_topic_score_codex":0.000022283,"about_ca_topic_score_gemma":0.00005083166,"teacher_disagreement_score":0.77696735,"about_ca_system_score_codex":0.000010033047,"about_ca_system_score_gemma":0.00090151065,"threshold_uncertainty_score":0.36344597},"labels":[],"label_agreement":null},{"id":"W3165174468","doi":"10.1136/annrheumdis-2021-eular.3391","title":"POS0187 THE PROGNOSTIC FACTORS IN PREDICTING RELAPSE FOR IGG4-RELATED DISEASE: A LONG-TERM STUDY BASED ON THE CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF THE PATIENTS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Regional Development Fund; National Health and Medical Research Council; Instituto de Salud Carlos III; Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; Pathological; IgG4-related disease; Internal medicine; Disease; Proportional hazards model; Gastroenterology; Multivariate analysis; Predictive value; Pathology","score_opus":0.05602936009756369,"score_gpt":0.33195151864480155,"score_spread":0.27592215854723784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165174468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938097,0.0004518019,0.0000017103754,0.002309927,0.00026975092,0.0027003265,0.0004135272,0.00002371579,0.000019528612],"genre_scores_gemma":[0.999038,0.00009781439,0.0000021689343,0.0005851102,0.000023654047,0.00012166949,0.000059931423,0.000026104573,0.000045545825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673676,0.0009669914,0.0011154523,0.00032382796,0.00057621324,0.00028073686],"domain_scores_gemma":[0.99496114,0.0030175394,0.00061748974,0.0009162013,0.000310182,0.00017744717],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.000665149,0.00025662602,0.0005538702,0.000044663706,0.00025509382,0.00003402353,0.00038594045,0.00008757879,0.0000464674],"category_scores_gemma":[0.016989935,0.00010271805,0.0004913593,0.00030324113,0.000558092,0.00006142621,0.00021086642,0.0003025001,0.0000013398183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058872206,0.0037868968,0.9929155,0.0003936378,0.00019907644,0.000014142135,0.00038861058,0.000019053648,0.0000030046021,0.000108418826,0.0001817011,0.0014012485],"study_design_scores_gemma":[0.0017844742,0.0004706798,0.99231,0.0026341625,0.0008387916,0.000001195689,0.0004466209,0.0010504533,0.000030580184,0.0003173293,0.0000041146077,0.000111615125],"about_ca_topic_score_codex":0.0000042370957,"about_ca_topic_score_gemma":0.0000027318379,"teacher_disagreement_score":0.016324786,"about_ca_system_score_codex":0.000012075684,"about_ca_system_score_gemma":0.0003034872,"threshold_uncertainty_score":0.9912904},"labels":[],"label_agreement":null},{"id":"W3165190312","doi":"10.1136/annrheumdis-2021-eular.4078","title":"POS0302 BURNOUT IN RHEUMATOLOGISTS IN LATIN AMERICA","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Burnout; Medicine; Emotional exhaustion; Depersonalization; Specialty; Family medicine; Depression (economics); Rheumatology; Internal medicine; Physical therapy; Demography; Clinical psychology","score_opus":0.10027573179644111,"score_gpt":0.4448237081592418,"score_spread":0.3445479763628007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165190312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96189135,0.010061086,0.000010167519,0.0238196,0.00055778114,0.0006170867,0.000128421,0.0000363152,0.0028782056],"genre_scores_gemma":[0.9920872,0.004007464,0.000119866745,0.002716956,0.000022678023,0.00014988206,0.000027139035,0.000021344806,0.0008475134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956367,0.001698192,0.001271331,0.0003030886,0.0004277568,0.00066290126],"domain_scores_gemma":[0.99677116,0.0016198996,0.00051928504,0.0006581198,0.00025475046,0.00017680712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051719917,0.00019676333,0.00068754045,0.00014384706,0.00023784477,0.000008304351,0.00041385533,0.00015284744,0.00075594505],"category_scores_gemma":[0.0033527296,0.00013284173,0.00017506865,0.0007364935,0.00013744392,0.00010923733,0.0003789821,0.0005236923,0.0000925351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009115527,0.0006199524,0.925287,0.0020270774,0.00003466259,0.000033149332,0.0027655407,0.00007131664,0.000014182526,0.0033053276,0.0050099306,0.06074067],"study_design_scores_gemma":[0.00078031543,0.000024043631,0.9635371,0.018982382,0.000009439039,0.0000014215605,0.0051188422,0.0003995783,0.000058355174,0.009757055,0.0011507294,0.0001807151],"about_ca_topic_score_codex":0.0023003519,"about_ca_topic_score_gemma":0.0010695119,"teacher_disagreement_score":0.060559954,"about_ca_system_score_codex":0.000048646,"about_ca_system_score_gemma":0.001099283,"threshold_uncertainty_score":0.8277068},"labels":[],"label_agreement":null},{"id":"W3165208447","doi":"10.1136/annrheumdis-2021-eular.2608","title":"OP0143 IMPACT OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY ON DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ANKYLOSING SPONDYLITIS OVER 24 MONTHS – RESULTS OF THE COMPLETE-AS CANADIAN OBSERVATIONAL STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; ABB (Canada); McMaster University; University of Toronto; Centre hospitalier de l'Université Laval","funders":"Samsung; Celgene; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; BASDAI; BASFI; Adalimumab; Ankylosing spondylitis; Internal medicine; Golimumab; Observational study; Quality of life (healthcare); Physical therapy; Rheumatoid arthritis; Psoriatic arthritis","score_opus":0.1354580345989451,"score_gpt":0.37086487646040367,"score_spread":0.23540684186145858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165208447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993463,0.0011274836,3.167412e-8,0.0011565057,0.00013145384,0.0008608994,0.00317957,0.0000042614215,0.0000767923],"genre_scores_gemma":[0.99944174,0.0002705961,0.000004368201,0.00015608706,0.0000042233387,0.000026685982,0.00006429476,0.000010380119,0.000021651236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985238,0.00017850101,0.00047152973,0.00022715559,0.00038953064,0.00020953469],"domain_scores_gemma":[0.9982292,0.00049669587,0.00037315435,0.00055656413,0.00018380195,0.00016056749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009813094,0.00018710921,0.00054778584,0.00007095472,0.00010468066,0.000009386184,0.000104922176,0.000028622879,0.000061390296],"category_scores_gemma":[0.0012996233,0.00010242278,0.00030412513,0.0002587694,0.00014638045,0.00005873942,0.000083397565,0.00006498762,3.15585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075473865,0.002481471,0.98307896,0.000053728923,0.001117015,0.000058199243,0.0007445732,0.00007085357,0.000044268618,0.000024197381,0.0001668228,0.004612528],"study_design_scores_gemma":[0.00797421,0.0012631915,0.98903996,0.0005823086,0.00013808993,0.0000017596664,0.00048015235,0.000061564046,0.00013867418,0.00022688323,0.000010714502,0.000082470964],"about_ca_topic_score_codex":0.08155293,"about_ca_topic_score_gemma":0.013474979,"teacher_disagreement_score":0.06807795,"about_ca_system_score_codex":0.00007353651,"about_ca_system_score_gemma":0.0005243311,"threshold_uncertainty_score":0.9245631},"labels":[],"label_agreement":null},{"id":"W3165266566","doi":"10.1136/annrheumdis-2021-eular.3046","title":"AB0851 CONDUCTING PATIENT SCHOOLS AS A WAY OF MANAGING RHEUMATOLOGIC DISEASES","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"HIV, TB, and STIs Epidemiology","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Quarter (Canadian coin); Pandemic; Alternative medicine; Pediatrics; Coronavirus disease 2019 (COVID-19); Disease; Internal medicine; Pathology","score_opus":0.11051132069298959,"score_gpt":0.37905730254490066,"score_spread":0.2685459818519111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165266566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747925,0.008008727,0.000028318778,0.009649912,0.00040200705,0.0002777482,0.00009570193,0.000055215933,0.006689879],"genre_scores_gemma":[0.9961448,0.0027018539,0.000120120254,0.00057847647,0.000024372765,0.000024117431,0.000010526479,0.000012083111,0.00038365534],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99682117,0.0012226849,0.00073405914,0.00028360545,0.00048869423,0.00044978753],"domain_scores_gemma":[0.99693,0.0013692026,0.00062540843,0.0005128152,0.0003236007,0.00023897509],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0005267229,0.00016914961,0.0006276219,0.00006776765,0.00045094808,0.000038847535,0.0005189681,0.000070370865,0.0004662044],"category_scores_gemma":[0.014255625,0.00012373942,0.0004042439,0.00039250404,0.00056610286,0.0001965973,0.00021337048,0.000111959416,0.000032709297],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017521493,0.0018926776,0.31812596,0.0019245446,0.0011213758,0.00007358942,0.02971893,0.00089529995,0.00015504181,0.3506222,0.061798584,0.23349656],"study_design_scores_gemma":[0.0013594826,0.00038376046,0.13323085,0.0075136875,0.0006757978,0.00003192106,0.17946935,0.0006786984,0.0032814767,0.6634198,0.008634462,0.0013207166],"about_ca_topic_score_codex":0.0013692046,"about_ca_topic_score_gemma":0.00012583719,"teacher_disagreement_score":0.3127976,"about_ca_system_score_codex":0.00001931435,"about_ca_system_score_gemma":0.00050781283,"threshold_uncertainty_score":0.9940477},"labels":[],"label_agreement":null},{"id":"W3165279409","doi":"10.1136/annrheumdis-2021-eular.1125","title":"POS0449 BIOLOGICS INITIATION IN MODERATE VS SEVERE RHEUMATOID ARTHRITIS PATIENTS: PROSPECTIVE OBSERVATIONAL STUDY FROM A CANADIAN REGISTRY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Kingston Health Sciences Centre","funders":"Canada Research Chairs; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Observational study; Logistic regression; Clinical trial; Severity of illness; Physical therapy","score_opus":0.05893972148790475,"score_gpt":0.3088752911553458,"score_spread":0.24993556966744104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165279409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902054,0.0050753173,0.0000033134104,0.0024972055,0.00012253603,0.00089882297,0.0007980826,0.00002330293,0.0003760152],"genre_scores_gemma":[0.988564,0.010245948,0.00007900675,0.00055734406,0.00001876624,0.000114050235,0.00035106333,0.000019562862,0.000050228213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978415,0.00038185384,0.00057045976,0.00032041,0.00053018826,0.0003556001],"domain_scores_gemma":[0.9980101,0.00031167403,0.00020068402,0.0005068002,0.0007040444,0.00026671833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021903575,0.00019149156,0.00048892933,0.000121239485,0.0001985328,0.000069801834,0.00020050646,0.00006917278,0.00028635026],"category_scores_gemma":[0.0034394288,0.00014870668,0.00014777572,0.00041352888,0.0001297636,0.0002455943,0.000090506044,0.0002117498,0.000016128975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034924241,0.0013274732,0.9885945,0.00004243099,0.00023952698,0.000037682123,0.0011580504,0.000054467517,0.000007727003,0.0004002056,0.0016657857,0.0061229235],"study_design_scores_gemma":[0.0027232696,0.00022918633,0.9814582,0.0015174667,0.00000557917,0.000007798204,0.0017181202,0.00023085832,0.0001914112,0.011658594,0.00010601006,0.00015354762],"about_ca_topic_score_codex":0.019411962,"about_ca_topic_score_gemma":0.043417647,"teacher_disagreement_score":0.024005685,"about_ca_system_score_codex":0.0000804195,"about_ca_system_score_gemma":0.001138819,"threshold_uncertainty_score":0.9871179},"labels":[],"label_agreement":null},{"id":"W3165299249","doi":"10.1136/annrheumdis-2021-eular.2735","title":"POS0186 METABOLOMIC SIGNATURES FOR KNEE CARTILAGE VOLUME LOSS OVER 10 YEARS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"European Regional Development Fund; National Health and Medical Research Council; Instituto de Salud Carlos III; Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; Cartilage; Osteoarthritis; Body mass index; Population; Prospective cohort study; Internal medicine; Cohort; Metabolite; Metabolomics; Pathology; Bioinformatics; Anatomy; Biology","score_opus":0.021328854559341543,"score_gpt":0.29072501519565364,"score_spread":0.2693961606363121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165299249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843308,0.013181208,0.000009108854,0.0010307825,0.00026241032,0.0005061945,0.0003167322,0.000033700813,0.00032910187],"genre_scores_gemma":[0.9896934,0.00018700244,0.00020478242,0.000674155,0.000049783794,0.00005691179,0.0000828347,0.000026326961,0.00902478],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990361,0.00004878913,0.0002450474,0.00018533942,0.00025465412,0.00023010463],"domain_scores_gemma":[0.9990649,0.00010627492,0.00011669988,0.00043918163,0.00014861053,0.0001243132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007744486,0.00013994466,0.00038046276,0.000040294184,0.000056070076,0.000020409918,0.000102965554,0.000056377823,0.00088719255],"category_scores_gemma":[0.0003852712,0.00010053737,0.0004469335,0.00011652053,0.000069885944,0.000072042276,0.000062569765,0.000045962483,0.000034377957],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049224575,0.006340239,0.01596051,0.0042569125,0.0035104263,0.00050853594,0.002198273,0.00012735942,0.05923928,0.018185439,0.2980192,0.5867314],"study_design_scores_gemma":[0.024799611,0.006058832,0.3095376,0.0062052994,0.007613327,0.00013672201,0.0015349109,0.00053936185,0.51235193,0.044908874,0.08476798,0.0015455642],"about_ca_topic_score_codex":0.00000658461,"about_ca_topic_score_gemma":0.000006033943,"teacher_disagreement_score":0.5851858,"about_ca_system_score_codex":0.000008729662,"about_ca_system_score_gemma":0.00014342916,"threshold_uncertainty_score":0.9714136},"labels":[],"label_agreement":null},{"id":"W3165306967","doi":"10.1136/annrheumdis-2021-eular.3972","title":"OP0040 HIPPOCAMPAL IMMUNE CELL TRAFFICKING AND A MYELOID PREDOMINANT INFLAMMATORY RESPONSE WITH ENHANCED ANTIGEN PRESENTATION AND DECREASED LEVELS OF NEUROTRANSMITTERS UNDERLY THE NEUROPSYCHIATRIC PHENOTYPE OF THE NZW/NZB MURINE LUPUS MODEL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National and Kapodistrian University of Athens","keywords":"Immune system; Systemic lupus erythematosus; Immunology; Medicine; Hippocampus; Phenotype; Hippocampal formation; Internal medicine; Biology; Disease","score_opus":0.025647885429504632,"score_gpt":0.27829885854808606,"score_spread":0.2526509731185814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165306967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924464,0.0040755947,0.0002583433,0.0018286679,0.00007725191,0.0012175129,0.00005027758,0.000012789751,0.00003316298],"genre_scores_gemma":[0.9988088,0.00074891414,0.00012979071,0.000086431086,0.000010385643,0.000031397918,0.0000023126843,0.000035623478,0.00014635021],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99725723,0.0008210369,0.0006795684,0.00027022627,0.00071880745,0.00025311],"domain_scores_gemma":[0.99729294,0.00090020464,0.0005259175,0.00084019965,0.00032337563,0.000117365766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056867645,0.00021251525,0.0005070863,0.000101430865,0.00013096897,0.000024207397,0.00031778327,0.00004341318,0.000013334015],"category_scores_gemma":[0.00069046655,0.00010764296,0.00018214894,0.00044436005,0.0004913513,0.00009433101,0.00013980248,0.00013748585,3.496653e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0372011,0.0025175416,0.24916251,0.029136881,0.0018500206,0.000040543327,0.039491553,0.011998192,0.61344206,0.00024759362,0.0005400513,0.014371974],"study_design_scores_gemma":[0.0060027023,0.00051258923,0.8560618,0.0052205822,0.000558584,0.0004192701,0.0046971464,0.016557626,0.10918567,0.0005323965,0.000003663326,0.00024796487],"about_ca_topic_score_codex":0.000033459124,"about_ca_topic_score_gemma":0.000009423169,"teacher_disagreement_score":0.60689926,"about_ca_system_score_codex":0.000011591357,"about_ca_system_score_gemma":0.00064643956,"threshold_uncertainty_score":0.43895525},"labels":[],"label_agreement":null},{"id":"W3165320040","doi":"10.1136/annrheumdis-2021-eular.1555","title":"POS1043 NETAKIMAB REDUCES PSORIATIC ARTHRITIS ACTIVITY IN PATIENTS WITH OR WITHOUT AXIAL DISEASE: SUBANALYSIS OF THE PATERA STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; University of California, San Diego; LEO Pharma; University of Toronto; Genentech; Griffith University; Kyowa Hakko Kirin; University of Glasgow; Institut National de la Santé et de la Recherche Médicale; Université François-Rabelais; University of Oxford; Universitat Autònoma de Barcelona; Dermira; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; GlaxoSmithKline; University of Washington; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Ankylosing spondylitis; Placebo; Internal medicine; Tolerability; Rheumatoid arthritis; Gastroenterology; Psoriasis Area and Severity Index; Mallinckrodt; Psoriasis; Inflammatory arthritis; Immunology; Adverse effect; Pathology","score_opus":0.022554011389906793,"score_gpt":0.25972162051621844,"score_spread":0.23716760912631166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165320040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957779,0.0026694054,0.0000011482203,0.00026154373,0.00026619437,0.00059119734,0.0004074221,0.0000116619,0.000013549862],"genre_scores_gemma":[0.9993327,0.00022250952,0.0000062459976,0.000034577337,0.0000075966527,0.000060688813,0.00005090549,0.000015122673,0.0002696433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979412,0.00092177634,0.00042783035,0.00028256435,0.00017361535,0.000252991],"domain_scores_gemma":[0.99841875,0.00021378818,0.00042709187,0.0007303771,0.00017147065,0.000038539452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014204031,0.00022603542,0.000627787,0.00006982861,0.00014538282,0.000017468596,0.00036796427,0.00005082905,0.00022835354],"category_scores_gemma":[0.00034613593,0.00011229113,0.00028029576,0.0004762238,0.0001898732,0.00011933125,0.00014926358,0.00007744744,0.0000067422334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022860882,0.005149915,0.9074368,0.00009899939,0.0018575542,0.0000046369155,0.00084274006,0.000039518258,0.000099510515,0.000010128045,0.00015071621,0.08202343],"study_design_scores_gemma":[0.0032044293,0.0002447352,0.98897856,0.00051169586,0.0009135508,8.640323e-7,0.00042984943,0.0000068301138,0.0054586767,0.00009923961,0.000009472773,0.00014210097],"about_ca_topic_score_codex":0.0001956954,"about_ca_topic_score_gemma":0.000329752,"teacher_disagreement_score":0.08188133,"about_ca_system_score_codex":0.000014315716,"about_ca_system_score_gemma":0.00023788364,"threshold_uncertainty_score":0.45790994},"labels":[],"label_agreement":null},{"id":"W3165322256","doi":"10.1136/annrheumdis-2021-eular.4091","title":"OP0229 THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) TREATMENT RECOMMENDATIONS 2021","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Genentech; Keele University; University of Leeds; Northwell Health; University of California, San Diego; Regeneron Pharmaceuticals; University of Toronto; Cleveland Clinic; Singapore General Hospital; University of Pennsylvania; Gilead Sciences; Sanofi; University College Dublin; GlaxoSmithKline; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; University of Washington","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Plaque psoriasis; Internal medicine","score_opus":0.12691008445262297,"score_gpt":0.43268202633789743,"score_spread":0.30577194188527446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165322256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88681346,0.07254956,0.00008413947,0.038075365,0.00016958265,0.001441093,0.0004026169,0.000010109554,0.00045405887],"genre_scores_gemma":[0.7569636,0.24175365,0.0007054732,0.00006387474,0.000032055315,0.00024750878,0.000039861257,0.00001287981,0.00018109586],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983102,0.0003478203,0.0003976429,0.00021407579,0.00044902373,0.0002812067],"domain_scores_gemma":[0.997227,0.0015350532,0.00012742911,0.0004992096,0.00045456676,0.00015670949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006484357,0.00012504174,0.0004091184,0.00008930249,0.0003324599,0.00006114354,0.0001206135,0.000031288113,0.0001637998],"category_scores_gemma":[0.0008998697,0.00007239692,0.00016559532,0.00027614474,0.00046458506,0.00008869218,0.00012226026,0.00009416426,7.7585935e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016684008,0.0013440445,0.0075923884,0.00048410095,0.0009529335,0.0000035873047,0.00080249674,0.0000014902421,0.00018843242,0.020705758,0.008169711,0.9595882],"study_design_scores_gemma":[0.020091321,0.0083697615,0.6651786,0.014246481,0.0003588586,0.0001831956,0.02138595,0.002726276,0.011749978,0.1824504,0.07258363,0.00067552703],"about_ca_topic_score_codex":0.00011964119,"about_ca_topic_score_gemma":0.00009150407,"teacher_disagreement_score":0.9589127,"about_ca_system_score_codex":0.000016170738,"about_ca_system_score_gemma":0.00027577925,"threshold_uncertainty_score":0.29522607},"labels":[],"label_agreement":null},{"id":"W3165336566","doi":"10.1136/annrheumdis-2021-eular.2216","title":"POS0093 HETEROGENEITY IN ADVERSE EVENT ASSESSMENT BETWEEN COUNTRIES PARTICIPATING IN AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS USING JANUS KINASE INHIBITORS (THE JAK-POT STUDY)","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Versus Arthritis; Marmara Üniversitesi; Diakonhjemmet; Aalborg Universitetshospital; KU Leuven; Leids Universitair Medisch Centrum; Tel Aviv University; Aalborg Universitet","keywords":"Medicine; Pharmacovigilance; Adverse effect; Rheumatoid arthritis; Tofacitinib; Internal medicine; Rheumatology; Observational study; Family medicine","score_opus":0.0491869244697225,"score_gpt":0.3831751483595168,"score_spread":0.3339882238897943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165336566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617463,0.0019290383,0.000011013125,0.00054583244,0.00013631619,0.00092263287,0.0002602257,0.000006948625,0.000013332536],"genre_scores_gemma":[0.9956098,0.0040749745,0.00007819535,0.00002958196,0.000013640629,0.0001107835,0.00006588151,0.000014783432,0.0000023212042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967757,0.0005919998,0.0012147571,0.00022400018,0.00094408146,0.00024947606],"domain_scores_gemma":[0.9976707,0.00028696997,0.00063630246,0.00049232406,0.00080962083,0.000104089406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006522352,0.00016701962,0.00058351766,0.00016560983,0.00008962304,0.00003333547,0.00023913184,0.000039712617,0.000049785413],"category_scores_gemma":[0.0013705955,0.00012400754,0.00014401482,0.000518882,0.00029653756,0.00037186366,0.00016490888,0.00011734417,4.860296e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021343637,0.0019387611,0.9868914,0.00015152732,0.00019291934,0.0000107072265,0.002147186,0.00066182524,0.00010919706,0.000106449166,0.000033080298,0.0075435154],"study_design_scores_gemma":[0.0027363917,0.00041775685,0.97748506,0.003502976,0.000013518147,0.000002096729,0.005552395,0.0006777279,0.009192511,0.00027361306,0.00003865495,0.000107326254],"about_ca_topic_score_codex":0.00054737506,"about_ca_topic_score_gemma":0.00096454454,"teacher_disagreement_score":0.009406363,"about_ca_system_score_codex":0.000065049506,"about_ca_system_score_gemma":0.0005622239,"threshold_uncertainty_score":0.505688},"labels":[],"label_agreement":null},{"id":"W3165353358","doi":"10.1136/annrheumdis-2021-eular.1334","title":"AB0538 POOLED SAFETY RESULTS FROM TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 1 YEAR","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"UCB Pharma; Celgene; Gilead Sciences; Celltrion; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Tolerability; Adverse effect; Internal medicine; Placebo; Surgery; Arthritis; Alternative medicine; Pathology","score_opus":0.10393573775434103,"score_gpt":0.4082990128892412,"score_spread":0.30436327513490014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165353358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836159,0.0077861054,0.000011675119,0.0048598414,0.0001407795,0.0005654683,0.002018546,0.00001280971,0.0009889188],"genre_scores_gemma":[0.99367726,0.005322162,0.0002729935,0.000486189,0.000040947638,0.000009627338,0.00014414015,0.00001385296,0.000032848886],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974235,0.0004992808,0.0011314146,0.0002184079,0.0005207871,0.0002065935],"domain_scores_gemma":[0.9962544,0.0022158667,0.0007048927,0.0004709383,0.00025653047,0.00009741485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005606384,0.00015488439,0.0009812482,0.000027941931,0.00005554763,0.000013066402,0.00014115726,0.00003215002,0.0004318005],"category_scores_gemma":[0.00821581,0.00009249979,0.0002437107,0.0002977931,0.000117555064,0.00014767148,0.00009551031,0.00011050244,0.000008038674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090206236,0.020888375,0.09042672,0.0019358664,0.011633665,0.00007818359,0.0058999276,0.0004647756,0.00017926823,0.001515956,0.021974498,0.7547965],"study_design_scores_gemma":[0.14279503,0.0016351755,0.8037407,0.014181801,0.0038330164,0.0000028322936,0.0020539637,0.00028912112,0.010691208,0.011891205,0.008293627,0.0005923121],"about_ca_topic_score_codex":0.0003918033,"about_ca_topic_score_gemma":0.000047396647,"teacher_disagreement_score":0.7542042,"about_ca_system_score_codex":0.000013668432,"about_ca_system_score_gemma":0.00013982828,"threshold_uncertainty_score":0.9835686},"labels":[],"label_agreement":null},{"id":"W3165364673","doi":"10.1136/annrheumdis-2021-eular.1390","title":"POS0405 GENETIC VARIANTS WITHIN PSORIATIC ARTHRITIS (PsA)-WEIGHTED GENES FBXL19 AND HLA-B*39 MAY SERVE AS A POTENTIAL LINK BETWEEN PsA AND OBESITY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Single-nucleotide polymorphism; Internal medicine; Body mass index; Oncology; Mendelian randomization; PTPN22; Population; Rheumatoid arthritis; Genotype; Genetics; Genetic variants; Gene","score_opus":0.020030026633281375,"score_gpt":0.25028087315060166,"score_spread":0.23025084651732028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165364673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.927244,0.070307985,0.00001783481,0.0011016754,0.0004584702,0.00030839714,0.00047951893,0.00003840522,0.00004370879],"genre_scores_gemma":[0.9893141,0.009446407,0.00022285993,0.00015923269,0.000072170864,0.000025061656,0.00015777908,0.000022301123,0.00058009085],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979452,0.00062871433,0.000546839,0.0004146437,0.000108924636,0.00035570635],"domain_scores_gemma":[0.99865484,0.00029214253,0.00030085558,0.0005091101,0.00014253242,0.000100545774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018949281,0.0003062754,0.00063644594,0.00007650202,0.0003231578,0.000055721015,0.00023894866,0.00019798802,0.00023692375],"category_scores_gemma":[0.00022720119,0.00023115243,0.00020844214,0.00018704274,0.00026360212,0.00011803817,0.00025349332,0.00010448915,0.00006403417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040507107,0.0008312454,0.23410463,0.00078771013,0.0061173253,0.00013624411,0.0017023899,0.000021929247,0.004453529,0.0010464188,0.0010336109,0.7493599],"study_design_scores_gemma":[0.0022272598,0.00021660287,0.9683755,0.0006877456,0.0012323891,0.00017795083,0.0002465633,0.000027885222,0.017101455,0.00917164,0.00018925127,0.00034572865],"about_ca_topic_score_codex":0.00019726784,"about_ca_topic_score_gemma":0.000037533006,"teacher_disagreement_score":0.74901414,"about_ca_system_score_codex":0.000007845996,"about_ca_system_score_gemma":0.00016183087,"threshold_uncertainty_score":0.9426123},"labels":[],"label_agreement":null},{"id":"W3165395110","doi":"10.1136/annrheumdis-2021-eular.535","title":"POS0087 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Genentech; Astellas Pharma; Eisai; Daiichi-Sankyo; Chugai Pharmaceutical; Celltrion; Regeneron Pharmaceuticals; Gilead Sciences; AbbVie; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Celgene; Myriad Genetics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Discontinuation; Adverse effect; Internal medicine; Methotrexate; Randomized controlled trial; Placebo; Surgery","score_opus":0.02352162895562803,"score_gpt":0.29087618588745834,"score_spread":0.2673545569318303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165395110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98484564,0.012513395,0.0000011669666,0.0007077192,0.000048871043,0.0011149651,0.00070484023,0.000019350762,0.000044027864],"genre_scores_gemma":[0.9820624,0.017533284,0.000023872692,0.00009887097,0.000010442955,0.000023066508,0.00015842682,0.00002840202,0.0000612335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723154,0.00042849564,0.000802686,0.00034538514,0.00084787153,0.00034404575],"domain_scores_gemma":[0.9973602,0.0010248014,0.00031996332,0.00081389095,0.00030505008,0.00017607369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027427345,0.0002250201,0.00073740963,0.00006737108,0.00013985802,0.000041539526,0.00028298277,0.000033889497,0.0001892943],"category_scores_gemma":[0.0013535401,0.00012322505,0.00013344001,0.00039825693,0.0003476129,0.0001181468,0.00025099522,0.00015524212,0.000005285688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014792596,0.0027783655,0.9343358,0.000108685366,0.00069519685,0.000050895578,0.003282395,0.000014023881,0.000007539353,0.000019021389,0.0008659689,0.04304946],"study_design_scores_gemma":[0.016913807,0.00073529966,0.97560287,0.0051658126,0.000020936008,0.000012123502,0.0010786455,0.000011781559,0.00019280717,0.000054413205,0.00007366298,0.00013787278],"about_ca_topic_score_codex":0.00035021687,"about_ca_topic_score_gemma":0.0014818113,"teacher_disagreement_score":0.042911585,"about_ca_system_score_codex":0.000021406704,"about_ca_system_score_gemma":0.0002911871,"threshold_uncertainty_score":0.5024972},"labels":[],"label_agreement":null},{"id":"W3165403689","doi":"10.1136/annrheumdis-2021-eular.2137","title":"POS0222 PREDICTORS OF RESPONSE: BASELINE CHARACTERISTICS AND EARLY TREATMENT RESPONSES ASSOCIATED WITH ACHIEVEMENT OF REMISSION AND LOW DISEASE ACTIVITY AMONG UPADACITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ABB (Canada); MaRS","funders":"Monash University","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Logistic regression; Concordance; Confidence interval; Univariate analysis; Methotrexate; Disease; Multivariate analysis","score_opus":0.016361041112897944,"score_gpt":0.2664683847085647,"score_spread":0.2501073435956668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165403689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965264,0.0009557572,0.0000041442286,0.00034744854,0.000016624108,0.00081069686,0.0013136078,0.000019995867,0.0000053142903],"genre_scores_gemma":[0.99776626,0.0017965139,0.00002247098,0.000018124036,0.0000047026037,0.00003398107,0.00011691665,0.000033144537,0.00020789588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972945,0.00067683915,0.0005511745,0.00032953187,0.0008673728,0.00028059614],"domain_scores_gemma":[0.99635917,0.001292569,0.000597755,0.00063981564,0.0007031289,0.0004075726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040109537,0.00026684313,0.0007731699,0.00012011448,0.00009349535,0.000021942898,0.00010103735,0.00005986061,0.000028366687],"category_scores_gemma":[0.004137122,0.00015909472,0.0001122537,0.000322929,0.0006183243,0.00013016279,0.00012857433,0.0000813555,1.7095184e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035996687,0.0025850327,0.9530759,0.0007205131,0.0008713227,0.00005998505,0.00039718323,0.0000052219902,0.00036449055,0.0000030190897,0.000056370613,0.0058643166],"study_design_scores_gemma":[0.01240726,0.0020028038,0.9663403,0.009669578,0.00028359404,0.000006296927,0.00009500666,0.00034756443,0.008692706,0.000010200694,0.0000056484146,0.00013904204],"about_ca_topic_score_codex":0.0002184299,"about_ca_topic_score_gemma":0.000015960863,"teacher_disagreement_score":0.023589425,"about_ca_system_score_codex":0.0003335831,"about_ca_system_score_gemma":0.0025550479,"threshold_uncertainty_score":0.64876944},"labels":[],"label_agreement":null},{"id":"W3165419638","doi":"10.1136/annrheumdis-2021-eular.1971","title":"POS1051 SECUKINUMAB IMPROVES PHYSICAL FUNCTION AND INHIBITS STRUCTURAL DAMAGE IN PsA PATIENTS WITH SUSTAINED REMISSION OR LOW DISEASE ACTIVITY: RESULTS FROM A PHASE 3 STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Novartis Pharma; Celgene; Novartis Pharmaceuticals Corporation; Pfizer; Eli Lilly and Company","keywords":"Medicine; Secukinumab; Psoriatic arthritis; Placebo; Internal medicine; Quality of life (healthcare); Physical therapy; Clinical trial; Disease; Alternative medicine; Pathology","score_opus":0.017236388266650155,"score_gpt":0.30996794671041455,"score_spread":0.2927315584437644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165419638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689996,0.0005071049,0.0000029642297,0.0009865791,0.000048923386,0.0009813332,0.00053264154,0.000026154297,0.000014307262],"genre_scores_gemma":[0.99930143,0.00025968542,0.000014324356,0.00007003693,0.000028667318,0.000030661584,0.00017950707,0.000023396671,0.00009225749],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99804896,0.00028178951,0.0003287847,0.000384486,0.0006649271,0.0002910443],"domain_scores_gemma":[0.9983501,0.00029286675,0.00018642156,0.00054130564,0.00027948644,0.00034984114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106345426,0.00022202113,0.00046529522,0.00008791685,0.00013063014,0.000068334084,0.00010533346,0.00002751496,0.00004599746],"category_scores_gemma":[0.0015731622,0.00012395332,0.00009724696,0.00032361312,0.00016011561,0.0003236115,0.00016129696,0.00015389734,0.0000010292744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25834262,0.033321578,0.33651718,0.0017028395,0.0017725436,0.00044479873,0.009180912,0.000038992814,0.003660826,0.00010915924,0.0014102911,0.35349825],"study_design_scores_gemma":[0.02500471,0.0019997582,0.96417016,0.00220499,0.000073973104,0.0000015808552,0.0018776129,0.0015390004,0.0012423653,0.0016907909,0.000012997529,0.00018207262],"about_ca_topic_score_codex":0.00014904834,"about_ca_topic_score_gemma":0.00008055836,"teacher_disagreement_score":0.62765294,"about_ca_system_score_codex":0.000022617813,"about_ca_system_score_gemma":0.00035958763,"threshold_uncertainty_score":0.50546694},"labels":[],"label_agreement":null},{"id":"W3165426775","doi":"10.1136/annrheumdis-2021-eular.17","title":"OP0043 INCREASED RISK OF SEVERE INFECTIONS AND MORTALITY IN PATIENTS WITH NEWLY DIAGNOSED SYSTEMIC LUPUS ERYTHEMATOSUS: A POPULATION-BASED STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Research Canada; Simon Fraser University","funders":"","keywords":"Medicine; Hazard ratio; Incidence (geometry); Population; Internal medicine; Cohort; Mortality rate; Confidence interval","score_opus":0.021600845530579043,"score_gpt":0.3003728883673428,"score_spread":0.27877204283676377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165426775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693894,0.00067734177,0.000012022651,0.000058018795,0.00006908936,0.001983301,0.00020532314,0.000024119478,0.000031814037],"genre_scores_gemma":[0.99963313,0.00005788064,0.000037034762,0.000029798875,0.000007570038,0.00012644535,0.000049954913,0.000027705617,0.0000305059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703074,0.0007427109,0.00079968956,0.00030411634,0.00088112766,0.00024164372],"domain_scores_gemma":[0.9968157,0.0009754282,0.00053087407,0.00093557703,0.0005636749,0.0001787916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048163082,0.00021267337,0.00081982446,0.00019569318,0.00008578088,0.000021390055,0.00015281711,0.00005522541,0.000048124337],"category_scores_gemma":[0.0028958998,0.00013690782,0.0001641841,0.0006891612,0.000091938964,0.00010192611,0.00010020382,0.00012865588,0.0000018798575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030602753,0.0035291587,0.99079865,0.0034125214,0.0005391577,0.000013175983,0.00063816144,0.0004582937,0.0000022247634,0.000017588709,0.00006484058,0.00022020903],"study_design_scores_gemma":[0.007649055,0.00032218487,0.98266995,0.006207567,0.00043134633,0.00010145434,0.0019338775,0.0003635824,0.000025071728,0.00016954556,2.922019e-7,0.00012608504],"about_ca_topic_score_codex":0.0026736741,"about_ca_topic_score_gemma":0.0005552885,"teacher_disagreement_score":0.008128703,"about_ca_system_score_codex":0.00005418116,"about_ca_system_score_gemma":0.00043715298,"threshold_uncertainty_score":0.55829394},"labels":[],"label_agreement":null},{"id":"W3165462202","doi":"10.1136/annrheumdis-2021-eular.903","title":"POS0447 PHYSICAL FUNCTION IN PATIENTS WITH RA, STRATIFIED BY SEROSTATUS AND TREATMENT LINE, FOLLOWING SC ABATACEPT: POST HOC ANALYSIS OF AN OBSERVATIONAL, 2-YEAR STUDY CONDUCTED IN ROUTINE CLINICAL PRACTICE (ASCORE)","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Research Chairs; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Serostatus; Internal medicine; Post-hoc analysis; Observational study; Physical therapy; Etanercept; Rheumatoid arthritis; Immunology; Rituximab","score_opus":0.048107372628534116,"score_gpt":0.3395413367980648,"score_spread":0.2914339641695307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165462202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964235,0.0026328268,0.0000020715256,0.00018489255,0.00009796706,0.00040644399,0.00023321119,0.000007961174,0.000011170983],"genre_scores_gemma":[0.99857247,0.00010651435,0.000012676737,0.00008969757,8.1449883e-7,0.00001600921,0.0011486122,0.00000858691,0.000044600834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805105,0.0007401759,0.0006348365,0.00027835596,0.00011544697,0.00018014111],"domain_scores_gemma":[0.9985711,0.00044511916,0.00036421744,0.00037215155,0.00023472254,0.000012690175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002488968,0.00016203501,0.00058788393,0.0000998273,0.00007918471,0.000016449176,0.00012552754,0.0000579235,0.000029162382],"category_scores_gemma":[0.00057630055,0.00011136542,0.0001714072,0.00067186804,0.00013565202,0.0003014385,0.00004976002,0.000111808775,0.0000013255088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047468077,0.028749876,0.9388127,0.000034856927,0.005009722,0.0000032888447,0.0034695894,0.00066933956,0.0014923742,0.000106135194,0.000028742363,0.01687657],"study_design_scores_gemma":[0.004886634,0.0019684723,0.98422736,0.00009094605,0.0010438473,1.9171713e-7,0.007266202,0.00010606879,0.00025886108,0.00002368048,0.000012644377,0.000115079696],"about_ca_topic_score_codex":0.0007242226,"about_ca_topic_score_gemma":0.000144402,"teacher_disagreement_score":0.045414675,"about_ca_system_score_codex":0.000012649712,"about_ca_system_score_gemma":0.00014503028,"threshold_uncertainty_score":0.454135},"labels":[],"label_agreement":null},{"id":"W3165462715","doi":"10.1136/annrheumdis-2021-eular.2138","title":"POS1428 VALIDATION OF ANCA-ASSOCIATED VASCULITIS AS THE CAUSE OF END-STAGE RENAL DISEASE IN THE UNITED STATES RENAL DATA SYSTEM","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; End stage renal disease; Dialysis; Internal medicine; Disease; Kidney disease; Intensive care medicine","score_opus":0.060269628291551615,"score_gpt":0.32160662917318145,"score_spread":0.2613370008816298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165462715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864041,0.0025396796,0.000016372893,0.0061582834,0.000072338255,0.0005119858,0.0041307975,0.000019300054,0.00014714891],"genre_scores_gemma":[0.99383056,0.0017460845,0.000008372826,0.00028489684,0.000015770742,0.000025401576,0.003872354,0.000015762436,0.00020079614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972592,0.0008326482,0.0007435119,0.0002150694,0.00073640153,0.00021315708],"domain_scores_gemma":[0.99673676,0.00067387917,0.0005262138,0.0015229718,0.00042835684,0.000111837966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067277875,0.00015684843,0.00042458484,0.0001063281,0.00012629176,0.00002657527,0.0005642199,0.000053524396,0.0002114953],"category_scores_gemma":[0.0018216697,0.00007962068,0.00030175992,0.0008374441,0.0002510659,0.00012406317,0.00018207,0.00015552928,0.000004052772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004747475,0.038144443,0.32976288,0.040863678,0.062465258,0.002620459,0.064533055,0.08203586,0.0035461234,0.1505264,0.19946337,0.02129102],"study_design_scores_gemma":[0.005806786,0.00033780932,0.9281869,0.019444656,0.0060775303,0.00007324238,0.015695503,0.012889998,0.0055031003,0.0044390205,0.0011103349,0.00043512092],"about_ca_topic_score_codex":0.0012618849,"about_ca_topic_score_gemma":0.000046306395,"teacher_disagreement_score":0.598424,"about_ca_system_score_codex":0.0000224284,"about_ca_system_score_gemma":0.00040790846,"threshold_uncertainty_score":0.32468373},"labels":[],"label_agreement":null},{"id":"W3165464689","doi":"10.1136/annrheumdis-2021-eular.372","title":"POS0681 VOCLOSPORIN FOR LUPUS NEPHRITIS: INTERIM ANALYSIS OF THE AURORA 2 EXTENSION STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Interim analysis; Lupus nephritis; Internal medicine; Placebo; Proteinuria; Urology; Renal function; Clinical trial; Kidney; Pathology; Disease","score_opus":0.08426041049018826,"score_gpt":0.38401348712465616,"score_spread":0.29975307663446793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165464689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928565,0.0032010942,0.000036196834,0.002023018,0.00032592198,0.0012953018,0.00014332861,0.00001779817,0.000100813806],"genre_scores_gemma":[0.99777734,0.00020830812,0.00006307512,0.0002050424,0.000023011477,0.00007783633,0.000017205124,0.000024284696,0.0016039227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997547,0.00033266895,0.0007365291,0.00028498602,0.0008368792,0.00026198264],"domain_scores_gemma":[0.99656326,0.00054828357,0.00037559116,0.0015207565,0.0008678096,0.00012432438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053042726,0.00016505574,0.0008605539,0.00016750178,0.00009246225,0.000020861287,0.0004497665,0.00004316113,0.00014854886],"category_scores_gemma":[0.0031238932,0.000090332884,0.000927125,0.0012344043,0.00015410873,0.000057033816,0.00035920597,0.0000874746,0.000003511738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074870815,0.0040918,0.9507873,0.0038967521,0.009313794,0.000029878514,0.004050055,0.00012607333,0.0013749967,0.0003421891,0.015917186,0.009321263],"study_design_scores_gemma":[0.0036445833,0.00066584826,0.9468743,0.007650777,0.008281034,0.0003935588,0.020197557,0.0033087267,0.006801363,0.0016524515,0.00024950266,0.0002802505],"about_ca_topic_score_codex":0.000109877255,"about_ca_topic_score_gemma":0.000052839732,"teacher_disagreement_score":0.016147502,"about_ca_system_score_codex":0.00002589998,"about_ca_system_score_gemma":0.00027769004,"threshold_uncertainty_score":0.37398177},"labels":[],"label_agreement":null},{"id":"W3165476304","doi":"10.1136/annrheumdis-2021-eular.850","title":"POS0446 FILGOTINIB-TREATED RHEUMATOID ARTHRITIS PATIENTS WITH HIGH BASELINE NEUTROPHIL-TO-LYMPHOCYTE RATIO SHOW BETTER CLINICAL RESPONSE RATES AND PATIENT-REPORTED OUTCOMES","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Arthritis Network; Vrije Universiteit Amsterdam; Canadian Institutes of Health Research; University of Leeds; Ontario Ministry of Health and Long-Term Care; Bristol-Myers Squibb; Universitätsspital Basel; Università degli Studi di Milano; Sanofi; Université Paris-Saclay; Pfizer","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Population; Post-hoc analysis; Rituximab; Methotrexate; Adalimumab; Neutrophil to lymphocyte ratio; Clinical trial; TNF inhibitor; Lymphocyte; Immunology; Gastroenterology; Lymphoma","score_opus":0.02917616228633254,"score_gpt":0.32424270681192835,"score_spread":0.29506654452559583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165476304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877775,0.0016364558,0.0000143726475,0.008906232,0.00016175397,0.001111849,0.0003061412,0.00006599936,0.000019704099],"genre_scores_gemma":[0.9940591,0.0013334698,0.00036594423,0.0036439418,0.000022923557,0.00007610431,0.00018954102,0.000069553505,0.00023943171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952408,0.0009706784,0.0014227176,0.0006572432,0.0011403852,0.00056816393],"domain_scores_gemma":[0.99411315,0.0022366617,0.0004985575,0.0013716074,0.0011389044,0.0006411255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006160276,0.00040993522,0.001151255,0.00016433194,0.0001759766,0.00008608208,0.000246971,0.00012023641,0.00030707827],"category_scores_gemma":[0.008063145,0.00025724457,0.0003312018,0.0005881412,0.0004187559,0.00017544793,0.00036809416,0.0001960607,0.000030830975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016728275,0.003206432,0.8818395,0.00048211354,0.0022829273,0.00057559623,0.00046077897,0.00012380737,0.00013400875,0.00003883618,0.015595322,0.07853239],"study_design_scores_gemma":[0.022136955,0.0010414892,0.9679506,0.0024679098,0.0001918398,0.000100495505,0.00014770814,0.00066528394,0.004420265,0.0001015828,0.00043372766,0.00034213433],"about_ca_topic_score_codex":0.0002698849,"about_ca_topic_score_gemma":0.000028670916,"teacher_disagreement_score":0.08611109,"about_ca_system_score_codex":0.0003247995,"about_ca_system_score_gemma":0.003515555,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W3165496145","doi":"10.1136/annrheumdis-2021-eular.3211","title":"OP0263-HPR THE ROLE OF PHYSICAL EXERCISES IN REDUCING CHRONIC FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Eli Lilly Canada; Sanofi Genzyme; Pfizer Canada; Bristol-Myers Squibb Canada; Gilead Sciences; Merck Canada; Bristol-Myers Squibb; AbbVie Canada; Sandoz Canada; Amgen","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Rehabilitation; Rating scale; Morning; Arthritis; Internal medicine","score_opus":0.01508037775148328,"score_gpt":0.2761969764945729,"score_spread":0.2611165987430896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165496145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965871,0.032458704,0.0000019273036,0.00073477905,0.000035509278,0.00055514986,0.000052855612,0.0000117335985,0.00027839417],"genre_scores_gemma":[0.97893757,0.020859059,0.000022706587,0.000039638486,0.000013429763,0.00006314108,0.00002297676,0.000024096586,0.00001735658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979534,0.00022786949,0.0005183204,0.00023479002,0.0006909366,0.000374682],"domain_scores_gemma":[0.9984696,0.00031844882,0.00020505094,0.00065220986,0.00024178428,0.00011291515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019043425,0.00018500898,0.0006344141,0.00011643075,0.00007281496,0.000026237904,0.00027566368,0.00003346321,0.00009971021],"category_scores_gemma":[0.0006724324,0.0001061766,0.00019858219,0.0005393202,0.00037902713,0.00016809715,0.00013574527,0.00018292452,0.00000431325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009401643,0.004043256,0.59218216,0.0006465472,0.0003338189,0.000019156805,0.004436517,0.0008130895,0.00038684628,0.0017863971,0.00050162844,0.39391044],"study_design_scores_gemma":[0.004291473,0.0005386141,0.9585095,0.016414994,0.00001047075,0.000008340555,0.0019098811,0.0007472252,0.013564997,0.0036342433,0.00017393217,0.00019630056],"about_ca_topic_score_codex":0.00037712697,"about_ca_topic_score_gemma":0.00018813132,"teacher_disagreement_score":0.39371413,"about_ca_system_score_codex":0.000029002988,"about_ca_system_score_gemma":0.00044228844,"threshold_uncertainty_score":0.43297562},"labels":[],"label_agreement":null},{"id":"W3165520902","doi":"10.1136/annrheumdis-2021-eular.1663","title":"POS1459-HPR IDENTIFYING MEANINGFUL CHANGE IN THE RA FLARE QUESTIONNAIRE SCORES IN RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Université de Sherbrooke; Osteoporosis Canada; University of Manitoba; Canadian Rheumatology Association; St. Joseph's Hospital; University of Calgary; McGill University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cohort; Internal medicine; Physical therapy; Minimal clinically important difference; Disease; Randomized controlled trial","score_opus":0.06379179542488975,"score_gpt":0.3435811079243944,"score_spread":0.27978931249950467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165520902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8679131,0.12113793,0.000007839023,0.009886404,0.00017736001,0.00062230515,0.0000377617,0.00003129817,0.0001859572],"genre_scores_gemma":[0.88250226,0.116325274,0.00003237078,0.00085143186,0.000037612077,0.00016311079,0.000028444114,0.000024903738,0.000034619137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970819,0.0006015999,0.0006660925,0.00029711865,0.0008567907,0.0004965324],"domain_scores_gemma":[0.9983975,0.00029966788,0.00018178606,0.0007397046,0.00023716509,0.00014413717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070140103,0.0002242478,0.0005530303,0.00021148592,0.00016443957,0.00011940902,0.0004316081,0.00006313797,0.00022049069],"category_scores_gemma":[0.0022288573,0.00014603714,0.00029065792,0.0007411545,0.00025742876,0.00035709166,0.00017556301,0.00027746346,0.000028628914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000400792,0.0020556983,0.6501935,0.001658778,0.0003421714,0.0006911153,0.023061747,0.000031989228,0.00026873557,0.008870358,0.0054460736,0.30697903],"study_design_scores_gemma":[0.0021638186,0.00011470051,0.955381,0.027167127,0.000007352349,0.00021538793,0.0043610507,0.00023907034,0.0010196338,0.0086801285,0.00042669804,0.0002240482],"about_ca_topic_score_codex":0.0008973932,"about_ca_topic_score_gemma":0.0017738917,"teacher_disagreement_score":0.30675498,"about_ca_system_score_codex":0.000026428488,"about_ca_system_score_gemma":0.0002655414,"threshold_uncertainty_score":0.5955222},"labels":[],"label_agreement":null},{"id":"W3165529004","doi":"10.1136/annrheumdis-2021-eular.719","title":"OP0005 DIETARY HYPERINSULINEMIC POTENTIAL AND RISK OF INCIDENT GOUT: 3 PROSPECTIVE COHORT STUDIES OF US MEN AND WOMEN","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Internal medicine; Hyperinsulinemia; Insulin resistance; Prospective cohort study; Confounding; Mendelian randomization; Insulin; Cohort study; Diabetes mellitus; Endocrinology; Cohort; Genotype","score_opus":0.021334713001890524,"score_gpt":0.2956457843069098,"score_spread":0.27431107130501925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165529004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97371423,0.025058815,0.000002749554,0.00034087637,0.000056468696,0.0004734802,0.00016317845,0.000012118014,0.00017808595],"genre_scores_gemma":[0.97313124,0.026424352,0.00013613579,0.00006786931,0.000020308487,0.000036622845,0.000006292931,0.000015724272,0.00016146225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985015,0.000119586795,0.0005255223,0.00023574021,0.00042707534,0.0001905868],"domain_scores_gemma":[0.99842983,0.00020857106,0.0004293184,0.00044152248,0.00036084873,0.00012990778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002746814,0.00017166154,0.0007800881,0.000056731864,0.000061382874,0.000006290816,0.00011054658,0.000040581897,0.00003637801],"category_scores_gemma":[0.0016220388,0.00011510444,0.00013177808,0.00017588983,0.00045610528,0.00007758541,0.00034953348,0.00009211003,8.291379e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038551117,0.0005318899,0.9804081,0.0020106637,0.005826018,0.00001675043,0.00422798,0.000057050613,0.0012694446,0.000017544653,0.0005146974,0.004734356],"study_design_scores_gemma":[0.0010501412,0.00023971986,0.98442394,0.0007709789,0.0017155865,0.00003947672,0.005534149,0.0002426464,0.004569979,0.0013033508,0.00000865439,0.00010140339],"about_ca_topic_score_codex":0.00017989823,"about_ca_topic_score_gemma":0.000004021891,"teacher_disagreement_score":0.004632952,"about_ca_system_score_codex":0.000025638767,"about_ca_system_score_gemma":0.0001296315,"threshold_uncertainty_score":0.4693823},"labels":[],"label_agreement":null},{"id":"W3165539233","doi":"10.1136/annrheumdis-2021-eular.2984","title":"OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA)","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Impact; University of Calgary; Toronto Western Hospital; McMaster University; Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Ontario Ministry of Health and Long-Term Care; AstraZeneca; National Institutes of Health; Pfizer","keywords":"Medicine; Hydroxychloroquine; Internal medicine; Comorbidity; Logistic regression; Coronavirus disease 2019 (COVID-19); Rheumatology; Mechanical ventilation; Systemic lupus erythematosus; Disease; Infectious disease (medical specialty)","score_opus":0.10453319305679719,"score_gpt":0.41641455734718186,"score_spread":0.31188136429038466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165539233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76497257,0.004031743,0.00035972902,0.21858189,0.0006028676,0.0020676968,0.009092065,0.0002239636,0.00006746649],"genre_scores_gemma":[0.9532414,0.005657278,0.00005481676,0.03951943,0.000033048633,0.00021059804,0.0004376348,0.000053167358,0.0007926204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99172235,0.002028903,0.0022286589,0.0011075918,0.0018395075,0.0010729836],"domain_scores_gemma":[0.93115884,0.060862973,0.0019754115,0.002933971,0.00079769496,0.0022710836],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022624999,0.0006743874,0.002461227,0.000095152696,0.000536615,0.0001105995,0.0013539245,0.00027595882,0.00019125763],"category_scores_gemma":[0.5057528,0.0003925001,0.0006936791,0.001269797,0.0012334875,0.00015224837,0.0010075277,0.0005717106,0.00004172664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032016546,0.0013920816,0.9424094,0.0045207343,0.002228369,0.0006648286,0.0018180195,0.00091369025,0.000004196806,0.0005796148,0.04183079,0.00043661785],"study_design_scores_gemma":[0.029868359,0.0007386227,0.9165899,0.010817793,0.0017446904,0.00069358316,0.006445043,0.0018575428,0.000018672805,0.019744305,0.009961443,0.0015200176],"about_ca_topic_score_codex":0.0041203257,"about_ca_topic_score_gemma":0.0024434237,"teacher_disagreement_score":0.5034903,"about_ca_system_score_codex":0.0010599619,"about_ca_system_score_gemma":0.008270727,"threshold_uncertainty_score":0.9998527},"labels":[],"label_agreement":null},{"id":"W3165557461","doi":"10.1136/annrheumdis-2021-eular.2236","title":"POS0051 THE IMPACT OF COVID-19 ON RHEUMATOLOGY TRAINING: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE TRAINEE SURVEY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Rheumatology; Internal medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Family medicine; Likert scale; Health care; Disease; Psychology","score_opus":0.26081149778019497,"score_gpt":0.4668149828381283,"score_spread":0.2060034850579333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165557461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7587256,0.0054099103,0.000105201056,0.2267404,0.00033635893,0.000898967,0.007523989,0.00007261268,0.00018695],"genre_scores_gemma":[0.9748627,0.0036075227,0.00002544046,0.020929676,0.00002800796,0.000033384837,0.00039410713,0.000036297,0.000082889324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934183,0.0025593287,0.0016742583,0.0006479821,0.00086838915,0.00083178445],"domain_scores_gemma":[0.97481567,0.019623987,0.0013451589,0.0024101958,0.00051927625,0.0012857369],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022868093,0.000500431,0.0015703457,0.00006540078,0.00042129972,0.000048092632,0.0011144505,0.00023510844,0.0003912432],"category_scores_gemma":[0.105536155,0.00025247983,0.000954917,0.0009455717,0.0010724262,0.00008867643,0.0002487141,0.00038780776,0.000023707744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0133774085,0.0027005686,0.48844862,0.002867335,0.0036514236,0.00014274438,0.020458614,0.0039399667,0.000030690808,0.00625829,0.44458354,0.013540787],"study_design_scores_gemma":[0.0055500576,0.00086527935,0.9683577,0.0014702388,0.00029241233,0.000408633,0.0032619287,0.00057338766,0.00005704251,0.016127268,0.002664541,0.00037154322],"about_ca_topic_score_codex":0.047894202,"about_ca_topic_score_gemma":0.0042730346,"teacher_disagreement_score":0.47990903,"about_ca_system_score_codex":0.00028167106,"about_ca_system_score_gemma":0.011852933,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W3165559185","doi":"10.1136/annrheumdis-2021-eular.2505","title":"OP0162 ETANERCEPT RESPONSE CLUSTERS IN JUVENILE IDIOPATHIC ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"Université de Paris; Assistance publique-Hôpitaux de Paris; Rigshospitalet; Wilhelmina Kinderziekenhuis; Universitat de Barcelona; Aarhus Universitet; Medical Research Council; Ospedale Pediatrico Bambino Gesù; Université de Lausanne; Aarhus Universitetshospital; National and Kapodistrian University of Athens; Swedish Orphan Biovitrum; Institut des maladies génétiques Imagine; Centre Hospitalier Universitaire Vaudois; Assistance Publique - Hôpitaux de Paris","keywords":"Etanercept; Medicine; Methotrexate; Arthritis; Juvenile; Internal medicine; Adverse effect; Rheumatoid arthritis","score_opus":0.03758520316686279,"score_gpt":0.3230414468044815,"score_spread":0.2854562436376187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165559185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96813333,0.01903642,0.000008267217,0.011625469,0.000077813565,0.00028677259,0.000020166382,0.000023042285,0.0007887159],"genre_scores_gemma":[0.9943641,0.0028011252,0.00002199701,0.000901364,0.000010660041,0.000031653963,0.000009340614,0.00001992072,0.0018398828],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99785644,0.0005206449,0.0006360692,0.00019594615,0.0004893228,0.00030158108],"domain_scores_gemma":[0.9986515,0.00020769627,0.0001505035,0.0006926416,0.00017616223,0.000121462195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072739844,0.00013231895,0.000551909,0.00011512345,0.00007359387,0.000021475042,0.00021239405,0.000061005532,0.0005116342],"category_scores_gemma":[0.0031333084,0.00009852226,0.00028043106,0.0004295696,0.00016641381,0.00011147917,0.00017192811,0.00017788421,0.00004992794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012863472,0.008091481,0.11178526,0.007534904,0.0010739183,0.00200473,0.011571981,0.0013218315,0.009194489,0.0013653043,0.09256141,0.7406312],"study_design_scores_gemma":[0.006735432,0.00050456554,0.95224434,0.014323494,0.00011110251,0.00017705902,0.0074392664,0.0023048518,0.0074330615,0.0020672854,0.0061877226,0.00047181797],"about_ca_topic_score_codex":0.000040345214,"about_ca_topic_score_gemma":0.000023374354,"teacher_disagreement_score":0.8404591,"about_ca_system_score_codex":0.000025681516,"about_ca_system_score_gemma":0.0008091733,"threshold_uncertainty_score":0.5602036},"labels":[],"label_agreement":null},{"id":"W3165573596","doi":"10.1136/annrheumdis-2021-eular.1856","title":"POS0220 INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Medac; Gilead Sciences; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adverse effect; Rheumatoid arthritis; Internal medicine; Discontinuation; MedDRA; Adalimumab; Surgery; Pharmacovigilance","score_opus":0.013307211157129472,"score_gpt":0.25851680106984,"score_spread":0.24520958991271052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165573596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994665,0.003316537,0.00001519096,0.00042298384,0.000044730397,0.00074588024,0.0006081749,0.000014410354,0.00016707527],"genre_scores_gemma":[0.9945853,0.0047122724,0.00034818833,0.000075856246,0.0000032813343,0.000036436144,0.00011903075,0.00002854597,0.00009110884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786574,0.00016732056,0.0006516637,0.00022901561,0.0007865902,0.0002996655],"domain_scores_gemma":[0.99800116,0.00016637727,0.00026791595,0.00059073727,0.0007805058,0.0001933066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017846169,0.00017605568,0.0007219011,0.00015642353,0.000035062316,0.000012956514,0.0002078383,0.000040945888,0.00036378772],"category_scores_gemma":[0.0007722468,0.00011429237,0.000120157434,0.0007205902,0.0002792218,0.00011989166,0.000089112706,0.000119862256,0.000004492863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009560694,0.0025952146,0.81036574,0.0011728116,0.00083522167,0.000034210334,0.0035797837,0.00012599368,0.00031360128,0.00076576945,0.0023616604,0.16828929],"study_design_scores_gemma":[0.0058294814,0.0016772229,0.96925336,0.013676405,0.000011022146,0.000011416023,0.0016397759,0.000012296426,0.00726407,0.00015177563,0.00031175933,0.00016144097],"about_ca_topic_score_codex":0.00018577551,"about_ca_topic_score_gemma":0.00012931145,"teacher_disagreement_score":0.16812785,"about_ca_system_score_codex":0.000013310698,"about_ca_system_score_gemma":0.00050138496,"threshold_uncertainty_score":0.46607077},"labels":[],"label_agreement":null},{"id":"W3165577823","doi":"10.1136/annrheumdis-2021-eular.325","title":"AB0198 EFFICACY AND SAFETY AFTER TRANSITION FROM REFERENCE ADALIMUMAB TO CT-P17 (ADALIMUMAB BIOSIMILAR: 100 MG/ML) IN COMPARISON WITH THE MAINTAINED TREATMENT (CT-P17 OR REFERENCE ADALIMUMAB) IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULT","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adalimumab; Medicine; Internal medicine; Rheumatoid arthritis; Randomization; Immunogenicity; Biosimilar; Gastroenterology; Nuclear medicine; Randomized controlled trial; Immunology; Antibody","score_opus":0.030039323359740033,"score_gpt":0.2870993156697347,"score_spread":0.25705999230999466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165577823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889301,0.0018224684,0.00007970357,0.005590029,0.000056332854,0.001214587,0.0021738906,0.000029323211,0.00010353363],"genre_scores_gemma":[0.9966037,0.0013241852,0.00043224686,0.0011323789,0.0000052014557,0.00014225487,0.00022733922,0.000032834512,0.0000998564],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99660957,0.0010547931,0.00078488205,0.00073923974,0.00023548656,0.00057601137],"domain_scores_gemma":[0.9977451,0.0007871611,0.00026829288,0.0008120431,0.0002440628,0.0001433375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024984454,0.00049359543,0.0010223348,0.00013355182,0.00022509955,0.00007053429,0.00037775657,0.00012331812,0.00030412388],"category_scores_gemma":[0.0002412492,0.00025908215,0.00010757054,0.00056155486,0.00034667467,0.00016583143,0.00016377696,0.00031990767,0.000016169774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5541578,0.022181317,0.080243155,0.0007436611,0.007484239,0.00036948736,0.02188603,0.0044499533,0.0015564209,0.0018133923,0.0063244468,0.29879013],"study_design_scores_gemma":[0.028349308,0.003950684,0.93720376,0.0076417946,0.0003842502,0.000030497073,0.005649714,0.00017896935,0.013072567,0.00080109946,0.0015620482,0.0011752883],"about_ca_topic_score_codex":0.00096334337,"about_ca_topic_score_gemma":0.0039926614,"teacher_disagreement_score":0.8569606,"about_ca_system_score_codex":0.00010520755,"about_ca_system_score_gemma":0.00027358095,"threshold_uncertainty_score":0.9999861},"labels":[],"label_agreement":null},{"id":"W3165603187","doi":"10.1136/annrheumdis-2021-eular.3343","title":"POS0036 AN ARTIFICIAL INTELLIGENCE MODEL IN RHEUMATOLOGY: INTERPRETATION OF THE SACROILIAC JOINT GRAPHY IN ANKYLOSING SPONDYLITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Alberta; Université de Sherbrooke; University of Calgary","keywords":"Ankylosing spondylitis; Medicine; Radiography; Sacroiliac joint; Radiology; Artificial intelligence; Rheumatology; Physical therapy; Medical physics; Internal medicine; Computer science","score_opus":0.04183304547471996,"score_gpt":0.28860134467762755,"score_spread":0.2467682992029076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165603187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991952,0.0013763974,0.0056671165,0.0006766843,0.00010818501,0.00007380307,0.00006260027,0.000019265679,0.00006396766],"genre_scores_gemma":[0.9993697,0.00033376686,0.00019973652,0.00006033463,0.0000022817933,0.0000071790128,0.000010278094,0.000010593804,0.000006150467],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986631,0.000179623,0.0006264534,0.00013592993,0.000219661,0.00017517719],"domain_scores_gemma":[0.9992573,0.00012686408,0.000108199936,0.00038563096,0.00006698557,0.0000549971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002382113,0.00011024656,0.00033196583,0.0001314405,0.000026801341,0.000017901624,0.00025402592,0.0000365503,0.000048921665],"category_scores_gemma":[0.0006888069,0.0000771162,0.00020316245,0.00061790843,0.00014673968,0.00014909462,0.000062707855,0.00012323618,0.0000010570577],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036153557,0.00064670824,0.022826027,0.0018572937,0.00020466188,0.000007234106,0.0061366516,0.8197499,0.0016472125,0.006125464,0.000278242,0.14048447],"study_design_scores_gemma":[0.00004432085,0.0000053551676,0.009306869,0.001906377,0.000031837222,0.0000023581822,0.0007599451,0.928564,0.008874424,0.05041568,9.764626e-7,0.00008782508],"about_ca_topic_score_codex":0.00011415575,"about_ca_topic_score_gemma":0.00009566205,"teacher_disagreement_score":0.14039664,"about_ca_system_score_codex":0.000011300377,"about_ca_system_score_gemma":0.000055628225,"threshold_uncertainty_score":0.31447074},"labels":[],"label_agreement":null},{"id":"W3165603393","doi":"10.1136/annrheumdis-2021-eular.1647","title":"POS0050 ARE PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) MORE LIKELY TO RECEIVE COVID-19 TESTS AND TEST POSITIVE FOR SARS-COV-2? A MATCHED POPULATION-BASED STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Waterloo; Sinai Health System; McGill University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Population; Psoriatic arthritis; Odds ratio; Internal medicine; Rheumatoid arthritis; Immunology; Environmental health","score_opus":0.03226498978115223,"score_gpt":0.3144991539567817,"score_spread":0.28223416417562947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165603393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869961,0.002936249,0.000011015353,0.0041269297,0.00008962691,0.0033141386,0.0024311543,0.00009053982,0.000004220053],"genre_scores_gemma":[0.9954747,0.00006910324,0.000059485483,0.003346968,0.000025647381,0.0003495589,0.0005859272,0.000060394646,0.00002823104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974629,0.00021441343,0.0007745483,0.00049317814,0.0007144609,0.00034047596],"domain_scores_gemma":[0.9952233,0.0019912776,0.00061509083,0.00072998484,0.0008867973,0.0005535675],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00014786629,0.00036967947,0.0008559294,0.00016487594,0.00025125942,0.00005912305,0.00020760295,0.00008436219,0.0000234301],"category_scores_gemma":[0.009898645,0.00023747442,0.000275244,0.00050827966,0.000107181724,0.00011818718,0.00010905191,0.00008444477,0.000004569978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013688308,0.0035683275,0.9897207,0.0012012206,0.00069645024,0.000019238525,0.0007885757,0.00011469774,0.00025485107,0.000005976891,0.0016542,0.0006069403],"study_design_scores_gemma":[0.005191349,0.0006125174,0.98407423,0.005608811,0.0012000516,0.0000031266352,0.0021108938,0.00012308633,0.00070540607,0.000071346934,0.000008357451,0.00029083778],"about_ca_topic_score_codex":0.00019958711,"about_ca_topic_score_gemma":0.000046196114,"teacher_disagreement_score":0.009750778,"about_ca_system_score_codex":0.0000784704,"about_ca_system_score_gemma":0.0006408733,"threshold_uncertainty_score":0.9984414},"labels":[],"label_agreement":null},{"id":"W3165606540","doi":"10.1136/annrheumdis-2021-eular.1510","title":"POS1449 SEGMENTED SHORT-FORMAT ONLINE EDUCATION SIGNIFICANTLY INCREASES PREDICTION, PROGNOSIS, AND MANAGEMENT OF FIBROSING INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pulmonologists; Interstitial lung disease; Competence (human resources); Connective tissue disease; Connective tissue; Internal medicine; Disease; Idiopathic pulmonary fibrosis; Physical therapy; Lung; Pathology; Intensive care medicine; Autoimmune disease","score_opus":0.019476589145604125,"score_gpt":0.29154145097651774,"score_spread":0.2720648618309136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165606540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857049,0.0077577364,0.00015428987,0.0013305625,0.00015609915,0.0012368988,0.0034733028,0.00005867564,0.0001275283],"genre_scores_gemma":[0.9963233,0.0015703285,0.00009518169,0.0003036181,0.000048128906,0.00010361829,0.0013423437,0.000033157463,0.00018031106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980538,0.00017881977,0.00058912847,0.00035484234,0.0005575118,0.0002659328],"domain_scores_gemma":[0.99795794,0.000122022575,0.0003072547,0.00044172147,0.0006458696,0.00052520714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001027943,0.0002759724,0.00047103156,0.00010461087,0.0001564051,0.000040601382,0.00014586082,0.000040606243,0.00006440301],"category_scores_gemma":[0.00038982855,0.00020274127,0.00022849027,0.0003368301,0.0003116035,0.0002629236,0.00017007235,0.000086919994,6.443501e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056341544,0.049711,0.73548144,0.057885118,0.011956918,0.00073060184,0.0015555678,0.0005639403,0.0013343627,0.008158324,0.02127372,0.055007465],"study_design_scores_gemma":[0.001224769,0.0009268304,0.94955504,0.035611294,0.004684209,0.000022244487,0.0023148751,0.0037360461,0.0010115465,0.0005406431,0.000051466664,0.00032106333],"about_ca_topic_score_codex":0.00005368609,"about_ca_topic_score_gemma":0.0000073411375,"teacher_disagreement_score":0.21407357,"about_ca_system_score_codex":0.000066398476,"about_ca_system_score_gemma":0.00061808457,"threshold_uncertainty_score":0.8267549},"labels":[],"label_agreement":null},{"id":"W3165637344","doi":"10.1136/annrheumdis-2021-eular.1466","title":"OP0285 COVID-19 HOSPITALIZATIONS, ICU ADMISSION, AND DEATH AMONG PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) – A POPULATION-BASED STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; McGill University; University of Waterloo; Women's College Hospital; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Population; Polymyalgia rheumatica; Intensive care unit; Psoriatic arthritis; Standardized mortality ratio; Confidence interval; Internal medicine; Pediatrics; Giant cell arteritis; Rheumatoid arthritis; Vasculitis; Disease","score_opus":0.019231763946968534,"score_gpt":0.27724688700060857,"score_spread":0.25801512305364005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165637344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882209,0.009085668,0.000016816042,0.00079366734,0.00010319763,0.0013616014,0.00030491006,0.000097436605,0.000015860083],"genre_scores_gemma":[0.99817103,0.00030794882,0.000016605434,0.00065669656,0.000017210155,0.00010970447,0.00061030005,0.000041231182,0.00006925608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749506,0.00032979573,0.0007483502,0.00037178514,0.00080741773,0.00024759735],"domain_scores_gemma":[0.9970091,0.0004395136,0.00050927926,0.00075669546,0.0004983737,0.00078702543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013252151,0.00028490156,0.00059421506,0.00013354217,0.00029361618,0.000054190976,0.0001754418,0.00007276309,0.0002223636],"category_scores_gemma":[0.0042177476,0.00017101201,0.0002132175,0.00046049012,0.000106642554,0.00015116206,0.000104350336,0.00007607932,0.0000030476012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025352548,0.0024853111,0.99412906,0.0007861435,0.00050724775,0.000015104781,0.00026082256,0.00035856364,0.000003651848,0.000033714165,0.0008171586,0.00034971195],"study_design_scores_gemma":[0.003679931,0.00019926786,0.990071,0.0033790525,0.0010259098,0.0000015877974,0.0009226267,0.00035375517,0.000028122708,0.00010773133,0.000015887143,0.00021510717],"about_ca_topic_score_codex":0.00021285668,"about_ca_topic_score_gemma":0.000013596774,"teacher_disagreement_score":0.009950205,"about_ca_system_score_codex":0.000044852553,"about_ca_system_score_gemma":0.00081299973,"threshold_uncertainty_score":0.6973667},"labels":[],"label_agreement":null},{"id":"W3165656578","doi":"10.1136/annrheumdis-2021-eular.1066","title":"POS0196 UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: 56-WEEK DATA FROM THE PHASE 3 SELECT-PSA 2 STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Novartis Pharma; Sun Pharma; Genentech; Novartis Pharmaceuticals Corporation; Celgene; Gilead Sciences; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Antirheumatic drugs; Refractory (planetary science); Antirheumatic Agents; Arthritis; Internal medicine; Pharmacology; Oncology","score_opus":0.06919873261772448,"score_gpt":0.34938884145337534,"score_spread":0.2801901088356509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165656578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750886,0.018375792,0.000019701718,0.0024830098,0.0001668498,0.0021264132,0.0016446589,0.000052503794,0.000042495023],"genre_scores_gemma":[0.9915255,0.0066038915,0.000121604455,0.0007455291,0.000050872462,0.00012572989,0.00073950895,0.00004916468,0.000038246457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561256,0.000902927,0.0009228957,0.00069543504,0.0012251224,0.00064106454],"domain_scores_gemma":[0.99510765,0.0012144536,0.00034771694,0.0024480494,0.00041715865,0.00046495156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059804023,0.0003817597,0.0008956855,0.00013563308,0.00029099858,0.00014387176,0.0010385652,0.000045559573,0.00041044684],"category_scores_gemma":[0.004578719,0.00021588503,0.00020596314,0.00083414215,0.00025815686,0.00036859445,0.0005999633,0.00028951603,0.00005881209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055978727,0.029164335,0.6568983,0.0005882551,0.0025438352,0.00015641662,0.006318061,0.000064134496,0.000035293528,0.00008753175,0.013759966,0.284786],"study_design_scores_gemma":[0.015104441,0.0020591177,0.96539253,0.008441216,0.00014543609,0.0000038082198,0.0060617607,0.00049671787,0.00006620412,0.0011818388,0.0006050129,0.00044193142],"about_ca_topic_score_codex":0.00041958663,"about_ca_topic_score_gemma":0.00018971099,"teacher_disagreement_score":0.30849418,"about_ca_system_score_codex":0.000032898446,"about_ca_system_score_gemma":0.00059402146,"threshold_uncertainty_score":0.8803536},"labels":[],"label_agreement":null},{"id":"W3165658027","doi":"10.1136/annrheumdis-2021-220168","title":"Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Women's College Hospital; University of Toronto; Arthritis Society; University Health Network","funders":"Women's College Research Institute; Krembil Foundation; Arthritis Society; National Psoriasis Foundation","keywords":"Medicine; Framingham Risk Score; Internal medicine; Proportional hazards model; Metabolite; Psoriatic arthritis; Endocrinology; Arthritis; Disease","score_opus":0.009946128909773946,"score_gpt":0.22223031267659468,"score_spread":0.21228418376682073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165658027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964534,0.034603875,0.000037456688,0.000015169766,0.000058266633,0.00049957115,0.0002391173,0.000002411062,0.000010172352],"genre_scores_gemma":[0.99197096,0.0077547864,0.00018275711,0.0000055552578,0.000010649177,0.000036569396,0.000022715583,0.000009685158,0.0000063441785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990265,0.00012893052,0.00029662484,0.00022188165,0.00022512116,0.00010094337],"domain_scores_gemma":[0.99907684,0.000021026637,0.0002258221,0.00032264,0.00031842725,0.000035212695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013831008,0.000117099786,0.00042815247,0.000036608028,0.000050868824,0.0000047673557,0.00007068317,0.000027197724,0.000002750625],"category_scores_gemma":[0.00037961875,0.00008037479,0.00011618122,0.00014385088,0.00008410275,0.000007807642,0.00013746489,0.00002814816,2.8315252e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007522411,0.0031261889,0.94648564,0.00087988,0.017938059,8.5802503e-7,0.0009021737,0.00024534052,0.004118692,0.00031533127,0.00008339853,0.02515221],"study_design_scores_gemma":[0.0021829142,0.00065674033,0.9516523,0.00015027427,0.0008394668,7.6841695e-7,0.0010707254,0.000019097533,0.042839214,0.00047913066,0.000018115594,0.00009125416],"about_ca_topic_score_codex":0.000025042047,"about_ca_topic_score_gemma":0.0000068763156,"teacher_disagreement_score":0.038720522,"about_ca_system_score_codex":0.0000020123425,"about_ca_system_score_gemma":0.000039338334,"threshold_uncertainty_score":0.32775888},"labels":[],"label_agreement":null},{"id":"W3165659910","doi":"10.1136/annrheumdis-2021-eular.3427","title":"POS0032 SCORING MRI STRUCTURAL LESIONS IN SACROILIAC JOINTS OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS: HOW MANY SLICES ARE OPTIMAL?","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lesion; Sacroiliac joint; Axial spondyloarthritis; Ankylosis; Magnetic resonance imaging; Nuclear medicine; Radiology; Orthodontics; Pathology; Sacroiliitis","score_opus":0.016049179851298247,"score_gpt":0.27982444023363556,"score_spread":0.26377526038233734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165659910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438566,0.0014153093,0.000034742123,0.0036419437,0.00015201214,0.00021905209,0.00007850999,0.000013776959,0.000058998918],"genre_scores_gemma":[0.99836504,0.00029867663,0.00092590885,0.00024094502,0.000026746466,0.0000069911175,0.000030748564,0.000020015925,0.000084922656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986265,0.000107547865,0.00034106712,0.00020522847,0.00048132174,0.0002383644],"domain_scores_gemma":[0.9988213,0.00013026483,0.00031026342,0.00037886103,0.00021360253,0.0001456712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012962292,0.00015023173,0.00048013448,0.00008681339,0.000070410446,0.000026544962,0.00017414155,0.000033275897,0.00008040909],"category_scores_gemma":[0.0011872523,0.0000974309,0.0001568524,0.00025522994,0.00019375172,0.0001263571,0.00011290601,0.00018278013,0.0000011137938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030564296,0.00044989746,0.9479585,0.0012000119,0.00021575308,0.000055739427,0.0005161301,0.0007286347,0.00011347937,0.00018719875,0.0007136121,0.04755535],"study_design_scores_gemma":[0.0015541846,0.00009797423,0.9893676,0.0052432423,0.00009578113,0.00000888839,0.00075151847,0.0017812296,0.0007182762,0.00022866177,0.00004008759,0.00011256927],"about_ca_topic_score_codex":0.000053559535,"about_ca_topic_score_gemma":0.000011302315,"teacher_disagreement_score":0.047442783,"about_ca_system_score_codex":0.000012302026,"about_ca_system_score_gemma":0.0001224866,"threshold_uncertainty_score":0.3973117},"labels":[],"label_agreement":null},{"id":"W3165662500","doi":"10.1136/annrheumdis-2021-eular.1133","title":"OP0289 LLDAS (LOW LUPUS DISEASE ACTIVITY STATE), LOW DISEASE ACTIVITY (LDA) AND REMISSION (ON- OR OFF-TREATMENT) PREVENT DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN A MULTINATIONAL MULTICENTER COHORT","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; Dalhousie University; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Toronto Western Hospital","funders":"","keywords":"Medicine; Prednisone; Internal medicine; Systemic lupus erythematosus; Cohort; Disease","score_opus":0.02849837067368927,"score_gpt":0.32583960168556914,"score_spread":0.29734123101187987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165662500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279535,0.0013721857,0.000007643235,0.000997956,0.00040595682,0.0036713025,0.00067063543,0.000044876593,0.00003408309],"genre_scores_gemma":[0.9956208,0.0017125149,0.00001956242,0.00009869642,0.00002783618,0.000493816,0.000111613284,0.00007161357,0.0018435335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490124,0.0010377093,0.00090096093,0.00087662705,0.0015765476,0.00070692797],"domain_scores_gemma":[0.99549633,0.0013438714,0.0005208717,0.001270231,0.00040974555,0.0009589532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005180704,0.0005540778,0.0011102941,0.0003414351,0.00014563653,0.000077492194,0.0003334225,0.000102789585,0.000112085545],"category_scores_gemma":[0.0041816058,0.0003635427,0.00036845004,0.00055527425,0.00022833367,0.0003832366,0.00042844086,0.00026163607,0.000015421147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011844793,0.011357173,0.9582357,0.008085897,0.0003392614,0.00042093283,0.0010896267,0.00019797034,0.00018723651,0.000008765287,0.0004254291,0.007807224],"study_design_scores_gemma":[0.011431091,0.00030035686,0.94798034,0.024223613,0.00024040029,0.00019147564,0.0004038716,0.013326459,0.0013552845,0.00012122249,0.000022117074,0.00040376472],"about_ca_topic_score_codex":0.00013266216,"about_ca_topic_score_gemma":0.00010659012,"teacher_disagreement_score":0.016137715,"about_ca_system_score_codex":0.00051750056,"about_ca_system_score_gemma":0.0012527998,"threshold_uncertainty_score":0.9998816},"labels":[],"label_agreement":null},{"id":"W3165680481","doi":"10.1136/annrheumdis-2021-eular.2127","title":"AB0550 EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2)","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Western University","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Ustekinumab; BASDAI; Rheumatology; Arthritis; Oligoarthritis; Gastroenterology; Adalimumab; Dermatology; Disease; Polyarthritis","score_opus":0.02732903308322123,"score_gpt":0.31549864724900356,"score_spread":0.28816961416578235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165680481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97482026,0.023601785,0.000006742481,0.0003803068,0.000024537996,0.0006588027,0.00048138262,0.000010129365,0.000016081714],"genre_scores_gemma":[0.9492137,0.050488103,0.00007267483,0.000057855257,0.000007044321,0.000043491564,0.000063630025,0.000018807521,0.00003469443],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976667,0.00026465888,0.00073677197,0.00031144125,0.00069796713,0.00032243697],"domain_scores_gemma":[0.9974577,0.00075721985,0.00043333645,0.00040303607,0.0007761715,0.00017256853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024546037,0.00023969986,0.0014590864,0.00035980338,0.000081117236,0.00002243405,0.00010741254,0.000042788728,0.00013119602],"category_scores_gemma":[0.002186725,0.00014944376,0.00019032347,0.0012253711,0.00052183686,0.00015484015,0.00010586984,0.00011361175,4.8657716e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027787587,0.019456366,0.2631571,0.006861491,0.047653563,0.00010216647,0.020577984,0.00012746331,0.0007441148,0.0007550964,0.0013158264,0.6114613],"study_design_scores_gemma":[0.017900072,0.002140722,0.9636134,0.007698681,0.0006515025,0.000007002191,0.0020574233,0.00033795787,0.004949754,0.00040357598,0.00001951683,0.00022038247],"about_ca_topic_score_codex":0.00015369162,"about_ca_topic_score_gemma":0.00026001854,"teacher_disagreement_score":0.7004563,"about_ca_system_score_codex":0.000019170195,"about_ca_system_score_gemma":0.00029409188,"threshold_uncertainty_score":0.6094139},"labels":[],"label_agreement":null},{"id":"W3165686712","doi":"10.1136/annrheumdis-2021-eular.1562","title":"POS1044 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB ON ACR CORE COMPONENTS AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE EXCEED STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Adalimumab; Dermatology; Dactylitis; Quality of life (healthcare); Arthritis; Psoriasis; Internal medicine; Rheumatoid arthritis; Enthesitis","score_opus":0.08620517503482013,"score_gpt":0.3538689077369571,"score_spread":0.267663732702137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165686712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932068,0.0040528066,2.0116107e-7,0.0009605296,0.000070639304,0.0013670765,0.0002908305,0.0000091059,0.00004202147],"genre_scores_gemma":[0.999338,0.00039556608,0.0000031674938,0.00008819765,0.0000039529327,0.000020552334,0.00012601759,0.000015662225,0.000008923815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645096,0.00097312813,0.0012429849,0.0002354876,0.00088392047,0.00021351704],"domain_scores_gemma":[0.9966597,0.0014515666,0.0007883449,0.00076065236,0.00023400412,0.00010571464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093627744,0.00017792381,0.0010517272,0.000060063856,0.00007871876,0.000009397402,0.00021022804,0.00004319682,0.000031111827],"category_scores_gemma":[0.002999119,0.00009834073,0.00012941514,0.00032287397,0.00021062561,0.000062012004,0.00013879473,0.00016998652,0.0000018334998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048175212,0.0053457986,0.9120925,0.0015232031,0.0017264902,0.00000688727,0.00569296,0.00008959326,0.00001875034,0.00006176085,0.0007431901,0.024523675],"study_design_scores_gemma":[0.03105471,0.0029718985,0.9602172,0.0034696152,0.00007774761,1.6970827e-7,0.0018395738,0.00008085592,0.00009394501,0.000112913745,0.0000018532048,0.00007955333],"about_ca_topic_score_codex":0.0027267279,"about_ca_topic_score_gemma":0.00015910552,"teacher_disagreement_score":0.04812469,"about_ca_system_score_codex":0.000019582885,"about_ca_system_score_gemma":0.00028359282,"threshold_uncertainty_score":0.4122015},"labels":[],"label_agreement":null},{"id":"W3165696657","doi":"10.1136/annrheumdis-2021-eular.3430","title":"OP0235 PRO-INFLAMMATORY DIET AND RISK OF INCIDENT GOUT: 3 PROSPECTIVE COHORT STUDIES OF US MEN AND WOMEN","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Internal medicine; Confounding; Hyperuricemia; Prospective cohort study; Cohort study; Diabetes mellitus; Nurses' Health Study; Type 2 diabetes; Uric acid; Physical therapy; Endocrinology","score_opus":0.02335852952479805,"score_gpt":0.3025999778284784,"score_spread":0.27924144830368036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165696657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145926,0.01694928,0.0000014339314,0.00029875452,0.000039887807,0.00075155235,0.00010310004,0.000014142306,0.000382603],"genre_scores_gemma":[0.9869748,0.012520408,0.0000800828,0.000051521223,0.000014171162,0.000089574445,0.000003259858,0.000016744645,0.00024945967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998414,0.00014473574,0.0005463916,0.00023180581,0.00046655483,0.00019651173],"domain_scores_gemma":[0.9980671,0.00032410282,0.00054167316,0.0004908264,0.00044043874,0.00013587085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043743613,0.0001720386,0.0007755766,0.0000576451,0.00006276301,0.000007348748,0.000109728346,0.000040717572,0.000027409824],"category_scores_gemma":[0.0027256308,0.00011287695,0.000112151014,0.0001719678,0.0005037364,0.000086521475,0.0003321479,0.00008751785,9.677593e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032683188,0.00032572073,0.9838217,0.002620721,0.0036706247,0.000009281974,0.0066218846,0.0000074516947,0.00021569127,0.00007512198,0.0007454733,0.0015594965],"study_design_scores_gemma":[0.00087564334,0.00031560176,0.98081666,0.0012443125,0.0010885771,0.00001358379,0.007410827,0.00005732255,0.005630595,0.0024227258,0.000022533528,0.00010160179],"about_ca_topic_score_codex":0.0000872649,"about_ca_topic_score_gemma":0.0000058748674,"teacher_disagreement_score":0.0055155307,"about_ca_system_score_codex":0.000034032033,"about_ca_system_score_gemma":0.00017507977,"threshold_uncertainty_score":0.46029884},"labels":[],"label_agreement":null},{"id":"W3165697488","doi":"10.1136/annrheumdis-2021-eular.1807","title":"AB0260 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA, BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: RESULTS AT 64 WEEKS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Adverse effect; Placebo; Randomized controlled trial; Rheumatology; Clinical endpoint; Surgery","score_opus":0.017607785603118903,"score_gpt":0.29254584305994724,"score_spread":0.2749380574568283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165697488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98338115,0.012548632,0.000012272005,0.0016263745,0.000041727424,0.00095401006,0.001388315,0.000024407864,0.000023124818],"genre_scores_gemma":[0.9785394,0.02092236,0.00012073863,0.00008737457,0.000007120065,0.000034654633,0.00020948779,0.000041362353,0.000037472546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966263,0.0006316635,0.0009369808,0.0005799366,0.000793061,0.00043204066],"domain_scores_gemma":[0.9971246,0.00088000676,0.0003714419,0.0006937349,0.00023584807,0.0006943597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005657783,0.0003341941,0.0008691275,0.00022275177,0.00023029941,0.000086307926,0.00017701491,0.00006046634,0.00007773547],"category_scores_gemma":[0.0021684964,0.00025081856,0.00011257267,0.0002871697,0.0006985925,0.00026897909,0.0003205317,0.00015190078,0.0000035521957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06351718,0.001961215,0.77265763,0.0013712187,0.00060997304,0.000089193505,0.009076441,0.000042583437,0.00017103691,0.00014975514,0.00012413075,0.15022965],"study_design_scores_gemma":[0.014260085,0.00069119426,0.96319944,0.019989476,0.000028899945,0.00002374881,0.000555697,0.00020818466,0.00037050122,0.00040372604,0.0000129270165,0.00025613772],"about_ca_topic_score_codex":0.00014948228,"about_ca_topic_score_gemma":0.00007163671,"teacher_disagreement_score":0.1905418,"about_ca_system_score_codex":0.000024767465,"about_ca_system_score_gemma":0.00024097555,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W3165701398","doi":"10.1136/annrheumdis-2021-eular.2955","title":"OP0222 THE INCIDENCE OF INTERSTITIAL LUNG DISEASE IN PSORIATIC ARTHRITIS COMPARED TO RHEUMATOID ARTHRITIS. DATA FROM OVER 89 000 BDMARD TREATMENT COURSES DERIVED FROM FIVE NORDIC REGISTERS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Research in Rheumatology; Ministerio de Ciencia e Innovación; NordForsk; Arthritis Society; Biogen; Celgene; Mylan; Gilead Sciences; Celltrion; Sanofi; Eli Lilly and Company; Pfizer; Samsung; National Psoriasis Foundation; Amgen","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Interstitial lung disease; Methotrexate; Incidence (geometry); Psoriatic arthritis; Rheumatology; Antirheumatic drugs; Antirheumatic Agents; Lung","score_opus":0.03907981450073105,"score_gpt":0.316525567794188,"score_spread":0.27744575329345694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165701398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94819593,0.034572445,0.000093776245,0.0038176288,0.00052307616,0.0009130193,0.011797728,0.000028791894,0.000057598027],"genre_scores_gemma":[0.98427975,0.013184898,0.000090165406,0.0009095956,0.00010030005,0.0000949554,0.0012477029,0.000038034654,0.00005460669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676496,0.00040570158,0.001037899,0.0006474581,0.00074252137,0.00040146837],"domain_scores_gemma":[0.99593174,0.0007391041,0.00046889175,0.002170191,0.0002335013,0.0004565439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015855048,0.0003842838,0.001062649,0.0001005633,0.0001373402,0.000071653536,0.00083966355,0.000061027684,0.0006283352],"category_scores_gemma":[0.0013020833,0.00026987656,0.000481877,0.00033111844,0.00040650042,0.0002892374,0.00065631804,0.00013752363,0.000016356897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08718494,0.021455815,0.4870495,0.00444059,0.012153917,0.0043071904,0.02186282,0.00570722,0.003997055,0.0011932779,0.13769701,0.21295069],"study_design_scores_gemma":[0.007105298,0.0009882862,0.907908,0.0513814,0.001335196,0.000026657011,0.0045078048,0.021368222,0.0013701735,0.0024012371,0.0007909585,0.00081675465],"about_ca_topic_score_codex":0.011680503,"about_ca_topic_score_gemma":0.001420079,"teacher_disagreement_score":0.42085853,"about_ca_system_score_codex":0.000105457926,"about_ca_system_score_gemma":0.0006920619,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W3165731211","doi":"10.1136/annrheumdis-2021-eular.574","title":"AB0529 CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Adalimumab; Post-hoc analysis; Dactylitis; Placebo; Gastroenterology; Enthesitis; Disease","score_opus":0.0607982413298367,"score_gpt":0.3807998506935578,"score_spread":0.32000160936372113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165731211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958077,0.0014283728,0.000021860451,0.0014566595,0.000026622005,0.0004329775,0.00075441995,0.000011132054,0.00006023766],"genre_scores_gemma":[0.9967654,0.0021613243,0.00007744439,0.00026621387,0.000017704266,0.0000134843585,0.00065818394,0.000012446311,0.000027834461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998053,0.00041644782,0.00070151954,0.0002055201,0.00046596484,0.0001575283],"domain_scores_gemma":[0.9977,0.0006582506,0.0007388715,0.00033329704,0.00044240014,0.00012721469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027200294,0.00015588479,0.0009781028,0.00009117675,0.000052220617,0.000017166121,0.000083763014,0.000028421386,0.0005186376],"category_scores_gemma":[0.0013674836,0.00008375522,0.00020950573,0.00081103167,0.000076002536,0.00015742902,0.000039966315,0.00007042269,0.000001336218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033692945,0.0064754314,0.5020078,0.00063216884,0.009625839,0.00003557803,0.0008655056,0.000066306675,0.002586299,0.00003261678,0.00009941463,0.44388014],"study_design_scores_gemma":[0.016353933,0.0010769676,0.9638281,0.0028090202,0.0048834323,8.9103884e-7,0.0002357221,0.0005118218,0.009881647,0.00007364829,0.0001798469,0.00016500964],"about_ca_topic_score_codex":0.00019262769,"about_ca_topic_score_gemma":0.00003411616,"teacher_disagreement_score":0.4618203,"about_ca_system_score_codex":0.000011074928,"about_ca_system_score_gemma":0.00009569876,"threshold_uncertainty_score":0.5678718},"labels":[],"label_agreement":null},{"id":"W3165793297","doi":"10.1136/annrheumdis-2021-eular.2695","title":"OP0228 EFFICACY AND SAFETY OF RISANKIZUMAB FOR ACTIVE PSORIATIC ARTHRITIS, INCLUDING PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC THERAPIES: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, KEEPSAKE 2 TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Keele University; University of California, San Diego; University of Toronto; University College Dublin; Singapore General Hospital; University of Leeds; Northwell Health; University of Pennsylvania; Cleveland Clinic; University of Washington","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Clinical endpoint; Rheumatology; Placebo; Psoriasis; Adverse effect; Randomized controlled trial; Gastroenterology; Arthritis; Immunology","score_opus":0.0822944902644143,"score_gpt":0.3282076787436841,"score_spread":0.24591318847926982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165793297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364407,0.007300047,0.000080607184,0.0014683716,0.00047923942,0.0033815089,0.0036179808,0.000018981815,0.000009187471],"genre_scores_gemma":[0.9966676,0.0020765027,0.00012874542,0.00017750893,0.000026703929,0.00039017713,0.00042146628,0.00001870259,0.000092553055],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967057,0.0016663537,0.00084850274,0.00038268964,0.000109126035,0.0002876245],"domain_scores_gemma":[0.9882988,0.010107414,0.00072584965,0.0005693061,0.00025166027,0.000047015463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082314,0.00028801296,0.0010263787,0.00006461604,0.00033957945,0.000025848802,0.00034634685,0.0001127037,0.00006210252],"category_scores_gemma":[0.004114953,0.000139076,0.00027893143,0.0002738181,0.00039500807,0.00009801587,0.00014795245,0.00009055805,0.0000045362835],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8019564,0.00135663,0.000027209386,0.000028427918,0.0019990753,0.0000011259278,0.0030949302,0.000018368482,0.00010962525,0.000051155286,0.00025343674,0.19110359],"study_design_scores_gemma":[0.9790414,0.0020835851,0.0051536798,0.001155648,0.0007524023,0.000001743661,0.0009152801,0.000006941902,0.009438484,0.0007765574,0.0004446715,0.00022961838],"about_ca_topic_score_codex":0.000109629385,"about_ca_topic_score_gemma":0.00005755821,"teacher_disagreement_score":0.19087397,"about_ca_system_score_codex":0.000016998405,"about_ca_system_score_gemma":0.00021606886,"threshold_uncertainty_score":0.5671355},"labels":[],"label_agreement":null},{"id":"W3165799091","doi":"10.1136/annrheumdis-2021-eular.2099","title":"POS0462 ALCOHOL AND INFLAMMATORY ARTHRITIS DISEASE ACTIVITY: PERSPECTIVES FROM A 979-PATIENT COHORT WITH SYSTEMATIC REVIEW AND META-ANALYSIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Cohort; Cohort study; Univariate analysis; Arthritis; Inflammatory arthritis; Multivariate analysis","score_opus":0.034140549050412194,"score_gpt":0.2995859884117403,"score_spread":0.2654454393613281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165799091","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45987338,0.5348521,0.0000064009723,0.0038023286,0.00000655583,0.0010884585,0.0003061224,0.00001911903,0.000045512374],"genre_scores_gemma":[0.78377926,0.21519867,0.00004205341,0.0005771451,0.0000044381272,0.0002674291,0.000020077978,0.00001828149,0.00009263763],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975724,0.0005289717,0.000498463,0.00041313685,0.00073629373,0.00025072863],"domain_scores_gemma":[0.9975339,0.00036960858,0.00032923167,0.0008925058,0.00041245748,0.0004623061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023425475,0.00027258947,0.0022003152,0.00011128723,0.00014523359,0.00008316776,0.0001179625,0.000027614557,0.00032937265],"category_scores_gemma":[0.001147042,0.00015456436,0.0007443631,0.00038724465,0.00038684442,0.00020852733,0.0001493115,0.00010975154,0.0000036240897],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095270603,0.0021823319,0.046498463,0.21005537,0.7302916,0.00047797535,0.0034081354,0.0000150309625,0.00007621846,0.0014395963,0.0017286742,0.0028739106],"study_design_scores_gemma":[0.002566047,0.0005527619,0.3858593,0.06885876,0.53371674,0.00016989428,0.0040514343,0.00021824447,0.0007376584,0.002290582,0.00006481304,0.00091378903],"about_ca_topic_score_codex":0.000101401056,"about_ca_topic_score_gemma":0.000050521438,"teacher_disagreement_score":0.33936083,"about_ca_system_score_codex":0.00001155921,"about_ca_system_score_gemma":0.00020248113,"threshold_uncertainty_score":0.63029516},"labels":[],"label_agreement":null},{"id":"W3165800964","doi":"10.1136/annrheumdis-2021-eular.834","title":"OP0170 DECLINE IN FORCED VITAL CAPACITY (FVC) IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) WITH AND WITHOUT DYSPNOEA: DATA FROM THE SENSCIS TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; David Geffen School of Medicine, University of California, Los Angeles; National Institutes of Health; Mitsubishi Tanabe Pharma Corporation; Fonds Wetenschappelijk Onderzoek; University College London; Seoul National University Hospital; Galápagos; Genentech; Vlaamse regering; Horizon Therapeutics; Savara Pharmaceuticals; Acceleron; Università degli Studi di Firenze; Hanyang University; Tel Aviv University; Mallinckrodt Pharmaceuticals; Immune Tolerance Network; GlaxoSmithKline; CSL Behring; Hospital for Special Surgery; Bristol-Myers Squibb; Eli Lilly and Company; United Therapeutics Corporation; Servier; Gilead Sciences; Seoul National University; Universitätsspital Zürich; Sanofi; Johns Hopkins University; Amgen; Pfizer","keywords":"Medicine; Vital capacity; Interstitial lung disease; Internal medicine; Nintedanib; Placebo; Pulmonary function testing; Spirometry; Diffusing capacity; Idiopathic pulmonary fibrosis; Lung; Asthma; Lung function; Pathology","score_opus":0.06800376561714887,"score_gpt":0.28526320629025287,"score_spread":0.217259440673104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165800964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906043,0.0047130706,0.000014662135,0.0010703045,0.00019754271,0.0016124897,0.0017373303,0.000029597833,0.000020741323],"genre_scores_gemma":[0.99817926,0.00054069323,0.000017379813,0.00045880864,0.000050724128,0.000057246227,0.00063142093,0.0000389577,0.000025503947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693954,0.0005249326,0.00081169384,0.00055061874,0.0008125624,0.00036063232],"domain_scores_gemma":[0.99711007,0.0005312799,0.0004943131,0.0012972696,0.00025831972,0.00030873972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038468433,0.00032507686,0.000832554,0.00008165477,0.00012470514,0.000083414874,0.00046499498,0.00009288135,0.000036046476],"category_scores_gemma":[0.0019746437,0.00016566731,0.00013830588,0.00046570288,0.00031440816,0.00024669623,0.0004170539,0.00021715627,0.0000021570918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022713428,0.001655793,0.97193986,0.00039086447,0.0007932683,0.000014612419,0.0005487396,0.00009220508,0.000032441058,0.000014047927,0.0010745872,0.000730131],"study_design_scores_gemma":[0.040588815,0.00021510449,0.92270327,0.031732146,0.0009891454,0.0000039314777,0.0009812063,0.0024642057,0.000034487784,0.000056814286,0.0000016126252,0.00022927918],"about_ca_topic_score_codex":0.0011462028,"about_ca_topic_score_gemma":0.0005456125,"teacher_disagreement_score":0.04923663,"about_ca_system_score_codex":0.00006643278,"about_ca_system_score_gemma":0.00042002462,"threshold_uncertainty_score":0.6755717},"labels":[],"label_agreement":null},{"id":"W3165803692","doi":"10.1136/annrheumdis-2021-eular.1570","title":"POS1045 Ixekizumab efficacy on spinal pain, disease activity and quality of life in patients with psoriatic arthritis presenting with symptoms suggestive of axial involvement","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; University of Toronto","funders":"","keywords":"Medicine; BASDAI; Ixekizumab; Psoriatic arthritis; Ankylosing spondylitis; Internal medicine; Spondylitis; Axial spondyloarthritis; Adalimumab; Quality of life (healthcare); Arthritis; Physical therapy; Disease; Secukinumab","score_opus":0.029776611549102484,"score_gpt":0.2919401522830814,"score_spread":0.2621635407339789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165803692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965108,0.0021543524,0.000004774042,0.00038773188,0.000031043674,0.00068062404,0.00019792427,0.0000074204127,0.000025297351],"genre_scores_gemma":[0.9994562,0.00033509813,0.00003248008,0.00008228635,0.000009365128,0.000033420307,0.000027701208,0.000014570651,0.000008848101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998151,0.00027863533,0.00047387628,0.000253191,0.00063463685,0.00020866282],"domain_scores_gemma":[0.99829644,0.00033211772,0.00047434462,0.0003906776,0.0003273791,0.00017904938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018724888,0.00019252824,0.0006996793,0.00006210866,0.000062876425,0.000008596441,0.00007124789,0.000022840048,0.000017515278],"category_scores_gemma":[0.0014997608,0.000121286525,0.00012399312,0.00023048534,0.0002491012,0.00007467912,0.00009728945,0.00006631787,3.4269095e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009235589,0.005365728,0.9511867,0.00155089,0.0007787572,0.000011645018,0.00034525432,0.000039446524,0.0000034697941,0.00013683825,0.000026219097,0.03131944],"study_design_scores_gemma":[0.008961049,0.0018192915,0.9820245,0.006188377,0.00019278572,3.5725986e-7,0.00030956615,0.000026979122,0.00027388046,0.000093062234,8.654759e-7,0.00010929619],"about_ca_topic_score_codex":0.00032735054,"about_ca_topic_score_gemma":0.00010239749,"teacher_disagreement_score":0.031210145,"about_ca_system_score_codex":0.000021001906,"about_ca_system_score_gemma":0.00021794852,"threshold_uncertainty_score":0.4945921},"labels":[],"label_agreement":null},{"id":"W3165807938","doi":"10.1136/annrheumdis-2021-eular.1323","title":"OP0022 RHO EXPRESSION FACILITATES T CELL MIGRATION TO LYMPH NODES IN RESPONSE INFLAMMATION","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Pfizer; Eli Lilly and Company","keywords":"RAC1; RHOA; Inflammation; Transcriptome; Arthritis; Cytotoxic T cell; Immunology; CDC42; T cell; Molecular biology; CD43; Medicine; Spleen; Lymph; Cell biology; Gene expression; Biology; Gene; Pathology; Immune system; Signal transduction; In vitro; Genetics; Antigen","score_opus":0.03822556029863239,"score_gpt":0.31453428657161187,"score_spread":0.2763087262729795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165807938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920525,0.00048702172,0.000089768335,0.006781868,0.00008831121,0.00021025378,0.00006341218,0.000019970155,0.00020692818],"genre_scores_gemma":[0.9986783,0.00010515349,0.00022161924,0.00029008652,0.000017849374,0.00003644224,0.00003454749,0.000009331475,0.00060665427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890095,0.00020115277,0.00037596922,0.00014873843,0.00024670942,0.00012649802],"domain_scores_gemma":[0.99889576,0.00034503645,0.00011517807,0.00034935324,0.00020532787,0.00008936105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021157425,0.000098953125,0.00020642711,0.00011664405,0.00005839956,0.000022490889,0.000083408835,0.000029030527,0.00023427677],"category_scores_gemma":[0.0020063354,0.00007050983,0.0001472899,0.0002699772,0.000025412051,0.0001246754,0.000060715778,0.000050091006,0.000029379367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015442929,0.0006509588,0.015064459,0.00054289115,0.00003787622,0.000010499214,0.003120827,0.0023347393,0.9604949,0.000055042437,0.0051735365,0.010969975],"study_design_scores_gemma":[0.00049778837,0.00006795374,0.26755485,0.002036192,0.000032054355,0.0000052318323,0.0011817433,0.00073594454,0.7265927,0.00038611132,0.0008209773,0.00008839525],"about_ca_topic_score_codex":0.000069120935,"about_ca_topic_score_gemma":0.000012293225,"teacher_disagreement_score":0.2524904,"about_ca_system_score_codex":0.000024342142,"about_ca_system_score_gemma":0.00015638479,"threshold_uncertainty_score":0.28753075},"labels":[],"label_agreement":null},{"id":"W3165812261","doi":"10.1136/annrheumdis-2021-eular.2144","title":"POS1352 ANTIINFLAMMATORY, ANTIOXIDANT AND ANTI-ATHEROSCLEROTIC EFFECTS OF A COMBINATION OF NATURAL SUPPLEMENTS ON PATIENTS WITH FMF RELATED AA AMYLOIDOSIS: A NON-RANDOMIZED 24 WEEKS OPEN LABEL INTERVENTIONAL STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biomarkers in Disease Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Familial Mediterranean fever; Internal medicine; Amyloidosis; Oxidative stress; Gastroenterology; Endothelial dysfunction; Pathology; Disease","score_opus":0.014226946810636892,"score_gpt":0.27028292442527846,"score_spread":0.25605597761464155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165812261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953499,0.0015317287,0.000010627143,0.000101393,0.00042407808,0.00234464,0.00021152505,0.000011236723,0.000014891327],"genre_scores_gemma":[0.999517,0.00008644747,0.00004096389,0.000034961933,0.0000010597753,0.000084679006,0.00012064453,0.000019842835,0.00009436451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975334,0.0010174838,0.00076296384,0.00028790435,0.000199644,0.00019862379],"domain_scores_gemma":[0.997795,0.00050146144,0.00085539155,0.00045524523,0.00035945748,0.000033475757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042098033,0.00022713796,0.00085883564,0.0001147395,0.000103718696,0.000021298085,0.00044856113,0.00007259811,0.00008598814],"category_scores_gemma":[0.0006174943,0.00014957659,0.00019988403,0.0002173093,0.00043531068,0.00014025846,0.00041306292,0.00010779444,0.0000035331882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101900645,0.14352377,0.5572129,0.011930931,0.041951608,0.000035074103,0.0066878325,0.000019745596,0.11295607,0.0077372235,0.0037277555,0.012316457],"study_design_scores_gemma":[0.14245574,0.001558371,0.77776533,0.0062701046,0.0009779086,0.0000025316647,0.00055556884,0.000051345374,0.06833287,0.0017983535,0.0000012426432,0.00023064074],"about_ca_topic_score_codex":0.000046607092,"about_ca_topic_score_gemma":0.0000050892745,"teacher_disagreement_score":0.22055241,"about_ca_system_score_codex":0.000010464422,"about_ca_system_score_gemma":0.00008466875,"threshold_uncertainty_score":0.6099556},"labels":[],"label_agreement":null},{"id":"W3165817137","doi":"10.1136/annrheumdis-2021-eular.873","title":"AB0107 CHANGES IN EXTRACELLULAR MATRIX BIOMARKER C3M CORRELATE WITH ABATACEPT RESPONSE IN SEROPOSITIVE EARLY RA","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; Pfizer; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Abatacept; Biomarker; Internal medicine; Population; Adalimumab; Rheumatoid arthritis; Gastroenterology; Immunology; Oncology","score_opus":0.02202277313827624,"score_gpt":0.2958334194159276,"score_spread":0.2738106462776514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165817137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826426,0.011261678,0.000015662099,0.0052159596,0.00009416964,0.0004337865,0.00012704794,0.000020846328,0.00018826452],"genre_scores_gemma":[0.9973106,0.00055942714,0.000040269275,0.0002729889,0.000016431954,0.00003976261,0.000033669767,0.000030725667,0.0016961672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816144,0.0004011903,0.00040371055,0.00029786382,0.00039865158,0.0003371706],"domain_scores_gemma":[0.9987038,0.00025690044,0.00017834044,0.00051323755,0.00017677166,0.00017097956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003219174,0.00021767558,0.00048008937,0.00017700378,0.00005253296,0.00002730656,0.00016508684,0.00007706284,0.00021993316],"category_scores_gemma":[0.0003632683,0.00015033741,0.00020841166,0.00054180244,0.0001861751,0.00012975364,0.000107203225,0.00015663383,0.00001880576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35037625,0.014814636,0.51831424,0.008732273,0.0027526924,0.016335106,0.011882503,0.0008242583,0.039930776,0.0037535839,0.007710766,0.02457289],"study_design_scores_gemma":[0.0017243504,0.0010872722,0.98438555,0.008349617,0.00022645177,0.000091480455,0.0010531632,0.0010033434,0.0014179648,0.00028995672,0.00013290554,0.00023792477],"about_ca_topic_score_codex":0.00022120126,"about_ca_topic_score_gemma":0.000040864084,"teacher_disagreement_score":0.4660713,"about_ca_system_score_codex":0.000044904424,"about_ca_system_score_gemma":0.000296748,"threshold_uncertainty_score":0.61305815},"labels":[],"label_agreement":null},{"id":"W3165819617","doi":"10.1136/annrheumdis-2021-eular.3964","title":"OP0070 ONSET TO DIAGNOSIS TIME PREDICTS SURVIVAL RATE IN TAKAYASU ARTERITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Survival rate; Proportional hazards model; Arteritis; Mortality rate; Retrospective cohort study; Cohort; Pediatrics; Survival analysis; Internal medicine; Vasculitis; Giant cell arteritis; Surgery; Disease","score_opus":0.028574606750277166,"score_gpt":0.2925052238779288,"score_spread":0.26393061712765165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165819617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97421163,0.0016653888,0.0000066619655,0.021996336,0.00019209662,0.00033485703,0.0004937239,0.00002926661,0.001070015],"genre_scores_gemma":[0.99550325,0.001591508,0.000033472163,0.0013677788,0.000025362096,0.00009517197,0.00009899307,0.000017031067,0.0012674341],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987725,0.00018652134,0.00036048106,0.00018774424,0.00026374593,0.00022897779],"domain_scores_gemma":[0.9988622,0.00023477741,0.000075410004,0.00046231426,0.00014769164,0.00021761456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015647712,0.000121310506,0.00037584198,0.00007787965,0.000060543593,0.000022864579,0.00013348961,0.00005066341,0.0013136914],"category_scores_gemma":[0.0010902565,0.00008800654,0.0002484383,0.00040144532,0.000068303285,0.00006304714,0.00008857457,0.000090937334,0.00015303749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003929814,0.008544084,0.27276632,0.0024302432,0.0032868776,0.0014615303,0.0029827505,0.0010747834,0.00090990076,0.0019900538,0.6040024,0.10015808],"study_design_scores_gemma":[0.0010582112,0.000116206895,0.98969066,0.003809972,0.0002026228,0.000036158508,0.00018632921,0.00017023375,0.0014940827,0.0019289607,0.001168669,0.0001378877],"about_ca_topic_score_codex":0.000057017653,"about_ca_topic_score_gemma":0.000023246246,"teacher_disagreement_score":0.71692437,"about_ca_system_score_codex":0.000013100876,"about_ca_system_score_gemma":0.00017508403,"threshold_uncertainty_score":0.9995992},"labels":[],"label_agreement":null},{"id":"W3165823523","doi":"10.1136/annrheumdis-2021-eular.397","title":"AB0523 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS AT 56 WEEKS FROM THE SELECT-PsA 1 STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Barrie Urology Group","funders":"","keywords":"Medicine; Psoriatic arthritis; Adalimumab; Internal medicine; Adverse effect; Psoriasis; Clinical endpoint; Rheumatoid arthritis; Surgery; Clinical trial; Dermatology","score_opus":0.014650262235609808,"score_gpt":0.2773083433380231,"score_spread":0.2626580811024133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165823523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837934,0.013884356,0.0000042284273,0.0003964273,0.00006335435,0.0013194764,0.0004723508,0.000012823444,0.00005362518],"genre_scores_gemma":[0.9919862,0.007732827,0.000012638829,0.000050527236,0.000014341647,0.0000453272,0.000111958885,0.00002151231,0.000024629762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720854,0.0009037701,0.0005931683,0.00030239738,0.0007063622,0.00028574633],"domain_scores_gemma":[0.99699867,0.001623428,0.00024917288,0.0006641822,0.00033180506,0.0001327732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053117494,0.00019816379,0.00066910114,0.000054578173,0.0001349449,0.000030003946,0.00020232759,0.00003599942,0.00007591735],"category_scores_gemma":[0.0015203224,0.00011041463,0.00013882943,0.00032686218,0.00029063984,0.00011277652,0.0001901288,0.00013359866,0.00000377354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007967428,0.0019927393,0.9571855,0.00036296935,0.0008177815,0.00002110165,0.0012973092,0.00001135671,0.000018530953,0.00003497857,0.00014559815,0.030144671],"study_design_scores_gemma":[0.011455785,0.0008672531,0.97881013,0.0072164587,0.00004666072,0.0000038357257,0.0004696978,0.000012094338,0.0006624468,0.00032992044,0.000012676267,0.00011303854],"about_ca_topic_score_codex":0.00026658064,"about_ca_topic_score_gemma":0.00044966635,"teacher_disagreement_score":0.030031633,"about_ca_system_score_codex":0.000020717613,"about_ca_system_score_gemma":0.00017213845,"threshold_uncertainty_score":0.45025778},"labels":[],"label_agreement":null},{"id":"W3165847528","doi":"10.1136/annrheumdis-2021-eular.1928","title":"POS0694 REAL-WORLD ECONOMIC IMPLICATIONS OF ACHIEVING LOW DISEASE ACTIVITY IN LUPUS NEPHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Lupus nephritis; Disease; Pharmacy; Population; Internal medicine; Systemic lupus erythematosus; Rheumatology; Connective tissue disease; Cyclophosphamide; Autoimmune disease; Environmental health; Chemotherapy","score_opus":0.04713770245985594,"score_gpt":0.3526590027247105,"score_spread":0.3055213002648546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165847528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878246,0.0021705693,0.000007378092,0.007664374,0.00012942072,0.00055157254,0.0002615301,0.000021214259,0.0013693201],"genre_scores_gemma":[0.99685055,0.0019382662,0.00003231409,0.00011228159,0.000026935824,0.00007142978,0.000021338743,0.000025872561,0.0009210164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828506,0.0002488006,0.000579017,0.00026856296,0.00032261317,0.00029594026],"domain_scores_gemma":[0.9975387,0.00056930433,0.00029158194,0.0011365105,0.00019181345,0.00027211788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027232635,0.00015188125,0.00057599426,0.00018681794,0.000056619505,0.000018647059,0.00029875044,0.00003426925,0.00021263471],"category_scores_gemma":[0.0009103286,0.000119696684,0.00033594822,0.00041600753,0.00016880954,0.00013359125,0.00022439966,0.00011264062,0.000016741056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000280006,0.0007626121,0.9796009,0.0043181083,0.00019841798,0.000015626156,0.00022521755,0.00008288716,0.0010695491,0.001777484,0.0032848609,0.0083843],"study_design_scores_gemma":[0.0009332864,0.000030253777,0.9884417,0.005836816,0.000106546235,0.00009830794,0.00022043787,0.00036087498,0.0019287453,0.0018664695,0.00005744478,0.00011912427],"about_ca_topic_score_codex":0.0004725723,"about_ca_topic_score_gemma":0.00044273288,"teacher_disagreement_score":0.009025924,"about_ca_system_score_codex":0.0000910447,"about_ca_system_score_gemma":0.0008748376,"threshold_uncertainty_score":0.4881089},"labels":[],"label_agreement":null},{"id":"W3165865880","doi":"10.1136/annrheumdis-2021-eular.960","title":"AB0532 MAINTENANCE OF RESPONSE THROUGH 5 YEARS OF CONTINUOUS GUSELKUMAB TREATMENT: RESULTS FROM THE PHASE-3 VOYAGE 1 TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Internal medicine; Adalimumab; Clinical trial; Clearance; Randomized controlled trial; Surgery; Immunology; Urology; Rheumatoid arthritis","score_opus":0.14984659691734917,"score_gpt":0.42414570423587705,"score_spread":0.2742991073185279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165865880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972873,0.009919529,0.000005184198,0.01403234,0.0001791033,0.00049883855,0.0016662529,0.000010311577,0.00081549556],"genre_scores_gemma":[0.9914133,0.007241824,0.00007394121,0.00062732707,0.000047377842,0.000015886979,0.000024627454,0.000011234155,0.0005444749],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981299,0.00050166785,0.00064739806,0.00017707878,0.0003606337,0.00018333006],"domain_scores_gemma":[0.9932824,0.005219273,0.00056899566,0.00065922097,0.00020219682,0.000067915666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00042430192,0.00012914334,0.0005928947,0.000012384226,0.00006475136,0.0000101488395,0.0002106753,0.000034134497,0.00015733113],"category_scores_gemma":[0.009071942,0.00006834743,0.00038466943,0.00020180854,0.00029986523,0.000073892494,0.00010157418,0.00007459895,0.0000053795293],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72931826,0.011080006,0.0007839733,0.00041243676,0.0063779713,0.00011669501,0.009692875,0.000025960766,0.003000083,0.00087126036,0.064893655,0.17342684],"study_design_scores_gemma":[0.38868833,0.009394298,0.16685791,0.008748313,0.008777744,0.000034453114,0.013677714,0.0004028036,0.12397215,0.011774587,0.26693478,0.0007369212],"about_ca_topic_score_codex":0.0004949428,"about_ca_topic_score_gemma":0.000012366455,"teacher_disagreement_score":0.34062994,"about_ca_system_score_codex":0.000012755149,"about_ca_system_score_gemma":0.00018128101,"threshold_uncertainty_score":0.9992751},"labels":[],"label_agreement":null},{"id":"W3165868341","doi":"10.1136/annrheumdis-2021-eular.2436","title":"AB0374 CHARACTERISTICS OF A GIANT CELL ARTERITIS COHORT IN LATINOAMERICA","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Giant cell arteritis; Vasculitis; Claudication; Cohort; Retrospective cohort study; Radiology; Dermatology; Surgery; Disease; Internal medicine; Vascular disease","score_opus":0.01639531417393057,"score_gpt":0.26648691434262833,"score_spread":0.25009160016869775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165868341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357015,0.0017363402,0.000016295688,0.0024825954,0.00008364282,0.00018902063,0.00022548159,0.000009423827,0.0016870731],"genre_scores_gemma":[0.9964892,0.0026957828,0.00009022279,0.00027711812,0.0000101626065,0.000014153894,0.000058217644,0.000009777714,0.0003553195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999067,0.00006204243,0.00042179658,0.000110152556,0.00020719337,0.00013179024],"domain_scores_gemma":[0.99913996,0.000075408476,0.00018539731,0.00035767542,0.0001628328,0.00007872392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060192688,0.00008243079,0.000383863,0.000044706812,0.00002622194,0.000006126844,0.000079187055,0.000036045552,0.00044084058],"category_scores_gemma":[0.0002724244,0.000058531936,0.00022648231,0.00022550742,0.00010872414,0.000030413907,0.00004387453,0.0000760934,0.000009469059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002620819,0.010901645,0.74348724,0.009042197,0.0024721,0.000687173,0.003099096,0.00007694735,0.015056739,0.0037657944,0.023922158,0.18722685],"study_design_scores_gemma":[0.0005036041,0.00005483213,0.99420696,0.0018842125,0.0001841474,0.00002649603,0.00020287004,0.00017881297,0.0019642445,0.0006046975,0.00012312093,0.00006599554],"about_ca_topic_score_codex":0.000049176255,"about_ca_topic_score_gemma":0.000002527043,"teacher_disagreement_score":0.25071973,"about_ca_system_score_codex":0.000005938511,"about_ca_system_score_gemma":0.00014349209,"threshold_uncertainty_score":0.48268953},"labels":[],"label_agreement":null},{"id":"W3165870151","doi":"10.1136/annrheumdis-2021-eular.1468","title":"POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministerio de Ciencia e Innovación; Arthritis Society; National Psoriasis Foundation","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Erythrocyte sedimentation rate; Intraclass correlation; Prospective cohort study; Rheumatoid arthritis; Physical therapy","score_opus":0.024991154299246806,"score_gpt":0.29964401797988827,"score_spread":0.27465286368064146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165870151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984087,0.00083254924,0.00007784929,0.0009835619,0.00009986435,0.007316335,0.00079160277,0.000017773502,0.00003962571],"genre_scores_gemma":[0.99804604,0.000072362716,0.00022134215,0.000075627366,0.00001609531,0.0014246514,0.000054266882,0.00004212316,0.000047477446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969169,0.00045045617,0.0005826458,0.00047378486,0.0012384059,0.00033780126],"domain_scores_gemma":[0.99662906,0.0004679356,0.0007522036,0.00055663375,0.0014505902,0.00014358161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027454816,0.00034499844,0.00079313875,0.000120349614,0.00022086852,0.000037651433,0.00017133898,0.000043453663,0.00002678085],"category_scores_gemma":[0.0025146164,0.00020486908,0.00025304506,0.0006482323,0.00025221964,0.00032548426,0.00012047689,0.00014127027,0.0000016139019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010240611,0.017178157,0.95948917,0.0006589716,0.002107548,0.000017796008,0.0022269124,0.00014929417,0.000013779012,0.00043489324,0.00008527716,0.007397598],"study_design_scores_gemma":[0.020243604,0.002151291,0.9668438,0.0056712446,0.00042654734,0.0000016349148,0.0016991654,0.00021760722,0.0010497229,0.0014765485,0.0000037764664,0.00021506347],"about_ca_topic_score_codex":0.0002070666,"about_ca_topic_score_gemma":0.0006453337,"teacher_disagreement_score":0.015026867,"about_ca_system_score_codex":0.00012090859,"about_ca_system_score_gemma":0.0005813463,"threshold_uncertainty_score":0.8354319},"labels":[],"label_agreement":null},{"id":"W3165880262","doi":"10.1136/annrheumdis-2021-eular.390","title":"AB0521 EARLY REAL-WORLD EXPERIENCE OF TOFACITINIB FOR PSORIATIC ARTHRITIS: DATA FROM A UNITED STATES HEALTHCARE CLAIMS DATABASE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Genentech; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tofacitinib; Janus kinase inhibitor; Apremilast; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Cohort; Physical therapy","score_opus":0.11896141465987749,"score_gpt":0.3932763311999898,"score_spread":0.2743149165401123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165880262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95002294,0.023542503,0.00010543777,0.0043846215,0.00016570659,0.0007221923,0.020980159,0.000037569782,0.000038863327],"genre_scores_gemma":[0.9040677,0.08809112,0.00069649157,0.0005374475,0.000043493088,0.000103109815,0.0062938035,0.00003274344,0.00013409265],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974587,0.00025458875,0.0007872038,0.00040623403,0.0006781297,0.00041513678],"domain_scores_gemma":[0.99588627,0.0009093024,0.00033447353,0.0019196286,0.000625067,0.00032525757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027056911,0.00020413108,0.0006837634,0.00014124296,0.00014324546,0.0000501493,0.0006139569,0.000037298643,0.0004247739],"category_scores_gemma":[0.0017330839,0.0001546408,0.00020315149,0.00056593464,0.00035329323,0.0003182744,0.00036334593,0.00011845167,0.0000068616614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008318444,0.0085326955,0.20756498,0.013429352,0.0062513147,0.0002648477,0.02939152,0.00008383481,0.0022850062,0.01819987,0.14771761,0.5579605],"study_design_scores_gemma":[0.030294916,0.002745262,0.56681526,0.098500624,0.000469303,0.00007883761,0.047405776,0.016900325,0.079800524,0.10216543,0.052544758,0.0022790022],"about_ca_topic_score_codex":0.004646189,"about_ca_topic_score_gemma":0.0009067576,"teacher_disagreement_score":0.5556815,"about_ca_system_score_codex":0.000010859628,"about_ca_system_score_gemma":0.00046007967,"threshold_uncertainty_score":0.7023679},"labels":[],"label_agreement":null},{"id":"W3165884485","doi":"10.1136/annrheumdis-2021-eular.912","title":"OP0179 DISCONTINUATION RATE OF TOFACITINIB IS SIMILAR WHEN COMPARED TO TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS: POOLED DATA FROM TWO RHEUMATOID ARTHRITIS REGISTRIES IN CANADA","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Montreal Clinical Research Institute; Toronto General Hospital","funders":"Merck Sharp and Dohme; Vrije Universiteit Amsterdam; Celgene; Gilead Sciences; Celltrion; Sanofi; Pfizer; Universitätsspital Basel; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Discontinuation; Internal medicine; Etanercept; Hazard ratio; Abatacept; Proportional hazards model; Cohort; Imputation (statistics); Missing data; Confidence interval; Rituximab; Statistics","score_opus":0.040189790315419326,"score_gpt":0.29461205157261655,"score_spread":0.25442226125719725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165884485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487159,0.035922006,0.0000142561485,0.007023574,0.0002759704,0.00097517075,0.006955596,0.00002115563,0.00009633864],"genre_scores_gemma":[0.92714834,0.07024105,0.00015442514,0.0006864271,0.000017908082,0.000062850006,0.0016161517,0.00004349332,0.000029373788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99518335,0.0005814062,0.0018453291,0.0006765193,0.0010632823,0.0006501283],"domain_scores_gemma":[0.9959791,0.0006797225,0.00059007807,0.0017884669,0.0005704244,0.00039220933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051789096,0.00039476765,0.0014261439,0.00024107339,0.00010952523,0.000088157096,0.0007795728,0.00006432827,0.0007372003],"category_scores_gemma":[0.004131472,0.00034691053,0.00020652023,0.0007116366,0.0002677006,0.0005441551,0.0006141751,0.00024632202,0.000012442176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013516267,0.0017421038,0.69297147,0.00036848147,0.000704634,0.00012307242,0.003802301,0.00020939152,0.00022668071,0.00034157047,0.09054327,0.20761542],"study_design_scores_gemma":[0.023498725,0.00033418354,0.8518944,0.05870537,0.000023503948,0.000023087669,0.010065423,0.0021877878,0.03110912,0.009230771,0.011744021,0.0011836316],"about_ca_topic_score_codex":0.44773707,"about_ca_topic_score_gemma":0.6543874,"teacher_disagreement_score":0.20665035,"about_ca_system_score_codex":0.000117310854,"about_ca_system_score_gemma":0.0023216095,"threshold_uncertainty_score":0.9998983},"labels":[],"label_agreement":null},{"id":"W3176557146","doi":"10.1136/annrheumdis-2021-220562","title":"Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Enthesitis; Internal medicine; Population; Physical therapy; Synovitis; Psoriasis; Fibromyalgia; Tenosynovitis; Severity of illness; Arthritis; Surgery; Dermatology","score_opus":0.01660031624562164,"score_gpt":0.29093747919144736,"score_spread":0.2743371629458257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176557146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993411,0.0049756356,0.000014987804,0.00020245959,0.00005583069,0.0005320576,0.00058507634,0.0000058072415,0.00021712415],"genre_scores_gemma":[0.9982249,0.000708912,0.00082227617,0.00002660437,0.0000055973537,0.00004866889,0.00008042688,0.000013615919,0.00006900275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989679,0.000034886394,0.00037418387,0.00012910891,0.00034831764,0.00014563747],"domain_scores_gemma":[0.9985334,0.00026765993,0.00030836914,0.00035457482,0.00047266547,0.000063297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048503112,0.000114872644,0.0004913674,0.00002852684,0.000048942642,0.000004706739,0.00007207221,0.000021050799,0.0000921022],"category_scores_gemma":[0.00036135328,0.00007293314,0.00022356266,0.00013935601,0.00010453192,0.0000418929,0.000039357004,0.000024040597,5.0691943e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053124275,0.005464349,0.9265116,0.0039811493,0.00307023,0.0000034504264,0.000478559,0.000034670815,0.00029822747,0.0016577003,0.0024232431,0.05554557],"study_design_scores_gemma":[0.0037810188,0.00080666045,0.9849519,0.0036566046,0.00038825863,0.0000029609016,0.0004373446,0.000020536798,0.004074914,0.0017495372,0.000057670582,0.00007256472],"about_ca_topic_score_codex":0.000032241453,"about_ca_topic_score_gemma":0.0000068532386,"teacher_disagreement_score":0.05844032,"about_ca_system_score_codex":0.000008593924,"about_ca_system_score_gemma":0.00014511091,"threshold_uncertainty_score":0.2974127},"labels":[],"label_agreement":null},{"id":"W3182621217","doi":"10.1136/annrheumdis-2019-eular.7900","title":"SAT0534 MAGNETIC RESONANCE IMAGING MARKERS IMPROVE THE PREDICTION MODEL FOR TOTAL KNEE REPLACEMENT OVER 13 YEARS IN OLDER ADULTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Magnetic resonance imaging; Knee pain; Receiver operating characteristic; WOMAC; Knee replacement; Synovitis; Intraclass correlation; Body mass index; Physical therapy; Arthroplasty; Arthritis; Internal medicine; Surgery; Radiology; Pathology","score_opus":0.008903861075276102,"score_gpt":0.2481656197184698,"score_spread":0.23926175864319368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182621217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921755,0.004258746,0.000019834177,0.00068906764,0.00024552573,0.0022380976,0.00017120692,0.000019901508,0.00018208734],"genre_scores_gemma":[0.9965805,0.00013895589,0.000082975894,0.0003232931,0.000018698725,0.00021441218,0.000021332638,0.000020573647,0.002599296],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989684,0.000040350104,0.00028900488,0.00020842168,0.00026973675,0.00022403624],"domain_scores_gemma":[0.99921334,0.00010732952,0.00011470169,0.00045395945,0.000052942345,0.000057755322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017229404,0.00012724624,0.00021232334,0.00004510332,0.00004113196,0.000015709476,0.000086369364,0.000027197437,0.0000871376],"category_scores_gemma":[0.000120261095,0.0000800752,0.00017489662,0.00007842997,0.000045058554,0.000103302176,0.000054708726,0.00006118583,0.0000072166345],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075656804,0.0012999784,0.098741755,0.0012232215,0.00011413948,0.000006000126,0.0032101427,0.0004763358,0.0005029901,0.00053053314,0.0109741045,0.8753551],"study_design_scores_gemma":[0.013924617,0.0017211222,0.7448102,0.0052582286,0.00026821558,0.0000094008365,0.0013534004,0.22983143,0.0005550302,0.0019107346,0.00013281588,0.0002247987],"about_ca_topic_score_codex":0.00004163028,"about_ca_topic_score_gemma":0.000009678048,"teacher_disagreement_score":0.8751303,"about_ca_system_score_codex":0.000025038245,"about_ca_system_score_gemma":0.00006783786,"threshold_uncertainty_score":0.3265372},"labels":[],"label_agreement":null},{"id":"W3183560558","doi":"10.1136/annrheumdis-2021-220679","title":"Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System","year":2021,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Natural Science Foundation of China","keywords":"Medicine; Adverse Event Reporting System; Pharmacovigilance; Pandemic; Population; Cohort; Adverse effect; Family medicine; Health care; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Environmental health","score_opus":0.23390414969073714,"score_gpt":0.4590180344291402,"score_spread":0.22511388473840305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183560558","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40877616,0.014777668,0.00082307024,0.56231254,0.0004908131,0.006630398,0.0046516974,0.00026316574,0.0012744457],"genre_scores_gemma":[0.2814525,0.000103135186,0.00012313049,0.71629226,0.00019825241,0.00024350875,0.00127277,0.000093745475,0.0002206648],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9942295,0.0008325745,0.0018583267,0.0010442548,0.0015570958,0.00047827046],"domain_scores_gemma":[0.99076146,0.0013390644,0.0024177982,0.005059669,0.00028497376,0.0001370446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024639997,0.0004728837,0.0018341385,0.00046443663,0.00029995476,0.00016673826,0.0018548265,0.0002505227,0.00007734725],"category_scores_gemma":[0.006851509,0.00031711653,0.00087399513,0.0009262509,0.0003232115,0.00016400852,0.0023556252,0.0006003743,0.000007800861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020898099,0.0024399767,0.34168202,0.06480915,0.043838378,0.007638075,0.0014565752,0.00057746633,0.00009989218,0.000044618224,0.5246334,0.010690632],"study_design_scores_gemma":[0.012500921,0.0012760038,0.3461557,0.065014586,0.04928394,0.00034123965,0.013081521,0.2397573,0.0013099652,0.0009924236,0.266455,0.0038313859],"about_ca_topic_score_codex":0.003321983,"about_ca_topic_score_gemma":0.00007854263,"teacher_disagreement_score":0.25817838,"about_ca_system_score_codex":0.00014326317,"about_ca_system_score_gemma":0.0025274456,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W3185322589","doi":"10.1136/annrheumdis-2021-220546","title":"Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis","year":2021,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Commission; H2020 European Research Council; Arthritis Society; ReumaNederland; Dutch Arthritis Society","keywords":"Medicine; Autoantibody; Asymptomatic; Rheumatoid arthritis; Immunology; Rheumatoid factor; Arthritis; Population; Human leukocyte antigen; Internal medicine; Antibody; Antigen","score_opus":0.06555753773651345,"score_gpt":0.34715403119304417,"score_spread":0.2815964934565307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185322589","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16905823,0.82853734,0.0000030067733,0.00018618203,0.00010931038,0.001763906,0.0002374357,0.000025707335,0.000078894096],"genre_scores_gemma":[0.11019064,0.8889499,0.00006233353,0.000047636993,0.000018180963,0.0005174178,0.00010358396,0.0000812055,0.000029149776],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99478924,0.0012435918,0.0018353141,0.0005608416,0.0009343288,0.0006366778],"domain_scores_gemma":[0.99457926,0.002954688,0.00089646113,0.0010844705,0.00024126685,0.00024384452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014484739,0.00068215217,0.0033500877,0.000320717,0.00026625916,0.00012517915,0.000640014,0.0001838564,0.00024336566],"category_scores_gemma":[0.0031991063,0.0003791891,0.00071109337,0.000604673,0.0003402281,0.00014690412,0.00048091103,0.00052070373,0.0000052163687],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006513265,0.00024838175,0.0008323673,0.010214701,0.0008333151,0.000019455505,0.0018744494,0.0000015657716,0.0000029274,0.00009990969,0.00029422276,0.98551357],"study_design_scores_gemma":[0.0023371992,0.0007014294,0.005576286,0.8191068,0.000057164285,0.00013102108,0.0011767872,0.000039913084,0.0005157189,0.00017402695,0.16942826,0.00075538945],"about_ca_topic_score_codex":0.000045380173,"about_ca_topic_score_gemma":0.00020728246,"teacher_disagreement_score":0.9847582,"about_ca_system_score_codex":0.000040052197,"about_ca_system_score_gemma":0.0010255023,"threshold_uncertainty_score":0.999866},"labels":[],"label_agreement":null},{"id":"W3188233590","doi":"10.1136/annrheumdis-2021-220043","title":"Preclinical models of arthritis for studying immunotherapy and immune tolerance","year":2021,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Janssen Biotech; Arthritis Queensland; China Medical University Hospital; Innovative Medicines Initiative; Universität Wien; Juvenile Diabetes Research Foundation Australia; National Health and Medical Research Council; Medizinische Universität Wien; European Commission; European Federation of Pharmaceutical Industries and Associations; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Autoimmunity; Disease; Arthritis; Immunotherapy; Immunology; Rheumatoid arthritis; Immune system; Autoimmune disease; Autoantibody; Antibody; Pathology","score_opus":0.11142410849942593,"score_gpt":0.3568920645400439,"score_spread":0.245467956040618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188233590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024866278,0.99501956,0.00005058673,0.00008413689,0.0006335683,0.0011407605,0.0005145412,0.00002021942,0.000050029957],"genre_scores_gemma":[0.012842015,0.9861143,0.000052451,0.00004540746,0.000013912536,0.00020857003,0.00013292924,0.00004381977,0.00054659334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969806,0.0006662573,0.0015449297,0.0003912824,0.00006220361,0.00035471577],"domain_scores_gemma":[0.9961089,0.0016024095,0.0012065154,0.00087343866,0.00018596595,0.000022762968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039600232,0.00039990176,0.0029661788,0.00008719559,0.00016325485,0.000014922192,0.0006777416,0.00037038932,0.000115514194],"category_scores_gemma":[0.0002892451,0.00026769578,0.0013322425,0.0001497934,0.00063478714,0.000078843455,0.00029604195,0.00026459649,0.000006989859],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080205034,0.00058240787,0.000005712938,0.007888589,0.0022647236,6.226049e-7,0.00015053783,0.000005585472,0.00040108414,0.0011104001,0.00077467994,0.98673546],"study_design_scores_gemma":[0.007928366,0.0015530541,0.00018167571,0.22188361,0.0045137955,0.00023339364,0.00071574596,0.000039896426,0.006087826,0.015167696,0.73964244,0.0020525113],"about_ca_topic_score_codex":0.000036906175,"about_ca_topic_score_gemma":0.0000021364365,"teacher_disagreement_score":0.9846829,"about_ca_system_score_codex":0.000006938199,"about_ca_system_score_gemma":0.0002620794,"threshold_uncertainty_score":0.9999775},"labels":[],"label_agreement":null},{"id":"W3190234011","doi":"10.1136/annrheumdis-2021-220884","title":"EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"European League Against Rheumatism; Medical Research Council; National Institute for Health and Care Research; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Observational study; Rheumatoid arthritis; Rheumatism; Clinical trial; Arthritis; Physical therapy; Inflammatory arthritis; Systematic review; Rheumatology; Internal medicine; Intensive care medicine; MEDLINE","score_opus":0.5203553419012159,"score_gpt":0.5149001395104645,"score_spread":0.005455202390751368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190234011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.913713,0.078141205,0.000012246163,0.0064794444,0.00017457701,0.00091873424,0.00053628633,0.0000098338505,0.000014709832],"genre_scores_gemma":[0.8217955,0.17638148,0.0010737901,0.0005495468,0.000023976834,0.00009083619,0.000025998977,0.000016206099,0.0000426094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959875,0.0012993509,0.0016858461,0.0002779644,0.00047636256,0.00027299224],"domain_scores_gemma":[0.9885959,0.00941599,0.0006531701,0.00038758287,0.00073020393,0.0002171619],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0048260386,0.00016190005,0.0014585059,0.00010800465,0.00012477979,0.000020034568,0.0001158947,0.000056779227,0.0001141538],"category_scores_gemma":[0.09329857,0.00011418171,0.00040354716,0.00022882037,0.00047451336,0.000112753536,0.00024533478,0.00010998334,0.0000033145068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062826445,0.0007737031,0.90179884,0.0009081835,0.0029096596,0.000010959174,0.0025517833,0.000024664716,0.0003596984,0.0023716544,0.02430565,0.06335692],"study_design_scores_gemma":[0.01297526,0.0007101804,0.89552593,0.017583057,0.0000902843,0.00009333432,0.00804565,0.00013939574,0.013958137,0.047189634,0.0033087754,0.00038037074],"about_ca_topic_score_codex":0.000029993887,"about_ca_topic_score_gemma":0.000054475837,"teacher_disagreement_score":0.09824028,"about_ca_system_score_codex":0.000012168182,"about_ca_system_score_gemma":0.00029933426,"threshold_uncertainty_score":0.91433895},"labels":[],"label_agreement":null},{"id":"W3193111611","doi":"10.1136/annrheumdis-2021-221014","title":"Response to: Correspondence on “New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE” by Pons-Estel et al","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Department of Medicine, University of Toronto; University of Toronto; Ikaria","keywords":"Medicine; Rheumatism; Internal medicine; Rheumatology; Cohort","score_opus":0.07005680633348943,"score_gpt":0.3928812580207338,"score_spread":0.3228244516872444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193111611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9401165,0.0023610715,0.000053962412,0.05595914,0.00036135392,0.0005925081,0.00016261311,0.00003300068,0.00035985545],"genre_scores_gemma":[0.9865131,0.0003703476,0.00014621211,0.0057521346,0.000010270495,0.000045944096,0.000041966483,0.000033803983,0.0070862714],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9963793,0.0012575923,0.000616932,0.00041488258,0.0009491466,0.00038210893],"domain_scores_gemma":[0.9959762,0.0021126706,0.00021076835,0.0010889713,0.00027297554,0.0003384035],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016013151,0.00020594338,0.0005247537,0.00019978784,0.000077190496,0.00005803652,0.00035918748,0.00007397172,0.00021449903],"category_scores_gemma":[0.011490638,0.00015850556,0.00018527947,0.0006158848,0.00008715847,0.00012808644,0.00021420704,0.0002066352,0.00020598232],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063590333,0.0008899444,0.053778317,0.00047390306,0.00010927227,0.000057170448,0.0017887423,0.000032279375,0.028605705,0.00041461282,0.90427935,0.0032116817],"study_design_scores_gemma":[0.0061780126,0.0009973841,0.9015178,0.026367927,0.00017973084,0.0010632601,0.0055168625,0.002187188,0.0396237,0.0015299208,0.01407367,0.0007645132],"about_ca_topic_score_codex":0.00014459583,"about_ca_topic_score_gemma":0.000015086197,"teacher_disagreement_score":0.8902057,"about_ca_system_score_codex":0.00009092032,"about_ca_system_score_gemma":0.0009911992,"threshold_uncertainty_score":0.996836},"labels":[],"label_agreement":null},{"id":"W3193847211","doi":"10.1136/annrheumdis-2021-eular.2612","title":"OP0276-PARE CREATING POLITICAL LEVERS TO IMPROVE AXIAL SPONDYLOARTHRITIS CARE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Spondylitis Association of America; Janssen Canada; Teva Pharmaceutical Industries; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Medicine; Nice; Excellence; Guideline; Axial spondyloarthritis; Hydrotherapy; Health care; Family medicine; Public administration; Alternative medicine; Political science; Law; Surgery; Pathology","score_opus":0.02824245260928576,"score_gpt":0.31775321780309146,"score_spread":0.2895107651938057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193847211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449403,0.005937568,0.0000054984043,0.003972561,0.00034282845,0.00048304477,0.0007029511,0.000034573502,0.0040269424],"genre_scores_gemma":[0.9971981,0.00019790785,0.00025359346,0.0014413783,0.00009944438,0.00006070623,0.00006455181,0.000026797286,0.00065752375],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843115,0.00006547831,0.00034550464,0.00029088606,0.00041616563,0.00045083102],"domain_scores_gemma":[0.99848807,0.00013185923,0.000083767416,0.00055664417,0.0003740994,0.0003655587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043792894,0.00019463777,0.0004692118,0.000046019723,0.00020318953,0.00002908378,0.00012824927,0.000044446322,0.0002676566],"category_scores_gemma":[0.0013515719,0.00014562308,0.00037196642,0.0002216823,0.00011597336,0.000046004945,0.00023242297,0.00007184087,0.000034962042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026446255,0.0054513994,0.3620074,0.00595356,0.004948418,0.0018405238,0.010467283,0.00007615432,0.0021659129,0.028222188,0.040102944,0.5361196],"study_design_scores_gemma":[0.009515415,0.001809961,0.90174156,0.008359437,0.0012158945,0.00024052785,0.031155111,0.000031401974,0.036702674,0.0024799139,0.00598153,0.00076654105],"about_ca_topic_score_codex":0.00021359643,"about_ca_topic_score_gemma":0.00005521248,"teacher_disagreement_score":0.5397342,"about_ca_system_score_codex":0.000037754107,"about_ca_system_score_gemma":0.00022748085,"threshold_uncertainty_score":0.5938337},"labels":[],"label_agreement":null},{"id":"W3196356596","doi":"10.1136/annrheumdis-2021-221244","title":"Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases","year":2021,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Bristol-Myers Squibb Canada; School of Medicine, Oregon Health and Science University; Pfizer","keywords":"Medicine; Immunogenicity; Immunology; Rituximab; Vaccination; Abatacept; Adalimumab; Rheumatoid arthritis; Immune system; Antibody","score_opus":0.0244854454438713,"score_gpt":0.34771083720148604,"score_spread":0.3232253917576147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196356596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.452869,0.5450978,6.100427e-7,0.00002949876,0.000045265115,0.0014653096,0.00046116317,0.000020454207,0.000010879969],"genre_scores_gemma":[0.31945923,0.68003243,0.000009668228,0.000011168566,0.000010996755,0.00011872058,0.00026108275,0.00008443797,0.000012282094],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945991,0.00081998267,0.0018591409,0.00062267337,0.001399451,0.00069965655],"domain_scores_gemma":[0.99493396,0.0010773339,0.0013392139,0.0016022498,0.0004079388,0.00063928246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003579136,0.0008963488,0.004099938,0.00062744366,0.00015114709,0.0000717737,0.00055928016,0.00013895449,0.00016469008],"category_scores_gemma":[0.0017626886,0.0005116001,0.001945222,0.0008060901,0.00044166882,0.0002698915,0.00035373747,0.0004349533,0.000008708655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013708058,0.003657715,0.13176294,0.10241209,0.0046233493,0.000020829078,0.00029735436,0.000029519928,1.2587618e-7,0.00013657594,0.00039843287,0.75529027],"study_design_scores_gemma":[0.005038376,0.0012679704,0.67688423,0.31422144,0.0010400036,0.000009384941,0.00010185922,0.00005353556,7.974081e-7,0.0002088467,0.0004969008,0.000676657],"about_ca_topic_score_codex":0.00010269747,"about_ca_topic_score_gemma":0.0000050410486,"teacher_disagreement_score":0.75461364,"about_ca_system_score_codex":0.00010964188,"about_ca_system_score_gemma":0.0014255488,"threshold_uncertainty_score":0.99973357},"labels":[],"label_agreement":null},{"id":"W3200243625","doi":"10.1136/annrheumdis-2021-221374","title":"Response to: Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance” by Bossuyt et al","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatism; Rheumatology; League; Internal medicine; Anti-nuclear antibody; Dermatology; Physical therapy; Family medicine; Immunology; Antibody; Autoantibody","score_opus":0.0490248560898783,"score_gpt":0.3558301703112239,"score_spread":0.3068053142213456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200243625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97143435,0.0009017196,0.000052669515,0.024931895,0.00035901504,0.0007804998,0.0006621087,0.0000555918,0.00082215236],"genre_scores_gemma":[0.99239016,0.00184964,0.00014843741,0.0033822977,0.0000049366886,0.00006631205,0.000069737944,0.000066942586,0.0020215304],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99421144,0.0024885728,0.0011808333,0.0005068198,0.0011250967,0.00048725135],"domain_scores_gemma":[0.994551,0.0022144897,0.00067319203,0.0015494009,0.0006528152,0.00035908396],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001989715,0.00031383266,0.0009994486,0.00027352272,0.00014299103,0.000027734173,0.00063474954,0.00005903869,0.00016934448],"category_scores_gemma":[0.008579832,0.00023882711,0.00029460684,0.000897133,0.0004794686,0.00013861405,0.0002970103,0.00023119559,0.00012829067],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010279018,0.0021254043,0.114132,0.003669179,0.0006735169,0.000081427206,0.0036899338,0.0000855033,0.053731453,0.0008201905,0.79106915,0.0196432],"study_design_scores_gemma":[0.00933654,0.004501083,0.7651086,0.07158468,0.000342044,0.0041249036,0.02220483,0.015497065,0.06971113,0.00025773846,0.03565002,0.0016813772],"about_ca_topic_score_codex":0.00004234278,"about_ca_topic_score_gemma":0.0000050482276,"teacher_disagreement_score":0.75541914,"about_ca_system_score_codex":0.000074188276,"about_ca_system_score_gemma":0.0006510368,"threshold_uncertainty_score":0.9997713},"labels":[],"label_agreement":null},{"id":"W3202510981","doi":"10.1136/annrheumdis-2021-220920","title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Placebo; Internal medicine; Clinical endpoint; Rituximab; Lupus nephritis; CD20; Gastroenterology; Surgery; Clinical trial; Lymphoma; Pathology","score_opus":0.05956355332456594,"score_gpt":0.3332283862371711,"score_spread":0.2736648329126052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202510981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95815706,0.007602816,0.00009432258,0.0015216897,0.00031397748,0.03190565,0.00012101123,0.000025359286,0.0002581255],"genre_scores_gemma":[0.9750201,0.00074298994,0.00003760798,0.00007185366,0.00008308183,0.021447087,0.000029287767,0.00003796052,0.0025300093],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972131,0.0004710296,0.00077104213,0.0002515517,0.0009784801,0.00031476674],"domain_scores_gemma":[0.9959529,0.0022505685,0.00063536933,0.00071159634,0.00033166228,0.00011789377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070541725,0.00023946188,0.0010907935,0.000119116456,0.0003281027,0.000025635085,0.0003239088,0.000035532918,0.0001417071],"category_scores_gemma":[0.00034605,0.000108860964,0.0007450667,0.00027398326,0.00018739379,0.000054501863,0.00006301051,0.00008601387,0.000002152207],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9873604,0.0020410956,0.0004168964,0.00073328475,0.0017003368,0.0000034310885,0.0024948854,0.00059371005,0.000027774911,0.00012656121,0.0035428964,0.0009586865],"study_design_scores_gemma":[0.98489755,0.005858291,0.000019989915,0.00049215084,0.0012073008,0.00021059408,0.0033712762,0.0022578642,0.0009833815,0.00020785298,0.00037928607,0.000114473376],"about_ca_topic_score_codex":0.000114100374,"about_ca_topic_score_gemma":0.000012398821,"teacher_disagreement_score":0.016863074,"about_ca_system_score_codex":0.00018127257,"about_ca_system_score_gemma":0.0010639671,"threshold_uncertainty_score":0.44392213},"labels":[],"label_agreement":null},{"id":"W3205730800","doi":"10.1136/annrheumdis-2018-eular.7223","title":"FRI0170 Consensus definitions for mri lesions in the sacroiliac joints of patients with axial spondyloarthritis: first analysis from the assessments in spondyloarthritis international society (ASAS) classification cohort","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Cohort; Radiology; Lesion; DICOM; Magnetic resonance imaging; Nuclear medicine; Internal medicine; Pathology; Sacroiliitis","score_opus":0.05565857231654359,"score_gpt":0.32174971107267053,"score_spread":0.26609113875612694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205730800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885047,0.00064592797,0.000047170874,0.004093577,0.0001583578,0.0013877213,0.0048131393,0.000010488083,0.00033893608],"genre_scores_gemma":[0.99694747,0.0010865818,0.00043850887,0.00035988685,0.000042312553,0.0003299423,0.0007571322,0.000016285492,0.000021856275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794877,0.00014785625,0.00069135835,0.0003075746,0.00063787895,0.00026659478],"domain_scores_gemma":[0.99740624,0.0010139886,0.00043500337,0.0006209182,0.00046354678,0.0000603157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033003182,0.00021155238,0.0005295404,0.00011452661,0.0003228633,0.00003295788,0.00034525312,0.00006215579,0.00012289837],"category_scores_gemma":[0.00047223698,0.0001189269,0.0004563071,0.000705472,0.00063462934,0.000087930064,0.00008800917,0.00011226986,0.000004991029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006330519,0.0017361017,0.9841374,0.0000384,0.001767944,0.000003366764,0.0010682861,0.000018432233,0.000003550592,0.00039201425,0.0051663266,0.0050351107],"study_design_scores_gemma":[0.004175036,0.0002998836,0.9897456,0.0008772311,0.0008822448,0.0000017059751,0.0019879418,0.00040470247,0.000028224173,0.0010770294,0.00041419495,0.000106164385],"about_ca_topic_score_codex":0.0006708266,"about_ca_topic_score_gemma":0.0030693328,"teacher_disagreement_score":0.008442813,"about_ca_system_score_codex":0.000048455084,"about_ca_system_score_gemma":0.00013366845,"threshold_uncertainty_score":0.48496982},"labels":[],"label_agreement":null},{"id":"W3214061818","doi":"10.1136/annrheumdis-2021-221653","title":"Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment","year":2021,"lang":"en","type":"editorial","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Manchester Biomedical Research Centre; National Institutes of Health","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Internal medicine; Rheumatism; Physical therapy; Disease; MEDLINE; Family medicine","score_opus":0.09859369144610118,"score_gpt":0.3375600665082895,"score_spread":0.23896637506218832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214061818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89034575,0.06381433,0.00003803398,0.004835138,0.033962317,0.0031777,0.0031886916,0.00007767393,0.0005603401],"genre_scores_gemma":[0.927146,0.06835004,0.00015002354,0.000099046694,0.0034152577,0.00056099123,0.00019656941,0.00005866304,0.00002338321],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9951219,0.00084494165,0.00093711505,0.0006513769,0.0018253174,0.00061937794],"domain_scores_gemma":[0.9957231,0.0013828041,0.0007183893,0.0010783406,0.0005542422,0.00054308615],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005939073,0.00053084973,0.0011552246,0.00014059289,0.00041963565,0.00020128468,0.000299851,0.00021409408,0.00009059719],"category_scores_gemma":[0.009305606,0.0003508521,0.00037922402,0.00037915874,0.0006664597,0.00026295456,0.0006124281,0.00086151046,0.0000031861741],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035508554,0.0056346417,0.019602388,0.005791941,0.0026120003,0.00069747516,0.002211426,0.00008846041,0.0003399913,0.0017260133,0.65112203,0.30662274],"study_design_scores_gemma":[0.017545262,0.0029719996,0.39278555,0.4698257,0.00033797635,0.00014052272,0.0155764045,0.0016237089,0.002814566,0.043858577,0.049018845,0.003500874],"about_ca_topic_score_codex":0.0005338775,"about_ca_topic_score_gemma":0.00019687922,"teacher_disagreement_score":0.60210323,"about_ca_system_score_codex":0.00016210573,"about_ca_system_score_gemma":0.002753414,"threshold_uncertainty_score":0.9998943},"labels":[],"label_agreement":null},{"id":"W3215913585","doi":"10.1136/annrheumdis-2021-221635","title":"Impact of adiposity on risk of female gout among those genetically predisposed: sex-specific prospective cohort study findings over >32 years","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Canadian Institutes of Health Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Rheumatology Research Foundation","keywords":"Medicine; Gout; Body mass index; Internal medicine; Prospective cohort study; Genetic predisposition; Cohort study; Relative risk; Single-nucleotide polymorphism; Obesity; Risk factor; Cohort; Demography; Genotype; Genetics; Confidence interval; Disease; Gene; Biology","score_opus":0.02238211637896925,"score_gpt":0.31100343634838595,"score_spread":0.2886213199694167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215913585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961098,0.0012248259,0.000009161877,0.000030324525,0.000080837286,0.001631885,0.0004031292,0.000026389076,0.00048368657],"genre_scores_gemma":[0.99897486,0.00048986915,0.000080764716,0.00002675532,0.000028129989,0.000040182087,0.000016740634,0.00003896006,0.00030376698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972159,0.0002890165,0.0007291789,0.00042785017,0.0010250835,0.0003129371],"domain_scores_gemma":[0.9972191,0.0003917699,0.00052490644,0.0012678745,0.00037031004,0.00022602375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004421725,0.00027609908,0.00093201554,0.0001088504,0.00006514845,0.000017282451,0.0003327296,0.00008604386,0.00033165366],"category_scores_gemma":[0.0012487074,0.00019194261,0.0006435407,0.00045560132,0.00031945325,0.00008981938,0.0002217204,0.00021094021,0.000009802568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048120244,0.004162999,0.98671544,0.00023044064,0.0027727622,0.000021837332,0.0025974186,0.00016243003,0.00049399247,0.0000244569,0.0009281932,0.0014088444],"study_design_scores_gemma":[0.0014015945,0.0011729549,0.9898884,0.0008484981,0.0013345225,0.000005530878,0.000520548,0.00012940554,0.0043178773,0.00021906549,0.0000033048614,0.00015829413],"about_ca_topic_score_codex":0.0002775589,"about_ca_topic_score_gemma":0.000009908618,"teacher_disagreement_score":0.003823885,"about_ca_system_score_codex":0.00007006008,"about_ca_system_score_gemma":0.0002808909,"threshold_uncertainty_score":0.78271925},"labels":[],"label_agreement":null},{"id":"W3216085374","doi":"10.1136/annrheumdis-2021-221780","title":"Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients' by Liu","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"thermodynamics and calorimetric analyses","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Calgary","funders":"","keywords":"Mosaic; Bioaccumulation; Coronavirus disease 2019 (COVID-19); Computer science; Medicine; Risk analysis (engineering); Computational biology; Biology; Ecology; Pathology","score_opus":0.01866239352135139,"score_gpt":0.30622610056334804,"score_spread":0.28756370704199663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216085374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367243,0.0016501995,0.000065879394,0.002729043,0.00004031361,0.00010742505,0.0012095222,0.000013559357,0.00051164237],"genre_scores_gemma":[0.9933463,0.00052480365,0.00004135587,0.00572678,0.000006638572,0.000009085794,0.000009281057,0.000018106939,0.00031768813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985443,0.00024172495,0.00031919777,0.0003296867,0.00032528423,0.00023983407],"domain_scores_gemma":[0.9968146,0.0021676605,0.00011203677,0.00034770853,0.00030100555,0.00025695894],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00021843967,0.0001907381,0.000396712,0.00008426722,0.000099883655,0.000056734123,0.00019193607,0.00005711415,0.00012870054],"category_scores_gemma":[0.013641614,0.00014522667,0.000112082096,0.0003298032,0.00028952697,0.00006354421,0.00019571488,0.00009295017,0.0000039858596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026394593,0.0060828486,0.8104453,0.0028972677,0.0024481637,0.00017810355,0.012585846,0.0005178999,0.029729705,0.012699126,0.03283339,0.06318774],"study_design_scores_gemma":[0.004583536,0.0005395713,0.89736867,0.0045231106,0.00042497355,0.00001985824,0.0070987,0.0019625432,0.06642226,0.011561277,0.00414331,0.0013521853],"about_ca_topic_score_codex":0.00021671975,"about_ca_topic_score_gemma":0.000009632078,"teacher_disagreement_score":0.08692335,"about_ca_system_score_codex":0.000027198972,"about_ca_system_score_gemma":0.0001280491,"threshold_uncertainty_score":0.9946669},"labels":[],"label_agreement":null},{"id":"W3217287927","doi":"10.1136/annrheumdis-2021-221048","title":"Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Placebo; Psoriatic arthritis; Internal medicine; Clinical endpoint; Rheumatology; Adverse effect; Psoriasis; Arthritis; Gastroenterology; Randomized controlled trial; Immunology; Pathology","score_opus":0.08340259515540617,"score_gpt":0.3537105301345444,"score_spread":0.27030793497913824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217287927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706894,0.01840205,0.000017536357,0.0035529286,0.00043970687,0.003544067,0.0031175208,0.00001603244,0.00022073166],"genre_scores_gemma":[0.98979855,0.009099275,0.000093036346,0.00019907775,0.000129256,0.0002528235,0.00028869975,0.000021698314,0.00011759602],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981028,0.00016116297,0.000826047,0.00030089953,0.0003701267,0.00023897023],"domain_scores_gemma":[0.9957047,0.0027853504,0.0005105209,0.00062021427,0.00025732451,0.000121869336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023561911,0.0002171702,0.00086849893,0.000029916073,0.00022728063,0.000024007515,0.00014553756,0.00005343189,0.00006860792],"category_scores_gemma":[0.0027893656,0.00012580877,0.00046671546,0.000172883,0.00024404818,0.00006976908,0.00010728238,0.00008078569,0.000002422079],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8356664,0.0030666555,0.000026800515,0.00011539655,0.0022985518,0.000010579906,0.0011553374,0.000005719477,0.000011996685,0.00011569837,0.0028965392,0.15463032],"study_design_scores_gemma":[0.9839532,0.0012896728,0.004921283,0.002291827,0.0014608668,0.000007928114,0.0012243147,0.00004085649,0.0023637773,0.0016074397,0.0007046513,0.00013421335],"about_ca_topic_score_codex":0.00015268146,"about_ca_topic_score_gemma":0.000053874894,"teacher_disagreement_score":0.1544961,"about_ca_system_score_codex":0.000012850406,"about_ca_system_score_gemma":0.00019461093,"threshold_uncertainty_score":0.5130333},"labels":[],"label_agreement":null},{"id":"W4200136537","doi":"10.1136/annrheumdis-2021-221575","title":"Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations","year":2021,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Vaccination; Rituximab; Internal medicine; Incidence (geometry); Observational study; Immunology; Physical therapy","score_opus":0.05505384058821546,"score_gpt":0.39280010580540237,"score_spread":0.3377462652171869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200136537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027006565,0.96629846,0.000009555527,0.0007014808,0.000070953254,0.0054235607,0.00043942122,0.000025793026,0.000024219764],"genre_scores_gemma":[0.007324508,0.9911741,0.00007509173,0.00020117876,0.000011522999,0.00088699686,0.0002711159,0.000047462345,0.0000080367445],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99579376,0.0010720507,0.0018128812,0.00043138463,0.00056271383,0.0003271864],"domain_scores_gemma":[0.9968037,0.0007751437,0.0011543577,0.00066107156,0.00043177922,0.00017396327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009379256,0.0005168259,0.0031915763,0.0006145689,0.000159953,0.00013947648,0.00019004458,0.00014432304,0.000008898813],"category_scores_gemma":[0.006030036,0.00034150548,0.00060208753,0.0013061715,0.00013263461,0.00039231966,0.00027638001,0.000316259,0.0000029587038],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011330336,0.00023770513,0.00042043166,0.56004524,0.00055292645,0.0000036294257,0.0003015391,1.0281891e-7,0.0000012914977,0.00007169654,0.0010079293,0.4373462],"study_design_scores_gemma":[0.0006975853,0.00024202715,0.0024013508,0.9860144,0.0012699752,0.00008450314,0.00009188535,0.00006698695,0.000016960274,0.00020071495,0.008579966,0.0003336003],"about_ca_topic_score_codex":0.00006167509,"about_ca_topic_score_gemma":0.00004979985,"teacher_disagreement_score":0.43701258,"about_ca_system_score_codex":0.00004736104,"about_ca_system_score_gemma":0.00026071575,"threshold_uncertainty_score":0.9999037},"labels":[],"label_agreement":null},{"id":"W4200253425","doi":"10.1136/annrheumdis-2021-221840","title":"Hypoglycaemia following JAK inhibitor treatment in patients with diabetes","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.007579392465843907,"score_gpt":0.22774201980985256,"score_spread":0.22016262734400865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200253425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975083,0.00176236,5.938597e-7,0.000246486,0.000072418465,0.00014629014,0.00005964434,0.000004210418,0.00019970043],"genre_scores_gemma":[0.99933046,0.000091364185,0.000020522431,0.00021745957,0.000010162712,0.000022039447,0.00011031286,0.000013427289,0.00018427747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992487,0.00006212778,0.00017067092,0.00016766922,0.00014581643,0.00020503333],"domain_scores_gemma":[0.9994935,0.000024201834,0.00009359543,0.00027744065,0.0000602588,0.00005100577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003898846,0.00012044174,0.00018474733,0.000018056002,0.000040010887,0.000017039285,0.00011207354,0.000038781123,0.000010128684],"category_scores_gemma":[0.00017251744,0.00007788064,0.0001857106,0.00012036704,0.000035011828,0.000005498821,0.00006525159,0.000020901953,0.0000017851252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031991272,0.0008512711,0.9831927,0.00003966207,0.00032939747,7.5668225e-7,0.000039375318,0.00009613258,0.0004921909,0.000010607511,0.0010620973,0.013853815],"study_design_scores_gemma":[0.002252971,0.00037524008,0.9571224,0.00045062866,0.00010211304,3.520971e-8,0.00017760506,0.000018870915,0.038311712,0.0002931254,0.0006696992,0.00022560754],"about_ca_topic_score_codex":0.000012755621,"about_ca_topic_score_gemma":0.000025538338,"teacher_disagreement_score":0.03781952,"about_ca_system_score_codex":0.00000799874,"about_ca_system_score_gemma":0.00009073694,"threshold_uncertainty_score":0.31758803},"labels":[],"label_agreement":null},{"id":"W4200318327","doi":"10.1136/annrheumdis-2021-221019","title":"Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Double blind; Internal medicine; Psoriasis; Physical therapy; Arthritis; Dermatology; Alternative medicine; Placebo; Pathology","score_opus":0.08568492154785824,"score_gpt":0.35424744896581456,"score_spread":0.26856252741795633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200318327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708709,0.018144757,0.00001787355,0.003568412,0.00043733872,0.0035488117,0.0031795732,0.000016032052,0.00021630921],"genre_scores_gemma":[0.9900071,0.008888163,0.00009483974,0.00019896177,0.0001275109,0.0002570707,0.00028746235,0.000021713708,0.00011718982],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981027,0.00016121141,0.00082571787,0.0003010998,0.00037020873,0.00023904833],"domain_scores_gemma":[0.99566835,0.0028207286,0.0005098936,0.00062128087,0.0002578369,0.00012188666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023676745,0.00021723154,0.0008683102,0.000029933482,0.00022726585,0.000023961324,0.00014560955,0.000053431613,0.000069776994],"category_scores_gemma":[0.0028195323,0.00012584531,0.0004667956,0.00017300245,0.00024405117,0.00006972664,0.00010729578,0.00008080222,0.0000024452672],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8384641,0.003075188,0.000027647526,0.00011476096,0.002304263,0.000010354936,0.0011573515,0.0000057093725,0.000012409024,0.000114203634,0.0029473545,0.1517667],"study_design_scores_gemma":[0.9838644,0.0012892669,0.0049916604,0.0023168114,0.0014653339,0.000007911198,0.0012353071,0.00004109374,0.0023764984,0.0015959073,0.00068134273,0.00013444157],"about_ca_topic_score_codex":0.0001513278,"about_ca_topic_score_gemma":0.00005359324,"teacher_disagreement_score":0.15163226,"about_ca_system_score_codex":0.000012847137,"about_ca_system_score_gemma":0.00019538337,"threshold_uncertainty_score":0.5131823},"labels":[],"label_agreement":null},{"id":"W4200559094","doi":"10.1136/annrheumdis-2021-221295","title":"Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Toronto Western Hospital; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre; McGill University; University of Calgary; McGill University Health Centre","funders":"Niilo Helanderin Säätiö; National Center for Chronic Disease Prevention and Health Promotion; Fonds de Recherche du Québec - Santé; Centers for Disease Control and Prevention; McGill University Health Centre; National Institutes of Health; National Center for Research Resources; Versus Arthritis; Novo Nordisk Fonden; National Center for Advancing Translational Sciences; Institut de recherche, Centre universitaire de santé McGill; National Research Foundation of Korea; Eusko Jaurlaritza; Arthritis Research UK; Novo Nordisk; National Institute for Health and Care Research; Canadian Institutes of Health Research; Gigtforeningen; McGill University; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Wellcome; Lupus Research Alliance; Manchester Clinical Research Facility; Sandwell and West Birmingham Hospitals NHS Trust; Wellcome Trust; University of Calgary; Arthritis Society; Johns Hopkins University; National Research Foundation","keywords":"Medicine; Hydroxychloroquine; Systemic lupus; Discontinuation; Systemic lupus erythematosus; Cohort; Internal medicine; Dermatology; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.04544910492875849,"score_gpt":0.3477999124252471,"score_spread":0.3023508074964886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200559094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832547,0.0032073895,0.000042503103,0.010006683,0.0016004643,0.00094128906,0.0005746934,0.00004432901,0.00032797246],"genre_scores_gemma":[0.99321896,0.0016396854,0.000108361826,0.00024318155,0.00045299073,0.00016031248,0.00034475874,0.000028327651,0.0038034127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966026,0.0004911396,0.0011357977,0.00038676985,0.0011483583,0.0002353277],"domain_scores_gemma":[0.9961666,0.00096101605,0.00062575896,0.0010505149,0.0010790754,0.00011706665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089701096,0.00019345662,0.00046965596,0.000060466402,0.00015030826,0.00010622726,0.0003794786,0.00008506833,0.00027823207],"category_scores_gemma":[0.006864154,0.0001036669,0.00024023886,0.0005176056,0.00018686125,0.00021895902,0.0002373279,0.00016524794,0.000038276266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076522203,0.001184525,0.8829979,0.0013885829,0.0026692844,0.000085156076,0.011827214,0.00037680243,0.0014401152,0.00019051356,0.069040574,0.021147171],"study_design_scores_gemma":[0.020221598,0.00088873506,0.72983,0.087327406,0.0027963622,0.011697398,0.1054501,0.021669408,0.010117624,0.0033191089,0.005187373,0.0014948873],"about_ca_topic_score_codex":0.0001205462,"about_ca_topic_score_gemma":0.000062400446,"teacher_disagreement_score":0.15316784,"about_ca_system_score_codex":0.00008818431,"about_ca_system_score_gemma":0.0005631105,"threshold_uncertainty_score":0.8217529},"labels":[],"label_agreement":null},{"id":"W4205864345","doi":"10.1136/annrheumdis-2021-eular.1632","title":"OP0006 ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Research Canada","funders":"National Institutes of Health; National Institute for Health and Care Research; Medpace; Gilead Sciences; Sanofi; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Rheumatoid arthritis; Tocilizumab; Internal medicine; Abatacept; Rheumatology; Hydroxychloroquine; Logistic regression; Concomitant; Tofacitinib; TNF inhibitor; Adalimumab; Janus kinase inhibitor; Golimumab; Rituximab; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.1498753205652555,"score_gpt":0.4255400967280882,"score_spread":0.2756647761628327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205864345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8907084,0.006980562,0.0005586788,0.08273786,0.000117283686,0.0012605586,0.017552864,0.00006489618,0.000018890218],"genre_scores_gemma":[0.9626993,0.030632233,0.0005104404,0.0057231006,0.0000086072405,0.00007858136,0.000280325,0.000017999362,0.00004941406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940534,0.0019598026,0.0018820602,0.0005961098,0.0009944496,0.0005141735],"domain_scores_gemma":[0.93541855,0.059571266,0.0015567947,0.0017754538,0.0010465503,0.000631402],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020496277,0.00032359664,0.0015936542,0.00006674566,0.00019044049,0.000023533754,0.0006237311,0.00015687518,0.000248445],"category_scores_gemma":[0.48106495,0.0001776143,0.0004250664,0.0012356264,0.0014701319,0.00012062924,0.0005328133,0.0002762067,0.000005326271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067029,0.003377695,0.95220715,0.0022021122,0.0017258488,0.00011078811,0.0008535549,0.0036745656,0.000038787555,0.0006276696,0.024936235,0.0035427075],"study_design_scores_gemma":[0.009859937,0.00065650034,0.9686201,0.005843108,0.00028537377,0.000025925337,0.0012284068,0.0023746295,0.00032937876,0.0066554053,0.0036958044,0.00042541145],"about_ca_topic_score_codex":0.0128021175,"about_ca_topic_score_gemma":0.005572855,"teacher_disagreement_score":0.47901532,"about_ca_system_score_codex":0.00020222909,"about_ca_system_score_gemma":0.0050315084,"threshold_uncertainty_score":0.99377173},"labels":[],"label_agreement":null},{"id":"W4205937265","doi":"10.1136/annrheumdis-2021-221775","title":"Managing the selection of placebo group switched to experimental treatment group in post-randomised controlled trial extension studies","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Medicine; Placebo; Group (periodic table); Selection (genetic algorithm); Extension (predicate logic); Placebo group; Randomized controlled trial; Group selection; Physical therapy; Internal medicine; Alternative medicine; Pathology; Artificial intelligence","score_opus":0.4935344145570708,"score_gpt":0.49480026765006074,"score_spread":0.0012658530929899325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205937265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459595,0.0055721584,0.00006709952,0.0025649427,0.00035198012,0.0066907243,0.000017292712,0.0000041105786,0.00013570761],"genre_scores_gemma":[0.9972318,0.0001281607,0.00006008265,0.00030843678,0.000017973365,0.001700521,0.0000025690922,0.00000924508,0.0005412442],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98007745,0.011181563,0.0050948355,0.00047310424,0.002967375,0.00020569321],"domain_scores_gemma":[0.9868582,0.007680937,0.0034829492,0.0015203572,0.00038144144,0.00007611731],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.027095888,0.000254086,0.0032884832,0.00029559058,0.00030917485,0.00009884474,0.0010675872,0.000016351527,0.0012671463],"category_scores_gemma":[0.017147934,0.00009227565,0.0022163803,0.0010068399,0.00006797515,0.000108054366,0.00030323546,0.000057698173,0.000018599301],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7370921,0.011359134,0.004140712,0.0004423951,0.013885008,0.000011349285,0.037634123,0.031194478,0.0048959474,0.0030763205,0.04531991,0.11094852],"study_design_scores_gemma":[0.7595229,0.0062589054,0.019956334,0.0007968831,0.0037354915,0.000015721933,0.13413416,0.054958858,0.001612365,0.016863747,0.0012725199,0.0008720911],"about_ca_topic_score_codex":0.00008458932,"about_ca_topic_score_gemma":0.00003727766,"teacher_disagreement_score":0.11007643,"about_ca_system_score_codex":0.000060228085,"about_ca_system_score_gemma":0.000050195256,"threshold_uncertainty_score":0.9996458},"labels":[],"label_agreement":null},{"id":"W4210442342","doi":"10.1136/annrheumdis-2021-221814","title":"The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS","year":2022,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto; London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; Rosetrees Trust","keywords":"Medicine; Rheumatology; Intensive care medicine; Internal medicine","score_opus":0.06363053757514664,"score_gpt":0.3445272392866079,"score_spread":0.28089670171146125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210442342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021406984,0.9706673,0.000013387963,0.0005563594,0.00045843777,0.002437497,0.004405929,0.000009263429,0.0000448313],"genre_scores_gemma":[0.018614851,0.9802253,0.00008933002,0.000035155044,0.000001361501,0.00054803886,0.000080404214,0.000040030667,0.0003654795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967035,0.0011803051,0.0014363227,0.00029613855,0.00007248689,0.00031123418],"domain_scores_gemma":[0.9918632,0.005321539,0.001983858,0.00056814495,0.00022792141,0.000035374564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087143027,0.00031565668,0.001978079,0.0001291548,0.00023383676,0.0000071835384,0.0005905805,0.000092078975,0.00007047106],"category_scores_gemma":[0.002096163,0.00021220243,0.00045106225,0.00021435301,0.0010106071,0.000035358244,0.0005198885,0.00012720881,0.000002998376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019128221,0.0008258267,0.0028823698,0.06685132,0.013333286,0.000002231611,0.0014509867,0.0000029444118,0.000016916909,0.022784375,0.063685045,0.82625186],"study_design_scores_gemma":[0.0016651963,0.0016781875,0.0039788065,0.032971576,0.002671487,0.00007301824,0.003771533,0.000004097543,0.00036156998,0.0007023763,0.95154864,0.0005735225],"about_ca_topic_score_codex":0.000084018895,"about_ca_topic_score_gemma":0.000034549674,"teacher_disagreement_score":0.8878636,"about_ca_system_score_codex":0.000026114694,"about_ca_system_score_gemma":0.00023838028,"threshold_uncertainty_score":0.86533636},"labels":[],"label_agreement":null},{"id":"W4210800508","doi":"10.1136/annrheumdis-2017-211400","title":"2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Polymyositis; Dermatomyositis; Rheumatism; Conjoint analysis; Pairwise comparison; Physical therapy; Rheumatology; Core (optical fiber); Internal medicine; Statistics; Mathematics; Preference","score_opus":0.0335628972654723,"score_gpt":0.3462731883854805,"score_spread":0.3127102911200082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210800508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883538,0.0015826032,0.000044598124,0.0076309307,0.00015646456,0.0008473421,0.0011801989,0.00002620803,0.00017783903],"genre_scores_gemma":[0.9936261,0.0046115206,0.00071751984,0.00085097837,0.000013704606,0.00004919573,0.000014099814,0.00004851848,0.000068354406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969229,0.0006961299,0.0013624834,0.00037831385,0.00024956468,0.00039062425],"domain_scores_gemma":[0.9963971,0.0009950812,0.001114052,0.0009303171,0.00028619377,0.0002772491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091504294,0.00030164103,0.0012636475,0.00016641522,0.00035413535,0.000058781883,0.00035486263,0.0000900151,0.000010598726],"category_scores_gemma":[0.0026433186,0.00023261877,0.0002744267,0.00008545562,0.0015651607,0.00026566442,0.00030856306,0.0001351802,0.000002794697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03940788,0.0017683977,0.75115746,0.009962443,0.0015108739,0.00061994797,0.003272631,0.0000071582945,0.00094247155,0.004277217,0.06542494,0.12164856],"study_design_scores_gemma":[0.0046908897,0.00054879615,0.9818129,0.0070724287,0.00016052637,0.00042320174,0.0007171367,0.0025701926,0.0009212875,0.0006629,0.000117772994,0.0003019707],"about_ca_topic_score_codex":0.00025158227,"about_ca_topic_score_gemma":0.00003304668,"teacher_disagreement_score":0.23065542,"about_ca_system_score_codex":0.000010975527,"about_ca_system_score_gemma":0.00019454144,"threshold_uncertainty_score":0.94859177},"labels":[],"label_agreement":null},{"id":"W4211012592","doi":"10.1136/annrheumdis-2021-221478","title":"Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"AstraZeneca","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Internal medicine; Immunology; Lupus erythematosus; Antibody; Disease","score_opus":0.028401891279584687,"score_gpt":0.31460210111496806,"score_spread":0.28620020983538336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211012592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592495,0.00037038673,0.0000012477511,0.00030075974,0.00034760858,0.0026843478,0.00016675194,0.000013059694,0.00019087382],"genre_scores_gemma":[0.9993893,0.00004768902,0.000009525231,0.00005301807,0.000021849726,0.00017627791,0.00003947097,0.000025345948,0.0002375419],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99762076,0.00037448894,0.0006137039,0.00019503136,0.00095882505,0.00023719895],"domain_scores_gemma":[0.9984627,0.0002836006,0.00038272314,0.000506785,0.0002553434,0.00010885983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034079287,0.00014810533,0.00067255454,0.00018438947,0.00009388072,0.000006808939,0.00027772662,0.000028861812,0.00033426643],"category_scores_gemma":[0.00084186904,0.00009678351,0.00018544153,0.0004571906,0.00013639586,0.0000817012,0.00028007623,0.0001579319,0.0000021530852],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9338696,0.012244783,0.021899294,0.0010758445,0.00050218106,0.000008177495,0.0028441406,0.000020912887,0.00008093088,0.000026089378,0.006176942,0.021251133],"study_design_scores_gemma":[0.95777875,0.027048735,0.0065448796,0.0036164483,0.00023033726,0.000050377694,0.0025339755,0.00024600571,0.0013548792,0.00023049697,0.00014643553,0.00021864877],"about_ca_topic_score_codex":0.00007127744,"about_ca_topic_score_gemma":0.000004757018,"teacher_disagreement_score":0.023909211,"about_ca_system_score_codex":0.0000691354,"about_ca_system_score_gemma":0.00031010553,"threshold_uncertainty_score":0.3946717},"labels":[],"label_agreement":null},{"id":"W4211109829","doi":"10.1136/ard.2007.081430","title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007","year":2007,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Statement (logic); MEDLINE; Intensive care medicine","score_opus":0.1001305684886688,"score_gpt":0.38348998685773183,"score_spread":0.28335941836906303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211109829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97376436,0.019345041,0.00009442065,0.0033136872,0.00025292436,0.0022834816,0.0007368606,0.00003704622,0.00017217109],"genre_scores_gemma":[0.9623894,0.03667902,0.0000750409,0.0003191657,0.000031035015,0.000115388735,0.000099529934,0.00002259015,0.0002688284],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99774444,0.00014612517,0.00080969575,0.00022717773,0.0005827253,0.0004898388],"domain_scores_gemma":[0.9967842,0.0016107776,0.00036692034,0.0006997539,0.00025228687,0.00028604016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044024043,0.0002492788,0.0005968679,0.00010097365,0.0001929437,0.000019942396,0.00027395386,0.000046067587,0.00042477463],"category_scores_gemma":[0.0007819559,0.00011584191,0.0005059833,0.00018717305,0.00053121184,0.000029474942,0.000043171825,0.00005459819,0.000019714878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015702493,0.01992149,0.05510797,0.001279624,0.0077135297,0.000046179994,0.0018965406,0.00032171898,0.00021004408,0.007977328,0.197479,0.69234407],"study_design_scores_gemma":[0.016696569,0.012323005,0.8635698,0.004518982,0.00036929102,0.000028670303,0.00351152,0.002096685,0.008013313,0.009340966,0.078890584,0.0006405979],"about_ca_topic_score_codex":0.00010099349,"about_ca_topic_score_gemma":0.000009932846,"teacher_disagreement_score":0.80846184,"about_ca_system_score_codex":0.00004365286,"about_ca_system_score_gemma":0.00015232936,"threshold_uncertainty_score":0.4723896},"labels":[],"label_agreement":null},{"id":"W4213060030","doi":"10.1136/annrheumdis-2021-221636","title":"Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Canadian Arthritis Patient Alliance; McGill University Health Centre; University of Calgary","funders":"UCB Pharma; Manchester Biomedical Research Centre; Bristol-Myers Squibb; Pfizer Australia; Samsung; Mylan; National Institutes of Health; Swedish Orphan Biovitrum; National Institute for Health and Care Research; Celltrion; Medac; Cilag; Medpace; Amgen; Rheumatology Research Foundation; European League Against Rheumatism; Gilead Sciences; Childhood Arthritis and Rheumatology Research Alliance; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; Celgene; Pfizer; Biogen; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; American College of Rheumatology Research and Education Foundation","keywords":"Medicine; Hydroxychloroquine; Internal medicine; Rheumatology; Rituximab; Comorbidity; Logistic regression; Systemic lupus erythematosus; Prednisone; Disease; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.09112374740822171,"score_gpt":0.36275547555638255,"score_spread":0.27163172814816083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213060030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95509225,0.0037070052,0.000103904364,0.026269617,0.00026651862,0.0025659408,0.011829521,0.00012268292,0.000042564883],"genre_scores_gemma":[0.99157745,0.00053551706,0.000049849314,0.0059484695,0.0000150544665,0.00046223062,0.001046252,0.0000651721,0.00029998698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930932,0.0018276441,0.0013064151,0.0007910486,0.0021993588,0.0007823502],"domain_scores_gemma":[0.98949385,0.0051640314,0.0014454621,0.0030049756,0.00020805509,0.00068360183],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002163938,0.0004876118,0.0017222906,0.0001143122,0.00049724156,0.000084211555,0.002816279,0.0001072212,0.0004010115],"category_scores_gemma":[0.01576538,0.00025761648,0.00019242126,0.0010999427,0.0006748073,0.00017900005,0.0015031007,0.00042437928,0.00002258132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007707845,0.0007869804,0.95515716,0.0019228266,0.0015994125,0.00011892453,0.0017840262,0.00016607987,0.0000013423679,0.0002881918,0.037338663,0.00006563064],"study_design_scores_gemma":[0.030942064,0.0013026679,0.8594897,0.01575218,0.002396458,0.036620136,0.03904271,0.0037410604,0.000009328235,0.0043619187,0.0045775124,0.0017642562],"about_ca_topic_score_codex":0.0019537848,"about_ca_topic_score_gemma":0.00053824374,"teacher_disagreement_score":0.09566743,"about_ca_system_score_codex":0.000596548,"about_ca_system_score_gemma":0.0034883122,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W4213301654","doi":"10.1136/annrheumdis-2021-221941","title":"Response to: Correspondence on ‘Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment' by Ferreira et al","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"National Institutes of Health","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Physical therapy; C-reactive protein; Arthritis; Immunology; Inflammation","score_opus":0.11869635632459345,"score_gpt":0.35100695691990375,"score_spread":0.23231060059531028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213301654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96425444,0.0038775953,0.00004050647,0.028753037,0.00008969249,0.0015942564,0.0012113465,0.00003735617,0.00014177592],"genre_scores_gemma":[0.9934244,0.0024391592,0.000070132395,0.0033138834,0.000002208096,0.0006782322,0.000022585167,0.000025605943,0.00002377753],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9958557,0.0016580145,0.0004887004,0.0004222331,0.0011397654,0.0004356011],"domain_scores_gemma":[0.9975005,0.0010570342,0.0002697088,0.0006300829,0.000111847614,0.00043082307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010766591,0.00026626154,0.00044696327,0.00014235181,0.00057587895,0.000090040245,0.00024502195,0.000025004425,0.0001403002],"category_scores_gemma":[0.0037232838,0.00018765472,0.00014192416,0.0004336111,0.00030750595,0.00020855242,0.0005249117,0.00040224317,0.0000041056646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12788345,0.01658553,0.18185876,0.00076311256,0.0013826317,0.0008708706,0.012382723,0.003339758,0.042425334,0.010391574,0.1569945,0.44512177],"study_design_scores_gemma":[0.0050333706,0.0034506512,0.9519542,0.014897612,0.000016604912,0.0001335713,0.007739778,0.002023287,0.0033854009,0.0068833833,0.0038275018,0.00065462553],"about_ca_topic_score_codex":0.0002128784,"about_ca_topic_score_gemma":0.000023933337,"teacher_disagreement_score":0.77009547,"about_ca_system_score_codex":0.00013199243,"about_ca_system_score_gemma":0.0007691594,"threshold_uncertainty_score":0.7652337},"labels":[],"label_agreement":null},{"id":"W4213451248","doi":"10.1136/annrheumdis-2021-222006","title":"EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update","year":2022,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Versus Arthritis; NIHR Newcastle Biomedical Research Centre; University College London; Department of Health and Social Care; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Medicine; Context (archaeology); Vaccination; Expert opinion; Intensive care medicine; Population; Family medicine; Immunology; Environmental health","score_opus":0.06272045395839879,"score_gpt":0.372207725173897,"score_spread":0.30948727121549824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213451248","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00909361,0.98082864,0.000029018118,0.0051917736,0.000059190254,0.004087915,0.00065080816,0.000005343054,0.000053720814],"genre_scores_gemma":[0.05773139,0.94085777,0.000032441334,0.00015404062,0.0000095484975,0.0010117247,0.0001444593,0.000029504195,0.000029124607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754995,0.00059209875,0.0008041902,0.00023381325,0.00058338826,0.00023656442],"domain_scores_gemma":[0.995844,0.002494548,0.000706109,0.0007841116,0.00012454746,0.00004667681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008469822,0.0002796481,0.0010846844,0.00014904258,0.00026187018,0.000048350204,0.0005185844,0.00003327257,0.00016505168],"category_scores_gemma":[0.00043460415,0.000113361515,0.00042701903,0.0004554094,0.0002888481,0.00011073417,0.0002445071,0.0001704191,8.770992e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011457751,0.00046416605,0.00021586941,0.022809163,0.0016875147,0.0000010794696,0.0011006413,0.0000016685469,1.4443286e-7,0.002839577,0.005190544,0.96557504],"study_design_scores_gemma":[0.0068965387,0.0015053696,0.030683946,0.07742228,0.006104372,0.00012393403,0.027293112,0.00076889026,0.000018239505,0.00820954,0.84011245,0.00086134253],"about_ca_topic_score_codex":0.00012367174,"about_ca_topic_score_gemma":0.00010212822,"teacher_disagreement_score":0.9647137,"about_ca_system_score_codex":0.000015798256,"about_ca_system_score_gemma":0.00014726716,"threshold_uncertainty_score":0.46227485},"labels":[],"label_agreement":null},{"id":"W4213453648","doi":"10.1136/annrheumdis-2021-221640","title":"Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Janssen Biotech","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Interleukin 23; Psoriasis; TNF inhibitor; Arthritis; Tumor necrosis factor alpha; Internal medicine; Dermatology; Etanercept; Interleukin; Adalimumab; Cytokine","score_opus":0.030184207865356392,"score_gpt":0.2624180464231692,"score_spread":0.2322338385578128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213453648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918245,0.0007727379,6.576204e-8,0.00033909944,0.00021831351,0.0030701389,0.0037316484,0.000014409255,0.000029075723],"genre_scores_gemma":[0.9990898,0.00028706595,0.000008544765,0.00004430583,0.00002233628,0.00039589047,0.00004342796,0.00002742055,0.000081225946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973599,0.00068796804,0.0005683466,0.000386392,0.00073053554,0.00026686006],"domain_scores_gemma":[0.9977159,0.0009418853,0.0004287656,0.0007101408,0.0001152244,0.00008806828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022368743,0.0002943024,0.00070373795,0.000063691405,0.00038441952,0.00002496694,0.00023733605,0.000022214906,0.00003196418],"category_scores_gemma":[0.0004292568,0.00012994463,0.00021439808,0.0004280202,0.00022759165,0.00007468308,0.00031655718,0.000112684094,0.0000012756512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008304339,0.0048786,0.9737281,0.00013562155,0.0008196345,0.000013356558,0.004864249,0.000024518837,0.000012473731,0.000010045531,0.00012612999,0.007082935],"study_design_scores_gemma":[0.016247634,0.003468171,0.9707921,0.0024985876,0.0003264016,0.0000011171261,0.0060097226,0.0000070212777,0.0004313177,0.00006413656,0.00001931662,0.00013444466],"about_ca_topic_score_codex":0.0029149342,"about_ca_topic_score_gemma":0.0017528102,"teacher_disagreement_score":0.007943294,"about_ca_system_score_codex":0.0001308525,"about_ca_system_score_gemma":0.0001792982,"threshold_uncertainty_score":0.5298988},"labels":[],"label_agreement":null},{"id":"W4220877828","doi":"10.1136/annrheumdis-2022-222362","title":"Response to: Correspondence on ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis' by Joanna C Robson et al and ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis' by Pimentel-Quiroz et al","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; University of Oxford; Vasculitis Foundation; Medical Research Council; Celgene","keywords":"Medicine; Granulomatosis with polyangiitis; Rheumatology; Internal medicine; Family medicine; Dermatology; Vasculitis; Disease","score_opus":0.0315069227350979,"score_gpt":0.3405850905802733,"score_spread":0.3090781678451754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220877828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8354713,0.0011723603,0.0043356456,0.04790595,0.00032827465,0.004151185,0.106561005,0.000055374283,0.000018935003],"genre_scores_gemma":[0.98862976,0.0018613003,0.0029950887,0.0018759458,0.0000020838422,0.0016822101,0.0025992224,0.00013675,0.00021762255],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9933725,0.002222006,0.0023071903,0.0008299159,0.000585254,0.0006831225],"domain_scores_gemma":[0.9886383,0.005099601,0.004145392,0.0008986271,0.0009782055,0.0002398995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021919678,0.00050294213,0.0021323857,0.00038177695,0.0005580245,0.000018610566,0.0007096571,0.0001061925,0.000041122214],"category_scores_gemma":[0.0039673084,0.00047331705,0.00061807944,0.00091207336,0.0012221644,0.00017591804,0.00017707207,0.00023545891,0.0000011884282],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014341523,0.0051733335,0.094503775,0.0025859824,0.003453607,0.0000027439355,0.0027563088,0.00009096953,0.07264337,0.02750133,0.77543473,0.0015123481],"study_design_scores_gemma":[0.04296201,0.027841618,0.8032829,0.011997624,0.004075795,0.00068554125,0.030132968,0.013820564,0.02024304,0.0042408896,0.0374315,0.0032855053],"about_ca_topic_score_codex":0.00027888216,"about_ca_topic_score_gemma":0.00006104261,"teacher_disagreement_score":0.7380032,"about_ca_system_score_codex":0.00013494659,"about_ca_system_score_gemma":0.0005379794,"threshold_uncertainty_score":0.99977183},"labels":[],"label_agreement":null},{"id":"W4220916590","doi":"10.1136/annrheumdis-2022-222168","title":"Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Dalhousie University; University of Manitoba; Toronto Western Hospital; Université Laval; Queen Elizabeth II Health Sciences Centre; University of Calgary","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; Novo Nordisk Fonden; LUPUS UK; National Institute for Health and Care Research; Sandwell and West Birmingham Hospitals NHS Trust; National Center for Advancing Translational Sciences; Wellcome Trust; Arthritis Society; Gigtforeningen; Sanofi; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline; Amgen; Canada Research Chairs; Lupus Foundation of America","keywords":"Medicine; Systemic lupus; Cohort; Systemic lupus erythematosus; Family medicine; Physical therapy; Internal medicine; Disease","score_opus":0.05755325868198033,"score_gpt":0.3757392628367153,"score_spread":0.31818600415473497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220916590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995676,0.0014396695,0.000023599763,0.0011697633,0.0002849897,0.00080173695,0.00021233276,0.000011509056,0.0003804467],"genre_scores_gemma":[0.9990792,0.0003258241,0.000017759721,0.00012530152,0.00002469465,0.00015513848,0.00007520093,0.000011843266,0.00018499151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99643934,0.00068463216,0.0009493716,0.00021447195,0.0015166742,0.00019553334],"domain_scores_gemma":[0.99744964,0.00076334056,0.0006444997,0.0007082793,0.0003778243,0.00005640868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020875246,0.00012212501,0.0006089634,0.0004526068,0.000118531774,0.000020713072,0.0006864732,0.000029889961,0.000248348],"category_scores_gemma":[0.0014290223,0.000075679694,0.00036398345,0.0022927877,0.0001320014,0.00007099809,0.0002639575,0.00016872054,0.0000027699953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018039114,0.00037265467,0.98984003,0.00055207184,0.0015530676,0.0000070405226,0.0019080314,0.0026695866,0.000030695817,0.00029968412,0.0017800146,0.00080675085],"study_design_scores_gemma":[0.0011241232,0.00018162743,0.9438521,0.0014640762,0.001502001,0.00054706994,0.023294237,0.027546117,0.000028181164,0.00025255725,0.00007646731,0.0001314136],"about_ca_topic_score_codex":0.00019930337,"about_ca_topic_score_gemma":0.0000393353,"teacher_disagreement_score":0.04598788,"about_ca_system_score_codex":0.00010445708,"about_ca_system_score_gemma":0.00027813078,"threshold_uncertainty_score":0.30861285},"labels":[],"label_agreement":null},{"id":"W4221064814","doi":"10.1136/annrheumdis-2021-222029","title":"Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Subclinical infection; Internal medicine; Arthritis; Juvenile; Clinical trial; Biomarker","score_opus":0.037699599841105116,"score_gpt":0.3125286068325058,"score_spread":0.27482900699140067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221064814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742224,0.021013312,0.000012890094,0.0016981614,0.00006535899,0.0017273114,0.0011972402,0.000011704999,0.000051585997],"genre_scores_gemma":[0.99483943,0.0044632014,0.000005961426,0.000038360384,0.000015018947,0.00020973478,0.00026678992,0.000015153652,0.00014633538],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964619,0.0011054361,0.0012152931,0.00020960243,0.00083999883,0.00016775703],"domain_scores_gemma":[0.9976198,0.0002980665,0.0011026318,0.0007746085,0.00013794383,0.000066970664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011501866,0.0001346518,0.00050658727,0.00006981176,0.00014530138,0.000011125109,0.00039809284,0.000032533426,0.00016756785],"category_scores_gemma":[0.0015032807,0.00008743975,0.00029657173,0.00034030146,0.00018279122,0.0001351161,0.000106936706,0.00020214423,0.0000012591908],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3484854,0.024572147,0.030373992,0.0014277817,0.0019753634,0.0000110992,0.012662751,0.002766207,0.0070648887,0.0008756584,0.04300173,0.526783],"study_design_scores_gemma":[0.117877096,0.006723654,0.7907109,0.007938385,0.00059845403,0.0000020364125,0.01287308,0.0049191075,0.019211061,0.037031367,0.0014733898,0.0006414425],"about_ca_topic_score_codex":0.00073369825,"about_ca_topic_score_gemma":0.000041558837,"teacher_disagreement_score":0.76033694,"about_ca_system_score_codex":0.000018197048,"about_ca_system_score_gemma":0.000613045,"threshold_uncertainty_score":0.35656893},"labels":[],"label_agreement":null},{"id":"W4224937817","doi":"10.1136/annrheumdis-2021-221714","title":"Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Reumatikerförbundet; Vetenskapsrådet; Stockholms Läns Landsting; Hjärt-Lungfonden; Svenska Forskningsrådet Formas; Karolinska Institutet; Torsten Söderbergs Stiftelse; Biogen; Sanofi","keywords":"Medicine; Fetus; Heart block; Gene; Fetal heart; Cardiology; Internal medicine; Block (permutation group theory); Bioinformatics; Genetics; Pregnancy; Electrocardiography; Biology","score_opus":0.06118105816525239,"score_gpt":0.3414944556491994,"score_spread":0.280313397483947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224937817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876147,0.0020869514,0.00004844485,0.006432708,0.00037691966,0.0021404603,0.0011333904,0.00006648095,0.00009995511],"genre_scores_gemma":[0.99745756,0.000031344003,0.000159583,0.00081667426,0.00007616372,0.0003279853,0.00006512078,0.00004678926,0.0010187986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709797,0.00022873147,0.0006523859,0.00040599884,0.0011065336,0.00050840544],"domain_scores_gemma":[0.9973431,0.00058266957,0.00021340846,0.00097392866,0.0005703896,0.00031647386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001062138,0.00023152404,0.00065696414,0.00013508528,0.00034243,0.00003237545,0.000288176,0.000053057352,0.00056955946],"category_scores_gemma":[0.0020676288,0.00016885702,0.00058629207,0.0005314616,0.00014017985,0.000100957164,0.00029544972,0.00018129779,0.000022198792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008887245,0.00734919,0.61560917,0.009054332,0.0030810968,0.000004358254,0.0031840247,0.00034872058,0.05691061,0.0001451748,0.2929752,0.0024508918],"study_design_scores_gemma":[0.02528733,0.008979496,0.83279383,0.0040334254,0.0028876935,0.0063449703,0.012633298,0.025247592,0.0561229,0.0033017697,0.020393653,0.0019740444],"about_ca_topic_score_codex":0.00026400515,"about_ca_topic_score_gemma":0.000033675344,"teacher_disagreement_score":0.27258152,"about_ca_system_score_codex":0.00010761078,"about_ca_system_score_gemma":0.00076159457,"threshold_uncertainty_score":0.68857896},"labels":[],"label_agreement":null},{"id":"W4225140016","doi":"10.1136/annrheumdis-2022-222161","title":"Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis'?'","year":2022,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Janssen Scientific Affairs; Celgene; Gilead Sciences; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Sun Pharma; GlaxoSmithKline","keywords":"Medicine; Psoriatic arthritis; Physical therapy; Spondylitis; Axial spondyloarthritis; Post-hoc analysis; Ankylosing spondylitis; Internal medicine; Psoriasis; Clinical trial; Arthritis; Dermatology; Sacroiliitis","score_opus":0.07413094542965035,"score_gpt":0.36320101735097715,"score_spread":0.28907007192132683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225140016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9302407,0.037530128,0.0000010876697,0.0133304745,0.0010652856,0.011006916,0.0066339653,0.00003460309,0.00015686934],"genre_scores_gemma":[0.94084173,0.035698295,0.00004205227,0.017228803,0.00033799862,0.002267444,0.002658233,0.00018711668,0.0007383158],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98952615,0.0022845773,0.00514538,0.0007771661,0.001522848,0.0007438622],"domain_scores_gemma":[0.9808726,0.012264985,0.0047678524,0.0012277149,0.0007479135,0.00011898176],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022148606,0.00086934876,0.008711905,0.0010899157,0.00013062281,0.00002728294,0.00054879976,0.00038376878,0.0010159211],"category_scores_gemma":[0.017009612,0.00061251665,0.003720738,0.0009800012,0.00046495337,0.00011499462,0.00012297691,0.00065227796,0.000009119486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70007807,0.01538873,0.0017229107,0.0038000369,0.028628293,0.0024720547,0.0013391819,0.00055755134,0.002326816,0.00014069006,0.105598845,0.13794681],"study_design_scores_gemma":[0.8713982,0.015116517,0.06312064,0.03214889,0.00573273,0.00007496668,0.0006570927,0.0002717474,0.0037821964,0.002206947,0.004012431,0.001477615],"about_ca_topic_score_codex":0.0005220888,"about_ca_topic_score_gemma":0.000029859904,"teacher_disagreement_score":0.17132014,"about_ca_system_score_codex":0.00008409435,"about_ca_system_score_gemma":0.0007506147,"threshold_uncertainty_score":0.9998973},"labels":[],"label_agreement":null},{"id":"W4226021965","doi":"10.1136/annrheumdis-2021-222054","title":"Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome","year":2022,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Medical Research Council; Novartis Pharma; Servier; National Institute for Health and Care Research; Innovative Medicines Initiative; Sjögren's Foundation; Birmingham Biomedical Research Centre; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Gilead Sciences; Union Chimique Belge; European Federation of Pharmaceutical Industries and Associations; European Commission; Sanofi; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Delphi method; Clinical endpoint; Delphi; Patient-reported outcome; Clinical trial; Randomized controlled trial; Physical therapy; Internal medicine; Quality of life (healthcare); Computer science; Artificial intelligence","score_opus":0.10682643145228155,"score_gpt":0.3749614523770789,"score_spread":0.26813502092479735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226021965","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53299195,0.46207878,0.000037927315,0.00019172879,0.00017389518,0.0041709165,0.00032297772,0.000015612724,0.000016210266],"genre_scores_gemma":[0.1623321,0.8245517,0.0034279982,0.00037313154,0.000061763494,0.0060457047,0.0024569328,0.0002405584,0.00051008456],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975137,0.0006697008,0.00091236,0.00032282993,0.00033599752,0.00024539776],"domain_scores_gemma":[0.99381024,0.004741492,0.000822423,0.00048336308,0.000072322044,0.00007018131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080700265,0.0003812473,0.0015972506,0.00021386717,0.000348352,0.000052724816,0.00017699153,0.00009467626,0.000015039449],"category_scores_gemma":[0.000977183,0.0002055739,0.0007118716,0.00029725963,0.0001348548,0.00010577186,0.00014797405,0.0001074512,2.4261897e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026990385,0.001301763,0.005076685,0.06676149,0.001203549,0.00001138071,0.00049956096,0.000023663599,0.0000050197323,0.000020480586,0.0005131804,0.9218842],"study_design_scores_gemma":[0.016896455,0.006846496,0.51194715,0.30048504,0.025465585,0.00072312995,0.0017224681,0.0005586826,0.00026314644,0.0007872992,0.1322836,0.002020945],"about_ca_topic_score_codex":0.000016460739,"about_ca_topic_score_gemma":8.5433646e-7,"teacher_disagreement_score":0.9198632,"about_ca_system_score_codex":0.00014468422,"about_ca_system_score_gemma":0.001375956,"threshold_uncertainty_score":0.838306},"labels":[],"label_agreement":null},{"id":"W4230293375","doi":"10.1136/annrheumdis-2016-eular.4801","title":"AB0220 What Proportion of Patients Fail To Achieve CDAI and SDAI Remission Based on Physician Global Assessment? An Analysis from A Prospective, Observational Registry","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Penticton Regional Hospital; McMaster University; St. Paul's Hospital; Université Laval; Ottawa Hospital; McGill University","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Psoriatic arthritis; Infliximab; Internal medicine; Observational study; Physical therapy; Receiver operating characteristic; Ankylosing spondylitis; Prospective cohort study; Disease; Adalimumab","score_opus":0.03089783996525286,"score_gpt":0.3401415876087599,"score_spread":0.30924374764350704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230293375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937462,0.00027527264,0.00028087682,0.0043538148,0.00004067561,0.0005668841,0.0006519167,0.00001758365,0.000066753164],"genre_scores_gemma":[0.9984744,0.0005926792,0.00027218988,0.00038254508,0.000016713833,0.00003851634,0.00017995977,0.0000102041995,0.000032758795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980788,0.00017996984,0.00038014972,0.00027914895,0.00090109423,0.00018083664],"domain_scores_gemma":[0.99835306,0.00015604644,0.00031217549,0.00052742014,0.00041348318,0.00023779548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019534168,0.00014972016,0.00040427825,0.00008695289,0.00008906865,0.000045963494,0.00016631324,0.00003603804,0.00007131991],"category_scores_gemma":[0.0005858546,0.00008326144,0.00019107401,0.00038109347,0.00015893651,0.0004186933,0.00005733843,0.000045631805,0.0000021573048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018171336,0.0013408492,0.91173655,0.0001065675,0.0005126025,9.541635e-7,0.000109388864,0.0000553669,0.00044928864,0.00037335235,0.0005359177,0.08296205],"study_design_scores_gemma":[0.0012754785,0.0007501176,0.9896062,0.0023286745,0.00007319546,1.0616509e-7,0.00020131828,0.0010826276,0.0006914269,0.0038499818,0.000046665875,0.000094194496],"about_ca_topic_score_codex":0.000100156074,"about_ca_topic_score_gemma":0.000018730998,"teacher_disagreement_score":0.08286785,"about_ca_system_score_codex":0.00004314964,"about_ca_system_score_gemma":0.00017784373,"threshold_uncertainty_score":0.33953032},"labels":[],"label_agreement":null},{"id":"W4230584095","doi":"10.1136/annrheumdis-2015-eular.2238","title":"FRI0047 The Patient Perspective on Absence of Disease Activity in Rheumatoid Arthritis: A Survey to Identify Key Domains of Patient Perceived Remission","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Perspective (graphical); Disease; Qualitative research; Family medicine; Physical therapy; Pediatrics; Internal medicine","score_opus":0.04594598885186391,"score_gpt":0.34753345375884415,"score_spread":0.30158746490698024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230584095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898373,0.0060522016,0.000009225769,0.0022313448,0.000121693985,0.0012006102,0.00034196157,0.000015397964,0.00019024852],"genre_scores_gemma":[0.9909944,0.008705697,0.000026499465,0.00014943905,0.0000064487895,0.000071016075,0.000009962055,0.00002347878,0.000013058907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964385,0.0008729425,0.00069000066,0.0003148932,0.0013238818,0.0003597931],"domain_scores_gemma":[0.9966442,0.00066566595,0.00043286913,0.0009256876,0.0007830305,0.00054855767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070811127,0.00023696093,0.0006578421,0.000198266,0.000092322014,0.000022432909,0.0003788197,0.00004326477,0.000055257264],"category_scores_gemma":[0.0067315283,0.0001412865,0.00029441115,0.0005041979,0.00042628995,0.00014525143,0.00022562986,0.00017466822,0.000010602357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06564259,0.025339225,0.512687,0.0021444345,0.0018940112,0.00011378081,0.12500139,0.0032507186,0.007195664,0.006361097,0.031167792,0.21920231],"study_design_scores_gemma":[0.0016575458,0.0013974799,0.97296333,0.009621347,0.000006725178,0.0000039248393,0.0065400014,0.00015235433,0.0033717148,0.0040433295,0.000069936366,0.00017231454],"about_ca_topic_score_codex":0.0024626476,"about_ca_topic_score_gemma":0.00023986935,"teacher_disagreement_score":0.4602763,"about_ca_system_score_codex":0.00007858222,"about_ca_system_score_gemma":0.00050773105,"threshold_uncertainty_score":0.8058755},"labels":[],"label_agreement":null},{"id":"W4230730269","doi":"10.1136/annrheumdis-2016-eular.3251","title":"FRI0134 Interleukin-6 Blockade Raises LDL via Reduced Catabolism Rather than via Increased Synthesis – A Cytokine-Specific Mechanism for Cholesterol Changes in Rheumatoid Arthritis","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Tocilizumab; Rheumatoid arthritis; Catabolism; Internal medicine; Cholesterol; Cytokine; Endocrinology; Blockade; Pharmacology; Immunology; Metabolism; Receptor","score_opus":0.037763421117267354,"score_gpt":0.29453116840539334,"score_spread":0.256767747288126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230730269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841483,0.0040577753,0.0006587978,0.0075459885,0.00032351917,0.0026391058,0.00044618596,0.00010788846,0.00007240175],"genre_scores_gemma":[0.98912174,0.008486507,0.00012379394,0.00027534296,0.0001254294,0.0014932295,0.000013623187,0.00012912808,0.00023121595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961227,0.00043819362,0.0010611179,0.00062476686,0.00091034913,0.000842847],"domain_scores_gemma":[0.99548644,0.0016302351,0.00055968587,0.0014642125,0.00045244468,0.00040696177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008003969,0.0004994274,0.0013137754,0.00050005945,0.0001361802,0.000052121326,0.00079604314,0.00017220195,0.0002677403],"category_scores_gemma":[0.0024384183,0.0002978402,0.00050817814,0.0004202565,0.00031526704,0.00020017585,0.0002490668,0.00014474305,0.00005985144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068377214,0.004609334,0.045337826,0.008718671,0.0024741576,0.00009281747,0.008441944,0.00000339148,0.5255191,0.0023259162,0.016885705,0.37875342],"study_design_scores_gemma":[0.014227955,0.00062935724,0.03010354,0.075200975,0.00022716046,0.0017133796,0.0021531654,0.00043625475,0.85943997,0.013320954,0.0013283972,0.0012188717],"about_ca_topic_score_codex":0.0004376368,"about_ca_topic_score_gemma":0.0002097373,"teacher_disagreement_score":0.37753457,"about_ca_system_score_codex":0.00009823443,"about_ca_system_score_gemma":0.00022202535,"threshold_uncertainty_score":0.99994737},"labels":[],"label_agreement":null},{"id":"W4231972505","doi":"10.1136/annrheumdis-2019-216655","title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2766,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"European League Against Rheumatism","keywords":"Medicine; Antirheumatic drugs; Rheumatoid arthritis; Antirheumatic Agents; Disease management; Intensive care medicine; Arthritis; Disease; Biological drugs; Physical therapy; Internal medicine","score_opus":0.05335807383794681,"score_gpt":0.3108790043369627,"score_spread":0.25752093049901587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231972505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8014477,0.10431826,0.0018443909,0.08844597,0.000106576415,0.0030367044,0.0006285083,0.00007756623,0.00009434517],"genre_scores_gemma":[0.73691297,0.2617025,0.00068911293,0.00049172994,0.000008089805,0.00012924886,0.00003294007,0.000021242642,0.000012187952],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982623,0.00013617161,0.0005604494,0.00028337163,0.00042794552,0.00032976564],"domain_scores_gemma":[0.9981793,0.00053669367,0.00029064837,0.0005245857,0.00016360248,0.00030516085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031294228,0.00022007783,0.0005391411,0.00005643406,0.00026898313,0.000047929487,0.00033580457,0.000028593291,0.00011703025],"category_scores_gemma":[0.0003081319,0.00011485431,0.000249405,0.000248858,0.0005712029,0.0001243915,0.0001779791,0.00009856662,0.0000074624904],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056286473,0.001810538,0.01832195,0.008296113,0.00735845,0.000025898526,0.0039307717,0.00026299185,0.0001170034,0.032423645,0.036352217,0.88547176],"study_design_scores_gemma":[0.054146126,0.0079858685,0.48259652,0.17483237,0.0014478519,0.00029773623,0.045644123,0.0615308,0.0051623727,0.06993142,0.09246451,0.003960318],"about_ca_topic_score_codex":0.000019482091,"about_ca_topic_score_gemma":9.410018e-7,"teacher_disagreement_score":0.88151145,"about_ca_system_score_codex":0.0000057776147,"about_ca_system_score_gemma":0.00007617471,"threshold_uncertainty_score":0.46836227},"labels":[],"label_agreement":null},{"id":"W4232672118","doi":"10.1136/annrheumdis-2013-eular.754","title":"THU0226 Baricitinib Effects on Serum Cholesterol and Circulating Lipid Particles in a Phase 2B Study in Patients with Rheumatoid Arthritis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cholesterol; Internal medicine; Placebo; Clinical endpoint; Gastroenterology; Urology; Endocrinology; Randomized controlled trial; Pathology","score_opus":0.017408410292779567,"score_gpt":0.28681375066511994,"score_spread":0.2694053403723404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232672118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954027,0.001355758,9.961545e-7,0.0006470384,0.000038815124,0.0024659429,0.000019602421,0.000025681464,0.00004344441],"genre_scores_gemma":[0.99796224,0.0014654454,0.00001632912,0.00023467648,0.000010234315,0.00027079036,0.0000063235107,0.000029387305,0.0000046005284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977916,0.00032516097,0.00055527186,0.0002929246,0.00058939797,0.0004456335],"domain_scores_gemma":[0.9986456,0.00039572726,0.00017775274,0.000441347,0.000114223,0.00022534496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026287002,0.00023254365,0.000595432,0.00019908645,0.00009139979,0.00007754981,0.00015343442,0.000034552642,0.000051934334],"category_scores_gemma":[0.00068128284,0.00014967193,0.000075097654,0.0003215087,0.00015372822,0.0002828678,0.000087427565,0.00016915683,0.000013993574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035496958,0.0030840773,0.7812008,0.00018437336,0.000095411735,0.000007427099,0.001263951,0.000014793695,0.000024243713,0.000032148917,0.00007025259,0.21366751],"study_design_scores_gemma":[0.015062176,0.002138734,0.97469366,0.0059802234,0.0000047504914,0.0000037527411,0.00088212854,0.0003207625,0.0003323724,0.00042704956,0.00000445739,0.00014995223],"about_ca_topic_score_codex":0.00034059118,"about_ca_topic_score_gemma":0.00011591287,"teacher_disagreement_score":0.21351756,"about_ca_system_score_codex":0.000015412972,"about_ca_system_score_gemma":0.000060073402,"threshold_uncertainty_score":0.61034447},"labels":[],"label_agreement":null},{"id":"W4233454438","doi":"10.1136/annrheumdis-2017-eular.6361","title":"SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; Montreal Clinical Research Institute","funders":"Chugai Pharmaceutical","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Rituximab; Internal medicine; Ustekinumab; TNF inhibitor; Hazard ratio; Proportional hazards model; Adalimumab; Confidence interval","score_opus":0.11409654221495438,"score_gpt":0.38338819610129793,"score_spread":0.2692916538863436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233454438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579836,0.0030863506,0.0000069720927,0.008827982,0.00020532135,0.00052738126,0.0015204237,0.000007983944,0.000019252564],"genre_scores_gemma":[0.99622756,0.003080143,0.00023379778,0.00026073866,0.000022848402,0.000029425251,0.00011409858,0.000008163747,0.000023250961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972039,0.001281227,0.00086976046,0.00029678916,0.000105211955,0.0002431242],"domain_scores_gemma":[0.99491173,0.002801459,0.00066308596,0.0015101758,0.00008164461,0.000031881296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001118073,0.00018925777,0.00070159655,0.000037802252,0.00026976824,0.000038847746,0.0008256914,0.00014585948,0.000043001528],"category_scores_gemma":[0.0025410394,0.00009612219,0.00042854695,0.00008421236,0.0016781058,0.00014763027,0.00026235712,0.00018139437,8.3950346e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003353306,0.0019151809,0.9272188,0.000084941865,0.0007394775,0.0000072163957,0.0009513408,6.443664e-7,0.00027421062,0.0007590852,0.005950247,0.061763544],"study_design_scores_gemma":[0.0019132977,0.00024720348,0.9784853,0.0007351869,0.00015530139,0.0000014150237,0.0014411206,0.0000065960403,0.0011951774,0.013742856,0.0019384451,0.00013813772],"about_ca_topic_score_codex":0.0034085216,"about_ca_topic_score_gemma":0.002819567,"teacher_disagreement_score":0.061625406,"about_ca_system_score_codex":0.000013265835,"about_ca_system_score_gemma":0.00011282591,"threshold_uncertainty_score":0.618305},"labels":[],"label_agreement":null},{"id":"W4235144735","doi":"10.1136/annrheumdis-2017-eular.6679","title":"SAT0273 Factors related to alexithymia in systemic lupus erythematosus","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Medicine; Mood; Quality of life (healthcare); Toronto Alexithymia Scale; Pittsburgh Sleep Quality Index; Internal medicine; Mood disorders; Epworth Sleepiness Scale; Physical therapy; Insomnia; Psychiatry; Sleep quality; Polysomnography; Anxiety","score_opus":0.0518059567994869,"score_gpt":0.3467112601839992,"score_spread":0.2949053033845123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235144735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936221,0.0015360006,0.0000016302273,0.0029046736,0.00023211505,0.00069007056,0.000029711275,0.000027329988,0.00095635804],"genre_scores_gemma":[0.9975538,0.00022108205,0.000018229688,0.000016472106,0.0000039160573,0.000027644086,0.0000072484077,0.000025395055,0.002126193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826235,0.000091593785,0.00047820233,0.00022775731,0.0005531453,0.00038693965],"domain_scores_gemma":[0.9978655,0.00015116266,0.00023968317,0.0013864872,0.00009324188,0.0002639135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025696118,0.00017749652,0.0005231173,0.00014056268,0.00016732325,0.00004623214,0.0006217123,0.00007406528,0.00020184659],"category_scores_gemma":[0.0015494827,0.00011021305,0.00024925955,0.00016702204,0.00020310658,0.00011318703,0.0002352359,0.00014755585,0.00008772803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024165236,0.00047335468,0.9730944,0.010769769,0.00038851687,0.000053501644,0.0017712017,0.000063757536,0.00036240125,0.001295136,0.009064752,0.0024215414],"study_design_scores_gemma":[0.0012029019,0.00019631743,0.97492677,0.01954039,0.000059646707,0.00018111047,0.0007026537,0.000201749,0.0010185139,0.001785304,0.00002354293,0.00016109808],"about_ca_topic_score_codex":0.00024593627,"about_ca_topic_score_gemma":0.000004682748,"teacher_disagreement_score":0.009041209,"about_ca_system_score_codex":0.000050156592,"about_ca_system_score_gemma":0.00024513464,"threshold_uncertainty_score":0.44943577},"labels":[],"label_agreement":null},{"id":"W4235754496","doi":"10.1136/annrheumdis-2021-eular.1154","title":"OP0221 TARGETED METABOLOMIC PROFILING AND PREDICTION OF CARDIOVASCULAR EVENTS: A PROSPECTIVE STUDY OF PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Waterloo; Women's College Hospital","funders":"Novartis Pharma; Ministerio de Ciencia e Innovación; Arthritis Society; National Psoriasis Foundation","keywords":"Medicine; Proportional hazards model; Internal medicine; Psoriatic arthritis; Psoriasis; Prospective cohort study; Metabolite; Arthritis; Immunology","score_opus":0.010076786323750399,"score_gpt":0.22300385686165516,"score_spread":0.21292707053790477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235754496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628696,0.0362029,0.00004028007,0.00001627123,0.00006310874,0.00053252844,0.00026181282,0.0000025439226,0.000010980435],"genre_scores_gemma":[0.99127996,0.008419055,0.00019953414,0.0000059536064,0.000011461992,0.000040908602,0.000025800648,0.000010457203,0.000006855652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895966,0.00013980591,0.00031476677,0.00023729996,0.00023983685,0.00010860485],"domain_scores_gemma":[0.99902433,0.000022402613,0.00023860009,0.0003430674,0.0003332883,0.000038337843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014973998,0.0001252274,0.00045420742,0.00003911986,0.000055342487,0.0000054242523,0.000077485434,0.000029075774,0.0000032016435],"category_scores_gemma":[0.00039835827,0.00008662071,0.00012390611,0.00015305085,0.00008833587,0.000008734748,0.00015114744,0.000030585954,3.0907096e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008396892,0.003600988,0.9391535,0.0009996451,0.020170432,0.0000010851484,0.0010309399,0.00030111603,0.004715812,0.0003474752,0.00009695391,0.028742379],"study_design_scores_gemma":[0.0023662644,0.0007083947,0.94826007,0.00016568457,0.0009014492,9.075806e-7,0.0012332955,0.000022225537,0.045727942,0.00049122784,0.000021051352,0.000101474936],"about_ca_topic_score_codex":0.000027530758,"about_ca_topic_score_gemma":0.0000072493167,"teacher_disagreement_score":0.041012127,"about_ca_system_score_codex":0.000002275838,"about_ca_system_score_gemma":0.000043347154,"threshold_uncertainty_score":0.35322902},"labels":[],"label_agreement":null},{"id":"W4235868565","doi":"10.1136/annrheumdis-2017-eular.2848","title":"FRI0174 A population based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Interstitial lung disease; Rheumatoid arthritis; Internal medicine; Hazard ratio; Comorbidity; Proportional hazards model; Cohort; Population; Lung; Confidence interval","score_opus":0.03352729408681696,"score_gpt":0.32828152691608303,"score_spread":0.29475423282926605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235868565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602735,0.0012462643,0.000016585507,0.00046609278,0.00027038247,0.0011915982,0.00062035734,0.000033317,0.00012802507],"genre_scores_gemma":[0.99897903,0.0006766174,0.000005209853,0.00010517957,0.000027341053,0.00005241404,0.0001110604,0.00002210234,0.000021049038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979587,0.00021376736,0.0006519854,0.00029739938,0.0006469261,0.00023120502],"domain_scores_gemma":[0.99742526,0.000105997635,0.0008121008,0.0011094462,0.00025347277,0.00029374566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034377852,0.00022711015,0.0007061825,0.000070954404,0.00039501546,0.00006013952,0.00032480145,0.000054397824,0.00008727092],"category_scores_gemma":[0.0013571013,0.00017453056,0.00034356077,0.00007039976,0.0002846913,0.00023116356,0.00021367255,0.000108509805,0.0000011495846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001345059,0.0022508036,0.9931213,0.000590248,0.00047939934,0.000018336495,0.00009467912,0.000024155006,0.000009685811,0.00012442839,0.00059529894,0.0013465956],"study_design_scores_gemma":[0.0015469972,0.00052305846,0.98644644,0.0039026416,0.0004375458,0.0000023265952,0.00013701717,0.006376363,0.000022430399,0.00044235477,0.0000051317074,0.0001576861],"about_ca_topic_score_codex":0.0033951683,"about_ca_topic_score_gemma":0.0001360803,"teacher_disagreement_score":0.0066748634,"about_ca_system_score_codex":0.000033093856,"about_ca_system_score_gemma":0.00014462469,"threshold_uncertainty_score":0.711715},"labels":[],"label_agreement":null},{"id":"W4236466662","doi":"10.1136/annrheumdis-2017-eular.1073","title":"SAT0072 Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Internal medicine; Adverse effect","score_opus":0.020334620699256612,"score_gpt":0.30907591177198274,"score_spread":0.2887412910727261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236466662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957013,0.0005825332,0.000004116795,0.00046371887,0.000051273353,0.0027563004,0.00022364741,0.000013914867,0.00020316757],"genre_scores_gemma":[0.9995192,0.00026047687,0.000019522666,0.00001268028,0.000012523619,0.000076911056,0.000016142247,0.000026378502,0.000056130142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722576,0.0002168736,0.0008944271,0.00032297775,0.0010110199,0.0003289338],"domain_scores_gemma":[0.9963012,0.00026601064,0.0010278585,0.0014293164,0.00076863915,0.00020699714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057549414,0.00020691346,0.0007937714,0.00017502999,0.00014197598,0.00002672719,0.00042692397,0.000038778395,0.000016041027],"category_scores_gemma":[0.0060445326,0.00013453061,0.00018912919,0.00022598024,0.0005910063,0.00023397172,0.0001934373,0.00012416784,0.0000011950938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03732212,0.007654764,0.9382538,0.0014247722,0.0007538925,0.000027699536,0.0021593948,0.0002084634,0.000016852578,0.00020671291,0.00029147355,0.011680042],"study_design_scores_gemma":[0.05423029,0.0012235247,0.9373875,0.004627727,0.00011200215,0.0000021661303,0.0013288382,0.0003860807,0.00018592492,0.00039881998,0.0000014006,0.00011572008],"about_ca_topic_score_codex":0.0012147994,"about_ca_topic_score_gemma":0.000049982656,"teacher_disagreement_score":0.01690817,"about_ca_system_score_codex":0.00038329276,"about_ca_system_score_gemma":0.0022748213,"threshold_uncertainty_score":0.72363067},"labels":[],"label_agreement":null},{"id":"W4237273913","doi":"10.1136/annrheumdis-2012-eular.2063","title":"THU0098 Long-term effects of rituximab on B-cell counts and autoantibody production in rheumatoid arthritis: Use of high-sensitivity flow-cytometry for more sensitive assessment of B-cell depletion","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Autoantibody; Flow cytometry; B cell; Internal medicine; Rheumatoid factor; CD19; Gastroenterology; Immunology; Rheumatology; Antibody","score_opus":0.031843730505461486,"score_gpt":0.33694890269026867,"score_spread":0.3051051721848072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237273913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969412,0.0015171528,0.00008936258,0.00024128162,0.00013641849,0.0008293181,0.00019765104,0.000006464916,0.000041155457],"genre_scores_gemma":[0.99619454,0.0032385935,0.0003603333,0.000037018373,0.000021201262,0.00001477016,0.00004942311,0.000014471915,0.00006967205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998608,0.00017301147,0.0003965076,0.00015607609,0.00045867125,0.00020776896],"domain_scores_gemma":[0.99833727,0.0007578396,0.00030598798,0.00025643923,0.000256069,0.00008642445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003792305,0.00014125677,0.0005640232,0.00016896984,0.000031993346,0.00000476679,0.000049596267,0.00005099701,0.0000084875055],"category_scores_gemma":[0.0005118952,0.00010069005,0.00015336458,0.00017508552,0.00023346413,0.00011762331,0.000059959253,0.00008852203,0.0000013952432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034606336,0.018776877,0.81517386,0.03766205,0.000708418,0.00001945405,0.0010404417,0.0001632749,0.06934071,0.000811358,0.0021052503,0.050737653],"study_design_scores_gemma":[0.0013144597,0.0003072003,0.82921785,0.003645584,0.000056725657,0.000008659294,0.000038931834,0.00072329247,0.16454953,0.00005348298,0.000004961631,0.00007934024],"about_ca_topic_score_codex":0.00014633375,"about_ca_topic_score_gemma":0.0000057164507,"teacher_disagreement_score":0.095208816,"about_ca_system_score_codex":0.000014839891,"about_ca_system_score_gemma":0.000078463796,"threshold_uncertainty_score":0.4106021},"labels":[],"label_agreement":null},{"id":"W4237364272","doi":"10.1136/annrheumdis-2021-eular.409","title":"POS1027 EFFICACY AND SAFETY OF GUSELKUMAB, A MONOCLONAL ANTIBODY SPECIFIC TO THE p19-SUBUNIT OF INTERLEUKIN-23, THROUGH 2 YEARS: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Population; Placebo; Discontinuation; Adverse effect; Internal medicine; Tolerability; Pathology","score_opus":0.04501951089408203,"score_gpt":0.3434633701486586,"score_spread":0.29844385925457656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237364272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573595,0.0061005712,0.000018896642,0.0008866347,0.00009195168,0.005873003,0.001211653,0.00001376009,0.00006757158],"genre_scores_gemma":[0.98893154,0.010356416,0.00010805636,0.00007084234,0.000022160484,0.00015828497,0.00030461032,0.000022999322,0.000025119138],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961142,0.001095939,0.0013550909,0.00040310386,0.00071025034,0.00032142646],"domain_scores_gemma":[0.9950845,0.0027038283,0.00069686695,0.0007508339,0.00061428675,0.00014964206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007335542,0.00028994895,0.0018505963,0.00016286962,0.00007924975,0.000039856706,0.00032713712,0.000057137848,0.00011849168],"category_scores_gemma":[0.0024692253,0.00015673263,0.00028090767,0.00054843706,0.00054024014,0.00016452918,0.00019623127,0.00020448338,0.0000039206034],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9595316,0.0063778185,0.0015871123,0.00006173022,0.0027184412,0.000025281443,0.011400147,0.00005700138,0.00013980232,0.000081267055,0.0003063747,0.017713435],"study_design_scores_gemma":[0.9347112,0.002073806,0.05138358,0.0039740205,0.00015501124,0.000005153552,0.0057142377,0.00006777686,0.0011627022,0.00048621692,0.0000761038,0.00019015669],"about_ca_topic_score_codex":0.00048319474,"about_ca_topic_score_gemma":0.00017589342,"teacher_disagreement_score":0.04979647,"about_ca_system_score_codex":0.000018846282,"about_ca_system_score_gemma":0.00025038503,"threshold_uncertainty_score":0.6391371},"labels":[],"label_agreement":null},{"id":"W4244583999","doi":"10.1136/ard.2008.100834","title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008","year":2008,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Versus Arthritis","keywords":"Medicine; Statement (logic); Intensive care medicine; MEDLINE; Biologic Agents; Internal medicine; Rheumatoid arthritis","score_opus":0.13222323601676716,"score_gpt":0.3647365937177404,"score_spread":0.23251335770097326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244583999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970456,0.021745384,0.00002064624,0.0045133,0.00015594406,0.0020552897,0.00093555875,0.00003601605,0.00008188117],"genre_scores_gemma":[0.8962453,0.10278266,0.000051898274,0.00024010951,0.000019608127,0.00022633297,0.00010489181,0.000020859614,0.00030836157],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978798,0.00020360993,0.000709923,0.0002314775,0.00057157344,0.0004035977],"domain_scores_gemma":[0.9973914,0.0010550629,0.00033818008,0.00072801317,0.00023941672,0.00024794444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015717417,0.00025278635,0.00065044494,0.00008394309,0.00029049153,0.000013095183,0.000276336,0.000040740084,0.00035418212],"category_scores_gemma":[0.0006656614,0.00011687395,0.00054063066,0.0001821565,0.00074850186,0.000032443797,0.000043731572,0.000051320316,0.000021019096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014471798,0.030000417,0.092333935,0.0014976708,0.0111514125,0.000095574665,0.0042160796,0.00087321847,0.00021991033,0.004767682,0.522587,0.31778532],"study_design_scores_gemma":[0.019399565,0.013766032,0.8831577,0.004110456,0.00033156265,0.000096384465,0.0019796286,0.0042477422,0.005539599,0.0063915397,0.060272504,0.0007073461],"about_ca_topic_score_codex":0.00011282513,"about_ca_topic_score_gemma":0.0000048647703,"teacher_disagreement_score":0.7908237,"about_ca_system_score_codex":0.000034303026,"about_ca_system_score_gemma":0.00023130527,"threshold_uncertainty_score":0.4765981},"labels":[],"label_agreement":null},{"id":"W4246483855","doi":"10.1136/annrheumdis-2017-eular.2866","title":"OP0034 Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the detect cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"EMD Serono; Pharmacyclics; Genentech; National Institutes of Health; Medac; aTyr; Covis Pharma; Anthera; United Therapeutics Corporation; Teva Pharmaceutical Industries; Biogen; Gilead Sciences; Sanofi; Pfizer; AOP Orphan; Ironwood Pharmaceuticals, Incorporated; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Interquartile range; Internal medicine; DLCO; Cohort; Pulmonary hypertension; Interstitial lung disease; Cohort study; Retrospective cohort study; Logistic regression; Longitudinal study; Diffusing capacity; Cardiology; Lung; Pathology; Lung function","score_opus":0.13489508966535768,"score_gpt":0.30607049956863935,"score_spread":0.17117540990328167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246483855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98884904,0.006866154,0.0000019759173,0.0006563168,0.00026591707,0.0018744364,0.0013807825,0.0000817025,0.000023643559],"genre_scores_gemma":[0.9980752,0.00082833844,0.0000027660003,0.00011759628,0.0000648543,0.00012519945,0.0006960388,0.000062461884,0.000027551338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963994,0.00050751853,0.0007322464,0.00066650566,0.001215713,0.00047860816],"domain_scores_gemma":[0.99423665,0.00097035855,0.0013217325,0.002809753,0.00031212874,0.00034940126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005312394,0.00043839816,0.0009507691,0.000073799616,0.0007312166,0.0002518308,0.001296662,0.00015118888,0.000034958666],"category_scores_gemma":[0.0052048094,0.0001949974,0.00023222255,0.00025315696,0.000622408,0.00040706512,0.00041324744,0.00023688919,0.000005734401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014930508,0.0012411536,0.99278647,0.00012324593,0.0012799605,0.00009098087,0.00011930549,0.000028803826,0.00021637743,0.0000012863519,0.0012778646,0.0013415205],"study_design_scores_gemma":[0.0028632542,0.00016230159,0.9171578,0.076220326,0.0018990396,0.000005024779,0.00026104684,0.0010344161,0.00010788742,0.000028815813,0.0000012841385,0.0002587961],"about_ca_topic_score_codex":0.0009668007,"about_ca_topic_score_gemma":0.00013946941,"teacher_disagreement_score":0.07609708,"about_ca_system_score_codex":0.00006798829,"about_ca_system_score_gemma":0.00044964638,"threshold_uncertainty_score":0.7951763},"labels":[],"label_agreement":null},{"id":"W4246760567","doi":"10.1136/annrheumdis-2015-eular.1613","title":"THU0531 The Initial Treatment of Systemic Juvenile Idiopathic Arthritis: An International Collaboration Among 7 Registries","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Medicine; Rheumatology; Arthritis; Pediatrics; Rash; Cohort; Internal medicine; Prospective cohort study; Family medicine; Physical therapy","score_opus":0.078833403166562,"score_gpt":0.3649764630762649,"score_spread":0.2861430599097029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246760567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859981,0.010264736,0.000011978378,0.0020609046,0.00019489844,0.00057190977,0.00007959369,0.000020528088,0.00079734204],"genre_scores_gemma":[0.99720454,0.0022642387,0.0000050537606,0.000051082734,0.000048233156,0.0000734876,0.00003947919,0.000011516108,0.0003023866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984039,0.00021780188,0.0005634289,0.00011662227,0.00056518294,0.00013303157],"domain_scores_gemma":[0.9983789,0.00006433697,0.0003812681,0.0005388135,0.0005428563,0.00009383643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003602029,0.0001111233,0.00038171193,0.00006177864,0.00007820811,0.00003578794,0.00025951248,0.00004097294,0.000035452933],"category_scores_gemma":[0.00083695207,0.00006130759,0.00013619792,0.00018649318,0.0003109056,0.00028439792,0.000047917445,0.000047136567,0.0000073398182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00664012,0.009366968,0.42817494,0.0033939206,0.0037571774,0.0001012192,0.06174917,0.0019853003,0.0012363334,0.014900014,0.041460305,0.42723453],"study_design_scores_gemma":[0.02109545,0.0101659885,0.74961364,0.024609111,0.0011044666,0.00025559025,0.12413974,0.0100556,0.035861585,0.012516924,0.009554173,0.0010277424],"about_ca_topic_score_codex":0.00025298639,"about_ca_topic_score_gemma":0.000037184913,"teacher_disagreement_score":0.42620677,"about_ca_system_score_codex":0.000041387386,"about_ca_system_score_gemma":0.00075127865,"threshold_uncertainty_score":0.2500051},"labels":[],"label_agreement":null},{"id":"W4247135939","doi":"10.1136/annrheumdis-2013-203348","title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Statement (logic); Table (database); MEDLINE; Intensive care medicine; Bioinformatics; Data mining","score_opus":0.09478116735593957,"score_gpt":0.35908257753774003,"score_spread":0.2643014101818005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247135939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677163,0.019918155,0.000022192895,0.008239811,0.0001691952,0.0031518368,0.00065100554,0.000034201894,0.00009730125],"genre_scores_gemma":[0.95586574,0.04266711,0.0000552899,0.00029443437,0.000020055684,0.00053243485,0.00010022712,0.00002187885,0.00044281041],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979865,0.00020393828,0.00068691,0.00021491495,0.00049241376,0.000415309],"domain_scores_gemma":[0.99727494,0.001113289,0.00033596795,0.00072994793,0.00027896176,0.00026688186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016481486,0.00024585502,0.00059702684,0.00007591011,0.00017774032,0.000032086424,0.00028132557,0.00004043932,0.0012056684],"category_scores_gemma":[0.00053640665,0.000109149834,0.0004790176,0.00014525563,0.0004943363,0.00006076665,0.000048908256,0.000048148166,0.00006227146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034581812,0.014077223,0.025346283,0.0010428467,0.0062130233,0.000007990388,0.0013223736,0.00024533522,0.00022390959,0.004788553,0.41586468,0.5274096],"study_design_scores_gemma":[0.015126548,0.01138597,0.884069,0.004490423,0.0003540536,0.000019189649,0.002780419,0.005617876,0.0040257606,0.020091305,0.051370922,0.0006685084],"about_ca_topic_score_codex":0.00020627455,"about_ca_topic_score_gemma":0.000005481266,"teacher_disagreement_score":0.85872275,"about_ca_system_score_codex":0.000030447625,"about_ca_system_score_gemma":0.0001362651,"threshold_uncertainty_score":0.99970734},"labels":[],"label_agreement":null},{"id":"W4247416892","doi":"10.1136/annrheumdis-2016-211053.10","title":"06.10 Effects of resveratrol and a resveratrol-salicylate hybrid molecule on activation of human cd4+ t- cells","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Resveratrol; Cytokine; Chemistry; CD28; T cell; Molecular biology; Inflammation; IL-2 receptor; Biochemistry; Pharmacology; Biology; Immune system; Immunology","score_opus":0.026307478093356724,"score_gpt":0.32584517219456877,"score_spread":0.29953769410121206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247416892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958889,0.00084848446,0.0000102944205,0.0016887077,0.00010609535,0.00060650887,0.00003550229,0.0000133073045,0.0008022051],"genre_scores_gemma":[0.9984062,0.00043061585,0.000026984357,0.00036693286,0.00006164018,0.000016216678,0.000011395137,0.000024678642,0.00065538415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983718,0.00012216535,0.00051799207,0.00022360487,0.00055683445,0.00020763394],"domain_scores_gemma":[0.99742365,0.00030079825,0.0007829154,0.0011158725,0.00022692495,0.00014986575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025940422,0.00020435435,0.0006791133,0.0001241269,0.00020741604,0.000021564209,0.0002988991,0.000057703477,0.000052570205],"category_scores_gemma":[0.0012778651,0.00012683666,0.00024353445,0.00006902778,0.00042675887,0.00010141317,0.0001155247,0.00012338223,0.0000031062034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003935201,0.0038744684,0.016309125,0.01516667,0.0027510265,0.0000680297,0.0012801564,0.00023451273,0.8405414,0.0024814154,0.093843125,0.019514868],"study_design_scores_gemma":[0.003773764,0.0017736845,0.15646583,0.006553769,0.00050226005,0.0000049413015,0.000066696084,0.0005013019,0.8287483,0.0013260058,0.00012058951,0.0001628871],"about_ca_topic_score_codex":0.00015591984,"about_ca_topic_score_gemma":9.830625e-7,"teacher_disagreement_score":0.1401567,"about_ca_system_score_codex":0.000010532068,"about_ca_system_score_gemma":0.00007596587,"threshold_uncertainty_score":0.5172249},"labels":[],"label_agreement":null},{"id":"W4247851911","doi":"10.1136/annrheumdis-2019-216653","title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis","year":2020,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European League Against Rheumatism","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Abatacept; Internal medicine; Tocilizumab; Observational study; Hazard ratio; Adalimumab; Confidence interval; Rituximab","score_opus":0.04964513609058727,"score_gpt":0.34539003284934683,"score_spread":0.29574489675875953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247851911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004983179,0.98300326,0.000030512829,0.007960981,0.00012270204,0.007341808,0.0014430197,0.00001028563,0.000037583264],"genre_scores_gemma":[0.0011479591,0.99784404,0.000083665895,0.00023523487,0.0000105464815,0.00053303357,0.00008526163,0.000029913914,0.000030331044],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99588144,0.00082981825,0.0021594134,0.00024423923,0.0006083709,0.00027669032],"domain_scores_gemma":[0.99413925,0.0020587717,0.0020212363,0.001340997,0.0003388208,0.000100915684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015378048,0.00038094952,0.002788616,0.00008024428,0.00021830264,0.000033245764,0.0010437979,0.00009092831,0.0000549912],"category_scores_gemma":[0.0017776447,0.00013828604,0.0015151675,0.00061917724,0.00065641355,0.000082813145,0.0005003032,0.0002582965,0.0000026007408],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000511645,0.00011010849,0.000006287117,0.50412965,0.0027017388,0.0000011022256,0.00022223502,5.541723e-7,1.5526446e-7,0.0034063435,0.004722976,0.48464772],"study_design_scores_gemma":[0.00038182948,0.00010736137,0.000055557735,0.82160884,0.0005764363,0.00007490024,0.00029888868,0.00001930967,0.000004531921,0.00050965114,0.176245,0.00011769058],"about_ca_topic_score_codex":0.000008760623,"about_ca_topic_score_gemma":0.0000012917496,"teacher_disagreement_score":0.48453003,"about_ca_system_score_codex":0.000013400139,"about_ca_system_score_gemma":0.00019565792,"threshold_uncertainty_score":0.5639141},"labels":[],"label_agreement":null},{"id":"W4252116227","doi":"10.1136/annrheumdis-2016-eular.3256","title":"FRI0447 Long-Term (156-Week) Efficacy and Safety Profile of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from A Phase III, Randomized, Controlled Trial and Open-Label Extension (Palace 1)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Apremilast; Psoriatic arthritis; Randomized controlled trial; Placebo; Internal medicine; Rheumatology; Surgery; Arthritis","score_opus":0.062148304918798795,"score_gpt":0.3675748343249025,"score_spread":0.3054265294061037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252116227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843519,0.0068830145,0.000012422879,0.0013263179,0.00013498079,0.006787674,0.00044816668,0.000012323995,0.000043241787],"genre_scores_gemma":[0.9939839,0.005420281,0.00010597438,0.00019268028,0.00003259546,0.0001671585,0.00004033393,0.00001742795,0.00003961908],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99711174,0.0006487495,0.0011959805,0.00036965378,0.00042663552,0.00024722234],"domain_scores_gemma":[0.9946202,0.0036282653,0.00088265864,0.00040805904,0.00021251888,0.00024831708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010244705,0.00026354505,0.0020047144,0.000053848576,0.00010339887,0.000042271018,0.00016794882,0.000054245156,0.00006019663],"category_scores_gemma":[0.004967803,0.0001216139,0.00009741167,0.000115413546,0.00041366674,0.00041077545,0.00023249695,0.00009686162,8.994411e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9008158,0.007030174,0.0021600823,0.000119018296,0.0005923278,0.000005757373,0.00032182803,5.110305e-7,0.000029705967,0.000010118644,0.000260959,0.08865375],"study_design_scores_gemma":[0.9571754,0.002536354,0.0331249,0.0055539384,0.0008168155,0.0000011019156,0.000065299675,0.00017119183,0.00023853453,0.00013954772,0.000014083496,0.00016287237],"about_ca_topic_score_codex":0.00020916817,"about_ca_topic_score_gemma":0.000032337044,"teacher_disagreement_score":0.08849088,"about_ca_system_score_codex":0.000012253232,"about_ca_system_score_gemma":0.000089258916,"threshold_uncertainty_score":0.5947283},"labels":[],"label_agreement":null},{"id":"W4252763409","doi":"10.1136/annrheumdis-2018-eular.5490","title":"THU0149 Trends in the incidence of infection in patients with rheumatoid arthritis in spain: an observational cohort study of hospital discharges from 1999 to 2015 (TREND-AR STUDY)","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Horizon Pharma; Celgene; Momenta Pharmaceuticals; Gilead Sciences; Genentech; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Incidence (geometry); Rheumatoid arthritis; Population; Retrospective cohort study; Observational study; Demography; Trend analysis; Pediatrics; Internal medicine; Environmental health; Statistics","score_opus":0.03504917723047292,"score_gpt":0.32489380195790063,"score_spread":0.2898446247274277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252763409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699116,0.00065070746,0.0000018730461,0.000505808,0.00007333113,0.001620884,0.00012433769,0.000009004389,0.000022894252],"genre_scores_gemma":[0.99872416,0.0009250281,0.000023241053,0.000045643534,0.000013799849,0.00018015242,0.00006687348,0.000017151608,0.0000039473152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690425,0.0005410293,0.0008472716,0.00029723826,0.0011382657,0.0002719503],"domain_scores_gemma":[0.9983942,0.00025003988,0.0003257202,0.0006558168,0.0002678709,0.00010638843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007533917,0.00020078217,0.00065699674,0.00042225613,0.000058609763,0.000022966351,0.00033860738,0.000033446107,0.00010016018],"category_scores_gemma":[0.00060469884,0.000121311,0.000079304686,0.0010261755,0.0002371334,0.00037192818,0.00009481741,0.00013302383,0.000002183809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074257527,0.011748902,0.96769416,0.00002823933,0.00014112832,0.0000031730842,0.011467501,0.000042225103,0.0000028290665,0.00003530922,0.00023959845,0.007854354],"study_design_scores_gemma":[0.003948746,0.006010677,0.98379,0.0018034943,0.000008002071,4.0223168e-7,0.0039455076,0.000064207736,0.00003095031,0.0002721502,0.000005270302,0.00012060016],"about_ca_topic_score_codex":0.013263634,"about_ca_topic_score_gemma":0.025382273,"teacher_disagreement_score":0.016095826,"about_ca_system_score_codex":0.000022898044,"about_ca_system_score_gemma":0.00009132938,"threshold_uncertainty_score":0.9933071},"labels":[],"label_agreement":null},{"id":"W4254828997","doi":"10.1136/annrheumdis-2011-201036","title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Statement (logic); MEDLINE; Intensive care medicine; Bioinformatics","score_opus":0.12823671507646572,"score_gpt":0.3772842218298273,"score_spread":0.24904750675336157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254828997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581072,0.034573074,0.000021179541,0.00403619,0.00025704096,0.002011445,0.00086438435,0.00003116015,0.00009834013],"genre_scores_gemma":[0.9521452,0.046923544,0.0000504638,0.00022530259,0.00003303014,0.00025156108,0.000100321995,0.000021371923,0.00024920003],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979879,0.00022120237,0.00063671515,0.00017248931,0.00048902706,0.0004926157],"domain_scores_gemma":[0.9974222,0.0010618173,0.00033271522,0.0006895127,0.0001781937,0.00031555997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027225597,0.00023814409,0.00057596737,0.00007305366,0.00017852845,0.000016373266,0.00024580752,0.00003984422,0.0006688318],"category_scores_gemma":[0.00050919416,0.0001073531,0.0004825751,0.00010878065,0.000449555,0.00004891815,0.000047969006,0.000046795296,0.000043512555],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009653793,0.031275067,0.16224861,0.0015662633,0.00970895,0.000009293001,0.003634561,0.00017249823,0.00020838612,0.011565822,0.31262517,0.45733157],"study_design_scores_gemma":[0.010976494,0.007235906,0.9051931,0.0027014986,0.00038592116,0.000019847146,0.0022528684,0.0011635799,0.0048373137,0.005231844,0.059488036,0.0005136107],"about_ca_topic_score_codex":0.00010842482,"about_ca_topic_score_gemma":0.0000034835202,"teacher_disagreement_score":0.7429445,"about_ca_system_score_codex":0.000033350156,"about_ca_system_score_gemma":0.000118337666,"threshold_uncertainty_score":0.73232394},"labels":[],"label_agreement":null},{"id":"W4255635546","doi":"10.1136/annrheumdis-2018-eular.2000","title":"SAT0253 Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AstraZeneca; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Internal medicine","score_opus":0.016091694757812455,"score_gpt":0.2963769753966236,"score_spread":0.28028528063881114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255635546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958123,0.0005493259,0.000009805108,0.00030072217,0.00005361284,0.0029007457,0.00020065304,0.000019480334,0.00015337333],"genre_scores_gemma":[0.99961114,0.00015017725,0.000030701638,0.000022192287,0.000020171812,0.0000754215,0.000018666022,0.000028664674,0.00004284321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697566,0.00029083155,0.0009875142,0.00033825473,0.0010563208,0.00035144383],"domain_scores_gemma":[0.996808,0.0003191367,0.00064390904,0.0008899069,0.0011302717,0.00020876263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056072074,0.00021191461,0.0007568762,0.00023538791,0.000068829264,0.000011548704,0.00026845583,0.000039253173,0.000030232532],"category_scores_gemma":[0.003802737,0.00013755762,0.0001651592,0.00066737126,0.0006826675,0.00015842213,0.00013603168,0.00011089784,0.00000226516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07802218,0.0137730045,0.88492155,0.0019665966,0.0012440413,0.000024232624,0.0059749447,0.00016310596,0.00005510994,0.000304014,0.0006878692,0.01286333],"study_design_scores_gemma":[0.053522903,0.0026814884,0.93579245,0.0044327653,0.00011937403,0.0000027846288,0.0019756125,0.0005889674,0.00035325173,0.00040147395,0.0000020111042,0.00012689545],"about_ca_topic_score_codex":0.0007054159,"about_ca_topic_score_gemma":0.000045611367,"teacher_disagreement_score":0.0508709,"about_ca_system_score_codex":0.00046691357,"about_ca_system_score_gemma":0.0025632817,"threshold_uncertainty_score":0.5609437},"labels":[],"label_agreement":null},{"id":"W4256686146","doi":"10.1136/annrheumdis-2012-eular.3080","title":"SAT0133 Golimumab 3-year safety update: An analysis of pooled data from the long term extensions of randomized, double-blind, placebo-controlled studies in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Placebo; Rheumatoid arthritis; Concomitant; Ankylosing spondylitis; Internal medicine; Randomized controlled trial; Clinical trial; Surgery; Adalimumab; Pathology","score_opus":0.09185075273306532,"score_gpt":0.3832808226158837,"score_spread":0.2914300698828184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256686146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84539753,0.15014574,0.000028055354,0.0006010243,0.00012291799,0.0022491175,0.0014129662,0.000017161672,0.000025493537],"genre_scores_gemma":[0.88017136,0.11884466,0.00011724069,0.000096961565,0.000044313834,0.00009702487,0.0005846126,0.000031599466,0.000012247787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943834,0.0013785695,0.002119525,0.000460902,0.0010811663,0.00057644414],"domain_scores_gemma":[0.9901228,0.005807886,0.0010275713,0.0023277705,0.00042492573,0.0002890534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038864275,0.00035780953,0.0035505374,0.00039670776,0.0001545443,0.000040270003,0.00074804394,0.000104551,0.00029131208],"category_scores_gemma":[0.006710024,0.00021123409,0.0006268604,0.00089536986,0.0013460814,0.0004976225,0.0007335088,0.00020788099,0.0000038462854],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86205596,0.0028512296,0.043125506,0.0015015765,0.03689982,0.000039306833,0.0068744216,0.00031901652,0.000061838444,0.0018666975,0.0008771242,0.04352752],"study_design_scores_gemma":[0.87032855,0.00011672522,0.09162981,0.01158078,0.006963706,0.0000425098,0.00397555,0.013703813,0.00031448857,0.0009933629,0.00000953458,0.00034118118],"about_ca_topic_score_codex":0.0021799044,"about_ca_topic_score_gemma":0.0008372835,"teacher_disagreement_score":0.048504304,"about_ca_system_score_codex":0.00025684046,"about_ca_system_score_gemma":0.0010955258,"threshold_uncertainty_score":0.8613876},"labels":[],"label_agreement":null},{"id":"W4281703831","doi":"10.1136/annrheumdis-2021-221801","title":"The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; Children's Hospital of Western Ontario; Lawson Health Research Institute; Alberta Children's Hospital; Western University","funders":"Chugai Pharmaceutical; EMD Serono; National Institutes of Health; Idorsia Pharmaceuticals; Swedish Orphan Biovitrum; European League Against Rheumatism; Ablynx; Regeneron Pharmaceuticals; Celgene; Biogen; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Rheumatology; Tumor necrosis factor alpha; Internal medicine; Pathology; Immunology","score_opus":0.012326600506929186,"score_gpt":0.2543578670574643,"score_spread":0.24203126655053514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281703831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867601,0.0067840377,0.000002189295,0.0013305745,0.00044838327,0.0013184755,0.0033358717,0.00000980645,0.00001057818],"genre_scores_gemma":[0.99670243,0.0026437,0.00002053217,0.00008353974,0.000002759257,0.00035274719,0.000057424673,0.000040120063,0.00009677255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680054,0.00070438004,0.0010450544,0.00043233178,0.0005390917,0.00047862332],"domain_scores_gemma":[0.99705774,0.00043648458,0.0013272602,0.000765361,0.00030257192,0.000110594236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005401729,0.00035457834,0.00071710045,0.000106286476,0.0008047659,0.00003811842,0.0010626831,0.000072411254,0.000043184395],"category_scores_gemma":[0.0020209074,0.00022375741,0.00047394956,0.00055666897,0.0013142208,0.000020744097,0.0012767066,0.00014713126,6.469903e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009613124,0.0017991671,0.9592638,0.0016573159,0.0020754104,0.000004485113,0.0029867094,0.00016172709,0.020736512,0.000389174,0.0063840817,0.003580329],"study_design_scores_gemma":[0.0024902988,0.0012988257,0.9411953,0.0016461659,0.00058895024,0.000024740271,0.016580055,0.00011133787,0.03389238,0.00036731886,0.001172221,0.0006324208],"about_ca_topic_score_codex":0.00018735876,"about_ca_topic_score_gemma":0.000049827202,"teacher_disagreement_score":0.01806849,"about_ca_system_score_codex":0.00006499303,"about_ca_system_score_gemma":0.0003150491,"threshold_uncertainty_score":0.9124562},"labels":[],"label_agreement":null},{"id":"W4282913371","doi":"10.1136/annrheumdis-2022-222586","title":"Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Galápagos; AbbVie; Pfizer","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Tofacitinib; Tocilizumab; Janus kinase; Antirheumatic Agents; TNF inhibitor; Methotrexate; Internal medicine; Pharmacology; Adalimumab; Rituximab; Cytokine","score_opus":0.010500451672065043,"score_gpt":0.25658075246224143,"score_spread":0.2460803007901764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282913371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760441,0.019478515,0.0000033913386,0.0015264445,0.0002921644,0.0019635544,0.0005977565,0.000025102914,0.00006897603],"genre_scores_gemma":[0.99097073,0.008365895,0.000024175764,0.00010332006,0.000022274819,0.00027554028,0.00017753894,0.00004313026,0.00001738531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592125,0.0011865336,0.00088215113,0.00043143457,0.0011550704,0.00042354054],"domain_scores_gemma":[0.9971355,0.0012351125,0.000504819,0.0006944636,0.00023178764,0.0001983033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000977632,0.00031060856,0.0008037647,0.0002580535,0.00026723745,0.000060193415,0.00033615946,0.000050082377,0.00006501658],"category_scores_gemma":[0.0010944502,0.00020530386,0.00017070696,0.0009954328,0.00056942354,0.00031235057,0.00029057797,0.00029414558,0.0000022770937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037956398,0.0016159476,0.95604783,0.0006162672,0.000310335,0.000022436649,0.003831578,0.0005605894,0.00031270352,0.00026864358,0.008625032,0.023992976],"study_design_scores_gemma":[0.014762472,0.0012698798,0.95569426,0.013933489,0.000023820885,0.000013239383,0.00668098,0.00019603569,0.004048322,0.0018348367,0.0011031199,0.00043951895],"about_ca_topic_score_codex":0.0025109744,"about_ca_topic_score_gemma":0.00059651607,"teacher_disagreement_score":0.023553457,"about_ca_system_score_codex":0.00009690133,"about_ca_system_score_gemma":0.0004549552,"threshold_uncertainty_score":0.8372048},"labels":[],"label_agreement":null},{"id":"W4282930645","doi":"10.1136/annrheumdis-2021-222081","title":"MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Lesion; SPINE (molecular biology); Spondylarthritis; Radiology; Magnetic resonance imaging; Nuclear medicine; Ankylosing spondylitis; Pathology; Surgery; Bioinformatics; Sacroiliitis","score_opus":0.036839398113065774,"score_gpt":0.2705114102807974,"score_spread":0.23367201216773162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282930645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502164,0.0024043804,0.0000059968233,0.001322127,0.00007125778,0.00063308614,0.0004460751,0.000006643985,0.000088788096],"genre_scores_gemma":[0.99867785,0.00092338433,0.000049990897,0.00011647146,0.000005885662,0.0000675133,0.00012951565,0.000013136015,0.000016242206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986927,0.0002038722,0.0003605037,0.0001504531,0.00044868316,0.00014377576],"domain_scores_gemma":[0.99908656,0.00008127724,0.000315109,0.0003969036,0.000074812975,0.000045311554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016580005,0.00012060696,0.00028571635,0.000054400225,0.00032304256,0.000008200496,0.00016262,0.000017329803,0.000059078437],"category_scores_gemma":[0.00009786575,0.000062967236,0.00010185922,0.00032124526,0.00022637757,0.00007202979,0.0002013676,0.000084160034,3.3801533e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011487551,0.005442371,0.93665147,0.00028064018,0.00045864447,0.0000042606944,0.0014865804,0.00030818727,0.000091751106,0.0033642063,0.0023478805,0.04841524],"study_design_scores_gemma":[0.003068887,0.00072647625,0.9919526,0.0012410402,0.00021004741,0.0000044901603,0.0009798913,0.000033099845,0.00025022234,0.0012936443,0.00016037366,0.000079209305],"about_ca_topic_score_codex":0.00016553854,"about_ca_topic_score_gemma":0.00007927842,"teacher_disagreement_score":0.055301134,"about_ca_system_score_codex":0.000013787093,"about_ca_system_score_gemma":0.000039304727,"threshold_uncertainty_score":0.25677294},"labels":[],"label_agreement":null},{"id":"W4282945243","doi":"10.1136/annrheumdis-2022-222747","title":"Instrument selection for the ASAS core outcome set for axial spondyloarthritis","year":2022,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Arthritis Society; University Health Network; Pfizer (Canada)","funders":"Assessment of SpondyloArthritis international Society","keywords":"Medicine; Ankylosing spondylitis; Dactylitis; Physical therapy; Enthesitis; BASFI; Spondylitis; Internal medicine; BASDAI; Psoriatic arthritis; Disease","score_opus":0.34017799496181145,"score_gpt":0.4450335063848478,"score_spread":0.10485551142303634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282945243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037905097,0.98721474,0.000013621718,0.00061409554,0.0009137393,0.0060613435,0.0046843532,0.000033948578,0.00008513271],"genre_scores_gemma":[0.0010752352,0.9924428,0.00006194126,0.00019142857,0.00014226462,0.004439375,0.0005866685,0.000070644965,0.0009896343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791694,0.000085530104,0.0008623699,0.00032838664,0.00043845765,0.00036832728],"domain_scores_gemma":[0.9971557,0.0013756829,0.0006893481,0.0005583304,0.00011976686,0.00010112052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027667265,0.0004059968,0.0016855868,0.00008880005,0.00060975464,0.000028153601,0.00032907492,0.00008348405,0.00034607135],"category_scores_gemma":[0.0009797014,0.00021649923,0.0020612816,0.00027073195,0.00013068024,0.000040774583,0.00018168619,0.00014343174,0.0000065238646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018709018,0.00030196845,0.0002454512,0.014082998,0.0019398116,0.0000019820584,0.000057091587,0.0000013083279,1.3583931e-8,0.00040463862,0.014580525,0.9681971],"study_design_scores_gemma":[0.0017404079,0.0007443152,0.00034006417,0.007915355,0.004780876,0.000078568875,0.00014553487,0.00002477693,8.544344e-7,0.0005598677,0.98346806,0.00020129858],"about_ca_topic_score_codex":0.0000664181,"about_ca_topic_score_gemma":0.000024308518,"teacher_disagreement_score":0.96888757,"about_ca_system_score_codex":0.00008317589,"about_ca_system_score_gemma":0.00028043144,"threshold_uncertainty_score":0.8828582},"labels":[],"label_agreement":null},{"id":"W4283383033","doi":"10.1136/ard-2022-222538","title":"Developing guidelines for ultrarare rheumatic disorders: a bumpy ride","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Scarcity; Process (computing); Realm; Product (mathematics); Systematic review; MEDLINE; Disease; Alternative medicine; Intensive care medicine; Management science; Engineering ethics; Pathology; Computer science","score_opus":0.5134306103617197,"score_gpt":0.5385985087997931,"score_spread":0.025167898438073433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283383033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7275131,0.0028971762,0.008263299,0.2558381,0.0008817645,0.0035992283,0.00068117474,0.00014323473,0.0001829191],"genre_scores_gemma":[0.9767396,0.0008616205,0.008520482,0.012610749,0.00007455855,0.00056936085,0.00021972603,0.00005246742,0.00035143696],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99699795,0.00019297953,0.0015996061,0.00025656316,0.0006637781,0.00028912755],"domain_scores_gemma":[0.99559414,0.0022772164,0.0008132604,0.0005983223,0.00059893297,0.00011811745],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010324842,0.00018966814,0.0004786356,0.00009657935,0.00033767198,0.00002363087,0.00037062017,0.000025170335,0.00043690237],"category_scores_gemma":[0.025404586,0.00013859011,0.00044451014,0.00035153443,0.000084313564,0.00017531322,0.00023631303,0.00012039173,0.000007288806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015318493,0.0016095445,0.019459372,0.0040231524,0.0012981612,0.0000029297062,0.0010803427,0.002295166,0.00008985333,0.0058895475,0.39818138,0.5645387],"study_design_scores_gemma":[0.023725275,0.0036628386,0.27519515,0.010875008,0.005000809,0.0002163428,0.050788026,0.051972125,0.0024405974,0.38378227,0.18968122,0.0026603525],"about_ca_topic_score_codex":0.00017749806,"about_ca_topic_score_gemma":0.000028076744,"teacher_disagreement_score":0.5618783,"about_ca_system_score_codex":0.0000486285,"about_ca_system_score_gemma":0.00052322674,"threshold_uncertainty_score":0.98280483},"labels":[],"label_agreement":null},{"id":"W4283576233","doi":"10.1136/annrheumdis-2022-eular.164","title":"OP0034 IXEKIZUMAB IMPROVES SIGNS, SYMPTOMS, AND QUALITY OF LIFE IN PATIENTS WITH AXIAL SpA IRRESPECTIVE OF DISEASE DURATION: RESULTS FROM THE COAST-V, COAST-W AND COAST-X TRIALS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Ixekizumab; Internal medicine; Axial spondyloarthritis; Demographics; Placebo; Physical therapy; Ankylosing spondylitis; Disease; Demography; Pathology; Secukinumab; Sacroiliitis","score_opus":0.048021408360177376,"score_gpt":0.3134336407927013,"score_spread":0.26541223243252393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283576233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835873,0.0076015806,0.0000055802157,0.002064411,0.00007160542,0.0013380175,0.0053068227,0.000010435963,0.0000142174795],"genre_scores_gemma":[0.9972534,0.0023015046,0.000017119548,0.0001432101,0.000023277089,0.00006433718,0.00016194483,0.000018135588,0.000017036027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573255,0.0014240656,0.001278072,0.0002978327,0.001036428,0.00023107418],"domain_scores_gemma":[0.9952295,0.0025773952,0.0010355024,0.00057800993,0.0003245902,0.00025504763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014102629,0.00020726021,0.0009716327,0.00009349367,0.00019129447,0.00002964198,0.00025045467,0.000027634358,0.000059212478],"category_scores_gemma":[0.008012323,0.00011785216,0.00016352948,0.0002559465,0.0006396529,0.00015628303,0.00032388954,0.00015736847,2.636291e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10813775,0.0038277511,0.81521636,0.0009249853,0.0018878528,0.0000044838193,0.010331475,0.00011635822,0.00026265698,0.0011583588,0.004367488,0.053764492],"study_design_scores_gemma":[0.011473357,0.0012268185,0.9805946,0.00087694137,0.00005877432,4.4617366e-7,0.0037565073,0.00007996389,0.00017581628,0.0015849258,0.000040822928,0.00013105328],"about_ca_topic_score_codex":0.0029899548,"about_ca_topic_score_gemma":0.00042211072,"teacher_disagreement_score":0.16537823,"about_ca_system_score_codex":0.000016263533,"about_ca_system_score_gemma":0.00043646607,"threshold_uncertainty_score":0.9592078},"labels":[],"label_agreement":null},{"id":"W4283576570","doi":"10.1136/annrheumdis-2022-eular.2441","title":"OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"UCB Pharma; Sahlgrenska Akademin; Universitätsspital Zürich; Diakonhjemmet; Universidade de Lisboa; Amsterdam University Medical Centers; Univerzita Karlova v Praze; Göteborgs Universitet; Vrije Universiteit Amsterdam; Dokuz Eylül Üniversitesi; Lunds Universitet; Skånes universitetssjukhus; Universität Zürich; Radboud Universiteit; University of Aberdeen; Helsingin Yliopisto; Háskóli Íslands; Aarhus Universitet; Aarhus Universitetshospital","keywords":"Medicine; Ankylosing spondylitis; Placebo; Clinical endpoint; BASDAI; Internal medicine; Mallinckrodt; Surgery; Gastroenterology; Randomized controlled trial; Arthritis","score_opus":0.026527281348669492,"score_gpt":0.3033886283584113,"score_spread":0.2768613470097418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283576570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98479605,0.0018709481,0.0000026367345,0.0002653408,0.0001554958,0.009269887,0.0035226594,0.00003747287,0.000079533085],"genre_scores_gemma":[0.9975307,0.00010599314,0.000047673406,0.0002368484,0.000015770396,0.001292452,0.0005889749,0.00004235577,0.00013925887],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99688065,0.00059338583,0.0007736921,0.00044529492,0.00088497106,0.00042198255],"domain_scores_gemma":[0.99738324,0.0011155341,0.00049067603,0.00067888584,0.00015380864,0.00017785886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019987194,0.00035626246,0.001301211,0.00015622436,0.00038398724,0.00002534278,0.00024041721,0.000027144055,0.0009798049],"category_scores_gemma":[0.0006556447,0.00023291547,0.00035218423,0.0003916918,0.00011750505,0.00012327694,0.00025796733,0.00018594868,0.000006808213],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82361615,0.06442419,0.06695609,0.00008803767,0.004139791,0.00010260541,0.007931579,0.00054664194,0.0000041686603,0.0000050622048,0.00068856427,0.031497143],"study_design_scores_gemma":[0.6761956,0.0033886966,0.31079164,0.00064653606,0.0014308537,0.0000028638692,0.0068846364,0.00009697305,0.000022634558,0.000054747663,0.00022983622,0.00025498585],"about_ca_topic_score_codex":0.00063046283,"about_ca_topic_score_gemma":0.00009718289,"teacher_disagreement_score":0.24383554,"about_ca_system_score_codex":0.00012563512,"about_ca_system_score_gemma":0.00014137743,"threshold_uncertainty_score":0.9999334},"labels":[],"label_agreement":null},{"id":"W4283579364","doi":"10.1136/annrheumdis-2022-eular.2534","title":"OP0016 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Foundation for Research in Rheumatology; Universitair Medisch Centrum Groningen; Eli Lilly and Company","keywords":"Medicine; BASDAI; Axial spondyloarthritis; Internal medicine; Placebo; Population; Ankylosing spondylitis; Randomized controlled trial; Clinical endpoint; Physical therapy; Gastroenterology; Surgery; Arthritis; Pathology; Psoriatic arthritis; Sacroiliitis","score_opus":0.02188170937855519,"score_gpt":0.29995646284363703,"score_spread":0.2780747534650818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283579364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776007,0.0019772148,0.00000269824,0.00030893224,0.00015555383,0.008936407,0.0005815746,0.000013252106,0.0002642939],"genre_scores_gemma":[0.9978928,0.0006477781,0.000016717975,0.00006435955,0.000022153463,0.0011835328,0.0000987346,0.000025015604,0.000048887836],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99750644,0.00035296704,0.00085957866,0.00029769028,0.00068360893,0.00029970618],"domain_scores_gemma":[0.9979177,0.0008072041,0.0006140561,0.00037757974,0.00014498306,0.00013849353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039404546,0.00027476123,0.0017839862,0.00028328216,0.00022991076,0.000012331239,0.0001547185,0.000035678248,0.00019977582],"category_scores_gemma":[0.00042017715,0.00017002149,0.00049339957,0.00047203168,0.00044578925,0.000094181,0.0001478252,0.00014555278,8.2635376e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97351253,0.0062526413,0.0028428577,0.00011118991,0.0018027077,0.000017217757,0.0005309329,0.000025374979,0.000001411858,0.00007228105,0.000061006285,0.014769847],"study_design_scores_gemma":[0.9717387,0.002999325,0.02274209,0.0008682018,0.0008840131,0.0000061313976,0.0003949001,0.00004450874,0.000030709132,0.00012234133,0.000019213134,0.00014987675],"about_ca_topic_score_codex":0.00013488151,"about_ca_topic_score_gemma":0.000012622361,"teacher_disagreement_score":0.019899232,"about_ca_system_score_codex":0.000023457087,"about_ca_system_score_gemma":0.0001384778,"threshold_uncertainty_score":0.6933275},"labels":[],"label_agreement":null},{"id":"W4283582365","doi":"10.1136/annrheumdis-2022-eular.1178","title":"OP0200-PARE BARING IT ALL: A REPORT ON THE SEXUAL AND REPRODUCTIVE HEALTH EXPERIENCES OF WOMEN+ WITH INFLAMMATORY ARTHRITIS, RHEUMATIC AND PSORIATIC DISEASES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"Cilag; Lungenliga Schweiz; Pfizer","keywords":"Medicine; Psoriatic arthritis; Reproductive health; Psoriasis; Family medicine; Mental health; Sexual dysfunction; Gerontology; Psychiatry; Population; Immunology; Environmental health","score_opus":0.035528053465040746,"score_gpt":0.31167104982118415,"score_spread":0.2761429963561434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283582365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97723573,0.012736094,0.0000052738887,0.009026908,0.00008055881,0.0007991488,0.00004695385,0.000023800096,0.000045544697],"genre_scores_gemma":[0.996428,0.0017947768,0.000016381238,0.0011492091,0.000016977296,0.00048650496,0.000010280626,0.000015199677,0.00008268041],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9978938,0.00027234544,0.0005831716,0.00030188667,0.00067030505,0.00027849764],"domain_scores_gemma":[0.99779266,0.00039621597,0.0007024845,0.00074977387,0.00007538216,0.00028348845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007681578,0.00016439261,0.0004934245,0.000074663156,0.000275724,0.000015736225,0.00017273266,0.000014579513,0.00013834007],"category_scores_gemma":[0.0025720547,0.000092440896,0.000049814927,0.00019053806,0.00046103852,0.00011364922,0.00014968282,0.00011972175,3.8162966e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004335986,0.0042100055,0.11899871,0.013993301,0.0036016256,0.00015822063,0.6094919,0.0004047936,0.000057979687,0.0036269191,0.03432206,0.20679855],"study_design_scores_gemma":[0.0026528945,0.003617999,0.624294,0.01179169,0.00032754443,0.00067868776,0.351722,0.0003287363,0.0002747169,0.0032069655,0.0006688687,0.00043593338],"about_ca_topic_score_codex":0.000049474078,"about_ca_topic_score_gemma":0.0000030795356,"teacher_disagreement_score":0.5052953,"about_ca_system_score_codex":0.000043457454,"about_ca_system_score_gemma":0.0005315007,"threshold_uncertainty_score":0.37696305},"labels":[],"label_agreement":null},{"id":"W4283583738","doi":"10.1136/annrheumdis-2022-eular.1695","title":"OP0160 HLA-DRB1 ASSOCIATIONS WITH AUTOANTIBODY-DEFINED SUBGROUPS IN IDIOPATHIC INFLAMMATORY MYOPATHIES (IIM)","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"EMD Serono; Argenx; Biogen; Gilead Sciences; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Autoantibody; Medicine; Immunology; Internal medicine; HLA-DRB1; Human leukocyte antigen; Dermatomyositis; Antigen; Antibody","score_opus":0.019861844573497628,"score_gpt":0.26367229805062686,"score_spread":0.24381045347712924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283583738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915576,0.0023782074,0.000013307991,0.0038980115,0.00022002654,0.0007607573,0.000217658,0.000110657704,0.0008437626],"genre_scores_gemma":[0.9980652,0.00016142479,0.000047020858,0.0011443445,0.00004028875,0.00021301059,0.000043976303,0.000047443893,0.00023734302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701124,0.0004193073,0.00084722484,0.00028705678,0.0009793971,0.0004557974],"domain_scores_gemma":[0.9980969,0.00021138613,0.0005870917,0.00074736506,0.00019628425,0.00016100073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007486707,0.00027742426,0.0007191883,0.00027136193,0.00045679833,0.000038422484,0.0003838294,0.00006106658,0.00019274032],"category_scores_gemma":[0.0005334511,0.00020241443,0.00032008218,0.00067693414,0.00021145518,0.00020213265,0.00030269747,0.00032310656,0.000015789494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001140157,0.0017083179,0.9457659,0.002598146,0.0006406567,0.00048743506,0.0053965617,0.002159165,0.0003713243,0.023310438,0.012702771,0.0037191436],"study_design_scores_gemma":[0.0019951344,0.00035828227,0.9879613,0.0014669864,0.00023753097,0.00014649365,0.0018495228,0.0011159353,0.0005730034,0.0030543348,0.00087869377,0.0003628186],"about_ca_topic_score_codex":0.00011844791,"about_ca_topic_score_gemma":0.000038181246,"teacher_disagreement_score":0.04219538,"about_ca_system_score_codex":0.00009231655,"about_ca_system_score_gemma":0.0005439895,"threshold_uncertainty_score":0.8254221},"labels":[],"label_agreement":null},{"id":"W4283583769","doi":"10.1136/annrheumdis-2022-eular.1444","title":"OP0037 USE OF PRIMARY HEALTHCARE AND RADIOLOGICAL IMAGING PRECEDING A DIAGNOSIS OF RHEUMATOID ARTHRITIS: A DANISH NATIONWIDE COHORT STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Medicine; Danish; Rheumatoid arthritis; Radiological weapon; Cohort; Cohort study; Family medicine; Physical therapy; Internal medicine; Pediatrics; Surgery","score_opus":0.07555231113027998,"score_gpt":0.3362328438119952,"score_spread":0.2606805326817152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283583769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848547,0.010237089,0.0000047084363,0.003681137,0.00013771773,0.0009639138,0.000069878944,0.000014229382,0.000036633028],"genre_scores_gemma":[0.9885695,0.010592514,0.00013724076,0.0003956137,0.000010191311,0.00024296342,0.000027321217,0.000010755003,0.000013885869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982774,0.00044934853,0.0005787638,0.00019833921,0.00035011105,0.00014599966],"domain_scores_gemma":[0.99780947,0.000984891,0.0006180909,0.00033120255,0.00016964736,0.0000866966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006660893,0.00010663035,0.000536073,0.00008350476,0.000234088,0.000017404407,0.00013731189,0.000019721689,0.000059116795],"category_scores_gemma":[0.0021156757,0.00008088052,0.00011311685,0.00020573883,0.00016836228,0.00019134133,0.00016464807,0.00011906416,1.9110686e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017746676,0.0010930038,0.97983426,0.00029902154,0.00024285438,0.0000021643061,0.0013400015,0.00006304064,0.000021260135,0.00009165393,0.0024938497,0.0143414065],"study_design_scores_gemma":[0.000558915,0.00038487648,0.99339914,0.0005428327,0.000097074175,0.000056771423,0.00416307,0.00021308048,0.00005701096,0.00034768606,0.00011147077,0.00006806701],"about_ca_topic_score_codex":0.0004849665,"about_ca_topic_score_gemma":0.0000067714564,"teacher_disagreement_score":0.014273339,"about_ca_system_score_codex":0.000024654086,"about_ca_system_score_gemma":0.00017140585,"threshold_uncertainty_score":0.3298212},"labels":[],"label_agreement":null},{"id":"W4283585710","doi":"10.1136/annrheumdis-2022-eular.4624","title":"OP0215 WHAT DOES THE PATIENT WELL-BEING VAS TELL US WHEN THE PHYSICIAN GLOBAL ASSESSMENT SCORE IS ZERO? ANALYSIS OF A LARGE MULTINATIONAL DATASET","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Istanbul Üniversitesi-Cerrahpasa; Universiteit Gent; Universitair Ziekenhuis Gent; Pennsylvania State University; University of Wisconsin-Madison; University of Pennsylvania; University of Alberta; Children's Hospital of Philadelphia","keywords":"Medicine; Visual analogue scale; Physical therapy; Arthritis; Quality of life (healthcare); Rheumatology; Psychological intervention; Disease; Internal medicine; Family medicine; Psychiatry; Nursing","score_opus":0.024857297461109783,"score_gpt":0.34380948257728194,"score_spread":0.3189521851161722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283585710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803604,0.0028802569,0.00004192287,0.0108579565,0.00011028741,0.0008792815,0.004337774,0.000012973272,0.0005191829],"genre_scores_gemma":[0.9937271,0.00053734554,0.000016299622,0.0044502215,0.000010437085,0.000111247515,0.0010365654,0.000012109397,0.0000986906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696517,0.0004422326,0.0006032414,0.00023141984,0.0014564695,0.00030145654],"domain_scores_gemma":[0.99781543,0.00032550155,0.0004992223,0.0010852994,0.00020548743,0.0000690476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062586536,0.00017492898,0.0004796082,0.00009899649,0.0005504076,0.00006781506,0.00075103616,0.000021478332,0.0013267467],"category_scores_gemma":[0.00019106953,0.00008014457,0.00051753904,0.0007702709,0.00024737578,0.00023240759,0.00080700463,0.00017901244,0.0000066119587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097234274,0.0099534225,0.43932864,0.0016921932,0.024092231,0.000024663741,0.016814109,0.010140186,0.00011976984,0.010824128,0.34229538,0.14374293],"study_design_scores_gemma":[0.001489145,0.0003519335,0.8941728,0.00071038,0.0033558048,0.000003034889,0.024633633,0.036574323,0.00047573418,0.0068102344,0.03111506,0.000307902],"about_ca_topic_score_codex":0.00024436487,"about_ca_topic_score_gemma":0.00002297675,"teacher_disagreement_score":0.45484418,"about_ca_system_score_codex":0.000048776117,"about_ca_system_score_gemma":0.00028163855,"threshold_uncertainty_score":0.99958616},"labels":[],"label_agreement":null},{"id":"W4283587187","doi":"10.1136/annrheumdis-2022-eular.4280","title":"OP0017 RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Placebo; Ankylosing spondylitis; Mallinckrodt; Internal medicine; Randomized controlled trial; Disease; Secukinumab; Family medicine","score_opus":0.010747014202556209,"score_gpt":0.24813015807809216,"score_spread":0.23738314387553594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283587187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98632157,0.004664018,6.744813e-7,0.0005443069,0.00012212721,0.0069097923,0.0012834424,0.000026978141,0.0001270671],"genre_scores_gemma":[0.9970679,0.00025573716,0.000053959084,0.00017582513,0.00002258673,0.0019738427,0.0001568136,0.000054537173,0.00023876871],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959577,0.00083099626,0.0010476455,0.0005154636,0.0012405902,0.00040765732],"domain_scores_gemma":[0.99719787,0.00072582735,0.00085722044,0.0007972156,0.000276845,0.00014501986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044110545,0.00046441774,0.0022871275,0.00017289768,0.00025942444,0.000024491512,0.00027751745,0.000044545606,0.0003294765],"category_scores_gemma":[0.0003835227,0.00024829817,0.00039921387,0.00040806306,0.000426824,0.00012353055,0.00022884176,0.0001969266,0.000002829742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76255196,0.006743365,0.22109811,0.00004161394,0.0027860592,0.00010236481,0.003583495,0.000093380746,9.405378e-7,0.00000398031,0.00025987523,0.0027348478],"study_design_scores_gemma":[0.57781833,0.0066080554,0.41182834,0.0009113867,0.0005865521,0.0000057779966,0.0018436055,0.000026887694,0.00003762664,0.000101365054,0.00002117453,0.00021090101],"about_ca_topic_score_codex":0.0010264062,"about_ca_topic_score_gemma":0.0005919556,"teacher_disagreement_score":0.19073021,"about_ca_system_score_codex":0.000067228975,"about_ca_system_score_gemma":0.00020487889,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W4283587683","doi":"10.1136/annrheumdis-2022-eular.3422","title":"OP0229 OSTEOARTHRITIS OF THE KNEE, INFLAMMATION, AND THE EFFECT OF ADALIMUMAB (OKINADA): A RANDOMIZED PLACEBO-CONTROLLED TRIAL","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université Laval; Alberta Bone and Joint Health Institute; University of Alberta","funders":"Sanofi Genzyme; Foundation for Research in Rheumatology; Universidad de Córdoba; Universidad de Granada; Teva Pharmaceutical Industries; Institute for Research in Biomedicine; Gilead Sciences; Universiteit Gent; Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológic; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Osteoarthritis; Internal medicine; Rheumatology; Placebo; Randomized controlled trial; Knee pain; Rheumatoid arthritis; Clinical endpoint; Synovitis; Surgery; Pathology","score_opus":0.008061060403945948,"score_gpt":0.26145841520268204,"score_spread":0.2533973547987361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283587683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96562546,0.020667301,0.0000035645114,0.0044761067,0.00025406838,0.008401513,0.000087340566,0.000013542971,0.0004710833],"genre_scores_gemma":[0.99498147,0.0031395182,0.000004714824,0.00006584531,0.000031912223,0.0015309516,0.0000065717677,0.00001844293,0.00022057809],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99397856,0.0034810333,0.0009930196,0.0001571922,0.0011509899,0.00023921783],"domain_scores_gemma":[0.9932,0.005043179,0.0008098663,0.00068762805,0.0001701767,0.00008913037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029890235,0.00019735988,0.0016092845,0.00009738215,0.00034466523,0.000023593166,0.0004126732,0.000029742932,0.0002825519],"category_scores_gemma":[0.006974335,0.000085013475,0.0009789282,0.00027171892,0.001332967,0.00007807823,0.00032206016,0.00017861564,8.155821e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97408956,0.00014040255,0.0002894565,0.00037363492,0.0009977894,0.0000012793041,0.0008821435,0.000073131225,0.00006242222,0.0019974287,0.0008688938,0.020223854],"study_design_scores_gemma":[0.9902907,0.0014114215,0.0006272634,0.0008847445,0.00022908737,0.000019188361,0.00037575423,0.00056608825,0.0021278234,0.00319568,0.00018449983,0.00008776769],"about_ca_topic_score_codex":0.00017884726,"about_ca_topic_score_gemma":0.000012904665,"teacher_disagreement_score":0.029355986,"about_ca_system_score_codex":0.000010374644,"about_ca_system_score_gemma":0.00022851024,"threshold_uncertainty_score":0.83494335},"labels":[],"label_agreement":null},{"id":"W4283587753","doi":"10.1136/annrheumdis-2022-eular.1762","title":"OP0027 ASSOCIATION BETWEEN BASELINE CARDIOVASCULAR RISK AND INCIDENCE RATES OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND MALIGNANCIES IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS RECEIVING TOFACITINIB","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Pfizer (Canada)","funders":"","keywords":"Medicine; Internal medicine; Myocardial infarction; Mace; Tofacitinib; Psoriatic arthritis; Dyslipidemia; Coronary artery disease; Cohort; Psoriasis; Arthritis; Surgery; Rheumatoid arthritis; Cardiology; Gastroenterology; Disease; Percutaneous coronary intervention; Dermatology","score_opus":0.012796983464369202,"score_gpt":0.21770257480153446,"score_spread":0.20490559133716527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283587753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496526,0.048614323,0.000009317411,0.000039850824,0.00009972617,0.00043751945,0.0011343856,0.000008924205,0.0000033623287],"genre_scores_gemma":[0.9924136,0.0073535535,0.000034033248,0.000011363744,0.00000627642,0.00006689993,0.000084118015,0.000012480877,0.00001766666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997823,0.0011016808,0.00039405245,0.00026446892,0.00020584087,0.00021093788],"domain_scores_gemma":[0.998679,0.00050840236,0.0003591182,0.00032180457,0.000100241276,0.00003147883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010525576,0.00017879705,0.0006815656,0.00010570919,0.00022470209,0.0000068196973,0.00012484865,0.00005932576,0.00003149632],"category_scores_gemma":[0.00074350735,0.00013763718,0.00023570006,0.00020421972,0.000099987396,0.00013230501,0.00018669221,0.00008753327,7.7796966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117320786,0.000102993254,0.86237395,0.00012104064,0.003400242,8.947923e-7,0.00043510547,0.00012630584,0.0000042748898,0.0000054775783,0.00002902647,0.13328336],"study_design_scores_gemma":[0.0031897388,0.00015574486,0.9933407,0.00043547514,0.0014635212,0.000002096519,0.00041046445,0.0000053081894,0.0005218579,0.00025113774,0.000077832825,0.00014616421],"about_ca_topic_score_codex":0.0005213606,"about_ca_topic_score_gemma":0.000022194163,"teacher_disagreement_score":0.1331372,"about_ca_system_score_codex":0.00002416424,"about_ca_system_score_gemma":0.000038893966,"threshold_uncertainty_score":0.56126815},"labels":[],"label_agreement":null},{"id":"W4283589428","doi":"10.1136/annrheumdis-2022-eular.1878","title":"OP0140 IMPACT OF TIME TO REMISSION, FLARES AND TIME ON IMMUNOSUPPRESSIVES ON THE ESTIMATED GLOMERULAR FILTRATION RATE IN LUPUS NEPHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"University of Toronto; Lupus Canada","keywords":"Medicine; Proteinuria; Lupus nephritis; Renal function; Internal medicine; Creatinine; Gastroenterology; Urology; Kidney disease; Systemic lupus erythematosus; Kidney; Disease","score_opus":0.03489892272778671,"score_gpt":0.33324665561736516,"score_spread":0.29834773288957844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283589428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920907,0.0017916468,5.640466e-7,0.004416713,0.00003337249,0.001083104,0.00017523614,0.00001859934,0.0003900743],"genre_scores_gemma":[0.9981023,0.00021362324,0.000008263842,0.00024313247,0.000008461132,0.00009948614,0.000031191234,0.000023460578,0.0012700733],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9977473,0.0006698487,0.00047331015,0.0002068734,0.00066066725,0.00024197418],"domain_scores_gemma":[0.99778706,0.0010530413,0.0002359575,0.0006704319,0.00012319251,0.00013034516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069050875,0.0001697473,0.000455195,0.00019030744,0.00014659768,0.000023101202,0.00032971878,0.000030678377,0.0015772538],"category_scores_gemma":[0.0023832645,0.00009244457,0.00017925802,0.00044085007,0.00011500714,0.00006018344,0.00019202265,0.00014281129,0.000045021774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013678998,0.0042219306,0.16192198,0.004351332,0.0022636668,0.0001226097,0.012856075,0.02066642,0.19441214,0.0004613725,0.55493534,0.030108152],"study_design_scores_gemma":[0.00821737,0.00837442,0.8246635,0.045205742,0.00040094432,0.001360589,0.0038294669,0.040566243,0.060490184,0.0053001493,0.00058015314,0.0010112184],"about_ca_topic_score_codex":0.0001248109,"about_ca_topic_score_gemma":4.5264937e-7,"teacher_disagreement_score":0.66274154,"about_ca_system_score_codex":0.00005541399,"about_ca_system_score_gemma":0.00018200601,"threshold_uncertainty_score":0.99933547},"labels":[],"label_agreement":null},{"id":"W4283590895","doi":"10.1136/annrheumdis-2022-eular.1753","title":"OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University","funders":"Michael Smith Health Research BC","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Comorbidity; Psoriasis; Epidemiology; Rheumatology; Hydroxychloroquine; Rheumatoid arthritis; Disease; Physical therapy; Immunology; Infectious disease (medical specialty); Coronavirus disease 2019 (COVID-19)","score_opus":0.05921945049366961,"score_gpt":0.30087400094580635,"score_spread":0.24165455045213674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283590895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661544,0.009484496,0.000023740378,0.009309089,0.00016441035,0.00069861975,0.01410473,0.000050715877,0.000009827761],"genre_scores_gemma":[0.99446887,0.001388696,0.000016947639,0.0022926785,0.000004714176,0.0001846626,0.0015291916,0.000018005654,0.00009622947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976351,0.0008932331,0.00047583494,0.0005019377,0.00015346399,0.0003404147],"domain_scores_gemma":[0.9966419,0.0015739944,0.0007359001,0.00090425217,0.000050741048,0.00009322181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043288685,0.00030417347,0.0007829114,0.0000348011,0.0006206205,0.000040709983,0.00066775817,0.0000810629,0.00011474898],"category_scores_gemma":[0.0025412,0.00018024776,0.00007081613,0.0003576465,0.0006409109,0.00013115659,0.00048984244,0.0001487493,0.0000028393013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019566538,0.00057779276,0.9806966,0.00012398607,0.0024125115,0.00004955877,0.00093955745,0.00002559832,0.000017373859,0.00023910501,0.00643812,0.0065231076],"study_design_scores_gemma":[0.004725632,0.0003110359,0.9878244,0.00023202438,0.0007177176,0.00014557647,0.002003918,0.000026465292,0.00003428349,0.0014294927,0.002211339,0.00033814032],"about_ca_topic_score_codex":0.0041204337,"about_ca_topic_score_gemma":0.0033066075,"teacher_disagreement_score":0.028314505,"about_ca_system_score_codex":0.00006310119,"about_ca_system_score_gemma":0.0005490584,"threshold_uncertainty_score":0.73502904},"labels":[],"label_agreement":null},{"id":"W4283591220","doi":"10.1136/annrheumdis-2022-eular.3458","title":"OP0141 TREAT TO TARGET IN SYSTEMIC LUPUS ERYTHEMATOSUS FROM THE PATIENTS' PERSPECTIVE – RESULTS FROM AN INTERNATIONAL PATIENT SURVEY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"Peking University Health Science Center; Sanofi Genzyme; Tokyo Women's Medical University; Peking University; Ingham Institute for Applied Medical Research; Chang Gung Medical Foundation; University of Toronto; Keio University; Hanyang University; University of New South Wales; Taichung Veterans General Hospital; Peking University First Hospital; Eli Lilly and Company; AstraZeneca; Medical University Sofia; Sanofi; GlaxoSmithKline; Universitas Padjadjaran; Lupus Canada; Universiti Malaya; Amgen","keywords":"Medicine; Family medicine; German; Internal medicine","score_opus":0.04222365891102604,"score_gpt":0.3291643796105326,"score_spread":0.28694072069950655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283591220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824097,0.0013513374,0.0000058793667,0.0028619047,0.0007951506,0.0017519632,0.010227636,0.000033666834,0.0005627563],"genre_scores_gemma":[0.99791044,0.000075695076,0.000036059515,0.0005277659,0.00005407333,0.0002787049,0.00082101976,0.000043077183,0.00025314893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949474,0.001523471,0.0009482023,0.00054610585,0.0016693069,0.0003655277],"domain_scores_gemma":[0.99531686,0.0020238708,0.00044538468,0.0014086828,0.00056038285,0.00024484517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008412411,0.00025919997,0.0006101641,0.00017815402,0.00019016772,0.000050667888,0.0010999232,0.00004323004,0.00034242563],"category_scores_gemma":[0.0049455664,0.00015658041,0.00023882613,0.00052769313,0.0001044612,0.00013928724,0.000701278,0.0002343627,0.000031971373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039975876,0.0017326011,0.94538385,0.00008548348,0.00043139188,0.000026340134,0.027602099,0.0007509581,0.000024615863,0.00012635108,0.018279605,0.0015591205],"study_design_scores_gemma":[0.008277437,0.0009384283,0.9209865,0.0036831733,0.00014633244,0.00036877714,0.059309382,0.0020033934,0.0003057108,0.0030380483,0.00046702384,0.00047580618],"about_ca_topic_score_codex":0.016019521,"about_ca_topic_score_gemma":0.0003339597,"teacher_disagreement_score":0.031707283,"about_ca_system_score_codex":0.00037528045,"about_ca_system_score_gemma":0.00027920934,"threshold_uncertainty_score":0.9905329},"labels":[],"label_agreement":null},{"id":"W4283592773","doi":"10.1136/annrheumdis-2022-eular.2946","title":"OP0149 RADIOGRAPHIC PROGRESSION FROM NON-RADIOGRAPHIC TO RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM A 5-YEAR MULTICOUNTRY PROSPECTIVE OBSERVATIONAL STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Axial spondyloarthritis; Sacroiliitis; Internal medicine; Radiography; Observational study; Rheumatology; Prospective cohort study; Ankylosing spondylitis; Physical therapy; Surgery","score_opus":0.05710332638314813,"score_gpt":0.328852419606143,"score_spread":0.27174909322299484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283592773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823585,0.0038409643,0.000013365064,0.0026094802,0.00048653784,0.0038229984,0.0066506923,0.00013850068,0.00007892329],"genre_scores_gemma":[0.9960322,0.00033178853,0.00055395294,0.0010180493,0.00020328173,0.0009706394,0.0007672831,0.000071029484,0.000051816183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99501646,0.0005056457,0.0011622385,0.00089035823,0.0018897562,0.0005355239],"domain_scores_gemma":[0.9965123,0.0006277433,0.0005839883,0.0013953297,0.00033685498,0.00054380024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005156072,0.0004688722,0.001005386,0.0007131711,0.000628493,0.00008127335,0.00064441434,0.00007602712,0.00041401965],"category_scores_gemma":[0.00096716493,0.00036834707,0.0010015423,0.0024736144,0.0003063301,0.0002466765,0.00043356253,0.00038441268,0.000015348178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008857532,0.0075917304,0.95413655,0.000117348405,0.0018714595,0.00010225906,0.0026038121,0.00023309147,0.00014999359,0.000081792015,0.018335527,0.005918901],"study_design_scores_gemma":[0.0075305514,0.0014167201,0.981518,0.0012591,0.00089089037,0.0000068647346,0.002983757,0.00043935073,0.0000931924,0.0031809397,0.0002769435,0.000403711],"about_ca_topic_score_codex":0.001972853,"about_ca_topic_score_gemma":0.00008179554,"teacher_disagreement_score":0.027381424,"about_ca_system_score_codex":0.000042196436,"about_ca_system_score_gemma":0.00034262572,"threshold_uncertainty_score":0.99987686},"labels":[],"label_agreement":null},{"id":"W4283593163","doi":"10.1136/annrheumdis-2022-eular.895","title":"OP0025 FACTORS ASSOCIATED WITH FATIGUE AND ITS IMPROVEMENT – A PRINCIPAL COMPONENT ANALYSIS OF PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS FROM GUSELKUMAB PHASE 3 TRIALS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Celgene; Pfizer; Amgen","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Quality of life (healthcare); Placebo; Physical therapy; Disease; Pathology","score_opus":0.07211055022452982,"score_gpt":0.32579575789627846,"score_spread":0.2536852076717486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283593163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842275,0.0015399319,0.0000042321612,0.00018661824,0.000054479682,0.0013030206,0.008462103,0.00001469764,0.000012167832],"genre_scores_gemma":[0.9985409,0.00026313338,0.000009895202,0.00008282423,0.000004247391,0.00016440403,0.000902181,0.000017565839,0.000014890415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779254,0.00026186815,0.00064746995,0.0002668298,0.0008155249,0.00021579319],"domain_scores_gemma":[0.9977394,0.00056264433,0.001007914,0.00031986652,0.00023921722,0.00013097122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017815076,0.00023588375,0.0013691877,0.00016222417,0.0002141392,0.000011752367,0.00011823921,0.000021585252,0.0002740102],"category_scores_gemma":[0.0005929474,0.00013571639,0.0002986019,0.00052332017,0.000093009934,0.00006904679,0.0001501911,0.00007270595,1.7192566e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017432548,0.035290577,0.625022,0.00042746705,0.17256276,0.0000340073,0.009225488,0.0008862563,0.000109822344,0.00014530435,0.00052860595,0.13833514],"study_design_scores_gemma":[0.01927159,0.0031754836,0.96503365,0.00067632465,0.0089309355,1.6046819e-7,0.0013588051,0.00033597977,0.0009826495,0.000055107957,0.0000137156385,0.00016558131],"about_ca_topic_score_codex":0.00031524664,"about_ca_topic_score_gemma":0.00008750359,"teacher_disagreement_score":0.34001166,"about_ca_system_score_codex":0.000059200956,"about_ca_system_score_gemma":0.00008751708,"threshold_uncertainty_score":0.5534354},"labels":[],"label_agreement":null},{"id":"W4283593432","doi":"10.1136/annrheumdis-2022-eular.1416","title":"OP0152 A DEEP LEARNING FRAMEWORK FOR MRI DETECTION OF ACTIVE INFLAMMATORY AND STRUCTURAL CHANGES IN THE SACROILIAC JOINT CONSISTENT WITH AXIAL SPONDYLOARTHRITIS: AN INTERNATIONAL COLLABORATIVE STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Ankylosing spondylitis; Receiver operating characteristic; Sacroiliac joint; Magnetic resonance imaging; Artificial intelligence; Cohort; Machine learning; Test (biology); Sacroiliitis; Physical therapy; Radiology; Pathology; Internal medicine; Computer science","score_opus":0.024566481953088238,"score_gpt":0.30464715155747146,"score_spread":0.2800806696043832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283593432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963327,0.0011916074,0.000014634898,0.00066715584,0.00010814582,0.001466741,0.00019646388,0.000008281119,0.000014247119],"genre_scores_gemma":[0.9990318,0.00023776578,0.000095945434,0.000079044985,0.000020975096,0.00050003355,0.000017608761,0.000010857922,0.0000059784647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988655,0.00023888171,0.00023247949,0.00016727798,0.00036775752,0.00012809988],"domain_scores_gemma":[0.9990886,0.00024058626,0.00027493353,0.0001767389,0.00018061088,0.000038570095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017157539,0.00012264178,0.00030479653,0.00007806413,0.0002619241,0.000015987262,0.000101822014,0.000017083466,0.00002690467],"category_scores_gemma":[0.00032316748,0.00007428353,0.00006342149,0.00018033218,0.00015319724,0.00007778073,0.00009414783,0.000119514676,8.176821e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021006726,0.0041457126,0.54500574,0.00063869165,0.004333367,0.00010736584,0.12648132,0.001415897,0.0003032185,0.0020965429,0.000036566253,0.29442886],"study_design_scores_gemma":[0.0038144814,0.004799702,0.85497934,0.00041547453,0.00022075568,0.000033586362,0.13337812,0.00034246533,0.000496932,0.0013690109,0.00004719791,0.00010292388],"about_ca_topic_score_codex":0.00007242323,"about_ca_topic_score_gemma":0.0005684482,"teacher_disagreement_score":0.30997363,"about_ca_system_score_codex":0.000029245548,"about_ca_system_score_gemma":0.00005094536,"threshold_uncertainty_score":0.30291948},"labels":[],"label_agreement":null},{"id":"W4283652546","doi":"10.1136/annrheumdis-2022-eular.2873","title":"POS0608 PROGRESSIVE INCREASE IN THE DIAGNOSTIC DELAY AND PERSISTENTLY SEVERE CLINICAL PRESENTATION OVER THE YEARS IN AUTOANTIBODY-NEGATIVE PATIENTS WITH RHEUMATOID ARTHRITIS IN THE SETTING OF AN EARLY ARTHRITIS CLINIC","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Samsung; Celgene; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Autoantibody; Internal medicine; Rheumatoid factor; Population; Referral; Arthritis; Immunology; Antibody; Family medicine","score_opus":0.019563773802132648,"score_gpt":0.32355723499856504,"score_spread":0.3039934611964324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283652546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873659,0.008537167,3.6812227e-7,0.001607205,0.00005135991,0.0021722515,0.00021406767,0.000008342703,0.000043330834],"genre_scores_gemma":[0.9875192,0.011614096,0.000020237521,0.00042205415,0.000011451288,0.0003350597,0.00005197004,0.000021149091,0.0000048067745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944633,0.002859536,0.00093412853,0.00029751932,0.0010824354,0.00036303466],"domain_scores_gemma":[0.994241,0.0044739554,0.00050847034,0.00054892985,0.00013145166,0.000096190844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019881488,0.00019395447,0.0005246993,0.00015010526,0.00021355729,0.00007102454,0.00053701736,0.000041254385,0.000094265255],"category_scores_gemma":[0.003550014,0.00010062628,0.00017351199,0.00061484077,0.00064578967,0.00029539765,0.00019751977,0.0004953154,0.0000016017299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007532433,0.001723308,0.93284875,0.000073631156,0.000118966265,0.00007291792,0.012772502,0.000052622512,4.4981337e-7,0.00009140993,0.00031301452,0.05117916],"study_design_scores_gemma":[0.004921855,0.0012633158,0.9773003,0.0023690502,0.000012831498,0.00004945066,0.01281257,0.00029130175,0.0000025282975,0.0008413275,0.000018548653,0.000116964235],"about_ca_topic_score_codex":0.0016174777,"about_ca_topic_score_gemma":0.0008722588,"teacher_disagreement_score":0.051062196,"about_ca_system_score_codex":0.000018014043,"about_ca_system_score_gemma":0.00021868132,"threshold_uncertainty_score":0.42499548},"labels":[],"label_agreement":null},{"id":"W4283687131","doi":"10.1136/annrheumdis-2022-eular.1186","title":"POS1024 EFFICACY AND SAFETY OF RISANKIZUMAB (RZB) FOR ACTIVE PSORIATIC ARTHRITIS (PsA): 52-WEEK RESULTS FROM KEEPsAKE 1","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Placebo; Adverse effect; Rheumatology; Clinical endpoint; Randomized controlled trial; Gastroenterology; Surgery; Arthritis","score_opus":0.02236427850623391,"score_gpt":0.2571326608538491,"score_spread":0.2347683823476152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283687131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93120515,0.059407633,0.000031417072,0.0010102245,0.00064096757,0.0007535982,0.0066786716,0.000028933353,0.00024337774],"genre_scores_gemma":[0.99758434,0.0014736595,0.000015497515,0.00014924635,0.0000026188193,0.0000748042,0.0004186779,0.000018023027,0.0002631242],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981993,0.0003721435,0.00073404954,0.00028433558,0.00010393619,0.00030625617],"domain_scores_gemma":[0.9973846,0.0013913445,0.0005946053,0.0005357086,0.00008138449,0.00001232217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003067855,0.0001956846,0.0005274416,0.00007739763,0.0005244511,0.000009935821,0.000491002,0.000063649386,0.00029770474],"category_scores_gemma":[0.0010487958,0.0001577478,0.00027895367,0.0001774143,0.00041924033,0.00008859102,0.00029671,0.00016489814,0.0000075336843],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016477222,0.0041304375,0.00010373638,0.00027467328,0.002529122,0.000001551023,0.012822194,0.0009321873,0.004153506,0.0041530915,0.006977111,0.94744515],"study_design_scores_gemma":[0.084198,0.0066480506,0.62559295,0.004645622,0.0023929514,0.00006417953,0.0437513,0.00060199347,0.0736629,0.07747674,0.07833698,0.002628332],"about_ca_topic_score_codex":0.00043053503,"about_ca_topic_score_gemma":0.0000044166945,"teacher_disagreement_score":0.9448168,"about_ca_system_score_codex":0.000012415397,"about_ca_system_score_gemma":0.000119519915,"threshold_uncertainty_score":0.6432768},"labels":[],"label_agreement":null},{"id":"W4283687195","doi":"10.1136/annrheumdis-2022-eular.1384","title":"POS1030 PAIN RESPONSE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB IS DRIVEN PREDOMINANTLY BY INFLAMMATION-INDEPENDENT EFFECTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; McGill University","funders":"","keywords":"Medicine; Inflammation; Fibromyalgia; Placebo; Internal medicine; Tumor necrosis factor alpha; Immunology; Pathology","score_opus":0.007817884318912328,"score_gpt":0.24692458908650017,"score_spread":0.23910670476758783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283687195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902384,0.00571041,0.000007497498,0.0021024821,0.000057235207,0.001547745,0.0002604919,0.000035319263,0.000040404033],"genre_scores_gemma":[0.99607986,0.0028313543,0.000021534195,0.00030366803,0.000008552929,0.00045179052,0.00008145793,0.00003670792,0.00018509653],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961281,0.001507515,0.00055163284,0.00027871132,0.0011270089,0.00040703814],"domain_scores_gemma":[0.99795043,0.0008350305,0.00028818767,0.0005620121,0.00016722511,0.00019712212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079191773,0.00022748992,0.0005274191,0.0002179979,0.00023691443,0.000038472772,0.0003124468,0.000035129768,0.00029985365],"category_scores_gemma":[0.0015679549,0.00016042186,0.00017498745,0.0004551238,0.00014988254,0.00016295451,0.00015117512,0.00018774523,0.000010671536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033543263,0.005852951,0.447585,0.0013863986,0.001523753,0.00015486163,0.007156794,0.00035280382,0.0009045653,0.00014576105,0.052261833,0.44913203],"study_design_scores_gemma":[0.023469413,0.009044478,0.9430574,0.0076792752,0.00007058956,0.00003411445,0.0010358571,0.0021750114,0.009274637,0.001327274,0.0022228414,0.00060907163],"about_ca_topic_score_codex":0.00016725533,"about_ca_topic_score_gemma":0.00002354898,"teacher_disagreement_score":0.49547246,"about_ca_system_score_codex":0.00007197782,"about_ca_system_score_gemma":0.00023701019,"threshold_uncertainty_score":0.65418136},"labels":[],"label_agreement":null},{"id":"W4283687562","doi":"10.1136/annrheumdis-2022-eular.1111","title":"POS1208 EQUITY CONSIDERATIONS IN COVID-19 VACCINATION STUDIES OF INDIVIDUALS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; University of Calgary; Cochrane; Bruyère; University of Ottawa","funders":"","keywords":"Medicine; Vaccination; Confounding; Demography; Ethnic group; Socioeconomic status; Health equity; Gerontology; Immunology; Environmental health; Population; Public health; Internal medicine","score_opus":0.16618595132358416,"score_gpt":0.45239853094649984,"score_spread":0.2862125796229157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283687562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545524,0.01520488,0.000016110374,0.02815673,0.000115067654,0.0014653653,0.0003637221,0.00006424558,0.00006149594],"genre_scores_gemma":[0.9949303,0.0011270245,0.00005013397,0.0035334267,0.00001014437,0.00022802835,0.00005010396,0.000023776076,0.000047036396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967993,0.0005504952,0.0010489854,0.00025124496,0.0010126397,0.0003373521],"domain_scores_gemma":[0.9956126,0.0021846686,0.000837398,0.0007217201,0.00032700834,0.00031660887],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008823342,0.00023307935,0.00085042446,0.00039630115,0.00040624916,0.000024117766,0.00025595908,0.000035982906,0.0005875712],"category_scores_gemma":[0.0101114055,0.00016532582,0.00020585327,0.0005871169,0.0002347532,0.00023397367,0.0004628936,0.00018818893,0.000002326743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001218897,0.0041689947,0.87350154,0.02509239,0.002274627,0.00007178487,0.023559034,0.011556644,0.000072350325,0.0087339245,0.020803092,0.028946705],"study_design_scores_gemma":[0.002461052,0.00052589306,0.970662,0.0020481816,0.00038417068,0.000026711043,0.0054008956,0.00024672606,0.00009156083,0.017841578,0.00011906668,0.00019214927],"about_ca_topic_score_codex":0.00042129736,"about_ca_topic_score_gemma":0.00014464163,"teacher_disagreement_score":0.09716046,"about_ca_system_score_codex":0.0002552049,"about_ca_system_score_gemma":0.0030960327,"threshold_uncertainty_score":0.9982268},"labels":[],"label_agreement":null},{"id":"W4283687598","doi":"10.1136/annrheumdis-2022-eular.1318","title":"AB0887 Designing a Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Guselkumab Dosing Interval in Psoriatic Arthritis Patients with Inadequate Response to Tumor Necrosis Factor Inhibition","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; Memorial University of Newfoundland; University of Glasgow; Janssen Scientific Affairs; Drexel University; Brigham and Women's Hospital; University of Rochester; Medical Center, University of Rochester; University of Pennsylvania; College of Medicine, Drexel University; University of Washington; York University","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Clinical endpoint; Population; Clinical trial; Oncology; Arthritis","score_opus":0.02649186919727261,"score_gpt":0.28875431326061024,"score_spread":0.26226244406333765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283687598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895292,0.0006069271,0.000032175474,0.00031861686,0.00029072788,0.008900805,0.00029394607,0.000025154575,0.0000024276446],"genre_scores_gemma":[0.99704355,0.00001257739,0.00002054406,0.00014078866,0.000004755351,0.0026753496,0.00004275241,0.000028464161,0.000031199317],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99192274,0.0062231976,0.00093786273,0.00032948918,0.00022255101,0.00036417722],"domain_scores_gemma":[0.9956387,0.003082207,0.0006393,0.00046880075,0.00009909431,0.000071849936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020108395,0.00033912068,0.0012754177,0.0003317741,0.00034027683,0.000036655503,0.00038095057,0.000031109408,0.00007992645],"category_scores_gemma":[0.0017756,0.00018872727,0.00035251252,0.00049060414,0.00016007993,0.00012269695,0.00027079595,0.000148592,0.000011846406],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9655303,0.0024619251,0.005130796,0.00007391546,0.0013758686,0.0000060016405,0.007899587,0.000749517,0.0011996998,0.0000028172497,0.00007783833,0.015491736],"study_design_scores_gemma":[0.9493556,0.0060841646,0.010582937,0.001255071,0.0010125391,0.0000029102087,0.0013604894,0.00006817437,0.02996046,0.000036417317,0.000004372927,0.00027684038],"about_ca_topic_score_codex":0.00035648097,"about_ca_topic_score_gemma":0.000068067806,"teacher_disagreement_score":0.02876076,"about_ca_system_score_codex":0.000059728503,"about_ca_system_score_gemma":0.00008985882,"threshold_uncertainty_score":0.7696074},"labels":[],"label_agreement":null},{"id":"W4283687672","doi":"10.1136/annrheumdis-2022-eular.59","title":"POS1570-PARE A PATIENT-LED SURVEY INTO THE BENEFITS AND LIMITATIONS OF TELEMEDICINE APPOINTMENTS FOR ASSESSING CHILDREN AND YOUNG PEOPLE WITH RHEUMATIC CONDITIONS: COMPARING EUROPEAN AND CANADIAN COHORTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Positive Living Society of British Columbia","funders":"","keywords":"Telemedicine; Medicine; Pandemic; Family medicine; Coronavirus disease 2019 (COVID-19); Health care; Pediatrics; Disease","score_opus":0.057709321774849304,"score_gpt":0.31785378982661394,"score_spread":0.2601444680517646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283687672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353147,0.0019350611,0.00001867089,0.0024283493,0.000044975746,0.0015962576,0.00038651816,0.000010473802,0.000048243885],"genre_scores_gemma":[0.9981256,0.0005202994,0.00012706047,0.0004347339,0.00000759435,0.000118762204,0.0006407454,0.00001983911,0.0000053475737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985745,0.000262617,0.0004876777,0.00017143451,0.000300795,0.00020297802],"domain_scores_gemma":[0.9983158,0.0006980112,0.00038874985,0.00021974814,0.00017450808,0.00020316768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005719745,0.00013535377,0.00037694667,0.00014011055,0.0005784206,0.000025220403,0.000084767526,0.000010129881,0.000014815256],"category_scores_gemma":[0.00079327874,0.00008503923,0.000032156684,0.00023388703,0.00016027635,0.000099665434,0.000085034684,0.00007613457,9.777638e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006404372,0.00009617946,0.9588989,0.0003553343,0.000240811,5.4479193e-7,0.0054045855,0.000030711177,0.0000029471105,0.00012714228,0.0010872775,0.033691548],"study_design_scores_gemma":[0.0016160179,0.0004714558,0.9897522,0.0006564859,0.00031310148,0.000047963662,0.0063990476,0.0004759169,0.000009018044,0.00016244044,0.000016827433,0.00007952998],"about_ca_topic_score_codex":0.024429636,"about_ca_topic_score_gemma":0.036719404,"teacher_disagreement_score":0.03361202,"about_ca_system_score_codex":0.000021927292,"about_ca_system_score_gemma":0.00018087705,"threshold_uncertainty_score":0.98206675},"labels":[],"label_agreement":null},{"id":"W4283687873","doi":"10.1136/annrheumdis-2022-eular.1158","title":"POS1070 BASELINE DETERMINANTS OF PAIN RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Memorial University of Newfoundland","funders":"Glenmark Pharmaceuticals; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Placebo; Univariate analysis; Arthritis; Multivariate analysis; Pathology; Alternative medicine","score_opus":0.015774657567564247,"score_gpt":0.24040266920247863,"score_spread":0.2246280116349144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283687873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954797,0.0032931499,0.0000032454323,0.00015825186,0.00020064574,0.00034820155,0.00049393065,0.000013394667,0.000009497092],"genre_scores_gemma":[0.99946207,0.00015827983,0.000023515151,0.00008679547,0.0000026529258,0.000072360024,0.00005716704,0.000015668076,0.00012150446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996614,0.0023557388,0.00049295154,0.00018144099,0.00011852114,0.00023734214],"domain_scores_gemma":[0.9980515,0.001029652,0.0003927304,0.00043116158,0.00007331753,0.000021614487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011341356,0.00015476688,0.00041601664,0.00013898505,0.00015019,0.000004134919,0.00031592324,0.00003768103,0.00042463362],"category_scores_gemma":[0.0011598119,0.0001085662,0.00013590412,0.00028425545,0.00010405081,0.00006449045,0.00013568003,0.00007274094,0.000006579622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009775296,0.0022047474,0.52001095,0.00014817396,0.00040545364,0.0000059788154,0.0009805515,0.00016493502,0.00013793218,0.000018306582,0.0013874233,0.46476027],"study_design_scores_gemma":[0.003212581,0.0010080532,0.99212706,0.0006325577,0.00010402767,0.0000028627906,0.0003380338,0.000026992799,0.002089755,0.0001952026,0.00011122933,0.00015161606],"about_ca_topic_score_codex":0.00008956455,"about_ca_topic_score_gemma":0.000033600496,"teacher_disagreement_score":0.47211614,"about_ca_system_score_codex":0.000020002006,"about_ca_system_score_gemma":0.0001057656,"threshold_uncertainty_score":0.464944},"labels":[],"label_agreement":null},{"id":"W4283688410","doi":"10.1136/annrheumdis-2022-eular.1922","title":"AB1474 LIPIDOMIC PROFILING IDENTIFIES SERUM LIPIDS ASSOCIATED WITH PERSISTENT MULTISITE MUSCULOSKELETAL PAIN","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Sun Pharma; LEO Pharma; Galderma; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Confounding; Internal medicine; Body mass index; Logistic regression; Cohort; Odds ratio","score_opus":0.013350278928884412,"score_gpt":0.25176552993946516,"score_spread":0.23841525101058075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283688410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993763,0.0047934004,0.00005619909,0.00035287716,0.00022535922,0.00037191913,0.00025350632,0.0000136948365,0.00017000858],"genre_scores_gemma":[0.99803966,0.00023040398,0.000044979497,0.000319871,0.000034566787,0.00009286459,0.00015693395,0.000026431222,0.0010543104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825615,0.00050605123,0.00029015905,0.00028102382,0.00038788593,0.0002787521],"domain_scores_gemma":[0.99899983,0.00005448134,0.0002613094,0.0005059391,0.00009480061,0.0000836261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005582028,0.00018092232,0.00023643849,0.00004318295,0.00027863454,0.000027211136,0.00045757517,0.000036128746,0.000107175154],"category_scores_gemma":[0.00044600034,0.0001326053,0.00039494428,0.00016465416,0.00013668473,0.0000061358414,0.00032884526,0.00007548285,0.000002296403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026007788,0.010457508,0.43075138,0.0042560715,0.010574375,0.000014247309,0.0038236524,0.086332954,0.08318958,0.0005892248,0.12145651,0.24595371],"study_design_scores_gemma":[0.013784191,0.006579186,0.778394,0.0013462919,0.0030018059,0.000030713727,0.035304405,0.009286939,0.1283738,0.0021223691,0.017598523,0.004177774],"about_ca_topic_score_codex":0.000027763765,"about_ca_topic_score_gemma":0.000017234212,"teacher_disagreement_score":0.3476426,"about_ca_system_score_codex":0.0000038806406,"about_ca_system_score_gemma":0.00009421299,"threshold_uncertainty_score":0.5407487},"labels":[],"label_agreement":null},{"id":"W4283688485","doi":"10.1136/annrheumdis-2022-eular.4114","title":"POS1361 THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CanRIO): A NATIONWIDE MULTI-CENTER PROSPECTIVE COHORT","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Dalhousie University; McGill University; University of Calgary; University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Cancer; Rheumatology; Clinical trial; Adverse effect; Cohort; Immunotherapy; Prospective cohort study; Disease","score_opus":0.042578178532789834,"score_gpt":0.32929879390116906,"score_spread":0.28672061536837923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283688485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715258,0.02177532,0.0000037281739,0.0033675847,0.0006541741,0.0012188215,0.00027043445,0.000015089025,0.0011690365],"genre_scores_gemma":[0.99854785,0.00036843104,0.0000047627796,0.00023951953,5.6953587e-7,0.0003913596,0.00008383928,0.000017103494,0.0003465506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960813,0.002083103,0.00073574577,0.0002764512,0.00019390206,0.00062951696],"domain_scores_gemma":[0.9979248,0.0007615791,0.0003630974,0.00067708443,0.00025704305,0.000016410873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019740069,0.00017285241,0.0004954036,0.0003816547,0.0011194813,0.000012639797,0.0012760267,0.000108903405,0.00052226806],"category_scores_gemma":[0.0010442729,0.00011863916,0.00022564859,0.0007607858,0.00135892,0.00008267645,0.000493723,0.0005858952,0.000025706822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013070824,0.008777169,0.8906471,0.0003370188,0.0019562494,0.000010006041,0.022738578,0.0007883246,0.0030270666,0.039630305,0.0068712225,0.023909882],"study_design_scores_gemma":[0.0032707944,0.00038841314,0.97083706,0.00021523943,0.0000519404,0.00007719581,0.0105382325,0.00012142816,0.0007403902,0.004384683,0.009129448,0.00024515815],"about_ca_topic_score_codex":0.15170719,"about_ca_topic_score_gemma":0.039174344,"teacher_disagreement_score":0.11253284,"about_ca_system_score_codex":0.00015743743,"about_ca_system_score_gemma":0.0009707641,"threshold_uncertainty_score":0.9783582},"labels":[],"label_agreement":null},{"id":"W4283689111","doi":"10.1136/annrheumdis-2022-eular.2416","title":"POS0939 BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO‑CONTROLLED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma","keywords":"Medicine; Axial spondyloarthritis; Placebo; Ankylosing spondylitis; BASDAI; Internal medicine; Clinical endpoint; Mallinckrodt; Randomized controlled trial; Gastroenterology; Sacroiliitis; Arthritis; Pathology","score_opus":0.018804805620293196,"score_gpt":0.2849293935157176,"score_spread":0.2661245878954244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283689111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373955,0.0022773931,0.000003115333,0.00027257123,0.00026077003,0.0110888425,0.0022577825,0.000042350537,0.000057589907],"genre_scores_gemma":[0.99675745,0.0002793385,0.000041985302,0.00023628396,0.000026541333,0.0020704372,0.0004475342,0.00005375045,0.00008667162],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996381,0.0005707287,0.00090988126,0.0005451999,0.0010755346,0.00051764306],"domain_scores_gemma":[0.9972744,0.0009448124,0.00055623316,0.0008011548,0.00018131928,0.00024208246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021959384,0.00045269655,0.0015789957,0.00030348293,0.0004889548,0.000026962993,0.0003189028,0.000040125014,0.00067039],"category_scores_gemma":[0.00047012113,0.00030655612,0.0005807319,0.0006913278,0.00020045457,0.00013578255,0.00025834324,0.00025185497,0.000008573571],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7523014,0.07489087,0.12897456,0.000081232705,0.005347119,0.00016893233,0.006514375,0.00043246444,0.000008185224,0.0000037930995,0.00096032285,0.030316735],"study_design_scores_gemma":[0.57373935,0.004642029,0.4157974,0.0005138472,0.0012541742,0.0000039092524,0.0035510638,0.000060358936,0.000012016775,0.00004215554,0.000116942094,0.00026677066],"about_ca_topic_score_codex":0.000731674,"about_ca_topic_score_gemma":0.00022040933,"teacher_disagreement_score":0.28682286,"about_ca_system_score_codex":0.00008651682,"about_ca_system_score_gemma":0.00016022111,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W4283689205","doi":"10.1136/annrheumdis-2022-eular.1181","title":"POS0731 ASSOCIATION OF PATIENT-REPORTED OUTCOMES WITH TYPE I INTERFERON GENE SIGNATURE FROM THE INTERNATIONAL SYSTEMIC LUPUS ERYTHEMATOSUS PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"AstraZeneca","keywords":"Medicine; Internal medicine; Observational study; Systemic lupus erythematosus; Prospective cohort study; Cohort; Cohort study; Quality of life (healthcare); Disease","score_opus":0.03399959167292375,"score_gpt":0.30538354030783327,"score_spread":0.2713839486349095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283689205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354786,0.0007803125,0.0000056257404,0.0015959278,0.00069765624,0.0029186052,0.00029782995,0.000034944187,0.000121212965],"genre_scores_gemma":[0.9982121,0.000033552406,0.000025796337,0.00020242613,0.000031771204,0.00036368906,0.00013467859,0.00003366608,0.0009623124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99558324,0.0004197926,0.00087664323,0.00032133106,0.002578645,0.00022036691],"domain_scores_gemma":[0.99567586,0.0010336326,0.0012985852,0.00078109483,0.0011368308,0.00007398156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007814736,0.00021447672,0.0006561641,0.000098977645,0.0001721832,0.000028330283,0.00060762954,0.000045894005,0.00027386082],"category_scores_gemma":[0.0019174037,0.00011564448,0.00022168354,0.0004675642,0.00007682742,0.00009681651,0.00038987203,0.00025309576,0.0000042640536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012476873,0.0011648445,0.98411673,0.00016318061,0.0040610987,0.000011020348,0.0036936756,0.00023645598,0.00017450399,0.000063762585,0.004980642,0.000086403285],"study_design_scores_gemma":[0.0022592521,0.00065635587,0.98166525,0.0008769129,0.000546569,0.00034867562,0.012479058,0.00027570993,0.0003680099,0.00037023966,0.000019811838,0.00013417315],"about_ca_topic_score_codex":0.00027944925,"about_ca_topic_score_gemma":0.000022233526,"teacher_disagreement_score":0.008785382,"about_ca_system_score_codex":0.00033356308,"about_ca_system_score_gemma":0.00043845133,"threshold_uncertainty_score":0.4715845},"labels":[],"label_agreement":null},{"id":"W4283689307","doi":"10.1136/annrheumdis-2022-eular.1827","title":"POS0740 IMPACT OF TIME TO REMISSION, FLARES AND EXPOSURE TO IMMUNOSUPPRESSIVES ON THE DEVELOPMENT OF ADVANCED CHRONIC KIDNEY DISEASE (STAGE IV OR WORSE) IN LUPUS NEPHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"AstraZeneca","keywords":"Medicine; Lupus nephritis; Proteinuria; Kidney disease; Internal medicine; Renal function; Stage (stratigraphy); Gastroenterology; Systemic lupus erythematosus; Creatinine; Urology; Disease; Kidney","score_opus":0.02891609082794944,"score_gpt":0.331617165953362,"score_spread":0.30270107512541256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283689307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915676,0.003227819,0.0000023001674,0.0029339688,0.00004917672,0.0017609396,0.00035504604,0.000012792302,0.00009036754],"genre_scores_gemma":[0.9963296,0.00015168244,0.00006723296,0.00023414708,0.0000094090965,0.00026395914,0.000020183816,0.000029999152,0.002893784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973323,0.00036562726,0.00077124476,0.000265086,0.00092730817,0.0003384807],"domain_scores_gemma":[0.99757314,0.00060959876,0.00030359207,0.00086394895,0.00016657184,0.00048312446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053123134,0.0002142675,0.0005963373,0.00024075195,0.0001428587,0.0000127851445,0.00053043035,0.000025070773,0.0017256014],"category_scores_gemma":[0.0034190675,0.00011293443,0.00019789563,0.0005728819,0.000111644375,0.000063072875,0.00055911444,0.00012774955,0.000009164886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04982053,0.0055855988,0.49805903,0.02290132,0.0028364742,0.00015115009,0.06082682,0.012450637,0.08308877,0.00016460457,0.18139432,0.08272074],"study_design_scores_gemma":[0.009528779,0.0058741225,0.87086916,0.067141965,0.00025920782,0.00025268234,0.016224856,0.0007843465,0.023851346,0.0004789326,0.0037945262,0.000940084],"about_ca_topic_score_codex":0.00004954186,"about_ca_topic_score_gemma":0.000004969812,"teacher_disagreement_score":0.37281013,"about_ca_system_score_codex":0.0001382022,"about_ca_system_score_gemma":0.00150667,"threshold_uncertainty_score":0.99918693},"labels":[],"label_agreement":null},{"id":"W4283689569","doi":"10.1136/annrheumdis-2022-eular.683","title":"AB0880 OPTIPSA: Nationwide survey on clinical/therapeutic inertia in psoriatic arthritis","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Glasgow; Janssen Scientific Affairs; University of Washington; Memorial University of Newfoundland; Amgen","keywords":"Medicine; Psoriatic arthritis; Oligoarthritis; Enthesitis; Polyarthritis; Psoriasis; Internal medicine; Physical therapy; Private practice; Arthritis; Family medicine; Dermatology","score_opus":0.09824675137705297,"score_gpt":0.3848060444363611,"score_spread":0.28655929305930816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283689569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97828805,0.015618126,0.000006857587,0.004414997,0.00042780995,0.00070845423,0.00021195355,0.000036155223,0.00028757093],"genre_scores_gemma":[0.97775644,0.020211792,0.000019850722,0.0015220469,0.000029770988,0.00013263337,0.000059499285,0.00003014058,0.000237809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962953,0.0012528888,0.00089501275,0.0002736851,0.00091753807,0.00036561282],"domain_scores_gemma":[0.99742013,0.001305935,0.0002722978,0.00065842643,0.0001573833,0.00018583109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016844831,0.00017762832,0.0005951754,0.0002183456,0.00020291081,0.000029383404,0.00039793906,0.00003517809,0.00067481666],"category_scores_gemma":[0.0028695376,0.0001325636,0.00031643483,0.00058494904,0.00021674445,0.00009195274,0.00017591118,0.0003298321,0.000034338424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019024063,0.0039818976,0.5173639,0.00017832425,0.00066910463,0.000031717238,0.00060425414,0.0006474329,0.000017061579,0.0023701484,0.023865625,0.44836813],"study_design_scores_gemma":[0.0025839235,0.00084986066,0.9884966,0.0007246335,0.000009067368,0.000010046012,0.00022064349,0.00043913283,0.000056214965,0.004515548,0.0019466997,0.00014763461],"about_ca_topic_score_codex":0.0004544174,"about_ca_topic_score_gemma":0.00019778537,"teacher_disagreement_score":0.4711327,"about_ca_system_score_codex":0.000026607278,"about_ca_system_score_gemma":0.0002994387,"threshold_uncertainty_score":0.73887694},"labels":[],"label_agreement":null},{"id":"W4283690221","doi":"10.1136/annrheumdis-2022-eular.4255","title":"AB0545 THYMUS VARIANTS ON IMAGING IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME AND POLYMYOSITIS/DERMATOMYOSITIS PATIENTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Medicine; Polymyositis; Dermatomyositis; Thymoma; Myasthenia gravis; Internal medicine; Juvenile dermatomyositis; Autoimmune disease; Gastroenterology; Serology; Systemic scleroderma; Systemic disease; Connective tissue disease; Rheumatology; Pathology; Immunopathology; Disease; Immunology; Antibody","score_opus":0.00505597862303726,"score_gpt":0.2048883084957476,"score_spread":0.19983232987271035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283690221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626327,0.0006883664,0.0000020902064,0.0011386115,0.00015267797,0.0007738356,0.0003456274,0.000036649413,0.00059887493],"genre_scores_gemma":[0.9963322,0.000060273447,0.000023368084,0.0033078687,0.0000073326614,0.00007310375,0.000108489825,0.000039594557,0.000047768724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780625,0.00019248009,0.00048851094,0.00029482233,0.00084841624,0.0003695425],"domain_scores_gemma":[0.99879307,0.00011104583,0.0002976274,0.00050818914,0.000119351906,0.00017069043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013232055,0.000251864,0.0005039442,0.00021420226,0.00030161263,0.000033573153,0.00022195619,0.000026413147,0.00011060164],"category_scores_gemma":[0.000070475886,0.00018332392,0.000120908044,0.00028878386,0.00014510393,0.0002532627,0.00030694035,0.00018328663,0.000005157364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007740694,0.0011815159,0.97265023,0.00047741082,0.000106549465,0.00015554331,0.00043736614,0.00003409104,0.0000016662356,0.00022196688,0.002090606,0.02186899],"study_design_scores_gemma":[0.0034748998,0.0004232706,0.9940496,0.001063534,0.000089856876,0.00008797036,0.00012149654,0.00008458003,0.000020595613,0.0002691165,0.00010465597,0.00021042333],"about_ca_topic_score_codex":0.000070111,"about_ca_topic_score_gemma":8.838689e-7,"teacher_disagreement_score":0.021658568,"about_ca_system_score_codex":0.000056385597,"about_ca_system_score_gemma":0.00013119768,"threshold_uncertainty_score":0.74757326},"labels":[],"label_agreement":null},{"id":"W4283690342","doi":"10.1136/annrheumdis-2022-eular.1419","title":"POS1385 INTERNATIONAL CONSENSUS FOR ULTRASOUND DEFINITIONS OF TENOSYNOVITIS IN JUVENILE IDIOPATHIC ARTHRITIS: RESULTS OF A DELPHI PROCESS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","keywords":"Tenosynovitis; Medicine; Delphi method; Synovitis; Physical therapy; Wrist; Delphi; Arthritis; Ankle; Juvenile rheumatoid arthritis; Surgery; Internal medicine","score_opus":0.06351748328996998,"score_gpt":0.3372808447640507,"score_spread":0.2737633614740807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283690342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880046,0.0045352736,0.000009239074,0.0035395506,0.000073164854,0.0007229221,0.002192656,0.00001083991,0.0009117521],"genre_scores_gemma":[0.9985619,0.00092062936,0.000042790252,0.00009893494,0.0000062729173,0.00019496887,0.000098120996,0.000013218387,0.00006312924],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981302,0.000112188274,0.00093845953,0.00013747237,0.00051271525,0.0001689601],"domain_scores_gemma":[0.9983285,0.00046308766,0.0004879404,0.00030201167,0.0003729217,0.000045547484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054920005,0.0000911636,0.000450198,0.0001842138,0.000083864514,0.0000049784517,0.0002746064,0.000025389621,0.00010836961],"category_scores_gemma":[0.003856352,0.00007596377,0.00021594147,0.00029390928,0.00021449312,0.00004678353,0.000091645175,0.00010983832,8.7306404e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058612093,0.053403858,0.20973735,0.049706206,0.0075089885,0.00025365342,0.057865623,0.020495966,0.021745559,0.06436454,0.16371511,0.29259107],"study_design_scores_gemma":[0.053878244,0.007260467,0.5525042,0.030010877,0.0007573418,0.0004776982,0.076866,0.0070967656,0.035773117,0.2299085,0.004097506,0.0013693091],"about_ca_topic_score_codex":0.00013380076,"about_ca_topic_score_gemma":0.00002146791,"teacher_disagreement_score":0.34276682,"about_ca_system_score_codex":0.000018544692,"about_ca_system_score_gemma":0.00056711497,"threshold_uncertainty_score":0.4616692},"labels":[],"label_agreement":null},{"id":"W4283690445","doi":"10.1136/annrheumdis-2022-eular.1337","title":"POS1028 GUSELKUMAB MAINTAINS RESOLUTION OF DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS THROUGH 2 YEARS FROM A PHASE 3 STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"University of Rochester; University of Leeds; University of Oxford; Leeds Biomedical Research Centre; Medical Center, University of Rochester; University of Washington; Amgen","keywords":"Dactylitis; Medicine; Psoriatic arthritis; Enthesitis; Dermatology; Psoriasis; Internal medicine","score_opus":0.016466273799569067,"score_gpt":0.27948023095898317,"score_spread":0.2630139571594141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283690445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929524,0.0017880514,0.0000032659293,0.00031493139,0.000053887336,0.001495856,0.0033067374,0.000022856451,0.00006201249],"genre_scores_gemma":[0.99923265,0.0002081254,0.000062661216,0.00010836145,0.000008185792,0.0001166756,0.00021536804,0.000028062646,0.00001988261],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99762005,0.00042984582,0.0006426773,0.00030610544,0.0007608131,0.00024053559],"domain_scores_gemma":[0.9982893,0.0003245046,0.0005389583,0.0006508314,0.000112554335,0.00008388242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018007273,0.00018261485,0.0005763319,0.00011430274,0.00011030103,0.00001141,0.00021588891,0.000023507308,0.00014869627],"category_scores_gemma":[0.0008399504,0.0001463142,0.000117167314,0.0003169511,0.0001831713,0.00014870615,0.00024435754,0.0001247889,0.0000012658595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06724683,0.0785657,0.37949255,0.0008030297,0.004171814,0.00028345644,0.058241088,0.00062549853,0.000016698432,0.00041966068,0.005088809,0.40504485],"study_design_scores_gemma":[0.015404708,0.002524614,0.9726497,0.0011923537,0.00033025653,0.00000263607,0.0064719124,0.000074079326,0.000050768085,0.0011215433,0.00003704185,0.00014039554],"about_ca_topic_score_codex":0.0019006702,"about_ca_topic_score_gemma":0.000046509198,"teacher_disagreement_score":0.5931571,"about_ca_system_score_codex":0.0000669628,"about_ca_system_score_gemma":0.0001931402,"threshold_uncertainty_score":0.596652},"labels":[],"label_agreement":null},{"id":"W4283690623","doi":"10.1136/annrheumdis-2022-eular.219","title":"POS1015 SAFETY OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO ARE BIO-NAÏVE OR TNFi-EXPERIENCED: POOLED RESULTS FROM 4 RANDOMIZED CLINICAL TRIALS THROUGH 2 YEARS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Adverse effect; Internal medicine; Population; Placebo; Golimumab; Randomized controlled trial; Surgery; Arthritis; Rheumatoid arthritis; Adalimumab; Pathology; Alternative medicine","score_opus":0.0590640130460358,"score_gpt":0.33362055878706526,"score_spread":0.27455654574102945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283690623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98742574,0.0034097321,0.0000074300624,0.0002957848,0.0006419461,0.0014702235,0.0066739926,0.000020365012,0.00005478729],"genre_scores_gemma":[0.99709725,0.0018697957,0.000048744252,0.00012821854,0.000014761048,0.00019785417,0.0004952043,0.000019780346,0.00012836895],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99085426,0.0063538547,0.0019133858,0.00038638033,0.00020757683,0.00028451165],"domain_scores_gemma":[0.99074197,0.006502599,0.001964143,0.0006272222,0.00012551331,0.00003853159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019211998,0.00025740755,0.0022390853,0.000095665346,0.00015574667,0.000009652466,0.000474568,0.000113694565,0.0006621751],"category_scores_gemma":[0.0072684307,0.00015257862,0.00061768753,0.0003316392,0.00043638799,0.00013377193,0.00020461892,0.00015801692,0.0000116604115],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.705588,0.00416948,0.008691193,0.000049671202,0.006099307,0.000009449219,0.008045399,0.00012567596,0.000015791717,0.00014872561,0.00258141,0.2644759],"study_design_scores_gemma":[0.41787282,0.0013767623,0.5664758,0.0017947215,0.001666642,0.000001928925,0.0053285137,0.000014278075,0.0022342906,0.0024277957,0.00033332474,0.00047311932],"about_ca_topic_score_codex":0.00049143337,"about_ca_topic_score_gemma":0.00005771877,"teacher_disagreement_score":0.5577846,"about_ca_system_score_codex":0.000029621637,"about_ca_system_score_gemma":0.00021125311,"threshold_uncertainty_score":0.8701515},"labels":[],"label_agreement":null},{"id":"W4283691218","doi":"10.1136/annrheumdis-2022-eular.1185","title":"POS1023 LONG-TERM SAFETY OF RISANKIZUMAB IN PATIENTS WITH PSORIATIC DISEASE: FINDINGS FROM INTEGRATED ANALYSES OF 17 CLINICAL TRIALS IN PSORIASIS AND 4 IN PSORIATIC ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Clinical trial; Disease; Internal medicine; Dermatology","score_opus":0.07345681402659911,"score_gpt":0.3533740556729263,"score_spread":0.2799172416463272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283691218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280054,0.013630503,0.0000030790354,0.000109612716,0.00031654537,0.0008341762,0.002290599,0.000008984918,0.000005929237],"genre_scores_gemma":[0.99662,0.0026896899,0.000023551855,0.000029078006,0.0000060948637,0.00009291524,0.00049806514,0.000018287064,0.000022315797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932858,0.003557766,0.0022965006,0.0003729773,0.00019538612,0.00029161593],"domain_scores_gemma":[0.995144,0.00306171,0.0011507494,0.00051016314,0.000078935074,0.000054449505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001646273,0.00027948106,0.0017805018,0.0004094588,0.000072108196,0.0000082817405,0.00039842617,0.00010260058,0.00049897423],"category_scores_gemma":[0.0028118615,0.00019399803,0.00037008573,0.00069412135,0.0002788352,0.00011910697,0.00019524935,0.000194648,0.0000019052422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008906535,0.0025142834,0.91403174,0.00014324381,0.0009858613,0.000005507741,0.0004962978,0.0001627491,0.00003264949,0.00002207544,0.00014557953,0.07255345],"study_design_scores_gemma":[0.011020874,0.0003771015,0.98516357,0.0014458864,0.0005592882,4.1918065e-7,0.00030717166,0.000019218025,0.00032864904,0.0005944821,0.00000436962,0.00017894128],"about_ca_topic_score_codex":0.0008895168,"about_ca_topic_score_gemma":0.0003769714,"teacher_disagreement_score":0.07237451,"about_ca_system_score_codex":0.00004118702,"about_ca_system_score_gemma":0.00020345509,"threshold_uncertainty_score":0.791101},"labels":[],"label_agreement":null},{"id":"W4283691489","doi":"10.1136/annrheumdis-2022-eular.2225","title":"AB0344 EFFICACY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) COMPARED WITH INTRAVENOUS INFLIXIMAB IN RHEUMATOID ARTHRITIS: A POST-HOC ANALYSIS OF A PHASE 3 RANDOMIZED CONTROLLED TRIAL","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Universidade de Lisboa; University of Toronto; Hanyang University; National Institute for Health and Care Research; Celltrion; Università degli Studi di Milano; University Hospital Southampton NHS Foundation Trust","keywords":"Medicine; Infliximab; Rheumatoid arthritis; Post-hoc analysis; Internal medicine; Randomized controlled trial; Surgery; Gastroenterology; Disease","score_opus":0.01764696314643345,"score_gpt":0.3015207210398597,"score_spread":0.2838737578934263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283691489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96617806,0.026195271,0.000012815543,0.00063596526,0.000101053185,0.0061912583,0.0005133054,0.000039075752,0.00013318581],"genre_scores_gemma":[0.9833353,0.0153708225,0.000052109706,0.000107600245,0.000010284201,0.0009136179,0.0001412068,0.00004277673,0.0000262933],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930359,0.0017175418,0.002601651,0.00039004273,0.0016909979,0.0005638572],"domain_scores_gemma":[0.9933764,0.0030954275,0.0016580361,0.0010133919,0.0005860515,0.000270734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016825637,0.00041309683,0.0057676136,0.0011913131,0.00017784504,0.00003575322,0.0006072621,0.00004030978,0.0008165808],"category_scores_gemma":[0.0031963321,0.00027192096,0.0018657908,0.0017967715,0.0009988253,0.00012822605,0.00022118945,0.0003100458,0.0000020921004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9599402,0.010127169,0.00036072027,0.00021438762,0.011648712,0.00012238834,0.002946654,0.003103321,0.00016418444,0.00036765472,0.00011448394,0.010890149],"study_design_scores_gemma":[0.98183423,0.005410934,0.00089226634,0.0017615644,0.0007008375,0.00012951826,0.0016595544,0.0066866386,0.00028752294,0.0003188734,0.000043980603,0.000274081],"about_ca_topic_score_codex":0.00079457957,"about_ca_topic_score_gemma":0.00012122595,"teacher_disagreement_score":0.021894053,"about_ca_system_score_codex":0.00004610735,"about_ca_system_score_gemma":0.0008155028,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W4283691499","doi":"10.1136/annrheumdis-2022-eular.3365","title":"POS0989 DEVELOPMENT OF INTERNATIONAL CONSENSUS ON A STANDARDIZED IMAGE ACQUISITION PROTOCOL FOR DIAGNOSTIC EVALUATION OF THE SACROILIAC JOINTS BY MRI – AN ASAS-SPARTAN COLLABORATION.","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"Eisai","keywords":"Medicine; Protocol (science); Medical physics; Spartan; Sacroiliac joint; Radiology; Pathology; Alternative medicine; Computer science; Computer hardware","score_opus":0.037612916628549264,"score_gpt":0.35532364872080274,"score_spread":0.3177107320922535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283691499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95118874,0.00018744516,0.0021711383,0.0038580734,0.00037387153,0.038693823,0.0030986376,0.00005982993,0.00036841613],"genre_scores_gemma":[0.975884,0.000004490933,0.0005971495,0.000058139536,0.000009541356,0.023327677,0.000075214535,0.000013723506,0.000030036765],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99810714,0.00023902964,0.0004837685,0.000104507315,0.00096889876,0.000096680145],"domain_scores_gemma":[0.9986012,0.00035019044,0.0002769614,0.00025210602,0.00047356158,0.000045983943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008405246,0.00009462546,0.00020372764,0.000054598473,0.00012132991,0.000017127726,0.00024972646,0.000013648913,0.00026748545],"category_scores_gemma":[0.0014725373,0.000064473905,0.0001153399,0.00020600283,0.00007634564,0.000052389074,0.000049418868,0.000043226202,5.790967e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096383493,0.004131845,0.005168277,0.0034887774,0.0031704144,8.985484e-7,0.0067331432,0.33840543,0.01855953,0.00061484193,0.4991542,0.1196088],"study_design_scores_gemma":[0.008612766,0.00035876984,0.034279108,0.0031482438,0.0009651632,0.0000023371729,0.0037750697,0.734484,0.19823347,0.008038951,0.0074803885,0.0006217074],"about_ca_topic_score_codex":0.000006846138,"about_ca_topic_score_gemma":0.000003326677,"teacher_disagreement_score":0.4916738,"about_ca_system_score_codex":0.000057440826,"about_ca_system_score_gemma":0.00021917235,"threshold_uncertainty_score":0.29287782},"labels":[],"label_agreement":null},{"id":"W4283691872","doi":"10.1136/annrheumdis-2022-eular.351","title":"POS0503 RISKS OF CARDIOVASCULAR EVENTS AFTER THE INTRODUCTION OF bDMARDs IN NEWLY DIAGNOSED RHEUMATOID ARTHRITIS PATIENTS: A POPULATION-BASED INTERRUPTED TIME-SERIES ANALYSIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Simon Fraser University; University of British Columbia; Research Canada","funders":"Manchester Biomedical Research Centre; Sorbonne Université; Université de Montpellier; University of British Columbia; National Institute for Health and Care Research; Assistance Publique - Hôpitaux de Paris; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Population; Cohort; Epidemiology; Rate ratio; Cohort study; Rheumatology; Confidence interval","score_opus":0.018590420302432333,"score_gpt":0.28341506925549875,"score_spread":0.2648246489530664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283691872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982231,0.015177709,0.000029574378,0.0012302997,0.00010813299,0.0007714425,0.00042260883,0.000015186966,0.000014010124],"genre_scores_gemma":[0.9922994,0.0070616477,0.00003886972,0.00005874884,0.000014541358,0.00024341265,0.00024176532,0.000022136888,0.00001950965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996599,0.00079008867,0.0009096896,0.00024966302,0.0011908229,0.00026070347],"domain_scores_gemma":[0.99795336,0.00023845513,0.00044287706,0.0009340961,0.0003437008,0.00008752768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067970465,0.00018940128,0.000906232,0.00043953952,0.00012747248,0.000012434341,0.0003323938,0.00003259407,0.00086288585],"category_scores_gemma":[0.0013062636,0.0001293198,0.0010778068,0.0012350982,0.00021625939,0.00015360901,0.00017337796,0.00015798061,0.0000024349783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023257774,0.0016606537,0.9211063,0.0002849948,0.0051476452,0.000004515885,0.0009425054,0.015597721,0.000014141157,0.00004247064,0.0010428405,0.05183048],"study_design_scores_gemma":[0.0024329287,0.00040203836,0.993446,0.000646578,0.00017625417,0.00000300462,0.0005109887,0.0010363503,0.00026533144,0.00048123632,0.00046946603,0.00012981091],"about_ca_topic_score_codex":0.0025195382,"about_ca_topic_score_gemma":0.000105097155,"teacher_disagreement_score":0.07233976,"about_ca_system_score_codex":0.00004304305,"about_ca_system_score_gemma":0.00013481392,"threshold_uncertainty_score":0.9447995},"labels":[],"label_agreement":null},{"id":"W4283692224","doi":"10.1136/annrheumdis-2022-eular.409","title":"AB0045 EFFECTS OF AEROBIC EXERCISE AND PREBIOTIC FIBRE SUPPLEMENTATION ON THE VASTUS LATERALIS AND SOLEUS MUSCLES IN A RAT MODEL OF DIET-INDUCED OBESITY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prebiotic; Aerobic exercise; Medicine; Internal medicine; Endocrinology; Osteoarthritis; Soleus muscle; Endurance training; Skeletal muscle; Food science; Chemistry; Pathology","score_opus":0.029288880108696305,"score_gpt":0.282992745639787,"score_spread":0.2537038655310907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283692224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687725,0.00046236155,0.000003798837,0.0014218743,0.000044817592,0.0011000714,0.000032195217,0.000006225314,0.0000514005],"genre_scores_gemma":[0.9992497,0.0003708998,0.000034454446,0.00015807227,0.0000022303986,0.00008500658,0.000013190138,0.000008994148,0.0000774459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900955,0.00011774905,0.00028931597,0.00013434116,0.00032044423,0.00012858269],"domain_scores_gemma":[0.9992459,0.0002173059,0.00018319867,0.00028028397,0.000030723022,0.000042618554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023090382,0.00011186829,0.00031135764,0.000084176194,0.00006186272,0.000009372856,0.000118312535,0.000013079113,0.000030680047],"category_scores_gemma":[0.00007289905,0.00007022144,0.00007814591,0.00012388275,0.00007786945,0.00005423163,0.00022122107,0.000053535732,1.4817256e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013478482,0.030069461,0.34183517,0.10548087,0.004218192,0.000060245395,0.059921853,0.020477068,0.046786204,0.02164979,0.041314412,0.31470826],"study_design_scores_gemma":[0.0074574035,0.0038002848,0.86641353,0.008010325,0.0017422655,0.0000018915789,0.005196,0.028338352,0.065908335,0.012706252,0.000016199321,0.0004091353],"about_ca_topic_score_codex":0.00013017925,"about_ca_topic_score_gemma":0.00001083351,"teacher_disagreement_score":0.5245784,"about_ca_system_score_codex":0.000011476145,"about_ca_system_score_gemma":0.00003517293,"threshold_uncertainty_score":0.28635472},"labels":[],"label_agreement":null},{"id":"W4283692455","doi":"10.1136/annrheumdis-2022-eular.2091","title":"POS1045 MASS SPECTROMETRY-BASED PROTEOMICS FOR THE IDENTIFICATION OF CANDIDATE SERUM PROTEIN BIOMARKERS THAT MAY PREDICT TREATMENT RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Toronto Western Hospital","funders":"Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Sun Pharma; GlaxoSmithKline","keywords":"Psoriatic arthritis; Medicine; Tofacitinib; Psoriasis; Internal medicine; Biomarker; Arthritis; Adalimumab; Proteomics; Pharmacology; Oncology; Disease; Immunology; Rheumatoid arthritis","score_opus":0.01768792877079223,"score_gpt":0.27056847057713485,"score_spread":0.2528805418063426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283692455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870807,0.0020460982,0.0002827036,0.0039371513,0.00006519339,0.0051919334,0.0013762044,0.000015998872,0.000004050145],"genre_scores_gemma":[0.99714965,0.00066497497,0.00035242137,0.00004075337,0.000006021203,0.0016189308,0.00007143484,0.000027404372,0.00006840405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977919,0.00043751884,0.0005279026,0.00021017493,0.00073741406,0.00029512067],"domain_scores_gemma":[0.99830496,0.00039393175,0.00045299207,0.00061947363,0.0001396249,0.000088993474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000799114,0.00016914953,0.0003745656,0.00022218165,0.00021407887,0.000027947372,0.0002749716,0.000020698206,0.00008441547],"category_scores_gemma":[0.0005926988,0.000096299744,0.00019323875,0.00042010116,0.00021189272,0.000084230975,0.000046672092,0.000074519354,8.082721e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1664959,0.009361699,0.7222875,0.0024087827,0.004688688,0.000017533213,0.0029920845,0.0024551975,0.007066299,0.0005964756,0.0013723086,0.08025755],"study_design_scores_gemma":[0.013007565,0.0053313975,0.94225043,0.0017385248,0.00007283556,0.0000028518266,0.0013086714,0.0021170252,0.03300913,0.0008479744,0.000118271775,0.00019533116],"about_ca_topic_score_codex":0.00015134743,"about_ca_topic_score_gemma":0.000022127948,"teacher_disagreement_score":0.21996295,"about_ca_system_score_codex":0.00009979395,"about_ca_system_score_gemma":0.00044109471,"threshold_uncertainty_score":0.39269897},"labels":[],"label_agreement":null},{"id":"W4283692756","doi":"10.1136/annrheumdis-2022-eular.2682","title":"POS1563-PARE SELF-MANAGEMENT STRATEGIES FOR ADVERSE DRUG REACTIONS AS REPORTED BY TNF-ALPHA INHIBITOR USERS: AN OBSERVATIONAL STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Etanercept; Adalimumab; Injection site; Cohort; Drug reaction; Observational study; Cohort study; Internal medicine; Drug; Disease; Pharmacology; Tumor necrosis factor alpha","score_opus":0.11691705678361215,"score_gpt":0.37676686132037535,"score_spread":0.2598498045367632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283692756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992488,0.00090928463,0.000042951786,0.0030355726,0.00059956656,0.0014773873,0.0009930291,0.000097442746,0.00035676357],"genre_scores_gemma":[0.9956822,0.000059579004,0.00033780865,0.0007101694,0.0000124053495,0.00033002387,0.00022172043,0.000016506829,0.002629605],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982294,0.0005107174,0.00056935835,0.00030157386,0.00014540892,0.00024354638],"domain_scores_gemma":[0.9986122,0.00029782552,0.00038145622,0.0005191908,0.00014359078,0.000045728826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005659134,0.00017148827,0.00029451604,0.00006510642,0.00053896854,0.00002462552,0.00040209707,0.00004147219,0.000634999],"category_scores_gemma":[0.00019448955,0.00012565083,0.0002356644,0.00023481592,0.000117961645,0.00019602684,0.00021942364,0.00012754451,0.000005023177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002836126,0.034370087,0.021774571,0.0012403701,0.0147071825,0.000024789879,0.0056207925,0.00069719483,0.004476817,0.037904706,0.85907257,0.017274804],"study_design_scores_gemma":[0.011781191,0.006023021,0.32209918,0.0007001713,0.0065317946,0.00007677667,0.27909088,0.00069186144,0.010347493,0.102699414,0.25768825,0.002269977],"about_ca_topic_score_codex":0.00012329406,"about_ca_topic_score_gemma":0.000011887356,"teacher_disagreement_score":0.60138434,"about_ca_system_score_codex":0.000024395013,"about_ca_system_score_gemma":0.00012381091,"threshold_uncertainty_score":0.6952794},"labels":[],"label_agreement":null},{"id":"W4283692802","doi":"10.1136/annrheumdis-2022-eular.4048","title":"POS0462 HYDROXYCHLOROQUINE REDUCES THE TITERS OF ANTI-DOMAIN 1 ANTIBODIES OVER TIME IN PATIENTS WITH PERSISTENTLY POSITIVE ANTIPHOSPHOLIPID ANTIBODIES: RESULTS FROM THE APS ACTION CLINICAL DATABASE AND REPOSITORY (“REGISTRY”)","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université Laval","funders":"Peking University; Directorate for Biological Sciences; Universidade do Estado do Rio de Janeiro; Hokkaido University; Università degli Studi di Torino; University College London; Universidad de Córdoba; Northwell Health; York University; Università degli Studi di Brescia; Peking University First Hospital; Università degli Studi di Milano; Euskal Herriko Unibertsitatea; European Commission; Johns Hopkins University; King's College London; Université Laval; Hospital for Special Surgery; Università degli Studi di Padova; Intermountain Healthcare","keywords":"Medicine; Antiphospholipid syndrome; Hydroxychloroquine; Cohort; Titer; Internal medicine; Antibody; Database; Immunology; Disease","score_opus":0.03466166399062531,"score_gpt":0.3196115191091856,"score_spread":0.2849498551185603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283692802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926552,0.0016555231,5.919065e-7,0.0022812295,0.00020404428,0.0010667078,0.0019135332,0.0000147664705,0.00020839603],"genre_scores_gemma":[0.9986314,0.0005548969,0.000028226226,0.00020330596,0.000044622047,0.000020579386,0.00025646167,0.000026394626,0.00023410677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996373,0.00087724696,0.00094472826,0.00041543547,0.0011043218,0.0002852634],"domain_scores_gemma":[0.9960236,0.0016708217,0.00084985123,0.0011429305,0.00020878167,0.0001040216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001137704,0.00022629321,0.0006549525,0.00008685065,0.00036747826,0.000035254485,0.0005257031,0.00004329646,0.000031213363],"category_scores_gemma":[0.001108465,0.00011163938,0.000234378,0.00034590714,0.0010261306,0.00016317103,0.00049312646,0.00028741994,0.000002190445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005714014,0.0011643331,0.97116417,0.00037447998,0.00090749084,0.000016863758,0.0039405124,0.000029579149,0.0008421957,0.000015314761,0.015258336,0.0005727191],"study_design_scores_gemma":[0.0038553772,0.00051558885,0.98295605,0.0032882558,0.00026619912,0.000076820426,0.0070563476,0.0002777735,0.001436223,0.000048796177,0.00006716684,0.00015538532],"about_ca_topic_score_codex":0.00075995066,"about_ca_topic_score_gemma":0.0000079930915,"teacher_disagreement_score":0.015191169,"about_ca_system_score_codex":0.000042777618,"about_ca_system_score_gemma":0.00019729271,"threshold_uncertainty_score":0.45525217},"labels":[],"label_agreement":null},{"id":"W4283693053","doi":"10.1136/annrheumdis-2022-eular.4233","title":"AB0719 ECONOMIC BURDEN IN SCLERODERMA | Annals of the Rheumatic Diseases","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cohort; Indirect costs; Health care; Scleroderma (fungus); Interstitial lung disease; Cohort study; Observational study; MEDLINE; Emergency medicine; Intensive care medicine; Internal medicine; Pathology; Lung","score_opus":0.05458016196159215,"score_gpt":0.30180801892664466,"score_spread":0.2472278569650525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283693053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96925616,0.02080833,7.7767163e-7,0.006962365,0.00053983234,0.0011101782,0.00075722154,0.000039537477,0.0005256075],"genre_scores_gemma":[0.99554646,0.0027475934,0.0000040333816,0.0009548962,0.000049124574,0.00017235604,0.00003111701,0.000046272748,0.00044811863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964788,0.0005901522,0.00129325,0.0003652961,0.0008224067,0.00045007057],"domain_scores_gemma":[0.99683905,0.0005026983,0.00090124796,0.0013843444,0.00010808503,0.00026457594],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004540961,0.00031403964,0.00092263776,0.00020930085,0.00026337526,0.00002700985,0.00092514674,0.00006214048,0.0010087376],"category_scores_gemma":[0.0007785337,0.0001902583,0.0009408147,0.0005146247,0.00034866016,0.00012788216,0.0005614827,0.00020889114,0.000023530369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032258825,0.00893371,0.47068852,0.011160865,0.005459739,0.000033489297,0.0071897847,0.058559984,0.00065933756,0.0041741775,0.30960086,0.12031366],"study_design_scores_gemma":[0.0023541003,0.00023734011,0.97521603,0.0093330825,0.0006771733,0.000029939723,0.003512786,0.003664677,0.0007963823,0.0033292298,0.00047215403,0.00037711585],"about_ca_topic_score_codex":0.00055835943,"about_ca_topic_score_gemma":0.000008824378,"teacher_disagreement_score":0.5045275,"about_ca_system_score_codex":0.000063330015,"about_ca_system_score_gemma":0.00055586593,"threshold_uncertainty_score":0.99990445},"labels":[],"label_agreement":null},{"id":"W4283694519","doi":"10.1136/annrheumdis-2022-eular.3408","title":"POS1434 USE OF BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND THE RISK OF LYMPHOMA IN RHEUMATOID ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Abatacept; Leflunomide; Rheumatoid arthritis; Tofacitinib; Hydroxychloroquine; Tocilizumab; Internal medicine; Rituximab; Etanercept; Sulfasalazine; Lymphoma; Diagnosis code; Infliximab; Adalimumab; Disease; Population","score_opus":0.03884315260165726,"score_gpt":0.276547160552637,"score_spread":0.23770400795097973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283694519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705546,0.026609994,0.000024166487,0.0010767254,0.00017152814,0.00056506955,0.0009697084,0.000016476377,0.000011727967],"genre_scores_gemma":[0.98225695,0.01728584,0.000105379884,0.00019951489,0.0000015875454,0.000059265843,0.000014317076,0.000015324205,0.000061800536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956905,0.0025411271,0.0009992803,0.000284342,0.00015054048,0.00033420193],"domain_scores_gemma":[0.99519587,0.0031409129,0.0008433975,0.00067622674,0.0000878972,0.00005569231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012020105,0.000243012,0.00094528863,0.00015285326,0.00026301452,0.000014873301,0.0005588375,0.000076081385,0.00041097894],"category_scores_gemma":[0.003766206,0.0001245055,0.00040153114,0.000446949,0.0016349521,0.00008509824,0.0005501989,0.00016994792,0.0000017785891],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02493378,0.01100081,0.442946,0.005063216,0.007877998,0.00003120722,0.009407322,0.0030364995,0.005952852,0.021324936,0.005139837,0.46328557],"study_design_scores_gemma":[0.013058508,0.00077683927,0.92362934,0.004952867,0.00090986176,0.000069281574,0.0052176667,0.0048463694,0.011543935,0.033412904,0.0006464291,0.00093599403],"about_ca_topic_score_codex":0.000626215,"about_ca_topic_score_gemma":0.000014616268,"teacher_disagreement_score":0.48068336,"about_ca_system_score_codex":0.000012497183,"about_ca_system_score_gemma":0.0001292874,"threshold_uncertainty_score":0.6024049},"labels":[],"label_agreement":null},{"id":"W4283694636","doi":"10.1136/annrheumdis-2022-eular.1380","title":"AB0583 REFERRAL PATTERN AND TREATMENT OF POLYMYALGIA RHEUMATICA IN GENERAL PRACTICE: AN INTERNATIONAL QUESTIONNAIRE BASED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Translation Studies and Practices","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital","funders":"Fiona Stanley Hospital; Medizinische Universität Graz; University of Toronto; Universidad de Chile; Universitätsklinikum Erlangen; Aarhus Universitet; Cairo University; Università degli Studi di Pavia; Universitair Medisch Centrum Groningen; Pontificia Universidade Catolica de Campinas; Karl-Franzens-Universität Graz; Rijksuniversiteit Groningen; University of Baghdad; University of Pittsburgh; Massachusetts General Hospital","keywords":"Medicine; Polymyalgia rheumatica; Referral; Respondent; Family medicine; Prednisolone; General practice; Clinical Practice; Physical therapy; Internal medicine; Disease; Giant cell arteritis","score_opus":0.08991844838093577,"score_gpt":0.353186021708807,"score_spread":0.2632675733278712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283694636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915395,0.0014438845,0.0000075930575,0.004991024,0.0002814136,0.00038338575,0.00024173822,0.000015175297,0.0010963068],"genre_scores_gemma":[0.99924225,0.00026479008,0.000027221406,0.00021210594,0.000025963205,0.00008325924,0.000016756841,0.000009589794,0.00011803908],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998602,0.00039860728,0.0004014257,0.00014340323,0.0003498594,0.00010470494],"domain_scores_gemma":[0.9990573,0.00023509805,0.0003479065,0.00023477491,0.0000867651,0.000038186066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022201063,0.000114748495,0.00022566739,0.00008874768,0.00024745788,0.000055016393,0.0001793927,0.0000082422675,0.00065974623],"category_scores_gemma":[0.00006397123,0.00008042279,0.00007716959,0.000046122514,0.0000971222,0.0003807125,0.000055261437,0.0000458003,9.2060105e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011973345,0.015942184,0.40872318,0.00030745284,0.0012270224,0.00001107861,0.11347815,0.0022134534,0.0000031099457,0.013895545,0.0008337797,0.4421677],"study_design_scores_gemma":[0.0040546213,0.0032661096,0.8933992,0.00032814205,0.0004509421,0.000005079146,0.060668617,0.009545848,0.000013072522,0.001996621,0.025847048,0.00042472078],"about_ca_topic_score_codex":0.0031070402,"about_ca_topic_score_gemma":0.000707516,"teacher_disagreement_score":0.484676,"about_ca_system_score_codex":0.000016859694,"about_ca_system_score_gemma":0.000046273042,"threshold_uncertainty_score":0.72237587},"labels":[],"label_agreement":null},{"id":"W4283694764","doi":"10.1136/annrheumdis-2022-eular.3592","title":"POS0900 SYSTEMIC PHARMACOLOGICAL TREATMENT OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: A SYSTEMATIC LITERATURE REVIEW","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Jewish General Hospital; University of Ottawa","funders":"David Geffen School of Medicine, University of California, Los Angeles; Chugai Pharmaceutical; Universitätsklinikum Köln; Sanofi; Universitätsspital Zürich; GlaxoSmithKline; Université Paris Descartes; Kissei; Jewish General Hospital; Astellas Pharma; Eisai; Leids Universitair Medisch Centrum; Vanderbilt University Medical Center; Università Degli Studi di Modena e Reggio Emila; Universiteit Leiden; Nippon Shinyaku; University College London; Eli Lilly and Company; AstraZeneca; CSL Behring; Vanderbilt University; Assiut University; Amgen; Actelion Pharmaceuticals; Pfizer; Glenmark Pharmaceuticals; Acceleron","keywords":"Medicine; Observational study; MEDLINE; Cochrane Library; Randomized controlled trial; Placebo; Systematic review; Meta-analysis; Clinical trial; Internal medicine; Physical therapy; Intensive care medicine; Alternative medicine; Pathology","score_opus":0.05780109585604916,"score_gpt":0.3132604365394436,"score_spread":0.25545934068339443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283694764","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49326226,0.5032551,4.4759952e-7,0.00044231667,0.0001778335,0.002404961,0.00034612961,0.000030115332,0.00008082498],"genre_scores_gemma":[0.8373122,0.1613891,0.000001812322,0.00026704016,0.000017882807,0.00077124685,0.000044112407,0.000024015302,0.00017255144],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99626577,0.0006640873,0.0016049925,0.00032546234,0.00082974095,0.0003099645],"domain_scores_gemma":[0.9975959,0.0003600579,0.00095739024,0.00070288236,0.00018022364,0.00020354232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037777214,0.00031808208,0.0016748423,0.00020245824,0.000103078,0.000028113982,0.00039683116,0.00006484741,0.00011816597],"category_scores_gemma":[0.00046518058,0.00017653365,0.0009201396,0.0009306991,0.00010717049,0.00010718951,0.00013135886,0.00012325699,0.000009284916],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011155686,0.008297577,0.020441758,0.9444991,0.0043693306,0.0001616401,0.00278452,0.0012042238,0.0026586668,0.00019329129,0.010086153,0.0041881893],"study_design_scores_gemma":[0.0026442278,0.00081309857,0.007780197,0.9811662,0.0030620382,0.0008204751,0.0027553958,0.00033576603,0.00030611982,0.000044806107,0.000008305966,0.00026339194],"about_ca_topic_score_codex":0.000015067389,"about_ca_topic_score_gemma":1.8776336e-7,"teacher_disagreement_score":0.34404996,"about_ca_system_score_codex":0.0002047175,"about_ca_system_score_gemma":0.00024873603,"threshold_uncertainty_score":0.7198833},"labels":[],"label_agreement":null},{"id":"W4283695118","doi":"10.1136/annrheumdis-2022-eular.1862","title":"POS1040 SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR: AS ASSESSED BY LABORATORY PARAMETERS – RESULTS FROM A PHASE 2 TRIAL IN PSORIATIC ARTHRITIS AND 2 PHASE 3 TRIALS IN PSORIASIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Medac; Celgene; Biogen; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Placebo; Internal medicine; Apremilast; Adverse effect; Clinical trial; Pharmacology; Gastroenterology; Arthritis; Dermatology; Pathology","score_opus":0.045903781331351916,"score_gpt":0.3313386473117772,"score_spread":0.2854348659804253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96261793,0.011786512,0.000002537491,0.00030762158,0.00060841034,0.0013379004,0.02329921,0.00002415053,0.000015703026],"genre_scores_gemma":[0.9958179,0.0021785817,0.000045882844,0.00011545315,0.000020151281,0.00026614594,0.0015073003,0.000025317077,0.000023243432],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920494,0.005176617,0.0017594965,0.00048433722,0.00017448163,0.00035567224],"domain_scores_gemma":[0.99533224,0.0028479085,0.0011125322,0.00052539527,0.00010739236,0.000074503805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021995804,0.00032474758,0.001461812,0.0002748489,0.00017730435,0.000023107432,0.00033482694,0.00013604463,0.00022104396],"category_scores_gemma":[0.004691349,0.00026695558,0.00026680334,0.0006513831,0.00022880199,0.00022678159,0.00012482896,0.00019080991,0.000003518879],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4237295,0.030552147,0.00089115556,0.00013459857,0.0023386213,0.000043700013,0.0050575985,0.00010870647,0.035741616,0.00014367167,0.0109985825,0.4902601],"study_design_scores_gemma":[0.6910001,0.011985168,0.007565103,0.0014110719,0.0014321203,0.000009883482,0.0049150316,0.00009432656,0.27478543,0.0043193647,0.0014522395,0.0010301388],"about_ca_topic_score_codex":0.0017301865,"about_ca_topic_score_gemma":0.00016129532,"teacher_disagreement_score":0.48922998,"about_ca_system_score_codex":0.00005141506,"about_ca_system_score_gemma":0.00033528736,"threshold_uncertainty_score":0.99997824},"labels":[],"label_agreement":null},{"id":"W4283695176","doi":"10.1136/annrheumdis-2022-eular.4453","title":"POS1559-HPR PHYSIOTHERAPISTS MAKE LIMITED USE OF BEHAVIOUR CHANGE TECHNIQUES DURING PHYSICAL ACTIVITY COUNSELLING FOR PEOPLE WITH AXIAL SPONDYLOARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Child Health, Behavior and Development; National Natural Science Foundation of China; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Children's Mercy Hospital; Children’s Hospital of Wisconsin Research Institute; University of Ottawa; Northumbria University; Seattle Children's Research Institute; University of Dundee","keywords":"Medicine; Physical therapy; Physical activity; Social support; Behaviour change; Self-efficacy; Observational study; Intervention (counseling); Psychology; Nursing; Social psychology; Internal medicine","score_opus":0.06790470134227172,"score_gpt":0.33154202948195827,"score_spread":0.26363732813968654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646366,0.000503455,0.000034841763,0.0007901668,0.000030888263,0.001634588,0.00049292756,0.000045738092,0.0000037165255],"genre_scores_gemma":[0.9986748,0.0003709192,0.00012294616,0.000019013258,0.00002276683,0.0005884053,0.000037292728,0.00004298239,0.000120878016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843055,0.00012430135,0.00020333318,0.0002233727,0.0007081151,0.00031030804],"domain_scores_gemma":[0.9987787,0.00023313868,0.00022735151,0.00048077042,0.00017877422,0.00010124572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001246711,0.00017221684,0.0005105237,0.00010683779,0.00019971214,0.00001722221,0.00020636877,0.000028325841,0.00008084605],"category_scores_gemma":[0.00006526384,0.00012491041,0.00030078625,0.00032362255,0.0001546247,0.00012333898,0.00008426818,0.00014720959,5.085154e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06033904,0.055575784,0.14509189,0.17930359,0.006549621,0.00023040308,0.03475981,0.000790922,0.19936967,0.0015690261,0.007815049,0.3086052],"study_design_scores_gemma":[0.005159151,0.0058695874,0.8438138,0.010893146,0.0004528508,0.0001536828,0.00086533447,0.0039384277,0.12758388,0.0005118402,0.00010562498,0.00065268995],"about_ca_topic_score_codex":0.0002793626,"about_ca_topic_score_gemma":0.000006972909,"teacher_disagreement_score":0.6987219,"about_ca_system_score_codex":0.000036270067,"about_ca_system_score_gemma":0.00014705137,"threshold_uncertainty_score":0.50936985},"labels":[],"label_agreement":null},{"id":"W4283695384","doi":"10.1136/annrheumdis-2022-eular.1291","title":"POS1026 PREDICTORS FOR ACHIEVEMENT OF LOW DISEASE ACTIVITY AT WEEK 56 IN PATIENTS WITH PSORIATIC ARTHRITIS WHO RECEIVED UPADACITINIB 15 MG ONCE DAILY: POOLED ANALYSIS OF TWO PHASE 3 STUDIES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Internal medicine; Enthesitis; Logistic regression; Golimumab; Body mass index; Post-hoc analysis; Psoriasis Area and Severity Index; Psoriasis; Arthritis; Disease; Immunology; Adalimumab","score_opus":0.030330806761450613,"score_gpt":0.295746787816304,"score_spread":0.26541598105485337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835186,0.007117264,0.000010106992,0.00018427739,0.00018342446,0.0009857639,0.007981887,0.000013214152,0.00000548092],"genre_scores_gemma":[0.99831915,0.0005733403,0.000015271302,0.00004010747,0.0000043594537,0.0003162679,0.00055900664,0.000016675422,0.00015580856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979606,0.0006079235,0.0006285471,0.0003100363,0.00020174042,0.00029109593],"domain_scores_gemma":[0.9977437,0.0006342529,0.00085832557,0.0005230537,0.00018870433,0.000051918596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002829404,0.000248099,0.0009896854,0.00026400428,0.00022149131,0.0000041604717,0.00031949175,0.000030705614,0.00016353499],"category_scores_gemma":[0.0003347911,0.0001774978,0.00052252435,0.000563337,0.00025452845,0.00010336831,0.000224548,0.00006017454,9.120319e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03772502,0.023864336,0.7587056,0.0014170579,0.061322812,0.00000477663,0.004361418,0.0037324459,0.0013545972,0.00013602631,0.0022736036,0.105102286],"study_design_scores_gemma":[0.016944624,0.0020472785,0.96427715,0.0007990577,0.008768376,1.8940757e-7,0.000678572,0.00015591587,0.0057397196,0.00027386664,0.0000344688,0.00028080403],"about_ca_topic_score_codex":0.000085900065,"about_ca_topic_score_gemma":0.000110225905,"teacher_disagreement_score":0.2055715,"about_ca_system_score_codex":0.000057578516,"about_ca_system_score_gemma":0.000102845195,"threshold_uncertainty_score":0.723815},"labels":[],"label_agreement":null},{"id":"W4283695675","doi":"10.1136/annrheumdis-2022-eular.2614","title":"POS0648 SEX DIFFERENCES IN ADVERSE DRUG REACTIONS FROM BIOLOGICAL USE IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma","keywords":"Medicine; Adalimumab; Etanercept; MedDRA; Rheumatoid arthritis; Internal medicine; Pharmacovigilance; Adverse effect","score_opus":0.03339306425167516,"score_gpt":0.25445691319523933,"score_spread":0.22106384894356418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963688,0.001296218,0.0000010399444,0.0004548559,0.00017062858,0.0003348294,0.0013308858,0.000024294119,0.000018403673],"genre_scores_gemma":[0.9991671,0.0001425829,0.00001912138,0.00025015304,0.0000031640686,0.00005928997,0.0001889874,0.000008774867,0.00016081485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778616,0.0010511836,0.00051907165,0.00025861716,0.00010808101,0.0002768883],"domain_scores_gemma":[0.9981549,0.0011263347,0.00026002686,0.00037227737,0.000043591303,0.000042907057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018350522,0.00018130822,0.00044142897,0.00012456399,0.00014447194,0.00000958552,0.00039957697,0.00006675656,0.000786666],"category_scores_gemma":[0.0007083647,0.00010565662,0.00015540943,0.0003075797,0.00038387725,0.000109836175,0.00029493045,0.00025809763,0.0000073055057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005968599,0.0013042813,0.9960403,0.000020966649,0.0001716767,0.0000026006444,0.0001478856,0.000020874699,0.00012826154,0.000069350936,0.0005028119,0.0009941255],"study_design_scores_gemma":[0.0011366024,0.000121398145,0.9967149,0.00015492093,0.00005079055,3.2717907e-7,0.0005563078,0.000020265772,0.00016011404,0.00069674896,0.00023428428,0.00015332551],"about_ca_topic_score_codex":0.00060817116,"about_ca_topic_score_gemma":0.000051003135,"teacher_disagreement_score":0.002798267,"about_ca_system_score_codex":0.000024368424,"about_ca_system_score_gemma":0.00006678869,"threshold_uncertainty_score":0.86134416},"labels":[],"label_agreement":null},{"id":"W4283695720","doi":"10.1136/annrheumdis-2022-eular.1386","title":"POS1031 EARLIER CLINICAL RESPONSE PREDICT LOW RATES OF RADIOGRAPHIC PROGRESSION IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; McGill University","funders":"Cilag; College of Medicine, Drexel University; Memorial University of Newfoundland; University of Glasgow; Janssen Scientific Affairs; School of Medicine, Kyorin University; McGill University; Drexel University","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Regimen; Ustekinumab; Arthritis; Rheumatoid arthritis","score_opus":0.03273134540151599,"score_gpt":0.31839783121207516,"score_spread":0.28566648581055915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886422,0.00873595,5.432502e-7,0.00025057892,0.0006692822,0.00087711215,0.0007798157,0.000022877026,0.00002164157],"genre_scores_gemma":[0.9960727,0.0033296035,0.000013775034,0.000033781955,0.000008900998,0.00027023535,0.0001552076,0.000019696983,0.00009607198],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99562407,0.0027838894,0.00081764814,0.00031588334,0.00014675967,0.0003117597],"domain_scores_gemma":[0.9974449,0.0012634587,0.00066364236,0.0004879495,0.00009580585,0.000044207194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057032035,0.0002392829,0.00065001217,0.00025521638,0.00023002074,0.000007661102,0.00033768738,0.000096376454,0.00024179458],"category_scores_gemma":[0.0007452425,0.0001645481,0.00048948516,0.0004477023,0.00028574656,0.00009837872,0.00017502796,0.000121607605,0.0000099970885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009265657,0.005835707,0.38693947,0.000071491886,0.0015413098,0.0000057640973,0.0017351981,0.000044506647,0.00018531196,0.000015031691,0.00094631646,0.59341425],"study_design_scores_gemma":[0.0051754443,0.002358152,0.9832877,0.0007993898,0.00025989665,0.000003346452,0.00048983324,0.000013193608,0.007024557,0.00028002725,0.00014557964,0.00016287962],"about_ca_topic_score_codex":0.00007590825,"about_ca_topic_score_gemma":0.0000124750895,"teacher_disagreement_score":0.5963482,"about_ca_system_score_codex":0.000048243986,"about_ca_system_score_gemma":0.00018118661,"threshold_uncertainty_score":0.67100763},"labels":[],"label_agreement":null},{"id":"W4283695722","doi":"10.1136/annrheumdis-2022-eular.1508","title":"POS1035 LOW RATES OF RADIOGRAPHIC PROGRESSION WITH 2 YEARS OF GUSELKUMAB, A SELECTIVE INHIBITOR OF THE INTERLEUKIN-23p19 SUBUNIT: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Sanofi Genzyme; LEO Pharma; EMD Serono; Bausch Health; Astellas Pharma; Dermira; Genentech; Coherus Biosciences; Valeant Pharmaceuticals International; Sun Pharma; Regeneron Pharmaceuticals; AbbVie; Baxalta; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Celgene; Galderma; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Placebo; Internal medicine; Rheumatoid arthritis; Physical therapy; Gastroenterology; Surgery; Pathology","score_opus":0.021564027764956976,"score_gpt":0.3094157466050552,"score_spread":0.28785171884009825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880882,0.002558288,0.0000027839549,0.00011940671,0.000079866164,0.007909536,0.001212369,0.000013098516,0.000016450225],"genre_scores_gemma":[0.9976617,0.0015109457,0.000031173862,0.000012587192,0.000009930861,0.0006551967,0.000081084196,0.000029732035,0.000007650604],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951346,0.0016116403,0.001334304,0.0003249518,0.0013089257,0.00028559804],"domain_scores_gemma":[0.9941586,0.0018015101,0.0023071426,0.0007202661,0.00089838204,0.00011405881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008221244,0.0002885963,0.0019737298,0.00036880214,0.00013220565,0.00001236862,0.00048543635,0.00004538156,0.000044967674],"category_scores_gemma":[0.0014281139,0.00014553577,0.000506544,0.000991796,0.000972067,0.00013236189,0.00021571481,0.00024648875,2.1022379e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.942267,0.011482413,0.016246473,0.00019683881,0.0050566243,0.000004024758,0.009927736,0.00013570845,0.0001681984,0.000018851357,0.00008387231,0.014412276],"study_design_scores_gemma":[0.9232179,0.012622952,0.037537962,0.0059709717,0.00042316763,0.0000036000029,0.007892754,0.00015102938,0.011627685,0.00036051602,0.0000020291113,0.00018945613],"about_ca_topic_score_codex":0.00082893553,"about_ca_topic_score_gemma":0.00013164796,"teacher_disagreement_score":0.021291487,"about_ca_system_score_codex":0.000022331962,"about_ca_system_score_gemma":0.00036105452,"threshold_uncertainty_score":0.5934776},"labels":[],"label_agreement":null},{"id":"W4283695735","doi":"10.1136/annrheumdis-2022-eular.902","title":"POS1017 GUSELKUMAB PROVIDES CONTINUED IMPROVEMENT IN KEY DOMAINS OF PSORIATIC ARTHRITIS THROUGH 2 YEARS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; McGill University","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Psoriatic arthritis; Dermatology; Psoriasis; Arthritis; Key (lock); Immunology","score_opus":0.02154011137893312,"score_gpt":0.25723012773835163,"score_spread":0.2356900163594185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679525,0.011148077,0.0000019343988,0.0003589089,0.0004417815,0.00053672557,0.00052353775,0.000018389894,0.00017538536],"genre_scores_gemma":[0.99843633,0.00079444645,0.000031186977,0.00012548122,0.000006331438,0.0001663906,0.000059795857,0.000013827348,0.00036622252],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985875,0.00034735026,0.00051259465,0.00018777768,0.00010769817,0.0002570811],"domain_scores_gemma":[0.9988979,0.00021246735,0.0003960112,0.00043609051,0.00004131858,0.000016193919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022314838,0.00014892932,0.00043532287,0.00007487269,0.00012427018,0.0000067473934,0.0003893156,0.000042544412,0.00044596646],"category_scores_gemma":[0.00017944876,0.000117709584,0.00024824246,0.00019855337,0.00015386762,0.000078805024,0.00021109634,0.00007815064,0.000014333887],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018009548,0.005805337,0.025251685,0.0006619035,0.0034776705,0.000027060694,0.012664515,0.00025568312,0.01833441,0.005829667,0.017335027,0.9085561],"study_design_scores_gemma":[0.019865876,0.0030483431,0.78570104,0.001919535,0.001108195,0.00003958436,0.008236413,0.000025298581,0.13022065,0.038729478,0.01002094,0.001084624],"about_ca_topic_score_codex":0.00042898813,"about_ca_topic_score_gemma":0.00006122466,"teacher_disagreement_score":0.9074715,"about_ca_system_score_codex":0.000022567843,"about_ca_system_score_gemma":0.00010414022,"threshold_uncertainty_score":0.488302},"labels":[],"label_agreement":null},{"id":"W4283695927","doi":"10.1136/annrheumdis-2022-eular.1667","title":"POS1217 ANTI-TNF THERAPY FOR IMMUNE MEDIATED INFLAMMATORY DISEASES MAY BE ASSOCIATED WITH LOWER ANTIBODY LEVELS AND VIRUS NEUTRALIZATION EFFICACY FOLLOWING SARS-CoV-2 mRNA VACCINATION","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Arthritis Society; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Immunology; Immune system; Rheumatoid arthritis; Psoriatic arthritis; Vaccination; Arthritis; Immunogenicity; Antibody","score_opus":0.06331538326646675,"score_gpt":0.37414114835989554,"score_spread":0.3108257650934288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245036,0.0035205225,0.000045961624,0.0014047015,0.00016993786,0.0018363041,0.0004337568,0.00010405242,0.000034430093],"genre_scores_gemma":[0.9933652,0.000120873476,0.0000066654234,0.006001186,0.000024751087,0.00019371841,0.00020050192,0.00006788735,0.000019188923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973338,0.00033589828,0.0005803581,0.00036768406,0.00095130585,0.00043095244],"domain_scores_gemma":[0.99788845,0.00076857884,0.00044073493,0.0005222524,0.00031370306,0.000066286324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005460581,0.00029948453,0.00062993076,0.00025578972,0.00046546722,0.00007384037,0.00035459662,0.00006545022,0.000026572246],"category_scores_gemma":[0.0014797992,0.0002141105,0.00038861626,0.00063319074,0.00011502515,0.00028012245,0.00015923636,0.0001563876,0.0000015998627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008968358,0.009538961,0.6915412,0.0018422115,0.006177801,0.00012260511,0.00257529,0.00024245503,0.25574213,0.00053002057,0.0047273627,0.017991595],"study_design_scores_gemma":[0.007140493,0.00089830736,0.92888236,0.0006519964,0.00044555674,0.0000061571805,0.00023629575,0.0025032728,0.057394195,0.00037463952,0.0011077215,0.0003589854],"about_ca_topic_score_codex":0.000093300034,"about_ca_topic_score_gemma":0.0000090409385,"teacher_disagreement_score":0.23734117,"about_ca_system_score_codex":0.00006512678,"about_ca_system_score_gemma":0.00041408342,"threshold_uncertainty_score":0.87311727},"labels":[],"label_agreement":null},{"id":"W4283696316","doi":"10.1136/annrheumdis-2022-eular.1902","title":"POS1042 IMPACT OF RISANKIZUMAB ON IMPROVING HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, AND REDUCING FATIGUE AMONG PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: A POOLED ANALYSIS OF TWO PHASE 3 CLINICAL TRIALS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Placebo; Psoriatic arthritis; Quality of life (healthcare); Minimal clinically important difference; Physical therapy; Confidence interval; Internal medicine; Randomized controlled trial; WOMAC; Dermatology Life Quality Index; Arthritis; Osteoarthritis; Disease","score_opus":0.10256875464522701,"score_gpt":0.4046384005273311,"score_spread":0.30206964588210405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283696316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919231,0.004673519,0.0000075118874,0.000079329766,0.00017214548,0.0009994418,0.0021265978,0.000012183598,0.0000061556507],"genre_scores_gemma":[0.9995286,0.00014339796,0.000014907614,0.0000100826755,0.000005521512,0.000052252533,0.00022040417,0.00001444326,0.000010375454],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99131495,0.0057141217,0.0021743304,0.0003537144,0.00019864635,0.00024426734],"domain_scores_gemma":[0.99214786,0.0024471728,0.004532662,0.0006109528,0.00019255701,0.00006877315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029994221,0.00023669435,0.0022774246,0.0003044011,0.00017480995,0.000005537122,0.00023876336,0.000066472494,0.00014064739],"category_scores_gemma":[0.004129853,0.00015342196,0.0008932846,0.00089786,0.00037778245,0.00010280332,0.00014155736,0.0001571987,2.771763e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01616946,0.008387642,0.3784552,0.000300994,0.035031285,4.243423e-7,0.0021334735,0.0018433651,0.00024666078,0.00003746985,0.00011222232,0.5572818],"study_design_scores_gemma":[0.009318895,0.002430001,0.98220694,0.0005424537,0.0034455585,3.2191176e-7,0.0003325846,0.000037682417,0.0013686211,0.00017456946,1.3024336e-7,0.00014226623],"about_ca_topic_score_codex":0.0025447372,"about_ca_topic_score_gemma":0.000045177083,"teacher_disagreement_score":0.6037517,"about_ca_system_score_codex":0.000032800268,"about_ca_system_score_gemma":0.00033989307,"threshold_uncertainty_score":0.6256366},"labels":[],"label_agreement":null},{"id":"W4283696495","doi":"10.1136/annrheumdis-2022-eular.4605","title":"POS1097 BIOMARKERS OF INFLAMMATION AND JOINT TISSUE TURNOVER CAN HELP IMPROVING THE DIFFERENTIATION BETWEEN OSTEOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Amgen","keywords":"Medicine; Psoriatic arthritis; Osteoarthritis; Inflammation; Psoriasis; Arthritis; Dermatology; Internal medicine; Physical therapy; Pathology; Alternative medicine","score_opus":0.017085558107723057,"score_gpt":0.25112348078833874,"score_spread":0.23403792268061568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283696495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869312,0.009712832,0.000008054542,0.0020526422,0.000102102465,0.000814405,0.00034347078,0.000013366864,0.000021913911],"genre_scores_gemma":[0.99624354,0.0034968064,0.000013363579,0.000044354685,0.000025625033,0.00006646903,0.00007443834,0.000016735363,0.000018651153],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99823594,0.00026688876,0.00050954474,0.00016541737,0.0006141153,0.00020809831],"domain_scores_gemma":[0.998854,0.00021228002,0.000374326,0.0003010323,0.00014197767,0.00011638383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030685056,0.0001380901,0.00036876,0.00011309272,0.00030646447,0.000039487004,0.00011540655,0.000024151528,0.00008004612],"category_scores_gemma":[0.00061004225,0.000092075985,0.00009715271,0.00017321351,0.00025210326,0.00012425827,0.00024603418,0.00010632918,5.65654e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015189682,0.00013671722,0.13182023,0.0005145629,0.0002928984,0.0000012253213,0.0016281713,0.0000034758598,0.0012377348,0.00024106698,0.00042301844,0.863549],"study_design_scores_gemma":[0.0024446517,0.0007595053,0.9863653,0.00090120424,0.00004997854,0.0000097050915,0.00078875176,0.00016883272,0.0061659403,0.00210217,0.00012187735,0.00012208425],"about_ca_topic_score_codex":0.0002966376,"about_ca_topic_score_gemma":0.000044252105,"teacher_disagreement_score":0.8634269,"about_ca_system_score_codex":0.000015559426,"about_ca_system_score_gemma":0.000072341165,"threshold_uncertainty_score":0.37547496},"labels":[],"label_agreement":null},{"id":"W4283696882","doi":"10.1136/annrheumdis-2022-eular.4177","title":"POS1406 EVALUATING THE QUALITY OF CARE FOR HEART FAILURE HOSPITALIZATIONS IN INFLAMMATORY ARTHRITIS- A POPULATION-BASED COHORT STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; Women's College Hospital; University of Toronto","funders":"Biogen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Cohort; Population; Internal medicine; Heart failure; Rheumatoid arthritis; Arthritis; Inflammatory arthritis; Ankylosing spondylitis; Physical therapy","score_opus":0.23067419627766222,"score_gpt":0.4598099206242526,"score_spread":0.22913572434659035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283696882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97944474,0.0026560929,0.00010687228,0.0123310555,0.00020069601,0.0037238987,0.0014927359,0.000016009237,0.000027906179],"genre_scores_gemma":[0.99682724,0.00001060163,0.00021408261,0.0013493934,0.000021642447,0.0014316441,0.00010443126,0.000021796382,0.00001918505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941372,0.0013751528,0.0036746042,0.00030101812,0.00028912732,0.00022287063],"domain_scores_gemma":[0.99400187,0.002311703,0.0026797405,0.0007660772,0.000184164,0.0000564585],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012455354,0.00013852942,0.00085214066,0.00018321356,0.0004671394,0.000034780725,0.00044649275,0.00003058596,0.0001766849],"category_scores_gemma":[0.008971857,0.00013146932,0.00028441809,0.00030457092,0.00006529415,0.00016006266,0.00010383397,0.00009017315,0.000005689632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025471667,0.00029855076,0.9575024,0.00061143795,0.00007053761,2.3915208e-8,0.0025548998,0.025768554,2.393749e-7,0.011185261,0.0018852855,0.00009733412],"study_design_scores_gemma":[0.00076791464,0.00019947588,0.97196454,0.0001829161,0.000015992799,1.4305438e-7,0.010741272,0.0061347927,0.0000013210451,0.009705467,0.00014571684,0.00014043605],"about_ca_topic_score_codex":0.0025883405,"about_ca_topic_score_gemma":0.00088289485,"teacher_disagreement_score":0.01963376,"about_ca_system_score_codex":0.00015357348,"about_ca_system_score_gemma":0.00030872732,"threshold_uncertainty_score":0.999376},"labels":[],"label_agreement":null},{"id":"W4283697152","doi":"10.1136/annrheumdis-2022-eular.1480","title":"AB1431 EPIDEMIOLOGICAL AND GENETIC FEATURES OF ANTI-3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE NECROTIZING MYOPATHY IN NORTHERN SPAIN: SINGLE-CENTER EXPERIENCE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Internal medicine; Epidemiology; myalgia; Population; Dyslipidemia; Myopathy; Statin; Rhabdomyolysis; Incidence (geometry); Single-nucleotide polymorphism; Obesity; Genotype; Gene","score_opus":0.034508708661926256,"score_gpt":0.2869212769244727,"score_spread":0.2524125682625465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283697152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991663,0.005722803,0.0000067834562,0.00177537,0.00012318348,0.0004928949,0.00009612011,0.000018529061,0.00010134479],"genre_scores_gemma":[0.9982923,0.00033773578,0.00018166639,0.0010605466,0.000022284232,0.00005941832,0.0000132049,0.00001627342,0.000016558188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978996,0.00042991273,0.00069715775,0.00027480148,0.0003845218,0.0003140208],"domain_scores_gemma":[0.9986338,0.0003016261,0.00037435154,0.0004793354,0.00007225748,0.0001386301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033227645,0.000202771,0.0006746906,0.000116685034,0.00015243147,0.000012029479,0.00021436423,0.000043867916,0.000088246416],"category_scores_gemma":[0.0008301743,0.00014228768,0.00023242774,0.00024567082,0.00034476147,0.00007567787,0.0003359632,0.00018311827,0.0000011993873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055021635,0.00126004,0.9664259,0.0010739239,0.0001226407,0.00035832153,0.004387899,0.0008816137,0.004931632,0.00017477029,0.0012035731,0.018629456],"study_design_scores_gemma":[0.001137922,0.00037742822,0.98926514,0.0009379086,0.0000747823,0.0006460792,0.0025468084,0.0006031523,0.0030484928,0.00085219304,0.00028043718,0.00022967922],"about_ca_topic_score_codex":0.00013497125,"about_ca_topic_score_gemma":0.000012338409,"teacher_disagreement_score":0.022839202,"about_ca_system_score_codex":0.000024772891,"about_ca_system_score_gemma":0.0000693333,"threshold_uncertainty_score":0.5802323},"labels":[],"label_agreement":null},{"id":"W4283697252","doi":"10.1136/annrheumdis-2022-eular.2138","title":"POS0938 MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; Novartis Pharma; Universitair Ziekenhuis Gent; Case Western Reserve University; Universiteit Leiden; Leids Universitair Medisch Centrum; Universiteit Gent; Second Military Medical University; Universität Bielefeld; University of Alberta","keywords":"Medicine; Ankylosing spondylitis; Post-hoc analysis; Post hoc; Internal medicine; Open label; Physical therapy; Clinical trial","score_opus":0.061566235882431083,"score_gpt":0.3267831128669879,"score_spread":0.2652168769845568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283697252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973566,0.0029973437,1.674804e-7,0.00023488751,0.000058725305,0.0010620888,0.0059023895,0.0000041434105,0.0000046053005],"genre_scores_gemma":[0.99949986,0.0000820122,0.000010292438,0.00010123288,0.000001212555,0.0000756514,0.00011941206,0.0000111388335,0.00009921093],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99824136,0.0009728606,0.00030239823,0.00022648851,0.000099219345,0.00015764753],"domain_scores_gemma":[0.99843276,0.00072739774,0.00030011972,0.0004091341,0.00010853126,0.000022051481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019963684,0.00014526425,0.00041717844,0.000092895934,0.00012569978,0.000008027022,0.0003198958,0.000023253664,0.00011593634],"category_scores_gemma":[0.00025120337,0.00008342617,0.00006336318,0.00026801287,0.00008595835,0.00008487629,0.00031822507,0.000041061114,0.0000012582218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3069843,0.03586028,0.29936025,0.000100801626,0.010033736,0.00003923614,0.042398926,0.00038936682,0.034847926,0.00010849647,0.0014053778,0.26847133],"study_design_scores_gemma":[0.005812864,0.004028333,0.9817235,0.0002370183,0.00035464042,9.2703016e-7,0.0036844637,0.0000034253017,0.0039464645,0.00005804735,0.00005692547,0.000093393246],"about_ca_topic_score_codex":0.0015735979,"about_ca_topic_score_gemma":0.00010077055,"teacher_disagreement_score":0.6823633,"about_ca_system_score_codex":0.00004137781,"about_ca_system_score_gemma":0.00010292329,"threshold_uncertainty_score":0.34020203},"labels":[],"label_agreement":null},{"id":"W4283697353","doi":"10.1136/annrheumdis-2022-eular.1637","title":"POS1216 POTENTIAL PREDICTORS OF OUTCOME FOR ANAKINRA TREATMENT IN COVID-19 PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Kawasaki Disease and Coronary Complications","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Anakinra; Medicine; Internal medicine; Tocilizumab; Macrophage activation syndrome; Disease","score_opus":0.037890668664759555,"score_gpt":0.3209637059233398,"score_spread":0.28307303725858024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283697353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571544,0.00016872467,0.000091309135,0.001627917,0.000048140162,0.0015097023,0.00079826714,0.000017902037,0.000022614873],"genre_scores_gemma":[0.99865294,0.000018403358,0.0000314587,0.00043169566,0.00000548123,0.00044157787,0.00029286038,0.00001590826,0.000109669054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998842,0.00008297762,0.00038808244,0.00016866613,0.0003664656,0.0001518294],"domain_scores_gemma":[0.99893594,0.00011993597,0.00028965317,0.0004193225,0.00008600762,0.0001491216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006698719,0.00012334266,0.00031428324,0.00012720327,0.0001280841,0.0000053170725,0.00016878283,0.00001545939,0.00015281509],"category_scores_gemma":[0.00014796648,0.000082012804,0.00020110082,0.00025961074,0.000068945235,0.000080942176,0.00006589326,0.00003693031,6.8773875e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021976293,0.005245944,0.98250234,0.00070403994,0.00045379004,0.000007178793,0.00032482875,0.0035651221,0.000027476131,0.00022365678,0.00065631216,0.004091679],"study_design_scores_gemma":[0.0028178897,0.0011692309,0.9942173,0.0001340061,0.00027068143,0.000004635776,0.00025229194,0.0002538781,0.00006984645,0.0006428007,0.00008820395,0.000079258876],"about_ca_topic_score_codex":0.00016366913,"about_ca_topic_score_gemma":0.0000047693047,"teacher_disagreement_score":0.011714933,"about_ca_system_score_codex":0.000101947386,"about_ca_system_score_gemma":0.00028490508,"threshold_uncertainty_score":0.3344385},"labels":[],"label_agreement":null},{"id":"W4283697588","doi":"10.1136/annrheumdis-2022-eular.1932","title":"POS0870 PATIENTS WITH SYSTEMIC SCLEROSIS HAVE IMPAIRED FORCED VITAL CAPACITY, EVEN IN THE ABSENCE OF INTERSTITIAL LUNG DISEASE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Vital capacity; Interstitial lung disease; Spirometry; Pulmonary function testing; Cohort; Internal medicine; Population; Diffusing capacity; Lung; Physical therapy; Lung function; Asthma","score_opus":0.03567851124641895,"score_gpt":0.2552803806646075,"score_spread":0.21960186941818854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283697588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940755,0.0030469194,0.00000868845,0.0005148577,0.00016413088,0.0013716308,0.0007243066,0.000020129411,0.00007384763],"genre_scores_gemma":[0.99922895,0.00014127625,0.0000039165593,0.00030820578,0.000017432727,0.00018237134,0.000056399622,0.000024507106,0.00003692472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736077,0.00038887994,0.00067050435,0.0002467095,0.0010565431,0.00027661203],"domain_scores_gemma":[0.99815255,0.00026853688,0.0005160335,0.0007080886,0.00017387347,0.0001809308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030221365,0.00021380604,0.00049309345,0.00013270907,0.00017002464,0.00001941072,0.0005391416,0.00003108678,0.00009226018],"category_scores_gemma":[0.0004051346,0.000114176306,0.00037739833,0.00036558672,0.0002394418,0.00010787598,0.00020502279,0.00014398145,0.0000016901215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029109572,0.0030288042,0.9758708,0.0027339924,0.00071939646,0.000012384731,0.004904757,0.0016918984,0.0003022638,0.00020035902,0.0056992993,0.0019250804],"study_design_scores_gemma":[0.0025540343,0.00034206174,0.9778004,0.012161267,0.0004660082,0.000011728168,0.004840041,0.0014239828,0.00009759954,0.00012524507,0.0000024410997,0.00017517064],"about_ca_topic_score_codex":0.00029579113,"about_ca_topic_score_gemma":0.0000048966112,"teacher_disagreement_score":0.009427275,"about_ca_system_score_codex":0.00006396859,"about_ca_system_score_gemma":0.00020506408,"threshold_uncertainty_score":0.46559745},"labels":[],"label_agreement":null},{"id":"W4283697637","doi":"10.1136/annrheumdis-2022-eular.5053","title":"AB1182 SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS) AND INFLAMMATORY NETWORKS IN PATIENTS AFFECTED BY ADULT ONSET STILL'S DISEASE (AOSD) AND COVID-19","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eli Lilly Canada; Sanofi Genzyme; Merck Canada; Bristol-Myers Squibb Canada; Gilead Sciences; Pfizer Canada; Janssen Canada; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pathogenesis; Inflammation; Peripheral blood mononuclear cell; Immunology; Flow cytometry; Coronavirus disease 2019 (COVID-19); Disease; Systemic inflammation; Internal medicine","score_opus":0.017101728003450493,"score_gpt":0.29342014471261424,"score_spread":0.27631841670916374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283697637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894829,0.0067308266,0.000007762417,0.0018260046,0.00008525547,0.0015220083,0.00024119359,0.000044734155,0.000059356913],"genre_scores_gemma":[0.99652153,0.0015717063,0.0000046684295,0.001339114,0.00001611294,0.00022107814,0.00016134308,0.000035147794,0.00012928645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728113,0.00051916117,0.0006339984,0.00033439847,0.0008136967,0.00041761174],"domain_scores_gemma":[0.99813396,0.0003447011,0.0003180145,0.0004902132,0.00012303905,0.0005900468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045476112,0.00024581212,0.00055191823,0.0002049435,0.00029464392,0.00003756769,0.00027109132,0.00004994921,0.0003231228],"category_scores_gemma":[0.0035678064,0.00019156354,0.0001325319,0.0003844213,0.00039368813,0.00015797412,0.00052355684,0.00027420715,0.0000018353879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022916226,0.0010823495,0.94597733,0.0015924199,0.00019565043,0.000027209986,0.0010618668,0.00035052383,0.000007630973,0.00015427946,0.03911094,0.008148149],"study_design_scores_gemma":[0.004665393,0.00021850802,0.9867834,0.00043024527,0.00010766343,0.0000023274283,0.00065696676,0.0049000536,0.000011163454,0.0004525703,0.0015335883,0.00023810717],"about_ca_topic_score_codex":0.00013093378,"about_ca_topic_score_gemma":0.000016028034,"teacher_disagreement_score":0.040806055,"about_ca_system_score_codex":0.000065650675,"about_ca_system_score_gemma":0.000503957,"threshold_uncertainty_score":0.7811734},"labels":[],"label_agreement":null},{"id":"W4283697911","doi":"10.1136/annrheumdis-2022-eular.5001","title":"AB1180 COVID-19 HAD DISPROPORTIONATE IMPACTS ON RA SYMPTOMS AND FUNCTION BY SEX AND AGE: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT (CATCH)","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Université de Sherbrooke; Canadian Rheumatology Association; Université Laval; Western University; University of Calgary; McGill University; McGill University Health Centre","funders":"Eli Lilly Canada; Sanofi Genzyme; Sandoz Canada; Merck Canada; Bristol-Myers Squibb Canada; Gilead Sciences; Pfizer Canada; Janssen Canada; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Cohort; Pandemic; Anxiety; Depression (economics); Physical therapy; Young adult; Cohort study; Disease; Coronavirus disease 2019 (COVID-19); Internal medicine; Psychiatry","score_opus":0.02326955476134096,"score_gpt":0.2844026023358671,"score_spread":0.26113304757452616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283697911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95966005,0.013847136,0.0000034313603,0.022139605,0.00011550701,0.00078164187,0.003230197,0.000031398977,0.00019103014],"genre_scores_gemma":[0.9805591,0.015200234,0.0000027494852,0.003373455,0.000025782481,0.00009050324,0.00038234104,0.000022247648,0.00034359563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795026,0.00029930836,0.00038133326,0.00029856613,0.00072376046,0.00034680142],"domain_scores_gemma":[0.99800825,0.0005082818,0.00018485695,0.00048880605,0.00006769121,0.00074212166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005714014,0.00017560492,0.00032966307,0.00008184237,0.00096657034,0.00011922587,0.00018648693,0.000035014775,0.00022312831],"category_scores_gemma":[0.0013938315,0.0001029835,0.000103772574,0.00016944145,0.00044457903,0.000111871035,0.000119112,0.00021806188,0.000005950996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032994752,0.00064146036,0.39534837,0.0001974481,0.0017514268,0.00013996159,0.004924113,0.000076777134,0.000104760555,0.0019091853,0.38468263,0.20692438],"study_design_scores_gemma":[0.0030188034,0.00076286483,0.96055615,0.0004549344,0.000042173502,0.00003613719,0.00071223616,0.00014061287,0.00006444674,0.00671046,0.027318118,0.00018306618],"about_ca_topic_score_codex":0.14333878,"about_ca_topic_score_gemma":0.01362124,"teacher_disagreement_score":0.5652078,"about_ca_system_score_codex":0.000066040106,"about_ca_system_score_gemma":0.00051251904,"threshold_uncertainty_score":0.8623658},"labels":[],"label_agreement":null},{"id":"W4283697961","doi":"10.1136/annrheumdis-2022-eular.733","title":"AB0881 Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Memorial University of Newfoundland","funders":"Amgen","keywords":"Medicine; Psoriatic arthritis; Visual analogue scale; Dactylitis; Dermatology Life Quality Index; Quality of life (healthcare); Internal medicine; Physical therapy; Placebo; Psoriasis; Arthritis; Enthesitis; Disease; Dermatology; Alternative medicine","score_opus":0.023741402733442288,"score_gpt":0.27098493470840657,"score_spread":0.2472435319749643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283697961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436146,0.0035003286,7.7323483e-7,0.00020680623,0.00013231655,0.00088575797,0.00088406453,0.000007871929,0.000020617377],"genre_scores_gemma":[0.9993933,0.00022036771,0.000010814699,0.000058692185,0.0000011617377,0.00009863491,0.0001496011,0.000012674652,0.000054749573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751234,0.00089401257,0.0009867027,0.00019719645,0.00015235499,0.00025740662],"domain_scores_gemma":[0.9981904,0.00030475686,0.0010618101,0.0003518667,0.00006997503,0.00002116901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003353933,0.00014834247,0.00068721443,0.00011042897,0.00006866939,0.0000028827312,0.0002686621,0.00004314691,0.00012364866],"category_scores_gemma":[0.00042472433,0.0001136451,0.00014066865,0.00037210018,0.00015945022,0.0001360867,0.0001505346,0.0000937259,0.0000014317259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010748503,0.010583169,0.5647463,0.0014220014,0.0025949855,0.000002331186,0.012374367,0.00062173104,0.0001746288,0.0013906282,0.0004715296,0.3948698],"study_design_scores_gemma":[0.0068649314,0.0007561618,0.98700076,0.0004487688,0.000042091026,1.6641884e-7,0.0023091456,0.0000021392452,0.00082372094,0.0016235358,0.000010781354,0.00011778684],"about_ca_topic_score_codex":0.004267136,"about_ca_topic_score_gemma":0.0002114795,"teacher_disagreement_score":0.42225444,"about_ca_system_score_codex":0.000053513795,"about_ca_system_score_gemma":0.00032226194,"threshold_uncertainty_score":0.64506614},"labels":[],"label_agreement":null},{"id":"W4283698327","doi":"10.1136/annrheumdis-2022-eular.2168","title":"POS1422 USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND RISK OF MULTIPLE MYELOMA IN PERSONS WITH RHEUMATOID ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Abatacept; Leflunomide; Tocilizumab; Rheumatoid arthritis; Hydroxychloroquine; Internal medicine; Rituximab; Sulfasalazine; Incidence (geometry); Etanercept; Infliximab; Medical prescription; Tofacitinib; Antirheumatic drugs; Antirheumatic Agents; Disease; Lymphoma; Pharmacology","score_opus":0.034062120496429184,"score_gpt":0.2689386530115542,"score_spread":0.234876532515125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283698327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862201,0.011512995,0.00004448919,0.0004643066,0.00007531094,0.00036810842,0.001288033,0.00001302497,0.0000135840755],"genre_scores_gemma":[0.99411404,0.0053923475,0.00029925298,0.0000716103,0.0000011365009,0.000032562122,0.000016062897,0.000016874605,0.0000561003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781054,0.00086598773,0.0006377845,0.00025039027,0.0001516385,0.00028367224],"domain_scores_gemma":[0.9976248,0.0011566947,0.0005872524,0.00048712225,0.00007777536,0.000066352004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004605896,0.00020064619,0.00068372994,0.00015793194,0.0001927832,0.000011005522,0.00030940544,0.000051050643,0.00020233562],"category_scores_gemma":[0.0009912408,0.00013588616,0.00022815209,0.0003299734,0.0007135808,0.00011530954,0.00031687279,0.00020322413,7.959793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002044957,0.0022584088,0.919043,0.0013035127,0.00163464,0.0000058918417,0.0034457608,0.00094949413,0.0020085077,0.0008541006,0.001376205,0.065075494],"study_design_scores_gemma":[0.0031054593,0.00047143508,0.9796846,0.0026893152,0.00030321156,0.000017272669,0.0039447257,0.001750134,0.005810727,0.0016054984,0.00022214932,0.00039547728],"about_ca_topic_score_codex":0.0006328556,"about_ca_topic_score_gemma":0.00003030465,"teacher_disagreement_score":0.06468002,"about_ca_system_score_codex":0.000009603035,"about_ca_system_score_gemma":0.000098473975,"threshold_uncertainty_score":0.5541277},"labels":[],"label_agreement":null},{"id":"W4283698581","doi":"10.1136/annrheumdis-2022-eular.1589","title":"AB0928 CHARACTERISTICS OF AXIAL PSORIATIC ARTHRITIS PATIENTS WITH SYMMETRICAL AND ASYMMETRICAL SACROILIITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Krembil Foundation; AstraZeneca","keywords":"Sacroiliitis; Medicine; Psoriatic arthritis; BASDAI; Sacroiliac joint; Internal medicine; Body surface area; Statistical significance; Psoriasis; Rheumatology; Nuclear medicine; Gastroenterology; Arthritis; Surgery; Dermatology","score_opus":0.013713508003096484,"score_gpt":0.2462347097306885,"score_spread":0.23252120172759203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283698581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407953,0.004031087,0.0000039918136,0.00040676692,0.00014352189,0.0004391493,0.00077677966,0.000012348629,0.0001068529],"genre_scores_gemma":[0.9983824,0.0012043677,0.00006854217,0.00017290637,0.000016329448,0.000050616123,0.000051738243,0.000017464807,0.000035617115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843025,0.00008463545,0.00042475146,0.00018327385,0.00066607207,0.0002109946],"domain_scores_gemma":[0.9989184,0.00020252525,0.00029166142,0.00029511418,0.00015976584,0.00013252322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000816963,0.00015041632,0.0005838994,0.00013963411,0.00018200891,0.000009063814,0.000110188965,0.000020970838,0.00013416115],"category_scores_gemma":[0.00064849196,0.0001002042,0.00015218736,0.0005473044,0.00018830955,0.00004250352,0.00021614201,0.000089799614,0.0000018699365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083943753,0.002835309,0.5925552,0.00032480722,0.0007089939,0.000027481703,0.00014532408,0.0000015763404,8.609388e-7,0.0005059956,0.0013705383,0.40068445],"study_design_scores_gemma":[0.0035883314,0.0015331757,0.9934993,0.00036876558,0.00026054875,0.000017044827,0.00008847549,0.000021982849,0.000032035307,0.00023944315,0.000252407,0.00009853209],"about_ca_topic_score_codex":0.000062853454,"about_ca_topic_score_gemma":0.0000016578703,"teacher_disagreement_score":0.40094402,"about_ca_system_score_codex":0.000020499361,"about_ca_system_score_gemma":0.00005928395,"threshold_uncertainty_score":0.40862086},"labels":[],"label_agreement":null},{"id":"W4283698989","doi":"10.1136/annrheumdis-2022-eular.4156","title":"POS1259 AXIAL SPONDYLOARTHRITIS, AGE AND MALE GENDER IMPACT COVID VACCINATION AEs MORE THAN RHEUMATOID ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Eli Lilly and Company; Leeds Biomedical Research Centre; Directorate for Biological Sciences; Manchester Biomedical Research Centre; University of Illinois at Urbana-Champaign; Örebro Universitet; Universitätsspital Zürich; Pomorski Uniwersytet Medyczny W Szczecinie; Universität Zürich; Faculdade de Medicina da Universidade de São Paulo; Karolinska Institutet; Faculty of Medicine and Health, University of Sydney; Università degli Studi di Pavia; Cairo University; University of Manchester; University of Leeds; Sanjay Gandhi Postgraduate Institute of Medical Sciences; National Institute for Health and Care Research; Instituto Mexicano del Seguro Social; King's College London; AstraZeneca; University of Pittsburgh; Pfizer; Friedrich-Alexander-Universität Erlangen-Nürnberg","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Vaccination; Univariate analysis; Prospective cohort study; Sacroiliitis; Multivariate analysis; Adverse effect; Arthritis; Physical therapy; Immunology","score_opus":0.03343210182146153,"score_gpt":0.3241977667819283,"score_spread":0.29076566496046674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283698989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93055475,0.06449162,0.000007885596,0.0028123048,0.00017741113,0.0007782204,0.00068954873,0.00006580151,0.00042245747],"genre_scores_gemma":[0.92559075,0.073351726,0.000044325836,0.00041491014,0.000032421925,0.00013534215,0.00013740218,0.00004257037,0.00025056888],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972095,0.00035483795,0.0005455979,0.0003425981,0.0010259056,0.00052155054],"domain_scores_gemma":[0.9983237,0.00023627108,0.00025657835,0.00059901376,0.0001495861,0.00043487383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004484436,0.00027726215,0.0006091683,0.00023322605,0.0006108956,0.00009101092,0.00032840087,0.00004583254,0.0040875403],"category_scores_gemma":[0.00067019125,0.00021646604,0.00041996155,0.0003500499,0.0002828494,0.00026254044,0.00037781053,0.00024900193,0.000012255731],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004383794,0.0035763427,0.28146404,0.0014560666,0.0023477275,0.0009413206,0.01046717,0.00038393802,0.0012574155,0.0052984105,0.1073647,0.5810591],"study_design_scores_gemma":[0.0067656194,0.0013704983,0.966002,0.0011645814,0.0000296912,0.0021222038,0.0038606683,0.0005328104,0.00065158977,0.009071652,0.00785359,0.00057507836],"about_ca_topic_score_codex":0.0003141589,"about_ca_topic_score_gemma":0.00003492611,"teacher_disagreement_score":0.684538,"about_ca_system_score_codex":0.000046196685,"about_ca_system_score_gemma":0.00031851252,"threshold_uncertainty_score":0.99682283},"labels":[],"label_agreement":null},{"id":"W4283699035","doi":"10.1136/annrheumdis-2022-eular.2568","title":"AB1119 GLUCOCORTICOIDS' TREATMENT IMPAIRS THE MEDIUM-TERM IMMUNOGENIC RESPONSE TO SARS-CoV-2 mRNA VACCINES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS.","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sorbonne Université; Centre hospitalier régional universitaire de Lille; Centre hospitalier universitaire Sainte-Justine; Assistance publique-Hôpitaux de Paris; Université Paris-Saclay; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Hydroxychloroquine; Immunology; Titer; Lupus erythematosus; Internal medicine; Antibody; Connective tissue disease; Systemic lupus erythematosus; Rheumatology; Immune system; Autoimmune disease; Disease; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.042727610632914616,"score_gpt":0.3432013701382817,"score_spread":0.3004737595053671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877305,0.004846772,0.0000015953835,0.0032328146,0.0003972663,0.0024933494,0.00014238995,0.000056206518,0.00005657828],"genre_scores_gemma":[0.9913318,0.00009773019,0.0000047692774,0.0073741972,0.000029496665,0.0010219582,0.000009490616,0.000054050757,0.000076500386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995996,0.00086544245,0.00094175484,0.00041039588,0.0011637461,0.00062268774],"domain_scores_gemma":[0.9969176,0.0009425383,0.00033532197,0.0015144757,0.00020594627,0.00008412043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008885583,0.00035820727,0.0007523717,0.0003522699,0.0003075366,0.000047078913,0.0009052605,0.000047444133,0.000036041754],"category_scores_gemma":[0.0013276343,0.00020243075,0.00056411966,0.0009229508,0.00012282818,0.00009312357,0.0005701724,0.0001980363,0.000051208444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03103934,0.007106644,0.86301976,0.00167855,0.001760261,0.00020916593,0.011519601,0.00008643065,0.05300035,0.000086653934,0.009285631,0.021207606],"study_design_scores_gemma":[0.017054059,0.006225039,0.8260713,0.0033680447,0.0009269391,0.00087560347,0.0071817636,0.0006782754,0.12913334,0.0010795168,0.006434565,0.00097150233],"about_ca_topic_score_codex":0.0005877121,"about_ca_topic_score_gemma":0.00005478165,"teacher_disagreement_score":0.07613299,"about_ca_system_score_codex":0.00035733066,"about_ca_system_score_gemma":0.00071374496,"threshold_uncertainty_score":0.8254886},"labels":[],"label_agreement":null},{"id":"W4283699039","doi":"10.1136/annrheumdis-2022-eular.447","title":"AB1090 IMPACT OF THE COVID19 PANDEMIC ON THE SOCIAL BEHAVIOR OF PATIENTS WITH RHEUMATIC DISEASES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society","keywords":"Medicine; Social support; Rheumatoid arthritis; Internal medicine; Depression (economics); Observational study; Epidemiology; Comorbidity; Pandemic; Physical therapy; Rheumatology; Social isolation; Coronavirus disease 2019 (COVID-19); Psychiatry; Disease","score_opus":0.08598142232106493,"score_gpt":0.4210895329375594,"score_spread":0.3351081106164945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944542,0.0004026065,0.0000012957131,0.0007036788,0.0002726933,0.0012661634,0.0027455129,0.000018527051,0.00013528836],"genre_scores_gemma":[0.99885154,0.000040023,8.0106236e-7,0.00063217035,0.0000114653685,0.00025646423,0.00003187144,0.000027514994,0.00014816513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726844,0.0007539366,0.00061544374,0.00021435847,0.0008195231,0.00032827083],"domain_scores_gemma":[0.9970754,0.00094083656,0.00092802726,0.00085408334,0.00009701802,0.00010463432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002947915,0.00022157464,0.00045860166,0.00006917029,0.00046710542,0.000009364352,0.0009036596,0.000031855234,0.001510364],"category_scores_gemma":[0.00022827185,0.00010202851,0.00057973905,0.00038068357,0.00041818147,0.00005025741,0.0002810893,0.00016947699,0.000006494627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011518488,0.0042076753,0.9631047,0.00044689496,0.00043205477,5.813137e-7,0.0037546745,0.00012449817,0.000004612369,0.0011961046,0.0119174775,0.013658829],"study_design_scores_gemma":[0.0009850718,0.0007473343,0.9950479,0.00027910352,0.00028430411,8.1189836e-7,0.0016709683,0.00001564058,0.00001412678,0.0007965536,0.000042359337,0.00011579377],"about_ca_topic_score_codex":0.0013012716,"about_ca_topic_score_gemma":0.00002821567,"teacher_disagreement_score":0.031943183,"about_ca_system_score_codex":0.00011691764,"about_ca_system_score_gemma":0.0005545834,"threshold_uncertainty_score":0.9994024},"labels":[],"label_agreement":null},{"id":"W4283699051","doi":"10.1136/annrheumdis-2022-eular.174","title":"POS1014 IMPACT OF SERUM INTERLEUKIN 22 AS A BIOMARKER FOR THE DIFFERENTIAL USE OF MOLECULAR TARGETED DRUGS FOR PSORIATIC ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hôpitaux Universitaires de Genève; Memorial University of Newfoundland; University of Oxford; Université de Genève; University of Glasgow; Janssen Scientific Affairs; University of Washington","keywords":"Medicine; Psoriatic arthritis; Cohort; Biomarker; Internal medicine; Immunology; Tumor necrosis factor alpha; Psoriasis; Oncology; TNF inhibitor; Disease; Etanercept","score_opus":0.031905624823694925,"score_gpt":0.29081742926777204,"score_spread":0.25891180444407713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98418146,0.008115704,0.00013057138,0.00028433173,0.00044196198,0.0010381129,0.0057902164,0.0000119754495,0.0000056731697],"genre_scores_gemma":[0.9989338,0.0002746464,0.00002399403,0.000052994063,0.0000055048645,0.0003190383,0.00017819833,0.000021036114,0.00019078299],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986914,0.00034020716,0.00047309828,0.00016424159,0.000083751314,0.00024730718],"domain_scores_gemma":[0.99785364,0.00106314,0.00048241927,0.00045833059,0.00011966853,0.000022797716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001804581,0.0001835806,0.000462999,0.00008600737,0.00018782669,0.0000093571125,0.00040060774,0.000049267906,0.0007988228],"category_scores_gemma":[0.00042105702,0.00010839195,0.0010044264,0.00014470416,0.00016407794,0.00005427583,0.00015929244,0.000043368476,0.000002126043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012395741,0.0046777753,0.007734409,0.0011728184,0.029835114,0.0000027305057,0.004541881,0.0006451957,0.104833126,0.0025153956,0.037590396,0.7940554],"study_design_scores_gemma":[0.019647505,0.0062132,0.52314883,0.0014385475,0.006215892,0.000040577062,0.0031980479,0.0016155929,0.416242,0.019447211,0.0017405788,0.001052012],"about_ca_topic_score_codex":0.00023022536,"about_ca_topic_score_gemma":0.000004657876,"teacher_disagreement_score":0.7930034,"about_ca_system_score_codex":0.000015121044,"about_ca_system_score_gemma":0.00011500681,"threshold_uncertainty_score":0.8746549},"labels":[],"label_agreement":null},{"id":"W4283699099","doi":"10.1136/annrheumdis-2022-eular.1904","title":"AB0897 Impact of risankizumab on improving symptoms and health-related quality of life and reducing fatigue and pain among psoriatic arthritis patients with moderate-to-severe skin involvement: Evidence from two Phase III trials","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Visual analogue scale; Quality of life (healthcare); Psoriatic arthritis; Physical therapy; Internal medicine; Dermatology Life Quality Index; Placebo; Confidence interval; Psoriasis Area and Severity Index; Minimal clinically important difference; Psoriasis; Randomized controlled trial; Arthritis; Disease; Dermatology; Alternative medicine","score_opus":0.08581209690795068,"score_gpt":0.3769269686141229,"score_spread":0.29111487170617223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709262,0.026272623,0.000046484798,0.00042888097,0.000034638393,0.0016386122,0.00063616445,0.0000138270625,0.0000025283073],"genre_scores_gemma":[0.993399,0.00628649,0.000056147797,0.00009901002,0.000009074263,0.00007384602,0.00004987197,0.000022994413,0.000003561147],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99542683,0.0017153029,0.0014140552,0.00034157926,0.0008038229,0.00029840076],"domain_scores_gemma":[0.99600047,0.0017519605,0.0012212357,0.0004406817,0.00017424743,0.00041142403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030714246,0.00023668596,0.001379907,0.00017533878,0.0002517871,0.000040499966,0.00014595344,0.000027849368,0.00009561402],"category_scores_gemma":[0.0038259448,0.00015853872,0.00016804905,0.00024620022,0.00028775382,0.000225734,0.00018136452,0.00015549318,1.0684441e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017253822,0.0016936993,0.285296,0.0017177335,0.0021360493,0.000002547963,0.010415223,0.0014177868,0.00016359531,0.0000843762,0.00044882618,0.67937034],"study_design_scores_gemma":[0.02995632,0.0075922473,0.93823165,0.014363278,0.00006300977,0.000002140487,0.0016893799,0.0059508835,0.00031678248,0.0015410982,7.872569e-7,0.00029240054],"about_ca_topic_score_codex":0.014459923,"about_ca_topic_score_gemma":0.0001053189,"teacher_disagreement_score":0.6790779,"about_ca_system_score_codex":0.00004017717,"about_ca_system_score_gemma":0.00035471036,"threshold_uncertainty_score":0.99210286},"labels":[],"label_agreement":null},{"id":"W4283699174","doi":"10.1136/annrheumdis-2022-eular.4240","title":"AB0720 Adult Onset Still's Disease: Points to Consider | Annals of the Rheumatic Diseases","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Adult-onset Still's disease; Rash; Anakinra; Etiology; Disease; Macrophage activation syndrome; Arthritis; Intensive care medicine; Myopericarditis; Incidence (geometry); Rheumatology; Dermatology; Pediatrics; Differential diagnosis; Epidemiology; Internal medicine; Pericarditis; Pathology","score_opus":0.05657775797988862,"score_gpt":0.3508062560762795,"score_spread":0.2942284980963909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522774,0.006705895,0.000008196614,0.036538027,0.0002567673,0.0019363536,0.0018292081,0.000063560205,0.0003845767],"genre_scores_gemma":[0.99091905,0.0007623365,0.000015929007,0.006439108,0.000018118082,0.0003216925,0.000061411505,0.000060588,0.0014017862],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9949979,0.00078772416,0.0011915816,0.00041417216,0.001958328,0.00065028854],"domain_scores_gemma":[0.99544865,0.0006688752,0.00065561105,0.0020273253,0.00060218206,0.0005973302],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053445296,0.00037300144,0.0009547395,0.00022158671,0.0004769597,0.000039695507,0.0011321339,0.00004248022,0.0025494914],"category_scores_gemma":[0.0063515403,0.00023344287,0.0009251342,0.0007848004,0.00061387435,0.00016748953,0.0011542139,0.00029355878,0.000063574895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004530083,0.00578083,0.20677929,0.008412105,0.002783615,0.000064404085,0.0037139799,0.002753859,0.00008350105,0.004832878,0.7148678,0.04539769],"study_design_scores_gemma":[0.0017116651,0.00041347815,0.9734083,0.0032692798,0.00053413387,0.000019239067,0.0026756604,0.0011289666,0.00065247697,0.010072597,0.005664327,0.0004499025],"about_ca_topic_score_codex":0.00016408878,"about_ca_topic_score_gemma":0.0000062072163,"teacher_disagreement_score":0.766629,"about_ca_system_score_codex":0.000043208773,"about_ca_system_score_gemma":0.0013195866,"threshold_uncertainty_score":0.9983623},"labels":[],"label_agreement":null},{"id":"W4283699516","doi":"10.1136/annrheumdis-2022-eular.1775","title":"AB0896 Comparative Effectiveness of Guselkumab in Psoriatic Arthritis: Updates to a Systematic Literature Review and Network Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Golimumab; Meta-analysis; Oncology; Secukinumab; Ustekinumab; Adverse effect; TNF inhibitor; Randomized controlled trial; Etanercept; Adalimumab; Arthritis; Rheumatoid arthritis","score_opus":0.05196865573754977,"score_gpt":0.308142508952681,"score_spread":0.25617385321513125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699516","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19225344,0.8053774,0.0000070024794,0.00023462347,0.00009288271,0.0014565764,0.0005459824,0.000010517359,0.000021528735],"genre_scores_gemma":[0.9840118,0.01468522,0.000019450414,0.00021099427,0.0000022268516,0.0008804045,0.0001026317,0.000008203659,0.000079038204],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995237,0.003523853,0.00068532024,0.00024643034,0.0000967262,0.00021066147],"domain_scores_gemma":[0.99768454,0.001216941,0.0004632389,0.0005079272,0.000097645876,0.000029705501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010401903,0.00022066005,0.002567785,0.00017338825,0.00013600444,0.000011476802,0.0003238883,0.000037415026,0.00021493393],"category_scores_gemma":[0.00023210631,0.00013739926,0.00081314094,0.0013068505,0.00007333294,0.000063134314,0.00019172017,0.00008423394,0.000006804034],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014168324,0.0029859354,0.0057620695,0.22728957,0.7292504,0.000021346174,0.006697163,0.0103424415,0.000193746,0.0037605094,0.008525027,0.0037549643],"study_design_scores_gemma":[0.003870458,0.0011832481,0.12537575,0.07967951,0.7776141,0.00007531001,0.0015810698,0.00006517351,0.002892163,0.0063149063,0.0001859864,0.001162282],"about_ca_topic_score_codex":0.000033062282,"about_ca_topic_score_gemma":0.00001838495,"teacher_disagreement_score":0.7917584,"about_ca_system_score_codex":0.000012305645,"about_ca_system_score_gemma":0.000038125323,"threshold_uncertainty_score":0.5602979},"labels":[],"label_agreement":null},{"id":"W4283699557","doi":"10.1136/annrheumdis-2022-eular.4899","title":"AB0563 ALEXITHYMIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Feeling; Personality; Medicine; Pathological; Clinical psychology; Psychiatry; Psychology; Internal medicine; Social psychology","score_opus":0.02268432269574265,"score_gpt":0.2777862680198316,"score_spread":0.2551019453240889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964874,0.0016381105,0.0000016262969,0.00071373914,0.000097805234,0.00072109106,0.00006704294,0.000020382768,0.00025281875],"genre_scores_gemma":[0.99916136,0.000050168637,0.000015423853,0.000032060245,0.0000028402756,0.000100186204,0.000030511883,0.000023516175,0.0005839198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998086,0.00015854847,0.00034192318,0.00018477539,0.00092078274,0.00030802173],"domain_scores_gemma":[0.9989609,0.00010328088,0.00015516632,0.0005772809,0.000085418,0.00011794115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019079614,0.00013500059,0.00037315415,0.00012986778,0.000108872184,0.000009577114,0.00029839817,0.000020352982,0.000510478],"category_scores_gemma":[0.00012869554,0.00008313868,0.00013799826,0.00042017724,0.000121483776,0.00005693902,0.00020032778,0.00016332242,0.000012966015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065977394,0.0010207833,0.9857233,0.005557336,0.0002003842,0.000016373717,0.0003967134,0.00028063546,0.0000046591304,0.00026345646,0.0049991445,0.0008774409],"study_design_scores_gemma":[0.0037135775,0.0008608635,0.98785114,0.005603531,0.000073276686,0.00016106038,0.00079337246,0.00027177882,0.000043883105,0.00043865453,0.000037180267,0.00015170344],"about_ca_topic_score_codex":0.00005297656,"about_ca_topic_score_gemma":7.3604986e-7,"teacher_disagreement_score":0.004961964,"about_ca_system_score_codex":0.00007322594,"about_ca_system_score_gemma":0.0002991232,"threshold_uncertainty_score":0.55893755},"labels":[],"label_agreement":null},{"id":"W4283699897","doi":"10.1136/annrheumdis-2022-eular.3098","title":"POS0888 NON-SURGICAL LOCAL TREATMENTS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: A SYSTEMATIC LITERATURE REVIEW","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Jewish General Hospital; University of Ottawa","funders":"","keywords":"Medicine; Systemic therapy; Systematic review; Scleroderma (fungus); Surgery; MEDLINE; Internal medicine; Pathology","score_opus":0.03138914314113709,"score_gpt":0.2918133273943661,"score_spread":0.260424184253229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283699897","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33326682,0.6586045,0.0000117670415,0.0012178639,0.00029623832,0.0054986686,0.000867776,0.00004776027,0.000188605],"genre_scores_gemma":[0.95215833,0.045084465,0.0000042730385,0.0005464423,0.000022832011,0.0016296738,0.000118040625,0.00003588362,0.00040003643],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99722475,0.00025957267,0.0011370699,0.00032881342,0.00071277865,0.0003370444],"domain_scores_gemma":[0.99804217,0.00035547029,0.0005199317,0.0007071914,0.00015217692,0.00022304336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038031724,0.00028584737,0.0012154045,0.00014714776,0.00015264277,0.000047025846,0.00036496625,0.00006208003,0.000052853375],"category_scores_gemma":[0.00043901455,0.000167774,0.0009148396,0.00067981484,0.000092499125,0.00012804916,0.00014399827,0.00013606188,0.000010002247],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015838501,0.005238601,0.0070336442,0.9294706,0.004170079,0.00016455539,0.0014938109,0.00074694864,0.000080386686,0.00027631051,0.03639407,0.013347146],"study_design_scores_gemma":[0.0034263448,0.0004254545,0.0069152666,0.98346376,0.0020289056,0.0004784626,0.0018141499,0.0010166334,0.000040309842,0.000101392994,0.000031205585,0.00025812787],"about_ca_topic_score_codex":0.000010211201,"about_ca_topic_score_gemma":2.220215e-7,"teacher_disagreement_score":0.61889154,"about_ca_system_score_codex":0.00012136526,"about_ca_system_score_gemma":0.00019168541,"threshold_uncertainty_score":0.6841625},"labels":[],"label_agreement":null},{"id":"W4283701030","doi":"10.1136/annrheumdis-2022-eular.2030","title":"POS1044 GUSELKUMAB PROVIDES CONSISTENT AND DURABLE PAIN IMPROVEMENT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF 2 PHASE 3, RANDOMIZED, CONTROLLED CLINICAL TRIALS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Research and Development; Sun Pharma; University College Dublin; Celgene; Gilead Sciences; Pfizer Canada; Sanofi; Amgen; Pfizer; University of Washington; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Placebo; Psoriatic arthritis; Visual analogue scale; Internal medicine; Physical therapy; Ankylosing spondylitis; Arthritis; Alternative medicine","score_opus":0.03881296192731053,"score_gpt":0.31647508208758685,"score_spread":0.2776621201602763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283701030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857038,0.008136887,0.000003345616,0.00045829668,0.00029394255,0.004102693,0.0012564064,0.000012284338,0.00003232148],"genre_scores_gemma":[0.99768126,0.0011414384,0.000014566874,0.00012538572,0.000005790921,0.0007703993,0.00014454081,0.000012035037,0.00010458981],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9886891,0.008526183,0.0021043832,0.00028403787,0.00015453121,0.00024173866],"domain_scores_gemma":[0.9894908,0.0080487,0.0019021593,0.0003732598,0.00014502357,0.00004004389],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0074664,0.00022493556,0.0024770584,0.00011720451,0.00015364416,0.00001080479,0.00020110836,0.00005973009,0.00012076928],"category_scores_gemma":[0.010047074,0.0001251617,0.0005929374,0.00013428077,0.000362908,0.00007182571,0.00011906022,0.00010899473,0.0000014003228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56572425,0.0051976326,0.0016510012,0.00010711949,0.004621272,0.0000016511995,0.00047957548,0.00002011117,0.000050180908,0.00009935696,0.00088527345,0.42116258],"study_design_scores_gemma":[0.9771527,0.0035175546,0.013089794,0.00065656553,0.0017421156,0.0000014084421,0.0010912817,0.00006638502,0.0014029678,0.0009909455,0.00007074315,0.00021752204],"about_ca_topic_score_codex":0.000154903,"about_ca_topic_score_gemma":0.00001889585,"teacher_disagreement_score":0.42094505,"about_ca_system_score_codex":0.00001854942,"about_ca_system_score_gemma":0.00017826904,"threshold_uncertainty_score":0.99829173},"labels":[],"label_agreement":null},{"id":"W4283701421","doi":"10.1136/annrheumdis-2022-eular.1650","title":"AB0929 Is there a correlation between skin severity and joint activity in Psoriatic Arthritis (PsA)?","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Arthritis Society; University Health Network","funders":"","keywords":"Medicine; Psoriasis; Sacroiliitis; Ankylosing spondylitis; Psoriatic arthritis; Internal medicine; Correlation; Cohort; Severity of illness; Psoriasis Area and Severity Index; BASDAI; Retrospective cohort study; Surgery; Physical therapy; Dermatology","score_opus":0.03682112746608081,"score_gpt":0.2899588191453711,"score_spread":0.2531376916792903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283701421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947805,0.00661207,0.0000054755646,0.0027402737,0.00008670029,0.00049082824,0.00029055643,0.0000143913085,0.00028166914],"genre_scores_gemma":[0.9977606,0.0017563205,0.000014495763,0.00021845078,0.000014864093,0.000078063335,0.000013560512,0.000011931742,0.00013173086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891454,0.00013496916,0.00027316858,0.00017436522,0.00032877782,0.00017418806],"domain_scores_gemma":[0.9993185,0.00012741024,0.00018104677,0.0002657073,0.00003292986,0.00007440286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015366547,0.00012643392,0.00042468894,0.00006180664,0.00018807488,0.000010210008,0.00005184342,0.00002261778,0.000250512],"category_scores_gemma":[0.00015784506,0.00009633846,0.00014530084,0.00019585423,0.00007871662,0.0000716578,0.00018191015,0.000110471745,0.0000048804227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025602852,0.001041731,0.64761215,0.00034967097,0.0005064513,0.000029577448,0.0018985261,0.000027046803,0.0000052956407,0.000087251734,0.0039957194,0.34419054],"study_design_scores_gemma":[0.0017240142,0.00021125059,0.99419254,0.0005331399,0.00011328803,0.000013305058,0.000376013,0.00033502086,0.00010116492,0.0020837854,0.00023035282,0.00008615326],"about_ca_topic_score_codex":0.00043659535,"about_ca_topic_score_gemma":0.000043898526,"teacher_disagreement_score":0.34658036,"about_ca_system_score_codex":0.00003300352,"about_ca_system_score_gemma":0.000051920015,"threshold_uncertainty_score":0.39285684},"labels":[],"label_agreement":null},{"id":"W4283701934","doi":"10.1136/annrheumdis-2022-eular.1298","title":"POS0521 RISKS OF SEVERE INFECTION AFTER THE INTRODUCTION OF bDMARDs IN NEWLY DIAGNOSED RHEUMATOID ARTHRITIS PATIENTS: A POPULATION-BASED INTERRUPTED TIME-SERIES ANALYSIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Research Canada; Simon Fraser University","funders":"Genentech; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Cohort; Population; Internal medicine; Cohort study; Pediatrics","score_opus":0.017955197655516612,"score_gpt":0.29290462366089887,"score_spread":0.27494942600538225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283701934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940798,0.0030062927,0.000017797434,0.001730466,0.00011515173,0.00066072977,0.00034575287,0.00001929002,0.000024708806],"genre_scores_gemma":[0.99515045,0.0042190687,0.000029775203,0.00008156802,0.000015097818,0.00019576766,0.0002615556,0.000018780453,0.000027954264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973406,0.0005900917,0.0008477221,0.00021233453,0.0007854757,0.0002237326],"domain_scores_gemma":[0.99814314,0.00028677113,0.0005434589,0.00060669356,0.0003457264,0.000074204305],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045288308,0.00017131411,0.0006442484,0.0004733466,0.00013667149,0.000017573671,0.00020563338,0.00003426993,0.00140842],"category_scores_gemma":[0.0013684363,0.000117933916,0.0004912913,0.0013124133,0.00022398001,0.00019151135,0.00013576352,0.00016607845,0.000002437454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024828862,0.0012094451,0.95489,0.00019973995,0.00088237406,0.000001654914,0.0007390194,0.006331583,0.000023230054,0.000047983696,0.0013206676,0.031871382],"study_design_scores_gemma":[0.0018015994,0.0004813679,0.99461997,0.0005485104,0.00006437214,0.0000039612696,0.00032505576,0.0010629876,0.0002587967,0.0005157845,0.00020883504,0.00010873542],"about_ca_topic_score_codex":0.003536088,"about_ca_topic_score_gemma":0.0004378303,"teacher_disagreement_score":0.03972996,"about_ca_system_score_codex":0.000046310335,"about_ca_system_score_gemma":0.00013378533,"threshold_uncertainty_score":0.99950445},"labels":[],"label_agreement":null},{"id":"W4283702023","doi":"10.1136/annrheumdis-2022-eular.1267","title":"POS1210 SAFETY AND IMMUNOGENICITY OF COVID-19 VACCINES IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Public Health Agency of Canada; University of Manitoba","funders":"","keywords":"Medicine; Immunology; Immunogenicity; Vaccination; Inflammatory bowel disease; Rheumatoid arthritis; Systemic lupus erythematosus; Arthritis; Immune system; Disease; Antibody; Internal medicine","score_opus":0.023352133787447164,"score_gpt":0.30688365669084516,"score_spread":0.283531522903398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283702023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993357,0.004062255,0.0000026933421,0.0013052754,0.00003841361,0.00083485706,0.0003379598,0.000022206592,0.000039363156],"genre_scores_gemma":[0.9953723,0.000080364065,0.000004423141,0.004411631,0.000005213449,0.000060615144,0.000033733388,0.000021376685,0.000010351039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977903,0.00028884973,0.0006167554,0.00022246035,0.00082023995,0.0002614115],"domain_scores_gemma":[0.99829084,0.00043270676,0.0003207952,0.00063526555,0.00017736881,0.0001430558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004530468,0.00017506564,0.00049226504,0.00021282842,0.00014809935,0.00000866738,0.00034520793,0.00002537279,0.00007678313],"category_scores_gemma":[0.0019421146,0.000117115895,0.00016111466,0.00051033386,0.00022003721,0.000094597075,0.00042831243,0.00015742473,0.0000016367648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010739023,0.0011009289,0.9844185,0.0012942775,0.000252926,0.000014376242,0.0003941424,0.000046563062,0.00017792877,0.00007580286,0.00014674675,0.0013387852],"study_design_scores_gemma":[0.004500192,0.0003094213,0.99263716,0.00028846003,0.00011350612,0.0000017632216,0.00029777965,0.00019212071,0.00049160485,0.00041571964,0.0006243535,0.00012794453],"about_ca_topic_score_codex":0.0003908541,"about_ca_topic_score_gemma":0.000015283134,"teacher_disagreement_score":0.008218635,"about_ca_system_score_codex":0.00006053073,"about_ca_system_score_gemma":0.000833529,"threshold_uncertainty_score":0.47758475},"labels":[],"label_agreement":null},{"id":"W4283702536","doi":"10.1136/annrheumdis-2022-eular.5116","title":"POS1569-PARE TESTING A NEW APPROACH TO IDENTIFY AND ASSESS PATIENT-VALUED TREATMENT GOALS IN RHEUMATOID ARTHRITIS (RA): A PATIENT-ENGAGED HEALTHCARE VALUATION STRATEGY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Goal Attainment Scaling; Valuation (finance); Health care; Patient participation; Outcomes research; Physical therapy; Alternative medicine; Family medicine; Rehabilitation","score_opus":0.536827135326511,"score_gpt":0.4457141047049713,"score_spread":0.09111303062153975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283702536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783035,0.008984809,0.00017342671,0.008390173,0.0002509171,0.0023685975,0.0011475692,0.000039683287,0.0003413491],"genre_scores_gemma":[0.9952931,0.00045457418,0.0008853893,0.002415527,0.000021902173,0.0007396405,0.00009477505,0.000038736274,0.00005640137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99231094,0.0027504016,0.003508748,0.0006432831,0.0003123539,0.00047425387],"domain_scores_gemma":[0.99490166,0.0016423503,0.0023065428,0.0006926911,0.00011330553,0.0003434816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063073197,0.00027734775,0.0010958464,0.0003870069,0.0007117908,0.00012634152,0.00034460853,0.000056797173,0.00014316826],"category_scores_gemma":[0.008167253,0.0002948769,0.00017222278,0.0005934507,0.0000525808,0.00037802712,0.00022187793,0.00022782593,0.000049563205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037524378,0.00520452,0.51021963,0.0035091946,0.00085335464,0.0000071590944,0.091471456,0.06750665,0.000015458627,0.04531721,0.038001012,0.2375191],"study_design_scores_gemma":[0.0045813126,0.0018668077,0.8126391,0.0023720758,0.000039129718,0.000037993777,0.052238524,0.038251646,0.000041088228,0.085336454,0.0012750013,0.0013208442],"about_ca_topic_score_codex":0.007916736,"about_ca_topic_score_gemma":0.0002303586,"teacher_disagreement_score":0.30241948,"about_ca_system_score_codex":0.00040667583,"about_ca_system_score_gemma":0.0005287862,"threshold_uncertainty_score":0.99995035},"labels":[],"label_agreement":null},{"id":"W4283702633","doi":"10.1136/annrheumdis-2022-eular.1377","title":"AB0890 Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: 52-Week Efficacy Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Trials","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"AbbVie; Bristol-Myers Squibb","keywords":"Medicine; Psoriasis; Placebo; Apremilast; Internal medicine; Psoriatic arthritis; Psoriasis Area and Severity Index; Clinical trial; Gastroenterology; Dermatology; Pathology","score_opus":0.08045805314873049,"score_gpt":0.3275665331738446,"score_spread":0.2471084800251141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283702633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749526,0.010353011,0.0000065694508,0.0032281843,0.00053102407,0.0013615234,0.009442264,0.00006107222,0.000063773216],"genre_scores_gemma":[0.9964696,0.001046138,0.00005953445,0.00086901523,0.00005677668,0.00028667407,0.0009235465,0.000040244257,0.0002484684],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99414974,0.0034143417,0.0010965969,0.0006411429,0.00018359607,0.0005145665],"domain_scores_gemma":[0.9957618,0.0025734904,0.00058218435,0.00083671254,0.00012937035,0.000116431394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013899836,0.00043755342,0.0010190693,0.00015822708,0.0006773366,0.000066217435,0.0006489975,0.0001322715,0.00021486841],"category_scores_gemma":[0.0020763213,0.0002837384,0.00031944935,0.0005299098,0.00019723232,0.00020705316,0.00035356623,0.00026213526,0.000028929813],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1386429,0.027041137,0.00349516,0.00021261655,0.007865703,0.00010614989,0.03287333,0.0035078342,0.024172466,0.0015914713,0.21263558,0.5478557],"study_design_scores_gemma":[0.2507801,0.01812401,0.24741592,0.00459819,0.008481087,0.00026836066,0.02781367,0.0008783383,0.364429,0.03837896,0.03282052,0.006011858],"about_ca_topic_score_codex":0.0015414429,"about_ca_topic_score_gemma":0.0002500434,"teacher_disagreement_score":0.5418438,"about_ca_system_score_codex":0.000048804228,"about_ca_system_score_gemma":0.00024713442,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W4283702815","doi":"10.1136/annrheumdis-2022-eular.2830","title":"POS0607 IMPROVING TREAT-TO-TARGET IMPLEMENTATION IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW OF BARRIERS, FACILITATORS, AND INTERVENTIONS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psychological intervention; Checklist; Critical appraisal; Systematic review; Family medicine; MEDLINE; Physical therapy; Nursing; Alternative medicine; Pathology; Psychology","score_opus":0.017791769072278637,"score_gpt":0.3300506201722435,"score_spread":0.3122588510999649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283702815","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37562883,0.61995625,0.000014870062,0.0018233798,0.00005553747,0.0017844163,0.00069324183,0.00001537645,0.00002810264],"genre_scores_gemma":[0.72472215,0.27435794,0.00008180522,0.00029026347,0.000003068779,0.0004516566,0.000046582154,0.000013941693,0.00003258794],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99734086,0.0005743535,0.0010339193,0.00021274357,0.0005758342,0.00026228212],"domain_scores_gemma":[0.99863136,0.00017811127,0.00035589666,0.00043741945,0.00017283497,0.00022438129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008943185,0.00016837193,0.0007888429,0.00027853332,0.00015291078,0.000027431051,0.00021335976,0.000018483295,0.0004568258],"category_scores_gemma":[0.0015875248,0.00012467238,0.00036648303,0.0005915873,0.00009478238,0.0001580831,0.0002288586,0.00013810255,0.000001787308],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004587106,0.00068251503,0.042219598,0.88040215,0.00084929436,0.00006503579,0.0069281617,0.000020827114,0.00031063502,0.0026076497,0.010450352,0.055005047],"study_design_scores_gemma":[0.0029412943,0.0011868085,0.03287848,0.95116806,0.00005633488,0.0003022945,0.008173085,0.0001229173,0.0005037168,0.0020609333,0.0002966992,0.0003093807],"about_ca_topic_score_codex":0.00010632779,"about_ca_topic_score_gemma":0.00002377987,"teacher_disagreement_score":0.34909335,"about_ca_system_score_codex":0.000030890886,"about_ca_system_score_gemma":0.00016338062,"threshold_uncertainty_score":0.5083992},"labels":[],"label_agreement":null},{"id":"W4283703197","doi":"10.1136/annrheumdis-2022-eular.4189","title":"POS1171 TRIPLE THE RATE OF EMERGENCY ROOM VISITS AND HOSPITALIZATIONS FOR GOUT AMONG US BLACKS VS WHITES – 2019 NATIONWIDE ANALYSIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Emergency department; Population; Demography; Gerontology; Emergency medicine; Pediatrics; Internal medicine; Environmental health","score_opus":0.01787901848426812,"score_gpt":0.29375329873245976,"score_spread":0.27587428024819166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283703197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899423,0.0032494883,0.00038537098,0.0044798334,0.00016759218,0.0009552372,0.00066822313,0.000022314742,0.00012964412],"genre_scores_gemma":[0.9970061,0.0004860249,0.000053716478,0.00031535243,0.000019213403,0.00013296913,0.00014394331,0.000021268717,0.0018213887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984184,0.00018816933,0.0005844317,0.00021167088,0.00040268898,0.00019465508],"domain_scores_gemma":[0.9980919,0.0003597881,0.0005489966,0.0006122254,0.00029199908,0.00009509641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004451893,0.00015517687,0.00046472755,0.00018950974,0.00030541373,0.000015075612,0.00032091574,0.00002831725,0.00038259936],"category_scores_gemma":[0.0015597394,0.000098889504,0.00044876288,0.0010926734,0.00006438047,0.00011312598,0.00018855423,0.00007212416,0.0000014649048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023126943,0.0007439346,0.93188804,0.00055576075,0.0046585943,0.0000010038742,0.0023991056,0.007053332,0.00009269196,0.00091010064,0.05033102,0.0011351441],"study_design_scores_gemma":[0.0006808503,0.00020661316,0.9776849,0.0000909378,0.004183243,0.0000015121379,0.0011906174,0.012311547,0.00029413795,0.0029324775,0.00028452397,0.00013864048],"about_ca_topic_score_codex":0.00019213857,"about_ca_topic_score_gemma":0.000027142354,"teacher_disagreement_score":0.050046496,"about_ca_system_score_codex":0.00001419702,"about_ca_system_score_gemma":0.00009486914,"threshold_uncertainty_score":0.41891947},"labels":[],"label_agreement":null},{"id":"W4283703578","doi":"10.1136/annrheumdis-2022-eular.4245","title":"POS1443 IDENTIFYING THE NEW EMERGENCE OF RACIAL DISPARITIES IN GOUT OVER THE PAST 3 DECADES – US NATIONAL SURVEY AND PROSPECTIVE COHORT DATA","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; National Health and Nutrition Examination Survey; Gout; Demography; Hyperuricemia; National Health Interview Survey; Cohort; Epidemiology; Gerontology; Cohort study; Odds ratio; Prospective cohort study; Odds; Race (biology); Population; Environmental health; Logistic regression; Uric acid; Internal medicine","score_opus":0.09045221035739523,"score_gpt":0.36564832093166016,"score_spread":0.27519611057426496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283703578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98978174,0.0053894077,0.000019373758,0.0029171736,0.00017355925,0.0007332298,0.0008325729,0.000009749253,0.00014317494],"genre_scores_gemma":[0.9986629,0.00050368626,0.00001611118,0.00042742788,0.00004258411,0.000049964383,0.00008546591,0.000013960873,0.00019793503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977665,0.0003658861,0.0004473267,0.00023747532,0.0009962196,0.00018661718],"domain_scores_gemma":[0.99798745,0.0008144984,0.00032024432,0.00069180597,0.00012309535,0.000062900894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012556617,0.00013533389,0.00030982547,0.000063007996,0.0002446912,0.000027550015,0.0007548376,0.000021331127,0.00025448317],"category_scores_gemma":[0.0024029377,0.00007402561,0.00008376027,0.0003817096,0.00032783885,0.00018365233,0.00091682334,0.00018432725,0.0000014281189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014459147,0.00017973306,0.97608626,0.00012924788,0.00028924004,0.00000116075,0.00094267144,0.0001118716,0.00001829472,0.00039764267,0.02124569,0.00045357598],"study_design_scores_gemma":[0.0003721382,0.000035159766,0.99500006,0.00013794428,0.00015877977,0.000009841025,0.0008047695,0.0005999642,0.000040257553,0.0026745931,0.00008854315,0.000077962526],"about_ca_topic_score_codex":0.003060177,"about_ca_topic_score_gemma":0.00032516077,"teacher_disagreement_score":0.021157147,"about_ca_system_score_codex":0.000021685657,"about_ca_system_score_gemma":0.0003126856,"threshold_uncertainty_score":0.46260926},"labels":[],"label_agreement":null},{"id":"W4283703611","doi":"10.1136/annrheumdis-2022-eular.2467","title":"POS1080 CHARACTERIZATION OF JOINT DISTRIBUTION AND DISEASE BURDEN IN PATIENTS WITH EARLY OLIGOARTICULAR PSORIATIC ARTHRITIS: RESULTS FROM THE ONGOING FOREMOST STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Amgen","keywords":"Medicine; Psoriatic arthritis; Context (archaeology); Internal medicine; Dactylitis; Quality of life (healthcare); Physical therapy; Disease; Enthesitis","score_opus":0.015888698973232345,"score_gpt":0.23351047124547705,"score_spread":0.21762177227224472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283703611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940674,0.0007235867,0.0000027164203,0.0011731166,0.00005675734,0.0012782067,0.0026860703,0.000008665283,0.0000035372418],"genre_scores_gemma":[0.99907476,0.00014589606,0.000004070362,0.000074843665,0.000012604106,0.00009575377,0.0005741222,0.0000115116545,0.000006437638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858135,0.00015988592,0.00044126317,0.00018695267,0.0004824423,0.00014812684],"domain_scores_gemma":[0.999028,0.0000977319,0.0003127373,0.00037489613,0.000097279655,0.00008934537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013805465,0.00012473321,0.00031856613,0.000028554023,0.0001943305,0.000015347174,0.00008734309,0.000009506223,0.000013693509],"category_scores_gemma":[0.0005113373,0.00007392966,0.00007504224,0.00020887452,0.00008424751,0.00007733445,0.00015847021,0.000060337403,5.690357e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002404175,0.0021050374,0.9767587,0.0000628937,0.00038772577,0.000012830124,0.0032243684,0.00004152635,0.000009942358,0.000035379748,0.0000672104,0.014890196],"study_design_scores_gemma":[0.006091216,0.00075150805,0.9903789,0.0008790465,0.00025805444,4.6353944e-7,0.0011764443,0.00010291629,0.000020366793,0.00026379482,0.0000074124328,0.00006985531],"about_ca_topic_score_codex":0.0006170116,"about_ca_topic_score_gemma":0.000028818256,"teacher_disagreement_score":0.01482034,"about_ca_system_score_codex":0.000023409217,"about_ca_system_score_gemma":0.000053504937,"threshold_uncertainty_score":0.3014764},"labels":[],"label_agreement":null},{"id":"W4283704189","doi":"10.1136/annrheumdis-2022-eular.1005","title":"POS1113 CONSTRUCT VALIDITY, RELIABILITY, RESPONSIVENESS AND INTERVAL SCALE TRANSFORMATION OF THE WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC) IN PATIENTS UNDERGOING KNEE ARTHROPLASTY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Medical Research Council; Pfizer","keywords":"WOMAC; Rasch model; Osteoarthritis; Medicine; Physical therapy; Intraclass correlation; Arthroplasty; Confidence interval; Oxford knee score; Ordinal data; Differential item functioning; Psychometrics; Statistics; Surgery; Mathematics; Item response theory; Internal medicine; Clinical psychology","score_opus":0.017624824647674973,"score_gpt":0.2418191290344519,"score_spread":0.22419430438677693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283704189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998025,0.00025551333,0.0000020592051,0.00056109374,0.00014395794,0.00065814005,0.00015076785,0.000007472258,0.00019601577],"genre_scores_gemma":[0.99951094,0.00006411598,0.000010106374,0.000105818624,0.000002679208,0.000014720275,0.000013728648,0.000008661201,0.0002691994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880433,0.000253935,0.00032418905,0.00014373325,0.00033537488,0.00013841095],"domain_scores_gemma":[0.99931294,0.00016351433,0.00017475724,0.00020620927,0.00008537527,0.000057224755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015674747,0.00012544135,0.0003042652,0.00008475404,0.0001460037,0.000014343732,0.00007884551,0.000028452052,0.00009587831],"category_scores_gemma":[0.00004558202,0.00008989752,0.000099610195,0.00012217785,0.0002546809,0.00018749641,0.00024644256,0.00010153063,2.7221745e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012022674,0.00026266617,0.9649926,0.0003430576,0.000036713187,0.000001974817,0.0048923376,0.000024864888,0.000011914984,0.00007875854,0.000022126445,0.028130714],"study_design_scores_gemma":[0.005823561,0.0020544985,0.9829724,0.0013326547,0.00012042864,0.000024204372,0.0058840774,0.00001768074,0.00048284023,0.0010984634,0.00008776759,0.000101453865],"about_ca_topic_score_codex":0.00048643647,"about_ca_topic_score_gemma":0.0034302447,"teacher_disagreement_score":0.02802926,"about_ca_system_score_codex":0.000055538534,"about_ca_system_score_gemma":0.0002329165,"threshold_uncertainty_score":0.36659142},"labels":[],"label_agreement":null},{"id":"W4283704737","doi":"10.1136/annrheumdis-2022-eular.1800","title":"POS0683 EFFICACY AND SAFETY OF UPADACITINIB IN TNFi-IR PATIENTS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Rheumatoid arthritis; Clinical trial; Internal medicine; Physical therapy","score_opus":0.0907575257936098,"score_gpt":0.3990842654537877,"score_spread":0.30832673966017793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283704737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990801,0.005761138,0.000016018294,0.0010822074,0.000071560025,0.0013585329,0.00074304355,0.000015688483,0.00015085962],"genre_scores_gemma":[0.9957145,0.00377184,0.00003475325,0.00021917754,0.000009149744,0.00006142898,0.00013925995,0.000023991133,0.00002589003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995856,0.0009864898,0.0018212486,0.0002699873,0.000804832,0.00026144052],"domain_scores_gemma":[0.99642843,0.0018228624,0.00079718506,0.00063396094,0.00016219789,0.00015534725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019707645,0.00018213256,0.0013336006,0.00013070618,0.0001349817,0.000012826054,0.00029327802,0.00004695557,0.0010195968],"category_scores_gemma":[0.004292758,0.00011932491,0.00028795915,0.00029653494,0.00039313396,0.00010923203,0.00029525958,0.0002648805,0.000003915959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01340087,0.005792337,0.5386592,0.00026638262,0.0007073587,0.000010417879,0.00053992483,0.00004492239,0.000022090306,0.00017239976,0.0030471815,0.4373369],"study_design_scores_gemma":[0.025815751,0.0014221929,0.96816486,0.001586047,0.00007495856,0.0000021380038,0.00052969804,0.0002892911,0.000095286094,0.0008839269,0.0009862201,0.0001496241],"about_ca_topic_score_codex":0.00017204513,"about_ca_topic_score_gemma":0.0000181372,"teacher_disagreement_score":0.43718728,"about_ca_system_score_codex":0.000012652558,"about_ca_system_score_gemma":0.00033907391,"threshold_uncertainty_score":0.9998936},"labels":[],"label_agreement":null},{"id":"W4283705540","doi":"10.1136/annrheumdis-2022-eular.1486","title":"AB0584 MANAGEMENT OF REFERRALS, TREATMENT STRATEGY, AND RESEARCH CHALLENGES IN POLYMYALGIA RHEUMATICA AMONGST RHEUMATOLOGISTS WORLDWIDE: A QUESTIONNAIRE BASED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"","keywords":"Medicine; Polymyalgia rheumatica; Respondent; Referral; Prednisolone; Family medicine; Clinical trial; Population; Rheumatology; Physical therapy; Internal medicine; Disease; Vasculitis; Environmental health; Giant cell arteritis","score_opus":0.16592366881473888,"score_gpt":0.39708090795404777,"score_spread":0.23115723913930888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283705540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96099496,0.031194326,0.0000011288303,0.0050428794,0.00040640912,0.001543195,0.00005000187,0.000032189775,0.00073489064],"genre_scores_gemma":[0.9880725,0.010254853,0.00005578038,0.00002368873,0.000004091548,0.0003746765,0.000011504936,0.00002632198,0.0011765974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674535,0.00084038445,0.00070890994,0.00035643516,0.00093996036,0.00040896345],"domain_scores_gemma":[0.9984221,0.0003018377,0.00025677675,0.00074277876,0.00010774331,0.00016875053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008394087,0.00021524637,0.00066972885,0.00038288548,0.00022272526,0.000018239862,0.00028630643,0.000041632313,0.0001055036],"category_scores_gemma":[0.0001947747,0.00015043268,0.00015489382,0.0005338864,0.00034948444,0.00005772961,0.00025751864,0.0002106161,0.0000025470022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023224535,0.035288054,0.5938357,0.014857302,0.0026215361,0.0006195245,0.015214974,0.0005840406,0.000031632255,0.014849439,0.0069016553,0.3128737],"study_design_scores_gemma":[0.0042057415,0.0027737448,0.9601358,0.0077447356,0.00024638826,0.000032825472,0.021675805,0.0003675546,0.00010380239,0.0023557208,0.00014690847,0.00021094232],"about_ca_topic_score_codex":0.0006852912,"about_ca_topic_score_gemma":0.00015534506,"teacher_disagreement_score":0.36630014,"about_ca_system_score_codex":0.00008259678,"about_ca_system_score_gemma":0.00018494674,"threshold_uncertainty_score":0.61344665},"labels":[],"label_agreement":null},{"id":"W4283706119","doi":"10.1136/annrheumdis-2022-eular.1184","title":"AB0463 PREVALENCE AND PREDICTORS OF COGNITIVE DYSFUNCTION IN PATIENTS WITH LUPUS NEPHRITIS: A CROSS-SECTIONAL COMPARISON WITH PATIENTS WITH OTHER CHRONIC KIDNEY DISEASES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lupus nephritis; Montreal Cognitive Assessment; Internal medicine; Kidney disease; Renal function; Cross-sectional study; Population; Systemic lupus erythematosus; Nephritis; Disease; Pathology; Cognitive impairment","score_opus":0.017303262620127637,"score_gpt":0.2859786978658682,"score_spread":0.26867543524574056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283706119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995167,0.001208859,0.00001218676,0.00004699346,0.00009825083,0.0019445281,0.001449778,0.000022653287,0.000049739112],"genre_scores_gemma":[0.9992275,0.000040119165,0.000008804665,0.00007405732,0.000015469528,0.000295404,0.00014055187,0.000039239272,0.00015885558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970436,0.00024077561,0.0005091793,0.00034976812,0.0015584058,0.00029823763],"domain_scores_gemma":[0.99812406,0.00029373675,0.00048603292,0.00035602791,0.0005032999,0.00023681152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016020803,0.00022323926,0.00050085137,0.00017654762,0.00015702182,0.000024554616,0.00018519185,0.000031581818,0.00022839184],"category_scores_gemma":[0.0004468833,0.00013233848,0.00007356507,0.00044104247,0.0005359767,0.00019807293,0.00014667325,0.00016515107,0.0000011802807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072238673,0.002112043,0.9854826,0.0032376295,0.0004460138,0.0000014465215,0.0005925681,0.00017944885,5.063979e-7,0.0000075379985,0.00038470107,0.00033165608],"study_design_scores_gemma":[0.010033818,0.0031261733,0.97897655,0.0069221337,0.00021183905,0.00002641938,0.00037474238,0.00013429306,0.000013805988,0.00002143637,0.000012654587,0.00014614731],"about_ca_topic_score_codex":0.0001081174,"about_ca_topic_score_gemma":0.000018347515,"teacher_disagreement_score":0.006506044,"about_ca_system_score_codex":0.00010983035,"about_ca_system_score_gemma":0.0005080087,"threshold_uncertainty_score":0.53966063},"labels":[],"label_agreement":null},{"id":"W4283706185","doi":"10.1136/annrheumdis-2022-eular.1074","title":"AB0046 RESISTANCE TO OXIDATIVE DEGRADATION OF A FORMULATION COMBINING HYALURONIC ACID AND NIACINAMIDE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Alberta Innovates; Killam Trusts; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Hyaluronic acid; Synovial fluid; Medicine; Niacinamide; Oxidative stress; Biochemistry; Osteoarthritis; Chemistry; Nicotinamide; Enzyme; Pathology","score_opus":0.029884360729812938,"score_gpt":0.28952487128681315,"score_spread":0.2596405105570002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283706185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965119,0.0015399837,0.00004547023,0.0010358954,0.00004637112,0.00050029746,0.000074367,0.000012898546,0.00023285787],"genre_scores_gemma":[0.99889344,0.000046520985,0.00030102298,0.00015316086,0.0000031859806,0.000058038804,0.00003556336,0.0000077118375,0.0005013503],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99921936,0.00006693932,0.00022915626,0.0001091429,0.0002712341,0.000104167186],"domain_scores_gemma":[0.9994009,0.00007481631,0.00018386937,0.00021133211,0.000067419336,0.00006165482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012571894,0.000078199315,0.0002132781,0.00006663843,0.00011243916,0.0000050773624,0.00006705966,0.0000105916015,0.000045990102],"category_scores_gemma":[0.0001801747,0.000060397084,0.000074783,0.00016623721,0.000027156135,0.00007318648,0.000084868916,0.000035778874,0.0000010960694],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009541141,0.0046377606,0.09478906,0.004616756,0.0013797494,0.000028353848,0.015816707,0.0007048527,0.076734856,0.117788665,0.006724823,0.6672373],"study_design_scores_gemma":[0.014883117,0.012572849,0.44247502,0.007637593,0.0016744819,0.000044602028,0.009888241,0.0014329791,0.43910307,0.068183795,0.0012772932,0.0008269723],"about_ca_topic_score_codex":0.000011920301,"about_ca_topic_score_gemma":0.000011817509,"teacher_disagreement_score":0.6664103,"about_ca_system_score_codex":0.000019249588,"about_ca_system_score_gemma":0.000054188207,"threshold_uncertainty_score":0.24629216},"labels":[],"label_agreement":null},{"id":"W4283706254","doi":"10.1136/annrheumdis-2022-eular.1691","title":"POS1037 EFFECT OF GUSELKUMAB, A SELECTIVE IL-23p19 INHIBITOR, ON AXIAL-RELATED ENDPOINTS IN PATIENTS WITH ACTIVE PsA: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY THROUGH 2 YEARS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Sanofi Genzyme; Gilead Sciences; LEO Pharma; Bausch Health; Astellas Pharma; Sun Pharma; Dermira; Genentech; Coherus Biosciences; College of Medicine, Drexel University; Janssen Scientific Affairs; Valeant Pharmaceuticals International; Leids Universitair Medisch Centrum; Universiteit Leiden; Drexel University; Regeneron Pharmaceuticals; Baxalta; AbbVie; Celgene; Amgen; Pfizer; EMD Serono; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; BASDAI; Placebo; Internal medicine; Axial spondyloarthritis; Sacroiliitis; Ankylosing spondylitis; Clinical endpoint; Randomized controlled trial; Surgery; Gastroenterology; Arthritis; Psoriatic arthritis; Pathology","score_opus":0.018386012583850544,"score_gpt":0.3039299250623363,"score_spread":0.28554391247848576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283706254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869137,0.00042178933,2.7522648e-7,0.00016008854,0.00017817834,0.010449877,0.0015104562,0.000026731914,0.00033890584],"genre_scores_gemma":[0.99823415,0.00008054623,0.0000065551676,0.00005754544,0.000012265129,0.0012989657,0.00021282563,0.000038413957,0.000058759044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99607754,0.0011685737,0.0009801863,0.00045747557,0.0010002883,0.00031595663],"domain_scores_gemma":[0.99634576,0.0019308942,0.00089391856,0.000558272,0.000178425,0.00009271637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055593316,0.00036718315,0.002070193,0.00019008853,0.00016758306,0.0000118857415,0.00020188994,0.00004617797,0.0000806691],"category_scores_gemma":[0.0011038186,0.00021956704,0.00049072085,0.00055771007,0.00018656964,0.000107783046,0.00017877152,0.00024889794,0.0000055958208],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96262807,0.0138382455,0.007024159,0.000039561848,0.0063726297,0.000040559065,0.006295466,0.00017600867,0.0000029840203,0.000009735298,0.0002901854,0.003282387],"study_design_scores_gemma":[0.9474072,0.011686506,0.03594404,0.0008629548,0.0018723245,0.0000012479434,0.0011786236,0.000040328923,0.0006353961,0.00019176009,0.0000034902498,0.0001761539],"about_ca_topic_score_codex":0.0012302912,"about_ca_topic_score_gemma":0.00005534898,"teacher_disagreement_score":0.02891988,"about_ca_system_score_codex":0.0001078025,"about_ca_system_score_gemma":0.0001262419,"threshold_uncertainty_score":0.8953684},"labels":[],"label_agreement":null},{"id":"W4283706537","doi":"10.1136/annrheumdis-2022-eular.4152","title":"POS1258 LESS THAN EXPECTED IMPACT OF RHEUMATOID ARTHRITIS AND AXIAL SPONDYLOARTHRITIS DISEASE ON COVID SEVERITY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Univariate analysis; Coronavirus disease 2019 (COVID-19); Pandemic; Ankylosing spondylitis; Rheumatology; Disease; Multivariate analysis; Physical therapy","score_opus":0.03391900374495804,"score_gpt":0.30883442390076893,"score_spread":0.2749154201558109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283706537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97543824,0.01936485,9.5125864e-7,0.001049832,0.00016483024,0.0007235974,0.0029352962,0.000043277923,0.00027911316],"genre_scores_gemma":[0.99091685,0.008369583,0.000011917864,0.00035163938,0.000018364433,0.00013594475,0.00011051495,0.00003329338,0.000051890675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782676,0.00023405446,0.00053318264,0.0003376903,0.0007124709,0.00035581924],"domain_scores_gemma":[0.9982282,0.00023010283,0.00034412908,0.0006545682,0.00012581264,0.00041720577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014528522,0.0002960979,0.0007782129,0.00011523754,0.00046278877,0.000019557228,0.00020349603,0.000025756777,0.00052359333],"category_scores_gemma":[0.00040957335,0.0002200121,0.0006229356,0.00028992794,0.00042475792,0.00009260392,0.0003318498,0.00013750854,0.0000034851416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022057617,0.012909332,0.7307455,0.0012787639,0.0048012626,0.0008639597,0.0034186845,0.00037941893,0.00014245017,0.0077132843,0.016556146,0.19913359],"study_design_scores_gemma":[0.006652281,0.00202401,0.9842577,0.001880107,0.0001302045,0.00015443565,0.0011049514,0.00006883919,0.00019517027,0.0029250728,0.00030965215,0.0002975884],"about_ca_topic_score_codex":0.0012364516,"about_ca_topic_score_gemma":0.000060448925,"teacher_disagreement_score":0.2535122,"about_ca_system_score_codex":0.000057801066,"about_ca_system_score_gemma":0.00024707316,"threshold_uncertainty_score":0.8971833},"labels":[],"label_agreement":null},{"id":"W4283706884","doi":"10.1136/annrheumdis-2022-eular.4850","title":"POS1372 THE 2021 EULAR AND ACR POINTS TO CONSIDER FOR DIAGNOSIS, MANAGEMENT AND MONITORING OF THE IL 1 MEDIATED AUTOINFLAMMATORY DISEASES: CAPS, TRAPS, MKD, AND DIRA","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; National Defence Medical Centre; University of Toronto; University of Calgary; Alberta Children's Hospital; Western University","funders":"","keywords":"Medicine; Anakinra; Delphi method; Intensive care medicine; Multidisciplinary approach; Disease; Internal medicine","score_opus":0.014592303122741504,"score_gpt":0.2615748086835548,"score_spread":0.2469825055608133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283706884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735602,0.022441138,0.000005119443,0.002655309,0.00012680129,0.0007544429,0.000432625,0.0000036187414,0.000020746169],"genre_scores_gemma":[0.99391437,0.00520489,0.000025133275,0.00039375512,0.000016859783,0.0003111177,0.000025295105,0.000017048502,0.00009151813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989812,0.0001512152,0.00027369353,0.00020924053,0.00019752607,0.00018716787],"domain_scores_gemma":[0.9991584,0.00012236698,0.00016351989,0.00043078893,0.000057151523,0.00006777603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020753381,0.0001481997,0.0001938382,0.000029556206,0.00032547957,0.000024652083,0.00027415037,0.000025707912,0.000016223374],"category_scores_gemma":[0.00028821125,0.00009040262,0.0001278796,0.0000886793,0.00022658607,0.0000090231015,0.00058309,0.00004592855,2.2510633e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014483755,0.0013129136,0.75735885,0.0039051676,0.0049502035,0.000009385533,0.005399447,0.00064427464,0.014344582,0.0019352759,0.07406417,0.13462737],"study_design_scores_gemma":[0.0019439171,0.00032859374,0.9323544,0.0004796675,0.00060173473,0.00000676267,0.008348877,0.0001225685,0.024175644,0.00247957,0.028719239,0.00043901367],"about_ca_topic_score_codex":0.000021054704,"about_ca_topic_score_gemma":0.000003617872,"teacher_disagreement_score":0.17499559,"about_ca_system_score_codex":0.0000040058258,"about_ca_system_score_gemma":0.000043352895,"threshold_uncertainty_score":0.36865118},"labels":[],"label_agreement":null},{"id":"W4283707245","doi":"10.1136/annrheumdis-2022-eular.2361","title":"POS1425 THE BURDEN OF OSTEOARTHRITIS ACROSS THE STATES OF INDIA, 1990–2019: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Global Health and Epidemiology","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Osteoarthritis; Burden of disease; Demography; Disease burden; Population; Epidemiology; Confidence interval; Environmental health; Internal medicine; Pathology","score_opus":0.05320636416852147,"score_gpt":0.42186643874649604,"score_spread":0.36866007457797456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283707245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415706,0.010063743,0.000001670781,0.026817452,0.00062057545,0.0024787274,0.018344251,0.000017278691,0.00008572661],"genre_scores_gemma":[0.9966524,0.0008894455,0.0000051299576,0.0018418783,0.00008972906,0.0002430226,0.00011130829,0.000019379448,0.00014770383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921002,0.0042909235,0.0017151795,0.0002994567,0.00085546804,0.0007388008],"domain_scores_gemma":[0.98994815,0.0063139447,0.0016835931,0.0015153057,0.0003067736,0.00023225258],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002715837,0.00026154539,0.00085923524,0.000029750887,0.0013720837,0.000008512411,0.0020991873,0.00006872688,0.00045996744],"category_scores_gemma":[0.0029527731,0.000123037,0.00041157784,0.00051286654,0.00074093946,0.00008297641,0.0015270584,0.0004206283,0.000021536529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002230019,0.0008930021,0.7366257,0.0010032738,0.0006437043,0.0000030565445,0.059445485,0.0044855014,0.000004596724,0.0016799436,0.18722866,0.005757083],"study_design_scores_gemma":[0.0013658997,0.00059030537,0.8672893,0.0008293516,0.00026493176,7.3453646e-7,0.10903356,0.00023906825,0.0000048764514,0.018338595,0.0018983926,0.00014494942],"about_ca_topic_score_codex":0.06300248,"about_ca_topic_score_gemma":0.00033488264,"teacher_disagreement_score":0.18533027,"about_ca_system_score_codex":0.00005042139,"about_ca_system_score_gemma":0.0007010936,"threshold_uncertainty_score":0.999928},"labels":[],"label_agreement":null},{"id":"W4283707386","doi":"10.1136/annrheumdis-2022-eular.3354","title":"POS0896 CRYOFIBRINOGEN-ASSOCIATED SYSTEMIC SCLEROSIS: POSSIBLE CORRELATIONS WITH SCLERODERMA DIGITAL ULCERS AND PULMONARY ARTERIAL HYPERTENSION","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, Los Angeles; Universität Zürich; Université Paris Descartes; School of Medicine, Stanford University; Universiteit Leiden; Leids Universitair Medisch Centrum; Università degli Studi di Firenze; University of Melbourne; Schulich School of Medicine and Dentistry; Università Degli Studi di Modena e Reggio Emila; University College London; University of Ottawa; McGill University; Universitätsklinikum Köln; Jewish General Hospital; University of Manchester; Vanderbilt University","keywords":"Medicine; Scleroderma (fungus); Cryoglobulins; Internal medicine; Dermatology; Fibrinogen; Gastroenterology; Pathology; Immunology; Antibody","score_opus":0.03802662841720293,"score_gpt":0.23054702432850313,"score_spread":0.1925203959113002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283707386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778003,0.009321994,0.000003823852,0.0009619214,0.00028294077,0.00074718037,0.0004994048,0.00008922626,0.0003134822],"genre_scores_gemma":[0.9983246,0.00079405715,0.0000049124437,0.0003239127,0.0000325141,0.000082363884,0.000122064295,0.000040698134,0.0002749278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979829,0.00016958526,0.00054190995,0.00031380265,0.00069464196,0.00029714787],"domain_scores_gemma":[0.99849856,0.0001772244,0.00041247613,0.00048850593,0.00017151891,0.00025171944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014283294,0.00023377246,0.00051848084,0.0001264908,0.0005007118,0.000070038,0.00019273147,0.00005797683,0.000099175],"category_scores_gemma":[0.00021745193,0.00015047062,0.00024712714,0.0003900258,0.00020766283,0.00019932403,0.0002037869,0.00013052265,0.000007730581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006712679,0.009804821,0.8475884,0.003044846,0.0064939223,0.00017289317,0.0020241058,0.0066394727,0.023117628,0.0004770462,0.04363299,0.050291184],"study_design_scores_gemma":[0.0023233977,0.00038852985,0.98015445,0.009711203,0.00089752505,0.0005883365,0.002559805,0.0027431464,0.00018434448,0.00013945928,0.000019702451,0.00029008463],"about_ca_topic_score_codex":0.00006814229,"about_ca_topic_score_gemma":6.6761805e-7,"teacher_disagreement_score":0.13256605,"about_ca_system_score_codex":0.000049286766,"about_ca_system_score_gemma":0.00022563296,"threshold_uncertainty_score":0.6136013},"labels":[],"label_agreement":null},{"id":"W4283707673","doi":"10.1136/annrheumdis-2022-eular.2859","title":"AB0357 INCIDENCE AND DETERMINANTS OF INFECTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB IN REAL-WORLD PRACTICE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Memorial University of Newfoundland; Université Laval","funders":"","keywords":"Medicine; Golimumab; Discontinuation; Rheumatoid arthritis; Incidence (geometry); Internal medicine; Cohort; Gee; Logistic regression; Generalized estimating equation; Etanercept","score_opus":0.021147305638752247,"score_gpt":0.31515254509291185,"score_spread":0.29400523945415963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283707673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545485,0.0032634705,4.237528e-7,0.00027000328,0.000031894484,0.0006537992,0.00005462715,0.000014129842,0.0002567794],"genre_scores_gemma":[0.9412597,0.058479566,0.000022655342,0.00006712635,0.0000022703664,0.000114283604,0.000011263503,0.000017277769,0.000025846897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978934,0.00045950155,0.0005779209,0.00020457819,0.0006006527,0.00026393257],"domain_scores_gemma":[0.9985748,0.00045079686,0.000372028,0.0003267876,0.00017130004,0.00010431441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004582622,0.00014691018,0.0004952907,0.0003524455,0.000112071735,0.000015065862,0.00012017545,0.000020291234,0.00006835602],"category_scores_gemma":[0.001136799,0.00010852387,0.00007061348,0.0007154788,0.00021989229,0.00030482275,0.00015713787,0.000190851,0.0000011419636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012696,0.0010822933,0.9593173,0.00018732391,0.000051236482,0.000022013995,0.0006656816,0.000045128476,0.000008630387,0.000073334864,0.00012717262,0.03715024],"study_design_scores_gemma":[0.0031752756,0.00080307963,0.9913827,0.0031163679,0.0000059299196,0.000037952137,0.00034736493,0.0002449578,0.00037413187,0.00030282477,0.00010389618,0.00010548413],"about_ca_topic_score_codex":0.008877606,"about_ca_topic_score_gemma":0.0034388306,"teacher_disagreement_score":0.055216096,"about_ca_system_score_codex":0.000042434873,"about_ca_system_score_gemma":0.00017178048,"threshold_uncertainty_score":0.9977224},"labels":[],"label_agreement":null},{"id":"W4283707937","doi":"10.1136/annrheumdis-2022-eular.1992","title":"POS0742 DISCRIMINATIVE POWER OF SALIVARY GLAND ULTRASOUND IN RELATION TO ENDOTYPES IN SUSPECTED AND DEFINITE PRIMARY SJÖGREN'S SYNDROME","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Lupus Canada","keywords":"Medicine; Rheumatology; Cohort; Internal medicine; Rheumatism; Rheumatoid arthritis; Population; Fibromyalgia; Cohort study; Physical therapy","score_opus":0.02160119894878346,"score_gpt":0.2659296130493784,"score_spread":0.24432841410059494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283707937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505246,0.0015602978,0.0000057210173,0.0012405188,0.00006502767,0.00041006083,0.00017255988,0.000009799708,0.0014835491],"genre_scores_gemma":[0.99924433,0.00017650721,0.00005335661,0.00032033672,0.0000023436667,0.000039241484,0.000058794798,0.000010616981,0.000094445386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899304,0.00013563695,0.00033518975,0.00014792924,0.00025333415,0.00013484508],"domain_scores_gemma":[0.9989531,0.00059770787,0.00012126695,0.00022069107,0.00004214635,0.00006510871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001638159,0.00010082695,0.00031070955,0.0002335372,0.00005712848,0.000005444954,0.00008431672,0.000020073287,0.00020974533],"category_scores_gemma":[0.0007327024,0.00007420012,0.00007348263,0.00047474165,0.00007002644,0.000073401956,0.00009807674,0.00009441165,0.0000011693407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001037484,0.0012661462,0.98877853,0.0003437383,0.00011581863,0.000022743767,0.00437483,0.0002834458,0.00013020895,0.0013848047,0.0013208634,0.00094139075],"study_design_scores_gemma":[0.0009824805,0.00035873265,0.9903276,0.00032821644,0.0000593538,0.000036966252,0.0021107611,0.000029215811,0.000020234642,0.005644957,0.000023425544,0.00007806306],"about_ca_topic_score_codex":0.00036512016,"about_ca_topic_score_gemma":0.000035552308,"teacher_disagreement_score":0.0042601526,"about_ca_system_score_codex":0.000022560234,"about_ca_system_score_gemma":0.0000784378,"threshold_uncertainty_score":0.3025793},"labels":[],"label_agreement":null},{"id":"W4283708782","doi":"10.1136/annrheumdis-2022-eular.986","title":"POS1206 UNDERSTANDING THE LANDSCAPE OF RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH IL-6 INHIBITORS DURING THE COVID-19 PANDEMIC","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universiteit Stellenbosch; University of Queensland; Monash University; Cumming School of Medicine, University of Calgary; Gilead Sciences; University of Ottawa; Sanofi; McMaster University; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Tocilizumab; Rheumatoid arthritis; Hydroxychloroquine; Abatacept; Internal medicine; Pandemic; Rheumatology; Cohort; Coronavirus disease 2019 (COVID-19); Family medicine; Disease; Physical therapy; Rituximab","score_opus":0.043118788120795976,"score_gpt":0.2865101804287462,"score_spread":0.24339139230795023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283708782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617494,0.008490319,0.0000110289,0.0036931455,0.00008770583,0.0009640288,0.0003500998,0.000054267435,0.00017444967],"genre_scores_gemma":[0.98038536,0.018852446,0.000003015206,0.0004487738,0.000014225629,0.00013343833,0.00003819388,0.000034953806,0.00008958689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971013,0.00049878785,0.0005640992,0.00023514047,0.0011873697,0.00041328813],"domain_scores_gemma":[0.99783325,0.00065441406,0.00043766212,0.00070708885,0.00013470963,0.00023284888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053275906,0.00022639851,0.0004763674,0.00013873212,0.0010111888,0.000042637657,0.0005044102,0.000028967892,0.00040975164],"category_scores_gemma":[0.00072408374,0.00010816417,0.0002846082,0.0005784777,0.00062662654,0.00011372925,0.00028752207,0.00025795677,0.000002998057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016759011,0.0006839189,0.979095,0.0003472031,0.0008002358,0.000011556919,0.0033191338,0.00047888138,0.00007956367,0.00073962816,0.008624808,0.0041441717],"study_design_scores_gemma":[0.023024991,0.0040338007,0.9013698,0.0056353705,0.0001200009,0.0006923418,0.047351174,0.0006935035,0.0015482174,0.008590869,0.0059498353,0.0009901137],"about_ca_topic_score_codex":0.00033256903,"about_ca_topic_score_gemma":0.000073178686,"teacher_disagreement_score":0.07772522,"about_ca_system_score_codex":0.00008843483,"about_ca_system_score_gemma":0.00031692223,"threshold_uncertainty_score":0.77773494},"labels":[],"label_agreement":null},{"id":"W4283708913","doi":"10.1136/annrheumdis-2022-eular.4007","title":"POS0995 VALIDATION OF THE SPARCC MRI-RETIC E-TOOL FOR INCREASING SCORING PROFICIENCY OF MRI LESIONS IN AXIAL SPONDYLOARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Concordance; Medical physics; Nuclear medicine; Radiology; Magnetic resonance imaging; Internal medicine","score_opus":0.02327377790176904,"score_gpt":0.2697044141086627,"score_spread":0.24643063620689365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283708913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718994,0.000833239,0.000804422,0.0005443489,0.00014190505,0.00028006677,0.00012944092,0.000017303373,0.000059355276],"genre_scores_gemma":[0.9996218,0.00011065211,0.00014500714,0.000021982529,0.000010663671,0.00004665315,0.000008806658,0.000012732812,0.000021672802],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987312,0.00016570883,0.00046338112,0.00009911178,0.00038004265,0.0001605713],"domain_scores_gemma":[0.99911475,0.00031835606,0.00016704823,0.0003111137,0.00005249279,0.00003626036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005241564,0.000088442015,0.00025667303,0.00010289168,0.000104102844,0.00000886788,0.00034282746,0.000014317153,0.000070375536],"category_scores_gemma":[0.0009318414,0.000062757295,0.00022271911,0.00044073618,0.00010078363,0.0000638012,0.00011867233,0.000080069854,3.8707066e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016248606,0.001493642,0.20458372,0.006728398,0.00056310126,0.0000034449242,0.0041709077,0.6496519,0.011490769,0.003987491,0.0033680457,0.11379611],"study_design_scores_gemma":[0.0025586872,0.00022302265,0.37407354,0.0096870335,0.00085910194,0.000015886973,0.0031206848,0.4952717,0.08977823,0.02342396,0.00019586625,0.00079228455],"about_ca_topic_score_codex":0.00012166282,"about_ca_topic_score_gemma":0.000002358011,"teacher_disagreement_score":0.16948982,"about_ca_system_score_codex":0.000014359724,"about_ca_system_score_gemma":0.00005598775,"threshold_uncertainty_score":0.25591683},"labels":[],"label_agreement":null},{"id":"W4283708948","doi":"10.1136/annrheumdis-2022-eular.1606","title":"AB0895 Residual burden and disease activity of Canadian PsA patients treated with advanced therapies: preliminary results from a multiple registry analysis (UNISON-PsA)","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; ABB (Canada); University of Toronto; University Health Network; Université de Montréal","funders":"","keywords":"Medicine; Observational study; Clinical endpoint; Internal medicine; Physical therapy; Psoriatic arthritis; Clinical trial; Disease","score_opus":0.03606273483239005,"score_gpt":0.30007936212340725,"score_spread":0.2640166272910172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283708948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97900015,0.0013501577,0.0000021388937,0.012596245,0.000014431743,0.0005584375,0.006389804,0.000016142536,0.000072510906],"genre_scores_gemma":[0.99812347,0.00066753506,0.00006167289,0.00027135893,0.000013662989,0.00008437382,0.0006212424,0.000017861048,0.00013881031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978477,0.0005416314,0.00039251425,0.00035637477,0.0005126248,0.00034916317],"domain_scores_gemma":[0.9969392,0.00092028343,0.00038033794,0.0008764366,0.00017869411,0.0007050487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025690117,0.00018368699,0.00063739915,0.00042866732,0.00022202414,0.000008970165,0.00027155047,0.000035477,0.00008888033],"category_scores_gemma":[0.003401313,0.00012223641,0.00021040911,0.0009233449,0.00028007413,0.00009367137,0.00015474754,0.00015042014,6.460818e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036837023,0.0009563975,0.9187355,0.00032124866,0.004800101,0.00003724435,0.0014447934,0.002095433,0.000082685016,0.000016160377,0.011311983,0.02336143],"study_design_scores_gemma":[0.002396868,0.0010950598,0.9908449,0.00024693884,0.0009950128,0.0000010589548,0.0007060105,0.0030827532,0.00007217801,0.00014399539,0.0002881332,0.00012707691],"about_ca_topic_score_codex":0.1506469,"about_ca_topic_score_gemma":0.0076534725,"teacher_disagreement_score":0.14299342,"about_ca_system_score_codex":0.000043547763,"about_ca_system_score_gemma":0.00042716198,"threshold_uncertainty_score":0.855009},"labels":[],"label_agreement":null},{"id":"W4283708968","doi":"10.1136/annrheumdis-2022-eular.1361","title":"AB1430 COMPARISON OF COGNITIVE ABILITY ACROSS THE IMMUNE MEDIATED INFLAMMATORY DISEASES: SYSTEMATIC REVIEW AND META-REGRESSION","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cognition; Observational study; Psoriatic arthritis; Meta-analysis; Cognitive decline; Rheumatoid arthritis; Gerontology; Internal medicine; Clinical psychology; Disease; Dementia; Psychiatry","score_opus":0.06806311913452325,"score_gpt":0.3939372266791788,"score_spread":0.32587410754465557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283708968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5863484,0.40593362,0.0000035010526,0.0021583417,0.00006269897,0.0045868265,0.00083107647,0.000031814034,0.000043690172],"genre_scores_gemma":[0.9948114,0.0034910068,0.0000021947221,0.000338852,0.000006407506,0.0011295688,0.000050357343,0.000029054749,0.00014114525],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99414945,0.0020553134,0.0016435502,0.000294808,0.0015164034,0.00034046013],"domain_scores_gemma":[0.9925536,0.00398625,0.0014209064,0.0013025902,0.00052684057,0.00020982664],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00218511,0.00029882757,0.0025846367,0.00006585549,0.00037260167,0.000019314188,0.0006356103,0.000037522786,0.00048861234],"category_scores_gemma":[0.010974984,0.00013119164,0.0007660635,0.0004907137,0.00068428845,0.00009255167,0.00081092305,0.00025205262,0.000007562435],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044776883,0.001454868,0.061664067,0.9184636,0.008090993,0.000007011905,0.0057805288,0.0000137840125,0.000060040686,0.00009252719,0.0037081076,0.000216684],"study_design_scores_gemma":[0.007067489,0.001288877,0.16938429,0.5665954,0.12932415,0.0010103635,0.11796457,0.0022509603,0.00206695,0.0018292323,0.000049036837,0.001168704],"about_ca_topic_score_codex":0.00005327553,"about_ca_topic_score_gemma":0.000002790079,"teacher_disagreement_score":0.408463,"about_ca_system_score_codex":0.00003075359,"about_ca_system_score_gemma":0.00024768466,"threshold_uncertainty_score":0.997356},"labels":[],"label_agreement":null},{"id":"W4283709118","doi":"10.1136/annrheumdis-2022-eular.1897","title":"POS1041 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 2 STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Adverse effect; Discontinuation; Internal medicine; Tolerability; Placebo; Psoriasis; Phases of clinical research; Clinical trial; Rheumatoid arthritis; Gastroenterology; Dermatology","score_opus":0.024719789285925924,"score_gpt":0.30612112472374725,"score_spread":0.2814013354378213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283709118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888177,0.006396369,0.0000021169574,0.0011794475,0.00006529966,0.0022677216,0.001226501,0.00001913281,0.000025744865],"genre_scores_gemma":[0.99502057,0.004460429,0.000022690743,0.0002186598,0.00001633573,0.00010449245,0.000116050884,0.000022463411,0.000018306757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972508,0.0006882676,0.0006845746,0.00031544128,0.00075149315,0.0003094553],"domain_scores_gemma":[0.9976401,0.0010316817,0.00031512772,0.0006970743,0.00016516502,0.00015090384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055032497,0.0002049585,0.00057505217,0.00011438359,0.00022608755,0.0000253803,0.0003783111,0.00002339366,0.00023962696],"category_scores_gemma":[0.0012059832,0.00011225559,0.000097420976,0.00043526295,0.00023734,0.000086262145,0.00023032592,0.000204027,0.0000032166784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037989363,0.012134831,0.7028097,0.00010557203,0.0012541291,0.000017638693,0.013274659,0.00004560431,0.000048186394,0.000052857886,0.0014181247,0.23084934],"study_design_scores_gemma":[0.022109238,0.00583433,0.9678672,0.0011318095,0.000025693895,0.0000016278908,0.0025376815,0.0000075187895,0.00004529518,0.00016651426,0.00014072664,0.00013237618],"about_ca_topic_score_codex":0.00028591554,"about_ca_topic_score_gemma":0.0000729692,"teacher_disagreement_score":0.2650575,"about_ca_system_score_codex":0.000021385184,"about_ca_system_score_gemma":0.00014165534,"threshold_uncertainty_score":0.457765},"labels":[],"label_agreement":null},{"id":"W4283709558","doi":"10.1136/annrheumdis-2022-eular.1373","title":"POS0733 DISCORDANCE BETWEEN PATIENT GLOBAL ASSESSMENT AND PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN THE MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS PROSPECTIVE OBSERVATIONAL COHORT STUDY (SPOCS)","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Tokyo Women's Medical University; University of Tokyo; Keio University; Kitasato University; Kanazawa University; University of Occupational and Environmental Health; Genentech; National Center for Child Health and Development; AstraZeneca","keywords":"Medicine; Concordance; Observational study; Internal medicine; Confidence interval; Prospective cohort study; Cohort; Cohort study; Systemic lupus erythematosus; Disease","score_opus":0.05107584265746225,"score_gpt":0.3790003393757954,"score_spread":0.3279244967183332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283709558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887771,0.0003853247,0.00009365146,0.0016407558,0.00014979215,0.007007376,0.0016752522,0.00002245064,0.0002483251],"genre_scores_gemma":[0.9981106,0.000024418547,0.000056519744,0.00019986462,0.000024691737,0.0015011411,0.000033980803,0.000020888414,0.000027883378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944344,0.0012263671,0.0008216903,0.0005447787,0.0025541757,0.0004185771],"domain_scores_gemma":[0.9973756,0.0004368161,0.00058201974,0.0010400579,0.00031026502,0.00025520622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010623585,0.00032544517,0.0009646797,0.00007320259,0.0002822693,0.000052533487,0.0005926524,0.000025280588,0.0000149648795],"category_scores_gemma":[0.0002282974,0.00020774506,0.0002356722,0.00093396736,0.00014871763,0.00017096342,0.00072720705,0.00020852993,9.584636e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008797949,0.0028921778,0.98905903,0.0013610689,0.0005757871,0.000018864781,0.0010123911,0.0017177658,0.000006925002,0.0010341604,0.00040536877,0.0010366483],"study_design_scores_gemma":[0.0016467862,0.00075457734,0.98369217,0.0013828292,0.00029119424,0.00015775255,0.0073802713,0.002092586,0.0000050294807,0.0024096882,0.0000014552111,0.00018566464],"about_ca_topic_score_codex":0.00032279664,"about_ca_topic_score_gemma":0.000028162356,"teacher_disagreement_score":0.00933354,"about_ca_system_score_codex":0.0007179758,"about_ca_system_score_gemma":0.0010337338,"threshold_uncertainty_score":0.8471598},"labels":[],"label_agreement":null},{"id":"W4283709628","doi":"10.1136/annrheumdis-2022-eular.1268","title":"POS0643 SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Odense Universitetshospital; Amgen; National Institute of Allergy and Infectious Diseases; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Discontinuation; Placebo; Methotrexate; Post-hoc analysis; Clinical trial; Pathology","score_opus":0.02712574030222329,"score_gpt":0.30762124868896323,"score_spread":0.2804955083867399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283709628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930444,0.0015625054,0.0000016679943,0.0020198792,0.00004009628,0.0019144004,0.0013692422,0.000016530657,0.00003128118],"genre_scores_gemma":[0.99940807,0.00017850722,0.000022654434,0.00011676331,0.00001546399,0.00009682074,0.00010872752,0.000024040679,0.000028959072],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99611217,0.0011896258,0.00081008294,0.00033389937,0.0011945401,0.0003596694],"domain_scores_gemma":[0.9953695,0.002877386,0.00040100628,0.0009563944,0.00028728784,0.000108443724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011524811,0.0001801223,0.000656892,0.000072379175,0.00015701013,0.00002008653,0.00043785496,0.000034396926,0.00006665762],"category_scores_gemma":[0.004511274,0.000111826135,0.00014775079,0.00053322857,0.00051378633,0.00010215724,0.000425431,0.00024227267,8.66125e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6405846,0.0026848994,0.3148654,0.000562585,0.000898725,0.00003389402,0.01115097,0.00040915495,0.0000027802885,0.0001362732,0.0077826628,0.020888077],"study_design_scores_gemma":[0.12631057,0.0015068201,0.8659473,0.0009107861,0.00006251008,0.0000035304327,0.0024282096,0.00009826428,0.0000734366,0.0022094136,0.00030985769,0.00013929834],"about_ca_topic_score_codex":0.0031655487,"about_ca_topic_score_gemma":0.000066811015,"teacher_disagreement_score":0.5510819,"about_ca_system_score_codex":0.00076212024,"about_ca_system_score_gemma":0.004306021,"threshold_uncertainty_score":0.76386964},"labels":[],"label_agreement":null},{"id":"W4283710632","doi":"10.1136/annrheumdis-2022-eular.893","title":"POS1067 DOMAINS CONTRIBUTING TO MINIMAL DISEASE ACTIVITY ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Hazard ratio; Proportional hazards model; Psoriasis Area and Severity Index; Physical therapy; Psoriasis; Arthritis; Immunology; Confidence interval","score_opus":0.016995550843786518,"score_gpt":0.2811539931800701,"score_spread":0.2641584423362836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283710632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934725,0.00069973385,0.000015882051,0.00405864,0.000065771565,0.0013835222,0.00019297565,0.000024898432,0.00008604933],"genre_scores_gemma":[0.9990106,0.00007557858,0.000024459201,0.00051321805,0.000009499911,0.00021660271,0.000034635337,0.000026013435,0.00008937126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973546,0.00031926323,0.00047797762,0.0002626477,0.0010394333,0.00054606644],"domain_scores_gemma":[0.99859875,0.00018118757,0.00024843065,0.00058097485,0.0001406809,0.00024998933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005651102,0.00018141807,0.00048700278,0.00016693799,0.0003588007,0.00002385774,0.00030473337,0.000017674556,0.0002743314],"category_scores_gemma":[0.0011142086,0.0001333781,0.000164983,0.0004924238,0.00008363345,0.00013942194,0.0005119803,0.0002001014,0.000007439787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060992637,0.0040253066,0.896395,0.00052299426,0.00029643145,0.00002149433,0.00075495604,0.00060205447,0.000022996355,0.00014815501,0.0014980771,0.08961325],"study_design_scores_gemma":[0.0035615093,0.0007552174,0.9934436,0.0009102858,0.0000610524,6.376864e-7,0.00043421765,0.00019891704,0.00007024753,0.00017250059,0.00023698916,0.0001548313],"about_ca_topic_score_codex":0.00008930357,"about_ca_topic_score_gemma":0.0000134189495,"teacher_disagreement_score":0.09704857,"about_ca_system_score_codex":0.00009328742,"about_ca_system_score_gemma":0.0003550349,"threshold_uncertainty_score":0.5439001},"labels":[],"label_agreement":null},{"id":"W4283710855","doi":"10.1136/annrheumdis-2022-eular.115","title":"POS1555-HPR EVALUATION OF CONVERSATIONS IN MOTION: A PROGRAM DESIGNED TO IMPROVE PATIENT-PROVIDER COMMUNICATION IN THE CARE OF RHEUMATOID ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Axdev Group (Canada)","funders":"","keywords":"Medicine; Rheumatoid arthritis; Family medicine; Physical therapy; Health professionals; Rating scale; Health care; Internal medicine","score_opus":0.045258888865055545,"score_gpt":0.30961390592955,"score_spread":0.2643550170644945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283710855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902115,0.00210672,0.000010013447,0.0050352053,0.000086509426,0.0023044476,0.00003424855,0.000018435978,0.00019295514],"genre_scores_gemma":[0.9986815,0.00007342013,0.00004216273,0.0002881372,0.0000048018683,0.0008642379,0.00003660099,0.000008216086,9.529153e-7],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982641,0.00031486896,0.000635816,0.00012245975,0.00052723597,0.00013554725],"domain_scores_gemma":[0.9982797,0.000113711576,0.00057927385,0.0005513396,0.00046834734,0.000007646776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009958362,0.00008492121,0.00023175702,0.00023724907,0.000116810435,0.000020102332,0.00043627547,0.000028481869,0.0000546662],"category_scores_gemma":[0.00076089054,0.00006375627,0.00008377564,0.0007890842,0.000068870366,0.00019875877,0.0002163668,0.00008042608,0.0000017875731],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006338218,0.0008752864,0.03574126,0.0009756501,0.000042750944,4.2561032e-7,0.006992382,0.0019407247,0.000040818526,0.01233689,0.00091271364,0.9400777],"study_design_scores_gemma":[0.0051763314,0.0006996491,0.69906634,0.0047896937,0.00013489938,0.0000047581384,0.21365191,0.024892662,0.0005243835,0.046341185,0.0040824316,0.0006357582],"about_ca_topic_score_codex":0.0064985487,"about_ca_topic_score_gemma":0.0011546705,"teacher_disagreement_score":0.939442,"about_ca_system_score_codex":0.000033470882,"about_ca_system_score_gemma":0.00010451406,"threshold_uncertainty_score":0.98239046},"labels":[],"label_agreement":null},{"id":"W4283710859","doi":"10.1136/annrheumdis-2022-eular.359","title":"POS0845 ASSESSING FRAILTY IN SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL STUDY COMPARING FRAIL AND EDMONTON FRAILTY SCALES WITH PHYSICAL FRAILTY PHENOTYPE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Muscle weakness; Frailty syndrome; Cross-sectional study; Weight loss; Disease; Weakness; Physical therapy; Gerontology; Internal medicine; Obesity; Pathology; Frailty Index; Surgery","score_opus":0.11259007735247337,"score_gpt":0.3506794431736506,"score_spread":0.2380893658211772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283710859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990654,0.007391466,0.000009411968,0.00019999554,0.00018723834,0.001156287,0.000099179844,0.00007782584,0.0002245913],"genre_scores_gemma":[0.9992557,0.00011478286,0.000017231532,0.0001807536,0.00007241233,0.00022224219,0.000024242374,0.000046205012,0.000066392815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965553,0.0004474921,0.0008268251,0.00054669735,0.0012246772,0.0003990079],"domain_scores_gemma":[0.9980405,0.00035372438,0.0005067422,0.00066127756,0.00018505413,0.00025272375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005012413,0.00034094305,0.0008986032,0.00017934815,0.00054162444,0.00014528746,0.00036363275,0.00006520666,0.00007343788],"category_scores_gemma":[0.00029214035,0.00022545786,0.00026736333,0.00057302613,0.00030642396,0.0002536474,0.00037630316,0.000380187,0.0000045074726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061611185,0.003078357,0.98844385,0.0005833237,0.0004952774,0.00000970691,0.001176253,0.002082092,0.0007862663,0.000057449823,0.00031153014,0.0023597535],"study_design_scores_gemma":[0.0030151613,0.0003972066,0.98552424,0.0036617708,0.00028636702,0.00004196034,0.00398686,0.0025770662,0.00008760726,0.00016464294,0.0000053686813,0.00025176627],"about_ca_topic_score_codex":0.00060828106,"about_ca_topic_score_gemma":0.000034983805,"teacher_disagreement_score":0.008601733,"about_ca_system_score_codex":0.00010895568,"about_ca_system_score_gemma":0.00026197542,"threshold_uncertainty_score":0.9193905},"labels":[],"label_agreement":null},{"id":"W4283711092","doi":"10.1136/annrheumdis-2022-eular.3442","title":"POS0898 SURGICAL MANAGEMENT OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: A SYSTEMATIC LITERATURE REVIEW.","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Jewish General Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dermatology; Systematic review; Scleroderma (fungus); MEDLINE; Intensive care medicine; Surgery; Pathology","score_opus":0.03274078783246672,"score_gpt":0.28637104870258556,"score_spread":0.25363026087011886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283711092","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46613503,0.5301898,6.1513265e-7,0.0007198062,0.00016143674,0.0019702318,0.00025162043,0.000026519136,0.00054491294],"genre_scores_gemma":[0.90946156,0.08964778,0.000003576818,0.0001859457,0.000008888775,0.00030982879,0.000037966638,0.000021211019,0.00032321425],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969489,0.00035134627,0.001270202,0.00024899028,0.0009365416,0.000244018],"domain_scores_gemma":[0.9981146,0.00017595864,0.00065189187,0.00078672613,0.00012577714,0.00014503936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005052037,0.00021242088,0.0010477892,0.0001673862,0.0000740707,0.000023669134,0.00041467373,0.000039513467,0.000086764936],"category_scores_gemma":[0.00019561223,0.00012967184,0.0006497082,0.0009464647,0.000084255764,0.00009882566,0.00025851975,0.00013829475,0.0000068110226],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043834856,0.0020555567,0.0100959,0.9711339,0.001846182,0.00017116136,0.00066258025,0.00032333037,0.000037743623,0.00087766425,0.010369266,0.0019883954],"study_design_scores_gemma":[0.0013800332,0.00013439098,0.016550636,0.97751004,0.0011074663,0.00027803637,0.0025922414,0.00013081817,0.00003575358,0.00010598097,0.000012341592,0.00016225933],"about_ca_topic_score_codex":0.00000632885,"about_ca_topic_score_gemma":8.7450836e-8,"teacher_disagreement_score":0.44332656,"about_ca_system_score_codex":0.000054180528,"about_ca_system_score_gemma":0.000077370816,"threshold_uncertainty_score":0.5287864},"labels":[],"label_agreement":null},{"id":"W4283711198","doi":"10.1136/annrheumdis-2022-eular.1806","title":"AB1072 HERPES ZOSTER IN INDIVIDUALS WITH AUTOIMMUNE DISEASES AND RECOMBINANT HERPES ZOSTER VACCINE AS A PREVENTATIVE STRATEGY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Observational study; Incidence (geometry); Immunosuppression; Pediatrics; Population; Vaccination; Retrospective cohort study; Immunology; Internal medicine; Environmental health","score_opus":0.024219858896083288,"score_gpt":0.310346509569403,"score_spread":0.2861266506733197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283711198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921394,0.004140704,0.0000017647084,0.0020300723,0.00008722431,0.00097668,0.0002173201,0.00003312093,0.000373701],"genre_scores_gemma":[0.99742955,0.00047101371,0.000029002818,0.0005012859,0.000008323099,0.00035201953,0.000042150466,0.000031304597,0.0011353766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982487,0.000309569,0.00046630122,0.00029141226,0.0003951113,0.00028888392],"domain_scores_gemma":[0.9988579,0.00022261123,0.0002743226,0.0004309226,0.00006560739,0.00014860436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017209869,0.00025184918,0.0005547257,0.00016240237,0.00022192593,0.000037754606,0.000151693,0.000029742721,0.00077647466],"category_scores_gemma":[0.0001005001,0.00015454662,0.00015432939,0.0003778184,0.000106355816,0.00018223272,0.00021646787,0.00010217154,0.000009117296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012518927,0.008845425,0.49242955,0.00071424997,0.0022630682,0.00010566443,0.002448245,0.00022358385,0.000005897421,0.0004331613,0.002414325,0.48886493],"study_design_scores_gemma":[0.004035206,0.0012269359,0.98468745,0.0010822178,0.0005120868,0.00006279564,0.001582578,0.000062093495,0.00010995595,0.0036912367,0.00274183,0.00020562435],"about_ca_topic_score_codex":0.0005382733,"about_ca_topic_score_gemma":0.000035265773,"teacher_disagreement_score":0.4922579,"about_ca_system_score_codex":0.000040060084,"about_ca_system_score_gemma":0.00021582346,"threshold_uncertainty_score":0.8501853},"labels":[],"label_agreement":null},{"id":"W4283711362","doi":"10.1136/annrheumdis-2022-eular.2094","title":"AB0900 A temporary antirheumatic drugs withdrawal does not cause an excess of disease flares in patients with psoriatic arthritis undergoing Covid-19 mRNA vaccination","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; Bausch Health; Incyte; Dermira; Astellas Pharma; Celldex Therapeutics; Genentech; Coherus Biosciences; Valeant Pharmaceuticals International; Sun Pharma; Regeneron Pharmaceuticals; Kiniksa Pharmaceuticals; Baxalta; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; Gilead Sciences; Sanofi; Amgen; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Leflunomide; Psoriatic arthritis; Vaccination; Psoriasis; Internal medicine; Arthritis; Concomitant; Methotrexate; Disease; Rheumatoid arthritis; Immunology","score_opus":0.020689232009944925,"score_gpt":0.2974675372151429,"score_spread":0.27677830520519797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283711362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922533,0.0034796032,0.000020088115,0.0021075984,0.00012816081,0.0013957643,0.0005344179,0.000051006013,0.000030033003],"genre_scores_gemma":[0.9951511,0.0039213756,0.000044460052,0.0004045516,0.000013376073,0.00019370668,0.00018383043,0.000047739133,0.000039836203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960045,0.00068857666,0.0008902464,0.000379628,0.0016099843,0.00042704173],"domain_scores_gemma":[0.99719477,0.00054872164,0.0006248168,0.00082649814,0.0002290853,0.0005761199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005632385,0.0002892919,0.0007266514,0.00041539155,0.0003558616,0.00005310979,0.0004692657,0.000030809053,0.00043601877],"category_scores_gemma":[0.0014427332,0.00018881842,0.0001977267,0.000615758,0.00022883459,0.00056199165,0.00023243346,0.00020076687,0.000002056903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061970507,0.0043463805,0.9524944,0.0035632814,0.00056762353,0.000037906528,0.004722069,0.0012698103,0.000009933773,0.0006421435,0.0007696471,0.025379749],"study_design_scores_gemma":[0.010852165,0.001588016,0.97194725,0.0036521903,0.00006519937,0.000006277353,0.0044186777,0.0010695715,0.00017332727,0.005808336,0.000040528877,0.00037848696],"about_ca_topic_score_codex":0.00061839866,"about_ca_topic_score_gemma":0.00018443036,"teacher_disagreement_score":0.025001261,"about_ca_system_score_codex":0.00008309872,"about_ca_system_score_gemma":0.0011455808,"threshold_uncertainty_score":0.7699792},"labels":[],"label_agreement":null},{"id":"W4283711664","doi":"10.1136/annrheumdis-2022-eular.1324","title":"AB0047 CARTILAGE DEGRADATION STATUS OF KNEE OSTEOARTHIRTIC PATIENTS CAN BE PREDICTED BY CHONDROCYTE GENE EXPRESSION ANALYSIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Alberta Innovates; Killam Trusts; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Cartilage; Osteoarthritis; Chondrocyte; Gene expression; Pathology; Housekeeping gene; Femur; Gene; Anatomy; Surgery; Biology; Genetics","score_opus":0.018187397057867805,"score_gpt":0.25769100744271256,"score_spread":0.23950361038484475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283711664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934547,0.001225219,0.000011934723,0.0001955124,0.00012330202,0.00067011995,0.0042231483,0.00003052319,0.00006557027],"genre_scores_gemma":[0.9969241,0.00015092742,0.000072409704,0.00016620822,0.0000066959074,0.000113328155,0.002100007,0.000019536525,0.00044676158],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803346,0.00017500047,0.00049389875,0.00021615556,0.00078696676,0.00029449447],"domain_scores_gemma":[0.99859416,0.00006366407,0.00043895177,0.0005308129,0.0001607657,0.00021164381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008220752,0.00016765462,0.00047095204,0.00017815163,0.00016286474,0.000008827315,0.00014236402,0.00003073502,0.0003573074],"category_scores_gemma":[0.0002053552,0.00012431155,0.00035256933,0.00057816214,0.00006569814,0.000077799865,0.00013804178,0.00007049382,6.2863603e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044334466,0.010310727,0.67330104,0.0014884764,0.003771726,0.000025383317,0.006374057,0.0014042557,0.1383695,0.00014014142,0.023391437,0.13698982],"study_design_scores_gemma":[0.010546075,0.0058661746,0.12933895,0.00075808255,0.0076072076,0.0000038143526,0.00170434,0.0005476416,0.8420822,0.00039601594,0.00069018244,0.0004592944],"about_ca_topic_score_codex":0.00011276285,"about_ca_topic_score_gemma":0.000019189034,"teacher_disagreement_score":0.7037127,"about_ca_system_score_codex":0.00004580558,"about_ca_system_score_gemma":0.00012262333,"threshold_uncertainty_score":0.5069278},"labels":[],"label_agreement":null},{"id":"W4283711666","doi":"10.1136/annrheumdis-2022-eular.1366","title":"AB0888 Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; Toronto Western Hospital; Memorial University of Newfoundland","funders":"Memorial University of Newfoundland; University of Glasgow; Janssen Scientific Affairs","keywords":"Medicine; Presenteeism; Psoriatic arthritis; Absenteeism; Placebo; Work productivity; Internal medicine; Physical therapy; Productivity; Arthritis; Alternative medicine","score_opus":0.012512518441388414,"score_gpt":0.2318985414583646,"score_spread":0.21938602301697618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283711666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710613,0.0012810006,9.982522e-7,0.00015700405,0.0001319686,0.00093605963,0.00036083386,0.000008649071,0.0000173401],"genre_scores_gemma":[0.99957895,0.00010204639,0.000010487131,0.000016884933,0.000002790126,0.00016675962,0.000040393603,0.000013006988,0.00006866036],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986289,0.00045222376,0.00028226405,0.0002683009,0.000119564254,0.0002487215],"domain_scores_gemma":[0.99905217,0.00020086847,0.0003473831,0.00033994857,0.000044806988,0.00001484198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001719377,0.00016115709,0.0004180377,0.000092588365,0.00009371631,0.000007158917,0.00019647263,0.000036741963,0.000036746704],"category_scores_gemma":[0.00021291978,0.00012207779,0.000075753196,0.00037242245,0.00018244938,0.00025770874,0.00021770992,0.00010667705,8.7093593e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004521921,0.0035991124,0.38255358,0.00020140092,0.0005671613,0.0000024716471,0.0029445924,0.000064137996,0.00018470077,0.00006666385,0.00011725444,0.605177],"study_design_scores_gemma":[0.0036804075,0.00045096784,0.989952,0.0002466553,0.000074385935,4.1561884e-7,0.0006612837,8.6907227e-7,0.003937829,0.0008471776,0.000018438981,0.00012953502],"about_ca_topic_score_codex":0.0005331045,"about_ca_topic_score_gemma":0.000116396586,"teacher_disagreement_score":0.60739845,"about_ca_system_score_codex":0.000043711,"about_ca_system_score_gemma":0.0001205762,"threshold_uncertainty_score":0.4978188},"labels":[],"label_agreement":null},{"id":"W4283712100","doi":"10.1136/annrheumdis-2022-eular.443","title":"AB1089 PSYCHOSOCIAL IMPACTS OF THE COVID-19 PANDEMIC ON ETHIOPIAN AND CANADIAN RHEUMATOLOGY PATIENTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University; University of Manitoba","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Psychosocial; Anxiety; Population; Fibromyalgia; Physical therapy; Pandemic; Rheumatoid arthritis; Disease; Coronavirus disease 2019 (COVID-19); Psychiatry; Infectious disease (medical specialty)","score_opus":0.10334678185842532,"score_gpt":0.419836541230809,"score_spread":0.31648975937238366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283712100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839225,0.0006353485,6.0007136e-7,0.012215917,0.0010451071,0.0006040496,0.0009112079,0.000015208375,0.0006500724],"genre_scores_gemma":[0.9842939,0.00016523013,9.703396e-7,0.0152847115,0.00000782633,0.00006060583,0.000015797503,0.000016103748,0.0001548602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788934,0.0007075137,0.00043332862,0.00022927726,0.00035152657,0.00038901984],"domain_scores_gemma":[0.9979546,0.0005906765,0.00040931278,0.00056107336,0.00003890072,0.00044543148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039694135,0.00015117093,0.0003177735,0.00012007644,0.00051765185,0.0000073069828,0.0005385126,0.00006064466,0.0007468049],"category_scores_gemma":[0.00065941113,0.000101329424,0.00017533275,0.0002616121,0.00026582688,0.00002901856,0.00016586002,0.00020340989,0.000008049485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027397496,0.0004516536,0.937371,0.0003816292,0.0001155448,9.380124e-7,0.0060795187,0.000018426996,0.0000012141588,0.0055380706,0.04200453,0.00776347],"study_design_scores_gemma":[0.0012607469,0.00030569904,0.9808937,0.00012504433,0.000043571534,0.000010287696,0.001323859,0.000006896622,0.000003851671,0.005761305,0.010132652,0.00013243436],"about_ca_topic_score_codex":0.1663835,"about_ca_topic_score_gemma":0.038700737,"teacher_disagreement_score":0.12768276,"about_ca_system_score_codex":0.00019942924,"about_ca_system_score_gemma":0.0012663009,"threshold_uncertainty_score":0.9788405},"labels":[],"label_agreement":null},{"id":"W4283712358","doi":"10.1136/annrheumdis-2022-eular.1219","title":"POS1560-HPR “MY GUT FEELING IS…”: IDENTIFYING HOW HEALTHCARE PROFESSIONALS COMMUNICATE ABOUT PAIN IN PAEDIATRIC RHEUMATOLOGY MULTI-DISCIPLINARY TEAM MEETINGS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Health care; Thematic analysis; Feeling; Family medicine; Health professionals; Nursing; Qualitative research; Psychology","score_opus":0.11081078415096544,"score_gpt":0.43420167134528775,"score_spread":0.3233908871943223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283712358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8726684,0.019775465,0.00002476889,0.103530034,0.0010201253,0.0023531888,0.0004279127,0.00012784394,0.00007230207],"genre_scores_gemma":[0.9861149,0.0032208748,0.00022489819,0.009404875,0.000051442537,0.00020510204,0.00009944548,0.00007124898,0.00060719677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874793,0.0081766555,0.0017964201,0.00053436134,0.000852988,0.00116026],"domain_scores_gemma":[0.9936924,0.0026310221,0.0017966661,0.0012843173,0.0002393034,0.00035626962],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0054146694,0.0003829522,0.0010179072,0.00039053615,0.0032993124,0.000024886145,0.001550776,0.00015956866,0.00030073087],"category_scores_gemma":[0.002060862,0.0002978497,0.0004020301,0.0009109357,0.00017469966,0.00021495348,0.0027417582,0.0016209219,0.000030059335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039346886,0.002906821,0.7858975,0.015636625,0.00014940044,0.000009272668,0.049741976,0.00025089525,0.000024727342,0.001330715,0.12791315,0.015745442],"study_design_scores_gemma":[0.004875902,0.00030377734,0.78071594,0.027911609,0.0001160514,0.000015643587,0.16249628,0.010218487,0.000017675333,0.009337431,0.002908474,0.0010827363],"about_ca_topic_score_codex":0.00093667896,"about_ca_topic_score_gemma":0.00022955521,"teacher_disagreement_score":0.12500466,"about_ca_system_score_codex":0.00017130312,"about_ca_system_score_gemma":0.0011175022,"threshold_uncertainty_score":0.99994737},"labels":[],"label_agreement":null},{"id":"W4283712656","doi":"10.1136/annrheumdis-2022-eular.1500","title":"POS0969 GENETIC AND MOLECULAR DISTINCTIONS BETWEEN AXIAL PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Leibniz-Gemeinschaft; Institut National de la Santé et de la Recherche Médicale; School of Medicine, Kyorin University","keywords":"Medicine; Psoriatic arthritis; Secukinumab; Ankylosing spondylitis; Ustekinumab; Immunology; Internal medicine; Human leukocyte antigen; BASDAI; Arthritis; Infliximab; Disease; Antigen","score_opus":0.02250244258152949,"score_gpt":0.2780260291226691,"score_spread":0.2555235865411396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283712656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655353,0.03089495,0.000014336227,0.0019301041,0.00010319314,0.0003778559,0.0009869535,0.00002068743,0.00013663278],"genre_scores_gemma":[0.99710315,0.0023326178,0.00012449718,0.00022409161,0.000028752445,0.00006718657,0.00005214767,0.000017460337,0.000050079194],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892145,0.00010025068,0.00028115042,0.00019920962,0.00029782776,0.00020009105],"domain_scores_gemma":[0.99932,0.00012565537,0.00011964648,0.00025659165,0.000043655717,0.0001344757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007182295,0.00013832565,0.00035464118,0.000058593963,0.0004210829,0.00002095678,0.00006680022,0.00001657065,0.00019455283],"category_scores_gemma":[0.00019198503,0.0001113348,0.00012220911,0.00015551045,0.00017761391,0.00003837453,0.00023747608,0.00007091613,0.0000012839266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031014683,0.00076360535,0.32126835,0.00071327173,0.0015324294,0.0001829882,0.0009028377,0.000016753007,0.00005161385,0.0013433875,0.0017352856,0.6711793],"study_design_scores_gemma":[0.0019910957,0.0005331615,0.98848355,0.0005944469,0.0005580452,0.00015778253,0.0004406111,0.00005456522,0.00009044365,0.005993822,0.00095843256,0.0001440729],"about_ca_topic_score_codex":0.00014087377,"about_ca_topic_score_gemma":0.000005977902,"teacher_disagreement_score":0.67103523,"about_ca_system_score_codex":0.0000143876305,"about_ca_system_score_gemma":0.00004038693,"threshold_uncertainty_score":0.45401013},"labels":[],"label_agreement":null},{"id":"W4283712894","doi":"10.1136/annrheumdis-2022-eular.2765","title":"AB0149 RNA SEQUENCING OF SKIN BIOPSY SAMPLES REVEALS UNIQUE BIOLOGICAL PROCESSES AMONG SPECIFIC GROUPS OF ADULT PATIENTS WITH IgA VASCULITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Pfizer","keywords":"Medicine; Skin biopsy; Biopsy; Transcriptome; KEGG; Fold change; Vasculitis; Internal medicine; Pathology; Gene; Biology; Disease; Genetics; Gene expression","score_opus":0.029100472248576714,"score_gpt":0.24778239529462576,"score_spread":0.21868192304604905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283712894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964337,0.0013616018,0.00004523594,0.00032252705,0.00005195197,0.00062667846,0.0009278838,0.000024794894,0.00020567059],"genre_scores_gemma":[0.9980629,0.0013019757,0.00021521327,0.000082728875,0.000012325741,0.0000774882,0.0001938753,0.000018840054,0.000034650217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981797,0.00019272827,0.00064549566,0.00022225924,0.00054395304,0.00021586605],"domain_scores_gemma":[0.9979987,0.00024460242,0.0005934691,0.00046967002,0.00057998847,0.00011352721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015822459,0.00017194102,0.000571251,0.00011844367,0.00015206593,0.0000070402566,0.00027363538,0.00005049708,0.00037782235],"category_scores_gemma":[0.0005470802,0.00010041381,0.00029923525,0.0005807018,0.00042161703,0.0000843928,0.0001252085,0.00014030904,0.0000010162356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007280645,0.004264293,0.9556032,0.0068131443,0.003033075,0.00002884267,0.003914046,0.001045811,0.0010416993,0.0090728225,0.0045495103,0.009905502],"study_design_scores_gemma":[0.001547662,0.0007192908,0.98341227,0.0035065205,0.00030151417,0.000019866176,0.0021665827,0.000015319243,0.003098536,0.004992384,0.00003339005,0.00018667783],"about_ca_topic_score_codex":0.00022244424,"about_ca_topic_score_gemma":0.000005125155,"teacher_disagreement_score":0.027809067,"about_ca_system_score_codex":0.000027659944,"about_ca_system_score_gemma":0.00018631095,"threshold_uncertainty_score":0.41368896},"labels":[],"label_agreement":null},{"id":"W4283713457","doi":"10.1136/annrheumdis-2022-eular.3826","title":"POS1093 EFFECT OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS ON DEPRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS IN A LONGITUDINAL COHORT","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Psoriasis Foundation","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Depression (economics); Cohort; Psoriasis; Minimal clinically important difference; Arthritis; Physical therapy; Randomized controlled trial; Immunology","score_opus":0.011017603924991843,"score_gpt":0.26335932200009776,"score_spread":0.2523417180751059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448043,0.0034657365,6.3883647e-7,0.00015977703,0.00009813634,0.0015465878,0.00016504477,0.000013903093,0.00006973227],"genre_scores_gemma":[0.9990163,0.00051107444,0.000008716003,0.000057055346,0.0000043038845,0.00031192147,0.000053314703,0.000025862606,0.000011486898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976847,0.00027668726,0.00057049526,0.00030089993,0.0008686451,0.0002985826],"domain_scores_gemma":[0.9986244,0.00032911677,0.00033582846,0.00052140927,0.000059456102,0.00012981484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002612002,0.00024115636,0.0008373591,0.00021620744,0.00013356109,0.000008162725,0.00016792903,0.000019528921,0.00010572227],"category_scores_gemma":[0.00040858556,0.00015465773,0.00019786289,0.00043967436,0.00010118427,0.000079558355,0.00018042879,0.00013213001,0.0000031517113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032866278,0.0022462627,0.9766979,0.00078821863,0.00024702091,0.000027493925,0.00023482964,0.00058797793,6.611319e-7,0.000016420587,0.00010307143,0.015763523],"study_design_scores_gemma":[0.00958484,0.0013813877,0.9811122,0.0070360084,0.0002081304,0.0000016374698,0.000112484515,0.00019991389,0.000064226966,0.00016817215,0.000001502688,0.00012953243],"about_ca_topic_score_codex":0.00024661006,"about_ca_topic_score_gemma":0.00001326352,"teacher_disagreement_score":0.015633991,"about_ca_system_score_codex":0.000062879575,"about_ca_system_score_gemma":0.00007428661,"threshold_uncertainty_score":0.6306759},"labels":[],"label_agreement":null},{"id":"W4283713624","doi":"10.1136/annrheumdis-2022-eular.1551","title":"AB0894 Efficacy and Safety of Guselkumab in Biologic-Naïve Patients With Active Axial Psoriatic Arthritis: Study Design of a Phase 4, Randomized, Double-Blind, Placebo-Controlled Trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Double blind; Placebo; Placebo-controlled study; Randomized controlled trial; Dermatology; Arthritis; Internal medicine; Psoriasis; Physical therapy; Alternative medicine; Pathology","score_opus":0.0411457160423803,"score_gpt":0.32015609733766615,"score_spread":0.2790103812952858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799097,0.002354992,0.000011822834,0.00009181895,0.00012758229,0.017244883,0.00020955906,0.0000102269705,0.000039396582],"genre_scores_gemma":[0.9975537,0.000660378,0.000032642576,0.000021753742,0.000011827646,0.0016621496,0.000027730917,0.000016538424,0.0000132567275],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970262,0.00089787156,0.0010263294,0.000261848,0.0005646991,0.00022302024],"domain_scores_gemma":[0.9969904,0.0015316925,0.00087864447,0.00034661172,0.00017356979,0.00007910041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006853852,0.00024453658,0.002021329,0.0001658151,0.00013777171,0.000006409909,0.00015086468,0.000029739776,0.000088938476],"category_scores_gemma":[0.0010326997,0.00014085168,0.00027359338,0.00029365002,0.00027192818,0.000060633236,0.0001543014,0.000102576945,4.1742578e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9595171,0.018887471,0.0018572666,0.00007777033,0.0031700798,0.000009015156,0.0017114364,0.00021281268,0.0000014693152,0.000027846643,0.00002567119,0.014502046],"study_design_scores_gemma":[0.9771918,0.011187802,0.007769423,0.000551694,0.001281929,0.0000019001925,0.0016201583,0.000073488474,0.000037278525,0.00016799111,0.0000010204573,0.00011548659],"about_ca_topic_score_codex":0.0001421055,"about_ca_topic_score_gemma":0.000013884982,"teacher_disagreement_score":0.017674714,"about_ca_system_score_codex":0.000027677865,"about_ca_system_score_gemma":0.00015252302,"threshold_uncertainty_score":0.57437646},"labels":[],"label_agreement":null},{"id":"W4283713699","doi":"10.1136/annrheumdis-2022-eular.2657","title":"AB0271 ALEXITHYMIA IN A PATIENT WITH RHEUMATOID ARTHRITIS: CONNECTION WITH DISEASES AND FUNCTIONAL ABILITY.","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Medicine; Rheumatoid arthritis; Toronto Alexithymia Scale; Disease; Anxiety; Depression (economics); Internal medicine; Physical therapy; Clinical psychology; Psychiatry","score_opus":0.016367323116034557,"score_gpt":0.24449726447277412,"score_spread":0.22812994135673956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926582,0.0046523716,0.000016937134,0.0013155274,0.000071915965,0.0007456893,0.00014761787,0.000029899322,0.0003618347],"genre_scores_gemma":[0.9985215,0.00062035123,0.000036118978,0.00036953582,0.000004562733,0.0003489197,0.000040056915,0.000019795907,0.00003917478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986232,0.00010819102,0.00031788286,0.00025190567,0.00050095195,0.00019789455],"domain_scores_gemma":[0.999111,0.00012845732,0.00020274076,0.00036470342,0.000059568203,0.0001335187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007160305,0.00017807935,0.00036116707,0.00009685864,0.00017715036,0.000016750975,0.00007029312,0.000015245708,0.0002958725],"category_scores_gemma":[0.00007821835,0.00010598888,0.00008970928,0.00028323522,0.00019323669,0.0000998335,0.000069394504,0.00008079571,0.0000018408558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004395969,0.005834855,0.95501715,0.00064929633,0.0007971051,0.00005386109,0.0013253321,0.0007249457,0.000008043238,0.001069895,0.001966275,0.028157244],"study_design_scores_gemma":[0.0040511005,0.0014847642,0.98236257,0.003151101,0.000072014474,0.00020444876,0.0030383084,0.00033326098,0.000024774701,0.004926431,0.00018479502,0.0001664319],"about_ca_topic_score_codex":0.00013985774,"about_ca_topic_score_gemma":0.00003076728,"teacher_disagreement_score":0.02799081,"about_ca_system_score_codex":0.000029261846,"about_ca_system_score_gemma":0.000138056,"threshold_uncertainty_score":0.43221012},"labels":[],"label_agreement":null},{"id":"W4283713931","doi":"10.1136/annrheumdis-2022-eular.453","title":"AB0241 COGNITIVE FRAILTY AND RISK OF FALLS AMONG EGYPTIAN OLDER ADULTS WITH RHEUMATOID ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Montreal Cognitive Assessment; Internal medicine; Population; Rheumatology; Outpatient clinic; Grip strength; Gerontology; Disease; Cognitive impairment","score_opus":0.014178252837647771,"score_gpt":0.2656076281100892,"score_spread":0.2514293752724414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690244,0.028536076,0.000018166007,0.00037651986,0.00005435934,0.00093317847,0.00076184724,0.000031626358,0.0002638283],"genre_scores_gemma":[0.92348677,0.0760873,0.000038747374,0.00009156449,0.000008287765,0.00014579992,0.000035621677,0.000032249056,0.000073676514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976567,0.0003304531,0.00049481913,0.0002851909,0.000878279,0.00035456393],"domain_scores_gemma":[0.9981423,0.0004310024,0.0004398752,0.00043984223,0.00027762188,0.0002693786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031593678,0.00021980704,0.0006171047,0.00014422751,0.00032101967,0.00002515208,0.00022617675,0.000031371543,0.0006641694],"category_scores_gemma":[0.00064437644,0.00014850961,0.00021995045,0.0003081858,0.0008043301,0.00015847989,0.000245979,0.00024582216,0.0000041318112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031484847,0.0016509959,0.7374298,0.0007961818,0.0020845227,0.00003602468,0.009042556,0.000034915876,0.000020888025,0.00036939175,0.0031364,0.24224986],"study_design_scores_gemma":[0.006235205,0.0012313691,0.96655816,0.009313604,0.000049307502,0.000088710905,0.0141532235,0.00023827248,0.00089874625,0.00079927145,0.00018353957,0.0002505726],"about_ca_topic_score_codex":0.00078136515,"about_ca_topic_score_gemma":0.00011418382,"teacher_disagreement_score":0.24199928,"about_ca_system_score_codex":0.000009118522,"about_ca_system_score_gemma":0.00017069557,"threshold_uncertainty_score":0.72721887},"labels":[],"label_agreement":null},{"id":"W4283798749","doi":"10.1136/ard-2022-222608","title":"Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"AbbVie","keywords":"Medicine; Ankylosing spondylitis; Placebo; Clinical endpoint; Internal medicine; Adverse effect; BASDAI; Tolerability; Spondylitis; Randomized controlled trial; Arthritis; Psoriatic arthritis; Pathology","score_opus":0.1075971404778814,"score_gpt":0.38302509043590727,"score_spread":0.2754279499580259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283798749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826445,0.004480424,0.000012626928,0.0012392701,0.00016554452,0.009457163,0.0018211938,0.000018305971,0.00016095348],"genre_scores_gemma":[0.99640673,0.001300462,0.00005444991,0.00028099355,0.00004746452,0.0016951151,0.00011576979,0.000018130504,0.00008087846],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983158,0.00023693994,0.00062046445,0.00026022422,0.00031737745,0.00024918307],"domain_scores_gemma":[0.9974368,0.0015957485,0.00038958353,0.0003030862,0.00012719029,0.00014757464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042248823,0.00020282624,0.0010651271,0.00009784749,0.00030486408,0.0000107054875,0.00013273774,0.000034601417,0.0003554248],"category_scores_gemma":[0.0009758665,0.00012319106,0.0004952144,0.00016958179,0.00014882271,0.000044289292,0.00012707416,0.000078170735,5.410846e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93981,0.002939502,0.00006125213,0.0000558708,0.0013311607,0.000004712163,0.000569991,0.000008074277,0.00012660761,0.00011230682,0.0003835494,0.05459701],"study_design_scores_gemma":[0.987255,0.0068397117,0.0013064336,0.00027077785,0.0003208617,0.000008335766,0.0007170141,0.000020413632,0.0006397402,0.00026287,0.0022355795,0.0001232746],"about_ca_topic_score_codex":0.000032260297,"about_ca_topic_score_gemma":0.0000015248562,"teacher_disagreement_score":0.054473735,"about_ca_system_score_codex":0.000026197113,"about_ca_system_score_gemma":0.00010904768,"threshold_uncertainty_score":0.50235856},"labels":[],"label_agreement":null},{"id":"W4289637928","doi":"10.1136/ard-2022-222405","title":"Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Pfizer (Canada)","funders":"Pfizer","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Internal medicine; Open label; Randomized controlled trial; Tumor necrosis factor alpha; Arthritis; Antirheumatic Agents; Surgery; Clinical trial; Rheumatoid factor; Dermatology","score_opus":0.04476710837765961,"score_gpt":0.3073059726280821,"score_spread":0.2625388642504225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289637928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98628885,0.0026140283,0.0000017020125,0.002552149,0.0006155111,0.00517914,0.002496301,0.000043538534,0.00020876144],"genre_scores_gemma":[0.9934317,0.005077293,0.000018615676,0.00016474443,0.000034026198,0.0009408334,0.00025496434,0.00003839404,0.000039461265],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99550736,0.0014289768,0.0011151806,0.0003954715,0.0010724451,0.0004805744],"domain_scores_gemma":[0.994374,0.003766137,0.00064469286,0.0007402624,0.00027472505,0.00020019362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010562622,0.00029592513,0.001145722,0.000117631054,0.0006565069,0.00019936699,0.0006687602,0.00004067964,0.0004570854],"category_scores_gemma":[0.007848321,0.00017242024,0.00026543465,0.0005718616,0.00028042434,0.00029919783,0.00045010462,0.00035470873,0.0000060418192],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8812822,0.0040502446,0.07965041,0.00002573266,0.0010290346,0.0000059371673,0.0011651582,0.000118716576,0.000015424674,0.000048580292,0.008841636,0.023766918],"study_design_scores_gemma":[0.8488017,0.002330933,0.14565203,0.0012066142,0.000014757141,0.0000020659268,0.00049003825,0.0001335446,0.000048457186,0.00024990196,0.0008316461,0.0002383469],"about_ca_topic_score_codex":0.0022721323,"about_ca_topic_score_gemma":0.00063656585,"teacher_disagreement_score":0.066001624,"about_ca_system_score_codex":0.00005666583,"about_ca_system_score_gemma":0.00043411797,"threshold_uncertainty_score":0.9395741},"labels":[],"label_agreement":null},{"id":"W4290973130","doi":"10.1136/annrheumdis-2022-eular.870","title":"OP0054 REDUCING THE BURDEN OF LOW BACK PAIN: RESULTS FROM A NEW MICROSIMULATION MODEL","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Research Canada; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Centre for Epidemiology Versus Arthritis, University of Manchester; Manchester Biomedical Research Centre; National Institutes of Health; Versus Arthritis; Hacettepe Üniversitesi; University of Manchester; Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Medicine; Psychological intervention; Population; Body mass index; Low back pain; Physical therapy; Gerontology; Demography; Environmental health; Psychiatry; Alternative medicine; Internal medicine","score_opus":0.03800761678256741,"score_gpt":0.3018654175882941,"score_spread":0.2638578008057267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290973130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784318,0.00091407995,0.0002963573,0.019076446,0.00009372166,0.0006905023,0.00021365487,0.000014923597,0.00026848618],"genre_scores_gemma":[0.99794877,0.000045816872,0.00029721207,0.0004394483,0.00005206481,0.00001339398,0.000083749284,0.000013304921,0.0011062467],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99841845,0.0003546261,0.0005133076,0.00016249313,0.00042892946,0.0001222068],"domain_scores_gemma":[0.9979743,0.00089845964,0.00034276734,0.00061466475,0.000095289346,0.000074560194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006943372,0.00010060382,0.00025033293,0.0000435692,0.00012011656,0.00000856284,0.00022517506,0.000022741244,0.00017655797],"category_scores_gemma":[0.0018588165,0.0000577334,0.00029142815,0.00019660551,0.000106908126,0.000051591414,0.00011591779,0.00008836854,0.000003977416],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013621891,0.0006127801,0.0005178923,0.002262487,0.00034142783,3.372525e-7,0.016313354,0.8492382,0.0066662077,0.00016894675,0.08752569,0.0349905],"study_design_scores_gemma":[0.002420184,0.00033336977,0.03812568,0.0032094296,0.00016329157,6.779819e-7,0.0036504471,0.9338455,0.0012262427,0.016635917,0.00020868194,0.00018057477],"about_ca_topic_score_codex":0.001337075,"about_ca_topic_score_gemma":0.0000019387087,"teacher_disagreement_score":0.087317005,"about_ca_system_score_codex":0.000017781136,"about_ca_system_score_gemma":0.00017960308,"threshold_uncertainty_score":0.23542997},"labels":[],"label_agreement":null},{"id":"W4290973909","doi":"10.1136/annrheumdis-2022-eular.4151","title":"POS0153 MRI SPINAL LESIONS IN PATIENTS WITHOUT MRI OR RADIOGRAPHIC LESIONS IN THE SACROILIAC JOINTS TYPICAL OF AXIAL SPONDYLOARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sacroiliitis; Ankylosing spondylitis; Radiology; Sacroiliac joint; Radiography; Magnetic resonance imaging; Axial spondyloarthritis; Nuclear medicine; Surgery","score_opus":0.04040707327105687,"score_gpt":0.31271284526267434,"score_spread":0.2723057719916175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290973909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253774,0.0018107007,0.0000026621124,0.004046745,0.00013473482,0.0008793595,0.00046016683,0.000016234022,0.00011165026],"genre_scores_gemma":[0.9981196,0.000689597,0.000045709512,0.0008699009,0.000020933257,0.00010787363,0.000052978106,0.00002172757,0.000071669994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724495,0.00053629867,0.00077868806,0.0002567713,0.0008416135,0.00034164547],"domain_scores_gemma":[0.9985237,0.00025343194,0.0002803692,0.00068279926,0.00010118311,0.00015851775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040849677,0.00020467813,0.00061648147,0.00033979086,0.00018091279,0.000012948578,0.00040950775,0.000043833814,0.0005258383],"category_scores_gemma":[0.000801331,0.00012223265,0.0004498087,0.0009836021,0.000309832,0.000096899654,0.00022626235,0.00026677927,0.000005974534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008580832,0.008537823,0.9246662,0.0006578521,0.00018646348,0.000072789946,0.001062074,0.00011460019,0.000022061198,0.0005943028,0.021052202,0.034452796],"study_design_scores_gemma":[0.0026171312,0.000952423,0.9916742,0.0014499542,0.00015957905,0.000016545979,0.0011830155,0.000075693286,0.000036253874,0.0013686214,0.00032720744,0.00013939259],"about_ca_topic_score_codex":0.0002819309,"about_ca_topic_score_gemma":0.00011644688,"teacher_disagreement_score":0.06700798,"about_ca_system_score_codex":0.00002196451,"about_ca_system_score_gemma":0.00030292151,"threshold_uncertainty_score":0.575756},"labels":[],"label_agreement":null},{"id":"W4290994087","doi":"10.1136/annrheumdis-2022-eular.2468","title":"POS0005 BASELINE BIOMARKERS PREDICT BETTER RESPONSES TO DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITOR, IN A PHASE 2 TRIAL IN PSORIATIC ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Secukinumab; Placebo; Oncology; Arthritis; Immunology; Pathology","score_opus":0.03291885164253951,"score_gpt":0.3062609298272585,"score_spread":0.273342078184719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290994087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905597,0.0039253426,0.0000056990298,0.0015138856,0.0006439873,0.0013194919,0.0019738856,0.00003976635,0.000018248915],"genre_scores_gemma":[0.99801886,0.00023534786,0.00004853487,0.0005896136,0.00003364613,0.00059710845,0.00032567998,0.000027621543,0.00012359527],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99565303,0.0025493011,0.0007830443,0.0004111038,0.00014888305,0.0004546503],"domain_scores_gemma":[0.9984447,0.0006521792,0.0002570055,0.0005009679,0.00006818425,0.00007698324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009740264,0.00028119414,0.0006071607,0.0004691814,0.00021228666,0.000019476289,0.00040591808,0.0000830417,0.00060062367],"category_scores_gemma":[0.0011574825,0.00023051583,0.00021917764,0.0008087528,0.0001291961,0.00015882021,0.00018939178,0.00015740201,0.00002217508],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2561756,0.018902222,0.018019453,0.0001590759,0.0014028444,0.00012702386,0.0041615157,0.0001893263,0.0077880844,0.000081511724,0.026786178,0.66620713],"study_design_scores_gemma":[0.48736313,0.029568642,0.34028727,0.0038561092,0.0015162821,0.0001458764,0.0068584997,0.0004892069,0.11390516,0.0050765495,0.008008935,0.0029243268],"about_ca_topic_score_codex":0.00046990943,"about_ca_topic_score_gemma":0.0002523528,"teacher_disagreement_score":0.6632828,"about_ca_system_score_codex":0.000062918756,"about_ca_system_score_gemma":0.00025789934,"threshold_uncertainty_score":0.94001627},"labels":[],"label_agreement":null},{"id":"W4290996954","doi":"10.1136/annrheumdis-2022-eular.1070","title":"POS0082 A NOVEL PSORIATIC ARTHRITIS COMPOSITE ENDPOINT COMBINING TREATMENT TARGETS FOR SKIN AND JOINTS: POOLED RESULTS FROM THE GUSELKUMAB DISCOVER-1 AND DISCOVER-2 STUDIES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"UCB Pharma; Regeneron Pharmaceuticals; Celgene; Gilead Sciences; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Secukinumab; Psoriasis; Dermatology; Disease","score_opus":0.047744164237551144,"score_gpt":0.28385856135729,"score_spread":0.23611439711973883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290996954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9081118,0.07641184,0.000016460675,0.0030508074,0.00043370388,0.00082994247,0.011107901,0.000022349248,0.000015207757],"genre_scores_gemma":[0.9919083,0.0065691303,0.00006858194,0.00025976732,0.000020477793,0.00032249032,0.0005858654,0.000020362508,0.00024498487],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983653,0.00037371085,0.00052046595,0.00035591156,0.00009421868,0.0002904078],"domain_scores_gemma":[0.99719125,0.0018750728,0.000404277,0.0004451778,0.000049543443,0.000034683348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002478491,0.00028639383,0.000611791,0.000044702192,0.0008749028,0.000039355575,0.0002394528,0.00003935785,0.000030130219],"category_scores_gemma":[0.00035255754,0.0001632457,0.00025459504,0.00009123662,0.00029519538,0.0001067307,0.00035127587,0.000068299654,0.0000029851512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023355335,0.011063802,0.014613388,0.00066183653,0.057870224,0.000025130586,0.09650815,0.000570129,0.012766859,0.007450501,0.038830906,0.7362837],"study_design_scores_gemma":[0.07875883,0.00652713,0.7522577,0.0030183801,0.010243677,0.00012619069,0.04803384,0.000394623,0.049570337,0.036617577,0.012332936,0.0021188082],"about_ca_topic_score_codex":0.00051167887,"about_ca_topic_score_gemma":0.00007557017,"teacher_disagreement_score":0.7376443,"about_ca_system_score_codex":0.000037525213,"about_ca_system_score_gemma":0.00006757619,"threshold_uncertainty_score":0.6729134},"labels":[],"label_agreement":null},{"id":"W4290997013","doi":"10.1136/annrheumdis-2022-eular.1004","title":"OP0309 WES ANALYSIS OF RARE FAMILIES POINTS TO A PATHOGENIC ROLE FOR THE cGAS/STING-TYPE I IFN AXIS IN SSc","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Sherbrooke","funders":"Eli Lilly Canada; Sanofi Genzyme; Sandoz Canada; Merck Canada; Bristol-Myers Squibb Canada; Gilead Sciences; Pfizer Canada; Janssen Canada; Sanofi; AbbVie Canada; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Genetics; Exome sequencing; Candidate gene; Disease; Population; Gene; In silico; Allele; Sting; Bioinformatics; Biology; Phenotype; Pathology","score_opus":0.04285611555118496,"score_gpt":0.3076960035263589,"score_spread":0.26483988797517394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760882,0.019678406,0.000009732466,0.002311901,0.00015648268,0.000994178,0.00065211824,0.000020059042,0.000088912726],"genre_scores_gemma":[0.9978764,0.0008979342,0.00002966837,0.00069599284,0.000016720312,0.00021940813,0.000047105306,0.000020011308,0.00019678142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980913,0.00020156769,0.00068076537,0.00023648365,0.0005409196,0.00024900225],"domain_scores_gemma":[0.9977284,0.0008628028,0.00034761205,0.0007327971,0.00020253134,0.00012586243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004902483,0.00016427414,0.0006653527,0.00032731742,0.00017712379,0.000012882494,0.00044771135,0.00003358059,0.00027859776],"category_scores_gemma":[0.0018971083,0.00009336534,0.00073942886,0.0016379599,0.000086679174,0.000038305003,0.00023352518,0.0000802898,0.0000031521786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060238517,0.0059812064,0.6800005,0.0036062205,0.023328198,0.0000150901515,0.018127188,0.06518285,0.004569785,0.00083390356,0.050456617,0.14187461],"study_design_scores_gemma":[0.001182255,0.000429058,0.9623532,0.00195961,0.004918014,0.000004490068,0.018938866,0.008529259,0.0005359942,0.00057682185,0.00037031103,0.0002021195],"about_ca_topic_score_codex":0.00037571773,"about_ca_topic_score_gemma":0.00003352925,"teacher_disagreement_score":0.28235272,"about_ca_system_score_codex":0.000026781478,"about_ca_system_score_gemma":0.00016592468,"threshold_uncertainty_score":0.3807328},"labels":[],"label_agreement":null},{"id":"W4290997069","doi":"10.1136/annrheumdis-2022-eular.2161","title":"POS0111 MORE METICULOUSLY FOLLOWING TREAT-TO-TARGET IN RA DOES NOT LEAD TO LESS RADIOGRAPHIC PROGRESSION: A LONGITUDINAL ANALYSIS IN BIODAM","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; McMaster University; Southlake Regional Health Center; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Toronto; Centre Hospitalier Universitaire de Sherbrooke; University of Alberta","funders":"Assistance publique-Hôpitaux de Paris; Université Paris Descartes; Università degli Studi di Ferrara; Institut National de la Santé et de la Recherche Médicale; Università degli Studi di Verona; Université de Bordeaux; Centre Hospitalier Régional Universitaire de Montpellier; Johns Hopkins University; Université de Sherbrooke; Pfizer; Diakonhjemmet; Eli Lilly and Company","keywords":"Medicine; Radiography; Lead (geology); Surgery","score_opus":0.027653749450616334,"score_gpt":0.3500600052131559,"score_spread":0.32240625576253956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682497,0.0013388643,0.00011421767,0.029382186,0.00013817205,0.00065309013,0.0000414095,0.00003174955,0.00005064753],"genre_scores_gemma":[0.9970368,0.000066751374,0.00087296794,0.001638692,0.00002105855,0.00019129617,0.000027239299,0.000025720536,0.00011948467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974067,0.00029829837,0.0006326471,0.00040590874,0.00083719124,0.0004192526],"domain_scores_gemma":[0.99869746,0.00023481474,0.00017392878,0.00055364164,0.000047238012,0.0002929353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086892524,0.00022395106,0.00084986223,0.0011938044,0.0001538262,0.00003300544,0.00043958958,0.00002981755,0.00009805302],"category_scores_gemma":[0.0010252954,0.000138553,0.00068598153,0.0031356693,0.000094787036,0.0000646348,0.00028329,0.00029748603,0.0000020666394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032894846,0.00079773297,0.96264553,0.00020063382,0.0006688834,0.0002245118,0.0014168655,0.009190864,0.00014225418,0.00002844802,0.00048643255,0.023868887],"study_design_scores_gemma":[0.0011829049,0.00026609984,0.98038435,0.001090005,0.0008301926,0.000017145258,0.0011456766,0.01428365,0.00022199916,0.0002389701,0.00010093726,0.0002380551],"about_ca_topic_score_codex":0.0009010219,"about_ca_topic_score_gemma":0.000059980375,"teacher_disagreement_score":0.028787127,"about_ca_system_score_codex":0.0000494746,"about_ca_system_score_gemma":0.00010350719,"threshold_uncertainty_score":0.5650028},"labels":[],"label_agreement":null},{"id":"W4290997084","doi":"10.1136/annrheumdis-2022-eular.2374","title":"POS0232 IDENTIFICATION OF THE CORE REGULATORY GENE NETWORKS REGULATING SUBCHONDRAL BONE AND MARROW ADIPOSE TISSUE REMODELING IN HUMAN KNEE OA","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada First Research Excellence Fund; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Stryker; Pfizer; Amgen; Eli Lilly and Company; National Institutes of Health; U.S. Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Adipose tissue; Bone marrow; Transcriptome; Adipocyte; Medicine; Pathology; Fibrosis; Osteoarthritis; Cell type; Cell; Gene; Biology; Gene expression; Internal medicine; Genetics","score_opus":0.03122476674023581,"score_gpt":0.2857954876993843,"score_spread":0.25457072095914846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918062,0.006866836,0.000008967883,0.00045489997,0.00015608734,0.0006186958,0.00003681335,0.000015505406,0.000036014757],"genre_scores_gemma":[0.99906033,0.000057964593,0.00005645737,0.000094900366,0.000021634802,0.000040908373,0.000041201933,0.000020912674,0.0006056777],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985974,0.00013040935,0.0005536648,0.00018144856,0.00036491005,0.00017218893],"domain_scores_gemma":[0.9988514,0.00006015794,0.00041954996,0.0005419163,0.0000656288,0.000061355444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035210038,0.00012279989,0.0003124838,0.000076593366,0.00022474231,0.000011017534,0.0001359401,0.00003296071,0.000038161357],"category_scores_gemma":[0.00012051227,0.00008782965,0.00012987704,0.0002182928,0.00010333835,0.0000705031,0.00019110707,0.00010131646,3.0075296e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013790391,0.0022493252,0.15222797,0.0020644418,0.00033370274,0.000038261707,0.0051682787,0.02607418,0.57241553,0.008709776,0.0031495474,0.22618996],"study_design_scores_gemma":[0.009583372,0.0021791244,0.7430224,0.0062684426,0.001591932,0.00024144803,0.0029952503,0.03993401,0.16185328,0.03140669,0.00012302592,0.0008010277],"about_ca_topic_score_codex":0.000039922892,"about_ca_topic_score_gemma":0.000017412978,"teacher_disagreement_score":0.59079444,"about_ca_system_score_codex":0.000025510715,"about_ca_system_score_gemma":0.00004594191,"threshold_uncertainty_score":0.35815892},"labels":[],"label_agreement":null},{"id":"W4290997104","doi":"10.1136/annrheumdis-2022-eular.1357","title":"POS0289 A CONCEPTUAL FRAMEWORK OF THE COURSE AND TIMEFRAME OF PATIENT-REPORTED ADVERSE DRUG REACTIONS OF BIOLOGICS IN IMMUNE-MEDIATED INFLAMMATORY DISEASES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacovigilance; Thematic analysis; Drug reaction; Health professionals; Drug; Family medicine; Pediatrics; Health care; Qualitative research; Pharmacology","score_opus":0.020507919322003722,"score_gpt":0.28455901348340584,"score_spread":0.2640510941614021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957778,0.0016451208,0.0000010698525,0.0007535701,0.00020705564,0.0007574379,0.00067574874,0.000021299318,0.00016091566],"genre_scores_gemma":[0.99938774,0.00031699723,0.000028646078,0.00009471488,0.0000067331125,0.00005561542,0.000039195664,0.000017614715,0.000052755164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772024,0.00032616084,0.0010475798,0.00018251341,0.000531565,0.00019195415],"domain_scores_gemma":[0.99641865,0.000988147,0.001458323,0.00078862964,0.00023474373,0.00011148294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022229296,0.00017245974,0.0005898043,0.00014404888,0.00010131214,0.0000021011676,0.00025187456,0.000058032307,0.000073339455],"category_scores_gemma":[0.003247096,0.0001142966,0.0003466131,0.0006082555,0.000901111,0.000090412286,0.00030301136,0.00027202413,9.16816e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011286851,0.0141636785,0.92051923,0.002838401,0.0036455889,0.000040606574,0.014389103,0.0061188242,0.013882233,0.0064110584,0.0016079454,0.015254669],"study_design_scores_gemma":[0.0011049304,0.00011582295,0.97313255,0.0020091147,0.00068290584,0.000016510985,0.017933968,0.00024774094,0.002323335,0.002010556,0.0002719171,0.00015067456],"about_ca_topic_score_codex":0.0002612872,"about_ca_topic_score_gemma":0.000004818132,"teacher_disagreement_score":0.052613318,"about_ca_system_score_codex":0.000032117703,"about_ca_system_score_gemma":0.00046827548,"threshold_uncertainty_score":0.46608803},"labels":[],"label_agreement":null},{"id":"W4290997231","doi":"10.1136/annrheumdis-2022-eular.2834","title":"POS0941 LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON‑RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Celgene; Gilead Sciences; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Certolizumab pegol; Ankylosing spondylitis; BASDAI; Internal medicine; Axial spondyloarthritis; Sacroiliitis; C-reactive protein; Placebo; Gastroenterology; Physical therapy; Adalimumab; Disease; Inflammation; Pathology; Psoriatic arthritis","score_opus":0.019855224350741395,"score_gpt":0.3017079740843017,"score_spread":0.28185274973356034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296635,0.0011759298,0.0000019866764,0.00062834413,0.00006380951,0.0024520368,0.0026572517,0.000012708146,0.00004157641],"genre_scores_gemma":[0.9986154,0.00054673135,0.000032744047,0.00004240618,0.000007659673,0.00037191017,0.00027927445,0.000027401478,0.0000764749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977723,0.00027728968,0.00067656895,0.00036337768,0.0005662425,0.00034423164],"domain_scores_gemma":[0.9984944,0.0002770889,0.00046591103,0.00043093265,0.0001407556,0.00019093898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007575128,0.000298758,0.00096251216,0.00015228118,0.0001639277,0.00001060257,0.00011404942,0.0000400994,0.000113923204],"category_scores_gemma":[0.00015410024,0.0001904773,0.00030711968,0.00030212785,0.00033251796,0.0001017141,0.00011659856,0.0001328873,6.839011e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005632617,0.0068554548,0.9475779,0.00010469495,0.0013698003,0.00006624088,0.00045075416,0.0000024768774,0.0000055962328,0.000014001069,0.00009498011,0.03782547],"study_design_scores_gemma":[0.015002785,0.005238952,0.97796595,0.00045356224,0.00037011196,0.000010532181,0.00051272876,0.000010660758,0.00019473041,0.000069602705,0.000011559918,0.00015882417],"about_ca_topic_score_codex":0.0007650531,"about_ca_topic_score_gemma":0.00020758131,"teacher_disagreement_score":0.037666645,"about_ca_system_score_codex":0.00006118676,"about_ca_system_score_gemma":0.0001748795,"threshold_uncertainty_score":0.7767439},"labels":[],"label_agreement":null},{"id":"W4290997271","doi":"10.1136/annrheumdis-2022-eular.799","title":"POS0081 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 1 STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Barrie Urology Group","funders":"","keywords":"Medicine; Psoriatic arthritis; Term (time); Internal medicine; Arthritis","score_opus":0.023983054301174915,"score_gpt":0.30715793203721375,"score_spread":0.28317487773603883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994997,0.0019108728,0.0000012787924,0.00066057144,0.00003192741,0.0017759178,0.00053758087,0.000011817534,0.00007303106],"genre_scores_gemma":[0.99926925,0.00036992543,0.0000058868504,0.00010067943,0.000007947153,0.00005817398,0.00012437122,0.000018527764,0.000045240435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976091,0.000427907,0.00071452203,0.00022393328,0.00079795,0.00022661468],"domain_scores_gemma":[0.9982708,0.0005246456,0.00034793618,0.00064737594,0.0001360442,0.00007319742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046678632,0.00015037964,0.00049205613,0.000076454424,0.00018457623,0.000014979155,0.00030932043,0.000018795967,0.00022844443],"category_scores_gemma":[0.0009303416,0.00008705191,0.000084757776,0.00036535336,0.00018868156,0.00008417373,0.00024300962,0.00019580097,0.0000025169838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020134872,0.009972437,0.8713561,0.00021308752,0.000746763,0.000013477526,0.0055791386,0.00008310118,0.000006759432,0.000031149197,0.0015268335,0.090336256],"study_design_scores_gemma":[0.024278581,0.0018820419,0.9705959,0.00075047783,0.00011012778,8.232454e-7,0.002101248,0.000045905035,0.000030303341,0.00007707943,0.000034621073,0.000092913724],"about_ca_topic_score_codex":0.00018290481,"about_ca_topic_score_gemma":0.000021922267,"teacher_disagreement_score":0.09923975,"about_ca_system_score_codex":0.000014602964,"about_ca_system_score_gemma":0.00019600845,"threshold_uncertainty_score":0.35498738},"labels":[],"label_agreement":null},{"id":"W4290997295","doi":"10.1136/annrheumdis-2022-eular.741","title":"POS0173 DATA-DRIVEN MRI DEFINITIONS FOR ACTIVE AND STRUCTURAL SACROILIAC JOINT LESIONS IN JUVENILE SPONDYLOARTHRITIS TYPICAL OF AXIAL DISEASE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Alberta; St. Michael's Hospital","funders":"Pfizer; Swedish Orphan Biovitrum; Eli Lilly and Company","keywords":"Medicine; Axial spondyloarthritis; Sacroiliac joint; Juvenile; Joint (building); Axial skeleton; Magnetic resonance imaging; Radiology; Sacroiliitis; Anatomy; Structural engineering","score_opus":0.11072880501909671,"score_gpt":0.3487258927170755,"score_spread":0.23799708769797878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988119,0.0019894238,0.0000149542075,0.0036043169,0.00005724691,0.00078982837,0.0053461357,0.000011009289,0.000068070694],"genre_scores_gemma":[0.9985962,0.0005458103,0.00009244183,0.0001287454,0.000010350775,0.00012304023,0.00043186304,0.000014800804,0.000056767516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986248,0.00014394576,0.00045777345,0.00020541978,0.00035468463,0.0002133766],"domain_scores_gemma":[0.9987599,0.00023934452,0.00017653887,0.0005956048,0.00009373428,0.00013484192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014042904,0.000109983426,0.00041046928,0.00011897218,0.00022099755,0.000009115585,0.0002782167,0.00002144593,0.0003823439],"category_scores_gemma":[0.0010031653,0.00008546779,0.00016638289,0.00018207154,0.00028738216,0.00013516458,0.0005437439,0.0001395461,0.0000013542307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042857047,0.011461387,0.17194946,0.014078513,0.002932781,0.00020689172,0.010609349,0.005372075,0.0025605138,0.054625846,0.12702975,0.5563164],"study_design_scores_gemma":[0.0030783333,0.00046471655,0.96600413,0.0007150479,0.00021527811,0.000014498267,0.0026969102,0.008548715,0.00029064252,0.016730186,0.0010495092,0.0001920374],"about_ca_topic_score_codex":0.000060060735,"about_ca_topic_score_gemma":0.000017174634,"teacher_disagreement_score":0.7940547,"about_ca_system_score_codex":0.000016190754,"about_ca_system_score_gemma":0.0004145769,"threshold_uncertainty_score":0.41863975},"labels":[],"label_agreement":null},{"id":"W4290997409","doi":"10.1136/annrheumdis-2022-eular.4402","title":"POS0161 WORK STATUS IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES: RESULTS OF A BELGIAN COMPARATIVE STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Università degli Studi di Padova; Universitair Ziekenhuis Gent; Ontario Ministry of Research, Innovation and Science; Medac; University of Toronto; Bundesministerium für Bildung und Forschung; Sanofi; Universiteit Gent; Pfizer; Arthritis Society; Eli Lilly and Company","keywords":"Medicine; Sick leave; Presenteeism; Flemish; Population; Rheumatoid arthritis; Epidemiology; Rheumatology; Physical therapy; Internal medicine; Family medicine; Absenteeism; Environmental health","score_opus":0.020376698357128572,"score_gpt":0.2915179510041774,"score_spread":0.2711412526470488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500465,0.0015754292,3.094173e-7,0.00016892768,0.000084594445,0.0021376857,0.00086776173,0.000020895668,0.00013976172],"genre_scores_gemma":[0.99940467,0.00006656281,0.000018767234,0.000041414725,0.0000046393316,0.0002614078,0.0001191618,0.000022847096,0.000060512306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972688,0.00033273367,0.0007968476,0.00029076636,0.0009537788,0.00035708502],"domain_scores_gemma":[0.9981573,0.0002528554,0.0005609492,0.00066486665,0.0001869991,0.0001770121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015071659,0.00026002116,0.00082899135,0.00016820448,0.00020187174,0.000009420829,0.00022233644,0.000016566572,0.0000991549],"category_scores_gemma":[0.0002692333,0.00016872775,0.0002333972,0.00065345445,0.00021948977,0.00009325222,0.00030340656,0.00012541984,0.00000418794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005007509,0.009520413,0.9743991,0.0003467829,0.0010742197,0.00001617569,0.0051284716,0.00024521412,1.655333e-7,0.000024152709,0.0008664656,0.003371355],"study_design_scores_gemma":[0.012632167,0.0028167428,0.9742131,0.0010621555,0.0004202075,6.9390944e-7,0.008555396,0.000014375265,0.0000027903172,0.00010608187,0.000025505691,0.00015077736],"about_ca_topic_score_codex":0.00022335055,"about_ca_topic_score_gemma":0.00006733873,"teacher_disagreement_score":0.0076246574,"about_ca_system_score_codex":0.00006897048,"about_ca_system_score_gemma":0.0001784096,"threshold_uncertainty_score":0.6880518},"labels":[],"label_agreement":null},{"id":"W4290997419","doi":"10.1136/annrheumdis-2022-eular.3472","title":"OP0307 PULMONARY FIBROSIS IN EARLY RHEUMATOID ARTHRITIS IN RELATION TO GENETIC LOCI AND INDIVIDUAL ACPA SPECIFICITIES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University Health Centre; Samsung; University of Manitoba; Sanofi; University of Calgary; Université de Sherbrooke; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Odds ratio; Single-nucleotide polymorphism; Confidence interval; Pulmonary fibrosis; Rheumatoid factor; Cohort; Immunology; Fibrosis; Genotype","score_opus":0.02644150212185053,"score_gpt":0.2586424598262966,"score_spread":0.23220095770444604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890338,0.007645106,0.000004270975,0.0018257698,0.000113587885,0.00064578553,0.00042145114,0.000019552985,0.00029064642],"genre_scores_gemma":[0.9972654,0.0019146088,0.00006494341,0.00040478256,0.000023324326,0.00014284225,0.000050680956,0.000025792897,0.00010764146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804616,0.00019747959,0.0006173847,0.00028678804,0.00054972427,0.00030249276],"domain_scores_gemma":[0.99915785,0.00012184333,0.00015676874,0.00034698652,0.000046985402,0.00016959201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024008025,0.00018322948,0.0004371081,0.00030171365,0.00013783993,0.000031254072,0.00022390527,0.000040738338,0.00021090118],"category_scores_gemma":[0.00017573962,0.0001621502,0.00016975169,0.00046498477,0.00012183936,0.00013667956,0.0003542314,0.0001809229,0.0000067639976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008388278,0.0027539148,0.8721388,0.0015193813,0.0002591621,0.00035268557,0.008189363,0.0025227899,0.0005212776,0.002038556,0.004940654,0.096375115],"study_design_scores_gemma":[0.0005693995,0.00082448765,0.99216276,0.001787669,0.000029807768,0.00005622249,0.0015577421,0.00050064037,0.000059889997,0.0020454223,0.00022928836,0.00017668886],"about_ca_topic_score_codex":0.00056749966,"about_ca_topic_score_gemma":0.000018545286,"teacher_disagreement_score":0.12002392,"about_ca_system_score_codex":0.00005139227,"about_ca_system_score_gemma":0.00011504225,"threshold_uncertainty_score":0.6612293},"labels":[],"label_agreement":null},{"id":"W4290997429","doi":"10.1136/annrheumdis-2022-eular.1204","title":"POS0159 SEX-RELATED DISPARITIES IN HEALTHCARE UTILIZATION IN PATIENTS WITH INFLAMMATORY ARTHRITIS: A POPULATION-BASED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Women's College Hospital","funders":"Canadian Institutes of Health Research; Ontario Ministry of Research, Innovation and Science; University of Toronto; Arthritis Society","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Health care; Rheumatoid arthritis; Medical prescription; Cohort; Internal medicine; Inflammatory arthritis; Depression (economics); Osteoporosis; Population; Physical therapy; Environmental health","score_opus":0.02308103021957995,"score_gpt":0.2905652848223618,"score_spread":0.26748425460278186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926905,0.0037665423,9.703137e-7,0.0016544261,0.000059315276,0.001677589,0.00010906306,0.00002989248,0.000011720827],"genre_scores_gemma":[0.99889815,0.0003656136,0.000005757359,0.00023188208,0.0000031890675,0.00027484648,0.00017014291,0.000025100042,0.00002533289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974505,0.0005584863,0.000607968,0.00021198389,0.0008742814,0.00029682423],"domain_scores_gemma":[0.99903965,0.00013583916,0.00019869267,0.00038761296,0.00012380768,0.000114412745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033441395,0.00015428243,0.00041171804,0.0003052197,0.00017314419,0.000021914962,0.00017636796,0.000024394552,0.00012020936],"category_scores_gemma":[0.00028514935,0.000117126074,0.00008006841,0.0005453692,0.00007130445,0.00014080295,0.00008825325,0.00019932912,0.000001500895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006793911,0.0022403966,0.98571056,0.00018916419,0.000066567,0.00000943713,0.0006421117,0.0011544075,1.7808694e-7,0.00024297825,0.00007721591,0.008987598],"study_design_scores_gemma":[0.005088777,0.0008249005,0.990093,0.0011805408,0.0000050302992,9.4806086e-7,0.0010670761,0.0005267624,0.0000043590135,0.0010852171,0.000010169014,0.000113250964],"about_ca_topic_score_codex":0.0014230321,"about_ca_topic_score_gemma":0.0008141554,"teacher_disagreement_score":0.008874347,"about_ca_system_score_codex":0.00006409406,"about_ca_system_score_gemma":0.00025462237,"threshold_uncertainty_score":0.47762626},"labels":[],"label_agreement":null},{"id":"W4290997499","doi":"10.1136/annrheumdis-2022-eular.735","title":"POS0302 TREATING SPONDYLOARTHRITIS EARLY: DOES IT MATTER? RESULTS FROM A SYSTEMATIC LITERATURE REVIEW","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Samsung; Gilead Sciences; Eisai; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Cochrane Library; Randomized controlled trial; Internal medicine; MEDLINE; Relative risk; Physical therapy; Cohort; Disease; Systematic review; Cohort study; Intensive care medicine; Confidence interval","score_opus":0.02097372365366068,"score_gpt":0.287296022335468,"score_spread":0.26632229868180735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6019131,0.37554622,4.9035737e-7,0.013768968,0.00033339515,0.0020396393,0.005090806,0.00005424926,0.0012531404],"genre_scores_gemma":[0.9477663,0.045006204,0.00006839533,0.004281932,0.0000454542,0.0004970155,0.00032448885,0.000039628518,0.0019705584],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973464,0.000375216,0.0009334436,0.00034557105,0.00069955084,0.00029981066],"domain_scores_gemma":[0.99772775,0.0004483054,0.0005890813,0.0009510504,0.00014343105,0.00014036021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026916477,0.0002750764,0.0010506007,0.000075969234,0.00037184104,0.00004226331,0.00028797428,0.000028994198,0.0007243534],"category_scores_gemma":[0.0008739727,0.00015564178,0.0005574957,0.00043734474,0.00007879201,0.000099138226,0.0002970195,0.00015182109,0.000050441846],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004709066,0.0073110755,0.08442059,0.50430924,0.011145889,0.0018837438,0.022385387,0.000049734295,0.00009800542,0.00048253505,0.33207428,0.031130452],"study_design_scores_gemma":[0.0068691927,0.00085527013,0.12616561,0.85675454,0.0030245134,0.0002942472,0.0027132407,0.000045191653,0.00013195886,0.0014666931,0.0011184164,0.0005611512],"about_ca_topic_score_codex":0.00020633507,"about_ca_topic_score_gemma":0.000015752094,"teacher_disagreement_score":0.3524453,"about_ca_system_score_codex":0.00003425996,"about_ca_system_score_gemma":0.000052631505,"threshold_uncertainty_score":0.7931162},"labels":[],"label_agreement":null},{"id":"W4291186556","doi":"10.1136/annrheumdis-2022-eular.4599","title":"OP0161 TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Polymyositis; Hydroxychloroquine; Internal medicine; Dermatomyositis; Azathioprine; Antisynthetase syndrome; Myositis; Leflunomide; Cohort; Interstitial lung disease; Gastroenterology; Methotrexate; Disease","score_opus":0.018675970075679973,"score_gpt":0.28414724368652744,"score_spread":0.2654712736108475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934062,0.00031354226,0.0000042121405,0.0002864839,0.00039324188,0.00059056445,0.004766245,0.0000239239,0.00021563449],"genre_scores_gemma":[0.9988275,0.00032756457,0.000013813813,0.0002490152,0.00004442193,0.00007302535,0.00037728378,0.000025713913,0.00006166003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972123,0.0002617381,0.0011230615,0.0002563023,0.0009569366,0.00018964736],"domain_scores_gemma":[0.99758524,0.00014679067,0.00097878,0.0008684676,0.00028883177,0.00013190675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029439383,0.00020902121,0.00061390636,0.00013770125,0.00010914821,0.000010099957,0.00040058448,0.000044397493,0.0003252271],"category_scores_gemma":[0.00030552177,0.0001535652,0.00037124314,0.00011740357,0.00012863877,0.00017708313,0.00025133698,0.00009984505,0.0000027348724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016169099,0.0017027655,0.9865878,0.00037752205,0.0006289395,0.000019197774,0.002588866,0.00019570871,0.000110779314,0.00025323188,0.00061773724,0.0053005377],"study_design_scores_gemma":[0.0028476806,0.00063262193,0.9897894,0.00093386875,0.0002458322,0.000005233854,0.00065550033,0.00043130026,0.0035926863,0.00032130786,0.0004065312,0.00013802199],"about_ca_topic_score_codex":0.00066120154,"about_ca_topic_score_gemma":0.000008734421,"teacher_disagreement_score":0.0054213493,"about_ca_system_score_codex":0.00006235256,"about_ca_system_score_gemma":0.00020365881,"threshold_uncertainty_score":0.6262207},"labels":[],"label_agreement":null},{"id":"W4291186557","doi":"10.1136/annrheumdis-2022-eular.1107","title":"OP0248 SEVERE COVID-19 OUTCOMES AMONG PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: A POPULATION-BASED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Research Canada","funders":"Versus Arthritis; Universitätsklinikum Jena; Universidade do Estado do Rio de Janeiro; Università degli Studi di Torino; Lunds Universitet; McMaster University; King's College London; Universidade de São Paulo; Friedrich-Schiller-Universität Jena; Pfizer; University of Otago; School of Medicine, Boston University; Massachusetts General Hospital; Faculdade de Medicina da Universidade de São Paulo; Michael Smith Health Research BC","keywords":"Medicine; Population; ARDS; Psoriatic arthritis; Intensive care unit; Comorbidity; Internal medicine; Rheumatoid arthritis","score_opus":0.024336532096581553,"score_gpt":0.2998088575681232,"score_spread":0.27547232547154166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940605,0.0008977669,0.0000056075887,0.0012707589,0.00017514286,0.0025442562,0.00090387324,0.00009752241,0.000044541823],"genre_scores_gemma":[0.997518,0.000017923998,0.000027109916,0.0011009175,0.0000051050674,0.00065331475,0.0003500095,0.000045916942,0.00028171935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715364,0.00028548294,0.00064125756,0.00035882805,0.0012082891,0.00035249838],"domain_scores_gemma":[0.9976734,0.00041483162,0.0005112579,0.00093314884,0.00014158482,0.000325789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014030938,0.00033958777,0.0008473493,0.00014824052,0.00080911734,0.000031986725,0.00032361233,0.000021375474,0.0008549274],"category_scores_gemma":[0.00088132534,0.00021060959,0.00037744956,0.00045513627,0.000116027295,0.0001134029,0.0002782886,0.00011358096,0.0000073959122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058726803,0.006607222,0.98578197,0.00040583353,0.0012814082,0.000021623078,0.0005889417,0.0014227306,2.0485174e-8,0.000027061993,0.0011588731,0.0021170636],"study_design_scores_gemma":[0.008688794,0.0010375553,0.98628736,0.00039513106,0.00092934765,0.0000020001592,0.0018952298,0.00019122998,2.3695327e-7,0.00031043054,0.00003813965,0.00022457854],"about_ca_topic_score_codex":0.001705279,"about_ca_topic_score_gemma":0.000097533826,"teacher_disagreement_score":0.008101527,"about_ca_system_score_codex":0.00014820365,"about_ca_system_score_gemma":0.00030774408,"threshold_uncertainty_score":0.9360856},"labels":[],"label_agreement":null},{"id":"W4291186565","doi":"10.1136/annrheumdis-2022-eular.3235","title":"OP0252 FACTORS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Versus Arthritis; Centre Hospitalier Universitaire de Bordeaux; Manchester Biomedical Research Centre; Université de Bordeaux; University of Manchester; Universidad de Guadalajara; Universidade de São Paulo; Université de Lille; European League Against Rheumatism; McMaster University; Temple University; University of Otago; Sorbonne Université; Karolinska Institutet; Institut National de la Santé et de la Recherche Médicale; School of Medicine, Boston University; Faculdade de Medicina da Universidade de São Paulo; Massachusetts General Hospital; Brigham and Women's Hospital; Pfizer","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Rheumatology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Internal medicine; Myopathy; Virology; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.060919278686201346,"score_gpt":0.30985405674617744,"score_spread":0.2489347780599761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744473,0.0011402951,0.000011513915,0.020610522,0.00013316965,0.0010968826,0.0023291935,0.00013262681,0.00009849361],"genre_scores_gemma":[0.9825203,0.00008372345,0.000004510525,0.016844185,0.0000061863493,0.00016014089,0.0002868448,0.000025071835,0.000069034024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957574,0.0008023199,0.0010831346,0.00059084484,0.0012482041,0.00051807857],"domain_scores_gemma":[0.99515224,0.0015758321,0.0015727914,0.0010964489,0.00020926284,0.00039345818],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0004833051,0.0004554496,0.0012472685,0.000045207278,0.0006236279,0.000031406857,0.0007522166,0.00009222659,0.000037896585],"category_scores_gemma":[0.012508176,0.0002279526,0.00027700464,0.0007020106,0.00068453234,0.00012296233,0.00046608524,0.00035661404,0.0000035341318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002400556,0.0011499539,0.9850113,0.0003006414,0.0010434457,0.00008682607,0.001108604,0.00112652,3.0893426e-7,0.0001385509,0.0074636727,0.00016967051],"study_design_scores_gemma":[0.006142805,0.0003160418,0.98729885,0.0006380848,0.0003225737,0.0000124183525,0.002349011,0.000050589955,0.000003222605,0.0019835352,0.0005668435,0.0003160519],"about_ca_topic_score_codex":0.0011753232,"about_ca_topic_score_gemma":0.00033276225,"teacher_disagreement_score":0.012024871,"about_ca_system_score_codex":0.00030985894,"about_ca_system_score_gemma":0.0013934496,"threshold_uncertainty_score":0.9958099},"labels":[],"label_agreement":null},{"id":"W4291186570","doi":"10.1136/annrheumdis-2022-eular.740","title":"OP0216 DEVELOPMENT, REFINEMENT AND WEIGHTING OF CANDIDATE CRITERIA FOR AXIAL DISEASE IN JUVENILE SPONDYLOARTHRITIS: AN INTERNATIONAL COLLABORATION","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children","funders":"Perelman School of Medicine, University of Pennsylvania; National Institutes of Health; Istanbul Üniversitesi-Cerrahpasa; Universiteit Gent; University of Alberta; Pennsylvania State University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Universitair Ziekenhuis Gent; University of Wisconsin-Madison; Hospital for Sick Children; University of Pennsylvania; Children's Hospital of Philadelphia","keywords":"Medicine; Juvenile; Weighting; Axial spondyloarthritis; Disease; Medical physics; Family medicine; Pathology; Radiology; Sacroiliitis; Genetics","score_opus":0.04041262070235,"score_gpt":0.35787497553033526,"score_spread":0.31746235482798524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614954,0.0012749798,0.000010286144,0.0015304459,0.00009355202,0.0005323702,0.00030898245,0.0000069289463,0.00009289802],"genre_scores_gemma":[0.998934,0.00020730063,0.0001413083,0.00013249877,0.000011505574,0.00021100513,0.00020785358,0.000010028406,0.00014454906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988437,0.00009474324,0.0004594608,0.00013202589,0.00033900377,0.00013104637],"domain_scores_gemma":[0.999346,0.00005205165,0.00019183593,0.00019348734,0.00014223786,0.00007438765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003652686,0.00007665624,0.00022250088,0.0001233403,0.00012793898,0.000016007292,0.00015461777,0.000011236255,0.00032967996],"category_scores_gemma":[0.00039359572,0.00006354751,0.000051104267,0.00015188016,0.00006557977,0.00015436443,0.00015046922,0.00004579051,3.5052904e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01477459,0.0060958476,0.62800604,0.0061266227,0.0008307975,0.000043375192,0.015355576,0.0008723645,0.0042273304,0.0068319696,0.014160681,0.30267483],"study_design_scores_gemma":[0.0053183637,0.00052821194,0.9537121,0.0012059718,0.00007830453,0.000003801276,0.0043305806,0.0072288923,0.002439705,0.0019578428,0.02295095,0.00024527055],"about_ca_topic_score_codex":0.000055633445,"about_ca_topic_score_gemma":0.000021737897,"teacher_disagreement_score":0.3257061,"about_ca_system_score_codex":0.000024360881,"about_ca_system_score_gemma":0.00045451891,"threshold_uncertainty_score":0.36097643},"labels":[],"label_agreement":null},{"id":"W4291186573","doi":"10.1136/annrheumdis-2022-eular.4363","title":"OP0031 SEROLOGICAL COLLAGEN BIOMARKERS CAN DIFFERENTIATE PATIENTS WITH PSORIASIS FROM PSORIATIC ARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Serology; Dermatology; Arthritis; Immunology; Pathology; Antibody","score_opus":0.018792380497803518,"score_gpt":0.2218333245832943,"score_spread":0.20304094408549078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903885,0.0043686065,0.0000031291459,0.00046353805,0.00082685327,0.000497463,0.0033348163,0.000048685557,0.00006837639],"genre_scores_gemma":[0.9982631,0.0003307783,0.000018062978,0.00023963494,0.000011456292,0.00018440891,0.0007294301,0.000021960523,0.0002011547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804133,0.00072243955,0.00039043126,0.0003224195,0.0001685259,0.00035485215],"domain_scores_gemma":[0.99867064,0.00031205488,0.00035289617,0.0005356696,0.00007501353,0.000053734817],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010949974,0.00025859405,0.00048650824,0.0000761684,0.00049895124,0.00001842087,0.0005159627,0.00006802606,0.0022786022],"category_scores_gemma":[0.00011977009,0.00016404809,0.00026113042,0.0002603612,0.00018880732,0.00005386987,0.00028341654,0.000071030285,0.00003301806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004156515,0.0046560173,0.55322766,0.00010418246,0.01125179,0.000014061946,0.00210125,0.00011722811,0.00029735328,0.00026753158,0.02036705,0.40343937],"study_design_scores_gemma":[0.0042660176,0.0005165096,0.9902465,0.00012538263,0.0006677064,0.0000025652955,0.0005421329,0.000005509945,0.0014647975,0.0012667036,0.00061497814,0.00028120406],"about_ca_topic_score_codex":0.0003546689,"about_ca_topic_score_gemma":0.00005887106,"teacher_disagreement_score":0.43701884,"about_ca_system_score_codex":0.000025514299,"about_ca_system_score_gemma":0.000078938116,"threshold_uncertainty_score":0.99863344},"labels":[],"label_agreement":null},{"id":"W4291186577","doi":"10.1136/annrheumdis-2022-eular.58","title":"OP0052 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS WITH COMPLETE CONTROL OF INFLAMMATION","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Foundation for Research in Rheumatology; National Institute for Health and Care Research","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Placebo; Adalimumab; Internal medicine; Psoriatic arthritis; Visual analogue scale; Etanercept; Arthritis; Janus kinase inhibitor; Gastroenterology; Surgery; Pathology","score_opus":0.008851067658780276,"score_gpt":0.23447381603789103,"score_spread":0.22562274837911075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907091,0.005950762,0.000015014322,0.0011100497,0.000029354605,0.0015815333,0.0005507336,0.00001221014,0.000041204912],"genre_scores_gemma":[0.9955106,0.0041140085,0.000016730995,0.000077712924,0.000006732022,0.00019285636,0.00005360851,0.00002308408,0.0000046720324],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967629,0.0011139122,0.0006208092,0.00019278274,0.0010380249,0.00027160736],"domain_scores_gemma":[0.9975323,0.0012744109,0.000474639,0.00046902816,0.00015339119,0.00009621978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011017432,0.00020178579,0.0007371784,0.00015653338,0.0001683194,0.000017812772,0.0002133922,0.000022783312,0.000112991744],"category_scores_gemma":[0.00092196185,0.000109102686,0.000107158085,0.0002982799,0.00047818,0.000101769234,0.00007931865,0.0001760234,7.790233e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012254412,0.00062565244,0.48627117,0.0008136531,0.00070879946,0.000008935383,0.0011897531,0.0007551499,0.00006377932,0.00088145456,0.0005234009,0.49590385],"study_design_scores_gemma":[0.028425707,0.016858693,0.9382847,0.011634613,0.00003232733,0.00002021486,0.000822575,0.00081497215,0.0017534054,0.0008088082,0.00028070965,0.00026325358],"about_ca_topic_score_codex":0.00013491214,"about_ca_topic_score_gemma":0.000043101416,"teacher_disagreement_score":0.4956406,"about_ca_system_score_codex":0.00001346326,"about_ca_system_score_gemma":0.00010271699,"threshold_uncertainty_score":0.44490784},"labels":[],"label_agreement":null},{"id":"W4291186615","doi":"10.1136/annrheumdis-2022-eular.1106","title":"OP0039 RISK OF ARRHYTHMIA AMONG NEW USERS OF HYDROXYCHLOROQUINE: A LONGITUDINAL POPULATION-BASED COHORT STUDY ON NEWLY DIAGNOSED RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Research Canada; Simon Fraser University","funders":"","keywords":"Medicine; Hydroxychloroquine; Rheumatoid arthritis; Internal medicine; Hazard ratio; Atrial fibrillation; Proportional hazards model; Cohort; Population; Propensity score matching; Cohort study; Disease; Confidence interval","score_opus":0.0163203641594706,"score_gpt":0.26157163610729356,"score_spread":0.24525127194782295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953958,0.0011987094,0.000013811532,0.00011122023,0.00026516998,0.0026066778,0.00034442433,0.000037092537,0.00002713008],"genre_scores_gemma":[0.99936354,0.0002820264,0.000030198164,0.0000393447,0.000014385294,0.00013263567,0.000061907136,0.000048433183,0.000027525633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627995,0.0004938014,0.0011628947,0.00041184068,0.0013615051,0.00029000943],"domain_scores_gemma":[0.99647444,0.00059730496,0.001435085,0.0010200897,0.00020998411,0.00026307887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005626565,0.00031809378,0.0011459138,0.00025754547,0.00018286475,0.000015467758,0.00029578916,0.0000494104,0.00006180924],"category_scores_gemma":[0.0018431694,0.0002541678,0.0003818497,0.00046419955,0.00014963729,0.00011089935,0.00018915739,0.0001992886,0.0000017458007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041444774,0.001698258,0.98780113,0.00050496537,0.0006645513,0.000014770508,0.00058317196,0.0034552908,0.000010306351,0.000019108393,0.0003396133,0.0044943527],"study_design_scores_gemma":[0.0052507673,0.0008641938,0.9879254,0.0031699082,0.00035090267,0.000026454629,0.0008811865,0.0009078606,0.00027215772,0.00015295953,0.0000017193946,0.00019650398],"about_ca_topic_score_codex":0.0030882098,"about_ca_topic_score_gemma":0.00008467829,"teacher_disagreement_score":0.00483632,"about_ca_system_score_codex":0.00006754644,"about_ca_system_score_gemma":0.000218488,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W4291186621","doi":"10.1136/annrheumdis-2022-eular.2973","title":"OP0251 IMPACT OF INTERSTITIAL LUNG DISEASE ON SEVERE COVID-19 OUTCOMES FOR PATIENTS WITH RHEUMATOID ARTHRITIS: A MULTICENTER STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Manchester Biomedical Research Centre; Versus Arthritis; Leeds Biomedical Research Centre; Université de Bordeaux; University of Manchester; Sorbonne Université; Faculdade de Medicina da Universidade de São Paulo; Karolinska Institutet; Institut National de la Santé et de la Recherche Médicale; Department of Health and Social Care; Universidad de Guadalajara; AstraZeneca; Universidade de São Paulo; Université de Lille; Wellcome Trust; European League Against Rheumatism; McMaster University; Temple University; Centre Hospitalier Universitaire de Bordeaux; University of Otago; School of Medicine, Boston University; National Institute for Health and Care Research; Massachusetts General Hospital; Brigham and Women's Hospital; Pfizer","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Interstitial lung disease; Population; Retrospective cohort study; Proportional hazards model; Outpatient clinic; Hazard ratio; Lung; Confidence interval","score_opus":0.022253614666363025,"score_gpt":0.3280100731849545,"score_spread":0.30575645851859146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989174,0.00056735944,0.00004550707,0.0008104649,0.00022731103,0.0032037122,0.0058995085,0.000037803966,0.000034350804],"genre_scores_gemma":[0.9983304,0.00007041239,0.000016740529,0.00080139894,0.000016827407,0.0004430638,0.00019955685,0.000044737513,0.0000768544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976092,0.00022235862,0.0006380774,0.00035074275,0.00084204675,0.00033759387],"domain_scores_gemma":[0.9976707,0.00035189427,0.0004746734,0.0007063544,0.0002458794,0.0005504718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018097149,0.0003157008,0.00072086544,0.00016105089,0.0002926648,0.000021319083,0.00036615328,0.00001954377,0.00047115787],"category_scores_gemma":[0.000980282,0.0001958868,0.0009567071,0.00018898991,0.000169407,0.00012416649,0.00025131935,0.0001240973,0.0000018531704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05957939,0.014381259,0.91026783,0.0013171134,0.0016964312,0.000032043346,0.00077251135,0.0017695808,0.0000012511395,0.00015266957,0.008653525,0.0013763882],"study_design_scores_gemma":[0.011766968,0.01494251,0.96598303,0.002199645,0.00067257456,0.0000059707686,0.0017310191,0.0019293055,0.0000031678662,0.00030356317,0.0000965472,0.00036571274],"about_ca_topic_score_codex":0.00026870743,"about_ca_topic_score_gemma":0.0000051571806,"teacher_disagreement_score":0.05571518,"about_ca_system_score_codex":0.00015394796,"about_ca_system_score_gemma":0.0005900345,"threshold_uncertainty_score":0.7988032},"labels":[],"label_agreement":null},{"id":"W4291186665","doi":"10.1136/annrheumdis-2022-eular.2107","title":"OP0029 PROSPECTIVE, DOUBLE-BLIND STUDY ON THE VALUE OF HANDHELD MUSCULOSKELETAL ULTRASOUND PERFORMED BY DERMATOLOGISTS FOR DETECTION OF PSORIATIC ARTHRITIS - THE PsoSone STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; Ministerio de Ciencia e Innovación; Krembil Foundation; Arthritis Society","keywords":"Medicine; Psoriatic arthritis; Rheumatology; Outpatient clinic; Dermatology; Physical examination; Psoriasis; Physical therapy; Internal medicine","score_opus":0.04313486789502702,"score_gpt":0.3326303575282736,"score_spread":0.28949548963324656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887763,0.003063062,0.00000768135,0.00081046845,0.00019235903,0.006805154,0.00027016367,0.000015160762,0.000059633938],"genre_scores_gemma":[0.99750614,0.0002941662,0.0000038858716,0.00006392687,0.000016209897,0.0020226699,0.000012705073,0.00002220629,0.00005811636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978755,0.00029422043,0.00060952373,0.00024659274,0.0007379997,0.0002361301],"domain_scores_gemma":[0.99763554,0.0009732074,0.00051754556,0.0006459801,0.0001776994,0.000050028237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805844,0.00021701764,0.00061167224,0.000060755352,0.0006514738,0.000014864701,0.00029946183,0.000021913167,0.00006053042],"category_scores_gemma":[0.00061157224,0.0001093533,0.0003695153,0.00031484925,0.00024536284,0.000050539995,0.00014684799,0.00013082931,0.0000012044032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035404734,0.076218106,0.79662603,0.0017368147,0.016301075,0.000018788649,0.023152256,0.00032931013,0.0007316835,0.0014559578,0.00589308,0.042132173],"study_design_scores_gemma":[0.04268306,0.016750647,0.8686217,0.0006132751,0.0021355106,0.00003837495,0.059011236,0.000106605614,0.008120852,0.0015900893,0.00005915316,0.000269479],"about_ca_topic_score_codex":0.0003538135,"about_ca_topic_score_gemma":0.0000861548,"teacher_disagreement_score":0.071995705,"about_ca_system_score_codex":0.000034428023,"about_ca_system_score_gemma":0.000067641944,"threshold_uncertainty_score":0.5010676},"labels":[],"label_agreement":null},{"id":"W4291186669","doi":"10.1136/annrheumdis-2022-eular.3909","title":"OP0142 COMPARISON OF ATTAINMENT AND PROTECTIVE EFFECTS OF THE LUPUS LOW DISEASE ACTIVITY STATE IN PATIENTS WITH NEWLY DIAGNOSED VERSUS ESTABLISHED SLE - A MULTICENTRE PROSPECTIVE STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Peking University Health Science Center; Sanofi Genzyme; Universitas Padjadjaran; Tokyo Women's Medical University; Peking University; Amgen; Universiti Malaya; Keio University; Hanyang University; University of New South Wales; Taichung Veterans General Hospital; Peking University First Hospital; Sanofi; Eli Lilly and Company; AstraZeneca; Ingham Institute for Applied Medical Research; Chang Gung Medical Foundation","keywords":"Medicine; Systemic lupus erythematosus; Disease; Prospective cohort study; Lupus erythematosus; Internal medicine; Pediatrics; Immunology; Antibody","score_opus":0.01797097932329528,"score_gpt":0.3040924537753773,"score_spread":0.286121474452082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887191,0.0004460109,0.0000060522166,0.00012040515,0.00016529053,0.01037269,0.00015075198,0.000010621549,0.000009087394],"genre_scores_gemma":[0.9992122,0.000010667301,0.000007334824,0.000008530659,0.0000030106787,0.0006948261,0.0000039572,0.000024771494,0.000034711935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673015,0.0008887008,0.0004397725,0.0003045248,0.0013658806,0.00027098757],"domain_scores_gemma":[0.99725825,0.0010070136,0.00060152647,0.000723214,0.00025135203,0.00015864127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030578364,0.00020564543,0.0007031506,0.00011509154,0.00013069082,0.000012717101,0.00031636006,0.000016447892,0.0000143968655],"category_scores_gemma":[0.001854339,0.00011590023,0.0001288173,0.000527154,0.00024846004,0.000107379296,0.0005229066,0.00019681132,2.751943e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017323403,0.011288987,0.9528688,0.0035250536,0.0005630394,0.0000069315124,0.011941682,0.0006728866,0.000019284547,0.000003744557,0.000103781116,0.0016823775],"study_design_scores_gemma":[0.018787,0.0023137957,0.96785736,0.0022347262,0.00027448367,0.0000013364967,0.0065219626,0.000981264,0.0008368623,0.000082845014,5.336951e-7,0.0001078192],"about_ca_topic_score_codex":0.0005373067,"about_ca_topic_score_gemma":0.000078346486,"teacher_disagreement_score":0.01498854,"about_ca_system_score_codex":0.00015768336,"about_ca_system_score_gemma":0.00026588692,"threshold_uncertainty_score":0.4726274},"labels":[],"label_agreement":null},{"id":"W4291186684","doi":"10.1136/annrheumdis-2022-eular.1038","title":"OP0130 SERIOUS INFECTIONS IN OFFSPRING EXPOSED TO TUMOUR NECROSIS FACTOR INHIBITORS DURING PREGNANCY: COMPARISON OF AGENTS WITH LOW AND HIGH PLACENTAL TRANSFER","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"UCB Pharma; Dutch Arthritis Association; Eli Lilly and Company","keywords":"Medicine; Infliximab; Adalimumab; Psoriatic arthritis; Golimumab; Offspring; Pregnancy; Etanercept; Population; Immunology; Internal medicine; Psoriasis; Obstetrics; Rheumatoid arthritis; Tumor necrosis factor alpha","score_opus":0.029790737493679963,"score_gpt":0.2987972873956034,"score_spread":0.26900654990192346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974855,0.00079086516,0.000018978382,0.00072421244,0.00007817616,0.00074210117,0.00011281534,0.000020972775,0.000026348587],"genre_scores_gemma":[0.99962986,0.00011481746,0.000015420766,0.00006608894,0.000005094991,0.00009954913,0.000008552079,0.000015613861,0.000044985376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998839,0.00007835058,0.00038708586,0.00015262,0.00036016313,0.0001827462],"domain_scores_gemma":[0.9993806,0.00006640737,0.00011614588,0.00023106497,0.00003508571,0.00017067866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050804876,0.00012450133,0.0003621487,0.00014663643,0.00011478035,0.0000073031306,0.000111042566,0.000018936546,0.000114188035],"category_scores_gemma":[0.00013913619,0.00009134723,0.000082690356,0.0003014086,0.00007038918,0.000089373076,0.00008156231,0.000111035486,6.387126e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010774668,0.0037666678,0.94961953,0.0035651415,0.00036180284,0.000012099719,0.014913929,0.0022173754,0.01203845,0.000041805255,0.00030307283,0.012082658],"study_design_scores_gemma":[0.0020419892,0.00042907498,0.9274505,0.007837223,0.00008278709,0.000013911205,0.0010304034,0.00019723938,0.060781002,0.000020282881,0.0000070626147,0.000108561595],"about_ca_topic_score_codex":0.00013222278,"about_ca_topic_score_gemma":0.00002679941,"teacher_disagreement_score":0.04874255,"about_ca_system_score_codex":0.00003419033,"about_ca_system_score_gemma":0.0001092578,"threshold_uncertainty_score":0.37250322},"labels":[],"label_agreement":null},{"id":"W4291186699","doi":"10.1136/annrheumdis-2022-eular.2969","title":"OP0166 CHRONIC KIDNEY DISEASE AND AMPLIFICATION OF SERUM URATE IMPACT ON GOUT RISK: POPULATION-BASED STUDY OF > 450,000 UK BIOBANK PARTICIPANTS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"Medical Research Council","keywords":"Medicine; Gout; Internal medicine; Kidney disease; Renal function; Proportional hazards model; Population; Prospective cohort study; Hazard ratio; Cohort; Confidence interval; Environmental health","score_opus":0.04490246085198505,"score_gpt":0.3367498664777729,"score_spread":0.2918474056257878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291186699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945062,0.0010788746,0.000007814735,0.0007541807,0.00008779707,0.0012832296,0.002238015,0.000027623775,0.00001629864],"genre_scores_gemma":[0.9994149,0.000083962026,0.0000108194,0.0001801084,0.000018548802,0.00011333976,0.000101780926,0.000031493342,0.00004501971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728364,0.00044266376,0.0007937342,0.0003155297,0.00084754755,0.00031687974],"domain_scores_gemma":[0.99702406,0.00032185818,0.0009773228,0.0010941346,0.00014253856,0.00044010507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045548557,0.00024660255,0.0006173903,0.0001837349,0.00018800929,0.000012334866,0.00029136852,0.000029066108,0.0005522173],"category_scores_gemma":[0.0015579904,0.00016880775,0.0002559852,0.0004613114,0.000106484236,0.00007266907,0.00013804615,0.00013229248,0.0000032947635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010453623,0.003012983,0.9809168,0.00072449096,0.0006575459,0.0000029556147,0.0006013068,0.009530661,0.00016429952,0.000030995478,0.00095623126,0.0023563786],"study_design_scores_gemma":[0.002005305,0.0012328613,0.9869075,0.0005282595,0.0013358995,8.828791e-7,0.0004682966,0.0066405325,0.0003846539,0.00034309935,0.0000070511987,0.00014565644],"about_ca_topic_score_codex":0.0007748087,"about_ca_topic_score_gemma":0.00000822587,"teacher_disagreement_score":0.005990712,"about_ca_system_score_codex":0.00009207984,"about_ca_system_score_gemma":0.00050951715,"threshold_uncertainty_score":0.688378},"labels":[],"label_agreement":null},{"id":"W4291187460","doi":"10.1136/annrheumdis-2022-eular.2265","title":"OP0255 BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND AN INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: 16-WEEK EFFICACY & SAFETY FROM BE COMPLETE, A PHASE 3, MULTICENTRE, RANDOMISED PLACEBO-CONTROLLED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation; Arthritis Society; University of Toronto","funders":"UCB Pharma","keywords":"Medicine; Psoriatic arthritis; Placebo; Internal medicine; Arthritis; Physical therapy; Randomized controlled trial; Necrosis; Surgery; Psoriasis; Alternative medicine; Dermatology; Pathology","score_opus":0.03223480344019919,"score_gpt":0.3141635530135369,"score_spread":0.2819287495733377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291187460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872425,0.0010922326,0.000012529361,0.0014658108,0.00009023607,0.008232096,0.0018161873,0.000041520816,0.0000068630325],"genre_scores_gemma":[0.99824035,0.00038714072,0.000065806504,0.00029799444,0.00001859672,0.0007409592,0.00016962718,0.000050526745,0.000028969542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99425834,0.0025117535,0.0009599063,0.00051305286,0.001228808,0.00052813406],"domain_scores_gemma":[0.9956339,0.0024978563,0.00042279944,0.00066478906,0.00023301141,0.0005476219],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006453027,0.0003822142,0.0013718519,0.00036277744,0.00041622706,0.0001093289,0.0003369703,0.00003132186,0.00042860373],"category_scores_gemma":[0.0035932,0.00026702,0.00021301938,0.0004893242,0.00017595585,0.00031852938,0.0002726633,0.00027590455,0.0000056981844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83592224,0.01774572,0.006142274,0.000051615814,0.0009989727,0.000024490824,0.012568552,0.00013080932,0.00013584802,0.0000033885342,0.00036410012,0.125912],"study_design_scores_gemma":[0.51599246,0.0067234808,0.46956092,0.001267715,0.000096519245,0.0000025853014,0.0054127993,0.00025564738,0.00011882661,0.00013702353,0.000094671304,0.0003373096],"about_ca_topic_score_codex":0.0010619223,"about_ca_topic_score_gemma":0.00039274312,"teacher_disagreement_score":0.46341866,"about_ca_system_score_codex":0.00010976291,"about_ca_system_score_gemma":0.00028292194,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W4292184487","doi":"10.1136/ard-2022-222537","title":"Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Actua; University of Toronto; University Health Network; University of Waterloo; Arthritis Society","funders":"Krembil Foundation; University of Toronto","keywords":"Psoriasis; Medicine; Psoriatic arthritis; Ankylosing spondylitis; Axial spondyloarthritis; Internal medicine; Spondylitis; Peripheral; Disease; Dermatology; Sacroiliitis","score_opus":0.019205505550991608,"score_gpt":0.26544689012448847,"score_spread":0.24624138457349687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292184487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97806257,0.01819886,0.000003304244,0.0022526798,0.00012730238,0.00056566554,0.0006702267,0.00002447785,0.0000949316],"genre_scores_gemma":[0.99683696,0.0024907012,0.000036746667,0.00031510481,0.000019550584,0.00013384297,0.000055324614,0.00002233446,0.00008945772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986197,0.000128693,0.0003307268,0.0002390652,0.00041293912,0.00026888397],"domain_scores_gemma":[0.9991626,0.000117365926,0.0001489104,0.00033894076,0.000053803098,0.00017836738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107885906,0.00017244041,0.00042853702,0.000107429856,0.00025622008,0.00001827225,0.000096886644,0.000014771242,0.0003744013],"category_scores_gemma":[0.00020164694,0.00012231298,0.00012515196,0.00036384494,0.00014552566,0.00008160602,0.0001689612,0.000096241194,0.0000017502184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009555149,0.003427086,0.522247,0.00094077113,0.0012386818,0.0008328273,0.002306946,0.00022509437,0.000008484864,0.001380028,0.0019896445,0.45584825],"study_design_scores_gemma":[0.007128338,0.0010591814,0.9836465,0.00238657,0.0003960255,0.00008833088,0.0009564789,0.0006334516,0.000022156679,0.0026995093,0.0007464379,0.00023700185],"about_ca_topic_score_codex":0.00028659755,"about_ca_topic_score_gemma":0.000042716365,"teacher_disagreement_score":0.4613995,"about_ca_system_score_codex":0.000029640974,"about_ca_system_score_gemma":0.00010800139,"threshold_uncertainty_score":0.49877787},"labels":[],"label_agreement":null},{"id":"W4292403578","doi":"10.1136/ard-2022-222784","title":"Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Swedish Orphan Biovitrum; National Institute for Health and Care Research; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Interleukin; Interleukin-1 receptor; Interleukin 1β; Statement (logic); Blocking (statistics); Immunology; Pharmacology; Internal medicine; Cytokine","score_opus":0.034522120989861946,"score_gpt":0.32340226370923686,"score_spread":0.2888801427193749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292403578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941159,0.0013952996,1.9595461e-7,0.0032992938,0.00017437704,0.0005027418,0.00033515992,0.000022226404,0.00015483021],"genre_scores_gemma":[0.9981471,0.00043394786,0.000022439961,0.0010668276,0.000009100691,0.00015429207,0.00006234889,0.000016231583,0.00008773581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873114,0.00016064935,0.00042656693,0.0001997536,0.0002872875,0.00019459227],"domain_scores_gemma":[0.99920875,0.00012724937,0.00019713136,0.00031869957,0.00004998615,0.000098211254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001583107,0.00014538203,0.0003015171,0.0001244271,0.0001839612,0.00001642748,0.00010928848,0.000014050082,0.0004114136],"category_scores_gemma":[0.0001391241,0.000108944696,0.00009206511,0.00011993508,0.00014628659,0.00004205945,0.00019903161,0.00010485068,0.0000074806776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008050811,0.013063275,0.6893047,0.0019720031,0.004025242,0.00065175205,0.013880881,0.0010213263,0.0006827523,0.013523321,0.09523033,0.15859358],"study_design_scores_gemma":[0.017948538,0.005912848,0.90287936,0.007556276,0.00055922294,0.00016904922,0.028471103,0.0008221424,0.0029874304,0.010470057,0.02133645,0.0008875191],"about_ca_topic_score_codex":0.00007087328,"about_ca_topic_score_gemma":0.000031246873,"teacher_disagreement_score":0.21357465,"about_ca_system_score_codex":0.00006332537,"about_ca_system_score_gemma":0.00006700532,"threshold_uncertainty_score":0.45046905},"labels":[],"label_agreement":null},{"id":"W4293240725","doi":"10.1136/ard-2022-222487","title":"Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University; Sinai Health System; Dalhousie University; University Health Network; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Toronto Western Hospital","funders":"National Center for Chronic Disease Prevention and Health Promotion; Centers for Disease Control and Prevention; National Institutes of Health; National Center for Research Resources; LUPUS UK; Versus Arthritis; Novo Nordisk Fonden; National Center for Advancing Translational Sciences; National Research Foundation of Korea; Eli Lilly and Company; Eusko Jaurlaritza; Amgen; National Research Foundation; Wellcome Trust; University College London; Novo Nordisk; National Institute for Health and Care Research; Arthritis Society; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; Lupus Research Alliance; Sandwell and West Birmingham Hospitals NHS Trust; Universidad Científica del Sur; University of Calgary; Gigtforeningen; Arthritis Research UK; GlaxoSmithKline; Johns Hopkins University; Pfizer; Bristol-Myers Squibb; AstraZeneca; Université Laval","keywords":"Medicine; Systemic lupus; Systemic lupus erythematosus; Cohort; Disease; Systemic disease; Accrual; Internal medicine; Immunology","score_opus":0.022746004737662855,"score_gpt":0.3034482329627575,"score_spread":0.28070222822509466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293240725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920401,0.0012679821,0.000011542781,0.0013854406,0.00066051935,0.003078225,0.001464121,0.00004461721,0.000047434092],"genre_scores_gemma":[0.9984611,0.00036376173,0.000017327211,0.00012289664,0.000060242117,0.00031679342,0.00026932452,0.000046885907,0.0003416319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99481165,0.0011503249,0.0010802182,0.0005692569,0.0020290154,0.0003595213],"domain_scores_gemma":[0.9957153,0.0013445845,0.001063332,0.0011713535,0.000427168,0.00027821862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015090964,0.00030723147,0.0006868461,0.00014842273,0.00033454795,0.000078012454,0.0006632317,0.00006474451,0.000045601308],"category_scores_gemma":[0.0027002157,0.000182102,0.00016059654,0.00055938645,0.00019600095,0.00024283293,0.0007450175,0.00036131078,0.0000040193736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006328185,0.0009550234,0.98428875,0.0014763842,0.00033745854,0.000016094224,0.0026728176,0.0005470378,0.000050213264,0.000018434645,0.0020057228,0.0013038848],"study_design_scores_gemma":[0.012180121,0.0004731057,0.93418413,0.028045917,0.00044031447,0.00064258184,0.010419718,0.012847081,0.00005331301,0.00019991575,0.000068608104,0.0004452104],"about_ca_topic_score_codex":0.00013818698,"about_ca_topic_score_gemma":0.000012951473,"teacher_disagreement_score":0.05010463,"about_ca_system_score_codex":0.00029846226,"about_ca_system_score_gemma":0.0006135272,"threshold_uncertainty_score":0.74259037},"labels":[],"label_agreement":null},{"id":"W4295125684","doi":"10.1136/ard.2011.149765","title":"American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials","year":2011,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":771,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rheumatism; Rheumatology; Rheumatoid arthritis; Internal medicine; Physical therapy; Clinical trial; Family medicine","score_opus":0.18783752680453605,"score_gpt":0.40200599913196455,"score_spread":0.2141684723274285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295125684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842259,0.010946812,0.0001412836,0.0007002743,0.00022601911,0.0017593058,0.0010449457,0.000033195207,0.0009222065],"genre_scores_gemma":[0.8554889,0.14221056,0.0020189153,0.00007845246,0.000008379572,0.00007502343,0.000060386385,0.000044163695,0.0000152479715],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9927217,0.0021352845,0.0036256514,0.00038470142,0.00068391487,0.00044877795],"domain_scores_gemma":[0.9931747,0.0029810742,0.002233351,0.0007761786,0.00052996614,0.00030478477],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005274574,0.0002995932,0.002315725,0.00034633663,0.00009638846,0.0000073605165,0.0004783463,0.00009725383,0.00012857447],"category_scores_gemma":[0.016731694,0.00021011666,0.0010230134,0.00044928878,0.0013058395,0.00017118841,0.0001678629,0.00022102393,0.000007658313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008505239,0.0065280404,0.28657317,0.0027992034,0.0013172326,0.000022260772,0.0018701259,0.0000067354604,0.0007368389,0.02251455,0.017400265,0.6517263],"study_design_scores_gemma":[0.021982437,0.0046745595,0.8402385,0.065493494,0.00007675585,0.0001577472,0.0040734336,0.00076310954,0.008704607,0.05208175,0.0009418088,0.0008118034],"about_ca_topic_score_codex":0.00022848765,"about_ca_topic_score_gemma":0.000037654965,"teacher_disagreement_score":0.65091455,"about_ca_system_score_codex":0.000014452525,"about_ca_system_score_gemma":0.00047229519,"threshold_uncertainty_score":0.9915508},"labels":[],"label_agreement":null},{"id":"W4295753422","doi":"10.1136/ard-2022-222731","title":"Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Placebo; Internal medicine; Physical therapy; Disease; Secukinumab; Alternative medicine","score_opus":0.010130615562038337,"score_gpt":0.23940024207408034,"score_spread":0.229269626512042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295753422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98726094,0.0054150424,2.3559744e-7,0.00041529382,0.000063838,0.005686494,0.0010596759,0.000018434084,0.00008006089],"genre_scores_gemma":[0.99781287,0.00032541962,0.000046862886,0.00011190406,0.000013576684,0.0013686923,0.00013204198,0.000040520186,0.00014808973],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971933,0.00041287107,0.0007240563,0.00046598658,0.00088450377,0.0003193184],"domain_scores_gemma":[0.9981692,0.00038767356,0.0005497689,0.0005856596,0.0001720838,0.00013561148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021589003,0.00039226425,0.00134046,0.0001271935,0.00022634419,0.000019443878,0.00014523884,0.00003546599,0.00016270475],"category_scores_gemma":[0.00014726643,0.00021117007,0.00019169853,0.00029824313,0.00025459615,0.00009076706,0.00016836126,0.00013184034,0.0000010115348],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53574795,0.0054742307,0.4496041,0.000034149136,0.0019162846,0.00009615344,0.0031178142,0.0000316577,0.000001402045,0.0000013054474,0.00012587818,0.0038491122],"study_design_scores_gemma":[0.34899172,0.010878016,0.63694483,0.0006663637,0.0004425113,0.0000064194332,0.0017948808,0.000012285838,0.000044743196,0.00004449192,0.000014886017,0.0001588447],"about_ca_topic_score_codex":0.0006661371,"about_ca_topic_score_gemma":0.00052206713,"teacher_disagreement_score":0.18734075,"about_ca_system_score_codex":0.000069141155,"about_ca_system_score_gemma":0.00013329696,"threshold_uncertainty_score":0.86112654},"labels":[],"label_agreement":null},{"id":"W4295753992","doi":"10.1136/ard-2022-222835","title":"After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Galápagos; AbbVie; Pfizer","keywords":"Medicine; Rheumatoid arthritis; Proportional hazards model; Cohort; Tofacitinib; Internal medicine; Confounding; Adverse effect; Demography","score_opus":0.05486921666849659,"score_gpt":0.3490218243617757,"score_spread":0.2941526076932791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295753992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83850735,0.007168892,0.000046328383,0.14970188,0.00018927926,0.001224129,0.0030986588,0.0000227374,0.00004075214],"genre_scores_gemma":[0.9935718,0.0018170158,0.00008620465,0.003700663,0.000065081134,0.00025562127,0.00013012097,0.000021437156,0.0003520332],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766445,0.0003905325,0.00039449343,0.00026077888,0.00105602,0.00023373481],"domain_scores_gemma":[0.9971863,0.0006024767,0.00021011155,0.0016221377,0.00022860394,0.00015035093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059988466,0.00015340169,0.00031555782,0.00005737952,0.00044825082,0.000080505866,0.00094590086,0.00002298748,0.0007987561],"category_scores_gemma":[0.002048808,0.00007383494,0.000106131156,0.00057567464,0.0001975512,0.00021019159,0.0013233928,0.00012198429,0.000020068053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048071113,0.0006294576,0.012341847,0.00020603594,0.00064767833,0.000009592073,0.013450674,0.00013798635,0.0005809241,0.00059100473,0.93582064,0.030777037],"study_design_scores_gemma":[0.0052968287,0.0032628663,0.34162125,0.009277748,0.00042498656,0.00005044357,0.06483458,0.0015641492,0.030160246,0.02224411,0.5202248,0.0010379563],"about_ca_topic_score_codex":0.0008029163,"about_ca_topic_score_gemma":0.0005383435,"teacher_disagreement_score":0.41559583,"about_ca_system_score_codex":0.000022056198,"about_ca_system_score_gemma":0.0003358312,"threshold_uncertainty_score":0.8745819},"labels":[],"label_agreement":null},{"id":"W4295925410","doi":"10.1136/ard-2022-222678","title":"2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Public Health Ontario; University of Toronto","funders":"Manchester Biomedical Research Centre; Versus Arthritis; European League Against Rheumatism; National Institute for Health and Care Research","keywords":"Medicine; Work (physics); Musculoskeletal disease; Physical therapy; Internal medicine; Disease","score_opus":0.023912879110946014,"score_gpt":0.32491209485065947,"score_spread":0.30099921573971344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295925410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688282,0.0040353253,0.00001909367,0.024978023,0.00004273069,0.0019313514,0.00010248789,0.000022691707,0.00004007786],"genre_scores_gemma":[0.9951413,0.0012890099,0.00013980412,0.0023930527,0.000010171439,0.0007154476,0.000016269523,0.000037112335,0.00025778153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972008,0.00036249682,0.0004962694,0.00039584204,0.00072846824,0.00081611995],"domain_scores_gemma":[0.99775267,0.0003573711,0.00010248471,0.0005431817,0.00016211112,0.0010821628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006102535,0.00024151921,0.0006732706,0.0002975549,0.00033406515,0.00007256594,0.00019681995,0.000019091449,0.0006747923],"category_scores_gemma":[0.001416373,0.00017479974,0.000100370686,0.00089728925,0.00013732738,0.0001422681,0.000609912,0.00013526197,0.000017997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014356144,0.003069761,0.8260789,0.004612302,0.00083774223,0.00034870196,0.018519435,0.0011728087,0.00003102416,0.0023223737,0.050566703,0.07808412],"study_design_scores_gemma":[0.0032392691,0.0053057782,0.9706585,0.0019446091,0.000065639026,0.00005867152,0.013483571,0.00008900418,0.000040423998,0.002003292,0.002676668,0.00043459248],"about_ca_topic_score_codex":0.00045991753,"about_ca_topic_score_gemma":0.00014846776,"teacher_disagreement_score":0.1445796,"about_ca_system_score_codex":0.000042024356,"about_ca_system_score_gemma":0.0003527841,"threshold_uncertainty_score":0.7388502},"labels":[],"label_agreement":null},{"id":"W4296696831","doi":"10.1136/ard-2022-222259","title":"Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Manchester Biomedical Research Centre; St. Jude Medical; Genentech; Idorsia Pharmaceuticals; Assistance publique-Hôpitaux de Paris; Regado Biosciences; Medicines Company; Acceleron; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; National Institutes of Health; Regeneron Pharmaceuticals; University of North Carolina at Chapel Hill; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Duke Clinical Research Institute; Eisai; Cytokinetics; Bristol-Myers Squibb; Cleveland Clinic; Belvoir Media Group; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Gilead Sciences; HLS Therapeutics; Gedeon Richter; GlaxoSmithKline; National Institute for Health and Care Research; CSL Behring; Eli Lilly and Company; Amgen; Moderna; Pfizer; Sanofi; American Heart Association","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Disease; Post-hoc analysis; Internal medicine; Adverse effect; Risk factor; Tumor necrosis factor alpha; Arthritis","score_opus":0.01861963224089894,"score_gpt":0.23284945253073033,"score_spread":0.2142298202898314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296696831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96855974,0.025546625,0.000024446352,0.000042008727,0.00009335853,0.0014844759,0.0042094276,0.000030531683,0.000009401001],"genre_scores_gemma":[0.99328613,0.006039343,0.00009509745,0.000016160056,0.00000676083,0.00022554204,0.00023677901,0.000073769064,0.000020392668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943628,0.000938403,0.00082877383,0.00058931345,0.0027742183,0.00050653203],"domain_scores_gemma":[0.9964841,0.00030693316,0.0007103735,0.0015360886,0.0005896179,0.00037288928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048235993,0.00044600814,0.002138283,0.0004247341,0.00013868787,0.00001112322,0.0004436544,0.000042460422,0.0003694177],"category_scores_gemma":[0.0005245064,0.000276338,0.0014259366,0.0011539926,0.0005824379,0.00022332117,0.000165515,0.00025650102,0.000001395827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030526992,0.0013146348,0.92872036,0.00028097574,0.026598983,0.000024288773,0.0012452211,0.006062229,0.0000058665096,0.000001986972,0.00004471115,0.0051737446],"study_design_scores_gemma":[0.019082818,0.0025310067,0.973373,0.002091948,0.0009902082,0.0000028104203,0.0011575603,0.00020209533,0.000050528026,0.000014209283,0.00014021047,0.0003636097],"about_ca_topic_score_codex":0.005646498,"about_ca_topic_score_gemma":0.0006794411,"teacher_disagreement_score":0.04465263,"about_ca_system_score_codex":0.00016623033,"about_ca_system_score_gemma":0.0008921785,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W4296711048","doi":"10.1136/ard-2022-222779","title":"Understanding sex-related differences in healthcare utilisation among patients with inflammatory arthritis: a population-based study","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Rheumatology; Internal medicine; Rheumatoid arthritis; Health care; Inflammatory arthritis; Arthritis; Population; Physical therapy; Disease","score_opus":0.05972850339130153,"score_gpt":0.27802758421525214,"score_spread":0.2182990808239506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296711048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973361,0.00061374914,0.0000016410418,0.0005639787,0.0000742479,0.0012854767,0.00008263978,0.000025487701,0.000016715621],"genre_scores_gemma":[0.9995825,0.000025710542,0.000003035372,0.000092994196,0.0000026267244,0.00018465024,0.00007819654,0.00001392139,0.000016340507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984844,0.00021578898,0.00038745283,0.000177768,0.000559989,0.00017462244],"domain_scores_gemma":[0.99927825,0.00011260152,0.00024571276,0.00024193276,0.00005391967,0.00006756094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011650195,0.00013193715,0.0003396825,0.00012243762,0.000297551,0.000011069987,0.00008207555,0.00001622686,0.00007106122],"category_scores_gemma":[0.0000886338,0.000090908376,0.000077354285,0.00029573732,0.000053672986,0.00006787882,0.000059584076,0.000090955335,5.2185254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021826028,0.0013770353,0.99564654,0.00008548597,0.00016520139,0.000008475161,0.00091849646,0.00018138665,2.7007513e-8,0.00010133869,0.0000227641,0.0012749773],"study_design_scores_gemma":[0.004136231,0.0007367954,0.9880953,0.0007082624,0.000063509906,4.2626007e-7,0.0050962805,0.00022290941,7.8321045e-7,0.00085618265,4.122347e-7,0.000082908744],"about_ca_topic_score_codex":0.00074509886,"about_ca_topic_score_gemma":0.0004811601,"teacher_disagreement_score":0.0075512533,"about_ca_system_score_codex":0.00011202537,"about_ca_system_score_gemma":0.00008002134,"threshold_uncertainty_score":0.3707136},"labels":[],"label_agreement":null},{"id":"W4297409492","doi":"10.1136/ard.2009.123885","title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009","year":2009,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Statement (logic); MEDLINE; Intensive care medicine; Bioinformatics; Family medicine","score_opus":0.09417159363662303,"score_gpt":0.37308396738406735,"score_spread":0.2789123737474443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297409492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619319,0.023327183,0.00002568203,0.011159455,0.0001338498,0.0022868556,0.000976108,0.0000407527,0.00011821487],"genre_scores_gemma":[0.94731027,0.05164669,0.000053654956,0.0005231306,0.00002054146,0.000116459094,0.00010298744,0.000014707864,0.00021155633],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979595,0.00018793948,0.0006980265,0.00022715637,0.0005227333,0.00040462366],"domain_scores_gemma":[0.9977008,0.0007985514,0.00033401768,0.0007145581,0.00021255626,0.00023950492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019695172,0.0002513467,0.00062741665,0.00008326705,0.00018572624,0.000024981013,0.0002798118,0.00004072751,0.00026938994],"category_scores_gemma":[0.00061231956,0.00011542917,0.00051487837,0.00017943424,0.0003591159,0.000032952346,0.000025450823,0.000050219474,0.000014950538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008017255,0.017337246,0.010160437,0.00051796896,0.003816123,0.00002063685,0.0012095004,0.00045190236,0.00019863431,0.00686396,0.17923066,0.77217567],"study_design_scores_gemma":[0.01791071,0.023366181,0.86847806,0.0052529806,0.00040680668,0.000026756326,0.0018256054,0.004634536,0.0056175427,0.027766468,0.044024866,0.0006895095],"about_ca_topic_score_codex":0.00005078552,"about_ca_topic_score_gemma":0.0000031034597,"teacher_disagreement_score":0.8583176,"about_ca_system_score_codex":0.000032293905,"about_ca_system_score_gemma":0.0001559077,"threshold_uncertainty_score":0.4707065},"labels":[],"label_agreement":null},{"id":"W4297928045","doi":"10.1136/annrheumdis-2022-eular.2583","title":"OP0286 DEVELOPMENT AND PRELIMINARY VALIDATION OF THE SJÖGREN'S TOOL FOR ASSESSING RESPONSE (STAR): A CONSENSUAL COMPOSITE SCORE FOR ASSESSING TREATMENT EFFECT IN PRIMARY SJÖGREN'S SYNDROME","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"Assistance publique-Hôpitaux de Paris; Novartis Pharma; Università degli Studi di Udine; Université de Bretagne Occidentale; Servier; Karolinska Institutet; Institut National de la Santé et de la Recherche Médicale; National Institute for Health and Care Research; Birmingham Biomedical Research Centre; Universitair Medisch Centrum Groningen; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Gilead Sciences; Union Chimique Belge; European Commission; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Sjögren's Foundation","keywords":"Medicine; Sjögren syndrome; Star (game theory); Composite number; Internal medicine; Physical therapy; Systemic disease; Immunopathology; Composite material; Astrophysics","score_opus":0.046508292923856026,"score_gpt":0.3212607339069144,"score_spread":0.2747524409830584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297928045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951089,0.0010414808,0.0001362908,0.0013361815,0.00013484096,0.0020438437,0.00016481287,0.000014951346,0.000018687122],"genre_scores_gemma":[0.9983458,0.000018230015,0.00070266455,0.0001985201,0.000006432254,0.0004973608,0.00011278894,0.000019347328,0.00009885127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985273,0.00036599557,0.00044747285,0.00019829883,0.00027473675,0.00018619596],"domain_scores_gemma":[0.9973362,0.0019404239,0.00030499668,0.00029259754,0.000074289535,0.000051472998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006065509,0.0001706953,0.00044443915,0.00011748147,0.00042529014,0.00003332705,0.00010691205,0.00002945973,0.000010974155],"category_scores_gemma":[0.00050873414,0.000101462276,0.0002137671,0.00019734619,0.000103699094,0.00010539359,0.000117115305,0.00005567168,1.18138225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02982232,0.005064359,0.8484875,0.0069099255,0.0013660783,0.00002603871,0.004630419,0.0018625002,0.002334982,0.00013449903,0.002471502,0.09688985],"study_design_scores_gemma":[0.0037043202,0.0012713465,0.98853165,0.0014117525,0.0004411282,0.00004875336,0.00083265745,0.00092552626,0.0022273497,0.00036750158,0.00010074735,0.00013726183],"about_ca_topic_score_codex":0.000026334561,"about_ca_topic_score_gemma":0.0000010290219,"teacher_disagreement_score":0.14004414,"about_ca_system_score_codex":0.00008051336,"about_ca_system_score_gemma":0.000501094,"threshold_uncertainty_score":0.41375116},"labels":[],"label_agreement":null},{"id":"W4298264284","doi":"10.1136/annrheumdis-2022-eular.31","title":"OP0093 INCREASED RISK OF SEVERE INFECTIONS AND MORTALITY IN PATIENTS WITH NEWLY DIAGNOSED ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS: A POPULATION-BASED STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Research Canada","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Anti-neutrophil cytoplasmic antibody; Vasculitis; Population; Incidence (geometry); Autoantibody; Mortality rate; Cohort; Cumulative incidence; Immunology; Antibody; Confidence interval; Disease","score_opus":0.010495306376846756,"score_gpt":0.26788014111288455,"score_spread":0.2573848347360378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298264284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727035,0.00015541534,0.000002833672,0.000121775716,0.00004727726,0.001219114,0.0011372227,0.000026070495,0.000019929072],"genre_scores_gemma":[0.9992719,0.0000606341,0.000009368569,0.00006944485,0.0000039358915,0.00008995302,0.00046934024,0.00001778094,0.000007632434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802005,0.000531846,0.00051218766,0.00021400538,0.00054684887,0.00017506385],"domain_scores_gemma":[0.99854535,0.00028822676,0.0004689254,0.00041904018,0.00017794754,0.00010051177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025781273,0.00015922893,0.00050254696,0.0001813396,0.00025281054,0.000011036062,0.00010868529,0.00003493058,0.00011430377],"category_scores_gemma":[0.0006568436,0.00011211492,0.00019719843,0.0006217657,0.000069323825,0.000079675374,0.00007423731,0.00018979853,4.8544797e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012557763,0.0066489335,0.98604697,0.00011699088,0.0009038215,0.000005306712,0.00017490603,0.0057126977,0.0000015312812,0.000020955424,0.00004614871,0.00019615184],"study_design_scores_gemma":[0.008792667,0.0009167732,0.98754144,0.00047966454,0.0010114069,0.000001380394,0.00031114754,0.0005634774,0.0000024919023,0.00025727073,8.6105734e-7,0.000121413796],"about_ca_topic_score_codex":0.00550849,"about_ca_topic_score_gemma":0.00023650144,"teacher_disagreement_score":0.008667089,"about_ca_system_score_codex":0.000035503654,"about_ca_system_score_gemma":0.00016420802,"threshold_uncertainty_score":0.8327226},"labels":[],"label_agreement":null},{"id":"W4298277439","doi":"10.1136/annrheumdis-2022-eular.2967","title":"POS0155 WHAT DRIVES RACIAL DISPARITIES IN GOUT IN THE US? – POPULATION-BASED, SEX-SPECIFIC, CASUAL MEDIATION ANALYSIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; National Health and Nutrition Examination Survey; Population; Body mass index; Hyperuricemia; Demography; Gerontology; Internal medicine; Kidney disease; Cohort; Health equity; Mediation; Public health; Environmental health; Uric acid; Pathology","score_opus":0.026913116752442057,"score_gpt":0.29939307604965476,"score_spread":0.2724799592972127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298277439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877083,0.0037210316,0.000020483129,0.007629026,0.00017375538,0.0005460129,0.00011367879,0.000020575284,0.000067160516],"genre_scores_gemma":[0.99750245,0.00044520939,0.000027284383,0.0014542176,0.000046798257,0.00014932126,0.00028537604,0.000017316894,0.00007205615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971577,0.00059029605,0.00064762676,0.00025686057,0.0010671951,0.0002803557],"domain_scores_gemma":[0.9982021,0.000692675,0.00031587292,0.0006545095,0.000060490776,0.00007434481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006624113,0.00018676075,0.00052232645,0.00042128368,0.00019422382,0.000067766145,0.00042004633,0.000043359105,0.0003173284],"category_scores_gemma":[0.00053862965,0.00012464651,0.0003462954,0.0013820834,0.000102485836,0.00028407105,0.00012083164,0.00022223718,0.0000042753345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017205939,0.000720433,0.9702746,0.00013065185,0.00028942848,0.00001551059,0.0038746917,0.017262558,0.000006628515,0.00027867348,0.00085026113,0.006124492],"study_design_scores_gemma":[0.00070411427,0.00006580075,0.98484296,0.00012716973,0.00037076575,0.0000038762155,0.0057918127,0.006857775,0.000028071689,0.00088578946,0.00018427423,0.0001375885],"about_ca_topic_score_codex":0.0013130341,"about_ca_topic_score_gemma":0.00034811557,"teacher_disagreement_score":0.014568348,"about_ca_system_score_codex":0.00009085398,"about_ca_system_score_gemma":0.00013220026,"threshold_uncertainty_score":0.5082937},"labels":[],"label_agreement":null},{"id":"W4299505553","doi":"10.1136/annrheumdis-2022-eular.1133","title":"POS0162 HOW ACCURATELY CAN WE IDENTIFY RHEUMATOID ARTHRITIS BY ICD-10 CODES? A LINKAGE OF CROSS-SECTIONAL SURVEY DATA WITH CLAIMS DATA","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medac; Bundesministerium für Bildung und Forschung; Public Health Agency of Canada; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Diagnosis code; Family medicine; Population; Health care; Cross-sectional study; Gold standard (test); Rheumatology; Rheumatism; Medical diagnosis; Rheumatoid arthritis; Internal medicine; Pathology","score_opus":0.1369821621846936,"score_gpt":0.39071954023253097,"score_spread":0.25373737804783736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4299505553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9009177,0.04002251,0.00005914594,0.0030001076,0.00021082578,0.000824714,0.054821484,0.000057176996,0.00008632135],"genre_scores_gemma":[0.9391702,0.05163983,0.000057056102,0.00014824922,0.000022054483,0.00006431288,0.008317029,0.00005753396,0.00052377506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99517554,0.0007639023,0.00084361143,0.0007256599,0.0019268933,0.00056436704],"domain_scores_gemma":[0.9938806,0.00085327827,0.0007265869,0.0036402415,0.0005447687,0.00035452226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017494251,0.00032675694,0.0008424313,0.0001670063,0.0005283609,0.00023227486,0.0027475294,0.00005997978,0.0019077472],"category_scores_gemma":[0.0022414592,0.00023823557,0.00017035675,0.0006120792,0.00088238757,0.0007273789,0.0022600738,0.0003713582,0.000011559109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033119386,0.0026368639,0.63004464,0.0010365682,0.0027848016,0.00005213773,0.0005452774,0.000055596083,0.00043840724,0.0002628599,0.331251,0.02757989],"study_design_scores_gemma":[0.004714437,0.00088857475,0.98029673,0.0021334584,0.00002730708,0.00025700807,0.0008990691,0.0012461619,0.0006921879,0.0014063629,0.0069559216,0.0004827786],"about_ca_topic_score_codex":0.0012595895,"about_ca_topic_score_gemma":0.0005383362,"teacher_disagreement_score":0.3502521,"about_ca_system_score_codex":0.00002801806,"about_ca_system_score_gemma":0.00089045835,"threshold_uncertainty_score":0.99900466},"labels":[],"label_agreement":null},{"id":"W4299526570","doi":"10.1136/annrheumdis-2022-eular.2518","title":"POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Versus Arthritis; Pfizer","keywords":"Medicine; BASDAI; BASFI; Ankylosing spondylitis; Placebo; Clinical endpoint; Internal medicine; Randomized controlled trial; Physical therapy; Arthritis; Psoriatic arthritis","score_opus":0.04194759857138649,"score_gpt":0.3306582363371709,"score_spread":0.28871063776578443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4299526570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828477,0.0021751437,0.0000016652436,0.0005261811,0.000097168064,0.007866997,0.0008834556,0.000012365387,0.00015224062],"genre_scores_gemma":[0.99840784,0.00052957615,0.00002538306,0.0001910147,0.000013444356,0.00065429084,0.00011879792,0.000017511758,0.000042158164],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979722,0.00045286474,0.00065847015,0.0002538294,0.00042559527,0.0002370642],"domain_scores_gemma":[0.9979818,0.0009903947,0.00047430943,0.00031106174,0.00013203666,0.00011038264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044354706,0.00021872504,0.0013713863,0.00017080118,0.00016544016,0.000009497816,0.000120873694,0.000028816621,0.00024187747],"category_scores_gemma":[0.00060925423,0.00012300734,0.00026696938,0.00028616024,0.00020322627,0.000061558545,0.00012626742,0.000104659935,6.36439e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9654177,0.0047515426,0.0018942197,0.0000461479,0.0011476214,0.0000065278373,0.00080881984,0.0000197558,0.0000040885716,0.00005006888,0.00004273514,0.02581081],"study_design_scores_gemma":[0.9745448,0.00538111,0.01846401,0.0004636703,0.00031002672,0.0000020420057,0.0004486749,0.000009969645,0.000063826745,0.00010222592,0.000091407324,0.0001182405],"about_ca_topic_score_codex":0.00011797083,"about_ca_topic_score_gemma":0.000005368288,"teacher_disagreement_score":0.02569257,"about_ca_system_score_codex":0.000037331174,"about_ca_system_score_gemma":0.00010539979,"threshold_uncertainty_score":0.5016094},"labels":[],"label_agreement":null},{"id":"W4299556061","doi":"10.1136/annrheumdis-2022-eular.1286","title":"POS0288 A CANADIAN RETROSPECTIVE CHART REVIEW EVALUATING CONCOMITANT METHOTREXATE DE-ESCALATION PATTERNS IN RA PATIENTS TREATED WITH BIOLOGIC OR TARGETED SYNTHETIC DMARDS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The Scarborough Hospital; Université Laval; University of Alberta; University of Saskatchewan; ABB (Canada); University of Toronto","funders":"University of Twente; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Amsterdam University Medical Centers; Bristol-Myers Squibb; National Institutes of Health; Universiteit van Amsterdam; National Institute of Allergy and Infectious Diseases; Amgen","keywords":"Medicine; Methotrexate; Rheumatoid arthritis; Tolerability; Concomitant; Internal medicine; Prednisone; Regimen; Cohort; Retrospective cohort study; Antifolate; Surgery; Adverse effect; Antimetabolite","score_opus":0.04659313253689018,"score_gpt":0.3392946291144187,"score_spread":0.29270149657752853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4299556061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845097,0.01097403,0.0000030684073,0.0023532666,0.000036482994,0.0014882428,0.0005078896,0.000023312303,0.00010399409],"genre_scores_gemma":[0.98446465,0.01422817,0.000045760487,0.0007396706,0.0000056027275,0.00030343118,0.00012075161,0.000023358352,0.00006859356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972647,0.0010090873,0.0004624543,0.0002476081,0.0005863027,0.0004298903],"domain_scores_gemma":[0.9986062,0.00023303047,0.0002652804,0.00038201304,0.0002609933,0.00025249855],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092296593,0.00018220261,0.00057099806,0.00018480435,0.00021221148,0.000016763308,0.0002181264,0.000025549785,0.0012296038],"category_scores_gemma":[0.0022164339,0.000105781946,0.00014485112,0.00053833885,0.00010556536,0.00007679275,0.00007508734,0.0001821947,0.000004043976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008649732,0.00045523595,0.95967126,0.00076296227,0.00031631353,0.00003210504,0.00048688496,0.000038030896,0.00004463997,0.000040265673,0.0010670191,0.036220312],"study_design_scores_gemma":[0.0017519101,0.0015879977,0.9871584,0.007580217,0.000054189743,0.000022121909,0.00033392513,0.00089806214,0.00013986597,0.00020133534,0.000112522386,0.00015941857],"about_ca_topic_score_codex":0.014478755,"about_ca_topic_score_gemma":0.003758483,"teacher_disagreement_score":0.036060892,"about_ca_system_score_codex":0.00022062556,"about_ca_system_score_gemma":0.0006218638,"threshold_uncertainty_score":0.9996834},"labels":[],"label_agreement":null},{"id":"W4300478699","doi":"10.1136/annrheumdis-2022-eular.2970","title":"POS0230 THE miR-320 FAMILY IS UPREGULATED IN FAST-PROGRESSING RADIOGRAPHIC KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University Health Network","funders":"Universidade da Coruña; Menzies Institute for Medical Research; Monash University; University of Tasmania","keywords":"Medicine; Osteoarthritis; microRNA; Cohort; Bioinformatics; Oncology; Biomarker; Population; Internal medicine; Pathology; Gene; Genetics; Biology","score_opus":0.06714434486052251,"score_gpt":0.3014723075184882,"score_spread":0.23432796265796568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300478699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92022437,0.06444755,0.0000027104593,0.008394964,0.00045591238,0.0019239073,0.0041073696,0.00006920784,0.00037402494],"genre_scores_gemma":[0.99403214,0.00069481647,0.000060523966,0.003797834,0.00006900941,0.0003490767,0.0008278221,0.000056756584,0.000112012036],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964061,0.0007786281,0.00074341847,0.0005455208,0.0009921102,0.00053425843],"domain_scores_gemma":[0.9964134,0.00072019454,0.00044658175,0.0021421986,0.00012306293,0.00015454524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005066525,0.0003673619,0.0006403707,0.00013609351,0.00072169676,0.00010314613,0.0012135592,0.00006674931,0.0005029048],"category_scores_gemma":[0.0003205289,0.0002150923,0.00039344298,0.0009469881,0.00049680163,0.00030529534,0.0010507145,0.0003852228,0.00002010449],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016185086,0.0016453149,0.03559187,0.00016667925,0.0009832208,0.00022562876,0.01063259,0.00004426962,0.00068266335,0.00032443128,0.02003588,0.92804897],"study_design_scores_gemma":[0.048014294,0.014706015,0.77640516,0.020860344,0.004528813,0.0004908258,0.070323996,0.0024251423,0.004920169,0.037864048,0.01698476,0.0024764214],"about_ca_topic_score_codex":0.0003289467,"about_ca_topic_score_gemma":0.0001368228,"teacher_disagreement_score":0.9255725,"about_ca_system_score_codex":0.000029131399,"about_ca_system_score_gemma":0.00024990053,"threshold_uncertainty_score":0.8771209},"labels":[],"label_agreement":null},{"id":"W4300550858","doi":"10.1136/annrheumdis-2022-eular.3727","title":"POS0341 CONSENSUS-DRIVEN DEFINITION FOR UNEQUIVOCAL SACROILIITIS ON RADIOGRAPHS IN JUVENILE SPONDYLOARTHRITIS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Cincinnati Children's Hospital Medical Center; F. Hoffmann-La Roche; Pfizer; Duke Clinical Research Institute; Bristol-Myers Squibb","keywords":"Sacroiliitis; Medicine; Radiography; Intraclass correlation; Radiology; Kappa; Sacroiliac joint; Cohen's kappa; Nuclear medicine; Magnetic resonance imaging","score_opus":0.05526439158552354,"score_gpt":0.30621068867505513,"score_spread":0.2509462970895316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300550858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875266,0.004378064,0.0000022036857,0.0031101387,0.0002579819,0.0010177029,0.0017962892,0.000029865767,0.0006550682],"genre_scores_gemma":[0.9974798,0.0008018672,0.00012620009,0.00082299445,0.000018389466,0.00048595914,0.00013430332,0.000025700916,0.000104803825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850047,0.00012349001,0.00043187142,0.00024252056,0.00038674424,0.00031490458],"domain_scores_gemma":[0.998915,0.00037665744,0.00017809692,0.0003576332,0.00007526006,0.000097346085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014294301,0.00017111069,0.00048551988,0.0001793787,0.00028561815,0.000010155978,0.00013325097,0.00002805935,0.00026218343],"category_scores_gemma":[0.00029816147,0.00013947122,0.00043908178,0.0003629175,0.0001634746,0.000026510976,0.00010192054,0.00010040441,0.000006596178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02032236,0.023954978,0.37453985,0.0031408388,0.0040835105,0.0011567986,0.0036135137,0.002330086,0.0004056017,0.06995508,0.15653439,0.339963],"study_design_scores_gemma":[0.03639667,0.011167706,0.8839425,0.006050238,0.0009970178,0.00044827163,0.0041308976,0.00090576493,0.0012334475,0.038763102,0.014951613,0.0010128109],"about_ca_topic_score_codex":0.00010311646,"about_ca_topic_score_gemma":0.000041118878,"teacher_disagreement_score":0.5094026,"about_ca_system_score_codex":0.00004245362,"about_ca_system_score_gemma":0.00009202571,"threshold_uncertainty_score":0.5687471},"labels":[],"label_agreement":null},{"id":"W4300561928","doi":"10.1136/annrheumdis-2022-eular.47","title":"POS0072 CONSISTENT LONG-TERM GUSELKUMAB EFFICACY ACROSS PSORIATIC ARTHRITIS DOMAINS IRRESPECTIVE OF BASELINE PATIENT CHARACTERISTICS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; McGill University","funders":"","keywords":"Dactylitis; Medicine; Enthesitis; Psoriatic arthritis; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Disease; Physical therapy; Dermatology; Pathology","score_opus":0.028449042912313764,"score_gpt":0.32003563067896085,"score_spread":0.2915865877666471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300561928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981915,0.013468531,0.000024619514,0.0013935852,0.0004340629,0.0009625997,0.0016973753,0.000038824288,0.00006542351],"genre_scores_gemma":[0.9880884,0.011227949,0.00004045074,0.00027508408,0.000037733083,0.00012123094,0.000113446535,0.00003746315,0.00005818632],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965959,0.0004917707,0.0009618189,0.00029137384,0.0011720071,0.00048713325],"domain_scores_gemma":[0.99709976,0.0007854006,0.0006146547,0.00083302666,0.00039551218,0.00027162567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004778494,0.00024711073,0.00081143825,0.00011545303,0.00037586666,0.000033090913,0.00036714703,0.000032364427,0.00083239516],"category_scores_gemma":[0.0021771789,0.00018787751,0.00052369596,0.00034221387,0.0004882728,0.0000885852,0.000438805,0.00022366084,0.000011946594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054020137,0.011686286,0.07533228,0.0016707516,0.0031764875,0.00022803814,0.010274892,0.00011878031,0.0006217314,0.0016801155,0.0082156425,0.881593],"study_design_scores_gemma":[0.006547732,0.0024054544,0.9792853,0.0035117064,0.000096373915,0.00018338829,0.0024104244,0.0002468528,0.0030687556,0.0009283056,0.0009292669,0.0003864641],"about_ca_topic_score_codex":0.00006464,"about_ca_topic_score_gemma":0.000013329825,"teacher_disagreement_score":0.903953,"about_ca_system_score_codex":0.000051322724,"about_ca_system_score_gemma":0.00028688746,"threshold_uncertainty_score":0.9114143},"labels":[],"label_agreement":null},{"id":"W4300888799","doi":"10.1136/annrheumdis-2022-eular.1817","title":"POS0054 DYSFUNCTION OF REGULATORY B CELLS IN GIANT CELL ARTERITIS (GCA)","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; European Commission; European Federation of Pharmaceutical Industries and Associations; McGill University; Diamond Light Source; Innovative Medicines Initiative; Science for Life Laboratory; Argenx; Wellcome Trust","keywords":"Medicine; Immunology; Regulatory B cells; Proinflammatory cytokine; Peripheral blood mononuclear cell; Pathogenesis; Interleukin 10; Internal medicine; Inflammation; Cytokine; Biology; In vitro","score_opus":0.028205059784582293,"score_gpt":0.28141208979918075,"score_spread":0.25320703001459843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300888799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468356,0.0020389203,0.0000059498125,0.00092838414,0.00023867737,0.0006236441,0.0001152102,0.000016671283,0.0013489613],"genre_scores_gemma":[0.9979216,0.00020791916,0.0000250884,0.0001334247,0.000014628539,0.00007270497,0.000009219043,0.000022437745,0.0015929878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997838,0.0002861573,0.00057389674,0.00018060938,0.0008815139,0.00023980276],"domain_scores_gemma":[0.9986275,0.00018179456,0.00028519184,0.0006903772,0.00011068232,0.00010444209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044936448,0.00011630284,0.0004350132,0.00019414356,0.00006529999,0.000005933575,0.00027922084,0.000028357592,0.0006996669],"category_scores_gemma":[0.00017265133,0.00008809971,0.00023089949,0.00038272396,0.00012664587,0.000054355256,0.00022013178,0.00012754684,0.000011193547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004596606,0.013199442,0.38285324,0.0486094,0.001189657,0.00023934658,0.012596234,0.0026430546,0.15541129,0.001620058,0.32102472,0.05601698],"study_design_scores_gemma":[0.014202452,0.0029045888,0.6885613,0.015845355,0.00059791625,0.0018425072,0.02758458,0.006997274,0.23033987,0.0072494843,0.0028281396,0.0010465152],"about_ca_topic_score_codex":0.00011823425,"about_ca_topic_score_gemma":0.000002877982,"teacher_disagreement_score":0.31819656,"about_ca_system_score_codex":0.000055858127,"about_ca_system_score_gemma":0.00023271058,"threshold_uncertainty_score":0.7660862},"labels":[],"label_agreement":null},{"id":"W4300911060","doi":"10.1136/annrheumdis-2022-eular.666","title":"POS0025 PREVALENCE OF ATTENTION DEFICIT HYPERACTIVITY DISORDER AMONG ADULT PATIENTS WITH FIBROMYALGIA","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fibromyalgia; Comorbidity; Attention deficit hyperactivity disorder; Impulsivity; Anxiety; Psychiatry; Montreal Cognitive Assessment; Internal medicine; Physical therapy; Cognition; Cognitive impairment","score_opus":0.01543007055829526,"score_gpt":0.2720582079777531,"score_spread":0.25662813741945784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300911060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978587,0.0005502819,0.000010800044,0.0005262836,0.000043894517,0.0006694312,0.00022897293,0.000016984413,0.00009462613],"genre_scores_gemma":[0.99880725,0.000075887634,0.000033123204,0.0000048369448,0.0000016054324,0.00006541291,0.000035363126,0.000020307914,0.00095619657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979325,0.00019813138,0.00033820848,0.0002107661,0.0010687537,0.00025162307],"domain_scores_gemma":[0.9985241,0.00015994719,0.00030871635,0.00057897443,0.00032390116,0.000104317915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014653642,0.00014328382,0.0003242838,0.000087262,0.00016392703,0.000007770532,0.00028014247,0.000024424082,0.0009146305],"category_scores_gemma":[0.00034151872,0.00009363097,0.00021165835,0.00033927461,0.00023448285,0.00013793347,0.00021731957,0.0001543823,0.0000036424483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034047267,0.0013225203,0.9840179,0.012150003,0.00020068203,0.0000012875422,0.0000623981,0.00012572919,0.000034625504,0.000076849574,0.0005241895,0.0011433273],"study_design_scores_gemma":[0.0011762728,0.00077495497,0.994531,0.0024678132,0.00017428523,0.0000040525247,0.00022660522,0.0003854992,0.00006905533,0.000088063876,0.0000024669298,0.00009995835],"about_ca_topic_score_codex":0.00020310484,"about_ca_topic_score_gemma":9.3497147e-7,"teacher_disagreement_score":0.010513057,"about_ca_system_score_codex":0.000032273118,"about_ca_system_score_gemma":0.00019375808,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W4301283258","doi":"10.1136/annrheumdis-2022-eular.787","title":"OP0269 BIOMARKERS TO PREDICT RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB OR TUMOUR NECROSIS FACTOR INHIBITORS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Sanofi Genzyme; Horizon Therapeutics; Sanofi; European Commission; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Tofacitinib; Etanercept; Internal medicine; Adalimumab; Rheumatoid arthritis; Hazard ratio; Rheumatoid factor; Pulmonary embolism; Gastroenterology; Surgery; Confidence interval","score_opus":0.0197678037723394,"score_gpt":0.262929628155183,"score_spread":0.24316182438284362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301283258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940482,0.0013933704,0.00000843832,0.0005222212,0.00032572623,0.00059553114,0.003038914,0.000022723512,0.00004489896],"genre_scores_gemma":[0.9989754,0.00053635397,0.00012990617,0.00021235578,0.0000032323503,0.000050057588,0.000029272956,0.000021501428,0.000041907955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977318,0.0007386238,0.00067109644,0.00029199864,0.00018949014,0.00037697665],"domain_scores_gemma":[0.99846476,0.00047714723,0.0004701599,0.0004142239,0.00010513155,0.00006859097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039802748,0.00022163993,0.00071629207,0.00016571347,0.00022053834,0.000012975728,0.00047144666,0.000075139425,0.0009554586],"category_scores_gemma":[0.0010479123,0.00013752164,0.00021784214,0.00055874523,0.00028920211,0.0000773526,0.0003649106,0.00020872115,0.000004065716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039808606,0.004879481,0.7479483,0.0003475925,0.0023337156,0.0000039431034,0.002342764,0.00023500125,0.0012643058,0.00007906002,0.015824882,0.2207601],"study_design_scores_gemma":[0.0017755349,0.001242621,0.98567116,0.0010311145,0.000075652155,0.0000033318513,0.00058776146,0.00001100924,0.008393324,0.0003504556,0.00060709,0.00025094612],"about_ca_topic_score_codex":0.00038843957,"about_ca_topic_score_gemma":0.000039871786,"teacher_disagreement_score":0.23772287,"about_ca_system_score_codex":0.000024432165,"about_ca_system_score_gemma":0.000115870156,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W4301350994","doi":"10.1136/annrheumdis-2022-eular.2076","title":"POS0296 INTEGRATED SAFETY ANALYSIS OF TOFACITINIB IN ANKYLOSING SPONDYLITIS CLINICAL TRIALS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline; Amgen","keywords":"Medicine; Tofacitinib; Ankylosing spondylitis; Clinical trial; Safety profile; Internal medicine; Intensive care medicine; Rheumatoid arthritis; Adverse effect","score_opus":0.17083523264088787,"score_gpt":0.4573708908815567,"score_spread":0.28653565824066884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301350994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834566,0.0069460333,0.000027048842,0.0020078744,0.0001332252,0.00057547045,0.0065472764,0.0000190193,0.00028743286],"genre_scores_gemma":[0.99137455,0.007604462,0.000055519875,0.0002700631,0.000012006319,0.00004121941,0.0005176541,0.000014804208,0.00010973481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99381614,0.0028785923,0.001997712,0.00023757613,0.0007734499,0.00029655636],"domain_scores_gemma":[0.9960327,0.0023196007,0.00064405525,0.00061511225,0.00020454914,0.00018396345],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005319768,0.00015317828,0.0016563796,0.0005468722,0.000118053555,0.000016343049,0.00034146,0.00003855025,0.0061265095],"category_scores_gemma":[0.0093366625,0.00010439582,0.0012647377,0.0017874046,0.0003156685,0.000083621446,0.00020322084,0.00025521664,0.0000019897018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0105380425,0.0042407108,0.5443243,0.00047475146,0.011159889,0.000052580872,0.0017687586,0.0010187209,0.00021954034,0.003905393,0.006657115,0.41564023],"study_design_scores_gemma":[0.0055614486,0.0009065049,0.96087015,0.0016901211,0.00073990814,0.000017591774,0.004049536,0.0052710744,0.0006550843,0.003177398,0.016783979,0.0002772318],"about_ca_topic_score_codex":0.00043388642,"about_ca_topic_score_gemma":0.000040657196,"teacher_disagreement_score":0.41654587,"about_ca_system_score_codex":0.000026821543,"about_ca_system_score_gemma":0.00034748515,"threshold_uncertainty_score":0.9990081},"labels":[],"label_agreement":null},{"id":"W4301652369","doi":"10.1136/annrheumdis-2022-eular.4310","title":"POS0011 COMPARISON OF PSYCHOMETRIC PROPERTIES OF FOUR GLOBAL MEASURES OF PRESENTEEISM IN PATIENTS WITH OSTEOARTHRITIS AND INFLAMMATORY ARTHRITIS: A EULAR-PRO STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia; Institute for Work & Health","funders":"","keywords":"Presenteeism; Medicine; Absenteeism; Physical therapy; Psoriatic arthritis; Quality of life (healthcare); Observational study; Sick leave; Rheumatoid arthritis; Internal medicine; Psychology; Nursing","score_opus":0.08071807572021596,"score_gpt":0.3584956672964208,"score_spread":0.27777759157620485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301652369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868229,0.010055548,0.0000017564389,0.00019428256,0.00012652489,0.0025139125,0.00015581222,0.000010794435,0.000118490585],"genre_scores_gemma":[0.99947727,0.0001958952,0.000015769096,0.00005238512,0.0000058969363,0.00022088645,0.000004061062,0.000014779928,0.00001308199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99601275,0.0012953915,0.0012935078,0.00019028425,0.00089016394,0.0003179212],"domain_scores_gemma":[0.9977905,0.00024249211,0.0011057828,0.0004159323,0.0003332719,0.000112031004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007417535,0.00015604029,0.00073601666,0.00022049862,0.0002460645,0.000003371341,0.0003064669,0.000039779054,0.00003499307],"category_scores_gemma":[0.00065809226,0.000110605775,0.00008095231,0.0007466317,0.0001746091,0.00010316806,0.0002975408,0.00021252433,5.618005e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013087575,0.0015881824,0.9754159,0.002163688,0.00008385339,5.0578944e-7,0.0041448637,0.00014757426,0.0000031199843,0.00008572015,0.0003514829,0.014706373],"study_design_scores_gemma":[0.0036484932,0.0012571064,0.9803148,0.0037619818,0.00004559251,2.9855622e-7,0.010343192,0.000037682083,0.0000446167,0.00043115145,0.000017611703,0.00009745645],"about_ca_topic_score_codex":0.0006574208,"about_ca_topic_score_gemma":0.00022605916,"teacher_disagreement_score":0.014608917,"about_ca_system_score_codex":0.00002447227,"about_ca_system_score_gemma":0.00030625032,"threshold_uncertainty_score":0.45103726},"labels":[],"label_agreement":null},{"id":"W4301702561","doi":"10.1136/annrheumdis-2022-eular.2342","title":"OP0266 TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS AS AN OVERALL MEASURE OF TOLERANCE AND SAFETY OF JAK-INHIBITORS: AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-pot” STUDY).","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Samsung; Université de Toulouse; Pfizer; Karolinska Institutet; Sanofi; Institut National de la Santé et de la Recherche Médicale; Eli Lilly and Company","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Adverse effect; Internal medicine; Intensive care medicine","score_opus":0.0188440350631102,"score_gpt":0.30245540782049407,"score_spread":0.28361137275738385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301702561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498254,0.0014952375,0.000010036998,0.00064608065,0.0001368894,0.0017952573,0.00088241184,0.000007355171,0.00004420584],"genre_scores_gemma":[0.994776,0.004841872,0.000046567227,0.000028013492,0.000010914086,0.00013072707,0.00012196671,0.000015605045,0.00002829641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715763,0.0004571666,0.0008969742,0.0002114913,0.0011304368,0.000146296],"domain_scores_gemma":[0.997648,0.00013996789,0.00079129974,0.000542177,0.0007603086,0.0001182171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043418448,0.00016299105,0.00058904086,0.00013310403,0.00013000115,0.000008450364,0.00028328286,0.00002252779,0.00009083291],"category_scores_gemma":[0.00069936266,0.00011359662,0.00014421734,0.00028055007,0.00021373972,0.00034277447,0.00013085328,0.000054171203,3.7455573e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013932359,0.02018698,0.72403914,0.00036155185,0.001956273,0.0000061452142,0.036778953,0.0022913693,0.0012841484,0.002221544,0.0008365414,0.196105],"study_design_scores_gemma":[0.009467776,0.009494613,0.94916964,0.0032928071,0.000046907026,0.000009049868,0.016323622,0.00036837935,0.010055556,0.0011346509,0.00042306382,0.00021391439],"about_ca_topic_score_codex":0.0006551844,"about_ca_topic_score_gemma":0.0001738477,"teacher_disagreement_score":0.22513053,"about_ca_system_score_codex":0.0000387279,"about_ca_system_score_gemma":0.00026325893,"threshold_uncertainty_score":0.4632336},"labels":[],"label_agreement":null},{"id":"W4301764150","doi":"10.1136/annrheumdis-2022-eular.892","title":"POS0074 IMMUNOLOGICAL DIFFERENCES BETWEEN PsA PATIENTS WHO ARE TUMOR NECROSIS FACTOR INHIBITOR-NAIVE AND WHO HAVE INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Cilag; University of Oxford; Janssen Scientific Affairs; Memorial University of Newfoundland; Drexel University; College of Medicine, Drexel University; University of Washington","keywords":"Medicine; TNF inhibitor; Tumor necrosis factor alpha; Rheumatoid arthritis; Cytokine; Internal medicine; Psoriatic arthritis; Adalimumab; Immunology; Oncology","score_opus":0.03738201722601285,"score_gpt":0.2635972635267192,"score_spread":0.22621524630070633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301764150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880023,0.0020819376,0.000001259694,0.0013630314,0.00048128483,0.00088075217,0.0071120993,0.00006245837,0.000014899916],"genre_scores_gemma":[0.998233,0.00014805843,0.000006998019,0.00042005297,0.000022351544,0.00024667187,0.00010738508,0.000036123634,0.00077932613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962646,0.0014904845,0.0007605499,0.0005872416,0.0002576718,0.0006394707],"domain_scores_gemma":[0.9972545,0.0011688843,0.00067333906,0.00059269654,0.0001598469,0.00015076318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023535655,0.0005107526,0.0010470927,0.00024808798,0.0008809795,0.000072193325,0.000699082,0.00011613242,0.00044276065],"category_scores_gemma":[0.0010325289,0.00035331896,0.00041615634,0.0003353136,0.00039393204,0.00017503444,0.0009543563,0.0002586896,0.00004237434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037068368,0.0010107243,0.9302527,0.00012547648,0.0011404373,0.000008369496,0.0033953092,0.0000030263338,0.0022027688,0.000022432718,0.0051957387,0.052936234],"study_design_scores_gemma":[0.00155477,0.0011303698,0.9791331,0.0004514338,0.00021739208,0.000003361368,0.0011706142,0.0000022527915,0.015140832,0.00028179656,0.00049809663,0.00041594316],"about_ca_topic_score_codex":0.00033759285,"about_ca_topic_score_gemma":0.00001294777,"teacher_disagreement_score":0.05252029,"about_ca_system_score_codex":0.00007457319,"about_ca_system_score_gemma":0.000105586,"threshold_uncertainty_score":0.9998919},"labels":[],"label_agreement":null},{"id":"W4302067767","doi":"10.1136/annrheumdis-2022-eular.1980","title":"POS0053 ABUNDANT AUTOANTIBODY ISOTYPES IN IDIOPATHIC INFLAMMATORY MYOPATHIES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Commission; Innovative Medicines Initiative; Science for Life Laboratory; European Federation of Pharmaceutical Industries and Associations; Diamond Light Source; McGill University","keywords":"Autoantibody; Medicine; Myositis; Antisynthetase syndrome; Immunology; Rheumatoid arthritis; Antibody; Isotype; Interstitial lung disease; Population; Antigen; Internal medicine; Lung; Monoclonal antibody","score_opus":0.017837310801276506,"score_gpt":0.27392082233922466,"score_spread":0.25608351153794817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302067767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895633,0.0062638833,0.000005061917,0.002927996,0.00036278134,0.00057320046,0.00008276053,0.00007956528,0.00074841414],"genre_scores_gemma":[0.99781597,0.00035024335,0.000020676,0.0013960927,0.00004045509,0.000107475054,0.0000137500965,0.000035282912,0.00022005467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748236,0.00034532693,0.00079394307,0.00024689466,0.00074196677,0.0003894989],"domain_scores_gemma":[0.9985519,0.00011365821,0.0003602085,0.00072173966,0.00011268367,0.00013977996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006320185,0.00022926819,0.000595892,0.00024344854,0.00034527024,0.000025381747,0.00039298754,0.00003761607,0.0003197946],"category_scores_gemma":[0.00036912833,0.00017274776,0.00036482135,0.00042397526,0.00021395757,0.00014398433,0.0004111857,0.0003070333,0.000026994512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027632979,0.003495553,0.8567489,0.010240076,0.0008331728,0.0014655885,0.011912276,0.0031037237,0.0022930114,0.028450802,0.03237778,0.046315834],"study_design_scores_gemma":[0.0014753407,0.00028607433,0.9817299,0.0019125941,0.0001577672,0.00031306033,0.0024512983,0.0018936516,0.0018106281,0.0042545544,0.0033452797,0.0003698268],"about_ca_topic_score_codex":0.00009768426,"about_ca_topic_score_gemma":0.0000091476995,"teacher_disagreement_score":0.12498104,"about_ca_system_score_codex":0.000046389643,"about_ca_system_score_gemma":0.00037420826,"threshold_uncertainty_score":0.70444494},"labels":[],"label_agreement":null},{"id":"W4306818321","doi":"10.1136/ard-2022-222787","title":"Tenderness and radiographic progression in rheumatoid arthritis and psoriatic arthritis","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Rheumatoid arthritis; Tenderness; Psoriatic arthritis; Internal medicine; Arthritis; Radiography; Rheumatology; Gastroenterology; Surgery","score_opus":0.019766181366146947,"score_gpt":0.2856037548744648,"score_spread":0.2658375735083179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306818321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8404174,0.15718552,6.556349e-7,0.001588082,0.00010607163,0.00053638377,0.00007159928,0.000019939032,0.000074377815],"genre_scores_gemma":[0.9032818,0.09626482,0.000037047146,0.00015369231,0.000006996512,0.00020639467,0.000012143124,0.00001606815,0.000021037042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986538,0.00012347607,0.00036789034,0.00023938423,0.00037229367,0.00024310981],"domain_scores_gemma":[0.9993002,0.00011217709,0.00016112061,0.00026962976,0.00003753981,0.000119323995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016918445,0.00016283103,0.00048070183,0.00014849137,0.00027878897,0.000018635801,0.00008373849,0.000022817007,0.00007986907],"category_scores_gemma":[0.00016130388,0.00011977494,0.00011885691,0.00033128314,0.00022650954,0.000073491305,0.00024635697,0.000103456376,7.885632e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020867572,0.0007249121,0.3329525,0.00024582064,0.00021129123,0.000066074375,0.0007548026,0.000004412275,0.000004882841,0.000509517,0.00076331926,0.6635538],"study_design_scores_gemma":[0.005337878,0.00056025374,0.9824014,0.0039561824,0.000049977865,0.00030651732,0.0017126391,0.00011454048,0.000048220103,0.0049721543,0.00036629947,0.00017395652],"about_ca_topic_score_codex":0.00013046217,"about_ca_topic_score_gemma":0.000041328836,"teacher_disagreement_score":0.66337985,"about_ca_system_score_codex":0.000011270269,"about_ca_system_score_gemma":0.000044598804,"threshold_uncertainty_score":0.48842803},"labels":[],"label_agreement":null},{"id":"W4307228818","doi":"10.1136/ard-2022-223413","title":"American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"Janssen Biotech","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Internal medicine; Methotrexate; Physical therapy; Placebo; Alternative medicine; Pathology","score_opus":0.029991004038436804,"score_gpt":0.33476798527900636,"score_spread":0.30477698124056957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307228818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95029426,0.03949199,0.00008940389,0.006093364,0.00032825366,0.0015297135,0.0019948867,0.000056010802,0.00012212817],"genre_scores_gemma":[0.93730366,0.061501354,0.00042502908,0.00023463751,0.000009599127,0.00021074091,0.00008421283,0.000046967587,0.0001838205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675554,0.00048416445,0.0010050501,0.000346824,0.000934697,0.0004737214],"domain_scores_gemma":[0.99724174,0.00055989914,0.00069124385,0.0008920659,0.00035156353,0.0002635169],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083654566,0.00024633802,0.0010895587,0.00022668194,0.00046239683,0.000012859088,0.0005307536,0.00003616637,0.0009512947],"category_scores_gemma":[0.0019953963,0.00018824145,0.00060774584,0.0005949972,0.0005779713,0.000118628166,0.0003990038,0.00018889934,0.0000042991196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082741035,0.0045082695,0.050436795,0.004340611,0.0017187062,0.000039886683,0.0018475943,0.00008894654,0.0055167885,0.01920159,0.5233937,0.38063303],"study_design_scores_gemma":[0.039667644,0.02054811,0.12686425,0.055446643,0.00027023425,0.0031524706,0.039659403,0.011987541,0.04511324,0.08488436,0.5689023,0.0035037927],"about_ca_topic_score_codex":0.00011932085,"about_ca_topic_score_gemma":0.0000046206715,"teacher_disagreement_score":0.37712923,"about_ca_system_score_codex":0.000029205527,"about_ca_system_score_gemma":0.00035153187,"threshold_uncertainty_score":0.999962},"labels":[],"label_agreement":null},{"id":"W4308769923","doi":"10.1136/ard-2022-223356","title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1788,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Medac; National Institute for Health and Care Research; European League Against Rheumatism; Biogen; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Antirheumatic drugs; Rheumatoid arthritis; Antirheumatic Agents; Arthritis; Hydroxychloroquine; Disease; Biological drugs; Intensive care medicine; Immunology; Internal medicine","score_opus":0.04105139998703397,"score_gpt":0.3078828312271989,"score_spread":0.26683143124016495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308769923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87242913,0.09851968,0.00050125545,0.024812315,0.00016612775,0.002624183,0.0008063037,0.00005195691,0.00008905793],"genre_scores_gemma":[0.7947681,0.20387347,0.00037966564,0.00025176778,0.0000051608445,0.00060650986,0.000052859665,0.00002387222,0.000038595317],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997921,0.0002541653,0.00056109723,0.0002851958,0.00062110263,0.00035744192],"domain_scores_gemma":[0.9980456,0.0006169311,0.00032933406,0.0006916227,0.00012780096,0.00018871152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065480947,0.00020734401,0.0004904186,0.00010870457,0.0007237894,0.00003853986,0.00040390313,0.000017400635,0.00041583373],"category_scores_gemma":[0.00017911935,0.00011675751,0.00026164416,0.00032481345,0.0005296649,0.000098268334,0.00037512224,0.00013970144,0.000002209393],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004969106,0.0032289447,0.01683902,0.0043380717,0.006512459,0.00003382848,0.0028632889,0.0006560792,0.00007514501,0.044474225,0.022052594,0.89395726],"study_design_scores_gemma":[0.050581105,0.008622943,0.37574604,0.07562064,0.0012669303,0.0008842501,0.111429654,0.04491244,0.0020958595,0.15161708,0.17339453,0.0038285402],"about_ca_topic_score_codex":0.000029681449,"about_ca_topic_score_gemma":0.0000016524422,"teacher_disagreement_score":0.8901287,"about_ca_system_score_codex":0.000015172341,"about_ca_system_score_gemma":0.000097336786,"threshold_uncertainty_score":0.5566876},"labels":[],"label_agreement":null},{"id":"W4308784882","doi":"10.1136/ard-2022-223365","title":"Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","year":2022,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Tofacitinib; Abatacept; Tocilizumab; Etanercept; Infliximab; Adalimumab; Certolizumab pegol; Internal medicine; Rheumatoid arthritis; Leflunomide; Anakinra; Systematic review; Rituximab; MEDLINE; Disease","score_opus":0.0694451409644183,"score_gpt":0.3605001889832167,"score_spread":0.2910550480187984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308784882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022547036,0.98758,0.000009331575,0.003175189,0.00015851004,0.007927251,0.00087596173,0.000010233952,0.00003806037],"genre_scores_gemma":[0.0015527768,0.9966382,0.000044133187,0.00017147779,0.000008828954,0.0014187205,0.00009408973,0.000032606968,0.000039180522],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955336,0.0011061693,0.0020402453,0.0002556452,0.00076510344,0.0002992696],"domain_scores_gemma":[0.9926075,0.003384799,0.0020887495,0.0016066857,0.00022872144,0.00008354142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021389537,0.00037273578,0.002493118,0.00011828632,0.00033723802,0.000033675507,0.00120642,0.00007147118,0.0002148434],"category_scores_gemma":[0.0023309297,0.00014125438,0.0016415546,0.0007716158,0.00064287137,0.00007316667,0.00069806585,0.00031412925,0.0000012482624],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004618304,0.00021534797,0.0000060365815,0.4604463,0.0024792203,0.0000011766467,0.00024064117,9.73813e-7,1.1199134e-7,0.00254076,0.0031276927,0.53089553],"study_design_scores_gemma":[0.00051542756,0.00013470033,0.00006247065,0.7728195,0.0006253721,0.00009471886,0.0005367567,0.000016219987,0.0000030737049,0.00045340648,0.22461046,0.00012788842],"about_ca_topic_score_codex":0.000008845362,"about_ca_topic_score_gemma":0.0000011625355,"teacher_disagreement_score":0.5307677,"about_ca_system_score_codex":0.000017676652,"about_ca_system_score_gemma":0.00019094015,"threshold_uncertainty_score":0.57601863},"labels":[],"label_agreement":null},{"id":"W4308993679","doi":"10.1136/ard-2022-223357","title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","year":2022,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Observational study; Internal medicine; Adverse effect; Randomized controlled trial; Safety profile","score_opus":0.06077201124255265,"score_gpt":0.3501212984992277,"score_spread":0.289349287256675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308993679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007780488,0.9870611,0.000015014051,0.0037935828,0.00016195403,0.007436945,0.0013886534,0.000009512521,0.000055469955],"genre_scores_gemma":[0.0009149425,0.99729323,0.000050182232,0.00019415969,0.000008050397,0.0013543668,0.00010710823,0.000031330826,0.000046604306],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953445,0.001162456,0.0021786818,0.00025025872,0.0007669315,0.00029714435],"domain_scores_gemma":[0.9932053,0.0027491513,0.002141275,0.0015755928,0.0002469462,0.000081705584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024617757,0.00036998757,0.0025419602,0.000110966146,0.00036928558,0.000029731715,0.0011688579,0.000073086085,0.00025941257],"category_scores_gemma":[0.0018430265,0.00014020242,0.0015787804,0.0007498617,0.0006434666,0.000079289224,0.00072055537,0.0003145754,0.0000010928873],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047835194,0.00015249618,0.00000711493,0.47739825,0.002483895,0.0000010821662,0.00022480014,9.3977906e-7,9.1433485e-8,0.0035411483,0.0029717819,0.51317054],"study_design_scores_gemma":[0.0003648038,0.000113244576,0.000042182575,0.7152161,0.0005318195,0.000094427305,0.0006432068,0.000017027858,0.0000022665515,0.0005896665,0.2822676,0.000117621385],"about_ca_topic_score_codex":0.000009803671,"about_ca_topic_score_gemma":0.0000017693635,"teacher_disagreement_score":0.51305294,"about_ca_system_score_codex":0.000020705553,"about_ca_system_score_gemma":0.00020230626,"threshold_uncertainty_score":0.5717289},"labels":[],"label_agreement":null},{"id":"W4309496718","doi":"10.1136/ard-2022-223358","title":"Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","year":2022,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Observational study; Clinical trial; Prednisone; Pharmacoepidemiology; Diabetes mellitus; Intensive care medicine; Pharmacology; Medical prescription","score_opus":0.05788886227386592,"score_gpt":0.3450418941427009,"score_spread":0.287153031868835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309496718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050952,0.9872525,0.000027826576,0.0018561843,0.00013170276,0.009038671,0.0011608439,0.0000072232265,0.000015557744],"genre_scores_gemma":[0.002173611,0.9964788,0.00007356541,0.00010312763,0.0000067816404,0.00092560006,0.00016650814,0.000034233795,0.00003775865],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99493814,0.00088919356,0.0028275484,0.00020943387,0.0008986958,0.00023701518],"domain_scores_gemma":[0.99191356,0.0026490395,0.0034026646,0.0015550642,0.0004102294,0.00006945405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018618812,0.00032987332,0.0022901176,0.00013463938,0.0002791771,0.00003560057,0.00084031525,0.000059036654,0.000108171545],"category_scores_gemma":[0.0023798484,0.00014237117,0.0013051123,0.0008397101,0.0004562499,0.00018049721,0.0004762475,0.00024403178,4.84595e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010291247,0.00024711434,0.000016107304,0.59509426,0.0030007332,7.627406e-7,0.00049913954,0.000003791807,6.662502e-7,0.0029561166,0.0022078736,0.39587054],"study_design_scores_gemma":[0.00084506656,0.00013295199,0.00026143994,0.87929845,0.00094270974,0.000056037014,0.0006589748,0.000046810477,0.000015780372,0.0002469602,0.117361255,0.00013356941],"about_ca_topic_score_codex":0.000024466442,"about_ca_topic_score_gemma":0.0000056905187,"teacher_disagreement_score":0.39573696,"about_ca_system_score_codex":0.000020404095,"about_ca_system_score_gemma":0.00025045758,"threshold_uncertainty_score":0.5805728},"labels":[],"label_agreement":null},{"id":"W4311621329","doi":"10.1136/ard-2022-222543","title":"Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eli Lilly Japan; Genentech; Idorsia Pharmaceuticals; Teijin Pharma; Taichung Veterans General Hospital; Assistance publique-Hôpitaux de Paris; Chugai Pharmaceutical; National Yang-Ming University; Duke Clinical Research Institute; Astellas Pharma; Eisai; Mitsubishi Tanabe Pharma Corporation; Medicines Company; Regado Biosciences; St. Jude Medical; Nippon Shinyaku; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; National Institutes of Health; Regeneron Pharmaceuticals; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Belvoir Media Group; Boehringer Ingelheim Japan; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Gilead Sciences; Bristol-Myers Squibb; Cleveland Clinic; Actelion Pharmaceuticals; Ministry of Science and Technology, Taiwan; Moderna; Pfizer; Biogen; HLS Therapeutics; GlaxoSmithKline; CSL Behring; Eli Lilly and Company; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Open label; Malignancy; Internal medicine; Dermatology; Randomized controlled trial; TNF inhibitor; Clinical trial; Arthritis; Oncology; Adalimumab","score_opus":0.05098159510434724,"score_gpt":0.3178714133574589,"score_spread":0.26688981825311164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311621329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96624494,0.020337194,0.0000023081195,0.0040665637,0.00057171506,0.0057360586,0.002367745,0.000044362263,0.000629107],"genre_scores_gemma":[0.9691026,0.029000567,0.000029933928,0.00023765903,0.00004578207,0.0013015086,0.00017344794,0.000042742515,0.00006572977],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941118,0.0022581252,0.0013151965,0.00047267645,0.001271705,0.00057053653],"domain_scores_gemma":[0.9935341,0.00409856,0.00086166605,0.0010766689,0.00020289408,0.00022610942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023334043,0.000338156,0.0014203662,0.00010578216,0.0005897694,0.00015105108,0.0010109305,0.000046079993,0.0004735825],"category_scores_gemma":[0.0066811657,0.00018755796,0.0003161227,0.0005691513,0.00043425398,0.00022424951,0.0004200418,0.00042934556,0.000009581924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9461612,0.0017926748,0.005327177,0.000023660397,0.0010739928,0.00003937745,0.0011355453,0.0001790836,0.000009519578,0.00019955184,0.010411245,0.033646982],"study_design_scores_gemma":[0.98017114,0.0022361972,0.009526576,0.0017192645,0.000026867137,0.000011832494,0.0023834945,0.00038387429,0.000118884585,0.001562016,0.0015668873,0.00029295843],"about_ca_topic_score_codex":0.002211972,"about_ca_topic_score_gemma":0.0006163081,"teacher_disagreement_score":0.034009956,"about_ca_system_score_codex":0.00003516188,"about_ca_system_score_gemma":0.00059967797,"threshold_uncertainty_score":0.79984623},"labels":[],"label_agreement":null},{"id":"W4312129185","doi":"10.1136/ard-2022-223469","title":"Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Versus Arthritis; National Institute for Health and Care Research; Henry Smith Charity; Advanced Medical Research Foundation; Action Medical Research; Cure JM Foundation; Great Ormond Street Hospital Charity; Kennedy Trust for Rheumatology Research; Wellcome Trust","keywords":"CD14; Peripheral blood mononuclear cell; Molecular biology; Mitochondrion; Mitochondrial DNA; Biology; Medicine; Biochemistry; Gene; In vitro; Flow cytometry","score_opus":0.014669223142698867,"score_gpt":0.2579271110617181,"score_spread":0.24325788791901926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312129185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331295,0.0035079436,0.0000016416054,0.0015683168,0.0002521081,0.0008629346,0.0000845944,0.000023298133,0.00038617945],"genre_scores_gemma":[0.9986487,0.0001481571,0.000023299202,0.00091545895,0.00003627522,0.00013789853,0.000031954947,0.000027517763,0.000030720377],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975099,0.000533198,0.0008241723,0.00020953579,0.0006136533,0.0003095466],"domain_scores_gemma":[0.99848354,0.0002584352,0.00039925557,0.0006756328,0.00010513271,0.00007797672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002960306,0.00021602522,0.00057796435,0.00020986093,0.000119714416,0.000017685934,0.0005686318,0.00007064307,0.00023399023],"category_scores_gemma":[0.00026413647,0.00014887433,0.0002851672,0.0005118918,0.00015506777,0.00012274066,0.00027775456,0.00034621565,0.0000058397677],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033888288,0.012503673,0.2734668,0.013564772,0.0022117486,0.001645978,0.12864056,0.010841484,0.31189454,0.0108665675,0.15257658,0.04789901],"study_design_scores_gemma":[0.010630605,0.0013991044,0.8404416,0.0046914634,0.0005029589,0.00036421345,0.03163622,0.004258573,0.08901469,0.009675983,0.006339057,0.0010455403],"about_ca_topic_score_codex":0.00009909609,"about_ca_topic_score_gemma":0.000029568193,"teacher_disagreement_score":0.5669748,"about_ca_system_score_codex":0.000048192665,"about_ca_system_score_gemma":0.00026002675,"threshold_uncertainty_score":0.6070919},"labels":[],"label_agreement":null},{"id":"W4313561946","doi":"10.1136/ard-2022-223561","title":"Matching researchers' needs and patients' contributions: practical tips for meaningful patient engagement from the field of rheumatology","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance; Glycemic Index Laboratories","funders":"","keywords":"Medicine; Rheumatology; Field (mathematics); Internal medicine; Medical education; Matching (statistics); Alternative medicine; Medical physics; Family medicine; Pathology","score_opus":0.3254918432794573,"score_gpt":0.513267671059948,"score_spread":0.18777582778049068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313561946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816902,0.0004929264,0.00018875701,0.013533313,0.0004829082,0.0023665803,0.0011030523,0.000026110642,0.00011609991],"genre_scores_gemma":[0.9956902,0.0006768488,0.00010925416,0.0027843448,0.000013307545,0.00043264753,0.00023315832,0.000012899758,0.00004730271],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99675506,0.0013080533,0.00085602846,0.00015291282,0.0004435458,0.00048441396],"domain_scores_gemma":[0.98196995,0.016578557,0.00056506944,0.0003943291,0.00032315834,0.00016890769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014899232,0.00012360314,0.00031944306,0.00007210855,0.00079553085,0.000007720928,0.00023201802,0.00007401284,0.00011790612],"category_scores_gemma":[0.004925791,0.000071670656,0.00011334177,0.00024400916,0.00011506807,0.000080917736,0.00039631577,0.0002484539,0.000020094249],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015604136,0.0011503105,0.5342445,0.0066618007,0.0005379008,5.6028915e-7,0.04855336,0.000024349752,0.000009071033,0.05006906,0.32490385,0.03228483],"study_design_scores_gemma":[0.010545983,0.0044575217,0.3423784,0.026867764,0.00062069535,0.0000010623233,0.22095211,0.003076607,0.0010654328,0.34279242,0.046364088,0.00087790325],"about_ca_topic_score_codex":0.0014049091,"about_ca_topic_score_gemma":0.00007324739,"teacher_disagreement_score":0.29272336,"about_ca_system_score_codex":0.00002860857,"about_ca_system_score_gemma":0.00024682702,"threshold_uncertainty_score":0.61186606},"labels":[],"label_agreement":null},{"id":"W4313639762","doi":"10.1136/ard-2022-223071","title":"Jack pot! What can we learn about registries with respect to treatment cycling in rheumatoid arthritis?","year":2023,"lang":"en","type":"editorial","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cycling; Physical therapy; Internal medicine","score_opus":0.034161760812742054,"score_gpt":0.32585564961894725,"score_spread":0.29169388880620517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313639762","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34407434,0.27707618,0.0000060067687,0.02784768,0.3429765,0.0049930476,0.0021939597,0.00044614667,0.00038611447],"genre_scores_gemma":[0.040624995,0.93409413,0.00004490456,0.00009466693,0.02158778,0.0004718812,0.00035434155,0.00021129451,0.002516023],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947551,0.000359877,0.001109767,0.0007411221,0.0020262212,0.0010079405],"domain_scores_gemma":[0.9946607,0.0022218234,0.00053226016,0.0014875026,0.00048495122,0.0006127721],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005173843,0.0006977569,0.0018485335,0.0005571728,0.00023847104,0.00039128747,0.0006519616,0.0002856349,0.000101064725],"category_scores_gemma":[0.005452779,0.00045364373,0.0005321758,0.0008472473,0.00050667336,0.0002953195,0.0002298459,0.0005492745,0.0001020351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002326616,0.0006706105,0.00092346466,0.0009737967,0.0010799898,0.00022390975,0.0031763182,0.00011358221,0.000006055013,0.000074044765,0.8408251,0.14960653],"study_design_scores_gemma":[0.008625336,0.0039963997,0.0048848563,0.1960552,0.00007183519,0.000039409137,0.008333572,0.000033315577,0.00054237904,0.0023836782,0.7737968,0.001237203],"about_ca_topic_score_codex":0.0019719987,"about_ca_topic_score_gemma":0.0035758424,"teacher_disagreement_score":0.65701795,"about_ca_system_score_codex":0.00017845008,"about_ca_system_score_gemma":0.0018432471,"threshold_uncertainty_score":0.9997915},"labels":[],"label_agreement":null},{"id":"W4313650505","doi":"10.1136/ard-2022-223541","title":"Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy","year":2023,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Rescue therapy; Daratumumab; Refractory (planetary science); Myopathy; Immunology; Immune system; Antibody; Internal medicine; Monoclonal antibody","score_opus":0.03365039358986817,"score_gpt":0.2984185273210256,"score_spread":0.26476813373115743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313650505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7177645,0.012867287,0.0000015646025,0.26386654,0.0017118253,0.001927093,0.0005877024,0.0002785776,0.0009949175],"genre_scores_gemma":[0.5968261,0.017547956,0.000029593544,0.37948754,0.00079976575,0.00024201216,0.0013061818,0.00044575537,0.0033151067],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99569756,0.000501559,0.0013799471,0.00053485617,0.0011137318,0.00077236065],"domain_scores_gemma":[0.99652874,0.0006322422,0.0007507014,0.0016434537,0.00029192065,0.0001529399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004450265,0.0006321103,0.0016131189,0.0004806181,0.00020615742,0.00008744658,0.0006805403,0.00061520014,0.00022709584],"category_scores_gemma":[0.0011433408,0.00044953168,0.0008611395,0.000690097,0.0003059292,0.00020744448,0.000253238,0.0014107714,0.0002688694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040756926,0.00028484847,0.0029625355,0.0034189823,0.00058980414,0.002381258,0.00089141144,0.000028308885,0.00008918184,0.000018035382,0.9820893,0.0068387557],"study_design_scores_gemma":[0.0105807865,0.0014615664,0.56234396,0.068739675,0.0008708186,0.0011150503,0.0013803068,0.0006788295,0.0014748083,0.0043354244,0.3440154,0.0030034008],"about_ca_topic_score_codex":0.00061646337,"about_ca_topic_score_gemma":0.00001007885,"teacher_disagreement_score":0.6380739,"about_ca_system_score_codex":0.000070672766,"about_ca_system_score_gemma":0.00063353876,"threshold_uncertainty_score":0.9997956},"labels":[],"label_agreement":null},{"id":"W4315475349","doi":"10.1136/ard-2022-223328","title":"Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; Versus Arthritis; University of Liverpool; Wellcome Trust; National Institute for Health and Care Research; Alder Hey Children's NHS Foundation Trust","keywords":"Medicine; Health care; Delphi method; Family medicine","score_opus":0.09849282097537208,"score_gpt":0.39332960696066144,"score_spread":0.29483678598528934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315475349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41272363,0.5788047,0.00006108938,0.0003665392,0.00038550334,0.0055422657,0.0018206047,0.00008270965,0.00021296184],"genre_scores_gemma":[0.058150385,0.9347447,0.0029062263,0.00020572211,0.0001393321,0.0014665149,0.0007433648,0.0003239457,0.0013197908],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.994303,0.00064277946,0.0023578056,0.000750744,0.0014018344,0.0005438303],"domain_scores_gemma":[0.99573505,0.0013199892,0.00088167196,0.001284887,0.00024290271,0.0005354712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011356642,0.00062108407,0.0030027844,0.00095251476,0.000083685714,0.00006893988,0.0010292907,0.00016959842,0.00006546552],"category_scores_gemma":[0.0041510207,0.000407169,0.00052454905,0.0006226666,0.00011022899,0.00016385253,0.00093411555,0.00027209503,0.000043187756],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011049075,0.0028447465,0.063556485,0.3778639,0.008389239,0.00025334704,0.053999078,0.00015380204,0.00002134489,0.00056265097,0.0042507336,0.48699975],"study_design_scores_gemma":[0.003998742,0.00032322088,0.016607566,0.94655704,0.0014059218,0.0062940987,0.003924116,0.00036222028,0.00015826631,0.002101093,0.016907375,0.0013603354],"about_ca_topic_score_codex":0.00018422576,"about_ca_topic_score_gemma":0.00003412601,"teacher_disagreement_score":0.5686931,"about_ca_system_score_codex":0.0002091195,"about_ca_system_score_gemma":0.0017514719,"threshold_uncertainty_score":0.999838},"labels":[],"label_agreement":null},{"id":"W4317103607","doi":"10.1136/ard-2022-223595","title":"Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; University Health Network","funders":"UCB Pharma","keywords":"Medicine; Internal medicine; Placebo; Ankylosing spondylitis; Adverse effect; Axial spondyloarthritis; Clinical endpoint; Upper respiratory tract infection; Physical therapy; Clinical trial; Sacroiliitis; Pathology; Alternative medicine","score_opus":0.06558204747201496,"score_gpt":0.377787311812416,"score_spread":0.312205264340401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317103607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860198,0.008828101,0.0000028973727,0.0010991481,0.00011457478,0.0027959412,0.0008167273,0.000021858328,0.00030095008],"genre_scores_gemma":[0.9906068,0.008979235,0.00004021026,0.000039085746,0.000022266637,0.000114432645,0.000065886125,0.000015602265,0.000116480056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967319,0.00050183,0.0018890557,0.00021476016,0.0004121684,0.00025028002],"domain_scores_gemma":[0.99492127,0.0034968248,0.0009088581,0.00040969433,0.0001515975,0.0001117849],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001520091,0.00020754682,0.0025918332,0.0002105539,0.000057431185,0.0000065749396,0.00012011538,0.000043719163,0.000053630432],"category_scores_gemma":[0.010605985,0.00012466863,0.0006271462,0.00040819848,0.00027687039,0.000051567706,0.00008764204,0.000057191286,0.0000036086544],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79641116,0.005259284,0.0028134896,0.000979314,0.004185219,0.00009282852,0.001592249,0.0001787455,0.00052462297,0.00048688328,0.0038152148,0.18366097],"study_design_scores_gemma":[0.92055655,0.0011541364,0.069797814,0.0042090565,0.0009501997,0.0000075862044,0.00037912463,0.00028012038,0.0011495162,0.0013196965,0.00005835297,0.0001378197],"about_ca_topic_score_codex":0.00016637523,"about_ca_topic_score_gemma":0.000022990245,"teacher_disagreement_score":0.18352315,"about_ca_system_score_codex":0.000008092683,"about_ca_system_score_gemma":0.00010794913,"threshold_uncertainty_score":0.9977281},"labels":[],"label_agreement":null},{"id":"W4319072151","doi":"10.1136/ard-2022-223568","title":"Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Office of Science; National Institutes of Health","keywords":"Neutrophil extracellular traps; Osteoclast; Bone resorption; Medicine; Synovial fluid; Rheumatoid arthritis; Immunology; Arthritis; Inflammation; CD14; Internal medicine; Immune system; Receptor; Pathology; Osteoarthritis","score_opus":0.028117300757326203,"score_gpt":0.24879147277856223,"score_spread":0.22067417202123601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319072151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877842,0.010048236,0.000016114933,0.0012921821,0.0002482958,0.00037450792,0.00011202869,0.00007250332,0.00005195161],"genre_scores_gemma":[0.9930051,0.0061759646,0.000003131752,0.00007195744,0.00000466037,0.000046747155,0.00016145506,0.000018140234,0.00051283214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99852353,0.0003459317,0.0005281583,0.00020719744,0.00008755358,0.00030763142],"domain_scores_gemma":[0.9991172,0.00021530708,0.00029727136,0.00025804172,0.00008131039,0.000030899788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027412976,0.00018684166,0.00039236486,0.00022611384,0.00017460444,0.000018355197,0.0001848495,0.000113923474,0.00009959496],"category_scores_gemma":[0.00023637572,0.00014368516,0.00013780956,0.00044087067,0.00017340505,0.0002639682,0.00008555005,0.00012319957,0.00008139414],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009231354,0.0016321716,0.010562523,0.0008818269,0.0009399151,0.000059542956,0.010051333,0.00051626,0.7633802,0.0203535,0.024122426,0.16657713],"study_design_scores_gemma":[0.008284629,0.0005899248,0.4973964,0.0040448946,0.00012757131,0.000081395345,0.003168631,0.00061677315,0.4536817,0.028128102,0.0028062523,0.0010737057],"about_ca_topic_score_codex":0.00009457134,"about_ca_topic_score_gemma":0.00005911869,"teacher_disagreement_score":0.48683387,"about_ca_system_score_codex":0.000020309604,"about_ca_system_score_gemma":0.000033640663,"threshold_uncertainty_score":0.58593106},"labels":[],"label_agreement":null},{"id":"W4320719537","doi":"10.1136/ard-2022-223499","title":"Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University Health Network; University of Toronto; McMaster University; Impact; Canadian Arthritis Patient Alliance","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; Agency for Healthcare Research and Quality; Clínica Alemana de Santiago; European League Against Rheumatism; Universidade Federal do Rio de Janeiro; Universidade Federal de Pernambuco; Universidade Federal de Uberlândia; Instituto de Seguriidad y Servicios Sociales de los Trabadores del Estado; Universidade Federal de Minas Gerais; Universidade do Estado do Rio de Janeiro; Strong; Hacettepe Üniversitesi; Brigham and Women's Hospital; Klaipedos Universitetas; Instituto Mexicano del Seguro Social; George Washington University; King's College London; Auckland District Health Board; Universidade Federal de Juiz de Fora; Georgetown University; Psoriasis Association; Massachusetts General Hospital; Hamad Medical Corporation; Kaiser Permanente; Cleveland Clinic; Universidade de São Paulo; National Center for Global Health and Medicine; National Institute for Health and Care Research; Hospital for Special Surgery","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Comorbidity; Psoriasis; Odds ratio; Rheumatology; Arthritis; Immunology","score_opus":0.0647814756032141,"score_gpt":0.33328133753818345,"score_spread":0.26849986193496933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320719537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96220773,0.008531047,0.000016046479,0.021071222,0.00013817813,0.0012563921,0.006655401,0.00010509992,0.00001885827],"genre_scores_gemma":[0.98124737,0.014054878,0.00003738414,0.0034624827,0.00002151888,0.00016972926,0.00094380777,0.000030809275,0.000032035397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746114,0.00026452806,0.000658998,0.00059484644,0.0005591664,0.00046135052],"domain_scores_gemma":[0.99648416,0.0013936548,0.0006637107,0.0010085129,0.00011017336,0.00033976283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036099163,0.0003806044,0.0011984439,0.000041663596,0.00042765928,0.000080474914,0.0003426319,0.000084863685,0.00002535227],"category_scores_gemma":[0.0063254707,0.00022247231,0.000086554996,0.0006200516,0.0008709612,0.00017809341,0.00034538054,0.00014161564,0.0000047127564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015386271,0.00051270134,0.9785526,0.0004003264,0.001968236,0.00037877564,0.0007963186,0.000008118124,8.3472696e-7,0.00051572477,0.0060081966,0.00931958],"study_design_scores_gemma":[0.00879636,0.0004195316,0.9829629,0.0021607992,0.00054863316,0.00014645421,0.0012647,0.0001254136,0.00000355139,0.00266263,0.0006319818,0.00027702533],"about_ca_topic_score_codex":0.007550261,"about_ca_topic_score_gemma":0.016669363,"teacher_disagreement_score":0.019039601,"about_ca_system_score_codex":0.000068789595,"about_ca_system_score_gemma":0.0005439068,"threshold_uncertainty_score":0.99905854},"labels":[],"label_agreement":null},{"id":"W4321200492","doi":"10.1136/ard-2022-223751","title":"What is a response in randomised controlled trials in giant cell arteritis?","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network","funders":"National Institutes of Health; Sanofi; European League Against Rheumatism; GlaxoSmithKline; American College of Rheumatology Research and Education Foundation; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Giant cell arteritis; Adverse effect; Erythrocyte sedimentation rate; Disease; Randomized controlled trial; Gold standard (test); Intensive care medicine; Clinical endpoint; Physical therapy; Internal medicine; Vasculitis","score_opus":0.04912421236013309,"score_gpt":0.3383008583350646,"score_spread":0.28917664597493153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321200492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96512645,0.0060845087,0.000002078471,0.026415534,0.00023684833,0.0018508686,0.0000711791,0.000029314568,0.00018322392],"genre_scores_gemma":[0.98484683,0.012840464,0.000006171595,0.00083486194,0.000013751632,0.000276698,0.000018380753,0.0000143635425,0.0011484632],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9967635,0.001378704,0.0011642227,0.00015969084,0.0002937894,0.00024006797],"domain_scores_gemma":[0.9959283,0.0032022381,0.00031438624,0.00038005307,0.00006628595,0.00010875169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031525774,0.00013463649,0.001479779,0.00032409024,0.00004010551,0.000041344396,0.00012734633,0.000069159534,0.0004086489],"category_scores_gemma":[0.005945218,0.00007742031,0.0008932969,0.00051460246,0.000078941,0.00012692998,0.000035976474,0.00010486708,0.00006136271],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5776933,0.0110903075,0.006520918,0.005361719,0.0067407093,0.0018861924,0.028600642,0.0019314355,0.014146219,0.0009599546,0.2501804,0.0948882],"study_design_scores_gemma":[0.45607737,0.00056711753,0.49031928,0.021872886,0.0011867005,0.000029944764,0.006766991,0.006203538,0.002716619,0.013473276,0.0003493176,0.00043695324],"about_ca_topic_score_codex":0.000032129476,"about_ca_topic_score_gemma":0.000004703663,"teacher_disagreement_score":0.48379838,"about_ca_system_score_codex":0.000013173897,"about_ca_system_score_gemma":0.00016643365,"threshold_uncertainty_score":0.71174103},"labels":[],"label_agreement":null},{"id":"W4324276896","doi":"10.1136/annrheumdis-2019-eular.6069","title":"SAT0667 TREATMENT RESPONSE CRITERIA FOR ANCA-ASSOCIATED VASCULITIS: RESULTS OF A SCOPING REVIEW","year":2019,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Insmed; Genentech; Celgene; Sanofi; Eli Lilly and Company; Chugai Pharmaceutical; Pfizer; Oak Foundation","keywords":"Medicine; Microscopic polyangiitis; Randomized controlled trial; Vasculitis; Internal medicine; Granulomatosis with polyangiitis; MEDLINE; Quality of life (healthcare); Physical therapy; Clinical trial; Intensive care medicine; Disease","score_opus":0.2823541088552351,"score_gpt":0.4932221882238513,"score_spread":0.21086807936861618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324276896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031003036,0.9905348,0.0000026324767,0.00067574874,0.00021687451,0.0055476045,0.0025459446,0.000023318282,0.00014305521],"genre_scores_gemma":[0.00016572392,0.9973596,0.000050585713,0.00044382524,0.000026589669,0.0004967384,0.00044926282,0.00004927715,0.00095845247],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963506,0.00085285906,0.0018401886,0.0003719973,0.00027638738,0.00030800747],"domain_scores_gemma":[0.99623317,0.00052066386,0.0016426949,0.0011844992,0.00030251572,0.000116451774],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008018181,0.00041822784,0.004340061,0.0001385271,0.00003755225,0.000008632158,0.00033585294,0.00015633527,0.000118004704],"category_scores_gemma":[0.008691249,0.00023315178,0.0030717412,0.00027289274,0.00011535639,0.000057717054,0.000100892714,0.00007544441,0.000024379226],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033385277,0.0006628245,0.0000020535895,0.49912906,0.0016311404,0.000003822198,0.00005637528,7.667142e-8,0.0000013931875,0.000014775827,0.0298144,0.46835023],"study_design_scores_gemma":[0.001819945,0.0016788847,0.00058895414,0.96135795,0.007821177,0.000015853495,0.000014062005,0.000004546737,0.000017707065,0.000049883893,0.02642469,0.00020633888],"about_ca_topic_score_codex":0.000036528167,"about_ca_topic_score_gemma":0.0000043166933,"teacher_disagreement_score":0.46814388,"about_ca_system_score_codex":0.00006124203,"about_ca_system_score_gemma":0.0009498589,"threshold_uncertainty_score":0.99965894},"labels":[],"label_agreement":null},{"id":"W4324277017","doi":"10.1136/annrheumdis-2019-eular.2352","title":"SAT0614 DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? – RESULTS FROM THE EUROSPA RESEARCH COLLABORATION","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Arthritis Society; Regeneron Pharmaceuticals; Biogen; Samsung; British Society for Rheumatology; Celgene; Celltrion; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Psoriatic arthritis; Medicine; Internal medicine; Adverse effect; Arthritis; Physical therapy","score_opus":0.017158038928618658,"score_gpt":0.29882606969022407,"score_spread":0.2816680307616054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324277017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98295766,0.00661113,7.9347495e-7,0.0042706295,0.00012499432,0.004564696,0.0014148189,0.000009568117,0.000045695408],"genre_scores_gemma":[0.9919763,0.00745664,0.000011595027,0.000060938557,0.000038731236,0.00025112682,0.000145549,0.000027334754,0.000031793683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644595,0.0016011955,0.00044836992,0.00032489316,0.00087928184,0.00030027865],"domain_scores_gemma":[0.9881417,0.010244002,0.00027677178,0.00084471755,0.00040778116,0.000085022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001240745,0.00020831135,0.00047552356,0.00005515685,0.00025986036,0.00009619337,0.0003066442,0.000040910276,0.000019464649],"category_scores_gemma":[0.0029243177,0.00007396451,0.000108891174,0.00035182323,0.00040606607,0.00014455516,0.00008330199,0.0001558495,0.0000035185503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04916751,0.0028907973,0.74506366,0.00053878967,0.0016523661,0.0000045796473,0.014257294,0.000117913565,0.00015052783,0.0013433887,0.005165038,0.17964812],"study_design_scores_gemma":[0.010542811,0.0020281815,0.96395946,0.010330992,0.000043540058,4.708367e-7,0.002611329,0.0001325607,0.004217575,0.0057178214,0.00028608288,0.0001292078],"about_ca_topic_score_codex":0.0027631428,"about_ca_topic_score_gemma":0.0017368816,"teacher_disagreement_score":0.21889575,"about_ca_system_score_codex":0.000034507146,"about_ca_system_score_gemma":0.00020614805,"threshold_uncertainty_score":0.41770637},"labels":[],"label_agreement":null},{"id":"W4327811397","doi":"10.1136/ard-2022-223468","title":"Meta-analysis of erosive hand osteoarthritis identifies four common variants that associate with relatively large effect","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society","keywords":"Osteoarthritis; Medicine; Genetics; Phenotype; Gene; Biology; Pathology","score_opus":0.20954319251151535,"score_gpt":0.37678506545212626,"score_spread":0.1672418729406109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327811397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066026314,0.9853858,0.000004720274,0.00009023688,0.00013017302,0.0024564895,0.005152735,0.000047802823,0.00012942322],"genre_scores_gemma":[0.03266291,0.9626727,0.000017601315,0.000044996646,0.000015467196,0.0005076994,0.0007302955,0.00010946221,0.0032388666],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99604493,0.0009945945,0.0010797202,0.00045707898,0.0009999084,0.00042376283],"domain_scores_gemma":[0.99460435,0.0018210687,0.0021457651,0.0010140038,0.00023778601,0.00017702642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075062306,0.00064393587,0.008093965,0.0004975671,0.00018886497,0.00006491131,0.00037208296,0.00020618741,0.00020726779],"category_scores_gemma":[0.00049426366,0.00033768857,0.006205631,0.001260403,0.0002252844,0.00014487792,0.00020731379,0.00021187872,0.000039800027],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002578969,0.0007253739,0.00059578905,0.03712919,0.7539348,0.00017888972,0.0005513059,0.0000040465384,0.0000016724443,0.00030138527,0.00075234176,0.20556729],"study_design_scores_gemma":[0.0016962618,0.0016185174,0.0012037364,0.030727621,0.9624664,0.000015723479,0.000099042096,0.0000031650043,0.00016477499,0.00044643937,0.0012022739,0.00035601304],"about_ca_topic_score_codex":0.000059746293,"about_ca_topic_score_gemma":0.00021145398,"teacher_disagreement_score":0.20853162,"about_ca_system_score_codex":0.000029246075,"about_ca_system_score_gemma":0.00019404122,"threshold_uncertainty_score":0.9999075},"labels":[],"label_agreement":null},{"id":"W4360612069","doi":"10.1136/ard-2022-223559","title":"Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University; University of Toronto","funders":"NIHR Cambridge Biomedical Research Centre; National Center for Advancing Translational Sciences; Wellcome Trust; Vasculitis Clinical Research Consortium; Genentech; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Versus Arthritis; University of Cambridge; University of Miyazaki; Ministry of Health, Labour and Welfare; National Institutes of Health; National Center for Research Resources; University of Pennsylvania; Cambridge University Hospitals; National Institute for Health and Care Research","keywords":"Medicine; Rituximab; Azathioprine; Internal medicine; Gastroenterology; Adverse effect; Maintenance therapy; Vasculitis; Surgery; Disease; Lymphoma; Chemotherapy","score_opus":0.02803968185622173,"score_gpt":0.3086604674213796,"score_spread":0.28062078556515785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360612069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250036,0.00031715847,0.00011441313,0.0014853439,0.0004236798,0.0043297512,0.0007297993,0.00003957584,0.000059940634],"genre_scores_gemma":[0.997814,0.00068002474,0.00011892271,0.000043699478,0.000033679968,0.00043158964,0.00058009883,0.000021641177,0.00027631546],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987616,0.00007064842,0.00046426573,0.00018704373,0.00033409294,0.00018233579],"domain_scores_gemma":[0.9979508,0.0007178194,0.00038230274,0.0002561924,0.00053255423,0.0001603632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002856472,0.0001285435,0.0005774456,0.00008247292,0.00012445425,0.000014048186,0.00011602736,0.00004781175,0.000022688686],"category_scores_gemma":[0.0047546444,0.00007493751,0.00041132193,0.00014416451,0.000109137654,0.000115294926,0.000030785122,0.000046087014,3.8133427e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97471803,0.0027396297,0.0026885509,0.00060883444,0.002893801,0.000001964371,0.00020772395,0.000091244445,0.000018833789,0.0011506964,0.003191666,0.011689017],"study_design_scores_gemma":[0.9250232,0.0010730416,0.06293321,0.0022548835,0.0012152179,3.4729356e-7,0.00008405366,0.00524909,0.00002015876,0.0019292046,0.000106571075,0.00011103768],"about_ca_topic_score_codex":0.000008145528,"about_ca_topic_score_gemma":0.0000015090326,"teacher_disagreement_score":0.060244657,"about_ca_system_score_codex":0.00001623525,"about_ca_system_score_gemma":0.00011621061,"threshold_uncertainty_score":0.5692097},"labels":[],"label_agreement":null},{"id":"W4361018439","doi":"10.1136/ard-2022-222852","title":"EULAR study group on ‘MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cilag; National Eye Institute; Medical Research Council; National Institutes of Health; Jacobs University; Swedish Orphan Biovitrum; Agence Nationale de la Recherche; Harvard University; Pfizer; Northwestern University; Massachusetts General Hospital; Sanofi; Amgen; Deutsche Forschungsgemeinschaft; Eli Lilly and Company","keywords":"Major histocompatibility complex; Medicine; Disease; MHC class I; Immunology; Immune system; Pathology","score_opus":0.16591875695054456,"score_gpt":0.458436390069173,"score_spread":0.29251763311862844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361018439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015407102,0.97991085,0.000010278194,0.0001921693,0.00045474953,0.0029222034,0.0009799164,0.0000948929,0.000027845645],"genre_scores_gemma":[0.020090338,0.9788211,0.000014984884,0.00007793596,0.000059973652,0.00040745686,0.00012887915,0.000117501986,0.00028180826],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.996939,0.0002913378,0.00087504595,0.00060837704,0.0007893609,0.0004968525],"domain_scores_gemma":[0.9975391,0.0005802438,0.0005751073,0.0009179567,0.00006985384,0.0003177558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040847962,0.00061220094,0.0021230518,0.00015310477,0.00053424924,0.00010541706,0.00033800091,0.00006724416,0.000016068876],"category_scores_gemma":[0.0008268226,0.00036330614,0.0009630313,0.00041833613,0.00016480165,0.00010168027,0.000749472,0.00020479607,0.000031553715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015689773,0.0019708837,0.0008991864,0.04231201,0.0038654737,0.00027372182,0.0008902085,0.0000027644048,6.633364e-8,0.00044049416,0.00048272216,0.94870555],"study_design_scores_gemma":[0.010448371,0.0035816394,0.12669736,0.742149,0.035084467,0.00009848883,0.014641913,0.00012493841,0.0000020511745,0.027918337,0.036219954,0.0030334857],"about_ca_topic_score_codex":0.00008400477,"about_ca_topic_score_gemma":0.000033518398,"teacher_disagreement_score":0.9456721,"about_ca_system_score_codex":0.000031939315,"about_ca_system_score_gemma":0.00010630279,"threshold_uncertainty_score":0.99988186},"labels":[],"label_agreement":null},{"id":"W4366598252","doi":"10.1136/ard-2022-223627","title":"Response to: Correspondence on “Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?” by Boers","year":2023,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"Sanofi Genzyme; Swedish Orphan Biovitrum; Sanofi; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Internal medicine","score_opus":0.05889792415545248,"score_gpt":0.37586629151666606,"score_spread":0.3169683673612136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366598252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6429092,0.022064801,0.00022733485,0.32153377,0.001390035,0.005856819,0.00586511,0.00012936418,0.000023519264],"genre_scores_gemma":[0.8622889,0.03724773,0.0007983485,0.089771405,0.00035945233,0.0073821475,0.0013831792,0.00044583372,0.00032302804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99431187,0.0008431145,0.0013210027,0.0008045581,0.0015928672,0.0011265671],"domain_scores_gemma":[0.9924807,0.004701644,0.0007910474,0.0012195862,0.00046623452,0.00034079017],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013204592,0.00068908394,0.0012862172,0.00025013232,0.0004575322,0.0002256849,0.0008818962,0.00021185275,0.000030380806],"category_scores_gemma":[0.009678233,0.00043273676,0.0006970166,0.00049357634,0.00025737076,0.00011263745,0.00040294617,0.00086591416,0.000013177261],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004541108,0.00043974296,0.002248962,0.0011263139,0.0002320492,0.00003951465,0.0003338238,0.00012982739,0.00006348455,0.00004294086,0.8960266,0.09477564],"study_design_scores_gemma":[0.013444592,0.0113920085,0.07807243,0.3289299,0.00016982428,0.00014530166,0.004834096,0.010756494,0.0013011526,0.007981946,0.5400114,0.002960868],"about_ca_topic_score_codex":0.00004440809,"about_ca_topic_score_gemma":0.0000132403065,"teacher_disagreement_score":0.3560152,"about_ca_system_score_codex":0.00022082879,"about_ca_system_score_gemma":0.0006256444,"threshold_uncertainty_score":0.9998124},"labels":[],"label_agreement":null},{"id":"W4366609951","doi":"10.1136/ard-2022-223808","title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McGill University Health Centre; University Health Network; University of Toronto; Dalhousie University; University of Manitoba; Toronto Western Hospital; Université Laval; Queen Elizabeth II Health Sciences Centre; University of Calgary","funders":"National Center for Research Resources; Lupus Foundation of America; Canada Research Chairs; Canadian Institutes of Health Research; LUPUS UK; National Institute for Health and Care Research; Versus Arthritis; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Society; Sandwell and West Birmingham Hospitals NHS Trust; National Center for Advancing Translational Sciences; Wellcome Trust; National Research Foundation of Korea","keywords":"Medicine; Autoantibody; Disease; Immunology; Systemic disease; Systemic lupus erythematosus; Internal medicine; Antibody","score_opus":0.045309635624162736,"score_gpt":0.3379266643569032,"score_spread":0.2926170287327405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366609951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909525,0.005642825,0.000047247133,0.0007499296,0.00038759352,0.0014971786,0.00043752618,0.00013863841,0.00014654726],"genre_scores_gemma":[0.9957955,0.0012715968,0.000015672758,0.00001431783,0.000021681964,0.00010091649,0.00007200654,0.00005680447,0.002651525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591595,0.00040449854,0.0012849999,0.0003618015,0.0015657562,0.00046697655],"domain_scores_gemma":[0.9960302,0.001088077,0.0010009344,0.0010048307,0.000584686,0.00029125842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008320811,0.00031845277,0.0012926161,0.00048220126,0.00011940339,0.00002043566,0.0005666435,0.000069988186,0.0000744638],"category_scores_gemma":[0.0040605464,0.00020013179,0.0007429261,0.00084669655,0.0005475219,0.00015956388,0.0004487705,0.00017925132,0.00002945076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073912094,0.00037102101,0.9675646,0.024801556,0.0011867709,0.000027650687,0.0018040844,0.00076786533,0.00033036064,0.00024065361,0.0018612891,0.00030505526],"study_design_scores_gemma":[0.0037314992,0.00047228258,0.90577173,0.046685364,0.0014245742,0.0010129896,0.0114396345,0.02432757,0.0030879544,0.0016142227,0.000011310253,0.0004208506],"about_ca_topic_score_codex":0.0001246167,"about_ca_topic_score_gemma":0.0000029771504,"teacher_disagreement_score":0.061792824,"about_ca_system_score_codex":0.000035770878,"about_ca_system_score_gemma":0.00036576216,"threshold_uncertainty_score":0.81611377},"labels":[],"label_agreement":null},{"id":"W4377090381","doi":"10.1136/ard-2023-224197","title":"Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience","year":2023,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; Université Laval; Toronto Western Hospital; Centre hospitalier universitaire de Québec; University of Calgary; McGill University Health Centre","funders":"","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Systemic lupus; Pregnancy; Immunology; Dermatology; Internal medicine; Disease","score_opus":0.05497392476642165,"score_gpt":0.3347435915772372,"score_spread":0.27976966681081555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377090381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79175794,0.05740944,0.000024665742,0.13357617,0.0075766146,0.008149116,0.0005231908,0.0003566943,0.00062615244],"genre_scores_gemma":[0.947622,0.018508187,0.000023207313,0.01620611,0.00090100174,0.0048391633,0.00012806738,0.0004381133,0.011334139],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99039376,0.0011949799,0.0025088114,0.0011026788,0.0033330088,0.0014667916],"domain_scores_gemma":[0.99119395,0.002699575,0.0019833713,0.0028249908,0.0010277339,0.00027036286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012346372,0.0009835056,0.0023019935,0.00058739295,0.00028633024,0.0002448821,0.0026499988,0.00064184243,0.00010894141],"category_scores_gemma":[0.0015337538,0.0005588145,0.0005069616,0.0015377953,0.0006786478,0.00027834394,0.0006580382,0.0016155633,0.00010523686],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002284532,0.0012124794,0.42700323,0.087280296,0.006884863,0.0035018232,0.09104309,0.0002854184,0.000050123206,0.00037219044,0.36254677,0.017535185],"study_design_scores_gemma":[0.015337072,0.0019548703,0.002248378,0.63816804,0.0012800808,0.1649764,0.14892414,0.0034976646,0.000047824753,0.0027592008,0.017649518,0.0031568196],"about_ca_topic_score_codex":0.0001068624,"about_ca_topic_score_gemma":0.00004560986,"teacher_disagreement_score":0.5508877,"about_ca_system_score_codex":0.000582331,"about_ca_system_score_gemma":0.0013340999,"threshold_uncertainty_score":0.99968636},"labels":[],"label_agreement":null},{"id":"W4378799384","doi":"10.1136/ard-2023-223845","title":"Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Osteoarthritis; Weight loss; Cohort; Internal medicine; Glucagon-like peptide 1 receptor; Agonist; Exenatide; Receptor; Glucagon-like peptide-1; Endocrinology; Diabetes mellitus; Obesity; Pathology; Type 2 diabetes; Alternative medicine","score_opus":0.023535050042451797,"score_gpt":0.28100615259784706,"score_spread":0.25747110255539524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378799384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96323866,0.015710318,0.0000061252194,0.013569262,0.00060087064,0.0035016562,0.0028756547,0.00023224246,0.00026523875],"genre_scores_gemma":[0.979506,0.008425453,0.000037311216,0.0034452025,0.00012389554,0.0016671141,0.0030685267,0.0000996503,0.0036268213],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99734074,0.00013626665,0.0005973487,0.00051050575,0.0007831319,0.00063200004],"domain_scores_gemma":[0.9971613,0.0010984737,0.000277529,0.0009343746,0.00016932395,0.0003589948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032501115,0.00041060074,0.0006636905,0.00010590697,0.00038044582,0.00011679447,0.00048930733,0.00007630856,0.00048668057],"category_scores_gemma":[0.00075203803,0.00025521172,0.00064967235,0.0004998638,0.00030849985,0.00019884914,0.00020850854,0.00010320282,0.00027797298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001882614,0.0011018595,0.13871706,0.00057592354,0.0029210236,0.000035351204,0.0011052289,0.0000074291056,0.00029993936,0.00032953336,0.56162196,0.2914021],"study_design_scores_gemma":[0.027168509,0.0049660807,0.6734849,0.010734283,0.0034111713,0.000005560125,0.0018158195,0.00060363417,0.0042589703,0.011845126,0.26003274,0.0016731868],"about_ca_topic_score_codex":0.00014889549,"about_ca_topic_score_gemma":0.000015016598,"teacher_disagreement_score":0.53476787,"about_ca_system_score_codex":0.000038598784,"about_ca_system_score_gemma":0.00013469213,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W4379510677","doi":"10.1136/annrheumdis-2023-eular.2515","title":"POS0888 NORMAL PERCENTILE REFERENCE CURVES FOR SKIN ULTRASOUND THICKNESS AND STIFFNESS AT RODNAN SITES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medizinische Universität Wien; Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Ultrasound; Percentile; Connective tissue disease; Rheumatology; Connective tissue; Disease; Internal medicine; Radiology; Pathology; Autoimmune disease","score_opus":0.07114107462623863,"score_gpt":0.32390426670436756,"score_spread":0.2527631920781289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800173,0.016759327,0.0000034212076,0.0016297842,0.00015281043,0.00071933575,0.00044816948,0.00008142655,0.00018843898],"genre_scores_gemma":[0.98299223,0.014822824,0.000008343671,0.00045974573,0.000035281908,0.000084709274,0.00017328777,0.000025689442,0.0013978666],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99856293,0.00008277015,0.00041297954,0.0002580434,0.00038457522,0.000298729],"domain_scores_gemma":[0.99833506,0.0005858693,0.00020703023,0.000454456,0.00020551318,0.00021205362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023680693,0.00018584321,0.00043146923,0.00007812615,0.00021783874,0.000028531154,0.00020403176,0.00007099224,0.0001258301],"category_scores_gemma":[0.0011654814,0.00011313677,0.00025055476,0.00027215687,0.00020464184,0.00009969703,0.0001322328,0.00005900337,0.000027862081],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023159543,0.0022833073,0.3860759,0.043704197,0.002661734,0.000016319123,0.003711967,0.0002451815,0.015111631,0.0013139877,0.48164427,0.06091553],"study_design_scores_gemma":[0.00090384233,0.000077298435,0.98379296,0.01155979,0.00050623744,0.000029520354,0.00086827105,0.00034664772,0.0010863051,0.0003677438,0.0002831674,0.00017820063],"about_ca_topic_score_codex":0.000058111542,"about_ca_topic_score_gemma":0.0000075995717,"teacher_disagreement_score":0.59771705,"about_ca_system_score_codex":0.000011646535,"about_ca_system_score_gemma":0.00008430434,"threshold_uncertainty_score":0.46135837},"labels":[],"label_agreement":null},{"id":"W4379510689","doi":"10.1136/annrheumdis-2023-eular.5053","title":"POS0882 SCREENING/REFERRAL STRATEGIES FOR THE EARLY RECOGNITION OF PSA AMONG PATIENTS WITH PSORIASIS: RESULTS OF A GRAPPA SURVEY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Innovative Medicines Initiative; European Commission; European Federation of Pharmaceutical Industries and Associations","keywords":"Medicine; Psoriasis; Referral; Family medicine; Dermatology","score_opus":0.081827927108435,"score_gpt":0.2851397575585802,"score_spread":0.20331183045014517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340796,0.00072513695,0.00002340452,0.00008324848,0.00020228427,0.0006157585,0.0048673213,0.000024521521,0.00005033708],"genre_scores_gemma":[0.9987109,0.0002118989,0.000019926403,0.000010924824,0.000005674429,0.00007842415,0.0008073854,0.000014297521,0.00014060184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987412,0.00032631474,0.00045678584,0.00016296687,0.00009702369,0.00021572589],"domain_scores_gemma":[0.9975505,0.0011438366,0.0005582,0.00037822445,0.00035094426,0.00001828701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041948617,0.0001573232,0.000346677,0.00009208304,0.00013136695,0.000010920698,0.00030642803,0.000072597,0.000019214838],"category_scores_gemma":[0.00044164166,0.00008254072,0.00022577659,0.00033188192,0.00030934383,0.00012571637,0.00005317163,0.000042892712,0.0000066518483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019773154,0.0018952225,0.6451657,0.00076582993,0.008684512,7.2824605e-7,0.003842093,0.00026092108,0.00031055056,0.0002930121,0.018573092,0.3004352],"study_design_scores_gemma":[0.0025045113,0.0004750105,0.9914787,0.00045424904,0.0003955424,1.9018485e-7,0.00067750376,0.000007731351,0.002859164,0.0010344305,0.000015433781,0.00009754063],"about_ca_topic_score_codex":0.0011253891,"about_ca_topic_score_gemma":0.00018966201,"teacher_disagreement_score":0.346313,"about_ca_system_score_codex":0.0000024923456,"about_ca_system_score_gemma":0.000062843435,"threshold_uncertainty_score":0.3365913},"labels":[],"label_agreement":null},{"id":"W4379510708","doi":"10.1136/annrheumdis-2023-eular.2116","title":"POS0918 VALIDATION OF A MODIFIED NEW YORK CRITERIA RETIC E-TOOL FOR INCREASING SCORING PROFICIENCY OF RADIOGRAPHS OF THE SACROILIAC JOINTS IN AXIAL SPONDYLOARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiography; Axial spondyloarthritis; Sacroiliac joint; Medical physics; Nuclear medicine; Orthodontics; Surgery; Ankylosing spondylitis; Sacroiliitis","score_opus":0.043559435304414126,"score_gpt":0.2907857854173049,"score_spread":0.24722635011289074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980577,0.0008518354,0.00034798108,0.00017904893,0.00013996703,0.00027004426,0.000090219175,0.000026499738,0.000036674966],"genre_scores_gemma":[0.9995899,0.00018294454,0.00014792387,0.000008526893,0.000013257743,0.0000141419005,0.000008751029,0.000014732978,0.00001979983],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99863344,0.00011715038,0.00063772907,0.00010864332,0.00032305013,0.00017999158],"domain_scores_gemma":[0.99900585,0.00030437298,0.00022064518,0.00034781228,0.000071950104,0.000049350907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053728826,0.00010644958,0.00038426352,0.00020494788,0.00003293928,0.000010583243,0.0002931048,0.000030238903,0.000018116543],"category_scores_gemma":[0.0016069855,0.00007500238,0.0003158576,0.0009403135,0.00013396915,0.0000711373,0.000050681247,0.0000494715,4.627403e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007811049,0.0015765068,0.29117706,0.03770686,0.0020813246,0.000005478553,0.016196623,0.17206275,0.15353145,0.002660916,0.014269188,0.3079507],"study_design_scores_gemma":[0.002751004,0.00011810631,0.41842008,0.022065094,0.0006312706,0.0000039981896,0.0010743063,0.31662753,0.21370289,0.024105983,0.000011687846,0.00048804557],"about_ca_topic_score_codex":0.00027960414,"about_ca_topic_score_gemma":0.0000025962595,"teacher_disagreement_score":0.30746266,"about_ca_system_score_codex":0.0000060779225,"about_ca_system_score_gemma":0.0000519739,"threshold_uncertainty_score":0.30585083},"labels":[],"label_agreement":null},{"id":"W4379510727","doi":"10.1136/annrheumdis-2023-eular.4791","title":"POS0881 SPECIFIC AI-GENERATED PATTERN OF TENDER JOINTS AND TENDERNESS AT ENTHESIAL SITES ARE PREDICTIVE FOR OBJECTIVE DETECTION OF MUSCULOSKELETAL INFLAMMATION IN PSORIASIS PATIENTS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi Genzyme; Genentech; Eli Lilly and Company; AstraZeneca; CSL Behring; Les Laboratories Pierre Fabre; Innovative Medicines Initiative; Biogen; European Federation of Pharmaceutical Industries and Associations; European Commission; Sanofi; CSL Limited; Pfizer","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Enthesitis; Internal medicine; Dermatology","score_opus":0.034930340265515454,"score_gpt":0.30756908580447,"score_spread":0.27263874553895456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982533,0.00023642086,0.00005961518,0.00022633465,0.00006534579,0.0009387828,0.00019479042,0.000015098203,0.000010345554],"genre_scores_gemma":[0.99956423,0.0001923228,0.0000065411436,0.0000025045786,0.000012219479,0.00007397899,0.000096615426,0.000018159832,0.000033427325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985468,0.0001365949,0.00046547034,0.0001967155,0.00045701567,0.00019744571],"domain_scores_gemma":[0.9987211,0.00024384096,0.00032266325,0.00023043736,0.00041488136,0.000067083005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019883076,0.00013467266,0.00039697718,0.000244256,0.00005259394,0.000005845475,0.000090633475,0.00006600294,0.00002932105],"category_scores_gemma":[0.00057059707,0.00009612685,0.00017600197,0.00038491405,0.00016872388,0.00010244163,0.00008920603,0.00006459344,0.0000025553438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035055643,0.0015496188,0.8312772,0.032004997,0.0014360602,0.000004835389,0.004694733,0.0004232657,0.034396082,0.000034813624,0.0009642743,0.08970857],"study_design_scores_gemma":[0.0017678033,0.00051584054,0.9197524,0.0017690372,0.00008424619,0.0000013438186,0.0008150041,0.0030271339,0.071760826,0.0004271224,9.633161e-7,0.00007824462],"about_ca_topic_score_codex":0.000064562155,"about_ca_topic_score_gemma":0.0000126806735,"teacher_disagreement_score":0.08963033,"about_ca_system_score_codex":0.000052495667,"about_ca_system_score_gemma":0.00007201798,"threshold_uncertainty_score":0.3919939},"labels":[],"label_agreement":null},{"id":"W4379510809","doi":"10.1136/annrheumdis-2023-eular.5073","title":"POS0807 A TRANSCRIPTIONAL PROFILE OF FATIGUE IN PRECLINICAL AUTOIMMUNITY WHICH IS PRESERVED IN SLE AND SJOGREN'S SYNDROME","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Autoimmunity; Immunology; Rheumatology; Antibody; Internal medicine","score_opus":0.14104863769410428,"score_gpt":0.37356037946502624,"score_spread":0.23251174177092196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923862,0.0012252112,0.000003753017,0.005302157,0.00007659514,0.00042168715,0.00018133028,0.000019548379,0.00038350114],"genre_scores_gemma":[0.99880797,0.0005011855,0.000031228992,0.00013724362,0.000004124211,0.000051826424,0.00005532595,0.000008344272,0.00040278022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893415,0.00011249516,0.00044438356,0.00013064014,0.00022795064,0.00015039495],"domain_scores_gemma":[0.99918294,0.0002919276,0.00009349459,0.0002892377,0.00007725468,0.0000651237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028521474,0.000090267706,0.00034475524,0.00014843117,0.000032819455,0.000005672138,0.00011611519,0.00005098585,0.00039054395],"category_scores_gemma":[0.00074898894,0.00006272113,0.00011449893,0.00062216015,0.00010879195,0.000080640835,0.00005592463,0.00010142999,0.000004572158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047041549,0.0014905417,0.9860838,0.0013943374,0.00014857785,0.0000049804603,0.0011518685,0.000110630186,0.00004035117,0.00026466866,0.0073776534,0.0014621811],"study_design_scores_gemma":[0.0012430252,0.0001755278,0.9915344,0.0009106124,0.00004799403,0.0000042534357,0.0003869401,0.0031863684,0.000027967866,0.0023729575,0.00005065295,0.000059297996],"about_ca_topic_score_codex":0.00054590614,"about_ca_topic_score_gemma":0.00007601868,"teacher_disagreement_score":0.0073270006,"about_ca_system_score_codex":0.000003932348,"about_ca_system_score_gemma":0.00011946096,"threshold_uncertainty_score":0.42761824},"labels":[],"label_agreement":null},{"id":"W4379510832","doi":"10.1136/annrheumdis-2023-eular.2670","title":"POS0827 CLINICAL OUTCOMES OF PATIENTS WITH RHEUMATOID ARTHRITIS WHO DISCONTINUED TOFACITINIB OR TUMOUR NECROSIS FACTOR INHIBITORS: RESULTS FROM ORAL SURVEILLANCE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Western University","funders":"","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Janus kinase inhibitor; Internal medicine; Adverse effect","score_opus":0.06375875872143158,"score_gpt":0.3549152026700373,"score_spread":0.29115644394860574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974925,0.0002627121,0.0000025669428,0.0013361516,0.00022079682,0.0009205755,0.0073615382,0.00008855097,0.000057851066],"genre_scores_gemma":[0.99706614,0.0016589528,0.000057465277,0.00014086135,0.00003175436,0.000034165947,0.00044389084,0.000054754393,0.0005120094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955742,0.00035675068,0.0016546004,0.0004948611,0.0013626692,0.00055696105],"domain_scores_gemma":[0.994432,0.002780582,0.00080084807,0.0011318837,0.00050077017,0.00035395153],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0005599052,0.00033165602,0.0014557062,0.00013540943,0.000092070695,0.000044865057,0.0005020135,0.00010927758,0.00017806981],"category_scores_gemma":[0.009421799,0.00018111986,0.0005380362,0.00066048815,0.00059568434,0.00018186969,0.00034807294,0.00018812931,0.000045581543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053682514,0.00092544034,0.9489777,0.00032044633,0.00092241314,0.000023976683,0.00056379894,0.000015389407,0.000007744956,0.000010596078,0.019466748,0.0233975],"study_design_scores_gemma":[0.020989176,0.00044161125,0.97381854,0.003119707,0.000043320968,0.0000016778671,0.00020962518,0.00029730736,0.00052822987,0.00014584554,0.00018757052,0.0002173797],"about_ca_topic_score_codex":0.001655834,"about_ca_topic_score_gemma":0.0002793945,"teacher_disagreement_score":0.024840852,"about_ca_system_score_codex":0.0001727901,"about_ca_system_score_gemma":0.0019632194,"threshold_uncertainty_score":0.9989223},"labels":[],"label_agreement":null},{"id":"W4379510879","doi":"10.1136/annrheumdis-2023-eular.2565","title":"POS0394 THE CAUSAL RELATIONSHIPS BETWEEN MEMBRANE-ASSOCIATED PROGESTERONE RECEPTOR AND OSTEOPOROSIS: EVIDENCE FROM HUMAN STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mendelian randomization; Medicine; Osteoporosis; Linkage disequilibrium; Bone mineral; Internal medicine; Femoral neck; Single-nucleotide polymorphism; Endocrinology; Genetics; Biology; Genotype; Genetic variants","score_opus":0.2818330403949761,"score_gpt":0.4319931703412864,"score_spread":0.15016012994631034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95315313,0.0100651905,1.9828559e-7,0.035430387,0.000078259305,0.00095049717,0.00021828234,0.000083292405,0.00002074869],"genre_scores_gemma":[0.9943978,0.004406413,0.000016156328,0.00026123947,0.00005167189,0.00012546581,0.000092192975,0.000024136521,0.0006249049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973497,0.00067069044,0.0006105695,0.00025700286,0.0007294553,0.00038261357],"domain_scores_gemma":[0.9955206,0.0030202537,0.0003118345,0.0005798169,0.0003094467,0.00025805942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013780533,0.0001739706,0.00052421575,0.00008941991,0.00062640256,0.00003884349,0.00026106637,0.00008103345,0.000042504616],"category_scores_gemma":[0.007733367,0.00009559163,0.00013356865,0.0005671608,0.0004303202,0.00015376286,0.00025184167,0.00028814227,0.000048383008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021242336,0.00024516915,0.9276157,0.0019146726,0.0011477093,0.000004160787,0.008453984,0.0000059507574,0.00071885495,0.000081992446,0.05110423,0.008495129],"study_design_scores_gemma":[0.00053319207,0.0002240285,0.9883948,0.004353293,0.0003013026,8.7379533e-7,0.0036993898,0.000033106837,0.00087357976,0.0014186598,0.00006842998,0.000099372344],"about_ca_topic_score_codex":0.00053520483,"about_ca_topic_score_gemma":0.00014213863,"teacher_disagreement_score":0.060779046,"about_ca_system_score_codex":0.00003081061,"about_ca_system_score_gemma":0.00017909649,"threshold_uncertainty_score":0.9258121},"labels":[],"label_agreement":null},{"id":"W4379510897","doi":"10.1136/annrheumdis-2023-eular.273","title":"POS0458 HAVING MORE TENDER THAN SWOLLEN JOINTS IS ASSOCIATED WITH WORSE FUNCTION, PAIN INTERFERENCE, SOCIAL PARTICIPATION AND OTHER HR-QOL OUTCOMES IN THE FIRST YEAR FOLLOWING RA DIAGNOSIS: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval; Canadian Rheumatology Association; University of Manitoba; McGill University; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; University of Calgary; University of Toronto; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Physical therapy; Rheumatology; Joint pain; Internal medicine; Osteoarthritis; Depression (economics); Anxiety; Patient-reported outcome; Psychiatry; Alternative medicine","score_opus":0.05042661240309003,"score_gpt":0.31305723811285746,"score_spread":0.2626306257097674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379510897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98206055,0.00053812715,0.0000012369619,0.015632553,0.00006715301,0.0012770141,0.00032893303,0.000033986795,0.00006042987],"genre_scores_gemma":[0.99777824,0.00041180316,0.0000016493517,0.0012482458,0.000024282952,0.00040111213,0.00003794416,0.00002542264,0.00007127738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761695,0.0005988054,0.00044076887,0.00025791585,0.0006936672,0.00039186623],"domain_scores_gemma":[0.9980359,0.0011582657,0.00017272147,0.00039634926,0.00010967909,0.00012708925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015118645,0.00018545802,0.00041811375,0.00012412098,0.0005600958,0.00016398724,0.00025113064,0.000051201667,0.000050826504],"category_scores_gemma":[0.002593118,0.00009464021,0.00015014409,0.0004632017,0.00019119645,0.00013681511,0.00006351066,0.00017899941,0.000009923169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018529326,0.00026429587,0.96723664,0.000009840022,0.0008260486,0.000015911595,0.021218648,0.0000033854417,2.1114452e-7,0.000015995494,0.006833801,0.003389925],"study_design_scores_gemma":[0.0020181744,0.00024488757,0.9814703,0.00152775,0.000063634085,3.9279456e-7,0.013812116,0.0000928838,0.000003004521,0.0005880523,0.00006964538,0.00010914778],"about_ca_topic_score_codex":0.06352057,"about_ca_topic_score_gemma":0.24410556,"teacher_disagreement_score":0.18058498,"about_ca_system_score_codex":0.0000321807,"about_ca_system_score_gemma":0.00015103452,"threshold_uncertainty_score":0.9427155},"labels":[],"label_agreement":null},{"id":"W4379511096","doi":"10.1136/annrheumdis-2023-eular.2638","title":"POS0338 DEVELOPMENT AND VALIDATION OF RANKED COMPOSITE IMPORTANT DIFFERENCE (RCID) SCORE IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Minimal clinically important difference; Physical therapy; Clinical trial; Placebo; Internal medicine; Randomized controlled trial; Pathology; Alternative medicine","score_opus":0.06517909296434243,"score_gpt":0.27906179003947734,"score_spread":0.2138826970751349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379511096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905223,0.00832353,0.0000030854624,0.00027166627,0.00010367941,0.00064520864,0.000061039595,0.000050248018,0.000019244819],"genre_scores_gemma":[0.99466515,0.0050937273,0.000017819753,0.00006154501,0.000008076646,0.000041025454,0.00004085436,0.000020025203,0.00005180705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980049,0.000114513416,0.00095909555,0.00022396892,0.00047196343,0.00022556094],"domain_scores_gemma":[0.9986264,0.0002520002,0.00044971472,0.00039419523,0.00012146805,0.00015623267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021020825,0.00018494269,0.0005976471,0.00019834224,0.00006719457,0.00001647812,0.00017288074,0.00006717541,0.000011859705],"category_scores_gemma":[0.00031639118,0.00011697859,0.00015392699,0.00046834763,0.00012830982,0.000044348395,0.00010621408,0.00006448911,0.0000058458704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005377437,0.0013166986,0.9363377,0.0056076725,0.00070214254,0.000026329846,0.002795956,0.00011503665,0.026791729,0.00010297218,0.0005048226,0.025161162],"study_design_scores_gemma":[0.0016467149,0.0000632666,0.9475376,0.03136468,0.00023523027,0.000042451495,0.0006729877,0.0005410009,0.01756359,0.00018685305,0.0000012604396,0.00014437638],"about_ca_topic_score_codex":0.00008259819,"about_ca_topic_score_gemma":0.0000029268056,"teacher_disagreement_score":0.025757005,"about_ca_system_score_codex":0.000022393064,"about_ca_system_score_gemma":0.00013641565,"threshold_uncertainty_score":0.47702485},"labels":[],"label_agreement":null},{"id":"W4379511338","doi":"10.1136/annrheumdis-2023-eular.1459","title":"POS0130 INFLAMMATORY ACTIVITY IS ASSOCIATED WITH COGNITIVE IMPAIRMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; Stroop effect; Trail Making Test; Internal medicine; Hospital Anxiety and Depression Scale; Rheumatoid arthritis; Physical therapy; Cohort; Prospective cohort study; Anxiety; Cognition; Dementia; Psychiatry; Disease; Cognitive impairment","score_opus":0.021742210795306683,"score_gpt":0.25385448233631663,"score_spread":0.23211227154100994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379511338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998208,0.000048725742,0.0000014692038,0.0005057602,0.000043674787,0.0006748726,0.0002952496,0.00009315207,0.0001290892],"genre_scores_gemma":[0.99907804,0.00027263942,0.0000010719652,0.0004945601,0.0000018984697,0.000059619426,0.000010445334,0.000025857647,0.000055879842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817723,0.00023424886,0.0002635991,0.00030270757,0.0006438027,0.00037840093],"domain_scores_gemma":[0.9986703,0.00054002245,0.000308684,0.00028594726,0.00009171345,0.000103356375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013337142,0.00020376004,0.00030896848,0.00013846775,0.00012855529,0.000039049213,0.00028246501,0.0000378486,0.000066656066],"category_scores_gemma":[0.0010285422,0.00012982175,0.00009869848,0.00083111,0.00029716565,0.0002690023,0.000114980416,0.000101145466,0.000035764424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021549875,0.0044544875,0.9427789,0.00030767507,0.00029559922,0.00003832311,0.004166773,0.00022492479,0.0001415311,0.0002084936,0.005930891,0.03929743],"study_design_scores_gemma":[0.0025489833,0.00027274346,0.9891028,0.0021024838,0.0000070028345,5.5272517e-7,0.00027778058,0.00011283682,0.004849441,0.0005255216,0.000005288512,0.00019459713],"about_ca_topic_score_codex":0.000031559768,"about_ca_topic_score_gemma":0.00004604219,"teacher_disagreement_score":0.046323884,"about_ca_system_score_codex":0.000018587385,"about_ca_system_score_gemma":0.00011907813,"threshold_uncertainty_score":0.5293977},"labels":[],"label_agreement":null},{"id":"W4379511960","doi":"10.1136/annrheumdis-2023-eular.660","title":"OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Sanofi Genzyme; Samsung; Alexion Pharmaceuticals; Gilead Sciences; Celltrion; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Mace; Rheumatoid arthritis; Internal medicine; Incidence (geometry); Cohort; Population; Abatacept; Myocardial infarction; Rituximab; Percutaneous coronary intervention","score_opus":0.030130388318710552,"score_gpt":0.30871980970713814,"score_spread":0.27858942138842757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379511960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532294,0.0010665173,0.000013101851,0.00046002743,0.000074021205,0.0016931455,0.0013298665,0.00002682782,0.000013566883],"genre_scores_gemma":[0.9965825,0.0024704754,0.00005492927,0.000023054648,0.000011214382,0.000080691716,0.000736484,0.000025607991,0.000015020876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682134,0.00036019832,0.0006890849,0.00035511507,0.0015390479,0.00023523967],"domain_scores_gemma":[0.9969822,0.00020100275,0.00037009866,0.0015541572,0.00074388867,0.00014862337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050158566,0.00020410598,0.0007085257,0.00022807,0.00008834348,0.00002106126,0.0007790364,0.000030172747,0.000041969433],"category_scores_gemma":[0.00096185965,0.00012178082,0.0001126404,0.0010804668,0.00027750502,0.0004953169,0.0002826002,0.00008334913,0.000005808229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026610629,0.0012526056,0.98636997,0.00008871022,0.0014807144,0.000010200928,0.00173332,0.00091095734,0.000012125318,0.00001186943,0.0008743202,0.004594129],"study_design_scores_gemma":[0.005311393,0.00078037794,0.98435694,0.0038455864,0.000041127558,0.0000016300429,0.004594221,0.00030839766,0.00046890462,0.00007216356,0.000086992426,0.00013228998],"about_ca_topic_score_codex":0.0026459962,"about_ca_topic_score_gemma":0.0012087085,"teacher_disagreement_score":0.0044618393,"about_ca_system_score_codex":0.000025589481,"about_ca_system_score_gemma":0.00027947602,"threshold_uncertainty_score":0.49660775},"labels":[],"label_agreement":null},{"id":"W4379511990","doi":"10.1136/annrheumdis-2023-eular.5552","title":"POS0032 TARGETS THAT WORK: IDENTIFYING MODIFIABLE PREDICTORS OF PRESENTEEISM OVER ONE YEAR IN WORKERS WITH INFLAMMATORY ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Advancing Health Outcomes; Institute for Work & Health; Simon Fraser University; Research Canada; Public Health Ontario; University of British Columbia","funders":"Arthritis Society; Alberta Health Services","keywords":"Presenteeism; Medicine; Absenteeism; Physical therapy; Marital status; Gerontology; Psychology; Population; Environmental health","score_opus":0.06384677349950213,"score_gpt":0.35839804209790016,"score_spread":0.29455126859839803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379511990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947566,0.0015625268,0.000016011978,0.0011859181,0.00042005887,0.001120391,0.00004825726,0.00008579016,0.0008044485],"genre_scores_gemma":[0.99654967,0.0017899878,0.00003798047,0.00017794836,0.00004459064,0.00015559985,0.000018746052,0.000040415653,0.0011850852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971533,0.00049811543,0.0007840281,0.00023198266,0.0006200969,0.00071249047],"domain_scores_gemma":[0.9977317,0.0008330894,0.0005714799,0.00054557715,0.000102487174,0.00021568229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083243503,0.00017996521,0.00048422333,0.0002391477,0.0002785157,0.000011170205,0.00034455574,0.00011162771,0.00023036268],"category_scores_gemma":[0.0004702294,0.00013353962,0.00012592069,0.000812095,0.00015018754,0.00024057066,0.00023732339,0.0003188318,0.000063905616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002753946,0.00010712196,0.96790695,0.0020356902,0.00009977581,0.000003771604,0.0025612775,0.0016556111,0.00000309367,0.0002668318,0.02413651,0.0009479967],"study_design_scores_gemma":[0.001008292,0.000029422139,0.9756683,0.017104287,0.000030102927,1.4139974e-7,0.0031207672,0.00025893806,0.00006307727,0.0023573425,0.00022201387,0.0001372857],"about_ca_topic_score_codex":0.00055193587,"about_ca_topic_score_gemma":0.00007685943,"teacher_disagreement_score":0.023914495,"about_ca_system_score_codex":0.000030204108,"about_ca_system_score_gemma":0.00038397074,"threshold_uncertainty_score":0.54455876},"labels":[],"label_agreement":null},{"id":"W4379512153","doi":"10.1136/annrheumdis-2023-eular.2265","title":"OP0186 DISTINCT PERIPHERAL IMMUNOPHENOTYPING UNDERLINES HISTOPATHOLOGICAL FEATURES IN PATIENTS WITH LUPUS NEPHRITIS IN A LARGE MULTI-CENTER COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, University of California, San Diego; Medical Center, University of Rochester; University of California, San Diego; York University; Cedars-Sinai Medical Center; University of South Carolina; University of Cincinnati; University of Rochester; Texas Tech University","keywords":"Medicine; Lupus nephritis; Immunophenotyping; Cohort; Peripheral; Center (category theory); Pathology; Nephritis; Immunology; Internal medicine; Flow cytometry; Disease","score_opus":0.031501012269834885,"score_gpt":0.3116063157587847,"score_spread":0.28010530348894985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379512153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965487,0.0012661141,0.000010381266,0.0006181307,0.0001756093,0.0011359744,0.00009853397,0.00005580447,0.00009074199],"genre_scores_gemma":[0.99874026,0.00020023003,0.000058249076,0.00014456858,0.000014832216,0.0001232133,0.00009189148,0.000032862325,0.0005939141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977543,0.00025595803,0.0005332106,0.0003063565,0.0006372071,0.00051301677],"domain_scores_gemma":[0.998856,0.00019566173,0.0001533741,0.00052944716,0.00014993493,0.00011558005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000425008,0.00021231173,0.0006078601,0.00021679308,0.00007309007,0.00002479096,0.0002980058,0.00007329873,0.000050849216],"category_scores_gemma":[0.0010986727,0.00012562049,0.00015343398,0.0006226979,0.00017357663,0.00009421651,0.00022060127,0.0002020382,0.000014320176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061557186,0.0013652234,0.9936675,0.00082376186,0.00006288556,0.00005038579,0.00075089565,0.000018584587,0.0000042783927,0.000032758642,0.001276161,0.0013320337],"study_design_scores_gemma":[0.0061237058,0.00013098566,0.98819846,0.004125783,0.000024298259,0.00008299591,0.0005588567,0.00047367197,0.000004622597,0.00010438484,0.00003802883,0.000134225],"about_ca_topic_score_codex":0.00012928403,"about_ca_topic_score_gemma":0.00015928858,"teacher_disagreement_score":0.0055081337,"about_ca_system_score_codex":0.00009599381,"about_ca_system_score_gemma":0.00010785248,"threshold_uncertainty_score":0.5122655},"labels":[],"label_agreement":null},{"id":"W4379513592","doi":"10.1136/annrheumdis-2023-eular.615","title":"OP0072 LOW-DOSE COLCHICINE IS ASSOCIATED WITH LOWER INCIDENCE OF KNEE AND HIP REPLACEMENTS: A POST-HOC ANALYSIS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Heart Research Institute; Radboud Universitair Medisch Centrum; Amsterdam University Medical Centers; McMaster University; Amgen","keywords":"Medicine; Hazard ratio; Placebo; Gout; Osteoarthritis; Randomization; Internal medicine; Interquartile range; Surgery; Post-hoc analysis; Randomized controlled trial; Colchicine; Confidence interval","score_opus":0.031097040537231294,"score_gpt":0.3220463962443015,"score_spread":0.2909493557070702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379513592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867703,0.0051699183,0.000009660622,0.0024790713,0.000099661884,0.005027505,0.0002599779,0.00004851615,0.0001354101],"genre_scores_gemma":[0.99092925,0.0073088617,0.000017071688,0.0003269296,0.000024478233,0.00046485953,0.00011873281,0.00002890318,0.000780947],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964211,0.00056961976,0.0010718218,0.00036476995,0.0011746918,0.00039797497],"domain_scores_gemma":[0.99502075,0.002504999,0.000816481,0.0007433316,0.00064056064,0.0002738809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001533301,0.00029392442,0.0023815301,0.00047753996,0.00012637246,0.00005571481,0.00026107114,0.00007869867,0.0006572556],"category_scores_gemma":[0.00430641,0.0001677261,0.00079350424,0.0012869312,0.00056957145,0.00017411572,0.00015166958,0.0001461827,0.000015146353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97901237,0.0008097216,0.0015817266,0.00012434913,0.015151269,0.000018861716,0.0009094257,0.000049137398,0.000039423012,0.000047146805,0.0014442652,0.00081230723],"study_design_scores_gemma":[0.9862248,0.0017488024,0.0030719116,0.0025544635,0.0015677705,0.0000020509574,0.00060349837,0.0032234043,0.00017580915,0.00064236985,0.000008853912,0.0001763048],"about_ca_topic_score_codex":0.0006257057,"about_ca_topic_score_gemma":0.00011774122,"teacher_disagreement_score":0.013583498,"about_ca_system_score_codex":0.000018391976,"about_ca_system_score_gemma":0.0003077865,"threshold_uncertainty_score":0.7196488},"labels":[],"label_agreement":null},{"id":"W4379517387","doi":"10.1136/annrheumdis-2023-eular.673","title":"OP0102 IDENTIFICATION OF NEW RISK LOCI AND PATHWAYS INVOLVED IN GCA PATHOGENESIS BY A GENOME-WIDE STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; Universitätsklinikum Erlangen; Universitat Autònoma de Barcelona; Université Paris Descartes; Università degli Studi di Ferrara; Assistance publique-Hôpitaux de Paris; Université Paris Diderot; Medizinischen Hochschule Hannover; Université de Toulouse; McMaster University; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Institut National de la Santé et de la Recherche Médicale; Universitat de Barcelona; Cleveland Clinic","keywords":"Giant cell arteritis; Genome-wide association study; Imputation (statistics); Medicine; DrugBank; Disease; Genetic association; Genetics; Bioinformatics; Vasculitis; Biology; Gene; Internal medicine; Genotype; Single-nucleotide polymorphism; Missing data","score_opus":0.037133727470230665,"score_gpt":0.29011339210535614,"score_spread":0.25297966463512545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934756,0.004510552,0.000012487774,0.00080327457,0.00036775888,0.00061116304,0.00017337991,0.00003087397,0.000014897121],"genre_scores_gemma":[0.9927984,0.005778694,0.00001684508,0.00007097159,0.000014007797,0.000025889247,0.000044298155,0.000019115818,0.0012318046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985959,0.0001380842,0.00056503416,0.00018807512,0.00033901408,0.00017390805],"domain_scores_gemma":[0.9988345,0.0002195471,0.0003230537,0.00041156076,0.00006549147,0.00014585158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027945105,0.00011942787,0.00038224482,0.0001545363,0.000051045117,0.000013395623,0.00014655676,0.000044413817,0.000022717933],"category_scores_gemma":[0.0012613405,0.00008618421,0.00011722046,0.00047072335,0.00011228999,0.000058871796,0.00007639521,0.00006840801,0.000011186206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008963572,0.000965879,0.93869597,0.000634683,0.0002226981,0.000012203406,0.004872624,0.000024410063,0.0026676508,0.000013472604,0.029285213,0.022515574],"study_design_scores_gemma":[0.0011243793,0.00016349986,0.99224156,0.0005270889,0.00021408079,0.000001269025,0.0025859508,0.00013407938,0.0016410293,0.0011630821,0.0001160923,0.00008787398],"about_ca_topic_score_codex":0.00035626435,"about_ca_topic_score_gemma":0.000054643184,"teacher_disagreement_score":0.053545617,"about_ca_system_score_codex":0.000008714715,"about_ca_system_score_gemma":0.00010892753,"threshold_uncertainty_score":0.351449},"labels":[],"label_agreement":null},{"id":"W4379517520","doi":"10.1136/annrheumdis-2023-eular.4646","title":"POS0929 VALUE OF LUNG ULTRASOUND FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Interstitial lung disease; Rheumatoid arthritis; Gold standard (test); Radiology; Lung; High-resolution computed tomography; Internal medicine","score_opus":0.022926566009940797,"score_gpt":0.31757148370183763,"score_spread":0.2946449176918968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995503,0.00071756076,0.0008009308,0.00081117504,0.00010704257,0.001464175,0.000551868,0.000025622701,0.000018640914],"genre_scores_gemma":[0.9984688,0.0010799434,0.000047415488,0.0000884888,0.000013580685,0.00018945716,0.00006868989,0.000022198561,0.000021418271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847704,0.00006799405,0.00068561005,0.00017725662,0.00040421574,0.00018788522],"domain_scores_gemma":[0.99572283,0.0029162115,0.0004116892,0.00057172735,0.0002711109,0.00010641882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027092954,0.00013154704,0.00038034463,0.00009349172,0.00007428524,0.000008621177,0.0002566777,0.00003591752,0.000035709338],"category_scores_gemma":[0.0033016081,0.00007621955,0.00026391415,0.00048035025,0.00035046236,0.00008109593,0.000054683966,0.000082672406,0.0000022777344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026233862,0.0017784499,0.9742281,0.0017536437,0.00062346755,3.777261e-7,0.0005900319,0.0009409691,0.00020661997,0.0013115824,0.0016110383,0.014332344],"study_design_scores_gemma":[0.0016805634,0.00021303023,0.98960245,0.0022627164,0.00017431767,5.251375e-7,0.0001591659,0.0028195304,0.0005579329,0.0024150952,0.000030530206,0.000084122905],"about_ca_topic_score_codex":0.0001220099,"about_ca_topic_score_gemma":0.000024072979,"teacher_disagreement_score":0.01537438,"about_ca_system_score_codex":0.000017282804,"about_ca_system_score_gemma":0.00011313768,"threshold_uncertainty_score":0.39525717},"labels":[],"label_agreement":null},{"id":"W4379517571","doi":"10.1136/annrheumdis-2023-eular.527","title":"POS0936 TUMOUR NECROSIS FACTOR INHIBITORS USE AND DISCONTINUATION AMONG PREGNANT WOMEN WITH CHRONIC INFLAMMATORY DISEASES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Computer Research Institute of Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Université de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Arthritis Society","keywords":"Medicine; Discontinuation; Psoriatic arthritis; Pregnancy; Medical prescription; Ankylosing spondylitis; Rheumatoid arthritis; Postpartum period; Gestation; Infliximab; Obstetrics; Pediatrics; Internal medicine; Tumor necrosis factor alpha; Pharmacology","score_opus":0.029412935835718863,"score_gpt":0.27851825516155065,"score_spread":0.2491053193258318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588376,0.0016677378,0.0000088454735,0.0013033905,0.000078598874,0.00073985494,0.00018360923,0.0001175873,0.000016633985],"genre_scores_gemma":[0.99733454,0.0017032234,0.0000040021587,0.000127778,0.00003852276,0.00015948013,0.00003822617,0.000028054756,0.0005661643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846464,0.00008958929,0.00037048094,0.0002206513,0.0004733673,0.00038125392],"domain_scores_gemma":[0.99849296,0.00024441702,0.00031291516,0.0004501254,0.00011136311,0.00038824137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012241522,0.00019513907,0.0003530597,0.00013659448,0.00011859317,0.000051195813,0.0001381025,0.000041909534,0.000057204536],"category_scores_gemma":[0.0011590767,0.00011304632,0.000105318904,0.00032551168,0.00034404197,0.0004976104,0.00009629433,0.000086922206,0.00000992802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042132253,0.00046484068,0.9412132,0.001876207,0.0005374122,0.00001260135,0.003404516,0.000058414298,0.0004566392,0.000115924784,0.0043599242,0.047078982],"study_design_scores_gemma":[0.00086223875,0.0002647544,0.9888561,0.0077354563,0.0001638561,0.000003254716,0.00036968608,0.0002392257,0.0009933425,0.00029195193,0.00008086774,0.0001392945],"about_ca_topic_score_codex":0.000056146502,"about_ca_topic_score_gemma":0.000014975995,"teacher_disagreement_score":0.047642857,"about_ca_system_score_codex":0.000047247584,"about_ca_system_score_gemma":0.0003601251,"threshold_uncertainty_score":0.46098953},"labels":[],"label_agreement":null},{"id":"W4379517577","doi":"10.1136/annrheumdis-2023-eular.5841","title":"POS0867 B-CELL SUBSETS IN PERIPHERAL BLOOD ACROSS DISEASE PHASES OF PSORIATIC ARTHRITIS AND THEIR CORRELATION WITH SYNOVIAL TISSUE FEATURES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Ottawa","keywords":"Psoriatic arthritis; Medicine; Immunoglobulin D; Psoriasis; B cell; Immunology; Antibody; Rheumatoid arthritis; Pathology; Rheumatology; Arthritis; Synovial fluid; Internal medicine; Osteoarthritis","score_opus":0.015551575462803066,"score_gpt":0.2602851051236385,"score_spread":0.24473352966083545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97429425,0.02401625,0.0000035548787,0.00022317498,0.00019584855,0.00033933268,0.00086691766,0.000032196385,0.000028492439],"genre_scores_gemma":[0.99674386,0.0025937012,0.0000063155044,0.000029366709,0.000010289095,0.000042592863,0.0001809813,0.000015163484,0.0003777291],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99897885,0.00019459485,0.000300649,0.00019823184,0.00006332538,0.0002643617],"domain_scores_gemma":[0.99909955,0.0003060359,0.00021513416,0.00028325876,0.000053172353,0.0000428366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012008146,0.0001938358,0.0003741984,0.00007333925,0.000121177414,0.000014127873,0.00016655012,0.000069357695,0.00006279593],"category_scores_gemma":[0.0001431644,0.00011945095,0.00010660146,0.00026511482,0.00026958363,0.00010159914,0.000066794135,0.000058620033,0.000008172193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048220335,0.005173942,0.23821533,0.0014504435,0.0022198027,0.00006737939,0.01494634,0.0008534522,0.009270583,0.00046036718,0.0048267078,0.7176936],"study_design_scores_gemma":[0.0056563243,0.00047025454,0.9504482,0.0014918124,0.00035010715,0.00001984842,0.0015471667,0.000044057,0.038407132,0.0011966452,0.000075365664,0.00029309935],"about_ca_topic_score_codex":0.0001259692,"about_ca_topic_score_gemma":0.00009514467,"teacher_disagreement_score":0.71740055,"about_ca_system_score_codex":0.0000043958785,"about_ca_system_score_gemma":0.000063315885,"threshold_uncertainty_score":0.48710686},"labels":[],"label_agreement":null},{"id":"W4379517699","doi":"10.1136/annrheumdis-2023-eular.609","title":"POS0562 FREQUENCY OF IN-PERSON AND VIRTUAL VISITS FOR RHEUMATOID ARTHRITIS: ANALYSIS OF THREE YEARS OF VISIT DATA BEFORE AND AFTER THE COVID PANDEMIC","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Moderna; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Pandemic; Rheumatoid arthritis; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Arthritis; Virology; Internal medicine; Disease; Outbreak","score_opus":0.07932900011787716,"score_gpt":0.37044594087868776,"score_spread":0.2911169407608106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938096,0.003053392,0.000039050712,0.0012858441,0.000024285988,0.00056173844,0.0012145799,0.000008366937,0.0000031562652],"genre_scores_gemma":[0.9963152,0.0031957116,0.000052836494,0.00021031561,0.0000067858364,0.000027844222,0.00017727548,0.000009672131,0.0000043855207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871147,0.000058242615,0.00061072956,0.00016602378,0.00029905877,0.00015446685],"domain_scores_gemma":[0.9984209,0.00051397533,0.00039549288,0.0004967286,0.000098302386,0.000074628544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005814663,0.000094047595,0.0005494002,0.00026009657,0.000027278777,0.0000037625243,0.00017893066,0.00003059296,0.000031368465],"category_scores_gemma":[0.00081055606,0.00006092338,0.00009827325,0.0006083164,0.00018044343,0.000094754614,0.00009979903,0.00004503044,2.2187659e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024529832,0.000082934814,0.89344585,0.0008761395,0.0006974991,0.0000012246135,0.0016647412,0.000008015273,0.00009212043,0.00018540079,0.0005070205,0.10219378],"study_design_scores_gemma":[0.0011608112,0.00034431237,0.99310756,0.0008533268,0.00050357764,0.0000033000324,0.001712174,0.001049987,0.000053585165,0.001154078,0.00001160602,0.000045671248],"about_ca_topic_score_codex":0.0006071061,"about_ca_topic_score_gemma":0.0012746349,"teacher_disagreement_score":0.10214811,"about_ca_system_score_codex":0.0000049157375,"about_ca_system_score_gemma":0.000096988144,"threshold_uncertainty_score":0.24843833},"labels":[],"label_agreement":null},{"id":"W4379517707","doi":"10.1136/annrheumdis-2023-eular.6315","title":"POS0584-HPR PROS AND DISEASE ACTIVITY IN YEAR PRIOR TO COVID PREDICT TRAJECTORIES OF DEPRESSION IN ADULTS WITH RA IN FIRST 2 YEARS OF PANDEMIC: DATA FROM THE CANADIAN EARLY ARTHRITIS COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Canadian Rheumatology Association; Université Laval; Western University; University of Calgary; McGill University; Université de Sherbrooke; McGill University Health Centre","funders":"Pfizer","keywords":"Medicine; Depression (economics); Pandemic; Cohort; Comorbidity; Physical therapy; Longitudinal study; Coronavirus disease 2019 (COVID-19); Disease; Pediatrics; Gerontology; Internal medicine","score_opus":0.04083228676409748,"score_gpt":0.3088623103640278,"score_spread":0.2680300235999303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955013,0.0014023643,4.6009686e-7,0.000992487,0.00001553407,0.0012274239,0.0008333934,0.000008157935,0.000018889636],"genre_scores_gemma":[0.99810034,0.0016800853,0.000005170314,0.000045686334,0.000004490167,0.0000656678,0.000068188594,0.000012716533,0.000017647882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869734,0.00012860275,0.00034099614,0.0002146845,0.00040082747,0.00021757036],"domain_scores_gemma":[0.9986449,0.00032139395,0.000113767834,0.00066612905,0.000050789437,0.00020305929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040758008,0.00009710935,0.00037110722,0.00016502109,0.000037459817,0.000010445076,0.00032741248,0.000039552775,0.000022238837],"category_scores_gemma":[0.0019420008,0.00006322905,0.000035518784,0.00043907552,0.00021327593,0.00015283837,0.00018535712,0.00012219693,0.0000017064401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014876032,0.0001323059,0.9839126,0.00039910816,0.000040998537,0.000015930105,0.0020620767,0.00004756702,0.000013017187,0.0000031402863,0.00055721134,0.011328442],"study_design_scores_gemma":[0.0014574125,0.00009371242,0.991904,0.0052610277,0.000020487985,3.6288117e-7,0.00060615956,0.00041439215,0.000039124618,0.00010743894,0.00003332977,0.00006254264],"about_ca_topic_score_codex":0.11465618,"about_ca_topic_score_gemma":0.21058017,"teacher_disagreement_score":0.095924,"about_ca_system_score_codex":0.000022949996,"about_ca_system_score_gemma":0.00088410574,"threshold_uncertainty_score":0.8912394},"labels":[],"label_agreement":null},{"id":"W4379517809","doi":"10.1136/annrheumdis-2023-eular.6049","title":"POS0332 IDENTIFICATION OF DISTINCT CELLULAR POPULATIONS IN THE SYNOVIUM OF EARLY- AND LATE-STAGE RADIOGRAPHIC KNEE OA USING SINGLE NUCLEUS RNA SEQUENCING","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"","keywords":"Medicine; RNA; Radiography; Stage (stratigraphy); Nucleus; Biology; Genetics; Surgery; Gene","score_opus":0.10945942570729256,"score_gpt":0.32772470903095124,"score_spread":0.2182652833236587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851805,0.0005134412,0.000021099067,0.00025120357,0.000059102127,0.0003999294,0.00014379206,0.0000132970235,0.00008008271],"genre_scores_gemma":[0.9997662,0.000059228645,0.000026458987,0.000016959531,0.000008268854,0.0000085607235,0.000036531834,0.000012170524,0.000065644395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987945,0.00010965449,0.0005276492,0.000116870775,0.00030196737,0.00014938084],"domain_scores_gemma":[0.9990367,0.00012887962,0.00035948487,0.0003552586,0.00007264208,0.000047024096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027255234,0.000105552106,0.0002801786,0.00015775193,0.000084776264,0.000014871214,0.000118593176,0.000028971122,0.000014726655],"category_scores_gemma":[0.00021684964,0.00006547274,0.00019254077,0.00059407967,0.00017198343,0.000099663215,0.000054995176,0.000042236476,0.0000010347893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002458207,0.0013558188,0.93746805,0.0058725,0.0007592208,0.000026133634,0.0051300726,0.0024156095,0.033543985,0.004240297,0.00006553005,0.008876942],"study_design_scores_gemma":[0.00038078276,0.00012039815,0.9904413,0.0007992199,0.0002494896,0.0000016264295,0.00069546164,0.0032369324,0.0019254416,0.0020783024,0.000002982122,0.000068031615],"about_ca_topic_score_codex":0.0023179555,"about_ca_topic_score_gemma":0.000029014052,"teacher_disagreement_score":0.052973263,"about_ca_system_score_codex":0.000013800335,"about_ca_system_score_gemma":0.000033233926,"threshold_uncertainty_score":0.3504071},"labels":[],"label_agreement":null},{"id":"W4379517978","doi":"10.1136/annrheumdis-2023-eular.1854","title":"POS0467 DISCORDANCE IN PATIENT AND EVALUATOR GLOBAL ASSESSMENT OF DISEASE ACTIVITY OVER TIME AND ACROSS DISEASE ACTIVITY LEVELS IN RECENT-ONSET RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Concordance; Rheumatoid arthritis; Internal medicine; Cohort; Concomitant; Disease; Physical therapy","score_opus":0.03713482182776046,"score_gpt":0.37719237609347156,"score_spread":0.3400575542657111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379517978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98539925,0.0077151665,0.0000032925,0.002736043,0.000076730714,0.0010949252,0.0029254504,0.000033559172,0.000015588688],"genre_scores_gemma":[0.9434514,0.056275886,0.000016158303,0.00007314303,0.0000059275576,0.0001093714,0.000029190789,0.00002285044,0.000016041668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969889,0.00050541555,0.0005562571,0.00044788833,0.0009189196,0.0005826332],"domain_scores_gemma":[0.99796164,0.0003931812,0.00028962208,0.000616563,0.00012681841,0.00061219704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060464407,0.00029291408,0.00075706857,0.00013467479,0.000118254466,0.000054405387,0.00018843636,0.000044977503,0.00008299428],"category_scores_gemma":[0.0013853234,0.0002259265,0.00016972143,0.00067754014,0.0005940074,0.00039212315,0.00041404256,0.00016561881,0.0000046233604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029803114,0.0016351119,0.8013921,0.00079788466,0.00015681474,0.00007061966,0.00051066873,0.00007202819,0.0003016052,0.00008805821,0.0005679636,0.19142684],"study_design_scores_gemma":[0.0027038036,0.00024926214,0.9857011,0.004394417,0.000007880211,0.0000061489404,0.00015865616,0.003973233,0.00013788008,0.0024353706,0.000030879244,0.00020138183],"about_ca_topic_score_codex":0.00035697757,"about_ca_topic_score_gemma":0.00019903666,"teacher_disagreement_score":0.19122547,"about_ca_system_score_codex":0.000065537766,"about_ca_system_score_gemma":0.0005343699,"threshold_uncertainty_score":0.92130154},"labels":[],"label_agreement":null},{"id":"W4379518108","doi":"10.1136/annrheumdis-2023-eular.1455","title":"POS0325 RHEUMATOID ARTHRITIS PATIENTS AND WEATHER PATTERNS: A RHUMADATA™ STUDY OF 14,200 PATIENT-REPORTED OUTCOMES MATCHED WITH METEOROLOGICAL DATA","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Pfizer","keywords":"Medicine; Rheumatoid arthritis; Arthritis; Internal medicine","score_opus":0.10273736451267935,"score_gpt":0.33208409112817117,"score_spread":0.22934672661549182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729526,0.00017159754,0.0000013814148,0.0007920461,0.00006305647,0.00083886494,0.0007524705,0.00004112457,0.000044207805],"genre_scores_gemma":[0.99796164,0.0014246544,0.000018064566,0.00039894186,0.0000023341688,0.000037780996,0.000114413546,0.000020195328,0.000021951575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997775,0.00015548574,0.0006438904,0.00036822679,0.00069858663,0.00035882066],"domain_scores_gemma":[0.99797875,0.0002359012,0.0005208087,0.0010400402,0.000035052573,0.00018946902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002891169,0.00020911057,0.0005090477,0.00005432067,0.00013101855,0.000026485644,0.00053154066,0.000038328955,0.00046833814],"category_scores_gemma":[0.00048577343,0.00012028577,0.000052807274,0.0002936684,0.00018101346,0.00029625394,0.0010477394,0.00006676318,0.000025203628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095273266,0.0011751618,0.9740618,0.000090114685,0.000105766216,0.0000063219586,0.0017969417,0.000020625908,0.000004011358,0.0000018231891,0.0055783857,0.017063798],"study_design_scores_gemma":[0.0012085768,0.0006517476,0.9950648,0.00037254146,0.000043244723,0.0000025327013,0.0020635962,0.000114649156,0.000020320338,0.0002777069,0.000037543105,0.0001427247],"about_ca_topic_score_codex":0.0013117385,"about_ca_topic_score_gemma":0.00042088956,"teacher_disagreement_score":0.021003041,"about_ca_system_score_codex":0.000010485902,"about_ca_system_score_gemma":0.000014704339,"threshold_uncertainty_score":0.5127974},"labels":[],"label_agreement":null},{"id":"W4379518115","doi":"10.1136/annrheumdis-2023-eular.646","title":"POS0116 EFFICACY AND SAFETY OF VOCLOSPORIN ACROSS PATIENT SUBGROUPS WITH PROTEINURIA ≥2 MG/MG: AN INTEGRATED ANALYSIS OF THE AURA-LV AND AURORA 1 STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"UCB Pharma; Idorsia Pharmaceuticals; Biogen; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Proteinuria; Medicine; Urology; Renal biopsy; Internal medicine; Lupus nephritis; Placebo; Creatinine; Gastroenterology; Renal function; Kidney; Pathology; Disease","score_opus":0.06138632291003115,"score_gpt":0.37045968825977843,"score_spread":0.3090733653497473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944762,0.0027094544,0.0000020559178,0.001023404,0.000045376928,0.001451131,0.00024977932,0.000028631102,0.000013965415],"genre_scores_gemma":[0.99905276,0.00065791217,0.00003079091,0.000029801271,0.0000064222736,0.000053074047,0.000019700012,0.000022918575,0.00012662001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759847,0.00033510834,0.00071580714,0.00027704137,0.0007813709,0.00029220816],"domain_scores_gemma":[0.99727815,0.00056981825,0.0005340778,0.00088276656,0.0005877766,0.00014741364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060635386,0.00021194991,0.0009739983,0.00017977865,0.00012174509,0.00001576886,0.00027658825,0.000046621808,0.000012406628],"category_scores_gemma":[0.0015067991,0.00009740341,0.00019551718,0.0017350013,0.0007909346,0.00008343836,0.00030310565,0.000101548976,9.0330866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050826715,0.001130876,0.91292036,0.008573453,0.011486414,0.000013339535,0.03723008,0.00026652098,0.0009748912,0.00015401968,0.000839003,0.021328354],"study_design_scores_gemma":[0.0024984698,0.0010154803,0.948231,0.0071322126,0.0018009975,0.000046430734,0.033945654,0.0016501865,0.0032820129,0.00019632463,0.000023125716,0.0001781533],"about_ca_topic_score_codex":0.00027061492,"about_ca_topic_score_gemma":0.000095166426,"teacher_disagreement_score":0.03531058,"about_ca_system_score_codex":0.000022584782,"about_ca_system_score_gemma":0.00011665352,"threshold_uncertainty_score":0.3971996},"labels":[],"label_agreement":null},{"id":"W4379518196","doi":"10.1136/annrheumdis-2023-eular.1965","title":"POS0058 OBESITY ASSOCIATES WITH HIGHER LEVELS OF INFLAMMATION DURING THE DISEASE COURSE, BUT ONLY IN ACPA-POSITIVE RA","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health and Lifestyle Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada","funders":"","keywords":"Medicine; Obesity; Inflammation; Disease; Immunology; Internal medicine","score_opus":0.07241346904963675,"score_gpt":0.403255146210676,"score_spread":0.33084167716103924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239696,0.0005825785,9.81152e-7,0.014597797,0.00017505507,0.0010064559,0.0006687059,0.000051255643,0.00052021025],"genre_scores_gemma":[0.9970616,0.00039911413,0.000003926203,0.0003962992,0.00007138453,0.00011127992,0.000015060605,0.000019090385,0.0019222271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973041,0.0008897487,0.0006676944,0.00016757584,0.00048132724,0.00048957387],"domain_scores_gemma":[0.9966968,0.0018101365,0.00063618313,0.00039780678,0.0002925358,0.00016649892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007620317,0.00016658375,0.00040959174,0.000082565864,0.00063192996,0.000007137365,0.00029794214,0.000055957127,0.00010279998],"category_scores_gemma":[0.001292401,0.00009049793,0.00011708453,0.00052010716,0.00019080531,0.00014839301,0.00020034332,0.00021824568,0.000040868454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029330302,0.00018955176,0.9870702,0.0023178267,0.00019929295,0.0000060441007,0.004192841,0.0001491871,0.000011970014,0.0012098004,0.003202324,0.0011576851],"study_design_scores_gemma":[0.0005842003,0.000031584266,0.9916546,0.0027688534,0.0000742568,1.4427674e-7,0.0030028517,0.000060803053,0.00004423386,0.0016322114,0.000047496917,0.00009876181],"about_ca_topic_score_codex":0.0005885779,"about_ca_topic_score_gemma":0.00030686363,"teacher_disagreement_score":0.0146646565,"about_ca_system_score_codex":0.000045083918,"about_ca_system_score_gemma":0.00074420613,"threshold_uncertainty_score":0.48603585},"labels":[],"label_agreement":null},{"id":"W4379518197","doi":"10.1136/annrheumdis-2023-eular.2286","title":"POS0020 DOES SUBJECTIVELY PERCEIVED LOSS OF HAND FUNCTION SUFFICIENTLY REPRESENT ULTRASONOGRAPHY-DETECTED SYNOVITIS AND TENOSYNOVITIS IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS?","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical Practices and Rehabilitation","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Women's College Hospital; University of Toronto","funders":"Chinese University of Hong Kong; Novartis Pharma; University of Hong Kong; Pfizer; Deutsche Forschungsgemeinschaft; Eli Lilly and Company","keywords":"Medicine; Synovitis; Psoriatic arthritis; Tenosynovitis; Psoriasis; Dermatology; Arthritis; Ultrasonography; Surgery; Internal medicine","score_opus":0.021657589399158208,"score_gpt":0.3220859395210846,"score_spread":0.3004283501219264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668366,0.00064327463,0.000015638636,0.0011498698,0.00024355903,0.0010463904,0.00016318791,0.000027948023,0.000026499963],"genre_scores_gemma":[0.99770135,0.0020507288,0.000025897958,0.000064641274,0.000016774085,0.00007348296,0.000022104445,0.000015688554,0.000029338962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767756,0.0007014326,0.00062309316,0.00027372976,0.00044396985,0.00028023127],"domain_scores_gemma":[0.9963778,0.002402897,0.00052144635,0.00027474333,0.00028845904,0.00013461271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051214587,0.00014665499,0.00038884746,0.00021049882,0.00030457345,0.000015591399,0.000101120866,0.00008266323,0.000059031925],"category_scores_gemma":[0.0032786746,0.000083055565,0.00007072222,0.0006654974,0.00043345787,0.0002192835,0.00007933256,0.00017492544,0.0000028176028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073975325,0.00040980882,0.9499052,0.0016792862,0.00014474482,0.0000011046416,0.0056545273,0.000021336338,0.00003603078,0.00010334031,0.00029188,0.041012954],"study_design_scores_gemma":[0.0019450889,0.0004556021,0.9874189,0.0026647937,0.00008039422,2.3352531e-7,0.0055515813,0.00014299483,0.0000156618,0.0016048893,0.000016726912,0.00010313099],"about_ca_topic_score_codex":0.00080596784,"about_ca_topic_score_gemma":0.00022334605,"teacher_disagreement_score":0.040909823,"about_ca_system_score_codex":0.000011315157,"about_ca_system_score_gemma":0.00008575612,"threshold_uncertainty_score":0.39251164},"labels":[],"label_agreement":null},{"id":"W4379518293","doi":"10.1136/annrheumdis-2023-eular.5397","title":"POS0106 INTRA-ARTICULAR MM-II, A NOVEL SUSPENSION OF LARGE EMPTY MULTILAMELLAR LIPOSOMES, IN PAINFUL KNEE OSTEOARTHRITIS: A 26 WEEK PHASE 2B RANDOMIZED TRIAL","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society; Regeneron Pharmaceuticals; Stryker; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Osteoarthritis; Suspension (topology); Randomized controlled trial; Surgery; Pathology","score_opus":0.025937930545352077,"score_gpt":0.3073281547449632,"score_spread":0.2813902241996111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538815,0.0024084896,0.00006366994,0.00055657513,0.00023188107,0.0010951663,0.00021016104,0.000020438387,0.00002548181],"genre_scores_gemma":[0.9982628,0.0010088934,0.000033838245,0.00024480352,0.000049148814,0.000100008816,0.00011641383,0.000025851565,0.00015823526],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99800956,0.00030950093,0.0007328363,0.00029934748,0.000295742,0.00035301238],"domain_scores_gemma":[0.99861765,0.00017117758,0.00034643058,0.00058413774,0.00018069295,0.000099897145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007982032,0.00022139298,0.00067691057,0.000120585464,0.0000779114,0.000016812177,0.0003278415,0.00011842402,0.000038745544],"category_scores_gemma":[0.0018747132,0.00016202829,0.00057458825,0.0002729426,0.00019164178,0.000013756062,0.00028446136,0.000078082485,0.000010655557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56148463,0.007922262,0.0004233937,0.0006954609,0.0013023262,0.000032120664,0.0017312979,0.00058246974,0.38351715,0.00023838448,0.014636899,0.027433597],"study_design_scores_gemma":[0.6894889,0.0036140527,0.00081804325,0.0014689205,0.00026962714,0.0000066682765,0.00088093,0.00303899,0.2984028,0.00083428033,0.0006845968,0.0004921957],"about_ca_topic_score_codex":0.00007416799,"about_ca_topic_score_gemma":0.00006669057,"teacher_disagreement_score":0.12800428,"about_ca_system_score_codex":0.0000044465887,"about_ca_system_score_gemma":0.00012222973,"threshold_uncertainty_score":0.66073215},"labels":[],"label_agreement":null},{"id":"W4379518295","doi":"10.1136/annrheumdis-2023-eular.1033","title":"OP0289 INEQUITIES IN ARTHRITIS CARE IN CANADA: AN INTERSECTIONAL ANALYSIS OF BIPOC WOMEN","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Arthritis; Family medicine; Internal medicine","score_opus":0.01898096894512201,"score_gpt":0.2942959876428572,"score_spread":0.27531501869773517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975007,0.0013875179,7.209952e-7,0.00064142834,0.000056993824,0.00017591908,0.00013065348,0.000006678738,0.00009934744],"genre_scores_gemma":[0.9992133,0.0005475248,0.000003941892,0.00008433553,0.000003935233,0.000039271163,0.0000723785,0.000005837649,0.000029515328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989908,0.00008209295,0.00039289796,0.00010844641,0.00027640298,0.00014937187],"domain_scores_gemma":[0.9994161,0.00012524183,0.000101358506,0.00020601455,0.00009024824,0.00006100042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013602231,0.000072979616,0.00038330205,0.0004401177,0.000016817361,0.0000032234018,0.000088156805,0.00001867318,0.00014438921],"category_scores_gemma":[0.00034170083,0.000052604657,0.00014339596,0.0012461231,0.00007086689,0.00006191674,0.000035749254,0.000042188323,6.1895156e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015694757,0.00028327425,0.9120546,0.0015436948,0.00052208337,0.0000039203533,0.010658946,0.0080947885,0.000031730688,0.0002171232,0.0005655375,0.06586738],"study_design_scores_gemma":[0.0003504209,0.000108922795,0.9611411,0.0006869086,0.0000577867,1.4886324e-7,0.034961402,0.0020399757,0.000017479808,0.00057748694,0.000009089179,0.000049240403],"about_ca_topic_score_codex":0.3313231,"about_ca_topic_score_gemma":0.7111729,"teacher_disagreement_score":0.37984982,"about_ca_system_score_codex":0.00009538175,"about_ca_system_score_gemma":0.0004970898,"threshold_uncertainty_score":0.6731297},"labels":[],"label_agreement":null},{"id":"W4379518346","doi":"10.1136/annrheumdis-2023-eular.5653","title":"POS0026 THE INDEPENDENT INFLUENCE OF SEX ON THE DISEASE IMPACT DOMAINS IN PSORIATIC ARTHRITIS IS MODEST, ONCE CONFOUNDERS ARE TAKEN INTO ACCOUNT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; University of Leeds; University of Glasgow; Janssen Scientific Affairs; School of Medicine, Kyorin University; McGill University; Leeds Biomedical Research Centre; University of Washington","keywords":"Medicine; Psoriatic arthritis; Confounding; Disease; Arthritis; Internal medicine","score_opus":0.033794001180524405,"score_gpt":0.2945953375326547,"score_spread":0.2608013363521303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120915,0.003932142,0.0000016004215,0.0035118908,0.00014786003,0.00061142014,0.00049610983,0.000029485282,0.000060355695],"genre_scores_gemma":[0.99674696,0.002282847,9.897202e-7,0.00063388335,0.000009620176,0.00011354038,0.000031363044,0.000017727452,0.0001630562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819815,0.00051600544,0.000486305,0.00024505836,0.00019694184,0.00035756],"domain_scores_gemma":[0.99741244,0.0011602939,0.00042776857,0.0008634414,0.000085895306,0.000050130366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043137674,0.0002568228,0.00041528424,0.000111025074,0.00025511766,0.00002844737,0.000749959,0.00008113696,0.00014633953],"category_scores_gemma":[0.00061967,0.00012611586,0.0003519299,0.0004292979,0.00041928396,0.000120731995,0.000166786,0.00013642864,0.000112206675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051630144,0.004774288,0.5824549,0.0014956502,0.009906102,0.0001011533,0.041776136,0.048363477,0.0028890555,0.010899918,0.039283127,0.25289318],"study_design_scores_gemma":[0.0011650476,0.00011963739,0.9777473,0.0012508353,0.00018800684,0.0000032822454,0.0026520789,0.00016097614,0.0018057842,0.014621306,0.00008558983,0.00020016027],"about_ca_topic_score_codex":0.0006783704,"about_ca_topic_score_gemma":0.00011426592,"teacher_disagreement_score":0.3952924,"about_ca_system_score_codex":0.00003855247,"about_ca_system_score_gemma":0.00019390856,"threshold_uncertainty_score":0.51428556},"labels":[],"label_agreement":null},{"id":"W4379518426","doi":"10.1136/annrheumdis-2023-eular.5892","title":"OP0200 ORAL DELIVERY OF DELTA-9-TETRAHYDROCANNABINOL PROVIDES SYMPTOM AND DISEASE MODIFICATION USING TWO MODELS OF KNEE OSTEOARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; Arthritis Society","funders":"Canadian Institutes of Health Research; School of Medicine, University of Missouri; School of Medicine, New York University; Arthritis Society","keywords":"Medicine; Osteoarthritis; WOMAC; Cannabinoid; Cannabinoid receptor; Joint pain; Internal medicine; Synovitis; Anesthesia; Pharmacology; Arthritis; Pathology; Receptor; Agonist","score_opus":0.07482679021949883,"score_gpt":0.34373713174546644,"score_spread":0.2689103415259676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183774,0.004340869,0.000044745135,0.0023605903,0.0000500736,0.00086948025,0.00040579977,0.00003443019,0.000056268615],"genre_scores_gemma":[0.9987187,0.0006540981,0.000051685387,0.00008597162,0.000017238784,0.000062156636,0.00004100107,0.000030812604,0.00033832982],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979482,0.00012358121,0.0006209977,0.00025823124,0.0007277236,0.0003212112],"domain_scores_gemma":[0.9981608,0.00005781712,0.00030874915,0.00060190633,0.0005023249,0.00036840886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028688225,0.00018447792,0.00052413996,0.00026619688,0.000091129696,0.000019773688,0.0002104948,0.000043697743,0.00002809334],"category_scores_gemma":[0.00058141444,0.00013794462,0.00029233497,0.0006002232,0.0004756227,0.00021966637,0.00018443016,0.00008349235,0.0000016892509],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006825235,0.0045633614,0.114984505,0.03412495,0.002193999,0.000083370294,0.004447339,0.061354376,0.024991013,0.011770314,0.048670053,0.68599147],"study_design_scores_gemma":[0.006610784,0.0015309149,0.409905,0.009548452,0.0015358037,0.00003462515,0.0021097048,0.5110117,0.01601749,0.040731784,0.00020381909,0.00075991795],"about_ca_topic_score_codex":0.00058676815,"about_ca_topic_score_gemma":0.000010861359,"teacher_disagreement_score":0.68523157,"about_ca_system_score_codex":0.000019524605,"about_ca_system_score_gemma":0.0006300691,"threshold_uncertainty_score":0.5625218},"labels":[],"label_agreement":null},{"id":"W4379518573","doi":"10.1136/annrheumdis-2023-eular.2620","title":"OP0290 WORSE OUTCOMES LINKED TO ETHNICITY FOR THE EARLY TREATMENT OF REFRACTORY SLE: RESULTS FROM THE BILAG-BR","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"National Research Foundation","keywords":"Medicine; Internal medicine; Belimumab; Ethnic group; Logistic regression; Decile; Demography; Gastroenterology; Immunology; Antibody","score_opus":0.1100332015912515,"score_gpt":0.3684448356506605,"score_spread":0.258411634059409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621268,0.0034309393,0.000014417217,0.029342374,0.00037046015,0.00226617,0.0022769312,0.000102327205,0.00006960086],"genre_scores_gemma":[0.9947271,0.0012517804,0.000049141898,0.0010660376,0.000067625144,0.00028243588,0.000095784526,0.000045130953,0.002414987],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99767226,0.00020485288,0.00083404535,0.00030952258,0.00061018893,0.0003691302],"domain_scores_gemma":[0.99083346,0.006277761,0.00051763013,0.0019515308,0.00025101192,0.00016858225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040189273,0.00028645748,0.000707984,0.00007950875,0.00023085652,0.000025422636,0.00069690944,0.000066528606,0.00006921147],"category_scores_gemma":[0.0066296714,0.000119991535,0.00081063155,0.0004871239,0.0002953835,0.00005956244,0.00020364656,0.00007857384,0.000057057918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015967175,0.009063835,0.17201513,0.0011025053,0.010527803,0.000028594997,0.034142595,0.0019265532,0.00092718465,0.0005409486,0.4525662,0.30119148],"study_design_scores_gemma":[0.0019654739,0.00048283592,0.9890282,0.00082477543,0.00087726855,4.4667985e-7,0.0011267145,0.00021084862,0.0005181834,0.001031282,0.0037976962,0.00013628851],"about_ca_topic_score_codex":0.0020559765,"about_ca_topic_score_gemma":0.000046700137,"teacher_disagreement_score":0.8170131,"about_ca_system_score_codex":0.00003579677,"about_ca_system_score_gemma":0.00025028316,"threshold_uncertainty_score":0.7936815},"labels":[],"label_agreement":null},{"id":"W4379518611","doi":"10.1136/annrheumdis-2023-eular.2143","title":"POS0059 CARDIOVASCULAR RISK AND ADVANCED THERAPIES RETENTION IN RHEUMATOID ARTHRITIS: RESULTS FROM THE OBRI","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Canadian Arthritis Network; Ontario Ministry of Health and Long-Term Care; Celgene; Gilead Sciences; Sanofi; Amgen","keywords":"Medicine; Discontinuation; Internal medicine; Rheumatoid arthritis; Body mass index; Proportional hazards model; Risk factor; Etanercept; Dyslipidemia; Lower risk; Confounding; Adverse effect; Disease; Confidence interval","score_opus":0.030470029972530198,"score_gpt":0.27979286952913446,"score_spread":0.24932283955660425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379518611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8520252,0.14234258,0.0000048773363,0.0041918964,0.00015735424,0.0006266987,0.00046184758,0.00007110057,0.00011842654],"genre_scores_gemma":[0.6340988,0.3656139,0.000021374935,0.000086712134,0.000022257009,0.000047700632,0.000050862913,0.000017810029,0.000040525218],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997511,0.0004940028,0.0005956145,0.00032754033,0.0006912133,0.00038061847],"domain_scores_gemma":[0.997711,0.00088732404,0.00020494865,0.0009318061,0.00012951891,0.00013537712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010021308,0.00019908987,0.0005647149,0.00011379171,0.00022756866,0.00006277104,0.0002762572,0.000053308355,0.000030404346],"category_scores_gemma":[0.002685021,0.00011646956,0.00045087206,0.00048922293,0.00039987278,0.0001912234,0.00015584154,0.00019675533,0.000030067882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016362304,0.00026784602,0.058360457,0.00015928094,0.002157591,0.00003637473,0.0056784363,0.00028040342,0.00016322489,0.00044207508,0.010760485,0.9200576],"study_design_scores_gemma":[0.0055005667,0.00016623603,0.96175843,0.005519629,0.000027761747,0.000015584152,0.0043498315,0.00045297778,0.0004378627,0.01534071,0.006218297,0.00021209905],"about_ca_topic_score_codex":0.0014319406,"about_ca_topic_score_gemma":0.0001562252,"teacher_disagreement_score":0.9198455,"about_ca_system_score_codex":0.000009773578,"about_ca_system_score_gemma":0.00008670446,"threshold_uncertainty_score":0.47494906},"labels":[],"label_agreement":null},{"id":"W4379520001","doi":"10.1136/annrheumdis-2023-eular.2083","title":"OP0067 SEX DIFFERENCES IN PERCEPTIONS OF PSORIATIC ARTHRITIS DISEASE IMPACT, MANAGEMENT AND PHYSICIAN INTERACTIONS: RESULTS FROM A GLOBAL PATIENT SURVEY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Women's College Hospital; University of Toronto","funders":"Medac; Celltrion; Biogen; Gilead Sciences; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Disease; Family medicine; Disease management; Alternative medicine; Physical therapy; Internal medicine; Pathology","score_opus":0.2892921774429074,"score_gpt":0.4300810699722894,"score_spread":0.14078889252938198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379520001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789758,0.0020145485,0.000032205855,0.0037068725,0.00024581683,0.00054833636,0.014260994,0.00001934478,0.000196111],"genre_scores_gemma":[0.9970619,0.0020388009,0.00004728861,0.0005018013,0.000020417028,0.00007870901,0.00018140013,0.000009691957,0.000059993083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964885,0.0004867987,0.0023511397,0.0003157023,0.00013053745,0.00022731342],"domain_scores_gemma":[0.99674493,0.0011371728,0.0014074511,0.00050881156,0.000047561545,0.00015405331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018116094,0.00014879083,0.0006970581,0.0001810171,0.00008829351,0.00004292147,0.0002350215,0.000025230644,0.00006639231],"category_scores_gemma":[0.0028089818,0.00013940787,0.00016858416,0.00039883298,0.00010485665,0.00024981712,0.00013064932,0.00004944099,0.00009132343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013588858,0.0005851371,0.9527489,0.00055569503,0.00035714544,0.000001090999,0.0029799207,0.00063540164,1.074053e-7,0.0029141682,0.020882005,0.018204574],"study_design_scores_gemma":[0.0004958386,0.000033856402,0.95545006,0.0009166903,0.0000126917275,1.00667016e-7,0.0020096116,0.0052613188,2.950532e-7,0.03565726,0.000041320254,0.000120939985],"about_ca_topic_score_codex":0.006432312,"about_ca_topic_score_gemma":0.0007020602,"teacher_disagreement_score":0.032743093,"about_ca_system_score_codex":0.000079843834,"about_ca_system_score_gemma":0.000063136424,"threshold_uncertainty_score":0.9723775},"labels":[],"label_agreement":null},{"id":"W4379520714","doi":"10.1136/annrheumdis-2023-eular.1409","title":"OP0026 INCREASED VASCULAR INFLAMMATION ON PET-CT IN PSORIATIC ARTHRITIS PATIENTS IN COMPARISON WITH HEALTHY CONTROLS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Canadian Rheumatology Association; University of British Columbia","funders":"Health~Holland; Pfizer","keywords":"Medicine; Psoriatic arthritis; Inflammation; Arthritis; Psoriasis; Pathology; Internal medicine; Dermatology","score_opus":0.02455842391003488,"score_gpt":0.2981931453717915,"score_spread":0.2736347214617566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379520714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996012,0.0012365249,6.418944e-7,0.0012087846,0.00007553184,0.0012086771,0.000069486494,0.00003309394,0.0001552737],"genre_scores_gemma":[0.9972257,0.0022178357,0.0000120276945,0.00023202082,0.000012202006,0.00015022283,0.00011866135,0.000018875742,0.000012458383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826366,0.00016403054,0.00057996216,0.00019887264,0.0004978159,0.00029565606],"domain_scores_gemma":[0.9989698,0.0002662269,0.00022878638,0.0003480373,0.000082740604,0.00010439287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020352886,0.0001751001,0.000644915,0.00021006908,0.00007464467,0.000013040213,0.00009500869,0.000012582289,0.000027179633],"category_scores_gemma":[0.000600162,0.00011646655,0.00012780253,0.0005315505,0.00006564462,0.00007428477,0.00004108353,0.00008522336,0.00003554307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017172408,0.00161909,0.93410873,0.00040804493,0.00030522616,0.000101900034,0.00033379957,0.00047911302,0.0000010984705,0.0001737431,0.0007467719,0.060005225],"study_design_scores_gemma":[0.012022861,0.0008638922,0.9815312,0.0038867912,0.00006541244,0.000002775332,0.00028501922,0.0007895361,0.000041839103,0.00032316562,0.00008368301,0.00010383953],"about_ca_topic_score_codex":0.00084709516,"about_ca_topic_score_gemma":0.00064738636,"teacher_disagreement_score":0.059901386,"about_ca_system_score_codex":0.000047396774,"about_ca_system_score_gemma":0.00007817878,"threshold_uncertainty_score":0.4749368},"labels":[],"label_agreement":null},{"id":"W4379520771","doi":"10.1136/annrheumdis-2023-eular.2163","title":"OP0025 MORTALITY AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST INITIATION IN PATIENTS WITH AUTOIMMUNE DISEASES AND TYPE 2 DIABETES: A POPULATION-BASED STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Population; Mace; Psoriatic arthritis; Hazard ratio; Type 1 diabetes; Diabetes mellitus; Immunology; Rheumatoid arthritis; Myocardial infarction; Percutaneous coronary intervention; Endocrinology","score_opus":0.021803871294045665,"score_gpt":0.2701286533260557,"score_spread":0.24832478203201003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379520771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706334,0.0009214061,6.481238e-7,0.00013892776,0.000097969954,0.0016013535,0.000120905774,0.00004538922,0.000010061157],"genre_scores_gemma":[0.99915206,0.000076460325,0.0000147885185,0.00012677808,0.000007370658,0.00019885747,0.00033597308,0.000021800992,0.00006587919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985959,0.00013373193,0.00031964862,0.00026435862,0.00047314586,0.00021323276],"domain_scores_gemma":[0.99909735,0.000083839455,0.00013425478,0.0004827353,0.0000966456,0.00010517593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017065692,0.00019272315,0.0004453275,0.00015080956,0.00007571889,0.000019649635,0.00007518324,0.000024340141,0.000029020894],"category_scores_gemma":[0.0001845077,0.00012937745,0.00013754063,0.00038205454,0.000053108095,0.00015113028,0.000098097895,0.0000377777,0.0000065277777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027425686,0.0012038108,0.99351066,0.00059119886,0.0011984934,0.0000030908036,0.00013588664,0.00010381681,1.9945652e-7,0.000003035908,0.000112131485,0.0028634137],"study_design_scores_gemma":[0.0031987145,0.00038209363,0.9936393,0.0008007746,0.0013720609,1.657164e-8,0.00017268134,0.00020015037,0.0000025416882,0.00007877213,0.000021391115,0.0001314832],"about_ca_topic_score_codex":0.00016670636,"about_ca_topic_score_gemma":0.000021775666,"teacher_disagreement_score":0.0029244577,"about_ca_system_score_codex":0.000029441186,"about_ca_system_score_gemma":0.000042366475,"threshold_uncertainty_score":0.5275859},"labels":[],"label_agreement":null},{"id":"W4379521354","doi":"10.1136/annrheumdis-2023-eular.2784","title":"POS0034 BIOLOGIC USE REGULATES THE IMPACT OF INFLAMMATION ON ISCHEMIC CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Beckett-Fonden; Novo Nordisk; Pfizer; Erik og Susanna Olesens Almenvelgørende Fond; H. Lundbeck A/S; Lundbeckfonden; Gigtforeningen; Gilead Sciences","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Mace; Unstable angina; Myocardial infarction; C-reactive protein; Cardiology; Systemic inflammation; Inflammation; Percutaneous coronary intervention","score_opus":0.03808642516282268,"score_gpt":0.30823831289912784,"score_spread":0.27015188773630516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98198193,0.016212147,0.0000015764114,0.0007324577,0.00005717255,0.0007120567,0.00015653798,0.000052913492,0.00009320795],"genre_scores_gemma":[0.8306958,0.1691339,0.0000069036387,0.000016575577,0.0000145944105,0.000049038328,0.00003564283,0.000019316865,0.000028233579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774987,0.00044656295,0.0006104769,0.00021568731,0.00059795403,0.0003794339],"domain_scores_gemma":[0.99764705,0.0007724734,0.00029318404,0.0009844931,0.00018924846,0.000113543225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086921797,0.00020923966,0.0006479212,0.00024688742,0.000118081036,0.00003534194,0.00031613078,0.00006596409,0.000069689064],"category_scores_gemma":[0.003547822,0.00010714233,0.0009758627,0.0007655559,0.00037949032,0.00017542721,0.00011705886,0.00018177304,0.00004019508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020281216,0.00093301176,0.52967906,0.0006372227,0.0062707225,0.000040493363,0.0033601266,0.017211119,0.0037908426,0.00087864767,0.033598937,0.4015717],"study_design_scores_gemma":[0.0016970518,0.00042897364,0.9797938,0.0038912718,0.000016986418,0.000018418532,0.00045896834,0.001488785,0.008069397,0.0036712342,0.00030574776,0.0001593783],"about_ca_topic_score_codex":0.001167132,"about_ca_topic_score_gemma":0.00002081944,"teacher_disagreement_score":0.45011473,"about_ca_system_score_codex":0.00002180543,"about_ca_system_score_gemma":0.00014664259,"threshold_uncertainty_score":0.43691376},"labels":[],"label_agreement":null},{"id":"W4379521430","doi":"10.1136/annrheumdis-2023-eular.1306","title":"POS0231 SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: RESULTS FROM THE PHASE 3 BE COMPLETE STUDY AND ITS OPEN-LABEL EXTENSION UP TO 1 YEAR","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"University of Toronto; University of Glasgow; Sorbonne Université; University of Washington; University of Occupational and Environmental Health; University of Rochester; Jikei University School of Medicine; Icahn School of Medicine at Mount Sinai","keywords":"Medicine; Psoriatic arthritis; Tolerability; Psoriasis; Adverse effect; Placebo; Internal medicine; Gastroenterology; Arthritis; Surgery; Immunology; Pathology","score_opus":0.058874061071566564,"score_gpt":0.34579343026140374,"score_spread":0.2869193691898372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875327,0.00081590284,7.1467576e-7,0.005785274,0.000037794263,0.0038039007,0.0020049184,0.000016810136,0.000002038706],"genre_scores_gemma":[0.99803823,0.0016328874,0.0000236634,0.00014135124,0.0000073773763,0.00005995364,0.0000412633,0.000025296906,0.00002995357],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976988,0.0005272215,0.00055397145,0.00036281737,0.00055380486,0.0003034018],"domain_scores_gemma":[0.99718845,0.0015989888,0.00020244082,0.0004192796,0.00029503755,0.00029578336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005725601,0.00020732643,0.00059894816,0.00018608393,0.00018578293,0.000080121,0.00022108656,0.000028431048,0.000008936248],"category_scores_gemma":[0.00529554,0.0001222766,0.000029619016,0.00054993556,0.0001455301,0.00018713123,0.00050275505,0.000106190826,0.0000028713905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3040267,0.004446333,0.009076426,0.00024523484,0.00077474327,0.000034293145,0.05168279,0.00001091425,0.0014444864,0.000029040872,0.0029699479,0.6252591],"study_design_scores_gemma":[0.04321498,0.0048384713,0.94080675,0.0040969285,0.000025552848,0.0000010169142,0.0060759247,0.00010141238,0.00054166216,0.000111053945,0.00003685544,0.00014937102],"about_ca_topic_score_codex":0.00058551074,"about_ca_topic_score_gemma":0.00014513395,"teacher_disagreement_score":0.93173033,"about_ca_system_score_codex":0.00001831575,"about_ca_system_score_gemma":0.00013195451,"threshold_uncertainty_score":0.6339639},"labels":[],"label_agreement":null},{"id":"W4379521440","doi":"10.1136/annrheumdis-2023-eular.4112","title":"POS0229 COMBINING MTX DOES NOT RESULT IN AN ADDITIONAL EFFICACY OF UST TREATMENT IN POLYARTHRITIC PSA: SUBGROUP ANALYSIS FROM A RANDOMIZED PLACEBO-CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Dutch Arthritis Association; National Institute for Health and Care Research; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Polyarthritis; Oligoarthritis; Internal medicine; Randomized controlled trial; Placebo; Cohort; Physical therapy; Arthritis; Pathology","score_opus":0.11189627398147149,"score_gpt":0.3991616797410457,"score_spread":0.2872654057595742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914013,0.0010299826,0.0000013858876,0.0020725038,0.00014799139,0.002800164,0.0024523484,0.000051416344,0.000042901556],"genre_scores_gemma":[0.992963,0.004530306,0.000048259975,0.0002161541,0.00005606084,0.0006413838,0.0014745606,0.000025387397,0.000044847013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99313724,0.0029070375,0.0023099966,0.0004081817,0.00079971,0.00043782342],"domain_scores_gemma":[0.98446894,0.013599719,0.0006346412,0.00065258174,0.0002000043,0.00044409235],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020121858,0.0002911295,0.002952718,0.00082836946,0.00008152399,0.00004455836,0.0002940342,0.000112294816,0.0008624504],"category_scores_gemma":[0.022582196,0.00016974403,0.0013231984,0.0012435985,0.00076441106,0.00018147941,0.00008055453,0.00019975497,0.000013565553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9587867,0.004495059,0.0248785,0.00007221568,0.004785645,0.000053218922,0.0011069837,0.00016505615,0.000060950915,0.00030980483,0.00069509074,0.004590774],"study_design_scores_gemma":[0.82034165,0.0010114004,0.16621765,0.001668786,0.0003882195,8.293322e-7,0.0005861912,0.006950165,0.00021624858,0.0024320022,0.000008871149,0.00017797573],"about_ca_topic_score_codex":0.0013089079,"about_ca_topic_score_gemma":0.00071933615,"teacher_disagreement_score":0.14133915,"about_ca_system_score_codex":0.0000311884,"about_ca_system_score_gemma":0.0006569769,"threshold_uncertainty_score":0.985651},"labels":[],"label_agreement":null},{"id":"W4379521441","doi":"10.1136/annrheumdis-2023-eular.43","title":"POS0087 ADHERENCE TO EULAR SERUM URATE MONITORING GUIDELINES AMONGST OLDER ADULTS WITH GOUT IN ONTARIO, CANADA: A POPULATION-BASED STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Gout; Internal medicine; Medical prescription; Retrospective cohort study; Pharmacy; Logistic regression; Population; Rheumatology; Cohort; Hyperuricemia; Emergency medicine; Family medicine; Uric acid","score_opus":0.05704570509031281,"score_gpt":0.32049084310391085,"score_spread":0.26344513801359803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564624,0.00017768252,0.000004252323,0.0023816633,0.00019100544,0.0014693303,0.000045402576,0.00006285988,0.000021593296],"genre_scores_gemma":[0.99864334,0.000007163785,0.00012727134,0.00043620824,0.000028394634,0.00014785788,0.000026718948,0.000035182762,0.00054783426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976181,0.00008788578,0.00067807833,0.00033800627,0.00088900735,0.00038895698],"domain_scores_gemma":[0.9982824,0.00015712286,0.00023858158,0.00072102563,0.00034775698,0.00025312038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023976967,0.00025391104,0.000509117,0.00015863613,0.00009000271,0.000022621414,0.00031645497,0.00003626895,0.00008561462],"category_scores_gemma":[0.0008850057,0.00016891025,0.000091235495,0.0008086099,0.000022881919,0.00009399463,0.000102429825,0.000140419,0.00001167649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022789484,0.00029587184,0.9895875,0.00022851174,0.0001449818,0.000058584137,0.0012172029,0.003893897,0.0000043960067,0.0000010277104,0.0023585893,0.0019815438],"study_design_scores_gemma":[0.0013865611,0.0002684777,0.98974913,0.003978818,0.00016888643,0.0000021656529,0.003211614,0.0008971454,0.00012331177,0.000016315264,0.000012672854,0.0001848717],"about_ca_topic_score_codex":0.92034787,"about_ca_topic_score_gemma":0.8338451,"teacher_disagreement_score":0.08650275,"about_ca_system_score_codex":0.00017172156,"about_ca_system_score_gemma":0.0012691186,"threshold_uncertainty_score":0.688796},"labels":[],"label_agreement":null},{"id":"W4379521519","doi":"10.1136/annrheumdis-2023-eular.1722","title":"POS0232 POST-MARKETING SAFETY SURVEILLANCE OF TOFACITINIB OVER 9 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"UCB Pharma; Medac; Eisai; Celgene; Biogen; Ortho Dermatologics; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Rheumatoid arthritis; Adverse effect; Internal medicine; Safety profile; Ulcerative colitis; Dermatology","score_opus":0.011433446367392599,"score_gpt":0.25199623909436375,"score_spread":0.24056279272697115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301404,0.0051794243,0.0000017705122,0.00047690546,0.0001267324,0.00024997385,0.0008772506,0.000020779773,0.000053149826],"genre_scores_gemma":[0.9940524,0.0056628967,0.000046552155,0.0001299375,0.0000023433697,0.0000066922084,0.000045181976,0.000012684022,0.00004130761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984108,0.00048665228,0.0005147429,0.00020225132,0.00010321214,0.0002823494],"domain_scores_gemma":[0.9984732,0.00084131304,0.00026154058,0.0002810827,0.00010850999,0.00003431648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006630353,0.00014516003,0.0004906423,0.000098775796,0.00005863343,0.00000954376,0.00018143283,0.000086534536,0.00023133341],"category_scores_gemma":[0.0013708308,0.00010024629,0.00011029003,0.00035218045,0.0003532358,0.000051998548,0.000135677,0.00010214301,0.000006664784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009894106,0.00030816978,0.58503276,0.00024199147,0.0003168296,0.0000023491036,0.00025479426,0.000010196822,0.000112627014,0.00025481643,0.0015242762,0.4109518],"study_design_scores_gemma":[0.0016608951,0.00013408634,0.9954373,0.0016516147,0.000009561127,0.0000017084642,0.00012490299,0.000012872929,0.00025702134,0.0003929486,0.00018868169,0.00012841183],"about_ca_topic_score_codex":0.000080723374,"about_ca_topic_score_gemma":0.00004757427,"teacher_disagreement_score":0.41082337,"about_ca_system_score_codex":0.0000047527133,"about_ca_system_score_gemma":0.00003990817,"threshold_uncertainty_score":0.4087925},"labels":[],"label_agreement":null},{"id":"W4379521570","doi":"10.1136/annrheumdis-2023-eular.2097","title":"POS0468 A PREDICTION MODEL FOR SWITCHING OF BIOLOGICS AND TSDMARDS IN RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Rheumatoid arthritis; Internal medicine","score_opus":0.08233124357665539,"score_gpt":0.3600108259228865,"score_spread":0.27767958234623114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438953,0.0021294707,0.000107752014,0.002513101,0.000033741188,0.00042415562,0.00030338217,0.000020397209,0.000078469486],"genre_scores_gemma":[0.9839151,0.01561789,0.00012754703,0.000093397495,0.000009508105,0.00003908289,0.000024259018,0.000008998663,0.00016424597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990336,0.000039444443,0.00036397701,0.00012809568,0.00023689699,0.00019804126],"domain_scores_gemma":[0.9992718,0.0002947975,0.00010715304,0.00014583283,0.000102036734,0.00007834619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029229818,0.0000902695,0.00032274827,0.0001283843,0.000054323864,0.0000062516233,0.00010137131,0.000039523533,0.000008376616],"category_scores_gemma":[0.00069077197,0.000056928166,0.0001460918,0.00021810239,0.00008820183,0.000050790073,0.00010362056,0.00006243084,0.0000014644319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036937448,0.0013478767,0.49741718,0.008855261,0.0007814315,0.00001301013,0.004538083,0.0047069155,0.0091655115,0.010376609,0.016777456,0.44232693],"study_design_scores_gemma":[0.0015135175,0.00041722352,0.5228066,0.0040182546,0.00002932715,0.000015060854,0.00047834645,0.43329877,0.0016404034,0.03552158,0.00013174067,0.00012922552],"about_ca_topic_score_codex":0.0001122985,"about_ca_topic_score_gemma":0.000015111684,"teacher_disagreement_score":0.44219768,"about_ca_system_score_codex":0.0000047753206,"about_ca_system_score_gemma":0.000085919535,"threshold_uncertainty_score":0.23214632},"labels":[],"label_agreement":null},{"id":"W4379521639","doi":"10.1136/annrheumdis-2023-eular.3688","title":"POS0568 THE RATIO BETWEEN BIOLOGICAL AND GLUCOCORTICOID USE IN VARIOUS COUNTRIES WORLDWIDE: RESULTS FROM THE METEOR REGISTRY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Versus Arthritis; University of British Columbia; Arthritis Society; Canadian Rheumatology Association; Simon Fraser University; Pfizer","keywords":"Medicine; Meteor (satellite); Glucocorticoid; Immunology; Meteorology","score_opus":0.4587276144516661,"score_gpt":0.42306125521547144,"score_spread":0.035666359236194656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87327963,0.0035978626,0.000044404547,0.1189137,0.00021178609,0.00075477356,0.0030841988,0.000024651825,0.00008901434],"genre_scores_gemma":[0.99254644,0.0014984597,0.00004914296,0.0053540585,0.00008120824,0.00006323032,0.00009329565,0.000014768348,0.0002994199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958145,0.00070231047,0.0026788635,0.00036508683,0.00013136068,0.00030790138],"domain_scores_gemma":[0.98215365,0.014933605,0.0017946217,0.000982702,0.000052141047,0.00008325456],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007211199,0.00016535982,0.00071907096,0.00008988888,0.00023809313,0.00016928467,0.0006029345,0.00007826199,0.00006777836],"category_scores_gemma":[0.022648377,0.00010109721,0.00014452946,0.00034948002,0.00031868508,0.00026100434,0.0001962317,0.00013906708,0.0003161015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105199135,0.000077241304,0.8923799,0.00018351908,0.0003031824,0.0000012413465,0.003473185,0.00050293223,5.989189e-7,0.032115817,0.06987562,0.0009815976],"study_design_scores_gemma":[0.00045601686,0.000024840034,0.9485158,0.0002464944,0.000017129993,4.728472e-7,0.00093410374,0.0016100243,0.000004803223,0.042700328,0.0053560925,0.00013393347],"about_ca_topic_score_codex":0.0029423956,"about_ca_topic_score_gemma":0.0003128626,"teacher_disagreement_score":0.119266815,"about_ca_system_score_codex":0.00004192023,"about_ca_system_score_gemma":0.00012292352,"threshold_uncertainty_score":0.98558426},"labels":[],"label_agreement":null},{"id":"W4379521675","doi":"10.1136/annrheumdis-2023-eular.353","title":"POS0588-HPR DISCOVERING THE POTENTIAL OF DIGITAL BIOMARKERS IN THE WORK PROCESS OF THE RHEUMATOLOGY HEALTHCARE PROFESSIONALS, A DESIGN THINKING APPROACH. PRELIMINARY RESULTS OF THE HEALTHCARE PROFESSIONALS PERSPECTIVE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Koninklijk Nederlands Genootschap voor Fysiotherapie; ZonMw; Arthritis Society; Dutch Arthritis Society; Pfizer","keywords":"Medicine; Health professionals; Health care; Perspective (graphical); Work (physics); Knowledge management; Computer science; Engineering; Artificial intelligence","score_opus":0.027547291540349857,"score_gpt":0.3043936982033117,"score_spread":0.27684640666296184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526802,0.0038503546,0.0001812302,0.0404453,0.0007740641,0.0016794365,0.00028752044,0.00005704832,0.000044866905],"genre_scores_gemma":[0.9994855,0.00017223007,0.000033126653,0.00007363092,0.000018080078,0.00014941557,0.000018408471,0.0000266442,0.000022970169],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9973988,0.00047940266,0.00080443046,0.00020703404,0.00077969447,0.00033066416],"domain_scores_gemma":[0.9977377,0.0008704168,0.00046495203,0.00068920694,0.00018311015,0.000054594966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090357655,0.00021598916,0.00038780764,0.000100526966,0.00020162448,0.000018511815,0.0012629665,0.00010909817,0.0000022059262],"category_scores_gemma":[0.0009866644,0.000088793495,0.0002577541,0.0013664167,0.00037888793,0.00014215865,0.00027213278,0.00030179147,5.6281937e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004485659,0.006431279,0.04916728,0.08520784,0.0039054,0.000005862207,0.41311413,0.3451607,0.00029930315,0.014395553,0.050079636,0.027747374],"study_design_scores_gemma":[0.0011167435,0.00023866257,0.7667592,0.024974741,0.0001792979,0.000024538407,0.14474414,0.030106707,0.0012758143,0.030103376,0.00001263287,0.0004641175],"about_ca_topic_score_codex":0.0002000491,"about_ca_topic_score_gemma":0.000006618892,"teacher_disagreement_score":0.71759194,"about_ca_system_score_codex":0.00003325797,"about_ca_system_score_gemma":0.00032141857,"threshold_uncertainty_score":0.36208937},"labels":[],"label_agreement":null},{"id":"W4379521692","doi":"10.1136/annrheumdis-2023-eular.233","title":"POS0585-HPR EFFECTIVENESS OF INSPIRATORY MUSCLE TRAINING ON AEROBIC CAPACITY, RESPIRATORY FUNCTIONS AND RESPIRATORY MUSCLE STRENGTH IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A SINGLE-BLINDED RANDOMISED CONTROLLED TRIAL","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eli Lilly Canada; Sanofi Genzyme; AbbVie Canada; Sandoz Canada; Merck Canada; Gilead Sciences; Pfizer Canada; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Vital capacity; Physical therapy; VO2 max; Aerobic exercise; Aerobic capacity; Lung volumes; Pulmonary function testing; Quality of life (healthcare); Internal medicine; Pulmonary rehabilitation; Cardiology; Heart rate; Lung; Rehabilitation; Blood pressure; Lung function; Diffusing capacity","score_opus":0.13159940984618818,"score_gpt":0.36557649617168486,"score_spread":0.23397708632549669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044204,0.0020149653,0.000004386027,0.00023163047,0.0003409583,0.006571514,0.00016778769,0.0001037006,0.00012300644],"genre_scores_gemma":[0.9982344,0.00016397156,0.000003097915,0.00045510594,0.00015629434,0.00090861716,0.000014569993,0.000049263785,0.000014701751],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9920172,0.0048817773,0.0015138325,0.0004129442,0.000583322,0.00059090223],"domain_scores_gemma":[0.9949253,0.0029422469,0.0010340579,0.00057710183,0.00026475685,0.0002565099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039856588,0.00032107864,0.001405058,0.00047240563,0.0005073418,0.000013151101,0.0002682684,0.00028266496,0.000025407337],"category_scores_gemma":[0.0032102324,0.00022828,0.00027929296,0.00087551307,0.0002540451,0.00016632618,0.000106249856,0.000699228,0.000011514955],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5888632,0.0052269404,0.28533936,0.010179389,0.0012028754,0.000021404368,0.01630782,0.00085245795,0.0010177558,0.0009898142,0.0021263051,0.087872714],"study_design_scores_gemma":[0.3977711,0.0012765307,0.5903095,0.007483489,0.00013818908,3.7766375e-7,0.0023120542,0.000037324247,0.00005131975,0.00030583967,0.00004477202,0.00026955048],"about_ca_topic_score_codex":0.00018910646,"about_ca_topic_score_gemma":0.00023684636,"teacher_disagreement_score":0.30497012,"about_ca_system_score_codex":0.00006746885,"about_ca_system_score_gemma":0.0011895316,"threshold_uncertainty_score":0.93089885},"labels":[],"label_agreement":null},{"id":"W4379521736","doi":"10.1136/annrheumdis-2023-eular.445","title":"POS0935 THE COURSE OF CYTOKINE AND CHEMOKINE GENE EXPRESSION IN CLINICALLY SUSPECT ARTHRALGIA PATIENTS DURING PROGRESSION TO INFLAMMATORY ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Arthritis Society","keywords":"Medicine; Chemokine; Immunology; Cytokine; Chemokine receptor; Arthritis; CCL17; Internal medicine; Inflammation","score_opus":0.026516774295218877,"score_gpt":0.3445925054591447,"score_spread":0.31807573116392585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379521736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502504,0.0015324762,0.0000014093624,0.001900641,0.00007994079,0.0013353215,0.000057738147,0.000035900543,0.00003153622],"genre_scores_gemma":[0.99778056,0.001845982,0.000053690128,0.00006344693,0.000028700919,0.00009436728,0.000015391763,0.00002821758,0.00008965794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757135,0.00020896422,0.0008847469,0.00024643642,0.00076322287,0.00032527506],"domain_scores_gemma":[0.99808997,0.0004228077,0.00033877033,0.00070240564,0.00025186955,0.000194183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073733117,0.00016928189,0.0005288263,0.00016041163,0.00007915763,0.000013851827,0.0002857598,0.000060731276,0.000032685424],"category_scores_gemma":[0.0018968775,0.00009090033,0.00014925454,0.0005025672,0.00020801523,0.00007214797,0.00042280843,0.00013148836,0.000010527387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007817957,0.00048653368,0.97083855,0.0019861287,0.00008161734,0.000016518976,0.001395958,0.000024669129,0.007891027,0.0000072697367,0.002600453,0.013889456],"study_design_scores_gemma":[0.0023674539,0.00023329757,0.948653,0.014463312,0.000024781028,0.000042617783,0.0005985868,0.00012481322,0.03317374,0.00020359381,0.0000129571945,0.00010183554],"about_ca_topic_score_codex":0.000008324221,"about_ca_topic_score_gemma":0.000004844699,"teacher_disagreement_score":0.025282713,"about_ca_system_score_codex":0.000016487184,"about_ca_system_score_gemma":0.0001225046,"threshold_uncertainty_score":0.37068078},"labels":[],"label_agreement":null},{"id":"W4379522186","doi":"10.1136/annrheumdis-2023-eular.769","title":"POS0019 PREDICTION OF PSORIATIC ARTHRITIS TOOL (PRESTO): DEVELOPMENT AND PERFORMANCE OF A NEW SCORING SYSTEM FOR PSORIATIC ARTHRITIS RISK","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Sunnybrook Hospital; University of Waterloo; Women's College Hospital; University of Toronto","funders":"Pfizer; Eli Lilly and Company","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Cohort; Internal medicine; Prospective cohort study; Physical therapy; Immunology","score_opus":0.036301900818684854,"score_gpt":0.26934237786581205,"score_spread":0.23304047704712721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866548,0.011432968,0.00002834751,0.00010729902,0.00031085542,0.0010472594,0.0003393139,0.00004781839,0.000031317704],"genre_scores_gemma":[0.98473626,0.014537087,0.00040043125,0.000010283041,0.00003912676,0.00013582315,0.000029551493,0.0000212944,0.000090117544],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983692,0.00003962814,0.0007668324,0.00019738993,0.0003824832,0.00024444296],"domain_scores_gemma":[0.99871176,0.00020832635,0.0004901131,0.00032732103,0.00016078936,0.00010167683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002369767,0.00017450808,0.00064510683,0.00011932411,0.0001478551,0.000009364786,0.000094036855,0.000040099243,0.000008800049],"category_scores_gemma":[0.00049515034,0.0001323894,0.00017990431,0.00027475806,0.00008160009,0.00009986872,0.00008605702,0.000043166223,0.0000040893083],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065040414,0.00031816596,0.11899375,0.006653109,0.0012677009,0.000004424944,0.0018699156,0.000093549,0.00003377886,0.00023102561,0.0014267209,0.86845744],"study_design_scores_gemma":[0.006213812,0.0011377162,0.9629086,0.02166149,0.00049273693,0.000022080394,0.0011066007,0.0014529031,0.004376555,0.00034906622,0.00012770567,0.0001507017],"about_ca_topic_score_codex":0.00011443447,"about_ca_topic_score_gemma":0.000015318607,"teacher_disagreement_score":0.86830676,"about_ca_system_score_codex":0.000022213091,"about_ca_system_score_gemma":0.00016537198,"threshold_uncertainty_score":0.5398683},"labels":[],"label_agreement":null},{"id":"W4379522190","doi":"10.1136/annrheumdis-2023-eular.1239","title":"OP0235 DEVELOPMENT AND PRELIMINARY VALIDATION OF THE NOVEL SCLERODERMA CLINICAL TRIALS CONSORTIUM ACTIVITY INDEX","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Merck Sharp and Dohme; Genentech; St Vincent's Hospital Melbourne; Foundation for Research in Rheumatology; University of Melbourne; Eli Lilly and Company; Amgen","keywords":"Medicine; Construct validity; Proportional hazards model; Face validity; Delphi method; Cohort; Cohort study; Hazard ratio; Physical therapy; Internal medicine; Artificial intelligence; Computer science; Surgery; Psychometrics; Confidence interval","score_opus":0.302750154091864,"score_gpt":0.42961688857944585,"score_spread":0.12686673448758184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951311,0.0012826553,0.000022136166,0.0021707665,0.0003457727,0.0008536874,0.00007362708,0.000034316785,0.00008596806],"genre_scores_gemma":[0.9985862,0.0009337977,0.000016031898,0.00017495985,0.00003229711,0.000037934675,0.000009682574,0.000014598784,0.00019453737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973868,0.0005917539,0.001140707,0.00020530574,0.0005061794,0.00016922395],"domain_scores_gemma":[0.996652,0.0016230787,0.00089545234,0.0005180905,0.00016276585,0.00014862638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021210152,0.00014473648,0.00069190253,0.00007222195,0.000114877046,0.000014125231,0.00020242749,0.00009785893,0.00002903773],"category_scores_gemma":[0.006498483,0.000072712406,0.00040804184,0.00032580472,0.00028486035,0.00006616727,0.0002135436,0.000097574404,0.000006157632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027501772,0.0040180287,0.67195976,0.0041071074,0.0034020988,0.0000028395332,0.0015703005,0.00047536014,0.004450662,0.00027931406,0.032015823,0.27496853],"study_design_scores_gemma":[0.0013362252,0.00006560575,0.9778473,0.0045606275,0.00041889877,0.0000041647704,0.000312322,0.0007209557,0.014483744,0.000112939604,0.000055213353,0.00008202414],"about_ca_topic_score_codex":0.000024105348,"about_ca_topic_score_gemma":5.569691e-7,"teacher_disagreement_score":0.30588752,"about_ca_system_score_codex":0.000008836457,"about_ca_system_score_gemma":0.00035234485,"threshold_uncertainty_score":0.77797604},"labels":[],"label_agreement":null},{"id":"W4379522264","doi":"10.1136/annrheumdis-2023-eular.4991","title":"OP0277-HPR PATTERNS OF PATIENT-REPORTED SYMPTOMS IN SYSTEMIC SCLEROSIS: A SCLERODERMA PATIENT-CENTERED INTERVENTION NETWORK (SPIN) COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Lawson Health Research Institute; Jewish General Hospital","funders":"Lady Davis Institute for Medical Research; Canadian Institutes of Health Research; Jewish General Hospital; Arthritis Society; Fondation de l'Hôpital général juif; McGill University","keywords":"Medicine; Anxiety; Depression (economics); Cohort; Sleep disorder; Physical therapy; Fibromyalgia; Latent class model; Cohort study; Psychiatry; Internal medicine; Cognition","score_opus":0.04390679789725096,"score_gpt":0.29747496933004897,"score_spread":0.25356817143279803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905399,0.0052597392,0.0000048067345,0.00012681559,0.0006676358,0.0031369415,0.000120742436,0.00011271193,0.00003068067],"genre_scores_gemma":[0.99793243,0.0014017601,0.0000022591994,0.000104837614,0.000030252426,0.00034450402,0.0000914508,0.000049653598,0.000042866646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953737,0.000545991,0.0021630758,0.00045404283,0.0009873464,0.00047583898],"domain_scores_gemma":[0.9968756,0.00017499927,0.0013588622,0.0010582149,0.00031113598,0.00022120711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052373146,0.00032559922,0.0010404245,0.00030464836,0.000089351626,0.000028791568,0.00032870032,0.000104452265,0.000075004544],"category_scores_gemma":[0.0005670053,0.00022511293,0.0006791543,0.0009967401,0.00009375643,0.00013684592,0.00026864625,0.00013555329,0.00001922355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034031924,0.0028851756,0.9712016,0.0014490283,0.0014969329,0.000016568258,0.0011357616,0.0011581677,0.00012551007,0.000010206355,0.0018044265,0.0183763],"study_design_scores_gemma":[0.0026123312,0.00058025366,0.93417054,0.055594623,0.00072749105,0.0000132729265,0.0049879197,0.00081352744,0.00026056514,0.000051250732,0.0000018404965,0.00018639074],"about_ca_topic_score_codex":0.00052766455,"about_ca_topic_score_gemma":0.000018302966,"teacher_disagreement_score":0.054145597,"about_ca_system_score_codex":0.00005187926,"about_ca_system_score_gemma":0.00010157006,"threshold_uncertainty_score":0.9179839},"labels":[],"label_agreement":null},{"id":"W4379522269","doi":"10.1136/annrheumdis-2023-eular.6101","title":"OP0229 CHANGES IN THE CAUSES AND PREDICTORS OF LUPUS MORTALITY IN SPAIN THROUGH THE LAST DECADES: DATA FROM THE RELESSER REGISTRY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Systemic lupus erythematosus; Data science; Demography; Internal medicine; Disease; Computer science","score_opus":0.15363083333507202,"score_gpt":0.39138342887452804,"score_spread":0.23775259553945602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97649294,0.0061736465,0.0000014978323,0.015368747,0.00014571921,0.0010523874,0.00060805783,0.000021171903,0.00013582321],"genre_scores_gemma":[0.993021,0.0061764573,0.0000042033116,0.0004233943,0.00006461703,0.00009217541,0.000077955025,0.000021224838,0.00011897579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698925,0.00089281757,0.000557896,0.00030496967,0.0009337102,0.00032135795],"domain_scores_gemma":[0.9930326,0.0039556804,0.0003039835,0.0025754697,0.00007705197,0.00005522138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002037628,0.00017934424,0.00047509267,0.00006201366,0.00009570667,0.00003714927,0.0015836478,0.000066304616,0.000031972093],"category_scores_gemma":[0.004447086,0.000071179784,0.0000872779,0.0007836699,0.00064817595,0.000118485565,0.00069796375,0.00022863876,0.0000054325124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008312849,0.00016022708,0.9554529,0.0010747529,0.00023387827,0.000013324334,0.009216022,0.000017984865,0.00002785833,0.00016400212,0.033202402,0.00035351215],"study_design_scores_gemma":[0.00070013467,0.000044746404,0.9534826,0.005159504,0.00015110873,0.00006528983,0.036846302,0.0005028074,0.00017005675,0.0022994603,0.00048634066,0.00009165099],"about_ca_topic_score_codex":0.004180692,"about_ca_topic_score_gemma":0.0050235474,"teacher_disagreement_score":0.032716062,"about_ca_system_score_codex":0.00001512591,"about_ca_system_score_gemma":0.0001781099,"threshold_uncertainty_score":0.6319984},"labels":[],"label_agreement":null},{"id":"W4379522315","doi":"10.1136/annrheumdis-2023-eular.199","title":"OP0271 INCIDENCE OF PSORIATIC ARTHRITIS AND PREVALENCE OF UNDIAGNOSED CASES IN A UK PRIMARY CARE POPULATION FOLLOWED PROSPECTIVELY FOR 2 YEARS - RESULTS FROM THE TUDOR RANDOMIZED CLINICAL TRIAL","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health; National Institute for Health and Care Research; Gilead Sciences; Sanofi; Chugai Pharmaceutical; Medizinische Universität Wien; Alan Turing Institute; Pfizer; Programme Grants for Applied Research; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Incidence (geometry); Population; Psoriasis; Rheumatology; Physical therapy; Physical examination; Pediatrics; Internal medicine; Epidemiology; Disease; Dermatology; Environmental health","score_opus":0.054167073910616224,"score_gpt":0.3338601235531854,"score_spread":0.2796930496425692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98250693,0.012708785,0.0000021891651,0.00011185385,0.00046648175,0.0021699877,0.0020161238,0.000012120386,0.00000552481],"genre_scores_gemma":[0.99369705,0.005714664,0.00003269282,0.000017241136,0.000016734031,0.000229035,0.00023610167,0.000007929705,0.000048528243],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976824,0.0009600393,0.0009228244,0.00021254405,0.00008243479,0.00013974191],"domain_scores_gemma":[0.9882434,0.010677237,0.0006800512,0.00031021642,0.00007356804,0.000015523572],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010285333,0.00011941508,0.00072802417,0.000058641857,0.00005889068,0.000005825746,0.00021592718,0.000085841704,0.000009172021],"category_scores_gemma":[0.0088409465,0.00007350739,0.00034092503,0.00017956494,0.00028679438,0.00005500204,0.000079783546,0.000045733766,0.0000017539575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5911704,0.0009023618,0.15244792,0.0009297494,0.0017736508,0.000007185596,0.005037457,0.00003854163,0.00015321534,0.00024785716,0.001299214,0.2459925],"study_design_scores_gemma":[0.1609467,0.0003018018,0.8337451,0.0015008494,0.00041468182,7.2624465e-7,0.0002774414,0.00001208028,0.0004340203,0.0022910282,0.0000025258114,0.00007300714],"about_ca_topic_score_codex":0.00097376195,"about_ca_topic_score_gemma":0.00016859238,"teacher_disagreement_score":0.68129724,"about_ca_system_score_codex":0.000009355711,"about_ca_system_score_gemma":0.00010007985,"threshold_uncertainty_score":0.999508},"labels":[],"label_agreement":null},{"id":"W4379522345","doi":"10.1136/annrheumdis-2023-eular.1446","title":"POS0030 METHOTREXATE USE ASSOCIATES WITH ISCHEMIC CARDIOVASCULAR RISK REDUCTION IN MALES BUT NOT FEMALES WITH RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Mace; Myocardial infarction; Coronary artery disease; Cardiology; Hazard ratio; Diabetes mellitus; Percutaneous coronary intervention; Endocrinology; Confidence interval","score_opus":0.06438943796105391,"score_gpt":0.30921929378852026,"score_spread":0.24482985582746636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064976,0.006862849,0.000014900598,0.001018995,0.00007514157,0.001007418,0.00014789873,0.00013409178,0.000088921195],"genre_scores_gemma":[0.9797627,0.018954681,0.0002489902,0.000025992525,0.000024064693,0.00016580896,0.00003790517,0.00007333065,0.00070654467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964743,0.00058070105,0.00061376713,0.0004365879,0.0013367563,0.0005578783],"domain_scores_gemma":[0.997192,0.00073580444,0.0003988776,0.0011032335,0.0003703018,0.00019978522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012378911,0.0003052242,0.0010364825,0.00033393118,0.00013661291,0.000062713996,0.0002944985,0.0000905669,0.000029070856],"category_scores_gemma":[0.002325558,0.00018253454,0.00045265147,0.0011287049,0.0003407148,0.0002719793,0.00012939809,0.00024238211,0.000050494196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010708376,0.00031710716,0.9774172,0.0020261,0.0035362334,0.0001131456,0.0017188981,0.0013672712,0.00050811254,0.000045774796,0.0037295527,0.008149811],"study_design_scores_gemma":[0.0060862373,0.00047103988,0.92318016,0.034501567,0.0006008212,0.0028977194,0.010036765,0.00092207984,0.019942679,0.0003572914,0.0003209856,0.00068265526],"about_ca_topic_score_codex":0.0013169843,"about_ca_topic_score_gemma":0.0000696826,"teacher_disagreement_score":0.054236997,"about_ca_system_score_codex":0.000060060203,"about_ca_system_score_gemma":0.00029374668,"threshold_uncertainty_score":0.74435425},"labels":[],"label_agreement":null},{"id":"W4379522394","doi":"10.1136/annrheumdis-2023-eular.2510","title":"POS0022 NAFLD IN PSORIATIC DISEASE: IDENTIFYING PATIENTS AT HIGH RISK OF SERIOUS LIVER DISEASE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Hepatology; Fatty liver; Gastroenterology; Cirrhosis; Population; Psoriasis; Liver biopsy; Arthritis; Disease; Biopsy; Dermatology","score_opus":0.032356300671543055,"score_gpt":0.2932045479860573,"score_spread":0.2608482473145142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138486,0.004740545,6.2886835e-7,0.00081405684,0.0002338378,0.0011468717,0.0015962436,0.00005682129,0.000026140158],"genre_scores_gemma":[0.9929443,0.0060777073,0.000009511109,0.00019175395,0.00002258421,0.00017523009,0.00029365625,0.000039256054,0.00024600717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975077,0.0002249406,0.0006653504,0.0003523969,0.00087124895,0.00037836775],"domain_scores_gemma":[0.9975281,0.00036969697,0.00047610985,0.00087673345,0.00018932995,0.00056006183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016581564,0.0002723047,0.00057406357,0.00023250835,0.00012557502,0.00001850255,0.0002823385,0.000034875993,0.0002608435],"category_scores_gemma":[0.0011573115,0.00018861261,0.0005684776,0.00061288354,0.00012629623,0.00015380469,0.00033046945,0.00007436004,0.00010881513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007899653,0.0027914974,0.9795913,0.002240457,0.000598973,0.000070558526,0.00028985355,0.00022432169,0.0000014105968,0.00019767112,0.004648547,0.008555457],"study_design_scores_gemma":[0.002176217,0.00010546781,0.9905288,0.0024191167,0.0015318694,2.6101253e-7,0.00005522579,0.000665682,0.000096843236,0.0022224966,0.000030421174,0.00016755304],"about_ca_topic_score_codex":0.0005383649,"about_ca_topic_score_gemma":0.000028968618,"teacher_disagreement_score":0.0109375585,"about_ca_system_score_codex":0.00007377511,"about_ca_system_score_gemma":0.00017464183,"threshold_uncertainty_score":0.7691399},"labels":[],"label_agreement":null},{"id":"W4379522547","doi":"10.1136/annrheumdis-2023-eular.6480","title":"OP0258 RISK OF INCIDENT GOUT ASSOCIATED WITH INITIATION OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS VERSUS OTHER SECOND-LINE AGENTS AMONG METFORMIN USERS WITH TYPE 2 DIABETES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Type 2 diabetes; Metformin; Internal medicine; Diabetes mellitus; Cohort; Population; Endocrinology; Insulin","score_opus":0.04170852233071445,"score_gpt":0.2863898619088582,"score_spread":0.24468133957814373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981938,0.00036165872,0.0000051804827,0.00009249933,0.00012720325,0.0006144894,0.00037776533,0.00005617256,0.00017125523],"genre_scores_gemma":[0.9992758,0.0002454193,0.000037756286,0.000074414456,0.000015906438,0.00002433412,0.00014912887,0.000048837122,0.00012841044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979212,0.00013324888,0.00066461693,0.00020924494,0.0007817558,0.00028988867],"domain_scores_gemma":[0.99738747,0.00043841195,0.0011308728,0.0005164014,0.00038496594,0.00014185651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042604285,0.00023632751,0.0006649874,0.00019684709,0.00005384966,0.000008182208,0.0002193493,0.00008305681,0.00016603255],"category_scores_gemma":[0.0010318249,0.00014700186,0.00019239193,0.00087414536,0.0002942308,0.00019545584,0.000052530195,0.00012781206,0.0000073085735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013659985,0.0006847338,0.9888061,0.0008993696,0.0031455026,0.000008501791,0.0016448738,0.0006433466,0.00033476285,0.000008341626,0.0012707482,0.0011877033],"study_design_scores_gemma":[0.0035786242,0.0010818366,0.9506496,0.0025777258,0.0019662776,6.329641e-7,0.0009988428,0.00092427095,0.03793751,0.00008287666,0.000014374553,0.00018740499],"about_ca_topic_score_codex":0.00023953684,"about_ca_topic_score_gemma":0.00013497905,"teacher_disagreement_score":0.0381565,"about_ca_system_score_codex":0.000035061672,"about_ca_system_score_gemma":0.00019626005,"threshold_uncertainty_score":0.5994562},"labels":[],"label_agreement":null},{"id":"W4379522672","doi":"10.1136/annrheumdis-2023-eular.2374","title":"POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Gilead Sciences; Pfizer; Celltrion; Eli Lilly and Company; Amgen","keywords":"Medicine; Placebo; Axial spondyloarthritis; Radiography; Internal medicine; Nuclear medicine; Radiology; Ankylosing spondylitis; Pathology; Alternative medicine","score_opus":0.018492636145039366,"score_gpt":0.26669854244644575,"score_spread":0.24820590630140638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959156,0.0011959075,0.0000011532295,0.00055041444,0.00006321756,0.0014984623,0.00028182846,0.000024447172,0.00046895404],"genre_scores_gemma":[0.997454,0.0021917543,0.000061441126,0.000069885886,0.000012862714,0.00006103498,0.000058449965,0.000022779379,0.0000678308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998505,0.00007046866,0.00048934005,0.00021568745,0.00044090257,0.00027861883],"domain_scores_gemma":[0.9989088,0.00030397472,0.0002300087,0.00034653538,0.000121611425,0.00008906163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013246092,0.000189984,0.0008381251,0.00015841189,0.00009049662,0.000008882495,0.000101404745,0.00004214976,0.000054833883],"category_scores_gemma":[0.00031616352,0.00012323895,0.00019428381,0.00057873025,0.00026729333,0.0000830257,0.000083323255,0.00006943127,0.0000065803424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045183484,0.0028589226,0.9301586,0.0006751624,0.0019084298,0.000023875471,0.0012340844,0.000029134595,0.000010177231,0.00042018303,0.0009524717,0.016545432],"study_design_scores_gemma":[0.058528464,0.0009110298,0.9369654,0.0026018894,0.00025850878,0.0000013023052,0.00021512595,0.000013713365,0.000041848903,0.00032994166,0.000025194457,0.000107547785],"about_ca_topic_score_codex":0.000116031784,"about_ca_topic_score_gemma":0.000027833259,"teacher_disagreement_score":0.016437884,"about_ca_system_score_codex":0.000007894538,"about_ca_system_score_gemma":0.00005136947,"threshold_uncertainty_score":0.5025538},"labels":[],"label_agreement":null},{"id":"W4379522745","doi":"10.1136/annrheumdis-2023-eular.3275","title":"POS0104 A PHASE 2B DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL OF SB-061, AN AGGRECAN MIMETIC, IN SUBJECTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Osteoarthritis; Aggrecan; Chondroitin sulfate; Placebo; Hyaluronic acid; Synovial fluid; Internal medicine; Tolerability; ADAMTS; Gastroenterology; Surgery; Pathology; Thrombospondin; Adverse effect; Matrix metalloproteinase; Articular cartilage; Metalloproteinase; Glycosaminoglycan","score_opus":0.06773160299057998,"score_gpt":0.37979583926524335,"score_spread":0.3120642362746634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879529,0.0011690311,0.000004303597,0.0006457596,0.00037365474,0.009320365,0.000071427945,0.000092693626,0.00036989336],"genre_scores_gemma":[0.9977366,0.00046676665,0.00009799429,0.00011324908,0.000071735434,0.0010013967,0.000108915294,0.00005127022,0.00035210612],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99549896,0.001077433,0.001809542,0.00039117283,0.00076262344,0.00046025516],"domain_scores_gemma":[0.9953578,0.002327513,0.0009211214,0.0008430566,0.00020435221,0.00034615333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021857554,0.0003667824,0.0027880375,0.0003907998,0.00007308604,0.000034128214,0.0002587851,0.0001295017,0.00012672842],"category_scores_gemma":[0.0021643003,0.00022092392,0.0009554046,0.0006452687,0.00041171839,0.00017261149,0.00007397492,0.00015728422,0.000023032773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9326434,0.0036227733,0.00031001368,0.00034005195,0.00064629276,0.0000669571,0.00046245696,0.000009989759,0.00005944207,0.00021149145,0.00008013511,0.06154696],"study_design_scores_gemma":[0.97556436,0.014992011,0.00024659172,0.003933393,0.0015265697,0.00001852798,0.0004002509,0.0005590883,0.0013735187,0.0011707223,0.000004284954,0.00021066055],"about_ca_topic_score_codex":0.0000658245,"about_ca_topic_score_gemma":0.00010115878,"teacher_disagreement_score":0.061336298,"about_ca_system_score_codex":0.000015148199,"about_ca_system_score_gemma":0.00042459107,"threshold_uncertainty_score":0.9009016},"labels":[],"label_agreement":null},{"id":"W4379522756","doi":"10.1136/annrheumdis-2023-eular.2237","title":"POS0228 MINIMAL IMPORTANT DIFFERENCE (MID), MINIMAL DETECTABLE CHANGE (MDC), AND DISEASE ACTIVITY THRESHOLDS FOR TWO NOVEL COMPOSITE INSTRUMENTS (3VAS, 4VAS) IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THREE PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Dutch Arthritis Association; National Institute for Health and Care Research; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Observational study; Physical therapy; Internal medicine; Arthritis","score_opus":0.06257389259337456,"score_gpt":0.3335799370908178,"score_spread":0.27100604449744325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98961526,0.0057347883,0.0000059946788,0.00037438385,0.00008347305,0.0016561148,0.0024996214,0.000027689619,0.000002682095],"genre_scores_gemma":[0.99766576,0.0015829946,0.00007030108,0.00007755834,0.00001367802,0.00041582185,0.00013764168,0.000026881411,0.000009345695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794096,0.000045450684,0.00063119427,0.00039968573,0.0005548126,0.00042790547],"domain_scores_gemma":[0.99828595,0.00026267828,0.0005067584,0.0004655117,0.00023339741,0.0002456792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001539312,0.00033008825,0.0012391905,0.00034404386,0.0001584411,0.000018772504,0.00015141965,0.000033367447,0.000009245983],"category_scores_gemma":[0.00038528195,0.00021910823,0.00031318332,0.0009257949,0.00026925973,0.00016242806,0.00020514031,0.000061510524,5.3957433e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061425976,0.0035110454,0.9390589,0.00072654954,0.0074390797,0.000010986931,0.00046060022,0.000009904946,0.000095888696,0.000028096088,0.000028555964,0.042487804],"study_design_scores_gemma":[0.01686693,0.0013896956,0.9721327,0.002051277,0.0047206916,7.1452064e-7,0.00024224838,0.0018220999,0.0003009617,0.00027620554,0.0000010575479,0.00019542531],"about_ca_topic_score_codex":0.00021900199,"about_ca_topic_score_gemma":0.0005237502,"teacher_disagreement_score":0.04229238,"about_ca_system_score_codex":0.000030617415,"about_ca_system_score_gemma":0.0000774856,"threshold_uncertainty_score":0.8934974},"labels":[],"label_agreement":null},{"id":"W4379522759","doi":"10.1136/annrheumdis-2023-eular.786","title":"POS0246 BIMEKIZUMAB REDUCED MRI INFLAMMATORY LESIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Axial spondyloarthritis; Magnetic resonance imaging; Radiology; Pathology; Sacroiliitis","score_opus":0.044618792497042405,"score_gpt":0.32496792967707244,"score_spread":0.28034913718003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821698,0.010285886,8.887483e-8,0.0025275818,0.00018375328,0.0017199209,0.0029937455,0.00006519,0.00005403412],"genre_scores_gemma":[0.99122536,0.007447167,0.000019174171,0.00029729784,0.000039325747,0.00047208616,0.00032207838,0.000034294477,0.00014321647],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978915,0.00015448536,0.000622526,0.00038686162,0.00056344416,0.00038120188],"domain_scores_gemma":[0.99788505,0.00080188474,0.0002765112,0.0006802899,0.00020832737,0.00014791594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020211695,0.00029523575,0.0006403985,0.000111345114,0.0003295826,0.0000280075,0.0001933133,0.00005105335,0.00003455391],"category_scores_gemma":[0.0007158251,0.0001627227,0.0001625197,0.00045273325,0.0004867098,0.00013419034,0.00027485756,0.0001250716,0.000012559395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038433187,0.020046268,0.31874532,0.0014318967,0.01063147,0.00071509473,0.051515173,0.0005554307,0.00012358873,0.00023902077,0.17869055,0.378873],"study_design_scores_gemma":[0.029729098,0.0032381527,0.94546914,0.004827672,0.0005712188,0.000005841649,0.012918212,0.000051578252,0.00028975378,0.000553065,0.0019997093,0.00034658617],"about_ca_topic_score_codex":0.00026353184,"about_ca_topic_score_gemma":0.00015960149,"teacher_disagreement_score":0.62672377,"about_ca_system_score_codex":0.000028633245,"about_ca_system_score_gemma":0.000111750254,"threshold_uncertainty_score":0.6635639},"labels":[],"label_agreement":null},{"id":"W4379522804","doi":"10.1136/annrheumdis-2023-eular.2151","title":"POS0044 EVIDENCE OF A CAUSAL RELATIONSHIP BETWEEN HYPERLIPIDEMIA AND PSORIASIS AND PSORIATIC ARTHRITIS: A MENDELIAN RANDOMIZATION STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Princess Margaret Cancer Centre","funders":"","keywords":"Mendelian randomization; Psoriatic arthritis; Medicine; Psoriasis; Population; Genome-wide association study; Single-nucleotide polymorphism; Internal medicine; Genetics; Immunology; Genotype; Biology","score_opus":0.11095889483941718,"score_gpt":0.3543852795169382,"score_spread":0.24342638467752103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259,0.0045582154,0.000022053626,0.0017395654,0.00007948345,0.0009128859,0.000036106176,0.00004168586,0.000020011385],"genre_scores_gemma":[0.9974875,0.0022586836,0.000041275125,0.000063247804,0.000037344056,0.00004020019,0.000011655374,0.000017484532,0.00004263284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822444,0.00027447206,0.0006998203,0.0002093798,0.00041017006,0.00018173302],"domain_scores_gemma":[0.9972411,0.0017845653,0.00031526387,0.00034956707,0.00015022261,0.00015928732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007180046,0.00015671327,0.0006152959,0.00020287269,0.000112053196,0.000017718367,0.00010427295,0.000056339897,0.0000085538195],"category_scores_gemma":[0.006519478,0.00010932894,0.00011524236,0.00057837996,0.00014233489,0.00021318404,0.000094325376,0.00009263828,0.000004238683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043715423,0.00015569064,0.98049223,0.0007386246,0.00028002326,0.0000018337323,0.001858972,0.000009234658,0.000026004911,0.00018760226,0.00093510014,0.014877548],"study_design_scores_gemma":[0.0033791314,0.00043338773,0.9886942,0.001978201,0.0005868323,0.0000029237806,0.001176603,0.00023539373,0.00013085936,0.0032800648,0.0000039917786,0.00009842084],"about_ca_topic_score_codex":0.000118370954,"about_ca_topic_score_gemma":0.0000067035103,"teacher_disagreement_score":0.014779127,"about_ca_system_score_codex":0.0000071843237,"about_ca_system_score_gemma":0.00008851456,"threshold_uncertainty_score":0.78048944},"labels":[],"label_agreement":null},{"id":"W4379522838","doi":"10.1136/annrheumdis-2023-eular.1423","title":"POS0057 WHICH ADVANCED TREATMENT SHOULD BE USED FOLLOWING THE FAILURE OF A FIRST-LINE ANTI-TNF IN PATIENTS WITH RHEUMATOID ARTHRITIS? 15 YEARS OF EVIDENCE FROM THE QUEBEC REGISTRY RHUMADATA™","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Osteoporosis Canada","funders":"Sanofi Genzyme; Ultragenyx Pharmaceutical; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Antirheumatic Agents; Immunology","score_opus":0.06821244600624869,"score_gpt":0.32504854929633287,"score_spread":0.25683610329008416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769442,0.010839573,0.0000042196993,0.010432305,0.00007581337,0.0011690033,0.00049636856,0.00003155535,0.000006983386],"genre_scores_gemma":[0.9674444,0.032124434,0.00003965856,0.000082013736,0.000010575591,0.000093207236,0.00012448394,0.0000342742,0.000046926492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971309,0.00026532923,0.0007391603,0.00029993767,0.0011697665,0.0003949331],"domain_scores_gemma":[0.99612314,0.0017435888,0.00045803876,0.0012978193,0.00025574688,0.00012165852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041153224,0.00025546786,0.0007881784,0.000104021776,0.00014377946,0.00003949598,0.0006265677,0.00005808496,0.00006499695],"category_scores_gemma":[0.002229883,0.00012095873,0.00031724607,0.0008156447,0.00039704813,0.0002915198,0.00017566026,0.00016096527,0.000005179094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015137431,0.0013097896,0.9249267,0.00033865377,0.0013410912,0.000020845077,0.0052508377,0.0007048658,0.00015261734,0.00009178228,0.0038332774,0.060515784],"study_design_scores_gemma":[0.004986532,0.0006842246,0.97031415,0.018950844,0.000041528085,0.0000019726406,0.0023752342,0.00019900923,0.0014448086,0.000361377,0.0004635523,0.00017675306],"about_ca_topic_score_codex":0.008533641,"about_ca_topic_score_gemma":0.018991705,"teacher_disagreement_score":0.06033903,"about_ca_system_score_codex":0.000030234298,"about_ca_system_score_gemma":0.00032907914,"threshold_uncertainty_score":0.9989091},"labels":[],"label_agreement":null},{"id":"W4379522860","doi":"10.1136/annrheumdis-2023-eular.4033","title":"OP0221 THERAPY WITH JAK INHIBITORS AND THE RISK OF CARDIOVASCULAR EVENTS IN A DUTCH RHEUMATOID ARTHRITIS POPULATION","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Simon Fraser University","funders":"Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Rheumatoid arthritis; Arthritis; Population; Internal medicine; Bioinformatics; Intensive care medicine; Environmental health","score_opus":0.02397577997080659,"score_gpt":0.27292006062750185,"score_spread":0.24894428065669527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909374,0.0075004585,0.000009162407,0.0008521769,0.000071365546,0.00052307924,0.000043514774,0.00001934721,0.000043473643],"genre_scores_gemma":[0.9733491,0.026494017,0.000010382806,0.000042671218,0.000012914316,0.000045434663,0.000015150936,0.00001432562,0.000016023969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879605,0.00020204968,0.0003760422,0.00012923681,0.00036921358,0.00012743716],"domain_scores_gemma":[0.99899936,0.0002516652,0.00021789764,0.00039483566,0.00009003538,0.00004618909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004848364,0.00010995532,0.00043668257,0.00010945261,0.00007643843,0.000007050391,0.00008587345,0.000024689354,0.000020261548],"category_scores_gemma":[0.00044953614,0.000054708635,0.0003390237,0.00039637566,0.00012163539,0.00007348353,0.000040330437,0.00007781628,0.0000018515892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024279787,0.00084124564,0.8103916,0.0006041046,0.00421727,0.000007809924,0.003947823,0.0076394593,0.00017051435,0.0007509154,0.0020899188,0.16691136],"study_design_scores_gemma":[0.004386046,0.00018222956,0.9845455,0.003956289,0.00013709313,0.000017941653,0.0007636547,0.0015133679,0.0016835126,0.0024674095,0.00024435826,0.00010257848],"about_ca_topic_score_codex":0.002052074,"about_ca_topic_score_gemma":0.000050226852,"teacher_disagreement_score":0.17415392,"about_ca_system_score_codex":0.0000062094064,"about_ca_system_score_gemma":0.000040543022,"threshold_uncertainty_score":0.31021357},"labels":[],"label_agreement":null},{"id":"W4379522945","doi":"10.1136/annrheumdis-2023-eular.500","title":"POS0154 A DEEP LEARNING MODEL TO LOCATE INFLAMMATORY CHANGES IN RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"ZonMw; Arthritis Society; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Dutch Arthritis Society; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Rheumatoid arthritis; Arthritis; Immunology; Artificial intelligence; Computer science","score_opus":0.039141401238853527,"score_gpt":0.27454649023362954,"score_spread":0.23540508899477602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688215,0.0022436886,0.0022401712,0.006767152,0.00019493981,0.0004844589,0.00003571243,0.00056691346,0.0005848017],"genre_scores_gemma":[0.99751484,0.0010292059,0.00042159262,0.00067980663,0.000007503073,0.00009926287,0.0000064553824,0.00002760054,0.00021370868],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979995,0.00010972422,0.0004260234,0.00037139564,0.0005587838,0.00053458224],"domain_scores_gemma":[0.9984134,0.000197815,0.00018901555,0.0008070393,0.00012356354,0.00026918686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030298435,0.00022424529,0.00034234347,0.00039027355,0.00011132464,0.00021808925,0.0014829093,0.00003001587,0.00000701592],"category_scores_gemma":[0.0010261001,0.00018882648,0.00017514794,0.0012612037,0.00010585655,0.0006820794,0.0009858531,0.00009321362,0.00018601326],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050745915,0.00060862367,0.021727435,0.0006005569,0.00015375137,0.000056909208,0.004960531,0.29788414,0.000106944986,0.017479924,0.01085461,0.64551586],"study_design_scores_gemma":[0.00096780405,0.00015176057,0.115465336,0.004459217,0.000016549251,0.00001350391,0.00062877644,0.7952761,0.0019493657,0.07959766,0.0005902751,0.00088364736],"about_ca_topic_score_codex":0.00004119506,"about_ca_topic_score_gemma":0.000067253066,"teacher_disagreement_score":0.64463216,"about_ca_system_score_codex":0.000016085329,"about_ca_system_score_gemma":0.000131283,"threshold_uncertainty_score":0.770012},"labels":[],"label_agreement":null},{"id":"W4379522960","doi":"10.1136/annrheumdis-2023-eular.3781","title":"POS0086 A TRANSVERSAL STUDY OF 826 UNTREATED GOUT PATIENTS SHOWS THAT ECHOGENICITY OF THE RENAL MEDULLA INCREASES WITH GOUT DURATION/SEVERITY AND STEROID USE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Gout; Echogenicity; Transversal (combinatorics); Internal medicine; Endocrinology; Medulla; Surgery; Ultrasonography","score_opus":0.04183092662285355,"score_gpt":0.2704164934833304,"score_spread":0.22858556686047687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997324,0.00014621815,0.0000033531364,0.00039726,0.00004377029,0.0014288435,0.00058723794,0.000041023937,0.000028329554],"genre_scores_gemma":[0.9995206,0.00011322934,0.000020478396,0.00011747068,0.00000792284,0.000031539024,0.000038493527,0.000027397671,0.00012289021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752575,0.00035857904,0.0006299964,0.00027678537,0.00096075045,0.00024814965],"domain_scores_gemma":[0.99768054,0.0004451734,0.00057364284,0.0008326836,0.00030949846,0.00015848457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023885892,0.00025845718,0.00065311976,0.000110949804,0.00011929444,0.000019827668,0.00032617303,0.00006113174,0.000041960517],"category_scores_gemma":[0.0009475768,0.00013777573,0.00020157367,0.0005564435,0.00034095286,0.00020822852,0.00018126506,0.00011532254,0.00000178805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001313389,0.0024854338,0.98922783,0.00049999426,0.0011449264,0.0000051494117,0.0032436666,0.00007783749,0.00033543032,0.0000061686337,0.0007617107,0.0008984428],"study_design_scores_gemma":[0.0031678434,0.00072425226,0.9874444,0.00092703523,0.0012896373,0.000008323242,0.0020523907,0.0003310216,0.003858361,0.000055592896,0.0000059457457,0.00013518198],"about_ca_topic_score_codex":0.0014982837,"about_ca_topic_score_gemma":0.00027868952,"teacher_disagreement_score":0.0035229307,"about_ca_system_score_codex":0.00002069205,"about_ca_system_score_gemma":0.0001598187,"threshold_uncertainty_score":0.5618331},"labels":[],"label_agreement":null},{"id":"W4379522997","doi":"10.1136/annrheumdis-2023-eular.4191","title":"POS0272 IMPACT OF THE COVID-19 PANDEMIC ON ADHERENCE TO DISEASE MODIFYING DRUGS AMONG PATIENTS WITH RHEUMATIC DISEASES: A POPULATION-BASED, INTERRUPTED TIME SERIES ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"Versus Arthritis; Taichung Veterans General Hospital; Pomorski Uniwersytet Medyczny W Szczecinie; Friedrich-Alexander-Universität Erlangen-Nürnberg; All-India Institute of Medical Sciences; Universitätsklinikum Erlangen; University College London Hospitals NHS Foundation Trust; Università degli Studi di Pavia; Mahidol University; Faculty of Medicine Siriraj Hospital, Mahidol University; University College London; North Bristol NHS Trust; Instituto Mexicano del Seguro Social; Faculty of Medicine and Health, University of Sydney; Karolinska Institutet; University of Bristol; Universidad de Guadalajara","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Disease; Population; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Intensive care medicine; Virology; Internal medicine; Outbreak; Infectious disease (medical specialty); Environmental health","score_opus":0.06748146094688946,"score_gpt":0.36676497364517346,"score_spread":0.299283512698284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379522997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962606,0.00008802553,0.000109742236,0.0014816135,0.000046548197,0.0012301482,0.00065254583,0.000098163175,0.000032627457],"genre_scores_gemma":[0.9977861,0.000030266798,0.000017952363,0.0010967484,0.000007754378,0.00018250634,0.00028990422,0.000025343972,0.00056340074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730474,0.0002552764,0.00069125526,0.00035476696,0.0010741302,0.000319856],"domain_scores_gemma":[0.9964638,0.0005104353,0.0007034572,0.0012764826,0.00028946868,0.00075638085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020768242,0.00029091444,0.00067244796,0.00032823978,0.00018941233,0.000031972875,0.00059262145,0.000038483042,0.0007214929],"category_scores_gemma":[0.003013994,0.00015386051,0.0006648263,0.0022871855,0.00024612012,0.00015496042,0.0001256715,0.00010697588,0.00009574313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009108346,0.00041812425,0.9751647,0.0007108764,0.0007683606,0.000001002544,0.00038350504,0.016847692,0.000001790788,0.000017423588,0.0028707688,0.0019049348],"study_design_scores_gemma":[0.00090643804,0.000314514,0.9828954,0.0027446358,0.0010934343,2.661512e-7,0.00018820394,0.011195959,0.0000050871954,0.00047990482,0.000004139186,0.00017201583],"about_ca_topic_score_codex":0.00073218904,"about_ca_topic_score_gemma":0.000020659225,"teacher_disagreement_score":0.007730716,"about_ca_system_score_codex":0.00009959299,"about_ca_system_score_gemma":0.00064428087,"threshold_uncertainty_score":0.78998417},"labels":[],"label_agreement":null},{"id":"W4379523004","doi":"10.1136/annrheumdis-2023-eular.2152","title":"POS0046 AUTOINFLAMMATORY GENETIC VARIANTS ARE OVER-REPRESENTED IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS COMPARED TO RHEUMATOID ARTHRITIS AND PSORIASIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Psoriasis; Rheumatoid arthritis; Dermatology; Spondylitis; Immunology","score_opus":0.013753367077569979,"score_gpt":0.2602319699936186,"score_spread":0.24647860291604862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98216355,0.016086636,0.000013034027,0.00073494884,0.00017520993,0.00045932326,0.00029018248,0.000027832637,0.000049257673],"genre_scores_gemma":[0.97417146,0.025307529,0.00005758748,0.00021355966,0.000023251938,0.000058900212,0.000079735604,0.00003209034,0.000055882876],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981943,0.0001946905,0.0005706331,0.00039510892,0.00023994039,0.00040533213],"domain_scores_gemma":[0.9989322,0.000076865625,0.00021664437,0.0005444653,0.00008358989,0.00014625808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023747327,0.00024151834,0.00042963767,0.00017358208,0.00014090288,0.000064873886,0.00024497177,0.0000875092,0.00003835051],"category_scores_gemma":[0.00071680837,0.00022486605,0.0001268022,0.00035612928,0.00016544003,0.000021428015,0.00035256578,0.000069151756,0.000008701008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013479454,0.0006732199,0.32386088,0.0013880309,0.0011394841,0.00011638531,0.0035330285,0.001959843,0.01956426,0.0005191512,0.025767198,0.6201306],"study_design_scores_gemma":[0.0016781919,0.00010254378,0.98846453,0.0018679257,0.00001693171,0.00002075577,0.00079798064,0.0006849738,0.00353979,0.0012975624,0.0011998232,0.0003289736],"about_ca_topic_score_codex":0.00018014545,"about_ca_topic_score_gemma":0.00018213286,"teacher_disagreement_score":0.66460365,"about_ca_system_score_codex":0.0000059872173,"about_ca_system_score_gemma":0.000069774636,"threshold_uncertainty_score":0.9169771},"labels":[],"label_agreement":null},{"id":"W4379523012","doi":"10.1136/annrheumdis-2023-eular.122","title":"POS0027 INDIVIDUAL ENTHESEAL POINTS HAVE DIFFERENTIAL FREQUENCY OF INVOLVEMENT AND IMPACT ON PATIENT REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital","funders":"Cilag; University of Leeds; University of Glasgow; Janssen Scientific Affairs; School of Medicine, Kyorin University; McGill University; Leeds Biomedical Research Centre; University of Washington","keywords":"Medicine; Enthesitis; Psoriatic arthritis; Internal medicine; Physical therapy; Randomized controlled trial; Clinical endpoint; Arthritis","score_opus":0.04694445755452893,"score_gpt":0.35860906045624646,"score_spread":0.31166460290171755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993906,0.0013404436,8.389912e-7,0.00020506678,0.00007537712,0.003715451,0.00072372216,0.000015478523,0.000017586282],"genre_scores_gemma":[0.99838704,0.0009135743,0.000011626124,0.000035682366,0.0000048398774,0.00041715853,0.0002018464,0.000019206094,0.000009039825],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966651,0.0003196559,0.0013806025,0.0003172842,0.001004134,0.00031320355],"domain_scores_gemma":[0.9966034,0.0010468552,0.001356873,0.00045816886,0.0004052514,0.00012944725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003631861,0.0003611087,0.0030729887,0.00072615605,0.000076262986,0.000012871428,0.00011353083,0.000039540624,0.00004462257],"category_scores_gemma":[0.0010794573,0.00018578769,0.00080737675,0.0006563201,0.0003286374,0.00009002746,0.00013115468,0.0000829872,6.351592e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4801722,0.005939724,0.4123483,0.00019000428,0.08750709,0.000019096711,0.0035254082,0.00008872417,0.0000024711244,0.000048135116,0.00002470217,0.0101341475],"study_design_scores_gemma":[0.50930256,0.0014460307,0.47602966,0.0012654163,0.010044409,3.2697372e-7,0.0011752407,0.00009956733,0.00017609831,0.0003522373,1.8958607e-8,0.00010845669],"about_ca_topic_score_codex":0.0004924194,"about_ca_topic_score_gemma":0.00018437,"teacher_disagreement_score":0.07746268,"about_ca_system_score_codex":0.00004493715,"about_ca_system_score_gemma":0.000083935534,"threshold_uncertainty_score":0.7576202},"labels":[],"label_agreement":null},{"id":"W4379523042","doi":"10.1136/annrheumdis-2023-eular.3343","title":"POS0566 SURVIVAL ON TREATMENT AFTER SWITCHING TO A BIOSIMILAR: POPULATION-BASED EVIDENCE FROM A NATURAL EXPERIMENT DUE TO A POLICY CHANGE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia","funders":"University of British Columbia; Simon Fraser University; Arthritis Society; Canadian Rheumatology Association","keywords":"Biosimilar; Medicine; Psoriatic arthritis; Etanercept; Discontinuation; Infliximab; Rheumatoid arthritis; Medical prescription; Internal medicine; Pharmacy; Family medicine; Disease; Pharmacology","score_opus":0.12199417997306101,"score_gpt":0.3917912002071095,"score_spread":0.2697970202340485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96089333,0.0018890328,0.000028157503,0.03558646,0.0004901087,0.00065932627,0.00038021922,0.00006157888,0.000011779544],"genre_scores_gemma":[0.9936914,0.000066628534,0.0001677823,0.0055376887,0.00005362336,0.00024499436,0.000027811133,0.000016698013,0.00019340677],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984844,0.00036660608,0.00033174144,0.00032708695,0.00012183328,0.00036834067],"domain_scores_gemma":[0.9983574,0.0008485722,0.00010095606,0.0005367419,0.00005475032,0.00010153489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019277558,0.00024244671,0.00043385196,0.00025882086,0.00012087671,0.00002676153,0.0003142735,0.000079015816,0.0001931348],"category_scores_gemma":[0.0009044202,0.0001398855,0.00030388826,0.00061342056,0.000039287595,0.00005400281,0.00014721099,0.00006970228,0.00013712753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017435739,0.0062569343,0.15761544,0.0007716343,0.005422365,0.000108204935,0.018834539,0.00061322044,0.08791967,0.0022242952,0.029768232,0.6730297],"study_design_scores_gemma":[0.000531114,0.0006366432,0.9433181,0.0018944012,0.00012705331,9.062278e-7,0.00017173748,0.00017140408,0.0516329,0.0006811466,0.0005270225,0.0003075702],"about_ca_topic_score_codex":0.0020559423,"about_ca_topic_score_gemma":0.00012269414,"teacher_disagreement_score":0.78570265,"about_ca_system_score_codex":0.00006039898,"about_ca_system_score_gemma":0.00006365592,"threshold_uncertainty_score":0.5704365},"labels":[],"label_agreement":null},{"id":"W4379523076","doi":"10.1136/annrheumdis-2023-eular.1204","title":"POS0326 POLYGENIC RISK SCORE OF RHEUMATOID ARTHRITIS PREDICTS BONY EROSION","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Pfizer","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Bone erosion; Population; Rheumatology; Quantile; Genome-wide association study; Physical therapy; Single-nucleotide polymorphism; Statistics; Environmental health; Genotype","score_opus":0.03445832367312355,"score_gpt":0.2982982043715121,"score_spread":0.26383988069838854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96558803,0.030848997,0.000011105811,0.001792177,0.00023383026,0.0006612107,0.00045735016,0.00013799396,0.00026931602],"genre_scores_gemma":[0.739645,0.2599553,0.000025841624,0.00008382198,0.00002160528,0.000037663624,0.00004292064,0.000033274755,0.00015458792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971399,0.00023057508,0.0007828715,0.0002759708,0.0010416678,0.0005290617],"domain_scores_gemma":[0.997646,0.00037705948,0.00043597777,0.0009043125,0.0002960984,0.00034055996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049099163,0.0002386446,0.0007030998,0.00027204855,0.00020073364,0.0000283641,0.00040839837,0.00007393174,0.00030927823],"category_scores_gemma":[0.0020835823,0.00016435218,0.00054887583,0.00077683345,0.0005059631,0.00017494352,0.00024623066,0.00018158567,0.00011172721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017539383,0.0018729084,0.4590067,0.0019268988,0.0017986989,0.00004570894,0.0023966145,0.00015899766,0.0037564714,0.0025436678,0.15199432,0.37274507],"study_design_scores_gemma":[0.0036114259,0.0008064268,0.9553558,0.013374743,0.000027488739,0.00005437907,0.00074947346,0.0009614613,0.013096587,0.0102044465,0.0014592557,0.0002984719],"about_ca_topic_score_codex":0.00033944065,"about_ca_topic_score_gemma":0.000029620127,"teacher_disagreement_score":0.49634913,"about_ca_system_score_codex":0.000010926174,"about_ca_system_score_gemma":0.00026785457,"threshold_uncertainty_score":0.67020875},"labels":[],"label_agreement":null},{"id":"W4379523143","doi":"10.1136/annrheumdis-2023-eular.4255","title":"POS0190 INFLUENCE OF AGE, PERIOD, AND BIRTH COHORT EFFECTS ON SECULAR TREND IN GOUT INCIDENCE IN THE UNITED KINGDOM","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"Central South University; National Natural Science Foundation of China","keywords":"Medicine; Incidence (geometry); Gout; Demography; Cohort; Rate ratio; Cohort study; Pediatrics; Internal medicine; Confidence interval","score_opus":0.03212763713608261,"score_gpt":0.3170077796970391,"score_spread":0.28488014256095645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726534,0.00038269078,5.454129e-7,0.0015310637,0.000027217266,0.00067770114,0.00002482874,0.000025519157,0.00006511338],"genre_scores_gemma":[0.99872804,0.00028301476,0.000012332422,0.0008512666,0.000008358385,0.000051877938,0.000016996526,0.000016611482,0.00003153076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981987,0.00030636383,0.00044056834,0.00021441636,0.0005835868,0.0002563958],"domain_scores_gemma":[0.9980665,0.00095473044,0.00021150295,0.00063364324,0.000052341627,0.00008126762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062732474,0.00017619308,0.00045521054,0.000365916,0.000045192744,0.000015422895,0.00034074511,0.000055047167,0.000007802713],"category_scores_gemma":[0.0030900177,0.00010313662,0.00010345883,0.001502367,0.00022763206,0.00007732777,0.00013363159,0.00017023165,0.000006735464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020053645,0.000333269,0.9877143,0.0019019238,0.00016343618,0.00021169845,0.0042767376,0.0016557002,0.00072255434,0.0002925802,0.0006820612,0.0018451826],"study_design_scores_gemma":[0.0007651757,0.00017991339,0.9931174,0.0033340722,0.000106769156,0.000019186438,0.0005156039,0.0006496711,0.0006164122,0.000561174,0.000036882662,0.00009775396],"about_ca_topic_score_codex":0.00082326384,"about_ca_topic_score_gemma":0.00005563562,"teacher_disagreement_score":0.005403065,"about_ca_system_score_codex":0.000017142744,"about_ca_system_score_gemma":0.00007435864,"threshold_uncertainty_score":0.42057893},"labels":[],"label_agreement":null},{"id":"W4379523317","doi":"10.1136/annrheumdis-2023-eular.2819","title":"POS0471 SPECIFIC SYMPTOM CLUSTERS AT DIAGNOSIS SIGNAL A POORER EARLY RA PROGNOSIS: DATA FROM THE CANADIAN EARLY ARTHRITIS COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Canadian Rheumatology Association; Western University; University of Calgary; McGill University; Université de Sherbrooke; McGill University Health Centre","funders":"Pfizer Pharmaceuticals; Pfizer Canada; Bristol-Myers Squibb; Samsung; Norges Forskningsråd; Genentech; Innovationsfonden; Merck Canada; Medac; NordForsk; Celltrion; Regeneron Pharmaceuticals; Sanofi Genzyme; AbbVie Canada; Sandoz Canada; Eli Lilly Canada; F. Hoffmann-La Roche; Gilead Sciences; Sanofi; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Cohort; Latent class model; Depression (economics); Anxiety; Internal medicine; Arthritis; Rheumatology; Physical therapy; Psychiatry","score_opus":0.07968141203749698,"score_gpt":0.312977785244127,"score_spread":0.23329637320663002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679177,0.008615853,9.863104e-7,0.019768987,0.00014221609,0.0014599196,0.0015160635,0.00007849807,0.000499803],"genre_scores_gemma":[0.9909328,0.006384751,0.000007754296,0.0011419953,0.00007255323,0.00028784442,0.0005921254,0.000052737956,0.00052741537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968649,0.00027273598,0.00064529356,0.00045756833,0.0010783651,0.00068110425],"domain_scores_gemma":[0.99669456,0.0006482149,0.00021689167,0.0018222682,0.00020121844,0.00041684342],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006187011,0.00026246204,0.0005543816,0.00016153498,0.0005770827,0.00015884901,0.0013557305,0.00009668957,0.0014175128],"category_scores_gemma":[0.00062629016,0.0001635549,0.0002973007,0.0006472913,0.00050834107,0.00028198777,0.0007169767,0.00023841974,0.00064371555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110630775,0.00012659385,0.7250304,0.00008117207,0.00063128833,0.000036894646,0.00072548713,0.000007805151,0.000009393172,0.000032381613,0.2504263,0.022781638],"study_design_scores_gemma":[0.0007207695,0.00011267287,0.9868622,0.0015771902,0.00015992169,0.0000037100506,0.0004504559,0.00045912873,0.000113203394,0.00035179348,0.00900247,0.00018647815],"about_ca_topic_score_codex":0.089352004,"about_ca_topic_score_gemma":0.016381625,"teacher_disagreement_score":0.2618318,"about_ca_system_score_codex":0.00006243174,"about_ca_system_score_gemma":0.0006604748,"threshold_uncertainty_score":0.9994953},"labels":[],"label_agreement":null},{"id":"W4379523335","doi":"10.1136/annrheumdis-2023-eular.4179","title":"POS0387 IMPACT OF RHEUMATIC DISEASE SUB-TYPES ON MATERNAL AND NEONATAL OUTCOMES: A POPULATION LEVEL ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Psoriatic arthritis; Pregnancy; Population; Comorbidity; Cohort; Rheumatoid arthritis; Pediatrics; Live birth; Obstetrics; Caesarean section; Internal medicine","score_opus":0.06833688983702896,"score_gpt":0.3756886828693382,"score_spread":0.30735179303230925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968338,0.00085425266,0.000044597935,0.0012907657,0.00005629081,0.00033075135,0.0005212569,0.000044562334,0.000023691402],"genre_scores_gemma":[0.99883026,0.0006847332,0.00001457042,0.00013500944,0.000007701795,0.000017029512,0.00012254406,0.00001527714,0.00017289013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845845,0.00010500706,0.00050380256,0.00017210298,0.00054598897,0.00021465305],"domain_scores_gemma":[0.9983274,0.00033633932,0.00037333777,0.00054756965,0.00009355859,0.0003218263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025151062,0.00017654756,0.00057428126,0.0003815806,0.00006293997,0.00001362542,0.0001593303,0.000035193076,0.000104330495],"category_scores_gemma":[0.001863801,0.00010219459,0.0005885794,0.00068861415,0.00011316403,0.00011560952,0.00006224763,0.0000605569,0.000014774428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032130844,0.00018630053,0.9517924,0.0008161523,0.0020762985,0.0000046007012,0.00026173837,0.0006238974,0.000014208983,0.00015078811,0.0006797631,0.04307253],"study_design_scores_gemma":[0.0005818878,0.00010603714,0.99053353,0.0018993991,0.0012226466,0.0000026588186,0.000039854418,0.0038732477,0.00019305838,0.001457706,0.000001199116,0.00008878269],"about_ca_topic_score_codex":0.00036076226,"about_ca_topic_score_gemma":0.0000070463702,"teacher_disagreement_score":0.042983748,"about_ca_system_score_codex":0.00002031007,"about_ca_system_score_gemma":0.00013022318,"threshold_uncertainty_score":0.41673747},"labels":[],"label_agreement":null},{"id":"W4379523514","doi":"10.1136/annrheumdis-2023-eular.2415","title":"POS0826 SAFETY PROFILE OF UPADACITINIB UP TO 6.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Chugai Pharmaceutical; Samsung; Genentech; Medac; H. Lundbeck A/S; Eisai; Astellas Pharma; Mylan; Gigtforeningen; Eli Lilly and Company; AstraZeneca; Kræftens Bekæmpelse; Daiichi-Sankyo; Teva Pharmaceutical Industries; Celgene; Biogen; Gilead Sciences; Kowa Company; Sanofi; Amgen; Pfizer","keywords":"Medicine; Adverse effect; Discontinuation; Internal medicine; Adalimumab; Rheumatoid arthritis; MedDRA; Population; Clinical trial; Pharmacovigilance","score_opus":0.021755609586488558,"score_gpt":0.27879290885957425,"score_spread":0.2570372992730857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746597,0.00076573755,0.000007940631,0.00039426849,0.00014149968,0.00037500486,0.00073373265,0.000014266584,0.000101598],"genre_scores_gemma":[0.9990938,0.00043252524,0.00011082131,0.000087571076,0.0000014758878,0.000012287876,0.000035376623,0.000010640717,0.00021550087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875695,0.0002171168,0.00053481886,0.00015652615,0.000105680185,0.00022891202],"domain_scores_gemma":[0.99894166,0.0002935725,0.00024031171,0.00035575603,0.00013510503,0.000033605975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000285412,0.00011417281,0.00046494656,0.00012054736,0.000028405258,0.000003005393,0.00028494565,0.00008018749,0.00025978708],"category_scores_gemma":[0.000590479,0.000075575634,0.00013782002,0.00050608057,0.0002531071,0.000040513947,0.00013384053,0.00007455363,0.000019250281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004254153,0.0017989115,0.6130694,0.0009458349,0.0010725209,0.0000027491233,0.002405328,0.0001367889,0.001927519,0.0022934717,0.025507944,0.34658536],"study_design_scores_gemma":[0.0012774921,0.00041316645,0.98636276,0.0013516478,0.000018527388,5.235273e-7,0.00029215778,0.000003301801,0.00935986,0.00046790394,0.00034525478,0.00010743226],"about_ca_topic_score_codex":0.000052677216,"about_ca_topic_score_gemma":0.000011770195,"teacher_disagreement_score":0.3732933,"about_ca_system_score_codex":0.000004045147,"about_ca_system_score_gemma":0.000054047985,"threshold_uncertainty_score":0.3081885},"labels":[],"label_agreement":null},{"id":"W4379523537","doi":"10.1136/annrheumdis-2023-eular.3522","title":"POS0404 SOLUBLE LOW AFFINITY NERVE GROWTH FACTOR RECEPTOR (LNGFR) MAY REGULATE PAIN IN KNEE OSTEOARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Élisabeth Bruyère Hospital; Ottawa Hospital","funders":"Bundesministerium für Bildung und Forschung; European Commission; Eurostars; Hallym University; University of Texas Rio Grande Valley","keywords":"Osteoarthritis; Medicine; Nerve growth factor; Knee pain; Receptor; Internal medicine; Pathology; Alternative medicine","score_opus":0.030624072805796786,"score_gpt":0.27698261734823815,"score_spread":0.24635854454244135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265385,0.0012891942,0.0000017940722,0.0038350297,0.0004492968,0.00095389015,0.00023944867,0.0001610155,0.0004164732],"genre_scores_gemma":[0.9957374,0.00041246056,0.000080258775,0.00030734413,0.000047686288,0.00011494987,0.00015383436,0.00004785135,0.003098265],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979108,0.0002804486,0.0004921258,0.0003108608,0.00048899226,0.0005167836],"domain_scores_gemma":[0.9984874,0.00032102998,0.00021346808,0.00059286563,0.00013674714,0.00024845457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004367282,0.0002732322,0.0005907429,0.00020375328,0.00010842628,0.000034055472,0.00022127276,0.000100614016,0.00044340512],"category_scores_gemma":[0.0010729467,0.00020227874,0.00038754568,0.0006198407,0.00012095626,0.00017683153,0.00014487297,0.0001244895,0.00021588692],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014841739,0.002330881,0.06305357,0.002832808,0.00045796696,0.00033622605,0.0017934832,0.00003438786,0.004075054,0.0024854944,0.0460733,0.8750427],"study_design_scores_gemma":[0.04635291,0.027081573,0.644209,0.05063791,0.0011313154,0.00014255154,0.0053439178,0.0010108451,0.15579796,0.059716392,0.005147447,0.0034281309],"about_ca_topic_score_codex":0.000090346446,"about_ca_topic_score_gemma":0.0000562327,"teacher_disagreement_score":0.8716145,"about_ca_system_score_codex":0.00002886402,"about_ca_system_score_gemma":0.00014362154,"threshold_uncertainty_score":0.82486874},"labels":[],"label_agreement":null},{"id":"W4379523571","doi":"10.1136/annrheumdis-2023-eular.3267","title":"POS0601-HPR DOING EVERYTHING POSSIBLE TO PRIORITIZE WORK: LIVED WORK EXPERIENCE OF YOUNG ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"UCB Pharma; Sanofi Genzyme; Medac; Celltrion; Nordic Pharma Group; Biogen; Celgene; Mylan; Gilead Sciences; Galápagos; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Work (physics); Lupus erythematosus; Systemic lupus erythematosus; Systemic lupus; Immunology; Internal medicine; Disease; Antibody","score_opus":0.03957559551451725,"score_gpt":0.35856358855288895,"score_spread":0.31898799303837166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932087,0.0015894173,0.000097907796,0.0014246209,0.0009667493,0.0018814947,0.000025817766,0.00019714484,0.0006081574],"genre_scores_gemma":[0.9967004,0.0005138128,0.00037465847,0.00049998733,0.0000674651,0.00034882707,0.000008389188,0.000056989473,0.0014294848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605453,0.00058080064,0.0012215187,0.00038491344,0.0007423706,0.0010158852],"domain_scores_gemma":[0.9957318,0.0017220399,0.0008540163,0.00088895194,0.0003604751,0.00044275814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087848166,0.00029452192,0.000734594,0.00022070676,0.00079890806,0.000025598478,0.00064582564,0.00012236414,0.00007494679],"category_scores_gemma":[0.0010611921,0.00019953743,0.00018481736,0.0017982788,0.00011653274,0.00020959352,0.00037066347,0.00031315032,0.0001405789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020735771,0.00016791637,0.8369691,0.011455449,0.00014709092,0.000019958248,0.1291049,0.0011068679,0.000032700787,0.0003609074,0.011581796,0.006979769],"study_design_scores_gemma":[0.0038626546,0.00038640847,0.5165354,0.30540472,0.00023143609,0.0000649379,0.17001373,0.00046061655,0.00038384245,0.0012360072,0.00032657207,0.0010936931],"about_ca_topic_score_codex":0.00035249675,"about_ca_topic_score_gemma":0.000023970571,"teacher_disagreement_score":0.32043368,"about_ca_system_score_codex":0.00005652355,"about_ca_system_score_gemma":0.00048226467,"threshold_uncertainty_score":0.81369},"labels":[],"label_agreement":null},{"id":"W4379523580","doi":"10.1136/annrheumdis-2023-eular.464","title":"POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University; Memorial University of Newfoundland","funders":"University of Toronto; University of Glasgow; Sorbonne Université; University of Washington; University of Occupational and Environmental Health; University of Rochester; Jikei University School of Medicine; Icahn School of Medicine at Mount Sinai","keywords":"Medicine; Internal medicine; Psoriatic arthritis; Logistic regression; Ankylosing spondylitis; Rheumatoid arthritis","score_opus":0.022426293072336366,"score_gpt":0.2883421436897537,"score_spread":0.26591585061741735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894831,0.008330048,0.0000010181678,0.00060495647,0.00024743064,0.00052138796,0.0004971868,0.000047220237,0.0002676564],"genre_scores_gemma":[0.99701774,0.0023938864,0.000014085808,0.00008557353,0.000017791694,0.00011121821,0.00017036451,0.000011880286,0.00017748335],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985992,0.0002886709,0.00043291305,0.00025415779,0.00010811905,0.00031694476],"domain_scores_gemma":[0.9991873,0.00022741899,0.00019163651,0.00032000046,0.00003108913,0.00004256929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009661064,0.00024713392,0.0004967054,0.00008189322,0.00014744257,0.000022600292,0.00016123032,0.000071214614,0.00006631614],"category_scores_gemma":[0.00004121506,0.00016686947,0.00018141423,0.00027873614,0.00015482094,0.00010594301,0.00015184638,0.00003947097,0.00009579087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008071942,0.0006395803,0.10769471,0.0001085021,0.0011352048,0.000006240044,0.002005521,0.000015021434,0.00016008942,0.0004700829,0.00127326,0.8864111],"study_design_scores_gemma":[0.0017840931,0.0004699753,0.98956084,0.00061833794,0.00024596404,0.0000011763894,0.00038209092,0.000017916687,0.0015077959,0.0045485236,0.00065561244,0.00020768472],"about_ca_topic_score_codex":0.0003338521,"about_ca_topic_score_gemma":0.00007769626,"teacher_disagreement_score":0.8862034,"about_ca_system_score_codex":0.00007876109,"about_ca_system_score_gemma":0.00009040033,"threshold_uncertainty_score":0.6804739},"labels":[],"label_agreement":null},{"id":"W4379523586","doi":"10.1136/annrheumdis-2023-eular.1416","title":"POS0359 SEX-RELATED INEQUITY IN RANDOMIZED CONTROLLED TRIALS IN PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; University of Ottawa; Women's College Hospital; University of Toronto","funders":"Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Sun Pharma; GlaxoSmithKline","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Psoriatic arthritis; Odds ratio; Confidence interval; Internal medicine; MEDLINE; Rheumatology; Physical therapy; Systematic review; Clinical endpoint; Arthritis","score_opus":0.148464602415704,"score_gpt":0.415338978852426,"score_spread":0.26687437643672196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523586","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05156123,0.9225661,0.0000019354216,0.015334574,0.00006937008,0.01025057,0.00012049381,0.00004399376,0.000051699008],"genre_scores_gemma":[0.79152215,0.20482114,0.000011689153,0.0016283192,0.000007131978,0.0015559617,0.000046661542,0.000014970141,0.00039200796],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.985226,0.009188476,0.004367255,0.0003354939,0.00057974015,0.000303081],"domain_scores_gemma":[0.986911,0.010542395,0.0013948597,0.0007814907,0.00021471,0.00015554667],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.022264946,0.0003033206,0.019100418,0.00073465455,0.000042896303,0.000040830742,0.0001875806,0.00010443124,0.0001540758],"category_scores_gemma":[0.057559066,0.00014301058,0.004400936,0.0026910813,0.000090102374,0.0000842859,0.000071932416,0.00018955019,0.0000067340816],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015008877,0.0006496865,0.0011516731,0.5776655,0.39525607,0.000108769986,0.005573759,0.00018575585,0.000001386141,0.0008890762,0.0015541251,0.0019553136],"study_design_scores_gemma":[0.15263657,0.00008616206,0.004857316,0.0882943,0.73818755,0.000021676135,0.00088873925,0.0030046206,0.0000060462144,0.011716904,0.0000025085249,0.00029762817],"about_ca_topic_score_codex":0.00007895661,"about_ca_topic_score_gemma":0.00004323755,"teacher_disagreement_score":0.7399609,"about_ca_system_score_codex":0.0000145235,"about_ca_system_score_gemma":0.000117272226,"threshold_uncertainty_score":0.99546206},"labels":[],"label_agreement":null},{"id":"W4379523600","doi":"10.1136/annrheumdis-2023-eular.4098","title":"POS0372 GROUP-BASED TRAJECTORIES OF ADHERENCE TO ANTI-TUMOUR NECROSIS FACTOR (TNF) AGENTS: A POPULATION-BASED LONGITUDINAL STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of British Columbia","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Medicine; Tumor necrosis factor alpha; Population; Necrosis; Tumor necrosis factor α; Internal medicine; Immunology; Oncology; Environmental health","score_opus":0.16149417001712352,"score_gpt":0.3926002992024547,"score_spread":0.2311061291853312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966149,0.000101362006,0.00020947019,0.0015504404,0.00016817928,0.0010735312,0.00017123824,0.000078394405,0.000032487053],"genre_scores_gemma":[0.99887383,0.000019146939,0.00010392899,0.00051495427,0.000018351173,0.00014384092,0.000062015766,0.00001882075,0.00024508507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979294,0.00012206023,0.0006225994,0.00027626852,0.00079703005,0.0002526736],"domain_scores_gemma":[0.9981642,0.00029502032,0.00037358564,0.00066957937,0.0002706623,0.00022697478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019638424,0.00019323848,0.0005287675,0.00017185036,0.00009960623,0.000019743722,0.00038336942,0.000033769044,0.00069329754],"category_scores_gemma":[0.0011238116,0.000136166,0.00024197443,0.001011009,0.000085637694,0.00007961746,0.000052943982,0.000071240764,0.00011462216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016728246,0.0012796335,0.98819566,0.0006154739,0.00012860468,0.0000037384261,0.00028515243,0.0003281173,0.00017306054,0.000048039587,0.004920996,0.0038542345],"study_design_scores_gemma":[0.0008691145,0.00065632426,0.99406767,0.0014101855,0.00012884424,4.019269e-7,0.00047607222,0.0011699696,0.000846246,0.00023047923,0.000018127916,0.00012654538],"about_ca_topic_score_codex":0.00067553617,"about_ca_topic_score_gemma":0.00002649267,"teacher_disagreement_score":0.0058720224,"about_ca_system_score_codex":0.00001627928,"about_ca_system_score_gemma":0.00021873318,"threshold_uncertainty_score":0.7591122},"labels":[],"label_agreement":null},{"id":"W4379523616","doi":"10.1136/annrheumdis-2023-eular.2446","title":"POS0564 THE IMPACT OF BIOSIMILAR SWITCHING POLICIES IN INFLAMMATORY ARTHRITIS ON UPTAKE AND SPENDING IN BRITISH COLUMBIA, CANADA","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Centre for Advancing Health Outcomes; University of Toronto; Providence Health Care; University of British Columbia","funders":"","keywords":"Biosimilar; Medicine; Inflammatory arthritis; Arthritis; Antirheumatic Agents; Internal medicine","score_opus":0.028388044956145803,"score_gpt":0.3001521578998069,"score_spread":0.2717641129436611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553853,0.0030204337,2.0662239e-7,0.0008593241,0.000099804274,0.00019376972,0.00022105135,0.000008333167,0.000058559453],"genre_scores_gemma":[0.9982672,0.0014590588,0.0000034344816,0.00016586577,0.0000043503237,0.000006478875,0.0000042858883,0.000008110073,0.000081230246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879646,0.00027822066,0.0004325818,0.00013706282,0.000069446956,0.0002862531],"domain_scores_gemma":[0.9989764,0.0005822462,0.00015757399,0.00023070013,0.000024967982,0.000028119592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046213414,0.00009575083,0.0003376341,0.00006953793,0.00009231651,0.000036036672,0.00024786795,0.00006779836,0.00009798122],"category_scores_gemma":[0.00053037377,0.00007657305,0.00012705919,0.0003245817,0.00021349169,0.000041801843,0.00012564656,0.00014792141,0.0000011782483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006847768,0.00020402855,0.8843053,0.00021895456,0.0003400898,0.000022655953,0.0005262373,0.00013691346,0.001864001,0.00017337764,0.013971252,0.09816872],"study_design_scores_gemma":[0.00032834557,0.000052563897,0.99545544,0.0011486149,0.000011932716,0.000008231486,0.0006430226,0.000051202,0.00053552265,0.0016290224,0.000052314757,0.00008377301],"about_ca_topic_score_codex":0.5760395,"about_ca_topic_score_gemma":0.70121884,"teacher_disagreement_score":0.12517934,"about_ca_system_score_codex":0.00002157316,"about_ca_system_score_gemma":0.00015833645,"threshold_uncertainty_score":0.42678368},"labels":[],"label_agreement":null},{"id":"W4379523773","doi":"10.1136/annrheumdis-2023-eular.1980","title":"POS0590-HPR IDENTIFICATION OF RESPONDER AND DISEASE ACTIVITY THRESHOLDS FOR THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM TWO PHASE 3 TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"UCB Pharma; Pfizer","keywords":"Medicine; Psoriatic arthritis; Disease; Arthritis; Rheumatoid arthritis; Internal medicine; Identification (biology); Clinical trial; Psoriasis; Physical therapy; Immunology","score_opus":0.10473476189468627,"score_gpt":0.4019777859804248,"score_spread":0.2972430240857385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720552,0.011645901,0.00009884432,0.00051122217,0.00015028648,0.0024881118,0.013030605,0.000018851742,9.73296e-7],"genre_scores_gemma":[0.9955145,0.0036928693,0.00004300635,0.000018851173,0.000035896377,0.00009885404,0.00055042433,0.00003747243,0.00000810809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968082,0.0004214339,0.0013548287,0.00041298635,0.00070919615,0.0002933778],"domain_scores_gemma":[0.9951732,0.0014165728,0.001496542,0.0013471929,0.00032507363,0.00024137797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088748394,0.00030009617,0.0012554342,0.00022707811,0.00014751582,0.000026074487,0.00031778566,0.000043143362,0.000034143028],"category_scores_gemma":[0.0061265887,0.00018111506,0.00040989087,0.00046409495,0.00036541795,0.0003466915,0.00020332281,0.000068222114,8.008904e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053822953,0.0075191045,0.6299437,0.0024437117,0.0060533164,0.000018044931,0.0010399604,0.00073744025,0.0003101933,0.00018097756,0.0010065183,0.29692402],"study_design_scores_gemma":[0.021108508,0.0007549002,0.95910084,0.006690552,0.0020103855,6.4341793e-7,0.00016310593,0.0062376717,0.00017964713,0.0035925426,0.0000013397403,0.00015985145],"about_ca_topic_score_codex":0.001125339,"about_ca_topic_score_gemma":0.000183423,"teacher_disagreement_score":0.3291571,"about_ca_system_score_codex":0.000040705687,"about_ca_system_score_gemma":0.00045675738,"threshold_uncertainty_score":0.73856574},"labels":[],"label_agreement":null},{"id":"W4379523801","doi":"10.1136/annrheumdis-2023-eular.1887","title":"POS0589-HPR NATURE AND SEVERITY OF FUNCTIONAL LIMITATIONS ACCORDING TO THE HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SEVERE FUNCTIONAL DISABILITY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Koninklijk Nederlands Genootschap voor Fysiotherapie; ZonMw; Arthritis Society; Dutch Arthritis Society; Pfizer","keywords":"Medicine; Quality of life (healthcare); Physical therapy; Rheumatoid arthritis; International Classification of Functioning, Disability and Health; Activities of daily living; Health assessment; Randomized controlled trial; Physical disability; Severity of illness; Physical medicine and rehabilitation; Rehabilitation; Internal medicine","score_opus":0.028211195469605894,"score_gpt":0.3089823217337238,"score_spread":0.28077112626411793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97879386,0.0022567068,0.00003534306,0.017522907,0.00010597011,0.0009770448,0.00026159832,0.000030192587,0.00001635471],"genre_scores_gemma":[0.9940464,0.0054183616,0.000037822134,0.00028407088,0.000013597951,0.00009616065,0.00008214911,0.000014071863,0.000007381684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788237,0.0003021193,0.00048619343,0.00029391656,0.0007544563,0.00028096265],"domain_scores_gemma":[0.9983593,0.00056644896,0.0001798202,0.00041302663,0.0002580557,0.0002232994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064974994,0.00017325704,0.0004234122,0.00007398896,0.0002893905,0.000037086276,0.000112493,0.000054113956,0.000026465415],"category_scores_gemma":[0.0011844442,0.00010402636,0.00009417179,0.00054620695,0.0006591581,0.0002258817,0.00017226533,0.00026072672,0.0000014655405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056573737,0.0005856767,0.9171566,0.00029654716,0.00010678014,2.669059e-7,0.00029167716,0.00016843571,6.538518e-7,0.00065745,0.00088527205,0.07928493],"study_design_scores_gemma":[0.0014179132,0.0003190275,0.9921485,0.0022132422,0.000004287033,0.000006027185,0.0011425671,0.0003754731,0.0000026200225,0.0022266153,0.000045274355,0.00009842483],"about_ca_topic_score_codex":0.00026520973,"about_ca_topic_score_gemma":0.0005799389,"teacher_disagreement_score":0.0791865,"about_ca_system_score_codex":0.000054925044,"about_ca_system_score_gemma":0.00026303527,"threshold_uncertainty_score":0.42420718},"labels":[],"label_agreement":null},{"id":"W4379523838","doi":"10.1136/annrheumdis-2023-eular.2615","title":"POS0849 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM THE SELECT-COMPARE STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Adalimumab; Adverse effect; Internal medicine; Rheumatoid arthritis; Placebo; Ustekinumab; Methotrexate; Surgery; Gastroenterology; Pathology","score_opus":0.051489105405125794,"score_gpt":0.32827784124355247,"score_spread":0.27678873583842667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913026,0.004947823,0.0000033453707,0.0007302954,0.000051464274,0.0016487503,0.0012454529,0.00004398989,0.000026298001],"genre_scores_gemma":[0.9796808,0.01972238,0.00001529339,0.00006413291,0.000013207338,0.000028267154,0.00041535075,0.000034825345,0.000025770065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972467,0.00035201377,0.00071374944,0.0003809674,0.00091371714,0.00039286583],"domain_scores_gemma":[0.9968287,0.0011261703,0.00027653592,0.0014024045,0.0001973323,0.00016886932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045183065,0.00023968103,0.0007350921,0.000118421434,0.00015864172,0.000051130628,0.0007307959,0.000030438614,0.00019932551],"category_scores_gemma":[0.001271469,0.00012241001,0.000085347165,0.00063788076,0.0003827661,0.00021997027,0.00048777755,0.00016822455,0.000015539932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058304206,0.0017411453,0.9553813,0.000137561,0.0006352801,0.000013803292,0.001438464,0.000015602245,0.0000017430964,0.000022170922,0.0020372733,0.03274528],"study_design_scores_gemma":[0.010833032,0.00072001823,0.9816533,0.00468923,0.000022398615,0.0000033959234,0.0016310131,0.00013422585,0.000027902066,0.00009715625,0.000049557617,0.00013880382],"about_ca_topic_score_codex":0.0004540069,"about_ca_topic_score_gemma":0.0008421458,"teacher_disagreement_score":0.032606475,"about_ca_system_score_codex":0.000009567077,"about_ca_system_score_gemma":0.0002384799,"threshold_uncertainty_score":0.49917352},"labels":[],"label_agreement":null},{"id":"W4379523884","doi":"10.1136/annrheumdis-2023-eular.3335","title":"POS0472 TREATMENT RESPONSE TO INTRAMUSCULAR STEROIDS IN PATIENTS LIVING WITH RHEUMATOID ARTHRITIS: AN EXPLORATORY ANALYSIS USING TRACKED DAILY SYMPTOMS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; AbbVie Canada; Sandoz Canada; Amgen","keywords":"Medicine; Rheumatoid arthritis; Physical therapy; Rheumatology; Internal medicine; Anesthesia","score_opus":0.08224592103431111,"score_gpt":0.37494601160980706,"score_spread":0.29270009057549595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702674,0.00029882262,0.00000904132,0.00090648973,0.00040980068,0.0012289975,0.00003692505,0.00007603209,0.000007147944],"genre_scores_gemma":[0.99877024,0.0005636546,0.00006476576,0.000110154906,0.000032612486,0.00041585442,0.000013497356,0.000023059443,0.000006154045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612665,0.0018556288,0.00051677256,0.0002918797,0.00073998637,0.00046908626],"domain_scores_gemma":[0.99697953,0.0016686944,0.000276056,0.000491453,0.00022495598,0.0003593015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013654064,0.00017203281,0.00043985576,0.00051174726,0.00038435368,0.000079333986,0.00035865116,0.000062814805,0.0000380544],"category_scores_gemma":[0.0042774044,0.00013636019,0.00015697992,0.0030084685,0.00020191667,0.00041194726,0.000048686034,0.000055602493,0.000013187833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026378952,0.00087625295,0.76822853,0.000047480695,0.00031624953,0.0000014653493,0.1728791,0.0016630264,0.0000058770884,0.000054768003,0.000047577116,0.05561587],"study_design_scores_gemma":[0.00035862756,0.0003067297,0.9709209,0.0008903644,0.000084260704,4.868248e-8,0.026837597,0.00026259525,0.000015284395,0.00012543533,0.00003565289,0.00016248452],"about_ca_topic_score_codex":0.0029214546,"about_ca_topic_score_gemma":0.003018921,"teacher_disagreement_score":0.20269237,"about_ca_system_score_codex":0.0002265637,"about_ca_system_score_gemma":0.00067975203,"threshold_uncertainty_score":0.55606073},"labels":[],"label_agreement":null},{"id":"W4379523896","doi":"10.1136/annrheumdis-2023-eular.6345","title":"POS0525 WORSENING BURDEN OF GOUT AMONG ASIAN AMERICAN ADULTS – GENERAL POPULATION-BASED STUDY (2011-2018)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"Novo Nordisk; Sanofi; Servier; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Gout; Demography; Ethnic group; Hyperuricemia; Health equity; Population; Biobank; Odds ratio; Gerontology; Race (biology); Odds; Public health; Internal medicine; Logistic regression; Environmental health; Uric acid; Pathology","score_opus":0.025180513484667235,"score_gpt":0.30642218824848777,"score_spread":0.28124167476382056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648535,0.00014630194,0.0000105100025,0.0019157074,0.00015679236,0.00088983536,0.00007732165,0.00012093633,0.00019721409],"genre_scores_gemma":[0.9988596,0.000021049416,0.00016344577,0.00015176162,0.0000778701,0.000049496844,0.00006762166,0.00004710894,0.00056203466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975517,0.00020826531,0.00072373083,0.00030925183,0.0008359697,0.00037107946],"domain_scores_gemma":[0.9976906,0.0002586438,0.00065973675,0.000985068,0.0001800801,0.000225824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030180754,0.00024586054,0.0007087905,0.00026035807,0.000105271225,0.000015805546,0.00037330523,0.000043122087,0.00014179139],"category_scores_gemma":[0.0010457478,0.00017546321,0.0003379598,0.00074951403,0.00018162007,0.000093793125,0.00013633481,0.00011775965,0.000046384295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002743261,0.00059707,0.9747237,0.00044440638,0.0005194582,0.0000123448,0.0022154455,0.0024782363,0.00003887477,0.0000139684835,0.003067169,0.015614993],"study_design_scores_gemma":[0.0010387861,0.00033320085,0.9873772,0.0009171041,0.0004382408,0.0000016951336,0.004022855,0.0054634493,0.00013090586,0.00009924641,0.0000118807975,0.00016540488],"about_ca_topic_score_codex":0.0056938534,"about_ca_topic_score_gemma":0.000051272833,"teacher_disagreement_score":0.015449588,"about_ca_system_score_codex":0.000027891687,"about_ca_system_score_gemma":0.00013505103,"threshold_uncertainty_score":0.8607441},"labels":[],"label_agreement":null},{"id":"W4379523942","doi":"10.1136/annrheumdis-2023-eular.3373","title":"POS0567 COMPARISON OF SURVIVAL ON TREATMENT AMONG NEW USERS OF BIOSIMILAR VS. ORIGINATOR BIOLOGICS IN INFLAMMATORY ARTHRITIS: POPULATION-BASED EVIDENCE FROM A NATURAL EXPERIMENT DUE TO A POLICY CHANGE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia","funders":"University of British Columbia; Simon Fraser University; Arthritis Society; Canadian Rheumatology Association","keywords":"Medicine; Biosimilar; Etanercept; Infliximab; Psoriatic arthritis; Discontinuation; Hazard ratio; Internal medicine; Rheumatoid arthritis; Population; Adalimumab; Tumor necrosis factor alpha; Environmental health; Confidence interval","score_opus":0.12592058147037297,"score_gpt":0.3951156928155578,"score_spread":0.2691951113451848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379523942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049854,0.0048716622,0.0000044617973,0.0035227626,0.00026294592,0.00052268425,0.00028813243,0.000024564575,0.0000042375445],"genre_scores_gemma":[0.9991161,0.0003960419,0.00010316623,0.000245909,0.000016341633,0.000041469433,0.00004069873,0.000009823568,0.000030447485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832946,0.00044938715,0.00061637873,0.00023463536,0.000108990454,0.00026117582],"domain_scores_gemma":[0.9981644,0.000966857,0.00034031074,0.00040091592,0.00006485607,0.000062661165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022085506,0.00020727859,0.00072594313,0.00029787954,0.000044012253,0.000007333245,0.00030813497,0.00012412178,0.00006163379],"category_scores_gemma":[0.0009421922,0.00012987627,0.00024894893,0.0005642039,0.00018446898,0.000054460583,0.00008598164,0.00007870116,0.0000073175574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014210804,0.001032092,0.9551054,0.00018422316,0.00050199346,0.0000043157756,0.0017184385,0.0002485344,0.0069645448,0.00084036594,0.0013972494,0.030581763],"study_design_scores_gemma":[0.0006768249,0.00058079476,0.89569724,0.002047466,0.000046966725,1.4128133e-7,0.0002634051,0.00018674218,0.099832155,0.00046471463,0.00006221215,0.00014131343],"about_ca_topic_score_codex":0.004116025,"about_ca_topic_score_gemma":0.0003001637,"teacher_disagreement_score":0.09286761,"about_ca_system_score_codex":0.000046123707,"about_ca_system_score_gemma":0.00013113287,"threshold_uncertainty_score":0.62222254},"labels":[],"label_agreement":null},{"id":"W4379524037","doi":"10.1136/annrheumdis-2023-eular.5353","title":"POS0368 PERSISTENT PREMATURE MORTALITY IN GOUT: NATIONWIDE PROSPECTIVE COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"Kowa Company; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals","keywords":"Medicine; Gout; National Health and Nutrition Examination Survey; Hazard ratio; Population; Internal medicine; Prospective cohort study; Cohort study; Kidney disease; Cohort; Demography; Confidence interval; Environmental health","score_opus":0.042802855553235625,"score_gpt":0.3367123641240002,"score_spread":0.2939095085707646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379524037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931451,0.0004748905,0.0000010906333,0.0022484153,0.00014820223,0.002572089,0.0000616292,0.00010066205,0.0012478916],"genre_scores_gemma":[0.99833727,0.00011402442,0.000013904193,0.00027733002,0.000025726338,0.0002105286,0.00002718751,0.000024201525,0.0009698136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978172,0.0001617463,0.00050296605,0.0003238455,0.00091114367,0.00028305425],"domain_scores_gemma":[0.9984531,0.00017489489,0.00022565396,0.00080495805,0.0002105118,0.00013089675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058145367,0.00019334709,0.00052435615,0.00015641993,0.000082013474,0.000019453242,0.00028008348,0.00005679691,0.000079214544],"category_scores_gemma":[0.0016818151,0.00012881972,0.00032182888,0.0008837931,0.00010607953,0.000111684654,0.0001716158,0.00016305358,0.000053058164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073036215,0.0012613317,0.9916047,0.0003581713,0.00090798346,0.000018644218,0.0021168736,0.00018165869,0.000009212908,0.00008215112,0.0031648194,0.00022140669],"study_design_scores_gemma":[0.00078353554,0.00016247717,0.9933712,0.00051797205,0.00060500245,0.0000062564227,0.0028888616,0.0005785653,0.000084402884,0.00086304045,0.000018210801,0.00012047172],"about_ca_topic_score_codex":0.00025037862,"about_ca_topic_score_gemma":0.000042017346,"teacher_disagreement_score":0.005192154,"about_ca_system_score_codex":0.000056134875,"about_ca_system_score_gemma":0.00016253298,"threshold_uncertainty_score":0.5253116},"labels":[],"label_agreement":null},{"id":"W4379524075","doi":"10.1136/annrheumdis-2023-eular.608","title":"POS0664 DEFINING THRESHOLDS OF PRESENTEEISM MEASURES FOR UNACCEPTABLE WORK PARTICIPATION IN AxSpA","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fault Detection and Control Systems","field":"Engineering","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Presenteeism; Medicine; Work (physics); Ankylosing spondylitis; Physical therapy; Absenteeism; Immunology; Social psychology","score_opus":0.0431551387079637,"score_gpt":0.30769039448520397,"score_spread":0.26453525577724024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379524075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648714,0.0016223683,0.00030061256,0.00023269441,0.00032175335,0.000401986,0.000044605593,0.00011409287,0.00047474264],"genre_scores_gemma":[0.99955016,0.000095670206,0.000010948127,0.00001635767,0.000012273764,0.00016762588,0.000005252642,0.00001699951,0.00012469472],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9991184,0.000046685334,0.00036907452,0.00007886919,0.00019556454,0.00019138936],"domain_scores_gemma":[0.999381,0.00021882907,0.00008530352,0.00022291053,0.000052543233,0.000039397757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025402295,0.00008656756,0.0002277942,0.00010049628,0.000032287804,0.000014553153,0.00015778297,0.0000322538,0.000011741252],"category_scores_gemma":[0.00039963616,0.000066769695,0.00013728616,0.00042772677,0.00003077566,0.000082272345,0.000023023833,0.00003335467,0.000008593349],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022538846,0.00022396668,0.08781922,0.0021496497,0.0004555447,7.70891e-7,0.0017502551,0.7720426,0.00060922216,0.0025203305,0.030208541,0.10199457],"study_design_scores_gemma":[0.0018656307,0.000111642665,0.5399977,0.0027736214,0.00013439187,7.780341e-7,0.0012774522,0.4324705,0.010528739,0.008606478,0.0018197272,0.00041333362],"about_ca_topic_score_codex":0.00005687462,"about_ca_topic_score_gemma":0.000022452725,"teacher_disagreement_score":0.45217848,"about_ca_system_score_codex":0.000007510164,"about_ca_system_score_gemma":0.000014871449,"threshold_uncertainty_score":0.27227893},"labels":[],"label_agreement":null},{"id":"W4379524175","doi":"10.1136/annrheumdis-2023-eular.2251","title":"POS0920 QUANTIFICATION OF TENOSYNOVITIS IN RA FROM WRIST MRIs, BASED ON DEEP LEARNING","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Gilead Sciences; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Dutch Arthritis Society; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Wrist; Tenosynovitis; Physical medicine and rehabilitation; Physical therapy; Artificial intelligence; Radiology; Surgery; Computer science","score_opus":0.030284115569071058,"score_gpt":0.3261604761007173,"score_spread":0.29587636053164623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379524175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98912096,0.0005985628,0.00040601488,0.009076852,0.00011374785,0.00021938978,0.000026863268,0.000050608644,0.00038701252],"genre_scores_gemma":[0.9986591,0.00045613316,0.0001596189,0.0004693962,0.00002046329,0.000010937895,0.0001056608,0.000019719806,0.000098979326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986953,0.00016097506,0.00040904837,0.0001685313,0.00039852445,0.00016760537],"domain_scores_gemma":[0.9985626,0.00067209295,0.0002508098,0.00035830823,0.00006793025,0.0000882903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039997025,0.00010376764,0.00033607634,0.00017753428,0.00005183294,0.000011382093,0.00017834269,0.000035437,0.00009548109],"category_scores_gemma":[0.0035138824,0.00007333296,0.00015548454,0.00042538514,0.00012247541,0.000035109122,0.0000384071,0.00018854906,0.000021533015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005744202,0.0012220317,0.5100308,0.0016963709,0.00024983383,0.000033881,0.0009900507,0.058677215,0.0029958095,0.0006007125,0.008348351,0.41458052],"study_design_scores_gemma":[0.00068669853,0.000087049295,0.6993981,0.0018488666,0.000059705333,6.1873214e-7,0.00018458492,0.2957622,0.00080886873,0.0008612618,0.00023052946,0.00007153848],"about_ca_topic_score_codex":0.00049731875,"about_ca_topic_score_gemma":0.000003705511,"teacher_disagreement_score":0.414509,"about_ca_system_score_codex":0.000009791158,"about_ca_system_score_gemma":0.00006240308,"threshold_uncertainty_score":0.42066994},"labels":[],"label_agreement":null},{"id":"W4379534383","doi":"10.1136/annrheumdis-2023-eular.2985","title":"POS0227 SERUM EXTRACELLULAR MATRIX BIOMARKERS IDENTIFY RESPONSE TO GUSELKUMAB IN PSORIATIC ARTHRITIS: POST-HOC ANALYSIS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY THROUGH 2 YEARS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Griffith University; University of Leeds; University of Oxford; Janssen Scientific Affairs; Celgene; McGill University; Gilead Sciences; Brigham and Women's Hospital; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Double blind; Post-hoc analysis; Placebo; Arthritis; Internal medicine; Dermatology; Pathology; Alternative medicine","score_opus":0.03736903366541654,"score_gpt":0.34420621260855694,"score_spread":0.3068371789431404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379534383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698193,0.023127299,0.000016913124,0.00090620725,0.00060236384,0.0042189513,0.0011859018,0.00011289659,0.000010189052],"genre_scores_gemma":[0.9964937,0.001144372,0.000031006828,0.000062498904,0.000015536605,0.0009571124,0.0003369972,0.000038494116,0.0009203069],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99370575,0.0035345876,0.0013586945,0.0005786935,0.0002478406,0.00057443825],"domain_scores_gemma":[0.9952541,0.0029219554,0.00057350233,0.0010314365,0.00013497492,0.00008401313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002386237,0.0004226694,0.002035045,0.00088145403,0.00019144826,0.000074956115,0.00069106114,0.00016991317,0.00070221466],"category_scores_gemma":[0.0012779321,0.00031105036,0.0013296662,0.0020380171,0.00017427301,0.00020197878,0.00021928536,0.000121393314,0.0005283163],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9513983,0.0024599973,0.0008684398,0.000031272557,0.023887731,0.0000813485,0.0050737616,0.00031854332,0.0012070349,0.000031823398,0.0008268207,0.013814919],"study_design_scores_gemma":[0.9495979,0.0007252679,0.031821664,0.00041471425,0.0090902,0.0000033815684,0.00572322,0.0001190709,0.001127032,0.00081194047,0.00007385799,0.000491753],"about_ca_topic_score_codex":0.0011183004,"about_ca_topic_score_gemma":0.00034669082,"teacher_disagreement_score":0.030953223,"about_ca_system_score_codex":0.000034976576,"about_ca_system_score_gemma":0.00015177843,"threshold_uncertainty_score":0.99993414},"labels":[],"label_agreement":null},{"id":"W4379646705","doi":"10.1136/annrheumdis-2023-eular.1092","title":"AB1758-HPR IDENTIFYING THE RISK OF STEROID INDUCED ADRENAL INSUFFICIENCY IN RHEUMATOLOGY PATIENTS WEANING FROM PROLONGED STEROID THERAPY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Koninklijk Nederlands Genootschap voor Fysiotherapie; ZonMw; Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Rheumatology; Steroid; Adrenal insufficiency; Internal medicine; Endocrinology; Hormone","score_opus":0.05637273014468661,"score_gpt":0.3134374486645922,"score_spread":0.2570647185199056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379646705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955654,0.0025941452,0.000013447398,0.00070235366,0.0001692912,0.00076168636,0.0001004432,0.000039392155,0.00005381868],"genre_scores_gemma":[0.99757403,0.0021161872,0.000014093262,0.00015751932,0.00000748946,0.000045311033,0.0000417583,0.000026548496,0.000017054957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769527,0.00032379827,0.00080736936,0.0002609006,0.00056163775,0.00035102532],"domain_scores_gemma":[0.9979444,0.0005464545,0.0006641368,0.0006037436,0.0001493344,0.000091934955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039173462,0.00021668566,0.0005767179,0.00018794589,0.0001334107,0.000018509969,0.0004590363,0.00007430132,0.000050929462],"category_scores_gemma":[0.00097436237,0.00012100694,0.0002826135,0.00064668007,0.00019587525,0.00012377983,0.00019909447,0.00019994451,0.00001671531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010267898,0.0017250336,0.9456237,0.0003788997,0.00046753197,0.000004375088,0.006237409,0.00017305734,0.000331925,0.0000773655,0.001050707,0.0429032],"study_design_scores_gemma":[0.002222602,0.00038087086,0.9906144,0.0010671192,0.000073771254,0.0000014746429,0.002085114,0.00093069725,0.00055176194,0.00194329,0.000007347119,0.00012154845],"about_ca_topic_score_codex":0.00091531285,"about_ca_topic_score_gemma":0.000057696612,"teacher_disagreement_score":0.0449907,"about_ca_system_score_codex":0.000011322551,"about_ca_system_score_gemma":0.00010832986,"threshold_uncertainty_score":0.49345195},"labels":[],"label_agreement":null},{"id":"W4379646784","doi":"10.1136/annrheumdis-2023-eular.2988","title":"AB1633 PREVALENCE TREND OF EGPA AND ANNUAL CHANGES IN ORAL CORTICOSTEROID USE BY PATIENTS WITH EGPA FOLLOWING MEPOLIZUMAB AVAILABILITY IN JAPAN","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Mepolizumab; Granulomatosis with polyangiitis; Eosinophilic; Pediatrics; Asthma; Retrospective cohort study; Internal medicine; Medical record; Eosinophil; Vasculitis; Pathology; Disease","score_opus":0.027303908616254525,"score_gpt":0.2894749800384819,"score_spread":0.26217107142222734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379646784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969827,0.0010186054,1.8884768e-7,0.00064935046,0.00004456463,0.0006510351,0.0006132728,0.000024261524,0.000016051734],"genre_scores_gemma":[0.9993722,0.00027825823,0.000017760747,0.00011145782,0.0000036419574,0.00003692455,0.00004189951,0.000021043346,0.00011681099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982792,0.000154015,0.00050057645,0.00027542945,0.0004903803,0.00030036332],"domain_scores_gemma":[0.99868256,0.00037605772,0.00023927854,0.00049275777,0.00007976308,0.00012959905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023265423,0.00018253631,0.0005431869,0.00017991071,0.000028495835,0.000012698076,0.00016673177,0.00004535662,0.000028857046],"category_scores_gemma":[0.0011474063,0.00012639139,0.0000846633,0.000532236,0.0002395227,0.00023807505,0.00013595664,0.00008792913,0.0000017769207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025862505,0.0006101884,0.98543197,0.0010851913,0.00007076255,0.000005468236,0.0012725402,0.0000040479695,0.000046287994,0.0000043073874,0.00045868417,0.010751905],"study_design_scores_gemma":[0.0019971298,0.0004619676,0.99377096,0.0025390314,0.00010628633,0.0000017200717,0.000318432,0.000103911145,0.00046645428,0.00011852824,0.0000047968024,0.00011077501],"about_ca_topic_score_codex":0.00040374423,"about_ca_topic_score_gemma":0.00043536432,"teacher_disagreement_score":0.01064113,"about_ca_system_score_codex":0.000024974632,"about_ca_system_score_gemma":0.0000542753,"threshold_uncertainty_score":0.5154092},"labels":[],"label_agreement":null},{"id":"W4379646817","doi":"10.1136/annrheumdis-2023-eular.777","title":"AB1733-PARE SHARED DECISION MAKING ABOUT RMD TREATMENT: WHICH VALUES MATTER TO PEOPLE WITH A MIGRATION BACKGROUND?","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"Erasmus+; Erasmus Medisch Centrum; Ministerstvo Školství, Mládeže a Tělovýchovy","keywords":"Health care; Medicine; Population; Erasmus+; Focus group; Family medicine; Sociology; History","score_opus":0.06420461753890123,"score_gpt":0.3660124844384271,"score_spread":0.3018078668995259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379646817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895827,0.0005128035,0.00013375965,0.0064598136,0.00011136027,0.0011447631,0.00016277948,0.00015125383,0.0017407689],"genre_scores_gemma":[0.99714935,0.00028904545,0.00018387682,0.0006614326,0.000043090284,0.0001959918,0.00014787835,0.000043552092,0.0012857765],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998211,0.000063171115,0.00039611536,0.00034486034,0.00062694185,0.00035786605],"domain_scores_gemma":[0.9983784,0.00024673546,0.0001853839,0.0008235065,0.0001983943,0.00016758972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000121784564,0.000264708,0.0004414693,0.00021716046,0.0001525982,0.00013743952,0.00025834813,0.000033758188,0.0009557725],"category_scores_gemma":[0.0001868635,0.0001608599,0.0002071903,0.0009926647,0.000052059393,0.0002356737,0.0001469058,0.000040635616,0.00048582445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003897611,0.0023579285,0.3722139,0.00556269,0.0027185779,0.000065354325,0.007943472,0.008317421,0.000050310533,0.0011025405,0.5258363,0.0699339],"study_design_scores_gemma":[0.0011450313,0.00033532255,0.98562694,0.00535784,0.00053159194,0.000004919487,0.0022402233,0.0019896694,0.00005031165,0.0019960706,0.0005145777,0.00020752012],"about_ca_topic_score_codex":0.000160076,"about_ca_topic_score_gemma":0.00035100346,"teacher_disagreement_score":0.61341304,"about_ca_system_score_codex":0.00006894709,"about_ca_system_score_gemma":0.00016340517,"threshold_uncertainty_score":0.9999575},"labels":[],"label_agreement":null},{"id":"W4379646822","doi":"10.1136/annrheumdis-2023-eular.5499","title":"AB1589 ESSENTIAL TREATMENT OF RHEUMATOID ARTHRITIS IN ZANZIBAR: A COST EFFECTIVENESS ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes; University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Arthritis; Immunology","score_opus":0.05865918078828249,"score_gpt":0.3925604549198901,"score_spread":0.33390127413160764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379646822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365586,0.0032793863,0.000017893946,0.0020150226,0.000055626155,0.0006860151,0.00014393845,0.000027716316,0.00011852719],"genre_scores_gemma":[0.9732362,0.026403993,0.000009016433,0.000056765126,0.000010068182,0.00014896123,0.000077799865,0.000012320535,0.000044854252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792343,0.0005641777,0.0005852975,0.00022487124,0.00033552735,0.00036671793],"domain_scores_gemma":[0.99776363,0.0012210625,0.00018880623,0.000539179,0.00011608455,0.00017126053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005389534,0.00015361726,0.0010814212,0.00047531648,0.000043905682,0.000006219266,0.00015291863,0.000054173972,0.00014262229],"category_scores_gemma":[0.0016329949,0.00009768453,0.00069889554,0.0015404195,0.00021730595,0.000048186863,0.0000700381,0.000053546264,0.000031562893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013929245,0.0022051395,0.852782,0.00078165386,0.0051246276,0.00004645386,0.00046669412,0.002962753,0.0004467658,0.0004335449,0.0028241216,0.13053332],"study_design_scores_gemma":[0.001836089,0.0003540505,0.98974425,0.0008885472,0.00018996533,0.000004627066,0.00014518625,0.002995787,0.0028289084,0.00076401903,0.00016583897,0.00008274818],"about_ca_topic_score_codex":0.00154978,"about_ca_topic_score_gemma":0.0002074568,"teacher_disagreement_score":0.13696223,"about_ca_system_score_codex":0.000032234486,"about_ca_system_score_gemma":0.0001334931,"threshold_uncertainty_score":0.39834598},"labels":[],"label_agreement":null},{"id":"W4379647098","doi":"10.1136/annrheumdis-2023-eular.3653","title":"AB1447 VALIDITY OF ULTRASONOGRAPHY IN DETECTING ENTHESITIS IN CHILDREN: A SYSTEMATIC LITERATURE REVIEW","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"NIH Clinical Center; Assistance publique-Hôpitaux de Paris; Università Cattolica del Sacro Cuore; Universidad Autónoma de Madrid; Institut National de la Santé et de la Recherche Médicale; Ospedale Pediatrico Bambino Gesù; University of Ottawa; Pfizer","keywords":"Enthesitis; Medicine; Systematic review; Physical therapy; Metric (unit); Population; MEDLINE; Arthritis; Internal medicine; Psoriatic arthritis","score_opus":0.03993654135913299,"score_gpt":0.32983663435183996,"score_spread":0.28990009299270697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379647098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8961542,0.101647526,7.5703457e-7,0.00062508264,0.000021481157,0.0013809693,0.000027716182,0.000024197052,0.000118026845],"genre_scores_gemma":[0.9243131,0.07535069,0.000006351072,0.00015946031,0.000004462433,0.00009972378,0.000015352514,0.000013603512,0.00003723836],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99783635,0.000432577,0.0008863593,0.0001504952,0.00044212918,0.00025206237],"domain_scores_gemma":[0.998585,0.00038547936,0.00032904398,0.0005385105,0.00010467486,0.000057290843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001083612,0.00013792586,0.0008592924,0.00037386475,0.00003282224,0.000011195546,0.0002636915,0.00004723934,0.000035237375],"category_scores_gemma":[0.003156247,0.00009000917,0.00037033568,0.001849875,0.00008588202,0.000101522084,0.0000730288,0.00015941555,0.000009685762],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006470609,0.0005338725,0.48339954,0.50499904,0.00028571923,0.000021321799,0.0012917892,0.000023746967,0.00009507437,0.00008602246,0.001653684,0.007545484],"study_design_scores_gemma":[0.0003899222,0.000060582708,0.64031714,0.35800257,0.000076138625,0.0000127175745,0.00027059563,0.00015531396,0.00042685063,0.00020569512,0.000004033675,0.00007844215],"about_ca_topic_score_codex":0.000036265643,"about_ca_topic_score_gemma":0.000004509799,"teacher_disagreement_score":0.15691759,"about_ca_system_score_codex":0.000009385944,"about_ca_system_score_gemma":0.00008424387,"threshold_uncertainty_score":0.37785503},"labels":[],"label_agreement":null},{"id":"W4379647416","doi":"10.1136/annrheumdis-2023-eular.4605","title":"AB1182 EFFECTIVENESS OF FATIGUE INTERVENTIONS IN OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Meta-analysis; Osteoarthritis; Systematic review; Psychological intervention; Physical therapy; MEDLINE; Alternative medicine; Internal medicine; Pathology; Psychiatry","score_opus":0.2877798932625632,"score_gpt":0.46519179740593136,"score_spread":0.17741190414336816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379647416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030017713,0.9938578,0.000006756193,0.00011908575,0.000015078554,0.005446827,0.00048657582,0.000016823267,0.00002100769],"genre_scores_gemma":[0.0013740249,0.9966431,0.000007399392,0.0000052640708,0.0000010150701,0.0015162354,0.00010590344,0.0000408803,0.00030617742],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943261,0.0023178118,0.0021101232,0.00034807378,0.0006273732,0.0002705108],"domain_scores_gemma":[0.9953545,0.0020066933,0.0011060635,0.0011860891,0.00020968581,0.00013701322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019595046,0.00038207395,0.011278133,0.0006516904,0.00003509591,0.00001638103,0.00043837633,0.000110252564,0.00018661568],"category_scores_gemma":[0.0027183106,0.00020733695,0.0074620084,0.002238458,0.00022729328,0.000058050977,0.00024918644,0.00022074064,0.000014397182],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000043023965,0.00016283656,0.0000035058679,0.88582855,0.11267962,0.0000070964907,0.000015268175,0.0000011611294,1.5543982e-8,0.00007651487,0.000058075424,0.0011630545],"study_design_scores_gemma":[0.00011423537,0.00008672333,0.00008606511,0.5504406,0.4490469,0.000013393115,0.00001530474,0.000002400555,5.203508e-7,0.00009707346,0.000008963037,0.00008780986],"about_ca_topic_score_codex":0.00007753315,"about_ca_topic_score_gemma":0.0000076092897,"teacher_disagreement_score":0.3363673,"about_ca_system_score_codex":0.000035579422,"about_ca_system_score_gemma":0.0003185568,"threshold_uncertainty_score":0.8454955},"labels":[],"label_agreement":null},{"id":"W4379647435","doi":"10.1136/annrheumdis-2023-eular.365","title":"AB1092 GUSELKUMAB RAPIDLY IMPROVES ACTIVITIES OF DAILY LIVING IN PATIENTS WITH ACTIVE PSA: POOLED ANALYSIS OF 2 PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Parkinson's Disease and Spinal Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority; McGill University; Memorial University of Newfoundland","funders":"Pfizer; Eli Lilly and Company","keywords":"Medicine; Placebo; Physical therapy; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.022794537215118187,"score_gpt":0.32296917014763016,"score_spread":0.30017463293251195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379647435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948758,0.0028150557,0.000008260425,0.0002626061,0.000041995583,0.0016360222,0.00022082364,0.000029079196,0.00011038529],"genre_scores_gemma":[0.9980613,0.0014699132,0.000011018759,0.00008556969,0.0000056183435,0.0002079944,0.000037367645,0.000022445754,0.00009876687],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9973639,0.00044695698,0.0009172412,0.00026527667,0.0007042522,0.00030235358],"domain_scores_gemma":[0.9958718,0.0021683173,0.0009772308,0.00051266083,0.00035881522,0.00011118019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057015085,0.00028543675,0.0027865402,0.00084134284,0.00006209421,0.000009451486,0.00022757855,0.000045479745,0.000039704293],"category_scores_gemma":[0.003703395,0.00016674267,0.0010443782,0.0014348546,0.00049758516,0.00019791743,0.00010481201,0.0000835827,0.0000012847983],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7955025,0.007903943,0.07305801,0.0030273402,0.09525406,0.0000068354434,0.008770826,0.0013315368,0.00016322412,0.00011313797,0.0007995085,0.014069064],"study_design_scores_gemma":[0.23140505,0.00062777806,0.7345224,0.0025879897,0.018210683,1.093635e-7,0.008387293,0.003173904,0.00057166,0.00030594214,0.0000011192199,0.00020607287],"about_ca_topic_score_codex":0.000137135,"about_ca_topic_score_gemma":0.000040237588,"teacher_disagreement_score":0.6614644,"about_ca_system_score_codex":0.000023270468,"about_ca_system_score_gemma":0.00019653088,"threshold_uncertainty_score":0.67995685},"labels":[],"label_agreement":null},{"id":"W4379647467","doi":"10.1136/annrheumdis-2023-eular.555","title":"AB1095 IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Dactylitis; Enthesitis; Internal medicine; Psoriatic arthritis; Placebo; BASDAI; Physical therapy; Arthritis; Pathology","score_opus":0.0447157044069695,"score_gpt":0.3523626437271072,"score_spread":0.3076469393201377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379647467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994158,0.0032670093,0.0000451849,0.000108979424,0.00009335102,0.001544901,0.0007241945,0.000025054818,0.000033311284],"genre_scores_gemma":[0.9960412,0.0031473148,0.000017002832,0.000014860686,0.00000575541,0.00031548762,0.00029461348,0.000014753137,0.00014903206],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974206,0.00094487175,0.0010338037,0.0002110473,0.00015628131,0.00023339217],"domain_scores_gemma":[0.99555933,0.0023615991,0.001241173,0.00048060014,0.00032774688,0.000029523162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196144,0.0002572788,0.0018761082,0.0005792607,0.000103510596,0.000006015036,0.00021913314,0.00005929741,0.0002108333],"category_scores_gemma":[0.0006918007,0.00014421476,0.0013052112,0.0008308305,0.00034113997,0.00007890155,0.00004278443,0.000048128313,0.0000091544935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7345143,0.0032747465,0.0015452787,0.0005182851,0.14976367,0.0000033906085,0.004640931,0.0062086796,0.0062919534,0.00045283063,0.00057345896,0.09221247],"study_design_scores_gemma":[0.934636,0.0025529133,0.011489096,0.0013650537,0.034711752,0.000001904253,0.004223679,0.0011333103,0.00839591,0.0012026129,7.0526124e-7,0.00028707553],"about_ca_topic_score_codex":0.00033601356,"about_ca_topic_score_gemma":0.00008737485,"teacher_disagreement_score":0.20012169,"about_ca_system_score_codex":0.000020814228,"about_ca_system_score_gemma":0.00010384672,"threshold_uncertainty_score":0.5880908},"labels":[],"label_agreement":null},{"id":"W4379647487","doi":"10.1136/annrheumdis-2023-eular.3807","title":"AB1160 SOFT TISSUE EDEMA VISUALIZED ON MUSCULOSKELETAL ULTRASOUND AS A DIAGNOSTIC TEST FOR PSORIATIC ARTHRITIS: A PILOT COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Psoriatic arthritis; Soft tissue; Edema; Ultrasound; Cohort; Psoriasis; Arthritis; Dermatology; Pathology; Radiology; Internal medicine","score_opus":0.033562665409439085,"score_gpt":0.37238522528905943,"score_spread":0.33882255987962034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379647487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900026,0.0027647938,0.0000068910394,0.0011085405,0.00036394605,0.0049843625,0.0003858296,0.0001552215,0.00022782997],"genre_scores_gemma":[0.9939571,0.0029914747,0.000019731198,0.0003237678,0.00009182685,0.0018228804,0.00010059257,0.000059459464,0.00063318457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977048,0.00011108118,0.00060954207,0.00041024375,0.0006884284,0.00047590418],"domain_scores_gemma":[0.9924928,0.006188413,0.00025304695,0.0006596811,0.00019144802,0.00021462602],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00030753505,0.00033158957,0.000861554,0.00012761044,0.0003139384,0.000039247447,0.00020279681,0.000038566377,0.0001768641],"category_scores_gemma":[0.018966852,0.00022870942,0.00036777233,0.00044319298,0.00015188244,0.00006856161,0.00009476253,0.00007059489,0.0002668484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023622646,0.034895726,0.7212571,0.0028340428,0.007725864,0.00035362857,0.0020266061,0.000060973704,0.00010572306,0.001029505,0.06347286,0.16387574],"study_design_scores_gemma":[0.009285475,0.010949601,0.9698816,0.0027457543,0.0013917296,0.000026012744,0.0012438954,0.000039339604,0.00018232202,0.0035396311,0.000421221,0.0002934052],"about_ca_topic_score_codex":0.00020531144,"about_ca_topic_score_gemma":0.000066131215,"teacher_disagreement_score":0.24862455,"about_ca_system_score_codex":0.000026277272,"about_ca_system_score_gemma":0.00010339205,"threshold_uncertainty_score":0.9892968},"labels":[],"label_agreement":null},{"id":"W4379647506","doi":"10.1136/annrheumdis-2023-eular.604","title":"AB1085 CHANGES IN SERUM CYTOKINES AND COLLAGEN PROTEINS CORRELATE WITH DURABILITY OF GUSELKUMAB EFFICACY AND CONTINUED DISEASE IMPROVEMENT THROUGH 2 YEARS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Weill Cornell Medical College; Universität zu Lübeck; Queen's University; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Cytokine; Immunology; Gastroenterology; Arthritis","score_opus":0.015748176923155388,"score_gpt":0.2679127038635007,"score_spread":0.2521645269403453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379647506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959151,0.00066500495,6.421469e-7,0.0009626995,0.000013963131,0.0022840432,0.00012897963,0.000015388796,0.000014143701],"genre_scores_gemma":[0.9986473,0.0010781242,0.000009492746,0.00004521125,0.0000027604967,0.00014210067,0.000019113126,0.000017651575,0.000038279002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986976,0.00009875456,0.00034868854,0.0002175054,0.00039652016,0.00024093429],"domain_scores_gemma":[0.99911016,0.00013078263,0.00021857706,0.00032850518,0.00012405936,0.00008794124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017541103,0.0001481426,0.00048476981,0.00011586649,0.000039542083,0.000012198347,0.000094485804,0.000030858595,0.00001859813],"category_scores_gemma":[0.00044995514,0.000094637435,0.000034931654,0.00043106603,0.0003098591,0.00012929125,0.00010961378,0.0000693161,9.832463e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007189748,0.0015401756,0.8563855,0.0026443521,0.00032777232,0.00002342896,0.004571134,0.00007104018,0.000053585594,0.00004125509,0.0001069537,0.12704504],"study_design_scores_gemma":[0.006735514,0.00084563583,0.9880078,0.0027984895,0.000056107474,3.094736e-7,0.0008201283,0.000104705236,0.00024013904,0.0002783472,0.000010141019,0.000102680526],"about_ca_topic_score_codex":0.0001599747,"about_ca_topic_score_gemma":0.00016509568,"teacher_disagreement_score":0.13162228,"about_ca_system_score_codex":0.000015797255,"about_ca_system_score_gemma":0.00015112871,"threshold_uncertainty_score":0.38592026},"labels":[],"label_agreement":null},{"id":"W4379647521","doi":"10.1136/annrheumdis-2023-eular.2118","title":"AB0937 TOFACITINIB EFFICACY AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS BY BASELINE C‑REACTIVE PROTEIN LEVELS: A POST HOC ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Ankylosing spondylitis; BASDAI; Internal medicine; Janus kinase inhibitor; Post-hoc analysis; Placebo; Gastroenterology; Disease; Rheumatoid arthritis; Psoriatic arthritis; Pathology","score_opus":0.020653519828513815,"score_gpt":0.2797876085933666,"score_spread":0.2591340887648528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379647521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906068,0.0010117091,0.000004606633,0.0012334011,0.000015720743,0.0009815256,0.0060476307,0.000033661,0.00006496426],"genre_scores_gemma":[0.9986567,0.00014773347,0.000042901753,0.00015623528,0.0000056781832,0.000054648055,0.0007953617,0.00001942983,0.000121301906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985374,0.00011138467,0.0003772252,0.00028310972,0.00039967967,0.00029119677],"domain_scores_gemma":[0.9989248,0.00023992702,0.00018650881,0.0003322098,0.00018427313,0.00013228912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016676709,0.00020416992,0.0005829356,0.00020798671,0.00011906226,0.000018198501,0.00008037956,0.000033323595,0.00013795403],"category_scores_gemma":[0.0005254885,0.00012943544,0.00015363234,0.001052616,0.00014846827,0.0001023033,0.00008859955,0.000067474626,0.0000055242317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008220842,0.002544395,0.90773666,0.00044993125,0.0043872464,0.00004796145,0.0011506017,0.000032870503,0.000033261713,0.00006828979,0.0008256448,0.074502274],"study_design_scores_gemma":[0.00578816,0.00066350057,0.9905022,0.0013637614,0.00068620284,0.000001192589,0.00040428014,0.000096586475,0.00011219645,0.00006171204,0.00018414405,0.00013611393],"about_ca_topic_score_codex":0.00023005067,"about_ca_topic_score_gemma":0.000040249437,"teacher_disagreement_score":0.08276547,"about_ca_system_score_codex":0.000024003657,"about_ca_system_score_gemma":0.000048632013,"threshold_uncertainty_score":0.52782243},"labels":[],"label_agreement":null},{"id":"W4379648450","doi":"10.1136/annrheumdis-2023-eular.3897","title":"AB0531 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO LUPUS NEPHRITIS TREATMENTS FROM THE PUBLISHED LITERATURE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Alexion Pharmaceuticals; Idorsia Pharmaceuticals; GlaxoSmithKline; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Disease; Intensive care medicine; Pathology","score_opus":0.10925784724137669,"score_gpt":0.3543432714515526,"score_spread":0.2450854242101759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379648450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96612996,0.0048062527,0.000016395168,0.024800926,0.0005242225,0.0028150799,0.00052118866,0.000060100043,0.00032588388],"genre_scores_gemma":[0.9967289,0.00075877813,0.000033518725,0.00077610655,0.00010623552,0.00096709275,0.0001542712,0.00003468354,0.0004404201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721706,0.00053367077,0.0005720247,0.00029278448,0.0010528272,0.00033162907],"domain_scores_gemma":[0.99629337,0.0011857522,0.00032833844,0.0017192371,0.00029223756,0.00018109339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000579108,0.00020988278,0.00036401447,0.000097678036,0.00035210673,0.00019695655,0.0008947217,0.000056681773,0.00007314156],"category_scores_gemma":[0.0030942815,0.00008658648,0.00039173602,0.0013141021,0.00019411353,0.00015590322,0.00033138588,0.0001581378,0.00003194168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020143902,0.0013138041,0.6575506,0.0041102236,0.0022891825,0.000030405088,0.02763569,0.0002272598,0.0025582623,0.0049574478,0.22576879,0.07154401],"study_design_scores_gemma":[0.00209883,0.000084161555,0.91336405,0.029218849,0.00088063534,0.00010200243,0.0056816107,0.0023726649,0.0008694223,0.04382911,0.0011965324,0.00030211476],"about_ca_topic_score_codex":0.00017559581,"about_ca_topic_score_gemma":0.000009877476,"teacher_disagreement_score":0.2558135,"about_ca_system_score_codex":0.000041408926,"about_ca_system_score_gemma":0.00016836675,"threshold_uncertainty_score":0.37043676},"labels":[],"label_agreement":null},{"id":"W4379648451","doi":"10.1136/annrheumdis-2023-eular.1493","title":"AB0607 ANALYSIS OF NAILFOLD CAPILLAROSCOPY FINDINGS AND CLINICAL FEATURES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PULMONARY ARTERIAL HYPERTENSION","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università degli Studi di Brescia; Association of Canadian Universities for Research in Astronomy; Fondazione IRCCS Policlinico San Matteo","keywords":"Medicine; Pulmonary hypertension; Cardiology; Internal medicine; Lupus erythematosus; Dermatology; Immunology; Antibody","score_opus":0.02354324841041987,"score_gpt":0.2908473014357013,"score_spread":0.26730405302528143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379648451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603146,0.0030737706,5.0327105e-7,0.00012863376,0.00010788206,0.00033630047,0.0002887619,0.000017521177,0.000015140082],"genre_scores_gemma":[0.998446,0.0013348568,0.000018506442,0.000067655434,0.000011067514,0.000007195919,0.00007068293,0.000014337082,0.000029715757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864084,0.00007455051,0.0005349607,0.00020761795,0.00038096824,0.00016107009],"domain_scores_gemma":[0.99842477,0.0005032401,0.00033635064,0.00038245507,0.00019864828,0.00015456666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016366837,0.00014763259,0.00085501553,0.00020922809,0.00004411619,0.0000098438495,0.00009672473,0.000055726796,0.000015110446],"category_scores_gemma":[0.0005925693,0.000084386316,0.00027693826,0.00050799386,0.00028629368,0.000053032498,0.00010112515,0.00004125143,6.245917e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008906217,0.00045326538,0.9926583,0.0014771017,0.00157377,0.000004620597,0.000087992354,0.000010943497,0.00010627423,0.000025736703,0.0012841222,0.0014272317],"study_design_scores_gemma":[0.0011548101,0.00024981287,0.99200404,0.0019327704,0.0034746516,0.000007713044,0.00026824957,0.0005214162,0.00017465773,0.00012624971,0.0000021554404,0.000083484025],"about_ca_topic_score_codex":0.000037775062,"about_ca_topic_score_gemma":0.0000018071573,"teacher_disagreement_score":0.0024144955,"about_ca_system_score_codex":0.0000031069837,"about_ca_system_score_gemma":0.000047055186,"threshold_uncertainty_score":0.34411743},"labels":[],"label_agreement":null},{"id":"W4379648560","doi":"10.1136/annrheumdis-2023-eular.843","title":"AB0503 GENICULAR ARTERY EMBOLIZATION IN THE MANAGEMENT OF PERSISTENT JUVENILE IDIOPATHIC ARTHRITIS OF THE KNEE: A CASE REPORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Arthritis; Surgery; Osteoarthritis; Hemarthrosis; Outpatient clinic; Knee pain; Internal medicine; Pathology","score_opus":0.040314346373235256,"score_gpt":0.31018730526963334,"score_spread":0.26987295889639806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379648560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948896,0.00677265,0.0000055550895,0.0023029393,0.00006305675,0.0008539064,0.000019070829,0.000012090851,0.00048176304],"genre_scores_gemma":[0.99780947,0.0016479825,0.000004515664,0.00010500609,0.0000061915052,0.0000760762,0.000011453338,0.000011910749,0.00032741093],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979984,0.00021786307,0.0007920359,0.00013564478,0.0006649988,0.00019106676],"domain_scores_gemma":[0.9984763,0.000059602193,0.00038448727,0.0009075432,0.00013701784,0.000034998564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009524441,0.00010511303,0.00038261907,0.00009956488,0.0000880621,0.000009077135,0.00027153423,0.000033915858,0.000043706794],"category_scores_gemma":[0.0003026304,0.000055613717,0.0005174062,0.0006487582,0.00017793092,0.00005874233,0.00016719208,0.00009005819,0.0000061327128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019642594,0.012658128,0.18783846,0.07790464,0.013713985,0.0428268,0.060245596,0.020702776,0.0015602089,0.010651177,0.073592424,0.49634153],"study_design_scores_gemma":[0.0040996047,0.00059543387,0.904356,0.020186497,0.0012063072,0.0042369687,0.04908414,0.008953508,0.0019618818,0.0038344783,0.0010950628,0.00039012285],"about_ca_topic_score_codex":0.00008959878,"about_ca_topic_score_gemma":0.000009842841,"teacher_disagreement_score":0.7165175,"about_ca_system_score_codex":0.000011619371,"about_ca_system_score_gemma":0.00012997705,"threshold_uncertainty_score":0.22678615},"labels":[],"label_agreement":null},{"id":"W4379648580","doi":"10.1136/annrheumdis-2023-eular.268","title":"AB0402 PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pfizer Pharmaceuticals; Sanofi Genzyme; Biogen; Gilead Sciences; Chugai Pharmaceutical; Celltrion; Sanofi; Amgen; Pfizer; Samsung; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Tocilizumab; Pharmacokinetics; Bioequivalence; Clinical endpoint; Area under the curve; Internal medicine; Pharmacodynamics; Nuclear medicine; Gastroenterology; Urology; Pharmacology; Randomized controlled trial; Rheumatoid arthritis","score_opus":0.10114464188552591,"score_gpt":0.39424986641269333,"score_spread":0.2931052245271674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379648580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879575,0.004214126,0.000023883205,0.0027743576,0.0001583115,0.0045195622,0.0001348794,0.000045482324,0.00017191173],"genre_scores_gemma":[0.99867296,0.00063296035,0.00011863736,0.00030046215,0.000006649049,0.00014201991,0.000028139984,0.000025691754,0.00007250216],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99572396,0.0016405792,0.0014156881,0.0004699405,0.00019783272,0.00055201165],"domain_scores_gemma":[0.99724096,0.0013903342,0.00060761184,0.0005172106,0.00015353892,0.000090355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016874399,0.0003712586,0.0016758573,0.000336761,0.000104686565,0.000022967128,0.00042922224,0.00009785858,0.00008553456],"category_scores_gemma":[0.0005970944,0.00022808329,0.00023758454,0.0011126021,0.00090821186,0.000089779045,0.00024266097,0.00031721956,0.0000038499047],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93507314,0.016479991,0.009505795,0.0011798728,0.0014813216,0.000030796393,0.0026007886,0.00019356624,0.0024914136,0.00040045625,0.0010879092,0.029474935],"study_design_scores_gemma":[0.9526799,0.004664158,0.008284301,0.0015581687,0.0009093005,0.0000194445,0.0035757336,0.002487415,0.023855198,0.0011863654,0.00016261975,0.0006174094],"about_ca_topic_score_codex":0.0004629023,"about_ca_topic_score_gemma":0.00050102064,"teacher_disagreement_score":0.028857525,"about_ca_system_score_codex":0.000031176693,"about_ca_system_score_gemma":0.00019005634,"threshold_uncertainty_score":0.9300966},"labels":[],"label_agreement":null},{"id":"W4379648703","doi":"10.1136/annrheumdis-2023-eular.2044","title":"AB0395 IMMUNE-MEDIATED SKIN LESIONS RELATED TO BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A 22-YEAR EXPERIENCE OF A TERTIARY CENTER","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Ministry of Health and Long Term Care","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Antirheumatic drugs; Center (category theory); Immune system; Disease; Dermatology; Immunology; Internal medicine; Antirheumatic Agents","score_opus":0.02778354573321913,"score_gpt":0.2935194576999167,"score_spread":0.2657359119666976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379648703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585904,0.011588133,0.0000099174,0.0009205155,0.0004509205,0.0005720767,0.00030338875,0.00014239785,0.00015360698],"genre_scores_gemma":[0.99777865,0.0013352729,0.0000060928,0.0002116272,8.772811e-7,0.00008995257,0.00021675116,0.00002397695,0.00033677812],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99747145,0.00043213513,0.0010103588,0.00035045654,0.00015234073,0.0005832708],"domain_scores_gemma":[0.9980448,0.0005489905,0.0004070122,0.0008440536,0.000112149915,0.000042987103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036116733,0.00028714477,0.00059113256,0.00024186366,0.00031696007,0.000016245278,0.0009480187,0.0001292703,0.0004519984],"category_scores_gemma":[0.0014933473,0.00019234412,0.0005067709,0.0009320513,0.00064431835,0.00013446438,0.00048351623,0.00017714669,0.00048076586],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058374,0.018411156,0.21485433,0.0056235595,0.0065837596,0.000052848427,0.15125562,0.0035658877,0.25840655,0.011508468,0.026931848,0.29696855],"study_design_scores_gemma":[0.00220198,0.00016908051,0.9692036,0.003439007,0.000103058956,0.000006534255,0.012556779,0.00028900232,0.008307196,0.0023473194,0.000809136,0.00056728726],"about_ca_topic_score_codex":0.000119822376,"about_ca_topic_score_gemma":3.3242318e-7,"teacher_disagreement_score":0.7543493,"about_ca_system_score_codex":0.00001015283,"about_ca_system_score_gemma":0.00009652141,"threshold_uncertainty_score":0.78435653},"labels":[],"label_agreement":null},{"id":"W4379648828","doi":"10.1136/annrheumdis-2023-eular.2287","title":"AB0196 IMPACT OF ANTIRHEUMATIC TREATMENTS ON THE INDIVIDUAL COMPONENTS OF THE ACR COMPOSITE SCORE IN PATIENTS WITH RA: REAL-WORLD DATA FROM TWO REGISTRIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Toronto General Hospital; University of Toronto; Université Laval","funders":"Canadian Institutes of Health Research; Eli Lilly Canada; Pfizer Pharmaceuticals; Sandoz Canada; Ontario Ministry of Health and Long-Term Care; Celgene; Teva Pharmaceutical Industries; Gilead Sciences; Canadian Arthritis Network; Pfizer Canada; Sanofi; Amgen Canada; AbbVie Canada; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Tofacitinib; Internal medicine; Abatacept; Rheumatoid arthritis; Clinical endpoint; Physical therapy; Randomized controlled trial; Rituximab","score_opus":0.13181290998301232,"score_gpt":0.36640709406423616,"score_spread":0.23459418408122384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379648828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936415,0.0005942102,3.1307587e-7,0.0009635396,0.00006724659,0.0010934038,0.0035338316,0.000019273963,0.00008667533],"genre_scores_gemma":[0.9963758,0.0027449115,0.000011907092,0.000044769717,0.0000075427174,0.00001876624,0.00071312184,0.000027357195,0.00005582812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971128,0.0004114919,0.0006599351,0.00025773642,0.0012141735,0.00034383958],"domain_scores_gemma":[0.9961662,0.0010184362,0.00067114836,0.0018767911,0.00015530734,0.00011210109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037603977,0.00025168297,0.0007338194,0.00018503943,0.00015374365,0.00003264566,0.0011612934,0.000023252449,0.000058614783],"category_scores_gemma":[0.00056119205,0.00010655706,0.00024628002,0.0008956785,0.00081592496,0.00015714721,0.00049098366,0.00014892394,0.000010335689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014142937,0.0010095432,0.9862848,0.00015920958,0.0015237746,0.0000021582375,0.0007511051,0.0000960691,0.000039268318,0.000095769916,0.0042854887,0.0043385476],"study_design_scores_gemma":[0.0034081095,0.00044219734,0.9870864,0.00721248,0.000069542446,5.212385e-7,0.0002276226,0.00030857645,0.00037421484,0.0007683976,0.000007715123,0.00009418775],"about_ca_topic_score_codex":0.005681246,"about_ca_topic_score_gemma":0.0003711449,"teacher_disagreement_score":0.0070532705,"about_ca_system_score_codex":0.000026228872,"about_ca_system_score_gemma":0.00018465353,"threshold_uncertainty_score":0.8588382},"labels":[],"label_agreement":null},{"id":"W4379648885","doi":"10.1136/annrheumdis-2023-eular.2506","title":"AB0197 PARASYMPATHETIC ACTIVITY IS NEGATIVELY ASSOCIATED WITH DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS – RESULTS OF AN EXPLORATORY PROSPECTIVE STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université Laval; Toronto General Hospital","funders":"Canadian Institutes of Health Research; Eli Lilly Canada; Pfizer Pharmaceuticals; Sandoz Canada; Ontario Ministry of Health and Long-Term Care; Celgene; Teva Pharmaceutical Industries; Gilead Sciences; Canadian Arthritis Network; Pfizer Canada; Sanofi; Amgen Canada; AbbVie Canada; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Heart rate variability; Rheumatoid arthritis; Vasoactive intestinal peptide; Internal medicine; Prospective cohort study; Autonomic nervous system; Electrocardiography; Cardiology; Heart rate; Analysis of variance; Blood pressure; Neuropeptide; Receptor","score_opus":0.027806651400857516,"score_gpt":0.27958788074526225,"score_spread":0.2517812293444047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379648885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958494,0.00003990611,0.0000037724951,0.00070820976,0.00003085604,0.0024544757,0.00082536764,0.00006782382,0.000020241017],"genre_scores_gemma":[0.99963754,0.000046849986,0.0000043971963,0.000050284485,0.0000044493363,0.00017315136,0.000025454958,0.000030069816,0.000027800877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740434,0.0006339041,0.00050523924,0.0004513197,0.00066207506,0.0003431118],"domain_scores_gemma":[0.9975388,0.00051068724,0.0005204582,0.00080784573,0.000354543,0.00026767128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007040911,0.00027168094,0.00083128497,0.0001622839,0.00010440444,0.000020434338,0.00018629432,0.000047916637,0.000016288139],"category_scores_gemma":[0.001395352,0.00017354423,0.00014033113,0.0008218346,0.0002958436,0.0003961784,0.00008365719,0.00017292066,0.000005225356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010351617,0.018783139,0.9417662,0.0002594587,0.00076804246,0.000019017825,0.008465848,0.00033927648,0.000051536535,0.000017101172,0.000089796886,0.019088961],"study_design_scores_gemma":[0.009108765,0.0021210932,0.9835305,0.0020356365,0.00009576523,1.6868303e-7,0.00079048116,0.0010858048,0.0006037325,0.00043830546,0.0000023659263,0.0001873805],"about_ca_topic_score_codex":0.00022127017,"about_ca_topic_score_gemma":0.00020482691,"teacher_disagreement_score":0.041764297,"about_ca_system_score_codex":0.00006613978,"about_ca_system_score_gemma":0.0006094468,"threshold_uncertainty_score":0.7076928},"labels":[],"label_agreement":null},{"id":"W4379649195","doi":"10.1136/annrheumdis-2023-eular.3308","title":"POS1544 LONG-TERM SAFETY AND EFFICACY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS BY PRIOR BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG EXPOSURE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Toronto Western Hospital","funders":"","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Internal medicine; Adverse effect; Placebo; Clinical trial; Janus kinase inhibitor; Rheumatoid arthritis; Pharmacology","score_opus":0.01821409370438421,"score_gpt":0.282099921861953,"score_spread":0.2638858281575688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98212075,0.01515799,0.000007736575,0.0008272577,0.00006586228,0.0012538495,0.0004923782,0.000056256402,0.000017933793],"genre_scores_gemma":[0.9658955,0.033677723,0.000019530806,0.000060533766,0.0000070254287,0.0000391579,0.00022422173,0.000031249187,0.000045084435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750453,0.00024205388,0.00078434957,0.00032018588,0.00067719846,0.00047166776],"domain_scores_gemma":[0.99807227,0.0005471196,0.00034407355,0.0005655756,0.00016500546,0.0003059337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033392562,0.00026836587,0.0007898966,0.00022388405,0.00013377568,0.000033645887,0.00025862455,0.000044291675,0.000096265816],"category_scores_gemma":[0.0011933708,0.00017117572,0.00018103578,0.00055787095,0.0004615844,0.00018345975,0.00015032555,0.00013283947,0.000009463146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018720863,0.0009076355,0.87172514,0.0014338136,0.00026494384,0.000010803856,0.0005664361,0.000018716335,0.000013681529,0.00011356434,0.00049995224,0.12257321],"study_design_scores_gemma":[0.0071843155,0.00040035826,0.9825714,0.008787379,0.000026946662,0.000002439228,0.00016262359,0.00008801156,0.00010906587,0.00047311455,0.000013556076,0.00018076967],"about_ca_topic_score_codex":0.000041575797,"about_ca_topic_score_gemma":0.000011665307,"teacher_disagreement_score":0.122392446,"about_ca_system_score_codex":0.000013215341,"about_ca_system_score_gemma":0.0001311991,"threshold_uncertainty_score":0.6980343},"labels":[],"label_agreement":null},{"id":"W4379649237","doi":"10.1136/annrheumdis-2023-eular.3273","title":"POS1543 EFFICACY OF RISANKIZUMAB IN THE TREATMENT OF PsA PATIENTS WITH LIMITED AND EXTENSIVE JOINT INVOLVEMENT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Celgene; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Joint (building); Intensive care medicine","score_opus":0.06387673655282537,"score_gpt":0.3239866740049901,"score_spread":0.2601099374521647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686676,0.0009619785,5.8865726e-7,0.00084553624,0.000020111302,0.0011745082,0.00006163094,0.000009126012,0.000059749644],"genre_scores_gemma":[0.99832827,0.001409651,0.000015583171,0.000103946164,0.0000061806118,0.000044594537,0.000032897857,0.00001316113,0.00004569021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983746,0.00013111053,0.0004360765,0.00015928324,0.0006819431,0.00021702042],"domain_scores_gemma":[0.99824053,0.00061553245,0.00023454492,0.00061002304,0.00022398186,0.000075404845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017873054,0.0001367545,0.0004472486,0.00014800027,0.000032204076,0.000006082589,0.00015383391,0.000026469956,0.000019934143],"category_scores_gemma":[0.00049818127,0.00006264729,0.00013459519,0.0004870285,0.00029789173,0.000033210872,0.000071576214,0.000038316295,0.0000030002611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01847641,0.048577737,0.51352334,0.015604582,0.0072930697,0.00020917454,0.080846876,0.001965227,0.00045514386,0.0012833657,0.019678041,0.29208702],"study_design_scores_gemma":[0.01585813,0.0021169262,0.9750707,0.0018105396,0.0002256244,0.0000029077653,0.0014974731,0.0010728075,0.0019309204,0.00030579968,0.000034104272,0.000074033385],"about_ca_topic_score_codex":0.0005313571,"about_ca_topic_score_gemma":0.000019684487,"teacher_disagreement_score":0.46154737,"about_ca_system_score_codex":0.00025494,"about_ca_system_score_gemma":0.00070087047,"threshold_uncertainty_score":0.25546825},"labels":[],"label_agreement":null},{"id":"W4379649250","doi":"10.1136/annrheumdis-2023-eular.3268","title":"POS1524 DURABLE CLINICALLY-MEANINGFUL IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE, FATIGUE, PAIN, AND WORK PRODUCTIVITY AMONG PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH RISANKIZUMAB AT WEEK 100","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Biogen; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Quality of life (healthcare); Physical therapy; Presenteeism; Work productivity; Productivity; Arthritis; Internal medicine; Nursing","score_opus":0.20865776486822726,"score_gpt":0.38043140838739337,"score_spread":0.1717736435191661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908894,0.0010774526,0.00002032833,0.005324906,0.00009422488,0.001868049,0.00060791825,0.000043035976,0.00007468904],"genre_scores_gemma":[0.9985361,0.00038510436,0.00008035249,0.0005484653,0.000011629019,0.00015317171,0.000088496694,0.00003674888,0.00015992936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922285,0.0014816367,0.004960764,0.00058559206,0.00026783647,0.0004756648],"domain_scores_gemma":[0.9903194,0.0022598465,0.006279446,0.00070838357,0.00017688471,0.00025605055],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0109862145,0.0002646628,0.001681031,0.0002699617,0.00019564458,0.000031727166,0.00026795128,0.00008702286,0.00007834586],"category_scores_gemma":[0.011411155,0.00022374772,0.00012708841,0.00084211794,0.00030500704,0.00044004354,0.000115738374,0.00014859675,0.00002429321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060116034,0.00072922825,0.98673993,0.001495662,0.00035178373,2.590673e-7,0.0016841484,0.00054374913,5.6436516e-8,0.000260702,0.0013990952,0.006194229],"study_design_scores_gemma":[0.002695637,0.0006109074,0.99087834,0.001956356,0.000012086455,1.2175312e-7,0.00060411333,0.0005498444,0.0000031166041,0.0024347918,0.000017911223,0.00023677028],"about_ca_topic_score_codex":0.0062375055,"about_ca_topic_score_gemma":0.0008259771,"teacher_disagreement_score":0.0076467064,"about_ca_system_score_codex":0.00015233764,"about_ca_system_score_gemma":0.00023203532,"threshold_uncertainty_score":0.9969162},"labels":[],"label_agreement":null},{"id":"W4379649269","doi":"10.1136/annrheumdis-2023-eular.45","title":"POS1527 EFFECTS OF APREMILAST ON CHANGES IN CARDIOMETABOLIC PARAMETERS BY DIABETES AND OBESITY STATUS IN PATIENTS WITH PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"LEO Pharma; Incyte; IC Design Education Center; Regeneron Pharmaceuticals; Sanofi; Pfizer","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Body mass index; Diabetes mellitus; Placebo; Gastroenterology; Apremilast; Population; Obesity; Arthritis; Endocrinology; Pathology","score_opus":0.008808702312123926,"score_gpt":0.2121055439803363,"score_spread":0.20329684166821238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167114,0.0073371837,8.462895e-8,0.000058919635,0.0001472373,0.00043526298,0.00032813303,0.000014113453,0.000007922075],"genre_scores_gemma":[0.9969883,0.0027966269,0.0000029906412,0.000034969173,0.0000015445655,0.00006270892,0.0000839868,0.00001022523,0.00001867151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989836,0.0002859012,0.00020351361,0.00016719577,0.000070672,0.0002891006],"domain_scores_gemma":[0.9990356,0.00054213795,0.00014328488,0.0002267684,0.000025739484,0.00002645891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010566858,0.00015025976,0.00046663967,0.00019938864,0.000034958714,0.000004847586,0.000110513465,0.0000553248,0.0000062477684],"category_scores_gemma":[0.0002496439,0.000099793586,0.00006451705,0.00037574183,0.00012959084,0.000043419775,0.000052659554,0.00004461406,0.0000067036476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017086597,0.00048654922,0.87269443,0.00030588708,0.00034934733,7.946582e-7,0.00043952244,0.00001847056,0.00020476275,0.000012488379,0.00035371212,0.12496316],"study_design_scores_gemma":[0.0023013283,0.00034804473,0.9834132,0.0009538497,0.000084590305,7.3413005e-8,0.000081538004,0.0000021500377,0.012565735,0.0001406815,0.000010506271,0.00009830215],"about_ca_topic_score_codex":0.000116704556,"about_ca_topic_score_gemma":0.000053895852,"teacher_disagreement_score":0.124864854,"about_ca_system_score_codex":0.000007649136,"about_ca_system_score_gemma":0.000017242459,"threshold_uncertainty_score":0.40694642},"labels":[],"label_agreement":null},{"id":"W4379649312","doi":"10.1136/annrheumdis-2023-eular.4556","title":"POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; University Health Network Foundation; Krembil Foundation; Arthritis Society; National Psoriasis Foundation","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Ustekinumab; Arthritis; Immunology; Adalimumab; Rheumatoid arthritis","score_opus":0.045186304967485644,"score_gpt":0.2937621905716569,"score_spread":0.24857588560417126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615194,0.028630441,0.00035122567,0.0028468978,0.002134123,0.0013280641,0.0030079759,0.0001645529,0.000017274388],"genre_scores_gemma":[0.9725345,0.024170268,0.00080909085,0.0003515253,0.00015346738,0.00081159873,0.000645785,0.00004115761,0.00048262737],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854106,0.00024862375,0.0004406786,0.00027745392,0.000054459048,0.00043772836],"domain_scores_gemma":[0.9975998,0.0013871448,0.00037979375,0.00041607203,0.00017468493,0.000042546802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039159477,0.00025719925,0.0004877965,0.000113088616,0.00048182483,0.000021249496,0.00039103406,0.00016291843,0.00006187773],"category_scores_gemma":[0.001456757,0.00016430992,0.0005571088,0.00029141188,0.00013741906,0.000076345714,0.00007570003,0.000050554754,0.000052639043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075170846,0.0002379229,0.0038832477,0.00034101502,0.0026172572,7.4297793e-7,0.0010153591,0.00001651539,0.00029245895,0.0053246706,0.030192297,0.9553268],"study_design_scores_gemma":[0.01959268,0.0018379,0.52314514,0.002649036,0.0038573886,0.000026304633,0.010227513,0.00018511563,0.05777478,0.28889504,0.08958656,0.0022225112],"about_ca_topic_score_codex":0.000031871623,"about_ca_topic_score_gemma":0.000022128486,"teacher_disagreement_score":0.9531043,"about_ca_system_score_codex":0.000011640582,"about_ca_system_score_gemma":0.000141416,"threshold_uncertainty_score":0.67003644},"labels":[],"label_agreement":null},{"id":"W4379649324","doi":"10.1136/annrheumdis-2023-eular.348","title":"POS1529 DOMAINS IMPACTING MINIMAL DISEASE ACTIVITY NON-ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO TNFI RECEIVING GUSELKUMAB (COSMOS)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Chugai Pharmaceutical; Novartis Pharma; Medac; Swedish Orphan Biovitrum; Celgene; Biogen; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Physical therapy; Arthritis; Dermatology","score_opus":0.020207636189265,"score_gpt":0.29586450958513993,"score_spread":0.2756568733958749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923804,0.0007634978,0.000009021027,0.0053355796,0.00007177489,0.0012230722,0.00014904523,0.00005122245,0.000016421945],"genre_scores_gemma":[0.9968303,0.0026911206,0.000065767905,0.0001858576,0.000015269798,0.00011371844,0.000015356007,0.00004029015,0.000042341388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974732,0.00036535272,0.00042997222,0.00033603903,0.00079558365,0.0005998605],"domain_scores_gemma":[0.9979275,0.0005963495,0.00018891333,0.0005459113,0.0001368333,0.0006045225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074138766,0.00025160727,0.0005190276,0.00033309683,0.00019871992,0.00007126225,0.00019529377,0.00003261024,0.000032318963],"category_scores_gemma":[0.0026391752,0.00017582171,0.00012540368,0.000719816,0.00016339106,0.00026715206,0.00021902563,0.00014941084,0.000017922306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03728945,0.0020438323,0.5589315,0.00084626203,0.00049137877,0.00007962619,0.0030839655,0.00013914221,0.0002721629,0.000046548994,0.0015728829,0.3952032],"study_design_scores_gemma":[0.004126925,0.0011003333,0.9880075,0.005309278,0.000017677925,0.0000018782092,0.00038068753,0.00027903813,0.00021637272,0.00032209943,0.000044949236,0.00019329006],"about_ca_topic_score_codex":0.00016660265,"about_ca_topic_score_gemma":0.00006354338,"teacher_disagreement_score":0.42907593,"about_ca_system_score_codex":0.00004801466,"about_ca_system_score_gemma":0.00024835696,"threshold_uncertainty_score":0.71698016},"labels":[],"label_agreement":null},{"id":"W4379649390","doi":"10.1136/annrheumdis-2023-eular.2581","title":"POS1540 EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psoriatic arthritis; Enthesitis; Psoriasis; Internal medicine; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Post-hoc analysis; Arthritis; Placebo; Dermatology; Gastroenterology; Pathology","score_opus":0.019944587159781375,"score_gpt":0.28119453567197605,"score_spread":0.2612499485121947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598783,0.0020807735,6.996708e-7,0.00007691537,0.000037515354,0.00074499374,0.0010315622,0.00003565095,0.000004052374],"genre_scores_gemma":[0.9989142,0.00060241594,0.000007750811,0.000015204745,0.0000025222823,0.000084115236,0.00010916637,0.00002566598,0.00023899614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726534,0.0013623206,0.00052173686,0.00033020903,0.00018109704,0.0003392842],"domain_scores_gemma":[0.9978599,0.00095943897,0.00048325918,0.0004915319,0.00016696256,0.000038923845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036819474,0.00025593102,0.0007898273,0.0004383229,0.000115006726,0.000026848806,0.00024775474,0.00008536792,0.000044249045],"category_scores_gemma":[0.000341316,0.00017552034,0.00019774595,0.0012923094,0.00023112328,0.00017010389,0.00007839493,0.00007135369,0.000014909302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02136096,0.002833142,0.9078224,0.000041402818,0.007041806,0.00005824522,0.0065408316,0.0000059507456,0.00010337666,0.0000034273858,0.000035024852,0.05415349],"study_design_scores_gemma":[0.008937105,0.0050168703,0.98172265,0.0004614303,0.0019809229,0.0000025435634,0.00054477586,8.6786747e-7,0.0011203289,0.000021570842,0.0000019452877,0.0001890161],"about_ca_topic_score_codex":0.0009419576,"about_ca_topic_score_gemma":0.00038034393,"teacher_disagreement_score":0.07390028,"about_ca_system_score_codex":0.00002137526,"about_ca_system_score_gemma":0.00008637942,"threshold_uncertainty_score":0.7157512},"labels":[],"label_agreement":null},{"id":"W4379649420","doi":"10.1136/annrheumdis-2023-eular.1691","title":"POS1536 ASSESSMENT OF PAIN OUTCOMES IN A PHASE 2 TRIAL OF DEUCRAVACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Samsung; Genentech; Servier; National Institute for Health and Care Research; Celltrion; Kiniksa Pharmaceuticals; Dutch Arthritis Association; Sun Pharma; Regeneron Pharmaceuticals; EMD Serono; University of Pennsylvania; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Physical therapy; Arthritis; Antirheumatic Agents; Internal medicine","score_opus":0.02611277474082342,"score_gpt":0.3490589343388839,"score_spread":0.3229461595980605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799633,0.00010088354,0.000016416974,0.0005413814,0.00003968478,0.0010439617,0.00016585152,0.000009059684,0.00008645286],"genre_scores_gemma":[0.9996048,0.00015562055,0.000040626095,0.00007478874,0.0000037426796,0.00004921653,0.00004335941,0.000012497399,0.000015337468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984013,0.00017439324,0.00064000697,0.00012661096,0.0004768593,0.00018081936],"domain_scores_gemma":[0.9987126,0.00044738816,0.00038852802,0.0002793794,0.00010608666,0.000066028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033712006,0.00012740858,0.00067181175,0.00020253051,0.0000142345825,0.0000029178784,0.000115538925,0.000030702657,0.000032930588],"category_scores_gemma":[0.0010408271,0.00007913626,0.00016764086,0.00046988667,0.0001029083,0.000069720816,0.000044964898,0.00006156999,7.617243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034378856,0.01281518,0.67912346,0.0011749585,0.000538749,0.000009813939,0.0013706438,0.0002212881,0.000007247409,0.00032458457,0.0005417266,0.26949346],"study_design_scores_gemma":[0.05984606,0.0021664603,0.9335099,0.0016534457,0.00006626711,1.1775534e-7,0.0010620134,0.0004734648,0.000051158106,0.0010905737,0.0000017221623,0.00007882609],"about_ca_topic_score_codex":0.00018765859,"about_ca_topic_score_gemma":0.000039583938,"teacher_disagreement_score":0.26941463,"about_ca_system_score_codex":0.000012044474,"about_ca_system_score_gemma":0.0001593577,"threshold_uncertainty_score":0.3227083},"labels":[],"label_agreement":null},{"id":"W4379649424","doi":"10.1136/annrheumdis-2023-eular.3209","title":"POS1542 THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) QUESTIONNAIRE IS VALID IN ARABIC AND STRONGLY LINKED TO DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ARAB-SPEAKING COUNTRIES: AN ARLAR INITIATIVE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"UCB Pharma; Sanofi Genzyme; Chugai Pharmaceutical; Gilead Sciences; LEO Pharma; Sorbonne Université; University of Jordan; Eisai; Astellas Pharma; Daiichi-Sankyo; King Faisal Specialist Hospital and Research Centre; Sun Pharma; Regeneron Pharmaceuticals; Cairo University; Sanofi; Celgene; Pfizer; Biogen; GlaxoSmithKline; Amgen; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; University of Baghdad","keywords":"Medicine; Psoriatic arthritis; Debriefing; Physical therapy; Disease; Cognitive interview; Rheumatology; Family medicine; Internal medicine; Psychiatry; Cognition","score_opus":0.045292381907434766,"score_gpt":0.3488651705055507,"score_spread":0.30357278859811593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990749,0.0034710572,0.0000018823201,0.0036084626,0.00006884202,0.001272784,0.00079138536,0.000028835915,0.00000775225],"genre_scores_gemma":[0.9965775,0.002913202,0.0000059904814,0.00029706035,0.000009907631,0.00014345099,0.000022054393,0.000023348139,0.0000075066932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980491,0.000232444,0.0005865532,0.00033522872,0.00045776038,0.00033893896],"domain_scores_gemma":[0.9982437,0.0003684343,0.00035138056,0.00052049843,0.00014619088,0.00036983544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020877556,0.00028175805,0.0006961684,0.0002158921,0.00013699784,0.000035134985,0.00011109032,0.000035742793,0.000016924687],"category_scores_gemma":[0.0017149914,0.00017113899,0.00020782086,0.0004307033,0.00025560166,0.000266695,0.0001474844,0.00010065613,0.0000017432327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015091388,0.00087641587,0.9720379,0.0003451105,0.00046203256,0.00009305593,0.004209025,0.0001515946,0.000005107574,0.00003912769,0.000091697715,0.020179803],"study_design_scores_gemma":[0.0024376584,0.00062142365,0.9901752,0.0035534422,0.00022530482,0.0000025444742,0.00088845985,0.0004887867,0.000012047783,0.0014393764,0.0000043093696,0.00015143074],"about_ca_topic_score_codex":0.0011870867,"about_ca_topic_score_gemma":0.0003982058,"teacher_disagreement_score":0.020028371,"about_ca_system_score_codex":0.000052385465,"about_ca_system_score_gemma":0.00023511706,"threshold_uncertainty_score":0.69788456},"labels":[],"label_agreement":null},{"id":"W4379649425","doi":"10.1136/annrheumdis-2023-eular.3116","title":"POS1541 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 1 STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Barrie Urology Group","funders":"Johnson and Johnson; Medac; Janssen Scientific Affairs; Janssen Pharmaceuticals; Celgene; Biogen; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Term (time); Internal medicine; Oncology; Arthritis","score_opus":0.020477378468535787,"score_gpt":0.29509663919975887,"score_spread":0.27461926073122306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952523,0.00082309055,0.000001670082,0.00067301997,0.00008208634,0.0014064761,0.0016852998,0.000027341533,0.000048727547],"genre_scores_gemma":[0.99902105,0.00051947904,0.0000072875987,0.000107232176,0.000033934513,0.000026146296,0.00022976885,0.000021836306,0.000033236454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981077,0.00020408307,0.0006557053,0.00026492667,0.00052626495,0.00024137691],"domain_scores_gemma":[0.998309,0.0005287065,0.00030222838,0.0005672719,0.00016686243,0.00012589993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002542523,0.0001878343,0.00049534184,0.00007764438,0.000091434486,0.000019230092,0.00021746922,0.000034186538,0.00004371612],"category_scores_gemma":[0.0008144621,0.00010443727,0.00012972673,0.0004172185,0.00018412658,0.0000928905,0.000117930125,0.00010557472,0.0000076077627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10448169,0.012894458,0.80784386,0.0008743137,0.0014193937,0.000068913505,0.004713862,0.000067087916,0.000018904488,0.000107458654,0.003307505,0.064202555],"study_design_scores_gemma":[0.014311845,0.0035415548,0.9762361,0.004577958,0.00032578627,9.743816e-7,0.00065508037,0.00008579321,0.00002453163,0.00011840818,0.0000068915833,0.0001150511],"about_ca_topic_score_codex":0.00022453527,"about_ca_topic_score_gemma":0.000023754066,"teacher_disagreement_score":0.16839226,"about_ca_system_score_codex":0.000011546887,"about_ca_system_score_gemma":0.000107918015,"threshold_uncertainty_score":0.42588282},"labels":[],"label_agreement":null},{"id":"W4379649489","doi":"10.1136/annrheumdis-2023-eular.2513","title":"POS1539 SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGICS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Leeds Biomedical Research Centre; University of Leeds; Genentech; Griffith University; Janssen Scientific Affairs; McGill University; University of Ottawa; Celgene; Gilead Sciences; University of Washington; Eli Lilly and Company; GlaxoSmithKline; Ottawa Hospital Research Institute; Amgen","keywords":"Medicine; Psoriatic arthritis; Adverse effect; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Rheumatology; Ustekinumab; Clinical endpoint; Tolerability; Randomized controlled trial; Gastroenterology; Adalimumab; Arthritis; Rheumatoid arthritis; Immunology","score_opus":0.02439458694575209,"score_gpt":0.2758261132775698,"score_spread":0.2514315263318177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949457,0.0013450029,7.4007664e-7,0.00062426337,0.00007904393,0.00088944443,0.0020888592,0.000020221527,0.000006746305],"genre_scores_gemma":[0.9990057,0.0006903982,0.000010165203,0.000054208824,0.0000043985387,0.000024717367,0.00015415685,0.000009659547,0.000046617242],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981109,0.00090215175,0.00044928124,0.00024960304,0.00007370275,0.00021439065],"domain_scores_gemma":[0.99703777,0.002249669,0.00022285989,0.00037563636,0.000080762075,0.00003330831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005326354,0.00016473359,0.00039411816,0.0000916697,0.00011216364,0.000010746813,0.00020041992,0.000052854906,0.00002018004],"category_scores_gemma":[0.001955722,0.00008770229,0.000048771137,0.00042012928,0.00016998127,0.000045690107,0.00013212468,0.000058937298,0.000015744688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10430887,0.003753066,0.24868749,0.000049900522,0.0017361477,0.0000078228395,0.013475646,0.00005100339,0.00031456712,0.00005744631,0.0014068139,0.6261512],"study_design_scores_gemma":[0.01465438,0.0016492688,0.9811858,0.00039468752,0.00012699897,4.263581e-7,0.001150832,0.0000029533712,0.00048975303,0.00015900408,0.00007872936,0.000107189284],"about_ca_topic_score_codex":0.00024448452,"about_ca_topic_score_gemma":0.00006315291,"teacher_disagreement_score":0.7324983,"about_ca_system_score_codex":0.0000057717175,"about_ca_system_score_gemma":0.000047381902,"threshold_uncertainty_score":0.35763958},"labels":[],"label_agreement":null},{"id":"W4379649511","doi":"10.1136/annrheumdis-2023-eular.3612","title":"POS1516 CHARACTERISATION OF AN ANA-ARTHRITIS BASKET POPULATION FOR CLINICAL TRIALS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Population; Internal medicine; Rheumatoid arthritis; Physical therapy; Clinical trial; Rheumatology; Medical diagnosis; Pathology","score_opus":0.37854704023321667,"score_gpt":0.533781891547571,"score_spread":0.15523485131435438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515975,0.00051074894,0.000030191328,0.001985388,0.00028692014,0.0016060844,0.0003378725,0.000049930743,0.000033147637],"genre_scores_gemma":[0.9975702,0.0014866635,0.00007634662,0.00009875956,0.000117234784,0.00010017092,0.0003122611,0.000024686795,0.000213639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656636,0.0009245447,0.0015445752,0.00019613614,0.00055959873,0.00020878488],"domain_scores_gemma":[0.99598396,0.002117361,0.0007842967,0.00061886286,0.0003370665,0.00015844425],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00534196,0.0001117928,0.0009274949,0.00016700488,0.000056455574,0.000014573258,0.0001971467,0.00007815096,0.000084281826],"category_scores_gemma":[0.016489457,0.00007293162,0.0005512085,0.00032343954,0.00008981374,0.00014034736,0.000053922075,0.000054527547,0.000013876185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022228505,0.0010773969,0.5474325,0.0061137327,0.0007743933,0.0000037142959,0.0009333051,0.000018013003,0.00075839966,0.0006317209,0.028567933,0.41146603],"study_design_scores_gemma":[0.0028884313,0.00055321347,0.98185384,0.0041559385,0.00019103845,0.000037895832,0.00069746404,0.0039957184,0.0013214846,0.004055617,0.00013545604,0.0001138784],"about_ca_topic_score_codex":0.00007280496,"about_ca_topic_score_gemma":0.000006341152,"teacher_disagreement_score":0.43442136,"about_ca_system_score_codex":0.000011032585,"about_ca_system_score_gemma":0.00013231402,"threshold_uncertainty_score":0.99179506},"labels":[],"label_agreement":null},{"id":"W4379649534","doi":"10.1136/annrheumdis-2023-eular.1828","title":"POS1474 TEMPORAL TRENDS IN JOINT SURGERY FOR LUPUS PATIENTS – A POPULATION BASED LONGITUDINAL STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto","funders":"Norske Kvinners Sanitetsforening; Ministry of Education, India","keywords":"Medicine; Systemic lupus erythematosus; Population; Joint (building); Internal medicine; Disease; Environmental health","score_opus":0.14718390331152356,"score_gpt":0.38575019317494774,"score_spread":0.23856628986342418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969153,0.000107634725,0.000008298443,0.0011398358,0.00030431736,0.001345195,0.00009864227,0.000055910095,0.000024869601],"genre_scores_gemma":[0.9988683,0.000010082642,0.000017935108,0.00004894212,0.0000230098,0.00024435704,0.00026341112,0.00003163907,0.00049230753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759763,0.00021869497,0.00077172875,0.00025510273,0.000801099,0.0003557324],"domain_scores_gemma":[0.9981847,0.0006263372,0.0002819022,0.0005525017,0.00022230174,0.00013225192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089417904,0.00016523816,0.0006449449,0.00073402026,0.00007191558,0.00002028057,0.00014267511,0.00004060446,0.000063143256],"category_scores_gemma":[0.0019999687,0.00010955607,0.00040042834,0.0010332586,0.000039335908,0.00008685888,0.00007937236,0.0000625422,0.000012061454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036815193,0.0012343099,0.9775768,0.001206188,0.00010105182,0.0000061563405,0.0002600051,0.0000435028,0.0000010826537,0.000009000022,0.013942318,0.00525142],"study_design_scores_gemma":[0.0019004971,0.00021693697,0.9928031,0.0017537582,0.00006643946,0.000009494782,0.00043744833,0.0023938732,0.00001499686,0.000294666,0.000009062127,0.000099734825],"about_ca_topic_score_codex":0.0004967657,"about_ca_topic_score_gemma":0.0000909752,"teacher_disagreement_score":0.015226279,"about_ca_system_score_codex":0.00005407105,"about_ca_system_score_gemma":0.00013245382,"threshold_uncertainty_score":0.4467567},"labels":[],"label_agreement":null},{"id":"W4379649639","doi":"10.1136/annrheumdis-2023-eular.3294","title":"POS1401-HPR LIVED EDUCATIONAL EXPERIENCE OF YOUNG ADULTS WITH CHILDHOOD- AND ADULT-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTI-CENTER CANADIAN QUALITATIVE STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Winnipeg; University of Toronto; University of Manitoba; Institute for Clinical Evaluative Sciences; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Medicine; Qualitative research; Young adult; Pediatrics; Gerontology","score_opus":0.04377956741767262,"score_gpt":0.36097388260699825,"score_spread":0.3171943151893256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951218,0.0010507912,0.0000026581083,0.0009786056,0.00013518092,0.0023185513,0.00030028023,0.000034402463,0.00005772762],"genre_scores_gemma":[0.99860257,0.00029062317,0.000051890343,0.00006853864,0.000017270057,0.0003792481,0.00005429279,0.000039780378,0.00049581553],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.997156,0.00044528994,0.00070716755,0.0003701364,0.0008782388,0.00044313117],"domain_scores_gemma":[0.99711794,0.0005820011,0.00037916788,0.0007379158,0.000744155,0.00043881912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045572335,0.00025778182,0.00066853507,0.00036176128,0.00014674409,0.00002707909,0.00036646312,0.000048947582,0.00004745025],"category_scores_gemma":[0.0016550032,0.00016082576,0.00013934141,0.00063569803,0.00035556353,0.00012276485,0.00012385639,0.000110251276,0.000024645706],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003231138,0.0013391713,0.6559243,0.0022546917,0.00045196328,0.000011670274,0.33772996,0.0000026275711,0.000007473324,0.00004989447,0.001783588,0.00012149893],"study_design_scores_gemma":[0.0053414423,0.00044334505,0.28653994,0.015157768,0.00012946474,0.0027256804,0.6889289,0.0003638363,0.000056197892,0.0000929799,0.0000017357444,0.00021867653],"about_ca_topic_score_codex":0.015292418,"about_ca_topic_score_gemma":0.0055408953,"teacher_disagreement_score":0.3693844,"about_ca_system_score_codex":0.000057857524,"about_ca_system_score_gemma":0.00082853326,"threshold_uncertainty_score":0.9912648},"labels":[],"label_agreement":null},{"id":"W4379649641","doi":"10.1136/annrheumdis-2023-eular.2523","title":"POS1522 CHANGES IN SERUM CYTOKINES BY WEEK 24 CORRELATE WITH LONG-TERM EFFICACY OF GUSELKUMAB THROUGH 2-YEARS IN BIO-NAÏVE ADULTS WITH PSA","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Sun Pharma; Genentech; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Immunology; Biomarker; Arthritis; Cytokine; Gastroenterology; C-reactive protein; Placebo; Inflammation; Pathology","score_opus":0.027363049130723238,"score_gpt":0.26097349458910146,"score_spread":0.23361044545837822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933648,0.004789139,0.000001170154,0.00063410396,0.0001705788,0.00048838987,0.0004741315,0.00004256223,0.000035104153],"genre_scores_gemma":[0.99645823,0.0027660823,0.000008889594,0.000055808432,0.0000048527604,0.00005818141,0.0001996948,0.000025252699,0.0004229931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987357,0.00020416074,0.00034022616,0.0002662005,0.00009222136,0.00036143782],"domain_scores_gemma":[0.9988574,0.00036493927,0.00028656423,0.0004139277,0.000052743613,0.000024459263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011334022,0.00023666788,0.0005050889,0.00016112385,0.000049809794,0.000007788837,0.00033033258,0.000103131075,0.00008353456],"category_scores_gemma":[0.0000870405,0.00014556487,0.000101317135,0.00062237843,0.00025448608,0.000098287775,0.00008953793,0.000086040396,0.000043670563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070420364,0.0032115902,0.9122804,0.0009041191,0.0019911616,0.00007750548,0.00736642,0.00024527882,0.0010395761,0.00010524838,0.004089745,0.061646964],"study_design_scores_gemma":[0.004311871,0.0006141726,0.9826728,0.002472084,0.0001839567,0.000009946279,0.0005276411,0.0000044856706,0.008889152,0.00009291061,0.000026890604,0.00019406981],"about_ca_topic_score_codex":0.0002998065,"about_ca_topic_score_gemma":0.0006392311,"teacher_disagreement_score":0.07039247,"about_ca_system_score_codex":0.000011614906,"about_ca_system_score_gemma":0.000060550254,"threshold_uncertainty_score":0.59359634},"labels":[],"label_agreement":null},{"id":"W4379649668","doi":"10.1136/annrheumdis-2023-eular.106","title":"POS1396-HPR DOES FIBROMYALGIA WORSEN CATASTROPHIZING IN PATIENTS WITH RHEUMATOID ARTHRITIS?","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society","keywords":"Medicine; Fibromyalgia; Rheumatoid arthritis; Physical therapy; Arthritis; Internal medicine","score_opus":0.019126830319233082,"score_gpt":0.27889936973576096,"score_spread":0.2597725394165279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963261,0.0008309203,0.000001714041,0.0018544185,0.00008255108,0.0006513847,0.000112024274,0.000073695446,0.00006721428],"genre_scores_gemma":[0.99842733,0.0010051173,0.000061244486,0.000013725173,0.0000047177514,0.000044760833,0.00013153754,0.00003997227,0.00027162267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765325,0.000114856986,0.00048675798,0.0002913019,0.00087505346,0.0005788119],"domain_scores_gemma":[0.9985551,0.0001853485,0.00016899624,0.0007090826,0.0001622234,0.00021923117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002158842,0.00022098685,0.00051172625,0.00025849964,0.000103152815,0.00003207228,0.00031716918,0.000056871762,0.00023420861],"category_scores_gemma":[0.0004097556,0.00012316482,0.00017975338,0.0008856517,0.00025000898,0.00015646398,0.00018738826,0.00018182746,0.00010053386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007639569,0.0009156412,0.965241,0.007369092,0.00041433517,0.000051163268,0.00069308194,0.00016197453,0.000043907552,0.0002504495,0.01199067,0.012104736],"study_design_scores_gemma":[0.002260731,0.00033283082,0.9822048,0.013751585,0.000019162593,0.0000061768924,0.00029285552,0.00015149573,0.00023509619,0.00055682915,0.000026134498,0.00016230563],"about_ca_topic_score_codex":0.00019459816,"about_ca_topic_score_gemma":0.000006216943,"teacher_disagreement_score":0.016963804,"about_ca_system_score_codex":0.00003616643,"about_ca_system_score_gemma":0.0002794477,"threshold_uncertainty_score":0.50225157},"labels":[],"label_agreement":null},{"id":"W4379649670","doi":"10.1136/annrheumdis-2023-eular.803","title":"POS1488 LUPUS DAMAGE INDEX REVISION – INITIAL ITEM REDUCTION PHASE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research; Toronto Western Hospital; University of Toronto; Mount Sinai Hospital; University of Calgary","funders":"","keywords":"Medicine; Delphi method; Likert scale; Delphi; Systemic lupus erythematosus; Rheumatology; Family medicine; Physical therapy; Internal medicine; Statistics; Artificial intelligence; Disease; Computer science; Mathematics","score_opus":0.2198915561769096,"score_gpt":0.5220572623897056,"score_spread":0.30216570621279604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802864,0.00024661224,0.00003628923,0.013234967,0.0006584749,0.000692275,0.00007221511,0.00030133317,0.0044713896],"genre_scores_gemma":[0.99708825,0.0010692569,0.000022307508,0.000079804406,0.00010137127,0.00003083621,0.000012948538,0.000016017415,0.0015792268],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9974993,0.00057415763,0.00034620668,0.00018696226,0.001034805,0.00035860433],"domain_scores_gemma":[0.9984204,0.0004961555,0.0001973332,0.00048198053,0.00024394096,0.00016014514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014445523,0.00010408198,0.00019774117,0.00019707526,0.0004435717,0.00009311769,0.00074430206,0.00006966821,0.00028848942],"category_scores_gemma":[0.0036808245,0.0000795795,0.00018657687,0.0011471275,0.0005106865,0.00031439614,0.00023405772,0.00011775823,0.00009236294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023668676,0.0010563899,0.0030959267,0.00046908026,0.000112631504,0.000019785897,0.007050754,0.00007722837,0.00023106392,0.010490693,0.5294026,0.44775712],"study_design_scores_gemma":[0.0066371877,0.001984029,0.1283589,0.015230892,0.00048193056,0.000039533195,0.09410774,0.0135378605,0.017328596,0.55858046,0.16070098,0.0030119119],"about_ca_topic_score_codex":0.00058373105,"about_ca_topic_score_gemma":0.000018759043,"teacher_disagreement_score":0.54808974,"about_ca_system_score_codex":0.00002843122,"about_ca_system_score_gemma":0.00022535514,"threshold_uncertainty_score":0.44065565},"labels":[],"label_agreement":null},{"id":"W4379649753","doi":"10.1136/annrheumdis-2023-eular.3642","title":"POS1369 CHANGES IN PAIN AND REACHING THE PATIENT ACCEPTABLE SYMPTOM STATE IN HAND OSTEOARTHRITIS OVER 4 YEARS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Minimal clinically important difference; Osteoarthritis; Physical therapy; Cohort; Logistic regression; Internal medicine; Randomized controlled trial","score_opus":0.039500886533123204,"score_gpt":0.2923074544609734,"score_spread":0.25280656792785017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917668,0.0012769056,5.601456e-7,0.0065635326,0.000043996373,0.000250509,0.000020855128,0.0000101228225,0.00006669145],"genre_scores_gemma":[0.9976355,0.0009563218,0.000003733168,0.0012775382,0.000008123168,0.000020604826,0.000004311557,0.000002669605,0.00009119179],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990383,0.00020078478,0.0001863554,0.00012007886,0.00025361977,0.00020086179],"domain_scores_gemma":[0.99925303,0.0004615544,0.000063819265,0.00012816188,0.000011791131,0.00008162914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075583195,0.00006459525,0.00017942557,0.00004751003,0.00004682827,0.000021274784,0.0001198037,0.000021948927,0.000090214344],"category_scores_gemma":[0.0012219561,0.000028121121,0.000038901107,0.00033175445,0.00022709704,0.000037188718,0.000119785946,0.00006997256,0.0000033685487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005409466,0.00011148472,0.23678121,0.00011297431,0.000011666978,0.000013087193,0.00155904,0.000010540974,0.00012653814,0.0000414237,0.0015588205,0.7596191],"study_design_scores_gemma":[0.00031529812,0.00027638752,0.9921787,0.0009634988,0.0000062063164,0.0000011165985,0.0006077093,0.00038448916,0.000084658546,0.0048202057,0.00031481087,0.00004691259],"about_ca_topic_score_codex":0.0005691837,"about_ca_topic_score_gemma":0.00038697224,"teacher_disagreement_score":0.7595722,"about_ca_system_score_codex":0.000004741885,"about_ca_system_score_gemma":0.000022882894,"threshold_uncertainty_score":0.1462884},"labels":[],"label_agreement":null},{"id":"W4379649807","doi":"10.1136/annrheumdis-2023-eular.5983","title":"POS1354 REGRESSION TO THE MEAN FOR PAIN OUTCOMES IN CLINICAL TRIALS FOR KNEE OSTEOARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Lunds Universitet; Dutch Arthritis Society; Universidad de Navarra; University College London; GlaxoSmithKline","keywords":"Osteoarthritis; Medicine; Physical therapy; Confidence interval; Clinical trial; Knee pain; Rating scale; Internal medicine; Alternative medicine","score_opus":0.7317752524643589,"score_gpt":0.5744795185167573,"score_spread":0.15729573394760166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6219327,0.0030099307,0.0018375223,0.35849166,0.0019959335,0.007929802,0.0046218415,0.00006847535,0.000112136026],"genre_scores_gemma":[0.96696496,0.00033195934,0.00070170267,0.027375257,0.00032237382,0.002624461,0.00009288868,0.00006233623,0.0015240337],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.990955,0.00204267,0.006123333,0.00037086633,0.00011894554,0.00038917587],"domain_scores_gemma":[0.96593714,0.030293774,0.0027014094,0.0007998232,0.00010175448,0.00016608303],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.091744184,0.00016686565,0.0016208959,0.00022464895,0.00019614724,0.000058383383,0.00053739845,0.000088478846,0.00005419352],"category_scores_gemma":[0.1704862,0.00011526655,0.00079965376,0.00026841983,0.00006793035,0.00014690052,0.00010090201,0.00007024332,0.00019326337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033297678,0.0004210914,0.14347737,0.0017566186,0.00037644737,2.936006e-7,0.0030102094,0.0007912722,3.9701516e-7,0.044861637,0.66934097,0.13563071],"study_design_scores_gemma":[0.00598361,0.0014283316,0.56245005,0.003154622,0.00007702103,7.582694e-7,0.005372586,0.019031268,0.000011861789,0.31831783,0.083424985,0.000747079],"about_ca_topic_score_codex":0.00014504544,"about_ca_topic_score_gemma":0.00021105136,"teacher_disagreement_score":0.585916,"about_ca_system_score_codex":0.00003917231,"about_ca_system_score_gemma":0.00012450117,"threshold_uncertainty_score":0.9352405},"labels":[],"label_agreement":null},{"id":"W4379649849","doi":"10.1136/annrheumdis-2023-eular.2262","title":"POS1246 EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN SUBGROUPS BY DISEASE ACTIVITY INDEX","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nintedanib; DLCO; Internal medicine; Interstitial lung disease; Scleroderma (fungus); Placebo; Diffusing capacity; Adverse effect; Vital capacity; Idiopathic pulmonary fibrosis; Gastroenterology; Physical therapy; Lung; Pathology","score_opus":0.014059236038560317,"score_gpt":0.2475475799862791,"score_spread":0.23348834394771878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921485,0.0047383877,0.00000637975,0.00033901312,0.00024859136,0.0018826529,0.00053544744,0.00008459742,0.000016406319],"genre_scores_gemma":[0.99848366,0.0009412577,6.3076834e-7,0.000117477124,0.000013391878,0.00015124715,0.00017269839,0.00005653745,0.000063125175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967618,0.0004807951,0.00083160686,0.00043539598,0.0009746329,0.0005157769],"domain_scores_gemma":[0.9973436,0.00054269907,0.00062140723,0.0007217138,0.0002194162,0.00055118895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002878502,0.00037052835,0.00092781446,0.0004115411,0.00006710252,0.000023981684,0.00037014965,0.000107666405,0.00002321295],"category_scores_gemma":[0.0018629133,0.00024701032,0.00038366378,0.0013059226,0.00024639614,0.0002063513,0.0001768742,0.00020315567,0.0000077687455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044139363,0.0034093368,0.9818274,0.00426592,0.00043065363,0.000022066186,0.00027276017,0.00030923568,0.00019052265,0.00001719572,0.0031496682,0.0016913054],"study_design_scores_gemma":[0.0055954875,0.00019800605,0.92990416,0.060320884,0.00047775486,3.4113015e-7,0.00017466623,0.0028641855,0.00018099294,0.000049681115,4.8664214e-7,0.0002333472],"about_ca_topic_score_codex":0.00037198263,"about_ca_topic_score_gemma":0.000016605221,"teacher_disagreement_score":0.056054965,"about_ca_system_score_codex":0.00013619545,"about_ca_system_score_gemma":0.00030858893,"threshold_uncertainty_score":0.9999982},"labels":[],"label_agreement":null},{"id":"W4379649869","doi":"10.1136/annrheumdis-2023-eular.2723","title":"POS1248 OVERALL SURVIVAL, PROGRESSION-FREE SURVIVAL AND RELAPSE RATES ARE SIMILAR IN FEMALES VERSUS MALES UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR AUTOIMMUNE DISEASE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Sheffield Teaching Hospitals NHS Foundation Trust; McGill University Health Centre; Health Canada; University of Ottawa","keywords":"Medicine; Hematopoietic stem cell transplantation; Disease; Haematopoiesis; Transplantation; Stem cell; Immunology; Autoimmune disease; Oncology; Internal medicine; Biology","score_opus":0.07144622825287815,"score_gpt":0.3351531402508487,"score_spread":0.26370691199797053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98935133,0.0032935145,0.00010519324,0.004665513,0.0003963757,0.0015015304,0.00040900937,0.00015679802,0.00012072329],"genre_scores_gemma":[0.994769,0.004346746,0.00016582501,0.0000560287,0.000018725537,0.00017800163,0.00020362486,0.00006037982,0.00020169844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974355,0.00028226565,0.00077996316,0.0004139485,0.00063327025,0.00045505006],"domain_scores_gemma":[0.99585533,0.0027426134,0.0003917318,0.0006422629,0.0001313037,0.00023677052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000545339,0.0003348012,0.00071376906,0.00021615856,0.00017568265,0.00004679112,0.00029688972,0.00010491602,0.000018077833],"category_scores_gemma":[0.00047360512,0.00025422956,0.0002695708,0.00037946127,0.00019890144,0.00017599388,0.000070265734,0.00011723519,0.000008868662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022210471,0.0030763731,0.7997833,0.13666755,0.0012305572,0.0007301017,0.010363411,0.0036414834,0.0015537376,0.009936739,0.0025109863,0.008295311],"study_design_scores_gemma":[0.007079007,0.00026720206,0.9702748,0.009217046,0.000675092,0.000014241346,0.0030728404,0.002920728,0.0023063114,0.0037994613,0.000013106272,0.0003601639],"about_ca_topic_score_codex":0.000024006313,"about_ca_topic_score_gemma":0.00005118,"teacher_disagreement_score":0.17049153,"about_ca_system_score_codex":0.000028581086,"about_ca_system_score_gemma":0.000258421,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W4379649887","doi":"10.1136/annrheumdis-2023-eular.2153","title":"POS1242 COMPUTED TOMOGRAPHY FINDINGS IN CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; University of Alberta; University of Saskatchewan; McGill University; University of Calgary; McMaster University; University of British Columbia","funders":"Bundesministerium für Bildung und Forschung","keywords":"Medicine; Interstitial lung disease; Usual interstitial pneumonia; Hypersensitivity pneumonitis; Connective tissue disease; Pathology; Mixed connective tissue disease; Dermatomyositis; Undifferentiated connective tissue disease; Honeycombing; Crackles; Idiopathic pulmonary fibrosis; Rheumatology; CTD; Rheumatoid arthritis; Internal medicine; Lung; Disease; Autoimmune disease","score_opus":0.020179396212795374,"score_gpt":0.30198104689122496,"score_spread":0.2818016506784296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552567,0.0030026988,0.000027723527,0.008042554,0.00062330376,0.00121168,0.00096201623,0.000224567,0.00037979407],"genre_scores_gemma":[0.9981718,0.0002795295,0.000008834505,0.00070589746,0.000058952293,0.000080381265,0.00029245735,0.000047028447,0.0003551088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975709,0.00019692676,0.0006951552,0.0004464925,0.0005784312,0.0005121431],"domain_scores_gemma":[0.9979299,0.00026708597,0.00019756626,0.0006633069,0.00021348691,0.0007287073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021560461,0.00032410832,0.0005807829,0.00048853055,0.00014752006,0.00003874508,0.00037852745,0.00006945339,0.00022674722],"category_scores_gemma":[0.0009458735,0.00024875838,0.00065988273,0.0013319007,0.0003551386,0.00021260539,0.0002700692,0.00019073144,0.00006318799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068418585,0.01030862,0.6306492,0.02222788,0.004063338,0.0050481185,0.005765202,0.0042758374,0.000772154,0.033254147,0.19132736,0.023889568],"study_design_scores_gemma":[0.0015687585,0.00046280553,0.960271,0.008222291,0.00068868935,0.000009299386,0.00040586627,0.020332117,0.0001178709,0.0073227366,0.00021107683,0.0003874873],"about_ca_topic_score_codex":0.00013666376,"about_ca_topic_score_gemma":0.0000032368434,"teacher_disagreement_score":0.32962182,"about_ca_system_score_codex":0.00005245955,"about_ca_system_score_gemma":0.00028369718,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W4379649973","doi":"10.1136/annrheumdis-2023-eular.3052","title":"POS1153 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO SYSTEMIC LUPUS ERYTHEMATOSUS TREATMENTS FROM THE PUBLISHED LITERATURE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Genentech; Idorsia Pharmaceuticals; Servier; Novo Nordisk; National Institute for Health and Care Research; Alexion Pharmaceuticals; Celgene; Biogen; Gilead Sciences; Sanofi; Amgen; Canadian Rheumatology Association; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Systemic lupus; Systemic disease; Disease; Intensive care medicine; Lupus erythematosus; Systemic lupus erythematosus; Immunology; Dermatology; Internal medicine; Antibody","score_opus":0.09746345810023767,"score_gpt":0.34576990490893916,"score_spread":0.2483064468087015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379649973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754703,0.005981855,0.000023272663,0.01319072,0.0006543826,0.0038821085,0.0004649093,0.00008305339,0.00024937117],"genre_scores_gemma":[0.99700934,0.0005317198,0.000025437968,0.00043732178,0.000107981214,0.0012457443,0.00013715001,0.000049111874,0.00045619626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963777,0.0007236812,0.00081253395,0.00037423574,0.0012981062,0.00041375787],"domain_scores_gemma":[0.99503547,0.0015158558,0.000544573,0.0022953434,0.00039298856,0.00021579904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008441239,0.00028568288,0.00052302156,0.00013539991,0.00040080678,0.00021268625,0.0011612078,0.000075208205,0.00004492628],"category_scores_gemma":[0.0031805856,0.00011532135,0.0005097212,0.0015771328,0.00020807343,0.00016038747,0.00040519272,0.00018900364,0.000046183166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024958858,0.0013283846,0.816882,0.009709522,0.0029921478,0.000032599037,0.032281753,0.00039430958,0.0034325405,0.0065872087,0.10820521,0.015658408],"study_design_scores_gemma":[0.005982207,0.00023154098,0.74471104,0.1380531,0.0031412996,0.0012434814,0.02708714,0.0076277214,0.0020111927,0.06837427,0.0006195675,0.00091746316],"about_ca_topic_score_codex":0.000120005214,"about_ca_topic_score_gemma":0.0000058142077,"teacher_disagreement_score":0.12834358,"about_ca_system_score_codex":0.00006806396,"about_ca_system_score_gemma":0.00022968464,"threshold_uncertainty_score":0.47026682},"labels":[],"label_agreement":null},{"id":"W4379650075","doi":"10.1136/annrheumdis-2023-eular.4884","title":"POS1069 SYSTEMATIC LITERATURE REVIEW INFORMING THE EULAR POINTS TO CONSIDER TASK FORCE ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Debreceni Egyetem; Hôpitaux Universitaires de Genève; Diakonhjemmet; Hacettepe Üniversitesi; Universita degli Studi di Bari Aldo Moro; Universität Wien; Celltrion; Aarhus Universitet; Medizinische Universität Wien; Aarhus Universitetshospital; Institut Gustave-Roussy; Gilead Sciences; Karolinska Institutet; Rigshospitalet; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Oncology; Task force; Cancer; Inflammatory arthritis; MEDLINE; Hazard ratio; Physical therapy; Rheumatoid arthritis; Confidence interval","score_opus":0.0248120749477799,"score_gpt":0.2841204645295113,"score_spread":0.2593083895817314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80706924,0.18780228,0.0000014522793,0.0037390448,0.0000876828,0.0011365255,0.00012350206,0.000008449676,0.000031801792],"genre_scores_gemma":[0.9864216,0.011023259,0.0000099195095,0.002376513,0.0000018650138,0.00007420084,0.000008229739,0.0000073414644,0.0000770858],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99871385,0.00050222717,0.00047308777,0.00009131392,0.00009526723,0.00012425092],"domain_scores_gemma":[0.9982775,0.000856551,0.0003811569,0.00029192428,0.00017825994,0.000014596031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006133329,0.000115847324,0.00040244457,0.00007375209,0.000042028783,0.0000048860984,0.00017554505,0.000047598623,0.000035695186],"category_scores_gemma":[0.0012221981,0.000046816916,0.00008806073,0.0002499212,0.0002699559,0.000057651916,0.000061644976,0.00008902517,0.0000014714935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00377297,0.0018594322,0.27779427,0.47839522,0.0096451,0.000009628902,0.05352601,0.00015892801,0.007643645,0.025517762,0.103683986,0.037993044],"study_design_scores_gemma":[0.0013955352,0.0005220978,0.6336957,0.3538537,0.00056612206,0.0000027205124,0.0011983784,0.000036078814,0.0048418166,0.0029959953,0.0005695118,0.00032232417],"about_ca_topic_score_codex":0.000014161157,"about_ca_topic_score_gemma":0.000011491693,"teacher_disagreement_score":0.35590145,"about_ca_system_score_codex":0.00001203819,"about_ca_system_score_gemma":0.00006156924,"threshold_uncertainty_score":0.19091384},"labels":[],"label_agreement":null},{"id":"W4379650100","doi":"10.1136/annrheumdis-2023-eular.2823","title":"AB0198 THRESHOLDS OF PRESENTEEISM MEASUREMENT INSTRUMENTS FOR UNACCEPTABLE WORK PARTICIPATION AND FUTURE ADVERSE WORK OUTCOMES IN RA","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Employment and Welfare Studies","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Care and Public Health Research Institute, Universiteit Maastricht; Universiteit Maastricht","keywords":"Presenteeism; Medicine; Work (physics); Adverse effect; Physical therapy; Absenteeism; Engineering; Mechanical engineering; Internal medicine","score_opus":0.16031862813873335,"score_gpt":0.4307382742750634,"score_spread":0.27041964613633007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98682976,0.0007334501,0.0000034343834,0.0103592,0.0004425668,0.0013147303,0.00005922905,0.000031318945,0.00022629174],"genre_scores_gemma":[0.9979244,0.0007503215,0.000015423158,0.00018772513,0.00003385215,0.00046494117,0.000010829318,0.000014355272,0.0005981803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832326,0.0001910056,0.0006003146,0.00014769136,0.00040088274,0.00033685597],"domain_scores_gemma":[0.9988156,0.00033570876,0.0003327364,0.0002823643,0.00017090229,0.000062667044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059899356,0.00013435073,0.00038454833,0.00009426573,0.00024551502,0.000003834751,0.0001686728,0.000053308384,0.00005287579],"category_scores_gemma":[0.0005200622,0.00008644355,0.00012636531,0.0004041104,0.00007165218,0.000113243215,0.00019598391,0.00007337855,0.000006557932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015637773,0.00015580074,0.97050345,0.0006999674,0.00017487754,9.9745165e-8,0.0022115752,0.000052597345,0.000001112144,0.0005293558,0.017365882,0.008148877],"study_design_scores_gemma":[0.00088205765,0.000034772456,0.9906084,0.0012629079,0.000066468005,5.8376664e-9,0.0025402955,0.00002956349,0.000021593578,0.003625467,0.0008491243,0.00007937409],"about_ca_topic_score_codex":0.00009971341,"about_ca_topic_score_gemma":0.000071259856,"teacher_disagreement_score":0.020104893,"about_ca_system_score_codex":0.000019663386,"about_ca_system_score_gemma":0.000058171663,"threshold_uncertainty_score":0.35250658},"labels":[],"label_agreement":null},{"id":"W4379650101","doi":"10.1136/annrheumdis-2023-eular.82","title":"POS1118 DISCRIMINATING CAPACITY OF THE ASAS HEALTH INDEX IN PATIENTS TREATED WITH IXEKIZUMAB IN THE COAST PROGRAMME","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Biogen; Chugai Pharmaceutical; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Ixekizumab; Index (typography); Internal medicine; Physical therapy; Arthritis; World Wide Web; Psoriatic arthritis; Computer science","score_opus":0.0362780431285062,"score_gpt":0.2672512376539451,"score_spread":0.2309731945254389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961557,0.0014485733,0.000001033875,0.0014179695,0.00008547016,0.00070238055,0.00008029734,0.000017905095,0.000090670655],"genre_scores_gemma":[0.99961776,0.000054889253,6.901764e-7,0.00015312489,3.9989538e-7,0.000049953167,0.000045382254,0.000010126337,0.00006770455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981247,0.00068637973,0.0005030155,0.00015301142,0.00012843203,0.00040444496],"domain_scores_gemma":[0.9988117,0.00022511532,0.00040952582,0.00048082953,0.00006646063,0.000006318245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005162497,0.0001561554,0.0003294607,0.00009706293,0.00020747875,0.000010687674,0.0006593435,0.000052262618,0.000012055954],"category_scores_gemma":[0.00038241927,0.000071137074,0.0001357103,0.0008336069,0.000474749,0.00007278685,0.00012892782,0.00019333085,0.0000052095143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004989784,0.0038888326,0.8180362,0.0007127871,0.00024138033,8.260702e-7,0.02878173,0.00044810603,0.00009605658,0.0009121748,0.00091321144,0.14546971],"study_design_scores_gemma":[0.0012010095,0.00016938009,0.9901601,0.00093533535,0.000018281195,0.0000011284907,0.0066574095,0.000038447815,0.00029464797,0.0003990949,0.000039553033,0.000085585714],"about_ca_topic_score_codex":0.003400905,"about_ca_topic_score_gemma":0.00022714847,"teacher_disagreement_score":0.17212392,"about_ca_system_score_codex":0.000015249704,"about_ca_system_score_gemma":0.00011248744,"threshold_uncertainty_score":0.51411736},"labels":[],"label_agreement":null},{"id":"W4379650122","doi":"10.1136/annrheumdis-2023-eular.2062","title":"AB0396 DISCONTINUATION AND EFFECTIVENESS OF ORIGINATOR AND BIOSIMILAR TNFI IN PATIENTS WITH RHEUMATOID ARTHRITIS: REAL WORLD DATA FROM A RHEUMATOID ARTHRITIS REGISTRY IN CANADA","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University of Toronto; Ministry of Health and Long Term Care","funders":"Canadian Institutes of Health Research","keywords":"Biosimilar; Medicine; Discontinuation; Rheumatoid arthritis; Internal medicine; Real world data; Arthritis; Physical therapy; Data science","score_opus":0.025077973140227573,"score_gpt":0.2789506569275707,"score_spread":0.2538726837873431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909609,0.006525125,0.0000028062566,0.00036161143,0.00010590328,0.00037160053,0.001641547,0.000011405222,0.000019134306],"genre_scores_gemma":[0.98644876,0.0132093225,0.000042279302,0.000038715312,0.0000015781463,0.000018307352,0.0002198903,0.000012995809,0.000008121363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815464,0.0005699942,0.00051998,0.00036404884,0.000118164586,0.00027317583],"domain_scores_gemma":[0.9981242,0.0008882362,0.00030707955,0.0005712912,0.00006249111,0.000046690006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005380943,0.00018982109,0.0006528891,0.00013528127,0.00005409676,0.000015699212,0.0003229793,0.00006055927,0.000025417055],"category_scores_gemma":[0.0005213452,0.00013196866,0.00003641214,0.00048226636,0.00043670303,0.00014742572,0.0002692043,0.00013426655,9.541815e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005568184,0.0002049669,0.96897995,0.00017277265,0.00015012488,0.000003548258,0.00006167033,0.000003738971,0.00008057536,0.00020437445,0.0008623981,0.028719028],"study_design_scores_gemma":[0.0020521225,0.00007861784,0.99038404,0.004807112,0.000012466094,9.0944985e-7,0.00020589955,0.00006407673,0.0012536343,0.0008985576,0.0000837226,0.00015883107],"about_ca_topic_score_codex":0.22733532,"about_ca_topic_score_gemma":0.42002225,"teacher_disagreement_score":0.19268695,"about_ca_system_score_codex":0.000024870405,"about_ca_system_score_gemma":0.00024669114,"threshold_uncertainty_score":0.7778099},"labels":[],"label_agreement":null},{"id":"W4379650129","doi":"10.1136/annrheumdis-2023-eular.4126","title":"POS1068 HUMORAL IMMUNE RESPONSE TO 13 VALENT-CONJUGATE AND 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINES IN RA PATIENTS TREATED WITH ABATACEPT: RESULTS OF THE OPEN RANDOMIZED CONTROLLED TRIAL VACINA (VACCINATION AGAINST PNEUMOCOCCAL IN NAÏVE ABATACEPT RHEUMATOID ARTHRITIS PATIENTS)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"Debreceni Egyetem; Hôpitaux Universitaires de Genève; Diakonhjemmet; Hacettepe Üniversitesi; Universita degli Studi di Bari Aldo Moro; Universität Wien; Celltrion; Aarhus Universitet; Medizinische Universität Wien; Aarhus Universitetshospital; Institut Gustave-Roussy; Gilead Sciences; Karolinska Institutet; Rigshospitalet; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Abatacept; Medicine; Pneumococcal conjugate vaccine; Pneumococcal polysaccharide vaccine; Vaccination; Immunology; Pneumococcal vaccine; Internal medicine; Streptococcus pneumoniae; Rituximab; Antibody; Microbiology; Pneumococcal disease","score_opus":0.011371530763473576,"score_gpt":0.2556850396082317,"score_spread":0.2443135088447581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520863,0.003519677,4.7349835e-7,0.00096982816,0.00046227605,0.009218628,0.000489415,0.00003532622,0.000095725874],"genre_scores_gemma":[0.99660546,0.0019468127,0.000001396197,0.00007646355,0.0000017863704,0.0007113295,0.000257562,0.000037449696,0.00036174394],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9930119,0.0031680833,0.0023784195,0.0005480588,0.00026175875,0.00063176866],"domain_scores_gemma":[0.9956875,0.0018134905,0.0013249572,0.0008396469,0.00029860952,0.000035804427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024849754,0.0004906601,0.0021794038,0.0004981936,0.0002813613,0.000065897235,0.0011216718,0.00016827483,0.000043991982],"category_scores_gemma":[0.005147073,0.0002909823,0.0005230798,0.0010110697,0.00030316738,0.00035707172,0.00069796946,0.00028679598,0.000028142265],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96697223,0.0023556964,0.0129667,0.00009214075,0.00047405213,0.0000023076907,0.0031268676,0.00044425856,0.005022299,0.000050697192,0.0001615371,0.00833124],"study_design_scores_gemma":[0.49225393,0.00052420417,0.5027892,0.0012327958,0.00006057753,0.0000010729792,0.0006039114,0.00006739508,0.0020973692,0.00010517728,0.000016849579,0.00024752755],"about_ca_topic_score_codex":0.00092087773,"about_ca_topic_score_gemma":0.00008519847,"teacher_disagreement_score":0.4898225,"about_ca_system_score_codex":0.000043683656,"about_ca_system_score_gemma":0.00019593022,"threshold_uncertainty_score":0.9999542},"labels":[],"label_agreement":null},{"id":"W4379650223","doi":"10.1136/annrheumdis-2023-eular.3010","title":"AB0411 ASSOCIATION BETWEEN ETHNICITY AND INITIAL RESPONSE TO TNF INHIBITORS IN PEOPLE WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER FOR RHEUMATOID ARTHRITIS (BSRBR-RA)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine and Dentistry, University of Alberta; Manchester Biomedical Research Centre; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Rheumatology; Ethnic group; Confidence interval; Demography","score_opus":0.04154518313750817,"score_gpt":0.31778499654930675,"score_spread":0.2762398134117986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583822,0.009892692,0.00013489343,0.023766631,0.00024202108,0.0030697589,0.0043512583,0.00014155648,0.00001897515],"genre_scores_gemma":[0.896943,0.10058534,0.00037397334,0.00061910704,0.000058812326,0.00077896955,0.0004717333,0.00007012586,0.00009897196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955402,0.00061968114,0.0013913165,0.0007075818,0.0007619584,0.0009792747],"domain_scores_gemma":[0.988493,0.009209566,0.000681167,0.00073811336,0.0005403378,0.00033780062],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030090075,0.00039458135,0.0013037723,0.00014264605,0.0007804786,0.0002886262,0.00046747408,0.0002687145,0.000015458481],"category_scores_gemma":[0.013504841,0.0002884178,0.0005870528,0.0008167137,0.0004793224,0.0002577505,0.00028857644,0.00032511738,0.000011959824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018588103,0.0007130624,0.4344598,0.0006414311,0.002384697,0.000021650698,0.011330497,0.000089379515,0.00018207333,0.00028317326,0.28183374,0.24947241],"study_design_scores_gemma":[0.01940185,0.0017381668,0.9342037,0.018078173,0.000037926333,0.000079682475,0.0052243765,0.00053358416,0.00084289693,0.007449147,0.011637555,0.0007729446],"about_ca_topic_score_codex":0.0030055966,"about_ca_topic_score_gemma":0.0047433954,"teacher_disagreement_score":0.4997439,"about_ca_system_score_codex":0.00008374377,"about_ca_system_score_gemma":0.0004453394,"threshold_uncertainty_score":0.9999568},"labels":[],"label_agreement":null},{"id":"W4379650226","doi":"10.1136/annrheumdis-2023-eular.2772","title":"AB0409 TIME TO FIRST REMISSION AND PREVALENCE OF SUSTAINED REMISSION AFTER ETANERCEPT BIOSIMILAR (ETA-B) OR ORIGINATOR (ETA-O) INITIATION IN RHEUMATOID ARTHRITIS (RA)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Alberta; Université de Sherbrooke; McGill University Health Centre","funders":"","keywords":"Medicine; Etanercept; Rheumatoid arthritis; Internal medicine; Hydroxychloroquine; Body mass index; Methotrexate; Cohort; Disease","score_opus":0.028991236289722642,"score_gpt":0.3059786104500527,"score_spread":0.27698737416033004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832621,0.0073319124,0.000015307376,0.008060484,0.00014113313,0.00064616575,0.00031971393,0.000057374113,0.00016577575],"genre_scores_gemma":[0.98830295,0.008562499,0.0001569802,0.0003525399,0.0000059607455,0.000037753027,0.0000169986,0.000018731807,0.002545562],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99811584,0.00040470218,0.0006773067,0.0003256866,0.0001344559,0.00034198872],"domain_scores_gemma":[0.99841285,0.00064917014,0.00025750673,0.00044667927,0.00014369114,0.000090133326],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006812055,0.00021858266,0.00054141483,0.00019868079,0.000102956496,0.000014603393,0.00030121053,0.00018618256,0.0021710952],"category_scores_gemma":[0.002271285,0.00013415886,0.00015889188,0.0006325496,0.00026203366,0.000118362565,0.0002483542,0.00012781113,0.00006153768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014913295,0.0036043918,0.13178088,0.016980505,0.0016846718,0.00011939706,0.006050722,0.00015501639,0.09231787,0.0011081623,0.30577677,0.42550832],"study_design_scores_gemma":[0.004209117,0.0014142726,0.7888406,0.02303664,0.00034900545,0.000056245335,0.0009863485,0.00094995124,0.14863521,0.006204888,0.024039418,0.0012783344],"about_ca_topic_score_codex":0.000017723834,"about_ca_topic_score_gemma":0.000006656434,"teacher_disagreement_score":0.65705967,"about_ca_system_score_codex":0.000015828093,"about_ca_system_score_gemma":0.00008808703,"threshold_uncertainty_score":0.99874103},"labels":[],"label_agreement":null},{"id":"W4379650502","doi":"10.1136/annrheumdis-2023-eular.1709","title":"AB1086 COVID-19–RELATED ADVERSE EVENTS IN THE PHASE 3 POETYK TRIALS OF THE ALLOSTERIC TYROSINE KINASE 2 INHIBITOR, DEUCRAVACITINIB, IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Janssen Research and Development; Universidade Federal de Uberlândia; McGill University; Bristol-Myers Squibb; University of Washington; Monash University","keywords":"Medicine; Adverse effect; Psoriasis; Allosteric regulation; Plaque psoriasis; Coronavirus disease 2019 (COVID-19); Tyrosine kinase; Dermatology; Virology; Internal medicine; Receptor","score_opus":0.05191540164228455,"score_gpt":0.31396138099783727,"score_spread":0.26204597935555274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431443,0.00044715698,0.000002309517,0.0020525632,0.00031254487,0.0015275208,0.0012925594,0.000024230989,0.000026673288],"genre_scores_gemma":[0.99873614,0.00015819214,0.0000069618504,0.0005455069,0.0000060065167,0.00015404621,0.00023630922,0.00001992292,0.00013691578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963316,0.0019204227,0.00094427314,0.00027527582,0.00017779903,0.0003506367],"domain_scores_gemma":[0.9976781,0.0009705294,0.00057806005,0.00063796405,0.000078170386,0.0000571826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010280827,0.00027412066,0.0006830613,0.00020045259,0.0001614054,0.000006042794,0.00059790886,0.00011967221,0.00013585118],"category_scores_gemma":[0.0015750481,0.0001332348,0.00030892435,0.0010002886,0.00013684593,0.000100241494,0.00016509344,0.0001095039,0.00003951941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06329708,0.02464245,0.72142804,0.001766726,0.0076072165,0.000066156856,0.036768712,0.013203242,0.0036643688,0.0011872031,0.021635408,0.10473342],"study_design_scores_gemma":[0.033579633,0.00085298077,0.94726485,0.0016716954,0.00075577263,0.0000073518445,0.0017002774,0.000043801814,0.010472854,0.0028945808,0.00027521214,0.00048098966],"about_ca_topic_score_codex":0.00020851176,"about_ca_topic_score_gemma":0.00007379594,"teacher_disagreement_score":0.22583684,"about_ca_system_score_codex":0.00003205766,"about_ca_system_score_gemma":0.00017694345,"threshold_uncertainty_score":0.54331577},"labels":[],"label_agreement":null},{"id":"W4379650518","doi":"10.1136/annrheumdis-2023-eular.3918","title":"AB0947 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO BIOLOGIC THERAPY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Ankylosing spondylitis; Placebo; Clinical endpoint; Internal medicine; BASDAI; Minimal clinically important difference; Secukinumab; Low back pain; Back pain; Randomized controlled trial; Physical therapy; Psoriatic arthritis; Arthritis","score_opus":0.024498655789993773,"score_gpt":0.31051058484283,"score_spread":0.28601192905283623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653906,0.00080879894,0.0000012755111,0.0014232242,0.000025489388,0.0009671924,0.00018544913,0.000025336569,0.000024194584],"genre_scores_gemma":[0.99801236,0.0017113324,0.000015708849,0.00013625468,0.0000050746157,0.000054200795,0.000025382362,0.00001795256,0.00002174039],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99782664,0.0010062102,0.00028926492,0.00020515948,0.0003790616,0.00029368635],"domain_scores_gemma":[0.9975085,0.0018115479,0.0001293407,0.00031652194,0.000095258736,0.00013882235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012745613,0.00015798432,0.00044816628,0.00030424914,0.00006728831,0.00001459831,0.00012175757,0.0000319998,0.00003154858],"category_scores_gemma":[0.003318316,0.00008730852,0.00008423128,0.00054805144,0.00019068335,0.000072199946,0.000055787135,0.0000888585,0.0000037852988],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06213108,0.0003849133,0.111483745,0.00040916924,0.00022337408,0.000012343589,0.0015991697,0.0000586677,0.0005418927,0.000044224536,0.00037057165,0.82274085],"study_design_scores_gemma":[0.0033890875,0.007882738,0.9750098,0.0057195476,0.000004725127,0.0000011167407,0.00021262144,0.00006341378,0.007249851,0.00027946726,0.00008558999,0.00010205158],"about_ca_topic_score_codex":0.00008834208,"about_ca_topic_score_gemma":0.0000031247912,"teacher_disagreement_score":0.86352605,"about_ca_system_score_codex":0.000014583292,"about_ca_system_score_gemma":0.00006391673,"threshold_uncertainty_score":0.39725742},"labels":[],"label_agreement":null},{"id":"W4379650530","doi":"10.1136/annrheumdis-2023-eular.512","title":"AB1094 GUSELKUMAB EFFECT ON INFLAMMATORY CARDIOVASCULAR (CV) RISK BIOMARKERS, EFFICACY, AND SAFETY IN PSORIATIC ARTHRITIS PATIENTS WITH CV RISK FACTORS: POST-HOC ANALYSIS OF 2 PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Vancouver General Hospital","funders":"Amgen","keywords":"Medicine; Psoriatic arthritis; Post-hoc analysis; Internal medicine; Double blind; Placebo; Randomized controlled trial; Psoriasis; Arthritis; Dermatology; Pathology; Alternative medicine","score_opus":0.019273057185131687,"score_gpt":0.2983857731465376,"score_spread":0.2791127159614059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96440166,0.029415503,0.0000017532207,0.00007902029,0.00012463758,0.005087647,0.0008210498,0.000049373808,0.000019363275],"genre_scores_gemma":[0.9646908,0.034637664,0.000008903204,0.000016623477,0.000012953807,0.0004123676,0.00017271112,0.000035875477,0.000012109925],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959355,0.0011084809,0.001156914,0.00046720888,0.0009325379,0.0003993291],"domain_scores_gemma":[0.99389994,0.003922625,0.0008564545,0.0008331883,0.00033619007,0.0001516133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014356915,0.0004912398,0.003965381,0.00073854503,0.00023664844,0.000021764612,0.00015674692,0.00007686643,0.00002040317],"category_scores_gemma":[0.003290558,0.00026848982,0.0016665222,0.0011860969,0.00044907382,0.00010160101,0.00013212796,0.0001363383,0.000005326123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72637725,0.0013092656,0.11204746,0.00044347806,0.12670612,0.000022877772,0.0011737768,0.00087313517,6.872733e-7,0.0000072784997,0.0000822953,0.030956393],"study_design_scores_gemma":[0.662397,0.002069213,0.30909926,0.0020568708,0.02337599,5.699046e-7,0.00050420855,0.00023579705,0.00003616257,0.00002833842,0.000005473402,0.00019111315],"about_ca_topic_score_codex":0.0005385705,"about_ca_topic_score_gemma":0.00013064142,"teacher_disagreement_score":0.19705178,"about_ca_system_score_codex":0.000048117083,"about_ca_system_score_gemma":0.00006565903,"threshold_uncertainty_score":0.99997675},"labels":[],"label_agreement":null},{"id":"W4379650729","doi":"10.1136/annrheumdis-2023-eular.2995","title":"AB1366 A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE PREVALENCE OF PAIN SENSITISATION AND NEUROPATHIC LIKE PAIN IN INFLAMMATORY ARTHRITIS, USING QUESTIONNAIRES","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuropathic pain; Meta-analysis; Physical therapy; PsycINFO; MEDLINE; Internal medicine; McGill Pain Questionnaire; Arthritis; Anesthesia; Visual analogue scale","score_opus":0.09964820765371979,"score_gpt":0.34551832871332216,"score_spread":0.24587012105960238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024568571,0.99495304,0.000007609358,0.00022227943,0.00002589734,0.0021424969,0.00017901094,0.000011535751,0.0000012696934],"genre_scores_gemma":[0.009861798,0.98954225,0.000008044336,0.00042772907,0.000002704185,0.000089417226,0.0000059561557,0.000026718695,0.000035372846],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9922066,0.0052885283,0.001663578,0.00026470723,0.00043419993,0.0001424091],"domain_scores_gemma":[0.9958308,0.0014522618,0.0017408921,0.0007571903,0.00015088728,0.00006802363],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0036067378,0.00029463528,0.0042660013,0.00022571548,0.000046639587,0.0000136720655,0.00019384606,0.00006842104,0.000011542828],"category_scores_gemma":[0.009873328,0.00015524644,0.0014261575,0.00089848205,0.000266982,0.000060254064,0.00014221742,0.00013150212,2.120186e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037300185,0.000053194315,0.00018772538,0.9827172,0.008001086,0.000004412138,0.00007759957,0.000020507563,2.7254018e-7,0.000021087431,0.000054890937,0.008858272],"study_design_scores_gemma":[0.00008541961,0.000058000598,0.001847427,0.597541,0.39909503,0.000015093814,0.00005337584,0.0010087795,2.2785152e-7,0.000100257384,0.000047303678,0.00014806831],"about_ca_topic_score_codex":0.00010915316,"about_ca_topic_score_gemma":0.000055691133,"teacher_disagreement_score":0.39109397,"about_ca_system_score_codex":0.000009898686,"about_ca_system_score_gemma":0.00017071542,"threshold_uncertainty_score":0.9984669},"labels":[],"label_agreement":null},{"id":"W4379650863","doi":"10.1136/annrheumdis-2023-eular.3149","title":"AB1294 SAFETY OF COVID-19 VACCINES AND HEALTH CARE UTILIZATION FOLLOWING VACCINATION AMONG ADULTS WITH RHEUMATOID ARTHRITIS – A POPULATION-BASED SELF-CONTROLLED CASE SERIES ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University Health Centre; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Vaccination; Coronavirus disease 2019 (COVID-19); Population; Immunology; Internal medicine; Environmental health; Disease","score_opus":0.03619491862786981,"score_gpt":0.3588661367516316,"score_spread":0.32267121812376176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194413,0.0042262864,0.00020167309,0.0018425459,0.000035126348,0.0014809318,0.00012257884,0.00012838583,0.000018363333],"genre_scores_gemma":[0.99746686,0.0005501158,0.000065492255,0.0016263523,0.000008357692,0.0001143115,0.00013831041,0.000025520263,0.0000046758464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771994,0.00026679592,0.0007727911,0.00030978105,0.00064733066,0.0002833403],"domain_scores_gemma":[0.9979483,0.0004998846,0.0005334409,0.00048648842,0.00038881137,0.00014307273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057249854,0.00021771544,0.0009582971,0.00062910526,0.00031296353,0.00003647666,0.0001257488,0.00005806834,0.000014747354],"category_scores_gemma":[0.0012974301,0.0001496237,0.00040684958,0.0019221372,0.000043488002,0.00021674321,0.000053860153,0.00006894647,8.9164604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002490335,0.00020494613,0.9769826,0.0030941435,0.0015370796,0.00006880325,0.0030932864,0.00084209157,0.0000035141686,0.00006699447,0.00014194692,0.011474243],"study_design_scores_gemma":[0.012483409,0.00048323732,0.9524755,0.002005512,0.0007544479,0.000048244437,0.0067922194,0.024163736,0.00033119792,0.00017491564,0.00005271385,0.00023489939],"about_ca_topic_score_codex":0.003712567,"about_ca_topic_score_gemma":0.0037897099,"teacher_disagreement_score":0.024507148,"about_ca_system_score_codex":0.00007808642,"about_ca_system_score_gemma":0.0006883148,"threshold_uncertainty_score":0.6101477},"labels":[],"label_agreement":null},{"id":"W4379650883","doi":"10.1136/annrheumdis-2023-eular.5756","title":"AB1199 PAIN ON WALKING AND PAIN AT REST IN PATIENTS WITH KNEE OSTEOARTHRITIS: IS THERE A DIFFERENCE?","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Obesity Canada; Lunds Universitet","keywords":"Medicine; Osteoarthritis; Visual analogue scale; Physical therapy; Body mass index; Univariate analysis; Knee pain; Rest (music); Internal medicine; Multivariate analysis","score_opus":0.01836301047519907,"score_gpt":0.24859454713793908,"score_spread":0.23023153666274002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969452,0.00094359566,6.799673e-7,0.0010412486,0.000040971558,0.0007266086,0.00008723017,0.000045903264,0.00016857621],"genre_scores_gemma":[0.99824834,0.00017538054,0.000012882035,0.0007437242,0.000009452652,0.00007639648,0.000050504234,0.000025184509,0.0006581109],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986628,0.00022987847,0.00024547902,0.00022020837,0.00037422415,0.0002673876],"domain_scores_gemma":[0.9989784,0.00037798507,0.00011622238,0.0003574191,0.00004742015,0.00012257078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029630578,0.00018056926,0.0003359464,0.000109441055,0.000089231486,0.000017973489,0.000082930055,0.000043949098,0.000066795285],"category_scores_gemma":[0.00040247888,0.00010855627,0.00008797845,0.00023444858,0.000083738196,0.000046993802,0.00007558914,0.00006356912,0.000018128523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007190985,0.00041500028,0.45807767,0.00032494968,0.000064647924,0.000025046382,0.00077453844,0.0000012649976,0.000019801484,0.0001131311,0.0008060192,0.53865886],"study_design_scores_gemma":[0.0042555872,0.004573081,0.98156536,0.006985604,0.00006346225,0.0000012676246,0.00041040944,0.000050638744,0.0002541192,0.0016283952,0.00006654803,0.00014555785],"about_ca_topic_score_codex":0.000022997452,"about_ca_topic_score_gemma":0.00006550948,"teacher_disagreement_score":0.5385133,"about_ca_system_score_codex":0.000017481527,"about_ca_system_score_gemma":0.000031565607,"threshold_uncertainty_score":0.4426796},"labels":[],"label_agreement":null},{"id":"W4379650925","doi":"10.1136/annrheumdis-2023-eular.6148","title":"AB1540 PREVALENCE AND DISTRIBUTION OF SONOGRAPHIC ELEMENTARY LESIONS IN PSA – RESULTS OF 2 COHORTS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Cohort; Enthesitis; Psoriatic arthritis; Synovitis; Internal medicine; Enthesis; Surgery; Arthritis; Tendon","score_opus":0.037006048667215304,"score_gpt":0.3173967056737749,"score_spread":0.28039065700655963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379650925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935438,0.004056456,5.11017e-7,0.0008346959,0.00003420669,0.00035013506,0.001120844,0.000008859018,0.000050502058],"genre_scores_gemma":[0.9870374,0.012759546,0.000008177851,0.00001845806,0.000002954823,0.000019851777,0.00010599488,0.000004219204,0.000043355773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913466,0.000041413718,0.00038787103,0.00010858211,0.00020597776,0.00012152496],"domain_scores_gemma":[0.9993233,0.00014581971,0.0001877503,0.00023341955,0.00006397375,0.00004570605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015136393,0.00007503539,0.00028871952,0.000068316076,0.000037138157,0.0000015828182,0.000058205285,0.000016980552,0.000010902629],"category_scores_gemma":[0.00032935393,0.00005084137,0.00010449909,0.00033492554,0.00016643002,0.000035122608,0.00007854181,0.000025339592,8.1274163e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045873618,0.0006534892,0.97164124,0.0014618277,0.00027384344,0.0000075118783,0.00028880223,0.000012102707,0.00003512467,0.00015619941,0.004491825,0.02051929],"study_design_scores_gemma":[0.001407388,0.00020116376,0.9940118,0.0026877287,0.00014289514,0.0000016032113,0.00025492933,0.000042264215,0.0004427884,0.00074383843,0.000027296237,0.00003626744],"about_ca_topic_score_codex":0.00028321813,"about_ca_topic_score_gemma":0.000042542586,"teacher_disagreement_score":0.022370588,"about_ca_system_score_codex":0.000004923467,"about_ca_system_score_gemma":0.00002666921,"threshold_uncertainty_score":0.20732509},"labels":[],"label_agreement":null},{"id":"W4379651075","doi":"10.1136/annrheumdis-2023-eular.1174","title":"AB1583 EVALUATING THE DIRECT EFFECT OF SLE IN THE PRESENCE OF INTERMEDIATE GC ON HEALTHCARE COST","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Health care","score_opus":0.4594771744523029,"score_gpt":0.5116346782383011,"score_spread":0.052157503785998205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379651075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96711797,0.0022143763,0.000004790813,0.027571034,0.0004208338,0.0015735398,0.0005380815,0.000014633011,0.00054473017],"genre_scores_gemma":[0.9975089,0.00049066596,0.0000061506234,0.0016048163,0.000035077097,0.00023269503,0.0000127324765,0.000015726782,0.00009326549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943262,0.0021753462,0.0026801943,0.00025218853,0.00026866657,0.00029744982],"domain_scores_gemma":[0.9835487,0.012869153,0.0025100375,0.000938748,0.0000744765,0.000058883823],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023351645,0.00015045401,0.000875198,0.00019017055,0.00012113807,0.0000225154,0.00089365605,0.000046470952,0.00004913107],"category_scores_gemma":[0.023864836,0.00009248751,0.00026277782,0.0005160274,0.00020201402,0.00012773385,0.0001189641,0.00012418455,0.00010518721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007270949,0.0009288918,0.69862556,0.021853587,0.00077126495,0.0000018146371,0.039316334,0.023598308,0.000011857627,0.053983003,0.122634456,0.037547812],"study_design_scores_gemma":[0.00097408553,0.0008265348,0.9400882,0.0036335671,0.00003406615,7.367014e-7,0.0029292018,0.031338155,0.00014484584,0.019412188,0.00039831805,0.0002201038],"about_ca_topic_score_codex":0.0011246959,"about_ca_topic_score_gemma":0.00008970662,"teacher_disagreement_score":0.24146262,"about_ca_system_score_codex":0.00004318404,"about_ca_system_score_gemma":0.00011466606,"threshold_uncertainty_score":0.98435754},"labels":[],"label_agreement":null},{"id":"W4379651163","doi":"10.1136/annrheumdis-2023-eular.3640","title":"AB1446 TREATMENT PATTERNS IN A POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS POPULATION IN GERMANY; A RETROSPECTIVE OBSERVATIONAL HEALTH CLAIMS DATA STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; Assistance publique-Hôpitaux de Paris; Università Cattolica del Sacro Cuore; Universidad Autónoma de Madrid; Institut National de la Santé et de la Recherche Médicale; Ospedale Pediatrico Bambino Gesù; University of Ottawa","keywords":"Medicine; Observational study; Diagnosis code; Retrospective cohort study; Population; Pediatrics; Arthritis; Polyarthritis; Physical therapy; Internal medicine; Environmental health","score_opus":0.2987056414709523,"score_gpt":0.4862201817280783,"score_spread":0.187514540257126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379651163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840022,0.0013033006,0.000005102063,0.011332454,0.00025604584,0.0022094364,0.0008305298,0.00005516562,0.000005778754],"genre_scores_gemma":[0.9969197,0.0016988708,0.0000057591537,0.0005846797,0.00009467492,0.00022375971,0.0003831102,0.000021862788,0.00006762088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958765,0.0014538702,0.0012881366,0.00035932075,0.0004961127,0.00052607927],"domain_scores_gemma":[0.9981075,0.00028505744,0.000544937,0.00083064643,0.00008345892,0.0001484336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014423928,0.00017381409,0.00061113754,0.00021589585,0.00030060057,0.000008738603,0.00034787192,0.00007186902,0.00006088138],"category_scores_gemma":[0.000524521,0.00013034134,0.000082385115,0.0008425472,0.000020094421,0.00020942042,0.0002460434,0.00024006273,0.00004640214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004755908,0.0006399959,0.9833021,0.00048152547,0.000021506814,0.0000089081595,0.006269692,0.00005395478,1.5226024e-7,0.00010163343,0.0014218914,0.007651059],"study_design_scores_gemma":[0.001221524,0.00015884741,0.9885049,0.0022103633,0.000012881417,2.787931e-7,0.0044223038,0.00147318,2.0979617e-7,0.0018621661,0.000029226574,0.00010415485],"about_ca_topic_score_codex":0.018972231,"about_ca_topic_score_gemma":0.021419764,"teacher_disagreement_score":0.012917475,"about_ca_system_score_codex":0.00028383703,"about_ca_system_score_gemma":0.0007032858,"threshold_uncertainty_score":0.9964368},"labels":[],"label_agreement":null},{"id":"W4379652640","doi":"10.1136/annrheumdis-2023-eular.3331","title":"AB1677 VALIDATION ANALYSIS OF THE PHYSICIAN GLOBAL ASSESSMENT (PGA) SCALE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INCLUDED IN RELESSER-PROS REGISTRY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sorbonne Université; University of Toronto; Assistance Publique - Hôpitaux de Paris; Sociedad Española de Reumatología; Fundación Española de Reumatología; Assistance publique-Hôpitaux de Paris; Université de Lorraine","keywords":"Medicine; Scale (ratio); Systemic lupus erythematosus; Lupus erythematosus; Internal medicine; Immunology; Disease; Antibody","score_opus":0.02430759463336631,"score_gpt":0.3282356871872611,"score_spread":0.3039280925538948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379652640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718964,0.00016755528,0.0000060159864,0.00054324506,0.00011151185,0.0015086783,0.0001680069,0.000031385753,0.00027395927],"genre_scores_gemma":[0.9995249,0.00006665082,0.00001637533,0.000041629944,0.000008817425,0.00012147116,0.00006807273,0.00002332241,0.00012878866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637234,0.00044084093,0.00095857383,0.00032713666,0.001524363,0.00037672726],"domain_scores_gemma":[0.9971873,0.00025967608,0.0007553311,0.0013475452,0.0003501612,0.00009999776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006799766,0.000222495,0.0009789526,0.00036134856,0.00006774618,0.00002328605,0.00058833737,0.00007585024,0.000009648716],"category_scores_gemma":[0.00044744715,0.00012457077,0.00034474846,0.004543745,0.00019675159,0.0001137947,0.00029107672,0.00014232019,0.0000061647916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002549886,0.00073417445,0.99239665,0.0028470824,0.000654963,0.0000027553242,0.0006589648,0.0013718043,0.000040325038,0.00008894383,0.00044900985,0.00050035253],"study_design_scores_gemma":[0.0021693711,0.00009000165,0.98195577,0.009344406,0.00051212945,0.000020130861,0.0025229338,0.0025516022,0.00034721865,0.0003635137,0.0000010477615,0.000121891426],"about_ca_topic_score_codex":0.0003478837,"about_ca_topic_score_gemma":0.00016944771,"teacher_disagreement_score":0.010440883,"about_ca_system_score_codex":0.00021627225,"about_ca_system_score_gemma":0.00036987753,"threshold_uncertainty_score":0.5079848},"labels":[],"label_agreement":null},{"id":"W4379652851","doi":"10.1136/annrheumdis-2023-eular.6231","title":"AB1767-HPR DOCUMENT SEARCH IN LARGE RHEUMATOLOGY DATABASES: ADVANCED KEYWORD QUERIES TO SELECT HOMOGENEOUS PHENOTYPES","year":2023,"lang":"en","type":"preprint","venue":"Annals of the Rheumatic Diseases","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Computer science; Homogeneous; Keyword search; Information retrieval; Database; World Wide Web; Mathematics","score_opus":0.05282673366597263,"score_gpt":0.3598819778971527,"score_spread":0.3070552442311801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379652851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844789,0.009298334,0.000629828,0.0031296695,0.00063915923,0.00072260475,0.0009630815,0.00006931845,0.00006908895],"genre_scores_gemma":[0.990829,0.0061402475,0.0011681891,0.00041229586,0.00003782082,0.00024717092,0.00049891334,0.000057727328,0.00060863583],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971373,0.00035645123,0.0007079958,0.0007235809,0.0004072983,0.0006673777],"domain_scores_gemma":[0.99783367,0.00023796213,0.00026931425,0.0013095858,0.0001556481,0.00019383569],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005183755,0.00039223413,0.0007503771,0.00016167745,0.00010570228,0.000036276502,0.0011081627,0.00024047005,0.000045491244],"category_scores_gemma":[0.002440257,0.0002963247,0.0003062142,0.0002775309,0.00029433044,0.000004903112,0.0026254219,0.00027377656,0.0000339267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005203051,0.0047610234,0.17820935,0.019855505,0.005815588,0.00016373792,0.006685252,0.025264248,0.0051756823,0.003755388,0.19829752,0.54681367],"study_design_scores_gemma":[0.010347421,0.0051966636,0.6005137,0.040462136,0.0011991996,0.00016277914,0.012782152,0.0020881526,0.1397965,0.050428446,0.12737773,0.009645107],"about_ca_topic_score_codex":0.0004989602,"about_ca_topic_score_gemma":0.0007929328,"teacher_disagreement_score":0.53716856,"about_ca_system_score_codex":0.000021891381,"about_ca_system_score_gemma":0.0004745159,"threshold_uncertainty_score":0.99994886},"labels":[],"label_agreement":null},{"id":"W4379652881","doi":"10.1136/annrheumdis-2023-eular.5197","title":"AB1710 LEARNING TO CARE FOR OLDER ADULTS WITH RHEUMATIC DISEASES: A NATIONAL SURVEY TO ASSESS CANADIAN RHEUMATOLOGY RESIDENTS' KNOWLEDGE AND INTEREST IN GERIATRIC-RHEUMATOLOGY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Family medicine; Geriatrics","score_opus":0.042851298327508176,"score_gpt":0.3455060750681287,"score_spread":0.3026547767406205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379652881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267197,0.0013875895,0.00004072242,0.003034348,0.00017583663,0.002291207,0.00029184658,0.0000457694,0.000060692502],"genre_scores_gemma":[0.99859995,0.00023416107,0.00009409064,0.000156822,0.0000054312122,0.00048092462,0.00028465345,0.00004485734,0.0000990932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776435,0.00036302183,0.0006569089,0.0004434152,0.00027568336,0.0004966295],"domain_scores_gemma":[0.9967291,0.0015400291,0.00019069543,0.00032282082,0.0006863507,0.00053105765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004669433,0.00026130304,0.00074203126,0.00079197844,0.00019284076,0.000036103986,0.00024842808,0.00009467578,0.00004046298],"category_scores_gemma":[0.0071159042,0.00018742068,0.00015581299,0.0010321953,0.00012238679,0.00010290328,0.000122842,0.0001209188,0.00002649873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010276341,0.0003745975,0.9380815,0.010862294,0.00025178178,0.0000039125953,0.015039602,0.00052301225,0.0000023170112,0.000908917,0.009738496,0.023185948],"study_design_scores_gemma":[0.0017069802,0.0003753309,0.98424554,0.004950208,0.000055995562,0.000007924998,0.007110202,0.0008133844,0.0000028230927,0.00044463406,0.00006823149,0.00021872568],"about_ca_topic_score_codex":0.022757689,"about_ca_topic_score_gemma":0.13061433,"teacher_disagreement_score":0.10785663,"about_ca_system_score_codex":0.00008418156,"about_ca_system_score_gemma":0.0007894935,"threshold_uncertainty_score":0.98374987},"labels":[],"label_agreement":null},{"id":"W4379652938","doi":"10.1136/annrheumdis-2023-eular.1380","title":"AB1678 CONSTRUCTION OF A COMPOSITE SCORE FOR PATIENT SELF-REPORT OF FLARE IN OSTEOARTHRITIS: A COMPARISON OF METHODS WITH THE FLARE-OA-16 QUESTIONNAIRE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sociedad Española de Reumatología; University of Toronto; Sorbonne Université; Lunds Universitet; Assistance Publique - Hôpitaux de Paris; Fundación Española de Reumatología; Assistance publique-Hôpitaux de Paris; Agence Nationale de la Recherche; Université de Lorraine","keywords":"Flare; Medicine; Osteoarthritis; Physical therapy; Pathology; Alternative medicine","score_opus":0.036387931544410446,"score_gpt":0.35376546203132647,"score_spread":0.317377530486916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379652938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452776,0.002730305,0.00024996625,0.00067214656,0.00010924386,0.0014693813,0.00015472718,0.000031208427,0.00005528046],"genre_scores_gemma":[0.9971154,0.000102168065,0.0025075702,0.000023304881,0.00000763366,0.00013273318,0.00007542933,0.000017065084,0.00001870461],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841785,0.00018356375,0.00073792157,0.00016124484,0.00033281033,0.0001666016],"domain_scores_gemma":[0.9981062,0.00025460374,0.0007815782,0.0004187341,0.00037786612,0.000061030718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031284516,0.00015319526,0.00067925965,0.0001337055,0.000060080773,0.000004668919,0.00011911082,0.000049084392,0.000008120974],"category_scores_gemma":[0.00024849782,0.0000896843,0.00024014815,0.0003986052,0.00022486258,0.000064311665,0.000056417965,0.00005735445,4.977332e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029992082,0.0028181113,0.2326803,0.0074509974,0.0011148355,0.000028872542,0.008219191,0.00031665002,0.006293743,0.003057044,0.001174101,0.73384696],"study_design_scores_gemma":[0.017685393,0.019883119,0.2638073,0.0567335,0.0034429778,0.00035193595,0.024837155,0.0016036229,0.6011231,0.009618502,0.00023697628,0.0006764493],"about_ca_topic_score_codex":0.000083560975,"about_ca_topic_score_gemma":0.00007874639,"teacher_disagreement_score":0.7331705,"about_ca_system_score_codex":0.000015983554,"about_ca_system_score_gemma":0.00015055135,"threshold_uncertainty_score":0.36572194},"labels":[],"label_agreement":null},{"id":"W4379653043","doi":"10.1136/annrheumdis-2023-eular.2023a","title":"AB1759-HPR THE USE OF PROMIS MEASURES IN CLINICAL STUDIES IN PATIENTS WITH INFLAMMATORY ARTHRITIS: A SYSTEMATIC REVIEW","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Koninklijk Nederlands Genootschap voor Fysiotherapie; ZonMw; Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Comparability; Interpretability; Metric (unit); Physical therapy; MEDLINE; Data extraction; Systematic review; Patient-Reported Outcomes Measurement Information System; Population; Rheumatoid arthritis; Inflammatory arthritis; Ankylosing spondylitis; Intensive care medicine; Internal medicine; Psychometrics; Computerized adaptive testing; Artificial intelligence","score_opus":0.33615889363998724,"score_gpt":0.44005458053685914,"score_spread":0.1038956868968719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379653043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005944495,0.9848868,3.8300985e-8,0.00012921018,0.00012351945,0.008700873,0.0001914579,0.000018559678,0.0000050497056],"genre_scores_gemma":[0.001118965,0.9971146,0.0000068319337,0.0001348637,0.000011972141,0.001469337,0.000028844688,0.000054840824,0.00005976982],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99412525,0.0011764115,0.003222755,0.0003403731,0.0008278722,0.00030735665],"domain_scores_gemma":[0.9944062,0.002012779,0.001960085,0.0011560317,0.0003783562,0.00008652558],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010739017,0.00047140935,0.0060259136,0.0001741826,0.00005869843,0.000012642088,0.0003499907,0.00009332245,0.0000056088916],"category_scores_gemma":[0.009083735,0.00020059162,0.0010320112,0.0007035469,0.00047752552,0.00008252118,0.00024394885,0.000244393,0.000014762167],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069674235,0.0007963543,0.010343667,0.9214444,0.0037785259,0.000032524073,0.00014005072,6.7843285e-7,1.9654209e-10,0.000013478865,0.0013758091,0.06200483],"study_design_scores_gemma":[0.0013192311,0.0002675948,0.019773893,0.9725502,0.004517091,0.000005844334,0.00011237024,5.099596e-7,2.1662276e-8,0.00003618147,0.0012521141,0.0001649604],"about_ca_topic_score_codex":0.00003836568,"about_ca_topic_score_gemma":0.00014811178,"teacher_disagreement_score":0.06183987,"about_ca_system_score_codex":0.00004979413,"about_ca_system_score_gemma":0.00031752756,"threshold_uncertainty_score":0.99926317},"labels":[],"label_agreement":null},{"id":"W4379653069","doi":"10.1136/annrheumdis-2023-eular.1661","title":"AB1722-PARE LINKING PATIENT PERCEIVED TREATMENT GOALS OF PEOPLE WITH RHEUMATOID ARTHRITIS (RA) AND SEVERE LIMITATIONS IN FUNCTION TO THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; International Classification of Functioning, Disability and Health; Rheumatoid arthritis; Physical therapy; Arthritis; Rehabilitation; Immunology","score_opus":0.08392462961063427,"score_gpt":0.31717362497266605,"score_spread":0.23324899536203178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379653069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824224,0.0029489654,0.000020325833,0.01356212,0.000065114444,0.0007881663,0.000116814736,0.00001727285,0.000058820628],"genre_scores_gemma":[0.9654731,0.034178335,0.000038779766,0.000073609815,0.000007521974,0.00012719724,0.00006616534,0.000010377553,0.000024910552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986643,0.00012799125,0.00046429565,0.00018383462,0.00040012412,0.00015946204],"domain_scores_gemma":[0.9988482,0.00032243348,0.00024519567,0.00028452123,0.00019476615,0.00010486489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002879269,0.00011327584,0.00032936453,0.00011051522,0.00012801541,0.000022581815,0.00008295666,0.000022229708,0.000024669669],"category_scores_gemma":[0.0003361925,0.000067280445,0.00007285983,0.0003320509,0.00020888509,0.000106837,0.00005834932,0.000053828346,0.0000016846805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005312751,0.00052427506,0.6979796,0.00030177648,0.00023201227,3.5048654e-7,0.008228366,0.00038502083,0.00010294163,0.0004709248,0.0006946627,0.29054874],"study_design_scores_gemma":[0.0009685065,0.0008851425,0.9872899,0.002236852,0.0000064705305,0.0000074802165,0.006839138,0.00087967794,0.00006242384,0.000551821,0.00021581608,0.000056789013],"about_ca_topic_score_codex":0.0006042274,"about_ca_topic_score_gemma":0.0023081193,"teacher_disagreement_score":0.29049194,"about_ca_system_score_codex":0.000038264476,"about_ca_system_score_gemma":0.00013621959,"threshold_uncertainty_score":0.2743617},"labels":[],"label_agreement":null},{"id":"W4379653153","doi":"10.1136/annrheumdis-2023-eular.6448","title":"AB1768-HPR SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATIC AUTOIMMUNE DISEASE: EXPERIENCE FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Western University; Dalhousie University; McGill University; University of Calgary; Université de Montréal; University of Alberta; University of British Columbia","funders":"Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Immunosuppression; Internal medicine; Ankylosing spondylitis; Rheumatology; Polymyalgia rheumatica; Rheumatoid arthritis; Cohort; Prospective cohort study; Retrospective cohort study; Oncology; Disease","score_opus":0.03664909965736421,"score_gpt":0.3305346509348274,"score_spread":0.2938855512774632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379653153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815835,0.007157044,7.068852e-7,0.0030609209,0.00014081268,0.0012545036,0.00016912339,0.000013513568,0.000045054978],"genre_scores_gemma":[0.99653864,0.0031626648,0.00001887291,0.000062782885,0.0000032233881,0.000082508464,0.00008382354,0.000027177384,0.000020297868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99643743,0.000594045,0.00145903,0.0003053098,0.00067711127,0.00052705273],"domain_scores_gemma":[0.9966391,0.001505608,0.00054388365,0.00092097983,0.00021962037,0.00017081782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013351325,0.00022906864,0.00090618385,0.00043524202,0.00016275438,0.000014613473,0.0005331944,0.00010226959,0.000100486664],"category_scores_gemma":[0.0015965434,0.00013796131,0.0002006807,0.0014284139,0.0015288723,0.000108402724,0.0002197115,0.00025032167,0.0000024763096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011129825,0.0011016119,0.94260925,0.0008220738,0.00043835177,0.000008897916,0.010369976,0.00005843603,0.00035271893,0.00021635563,0.00026468106,0.03262782],"study_design_scores_gemma":[0.0051305327,0.00039215237,0.9853384,0.005712417,0.00004465111,0.0000017581203,0.0024025121,0.00017296727,0.00021841895,0.00036181597,0.0000917221,0.0001326733],"about_ca_topic_score_codex":0.2360183,"about_ca_topic_score_gemma":0.042536113,"teacher_disagreement_score":0.19348219,"about_ca_system_score_codex":0.00017557196,"about_ca_system_score_gemma":0.0010386234,"threshold_uncertainty_score":0.9749351},"labels":[],"label_agreement":null},{"id":"W4379653209","doi":"10.1136/annrheumdis-2023-eular.3381","title":"AB1723-PARE A CANADIAN PATIENT-DRIVEN SURVEY TO HIGHLIGHT WHICH PREDNISONE-RELATED SIDE EFFECTS MATTER THE MOST","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prednisone; Internal medicine; Pharmacist; Mood; Rheumatology; Pediatrics; Physical therapy; Pharmacy; Family medicine; Psychiatry","score_opus":0.034468055342182856,"score_gpt":0.28935266702570844,"score_spread":0.2548846116835256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379653209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92768234,0.00021960451,7.2767796e-7,0.069830425,0.00024886845,0.0007074157,0.00017847077,0.000037609614,0.0010945221],"genre_scores_gemma":[0.992505,0.00007430158,0.000005300843,0.006535963,0.00001712174,0.000051330033,0.000060847047,0.000007713727,0.0007423793],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981858,0.00032481068,0.00033708144,0.00022776374,0.00048780482,0.00043670594],"domain_scores_gemma":[0.9978842,0.00083522574,0.000105224826,0.0004021353,0.00015000826,0.00062320265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039952944,0.00014451997,0.00030885587,0.00006759564,0.00019365735,0.000027706394,0.00044942243,0.00006350293,0.00045268348],"category_scores_gemma":[0.0036277007,0.00005729705,0.00011623219,0.0012605805,0.00017616659,0.000037838694,0.00015053766,0.000094220515,0.00052282587],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014482602,0.0003155516,0.48006713,0.0004693754,0.000312922,0.000026612532,0.000895775,0.00015656819,0.00017742575,0.00020162654,0.48055136,0.036680814],"study_design_scores_gemma":[0.00018348267,0.00020596718,0.99625516,0.00070058374,0.000046232773,0.0000023973141,0.00008960058,0.0003108726,0.00018351915,0.0006989766,0.0012295998,0.00009358738],"about_ca_topic_score_codex":0.023252444,"about_ca_topic_score_gemma":0.016008446,"teacher_disagreement_score":0.516188,"about_ca_system_score_codex":0.000015415138,"about_ca_system_score_gemma":0.00020898329,"threshold_uncertainty_score":0.9832518},"labels":[],"label_agreement":null},{"id":"W4379793005","doi":"10.1136/annrheumdis-2023-eular.1494","title":"AB1592 WORK-RELATED IMPACT IN YOUNG PATIENTS WITH CHRONIC BACK PAIN AWAITING A MAGNETIC RESONANCE IMAGING","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; Canadian Institutes of Health Research; Nordic Pharma Group; Abbott Laboratories; Sanofi; Pfizer; Eli Lilly and Company; Biogen","keywords":"Medicine; Magnetic resonance imaging; Back pain; Work (physics); Physical therapy; Radiology; Alternative medicine; Pathology","score_opus":0.01065290131515301,"score_gpt":0.2769282213617392,"score_spread":0.2662753200465862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379793005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942113,0.0033579825,0.0000032987475,0.0013157488,0.000052059197,0.00072935416,0.000013566044,0.00004537551,0.00027130128],"genre_scores_gemma":[0.9994066,0.00010897794,0.000021959348,0.00007893976,0.0000109097655,0.000029064773,0.000038611895,0.000025152793,0.00027980088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984329,0.0002773732,0.00042181587,0.00019068929,0.00036295503,0.00031431246],"domain_scores_gemma":[0.9988897,0.0003883029,0.00016240003,0.0003589787,0.00010165201,0.00009896789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061865925,0.00015368871,0.00029505164,0.00014724593,0.000053227614,0.0000151845115,0.00012456691,0.00002910949,0.00015915417],"category_scores_gemma":[0.0012437988,0.00008936163,0.00019768662,0.00095147744,0.00014750825,0.00009665666,0.000047364807,0.00010301529,0.000041030686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010979166,0.0001789857,0.91858125,0.0009354956,0.00002734673,0.0000014016866,0.00034237746,0.00025320542,0.00000779127,0.000011892832,0.0013971676,0.07815331],"study_design_scores_gemma":[0.001367545,0.00024225522,0.98281235,0.007657848,0.000026175725,3.8729374e-7,0.00013897277,0.0073209447,0.000002908525,0.00032100698,0.000010672085,0.000098930555],"about_ca_topic_score_codex":0.00014901726,"about_ca_topic_score_gemma":0.000017270511,"teacher_disagreement_score":0.07805438,"about_ca_system_score_codex":0.00005379648,"about_ca_system_score_gemma":0.0001135957,"threshold_uncertainty_score":0.36440617},"labels":[],"label_agreement":null},{"id":"W4379793177","doi":"10.1136/annrheumdis-2023-eular.632","title":"AB1096 IMPROVEMENT IN KEY PSORIATIC ARTHRITIS CORE DOMAINS WITH GUSELKUMAB TREATMENT IN AN ENRICHED POPULATION OF ACR20 NON-RESPONDERS AT WEEK 24: POST HOC ANALYSIS OF TWO PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Barrie Urology Group","funders":"Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Dactylitis; Psoriatic arthritis; Internal medicine; Post-hoc analysis; Population; Enthesitis; Rheumatology; Placebo; Gastroenterology; Rheumatoid arthritis; Pathology","score_opus":0.08217878608255655,"score_gpt":0.40418006527090433,"score_spread":0.32200127918834776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379793177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963238,0.0020335463,0.0000022753886,0.00045665514,0.000026958185,0.000996968,0.0001314946,0.000015310558,0.00001295086],"genre_scores_gemma":[0.99582744,0.0036280914,0.000022434024,0.000042086303,0.000004067243,0.000118574244,0.00023502146,0.000019417375,0.00010286348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977599,0.00015204777,0.0009414884,0.00023948927,0.0006111193,0.0002959703],"domain_scores_gemma":[0.99832463,0.0002557227,0.0004870403,0.00061127404,0.00023423912,0.00008706629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039932062,0.00020667369,0.0011035266,0.00085022155,0.000059287428,0.0000071735967,0.00017227835,0.000036365742,0.00006050253],"category_scores_gemma":[0.00032927163,0.00013398402,0.000271598,0.0017246233,0.0001895023,0.00014625865,0.00009519204,0.000057541776,0.0000026967093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01543451,0.012212496,0.73527807,0.003064089,0.012505018,0.000096684904,0.032690458,0.009738982,0.008190371,0.00026393394,0.000402519,0.17012289],"study_design_scores_gemma":[0.011911468,0.0048324494,0.96155304,0.0011765934,0.0009789409,6.908241e-7,0.010419117,0.007358525,0.0011578561,0.00044360285,0.0000038359517,0.00016386708],"about_ca_topic_score_codex":0.0013055255,"about_ca_topic_score_gemma":0.0038503208,"teacher_disagreement_score":0.226275,"about_ca_system_score_codex":0.00011674515,"about_ca_system_score_gemma":0.00018919342,"threshold_uncertainty_score":0.546371},"labels":[],"label_agreement":null},{"id":"W4379793426","doi":"10.1136/annrheumdis-2023-eular.887","title":"POS1063 CARDIOVASCULAR AND THROMBOEMBOLIC EVENTS IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS OVER 3 YEARS BEFORE AND 3 YEARS AFTER INITIATION OF A FIRST ADVANCED THERAPY. DATA FROM THE UNIVERSITY OF SHERBROOKE REGISTRY OF ADVANCED THERAPIES (USRAT)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Pfizer Canada; Pfizer; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Rheumatoid arthritis; Arthritis; Internal medicine","score_opus":0.01897736099111891,"score_gpt":0.25602585911721576,"score_spread":0.23704849812609685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379793426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88931066,0.1092455,0.000001917123,0.00015393998,0.00003999189,0.0005516502,0.0006811618,0.000009821895,0.0000053653707],"genre_scores_gemma":[0.6536445,0.34622854,0.00003428942,0.000014642049,0.0000036969227,0.0000061278115,0.000053518117,0.000012498599,0.0000021915196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998489,0.00017761743,0.0004037588,0.00025497784,0.00048431405,0.00019031834],"domain_scores_gemma":[0.998548,0.00023673297,0.00025430555,0.00077710435,0.00010689006,0.000077019125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028336942,0.00015009978,0.0006486527,0.000097105985,0.000058640162,0.000009034398,0.00025822019,0.000052940515,0.000035428387],"category_scores_gemma":[0.00036787524,0.000115592295,0.00013448046,0.00026404162,0.0005013786,0.00028694514,0.00026222807,0.00008739552,7.247295e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075346255,0.0002837189,0.5983793,0.0004523074,0.00084174424,0.000006883298,0.007031174,0.00002444155,0.00006937423,0.000035592795,0.00019461087,0.3919274],"study_design_scores_gemma":[0.0044600163,0.00020678148,0.9856091,0.00594777,0.000017627775,0.0000020550144,0.0016241298,0.000114051545,0.00007348768,0.0016367118,0.00021805783,0.00009019245],"about_ca_topic_score_codex":0.0007359919,"about_ca_topic_score_gemma":0.0006563011,"teacher_disagreement_score":0.39183718,"about_ca_system_score_codex":0.0000072620137,"about_ca_system_score_gemma":0.000060853436,"threshold_uncertainty_score":0.4713717},"labels":[],"label_agreement":null},{"id":"W4379794089","doi":"10.1136/annrheumdis-2023-eular.833","title":"POS1106 ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"BASDAI; Medicine; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine; Placebo; Physical therapy; Disease; Gastroenterology; Pathology; Alternative medicine","score_opus":0.03783609211465162,"score_gpt":0.33059784372304274,"score_spread":0.29276175160839113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379794089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144805,0.0025627739,8.39789e-8,0.0013015554,0.00010010765,0.0022032321,0.012326284,0.00002851301,0.000029390008],"genre_scores_gemma":[0.99458885,0.0042222007,0.0000040097557,0.00017530128,0.0000238767,0.0005051262,0.000362384,0.000028754346,0.00008952023],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99803066,0.00016543406,0.00043835677,0.0004184095,0.0006144053,0.00033274788],"domain_scores_gemma":[0.9978048,0.000865951,0.00034836406,0.0006751282,0.00013901158,0.00016669533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102426755,0.00034372503,0.0007359511,0.0001036213,0.00020323196,0.000015641905,0.00013462367,0.00003776087,0.00003386968],"category_scores_gemma":[0.00034123706,0.00018160648,0.00022118069,0.00035881114,0.00040905658,0.00012698362,0.00016942905,0.000082811355,0.0000035442174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14994465,0.045236863,0.26894215,0.00083730044,0.010132789,0.00024400759,0.015491812,0.0003879146,0.00005447653,0.00007927425,0.0056693004,0.50297946],"study_design_scores_gemma":[0.03041317,0.006711512,0.9568857,0.002232648,0.0005605493,4.1767376e-7,0.0018519986,0.000045262965,0.0007518588,0.000177659,0.00018052709,0.00018867762],"about_ca_topic_score_codex":0.00062299526,"about_ca_topic_score_gemma":0.00017399077,"teacher_disagreement_score":0.6879436,"about_ca_system_score_codex":0.00007260303,"about_ca_system_score_gemma":0.00009651881,"threshold_uncertainty_score":0.7405697},"labels":[],"label_agreement":null},{"id":"W4379794110","doi":"10.1136/annrheumdis-2023-eular.515","title":"AB1084 GUSELKUMAB PROVIDES RAPID CLINICALLY MEANINGFUL IMPROVEMENTS IN CLINICAL AND PATIENT REPORTED OUTCOMES AND SUSTAINED DISEASE CONTROL OF PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McGill University","funders":"Bundesministerium für Bildung und Forschung; Janssen Scientific Affairs; Jazz Pharmaceuticals; Celgene; Novavax; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Psoriatic arthritis; Quality of life (healthcare); Visual analogue scale; Dermatology Life Quality Index; Physical therapy; Psoriasis; Internal medicine; Ustekinumab; Placebo; Disease; Dermatology; Adalimumab; Alternative medicine","score_opus":0.03441002239376385,"score_gpt":0.3097852246297757,"score_spread":0.27537520223601186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379794110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906066,0.006965913,0.0000028424724,0.0010110624,0.00031831843,0.00082091615,0.00022375966,0.00003787585,0.000012717255],"genre_scores_gemma":[0.9955112,0.004049728,0.000012285812,0.00020268133,0.0000058048436,0.00008363893,0.00003596687,0.000015461252,0.0000832305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719155,0.00057332247,0.0015112187,0.0003192099,0.00010448124,0.00030022732],"domain_scores_gemma":[0.9972382,0.0013373727,0.0007563452,0.00046326497,0.000117984804,0.00008678407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069799146,0.00021047295,0.0007728422,0.0001228893,0.00008696905,0.0000130228955,0.00017004716,0.00009625766,0.000031190688],"category_scores_gemma":[0.0042050844,0.00014042301,0.00027329059,0.00018525163,0.00041184726,0.000089646266,0.00015563736,0.00008088945,0.0000052967353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011396725,0.0006793295,0.5975273,0.0002275378,0.0011212326,0.000014583478,0.00038158405,0.0000035454495,0.0000640669,0.00015622814,0.0004782022,0.39820668],"study_design_scores_gemma":[0.005912512,0.0004652581,0.98908806,0.00049314846,0.00039684164,0.0000018739726,0.0005565403,0.00004829372,0.00016322288,0.0026690038,0.000056435587,0.00014883009],"about_ca_topic_score_codex":0.00006154977,"about_ca_topic_score_gemma":0.000011375385,"teacher_disagreement_score":0.39805788,"about_ca_system_score_codex":0.0000053924978,"about_ca_system_score_gemma":0.00013155934,"threshold_uncertainty_score":0.57262844},"labels":[],"label_agreement":null},{"id":"W4379794351","doi":"10.1136/annrheumdis-2023-eular.447","title":"AB1115 STUDY DESIGN AND FULL BASELINE SAMPLE CHARACTERISTICS OF PATIENTS FROM THE 24-MONTH MULTINATIONAL PROSPECTIVE PSORIATIC ARTHRITIS OBSERVATIONAL STUDY OF PERSISTENCE OF TREATMENT (PRO-SPIRIT)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"UCB Pharma; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Observational study; Persistence (discontinuity); Multinational corporation; Arthritis; Baseline (sea); Physical therapy; Internal medicine","score_opus":0.12960873523478963,"score_gpt":0.3233907361498229,"score_spread":0.19378200091503325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379794351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388397,0.0007861637,0.000013957228,0.00026412812,0.0000822222,0.0026628706,0.0022939423,0.000009907905,0.0000028626914],"genre_scores_gemma":[0.9987914,0.00055922236,0.00021861709,0.000020758967,0.000015665211,0.00021185071,0.00015459105,0.0000128905895,0.000015013796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818623,0.00020401143,0.0006966539,0.00021513573,0.0005614228,0.00013652186],"domain_scores_gemma":[0.9969199,0.001500876,0.00057714566,0.00034809398,0.0006006645,0.000053336094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022604092,0.0001755917,0.0006395283,0.000054907985,0.00012153161,0.0000064468863,0.00012414361,0.000019861556,0.000036420297],"category_scores_gemma":[0.001624851,0.0001040418,0.0001389376,0.00027002624,0.00015647236,0.000056132656,0.00009924153,0.00003418096,9.4231814e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084598054,0.010127359,0.9648594,0.000100535035,0.0013536304,0.0000022395818,0.005633575,0.000053237905,0.000008660944,0.000022315366,0.00012624262,0.016866788],"study_design_scores_gemma":[0.006209123,0.0050907675,0.9800684,0.0005520729,0.0005514275,3.0662795e-7,0.006295171,0.0007602354,0.00006083857,0.00033826276,0.0000032947885,0.00007011402],"about_ca_topic_score_codex":0.00074523594,"about_ca_topic_score_gemma":0.00014012083,"teacher_disagreement_score":0.016796673,"about_ca_system_score_codex":0.000029105098,"about_ca_system_score_gemma":0.000102723534,"threshold_uncertainty_score":0.42427015},"labels":[],"label_agreement":null},{"id":"W4379794524","doi":"10.1136/annrheumdis-2023-eular.4165","title":"AB0720 DEVELOPMENT OF RESPONSE CRITERIA FOR GCA: AN SLR INFORMING AN INTERNATIONAL TASK FORCE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Behavioral and Psychological Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Sanofi; GlaxoSmithKline; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Task force; Task (project management); Systems engineering; Engineering","score_opus":0.3801550629849693,"score_gpt":0.46834643108630847,"score_spread":0.08819136810133915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379794524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973693,0.00009908472,0.000071670045,0.00088379835,0.0005742257,0.00029616026,0.00024937213,0.000049166818,0.0004072348],"genre_scores_gemma":[0.9982515,0.000025339936,0.00034191986,0.00025185797,0.000025501504,0.00014595942,0.000050422,0.000010924068,0.00089654804],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988134,0.000121732955,0.00047245843,0.00017307246,0.00020294955,0.0002163824],"domain_scores_gemma":[0.99896246,0.00027038492,0.00022343783,0.0003241819,0.00013674502,0.00008279706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048446772,0.00012052412,0.00022906452,0.0000733886,0.00012762997,0.000016591866,0.0004989421,0.00004545783,0.00036342585],"category_scores_gemma":[0.00029852003,0.000077829936,0.00013198389,0.00015325272,0.00011180495,0.00016011245,0.00011136838,0.000036630612,0.000029150411],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009006464,0.0028008167,0.035017423,0.00037536514,0.0008918624,0.000006728796,0.03350867,0.000034768498,0.00193562,0.006021186,0.03585621,0.8745449],"study_design_scores_gemma":[0.0005218339,0.0003109634,0.9864912,0.00017292557,0.00003445979,0.000001489054,0.0022296256,0.000062194784,0.00049507903,0.0045195,0.0050132135,0.00014751253],"about_ca_topic_score_codex":0.000021389493,"about_ca_topic_score_gemma":0.000005952301,"teacher_disagreement_score":0.9514738,"about_ca_system_score_codex":0.0000061935134,"about_ca_system_score_gemma":0.000027348191,"threshold_uncertainty_score":0.39792582},"labels":[],"label_agreement":null},{"id":"W4379794771","doi":"10.1136/annrheumdis-2023-eular.1080","title":"POS1222 PROGRESSIVE PULMONARY FIBROSIS IN ANTI-SYNTHETASE SYNDROME: A SINGLE CENTER COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Interstitial lung disease; Cohort; Retrospective cohort study; Internal medicine; Single Center; Gastroenterology; Pulmonary function testing; Pulmonary fibrosis; Hydroxychloroquine; Dermatomyositis; Pulmonary hypertension; Lung; Disease","score_opus":0.026136078276059686,"score_gpt":0.28466696741253694,"score_spread":0.25853088913647726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379794771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946197,0.0009404909,7.307985e-7,0.0026654133,0.00013922175,0.00068722747,0.00022248705,0.00009093898,0.000633771],"genre_scores_gemma":[0.9989193,0.00024288971,0.000017456503,0.0004100289,0.00001606372,0.00008989132,0.000076311204,0.000028762664,0.00019926149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984145,0.000108322696,0.00047779243,0.00021538798,0.0004262553,0.00035775086],"domain_scores_gemma":[0.99889296,0.00012896005,0.0002033336,0.00053735095,0.00009410083,0.0001432857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001823376,0.00017955384,0.0004856098,0.00018023272,0.00008519522,0.000025424963,0.0001989526,0.000053937154,0.00018754754],"category_scores_gemma":[0.00028606987,0.00012300724,0.0002827505,0.0005096213,0.00016684984,0.0001329732,0.00016294232,0.00008967605,0.00009323148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032530882,0.0018280215,0.95811576,0.002921887,0.00039082035,0.0024037356,0.00046126256,0.00006266648,0.00049551023,0.00015098722,0.022876121,0.009967946],"study_design_scores_gemma":[0.0005535299,0.000101683974,0.990165,0.00440301,0.00010877627,0.00058293936,0.00025534933,0.0007329918,0.0020564415,0.0005297995,0.0003443596,0.00016613083],"about_ca_topic_score_codex":0.000028122167,"about_ca_topic_score_gemma":0.0000010251166,"teacher_disagreement_score":0.032049254,"about_ca_system_score_codex":0.000017629805,"about_ca_system_score_gemma":0.00007232808,"threshold_uncertainty_score":0.50160897},"labels":[],"label_agreement":null},{"id":"W4379794924","doi":"10.1136/annrheumdis-2023-eular.2516","title":"AB1088 EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Saskatchewan","funders":"","keywords":"Dactylitis; Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Enthesitis; Quality of life (healthcare); Internal medicine; Population; Physical therapy; Clinical endpoint; Visual analogue scale; Clinical trial; Arthritis; Disease","score_opus":0.058408884931000146,"score_gpt":0.3587095173051938,"score_spread":0.30030063237419363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379794924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947929,0.0025338116,0.000001105707,0.00006639853,0.00012368601,0.0011200439,0.0013309321,0.000026141573,0.0000049769596],"genre_scores_gemma":[0.9982499,0.0012561881,0.000005587939,0.000026434256,0.000002879968,0.00005777092,0.00034404846,0.000016167918,0.000041054696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959263,0.0011350622,0.00215238,0.00029663945,0.00021147831,0.00027811198],"domain_scores_gemma":[0.99665016,0.0006529883,0.0017399393,0.00065085304,0.00025106355,0.00005499376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067106367,0.00020853111,0.0014940553,0.00024691722,0.00004745334,0.000004245836,0.00032505044,0.00010560655,0.000112014066],"category_scores_gemma":[0.00058343774,0.00014819755,0.00050168706,0.0010641703,0.00027342624,0.00008782137,0.00009830503,0.000079696954,0.0000107397855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003649506,0.009807083,0.9123126,0.0002529752,0.00983753,0.0000023886703,0.0025553512,0.000017874287,0.00006241025,0.00001650196,0.0000595176,0.06142624],"study_design_scores_gemma":[0.011572458,0.007452204,0.9782743,0.0004922594,0.0011093444,1.5961736e-7,0.0005219135,0.0000035556889,0.00039111672,0.00006910666,3.3283334e-7,0.00011326638],"about_ca_topic_score_codex":0.0038458076,"about_ca_topic_score_gemma":0.0004038758,"teacher_disagreement_score":0.06596167,"about_ca_system_score_codex":0.000015324,"about_ca_system_score_gemma":0.00019979637,"threshold_uncertainty_score":0.60433203},"labels":[],"label_agreement":null},{"id":"W4379794951","doi":"10.1136/annrheumdis-2023-eular.4418","title":"POS1231 IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A CROSS-SECTIONAL ANALYSIS FROM AN INTERNATIONAL E-SURVEY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Myositis Association","keywords":"Medicine; Cross-sectional study; Quality of life (healthcare); Physical therapy; Pathology","score_opus":0.05015631388654104,"score_gpt":0.34579040116949533,"score_spread":0.29563408728295426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379794951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731964,0.00036916445,0.00000958371,0.00035668712,0.00022400911,0.00045784735,0.0011736186,0.00006901162,0.000020456238],"genre_scores_gemma":[0.9987465,0.00007823522,0.000011024704,0.00033054274,0.00002390039,0.000028790835,0.0007409394,0.000024044411,0.000015998905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995755,0.0007702342,0.0018138145,0.00032292836,0.0010449892,0.000293042],"domain_scores_gemma":[0.99692273,0.0002612335,0.0011998143,0.00071298494,0.00064432627,0.0002588921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016896294,0.00021845204,0.00097286224,0.00047308928,0.00011051593,0.00003559864,0.00035224418,0.00009996457,0.0000880989],"category_scores_gemma":[0.0016365938,0.00015715085,0.00037980155,0.001261198,0.0002593717,0.00030518428,0.00012569533,0.00016466975,0.0000116571055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018306505,0.0004929825,0.9935877,0.00040976584,0.0011212913,0.0000041995677,0.00074780657,0.0011226155,0.000004416505,0.00006257692,0.00010515583,0.0005108895],"study_design_scores_gemma":[0.0021888467,0.00017740724,0.9947101,0.00064978976,0.00008927928,6.765665e-7,0.00014354676,0.0015450061,0.000021204965,0.00032274178,0.000002116731,0.000149268],"about_ca_topic_score_codex":0.0032726284,"about_ca_topic_score_gemma":0.00036162973,"teacher_disagreement_score":0.0029109986,"about_ca_system_score_codex":0.000049924485,"about_ca_system_score_gemma":0.0004901939,"threshold_uncertainty_score":0.64084256},"labels":[],"label_agreement":null},{"id":"W4379795143","doi":"10.1136/annrheumdis-2023-eular.1533","title":"AB1098 DEUCRAVACITINIB IN PLAQUE PSORIASIS: 2-YEAR LABORATORY RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Manchester Biomedical Research Centre; Sanofi Genzyme; LEO Pharma; Astellas Pharma; Eisai; University of Glasgow; Genentech; University of Oxford; National Institute for Health and Care Research; Glenmark Pharmaceuticals; UCB Pharma; Valeant Pharmaceuticals International; Argenx; Pfizer; Icahn School of Medicine at Mount Sinai; Biogen; University of Rochester; Incyte; Prothena; Sun Pharma; Dermira; Regeneron Pharmaceuticals; Galderma; University of Manchester; XBiotech; Brigham and Women's Hospital; Kyowa Hakko Kirin; Sanofi; Celgene; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Johns Hopkins University; Amgen","keywords":"Medicine; Plaque psoriasis; Psoriasis; Dermatology","score_opus":0.04608898550564392,"score_gpt":0.31764476655338014,"score_spread":0.2715557810477362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379795143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864662,0.0040950985,4.8625014e-7,0.0028268164,0.00056383613,0.0006613369,0.0049371663,0.00015646496,0.0002925543],"genre_scores_gemma":[0.99672955,0.0016206733,0.000022078024,0.00023521039,0.000039051683,0.00019213697,0.00073917187,0.000023632363,0.00039852218],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980086,0.00061990676,0.0005585711,0.00030687178,0.000102696446,0.0004033536],"domain_scores_gemma":[0.99768317,0.0011365515,0.00028577205,0.0007675666,0.00008643637,0.00004048551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004404391,0.00023358336,0.00038034236,0.000086960164,0.00019213148,0.000026897795,0.0006088147,0.00013779543,0.00013837116],"category_scores_gemma":[0.0009076447,0.00013583113,0.00024020256,0.00062092434,0.0002479041,0.00009580373,0.0001383534,0.00012973347,0.0004798298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064670932,0.0055114324,0.022548225,0.00020323729,0.003660222,0.000045940564,0.0063959034,0.00007620096,0.002339956,0.0019117177,0.29930398,0.6515361],"study_design_scores_gemma":[0.029974217,0.0009276437,0.84229964,0.0024917743,0.0011531791,0.000006701703,0.0069948267,0.0000793612,0.04259832,0.010145092,0.06227562,0.0010536356],"about_ca_topic_score_codex":0.00031906023,"about_ca_topic_score_gemma":0.00009546504,"teacher_disagreement_score":0.8197514,"about_ca_system_score_codex":0.000011914366,"about_ca_system_score_gemma":0.00013993059,"threshold_uncertainty_score":0.6167401},"labels":[],"label_agreement":null},{"id":"W4379795837","doi":"10.1136/annrheumdis-2023-eular.3180","title":"AB0772 AZATHIOPRINE VERSUS METHOTREXATE AS INDUCTION AND MAINTENANCE THERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MONOCENTRIC RETROSPECTIVE STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Erasmus Universitair Medisch Centrum Rotterdam; Liverpool University Hospitals NHS Foundation Trust; Barts Health NHS Trust; Istanbul Üniversitesi-Cerrahpasa; Medizinische Universität Innsbruck; Università di Pisa; York University; Universität Innsbruck; Edge Hill University; National and Kapodistrian University of Athens; Queen Mary University of London","keywords":"Granulomatosis with polyangiitis; Medicine; Azathioprine; Methotrexate; Eosinophilic; Induction therapy; Dermatology; Retrospective cohort study; Maintenance therapy; Internal medicine; Immunology; Vasculitis; Pathology; Chemotherapy; Disease","score_opus":0.04341415253685135,"score_gpt":0.3189271717913348,"score_spread":0.27551301925448346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379795837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931841,0.0018582729,0.000002220944,0.0033730846,0.00011159574,0.0011086944,0.000024674391,0.00007013231,0.00026725844],"genre_scores_gemma":[0.9942542,0.0051501123,0.000024523071,0.00014936259,0.000012838666,0.00009168621,0.0000078925395,0.000031530493,0.0002778808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983343,0.00014790767,0.0003695924,0.00034401185,0.00047308626,0.00033112595],"domain_scores_gemma":[0.99892443,0.00012927003,0.00020330295,0.00048263723,0.00013283269,0.0001274992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030696357,0.00023023286,0.00057502557,0.00030725062,0.000102829246,0.000028317854,0.00016178709,0.000045808156,0.000045445184],"category_scores_gemma":[0.00042480734,0.00014204842,0.00012575791,0.0013702696,0.00018838035,0.00013259494,0.00008392072,0.00012754663,0.000010882319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040787836,0.0030225655,0.89246184,0.00042353774,0.0012884664,0.00013573036,0.005565231,0.00004440596,0.00010344036,0.0011097783,0.0013002508,0.09046597],"study_design_scores_gemma":[0.004916218,0.001715282,0.9857463,0.0006206388,0.00012293053,0.00002793063,0.002911644,0.0001304905,0.00014403851,0.0034896473,0.000017607812,0.00015725917],"about_ca_topic_score_codex":0.00068025396,"about_ca_topic_score_gemma":0.000050211573,"teacher_disagreement_score":0.09328447,"about_ca_system_score_codex":0.000026997375,"about_ca_system_score_gemma":0.00008236511,"threshold_uncertainty_score":0.57925665},"labels":[],"label_agreement":null},{"id":"W4379796238","doi":"10.1136/annrheumdis-2023-eular.3276","title":"AB1534 A VALIDATION OF REGISTER DERIVED DIAGNOSES OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH INFLAMMATORY ARTHRITIS. DATA FROM NOR-DMARD","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta; University of Washington; Amgen","keywords":"Medicine; Medical diagnosis; Interstitial lung disease; Norwegian; Diagnosis code; Gold standard (test); Internal medicine; Medical record; Observational study; Physical therapy; Pediatrics; Lung; Pathology; Population","score_opus":0.032679105873847626,"score_gpt":0.2869461825442833,"score_spread":0.25426707667043563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379796238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940912,0.0009311415,0.000020022258,0.00042886432,0.00013939918,0.0006387732,0.0036896232,0.000025085626,0.0000358614],"genre_scores_gemma":[0.9979624,0.0005179268,0.000020164834,0.00008149158,0.000033936332,0.000030336088,0.0013100713,0.000025150917,0.000018497307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981293,0.00013232435,0.00069295213,0.00028270762,0.00055698573,0.00020569471],"domain_scores_gemma":[0.99785674,0.00024439883,0.0004710215,0.001033649,0.00022431232,0.00016989882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014140941,0.00017731496,0.0005217782,0.00016092339,0.000034020013,0.00001192855,0.00041140596,0.00004054138,0.00008738792],"category_scores_gemma":[0.0008358234,0.00013053398,0.00019688328,0.00027682033,0.00028699316,0.000290176,0.00032843644,0.00007171409,0.000006125096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013054364,0.0013581835,0.9721841,0.0026658103,0.00039576463,0.000038373142,0.00038761992,0.00021873598,0.000093211,0.00007735769,0.0047176583,0.0048087826],"study_design_scores_gemma":[0.0018769617,0.00041420737,0.98238564,0.012675555,0.0003440379,3.010193e-7,0.000140179,0.001255349,0.00040997245,0.00033614325,0.000021071279,0.00014056423],"about_ca_topic_score_codex":0.0002733266,"about_ca_topic_score_gemma":0.00002005632,"teacher_disagreement_score":0.011177402,"about_ca_system_score_codex":0.00001760678,"about_ca_system_score_gemma":0.00020103007,"threshold_uncertainty_score":0.53230214},"labels":[],"label_agreement":null},{"id":"W4379796311","doi":"10.1136/annrheumdis-2023-eular.4755","title":"POS1565 ACUTE PERICARDITIS WITH PLEUROPULMONARY INVOLVEMENT, FEVER AND ELEVATED C-REACTIVE PROTEIN: A SYSTEMIC AUTOINFLAMMATORY DISEASE? A COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pericarditis and Cardiac Tamponade","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"Gilead Sciences; National Institutes of Health; Pfizer; Eli Lilly and Company","keywords":"Medicine; Pericarditis; C-reactive protein; Cohort; Acute pericarditis; Disease; Familial Mediterranean fever; Immunology; Internal medicine; Inflammation","score_opus":0.018733124676487287,"score_gpt":0.2697124923364059,"score_spread":0.2509793676599186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379796311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942403,0.001084995,0.000005367057,0.0006662288,0.00007184178,0.0032189086,0.00039048458,0.00018117236,0.00014069701],"genre_scores_gemma":[0.9979473,0.000267562,0.000007360499,0.00022879717,0.000040249677,0.000848768,0.000078555175,0.000054192566,0.00052722555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976049,0.00028057984,0.00042874395,0.000434746,0.00088979874,0.00036124757],"domain_scores_gemma":[0.9982561,0.000092917406,0.00028329997,0.0007860524,0.0002102283,0.0003714348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026639062,0.0003024766,0.00077493174,0.00013250906,0.00017419716,0.00003959409,0.00019010749,0.00003500625,0.000027221391],"category_scores_gemma":[0.00017904311,0.00019099849,0.00031134128,0.0005453621,0.0002604658,0.00015758314,0.00021342793,0.00012687294,0.000020359315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063223107,0.0005544845,0.98744404,0.0009069089,0.003103735,0.000564396,0.00055323535,0.000026006825,0.0006355993,0.000040240197,0.0043993625,0.0011397462],"study_design_scores_gemma":[0.0010471418,0.0003092853,0.99352264,0.0015758871,0.0014277976,0.00007230669,0.0013427349,0.0001236614,0.00010558932,0.00010562789,0.00014315317,0.00022414788],"about_ca_topic_score_codex":0.00008161247,"about_ca_topic_score_gemma":0.0000013318202,"teacher_disagreement_score":0.006078612,"about_ca_system_score_codex":0.000037789763,"about_ca_system_score_gemma":0.00027568312,"threshold_uncertainty_score":0.7788692},"labels":[],"label_agreement":null},{"id":"W4379796608","doi":"10.1136/annrheumdis-2023-eular.1562","title":"POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma","keywords":"Medicine; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine; Placebo; Radiography; Gastroenterology; Surgery; Pathology","score_opus":0.02776561906049646,"score_gpt":0.31263786867022364,"score_spread":0.2848722496097272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379796608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871416,0.007600179,9.648206e-7,0.0010787217,0.000125838,0.0023311283,0.001633378,0.000043745535,0.000044461074],"genre_scores_gemma":[0.98924804,0.0098072095,0.00016524264,0.00016940445,0.00001781101,0.0001711765,0.00036239927,0.000035681227,0.000023008273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729,0.00015873685,0.00090471684,0.0006003307,0.0005117468,0.0005344479],"domain_scores_gemma":[0.99838704,0.00042927486,0.0003489863,0.0005196464,0.00014414644,0.00017088796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025658676,0.00040671742,0.0010489316,0.00039562822,0.00021947108,0.000035595815,0.00013409923,0.000058860456,0.000011645266],"category_scores_gemma":[0.0004634842,0.00027614934,0.00020058919,0.0010096162,0.00069390715,0.0001762286,0.00022382438,0.00014750048,0.00000335663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028479569,0.0047751926,0.8992884,0.0005797758,0.0034961645,0.00037186564,0.0048236535,0.000025415276,0.000014185995,0.00012285696,0.0009104761,0.0571124],"study_design_scores_gemma":[0.07939012,0.0018033228,0.91166896,0.0038489143,0.00031066407,0.0000056908148,0.0015312771,0.000098229124,0.000033282977,0.0010314899,0.000024135607,0.0002538994],"about_ca_topic_score_codex":0.001022937,"about_ca_topic_score_gemma":0.00041375402,"teacher_disagreement_score":0.056858502,"about_ca_system_score_codex":0.00003398388,"about_ca_system_score_gemma":0.00007651876,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W4379796782","doi":"10.1136/annrheumdis-2023-eular.5474","title":"POS1196-HPR WHAT OUTCOMES MATTER TO PATIENTS WITH FOOT AND ANKLE DISORDERS IN RHEUMATIC AND MUSCULOSKELETAL DISEASES? FINDINGS FROM A QUALITATIVE SYNTHESIS AND SCOPING REVIEW OF THE LITERATURE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Foot (prosody); Physical therapy; Ankle; Physical medicine and rehabilitation; Qualitative research; Pathology","score_opus":0.012507695241320987,"score_gpt":0.3250712927421843,"score_spread":0.3125635975008633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379796782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613823,0.024700044,0.0000018175614,0.011791846,0.0000424202,0.0018908811,0.0001708079,0.000010882555,0.000008948588],"genre_scores_gemma":[0.97960687,0.019472925,0.000046548397,0.0006597827,0.000002395903,0.0001412163,0.00003092717,0.000021199703,0.000018136103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832445,0.00030735505,0.0004931299,0.00027830378,0.00040394123,0.0001928216],"domain_scores_gemma":[0.9979088,0.001280335,0.00021620835,0.00036438517,0.00010257976,0.00012770895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023829335,0.00021967762,0.00065370864,0.00013200259,0.00008403236,0.00004695962,0.00011952741,0.000039070444,0.000033817865],"category_scores_gemma":[0.0020590683,0.00011055428,0.00017944646,0.00050544366,0.00027907532,0.0002801985,0.00016243396,0.000073745396,0.0000018040463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011577074,0.00030311532,0.9007411,0.06866043,0.00022357218,2.683627e-7,0.008696685,0.0000029595296,0.0000035519472,0.000042092084,0.00032090332,0.020889549],"study_design_scores_gemma":[0.00052962813,0.00010324922,0.8080646,0.18735912,0.0002004357,1.8313138e-7,0.0022485135,0.00001592394,0.0000030356653,0.0013628122,9.646183e-7,0.00011157984],"about_ca_topic_score_codex":0.00013483694,"about_ca_topic_score_gemma":0.00007163053,"teacher_disagreement_score":0.11869869,"about_ca_system_score_codex":0.000008217557,"about_ca_system_score_gemma":0.00004100821,"threshold_uncertainty_score":0.45082727},"labels":[],"label_agreement":null},{"id":"W4379796845","doi":"10.1136/annrheumdis-2023-eular.1338","title":"POS1269 INVESTIGATING THE TRAJECTORY OF FUNCTIONAL DISABILITY IN SYSTEMIC SCLEROSIS: GROUP BASED TRAJECTORY MODELLING OF THE HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Nemzeti Kutatási, Fejlesztési és Innovaciós Alap","keywords":"Medicine; Physical therapy; Quality of life (healthcare); Proportional hazards model; Wilcoxon signed-rank test; Hazard ratio; Cohort; Physical medicine and rehabilitation; Internal medicine; Confidence interval; Mann–Whitney U test","score_opus":0.11529034624720548,"score_gpt":0.3177589984665322,"score_spread":0.20246865221932675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379796845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968375,0.0050179823,0.00018167001,0.0031729,0.0003253619,0.0013854852,0.00016317102,0.00005310655,0.000016586291],"genre_scores_gemma":[0.9991216,0.0003762195,0.000018673647,0.00025086582,0.000035040346,0.00014288203,0.000022434788,0.000025356185,0.000006931679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546635,0.0012976318,0.0015199181,0.0003412887,0.0010560742,0.00031874175],"domain_scores_gemma":[0.996618,0.0009702959,0.00096993666,0.0010887326,0.0001798417,0.0001732065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001951489,0.00024877058,0.00074702274,0.00006858817,0.00021557513,0.000013081368,0.00041486934,0.00009606046,0.000021509077],"category_scores_gemma":[0.00096641056,0.00012637457,0.000657631,0.0009620885,0.0012085536,0.00009507557,0.00011237896,0.00025786305,8.823865e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015087321,0.0013226712,0.8676562,0.0061556688,0.00021050085,1.4087664e-7,0.0006938865,0.11964394,0.0004650435,0.00023377457,0.00037853938,0.0030887993],"study_design_scores_gemma":[0.00078452163,0.00008907721,0.89696586,0.028056217,0.00014496727,0.0000016948038,0.0021983627,0.07095228,0.00015367958,0.0005541941,3.130888e-7,0.00009881637],"about_ca_topic_score_codex":0.0012997893,"about_ca_topic_score_gemma":0.00006701276,"teacher_disagreement_score":0.048691664,"about_ca_system_score_codex":0.00018047381,"about_ca_system_score_gemma":0.00077873573,"threshold_uncertainty_score":0.5153405},"labels":[],"label_agreement":null},{"id":"W4379796851","doi":"10.1136/annrheumdis-2023-eular.4633","title":"POS1258 RESULTS FROM A NOMINAL GROUP TECHNIQUE EXERCISE FOR THE CREATION OF A COMBINED RESPONSE INDEX FOR LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: THE CRISTAL PROJECT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"David Geffen School of Medicine, University of California, Los Angeles; Sight Research UK; National Scleroderma Foundation; School of Medicine, Stanford University; Northwestern University; University College London Hospitals NHS Foundation Trust; North Bristol NHS Trust; Johns Hopkins University; Yale University","keywords":"Medicine; Index (typography); Physical therapy; Dermatology; Computer science; World Wide Web","score_opus":0.0845804700508803,"score_gpt":0.333630152958187,"score_spread":0.24904968290730667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379796851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964019,0.00113156,0.0062738815,0.008987071,0.00013666689,0.016306918,0.0027257723,0.00038999965,0.000029102168],"genre_scores_gemma":[0.995629,0.00033273228,0.0005016468,0.00016767146,0.00002840026,0.0030308252,0.00017230921,0.000038555758,0.00009884133],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978475,0.00032164075,0.0008120386,0.00025040223,0.00053285237,0.0002355542],"domain_scores_gemma":[0.99450386,0.0033001185,0.000653196,0.00094073993,0.0005472067,0.00005486956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015809686,0.00020541863,0.0004778126,0.00018011694,0.00023299118,0.000037035687,0.0004854031,0.00008286526,0.0000035498208],"category_scores_gemma":[0.0033399693,0.00010835621,0.00043069787,0.0004871458,0.00023068523,0.00006926293,0.000096532116,0.000094884,0.0000012168713],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4044546,0.0037665747,0.0019830926,0.007962244,0.0028432207,0.000013228817,0.007108492,0.00028611787,0.31001696,0.0011259872,0.22239545,0.038044043],"study_design_scores_gemma":[0.026853047,0.011730934,0.32793528,0.13387814,0.009352335,0.00017826099,0.012133789,0.07862245,0.37509456,0.021825349,0.00083370256,0.0015621368],"about_ca_topic_score_codex":0.00028003758,"about_ca_topic_score_gemma":0.000007645334,"teacher_disagreement_score":0.37760153,"about_ca_system_score_codex":0.00004013456,"about_ca_system_score_gemma":0.00020980655,"threshold_uncertainty_score":0.4418638},"labels":[],"label_agreement":null},{"id":"W4379797178","doi":"10.1136/annrheumdis-2023-eular.2169","title":"AB1593 SEVERE IMPACT OF THE ECONOMIC CRISIS ON TREATMENT PERSISTENCE IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES: A MULTICENTRIC CROSS-SECTIONAL STUDY IN LEBANON","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; Canadian Institutes of Health Research; Nordic Pharma Group; Abbott Laboratories; Sanofi; Pfizer; Eli Lilly and Company; Biogen","keywords":"Medicine; Persistence (discontinuity); Cross-sectional study; Physical therapy; Pediatrics; Pathology","score_opus":0.046599122006915114,"score_gpt":0.3123868108819526,"score_spread":0.26578768887503745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379797178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739194,0.00036304607,2.4114973e-7,0.000120783974,0.0001418872,0.0011845552,0.0007506278,0.000008835733,0.000038061677],"genre_scores_gemma":[0.9996281,0.00019887269,0.000001193424,0.0000135285245,0.000006993621,0.00007338834,0.000010425123,0.000016601807,0.0000508431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983216,0.000092876966,0.00088817877,0.00030547866,0.00011662231,0.0002752386],"domain_scores_gemma":[0.99868405,0.0001548575,0.0005684762,0.00046099012,0.00003491356,0.00009671518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003023698,0.00019911709,0.0005494535,0.00026965878,0.00009929292,0.000037527487,0.00024845515,0.000043933836,0.000036993708],"category_scores_gemma":[0.00022529806,0.00010181301,0.0003178228,0.0004006991,0.00008959611,0.00016414054,0.00007798464,0.00006661566,0.000019669029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010898134,0.00078299874,0.9909449,0.00027245365,0.00017056888,5.177938e-7,0.00093164266,0.0054590576,1.6124655e-8,0.000057849247,0.000021875421,0.0012490974],"study_design_scores_gemma":[0.0019248986,0.00060747773,0.99484795,0.00025535873,0.000010412228,3.7902225e-7,0.0006033656,0.0012086752,3.7694915e-7,0.00041516265,0.0000012064955,0.00012473589],"about_ca_topic_score_codex":0.009649282,"about_ca_topic_score_gemma":0.0003879177,"teacher_disagreement_score":0.009261364,"about_ca_system_score_codex":0.0003241682,"about_ca_system_score_gemma":0.00012774565,"threshold_uncertainty_score":0.99694556},"labels":[],"label_agreement":null},{"id":"W4379797207","doi":"10.1136/annrheumdis-2023-eular.4716","title":"POS1371 THE ASSOCIATION BETWEEN X-RAY PROGRESSION AND CLINICAL OUTCOMES IN PATIENTS WITH HAND OSTEOARTHRITIS WITH 5-YEAR FOLLOW-UP","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Orthopedic Surgery and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Osteoarthritis; Internal medicine; Association (psychology); Physical therapy; Alternative medicine; Pathology","score_opus":0.02484824261646273,"score_gpt":0.3233168528727266,"score_spread":0.29846861025626387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379797207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587685,0.000096732925,6.2178776e-7,0.0030966634,0.00012801094,0.00070424087,0.000037988255,0.00002101976,0.000037899612],"genre_scores_gemma":[0.99940604,0.00006538634,0.000014313472,0.00009613337,0.000017615477,0.000025639934,0.000032618205,0.000011847156,0.00033042027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986032,0.000232383,0.00036070816,0.00014658444,0.000499912,0.00015719915],"domain_scores_gemma":[0.9980885,0.0012005131,0.0002565127,0.00023852318,0.00014019306,0.000075768134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067498634,0.000099381425,0.00034069686,0.00006148648,0.00010150611,0.000020752266,0.00006261624,0.00004988624,0.0000069304942],"category_scores_gemma":[0.0017704513,0.00004175681,0.00010668035,0.00028878974,0.0001792349,0.00009376475,0.00004137454,0.00009376734,0.000004656648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042865344,0.00018545016,0.94421333,0.0001011157,0.00016757048,7.3086903e-7,0.0002735734,0.0000021583917,2.9491213e-7,0.0000055132296,0.0002171309,0.05440445],"study_design_scores_gemma":[0.0028333694,0.0009884438,0.9941554,0.0013816585,0.00018126452,1.11432215e-7,0.00023952272,0.0000066033754,0.0000072575463,0.00009128652,0.000055554883,0.000059545036],"about_ca_topic_score_codex":0.00001635574,"about_ca_topic_score_gemma":0.000019375428,"teacher_disagreement_score":0.054344904,"about_ca_system_score_codex":0.000009345492,"about_ca_system_score_gemma":0.000066175,"threshold_uncertainty_score":0.21195234},"labels":[],"label_agreement":null},{"id":"W4379797691","doi":"10.1136/annrheumdis-2023-eular.3412","title":"AB1105 LONG-TERM SAFETY OF IXEKIZUMAB TREATMENT IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POST-HOC ANALYSIS OF END-OF-STUDY PROGRAM DATA RELATING TO MAJOR ADVERSE CARDIOVASCULAR EVENTS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Memorial University of Newfoundland","funders":"Agencia Estatal de Investigación; Sanofi Genzyme; Bausch Health; Sanofi; Kyowa Hakko Kirin; Celltrion; Galderma; XBiotech; National Psoriasis Foundation; Pfizer; Biogen; Incyte; Castle Biosciences; Sun Pharma; Dermira; Regeneron Pharmaceuticals; Helsinn; Celgene; LEO Pharma; Ortho Dermatologics; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; Meiji Seika Pharma; Coherus Biosciences; UCB Pharma; Valeant Pharmaceuticals International; Helsinn Therapeutics; Amgen","keywords":"Medicine; Ixekizumab; Psoriatic arthritis; Psoriasis; Post-hoc analysis; Arthritis; Adverse effect; Dermatology; Internal medicine; Secukinumab","score_opus":0.028858596229654143,"score_gpt":0.2903887033458657,"score_spread":0.26153010711621155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379797691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859024,0.0033927436,0.000002854197,0.000033602533,0.0002226801,0.0024396745,0.0052746735,0.000034535842,0.0000089926725],"genre_scores_gemma":[0.9960039,0.0015424284,0.0000839334,0.0000066352977,0.000008102414,0.00024061036,0.0020377333,0.000027171613,0.00004944802],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968734,0.00071396213,0.0012038964,0.00049934647,0.0003149368,0.00039447795],"domain_scores_gemma":[0.99695355,0.00039357095,0.0006872991,0.0015836643,0.00032042566,0.00006146741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041729436,0.00034395495,0.0015093928,0.0005468962,0.00010048108,0.0000052703663,0.0006233419,0.00010441221,0.00010048737],"category_scores_gemma":[0.00055711775,0.00022507542,0.0006883605,0.0016995826,0.00015019224,0.00016143156,0.0002885815,0.00006133332,0.000012189887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061651664,0.005226774,0.4194433,0.00024239295,0.023646966,0.000016809774,0.0018035667,0.00035179433,0.000013011019,0.000009391084,0.000028672752,0.54305214],"study_design_scores_gemma":[0.009938043,0.0032987061,0.97678196,0.0014609356,0.006974129,0.0000018849347,0.0009677835,0.000016884605,0.00031581116,0.0000103388975,0.000016242586,0.00021728249],"about_ca_topic_score_codex":0.0011526693,"about_ca_topic_score_gemma":0.002132996,"teacher_disagreement_score":0.55733865,"about_ca_system_score_codex":0.000036324975,"about_ca_system_score_gemma":0.00019710748,"threshold_uncertainty_score":0.91783094},"labels":[],"label_agreement":null},{"id":"W4379797966","doi":"10.1136/annrheumdis-2023-eular.1018","title":"POS1567 OUTCOMES AND PREDICTORS OF CHRONIC IMMUNE CHECKPOINT INHIBITOR INDUCED INFLAMMATORY ARTHRITIS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO) RETROSPECTIVE COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Alberta; Université de Montréal; Western University; University of British Columbia; McGill University","funders":"National Institutes of Health","keywords":"Medicine; Rheumatology; Internal medicine; Retrospective cohort study; Oncology; Inflammatory arthritis; Arthritis; Cohort; Ipilimumab; Immunology; Immunotherapy; Cancer","score_opus":0.0665424352592655,"score_gpt":0.35586201548970237,"score_spread":0.28931958023043686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379797966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813905,0.012401718,1.5609629e-7,0.0039818464,0.00033767754,0.001037587,0.0007536135,0.000017168772,0.00007975816],"genre_scores_gemma":[0.9898045,0.0098365415,0.000005147987,0.00006548164,0.000018990497,0.00006683747,0.00015926814,0.000024105062,0.000019125155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970333,0.0005197225,0.0011060211,0.00032350133,0.00058818655,0.00042929465],"domain_scores_gemma":[0.996804,0.0009986322,0.00047067154,0.0013618984,0.00023899815,0.00012581875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022324605,0.00018617888,0.0009214759,0.0003271459,0.00014470397,0.0000142295585,0.0007276392,0.00015775887,0.00009823007],"category_scores_gemma":[0.0020279747,0.00011971283,0.00017274606,0.000726457,0.0011864397,0.0001258813,0.00047166616,0.0003050086,0.0000032644843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007484495,0.0002112864,0.9830285,0.00032579128,0.0011795238,0.000008696005,0.0013578006,0.0000013296369,0.003565741,0.00011571449,0.0022203783,0.007236795],"study_design_scores_gemma":[0.0020886844,0.0004076136,0.99107975,0.0025067104,0.000071259106,0.000008549283,0.0013440382,0.000089253794,0.0015632631,0.00062211964,0.000120194156,0.00009857262],"about_ca_topic_score_codex":0.27308565,"about_ca_topic_score_gemma":0.24030104,"teacher_disagreement_score":0.032784615,"about_ca_system_score_codex":0.00024144795,"about_ca_system_score_gemma":0.0018745926,"threshold_uncertainty_score":0.7735615},"labels":[],"label_agreement":null},{"id":"W4379798345","doi":"10.1136/annrheumdis-2023-eular.3792","title":"POS1370 METABOLIC SYNDROME IS ASSOCIATED WITH MORE PAIN IN HAND OSTEOARTHRITIS: RESULTS FROM THE DIGICOD COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Osteoarthritis; Cohort; Physical therapy; Internal medicine; Alternative medicine; Pathology","score_opus":0.03261760153585602,"score_gpt":0.2985442273477872,"score_spread":0.26592662581193116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379798345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794464,0.003670759,4.0192913e-7,0.014315131,0.000052906067,0.00087308633,0.0014766145,0.000050420647,0.000114273695],"genre_scores_gemma":[0.9962024,0.0007692831,0.0000064508163,0.0020592362,0.000006953894,0.000098870354,0.00034620223,0.000023211718,0.00048737106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823916,0.00021560249,0.000464926,0.00023168435,0.00050782063,0.00034079002],"domain_scores_gemma":[0.998013,0.0008889567,0.00024315061,0.00059167406,0.00009277467,0.0001704388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005332287,0.0001745794,0.00054310827,0.000064814194,0.00013751109,0.000028365386,0.00017594497,0.00005255481,0.000032086304],"category_scores_gemma":[0.001979409,0.00008778247,0.00014364153,0.00061542826,0.00017074926,0.000069895745,0.00005728794,0.00010611882,0.000032180193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013618107,0.0011974762,0.9130071,0.00018129827,0.0018161742,0.0003347764,0.0028755355,0.00002895961,0.0000037754244,0.000046785204,0.026756736,0.05238961],"study_design_scores_gemma":[0.0033276684,0.00027280158,0.99180514,0.0027929884,0.00028441477,0.000009133261,0.00029119148,0.00013516445,0.000053509957,0.0007664121,0.00017320257,0.00008839591],"about_ca_topic_score_codex":0.0018699657,"about_ca_topic_score_gemma":0.0002788411,"teacher_disagreement_score":0.078798056,"about_ca_system_score_codex":0.000014339443,"about_ca_system_score_gemma":0.00017938325,"threshold_uncertainty_score":0.35796654},"labels":[],"label_agreement":null},{"id":"W4379798807","doi":"10.1136/annrheumdis-2023-eular.3293","title":"AB1535 EFFICACY OF APREMILAST ON WHOLE-BODY INFLAMMATION INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS: ASSESSMENTS BY WHOLE-BODY MAGNETIC RESONANCE IMAGING IN THE PHASE 4 MOSAIC STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Gilead Sciences; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Psoriatic arthritis; Apremilast; Enthesitis; Dactylitis; Enthesis; Magnetic resonance imaging; Rheumatology; Arthritis; Internal medicine; Radiology; Surgery","score_opus":0.016641338964856017,"score_gpt":0.3255479993729449,"score_spread":0.30890666040808884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379798807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116766,0.005099445,0.0000022016825,0.0010126148,0.000060713737,0.0023226994,0.00024686614,0.000030613148,0.000057205525],"genre_scores_gemma":[0.9978007,0.0016411009,0.000007215519,0.000081018334,0.000016400874,0.00022339889,0.00017057337,0.000030800715,0.000028756762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99643284,0.0005728591,0.00084140984,0.00031503374,0.001396923,0.00044090484],"domain_scores_gemma":[0.99808913,0.00059667666,0.00037381265,0.0006864391,0.00014811575,0.00010580154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007558317,0.00025785467,0.00055944093,0.00037198927,0.00011402778,0.000064722844,0.00047175045,0.00003248836,0.0000345335],"category_scores_gemma":[0.0007691535,0.00015804832,0.00010822688,0.001026038,0.00024423373,0.00028872836,0.00009342599,0.00021806164,0.000019585928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025480755,0.008602894,0.6233023,0.0003313421,0.000114588445,0.000028955856,0.0036796634,0.00009317503,0.00013488815,0.000060412116,0.0031480857,0.35795563],"study_design_scores_gemma":[0.017749954,0.0023266273,0.97013193,0.0057194736,0.000022235063,0.0000011268565,0.0025147737,0.0007114007,0.00017774037,0.00031670526,0.00017201847,0.00015601006],"about_ca_topic_score_codex":0.00014109629,"about_ca_topic_score_gemma":0.000042627984,"teacher_disagreement_score":0.35779965,"about_ca_system_score_codex":0.000027731317,"about_ca_system_score_gemma":0.00012726198,"threshold_uncertainty_score":0.64450234},"labels":[],"label_agreement":null},{"id":"W4379799023","doi":"10.1136/annrheumdis-2023-eular.1918","title":"AB1087 LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; Toronto Western Hospital","funders":"","keywords":"Medicine; Post-hoc analysis; Double blind; Placebo; Randomized controlled trial; Term (time); Physical therapy; Internal medicine; Alternative medicine; Pathology","score_opus":0.0496325501211056,"score_gpt":0.3535877099984017,"score_spread":0.3039551598772961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379799023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190843,0.0020162181,0.0000029372427,0.00006186627,0.000034371827,0.005544049,0.00041715082,0.000010589655,0.0000043970235],"genre_scores_gemma":[0.9965717,0.0027399037,0.000011922369,0.0000047288227,0.0000028364507,0.00043899525,0.00020753386,0.000013399962,0.0000089363975],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99761647,0.0003356654,0.0011954636,0.00028150616,0.00037503376,0.00019583956],"domain_scores_gemma":[0.99735475,0.00082867924,0.0010623819,0.00040138033,0.00030053183,0.000052252395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002861112,0.0002234646,0.0020412009,0.00044279164,0.000034338518,0.000008490391,0.00010901773,0.000044262775,0.00001868338],"category_scores_gemma":[0.00054906576,0.00013757235,0.0003569525,0.0010803565,0.0002825417,0.00011439524,0.000051431995,0.000044783465,7.9171906e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6839589,0.013303633,0.26329818,0.00018409546,0.011619878,0.000018159426,0.008740718,0.000122029414,0.000032318563,0.000013838516,0.0000026599112,0.0187056],"study_design_scores_gemma":[0.45485803,0.0021189493,0.53908557,0.0005312418,0.0019424988,2.1698095e-7,0.0010894535,0.000027939459,0.00024865175,0.0000345565,2.1184759e-8,0.00006286066],"about_ca_topic_score_codex":0.0010339582,"about_ca_topic_score_gemma":0.0003776116,"teacher_disagreement_score":0.27578738,"about_ca_system_score_codex":0.00003208539,"about_ca_system_score_gemma":0.00007137352,"threshold_uncertainty_score":0.5610038},"labels":[],"label_agreement":null},{"id":"W4379799256","doi":"10.1136/annrheumdis-2023-eular.2975","title":"POS1110 PATIENT CLUSTERS IDENTIFIED BY MACHINE LEARNING: DATA FROM A POOLED ANALYSIS OF PHASE-3 TRIALS OF SECUKINUMAB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Mitacs","keywords":"Medicine; Psoriatic arthritis; Secukinumab; Ankylosing spondylitis; Psoriasis; Internal medicine; Enthesitis; Enthesis; Cluster (spacecraft); Demographics; Arthritis; Dermatology; Surgery; Demography","score_opus":0.05991838261806893,"score_gpt":0.34395675155801075,"score_spread":0.28403836893994183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379799256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595939,0.018996207,0.00003288206,0.00051710254,0.000105694155,0.00087883446,0.019827818,0.000027452825,0.000020117603],"genre_scores_gemma":[0.98235345,0.011769037,0.00011770988,0.000045357174,0.0000130429935,0.000052006213,0.0055975923,0.00002786102,0.000023921419],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965331,0.0005140536,0.0015747485,0.0004190883,0.0006599294,0.00029908336],"domain_scores_gemma":[0.99660116,0.0012253734,0.0011231508,0.0007508832,0.00016460387,0.00013483189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060319074,0.00026692185,0.0017456432,0.0004848458,0.00012085871,0.00003180209,0.00021754716,0.00005278468,0.00023013505],"category_scores_gemma":[0.0023085498,0.00019806359,0.0003028869,0.00131186,0.00022235258,0.00018287085,0.00021745567,0.00010504655,0.0000021018966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011491655,0.010086929,0.14118011,0.0024350807,0.059117816,0.000531152,0.014897793,0.0012992516,0.00091798825,0.00024079169,0.005790868,0.7520106],"study_design_scores_gemma":[0.0891394,0.006229071,0.7501699,0.027316662,0.04265917,0.0000703856,0.016580405,0.060108844,0.00209986,0.00390532,0.00040154622,0.0013194397],"about_ca_topic_score_codex":0.0027529008,"about_ca_topic_score_gemma":0.0013329723,"teacher_disagreement_score":0.7506911,"about_ca_system_score_codex":0.000019886738,"about_ca_system_score_gemma":0.00010141821,"threshold_uncertainty_score":0.80767983},"labels":[],"label_agreement":null},{"id":"W4379799308","doi":"10.1136/annrheumdis-2023-eular.4672","title":"POS1353 SEMIQUANTITATIVE ASSESSMENT OF KNEE OSTEOARTHRITIS-RELATED SYNOVITIS COMPARED TO CHRONIC INFLAMMATORY ARTHRITIDES: RELATION TO AGE AND IMPACT ON BONE/STRUCTURAL DAMAGE","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Synovitis; Osteoarthritis; Rheumatoid arthritis; Psoriatic arthritis; Synovial membrane; Arthritis; Inflammation; Population; Pathology; Internal medicine; Biopsy; Inflammatory arthritis; Gastroenterology","score_opus":0.026997483333209768,"score_gpt":0.3581101844779411,"score_spread":0.3311127011447313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379799308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940804,0.0021415243,0.0000063037023,0.0015896055,0.000102792124,0.0013661024,0.00036900648,0.000073605035,0.000270607],"genre_scores_gemma":[0.9979283,0.0015810143,0.000068084955,0.00012549372,0.000015809153,0.000072454575,0.00009467748,0.000034319295,0.00007980016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976931,0.00023497801,0.0006572621,0.00027293817,0.00069980987,0.00044191213],"domain_scores_gemma":[0.99819267,0.00048160984,0.00023092788,0.0004907272,0.0002247535,0.0003793327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003883675,0.00024656515,0.00065718964,0.0003981404,0.00014635449,0.000048894188,0.00017418603,0.000055097105,0.00013091262],"category_scores_gemma":[0.0007844219,0.0001781207,0.00024643666,0.00060420966,0.0002656374,0.00018014656,0.0001724551,0.00017337503,0.000036415742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006517097,0.0013647617,0.3517598,0.00587552,0.0054763947,0.0008762047,0.024288401,0.029341599,0.040320277,0.040903006,0.029090686,0.46418625],"study_design_scores_gemma":[0.0019334402,0.0022803997,0.98278266,0.0065217004,0.000020526553,0.000020340569,0.000616919,0.0016102327,0.0006387838,0.0033392494,0.00005109652,0.00018465576],"about_ca_topic_score_codex":0.00010793276,"about_ca_topic_score_gemma":0.0000504114,"teacher_disagreement_score":0.6310229,"about_ca_system_score_codex":0.00006078878,"about_ca_system_score_gemma":0.00028555284,"threshold_uncertainty_score":0.72635514},"labels":[],"label_agreement":null},{"id":"W4379799338","doi":"10.1136/annrheumdis-2023-eular.4414","title":"POS1446 VARIATION IN SYSTEMIC DISEASE ACTIVITY MEASURED WITH ESSDAI IN A PROSPECTIVE LONGITUDINAL COHORT OF PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME WITHOUT IMMUNOSUPPRESSIVE TREATMENT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Arthritis Society; Argenx; Dutch Arthritis Society; Union Chimique Belge; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Prospective cohort study; Cohort; Systemic disease; Disease; Immunology; Internal medicine","score_opus":0.0195046111085783,"score_gpt":0.2583730498911115,"score_spread":0.2388684387825332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379799338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709505,0.00029999812,0.00002367702,0.00020299533,0.000051332703,0.0019488534,0.00023071028,0.00002998771,0.000117422256],"genre_scores_gemma":[0.9993521,0.000100838675,0.000008988099,0.0000143734305,0.0000052052524,0.0003384792,0.00009323819,0.00002055664,0.000066252695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985761,0.00012411675,0.00032257964,0.00026484294,0.0005031778,0.00020916181],"domain_scores_gemma":[0.99882287,0.00011952464,0.00030700144,0.00044889704,0.00020021622,0.00010148249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012009635,0.00019997609,0.0005851587,0.00021071489,0.00005812724,0.000010070107,0.000094337716,0.000032967997,0.000012716754],"category_scores_gemma":[0.00015537205,0.00011102297,0.00010739278,0.00064070267,0.00012025607,0.00016599451,0.000036307032,0.00006444944,0.0000021581366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062270537,0.0019552435,0.98913044,0.000674684,0.0005027327,0.000019052226,0.00050173234,0.00063758844,0.0000096340655,0.000025290798,0.000024646373,0.00029192163],"study_design_scores_gemma":[0.0045181215,0.00085108035,0.9905289,0.002894905,0.00045982836,0.0000054399375,0.00014292418,0.00023522557,0.000017691524,0.00022410911,3.7853297e-7,0.00012140851],"about_ca_topic_score_codex":0.00048188085,"about_ca_topic_score_gemma":0.0000433662,"teacher_disagreement_score":0.0022570447,"about_ca_system_score_codex":0.000096770505,"about_ca_system_score_gemma":0.00033914496,"threshold_uncertainty_score":0.45273855},"labels":[],"label_agreement":null},{"id":"W4379799533","doi":"10.1136/annrheumdis-2023-eular.3727","title":"AB0719 IS AORTIC 18FDG-UPTAKE PREVALENCE UNDERESTIMATED? DATA FROM A LARGE HOSPITAL-BASED COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Medizinische Universität Graz; Karl-Franzens-Universität Graz; Leids Universitair Medisch Centrum; Universiteit Leiden; University of Toronto; Cleveland Clinic; Sanofi; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Aortitis; Giant cell arteritis; Polymyalgia rheumatica; Cohort; Vasculitis; Fever of unknown origin; Arteritis; Internal medicine; Retrospective cohort study; Aorta; Surgery; Pediatrics; Disease","score_opus":0.06342729080957187,"score_gpt":0.34404134233262296,"score_spread":0.2806140515230511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379799533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771773,0.0033346417,0.00009532918,0.011728594,0.0002622598,0.0007692522,0.0061581545,0.00019975251,0.00027469252],"genre_scores_gemma":[0.9945227,0.0022261287,0.000060138704,0.0010785832,0.000027135704,0.00004612483,0.0013026795,0.000030517767,0.0007059758],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982233,0.000068746194,0.00045972306,0.00036518674,0.0005451106,0.00033793985],"domain_scores_gemma":[0.9973805,0.0002492806,0.00020429521,0.001835283,0.00012720874,0.00020344886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020281883,0.0001798593,0.00037946517,0.00008311352,0.00016308701,0.00003325451,0.0005943785,0.00007294765,0.0014772927],"category_scores_gemma":[0.0008224526,0.000120052595,0.00026282348,0.00045186127,0.0001567656,0.00013428327,0.00024549777,0.0001250378,0.00045126752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010770239,0.0027056988,0.37497416,0.0030194807,0.0038579402,0.00008206713,0.0006256241,0.00029671905,0.00005680248,0.0005869083,0.6064235,0.007263404],"study_design_scores_gemma":[0.0010059201,0.0000821293,0.96246696,0.003153906,0.001192877,0.0000021454935,0.00014079703,0.027518842,0.0001294801,0.0036935706,0.00044758338,0.00016579442],"about_ca_topic_score_codex":0.00012100089,"about_ca_topic_score_gemma":0.000004307316,"teacher_disagreement_score":0.6059759,"about_ca_system_score_codex":0.000011717242,"about_ca_system_score_gemma":0.00023945118,"threshold_uncertainty_score":0.9994355},"labels":[],"label_agreement":null},{"id":"W4379799670","doi":"10.1136/annrheumdis-2023-eular.1171","title":"POS1151 THERAPEUTIC DRUG MONITORING OF AZATHIOPRINE AND TACROLIMUS IN SLE PREGNANCIES: PRELIMINARY RESULTS FROM THE LEGACY COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Canadian Rheumatology Association","keywords":"Medicine; Azathioprine; Tacrolimus; Cohort; Drug; Therapeutic drug monitoring; Internal medicine; Intensive care medicine; Pharmacology; Transplantation; Disease","score_opus":0.04889245988586453,"score_gpt":0.3283367331436223,"score_spread":0.2794442732577577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379799670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759487,0.015827466,0.0000032828327,0.007096042,0.00019152733,0.0005990993,0.00012516712,0.00003755721,0.00017119208],"genre_scores_gemma":[0.9912856,0.0079363305,0.000016691274,0.00017759149,0.00003497742,0.000043721953,0.000023405444,0.000014474548,0.00046718505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857,0.00012024208,0.0005061977,0.00017993305,0.00038959674,0.0002340317],"domain_scores_gemma":[0.9978353,0.0010342891,0.0002748792,0.0006789074,0.00007829226,0.00009838016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049882097,0.00013010962,0.00033652192,0.00007004998,0.00006430757,0.000012339603,0.00026775082,0.000036713674,0.000010336448],"category_scores_gemma":[0.0018001419,0.00007251665,0.00011359399,0.0003697265,0.00020682722,0.00013449394,0.00012878042,0.00011975786,0.0000049460223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018858372,0.0006819615,0.9015561,0.0011390231,0.0006655675,0.0000141194905,0.01328186,0.00015406977,0.00042614638,0.00024050109,0.0049366457,0.0750182],"study_design_scores_gemma":[0.0010639773,0.00010094957,0.9850169,0.00768556,0.00015397574,0.0000033570195,0.0019280029,0.0003088465,0.0020747157,0.0015284644,0.000067263696,0.00006801551],"about_ca_topic_score_codex":0.0004549399,"about_ca_topic_score_gemma":0.0000055346018,"teacher_disagreement_score":0.0834608,"about_ca_system_score_codex":0.000011014422,"about_ca_system_score_gemma":0.00017641467,"threshold_uncertainty_score":0.2957143},"labels":[],"label_agreement":null},{"id":"W4379800032","doi":"10.1136/annrheumdis-2023-eular.2557","title":"AB0260 DISABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RELATIONSHIP WITH ALEXITHYMIA.","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Medicine; Rheumatoid arthritis; Toronto Alexithymia Scale; Visual analogue scale; Physical therapy; Depression (economics); Anxiety; Internal medicine; Clinical psychology; Psychiatry","score_opus":0.033531447641402444,"score_gpt":0.29790866564524787,"score_spread":0.26437721800384545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379800032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961183,0.00053408585,0.0000047055787,0.0018343291,0.000021108179,0.00077872357,0.0000427062,0.00006293202,0.00060312235],"genre_scores_gemma":[0.99915844,0.00038475625,0.000019451203,0.000086243876,0.000003622846,0.000081197635,0.000049128415,0.000025644362,0.00019154017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998088,0.0001279654,0.00046173186,0.00021187295,0.0007892664,0.00032118047],"domain_scores_gemma":[0.99863905,0.0002588027,0.00016686066,0.0006879336,0.00013452978,0.00011285119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030299454,0.0001570284,0.0004081573,0.000078611774,0.00011314286,0.000018571563,0.00020080409,0.000042948453,0.00011131479],"category_scores_gemma":[0.00084207894,0.000089703404,0.000104604434,0.0008096244,0.00046967124,0.00019630326,0.00008752276,0.00016124039,0.000051065315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006302741,0.0005675721,0.9860643,0.00034981407,0.00007705747,0.000002935371,0.00025096495,0.00015354044,3.2814702e-7,0.00022597471,0.0013086724,0.010368542],"study_design_scores_gemma":[0.0022149468,0.00026923761,0.9927724,0.0029933455,0.000012656545,0.0000012103621,0.000449547,0.00016483982,0.000026600084,0.00089889235,0.00008246656,0.00011386825],"about_ca_topic_score_codex":0.000056591536,"about_ca_topic_score_gemma":0.00004019826,"teacher_disagreement_score":0.010254674,"about_ca_system_score_codex":0.000021089241,"about_ca_system_score_gemma":0.00016989376,"threshold_uncertainty_score":0.36579987},"labels":[],"label_agreement":null},{"id":"W4379800129","doi":"10.1136/annrheumdis-2023-eular.2612","title":"POS1122 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: ONE-YEAR RESULTS FROM A PHASE 3 STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Placebo; Imputation (statistics); Adverse effect; Clinical endpoint; Clinical trial; Gastroenterology; Physical therapy; Missing data","score_opus":0.05700709635118935,"score_gpt":0.34676436090299134,"score_spread":0.289757264551802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379800129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929538,0.00029793926,3.182803e-7,0.0006986795,0.000021196096,0.0015505009,0.004441615,0.000021066406,0.000014886762],"genre_scores_gemma":[0.999192,0.00042962513,0.000049393202,0.00007713521,0.0000063781536,0.00003164673,0.0001843743,0.000015679927,0.000013748729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984778,0.00032957023,0.00039877076,0.0003078102,0.0002754814,0.0002105345],"domain_scores_gemma":[0.9985339,0.00065582857,0.0001878329,0.00037087788,0.000112779686,0.00013875443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028887985,0.00017270568,0.000518556,0.00015163724,0.0000905071,0.0000125191455,0.0000849229,0.000028457293,0.000019642006],"category_scores_gemma":[0.0009327103,0.00010745651,0.000044627228,0.0003893795,0.00014442489,0.000083460414,0.00011447936,0.000053742366,0.0000015522035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3655878,0.008937841,0.37896925,0.00006993158,0.0009857259,0.00004061029,0.011971774,0.000008713912,0.000089967085,0.000012599507,0.00006161607,0.23326415],"study_design_scores_gemma":[0.033178627,0.008144325,0.9541912,0.0011518309,0.00009771486,4.0381846e-7,0.0027950376,0.00000785606,0.00015935657,0.00015300672,0.000019155837,0.000101497215],"about_ca_topic_score_codex":0.00041818427,"about_ca_topic_score_gemma":0.00003563715,"teacher_disagreement_score":0.57522196,"about_ca_system_score_codex":0.000014164681,"about_ca_system_score_gemma":0.00004097735,"threshold_uncertainty_score":0.43819493},"labels":[],"label_agreement":null},{"id":"W4379800235","doi":"10.1136/annrheumdis-2023-eular.2664","title":"POS1608 MIRNA BIOMARKERS FOR ARTICULAR AND CUTANEOUS RESPONSE TO METHOTREXATE IN PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"Canadian Institutes of Health Research; University Health Network Foundation; Krembil Foundation; Arthritis Society; National Psoriasis Foundation","keywords":"Medicine; Psoriatic arthritis; Psoriasis; microRNA; Methotrexate; Oncology; Internal medicine; Arthritis; Disease; Rheumatoid arthritis; Personalized medicine; Bioinformatics; Immunology; Gene","score_opus":0.035920099188305916,"score_gpt":0.3413944289896136,"score_spread":0.3054743298013077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379800235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788151,0.006478384,0.000026812862,0.013291463,0.00009717932,0.001120561,0.00009824334,0.00004820977,0.000024062836],"genre_scores_gemma":[0.98690325,0.01206231,0.0003059525,0.00036143156,0.000012216311,0.00016919449,0.000009356835,0.00002663063,0.000149678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983259,0.000277885,0.00040675767,0.00022085341,0.00035866786,0.00040995973],"domain_scores_gemma":[0.99803966,0.0010915154,0.00008428007,0.0003898064,0.000111912035,0.0002828349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075838756,0.00014661088,0.00042391088,0.00029975825,0.000091494374,0.00004340175,0.00014823831,0.000034910194,0.000039036688],"category_scores_gemma":[0.005100591,0.00010577886,0.00018092475,0.0005686306,0.00015036805,0.00008712759,0.00009267528,0.000055431254,0.000027679303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02250696,0.00093724945,0.013910663,0.0019263885,0.0016872504,0.00037231145,0.0060680453,0.00014832031,0.011691169,0.0010625847,0.035641767,0.9040473],"study_design_scores_gemma":[0.014970391,0.0038997277,0.873452,0.019063877,0.000120073135,0.00044564225,0.005825147,0.0076230983,0.021368623,0.04081061,0.0113807125,0.0010401098],"about_ca_topic_score_codex":0.00006813541,"about_ca_topic_score_gemma":0.00002652761,"teacher_disagreement_score":0.9030072,"about_ca_system_score_codex":0.000011597742,"about_ca_system_score_gemma":0.00011128385,"threshold_uncertainty_score":0.6106252},"labels":[],"label_agreement":null},{"id":"W4379800625","doi":"10.1136/annrheumdis-2023-eular.4065","title":"AB1448 BISPHOSPHONATES IN (MONA) SPECTRUM DISORDER: TWO CASE REPORTS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; Assistance publique-Hôpitaux de Paris; Universidad Autónoma de Madrid; Institut National de la Santé et de la Recherche Médicale; Ospedale Pediatrico Bambino Gesù; University of Ottawa; Pfizer","keywords":"Medicine; Bisphosphonate; Osteoporosis; Surgery; Dermatology; Internal medicine","score_opus":0.027068996379301335,"score_gpt":0.33904618504354284,"score_spread":0.3119771886642415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379800625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920686,0.005096782,0.000009145901,0.0020356963,0.00010010327,0.00033671656,0.000051320705,0.00002015903,0.00028148087],"genre_scores_gemma":[0.9978978,0.0010977656,0.0000061319847,0.000073402385,0.000013574742,0.000059841634,0.000050922477,0.000024577137,0.00077596254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986673,0.00011927309,0.0003167819,0.00030718988,0.0002476448,0.00034180083],"domain_scores_gemma":[0.99896395,0.00008730826,0.00013082892,0.00066297466,0.00007217769,0.00008276162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029557728,0.00014572877,0.00020350583,0.00010262938,0.000083350904,0.000019487385,0.0002146473,0.00004189222,0.00008321353],"category_scores_gemma":[0.0011737564,0.00011448432,0.00018001771,0.00050910545,0.00014951878,0.0000063333864,0.00034247787,0.00006414393,0.00001889296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007047005,0.0023027752,0.7097311,0.0012833215,0.001002623,0.006051728,0.0011277766,0.006920339,0.011903357,0.0013825924,0.07637251,0.1812172],"study_design_scores_gemma":[0.0031537642,0.00074331625,0.76609266,0.0009364214,0.0001144304,0.001786363,0.0045154663,0.0034575243,0.14358269,0.057420466,0.016679574,0.0015173138],"about_ca_topic_score_codex":0.0012909694,"about_ca_topic_score_gemma":0.0013409539,"teacher_disagreement_score":0.17969987,"about_ca_system_score_codex":0.0000060935627,"about_ca_system_score_gemma":0.00010294884,"threshold_uncertainty_score":0.4668535},"labels":[],"label_agreement":null},{"id":"W4379801140","doi":"10.1136/annrheumdis-2023-eular.2777","title":"POS1232 EFFECT MODIFICATION OF CANCER ON THE ASSOCIATION BETWEEN DYSPHAGIA AND MORTALITY IN EARLY IDIOPATHIC INFLAMMATORY MYOPATHIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Gilead Sciences; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Dysphagia; Hazard ratio; Internal medicine; Dermatomyositis; Proportional hazards model; Cancer; Cohort; Cohort study; Mortality rate; Cancer registry; Surgery; Pediatrics; Confidence interval","score_opus":0.034846396416222405,"score_gpt":0.3225911912529453,"score_spread":0.2877447948367229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379801140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626935,0.0011124818,0.0000012323766,0.0016886999,0.0000890557,0.00063652854,0.00007432833,0.000036741112,0.000091581845],"genre_scores_gemma":[0.99899536,0.00066470157,8.374887e-7,0.00014104223,0.000034181583,0.00010373076,0.00000876094,0.000014958328,0.000036448673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820524,0.00037716838,0.00053831213,0.0001500301,0.00052617554,0.00020305766],"domain_scores_gemma":[0.99827206,0.00063651055,0.00048406064,0.00040821763,0.00013611787,0.00006300597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012100607,0.00014425743,0.00044544414,0.000119110875,0.00009382183,0.00001805251,0.00014697338,0.00007944886,0.000008475154],"category_scores_gemma":[0.0010642047,0.00008558039,0.00014781323,0.00035871204,0.00012390185,0.00009460987,0.00006666011,0.00014339117,0.000010216362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007799444,0.00003452147,0.99283427,0.0011160001,0.00019656429,0.000003190047,0.00094602647,0.000061162275,0.00013680433,0.00066673715,0.00024511115,0.0036816443],"study_design_scores_gemma":[0.00040658223,0.00009444405,0.9910198,0.0016712517,0.0001988761,5.267407e-7,0.0001172199,0.0005531543,0.004627953,0.001223261,0.000009375346,0.00007754828],"about_ca_topic_score_codex":0.0002452537,"about_ca_topic_score_gemma":0.000018667186,"teacher_disagreement_score":0.0044911485,"about_ca_system_score_codex":0.000034403572,"about_ca_system_score_gemma":0.00007783432,"threshold_uncertainty_score":0.34898672},"labels":[],"label_agreement":null},{"id":"W4379801286","doi":"10.1136/annrheumdis-2023-eular.3708","title":"POS1111 TREATMENT WITH UPADACITINIB RESULTS IN THE INHIBITION OF A BROAD RANGE OF POTENTIALLY PATHOGENIC PATHWAYS IN NR-AXSPA AND BDMARD-IR AS PATIENTS: PROTEOMIC ANALYSIS FROM THE SELECT-AXIS 2 PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Mitacs","keywords":"Medicine; Axial spondyloarthritis; Immunology; Bioinformatics; Ankylosing spondylitis","score_opus":0.032392153068270375,"score_gpt":0.31029568811625385,"score_spread":0.2779035350479835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379801286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945237,0.0029138373,0.0000036459655,0.000539569,0.000017558123,0.0009375181,0.001022851,0.000003994649,0.000037329886],"genre_scores_gemma":[0.995419,0.0041688033,0.000009427059,0.00006210739,0.000008220546,0.00009190148,0.00021647441,0.000008814859,0.00001521297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983437,0.00048212087,0.0005451005,0.00022414941,0.00023665692,0.000168253],"domain_scores_gemma":[0.99884826,0.00015116089,0.0004384789,0.00036500354,0.00016373613,0.000033370867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040625889,0.0001518492,0.00038477228,0.00009522165,0.000060935396,0.0000081236285,0.00015173973,0.000054101474,0.0000018130837],"category_scores_gemma":[0.00031910744,0.00006913696,0.0001721283,0.0005768597,0.0001516666,0.0000076115475,0.00006231129,0.000042924694,6.930038e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02091298,0.013162556,0.7353348,0.0027376642,0.018559478,0.00004881067,0.054253265,0.0030479461,0.05888606,0.00025622634,0.0026196234,0.09018059],"study_design_scores_gemma":[0.008211437,0.0036462478,0.9604912,0.0017018912,0.00091478275,0.0000020060754,0.005458844,0.00014562927,0.01852299,0.0006481693,0.00003113842,0.00022569727],"about_ca_topic_score_codex":0.0008811056,"about_ca_topic_score_gemma":0.00042327208,"teacher_disagreement_score":0.22515637,"about_ca_system_score_codex":0.00001034813,"about_ca_system_score_gemma":0.00012220432,"threshold_uncertainty_score":0.28193232},"labels":[],"label_agreement":null},{"id":"W4379801320","doi":"10.1136/annrheumdis-2023-eular.2306","title":"POS1065 DAS28-GGT FOR THE PREDICTION OF MAJOR CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE ESPOIR COHORT","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Mace; Framingham Risk Score; Disease; Myocardial infarction","score_opus":0.03655716301196262,"score_gpt":0.29286396951767596,"score_spread":0.25630680650571336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379801320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9316834,0.056252472,0.000046164358,0.006652369,0.00034549262,0.0023080185,0.0025737553,0.00006399971,0.00007431186],"genre_scores_gemma":[0.86288625,0.13634762,0.000015424886,0.00010942352,0.000047821366,0.00027241666,0.00021684059,0.000031666306,0.000072513365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703324,0.0003291172,0.00087760243,0.00030288292,0.0010410063,0.00041617014],"domain_scores_gemma":[0.99612486,0.0019151275,0.0002698182,0.0013211935,0.00025009038,0.00011893204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015314461,0.00020624447,0.00065664767,0.00011156028,0.00026586917,0.000024004268,0.00058897905,0.000065008106,0.00004130538],"category_scores_gemma":[0.003592257,0.00010728844,0.0008206611,0.0005533204,0.0003485588,0.00013683525,0.00017084587,0.00015927656,0.00001879472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010184508,0.0022113668,0.4196816,0.0013875924,0.020801893,0.000029767178,0.00882348,0.0029697209,0.00038846405,0.002002612,0.16041817,0.3711008],"study_design_scores_gemma":[0.005384527,0.00020108196,0.97412,0.0057992036,0.00007881465,0.000011720536,0.0017070132,0.0017937684,0.0009695806,0.0059269774,0.0038752973,0.00013197384],"about_ca_topic_score_codex":0.0012038898,"about_ca_topic_score_gemma":0.000115936295,"teacher_disagreement_score":0.5544384,"about_ca_system_score_codex":0.000017267144,"about_ca_system_score_gemma":0.0001777682,"threshold_uncertainty_score":0.43750957},"labels":[],"label_agreement":null},{"id":"W4379801408","doi":"10.1136/annrheumdis-2023-eular.642","title":"AB1108 EFFECT OF GUSELKUMAB ADMINISTERED EVERY 8 WEEKS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS PERSISTS BETWEEN CONSECUTIVE DOSES AND IS DURABLE: POST HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; McGill University; Arthritis Society; University of Toronto","funders":"Pfizer","keywords":"Medicine; Psoriatic arthritis; Placebo; Post-hoc analysis; Double blind; Arthritis; Randomized controlled trial; Randomization; Surgery; Internal medicine; Alternative medicine; Pathology","score_opus":0.14425802298856716,"score_gpt":0.4125696409121257,"score_spread":0.26831161792355857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379801408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836,0.001342891,0.000008694963,0.0011899021,0.00007708081,0.0055124224,0.003443553,0.000014953664,0.00005050234],"genre_scores_gemma":[0.9988842,0.00030778573,0.000011235853,0.00015631353,0.000010104866,0.0004617232,0.000108013846,0.000023592205,0.000037010937],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9932504,0.0016273559,0.004053661,0.00046198865,0.00028770766,0.00031883086],"domain_scores_gemma":[0.9848139,0.009463844,0.0047062538,0.0006167292,0.00024861566,0.00015060986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007677172,0.00030523702,0.004657216,0.0011417083,0.00010789118,0.000039327104,0.0003171446,0.000081631064,0.00012621701],"category_scores_gemma":[0.0061559347,0.00024394617,0.000576341,0.0010958691,0.00030218522,0.00031416048,0.00009193201,0.00009717087,0.00001682728],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62470853,0.0021299974,0.32932532,0.0018154238,0.021856915,0.0000014281669,0.016938947,0.00029364336,1.8041221e-7,0.00023650071,0.0006900566,0.002003039],"study_design_scores_gemma":[0.63270104,0.002078731,0.3558735,0.000976629,0.0020160822,1.8374067e-7,0.0041326,0.001488574,0.00002003404,0.00041732437,0.000002311032,0.00029300086],"about_ca_topic_score_codex":0.0009703101,"about_ca_topic_score_gemma":0.00016397842,"teacher_disagreement_score":0.026548184,"about_ca_system_score_codex":0.00006586193,"about_ca_system_score_gemma":0.00018745326,"threshold_uncertainty_score":0.9947836},"labels":[],"label_agreement":null},{"id":"W4379801671","doi":"10.1136/annrheumdis-2023-eular.5587","title":"POS1064 PRE-DIABETES INCREASED THE RISK OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH INFLAMMATORY ARTHRITIS: A POPULATION-BASED COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Pfizer; Eli Lilly and Company","keywords":"Medicine; Mace; Internal medicine; Psoriatic arthritis; Rheumatoid arthritis; Cohort; Diabetes mellitus; Hazard ratio; Population; Arthritis; Proportional hazards model; Cohort study; Myocardial infarction; Endocrinology; Confidence interval; Percutaneous coronary intervention","score_opus":0.008414451638447104,"score_gpt":0.2461017738078738,"score_spread":0.23768732216942667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379801671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935849,0.0030333397,0.0000014238498,0.00014127666,0.000046633835,0.0029861892,0.00015490444,0.00004268302,0.000008692179],"genre_scores_gemma":[0.9984501,0.0010601882,0.000007473296,0.00003774519,0.000009752855,0.00031779893,0.000076519966,0.00003127932,0.000009169487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967216,0.0007617849,0.0005996499,0.0002351097,0.0013428946,0.00033892595],"domain_scores_gemma":[0.99786955,0.00045099584,0.00029393923,0.0009779634,0.00027575056,0.00013182803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010929416,0.00019823077,0.0006781394,0.00022103438,0.00013733804,0.000013539516,0.00030628577,0.00003468161,0.0000365939],"category_scores_gemma":[0.0014249218,0.00010941647,0.00038710414,0.00062184024,0.00016153778,0.00011255911,0.00008807178,0.00013352526,0.0000076275746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044972188,0.0009473508,0.99134344,0.00023644946,0.0018779191,0.0000024137014,0.00023284738,0.0007618599,0.0000011216413,0.000008021449,0.000114173854,0.0040246886],"study_design_scores_gemma":[0.004571284,0.00042905365,0.9916805,0.0020814384,0.000116594994,2.3273068e-7,0.0002288561,0.00035976263,0.00005482678,0.00035903673,0.0000068310014,0.00011160613],"about_ca_topic_score_codex":0.001291196,"about_ca_topic_score_gemma":0.00014988515,"teacher_disagreement_score":0.0048652156,"about_ca_system_score_codex":0.000017586583,"about_ca_system_score_gemma":0.00017476105,"threshold_uncertainty_score":0.4461874},"labels":[],"label_agreement":null},{"id":"W4379801948","doi":"10.1136/annrheumdis-2023-eular.2599","title":"POS1152 ATTAINMENT OF EULAR/ERA-EDTA TREATMENT TARGETS IN THE FIRST YEAR IN LUPUS NEPHRITIS: A MULTICENTER OBSERVATIONAL STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Canadian Rheumatology Association","keywords":"Medicine; Lupus nephritis; Belimumab; Prednisone; Internal medicine; Proteinuria; Retrospective cohort study; Systemic lupus erythematosus; Renal function; Surgery; Kidney; Disease; Immunology","score_opus":0.1365816201097069,"score_gpt":0.3820228239355464,"score_spread":0.24544120382583948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379801948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906229,0.0010692261,8.8350413e-7,0.00575429,0.00010025879,0.0022865392,0.00006698671,0.000014896733,0.00008406317],"genre_scores_gemma":[0.9986329,0.00048035526,0.000021464128,0.00017850609,0.000017781176,0.0003297723,0.000024838262,0.00001828238,0.00029611072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976252,0.00030131018,0.0006543447,0.00020642519,0.00091284054,0.00029992047],"domain_scores_gemma":[0.9984251,0.00059763703,0.0001706731,0.00063274003,0.00010766441,0.00006614385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006792928,0.00015815193,0.00046470025,0.00019831255,0.00004898692,0.0000145028325,0.00035701363,0.000032246277,0.000068840076],"category_scores_gemma":[0.00063542696,0.00008755331,0.00018823126,0.0006242921,0.00009087771,0.00006449313,0.00013154694,0.00008307966,0.000030454912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025604133,0.0027285186,0.9823171,0.0007331894,0.00021658813,0.000041562962,0.008707072,0.00010912134,0.000011958903,0.00008263692,0.004093054,0.00070319505],"study_design_scores_gemma":[0.0040023606,0.00036952007,0.9771666,0.0023051435,0.00006447391,0.000029711427,0.014518047,0.0009130643,0.0000675495,0.00033418744,0.00014873772,0.00008060024],"about_ca_topic_score_codex":0.00051422464,"about_ca_topic_score_gemma":0.00025108783,"teacher_disagreement_score":0.0080100335,"about_ca_system_score_codex":0.00007666055,"about_ca_system_score_gemma":0.00014647486,"threshold_uncertainty_score":0.35703203},"labels":[],"label_agreement":null},{"id":"W4379802255","doi":"10.1136/annrheumdis-2023-eular.3015","title":"AB1103 UPADACITINIB REAL-LIFE EFFICACY AND SAFETY IN PSORIATIC ARTHRITIS: RESULTS AT 24 WEEKS OF A MULTICENTRIC ITALIAN STUDY (UP-REAL)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Brigham and Women's Hospital; McGill University; Drexel University; College of Medicine, Drexel University; University of Washington; Université de Genève; University of Glasgow; Janssen Scientific Affairs","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology","score_opus":0.0435757214384568,"score_gpt":0.2966996287833561,"score_spread":0.2531239073448993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379802255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922614,0.0046872776,2.5459076e-7,0.00042420777,0.00050776737,0.0009772669,0.00087130646,0.000056089168,0.00021443523],"genre_scores_gemma":[0.98794657,0.010861178,0.000003916048,0.000025864267,0.000010571086,0.000059472783,0.00016665332,0.000019648587,0.0009061023],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976133,0.00063805823,0.00090782915,0.0003360097,0.00012172714,0.00038303752],"domain_scores_gemma":[0.9976649,0.0011713597,0.00044910877,0.0005736765,0.000072158364,0.00006877944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004929926,0.00024519127,0.0006680605,0.00021602486,0.00016348065,0.000010302245,0.00029378105,0.00010516855,0.000070588205],"category_scores_gemma":[0.0012337675,0.00017803295,0.00017821079,0.00054532365,0.00020098737,0.000078096564,0.00022199495,0.00007376017,0.00008453367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023375731,0.012674947,0.29928464,0.0017737058,0.007829446,0.000096787786,0.038775746,0.0003744428,0.0021954721,0.0011201068,0.02445325,0.5880457],"study_design_scores_gemma":[0.011021457,0.00039211908,0.9831342,0.00079182955,0.00031154364,0.0000037987209,0.0027848214,0.000027201875,0.0010477519,0.00017861906,0.00010840751,0.0001982295],"about_ca_topic_score_codex":0.00082365406,"about_ca_topic_score_gemma":0.00034930903,"teacher_disagreement_score":0.6838496,"about_ca_system_score_codex":0.00001910307,"about_ca_system_score_gemma":0.00008231081,"threshold_uncertainty_score":0.72599727},"labels":[],"label_agreement":null},{"id":"W4379802644","doi":"10.1136/annrheumdis-2023-eular.3915","title":"AB0823 A BAYESIAN APPROACH TO DETERMINE THE ROLE OF ORAL ANTICOAGULANTS FOR THE OCCURRENCE OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS – A EUSTAR OBSERVATIONAL STUDY","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Universität Zürich; Leids Universitair Medisch Centrum; Universitätsspital Zürich; Università degli Studi di Firenze; Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; Fundació la Marató de TV3; Universiteit Leiden; University of Bern","keywords":"Medicine; Observational study; Multiple sclerosis; Bayesian probability; Intensive care medicine; Dermatology; Internal medicine; Immunology; Artificial intelligence; Computer science","score_opus":0.21428918243254208,"score_gpt":0.34730471270673374,"score_spread":0.13301553027419166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379802644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932837,0.0024963054,0.000037423535,0.000527831,0.0000861397,0.0025232246,0.0009929434,0.000019873196,0.000032575463],"genre_scores_gemma":[0.99931574,0.00025242422,0.000015197536,0.00006652351,0.000013057964,0.00025976062,0.000034472352,0.000015039411,0.000027768821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980378,0.00011631933,0.0007962327,0.00020985208,0.0005984361,0.00024133635],"domain_scores_gemma":[0.9977867,0.000885212,0.00039031683,0.0006109954,0.00022930764,0.00009749587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005252448,0.00016833552,0.00058643194,0.00012984424,0.00008512665,0.00002433617,0.0005200425,0.000038757622,0.0000061813607],"category_scores_gemma":[0.0013100912,0.00007901538,0.00031337255,0.0008422185,0.00016139584,0.000082150436,0.00013596752,0.000057281013,0.0000026572338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010167494,0.0035969047,0.9388609,0.0027780996,0.0016141143,0.0000012518167,0.0059636445,0.0045188074,0.0010343211,0.00025805453,0.005508716,0.03484845],"study_design_scores_gemma":[0.001289641,0.00022171644,0.95440656,0.0064208824,0.00056974584,0.000004950186,0.01907124,0.017202763,0.000371795,0.00030827918,0.0000069371495,0.0001254886],"about_ca_topic_score_codex":0.00015393936,"about_ca_topic_score_gemma":0.0000048663182,"teacher_disagreement_score":0.034722965,"about_ca_system_score_codex":0.000013910581,"about_ca_system_score_gemma":0.00017348652,"threshold_uncertainty_score":0.32221538},"labels":[],"label_agreement":null},{"id":"W4379984509","doi":"10.1136/ard-2023-224148","title":"EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Swedish Orphan Biovitrum; European League Against Rheumatism; National Institute for Health and Care Research; Pfizer","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Arthritis; Radiology; Internal medicine","score_opus":0.09290672303102458,"score_gpt":0.412756844122108,"score_spread":0.3198501210910834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379984509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663415,0.008653173,0.00007428195,0.021371162,0.0003975818,0.0023213483,0.0007922413,0.00002842444,0.000020282716],"genre_scores_gemma":[0.99460614,0.0020756146,0.0017673357,0.0010871,0.000073653704,0.00030617608,0.000042138356,0.000019885407,0.000021968659],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988615,0.000054545344,0.00046267445,0.00019976491,0.00022600063,0.00019552388],"domain_scores_gemma":[0.9974579,0.0017510513,0.00017150115,0.00029852623,0.00020190982,0.00011910339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028819297,0.00012369611,0.00046995626,0.000052272553,0.0001594355,0.000016465923,0.000085857704,0.000027808424,0.000012265304],"category_scores_gemma":[0.0039055475,0.000070059665,0.000261545,0.00014499364,0.00011276664,0.00003198465,0.000098803255,0.000032975302,0.0000042499546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021642612,0.0005799567,0.065356836,0.00059305393,0.001268047,0.000008806799,0.0013702866,0.0000087044455,0.000029414055,0.0012940246,0.07709254,0.8502341],"study_design_scores_gemma":[0.0065130778,0.0008743536,0.94004864,0.005081113,0.0008693415,0.0000064159267,0.0018412139,0.00018372883,0.0007930905,0.042846866,0.0007816605,0.00016051458],"about_ca_topic_score_codex":0.000079842306,"about_ca_topic_score_gemma":0.00002929185,"teacher_disagreement_score":0.8746918,"about_ca_system_score_codex":0.0000038324342,"about_ca_system_score_gemma":0.00004232415,"threshold_uncertainty_score":0.46755874},"labels":[],"label_agreement":null},{"id":"W4380879920","doi":"10.1136/ard-2023-223859","title":"Tripterygium wilfordii derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; University of Saskatchewan","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Alberta Innovates; Killam Trusts; Arthritis Society; School of Graduate Studies, Utah State University","keywords":"Celastrol; Fibrosis; CTGF; Medicine; Cancer research; Bleomycin; Dermal fibroblast; Transforming growth factor; Fibroblast; Pathology; Biology; Growth factor; Endocrinology; Internal medicine; Cell culture; Apoptosis; Receptor","score_opus":0.07306366824157232,"score_gpt":0.28389725543804567,"score_spread":0.21083358719647335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380879920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755646,0.008552124,0.000017327959,0.0013636027,0.0006700532,0.0014843948,0.00007334813,0.00015430739,0.00012837393],"genre_scores_gemma":[0.9976271,0.0015049201,0.000014964645,0.00025991045,0.000065414555,0.00018791085,0.000028998127,0.0000476253,0.00026318798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728674,0.00031762294,0.00088121474,0.0003706192,0.00064350286,0.00050028483],"domain_scores_gemma":[0.9978276,0.0006263961,0.00040129264,0.00072678964,0.00015468037,0.0002632305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003613688,0.00030896396,0.00087622745,0.0003647146,0.00014665842,0.000055736826,0.00030428695,0.0001227939,0.000035978584],"category_scores_gemma":[0.0013285122,0.0001985788,0.0005404716,0.0013126418,0.00026763114,0.00015180893,0.00016377938,0.00015057645,0.00011579361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029926805,0.005330257,0.5837211,0.041770548,0.004163825,0.00018639023,0.0072626155,0.002826918,0.07057854,0.0007822512,0.19301583,0.087369025],"study_design_scores_gemma":[0.0036512932,0.00032303965,0.8923374,0.087437205,0.0004962678,0.000028050243,0.0014380772,0.0014982772,0.011934577,0.0005048996,0.00003256148,0.00031836604],"about_ca_topic_score_codex":0.00008898247,"about_ca_topic_score_gemma":0.00000223775,"teacher_disagreement_score":0.30861625,"about_ca_system_score_codex":0.00004376658,"about_ca_system_score_gemma":0.0002425234,"threshold_uncertainty_score":0.80978084},"labels":[],"label_agreement":null},{"id":"W4385224046","doi":"10.1136/ard-2023-224123","title":"The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Lawson Health Research Institute; Western University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; Swedish Orphan Biovitrum; National Institutes of Health; Incyte; Adaptive Biotechnologies; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Pfizer; Eli Lilly and Company","keywords":"Medicine; Macrophage activation syndrome; Delphi method; Intensive care medicine; Disease; Multidisciplinary approach; Rheumatology; Internal medicine","score_opus":0.08957347039567064,"score_gpt":0.3815346864440365,"score_spread":0.29196121604836583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385224046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09272427,0.9017372,0.0000022189286,0.0013408227,0.00008963698,0.0036412224,0.00031707075,0.000029851593,0.00011766193],"genre_scores_gemma":[0.03554873,0.96138006,0.0000072994494,0.000073565374,0.000007719232,0.0006066955,0.000043811116,0.00007156526,0.002260523],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99625206,0.00057304936,0.001352726,0.00035288738,0.0010751535,0.00039409494],"domain_scores_gemma":[0.99531835,0.0018294576,0.0010771176,0.0013442229,0.00029128863,0.00013956871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008633959,0.00039200336,0.0016980013,0.00022270194,0.00032346076,0.00004233609,0.0006659239,0.00010396425,0.00020818574],"category_scores_gemma":[0.0014423274,0.00019902109,0.0006620652,0.00089378847,0.00063473213,0.00008429327,0.0008943469,0.0001862572,0.00004476962],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037034237,0.0007369026,0.001737853,0.1645718,0.009615305,0.00010714226,0.0006976064,0.000015563035,0.000008285756,0.00132055,0.026057752,0.7947609],"study_design_scores_gemma":[0.0056818146,0.0019374936,0.38548508,0.38915077,0.015988627,0.00017584531,0.0040963027,0.00009295744,0.0015912346,0.0036362556,0.19026126,0.0019023425],"about_ca_topic_score_codex":0.00014796683,"about_ca_topic_score_gemma":0.000008097064,"teacher_disagreement_score":0.79285854,"about_ca_system_score_codex":0.000103722734,"about_ca_system_score_gemma":0.00035720476,"threshold_uncertainty_score":0.8115845},"labels":[],"label_agreement":null},{"id":"W4385483672","doi":"10.1136/ard-2022-223791","title":"Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University Health Network; University of Toronto; Princess Margaret Cancer Centre; Toronto Western Hospital; Discovery Centre","funders":"","keywords":"Microvesicles; Exosome; microRNA; Flow cytometry; Inflammation; Immune system; Downregulation and upregulation; Immunology; CD63; Medicine; Cell biology; Biology; Molecular biology; Gene; Genetics","score_opus":0.024806377399040277,"score_gpt":0.26397150780990647,"score_spread":0.23916513041086618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385483672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967322,0.0008801169,6.5555355e-7,0.00025766736,0.00004716743,0.00071806676,0.0012794322,0.000025767618,0.00005897807],"genre_scores_gemma":[0.99905246,0.00043690152,0.00022519384,0.000031797197,0.000010236276,0.000038721093,0.0001428761,0.00001790055,0.00004389263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991435,0.000030983636,0.00025666424,0.00015977168,0.00023813239,0.00017095498],"domain_scores_gemma":[0.99931043,0.00010211619,0.00018057077,0.00024904977,0.00008757677,0.00007024708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044286546,0.00012576317,0.0003615221,0.000063883715,0.00007977128,0.000008544277,0.00006872884,0.000021277638,0.00004062414],"category_scores_gemma":[0.00014387889,0.000076017655,0.000085688,0.00016244281,0.00014728878,0.000055942102,0.00009464528,0.000032828866,0.0000047802187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071594556,0.00031352596,0.9818454,0.00049610715,0.0006100322,0.000007736799,0.00041053185,0.000008967173,0.00028814035,0.000064010266,0.00017764221,0.015062002],"study_design_scores_gemma":[0.002297833,0.00027596566,0.9894081,0.0017305367,0.00019846027,0.0000015812735,0.00022162302,0.000077550045,0.0050612567,0.0006341965,0.000017493998,0.00007540565],"about_ca_topic_score_codex":0.00011360787,"about_ca_topic_score_gemma":0.0000036888055,"teacher_disagreement_score":0.014986597,"about_ca_system_score_codex":0.0000083875475,"about_ca_system_score_gemma":0.000043846816,"threshold_uncertainty_score":0.309991},"labels":[],"label_agreement":null},{"id":"W4386220262","doi":"10.1136/ard-2023-224609","title":"2023 ACR/EULAR antiphospholipid syndrome classification criteria","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Internal medicine; Lupus anticoagulant; Rheumatology; Gold standard (test); Cohort; Physical therapy; Thrombosis","score_opus":0.10965159876066244,"score_gpt":0.38791188861707093,"score_spread":0.2782602898564085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386220262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908147,0.0011760554,0.000010303891,0.0056956676,0.00037375838,0.000698638,0.0000983588,0.00013101468,0.0010015339],"genre_scores_gemma":[0.9942835,0.0009298092,0.000022375381,0.00017931453,0.000036252386,0.00007939616,0.000051156538,0.000036030313,0.0043821675],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99788314,0.00015929293,0.00051243417,0.00024937562,0.00081686355,0.00037891333],"domain_scores_gemma":[0.99803865,0.00028160584,0.0002013731,0.0010428727,0.00023583061,0.00019964277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005584423,0.00015850709,0.00046214406,0.00018923933,0.00010372663,0.000032422893,0.00040471784,0.000065599845,0.00043251753],"category_scores_gemma":[0.0015586637,0.00010449923,0.0002899058,0.00091978547,0.00017890902,0.00010404747,0.0001809232,0.000095247124,0.0008303459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046987945,0.0010517029,0.23980394,0.014561255,0.0012754336,0.0001610549,0.0018659655,0.000026448932,0.006366005,0.0019770574,0.71633434,0.01610694],"study_design_scores_gemma":[0.0013899328,0.00019882449,0.9742585,0.007232806,0.00021172025,0.0012272435,0.0023123114,0.004845578,0.0025072598,0.003501208,0.0020303847,0.00028425813],"about_ca_topic_score_codex":0.000041606425,"about_ca_topic_score_gemma":9.2321085e-7,"teacher_disagreement_score":0.7344545,"about_ca_system_score_codex":0.000024320463,"about_ca_system_score_gemma":0.00017338298,"threshold_uncertainty_score":0.9999476},"labels":[],"label_agreement":null},{"id":"W4386924033","doi":"10.1136/ard-2023-224756","title":"Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dupilumab; Granulomatosis with polyangiitis; Eosinophilia; Prednisone; Mepolizumab; Internal medicine; Eosinophil; Eosinophilic; Asthma; Adverse effect; Gastroenterology; Refractory (planetary science); Vasculitis; Retrospective cohort study; Dermatology; Pathology","score_opus":0.0386352209467026,"score_gpt":0.31373134025452987,"score_spread":0.2750961193078273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386924033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563736,0.0004441964,0.000021507205,0.002076172,0.00006548458,0.0012180359,0.0002109668,0.00008572251,0.00024055263],"genre_scores_gemma":[0.99835026,0.0005703893,0.00009215919,0.00012281368,0.000019878997,0.000111287765,0.000042843145,0.000039804665,0.0006505394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873084,0.0001563945,0.00036677718,0.00023705521,0.00027405884,0.0002349023],"domain_scores_gemma":[0.9990343,0.00023220768,0.00016197194,0.00033569467,0.00012462691,0.0001111865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022581626,0.00015253232,0.00032562818,0.00021180917,0.00021255185,0.000028132734,0.000105352716,0.000030165866,0.000045675217],"category_scores_gemma":[0.000519051,0.00008441344,0.00012421457,0.00057194853,0.00013402081,0.00011909771,0.00005519673,0.00010717491,0.000008977313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012628113,0.021557014,0.7293984,0.006443613,0.009281481,0.003809576,0.05340812,0.00045862055,0.00040508,0.007999341,0.034989744,0.11962086],"study_design_scores_gemma":[0.00295108,0.001415007,0.98643005,0.0025482392,0.00029253997,0.0001017779,0.0048379498,0.0002540089,0.000009942733,0.0010048293,0.000028904022,0.00012568638],"about_ca_topic_score_codex":0.00008409735,"about_ca_topic_score_gemma":0.00012155292,"teacher_disagreement_score":0.2570316,"about_ca_system_score_codex":0.000024047291,"about_ca_system_score_gemma":0.00012725878,"threshold_uncertainty_score":0.34422803},"labels":[],"label_agreement":null},{"id":"W4387343815","doi":"10.1136/ard-2023-224803","title":"Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma","keywords":"Medicine; Ankylosing spondylitis; Axial spondyloarthritis; Placebo; Internal medicine; Clinical endpoint; Adverse effect; Spondylitis; Gastroenterology; Randomized controlled trial; Pathology; Sacroiliitis","score_opus":0.03977633189661097,"score_gpt":0.325611915263223,"score_spread":0.285835583366612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387343815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97842366,0.0153319,3.0767777e-7,0.0010600048,0.00007535613,0.0034886217,0.001554694,0.00003658423,0.000028854929],"genre_scores_gemma":[0.9798804,0.018600553,0.000018750297,0.00018807956,0.00002242192,0.00097414706,0.00020836895,0.000026298725,0.00008100754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983883,0.0001619493,0.00042045861,0.00034737398,0.00036384418,0.00031806412],"domain_scores_gemma":[0.99792475,0.001228859,0.00020107273,0.0004043763,0.00010926626,0.00013167906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010613966,0.00031501733,0.00083673693,0.000068551446,0.0002834118,0.000023255227,0.0000972655,0.000038315888,0.000044128636],"category_scores_gemma":[0.0002917025,0.00015683775,0.0001463898,0.00026308667,0.00045819613,0.00009922367,0.00014072681,0.000068006266,0.0000036541323],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15241462,0.017041495,0.11509587,0.00041876704,0.011375691,0.00018824916,0.029647632,0.00020950448,0.000012494193,0.000051901792,0.004519197,0.6690246],"study_design_scores_gemma":[0.19009759,0.0059132604,0.79190665,0.0017063852,0.00095426454,0.000004087325,0.0080039585,0.000044716187,0.00009991735,0.00026038176,0.00075650145,0.0002522606],"about_ca_topic_score_codex":0.0003109605,"about_ca_topic_score_gemma":0.00013100986,"teacher_disagreement_score":0.6768108,"about_ca_system_score_codex":0.00003917868,"about_ca_system_score_gemma":0.00006568035,"threshold_uncertainty_score":0.63956577},"labels":[],"label_agreement":null},{"id":"W4387569385","doi":"10.1136/ard-2023-224762","title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":933,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Versus Arthritis; Pfizer; Eli Lilly and Company; European League Against Rheumatism; Amgen","keywords":"Medicine; Belimumab; Azathioprine; Rituximab; Hydroxychloroquine; Lupus nephritis; Nintedanib; Efalizumab; Systemic lupus erythematosus; Abatacept; Prednisone; Maintenance therapy; Internal medicine; Intensive care medicine; Immunology; Disease; Infliximab; Idiopathic pulmonary fibrosis; B-cell activating factor","score_opus":0.07888403940579979,"score_gpt":0.3650390042871462,"score_spread":0.2861549648813464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387569385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9269458,0.015017315,0.00079454563,0.04608199,0.001588436,0.0075189793,0.0008551839,0.0002048476,0.0009929187],"genre_scores_gemma":[0.9821744,0.01010922,0.00019129372,0.00018016524,0.00003997347,0.0006840861,0.000070764385,0.00005088917,0.0064992267],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99788785,0.00013189415,0.0007470838,0.00021367983,0.00066424155,0.00035527025],"domain_scores_gemma":[0.997158,0.0008712517,0.00038378855,0.0011763853,0.0003024169,0.000108165375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009905157,0.00016815607,0.0004951369,0.00016081236,0.00016395721,0.00001996821,0.0006016994,0.000040815135,0.00012861569],"category_scores_gemma":[0.00036020848,0.00009099566,0.00044465318,0.0007730753,0.00015766823,0.0000628946,0.00027583496,0.00007029974,0.00011067884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059884274,0.000686738,0.022798978,0.059425045,0.0068081794,0.000016920514,0.0025494478,0.00036263332,0.00015093527,0.017248066,0.8588862,0.030468008],"study_design_scores_gemma":[0.036513194,0.00171274,0.04935854,0.36763114,0.015314573,0.011277061,0.26668522,0.068167046,0.010528639,0.099856175,0.069947176,0.003008478],"about_ca_topic_score_codex":0.000020776653,"about_ca_topic_score_gemma":0.0000012855483,"teacher_disagreement_score":0.78893906,"about_ca_system_score_codex":0.000024527104,"about_ca_system_score_gemma":0.000096360425,"threshold_uncertainty_score":0.37106952},"labels":[],"label_agreement":null},{"id":"W4388041144","doi":"10.1136/ard-2023-224571","title":"Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Research Board; Science Foundation Ireland; Engineering and Physical Sciences Research Council; Wellcome Trust; Crafoordska Stiftelsen; Health Service Executive; Horizon 2020 Framework Programme; Deutsche Forschungsgemeinschaft; Vetenskapsrådet; European Regional Development Fund; European Commission; Canadian Institute for Theoretical Astrophysics","keywords":"Medicine; Granulomatosis with polyangiitis; SPARQL; Vasculitis; Database; Internal medicine; Computer science; Information retrieval; Disease; Semantic Web","score_opus":0.28531799392970425,"score_gpt":0.4177101496896178,"score_spread":0.13239215575991353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388041144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018983707,0.9387347,0.000003257619,0.00089343404,0.00020574046,0.0010636704,0.05699844,0.00008215703,0.000120213015],"genre_scores_gemma":[0.0019638147,0.95839745,0.000005570824,0.00014959223,0.000027277865,0.000010743527,0.039145634,0.000077942386,0.00022199315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952192,0.0012957393,0.0018661813,0.00069814397,0.00056664547,0.0003541058],"domain_scores_gemma":[0.9946832,0.00073069875,0.0014304179,0.0027673915,0.00016736794,0.00022093821],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012469022,0.0003972642,0.0021398864,0.000120804885,0.00019404857,0.00011098819,0.00097237364,0.00018422009,0.00003951188],"category_scores_gemma":[0.0100757675,0.00026684158,0.00030210122,0.0007017589,0.00022653317,0.00018222861,0.001403642,0.00044486488,0.000023312794],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003578961,0.0006756365,0.00017835559,0.030483397,0.0033231874,0.00007579726,0.00014098872,1.8257083e-7,2.0344982e-7,0.000038397877,0.12754543,0.8375026],"study_design_scores_gemma":[0.002404174,0.00020545731,0.02534662,0.32326716,0.0080659585,0.00006887458,0.0004979434,0.00030401422,6.3652084e-7,0.00023633195,0.63845414,0.0011487204],"about_ca_topic_score_codex":0.0002413362,"about_ca_topic_score_gemma":0.000019154704,"teacher_disagreement_score":0.8363539,"about_ca_system_score_codex":0.000045803525,"about_ca_system_score_gemma":0.0004872845,"threshold_uncertainty_score":0.99997836},"labels":[],"label_agreement":null},{"id":"W4388215853","doi":"10.1136/ard-2023-224623","title":"Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"LEO Pharma; Grifols; Swedish Orphan Biovitrum; CSL Behring; Alexion Pharmaceuticals; Chugai Pharmaceutical; Amgen; Pfizer; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Rituximab; Regimen; Internal medicine; Maintenance therapy; Adverse effect; Gastroenterology; Azathioprine; Surgery; Chemotherapy; Lymphoma; Disease","score_opus":0.06751725231584306,"score_gpt":0.3712845593348157,"score_spread":0.30376730701897264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388215853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928802,0.0013992874,0.000015064218,0.003493164,0.00006366493,0.0015020489,0.00057771115,0.000024570825,0.000044238663],"genre_scores_gemma":[0.9956693,0.0031024448,0.00000986866,0.000592773,0.000010336725,0.00015640215,0.00030133504,0.000015815938,0.00014170964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975291,0.0005036572,0.0010385616,0.00020650908,0.00044246504,0.00027972847],"domain_scores_gemma":[0.9973132,0.0012524455,0.00058419193,0.00049385027,0.0002738667,0.00008244226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016351597,0.00017427988,0.0011748057,0.00027580446,0.00012164795,0.000023007358,0.00025919467,0.000079081925,0.00006623748],"category_scores_gemma":[0.0043451004,0.00008901719,0.0010413405,0.001175158,0.00015675185,0.00006795197,0.00005731453,0.00009172573,0.0000040631153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052896823,0.0030738397,0.9600929,0.00077090063,0.011462925,0.000007706265,0.0020950262,0.00005400268,0.000032745047,0.0007452749,0.002976338,0.01815935],"study_design_scores_gemma":[0.0076320055,0.00020904928,0.98362815,0.00079461304,0.002473122,9.0571694e-7,0.00037430768,0.00014689904,0.00008942259,0.0045419196,0.0000103353,0.00009929342],"about_ca_topic_score_codex":0.00013677299,"about_ca_topic_score_gemma":0.000048426053,"teacher_disagreement_score":0.023535203,"about_ca_system_score_codex":0.000014801595,"about_ca_system_score_gemma":0.00006434262,"threshold_uncertainty_score":0.52018046},"labels":[],"label_agreement":null},{"id":"W4388425491","doi":"10.1136/ard-2023-224356","title":"Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies","year":2023,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute on Aging; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Observational study; Skin cancer; Tofacitinib; Internal medicine; Randomized controlled trial; Dermatology; Cancer; Melanoma; Oncology; Physical therapy","score_opus":0.2197113387050415,"score_gpt":0.43875849608728407,"score_spread":0.21904715738224256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388425491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20862177,0.7839401,3.7263874e-7,0.00012940826,0.00007727179,0.0066582616,0.0005567665,0.000009199512,0.0000068571935],"genre_scores_gemma":[0.035497814,0.96249527,0.000013819997,0.000022315095,0.00001661194,0.0017811435,0.000118172684,0.00004101419,0.000013851495],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943769,0.0017009457,0.0020538075,0.00032823582,0.0012732195,0.00026686463],"domain_scores_gemma":[0.99111056,0.005353808,0.0017415362,0.00036327832,0.0012967517,0.00013407045],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0024882676,0.00040922128,0.006702107,0.00034358952,0.00008533233,0.00003206464,0.00014954076,0.00009178254,0.00005585372],"category_scores_gemma":[0.008505671,0.00021476582,0.0005998147,0.00036677453,0.00048077467,0.00013198057,0.00012156861,0.00014914201,0.0000015435547],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00578875,0.0003865576,0.004409165,0.018813368,0.0089158695,0.0000018226048,0.00058104773,0.00001512873,1.7604701e-7,0.000043367156,0.00072384736,0.9603209],"study_design_scores_gemma":[0.26287323,0.00090298196,0.18857512,0.5398541,0.0022052627,0.000009451651,0.0011035064,0.00036017117,0.0000044925278,0.0013859618,0.002089853,0.0006358382],"about_ca_topic_score_codex":0.00008144805,"about_ca_topic_score_gemma":0.000059838996,"teacher_disagreement_score":0.9596851,"about_ca_system_score_codex":0.000033533317,"about_ca_system_score_gemma":0.0008104304,"threshold_uncertainty_score":0.9998461},"labels":[],"label_agreement":null},{"id":"W4388668689","doi":"10.1136/ard-2023-225087","title":"Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey","year":2023,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Ottawa","funders":"","keywords":"Medicine; Psoriatic arthritis; Dermatology; Arthritis; Psoriasis; Immunology","score_opus":0.06864981159764932,"score_gpt":0.3318573991356953,"score_spread":0.26320758753804596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388668689","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23407286,0.003297581,5.902995e-7,0.7178198,0.0009408512,0.0019850165,0.040761758,0.0000783238,0.0010431908],"genre_scores_gemma":[0.72426397,0.015984476,0.000070347174,0.2192354,0.003249094,0.0010196366,0.017991625,0.0003862848,0.017799174],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9971182,0.00031035152,0.0008187573,0.00047583188,0.0009421557,0.00033475584],"domain_scores_gemma":[0.99642265,0.0012432254,0.00043212125,0.001283234,0.00045771443,0.000161048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025579848,0.000364772,0.00096224697,0.00013381203,0.00010459312,0.000032976903,0.00071207486,0.00014411146,0.0003312044],"category_scores_gemma":[0.002906405,0.00020635135,0.0003531169,0.00031103913,0.00013893156,0.000059585906,0.00031767998,0.00022044346,0.00035388448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007211961,0.0005387527,0.00029337854,0.0001552166,0.0014242674,0.000069512884,0.0010925482,0.00002405537,0.0000013449093,0.000003473006,0.96307373,0.03260251],"study_design_scores_gemma":[0.009594984,0.0026288924,0.8825117,0.027658736,0.0017204755,0.000012585264,0.0006227173,0.000103365914,0.00014418615,0.00093581714,0.0730542,0.0010123753],"about_ca_topic_score_codex":0.0021458203,"about_ca_topic_score_gemma":0.00033344553,"teacher_disagreement_score":0.89001954,"about_ca_system_score_codex":0.000030324449,"about_ca_system_score_gemma":0.00008468655,"threshold_uncertainty_score":0.8414764},"labels":[],"label_agreement":null},{"id":"W4388977981","doi":"10.1136/ard-2023-224467","title":"Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Hellenic Foundation for Research and Innovation; European Regional Development Fund; General Secretariat for Research and Technology","keywords":"Polymyalgia rheumatica; Giant cell arteritis; Senescence; Inflammation; Medicine; Pathology; Phenotype; Adventitia; Interleukin 8; Arteritis; Immunology; Vasculitis; Internal medicine; Biology; Disease","score_opus":0.027450288889701913,"score_gpt":0.29146604275813104,"score_spread":0.2640157538684291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388977981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778306,0.00040158496,0.00001416783,0.0006907701,0.00020522081,0.0004949209,0.00021410927,0.000059410857,0.00013674506],"genre_scores_gemma":[0.99870527,0.00073572586,0.000020014548,0.00016055757,0.000027115235,0.00016476275,0.0000557323,0.00002934992,0.00010148212],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99820673,0.00018173514,0.00063392683,0.00023389101,0.00036048715,0.00038323525],"domain_scores_gemma":[0.9989991,0.0000877965,0.0001705522,0.00048468536,0.000059758324,0.00019806162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027690083,0.00017211794,0.00037664638,0.0001808009,0.000072691604,0.000020380397,0.00017255105,0.00007812527,0.00020450896],"category_scores_gemma":[0.000101159734,0.00012769828,0.00013419926,0.00039911421,0.00008342866,0.00012662,0.00009694488,0.0001683949,0.0001255643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010541964,0.015284368,0.15726194,0.012678464,0.0009371748,0.0025957783,0.03207041,0.020922484,0.29485402,0.002214326,0.015615886,0.44451097],"study_design_scores_gemma":[0.0021527864,0.0004347527,0.9223627,0.0049605514,0.00019912272,0.00001243674,0.0018932498,0.012034927,0.05180311,0.0035030853,0.00020386203,0.00043941883],"about_ca_topic_score_codex":0.0001799622,"about_ca_topic_score_gemma":0.00009226355,"teacher_disagreement_score":0.7651008,"about_ca_system_score_codex":0.00003003125,"about_ca_system_score_gemma":0.000118341675,"threshold_uncertainty_score":0.5207385},"labels":[],"label_agreement":null},{"id":"W4389475481","doi":"10.1136/ard-2023-225185","title":"Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Sacroiliitis; Ankylosing spondylitis; Medicine; Terminology; Axial spondyloarthritis; Spondylitis; Spondylarthritis; Term (time); Physical therapy; HLA-B27; Disease; Meaning (existential); Sacroiliac joint; Nomenclature; Radiography; Acronym; Medical physics; Internal medicine; Radiology; Human leukocyte antigen; Immunology; Linguistics; Psychology","score_opus":0.02833052617362306,"score_gpt":0.2993746008801183,"score_spread":0.2710440747064952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389475481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9228608,0.0039615897,0.0000042489282,0.06614748,0.00048470328,0.0020084719,0.0014530724,0.00014768395,0.0029319534],"genre_scores_gemma":[0.97832286,0.00054446777,0.00007133039,0.0048826453,0.00025561955,0.00029828414,0.00013251357,0.000072892544,0.015419399],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99740726,0.00018400839,0.0005325172,0.00041597986,0.0007841314,0.00067610753],"domain_scores_gemma":[0.9975431,0.0005550691,0.00018268247,0.0012229552,0.00017816867,0.00031803304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004114379,0.00036167126,0.00061585807,0.00013990539,0.00066559325,0.00010020196,0.00060893444,0.00006964762,0.0009024882],"category_scores_gemma":[0.0011177267,0.0001845806,0.00047226605,0.0011843065,0.00020218702,0.00009620524,0.00054075324,0.0001783882,0.0018074175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036369609,0.0017468457,0.009377947,0.0008217833,0.0028667839,0.00038580448,0.009555107,0.00031144952,0.0014241225,0.0035499556,0.70860094,0.25772232],"study_design_scores_gemma":[0.0049797483,0.0019151646,0.75229734,0.0071036397,0.0011121912,0.00020894312,0.0022139056,0.00020186264,0.0019611462,0.004428141,0.22264235,0.000935547],"about_ca_topic_score_codex":0.00008621832,"about_ca_topic_score_gemma":0.000038290967,"teacher_disagreement_score":0.74291945,"about_ca_system_score_codex":0.000035306144,"about_ca_system_score_gemma":0.000114083065,"threshold_uncertainty_score":0.9989698},"labels":[],"label_agreement":null},{"id":"W4389475522","doi":"10.1136/ard-2023-224670","title":"Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Galápagos; AbbVie; Pfizer; Eli Lilly and Company","keywords":"Medicine; Discontinuation; Rheumatoid arthritis; Adverse effect; Internal medicine; Tofacitinib; Arthritis; Rheumatology; Physical therapy","score_opus":0.06434727445090424,"score_gpt":0.38679655944164715,"score_spread":0.3224492849907429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389475522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954814,0.0012620407,0.00001263342,0.0010647229,0.00015636769,0.0018173726,0.00016624211,0.000008290523,0.000030982075],"genre_scores_gemma":[0.9921725,0.007516816,0.000028939601,0.000010412467,0.00001111585,0.00016165114,0.0000706123,0.000012558317,0.000015388425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974061,0.00039597115,0.00075348973,0.00015553576,0.0011548406,0.00013405121],"domain_scores_gemma":[0.9976385,0.00026482693,0.00055983063,0.00034317418,0.0011381136,0.00005551418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002094541,0.00010621753,0.00036968818,0.000247166,0.00005010415,0.000008063895,0.00018049698,0.000029648902,0.000021465066],"category_scores_gemma":[0.0027193637,0.000073497795,0.00011746666,0.00045444712,0.00021188722,0.0003198831,0.00006567617,0.000042123997,5.052955e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023406816,0.003706047,0.60627484,0.0007364014,0.0011729071,0.0000014365597,0.018191047,0.0019560175,0.0022006524,0.0012518407,0.0016443802,0.36052376],"study_design_scores_gemma":[0.0064859013,0.0010344058,0.9531704,0.0040127584,0.000047809262,0.0000020103287,0.015554454,0.011520374,0.003848463,0.004169558,0.00004496287,0.000108901666],"about_ca_topic_score_codex":0.00014653275,"about_ca_topic_score_gemma":0.00031006057,"teacher_disagreement_score":0.36041486,"about_ca_system_score_codex":0.00002028043,"about_ca_system_score_gemma":0.00024796563,"threshold_uncertainty_score":0.32555288},"labels":[],"label_agreement":null},{"id":"W4390595018","doi":"10.1136/ard-2023-224912","title":"Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Koninklijk Nederlands Genootschap voor Fysiotherapie; ZonMw; Ministerie van Volksgezondheid, Welzijn en Sport; Arthritis Society; ReumaNederland; Dutch Arthritis Society","keywords":"Medicine; Physical therapy; Rheumatoid arthritis; Quality of life (healthcare); Adverse effect; Clinical endpoint; Randomized controlled trial; Internal medicine; Clinical trial","score_opus":0.0332581930378263,"score_gpt":0.2940896511806893,"score_spread":0.260831458142863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390595018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8842454,0.10809257,0.00042411682,0.00020813396,0.00011114991,0.0066673816,0.00015212204,0.000041214375,0.000057935795],"genre_scores_gemma":[0.94206476,0.055999156,0.000093050854,0.000011143652,0.000016020884,0.0016998145,0.00006388385,0.000033327,0.000018859535],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99831903,0.00022918516,0.00043753142,0.0002475479,0.0005299123,0.00023680888],"domain_scores_gemma":[0.99594116,0.0030135897,0.00017023292,0.0002457684,0.00048916845,0.00014009312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042117838,0.000219464,0.0011042741,0.00015004801,0.00017762296,0.000076423574,0.00009259414,0.000038003807,0.000040665487],"category_scores_gemma":[0.0004948151,0.00011830467,0.0003115508,0.0002520451,0.0002983233,0.00018204519,0.000022185353,0.00008016037,6.927295e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9472239,0.0005094582,0.0017146551,0.003104503,0.0019743894,0.0000047859594,0.0022536656,0.00015018911,0.000081268816,0.00078266184,0.00029506412,0.041905485],"study_design_scores_gemma":[0.930758,0.0037673754,0.019656243,0.037750505,0.00012228634,0.000070137474,0.003804745,0.0010145532,0.0013243585,0.0013775318,0.000081572725,0.00027270432],"about_ca_topic_score_codex":0.000037042704,"about_ca_topic_score_gemma":0.000031431053,"teacher_disagreement_score":0.057819363,"about_ca_system_score_codex":0.000014696382,"about_ca_system_score_gemma":0.00041837263,"threshold_uncertainty_score":0.48243243},"labels":[],"label_agreement":null},{"id":"W4392094978","doi":"10.1136/ard-2023-225294","title":"Acute rheumatic fever in the province of Manitoba, Canada, before and after the coronavirus (COVID-19) pandemic","year":2024,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus; Virology; Betacoronavirus; Coronavirus Infections; Pneumonia; Hydroxychloroquine; Outbreak; Pathology; Infectious disease (medical specialty); Internal medicine; Disease","score_opus":0.07013943451646794,"score_gpt":0.3404265835242853,"score_spread":0.27028714900781736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392094978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70956796,0.005912817,0.0000023844225,0.28033236,0.0002900098,0.0024414232,0.0012857683,0.000023410557,0.00014385796],"genre_scores_gemma":[0.8359163,0.00080590753,0.0000048814036,0.16149704,0.000086205204,0.0004911742,0.00007974296,0.000040108447,0.0010786599],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99807703,0.00020574604,0.0005758467,0.00027441364,0.00057711557,0.0002898428],"domain_scores_gemma":[0.9980359,0.0006387471,0.00031907376,0.00085103576,0.00006580235,0.000089448265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018306785,0.00032654943,0.00058686506,0.000088453766,0.00009935631,0.0000375281,0.00036244784,0.00013854074,0.00010160249],"category_scores_gemma":[0.00027214625,0.00013823596,0.00028182773,0.00022215571,0.00035570507,0.0000506605,0.00014686355,0.0005062917,0.0000066494586],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013904249,0.0002487123,0.2683666,0.005552068,0.0021641098,0.00048824996,0.00054316054,0.000007312507,3.988988e-7,0.000037730846,0.71124864,0.011204003],"study_design_scores_gemma":[0.0013064747,0.0002939601,0.92968893,0.007996566,0.003969327,0.00048052744,0.00062683347,0.000120410754,0.0000096455915,0.006543958,0.048593067,0.00037027887],"about_ca_topic_score_codex":0.133911,"about_ca_topic_score_gemma":0.23354843,"teacher_disagreement_score":0.66265553,"about_ca_system_score_codex":0.00012864977,"about_ca_system_score_gemma":0.0011150144,"threshold_uncertainty_score":0.87185633},"labels":[],"label_agreement":null},{"id":"W4392242276","doi":"10.1136/ard-2023-225389","title":"Changes in alcohol intake and serum urate changes: longitudinal analyses of annual medical examination database","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Research Canada","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Medicine; Alcohol intake; Alcohol; Gout; Hyperuricemia; Longitudinal study; Internal medicine; Cross-sectional study; Uric acid; Physiology; Pathology; Biochemistry","score_opus":0.11416519905524665,"score_gpt":0.3917847044840937,"score_spread":0.27761950542884706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392242276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98072696,0.010038963,0.000028949029,0.008008659,0.00013056096,0.0003471423,0.0005830184,0.000034633755,0.00010113455],"genre_scores_gemma":[0.9963251,0.0030479762,0.000047894464,0.00030731494,0.000057729147,0.000021672575,0.00007553423,0.000017672615,0.00009913229],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99813986,0.00016358976,0.00040852258,0.00028207127,0.00077011203,0.00023585581],"domain_scores_gemma":[0.9987002,0.00038866626,0.00016630355,0.00043211196,0.00012357214,0.00018914502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065145455,0.0001880789,0.0004864975,0.00032474083,0.00003148021,0.000017284667,0.00021224949,0.00007657212,0.00031724243],"category_scores_gemma":[0.0015571697,0.0001229349,0.00009653191,0.00059973553,0.00026360844,0.00016509909,0.00016668851,0.00015195756,0.0000052076457],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004576951,0.0017811689,0.35503122,0.02041939,0.0027706434,0.0004795779,0.0065284614,0.000050757986,0.0014767762,0.00055875425,0.0078056287,0.6026399],"study_design_scores_gemma":[0.0007110481,0.00024754473,0.97889423,0.006710832,0.0006782852,0.00007602597,0.0014874678,0.004963603,0.005728275,0.00024694446,0.00009286352,0.00016287912],"about_ca_topic_score_codex":0.00036046962,"about_ca_topic_score_gemma":0.00035643455,"teacher_disagreement_score":0.623863,"about_ca_system_score_codex":0.000014885301,"about_ca_system_score_gemma":0.00015758391,"threshold_uncertainty_score":0.5013139},"labels":[],"label_agreement":null},{"id":"W4392926454","doi":"10.1136/ard-2024-225531","title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","year":2024,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":331,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Medical Research Council; European League Against Rheumatism","keywords":"Medicine; Psoriatic arthritis; Arthritis; Intensive care medicine; Alternative medicine; Dermatology; Psoriasis; Internal medicine; Pathology","score_opus":0.11142409672189743,"score_gpt":0.41030094919672605,"score_spread":0.29887685247482865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392926454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041169926,0.9912466,0.000020659012,0.0039357855,0.0003523571,0.0030850868,0.0011721461,0.000021366553,0.0001248364],"genre_scores_gemma":[0.00040944887,0.9970326,0.00025935183,0.00017366286,0.000041236985,0.001408292,0.00012996487,0.000038919647,0.00050653174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985136,0.00008731931,0.00064235367,0.00024296189,0.00029188037,0.00022190176],"domain_scores_gemma":[0.9985678,0.00036996123,0.00042496418,0.0004717831,0.000102044665,0.00006339769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017272848,0.0003125643,0.0012632246,0.000063172265,0.0001473768,0.000020817288,0.0002787072,0.000046378274,0.000273366],"category_scores_gemma":[0.00003478941,0.0001270656,0.00089029415,0.0003247139,0.00017667984,0.000029019413,0.0001462695,0.00010226833,0.000025155745],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000570081,0.00037475515,0.00000208513,0.023083426,0.015585524,0.000011428458,0.000050410636,6.677868e-7,6.3921988e-9,0.00076851074,0.03157112,0.92849505],"study_design_scores_gemma":[0.0013152316,0.00035376524,0.000066338296,0.101300396,0.026758397,0.000019333234,0.00037449042,0.000013421078,0.0000010488823,0.0011743479,0.8684556,0.0001676268],"about_ca_topic_score_codex":0.00001022517,"about_ca_topic_score_gemma":0.0000026797352,"teacher_disagreement_score":0.92832744,"about_ca_system_score_codex":0.000018744062,"about_ca_system_score_gemma":0.00008554779,"threshold_uncertainty_score":0.5181585},"labels":[],"label_agreement":null},{"id":"W4393188212","doi":"10.1136/ard-2023-225278","title":"Validation and incorporation of digital entheses into a preliminary GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Pfizer; Eli Lilly and Company","keywords":"Dactylitis; Medicine; Psoriatic arthritis; Enthesis; Enthesitis; Arthritis; Dermatology; Enthesopathy; Internal medicine; Radiology; Surgery; Tendon","score_opus":0.02668343650396114,"score_gpt":0.30607281975398687,"score_spread":0.2793893832500257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393188212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97755885,0.020654263,0.000009726454,0.0006930636,0.00012427468,0.00042082573,0.00030257378,0.00002036709,0.00021603273],"genre_scores_gemma":[0.9952635,0.00450279,0.00003827104,0.00002639772,0.000016793092,0.000033794313,0.00008351471,0.000010281495,0.000024625571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989678,0.00004228069,0.00040438786,0.00017676775,0.00028031023,0.00012841047],"domain_scores_gemma":[0.999233,0.0002905738,0.00013801166,0.00020278402,0.00007063137,0.00006498048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077920486,0.00013561061,0.000330732,0.00006924592,0.000045023462,0.000051316973,0.000060128343,0.0000315723,0.000031748525],"category_scores_gemma":[0.00072834495,0.000097027514,0.00012272614,0.00028434122,0.00014552343,0.00029375518,0.000060033446,0.000039028375,0.0000045790575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058525003,0.0012547688,0.5515225,0.0029075686,0.0007145205,0.00005886943,0.0020341866,0.000024369976,0.000055124336,0.0019735235,0.0010690376,0.4378003],"study_design_scores_gemma":[0.0013520563,0.00074820843,0.9563834,0.011303476,0.00027111202,0.00011573327,0.0011031317,0.00014869112,0.0006938178,0.027695142,0.000033303928,0.0001519134],"about_ca_topic_score_codex":0.00027523717,"about_ca_topic_score_gemma":0.000038786424,"teacher_disagreement_score":0.43764836,"about_ca_system_score_codex":0.000029480376,"about_ca_system_score_gemma":0.00008524539,"threshold_uncertainty_score":0.39566672},"labels":[],"label_agreement":null},{"id":"W4396532139","doi":"10.1136/ard-2024-225688","title":"Is tooth extraction as proxy for periodontal disease related to the development of RA? Lessons from a longitudinal study in the at-risk stage of clinically suspect arthralgia","year":2024,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Commission; H2020 European Research Council; Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Suspect; Stage (stratigraphy); Periodontal disease; Dentistry; Disease; Proxy (statistics); Internal medicine","score_opus":0.10984844255775655,"score_gpt":0.4304647061930589,"score_spread":0.3206162636353023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396532139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9147866,0.0018806328,0.0000112766675,0.072228,0.0004264595,0.003016514,0.007600033,0.000014733661,0.000035750865],"genre_scores_gemma":[0.9898064,0.00017746584,0.00006974737,0.003920514,0.00008484812,0.0004464529,0.00036179562,0.000049228074,0.005083528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955713,0.0011309409,0.0016418251,0.00056974235,0.0006885348,0.0003976454],"domain_scores_gemma":[0.9959472,0.0017123256,0.0008949165,0.0011433719,0.00022137654,0.000080849495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014608197,0.0003587266,0.0008107594,0.0001495171,0.0002611412,0.00008934319,0.0013209584,0.00024712807,0.00085653225],"category_scores_gemma":[0.0014951037,0.00019128853,0.0007119401,0.00033615698,0.00033713304,0.0000853551,0.0004993027,0.0008763409,0.000110549656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026942748,0.0018036064,0.516862,0.002253562,0.0026032724,0.00015911345,0.01182527,0.000031057552,0.000040730825,0.000032217504,0.4575971,0.004097815],"study_design_scores_gemma":[0.000832763,0.00041020339,0.97903585,0.0019000686,0.00053467095,0.0000071903673,0.0020416153,0.000040229133,0.000107796055,0.0010951882,0.01369587,0.00029854],"about_ca_topic_score_codex":0.000734736,"about_ca_topic_score_gemma":0.0015867933,"teacher_disagreement_score":0.4621739,"about_ca_system_score_codex":0.00005268518,"about_ca_system_score_gemma":0.0006200777,"threshold_uncertainty_score":0.9378427},"labels":[],"label_agreement":null},{"id":"W4396919985","doi":"10.1136/ard-2024-225652","title":"Gout risk in adults with pre-diabetes initiating metformin","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"Harvard T.H. Chan School of Public Health; National Institutes of Health; Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eli Lilly and Company","keywords":"Metformin; Medicine; Gout; Diabetes mellitus; Internal medicine; Propensity score matching; Proportional hazards model; Relative risk; Cohort; Incidence (geometry); Lower risk; Cohort study; Endocrinology; Confidence interval","score_opus":0.01683262321372447,"score_gpt":0.28530656846990704,"score_spread":0.26847394525618257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396919985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871433,0.009864419,0.000016980204,0.000989699,0.00009473811,0.00055349595,0.000088983856,0.00008813479,0.0011602448],"genre_scores_gemma":[0.9983982,0.0006551145,0.0003148449,0.00029355809,0.000037125545,0.000069790236,0.000014284144,0.000035993948,0.00018108082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984357,0.00010194859,0.00045093618,0.00024314257,0.00045348326,0.00031481992],"domain_scores_gemma":[0.99856085,0.0005406213,0.0001809603,0.0005122751,0.0000763343,0.0001289843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003326731,0.00019377514,0.00041247194,0.00015009218,0.00005056823,0.000030377729,0.00021084594,0.000049637867,0.00009805296],"category_scores_gemma":[0.0014747321,0.00011017704,0.00017765409,0.0005231443,0.00012224584,0.00020130613,0.00009487811,0.00020415924,0.000028063245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007622422,0.0011698975,0.6875932,0.014404181,0.002087833,0.00010797992,0.010384294,0.00049561175,0.000068577334,0.00055488374,0.008173031,0.27419826],"study_design_scores_gemma":[0.0028145013,0.0009259496,0.9060847,0.048246186,0.001776581,0.000052759748,0.0028133977,0.026723022,0.004208458,0.0052211466,0.0005420575,0.00059120427],"about_ca_topic_score_codex":0.00016514173,"about_ca_topic_score_gemma":0.000014158423,"teacher_disagreement_score":0.27360705,"about_ca_system_score_codex":0.000023524737,"about_ca_system_score_gemma":0.00018893144,"threshold_uncertainty_score":0.44928893},"labels":[],"label_agreement":null},{"id":"W4396950565","doi":"10.1136/ard-2024-225613","title":"Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Calgary; Mount Sinai Hospital; McGill University Health Centre; University Health Network; Dalhousie University; University of Toronto; Université Laval; Queen Elizabeth II Health Sciences Centre; University of Manitoba; Toronto Western Hospital; Krembil Foundation","funders":"National Institutes of Health; UCLH Biomedical Research Centre; Novo Nordisk Fonden; National Research Foundation of Korea; Eusko Jaurlaritza; National Research Foundation; University College London; LUPUS UK; Novo Nordisk; National Institute for Health and Care Research; Canadian Institutes of Health Research; Lupus Research Alliance; Sandwell and West Birmingham Hospitals NHS Trust; Wellcome Trust; University of Calgary; Gigtforeningen; McGill University; Arthritis Society; Johns Hopkins University; Manchester Biomedical Research Centre; Université Laval","keywords":"Medicine; Prednisone; Cohort; Systemic lupus erythematosus; Internal medicine; Workforce; Cohort study; Disease; Pediatrics; Physical therapy","score_opus":0.0389058187277448,"score_gpt":0.34789059070513445,"score_spread":0.30898477197738966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396950565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768124,0.006040555,0.000012114848,0.013345963,0.0006508875,0.0012657066,0.001719524,0.00008560147,0.0000672476],"genre_scores_gemma":[0.997128,0.0017904115,0.0000064127667,0.0002427788,0.00011202492,0.00006977656,0.00017591445,0.000035358687,0.0004392906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704456,0.00054369,0.0006089624,0.00041410196,0.0011417427,0.00024696474],"domain_scores_gemma":[0.99592227,0.0019493122,0.00050563033,0.0006912285,0.0006433563,0.0002881898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009988913,0.00020991986,0.00045036277,0.00006996266,0.0001858014,0.00013051416,0.00029158732,0.00008519119,0.000021896085],"category_scores_gemma":[0.0067640464,0.000108540626,0.00014009992,0.00044288824,0.0002041302,0.00017839034,0.0001737138,0.00025662177,0.0000073177202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003255194,0.00031539318,0.9736545,0.0022599432,0.00090048916,0.0000532737,0.001185293,0.000030654526,0.00006568776,0.000051582134,0.013587768,0.0046402295],"study_design_scores_gemma":[0.0033846113,0.00027782758,0.7917552,0.16666394,0.0006447953,0.00027793285,0.0062482897,0.029740447,0.000063748266,0.00042111665,0.00017641709,0.0003456508],"about_ca_topic_score_codex":0.00022952049,"about_ca_topic_score_gemma":0.000065401815,"teacher_disagreement_score":0.18189926,"about_ca_system_score_codex":0.00024248587,"about_ca_system_score_gemma":0.0006745624,"threshold_uncertainty_score":0.8097684},"labels":[],"label_agreement":null},{"id":"W4399303537","doi":"10.1136/ard-2024-226025","title":"Eng Meng Tan","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; South Health Campus","funders":"","keywords":"Medicine; Family medicine","score_opus":0.07550249554853143,"score_gpt":0.32964998924906097,"score_spread":0.2541474937005295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399303537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920474,0.002528599,0.000047231755,0.0024760787,0.0005943546,0.00027178344,0.00019876126,0.00011912996,0.0017166149],"genre_scores_gemma":[0.99785316,0.00037470233,0.000016405638,0.000983687,0.000035100493,0.000031684103,0.0000014533606,0.000025664342,0.0006781618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843836,0.00026327246,0.00028140532,0.00032636564,0.00044434477,0.0002462707],"domain_scores_gemma":[0.99867284,0.00056086533,0.000076208475,0.0005175657,0.000043240994,0.00012925337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000892791,0.00016120345,0.00017772024,0.00007338311,0.00012259185,0.0001022852,0.0005267375,0.000017957165,0.00026428467],"category_scores_gemma":[0.0017529565,0.00010436412,0.0002603003,0.0003768275,0.00020520556,0.00014065801,0.00016509708,0.000068659,0.0001132239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015609586,0.0018974215,0.0030924347,0.0040907343,0.0003448479,0.00010448677,0.0028343129,0.0047217226,0.39582637,0.15001976,0.16497183,0.27194],"study_design_scores_gemma":[0.00011100382,0.000051483516,0.0101388665,0.00058014726,0.0000754952,0.0000060841658,0.00008269636,0.0023692825,0.9683626,0.016254434,0.0017647573,0.00020309295],"about_ca_topic_score_codex":0.000006465418,"about_ca_topic_score_gemma":8.751513e-7,"teacher_disagreement_score":0.5725363,"about_ca_system_score_codex":0.0000059834792,"about_ca_system_score_gemma":0.00011007525,"threshold_uncertainty_score":0.42558452},"labels":[],"label_agreement":null},{"id":"W4399427565","doi":"10.1136/ard-2023-225094","title":"Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Pfizer","keywords":"Medicine; Tofacitinib; Tolerability; Internal medicine; Adverse effect; Arthritis; Rheumatology; Surgery; Rheumatoid arthritis","score_opus":0.05586266030403727,"score_gpt":0.3565925642774992,"score_spread":0.30072990397346194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399427565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97901434,0.016836712,0.00000877035,0.0003118191,0.000031880067,0.0031976162,0.0005730925,0.000009117614,0.000016645185],"genre_scores_gemma":[0.99654365,0.0031752067,0.00001755509,0.000012560835,0.000005083878,0.00007976538,0.00006506366,0.00001907457,0.00008204391],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831367,0.00014011633,0.0007911974,0.0002104415,0.00039842536,0.00014613132],"domain_scores_gemma":[0.9981981,0.00044861066,0.00032908158,0.0006693162,0.0002921787,0.0000627066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004098983,0.00014300735,0.0006482625,0.00006620154,0.00008255273,0.0000156304,0.00023811928,0.000029017932,0.000014840025],"category_scores_gemma":[0.0003874216,0.00007031082,0.00008775296,0.00016008774,0.00024843478,0.0001363104,0.00011374794,0.000043524255,4.0602268e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055756617,0.031405043,0.03939262,0.0044395765,0.0016641273,0.000014916794,0.006833371,0.00007823932,0.00011749096,0.00008085391,0.00035234768,0.8598648],"study_design_scores_gemma":[0.014393912,0.027606752,0.9490072,0.005965679,0.0004526144,0.0000021220608,0.0008516396,0.00045059682,0.0010581287,0.00007362241,0.00005342224,0.000084309606],"about_ca_topic_score_codex":0.00006963902,"about_ca_topic_score_gemma":0.00000931708,"teacher_disagreement_score":0.90961456,"about_ca_system_score_codex":0.000008900321,"about_ca_system_score_gemma":0.00020073062,"threshold_uncertainty_score":0.28671923},"labels":[],"label_agreement":null},{"id":"W4399481173","doi":"10.1136/annrheumdis-2024-eular.352","title":"POS1173 COMPARATIVE RISK OF MORTALITY IN NEW USERS OF PRESCRIPTION OPIOIDS FOR NON-CANCER PAIN: RESULTS FROM THE INTERNATIONAL PHARMACOSURVEILLANCE STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medical prescription; Cancer; Medicine; Pharmacology; Internal medicine","score_opus":0.10660115692916426,"score_gpt":0.40143371305207703,"score_spread":0.29483255612291276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375194,0.001493011,0.00018451472,0.0017036736,0.00030398808,0.0012250643,0.0012332969,0.000010756049,0.00009377692],"genre_scores_gemma":[0.99838084,0.0010391374,0.000046075525,0.000156342,0.000059403934,0.00004487844,0.00005834901,0.0000071840336,0.00020779968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866295,0.00020846889,0.0005158024,0.0001642456,0.0003539035,0.00009463177],"domain_scores_gemma":[0.9982158,0.0010469976,0.00029196386,0.00031163872,0.00009613457,0.000037446323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009565595,0.000102730904,0.00031238174,0.0000543805,0.00002217958,0.000016692313,0.00030018255,0.000015515781,0.000031691226],"category_scores_gemma":[0.0006397347,0.000059182355,0.00017854784,0.00018080312,0.00007564394,0.00007861222,0.000059816484,0.00006208423,6.466266e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001239575,0.0006304582,0.92679423,0.00041485176,0.0017022456,6.839131e-7,0.0055505997,0.00074413046,0.00009353778,0.00006254569,0.05834956,0.0044175824],"study_design_scores_gemma":[0.0015979644,0.000111190384,0.96426445,0.0013681018,0.00031126526,1.0087711e-8,0.001580852,0.02891302,0.00038337577,0.0010808164,0.00033511818,0.0000538599],"about_ca_topic_score_codex":0.0030154376,"about_ca_topic_score_gemma":0.00041845592,"teacher_disagreement_score":0.05801444,"about_ca_system_score_codex":0.0000142772315,"about_ca_system_score_gemma":0.00011643654,"threshold_uncertainty_score":0.45584598},"labels":[],"label_agreement":null},{"id":"W4399481236","doi":"10.1136/annrheumdis-2024-eular.2219","title":"POS0568 PREVALENCE OF ULTRASOUND FINDINGS SUGGESTIVE OF INFLAMMATORY ARTHRITIS AND GOUT-SPECIFIC LESIONS IN PATIENTS WITH GOUT: THE ECHOGOUT STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Gout; Medicine; Inflammatory arthritis; Arthritis; Gouty arthritis; Ultrasound; Internal medicine; Dermatology; Pathology; Radiology","score_opus":0.015060065946346946,"score_gpt":0.26158399431430984,"score_spread":0.24652392836796289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891411,0.0088796625,0.0000039423476,0.00030235233,0.00006670284,0.0012829601,0.00023194519,0.00001997068,0.0000713574],"genre_scores_gemma":[0.99789137,0.0018689347,0.000029054361,0.000036449284,0.000009202115,0.000038026785,0.000006163281,0.000024142086,0.00009668453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981174,0.00016098704,0.00060952455,0.00026022276,0.00064741937,0.00020443542],"domain_scores_gemma":[0.99795717,0.00093381584,0.00023387505,0.00060148665,0.00018140406,0.00009226612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036314185,0.00019813981,0.0004664667,0.00014114786,0.00006126809,0.00001938669,0.00027366652,0.000043199485,0.00005938608],"category_scores_gemma":[0.0007851262,0.00010800829,0.00011670569,0.00040980562,0.00048587532,0.00014777973,0.00012279446,0.00017021004,0.0000038485755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025026832,0.0010512382,0.98076373,0.0016955322,0.0003525224,0.000007887159,0.006553261,0.000022031747,0.000052617004,0.0001567891,0.0007251427,0.008368983],"study_design_scores_gemma":[0.0010367811,0.00055669044,0.9880344,0.0071151303,0.0003038575,0.000006533128,0.0021226213,0.000019304112,0.0003906693,0.00029126904,0.000017686889,0.00010504233],"about_ca_topic_score_codex":0.00005731305,"about_ca_topic_score_gemma":0.000007983272,"teacher_disagreement_score":0.008750236,"about_ca_system_score_codex":0.000020723179,"about_ca_system_score_gemma":0.00014730562,"threshold_uncertainty_score":0.440445},"labels":[],"label_agreement":null},{"id":"W4399481278","doi":"10.1136/annrheumdis-2024-eular.4699","title":"POS0574 POPULATION-BASED ANALYSIS OF THE ASSOCIATION BETWEEN SARS-CoV-2 INFECTION AND INCIDENT AUTOIMMUNE DISEASES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Population; Virology; Immunology; 2019-20 coronavirus outbreak; Disease; Outbreak; Infectious disease (medical specialty); Environmental health; Internal medicine","score_opus":0.17428265432511042,"score_gpt":0.4306083847674356,"score_spread":0.2563257304423252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934681,0.0016869147,0.00026033516,0.0036927762,0.00011547425,0.00034092824,0.00033611327,0.00007723082,0.000022127932],"genre_scores_gemma":[0.99941194,0.00017064686,0.000031624117,0.00026577487,0.000018457928,0.000030064799,0.000023893632,0.000012343733,0.000035226043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785995,0.0005008115,0.0007479376,0.00021402755,0.0004972866,0.00017998664],"domain_scores_gemma":[0.99179035,0.006893641,0.0006854436,0.0004522469,0.00014310787,0.000035234316],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00070335995,0.00017494767,0.0006874389,0.00015958167,0.00017603728,0.000042230957,0.00023040363,0.000064404674,0.000019114863],"category_scores_gemma":[0.015271181,0.00009563634,0.00070260884,0.0010147727,0.00009739059,0.00010200023,0.00021406573,0.00008781713,0.0000016820792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009206266,0.00011969201,0.9905338,0.0006985846,0.0022898954,1.3501067e-7,0.00011683007,0.0005032687,0.000018292274,0.001970696,0.0014527452,0.002286832],"study_design_scores_gemma":[0.00008185289,0.000020463343,0.9267625,0.00051377877,0.0038882596,4.283422e-8,0.000013165041,0.00488987,0.00016480469,0.06352429,0.00004483989,0.00009609581],"about_ca_topic_score_codex":0.0017207887,"about_ca_topic_score_gemma":0.00017475685,"teacher_disagreement_score":0.063771285,"about_ca_system_score_codex":0.00010120197,"about_ca_system_score_gemma":0.000062201456,"threshold_uncertainty_score":0.99302363},"labels":[],"label_agreement":null},{"id":"W4399481287","doi":"10.1136/annrheumdis-2024-eular.1245","title":"OP0118 BASELINE AND PRE-BIOLOGIC PREDICTORS OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS WITH RECENT ONSET DISEASE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Rheumatoid arthritis; Baseline (sea); Medicine; Disease; Internal medicine; Biology","score_opus":0.020215813926371187,"score_gpt":0.2888861978765308,"score_spread":0.26867038395015963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9026319,0.08964664,0.0000544601,0.005572834,0.00012294929,0.0009304389,0.00086473196,0.000092604605,0.00008347781],"genre_scores_gemma":[0.81032443,0.18906207,0.0000785831,0.00016968827,0.000022416505,0.000087385415,0.00007042044,0.00003035077,0.00015464447],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978503,0.00020660511,0.0005620434,0.0003745963,0.000620737,0.00038574432],"domain_scores_gemma":[0.9978664,0.0004520278,0.00012365136,0.0006132241,0.00029747255,0.00064720487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031670232,0.00028031858,0.00061035086,0.00017706402,0.000104076746,0.000056223955,0.0002273095,0.00004378236,0.00027856466],"category_scores_gemma":[0.0014535922,0.00015400883,0.00018524975,0.00050305435,0.0005393788,0.00013615866,0.00015474245,0.0001291462,0.000014066323],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010019531,0.0036406384,0.2927405,0.007703653,0.0025086214,0.00024494517,0.0029741647,0.00021651924,0.00079984905,0.0019537432,0.095984444,0.5812134],"study_design_scores_gemma":[0.004181519,0.003331976,0.9197936,0.047894076,0.00015826177,0.00023985861,0.000842594,0.0016242018,0.0051890393,0.003223824,0.012780666,0.0007403719],"about_ca_topic_score_codex":0.00006936006,"about_ca_topic_score_gemma":0.000017157905,"teacher_disagreement_score":0.6270531,"about_ca_system_score_codex":0.000014146154,"about_ca_system_score_gemma":0.00032168787,"threshold_uncertainty_score":0.62802976},"labels":[],"label_agreement":null},{"id":"W4399481337","doi":"10.1136/annrheumdis-2024-eular.3059","title":"POS0512 SEX-RELATED DIFFERENCES IN TRIAL OUTCOMES IN AXIAL SPONDYLOARTHRITIS RANDOMIZED CLINICAL TRIALS: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; University of Ottawa; Queen's University; Women's College Hospital; University of Toronto","funders":"","keywords":"Meta-analysis; Randomized controlled trial; Medicine; Systematic review; Axial spondyloarthritis; Physical therapy; MEDLINE; Internal medicine; Ankylosing spondylitis; Biology; Sacroiliitis","score_opus":0.16183537538645304,"score_gpt":0.43910195154322385,"score_spread":0.2772665761567708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481337","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23196356,0.75646436,0.0000015673794,0.0058556045,0.00020191421,0.0051500835,0.00029000724,0.000026309093,0.000046610046],"genre_scores_gemma":[0.82205385,0.17612287,0.000013861811,0.0004277664,0.000013326746,0.00075196486,0.000028320908,0.000014570958,0.0005734732],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98990476,0.005553118,0.0034106865,0.00040974247,0.00047561113,0.00024606154],"domain_scores_gemma":[0.9899109,0.008760873,0.0006028694,0.00050803315,0.00008481222,0.00013254047],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007528695,0.00034820894,0.011142103,0.0003865901,0.000044843546,0.00008253865,0.00016079958,0.00011066858,0.0002484259],"category_scores_gemma":[0.016757099,0.00015721627,0.004853821,0.001139989,0.00023278884,0.00010971726,0.00009091936,0.00022192803,0.0000057105703],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07880322,0.003658408,0.015942553,0.15459535,0.7367193,0.00066754234,0.0020522263,0.000002969636,2.1743645e-7,0.0013029564,0.00086291105,0.0053923447],"study_design_scores_gemma":[0.2441143,0.00037363867,0.012852799,0.051644467,0.687786,0.000029718194,0.00021763702,0.0002913914,8.8080026e-7,0.0024141558,0.0000064033784,0.00026864157],"about_ca_topic_score_codex":0.000070623886,"about_ca_topic_score_gemma":0.000055971384,"teacher_disagreement_score":0.5900903,"about_ca_system_score_codex":0.000012431526,"about_ca_system_score_gemma":0.0000741892,"threshold_uncertainty_score":0.9915252},"labels":[],"label_agreement":null},{"id":"W4399481376","doi":"10.1136/annrheumdis-2024-eular.250","title":"POS0527 DEUCRAVACITINIB, A FIRST-IN-CLASS, ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): EFFICACY BY BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN THE PHASE 2 PAISLEY TRIAL","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Demographics; Systemic lupus erythematosus; Internal medicine; Pharmacology; Disease; Oncology; Demography","score_opus":0.033007739118302834,"score_gpt":0.31782851903221365,"score_spread":0.2848207799139108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830065,0.008986646,0.00003355566,0.0048522227,0.0005365095,0.0017275381,0.0007883665,0.000048955713,0.000019707735],"genre_scores_gemma":[0.99681157,0.002071673,0.000013166219,0.0005542284,0.00009226205,0.00018505241,0.00018283419,0.00004500879,0.000044235472],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971712,0.00044174286,0.0011111306,0.00042338233,0.000459135,0.00039339313],"domain_scores_gemma":[0.99748725,0.001362683,0.0002562458,0.0005205014,0.000119542034,0.00025377263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007964396,0.00035029682,0.0007348089,0.00041794873,0.00009487929,0.000118770506,0.0002477385,0.000079537764,0.000042698826],"category_scores_gemma":[0.002812132,0.00022211694,0.00029985368,0.0011083195,0.00017982462,0.00018073713,0.00008535064,0.00037164692,0.000005100354],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18559977,0.08183985,0.28940398,0.042466916,0.0024616595,0.0037367006,0.0150004765,0.00036308114,0.0152546745,0.0033167645,0.29249996,0.068056196],"study_design_scores_gemma":[0.3337915,0.013839259,0.19685847,0.22120434,0.00662961,0.0030299232,0.006722348,0.18071884,0.0047535514,0.0054533277,0.021922275,0.005076563],"about_ca_topic_score_codex":0.00014013062,"about_ca_topic_score_gemma":0.000074275435,"teacher_disagreement_score":0.27057767,"about_ca_system_score_codex":0.00004988323,"about_ca_system_score_gemma":0.00030932936,"threshold_uncertainty_score":0.9057666},"labels":[],"label_agreement":null},{"id":"W4399481411","doi":"10.1136/annrheumdis-2024-eular.1176","title":"POS1436-PARE HEALTH LITERACY IN ARTHRITIS CARE IN CANADA: THE PERSPECTIVE OF BIPOC MEN","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Royal University; Statistics Canada; Research Canada; University of British Columbia","funders":"","keywords":"Perspective (graphical); Literacy; Health literacy; Health care; Sociology; Computer science; Political science; Pedagogy; Artificial intelligence; Law","score_opus":0.05037866169020035,"score_gpt":0.43232175213285523,"score_spread":0.3819430904426549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6709525,0.253474,0.0000016190133,0.07103487,0.00058437925,0.0016654541,0.0012159012,0.000022883169,0.0010483641],"genre_scores_gemma":[0.9872736,0.011212573,0.000005807877,0.0012586829,0.00006546996,0.000058621255,0.000017004175,0.000017331446,0.00009095309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971079,0.001019059,0.0008580048,0.000196815,0.0003718212,0.00044636722],"domain_scores_gemma":[0.9980197,0.000947964,0.00026913357,0.00039187472,0.00023723466,0.00013408945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045492782,0.00014100381,0.00042353335,0.00012822176,0.00018214402,0.0000073163915,0.00032889962,0.00004734317,0.0001183232],"category_scores_gemma":[0.0004424693,0.000084605446,0.00010908289,0.0006239959,0.000057046516,0.00009911511,0.000119511365,0.00040023043,0.000006993238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011656079,0.0001224075,0.63400304,0.0109581575,0.00006139869,0.000015123872,0.11640525,0.00007278942,2.1211197e-7,0.005136403,0.069246806,0.16386183],"study_design_scores_gemma":[0.00043513154,0.000058497935,0.8487014,0.016919136,0.000014303202,7.104057e-7,0.12788717,0.00037459502,0.0000025732807,0.003890993,0.0015853948,0.00013009812],"about_ca_topic_score_codex":0.8352677,"about_ca_topic_score_gemma":0.8038292,"teacher_disagreement_score":0.31632105,"about_ca_system_score_codex":0.00048268336,"about_ca_system_score_gemma":0.008788774,"threshold_uncertainty_score":0.99683046},"labels":[],"label_agreement":null},{"id":"W4399481413","doi":"10.1136/annrheumdis-2024-eular.2434","title":"POS1174 ALEXITHYMIA IS HIGHLY PREVALENT AMONG PATIENTS WITH CHRONIC PAIN SYNDROMES BUT DOES NOT DIMINISH MULTIMODAL PROGRAM TREATMENT EFFICACY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Chronic pain; Medicine; Multimodal therapy; Physical therapy; Clinical psychology; Internal medicine","score_opus":0.02175860757907071,"score_gpt":0.29915427076994455,"score_spread":0.27739566319087383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911064,0.0026060124,0.0000086777245,0.0021516206,0.00025135855,0.0029330985,0.000547218,0.00019424057,0.00020139707],"genre_scores_gemma":[0.9966892,0.00072471966,0.00014681918,0.00021182971,0.00003126893,0.00047354755,0.000105105755,0.000063200634,0.0015543224],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977871,0.00013719202,0.000522241,0.0004550099,0.00066007546,0.0004383605],"domain_scores_gemma":[0.9983146,0.00029861997,0.0002130108,0.00081241457,0.00009644049,0.0002649221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011746212,0.0004329549,0.00062211574,0.0001084665,0.00011747004,0.000091467096,0.00024731614,0.00006552545,0.00021139198],"category_scores_gemma":[0.00010848009,0.00019674626,0.00048631258,0.00022055529,0.000284236,0.00015597745,0.00006149053,0.00007508219,0.000035992696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009236127,0.019984605,0.4765355,0.0064923964,0.007847644,0.000057508012,0.002293005,0.000027452617,0.000008396564,0.00015666481,0.0027571144,0.48291612],"study_design_scores_gemma":[0.004340526,0.004238609,0.9693676,0.01672123,0.0011722192,0.0000046910636,0.00015213626,0.0020987927,0.0006703465,0.0004075471,0.0005019567,0.0003243379],"about_ca_topic_score_codex":0.0002450161,"about_ca_topic_score_gemma":0.000015672726,"teacher_disagreement_score":0.49283212,"about_ca_system_score_codex":0.0001179344,"about_ca_system_score_gemma":0.00020238294,"threshold_uncertainty_score":0.80230796},"labels":[],"label_agreement":null},{"id":"W4399481422","doi":"10.1136/annrheumdis-2024-eular.1547","title":"POS1197 VALIDATION OF PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) QUESTIONNAIRES FOR CHILDREN WITH CHRONIC NONBACTERIAL OSTEOMYELITIS USING THE CHOIR DATA","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children; University of Toronto; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Patient-Reported Outcomes Measurement Information System; Osteomyelitis; Surgery; Psychometrics; Clinical psychology","score_opus":0.047336239927860776,"score_gpt":0.31086435262127826,"score_spread":0.26352811269341747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291044,0.0010316051,0.0014740898,0.0018625909,0.00030716776,0.0020705566,0.0002942434,0.0000383555,0.000010941866],"genre_scores_gemma":[0.9993604,0.000032698863,0.0001400516,0.00002570117,0.000044975735,0.00006558702,0.00031468607,0.000012806784,0.000003121211],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99846166,0.00008947764,0.0006173388,0.00014232256,0.0005681291,0.00012109488],"domain_scores_gemma":[0.99845123,0.0000978585,0.000389429,0.0006294363,0.00039002084,0.000041995474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039851695,0.00013119409,0.00026866898,0.00007451611,0.00009545768,0.00004681957,0.0001702082,0.000032158936,0.000009518612],"category_scores_gemma":[0.0007494355,0.00006282772,0.000166341,0.00016606289,0.000100012396,0.00041788406,0.000060644947,0.000039056766,8.7489497e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021870404,0.0009381961,0.1644734,0.07617212,0.010251865,0.0000012701142,0.008177579,0.0047171805,0.0021053795,0.0037637518,0.0048865066,0.7223257],"study_design_scores_gemma":[0.0016493684,0.00069043465,0.9665367,0.0125480825,0.0015685061,0.000015923772,0.00081650104,0.014240625,0.0013833771,0.0002610396,0.00010685391,0.00018256991],"about_ca_topic_score_codex":0.00035910495,"about_ca_topic_score_gemma":0.000012990916,"teacher_disagreement_score":0.80206335,"about_ca_system_score_codex":0.000059123646,"about_ca_system_score_gemma":0.00034699214,"threshold_uncertainty_score":0.25620398},"labels":[],"label_agreement":null},{"id":"W4399481444","doi":"10.1136/annrheumdis-2024-eular.5963","title":"OP0334 OUTCOMES IN PATIENTS WITH PRE-EXISTING AUTOIMMUNE DISEASE ON IMMUNE CHECKPOINT INHIBITOR THERAPY FOR TREATMENT OF CANCER","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Cancer; Disease; Immune checkpoint; Immune system; Immunotherapy; Autoimmune disease; Immunology; Oncology; Internal medicine","score_opus":0.04090105439869998,"score_gpt":0.3494708122231483,"score_spread":0.3085697578244483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973836,0.021684984,0.000002841667,0.0022082243,0.00021547149,0.0016187318,0.00037961156,0.000027688646,0.00002645499],"genre_scores_gemma":[0.99690396,0.0020976143,0.00002370169,0.00013227672,0.000017965285,0.0003288139,0.00003638633,0.000032062493,0.0004272359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998728,0.000039237653,0.0005320113,0.00020100645,0.00030398765,0.00019576063],"domain_scores_gemma":[0.999021,0.0001984109,0.00020565197,0.00041679427,0.00009165724,0.000066496636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098816396,0.00020877249,0.00051670446,0.00010752025,0.000043986136,0.000016156191,0.00011360703,0.0000234139,0.00005918565],"category_scores_gemma":[0.00008482334,0.00010502997,0.00043571918,0.00020200333,0.00012153568,0.000060658604,0.000016686774,0.000029696033,6.767083e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036245305,0.0066853235,0.5219693,0.0026083202,0.0028984984,0.0000043180185,0.0013905889,0.00014303945,0.00044227464,0.00010902556,0.00028018042,0.4272238],"study_design_scores_gemma":[0.005267614,0.0016928659,0.982223,0.0055296607,0.00017881804,1.2850188e-7,0.00004930532,0.0002464223,0.004192399,0.00013812113,0.0003605268,0.0001211675],"about_ca_topic_score_codex":0.00043542866,"about_ca_topic_score_gemma":0.000011595379,"teacher_disagreement_score":0.46025363,"about_ca_system_score_codex":0.00007764817,"about_ca_system_score_gemma":0.00024931235,"threshold_uncertainty_score":0.42829978},"labels":[],"label_agreement":null},{"id":"W4399481497","doi":"10.1136/annrheumdis-2024-eular.2328","title":"POS0048 GOUT RISK IN PREDIABETIC ADULTS INITIATING METFORMIN","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Metformin; Gout; Medicine; Prediabetes; Diabetes mellitus; Internal medicine; Endocrinology; Type 2 diabetes","score_opus":0.024897755975612574,"score_gpt":0.30874639826134265,"score_spread":0.2838486422857301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97698534,0.020020783,0.000001916237,0.001160623,0.00015119965,0.00057360064,0.00028898005,0.000052623047,0.0007649658],"genre_scores_gemma":[0.9969561,0.0025148876,0.00004458235,0.00021536608,0.000030665928,0.00011482561,0.000029275532,0.000020771484,0.000073510884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987596,0.00008972058,0.0003939698,0.00020989477,0.0003194534,0.00022735016],"domain_scores_gemma":[0.99887115,0.0004378552,0.00010856774,0.00037091423,0.000060729886,0.00015077127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015862573,0.00015689562,0.0003256587,0.000118200325,0.00004416422,0.000031075877,0.00012861894,0.000032485364,0.00014877826],"category_scores_gemma":[0.0006601905,0.00009404717,0.00032224902,0.00028733775,0.00006751389,0.00012943154,0.00007405633,0.00008994059,0.00004999967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029390038,0.0027670865,0.6832102,0.0053106844,0.0014769259,0.00014329098,0.00278804,0.00008346796,0.00000441434,0.0012827811,0.0053727063,0.2972665],"study_design_scores_gemma":[0.0011749284,0.00022645727,0.9759644,0.012049031,0.00095009594,0.00000687555,0.00050357485,0.0035604206,0.00092753203,0.004383187,0.00010588557,0.00014758305],"about_ca_topic_score_codex":0.00020035915,"about_ca_topic_score_gemma":0.000010848044,"teacher_disagreement_score":0.29711893,"about_ca_system_score_codex":0.00002770349,"about_ca_system_score_gemma":0.00015687062,"threshold_uncertainty_score":0.38351324},"labels":[],"label_agreement":null},{"id":"W4399481582","doi":"10.1136/annrheumdis-2024-eular.182","title":"POS0374 GLUCOSAMINE AND CANCER INCIDENCE IN PATIENTS WITH OSTEOARTHRITIS: REAL-WORLD OBSERVATIONAL STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Observational study; Osteoarthritis; Incidence (geometry); Glucosamine; Medicine; Internal medicine; Pathology; Mathematics; Alternative medicine; Biology","score_opus":0.047761772388613635,"score_gpt":0.3282054493910682,"score_spread":0.2804436770024546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363506,0.004296159,6.11506e-7,0.0006966541,0.00010571334,0.0009904546,0.0001238477,0.00002905871,0.000122453],"genre_scores_gemma":[0.9988088,0.00036849163,0.000035970945,0.00015133513,0.000016865677,0.00012700776,0.00003760691,0.000016820533,0.00043710292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989527,0.000046141562,0.0002669522,0.00020025154,0.0003811818,0.00015280688],"domain_scores_gemma":[0.99942344,0.00010649426,0.000066982015,0.00021816585,0.00010014612,0.00008477401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008442914,0.00013591883,0.00027410372,0.00010855703,0.000041859228,0.000027426337,0.00007251124,0.000017192677,0.00006373823],"category_scores_gemma":[0.000070655406,0.0000833371,0.00005201729,0.00032177474,0.00006713295,0.00016867452,0.000055682925,0.000059208527,0.0000031870193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030194272,0.0006864205,0.9080854,0.00024100469,0.00008530059,0.000019650217,0.0003336515,0.0000039821525,0.0000069473813,0.0006062734,0.00013961722,0.089489795],"study_design_scores_gemma":[0.0025227615,0.0015152141,0.9905106,0.0041110185,0.00016181376,0.0000013903358,0.0001536365,0.000029201135,0.00010103095,0.0007715293,0.000032766922,0.00008907373],"about_ca_topic_score_codex":0.0003345612,"about_ca_topic_score_gemma":0.0010824463,"teacher_disagreement_score":0.089400716,"about_ca_system_score_codex":0.00002075582,"about_ca_system_score_gemma":0.0001317112,"threshold_uncertainty_score":0.33983883},"labels":[],"label_agreement":null},{"id":"W4399481600","doi":"10.1136/annrheumdis-2024-eular.3336","title":"POS1127 THE MOCA TEST IN THE EVALUATION OF COGNITIVE DEFICITS IN SYSTEMIC LUPUS ERYTHEMATOSUS: ANALYSIS OF A MONOCENTRIC COHORT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Medicine; Test (biology); Montreal Cognitive Assessment; Cognition; Internal medicine; Cognitive impairment; Psychiatry","score_opus":0.06689677220693246,"score_gpt":0.37427405586465395,"score_spread":0.3073772836577215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692662,0.026418922,0.000015360076,0.0008116218,0.00008754365,0.0026939502,0.00016897492,0.000012904527,0.00052457297],"genre_scores_gemma":[0.99846166,0.0010750981,0.0000021721587,0.000053416734,0.0000106037,0.0002830447,0.000028151819,0.00002095002,0.00006489577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950818,0.0011075571,0.0012028026,0.00027697932,0.0020346818,0.0002962001],"domain_scores_gemma":[0.992071,0.0058519226,0.00043790994,0.0008357897,0.0007441482,0.00005926051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046260217,0.00019975782,0.0009016803,0.0008571455,0.000039545874,0.000027725886,0.0005308328,0.00006632045,0.00007053196],"category_scores_gemma":[0.00831026,0.00009421598,0.00049172837,0.0042467085,0.0002491361,0.00008517418,0.00010726618,0.0001741636,0.000008744055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001797192,0.00081121584,0.9758808,0.0052676355,0.0024916856,0.0000112171765,0.009936127,0.0010294224,0.00005322985,0.0003313928,0.0006467928,0.0033607509],"study_design_scores_gemma":[0.0023718246,0.00023547046,0.69699156,0.042028353,0.011863879,0.0010705929,0.03889055,0.20395629,0.00053599675,0.0018310979,0.0000023854145,0.0002220124],"about_ca_topic_score_codex":0.00036221455,"about_ca_topic_score_gemma":0.000081476705,"teacher_disagreement_score":0.27888927,"about_ca_system_score_codex":0.00008476923,"about_ca_system_score_gemma":0.0005652788,"threshold_uncertainty_score":0.9948758},"labels":[],"label_agreement":null},{"id":"W4399481734","doi":"10.1136/annrheumdis-2024-eular.4696","title":"POS0053 CARDIOVASCULAR SAFETY OF COLCHICINE AND NSAID PROPHYLAXIS WITH URATE-LOWERING THERAPY INITIATION: TARGET TRIAL EMULATION (TTE) ANALYSES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Colchicine; Emulation; Medicine; Pharmacology; Internal medicine; Psychology","score_opus":0.06995949767068035,"score_gpt":0.3379173329422202,"score_spread":0.2679578352715398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700423,0.027028523,0.00048202873,0.00081821124,0.00013413609,0.0011325339,0.0000608541,0.000052592393,0.0002488228],"genre_scores_gemma":[0.9977761,0.0016800985,0.00020183247,0.00009581904,0.00008638518,0.00003334312,0.000034200824,0.000030446368,0.00006177864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982034,0.00014243963,0.0005459832,0.0002580515,0.0006787045,0.00017142802],"domain_scores_gemma":[0.9986774,0.00023708459,0.0001931728,0.0005693825,0.00022166155,0.00010130773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037969276,0.00020522077,0.0006929481,0.00014871331,0.00007606621,0.0000295083,0.000119651835,0.000058470327,0.00008780656],"category_scores_gemma":[0.0003748054,0.00011731822,0.00038341153,0.00054665725,0.00016150874,0.0001850423,0.000047104953,0.000110504945,0.0000023138416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20451033,0.0070272856,0.1340081,0.036316816,0.10133618,0.00038439687,0.018291993,0.053066425,0.012934561,0.0016631121,0.0055463403,0.42491448],"study_design_scores_gemma":[0.082277544,0.011755817,0.7816359,0.01793707,0.0115079405,0.0002608629,0.0022399216,0.020989178,0.0632316,0.0036592856,0.0028736496,0.0016312693],"about_ca_topic_score_codex":0.00008428542,"about_ca_topic_score_gemma":0.0000012039721,"teacher_disagreement_score":0.6476278,"about_ca_system_score_codex":0.000018900677,"about_ca_system_score_gemma":0.0002135721,"threshold_uncertainty_score":0.4784098},"labels":[],"label_agreement":null},{"id":"W4399481771","doi":"10.1136/annrheumdis-2024-eular.1667","title":"OP0015 THE ROLE OF MULTI-CRITERIA DECISION ANALYSIS IN THE DEVELOPMENT OF CANDIDATE CLASSIFICATION CRITERIA FOR ANTISYNTHETASE SYNDROME: ANALYSIS FROM THE CLASS PROJECT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Antisynthetase syndrome; Computer science; Class (philosophy); Artificial intelligence; Linguistics; Philosophy","score_opus":0.08484319331023812,"score_gpt":0.3968394934648648,"score_spread":0.31199630015462665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797066,0.011366318,0.0033353835,0.0023870298,0.00017072396,0.0007934001,0.002201153,0.000011486403,0.000027926262],"genre_scores_gemma":[0.9980811,0.00026218075,0.0012804791,0.00011255298,0.000004608769,0.00007497978,0.00014299873,0.000008245778,0.00003285936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99753255,0.0009833038,0.0008691319,0.0002685063,0.0001379264,0.00020857749],"domain_scores_gemma":[0.9959096,0.0028401024,0.00033665728,0.00076705636,0.00013120823,0.000015402211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016302513,0.00017577622,0.0005965239,0.00022397425,0.00015690854,0.000046029174,0.000874844,0.000098947276,0.00016488029],"category_scores_gemma":[0.0007549258,0.00006890946,0.00066974637,0.0016037456,0.00038084216,0.000059029695,0.00013303572,0.00011145349,0.0000022239508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029500162,0.0056299237,0.081892364,0.0014916193,0.100285985,0.0000063380744,0.028621163,0.00032016778,0.07699597,0.0047596996,0.0192966,0.6777502],"study_design_scores_gemma":[0.000712706,0.00013051605,0.8949063,0.0009800316,0.015096384,0.000003948796,0.006791834,0.03567389,0.035565816,0.0053906008,0.0044232523,0.00032473923],"about_ca_topic_score_codex":0.0003594501,"about_ca_topic_score_gemma":0.00040667376,"teacher_disagreement_score":0.8130139,"about_ca_system_score_codex":0.000011216017,"about_ca_system_score_gemma":0.00012700862,"threshold_uncertainty_score":0.28100464},"labels":[],"label_agreement":null},{"id":"W4399481844","doi":"10.1136/annrheumdis-2024-eular.1455","title":"POS0744 “I COULDN’T CARRY ON TAKING A DRUG LIKE THAT”: A QUALITATIVE STUDY OF PATIENT PERSPECTIVES ON SIDE EFFECTS FROM DRUG TREATMENT IN RHEUMATOLOGY FROM THE OMERACT SAFETY WORKING GROUP","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Innovations in Medical Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary; McGill University","funders":"","keywords":"Drug; Medicine; Qualitative research; Qualitative analysis; Side effect (computer science); Rheumatology; Internal medicine; Pharmacology; Computer science","score_opus":0.03845143004169077,"score_gpt":0.37863920868829737,"score_spread":0.3401877786466066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864607,0.0054774005,0.000007897208,0.005504799,0.000690335,0.00159946,0.00008220856,0.00003703215,0.00014015826],"genre_scores_gemma":[0.9986567,0.00041101937,0.00006331622,0.000479039,0.000032010208,0.00023855128,0.00006374571,0.000031940734,0.000023686049],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99672145,0.0011491543,0.0007385543,0.00041776468,0.0007342713,0.00023880434],"domain_scores_gemma":[0.99175245,0.0068535823,0.0005149333,0.00071275205,0.00010757216,0.000058689155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005225608,0.0002791697,0.00067637453,0.00021155686,0.00012952513,0.000027760878,0.0002505435,0.000049837687,0.000056066303],"category_scores_gemma":[0.0023275092,0.0001538555,0.0002145717,0.0005636519,0.00021297854,0.000073330004,0.00007174951,0.0002890893,0.000008766684],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011938999,0.0075635067,0.018570442,0.00039426718,0.0017358594,0.000020970208,0.87781215,0.00015623313,0.00001811091,0.0017772713,0.001901317,0.08885595],"study_design_scores_gemma":[0.0019049341,0.0011391011,0.2707201,0.018722884,0.00047717663,0.0000018935517,0.70200145,0.0007602716,0.00025835267,0.0037120208,0.000086304426,0.00021549928],"about_ca_topic_score_codex":0.007709332,"about_ca_topic_score_gemma":0.00024340152,"teacher_disagreement_score":0.25214967,"about_ca_system_score_codex":0.00023447744,"about_ca_system_score_gemma":0.00019787598,"threshold_uncertainty_score":0.99889845},"labels":[],"label_agreement":null},{"id":"W4399481853","doi":"10.1136/annrheumdis-2024-eular.2467","title":"POS0508 WHAT FACTORS ARE ASSOCIATED WITH PAIN INTENSITY IN AXIAL SPONDYLOARTHRITIS? RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Medicine; BASDAI; Physical therapy; Fibromyalgia; Anxiety; Back pain; Depression (economics); Neck pain; Visual analogue scale; Ankylosing spondylitis; Body mass index; Pain disorder; Mental health; Disease; Physical medicine and rehabilitation; Chronic pain; Internal medicine; Psychiatry; Psoriatic arthritis; Alternative medicine","score_opus":0.03311725576209577,"score_gpt":0.27253932227902405,"score_spread":0.2394220665169283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715933,0.013410522,0.0000027029532,0.01006469,0.0009626724,0.0005802664,0.003241699,0.000051468523,0.000092672366],"genre_scores_gemma":[0.99642277,0.002221441,0.000016648733,0.0004687104,0.00008852916,0.000029828701,0.0005506336,0.000034671142,0.00016679188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974689,0.00021179923,0.00075123523,0.00040335138,0.00082552835,0.0003392149],"domain_scores_gemma":[0.9972595,0.0014033229,0.00037727662,0.0005300833,0.00031260095,0.000117220305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005228165,0.00031344057,0.0007402351,0.00012658928,0.000115698975,0.00011398849,0.0003604236,0.00008955237,0.00019221324],"category_scores_gemma":[0.0020901926,0.00018045056,0.0004008433,0.00034701926,0.0003981737,0.00031424555,0.00019921955,0.00022495365,0.000013039976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011120666,0.0040307003,0.7980444,0.0005742636,0.006761646,0.0012447402,0.011469464,0.00007319931,0.0001154253,0.00054437545,0.04211182,0.123909295],"study_design_scores_gemma":[0.0053540603,0.0004983273,0.95858836,0.024250751,0.00031652625,0.000017208667,0.007216075,0.00025143457,0.00055445655,0.0015849139,0.0011016038,0.00026626477],"about_ca_topic_score_codex":0.0012384183,"about_ca_topic_score_gemma":0.0017622143,"teacher_disagreement_score":0.16054398,"about_ca_system_score_codex":0.00006683521,"about_ca_system_score_gemma":0.00014663592,"threshold_uncertainty_score":0.735856},"labels":[],"label_agreement":null},{"id":"W4399481861","doi":"10.1136/annrheumdis-2024-eular.2474","title":"POS1386 REGIONAL DIFFERENCES IN PATIENT DIAGNOSIS JOURNEY AND HEALTHCARE UTILIZATION. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Axial spondyloarthritis; Health care; Computer science; Medicine; Intensive care medicine; Internal medicine; Political science; Ankylosing spondylitis","score_opus":0.09677307331639964,"score_gpt":0.32877228582319906,"score_spread":0.23199921250679942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9013223,0.049711257,9.79111e-7,0.046497006,0.0003545761,0.00030083166,0.0017457491,0.00001099177,0.000056274213],"genre_scores_gemma":[0.9828456,0.016411472,0.00002367432,0.00046617695,0.000045507102,0.000047275516,0.000111028225,0.000009299846,0.000039981624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986836,0.00008127595,0.0004768307,0.00019569922,0.00043060674,0.00013200185],"domain_scores_gemma":[0.9987652,0.0006723334,0.000153519,0.00022185293,0.00011859431,0.00006851764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009582693,0.00012329582,0.00028679857,0.00006503457,0.000073241725,0.00002979219,0.00014020562,0.000031023676,0.00009321226],"category_scores_gemma":[0.0004582149,0.00006886547,0.00013800284,0.0001345534,0.00018287488,0.00007200818,0.00011473009,0.00007375684,0.0000032247506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013590186,0.001108266,0.6907189,0.00050037645,0.001038165,0.00009633554,0.006813829,0.000006825066,0.000006103311,0.002990359,0.043564238,0.2517976],"study_design_scores_gemma":[0.0015997897,0.00028691845,0.98122287,0.007433859,0.000101803635,0.000014420159,0.0015837714,0.00021211663,0.00011272419,0.0050899712,0.0022542756,0.00008748406],"about_ca_topic_score_codex":0.001241592,"about_ca_topic_score_gemma":0.00033701424,"teacher_disagreement_score":0.29050398,"about_ca_system_score_codex":0.0000166772,"about_ca_system_score_gemma":0.000086746375,"threshold_uncertainty_score":0.28082523},"labels":[],"label_agreement":null},{"id":"W4399481862","doi":"10.1136/annrheumdis-2024-eular.4663","title":"POS0251 COMPARATIVE EFFECTIVENESS OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS FOR THE RISK OF KIDNEY STONE AMONG GOUT PATIENTS WITH TYPE 2 DIABETES: TARGET TRIAL EMULATION STUDIES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Research Canada","funders":"","keywords":"Emulation; Gout; Cotransporter; Type 2 diabetes; Medicine; Diabetes mellitus; Internal medicine; Computer science; Endocrinology; Sodium; Chemistry; Psychology","score_opus":0.028276169740072313,"score_gpt":0.31690449512697333,"score_spread":0.28862832538690103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98577267,0.010913786,0.00003960178,0.0001711773,0.00045132023,0.002149881,0.0004528984,0.000019293258,0.000029386618],"genre_scores_gemma":[0.999034,0.0007052938,0.000018350367,0.000025825217,0.000016583,0.00007009171,0.00009228801,0.000017484927,0.000020111262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986691,0.0002096359,0.00046460357,0.00015821017,0.00034569055,0.00015274652],"domain_scores_gemma":[0.99751866,0.0013320277,0.00036940348,0.0002649308,0.00042516287,0.00008982597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035594855,0.00017235892,0.000634011,0.00008032988,0.00008111099,0.000006644283,0.00011407491,0.00005045794,0.000009424006],"category_scores_gemma":[0.00087236403,0.0000791499,0.00029331495,0.00029614015,0.00048227943,0.000097466815,0.000023646247,0.00009735717,8.373635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073590994,0.0050833975,0.84603333,0.022553813,0.023676451,0.0000013827765,0.01133166,0.0044385144,0.00030481588,0.000263817,0.007076419,0.0056453827],"study_design_scores_gemma":[0.022857817,0.003106575,0.93347955,0.014111142,0.0050843293,1.2732453e-7,0.0014563448,0.0037344275,0.0139403045,0.0019404581,0.00006105901,0.00022787516],"about_ca_topic_score_codex":0.00004256644,"about_ca_topic_score_gemma":0.0000031583336,"teacher_disagreement_score":0.08744619,"about_ca_system_score_codex":0.000012444341,"about_ca_system_score_gemma":0.00021041557,"threshold_uncertainty_score":0.32276392},"labels":[],"label_agreement":null},{"id":"W4399481875","doi":"10.1136/annrheumdis-2024-eular.2754","title":"AB1668-PARE IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES THROUGH 6 MONTHS OF GUSELKUMAB TREATMENT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: REAL-WORLD DATA FROM THE COREVITAS PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS REGISTRY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Psoriatic arthritis; Medicine; Dermatology; Psoriasis; Arthritis; Ankylosing spondylitis; Internal medicine","score_opus":0.041617032959590745,"score_gpt":0.3191211657684884,"score_spread":0.2775041328088977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96578956,0.023739338,0.0000013171245,0.0010024764,0.0004149595,0.002966206,0.0058403313,0.000047503894,0.00019830621],"genre_scores_gemma":[0.98278594,0.015280398,0.00010771367,0.00018305947,0.000032603108,0.00039626355,0.0010841243,0.000067545676,0.000062358165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958754,0.00024171417,0.0015517734,0.0007890595,0.0009825624,0.0005594472],"domain_scores_gemma":[0.99599135,0.00066532695,0.0008449977,0.0021676584,0.00019694296,0.00013373396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016464606,0.00056742074,0.0015303076,0.00017037026,0.00013238328,0.000061483785,0.00049744546,0.00007023936,0.00011080474],"category_scores_gemma":[0.00059557706,0.0003292939,0.00032125198,0.00086683786,0.00039211268,0.00046111547,0.00032351154,0.00019809029,0.00001061565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016154557,0.0038003689,0.5414258,0.0003287486,0.0027559367,0.00027096894,0.0021764613,0.000016259142,0.0000010768124,0.00012436869,0.0016271169,0.4458574],"study_design_scores_gemma":[0.011807245,0.0013685602,0.96841,0.01390761,0.00071267405,0.0000049930136,0.0016251659,0.00006418827,0.00011650237,0.0013931333,0.00028097403,0.00030895663],"about_ca_topic_score_codex":0.014501998,"about_ca_topic_score_gemma":0.01686198,"teacher_disagreement_score":0.44554844,"about_ca_system_score_codex":0.00017751924,"about_ca_system_score_gemma":0.00034684737,"threshold_uncertainty_score":0.9999159},"labels":[],"label_agreement":null},{"id":"W4399481889","doi":"10.1136/annrheumdis-2024-eular.1852","title":"POS0149 DO POLICIES THAT IMPROVE BIOSIMILAR UPTAKE ALSO HELP ACHIEVE GREATER EXPENDITURE CONTROL? A CROSS-COUNTRY POLICY ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University of British Columbia; Centre for Advancing Health Outcomes","funders":"","keywords":"Biosimilar; Control (management); Business; Computer science; Medicine; Artificial intelligence; Internal medicine","score_opus":0.030416221144762702,"score_gpt":0.3427143278562319,"score_spread":0.3122981067114692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8391201,0.09315505,0.0005677268,0.049056903,0.0025170436,0.0012472743,0.011418463,0.00037633692,0.0025411302],"genre_scores_gemma":[0.9930458,0.00092495204,0.000040433963,0.003439431,0.000093186274,0.000031867265,0.000048457016,0.000031194813,0.0023446567],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976438,0.00039934664,0.00063529366,0.0004957424,0.00017245032,0.00065331237],"domain_scores_gemma":[0.99814415,0.00050546264,0.00024289972,0.00088409893,0.0001235239,0.000099863275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049860316,0.000415685,0.00088235777,0.00040498166,0.0002453407,0.0002304208,0.00074257917,0.00033506643,0.0010259628],"category_scores_gemma":[0.00046929653,0.00023254869,0.0012141687,0.00088521885,0.0008919373,0.00018832741,0.00023592329,0.00028836422,0.00006519356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005120355,0.0037235345,0.17491563,0.005433001,0.14026849,0.00011588458,0.006440987,0.000475927,0.055133224,0.06670586,0.27923527,0.26243186],"study_design_scores_gemma":[0.0035300576,0.00097637536,0.7709129,0.0020849567,0.015521398,0.00009101396,0.0017177182,0.00093971984,0.10753489,0.03560739,0.05892611,0.002157509],"about_ca_topic_score_codex":0.00034239932,"about_ca_topic_score_gemma":0.00001579136,"teacher_disagreement_score":0.5959972,"about_ca_system_score_codex":0.0000259297,"about_ca_system_score_gemma":0.00014680123,"threshold_uncertainty_score":0.9998872},"labels":[],"label_agreement":null},{"id":"W4399481929","doi":"10.1136/annrheumdis-2024-eular.1331","title":"POS1109 EVALUATING THE CONCORDANCE BETWEEN SRI-4 AND BICLA IN THE EXPLORER AND ATHOS TRIALS IN ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Concordance; Medicine; Internal medicine","score_opus":0.18934271587171977,"score_gpt":0.4370113956812427,"score_spread":0.24766867980952292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95672864,0.035200708,0.000007474009,0.0049401633,0.00018029938,0.0026766902,0.00007059328,0.000026937407,0.00016848433],"genre_scores_gemma":[0.9974342,0.0017500971,0.0000168506,0.00019529842,0.00008222393,0.00038021128,0.000004473576,0.000029651095,0.00010700932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994529,0.002563782,0.0012113904,0.00037102203,0.00093496573,0.0003898488],"domain_scores_gemma":[0.98723227,0.011442128,0.00035334827,0.0007407209,0.000121022094,0.000110522546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007903889,0.00025760688,0.0011153253,0.0002138562,0.00011140625,0.00012593363,0.0004313622,0.00007553627,0.000018023191],"category_scores_gemma":[0.008283359,0.00011205626,0.00022675382,0.0006265257,0.00036469268,0.00016653644,0.00021146143,0.0003103946,0.000008479888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013053743,0.00031537222,0.7892134,0.02131012,0.0011935172,0.00010579525,0.10326502,0.000033263783,0.0007177337,0.002218514,0.0036768392,0.076645054],"study_design_scores_gemma":[0.01545382,0.0019505584,0.38443384,0.23049343,0.002679673,0.01970774,0.27960023,0.017418617,0.002116309,0.04446294,0.00034800486,0.0013348273],"about_ca_topic_score_codex":0.00015543985,"about_ca_topic_score_gemma":0.000014948253,"teacher_disagreement_score":0.40477955,"about_ca_system_score_codex":0.000054934822,"about_ca_system_score_gemma":0.00029170752,"threshold_uncertainty_score":0.99165523},"labels":[],"label_agreement":null},{"id":"W4399481949","doi":"10.1136/annrheumdis-2024-eular.6042","title":"POS0172 WORLDWIDE EVALUATION OF CLINICAL PRACTICE STRATEGIES (CliPS) FOR LUNG DISEASE IN STILL’S DISEASE WITHIN THE JIR-CliPS NETWORK: A COST ACTION","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"CLIPS; Disease; Action (physics); Medicine; Computer science; Artificial intelligence; Pathology","score_opus":0.22299472202669138,"score_gpt":0.4366133776356065,"score_spread":0.2136186556089151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88723177,0.079375215,0.0029297327,0.01699999,0.004045058,0.0039748163,0.0022943555,0.00006111049,0.0030879362],"genre_scores_gemma":[0.9963657,0.002207076,0.00009423142,0.00056527765,0.00024400011,0.00028741092,0.00003224714,0.00003327946,0.00017072541],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99711,0.00021848829,0.0017605623,0.00040625958,0.00017928015,0.0003253725],"domain_scores_gemma":[0.99596447,0.0016272306,0.0013148513,0.0006614218,0.00022776374,0.00020428293],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0046923403,0.00021206382,0.0005935346,0.00012627701,0.00011038335,0.0001775895,0.00044459372,0.00006529396,0.00009977116],"category_scores_gemma":[0.009016043,0.00015908857,0.00050619955,0.0003403009,0.00023721109,0.0010821281,0.000088966735,0.00018376886,0.000016061313],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002808615,0.0010396024,0.108498156,0.002127026,0.0009102336,0.000003888283,0.0010594609,0.20367658,3.881547e-7,0.55615807,0.03192061,0.09179735],"study_design_scores_gemma":[0.00071308773,0.000047002526,0.39772153,0.0010058578,0.00037970615,4.0328234e-7,0.00038641805,0.353858,0.0000020175669,0.24061133,0.0050433897,0.00023127513],"about_ca_topic_score_codex":0.0002766989,"about_ca_topic_score_gemma":0.00013515083,"teacher_disagreement_score":0.31554675,"about_ca_system_score_codex":0.0000750742,"about_ca_system_score_gemma":0.0008649221,"threshold_uncertainty_score":0.9993314},"labels":[],"label_agreement":null},{"id":"W4399482012","doi":"10.1136/annrheumdis-2024-eular.1769","title":"OP0092 INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO bDMARDs: FINDINGS FROM AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Rheumatoid arthritis; Medicine; Internal medicine","score_opus":0.015926676073619243,"score_gpt":0.30123882218009235,"score_spread":0.2853121461064731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503064,0.0009179038,0.000020658747,0.0018983296,0.00015214583,0.0014997072,0.0003477458,0.000048201775,0.00008464263],"genre_scores_gemma":[0.99810547,0.0014080704,0.000038761467,0.00007469594,0.00001566935,0.00013820987,0.00015364894,0.000030593186,0.00003486791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979287,0.00019783934,0.0005355672,0.00028873124,0.00082729955,0.00022189207],"domain_scores_gemma":[0.99851114,0.00021690429,0.00014930178,0.00051245675,0.0004455957,0.00016457961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020001562,0.00020225269,0.00043933306,0.00029748154,0.0001158531,0.00013333008,0.0002712867,0.000030198447,0.000098613],"category_scores_gemma":[0.000318653,0.00011402545,0.00009140729,0.0008996329,0.00023092603,0.0004145658,0.000067413326,0.00011926742,0.0000074074574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016253653,0.002202982,0.97811747,0.00008107975,0.0008108038,0.000010050328,0.0044194907,0.00036171204,0.000022992792,0.00011950123,0.002473716,0.009754829],"study_design_scores_gemma":[0.0039898157,0.002008927,0.9816197,0.0074417773,0.000025204421,0.0000050302842,0.003362756,0.00038937514,0.0004024261,0.00015192678,0.00042787366,0.00017518946],"about_ca_topic_score_codex":0.0012607488,"about_ca_topic_score_gemma":0.0012216087,"teacher_disagreement_score":0.00957964,"about_ca_system_score_codex":0.00004623857,"about_ca_system_score_gemma":0.00022098297,"threshold_uncertainty_score":0.46498233},"labels":[],"label_agreement":null},{"id":"W4399482037","doi":"10.1136/annrheumdis-2024-eular.432","title":"POS0168 ROTAVIRUS VACCINE IN OFFSPRING EXPOSED TO TUMOUR NECROSIS FACTOR INHIBITORS DOES NOT INCREASE DIARRHEA-ASSOCIATED HEALTHCARE EVENTS: REAL-WORLD EVIDENCE TO GUIDE BEST PRACTICES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Diarrhea; Offspring; Rotavirus; Medicine; Health care; Rotavirus vaccine; Necrosis; Tumor necrosis factor alpha; Immunology; Internal medicine; Biology; Pregnancy; Political science","score_opus":0.1338758496104166,"score_gpt":0.43515532857860134,"score_spread":0.30127947896818474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9002381,0.0014880063,0.000005936082,0.09628054,0.0002542732,0.0012538576,0.000375571,0.00007081267,0.000032893975],"genre_scores_gemma":[0.9924384,0.0029255345,0.00013765981,0.0031397545,0.000090430476,0.00020158058,0.000020462083,0.000044201373,0.0010020139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958915,0.00088323076,0.0012045321,0.00053789176,0.00068985665,0.0007929974],"domain_scores_gemma":[0.99680823,0.0009835759,0.00040918338,0.0006024699,0.00029549858,0.00090104545],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012142734,0.0003067235,0.0008783278,0.00048713144,0.00010515344,0.000068158646,0.0004649541,0.00006617164,0.00011859163],"category_scores_gemma":[0.032178964,0.00019510888,0.0003163865,0.0009184468,0.00004669679,0.00042294338,0.00041155086,0.00030928047,0.00007490973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004228223,0.001416779,0.89882547,0.0043136002,0.00059788337,0.00025509842,0.0012920034,0.00012106736,0.02412667,0.00006242911,0.026944786,0.037816014],"study_design_scores_gemma":[0.0007444915,0.0012029962,0.9546389,0.03323856,0.00012568952,0.000009742049,0.0004037607,0.00030460424,0.008373535,0.00026743038,0.0004267749,0.00026353044],"about_ca_topic_score_codex":0.038787324,"about_ca_topic_score_gemma":0.010634477,"teacher_disagreement_score":0.09314078,"about_ca_system_score_codex":0.00024687508,"about_ca_system_score_gemma":0.00041470394,"threshold_uncertainty_score":0.9759734},"labels":[],"label_agreement":null},{"id":"W4399482038","doi":"10.1136/annrheumdis-2024-eular.2314","title":"POS0798 EFFICACY, SAFETY AND RADIOGRAPHIC OUTCOMES FROM THE PHASE 3 SELECT-AXIS 2 STUDY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: 2-YEAR DATA","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Arthritis Society; University of Toronto; University Health Network","funders":"","keywords":"Ankylosing spondylitis; Medicine; Radiography; Internal medicine; Radiology","score_opus":0.05781690662898581,"score_gpt":0.35350038949302237,"score_spread":0.29568348286403656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919827,0.0035380644,0.0000011013852,0.0012870624,0.00004079451,0.001474786,0.004434521,0.000019342106,0.000006087927],"genre_scores_gemma":[0.99848247,0.0010892504,0.000030669795,0.00014967326,0.0000076201313,0.000021879845,0.00019372992,0.000018497836,0.0000062082686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834204,0.0004381311,0.0003562244,0.00038031608,0.00028424786,0.00019906873],"domain_scores_gemma":[0.99793345,0.0010875037,0.000115496056,0.00067915587,0.000076276854,0.00010810879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032264093,0.00020956788,0.0005398883,0.00013181275,0.000118842836,0.000033375603,0.00020848365,0.000028044922,0.00003239686],"category_scores_gemma":[0.00048086143,0.000101320904,0.00005894368,0.00045528173,0.00020056787,0.00014242764,0.00019325504,0.00008421742,5.7421585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035485238,0.0031707422,0.7841004,0.00005405981,0.0014126287,0.000020594323,0.0047730836,0.00000213046,0.000009542045,0.00001093306,0.00009365967,0.17086697],"study_design_scores_gemma":[0.010342636,0.004616769,0.9812471,0.00090717524,0.00023593237,0.0000015093248,0.0023268415,0.000026174506,0.00002306172,0.00008243072,0.00008516285,0.00010515354],"about_ca_topic_score_codex":0.0006563467,"about_ca_topic_score_gemma":0.00010720162,"teacher_disagreement_score":0.19714673,"about_ca_system_score_codex":0.000011235685,"about_ca_system_score_gemma":0.000048337482,"threshold_uncertainty_score":0.41317466},"labels":[],"label_agreement":null},{"id":"W4399482043","doi":"10.1136/annrheumdis-2024-eular.2157","title":"POS0419-HPR WHAT CHALLENGES AND OPPORTUNITIES DO PHYSIOTHERAPISTS ENCOUNTER IN INTEGRATING INTERVENTIONS TO PROMOTE SLEEP FOR INDIVIDUALS WITH ARTHRITIS?","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Research Canada; University of British Columbia","funders":"","keywords":"Psychological intervention; Sleep (system call); Arthritis; Medicine; Psychology; Computer science; Physical therapy; Physical medicine and rehabilitation; Nursing","score_opus":0.08703637328160184,"score_gpt":0.36584863170248316,"score_spread":0.2788122584208813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7510208,0.22569947,0.0000827208,0.021416951,0.000073850344,0.0013683351,0.000061024493,0.000038903243,0.00023794798],"genre_scores_gemma":[0.96070445,0.038255546,0.00013014744,0.0003101214,0.000015417152,0.0002759991,0.0000120535215,0.000027141186,0.00026914402],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99888355,0.00006721816,0.00038045112,0.00019390057,0.00026254368,0.00021233197],"domain_scores_gemma":[0.9993267,0.0001407138,0.00007668693,0.00025860997,0.00010966924,0.00008762101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036012375,0.00014384593,0.00035000796,0.00019967483,0.000057560486,0.00014612402,0.0001390545,0.000031811906,0.00006380203],"category_scores_gemma":[0.00017925848,0.000088174704,0.0001665962,0.00010928395,0.00013325778,0.00042215973,0.00008122263,0.000093896706,0.000002694297],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012996103,0.0003131214,0.00043699273,0.009561602,0.00032193353,0.0000092116015,0.010324557,0.000007128859,0.00004707925,0.003270451,0.0009628325,0.97461516],"study_design_scores_gemma":[0.0066472935,0.006392727,0.13869707,0.61991286,0.0004142065,0.0001153126,0.15295076,0.003542923,0.0022692615,0.045947243,0.02174499,0.0013653268],"about_ca_topic_score_codex":0.0000118985645,"about_ca_topic_score_gemma":0.000031991418,"teacher_disagreement_score":0.9732498,"about_ca_system_score_codex":0.000010478243,"about_ca_system_score_gemma":0.00010964745,"threshold_uncertainty_score":0.359566},"labels":[],"label_agreement":null},{"id":"W4399482083","doi":"10.1136/annrheumdis-2024-eular.5385","title":"POS0083-PARE GETTING RESEARCH INTO THE HANDS OF PEOPLE LIVING WITH RHEUMATOID ARTHRITIS: A NOVEL APPROACH FROM THE CANADIAN EARLY ARTHRITIS COHORT (CATCH)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Canadian Arthritis Patient Alliance; Western University; University of Toronto; Université de Sherbrooke; University of Manitoba; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Glycemic Index Laboratories; University of Calgary; McGill University; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Canadian Arthritis Network","funders":"","keywords":"Rheumatoid arthritis; Cohort; Arthritis; Medicine; Physical therapy; Physical medicine and rehabilitation; Internal medicine","score_opus":0.03563412584823759,"score_gpt":0.30379531360736955,"score_spread":0.26816118775913195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8870007,0.10156917,0.000046525558,0.008628563,0.00011268179,0.0012975908,0.00027578647,0.000059222533,0.0010098076],"genre_scores_gemma":[0.9535842,0.04545443,0.00015394832,0.00020192034,0.000081327344,0.00027740956,0.00004815468,0.000073852236,0.00012474552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955314,0.00053289474,0.0007400243,0.00048632376,0.0018411739,0.00086822594],"domain_scores_gemma":[0.99492294,0.0024496885,0.00018184562,0.00128889,0.000692644,0.00046399116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021155872,0.00031837443,0.00070666027,0.0002475045,0.0011077152,0.00045946805,0.00097307743,0.000096407646,0.00020325309],"category_scores_gemma":[0.0023030902,0.00016119698,0.00036291598,0.0011208545,0.0013267801,0.0002937448,0.00030043718,0.000676452,0.000027303988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059399335,0.0013170288,0.58549017,0.0017974009,0.005303946,0.000062077444,0.09848678,0.00014133072,0.00029844436,0.010965126,0.039843306,0.25570038],"study_design_scores_gemma":[0.00198473,0.00076374016,0.9155416,0.05159917,0.000058633734,0.00019044563,0.019151889,0.0024257037,0.0006060753,0.0048022266,0.0023655186,0.00051027245],"about_ca_topic_score_codex":0.2702855,"about_ca_topic_score_gemma":0.12640569,"teacher_disagreement_score":0.33005142,"about_ca_system_score_codex":0.0000651791,"about_ca_system_score_gemma":0.0017659329,"threshold_uncertainty_score":0.8895351},"labels":[],"label_agreement":null},{"id":"W4399482171","doi":"10.1136/annrheumdis-2024-eular.1198","title":"POS0943 GUSELKUMAB PROVIDES DURABLE IMPROVEMENTS IN PAIN AMONG PATIENTS WITH PSORIATIC ARTHRITIS AND AN INADEQUATE RESPONSE TO TNFi: COSMOS PHASE 3b TRIAL","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Psoriatic arthritis; Medicine; Phase (matter); Physical therapy; Dermatology; Psoriasis; Physics","score_opus":0.024717254516531163,"score_gpt":0.3262730218248992,"score_spread":0.30155576730836803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937189,0.0016747058,0.000016562017,0.001528968,0.00007636094,0.0028386232,0.00007274968,0.000043202755,0.000029923473],"genre_scores_gemma":[0.99877584,0.00029876162,0.000024412257,0.00028363641,0.000014685806,0.00028479836,0.000029920915,0.000036051606,0.0002519046],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99750096,0.0005756821,0.00062958273,0.00031484477,0.00060760876,0.00037130225],"domain_scores_gemma":[0.9986342,0.00035508742,0.000132454,0.0005010126,0.00014056661,0.00023665903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013219661,0.0002080242,0.00048347225,0.00026438362,0.00009927466,0.00010227521,0.0001963449,0.000048607464,0.000078612175],"category_scores_gemma":[0.0022656512,0.00013460932,0.000094537834,0.00043927887,0.00016455994,0.00041662308,0.00009744935,0.00014496909,0.000008493022],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08833247,0.003348298,0.016209204,0.0018548232,0.00038583545,0.000048175672,0.0021789086,0.000024900663,0.00014895572,0.000072441944,0.0030655398,0.88433045],"study_design_scores_gemma":[0.14791861,0.028241513,0.7803977,0.023886507,0.00036092533,0.000004484662,0.0029497314,0.009338076,0.0014542292,0.003136554,0.00140514,0.00090648665],"about_ca_topic_score_codex":0.00024300723,"about_ca_topic_score_gemma":0.000048252776,"teacher_disagreement_score":0.883424,"about_ca_system_score_codex":0.00003401978,"about_ca_system_score_gemma":0.0003835242,"threshold_uncertainty_score":0.54892087},"labels":[],"label_agreement":null},{"id":"W4399482208","doi":"10.1136/annrheumdis-2024-eular.1387","title":"POS1014 USE OF AN INTERACTIVE ADAPTIVE-TRIAL AI SIMULATION TOOL TO INCREASE EFFICIENCY AND PROMOTE INFORMED DECISION MAKING WITHIN LUPUS CLINICAL TRIAL TEAMS, A CASE STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Computer science; Systemic lupus erythematosus; Interactive simulation; Management science; Clinical trial; Group decision-making; Clinical decision making; Knowledge management; Machine learning; Medical physics; Artificial intelligence; Human–computer interaction; Psychology; Medicine; Simulation; Intensive care medicine; Engineering; Social psychology","score_opus":0.06516686963904823,"score_gpt":0.40100968529522557,"score_spread":0.33584281565617735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924854,0.00010162158,0.004480422,0.00003495533,0.0014987653,0.0012712737,0.000039475653,0.000085482505,0.000002625322],"genre_scores_gemma":[0.9991775,0.000010611823,0.0006346792,0.000026894188,0.00008116418,0.0000406831,0.0000040857976,0.000018133558,0.0000062069744],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985617,0.00009873208,0.0007401592,0.00017306047,0.00029436324,0.00013198337],"domain_scores_gemma":[0.99818224,0.001238141,0.00009023791,0.00027403256,0.000080218604,0.00013513022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004972977,0.00014592371,0.00028233376,0.0001506492,0.000041114756,0.00008046903,0.0001283913,0.000056418216,0.000009573065],"category_scores_gemma":[0.0030004296,0.0000995618,0.00010276337,0.00030271398,0.000049706818,0.0004167781,0.000079199264,0.00013231703,0.0000020777286],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06788261,0.0032197242,0.0003708665,0.0014419734,0.00056678307,0.000069402944,0.010990217,0.27452484,0.000012759187,0.00007523654,0.0009636594,0.6398819],"study_design_scores_gemma":[0.010630268,0.0022351532,0.0025752184,0.0019790076,0.00015942716,0.000028159842,0.00081174605,0.98093235,0.000017270315,0.00039161002,0.000047793048,0.00019201511],"about_ca_topic_score_codex":0.000119603355,"about_ca_topic_score_gemma":0.00002263173,"teacher_disagreement_score":0.7064075,"about_ca_system_score_codex":0.000023778099,"about_ca_system_score_gemma":0.00010584815,"threshold_uncertainty_score":0.40600124},"labels":[],"label_agreement":null},{"id":"W4399482245","doi":"10.1136/annrheumdis-2024-eular.5269","title":"POS0008-PARE PATIENTS’ AND HEALTHCARE PROFESSIONALS’ PERCEPTIONS ON WEIGHT REDUCTION IN THE TREATMENT OF KNEE OSTEOARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Osteoarthritis; Health professionals; Health care; Reduction (mathematics); Perception; Physical therapy; Medicine; Psychology; Alternative medicine; Political science; Mathematics; Pathology; Neuroscience","score_opus":0.028930998560296177,"score_gpt":0.3527133358177762,"score_spread":0.32378233725748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753847,0.007982914,1.16149735e-7,0.015449212,0.00018604244,0.0007486625,0.00015387332,0.000011667845,0.000082797866],"genre_scores_gemma":[0.99671805,0.002561993,0.000006460671,0.00033312393,0.000023235318,0.000119206576,0.000048282265,0.0000063569805,0.00018331334],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99920267,0.00016835738,0.00021525891,0.00012481325,0.00018301026,0.000105876585],"domain_scores_gemma":[0.9995202,0.00014399238,0.00005614061,0.00017729927,0.00005031757,0.000052076404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061331506,0.00009828772,0.00019826606,0.00007287192,0.00008334783,0.0000049759174,0.00004747124,0.00003324597,0.00008142628],"category_scores_gemma":[0.000028564378,0.00004791237,0.00011664443,0.00012588894,0.00010279635,0.000042786713,0.00001231533,0.000051469342,0.0000068518452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016733173,0.022159105,0.27408817,0.0031844247,0.000900855,0.00004038241,0.03175804,0.000021166492,0.00013899207,0.002464346,0.017256737,0.6463145],"study_design_scores_gemma":[0.0012846914,0.0028188508,0.9897183,0.0023765578,0.00025175425,0.000012184884,0.0014497475,0.000027720844,0.00058749947,0.0011853807,0.00023101085,0.000056268404],"about_ca_topic_score_codex":0.000048668477,"about_ca_topic_score_gemma":0.000010511338,"teacher_disagreement_score":0.7156302,"about_ca_system_score_codex":0.000029251334,"about_ca_system_score_gemma":0.00007710276,"threshold_uncertainty_score":0.19538097},"labels":[],"label_agreement":null},{"id":"W4399482262","doi":"10.1136/annrheumdis-2024-eular.1845","title":"POS0874 COMPARABLE SAFETY AND EFFECTIVENESS AMONG NEW USERS OF BIOSIMILAR VS ORIGINATOR ANTI-TNFS IN INFLAMMATORY ARTHRITIS: POPULATION-BASED EVIDENCE FROM A POLICY CHANGE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia","funders":"","keywords":"Biosimilar; Medicine; Population; Arthritis; Computer science; Pharmacology; Internal medicine; Environmental health","score_opus":0.04622181934063255,"score_gpt":0.3329080716615825,"score_spread":0.2866862523209499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554537,0.041608017,0.00005505163,0.0019591132,0.00020321454,0.00042023958,0.00026529512,0.000028198017,0.0000072017365],"genre_scores_gemma":[0.9975449,0.0021036183,0.000062774125,0.00021135228,0.000016731521,0.000014924506,0.000016305632,0.000012658048,0.000016744409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983607,0.00060708856,0.00046558393,0.00025609205,0.00007940353,0.0002311364],"domain_scores_gemma":[0.99785644,0.0015664075,0.00016230381,0.00030677495,0.000050923594,0.000057144276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004479292,0.0001813314,0.00056733825,0.00018377323,0.00006053752,0.000025966274,0.00023481138,0.000132221,0.000101407124],"category_scores_gemma":[0.00069548097,0.0001267125,0.00017397954,0.00037686393,0.00032546924,0.0002368647,0.00008377482,0.00013053308,0.000004116825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005917036,0.00018473127,0.9727686,0.0013917251,0.0004100427,0.0000050647463,0.00028119105,0.00008176637,0.0018829119,0.0017729083,0.00044529547,0.020184051],"study_design_scores_gemma":[0.00050119555,0.000075928314,0.9760886,0.009889364,0.0000903496,0.0000010292651,0.000031680087,0.0004255664,0.010089597,0.0025179584,0.00014697142,0.00014179574],"about_ca_topic_score_codex":0.0046856687,"about_ca_topic_score_gemma":0.000114627,"teacher_disagreement_score":0.04209122,"about_ca_system_score_codex":0.000022280967,"about_ca_system_score_gemma":0.00017529739,"threshold_uncertainty_score":0.70833606},"labels":[],"label_agreement":null},{"id":"W4399482309","doi":"10.1136/annrheumdis-2024-eular.3541","title":"POS0155 PRE-DIAGNOSTIC IMMUNOMODULATORY AMINO ACID METABOLITES AND RISK OF GOUT, ACCOUNTING FOR SERUM URATE: A PROSPECTIVE STUDY OF 249,677 INDIVIDUALS AND MENDELIAN RANDOMIZATION ANALYSES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Mendelian randomization; Gout; Medicine; Uric acid; Internal medicine; Chemistry; Biochemistry; Gene; Genotype; Genetic variants","score_opus":0.01762231872130951,"score_gpt":0.31226108455106605,"score_spread":0.29463876582975657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9275134,0.0706076,0.00019523223,0.0000296956,0.00006655501,0.0010113786,0.00055807363,0.000005820585,0.000012225294],"genre_scores_gemma":[0.9941768,0.0055116983,0.00011535095,0.00001533511,0.000017329425,0.00009136559,0.000026179197,0.00001815809,0.000027783115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871224,0.00019146323,0.0004917714,0.00027229008,0.0001857888,0.00014647217],"domain_scores_gemma":[0.9988417,0.00025813456,0.00035825314,0.00031432213,0.00018141863,0.0000461573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043198332,0.00017369173,0.00043573303,0.000093971765,0.0000767134,0.000038894916,0.00016857142,0.00004757666,0.0000059597796],"category_scores_gemma":[0.0016066057,0.00011954015,0.00014838533,0.00016865676,0.00015362934,0.000019255718,0.0001393839,0.000033696153,1.21756e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001198384,0.0015864093,0.8833068,0.0035460088,0.009514811,4.5877334e-7,0.006334347,0.0018720604,0.037862875,0.00034709857,0.00065942976,0.053771324],"study_design_scores_gemma":[0.002715583,0.0003675859,0.9159726,0.00030589692,0.001959643,0.0000011653805,0.002341902,0.0006915675,0.073242284,0.0021711572,0.00004538289,0.00018523075],"about_ca_topic_score_codex":0.00009119278,"about_ca_topic_score_gemma":0.000017976468,"teacher_disagreement_score":0.066663384,"about_ca_system_score_codex":9.038453e-7,"about_ca_system_score_gemma":0.000067660774,"threshold_uncertainty_score":0.48747057},"labels":[],"label_agreement":null},{"id":"W4399482326","doi":"10.1136/annrheumdis-2024-eular.4202","title":"POS1047 STATIN USE ATTENUATES THE IMPACT OF SYSTEMIC INFLAMMATION ON ISCHEMIC CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Rheumatoid arthritis; Medicine; Systemic inflammation; Inflammation; Statin; Internal medicine; Cardiology","score_opus":0.015512449619587565,"score_gpt":0.27142877444859853,"score_spread":0.25591632482901094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660945,0.032176983,0.000011729522,0.00021534422,0.00005640769,0.0010279906,0.00034803347,0.000034026118,0.000034980323],"genre_scores_gemma":[0.96035254,0.039455682,0.000012691904,0.000010948837,0.000012294408,0.000062688436,0.00004453301,0.000034653272,0.000013960765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976075,0.00035868597,0.0006028577,0.00023042299,0.0008902678,0.00031021223],"domain_scores_gemma":[0.9980049,0.0006009293,0.00022636453,0.000776587,0.0002778693,0.00011334528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000504011,0.00023088572,0.00060380925,0.00019586584,0.000082202765,0.00007788317,0.00022894605,0.000043041095,0.000043617434],"category_scores_gemma":[0.001012696,0.00011100221,0.00059362396,0.00044341444,0.00025254328,0.00028517513,0.000059188846,0.0002098663,0.0000176387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018775434,0.000667122,0.7999305,0.0014916509,0.004791453,0.000017850785,0.0034463925,0.005090917,0.00014914559,0.0002741828,0.0047840737,0.17747913],"study_design_scores_gemma":[0.0027766086,0.0008729579,0.9680146,0.024764067,0.000047459598,0.00001988824,0.0005182727,0.0010034165,0.0012721221,0.00042399208,0.00008738766,0.0001992022],"about_ca_topic_score_codex":0.001170567,"about_ca_topic_score_gemma":0.000018314158,"teacher_disagreement_score":0.17727993,"about_ca_system_score_codex":0.00004055552,"about_ca_system_score_gemma":0.00024334692,"threshold_uncertainty_score":0.45265388},"labels":[],"label_agreement":null},{"id":"W4399482390","doi":"10.1136/annrheumdis-2024-eular.5444","title":"OP0066 FIBROBLAST ACTIVATION DEFINES DISEASE PROGRESSION: SYNOVIUM ATLAS IN KNEE OSTEOARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Oral and gingival health research","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"","keywords":"Osteoarthritis; Atlas (anatomy); Fibroblast; Medicine; Computer science; Pathology; Biology; Anatomy; Biochemistry","score_opus":0.10864875970712831,"score_gpt":0.46929673656449833,"score_spread":0.36064797685737005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96133715,0.0067354175,0.000010187596,0.027915034,0.0005151979,0.001795384,0.00022079305,0.00013846454,0.0013323844],"genre_scores_gemma":[0.99662846,0.0002713925,0.000026516012,0.00040207795,0.00013361983,0.00042829837,0.00003202191,0.000031451622,0.0020461483],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972066,0.00059876824,0.0006946717,0.00029373507,0.00059551734,0.00061070855],"domain_scores_gemma":[0.9976851,0.0012121416,0.00016127764,0.0004464828,0.00016286696,0.00033212802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047249414,0.00018627981,0.00030665746,0.00019613816,0.00039995348,0.00003408424,0.0002985976,0.00008304688,0.00044945706],"category_scores_gemma":[0.0010874406,0.000116055984,0.00018303758,0.0007005569,0.00014278908,0.00032188185,0.0002880148,0.00037125434,0.00026489815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018818843,0.00106684,0.21071972,0.052468773,0.00012607727,0.00005878283,0.0027630802,0.00018243886,0.00011719348,0.017472362,0.08188985,0.631253],"study_design_scores_gemma":[0.0010097094,0.00039602246,0.8602115,0.094395556,0.00003847549,0.0000014352861,0.0009191027,0.0024457222,0.00022822172,0.03090261,0.009078049,0.00037361818],"about_ca_topic_score_codex":0.00026351854,"about_ca_topic_score_gemma":0.000059520764,"teacher_disagreement_score":0.6494918,"about_ca_system_score_codex":0.000047081227,"about_ca_system_score_gemma":0.00079289236,"threshold_uncertainty_score":0.49212396},"labels":[],"label_agreement":null},{"id":"W4399482407","doi":"10.1136/annrheumdis-2024-eular.3226","title":"POS0136 IS GROWTH ADVERSELY AFFECTED IN CHILDREN WITH CHRONIC NON-BACTERIAL OSTEOMYELITIS?","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Orthopedic Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Osteomyelitis; Medicine; Chronic recurrent multifocal osteomyelitis; Intensive care medicine; Surgery; Osteitis","score_opus":0.009900069880641302,"score_gpt":0.26813622726281267,"score_spread":0.25823615738217137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959064,0.0011336337,0.000005843296,0.0012643607,0.00016565122,0.0006677312,0.00016959991,0.00005010253,0.0006366944],"genre_scores_gemma":[0.9988537,0.0004484145,0.000017210574,0.000105134415,0.00010695797,0.00004854056,0.000058280544,0.000023777035,0.00033800644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909747,0.000041145253,0.00022643436,0.00019506465,0.00023018134,0.00020972181],"domain_scores_gemma":[0.99944186,0.00004558673,0.000064780455,0.0002907818,0.00006264552,0.00009436736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060873033,0.00015925911,0.00027642125,0.00012879206,0.000050393668,0.000028389099,0.00006427156,0.000039021706,0.0004042447],"category_scores_gemma":[0.000056022636,0.00009132422,0.00017208951,0.00037215196,0.00009300753,0.00011847902,0.000038946324,0.00008287174,0.000051073457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004097553,0.0012299924,0.8774607,0.0020928795,0.0033729027,0.000077551216,0.00071160134,0.000018192437,0.00011049541,0.00040807726,0.0073094345,0.10679838],"study_design_scores_gemma":[0.0015310087,0.00051378086,0.99348634,0.0028786105,0.0004094962,0.000062922525,0.000018337649,0.00013709273,0.00058925047,0.00015771229,0.00011104644,0.00010437065],"about_ca_topic_score_codex":0.00055944844,"about_ca_topic_score_gemma":0.000032885288,"teacher_disagreement_score":0.116025634,"about_ca_system_score_codex":0.0000408137,"about_ca_system_score_gemma":0.00030214345,"threshold_uncertainty_score":0.4426196},"labels":[],"label_agreement":null},{"id":"W4399482436","doi":"10.1136/annrheumdis-2024-eular.4397","title":"OP0170 RISK OF MORTALITY IN PATIENTS WITH TOPHACEOUS VERSUS NON-TOPHACEOUS GOUT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Gout; Medicine; Internal medicine","score_opus":0.026193470569405027,"score_gpt":0.2948545725251518,"score_spread":0.2686611019557468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874797,0.010470257,0.0000031315028,0.00013718136,0.00040807886,0.00061932247,0.00025304322,0.000032645137,0.00059663295],"genre_scores_gemma":[0.9984824,0.0012520166,0.000011510854,0.00004260163,0.000022265833,0.000023125443,0.000020151905,0.00002432147,0.00012157335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983055,0.0001066559,0.0005595903,0.00023784039,0.00057398505,0.00021643954],"domain_scores_gemma":[0.9985488,0.00029401178,0.00024748957,0.00061008136,0.00014873646,0.0001508654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018002819,0.00018570897,0.0005222993,0.000113108676,0.000037731505,0.000017431326,0.0001943765,0.00006596031,0.00009408393],"category_scores_gemma":[0.00047417232,0.00010154734,0.0003086068,0.00037868673,0.0001661601,0.00007841416,0.0000655882,0.000113045804,0.000014883145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017902256,0.001601889,0.9644847,0.002611617,0.0017901179,0.000018379633,0.00056378,0.00036139233,0.000014312352,0.00006968704,0.0024062328,0.02428767],"study_design_scores_gemma":[0.0024000383,0.00038010412,0.98599243,0.009079637,0.00087638287,0.0000013111483,0.0002130304,0.000494986,0.0002844127,0.00013669608,0.000022625882,0.00011834293],"about_ca_topic_score_codex":0.00039852754,"about_ca_topic_score_gemma":0.000010878279,"teacher_disagreement_score":0.024169328,"about_ca_system_score_codex":0.000025235193,"about_ca_system_score_gemma":0.00018985565,"threshold_uncertainty_score":0.41409802},"labels":[],"label_agreement":null},{"id":"W4399482438","doi":"10.1136/annrheumdis-2024-eular.3243","title":"OP0177 COMPARATIVE EFFECTIVENESS OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS VS SULFONYLUREAS FOR PRIMARY AND SECONDARY GOUT PREVENTION AMONG PATIENTS WITH TYPE 2 DIABETES RECEIVING METFORMIN MONOTHERAPY: TARGET TRIAL EMULATION STUDIES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Research Canada","funders":"","keywords":"Metformin; Medicine; Type 2 diabetes; Gout; Internal medicine; Glipizide; Diabetes mellitus; Pharmacology; Cotransporter; Endocrinology; Sodium; Chemistry","score_opus":0.03131485296954073,"score_gpt":0.3135715604556724,"score_spread":0.2822567074861317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98795915,0.008549085,0.000047614183,0.0000542059,0.00021108941,0.0030224759,0.000081696555,0.000028565211,0.00004614075],"genre_scores_gemma":[0.99892604,0.00034975787,0.00016997635,0.000019471725,0.000018629054,0.00019981075,0.00022814171,0.000019839168,0.000068307476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989491,0.00011826203,0.00035778966,0.00019985822,0.0002302836,0.00014471183],"domain_scores_gemma":[0.9988546,0.0005095124,0.00022133611,0.00017153441,0.00019401665,0.00004903076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003233183,0.00018179922,0.0006214338,0.00010733194,0.00005872029,0.000020133215,0.000057423855,0.000029997425,0.000008745454],"category_scores_gemma":[0.00007429597,0.00010951413,0.0001688263,0.00016082071,0.00015089076,0.00027091263,0.000028383403,0.000040401643,3.6411427e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062951215,0.004628255,0.7067893,0.042138446,0.018542767,0.0000025387353,0.0047997623,0.00019294038,0.00032788864,0.00045194192,0.001567657,0.15760726],"study_design_scores_gemma":[0.015948469,0.0035372502,0.95741445,0.008226582,0.0017174793,7.1482624e-8,0.00021752183,0.00043307664,0.009885207,0.002375266,0.00006837543,0.00017625807],"about_ca_topic_score_codex":0.000006879858,"about_ca_topic_score_gemma":0.000003145271,"teacher_disagreement_score":0.2506251,"about_ca_system_score_codex":0.000027814467,"about_ca_system_score_gemma":0.00006752712,"threshold_uncertainty_score":0.44658566},"labels":[],"label_agreement":null},{"id":"W4399482454","doi":"10.1136/annrheumdis-2024-eular.4638","title":"POS1094 AUTOANTIBODIES TO 14-3-3Η IN AXIAL SPONDYLOARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Autoantibody; Axial spondyloarthritis; Computer science; Medicine; Immunology; Ankylosing spondylitis; Antibody; Sacroiliitis","score_opus":0.019312290664837365,"score_gpt":0.3217185349779694,"score_spread":0.302406244313132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794466,0.0064806,0.00006990437,0.0035521733,0.00053946004,0.00030142852,0.00022278435,0.000023218769,0.0008657711],"genre_scores_gemma":[0.99767,0.00048098323,0.000098021985,0.00035770197,0.00006796875,0.000055923552,0.000025510493,0.00001882655,0.0012250713],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910724,0.00007183839,0.00025737804,0.00021692095,0.00015263601,0.00019395565],"domain_scores_gemma":[0.9993942,0.00004656968,0.0000444654,0.0003798259,0.00006266895,0.00007227554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011251266,0.000121698264,0.00015039011,0.0000852766,0.00004435304,0.000047451835,0.00027094752,0.00004642889,0.000112884765],"category_scores_gemma":[0.00060723926,0.00009384484,0.00018780843,0.0001718436,0.00007291076,0.000009550567,0.00017915221,0.000062540494,0.00006435639],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009224295,0.0015612732,0.016536793,0.0023899598,0.0013637,0.00008525619,0.0022384322,0.0018335737,0.17215364,0.0073196366,0.45119706,0.34239826],"study_design_scores_gemma":[0.0013553195,0.001331372,0.32527554,0.010679996,0.00021164387,0.000120955665,0.0009577667,0.00071977853,0.4043357,0.017390355,0.23607104,0.0015505368],"about_ca_topic_score_codex":0.00008760501,"about_ca_topic_score_gemma":0.00008373986,"teacher_disagreement_score":0.34084773,"about_ca_system_score_codex":0.0000068685194,"about_ca_system_score_gemma":0.00009650682,"threshold_uncertainty_score":0.38268816},"labels":[],"label_agreement":null},{"id":"W4399482463","doi":"10.1136/annrheumdis-2024-eular.2451","title":"POS0507 FACTORS ASSOCIATED WITH POOR MENTAL HEALTH IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Axial spondyloarthritis; Mental health; Medicine; Psychology; Computer science; Physical therapy; Psychiatry; Ankylosing spondylitis; Surgery","score_opus":0.027793203766564776,"score_gpt":0.28979551534727627,"score_spread":0.26200231158071147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760353,0.002115037,0.0000014811815,0.014177167,0.00026657895,0.0007621037,0.006549352,0.000028290844,0.000064687934],"genre_scores_gemma":[0.99781,0.00019324913,0.000018606128,0.000071564944,0.000018927776,0.0000137160705,0.0016915178,0.000032160922,0.00015024378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973067,0.00019781153,0.00062065595,0.0003061614,0.0012075321,0.0003611629],"domain_scores_gemma":[0.9985099,0.0005145136,0.0002608705,0.0003887289,0.0001750884,0.00015089099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034366237,0.00021782452,0.0004874591,0.00013290971,0.00008837016,0.000049804985,0.00038646883,0.00005563105,0.0003274438],"category_scores_gemma":[0.0004913337,0.00011566206,0.00018105342,0.000336633,0.0003518681,0.00016031659,0.00012048292,0.0002327693,0.00000858366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023478901,0.008187516,0.75280064,0.0047368584,0.006789517,0.00012975806,0.014140519,0.00011836043,0.00015136194,0.0010867249,0.1336928,0.054687012],"study_design_scores_gemma":[0.006763479,0.0014355024,0.97124976,0.018779172,0.00006305174,0.0000035686542,0.00057338516,0.00019759424,0.00022888914,0.00026779622,0.00027430206,0.00016347275],"about_ca_topic_score_codex":0.0009958978,"about_ca_topic_score_gemma":0.00014978294,"teacher_disagreement_score":0.21844912,"about_ca_system_score_codex":0.000113716495,"about_ca_system_score_gemma":0.0007001644,"threshold_uncertainty_score":0.47165617},"labels":[],"label_agreement":null},{"id":"W4399482467","doi":"10.1136/annrheumdis-2024-eular.2406","title":"POS0811 IMPACT OF DISEASE MANIFESTATIONS ON FIRST BIOLOGIC DRUG SURVIVAL IN AXIAL SPONDYLOARTHRITIS: A REAL-WORLD CANADIAN STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Western University; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Disease; Drug; Medicine; Computer science; Internal medicine; Pharmacology","score_opus":0.04278802390800808,"score_gpt":0.35076934790125586,"score_spread":0.3079813239932478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087787,0.0033267783,1.2231688e-7,0.001721264,0.0002472199,0.0010153111,0.0016889934,0.000029980973,0.0010924735],"genre_scores_gemma":[0.9982606,0.00119487,0.00000397032,0.00005048101,0.00002804534,0.00008975849,0.000070346054,0.00002252016,0.0002794072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985124,0.00013138658,0.00045339606,0.00026422137,0.0003099969,0.00032863018],"domain_scores_gemma":[0.9987139,0.00033453864,0.00009592826,0.000443497,0.00008363945,0.00032849665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016694704,0.00021955154,0.00047806013,0.0003853679,0.00013343306,0.000023204491,0.00015386056,0.000020570962,0.00023744545],"category_scores_gemma":[0.0002726769,0.00013941195,0.000396403,0.0005776208,0.00013243798,0.000068276415,0.00005372749,0.00008951137,0.000023045925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007710804,0.0024741744,0.9852133,0.0004140496,0.0010776256,0.00069162034,0.0011349426,0.00016903365,8.011891e-7,0.0011228824,0.0024523246,0.0044781673],"study_design_scores_gemma":[0.001212538,0.00073300244,0.99333185,0.00253318,0.00030040092,0.000003522741,0.00069963606,0.00007845562,0.0000035886965,0.0009442611,0.00004493243,0.000114642564],"about_ca_topic_score_codex":0.15567736,"about_ca_topic_score_gemma":0.31735063,"teacher_disagreement_score":0.16167326,"about_ca_system_score_codex":0.00009748511,"about_ca_system_score_gemma":0.00041088078,"threshold_uncertainty_score":0.84994507},"labels":[],"label_agreement":null},{"id":"W4399482478","doi":"10.1136/annrheumdis-2024-eular.2292","title":"POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Ankylosing spondylitis; Internal medicine; Gastroenterology","score_opus":0.03559249761411731,"score_gpt":0.36969803192342915,"score_spread":0.33410553430931184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9154842,0.07667935,0.000002948228,0.0032748966,0.000258363,0.0007370534,0.003449496,0.000031431813,0.00008228764],"genre_scores_gemma":[0.9854527,0.0141364485,0.0000209961,0.00004431562,0.00008495327,0.000016225333,0.00008006518,0.000025930163,0.0001383264],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99797374,0.00011715645,0.0008151133,0.00031918974,0.00044976865,0.00032502846],"domain_scores_gemma":[0.9977014,0.0010506928,0.00030754413,0.00064456003,0.00019276055,0.00010300782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027140204,0.00025941862,0.000803828,0.000063362924,0.00017764131,0.00002716802,0.00020339513,0.000038886814,0.000055192166],"category_scores_gemma":[0.0009978126,0.00014467211,0.0003400382,0.00029949428,0.00080768805,0.00008897502,0.00028906463,0.000102069054,0.000005333464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11864908,0.010354322,0.047186032,0.010288312,0.036292143,0.0012352739,0.04616822,0.00006778693,0.0012787073,0.0054265647,0.0111463955,0.71190715],"study_design_scores_gemma":[0.09168965,0.0066819573,0.8249416,0.033750586,0.004334285,0.00014227521,0.01880501,0.00021238915,0.009681967,0.008489859,0.0004975487,0.00077291194],"about_ca_topic_score_codex":0.00021264817,"about_ca_topic_score_gemma":0.00010729352,"teacher_disagreement_score":0.7777555,"about_ca_system_score_codex":0.000021821812,"about_ca_system_score_gemma":0.00010383712,"threshold_uncertainty_score":0.5899558},"labels":[],"label_agreement":null},{"id":"W4399482514","doi":"10.1136/annrheumdis-2024-eular.40","title":"AB0222 THE IMPACT OF BIOSIMILAR USE ON HEALTHCARE UTILIZATION AMONG NEW USERS OF ETANERCEPT FOR INFLAMMATORY ARTHRITIS: A POPULATION-BASED REGRESSION DISCONTINUITY ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Research Canada; Simon Fraser University","funders":"","keywords":"Biosimilar; Etanercept; Regression discontinuity design; Regression analysis; Population; Discontinuity (linguistics); Health care; Regression; Computer science; Medicine; Statistics; Economics; Environmental health; Machine learning; Rheumatoid arthritis; Internal medicine; Mathematics","score_opus":0.08979890712339454,"score_gpt":0.3908102563034888,"score_spread":0.30101134918009426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896708,0.006322731,0.0005008159,0.001831822,0.00013619877,0.0005239503,0.0009856835,0.000022831131,0.00000517971],"genre_scores_gemma":[0.99916923,0.0004174324,0.000067375724,0.00010439486,0.000007958678,0.000012791411,0.000109206616,0.000012271163,0.00009936236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838513,0.0004948308,0.00062191946,0.00020469469,0.000103498045,0.00018994526],"domain_scores_gemma":[0.9977758,0.0011146216,0.00042347744,0.00049970305,0.00014111448,0.000045267327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039910045,0.00017410642,0.000517495,0.00018207204,0.00009942642,0.000021832157,0.0002540016,0.0001323925,0.00014606034],"category_scores_gemma":[0.00092008774,0.0000837889,0.0009932463,0.0005486608,0.00027261054,0.000099820674,0.000042804044,0.00010269455,6.3785035e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017834855,0.000866491,0.77006847,0.0020314362,0.008477061,0.0000013510582,0.0011048521,0.005460608,0.0025399213,0.0034818705,0.019997753,0.1841867],"study_design_scores_gemma":[0.00035530335,0.0002555954,0.98294604,0.0023428337,0.00083379436,3.5653756e-7,0.00013702252,0.0032391741,0.007940559,0.0017698403,0.00005603455,0.00012343128],"about_ca_topic_score_codex":0.001109472,"about_ca_topic_score_gemma":0.00017481092,"teacher_disagreement_score":0.21287759,"about_ca_system_score_codex":0.000017405495,"about_ca_system_score_gemma":0.00016359334,"threshold_uncertainty_score":0.34168124},"labels":[],"label_agreement":null},{"id":"W4399482591","doi":"10.1136/annrheumdis-2024-eular.2283","title":"POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Axial spondyloarthritis; Medicine; Radiography; Phase (matter); Radiology; Nuclear medicine; Medical physics; Physics; Magnetic resonance imaging","score_opus":0.02859502518855085,"score_gpt":0.3156712254769249,"score_spread":0.28707620028837405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885787,0.0051314123,0.0000020500302,0.00044471503,0.00008813719,0.0016061066,0.0040709907,0.000017819246,0.00006006346],"genre_scores_gemma":[0.99841905,0.0011027327,0.000022411348,0.000059000253,0.000025036314,0.000033136508,0.00030182392,0.00002362364,0.000013169508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984166,0.00012647129,0.0004174207,0.0003613549,0.00045851435,0.0002196431],"domain_scores_gemma":[0.9983513,0.00053136377,0.00014043586,0.00078513176,0.0001019405,0.000089865796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001511223,0.00021237675,0.00052881683,0.000096917924,0.000113699425,0.000026708927,0.00027756498,0.000029433717,0.000090546855],"category_scores_gemma":[0.00027454988,0.0001130337,0.00010003379,0.0005165869,0.0002856639,0.00015472929,0.00022302376,0.000120310964,0.0000039500624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013194472,0.009862973,0.83590186,0.00029019924,0.0041499417,0.000060491402,0.0039125104,0.0000035978394,0.0000059283466,0.000042069165,0.0023382003,0.13023774],"study_design_scores_gemma":[0.015380452,0.0019305205,0.9775829,0.0027507339,0.0005950029,0.0000020828452,0.0013689207,0.00004370907,0.000027274082,0.00010836818,0.000099962446,0.00011011557],"about_ca_topic_score_codex":0.0005068983,"about_ca_topic_score_gemma":0.00015431958,"teacher_disagreement_score":0.14168099,"about_ca_system_score_codex":0.000010252191,"about_ca_system_score_gemma":0.00008955393,"threshold_uncertainty_score":0.46093804},"labels":[],"label_agreement":null},{"id":"W4399482592","doi":"10.1136/annrheumdis-2024-eular.4976","title":"AB1516 SYSTEMATIC ASSESSMENT OF REGULATOR ADVICE ABOUT ANTI-RHEUMATIC DRUGS USE IN PREGNANCY – AN INTERIM ANALYSIS FROM THE EU, UK, USA, CANADA, BRAZIL AND JAPAN","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnancy; Medicine; Interim; Family medicine; Systematic review; Interim analysis; Alternative medicine; Pediatrics; MEDLINE; Pathology","score_opus":0.03148393611436013,"score_gpt":0.34636203378394387,"score_spread":0.31487809766958375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734024,0.022813737,0.000054077675,0.0021477567,0.00015968559,0.00096699764,0.0003452346,0.00002529074,0.0000848297],"genre_scores_gemma":[0.99727833,0.0017743998,0.00008083734,0.00048429673,0.000011529434,0.00008315254,0.00005056932,0.000021725371,0.00021513762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705505,0.00044369212,0.0011370877,0.00031340585,0.00078148016,0.00026927097],"domain_scores_gemma":[0.9964686,0.0014034526,0.0005281849,0.0012052594,0.00013834375,0.0002561719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053784094,0.0002507651,0.0010566424,0.00020271487,0.0000737719,0.00007092353,0.00041567974,0.00005594805,0.00019028541],"category_scores_gemma":[0.001286395,0.0001379746,0.00028442475,0.000800727,0.00021047237,0.00027450174,0.00010605076,0.00015097727,0.0000018203322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015483715,0.0016160865,0.8329377,0.10800549,0.013154532,0.00003433743,0.01514344,0.0004896665,0.00021128272,0.0024990346,0.008924657,0.016828936],"study_design_scores_gemma":[0.00042130143,0.000060755865,0.83435786,0.14836982,0.0023552545,0.000005120713,0.0012758612,0.012755928,0.000085876185,0.0001741732,0.000008403455,0.00012963547],"about_ca_topic_score_codex":0.1159195,"about_ca_topic_score_gemma":0.045375623,"teacher_disagreement_score":0.07054388,"about_ca_system_score_codex":0.00006601679,"about_ca_system_score_gemma":0.00097514654,"threshold_uncertainty_score":0.9720438},"labels":[],"label_agreement":null},{"id":"W4399482599","doi":"10.1136/annrheumdis-2024-eular.5919","title":"POS0031 VARIABILITY IN INITIAL MTX RESPONSE IN NEWLY DIAGNOSED RA PATIENTS WITH DISTINCT PRO SYMPTOM CLUSTERS: A LONGITUDINAL ANALYSIS OF THE CANADIAN EARLY ARTHRITIS COHORT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; University of Calgary; McGill University; Arthritis Research Centre of Canada; University of Manitoba; Western University","funders":"","keywords":"Cohort; Arthritis; Medicine; Longitudinal study; Internal medicine; Physical therapy; Pediatrics; Demography; Pathology","score_opus":0.01918234552432721,"score_gpt":0.2964861056709473,"score_spread":0.27730376014662006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944851,0.0014864169,0.00000602379,0.0019388404,0.00008737192,0.0013041863,0.00057984365,0.000015535386,0.00009670727],"genre_scores_gemma":[0.99928105,0.00040937104,0.0000117685495,0.00008106138,0.000008793894,0.00012511053,0.000041681884,0.000020576626,0.000020559432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967825,0.00096204906,0.0006746606,0.00032989384,0.0008178782,0.00043305085],"domain_scores_gemma":[0.9974261,0.0012096383,0.00014546052,0.0007035038,0.00024705,0.00026826476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012788475,0.00020684343,0.00068045885,0.0005890887,0.00010267955,0.00008222139,0.00033698816,0.00006121787,0.00014561195],"category_scores_gemma":[0.0034429822,0.00012042487,0.00032337458,0.0018900607,0.0005202455,0.000191805,0.000099536795,0.00022692973,0.0000029736084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020336756,0.00052946736,0.98512244,0.00021452628,0.0010558302,0.00004800522,0.0013027895,0.000110648514,0.0000013319518,0.00008156811,0.00016322224,0.009336463],"study_design_scores_gemma":[0.0016086152,0.00033352812,0.99177104,0.0043736612,0.0001344535,0.000002676866,0.0001066001,0.0011254286,0.000020467136,0.00037761006,0.000023766128,0.00012214477],"about_ca_topic_score_codex":0.07680735,"about_ca_topic_score_gemma":0.18010029,"teacher_disagreement_score":0.103292935,"about_ca_system_score_codex":0.00011816075,"about_ca_system_score_gemma":0.0012734806,"threshold_uncertainty_score":0.92934024},"labels":[],"label_agreement":null},{"id":"W4399482631","doi":"10.1136/annrheumdis-2024-eular.4903","title":"POS0058 IMPACT OF BIMEKIZUMAB ON MRI INFLAMMATORY AND STRUCTURAL LESIONS IN THE SACROILIAC JOINTS OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS AND POST HOC ANALYSES FROM THE BE MOBILE 1 AND 2 PHASE 3 STUDIES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Axial spondyloarthritis; Medicine; Sacroiliac joint; Magnetic resonance imaging; Post-hoc analysis; Physical medicine and rehabilitation; Physical therapy; Radiology; Internal medicine; Sacroiliitis","score_opus":0.048044765921493475,"score_gpt":0.37189580778752956,"score_spread":0.3238510418660361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438582,0.050400242,6.743169e-8,0.000665181,0.000042683743,0.0006983766,0.0043155495,0.000007677449,0.000011987772],"genre_scores_gemma":[0.99192053,0.007859006,0.000013011802,0.000071659124,0.000014184107,0.00002985826,0.00007139997,0.000013270204,0.0000070656843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860513,0.00015201728,0.00046544784,0.00023282677,0.0003711224,0.00017346075],"domain_scores_gemma":[0.99822366,0.0009818559,0.00021427064,0.00035730193,0.00015450525,0.00006841419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014417038,0.00022220534,0.00055174646,0.0000902951,0.0001394801,0.000026928654,0.00010157147,0.000029700228,0.000012612103],"category_scores_gemma":[0.0004138085,0.00009206672,0.00014479486,0.00019867119,0.00066498236,0.00010611708,0.00011464482,0.00008971026,3.0088148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040984817,0.0052120746,0.48825133,0.002726297,0.015751105,0.00024582844,0.060546286,0.00011813629,0.0004336071,0.00024199428,0.0062731006,0.37921542],"study_design_scores_gemma":[0.0058895308,0.0038622972,0.9802028,0.0034873444,0.0005598882,0.0000093384115,0.0052717635,0.000046945937,0.00015646133,0.00040016283,0.000014879551,0.000098585195],"about_ca_topic_score_codex":0.00049964554,"about_ca_topic_score_gemma":0.00017626613,"teacher_disagreement_score":0.49195147,"about_ca_system_score_codex":0.000013290714,"about_ca_system_score_gemma":0.00007215131,"threshold_uncertainty_score":0.3754372},"labels":[],"label_agreement":null},{"id":"W4399482662","doi":"10.1136/annrheumdis-2024-eular.4358","title":"POS0038 ANATOMICAL DISTRIBUTION OF MRI LESIONS IN axSpA AND DIFFERENCES BETWEEN PATIENTS WITH AND WITHOUT PERIPHERAL INVOLVEMENT: RESULTS FROM THE ASAS CLASSIFICATION COHORT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cohort; Peripheral; Medicine; Artificial intelligence; Computer science; Internal medicine","score_opus":0.030293040885788432,"score_gpt":0.306093030869206,"score_spread":0.27579998998341754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145806,0.0009315033,0.0001309817,0.006754214,0.00003085764,0.00029466263,0.00036805234,0.000010162709,0.000021481692],"genre_scores_gemma":[0.99914676,0.00043810534,0.00004287883,0.000066724024,0.00001594978,0.000008122619,0.00026018813,0.0000069072908,0.000014344483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990685,0.00010109223,0.0003010082,0.00016599197,0.00026792032,0.00009550402],"domain_scores_gemma":[0.9992137,0.0003566146,0.00011218278,0.00019224157,0.000050624945,0.000074647636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022381924,0.00008926568,0.00023933181,0.000026584687,0.00005552379,0.0000289858,0.00008833434,0.000026745485,0.0000046972823],"category_scores_gemma":[0.00057480717,0.000042787306,0.0000373876,0.00012103,0.00031316394,0.00005860071,0.000050596565,0.00012645501,1.854306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110112385,0.00008216024,0.98195934,0.00013119461,0.00012097769,2.3554449e-7,0.00036235814,0.0000032941027,0.0000063555844,0.0002456747,0.00046744783,0.016510833],"study_design_scores_gemma":[0.00066584186,0.00007208659,0.98540014,0.0019465388,0.00017865017,2.976821e-7,0.00018318224,0.010585568,0.000012924826,0.0008589059,0.000047736103,0.000048102665],"about_ca_topic_score_codex":0.00047421004,"about_ca_topic_score_gemma":0.000013197276,"teacher_disagreement_score":0.01646273,"about_ca_system_score_codex":0.000011393946,"about_ca_system_score_gemma":0.00005275784,"threshold_uncertainty_score":0.17448157},"labels":[],"label_agreement":null},{"id":"W4399482708","doi":"10.1136/annrheumdis-2024-eular.1913","title":"POS0628 EROSIVE PROGRESSION ASSESSED BY HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY COMPARED TO CONVENTIONAL RADIOGRAPHY: A ONE-YEAR COHORT STUDY IN 310 PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Quantitative computed tomography; Gold standard (test); Nuclear medicine; Radiography; Prospective cohort study; Radiology; Peripheral; Cohort; Internal medicine; Bone mineral; Osteoporosis","score_opus":0.01800204774386789,"score_gpt":0.30282783721038864,"score_spread":0.28482578946652076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417264,0.009863119,0.00024172466,0.00078277715,0.0002070598,0.0040222555,0.000564825,0.00011586057,0.000029750383],"genre_scores_gemma":[0.9961482,0.0021082025,0.00071578106,0.00007901748,0.000011370667,0.0003904588,0.0004880937,0.00004797791,0.000010855345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625236,0.00047637918,0.00077113346,0.000539764,0.0014530905,0.00050726364],"domain_scores_gemma":[0.9980914,0.00029982228,0.00021498477,0.0004630083,0.00058583904,0.00034492413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004223775,0.00033864862,0.0008733024,0.0006020049,0.00019151141,0.00022131372,0.0003038455,0.0000565432,0.0001524722],"category_scores_gemma":[0.00025268746,0.0002389245,0.00030514697,0.0015614637,0.00037268002,0.00043413538,0.00011362313,0.00023696484,0.000009837003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025955578,0.005866989,0.974822,0.0003283653,0.0015286435,0.0000146503035,0.0014045513,0.00013320555,0.000059394748,0.0005463954,0.008526542,0.004173712],"study_design_scores_gemma":[0.0056681097,0.0021151428,0.97860074,0.010508486,0.00003073723,0.0000029944354,0.0012086844,0.0010095326,0.00009922989,0.00038776084,0.000096476746,0.00027209747],"about_ca_topic_score_codex":0.0006169053,"about_ca_topic_score_gemma":0.00016385056,"teacher_disagreement_score":0.011975614,"about_ca_system_score_codex":0.000048079783,"about_ca_system_score_gemma":0.00023152978,"threshold_uncertainty_score":0.97430587},"labels":[],"label_agreement":null},{"id":"W4399482762","doi":"10.1136/annrheumdis-2024-eular.1525","title":"AB0138 UNRAVELLING THE NUANCES OF PAIN IN PRIMARY SJÖGREN’S SYNDROME","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fibromyalgia; Medicine; Visual analogue scale; Physical therapy; McGill Pain Questionnaire; Neuropathic pain; Quality of life (healthcare); Rheumatology; Pain scale; Internal medicine; Anesthesia","score_opus":0.03216519058641675,"score_gpt":0.28672841341292676,"score_spread":0.25456322282651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9591964,0.03047879,0.0001333479,0.0071233413,0.00024459235,0.00033638466,0.000049821378,0.00002981998,0.0024075047],"genre_scores_gemma":[0.99758047,0.0014997438,0.000021779368,0.00054343964,0.000015033791,0.000021270376,0.000009986646,0.0000101651685,0.0002981185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991297,0.00009029517,0.00031477952,0.00010929988,0.00022830574,0.00012763299],"domain_scores_gemma":[0.99902856,0.0005223269,0.00007246075,0.0002987595,0.000036119553,0.000041753956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038187954,0.00008960745,0.00024908074,0.000076105665,0.000040991086,0.00001294691,0.00014172152,0.00002436627,0.00012497658],"category_scores_gemma":[0.00030332123,0.000043767464,0.00019733475,0.00031863668,0.00012336779,0.000055734377,0.00003619089,0.00007380037,0.0000072446483],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097428955,0.0039064097,0.3862912,0.023634508,0.0024810957,0.00013754974,0.00782117,0.003081373,0.00017460475,0.02368951,0.11673713,0.43107113],"study_design_scores_gemma":[0.0006005992,0.00036158174,0.949847,0.0085715195,0.00032419254,0.000039355273,0.0019358264,0.005930986,0.00008193418,0.030678602,0.0014597268,0.00016867089],"about_ca_topic_score_codex":0.0001526095,"about_ca_topic_score_gemma":0.0000074719064,"teacher_disagreement_score":0.5635558,"about_ca_system_score_codex":0.000006900495,"about_ca_system_score_gemma":0.00012457107,"threshold_uncertainty_score":0.17847854},"labels":[],"label_agreement":null},{"id":"W4399482868","doi":"10.1136/annrheumdis-2024-eular.1846","title":"AB0192 COMPARABLE SAFETY AND EFFECTIVENESS AFTER TRANSITION TO A BIOSIMILAR ANTI-TNF IN INFLAMMATORY ARTHRITIS: POPULATION-BASED EVIDENCE FROM A POLICY CHANGE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia","funders":"","keywords":"Biosimilar; Inflammatory arthritis; Arthritis; Transition (genetics); Medicine; Tumor necrosis factor alpha; Population; Immunology; Internal medicine; Chemistry; Environmental health","score_opus":0.040275142744125414,"score_gpt":0.32882825811243993,"score_spread":0.2885531153683145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527066,0.03952214,0.00023588243,0.006349037,0.0001598647,0.0005300475,0.00045939075,0.000032095973,0.000004950146],"genre_scores_gemma":[0.9976297,0.0010542767,0.00006373792,0.0011215787,0.000018486655,0.00007787369,0.00001830506,0.000010715899,0.000005297225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985228,0.00060572964,0.00033986257,0.0002552801,0.00006148789,0.00021483177],"domain_scores_gemma":[0.9987074,0.0009204583,0.000052835607,0.00023547956,0.000037655696,0.00004618145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040231136,0.0001560192,0.0003752039,0.00016848854,0.000060304756,0.000034223875,0.0001361173,0.00010338583,0.00011179692],"category_scores_gemma":[0.00031424602,0.00010918778,0.00013676542,0.00032431787,0.00013211808,0.00014818773,0.000049316586,0.000103436556,0.000012354328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007603715,0.0014987031,0.56990016,0.008387438,0.0016429571,0.00006853505,0.00544117,0.00095019955,0.018259425,0.0025077085,0.0014796848,0.3822603],"study_design_scores_gemma":[0.00034587458,0.000072080446,0.982001,0.010415273,0.00006670951,0.0000018107555,0.000032630123,0.00050936156,0.00468415,0.0015674914,0.00015649306,0.00014712589],"about_ca_topic_score_codex":0.0010589381,"about_ca_topic_score_gemma":0.000093120594,"teacher_disagreement_score":0.41210082,"about_ca_system_score_codex":0.000020558258,"about_ca_system_score_gemma":0.00006329155,"threshold_uncertainty_score":0.44525483},"labels":[],"label_agreement":null},{"id":"W4399482869","doi":"10.1136/annrheumdis-2024-eular.2854","title":"AB1439 UPDATE OF THE EULAR POINTS TO CONSIDER FOR USE OF ANTIRHEUMATIC DRUGS IN REPRODUCTION, PREGNANCY AND LACTATION","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Pregnancy; Antirheumatic drugs; Lactation; Reproduction; Medicine; Antirheumatic Agents; Computer science; Internal medicine; Biology; Methotrexate","score_opus":0.06530022656591306,"score_gpt":0.35711685045000024,"score_spread":0.2918166238840872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772018,0.008843342,0.00015040558,0.012337208,0.0001816404,0.0011510407,0.00009813723,0.000014315267,0.000022111371],"genre_scores_gemma":[0.9977134,0.0015193886,0.0003090441,0.00024119897,0.000006671012,0.00004175933,0.0000071023983,0.000011791609,0.00014968135],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99888486,0.00008675893,0.0005066177,0.00016572542,0.00024233585,0.00011370589],"domain_scores_gemma":[0.9986864,0.00035621924,0.00021985835,0.00050927163,0.00016034814,0.000067950736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029923086,0.00009083608,0.0002891056,0.00010850981,0.000027594158,0.000009689574,0.00009608543,0.00002694228,0.000024399784],"category_scores_gemma":[0.0039533284,0.000052325224,0.00012604462,0.00030354972,0.0001455493,0.00015611276,0.000044772492,0.00004597016,0.0000014562868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018617675,0.0033262195,0.1809984,0.08821386,0.002683948,0.0000053025815,0.043276057,0.00057284685,0.0041908217,0.022528913,0.089501135,0.5628407],"study_design_scores_gemma":[0.0019166584,0.00030632416,0.79688406,0.1308567,0.0007268941,0.000024749945,0.0010532155,0.0029434136,0.039429642,0.024932932,0.0006948375,0.00023060138],"about_ca_topic_score_codex":0.000038923634,"about_ca_topic_score_gemma":0.0000030386755,"teacher_disagreement_score":0.6158857,"about_ca_system_score_codex":0.000007868976,"about_ca_system_score_gemma":0.00017112699,"threshold_uncertainty_score":0.47327885},"labels":[],"label_agreement":null},{"id":"W4399482910","doi":"10.1136/annrheumdis-2024-eular.2868","title":"AB1381 GUSELKUMAB AND GOLIMUMAB COMBINATION INDUCTION THERAPY IN ULCERATIVE COLITIS RESULTS IN EARLY LOCAL TISSUE HEALING THAT IS SUSTAINED THROUGH GUSELKUMAB MAINTENANCE THERAPY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Golimumab; Medicine; Ulcerative colitis; Maintenance therapy; Immunology; Surgery; Tumor necrosis factor alpha; Internal medicine; Chemotherapy; Infliximab; Disease","score_opus":0.04642710743840725,"score_gpt":0.32700766874513126,"score_spread":0.28058056130672404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638852,0.00505057,0.000077571785,0.029363807,0.0002357378,0.0011239485,0.000096504635,0.00006363885,0.00010303677],"genre_scores_gemma":[0.98367196,0.014661618,0.000034592573,0.0012805866,0.000027617636,0.00010102087,0.000025570305,0.000035997826,0.00016105578],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976718,0.00036754497,0.0007029562,0.0004387968,0.00036690096,0.00045203557],"domain_scores_gemma":[0.99880815,0.00028885715,0.0002043256,0.00038400077,0.00023256952,0.000082116465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046399503,0.00029481124,0.0006082873,0.00024028293,0.00009719118,0.000055043256,0.0001615887,0.00012904753,0.0000152215025],"category_scores_gemma":[0.00027878812,0.0002067386,0.000107955384,0.00057369843,0.00041980916,0.00040151496,0.000075426244,0.00033046646,0.0000051083216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0368209,0.004500343,0.10813663,0.0025300903,0.004852799,0.00035729475,0.18156986,0.00036953614,0.00034146634,0.0056442944,0.021815896,0.6330609],"study_design_scores_gemma":[0.008951706,0.0020368001,0.9686156,0.0043348023,0.00007485096,0.00003752062,0.004320269,0.0009748537,0.0025460979,0.0074027446,0.00046917784,0.00023557295],"about_ca_topic_score_codex":0.0011025375,"about_ca_topic_score_gemma":0.00021057832,"teacher_disagreement_score":0.860479,"about_ca_system_score_codex":0.00014406936,"about_ca_system_score_gemma":0.00014351749,"threshold_uncertainty_score":0.8430555},"labels":[],"label_agreement":null},{"id":"W4399482982","doi":"10.1136/annrheumdis-2024-eular.245","title":"AB1374 DEUCRAVACITINIB IN PLAQUE PSORIASIS: MAINTENANCE OF RESPONSE OVER 3 YEARS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Psoriasis; Medicine; Placebo; Psoriasis Area and Severity Index; Psoriatic arthritis; Apremilast; Internal medicine; Clinical endpoint; Clinical trial; Plaque psoriasis; Randomized controlled trial; Dermatology","score_opus":0.025947630980426926,"score_gpt":0.28446363461567886,"score_spread":0.25851600363525196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826047,0.015504721,0.000003661545,0.00053343753,0.0005622712,0.00018875726,0.00040673162,0.000028772762,0.00016697255],"genre_scores_gemma":[0.99767953,0.0010389506,0.000014221702,0.00007246786,0.000008227668,0.000029892251,0.000016793201,0.000014300122,0.0011255853],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987796,0.00037548912,0.0003802723,0.00018002825,0.00005960432,0.00022502829],"domain_scores_gemma":[0.9988044,0.00065857026,0.000120511286,0.00036215887,0.00003457973,0.000019772846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003406729,0.00013686315,0.00031194088,0.00014140872,0.00002860267,0.000008847988,0.0002765498,0.00008791702,0.00032354653],"category_scores_gemma":[0.00038811637,0.00009360795,0.00024671204,0.00025662902,0.0001732396,0.00007520255,0.00006953912,0.00007111484,0.00008343596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018701114,0.00318105,0.053249914,0.0026296657,0.006136595,0.00017176058,0.010144004,0.0002080891,0.03193416,0.023896994,0.15631697,0.6934297],"study_design_scores_gemma":[0.0017480167,0.00019349132,0.9547659,0.0032055746,0.0002654175,0.000017332673,0.00046064192,0.000028978437,0.028129885,0.0056730825,0.0052650026,0.00024665223],"about_ca_topic_score_codex":0.00010396342,"about_ca_topic_score_gemma":0.000018937977,"teacher_disagreement_score":0.901516,"about_ca_system_score_codex":0.000012787381,"about_ca_system_score_gemma":0.000119373886,"threshold_uncertainty_score":0.38172215},"labels":[],"label_agreement":null},{"id":"W4399482988","doi":"10.1136/annrheumdis-2024-eular.5719","title":"POS0213 INFRAPATELLAR FAT PAD IN KNEE OSTEOARTHRITIS: CELLULAR AND TRANSCRIPTOMIC ATLAS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; Arthritis Society","funders":"","keywords":"Infrapatellar fat pad; Osteoarthritis; Atlas (anatomy); Fat pad; Transcriptome; Medicine; Adipose tissue; Anatomy; Biology; Internal medicine; Pathology; Gene expression; Gene","score_opus":0.0191920574650387,"score_gpt":0.26200864618298564,"score_spread":0.24281658871794692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399482988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9360466,0.061530564,0.0000057806847,0.001008355,0.00024781693,0.0005985236,0.00006280849,0.00005561424,0.00044395105],"genre_scores_gemma":[0.99716866,0.001906044,0.000039682127,0.00019338628,0.00002940526,0.00004390357,0.000025537453,0.000028056262,0.0005653168],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988617,0.00006796548,0.000348068,0.00022723562,0.0002490543,0.0002460039],"domain_scores_gemma":[0.99939054,0.000092952025,0.000047467132,0.00029509646,0.000034746146,0.00013921078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010077862,0.00018685606,0.00037476898,0.00013613908,0.00004344659,0.000041685347,0.00008732978,0.000063013664,0.00012336925],"category_scores_gemma":[0.000063651205,0.00012974619,0.00021540477,0.00021411087,0.000109824265,0.00013173828,0.00003992332,0.000097818556,0.000031242333],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056327146,0.00081922236,0.012434949,0.0040616263,0.00040625533,0.0004614195,0.0037128192,0.000009325524,0.021775449,0.00465368,0.002132107,0.9489699],"study_design_scores_gemma":[0.03817174,0.021907916,0.15024906,0.11175205,0.0049025705,0.0006801812,0.00879152,0.0024610097,0.5075672,0.1369524,0.013412987,0.0031513635],"about_ca_topic_score_codex":0.000033368797,"about_ca_topic_score_gemma":0.000027105876,"teacher_disagreement_score":0.9458185,"about_ca_system_score_codex":0.000011547224,"about_ca_system_score_gemma":0.00006621504,"threshold_uncertainty_score":0.52908957},"labels":[],"label_agreement":null},{"id":"W4399483014","doi":"10.1136/annrheumdis-2024-eular.759","title":"POS0258 THE EPIDEMIOLOGY OF BEHÇET’S SYNDROME IN ENGLAND; A RETROSPECTIVE CASE CONTROL STUDY NESTED WITHIN THE CLINICAL PRACTICE RESEARCH DATALINK (CPRD) AND CPRD LINKED HOSPITAL EPISODES STATISTICS (HES)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Epidemiology; Nested case-control study; Medicine; Clinical Practice; Pediatrics; Computer science; Case-control study; Family medicine; Internal medicine","score_opus":0.12828909412125414,"score_gpt":0.4646038009010875,"score_spread":0.33631470677983333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96615136,0.012879172,0.00006115723,0.016087294,0.00040100137,0.0027930278,0.0015730066,0.000029899276,0.000024066081],"genre_scores_gemma":[0.99810994,0.0009910442,0.00015715926,0.0004076173,0.000065255,0.00011550636,0.000027095379,0.000038271297,0.00008808641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922127,0.0043858513,0.001601098,0.00055297284,0.0007866718,0.0004606763],"domain_scores_gemma":[0.978272,0.018975437,0.0005636273,0.0013141015,0.0006176356,0.0002572026],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009440317,0.00028248725,0.0011109621,0.00015921246,0.00022608203,0.000054379,0.0005005442,0.00012173873,0.000053081025],"category_scores_gemma":[0.043134023,0.00013560077,0.00029454127,0.0006468651,0.001385175,0.00020912215,0.0003605981,0.0008223902,0.000007702698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020052602,0.007237464,0.9428877,0.0018345659,0.004481245,0.006949731,0.0075310883,0.000071082904,0.0000031465893,0.007321965,0.0042355163,0.015441218],"study_design_scores_gemma":[0.0021878395,0.003052992,0.96984935,0.0013468359,0.0016274351,0.0015122078,0.0068201236,0.003964106,0.0000013620603,0.009374033,0.00009935873,0.00016437095],"about_ca_topic_score_codex":0.001239474,"about_ca_topic_score_gemma":0.00021400698,"teacher_disagreement_score":0.033693705,"about_ca_system_score_codex":0.000034566307,"about_ca_system_score_gemma":0.0004371708,"threshold_uncertainty_score":0.96492606},"labels":[],"label_agreement":null},{"id":"W4399483084","doi":"10.1136/annrheumdis-2024-eular.1527","title":"AB1428 ADALIMUMAB AND TOCILIZUMAB BIOSIMILARS IN EUROPE: BUDGET-IMPACT AND OPPORTUNITY FOR EXPANDED PATIENT ACCESS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Biosimilar; Adalimumab; Tocilizumab; Medicine; Internal medicine; Rheumatoid arthritis","score_opus":0.07246973880904191,"score_gpt":0.38171561327561515,"score_spread":0.30924587446657326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95836973,0.0338999,0.000046852725,0.005732057,0.00030108273,0.00065058423,0.00073425897,0.00003700471,0.0002285454],"genre_scores_gemma":[0.99659455,0.0023503008,0.000046992907,0.00079700164,0.0000054630364,0.000028548398,0.000015095251,0.000013887249,0.00014817523],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99880654,0.00026986623,0.00036372064,0.00024995033,0.000050475304,0.0002594603],"domain_scores_gemma":[0.9988986,0.0006064401,0.00009316659,0.00024438094,0.00008239271,0.00007498882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031279505,0.00017690938,0.00035493146,0.00009559607,0.00008476238,0.00006326971,0.00021739888,0.00009686157,0.00014219292],"category_scores_gemma":[0.0009185916,0.00010212744,0.00013607681,0.00024013316,0.00032854217,0.00013237774,0.00022772493,0.00011276198,0.0000014079662],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001302148,0.0009264755,0.00915371,0.0022838293,0.0013585548,0.00001371793,0.0010589722,0.000010588418,0.0024086155,0.0020982784,0.08497977,0.89440536],"study_design_scores_gemma":[0.009571244,0.004765386,0.7205509,0.01000279,0.0017772012,0.00022826152,0.002301078,0.0033692606,0.08414043,0.102434345,0.05833272,0.0025263987],"about_ca_topic_score_codex":0.000054706292,"about_ca_topic_score_gemma":0.0000149978505,"teacher_disagreement_score":0.89187896,"about_ca_system_score_codex":0.000009131166,"about_ca_system_score_gemma":0.00012756254,"threshold_uncertainty_score":0.4164636},"labels":[],"label_agreement":null},{"id":"W4399483106","doi":"10.1136/annrheumdis-2024-eular.2132","title":"AB1410 EARLY SYMPTOMATIC IMPROVEMENT WITH GUSELKUMAB INDUCTION TREATMENT IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ulcerative colitis; Medicine; Quasar; Phase (matter); Internal medicine; Gastroenterology; Physics; Disease","score_opus":0.05356721853829596,"score_gpt":0.343808716522655,"score_spread":0.29024149798435905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98869115,0.00039583584,0.000018321443,0.0056989403,0.00022039417,0.004061104,0.000748732,0.000078553676,0.000086967404],"genre_scores_gemma":[0.99859166,0.00008942605,0.000046754405,0.00028067938,0.00008955043,0.0005893145,0.00006087625,0.000040834297,0.00021090487],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99752164,0.00033731022,0.000689218,0.0005049089,0.0006522627,0.0002946463],"domain_scores_gemma":[0.9981765,0.00047920263,0.00022901765,0.00075089885,0.00020109862,0.00016329299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002608444,0.00032836906,0.00053299015,0.00015924436,0.00014463822,0.00011264266,0.0001974356,0.000057952646,0.000034004835],"category_scores_gemma":[0.00035232955,0.00017407774,0.00013944403,0.0006038628,0.00011610197,0.00033290812,0.000068239235,0.00018470877,0.000023788853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07302695,0.028341103,0.0042749043,0.000860546,0.011273043,0.00026220147,0.26789603,0.0017113369,0.0005423429,0.0006194189,0.004859594,0.60633254],"study_design_scores_gemma":[0.0074046827,0.008811653,0.95514464,0.00404443,0.0008865365,0.000016528586,0.012499992,0.0012319015,0.0074329223,0.0022325963,0.000018525236,0.00027560737],"about_ca_topic_score_codex":0.00579836,"about_ca_topic_score_gemma":0.00074773416,"teacher_disagreement_score":0.95086974,"about_ca_system_score_codex":0.00029371667,"about_ca_system_score_gemma":0.00040652812,"threshold_uncertainty_score":0.8765424},"labels":[],"label_agreement":null},{"id":"W4399483123","doi":"10.1136/annrheumdis-2024-eular.5113","title":"AB1372 PEDIATRIC AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TREATMENT-RESISTANT AUTOIMMUNE DISEASES: A REAL-LIFE SINGLE-CENTER EXPERIENCE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Hematopoietic stem cell transplantation; Medicine; Stem cell; Single Center; Transplantation; Center (category theory); Biology; Internal medicine","score_opus":0.024238897457204627,"score_gpt":0.2643523849173792,"score_spread":0.2401134874601746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86161673,0.136224,0.000025757392,0.00029299143,0.000651045,0.00046259785,0.00030206694,0.00012758322,0.00029720078],"genre_scores_gemma":[0.9924557,0.006547741,0.0000016715876,0.00007339121,0.0000030531903,0.00014064503,0.00010207799,0.000029149985,0.000646551],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99785584,0.00033934705,0.000798561,0.00039136485,0.000116988,0.0004979159],"domain_scores_gemma":[0.99880004,0.0003627264,0.0002243768,0.00054600846,0.00004181542,0.00002500636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011630403,0.00032945737,0.0005233226,0.00021830412,0.00019877365,0.000053542288,0.0004838363,0.000119832344,0.00019994804],"category_scores_gemma":[0.000043093416,0.00022788855,0.00040898586,0.0004956771,0.00029334408,0.0002163218,0.00006132551,0.00012564767,0.0001083527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096859,0.05711356,0.10068373,0.0347451,0.0040076426,0.00064479845,0.29201415,0.0035163353,0.11767523,0.018354392,0.0054457407,0.35611343],"study_design_scores_gemma":[0.011384203,0.002075876,0.913172,0.0066919974,0.0024204904,0.00016581474,0.02504969,0.0009199297,0.028945742,0.0026627507,0.0038736407,0.0026378355],"about_ca_topic_score_codex":0.00026974882,"about_ca_topic_score_gemma":0.000006371166,"teacher_disagreement_score":0.8124883,"about_ca_system_score_codex":0.00004851134,"about_ca_system_score_gemma":0.00025148373,"threshold_uncertainty_score":0.9293026},"labels":[],"label_agreement":null},{"id":"W4399483149","doi":"10.1136/annrheumdis-2024-eular.lba25","title":"LBA0001 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH GIANT CELL ARTERITIS (SELECT-GCA): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Giant cell arteritis; Double blind; Medicine; Randomized controlled trial; Internal medicine; Vasculitis; Pathology","score_opus":0.018640530572859804,"score_gpt":0.2994161056757746,"score_spread":0.2807755751029148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878964,0.004752633,0.000033236665,0.001154143,0.00013700228,0.005218707,0.00021291159,0.00002465922,0.0005703029],"genre_scores_gemma":[0.9980926,0.0012492383,0.000022005639,0.000057973615,0.000020429927,0.0002030831,0.00007981437,0.000019249283,0.0002556228],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981472,0.00021324058,0.0008845834,0.00019887248,0.0003614321,0.0001946594],"domain_scores_gemma":[0.99855673,0.0006529212,0.00025200433,0.00027137547,0.0001381946,0.00012878454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003334657,0.00018045583,0.0013805113,0.00016895523,0.000051291903,0.000029234949,0.000088800494,0.00006128068,0.00027292446],"category_scores_gemma":[0.00032043122,0.00009260005,0.00046909635,0.00027634721,0.0002601884,0.00007893481,0.00002615116,0.00012905944,0.000003846095],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9889767,0.002578966,0.00006965516,0.00062482024,0.0015077558,0.000009074788,0.00032660706,0.000018299303,0.000011715041,0.00037281378,0.00042843376,0.0050751627],"study_design_scores_gemma":[0.9904697,0.0009299837,0.0018307366,0.003736822,0.0017507474,0.00000451209,0.000054005977,0.0006705928,0.00011629217,0.00028446713,0.000043111213,0.00010905262],"about_ca_topic_score_codex":0.000037643935,"about_ca_topic_score_gemma":0.0000020109635,"teacher_disagreement_score":0.010196179,"about_ca_system_score_codex":0.000007408002,"about_ca_system_score_gemma":0.00018148145,"threshold_uncertainty_score":0.37761205},"labels":[],"label_agreement":null},{"id":"W4399483155","doi":"10.1136/annrheumdis-2024-eular.651","title":"AB1435 BUDGET IMPACT ANALYSIS OF A TOCILIZUMAB BIOSIMILAR: A UK PAYER PERSPECTIVE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Biosimilar; Tocilizumab; Perspective (graphical); Computer science; Medicine; Rheumatoid arthritis; Artificial intelligence; Internal medicine","score_opus":0.03591416034762759,"score_gpt":0.37284060070753955,"score_spread":0.336926440359912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85808855,0.11850993,0.00046170602,0.012487891,0.00084799476,0.00077345315,0.0046417927,0.00013347915,0.0040552053],"genre_scores_gemma":[0.9984003,0.0006090264,0.000062969404,0.0002770391,0.000008129108,0.000010558597,0.000017170294,0.000011640548,0.0006031864],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99850255,0.00033923239,0.00047903968,0.00028516946,0.00010309113,0.000290929],"domain_scores_gemma":[0.9983523,0.00066568726,0.00017406623,0.0005472839,0.00021180396,0.000048857022],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035235126,0.00021071667,0.0007062113,0.00030472214,0.00007008529,0.000023493494,0.0004005685,0.0001361348,0.0027765522],"category_scores_gemma":[0.00068232755,0.00011277439,0.0014765164,0.0012461517,0.00049673516,0.000058057645,0.00014192743,0.00014660133,0.0000194169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031619046,0.005293914,0.048876137,0.0028617082,0.25908387,0.00003734936,0.009325536,0.0006623324,0.036827862,0.102988005,0.3583027,0.17257866],"study_design_scores_gemma":[0.002080263,0.001799312,0.7476769,0.0031573107,0.038269207,0.00003929852,0.0052249567,0.0048687933,0.11133539,0.07947002,0.0045447997,0.0015337308],"about_ca_topic_score_codex":0.0003355791,"about_ca_topic_score_gemma":0.000023482655,"teacher_disagreement_score":0.6988008,"about_ca_system_score_codex":0.000029179038,"about_ca_system_score_gemma":0.00014059503,"threshold_uncertainty_score":0.99813503},"labels":[],"label_agreement":null},{"id":"W4399483244","doi":"10.1136/annrheumdis-2024-eular.602","title":"OP0046 EFFECT OF IXEKIZUMAB TREATMENT ON MRI STRUCTURAL LESIONS IN THE SACROILIAC JOINTS OF PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS; A POST-HOC ANALYSIS OF A PLACEBO AND ACTIVE CONTROLLED RCT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ixekizumab; Medicine; Axial spondyloarthritis; Post-hoc analysis; Placebo; Randomized controlled trial; Radiography; Sacroiliac joint; Physical therapy; Magnetic resonance imaging; Radiology; Internal medicine; Sacroiliitis; Arthritis; Pathology; Secukinumab; Alternative medicine","score_opus":0.011981831521882905,"score_gpt":0.2960203829028881,"score_spread":0.2840385513810052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953323,0.0022531548,0.0000012407515,0.00033596111,0.000037375496,0.0011279302,0.0008628068,0.0000058163196,0.00004340611],"genre_scores_gemma":[0.9994512,0.00034129224,0.000009810604,0.000049904596,0.000004257359,0.000058216054,0.00006400304,0.00000972765,0.000011586714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984734,0.00038970896,0.0004914246,0.0001835585,0.0003180449,0.0001438397],"domain_scores_gemma":[0.99882656,0.00039505516,0.00026416784,0.00034826115,0.000114025206,0.000051929364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016802875,0.00018910675,0.0011329697,0.0004781838,0.00002756098,0.0000065688146,0.00012255408,0.00004017208,0.000068875954],"category_scores_gemma":[0.00033106934,0.00008126942,0.0006759523,0.0006293841,0.0002960389,0.000060406575,0.000029407924,0.00006626773,3.892817e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20126657,0.0074439226,0.2793621,0.006594223,0.05242416,0.0001399224,0.021240914,0.00060677784,0.0018576389,0.0013784283,0.0009283374,0.426757],"study_design_scores_gemma":[0.010392281,0.01209855,0.9689746,0.0020236354,0.0037577038,0.0000040977416,0.00039188375,0.0008030341,0.0013841541,0.000095223266,9.1914654e-7,0.00007392157],"about_ca_topic_score_codex":0.00021509545,"about_ca_topic_score_gemma":0.000068097936,"teacher_disagreement_score":0.6896125,"about_ca_system_score_codex":0.000012547632,"about_ca_system_score_gemma":0.00006226502,"threshold_uncertainty_score":0.33140707},"labels":[],"label_agreement":null},{"id":"W4399483266","doi":"10.1136/annrheumdis-2024-eular.3269","title":"OP0005 NAVIGATING COMPLEXITIES OF MULTIPLE POSITIVE MYOSITIS AUTOANTIBODIES: ANALYSIS FROM CLASSIFICATION CRITERIA OF ANTI-SYNTHETASE SYNDROME (CLASS) PROJECT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Autoantibody; Myositis; Class (philosophy); Computer science; Computational biology; Medicine; Artificial intelligence; Antibody; Immunology; Biology; Internal medicine","score_opus":0.055011909674450826,"score_gpt":0.352352670726371,"score_spread":0.2973407610519202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900383,0.003040861,0.00017364988,0.0011131585,0.0001390105,0.0005061958,0.004661178,0.000065301996,0.0002623793],"genre_scores_gemma":[0.9986682,0.0002884678,0.0004388883,0.00011707627,0.000022723065,0.000027595697,0.0003847526,0.000027554383,0.000024729674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977291,0.00023106486,0.000990372,0.00027785538,0.0005468997,0.00022471156],"domain_scores_gemma":[0.99769723,0.00075509376,0.00052621454,0.00061813334,0.00032177637,0.00008152096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025164444,0.0002316212,0.0009989279,0.000244448,0.00010332265,0.000049027123,0.00025124403,0.000068755624,0.00017006249],"category_scores_gemma":[0.00039569993,0.00016770336,0.0007468207,0.00069414394,0.00044211594,0.00020932766,0.00014857927,0.00012158594,0.0000059138138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031096875,0.006457141,0.5295849,0.07350001,0.07548467,0.0010802655,0.06887412,0.0015205189,0.1069339,0.028079461,0.025903886,0.07947148],"study_design_scores_gemma":[0.0005597313,0.00018497754,0.87175196,0.014559764,0.003839589,0.000058563644,0.0041050487,0.076872475,0.026097402,0.0016398517,0.000052452335,0.000278169],"about_ca_topic_score_codex":0.0013537045,"about_ca_topic_score_gemma":0.00001487522,"teacher_disagreement_score":0.3421671,"about_ca_system_score_codex":0.000021484679,"about_ca_system_score_gemma":0.00017790776,"threshold_uncertainty_score":0.6838744},"labels":[],"label_agreement":null},{"id":"W4399483326","doi":"10.1136/annrheumdis-2024-eular.1319","title":"AB0102 DIFFERENTIAL EXPRESSION OF ORTHOLOGUE GENES INVOLVED IN GLYCINE AND PYRUVATE METABOLISM CHARACTERIZE THE GUT MICROBIOME META-TRANSCRIPTOME OF SUBJECTS WITH ASYMPTOMATIC HYPERURICEMIA AND GOUT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperuricemia; Transcriptome; Gut microbiome; Biology; Gout; Asymptomatic; Gene; Microbiome; Bioinformatics; Gene expression; Computational biology; Genetics; Medicine; Uric acid; Endocrinology; Internal medicine; Biochemistry","score_opus":0.01953525729802681,"score_gpt":0.24870622369555265,"score_spread":0.22917096639752585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9337155,0.06537171,0.000038632956,0.00026164448,0.000081140635,0.00030010773,0.00021506978,0.0000050329522,0.00001115813],"genre_scores_gemma":[0.9919671,0.0077328854,0.00006510716,0.00006945415,0.000014003875,0.00003550358,0.00004606655,0.000018573539,0.00005132767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988074,0.0001748637,0.00042856604,0.00024711553,0.00017024741,0.00017186569],"domain_scores_gemma":[0.99921,0.000063955966,0.00019806407,0.0004030054,0.00007084521,0.000054105836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018286114,0.00021061442,0.000527032,0.00008401213,0.000035910078,0.000021810583,0.0002438903,0.00006297872,0.000020544165],"category_scores_gemma":[0.000068921225,0.00010416331,0.00015536751,0.00019291519,0.00037530504,0.000012933355,0.00013372042,0.000049821087,2.3725887e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020965892,0.0001448063,0.004405714,0.0013898676,0.00075318414,8.481285e-7,0.0005698447,0.000012344647,0.9885517,0.00007872792,0.00010828679,0.0037750285],"study_design_scores_gemma":[0.001044095,0.00013724166,0.4843318,0.00071598525,0.0013539044,0.0000072783578,0.0003742338,0.000093347066,0.51085293,0.00048986956,0.00035785334,0.00024149084],"about_ca_topic_score_codex":0.00007502402,"about_ca_topic_score_gemma":0.000028671082,"teacher_disagreement_score":0.47992608,"about_ca_system_score_codex":5.305708e-7,"about_ca_system_score_gemma":0.000055076285,"threshold_uncertainty_score":0.42476565},"labels":[],"label_agreement":null},{"id":"W4399483383","doi":"10.1136/annrheumdis-2024-eular.618","title":"POS0899 FIRST-IN-HUMAN SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS DATA WITH MK-6194, A MODIFIED FORM OF INTERLEUKIN-2, DESIGNED TO SELECTIVELY ACTIVATE REGULATORY T-CELLS – SINGLE ASCENDING DOSE AND MULTIPLE ASCENDING DOSE TRIALS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Pharmacology; Chemistry; Medicine","score_opus":0.09399967121303109,"score_gpt":0.36951362545309985,"score_spread":0.27551395424006875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902913,0.0054593426,0.00096584985,0.0010213738,0.00029168514,0.0009875196,0.0008592603,0.000041868214,0.00008180178],"genre_scores_gemma":[0.99817806,0.0009144811,0.0005606839,0.0001587611,0.000015381947,0.000010607637,0.000030992378,0.000030437948,0.00010061151],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768645,0.0005676731,0.00078247784,0.0004829511,0.00010885889,0.00037159232],"domain_scores_gemma":[0.99728036,0.0017990274,0.0003134772,0.00044231894,0.00007270344,0.000092097216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014764948,0.0002927394,0.000816963,0.00024596334,0.00014473041,0.000053979882,0.00046785717,0.00011118697,0.000044239932],"category_scores_gemma":[0.00063304737,0.00018928053,0.0001266919,0.00033695746,0.00037811595,0.00021588006,0.000480867,0.00019423976,9.635885e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043122885,0.00097438967,0.001019323,0.001998469,0.002375819,0.000010064549,0.0014130535,0.0001920512,0.9001299,0.0006541327,0.0018818537,0.085038625],"study_design_scores_gemma":[0.0080052465,0.0012783441,0.021618927,0.007695958,0.0020079508,0.000038533264,0.0007134181,0.018972732,0.93519145,0.0024794627,0.0010524411,0.00094553124],"about_ca_topic_score_codex":0.00006696273,"about_ca_topic_score_gemma":0.000029844166,"teacher_disagreement_score":0.084093094,"about_ca_system_score_codex":0.00003628831,"about_ca_system_score_gemma":0.0000629374,"threshold_uncertainty_score":0.77186364},"labels":[],"label_agreement":null},{"id":"W4399483423","doi":"10.1136/annrheumdis-2024-eular.4719","title":"AB0699 THE PREDICTION OF RESPONSE TO ADVANCED THERAPIES ON A JOINT LEVEL IN RHEUMATOID ARTHRITIS: THE INTERPRETATION OF TENDERNESS AND DOPPLER ULTRASOUND","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rheumatoid arthritis; Medicine; Tenderness; Ultrasound; Joint (building); Doppler effect; Interpretation (philosophy); Doppler ultrasound; Radiology; Computer science; Internal medicine; Surgery; Engineering; Physics","score_opus":0.04114107905909197,"score_gpt":0.31162738602001727,"score_spread":0.2704863069609253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95907587,0.0320395,0.00012625365,0.0074155172,0.00012875702,0.0008714039,0.00025830846,0.000021739119,0.000062651256],"genre_scores_gemma":[0.96200633,0.03762149,0.000033352124,0.0001705447,0.000008510883,0.000084358195,0.000005908854,0.000019671968,0.000049828952],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806076,0.00040844645,0.0005962981,0.00019116659,0.00054290163,0.00020040985],"domain_scores_gemma":[0.99756396,0.0015762754,0.00015291852,0.00047436115,0.00015752783,0.000074980024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008645337,0.00015804943,0.00038583958,0.00018826513,0.000082238985,0.000040445106,0.00020695936,0.000033927572,0.000045465717],"category_scores_gemma":[0.0019069202,0.000075982825,0.00017287052,0.0003590186,0.00046150308,0.00013923307,0.000066547116,0.00014569465,0.000003176237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018880105,0.0014576983,0.016379384,0.0024131152,0.0018197199,0.000013133968,0.07029721,0.0012128301,0.023382438,0.009098046,0.007282088,0.84776425],"study_design_scores_gemma":[0.0022898624,0.0015062592,0.920443,0.031021588,0.00002404192,0.00010285476,0.012881211,0.0026837266,0.014529216,0.013564002,0.0007619379,0.00019227673],"about_ca_topic_score_codex":0.00010387525,"about_ca_topic_score_gemma":0.00003828125,"teacher_disagreement_score":0.90406364,"about_ca_system_score_codex":0.000014785433,"about_ca_system_score_gemma":0.0001474296,"threshold_uncertainty_score":0.30984896},"labels":[],"label_agreement":null},{"id":"W4399483447","doi":"10.1136/annrheumdis-2024-eular.430","title":"POS0898 PREGNANT WOMEN ON TNFI MAY HAVE HIGHER RISK OF HOSPITALIZATION FOR INFECTIONS DURING GESTATION AND POSTPARTUM","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"COVID-19 Impact on Reproduction","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Gestation; Medicine; Obstetrics; Pregnancy; Biology","score_opus":0.028874484253207527,"score_gpt":0.33828819592095966,"score_spread":0.3094137116677521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929954,0.0008121671,0.00012254136,0.00478922,0.000232045,0.00076176244,0.00017418522,0.00005252992,0.000060171686],"genre_scores_gemma":[0.9981739,0.00089288695,0.000020189216,0.00010524487,0.000035836314,0.00008618244,0.00002137886,0.000020702759,0.000643668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991599,0.000055188953,0.00026824322,0.00018151186,0.00020138563,0.00013377714],"domain_scores_gemma":[0.99908566,0.00021345138,0.00017280292,0.00029856127,0.00013685047,0.00009266336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017423558,0.000104006234,0.00019427329,0.00014455583,0.00006939902,0.000022722543,0.000040653096,0.000029148712,0.00003869455],"category_scores_gemma":[0.0014529224,0.00007099379,0.00011034338,0.00016069239,0.00006940799,0.00013254725,0.00002515567,0.00004481997,0.0000018864994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035700207,0.0055350745,0.7367198,0.06438131,0.004545591,0.000008383798,0.016376708,0.00543891,0.0059049292,0.014797679,0.013721084,0.12900048],"study_design_scores_gemma":[0.0005788966,0.00076638,0.98123866,0.0043890662,0.00036789372,0.0000050032336,0.00023169427,0.0012545496,0.0055342726,0.0053051375,0.00022653653,0.00010191215],"about_ca_topic_score_codex":0.000052483487,"about_ca_topic_score_gemma":0.0000013152242,"teacher_disagreement_score":0.24451885,"about_ca_system_score_codex":0.00004324989,"about_ca_system_score_gemma":0.00009154399,"threshold_uncertainty_score":0.28950426},"labels":[],"label_agreement":null},{"id":"W4399483612","doi":"10.1136/annrheumdis-2024-eular.4920","title":"OP0188 EFFECT OF BENRALIZUMAB VERSUS MEPOLIZUMAB ON REDUCTION IN ORAL GLUCOCORTICOID USE IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Granulomatosis with polyangiitis; Benralizumab; Mepolizumab; Medicine; Eosinophilic; Glucocorticoid; Dermatology; Immunology; Internal medicine; Vasculitis; Pathology; Asthma; Eosinophil; Disease","score_opus":0.01945494451217099,"score_gpt":0.2843926783426114,"score_spread":0.2649377338304404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965634,0.0010860348,7.9155336e-7,0.00055306463,0.0002070208,0.0013312484,0.00011318245,0.000045549903,0.00009975173],"genre_scores_gemma":[0.99959534,0.00010704043,0.000030657793,0.00004288702,0.000012899416,0.00006860432,0.000048334146,0.000054840177,0.00003936676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777323,0.00021321043,0.0005683922,0.00035800517,0.0007472268,0.00033996077],"domain_scores_gemma":[0.9984324,0.0004621517,0.00020617343,0.00068129145,0.000101853046,0.00011615713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014115988,0.00030137168,0.0007370184,0.00045059956,0.000028902392,0.000031450883,0.00017886647,0.00006918082,0.000039350158],"category_scores_gemma":[0.00038062906,0.00017920727,0.00017200988,0.0009459732,0.00024427797,0.00029243785,0.000054355412,0.00016862384,0.000008841141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025016604,0.0021761418,0.9247737,0.005284908,0.0009040962,0.00007797107,0.0008116667,0.00052946206,0.000082786384,0.0007419033,0.0005400459,0.0390607],"study_design_scores_gemma":[0.007954693,0.006079882,0.9675171,0.011990233,0.00040171822,0.000018406554,0.00005496985,0.00016598047,0.0055006314,0.000112794274,0.000004111781,0.00019947991],"about_ca_topic_score_codex":0.0010051494,"about_ca_topic_score_gemma":0.00007651536,"teacher_disagreement_score":0.04274339,"about_ca_system_score_codex":0.000097829434,"about_ca_system_score_gemma":0.00016244454,"threshold_uncertainty_score":0.730786},"labels":[],"label_agreement":null},{"id":"W4399483621","doi":"10.1136/annrheumdis-2024-eular.308","title":"OP0280 DEEP CELLULAR IMMUNE PROFILING IN PSORIATIC ARTHRITIS CORRELATES WITH IMAGING PHENOTYPES AND RESPONSE TO TARGETED ADVANCED THERAPY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Actua; University Health Network; Women's College Hospital; University of Waterloo; University of Toronto","funders":"","keywords":"Psoriatic arthritis; Profiling (computer programming); Medicine; Phenotype; Immune system; Computational biology; Arthritis; Computer science; Immunology; Biology; Genetics; Gene","score_opus":0.014981765606015784,"score_gpt":0.2928996646942742,"score_spread":0.2779178990882584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8694052,0.12691975,0.00008982144,0.0022313949,0.000119758435,0.0011223232,0.000014161344,0.000055515535,0.000042070016],"genre_scores_gemma":[0.9965653,0.0025808548,0.00040560547,0.00010442297,0.00001606508,0.00012380486,0.000006462471,0.000046117646,0.00015137433],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982079,0.0002565309,0.00046820453,0.0002850066,0.00045733177,0.00032500882],"domain_scores_gemma":[0.9984466,0.0007266793,0.00008859574,0.0004587442,0.00012962469,0.00014978876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066384394,0.0001905342,0.0004737546,0.00025291927,0.00006192369,0.00005550085,0.00017259245,0.000030083762,0.000044476114],"category_scores_gemma":[0.0010641571,0.000115647184,0.000098417666,0.0005558354,0.00012561015,0.00013605203,0.00008248518,0.00013683869,0.000014891265],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02151276,0.0009453693,0.17484039,0.010412617,0.0013264706,0.0005035497,0.024220772,0.001065956,0.07215986,0.0008091705,0.00063865766,0.69156444],"study_design_scores_gemma":[0.028909544,0.0040115966,0.26052728,0.26296708,0.00065437955,0.0031695345,0.04239586,0.11155039,0.26495308,0.017405812,0.0008357773,0.0026196842],"about_ca_topic_score_codex":0.000042825828,"about_ca_topic_score_gemma":0.0000055106716,"teacher_disagreement_score":0.68894476,"about_ca_system_score_codex":0.00003279684,"about_ca_system_score_gemma":0.00023414502,"threshold_uncertainty_score":0.47159553},"labels":[],"label_agreement":null},{"id":"W4399483679","doi":"10.1136/annrheumdis-2024-eular.2033","title":"POS1428 GIANT CELL ARTERITIS SIGNS AND SYMPTOMS LEXICON: AN INTERNATIONAL EXPERT CONSENSUS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; University of Ottawa; Ottawa Hospital; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Lexicon; Giant cell arteritis; Computer science; Natural language processing; Medicine; Pathology; Vasculitis; Disease","score_opus":0.027548709594725364,"score_gpt":0.31165043678015997,"score_spread":0.2841017271854346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966333,0.012431092,0.000029379837,0.017028539,0.00057116855,0.00025567747,0.0003202391,0.00008029133,0.0029506222],"genre_scores_gemma":[0.99638003,0.0020261873,0.00006954768,0.0006449158,0.000059511352,0.000016924401,0.000047022022,0.00001561095,0.00074027886],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992128,0.000043591444,0.00023950661,0.00016530197,0.00020992795,0.00012884749],"domain_scores_gemma":[0.9993903,0.00008570001,0.000047653175,0.0002536541,0.000071875314,0.0001507856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057587313,0.00010582264,0.00018335905,0.000067975125,0.000064124404,0.000058903763,0.000105654784,0.00004308942,0.0004989241],"category_scores_gemma":[0.00005917321,0.00006799811,0.00016965218,0.000077780714,0.00017926058,0.00008519414,0.000042298376,0.00007674449,0.00002007267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045744583,0.004893734,0.007497854,0.0045599807,0.007484789,0.0011552029,0.011665079,0.00017204361,0.021634063,0.065236114,0.19297256,0.6822711],"study_design_scores_gemma":[0.012369728,0.006384496,0.7003349,0.048686773,0.0040931627,0.0051041734,0.010477287,0.061586678,0.023372443,0.07922071,0.04557631,0.0027933398],"about_ca_topic_score_codex":0.000040943993,"about_ca_topic_score_gemma":0.0000016211799,"teacher_disagreement_score":0.69283706,"about_ca_system_score_codex":0.000007749057,"about_ca_system_score_gemma":0.000094942276,"threshold_uncertainty_score":0.54628694},"labels":[],"label_agreement":null},{"id":"W4399483715","doi":"10.1136/annrheumdis-2024-eular.4851","title":"AB0092 COVID-19 MRNA VACCINES BASED ON THE ANCESTRAL WUHAN STRAIN GENERATE ANTI-SARSCOV2 ANTIBODIES WITH LOW VIRAL INHIBITION LEVELS TO OMICRON VARIANTS IN PEOPLE WITH IMMUNE MEDIATED INFLAMMATORY DISEASES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Public Health Agency of Canada; University of Manitoba","funders":"","keywords":"Virology; Antibody; Strain (injury); Coronavirus disease 2019 (COVID-19); Immune system; Messenger RNA; Biology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Immunology; Medicine; Gene; Genetics; Disease; Infectious disease (medical specialty)","score_opus":0.020676687258725138,"score_gpt":0.2728444136770512,"score_spread":0.2521677264183261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826339,0.008401689,0.00010013036,0.006427505,0.00026290305,0.0009108932,0.0011500965,0.00009871991,0.000014145884],"genre_scores_gemma":[0.9973783,0.0005356354,0.00001394032,0.0015230587,0.000017163888,0.00011234281,0.00017487581,0.00004737774,0.00019729731],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974004,0.00087489665,0.00061798445,0.00040944497,0.00016776167,0.0005295232],"domain_scores_gemma":[0.9978465,0.0010667498,0.00026249714,0.0006625277,0.00009233556,0.000069434456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004751761,0.00043140128,0.0006017712,0.00030905084,0.0003439698,0.0001139049,0.00047269772,0.00010930455,0.00027542832],"category_scores_gemma":[0.00050151814,0.00021146252,0.0002014191,0.0005734402,0.00039225904,0.00028719028,0.000081334016,0.0002437876,0.000049006652],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030701948,0.0040479675,0.090445496,0.0051502455,0.0044005276,0.00025290015,0.009164128,0.027492277,0.8041902,0.0023226915,0.008565272,0.013266354],"study_design_scores_gemma":[0.0028775516,0.0009034958,0.9015025,0.0053498535,0.00017877284,0.000034772278,0.0007698485,0.00045137442,0.086635806,0.00035869662,0.0003364613,0.0006008516],"about_ca_topic_score_codex":0.0002850756,"about_ca_topic_score_gemma":0.00011729082,"teacher_disagreement_score":0.81105703,"about_ca_system_score_codex":0.00004990463,"about_ca_system_score_gemma":0.0008320599,"threshold_uncertainty_score":0.8623191},"labels":[],"label_agreement":null},{"id":"W4399483733","doi":"10.1136/annrheumdis-2024-eular.4464","title":"POS0556 DNA METHYLATION ESTIMATES OF HYPER-AGING IN SYSTEMIC SCLEROSIS AND IDIOPATHIC PULMONARY FIBROSIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Providence Health Care; Institute of Infection and Immunity; BC Children's Hospital; University of Calgary; University of Northern British Columbia; University of British Columbia","funders":"","keywords":"DNA methylation; Pulmonary fibrosis; Medicine; Multiple sclerosis; Fibrosis; DNA; Methylation; Idiopathic pulmonary fibrosis; Pathology; Immunology; Internal medicine; Biology; Lung; Genetics; Gene","score_opus":0.042985570325421156,"score_gpt":0.2919383067518168,"score_spread":0.24895273642639565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79107356,0.20764041,0.000011047903,0.00061884464,0.00013944575,0.00034177478,0.000050425548,0.000044212553,0.00008028703],"genre_scores_gemma":[0.99042606,0.0093738055,0.000032319174,0.000047808822,0.00002445352,0.000031575208,0.000009753078,0.000026350956,0.000027890435],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99834645,0.00013064755,0.00071868073,0.00024589387,0.00036735716,0.00019094496],"domain_scores_gemma":[0.99885243,0.00038263015,0.0002014181,0.00035205533,0.00009233069,0.000119124576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039092868,0.00017966569,0.0005591402,0.00023294357,0.0000498029,0.000031208303,0.00013081111,0.00007924014,0.000021537582],"category_scores_gemma":[0.00051103334,0.00011406356,0.00025793648,0.00046643105,0.00014547116,0.00014854889,0.00008161849,0.000089988534,0.000005069572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005459909,0.0014012229,0.3161391,0.06237971,0.001553161,0.00003406442,0.0033746029,0.00080168684,0.25701067,0.0013443027,0.001280034,0.35413545],"study_design_scores_gemma":[0.0005805175,0.0001299853,0.74116427,0.20870316,0.0009745667,0.000097293676,0.0012922254,0.01368,0.03164752,0.0014907839,0.000005075857,0.00023458916],"about_ca_topic_score_codex":0.00013291648,"about_ca_topic_score_gemma":8.134289e-7,"teacher_disagreement_score":0.42502517,"about_ca_system_score_codex":0.00002085778,"about_ca_system_score_gemma":0.00011811907,"threshold_uncertainty_score":0.4651377},"labels":[],"label_agreement":null},{"id":"W4399483768","doi":"10.1136/annrheumdis-2024-eular.27","title":"OP0142 INCREASED RISK OF SEVERE INFECTION IN PATIENTS WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES: A POPULATION-BASED TREND ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Research Canada","funders":"","keywords":"Anti-neutrophil cytoplasmic antibody; Medicine; Antibody; Population; Internal medicine; Immunology; Vasculitis; Disease; Environmental health","score_opus":0.007865148044839183,"score_gpt":0.2619489693256469,"score_spread":0.2540838212808077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804085,0.0004133701,0.000022366208,0.00020988064,0.00004772231,0.00035706,0.0007986405,0.00004809066,0.000062017534],"genre_scores_gemma":[0.99830806,0.00032890378,0.000018315648,0.00003977793,0.000006658234,0.000014838182,0.0012427444,0.000018751005,0.000021945378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998455,0.00020493096,0.0005270845,0.00021192717,0.00042551206,0.00017556507],"domain_scores_gemma":[0.998841,0.00024409189,0.00030112025,0.0003627864,0.00016205608,0.000088972076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016766673,0.00016667548,0.00055036315,0.0005385223,0.00007125252,0.000019966654,0.00007819776,0.000074180534,0.000117711774],"category_scores_gemma":[0.00039777532,0.000102505895,0.00059977506,0.0018441074,0.00007121675,0.00010893884,0.000018625422,0.00013529228,0.0000026656924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109597066,0.0008478661,0.9850435,0.0004249365,0.0036138878,0.00000304278,0.00006640578,0.008918999,0.0000033770684,0.000051515824,0.00009080933,0.0008260122],"study_design_scores_gemma":[0.0019098549,0.00017356295,0.98313177,0.0026580999,0.004669551,8.289109e-7,0.000016956705,0.0069991164,0.0000303757,0.00029269565,0.0000029569044,0.00011421153],"about_ca_topic_score_codex":0.0033859976,"about_ca_topic_score_gemma":0.0002869435,"teacher_disagreement_score":0.003099054,"about_ca_system_score_codex":0.000035718294,"about_ca_system_score_gemma":0.00013192523,"threshold_uncertainty_score":0.5118638},"labels":[],"label_agreement":null},{"id":"W4399483843","doi":"10.1136/annrheumdis-2024-eular.5898","title":"AB0630 IMPACT OF JOINT INVOLVEMENT ON CHANGES IN PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Centre hospitalier de l'Université Laval; Montreal Clinical Research Institute; McGill University; GDI Integrated Facility Services (Canada); Western University","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Medicine; Joint (building); Physical therapy; Internal medicine; Engineering","score_opus":0.04534090097797043,"score_gpt":0.32686036304876537,"score_spread":0.2815194620707949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950675,0.0024136442,4.8689725e-7,0.00053638575,0.000071278686,0.0015553384,0.00016298043,0.000035382036,0.00015703445],"genre_scores_gemma":[0.9979558,0.0016620877,0.0000073632386,0.000051402654,0.000003880303,0.00015732556,0.000048380574,0.00004038181,0.00007340471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971808,0.0001770202,0.0009583777,0.00031116308,0.0009907456,0.0003818555],"domain_scores_gemma":[0.99832815,0.00029141016,0.00032914858,0.0006824626,0.00021237723,0.00015646775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029541765,0.00027599034,0.00091994245,0.0006150327,0.000022758715,0.00002212342,0.00016743476,0.000058100002,0.00013897306],"category_scores_gemma":[0.0007203803,0.00014717803,0.000291221,0.00070585386,0.00013752987,0.00009181656,0.00009295006,0.00014410932,0.000010298963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004433243,0.0016819614,0.98051536,0.0016537786,0.0006140508,0.00006463442,0.0019578314,0.000054282522,0.00004911872,0.000024104145,0.0011004701,0.011841091],"study_design_scores_gemma":[0.0030442104,0.0018890513,0.9529281,0.038042713,0.000036281082,0.00005027909,0.000876006,0.0003367423,0.0024775236,0.00013537597,0.000008061066,0.00017564805],"about_ca_topic_score_codex":0.0014809851,"about_ca_topic_score_gemma":0.00028311103,"teacher_disagreement_score":0.036388934,"about_ca_system_score_codex":0.000149278,"about_ca_system_score_gemma":0.00027989407,"threshold_uncertainty_score":0.60017455},"labels":[],"label_agreement":null},{"id":"W4399483854","doi":"10.1136/annrheumdis-2024-eular.864","title":"AB0004 HEALTH INFORMATION USE BY PATIENTS LIVING WITH ANTIPHOSPHOLIPID ANTIBODIES AND ANTIPHOSPHOLIPID SYNDROME","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Calgary","funders":"","keywords":"Antiphospholipid syndrome; Medicine; Antibody; Immunology","score_opus":0.01823598961640036,"score_gpt":0.29245571732949405,"score_spread":0.27421972771309366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048376,0.0067403414,0.000035074743,0.0014566034,0.00015399675,0.0006910577,0.00026604757,0.000084420855,0.00008869776],"genre_scores_gemma":[0.9945275,0.004303117,0.00007174778,0.00073334365,0.000010474907,0.000017415678,0.00006628394,0.000029029032,0.0002410819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801785,0.000074924246,0.0005088399,0.0002224702,0.00076393486,0.00041198864],"domain_scores_gemma":[0.9984636,0.00041258117,0.00018698024,0.00048434825,0.00019017074,0.000262325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027624093,0.00021931872,0.00046805796,0.00014070043,0.00013872472,0.0001826569,0.00017577386,0.000048301266,0.000049434846],"category_scores_gemma":[0.000677841,0.00013213535,0.00012191726,0.00039603424,0.0003034085,0.000879303,0.00018444902,0.00013526321,0.00002711443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009526162,0.0020989364,0.41182747,0.044299018,0.0028309382,0.000059161626,0.010088062,0.00012877841,0.000029873288,0.0013158579,0.3187209,0.2076484],"study_design_scores_gemma":[0.0045148134,0.0012204923,0.9551629,0.025740447,0.0002519769,0.00028273667,0.00062183634,0.0062302463,0.0005646486,0.00015858143,0.0048065805,0.0004447686],"about_ca_topic_score_codex":0.00086947076,"about_ca_topic_score_gemma":0.0000053620493,"teacher_disagreement_score":0.5433354,"about_ca_system_score_codex":0.00038774186,"about_ca_system_score_gemma":0.0018870266,"threshold_uncertainty_score":0.5388323},"labels":[],"label_agreement":null},{"id":"W4399483881","doi":"10.1136/annrheumdis-2024-eular.610","title":"AB1023 CONSENSUS-BASED RECOMMENDATIONS FOR GLUCOCORTICOID TAPERING IN SYSTEMIC LUPUS ERYTHEMATOSUS: RATIONALE AND DESIGN OF A MODIFIED DELPHI CONSENSUS PROJECT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Tapering; Glucocorticoid; Delphi; Delphi method; Medicine; Computer science; Immunology; Artificial intelligence","score_opus":0.13677476918404638,"score_gpt":0.3763129562218786,"score_spread":0.23953818703783222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775828,0.009088019,0.0020005745,0.004419892,0.00025543015,0.0061867363,0.00035131775,0.00006019297,0.000055042623],"genre_scores_gemma":[0.99745,0.00031226894,0.0011666905,0.00007163525,0.000014910259,0.0006287906,0.000026314796,0.000041458905,0.00028791837],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99775493,0.00027835657,0.0009693599,0.0002958935,0.00041523972,0.00028621193],"domain_scores_gemma":[0.9948918,0.003972293,0.00026354069,0.00046624657,0.00031685742,0.00008923704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085529796,0.0001961148,0.0006432772,0.0003748123,0.000057767083,0.00003465642,0.00015632958,0.00006787278,0.000017347124],"category_scores_gemma":[0.0022242174,0.00013812697,0.00020908138,0.00044988104,0.00020757309,0.000040696472,0.000057576006,0.00009502404,0.0000035347966],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016755624,0.005388341,0.12654965,0.5278397,0.007228083,0.00022016972,0.03318642,0.04283034,0.040950682,0.027137155,0.14541113,0.026502676],"study_design_scores_gemma":[0.00955409,0.00077924813,0.0010164198,0.08926154,0.000686475,0.0056435154,0.012300701,0.86896473,0.0064660665,0.0045142253,0.00022609488,0.0005868721],"about_ca_topic_score_codex":0.00006293535,"about_ca_topic_score_gemma":0.000006313285,"teacher_disagreement_score":0.8261344,"about_ca_system_score_codex":0.000055279685,"about_ca_system_score_gemma":0.0010991708,"threshold_uncertainty_score":0.56326544},"labels":[],"label_agreement":null},{"id":"W4399483910","doi":"10.1136/annrheumdis-2024-eular.5050","title":"POS0862 THE EFFICACY OF EOSINOPHIL-TARGETING THERAPIES ACCORDING TO ANCA STATUS IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A POST-HOC ANALYSIS OF THE PHASE 3 MANDARA STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Granulomatosis with polyangiitis; Eosinophilic; Medicine; Post-hoc analysis; Eosinophil; Post hoc; Internal medicine; Pathology; Vasculitis; Disease; Asthma","score_opus":0.014100716319048188,"score_gpt":0.30331604567230663,"score_spread":0.28921532935325844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98853314,0.0059819105,0.000007684385,0.0023364604,0.000085354826,0.00236012,0.0006257366,0.000041741027,0.000027834334],"genre_scores_gemma":[0.9992737,0.00012019452,0.000060686918,0.00033765004,0.000018035164,0.00007941771,0.000033237382,0.000059675684,0.000017372424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648756,0.0003690695,0.0009711068,0.00043628452,0.0012555076,0.00048045747],"domain_scores_gemma":[0.9968026,0.0007911452,0.0005143909,0.0012542069,0.00047471558,0.0001629415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044609798,0.0003852143,0.0010830029,0.00060650863,0.00016357082,0.00006104691,0.0006207466,0.000046047073,0.000050211675],"category_scores_gemma":[0.0005501162,0.00017251313,0.00048907154,0.0035356898,0.00040277996,0.00018795967,0.00022329303,0.00019358355,0.0000016305939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037807648,0.0043124952,0.9552875,0.0007438671,0.0062694624,0.00000920908,0.0113988025,0.0004031096,0.00016258105,0.000081320024,0.000129799,0.017421056],"study_design_scores_gemma":[0.003792441,0.0028356253,0.9798975,0.0037671283,0.0038885763,0.00000217945,0.0046971925,0.00018217797,0.00065737544,0.0000760168,0.000006233496,0.00019754241],"about_ca_topic_score_codex":0.0007960619,"about_ca_topic_score_gemma":0.0001219874,"teacher_disagreement_score":0.02460998,"about_ca_system_score_codex":0.00004530111,"about_ca_system_score_gemma":0.0002613048,"threshold_uncertainty_score":0.7034881},"labels":[],"label_agreement":null},{"id":"W4399483963","doi":"10.1136/annrheumdis-2024-eular.1945","title":"POS1190 POINTS TO CONSIDER FOR THE DIAGNOSIS AND MANAGEMENT OF CHRONIC NONBACTERIAL OSTEITIS (CNO) IN ADULTS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteomyelitis and Bone Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute","funders":"","keywords":"Osteitis; Medicine; Computer science; Artificial intelligence; Surgery; Osteomyelitis","score_opus":0.05540737334703029,"score_gpt":0.3701954339882736,"score_spread":0.3147880606412433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399483963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95573145,0.01594936,0.000009897683,0.0259156,0.00014542638,0.0018336904,0.00025566213,0.000009013434,0.00014988081],"genre_scores_gemma":[0.98990184,0.009304566,0.00003797943,0.00022711628,0.00002667412,0.0003160746,0.000009129206,0.00001425696,0.0001623567],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999055,0.000041966174,0.00029917734,0.00016020042,0.00024935015,0.00019430631],"domain_scores_gemma":[0.9990673,0.0004583876,0.000044083114,0.00028030426,0.00007677759,0.00007316417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020231749,0.00009572644,0.00024921354,0.00007892896,0.00003615737,0.000027403683,0.00012470565,0.000021809396,0.00015861566],"category_scores_gemma":[0.00023591383,0.000053259304,0.00013794516,0.00018662159,0.00011675796,0.000045913832,0.00013410706,0.000042131884,0.0000056832505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012706295,0.0006304079,0.011025271,0.023390021,0.0008849539,0.000028543744,0.0012968939,0.000015770744,0.00006082754,0.003232105,0.028501743,0.9296628],"study_design_scores_gemma":[0.004847269,0.0017529088,0.92589533,0.048614845,0.00055248523,0.000015303418,0.0023246421,0.0017342559,0.002593378,0.004943306,0.006435718,0.00029056185],"about_ca_topic_score_codex":0.00021158581,"about_ca_topic_score_gemma":0.000092307455,"teacher_disagreement_score":0.92937225,"about_ca_system_score_codex":0.000013039014,"about_ca_system_score_gemma":0.00007549653,"threshold_uncertainty_score":0.21718514},"labels":[],"label_agreement":null},{"id":"W4399484116","doi":"10.1136/annrheumdis-2024-eular.3024","title":"OP0008 SAFETY AND EFFICACY OF ISCALIMAB IN PATIENTS WITH SJÖGREN’S DISEASE: 48-WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Dose-ranging study; Placebo; Medicine; Randomized controlled trial; Internal medicine; Double blind; Alternative medicine; Pathology","score_opus":0.021871913244690233,"score_gpt":0.28802634903561597,"score_spread":0.26615443579092574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889336,0.0049238773,0.00005788186,0.0014536513,0.00024300425,0.0026548554,0.001347104,0.00003617797,0.00034981823],"genre_scores_gemma":[0.99890375,0.00042272347,0.00002300781,0.00011102855,0.00003987514,0.000076275566,0.00024788734,0.000023242534,0.00015221411],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981151,0.00015567295,0.0007987602,0.00029196247,0.00042402127,0.00021445187],"domain_scores_gemma":[0.99764335,0.0014251256,0.00022235331,0.0004264776,0.00007890409,0.00020381351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000255082,0.00021374175,0.00079182774,0.00016394294,0.000072656156,0.000031328538,0.000113694136,0.00004010888,0.00009849476],"category_scores_gemma":[0.0016072881,0.000118589145,0.00033684625,0.00026975144,0.00015159075,0.00011922531,0.000049143746,0.000096807846,0.00000385578],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97622514,0.0034299633,0.0057690097,0.00032191427,0.00072770054,0.000008146639,0.0005403633,0.00011756381,0.0000011666436,0.00006541287,0.0019007019,0.010892896],"study_design_scores_gemma":[0.87684387,0.0007458497,0.1138388,0.0031076318,0.0013763533,6.6243337e-7,0.00019121252,0.003162671,0.00000540446,0.0004314118,0.00013112112,0.00016500354],"about_ca_topic_score_codex":0.00018145716,"about_ca_topic_score_gemma":0.000008497913,"teacher_disagreement_score":0.108069785,"about_ca_system_score_codex":0.00001243071,"about_ca_system_score_gemma":0.0001974824,"threshold_uncertainty_score":0.48359248},"labels":[],"label_agreement":null},{"id":"W4399484120","doi":"10.1136/annrheumdis-2024-eular.209","title":"AB0027 PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH INTRAVENOUS EU-APPROVED TOCILIZUMAB AND US-LICENSED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, THREE-ARM, SINGLE-DOSE STUDY IN HEALTHY JAPANESE SUBJECTS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tocilizumab; Biosimilar; Medicine; Pharmacokinetics; Pharmacology; Internal medicine; Rheumatoid arthritis","score_opus":0.06634039404615578,"score_gpt":0.35883441166264973,"score_spread":0.29249401761649396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680022,0.023795698,0.00003187897,0.0021738298,0.00018395517,0.005439066,0.00017620825,0.000046946665,0.00015020437],"genre_scores_gemma":[0.9982437,0.0010773252,0.00013707721,0.0002761255,0.000010164665,0.00015353887,0.000022036933,0.00003674846,0.0000433097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956321,0.0013163205,0.0015512562,0.0006709275,0.00022850113,0.0006008873],"domain_scores_gemma":[0.99716586,0.00155388,0.00045200725,0.00053630985,0.00016480422,0.00012714209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014466083,0.00051112374,0.0019200613,0.00034717037,0.000121140714,0.000063015934,0.00038577593,0.00016535443,0.000102940285],"category_scores_gemma":[0.00044532985,0.000316407,0.0002383057,0.00078125024,0.0012992421,0.00013651903,0.00023558353,0.0004708669,0.0000018427195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89332676,0.015883716,0.0037794295,0.0034526917,0.0023942485,0.0000790324,0.007599605,0.00006453769,0.0027199604,0.00042074325,0.00035375624,0.06992552],"study_design_scores_gemma":[0.9360204,0.012346838,0.01149355,0.0049796654,0.0025257883,0.00017556407,0.006358234,0.006996774,0.01586637,0.0016288646,0.00031309514,0.0012948962],"about_ca_topic_score_codex":0.0011305723,"about_ca_topic_score_gemma":0.0015743225,"teacher_disagreement_score":0.06863062,"about_ca_system_score_codex":0.00005497216,"about_ca_system_score_gemma":0.00027142343,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W4399484237","doi":"10.1136/annrheumdis-2024-eular.3954","title":"AB1092 MONTREAL COGNITIVE ASSESSMENT (MOCA) AND SYMBOL DIGIT MODALITIES TEST(SDMT) AS A SCREENING TOOL FOR EVALUATION OF COGNITIVE IMPAIRMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Modalities; Cognitive impairment; Cognition; Test (biology); Trail Making Test; Medicine; Audiology; Psychiatry","score_opus":0.058656794239062594,"score_gpt":0.3839829182994478,"score_spread":0.3253261240603852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98347455,0.009047156,0.00023847532,0.0004550585,0.00011788889,0.005409634,0.00066411967,0.000045528413,0.0005475731],"genre_scores_gemma":[0.99775904,0.0003978346,0.000032903463,0.000042988464,0.000031116255,0.0013054995,0.00006340029,0.00004647661,0.00032075492],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99640447,0.00036833633,0.0009485795,0.0003971121,0.0014880777,0.0003934513],"domain_scores_gemma":[0.99315786,0.0050460873,0.0003210292,0.00033038843,0.0009962395,0.00014841932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017232054,0.00028350527,0.00082799635,0.00033027653,0.00007345293,0.00007678924,0.00015772751,0.00008008389,0.000042847274],"category_scores_gemma":[0.004363763,0.00019502311,0.00030559298,0.00034521363,0.00024553228,0.00021691826,0.00014342324,0.00012839091,0.000004277363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042490754,0.0031811502,0.7454579,0.081474386,0.0051019657,0.000076085,0.027861688,0.00023519025,0.00026089142,0.0014286343,0.0020362805,0.12863675],"study_design_scores_gemma":[0.027651088,0.0036199256,0.22280732,0.36829337,0.0057345587,0.0072272755,0.14221798,0.19755714,0.004052713,0.01985269,0.0000034009572,0.0009825279],"about_ca_topic_score_codex":0.00020636739,"about_ca_topic_score_gemma":0.000012822716,"teacher_disagreement_score":0.5226506,"about_ca_system_score_codex":0.0001222644,"about_ca_system_score_gemma":0.00081812334,"threshold_uncertainty_score":0.7952812},"labels":[],"label_agreement":null},{"id":"W4399484283","doi":"10.1136/annrheumdis-2024-eular.1435","title":"AB0906 RISK OF ACUTE MYOCARDIAL INFARCTION AND ISCHEMIC STROKE IN ADULTS WITH ANKYLOSING SPONDYLITIS: A POPULATION-BASED STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Research Canada; University of British Columbia","funders":"","keywords":"Ankylosing spondylitis; Medicine; Internal medicine; Stroke (engine); Cardiology; Myocardial infarction; Ischemic stroke; Ischemia; Engineering","score_opus":0.011511243840594682,"score_gpt":0.28096473677510053,"score_spread":0.2694534929345058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939189,0.0041053155,0.000003664014,0.0002451811,0.00006056811,0.00065502734,0.00093517185,0.000019941426,0.00005622953],"genre_scores_gemma":[0.9992549,0.0005150356,0.00004990781,0.00003052642,0.000012725862,0.000045792378,0.000056684115,0.000013570506,0.000020893893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990725,0.0000655911,0.00029059284,0.00017406973,0.00026950147,0.00012773497],"domain_scores_gemma":[0.99942225,0.00013347232,0.0001163332,0.00021355927,0.00006249191,0.00005188503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009763428,0.00012630521,0.00033926862,0.00011496676,0.00005054511,0.000013639528,0.000041100404,0.000021893751,0.000023327995],"category_scores_gemma":[0.000099581324,0.00007873113,0.00011226491,0.00021768957,0.00005640993,0.00007765633,0.000030603398,0.000062741594,7.149814e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012469294,0.0005183812,0.98496085,0.00045943726,0.001376661,0.000020324707,0.00070840196,0.000035171066,0.0000082279075,0.000016048743,0.00009325059,0.01055631],"study_design_scores_gemma":[0.00259645,0.0006448652,0.990382,0.0039910437,0.0009574783,0.000006409632,0.0007479766,0.00043537433,0.00007450725,0.00008178603,0.00001336549,0.00006874668],"about_ca_topic_score_codex":0.0011587061,"about_ca_topic_score_gemma":0.00009784175,"teacher_disagreement_score":0.010487563,"about_ca_system_score_codex":0.000016735818,"about_ca_system_score_gemma":0.000056081968,"threshold_uncertainty_score":0.32105622},"labels":[],"label_agreement":null},{"id":"W4399484329","doi":"10.1136/annrheumdis-2024-eular.623","title":"AB0868 HOW DO EARLY DISEASE ACTIVITY AND EARLY CLINICAL RESPONSE ASSOCIATE WITH LONG-TERM OUTCOMES WITH IXEKIZUMAB IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS?","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Ixekizumab; Medicine; Axial spondyloarthritis; Term (time); Disease; Physical therapy; Internal medicine; Sacroiliitis; Secukinumab","score_opus":0.039318869538262344,"score_gpt":0.3362826963789062,"score_spread":0.2969638268406438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978622,0.013967654,0.000003730115,0.005983765,0.0001532726,0.0009023598,0.00027526275,0.000070674534,0.000021282414],"genre_scores_gemma":[0.99692047,0.0024861412,0.00001912116,0.00010587388,0.000032277483,0.00010185133,0.000007475121,0.000049820068,0.0002769842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976136,0.00039915307,0.00040312283,0.00050656806,0.0006368347,0.00044070475],"domain_scores_gemma":[0.9978607,0.0008605265,0.00020178132,0.00057556573,0.00010805307,0.00039335582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004450268,0.0003616135,0.0009141152,0.00024586354,0.00015422495,0.00016629472,0.00015576644,0.00007411715,0.000021135278],"category_scores_gemma":[0.00051677105,0.00020674604,0.00041359573,0.0005308233,0.0006189135,0.00030593947,0.000110480236,0.00024279303,0.0000049792525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013823698,0.0008879384,0.9460584,0.0003623522,0.0013330564,0.0011353085,0.00029793044,7.5753957e-7,0.0000017882539,0.0000494664,0.00012519566,0.03592411],"study_design_scores_gemma":[0.0051866323,0.0018167148,0.9867364,0.005028851,0.0006652701,0.0000341858,0.00006210581,0.000008551871,0.000011368052,0.0002001818,0.000020220465,0.00022952876],"about_ca_topic_score_codex":0.0001469844,"about_ca_topic_score_gemma":0.00013971972,"teacher_disagreement_score":0.040677994,"about_ca_system_score_codex":0.000029648812,"about_ca_system_score_gemma":0.00023289105,"threshold_uncertainty_score":0.8430859},"labels":[],"label_agreement":null},{"id":"W4399484400","doi":"10.1136/annrheumdis-2024-eular.1413","title":"OP0072 DIRECT AND INDIRECT EFFECTS OF UPADACITINIB OR ADALIMUMAB ON PAIN IN RHEUMATOID ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Adalimumab; Rheumatoid arthritis; Medicine; Placebo; Methotrexate; Internal medicine; Randomized controlled trial; Joint pain; Pathology","score_opus":0.027832118337093464,"score_gpt":0.33148910556369104,"score_spread":0.30365698722659756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92311823,0.07241777,0.000007909594,0.0008189823,0.0001760151,0.0027004462,0.00046054195,0.00007438554,0.0002257235],"genre_scores_gemma":[0.9309155,0.06849953,0.000036007317,0.00011645055,0.00002091992,0.0002618603,0.000037521775,0.000038863287,0.0000733606],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954844,0.0017507717,0.0011532889,0.00044963034,0.0007903375,0.00037156267],"domain_scores_gemma":[0.98881537,0.009981208,0.00025426553,0.0006218961,0.00009900711,0.00022825752],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0022806767,0.00031753926,0.0017024311,0.00036791633,0.00007650911,0.000075798576,0.00023186981,0.00006211727,0.00008692576],"category_scores_gemma":[0.014416063,0.00018368465,0.00037108044,0.0004971975,0.0004316521,0.00015035934,0.000107616754,0.00020138237,0.0000069646994],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21447353,0.007067467,0.0011487557,0.0019786872,0.0031607628,0.00045455017,0.009403974,0.000011583261,0.00017791873,0.00026477565,0.0051420345,0.75671595],"study_design_scores_gemma":[0.779006,0.0133195,0.020203773,0.1512051,0.00021466827,0.000046165922,0.004746659,0.0044046333,0.01604843,0.00884623,0.0010499224,0.0009089162],"about_ca_topic_score_codex":0.0007250783,"about_ca_topic_score_gemma":0.00010935333,"teacher_disagreement_score":0.75580704,"about_ca_system_score_codex":0.000015939957,"about_ca_system_score_gemma":0.0002574247,"threshold_uncertainty_score":0.99388593},"labels":[],"label_agreement":null},{"id":"W4399484413","doi":"10.1136/annrheumdis-2024-eular.4382","title":"POS0732 SHORT AND LONG-TERM OUTCOMES OF PATIENTS WITH PURE MEMBRANOUS LUPUS NEPHRITIS COMPARED TO PATIENTS WITH PROLIFERATIVE DISEASE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Lupus nephritis; Disease; Medicine; Term (time); Internal medicine; Immunology","score_opus":0.02838573443532601,"score_gpt":0.31054697920027297,"score_spread":0.282161244764947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993204,0.0020143029,0.000016808282,0.00086254877,0.0001132781,0.002954963,0.0007462447,0.000046750614,0.000041088722],"genre_scores_gemma":[0.9991419,0.000090272515,0.000033090062,0.00019997184,0.000011995799,0.00014756042,0.00010796645,0.000052307216,0.00021496126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973798,0.00012203575,0.00051550363,0.00036828886,0.001272762,0.00034165097],"domain_scores_gemma":[0.9978128,0.00028915584,0.00012461151,0.00064933865,0.0006124578,0.0005116562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010967146,0.00029906418,0.0007837594,0.00019209026,0.00007833455,0.000059071597,0.00025323845,0.000036823894,0.0000628329],"category_scores_gemma":[0.0004124205,0.00015295992,0.00015091279,0.0003805049,0.00026916544,0.00018049189,0.00016183607,0.00010350736,0.000005869391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018478895,0.0009458558,0.98610914,0.005899049,0.00091964897,0.0000199761,0.0010216878,0.000013170732,0.0000017023841,0.0000413435,0.00086976256,0.0023107892],"study_design_scores_gemma":[0.0018432973,0.00049374823,0.9873149,0.009458865,0.0003979033,0.000020517466,0.000110354704,0.000069408845,0.00004839321,0.000054799744,0.000009869381,0.00017795894],"about_ca_topic_score_codex":0.00001951998,"about_ca_topic_score_gemma":0.000018073262,"teacher_disagreement_score":0.0059378594,"about_ca_system_score_codex":0.000032295724,"about_ca_system_score_gemma":0.0002652467,"threshold_uncertainty_score":0.6237525},"labels":[],"label_agreement":null},{"id":"W4399484434","doi":"10.1136/annrheumdis-2024-eular.774","title":"OP0247 EFFICACY OF A NOVEL LONG-ACTING FLUTICASONE PROPIONATE INTRA ARTICULAR INJECTION (EP-104IAR) IN KNEE OSTEOARTHRITIS: PER-PROTOCOL ANALYSIS OF A RANDOMISED, DOUBLE-BLIND, PHASE 2 TRIAL OF EP-104IAR VS VEHICLE PLACEBO (SPRINGBOARD)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Osteoarthritis; Medicine; Double blind; Intra articular; Fluticasone propionate; Viscosupplementation; Internal medicine; Corticosteroid; Alternative medicine; Pathology","score_opus":0.045829832561291646,"score_gpt":0.37035765041675045,"score_spread":0.3245278178554588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680728,0.00042658646,0.001038335,0.00022791419,0.00019015596,0.029870937,0.000052524694,0.000039783492,0.00008100595],"genre_scores_gemma":[0.9926062,0.000029879966,0.00017689937,0.000023435929,0.000051807696,0.007012437,0.000023207695,0.000034837987,0.00004129161],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968366,0.00027266477,0.0014723642,0.00036216553,0.0007228195,0.0003334061],"domain_scores_gemma":[0.9975602,0.00070678286,0.0005906951,0.00065058854,0.0003490185,0.00014273972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001161335,0.00028009622,0.0012785528,0.00081588124,0.00007298525,0.000036359026,0.00018648329,0.00012869407,0.00013262013],"category_scores_gemma":[0.0013975311,0.00020470843,0.0011671856,0.0017824195,0.00027161976,0.00017179163,0.0000914757,0.00024683902,0.0000028730476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8733057,0.012660945,0.0008557681,0.010381947,0.007962843,0.000038241735,0.002436829,0.013576729,0.015951686,0.00046027236,0.00010693052,0.062262136],"study_design_scores_gemma":[0.79464173,0.0060326853,0.004003759,0.01250195,0.008996181,0.00003566697,0.0008277379,0.10439962,0.06792398,0.00010011878,0.000065932145,0.00047060824],"about_ca_topic_score_codex":0.00030955515,"about_ca_topic_score_gemma":0.000032125023,"teacher_disagreement_score":0.0908229,"about_ca_system_score_codex":0.000045843015,"about_ca_system_score_gemma":0.0003127777,"threshold_uncertainty_score":0.83477676},"labels":[],"label_agreement":null},{"id":"W4399484435","doi":"10.1136/annrheumdis-2024-eular.6058","title":"AB0634 PREDICTORS OF CDAI TRAJECTORIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT: A REAL-WORLD STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Centre hospitalier de l'Université Laval; Montreal Clinical Research Institute; McGill University; Western University; GDI Integrated Facility Services (Canada)","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Medicine; Physical therapy; Real world data; Internal medicine; Computer science; Data science","score_opus":0.02710803090291798,"score_gpt":0.31337772496964067,"score_spread":0.2862696940667227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332696,0.0034309675,0.0000012006711,0.00017879068,0.0001506263,0.0019641581,0.00019796824,0.00008240923,0.0006669284],"genre_scores_gemma":[0.99705195,0.002123623,0.000009371382,0.000011324435,0.00001734272,0.00016732114,0.000029219524,0.000052932948,0.00053691986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969552,0.00026788327,0.0009242133,0.00034214157,0.0011508958,0.00035963283],"domain_scores_gemma":[0.9980517,0.00049282686,0.00022320522,0.0007631467,0.00029266314,0.00017645066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000389806,0.0002646603,0.0008692564,0.0004662534,0.00004776914,0.00003394152,0.000302618,0.00004442247,0.000119189644],"category_scores_gemma":[0.000538367,0.00015429956,0.00021191024,0.0013076453,0.00026614135,0.00016754192,0.000103164086,0.00015249841,0.0000106429325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050762645,0.0018272478,0.98379064,0.0025763314,0.0006772868,0.000030698844,0.0047905007,0.000010138619,0.00000841712,0.00008410396,0.002604083,0.0030929511],"study_design_scores_gemma":[0.0031917251,0.0011907849,0.96545756,0.025317533,0.000120867146,0.000050624614,0.0036128152,0.0001463318,0.0005405435,0.00014251197,0.000047185098,0.00018153117],"about_ca_topic_score_codex":0.001568514,"about_ca_topic_score_gemma":0.00064413855,"teacher_disagreement_score":0.0227412,"about_ca_system_score_codex":0.00005979783,"about_ca_system_score_gemma":0.00035363773,"threshold_uncertainty_score":0.62921536},"labels":[],"label_agreement":null},{"id":"W4399484498","doi":"10.1136/annrheumdis-2024-eular.2484","title":"AB0945 THE IMPACT OF AXIAL SPONDYLOARTHRITIS ON PATIENTS’ SEXUAL LIFE. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Axial spondyloarthritis; Medicine; Ankylosing spondylitis; Internal medicine","score_opus":0.033113327230261974,"score_gpt":0.31028796284453075,"score_spread":0.2771746356142688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696785,0.008746416,0.0000014099588,0.005913771,0.0011064871,0.0007502347,0.013153689,0.000033121014,0.0006163353],"genre_scores_gemma":[0.9974355,0.0012782981,0.000014858819,0.00024764184,0.00026703256,0.000043032735,0.00042668235,0.000037916085,0.00024904168],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99710023,0.00017882975,0.00096802955,0.00037203127,0.001051101,0.00032975985],"domain_scores_gemma":[0.9967542,0.0014548686,0.00044601352,0.00086851965,0.00032836315,0.00014800015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030187183,0.00033387652,0.0006541789,0.00010239921,0.00016734654,0.000055000964,0.0005737749,0.00007525105,0.0005745793],"category_scores_gemma":[0.0016904847,0.00016406739,0.00077839865,0.00027194133,0.00054138,0.00012715433,0.00026433961,0.00020083312,0.000052745625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023172589,0.008700144,0.14587002,0.0008570219,0.015078244,0.00019743075,0.010471904,0.00043689058,0.00034029796,0.0031166233,0.3995837,0.39217517],"study_design_scores_gemma":[0.009479801,0.0030617584,0.97231734,0.006035093,0.0006449569,0.000017354154,0.0012999249,0.00036662683,0.000879544,0.0026314172,0.0029479417,0.00031824445],"about_ca_topic_score_codex":0.0020460577,"about_ca_topic_score_gemma":0.000090060516,"teacher_disagreement_score":0.8264473,"about_ca_system_score_codex":0.00004293423,"about_ca_system_score_gemma":0.0002709129,"threshold_uncertainty_score":0.6690474},"labels":[],"label_agreement":null},{"id":"W4399484504","doi":"10.1136/annrheumdis-2024-eular.5012","title":"POS0858 HOW SYMPTOMS AND TREATMENTS IMPACT THE EXPERIENCES OF PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS PARTICIPATING IN A CLINICAL TRIAL","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Granulomatosis with polyangiitis; Eosinophilic; Medicine; Clinical trial; Dermatology; Internal medicine; Pathology; Vasculitis; Disease","score_opus":0.04162971948844116,"score_gpt":0.36153417054145043,"score_spread":0.31990445105300924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940428,0.00336872,0.0000016094854,0.001253138,0.00009218613,0.0011065443,0.000085534084,0.000024168503,0.000025304027],"genre_scores_gemma":[0.9993028,0.00017775536,0.000022905568,0.00009433851,0.000026010188,0.00031704875,0.000010559081,0.000025191206,0.00002335992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998122,0.00022128997,0.0005706012,0.00026811,0.0005430315,0.00027497494],"domain_scores_gemma":[0.99830323,0.0007091433,0.00027625516,0.0004676117,0.00009172276,0.00015201666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025344008,0.00021936906,0.0005975691,0.00009948511,0.00006639285,0.000050454815,0.00017467454,0.000045532695,0.00004042738],"category_scores_gemma":[0.00048181304,0.000091851114,0.00022405887,0.0004277593,0.00063139835,0.00017347638,0.000065023916,0.00010083627,8.215994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069524944,0.0014062222,0.9469059,0.0004967611,0.0010284246,0.000013871014,0.0091321515,0.00000520087,0.00000202405,0.000057902773,0.00020695629,0.033792075],"study_design_scores_gemma":[0.01047163,0.0039853314,0.9794916,0.0034232158,0.0005690218,0.000009749593,0.0013724375,0.00023408132,0.00016465911,0.00016109014,0.0000021469812,0.00011505534],"about_ca_topic_score_codex":0.00014329804,"about_ca_topic_score_gemma":0.000013828461,"teacher_disagreement_score":0.03367702,"about_ca_system_score_codex":0.000016554615,"about_ca_system_score_gemma":0.00017224942,"threshold_uncertainty_score":0.37455797},"labels":[],"label_agreement":null},{"id":"W4399484506","doi":"10.1136/annrheumdis-2024-eular.5207","title":"POS1139 LUPUS DAMAGE INDEX REVISION – ITEM GENERATION AND REDUCTION PHASE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital; University of Calgary","funders":"","keywords":"Reduction (mathematics); Index (typography); Systemic lupus erythematosus; Phase (matter); Computer science; Statistics; Artificial intelligence; Mathematics; Chemistry; Medicine; Internal medicine; Geometry","score_opus":0.06929528047394991,"score_gpt":0.38537730605605114,"score_spread":0.31608202558210124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796263,0.015235964,0.00008915541,0.003607749,0.0004998313,0.00061787176,0.000028974557,0.000059356575,0.00023479323],"genre_scores_gemma":[0.9953625,0.0023923486,0.00003764833,0.000066024906,0.00014095276,0.000018368952,0.000027482223,0.000023588473,0.001931071],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985907,0.00014054246,0.0003720831,0.00022633436,0.00050265924,0.00016769719],"domain_scores_gemma":[0.9990277,0.00014744846,0.00009037254,0.0004493335,0.00014482827,0.00014028492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039047023,0.00012489985,0.00027293438,0.00015833353,0.00008114904,0.000072691866,0.00010634582,0.00004910874,0.00010136904],"category_scores_gemma":[0.00071430096,0.00007657691,0.00013647384,0.00029971334,0.000113649054,0.0001774626,0.00008211699,0.000095082694,0.000020341404],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009123716,0.0014749148,0.03840196,0.03179815,0.0011812508,0.00008308819,0.005694432,0.000049710692,0.022650978,0.0037378252,0.3277182,0.5662971],"study_design_scores_gemma":[0.018889243,0.0037574645,0.045260474,0.16019732,0.0032137579,0.029918589,0.011680755,0.61803705,0.06528171,0.01707744,0.024478614,0.0022075688],"about_ca_topic_score_codex":0.000024155042,"about_ca_topic_score_gemma":7.8609196e-7,"teacher_disagreement_score":0.61798733,"about_ca_system_score_codex":0.000025792388,"about_ca_system_score_gemma":0.00012902085,"threshold_uncertainty_score":0.31227157},"labels":[],"label_agreement":null},{"id":"W4399484604","doi":"10.1136/annrheumdis-2024-eular.2614","title":"AB0913 EFFICACY OF CERTOLIZUMAB PEGOL IN PREVENTING ANTERIOR UVEITIS FLARES COMPARED WITH STANDARD NON-BIOLOGIC TREATMENT: A MATCHED CONTROL STUDY IN HIGH-RISK PATIENTS WITH AXIAL SPONDYLOARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"","keywords":"Certolizumab pegol; Medicine; Axial spondyloarthritis; Internal medicine; Adalimumab; Ankylosing spondylitis; Tumor necrosis factor alpha","score_opus":0.01276287471185532,"score_gpt":0.2736862577303694,"score_spread":0.2609233830185141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934204,0.0021668887,0.000009301292,0.0001785747,0.00006183005,0.002743039,0.0013744548,0.000033296525,0.000012168565],"genre_scores_gemma":[0.9994929,0.00021100542,0.00003551779,0.000010835288,0.000012477652,0.00012553074,0.000054603217,0.000033818393,0.000023341334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978444,0.0002459844,0.00070597825,0.00036829174,0.00049718464,0.00033815505],"domain_scores_gemma":[0.9987325,0.0002416204,0.00030950154,0.00046358118,0.00012256186,0.00013024808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009834408,0.0003065173,0.0011270181,0.00021819133,0.000052053434,0.000040533483,0.00018135324,0.000042863434,0.0001206084],"category_scores_gemma":[0.0001538916,0.00016797465,0.00025090342,0.00041705667,0.00015734902,0.000119664546,0.000053774143,0.000099741825,0.0000027598908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069357576,0.0046924017,0.9643248,0.0008100799,0.0008241145,0.00039821983,0.0015717183,0.000108815155,0.000009938667,0.0000030596361,0.000014569084,0.020306528],"study_design_scores_gemma":[0.021068227,0.0055817463,0.96241075,0.008579779,0.00075559336,0.00002142234,0.00094387727,0.0003303583,0.000055539982,0.00006670435,0.0000028682912,0.00018316356],"about_ca_topic_score_codex":0.0011573889,"about_ca_topic_score_gemma":0.0003912562,"teacher_disagreement_score":0.020123364,"about_ca_system_score_codex":0.00006893815,"about_ca_system_score_gemma":0.00021952468,"threshold_uncertainty_score":0.68498075},"labels":[],"label_agreement":null},{"id":"W4399484611","doi":"10.1136/annrheumdis-2024-eular.5946","title":"OP0064 CHARACTERIZING PREVALENT NON-ARTICULAR PAIN AT EARLY RA DIAGNOSIS AND EVOLUTION OVER THE FIRST YEAR OF RA TREATMENT: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval; University of Toronto; University of Manitoba; Arthritis Research Centre of Canada; McGill University; University of Calgary; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Cohort; Arthritis; Physical therapy; Internal medicine","score_opus":0.021844223114138056,"score_gpt":0.27295414136893786,"score_spread":0.2511099182547998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632817,0.028420327,0.0000017174725,0.005347797,0.0001168436,0.0019236725,0.00085552124,0.000019852505,0.000032600932],"genre_scores_gemma":[0.9694546,0.02993023,0.000003890706,0.0001277662,0.000051732542,0.00029524765,0.000032154338,0.000024531879,0.00007988749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797124,0.00036339092,0.00047156785,0.0002864135,0.00058351853,0.00032384615],"domain_scores_gemma":[0.9978364,0.0010141706,0.00013304262,0.0006975574,0.00010110686,0.00021770992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008212812,0.0001941626,0.00038794574,0.00007552063,0.0003932386,0.00014212882,0.00022009348,0.00004105339,0.000118468684],"category_scores_gemma":[0.000695944,0.00009796329,0.0002348813,0.00020513077,0.000317313,0.00014501385,0.00008185352,0.00010288608,0.000019417741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002883596,0.0004378711,0.96643955,0.000108657405,0.0012649928,0.00002308938,0.0073816082,0.0000035552296,0.000018610475,0.000065140295,0.0045438004,0.019424766],"study_design_scores_gemma":[0.0012984775,0.0007128924,0.9917042,0.0031955375,0.00010529874,0.0000025912111,0.0004988883,0.000261984,0.00017275591,0.00027032322,0.0016804894,0.00009655988],"about_ca_topic_score_codex":0.11207384,"about_ca_topic_score_gemma":0.047023024,"teacher_disagreement_score":0.06505082,"about_ca_system_score_codex":0.00008975509,"about_ca_system_score_gemma":0.00018940141,"threshold_uncertainty_score":0.9703663},"labels":[],"label_agreement":null},{"id":"W4399484638","doi":"10.1136/annrheumdis-2024-eular.5519","title":"AB0961 THE FREQUENCY OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS (DISH) IN SPONDYLOARTHRITIS IN COMPARISON TO AGE AND SEX-MATCHED CONTROLS AND IMPACT OF SPA ON ONSET AGE OF DISH","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Diffuse Idiopathic Skeletal Hyperostosis; Hyperostosis; Medicine; Pathology; Anatomy; Ossification","score_opus":0.029844399099414044,"score_gpt":0.3227723524584795,"score_spread":0.29292795335906546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96975386,0.02791331,7.89321e-7,0.0006237783,0.000042042706,0.00079158583,0.0008030396,0.000007825148,0.000063772524],"genre_scores_gemma":[0.9974608,0.0023637388,0.000011698525,0.000058761783,0.000006670667,0.00004733338,0.00001756342,0.000017963644,0.000015495309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984097,0.00015016497,0.00069786893,0.00021155404,0.00030974072,0.00022100513],"domain_scores_gemma":[0.99882954,0.00046893663,0.0001859452,0.00036918194,0.000043463926,0.00010292832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025465415,0.0002080907,0.0010432283,0.00016394356,0.000034029465,0.000016132748,0.00012293782,0.00004610882,0.000017945798],"category_scores_gemma":[0.000520394,0.00012091977,0.0002430743,0.00030803803,0.0003551761,0.00006058967,0.00009473471,0.00010827593,0.0000010109334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077808934,0.002593446,0.9545356,0.002006684,0.0008215881,0.00020286338,0.0063429954,0.00003480323,0.0022571906,0.0002940129,0.00024303948,0.029889679],"study_design_scores_gemma":[0.0028801016,0.0012312629,0.98460734,0.0083285235,0.00018982319,0.000012616761,0.00092206936,0.00008430331,0.0006194194,0.0010197349,0.000004378552,0.00010044104],"about_ca_topic_score_codex":0.0018799702,"about_ca_topic_score_gemma":0.0005798481,"teacher_disagreement_score":0.030071715,"about_ca_system_score_codex":0.000020692869,"about_ca_system_score_gemma":0.000061428895,"threshold_uncertainty_score":0.49309653},"labels":[],"label_agreement":null},{"id":"W4399484652","doi":"10.1136/annrheumdis-2024-eular.3293","title":"AB1176 SCOPING REVIEW TO GUIDE THE DEVELOPMENT OF AN ARTICULAR SCORE IN SYSTEMIC SCLEROSIS (ASSESS SCORE)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Computer science; Medicine; Physical therapy; Physical medicine and rehabilitation","score_opus":0.1473114295016652,"score_gpt":0.37293536023705637,"score_spread":0.22562393073539116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74615186,0.25042272,0.00004119063,0.001283737,0.0001935176,0.001756989,0.000019734238,0.00003824939,0.0000919988],"genre_scores_gemma":[0.9801389,0.018642588,0.00011447328,0.0007612398,0.000027219343,0.00021788877,0.000010643049,0.000030749798,0.000056320467],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99705,0.00024986232,0.001421248,0.0003085892,0.0006863806,0.00028393386],"domain_scores_gemma":[0.99818003,0.0002790082,0.00026457405,0.0008475424,0.00020090924,0.00022792265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001001199,0.000221607,0.00073113345,0.00014564754,0.000085846266,0.000040847284,0.00042367887,0.000052339292,0.00007414645],"category_scores_gemma":[0.00094920746,0.00011315863,0.0003262793,0.00077470887,0.00010263804,0.0001177145,0.00014037584,0.000094649564,0.000028037231],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039683687,0.0029261687,0.03641387,0.5371744,0.0030727184,0.000058120262,0.009192159,0.0017266159,0.015247144,0.0010625168,0.027946193,0.36478326],"study_design_scores_gemma":[0.00026670628,0.00005657441,0.06896393,0.9234292,0.00044272322,0.000019539344,0.0006389396,0.00026749252,0.0056910315,0.00005037464,0.000021933842,0.00015154896],"about_ca_topic_score_codex":0.000062370644,"about_ca_topic_score_gemma":0.000018320856,"teacher_disagreement_score":0.38625482,"about_ca_system_score_codex":0.000052359544,"about_ca_system_score_gemma":0.0008357134,"threshold_uncertainty_score":0.4614475},"labels":[],"label_agreement":null},{"id":"W4399484688","doi":"10.1136/annrheumdis-2024-eular.4778","title":"AB0547 PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS HAVE HIGHER LEVELS OF INFLAMMATION ON ULTRASOUND","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Rheumatology; Synovitis; Cohort; Physical therapy","score_opus":0.022844197082812472,"score_gpt":0.2854404873249499,"score_spread":0.26259629024213743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041057,0.005485336,0.000016105985,0.0017351663,0.00015741786,0.00083049916,0.00047123575,0.00006820614,0.0008254934],"genre_scores_gemma":[0.99271256,0.0065687564,0.000045556964,0.00010321741,0.000030245244,0.000058813406,0.000050781677,0.000043217566,0.0003868341],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776757,0.0001092685,0.0005442755,0.0002742309,0.0009719896,0.0003326909],"domain_scores_gemma":[0.99814975,0.00046737827,0.0001533319,0.00056538946,0.0004096959,0.00025443014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015018455,0.00025003369,0.0005131909,0.00021293607,0.00009644352,0.000072152085,0.00022184527,0.00005043152,0.0004951242],"category_scores_gemma":[0.00060230284,0.00014499646,0.00021438084,0.0003855449,0.00024699233,0.00019986724,0.00005775791,0.00012352782,0.0000713681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045254417,0.003577027,0.1442344,0.0047415784,0.002639214,0.000048705366,0.0049215215,0.00044256303,0.0035840143,0.013572909,0.049042646,0.76866996],"study_design_scores_gemma":[0.0026406327,0.0016458675,0.9498323,0.022255948,0.000028654655,0.000013763101,0.00023480644,0.0000595345,0.018958371,0.0018692868,0.0021461584,0.00031464468],"about_ca_topic_score_codex":0.000056748486,"about_ca_topic_score_gemma":0.000013346187,"teacher_disagreement_score":0.8055979,"about_ca_system_score_codex":0.000023129376,"about_ca_system_score_gemma":0.00014102066,"threshold_uncertainty_score":0.59127843},"labels":[],"label_agreement":null},{"id":"W4399711259","doi":"10.1136/ard-2024-225566","title":"EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"European League Against Rheumatism; Biogen; Celltrion; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Rheumatology; Family medicine; Internal medicine; Physical therapy","score_opus":0.6833277995135901,"score_gpt":0.6021157421575405,"score_spread":0.08121205735604964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399711259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8889959,0.018779548,0.000055844153,0.07853339,0.0025521195,0.008980763,0.0011710472,0.00003919211,0.0008922031],"genre_scores_gemma":[0.98974013,0.006356123,0.000074548436,0.0007529484,0.000020762476,0.0023868561,0.00016826285,0.00002483149,0.00047554326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936831,0.0029249848,0.0013554108,0.00028364093,0.0008924948,0.00086034095],"domain_scores_gemma":[0.989177,0.009110519,0.0002595076,0.00071967265,0.00056033896,0.00017296323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006918703,0.0001359045,0.00033673443,0.00037526802,0.0009153323,0.00001426546,0.0006014261,0.000080302394,0.0005442401],"category_scores_gemma":[0.0011426837,0.00007832675,0.0001668095,0.0009942657,0.00038461573,0.00009810126,0.0004664969,0.000548988,0.00011485155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047905341,0.0010872475,0.02103961,0.024904808,0.00027809895,0.0000014577697,0.017937452,0.00012682672,0.000009304294,0.101749375,0.78894377,0.043442994],"study_design_scores_gemma":[0.0027231711,0.0020418726,0.013934791,0.06908843,0.0001339726,0.0000011056464,0.13869978,0.011473454,0.0009840224,0.3136801,0.44669425,0.0005450275],"about_ca_topic_score_codex":0.0020628101,"about_ca_topic_score_gemma":0.00048691098,"teacher_disagreement_score":0.34224954,"about_ca_system_score_codex":0.00011541556,"about_ca_system_score_gemma":0.0008271195,"threshold_uncertainty_score":0.7040089},"labels":[],"label_agreement":null},{"id":"W4400036361","doi":"10.1136/ard-2024-225942","title":"Cardiac valve immune profiling in non-radiographic axial spondyloarthritis","year":2024,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Axial spondyloarthritis; Radiography; Profiling (computer programming); Radiology; Ankylosing spondylitis; Pathology; Internal medicine; Sacroiliitis","score_opus":0.023080387441195477,"score_gpt":0.2870009262667242,"score_spread":0.2639205388255287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400036361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43483284,0.24507865,6.9490017e-7,0.3080194,0.0037224425,0.00338371,0.002755349,0.00012965743,0.0020772337],"genre_scores_gemma":[0.8641836,0.038971443,0.00011127091,0.089248456,0.0019701237,0.0009661327,0.0014785436,0.00033108913,0.0027393394],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99710304,0.00013924477,0.0008646773,0.00051550224,0.00076273317,0.00061481947],"domain_scores_gemma":[0.998276,0.00023346106,0.00030455293,0.0009477599,0.00013782087,0.000100429424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019386201,0.0005264667,0.0015530908,0.00044957025,0.00010622439,0.000048264268,0.0003158272,0.00031180953,0.000095962314],"category_scores_gemma":[0.00023468751,0.00036855962,0.0023068008,0.00069461565,0.00030195454,0.00007054914,0.00023652763,0.0008132556,0.0000738674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022158596,0.0005337367,0.021399274,0.0071927574,0.0056108753,0.0014558567,0.00042742264,0.0000041174503,0.000016381413,0.00006450894,0.941523,0.021550443],"study_design_scores_gemma":[0.011310541,0.0021713811,0.6138697,0.13051228,0.011658344,0.00031733068,0.0010227968,0.00011405239,0.0011410434,0.0116302995,0.21334282,0.0029094028],"about_ca_topic_score_codex":0.0003726002,"about_ca_topic_score_gemma":0.000009945965,"teacher_disagreement_score":0.7281802,"about_ca_system_score_codex":0.000042516764,"about_ca_system_score_gemma":0.00018417348,"threshold_uncertainty_score":0.9998766},"labels":[],"label_agreement":null},{"id":"W4400410533","doi":"10.1136/ard-2024-225933","title":"Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"UCB Pharma","keywords":"Medicine; Uveitis; Placebo; Internal medicine; Incidence (geometry); Axial spondyloarthritis; Clinical trial; Gastroenterology; Ankylosing spondylitis; Immunology; Pathology; Alternative medicine","score_opus":0.02845233097141929,"score_gpt":0.31170073602644716,"score_spread":0.28324840505502785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400410533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749125,0.0036648018,0.0000056094545,0.0010365787,0.0001223396,0.0012315297,0.0062467563,0.00008724711,0.00011386948],"genre_scores_gemma":[0.99794143,0.00032911816,0.000045566114,0.00015470736,0.00006278199,0.000054896278,0.0011459774,0.00005466865,0.00021085565],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972031,0.00030693976,0.0009363112,0.00047169835,0.00071936485,0.00036254493],"domain_scores_gemma":[0.9979639,0.00057142065,0.00031125898,0.0006784785,0.00018660577,0.00028832656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030821442,0.00034531872,0.0010696169,0.00021791646,0.00006771779,0.00010021546,0.00020803984,0.000072662566,0.0005371531],"category_scores_gemma":[0.00096009433,0.00018510269,0.00038330583,0.000628318,0.00020444562,0.00022728335,0.000054154763,0.0001297488,0.000030608742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11121213,0.02393106,0.20669787,0.0034240566,0.008768833,0.002088738,0.0013990472,0.00021568289,0.00023981548,0.00015788541,0.016368082,0.6254968],"study_design_scores_gemma":[0.053518083,0.004456761,0.903861,0.028845482,0.0029696883,0.000020829246,0.00024270857,0.0007443789,0.0034608154,0.0007403977,0.00046025432,0.000679614],"about_ca_topic_score_codex":0.00057889306,"about_ca_topic_score_gemma":0.000040763072,"teacher_disagreement_score":0.6971631,"about_ca_system_score_codex":0.000030016394,"about_ca_system_score_gemma":0.00030640574,"threshold_uncertainty_score":0.75482684},"labels":[],"label_agreement":null},{"id":"W4400727636","doi":"10.1136/ard-2024-225746","title":"Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"ZonMw; Arthritis Society; Dutch Arthritis Society","keywords":"Medicine; Rheumatoid arthritis; Identification (biology); Intensive care medicine; Arthritis; Physical therapy; Internal medicine; Immunology","score_opus":0.028730135934908873,"score_gpt":0.3198540014769724,"score_spread":0.29112386554206354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400727636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94717836,0.046713717,0.000011869637,0.0042111096,0.00036928023,0.0008224183,0.00023900114,0.00009098084,0.00036326717],"genre_scores_gemma":[0.8550351,0.14415236,0.000012335231,0.00004566551,0.00001603051,0.00008989064,0.000032905293,0.000031064163,0.0005846321],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977845,0.0001465424,0.00089254224,0.00027468795,0.00058655615,0.00031517938],"domain_scores_gemma":[0.9983596,0.00033302532,0.00025795033,0.0006299128,0.00022650615,0.0001929908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029729045,0.00021469063,0.000524941,0.000212127,0.00011243366,0.00009844648,0.00025132703,0.00006981605,0.00036804876],"category_scores_gemma":[0.00066696265,0.00012474287,0.00042860635,0.0004403484,0.0003977086,0.0002994459,0.00006442263,0.00011617554,0.00009238228],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005544454,0.0025243694,0.017810699,0.0016365539,0.0035799982,0.0000485117,0.008271571,0.000021669948,0.007870692,0.010584199,0.012419354,0.93467796],"study_design_scores_gemma":[0.011031011,0.003334518,0.62903225,0.08414561,0.00024762776,0.00033996784,0.007109844,0.0030126288,0.1705503,0.062345333,0.027377881,0.0014729976],"about_ca_topic_score_codex":0.00025527648,"about_ca_topic_score_gemma":0.00002019165,"teacher_disagreement_score":0.93320495,"about_ca_system_score_codex":0.000028225699,"about_ca_system_score_gemma":0.00027535664,"threshold_uncertainty_score":0.50868666},"labels":[],"label_agreement":null},{"id":"W4401169646","doi":"10.1136/annrheumdis-2024-eular.1426","title":"POS0978 DIRECT AND INDIRECT EFFECTS OF UPADACITINIB OR ADALIMUMAB ON PAIN IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 3 STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Adalimumab; Psoriatic arthritis; Medicine; Randomized controlled trial; Arthritis; Internal medicine; Rheumatoid arthritis","score_opus":0.026840289427396122,"score_gpt":0.32673475623735426,"score_spread":0.2998944668099581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401169646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96090376,0.035227872,0.0000014323085,0.00046956787,0.00020818034,0.002415016,0.0005352237,0.000040991523,0.00019792306],"genre_scores_gemma":[0.99445665,0.004990008,0.000030472014,0.00010345943,0.000025023994,0.00024524788,0.00003200223,0.00002368019,0.00009346522],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99756056,0.00070716295,0.0007747263,0.0003305883,0.0004130519,0.00021391157],"domain_scores_gemma":[0.9936188,0.0056225127,0.0002092828,0.0003969507,0.0000509525,0.000101497164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078126247,0.00024405553,0.0013907097,0.00016494413,0.000054251028,0.00002524937,0.00009394614,0.00003806817,0.000032228094],"category_scores_gemma":[0.007197537,0.00013538507,0.00027868958,0.00032453067,0.00015496674,0.00005847512,0.00006567073,0.000081857885,0.0000035618286],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19782051,0.009526269,0.0013228583,0.0019416844,0.0052723708,0.0007552395,0.0073912293,0.000005735607,0.000023131744,0.000068752815,0.0019547443,0.7739175],"study_design_scores_gemma":[0.8562563,0.012803425,0.04667255,0.07048264,0.0030366934,0.000014579393,0.0026261131,0.0010162608,0.0028335594,0.0036453207,0.0001300029,0.0004825708],"about_ca_topic_score_codex":0.00062300457,"about_ca_topic_score_gemma":0.00011144675,"teacher_disagreement_score":0.7734349,"about_ca_system_score_codex":0.000015784768,"about_ca_system_score_gemma":0.000089377136,"threshold_uncertainty_score":0.86166435},"labels":[],"label_agreement":null},{"id":"W4401170271","doi":"10.1136/annrheumdis-2024-eular.1460","title":"OP0272 SINGLE-CELL ANALYSIS OF PERIPHERAL BLOOD MONONUCLEAR CELLS IDENTIFIES IMMUNE SIGNATURES AT DIFFERENT STAGES OF ACTIVE RHEUMATOID ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Rheumatoid arthritis; Peripheral blood mononuclear cell; Immune system; Peripheral blood; Immunology; Cell; Peripheral; Medicine; Biology; Internal medicine","score_opus":0.024434435278572576,"score_gpt":0.2882770274196235,"score_spread":0.26384259214105094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401170271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94704545,0.051062707,0.000010496516,0.00023819921,0.00017893684,0.0005946236,0.0005466962,0.000045345743,0.0002775246],"genre_scores_gemma":[0.9878601,0.0103684915,0.00002179904,0.000015324084,0.000013129541,0.000028923823,0.00003888846,0.000051294814,0.0016020358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967491,0.0002854285,0.0011087215,0.000362728,0.0011322547,0.00036177292],"domain_scores_gemma":[0.9971932,0.0008059398,0.00051940756,0.0009626498,0.00035142596,0.00016734657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002640497,0.00030406454,0.001434118,0.000532839,0.00007964864,0.000047241123,0.00046572028,0.000101894046,0.00085129595],"category_scores_gemma":[0.00036291883,0.0001980581,0.0012667662,0.0008854618,0.00045181683,0.0001323888,0.0003554416,0.00016749157,0.000008681293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020555127,0.007136376,0.05336019,0.034611616,0.04113007,0.000088828085,0.022964342,0.0015448713,0.8126259,0.00041959298,0.009951127,0.014111573],"study_design_scores_gemma":[0.0016661139,0.0005232253,0.038678274,0.015415583,0.0030277616,0.000056564273,0.005482511,0.0019385462,0.93240786,0.0004337584,0.00003676625,0.00033301944],"about_ca_topic_score_codex":0.00020924916,"about_ca_topic_score_gemma":0.00002644754,"teacher_disagreement_score":0.11978197,"about_ca_system_score_codex":0.000050673538,"about_ca_system_score_gemma":0.00010974312,"threshold_uncertainty_score":0.93210936},"labels":[],"label_agreement":null},{"id":"W4401170327","doi":"10.1136/annrheumdis-2024-eular.102","title":"AB0401 EFFECTS OF GUSELKUMAB ON cDAPSA DISEASE ACTIVITY STATE AND ITS ASSOCIATION WITH LONG-TERM RADIOGRAPHIC PROGRESSION IN A COHORT OF PATIENTS WITH MODERATELY-HIGHLY ACTIVE PSORIATIC ARTHRITIS: POST HOC ANALYSES OF PHASE 3 RANDOMIZED CONTROLLED STUDIES","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; McGill University; University of Saskatchewan; Saskatchewan Health Authority","funders":"","keywords":"Medicine; Psoriatic arthritis; Cohort; Post-hoc analysis; Post hoc; Disease; Dermatology; Internal medicine","score_opus":0.019753117397883987,"score_gpt":0.35555305436993434,"score_spread":0.33579993697205035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401170327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96301824,0.03195826,0.000009501972,0.00018196934,0.000031332736,0.0046249363,0.00015457657,0.000013058031,0.0000080979],"genre_scores_gemma":[0.98688483,0.012644358,0.0000044882377,0.000012335701,0.0000032590056,0.0003811376,0.000027339753,0.000021923377,0.000020300664],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969233,0.00078837416,0.00080631283,0.00025088456,0.0010054673,0.00022566065],"domain_scores_gemma":[0.9958778,0.0019403339,0.0010049306,0.0002866158,0.0007834941,0.000106838714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006511646,0.00025951644,0.002264173,0.00044195607,0.000052502182,0.00001764657,0.000102292,0.000042412077,0.000008015875],"category_scores_gemma":[0.0025648994,0.00013270437,0.0003581059,0.000518321,0.00032669603,0.00026001356,0.000048083493,0.00013055808,3.0335534e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8292756,0.0065789944,0.08534004,0.016835498,0.0169538,0.000033709548,0.0018019562,0.00022457262,0.0003970505,0.00003151923,0.000027083726,0.042500183],"study_design_scores_gemma":[0.22937068,0.003162551,0.72438836,0.026455713,0.002820907,3.944813e-7,0.00013778002,0.0024361785,0.010861337,0.00019327975,1.0053641e-7,0.00017273866],"about_ca_topic_score_codex":0.000024977579,"about_ca_topic_score_gemma":0.0000084933245,"teacher_disagreement_score":0.6390483,"about_ca_system_score_codex":0.000033006345,"about_ca_system_score_gemma":0.00032410858,"threshold_uncertainty_score":0.5411528},"labels":[],"label_agreement":null},{"id":"W4401180212","doi":"10.1136/annrheumdis-2024-eular.3294","title":"AB0534 PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING TNF INHIBITORS IN REAL LIFE IN FRANCE IN 2016-2022 ARE DIFFERENT FROM PATIENTS INCLUDED IN SIMILAR COHORTS AND IN CLINICAL TRIALS. DATA FROM THE ART-SFR REGISTRY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Rheumatoid arthritis; Medicine; Clinical trial; Arthritis; Tumor necrosis factor alpha; Internal medicine; Physical therapy","score_opus":0.07620785169222918,"score_gpt":0.3633956141561416,"score_spread":0.2871877624639124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401180212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96282965,0.03167009,0.0000013751783,0.0017225964,0.00026477745,0.0015287029,0.0019367997,0.000021727557,0.000024253617],"genre_scores_gemma":[0.90365523,0.0951204,0.000016440224,0.00026356787,0.00003981138,0.0001255299,0.00073500496,0.000039683793,0.0000043460273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933042,0.0019503807,0.002567972,0.00072560995,0.0009393559,0.00051249104],"domain_scores_gemma":[0.9935568,0.0044128536,0.0005989691,0.0011004992,0.000085151434,0.0002457013],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023230703,0.0003625021,0.0016083067,0.00030406975,0.00006223045,0.000113085436,0.00058682077,0.00014904549,0.0000934267],"category_scores_gemma":[0.010240916,0.0002231441,0.000142294,0.00062728516,0.0003768644,0.00045268415,0.00060814316,0.0007750644,0.000006093377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010168471,0.0015521067,0.96052563,0.00016638944,0.00013461708,0.000061541374,0.0010249185,0.000016031168,0.0000016943201,0.000009002766,0.0031022474,0.032388974],"study_design_scores_gemma":[0.0082113175,0.00014682,0.9532118,0.034825634,0.000008647659,5.183285e-7,0.0006984362,0.0014195563,0.000011770329,0.0011642163,0.00008666184,0.00021466323],"about_ca_topic_score_codex":0.005572176,"about_ca_topic_score_gemma":0.013727125,"teacher_disagreement_score":0.063450314,"about_ca_system_score_codex":0.000054595457,"about_ca_system_score_gemma":0.00033475767,"threshold_uncertainty_score":0.9980962},"labels":[],"label_agreement":null},{"id":"W4401228463","doi":"10.1136/annrheumdis-2024-eular.738","title":"AB0477 EXPERIENCES AND PERSPECTIVES OF PATIENTS WITH PSORIATIC ARTHRITIS PARTICIPATING IN A RANDOMIZED CONTROLLED TRIAL OF DIETARY INTERVENTIONS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Therapeutic Uses of Natural Elements","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Psoriatic arthritis; Psychological intervention; Randomized controlled trial; Medicine; Physical therapy; Alternative medicine; Arthritis; Internal medicine; Nursing; Pathology","score_opus":0.09513271771348572,"score_gpt":0.4348143369062157,"score_spread":0.33968161919273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401228463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786484,0.016882477,0.000007982093,0.0005177992,0.00028689718,0.0035419278,0.000056471188,0.000013287503,0.000044745717],"genre_scores_gemma":[0.99701107,0.0009731771,0.000051686548,0.000026155927,0.0000121189805,0.001883835,0.0000030703452,0.000010224247,0.000028688612],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968199,0.0011687526,0.0013318247,0.00014703973,0.0003404325,0.00019203861],"domain_scores_gemma":[0.9956646,0.0031765362,0.00073990424,0.00019885524,0.00017278008,0.000047349382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088977616,0.0001277721,0.0011905519,0.00012527067,0.00008344366,0.0000070405863,0.00015591859,0.000035380624,0.0002475354],"category_scores_gemma":[0.0027357996,0.0000673877,0.0003979986,0.00020117489,0.00032019516,0.00014924338,0.00008159207,0.00011631405,7.2603336e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80774313,0.00232784,0.011088912,0.00444638,0.0024504436,8.79741e-7,0.13538101,0.000025448313,0.0000039200413,0.0018641697,0.00017465129,0.034493186],"study_design_scores_gemma":[0.8697802,0.0007167491,0.052457195,0.022210505,0.0005457253,6.851424e-8,0.048605047,0.0008554597,0.00001657572,0.0046698335,0.0000026323542,0.00014001354],"about_ca_topic_score_codex":0.0001501062,"about_ca_topic_score_gemma":0.000054470696,"teacher_disagreement_score":0.08677597,"about_ca_system_score_codex":0.000010565477,"about_ca_system_score_gemma":0.0001164754,"threshold_uncertainty_score":0.32752055},"labels":[],"label_agreement":null},{"id":"W4401228550","doi":"10.1136/annrheumdis-2024-eular.760","title":"POS0973 DECODING THE COMPLEXITY OF REFRACTORY PSORIATIC ARTHRITIS: RESULTS FROM A GLOBAL HEALTHCARE SURVEY INFORMED BY GRAPPA SPECIALISTS’ EXPERTISE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of Toronto; Arthritis Society; Women's College Hospital","funders":"","keywords":"Psoriatic arthritis; Decoding methods; Health care; Computer science; Refractory (planetary science); Medicine; Arthritis; Telecommunications; Political science; Internal medicine","score_opus":0.5160995962364306,"score_gpt":0.4630351276213534,"score_spread":0.05306446861507724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401228550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78145385,0.09680435,0.00022787474,0.069072254,0.0017979287,0.0011343064,0.04871101,0.00007092613,0.00072750484],"genre_scores_gemma":[0.99171364,0.004583837,0.000115214134,0.0030204894,0.000120115925,0.000048906804,0.00032610193,0.000021673377,0.000049994975],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9935098,0.00090782816,0.0045542135,0.0004094371,0.00025234412,0.00036632377],"domain_scores_gemma":[0.99291223,0.003381457,0.0024119504,0.0009647356,0.00013393933,0.0001957115],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006324262,0.0002274449,0.0010494076,0.00009729217,0.00021187995,0.00012510124,0.00069889234,0.00009243616,0.00016147287],"category_scores_gemma":[0.0140687935,0.00018713702,0.00033671266,0.00038165404,0.00043278924,0.0003993408,0.00012976611,0.00012962645,0.00013157196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000442264,0.00064094644,0.042310376,0.0040094657,0.001176248,0.0000017562455,0.012911865,0.00010041494,0.0000011529118,0.13291726,0.7769617,0.028526554],"study_design_scores_gemma":[0.001519918,0.00015290514,0.7210548,0.005620387,0.000040623672,0.0000027824067,0.0026732488,0.0060780235,0.000022159173,0.25297588,0.009280648,0.0005786259],"about_ca_topic_score_codex":0.024708688,"about_ca_topic_score_gemma":0.0036591222,"teacher_disagreement_score":0.76768106,"about_ca_system_score_codex":0.00022594717,"about_ca_system_score_gemma":0.00046328548,"threshold_uncertainty_score":0.9942361},"labels":[],"label_agreement":null},{"id":"W4401228666","doi":"10.1136/annrheumdis-2024-eular.5744","title":"POS0987 REDUCED ULTRASOUND SCANNING MODEL/SCORE FOR ASSESSMENT OF ELEMENTARY LESIONS IN PSORIATIC ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Psoriatic arthritis; Ultrasound; Medicine; Arthritis; Computer science; Radiology; Internal medicine","score_opus":0.0681992287712274,"score_gpt":0.3813834875655213,"score_spread":0.3131842587942939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401228666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713023,0.024176588,0.00035977428,0.0024445984,0.00016299529,0.000986931,0.00033776477,0.000030928328,0.00019815018],"genre_scores_gemma":[0.97580624,0.022744812,0.000977658,0.000111044596,0.000025082123,0.0001578073,0.00005586647,0.000028194716,0.00009327984],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982698,0.000085670334,0.00062527263,0.0002119643,0.00048685767,0.00032046283],"domain_scores_gemma":[0.9986857,0.0005517968,0.00011908957,0.00037563615,0.00013016844,0.00013761714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039117574,0.00015468731,0.00046789684,0.00020423478,0.0000784619,0.000036170444,0.00019930965,0.000033640357,0.00010931992],"category_scores_gemma":[0.0005639056,0.00011043263,0.00032234335,0.0002803378,0.00016427485,0.00015667091,0.00005935539,0.00011604503,0.0000016084942],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083592715,0.0031990071,0.032041226,0.0105235195,0.0027150342,0.000039822484,0.0046152743,0.00511606,0.011008194,0.03379727,0.046168957,0.8499397],"study_design_scores_gemma":[0.010888068,0.0028191642,0.43430886,0.117660195,0.00033038133,0.00012748719,0.0063940184,0.22264232,0.018179953,0.18443319,0.0010920677,0.0011242848],"about_ca_topic_score_codex":0.0001281423,"about_ca_topic_score_gemma":0.000035585985,"teacher_disagreement_score":0.84881544,"about_ca_system_score_codex":0.000028553886,"about_ca_system_score_gemma":0.0005132143,"threshold_uncertainty_score":0.4503312},"labels":[],"label_agreement":null},{"id":"W4401230190","doi":"10.1136/annrheumdis-2024-eular.4036","title":"AB0540 TREAT (DEPRESSION TO REACH)-TO-TARGET IN RHEUMATOID ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rheumatoid arthritis; Depression (economics); Computer science; Medicine; Internal medicine; Economics","score_opus":0.026472237573830455,"score_gpt":0.32504368437937964,"score_spread":0.2985714468055492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401230190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91640013,0.06976197,0.000064792264,0.010339558,0.00027608903,0.0009819674,0.0001401673,0.00012271691,0.0019125942],"genre_scores_gemma":[0.9603698,0.037874624,0.0002293994,0.00063004665,0.000036725192,0.000153313,0.000019306668,0.000047582755,0.00063920335],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976514,0.00015100418,0.0005846225,0.00038727422,0.00070570316,0.0005199919],"domain_scores_gemma":[0.99831074,0.0002781966,0.000055943725,0.0007096918,0.00011155868,0.00053388346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003630687,0.00024364691,0.0005756058,0.0004222372,0.000091824695,0.00009829664,0.00033914603,0.000056619596,0.00051982846],"category_scores_gemma":[0.0010878311,0.00016160728,0.00030255606,0.00074671,0.00011194154,0.00019296799,0.00020131735,0.00017320518,0.00031255052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001031691,0.0010582533,0.030425841,0.0011883473,0.00034209664,0.00029689784,0.0040046675,0.00023007563,0.0016690292,0.0021774627,0.14378902,0.8137866],"study_design_scores_gemma":[0.005898056,0.0020335196,0.6502968,0.13213374,0.000034285003,0.00069198664,0.002306779,0.0026096588,0.028750435,0.03244949,0.1412794,0.0015158505],"about_ca_topic_score_codex":0.0003038542,"about_ca_topic_score_gemma":0.00005008161,"teacher_disagreement_score":0.81227076,"about_ca_system_score_codex":0.00003078243,"about_ca_system_score_gemma":0.00020434143,"threshold_uncertainty_score":0.65901536},"labels":[],"label_agreement":null},{"id":"W4401230303","doi":"10.1136/annrheumdis-2024-eular.520","title":"POS0614 ASSOCIATIONS BETWEEN DISEASE ACTIVITY, PHYSICAL FUNCTION AND ANTI-RHEUMATIC MEDICATIONS WITH ALL-CAUSE MORTALITY IN RHEUMATOID ARTHRITIS (RA): DATA FROM A CANADIAN RA REGISTRY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Ottawa; University of Toronto; Toronto General Hospital","funders":"","keywords":"Rheumatoid arthritis; Medicine; Disease; Rheumatic disease; Internal medicine; Immunology","score_opus":0.07475817693928896,"score_gpt":0.3541783973924982,"score_spread":0.27942022045320924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401230303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96797895,0.014223369,0.000058871887,0.011228281,0.000103146245,0.00072681723,0.005504839,0.00007932919,0.00009638662],"genre_scores_gemma":[0.97048366,0.027850373,0.000021496506,0.00012840348,0.000056625195,0.000074617885,0.0013157479,0.000040641928,0.00002840881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973533,0.0002786957,0.0004998364,0.0005343009,0.00085487444,0.00047895758],"domain_scores_gemma":[0.99670357,0.00076345453,0.00019594228,0.001379055,0.00011926874,0.00083868526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004215983,0.00027427217,0.0006732445,0.0002449053,0.00021848071,0.00018676092,0.00044534967,0.000069227906,0.000111707675],"category_scores_gemma":[0.0010761457,0.00020000257,0.00014057793,0.00050557195,0.00048346486,0.00063087133,0.00020692399,0.00031628064,0.000026480891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024807276,0.0013230328,0.91352487,0.00090765225,0.007729205,0.00010645811,0.0014067111,0.000020551546,0.000058832688,0.0020048695,0.017913261,0.05475651],"study_design_scores_gemma":[0.0009745688,0.00008261013,0.9821721,0.0056685624,0.00023906297,0.0000071520253,0.00018565459,0.0027323698,0.0000205653,0.007396327,0.00030654267,0.00021451637],"about_ca_topic_score_codex":0.04143725,"about_ca_topic_score_gemma":0.026914924,"teacher_disagreement_score":0.06864723,"about_ca_system_score_codex":0.00006934012,"about_ca_system_score_gemma":0.0013394913,"threshold_uncertainty_score":0.9908413},"labels":[],"label_agreement":null},{"id":"W4401230917","doi":"10.1136/annrheumdis-2024-eular.369","title":"AB0403 INFLUENCE OF BODY WEIGHT, SEX AND PRIOR BIOLOGIC HISTORY ON TREATMENT OUTCOMES ASSOCIATED WITH TAK-279, A HIGHLY SELECTIVE ORAL TYROSINE KINASE 2 (TYK2) INHIBITOR, IN A PHASE 2B RANDOMIZED TRIAL IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Randomized controlled trial; Medicine; Internal medicine; Tyrosine-kinase inhibitor; Oncology","score_opus":0.020515900582026264,"score_gpt":0.29239611292320883,"score_spread":0.27188021234118254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401230917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624926,0.0009026156,0.000001940522,0.0002670588,0.000104055805,0.0022053786,0.0002142609,0.000027537837,0.000027894986],"genre_scores_gemma":[0.999282,0.0002279351,0.000017746095,0.00008446363,0.000011218977,0.0002543054,0.00005041174,0.000019803347,0.000052131538],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982962,0.00033157002,0.0006037164,0.00027458038,0.00029881607,0.00019513459],"domain_scores_gemma":[0.99817145,0.0010059299,0.0003720312,0.00020483987,0.00016278833,0.00008296196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021719674,0.00026224655,0.001155847,0.0002785588,0.000034101322,0.000012739592,0.000063859465,0.000052792264,0.000023777895],"category_scores_gemma":[0.0013557683,0.00013117547,0.00018583488,0.0003155043,0.00023459422,0.00013848316,0.000020451613,0.00013245901,8.1834355e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9153811,0.019511512,0.030451547,0.00042072727,0.0029571275,0.000059693324,0.004829163,0.00018676305,0.00034392436,0.00020484591,0.00038929158,0.025264358],"study_design_scores_gemma":[0.7362572,0.013508704,0.23494278,0.010134672,0.000787131,0.0000021653495,0.00014542376,0.00065529085,0.0029696582,0.00029806263,0.000027171658,0.00027176886],"about_ca_topic_score_codex":0.0005031962,"about_ca_topic_score_gemma":0.00009907068,"teacher_disagreement_score":0.20449123,"about_ca_system_score_codex":0.00027065413,"about_ca_system_score_gemma":0.00036982482,"threshold_uncertainty_score":0.53491807},"labels":[],"label_agreement":null},{"id":"W4401230981","doi":"10.1136/annrheumdis-2024-eular.4606","title":"POS0949 CHRONIC KIDNEY DISEASE IN PATIENTS WITH PSORIATIC ARTHRITIS: A COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Toronto Western Hospital","funders":"","keywords":"Psoriatic arthritis; Medicine; Cohort; Kidney disease; Arthritis; Internal medicine; Dermatology","score_opus":0.011624732598651762,"score_gpt":0.27312853749962834,"score_spread":0.2615038049009766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401230981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98107177,0.015254188,0.0000010526667,0.00096101087,0.00022436363,0.002083494,0.00023302539,0.00005067901,0.000120420395],"genre_scores_gemma":[0.99832207,0.0009896635,0.0000071359395,0.00018001901,0.000028611143,0.00025724949,0.000053914788,0.000031305895,0.00013005923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983762,0.000074636126,0.00038384742,0.00030659782,0.00057485874,0.00028384506],"domain_scores_gemma":[0.99894667,0.00007395994,0.00008343805,0.00051947235,0.000094052964,0.00028242252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009835278,0.00021635288,0.0004766617,0.000110533816,0.00007594523,0.00003341642,0.00012235015,0.000019116267,0.00017274174],"category_scores_gemma":[0.00030166423,0.00012721357,0.00017304042,0.00037407357,0.000104876955,0.00011153724,0.00008579029,0.000081647944,0.000033290416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040015054,0.002920759,0.97316116,0.00056768634,0.00095965917,0.00008609119,0.00021956982,0.000011193709,6.7455844e-8,0.00008548075,0.001887547,0.019700618],"study_design_scores_gemma":[0.004137924,0.00095060497,0.98678327,0.0067721084,0.00056397455,0.0000012315409,0.00009955462,0.00008889333,0.0000023560835,0.00038317053,0.000090934045,0.00012598641],"about_ca_topic_score_codex":0.00014613298,"about_ca_topic_score_gemma":0.000050200568,"teacher_disagreement_score":0.019574633,"about_ca_system_score_codex":0.000058665042,"about_ca_system_score_gemma":0.00031936725,"threshold_uncertainty_score":0.5187619},"labels":[],"label_agreement":null},{"id":"W4401230985","doi":"10.1136/annrheumdis-2024-eular.4582","title":"AB0465 DEGENERATIVE DISC DISEASE IN YOUNG ADULTS WITH PSORIATIC ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Toronto Western Hospital","funders":"","keywords":"Psoriatic arthritis; Medicine; Disease; Arthritis; Dermatology; Degenerative arthritis; Pathology; Internal medicine; Osteoarthritis","score_opus":0.016923641904808724,"score_gpt":0.2827561177016462,"score_spread":0.2658324757968375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401230985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94968134,0.045688853,0.0000088098905,0.0030642808,0.00022170073,0.00067232334,0.00023965669,0.000044478402,0.0003785814],"genre_scores_gemma":[0.9940273,0.0052037435,0.00004559305,0.00012674271,0.000040426974,0.00016731607,0.000035906876,0.000026458598,0.00032650997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987511,0.000055613546,0.00031787198,0.0002602593,0.00035940274,0.0002557337],"domain_scores_gemma":[0.99923533,0.0000887692,0.00007018756,0.00035391,0.000072536895,0.00017926368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047759062,0.00019894323,0.00038389818,0.00008251909,0.00008020453,0.000033609187,0.000096212854,0.000020939171,0.000114968694],"category_scores_gemma":[0.00019006703,0.000111948684,0.00019480671,0.00033196926,0.00015033515,0.0001214964,0.00005995996,0.00007407832,0.000024062614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047957865,0.004317583,0.5927327,0.0059790737,0.0033690943,0.0016622357,0.009512661,0.00028575782,0.000012799743,0.0076671676,0.014148279,0.35551685],"study_design_scores_gemma":[0.0033387628,0.0004576347,0.96729606,0.023347022,0.000425367,0.000028312832,0.0010011884,0.00095169817,0.00013956516,0.0026393349,0.00013682757,0.00023819364],"about_ca_topic_score_codex":0.0002728171,"about_ca_topic_score_gemma":0.0004648496,"teacher_disagreement_score":0.37456337,"about_ca_system_score_codex":0.000023705265,"about_ca_system_score_gemma":0.000141056,"threshold_uncertainty_score":0.4565135},"labels":[],"label_agreement":null},{"id":"W4401231162","doi":"10.1136/annrheumdis-2024-eular.307","title":"AB0402 HIGHER LEVELS OF HIGH-SENSITIVITY CRP IS ASSOCIATED WITH FUTURE DEVELOPMENT OF PSORIATIC ARTHRITIS IN PSORIASIS: A PROSPECTIVE COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; University Health Network; Arthritis Society; Women's College Hospital; Toronto Western Hospital","funders":"","keywords":"Psoriatic arthritis; Psoriasis; Medicine; Prospective cohort study; Cohort; Dermatology; Internal medicine","score_opus":0.02266674959650849,"score_gpt":0.2609871561671661,"score_spread":0.23832040657065762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401231162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969716,0.007867494,0.000007660055,0.0001724285,0.0005871319,0.0010020869,0.0005712878,0.000034325272,0.000060415463],"genre_scores_gemma":[0.9992374,0.00021098707,0.000042590324,0.00002088932,0.000014643269,0.00012865076,0.00003132658,0.000021391104,0.00029210703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980409,0.00050772785,0.00067694456,0.00032053466,0.00017640325,0.0002774589],"domain_scores_gemma":[0.99864364,0.00039744223,0.00037525466,0.00037279763,0.00018554846,0.000025297852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000556364,0.00025988818,0.00085481256,0.00014586825,0.000085688494,0.000010751616,0.00018121062,0.00011684945,0.00023969715],"category_scores_gemma":[0.00014888546,0.00016678374,0.00017598148,0.000492891,0.00015876767,0.00010240882,0.00008613079,0.00010341417,0.000013783793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012448789,0.008866948,0.6909697,0.000894234,0.022807086,0.000054425367,0.020710602,0.0000379516,0.0010122422,0.0013997211,0.0018602085,0.25014198],"study_design_scores_gemma":[0.0017896475,0.00026090175,0.97755593,0.0018769116,0.00053839147,0.000002909517,0.0008063551,0.0000026172095,0.01618379,0.00079018436,0.000018444242,0.00017393274],"about_ca_topic_score_codex":0.00018598832,"about_ca_topic_score_gemma":0.0003240399,"teacher_disagreement_score":0.2865862,"about_ca_system_score_codex":0.000041191328,"about_ca_system_score_gemma":0.00025752772,"threshold_uncertainty_score":0.68012434},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4401231182","doi":"10.1136/annrheumdis-2024-eular.3224","title":"AB0272 IMPROVED RATES OF SUCCESSFUL TRANSFER OF CARE WITH THE IMPLEMENTATION OF A MULTIDISCIPLINARY TRANSITION CLINIC FOR YOUNG ADULTS WITH JUVENILE ARTHRITIS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de réadaptation Lethbridge-Layton-Mackay; McGill University","funders":"","keywords":"Juvenile; Multidisciplinary approach; Arthritis; Medicine; Computer science; Internal medicine; Biology; Sociology; Ecology; Social science","score_opus":0.043306859478827855,"score_gpt":0.4235780573558695,"score_spread":0.38027119787704167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401231182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98648137,0.0054568886,0.0004773365,0.0023506684,0.00011617189,0.002539823,0.002544672,0.000016794324,0.00001627711],"genre_scores_gemma":[0.9981706,0.0012479868,0.000059845213,0.000046693123,0.000040800434,0.0002375462,0.00015140454,0.000024672707,0.000020422453],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9981861,0.0002853727,0.0008591137,0.00016776391,0.0002698422,0.00023180152],"domain_scores_gemma":[0.9980914,0.00071379065,0.00034878886,0.0002665927,0.00051794155,0.00006150513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033550902,0.00014247156,0.00043168248,0.000068546215,0.0001878013,0.0000037837474,0.00017845874,0.00006237252,0.000089133115],"category_scores_gemma":[0.000030978295,0.00007376299,0.00020639955,0.0002643857,0.00014787006,0.00012964327,0.000020956357,0.00012662532,7.4567686e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010616273,0.0007928182,0.31367615,0.19026169,0.0009004687,0.0000025086554,0.37878376,0.00010845967,0.00024155968,0.0005436505,0.0039470308,0.10012562],"study_design_scores_gemma":[0.007417708,0.0038468314,0.4662333,0.038578853,0.0009903641,0.0000018811278,0.47690952,0.0011819089,0.0037564419,0.0006412911,0.000067945344,0.00037397142],"about_ca_topic_score_codex":0.0009472362,"about_ca_topic_score_gemma":0.00255009,"teacher_disagreement_score":0.15255713,"about_ca_system_score_codex":0.000011373142,"about_ca_system_score_gemma":0.00065000716,"threshold_uncertainty_score":0.30079675},"labels":[],"label_agreement":null},{"id":"W4401231822","doi":"10.1136/annrheumdis-2024-eular.25","title":"AB0472 EFFICACY OF GUSELKUMAB IN BIONAIVE PSORIATIC ARTHRITIS PATIENTS WITH SEVERE DISEASE ACTIVITY: POST-HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Psoriatic arthritis; Medicine; Placebo; Double blind; Post-hoc analysis; Arthritis; Internal medicine; Dermatology; Alternative medicine; Pathology","score_opus":0.08820157614001951,"score_gpt":0.42176197818181704,"score_spread":0.33356040204179754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401231822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017215,0.001822763,0.00003402821,0.00041888075,0.0003452559,0.00622853,0.0008747029,0.00003983906,0.00006383634],"genre_scores_gemma":[0.9986425,0.00052396033,0.0000074253117,0.00008491245,0.000019693254,0.0005970357,0.00005951668,0.000025570518,0.00003940666],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956336,0.0020272688,0.0010846166,0.0003835419,0.0005555514,0.000315416],"domain_scores_gemma":[0.9953325,0.0028957499,0.00076476234,0.00046082083,0.0003335001,0.00021271536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014129801,0.00033842924,0.0017470117,0.00075605384,0.00012244386,0.000029494551,0.00035557337,0.00012775608,0.0003182574],"category_scores_gemma":[0.0008135264,0.00022474308,0.0008975837,0.0015130272,0.00032607443,0.00026563086,0.00010029492,0.0003587728,0.000006680477],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91054827,0.014005066,0.0041641747,0.0007054379,0.014503003,0.000011904253,0.0027667321,0.005798344,0.000040728657,0.00018654854,0.000046003024,0.04722381],"study_design_scores_gemma":[0.93999505,0.0014125956,0.017333923,0.001239327,0.01623075,8.801869e-7,0.00047240112,0.021090057,0.0010203132,0.0007660587,0.000018249646,0.00042036557],"about_ca_topic_score_codex":0.00023064084,"about_ca_topic_score_gemma":0.00014077743,"teacher_disagreement_score":0.046803445,"about_ca_system_score_codex":0.00003697015,"about_ca_system_score_gemma":0.00030756256,"threshold_uncertainty_score":0.91647565},"labels":[],"label_agreement":null},{"id":"W4401232044","doi":"10.1136/annrheumdis-2024-eular.2938","title":"POS0983 POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES TO LONGITUDINALLY EVALUATE THE NOVEL PSORIATIC ARTHRITIS 5-THERMOMETER SCALE (PSA-5TS) DOMAINS DURING GUSELKUMAB TREATMENT","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital","funders":"","keywords":"Psoriatic arthritis; Placebo; Medicine; Double blind; Thermometer; Dermatology; Psoriasis; Physics; Pathology","score_opus":0.0667616839851884,"score_gpt":0.3449086537650987,"score_spread":0.2781469697799103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401232044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933298,0.060744785,0.00014884243,0.0014048927,0.00062020007,0.003087428,0.0005655048,0.000061730316,0.00006861868],"genre_scores_gemma":[0.9930444,0.004690297,0.000029501549,0.000055751807,0.00003278013,0.0013465286,0.00006408482,0.00003432106,0.0007023321],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99680555,0.0007564674,0.0012317116,0.000489278,0.00024519645,0.0004717919],"domain_scores_gemma":[0.99584657,0.0024953282,0.00041240503,0.0009176701,0.00025988216,0.00006812838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001124781,0.00051207177,0.0025088678,0.00054789224,0.0003482041,0.000062285,0.0005255945,0.000107309344,0.00033338804],"category_scores_gemma":[0.00046633338,0.00024851898,0.002335088,0.0010156145,0.00042609288,0.00012518646,0.00016812615,0.00008603808,0.00007987494],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4965943,0.003159698,0.00037820401,0.00038470564,0.41550985,0.000013916201,0.0053933603,0.0015397753,0.0050143683,0.00062773714,0.00033317396,0.0710509],"study_design_scores_gemma":[0.78076434,0.00086594926,0.0070073204,0.001912184,0.18243153,0.000022714767,0.00097101677,0.0008738801,0.023147263,0.001348214,0.00003949836,0.0006160937],"about_ca_topic_score_codex":0.00016710626,"about_ca_topic_score_gemma":0.00039327735,"teacher_disagreement_score":0.28417,"about_ca_system_score_codex":0.00006539527,"about_ca_system_score_gemma":0.00013434398,"threshold_uncertainty_score":0.9999967},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4401232216","doi":"10.1136/annrheumdis-2024-eular.2113","title":"POS0651 INFLUENCE OF AGE AND SEX ON FIRST CDAI REMISSION IN RHEUMATOID ARTHRITIS: RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Medicine; Physical therapy; Internal medicine","score_opus":0.12691814218111333,"score_gpt":0.3915654315866615,"score_spread":0.26464728940554816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401232216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951719,0.035868127,3.275351e-7,0.009628136,0.00006371483,0.0006906218,0.0002724917,0.000021170577,0.0017364079],"genre_scores_gemma":[0.888393,0.11111498,0.000024677876,0.00013750428,0.000019626374,0.000044395187,0.000027200324,0.00002015237,0.00021848682],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99683005,0.00057747314,0.00073233066,0.00038128288,0.0011006636,0.0003782025],"domain_scores_gemma":[0.99279183,0.0057445816,0.0003149984,0.0007158787,0.0002443703,0.00018834272],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014777125,0.00019726116,0.00047527847,0.00020219151,0.00025344887,0.00012866785,0.0003824435,0.00007350606,0.00007484014],"category_scores_gemma":[0.009354491,0.00011264499,0.00013315256,0.00048625024,0.00079335755,0.00035272818,0.00024402891,0.00057684054,0.000018127777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0141806565,0.0063226027,0.20216957,0.00374657,0.0029234448,0.0013669324,0.19853817,0.0005730328,0.001423198,0.0069969236,0.05686111,0.5048978],"study_design_scores_gemma":[0.0042163758,0.0018021101,0.8151736,0.1209868,0.000025135081,0.000056008317,0.012555596,0.00042385553,0.0041361507,0.021934398,0.018313702,0.0003762603],"about_ca_topic_score_codex":0.038832758,"about_ca_topic_score_gemma":0.018292872,"teacher_disagreement_score":0.613004,"about_ca_system_score_codex":0.00004482641,"about_ca_system_score_gemma":0.0005006261,"threshold_uncertainty_score":0.99962074},"labels":[],"label_agreement":null},{"id":"W4401232263","doi":"10.1136/annrheumdis-2024-eular.1901","title":"AB0389 CONTENT VALIDITY OF WESTERN ONTARIO ROTATOR CUFF PHYSICAL SYMPTOMS DOMAIN AND THE PROMIS v2.0 UPPER EXTREMITY SHORT FORM 7a FOR USE IN PATIENTS WITH MODERATE-TO-SEVERE ROTATOR CUFF TENDINOPATHY: A QUALITATIVE STUDY","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rotator cuff; Medicine; Tendinopathy; Rotator cuff injury; Physical therapy; Physical medicine and rehabilitation; Surgery; Tendon","score_opus":0.07307331331602186,"score_gpt":0.3295991151371446,"score_spread":0.2565258018211228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401232263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916879,0.00011360346,0.000090134745,0.0004836412,0.00007154891,0.0072541013,0.0002584931,0.00002210627,0.000018478828],"genre_scores_gemma":[0.9984053,0.000020534457,0.000089273,0.00023158742,0.000015792153,0.0010771643,0.000022036404,0.000034556037,0.00010378217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978424,0.0002783037,0.0005768651,0.00038754262,0.0006131739,0.00030174787],"domain_scores_gemma":[0.99823296,0.00068725186,0.00017449599,0.0005049524,0.0002378317,0.00016252272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006181807,0.00029224993,0.0010214304,0.00009921561,0.000093440474,0.00007824516,0.00020810113,0.000029863715,0.000011474209],"category_scores_gemma":[0.0002628863,0.0001460026,0.00025001963,0.00017176957,0.00019761815,0.00024648703,0.00017830174,0.000115340976,0.0000014950958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005498951,0.010242368,0.8295718,0.0016762792,0.001983789,0.000006144169,0.14400984,0.000052193474,0.0000033203635,0.002010642,0.00094737206,0.00399728],"study_design_scores_gemma":[0.0051874123,0.0017162223,0.9743092,0.0023873993,0.0009044129,7.9397194e-7,0.011018142,0.0005045293,0.000099503435,0.0036323688,0.00002474582,0.00021523492],"about_ca_topic_score_codex":0.0030378297,"about_ca_topic_score_gemma":0.0024080917,"teacher_disagreement_score":0.14473742,"about_ca_system_score_codex":0.00008436272,"about_ca_system_score_gemma":0.00017025863,"threshold_uncertainty_score":0.5953813},"labels":[],"label_agreement":null},{"id":"W4401232426","doi":"10.1136/annrheumdis-2024-eular.1873","title":"AB0459 BASELINE (BL) DEMOGRAPHICS AND DISEASE CHARACTERISTICS BY MENOPAUSAL STATUS AND SEX IN PATIENTS FROM A PHASE 2 TRIAL OF DEUCRAVACITINIB, A FIRST-IN-CLASS, ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (PsA)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Microscopic Colitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Demographics; Internal medicine; Medicine; Disease; Kinase; Class (philosophy); Allosteric regulation; Pharmacology; Oncology; Biology; Genetics; Computer science; Demography; Receptor; Artificial intelligence","score_opus":0.010791621002219705,"score_gpt":0.2683150582866748,"score_spread":0.2575234372844551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401232426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893225,0.0024272113,0.0000049506216,0.0003145469,0.00013729575,0.0019192327,0.0058543505,0.000016507956,0.0000033988495],"genre_scores_gemma":[0.997021,0.0020153231,0.00004251917,0.00013184354,0.00002017066,0.000096385666,0.0006269572,0.000038068676,0.000007705237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760234,0.00024123848,0.00085975754,0.0004368776,0.0004823409,0.00037743888],"domain_scores_gemma":[0.99840796,0.0004816236,0.00029145536,0.00032349763,0.00014755575,0.0003478981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017289794,0.00031292677,0.00082645926,0.00029652796,0.00003832188,0.00004184571,0.00009652729,0.00006952774,0.000035868306],"category_scores_gemma":[0.001292428,0.0002456968,0.000059669816,0.0005989711,0.00024053273,0.00020963985,0.00011059309,0.00019430152,4.259772e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04522066,0.0090197865,0.8337072,0.0020590227,0.00031416508,0.000039275696,0.0012202468,0.0000016309951,0.00004102968,0.000013787313,0.0009892487,0.10737396],"study_design_scores_gemma":[0.06355323,0.00304449,0.9237615,0.007831409,0.00027737865,3.5173412e-7,0.0000801306,0.00070356944,0.00012231249,0.0002938296,0.000077407516,0.00025441786],"about_ca_topic_score_codex":0.00062284217,"about_ca_topic_score_gemma":0.0003522521,"teacher_disagreement_score":0.107119545,"about_ca_system_score_codex":0.00006247718,"about_ca_system_score_gemma":0.00031551658,"threshold_uncertainty_score":0.9999995},"labels":[],"label_agreement":null},{"id":"W4401232450","doi":"10.1136/annrheumdis-2024-eular.2234","title":"AB0410 COMPARISON OF ON-LABEL TREATMENT PERSISTENCE IN REAL-WORLD PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB VERSUS SUBCUTANEOUS TNF INHIBITORS","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"","keywords":"Psoriatic arthritis; Medicine; Persistence (discontinuity); Dermatology; Psoriasis; Subcutaneous injection; Tumor necrosis factor alpha; Internal medicine","score_opus":0.1326324118945556,"score_gpt":0.40026901625836614,"score_spread":0.26763660436381054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401232450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878689,0.0077234334,4.2879685e-7,0.0018964971,0.00035330112,0.00048381556,0.00006411059,0.000027066708,0.0015824349],"genre_scores_gemma":[0.99418414,0.005557604,0.00003835352,0.00006277817,0.000023049608,0.00002475874,0.000009262802,0.000017076329,0.0000830011],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99852115,0.000103732214,0.00047023836,0.00021246079,0.0004624295,0.00022997262],"domain_scores_gemma":[0.9980435,0.0012742009,0.0002065879,0.00027403678,0.00008717033,0.00011454484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010739691,0.00018307715,0.0005256245,0.00009501918,0.00007118162,0.000021437407,0.00011275834,0.000025287229,0.000076123026],"category_scores_gemma":[0.00041583308,0.00010692872,0.00013984682,0.00039516255,0.0001386405,0.00009501483,0.000046271885,0.00011208313,0.000009418871],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008964283,0.00671324,0.12923329,0.0022788823,0.002159979,0.00006391873,0.0036755917,0.0002641861,0.000009700428,0.00042888257,0.0033968508,0.8428112],"study_design_scores_gemma":[0.024492262,0.024057228,0.8627543,0.05634287,0.0045141233,0.000015241773,0.005869049,0.010686104,0.003705903,0.00088361296,0.005512314,0.0011669854],"about_ca_topic_score_codex":0.0003867074,"about_ca_topic_score_gemma":0.0002990309,"teacher_disagreement_score":0.8416442,"about_ca_system_score_codex":0.000078680736,"about_ca_system_score_gemma":0.00008878132,"threshold_uncertainty_score":0.43604264},"labels":[],"label_agreement":null},{"id":"W4401406670","doi":"10.1136/ard-2024-225882","title":"Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"Berlin Institute of Health; AstraZeneca; Celgene; Radiological Society of North America; Pfizer; Eli Lilly and Company","keywords":"Medicine; Protocol (science); Medical physics; Sacroiliac joint; Spartan; Radiology; Pathology; Alternative medicine; Engineering","score_opus":0.05959278034246444,"score_gpt":0.41047850261147506,"score_spread":0.3508857222690106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401406670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93994427,0.00042523153,0.00005364883,0.0031068984,0.00026337669,0.05394491,0.001940592,0.000019646339,0.00030142796],"genre_scores_gemma":[0.97211117,0.000020288539,0.00040589253,0.00005005387,0.000016065002,0.027240789,0.000094238334,0.000013674066,0.000047853442],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984143,0.0001087305,0.00046084053,0.00015150674,0.00076571695,0.00009893006],"domain_scores_gemma":[0.99836606,0.00029489724,0.00026314447,0.00024018795,0.00079287885,0.000042836724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039684918,0.0001143062,0.0002337782,0.000047949754,0.00009164802,0.000019927273,0.00009248737,0.0000246662,0.00009539518],"category_scores_gemma":[0.0011212006,0.0000670326,0.00013166605,0.00015277172,0.00011013034,0.000060595787,0.00003453,0.000025954441,0.0000017141236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016189078,0.018517463,0.030970456,0.015079751,0.010621252,0.000011453627,0.018026277,0.0009407468,0.02320826,0.0039547365,0.41889912,0.44358143],"study_design_scores_gemma":[0.028595565,0.0031996479,0.56773037,0.03818582,0.002856692,0.000011815761,0.005593577,0.014266848,0.31874028,0.010947038,0.009249911,0.0006224623],"about_ca_topic_score_codex":0.000007741568,"about_ca_topic_score_gemma":0.000017562821,"teacher_disagreement_score":0.5367599,"about_ca_system_score_codex":0.0000707838,"about_ca_system_score_gemma":0.00043373744,"threshold_uncertainty_score":0.27335098},"labels":[],"label_agreement":null},{"id":"W4401665200","doi":"10.1136/ard-2024-225868","title":"Plasma proteome profiling in giant cell arteritis","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Center for Individualized Medicine, Mayo Clinic; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Center for Research Resources","keywords":"Giant cell arteritis; Proteome; Medicine; Plasma cell; Disease; Blood proteins; Arteritis; Computational biology; Bioinformatics; Immunology; Pathology; Internal medicine; Vasculitis; Biology; Antibody","score_opus":0.023563961432621468,"score_gpt":0.28574001798757914,"score_spread":0.2621760565549577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401665200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853743,0.005136929,0.000016565897,0.0061691287,0.00019424321,0.0006289981,0.00010274656,0.000053665513,0.0023234321],"genre_scores_gemma":[0.99811506,0.00074763305,0.00010878777,0.00011422373,0.000021296517,0.00007411359,0.000018673803,0.000014499383,0.0007857372],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99920434,0.000037381946,0.0002776889,0.00013161615,0.00018911055,0.00015985899],"domain_scores_gemma":[0.9995562,0.00005560362,0.000042086667,0.00023254112,0.00003566784,0.00007794108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008375506,0.00008826531,0.0001998614,0.000093184266,0.00003666721,0.000024304638,0.00008724344,0.000039950544,0.00018972227],"category_scores_gemma":[0.00009095443,0.00005398079,0.00020942699,0.00023428393,0.00006709513,0.00006743798,0.00003252708,0.00011718219,0.000054347212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084432773,0.01188348,0.030783024,0.08527306,0.0053321356,0.0031530617,0.012263676,0.002288534,0.039941937,0.054749344,0.13663706,0.6168504],"study_design_scores_gemma":[0.00836057,0.0014154278,0.6058206,0.106328905,0.0019747673,0.000793096,0.0033386222,0.066322885,0.12907237,0.07024588,0.004868719,0.0014581615],"about_ca_topic_score_codex":0.000022993492,"about_ca_topic_score_gemma":0.000001863432,"teacher_disagreement_score":0.6153922,"about_ca_system_score_codex":0.000009728053,"about_ca_system_score_gemma":0.00012006308,"threshold_uncertainty_score":0.22012728},"labels":[],"label_agreement":null},{"id":"W4401695143","doi":"10.1136/ard-2024-225686","title":"Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Medical Research Council","keywords":"Medicine; Belimumab; Rituximab; Placebo; Internal medicine; Adverse effect; Phases of clinical research; BLISS; Dermatology; Clinical trial; Immunology; Antibody; Alternative medicine; B-cell activating factor; Pathology","score_opus":0.020167634663572243,"score_gpt":0.302727449078991,"score_spread":0.2825598144154188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401695143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97762394,0.012763967,0.000017339125,0.00027498207,0.000060361348,0.009090956,0.00009610763,0.000026484602,0.000045873105],"genre_scores_gemma":[0.99852103,0.0011010646,0.000016509886,0.000016073967,0.000013016497,0.000208421,0.000008554259,0.000049755163,0.000065545835],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99652416,0.00059618545,0.0010913879,0.00035775788,0.0011159276,0.00031455632],"domain_scores_gemma":[0.9963296,0.0018895053,0.00057021825,0.00074693665,0.0003256971,0.00013804602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010325528,0.00031357436,0.0016038994,0.00023789582,0.00008259925,0.00004371243,0.0002815948,0.00005583179,0.00002568226],"category_scores_gemma":[0.00050205877,0.00014180213,0.00016340594,0.00044870545,0.00049022736,0.000106505504,0.00011004115,0.00016872885,0.0000011747601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79439306,0.015017572,0.14853376,0.011381641,0.0063706543,0.00007867333,0.015395009,0.00012275108,0.0001790698,0.0001347059,0.00009960158,0.008293523],"study_design_scores_gemma":[0.93291676,0.008381297,0.011414247,0.033147067,0.0017953144,0.0022334903,0.0073451563,0.0016586714,0.00045956738,0.0002784595,0.0000027612864,0.00036720815],"about_ca_topic_score_codex":0.00010926224,"about_ca_topic_score_gemma":0.000018334555,"teacher_disagreement_score":0.13852371,"about_ca_system_score_codex":0.000031152846,"about_ca_system_score_gemma":0.0003193806,"threshold_uncertainty_score":0.5782523},"labels":[],"label_agreement":null},{"id":"W4401729477","doi":"10.1136/ard-2024-225833","title":"Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Genentech; Novo Nordisk; National Institute for Health and Care Research; Gilead Sciences; Sanofi; Celgene; Biogen; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Apremilast; Medicine; Psoriatic arthritis; Dermatology; Randomized controlled trial; Internal medicine; Arthritis; Physical therapy","score_opus":0.025477146122116875,"score_gpt":0.2764651262205257,"score_spread":0.25098798009840884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401729477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502414,0.04166909,0.000007696126,0.002773668,0.0003504469,0.004227702,0.00031644924,0.00003729377,0.0003762781],"genre_scores_gemma":[0.9940189,0.004449404,0.00003729266,0.00018143129,0.0000683992,0.0006469293,0.000046198027,0.00003121771,0.0005202344],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99813366,0.0001506544,0.0006699667,0.00024771207,0.0005387466,0.00025926225],"domain_scores_gemma":[0.99735725,0.0015733512,0.0002619237,0.00059586356,0.00009869818,0.000112888294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102494174,0.00028934766,0.0013372779,0.00003992424,0.00014788393,0.000031758995,0.0001314357,0.00003927742,0.00014429829],"category_scores_gemma":[0.0003204251,0.00011881513,0.00091634924,0.00015297845,0.00024356693,0.00006372863,0.000058078072,0.00004216085,0.000016610029],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78981274,0.0057539525,0.04244874,0.00054778956,0.025640227,0.00017925318,0.0034264368,0.00002091736,0.000059005197,0.00027586956,0.004682973,0.12715207],"study_design_scores_gemma":[0.8746652,0.004731399,0.11024199,0.0030974546,0.004607584,0.000017017072,0.00032260205,0.000105189,0.0005552825,0.0010957109,0.00035788893,0.00020268581],"about_ca_topic_score_codex":0.00040216284,"about_ca_topic_score_gemma":0.00007969063,"teacher_disagreement_score":0.12694938,"about_ca_system_score_codex":0.00006738819,"about_ca_system_score_gemma":0.00014927589,"threshold_uncertainty_score":0.48451406},"labels":[],"label_agreement":null},{"id":"W4402267978","doi":"10.1136/ard-2024-226392","title":"Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al","year":2024,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"Childhood Arthritis and Rheumatology Research Alliance; Seattle Children's Research Institute; Lupus Foundation of America","keywords":"Medicine; Lupus erythematosus; Systemic lupus; Intensive care medicine; Dermatology; Internal medicine; Physical therapy; Immunology; Antibody; Disease","score_opus":0.05847393366444291,"score_gpt":0.36463293859393187,"score_spread":0.30615900492948894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402267978","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004606105,0.024719926,0.00024553257,0.95824665,0.0022952396,0.005156394,0.0041782004,0.00007459676,0.00047736723],"genre_scores_gemma":[0.038865663,0.05703697,0.000409103,0.7560899,0.00063248776,0.0053993277,0.0027930313,0.0006864954,0.13808699],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954388,0.00045751192,0.0012883336,0.00057708914,0.001678992,0.0005592774],"domain_scores_gemma":[0.99389875,0.0026064198,0.0008496294,0.0021441225,0.00038628498,0.00011477086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012986613,0.0004981013,0.001126501,0.00029345017,0.00014747719,0.000083615334,0.0013071815,0.00021719618,0.00036155878],"category_scores_gemma":[0.0004683406,0.00027311954,0.0009434214,0.0005045768,0.0002689407,0.00007503704,0.00040767362,0.0006767049,0.00021223105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025917956,0.00018079758,0.000111543675,0.026811728,0.0030049297,0.000035158475,0.00033640632,0.000012882396,0.000008200726,0.00052626536,0.96753573,0.0011771517],"study_design_scores_gemma":[0.00158648,0.00030330996,0.0000208809,0.11878035,0.002292469,0.0018128026,0.0028671685,0.0007072659,0.00019731892,0.0021321636,0.8688576,0.00044214394],"about_ca_topic_score_codex":0.000041826326,"about_ca_topic_score_gemma":0.0000010595726,"teacher_disagreement_score":0.20215671,"about_ca_system_score_codex":0.00009262785,"about_ca_system_score_gemma":0.00029798588,"threshold_uncertainty_score":0.9999721},"labels":[],"label_agreement":null},{"id":"W4402305148","doi":"10.1136/ard-2023-224211","title":"Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease","year":2024,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Cilag; Samsung; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Swedish Orphan Biovitrum; National Institutes of Health; ReCor Medical; King's College London; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Rheumatoid arthritis; Clinical trial; Population; Subclinical infection; Disease; Tocilizumab; Rituximab; Intensive care medicine; Internal medicine; Physical therapy; Immunology","score_opus":0.06963598372682993,"score_gpt":0.4071623247681928,"score_spread":0.33752634104136287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402305148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032664094,0.96141326,0.0000046017235,0.0006262056,0.0002824191,0.0030270275,0.0018737732,0.00004679994,0.000061797335],"genre_scores_gemma":[0.04944734,0.9495476,0.000026094625,0.00012803709,0.00003833292,0.00039791394,0.00013127213,0.00010609774,0.00017731516],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99387324,0.0011461278,0.002664797,0.0005940855,0.0011133231,0.0006084436],"domain_scores_gemma":[0.9956653,0.00091277005,0.0010975992,0.0014010179,0.00018564546,0.00073765236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013031497,0.00064533745,0.0032003657,0.0006537348,0.000081448656,0.00006199099,0.0007562785,0.00018257245,0.00049838016],"category_scores_gemma":[0.0027525197,0.0003877709,0.0024193902,0.00080582127,0.00038584595,0.0001202275,0.00066275964,0.0005302919,0.00025895846],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002147981,0.001194711,0.002724426,0.018727992,0.0018381729,0.000012814702,0.0005293751,0.0000041677717,4.2315668e-7,0.0000963685,0.0059659304,0.9686908],"study_design_scores_gemma":[0.0015752331,0.0012659894,0.026665745,0.67235667,0.0009254211,0.00006881013,0.00023194446,0.00003887801,0.000010588766,0.0066483123,0.28933433,0.0008780964],"about_ca_topic_score_codex":0.00009478488,"about_ca_topic_score_gemma":0.00004248516,"teacher_disagreement_score":0.9678127,"about_ca_system_score_codex":0.000100995094,"about_ca_system_score_gemma":0.0009370943,"threshold_uncertainty_score":0.9998574},"labels":[],"label_agreement":null},{"id":"W4402654079","doi":"10.1136/ard-2024-226286","title":"Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Dutch Arthritis Association; ReumaNederland; Dutch Arthritis Society; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; ZonMw; Leids Universitair Medisch Centrum; Arthritis Society","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Placebo; Randomized controlled trial; Physical therapy; Internal medicine; Arthritis; Alternative medicine; Intensive care medicine; Pathology","score_opus":0.021160463724157415,"score_gpt":0.3249224586951942,"score_spread":0.3037619949710368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402654079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96457285,0.012602925,0.0001058589,0.0002521271,0.00014236609,0.020542167,0.0017073988,0.000022587063,0.00005170771],"genre_scores_gemma":[0.98562795,0.01005843,0.000025763282,0.000025759133,0.000010520514,0.004089167,0.000046645648,0.000046500278,0.00006927906],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99584097,0.0014619504,0.0010123374,0.00040769574,0.0008383051,0.0004387221],"domain_scores_gemma":[0.9931708,0.0047380757,0.00063527323,0.0007996856,0.00047783466,0.00017832355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015149561,0.00036938544,0.0022878249,0.00042963977,0.00013575262,0.00003959495,0.00030904575,0.00008873684,0.0001924757],"category_scores_gemma":[0.0020276434,0.00018520387,0.0018101342,0.0011280214,0.0005434148,0.00015333638,0.000107047854,0.00018246756,0.000002729901],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7596982,0.0022576372,0.14884381,0.0011136719,0.016590243,0.000002799239,0.0013597207,0.0004928009,0.00007930142,0.00013439002,0.0005630557,0.06886434],"study_design_scores_gemma":[0.5501275,0.0019013677,0.427635,0.008669885,0.0014401339,0.0000021225308,0.00023893746,0.0032259498,0.005755293,0.00058688584,0.00014265829,0.00027423206],"about_ca_topic_score_codex":0.00019488466,"about_ca_topic_score_gemma":0.0001362141,"teacher_disagreement_score":0.27879122,"about_ca_system_score_codex":0.000054181874,"about_ca_system_score_gemma":0.00026628913,"threshold_uncertainty_score":0.7552395},"labels":[],"label_agreement":null},{"id":"W4402654293","doi":"10.1136/ard-2024-226224","title":"m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren's disease","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Université Paris-Saclay; Mount Allison University; National Institute of Dental and Craniofacial Research; Fondation pour la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Proinflammatory cytokine; Gene knockdown; Pathogenesis; Salivary gland; Immune system; RNA; Downregulation and upregulation; RNA silencing; Gene silencing; Gene expression; Cell biology; Autoantibody; Immunology; Messenger RNA; Medicine; Inflammation; RNA interference; Gene; Biology; Pathology; Biochemistry; Antibody","score_opus":0.018421951773768097,"score_gpt":0.26299774666864306,"score_spread":0.24457579489487496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402654293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97565967,0.021038264,0.0010896137,0.0012697828,0.000098972225,0.0004646255,0.00019372115,0.000010674635,0.00017468176],"genre_scores_gemma":[0.9989449,0.00054125674,0.00001292934,0.00008877117,0.000048144084,0.0001285149,0.000035672434,0.000011845116,0.00018796528],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999298,0.00010194131,0.00017946414,0.00020038841,0.000111509806,0.00010870663],"domain_scores_gemma":[0.9995561,0.000027307793,0.00007180732,0.00023131173,0.0000475458,0.00006590989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012742242,0.00009945783,0.000113903596,0.000043913373,0.000060715385,0.000050603892,0.00008967818,0.000037997823,0.000015372783],"category_scores_gemma":[0.00010383177,0.000070129056,0.000095270785,0.00009368923,0.000086464446,0.000012899438,0.000045351222,0.000043505086,0.0000026959099],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042409943,0.0015057969,0.016754005,0.0025743174,0.0009594231,0.000006797798,0.0010996195,0.004560473,0.61445504,0.0035528247,0.0069898665,0.34330082],"study_design_scores_gemma":[0.0028812382,0.00068064174,0.775353,0.0014628406,0.0005663105,0.0000031232344,0.0005827487,0.014861233,0.107592,0.085765675,0.009480009,0.0007711629],"about_ca_topic_score_codex":0.000071181115,"about_ca_topic_score_gemma":0.000011669936,"teacher_disagreement_score":0.758599,"about_ca_system_score_codex":0.0000057622756,"about_ca_system_score_gemma":0.000114285445,"threshold_uncertainty_score":0.285978},"labels":[],"label_agreement":null},{"id":"W4402812243","doi":"10.1136/ard-2024-226280","title":"Clinical information on imaging referrals for suspected or known axial spondyloarthritis: recommendations from the Assessment of Spondyloarthritis International Society (ASAS)","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Leeds Biomedical Research Centre; Swedish Orphan Biovitrum; National Institute for Health and Care Research; UCB Pharma; Regeneron Pharmaceuticals; Medac; University College London; Celgene; Gilead Sciences; Sanofi; University College London Hospitals NHS Foundation Trust; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Medical physics; Ankylosing spondylitis; Axial spondyloarthritis; Delphi method; CLARITY; Modalities; Medical diagnosis; Sacroiliitis; Physical therapy; Radiology; Artificial intelligence; Surgery","score_opus":0.07194516021132882,"score_gpt":0.4168023899607689,"score_spread":0.3448572297494401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402812243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8798018,0.007394924,0.00060197676,0.08483444,0.005202631,0.0033230043,0.014991152,0.00020177047,0.0036483095],"genre_scores_gemma":[0.99002415,0.005820303,0.0012141736,0.0011938739,0.00023732148,0.00019639898,0.0009317015,0.00002301177,0.0003590729],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99802,0.00010746271,0.0009664299,0.00022556481,0.0004627173,0.00021780314],"domain_scores_gemma":[0.9971833,0.0016203768,0.0003292684,0.0004377265,0.00034294685,0.00008635145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041924434,0.00019970353,0.00045988412,0.00006601842,0.00020529912,0.00008325406,0.00026252263,0.000053229,0.00047541066],"category_scores_gemma":[0.00096701813,0.000114126655,0.0007267293,0.00023844434,0.00022676427,0.00031971047,0.00012994315,0.0001573178,0.0000132970345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009756058,0.0011499685,0.028417215,0.00035059586,0.002498993,0.000009991856,0.0009766927,0.000014376905,0.000017492972,0.00579338,0.3817271,0.57806855],"study_design_scores_gemma":[0.009847965,0.0013585424,0.7481636,0.014377075,0.0011500366,0.000037745307,0.0041207937,0.005983656,0.00024175609,0.006811593,0.20747674,0.0004305233],"about_ca_topic_score_codex":0.00009158787,"about_ca_topic_score_gemma":0.000036762183,"teacher_disagreement_score":0.71974635,"about_ca_system_score_codex":0.000048361013,"about_ca_system_score_gemma":0.000299777,"threshold_uncertainty_score":0.5205413},"labels":[],"label_agreement":null},{"id":"W4403183912","doi":"10.1136/ard-2024-225928","title":"Cell and transcriptomic diversity of infrapatellar fat pad during knee osteoarthritis","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary; Public Health Ontario; Research Canada; Princess Margaret Cancer Centre; Toronto Rehabilitation Institute; Arthritis Society; University of Toronto; University Health Network","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Research Foundation; Canada Foundation for Innovation; Canadian Arthritis Network; Arthritis Society; Canada Research Chairs; University Health Network","keywords":"Infrapatellar fat pad; Medicine; Osteoarthritis; Fat pad; Transcriptome; Bioinformatics; Adipose tissue; Pathology; Internal medicine; Gene; Biology; Gene expression; Genetics; Alternative medicine","score_opus":0.018969623937014235,"score_gpt":0.24426087862630114,"score_spread":0.2252912546892869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403183912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725525,0.026134985,0.0000029352352,0.00023464682,0.00016055592,0.00035421242,0.00014448285,0.000037599566,0.00037811467],"genre_scores_gemma":[0.9976784,0.0017323147,0.0000293056,0.00004479487,0.000014306928,0.0000071570507,0.000008659267,0.0000137744055,0.00047131366],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992068,0.00003596248,0.00022749159,0.00014928017,0.00022845049,0.00015202325],"domain_scores_gemma":[0.9995032,0.000059091522,0.00006147436,0.00022720113,0.000043514276,0.00010551776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053209686,0.00012688634,0.00030037717,0.000078459656,0.00008858571,0.000013543576,0.00007884997,0.000039061513,0.00009598183],"category_scores_gemma":[0.00002883935,0.00009035911,0.00022220319,0.00011671453,0.00011192445,0.00010058887,0.0001110229,0.00005361411,0.000007309169],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020917177,0.002218427,0.12878853,0.03138602,0.0014603143,0.0003687384,0.017196702,0.000019612608,0.077147804,0.0024336297,0.003280136,0.73360837],"study_design_scores_gemma":[0.01296664,0.006301583,0.20559175,0.022090487,0.0030277139,0.0001273962,0.0032623175,0.00015688637,0.7320745,0.013164883,0.00048830063,0.00074750895],"about_ca_topic_score_codex":0.000024027464,"about_ca_topic_score_gemma":0.0000049771006,"teacher_disagreement_score":0.73286086,"about_ca_system_score_codex":0.000006595051,"about_ca_system_score_gemma":0.00003150284,"threshold_uncertainty_score":0.36847377},"labels":[],"label_agreement":null},{"id":"W4403213438","doi":"10.1136/ard-2024-226528","title":"Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Ottawa; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Childhood Arthritis and Rheumatology Research Alliance; Arthritis Foundation","keywords":"Medicine; Immunology; Systemic lupus erythematosus; Pathology; Disease","score_opus":0.1521768462911787,"score_gpt":0.4113319354169385,"score_spread":0.2591550891257598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403213438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889481,0.005585555,0.000032483676,0.0011445159,0.0003952703,0.0019952059,0.0017675332,0.000035111567,0.00009623328],"genre_scores_gemma":[0.9982399,0.00017303677,0.00063546863,0.000031248113,0.000030718875,0.00029671402,0.00028697855,0.00003717184,0.0002687872],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99678165,0.00021786321,0.0010292764,0.00040438486,0.0011543165,0.00041251906],"domain_scores_gemma":[0.9961214,0.0021236641,0.00023035449,0.0008273327,0.0005069903,0.000190271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018666424,0.00021054498,0.0006330029,0.0005142865,0.00009305368,0.000050225128,0.0005031938,0.00008509804,0.0000400013],"category_scores_gemma":[0.004598195,0.00014374754,0.00017585425,0.00044352864,0.00039550103,0.000051542036,0.00022141219,0.00019705146,0.000004842171],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005120879,0.0030313325,0.5578958,0.116151124,0.0037433577,0.0002911361,0.020801505,0.000147631,0.004575274,0.002089373,0.26405403,0.022098579],"study_design_scores_gemma":[0.052834123,0.001678973,0.16178507,0.5239397,0.0012855371,0.035641715,0.07065257,0.06931829,0.055744544,0.014147459,0.010214693,0.0027573039],"about_ca_topic_score_codex":0.000060605173,"about_ca_topic_score_gemma":0.000020241745,"teacher_disagreement_score":0.4077886,"about_ca_system_score_codex":0.00009422778,"about_ca_system_score_gemma":0.0014456885,"threshold_uncertainty_score":0.58618546},"labels":[],"label_agreement":null},{"id":"W4403512567","doi":"10.1136/ard-2024-225876","title":"Single-cell transcriptomics reveal potent extrafollicular B cell response linked with granzyme K+ CD8 T cell activation in lupus kidney","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Science and Technology Plan Project of Taizhou; Beijing Institute of Genomics, Chinese Academy of Sciences; Renji Hospital; Shanghai Hospital Development Center; Chinese Academy of Sciences; Science and Technology Program of Suzhou; National Natural Science Foundation of China","keywords":"Medicine; Cytotoxic T cell; Granzyme B; Systemic lupus erythematosus; Kidney; B cell; CD8; Cell; Granzyme; Immunology; Granzyme A; T cell; Molecular biology; Immune system; Biology; Perforin; Pathology; Antibody; Internal medicine; Biochemistry; In vitro","score_opus":0.036440947030319484,"score_gpt":0.2851039771190901,"score_spread":0.2486630300887706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777366,0.004043662,0.00020494244,0.0053336443,0.00025917127,0.0014715451,0.00007052853,0.000091247195,0.00075159944],"genre_scores_gemma":[0.99378854,0.00035408832,0.0001886753,0.00039932563,0.000038235296,0.000084436884,0.00003349852,0.00008131252,0.0050318656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99677247,0.000540359,0.0007379263,0.00043614948,0.0010207415,0.0004923831],"domain_scores_gemma":[0.9977581,0.0006240722,0.0001911425,0.0008355395,0.00019986756,0.0003912756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087597925,0.00031920255,0.0006141809,0.00037531482,0.00007327898,0.00007643496,0.0003693693,0.00012624456,0.0000634828],"category_scores_gemma":[0.0004837464,0.00020148508,0.00036644502,0.000780833,0.00016450418,0.00018824566,0.00006278492,0.00029778166,0.000036187652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025837222,0.009514291,0.028495422,0.072786674,0.0008188088,0.00066777645,0.019384002,0.0007365649,0.7525591,0.00014984567,0.08157629,0.007473967],"study_design_scores_gemma":[0.021307759,0.0037991537,0.012720946,0.09003297,0.0015791055,0.0020726616,0.009458627,0.010112735,0.83585876,0.0022630857,0.0088909045,0.001903269],"about_ca_topic_score_codex":0.00008028353,"about_ca_topic_score_gemma":0.0000032748687,"teacher_disagreement_score":0.083299644,"about_ca_system_score_codex":0.0001369082,"about_ca_system_score_gemma":0.0007648021,"threshold_uncertainty_score":0.8216323},"labels":[],"label_agreement":null},{"id":"W4403513410","doi":"10.1136/ard-2023-225434","title":"Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japanese Society of Nephrology; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Tolerability; Placebo; Osteoarthritis; Analgesic; Physical therapy; Knee pain; Internal medicine; Adverse effect; Anesthesia; Alternative medicine; Pathology","score_opus":0.0225735015094313,"score_gpt":0.31362086917347015,"score_spread":0.2910473676640388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403513410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814253,0.0090373345,0.00006660123,0.00022239219,0.000059746642,0.008897848,0.00026214978,0.000018049255,0.000010579084],"genre_scores_gemma":[0.999388,0.00019515335,0.00010785892,0.000031488624,0.00001114849,0.00016346603,0.000060901126,0.00003064801,0.000011344747],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99725205,0.0004042172,0.0010640151,0.0005091727,0.00047666943,0.00029388384],"domain_scores_gemma":[0.9981459,0.00057195855,0.00040579354,0.00039904358,0.00020624328,0.00027108207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089498085,0.00035578705,0.0015969169,0.0002432702,0.00008917391,0.000033822507,0.00009499976,0.000081815255,0.000013943865],"category_scores_gemma":[0.00025586906,0.00023481087,0.00013728332,0.0002568461,0.00044970558,0.00024865492,0.00009753926,0.00012962992,5.5977438e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51384205,0.009812329,0.06325277,0.003901441,0.0009107983,0.000030191259,0.0053731613,0.000026888456,0.00012955946,0.00025729023,0.0000063434113,0.40245715],"study_design_scores_gemma":[0.8777713,0.06240117,0.037387297,0.0077329553,0.0016866617,0.000028217346,0.0027982073,0.00236398,0.0063080913,0.0010335105,0.000004085937,0.00048449775],"about_ca_topic_score_codex":0.00012634778,"about_ca_topic_score_gemma":0.00008009263,"teacher_disagreement_score":0.40197265,"about_ca_system_score_codex":0.000013010758,"about_ca_system_score_gemma":0.00019145806,"threshold_uncertainty_score":0.9575309},"labels":[],"label_agreement":null},{"id":"W4403869038","doi":"10.1136/ard-2024-226226","title":"Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjögren's disease","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Margaret M. and Albert B. Alkek Department of Medicine","keywords":"Autoantibody; Immunology; Medicine; Antibody; Autoimmunity; Pathogenesis; Antigen; Virus; Epstein–Barr virus; Molecular mimicry; Ribonucleoprotein; Virology; Biology; Gene","score_opus":0.06460551334220974,"score_gpt":0.34090578600926896,"score_spread":0.27630027266705925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403869038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645594,0.013943063,0.00012621447,0.01942246,0.0008524944,0.0006446405,0.00015586065,0.00012839992,0.00016749052],"genre_scores_gemma":[0.9863054,0.011734921,0.0000094314255,0.00045492288,0.000058333953,0.00007355517,0.00007484036,0.000022908138,0.0012656482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868476,0.000103787694,0.00030415945,0.00030681357,0.00038424766,0.0002162188],"domain_scores_gemma":[0.9990151,0.00015643069,0.00011769328,0.00046963873,0.00006836772,0.00017275185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001632378,0.00017678166,0.0002720072,0.00015983889,0.000096758464,0.00005050364,0.000111130474,0.000042745894,0.0002172139],"category_scores_gemma":[0.0007876531,0.00011634275,0.0002626331,0.00046738348,0.00012491469,0.00035386698,0.000057778023,0.00012270393,0.000029892179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076459534,0.001347527,0.79443717,0.002530278,0.000652179,0.00003399087,0.0005632318,0.0005182549,0.00070299505,0.00042987216,0.17850095,0.019518955],"study_design_scores_gemma":[0.0004493336,0.00020140375,0.9819542,0.007762239,0.0009642632,0.000018031984,0.00012657093,0.0031157075,0.0011523439,0.0020352874,0.0019708078,0.0002498192],"about_ca_topic_score_codex":0.00048835145,"about_ca_topic_score_gemma":0.000037865146,"teacher_disagreement_score":0.18751702,"about_ca_system_score_codex":0.000026614343,"about_ca_system_score_gemma":0.00019419758,"threshold_uncertainty_score":0.47443196},"labels":[],"label_agreement":null},{"id":"W4404372684","doi":"10.1136/ard-2024-226150","title":"Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium","year":2024,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Argenx; Vanderbilt University Medical Center; UCB Pharma; Regeneron Pharmaceuticals; RRF Foundation for Aging; University of Utah; Cleveland Clinic; New York University; University of Pennsylvania; Gilead Sciences; Vanderbilt University; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Celgene; Sanofi Genzyme; Rheumatology Research Foundation; Sanofi; Amgen; Pfizer; York University; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Cohort; Arthritis; Association (psychology); Cohort study; Longitudinal study; Dermatology; Internal medicine; Pathology","score_opus":0.05402216690792375,"score_gpt":0.3489364624393946,"score_spread":0.29491429553147086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404372684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564943,0.03273941,0.0000025100478,0.0071717454,0.0003118313,0.002550843,0.00043311965,0.000067379195,0.00022889198],"genre_scores_gemma":[0.98081964,0.017632864,0.000018852596,0.00010816853,0.00011072731,0.00050303317,0.00003531641,0.000043752007,0.000727618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965438,0.00093442027,0.0005779075,0.0005248485,0.0009399404,0.00047906637],"domain_scores_gemma":[0.99481666,0.0037230304,0.00021749863,0.00077604625,0.0002962594,0.00017050246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011838021,0.0003368574,0.0008008516,0.0001444611,0.00051181426,0.00017226418,0.00017242084,0.00005093398,0.00011685244],"category_scores_gemma":[0.0009618978,0.00016732476,0.00021892173,0.0006613218,0.0003122119,0.00012412912,0.00013733587,0.00019757132,0.000026814494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029439568,0.0018574469,0.83769524,0.00013724448,0.007304414,0.00014783377,0.0056767417,0.000006984428,0.0000054574803,0.00020235304,0.006522662,0.13749966],"study_design_scores_gemma":[0.0036518811,0.0021626442,0.9840091,0.0034234375,0.0008430169,0.000013941181,0.0037224086,0.00012958718,0.00006258096,0.0013044927,0.0005083303,0.00016857381],"about_ca_topic_score_codex":0.0043437653,"about_ca_topic_score_gemma":0.0045537557,"teacher_disagreement_score":0.14631386,"about_ca_system_score_codex":0.00023652628,"about_ca_system_score_gemma":0.0003279827,"threshold_uncertainty_score":0.68233055},"labels":[],"label_agreement":null},{"id":"W4404873431","doi":"10.1136/ard-2024-226446","title":"Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults","year":2025,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Osteomyelitis and Bone Disorders Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Universiteit Leiden","keywords":"Medicine; Osteitis; Dermatology; MEDLINE; Consensus conference; Intensive care medicine; Surgery; Osteomyelitis; Internal medicine","score_opus":0.12914556715327907,"score_gpt":0.4313630841725496,"score_spread":0.3022175170192705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404873431","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00157966,0.9866774,7.900279e-7,0.005762625,0.0001698414,0.0039232876,0.0018250218,0.000004805572,0.000056565095],"genre_scores_gemma":[0.0017109083,0.99558204,0.000016195008,0.000036409656,0.00005341716,0.0020924604,0.00022520883,0.000019536257,0.0002637947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849147,0.00016387584,0.0007192583,0.00022180806,0.00017968594,0.00022389309],"domain_scores_gemma":[0.9961461,0.0028166142,0.00032174584,0.00051447796,0.0001316069,0.00006947465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013035901,0.00024010908,0.0013618025,0.00014274329,0.00007935035,0.000017256458,0.00018010841,0.00008334228,0.00013085628],"category_scores_gemma":[0.0007530612,0.00012102284,0.00063270633,0.00022994055,0.00019976428,0.000018349627,0.00007899007,0.00005971886,0.0000011758591],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001111156,0.00053024467,0.00006047056,0.026412183,0.00040237274,0.0000010393053,0.00016538425,1.7457239e-7,6.4633674e-8,0.000020405982,0.0073673907,0.96492916],"study_design_scores_gemma":[0.0041925833,0.0017852408,0.0014903459,0.27596918,0.0017712738,0.00000877277,0.00058114354,0.00008136865,0.000025359133,0.00013204731,0.71369195,0.00027075424],"about_ca_topic_score_codex":0.00071012415,"about_ca_topic_score_gemma":0.00019930003,"teacher_disagreement_score":0.9646584,"about_ca_system_score_codex":0.000054489745,"about_ca_system_score_gemma":0.0007768955,"threshold_uncertainty_score":0.4935168},"labels":[],"label_agreement":null},{"id":"W4406045900","doi":"10.1016/s0003-4967(24)43295-0","title":"Author's reply: Long term treatment of psoriatic arthritis with infliximab","year":2004,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Infliximab; Dermatology; Term (time); Psoriasis; Arthritis; Immunology; Tumor necrosis factor alpha","score_opus":0.03586594076970206,"score_gpt":0.3114960722350745,"score_spread":0.2756301314653724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406045900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819056,0.014126028,0.000010767228,0.0028391774,0.00009069096,0.0006369818,0.00008292164,0.000027320564,0.00028052717],"genre_scores_gemma":[0.9958382,0.0034604205,0.00018333549,0.00014190642,0.000022455184,0.0000725712,0.000017014705,0.000020387564,0.0002437009],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988183,0.000028728757,0.00039924963,0.0001839288,0.000348121,0.00022170959],"domain_scores_gemma":[0.9988414,0.00006284639,0.0002732126,0.00057600735,0.00012466307,0.00012186542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039043534,0.00019465781,0.0005920769,0.00005810468,0.00008833275,0.000009029538,0.000086847846,0.000025111001,0.00005910313],"category_scores_gemma":[0.00011498725,0.00010818064,0.0002637059,0.00018169182,0.00020268714,0.00006264726,0.000034539702,0.000026183936,0.000008503696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019867343,0.011049332,0.34969485,0.0012573497,0.00533254,0.00029072489,0.0036799712,0.00014272962,0.000043518707,0.0012555957,0.00087784237,0.6243888],"study_design_scores_gemma":[0.01085682,0.0034590126,0.97303957,0.0053530824,0.000752254,0.00008454374,0.00031486736,0.0000046635714,0.00425483,0.0015645863,0.00015298043,0.00016277365],"about_ca_topic_score_codex":0.00025196042,"about_ca_topic_score_gemma":0.00005727378,"teacher_disagreement_score":0.62422603,"about_ca_system_score_codex":0.000038946924,"about_ca_system_score_gemma":0.00013911915,"threshold_uncertainty_score":0.44114783},"labels":[],"label_agreement":null},{"id":"W4406973781","doi":"10.1016/j.ard.2024.11.006","title":"EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteomyelitis and Bone Disorders Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Western University; BC Children's Hospital; University of British Columbia","funders":"European League Against Rheumatism; Seattle Children's Research Institute; Rheumatology Research Foundation","keywords":"Medicine; Osteomyelitis; Dermatology; Pediatrics; Intensive care medicine; Surgery","score_opus":0.06629248777290449,"score_gpt":0.39303924184112365,"score_spread":0.3267467540682192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406973781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95457727,0.007317841,0.00032921543,0.032259237,0.000668499,0.0022958268,0.0005408605,0.00005874479,0.0019525294],"genre_scores_gemma":[0.99596435,0.0013155483,0.00009177743,0.0003391774,0.0002506891,0.00021863762,0.00014350827,0.00002077931,0.0016555402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998448,0.00011701623,0.00050402497,0.00025333118,0.00033317364,0.00034443563],"domain_scores_gemma":[0.9984618,0.00027111717,0.00016659577,0.0006025472,0.0003834061,0.00011452862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027663226,0.00016211957,0.00041339584,0.000164251,0.0001470671,0.00005483421,0.00027829266,0.000073859715,0.00032270694],"category_scores_gemma":[0.0011322453,0.00011472303,0.00040318695,0.00039644574,0.00015613611,0.00010002064,0.0001088481,0.00008111517,0.00001638765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013154243,0.00068717176,0.00687725,0.007696016,0.0005199692,0.0000027567423,0.00022357423,0.0000058625465,0.0065890267,0.0050883093,0.08710549,0.88388914],"study_design_scores_gemma":[0.009099613,0.0018345658,0.9013145,0.004595447,0.001091564,0.000010222655,0.000924873,0.0047981404,0.010762443,0.017081164,0.04792101,0.00056648266],"about_ca_topic_score_codex":0.000052271873,"about_ca_topic_score_gemma":0.000009710956,"teacher_disagreement_score":0.89443725,"about_ca_system_score_codex":0.000040993906,"about_ca_system_score_gemma":0.0005518435,"threshold_uncertainty_score":0.46782693},"labels":[],"label_agreement":null},{"id":"W4407053259","doi":"10.1016/j.ard.2025.01.025","title":"Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Toronto Western Hospital","funders":"AstraZeneca","keywords":"Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Propensity score matching; Rheumatology; Systemic lupus erythematosus; Clinical trial; Confidence interval; Disease","score_opus":0.032844651131317085,"score_gpt":0.3620983569068815,"score_spread":0.32925370577556445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407053259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995573,0.000119097116,0.000023050017,0.00085078605,0.00008939104,0.001851523,0.000201333,0.000019676618,0.0012721684],"genre_scores_gemma":[0.99920803,0.000026101756,0.000071531875,0.00015081801,0.000008884403,0.000053243413,0.000034984434,0.000019878576,0.0004265153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997862,0.00018641545,0.0006140481,0.00022443902,0.00086934614,0.000243784],"domain_scores_gemma":[0.99769855,0.00030790735,0.0002690278,0.0006947426,0.0008986771,0.00013110544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017013712,0.00016465929,0.0007450636,0.00033183704,0.000048452606,0.000018901928,0.0002862239,0.000033184107,0.00004328161],"category_scores_gemma":[0.0009592697,0.00010625166,0.000109675006,0.000613796,0.00008060265,0.00006591145,0.00009132003,0.00009132092,0.000003997581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013710855,0.0004909776,0.9730785,0.003345448,0.00022425671,0.0000042351453,0.0025535193,0.0009975982,0.00021422727,0.0005581734,0.0025463318,0.0022759172],"study_design_scores_gemma":[0.009705394,0.0006900664,0.9584891,0.02480113,0.000113422466,0.0000015972914,0.0018122714,0.00072741805,0.0032600726,0.00025993958,0.000012260446,0.00012731868],"about_ca_topic_score_codex":0.0006027704,"about_ca_topic_score_gemma":0.0004444213,"teacher_disagreement_score":0.021455681,"about_ca_system_score_codex":0.00016537988,"about_ca_system_score_gemma":0.00041211277,"threshold_uncertainty_score":0.4332817},"labels":[],"label_agreement":null},{"id":"W4407167998","doi":"10.1016/j.ard.2024.12.003","title":"Response to Correspondence on ‘Why the term nr-axSpA should not be used for diagnosis’","year":2025,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University Health Network","funders":"","keywords":"Medicine; MEDLINE; Bioinformatics; Internal medicine","score_opus":0.11306773639883357,"score_gpt":0.37389857041029484,"score_spread":0.2608308340114613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407167998","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08568176,0.0015762086,0.000004305738,0.90614486,0.00076162536,0.0028946842,0.0027701012,0.000042194173,0.00012427403],"genre_scores_gemma":[0.08326182,0.0008501646,0.000023408238,0.9022932,0.00025687937,0.0021663988,0.00013416776,0.00006308673,0.010950877],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709684,0.00033809105,0.0005610742,0.00048783005,0.001004966,0.0005112014],"domain_scores_gemma":[0.9908187,0.0069729686,0.000326521,0.001507835,0.00024850128,0.00012552022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039766423,0.0004795386,0.00094987295,0.00019666282,0.00033605477,0.00005545392,0.00068841997,0.00020893388,0.00016251282],"category_scores_gemma":[0.005145671,0.00025833322,0.00085314835,0.0003031001,0.00022693371,0.00003872285,0.0002675123,0.00036940514,0.000030161218],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044589317,0.00036633367,0.001574659,0.0006061421,0.0008320563,0.000059392074,0.00027233514,0.00000467021,0.000004577803,0.00004810205,0.98719823,0.004574581],"study_design_scores_gemma":[0.0026241757,0.0016900504,0.045497812,0.012368946,0.0014462925,0.000009800097,0.0001469855,0.000009972708,0.0010500982,0.00047191314,0.9342921,0.0003919061],"about_ca_topic_score_codex":0.000082721504,"about_ca_topic_score_gemma":0.000018157958,"teacher_disagreement_score":0.05290617,"about_ca_system_score_codex":0.000057528014,"about_ca_system_score_gemma":0.00026897583,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W4407168149","doi":"10.1016/j.ard.2025.01.007","title":"Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Race and Difference Initiative, Emory University","keywords":"Medicine; Discontinuation; Axial spondyloarthritis; Internal medicine; Oncology; Ankylosing spondylitis; Sacroiliitis","score_opus":0.0813476918818714,"score_gpt":0.41675798024261534,"score_spread":0.33541028836074394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407168149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907521,0.0071102125,0.0000012148071,0.0011191557,0.00010094595,0.00043056704,0.00010350789,0.000008308672,0.00037397884],"genre_scores_gemma":[0.98534614,0.014352127,0.000009602307,0.00012705658,0.000016649697,0.000018547866,0.000018738117,0.000005655759,0.00010551055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989566,0.000099539895,0.00051477004,0.00016182815,0.00013038173,0.00013685039],"domain_scores_gemma":[0.99901986,0.0004065295,0.00020312698,0.00026215406,0.000059847393,0.00004850966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020095006,0.00012533179,0.00055433076,0.00008227137,0.000050535993,0.0000056857066,0.000071432936,0.000048122685,0.00004609368],"category_scores_gemma":[0.00080107205,0.00006955863,0.00028230037,0.0001870632,0.00018662162,0.000032620563,0.000047191697,0.00006055889,0.0000015019964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010400853,0.0013386316,0.78741866,0.000050135433,0.00029334024,0.000003990535,0.000072441886,0.000009995917,0.000005208132,0.00015973081,0.00032129514,0.20928651],"study_design_scores_gemma":[0.0038323367,0.0017643524,0.9915004,0.0012442964,0.00004586424,0.0000013205612,0.000047949463,0.00005589243,0.00012423178,0.0012698803,0.000062185034,0.000051284125],"about_ca_topic_score_codex":0.00026658466,"about_ca_topic_score_gemma":0.0000888492,"teacher_disagreement_score":0.20923522,"about_ca_system_score_codex":0.000008655652,"about_ca_system_score_gemma":0.00006640402,"threshold_uncertainty_score":0.28365186},"labels":[],"label_agreement":null},{"id":"W4407314293","doi":"10.1136/annrheumdis-2019-eular.1325","title":"FRI0464B EFFECT OF FILGOTINIB ON PATIENT-REPORTED OUTCOMES IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Randomized controlled trial; Arthritis; Physical therapy","score_opus":0.022414113430780123,"score_gpt":0.3360329780539362,"score_spread":0.3136188646231561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407314293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904373,0.0033008466,0.000001587928,0.00043198545,0.0002670274,0.0047611883,0.0005173505,0.00002897774,0.0002537278],"genre_scores_gemma":[0.99714226,0.0024009515,0.000012864543,0.00008093533,0.000011770037,0.00021488573,0.000060581948,0.000028280267,0.000047472065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99550164,0.0012829985,0.0014541661,0.0003654414,0.0010490286,0.00034672357],"domain_scores_gemma":[0.99273103,0.005076794,0.0008498636,0.0009907305,0.0001708717,0.00018071428],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00095368247,0.00030389463,0.0020076314,0.00023369727,0.000044910255,0.000019680478,0.00025885628,0.00005540748,0.00022383893],"category_scores_gemma":[0.01096391,0.00017593314,0.0006000585,0.00028088767,0.00020935856,0.0001413439,0.00010184058,0.00019164462,0.000036337628],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.508704,0.014044934,0.052821953,0.00044446968,0.005394431,0.000078213256,0.008157755,0.00007178554,0.00012459197,0.00012862483,0.00079458376,0.40923467],"study_design_scores_gemma":[0.81234133,0.01051216,0.14872403,0.011012948,0.00021257799,0.0000048344173,0.0025901787,0.0006973187,0.010759453,0.0027277265,0.000027059752,0.00039037273],"about_ca_topic_score_codex":0.0009865147,"about_ca_topic_score_gemma":0.000032882577,"teacher_disagreement_score":0.4088443,"about_ca_system_score_codex":0.000019221285,"about_ca_system_score_gemma":0.0001395571,"threshold_uncertainty_score":0.99736714},"labels":[],"label_agreement":null},{"id":"W4407399999","doi":"10.1016/j.ard.2025.01.012","title":"Deep learning–based clustering for endotyping and post-arthroplasty response classification using knee osteoarthritis multiomic data","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Princess Margaret Cancer Centre; Western University; University Health Network","funders":"Canada Foundation for Innovation; Race and Difference Initiative, Emory University; Natural Sciences and Engineering Research Council of Canada; University Health Network Foundation; Canada Research Chairs; Canadian Arthritis Network; Arthritis Society","keywords":"Medicine; Osteoarthritis; Cluster analysis; Arthroplasty; Artificial intelligence; Physical therapy; Physical medicine and rehabilitation; Surgery; Pathology; Computer science","score_opus":0.0639821070942009,"score_gpt":0.338414869444733,"score_spread":0.2744327623505321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407399999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897385,0.0029066575,0.0043650386,0.0014551474,0.00021362492,0.0010810068,0.00016656768,0.000049518698,0.000023907343],"genre_scores_gemma":[0.997104,0.00009975667,0.0020290879,0.00033665047,0.000015588537,0.00005368121,0.00014639382,0.000020286774,0.00019458873],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988748,0.00015365689,0.0003360572,0.00027641788,0.00015246133,0.00020663004],"domain_scores_gemma":[0.9984122,0.0005443032,0.00018756816,0.00057674386,0.00019673181,0.00008246276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000259656,0.00015369378,0.0003021987,0.00013363973,0.00023759881,0.000037059533,0.00012458465,0.000052669544,0.00001244471],"category_scores_gemma":[0.0020060872,0.00012317109,0.00011358621,0.00013159345,0.00010910295,0.00015437634,0.00014673348,0.00006443149,0.0000016489412],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007623998,0.00043236258,0.0074197184,0.0015511162,0.00025680143,0.000005822554,0.00029802724,0.00045793504,0.025110846,0.00041012914,0.00010342717,0.9563298],"study_design_scores_gemma":[0.024803752,0.0048483484,0.19885343,0.015522242,0.002137112,0.000059595193,0.0033065379,0.7333762,0.014404392,0.0010562367,0.00096028385,0.000671884],"about_ca_topic_score_codex":0.0000195556,"about_ca_topic_score_gemma":0.0000272172,"teacher_disagreement_score":0.95565796,"about_ca_system_score_codex":0.000019746027,"about_ca_system_score_gemma":0.00016978252,"threshold_uncertainty_score":0.50227714},"labels":[],"label_agreement":null},{"id":"W4407425167","doi":"10.1016/j.ard.2025.01.017","title":"Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European League Against Rheumatism; Ministerio de Ciencia e Innovación","keywords":"Medicine; Physical therapy; Alternative medicine; MEDLINE; Patient education; Intensive care medicine; Family medicine; Pathology","score_opus":0.02697106651607339,"score_gpt":0.40909785010017724,"score_spread":0.38212678358410385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407425167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9458141,0.03756993,0.000045324712,0.0106332805,0.00011249608,0.005638847,0.000113181944,0.000010658366,0.00006218013],"genre_scores_gemma":[0.99244153,0.0050756494,0.000059134578,0.0018840196,0.000015054918,0.00048060226,0.000010322645,0.0000051500165,0.000028525881],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985088,0.000642527,0.00042855644,0.00009969878,0.00017345272,0.00014692699],"domain_scores_gemma":[0.99851996,0.00073282234,0.0002436829,0.00022934613,0.00022474973,0.0000494537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046513387,0.00009287966,0.00031776636,0.000059232054,0.00018825293,0.000004589769,0.00010191485,0.000029707691,0.0000024903597],"category_scores_gemma":[0.00044571492,0.00005352586,0.00010099546,0.00024787753,0.000017219261,0.00006434755,0.000061162624,0.000095965304,5.8205745e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005114503,0.00025476678,0.002677965,0.96740586,0.00007938763,2.4272893e-7,0.012608282,0.0000076027604,7.374943e-7,0.0011903092,0.0021331015,0.013590625],"study_design_scores_gemma":[0.00044506358,0.000043984786,0.13136752,0.84889805,0.0003352143,3.9758473e-7,0.01691701,0.00021696549,0.000026521415,0.0014906937,0.00012826153,0.00013033334],"about_ca_topic_score_codex":0.000015093709,"about_ca_topic_score_gemma":0.000007690411,"teacher_disagreement_score":0.12868956,"about_ca_system_score_codex":0.000032216045,"about_ca_system_score_gemma":0.00029366036,"threshold_uncertainty_score":0.21827212},"labels":[],"label_agreement":null},{"id":"W4407556868","doi":"10.1016/j.ard.2025.01.031","title":"Anti-myxovirus resistance protein 1: a novel biomarker for autoimmune myositis and interstitial lung disease in systemic lupus erythematosus","year":2025,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of British Columbia; University of Calgary; McGill University; McGill University Health Centre; Mitel (Canada)","funders":"Institut de recherche, Centre universitaire de santé McGill","keywords":"Medicine; Interstitial lung disease; Myositis; Biomarker; Immunology; Systemic lupus erythematosus; Systemic disease; Autoimmune disease; Connective tissue disease; Disease; Antibody; Lung; Pathology; Immunopathology; Internal medicine","score_opus":0.02249956335370099,"score_gpt":0.2801103251077056,"score_spread":0.2576107617540046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407556868","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41991642,0.058057424,0.0008518891,0.49930206,0.0020539488,0.012255495,0.0068742963,0.00022813989,0.0004603242],"genre_scores_gemma":[0.90296245,0.0011017842,0.00022420903,0.08661231,0.00034696993,0.0016803938,0.00049698615,0.0001653621,0.0064095664],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970357,0.0001734356,0.0011612078,0.00053430063,0.00053855265,0.0005568122],"domain_scores_gemma":[0.99750096,0.00039630593,0.0006778193,0.0010234826,0.0002503627,0.00015104617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027207,0.0005326987,0.0014059427,0.0003750906,0.00016077181,0.000086279,0.00041414556,0.00030185323,0.000023478491],"category_scores_gemma":[0.0007340999,0.00040406393,0.0006100686,0.00028707512,0.0003384145,0.00013653046,0.0002517549,0.00041534376,0.000002495759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021048477,0.00031637837,0.004993788,0.09800779,0.00093564123,0.00070695765,0.0003672452,0.000007663934,0.000203426,0.0005909824,0.8905867,0.0011785929],"study_design_scores_gemma":[0.023171874,0.00033736645,0.13897288,0.6650988,0.006717497,0.0016209888,0.0006767198,0.012481372,0.0009111417,0.0054219803,0.14062366,0.0039657615],"about_ca_topic_score_codex":0.00008330367,"about_ca_topic_score_gemma":0.0000072217185,"teacher_disagreement_score":0.74996305,"about_ca_system_score_codex":0.00008147609,"about_ca_system_score_gemma":0.00053908606,"threshold_uncertainty_score":0.9998411},"labels":[],"label_agreement":null},{"id":"W4407582812","doi":"10.1016/j.ard.2025.01.035","title":"The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis","year":2025,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Leeds Biomedical Research Centre; National Institute for Health and Care Research; Assessment of SpondyloArthritis international Society","keywords":"Medicine; Axial spondyloarthritis; Refractory (planetary science); Consensus conference; Medical physics; Spondylitis; Physical therapy; Intensive care medicine; Ankylosing spondylitis; Surgery; Sacroiliitis; Internal medicine","score_opus":0.09462649092379641,"score_gpt":0.407945741001253,"score_spread":0.31331925007745665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407582812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006276626,0.98352313,0.000014420061,0.0011246009,0.00081861235,0.0024259414,0.0041805743,0.000037575217,0.0015985265],"genre_scores_gemma":[0.021588871,0.97624505,0.0005649823,0.0001229327,0.00007570734,0.0005259829,0.00050387153,0.00004926717,0.00032334286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963001,0.000290583,0.0016224561,0.0004755478,0.00090148253,0.00040985885],"domain_scores_gemma":[0.99479324,0.0021137306,0.0013856614,0.00096468785,0.0005756383,0.00016704408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002770675,0.0006291471,0.0024938404,0.00022653556,0.00034401604,0.000038736434,0.0005220687,0.00017442877,0.00009292076],"category_scores_gemma":[0.00093452254,0.0003736712,0.0023919994,0.00062264403,0.00051950465,0.00005050628,0.00032317376,0.00017031979,0.000005248399],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023440499,0.0023056609,0.00042231905,0.009273348,0.004387605,0.000030045288,0.0002158758,0.0000054813895,0.0000038995454,0.0007619331,0.008156839,0.9742026],"study_design_scores_gemma":[0.009590302,0.0025487673,0.0070356615,0.22690783,0.006192509,0.000060157145,0.0009754965,0.000067681955,0.00011253771,0.00057459663,0.74502474,0.00090972724],"about_ca_topic_score_codex":0.00016135717,"about_ca_topic_score_gemma":0.00004956301,"teacher_disagreement_score":0.9732929,"about_ca_system_score_codex":0.00020874453,"about_ca_system_score_gemma":0.00092306326,"threshold_uncertainty_score":0.99987155},"labels":[],"label_agreement":null},{"id":"W4407618719","doi":"10.1016/j.ard.2025.01.013","title":"Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Hospital for Sick Children; University of British Columbia; SickKids Foundation; University of Toronto","funders":"Universitetssykehuset Nord-Norge; Childhood Arthritis and Rheumatology Research Alliance; Universitetet i Tromsø","keywords":"Medicine; Task force; Voting; Consensus conference; Arthritis; Majority rule; Physical therapy; Disease; Family medicine; Pathology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.03008650610531098,"score_gpt":0.3812303544034654,"score_spread":0.3511438482981544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407618719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98114604,0.0011769697,0.0002752647,0.014929905,0.00013942522,0.00047806356,0.0008330931,0.000021020192,0.0010002032],"genre_scores_gemma":[0.9986564,0.0003131602,0.00006677403,0.00071153964,0.000009999906,0.000057202244,0.00011216849,0.000007429198,0.00006532144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844927,0.0002546796,0.00053185417,0.00019690747,0.00039599015,0.00017132817],"domain_scores_gemma":[0.9986968,0.00016392677,0.00028131163,0.0005553195,0.00020502247,0.00009763703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002679165,0.00012661802,0.00044488313,0.000101744554,0.00006403487,0.000017917057,0.00029121654,0.00003538707,0.00008805426],"category_scores_gemma":[0.00056302967,0.000104049825,0.00021337206,0.00029886866,0.00017419583,0.00014445085,0.0001040841,0.00011426067,0.000002078715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029589492,0.010666139,0.5652076,0.0018333427,0.0009721161,0.000020712812,0.00021113381,0.0021153935,0.0013801458,0.007487328,0.0077768564,0.39937025],"study_design_scores_gemma":[0.0019203338,0.00011655491,0.9646553,0.0041909018,0.00008008897,1.4611832e-7,0.0002624144,0.020021684,0.0007755749,0.007666975,0.00021018308,0.000099856894],"about_ca_topic_score_codex":0.0003291098,"about_ca_topic_score_gemma":0.000056520683,"teacher_disagreement_score":0.39944768,"about_ca_system_score_codex":0.000063897176,"about_ca_system_score_gemma":0.0011871419,"threshold_uncertainty_score":0.42430288},"labels":[],"label_agreement":null},{"id":"W4408098401","doi":"10.1016/j.ard.2025.01.032","title":"Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta","funders":"Novo Nordisk; Karolinska Institutet; Eisai; Samsung; Galápagos; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Celltrion; AbbVie; Medizinische Universität Wien; Alnylam Pharmaceuticals; Gilead Sciences; Celgene; Biogen; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Pfizer; Sanofi; UCB Pharma; Abbott Laboratories","keywords":"Medicine; Statement (logic); Janus kinase; Immune system; Immunology; Bioinformatics; Cytokine","score_opus":0.026406172381272925,"score_gpt":0.3157569184598979,"score_spread":0.289350746078625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408098401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516753,0.023946729,0.00000648811,0.02189302,0.00024441685,0.0012897112,0.00033716054,0.000039353297,0.0005678061],"genre_scores_gemma":[0.99225175,0.0056505543,0.000010271841,0.0011300959,0.000021190705,0.00018949271,0.000045701632,0.0000142090275,0.0006867013],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983416,0.00016687368,0.0006419268,0.00017811022,0.00044564172,0.00022580737],"domain_scores_gemma":[0.99777466,0.0006385942,0.0003998245,0.0008579548,0.00015818301,0.00017075811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001344828,0.00022018762,0.00043981316,0.00011254112,0.000095250034,0.000011350524,0.0001833935,0.000033800592,0.00017875296],"category_scores_gemma":[0.0007383348,0.00009952751,0.00025667448,0.00026173439,0.00041819472,0.000037906662,0.000037612674,0.00005690071,0.000013435248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017495474,0.034172047,0.10737854,0.008105133,0.015500689,0.00020240017,0.011025577,0.00046783654,0.0024309887,0.009092055,0.53359574,0.2605335],"study_design_scores_gemma":[0.016567523,0.005327733,0.7083517,0.06256382,0.0034483608,0.000015960606,0.007918079,0.0007380681,0.14590742,0.0035373028,0.044753328,0.00087074406],"about_ca_topic_score_codex":0.00006830358,"about_ca_topic_score_gemma":0.0000035773035,"teacher_disagreement_score":0.6009731,"about_ca_system_score_codex":0.000048716713,"about_ca_system_score_gemma":0.00057529623,"threshold_uncertainty_score":0.4058614},"labels":[],"label_agreement":null},{"id":"W4408559551","doi":"10.1016/j.ard.2025.01.050","title":"The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Istituto di Ricovero e Cura a Carattere Scientifico; EMD Serono; National Institutes of Health; Nordic Pharma Group; Department of Health and Social Care; National Institute for Health and Care Research; Canadian Anesthesiologists' Society; National Institute of Environmental Health Sciences; Horizon Therapeutics; Manchester Biomedical Research Centre; Alexion Pharmaceuticals; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; American College of Rheumatology Research and Education Foundation; Pfizer; PTC Therapeutics","keywords":"Antisynthetase syndrome; Medicine; Class (philosophy); Artificial intelligence; Computer science; Immunology; Autoantibody","score_opus":0.030471814551105068,"score_gpt":0.3537909601718494,"score_spread":0.3233191456207443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408559551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452484,0.0016562312,0.00080540864,0.0014937865,0.0000610961,0.00091199216,0.00047620462,0.0000066886078,0.00006377321],"genre_scores_gemma":[0.9987985,0.00023357473,0.00054074655,0.00015315875,0.000005509244,0.00013786014,0.0001078234,0.000007383346,0.00001544324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780864,0.00035529782,0.00104615,0.00019150722,0.00041144568,0.00018698853],"domain_scores_gemma":[0.99622697,0.0019359647,0.00054188963,0.0009918162,0.00027405092,0.000029336705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009639251,0.00015577817,0.0006273446,0.0002614722,0.00024380015,0.000045917004,0.0005583407,0.000047221467,0.000021413458],"category_scores_gemma":[0.00089068216,0.000067243294,0.00056634576,0.001536703,0.00020115319,0.00006277278,0.000099091136,0.00006377736,6.559545e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051360033,0.0026363244,0.66378105,0.0023050867,0.037276793,0.000012549224,0.02614205,0.00063223025,0.0049166977,0.00448295,0.009602335,0.24307594],"study_design_scores_gemma":[0.000537346,0.000030155172,0.9574004,0.0008037408,0.0049497792,0.0000013638211,0.005261229,0.024304286,0.004378195,0.001547709,0.00069823494,0.00008758113],"about_ca_topic_score_codex":0.00039311222,"about_ca_topic_score_gemma":0.00042143476,"teacher_disagreement_score":0.29361933,"about_ca_system_score_codex":0.000018107037,"about_ca_system_score_gemma":0.00023503823,"threshold_uncertainty_score":0.27421018},"labels":[],"label_agreement":null},{"id":"W4409329618","doi":"10.1016/j.ard.2025.02.012","title":"Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; UCB US; Morris and Alma Schapiro Fund; UCB; University of Utah; National Institutes of Health; Lupus Foundation of America","keywords":"Medicine; Certolizumab pegol; Antiphospholipid syndrome; Lupus anticoagulant; Open label; Adverse effect; Pregnancy; Internal medicine; Thrombosis; Rheumatoid arthritis; Adalimumab","score_opus":0.0484876954714769,"score_gpt":0.3745565106117787,"score_spread":0.3260688151403018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409329618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896652,0.00063905376,0.000004054354,0.0007792438,0.00018082815,0.008111554,0.00037514532,0.00001808456,0.00022680538],"genre_scores_gemma":[0.9988483,0.000076021715,0.00007706223,0.000028853827,0.0000032116498,0.00014665847,0.000018277518,0.000027261956,0.00077432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997129,0.00021924589,0.0010253614,0.00042840725,0.00078886957,0.00040907649],"domain_scores_gemma":[0.99764526,0.00034930743,0.00045756972,0.00095669966,0.00035872945,0.00023245232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019528998,0.0002947515,0.0012663936,0.00033010246,0.00006135885,0.00003397373,0.0005019876,0.000061033556,0.000020043653],"category_scores_gemma":[0.0022174118,0.00016836863,0.00013621894,0.0007113573,0.00018257956,0.00019218701,0.00046619793,0.00011119148,0.0000026810803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116355464,0.043654375,0.8264467,0.0043837563,0.0012760552,0.000080784324,0.0017146326,0.000010343697,0.0000437702,0.000079239355,0.00120875,0.004746144],"study_design_scores_gemma":[0.35775205,0.016239021,0.5614916,0.060651448,0.0005050629,0.00029179017,0.000631163,0.00013218647,0.0014491595,0.00045441298,0.0000097309085,0.0003923725],"about_ca_topic_score_codex":0.00027505375,"about_ca_topic_score_gemma":0.000019626457,"teacher_disagreement_score":0.2649551,"about_ca_system_score_codex":0.0000994894,"about_ca_system_score_gemma":0.0004530168,"threshold_uncertainty_score":0.68658733},"labels":[],"label_agreement":null},{"id":"W4409367210","doi":"10.1016/j.ard.2025.02.002","title":"Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ–positive juvenile dermatomyositis","year":2025,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut Universitaire de Gériatrie de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"CHU Sainte-Justine Foundation; Wallonie-Bruxelles International; Centre hospitalier universitaire Sainte-Justine","keywords":"Medicine; Juvenile dermatomyositis; Dermatomyositis; Refractory (planetary science); Juvenile; Transcriptome; Immunology; Dermatology; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.03003028609391442,"score_gpt":0.320757294292814,"score_spread":0.29072700819889963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409367210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5641435,0.004977642,0.000008425581,0.4276272,0.000554636,0.001350415,0.0009196565,0.000058080535,0.0003604871],"genre_scores_gemma":[0.544368,0.0026647612,0.00007474971,0.4514477,0.00026304615,0.0001029797,0.00012687007,0.000076488875,0.0008753987],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951139,0.0013690505,0.0016730207,0.0006201304,0.00064271485,0.0005811626],"domain_scores_gemma":[0.9965711,0.0013319982,0.00047413603,0.0011183174,0.0002484525,0.0002559633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008054214,0.0005254941,0.0018497433,0.00050305354,0.00014179196,0.00006615907,0.0004555172,0.0005916771,0.00011904668],"category_scores_gemma":[0.0010348598,0.0004168321,0.0007508595,0.00039556387,0.00045613069,0.00014880071,0.00021663895,0.0011285881,0.000027196184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021129204,0.00028989074,0.0057670143,0.0026305013,0.00043672023,0.0009997953,0.000636712,0.0000016828218,0.000030933184,0.000016717293,0.9727477,0.014329418],"study_design_scores_gemma":[0.0037733046,0.0005971815,0.6746435,0.01905646,0.00093596766,0.0003159888,0.00024929628,0.00009703438,0.00057608663,0.00041930628,0.2985625,0.0007733195],"about_ca_topic_score_codex":0.00010801558,"about_ca_topic_score_gemma":0.00000831885,"teacher_disagreement_score":0.67418516,"about_ca_system_score_codex":0.000051091203,"about_ca_system_score_gemma":0.0007538833,"threshold_uncertainty_score":0.99982834},"labels":[],"label_agreement":null},{"id":"W4409451046","doi":"10.1016/j.ard.2025.02.009","title":"Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"GlaxoSmithKline Biologicals; Janssen Pharmaceuticals; Bristol-Myers Squibb Canada; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Pfizer; Novartis Pharmaceuticals Corporation; Schawarz Pharma; Amgen Foundation; Eli Lilly and Company; Sun Pharma; GlaxoSmithKline; Amgen; Union Chimique Belge; AbbVie","keywords":"Medicine; Intensive care medicine","score_opus":0.017061498251962716,"score_gpt":0.3065417059039769,"score_spread":0.28948020765201415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409451046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66094834,0.31520638,0.000004703317,0.020038016,0.0005108573,0.00058015704,0.000055816487,0.000021485243,0.0026342473],"genre_scores_gemma":[0.98697466,0.010881568,0.000052048894,0.0014341642,0.00003208754,0.00007107422,0.000011553946,0.000010468355,0.0005324052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882835,0.000115513125,0.00040299018,0.00018180798,0.00026873074,0.00020260457],"domain_scores_gemma":[0.9985916,0.0005138121,0.00022519293,0.00056668755,0.00007259382,0.000030095209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020900027,0.00015138977,0.0003307987,0.00003338042,0.00024615566,0.000024355591,0.00017839675,0.000024346156,0.00013423641],"category_scores_gemma":[0.000822908,0.000063042964,0.00020808914,0.00029316446,0.00021833107,0.00006906303,0.000114908566,0.00008605238,0.000003203935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040718942,0.0009370898,0.8296758,0.00029383425,0.0019012202,0.00007176561,0.0045879646,0.00013129343,0.00005627261,0.00084074,0.034792278,0.12630458],"study_design_scores_gemma":[0.0010694613,0.00007765464,0.9290552,0.0052914782,0.0003224778,0.0000074676027,0.00541014,0.000096725766,0.0008881321,0.036432367,0.021213938,0.00013496996],"about_ca_topic_score_codex":0.0005435501,"about_ca_topic_score_gemma":0.00013242748,"teacher_disagreement_score":0.3260263,"about_ca_system_score_codex":0.000012417465,"about_ca_system_score_gemma":0.00007189219,"threshold_uncertainty_score":0.25708175},"labels":[],"label_agreement":null},{"id":"W4410211788","doi":"10.1016/j.ard.2025.01.021","title":"EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Arthritis Research Centre of Canada; Research Canada","funders":"European League Against Rheumatism; Aid for Cancer Research","keywords":"Medicine; Rheumatoid arthritis; Risk stratification; Stage (stratigraphy); Internal medicine","score_opus":0.041062775237166727,"score_gpt":0.3520863987687751,"score_spread":0.3110236235316084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410211788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780658,0.018105237,0.000785327,0.00094543444,0.00008672194,0.0013177247,0.00047613477,0.000012511268,0.00020509238],"genre_scores_gemma":[0.94554645,0.053197313,0.0009070507,0.000053146665,0.0000049387804,0.00016726821,0.000036990677,0.000012314178,0.000074552714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976016,0.00038058058,0.0010713971,0.00019431343,0.00048500788,0.00026708283],"domain_scores_gemma":[0.99766034,0.000678682,0.00060411677,0.00066503626,0.0003262388,0.000065557775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012500318,0.00016873392,0.0005697888,0.00018473771,0.00015619255,0.000025935939,0.00038976007,0.000048606824,0.000098675104],"category_scores_gemma":[0.002014958,0.00010512871,0.00027132817,0.00037318096,0.00031069116,0.00011017189,0.000063691514,0.00012404221,0.0000021130634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023270892,0.0039277584,0.12848528,0.0051385188,0.0018061141,0.0000029266005,0.013189536,0.00013839996,0.0029221126,0.022472426,0.011970888,0.807619],"study_design_scores_gemma":[0.005709375,0.0004980883,0.88463074,0.012607492,0.000039111244,0.000004486952,0.006860631,0.0013787331,0.053672995,0.029034618,0.005269108,0.00029459666],"about_ca_topic_score_codex":0.00017929677,"about_ca_topic_score_gemma":0.00014703974,"teacher_disagreement_score":0.80732435,"about_ca_system_score_codex":0.000011165826,"about_ca_system_score_gemma":0.0004388076,"threshold_uncertainty_score":0.42870244},"labels":[],"label_agreement":null},{"id":"W4410600783","doi":"10.1016/j.ard.2025.04.024","title":"Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; University of Toronto; SickKids Foundation; Dalhousie University; Hospital for Sick Children; Institute for Clinical Evaluative Sciences","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; Regione Liguria; Ministero della Salute; National Institute for Health and Care Research","keywords":"Medicine; Juvenile dermatomyositis; Rheumatology; Task force; Internal medicine; Arthritis; Physical therapy; Juvenile; Dermatomyositis; Family medicine","score_opus":0.023102311534247157,"score_gpt":0.3360113274642633,"score_spread":0.3129090159300162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410600783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637859,0.005747721,0.00048580838,0.025912058,0.0005244864,0.0007980487,0.00053368,0.000112582864,0.002099704],"genre_scores_gemma":[0.9874052,0.0077211577,0.0021441327,0.0020932944,0.00003773276,0.000103725804,0.00024586185,0.000041862968,0.00020704907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968706,0.0007455952,0.00096305873,0.00048489333,0.00042728434,0.0005086203],"domain_scores_gemma":[0.9973941,0.0008835256,0.00030141743,0.000702438,0.0004250099,0.0002935225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060999487,0.00026613192,0.0007055471,0.00024033016,0.0005480813,0.00010408254,0.00050193345,0.00010015732,0.00022149434],"category_scores_gemma":[0.0011380842,0.00022706564,0.00029091942,0.00054456043,0.00028610943,0.0002986486,0.00043571403,0.00029170566,0.00004012605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048028718,0.0016941704,0.36996076,0.0013922037,0.0020875516,0.00014222789,0.013833741,0.00013685702,0.00025738162,0.010235312,0.23418958,0.36558995],"study_design_scores_gemma":[0.0073352116,0.0004777907,0.91910326,0.012737351,0.0003675452,0.0009005487,0.008644036,0.0054840697,0.0021952176,0.021004055,0.020829635,0.0009212854],"about_ca_topic_score_codex":0.00028184708,"about_ca_topic_score_gemma":0.000029144328,"teacher_disagreement_score":0.5491425,"about_ca_system_score_codex":0.00004082917,"about_ca_system_score_gemma":0.0002665555,"threshold_uncertainty_score":0.92594683},"labels":[],"label_agreement":null},{"id":"W4411394482","doi":"10.1016/j.ard.2025.05.117","title":"OP0095 Efficacy and safety of deucravacitinib up to week 52 from POETYK PsA-2: a multicenter, randomized, double-blind, placebo-controlled, phase 3 study in patients with psoriatic arthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Double blind; Multicenter study; Internal medicine; Arthritis; Randomized controlled trial; Dermatology; Alternative medicine; Pathology","score_opus":0.023921558269499748,"score_gpt":0.2943720277713867,"score_spread":0.27045046950188695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411394482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748606,0.0053849863,0.000028838649,0.00020644593,0.00039360215,0.0059306743,0.0004954012,0.000019058409,0.000054944067],"genre_scores_gemma":[0.9986688,0.0005057954,0.000031544463,0.000076381955,0.000005684869,0.00042373996,0.000108167056,0.000015137111,0.00016477627],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974018,0.00087007065,0.0009742383,0.00034425498,0.00011700027,0.0002926698],"domain_scores_gemma":[0.9971105,0.0017497315,0.00043722367,0.00050237513,0.00014569316,0.00005450917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043060572,0.000310616,0.0015113222,0.00022136829,0.00011944825,0.000019419002,0.00031672695,0.000083053565,0.00010734824],"category_scores_gemma":[0.0006481216,0.00019339853,0.00024315456,0.00026766208,0.0002128492,0.000091094436,0.00013918019,0.00008463724,0.000013121541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9040136,0.006856874,0.02168572,0.00007732795,0.0039989613,0.0000015682941,0.002176357,0.000025562715,0.000019251434,0.00007649129,0.00015611282,0.060912214],"study_design_scores_gemma":[0.9094125,0.0007155572,0.08530017,0.0013915581,0.0013472899,2.7286418e-7,0.0008800604,0.000012028908,0.0005810672,0.00016485606,0.000015228371,0.000179421],"about_ca_topic_score_codex":0.00048246866,"about_ca_topic_score_gemma":0.00014029158,"teacher_disagreement_score":0.06361445,"about_ca_system_score_codex":0.000013632744,"about_ca_system_score_gemma":0.00008839816,"threshold_uncertainty_score":0.78865635},"labels":[],"label_agreement":null},{"id":"W4411394543","doi":"10.1016/j.ard.2025.06.020","title":"POS0659 EFFICACY, SAFETY AND IMMUNOGENICITY OF THE PROPOSED TOCILIZUMAB BIOSIMILAR RGB-19, INTRAVENOUSLY ADMINISTERED TO PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS: WEEK 24 DATA FROM A PHASE 3 STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Biosimilar; Tocilizumab; Immunogenicity; Rheumatoid arthritis; Pharmacology; Immunology; Internal medicine; Antibody","score_opus":0.09250792226928192,"score_gpt":0.3679126803776471,"score_spread":0.2754047581083652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411394543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98385984,0.005724841,0.0001031509,0.0041242586,0.0002364225,0.0018406966,0.0040409165,0.000024685378,0.00004519391],"genre_scores_gemma":[0.9983816,0.0006696284,0.0001483808,0.00060992525,0.00000392603,0.00002304676,0.00004752843,0.0000143705265,0.00010160779],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99710214,0.0010176402,0.0008229712,0.0005078126,0.00014882979,0.00040061254],"domain_scores_gemma":[0.99680007,0.0008419471,0.00041103712,0.001701058,0.0001566457,0.00008923445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052159117,0.0002956028,0.0008417165,0.000065569446,0.00030532308,0.000031086474,0.0012659469,0.00011488994,0.000155476],"category_scores_gemma":[0.0016937352,0.00015819084,0.00016715452,0.00040908816,0.0007725242,0.000093498056,0.001076224,0.00020478191,0.00000409641],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12124506,0.07539288,0.042189058,0.0014041384,0.036783274,0.000033568147,0.016868787,0.000044886197,0.03731119,0.0013719792,0.02183325,0.64552194],"study_design_scores_gemma":[0.030044995,0.007406262,0.6946745,0.007712558,0.0026354757,0.000024823961,0.012188546,0.00018593963,0.23843949,0.0031960916,0.002428061,0.0010632642],"about_ca_topic_score_codex":0.00048539575,"about_ca_topic_score_gemma":0.0002991331,"teacher_disagreement_score":0.65248543,"about_ca_system_score_codex":0.000016425149,"about_ca_system_score_gemma":0.000356578,"threshold_uncertainty_score":0.64508355},"labels":[],"label_agreement":null},{"id":"W4411395031","doi":"10.1016/j.ard.2025.06.937","title":"ABS0657 INSIGHTS FROM A ONE-YEAR INTERNATIONAL MONTHLY QUIZ ON AA AMYLOIDOSIS CAUSES: ENGAGING 2,597 VOTERS ACROSS FRENCH-SPEAKING COUNTRIES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Amyloidosis; Family medicine; Dermatology; Medical education; Internal medicine","score_opus":0.020237071033022573,"score_gpt":0.30562780460398975,"score_spread":0.28539073357096717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144167,0.0032779002,0.000049173545,0.002689844,0.00049559906,0.00029319068,0.0008238097,0.000031154435,0.00089763786],"genre_scores_gemma":[0.99571353,0.001514673,0.000091972615,0.0020844035,0.00006725197,0.000085658634,0.00017931142,0.000025903884,0.00023729638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983281,0.00013516216,0.0004471791,0.0004226264,0.00037215467,0.00029476726],"domain_scores_gemma":[0.9984538,0.00026351394,0.00031135068,0.00072446244,0.0001581951,0.00008867046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009780789,0.0002884453,0.00035369524,0.00008201335,0.00023383695,0.00011080622,0.000694258,0.00010072888,0.000055894296],"category_scores_gemma":[0.00065924256,0.00022222115,0.00033317046,0.00013518377,0.00022201342,0.000023935689,0.00037027788,0.0000947384,0.000020279444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011914624,0.003992386,0.8767777,0.0007015942,0.013874882,0.000017989178,0.007765717,0.0035270671,0.008255397,0.0042229644,0.055620745,0.024052095],"study_design_scores_gemma":[0.0023910163,0.00019881221,0.82222307,0.0028703215,0.00043574057,5.2838556e-7,0.002426082,0.00019578364,0.1555528,0.0029132501,0.0101279365,0.0006646704],"about_ca_topic_score_codex":0.0009246473,"about_ca_topic_score_gemma":0.00030318924,"teacher_disagreement_score":0.14729741,"about_ca_system_score_codex":0.00004014146,"about_ca_system_score_gemma":0.0001110723,"threshold_uncertainty_score":0.9061915},"labels":[],"label_agreement":null},{"id":"W4411395159","doi":"10.1016/j.ard.2025.06.1793","title":"ABS1148 PERIODONTAL DISEASE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Axial spondyloarthritis; Periodontal disease; Dermatology; Dentistry; Disease; Internal medicine; Sacroiliitis","score_opus":0.010351984339036445,"score_gpt":0.261432094955086,"score_spread":0.25108011061604957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934058,0.0031275444,0.0000012547852,0.0015922392,0.00014001646,0.0006509976,0.00020522063,0.000019606921,0.00085731986],"genre_scores_gemma":[0.99882543,0.00023843626,0.000020615304,0.00041193794,0.000009717092,0.00005572138,0.000042358653,0.0000127134435,0.00038306508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890697,0.000040741405,0.0002911612,0.00019892919,0.00032141534,0.00024078718],"domain_scores_gemma":[0.99921095,0.000056525696,0.00009138963,0.00040051527,0.00011223648,0.0001283764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004123321,0.00016801435,0.00038543553,0.00010198557,0.00009924819,0.000014621103,0.00011995653,0.00002380366,0.00009581166],"category_scores_gemma":[0.00021823896,0.00010450979,0.00018162196,0.00029024723,0.00017927118,0.000074268966,0.00009485896,0.000060271665,0.000009020434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017019756,0.001372027,0.9735355,0.00022049755,0.00020257253,0.000022618897,0.0000886267,0.000007204299,3.1218963e-7,0.00028496003,0.0011742912,0.021389453],"study_design_scores_gemma":[0.0050806035,0.00022798314,0.9911529,0.0024314162,0.0001582297,5.8518003e-7,0.00007562516,0.000011623104,0.000015417803,0.0004219553,0.0003325422,0.00009112025],"about_ca_topic_score_codex":0.0001616578,"about_ca_topic_score_gemma":0.000084722946,"teacher_disagreement_score":0.021298332,"about_ca_system_score_codex":0.00002489592,"about_ca_system_score_gemma":0.00014001524,"threshold_uncertainty_score":0.42617854},"labels":[],"label_agreement":null},{"id":"W4411395227","doi":"10.1016/j.ard.2025.06.275","title":"POS0920 BIMEKIZUMAB DEMONSTRATES COMPARABLE ONE-YEAR EFFICACY IN MALE AND FEMALE PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Axial spondyloarthritis; Phase (matter); Internal medicine; Physical therapy; Family medicine; Ankylosing spondylitis; Sacroiliitis","score_opus":0.04271160780457793,"score_gpt":0.3397862979433387,"score_spread":0.29707469013876076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771301,0.019714426,6.4406254e-7,0.0008096568,0.00009413756,0.0007854165,0.00086798705,0.00002314097,0.00057445973],"genre_scores_gemma":[0.99671334,0.0026670985,0.00016441969,0.00013686981,0.000015198426,0.000033985,0.00010964422,0.0000136688905,0.00014578203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848264,0.00008611295,0.000512674,0.00032767886,0.00030861952,0.00028227895],"domain_scores_gemma":[0.9986268,0.00045662493,0.00019018736,0.0004021508,0.00022554898,0.00009867907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009123845,0.00023049688,0.0007153128,0.00011287611,0.00015930792,0.00002618326,0.000117565076,0.000031774198,0.00003332222],"category_scores_gemma":[0.00059371465,0.00015389826,0.00009954809,0.00036267008,0.0003566278,0.00010357918,0.00013043544,0.000085457854,0.000007486796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019338269,0.009932968,0.8716999,0.000535088,0.0032868416,0.00007022526,0.0015430027,0.000054634973,0.00001844553,0.00039460178,0.0021257116,0.091000274],"study_design_scores_gemma":[0.05136818,0.0010521152,0.9363011,0.007817077,0.00050419645,0.0000025862603,0.0013943274,0.000037749214,0.00043766623,0.000804142,0.00009153876,0.0001893055],"about_ca_topic_score_codex":0.00048791626,"about_ca_topic_score_gemma":0.00023363798,"teacher_disagreement_score":0.09081097,"about_ca_system_score_codex":0.000020480298,"about_ca_system_score_gemma":0.00009539346,"threshold_uncertainty_score":0.62757885},"labels":[],"label_agreement":null},{"id":"W4411395283","doi":"10.1016/j.ard.2025.06.682","title":"POS1333 FROM ONSET TO INSIGHTS: LONGITUDINAL ASSESSMENT OF DISEASE ACTIVITY, FLARES, AND DAMAGE ACCRUAL IN PATIENTS WITH SLE ACROSS 5 REGISTRIES IN THE LUPUS FEDERATED DATA NETWORK (LUPUSNET)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Systemic lupus erythematosus; Accrual; Longitudinal data; Disease; Internal medicine; Demography","score_opus":0.05254864405399057,"score_gpt":0.37759577238918757,"score_spread":0.325047128335197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380904,0.0012313675,0.00003841722,0.0023292801,0.00012199837,0.0015661963,0.00083623256,0.000011446122,0.00005599427],"genre_scores_gemma":[0.9991132,0.0001444226,0.000046304755,0.00019403148,0.000013452912,0.00006433516,0.00028192165,0.000016447355,0.00012591177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972395,0.000549486,0.00054469844,0.000424443,0.0008668865,0.00037499916],"domain_scores_gemma":[0.996811,0.0010174661,0.00024982484,0.0015533967,0.000205581,0.0001627645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005894793,0.00023081564,0.0006447082,0.00012061702,0.00013620782,0.00010166555,0.0007946331,0.0000498509,0.000012655242],"category_scores_gemma":[0.0011744348,0.00012573453,0.000060724426,0.0008456735,0.00029029758,0.00022941017,0.00092726725,0.00019009397,8.701133e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026397607,0.00095694396,0.979552,0.00094723847,0.00023496946,0.000017086059,0.00079531036,0.00012754559,0.000002467019,0.000048816957,0.0138868,0.0007911194],"study_design_scores_gemma":[0.0025260372,0.00019349725,0.9870863,0.007261689,0.00010574415,0.0000046580244,0.0013106685,0.00093027717,0.00001806288,0.00038436134,0.00006261114,0.00011612083],"about_ca_topic_score_codex":0.0012762732,"about_ca_topic_score_gemma":0.0013617078,"teacher_disagreement_score":0.013824189,"about_ca_system_score_codex":0.000052362415,"about_ca_system_score_gemma":0.0005713531,"threshold_uncertainty_score":0.51273054},"labels":[],"label_agreement":null},{"id":"W4411395305","doi":"10.1016/j.ard.2025.05.874","title":"POS0492 A SINGLE INTRA-ARTICULAR INJECTION OF THE GENE THERAPY PCRX-201 WAS SAFE AND PROVIDED SUSTAINED CLINICAL BENEFITS FOR PATIENTS WITH MODERATE-TO-SEVERE KNEE OSTEOARTHRITIS THROUGH 3 YEARS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Intra articular; Genetic enhancement; Physical therapy; Surgery; Internal medicine; Alternative medicine; Pathology; Gene","score_opus":0.03326681522957063,"score_gpt":0.31138730335086245,"score_spread":0.2781204881212918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98295987,0.0010643293,0.0003295897,0.013777775,0.00013841197,0.0016316698,0.00006703979,0.000010787513,0.00002051118],"genre_scores_gemma":[0.997981,0.00022180109,0.00030709937,0.0013067878,0.000018395882,0.000044411347,0.000019207851,0.000012518613,0.00008876556],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99878806,0.000117388576,0.00044085077,0.00017771682,0.00032503635,0.0001509526],"domain_scores_gemma":[0.9987433,0.0002365288,0.00020440975,0.0003211062,0.00041585843,0.00007879191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024887113,0.00011270362,0.000324588,0.0000410747,0.00010534395,0.000016843822,0.00009689024,0.00009679017,0.000006841612],"category_scores_gemma":[0.00064368657,0.000058705744,0.0001530208,0.00024904695,0.0003402932,0.00006636761,0.00006475466,0.00008098255,2.3969022e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009277983,0.0033120832,0.027998086,0.0015963938,0.0010134542,8.670366e-7,0.0023027093,0.0005633574,0.00023392685,0.0044815512,0.0026187417,0.94660085],"study_design_scores_gemma":[0.015363002,0.0068381215,0.92337185,0.00572259,0.0005852828,0.000005462175,0.000601659,0.001905556,0.005383517,0.03927778,0.00063609367,0.00030905547],"about_ca_topic_score_codex":0.00003467806,"about_ca_topic_score_gemma":0.00001252113,"teacher_disagreement_score":0.9462918,"about_ca_system_score_codex":0.000013445393,"about_ca_system_score_gemma":0.00019338072,"threshold_uncertainty_score":0.23939507},"labels":[],"label_agreement":null},{"id":"W4411395318","doi":"10.1016/j.ard.2025.06.891","title":"ABS0847 RETROSPECTIVE SINGLE-CENTRE ANALYSIS OF SURVIVAL AND SAFETY SIGNALS IN AUTOIMMUNE RHEUMATIC DISEASE PATIENTS UNDERGOING LUNG TRANSPLANTATION","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Rheumatic disease; Lung transplantation; Transplantation; Retrospective cohort study; Interstitial lung disease; Autoimmune disease; Internal medicine; Disease; Lung","score_opus":0.0174222043929866,"score_gpt":0.2693891935572503,"score_spread":0.2519669891642637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901856,0.0074156374,0.00006646053,0.00075258064,0.00012817049,0.00073850044,0.00030217646,0.00002282476,0.00038800164],"genre_scores_gemma":[0.99651176,0.003134313,0.0000089932955,0.00008920274,0.0000032346882,0.0000140400625,0.00011107827,0.0000131029365,0.00011430515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780506,0.0002296561,0.0009893021,0.0002721882,0.00048664786,0.00021714861],"domain_scores_gemma":[0.9980496,0.00067933474,0.00046996775,0.00041794666,0.00024114305,0.00014199824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026370262,0.00020452478,0.0008980343,0.000454424,0.00008273159,0.000019009412,0.0001498742,0.00006285917,0.00007586658],"category_scores_gemma":[0.0010496123,0.00014416133,0.00043657905,0.001276276,0.00015273255,0.000105538995,0.000052889467,0.00007599281,7.3077587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087853946,0.0013719149,0.98530173,0.0034947211,0.0029597627,0.0000022003428,0.00072800205,0.0014484572,0.00007522243,0.00039941585,0.00017909786,0.0031609584],"study_design_scores_gemma":[0.0022201175,0.000046947018,0.97048724,0.01603475,0.0048737545,1.5364539e-7,0.0005867854,0.005077552,0.0001044878,0.00045074162,7.938353e-7,0.00011669389],"about_ca_topic_score_codex":0.00010558906,"about_ca_topic_score_gemma":0.000037192705,"teacher_disagreement_score":0.014814486,"about_ca_system_score_codex":0.000069335205,"about_ca_system_score_gemma":0.00019012009,"threshold_uncertainty_score":0.5878728},"labels":[],"label_agreement":null},{"id":"W4411395368","doi":"10.1016/j.ard.2025.06.112","title":"POS0752 RAPID EFFECTIVENESS OF JAK-INHIBITORS, BIOLOGICS, AND CONCOMITANT GLUCOCORTICOID DURING THE FIRST MONTHS. AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE JAK-POT STUDY)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Rheumatoid arthritis; Concomitant; Glucocorticoid; Antirheumatic Agents; Internal medicine","score_opus":0.01575397931640274,"score_gpt":0.3035151953516137,"score_spread":0.287761216035211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326724,0.003028314,0.0000059198273,0.0006297146,0.00028095944,0.00252396,0.00014569139,0.000009761079,0.000108440356],"genre_scores_gemma":[0.99725485,0.002563091,0.0000066220477,0.00002906912,0.000008201016,0.00008751858,0.00001634703,0.000012936636,0.000021340884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974247,0.00061996875,0.00093864603,0.0002257475,0.0006270488,0.00016386283],"domain_scores_gemma":[0.9963552,0.0011798725,0.00077685097,0.00076797925,0.0008672669,0.000052857013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090516417,0.00016760558,0.0006596562,0.00014365808,0.00010376652,0.000019660985,0.00044751313,0.0000496462,0.000011511427],"category_scores_gemma":[0.0023298273,0.00008898923,0.00016022261,0.00042099803,0.00051954266,0.000121811085,0.00024235388,0.00008111164,4.8950193e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014421577,0.0011635211,0.9883517,0.0031020574,0.0007508315,0.0000012034861,0.0017772057,0.00007245526,0.0008090335,0.00028094932,0.00021476317,0.0020341214],"study_design_scores_gemma":[0.004364373,0.00075001456,0.9619271,0.011028539,0.00008388522,0.00001539711,0.0065631764,0.00033061157,0.014550606,0.00026000064,0.000027838618,0.00009846627],"about_ca_topic_score_codex":0.0002207873,"about_ca_topic_score_gemma":0.000039231436,"teacher_disagreement_score":0.02642461,"about_ca_system_score_codex":0.000042589356,"about_ca_system_score_gemma":0.00019281033,"threshold_uncertainty_score":0.36288756},"labels":[],"label_agreement":null},{"id":"W4411395416","doi":"10.1016/j.ard.2025.06.302","title":"POS0947 ANTI-NOR-90 ANTIBODIES IN AN INTERNATIONAL COHORT OF 2140 SYSTEMIC SCLEROSIS SUBJECTS: CLINICAL ASSOCIATIONS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Southlake Regional Health Center; University of Alberta; Centre Hospitalier de l’Université de Montréal; McGill University; University of Calgary; Western University; Hôpital du Sacré-Cœur de Montréal; McMaster University; Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Antibody; Multiple sclerosis; Cohort study; Immunology; Dermatology; Internal medicine","score_opus":0.08007723719856148,"score_gpt":0.385411049138696,"score_spread":0.30533381194013454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902734,0.006092318,0.0000062461822,0.0010282851,0.0006930047,0.0006205277,0.0003394288,0.00003776119,0.00090901594],"genre_scores_gemma":[0.98985595,0.0094980765,0.000021492771,0.000321774,0.000037222082,0.000027605422,0.000068567286,0.000014181003,0.0001551192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972715,0.00033626525,0.0014082137,0.00027062523,0.0005058586,0.00020754126],"domain_scores_gemma":[0.99759924,0.0005478955,0.0006423344,0.00061791815,0.00047129087,0.000121326746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006940397,0.00017097505,0.0008296928,0.00025750493,0.000068435285,0.000026196432,0.00041745932,0.00012886857,0.00004537099],"category_scores_gemma":[0.0024863866,0.00011721601,0.00049654586,0.00046484626,0.00021960461,0.00016447593,0.000117106785,0.00012518486,0.0000060953057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009164618,0.0012401913,0.9910907,0.00048097872,0.000884476,0.0000012141759,0.00012262461,0.00007325279,0.0003703794,0.00052212685,0.0021143644,0.0030080052],"study_design_scores_gemma":[0.0010806427,0.00006229518,0.9796094,0.016966945,0.00048496487,0.0000023225211,0.00059543,0.0004485489,0.00042858112,0.0002174556,0.0000074935874,0.00009596496],"about_ca_topic_score_codex":0.00022129736,"about_ca_topic_score_gemma":0.000011370879,"teacher_disagreement_score":0.016485967,"about_ca_system_score_codex":0.000041687403,"about_ca_system_score_gemma":0.0003191314,"threshold_uncertainty_score":0.47799304},"labels":[],"label_agreement":null},{"id":"W4411395427","doi":"10.1016/j.ard.2025.05.760","title":"POS0374 CLINICAL IMPACT OF SIGNS OF CALCIUM PYROPHOSPHATE DEPOSITION DISEASE (CPPD) ON RADIOGRAPHS OF HANDS AND WRISTS IN A REAL-WORLD COHORT OF PATIENTS WITH EARLY RHEUMATOID ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cohort; Radiography; Chondrocalcinosis; Calcium pyrophosphate; Wrist; Dermatology; Disease; Internal medicine; Surgery; Pathology; Calcium; Osteoarthritis; Alternative medicine","score_opus":0.02243572103931495,"score_gpt":0.34605973982383026,"score_spread":0.3236240187845153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99152374,0.0067402595,0.000012160808,0.00010337901,0.000038321832,0.00096861814,0.00049298705,0.00000932301,0.00011118482],"genre_scores_gemma":[0.9592961,0.040545538,0.000029638328,0.000019099942,0.0000028975721,0.000029138544,0.000044194974,0.000018946486,0.00001441372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721867,0.00027751902,0.0013136317,0.00024854817,0.0006713094,0.00027031917],"domain_scores_gemma":[0.9974351,0.0005157865,0.00072004885,0.0005900532,0.00048103178,0.0002579846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039043205,0.00022185368,0.0011644999,0.00049494684,0.000039714785,0.00000973698,0.000202684,0.000052404976,0.00003331903],"category_scores_gemma":[0.0005849255,0.00014623703,0.00049920956,0.00072417315,0.0009339932,0.00012187636,0.00007842528,0.00012392562,2.872496e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008275409,0.0025595408,0.9761515,0.0009424368,0.00093544734,0.0000043894643,0.0001832752,0.000037273316,0.000074917596,0.00041923462,0.0002643676,0.010152177],"study_design_scores_gemma":[0.006099625,0.0026726734,0.97390056,0.014046836,0.000051775034,5.4071023e-7,0.000044017626,0.00009179121,0.0021000437,0.0008848443,0.0000012833306,0.000105987296],"about_ca_topic_score_codex":0.0022592663,"about_ca_topic_score_gemma":0.00011349787,"teacher_disagreement_score":0.033805277,"about_ca_system_score_codex":0.0000150945,"about_ca_system_score_gemma":0.00035090832,"threshold_uncertainty_score":0.5963373},"labels":[],"label_agreement":null},{"id":"W4411395434","doi":"10.1016/j.ard.2025.06.321","title":"POS0966 OBINUTUZUMAB SHOWS PROMISE IN LUPUS NEPHRITIS REGARDLESS OF BASELINE SEROLOGICAL BIOMARKERS: AN EXPLORATORY POST HOC ANALYSIS OF THE PHASE II NOBILITY STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Belimumab; Lupus nephritis; Obinutuzumab; Post-hoc analysis; Serology; Immunology; Internal medicine; Antibody; Rituximab; Disease","score_opus":0.05714294651728946,"score_gpt":0.37364856662102225,"score_spread":0.3165056201037328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933645,0.0022940757,0.000008185658,0.0010295123,0.0001273836,0.002590698,0.0004946642,0.00002422899,0.00006674147],"genre_scores_gemma":[0.999235,0.00016690267,0.000027983166,0.00016591202,0.000008766592,0.00016689191,0.000034421657,0.000017074584,0.00017707917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947913,0.0018947561,0.0014823297,0.0004675019,0.0010110434,0.00035304407],"domain_scores_gemma":[0.99548763,0.00079715997,0.00057096564,0.002159989,0.0008057614,0.0001784694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002391059,0.00027460902,0.0014549567,0.00056751544,0.000111454334,0.00001535454,0.00092225015,0.00010432554,0.00017999276],"category_scores_gemma":[0.003336555,0.00015385235,0.0007079637,0.0025334624,0.0005524623,0.00015080182,0.0005783695,0.0001795098,8.805587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0112212915,0.022389725,0.9276872,0.0050267535,0.007181755,0.00002946776,0.00925381,0.000218247,0.0019687878,0.00010422005,0.002144846,0.012773841],"study_design_scores_gemma":[0.03518784,0.010786383,0.80650836,0.016545834,0.011288026,0.0001334647,0.080732845,0.02850213,0.007964978,0.0014696857,0.000061423045,0.0008190071],"about_ca_topic_score_codex":0.00052091444,"about_ca_topic_score_gemma":0.00079859176,"teacher_disagreement_score":0.12117888,"about_ca_system_score_codex":0.00011289665,"about_ca_system_score_gemma":0.0008658275,"threshold_uncertainty_score":0.6273917},"labels":[],"label_agreement":null},{"id":"W4411395445","doi":"10.1016/j.ard.2025.06.147","title":"POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Open label; Axial spondyloarthritis; Extension (predicate logic); Phase (matter); Physical therapy; Physical medicine and rehabilitation; Internal medicine; Adverse effect; Ankylosing spondylitis; Sacroiliitis","score_opus":0.049688517571824464,"score_gpt":0.37946158080872605,"score_spread":0.3297730632369016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9373932,0.05292047,0.000004640224,0.00657474,0.00013744344,0.0011851066,0.0016331996,0.00002275993,0.00012847473],"genre_scores_gemma":[0.98707145,0.012423728,0.000059180555,0.00020168298,0.000023182647,0.000020732594,0.000055467623,0.000015867055,0.00012872851],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982258,0.00017544342,0.00068625726,0.0003738079,0.00021956266,0.00031914443],"domain_scores_gemma":[0.9975873,0.0010681567,0.00032824322,0.00064607576,0.0002679704,0.000102206315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033261382,0.00028329896,0.0008473998,0.000053677533,0.00045869828,0.000052192692,0.00024814357,0.000035150904,0.000010858376],"category_scores_gemma":[0.0015063294,0.00014923287,0.00010767499,0.00032837855,0.00083377684,0.000106846244,0.0006333429,0.00010318398,0.000001249357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1709775,0.01197634,0.011216881,0.0020269188,0.017801646,0.00032744426,0.014883913,0.00003229534,0.0027463215,0.005472176,0.0118067,0.7507319],"study_design_scores_gemma":[0.35128602,0.007958392,0.4719677,0.030987976,0.0032549212,0.00016501156,0.07796083,0.0008689875,0.012319416,0.04130363,0.00086841185,0.0010587039],"about_ca_topic_score_codex":0.00041859905,"about_ca_topic_score_gemma":0.00015321549,"teacher_disagreement_score":0.7496732,"about_ca_system_score_codex":0.000018262217,"about_ca_system_score_gemma":0.00012099012,"threshold_uncertainty_score":0.608554},"labels":[],"label_agreement":null},{"id":"W4411395455","doi":"10.1016/j.ard.2025.05.551","title":"POS0163 ANXIETY AT 3 MONTHS IS ASSOCIATED WITH WORSE DISEASE ACTIVITY, PROs, AND PREDICTS PROGRESSION TO ADVANCED THERAPIES BY 12 MONTHS IN EARLY RA: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT (CATCH)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; University of Manitoba; Université Laval; Arthritis Research Centre of Canada; McGill University; University of Calgary; Université de Sherbrooke; Western University","funders":"","keywords":"Medicine; Cohort; Anxiety; Physical therapy; Internal medicine; Arthritis; Disease; Gerontology; Psychiatry","score_opus":0.008440930348262404,"score_gpt":0.26468090273347716,"score_spread":0.2562399723852148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96585536,0.005715769,0.0000017289425,0.023983408,0.000050996394,0.0028413683,0.0013742343,0.000027655713,0.00014949095],"genre_scores_gemma":[0.9972836,0.0011774814,0.000022824483,0.00073330535,0.00000698827,0.00026080804,0.000115579205,0.000020670816,0.00037879025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998275,0.00020570266,0.00035716317,0.00037368474,0.0004731561,0.00031532827],"domain_scores_gemma":[0.998439,0.00033824175,0.00019310808,0.0005284628,0.00015611223,0.00034503522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000250303,0.00022909776,0.0004062497,0.00008068325,0.00026053787,0.000055646124,0.00017920265,0.00007406952,0.00001387191],"category_scores_gemma":[0.0012531148,0.00012348253,0.0001297376,0.00035479106,0.0002607004,0.00017136209,0.00009214706,0.00012568696,0.0000015199361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002842446,0.0005493996,0.9121845,0.0001575045,0.00034996954,0.0000032164064,0.0037517864,0.00002150274,0.00005899909,0.000012598383,0.0094773825,0.070590705],"study_design_scores_gemma":[0.0022189822,0.00030745607,0.99043363,0.005504901,0.00012470457,1.4288771e-7,0.00026064288,0.0001502139,0.0000719021,0.00063382136,0.00015630173,0.00013732031],"about_ca_topic_score_codex":0.05420044,"about_ca_topic_score_gemma":0.08411081,"teacher_disagreement_score":0.07824912,"about_ca_system_score_codex":0.00007965295,"about_ca_system_score_gemma":0.00032547308,"threshold_uncertainty_score":0.9520977},"labels":[],"label_agreement":null},{"id":"W4411395469","doi":"10.1016/j.ard.2025.05.581","title":"POS0194-PARE USE OF E-LEARNING IMPROVES KNOWLEDGE AND CONFIDENCE TO MANAGE PAIN AND FLARES IN RA","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Dental Research and COVID-19","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"","keywords":"Medicine; Confidence interval; Medical physics; Family medicine; Internal medicine","score_opus":0.041109104689243295,"score_gpt":0.35999425514998046,"score_spread":0.3188851504607372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993844,0.0049537467,0.00011735177,0.00043276287,0.000040555322,0.0003067059,0.00004687055,0.000012307299,0.00024572737],"genre_scores_gemma":[0.9972592,0.0003582352,0.000024432795,0.0002787801,0.0000023296968,0.000019566198,0.0000029580603,0.00000655565,0.0020479416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988097,0.0003358885,0.00028179414,0.00017819987,0.00020356488,0.00019087305],"domain_scores_gemma":[0.9978881,0.0015561281,0.00009105589,0.00026036066,0.000078291065,0.00012610115],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0004585035,0.0001024015,0.00024030199,0.00015187035,0.00006421087,0.00008086166,0.00024781408,0.000028086688,0.000031409752],"category_scores_gemma":[0.008608316,0.00007714905,0.00006514265,0.00028136472,0.00014755655,0.00015453812,0.0004362953,0.00007759836,0.000005391138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010738904,0.0007631075,0.56626296,0.012011511,0.00044573974,0.00005565915,0.0030048597,0.00015932418,0.0023918778,0.0142718535,0.034021124,0.36553812],"study_design_scores_gemma":[0.0005854668,0.00014570043,0.9769794,0.003237206,0.000036783185,0.0000020891175,0.0021183027,0.0016077379,0.001175049,0.013205023,0.00076039066,0.0001468628],"about_ca_topic_score_codex":0.0006317562,"about_ca_topic_score_gemma":0.00032340578,"teacher_disagreement_score":0.41071644,"about_ca_system_score_codex":0.000008841748,"about_ca_system_score_gemma":0.00006334269,"threshold_uncertainty_score":0.99974257},"labels":[],"label_agreement":null},{"id":"W4411395481","doi":"10.1016/j.ard.2025.05.684","title":"POS0297 SACROILIAC JOINT INVOLVEMENT IN PSORIATIC ARTHRITIS – MRI, RADIOGRAPHIC AND CLINICAL FINDINGS IN 581 EUROPEAN ROUTINE CARE PATIENTS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psoriatic arthritis; Sacroiliac joint; Radiography; Sacroiliitis; Arthritis; Psoriasis; Dermatology; Axial spondyloarthritis; Radiology; Physical therapy; Internal medicine","score_opus":0.023369940446911493,"score_gpt":0.30546909112946313,"score_spread":0.28209915068255165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974502,0.022764934,6.2099616e-7,0.0011849036,0.00022041285,0.0007546831,0.00007469306,0.000014196542,0.00048351826],"genre_scores_gemma":[0.9823941,0.016922923,0.000035234625,0.0005150972,0.000010639497,0.000029653927,0.00003625386,0.0000140148795,0.00004211251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981811,0.00020676304,0.0008236245,0.00027976444,0.00024564005,0.00026309476],"domain_scores_gemma":[0.9991768,0.00012950889,0.00014752042,0.0003472286,0.000098458186,0.00010046075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020751017,0.00018592579,0.0006069715,0.0002279138,0.0000749772,0.00001723978,0.000110179586,0.000036210786,0.000021698643],"category_scores_gemma":[0.0005484134,0.00013545227,0.000246226,0.00042434552,0.0001476583,0.00005410594,0.0001942942,0.00011399172,0.0000036710853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012742735,0.0010034359,0.91776305,0.00040549933,0.00022208247,0.000019164258,0.0007033258,0.0000020864882,3.7759463e-7,0.00007546773,0.0010634915,0.07861459],"study_design_scores_gemma":[0.0066335285,0.00034980386,0.9855868,0.0055677523,0.000125572,8.6839856e-7,0.0010710892,0.000021658634,0.00002021043,0.00044137784,0.00008326806,0.00009802652],"about_ca_topic_score_codex":0.00028842743,"about_ca_topic_score_gemma":0.00035249858,"teacher_disagreement_score":0.078516565,"about_ca_system_score_codex":0.000032137385,"about_ca_system_score_gemma":0.00005014694,"threshold_uncertainty_score":0.5523583},"labels":[],"label_agreement":null},{"id":"W4411395488","doi":"10.1016/j.ard.2025.05.391","title":"LB0004 RANDOMISED, PLACEBO-CONTROLLED PHASE II STUDY OF ORAL ENPATORAN, A FIRST-IN-CLASS TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN SYSTEMIC LUPUS ERYTHEMATOSUS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Immunology; Pharmacology; Dermatology; Alternative medicine; Pathology","score_opus":0.016681122329187822,"score_gpt":0.3002304218332059,"score_spread":0.2835492995040181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888825,0.0029195377,0.00000376861,0.0004927559,0.0010377619,0.006455031,0.000032452775,0.0000364566,0.00013974913],"genre_scores_gemma":[0.99850494,0.00018960242,0.000007776664,0.000120630924,0.00002761005,0.00077555206,0.0000071119753,0.000028825867,0.00033797356],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964363,0.0005972862,0.0016156766,0.00033754884,0.00060131657,0.00041184976],"domain_scores_gemma":[0.9971944,0.0010789471,0.000601127,0.00078042573,0.00017774591,0.00016734663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012684145,0.00036260328,0.0020805085,0.00037644978,0.00010141963,0.000015834878,0.00033612282,0.00011359149,0.000073465606],"category_scores_gemma":[0.0019837108,0.00023828176,0.000487467,0.000623074,0.00012514592,0.00011140828,0.00015048018,0.00020635751,0.0000075856155],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5696872,0.04642034,0.28251398,0.02558889,0.00408482,0.0002879473,0.020158703,0.0013137473,0.0015621812,0.00040092328,0.03229676,0.015684552],"study_design_scores_gemma":[0.9400889,0.0040029734,0.0051008174,0.030126536,0.0015536603,0.000053171487,0.008213089,0.0055685146,0.004070486,0.00033035537,0.00025988749,0.0006315888],"about_ca_topic_score_codex":0.00019139003,"about_ca_topic_score_gemma":0.00018051262,"teacher_disagreement_score":0.37040177,"about_ca_system_score_codex":0.00007665317,"about_ca_system_score_gemma":0.00039573153,"threshold_uncertainty_score":0.9716848},"labels":[],"label_agreement":null},{"id":"W4411395529","doi":"10.1016/j.ard.2025.05.521","title":"POS0133 THE FINDINGS FROM MOST RANDOMIZED CONTROLLED TRIALS OF GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS ARE FRAGILE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Giant cell arteritis; Takayasu arteritis; Randomized controlled trial; Arteritis; Takayasu's arteritis; Vasculitis; Internal medicine; Disease","score_opus":0.01895459684032067,"score_gpt":0.2856441517672757,"score_spread":0.266689554926955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94382656,0.02958712,0.00009901595,0.020946996,0.00031188902,0.002543482,0.0013817959,0.000025478077,0.0012776587],"genre_scores_gemma":[0.9900768,0.007815755,0.000039363764,0.000984231,0.000023307977,0.00019574192,0.00005439745,0.000012223681,0.0007981861],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99718374,0.0007687163,0.0013857624,0.00018253198,0.00030110753,0.00017812116],"domain_scores_gemma":[0.99505866,0.003413482,0.0007489292,0.0004802259,0.00020372366,0.00009495497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010640803,0.00019296717,0.0028074689,0.00010096034,0.00015548615,0.00004474861,0.00018830768,0.00008499489,0.00058955164],"category_scores_gemma":[0.0047017504,0.0000902553,0.0012725211,0.00018989803,0.00043864883,0.000055865446,0.00006839598,0.000119397184,0.0000041874605],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22696587,0.009012412,0.009818985,0.009327578,0.072303444,0.00020223636,0.010193842,0.00017822077,0.019253233,0.020495132,0.51122653,0.11102249],"study_design_scores_gemma":[0.68310827,0.00027928452,0.2011582,0.02604931,0.0166134,0.000034638237,0.003791861,0.0024271563,0.007124352,0.05830034,0.0006150219,0.00049817323],"about_ca_topic_score_codex":0.0002300007,"about_ca_topic_score_gemma":0.0000062137783,"teacher_disagreement_score":0.51061153,"about_ca_system_score_codex":0.0000059783624,"about_ca_system_score_gemma":0.00011475416,"threshold_uncertainty_score":0.6455177},"labels":[],"label_agreement":null},{"id":"W4411395530","doi":"10.1016/j.ard.2025.05.388","title":"LB0001 EFFICACY AND SAFETY OF DEUCRAVACITINIB UP TO WEEK 16 FROM POETYK PsA-1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Double blind; Multicenter study; Internal medicine; Arthritis; Randomized controlled trial; Dermatology; Alternative medicine; Pathology","score_opus":0.02808955022993623,"score_gpt":0.33898889167078766,"score_spread":0.3108993414408514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863502,0.0016044051,0.00005926047,0.00065279595,0.000086879045,0.010808209,0.00013631248,0.000016395335,0.00028556655],"genre_scores_gemma":[0.9985378,0.00053731404,0.000024451585,0.00015082498,0.0000071633776,0.0004900997,0.000043056578,0.000021182486,0.0001881522],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970218,0.00052465906,0.0011902895,0.000327708,0.0006178858,0.00031768106],"domain_scores_gemma":[0.99713314,0.0013320319,0.00043668365,0.00059835234,0.00034153578,0.00015825286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005770834,0.0002769602,0.0018292814,0.00031570272,0.00009583516,0.000027906797,0.0002691641,0.00005355424,0.00013997425],"category_scores_gemma":[0.0019351941,0.00017124022,0.00024433763,0.00041603998,0.00026529058,0.00015264818,0.00017464232,0.00016730391,0.0000057011666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90340173,0.007374834,0.012995069,0.00027508647,0.001977856,0.0000029200623,0.0029922053,0.00002386273,0.0000025979455,0.00004802702,0.00020459392,0.0707012],"study_design_scores_gemma":[0.88698435,0.0010155228,0.103735745,0.003488765,0.00058814033,1.7852238e-7,0.0034664415,0.0002135706,0.00014496624,0.00019833844,0.000019104724,0.00014489304],"about_ca_topic_score_codex":0.0006090816,"about_ca_topic_score_gemma":0.000093995935,"teacher_disagreement_score":0.09074068,"about_ca_system_score_codex":0.000031653257,"about_ca_system_score_gemma":0.0002977504,"threshold_uncertainty_score":0.6982973},"labels":[],"label_agreement":null},{"id":"W4411395569","doi":"10.1016/j.ard.2025.05.312","title":"OP0310 DIFFERENCES IN STRUCTURAL LESIONS OF THE SPINE BETWEEN PATIENTS WITH EARLY axSpA AND NON-axSpA CHRONIC BACK PAIN: 2-YEAR RESULTS OF THE SPACE COHORT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axial spondyloarthritis; Cohort; Back pain; Chronic pain; Ankylosing spondylitis; Physical therapy; Internal medicine; Pathology; Sacroiliitis; Alternative medicine","score_opus":0.01935083170732377,"score_gpt":0.2802526932220132,"score_spread":0.2609018615146894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527204,0.00037603118,0.0000059831013,0.0030539678,0.00008243644,0.0006805963,0.00017341418,0.0000036206864,0.0003519249],"genre_scores_gemma":[0.99935585,0.00008712905,0.000022055345,0.00014260858,0.000010115721,0.000009173478,0.00000977972,0.0000075729613,0.00035574194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987053,0.00019948323,0.00047105056,0.00017060332,0.0002830543,0.00017046368],"domain_scores_gemma":[0.9988185,0.00007299012,0.00033836003,0.00058598514,0.00013708814,0.00004708351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017764657,0.0001478879,0.0004983065,0.000060836534,0.000053851563,0.0000067333494,0.00035672955,0.000047484365,0.000029386698],"category_scores_gemma":[0.00077149825,0.0000614673,0.00016162034,0.00031591466,0.00046647736,0.000056203284,0.00023518511,0.000114508504,7.613139e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007340037,0.00010484238,0.99594706,0.0004879795,0.00016283165,1.6592412e-7,0.00019006066,0.0000040590894,0.000045992158,0.00011884205,0.0013366544,0.0015280793],"study_design_scores_gemma":[0.0015668547,0.0004718294,0.99164915,0.004477615,0.00016483983,2.3106064e-7,0.0001316817,0.0001086656,0.00094199996,0.00042178965,0.0000035624896,0.00006178103],"about_ca_topic_score_codex":0.00048978726,"about_ca_topic_score_gemma":0.00009776504,"teacher_disagreement_score":0.004297943,"about_ca_system_score_codex":0.000012584515,"about_ca_system_score_gemma":0.00014092684,"threshold_uncertainty_score":0.25065637},"labels":[],"label_agreement":null},{"id":"W4411395643","doi":"10.1016/j.ard.2025.05.179","title":"OP0166 EFFICACY AND SAFETY OF TWO YEARS OF TREATMENT WITH ANTI-IL-5/R THERAPIES FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University","funders":"","keywords":"Medicine; Granulomatosis with polyangiitis; Eosinophilic; Dermatology; Microscopic polyangiitis; Churg-strauss syndrome; Immunology; Vasculitis; Pathology; Disease","score_opus":0.019928217972004995,"score_gpt":0.30284666251920683,"score_spread":0.28291844454720183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878141,0.008547242,0.000045816174,0.0018654623,0.000025070187,0.0011536515,0.00039478543,0.000020728365,0.00013308896],"genre_scores_gemma":[0.99710983,0.0020547402,0.00046436393,0.00013977176,0.000008074316,0.00005272413,0.000015279811,0.000023553077,0.00013163824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889374,0.00005594865,0.00041670472,0.00020228815,0.00023845179,0.00019287306],"domain_scores_gemma":[0.998364,0.00053355563,0.0002950478,0.0005513894,0.00017552033,0.00008049874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009115243,0.0001926733,0.0007317947,0.00013713528,0.000054591375,0.000008182924,0.00014520719,0.000032414733,0.00001606501],"category_scores_gemma":[0.0001069072,0.00011253553,0.00016127709,0.00029241745,0.00051017635,0.000058862086,0.000040547267,0.00003109726,3.1549385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008635442,0.005332228,0.51883006,0.0076439474,0.010603189,0.000013670386,0.0046103364,0.00015113787,0.0035375701,0.010226515,0.0010768778,0.42933902],"study_design_scores_gemma":[0.009002957,0.0030912762,0.95721376,0.006709543,0.0014845298,0.000020083455,0.00032055107,0.00005660178,0.020224385,0.0016210745,0.00009213281,0.00016310433],"about_ca_topic_score_codex":0.0002597013,"about_ca_topic_score_gemma":0.000015594333,"teacher_disagreement_score":0.4383837,"about_ca_system_score_codex":0.000016861131,"about_ca_system_score_gemma":0.0002087616,"threshold_uncertainty_score":0.45890656},"labels":[],"label_agreement":null},{"id":"W4411395644","doi":"10.1016/j.ard.2025.05.141","title":"OP0119-HPR A CANADIAN ADVANCED PHYSIOTHERAPIST PRACTITIONER (APP) SHARED-CARE MODEL OFFERS SAFE AND EFFECTIVE CARE IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Juvenile; Arthritis; Physical therapy; Alternative medicine; Internal medicine; Pathology","score_opus":0.027803665847926765,"score_gpt":0.3836431465009517,"score_spread":0.35583948065302495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9054677,0.06423395,0.000087170614,0.015703833,0.00042222717,0.0067860726,0.001855198,0.00004027732,0.0054035997],"genre_scores_gemma":[0.99297076,0.004748871,0.000057466354,0.0016582351,0.000019167659,0.00037608293,0.000041216845,0.0000140978,0.00011407488],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99801946,0.0006145864,0.0005499598,0.00021130795,0.0002599112,0.00034480193],"domain_scores_gemma":[0.9986079,0.00028118197,0.00031694092,0.00044064183,0.00023692883,0.00011640964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003147011,0.00016194447,0.00039451057,0.00013565054,0.00044189283,0.000009237219,0.00029676917,0.00008360182,0.000029902332],"category_scores_gemma":[0.00013875305,0.000109378816,0.00011563371,0.00035614613,0.000078027624,0.00012232318,0.00009032041,0.00025488934,0.0000043511864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011417533,0.000576383,0.09854407,0.1027358,0.00054641126,0.000022902648,0.16402511,0.003137057,0.000010733804,0.012163795,0.01935965,0.59773636],"study_design_scores_gemma":[0.0035197013,0.00018936401,0.75100744,0.043959185,0.00021398203,5.9242274e-7,0.1893944,0.0012078981,0.000024601251,0.00818733,0.0018925479,0.00040296034],"about_ca_topic_score_codex":0.008652512,"about_ca_topic_score_gemma":0.014525347,"teacher_disagreement_score":0.6524634,"about_ca_system_score_codex":0.00011494257,"about_ca_system_score_gemma":0.0007466119,"threshold_uncertainty_score":0.99794894},"labels":[],"label_agreement":null},{"id":"W4411395648","doi":"10.1016/j.ard.2025.05.084","title":"OP0061 A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; University of Ottawa; Mount Sinai Hospital","funders":"","keywords":"Medicine; Giant cell arteritis; Measure (data warehouse); Delphi; Delphi method; Physical therapy; Internal medicine; Vasculitis; Disease; Data mining; Artificial intelligence","score_opus":0.03303132345087069,"score_gpt":0.320151755220862,"score_spread":0.2871204317699913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98568887,0.0012131801,0.000078109195,0.011358305,0.000085294305,0.0010530195,0.00006239161,0.000011703945,0.0004491202],"genre_scores_gemma":[0.9979726,0.00017608293,0.0005022738,0.00047691134,0.0000035845098,0.0002129762,0.000008405443,0.000007929186,0.0006392158],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988481,0.00008522814,0.00053150055,0.00012240848,0.00023112824,0.00018166442],"domain_scores_gemma":[0.9991044,0.00013785616,0.000084471,0.0004295375,0.00012578894,0.00011798488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028135726,0.00012714385,0.00033695134,0.00018463563,0.00009657145,0.000014831161,0.0001764508,0.00003566218,0.0000634884],"category_scores_gemma":[0.0003223267,0.00006948428,0.00017046343,0.00040720185,0.000043979213,0.00003855794,0.00008189036,0.00004364539,0.000011175281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066614556,0.004237138,0.0032906008,0.0024590213,0.0013591034,0.00005229758,0.0740949,0.0006312449,0.011777147,0.00039871203,0.019512156,0.87552625],"study_design_scores_gemma":[0.0037641816,0.00060834194,0.9098007,0.028073562,0.00063789595,0.000013766357,0.009193779,0.00021895475,0.040865067,0.00090135046,0.005591054,0.00033134993],"about_ca_topic_score_codex":0.00006880973,"about_ca_topic_score_gemma":0.000042918175,"teacher_disagreement_score":0.9065101,"about_ca_system_score_codex":0.00004525655,"about_ca_system_score_gemma":0.00044440627,"threshold_uncertainty_score":0.28334868},"labels":[],"label_agreement":null},{"id":"W4411395671","doi":"10.1016/j.ard.2025.05.062","title":"OP0038 Increase in Prevalence and Incidence Rates of Psoriatic Arthritis in Catalonia, Spain: A Population-Based Study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Psoriatic arthritis; Incidence (geometry); Population; Prevalence; Epidemiology; Dermatology; Demography; Environmental health; Psoriasis; Internal medicine","score_opus":0.02108354229278054,"score_gpt":0.32483803679332035,"score_spread":0.3037544945005398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411395671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684037,0.011486744,0.0000011422284,0.0005935409,0.000037281843,0.00095739134,0.00005677875,0.0000063464736,0.00002041075],"genre_scores_gemma":[0.99891967,0.0007686282,0.000033160355,0.00013034893,0.0000026266957,0.00009785248,0.000009068843,0.000005801821,0.000032825126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988187,0.00014185302,0.0004999321,0.0001784103,0.00021707789,0.00014403164],"domain_scores_gemma":[0.9990008,0.00039635136,0.00016021622,0.0003197249,0.00007406585,0.000048867576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022592959,0.00012370355,0.00047015684,0.00016433159,0.000041488016,0.000007711544,0.00009940538,0.00002173679,0.000019590238],"category_scores_gemma":[0.0015462524,0.00009206058,0.000065017855,0.00041034268,0.00007454306,0.000065630054,0.00008020511,0.000047695125,7.215443e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020187012,0.0013326891,0.98710406,0.0009289594,0.00007527203,0.000017145625,0.00023292139,0.00003414547,0.0000012853051,0.000055187764,0.00003129854,0.009985176],"study_design_scores_gemma":[0.0029862134,0.00020927409,0.9879015,0.007332034,0.00009170113,0.0000010977376,0.0002880789,0.0002504336,0.000056619796,0.0008218931,6.9601066e-7,0.000060452196],"about_ca_topic_score_codex":0.0074387277,"about_ca_topic_score_gemma":0.0044400664,"teacher_disagreement_score":0.012079323,"about_ca_system_score_codex":0.000021213678,"about_ca_system_score_gemma":0.00012745406,"threshold_uncertainty_score":0.99917084},"labels":[],"label_agreement":null},{"id":"W4411396570","doi":"10.1016/j.ard.2025.06.1888","title":"ABS0796 COMPARATIVE ANALYSIS OF DAMAGE ACCRUAL IN LUPUS NEPHRITIS STRATIFIED BY BIOLOGIC SEX","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Accrual; Immunology; Internal medicine; Nephritis; Disease","score_opus":0.06245056774986182,"score_gpt":0.3856405545200613,"score_spread":0.3231899867701995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411396570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910946,0.004255524,0.000022343524,0.0008078486,0.00006730824,0.0006357343,0.0002918621,0.00001691386,0.0028078565],"genre_scores_gemma":[0.99731183,0.0006080519,0.00002518692,0.00014843696,0.00000415886,0.000043088265,0.00006800551,0.000005692108,0.0017855252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795777,0.00034995333,0.0007673456,0.00023497758,0.00043140491,0.00025852938],"domain_scores_gemma":[0.99797577,0.0007845146,0.00027738055,0.00067394826,0.00019783348,0.00009056507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032606348,0.00016460665,0.0010809241,0.0004791059,0.000041154355,0.00001572594,0.0003973057,0.000070381146,0.00018867047],"category_scores_gemma":[0.0006426915,0.000105870895,0.0003563645,0.0017645906,0.0003061035,0.00006225779,0.00014041722,0.000114560375,0.00000466167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042092727,0.0011962699,0.9438053,0.002601564,0.004731416,0.000007855976,0.0024555936,0.00022969944,0.0019692988,0.0011489934,0.038076892,0.0033562046],"study_design_scores_gemma":[0.00490712,0.00045266753,0.92414147,0.010146345,0.002819919,0.000041925636,0.022038043,0.013144815,0.017765703,0.0038088204,0.000284804,0.00044838543],"about_ca_topic_score_codex":0.0003163372,"about_ca_topic_score_gemma":0.00009442477,"teacher_disagreement_score":0.037792087,"about_ca_system_score_codex":0.000028555802,"about_ca_system_score_gemma":0.00021060843,"threshold_uncertainty_score":0.431729},"labels":[],"label_agreement":null},{"id":"W4411396668","doi":"10.1016/j.ard.2025.06.1714","title":"ABS0100 THE 14-3-3? AUTOANTIBODY ASSAY COMBINES WITH CRP AND HLA-B27 TO MAXIMIZE THE IDENTIFICATION OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS INCLUDING IN HLA-B27 NEGATIVE PATIENTS; A VALIDATION STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; HLA-B27; Autoantibody; Human leukocyte antigen; Immunology; Axial spondyloarthritis; Identification (biology); Ankylosing spondylitis; Antibody; Antigen; Sacroiliitis","score_opus":0.017504903646937083,"score_gpt":0.2950536800902573,"score_spread":0.2775487764433202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411396668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943243,0.00039716347,0.000029020921,0.0018041149,0.00012317138,0.0030148749,0.00019300949,0.000015496009,0.000098795885],"genre_scores_gemma":[0.9992712,0.00012480006,0.000031179934,0.00017457969,0.000007616342,0.00022381182,0.00004959045,0.000018166807,0.000099040095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979049,0.0002967217,0.00065780693,0.00029305284,0.0006218011,0.00022573139],"domain_scores_gemma":[0.9978544,0.0005327479,0.00046964656,0.000554665,0.00052772934,0.000060796774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040022578,0.00023912816,0.00050787075,0.00014767944,0.00031947,0.00005142515,0.00023205826,0.000030658004,0.000016632868],"category_scores_gemma":[0.00096307416,0.00011351934,0.00008671839,0.0006861221,0.00027569247,0.00014809002,0.00021095428,0.00009665058,0.0000020310151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015627391,0.0025697898,0.9774279,0.00016158808,0.00058945414,0.000002400002,0.0030802046,0.00004967865,0.000007676031,0.00016450962,0.00032626354,0.014057797],"study_design_scores_gemma":[0.006248846,0.00096011703,0.98738986,0.0015556581,0.00040189232,6.9730993e-7,0.002288228,0.000038964023,0.0003873386,0.00059833965,0.000019198591,0.000110837],"about_ca_topic_score_codex":0.00043342408,"about_ca_topic_score_gemma":0.00025490622,"teacher_disagreement_score":0.013946961,"about_ca_system_score_codex":0.000031975655,"about_ca_system_score_gemma":0.00007996855,"threshold_uncertainty_score":0.4629184},"labels":[],"label_agreement":null},{"id":"W4411397737","doi":"10.1016/j.ard.2025.06.223","title":"POS0867 MACHINE LEARNING MODEL OUTPERFORMS CONVENTIONAL LOGISTIC REGRESSION IN PREDICTING SPINAL RADIOGRAPHIC PROGRESSION OVER 2-YEAR INTERVALS IN AXIAL SPONDYLOARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Axial spondyloarthritis; Logistic regression; Radiography; Machine learning; Radiology; Internal medicine; Magnetic resonance imaging; Sacroiliitis","score_opus":0.024476567245903653,"score_gpt":0.31468019684927834,"score_spread":0.2902036296033747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411397737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280465,0.0050849137,0.0011687891,0.00036510552,0.00014908223,0.00015470297,0.000027334356,0.00006695577,0.00017849657],"genre_scores_gemma":[0.9988892,0.00077960774,0.0001295813,0.000042094507,0.000013067605,0.000023584673,0.000025222967,0.000013169439,0.00008447566],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986091,0.00011088834,0.00053701736,0.00016911767,0.00032813332,0.00024569492],"domain_scores_gemma":[0.999497,0.00009770406,0.00010607057,0.00019254684,0.000034829747,0.000071878465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041560055,0.00015839828,0.00034483912,0.00036762876,0.00006175454,0.000029231822,0.00023752925,0.000053969296,0.000059024223],"category_scores_gemma":[0.000728808,0.000108325075,0.00022115652,0.00052990316,0.00011979009,0.00012986305,0.00009257018,0.00028054052,0.0000016380567],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011628859,0.00027703602,0.7940886,0.0013811048,0.00013865554,0.000010848932,0.00018197927,0.12764695,0.00008822349,0.00038437636,0.0006967028,0.07498922],"study_design_scores_gemma":[0.00068979326,0.000025701096,0.12813756,0.0105179595,0.000039863266,0.0000010839518,0.00006512739,0.85732645,0.00009379885,0.00298398,0.000012339915,0.00010633094],"about_ca_topic_score_codex":0.00006934539,"about_ca_topic_score_gemma":0.00001451533,"teacher_disagreement_score":0.7296795,"about_ca_system_score_codex":0.000020132016,"about_ca_system_score_gemma":0.00003736492,"threshold_uncertainty_score":0.44173685},"labels":[],"label_agreement":null},{"id":"W4411397815","doi":"10.1016/j.ard.2025.06.063","title":"POS0702 SEX DIFFERENCES IN SERUM PROTEIN PROFILES OF MALES AND FEMALES WITH PSORIATIC ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; University of Waterloo; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Arthritis; Psoriasis; Internal medicine; Immunology","score_opus":0.02829154812626388,"score_gpt":0.29188113874535787,"score_spread":0.263589590619094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411397815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965154,0.030370884,0.0000054029492,0.0032550583,0.000022814782,0.00085184805,0.000057723642,0.000015344374,0.00026693044],"genre_scores_gemma":[0.98263484,0.016777568,0.00011924296,0.00005705477,0.000005928143,0.00009788542,0.0000034896964,0.000009614271,0.00029438428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987161,0.00014129505,0.0003962715,0.00017021196,0.0003443601,0.00023173353],"domain_scores_gemma":[0.9991635,0.00018414998,0.00014909005,0.00030897633,0.00011004861,0.00008421496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017019364,0.00014876452,0.0005415998,0.00016683084,0.00006038927,0.000023656861,0.00016247583,0.000033445973,0.000058012407],"category_scores_gemma":[0.000431928,0.00008707739,0.00008267209,0.00027551112,0.000493118,0.00009805742,0.000083123705,0.00008273043,0.000001051027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004916927,0.00061930757,0.84399486,0.0028874923,0.00038138198,0.0000090581725,0.0006418736,0.000002161228,0.00023576959,0.00582424,0.0002794704,0.1446327],"study_design_scores_gemma":[0.0015116449,0.0003801601,0.9656548,0.016987937,0.000013991924,0.000008179436,0.001359717,0.000095384996,0.0061062677,0.0077439435,0.00003637977,0.000101632366],"about_ca_topic_score_codex":0.000118723474,"about_ca_topic_score_gemma":0.0000917884,"teacher_disagreement_score":0.14453106,"about_ca_system_score_codex":0.0000047982717,"about_ca_system_score_gemma":0.00019394902,"threshold_uncertainty_score":0.3550913},"labels":[],"label_agreement":null},{"id":"W4411398180","doi":"10.1016/j.ard.2025.05.423","title":"POS0026 Risk of pneumonia-related hospitalisation in patients with giant cell arteritis and small vessel vasculitis: a nationwide population-based cohort study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Giant cell arteritis; Vasculitis; Cohort; Pneumonia; Arteritis; Cohort study; Systemic vasculitis; Population; Internal medicine; Pediatrics; Disease; Environmental health","score_opus":0.0052647201054182155,"score_gpt":0.22399878215715513,"score_spread":0.21873406205173693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411398180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971574,0.0004489061,0.00002231724,0.0005519883,0.000054038555,0.0014467231,0.00015097206,0.000018016492,0.0001496689],"genre_scores_gemma":[0.9994816,0.00013981477,0.000043334687,0.000058283935,0.000001885683,0.00006527568,0.00014790506,0.000011395849,0.000050465147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869233,0.00016446548,0.0005301602,0.00019083422,0.00029891805,0.00012331014],"domain_scores_gemma":[0.99891436,0.00013396918,0.00031073784,0.00033391727,0.00024718998,0.000059833525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017058333,0.00013166177,0.00036995966,0.00019036875,0.000083340914,0.000014440959,0.00008303668,0.000051399613,0.000026919734],"category_scores_gemma":[0.00026878508,0.000089604204,0.00011916982,0.0003863574,0.000075882264,0.000074392134,0.000024380184,0.00009179679,8.061364e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054613058,0.0018895699,0.994971,0.0002829443,0.0004524216,0.0000014421155,0.0002566926,0.00050165615,0.0000023874004,0.00011903513,0.000038906248,0.0014293528],"study_design_scores_gemma":[0.0036151006,0.00030773674,0.9914122,0.0016822717,0.0006666344,3.9803007e-7,0.0002454437,0.0007114316,0.000027528748,0.0012428969,7.716657e-7,0.000087535904],"about_ca_topic_score_codex":0.00087249425,"about_ca_topic_score_gemma":0.000059278947,"teacher_disagreement_score":0.0035604876,"about_ca_system_score_codex":0.000018708462,"about_ca_system_score_gemma":0.00009665532,"threshold_uncertainty_score":0.36539534},"labels":[],"label_agreement":null},{"id":"W4411400277","doi":"10.1016/j.ard.2025.06.1825","title":"ABS0235 WIDE-ANGLED SERUM AUTOANTIBODY PROFILING IN SYSTEMIC LUPUS ERYTHEMATOSUS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Autoantibody; Immunology; Lupus erythematosus; Systemic lupus; Dermatology; Antibody; Internal medicine; Disease","score_opus":0.03244984113455335,"score_gpt":0.33997304460946126,"score_spread":0.3075232034749079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411400277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830239,0.008513996,0.000048843645,0.0027155655,0.0005747775,0.001957595,0.000043711807,0.000102589096,0.0030190498],"genre_scores_gemma":[0.99481696,0.00048637597,0.000072739305,0.0002872312,0.000020998486,0.00013988337,0.000010722541,0.000038356982,0.0041267322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996827,0.00031052544,0.0011057634,0.00038124708,0.000798881,0.00057658064],"domain_scores_gemma":[0.99710226,0.0008298974,0.00033374171,0.0012515358,0.00031227755,0.00017030278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008415595,0.00028698152,0.0009947763,0.0004582153,0.000095731324,0.00003936942,0.0005940798,0.000113521986,0.00007669008],"category_scores_gemma":[0.0028161693,0.0001881287,0.0004059119,0.0010408568,0.00018921203,0.00011530818,0.00029158074,0.00022051272,0.000056631026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003196501,0.0005080769,0.9690186,0.017291225,0.00044514844,0.000039702107,0.00059958786,0.00007432451,0.00046786098,0.002403564,0.0070739496,0.001758341],"study_design_scores_gemma":[0.026427308,0.00065546064,0.49570736,0.3386793,0.0017657295,0.013164179,0.02584717,0.023945626,0.03875721,0.032437332,0.0006336654,0.0019796642],"about_ca_topic_score_codex":0.000079174235,"about_ca_topic_score_gemma":0.000010323103,"teacher_disagreement_score":0.47331122,"about_ca_system_score_codex":0.00009594208,"about_ca_system_score_gemma":0.000667554,"threshold_uncertainty_score":0.76716655},"labels":[],"label_agreement":null},{"id":"W4411400546","doi":"10.1016/j.ard.2025.06.698","title":"POS1349 SYNOVIAL-FLUID BASED PROTEOMIC SIGNATURES OF BIOLOGICAL AGING IN KNEE OSTEOARTHRITIS: IDENTIFICATION OF AGE-ASSOCIATED PATHWAYS AND PREDICTIVE MARKERS USING STEpUP OA","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Arthritis Network; Western University","funders":"","keywords":"Medicine; Synovial fluid; Osteoarthritis; Identification (biology); Bioinformatics; Pathology; Internal medicine; Alternative medicine","score_opus":0.020890912626600918,"score_gpt":0.2891181108834577,"score_spread":0.26822719825685676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411400546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568576,0.0025203691,0.00014082716,0.0003000902,0.000054285003,0.0011196121,0.00013321063,0.000010282013,0.000035546564],"genre_scores_gemma":[0.99969095,0.000095131116,0.00006862667,0.00005013113,0.0000025574657,0.000035143035,0.000042699376,0.0000064627275,0.000008272501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867666,0.00025716043,0.0005830848,0.00016327544,0.00020098017,0.00011881725],"domain_scores_gemma":[0.99892914,0.00031042338,0.00035073573,0.00020465485,0.0001705456,0.00003451604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039040073,0.0001076039,0.00037959035,0.00017776941,0.000038960625,0.0000069445773,0.00008421207,0.00007629233,0.000008238148],"category_scores_gemma":[0.0020398654,0.00007454454,0.00016553643,0.0003220806,0.00029004482,0.000059518425,0.00004505751,0.000066228524,1.0075868e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005077865,0.005504477,0.463757,0.020430885,0.0012909486,0.0000075668577,0.0026724169,0.005458169,0.39356905,0.0012039708,0.0003560565,0.10067159],"study_design_scores_gemma":[0.0012993338,0.000516189,0.9781142,0.0053487937,0.00012449487,1.7714042e-7,0.00077895867,0.007397592,0.0037049346,0.0026478719,3.1918674e-7,0.00006713042],"about_ca_topic_score_codex":0.00008449894,"about_ca_topic_score_gemma":0.0000063761468,"teacher_disagreement_score":0.5143572,"about_ca_system_score_codex":0.000018662018,"about_ca_system_score_gemma":0.00010791434,"threshold_uncertainty_score":0.30398384},"labels":[],"label_agreement":null},{"id":"W4411400641","doi":"10.1016/j.ard.2025.06.565","title":"POS1215 INVESTIGATING THE GENETICS OF DEPRESSION AND ANXIETY IN A MULTI-ANCESTRAL COHORT OF CHILDREN AND ADOLESCENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Holland Bloorview Kids Rehabilitation Hospital; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Cohort; Depression (economics); Anxiety; Systemic lupus erythematosus; Cohort study; Immunology; Psychiatry; Genetics; Internal medicine; Disease; Biology","score_opus":0.021283291686240668,"score_gpt":0.30498677194767093,"score_spread":0.2837034802614303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411400641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835931,0.015073496,0.000023035764,0.00024195622,0.000014616127,0.000993564,0.000031637665,0.000005018006,0.000023568939],"genre_scores_gemma":[0.9951233,0.0046851975,0.00007457161,0.000059053742,0.0000023903153,0.000023276743,0.0000040558325,0.000006510509,0.000021601472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900585,0.00008799759,0.00031889742,0.00014488857,0.0002960915,0.00014626692],"domain_scores_gemma":[0.9992634,0.000052197942,0.00018712833,0.0003189749,0.00008285933,0.000095433184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020125475,0.000102701415,0.00030711925,0.00007038616,0.00003600499,0.000009084185,0.0001296485,0.000020556148,0.0000012266837],"category_scores_gemma":[0.00023677459,0.000053342806,0.0000575915,0.0001888244,0.0003157214,0.000033384196,0.00017650703,0.000060011378,7.039666e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015593263,0.00023118751,0.9875589,0.0040845363,0.00018269969,7.858032e-7,0.00014362566,0.000053779764,0.00013959338,0.000032039177,0.00013927782,0.0072776577],"study_design_scores_gemma":[0.0013687507,0.00005016298,0.9811494,0.014493163,0.00021298837,0.0000152468565,0.00031706344,0.0011978028,0.0010259836,0.00012394386,6.975285e-7,0.000044830165],"about_ca_topic_score_codex":0.00015705683,"about_ca_topic_score_gemma":0.000016893433,"teacher_disagreement_score":0.0115302345,"about_ca_system_score_codex":0.0000061386236,"about_ca_system_score_gemma":0.00010255122,"threshold_uncertainty_score":0.21752565},"labels":[],"label_agreement":null},{"id":"W4411400707","doi":"10.1016/j.ard.2025.06.505","title":"POS1155 IMPROVEMENT OF FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH DAPIROLIZUMAB PEGOL: 48-WEEK RESULTS FROM A PHASE 3 TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Certolizumab pegol; Internal medicine; Lupus erythematosus; Immunology; Rheumatoid arthritis; Antibody","score_opus":0.036652797494042766,"score_gpt":0.31982880321957874,"score_spread":0.283176005725536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411400707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277794,0.00078101223,0.000028541226,0.0004057956,0.00015606459,0.004513138,0.00090562564,0.000041083535,0.00039078805],"genre_scores_gemma":[0.9987759,0.00007966859,0.000040012565,0.00004193002,0.000016197586,0.00023554538,0.00019275183,0.000041472103,0.00057654094],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960858,0.00025833922,0.0014918956,0.0004786728,0.0012363181,0.00044895872],"domain_scores_gemma":[0.9963145,0.0006195665,0.00087818294,0.0014153499,0.0005830969,0.00018925968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032443312,0.0003665185,0.0012918164,0.00038646028,0.00006229921,0.000026962285,0.0004790587,0.00009252581,0.000033625714],"category_scores_gemma":[0.0010073547,0.00019949007,0.00022976668,0.00083192973,0.00026027823,0.0001170052,0.00014348721,0.0001577955,0.0000045887173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48685548,0.015507422,0.46952787,0.008759441,0.0030863185,0.0000625925,0.002950574,0.00008742855,0.00020975842,0.00014752624,0.0045677195,0.00823787],"study_design_scores_gemma":[0.8339936,0.0130125135,0.041314457,0.0946749,0.0017373577,0.00025364495,0.0058123874,0.0012168845,0.0066425423,0.0005817556,0.00002804953,0.00073190563],"about_ca_topic_score_codex":0.0009648016,"about_ca_topic_score_gemma":0.000045884302,"teacher_disagreement_score":0.42821342,"about_ca_system_score_codex":0.00011229026,"about_ca_system_score_gemma":0.000640444,"threshold_uncertainty_score":0.8134969},"labels":[],"label_agreement":null},{"id":"W4411401259","doi":"10.1016/j.ard.2025.05.567","title":"POS0179 CHARACTERIZATION OF MEMORY T CELL SUBSETS DURING FLARES AND DISEASE QUIESCENCE IN LUPUS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Krembil Foundation","funders":"","keywords":"Medicine; Systemic lupus erythematosus; Immunology; Characterization (materials science); Disease; Pathology","score_opus":0.018773026150916743,"score_gpt":0.2963802454821285,"score_spread":0.27760721933121174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411401259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458057,0.0029713681,0.000005884747,0.0014574958,0.00011237095,0.00061336433,0.000055261244,0.000014077831,0.00018959663],"genre_scores_gemma":[0.99742806,0.0011043067,0.0000066364382,0.00008347804,0.0000074675345,0.00002864106,0.000012326195,0.000010838292,0.0013182544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869263,0.00012873106,0.0004481259,0.00017698035,0.00036149053,0.00019202742],"domain_scores_gemma":[0.99888957,0.00015344491,0.00018424545,0.00048072767,0.00013986076,0.00015213505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018976386,0.00011871354,0.00036981195,0.0002089085,0.00004359013,0.000012180606,0.00019223965,0.000031597265,0.000027076669],"category_scores_gemma":[0.001018117,0.00008333166,0.0001013505,0.0003296814,0.00016488909,0.00009945793,0.00015813627,0.00006266154,0.0000023774815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054122746,0.00039234172,0.96336764,0.01709217,0.000067067194,0.000010494467,0.00086246,0.0000071747763,0.01610569,0.000095526804,0.00031158308,0.0011466389],"study_design_scores_gemma":[0.0011419819,0.000023621118,0.96429646,0.010192216,0.00007851403,0.000024023748,0.000562238,0.0003453434,0.022743128,0.00050719426,0.0000040827645,0.0000811923],"about_ca_topic_score_codex":0.000042418047,"about_ca_topic_score_gemma":0.0000035892533,"teacher_disagreement_score":0.0068999543,"about_ca_system_score_codex":0.000018827668,"about_ca_system_score_gemma":0.0002459573,"threshold_uncertainty_score":0.33981663},"labels":[],"label_agreement":null},{"id":"W4411401262","doi":"10.1016/j.ard.2025.05.708","title":"POS0321 KIDNEY-RELATED OUTCOMES WITH OBINUTUZUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A PRE-SPECIFIED EXPLORATORY ANALYSIS OF THE REGENCY STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lupus nephritis; Obinutuzumab; Nephritis; Internal medicine; Immunology; Rituximab; Lymphoma","score_opus":0.018923189072071904,"score_gpt":0.2999134864998287,"score_spread":0.2809902974277568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411401262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544156,0.0005161366,0.0000043250225,0.00068732793,0.000109755674,0.0028081094,0.0001251506,0.000023329516,0.0002842895],"genre_scores_gemma":[0.99873745,0.000055436914,0.000009710147,0.00013613341,0.0000023674422,0.00018960997,0.000016495333,0.00002456246,0.0008282209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967654,0.00052785326,0.0008318084,0.00034829328,0.0012135196,0.00031317832],"domain_scores_gemma":[0.99683946,0.000367414,0.0005314215,0.0014829425,0.0006311314,0.00014762921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030852063,0.00026615648,0.0011229711,0.0005552586,0.00008992698,0.000017649862,0.00059551763,0.000059194255,0.000066049644],"category_scores_gemma":[0.0011963235,0.00012455649,0.0003414092,0.0031108952,0.00028743458,0.00013871153,0.00023106764,0.00019176776,0.0000017761306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002402934,0.0019112207,0.9805705,0.00067401165,0.007069837,0.000004234542,0.005518583,0.00014746017,0.0000020549983,0.000110846464,0.00085839874,0.0007299195],"study_design_scores_gemma":[0.0051709465,0.00040101225,0.9787796,0.005267479,0.0020846662,0.000003857172,0.007766699,0.00013145334,0.000096766176,0.00017018433,0.000004789769,0.0001225056],"about_ca_topic_score_codex":0.0002497524,"about_ca_topic_score_gemma":0.00016015692,"teacher_disagreement_score":0.0049851704,"about_ca_system_score_codex":0.00014999052,"about_ca_system_score_gemma":0.00090879865,"threshold_uncertainty_score":0.50792664},"labels":[],"label_agreement":null},{"id":"W4411401322","doi":"10.1016/j.ard.2025.05.849","title":"POS0467 Methotrexate use influenced the effect of inflammation on cardiovascular risk differently in anticitrullinated protein antibody negative and positive patients with rheumatoid arthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Rheumatoid arthritis; Methotrexate; Inflammation; Antibody; Internal medicine; Immunology","score_opus":0.007445955169003276,"score_gpt":0.2702574990257799,"score_spread":0.26281154385677663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411401322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282265,0.0038559628,0.00003816769,0.00034425422,0.00003022069,0.0026922193,0.00016884945,0.000015534559,0.000032140142],"genre_scores_gemma":[0.988793,0.010993229,0.000028332535,0.00002699123,0.0000029336416,0.00009617137,0.00003248792,0.000017540911,0.000009303648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970505,0.0012417276,0.00052456645,0.000258366,0.0006495982,0.00027523594],"domain_scores_gemma":[0.997412,0.001259277,0.00032854502,0.0005662038,0.00034770748,0.000086218104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005347421,0.0002567854,0.00080942997,0.00023902174,0.00015155111,0.000050215636,0.00018606376,0.00005315219,0.0000069986627],"category_scores_gemma":[0.003335227,0.00012934643,0.00025875217,0.0005301067,0.0005139277,0.00022128379,0.00009677843,0.00021390327,0.0000012468795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054488927,0.00041659837,0.9016532,0.00066749234,0.0030820959,0.000007785405,0.0011324374,0.00031667345,0.0009101027,0.00056411274,0.000023907243,0.08577674],"study_design_scores_gemma":[0.0052977945,0.0011372945,0.93529373,0.013487425,0.000055095657,0.0000013765417,0.00010063015,0.00021530416,0.043513797,0.00077738333,0.0000046925584,0.000115467985],"about_ca_topic_score_codex":0.00082806766,"about_ca_topic_score_gemma":0.00002933475,"teacher_disagreement_score":0.08566127,"about_ca_system_score_codex":0.000016959339,"about_ca_system_score_gemma":0.00008112872,"threshold_uncertainty_score":0.52745944},"labels":[],"label_agreement":null},{"id":"W4411401415","doi":"10.1016/j.ard.2025.05.499","title":"POS0111 THE LACK OF ASSOCIATION BETWEEN CUMULATIVE METHOTREXATE DOSE AND LIVER FIBROSIS IN PSORIATIC ARTHRITIS: A COHORT STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Krembil Foundation","funders":"","keywords":"Medicine; Psoriatic arthritis; Methotrexate; Cohort; Liver fibrosis; Internal medicine; Antirheumatic Agents; Arthritis; Oncology; Fibrosis; Dermatology","score_opus":0.05116702041293283,"score_gpt":0.35881227580007763,"score_spread":0.3076452553871448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411401415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898519,0.007213355,0.0000018443877,0.0012404983,0.00005076881,0.0012777006,0.00009927263,0.000008344885,0.0002563457],"genre_scores_gemma":[0.9965818,0.0029513685,0.000028403045,0.000114548144,0.0000083659,0.00007834358,0.00000654732,0.000007082656,0.0002235756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986487,0.00028221603,0.00044578308,0.00015728753,0.00031299682,0.00015299008],"domain_scores_gemma":[0.9983498,0.0008861094,0.00030080674,0.00028819576,0.00013818803,0.000036888752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043427438,0.00012760489,0.00057312765,0.00007454072,0.0000859809,0.000011531532,0.00009311141,0.00003146735,0.000021208874],"category_scores_gemma":[0.0010998992,0.000074628755,0.00013424695,0.00032060585,0.00008590551,0.000056096877,0.00011779596,0.000064087704,0.0000019423833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010850017,0.00059395446,0.97448575,0.00015728177,0.0016885799,0.000002457798,0.0012936973,0.0000049059536,0.0000015994293,0.00009600392,0.00038906155,0.021178216],"study_design_scores_gemma":[0.00223139,0.00023788853,0.9919061,0.0015822063,0.00085147086,3.3428717e-7,0.0010238081,0.000052308453,0.00008649921,0.0019615118,0.000013480667,0.000052982963],"about_ca_topic_score_codex":0.00082473794,"about_ca_topic_score_gemma":0.00014397338,"teacher_disagreement_score":0.021125233,"about_ca_system_score_codex":0.000030737625,"about_ca_system_score_gemma":0.00004844249,"threshold_uncertainty_score":0.30432725},"labels":[],"label_agreement":null},{"id":"W4411401439","doi":"10.1016/j.ard.2025.05.518","title":"POS0130 INHIBITION OF NEW BONE FORMATION BY SECUKINUMAB VISUALIZED BY Na[18F]F PET/CT IN AXIAL SPONDYLOARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Orthopedic Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Secukinumab; Axial spondyloarthritis; Nuclear medicine; Ankylosing spondylitis; Internal medicine; Arthritis; Sacroiliitis; Psoriatic arthritis","score_opus":0.014522456890232035,"score_gpt":0.3188396313667872,"score_spread":0.3043171744765552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411401439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944361,0.0027995796,0.00008302795,0.00092147005,0.00011075749,0.00050158467,0.00025386375,0.000022203794,0.000871425],"genre_scores_gemma":[0.9976912,0.0009163167,0.00003089113,0.00023503441,0.000008088408,0.000027415394,0.00021674116,0.00000948826,0.0008648309],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988515,0.000093409384,0.0005230801,0.00012219259,0.00025680175,0.00015302577],"domain_scores_gemma":[0.9992836,0.00008469007,0.00023285244,0.00024402866,0.00008191896,0.00007291245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013852282,0.00013055965,0.000365371,0.00015898889,0.000061073595,0.000013112041,0.000041311545,0.000013783692,0.00019042016],"category_scores_gemma":[0.00026939725,0.000098157616,0.00018851776,0.00036504798,0.00008474508,0.00017387293,0.000039416635,0.00006236468,0.0000069472553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00304853,0.013549374,0.093418814,0.005426441,0.0014613878,0.00024612912,0.0013021477,0.000047611073,0.0047357325,0.003814449,0.48777333,0.38517606],"study_design_scores_gemma":[0.09753281,0.0046831626,0.48862627,0.051473014,0.0037613732,0.0014729621,0.0033272302,0.003932029,0.28287327,0.041760985,0.018733641,0.0018232532],"about_ca_topic_score_codex":0.00066638127,"about_ca_topic_score_gemma":0.000018559404,"teacher_disagreement_score":0.46903968,"about_ca_system_score_codex":0.00003316364,"about_ca_system_score_gemma":0.0001346072,"threshold_uncertainty_score":0.40027514},"labels":[],"label_agreement":null},{"id":"W4411409949","doi":"10.1016/j.ard.2025.06.1852","title":"ABS0487 RESPONSE TO PLACEBO IN ACTIVE LUPUS NEPHRITIS: A SYSTEMATIC REVIEW AND POOLED ANALYSIS","year":2025,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Medicine; Lupus nephritis; Placebo; Internal medicine; Systemic lupus erythematosus; Nephritis; Dermatology; Immunology; Pathology; Alternative medicine; Disease","score_opus":0.03841828741143281,"score_gpt":0.3862464250211317,"score_spread":0.3478281376096989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411409949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043446013,0.98826015,0.000010002,0.0069831433,0.00006853549,0.004379359,0.00020122304,0.000014284221,0.00003988043],"genre_scores_gemma":[0.00040358456,0.99675447,0.000019011532,0.0013673243,0.0000073852975,0.00043320536,0.000051630726,0.0000166062,0.000946792],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99639153,0.0012695343,0.001304494,0.0003191293,0.00051099807,0.00020430966],"domain_scores_gemma":[0.996269,0.0018822987,0.0006597982,0.0007899415,0.0001667841,0.00023220471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013097039,0.00031258242,0.004424465,0.0006842918,0.00004705407,0.000024222169,0.00027877223,0.00021266539,0.00004496222],"category_scores_gemma":[0.006080087,0.0001700785,0.0010261687,0.0022666429,0.00021714297,0.000035451703,0.00018244024,0.00024547582,0.000006525198],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011401518,0.00009752027,0.000001639838,0.88281834,0.002912515,0.00000473028,0.00007036131,5.536974e-7,2.7129643e-8,0.00008422448,0.00068876933,0.113207296],"study_design_scores_gemma":[0.0002588578,0.000050888877,0.0003036412,0.93300384,0.061713427,0.000014971572,0.000043206437,0.000018824056,1.3157863e-7,0.00022700762,0.004212794,0.00015240304],"about_ca_topic_score_codex":0.000030302634,"about_ca_topic_score_gemma":0.000011260485,"teacher_disagreement_score":0.113054894,"about_ca_system_score_codex":0.000048253736,"about_ca_system_score_gemma":0.0006096272,"threshold_uncertainty_score":0.7278871},"labels":[],"label_agreement":null},{"id":"W4411409952","doi":"10.1016/j.ard.2025.06.1779","title":"ABS0987 ULTRASOUND FEATURES OF ENTHESITIS IN RADIOGRAPHIC AND NON-RADIOGRAPHIC AXIAL SPONDYLARTHRITIS: INSIGHTS FROM AN EGYPTION COHORT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Spondylarthritis; Radiography; Enthesitis; Cohort; Radiology; Ultrasound; Surgery; Pathology; Internal medicine; Ankylosing spondylitis; Arthritis","score_opus":0.009406867372809274,"score_gpt":0.27473010492903277,"score_spread":0.2653232375562235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411409952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96008664,0.038155977,0.0000030487495,0.00033754512,0.00014307351,0.0006252882,0.00020828524,0.000017584342,0.00042253715],"genre_scores_gemma":[0.98058265,0.01898644,0.000047016136,0.00018244516,0.000019679796,0.000053701773,0.000080379585,0.000013191158,0.00003450568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986753,0.00011043493,0.000443778,0.00027972003,0.0002962898,0.00019451106],"domain_scores_gemma":[0.99890816,0.00027104613,0.0001736279,0.0004496423,0.00009357566,0.000103972416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090196845,0.00020512423,0.0006398271,0.00039005186,0.0001026473,0.000020352378,0.00013597756,0.00007451351,0.000032404492],"category_scores_gemma":[0.00018196071,0.0001499449,0.00026582112,0.0006001583,0.0003489424,0.00012571744,0.00004893525,0.00008891327,7.118885e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000472585,0.0009948374,0.97110313,0.00028027486,0.0010086321,0.000025270554,0.0005223237,0.0000035539406,0.00027579733,0.00057999487,0.0004909252,0.024242645],"study_design_scores_gemma":[0.0022579527,0.00023629768,0.9878414,0.002958641,0.00039258556,0.000009646433,0.00037107957,0.000012857495,0.0006976635,0.0050794263,0.000033635697,0.000108801316],"about_ca_topic_score_codex":0.001750949,"about_ca_topic_score_gemma":0.0006786663,"teacher_disagreement_score":0.024133844,"about_ca_system_score_codex":0.000009770698,"about_ca_system_score_gemma":0.00005230806,"threshold_uncertainty_score":0.6114575},"labels":[],"label_agreement":null},{"id":"W4411409986","doi":"10.1016/j.ard.2025.06.1749","title":"ABS0628 FUNCTIONAL LIMITATIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. A GLOBAL OVERVIEW FROM THE IMAS STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Axial spondyloarthritis; Intensive care medicine; Ankylosing spondylitis; Physical therapy; Internal medicine; Sacroiliitis","score_opus":0.0607428013046954,"score_gpt":0.3028923103369896,"score_spread":0.2421495090322942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411409986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98763406,0.0072278855,0.0000032181383,0.0024814734,0.0001951268,0.0010678079,0.0004966038,0.000015717924,0.0008780758],"genre_scores_gemma":[0.9985463,0.00035910835,0.000020421245,0.00072318874,0.000017674352,0.00011197168,0.00006950219,0.0000073133874,0.00014454155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987851,0.00010087839,0.00032502876,0.00019848111,0.00041240032,0.00017814522],"domain_scores_gemma":[0.99900985,0.00024206532,0.00011498947,0.00041753828,0.00016393566,0.000051636576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071172944,0.00015643873,0.00033845153,0.0000330735,0.00016203348,0.000021802854,0.00013705579,0.000021444808,0.00013671136],"category_scores_gemma":[0.00035984765,0.000082617895,0.00015006353,0.0004298601,0.00012980336,0.00006933231,0.000107424275,0.000061707266,0.000014416953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007627544,0.002874744,0.9607982,0.000037940375,0.00064278493,0.000005444074,0.00017350748,0.0000138029445,6.443039e-8,0.00055131916,0.0044054915,0.02973393],"study_design_scores_gemma":[0.005829303,0.0003540857,0.98880357,0.0011515493,0.00030013308,5.4873635e-7,0.0007223581,0.0000062210593,0.0000010155118,0.0024290567,0.00033469714,0.00006747172],"about_ca_topic_score_codex":0.00053648296,"about_ca_topic_score_gemma":0.0012630974,"teacher_disagreement_score":0.029666457,"about_ca_system_score_codex":0.00003307009,"about_ca_system_score_gemma":0.00013444696,"threshold_uncertainty_score":0.33690602},"labels":[],"label_agreement":null},{"id":"W4411410150","doi":"10.1016/j.ard.2025.06.1575","title":"ABS0675 COMPARATIVE EFFECTIVENESS OF UPADACITINIB VERSUS OTHER JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A GLOBAL REAL-WORLD SETTING","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Antirheumatic Agents","score_opus":0.025289708193905636,"score_gpt":0.33412327754639964,"score_spread":0.308833569352494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994551,0.0003497678,0.000008543045,0.00014671472,0.00014846506,0.00064189325,0.00017695189,0.000013775102,0.003962906],"genre_scores_gemma":[0.9997698,0.000063809755,0.000033432847,0.000046019308,0.000004633951,0.000039012593,0.00002002856,0.000008588899,0.0000146488865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865067,0.00020593354,0.00053052057,0.00017705481,0.00025633883,0.00017949242],"domain_scores_gemma":[0.99868983,0.000567213,0.00025282247,0.0002663126,0.00017440702,0.000049429043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022163206,0.00015364317,0.000571282,0.0001802926,0.000036053054,0.000009964812,0.000109586756,0.000027823518,0.000037553524],"category_scores_gemma":[0.00032488036,0.000107088046,0.00013806002,0.0007029869,0.00013374096,0.00009224178,0.000054244552,0.00009913749,0.0000018701326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044723745,0.0012789086,0.98529506,0.0006314395,0.00025662265,0.0000015861273,0.00033209997,0.00043293543,0.000054285953,0.0012777247,0.0005031746,0.0054637976],"study_design_scores_gemma":[0.0055784862,0.0002718935,0.9666128,0.022316372,0.000030556468,2.9997025e-7,0.00034522905,0.000121200675,0.0041649193,0.00041904772,0.00004430528,0.000094855954],"about_ca_topic_score_codex":0.0016021108,"about_ca_topic_score_gemma":0.00080111093,"teacher_disagreement_score":0.021684933,"about_ca_system_score_codex":0.00006337975,"about_ca_system_score_gemma":0.0001828244,"threshold_uncertainty_score":0.4366924},"labels":[],"label_agreement":null},{"id":"W4411410168","doi":"10.1016/j.ard.2025.06.1415","title":"ABS0974 EARLY IMPROVEMENTS IN CLINICAL DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS AND ITS COMPONENTS WITH GUSELKUMAB PREDICT CLINICAL RESPONSE IN TNFi-EXPERIENCED AND BIOLOGIC-NAÏVE PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS: POST HOC ANALYSES OF THREE PHASE 3, RANDOMIZED, CONTROLLED STUDIES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Arthritis; Clinical trial; Internal medicine","score_opus":0.11866732804300405,"score_gpt":0.4566904498972508,"score_spread":0.33802312185424677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545313,0.03812704,0.00006023883,0.0009564561,0.00011761215,0.0058974875,0.00029064502,0.000016504653,0.0000026870512],"genre_scores_gemma":[0.93509996,0.06343885,0.000048180274,0.000104766514,0.00001638856,0.0012540106,0.000010566963,0.000019256466,0.0000080057425],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99429524,0.0020758552,0.0019601888,0.0005625253,0.0005652644,0.0005409405],"domain_scores_gemma":[0.98947823,0.008122202,0.0009286333,0.00048064403,0.0006237146,0.0003665651],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0031984984,0.00038563312,0.0034752013,0.0003580408,0.00013111964,0.000043886328,0.0002203692,0.00009656349,0.000009211838],"category_scores_gemma":[0.021938471,0.0002163498,0.00041498654,0.00039169914,0.0016637392,0.00030916152,0.00016448452,0.00024439942,3.8690055e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8124799,0.0035036998,0.049225416,0.00045104334,0.003944539,0.000025253976,0.0007357938,0.00001294932,0.00006158492,0.00006578736,0.000011587836,0.12948242],"study_design_scores_gemma":[0.3739106,0.005498965,0.6042364,0.00958684,0.00030073567,0.0000018183842,0.001054277,0.0036817256,0.00023057921,0.0013133826,9.639062e-7,0.00018368367],"about_ca_topic_score_codex":0.00015716611,"about_ca_topic_score_gemma":0.00030004047,"teacher_disagreement_score":0.55501103,"about_ca_system_score_codex":0.000024644953,"about_ca_system_score_gemma":0.0005502705,"threshold_uncertainty_score":0.9863002},"labels":[],"label_agreement":null},{"id":"W4411410182","doi":"10.1016/j.ard.2025.06.1423","title":"ABS1069 SEX-RELATED DIFFERENCES IN BASELINE PATIENT AND DISEASE CHARACTERISTICS: POST HOC ANALYSES OF THREE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; McGill University","funders":"","keywords":"Medicine; Post-hoc analysis; Placebo; Psoriatic arthritis; Randomized controlled trial; Post hoc; Internal medicine; Physical therapy; Arthritis; Alternative medicine; Pathology","score_opus":0.04464664890014471,"score_gpt":0.3410571418488162,"score_spread":0.2964104929486715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97614735,0.019164113,0.0000036418794,0.0006190944,0.00010844549,0.0035247628,0.00039504757,0.000011441602,0.000026111955],"genre_scores_gemma":[0.9934672,0.005818135,0.000014949198,0.00010344035,0.0000051876827,0.00047427026,0.00007688645,0.000013157725,0.00002676442],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976352,0.00027798535,0.0011268456,0.00030296028,0.0004058998,0.0002511293],"domain_scores_gemma":[0.9973868,0.0011295236,0.0006211435,0.00034232473,0.0003832916,0.00013692556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024684213,0.00031876971,0.0022138793,0.00033323155,0.000081804916,0.000014163336,0.00010358876,0.000040012404,0.00002712882],"category_scores_gemma":[0.0021536537,0.00017655421,0.00026995415,0.0003916702,0.0005065166,0.00010409175,0.00011085719,0.00009446121,6.974394e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7784326,0.004682034,0.14169104,0.00066552265,0.004926247,0.00002510068,0.0012810314,0.0000105916315,9.788324e-7,0.00008029018,0.000028156452,0.068176374],"study_design_scores_gemma":[0.6683504,0.0007802909,0.31903315,0.0074755144,0.0017169771,4.7365694e-7,0.0012311955,0.00034641748,0.00003199653,0.0008861488,4.065909e-7,0.00014702165],"about_ca_topic_score_codex":0.00018494745,"about_ca_topic_score_gemma":0.00012391373,"teacher_disagreement_score":0.17734209,"about_ca_system_score_codex":0.000030650568,"about_ca_system_score_gemma":0.0001518884,"threshold_uncertainty_score":0.7199671},"labels":[],"label_agreement":null},{"id":"W4411410187","doi":"10.1016/j.ard.2025.06.1445","title":"ABS0902 DEUCRAVACITINIB IN PLAQUE PSORIASIS: IMMUNE RESPONSE TO AND SAFETY OF PNEUMOCOCCUS AND TETANUS TOXOID VACCINES IN THE POETYK LTE TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Toxoid; Tetanus; Immune system; Immunology; Psoriasis; Plaque psoriasis; Vaccination","score_opus":0.021205998693083126,"score_gpt":0.28544844599958175,"score_spread":0.2642424473064986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98227143,0.0128187025,0.000001668194,0.0034037728,0.00025920218,0.00091014797,0.00017658153,0.000008872731,0.00014961955],"genre_scores_gemma":[0.997704,0.0017225953,0.000009875417,0.0001790992,0.0000064445017,0.00010183727,0.000011649128,0.000006847644,0.00025760537],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99790204,0.0009869298,0.0006213559,0.00020934491,0.000054340086,0.0002259965],"domain_scores_gemma":[0.997616,0.0017120114,0.00018294128,0.00042446595,0.000044199765,0.000020359817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088260847,0.00018415411,0.00051015295,0.00021393089,0.00009148679,0.000012846128,0.00032585723,0.00009667375,0.000028437606],"category_scores_gemma":[0.0010743769,0.00010970464,0.00012562827,0.0003523356,0.00012569716,0.00006004879,0.0001363364,0.00008150617,0.0000038454705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4764269,0.0038660874,0.06489194,0.0010769963,0.0025494383,0.000026734691,0.013611506,0.00008068057,0.031407073,0.0041770195,0.0038112411,0.3980744],"study_design_scores_gemma":[0.019032042,0.0004000308,0.96557516,0.000944869,0.0002096533,0.0000075779544,0.0015399846,0.0000031740508,0.0093008615,0.0023328643,0.0004975773,0.00015620196],"about_ca_topic_score_codex":0.00020687988,"about_ca_topic_score_gemma":0.000100260826,"teacher_disagreement_score":0.9006832,"about_ca_system_score_codex":0.000009084877,"about_ca_system_score_gemma":0.000088584165,"threshold_uncertainty_score":0.44736254},"labels":[],"label_agreement":null},{"id":"W4411410256","doi":"10.1016/j.ard.2025.06.1043","title":"ABS0418 LOW INCIDENCE OF NEONATAL INFECTION WITH TNF AND NON-TNF BIOLOGIC DMARD USE IN THE SECOND AND THIRD TRIMESTERS OF PREGNANCY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pregnancy; Tumor necrosis factor alpha; Incidence (geometry); TNF inhibitor; Obstetrics; Immunology; Internal medicine; Infliximab","score_opus":0.03342110894431751,"score_gpt":0.3130442978652183,"score_spread":0.2796231889209008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995625,0.0031790326,0.0000401903,0.00032037255,0.00003993931,0.00047451118,0.000034001616,0.000007605421,0.00027934756],"genre_scores_gemma":[0.9980006,0.0016054708,0.000029576897,0.00020319522,0.0000027482984,0.000028610797,0.0000016681038,0.0000039245997,0.00012417955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991825,0.0001149325,0.0003265015,0.0001282505,0.00014602173,0.000101760794],"domain_scores_gemma":[0.99875855,0.0005902686,0.00025205754,0.0002602527,0.00011193589,0.000026911495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021382018,0.00011389234,0.00037042447,0.00012323401,0.000045071578,0.000009264113,0.00007677069,0.000033727625,0.000008797362],"category_scores_gemma":[0.0006399617,0.00005804791,0.000066152636,0.00029653576,0.0004216782,0.00013403241,0.00008590121,0.000069605565,5.948653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031860246,0.00022284256,0.9839837,0.0020811448,0.00023824582,0.0000020994964,0.0008887609,0.0000184425,0.00018637917,0.000104486404,0.0010570358,0.010898248],"study_design_scores_gemma":[0.0008046897,0.00017308116,0.9901946,0.0048254677,0.0001202487,0.000009433018,0.00034079226,0.000045163702,0.0028347964,0.0005642946,0.000032781958,0.000054614906],"about_ca_topic_score_codex":0.00029984058,"about_ca_topic_score_gemma":0.00014018464,"teacher_disagreement_score":0.010843634,"about_ca_system_score_codex":0.0000052602595,"about_ca_system_score_gemma":0.000073163996,"threshold_uncertainty_score":0.2367125},"labels":[],"label_agreement":null},{"id":"W4411410441","doi":"10.1016/j.ard.2025.06.833","title":"POS1489-HPR PSYCHOMETRIC PROPERTIES OF THE FREMANTLE KNEE AWARENESS QUESTIONNAIRE (FreKAQ) IN TURKISH PATIENTS WITH KNEE OSTEOARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Turkish; Physical therapy; Psychometric testing; Psychometrics; Alternative medicine; Clinical psychology; Pathology","score_opus":0.022720299651589882,"score_gpt":0.28581749219012037,"score_spread":0.2630971925385305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891332,0.0077704564,0.0000037651405,0.0016414835,0.00016379988,0.0009802673,0.000042533637,0.00001697744,0.00024750808],"genre_scores_gemma":[0.9991082,0.00014605185,0.000010807352,0.000041378484,0.000004203657,0.000072731076,0.0000066979646,0.000017379976,0.0005925821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981403,0.00017015327,0.0004701883,0.0002114231,0.0007185216,0.00028941673],"domain_scores_gemma":[0.9985272,0.000084235115,0.000186716,0.00076323835,0.00036176143,0.000076826385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015058227,0.00017599615,0.00044861046,0.0002933585,0.00010139959,0.000019367242,0.0003609498,0.000060608065,0.000056751192],"category_scores_gemma":[0.0009180295,0.00008925812,0.00019182866,0.0014310014,0.00039813385,0.00010478321,0.00015583097,0.00015111304,0.0000042082524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056983216,0.0013510466,0.95566267,0.01158999,0.00027302006,0.0000018318266,0.0003536436,0.000062787534,0.000059447666,0.00023233968,0.0018634556,0.027979966],"study_design_scores_gemma":[0.002146401,0.0005358654,0.96535593,0.029667681,0.000087398126,0.000002737158,0.00018991773,0.00007010025,0.0013921267,0.0004317229,0.000018488035,0.00010161175],"about_ca_topic_score_codex":0.00038557276,"about_ca_topic_score_gemma":0.000028111923,"teacher_disagreement_score":0.027878353,"about_ca_system_score_codex":0.000041561376,"about_ca_system_score_gemma":0.0005967502,"threshold_uncertainty_score":0.36398408},"labels":[],"label_agreement":null},{"id":"W4411410478","doi":"10.1016/j.ard.2025.06.771","title":"POS1423 ALTERATIONS IN INNATE IMMUNE POPULATIONS DURING SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE DEVELOPMENT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Toronto Western Hospital; Mount Sinai Hospital; Krembil Foundation","funders":"","keywords":"Medicine; Innate immune system; Immunology; Rheumatic disease; Autoimmune disease; Immune system; Disease; Rheumatology; Rheumatoid arthritis; Antibody; Internal medicine","score_opus":0.022445086375319123,"score_gpt":0.2775422174603643,"score_spread":0.25509713108504517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9217712,0.07530053,0.00008168671,0.0010419424,0.00075678964,0.0006296705,0.0000466775,0.00007226145,0.0002992273],"genre_scores_gemma":[0.9965762,0.0003515648,0.000013677532,0.000103043836,7.193895e-7,0.00016175654,0.00012527367,0.000016623373,0.0026511732],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99758273,0.00034669368,0.0012511457,0.00027102497,0.00010046763,0.0004479415],"domain_scores_gemma":[0.9985479,0.00015227731,0.00037818548,0.0007896615,0.000117016134,0.000014948851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030577465,0.0002733865,0.0005127666,0.00035878443,0.0006340376,0.000037198042,0.0006869492,0.000085311745,0.00014087204],"category_scores_gemma":[0.0005840212,0.00021486694,0.00026509262,0.00066995906,0.0002448527,0.00020195427,0.00027435942,0.00019816888,0.000083601866],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004338102,0.021263195,0.1929302,0.025028266,0.008195666,0.000036622157,0.045575663,0.072775915,0.118065216,0.18870832,0.0031152987,0.31996754],"study_design_scores_gemma":[0.001245962,0.000011994594,0.9855109,0.005200517,0.00009472224,0.0000051010843,0.0009522703,0.00023782995,0.0035935056,0.0026665148,0.00020273612,0.0002779553],"about_ca_topic_score_codex":0.0002303597,"about_ca_topic_score_gemma":0.000010518951,"teacher_disagreement_score":0.79258066,"about_ca_system_score_codex":0.000051734434,"about_ca_system_score_gemma":0.00039178572,"threshold_uncertainty_score":0.876202},"labels":[],"label_agreement":null},{"id":"W4411410479","doi":"10.1016/j.ard.2025.06.760","title":"POS1412 SINGLE-CELL ANALYSIS REVEALS THE PHENOTYPIC AND FUNCTIONAL HETEROGENEITY OF PERIPHERAL HELPER T CELLS IN THE SYNOVIUM OF RHEUMATOID ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Phenotype; Immunology; Arthritis; Peripheral; Synovial membrane; Internal medicine; Genetics; Biology","score_opus":0.036473938664130595,"score_gpt":0.30026099893032476,"score_spread":0.26378706026619414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812594,0.013170155,0.000023175386,0.004335234,0.00005834356,0.000369265,0.00015644901,0.0000042149636,0.00062375655],"genre_scores_gemma":[0.9944607,0.004475259,0.000028898714,0.00055995816,0.00001171149,0.000019159936,0.000014756622,0.000006750114,0.00042282665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980912,0.00034131872,0.00061192655,0.00017911925,0.00055629713,0.0002201428],"domain_scores_gemma":[0.99825823,0.0007361825,0.00023814026,0.0005023824,0.00020490498,0.000060132857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052403164,0.00015440879,0.0005695027,0.00015574775,0.00010539136,0.000017421627,0.00029360107,0.000043092583,0.0001390782],"category_scores_gemma":[0.00022335548,0.00007499,0.0004542797,0.00071471307,0.0005275366,0.00005676903,0.00014814633,0.00012420901,0.0000015192295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028355615,0.004645541,0.9234853,0.0042887097,0.0047685695,0.000009504946,0.0030637323,0.0010904165,0.019910991,0.0046492056,0.011705339,0.019547174],"study_design_scores_gemma":[0.00080832385,0.00019996396,0.9793694,0.0011479601,0.00030424853,0.000007113815,0.000980915,0.000590546,0.0143805435,0.0017878386,0.00031484544,0.00010828457],"about_ca_topic_score_codex":0.00045055794,"about_ca_topic_score_gemma":0.000110961446,"teacher_disagreement_score":0.055884164,"about_ca_system_score_codex":0.000009209264,"about_ca_system_score_gemma":0.000109848304,"threshold_uncertainty_score":0.30580035},"labels":[],"label_agreement":null},{"id":"W4411410510","doi":"10.1016/j.ard.2025.06.1399","title":"ABS0774 PUSTULAR PSORIASIS IS LINKED TO A SEVERE DISEASE PHENOTYPE IN PSORIATIC ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Krembil Foundation; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Pustular psoriasis; Disease; Arthritis; Immunology; Pathology","score_opus":0.02199290902070357,"score_gpt":0.27500821185692814,"score_spread":0.2530153028362246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675239,0.024662923,0.000017924584,0.00491175,0.0011028368,0.0007523262,0.0004622023,0.00005163889,0.0005145487],"genre_scores_gemma":[0.99434257,0.0016537384,0.00003280649,0.0014667867,0.000017426604,0.00015244295,0.000048686856,0.000017021084,0.0022685006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983438,0.00029457005,0.00053342077,0.00034151645,0.00009271915,0.00039392966],"domain_scores_gemma":[0.998609,0.00029347936,0.00015968544,0.0007579203,0.000099949255,0.000079947866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017867988,0.00026404354,0.0005231334,0.0002219469,0.00015078425,0.000022355676,0.0005067096,0.00011099458,0.0005561534],"category_scores_gemma":[0.00068032625,0.00019866391,0.0003402476,0.0005837538,0.000106315056,0.00009104717,0.00018887426,0.00009166512,0.00027757723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014398174,0.0019680818,0.051030565,0.00066677347,0.0021159363,0.000016098058,0.0022453996,0.0001759155,0.0003203702,0.0033413188,0.058131218,0.8785485],"study_design_scores_gemma":[0.0038370378,0.00010987588,0.96163595,0.0028547568,0.00068920257,0.0000022382349,0.0004370764,0.000023992423,0.0018406761,0.02131709,0.00679647,0.00045565993],"about_ca_topic_score_codex":0.00018494077,"about_ca_topic_score_gemma":0.00004558762,"teacher_disagreement_score":0.9106054,"about_ca_system_score_codex":0.00002553705,"about_ca_system_score_gemma":0.00019980648,"threshold_uncertainty_score":0.8101279},"labels":[],"label_agreement":null},{"id":"W4411410523","doi":"10.1016/j.ard.2025.06.1312","title":"ABS0319 CANNABIS-BASED PRODUCTS FOR PAIN MANAGEMENT IN RHEUMATIC DISEASES: HIGH PATIENT-REPORTED EFFICACY AND OPENNESS TO THERAPY DESPITE LOW PRESCRIPTION RATES IN GERMANY AFTER LEGALIZATION OF NON-MEDICAL CANNABIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cannabis; Medical prescription; Legalization; Openness to experience; Medical cannabis; Psychiatry; Physical therapy; Pharmacology","score_opus":0.014608843812693222,"score_gpt":0.3207721267560158,"score_spread":0.30616328294332257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667616,0.0019913113,0.00029653625,0.025223903,0.00013941743,0.0054642274,0.00008685161,0.000017929282,0.00001822115],"genre_scores_gemma":[0.9952199,0.00037059313,0.00006739252,0.00133447,0.000012387614,0.0021126114,0.00006553341,0.000032995933,0.00078415434],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99695927,0.00030420092,0.0010721802,0.00046961347,0.00076014263,0.0004345678],"domain_scores_gemma":[0.9982456,0.000069816895,0.00028584394,0.0006892168,0.00047219972,0.00023735223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009213806,0.0002791278,0.00068243186,0.0005979956,0.00006207016,0.00004929289,0.00028796718,0.00008194563,0.00005456478],"category_scores_gemma":[0.0022107905,0.00020344924,0.00015311308,0.0010875087,0.0001975478,0.00014206037,0.00014537547,0.00010681216,7.067979e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019635728,0.013431922,0.13376634,0.045785956,0.0013959471,0.00011220864,0.0039012518,0.0033394892,0.0008535863,0.0005099763,0.18567884,0.59158874],"study_design_scores_gemma":[0.0049250284,0.0005051798,0.97506267,0.008708719,0.00012607992,0.0000011659764,0.00031675148,0.0072077294,0.0018883595,0.0003708038,0.000660908,0.0002265934],"about_ca_topic_score_codex":0.0012612105,"about_ca_topic_score_gemma":0.00019151084,"teacher_disagreement_score":0.8412964,"about_ca_system_score_codex":0.000084473584,"about_ca_system_score_gemma":0.0007024839,"threshold_uncertainty_score":0.82964194},"labels":[],"label_agreement":null},{"id":"W4411410596","doi":"10.1016/j.ard.2025.06.1258","title":"ABS0448 ZASOCITINIB (TAK-279), AN ORAL, ALLOSTERIC, SELECTIVE TYK2 INHIBITOR, IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: EFFICACY ANALYSIS BY BASELINE CHARACTERISTICS FROM A RANDOMISED PHASE 2B TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Internal medicine; Randomized controlled trial; Clinical trial; Pharmacology; Dermatology","score_opus":0.028502580437707144,"score_gpt":0.314214772876351,"score_spread":0.2857121924386439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107504,0.0019038523,0.0002092031,0.00061784126,0.00060302543,0.0014792967,0.0039916956,0.00005842447,0.000061651066],"genre_scores_gemma":[0.9956993,0.00049212895,0.000055009295,0.00056391564,0.0000418684,0.00028072653,0.0023478048,0.000025158213,0.0004940786],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963648,0.0015011748,0.0010246044,0.0005517376,0.000120759825,0.00043694183],"domain_scores_gemma":[0.9972266,0.0013434674,0.0004587443,0.000670499,0.00020493027,0.00009578055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004925153,0.00042417322,0.0013614726,0.0003425359,0.00020589212,0.000060598253,0.0005115069,0.0002341417,0.0003875562],"category_scores_gemma":[0.0012152803,0.00031817498,0.0005964681,0.0009838624,0.00012541651,0.00016659807,0.00011936803,0.0001579686,0.000041298827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6960182,0.01970816,0.0041262712,0.00017505253,0.025724446,0.000017665287,0.003173984,0.00038301133,0.009716042,0.000088920955,0.038885344,0.20198289],"study_design_scores_gemma":[0.8376994,0.0024727618,0.04981393,0.0016764981,0.017945554,0.000003422256,0.001272224,0.0020229337,0.081126474,0.0018961593,0.002157439,0.0019131756],"about_ca_topic_score_codex":0.0004889391,"about_ca_topic_score_gemma":0.000104921186,"teacher_disagreement_score":0.20006971,"about_ca_system_score_codex":0.00004418941,"about_ca_system_score_gemma":0.00024437677,"threshold_uncertainty_score":0.99992704},"labels":[],"label_agreement":null},{"id":"W4411410698","doi":"10.1016/j.ard.2025.06.1198","title":"ABS0237 SYNOVITIS AS A BYSTANDER OR POTENTIAL PERPETUATOR OF CARTILAGE DEGRADATION IN OSTEOARTHRITIS: APPLICATION OF TISSUE AND SYNOVIAL FLUID METRICS ALONGSIDE PATIENT-REPORTED ASSESSMENTS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Synovitis; Synovial fluid; Osteoarthritis; Cartilage; Bystander effect; Pathology; Articular cartilage; Arthritis; Internal medicine; Anatomy; Immunology","score_opus":0.018590083258237047,"score_gpt":0.31964839273557694,"score_spread":0.3010583094773399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953659,0.00238814,0.00039505874,0.00019662626,0.00010795469,0.0012326842,0.00011796785,0.000015408892,0.00018022447],"genre_scores_gemma":[0.9990268,0.00028584473,0.0002585192,0.00006687548,0.0000058506885,0.00009305697,0.00007097498,0.000013401164,0.00017870628],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983558,0.00008374254,0.00074896845,0.00021365422,0.00043507727,0.00016276364],"domain_scores_gemma":[0.99875087,0.0001282615,0.0004397713,0.00036187688,0.0002405893,0.00007864708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014584429,0.00015548004,0.00050614047,0.00026911093,0.00004226521,0.00001163153,0.00009067459,0.000070033435,0.000037986796],"category_scores_gemma":[0.000517699,0.00011557132,0.00011238841,0.00052642636,0.00010684897,0.00012428079,0.00007206948,0.000047320067,0.0000010045511],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022234945,0.0022359013,0.02263343,0.0023178447,0.00038596848,0.000097040975,0.00049375894,0.000017961514,0.046693478,0.0016155879,0.00031241085,0.9209731],"study_design_scores_gemma":[0.016719636,0.008021714,0.109234944,0.009887462,0.0024908988,0.00018010536,0.0038044252,0.00077062065,0.84196866,0.006231294,0.0001656493,0.0005245887],"about_ca_topic_score_codex":0.00027192305,"about_ca_topic_score_gemma":0.00007740445,"teacher_disagreement_score":0.92044854,"about_ca_system_score_codex":0.00002399441,"about_ca_system_score_gemma":0.0002370189,"threshold_uncertainty_score":0.47128618},"labels":[],"label_agreement":null},{"id":"W4411410724","doi":"10.1016/j.ard.2025.06.619","title":"POS1269 EULAR POINTS TO CONSIDER FOR THE DEFINITIONS OF DIFFICULT-TO-MANAGE AND TREATMENT-REFRACTORY PSORIATIC ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psoriatic arthritis; Refractory (planetary science); Dermatology; Intensive care medicine; Psoriasis","score_opus":0.358877567582779,"score_gpt":0.4345948657184073,"score_spread":0.07571729813562827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83345157,0.013928528,0.0020832322,0.14341119,0.0005007201,0.0028641175,0.0031197725,0.000024565594,0.0006162744],"genre_scores_gemma":[0.98662186,0.0024473155,0.0006016027,0.009653826,0.000027241502,0.0003815221,0.000013652993,0.000015438422,0.00023754142],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9975195,0.00015895517,0.0017877773,0.0002499763,0.00006724042,0.00021654289],"domain_scores_gemma":[0.9947612,0.0035870697,0.00082262425,0.00059419335,0.00011419508,0.000120717916],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016492887,0.00014516531,0.000711339,0.00018900415,0.00021151615,0.000041034593,0.00024977673,0.000039454822,0.00007344195],"category_scores_gemma":[0.00845089,0.00011401681,0.0001961198,0.00022636414,0.00010236427,0.000112569855,0.00007479848,0.000031552405,0.000064074346],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016072902,0.001491855,0.018876003,0.00274501,0.0022932533,5.324386e-7,0.009493253,0.0011902857,0.0000061909636,0.7567523,0.17611992,0.030870652],"study_design_scores_gemma":[0.003686696,0.00058818917,0.55401933,0.0034395065,0.00030590224,0.0000024613955,0.00603176,0.0029970084,0.00010911942,0.38701457,0.0411607,0.0006447429],"about_ca_topic_score_codex":0.00044974592,"about_ca_topic_score_gemma":0.00013407318,"teacher_disagreement_score":0.5351434,"about_ca_system_score_codex":0.00005226064,"about_ca_system_score_gemma":0.00009876028,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W4411410749","doi":"10.1016/j.ard.2025.06.646","title":"POS1297 DIAGNOSTIC ACCURACY AND TRAJECTORIES OF REFERRALS FOR GOUT TO RHEUMATOLOGY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"William Osler Health System; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gout; Rheumatology; Internal medicine; Physical therapy; Medical physics","score_opus":0.03924304047487357,"score_gpt":0.36038902531679773,"score_spread":0.32114598484192414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411410749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833203,0.004790549,0.00020733493,0.00972027,0.00023503872,0.0012034978,0.00016295133,0.000031638705,0.0003284032],"genre_scores_gemma":[0.9973281,0.00079028605,0.00038250408,0.0008995038,0.000009449928,0.0001277849,0.0000118980115,0.00001713269,0.00043331692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986232,0.00007445112,0.00060208526,0.00022422451,0.00021915122,0.0002568691],"domain_scores_gemma":[0.9950669,0.0036841205,0.00025760147,0.0006095189,0.00024129964,0.00014055142],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00020270517,0.00017965623,0.0007217061,0.00014028797,0.00007236989,0.00001125298,0.0002605055,0.00006910229,0.000034254685],"category_scores_gemma":[0.021135319,0.0001217883,0.00020821292,0.0003056757,0.00019968295,0.00007504824,0.00014980826,0.00006387579,0.0000034196983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030043349,0.0028335575,0.5846179,0.028721787,0.00468075,0.000009554415,0.0060489653,0.00013586301,0.0021774247,0.03533009,0.21407303,0.11836672],"study_design_scores_gemma":[0.0030881823,0.00077200873,0.9413356,0.008527763,0.0018561524,0.00004030458,0.0015799642,0.00020083097,0.01616594,0.023133222,0.0029241114,0.00037591645],"about_ca_topic_score_codex":0.00013862332,"about_ca_topic_score_gemma":0.0000067103633,"teacher_disagreement_score":0.35671768,"about_ca_system_score_codex":0.000012108091,"about_ca_system_score_gemma":0.00021300692,"threshold_uncertainty_score":0.9871101},"labels":[],"label_agreement":null},{"id":"W4411411094","doi":"10.1016/j.ard.2025.06.426","title":"POS1072 Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23-Receptor, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3, Randomized, Double-Blind, Placebo-Controlled ICONIC-LEAD Trial","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Interleukin 23; Randomized controlled trial; Internal medicine; Dermatology; Gastroenterology; Interleukin; Cytokine","score_opus":0.06217196332027962,"score_gpt":0.323081874671518,"score_spread":0.26090991135123837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620087,0.013339871,0.00021210434,0.005709274,0.0023291472,0.01383401,0.0022141007,0.00004074744,0.00031204105],"genre_scores_gemma":[0.98982245,0.0016799497,0.000047533023,0.00022555912,0.00004815127,0.0032193928,0.0001268197,0.00003077684,0.0047993506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956701,0.0017580221,0.0013970187,0.0004641309,0.00019765788,0.00051310175],"domain_scores_gemma":[0.99069846,0.0064916303,0.0012730415,0.0011268036,0.00037228255,0.000037759735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095435296,0.0005615646,0.001979098,0.00012513726,0.0005710729,0.000045691853,0.0011341167,0.00021798137,0.00007834008],"category_scores_gemma":[0.0011132592,0.0002262411,0.0021131642,0.00042300476,0.00065524684,0.00011431339,0.00014561674,0.00014831404,0.000010543145],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9590601,0.0034791888,0.000029839648,0.000073160794,0.013884192,2.942983e-7,0.0035176247,0.00046892455,0.0005924401,0.0007454303,0.01095217,0.0071966606],"study_design_scores_gemma":[0.8852986,0.0016328436,0.00007433923,0.0005344554,0.0050544306,0.0000030239314,0.0013612354,0.00022028293,0.102559544,0.001779634,0.001247581,0.00023403017],"about_ca_topic_score_codex":0.0005541664,"about_ca_topic_score_gemma":0.00017350038,"teacher_disagreement_score":0.101967104,"about_ca_system_score_codex":0.00006498686,"about_ca_system_score_gemma":0.00050336716,"threshold_uncertainty_score":0.9225844},"labels":[],"label_agreement":null},{"id":"W4411411118","doi":"10.1016/j.ard.2025.06.133","title":"POS0773 LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS OR PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB: LONG-TERM RESULTS FROM PHASE 2B/3 TRIALS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Psoriatic arthritis; Dermatology; Axial spondyloarthritis; Psoriasis; Uveitis; Arthritis; Internal medicine; Ophthalmology; Sacroiliitis","score_opus":0.030435266980283714,"score_gpt":0.32601648740084016,"score_spread":0.29558122042055646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860928,0.0056291395,0.0000056359636,0.0008484713,0.00020757016,0.0023443273,0.0046096146,0.00006286161,0.00019959571],"genre_scores_gemma":[0.9949518,0.0030589104,0.00008348496,0.0002852057,0.000051802435,0.00019950261,0.0009879516,0.000046674588,0.00033466317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642134,0.00037656658,0.0014098814,0.0005900832,0.000669043,0.00053311343],"domain_scores_gemma":[0.9968314,0.001045237,0.00068661035,0.0008713468,0.0003508987,0.00021447673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026816555,0.00051067123,0.0018225432,0.00028222823,0.0001994212,0.00007332783,0.00025125855,0.00010084093,0.00031728647],"category_scores_gemma":[0.001868226,0.00028239217,0.00031873514,0.0008596086,0.0003358734,0.0002119538,0.00010249525,0.000144825,0.00001501478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07452671,0.00830129,0.47156364,0.0004162486,0.0031040353,0.0005082314,0.00040188778,0.000012691697,0.000005734214,0.000034582947,0.0020266667,0.4390983],"study_design_scores_gemma":[0.09506924,0.0033662699,0.8806179,0.018479731,0.00083343283,0.000008466514,0.00014257664,0.000016638405,0.0009278762,0.00017565109,0.00005008698,0.0003121315],"about_ca_topic_score_codex":0.0009983114,"about_ca_topic_score_gemma":0.0010527467,"teacher_disagreement_score":0.43878615,"about_ca_system_score_codex":0.000060383867,"about_ca_system_score_gemma":0.00033884737,"threshold_uncertainty_score":0.9999628},"labels":[],"label_agreement":null},{"id":"W4411411135","doi":"10.1016/j.ard.2025.06.220","title":"POS0864 ACHIEVEMENT OF REMISSION DEFINED BY ABSENCE OF OBJECTIVE SIGNS OF INFLAMMATION VERSUS ASDAS INACTIVE DISEASE IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axial spondyloarthritis; Inflammation; Internal medicine; Disease; Rheumatology; Physical therapy; Gastroenterology","score_opus":0.03120561658890089,"score_gpt":0.3344815094208204,"score_spread":0.3032758928319195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956075,0.00095470255,0.000009385322,0.00033277494,0.000028733459,0.0011316211,0.0018640799,0.00000947147,0.00006171755],"genre_scores_gemma":[0.99922675,0.0002902194,0.000058783113,0.00000232518,0.0000027404967,0.000036788257,0.00032815544,0.000014473241,0.000039741684],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977136,0.0002499461,0.00071673107,0.00030054504,0.0007937566,0.0002253734],"domain_scores_gemma":[0.9969692,0.00091255055,0.0007108184,0.00049062195,0.00079605693,0.00012071319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015458872,0.00022972534,0.0007371197,0.00023189066,0.000051927083,0.0000046854743,0.00018450803,0.00004228575,0.000018899103],"category_scores_gemma":[0.0016252837,0.00014489573,0.0001264413,0.0006707554,0.0005142857,0.00016672039,0.00010156187,0.00011664148,4.5667275e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6945118,0.02127249,0.17817697,0.012352341,0.009099739,0.000038683807,0.009411164,0.0011207457,0.010998788,0.00028691874,0.0008425175,0.061887886],"study_design_scores_gemma":[0.04874454,0.008941397,0.8087314,0.028352117,0.0006046101,1.950529e-7,0.0029268174,0.00027341506,0.100660846,0.0005467817,0.0000016565498,0.0002162352],"about_ca_topic_score_codex":0.0012418096,"about_ca_topic_score_gemma":0.00002399787,"teacher_disagreement_score":0.6457672,"about_ca_system_score_codex":0.00012877375,"about_ca_system_score_gemma":0.0006104258,"threshold_uncertainty_score":0.59086764},"labels":[],"label_agreement":null},{"id":"W4411411145","doi":"10.1016/j.ard.2025.06.206","title":"POS0850 EFFECTS OF SINGLE AND DUAL TASK ON COGNITION AND LOWER EXTREMITY PERFORMANCE IN INDIVIDUALS WITH PRIMARY SJOGREN'S SYNDROME: A RANDOMIZED CONTROLLED TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Cognition; Physical therapy; Physical medicine and rehabilitation; Task (project management); Audiology; Internal medicine; Psychiatry","score_opus":0.009817376685827127,"score_gpt":0.24356956983779826,"score_spread":0.23375219315197113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317396,0.0024896108,0.0000134335105,0.00058403175,0.00009454463,0.0027394078,0.00001930118,0.000009723435,0.00087596127],"genre_scores_gemma":[0.9987263,0.0006114155,0.000016333866,0.00034649525,0.000005357462,0.0001759785,0.000013562819,0.000005657094,0.000098864766],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999016,0.0001756551,0.00036743892,0.00012945388,0.00020526779,0.00010617767],"domain_scores_gemma":[0.998073,0.0014613359,0.00020068772,0.00015699306,0.000059132886,0.000048873993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030906324,0.00012436316,0.00096990867,0.00014559765,0.000046738125,0.000011107898,0.000034432298,0.000038350077,0.0000108974145],"category_scores_gemma":[0.001041654,0.000066028544,0.00013163679,0.00016611248,0.00022997297,0.00006179162,0.00003033284,0.000056499957,2.4974554e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9534579,0.0026787377,0.036593955,0.0020399536,0.00090583385,0.000005979438,0.00018878873,0.0000098988085,0.000030034704,0.00012735648,0.00035587724,0.003605711],"study_design_scores_gemma":[0.7390432,0.0009946679,0.25376335,0.004152134,0.001033808,0.00000822812,0.00005587404,0.000110653535,0.00006373329,0.0006986381,0.0000034950551,0.000072260824],"about_ca_topic_score_codex":0.0000125650995,"about_ca_topic_score_gemma":0.000001412274,"teacher_disagreement_score":0.21716937,"about_ca_system_score_codex":0.000004436912,"about_ca_system_score_gemma":0.00008227219,"threshold_uncertainty_score":0.2692566},"labels":[],"label_agreement":null},{"id":"W4411411356","doi":"10.1016/j.ard.2025.05.922","title":"POS0540 Long-Term Safety and Efficacy of Upadacitinib or Adalimumab in Patients With Rheumatoid Arthritis: 7-Year Data From the SELECT-COMPARE Study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Term (time); Internal medicine","score_opus":0.03467434456328042,"score_gpt":0.32426724906405224,"score_spread":0.2895929045007718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841372,0.012256242,0.000010381119,0.0008583632,0.000054934113,0.0017450016,0.00084458134,0.000022511827,0.00007082737],"genre_scores_gemma":[0.98420435,0.015343928,0.00002911885,0.00012484254,0.000008153458,0.000025502088,0.000208805,0.000021655804,0.00003367029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975032,0.00036164108,0.00074203464,0.00037375255,0.0006925217,0.00032680915],"domain_scores_gemma":[0.9968784,0.0010628323,0.00025952846,0.0014452293,0.00022875557,0.00012525717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003607183,0.00023839196,0.0007651162,0.00011017971,0.00015501279,0.00005401729,0.0007604493,0.000031764906,0.00017846949],"category_scores_gemma":[0.0012506738,0.000121800906,0.00008397783,0.00047417847,0.00041052414,0.00020208932,0.0004679054,0.00017679184,0.0000035238659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00769219,0.002584194,0.9453268,0.00017003542,0.0008301058,0.000005855065,0.0007990882,0.0000052455102,0.000001509381,0.000074363576,0.0014901067,0.041020513],"study_design_scores_gemma":[0.012426229,0.00055403315,0.97780365,0.007597019,0.000033220964,0.0000020121327,0.00115787,0.000045167333,0.000043461012,0.00014723992,0.00006844966,0.00012165708],"about_ca_topic_score_codex":0.0005479268,"about_ca_topic_score_gemma":0.0010225306,"teacher_disagreement_score":0.040898852,"about_ca_system_score_codex":0.000012366606,"about_ca_system_score_gemma":0.0003544438,"threshold_uncertainty_score":0.49668968},"labels":[],"label_agreement":null},{"id":"W4411411404","doi":"10.1016/j.ard.2025.05.992","title":"POS0612 HOW DO WE PREDICT TREATMENT RESPONSE IN OSTEOARTHRITIS ANALYSIS OF A COHORT STUDY IN PEOPLE WITH KNEE OSTEOARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Cohort; Physical therapy; Cohort study; Internal medicine; Alternative medicine; Pathology","score_opus":0.014369997911512942,"score_gpt":0.2817606419282791,"score_spread":0.26739064401676615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877102,0.006830709,0.00000272751,0.0016593903,0.00006848354,0.0032122727,0.00028288356,0.000027316572,0.00020604469],"genre_scores_gemma":[0.99760634,0.0008417976,0.00003481134,0.00004236213,0.0000051346583,0.00060847646,0.00004087132,0.000021302998,0.00079888286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756396,0.00046288548,0.00066809345,0.00041305897,0.0005441306,0.00034786086],"domain_scores_gemma":[0.99807733,0.00044899515,0.00027381052,0.0009177107,0.00015518139,0.00012698885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035705854,0.00031644,0.0014031011,0.0010353109,0.000054306463,0.000029416562,0.00017708245,0.00006990779,0.00007260558],"category_scores_gemma":[0.00032822785,0.00021400276,0.0004091265,0.0023077666,0.00013048296,0.00012382845,0.00008269251,0.000084459476,0.0000017999248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066970456,0.0035814613,0.9031928,0.00014747168,0.0018266691,0.0000955738,0.0016745374,0.00008809537,0.00006322413,0.000058074635,0.000032515713,0.08254253],"study_design_scores_gemma":[0.01197045,0.015035908,0.9606865,0.0036953718,0.0037603138,0.0000068189233,0.003615392,0.000060162914,0.00083319296,0.00014909133,0.000024847051,0.00016197196],"about_ca_topic_score_codex":0.00038648324,"about_ca_topic_score_gemma":0.0040697195,"teacher_disagreement_score":0.082380556,"about_ca_system_score_codex":0.00009063436,"about_ca_system_score_gemma":0.00035662443,"threshold_uncertainty_score":0.8726779},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4411411511","doi":"10.1016/j.ard.2025.05.550","title":"POS0162 THE INFLUENCE OF BODY MASS INDEX ON CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS VARIES ACROSS ANTICITRULLINATED PROTEIN ANTIBODY STATUS AND BIOLOGIC USE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Rheumatoid arthritis; Body mass index; Antibody; Internal medicine; Immunology","score_opus":0.01628764801999598,"score_gpt":0.3063410063498178,"score_spread":0.2900533583298218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634775,0.034284387,0.000038219932,0.0005318556,0.00004150001,0.0012914352,0.00027811754,0.000029719617,0.00002729914],"genre_scores_gemma":[0.8551318,0.14463031,0.000026718675,0.000091916874,0.0000034622547,0.00006519437,0.000013141136,0.00001462409,0.000022828095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972601,0.0006080662,0.00069803855,0.00031909213,0.00056936557,0.0005453359],"domain_scores_gemma":[0.99773085,0.0006551845,0.00028273131,0.00091515505,0.00028940503,0.0001267001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007816795,0.00025850357,0.00084715884,0.00017979529,0.00023488152,0.00008595242,0.00032999294,0.00008851704,0.000013132068],"category_scores_gemma":[0.0040073236,0.00014770834,0.00033890767,0.0006336137,0.001175399,0.00020611905,0.00020000471,0.00028567834,0.0000025206075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013049662,0.00062837993,0.9606219,0.00071020593,0.0017487594,0.000020326223,0.00073036744,0.0013841197,0.001642126,0.002724194,0.00009582228,0.028388847],"study_design_scores_gemma":[0.002102106,0.00028503092,0.978968,0.0071252002,0.000016899392,0.0000055250775,0.00058776734,0.00031972752,0.0031681159,0.007023151,0.00025683662,0.00014164294],"about_ca_topic_score_codex":0.0020620816,"about_ca_topic_score_gemma":0.0000447115,"teacher_disagreement_score":0.11034593,"about_ca_system_score_codex":0.000014750629,"about_ca_system_score_gemma":0.00021847422,"threshold_uncertainty_score":0.6023371},"labels":[],"label_agreement":null},{"id":"W4411411589","doi":"10.1016/j.ard.2025.06.730","title":"POS1382 INCIDENCE AND PREVALENCE OF CONNECTIVE TISSUE DISEASES WITH INTERSTITIAL LUNG DISEASE IN THE UNITED STATES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Incidence (geometry); Connective tissue; Interstitial lung disease; Pathology; Connective tissue disease; Lung; Disease; Dermatology; Internal medicine; Autoimmune disease","score_opus":0.017456139802747305,"score_gpt":0.30778448794225766,"score_spread":0.29032834813951036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716044,0.024295943,0.000047004734,0.0026367176,0.0000643425,0.00092814665,0.0003325977,0.000019080244,0.0000717842],"genre_scores_gemma":[0.99463767,0.004401056,0.000006690091,0.0007423978,0.000010074174,0.000068430345,0.000029293382,0.000010269894,0.00009410881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984297,0.0002783678,0.00045764752,0.00023756003,0.00040325042,0.00019348],"domain_scores_gemma":[0.99793243,0.0008974242,0.0002597842,0.0005278556,0.00022892261,0.00015358989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017226824,0.00018829374,0.00039500915,0.00018784766,0.00008026684,0.000023830939,0.00032146505,0.000034210945,0.00003606593],"category_scores_gemma":[0.0012471122,0.00009308541,0.000118575146,0.0006133338,0.00057036226,0.00010380111,0.00011529994,0.0000870766,7.372638e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025887524,0.0013131012,0.973852,0.009714647,0.00060116686,0.000028498524,0.0021032363,0.0008859882,0.000046899437,0.0017735683,0.003754077,0.003338076],"study_design_scores_gemma":[0.0010457941,0.00016676149,0.9665872,0.024652472,0.0011340211,0.000004963542,0.0022121868,0.0025551796,0.00026632918,0.0012456754,0.00001475233,0.00011469634],"about_ca_topic_score_codex":0.00042230543,"about_ca_topic_score_gemma":0.00000839481,"teacher_disagreement_score":0.023033297,"about_ca_system_score_codex":0.000017598519,"about_ca_system_score_gemma":0.00024142687,"threshold_uncertainty_score":0.3795913},"labels":[],"label_agreement":null},{"id":"W4411411655","doi":"10.1016/j.ard.2025.05.653","title":"POS0266 DEVELOPMENT OF AN ARTICULAR SCORE IN SYSTEMIC SCLEROSIS (ASSESS): IDENTIFICATION OF CORE INSTRUMENTS TO ASSESS DISEASE ACTIVITY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Disease; Identification (biology); Physical therapy; Multiple sclerosis; Internal medicine; Intensive care medicine; Immunology","score_opus":0.1343741960401958,"score_gpt":0.35143000342943254,"score_spread":0.21705580738923674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964764,0.0016643212,0.00010239705,0.00024674227,0.00018941452,0.0011541706,0.00011463537,0.000020911179,0.00003098812],"genre_scores_gemma":[0.9993325,0.00030337498,0.000069999594,0.00008322011,0.000006101416,0.000112195754,0.000027190796,0.000016000604,0.00004944183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974818,0.00018488377,0.0011844082,0.000298929,0.0006313039,0.00021864034],"domain_scores_gemma":[0.99778914,0.000117353935,0.0006467617,0.00083807926,0.00034372119,0.0002649272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044148703,0.00019831545,0.0006475236,0.00030697545,0.00006895812,0.000018408811,0.00035427694,0.00006760212,0.00001712797],"category_scores_gemma":[0.0008163892,0.00014169533,0.00023649629,0.0007536366,0.00011415957,0.00016258315,0.00014035465,0.00006736083,0.0000033225467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002119188,0.0070649944,0.6648619,0.01568461,0.001246019,0.0000042399156,0.0012015195,0.0010429614,0.21368846,0.00055954786,0.00047937644,0.09204713],"study_design_scores_gemma":[0.00078791735,0.000048912338,0.8684237,0.031196203,0.00033282247,9.0352256e-7,0.0005618691,0.0007745337,0.09760707,0.00015919674,9.73015e-7,0.00010587061],"about_ca_topic_score_codex":0.00007567992,"about_ca_topic_score_gemma":0.000007007524,"teacher_disagreement_score":0.20356178,"about_ca_system_score_codex":0.000066009205,"about_ca_system_score_gemma":0.00066869485,"threshold_uncertainty_score":0.5778168},"labels":[],"label_agreement":null},{"id":"W4411411712","doi":"10.1016/j.ard.2025.05.683","title":"POS0296 MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLIC EVENTS, SERIOUS INFECTIONS AND MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB COMPARED TO BIOLOGIC TREATMENTS IN THE UNITED STATES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Myocardial infarction; Malignancy; Stroke (engine); Dermatology; Arthritis; Internal medicine; Rheumatoid arthritis; Surgery; Cardiology","score_opus":0.012506730217056308,"score_gpt":0.2731981105292067,"score_spread":0.2606913803121504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555415,0.0013464162,0.000004201118,0.0010214539,0.000032691692,0.0016782247,0.0002751221,0.000023523167,0.0000641944],"genre_scores_gemma":[0.99347496,0.005654885,0.000011825819,0.00037950676,0.000004103221,0.00023797405,0.00020968569,0.00001245175,0.0000146195525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984668,0.00031176422,0.00036787376,0.00021409112,0.00031775574,0.00032170364],"domain_scores_gemma":[0.9991139,0.00015816833,0.000109829074,0.00034553627,0.00017293898,0.00009962603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012633797,0.0002084007,0.0005154149,0.00037810582,0.00014803188,0.000034528806,0.00013903785,0.00003527931,0.00002187301],"category_scores_gemma":[0.00017934277,0.00011001126,0.000066647895,0.000988526,0.00017269264,0.000098455515,0.000038190374,0.00010646105,0.0000026180244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008101079,0.0021062375,0.9855923,0.00008408484,0.00051792304,0.000005167941,0.0011215808,0.00038504053,0.0000024247756,0.00008965322,0.00015888027,0.009126593],"study_design_scores_gemma":[0.0054954705,0.0017140686,0.9884324,0.002366289,0.000042891108,0.0000062771883,0.00095128256,0.000046533147,0.00002959744,0.0007325477,0.000074213545,0.00010845075],"about_ca_topic_score_codex":0.0014708231,"about_ca_topic_score_gemma":0.00036381144,"teacher_disagreement_score":0.009018143,"about_ca_system_score_codex":0.000029226872,"about_ca_system_score_gemma":0.000116563126,"threshold_uncertainty_score":0.4486129},"labels":[],"label_agreement":null},{"id":"W4411411797","doi":"10.1016/j.ard.2025.05.428","title":"POS0031 Exploring the Potential for Cardiorenal-Metabolic Therapies to Target Comorbidities in Early Rheumatoid Arthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval; Canadian Rheumatology Association; Research Canada; University of Manitoba; Université de Sherbrooke; University of Calgary; Arthritis Research Centre of Canada; McGill University; University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Intensive care medicine; Arthritis; Internal medicine","score_opus":0.025816038098942264,"score_gpt":0.29153612824608494,"score_spread":0.26572009014714265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756202,0.019856049,0.00051342626,0.0030824752,0.00016999713,0.00053668267,0.00012766168,0.000007164556,0.00008636034],"genre_scores_gemma":[0.99248344,0.006208828,0.000110033754,0.00054956315,0.000033719323,0.00035363715,0.000024959043,0.000014964224,0.0002208855],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888563,0.0001218844,0.0002736715,0.0002166788,0.00020553441,0.000296618],"domain_scores_gemma":[0.9992189,0.00005120688,0.00005723806,0.00047386927,0.00013274951,0.00006607967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022077264,0.00014456025,0.00024431717,0.00006328489,0.00012157537,0.000046174107,0.0005217465,0.00004472656,0.0000061501446],"category_scores_gemma":[0.0004067927,0.00009094887,0.0003021561,0.00019593157,0.00014702133,0.000007323528,0.00028202485,0.00006754582,0.000002007219],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033647253,0.0017611167,0.019355446,0.001567862,0.0043785833,0.000016382097,0.003466412,0.003282199,0.3628563,0.019605078,0.09839708,0.4819488],"study_design_scores_gemma":[0.0017516868,0.00030677518,0.13887624,0.0013698405,0.00005004282,0.000008820004,0.0013785926,0.00013713397,0.7987076,0.0154741965,0.041410785,0.00052825],"about_ca_topic_score_codex":0.00011115032,"about_ca_topic_score_gemma":0.000016633727,"teacher_disagreement_score":0.48142055,"about_ca_system_score_codex":0.0000032577152,"about_ca_system_score_gemma":0.00009439766,"threshold_uncertainty_score":0.37087876},"labels":[],"label_agreement":null},{"id":"W4411411800","doi":"10.1016/j.ard.2025.05.488","title":"POS0100 COMBINATION THERAPY WITH TWO BIOLOGIC/TARGETED SYNTHETIC DMARDS IN 1260 PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES. A SYSTEMATIC LITERATURE REVIEW FOR CURRENT LANDSCAPE IN EFFICACY AND SAFETY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Immune system; Combination therapy; Oncology; Immunology; Pharmacology; Internal medicine","score_opus":0.006568592272636655,"score_gpt":0.2502056172716785,"score_spread":0.24363702499904186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5131184,0.48426566,0.0000059833537,0.00027487034,0.00009539705,0.002084576,0.0001247235,0.000018409075,0.000011969318],"genre_scores_gemma":[0.9536888,0.04530159,0.000001653893,0.00015516893,4.1691428e-7,0.0003345272,0.00048304666,0.000012551218,0.000022236407],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99798304,0.000601442,0.00076364464,0.00026884396,0.00008584634,0.00029715567],"domain_scores_gemma":[0.9982463,0.0006751278,0.0004300677,0.00043980998,0.00019690068,0.000011784795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040773125,0.00027846076,0.00080357696,0.00021961148,0.00012965623,0.000020743235,0.000341183,0.00007450999,0.000015951091],"category_scores_gemma":[0.00076618546,0.000149613,0.0001230281,0.0006009969,0.00024097822,0.00011977882,0.000067609595,0.00016739742,0.0000019620406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022988692,0.024162015,0.39055157,0.40269545,0.004213565,0.000010089095,0.0056840996,0.00057735416,0.0007491232,0.0074369204,0.0008433872,0.14008772],"study_design_scores_gemma":[0.011267234,0.00036429137,0.8132914,0.17372504,0.00024572358,0.0000018999532,0.00016768745,0.00007156276,0.00009983203,0.00034423106,0.000118023476,0.0003030828],"about_ca_topic_score_codex":0.0000120400055,"about_ca_topic_score_gemma":0.0000036386698,"teacher_disagreement_score":0.44057038,"about_ca_system_score_codex":0.000017320968,"about_ca_system_score_gemma":0.00012279795,"threshold_uncertainty_score":0.6101041},"labels":[],"label_agreement":null},{"id":"W4411411814","doi":"10.1016/j.ard.2025.05.439","title":"POS0042 EPIDEMIOLOGICAL ANALYSIS OF SYSTEMIC SCLEROSIS PREVALENCE AND SURVIVAL IN ISRAEL USING THE CLALIT HEALTH SERVICES DATABASE: GEOGRAPHIC DISTRIBUTION, DEMOGRAPHICS, AND MORTALITY TRENDS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Demographics; Database; Environmental health; Health services; Demography; Population; Internal medicine","score_opus":0.07503635463882194,"score_gpt":0.3640829614624281,"score_spread":0.28904660682360617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.871595,0.12540324,0.00004814812,0.0011784078,0.000062428604,0.00034485693,0.001346796,0.000015280502,0.0000058232763],"genre_scores_gemma":[0.94815445,0.05135185,0.000009552206,0.00032822258,0.0000066826174,0.000017659815,0.00011850279,0.000005690667,0.000007384593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970249,0.0008848749,0.0011048586,0.00035479586,0.00036602412,0.0002645579],"domain_scores_gemma":[0.99754286,0.0007464508,0.0006480561,0.0007243351,0.00018041102,0.0001578993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016219665,0.0002091577,0.0010606193,0.00033033366,0.00017018172,0.000021250366,0.00025962267,0.00008841809,0.000010532225],"category_scores_gemma":[0.00047975115,0.000111242676,0.00040825657,0.0021612262,0.00057935156,0.00008400697,0.00018418719,0.00011820266,5.8477173e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007045628,0.00023884243,0.9908879,0.004319538,0.0017778573,3.5276088e-7,0.00009204351,0.0001436455,0.00003891261,0.0010159973,0.00005054179,0.0013639404],"study_design_scores_gemma":[0.0004134399,0.000035667596,0.96944565,0.019360704,0.0033607034,0.0000021644685,0.0013582862,0.0057125315,0.000010388926,0.00021559821,7.565104e-7,0.000084129686],"about_ca_topic_score_codex":0.0039592925,"about_ca_topic_score_gemma":0.0001459641,"teacher_disagreement_score":0.07655944,"about_ca_system_score_codex":0.000018673245,"about_ca_system_score_gemma":0.00011230419,"threshold_uncertainty_score":0.5985293},"labels":[],"label_agreement":null},{"id":"W4411411935","doi":"10.1016/j.ard.2025.05.371","title":"OP0369 Osteoarthritis-Driven Inflammatory Imprinting of Synovial Fibroblasts contributes to Gout Exacerbation through m6A modification of S100A4","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gout; Osteoarthritis; Imprinting (psychology); Inflammatory arthritis; Exacerbation; Synovial fluid; Immunology; Arthritis; Internal medicine; Pathology; Alternative medicine; Biochemistry","score_opus":0.018086221438701075,"score_gpt":0.3025884797723552,"score_spread":0.2845022583336541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931158,0.002038403,0.0032583813,0.0006094184,0.00011375136,0.00039284964,0.00012558352,0.000006001515,0.00033981926],"genre_scores_gemma":[0.9991477,0.00033846364,0.00015041533,0.00008608102,0.000018648028,0.00005806048,0.000040126153,0.000008135507,0.00015233518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902964,0.00007337287,0.00047285212,0.00016968862,0.00013397525,0.00012046569],"domain_scores_gemma":[0.9987597,0.00004557398,0.00034604184,0.00049891276,0.00032092194,0.000028837247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011933906,0.000101059144,0.00020943262,0.000049064074,0.000057046742,0.000011026665,0.0002809952,0.0000601645,0.000007778302],"category_scores_gemma":[0.0004088502,0.000085585554,0.00014904822,0.00015942051,0.00012448561,0.000011677242,0.00012687506,0.00002821592,0.0000013998654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040890713,0.0004319106,0.016086934,0.0013661829,0.00048203333,1.1679827e-7,0.00040993202,0.009469074,0.8874423,0.012819296,0.0068983478,0.06418495],"study_design_scores_gemma":[0.00073194184,0.00016266268,0.12471467,0.0013995236,0.00008933278,3.5652997e-7,0.00030056798,0.00040955335,0.86776835,0.0028686414,0.0014028077,0.00015161396],"about_ca_topic_score_codex":0.000043531738,"about_ca_topic_score_gemma":0.000010672369,"teacher_disagreement_score":0.108627744,"about_ca_system_score_codex":0.000008495746,"about_ca_system_score_gemma":0.00015244733,"threshold_uncertainty_score":0.3490078},"labels":[],"label_agreement":null},{"id":"W4411411983","doi":"10.1016/j.ard.2025.05.314","title":"OP0312 PATTERNS OF INFLAMMATORY AND STRUCTURAL SACROILIAC JOINT MRI LESIONS IN 1,946 EUROPEAN PATIENTS WITH AXIAL SPONDYLOARTHRITIS FROM ROUTINE CARE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Sacroiliac joint; Axial spondyloarthritis; Ankylosing spondylitis; Sacroiliitis; Magnetic resonance imaging; Joint (building); Spondylarthritis; Radiology; Surgery","score_opus":0.01131982034466896,"score_gpt":0.24949971866317594,"score_spread":0.23817989831850697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934111,0.004448954,0.0000021841925,0.0003091584,0.000099598234,0.00047799415,0.001025687,0.000012892897,0.00021241538],"genre_scores_gemma":[0.9990574,0.00061648607,0.000040285464,0.00009998635,0.000011526211,0.000012299838,0.000111841204,0.000015305994,0.000034879067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998831,0.00010266842,0.00043113806,0.00020192354,0.00024992545,0.00018337631],"domain_scores_gemma":[0.9991527,0.0000762089,0.00018240475,0.00035791233,0.00015119046,0.00007959215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000409214,0.00017833927,0.0004660602,0.00009027004,0.00008515777,0.000010658895,0.00009942075,0.000025262456,0.000048068847],"category_scores_gemma":[0.0001392312,0.00011430235,0.000117724216,0.00012306479,0.00014634195,0.00006276541,0.00017931277,0.000070196875,0.0000013297962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031867964,0.0001703201,0.9618102,0.00034993733,0.0002273638,0.000016351563,0.0008091603,0.0000079176825,0.0000065661097,0.000052486048,0.00010686641,0.036124166],"study_design_scores_gemma":[0.004477818,0.00020679872,0.9887536,0.004815794,0.00015792821,0.0000010298833,0.0010877637,0.000008539891,0.00023373138,0.00013667624,0.000029512365,0.00009081122],"about_ca_topic_score_codex":0.0004752411,"about_ca_topic_score_gemma":0.00030236936,"teacher_disagreement_score":0.036033355,"about_ca_system_score_codex":0.000017449996,"about_ca_system_score_gemma":0.00005521509,"threshold_uncertainty_score":0.46611145},"labels":[],"label_agreement":null},{"id":"W4411411999","doi":"10.1016/j.ard.2025.05.374","title":"OP0372-PARE Beyond the Doctor's Office: The School and Workplace Needs of Young People Living with Rheumatic Disease","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Canadian Arthritis Patient Alliance; University of Ottawa","funders":"","keywords":"Medicine; Rheumatic disease; Family medicine; Office workers; Alternative medicine; Gerontology; Disease; Internal medicine; Management; Pathology","score_opus":0.03267203782928741,"score_gpt":0.36633857318396407,"score_spread":0.33366653535467666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411411999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959472,0.010764086,0.0000700572,0.025593756,0.00045302176,0.0019180839,0.00016460998,0.00004865169,0.0015157124],"genre_scores_gemma":[0.99325573,0.0022145396,0.0000140439615,0.0015732477,0.0000726875,0.00014883511,0.0000090834155,0.00002225745,0.0026895963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967785,0.0011660117,0.00083808554,0.00019324066,0.000520022,0.0005041789],"domain_scores_gemma":[0.99358135,0.004068997,0.0006716177,0.0010499706,0.00033572994,0.00029233145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095555786,0.00026202164,0.0004998428,0.00012141299,0.0012503569,0.000034082033,0.0007520466,0.00008139107,0.00023983725],"category_scores_gemma":[0.0029019958,0.00011880923,0.00017566101,0.00094810047,0.00028625433,0.00015595635,0.000432297,0.00044209964,0.000017493565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026614,0.0001698264,0.935288,0.0067707906,0.00018133479,4.511528e-7,0.007819609,0.00007436714,4.2962907e-7,0.0029560637,0.04438778,0.0020852156],"study_design_scores_gemma":[0.0004376392,0.000033345863,0.9631801,0.008518555,0.00032690619,8.550298e-7,0.025168609,0.0003318337,0.0000010232715,0.0015081941,0.0003467967,0.00014611286],"about_ca_topic_score_codex":0.000567544,"about_ca_topic_score_gemma":0.00034155406,"teacher_disagreement_score":0.04404098,"about_ca_system_score_codex":0.000030805088,"about_ca_system_score_gemma":0.0012453573,"threshold_uncertainty_score":0.9616861},"labels":[],"label_agreement":null},{"id":"W4411412192","doi":"10.1016/j.ard.2025.05.116","title":"OP0094 Biological Sex-Related Differences in Radiographic Progression and Relationship with Early Clinical Response: Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Biologic-Naive Participants with Active Psoriatic Arthritis Treated with Guselkumab","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Post-hoc analysis; Post hoc; Placebo; Physical therapy; Internal medicine; Randomized controlled trial; Pathology; Alternative medicine","score_opus":0.08149713340914892,"score_gpt":0.4016841369070029,"score_spread":0.32018700349785395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411412192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98727363,0.0059518125,0.00000695208,0.0006649058,0.0000128842075,0.005990068,0.000056694156,0.00002626623,0.000016759823],"genre_scores_gemma":[0.993481,0.0054556797,0.00003523989,0.0000193071,0.0000023831346,0.00094392966,0.000034604127,0.000011894559,0.00001595579],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99343526,0.0038461245,0.0013532374,0.00047423242,0.00048340732,0.0004077273],"domain_scores_gemma":[0.9927239,0.005663848,0.00067586056,0.00045545967,0.00029410515,0.00018685486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023977899,0.00032612676,0.0027702793,0.0012287695,0.00011911894,0.00004408023,0.00020999186,0.00012284634,0.000027514323],"category_scores_gemma":[0.0025288046,0.00014424701,0.00031083438,0.0026547553,0.0014563258,0.0001443341,0.00006029625,0.0003061189,3.3253627e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5220727,0.0030594855,0.46320778,0.000029385465,0.0053394735,0.000028077686,0.0011225897,0.000016935901,0.0000032947462,0.00005431643,0.0000011396432,0.0050648577],"study_design_scores_gemma":[0.4155451,0.007355465,0.57113415,0.0024643966,0.0007059097,0.0000029232274,0.002005201,0.0005190087,0.000021214262,0.00013819,9.744544e-8,0.000108324784],"about_ca_topic_score_codex":0.00030334,"about_ca_topic_score_gemma":0.00047453676,"teacher_disagreement_score":0.107926376,"about_ca_system_score_codex":0.000016378113,"about_ca_system_score_gemma":0.00031158264,"threshold_uncertainty_score":0.58822227},"labels":[],"label_agreement":null},{"id":"W4411412222","doi":"10.1016/j.ard.2025.05.029","title":"OP0006 OBINUTUZUMAB DEMONSTRATES CONSISTENT BENEFIT ACROSS NUMEROUS PRIMARY ENDPOINT DEFINITIONS USING REGENCY STUDY RESULTS OF PATIENTS WITH ACTIVE LUPUS NEPHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Obinutuzumab; Lupus nephritis; Clinical endpoint; Systemic lupus erythematosus; Immunology; Internal medicine; Clinical trial; Rituximab; Lymphoma; Disease","score_opus":0.053759055397508,"score_gpt":0.32834285397147134,"score_spread":0.2745837985739633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411412222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260354,0.0017124297,0.000016300482,0.00027070445,0.00016455432,0.002304171,0.0019482102,0.00003309952,0.00094698905],"genre_scores_gemma":[0.9990397,0.00027173496,0.0001754556,0.000074842625,0.000008583583,0.00009603679,0.00009615618,0.000027658723,0.00020982839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697965,0.00023142798,0.0010586035,0.0003712213,0.00093318906,0.00042588866],"domain_scores_gemma":[0.99668914,0.00068341976,0.00060780835,0.0010003526,0.00085967156,0.00015958637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030584112,0.00027322653,0.000856297,0.00016529873,0.00023359792,0.000032248394,0.00035308235,0.00006659045,0.00002279596],"category_scores_gemma":[0.00081545534,0.00017979098,0.00027649506,0.0006275247,0.00042730782,0.00013925925,0.00028187985,0.00015343801,0.000003167332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009665124,0.0074391984,0.9461366,0.00721977,0.003769748,0.000035852467,0.0066796816,0.0003390731,0.0000913295,0.00085658446,0.0016255012,0.016141538],"study_design_scores_gemma":[0.01461789,0.0014271749,0.9374809,0.01921725,0.0011925003,0.0002076868,0.020526515,0.00022988647,0.002289945,0.002383877,0.000026662789,0.00039967627],"about_ca_topic_score_codex":0.0005199808,"about_ca_topic_score_gemma":0.00006779455,"teacher_disagreement_score":0.01574186,"about_ca_system_score_codex":0.00019363294,"about_ca_system_score_gemma":0.00089612015,"threshold_uncertainty_score":0.73316634},"labels":[],"label_agreement":null},{"id":"W4411412366","doi":"10.1016/j.ard.2025.05.070","title":"OP0047 Estimating the impact of a training workshop on the reliability of salivary gland ultrasound scoring in Sjögren's syndrome","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Salivary gland; Ultrasound; Sjögren syndrome; Reliability (semiconductor); Physical therapy; Pathology; Radiology; Systemic disease; Immunopathology","score_opus":0.05808250586929599,"score_gpt":0.3483883097037505,"score_spread":0.29030580383445453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411412366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949106,0.0008891754,0.00007998818,0.0020976937,0.000106694875,0.00046952933,0.00004712941,0.000012063727,0.0013871506],"genre_scores_gemma":[0.9995675,0.00010376356,0.00006978379,0.00015483957,0.000009583358,0.000025794596,0.000005962953,0.000008827629,0.00005391404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987307,0.00016483193,0.0005234762,0.00014469132,0.00025089193,0.00018537283],"domain_scores_gemma":[0.99572456,0.003197308,0.00026127938,0.0006857714,0.000085065396,0.000046039706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060070684,0.00014204143,0.00043539825,0.000091983144,0.00010568331,0.000012628794,0.0002569629,0.000037074344,0.00008258682],"category_scores_gemma":[0.005044292,0.000061400126,0.0003605118,0.00054965867,0.00025168338,0.000056542787,0.00006138889,0.00014559229,7.2488666e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012090394,0.001980599,0.9252271,0.0015663282,0.0009821646,0.00000511502,0.0059562656,0.04165645,0.00008665808,0.0018536397,0.0041064844,0.0153701715],"study_design_scores_gemma":[0.00063031155,0.00015648307,0.97406596,0.0057342467,0.00015950331,0.000009230584,0.002617096,0.0046556843,0.00004644523,0.011854923,0.0000023185114,0.00006781108],"about_ca_topic_score_codex":0.0006505507,"about_ca_topic_score_gemma":0.000010857263,"teacher_disagreement_score":0.04883886,"about_ca_system_score_codex":0.000016010203,"about_ca_system_score_gemma":0.00022617454,"threshold_uncertainty_score":0.60388535},"labels":[],"label_agreement":null},{"id":"W4411413832","doi":"10.1016/j.ard.2025.06.1860","title":"ABS0552 VARIATIONS IN TACROLIMUS WHOLE BLOOD CONCENTRATIONS DURING PREGNANCY AND ITS IMPLICATIONS FOR THERAPEUTIC DRUG MONITORING: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2025,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Tacrolimus; Therapeutic drug monitoring; Drug; Meta-analysis; Pregnancy; Whole blood; Pharmacology; Internal medicine; Intensive care medicine; Bioinformatics","score_opus":0.13792689035072841,"score_gpt":0.42020764487196677,"score_spread":0.28228075452123835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411413832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010081969,0.98758996,0.000042735806,0.0038379368,0.00002443624,0.007119319,0.0013301306,0.000023420947,0.000021996088],"genre_scores_gemma":[0.006874116,0.9868117,0.000031275646,0.00014548333,0.0000073148176,0.0050838925,0.000097668766,0.000019871213,0.00092866423],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975349,0.0003409585,0.0013490001,0.00034078408,0.00019812312,0.00023627434],"domain_scores_gemma":[0.99652934,0.001204115,0.0010018193,0.00087462284,0.00022086571,0.00016922092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028063462,0.00033566594,0.00403722,0.0002958267,0.00016341808,0.00003389738,0.0002695072,0.00008367278,0.000016913848],"category_scores_gemma":[0.0017922579,0.00020121405,0.0014580889,0.0009790696,0.00006389769,0.00011373177,0.00007272121,0.00012860102,0.0000010020219],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001599342,0.00022920521,0.000050203653,0.9379875,0.058717515,3.835364e-7,0.0001189709,8.490056e-7,1.9046126e-7,0.00080441317,0.000042647647,0.0020464906],"study_design_scores_gemma":[0.00021592631,0.000011781139,0.0010126902,0.34262222,0.65553933,0.000011218087,0.000016532977,0.000006960053,0.0000018023546,0.00029979917,0.00013638086,0.00012537395],"about_ca_topic_score_codex":0.000007241806,"about_ca_topic_score_gemma":0.000002856169,"teacher_disagreement_score":0.5968218,"about_ca_system_score_codex":0.000020217103,"about_ca_system_score_gemma":0.00042425207,"threshold_uncertainty_score":0.8205271},"labels":[],"label_agreement":null},{"id":"W4411413842","doi":"10.1016/j.ard.2025.06.1898","title":"ABS0880 A REAL-WORLD PERSPECTIVE ON THE ASSOCIATION OF IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE OUTCOMES AND DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Perspective (graphical); Quality of life (healthcare); Disease; Association (psychology); Immunology; Systemic lupus erythematosus; Intensive care medicine; Internal medicine; Nursing","score_opus":0.04911203582472112,"score_gpt":0.37529594472922095,"score_spread":0.32618390890449983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411413842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97726834,0.0019176006,0.00000206132,0.018074516,0.000102926715,0.002001634,0.000097444325,0.00001310708,0.00052237435],"genre_scores_gemma":[0.99815387,0.00065357896,0.000002615489,0.00018001696,0.0000033020704,0.00011329696,0.0000023329599,0.000012777853,0.00087821955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961497,0.001104313,0.0013810294,0.00025862938,0.00082155265,0.00028474932],"domain_scores_gemma":[0.9944182,0.0031191374,0.0012824261,0.0007204661,0.00029475318,0.00016500261],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0029049155,0.0001842506,0.0011597864,0.00037172684,0.000047892525,0.00000970232,0.00023715729,0.00005360586,0.000013836023],"category_scores_gemma":[0.010701423,0.000106802596,0.00025385927,0.0007543864,0.00015686666,0.000058787435,0.00014426766,0.00018473885,0.0000010791779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013290116,0.001007843,0.9715176,0.010600816,0.00044291758,0.0000012615831,0.002052556,0.000035217003,0.000095893,0.0119719235,0.0005553601,0.00038955567],"study_design_scores_gemma":[0.0028743523,0.000118833115,0.9698329,0.013627591,0.0000623941,0.0000035941719,0.0055414815,0.00041753452,0.00018942557,0.007243399,7.280065e-7,0.00008777633],"about_ca_topic_score_codex":0.006835297,"about_ca_topic_score_gemma":0.000554804,"teacher_disagreement_score":0.020885525,"about_ca_system_score_codex":0.00048209648,"about_ca_system_score_gemma":0.00092079845,"threshold_uncertainty_score":0.9997783},"labels":[],"label_agreement":null},{"id":"W4411413907","doi":"10.1016/j.ard.2025.06.1895","title":"ABS0857 PHARMACODYNAMIC EFFECTS OF OBINUTUZUMAB ON B CELLS AND SEROLOGICAL MARKERS IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: RESULTS FROM THE PHASE III REGENCY STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lupus nephritis; Obinutuzumab; Serology; Belimumab; Pharmacodynamics; Nephritis; Immunology; Internal medicine; Systemic lupus erythematosus; Antibody; Rituximab; B cell; Pharmacokinetics; Disease","score_opus":0.01539676927004406,"score_gpt":0.3132327296140774,"score_spread":0.2978359603440333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411413907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948671,0.0008031256,0.0000023290595,0.00039419986,0.00016474612,0.00329347,0.00027379623,0.000014957038,0.00018627562],"genre_scores_gemma":[0.9992238,0.00029993587,0.000008399045,0.00017164362,0.000007699936,0.00010034452,0.000020767462,0.0000141521,0.00015322055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975866,0.00058695517,0.00058797613,0.0003279752,0.00065487676,0.00025558993],"domain_scores_gemma":[0.9964307,0.0023334385,0.00030419262,0.0006697122,0.00016354703,0.00009839262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034674056,0.00020924654,0.000614821,0.00011946918,0.00007143498,0.000012995118,0.00033864795,0.000050179864,0.000016562557],"category_scores_gemma":[0.0009887312,0.00010343388,0.000107221385,0.00038469888,0.00024390647,0.00006355397,0.0001692693,0.0001880978,0.0000020157977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13819629,0.016778208,0.73429227,0.0047676833,0.004213915,0.000094850635,0.011316663,0.00014418749,0.00040382397,0.00008983486,0.012445995,0.07725629],"study_design_scores_gemma":[0.06147722,0.0032484333,0.91395235,0.013412486,0.00055073865,0.000007762944,0.004039798,0.00073202007,0.0019641353,0.00042505487,0.000011004592,0.00017901706],"about_ca_topic_score_codex":0.00043741276,"about_ca_topic_score_gemma":0.00002791557,"teacher_disagreement_score":0.17966007,"about_ca_system_score_codex":0.00006837682,"about_ca_system_score_gemma":0.00019142844,"threshold_uncertainty_score":0.4217911},"labels":[],"label_agreement":null},{"id":"W4411414061","doi":"10.1016/j.ard.2025.06.1651","title":"ABS1115 EFFECT OF A MULTIDISCIPLINARY LIFESTYLE INTERVENTION ON STRESS-RELATED PARAMETERS IN PEOPLE WITH RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS: SECONDARY ANALYSIS OF THE “PLANTS FOR JOINTS” RANDOMIZED CONTROLLED TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Randomized controlled trial; Osteoarthritis; Physical therapy; Multidisciplinary approach; Intervention (counseling); Alternative medicine; Internal medicine; Psychiatry; Pathology","score_opus":0.009766050044539272,"score_gpt":0.29999220408186383,"score_spread":0.29022615403732455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411414061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676836,0.0066873934,0.000008833128,0.00044696737,0.000086851236,0.0057306783,0.00021128787,0.000007679621,0.000051955263],"genre_scores_gemma":[0.9978444,0.001403386,0.00001367482,0.000004484644,0.0000010512824,0.00058628136,0.00004488189,0.000011216867,0.00009061075],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971982,0.00092903257,0.0010653876,0.00021267166,0.00039222735,0.00020247194],"domain_scores_gemma":[0.9951418,0.0036508732,0.0006004465,0.0004370707,0.000109197834,0.000060611364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012392859,0.00018767796,0.002297275,0.000394912,0.00006279489,0.000011987205,0.00017364857,0.00006928569,0.000041053278],"category_scores_gemma":[0.002286705,0.000093844894,0.0011797782,0.0005674789,0.0004005291,0.000052143496,0.000090785936,0.00013346491,2.739808e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.955515,0.0010770571,0.01860871,0.0062865103,0.00800145,0.0000024493386,0.00057293614,0.00050144456,0.00004045878,0.0000932607,0.00010120603,0.009199515],"study_design_scores_gemma":[0.86825377,0.0025972517,0.08435965,0.034818828,0.0015736887,0.0000035473977,0.00037580568,0.0051885652,0.002343596,0.00038892071,1.4155445e-7,0.00009623928],"about_ca_topic_score_codex":0.00020204003,"about_ca_topic_score_gemma":0.00007775709,"teacher_disagreement_score":0.087261245,"about_ca_system_score_codex":0.000017502885,"about_ca_system_score_gemma":0.00019921767,"threshold_uncertainty_score":0.38268837},"labels":[],"label_agreement":null},{"id":"W4411414432","doi":"10.1016/j.ard.2025.06.1192","title":"ABS0147 EARLY IMPROVEMENTS IN QUADRICEPS MUSCLE INHIBITION AS A KEY DETERMINANT OF FUNCTIONAL RECOVERY FOLLOWING TOTAL KNEE ARTHROPLASTY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quadriceps muscle; Total knee arthroplasty; Arthroplasty; Surgery; Physical medicine and rehabilitation","score_opus":0.016685854491524415,"score_gpt":0.27708592520061665,"score_spread":0.2604000707090922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411414432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697393,0.0004369509,0.000051859035,0.00069607503,0.0006786589,0.00053171575,0.000045334356,0.000024053164,0.0005614398],"genre_scores_gemma":[0.99849176,0.000044308606,0.000057601846,0.00036213396,0.000015945021,0.000040858904,0.0000122578385,0.000015439211,0.0009596791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983273,0.000088084744,0.00066834275,0.00022228665,0.00044308766,0.0002508883],"domain_scores_gemma":[0.99883616,0.00030391326,0.0002706862,0.0003918918,0.000114569004,0.00008275275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002141028,0.0001792788,0.00046978556,0.00022802496,0.0000738933,0.000014854051,0.000059236016,0.000057957746,0.00011521717],"category_scores_gemma":[0.0012313698,0.00013400901,0.00045854287,0.00037334443,0.00011017683,0.00023624607,0.00013586912,0.00011598902,0.000023382807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025586956,0.004750027,0.6981993,0.003734995,0.0017249717,0.000073091054,0.001712078,0.000773825,0.011877834,0.0011817045,0.0066774804,0.266736],"study_design_scores_gemma":[0.0019215441,0.0003215846,0.99012387,0.002771871,0.00013745551,0.000004298261,0.00034343792,0.00016778767,0.0022163852,0.0018372976,0.00004175437,0.00011273564],"about_ca_topic_score_codex":0.0002772307,"about_ca_topic_score_gemma":0.00004272548,"teacher_disagreement_score":0.29192457,"about_ca_system_score_codex":0.000034958237,"about_ca_system_score_gemma":0.0002332977,"threshold_uncertainty_score":0.5464729},"labels":[],"label_agreement":null},{"id":"W4411414466","doi":"10.1016/j.ard.2025.06.1279","title":"ABS0059 THE PERSPECTIVES OF EUROPEAN RHEUMATOLOGISTS ON THE POTENTIAL FUTURE OF JANUS KINASE INHIBITOR (JAKI) USE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): A DELPHI STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Tofacitinib; Janus kinase inhibitor; Janus kinase; Musculoskeletal disease; Janus; Physical therapy; Internal medicine; Disease; Rheumatoid arthritis","score_opus":0.028459843430059337,"score_gpt":0.30931118890862613,"score_spread":0.28085134547856677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411414466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534226,0.0043591475,0.000005095492,0.008968072,0.00012441084,0.00095799094,0.000051926327,0.000014730034,0.00017637122],"genre_scores_gemma":[0.99841946,0.0011893399,0.000009418551,0.00027063288,0.000024110732,0.00002709046,0.0000030146919,0.0000061535447,0.000050784918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973312,0.0008526206,0.00068696996,0.00028978902,0.00059836154,0.00024105265],"domain_scores_gemma":[0.99761367,0.0012055392,0.00036320835,0.00055149366,0.00014061903,0.00012547748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074472214,0.0002128959,0.000578709,0.00008910683,0.00014284218,0.00002649308,0.00053675176,0.000042460168,0.00009826764],"category_scores_gemma":[0.0040132417,0.00007717484,0.0002907358,0.00047226044,0.0013790742,0.00006777525,0.0003055088,0.00017008859,0.0000022196073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002793697,0.022279577,0.78640205,0.0046055396,0.0017108469,0.000076725344,0.01114087,0.000121583675,0.00046420647,0.028167691,0.0062393113,0.1359979],"study_design_scores_gemma":[0.0008476229,0.0006481321,0.9734477,0.0018495003,0.00021080696,0.000002898367,0.020220483,0.00017896411,0.00005522792,0.0024235575,0.000021786978,0.00009336597],"about_ca_topic_score_codex":0.00019847011,"about_ca_topic_score_gemma":0.000028118482,"teacher_disagreement_score":0.1870456,"about_ca_system_score_codex":0.00000941705,"about_ca_system_score_gemma":0.00009571759,"threshold_uncertainty_score":0.5081256},"labels":[],"label_agreement":null},{"id":"W4411414557","doi":"10.1016/j.ard.2025.06.1298","title":"ABS0830 FAMILY SIZE AND ITS PREDICTORS IN RHEUMATIC DISEASES: A SYNDEMIC ANALYSIS FROM THE CoVAD-3 STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Syndemic; Rheumatic disease; Environmental health; Internal medicine; Family medicine; Rheumatoid arthritis","score_opus":0.028914782185368967,"score_gpt":0.30552707771316756,"score_spread":0.2766122955277986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411414557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935124,0.06105856,0.000007870665,0.0013883039,0.00019873284,0.0016508306,0.00040141982,0.000057948455,0.000112362446],"genre_scores_gemma":[0.9936962,0.0047866763,0.000005107402,0.0010376063,0.000020152755,0.00017099855,0.000028023609,0.000022001343,0.00023322801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686736,0.0005315202,0.001107354,0.0004633997,0.00069198903,0.0003384035],"domain_scores_gemma":[0.9955663,0.0025309718,0.0004084798,0.0010777623,0.00016913371,0.00024736195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041145997,0.00033741907,0.0011184509,0.00024602938,0.00018217959,0.00006546878,0.0005455978,0.00009485933,0.00012386865],"category_scores_gemma":[0.003397932,0.0001789723,0.00058897614,0.001685635,0.00020572738,0.000113105125,0.00026113598,0.00017927564,0.0000097371185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003466014,0.0020195155,0.9793176,0.0006321141,0.0077270684,0.00000846816,0.001469158,0.00035295208,0.000042038093,0.00008234605,0.0044584796,0.0035436484],"study_design_scores_gemma":[0.0019939833,0.00008918119,0.97256726,0.006646493,0.008046578,0.0000010021788,0.0063748914,0.0034317519,0.000011852989,0.00066669233,0.000010886379,0.00015939902],"about_ca_topic_score_codex":0.0009181778,"about_ca_topic_score_gemma":0.000048792008,"teacher_disagreement_score":0.058572233,"about_ca_system_score_codex":0.00003968461,"about_ca_system_score_gemma":0.00030087016,"threshold_uncertainty_score":0.7298279},"labels":[],"label_agreement":null},{"id":"W4411415043","doi":"10.1016/j.ard.2025.06.393","title":"POS1039 SELF-EFFICACY IN IDIOPATHIC INFLAMMATORY MYOPATHIES: A CROSS-SECTIONAL STUDY FROM THE COVAD-3 DATASET","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cross-sectional study; Pathology","score_opus":0.02827388002178681,"score_gpt":0.3363333176434005,"score_spread":0.3080594376216137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411415043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926712,0.0026534668,0.0000062059107,0.0014221971,0.00041160436,0.0013869929,0.0012046274,0.00007604387,0.00016765836],"genre_scores_gemma":[0.99721646,0.00017773728,0.000012773565,0.002147419,0.00007748686,0.00011676745,0.00017606502,0.00002147895,0.000053832413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704707,0.00046782213,0.0011088419,0.0003615572,0.0006759718,0.0003387568],"domain_scores_gemma":[0.9972602,0.0007370764,0.00034744304,0.0013375669,0.00020548396,0.00011224393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009318848,0.000280805,0.0005772797,0.00014557752,0.00031937714,0.000112772555,0.00065615727,0.000096904085,0.000094340096],"category_scores_gemma":[0.0012602798,0.00017021445,0.00028528753,0.00048217675,0.00028753883,0.00019756127,0.00038511792,0.00032746373,0.000046044403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043435127,0.0022109502,0.98176426,0.00048927095,0.00044174917,0.00006779237,0.001293715,0.000097705815,0.000015509047,0.0005685513,0.011661908,0.0009542545],"study_design_scores_gemma":[0.0022136495,0.0000961292,0.99255425,0.0013191999,0.0001906978,0.000014511072,0.00082582055,0.00029286294,0.00012911553,0.0010236768,0.0011843715,0.00015572963],"about_ca_topic_score_codex":0.00042977184,"about_ca_topic_score_gemma":0.00006027062,"teacher_disagreement_score":0.010789993,"about_ca_system_score_codex":0.000046885307,"about_ca_system_score_gemma":0.0005052604,"threshold_uncertainty_score":0.6941144},"labels":[],"label_agreement":null},{"id":"W4411415108","doi":"10.1016/j.ard.2025.06.510","title":"POS1160 A PHASE IB, MULTICENTRE, OPEN-LABEL, DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED MOSUNETUZUMAB IN PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Tolerability; Pharmacology; Adverse effect; Anesthesia","score_opus":0.0900225317181723,"score_gpt":0.43357420136445196,"score_spread":0.34355166964627964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411415108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867706,0.0016534415,0.00004009123,0.0019270466,0.00019186144,0.009114003,0.00013342431,0.000026761201,0.00014279962],"genre_scores_gemma":[0.9987135,0.00037033687,0.000058079953,0.00019161346,0.000010472544,0.0002934967,0.000010908781,0.00003965447,0.0003119174],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9953434,0.0010046101,0.001544916,0.00050269684,0.0010521719,0.0005522105],"domain_scores_gemma":[0.99631196,0.0012011512,0.0004409194,0.00118054,0.00058280263,0.00028263358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016407759,0.00036271504,0.0011684926,0.00024358492,0.00014004052,0.0000804707,0.000878841,0.00004914408,0.000037375456],"category_scores_gemma":[0.0011533396,0.00020566315,0.00009586524,0.0010062488,0.00027680444,0.00012946555,0.0007523598,0.00019587173,0.0000042454267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046709545,0.028571317,0.85320926,0.015863331,0.0031973934,0.000149973,0.02490141,0.0021162094,0.003044578,0.00024056893,0.0010477945,0.020948607],"study_design_scores_gemma":[0.2410493,0.01514004,0.11399584,0.076449335,0.009992776,0.0076278397,0.075329855,0.450334,0.006527798,0.0016274957,0.00006371266,0.0018619928],"about_ca_topic_score_codex":0.00021386139,"about_ca_topic_score_gemma":0.00016263062,"teacher_disagreement_score":0.7392134,"about_ca_system_score_codex":0.00012313543,"about_ca_system_score_gemma":0.0005849678,"threshold_uncertainty_score":0.83866996},"labels":[],"label_agreement":null},{"id":"W4411415228","doi":"10.1016/j.ard.2025.06.195","title":"POS0839 EPIDEMIOLOGY OF SJÖGREN SYNDROME IN CATALONIA SPAIN. A POPULATION-BASED COHORT STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epidemiology; Cohort; Cohort study; Population; Dermatology; Pediatrics; Environmental health; Internal medicine","score_opus":0.03779349741574684,"score_gpt":0.3447108135344399,"score_spread":0.30691731611869305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411415228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475753,0.0013475743,0.00007279324,0.0026111798,0.00010848835,0.00083597685,0.00005253738,0.000015509977,0.00019838943],"genre_scores_gemma":[0.999024,0.000023336326,0.000035258377,0.0006158044,0.0000033335193,0.000055961817,0.00006726086,0.000006502748,0.00016858915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987674,0.00020991456,0.000572333,0.00015745213,0.00014366602,0.00014923987],"domain_scores_gemma":[0.99845225,0.00073477847,0.00018808212,0.0004937891,0.00007651002,0.000054616085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042639443,0.000105629195,0.0005722891,0.00018720246,0.000041788666,0.0000017042973,0.00013111983,0.000037392994,0.000080352846],"category_scores_gemma":[0.0020762782,0.0000693385,0.00017703373,0.00039135432,0.00006829272,0.0000292809,0.000039179555,0.000057921527,0.0000028998968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013715102,0.0012985339,0.9958344,0.000281947,0.00019910866,0.0000026531684,0.000035784473,0.00039298527,3.1597148e-7,0.0005252243,0.0006156823,0.00067623233],"study_design_scores_gemma":[0.00094475463,0.00018065199,0.9927183,0.0006298229,0.000226341,0.0000020412824,0.00014449978,0.00074530183,0.00000226472,0.0043476596,0.0000051005723,0.000053284268],"about_ca_topic_score_codex":0.0048912843,"about_ca_topic_score_gemma":0.0002431571,"teacher_disagreement_score":0.004648127,"about_ca_system_score_codex":0.000011764161,"about_ca_system_score_gemma":0.00014682267,"threshold_uncertainty_score":0.73941916},"labels":[],"label_agreement":null},{"id":"W4411415265","doi":"10.1016/j.ard.2025.06.160","title":"POS0803 A LONGITUDINAL ANALYSIS OF OUTCOMES OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS COMMENCING ANTIMALARIAL MEDICATION USING A MULTISTATE MODEL APPROACH","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Simon Fraser University","funders":"","keywords":"Medicine; Hydroxychloroquine; Dermatology; Lupus erythematosus; Antimalarial Agent; Chloroquine; Intensive care medicine; Internal medicine; Immunology; Malaria; Disease; Coronavirus disease 2019 (COVID-19); Antibody","score_opus":0.06331251560337177,"score_gpt":0.36031033021873693,"score_spread":0.2969978146153652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411415265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911891,0.00091624534,0.006140994,0.00016610179,0.00014016333,0.0010736348,0.00021884558,0.000019220592,0.00013568555],"genre_scores_gemma":[0.99874514,0.000117335774,0.00089953287,0.00003066565,0.000005002863,0.000033542594,0.000051964143,0.000019306108,0.00009752134],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99660337,0.00026436255,0.0014304996,0.00029368282,0.0011135467,0.00029454046],"domain_scores_gemma":[0.99647886,0.0005229759,0.001092978,0.0009953072,0.00079268566,0.00011720781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072182267,0.00022979765,0.0015550948,0.00077393645,0.00008123336,0.000012079754,0.00045356192,0.000082625804,0.00001075271],"category_scores_gemma":[0.0015441685,0.00015100265,0.00069369614,0.0013183411,0.0002720229,0.00010012605,0.00023768756,0.00010102198,5.661894e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033158367,0.0010566984,0.974557,0.008371809,0.00551422,8.0205166e-7,0.0013258953,0.007556504,0.00023665675,0.00040496234,0.00022992402,0.00041396226],"study_design_scores_gemma":[0.0033975206,0.0000743425,0.25037745,0.0090950215,0.0064398292,0.00007086797,0.0017623457,0.7276884,0.0005998585,0.00032832747,2.5052947e-7,0.0001658002],"about_ca_topic_score_codex":0.00038408083,"about_ca_topic_score_gemma":0.0000051744464,"teacher_disagreement_score":0.7241795,"about_ca_system_score_codex":0.00007159563,"about_ca_system_score_gemma":0.00041780458,"threshold_uncertainty_score":0.61577094},"labels":[],"label_agreement":null},{"id":"W4411415360","doi":"10.1016/j.ard.2025.06.168","title":"POS0811-PARE THE VOCABULARY OF RHEUMATOLOGY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Federation of Science Journalists","funders":"","keywords":"Medicine; Rheumatology; Internal medicine; Family medicine","score_opus":0.040104900264964334,"score_gpt":0.33165670177584816,"score_spread":0.29155180151088383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411415360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479443,0.0033408252,0.000022036376,0.04563785,0.00017108694,0.00023280091,0.000017156988,0.0000132654395,0.002620719],"genre_scores_gemma":[0.9966116,0.0005808601,0.000020862793,0.0021605892,0.000004471251,0.000009124896,0.0000030051308,0.0000015618999,0.0006079389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900323,0.00011535876,0.0003481132,0.0001128549,0.00026466657,0.00015577412],"domain_scores_gemma":[0.9988319,0.0005244784,0.00014854368,0.00033311895,0.00008641214,0.00007552754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002732241,0.00007845769,0.00032581386,0.00002727649,0.000072655836,0.000004202681,0.00041113273,0.000042226908,0.0002984331],"category_scores_gemma":[0.0016748569,0.000027644832,0.00019945636,0.00030684267,0.00074313395,0.000019316694,0.00014820677,0.00006569987,0.0000062632485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037970938,0.0013853305,0.712761,0.0022369602,0.00068663614,0.000003398079,0.0002634505,0.0000118293365,0.00030321008,0.042770762,0.07383457,0.16536318],"study_design_scores_gemma":[0.00040216878,0.0002028934,0.9467673,0.0019559935,0.00018347315,0.000010492885,0.0004365925,0.00025560148,0.0012821205,0.046766102,0.0016672213,0.00007006137],"about_ca_topic_score_codex":0.00010008577,"about_ca_topic_score_gemma":0.0000042513493,"teacher_disagreement_score":0.2340063,"about_ca_system_score_codex":0.0000023421878,"about_ca_system_score_gemma":0.000120915975,"threshold_uncertainty_score":0.32676333},"labels":[],"label_agreement":null},{"id":"W4411416050","doi":"10.1016/j.ard.2025.06.062","title":"POS0701 LUNG TRANSPLANTATION OUTCOMES IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthritis Research Centre of Canada; Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Lung transplantation; Pneumonia; Lung; Transplantation; Interstitial pneumonia; Immunology; Intensive care medicine; Internal medicine","score_opus":0.00946161734942466,"score_gpt":0.3009694385517439,"score_spread":0.2915078212023193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411416050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534243,0.00029507012,0.00052765873,0.0026815764,0.00011141494,0.0005681079,0.00009215605,0.000029977726,0.00035158842],"genre_scores_gemma":[0.99823,0.00011256812,0.0006978868,0.00055372604,0.000003448183,0.000022653036,0.00005533023,0.000012403558,0.00031201623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989591,0.00009774403,0.00031486715,0.00015510141,0.00030487298,0.0001682978],"domain_scores_gemma":[0.99923784,0.00022133469,0.00012418907,0.00027027566,0.00009914763,0.00004724216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095306386,0.0001658573,0.00041868622,0.00015089744,0.000055599965,0.000017409391,0.00014118198,0.000035588262,0.000020761114],"category_scores_gemma":[0.00006652212,0.00008562012,0.00011418658,0.0002606626,0.0001024794,0.00011144588,0.00001202508,0.00009733526,7.767774e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021710112,0.00040018553,0.9894975,0.0011658585,0.00035123836,0.0000070219858,0.0005366532,0.00008678216,0.000011506641,0.0005123124,0.000085498745,0.0051744618],"study_design_scores_gemma":[0.0032072696,0.00019342215,0.99219036,0.003205127,0.00045670118,0.0000027853598,0.00011387793,0.00003357666,0.00029078993,0.00020374294,0.000005437719,0.00009690245],"about_ca_topic_score_codex":0.0001329602,"about_ca_topic_score_gemma":0.0000706582,"teacher_disagreement_score":0.0050775595,"about_ca_system_score_codex":0.000015367023,"about_ca_system_score_gemma":0.00010840567,"threshold_uncertainty_score":0.34914872},"labels":[],"label_agreement":null},{"id":"W4411416212","doi":"10.1016/j.ard.2025.06.119","title":"POS0759 CHARACTERISTICS OF RELAPSES AND THERAPEUTIC MANAGEMENTS IN GIANT CELL ARTERITIS IN MODERN ERA, NEWTON STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Giant cell arteritis; Arteritis; Immunology; Pathology; Vasculitis; Disease","score_opus":0.016830952936412697,"score_gpt":0.2870948120128574,"score_spread":0.27026385907644473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411416212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431086,0.0027064537,0.000012882399,0.0017826639,0.000063483414,0.00058692886,0.000043144842,0.0000067593805,0.00048681872],"genre_scores_gemma":[0.9973779,0.0018113209,0.000011371952,0.00022850398,0.0000024784529,0.000025277945,0.000008664277,0.000007270469,0.000527238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908674,0.000084720916,0.00042558069,0.00012844849,0.00015023585,0.00012429316],"domain_scores_gemma":[0.999454,0.000063912536,0.000118135285,0.00028548666,0.000042004216,0.000036469035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010246087,0.00009659392,0.00034116095,0.00016642633,0.000028222341,0.000009570152,0.00010000521,0.00003220317,0.00002723906],"category_scores_gemma":[0.000057322715,0.00006828707,0.00008089282,0.00021772309,0.00006987396,0.000036461348,0.000052256026,0.000086626846,0.0000010229219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003691626,0.009827547,0.71754706,0.0037895045,0.0011864783,0.000092769464,0.0042592925,0.000092267386,0.00067976245,0.0018255045,0.0012035852,0.25912705],"study_design_scores_gemma":[0.0015178277,0.00013157545,0.98927873,0.002194085,0.00020790848,0.0000014975277,0.0009931579,0.0007583113,0.000091802314,0.0047587296,0.000009813855,0.00005653714],"about_ca_topic_score_codex":0.00013733571,"about_ca_topic_score_gemma":0.000021868553,"teacher_disagreement_score":0.27173167,"about_ca_system_score_codex":0.000008725148,"about_ca_system_score_gemma":0.00004486164,"threshold_uncertainty_score":0.27846658},"labels":[],"label_agreement":null},{"id":"W4411416350","doi":"10.1016/j.ard.2025.05.775","title":"POS0389 PREVALENCE OF HYPOPHOSPHATASIA IN RHEUMATOLOGY AND OSTEOPOROSIS CARE CLINICS: A SYSTEMATIC LITERATURE REVIEW","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Alkaline Phosphatase Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Hypophosphatasia; Rheumatology; Osteoporosis; Internal medicine; Family medicine; Pediatrics; Alkaline phosphatase","score_opus":0.020123499518731523,"score_gpt":0.3619656825061317,"score_spread":0.34184218298740016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411416350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.113625064,0.8815617,0.0000013632442,0.002575811,0.000058408637,0.0017646917,0.00034431307,0.00001216833,0.00005649712],"genre_scores_gemma":[0.47658873,0.5228323,0.0000544337,0.00029879983,0.0000013431065,0.00011067007,0.000017436303,0.000007465584,0.0000888545],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99767095,0.00032476752,0.001109846,0.00025680088,0.000393193,0.000244455],"domain_scores_gemma":[0.99717426,0.0009743094,0.00045859965,0.0008114184,0.0004882331,0.00009315397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005469429,0.00020329037,0.0013415564,0.00015358413,0.00005135327,0.000010375219,0.00031332695,0.000058531587,0.000016511065],"category_scores_gemma":[0.007722658,0.00012394378,0.00025115465,0.00068978046,0.00032183208,0.000088990004,0.00031865548,0.00014471727,0.0000021361398],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010407025,0.00019610158,0.06755173,0.92483795,0.00032854363,0.0000084278245,0.0007193726,8.0937093e-7,0.0000015444422,0.00058966066,0.0029563054,0.0027054793],"study_design_scores_gemma":[0.0007792008,0.0001467076,0.12446762,0.8710476,0.00080886285,0.000023112698,0.0010184367,0.00004700728,0.00021314264,0.0013231898,0.000016138123,0.00010898294],"about_ca_topic_score_codex":0.000038385995,"about_ca_topic_score_gemma":0.0000046126265,"teacher_disagreement_score":0.36296365,"about_ca_system_score_codex":0.000018806273,"about_ca_system_score_gemma":0.00023445768,"threshold_uncertainty_score":0.9245301},"labels":[],"label_agreement":null},{"id":"W4411416439","doi":"10.1016/j.ard.2025.05.843","title":"POS0460 Pediatric ANCA-Associated Vasculitis Study of Avacopan Efficacy, Pharmacokinetics, and Safety: A Phase 3 Trial in Progress","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto; BC Children's Hospital; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; ANCA-Associated Vasculitis; Pharmacokinetics; Vasculitis; Clinical trial; Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.026710399876818974,"score_gpt":0.3568133529890065,"score_spread":0.3301029531121875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411416439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896446,0.0062135626,0.0000015169172,0.0015232613,0.00019700633,0.0021089346,0.00014171927,0.000025063971,0.000144375],"genre_scores_gemma":[0.99713093,0.0025110024,0.0000068645495,0.00007892764,0.000029608917,0.00006582456,0.000029448518,0.000011941151,0.00013544555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982769,0.00024554873,0.000732365,0.00020695348,0.0003296818,0.00020857765],"domain_scores_gemma":[0.9988621,0.0002445213,0.00028015804,0.00034242528,0.00016621845,0.000104595994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002659506,0.00015619468,0.0006016622,0.00023570933,0.00007680324,0.000012739036,0.00015861393,0.00005975907,0.00006780871],"category_scores_gemma":[0.00065861066,0.000107784,0.00023480249,0.00067026954,0.0001286645,0.00004726195,0.00009386894,0.00013641485,0.0000011970926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055534955,0.17556246,0.45846677,0.005878146,0.013222953,0.00012873851,0.009322117,0.00030369486,0.00007962446,0.0009809338,0.033528436,0.24699117],"study_design_scores_gemma":[0.20052569,0.0017256585,0.7915074,0.0015636907,0.0028312365,0.0000029403077,0.0007255913,0.00031568873,0.00009172569,0.00050572964,0.000050676575,0.00015398338],"about_ca_topic_score_codex":0.00009043332,"about_ca_topic_score_gemma":0.000012846206,"teacher_disagreement_score":0.33304062,"about_ca_system_score_codex":0.0000126458835,"about_ca_system_score_gemma":0.000172326,"threshold_uncertainty_score":0.4395304},"labels":[],"label_agreement":null},{"id":"W4411417089","doi":"10.1016/j.ard.2025.06.005","title":"POS0644 USE OF PARENTERAL COMPARED TO ORAL GLUCOCORTICOIDS IN EARLY RHEUMATOID ARTHRITIS IS SUPERIOR FOR CHANCE OF BEING OFF STEROIDS AND ESCALATION OF THERAPY AT 1 YEAR","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; Southlake Regional Health Center; University of Manitoba; Centre hospitalier universitaire de Québec; Université de Sherbrooke; University of Calgary; McGill University; Centre hospitalier de l'Université Laval; Western University","funders":"","keywords":"Medicine; Rheumatoid arthritis; Adrenal cortex hormones; Internal medicine; Intensive care medicine","score_opus":0.04468348167227952,"score_gpt":0.3240956810941408,"score_spread":0.27941219942186124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411417089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904265,0.00735797,0.00004065936,0.00075579423,0.00005546127,0.0010743809,0.0002701686,0.0000078159765,0.000011262095],"genre_scores_gemma":[0.9757318,0.023792697,0.00023395507,0.00010209869,0.0000032463845,0.000061419036,0.000015233993,0.000014393824,0.000045175937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998392,0.00009785813,0.00076939276,0.00017833278,0.0003314198,0.00023099685],"domain_scores_gemma":[0.99874794,0.00027338788,0.00022778288,0.00036048694,0.0002928038,0.000097596974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018413452,0.00014610671,0.00072491344,0.00022061034,0.000042882442,0.000016461156,0.0001501709,0.000038815495,0.000034152774],"category_scores_gemma":[0.00039807326,0.0001130501,0.00019306543,0.00027150768,0.00025191685,0.00015767191,0.00010403253,0.000047556885,5.0278317e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043031396,0.00074311194,0.868294,0.0009835175,0.000422746,8.688137e-7,0.004935586,0.000025102821,0.009601464,0.0006075462,0.0007943603,0.10928854],"study_design_scores_gemma":[0.0047177435,0.0007443532,0.9337808,0.008793071,0.00000931935,0.0000019973925,0.0004025228,0.0006471015,0.049529538,0.0010750797,0.00018586137,0.00011261615],"about_ca_topic_score_codex":0.00034868525,"about_ca_topic_score_gemma":0.00008569669,"teacher_disagreement_score":0.10917593,"about_ca_system_score_codex":0.000012091781,"about_ca_system_score_gemma":0.00008791355,"threshold_uncertainty_score":0.4610049},"labels":[],"label_agreement":null},{"id":"W4411417568","doi":"10.1016/j.ard.2025.05.243","title":"OP0232 CANCER INCIDENCE AMONG RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK-INHIBITORS COMPARED TO bDMARDs: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Rheumatoid arthritis; Incidence (geometry); Tofacitinib; Internal medicine; Biologic Agents; Oncology; Arthritis","score_opus":0.03713003997147955,"score_gpt":0.3569601483590484,"score_spread":0.3198301083875688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411417568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920876,0.0021376782,0.00002492347,0.0024893628,0.00024302243,0.0016281039,0.0012451286,0.00003241161,0.00011174933],"genre_scores_gemma":[0.99262905,0.006432623,0.000045123,0.00023411948,0.000020391532,0.00015334309,0.0003837238,0.000020910338,0.00008074013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736476,0.00030517005,0.0007029655,0.0003967718,0.0009871675,0.00024317481],"domain_scores_gemma":[0.9968187,0.00025598926,0.00040696928,0.0014390263,0.00089276646,0.00018654339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002837772,0.00021905501,0.0005507097,0.00017408356,0.00017906346,0.00010583723,0.0010381384,0.000034278524,0.00012050573],"category_scores_gemma":[0.0010394669,0.00013359214,0.00008289999,0.00068296154,0.00038514272,0.0005614802,0.0003585772,0.00010147091,0.000003978737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013394322,0.0013249957,0.96236026,0.00006400893,0.0009191832,0.0000039768865,0.001616636,0.00017527892,0.000032532673,0.000035915986,0.01383506,0.018292729],"study_design_scores_gemma":[0.0030770057,0.0004377747,0.9835577,0.0067762444,0.00003661512,8.170435e-7,0.003475303,0.0010396645,0.0008256255,0.00012874039,0.0004916907,0.00015281235],"about_ca_topic_score_codex":0.0062823696,"about_ca_topic_score_gemma":0.004527826,"teacher_disagreement_score":0.021197455,"about_ca_system_score_codex":0.000042317708,"about_ca_system_score_gemma":0.00037624317,"threshold_uncertainty_score":0.9497105},"labels":[],"label_agreement":null},{"id":"W4411418475","doi":"10.1016/j.ard.2025.05.216","title":"OP0204 LUPUS DAMAGE INDEX REVISION – ITEM GENERATION AND REDUCTION PHASE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Mount Sinai Hospital; University of Calgary","funders":"","keywords":"Medicine; Systemic lupus erythematosus; Reduction (mathematics); Index (typography); Internal medicine; Disease; World Wide Web","score_opus":0.05675486073381215,"score_gpt":0.38562191381783817,"score_spread":0.32886705308402603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411418475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910403,0.005249721,0.00015825109,0.0038210328,0.00034320788,0.0007479206,0.000015831169,0.00002957294,0.000530403],"genre_scores_gemma":[0.9952744,0.0015125745,0.00004243349,0.00015322767,0.00005463021,0.000022569073,0.000019824369,0.000011812407,0.0029084804],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99867994,0.0001646619,0.0004011441,0.000201055,0.00039242423,0.00016080511],"domain_scores_gemma":[0.99883986,0.00013673957,0.00015391863,0.00054658076,0.00021792519,0.00010497352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003598002,0.00011839975,0.00031824567,0.00016064408,0.00011250507,0.000035402947,0.00013318998,0.000051285486,0.000052996413],"category_scores_gemma":[0.0012915613,0.00007656009,0.0001154225,0.00033329029,0.00012755794,0.00011839287,0.00011234866,0.00007931915,0.000005853007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015987175,0.0023464845,0.1983294,0.018550728,0.0010540782,0.000016660299,0.0023121233,0.00008123595,0.017161353,0.0036373253,0.3411652,0.41374668],"study_design_scores_gemma":[0.061621964,0.0035112258,0.26363346,0.16311702,0.0042250208,0.007378745,0.019236276,0.28222835,0.14592505,0.025708841,0.020830624,0.0025834162],"about_ca_topic_score_codex":0.000029120965,"about_ca_topic_score_gemma":0.0000011904009,"teacher_disagreement_score":0.41116327,"about_ca_system_score_codex":0.000025817324,"about_ca_system_score_gemma":0.00015002296,"threshold_uncertainty_score":0.312203},"labels":[],"label_agreement":null},{"id":"W4411418479","doi":"10.1016/j.ard.2025.05.189","title":"OP0176 IDENTIFICATION OF INFLAMMATORY AND NON-INFLAMMATORY MECHANISMS TO IMPROVE TREATMENT STRATEGIES IN DIFFICULT-TO-TREAT PSA PATIENTS USING CLINICAL AND SONOGRAPHIC FINDINGS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Identification (biology); Intensive care medicine; Internal medicine","score_opus":0.02785501365278908,"score_gpt":0.3418971638999449,"score_spread":0.3140421502471558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411418479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788535,0.00031261425,0.00019639933,0.0005177396,0.00006548428,0.00094064843,0.000044097058,0.00001004168,0.000027609829],"genre_scores_gemma":[0.99911875,0.0004932423,0.00014990571,0.00016281495,0.0000032277383,0.000042755826,0.0000060398575,0.0000073956885,0.000015897036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864805,0.00006349735,0.0007436478,0.00022288952,0.00016291706,0.0001589885],"domain_scores_gemma":[0.99896705,0.00030140806,0.00016933121,0.00027472997,0.00013840661,0.00014905255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018178493,0.00015140958,0.00046791902,0.00017343082,0.000053187305,0.000027092423,0.0000911947,0.000071648275,0.0000033771476],"category_scores_gemma":[0.001145708,0.00009805581,0.000105969244,0.0002406929,0.00014949776,0.000075012074,0.00010111926,0.000044710727,0.0000010503865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040382743,0.0015068513,0.9745426,0.001767469,0.00015650662,0.0000035782646,0.0006799596,0.00008415038,0.0017156537,0.0033356093,0.00019379337,0.015609994],"study_design_scores_gemma":[0.0012169838,0.00037512853,0.987637,0.0013650042,0.00016977395,3.4824004e-7,0.0007868052,0.00046991077,0.0029569122,0.0049274047,0.0000034288616,0.0000912954],"about_ca_topic_score_codex":0.000048171067,"about_ca_topic_score_gemma":0.000014858073,"teacher_disagreement_score":0.015518699,"about_ca_system_score_codex":0.000010937613,"about_ca_system_score_gemma":0.00010987155,"threshold_uncertainty_score":0.39986},"labels":[],"label_agreement":null},{"id":"W4411418821","doi":"10.1016/j.ard.2025.06.1778","title":"ABS0977 PERFORMANCE OF THE ASAS PRELIMINARY DATA-DRIVEN MRI LESION CUT-OFFS FOR A POSITIVE MRI OF THE SACROILIAC JOINTS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS WITH AND WITHOUT PSORIASIS, IRITIS, AND COLITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Arthritis Research Centre of Canada; Research Canada; University of Ottawa","funders":"","keywords":"Medicine; Psoriasis; Lesion; Axial spondyloarthritis; Radiology; Sacroiliac joint; Colitis; Sacroiliitis; Magnetic resonance imaging; Dermatology; Surgery; Internal medicine","score_opus":0.022341546777683675,"score_gpt":0.29366876813994575,"score_spread":0.27132722136226206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411418821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953618,0.0009867322,0.000012214194,0.001292805,0.00007195351,0.0012302324,0.00094339397,0.0000044576527,0.000096416064],"genre_scores_gemma":[0.99889994,0.0005045934,0.0001517319,0.00022876602,0.000007179372,0.00003835575,0.000041850228,0.0000120613095,0.00011552089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988758,0.000115704424,0.00037267272,0.00022630767,0.00024262916,0.00016686966],"domain_scores_gemma":[0.9988339,0.000054662938,0.000283404,0.00059252366,0.00019129085,0.00004424433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012463334,0.00015159369,0.0004537009,0.000059741622,0.000082692386,0.000008151849,0.0002783879,0.000044732915,0.000008477336],"category_scores_gemma":[0.00023581536,0.000073291216,0.00007774009,0.00017745182,0.00062433333,0.00015038304,0.00031582607,0.00008180691,1.632289e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004110891,0.0006994434,0.97363317,0.0018770054,0.00026903697,0.0000011123924,0.00057061616,0.00001460499,0.00003926288,0.00018493067,0.003317477,0.015282446],"study_design_scores_gemma":[0.0032568232,0.0017634197,0.9814957,0.01061387,0.00027437057,0.000009532958,0.00021065948,0.0006016536,0.0015217448,0.00015947508,0.000014498186,0.000078279474],"about_ca_topic_score_codex":0.00015111406,"about_ca_topic_score_gemma":0.0001519393,"teacher_disagreement_score":0.015204166,"about_ca_system_score_codex":0.00000891175,"about_ca_system_score_gemma":0.00013318688,"threshold_uncertainty_score":0.29887292},"labels":[],"label_agreement":null},{"id":"W4411419447","doi":"10.1016/j.ard.2025.06.1588","title":"ABS0730 TREATMENT SEQUENCING AND LINE OF THERAPY FOR BIOLOGICS AND JAK INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS: IMPLICATIONS FOR DESIGN AND UPTAKE OF NEW DRUGS AND DIAGNOSTICS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Riverview Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Antirheumatic Agents; Internal medicine; Second line; Oncology; Pharmacology; First line","score_opus":0.08405174068899665,"score_gpt":0.3639019175314554,"score_spread":0.2798501768424587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411419447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95983106,0.035961967,0.00016797891,0.002390603,0.000015515367,0.0012945737,0.00032727164,0.000003250741,0.000007772479],"genre_scores_gemma":[0.83874685,0.15982239,0.0011906846,0.000093208684,0.000005108436,0.000074249,0.00002164405,0.000005516115,0.00004037293],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999266,0.000032430922,0.00037507873,0.000135253,0.00006896965,0.00012223999],"domain_scores_gemma":[0.998217,0.0013162869,0.00013314826,0.00011893324,0.0001367867,0.00007786052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014698811,0.000106443986,0.0003652102,0.00008298975,0.000055674038,0.000007710248,0.000043589804,0.00003548423,0.0000014519661],"category_scores_gemma":[0.0006427368,0.000065269545,0.00005875797,0.00009035359,0.00021342687,0.00003199271,0.000043533495,0.000023390121,1.7309914e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096878875,0.00040991965,0.215224,0.0011095492,0.0002574604,1.5369592e-7,0.0010325823,0.000016921398,0.00043313368,0.0018527106,0.0010603131,0.7776345],"study_design_scores_gemma":[0.006648254,0.0030280645,0.9352159,0.004293443,0.00009413471,0.0000031895968,0.00065821805,0.0012455265,0.009842222,0.038038388,0.0007737919,0.00015887895],"about_ca_topic_score_codex":0.00022908988,"about_ca_topic_score_gemma":0.000012877723,"teacher_disagreement_score":0.7774756,"about_ca_system_score_codex":0.000009219588,"about_ca_system_score_gemma":0.00014701161,"threshold_uncertainty_score":0.26616147},"labels":[],"label_agreement":null},{"id":"W4411419547","doi":"10.1016/j.ard.2025.06.1751","title":"ABS0655 EVALUATION OF CONCOMITANT PERIPHERAL ARTHRITIS IN EARLY AXIAL SPONDYLOARTHRITIS: RESULTS FROM A 72-MONTH FOLLOW-UP ITALIAN ARM OF SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concomitant; Axial spondyloarthritis; Cohort; Arthritis; Peripheral; Ankylosing spondylitis; Internal medicine; Physical therapy; Sacroiliitis","score_opus":0.02781007617473225,"score_gpt":0.30344245361051275,"score_spread":0.2756323774357805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411419547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630308,0.027053636,0.0000045120814,0.0012609112,0.000672881,0.0020180456,0.0039124875,0.000031142805,0.0020155674],"genre_scores_gemma":[0.9952432,0.0035557153,0.00011168204,0.00010339507,0.000044265864,0.0001859673,0.0002229192,0.000038627826,0.0004942624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952029,0.00043406818,0.0018191418,0.00058482226,0.0014003959,0.0005586998],"domain_scores_gemma":[0.99658155,0.00047184972,0.00082831265,0.0010587098,0.000869779,0.00018977826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091205473,0.0004396563,0.0016420261,0.00030912098,0.00014126138,0.00003441572,0.00033558675,0.0001653423,0.00025918765],"category_scores_gemma":[0.0021316484,0.0003724254,0.00069346407,0.00074481376,0.0005644125,0.00023380487,0.0001948002,0.00019057067,0.000008124501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015575254,0.005305881,0.74190265,0.00076548086,0.0044558393,0.00023530769,0.007935607,0.00011908561,0.0006428187,0.0020543535,0.0067735733,0.21423414],"study_design_scores_gemma":[0.028117504,0.0009727286,0.9495968,0.01185738,0.00085311476,0.000009645151,0.0011803765,0.00015752329,0.0026850214,0.0040562637,0.00021391004,0.00029968366],"about_ca_topic_score_codex":0.007718704,"about_ca_topic_score_gemma":0.004023217,"teacher_disagreement_score":0.21393445,"about_ca_system_score_codex":0.00010411421,"about_ca_system_score_gemma":0.00054801337,"threshold_uncertainty_score":0.99987274},"labels":[],"label_agreement":null},{"id":"W4411420041","doi":"10.1016/j.ard.2025.06.1235","title":"ABS1043 INVESTIGATION OF FACTORS AFFECTING HOME EXERCISE ADHERENCE AFTER TOTAL KNEE ARTHROPLASTY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Total knee arthroplasty; Physical therapy; Arthroplasty; Surgery","score_opus":0.022824922793963694,"score_gpt":0.282996213162518,"score_spread":0.2601712903685543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996561,0.0016898754,0.000015249707,0.0004809724,0.00046329363,0.00052510947,0.00005574129,0.000045848374,0.00016291211],"genre_scores_gemma":[0.9989661,0.00007994482,0.00007276264,0.00011802453,0.0000119162805,0.000022292952,0.000007816087,0.000015307482,0.000705817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864376,0.00008583561,0.00050337584,0.00019438397,0.00035479642,0.00021783984],"domain_scores_gemma":[0.99852306,0.00041375,0.00029030393,0.0005026633,0.00014594302,0.00012430528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013706002,0.00019463366,0.0005203663,0.00014102856,0.000072691655,0.000014403195,0.00009103601,0.00005432408,0.00017038784],"category_scores_gemma":[0.00093486306,0.00012955388,0.0003240114,0.00037662208,0.000319969,0.0001624168,0.00014091087,0.000109901775,0.000017129323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029484628,0.00021839788,0.98214597,0.0021197635,0.00025557936,0.0000024948522,0.0013725861,0.00006529994,0.00028426838,0.00012413485,0.001515662,0.011600978],"study_design_scores_gemma":[0.0006685121,0.00013998777,0.9851923,0.004507802,0.00021640617,0.0000024128299,0.00075317844,0.000065625376,0.0072932937,0.0010437786,0.000007967892,0.000108718144],"about_ca_topic_score_codex":0.000071511415,"about_ca_topic_score_gemma":0.000009080951,"teacher_disagreement_score":0.01149226,"about_ca_system_score_codex":0.0000137235065,"about_ca_system_score_gemma":0.00016821263,"threshold_uncertainty_score":0.5283054},"labels":[],"label_agreement":null},{"id":"W4411420080","doi":"10.1016/j.ard.2025.06.819","title":"POS1475-HPR EXPLORING CHANGES IN BENEFIT STATUS IN THE YEAR BEFORE AND AFTER REHABILITATION: A CASE-CONTROL STUDY.","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Medicine; Rehabilitation; Physical therapy; Gerontology","score_opus":0.04292741164932269,"score_gpt":0.3552770013609667,"score_spread":0.312349589711644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775056,0.00088187854,0.0000023527311,0.020051183,0.00005746286,0.0014042805,0.000050251765,0.000008705733,0.00003824414],"genre_scores_gemma":[0.99756616,0.00014464308,0.000036838795,0.00171406,0.000018892952,0.00049020373,0.0000036786778,0.0000064733704,0.000019016281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989278,0.00014475647,0.0003685963,0.0001364474,0.00021793904,0.00020451657],"domain_scores_gemma":[0.9989905,0.00052508427,0.00008792264,0.00028659907,0.00005887496,0.00005103996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048524066,0.00009681051,0.000255666,0.00018673367,0.000044523484,0.000011485418,0.000069297006,0.000016653288,0.000050396895],"category_scores_gemma":[0.00061189587,0.000056040935,0.000041528783,0.00034077457,0.00005553254,0.000083322644,0.000033983673,0.00007868583,6.9214076e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024785238,0.00031371842,0.8955073,0.0005092287,0.000048344373,0.00003806473,0.013843791,0.0000033575434,4.6469398e-7,0.00024203365,0.00023257999,0.08901329],"study_design_scores_gemma":[0.0021724321,0.0005577865,0.9577974,0.0007115613,0.00010237682,0.0000088484185,0.036942165,0.000044185483,0.0000031627217,0.0015565711,0.00006502808,0.000038458915],"about_ca_topic_score_codex":0.0006838159,"about_ca_topic_score_gemma":0.0048582936,"teacher_disagreement_score":0.08897483,"about_ca_system_score_codex":0.000019224859,"about_ca_system_score_gemma":0.000059265014,"threshold_uncertainty_score":0.2711042},"labels":[],"label_agreement":null},{"id":"W4411420281","doi":"10.1016/j.ard.2025.06.857","title":"POS1514-HPR THE IMPACT OF PARENT AND PATIENT GENDER ON SATISFACTION WITH AN ADVANCED PHYSIOTHERAPIST PRACTITIONER (APP) SHARED CARE MODEL IN PEDIATRIC RHEUMATOLOGY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interprofessional Education and Collaboration","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Rheumatology; Family medicine; Patient satisfaction; Physical therapy; Internal medicine; Alternative medicine; Nursing; Pathology","score_opus":0.03750309391626651,"score_gpt":0.4414588894172664,"score_spread":0.4039557955009999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996189,0.00065806264,0.000051367733,0.0017301121,0.0001663035,0.00080281094,0.00012731756,0.000012425817,0.00026259146],"genre_scores_gemma":[0.9987826,0.0003310744,0.000058974398,0.00050816825,0.000005316643,0.00022701225,0.000031287876,0.000010125269,0.000045491415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860483,0.00045370858,0.000432133,0.00015669006,0.00019898849,0.00015361723],"domain_scores_gemma":[0.9984447,0.0003184209,0.00048820503,0.00031870094,0.00038356354,0.00004641577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009098735,0.00012587698,0.00022781453,0.00011574454,0.00026366432,0.000007691863,0.00011097657,0.000052299743,0.00007047299],"category_scores_gemma":[0.00018354961,0.00006423017,0.00006013915,0.00029555694,0.00005511658,0.0001718094,0.000038329617,0.00014909622,0.0000020771715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057520373,0.0017150595,0.8131357,0.0030880359,0.0002969463,3.0965379e-7,0.067138806,0.055958435,0.00011241323,0.011221787,0.012321505,0.029258963],"study_design_scores_gemma":[0.0005842895,0.00020224022,0.9730982,0.0009911621,0.000027846283,2.1208447e-7,0.016803654,0.004299814,0.0000203134,0.0038889132,0.0000042579577,0.00007905027],"about_ca_topic_score_codex":0.0008059436,"about_ca_topic_score_gemma":0.00033074667,"teacher_disagreement_score":0.15996255,"about_ca_system_score_codex":0.00006555112,"about_ca_system_score_gemma":0.0010467696,"threshold_uncertainty_score":0.26192302},"labels":[],"label_agreement":null},{"id":"W4411420470","doi":"10.1016/j.ard.2025.06.401","title":"POS1047 CLINICAL AND ULTRASOUND FEATURES IN AN INCEPTION COHORT OF TREATMENT NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Cohort; Dermatology; Ultrasound; Internal medicine; Psoriasis; Radiology","score_opus":0.018463197035823695,"score_gpt":0.3303448506574345,"score_spread":0.3118816536216108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948309,0.0039048337,8.3865706e-7,0.00021888335,0.000077499,0.0007226868,0.00009995398,0.000008090749,0.00013633208],"genre_scores_gemma":[0.9951051,0.0045823404,0.000055067903,0.00010424221,0.000007684033,0.000043604927,0.000043334676,0.0000072768876,0.00005134081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990244,0.00009131183,0.00040022188,0.00017899656,0.0001758316,0.00012925948],"domain_scores_gemma":[0.9991656,0.00019975315,0.00015557354,0.00029180787,0.00011859856,0.00006866118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007852858,0.00013383756,0.0005031128,0.000066390174,0.000051959316,0.000008470003,0.000054850174,0.000037460464,0.000017257105],"category_scores_gemma":[0.00024727083,0.00007740073,0.00010196901,0.00015191187,0.00024042426,0.00006538375,0.00002863464,0.000039510775,5.9502594e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050002267,0.0017208307,0.9267779,0.00010758558,0.0003898071,0.0000020110406,0.00017878796,0.0000031255838,0.0000010489846,0.00014127835,0.00014605267,0.07003152],"study_design_scores_gemma":[0.004846503,0.001578576,0.9906293,0.0015796202,0.00029008827,0.0000017223401,0.00026939754,0.0000049678174,0.00004069372,0.00069050613,0.000010702273,0.000057914905],"about_ca_topic_score_codex":0.0002804504,"about_ca_topic_score_gemma":0.00028599813,"teacher_disagreement_score":0.06997361,"about_ca_system_score_codex":0.000020029931,"about_ca_system_score_gemma":0.00007801014,"threshold_uncertainty_score":0.315631},"labels":[],"label_agreement":null},{"id":"W4411420558","doi":"10.1016/j.ard.2025.06.260","title":"POS0905 EARLY MEANINGFUL IMPROVEMENTS IN SPINAL PAIN AND CORRELATION WITH OTHER CLINICAL OUTCOMES IN PATIENTS TREATED WITH FILGOTINIB FOR RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A POST HOC ANALYSIS OF THE PHASE 2 TORTUGA TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Post-hoc analysis; Post hoc; Radiography; Clinical trial; Physical therapy; Axial spondyloarthritis; Subgroup analysis; Double blinded; Internal medicine; Surgery; Confidence interval; Alternative medicine; Pathology; Placebo; Ankylosing spondylitis","score_opus":0.02499772838876637,"score_gpt":0.3413070128346695,"score_spread":0.31630928444590317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587584,0.00016147585,0.00008955127,0.00045827526,0.000055996592,0.0029857936,0.00034161692,0.000009153588,0.00002228186],"genre_scores_gemma":[0.9990955,0.000020498675,0.00009614695,0.0004996605,0.0000047614217,0.00012721411,0.000064170745,0.000014854255,0.00007719081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976929,0.0004302735,0.000924947,0.000275729,0.00046858165,0.00020760625],"domain_scores_gemma":[0.99823546,0.00045139008,0.0005799244,0.00046205425,0.00018421661,0.0000869316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009246189,0.00020078925,0.00082830846,0.00052015047,0.000043866447,0.000019494273,0.00017773826,0.000042534462,0.000025357944],"category_scores_gemma":[0.0014129262,0.00010934054,0.0003924241,0.0011135248,0.00021427344,0.00009887003,0.00005103214,0.000084223306,1.3108422e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07963935,0.0034518086,0.8902141,0.0002805219,0.0022839278,0.0000015448039,0.00012277551,0.000021003545,6.200887e-7,0.00007405882,0.000057868605,0.02385241],"study_design_scores_gemma":[0.0694248,0.0051572793,0.91922295,0.0014136116,0.0031997429,6.252429e-8,0.0001921998,0.0011900351,0.0000029627565,0.00009236365,0.0000058368164,0.000098181634],"about_ca_topic_score_codex":0.00030362658,"about_ca_topic_score_gemma":0.00020772517,"teacher_disagreement_score":0.029008817,"about_ca_system_score_codex":0.000013377573,"about_ca_system_score_gemma":0.000115540475,"threshold_uncertainty_score":0.44587776},"labels":[],"label_agreement":null},{"id":"W4411420593","doi":"10.1016/j.ard.2025.06.382","title":"POS1028 Long-term response to faecal microbiota transplantation in psoriatic arthritis is associated with gut microbiota community types in recipients","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Gut flora; Fecal bacteriotherapy; Immunology; Transplantation; Psoriasis; Reactive arthritis; Microbiome; Arthritis; Clostridium difficile; Microbiology; Bioinformatics; Internal medicine; Biology; Antibiotics","score_opus":0.028436102551313798,"score_gpt":0.3308903143616602,"score_spread":0.30245421181034643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930694,0.0006209996,0.0000035722926,0.004969906,0.000063692154,0.00076907914,0.00041035155,0.000014793213,0.00007819367],"genre_scores_gemma":[0.9974074,0.00095407915,0.00002403702,0.0012430239,0.0000035837913,0.0000472607,0.000095448915,0.000012715353,0.0002124657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980015,0.000833812,0.00044060833,0.00017036256,0.00023846379,0.00031525726],"domain_scores_gemma":[0.9981741,0.0009665054,0.000106901854,0.00047438763,0.00014509469,0.00013304352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006274353,0.00015887718,0.00043836044,0.00034019633,0.00007753934,0.000032958447,0.00028121023,0.00006992552,0.00009939495],"category_scores_gemma":[0.0020412481,0.0001165756,0.00010593078,0.0007890899,0.00009774769,0.00008033031,0.00007651263,0.00021987941,0.000013220376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009373879,0.002468431,0.964043,0.0009936661,0.00029209012,0.000053163953,0.002076021,0.000012434259,0.00596814,0.000007890574,0.004505481,0.010205779],"study_design_scores_gemma":[0.0025169475,0.0002984276,0.9788577,0.01412591,0.00007346692,0.000005008253,0.00008639673,0.000012264855,0.0038334976,0.000077876495,0.000008522754,0.000104001825],"about_ca_topic_score_codex":0.00060653395,"about_ca_topic_score_gemma":0.0013257585,"teacher_disagreement_score":0.014814655,"about_ca_system_score_codex":0.00007515216,"about_ca_system_score_gemma":0.00026058007,"threshold_uncertainty_score":0.4753815},"labels":[],"label_agreement":null},{"id":"W4411420633","doi":"10.1016/j.ard.2025.06.607","title":"POS1257 INHIBITION OF RADIOGRAPHIC PROGRESSION WITH BIMEKIZUMAB TREATMENT OBSERVED IN BDMARD-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AT 2 YEARS: RESULTS FROM A PHASE 3 STUDY AND ITS OPEN-LABEL EXTENSION","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Open label; Internal medicine; Dermatology; Arthritis; Clinical trial","score_opus":0.050487410931535186,"score_gpt":0.3366771507743932,"score_spread":0.286189739842858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897426,0.0056093456,2.9400175e-7,0.00025491545,0.000039440896,0.0034552265,0.000858216,0.000012819034,0.000027168548],"genre_scores_gemma":[0.997681,0.0017231631,0.00006665585,0.000034870092,0.000004088428,0.00022691427,0.00021701804,0.000016523223,0.00002974627],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984388,0.00014858594,0.00048137427,0.00037536462,0.000366129,0.00018976335],"domain_scores_gemma":[0.99872583,0.00017599184,0.00038530328,0.00041126576,0.00021387906,0.00008773567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007844374,0.00023277359,0.00069936813,0.00016281728,0.0001063798,0.00001868387,0.00008518455,0.00003630038,0.000008643921],"category_scores_gemma":[0.00017204652,0.00013244552,0.00006183751,0.00048272422,0.00011147106,0.00015073316,0.00015687245,0.000047227506,7.171163e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07251554,0.056408934,0.28844988,0.00029003894,0.0033759268,0.00016304619,0.0041074515,0.0000074002273,0.000069830276,0.000017820705,0.00023069777,0.5743634],"study_design_scores_gemma":[0.09498054,0.009139878,0.8827269,0.010543636,0.0005942393,0.0000016393601,0.00074599474,0.000052739215,0.00096449716,0.00012835536,0.0000048700776,0.00011671653],"about_ca_topic_score_codex":0.00064807903,"about_ca_topic_score_gemma":0.00041860063,"teacher_disagreement_score":0.594277,"about_ca_system_score_codex":0.000056221612,"about_ca_system_score_gemma":0.00008839864,"threshold_uncertainty_score":0.5400972},"labels":[],"label_agreement":null},{"id":"W4411420706","doi":"10.1016/j.ard.2025.06.458","title":"POS1107 TIMING OF MATERNAL DEXAMETHASONE AND PREGNANCY OUTCOMES IN ANTI-SSA/Ro POSITIVE PREGNANCIES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Medicine; Pregnancy; Dexamethasone; Obstetrics; Gynecology; Internal medicine","score_opus":0.040121798474223064,"score_gpt":0.33066770823519526,"score_spread":0.29054590976097217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534061,0.04240089,0.00003808716,0.0018020618,0.00008996678,0.0005111575,0.00008131586,0.000017549926,0.0016528922],"genre_scores_gemma":[0.9958498,0.0031806193,0.00017672227,0.00018461914,0.0000022476295,0.00001764052,0.000002626069,0.000009115813,0.0005765953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987925,0.000102978505,0.0004819154,0.00018048611,0.00022655763,0.00021553761],"domain_scores_gemma":[0.9987981,0.0004659156,0.00022680151,0.0003559402,0.0001045349,0.000048764978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013094743,0.00017462588,0.00070224644,0.00014012597,0.00006345798,0.000009910802,0.00017345544,0.000046411016,0.000017158338],"category_scores_gemma":[0.00071772793,0.00011287488,0.00017258787,0.00022114482,0.0002847283,0.00010724579,0.00021642825,0.000083754145,8.096965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099122706,0.00033417286,0.9673937,0.002516892,0.0005285547,0.000006260997,0.0010715486,0.000009273323,0.00011583628,0.0012778885,0.00011487402,0.026531858],"study_design_scores_gemma":[0.0008318558,0.00007554865,0.9484436,0.038516607,0.00021805715,0.0000024307171,0.00028118622,0.000074773474,0.007782177,0.0036850364,0.0000030882004,0.000085674794],"about_ca_topic_score_codex":0.0001379393,"about_ca_topic_score_gemma":0.000015247505,"teacher_disagreement_score":0.042443734,"about_ca_system_score_codex":0.000008569417,"about_ca_system_score_gemma":0.00008128185,"threshold_uncertainty_score":0.46029037},"labels":[],"label_agreement":null},{"id":"W4411420777","doi":"10.1016/j.ard.2025.05.1010","title":"POS0630 EXPLORING THE INFLUENCE OF UNILATERAL VS. BILATERAL KNEE OSTEOARTHRITIS ON STRUCTURAL KNEE OUTCOMES: DOES DISEASE BURDEN AFFECT PROGRESSION","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Affect (linguistics); Osteoarthritis; Knee Joint; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Surgery; Pathology; Alternative medicine","score_opus":0.02272425936794766,"score_gpt":0.31065580285968236,"score_spread":0.2879315434917347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936615,0.000896141,4.7078615e-7,0.003335678,0.0004511566,0.0013839903,0.00013355781,0.000058470636,0.00007903059],"genre_scores_gemma":[0.9985481,0.00010053256,0.000026552152,0.0004274581,0.00002696307,0.0002033839,0.000027760321,0.000022701137,0.00061657175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818456,0.00015935663,0.00051749096,0.0002743722,0.0005277637,0.00033645198],"domain_scores_gemma":[0.9983212,0.0002826425,0.00025364838,0.00081917323,0.00014613995,0.00017719944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012517568,0.00030773345,0.0005694312,0.00014051356,0.00019037245,0.00004124646,0.00028618384,0.00004274265,0.000041581123],"category_scores_gemma":[0.00044044308,0.00013766461,0.00043846984,0.0002527772,0.0002433624,0.00023011904,0.00018572122,0.000121480865,0.000006094478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005194207,0.00071849086,0.5430403,0.0030199578,0.0008672328,0.00009251881,0.0019011624,0.0007777072,0.0015327157,0.004575125,0.00025483922,0.43802577],"study_design_scores_gemma":[0.0030004738,0.0018958694,0.9722755,0.011149586,0.00048090456,0.000004530765,0.00022584217,0.000056057102,0.0058477893,0.004814204,0.000053196974,0.00019602553],"about_ca_topic_score_codex":0.00004472754,"about_ca_topic_score_gemma":0.000006970975,"teacher_disagreement_score":0.43782976,"about_ca_system_score_codex":0.00002121346,"about_ca_system_score_gemma":0.0001291976,"threshold_uncertainty_score":0.56137997},"labels":[],"label_agreement":null},{"id":"W4411420820","doi":"10.1016/j.ard.2025.05.821","title":"POS0435 MEASUREMENT OF SYNDEMICS OF RHEUMATIC AND MUSCULOSKELETAL DISEASES IN MAYAN-YUCATECAN INDIGENOUS COMMUNITIES: A NETWORK ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health and Medical Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Indigenous; Family medicine; Gerontology; Ecology","score_opus":0.06836834574093759,"score_gpt":0.44017214924826165,"score_spread":0.37180380350732406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882559,0.0082994085,0.00011864882,0.001589606,0.0002363577,0.0010063766,0.00012880383,0.000014824774,0.00035004597],"genre_scores_gemma":[0.9961693,0.0029339283,0.000046067245,0.0006069385,0.000012478512,0.00013860334,0.00003319125,0.000010274174,0.000049206603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622405,0.0012314506,0.0014331528,0.00013470699,0.00053367525,0.00044294685],"domain_scores_gemma":[0.99634135,0.0015597597,0.00080690085,0.0006567685,0.0003960121,0.00023919753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014814326,0.00016508605,0.0008533198,0.00034472873,0.00026383312,0.0000039538495,0.00040138717,0.00009852871,0.00010246887],"category_scores_gemma":[0.0025554497,0.000119378456,0.00024333915,0.0012377482,0.00029699603,0.000066704604,0.00017566916,0.00024472797,0.0000012701626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015386408,0.001178503,0.9214626,0.020369813,0.0011329502,2.4788443e-7,0.013377192,0.00045732033,0.0000021465105,0.0013186624,0.0027032418,0.037843447],"study_design_scores_gemma":[0.0005449055,0.000081542814,0.9649252,0.008075169,0.0009473222,1.09412e-7,0.01936479,0.00075446744,0.0000050835974,0.0050933794,0.00010058858,0.00010741365],"about_ca_topic_score_codex":0.009247747,"about_ca_topic_score_gemma":0.0016647363,"teacher_disagreement_score":0.04346262,"about_ca_system_score_codex":0.00009355798,"about_ca_system_score_gemma":0.0019486338,"threshold_uncertainty_score":0.99734974},"labels":[],"label_agreement":null},{"id":"W4411420878","doi":"10.1016/j.ard.2025.05.734","title":"POS0347-PARE A NATIONAL SURVEY OF RHEUMATOLOGY TELEPHONE ADVICE LINE SUPPORT IN THE UNITED KINGDOM: USER PERSPECTIVES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society","funders":"","keywords":"Medicine; Advice (programming); Family medicine; Rheumatology; Telephone survey; Medical education; Internal medicine; Advertising","score_opus":0.08688930567767077,"score_gpt":0.3537493399694621,"score_spread":0.26686003429179134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851139,0.00041298976,0.000021002414,0.012565683,0.00016637583,0.00039564483,0.00006202782,0.000045070352,0.0012172834],"genre_scores_gemma":[0.9984094,0.000062727915,0.000010359168,0.0013241475,0.00001258122,0.00003506773,0.000055940767,0.000009878036,0.000079919715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843854,0.00017328425,0.0006462319,0.00018595559,0.00032823006,0.00022773929],"domain_scores_gemma":[0.9976485,0.0005721922,0.00048266925,0.0003880187,0.000899872,0.000008791819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011448088,0.00014301206,0.0004042941,0.00054436544,0.0001010701,0.000032576107,0.0006633529,0.00007913929,0.000084735024],"category_scores_gemma":[0.0037571476,0.0000886226,0.00010933643,0.001845699,0.00019225848,0.00018201304,0.00019298961,0.000120826095,0.000011549345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013842151,0.0008241565,0.69886607,0.002308424,0.00024376756,0.0000024134824,0.00045969567,0.00012953754,0.0000047348444,0.2598613,0.03457364,0.002587855],"study_design_scores_gemma":[0.00052267703,0.000020063822,0.97926193,0.0007972858,0.00003292728,0.0000031675095,0.0021615452,0.00092186837,0.000010481391,0.010810269,0.005333833,0.0001239429],"about_ca_topic_score_codex":0.047385115,"about_ca_topic_score_gemma":0.003981441,"teacher_disagreement_score":0.28039587,"about_ca_system_score_codex":0.000013437689,"about_ca_system_score_gemma":0.00019558161,"threshold_uncertainty_score":0.95895845},"labels":[],"label_agreement":null},{"id":"W4411420903","doi":"10.1016/j.ard.2025.05.845","title":"POS0463 High-Resolution Computerized Tomography Chest Radiographic Patterns and their Impact on Systemic Sclerosis-associated Interstitial Lung Disease Survival","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Interstitial lung disease; Radiography; High-resolution computed tomography; Radiology; Lung; Scleroderma (fungus); Disease; High resolution; Computed tomography; Pathology; Internal medicine","score_opus":0.024549750721013675,"score_gpt":0.27361050449175356,"score_spread":0.24906075377073988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411420903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830056,0.012906475,0.00017311747,0.0011305653,0.0007267193,0.000975189,0.0009233562,0.00012049826,0.000038467937],"genre_scores_gemma":[0.99535143,0.003905154,0.0000032351954,0.00043483052,0.000048903123,0.00005580061,0.00014260228,0.000030018791,0.000028043243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976713,0.00044966672,0.00069627806,0.0003912639,0.00040765136,0.00038384672],"domain_scores_gemma":[0.9978464,0.00046202028,0.0004039922,0.0006880305,0.00019537761,0.00040416216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029347307,0.0004113601,0.00088707224,0.0004218345,0.00021373783,0.00007683453,0.0003076307,0.00011540773,0.000030731695],"category_scores_gemma":[0.00032585583,0.00022885222,0.000995748,0.00068468397,0.0002544078,0.000097041906,0.00014045514,0.00015573717,0.0000019850672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046702945,0.003418543,0.9456714,0.0056137573,0.008113654,0.000013475618,0.0005232254,0.00054797786,0.0012267425,0.0007506076,0.009597931,0.019852398],"study_design_scores_gemma":[0.002470775,0.00016758063,0.9487467,0.041892573,0.00087978033,0.0000036829076,0.00029659847,0.0050232555,0.00010436509,0.00021163368,0.0000017845388,0.00020129453],"about_ca_topic_score_codex":0.00041107723,"about_ca_topic_score_gemma":0.0000044047574,"teacher_disagreement_score":0.036278814,"about_ca_system_score_codex":0.000064620996,"about_ca_system_score_gemma":0.00016883526,"threshold_uncertainty_score":0.93323225},"labels":[],"label_agreement":null},{"id":"W4411421207","doi":"10.1016/j.ard.2025.05.707","title":"POS0320 TREATMENT WITH ANIFROLUMAB PREVENTS LONG-TERM ORGAN DAMAGE COMPARED TO REAL-WORLD STANDARD OF CARE: FINDINGS FROM THE LASER STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Standard of care; Term (time); Intensive care medicine; Dermatology; Immunology; Internal medicine","score_opus":0.19208416898351452,"score_gpt":0.43065040839189317,"score_spread":0.23856623940837865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411421207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97921824,0.0009276995,0.000060593502,0.014574909,0.00016987797,0.002055519,0.002545115,0.000019951693,0.00042807948],"genre_scores_gemma":[0.99740136,0.00014599926,0.00009746741,0.0012828639,0.000021834967,0.00013020709,0.000051349758,0.000021629447,0.00084728166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966568,0.00039639542,0.0021381832,0.000375432,0.00017844872,0.0002547605],"domain_scores_gemma":[0.9963244,0.0010676141,0.001243983,0.0011158079,0.00012594099,0.00012221218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014897836,0.00021926216,0.0011258436,0.00016470473,0.00020578597,0.000068199835,0.0006425157,0.00003060649,0.00021007564],"category_scores_gemma":[0.0006695141,0.00015704644,0.00017696769,0.00037120105,0.000095013624,0.00015385736,0.00013633419,0.00005612766,0.000047040234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026386784,0.0006052253,0.98053217,0.0003498801,0.0006856114,5.540942e-7,0.005972811,0.00019896097,3.2958638e-7,0.0010539175,0.009991661,0.00034499183],"study_design_scores_gemma":[0.0014706496,0.00046977348,0.99116397,0.0009773986,0.00011075806,9.074843e-8,0.0033323737,0.00006349495,0.00006347583,0.0019321466,0.0002604025,0.00015544584],"about_ca_topic_score_codex":0.006519669,"about_ca_topic_score_gemma":0.0071793827,"teacher_disagreement_score":0.018183112,"about_ca_system_score_codex":0.00023231459,"about_ca_system_score_gemma":0.0002790472,"threshold_uncertainty_score":0.9855833},"labels":[],"label_agreement":null},{"id":"W4411421224","doi":"10.1016/j.ard.2025.05.967","title":"POS0585 SEX DIFFERENCES IN THE SAFETY PROFILE OF JANUS KINASE INHIBITORS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE JAK-POT INTERNATIONAL COLLABORATION","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Janus kinase; Rheumatoid arthritis; Janus kinase inhibitor; Tofacitinib; Dermatology; Janus; Internal medicine; Receptor","score_opus":0.03913187294183144,"score_gpt":0.34826958363718125,"score_spread":0.3091377106953498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411421224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95409966,0.00488347,0.000004394149,0.036209513,0.00028275725,0.001176597,0.001067875,0.000011623418,0.002264087],"genre_scores_gemma":[0.99419147,0.0048540127,0.000023670631,0.00048523565,0.00003136473,0.00012180476,0.000098937766,0.000008995929,0.00018452776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997189,0.0005721246,0.00092246255,0.00023826574,0.0008596317,0.0002185389],"domain_scores_gemma":[0.99705356,0.0016778888,0.00029360937,0.0006636425,0.0002626136,0.00004870154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010220476,0.00015055067,0.00039378268,0.00015012622,0.00007802686,0.00005002365,0.0007034239,0.00005968439,0.00009579675],"category_scores_gemma":[0.0044359853,0.00007935435,0.00012000763,0.0008565631,0.0003155479,0.000108685526,0.00017212443,0.00021811169,0.000004974396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049640443,0.002904773,0.6597156,0.00078794075,0.00058894284,0.000030758,0.019642083,0.0002448434,0.00039147487,0.0034244622,0.09149797,0.21580714],"study_design_scores_gemma":[0.002778013,0.00012142569,0.96832824,0.010090091,0.000022801387,0.0000017549612,0.009307841,0.0010944768,0.0027934585,0.0043941964,0.0009550383,0.00011264414],"about_ca_topic_score_codex":0.0024222042,"about_ca_topic_score_gemma":0.0010763395,"teacher_disagreement_score":0.3086127,"about_ca_system_score_codex":0.000058065278,"about_ca_system_score_gemma":0.00065309496,"threshold_uncertainty_score":0.53106093},"labels":[],"label_agreement":null},{"id":"W4411421244","doi":"10.1016/j.ard.2025.06.694","title":"POS1345 APREMILAST REDUCES MRI INFLAMMATION IN INDIVIDUAL JOINTS AND CLINICAL DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: DYNAMIC CONTRAST-ENHANCED MRI (DCE-MRI) RESULTS FROM THE PHASE 4 MOSAIC STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dactylitis; Psoriatic arthritis; Apremilast; Dynamic contrast-enhanced MRI; Magnetic resonance imaging; Radiology; Dynamic contrast; Pathology; Psoriasis; Enthesitis; Dermatology","score_opus":0.02142679563925757,"score_gpt":0.34006066987797673,"score_spread":0.31863387423871914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411421244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892803,0.0040333676,0.000017072498,0.0030609374,0.00015924458,0.0025370582,0.0008436666,0.000025458445,0.000042907177],"genre_scores_gemma":[0.9896336,0.009765583,0.000046925838,0.00012657368,0.000022530712,0.00011681918,0.00025030485,0.000019492203,0.000018169718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961823,0.0008191963,0.0013870372,0.00044729383,0.00076875795,0.0003954027],"domain_scores_gemma":[0.99708325,0.0014696318,0.00042837474,0.0006505942,0.00020881603,0.00015933948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000989882,0.00026942504,0.00078420027,0.000196706,0.00013127945,0.00010459743,0.00036601897,0.00007435465,0.000030831394],"category_scores_gemma":[0.0028885792,0.00016429441,0.000121515455,0.00047306434,0.00044859725,0.00029828202,0.00017008097,0.0003251436,0.0000039613715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0108790845,0.0072357105,0.5298322,0.00017436175,0.0014850486,0.000019638339,0.008924194,0.000071198505,0.000026454098,0.000054028777,0.0016736948,0.43962443],"study_design_scores_gemma":[0.02936894,0.0011409508,0.95722014,0.0069696526,0.000059961578,8.1418654e-7,0.0027485264,0.00063274725,0.00017139324,0.0015089103,0.00002145103,0.00015653673],"about_ca_topic_score_codex":0.00046693443,"about_ca_topic_score_gemma":0.0020649864,"teacher_disagreement_score":0.43946788,"about_ca_system_score_codex":0.000030619096,"about_ca_system_score_gemma":0.0002738569,"threshold_uncertainty_score":0.66997313},"labels":[],"label_agreement":null},{"id":"W4411421315","doi":"10.1016/j.ard.2025.05.118","title":"OP0096 Impact of sonelokimab, a novel IL-17A- and IL-17F-inhibiting Nanobody, on multidomain clinical outcomes in active psoriatic arthritis: results from the randomized, double-blind, placebo-controlled Phase 2 ARGO trial","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Double blind; Internal medicine; Placebo-controlled study; Randomized controlled trial; Arthritis; Physical therapy; Immunology; Alternative medicine; Pathology","score_opus":0.05849382257027811,"score_gpt":0.37139902831729904,"score_spread":0.3129052057470209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411421315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870086,0.003312856,0.000021063755,0.0009899046,0.0007503484,0.0041234666,0.0036537312,0.000024929583,0.000115145296],"genre_scores_gemma":[0.99751765,0.0014986184,0.00003746338,0.00012960828,0.000039380557,0.0004140827,0.00018488061,0.00001763346,0.00016066169],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99501026,0.0020096903,0.00199077,0.00045382624,0.00013999124,0.00039549443],"domain_scores_gemma":[0.97836345,0.019576056,0.0012656756,0.0006298706,0.00011389548,0.000051066672],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021636654,0.0004188987,0.002400469,0.00017711786,0.00020738838,0.00003263444,0.00041936318,0.00023596984,0.000038210976],"category_scores_gemma":[0.008883831,0.0002161778,0.0015277693,0.00023966664,0.0005748466,0.00011322573,0.00016092032,0.00024109083,0.00000963088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93721277,0.003467983,0.000657252,0.000025797302,0.006353874,0.000002257162,0.00069916906,0.00004561045,0.000215179,0.00024771862,0.00044667115,0.050625723],"study_design_scores_gemma":[0.98458624,0.0005365007,0.0075862883,0.0013645062,0.0012089667,0.0000012973856,0.00050571526,0.00012547862,0.002476355,0.0013995817,0.000009042157,0.00020005673],"about_ca_topic_score_codex":0.001163565,"about_ca_topic_score_gemma":0.00013250494,"teacher_disagreement_score":0.050425667,"about_ca_system_score_codex":0.000027361673,"about_ca_system_score_gemma":0.0003091677,"threshold_uncertainty_score":0.99946475},"labels":[],"label_agreement":null},{"id":"W4411421342","doi":"10.1016/j.ard.2025.05.479","title":"POS0082 EXPLORING THE GENETIC BASIS OF CLINICAL HETEROGENEITY IN GIANT CELL ARTERITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Giant cell arteritis; Medicine; Genetic heterogeneity; Arteritis; Evolutionary biology; Pathology; Genetics; Vasculitis; Phenotype; Disease; Biology; Gene","score_opus":0.08581147978890828,"score_gpt":0.3593802345402535,"score_spread":0.2735687547513452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411421342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906131,0.0036009047,0.00002272769,0.0045949724,0.00020570698,0.00029036356,0.000053114618,0.000009395873,0.00060969003],"genre_scores_gemma":[0.9946798,0.0046537705,0.00006043344,0.00041244723,0.000014255029,0.00004086979,0.000005173091,0.0000070674964,0.0001261629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986491,0.00017658775,0.0007058806,0.00013355783,0.00018911136,0.00014571303],"domain_scores_gemma":[0.9989146,0.00025157953,0.00016043353,0.000528298,0.00007887829,0.00006618236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021972178,0.00009104443,0.00038148323,0.000066293185,0.00005665723,0.0000074871537,0.00020154567,0.000039727856,0.00006806185],"category_scores_gemma":[0.00035750904,0.000050371407,0.00045585132,0.00024341012,0.00018452336,0.000036552356,0.00008283529,0.00011592932,0.0000054340453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003339313,0.005046537,0.5379108,0.003700308,0.0021816073,0.000057742884,0.0011586486,0.0007309472,0.0005300449,0.0019211936,0.01657788,0.42985034],"study_design_scores_gemma":[0.0007095231,0.000070583956,0.9930005,0.0016943146,0.00023169247,0.000004491732,0.0002203665,0.00030499825,0.0023294613,0.0012667602,0.0001176215,0.00004966479],"about_ca_topic_score_codex":0.00009483232,"about_ca_topic_score_gemma":0.00001627521,"teacher_disagreement_score":0.4550897,"about_ca_system_score_codex":0.0000051258894,"about_ca_system_score_gemma":0.00011238119,"threshold_uncertainty_score":0.20540863},"labels":[],"label_agreement":null},{"id":"W4411422034","doi":"10.1016/j.ard.2025.05.308","title":"OP0306 ANAEROBICIDAL ANTIBIOTIC USE AND RISK OF GOUT FLARES: TARGET TRIAL EMULATION FOR POTENTIAL ROLE OF THE MICROBIOME IN GOUT WITH CHRONIC KIDNEY DISEASE (CKD)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Kidney disease; Microbiome; Internal medicine; Intensive care medicine; Bioinformatics","score_opus":0.012892038069615896,"score_gpt":0.2658537419183972,"score_spread":0.2529617038487813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411422034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927355,0.0029677642,0.00013936976,0.0008842181,0.00014661041,0.0021561224,0.0009443706,0.000013620577,0.00001239264],"genre_scores_gemma":[0.9990281,0.00038114097,0.00021721798,0.00012706335,0.000030111874,0.000022332963,0.00005609808,0.000023161225,0.00011481332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823505,0.00021113492,0.00068548083,0.0002730865,0.0003316721,0.00026356798],"domain_scores_gemma":[0.9980214,0.00027706113,0.00060083956,0.0007428422,0.00020043981,0.00015739407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000269987,0.00022378076,0.0006312378,0.00017723026,0.00008784636,0.00002110931,0.0002812479,0.00007314576,0.00001829038],"category_scores_gemma":[0.0018112753,0.00013009796,0.00032878754,0.00044122906,0.00035841702,0.00015616567,0.00015362218,0.00010778876,5.079636e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044816885,0.0033710126,0.91323364,0.008217122,0.0029109041,0.000004964825,0.0010947833,0.00512463,0.013325451,0.0004048061,0.004269487,0.0032263056],"study_design_scores_gemma":[0.026410196,0.0006246738,0.9424826,0.005619497,0.0028834504,0.0000029014457,0.0003058476,0.0084059425,0.011599112,0.0013507952,0.0000912374,0.00022377471],"about_ca_topic_score_codex":0.0004749247,"about_ca_topic_score_gemma":0.000024638672,"teacher_disagreement_score":0.029248925,"about_ca_system_score_codex":0.00004093197,"about_ca_system_score_gemma":0.0007583627,"threshold_uncertainty_score":0.53052413},"labels":[],"label_agreement":null},{"id":"W4411422331","doi":"10.1016/j.ard.2025.06.246","title":"POS0891 REAL-WORLD EFFECTIVENESS OF UPADACITINIB ON EARLY PAIN CONTROL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: INTERIM RESULTS FROM THE UPSTAND OBSERVATIONAL STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Observational study; Interim; Interim analysis; Pain control; Physical therapy; Axial spondyloarthritis; Medical physics; Internal medicine; Randomized controlled trial; Ankylosing spondylitis; Surgery; Sacroiliitis","score_opus":0.040189695921266366,"score_gpt":0.31782213258487046,"score_spread":0.2776324366636041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411422331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948044,0.00033970605,0.0000064115247,0.00071066327,0.00011012379,0.0020002732,0.0016877676,0.00001219176,0.00032849854],"genre_scores_gemma":[0.99933934,0.000046539357,0.000009435961,0.00031273803,0.000012169972,0.000117899195,0.00009862921,0.000013240558,0.000049993316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977819,0.00072204194,0.0005658617,0.0002554172,0.000486375,0.00018840774],"domain_scores_gemma":[0.9960636,0.0028536855,0.0002731805,0.0005125122,0.00025004175,0.00004701173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006159605,0.00019907717,0.00060178497,0.00009082135,0.0000994566,0.000016496568,0.00019186016,0.000026039885,0.000017594237],"category_scores_gemma":[0.0012157899,0.00010674374,0.00014716799,0.00037229483,0.00017782138,0.00006198508,0.00006637212,0.00009216532,0.0000013711093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023198916,0.003148418,0.96489,0.000098933,0.00086110225,0.000007693156,0.000439881,0.000022553204,0.0000025145632,0.0003429221,0.0003004562,0.0066865906],"study_design_scores_gemma":[0.020830898,0.0019666501,0.9687669,0.006738069,0.00020574675,8.469676e-8,0.00040586083,0.000014562255,0.000046566372,0.00092881435,0.000014951166,0.00008088877],"about_ca_topic_score_codex":0.002139806,"about_ca_topic_score_gemma":0.00065776723,"teacher_disagreement_score":0.006639136,"about_ca_system_score_codex":0.000034499368,"about_ca_system_score_gemma":0.00010450972,"threshold_uncertainty_score":0.43528834},"labels":[],"label_agreement":null},{"id":"W4411422605","doi":"10.1016/j.ard.2025.05.115","title":"OP0093 Effectiveness of Combination csDMARD Therapy in Psoriatic Arthritis Using Data from the MONITOR-PsA Cohort","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Cohort; Oncology; Internal medicine; Arthritis","score_opus":0.0615779596448154,"score_gpt":0.3586757050365792,"score_spread":0.2970977453917638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411422605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756221,0.022118604,0.000015907099,0.00055804796,0.00027774024,0.00096124347,0.00031870295,0.000009253373,0.000118400654],"genre_scores_gemma":[0.9918223,0.007903904,0.00003086625,0.00010026688,0.000013037298,0.00004187982,0.00006791164,0.0000094832785,0.000010319717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865925,0.00030206487,0.0003651824,0.00019504158,0.00033984592,0.00013861636],"domain_scores_gemma":[0.9977344,0.0010568134,0.0001789091,0.0008439449,0.00015731007,0.000028624705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042072017,0.00013172132,0.0004908548,0.000051460258,0.00009088977,0.000012884464,0.00030685088,0.000032102067,0.000023561732],"category_scores_gemma":[0.00090686406,0.00007757226,0.00011990071,0.00029153057,0.00014465998,0.00008649846,0.00018465938,0.00005691817,0.000001542049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005814789,0.0012884183,0.8947468,0.00030676773,0.0013190021,0.0000040514215,0.00014667954,0.000028192351,0.000079261954,0.00025680056,0.0006727064,0.10056985],"study_design_scores_gemma":[0.0032810268,0.00011757649,0.98319376,0.0062708575,0.00020788841,7.9451223e-7,0.00019086454,0.0004986322,0.0010470996,0.0051116813,0.000022215521,0.000057599806],"about_ca_topic_score_codex":0.002083997,"about_ca_topic_score_gemma":0.000061508355,"teacher_disagreement_score":0.10051225,"about_ca_system_score_codex":0.000027851582,"about_ca_system_score_gemma":0.00010641123,"threshold_uncertainty_score":0.3163305},"labels":[],"label_agreement":null},{"id":"W4411424561","doi":"10.1016/j.ard.2025.06.1840","title":"ABS0383 PREGNANCY OUTCOMES IN PATIENTS EXPOSED TO VOCLOSPORIN: A SUMMARY OF AVAILABLE DATA FROM CLINICAL TRIALS AND POST-MARKETING SOURCES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Pregnancy; Clinical trial; Family medicine; Medical physics; Obstetrics; Intensive care medicine; Internal medicine","score_opus":0.21242790489851823,"score_gpt":0.43343810630644747,"score_spread":0.22101020140792924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411424561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98583764,0.009115341,0.0000063537937,0.0027864198,0.0001904894,0.00093830575,0.0007440599,0.000014561911,0.00036685623],"genre_scores_gemma":[0.9965821,0.0012368461,0.00014261018,0.0009842252,0.000010574111,0.000014630557,0.00011290983,0.000009587187,0.00090652314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710447,0.000675372,0.0014193966,0.00028862967,0.00033323336,0.00017892878],"domain_scores_gemma":[0.99344856,0.0043332623,0.0006367972,0.0012296414,0.00015814991,0.00019361306],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0022696077,0.00014081344,0.0010185624,0.00012726683,0.000034435594,0.000010233586,0.00044138258,0.00006212502,0.00014302845],"category_scores_gemma":[0.05387972,0.000087682325,0.0001746296,0.0002066633,0.00012055014,0.000104955994,0.0003800891,0.00009271976,0.0000060310754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000751666,0.0009792269,0.927902,0.0006865608,0.00036072155,7.317279e-7,0.0002169887,8.2501816e-7,0.000021412387,0.000009898545,0.010026495,0.05904349],"study_design_scores_gemma":[0.0024182682,0.00012384068,0.97546065,0.020789754,0.00027670275,6.93852e-8,0.00019227064,0.00006248761,0.00026315489,0.000233862,0.000106282234,0.00007266196],"about_ca_topic_score_codex":0.00016725168,"about_ca_topic_score_gemma":0.0000112173475,"teacher_disagreement_score":0.058970828,"about_ca_system_score_codex":0.0000068926165,"about_ca_system_score_gemma":0.0002843366,"threshold_uncertainty_score":0.9540899},"labels":[],"label_agreement":null},{"id":"W4411424563","doi":"10.1016/j.ard.2025.06.1794","title":"ABS1149 INTERIM ANALYSIS OF A EUROPEAN REAL-WORLD STUDY ON THE EFFECTIVENESS, PHYSICIAN SATISFACTION, AND PATIENT CHARACTERISTICS IN AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: INSIGHTS FROM GERMANY, SPAIN, AND THE UNITED KINGDOM","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Interim analysis; Axial spondyloarthritis; Family medicine; Interim; Patient satisfaction; Alternative medicine; Physical therapy; Ankylosing spondylitis; Internal medicine; Surgery; Pathology","score_opus":0.022873483217547733,"score_gpt":0.2869235948700102,"score_spread":0.26405011165246245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411424563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757236,0.0005089082,0.0000015431607,0.00039644443,0.000034637844,0.0010482246,0.00016774671,0.000012378026,0.00025775735],"genre_scores_gemma":[0.99913347,0.0004701473,0.0000016769064,0.0002720034,0.00000701143,0.00006032805,0.00003404038,0.00001322991,0.000008119588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812895,0.0008861141,0.00041061811,0.0002224018,0.00022802036,0.00012388201],"domain_scores_gemma":[0.9980115,0.0010913608,0.00028802696,0.00044098074,0.000128213,0.000039893675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017239823,0.0002024417,0.0007089339,0.00029976547,0.0001571446,0.000027664373,0.00008370592,0.000015288504,0.000007772299],"category_scores_gemma":[0.0002150833,0.00009268947,0.0001230675,0.0010499082,0.0003841634,0.000036512407,0.00011137454,0.000085997635,5.926616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057962458,0.0012624076,0.9630432,0.00010099969,0.006146687,0.000037854352,0.002406381,0.0000139975655,0.000033631226,0.0013125109,0.00003677563,0.019809274],"study_design_scores_gemma":[0.0039373715,0.0005313604,0.98990893,0.002096776,0.0019344634,4.9697104e-7,0.0010783381,0.00014247613,0.00007633485,0.00019830704,0.00001779756,0.00007736639],"about_ca_topic_score_codex":0.007628264,"about_ca_topic_score_gemma":0.001586237,"teacher_disagreement_score":0.026865676,"about_ca_system_score_codex":0.000020950267,"about_ca_system_score_gemma":0.000024184847,"threshold_uncertainty_score":0.99898005},"labels":[],"label_agreement":null},{"id":"W4411424572","doi":"10.1016/j.ard.2025.06.1745","title":"ABS0602 SACROILIITIS RATE IN PATIENTS WITH PSORIASIS BASED ON MRI FINDINGS AND THE ASAS DEFINITION FOR ACTIVE SACROILIITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sacroiliitis; Medicine; Psoriasis; Dermatology; Axial spondyloarthritis; Internal medicine; Arthritis","score_opus":0.015774873344233845,"score_gpt":0.26842793659407005,"score_spread":0.2526530632498362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411424572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934483,0.00053081545,0.000016229693,0.003659198,0.00008181323,0.0012607718,0.0004119545,0.000011506016,0.0005794057],"genre_scores_gemma":[0.99818254,0.00040573746,0.000062176936,0.0009374443,0.0000053474314,0.00026001275,0.000045856617,0.000011833376,0.00008906419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991113,0.00008118629,0.0002399108,0.00018924092,0.00019047532,0.00018792051],"domain_scores_gemma":[0.99868065,0.0007630169,0.00011506544,0.00026674804,0.0001309813,0.000043532727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012583668,0.00015544503,0.00038429876,0.00008440112,0.00017087339,0.000018631881,0.000077389384,0.000030040186,0.000021843998],"category_scores_gemma":[0.0005540638,0.00008154051,0.00013968475,0.00020640164,0.00022673035,0.000052444604,0.00003645578,0.000052639123,0.0000016431429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05028662,0.00537947,0.7593022,0.0022644391,0.0029946892,0.000014929536,0.0013332483,0.00015310553,0.000003379349,0.01702935,0.010052065,0.15118653],"study_design_scores_gemma":[0.017598677,0.0005278296,0.9736376,0.0027593633,0.00031910857,3.4519283e-7,0.00014192789,0.00016105502,0.00020361334,0.004447145,0.00011939253,0.00008395085],"about_ca_topic_score_codex":0.00006727847,"about_ca_topic_score_gemma":0.000036404464,"teacher_disagreement_score":0.21433543,"about_ca_system_score_codex":0.000025692565,"about_ca_system_score_gemma":0.000057476438,"threshold_uncertainty_score":0.33251253},"labels":[],"label_agreement":null},{"id":"W4411424905","doi":"10.1016/j.ard.2025.06.1064","title":"ABS0080 THREE YEARS REAL WORLD PERSISTENCE DATA OF FRESENIUS KABI – ADALIMUMAB BIOSIMILAR (FK-ada), MSB11022, IN INFLAMMATORY ARTHRITIS (IA)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adalimumab; Biosimilar; Persistence (discontinuity); Arthritis; Etanercept; Immunology; Antirheumatic Agents; Inflammatory arthritis; Internal medicine; Rheumatoid arthritis","score_opus":0.06645904673448745,"score_gpt":0.3440475213404774,"score_spread":0.27758847460598995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411424905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95777166,0.034944896,0.000008130635,0.003626448,0.00018663018,0.0007146222,0.00046746785,0.000040993553,0.0022391418],"genre_scores_gemma":[0.96029365,0.038952935,0.000119609125,0.0002051134,0.00002169804,0.000033042157,0.000052907242,0.000023191655,0.0002978673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973399,0.00022668041,0.0008083515,0.00037097195,0.0008097586,0.0004443239],"domain_scores_gemma":[0.99706995,0.0005012775,0.0002583703,0.0017918469,0.00019557831,0.00018294758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006793136,0.00021682405,0.0006888844,0.00042673113,0.000087594766,0.00003998488,0.0010472963,0.000062644016,0.00023074873],"category_scores_gemma":[0.0013962492,0.00017460545,0.00025847883,0.00070346135,0.00068967836,0.00026802928,0.0005880399,0.00020815573,0.00001201799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026921136,0.0022697786,0.58528996,0.0030947253,0.001681404,0.00016324119,0.0011701861,0.00009071714,0.0007841996,0.0063870833,0.07865452,0.31772205],"study_design_scores_gemma":[0.0031538066,0.00018140297,0.97242385,0.012160377,0.00004281821,0.000008887627,0.0007893935,0.00089546596,0.0013063762,0.0055166343,0.0032764217,0.00024456764],"about_ca_topic_score_codex":0.0008320203,"about_ca_topic_score_gemma":0.0024463194,"teacher_disagreement_score":0.38713387,"about_ca_system_score_codex":0.000025958345,"about_ca_system_score_gemma":0.0005855026,"threshold_uncertainty_score":0.71202034},"labels":[],"label_agreement":null},{"id":"W4411424936","doi":"10.1016/j.ard.2025.06.1140","title":"ABS1110 CLINICAL CHARACTERISTICS AND EVOLUTION OF INTERSTITIAL LUNG DISEASE IN A RETROSPECTIVE ANALYSIS OF PATIENTS WITH ANTISYNTHETASE SYNDROME, ANTI-MDA5 SYNDROME, AND SCLEROMYOSITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Antisynthetase syndrome; Medicine; Interstitial lung disease; MDA5; Lung; Retrospective cohort study; Disease; Dermatology; Pathology; Internal medicine","score_opus":0.008644191206152682,"score_gpt":0.2777277122406889,"score_spread":0.2690835210345362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411424936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739015,0.00078575633,0.000101740254,0.00020428289,0.00006734311,0.00045586313,0.00096593524,0.000009141662,0.000019776477],"genre_scores_gemma":[0.99936086,0.00046028759,0.000037308317,0.000062080435,0.000002830038,0.000009678202,0.000048277347,0.000009936266,0.00000872728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982895,0.00014543903,0.00085294456,0.00024255957,0.00030516865,0.00016438453],"domain_scores_gemma":[0.9985186,0.0001879225,0.0005013699,0.0003963337,0.00026080245,0.00013500548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022549683,0.0001668269,0.0010354628,0.00042546281,0.00005077844,0.0000122282745,0.00010433146,0.000053640924,0.000020143758],"category_scores_gemma":[0.0004576295,0.00011908028,0.00021975012,0.00065893336,0.0005300146,0.00012282227,0.00013038183,0.000097054595,1.966014e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059018476,0.0005531881,0.9947415,0.0015528548,0.0012421958,0.00003615319,0.00007437801,0.00000945597,0.000003148454,0.00032909992,0.00007326501,0.00079454767],"study_design_scores_gemma":[0.0011980529,0.00018912017,0.98830956,0.0044300365,0.0024633456,0.000006480507,0.00006377233,0.0030804034,0.000016177544,0.00014073543,0.0000012918537,0.00010099512],"about_ca_topic_score_codex":0.000101325604,"about_ca_topic_score_gemma":0.000009973938,"teacher_disagreement_score":0.00643194,"about_ca_system_score_codex":0.00002637919,"about_ca_system_score_gemma":0.00012485961,"threshold_uncertainty_score":0.4855953},"labels":[],"label_agreement":null},{"id":"W4411425393","doi":"10.1016/j.ard.2025.06.683","title":"POS1334 ACHIEVEMENT OF PROTEINURIA TARGETS =0.4 g/g IN LUPUS NEPHRITIS: A POST HOC ANALYSIS OF THE AURORA 1 STUDY OF VOCLOSPORIN","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Lupus nephritis; Proteinuria; Post-hoc analysis; Nephritis; Post hoc; Internal medicine; Immunology; Kidney; Disease","score_opus":0.016845958139972774,"score_gpt":0.30375156693085287,"score_spread":0.2869056087908801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411425393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988806,0.007853962,0.0000019998338,0.0013306155,0.00009286553,0.0014973144,0.00031559519,0.0000069873604,0.000094664734],"genre_scores_gemma":[0.99916685,0.000405424,0.000018831222,0.00012900885,0.000004656204,0.000063362495,0.000012892899,0.000010009999,0.00018894482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976323,0.00025501545,0.0010457034,0.00020578587,0.00066591,0.00019525815],"domain_scores_gemma":[0.99782056,0.00014693395,0.00067613303,0.0009063745,0.00037461155,0.000075406955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027838245,0.00018662278,0.0010018215,0.0003791835,0.00004042688,0.000006451034,0.00041399206,0.000038100625,0.00005492195],"category_scores_gemma":[0.00068035565,0.000106779946,0.0006904009,0.001736324,0.00020693014,0.00005896542,0.00023690925,0.000081677375,4.844037e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026086848,0.011402611,0.95837796,0.0048206407,0.006439784,0.000008565726,0.0030718124,0.0006838946,0.0007788056,0.0006734433,0.00076337747,0.010370451],"study_design_scores_gemma":[0.0014240807,0.0007396809,0.98524034,0.0032226513,0.0028691238,4.3511545e-7,0.0039885426,0.00016799924,0.0016073822,0.000643769,0.000012874058,0.00008311785],"about_ca_topic_score_codex":0.0013264751,"about_ca_topic_score_gemma":0.0002754982,"teacher_disagreement_score":0.026862413,"about_ca_system_score_codex":0.000015789945,"about_ca_system_score_gemma":0.00021510535,"threshold_uncertainty_score":0.43543598},"labels":[],"label_agreement":null},{"id":"W4411425692","doi":"10.1016/j.ard.2025.06.778","title":"POS1431 CIRCULATING CD14+ MONOCYTES DISPLAY A PRO-MIGRATORY AND PRO-INFLAMMATORY PHENOTYPE IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Interstitial lung disease; CD14; Phenotype; Immunology; Lung; Arthritis; Inflammation; Pathology; Internal medicine; Immune system; Gene","score_opus":0.01089239156590277,"score_gpt":0.25966634087129126,"score_spread":0.2487739493053885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411425692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97883564,0.019721074,0.00020620022,0.00024409565,0.00008269211,0.00065678207,0.00010820564,0.000025484338,0.00011981819],"genre_scores_gemma":[0.998667,0.0007982644,0.00005033053,0.00017983097,0.000015694064,0.00011260497,0.00006942604,0.000031379943,0.000075467105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983235,0.0002291095,0.0004779863,0.0003987178,0.00024663916,0.00032403346],"domain_scores_gemma":[0.9987566,0.000094879135,0.00028005108,0.0005604248,0.00012743907,0.00018061973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002338842,0.00026734482,0.00030999663,0.00009229309,0.00012805183,0.00005548927,0.0003442852,0.000079813835,0.000009779766],"category_scores_gemma":[0.0012125886,0.00021248446,0.00015685215,0.00020552347,0.0003126988,0.000025257776,0.00028044748,0.0001061212,9.745994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090054696,0.0007712685,0.9741301,0.0010716553,0.00071175833,0.00004498729,0.0003894548,0.00062930974,0.0043876255,0.0020982942,0.0017688512,0.013096182],"study_design_scores_gemma":[0.0023880973,0.00011912369,0.9722947,0.00824262,0.0001641748,0.00000457288,0.00046415723,0.0052297255,0.007943496,0.0024139637,0.00010688463,0.0006284935],"about_ca_topic_score_codex":0.000019889105,"about_ca_topic_score_gemma":0.00007480343,"teacher_disagreement_score":0.019831354,"about_ca_system_score_codex":0.000023744355,"about_ca_system_score_gemma":0.0003578069,"threshold_uncertainty_score":0.8664865},"labels":[],"label_agreement":null},{"id":"W4411425995","doi":"10.1016/j.ard.2025.06.474","title":"POS1123 Myositis Community Proposes a Framework to Guide Clinical Trials and Ensure Patient Safety during Influx of CAR-Based Therapies","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University; McMaster University; Western University","funders":"","keywords":"Medicine; Myositis; Clinical trial; Intensive care medicine; Medical emergency; Medical physics; Physical therapy; Physical medicine and rehabilitation; Pathology","score_opus":0.10906606922843677,"score_gpt":0.4587433349540313,"score_spread":0.34967726572559454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411425995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96473485,0.002166647,0.00023944752,0.031739634,0.000141381,0.00075835397,0.0001107923,0.000018166738,0.00009073739],"genre_scores_gemma":[0.996764,0.0006042492,0.0005539983,0.0019717317,0.000017253256,0.000014676887,0.000010835671,0.000008092714,0.000055173594],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996876,0.0013490302,0.0011623787,0.00011837356,0.00036667206,0.00012755489],"domain_scores_gemma":[0.99556345,0.0030150395,0.00040627553,0.0005496453,0.0003176899,0.00014792976],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021006975,0.00012160707,0.000735899,0.00008927741,0.00016151265,0.00001232797,0.00015747559,0.00015033486,0.000031859312],"category_scores_gemma":[0.010265716,0.00006899107,0.00029601395,0.00025303123,0.000701787,0.000024477677,0.00014599765,0.00026281978,4.9294414e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00643761,0.0046837702,0.1522979,0.013076513,0.0034892608,0.0000049331106,0.009127884,0.00023523695,0.0018857572,0.01020759,0.0063665905,0.792187],"study_design_scores_gemma":[0.0011351409,0.0004636156,0.9711564,0.009709925,0.00032904395,9.81918e-7,0.0008187214,0.00013551555,0.0035286797,0.012170115,0.00045857704,0.000093285984],"about_ca_topic_score_codex":0.00023546499,"about_ca_topic_score_gemma":0.0000128023885,"teacher_disagreement_score":0.8188585,"about_ca_system_score_codex":0.000010836031,"about_ca_system_score_gemma":0.0002873425,"threshold_uncertainty_score":0.99807125},"labels":[],"label_agreement":null},{"id":"W4411426019","doi":"10.1016/j.ard.2025.06.520","title":"POS1170 DECIPHERING DIFFICULT-TO-TREAT PSORIATIC ARTHRITIS (D2T-PsA): INSIGHTS FROM AN INTERNATIONAL GRAPPA PATIENT SURVEY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Canadian Arthritis Network; Arthritis Research Centre of Canada; Arthritis Society","funders":"","keywords":"Medicine; Psoriatic arthritis; Dermatology; Psoriasis; Family medicine; Medical physics","score_opus":0.01705040123242437,"score_gpt":0.3144056722411564,"score_spread":0.29735527100873205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411426019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939877,0.0020333482,0.00014471175,0.002034099,0.00053084455,0.0005837698,0.00017789505,0.000034006167,0.00047362302],"genre_scores_gemma":[0.9981573,0.00058251957,0.00014677209,0.0007240631,0.000023129794,0.000048638387,0.00020360717,0.000014527157,0.00009939985],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99849606,0.0001934458,0.00048971036,0.00026140446,0.00040154048,0.00015786938],"domain_scores_gemma":[0.9985323,0.00033235556,0.00014387367,0.0005123184,0.00031895927,0.00016020008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008392579,0.00017164726,0.00035406125,0.00012320287,0.000092826354,0.000036545054,0.00024329456,0.00004702518,0.000114919356],"category_scores_gemma":[0.0015806858,0.00011158853,0.000216644,0.00036255908,0.00008604898,0.00014266928,0.00010438888,0.00006310868,0.0000126879595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007645289,0.0036392268,0.14122097,0.00076355785,0.0008355899,0.000004636397,0.0031655917,0.000703816,0.0005208769,0.0016816374,0.008769718,0.83792984],"study_design_scores_gemma":[0.0007708053,0.0002144482,0.9909742,0.0018396964,0.0000788272,3.519986e-7,0.0004585236,0.00057412375,0.00025161938,0.004533894,0.00018407402,0.00011942006],"about_ca_topic_score_codex":0.001222448,"about_ca_topic_score_gemma":0.00029320896,"teacher_disagreement_score":0.84975326,"about_ca_system_score_codex":0.00002178641,"about_ca_system_score_gemma":0.00008581578,"threshold_uncertainty_score":0.45504484},"labels":[],"label_agreement":null},{"id":"W4411426123","doi":"10.1016/j.ard.2025.06.1387","title":"ABS0537 EARLY IMPROVEMENT OF PAIN, LONG-TERM DISEASE CONTROL, AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Quality of life (healthcare); Term (time); Pain control; Arthritis; Physical therapy; Internal medicine; Surgery","score_opus":0.016383559944064808,"score_gpt":0.2792863265252516,"score_spread":0.2629027665811868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411426123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947424,0.0030419757,0.000009985391,0.00048111117,0.000021153191,0.0011799637,0.00048439286,0.0000098469045,0.00002918294],"genre_scores_gemma":[0.99912333,0.00045121822,0.000014197549,0.00024751242,0.0000022775612,0.000078579076,0.000026768234,0.0000118085845,0.000044327797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984297,0.00011210699,0.0006701722,0.00019776975,0.00039573008,0.00019450599],"domain_scores_gemma":[0.9984635,0.00030226223,0.0004259768,0.00040630074,0.000260656,0.00014130666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016018482,0.00020155824,0.0009181967,0.000095711745,0.00004441967,0.0000079487345,0.000086336644,0.000023858433,0.000017311648],"category_scores_gemma":[0.00061236,0.000112395384,0.0001358199,0.00019332935,0.0002558972,0.000065651344,0.000046829606,0.000040608917,2.3852897e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039244327,0.0020610138,0.97119963,0.0012300464,0.0012531186,0.0000033341103,0.000082572784,0.000002677067,0.000002281981,0.000091083464,0.000025454348,0.020124355],"study_design_scores_gemma":[0.016809657,0.0012524402,0.977209,0.0040079528,0.00036686411,6.1425915e-8,0.000092643844,0.000005732147,0.00004769261,0.000114527385,4.5379912e-7,0.00009297531],"about_ca_topic_score_codex":0.00055355823,"about_ca_topic_score_gemma":0.00014873706,"teacher_disagreement_score":0.02003138,"about_ca_system_score_codex":0.000012897675,"about_ca_system_score_gemma":0.00010924642,"threshold_uncertainty_score":0.45833507},"labels":[],"label_agreement":null},{"id":"W4411426356","doi":"10.1016/j.ard.2025.06.026","title":"POS0665 APREMILAST IMPROVES PATIENT-REPORTED PAIN REGARDLESS OF SEX AND AGE IN EARLY OLIGOARTICULAR PSORIATIC ARTHRITIS: A POST-HOC ANALYSIS FROM FOREMOST","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Apremilast; Psoriatic arthritis; Post-hoc analysis; Dermatology; Physical therapy; Post hoc; Arthritis; Internal medicine","score_opus":0.011702256737199733,"score_gpt":0.260099416221658,"score_spread":0.24839715948445826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411426356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822157,0.016266046,0.000011918156,0.0005427849,0.000057971367,0.0005919009,0.00018805175,0.000015962205,0.00010964141],"genre_scores_gemma":[0.99797416,0.0014456457,0.00009638479,0.00030603926,0.00000586441,0.000053814274,0.000055149754,0.000012191179,0.0000507473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826396,0.00016327786,0.00075466663,0.0002729268,0.00030913216,0.0002360333],"domain_scores_gemma":[0.99853337,0.0003151018,0.0003348094,0.00055174297,0.00016881958,0.00009616955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018825407,0.0001971251,0.00088337564,0.00021465067,0.00006670519,0.000020047164,0.00010409663,0.00005207327,0.000015124832],"category_scores_gemma":[0.0009382906,0.00014200498,0.00035027022,0.00064201705,0.0001783093,0.00006694119,0.00012650668,0.00006148735,6.4850093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00122114,0.0018056768,0.5989593,0.00074800075,0.010642074,0.00016698902,0.0041536335,0.000026026453,0.00042857748,0.00012564719,0.00036647258,0.38135642],"study_design_scores_gemma":[0.0030700818,0.00059781957,0.9849795,0.0032900458,0.002042488,0.000002154792,0.002276781,0.00034083176,0.0010344664,0.0022119426,0.000017773908,0.0001360987],"about_ca_topic_score_codex":0.0016944883,"about_ca_topic_score_gemma":0.00059140136,"teacher_disagreement_score":0.38602018,"about_ca_system_score_codex":0.000016145606,"about_ca_system_score_gemma":0.00006799974,"threshold_uncertainty_score":0.5790795},"labels":[],"label_agreement":null},{"id":"W4411426663","doi":"10.1016/j.ard.2025.06.102","title":"POS0742 THE EFFECT OF DISEASE ACTIVITY ON CARDIOVASCULAR RISK VARIES ACCORDING TO RHEUMATOID FACTOR AND ANTICITRULLINATED PROTEIN ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Rheumatoid arthritis; Rheumatoid factor; Internal medicine; Antibody; Immunology; Risk factor","score_opus":0.00815709446966491,"score_gpt":0.272468165774519,"score_spread":0.2643110713048541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411426663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857035,0.010040837,0.00006393457,0.0005181544,0.00007213823,0.003133587,0.00040285688,0.0000356726,0.000029313187],"genre_scores_gemma":[0.98047197,0.01925611,0.000022702183,0.00004348204,0.000003995991,0.00014307557,0.000016373313,0.000032693988,0.000009615259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967489,0.0008166205,0.00053033617,0.00040815244,0.000944007,0.0005519704],"domain_scores_gemma":[0.9973305,0.00085575366,0.00026735247,0.0010021302,0.00022988027,0.00031437606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054190046,0.00036725204,0.0011177238,0.00031882862,0.0002603132,0.000075946766,0.0003041602,0.00005419686,0.00001712],"category_scores_gemma":[0.0032471048,0.00019830733,0.0003757751,0.0007158215,0.00047710774,0.00019667788,0.00021506184,0.0002619753,0.0000028139523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008861849,0.0005725622,0.893157,0.0009116737,0.0013731063,0.0000050854155,0.00030592445,0.0001577472,0.00007550491,0.00017329364,0.000058062793,0.09434821],"study_design_scores_gemma":[0.005127383,0.0015338071,0.97623754,0.012066761,0.000038466827,8.259887e-7,0.00014902273,0.00011560532,0.004089988,0.00037836068,0.00006580349,0.00019644025],"about_ca_topic_score_codex":0.0007755946,"about_ca_topic_score_gemma":0.000022687487,"teacher_disagreement_score":0.094151765,"about_ca_system_score_codex":0.000029398052,"about_ca_system_score_gemma":0.0002318933,"threshold_uncertainty_score":0.8086738},"labels":[],"label_agreement":null},{"id":"W4411426729","doi":"10.1016/j.ard.2025.05.359","title":"OP0357-HPR A Syndemic Care Model for the Management of Rheumatic and Musculoskeletal Diseases in Indigenous Maya-Yucatec Populations: A Mixed-Methods Study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; Alberta Health Services","funders":"","keywords":"Medicine; Syndemic; Indigenous; Family medicine; Traditional medicine; Human immunodeficiency virus (HIV)","score_opus":0.029964759671594985,"score_gpt":0.4116813503153999,"score_spread":0.38171659064380487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411426729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702548,0.01972169,0.0040828693,0.0010630455,0.00012411366,0.004594895,0.00009351237,0.000021037593,0.000044081],"genre_scores_gemma":[0.996013,0.0009770279,0.0020351976,0.000074513315,0.0000037506086,0.00073527446,0.000027217018,0.000019314082,0.00011472627],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982203,0.00023913512,0.0007344947,0.00026812396,0.0003053706,0.00023257731],"domain_scores_gemma":[0.9983084,0.000558319,0.0002593856,0.00064958713,0.00015332154,0.00007093757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004230335,0.00021205499,0.0005337604,0.00020859088,0.00017412243,0.000017991952,0.0002679609,0.00004653403,0.000007297623],"category_scores_gemma":[0.00048070133,0.000123854,0.00037780093,0.00043174083,0.00020696646,0.00008259557,0.00017184716,0.00007760835,3.5957487e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046087947,0.0043181465,0.13811415,0.04508717,0.0018797864,0.0000012744486,0.014193661,0.007245788,0.000010511256,0.004628552,0.00052608846,0.783534],"study_design_scores_gemma":[0.0015865546,0.00028108264,0.9214969,0.0030666545,0.0014612516,5.588408e-7,0.027458536,0.023443133,0.0000042991282,0.021063862,0.0000051272614,0.00013204338],"about_ca_topic_score_codex":0.00023176157,"about_ca_topic_score_gemma":0.00006773412,"teacher_disagreement_score":0.78340197,"about_ca_system_score_codex":0.000031111307,"about_ca_system_score_gemma":0.00013159995,"threshold_uncertainty_score":0.505062},"labels":[],"label_agreement":null},{"id":"W4411426894","doi":"10.1016/j.ard.2025.06.433","title":"POS1079 Pharmacodynamic Response of JNJ-77242113 in Serum and Skin of Patients with Moderate-to-Severe Psoriasis: 1-Year Results from FRONTIER 1 & 2","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Pharmacodynamics; Dermatology; Internal medicine; Pharmacokinetics","score_opus":0.03141363814608031,"score_gpt":0.34225722225325744,"score_spread":0.31084358410717716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411426894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922787,0.0014708822,0.000016306196,0.0040917727,0.000080626065,0.0004967239,0.0012904871,0.000006910719,0.00026759107],"genre_scores_gemma":[0.99826586,0.00074209925,0.00020307604,0.00053091836,0.0000056836648,0.000011923838,0.000020311925,0.0000098658975,0.00021026707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985117,0.00026196757,0.0005285285,0.00020238713,0.0003221877,0.00017324834],"domain_scores_gemma":[0.9981881,0.0008948814,0.0002816512,0.00033204074,0.00019927393,0.00010406079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033305158,0.00014555504,0.00050526496,0.00010456811,0.000041371724,0.000008156785,0.00015692065,0.000035169498,0.00005505479],"category_scores_gemma":[0.0015088524,0.00009113109,0.000084253275,0.0003014086,0.00012259888,0.00010308312,0.00015415912,0.00009520808,0.0000020370771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3730378,0.0045691817,0.5379189,0.0024498808,0.003650392,0.0000057012253,0.0042106663,0.0008839525,0.00042448484,0.00012449623,0.018171053,0.054553464],"study_design_scores_gemma":[0.006493582,0.0001765095,0.98747414,0.0020214813,0.0004205856,1.7982347e-7,0.00037549596,0.0005729396,0.0011041753,0.00067775144,0.00057620765,0.00010696703],"about_ca_topic_score_codex":0.0003499537,"about_ca_topic_score_gemma":0.00003808138,"teacher_disagreement_score":0.4495552,"about_ca_system_score_codex":0.000012996166,"about_ca_system_score_gemma":0.00009226192,"threshold_uncertainty_score":0.37162182},"labels":[],"label_agreement":null},{"id":"W4411426977","doi":"10.1016/j.ard.2025.05.172","title":"OP0151 UPREGULATION OF TYPE 1 INTERFERON STIMULATED GENES IN CIRCULATING INNATE IMMUNE CELLS PRECEDES THE ONSET OF SUBCLINICAL SYNOVITIS IN ANTI-CCP+ AT-RISK INDIVIDUALS WHO IMMINENTLY PROGRESS TO RHEUMATOID ARTHRITIS.","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Immunology; Innate immune system; Subclinical infection; Synovitis; Interferon; Downregulation and upregulation; Immune system; Gene; Internal medicine; Genetics","score_opus":0.016184672603186928,"score_gpt":0.28813040867710316,"score_spread":0.27194573607391626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411426977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93630403,0.062087197,0.000007965245,0.00032608514,0.00030614994,0.0007702464,0.00016113582,0.000015343314,0.000021870192],"genre_scores_gemma":[0.9960766,0.0036977192,0.000010442409,0.00003440406,5.596613e-7,0.00003483832,0.000068880276,0.000014946,0.000061624036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969335,0.000779042,0.001554673,0.00027027936,0.00011588024,0.00034661096],"domain_scores_gemma":[0.99760634,0.0007901469,0.00080124993,0.0006165318,0.00017600057,0.000009725204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008952261,0.00023117459,0.00079617766,0.00027665196,0.00013636406,0.000014981193,0.0006753603,0.00015620208,0.00006978863],"category_scores_gemma":[0.0009424551,0.00016660766,0.00022475088,0.0008399737,0.0005821123,0.00010641412,0.00043074277,0.00020241173,0.0000084652065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015754562,0.0027732493,0.75271094,0.0010020786,0.0011012172,0.0000020249422,0.008048767,0.020192254,0.05884803,0.0005532729,0.00030202445,0.15289068],"study_design_scores_gemma":[0.0013489544,0.00018325276,0.91433454,0.005305615,0.00004388499,0.0000022799402,0.000916737,0.0004045398,0.07671097,0.00053633505,0.000043370135,0.0001695312],"about_ca_topic_score_codex":0.0008532917,"about_ca_topic_score_gemma":0.000048224505,"teacher_disagreement_score":0.16162358,"about_ca_system_score_codex":0.000018831151,"about_ca_system_score_gemma":0.0001280426,"threshold_uncertainty_score":0.67940634},"labels":[],"label_agreement":null},{"id":"W4411427382","doi":"10.1016/j.ard.2025.05.264","title":"OP0254 MICROBIOTA AND CLINICAL RESPONSES TO BIOLOGICAL TREATMENT IN AXIAL SPONDYLOARTHRITIS: INSIGHTS FROM 2 YEAR FOLLOW UP OF THE GESPIC COHORT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Western Hospital","funders":"","keywords":"Medicine; Axial spondyloarthritis; Cohort; Cohort study; Physical therapy; Ankylosing spondylitis; Internal medicine; Sacroiliitis","score_opus":0.04840919819488753,"score_gpt":0.3464966512048356,"score_spread":0.29808745300994804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411427382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879945,0.008051895,5.54544e-7,0.0021393907,0.00033986187,0.00096407323,0.0003331159,0.00001032617,0.00016629927],"genre_scores_gemma":[0.9953274,0.0036203621,0.000049321592,0.0004428651,0.000018722056,0.00005114874,0.0000133887515,0.000007793899,0.00046898142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985625,0.00026348702,0.0005618521,0.00027616203,0.00016039253,0.0001755811],"domain_scores_gemma":[0.99861014,0.0005870132,0.00013469433,0.0005099998,0.000069364,0.00008879054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110218956,0.00017567964,0.000666155,0.000079655125,0.000082980805,0.000010611997,0.00016922149,0.000075739415,0.000038528786],"category_scores_gemma":[0.0009753807,0.00008996802,0.0003265745,0.00025763208,0.00031026508,0.000023850384,0.00022216768,0.000063409876,0.0000055381283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021293792,0.0010249518,0.9778718,0.000038379818,0.0007083797,0.000012802014,0.00022804645,5.514909e-7,0.00014500313,0.00022178597,0.0011065718,0.016512398],"study_design_scores_gemma":[0.004193065,0.0006084368,0.99066806,0.001595195,0.00024708256,0.0000021491715,0.00025677122,0.0000025692061,0.00079220335,0.0008954273,0.0006656494,0.00007340417],"about_ca_topic_score_codex":0.0005562493,"about_ca_topic_score_gemma":0.0003090625,"teacher_disagreement_score":0.016438995,"about_ca_system_score_codex":0.00002605633,"about_ca_system_score_gemma":0.0001395077,"threshold_uncertainty_score":0.36687896},"labels":[],"label_agreement":null},{"id":"W4411427447","doi":"10.1016/j.ard.2025.06.1783","title":"ABS1071 MUSCULOSKELETAL MANIFESTATIONS OF ENTEROPATHIC ARTHRITIS VARY IN RELATION TO INFLAMMATORY BOWEL DISEASE BEHAVIOUR, LOCALIZATION, AND EXTENT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Inflammatory bowel disease; Arthritis; Disease; Inflammatory arthritis; Musculoskeletal disease; Dermatology; Immunology; Internal medicine","score_opus":0.009775558358133174,"score_gpt":0.2806917268835895,"score_spread":0.27091616852545636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411427447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454165,0.0022607779,0.0005113834,0.0017181961,0.000103684964,0.00062674267,0.00007321744,0.000021343312,0.00014299543],"genre_scores_gemma":[0.9982714,0.0008845696,0.000047374506,0.0006073278,0.000009123241,0.00005935724,0.000029252104,0.0000122084375,0.00007938784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863803,0.00011792396,0.0006546385,0.0001692446,0.00026813423,0.0001520292],"domain_scores_gemma":[0.99899256,0.000084997475,0.0001833612,0.00037088373,0.00018612666,0.0001820607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018643579,0.00013238026,0.00026374575,0.00023463627,0.00008010823,0.000013611586,0.00009705193,0.000040631483,0.00004279578],"category_scores_gemma":[0.0005091345,0.00010970751,0.00014020488,0.00022633467,0.00013160467,0.00013270303,0.00009747283,0.00006973818,0.000004367766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020466713,0.00035276174,0.9850316,0.0022623446,0.000058692458,0.00006361087,0.000549744,0.00073214975,0.00003377912,0.003396404,0.0017436653,0.0055705793],"study_design_scores_gemma":[0.00063831004,0.00005878853,0.9906385,0.0045675174,0.000115840376,0.000011213398,0.00023961964,0.0012801317,0.000093030874,0.0022290966,0.00004161306,0.00008635809],"about_ca_topic_score_codex":0.000044784225,"about_ca_topic_score_gemma":0.000016074286,"teacher_disagreement_score":0.0056068785,"about_ca_system_score_codex":0.000019588839,"about_ca_system_score_gemma":0.00017941212,"threshold_uncertainty_score":0.44737422},"labels":[],"label_agreement":null},{"id":"W4411427508","doi":"10.1016/j.ard.2025.06.1723","title":"ABS0273 NEW PATHOGENIC PATHWAYS IN ANKYLOSING SPONDYLITIS IDENTIFIED THROUGH MULTI-ANCESTRY GENOMEWIDE ASSOCIATION STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Ankylosing spondylitis; Spondylitis; Association (psychology); Genetic association; Genome-wide association study; Bioinformatics; Genetics; Immunology; Single-nucleotide polymorphism; Genotype; Biology; Gene","score_opus":0.08850241347290908,"score_gpt":0.3585714617548236,"score_spread":0.27006904828191447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411427508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839958,0.013038692,0.00002745696,0.0008880263,0.00037960327,0.0009630956,0.00021233858,0.000031861233,0.0004631275],"genre_scores_gemma":[0.9964595,0.0009179868,0.00013419829,0.00034820253,0.000023172963,0.0000684435,0.000031487478,0.00001453956,0.0020025065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998357,0.0001292972,0.00056355336,0.00027186394,0.00036893564,0.00030935006],"domain_scores_gemma":[0.99884737,0.00022055201,0.0002821167,0.0004626773,0.00011515125,0.00007216078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020882151,0.0001867629,0.00052661664,0.00008955041,0.00013238538,0.000032157903,0.00016297697,0.00005313883,0.00012441303],"category_scores_gemma":[0.0007809675,0.00014108207,0.00025689628,0.00046403724,0.000040552655,0.00013143313,0.00013215965,0.000095648604,0.000014437378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023672334,0.0030206165,0.9677357,0.00025777108,0.0011677442,0.00006612155,0.003185275,0.000018387884,0.00007774875,0.00033634622,0.002470221,0.021427335],"study_design_scores_gemma":[0.003610917,0.00012848852,0.9890052,0.0013191699,0.00036680914,0.0000016663861,0.002593929,0.000018414548,0.0001508799,0.0025443516,0.00015622114,0.000103940554],"about_ca_topic_score_codex":0.0008643992,"about_ca_topic_score_gemma":0.0002117792,"teacher_disagreement_score":0.021323396,"about_ca_system_score_codex":0.00011029619,"about_ca_system_score_gemma":0.00019079828,"threshold_uncertainty_score":0.57531595},"labels":[],"label_agreement":null},{"id":"W4411427811","doi":"10.1016/j.ard.2025.06.1289","title":"ABS0470 POST INTRAVESICAL BCG REACTIVE ARTHRITIS: CLINICAL FEATURES AND OUTCOMES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Medicine; Reactive arthritis; Arthritis; Internal medicine; Dermatology","score_opus":0.025645644095351482,"score_gpt":0.3716555970422276,"score_spread":0.34600995294687614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411427811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95691806,0.009165208,0.00000442063,0.031124964,0.00023534065,0.00043176263,0.00009175344,0.000043027117,0.0019854815],"genre_scores_gemma":[0.99159837,0.0018804523,0.00009840195,0.005470438,0.00003520034,0.000016062773,0.0000105034005,0.000013127002,0.00087745953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985821,0.00013821684,0.0005447696,0.00024259186,0.00028536143,0.00020690821],"domain_scores_gemma":[0.9979259,0.0009911829,0.00017049053,0.0005501261,0.00018588502,0.00017643356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023904731,0.00017009475,0.0006408374,0.00008189601,0.000076551034,0.000025136787,0.00018252998,0.000088664885,0.000050293565],"category_scores_gemma":[0.004282663,0.000107004606,0.00030866434,0.00015154091,0.0005097368,0.00008567505,0.00016169166,0.00020153285,0.000009611181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058369717,0.001603039,0.52455413,0.00080681674,0.0014684625,0.000037525562,0.0003815913,8.1985047e-7,0.00006161133,0.0128479665,0.046007156,0.4116472],"study_design_scores_gemma":[0.0009927105,0.000169357,0.9862675,0.0018401988,0.00021354093,0.000029109555,0.00019986015,0.000010380256,0.00050710206,0.0095573915,0.00012492658,0.00008792339],"about_ca_topic_score_codex":0.0000757665,"about_ca_topic_score_gemma":0.000011727544,"teacher_disagreement_score":0.46171337,"about_ca_system_score_codex":0.000008642444,"about_ca_system_score_gemma":0.00017721114,"threshold_uncertainty_score":0.51270574},"labels":[],"label_agreement":null},{"id":"W4411427817","doi":"10.1016/j.ard.2025.06.1221","title":"ABS0648 EFFECT OF SPINOPELVIC MOBILITY AND FUNCTIONAL SAFE ZONE ALIGNMENT ON PATIENT-REPORTED OUTCOMES IN TOTAL HIP ARTHROPLASTY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Arthroplasty; Total hip arthroplasty; Total hip replacement; Surgery; Physical therapy","score_opus":0.017361630065219735,"score_gpt":0.2844536927095473,"score_spread":0.26709206264432755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411427817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972832,0.00045095687,0.000010873095,0.00082423375,0.00030969028,0.0006813148,0.00007897338,0.000012273147,0.00034845155],"genre_scores_gemma":[0.99934494,0.00010035748,0.00000854068,0.00024700043,0.0000067706014,0.000028859564,0.000012695699,0.000006912044,0.00024392454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852365,0.00011810055,0.00058758276,0.00020846444,0.0003828593,0.00017933507],"domain_scores_gemma":[0.9988123,0.00044198622,0.000234839,0.00036938084,0.00005442971,0.000087018925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023337586,0.00017398561,0.0005516489,0.000108652974,0.00005178527,0.0000063923903,0.00003883635,0.000039922645,0.00014475426],"category_scores_gemma":[0.00063689874,0.000099252866,0.00019072348,0.00014746483,0.00020253315,0.00003918408,0.00008503473,0.00007855447,0.0000036152287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013119759,0.0012204235,0.8964245,0.0009965191,0.00039534486,0.0000099152185,0.00008701717,0.000112190195,0.000067025714,0.00020662951,0.0010586513,0.098109856],"study_design_scores_gemma":[0.0021824795,0.00072891003,0.99370193,0.0012885062,0.00014093705,0.000010841335,0.000075165946,0.00010649067,0.0014623094,0.00015325213,0.00007306351,0.00007612081],"about_ca_topic_score_codex":0.00007811985,"about_ca_topic_score_gemma":0.000007537336,"teacher_disagreement_score":0.09803373,"about_ca_system_score_codex":0.000015139376,"about_ca_system_score_gemma":0.00009884719,"threshold_uncertainty_score":0.40474147},"labels":[],"label_agreement":null},{"id":"W4411428019","doi":"10.1016/j.ard.2025.06.775","title":"POS1427 ALTERED MITOCHONDRIAL BIOENERGETICS IN HYPOPHOSPHATASIA AND THE INFLUENCE OF EFZIMFOTASE ALFA","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Alkaline Phosphatase Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Bioenergetics; Hypophosphatasia; Energy metabolism; Internal medicine; Endocrinology; Mitochondrion; Biochemistry; Alkaline phosphatase; Enzyme; Biology","score_opus":0.01792156189327901,"score_gpt":0.33087153914195355,"score_spread":0.31294997724867457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9371161,0.0501764,0.000004724596,0.011473362,0.0001320034,0.00077134086,0.00025370662,0.000009288029,0.00006310426],"genre_scores_gemma":[0.9869666,0.01216798,0.00009373256,0.00057074666,0.000016499218,0.000038951097,0.000015234644,0.000008656973,0.00012160559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984292,0.00017456507,0.00056299526,0.0001802767,0.0004120693,0.00024093573],"domain_scores_gemma":[0.99795514,0.0008851994,0.00021303663,0.00064379314,0.00021857907,0.00008426003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032000866,0.00015683731,0.00055956165,0.000111911155,0.0000766214,0.000013057394,0.00031252162,0.000032632317,0.000011491117],"category_scores_gemma":[0.004706979,0.00008225185,0.000165075,0.00047213113,0.0011073266,0.000069669484,0.00037665348,0.00011461615,0.0000015798137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02921855,0.0076998724,0.33912304,0.025604649,0.009401702,0.00008516015,0.0062611583,0.0047552655,0.0029820474,0.13566236,0.2598262,0.17937997],"study_design_scores_gemma":[0.010961248,0.0002642357,0.91266125,0.0071362313,0.00072069024,0.000007678247,0.00089506793,0.0014233779,0.011829749,0.053006735,0.0008412107,0.00025251074],"about_ca_topic_score_codex":0.0005661623,"about_ca_topic_score_gemma":0.00002062273,"teacher_disagreement_score":0.57353824,"about_ca_system_score_codex":0.000011320812,"about_ca_system_score_gemma":0.00020551596,"threshold_uncertainty_score":0.5635033},"labels":[],"label_agreement":null},{"id":"W4411428084","doi":"10.1016/j.ard.2025.06.862","title":"ABS0046 THE EVOLVING ROLE OF JANUS KINASE INHIBITORS (JAKI) IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): AN INTERNATIONAL DELPHI STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Janus kinase; Tofacitinib; Janus; Musculoskeletal disease; Immunology; Internal medicine; Rheumatoid arthritis; Disease","score_opus":0.02332043944249353,"score_gpt":0.3379624829299438,"score_spread":0.3146420434874503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930434,0.002862855,0.000003423566,0.002998772,0.00013537622,0.00056576025,0.000028415969,0.000014298502,0.0003476852],"genre_scores_gemma":[0.99930185,0.00031526253,0.000016801268,0.0002566022,0.000021645452,0.00003577817,0.0000063004773,0.0000035571263,0.000042228112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830383,0.00021502798,0.000543317,0.00022286607,0.0005258024,0.00018915765],"domain_scores_gemma":[0.9987013,0.0005152194,0.00019516548,0.00032993447,0.00010470866,0.00015367339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004721093,0.00013955162,0.00036304156,0.000092221635,0.00009002837,0.000025562496,0.000456228,0.000035170964,0.00023316167],"category_scores_gemma":[0.0028428305,0.00006141048,0.00015065304,0.0003346117,0.0004969926,0.00012982923,0.00024954055,0.00009536905,0.0000018858234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013666201,0.0029753305,0.8617574,0.0004105769,0.00018150399,0.0000039981983,0.0006998244,0.000020036012,0.000104204984,0.00087516353,0.000347665,0.13248762],"study_design_scores_gemma":[0.00060649356,0.00033340332,0.982675,0.0011125995,0.0001279128,0.0000011050611,0.0039162147,0.0018018481,0.00006391964,0.009262026,0.00002671328,0.000072736104],"about_ca_topic_score_codex":0.00036613544,"about_ca_topic_score_gemma":0.000040880797,"teacher_disagreement_score":0.13241489,"about_ca_system_score_codex":0.000010881692,"about_ca_system_score_gemma":0.000097459706,"threshold_uncertainty_score":0.34033388},"labels":[],"label_agreement":null},{"id":"W4411428233","doi":"10.1016/j.ard.2025.06.1517","title":"ABS0324 IMPROVEMENT IN COGNITIVE PERFORMANCE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Cognition; Tumor necrosis factor alpha; TNF inhibitor; Internal medicine; Immunology; Physical therapy; Bioinformatics; Etanercept; Psychiatry","score_opus":0.010919238466972736,"score_gpt":0.2615250286238638,"score_spread":0.25060579015689105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388665,0.003654163,0.000002860238,0.0004581179,0.00003459487,0.0012323846,0.000051091516,0.00002317471,0.0006569611],"genre_scores_gemma":[0.98536843,0.014136869,0.0000133057965,0.00017278221,0.0000034065613,0.00015648403,0.000034802415,0.000019032452,0.0000948605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825144,0.00007732498,0.0004958265,0.00025413942,0.0005239062,0.00039735218],"domain_scores_gemma":[0.99902093,0.0001326148,0.00015471708,0.0003205464,0.0002558831,0.000115321396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016469593,0.00022154601,0.0005088474,0.00031710134,0.000075538475,0.000028632414,0.00015173132,0.000039430313,0.00006245829],"category_scores_gemma":[0.00021025077,0.00013103377,0.000080578975,0.00068820873,0.0003027131,0.00020388147,0.000071022885,0.00015944538,0.000005290668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021843226,0.001176579,0.85363126,0.00030132834,0.00018968506,0.000006182154,0.00023704699,0.000017492122,0.000004244522,0.000051311657,0.00023538507,0.14196514],"study_design_scores_gemma":[0.009136855,0.0011894328,0.96044093,0.026255226,0.000007275004,0.0000016780309,0.0004684279,0.000086496584,0.0020994134,0.00011723414,0.000048664686,0.00014836896],"about_ca_topic_score_codex":0.00027219922,"about_ca_topic_score_gemma":0.00020441902,"teacher_disagreement_score":0.14181677,"about_ca_system_score_codex":0.000035582856,"about_ca_system_score_gemma":0.00024986573,"threshold_uncertainty_score":0.5343402},"labels":[],"label_agreement":null},{"id":"W4411428363","doi":"10.1016/j.ard.2025.06.1547","title":"ABS0512 STABLE PATIENT-REPORTED OUTCOMES DESPITE IMPROVING CLINICAL OUTCOMES OVER 25 YEARS. THE EARLY UNDIFFERENTIATED POLYARTHRITIS (EUPA) COHORT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centres Intégré Universitaires de Santé et de Services Sociaux; Eion (Canada); Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Polyarthritis; Cohort; Cohort study; Pediatrics; Physical therapy; Arthritis; Internal medicine; Family medicine","score_opus":0.07229156528176861,"score_gpt":0.4084682779557413,"score_spread":0.3361767126739727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879189,0.0035345093,0.000012990058,0.0063594566,0.0006244798,0.00081380067,0.00007422434,0.000056972513,0.00060466834],"genre_scores_gemma":[0.99323547,0.0014379269,0.000021109125,0.0042133606,0.000017632128,0.000041753046,0.000009305175,0.000018280381,0.0010051662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753606,0.00026359045,0.00098419,0.0002784697,0.00055559276,0.00038210928],"domain_scores_gemma":[0.9967327,0.0016676144,0.00054783485,0.0007128711,0.00016891645,0.00017003757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005025656,0.00022925633,0.00075184763,0.000059310132,0.00020755261,0.00007501614,0.00030340152,0.000070733855,0.0002844431],"category_scores_gemma":[0.003340652,0.000119689415,0.0006112743,0.0002911817,0.0002972599,0.00015986808,0.00036026453,0.00026268858,0.00001518634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017044024,0.0005301025,0.94771534,0.00013963967,0.0023937132,0.000008289073,0.000090978836,0.0000011835019,0.0000065803297,0.0002096767,0.0036848285,0.04504921],"study_design_scores_gemma":[0.0012187994,0.00010523995,0.9928522,0.00037922556,0.0012028881,0.0000016414928,0.00010549595,0.00008916002,0.000066657936,0.00076463324,0.0030892338,0.00012482319],"about_ca_topic_score_codex":0.00094436255,"about_ca_topic_score_gemma":0.000029244551,"teacher_disagreement_score":0.045136843,"about_ca_system_score_codex":0.00001708584,"about_ca_system_score_gemma":0.00013481067,"threshold_uncertainty_score":0.48807925},"labels":[],"label_agreement":null},{"id":"W4411428396","doi":"10.1016/j.ard.2025.06.1422","title":"ABS1067 WHOLE BODY-MRI IDENTIFIES LOW LEVELS OF INFLAMMATION IN PERIPHERAL JOINTS, BUT HIGHER PREVALENCE OF AXIAL INVOLVEMENT IN EARLY, TREATMENT-NAÏVE PSORIATIC ARTHRITIS: DATA FROM THE GOLMePsA CLINICAL TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psoriatic arthritis; Peripheral; Clinical trial; Inflammation; Internal medicine; Arthritis; Physical therapy; Pathology","score_opus":0.08185193704978215,"score_gpt":0.37684202749984264,"score_spread":0.29499009045006047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912608,0.0035365475,0.000016372765,0.0025818518,0.00043590285,0.00156553,0.00055291544,0.000007114271,0.00004296496],"genre_scores_gemma":[0.9972051,0.0021855785,0.00004421318,0.00006216757,0.0000585693,0.00007273603,0.00008888138,0.000008843169,0.0002739495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722964,0.00048482363,0.0014510168,0.00027591595,0.00040198406,0.00015659572],"domain_scores_gemma":[0.9975821,0.0007984567,0.00051078614,0.00094624737,0.00012023246,0.000042223175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006851766,0.00015879756,0.0006175003,0.00008687347,0.000034343884,0.000018197816,0.00038717187,0.00007554213,0.00015103158],"category_scores_gemma":[0.0015827685,0.00009470518,0.00028051654,0.00023748503,0.00031377343,0.0002133654,0.00016629197,0.00009085211,0.0000030393194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02053574,0.012473154,0.6996244,0.013113003,0.0022627632,0.0000052951127,0.0077433526,0.00038464213,0.0018696036,0.0016099772,0.006154858,0.2342232],"study_design_scores_gemma":[0.0134649165,0.00047576538,0.9731033,0.0054850653,0.00020303697,4.8494808e-8,0.0006822843,0.0006783782,0.00034674516,0.0054610977,0.000022445096,0.000076960074],"about_ca_topic_score_codex":0.0015008494,"about_ca_topic_score_gemma":0.00045139014,"teacher_disagreement_score":0.27347887,"about_ca_system_score_codex":0.000028045884,"about_ca_system_score_gemma":0.0002470657,"threshold_uncertainty_score":0.38619652},"labels":[],"label_agreement":null},{"id":"W4411428627","doi":"10.1016/j.ard.2025.06.528","title":"POS1178 DRUG DISCONTINUATION IN INFLAMMATORY ARTHRITIS FOLLOWING MANDATORY NON-MEDICAL SWITCHING FROM ORIGINATOR TO BIOSIMILAR IN QUEBEC, CANADA","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Montreal Clinical Research Institute; McGill University Health Centre","funders":"","keywords":"Medicine; Biosimilar; Discontinuation; Drug; Arthritis; Drug approval; Rheumatoid arthritis; Intensive care medicine; Pharmacology; Dermatology; Internal medicine","score_opus":0.007377121633257179,"score_gpt":0.277455790872275,"score_spread":0.27007866923901785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97955525,0.004746009,0.000057574653,0.014364527,0.0007899781,0.00029835972,0.00006868324,0.000011222388,0.00010839198],"genre_scores_gemma":[0.9967691,0.00015512592,0.000042739408,0.0025568665,0.0000088877205,0.000026954975,0.000013819353,0.000008181957,0.00041832845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829,0.00036931943,0.00062979583,0.00025968588,0.00014011783,0.00031108657],"domain_scores_gemma":[0.9988587,0.0005846179,0.00011929082,0.00033819716,0.000034858793,0.000064372456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051038293,0.00017268157,0.0004555849,0.00014825244,0.00007369345,0.000022781827,0.0004483052,0.0001234831,0.00017801838],"category_scores_gemma":[0.0012393637,0.00012643157,0.00015617651,0.0003153472,0.000079045814,0.00010075293,0.00019031976,0.00022705916,0.0000049357723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048115692,0.0011284662,0.56968886,0.00041348895,0.0010979323,0.000101921316,0.0015397872,0.000043563545,0.004387335,0.0021471805,0.10781101,0.3111593],"study_design_scores_gemma":[0.001998211,0.00002581988,0.9604015,0.008295126,0.00008385253,6.431998e-7,0.0010452349,0.00015900725,0.01762569,0.002994841,0.006975688,0.00039443123],"about_ca_topic_score_codex":0.3435594,"about_ca_topic_score_gemma":0.78331846,"teacher_disagreement_score":0.43975905,"about_ca_system_score_codex":0.000067158915,"about_ca_system_score_gemma":0.0007808896,"threshold_uncertainty_score":0.6608119},"labels":[],"label_agreement":null},{"id":"W4411428628","doi":"10.1016/j.ard.2025.06.593","title":"POS1243 SERUM URATE LEVELS AND RECURRENT GOUT FLARE EVENTS AND GOUT-PRIMARY HOSPITALISATIONS: GENERAL POPULATION-BASED INCEPTION COHORT OF >62,000 NEWLY-DIAGNOSED GOUT PATIENTS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Abdominal Trauma and Injuries","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Gout; Internal medicine; Cohort; Hyperuricemia; Uric acid; Population; Pediatrics; Environmental health","score_opus":0.020467223315677577,"score_gpt":0.3012932832428555,"score_spread":0.2808260599271779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950033,0.0018858169,0.000022209726,0.0011721525,0.0001910476,0.0008882497,0.0006971729,0.000021930537,0.00011812209],"genre_scores_gemma":[0.9983645,0.000363024,0.00013961879,0.0005862095,0.000018809695,0.00004503663,0.00026966335,0.0000149854295,0.00019814535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837583,0.00014340057,0.0006594059,0.00024221842,0.00039428007,0.00018486417],"domain_scores_gemma":[0.998668,0.00020092439,0.00037302048,0.00035504947,0.00028382117,0.00011919367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017514412,0.00021065953,0.00050549523,0.0001171758,0.00014813301,0.000021138181,0.00012629626,0.000068031295,0.000054342865],"category_scores_gemma":[0.0006205939,0.0001550466,0.00015396034,0.00020550375,0.0001656975,0.000196625,0.00008292732,0.00007353322,0.0000015514972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026083077,0.0004189109,0.9692959,0.0010610698,0.00019515262,4.6331655e-7,0.00022360044,0.00003233068,0.000025898067,0.0001570945,0.0012126507,0.02711609],"study_design_scores_gemma":[0.0015994977,0.0002460206,0.9924457,0.0024994435,0.00038026605,4.075788e-7,0.00011875041,0.000517695,0.00033279354,0.0017001268,0.000023806593,0.00013546263],"about_ca_topic_score_codex":0.00019741089,"about_ca_topic_score_gemma":0.000010486669,"teacher_disagreement_score":0.026980627,"about_ca_system_score_codex":0.0000364691,"about_ca_system_score_gemma":0.00014877299,"threshold_uncertainty_score":0.63226163},"labels":[],"label_agreement":null},{"id":"W4411428633","doi":"10.1016/j.ard.2025.06.544","title":"POS1194 RISK OF INCIDENT POLYMYALGIA RHEUMATICA FOLLOWING EXPOSURE TO RECOMBINANT ZOSTER VACCINE IN ADULTS ≥50 YEARS OF AGE IN THE UNITED STATES","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Medicine; Polymyalgia rheumatica; Pediatrics; Dermatology; Internal medicine; Giant cell arteritis; Disease; Vasculitis","score_opus":0.012657027787188899,"score_gpt":0.28547568931755285,"score_spread":0.27281866153036394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411428633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940377,0.0011082446,0.000012110776,0.0038871274,0.000119679455,0.00068021595,0.000051835894,0.000008780886,0.00009431999],"genre_scores_gemma":[0.99853504,0.00090963015,0.000042266176,0.0003396126,0.0000019395811,0.00003474687,0.000039782215,0.000010438228,0.00008655659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824375,0.00028148555,0.00082408614,0.00013912689,0.00031052166,0.00020100742],"domain_scores_gemma":[0.9983442,0.00068727316,0.0002555289,0.0005616166,0.00008724222,0.00006417397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003868211,0.00012930647,0.0004867939,0.00043874062,0.000033486027,0.000008369438,0.00030348924,0.000059897317,0.000033698252],"category_scores_gemma":[0.0012428012,0.00007736498,0.00024914235,0.0010271436,0.000056352754,0.00004741903,0.00010162279,0.00015239902,0.0000028395946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027140842,0.0060223364,0.90916365,0.0031566222,0.004462029,0.00011095904,0.04132789,0.002778863,0.00052622764,0.0028500769,0.009659797,0.017227456],"study_design_scores_gemma":[0.0019583094,0.00029544558,0.9776254,0.011096804,0.000624469,0.000001921335,0.0032139826,0.00033309092,0.0003071621,0.0044486877,0.000015179089,0.000079529964],"about_ca_topic_score_codex":0.0017719609,"about_ca_topic_score_gemma":0.00011536303,"teacher_disagreement_score":0.06846176,"about_ca_system_score_codex":0.000015921418,"about_ca_system_score_gemma":0.000096051976,"threshold_uncertainty_score":0.31548524},"labels":[],"label_agreement":null},{"id":"W4411429089","doi":"10.1016/j.ard.2025.05.538","title":"POS0150 EVOLUTION OF JANUS KINASE INHIBITORS (JAKi) PRESCRIPTIONS SINCE 2015 IN AN INTERNATIONAL COLLABORATION OF RHEUMATOID ARTHRITIS REGISTERS (THE ‘JAK-pot' STUDY): EFFECT OF REGULATORY WARNINGS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Tofacitinib; Janus kinase; Medicine; Rheumatoid arthritis; Janus kinase inhibitor; Ruxolitinib; Medical prescription; Janus kinase 3; Bioinformatics; Pharmacology; Immunology; Internal medicine; Receptor; Biology; Immune system","score_opus":0.01923922208438829,"score_gpt":0.35624712036636175,"score_spread":0.3370078982819735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884545,0.0034207916,0.000016413396,0.0057772994,0.00037901485,0.0016919024,0.00011652575,0.000014362297,0.00012918327],"genre_scores_gemma":[0.9992089,0.00051315775,0.000013575843,0.00006470695,0.000019784808,0.00007196837,0.000023430233,0.000011493142,0.000072968236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965829,0.0010433348,0.0013322381,0.00020823533,0.0006494544,0.000183794],"domain_scores_gemma":[0.9970369,0.00036911934,0.0009559279,0.000699789,0.0008208534,0.00011742981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016007983,0.00015340789,0.0006481525,0.0003348987,0.00007242175,0.000012412913,0.00028571734,0.0000751529,0.0000109316825],"category_scores_gemma":[0.0021361548,0.000103724225,0.00015552001,0.000777478,0.0002476141,0.00026924102,0.00007493142,0.00012363585,5.9782735e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017482225,0.0027785178,0.92202646,0.006422567,0.0004730484,0.000003779667,0.008894983,0.00041230975,0.0011255231,0.004248407,0.011521608,0.04034459],"study_design_scores_gemma":[0.0021459728,0.001379867,0.9785889,0.0105305305,0.00005313914,0.000004353901,0.0042738398,0.0009739,0.0012039929,0.00029690698,0.0004485248,0.000100107914],"about_ca_topic_score_codex":0.0046082675,"about_ca_topic_score_gemma":0.0004627018,"teacher_disagreement_score":0.05656242,"about_ca_system_score_codex":0.00011418556,"about_ca_system_score_gemma":0.0012148592,"threshold_uncertainty_score":0.69663525},"labels":[],"label_agreement":null},{"id":"W4411429111","doi":"10.1016/j.ard.2025.05.587","title":"POS0200 TYPE I INTERFERON ACTIVITY IN PERSISTENTLY ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PATIENTS WITH OR WITHOUT LUPUS: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) CLINICAL DATABASE AND REPOSITORY (“REGISTRY”)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; University of Calgary","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Clinical trial; Systemic lupus erythematosus; Immunology; Antibody; Alliance; Internal medicine; Disease","score_opus":0.20776187584182348,"score_gpt":0.48336670504864276,"score_spread":0.2756048292068193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992665,0.0016742445,0.000086434215,0.001027189,0.0019200793,0.0018370152,0.00067016255,0.000023134091,0.00009672984],"genre_scores_gemma":[0.99310505,0.0052695707,0.0002425011,0.00018849749,0.00012789335,0.000033442986,0.00020556584,0.000024012272,0.0008034391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960421,0.0008945563,0.0016142626,0.00068768987,0.00045812048,0.0003032721],"domain_scores_gemma":[0.99296916,0.0045828614,0.0010240516,0.000753379,0.00045812604,0.00021242823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024645226,0.0002697057,0.0013676403,0.00010112261,0.00013126324,0.000083362516,0.0003370152,0.00014906522,0.000008351116],"category_scores_gemma":[0.007589616,0.00016740392,0.00024968493,0.00027045957,0.0005284724,0.0002607648,0.0003031888,0.00030738645,0.0000012504357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041140363,0.0009836974,0.94107634,0.0007185037,0.0011368607,0.000015339712,0.00017022614,0.000002167573,0.00003642645,0.00000862195,0.0032387646,0.01147271],"study_design_scores_gemma":[0.015046629,0.0011975346,0.957132,0.021922287,0.0005919654,0.00014108997,0.00065692654,0.0022159182,0.00026022864,0.00005363174,0.00052080443,0.0002610056],"about_ca_topic_score_codex":0.00023550571,"about_ca_topic_score_gemma":0.00004098717,"teacher_disagreement_score":0.026093733,"about_ca_system_score_codex":0.000055365013,"about_ca_system_score_gemma":0.00038701177,"threshold_uncertainty_score":0.9086028},"labels":[],"label_agreement":null},{"id":"W4411429142","doi":"10.1016/j.ard.2025.05.519","title":"POS0131 DEVELOPMENT AND VALIDATION OF A TIME-EFFICIENT SIMPLIFIED SPARCC MRI SCORE IN AXIAL SPONDYLOARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Axial spondyloarthritis; Nuclear medicine; Internal medicine; Ankylosing spondylitis; Sacroiliitis","score_opus":0.02636284678125799,"score_gpt":0.29352763463729503,"score_spread":0.26716478785603703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939992,0.0037373633,0.000012943105,0.0009823947,0.00006711351,0.0005347849,0.000050914656,0.0000106734105,0.00060464913],"genre_scores_gemma":[0.9989866,0.00048649733,0.00011565205,0.00011246291,0.0000048645334,0.000035038604,0.00002357739,0.000007062783,0.00022824465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989668,0.000045006436,0.00042585717,0.00016197558,0.00023344677,0.00016692268],"domain_scores_gemma":[0.9993619,0.000114747076,0.00013831386,0.00023143104,0.00009741559,0.000056213543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012333482,0.0001256896,0.00039180307,0.00013269977,0.00006732207,0.000008244778,0.00007681109,0.000030361098,0.000051387353],"category_scores_gemma":[0.00024130111,0.000090679365,0.00009232901,0.00026244647,0.00012463977,0.000027419048,0.00011261675,0.0000378682,0.0000049906807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002812064,0.00630586,0.60364974,0.003804731,0.0018337332,0.000068709014,0.004170165,0.00074328086,0.00067106064,0.0034364942,0.0056029386,0.36690122],"study_design_scores_gemma":[0.0040629175,0.00019716422,0.970962,0.00589184,0.00017364044,0.000008074774,0.0003517763,0.0002565838,0.01660557,0.0010535221,0.00030014003,0.00013675725],"about_ca_topic_score_codex":0.00006812979,"about_ca_topic_score_gemma":0.000015108708,"teacher_disagreement_score":0.36731228,"about_ca_system_score_codex":0.00001819388,"about_ca_system_score_gemma":0.00013606402,"threshold_uncertainty_score":0.3697797},"labels":[],"label_agreement":null},{"id":"W4411429169","doi":"10.1016/j.ard.2025.05.842","title":"POS0459 Patients Perspective toward Rheumatic and Musculoskeletal Diseases: Insights from a Large-Scale Survey","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Perspective (graphical); Scale (ratio); Physical therapy; Family medicine; Cartography","score_opus":0.012963077820436876,"score_gpt":0.30752014998581284,"score_spread":0.29455707216537597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870326,0.008261996,0.00010900442,0.002131733,0.00021931794,0.0009998824,0.0005960988,0.00004083857,0.00060852634],"genre_scores_gemma":[0.99842006,0.0006335473,0.0000594368,0.00041932287,0.000011818034,0.00005300666,0.00021492179,0.000020849096,0.00016705679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800766,0.00036244493,0.0005285966,0.0003845296,0.0004602291,0.00025653504],"domain_scores_gemma":[0.9978843,0.00061597355,0.00022178394,0.00057106145,0.0005022328,0.00020470304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012903489,0.00026213663,0.0006168454,0.00015297634,0.00016239958,0.000034301465,0.00020810755,0.00007614019,0.000091168244],"category_scores_gemma":[0.0025065783,0.00016646854,0.0004407921,0.00041950817,0.00029660919,0.00016460741,0.0001861593,0.00011061956,0.000009711833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000685993,0.0053052795,0.9449377,0.0044168103,0.0014080224,0.0000011951614,0.0062062284,0.000015685127,0.000016567625,0.0031931757,0.007976844,0.025836471],"study_design_scores_gemma":[0.0017718192,0.0002159797,0.9715734,0.0015260893,0.0004267333,1.3425009e-7,0.0032844567,0.0006027874,0.000009827791,0.020382809,0.0000412733,0.00016467963],"about_ca_topic_score_codex":0.0010873228,"about_ca_topic_score_gemma":0.000117196345,"teacher_disagreement_score":0.026635684,"about_ca_system_score_codex":0.00003716471,"about_ca_system_score_gemma":0.0001706578,"threshold_uncertainty_score":0.67883897},"labels":[],"label_agreement":null},{"id":"W4411429311","doi":"10.1016/j.ard.2025.05.321","title":"OP0319 LUNG TRANSPLANT OUTCOMES IN PATIENTS WITH MYOSITIS- AND SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE COMPARED TO IDIOPATHIC PULMONARY FIBROSIS: A MULTICENTRIC RETROSPECTIVE ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Interstitial lung disease; Idiopathic pulmonary fibrosis; Myositis; Pulmonary fibrosis; Lung fibrosis; Lung; Scleroderma (fungus); Fibrosis; Retrospective cohort study; Pathology; Internal medicine; Lung disease; Connective tissue disease; Disease; Autoimmune disease","score_opus":0.014675164344751686,"score_gpt":0.27781989806132523,"score_spread":0.26314473371657354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233764,0.004349097,0.00015169868,0.001790135,0.000095986165,0.0008458792,0.0003684505,0.000036831545,0.000024258767],"genre_scores_gemma":[0.99894136,0.00025071963,0.0000147549035,0.0006037153,0.000004907192,0.000077083736,0.000048781323,0.000010917324,0.000047740537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981887,0.0002648956,0.00051744893,0.00032745948,0.00040880652,0.00029270124],"domain_scores_gemma":[0.99881905,0.00022307577,0.00018888651,0.00034342328,0.0001889915,0.00023656395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022353734,0.0002260838,0.0009845968,0.000370632,0.00012551114,0.00002028139,0.0001649948,0.000043430206,0.0000065399645],"category_scores_gemma":[0.0009291474,0.00014254726,0.00022085538,0.0009203516,0.00021590815,0.00006403425,0.00009423688,0.00014305797,8.013491e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009747737,0.00082761404,0.9936043,0.0010347252,0.0020144368,0.000020031763,0.00077155366,0.00009974012,0.0000044540966,0.000011461309,0.00020789575,0.000429021],"study_design_scores_gemma":[0.0018560366,0.00006971077,0.9718927,0.015542393,0.0040040296,6.9696927e-7,0.00025518105,0.006217936,0.0000068667127,0.000024109473,1.2573629e-7,0.0001302246],"about_ca_topic_score_codex":0.00014045047,"about_ca_topic_score_gemma":0.000023280412,"teacher_disagreement_score":0.021711603,"about_ca_system_score_codex":0.000076998935,"about_ca_system_score_gemma":0.00008490181,"threshold_uncertainty_score":0.5812909},"labels":[],"label_agreement":null},{"id":"W4411429312","doi":"10.1016/j.ard.2025.05.283","title":"OP0273 CERTOLIZUMAB PEGOL TO PREVENT ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND LUPUS ANTICOAGULANT (IMPACT): RESULTS OF A PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PHASE 2 TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; CReATe Fertility Centre; Ottawa Fertility Centre; University of Toronto","funders":"","keywords":"Medicine; Certolizumab pegol; Antiphospholipid syndrome; Lupus anticoagulant; Open label; Adverse effect; Pregnancy; Internal medicine; Thrombosis; Rheumatoid arthritis","score_opus":0.04706207607641542,"score_gpt":0.3750567869153794,"score_spread":0.327994710838964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896761,0.00065099297,0.0000041996373,0.0007552506,0.00018348223,0.008075485,0.00038914802,0.000018220933,0.00024707563],"genre_scores_gemma":[0.99876165,0.00007636178,0.00008294213,0.000028794027,0.0000034447448,0.00015325648,0.000019436806,0.000027734055,0.0008463521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712944,0.00021548392,0.0010221362,0.00043485963,0.00078295986,0.00041512007],"domain_scores_gemma":[0.9976472,0.0003391993,0.00045768256,0.00096691604,0.0003519964,0.00023699437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001984957,0.00029639318,0.0012717405,0.00032558196,0.00006362517,0.00003566591,0.00051044696,0.00006119347,0.000021248534],"category_scores_gemma":[0.0021560811,0.00017068471,0.0001369122,0.0007046917,0.00018155719,0.0001978685,0.00047584673,0.00011153641,0.000002870906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11615769,0.05009182,0.81967664,0.004597759,0.0013567712,0.00008809932,0.0018845195,0.000013559217,0.000055221866,0.00008565737,0.0014207035,0.004571567],"study_design_scores_gemma":[0.36135298,0.017318249,0.55458784,0.062169846,0.0005188192,0.00030441227,0.0007285116,0.00014717769,0.0019247651,0.00051267585,0.000011032457,0.0004237199],"about_ca_topic_score_codex":0.00028983323,"about_ca_topic_score_gemma":0.000020444388,"teacher_disagreement_score":0.26508883,"about_ca_system_score_codex":0.00010148286,"about_ca_system_score_gemma":0.00046102307,"threshold_uncertainty_score":0.69603205},"labels":[],"label_agreement":null},{"id":"W4411429315","doi":"10.1016/j.ard.2025.05.215","title":"OP0203 ATTAINMENT OF LLDAS AND DORIS REMISSION DURING ANIFROLUMAB TREATMENT: INTERIM 6-MONTH RESULTS FROM A MULTINATIONAL, OBSERVATIONAL, POST-LAUNCH STUDY OF TREATMENT EFFECTIVENESS IN THE REAL WORLD","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Interim; Observational study; Interim analysis; Physical therapy; Pediatrics; Internal medicine; Randomized controlled trial","score_opus":0.09082477393332254,"score_gpt":0.3753965429927392,"score_spread":0.28457176905941667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963319,0.00069756253,0.0000011750758,0.0014853091,0.000027818904,0.0011408797,0.00016487604,0.0000067225697,0.00014379555],"genre_scores_gemma":[0.9991058,0.0004963354,0.000030184881,0.000045115707,0.0000075063986,0.00005917609,0.00007304139,0.0000068726963,0.00017595646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847597,0.00030339262,0.0005702259,0.0002052611,0.0003494985,0.000095665586],"domain_scores_gemma":[0.99806863,0.0010010506,0.0002841515,0.0003806199,0.00022078662,0.000044760716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023981553,0.00014989049,0.00046549784,0.000143894,0.0000741753,0.0000085922275,0.00010475927,0.000027740687,0.000011737765],"category_scores_gemma":[0.00048728092,0.00007911953,0.000124678,0.00027484822,0.000070649185,0.000057420144,0.00005692638,0.000033788332,2.3298274e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01867123,0.01967862,0.8635504,0.0008976273,0.0017830412,0.000021758491,0.012980237,0.00071353855,0.008656637,0.0004722162,0.00016973609,0.072404936],"study_design_scores_gemma":[0.0061697867,0.0011451038,0.9844101,0.0019962776,0.00024055781,7.8316907e-7,0.002027179,0.0008965111,0.0027751436,0.00025372131,0.000030438467,0.000054364955],"about_ca_topic_score_codex":0.0038469138,"about_ca_topic_score_gemma":0.0003296426,"teacher_disagreement_score":0.12085971,"about_ca_system_score_codex":0.00011156374,"about_ca_system_score_gemma":0.0001426668,"threshold_uncertainty_score":0.5815409},"labels":[],"label_agreement":null},{"id":"W4411429415","doi":"10.1016/j.ard.2025.05.112","title":"OP0090 Combination of Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of Toronto; Women's College Hospital; Arthritis Society","funders":"","keywords":"Medicine; Psoriatic arthritis; Antirheumatic drugs; Antirheumatic Agents; Arthritis; Psoriasis; Disease; Dermatology; Pharmacology; Internal medicine","score_opus":0.02760317890546372,"score_gpt":0.3139901307098705,"score_spread":0.28638695180440676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954904,0.0413621,0.000027696244,0.0026824675,0.000104152285,0.00069332705,0.00004573079,0.000019754969,0.00016073512],"genre_scores_gemma":[0.9527825,0.04696146,0.000054370623,0.000088005596,0.000003959022,0.000047171452,0.000015094762,0.000010440193,0.000036997328],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981301,0.00027955166,0.0006922857,0.0002260919,0.00038452583,0.00028746884],"domain_scores_gemma":[0.998487,0.00057051744,0.00021463372,0.0004200477,0.0001513998,0.00015638395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004050158,0.000174691,0.0006384101,0.0002868286,0.00008973617,0.000024973466,0.00020107375,0.000049747727,0.000085915],"category_scores_gemma":[0.0025259,0.00012049225,0.00019092899,0.00045664553,0.00048376556,0.00011628584,0.00012767382,0.00010873471,0.0000037418151],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017359761,0.0039542317,0.3888095,0.006285118,0.00087305665,0.000017530247,0.0024770966,0.00006227579,0.00061376486,0.02611162,0.0013783647,0.5676815],"study_design_scores_gemma":[0.0035569128,0.00021998632,0.927954,0.016727336,0.00003184768,0.0000050384056,0.0008839907,0.0027675573,0.0011543455,0.04648697,0.000046674093,0.00016531936],"about_ca_topic_score_codex":0.00006425571,"about_ca_topic_score_gemma":0.000004836596,"teacher_disagreement_score":0.56751615,"about_ca_system_score_codex":0.00001410621,"about_ca_system_score_gemma":0.00017357123,"threshold_uncertainty_score":0.49135315},"labels":[],"label_agreement":null},{"id":"W4411429448","doi":"10.1016/j.ard.2025.05.120","title":"OP0098 Assessing the Frequency of Difficult-to-Manage (D2M) and Treatment-Refractory (TR-axSpA) Cases in the RABBIT-SpA Register: An Analysis Based on Recent ASAS Definitions","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Register (sociolinguistics); Refractory (planetary science); Family medicine; Internal medicine; Pediatrics; Linguistics","score_opus":0.4290323795947398,"score_gpt":0.46245310861674593,"score_spread":0.03342072902200616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436784,0.0029228735,0.00030409067,0.04931753,0.00011957835,0.00088971714,0.00075964147,0.000014809478,0.0019933714],"genre_scores_gemma":[0.9928381,0.0009252245,0.00015872711,0.0057601533,0.000017819713,0.00016078958,0.000050334882,0.0000123629425,0.00007652674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605346,0.0010970331,0.0020763818,0.00036995116,0.00015162483,0.00025152217],"domain_scores_gemma":[0.9925321,0.004564358,0.0014818098,0.001229832,0.00009718045,0.00009475169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003906787,0.00020609447,0.00086225604,0.00054198987,0.00030139778,0.00012780633,0.0005253495,0.000057178055,0.000079924306],"category_scores_gemma":[0.0056471797,0.00013552362,0.0002703962,0.000981411,0.00017295674,0.0002523285,0.000048298712,0.00008837963,0.000015303238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018407672,0.008218469,0.7188052,0.0023616229,0.0032763036,0.0000104756355,0.015994767,0.036056742,0.000008094464,0.17668247,0.019403089,0.01899872],"study_design_scores_gemma":[0.00069527846,0.00023332571,0.9636038,0.00089897204,0.0003329574,9.64742e-7,0.0060385033,0.012644321,0.000013021959,0.013600512,0.0016924776,0.00024585615],"about_ca_topic_score_codex":0.0033468453,"about_ca_topic_score_gemma":0.0010780003,"teacher_disagreement_score":0.24479865,"about_ca_system_score_codex":0.00013469883,"about_ca_system_score_gemma":0.0001691292,"threshold_uncertainty_score":0.676061},"labels":[],"label_agreement":null},{"id":"W4411430428","doi":"10.1016/j.ard.2025.06.1362","title":"ABS0293 JOINT GROUPS INVOLVED IN EARLY OLIGOARTICULAR PSORIATIC ARTHRITIS AND THE IMPACT OF APREMILAST TREATMENT: DATA FROM FOREMOST","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Apremilast; Medicine; Psoriatic arthritis; Dermatology; Immunology; Psoriasis","score_opus":0.05184073833778515,"score_gpt":0.3227623594322187,"score_spread":0.2709216210944336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411430428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959378,0.03788963,0.000004112464,0.0010575019,0.00006592644,0.0007583546,0.0006742813,0.000009694179,0.00016246959],"genre_scores_gemma":[0.988255,0.011447142,0.000030233172,0.00008497543,0.000013801656,0.000047442187,0.000079039644,0.000011073163,0.000031244825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987366,0.00011206991,0.00051129406,0.00023098003,0.00020123436,0.00020778578],"domain_scores_gemma":[0.998326,0.0003513039,0.00020542958,0.0009801873,0.00006489485,0.00007220835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014302312,0.00019288331,0.00073507574,0.00006918511,0.00008223198,0.000020292355,0.0002016644,0.000034528606,0.000034345263],"category_scores_gemma":[0.0005678427,0.00009592964,0.0002695265,0.00023453817,0.0003392738,0.000094128365,0.0002448257,0.000049724906,0.000003094022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032018605,0.0035127134,0.7708116,0.0005417933,0.008025103,0.00004832315,0.004066768,0.000053658572,0.00007640477,0.0013060777,0.0043178587,0.20403783],"study_design_scores_gemma":[0.010301883,0.0003046728,0.9740054,0.0036387343,0.00051533047,0.0000023172022,0.0005306929,0.0009847974,0.00030841908,0.009315661,0.000012333548,0.00007976144],"about_ca_topic_score_codex":0.007274732,"about_ca_topic_score_gemma":0.0005544593,"teacher_disagreement_score":0.20395806,"about_ca_system_score_codex":0.000029779596,"about_ca_system_score_gemma":0.000098845165,"threshold_uncertainty_score":0.9993359},"labels":[],"label_agreement":null},{"id":"W4411430599","doi":"10.1016/j.ard.2025.06.1115","title":"ABS0546 MEDITERRANEAN DIET ADHERENCE IN IDIOPATHIC INFLAMMATORY MYOPATHIES AND OTHER RMDS: A COVAD GROUP STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial Mediterranean fever; Internal medicine; Mediterranean diet; Physical therapy; Immunology; Disease","score_opus":0.031817438013733344,"score_gpt":0.31440166674700687,"score_spread":0.28258422873327355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411430599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898704,0.0071825306,0.000011053237,0.0008325537,0.00025043965,0.0011124427,0.000032131706,0.00005511522,0.0006533152],"genre_scores_gemma":[0.9978991,0.00038780633,0.000015278825,0.0014001508,0.000032853328,0.00013936084,0.0000024237272,0.000021172464,0.00010184867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979384,0.000281814,0.0007821897,0.00028345225,0.0004158763,0.00029829948],"domain_scores_gemma":[0.9986797,0.0001837628,0.00025297323,0.00065156777,0.00010900724,0.00012298457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062702113,0.00025450753,0.00066237873,0.00022924996,0.00012545697,0.000038264712,0.0002688569,0.00007694084,0.00004714229],"category_scores_gemma":[0.000562272,0.00017619401,0.00016527352,0.0003519874,0.0003242534,0.0001455932,0.00021883614,0.00019196911,0.000009099917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017744882,0.001567799,0.95410764,0.0064410246,0.00043250606,0.00017880063,0.008243562,0.000015221435,0.00012248948,0.0033208304,0.003040733,0.020754917],"study_design_scores_gemma":[0.0025696491,0.0006985003,0.977288,0.009013988,0.00022643823,0.00002487952,0.004832433,0.0004477309,0.00024870006,0.0039139544,0.0004852145,0.00025051605],"about_ca_topic_score_codex":0.00014698812,"about_ca_topic_score_gemma":0.0000983646,"teacher_disagreement_score":0.023180367,"about_ca_system_score_codex":0.000017376837,"about_ca_system_score_gemma":0.00014326861,"threshold_uncertainty_score":0.7184983},"labels":[],"label_agreement":null},{"id":"W4411430640","doi":"10.1016/j.ard.2025.06.1582","title":"ABS0711 PRIORITY SETTING OF PHYSICAL ACTIVITY BARRIERS AND FACILITATORS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS: A NOMINAL GROUP TECHNIQUE STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Rheumatoid arthritis; Nominal group technique; Physical therapy; Nominal group; Family medicine; Internal medicine","score_opus":0.010895409496123621,"score_gpt":0.2977236664889078,"score_spread":0.2868282569927842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411430640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485296,0.0024827374,0.00009946203,0.00038862368,0.000026382226,0.0018667884,0.00013489736,0.000044141987,0.000104032086],"genre_scores_gemma":[0.99784696,0.0017225229,0.00012551801,0.000023670327,0.0000059668296,0.00023742812,0.0000034448549,0.0000168371,0.00001766881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797326,0.0003381739,0.00039801546,0.00031446197,0.00063525693,0.00034081913],"domain_scores_gemma":[0.99831045,0.00043150992,0.000274016,0.00054921815,0.00018132925,0.0002534997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006045112,0.0002505883,0.00081943866,0.00019469942,0.0002044193,0.000039770333,0.00024398744,0.000048937272,0.000021786402],"category_scores_gemma":[0.0010282099,0.00016598073,0.00020041353,0.00041442653,0.00079128146,0.00024124754,0.00021527635,0.00022373222,7.3667854e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005435662,0.0014579732,0.92887354,0.00072413165,0.0008983669,0.000005823634,0.002630392,0.00000449909,0.00033288088,0.0004854983,0.00023216625,0.06381115],"study_design_scores_gemma":[0.0021337678,0.0009966608,0.9812308,0.0054356973,0.000034099434,0.000010316402,0.00456171,0.000114725255,0.0038401498,0.0014459942,0.000033944245,0.00016214683],"about_ca_topic_score_codex":0.00048254617,"about_ca_topic_score_gemma":0.000083784886,"teacher_disagreement_score":0.063649006,"about_ca_system_score_codex":0.00001502499,"about_ca_system_score_gemma":0.00027009042,"threshold_uncertainty_score":0.6768498},"labels":[],"label_agreement":null},{"id":"W4411430927","doi":"10.1016/j.ard.2025.05.896","title":"POS0514 Long-term use of glucocorticoids in people with rheumatoid arthritis: a Cochrane living systematic review","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Systematic review; Term (time); Intensive care medicine; Cochrane collaboration; MEDLINE; Physical therapy; Immunology; Meta-analysis; Internal medicine; Cochrane Library","score_opus":0.0216347633561633,"score_gpt":0.3125839700793954,"score_spread":0.2909492067232321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411430927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67051,0.32617235,0.000042261305,0.0011078061,0.00004774547,0.0019875981,0.000031058196,0.000028885353,0.00007228076],"genre_scores_gemma":[0.6326643,0.36666834,0.0000314398,0.00032869016,0.0000023775183,0.00017439004,0.0000070916344,0.000017461754,0.000105856845],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99683744,0.00040641913,0.0013162644,0.00025974534,0.0007718893,0.00040824173],"domain_scores_gemma":[0.9967369,0.0011154886,0.0005046702,0.0010591412,0.00041523855,0.00016859829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055763137,0.00026846706,0.00179326,0.00026932452,0.00007714179,0.000046443423,0.0003573291,0.000047316622,0.00012763627],"category_scores_gemma":[0.0049632727,0.0001671251,0.0003541509,0.00086818513,0.0003070764,0.00025611703,0.0001519141,0.0001552158,0.000007637691],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040958964,0.0017298578,0.3348718,0.6533631,0.001275295,0.000037740196,0.0006548619,0.000017728049,0.00008332383,0.0010479261,0.001272121,0.005236674],"study_design_scores_gemma":[0.0008776666,0.00017353537,0.2960993,0.70206225,0.000066954104,0.000054171134,0.00012677885,0.00006851259,0.00023251717,0.00011590829,0.0000028603686,0.00011953226],"about_ca_topic_score_codex":0.00025606484,"about_ca_topic_score_gemma":0.0002960786,"teacher_disagreement_score":0.048699155,"about_ca_system_score_codex":0.00002408356,"about_ca_system_score_gemma":0.0004115199,"threshold_uncertainty_score":0.68151635},"labels":[],"label_agreement":null},{"id":"W4411431053","doi":"10.1016/j.ard.2025.06.574","title":"POS1224 CONSENSUS-BASED GUIDANCE FOR GLUCOCORTICOID TAPERING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A MODIFIED DELPHI CONSENSUS PROJECT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Tapering; Glucocorticoid; Delphi; Consensus conference; Delphi method; Immunology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.041764676575018506,"score_gpt":0.3235913379671413,"score_spread":0.28182666139212276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873246,0.001968108,0.00010502249,0.0013428199,0.00027277786,0.006245761,0.0009838582,0.00007142478,0.00027774222],"genre_scores_gemma":[0.99824566,0.000030097382,0.0004510938,0.00024123448,0.000014407633,0.00044515255,0.00008519296,0.000051528626,0.00043564814],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962905,0.00029636588,0.0014637046,0.00056950207,0.00081318495,0.00056675123],"domain_scores_gemma":[0.9943386,0.0027055338,0.00066693756,0.0013810273,0.0007772075,0.00013074199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005806407,0.00036071418,0.0010966281,0.0003633886,0.00009445279,0.00004058231,0.00043249872,0.00011218329,0.00000527027],"category_scores_gemma":[0.005014439,0.00023210702,0.0002996849,0.0006934502,0.00026637575,0.000038329126,0.00012228891,0.00015109648,0.000005716141],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03362104,0.0019028203,0.92446893,0.021618847,0.0013108489,0.000028815428,0.0016862784,0.0026253664,0.000268203,0.00036851948,0.010635123,0.0014652],"study_design_scores_gemma":[0.17665403,0.002712256,0.30429053,0.3553297,0.0020381697,0.0006490789,0.012010864,0.13475172,0.00657762,0.0026224004,0.00022864611,0.0021349755],"about_ca_topic_score_codex":0.00040105006,"about_ca_topic_score_gemma":0.00003573577,"teacher_disagreement_score":0.6201784,"about_ca_system_score_codex":0.00013069187,"about_ca_system_score_gemma":0.0013616052,"threshold_uncertainty_score":0.94650495},"labels":[],"label_agreement":null},{"id":"W4411431252","doi":"10.1016/j.ard.2025.05.375","title":"OP0374 Clinical Meaningfulness of Pain Improvements and Time to Onset of Pain Relief of a Novel OA Therapy: Analyses from a Randomised Controlled Phase 2 Trial with LEVI-04, a Novel Neurotrophin-3 Inhibitor","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pain relief; Pain therapy; Physical therapy; Clinical trial; Randomized controlled trial; Pain management; Anesthesia; Internal medicine","score_opus":0.07854496551538065,"score_gpt":0.38869256177454525,"score_spread":0.3101475962591646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900422,0.00069148606,0.0039973687,0.0007816414,0.00005977536,0.0038295584,0.0005610043,0.000012994842,0.000023978704],"genre_scores_gemma":[0.9977599,0.0001097413,0.00089960534,0.00084166904,0.000020375335,0.00021640267,0.000032139636,0.000021863234,0.00009832195],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99669915,0.000836381,0.0014824453,0.00032223944,0.0004617582,0.00019801909],"domain_scores_gemma":[0.99416274,0.0036304495,0.0010962241,0.0006222245,0.00032163304,0.00016674535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002323685,0.00027839845,0.0020150184,0.00018057636,0.000047122925,0.0000115807325,0.00022621972,0.00006890926,0.00005783339],"category_scores_gemma":[0.0071812915,0.0001555838,0.0005906927,0.00032320555,0.00019393199,0.00005150909,0.00008523144,0.000080109254,4.4293054e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8758156,0.0248685,0.0010563234,0.00075579033,0.008948935,0.000007725671,0.00028915307,0.00004876338,0.042311378,0.000059435235,0.0011632956,0.044675138],"study_design_scores_gemma":[0.9460027,0.010532304,0.0036976011,0.0050009782,0.002605127,7.8004143e-7,0.00019989473,0.009274737,0.021841565,0.0006248413,0.000014950772,0.00020448214],"about_ca_topic_score_codex":0.00030612721,"about_ca_topic_score_gemma":0.0000040365185,"teacher_disagreement_score":0.070187174,"about_ca_system_score_codex":0.000008840218,"about_ca_system_score_gemma":0.000288594,"threshold_uncertainty_score":0.8597195},"labels":[],"label_agreement":null},{"id":"W4411431264","doi":"10.1016/j.ard.2025.06.118","title":"POS0758 EFFECTIVENESS AND SAFETY OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Giant cell arteritis; Janus kinase; Pathology; Internal medicine; Vasculitis; Disease","score_opus":0.021971037590238787,"score_gpt":0.3737573269083005,"score_spread":0.3517862893180617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8187846,0.17642201,0.000002281129,0.0026610475,0.00013361042,0.0013891901,0.00004296771,0.000011415609,0.0005528986],"genre_scores_gemma":[0.9158225,0.08335595,0.000040602034,0.00060409866,0.000016368596,0.000023279637,0.000009142901,0.000009046667,0.00011898994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979557,0.0005992539,0.0008364133,0.00024605906,0.00022493195,0.00013763693],"domain_scores_gemma":[0.9975049,0.0014724415,0.00033877444,0.00038389346,0.00019678962,0.00010318128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010699471,0.00015982792,0.00074406597,0.00011322163,0.000050100705,0.000018693423,0.0000898542,0.000043492153,0.00000822682],"category_scores_gemma":[0.0019174422,0.000110340334,0.00015501762,0.00048558068,0.0001586246,0.00014454272,0.000110527246,0.000118003045,4.3540965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022470506,0.005159629,0.7125337,0.03434517,0.0004857189,0.00010917261,0.0012127846,0.0000031230386,0.000046863996,0.0006389653,0.0035437357,0.23967408],"study_design_scores_gemma":[0.0017216527,0.00028496457,0.9493759,0.046870593,0.0004842371,0.000008583693,0.00027413203,0.0000322358,0.00017123602,0.00042230482,0.00026463158,0.000089495115],"about_ca_topic_score_codex":0.00019508212,"about_ca_topic_score_gemma":0.000039228176,"teacher_disagreement_score":0.23958458,"about_ca_system_score_codex":0.000009180971,"about_ca_system_score_gemma":0.000112843714,"threshold_uncertainty_score":0.44995484},"labels":[],"label_agreement":null},{"id":"W4411431303","doi":"10.1016/j.ard.2025.05.858","title":"POS0476 Analysing the Economic Impact of Denosumab in the Treatment of Osteoporosis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Denosumab; Osteoporosis; Intensive care medicine; Internal medicine","score_opus":0.29339231975101376,"score_gpt":0.4797126375989634,"score_spread":0.1863203178479496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97915244,0.007811531,0.000023450497,0.010826587,0.00013075053,0.0006540481,0.0005408426,0.000004525498,0.0008558207],"genre_scores_gemma":[0.99790585,0.0012324918,0.000028474724,0.00065351493,0.000017987748,0.00005298141,0.000009781696,0.000009025575,0.00008988751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960232,0.0004979914,0.0029712582,0.00020864145,0.00008047296,0.00021848263],"domain_scores_gemma":[0.99421895,0.0022912624,0.002425722,0.0009771662,0.00004741028,0.000039501967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037178549,0.0001585093,0.0009805342,0.00025459612,0.000106237945,0.000031441647,0.00063814106,0.000045047924,0.0001434139],"category_scores_gemma":[0.0011654204,0.00009550764,0.0006533925,0.00030379332,0.00018073435,0.00014585911,0.00004113003,0.0000434969,0.000028119088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020320255,0.0019176158,0.8197245,0.0018275479,0.0033229245,3.874972e-7,0.02464543,0.039671037,0.0000062337826,0.071497016,0.025665382,0.011518706],"study_design_scores_gemma":[0.0009147127,0.00025845083,0.94076943,0.00051804003,0.00012310312,8.164491e-7,0.0041627595,0.010954571,0.00008462093,0.04161383,0.00043717035,0.00016252077],"about_ca_topic_score_codex":0.008365353,"about_ca_topic_score_gemma":0.0003499352,"teacher_disagreement_score":0.12104489,"about_ca_system_score_codex":0.0003319974,"about_ca_system_score_gemma":0.00040448873,"threshold_uncertainty_score":0.998238},"labels":[],"label_agreement":null},{"id":"W4411431338","doi":"10.1016/j.ard.2025.05.242","title":"OP0231 DEFINING SONOGRAPHIC ENTHESITIS IN PSORIATIC ARTHRITIS: DEVELOPING A DATA- AND EXPERT-DRIVEN DIAGNOSTIC CRITERIA FOR INFLAMMATORY ENTHESITIS AT THE SINGLE ENTHESIS LEVEL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University of Ottawa","funders":"","keywords":"Enthesitis; Medicine; Enthesis; Psoriatic arthritis; Dermatology; Spondyloarthropathy; Arthritis; Psoriasis; Pathology; Immunology","score_opus":0.08924336208061755,"score_gpt":0.346496846122354,"score_spread":0.2572534840417364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92769134,0.06410439,0.00008063362,0.00583923,0.00023037066,0.0012524697,0.00067262194,0.00003070748,0.0000982366],"genre_scores_gemma":[0.9798862,0.018063389,0.00056535983,0.0008106968,0.000024949237,0.00048722595,0.00007306205,0.00002628242,0.00006284497],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99824536,0.00016250234,0.0006012009,0.00036765044,0.0002485405,0.0003747341],"domain_scores_gemma":[0.9961657,0.002722081,0.00022087512,0.0007206569,0.000091278416,0.00007941912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027210359,0.00025547014,0.0005906877,0.00015117678,0.00035393267,0.000054921336,0.00031932583,0.000054682805,0.000042744945],"category_scores_gemma":[0.0031840722,0.0001720098,0.00018168661,0.0002540782,0.0002697622,0.00013823695,0.0004831974,0.000059405596,0.0000039378765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053130876,0.0009776872,0.18261234,0.0019156499,0.0019900287,0.000059865175,0.0037286966,0.000009857112,0.00009373261,0.0017045683,0.013637261,0.792739],"study_design_scores_gemma":[0.005251519,0.00026261617,0.955112,0.025555538,0.00074869924,0.000043131757,0.0031734018,0.000585703,0.0018842613,0.0034840205,0.003454649,0.00044448904],"about_ca_topic_score_codex":0.000122011275,"about_ca_topic_score_gemma":0.00045515655,"teacher_disagreement_score":0.7922945,"about_ca_system_score_codex":0.000050893002,"about_ca_system_score_gemma":0.00013127459,"threshold_uncertainty_score":0.70143557},"labels":[],"label_agreement":null},{"id":"W4411431344","doi":"10.1016/j.ard.2025.05.397","title":"LB0010 INHIBITION OF STRUCTURAL DAMAGE PROGRESSION WITH GUSELKUMAB, A SELECTIVE IL-23i, IN PARTICIPANTS WITH ACTIVE PsA: RESULTS THROUGH WEEK 24 OF THE PHASE 3b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED APEX STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Placebo; Randomized controlled trial; Internal medicine; Apex (geometry); Oncology; Pathology; Alternative medicine","score_opus":0.06337347291886843,"score_gpt":0.40028635559025183,"score_spread":0.3369128826713834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865344,0.00035551135,0.000015981146,0.0009839333,0.00005871441,0.011469896,0.0001187058,0.000020566915,0.00044226222],"genre_scores_gemma":[0.99872524,0.000054445085,0.00007018296,0.000053461015,0.000012692498,0.0008612017,0.000018965611,0.000026352402,0.00017747498],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955692,0.0010564722,0.00122539,0.00041832429,0.0012548527,0.0004757235],"domain_scores_gemma":[0.9953986,0.0017465273,0.00110581,0.00093585637,0.00070520735,0.00010802431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011220813,0.00033955282,0.0017347513,0.00021068729,0.00012908583,0.000023765584,0.00037234978,0.000079839156,0.000019328354],"category_scores_gemma":[0.0024193171,0.00014911723,0.00031448714,0.0012208702,0.0009855616,0.00024428236,0.00022379772,0.00029615522,7.1472914e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.981806,0.004150407,0.00116398,0.00088593585,0.0024248797,0.000017189106,0.0073072957,0.00063074037,0.00013806038,0.00013665312,0.0002208168,0.0011180679],"study_design_scores_gemma":[0.9397676,0.001915882,0.005977319,0.007455484,0.0016133549,0.000007519976,0.0046987263,0.0054606255,0.032052144,0.00089550304,8.201829e-7,0.00015500086],"about_ca_topic_score_codex":0.0009412619,"about_ca_topic_score_gemma":0.00038758045,"teacher_disagreement_score":0.042038355,"about_ca_system_score_codex":0.0005289205,"about_ca_system_score_gemma":0.0044528665,"threshold_uncertainty_score":0.7899194},"labels":[],"label_agreement":null},{"id":"W4411431416","doi":"10.1016/j.ard.2025.05.584","title":"POS0197-PARE HEALTH LITERACY AND DISEASE OUTCOMES IN INFLAMMATORY ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Systematic review; Alternative medicine; Arthritis; Inflammatory arthritis; Disease; Immunology; Family medicine; Intensive care medicine; MEDLINE; Dermatology; Internal medicine; Pathology","score_opus":0.017972865451137604,"score_gpt":0.352869477681395,"score_spread":0.33489661223025735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431416","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.113742754,0.8467252,0.0000042409306,0.0367137,0.00006159939,0.002490129,0.00006978818,0.000035192974,0.00015737396],"genre_scores_gemma":[0.67095184,0.317242,0.000019854091,0.010357392,0.000006356276,0.00030227652,0.000034695226,0.000020494495,0.0010650912],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974099,0.00043771244,0.0011641936,0.00024072111,0.00042967784,0.0003178065],"domain_scores_gemma":[0.99809974,0.00026476636,0.00034851933,0.000834544,0.00018067118,0.00027174831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006173243,0.00022759796,0.0012058808,0.0002502599,0.000104729224,0.000065913715,0.00025377082,0.00004124664,0.00003053982],"category_scores_gemma":[0.0032904681,0.00014165099,0.0002997462,0.00054218975,0.00014169383,0.00023645698,0.00017958431,0.0001942687,0.00000698038],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001341028,0.00052954664,0.12473216,0.838306,0.0003130352,0.000047179372,0.0006825783,0.000002537368,0.0000015200164,0.0025010805,0.011092632,0.021657612],"study_design_scores_gemma":[0.0007928241,0.00004718869,0.35845014,0.637989,0.00009511169,0.0000069365065,0.00013572475,0.00012493655,0.0000032070404,0.0019957921,0.00024675517,0.00011238541],"about_ca_topic_score_codex":0.000012847999,"about_ca_topic_score_gemma":0.0000036878794,"teacher_disagreement_score":0.5572091,"about_ca_system_score_codex":0.000024475605,"about_ca_system_score_gemma":0.00071067724,"threshold_uncertainty_score":0.57763594},"labels":[],"label_agreement":null},{"id":"W4411431438","doi":"10.1016/j.ard.2025.05.188","title":"OP0175 ESTABLISHING DEFINITIONS FOR DIFFICULT-TO-TREAT PSORIATIC ARTHRITIS (D2T-PsA) AND COMPLEX-TO-MANAGE PSORIATIC ARTHRITIS (C2M-PsA): INSIGHTS FROM THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) INITIATIVE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of Toronto; Women's College Hospital","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Arthritis; Dermatology; Immunology","score_opus":0.10770370491599082,"score_gpt":0.38717710004384903,"score_spread":0.2794733951278582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95263773,0.0211835,0.0037262298,0.013784871,0.00036291906,0.006306121,0.001668827,0.000040577557,0.00028923192],"genre_scores_gemma":[0.9772538,0.015929952,0.004315531,0.00072840566,0.000079774916,0.0013815442,0.00023942992,0.00004236323,0.000029234066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967,0.00047179384,0.0010416358,0.0006243905,0.00067447353,0.00048773267],"domain_scores_gemma":[0.99061686,0.0072699185,0.00033995052,0.00067279977,0.0007901468,0.00031032856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007642695,0.00036999845,0.0010765591,0.00040520725,0.0007591032,0.0002134091,0.0002882304,0.00011701672,0.00001913384],"category_scores_gemma":[0.006070034,0.0002564544,0.00027521394,0.0009038501,0.0006355542,0.00030838733,0.00028216638,0.00020726751,9.3938115e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096375303,0.0022712226,0.004488394,0.007492847,0.001481077,0.0000034554491,0.00891564,0.000056009565,0.00029451636,0.10328689,0.017812667,0.8529335],"study_design_scores_gemma":[0.007152563,0.002059888,0.7118248,0.012037799,0.00063006405,0.0000031446054,0.009117846,0.0021148464,0.00008081031,0.2538175,0.00077576406,0.0003849923],"about_ca_topic_score_codex":0.0005227714,"about_ca_topic_score_gemma":0.0008044023,"teacher_disagreement_score":0.85254854,"about_ca_system_score_codex":0.0000368143,"about_ca_system_score_gemma":0.00016563211,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W4411431464","doi":"10.1016/j.ard.2025.05.101","title":"OP0079 Clinical, Cellular Kinetics, Pharmacodynamics and Biomarker Data Up to 12 Months After YTB323 (Rapcabtagene Autoleucel), a Rapidly Manufactured CD19 CAR-T Therapy, From an Open-Label, Phase 1/2 Study in Severe Refractory SLE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacodynamics; Biomarker; Pharmacology; Pharmacokinetics","score_opus":0.1711146996053166,"score_gpt":0.4758479427257691,"score_spread":0.30473324312045247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432326,0.007075854,0.000033564815,0.002145094,0.0005462901,0.004176105,0.0015405333,0.000044804845,0.000114516835],"genre_scores_gemma":[0.99092245,0.0038334185,0.00017614121,0.002331826,0.000053464955,0.00017851013,0.00037893126,0.00007426898,0.0020509604],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99544144,0.001085979,0.0012109424,0.0010062044,0.00073467696,0.0005207508],"domain_scores_gemma":[0.9951413,0.000663137,0.00028072673,0.0032065741,0.0001913832,0.00051684614],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013196757,0.00045149785,0.0011274555,0.00030308217,0.000105394516,0.00018072037,0.0019491772,0.0001396638,0.0012023681],"category_scores_gemma":[0.000509309,0.00033011127,0.00012914668,0.00046588664,0.00027156208,0.00036316115,0.0017235412,0.0003527192,0.000008832988],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042743124,0.03820259,0.056654118,0.0005703232,0.0044519366,0.00020679616,0.0029806593,0.000022751843,0.03696692,0.000004295448,0.037121598,0.7800749],"study_design_scores_gemma":[0.08676921,0.009345207,0.84106195,0.003146023,0.0017628242,0.0000070185133,0.0035131874,0.019569773,0.010677744,0.0010906517,0.021534141,0.0015222823],"about_ca_topic_score_codex":0.0015186069,"about_ca_topic_score_gemma":0.00041387219,"teacher_disagreement_score":0.7844078,"about_ca_system_score_codex":0.00005348088,"about_ca_system_score_gemma":0.00038027434,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W4411431504","doi":"10.1016/j.ard.2025.05.052","title":"OP0386 PREDICTORS OF PRESENTEEISM OVER TIME IN INDIVIDUALS WITH INFLAMMATORY AND NON-INFLAMMATORY ARTHRITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Canada; University of British Columbia","funders":"","keywords":"Medicine; Inflammatory arthritis; Arthritis; Presenteeism; Internal medicine; Inflammation; Immunology; Physical therapy; Absenteeism","score_opus":0.007335725850077911,"score_gpt":0.26038972072748795,"score_spread":0.25305399487741004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411431504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847949,0.012651226,0.0000035658575,0.000890417,0.000051175448,0.00079182984,0.00008143642,0.000021807022,0.0007136418],"genre_scores_gemma":[0.9874699,0.01187371,0.00002674344,0.00011414569,0.000012902023,0.00006265286,0.000009106337,0.000017906015,0.00041289983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982613,0.0001325331,0.00057111273,0.00020540571,0.0005361129,0.000293548],"domain_scores_gemma":[0.99871814,0.00029073507,0.00021018274,0.0004922824,0.0001341673,0.00015451088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031025923,0.00018491183,0.00056640385,0.00029382063,0.00005881027,0.000023640512,0.00022452112,0.000059810664,0.00011032323],"category_scores_gemma":[0.00046627744,0.00012357792,0.00012779566,0.00028903614,0.0006071597,0.0001909957,0.00017659755,0.00013385876,0.0000042282813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002819632,0.00035241013,0.979238,0.0009794403,0.00056898623,0.00001020051,0.0006437217,0.000018527235,0.00020196057,0.00044218285,0.006894517,0.010368099],"study_design_scores_gemma":[0.0027181003,0.00018307933,0.9841771,0.008930106,0.000021189724,0.0000057373136,0.00016920845,0.0001279578,0.0017192679,0.0011932306,0.00064771634,0.00010728652],"about_ca_topic_score_codex":0.000056535155,"about_ca_topic_score_gemma":0.000025606161,"teacher_disagreement_score":0.010260813,"about_ca_system_score_codex":0.000010062541,"about_ca_system_score_gemma":0.0003316202,"threshold_uncertainty_score":0.5039362},"labels":[],"label_agreement":null},{"id":"W4411432504","doi":"10.1016/j.ard.2025.06.1590","title":"ABS0740 UPADACITINIB'S EFFECT ON PAIN CONTROL IN RHEUMATOID ARTHRITIS: A REAL-LIFE SINGLE-CENTER EXPERIENCE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Single Center; Pain control; Physical therapy; Internal medicine; Surgery","score_opus":0.019812852107013175,"score_gpt":0.29061709623020127,"score_spread":0.2708042441231881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411432504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990506,0.0028867454,0.0000484393,0.003045077,0.00020147626,0.00076423684,0.000042693486,0.000050462553,0.002454863],"genre_scores_gemma":[0.9892842,0.0015070154,0.000005549187,0.0089204265,0.000008551822,0.00013669036,0.0000058126443,0.000016636513,0.00011511097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981655,0.00042099762,0.0005184994,0.00025760487,0.0003229644,0.0003144697],"domain_scores_gemma":[0.9985733,0.0005515228,0.00015693514,0.0005119605,0.00006068777,0.00014558861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034245406,0.00021385445,0.00056945335,0.000113162125,0.00007470948,0.000027190568,0.00021700092,0.000048518246,0.00009732828],"category_scores_gemma":[0.0030529066,0.0001439765,0.0002780974,0.0002882,0.00019342569,0.00007417918,0.000054067274,0.0001116797,0.000007190448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009630276,0.007593061,0.49793807,0.0032951757,0.00043589843,0.0001125871,0.0020572178,0.00031215133,0.001559243,0.0029108934,0.06780646,0.40634897],"study_design_scores_gemma":[0.045881532,0.008412063,0.8417657,0.07355008,0.000168002,0.000031774,0.0048607374,0.008616793,0.002989444,0.003802287,0.008546034,0.0013755781],"about_ca_topic_score_codex":0.0001535057,"about_ca_topic_score_gemma":0.00004558455,"teacher_disagreement_score":0.4049734,"about_ca_system_score_codex":0.000017927649,"about_ca_system_score_gemma":0.00009801855,"threshold_uncertainty_score":0.58711916},"labels":[],"label_agreement":null},{"id":"W4411432573","doi":"10.1016/j.ard.2025.06.791","title":"POS1445-HPR INVESTIGATION OF THE SYNERGISTIC BENEFITS OF COMBINING TOPICAL DICLOFENAC WITH STRUCTURED EXERCISE IN KNEE OSTEOARTHRITIS: A RANDOMIZED CONTROLLED TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Diclofenac; Randomized controlled trial; Physical therapy; Alternative medicine; Pharmacology; Internal medicine; Pathology","score_opus":0.01105711412063581,"score_gpt":0.25479369913484756,"score_spread":0.24373658501421175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411432573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190754,0.0028364433,0.0000052688774,0.00053509703,0.00034199006,0.0042322935,0.00001696526,0.000009939747,0.00011447134],"genre_scores_gemma":[0.9994141,0.00009651022,0.00002001731,0.00010397551,0.000017296577,0.0002652306,0.000005110122,0.000009705478,0.0000680874],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978424,0.00049692375,0.0009326513,0.00013386295,0.0004357806,0.00015843908],"domain_scores_gemma":[0.9973663,0.0013346242,0.00062285975,0.0004227009,0.00018347893,0.000070053306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059726037,0.00016612353,0.0016192601,0.00012327342,0.000045897086,0.0000072255175,0.00017669392,0.00006778728,0.000019144396],"category_scores_gemma":[0.003560568,0.00007957111,0.00042154145,0.00030249605,0.00044946017,0.000044343582,0.000061016515,0.00010893946,2.3764471e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9695303,0.00029966587,0.012730684,0.0024020674,0.00054548687,0.0000027114438,0.001001248,0.00038627052,0.00025140255,0.005102124,0.00015442206,0.0075936248],"study_design_scores_gemma":[0.8954862,0.0004469486,0.07225473,0.018884761,0.0012095937,0.0000012473018,0.0001720816,0.0006874287,0.0065208734,0.004230781,8.9633215e-7,0.00010449685],"about_ca_topic_score_codex":0.00006321975,"about_ca_topic_score_gemma":0.000017383187,"teacher_disagreement_score":0.07404414,"about_ca_system_score_codex":0.000010257075,"about_ca_system_score_gemma":0.000319118,"threshold_uncertainty_score":0.42625898},"labels":[],"label_agreement":null},{"id":"W4411432910","doi":"10.1016/j.ard.2025.05.714","title":"POS0327 EFFICACY OF TWO YEARS OF TREATMENT WITH ANTI-IL-5/R THERAPIES ACCORDING TO HISTORIC DISEASE SEVERITY IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Granulomatosis with polyangiitis; Eosinophilic; Anakinra; Dermatology; Rituximab; Microscopic polyangiitis; Churg-strauss syndrome; Disease; Immunology; Vasculitis; Internal medicine; Pathology; Antibody","score_opus":0.01341933210807576,"score_gpt":0.2751599682438605,"score_spread":0.26174063613578474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411432910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957716,0.0017745371,0.000010639722,0.0008165215,0.000040733157,0.0012457548,0.00025325725,0.000026605365,0.00006038604],"genre_scores_gemma":[0.99927366,0.00018047162,0.00019139076,0.00017797465,0.0000067976316,0.00005495213,0.000022975599,0.0000337967,0.00005797755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828714,0.00010160315,0.0004935841,0.00030845523,0.0005245704,0.00028462973],"domain_scores_gemma":[0.9981526,0.00024205781,0.00034271312,0.00082447316,0.00024458172,0.00019356231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007745719,0.0002783912,0.0008445756,0.00034394563,0.000048643327,0.000010299431,0.00025007725,0.000028940989,0.000015866082],"category_scores_gemma":[0.00014591141,0.00016881287,0.00016080869,0.0009310307,0.00028126722,0.000115551986,0.000069799426,0.00005976404,0.0000011115553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025043616,0.0023992932,0.97163904,0.00062370946,0.0006380853,0.000008709491,0.0007138652,0.00011087247,0.000035988578,0.00010601282,0.00006272352,0.021157335],"study_design_scores_gemma":[0.005141673,0.0015737304,0.9859569,0.0054547666,0.0006054877,0.0000016,0.00015534459,0.000013712322,0.0007947044,0.00013384128,0.000009294018,0.00015896192],"about_ca_topic_score_codex":0.00096276775,"about_ca_topic_score_gemma":0.000044317312,"teacher_disagreement_score":0.020998374,"about_ca_system_score_codex":0.00011620242,"about_ca_system_score_gemma":0.00039005998,"threshold_uncertainty_score":0.6883989},"labels":[],"label_agreement":null},{"id":"W4411432922","doi":"10.1016/j.ard.2025.06.077","title":"POS0717 VALIDATION OF ANTI-14-3-3? (ETA) MULTIPLEX LABORATORY DEVELOPED TEST (LDT) FOR THE DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS (axSpA)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Axial spondyloarthritis; Multiplex; Test (biology); Ankylosing spondylitis; Medical physics; Internal medicine; Physical therapy; Bioinformatics; Sacroiliitis","score_opus":0.028365228906301783,"score_gpt":0.32006883981958983,"score_spread":0.29170361091328806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411432922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312776,0.002873846,0.00035987925,0.0012835584,0.00025109755,0.0007262409,0.0013033134,0.0000068702957,0.00006740314],"genre_scores_gemma":[0.9979251,0.0011603482,0.00024093935,0.00015416404,0.00003123843,0.00023597907,0.00006881547,0.000013705543,0.0001696974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898195,0.00010061767,0.00044476188,0.00016968313,0.00016097806,0.00014203256],"domain_scores_gemma":[0.99795216,0.00055211317,0.00033550803,0.00053483027,0.0005930077,0.000032399243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021756272,0.00012902108,0.0002387463,0.00005503592,0.00010511557,0.000014609623,0.00040366247,0.0000660499,0.000029998466],"category_scores_gemma":[0.0048153363,0.00009083945,0.00023938867,0.00020691587,0.00020658196,0.000012296543,0.0001400711,0.00004145545,0.0000012522531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010838258,0.003828889,0.29418734,0.0035271484,0.0032040179,0.0000011750103,0.0005692511,0.0028132638,0.49343008,0.0016002782,0.11300112,0.082753606],"study_design_scores_gemma":[0.00053586136,0.00012310965,0.09717222,0.00054692343,0.00012983156,5.226435e-7,0.00012752402,0.000094185525,0.89704216,0.00029506462,0.0038294543,0.000103163766],"about_ca_topic_score_codex":0.00007099977,"about_ca_topic_score_gemma":0.000027125676,"teacher_disagreement_score":0.40361205,"about_ca_system_score_codex":0.000004954648,"about_ca_system_score_gemma":0.00022786969,"threshold_uncertainty_score":0.5764755},"labels":[],"label_agreement":null},{"id":"W4411432923","doi":"10.1016/j.ard.2025.05.801","title":"POS0415-HPR DEVELOPING A REHABILITATION REGISTRY IN RHEUMATOLOGY: FROM CORE SET SELECTION TO FUTURE APPLICATIONS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatology; Rehabilitation; Core (optical fiber); Selection (genetic algorithm); Internal medicine; Physical therapy; Family medicine; Medical physics; Artificial intelligence","score_opus":0.026840566032048166,"score_gpt":0.35249448474811385,"score_spread":0.3256539187160657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411432923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624332,0.004447944,0.0012442813,0.030296035,0.00012689328,0.0011242501,0.000085039246,0.00005188914,0.0001904742],"genre_scores_gemma":[0.99446756,0.0026804744,0.0016953971,0.0005800416,0.000017303082,0.00037860734,0.000062100065,0.000012789367,0.00010573433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866575,0.00011974247,0.00046757777,0.00024511156,0.0002655312,0.00023628378],"domain_scores_gemma":[0.99862623,0.00045401294,0.00012992782,0.0004496856,0.0002360768,0.00010405737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020270392,0.00013588033,0.0003704801,0.00022977205,0.00012670699,0.00002960715,0.00023359337,0.000069877744,0.000056028282],"category_scores_gemma":[0.0010835925,0.00010404727,0.00012910234,0.0008149757,0.00012513496,0.00010882992,0.0000831952,0.00013242433,0.000014937261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013235682,0.0009445759,0.6787116,0.0028121124,0.000702184,0.0000033703002,0.004318815,0.00017312179,0.0006535293,0.06411593,0.079942025,0.16629916],"study_design_scores_gemma":[0.001380371,0.000148958,0.90763277,0.006807936,0.000021554115,0.000010337329,0.0044884165,0.00035193653,0.00058030104,0.06459292,0.013786561,0.00019792077],"about_ca_topic_score_codex":0.000515653,"about_ca_topic_score_gemma":0.0002539569,"teacher_disagreement_score":0.22892119,"about_ca_system_score_codex":0.000048132926,"about_ca_system_score_gemma":0.00047291344,"threshold_uncertainty_score":0.42429245},"labels":[],"label_agreement":null},{"id":"W4411433001","doi":"10.1016/j.ard.2025.05.402","title":"POS0005 Inhaled Pirfenidone as an innovative therapeutic approach to treat autoimmune ILD and other forms of Progressive Pulmonary Fibrosis: Phase 2b Study Design","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pirfenidone; Pulmonary fibrosis; Idiopathic pulmonary fibrosis; Fibrosis; Immunology; Intensive care medicine; Internal medicine; Lung","score_opus":0.04320937028852039,"score_gpt":0.35698412367192073,"score_spread":0.31377475338340033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876417,0.0052821296,0.00029230828,0.00066626177,0.000053459436,0.0033079048,0.0002233851,0.000050105584,0.0013603056],"genre_scores_gemma":[0.9980732,0.00006063274,0.00019074601,0.0009150432,0.000019764091,0.000334254,0.000026667582,0.000034698744,0.0003449805],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978664,0.0003113734,0.0007051063,0.00039034398,0.0004209011,0.00030588012],"domain_scores_gemma":[0.9982235,0.00013586227,0.00033957118,0.0007375304,0.00038399154,0.00017954572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032714067,0.00032848213,0.00077888434,0.00025537523,0.00014856501,0.000034231973,0.00033648632,0.00007130766,0.0000337082],"category_scores_gemma":[0.00020173509,0.00020530872,0.00021520934,0.0008093849,0.00029198203,0.00019996233,0.00017895809,0.00011344645,0.0000017823811],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21117166,0.18808325,0.041017633,0.018819897,0.011520189,0.00025623402,0.033774134,0.00037929323,0.025872461,0.023077372,0.0028584078,0.44316947],"study_design_scores_gemma":[0.03362891,0.11450187,0.6496329,0.0394504,0.0118033495,0.0004524983,0.05676989,0.016636493,0.037225332,0.036457453,0.00039968773,0.0030412371],"about_ca_topic_score_codex":0.00013533591,"about_ca_topic_score_gemma":4.841604e-7,"teacher_disagreement_score":0.6086153,"about_ca_system_score_codex":0.000025772837,"about_ca_system_score_gemma":0.00027161604,"threshold_uncertainty_score":0.83722466},"labels":[],"label_agreement":null},{"id":"W4411433090","doi":"10.1016/j.ard.2025.05.193","title":"OP0180 ACUTE PSORIATIC DACTYLITIS: THE ROLE OF HLA GENETIC SUSCEPTIBILITY MARKERS AND CLINICAL ASSOCIATIONS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Krembil Foundation","funders":"","keywords":"Medicine; Dactylitis; Human leukocyte antigen; Psoriasis; Psoriatic arthritis; Immunology; Dermatology; Genetic predisposition; Enthesitis; Pathology; Antigen; Disease","score_opus":0.021213516087357383,"score_gpt":0.3561037147869903,"score_spread":0.33489019869963293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97483414,0.018613087,0.000014219831,0.0046416814,0.0001317205,0.00063791126,0.00019722935,0.000017870363,0.0009121649],"genre_scores_gemma":[0.97338533,0.026032567,0.00008462246,0.00025232128,0.000017548657,0.000024956209,0.000009960044,0.00000890263,0.00018380037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980652,0.00044646332,0.00068344944,0.00018080985,0.0003922443,0.00023186154],"domain_scores_gemma":[0.9974741,0.0012546167,0.00025910573,0.00065153657,0.00023561709,0.0001250752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006808643,0.00012258769,0.0004709036,0.000060794402,0.00015433766,0.000028780667,0.00028263213,0.000051087296,0.00009381367],"category_scores_gemma":[0.003074687,0.00007047538,0.0003302912,0.000239393,0.000619548,0.00006282658,0.0001595941,0.0001341799,0.0000036388922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040935204,0.0009068931,0.7035118,0.00035405907,0.0030127617,0.0000015425018,0.00047134655,0.000003808515,0.000051286206,0.0031913195,0.007899912,0.2801859],"study_design_scores_gemma":[0.0008382028,0.00016761437,0.9742644,0.00077217765,0.00015746731,0.0000023546559,0.0007022603,0.00043336037,0.00017510935,0.021927468,0.0004994457,0.000060126327],"about_ca_topic_score_codex":0.00018869143,"about_ca_topic_score_gemma":0.00005015509,"teacher_disagreement_score":0.2801258,"about_ca_system_score_codex":0.000011777394,"about_ca_system_score_gemma":0.0002851258,"threshold_uncertainty_score":0.36809096},"labels":[],"label_agreement":null},{"id":"W4411433180","doi":"10.1016/j.ard.2025.06.628","title":"POS1278 VALIDATION OF HANDHELD ULTRASOUND DEVICES FOR POINT OF CARE USE IN RHEUMATOLOGY: ANALYSIS FOR JOINTS AND NAILS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Novartis (Canada); University of Ottawa","funders":"","keywords":"Medicine; Rheumatology; Mobile device; Internal medicine; Point of care; Medical physics; Pathology; World Wide Web","score_opus":0.04294756298827672,"score_gpt":0.3269548125089287,"score_spread":0.284007249520652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98619103,0.011807592,0.00015826797,0.00034855306,0.00006632412,0.0009645022,0.0004371531,0.0000074920736,0.000019094792],"genre_scores_gemma":[0.9983769,0.0012093516,0.00014941124,0.00006742314,0.0000021537203,0.00007037445,0.00007638919,0.000007966344,0.00004003529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870926,0.00007754291,0.0007464414,0.00017395482,0.00015849469,0.00013428397],"domain_scores_gemma":[0.9973063,0.0014274691,0.00047068234,0.00033120107,0.0004068537,0.000057489342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021581749,0.00012102372,0.00076806906,0.0003060647,0.000041743235,0.00001208643,0.000111614856,0.00007265167,0.000011380891],"category_scores_gemma":[0.0025458431,0.00007941809,0.0004472519,0.0004285067,0.00012955882,0.00008324481,0.00003206786,0.000026691097,1.1844786e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065011083,0.0003677588,0.9816552,0.010524099,0.0024104873,1.1614076e-7,0.0007284242,0.00019689374,0.00065190194,0.00053418387,0.0008069812,0.0014738893],"study_design_scores_gemma":[0.001964618,0.00015972706,0.95630556,0.012566051,0.003434034,0.0000015405903,0.0030839636,0.00034020934,0.02089416,0.0011484697,0.0000074421746,0.00009422338],"about_ca_topic_score_codex":0.0003158981,"about_ca_topic_score_gemma":0.000064459906,"teacher_disagreement_score":0.025349593,"about_ca_system_score_codex":0.000010354121,"about_ca_system_score_gemma":0.0001138584,"threshold_uncertainty_score":0.32385755},"labels":[],"label_agreement":null},{"id":"W4411433296","doi":"10.1016/j.ard.2025.06.1750","title":"ABS0635 FACTORS ASSOCIATED WITH PHYSICAL ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. INSIGHTS FROM THE IMAS STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Axial spondyloarthritis; Physical therapy; Intensive care medicine; Ankylosing spondylitis; Internal medicine; Sacroiliitis","score_opus":0.02345641084793461,"score_gpt":0.2808321612633493,"score_spread":0.2573757504154147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751556,0.00039751554,7.309939e-7,0.0003834874,0.0000746222,0.0012119076,0.00024056871,0.00002278114,0.00015280108],"genre_scores_gemma":[0.9996924,0.000023090166,0.0000016132258,0.00010442717,0.000010545869,0.00005893503,0.0000455303,0.000015355796,0.00004810509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866706,0.00016462401,0.0001967628,0.00024850678,0.0005051147,0.0002179414],"domain_scores_gemma":[0.9986664,0.00049061095,0.00017741966,0.00046136347,0.00014127462,0.0000629042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040260536,0.00023172978,0.0005634182,0.000050923787,0.00017603302,0.000022926595,0.00017142581,0.000028496948,0.000016146207],"category_scores_gemma":[0.00031444212,0.00010249326,0.00013120467,0.00041718912,0.00020205835,0.00009796689,0.00010671711,0.00012319411,0.0000019436236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011135415,0.008231216,0.9826675,0.000019349007,0.0011807835,0.000008850014,0.0011321828,0.000006195045,0.0000013462005,0.000038857706,0.00020363314,0.005396544],"study_design_scores_gemma":[0.0072304155,0.0008552771,0.9886709,0.0014108332,0.00039498578,6.098422e-8,0.00089216285,0.000011876541,0.000086941815,0.00033535418,0.000008888023,0.00010233781],"about_ca_topic_score_codex":0.00074233563,"about_ca_topic_score_gemma":0.0008624543,"teacher_disagreement_score":0.0073759393,"about_ca_system_score_codex":0.000036841346,"about_ca_system_score_gemma":0.000110735535,"threshold_uncertainty_score":0.41795537},"labels":[],"label_agreement":null},{"id":"W4411433307","doi":"10.1016/j.ard.2025.06.1739","title":"ABS0543 INTERIM ANALYSIS OF A EUROPEAN REAL-WORLD STUDY ON THE EFFECTIVENESS, PHYSICIAN SATISFACTION, AND PATIENT CHARACTERISTICS IN PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB: INSIGHTS FROM GERMANY, SPAIN, AND THE UNITED KINGDOM","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Interim; Interim analysis; Family medicine; Arthritis; Alternative medicine; Internal medicine; Pathology","score_opus":0.12840801768473617,"score_gpt":0.3660408788624373,"score_spread":0.23763286117770113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527687,0.0005641658,0.000030825777,0.002445087,0.00005964103,0.0010804092,0.00028961815,0.00001023904,0.00024316696],"genre_scores_gemma":[0.99805945,0.0003439927,0.000004895326,0.0014637008,0.000009644623,0.00008008325,0.00001935487,0.000013004126,0.000005846971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995435,0.0023298017,0.0017342896,0.00027478798,0.00009827368,0.00012783805],"domain_scores_gemma":[0.9934896,0.004164364,0.0016463281,0.0005761298,0.000081830876,0.00004175258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002522735,0.00017044817,0.0010280713,0.00051550695,0.00015052853,0.000063307045,0.0001766579,0.0000202228,0.000012689578],"category_scores_gemma":[0.0015497495,0.00010509929,0.00010468247,0.0009125193,0.00023389404,0.00009977423,0.00008229618,0.00008827807,0.000004420959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059265905,0.0006155638,0.93620574,0.00033197072,0.0032924688,0.0000011824279,0.0065677306,0.00033661723,0.0000012211872,0.04719952,0.00020168684,0.004653646],"study_design_scores_gemma":[0.0011036491,0.000106018226,0.98844784,0.0011000518,0.00020454734,5.640201e-8,0.0012941596,0.0035578723,0.000004135409,0.004044991,0.000036984504,0.000099669756],"about_ca_topic_score_codex":0.014544143,"about_ca_topic_score_gemma":0.0017409805,"teacher_disagreement_score":0.052242134,"about_ca_system_score_codex":0.000050793285,"about_ca_system_score_gemma":0.000037345042,"threshold_uncertainty_score":0.9920181},"labels":[],"label_agreement":null},{"id":"W4411433367","doi":"10.1016/j.ard.2025.06.1386","title":"ABS0532 VALIDATION OF HANDHELD ULTRASOUND DEVICES FOR POINT OF CARE USE IN RHEUMATOLOGY: ANALYSIS FOR ENTHESITIS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Novartis (Canada); University of Ottawa","funders":"","keywords":"Medicine; Enthesitis; Rheumatology; Internal medicine; Mobile device; Medical physics; Arthritis","score_opus":0.041939603057128204,"score_gpt":0.32627392493558677,"score_spread":0.2843343218784586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881651,0.00942114,0.00034009365,0.00033321948,0.00008599298,0.0010159288,0.0005973207,0.000009733804,0.000031501364],"genre_scores_gemma":[0.99846476,0.0010263928,0.00015223374,0.00006620461,0.0000029054206,0.00010835419,0.0001149916,0.0000093471535,0.000054804466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985804,0.00008716831,0.00082658685,0.00017243648,0.00018658141,0.00014680371],"domain_scores_gemma":[0.9966833,0.0018922173,0.00052849855,0.0004049973,0.00043886172,0.000052142746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021277956,0.0001253047,0.00079985213,0.00032686416,0.00004056614,0.000010340545,0.00016110981,0.00007625358,0.000025084597],"category_scores_gemma":[0.0024631582,0.00008372193,0.00072105584,0.00051715487,0.00010849095,0.00007576288,0.00002690626,0.000026784386,2.5838168e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000708507,0.0005631586,0.9784073,0.010836506,0.0031719273,1.6358631e-7,0.0008097432,0.00075301935,0.0005653668,0.000737733,0.0013532414,0.0020933147],"study_design_scores_gemma":[0.0018030158,0.00015422665,0.94164866,0.014263461,0.0043085953,0.0000011214482,0.003366407,0.0003963831,0.03299669,0.00093814405,0.00001570275,0.00010760979],"about_ca_topic_score_codex":0.0004511819,"about_ca_topic_score_gemma":0.0000804347,"teacher_disagreement_score":0.036758676,"about_ca_system_score_codex":0.000015118755,"about_ca_system_score_gemma":0.00013945509,"threshold_uncertainty_score":0.3414081},"labels":[],"label_agreement":null},{"id":"W4411433390","doi":"10.1016/j.ard.2025.06.940","title":"ABS0783 DIAGNOSTIC DELAY IN SYSTEMIC AUTOINFLAMMATORY DISEASE: PRELIMINARY RESULTS FROM THE EUROFEVER REGISTRY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Systemic disease; Dermatology; Disease; Pathology","score_opus":0.025251561317765635,"score_gpt":0.28268928775695207,"score_spread":0.25743772643918644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90803134,0.079707235,0.000006020186,0.00915843,0.00056673976,0.0011457322,0.0006003675,0.00007468083,0.00070946413],"genre_scores_gemma":[0.99248314,0.0048454264,0.0000058064647,0.0012962259,0.000064266176,0.00011921302,0.00008047951,0.000026479476,0.0010789349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971808,0.00041407516,0.0011244925,0.00040559794,0.0005488747,0.0003261314],"domain_scores_gemma":[0.9936716,0.0037917816,0.00048524168,0.0016690337,0.00015620381,0.00022614283],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00039490097,0.0002775525,0.0005510521,0.00010090921,0.00014672158,0.000037221944,0.0006298291,0.000106684114,0.00004482717],"category_scores_gemma":[0.009347447,0.00015076541,0.00044217063,0.0004662197,0.00027888519,0.00008971634,0.00023169852,0.00020811368,0.00003646118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007581105,0.002205996,0.51021504,0.0047430014,0.0019499816,0.00030208039,0.0017670747,0.002257662,0.00015709014,0.0013621345,0.44666034,0.020798488],"study_design_scores_gemma":[0.0018459577,0.000042720916,0.9486471,0.045783345,0.000766089,0.000009393336,0.0006723921,0.00074572564,0.00008493439,0.00081131584,0.00043288543,0.00015817808],"about_ca_topic_score_codex":0.0002846775,"about_ca_topic_score_gemma":0.000008075275,"teacher_disagreement_score":0.44622746,"about_ca_system_score_codex":0.000046501704,"about_ca_system_score_gemma":0.0005973811,"threshold_uncertainty_score":0.9989972},"labels":[],"label_agreement":null},{"id":"W4411433433","doi":"10.1016/j.ard.2025.06.1009","title":"ABS1194-HPR INVESTIGATION OF BALANCE AND CORE ENDURANCE IN PATIENTS WITH FIBROMYALGIA SYNDROME","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fibromyalgia; Physical therapy; Balance (ability); Fibromyalgia syndrome; Core (optical fiber); Chronic fatigue syndrome; Physical medicine and rehabilitation; Internal medicine","score_opus":0.02029957343695527,"score_gpt":0.2827946371619792,"score_spread":0.26249506372502396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694574,0.0015234329,0.00000373106,0.0008914829,0.000026149326,0.00048394527,0.000037038437,0.00000904522,0.00007944596],"genre_scores_gemma":[0.9995429,0.0001448107,0.00007112161,0.000018581897,5.9283724e-7,0.000017892533,0.000018362254,0.000008569084,0.0001771559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890727,0.00005225249,0.00032767365,0.00016142041,0.00036779753,0.00018359494],"domain_scores_gemma":[0.9991237,0.00013802019,0.0001470266,0.00036981006,0.00014240418,0.000079050675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011110116,0.0001155909,0.0003613907,0.00012210144,0.00003296429,0.000006556737,0.00014745795,0.00004012873,0.000032356547],"category_scores_gemma":[0.00024779877,0.000073770774,0.000058605474,0.00043074178,0.00034243776,0.00008397714,0.000069150585,0.00008908693,0.0000014406355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021153092,0.00015128164,0.98543704,0.012071234,0.0001101658,0.0000023015139,0.00012604862,0.000014408092,0.00006261598,0.0003506391,0.00072717894,0.0007355569],"study_design_scores_gemma":[0.0014384532,0.00023852623,0.98178184,0.014403777,0.000043109212,0.0000033084154,0.000048699632,0.00022169627,0.0004509405,0.0013053311,0.0000015415321,0.00006279634],"about_ca_topic_score_codex":0.0000706806,"about_ca_topic_score_gemma":8.6383614e-7,"teacher_disagreement_score":0.003655218,"about_ca_system_score_codex":0.000018410525,"about_ca_system_score_gemma":0.00023377157,"threshold_uncertainty_score":0.3008285},"labels":[],"label_agreement":null},{"id":"W4411433443","doi":"10.1016/j.ard.2025.06.1199","title":"ABS0240 MECHANO-ACTIVATED CHONDROPROGENITORS (MACS) DERIVED FROM ARTICULAR CHONDROCYTES, WHICH DRIVE INTRINSIC CARTILAGE REPAIR","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cartilage; Articular cartilage; Anatomy; Pathology; Osteoarthritis","score_opus":0.016347225159268706,"score_gpt":0.2770299096198082,"score_spread":0.2606826844605395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794879,0.0154751185,0.0004714966,0.0027907244,0.00079782214,0.0005849668,0.000052622854,0.00022236776,0.000116956006],"genre_scores_gemma":[0.99701285,0.00036719628,0.000327705,0.00023031348,0.000105489875,0.000059208505,0.00005420575,0.00003105543,0.0018119668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983143,0.00011748533,0.0005113299,0.00033092502,0.00041224845,0.00031370594],"domain_scores_gemma":[0.99834013,0.000171873,0.00017015195,0.0007942579,0.00031148904,0.00021210748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011702805,0.0002855703,0.0006611055,0.0001595757,0.0001223856,0.000011895998,0.00021419537,0.00009240654,0.00015331025],"category_scores_gemma":[0.0012020948,0.00018147033,0.000327746,0.0007146951,0.00014946064,0.00006906251,0.0001108598,0.00018571063,0.000019294237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013248854,0.0025951618,0.024301706,0.0035887675,0.007254387,0.00016588581,0.0035252722,0.0021773018,0.8721107,0.002796728,0.048049174,0.032109987],"study_design_scores_gemma":[0.0016380318,0.00016418089,0.07503605,0.0034164265,0.00086488883,0.000008854693,0.0004989065,0.0012861192,0.9147097,0.00051731954,0.0016147812,0.0002447315],"about_ca_topic_score_codex":0.0001473475,"about_ca_topic_score_gemma":0.000012819057,"teacher_disagreement_score":0.050734345,"about_ca_system_score_codex":0.00004041475,"about_ca_system_score_gemma":0.00020063571,"threshold_uncertainty_score":0.7400145},"labels":[],"label_agreement":null},{"id":"W4411433548","doi":"10.1016/j.ard.2025.06.609","title":"POS1259 THINK OUTSIDE THE JOINTS: THE IMPACT OF REGIONAL AND WIDESPREAD NON-ARTICULAR PAIN ON SYMPTOMS AND FUNCTION IN THE CANADIAN EARLY ARTHRITIS COHORT","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Hip disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Research Canada; University of Manitoba; Canadian Rheumatology Association; Université Laval; University of Toronto; Arthritis Research Centre of Canada; McGill University; University of Calgary; Université de Sherbrooke","funders":"","keywords":"Medicine; Cohort; Arthritis; Physical therapy; Internal medicine","score_opus":0.015464656412108462,"score_gpt":0.2863356481153515,"score_spread":0.270870991703243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97912186,0.0034651884,0.000003754637,0.016115319,0.000030233039,0.00079220143,0.00003567666,0.000004315309,0.00043145524],"genre_scores_gemma":[0.9970006,0.0006413506,0.0000014737453,0.0022289983,0.000006147383,0.000043698008,0.00000843771,0.000006834803,0.00006247811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989393,0.00026925353,0.00024340389,0.00012772583,0.00024702158,0.00017332198],"domain_scores_gemma":[0.99876934,0.0005612928,0.00010273712,0.00042525717,0.00006475854,0.00007663664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058334233,0.00012944957,0.00024560798,0.00007151514,0.00019459015,0.00003762439,0.00012921498,0.000035519097,0.000015484206],"category_scores_gemma":[0.00051768,0.00005021868,0.0001491282,0.00019274502,0.0002720388,0.000050376424,0.000025089623,0.000094315335,0.0000015644174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024097467,0.00035488058,0.94881326,0.00009932747,0.00097120827,0.000007576056,0.0022495904,0.000048050733,0.0000072196326,0.0010444403,0.010548737,0.035614733],"study_design_scores_gemma":[0.000667483,0.00033413578,0.98977613,0.0012792702,0.00018113798,0.0000055292785,0.00068966043,0.00030388334,0.000019022866,0.0066664326,0.000032309992,0.000045009307],"about_ca_topic_score_codex":0.06598174,"about_ca_topic_score_gemma":0.012405521,"teacher_disagreement_score":0.053576216,"about_ca_system_score_codex":0.00002159453,"about_ca_system_score_gemma":0.00021751744,"threshold_uncertainty_score":0.940238},"labels":[],"label_agreement":null},{"id":"W4411433553","doi":"10.1016/j.ard.2025.06.818","title":"POS1474-HPR VALIDATION OF THE DANISH TRANSLATION OF THE ILLNESS INTRUSIVENESS RATING SCALE IN PATIENTS WITH RHEUMATIC DISEASE","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Danish; Rating scale; Disease; Severity of illness; Physical therapy; Scale (ratio); Internal medicine; Statistics","score_opus":0.01701024765021691,"score_gpt":0.30371411222644046,"score_spread":0.28670386457622354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595076,0.000318437,0.000086064996,0.0023040967,0.00018372326,0.0009341884,0.000088137465,0.000008546514,0.00012603306],"genre_scores_gemma":[0.99959326,0.000055384156,0.000036640242,0.00020398207,0.0000054701277,0.000030140895,0.000020761063,0.0000113739925,0.00004298596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980988,0.0002912949,0.00073112914,0.00016306098,0.0005679114,0.00014782517],"domain_scores_gemma":[0.9952994,0.0030409065,0.00057683,0.0007121252,0.00029881555,0.000071900104],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0003315785,0.00014153967,0.0004263897,0.000057666985,0.0000945132,0.000011701312,0.00033154778,0.00004070103,0.00002379395],"category_scores_gemma":[0.015760344,0.00006752292,0.000248762,0.0005818339,0.000297821,0.000076712844,0.00009412725,0.00009473569,5.1638426e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046253207,0.001102867,0.96943855,0.0011406698,0.00010466954,1.1708826e-7,0.0005923095,0.0015675313,0.0000096036765,0.00026160013,0.00013533956,0.02518423],"study_design_scores_gemma":[0.0016423787,0.000057259236,0.96777844,0.025079323,0.00037051563,1.4491361e-7,0.00022953005,0.00067200983,0.0019353295,0.002158643,0.0000026958928,0.000073732204],"about_ca_topic_score_codex":0.00012435946,"about_ca_topic_score_gemma":0.000016006286,"teacher_disagreement_score":0.025110498,"about_ca_system_score_codex":0.000016653968,"about_ca_system_score_gemma":0.0003160706,"threshold_uncertainty_score":0.99253035},"labels":[],"label_agreement":null},{"id":"W4411433611","doi":"10.1016/j.ard.2025.06.731","title":"POS1383 AUTOANTIBODIES IDENTIFIED IN MYOSITIS-SPECIFIC AUTOANTIBODY NEGATIVE JUVENILE MYOSITIS PATIENTS USING IMMUNOPRECIPITATION-MASS SPECTROMETRY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Autoantibody; Medicine; Myositis; Immunoprecipitation; Juvenile; Immunology; Antibody; Pathology; Genetics; Biology","score_opus":0.017842483687874843,"score_gpt":0.30321761155417315,"score_spread":0.2853751278662983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247885,0.0029752206,0.00029727386,0.00087283505,0.00075045193,0.00083585177,0.00018864374,0.00006721151,0.00153364],"genre_scores_gemma":[0.9976875,0.00061995955,0.0007500194,0.0004447272,0.000029024355,0.000025261794,0.0000641862,0.00003174412,0.00034758833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972539,0.00030211924,0.0010568795,0.00035324064,0.00057723094,0.00045662106],"domain_scores_gemma":[0.99780107,0.0004873759,0.00047203575,0.00070134836,0.00043058657,0.00010756608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003205256,0.00031470586,0.0008014676,0.0005345424,0.00026668078,0.00009313303,0.0003459751,0.00010144939,0.00016068968],"category_scores_gemma":[0.0007373779,0.00025787094,0.00041209857,0.0009713347,0.0002796868,0.00035481408,0.0001689812,0.00020749978,0.000022855102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002951353,0.004355802,0.87624687,0.0073062596,0.0029878002,0.00027471664,0.008548133,0.0011158129,0.01637683,0.019881751,0.033762787,0.026191887],"study_design_scores_gemma":[0.001717941,0.00008787995,0.9754187,0.004898714,0.00018877849,0.000008627739,0.0007750196,0.0012482074,0.00920036,0.006083227,0.00011738662,0.00025514752],"about_ca_topic_score_codex":0.00019269403,"about_ca_topic_score_gemma":0.0000075090206,"teacher_disagreement_score":0.09917185,"about_ca_system_score_codex":0.000117798394,"about_ca_system_score_gemma":0.00025837854,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W4411433641","doi":"10.1016/j.ard.2025.06.229","title":"POS0874 THE EFFECT OF INFLAMMATION ON CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS VARIES ACCORDING TO SEX AND ANTICITRULLINATED PROTEIN ANTIBODY STATUS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Rheumatoid arthritis; Inflammation; Antibody; Internal medicine; Immunology","score_opus":0.009417658304246639,"score_gpt":0.2921106670713236,"score_spread":0.282693008767077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97391015,0.022754828,0.00009974357,0.0009935822,0.00005967741,0.0019530661,0.000060965493,0.000025379279,0.00014260331],"genre_scores_gemma":[0.96241605,0.037353657,0.000026606123,0.00003842239,0.0000079156725,0.00010879777,0.000011243723,0.000016234202,0.000021093694],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975657,0.0007183975,0.00056002935,0.00023603384,0.0005638987,0.00035592954],"domain_scores_gemma":[0.9981888,0.00072527135,0.00018179616,0.00065420923,0.00013435516,0.00011559182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010858017,0.00020996347,0.0007834206,0.00028722652,0.00017187277,0.000055459073,0.00021058746,0.000050574054,0.000011476453],"category_scores_gemma":[0.003589483,0.0001216256,0.0002955986,0.0005862569,0.00028469975,0.0001405274,0.00014728287,0.00018016798,0.0000032511648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023362837,0.0002516539,0.39282417,0.0019828219,0.0022480856,0.00001363002,0.0015635873,0.00093833776,0.002606882,0.0025372517,0.00021878326,0.5924785],"study_design_scores_gemma":[0.007653306,0.002076693,0.80865866,0.033002954,0.000098880155,0.000014450979,0.0019081976,0.0018258765,0.13672747,0.006885331,0.0007684273,0.00037976826],"about_ca_topic_score_codex":0.0007680595,"about_ca_topic_score_gemma":0.000023054237,"teacher_disagreement_score":0.5920988,"about_ca_system_score_codex":0.000015792402,"about_ca_system_score_gemma":0.00012113999,"threshold_uncertainty_score":0.49597478},"labels":[],"label_agreement":null},{"id":"W4411433673","doi":"10.1016/j.ard.2025.06.191","title":"POS0835 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 5-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 1 STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Sudbury","funders":"","keywords":"Medicine; Psoriatic arthritis; Term (time); Internal medicine; Oncology; Arthritis","score_opus":0.016036705484637245,"score_gpt":0.30899349870208265,"score_spread":0.2929567932174454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903302,0.0062108473,0.0000065868944,0.0010772446,0.00005746088,0.0016694346,0.0005285107,0.000015869477,0.00010380545],"genre_scores_gemma":[0.99397814,0.0057310327,0.000019039962,0.00010616974,0.000011777164,0.000025669055,0.00007417423,0.000014528209,0.00003947655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786717,0.0003217061,0.00071923324,0.00025795904,0.0005669176,0.0002670431],"domain_scores_gemma":[0.9977286,0.0010292322,0.00025288053,0.00065856305,0.00022249082,0.000108271684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035391687,0.00018483675,0.00057610194,0.00010501619,0.00011459742,0.000033468725,0.00027293264,0.00003130515,0.000056023655],"category_scores_gemma":[0.001833089,0.00010073922,0.00010386217,0.00040140387,0.0003099622,0.00010458993,0.000119263816,0.00014350908,0.0000026894338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017743472,0.006604924,0.7916361,0.00018500898,0.0010345322,0.0000072802372,0.002305517,0.000009225756,0.0000051587954,0.00015045353,0.00086464034,0.17945367],"study_design_scores_gemma":[0.031134866,0.0011190356,0.96145797,0.0050512357,0.000050823586,6.023142e-7,0.0006313635,0.000024592084,0.00010614922,0.00030582037,0.000026626445,0.000090944864],"about_ca_topic_score_codex":0.00028216158,"about_ca_topic_score_gemma":0.00013840366,"teacher_disagreement_score":0.17936273,"about_ca_system_score_codex":0.000010780224,"about_ca_system_score_gemma":0.00018292626,"threshold_uncertainty_score":0.41080263},"labels":[],"label_agreement":null},{"id":"W4411433754","doi":"10.1016/j.ard.2025.05.695","title":"POS0308 HEMODYNAMIC FORCES: A NOVEL CARDIAC MRI PARAMETER TO ASSESS CARDIAC INVOLVEMENT IN SARCOIDOSIS PATIENTS","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Cardiac sarcoidosis; Sarcoidosis; Hemodynamics; Cardiology; Internal medicine","score_opus":0.0636475483233101,"score_gpt":0.3564925118979491,"score_spread":0.292844963574639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919031,0.00092608866,0.000086314,0.0040281583,0.00028075092,0.0016290027,0.00037675552,0.000023090326,0.0007466911],"genre_scores_gemma":[0.9968912,0.00046849888,0.00023582001,0.0016003215,0.000018248096,0.00023590805,0.0000400862,0.000023742734,0.0004861516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743855,0.00018199522,0.00063854846,0.0003784208,0.00085776346,0.00050470943],"domain_scores_gemma":[0.9979204,0.00051984465,0.00013221393,0.00087352586,0.00031810292,0.00023593442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046247925,0.00025089193,0.00081776065,0.00035822153,0.000087212575,0.000050663606,0.00042998375,0.00007670552,0.00003699092],"category_scores_gemma":[0.0011044464,0.0001724109,0.000617601,0.00090951246,0.00011813306,0.000108053144,0.0003827951,0.00015860013,0.000015000519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033101233,0.0026941174,0.95447123,0.0015398453,0.0008849729,0.0000011174184,0.0004007508,0.00015732484,0.0011411514,0.0003972886,0.008688242,0.02929295],"study_design_scores_gemma":[0.0010400998,0.00020540418,0.9873111,0.0027590322,0.00023214803,1.2736594e-7,0.00033139955,0.00092058966,0.006095031,0.0005492447,0.00035923265,0.00019654629],"about_ca_topic_score_codex":0.0005680521,"about_ca_topic_score_gemma":0.000026384938,"teacher_disagreement_score":0.03283992,"about_ca_system_score_codex":0.00010319952,"about_ca_system_score_gemma":0.00025857522,"threshold_uncertainty_score":0.7030713},"labels":[],"label_agreement":null},{"id":"W4411433868","doi":"10.1016/j.ard.2025.05.288","title":"OP0278 EFFICACY OF IMMERSIVE VIRTUAL REALITY-BASED BIOFEEDBACK ON CHRONIC PAIN AND DAILY LIFE IMPACT IN FIBROMYALGIA: A PILOT RANDOMIZED CONTROLLED TRIAL","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pain Management and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fibromyalgia; Biofeedback; Randomized controlled trial; Virtual reality; Physical therapy; Chronic pain; Physical medicine and rehabilitation; Pilot trial; Human–computer interaction; Surgery","score_opus":0.027969595710269576,"score_gpt":0.33188312965920164,"score_spread":0.30391353394893206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411433868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853741,0.0026658138,0.00011109634,0.0049937638,0.00008152113,0.0063525783,0.000039927716,0.000014719941,0.00036650978],"genre_scores_gemma":[0.99884796,0.00034395393,0.000008731888,0.00031877094,0.000013169678,0.00022493573,0.000028898748,0.000010425213,0.00020316761],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99707294,0.0013596064,0.0008158791,0.00021331562,0.0003187624,0.00021952539],"domain_scores_gemma":[0.9932368,0.0056750975,0.0004491337,0.00045061612,0.000070492395,0.000117886404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018294997,0.00023578304,0.0017633025,0.00027097887,0.000044502034,0.000014153527,0.00014621434,0.000040713498,0.000059677728],"category_scores_gemma":[0.006645131,0.00012860895,0.0007601703,0.00028467673,0.0002722746,0.00003558429,0.000054099786,0.00007487654,0.0000021975516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9855782,0.0032058202,0.0008443915,0.0011641092,0.0028727294,0.0000037318487,0.00010074111,0.000615659,0.00002278644,0.00057707395,0.0022056922,0.0028091017],"study_design_scores_gemma":[0.955304,0.0035926418,0.028816467,0.004768663,0.0012540438,8.07006e-8,0.00012463973,0.0053313496,0.00010879489,0.00059711054,0.0000030163167,0.00009918996],"about_ca_topic_score_codex":0.00025720394,"about_ca_topic_score_gemma":0.0000037849795,"teacher_disagreement_score":0.030274162,"about_ca_system_score_codex":0.000050374965,"about_ca_system_score_gemma":0.0004537939,"threshold_uncertainty_score":0.7955322},"labels":[],"label_agreement":null},{"id":"W4412483436","doi":"10.1016/j.ard.2025.06.2129","title":"Frontoparietal functional connectivity is related to active disease and processing speed in adolescents with childhood-onset lupus","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Eastern Ontario; Hospital for Sick Children; SickKids Foundation","funders":"Canadian Institutes of Health Research; Lupus Research Alliance; U.S. Department of Defense","keywords":"Medicine; Systemic lupus erythematosus; Disease; Pediatrics; Pathology","score_opus":0.02302930888225716,"score_gpt":0.31071952369820327,"score_spread":0.2876902148159461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412483436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992605,0.0018783058,0.000026883228,0.0038862054,0.000089549794,0.001199184,0.000054992455,0.000026530462,0.0002333874],"genre_scores_gemma":[0.9986685,0.000045571218,0.000009047868,0.00054990704,0.000007165586,0.00004080263,0.0000076029696,0.000016171323,0.0006552102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843466,0.00013599083,0.0003320222,0.0003170289,0.0005142114,0.00026609216],"domain_scores_gemma":[0.9989235,0.00010071974,0.0001278047,0.0003852145,0.00019647239,0.00026633672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019095834,0.00017896098,0.00042538065,0.00019521186,0.00010003566,0.000029877247,0.0001363593,0.00004273158,0.000031554944],"category_scores_gemma":[0.0010104638,0.00011426469,0.00009605493,0.0005144637,0.00018126462,0.00013310315,0.0001422517,0.0001451779,0.000006259401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025878614,0.00079598796,0.9859313,0.0022280721,0.00021263778,0.000009982343,0.0013659599,0.00003136549,0.000016048602,0.00004394716,0.0017635785,0.005013289],"study_design_scores_gemma":[0.0022059022,0.000076277174,0.97497386,0.018936208,0.00014785602,0.00010036203,0.0010643966,0.0006951972,0.00017927377,0.0015032167,0.000006415313,0.00011102046],"about_ca_topic_score_codex":0.00007425051,"about_ca_topic_score_gemma":0.000021284679,"teacher_disagreement_score":0.016708136,"about_ca_system_score_codex":0.00005565345,"about_ca_system_score_gemma":0.0005841618,"threshold_uncertainty_score":0.46595785},"labels":[],"label_agreement":null},{"id":"W4412783363","doi":"10.1016/j.ard.2025.07.005","title":"Precision medicine and the chaos theory in rheumatoid arthritis","year":2025,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"CHU Sainte-Justine Foundation; Wallonie-Bruxelles International; Université Catholique de Louvain","keywords":"Medicine; Rheumatoid arthritis; Internal medicine","score_opus":0.04947492739638501,"score_gpt":0.37138395739140234,"score_spread":0.32190902999501736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412783363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000226611,0.9925714,0.000007533365,0.0030279246,0.00025170424,0.002670426,0.00009687458,0.000029564964,0.0011179533],"genre_scores_gemma":[0.0015588428,0.99716353,0.000009446485,0.00028664444,0.000041686104,0.00037637347,0.00003587122,0.00003992428,0.00048769356],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.995449,0.0015542723,0.0013867803,0.00039759654,0.0007764572,0.0004359075],"domain_scores_gemma":[0.99219674,0.0057368493,0.0005520777,0.0011618914,0.00015584956,0.00019660461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019856135,0.0004778071,0.0032051846,0.0004342121,0.00017555935,0.000043426022,0.00066186185,0.00015441536,0.0002681562],"category_scores_gemma":[0.008297615,0.00020944174,0.00079631153,0.00069024303,0.0017486897,0.000095440424,0.00041170497,0.00045230324,0.000014516161],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002841092,0.0001367545,0.000028775696,0.015079264,0.00044957784,0.0000076065826,0.00042278285,2.1063443e-7,2.4611515e-8,0.011651184,0.0060831187,0.9658566],"study_design_scores_gemma":[0.0044395747,0.00016247177,0.0003671609,0.5918279,0.00014181776,0.000122907,0.0004206473,0.000015495829,0.0000011509676,0.03960743,0.36262268,0.0002707221],"about_ca_topic_score_codex":0.00011179051,"about_ca_topic_score_gemma":0.00002234121,"teacher_disagreement_score":0.9655859,"about_ca_system_score_codex":0.000020257488,"about_ca_system_score_gemma":0.0005590139,"threshold_uncertainty_score":0.993362},"labels":[],"label_agreement":null},{"id":"W4412784774","doi":"10.1016/j.ard.2025.06.2126","title":"A glossary of signs and symptoms of giant cell arteritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; University of Ottawa; Ottawa Hospital; University Health Network; Mount Sinai Hospital","funders":"European League Against Rheumatism; National Institute for Health and Care Research; Ministerio de Ciencia, Innovación y Universidades; AstraZeneca","keywords":"Medicine; Giant cell arteritis; Context (archaeology); Claudication; Dactylitis; Physical therapy; Pediatrics; Surgery; Internal medicine; Arthritis; Disease; Vasculitis; Vascular disease; Psoriatic arthritis","score_opus":0.012538313716653688,"score_gpt":0.2710433716662266,"score_spread":0.2585050579495729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412784774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611796,0.008359101,0.000035496138,0.0019322651,0.000059758473,0.00022718821,0.00019119012,0.000008562476,0.003068484],"genre_scores_gemma":[0.9981702,0.0011553589,0.000037844573,0.00015517548,0.0000035227051,0.0000071396653,0.000008863077,0.000004576005,0.00045732994],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993632,0.000034293058,0.00030530282,0.00007809987,0.00013414901,0.000084956504],"domain_scores_gemma":[0.9993651,0.00008997335,0.00013272844,0.00026528267,0.00009443488,0.000052473955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005037207,0.00006796907,0.0002929444,0.0000643087,0.00003017453,0.0000031946581,0.000079148405,0.000034085286,0.000091577196],"category_scores_gemma":[0.000094452655,0.000043658114,0.0001885694,0.00014805901,0.00020638558,0.000028054423,0.00004699432,0.000039553688,0.0000010893582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010065809,0.013803752,0.112925224,0.05736479,0.012054483,0.00007736046,0.005357934,0.00027717726,0.06291761,0.060819253,0.1239793,0.54941654],"study_design_scores_gemma":[0.003005463,0.0009310363,0.9318983,0.015658572,0.0016397896,0.000024895999,0.0008625977,0.0005661066,0.024068912,0.020930205,0.00023332321,0.00018077358],"about_ca_topic_score_codex":0.000042430012,"about_ca_topic_score_gemma":8.12686e-7,"teacher_disagreement_score":0.8189731,"about_ca_system_score_codex":0.000002349192,"about_ca_system_score_gemma":0.00008114859,"threshold_uncertainty_score":0.17803262},"labels":[],"label_agreement":null},{"id":"W4413039147","doi":"10.1016/j.ard.2025.06.2131","title":"Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; St. Joseph’s Healthcare Hamilton","funders":"Working Artist Org; AstraZeneca; American Academy of Allergy Asthma and Immunology","keywords":"Granulomatosis with polyangiitis; Medicine; Eosinophilic; Immunology; Dermatology; Microscopic polyangiitis; Pathology; Vasculitis; Disease","score_opus":0.014727137350449476,"score_gpt":0.2876320263203711,"score_spread":0.2729048889699216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413039147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889015,0.0043916577,0.000063598774,0.004886458,0.00007701946,0.00085832394,0.00028201035,0.000023578561,0.00051584333],"genre_scores_gemma":[0.9958564,0.0033930657,0.00015180928,0.0003022898,0.000011221395,0.00003739936,0.000030471041,0.000014019953,0.00020329074],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99919575,0.00004226994,0.00031407515,0.00014539946,0.00015228208,0.0001502433],"domain_scores_gemma":[0.99906796,0.00023960123,0.00014274236,0.00033302695,0.00014393205,0.00007271646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007681344,0.00012568323,0.00040425026,0.00009544688,0.00009960813,0.000010773466,0.000116062045,0.00003749348,0.0000790375],"category_scores_gemma":[0.0001170467,0.000071749695,0.00022062479,0.00020842702,0.00023275429,0.0000431436,0.000030727293,0.000049915743,0.000001368237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015956607,0.012108873,0.2839754,0.013106052,0.02772028,0.000011898922,0.0047393404,0.00026042364,0.0118146725,0.17089126,0.074943826,0.3844714],"study_design_scores_gemma":[0.018042782,0.0010799357,0.94253606,0.011331458,0.0011785056,0.00002037802,0.0008388727,0.000102050384,0.01978752,0.003966763,0.00084689783,0.00026878525],"about_ca_topic_score_codex":0.000045513254,"about_ca_topic_score_gemma":0.0000019819233,"teacher_disagreement_score":0.6585607,"about_ca_system_score_codex":0.000006153315,"about_ca_system_score_gemma":0.00009358169,"threshold_uncertainty_score":0.29258674},"labels":[],"label_agreement":null},{"id":"W4413403161","doi":"10.1016/j.ard.2025.07.016","title":"Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"U.S. Department of Defense; National Heart, Lung, and Blood Institute; Johns Hopkins University; NHLBI Division of Intramural Research; Alexion Pharmaceuticals; American Society of Hematology","keywords":"Medicine; Antiphospholipid syndrome; Epigenetics; Immune dysregulation; Catastrophic antiphospholipid syndrome; Immunology; Genetics; Antibody; Immune system; Gene","score_opus":0.016259860750058728,"score_gpt":0.25574245560144665,"score_spread":0.23948259485138793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413403161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98752654,0.011081553,0.000038145685,0.00036658134,0.00012613776,0.00039330445,0.00040477567,0.000018238792,0.00004472165],"genre_scores_gemma":[0.9993766,0.0001431538,0.0000126384075,0.00009132812,0.0000013582709,0.000022227769,0.000039152386,0.000009222653,0.00030434245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989107,0.00020227607,0.0004320789,0.00018360029,0.000079160236,0.00019218202],"domain_scores_gemma":[0.998785,0.0002414074,0.00036311022,0.0004571024,0.00013117008,0.000022194212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009826606,0.000146734,0.00038564298,0.000095128686,0.000100507124,0.000009032404,0.00026835458,0.000048964765,0.00021497301],"category_scores_gemma":[0.00022805949,0.00010176472,0.00010406431,0.00023597274,0.0003439478,0.000039151488,0.00012961176,0.00004067941,0.00000612702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041022172,0.0013080372,0.9557255,0.0019914024,0.0041309693,0.000004497729,0.0005775688,0.00044350294,0.0044837343,0.0011191136,0.016841345,0.012964109],"study_design_scores_gemma":[0.00065813906,0.000113019785,0.99038774,0.0016279762,0.00030827013,0.0000073217657,0.00009167951,0.000033957156,0.0054032854,0.0012295885,0.000044155615,0.00009485942],"about_ca_topic_score_codex":0.00010361914,"about_ca_topic_score_gemma":0.000010498002,"teacher_disagreement_score":0.03466225,"about_ca_system_score_codex":0.000008873913,"about_ca_system_score_gemma":0.00009700989,"threshold_uncertainty_score":0.4149845},"labels":[],"label_agreement":null},{"id":"W4413431989","doi":"10.1016/j.ard.2025.07.024","title":"SLE classification criteria item relationships: implications on SLE as a disease entity","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Mount Sinai Hospital","funders":"Schleswig-Holstein; University of South Carolina; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Leeds Biomedical Research Centre; Department of Internal Medicine, University of Utah; Biocruces Bizkaia es el Instituto de Investigación Sanitaria; Berlin Institute of Health; Technische Universität Dresden; Medizinische Universität Graz; Sveučilište u Zagrebu; Cedars-Sinai Medical Center; European League Against Rheumatism; Karl-Franzens-Universität Graz; Université Paris-Saclay; Universidade do Porto; Universitat de Barcelona; Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; Euskal Herriko Unibertsitatea; Medizinische Universität Wien; National and Kapodistrian University of Athens; Rigshospitalet; Università degli Studi di Padova; National Institutes of Health; Istituto Auxologico Italiano; Università di Pisa; University of Cambridge; Cumming School of Medicine, University of Calgary; University of Cyprus; University of Leeds; Gentofte Hospital; Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf; Hospital for Special Surgery; National Institute for Health and Care Research; Veterans Administration Medical Center; York University; University Health Network; Commissariat à l'Énergie Atomique et aux Énergies Alternatives; University of Crete; Institut National de la Santé et de la Recherche Médicale; Margaret M. and Albert B. Alkek Department of Medicine; Universität Wien; Edge Hill University; McMaster University; School of Medicine, New York University; University of Toronto; Brigham and Women's Hospital; Általános Orvostudományi Kar, Pécsi Tudományegyetem; Aid for Cancer Research","keywords":"Medicine; Disease; Immunology; Internal medicine","score_opus":0.14378089890866408,"score_gpt":0.4232332653194653,"score_spread":0.27945236641080123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413431989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528142,0.0015150949,0.00015866746,0.034277387,0.00047041912,0.0014614204,0.0001638327,0.000096767115,0.009042179],"genre_scores_gemma":[0.9891736,0.00023763353,0.000043715554,0.00057813164,0.000026010897,0.00026929934,0.000059800546,0.00001805912,0.009593739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981452,0.00032893926,0.00053279515,0.00028337294,0.00047405742,0.00023562097],"domain_scores_gemma":[0.99686253,0.0009206692,0.00021635545,0.0013714177,0.00037847846,0.00025053063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040738194,0.000152098,0.0003074226,0.00022479723,0.00027257728,0.000047340625,0.0003591828,0.000055687597,0.00020065678],"category_scores_gemma":[0.007294928,0.00010726885,0.00027321727,0.00061370083,0.00016739358,0.00011393948,0.00010677119,0.00014614199,0.0001452273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005371387,0.0015856076,0.71744525,0.0034486516,0.0003821664,0.0000022740098,0.00044600834,0.000011893352,0.0003886074,0.07196315,0.1994997,0.004289534],"study_design_scores_gemma":[0.00072436663,0.000054899312,0.9557404,0.0045662425,0.00026430684,0.000018782388,0.00062953104,0.0014912027,0.00035548976,0.033989854,0.002040718,0.00012418984],"about_ca_topic_score_codex":0.000032834545,"about_ca_topic_score_gemma":0.000004050947,"teacher_disagreement_score":0.23829514,"about_ca_system_score_codex":0.00006805725,"about_ca_system_score_gemma":0.0004876895,"threshold_uncertainty_score":0.87332374},"labels":[],"label_agreement":null},{"id":"W4413440167","doi":"10.1016/j.ard.2025.07.008","title":"Cannabidiol versus placebo in patients with fibromyalgia: a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Minister Erna Hamiltons Legat for Videnskab og Kunst; Region Hovedstaden; Gentofte Hospital; Rigshospitalet; Parker Institute for Cancer Immunotherapy; Gigtforeningen; Hamilton Community Foundation; Aase og Ejnar Danielsens Fond; Ministero dell'Università e della Ricerca; Oak Foundation","keywords":"Medicine; Placebo; Fibromyalgia; Cannabidiol; Single blind; Physical therapy; Double blind; Randomized controlled trial; Placebo group; Internal medicine; Clinical trial; Alternative medicine; Psychiatry; Cannabis; Pathology","score_opus":0.03255562435813209,"score_gpt":0.30657194890640865,"score_spread":0.27401632454827657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413440167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727378,0.0010835823,0.000011800294,0.012689431,0.00039592784,0.0112417955,0.00005209072,0.000040218576,0.001747379],"genre_scores_gemma":[0.99129784,0.00006516701,0.000025502557,0.00020705535,0.000042864194,0.0011173189,0.0000605094,0.000039090835,0.0071446598],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99670047,0.00033216624,0.0009008312,0.00043420677,0.0009938112,0.0006384913],"domain_scores_gemma":[0.9978319,0.0002938752,0.0003546964,0.00082504394,0.00040323826,0.00029126523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005412632,0.00037116953,0.0012283805,0.000338539,0.0001371104,0.00007472112,0.0004264669,0.00012752549,0.0002166752],"category_scores_gemma":[0.0012296499,0.00022344835,0.000595961,0.0007056856,0.0002748576,0.0001312428,0.00016798144,0.00027520317,0.000010037973],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9479246,0.002643871,0.0040355176,0.0008637324,0.000872909,0.0000071218465,0.00014228487,0.00017932997,0.000003410934,0.00023112223,0.04084737,0.0022486926],"study_design_scores_gemma":[0.9817079,0.0014206293,0.012876263,0.00199809,0.0005268055,5.619085e-7,0.00027146758,0.0001639379,0.000070782786,0.000119411685,0.00061177224,0.00023241005],"about_ca_topic_score_codex":0.0002363137,"about_ca_topic_score_gemma":0.0001205017,"teacher_disagreement_score":0.040235594,"about_ca_system_score_codex":0.00012304059,"about_ca_system_score_gemma":0.00078582583,"threshold_uncertainty_score":0.91119593},"labels":[],"label_agreement":null},{"id":"W4413976517","doi":"10.1016/j.ard.2025.06.2127","title":"Correspondence on ‘Pulmonary arterial hypertension in adults with Still’s disease: another pulmonary manifestation associated with HLA-DRB1*15’","year":2025,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Lucile Packard Foundation for Children's Health","keywords":"Medicine; Pulmonary hypertension; Disease; Human leukocyte antigen; Cardiology; Internal medicine; Immunology; Antigen","score_opus":0.027397344012966587,"score_gpt":0.2729267189209542,"score_spread":0.24552937490798762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413976517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72130084,0.002834577,0.000011164439,0.2683222,0.00035889313,0.0038888496,0.00084925734,0.00014531058,0.0022888728],"genre_scores_gemma":[0.87438667,0.0008864514,0.0000083197465,0.112010375,0.00015236752,0.0002977575,0.0015513812,0.00013195313,0.010574731],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9961978,0.0004686757,0.00071170134,0.00058150385,0.0014935281,0.0005467621],"domain_scores_gemma":[0.99723196,0.00060272473,0.0005888262,0.0010635961,0.0003977233,0.00011515674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022651587,0.0005174709,0.0009746805,0.00043401832,0.00011455071,0.000041176125,0.0004697037,0.00027682792,0.00030881687],"category_scores_gemma":[0.00089630357,0.000309845,0.00024779243,0.0005647016,0.00036909504,0.00018293824,0.00011866683,0.0007875115,0.000030095098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038731594,0.0037102718,0.020716589,0.00952303,0.0010559729,0.0073737823,0.00041306013,0.00033385583,0.000037044767,0.00002766449,0.89580745,0.022269689],"study_design_scores_gemma":[0.0034269022,0.0009395559,0.8949093,0.08459406,0.0006059528,0.0000514322,0.00030225792,0.0032737544,0.000041671487,0.00038010956,0.010736503,0.000738491],"about_ca_topic_score_codex":0.000113397844,"about_ca_topic_score_gemma":0.00001290473,"teacher_disagreement_score":0.8850709,"about_ca_system_score_codex":0.000075738,"about_ca_system_score_gemma":0.0010510577,"threshold_uncertainty_score":0.9999354},"labels":[],"label_agreement":null},{"id":"W4414299453","doi":"10.1016/j.ard.2025.08.006","title":"Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Johnson and Johnson","keywords":"Monoclonal antibody; Apex (geometry); Phases of clinical research; Monoclonal; Antibody; Adverse effect","score_opus":0.04782480471194316,"score_gpt":0.3638871782904056,"score_spread":0.31606237357846245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414299453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894653,0.00067779835,0.000003232206,0.0015365722,0.000091726746,0.0077726776,0.00014135995,0.000014011057,0.00029734918],"genre_scores_gemma":[0.99892884,0.000055699773,0.000021116886,0.0000661882,0.000013744777,0.0007727306,0.000017131146,0.000018038801,0.00010647831],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975729,0.00042741248,0.0007876061,0.0003024065,0.0006043605,0.0003053008],"domain_scores_gemma":[0.997468,0.0006138732,0.00088566606,0.00058453035,0.0003952154,0.000052709573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032600178,0.0002984273,0.0010286355,0.00009529667,0.0002032915,0.00001852224,0.00021126779,0.000043636435,0.000008205246],"category_scores_gemma":[0.00046627663,0.00011546008,0.0002387207,0.00068396213,0.00048785497,0.00016109366,0.00015456638,0.00017812286,4.878204e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9585476,0.006027843,0.013656344,0.00033722317,0.0037912717,0.000016894142,0.013906699,0.00013270297,0.00014303083,0.00006469646,0.00052163104,0.0028540993],"study_design_scores_gemma":[0.82431066,0.005350921,0.100093074,0.009386145,0.0026673167,0.000005982002,0.021668022,0.00018521595,0.035732877,0.00040438471,0.000003512098,0.00019191025],"about_ca_topic_score_codex":0.00021972288,"about_ca_topic_score_gemma":0.00057201664,"teacher_disagreement_score":0.13423693,"about_ca_system_score_codex":0.000049813996,"about_ca_system_score_gemma":0.00026831604,"threshold_uncertainty_score":0.47083256},"labels":[],"label_agreement":null},{"id":"W4415245273","doi":"10.1016/j.ard.2025.08.032","title":"Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Research Council; Novartis Pharma; Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg; Forschungszentrum Jülich; Innovative Medicines Initiative; Bundesministerium für Bildung und Forschung; Horizon 2020 Framework Programme; Deutsche Forschungsgemeinschaft; European Federation of Pharmaceutical Industries and Associations","keywords":"Biopsy; Enthesis; Psoriatic arthritis; Enthesitis; Enthesopathy","score_opus":0.02460901439640256,"score_gpt":0.3250948401272061,"score_spread":0.3004858257308035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415245273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974389,0.005434074,0.0000017566445,0.016934184,0.00022087176,0.0020202775,0.0008069048,0.000022969558,0.00016994902],"genre_scores_gemma":[0.9980762,0.0006587048,0.000024828794,0.0007094998,0.00003105643,0.0002268915,0.000039505663,0.000015364812,0.00021795821],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99748045,0.00061151554,0.00072345557,0.00036894198,0.0004815481,0.00033406037],"domain_scores_gemma":[0.9975186,0.0013965344,0.0001602218,0.0007226191,0.00010076155,0.00010124846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006596524,0.00023205085,0.00055063795,0.00020514253,0.000120546145,0.000034671066,0.00020617958,0.00006577389,0.000042704156],"category_scores_gemma":[0.0038355936,0.00014155047,0.00014118472,0.000804715,0.0001087963,0.000075058924,0.00021620741,0.0001737268,0.000022282615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09512176,0.030712826,0.2739744,0.00060518493,0.0031788577,0.0018456787,0.05463268,0.00038119944,0.0018344393,0.00078960543,0.043462448,0.49346092],"study_design_scores_gemma":[0.008000855,0.00064485334,0.9746468,0.0066659995,0.0001370932,0.000003761044,0.0065093003,0.000020069525,0.0009143027,0.0019345435,0.00037781714,0.00014459877],"about_ca_topic_score_codex":0.0016818565,"about_ca_topic_score_gemma":0.0015788106,"teacher_disagreement_score":0.7006724,"about_ca_system_score_codex":0.00006574744,"about_ca_system_score_gemma":0.00015666362,"threshold_uncertainty_score":0.57722604},"labels":[],"label_agreement":null},{"id":"W4415245495","doi":"10.1016/j.ard.2025.09.007","title":"EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"European League Against Rheumatism","keywords":"Kidney; Lupus erythematosus; MEDLINE; Kidney disease; Lupus nephritis; Disease management","score_opus":0.04633658227898679,"score_gpt":0.34040783580083706,"score_spread":0.29407125352185026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415245495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7327471,0.05308796,0.0137841,0.16310555,0.0022406536,0.025198707,0.0015871585,0.00024362373,0.008005178],"genre_scores_gemma":[0.986,0.0050591617,0.0006471775,0.0010115862,0.000018430952,0.0008401479,0.0000617638,0.00003403657,0.006327679],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.998047,0.00012503036,0.00072508096,0.000238135,0.00055935537,0.00030541435],"domain_scores_gemma":[0.9973203,0.0005017149,0.00039152981,0.0012408358,0.00041806203,0.00012753409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006479084,0.00019686877,0.000535364,0.0001605492,0.00017525758,0.000025322539,0.00060089823,0.000038540125,0.00008144626],"category_scores_gemma":[0.00025035735,0.00009934574,0.00029767185,0.0005774646,0.00020241308,0.00006480147,0.00023368803,0.000078861645,0.000008652288],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002059845,0.0017886183,0.08546246,0.122834854,0.016265826,0.000010433137,0.0019999102,0.00019551108,0.000106813044,0.08349152,0.6639745,0.021809693],"study_design_scores_gemma":[0.043971594,0.0016191192,0.013343969,0.6508143,0.020248843,0.0025570386,0.12906754,0.013606873,0.014876819,0.044668783,0.0634034,0.0018217012],"about_ca_topic_score_codex":0.00003723535,"about_ca_topic_score_gemma":0.0000028334448,"teacher_disagreement_score":0.6005711,"about_ca_system_score_codex":0.00004189723,"about_ca_system_score_gemma":0.00030790985,"threshold_uncertainty_score":0.40512016},"labels":[],"label_agreement":null},{"id":"W4415544009","doi":"10.1016/j.ard.2025.09.015","title":"Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Stiftelsen Professor Nanna Svartz Fond; Alex och Eva Wallströms Stiftelse för Vetenskaplig Forskning och Utbildning; Uppsala Universitet; Akademiska Sjukhuset; Science for Life Laboratory; Vetenskapsrådet; National Health and Medical Research Council; Reumatikerförbundet; Knut och Alice Wallenbergs Stiftelse; Uppsala Multidisciplinary Center for Advanced Computational Science; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Stiftelsen Konung Gustaf V:s 80-årsfond; Karolinska Institutet; Myositis Association; Hjärt-Lungfonden; Åke Wiberg Stiftelse","keywords":"Epitope; Antisynthetase syndrome; T-cell receptor; T cell; Antigen; T lymphocyte","score_opus":0.010601031543166892,"score_gpt":0.251053295990568,"score_spread":0.24045226444740114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415544009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958657,0.0004940001,0.000014166359,0.001113905,0.00031732998,0.001051645,0.00024700703,0.000045295183,0.00085091987],"genre_scores_gemma":[0.99830824,0.00016683656,0.00005826342,0.00086484675,0.000010848349,0.00002711466,0.00003893125,0.000028565648,0.0004963517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980987,0.00014035856,0.00059047336,0.00033783514,0.00048864173,0.00034404837],"domain_scores_gemma":[0.99821794,0.00025828616,0.0003203024,0.0008033635,0.00017597957,0.00022410892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016612234,0.0002883652,0.00076530443,0.00028788936,0.000103591934,0.00003984153,0.00022000258,0.00007380623,0.00011350714],"category_scores_gemma":[0.00043764745,0.00019000107,0.00028020536,0.0004166077,0.00016162089,0.0001660725,0.0000944512,0.0001672638,0.000049889055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015613691,0.017455168,0.5973092,0.011378231,0.004655665,0.0024273936,0.0015417708,0.0005071027,0.0009312112,0.0023564133,0.11335764,0.23246652],"study_design_scores_gemma":[0.003025948,0.0003287986,0.97330636,0.010821109,0.00051497197,0.000018090805,0.00008710415,0.00014581585,0.010640605,0.00059502944,0.00026418158,0.0002520153],"about_ca_topic_score_codex":0.00014295513,"about_ca_topic_score_gemma":0.0000038969756,"teacher_disagreement_score":0.37599716,"about_ca_system_score_codex":0.000052495598,"about_ca_system_score_gemma":0.00039571908,"threshold_uncertainty_score":0.7748019},"labels":[],"label_agreement":null},{"id":"W4415675605","doi":"10.1016/j.ard.2025.10.002","title":"EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Ottawa Hospital; University of Ottawa","funders":"Leeds Biomedical Research Centre; Samsung; Swedish Orphan Biovitrum; European League Against Rheumatism; University College London Hospitals NHS Foundation Trust; Celltrion; Teijin Pharma; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Celgene; Biogen; Amgen; Pfizer; University College London; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Psoriatic arthritis; MEDLINE; Disease; Arthritis; Alternative medicine; Psoriasis; Consensus conference","score_opus":0.05640962312225958,"score_gpt":0.32849561990365056,"score_spread":0.272085996781391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415675605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97323465,0.011356717,0.000022526117,0.01292599,0.00011590473,0.0014119473,0.00058343494,0.000024081992,0.00032474153],"genre_scores_gemma":[0.9935932,0.0036296528,0.00043624718,0.0017460224,0.000010775848,0.00024120446,0.000016963972,0.000012342872,0.0003135612],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991844,0.00003652586,0.00026322858,0.00021132041,0.0001080371,0.0001964323],"domain_scores_gemma":[0.99885345,0.00051248405,0.00006642669,0.00026888747,0.00012602906,0.0001727003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045506527,0.00016405144,0.00043425758,0.00009431333,0.00019337739,0.000021405058,0.000039236136,0.000026523736,0.000018779125],"category_scores_gemma":[0.0009719575,0.000111122754,0.00011346012,0.0001522462,0.00012523751,0.00002068924,0.00007050279,0.000021424934,0.0000063160664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002148052,0.0051084985,0.054938015,0.0020373983,0.0076605757,0.000111717556,0.0040240055,0.000016871922,0.00017588954,0.026034439,0.08353631,0.8142082],"study_design_scores_gemma":[0.015742356,0.0024082453,0.93181705,0.0068673464,0.0022674554,0.00005212513,0.0028662833,0.00006466671,0.0006910161,0.025704065,0.011082334,0.0004370792],"about_ca_topic_score_codex":0.000085511,"about_ca_topic_score_gemma":0.00007838201,"teacher_disagreement_score":0.87687904,"about_ca_system_score_codex":0.000016583781,"about_ca_system_score_gemma":0.000046286434,"threshold_uncertainty_score":0.45314544},"labels":[],"label_agreement":null},{"id":"W4415683481","doi":"10.1016/j.ard.2025.09.016","title":"Understanding the drivers of BASDAI and back pain scores in psoriatic arthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Krembil Foundation","funders":"Krembil Foundation","keywords":"BASDAI; Psoriatic arthritis; Back pain; Limiting; Arthritis; Low back pain","score_opus":0.06379968211645343,"score_gpt":0.30042319614987006,"score_spread":0.23662351403341664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415683481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97637063,0.015760392,0.0000725789,0.0059387563,0.000113059046,0.000547602,0.000040713774,0.0000073520255,0.0011489431],"genre_scores_gemma":[0.99326515,0.0062002023,0.000023682962,0.00035451035,0.0000041086496,0.00001325602,0.0000023149098,0.0000049120767,0.00013187433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924016,0.000106830754,0.00026254266,0.00010066395,0.00015879098,0.0001310176],"domain_scores_gemma":[0.9991293,0.00047033574,0.000103192004,0.00022982118,0.000034166806,0.000033188928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020847529,0.00009107237,0.00030233065,0.00006550912,0.00007610442,0.000008340344,0.00008125807,0.000019199875,0.00005331708],"category_scores_gemma":[0.0005693841,0.00005164086,0.00010508746,0.00022179118,0.00024672432,0.000034467335,0.00007287746,0.00003932839,0.0000015427986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003799683,0.0008191131,0.8562397,0.0021900178,0.0013118841,0.000015949578,0.0025404452,0.000055420995,0.000015289012,0.013576635,0.01583638,0.107019246],"study_design_scores_gemma":[0.004360435,0.00027273598,0.9378274,0.014378458,0.0002423253,0.0000037603234,0.0077473903,0.00042677548,0.00017292208,0.034335323,0.0001203284,0.00011212891],"about_ca_topic_score_codex":0.00012139134,"about_ca_topic_score_gemma":0.0000912438,"teacher_disagreement_score":0.106907114,"about_ca_system_score_codex":0.000017639008,"about_ca_system_score_gemma":0.00005084131,"threshold_uncertainty_score":0.21058533},"labels":[],"label_agreement":null},{"id":"W4416027282","doi":"10.1016/j.ard.2025.10.011","title":"CD3+ immune cell endotypes are associated with PsA disease phenotype and response to advanced therapy: an integrated mass cytometry and proteomics cohort study","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Krembil Foundation; University of Waterloo; University of Toronto; Women's College Hospital","funders":"Canada Research Chairs; National Psoriasis Foundation","keywords":"Immune system; Mass cytometry; Proteomics; Phenotype; Disease; Cell; Cohort study; Flow cytometry","score_opus":0.010603898398147179,"score_gpt":0.25701634258053296,"score_spread":0.24641244418238578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416027282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97024673,0.027197286,0.00007446686,0.0004456373,0.00011623873,0.00166845,0.00016196155,0.000057076435,0.00003215257],"genre_scores_gemma":[0.9984893,0.00042859654,0.000017495442,0.00023883325,4.6137797e-7,0.00014299505,0.000044570468,0.000019957399,0.00061777636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807966,0.0007888744,0.00038906027,0.00035048454,0.00008723159,0.00030467333],"domain_scores_gemma":[0.9985476,0.0003616407,0.00027979407,0.000591177,0.00018910647,0.000030680298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005411476,0.00027275202,0.00050743204,0.00018003387,0.00034238936,0.000042201544,0.0003754719,0.00007015975,0.000028833034],"category_scores_gemma":[0.0009907658,0.00017690545,0.00007765256,0.00052221783,0.00033063025,0.00013960607,0.0001313479,0.00016308035,0.0000039970205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048129458,0.009835667,0.76049423,0.00040794464,0.0034818829,0.000011841955,0.005338315,0.00047274237,0.11414009,0.00021111728,0.00019025177,0.057286456],"study_design_scores_gemma":[0.002338829,0.0006051317,0.98518574,0.00055862585,0.00017870388,4.7847175e-7,0.0044405046,0.00002298527,0.006008147,0.00034395812,0.000087900575,0.00022896532],"about_ca_topic_score_codex":0.00007849425,"about_ca_topic_score_gemma":0.00000605372,"teacher_disagreement_score":0.22469154,"about_ca_system_score_codex":0.000016921504,"about_ca_system_score_gemma":0.00018004004,"threshold_uncertainty_score":0.7213995},"labels":[],"label_agreement":null},{"id":"W4416419754","doi":"10.1016/j.ard.2025.10.019","title":"Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université Laval","funders":"","keywords":"Thrombosis; Prospective cohort study; Clinical trial; Antiphospholipid syndrome; Disease; MEDLINE","score_opus":0.060942985604609076,"score_gpt":0.41867924614851104,"score_spread":0.35773626054390195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416419754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970089,0.00075624214,0.000009108748,0.00046969886,0.0003813217,0.00068862,0.00031565304,0.000006438888,0.00036397006],"genre_scores_gemma":[0.997634,0.002105203,0.000023064193,0.00006741074,0.000017573584,0.000013280076,0.000041155432,0.00000531777,0.00009300732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748886,0.00046960873,0.0011266699,0.00032357042,0.00045893725,0.0001323475],"domain_scores_gemma":[0.997171,0.0010115443,0.00069896446,0.00059518695,0.00044939798,0.00007390735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008532932,0.00012917603,0.0007728435,0.00021160368,0.000060412593,0.000011706603,0.0003094829,0.00008870945,0.000008182634],"category_scores_gemma":[0.003952003,0.00007316176,0.00042730776,0.0006475666,0.0011739875,0.000088897636,0.00038810773,0.00016513599,1.569919e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047417916,0.001051416,0.9928689,0.00064272695,0.0032449698,6.345052e-7,0.0002627896,0.0000034421334,0.00014874345,0.000120742174,0.00047275427,0.0007086913],"study_design_scores_gemma":[0.0012572145,0.00016960707,0.9915852,0.0029432185,0.0012543057,0.0000050512654,0.001249407,0.0006121303,0.0007885396,0.00007471906,0.000007304257,0.00005332344],"about_ca_topic_score_codex":0.00024138202,"about_ca_topic_score_gemma":0.00001916386,"teacher_disagreement_score":0.00309871,"about_ca_system_score_codex":0.000028859356,"about_ca_system_score_gemma":0.00018347015,"threshold_uncertainty_score":0.47312024},"labels":[],"label_agreement":null},{"id":"W4417292326","doi":"10.1016/j.ard.2025.11.007","title":"Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Manitoba; Toronto Western Hospital; University Health Network; McGill University; University of Calgary; McGill University Health Centre; Queen Elizabeth II Health Sciences Centre; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; National Institutes of Health; National Research Foundation of Korea; Ministry of Education","keywords":"Antibody; Connective tissue disease; Lupus erythematosus; Autoantibody; Rheumatoid arthritis; Systemic lupus erythematosus; Rheumatology","score_opus":0.02498364659541252,"score_gpt":0.3022290815864834,"score_spread":0.27724543499107085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417292326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98880565,0.00879494,0.000014214367,0.00041408252,0.0003114568,0.0013919664,0.00013107942,0.000041315012,0.00009529829],"genre_scores_gemma":[0.9973814,0.0022315264,0.000015168962,0.00006205077,0.000028878381,0.000072240604,0.000017522298,0.000021276353,0.00016993516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770784,0.00034956212,0.0006239276,0.0003399526,0.0006336984,0.0003450142],"domain_scores_gemma":[0.99845546,0.00033483785,0.0003031076,0.0005706615,0.00019789579,0.0001380504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047978375,0.00024113695,0.00093632156,0.00019454552,0.00009885591,0.000041307343,0.0001881033,0.000101354526,0.000010088234],"category_scores_gemma":[0.001465751,0.000154488,0.00013877462,0.0003640693,0.00031895554,0.00011966945,0.00018242163,0.00013314962,8.782558e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036955232,0.00029041964,0.991077,0.005177098,0.00089481176,0.000019916395,0.00035622917,0.0000062321924,0.00009925175,0.00012197121,0.0012863949,0.0003010967],"study_design_scores_gemma":[0.0059449137,0.00010551979,0.9470737,0.04242252,0.00043640428,0.0007731725,0.0014425085,0.00043270984,0.00014021267,0.0010475928,0.000009176964,0.00017155526],"about_ca_topic_score_codex":0.000115609604,"about_ca_topic_score_gemma":0.0000646361,"teacher_disagreement_score":0.044003315,"about_ca_system_score_codex":0.000035496632,"about_ca_system_score_gemma":0.00021367802,"threshold_uncertainty_score":0.62998384},"labels":[],"label_agreement":null},{"id":"W840384005","doi":"10.1136/annrheumdis-2015-eular.5131","title":"FRI0432 Limited Scleroderma (Crest Syndrome) is Associated with Worse Xerostomia and Xerophthalmia in Patients Being Evaluated for Primary Sjogren's Syndrome","year":2015,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Xerophthalmia; CREST Syndrome; Sicca syndrome; Internal medicine; Rheumatology; Gastroenterology; Scleroderma (fungus); Serology; Dermatology; Pathology; Connective tissue disease; Disease; Autoimmune disease; Antibody; Immunology","score_opus":0.0488913927092381,"score_gpt":0.2787788485430559,"score_spread":0.2298874558338178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W840384005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677855,0.0006759289,0.0000072294392,0.00090950925,0.00009592535,0.0010898542,0.00018427135,0.000040850417,0.00021791166],"genre_scores_gemma":[0.9986788,0.00006430678,0.000047454658,0.0006845659,0.000005157516,0.0000744968,0.00024303468,0.00003549921,0.00016666981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841183,0.00010795444,0.00042143906,0.00026359412,0.00048302073,0.00031216678],"domain_scores_gemma":[0.9985054,0.00024488277,0.00025097333,0.00038350362,0.00035779184,0.00025744946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025163684,0.0002222645,0.00056697946,0.00016631953,0.00010541068,0.000028484144,0.00013162318,0.00008114528,0.000035234676],"category_scores_gemma":[0.0010595946,0.00014605255,0.00012608347,0.00045556188,0.00013765672,0.0001635869,0.00007631204,0.00009618039,0.000004397881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010980914,0.0013364069,0.99028325,0.0003136968,0.0004182176,0.000018391893,0.00049065304,0.000065258835,0.0000014882653,0.000011272813,0.004518925,0.001444374],"study_design_scores_gemma":[0.0061758375,0.0010535036,0.98802054,0.0021925417,0.0003913516,0.000034338238,0.00021696374,0.0009372156,0.0000060659017,0.00078081473,0.000011539671,0.00017931791],"about_ca_topic_score_codex":0.00010013353,"about_ca_topic_score_gemma":0.000009016514,"teacher_disagreement_score":0.005077746,"about_ca_system_score_codex":0.000039620645,"about_ca_system_score_gemma":0.00019669211,"threshold_uncertainty_score":0.595585},"labels":[],"label_agreement":null}]}